FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Doshida, Y
   Hashimoto, S
   Iwabuchi, S
   Takino, Y
   Ishiwata, T
   Aigaki, T
   Ishigami, A
AF Doshida, Yuta
   Hashimoto, Shinichi
   Iwabuchi, Sadahiro
   Takino, Yuka
   Ishiwata, Toshiyuki
   Aigaki, Toshiro
   Ishigami, Akihito
TI Single-cell RNA sequencing to detect age-associated genes that identify
   senescent cells in the liver of aged mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID P53 TARGET GENE; SECRETORY PHENOTYPE; INHIBITION; CANCER; INFLAMMATION;
   CLEC12A; TISSUE; LONG
AB Senescent cells are predicted to occur and increase in animal tissues with aging. However, senescent cells in the tissues of aged animals remain to be identified. We refer to the marker genes to identify senescent cells in tissues as "age-associated genes". In this study, we searched for age-associated genes to identify senescent cells in the livers of aged animals. We performed single-cell RNA sequencing (scRNA-seq) to screen candidates for age-associated genes using young and aged rat primary hepatocytes. To remove animal species specificity, gene expression analyses in mouse livers were performed, confirming age-associated increases in the mRNA expression levels of Glipr1, Clec12a, and Phlda3. Moreover, the mRNA expression levels of Glipr1 and Phlda3 were increased by stress-induced premature senescence using doxorubicin in primary hepatocytes and livers of young mice. Transcriptome data of aged rat hepatocytes suggested that Glipr1, Clec12a, and Phlda3 were expressed in almost identical cells. Fluorescence in situ hybridization (FISH) confirmed the presence of cells with abundant Glipr1, Clec12a, and Phlda3 mRNA in 27-month-old mouse primary hepatocytes, which are considered to be senescent cells. This study is the first to identify Glipr1, Clec12a, and Phlda3 as age-associated genes in the mouse liver.
C1 [Doshida, Yuta; Takino, Yuka; Ishigami, Akihito] Tokyo Metropolitan Inst Geriatr & Gerontol, Mol Regulat Aging, 35-2 Sakae Cho,Itabashi Ku, Tokyo 1730015, Japan.
   [Doshida, Yuta; Aigaki, Toshiro; Ishigami, Akihito] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan.
   [Hashimoto, Shinichi; Iwabuchi, Sadahiro] Wakayama Med Univ, Inst Adv Med, Dept Mol Immunol, Wakayama 6418509, Japan.
   [Ishiwata, Toshiyuki] Tokyo Metropolitan Inst Geriatr & Gerontol, Aging & Carcinogenesis, Tokyo 1730015, Japan.
C3 Tokyo Metropolitan University; Wakayama Medical University
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Geriatr & Gerontol, Mol Regulat Aging, 35-2 Sakae Cho,Itabashi Ku, Tokyo 1730015, Japan.; Ishigami, A (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan.
EM ishigami@tmig.or.jp
RI AIGAKI, TOSHIRO/JNT-2407-2023
FU We thank Dr. Hideki Ito (Tokyo Metropolitan Institute for Geriatrics and
   Gerontology) for valuable advice and preparation of the manuscript. We
   also thank Ms. Haruka Sano for the technical support.
FX We thank Dr. Hideki Ito (Tokyo Metropolitan Institute for Geriatrics and
   Gerontology) for valuable advice and preparation of the manuscript. We
   also thank Ms. Haruka Sano for the technical support.
CR Atwood Allison A, 2011, Small GTPases, V2, P41
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Cahu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.183
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   de Keizer PLJ, 2017, TRENDS MOL MED, V23, P6, DOI 10.1016/j.molmed.2016.11.006
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032
   Goto S., 2015, AGING MECH, P3, DOI [10.1007/978-4-431-55763-0_1, DOI 10.1007/978-4-431-55763-0_1]
   Haim Y, 2017, MOL METAB, V6, P725, DOI 10.1016/j.molmet.2017.05.003
   Hashimoto S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14676-3
   Ishigami A, 2015, GERIATR GERONTOL INT, V15, P804, DOI 10.1111/ggi.12347
   Iwama M, 2012, J NUTR SCI VITAMINOL, V58, P169, DOI 10.3177/jnsv.58.169
   Johmura Y, 2021, SCIENCE, V371, P265, DOI 10.1126/science.abb5916
   Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002
   Kim JA, 2013, J BIOL CHEM, V288, P28713, DOI 10.1074/jbc.M113.488346
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li LK, 2011, CANCER RES, V71, P7694, DOI 10.1158/0008-5472.CAN-11-1714
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Neumann K, 2014, IMMUNITY, V40, P389, DOI 10.1016/j.immuni.2013.12.015
   Nitta K, 2013, KIDNEY BLOOD PRESS R, V38, P109, DOI 10.1159/000355760
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Panda S, 2008, MECH AGEING DEV, V129, P332, DOI 10.1016/j.mad.2008.02.014
   Pasillas MP, 2015, MOL CELL PROTEOMICS, V14, P1, DOI 10.1074/mcp.M114.037697
   Pyz E, 2008, EUR J IMMUNOL, V38, P1157, DOI 10.1002/eji.200738057
   Redelinghuys P, 2016, ANN RHEUM DIS, V75, P1386, DOI 10.1136/annrheumdis-2014-206644
   Ren CH, 2002, MOL CELL BIOL, V22, P3345, DOI 10.1128/MCB.22.10.3345-3357.2002
   Ren CZ, 2006, GENOMICS, V88, P163, DOI 10.1016/j.ygeno.2006.03.021
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   SASS B, 1975, J NATL CANCER I, V54, P1449, DOI 10.1093/jnci/54.6.1449
   Saul D, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-32552-1
   Segerstolpe Å, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020
   Shahmirzadi AA, 2020, CELL METAB, V32, P447, DOI 10.1016/j.cmet.2020.08.004
   Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031
   Wang XJ, 2018, FEBS J, V285, P4071, DOI 10.1111/febs.14653
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112
   Yang F, 2014, BBA-REV CANCER, V1845, P84, DOI 10.1016/j.bbcan.2013.12.002
NR 42
TC 0
Z9 0
U1 3
U2 3
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 30
PY 2023
VL 13
IS 1
AR 14186
DI 10.1038/s41598-023-41352-6
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA Q7AM6
UT WOS:001059012700069
PM 37648885
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU KROPACOVA, K
   MISUROVA, E
AF KROPACOVA, K
   MISUROVA, E
TI INFLUENCE OF AGE AND GAMMA-IRRADIATION ON THE PROLIFERATIVE ACTIVITY IN
   REGENERATING RAT-LIVER
SO PHYSIOLOGICAL RESEARCH
LA English
DT Article
DE CELL PROLIFERATION; CHROMOSOMAL ABERRATIONS; RAT LIVER; LIVER
   REGENERATION; AGE; GAMMA-IRRADIATION
AB The effect of aging (2-14 months) and total body irradiation (5.7 Gy of gamma radiation) on liver regeneration was investigated in rats 30 h after partial hepatectomy. Exposure of rats to irradiation 30 min before partial hepatectomy caused latent injury in thc remaining liver cells. During the course of liver regeneration this became manifested as a delay in increasing the nucleic acid concentration and content and liver weight and, furthermore, as inhibition of thc increase in thc mitotic index and cellularity and pronounced increase in thc frequency of chromosome aberrations in thc postmetaphase. The pattern of age-related changes during liver regeneratin was thc same as that after irradiation, so that thc differences between irradiated and nonirradiated animals became smaller with age.
RP KROPACOVA, K (corresponding author), PJ SAFARIK UNIV,DEPT CELLULAR & MOLEC BIOL,MOYZESOVA 11,CS-04167 KOSICE,CZECHOSLOVAKIA.
CR ALBERT MD, 1958, J NATL CANCER I, V20, P309
   BARBASON H, 1983, BRIT J CANCER, V47, P517, DOI 10.1038/bjc.1983.82
   BUCHER NLR, 1964, CANCER RES, V24, P509
   CANEV R. G., 1960, Biohimija, V25, P151
   CARTER DB, 1956, ACTA RADIOL, V46, P655
   CURTIS H, 1963, RADIAT RES, V19, P337, DOI 10.2307/3571455
   CURTIS HJ, 1964, RADIAT RES, V22, P730, DOI 10.2307/3571554
   FABIANOVA B, 1981, B EXP BIOL MED, V4, P490
   FABRIKANT JI, 1969, EXP CELL RES, V55, P277, DOI 10.1016/0014-4827(69)90493-5
   Gil'iano N Ia, 1977, Tsitologiia, V19, P367
   Gil'iano N Ia, 1976, Tsitologiia, V18, P1284
   GILIANO NY, 1984, TSITOLOGIYA IGENETIK, V4, P256
   GUSHCHIN VA, 1975, TSITOLOGIYA+, V17, P552
   HARPER JF, 1984, COMPUT BIOL MED, V14, P437, DOI 10.1016/0010-4825(84)90044-1
   HIGGINS GM, 1931, ARCH PATHOL, V12, P187
   KROPACHOVA K, 1988, Radiobiologiya, V28, P44
   KROPACOVA K, 1985, VOJ ZDRAV LISTY, V54, P117
   KROPACOVA K, 1980, RADIOBIOL RADIOTHER, V1, P55
   KROPACOVA K, 1981, B EXP BIOL MED, V3, P359
   KROPATCHOVA K, 1989, B EKSP BIOL MED, V6, P756
   LAJTHA LG, 1964, MEDICINE, V43, P625, DOI 10.1097/00005792-196411000-00004
   MALINOVS.OV, 1973, TSITOLOGIYA+, V15, P1048
   MISUROVA E, 1987, Radiobiologia Radiotherapia, V28, P59
   MISUROVA E, 1974, RADIOBIOL RADIOTHER, V6, P709
   OBOLENSKAYA MY, 1976, TSITOLOGIYA+, V18, P857
   SIMEK J, 1989, CS FYSIOL, V38, P199
   STEWENSON KG, 1961, RADIAT RES, V15, P774
   WHEATLEY DN, 1972, EXP CELL RES, V74, P455, DOI 10.1016/0014-4827(72)90401-6
   WITCOFSKI RL, 1974, RADIOLOGY, V110, P209, DOI 10.1148/110.1.209
   YAKOVLEV AY, 1979, TSITOLOGIYA+, V21, P1243
   ZORIN AV, 1975, TSITOLOGIYA+, V17, P783
NR 31
TC 9
Z9 9
U1 0
U2 0
PU CZECHOSLOVAK ACAD SCIENCES INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4, CZECH REPUBLIC 142 20
SN 0862-8408
J9 PHYSIOL RES
JI Physiol. Res.
PY 1992
VL 41
IS 2
BP 135
EP 140
PG 6
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA HW898
UT WOS:A1992HW89800006
PM 1283699
DA 2024-02-19
ER

PT J
AU Majeed, SK
AF Majeed, SK
TI Studies of the incidence of spontaneous pancreatic tumours in ageing CD
   rats
SO ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH
LA English
DT Article
DE pancreatic tumours, incidence in ageing rats, spontaneous; tumours,
   spontaneous pancreatic
ID ISLET CELL TUMORS; FERRET; DOGS; DIAGNOSIS
AB A survey of the incidence of spontaneous pancreatic tumours in CD rats was carried out. The survey revealed islet cell adenomas to be the most common of pancreatic tumours with a higher incidence in untreated males (11.7 % in comparison to in females 5.5 %). 9040 untreated and 24578 treated rats were included in this survey. These rats were from two year carcinogenicity studies over a 15 year period. The sex difference appeared also in the incidence of islet cell carcinoma (males 2.4 % vs females 1 %). The third type of tumour was exocrine adenoma with an incidence of 2 % in males, 0.1 % in females. The last type, which was Very rare in this strain, was exocrine carcinoma (0.08 % in males, 0.02 % in females). The tumour incidences were more in rats killed at termination than in those died or killed earlier during the study suggesting a late onset of these tumours. Exocrine carcinoma was rarest of all pancreatic tumours. In contrast to man, rat pancreatic tumours were not life threatening in rats, except for exocrine carcinoma. Pancreatic tumours are somewhat age-related as they were very rare in young rats and appeared mainly in rats over 70 weeks of age. Cystic exocrine adenoma, cystic or duct exocrine adenocarcinoma reported in man, were not seen in rats. Exocrine tumours are fatal tumours in man with very poor prognosis. Pancreatic carcinomas in rats mostly showed only local invasion. On very rare occasions they showed metastasis in to liver, lung and bone marrow. Ductal/cystic exocrine carcinoma of man showed metastasis to liver, peripancreatic lymph nodes, lymphatics, skeletal muscle and the lung. Exocrine adenocarcinoma in man was twice as common in males as in females, comparable to the general incidence of pancreatic tumours in rats. Islet cell tumours in man show no clear difference between males and females which is in contrast to rats. Both in man and in rats pancreatic tumours appear to occur in the latter half of life span.
RP Majeed, SK (corresponding author), HUNTINGDON LIFE SCI,DEPT PATHOL,POB 2,HUNTINGDON PE18 6ES,CAMBS,ENGLAND.
CR ALTHOFF J, 1976, AM J PATHOL, V83, P517
   BENIRSCHKE K, 1978, PATHOLOGY LAB ANIMAL, V1, P282
   BENIRSCHKE K, 1978, PATHOLOGY LAB ANIMAL, V2, P1148
   Boorman G. A., 1985, MONOGRAPHS PATHOLOGY, P219
   BOORMAN GA, 1990, PATHOLOGY FISCHER RA, P545
   BOORMAN GA, 1990, PATHOLOGY FISCHER RA, P95
   BUREK JD, 1978, PATHOLOGY AGING RATS, P54
   CAYWOOD DD, 1979, J AM VET MED ASSOC, V174, P714
   GOWING NFC, 1980, COLOUR ATLAS TUMOUR, P56
   HAWKINS KL, 1987, VET PATHOL, V24, P170, DOI 10.1177/030098588702400211
   HILL FWG, 1974, J SMALL ANIM PRACT, V15, P119, DOI 10.1111/j.1748-5827.1974.tb05668.x
   HIXTABLE CR, 1979, J SMALL ANIM PRACT, V20, P737
   JERGENS AE, 1989, J AM VET MED ASSOC, V194, P269
   JONES TC, 1985, MONOGRAPHS PATHOLOGY, P297
   KAUFMAN J, 1984, J AM VET MED ASSOC, V185, P998
   KRUTH SA, 1982, J AM VET MED ASSOC, V181, P54
   LEIFER CE, 1986, J AM VET MED ASSOC, V188, P60
   LEVITT MH, 1977, AM J PATHOL, V88, P1
   LUTTGEN PJ, 1986, J AM VET MED ASSOC, V189, P920
   MATTHEEUWS D, 1976, ANIM PRACT, V7, P313
   Nielsen SW, 1964, FELINE MEDICINE SURG
   POUR P, 1974, AM J PATHOL, V76, P349
   REDDY JK, 1974, J NATL CANCER I, V52, P991, DOI 10.1093/jnci/52.3.991
   ROBBINS SL, 1972, PANCREAS, P1056
   SPENCER AJ, 1986, VET PATHOL, V23, P11, DOI 10.1177/030098588602300102
   STRAFUSS AC, 1971, J AM VET MED ASSOC, V159, P1008
   TURASOV VA, 1973, IARC SCI PUBL, P141
   TURASOV VS, 1979, PATHOLOGY TUMOURS LA, V2, P235
   WILLIAMS BH, 1995, PATHOLOGY DOMESTIC F
   WILSON JW, 1974, J AM VET MED ASSOC, V164, P603
   WRIGHT GP, 1966, SYSTEMIC PATHOLOGY, V1, P689
NR 31
TC 6
Z9 6
U1 0
U2 2
PU ECV-EDITIO CANTOR VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI AULENDORF
PA BANDELSTOCKWEG 20, POSTFACH 1255, D-88322 AULENDORF, GERMANY
SN 0004-4172
J9 ARZNEIMITTEL-FORSCH
JI Arzneimittelforschung
PD JUL
PY 1997
VL 47
IS 7
BP 879
EP 884
PG 6
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Chemistry
GA XM502
UT WOS:A1997XM50200018
PM 9272249
DA 2024-02-19
ER

PT J
AU Bondarenko, TI
   Sorokina, IA
   Mayboroda, EA
   Durkanaeva, OA
   Kutilin, DS
   Mikhaleva, II
AF Bondarenko, T. I.
   Sorokina, I. A.
   Mayboroda, E. A.
   Durkanaeva, O. A.
   Kutilin, D. S.
   Mikhaleva, I. I.
TI Effect of Delta Sleep-Inducing Peptide on Oxidative Modification of
   Proteins in Rat Tissues and Blood during Physiological Aging
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE delta sleep-inducing peptide; aging; oxidative modification of proteins
AB Accumulation of oxidized proteins (evaluated by the levels of carbonyl and SH groups) in tissues of 2-24-month-old rats (spleen > myocardium > testicles > liver > skeletal muscles) has been demonstrated. Exogenous delta sleep-inducing peptide injected subcutaneously to rats of different age in a dose of 100 mu g/kg by monthly 5-day courses protected proteins of the studied tissues from oxidation; its effect was tissue-specific. Delta sleep-inducing peptide exhibited a hypoglycemic effect: it prevented nonenzymatic glycosylation of hemoglobin and reduced the level of defective protein molecules during aging.
C1 [Bondarenko, T. I.; Sorokina, I. A.; Mayboroda, E. A.; Durkanaeva, O. A.; Kutilin, D. S.] So Fed Univ, Rostov Na Donu, Russia.
   [Mikhaleva, I. I.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Organ Bioche, Moscow, Russia.
C3 Southern Federal University; Russian Academy of Sciences; Pushchino
   Scientific Center for Biological Research (PSCBI) of the Russian Academy
   of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of
   Sciences
RP Bondarenko, TI (corresponding author), So Fed Univ, Rostov Na Donu, Russia.
EM tomabon@yandex.ru
RI Kutilin, Denis/T-4603-2019; Kutilin, Denis/L-6795-2016
OI Kutilin, Denis/0000-0002-8942-3733
CR Anisimov, 2008, MOL PHYSIOLOGICAL ME
   Bondarenko T. I., 2010, VOPR BIOL MED FARM K, P38
   Dubinina E. E., 1995, Voprosy Meditsinskoi Khimii, V41, P24
   Facchini FS, 2000, FREE RADICAL BIO MED, V29, P1302, DOI 10.1016/S0891-5849(00)00438-X
   GRAF M, 1981, EXPERIENTIA, V37, P625
   [Хавинсон В.Х. Khavinson V. Kh.], 2009, [Успехи геронтологии, Uspekhi gerontologii], V22, P11
   Lushchak VI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P809, DOI 10.1134/S0006297907080020
   Mikhaleva I. I, 2007, NOVYE LEKARSTV PREPA, P6
   [Москалёв А.А. Moskalev A.A.], 2010, [Успехи геронтологии, Uspekhi gerontologii], V23, P9
   Muravleva L.Ye., 2010, FUNDAM ISSLED, P74
   Popovich IG, 2003, MECH AGEING DEV, V124, P721, DOI 10.1016/S0047-6374(03)00082-4
   Pushkina N. V., 1976, IZV SEV KAV NAUCH EN, P95
   RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9
   Ryzhak G. A., 2004, GEROPROTECTORS PREVE
   SCHACTERLE GR, 1973, ANAL BIOCHEM, V51, P654, DOI 10.1016/0003-2697(73)90523-X
   Tereshina E. V., 2005, MANUAL GERONTOLOGY
NR 16
TC 1
Z9 3
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4888
EI 1573-8221
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD JUL
PY 2012
VL 153
IS 3
BP 371
EP 374
DI 10.1007/s10517-012-1719-3
PG 4
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 991OG
UT WOS:000307710400022
PM 22866315
DA 2024-02-19
ER

PT J
AU Fukuwatari, T
   Wada, H
   Shibata, K
AF Fukuwatari, Tsutomu
   Wada, Hideko
   Shibata, Katsumi
TI Age-Related Alterations of B-Group Vitamin Contents in Urine, Blood and
   Liver from Rats
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE aging; vitamin B-2; vitamin B-6; folate; biomarker
ID TRYPTOPHAN-NICOTINAMIDE; 4-PYRIDOXIC ACID; METABOLITES; DETERMINANTS;
   DEFICIENCY; SERUM; DIET; FOOD
AB To investigate how aging alters B-group vitamin metabolism, rats were fed with niacin-free 20% casein diet from 3 to 80 wk old, and the urinary excretions of the B group vitamins were periodically measured. The blood and liver B-group vitamin levels in 80-wk-old rats were also compared with those in 8-wk-old rats. The urinary excretion of thiamin, riboflavin, vitamin B-6 metabolite 4-pyridoxic acid. pantothenic acid, folic acid and biotin were not altered during 540 d. The urinary vitamin B-12 increased by 8-fold at 29 wk old, and further increased at 80 wk old. Conversion of nicotinamide from tryptophan gradually decreased to 60% from 29 to 48 wk old. Plasma PLP vitamin B-12 and folate levels in 80-wk-old rats were lower than those in 8-wk-old rats, consistent with lower liver vitamin B-6 and folate levels in aged rats. Plasma and liver biotin levels in aged rats were higher than those in young rats. Other B-group vitamins Such as vitamin B-1, vitamin B-2, niacin and pantothenic acid levels in blood and liver from aged rats were same as those from young rats. Alteration of vitamin B-6 metabolism in particular is similar to the observations in eldery humans reported previously. Our findings Suggest that aged rats can be useful models to investigate aging-related B-group vitamin metabolism.
C1 [Fukuwatari, Tsutomu; Wada, Hideko; Shibata, Katsumi] Univ Shiga Prefecture, Dept Food Sci & Nutr, Sch Human Cultures, Hikone, Shiga 5228533, Japan.
C3 University Shiga Prefecture
RP Fukuwatari, T (corresponding author), Univ Shiga Prefecture, Dept Food Sci & Nutr, Sch Human Cultures, 2500 Hassaka, Hikone, Shiga 5228533, Japan.
EM fukkie@shc.usp.ac.jp
FU Ministry of Health, Labor and Welfare
FX This report is a part of the studies on the Japanese Dietary Reference
   Intakes (Principle investigator, Katsumi Shibata) and the investigation
   was supported by a grant from the Ministry of Health, Labor and Welfare
   (Comprehensive Research on Cardiovascular Diseases).
CR Aiso K, 1998, J NUTR SCI VITAMINOL, V44, P361, DOI 10.3177/jnsv.44.361
   Allen R H, 1975, Prog Hematol, V9, P57
   *ASS OFF AN CHEM, 2000, OFF METH AN
   BAKER EM, 1964, AM J CLIN NUTR, V15, P59, DOI 10.1093/ajcn/15.2.59
   Birn H, 2002, AM J PHYSIOL-RENAL, V282, pF408, DOI 10.1152/ajprenal.00206.2000
   Birn H, 2006, AM J PHYSIOL-RENAL, V291, pF22, DOI 10.1152/ajprenal.00385.2005
   BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201
   *CLEA JAP INC, 2006, BOD WEIGHT CURV JCL
   Food and Nutrition Board, 1998, DIETARY REFERENCE IN
   FUKUI T, 1994, J NUTR SCI VITAMINOL, V40, P491, DOI 10.3177/jnsv.40.491
   Fukuwatari T, 2004, J FOOD HYG SOC JPN, V45, P231, DOI 10.3358/shokueishi.45.231
   Gallus S, 2004, EUR J CANCER PREV, V13, P447, DOI 10.1097/00008469-200410000-00013
   GREGORY JF, 1979, AM J CLIN NUTR, V32, P879, DOI 10.1093/ajcn/32.4.879
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hatanaka E, 2006, FREE RADICAL BIO MED, V41, P1124, DOI 10.1016/j.freeradbiomed.2006.06.014
   KANT AK, 1988, AM J CLIN NUTR, V48, P1284, DOI 10.1093/ajcn/48.5.1284
   Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481
   Kimura N, 2003, J NUTR SCI VITAMINOL, V49, P149, DOI 10.3177/jnsv.49.149
   LINDENBAUM J, 1994, AM J CLIN NUTR, V60, P2, DOI 10.1093/ajcn/60.1.2
   Ministry of Healthy Labour and Welfare Japan, 2005, DIET REF INT JAP
   MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I
   OHKAWA H, 1983, J BIOL CHEM, V258, P5623
   PULLMAN ME, 1954, J BIOL CHEM, V206, P121
   Reeves PG, 1997, J NUTR, V127, pS838
   Refsum H, 2006, J NUTR, V136, p1731S, DOI 10.1093/jn/136.6.1731S
   RIBAYAMERCADO JD, 1991, J NUTR, V121, P1062, DOI 10.1093/jn/121.7.1062
   Rybak ME, 2004, ANAL BIOCHEM, V333, P336, DOI 10.1016/j.ab.2004.06.036
   SAID HM, 1990, EXP GERONTOL, V25, P67, DOI 10.1016/0531-5565(90)90011-P
   SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693
   SHIBATA K, 1995, BIOSCI BIOTECH BIOCH, V59, P2060, DOI 10.1271/bbb.59.2060
   SHIBATA K, 1988, J CHROMATOGR-BIOMED, V424, P23, DOI 10.1016/S0378-4347(00)81072-5
   SHIBATA K, 1989, AGR BIOL CHEM TOKYO, V53, P1333, DOI 10.1080/00021369.1989.10869481
   SHIBATA K, 1992, BIOSCI BIOTECH BIOCH, V56, P1104, DOI 10.1271/bbb.56.1104
   Shibata K, 1982, VITAMINS, V56, P469
   Shibata K, 1986, NUTR INT, V2, P177
   Shibata Katsumi, 1994, Vitamins (Kyoto), V68, P365
   Skeggs HR, 1944, J BIOL CHEM, V156, P21
   van Asselt DZB, 1998, AM J CLIN NUTR, V68, P328, DOI 10.1093/ajcn/68.2.328
   Wada Hideko, 2006, Vitamins (Kyoto), V80, P125
   Watanabe F, 1999, J AGR FOOD CHEM, V47, P4736, DOI 10.1021/jf990541b
   Watanabe T, 1998, J AM COLL NUTR, V17, P48, DOI 10.1080/07315724.1998.10720454
NR 41
TC 21
Z9 22
U1 0
U2 6
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
EI 1881-7742
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PD OCT
PY 2008
VL 54
IS 5
BP 357
EP 362
DI 10.3177/jnsv.54.357
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 367PZ
UT WOS:000260565600004
PM 19001766
OA gold
DA 2024-02-19
ER

PT J
AU Hsu, CY
   Qiu, JT
   Chan, YP
AF Hsu, Chin-Yuan
   Qiu, Jiantai Timothy
   Chan, Yu-Pei
TI Cellular degradation activity is maintained during aging in long-living
   queen bees
SO BIOGERONTOLOGY
LA English
DT Article
DE Aging; Degradation; Autophagy; Longevity; Queens
ID CHAPERONE-MEDIATED AUTOPHAGY; HONEYBEES APIS-MELLIFERA; MITOCHONDRIAL
   ENERGY-UTILIZATION; PROTEASOME ACTIVITY; FAT-CELLS; RAT-LIVER; LYSOSOMAL
   ACTIVITY; WORKER HONEYBEES; LIFE-SPAN; OXIDATIVE STRESS
AB Queen honeybees (Apis mellifera) have a much longer lifespan than worker bees. Whether cellular degradation activity is involved in the longevity of queen bees is unknown. In the present study, cellular degradation activity was evaluated in the trophocytes and oenocytes of young and old queen bees. The results indicated that (i) 20S proteasome activity and the size of autophagic vacuoles decreased with aging, and (ii) there were no significant differences between young and old queen bees with regard to 20S proteasome expression or efficiency, polyubiquitin aggregate expression, microtubule-associated protein 1 light chain 3-II (LC3-II) expression, 70 kDa heat shock cognate protein (Hsc70) expression, the density of autophagic vacuoles, p62/SQSTM1 expression, the activity or density of lysosomes, or molecular target of rapamycin expression. These results indicate that cellular degradation activity maintains a youthful status in the trophocytes and oenocytes of queen bees during aging and that cellular degradation activity is involved in maintaining the longevity of queen bees.
C1 [Hsu, Chin-Yuan; Qiu, Jiantai Timothy] Chang Gung Univ, Dept Biomed Sci, Coll Med, 259 Wen Hwa 1st Rd, Taoyuan 333, Taiwan.
   [Hsu, Chin-Yuan; Qiu, Jiantai Timothy; Chan, Yu-Pei] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan.
   [Hsu, Chin-Yuan; Qiu, Jiantai Timothy] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Linkou, Taiwan.
C3 Chang Gung University; Chang Gung University; Chang Gung Memorial
   Hospital
RP Hsu, CY (corresponding author), Chang Gung Univ, Dept Biomed Sci, Coll Med, 259 Wen Hwa 1st Rd, Taoyuan 333, Taiwan.
EM hsu@mail.cgu.edu.tw
RI Timothy, Qiu J./AAV-3086-2020
OI Meir, Yaa-Jyuhn/0000-0001-6084-3446; Qiu, JT/0000-0001-7090-6906
FU Chang Gung Memorial Hospital, Linkou, Taiwan [CMRPD1C0081, CMRPD180353,
   CMRPD190631, CRRPG 3D0051, CMRPD1E0021, CMRPD1E0381, CMRPD1E0 022]
FX This work was supported by Grants (CMRPD1C0081, CMRPD180353,
   CMRPD190631, CRRPG 3D0051, CMRPD1E0021, CMRPD1E0381, and CMRPD1E0 022)
   from Chang Gung Memorial Hospital, Linkou, Taiwan.
CR Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07
   Beedholm R, 2004, CELL STRESS CHAPERON, V9, P49, DOI 10.1379/1466-1268(2004)009<0049:MHSSSP>2.0.CO;2
   Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002
   Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663
   Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200
   Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4
   Caramés B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305
   Carrard G, 2003, INT J BIOCHEM CELL B, V35, P728, DOI 10.1016/S1357-2725(02)00356-4
   Chan QWT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024794
   Chuang YL, 2013, AGE, V35, P1867, DOI 10.1007/s11357-012-9490-y
   Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552
   CRISTOFALO VJ, 1975, MECH AGEING DEV, V4, P19, DOI 10.1016/0047-6374(75)90004-4
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x
   Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9
   Cui J, 2012, AGE, V34, P329, DOI 10.1007/s11357-011-9237-1
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518
   DEPRIESTER W, 1984, MECH AGEING DEV, V26, P205, DOI 10.1016/0047-6374(84)90094-0
   Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje
   Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A
   Hansen TO, 2012, BIOGERONTOLOGY, V13, P429, DOI 10.1007/s10522-012-9387-2
   Hsieh YS, 2013, REJUV RES, V16, P295, DOI 10.1089/rej.2013.1420
   Hsieh YS, 2011, APIDOLOGIE, V42, P728, DOI 10.1007/s13592-011-0085-x
   Hsieh YS, 2011, EXP GERONTOL, V46, P233, DOI 10.1016/j.exger.2010.10.007
   Hsu CY, 2015, APIDOLOGIE, V46, P583, DOI 10.1007/s13592-015-0348-z
   Hsu CY, 2014, BIOGERONTOLOGY, V15, P389, DOI 10.1007/s10522-014-9509-0
   Hsu CY, 2014, BIOGERONTOLOGY, V15, P129, DOI 10.1007/s10522-013-9485-9
   Hsu CY, 2014, EXP GERONTOL, V50, P128, DOI 10.1016/j.exger.2013.12.003
   Hsu CY, 2013, AGE, V35, P149, DOI 10.1007/s11357-011-9344-z
   Husom AD, 2004, ARCH BIOCHEM BIOPHYS, V421, P67, DOI 10.1016/j.abb.2003.10.010
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1
   Lu CY, 2015, AGE, V37, DOI 10.1007/s11357-015-9775-z
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239
   Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013
   Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005
   McMullen CA, 2009, EXP GERONTOL, V44, P420, DOI 10.1016/j.exger.2009.03.006
   Morse RA, 1990, ENCY PERTAINING SCI, P387
   Nilsen KA, 2011, J EXP BIOL, V214, P1488, DOI 10.1242/jeb.050393
   OHTSUKA H, 1995, J GERONTOL A-BIOL, V50, pB277, DOI 10.1093/gerona/50A.5.B277
   Omholt Stig W, 2004, Sci Aging Knowledge Environ, V2004, ppe28, DOI 10.1126/sageke.2004.26.pe28
   Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220
   Ponnappan U, 1999, CELL IMMUNOL, V192, P167, DOI 10.1006/cimm.1998.1418
   Remolina SC, 2008, AGE, V30, P177, DOI 10.1007/s11357-008-9061-4
   Rueppell O, 2007, EXP GERONTOL, V42, P1020, DOI 10.1016/j.exger.2007.06.002
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490
   Sitte N, 2000, FASEB J, V14, P2503, DOI 10.1096/fj.00-0210com
   Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947
   VANMANEN R, 1983, MECH AGEING DEV, V22, P159, DOI 10.1016/0047-6374(83)90109-4
   Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016
   Verdugo ME, 1997, EXP EYE RES, V65, P231, DOI 10.1006/exer.1997.0325
   Viteri G, 2004, ARCH BIOCHEM BIOPHYS, V427, P197, DOI 10.1016/j.abb.2004.05.006
   Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006
   Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007
   Yoon J, 2010, MOL CELL BIOCHEM, V340, P175, DOI 10.1007/s11010-010-0415-8
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhuo L, 2009, MECH AGEING DEV, V130, P700, DOI 10.1016/j.mad.2009.08.005
NR 64
TC 8
Z9 8
U1 1
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD NOV
PY 2016
VL 17
IS 5-6
BP 829
EP 840
DI 10.1007/s10522-016-9652-x
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA EA1VX
UT WOS:000386381300004
PM 27230748
DA 2024-02-19
ER

PT J
AU Vaidya, H
   Jeong, HS
   Keith, K
   Maegawa, S
   Calendo, G
   Madzo, J
   Jelinek, J
   Issa, JPJ
AF Vaidya, Himani
   Jeong, Hye Seon
   Keith, Kelsey
   Maegawa, Shinji
   Calendo, Gennaro
   Madzo, Jozef
   Jelinek, Jaroslav
   Issa, Jean-Pierre J.
TI DNA methylation entropy as a measure of stem cell replication and aging
SO GENOME BIOLOGY
LA English
DT Article
DE DNA methylation; Aging; Stem cell; Cell division; Epigenetic clock
ID AGE; TWINS
AB Background: Epigenetic marks are encoded by DNA methylation and accumulate errors as organisms age. This drift correlates with lifespan, but the biology of how this occurs is still unexplained. We analyze DNA methylation with age in mouse intestinal stem cells and compare them to nonstem cells.
   Results: Age-related changes in DNA methylation are identical in stem and nonstem cells, affect most prominently CpG islands and correlate weakly with gene expression. Age-related DNA methylation entropy, measured by the Jensen-Shannon Distribution, affects up to 25% of the detectable CpG sites and is a better measure of aging than individual CpG methylation. We analyze this entropy as a function of age in seven other tissues (heart, kidney, skeletal muscle, lung, liver, spleen, and blood) and it correlates strikingly with tissue-specific stem cell division rates. Thus, DNA methylation drift and increased entropy with age are primarily caused by and are sensors for, stem cell replication in adult tissues.
   Conclusions: These data have implications for the mechanisms of tissue-specific functional declines with aging and for the development of DNA-methylation-based biological clocks.
C1 [Vaidya, Himani; Jeong, Hye Seon; Keith, Kelsey; Calendo, Gennaro; Madzo, Jozef; Jelinek, Jaroslav; Issa, Jean-Pierre J.] Coriell Inst Med Res, Camden, NJ 08013 USA.
   [Jeong, Hye Seon] Chungnam Natl Univ Hosp, Dept Neurol, Daejeon, South Korea.
   [Maegawa, Shinji] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX USA.
C3 Coriell Institute for Medical Research; Chungnam National University;
   Chungnam National University Hospital; University of Texas System; UTMD
   Anderson Cancer Center
RP Issa, JPJ (corresponding author), Coriell Inst Med Res, Camden, NJ 08013 USA.
EM jpissa@coriell.org
RI Calendo, Gennaro/KBA-0187-2024; Madzo, Jozef/IUP-6059-2023
OI Vaidya, Himani/0000-0002-2779-3069; Issa,
   Jean-Pierre/0000-0003-2258-5030; Keith, Kelsey/0000-0002-7451-5117
CR Aran D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01027-z
   Bell CG, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1824-y
   Bell CG, 2009, GENOME MED, V1, DOI 10.1186/gm56
   Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877
   Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003
   Christiansen L, 2016, AGING CELL, V15, P149, DOI 10.1111/acel.12421
   Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x
   Gehart H, 2019, NAT REV GASTRO HEPAT, V16, P19, DOI 10.1038/s41575-018-0081-y
   Gross AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142618
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Issa JP, 2014, J CLIN INVEST, V124, P24, DOI 10.1172/JCI69735
   Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0
   ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536
   Jenkinson G, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2086-5
   Jenkinson G, 2017, NAT GENET, V49, P719, DOI 10.1038/ng.3811
   Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442
   Li S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0472-5
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maegawa S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00607-3
   Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109
   Marioni RE, 2019, J GERONTOL A-BIOL, V74, P57, DOI 10.1093/gerona/gly060
   Pal S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600584
   Panjarian S, 2021, BREAST CANCER RES, V23, DOI 10.1186/s13058-021-01434-7
   Pirazzini C, 2012, AGING-US, V4, P509, DOI 10.18632/aging.100476
   Roos L, 2014, EPIGENOMICS-UK, V6, P299, DOI [10.2217/EPI.14.13, 10.2217/epi.14.13]
   Shibata D, 2009, J PATHOL, V217, P199, DOI 10.1002/path.2461
   Sun XW, 2018, BIOINFORMATICS, V34, P2715, DOI 10.1093/bioinformatics/bty174
   Thompson MJ, 2017, AGING-US, V9, P1055, DOI 10.18632/aging.101211
   Wang HQ, 2011, BIOINFORMATICS, V27, P225, DOI 10.1093/bioinformatics/btq650
   Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24
   Zhang ZY, 2002, MECH AGEING DEV, V123, P1257, DOI 10.1016/S0047-6374(02)00014-3
NR 33
TC 4
Z9 4
U1 6
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PD FEB 16
PY 2023
VL 24
IS 1
AR 27
DI 10.1186/s13059-023-02866-4
PG 18
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 9E6JS
UT WOS:000936890100001
PM 36797759
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Bajotto, G
   Murakami, T
   Nagasaki, M
   Sato, Y
   Shimomura, Y
AF Bajotto, Gustavo
   Murakami, Taro
   Nagasaki, Masaru
   Sato, Yuzo
   Shimomura, Yoshiharu
TI Decreased enzyme activity and contents of hepatic branched-chain α-keto
   acid dehydrogenase complex subunits in a rat model for type 2 diabetes
   mellitus
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
ID SKELETAL-MUSCLE; PROTEIN-METABOLISM; AMINO-ACIDS; ACTIVITY STATE;
   POSTNATAL-DEVELOPMENT; INSULIN-RESISTANCE; STARVED RATS; FATTY RAT;
   LIVER; CATABOLISM
AB The mitochondrial branched-chain a-keto acid dehydrogenase complex (BCKDC) is responsible for the committed step in branched-chain amino acid catabolism. In the present study, we examined BCKDC regulation in Otsuka Long-Evans Tokushima Fatty (OLETF) rats both before (8 weeks of age) and after (25 weeks of age) the onset of type 2 diabetes mellitus. Long-Evans Tokushima Otsuka (LETO) rats Were used as controls. Plasma branched-chain amino acid and branched-chain a-keto acid concentrations were significantly increased in young and middle-aged OLETF rats. Although the hepatic complex was nearly 100% active in all animals, total BCKDC activity and protein abundance of E1 alpha, E1 beta, and E2 Subunits were markedly lower in OLETF than in LETO rats at 8 and 25 weeks of age. In addition, hepatic BCKDC activity and protein amounts were significantly decreased in LETO rats aged 25 weeks than in LETO rats aged 8 weeks. In skeletal Muscle, E1 beta and E2 proteins were significantly reduced, whereas Eta tended to increase in OLETF rats. Taken together, these results Suggest that (1) whole-body branched-chain a-keto acid oxidation capacity is extremely reduced in OLETF rats independently of diabetes development, (2) the aging process decreases BCKDC activity and protein abundance in the fiver of normal rats, and (3) differential postranscriptional regulation for the subunits of BCKDC may exist in skeletal Muscle. (c) 2009 Elsevier Inc. All rights reserved.
C1 [Bajotto, Gustavo; Shimomura, Yoshiharu] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan.
   [Bajotto, Gustavo; Nagasaki, Masaru; Sato, Yuzo] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Dept Hlth Sci, Nisshin 4700195, Japan.
   [Murakami, Taro] Chukyo Womens Univ, Fac Wellness, Dept Nutr, Obu 4748651, Japan.
C3 Nagoya University; Aichi Gakuin University
RP Shimomura, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan.
EM shimo@agr.nagoya-u.ac.jp
OI Murakami, Taro/0000-0002-5367-2658
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   [20300216, 11670066]; Ministry of Health, Labour, and Welfare of Japan
   [H13-009]; Grants-in-Aid for Scientific Research [11670066, 20300216]
   Funding Source: KAKEN
FX This work was supported in part by Grants-in-Aid for Scientific Research
   (20300216 to Y Shimomura and 11670066 to Y Sato) from the Ministry of
   Education, Culture, Sports, Science, and Technology of Japan and a
   Longevity Science Research Grant (H13-009 to Y Sato) from the Ministry
   of Health, Labour, and Welfare of Japan. Authors acknowledge Dr Kazuya
   Kawano (Otsuka Pharmaceutical) for providing the animals used in this
   study.
CR AFTRING RP, 1988, AM J PHYSIOL, V254, pE292, DOI 10.1152/ajpendo.1988.254.3.E292
   Bajotto G, 2006, METABOLISM, V55, P317, DOI 10.1016/j.metabol.2005.09.014
   Bajotto G, 2004, LIFE SCI, V75, P2117, DOI 10.1016/j.lfs.2004.04.016
   Beckett PR, 1996, ANAL BIOCHEM, V240, P48, DOI 10.1006/abio.1996.0329
   Beckett PR, 2000, METHOD ENZYMOL, V324, P40
   BEGGS M, 1988, BIOCHEM J, V256, P929, DOI 10.1042/bj2560929
   BRANDT H, 1975, J BIOL CHEM, V250, P8038
   GIBSON R, 1993, ARCH BIOCHEM BIOPHYS, V306, P22, DOI 10.1006/abbi.1993.1475
   GILLIM SE, 1983, BIOCHEM BIOPH RES CO, V111, P74, DOI 10.1016/S0006-291X(83)80119-3
   Giroix MH, 1999, DIABETOLOGIA, V42, P965
   GOODWIN GW, 1987, ANAL BIOCHEM, V162, P536, DOI 10.1016/0003-2697(87)90430-1
   Gougeon R, 2008, DIABETES CARE, V31, P128, DOI 10.2337/dc07-1268
   GROGAN CK, 1988, BIOL NEONATE, V54, P224, DOI 10.1159/000242856
   HARRIS RA, 1989, ANN NY ACAD SCI, V573, P306, DOI 10.1111/j.1749-6632.1989.tb15007.x
   Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007
   Harris RA, 2001, J NUTR, V131, p841S, DOI 10.1093/jn/131.3.841S
   HARRIS RA, 1985, ARCH BIOCHEM BIOPHYS, V243, P542, DOI 10.1016/0003-9861(85)90531-4
   Honda T, 2004, J HEPATOL, V40, P439, DOI 10.1016/j.jhep.2003.11.003
   HUTSON SM, 1989, ANN NY ACAD SCI, V573, P230, DOI 10.1111/j.1749-6632.1989.tb15000.x
   Ichikawa M, 2000, J NUTR, V130, P2562, DOI 10.1093/jn/130.10.2562
   KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422
   Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S
   Kobayashi R, 1997, BIOCHEM J, V327, P449, DOI 10.1042/bj3270449
   Kobayashi R, 2002, ARCH BIOCHEM BIOPHYS, V407, P231, DOI 10.1016/S0003-9861(02)00472-1
   Kuzuya T, 2008, BIOCHEM BIOPH RES CO, V373, P94, DOI 10.1016/j.bbrc.2008.05.167
   Li ZH, 2001, J NUTR SCI VITAMINOL, V47, P345, DOI 10.3177/jnsv.47.345
   Lombardo YB, 1998, P ASSOC AM PHYSICIAN, V110, P40
   Lombardo YB, 1999, AM J PHYSIOL-ENDOC M, V277, pE685, DOI 10.1152/ajpendo.1999.277.4.E685
   MARLISS EB, 1982, DIABETOLOGIA, V22, P225, DOI 10.1007/BF00281296
   MAY ME, 1980, AM J PHYSIOL, V239, pE215, DOI 10.1152/ajpendo.1980.239.3.E215
   Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132
   Mitsubuchi H, 2005, J NUTR, V135, p1565S, DOI 10.1093/jn/135.6.1565S
   Mukakami T, 2005, J NUTR SCI VITAMINOL, V51, P48, DOI 10.3177/jnsv.51.48
   Nakai N, 2000, METHOD ENZYMOL, V324, P48
   PAIN VM, 1983, AM J PHYSIOL, V245, pE604, DOI 10.1152/ajpendo.1983.245.6.E604
   PATSTON PA, 1984, BIOCHEM J, V222, P711, DOI 10.1042/bj2220711
   Pereira S, 2008, DIABETES, V57, P56, DOI 10.2337/db07-0887
   RANDLE PJ, 1985, DIABETOLOGIA, V28, P479, DOI 10.1007/BF00281981
   Rodriguez T, 1998, INT J MOL MED, V1, P971
   Rodriguez T, 1997, BIOCHEM MOL MED, V61, P87, DOI 10.1006/bmme.1997.2585
   SAMBROOK J, 1989, PRODUCTION ANTIBODIE
   Serdikoff C, 2001, J NUTR, V131, P1682, DOI 10.1093/jn/131.6.1682
   She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007
   Shimomura Y, 2004, HEPATOL RES, V30, pS3, DOI 10.1016/j.hepres.2004.09.001
   SOLOMON M, 1987, BIOCHIM BIOPHYS ACTA, V931, P335, DOI 10.1016/0167-4889(87)90224-2
   STERNICZUK A, 1991, CELL BIOCHEM FUNCT, V9, P13, DOI 10.1002/cbf.290090104
   Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72
   VEERKAMP JH, 1987, INT J BIOCHEM, V19, P205, DOI 10.1016/0020-711X(87)90334-X
   Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI 10.1139/Y04-067
   Xu M, 2000, BIOCHEM BIOPH RES CO, V276, P1080, DOI 10.1006/bbrc.2000.3566
   ZHAO Y, 1994, ARCH BIOCHEM BIOPHYS, V308, P446, DOI 10.1006/abbi.1994.1063
   ZHAO Y, 1993, BIOCHEM J, V290, P395, DOI 10.1042/bj2900395
NR 52
TC 19
Z9 21
U1 3
U2 10
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 1532-8600
J9 METABOLISM
JI Metab.-Clin. Exp.
PD OCT
PY 2009
VL 58
IS 10
BP 1489
EP 1495
DI 10.1016/j.metabol.2009.04.029
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 500TF
UT WOS:000270327100019
PM 19586643
DA 2024-02-19
ER

PT J
AU Li, N
   Li, J
   Hao, JY
   Zhang, M
   Yin, JJ
   Geng, JT
   Wu, T
   Lyv, XL
AF Li, Na
   Li, Jing
   Hao, Junyu
   Zhang, Min
   Yin, Jinjin
   Geng, Jieting
   Wu, Tao
   Lyv, Xiaoling
TI Bilberry anthocyanin improves the serum cholesterol in aging
   perimenopausal rats <i>via</i> the estrogen receptor signaling pathway
SO FOOD & FUNCTION
LA English
DT Article
ID HORMONE-THERAPY; WOMEN; ADIPOCYTES; RASPBERRY; ALPHA
AB With aging, there is an increasing risk for women to develop perimenopause syndrome, which is harmful to women's physical and mental health. The present study investigated the health benefits of bilberry anthocyanin (BA) on aging perimenopausal Sprague-Dawley rats. Rats that entered into perimenopause through natural aging were treated for 8 weeks with BA, and received either a low dose (LD, 35 mg per kg of bodyweight), medium dose (MD, 70 mg per kg of bodyweight), or high dose (HD, 140 mg per kg of bodyweight). The experimental results suggested that all three dosages of BA, especially the high dose, significantly reduced the serum total cholesterol (TC), triglyceride (TG) and low density lipoprotein cholesterol (LDL-C) levels. In addition, BA supplementation markedly reduced the serum malondialdehyde (MDA), effectively increased the activity of hepatic total superoxide dismutase (T-SOD), significantly raised the high density lipoprotein cholesterol (HDL-C), increased the number of estrogen receptors, and effectively up-regulated the expression levels of G protein-coupled receptor 30 (GPR30), protein kinase B (AKT), and extracellular regulated protein kinase 2 (ERK2). In summary, BA has a great effect on improving the serum cholesterol in natural aging perimenopausal rats via the estrogen receptor signaling pathway, and it may be used as a dietary supplement for perimenopause women to decrease the risk of cardiovascular disease.
C1 [Li, Na; Li, Jing; Hao, Junyu; Zhang, Min; Yin, Jinjin; Wu, Tao; Lyv, Xiaoling] Tianjin Univ Sci & Technol, State Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
   [Geng, Jieting] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, Konan 4-5-7, Tokyo 1088477, Japan.
   [Wu, Tao] Beijing Technol & Business Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.
C3 Tianjin University Science & Technology; Tokyo University of Marine
   Science & Technology; Beijing Technology & Business University
RP Wu, T; Lyv, XL (corresponding author), Tianjin Univ Sci & Technol, State Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.; Wu, T (corresponding author), Beijing Technol & Business Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.
EM wutaoxx@gmail.com; lxling@tust.edu.cn
RI ; Wu, Tao/E-7769-2011
OI Li, Jing/0000-0002-6896-3474; Wu, Tao/0000-0002-0629-8421; GENG,
   Jieting/0000-0002-6497-9815
FU Natural Science Foundation of Tianjin [18JCQNJC0600]; Tianjin Science
   and Technology Fund Planning Project [18ZYPTJC00020]; Tianjin One Belt
   and One Road Technological Innovation Project [18PTZWHZ00080]; National
   Natural Science Foundation of China [31501475]
FX This work was supported by Natural Science Foundation of Tianjin
   [18JCQNJC0600], Tianjin Science and Technology Fund Planning Project
   [18ZYPTJC00020], Tianjin One Belt and One Road Technological Innovation
   Project [18PTZWHZ00080] and National Natural Science Foundation of China
   [31501475].
CR Armeni E, 2017, MATURITAS, V104, P54, DOI 10.1016/j.maturitas.2017.07.010
   Basu P, 2018, BIOMED PHARMACOTHER, V107, P1648, DOI 10.1016/j.biopha.2018.08.100
   Bertotto LB, 2019, SCI TOTAL ENVIRON, V651, P2424, DOI 10.1016/j.scitotenv.2018.10.079
   Brinton R. D., 2018, NEUROBIOL AGING, V74, P213
   Chockchaisawasdee S, 2016, TRENDS FOOD SCI TECH, V55, P72, DOI 10.1016/j.tifs.2016.07.002
   Corrêa TAF, 2019, NUTRITION, V59, P150, DOI 10.1016/j.nut.2018.08.010
   de Pascual-Teresa S, 2014, ARCH BIOCHEM BIOPHYS, V559, P68, DOI 10.1016/j.abb.2014.04.012
   Fortini F, 2019, J STEROID BIOCHEM, V189, P87, DOI 10.1016/j.jsbmb.2019.02.008
   Fraile-Bermúdez AB, 2017, EXP GERONTOL, V92, P46, DOI 10.1016/j.exger.2017.03.012
   Fu ZN, 2018, SAUDI J BIOL SCI, V25, P487, DOI 10.1016/j.sjbs.2017.08.009
   Gogola J, 2019, CHEMOSPHERE, V217, P100, DOI 10.1016/j.chemosphere.2018.11.018
   Gordon J, 2019, PSYCHONEUROENDOCRINO, V100, pS42, DOI 10.1016/j.psyneuen.2018.12.145
   Gulei D, 2018, MOL THER-NUCL ACIDS, V12, P787, DOI 10.1016/j.omtn.2018.07.013
   Hairi HA, 2019, CURR DRUG TARGETS, V20, P192, DOI 10.2174/1389450118666170816123740
   Hilton HN, 2018, MOL CELL ENDOCRINOL, V466, P2, DOI 10.1016/j.mce.2017.08.011
   Kasote DM, 2019, FOOD CHEM, V290, P56, DOI 10.1016/j.foodchem.2019.03.109
   Lee H, 2019, J FUNCT FOODS, V54, P433, DOI 10.1016/j.jff.2019.01.045
   Li J, 2019, FOOD FUNCT, V10, P333, DOI 10.1039/c8fo01962b
   Lindh-Åstrand L, 2019, MATURITAS, V123, P55, DOI 10.1016/j.maturitas.2019.02.009
   Ma L, 2018, SCI TOTAL ENVIRON, V640, P529, DOI 10.1016/j.scitotenv.2018.05.301
   Popovic D, 2019, CHEM-BIOL INTERACT, V304, P61, DOI 10.1016/j.cbi.2019.02.022
   Rozenberg S, 2013, NAT REV ENDOCRINOL, V9, P216, DOI 10.1038/nrendo.2013.17
   Sanz-Buenhombre M., 2016, FOOD RES INT, V88, P284
   Shi C, 2012, BBA-GEN SUBJECTS, V1820, P453, DOI 10.1016/j.bbagen.2011.12.005
   Spencer L. E., 2017, SCI HORTIC, V224, P332
   Tucakovic L, 2018, J FUNCT FOODS, V45, P173, DOI 10.1016/j.jff.2018.03.042
   Vercellini P, 2018, BEST PRACT RES CL OB, V51, P151, DOI 10.1016/j.bpobgyn.2018.01.017
   Wang YS, 2018, AM J TRANSL RES, V10, P114
   Wen Y., 2018, CHEMOSPHERE, V220, P362
   Willi J, 2019, J AFFECT DISORDERS, V249, P216, DOI 10.1016/j.jad.2019.02.029
   Wimalawansa SJ, 2018, J STEROID BIOCHEM, V175, P29, DOI 10.1016/j.jsbmb.2016.12.016
   Zhang JF, 2018, MATURITAS, V111, P77, DOI 10.1016/j.maturitas.2018.01.019
   Zhang QZ, 2019, J FUNCT FOODS, V54, P175, DOI 10.1016/j.jff.2019.01.016
NR 33
TC 7
Z9 9
U1 0
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD JUN 1
PY 2019
VL 10
IS 6
BP 3430
EP 3438
DI 10.1039/c9fo00639g
PG 9
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA IK4BD
UT WOS:000476531200034
PM 31134999
DA 2024-02-19
ER

PT J
AU Nasi, M
   Pinti, M
   De Biasi, S
   Gibellini, L
   Ferraro, D
   Mussini, C
   Cossarizza, A
AF Nasi, Milena
   Pinti, Marcello
   De Biasi, Sara
   Gibellini, Lara
   Ferraro, Diana
   Mussini, Cristina
   Cossarizza, Andrea
TI Aging with HIV infection: A journey to the center of inflammAIDS,
   immunosenescence and neuroHIV
SO IMMUNOLOGY LETTERS
LA English
DT Article
DE Aging; HIV; AIDS; Inflammation; Immune activation; Neurocognitive
   impairment
ID SYSTEMIC IMMUNE ACTIVATION; MICROBIAL TRANSLOCATION; NEUROCOGNITIVE
   DISORDERS; MITOCHONDRIAL-DNA; BRAIN; DEMENTIA; CELLS; CENTENARIANS;
   INDIVIDUALS; REPLICATION
AB In the last years, a significant improvement in life expectancy of HIV+ patients has been observed in Western countries. The parallel increase in the mean age of these patients causes a parallel increase in the frequency of non-AIDS related complications (i.e., neurocognitive, cardiovascular, liver and kidney diseases, metabolic syndrome, osteoporosis, non-HIV associated cancers, among others), even when antiviral treatment is successful. Immune activation and persistent inflammation characterizes both HIV infection and physiological aging, and both conditions share common detrimental pathways that lead to early immunosenescence. Furthermore, HIV-associated neurocognitive disorders represent important consequences of the infection. The persistent systemic immune activation, the continuous migration of activated monocytes to the central nervous system and progressive patients' aging contribute to develop neuronal injuries, that are in turn linked to HIV-associated neurocognitive disorders, which can persist despite successful antiretroviral treatment. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Nasi, Milena; De Biasi, Sara; Gibellini, Lara; Mussini, Cristina; Cossarizza, Andrea] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, I-41125 Modena, Italy.
   [Pinti, Marcello] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy.
   [Ferraro, Diana] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurosci, Modena, Italy.
   [Mussini, Cristina] Azienda Osped Univ Policlin Modena, Infect Dis Clin, Modena, Italy.
C3 Universita di Modena e Reggio Emilia; Universita di Modena e Reggio
   Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e
   Reggio Emilia; Universita di Modena e Reggio Emilia Hospital
RP Cossarizza, A (corresponding author), Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, Via Campi 287, I-41125 Modena, Italy.
EM andrea.cossarizza@unimore.it
RI Mussini, Cristina/K-8672-2016; De Biasi, Sara/AAB-7520-2019; Nasi,
   Milena/J-4425-2016; Ferraro, Diana/H-9512-2014; Pinti,
   Marcello/C-9351-2015; Leung, Wing Yin/HLW-3074-2023
OI Mussini, Cristina/0000-0002-6615-4198; De Biasi,
   Sara/0000-0002-3217-9821; Nasi, Milena/0000-0003-3079-8001; Ferraro,
   Diana/0000-0003-4818-3806; Pinti, Marcello/0000-0001-9118-1262;
   Cossarizza, Andrea/0000-0002-5381-1558
CR Achim CL, 2009, J NEUROIMMUNE PHARM, V4, P190, DOI 10.1007/s11481-009-9152-8
   Ances BM, 2010, NEUROLOGY, V75, P111, DOI 10.1212/WNL.0b013e3181e7b66e
   Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516
   Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037
   Anthony IC, 2006, ACTA NEUROPATHOL, V111, P529, DOI 10.1007/s00401-006-0037-0
   Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529
   Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b
   Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276
   Bart J, 2000, CANCER TREAT REV, V26, P449, DOI 10.1053/ctrv.2000.0194
   Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511
   Brenchley JM, 2008, CURR OPIN HIV AIDS, V3, P356, DOI 10.1097/COH.0b013e3282f9ae9c
   Brew BJ, 2010, CLIN INFECT DIS, V50, P930, DOI 10.1086/650744
   Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758
   Ciccarelli N, 2012, J AM GERIATR SOC, V60, P2048, DOI 10.1111/j.1532-5415.2012.04213.x
   Clifford DB, 2009, NEUROLOGY, V73, P1982, DOI 10.1212/WNL.0b013e3181c5b445
   Cossarizza A, 2011, MITOCHONDRION, V11, P750, DOI 10.1016/j.mito.2011.06.005
   De Biasi A., 2011, J. Exp. Clin. Med, V3, P143, DOI [10.1016/j.jecm.2011.06.001, DOI 10.1016/J.JECM.2011.06.001, DOI 10.1016/j.jecm.2011.06.001]
   de Souza RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087454
   Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001
   Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262
   Deeks Steven G, 2009, Top HIV Med, V17, P118
   Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4
   Desplats P, 2013, NEUROLOGY, V80, P1415, DOI 10.1212/WNL.0b013e31828c2e9e
   Douek Daniel C, 2013, Top Antivir Med, V21, P128
   Edén A, 2007, J INFECT DIS, V196, P1779, DOI 10.1086/523648
   Effros RB, 2009, HDB IMMUNOSENESCENCE, P949
   Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150
   Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040
   Ernst T, 2004, AIDS, V18, pS61, DOI 10.1097/00002030-200401001-00009
   Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29
   Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052
   Ettenhofer ML, 2009, AM J GERIAT PSYCHIAT, V17, P281, DOI 10.1097/JGP.0b013e31819431bd
   Fabbiani M, 2013, HIV MED, V14, P136, DOI 10.1111/j.1468-1293.2012.01044.x
   Franceschi C, 1996, NEPHROL DIAL TRANSPL, V11, P18
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Gannon P, 2011, CURR OPIN NEUROL, V24, P275, DOI 10.1097/WCO.0b013e32834695fb
   Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28
   Gisslén M, 2007, J INFECT DIS, V195, P1774, DOI 10.1086/518043
   Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016
   Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005
   Guaraldi G, 2014, JAIDS-J ACQ IMM DEF, V65, P175, DOI 10.1097/QAI.0000000000000018
   Hardy DJ, 2009, NEUROPSYCHOL REV, V19, P263, DOI 10.1007/s11065-009-9087-0
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Jahanshad N, 2012, BRAIN CONNECT, V2, P335, DOI 10.1089/brain.2012.0105-Rev
   Jamilloux Y, 2013, GLIA, V61, P539, DOI 10.1002/glia.22454
   Khanlou N, 2009, J NEUROVIROL, V15, P131, DOI 10.1080/13550280802578075
   Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38
   Klatt NR, 2013, J CLIN INVEST, V123, P903, DOI 10.1172/JCI66227
   Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001
   Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12
   Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501
   Nasi M, 2006, AGING CELL, V5, P167, DOI 10.1111/j.1474-9726.2006.00204.x
   Nasi M, 2014, IMMUNOL LETT
   Nguyen N, 2008, CLIN INTERV AGING, V3, P453
   Orenstein JM, 2007, ULTRASTRUCT PATHOL, V31, P151, DOI 10.1080/01913120701344343
   Pinti M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.47
   Pinti M, 2010, CURR PHARM DESIGN, V16, P597, DOI 10.2174/138161210790883705
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Ranasinghe C, 2014, IMMUNOL LETT, V161, P204, DOI 10.1016/j.imlet.2014.01.006
   Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644
   Sacktor N, 2007, J NEUROVIROL, V13, P203, DOI 10.1080/13550280701258423
   Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848
   Sebastián C, 2005, IMMUNOBIOLOGY, V210, P121, DOI 10.1016/j.imbio.2005.05.006
   Sinha B, 2014, IMMUNOPHARM IMMUNOT, V36, P89, DOI 10.3109/08923973.2014.890217
   Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154
   Streit WJ, 2002, E SCHERING RES FDN W, V39, P11
   Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D
   Valcour Victor, 2011, Curr HIV/AIDS Rep, V8, P54, DOI 10.1007/s11904-010-0070-4
   Valcour Victor G, 2013, Top Antivir Med, V21, P119
   Vehmas A, 2004, J NEUROIMMUNOL, V157, P99, DOI 10.1016/j.jneuroim.2004.08.035
   Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638
   Xu JQ, 2009, J NEUROIMMUNE PHARM, V4, P200, DOI 10.1007/s11481-008-9136-0
   Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010
NR 73
TC 43
Z9 52
U1 0
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0165-2478
EI 1879-0542
J9 IMMUNOL LETT
JI Immunol. Lett.
PD NOV
PY 2014
VL 162
IS 1
SI SI
BP 329
EP 333
DI 10.1016/j.imlet.2014.06.012
PN B
PG 5
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA AY7QI
UT WOS:000347753800009
PM 24996041
DA 2024-02-19
ER

PT J
AU Li, XT
   Zhang, YK
   Kuang, HX
   Jin, FX
   Liu, DW
   Gao, MB
   Liu, Z
   Xin, XJ
AF Li, Xing-Tai
   Zhang, Ya-Kui
   Kuang, Hai-Xue
   Jin, Feng-Xin
   Liu, De-Wen
   Gao, Ming-Bo
   Liu, Ze
   Xin, Xiao-Juan
TI Mitochondrial Protection and Anti-aging Activity of <i>Astragalus</i>
   Polysaccharides and Their Potential Mechanism
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Astragalus polysaccharides; mitochondria; anti-aging; antioxidant;
   reactive oxygen species; mitochondrial permeability transition
ID PERMEABILITY TRANSITION PORE; RAT-HEART MITOCHONDRIA; FREE-RADICAL
   THEORY; LIPID-PEROXIDATION; OXIDATIVE DAMAGE; ANTIOXIDANT ACTIVITIES;
   ALPHA-TOCOPHEROL; CYTOCHROME-C; IN-VITRO; MEMBRANACEUS
AB The current study was performed to investigate mitochondrial protection and anti-aging activity of Astragalus polysaccharides (APS) and the potential underlying mechanism. Lipid peroxidation of liver and brain mitochondria was induced by Fe2+-Vit C in vitro. Thiobarbituric acid (TBA) colorimetry was used to measure the content of thiobarbituric acid reactive substances (TBARS). Mouse liver mitochondrial permeability transition (PT) was induced by calcium overload in vitro and spectrophotometry was used to measure it. The scavenging activities of APS on superoxide anion (O-2(center dot-)) and hydroxyl radical (center dot OH), which were produced by reduced nicotinamide adenine dinucleotide (NADH)-N-Methylphenazonium methyl sulfate (PMS) and hydrogen peroxide (H2O2)-Fe2+ system respectively, were measured by 4-nitrobluetetrazolium chloride (NBT) reduction and Fenton reaction colorimetry respectively. The Na2S2O3 titration method was used to measure the scavenging activities of APS on H2O2. APS could inhibit TBARS production, protect mitochondria from PT, and scavenge O-2(center dot-), center dot OH and H2O2 significantly in a concentration-dependent manner respectively. The back of the neck of mice was injected subcutaneously with D-galactose to induce aging at a dose of 100 mg/kg/d for seven weeks. Moreover, the activities of catalase (CAT), surperoxide dismutase (SOD) and glutathione peroxidase (GPx) and anti-hydroxyl radical which were assayed by using commercial monitoring kits were increased significantly in vivo by APS. According to this research, APS protects mitochondria by scavenging reactive oxygen species (ROS), inhibiting mitochondrial PT and increasing the activities of antioxidases. Therefore, APS has the effect of promoting health.
C1 [Li, Xing-Tai; Gao, Ming-Bo; Liu, Ze] Dalian Nationalities Univ, Coll Life Sci, Dalian 116600, Peoples R China.
   [Zhang, Ya-Kui; Jin, Feng-Xin; Liu, De-Wen; Xin, Xiao-Juan] Daxinganling Acad Agr & Forestry Sci, Jiagedaqi 165000, Peoples R China.
   [Kuang, Hai-Xue] Heilongjiang Univ Tradit Chinese Med, Coll Pharm, Harbin 150040, Peoples R China.
C3 Dalian Minzu University; Heilongjiang University of Chinese Medicine
RP Li, XT (corresponding author), Dalian Nationalities Univ, Coll Life Sci, 18 Liaohe W Rd, Dalian 116600, Peoples R China.
EM xtli@dlnu.edu.cn; zhangyk02@yahoo.com.cn; hxkuang@hotmail.com;
   lksjfx@126.com; ldwen817@yahoo.com.cn; lily@dlnu.edu.cn;
   liuze@dlnu.edu.cn; xinxiaojuan323@163.com
FU Fundamental Research Funds for the Central Universities in China
   [C10030105]; Post-doctoral Research Station of Daxing'anling Beiqishen
   Green Industry Group, Doctoral Research Center of Heilongjiang
   University of Traditional Chinese Medicine [LRB10-316]; Dalian
   Nationalities University [20116126]
FX This work was supported by the Fundamental Research Funds for the
   Central Universities in China (grant number: C10030105); the
   Post-doctoral Research Station of Daxing'anling Beiqishen Green Industry
   Group, Doctoral Research Center of Heilongjiang University of
   Traditional Chinese Medicine (No.LRB10-316); and the Talents Project of
   Dalian Nationalities University (No. 20116126).
CR Aardt M.V., 2005, J DAIRY SCI, V88, P872
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Armstrong JS, 2006, MITOCHONDRION, V6, P225, DOI 10.1016/j.mito.2006.07.006
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chen GT, 2007, J SCI FOOD AGR, V87, P357, DOI 10.1002/jsfa.2744
   Chen RF, 2011, AM J CHINESE MED, V39, P879, DOI 10.1142/S0192415X11009275
   Cheng XD, 2004, ACTA BIOCH BIOPH SIN, V36, P211, DOI 10.1093/abbs/36.3.211
   Chitra S, 2008, Indian J Med Sci, V62, P141
   Cho WCS, 2007, CANCER LETT, V252, P43, DOI 10.1016/j.canlet.2006.12.001
   Cuddihy SL, 2008, J BIOL CHEM, V283, P6915, DOI 10.1074/jbc.M702572200
   Datta H.S., 2011, EVID-BASED COMPL ALT, V2011
   Datta HS, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep015
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Faist V, 1998, PFLUG ARCH EUR J PHY, V437, P168, DOI 10.1007/s004240050764
   Fink B. D., 2005, AM J PHYSIOL-ENDOC M, V288, P71
   Gustafsson ÅB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005
   Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   He LH, 2000, J BIOL CHEM, V275, P12175, DOI 10.1074/jbc.275.16.12175
   HONG CY, 1994, AM J CHINESE MED, V22, P63, DOI 10.1142/S0192415X94000085
   HRUSZKEWYCZ AM, 1992, MUTAT RES, V275, P243, DOI 10.1016/0921-8734(92)90028-N
   KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884
   Ko JKS, 2009, CYTOKINE, V47, P85, DOI 10.1016/j.cyto.2009.05.014
   Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619
   Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x
   Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896
   Li SG, 2009, CARBOHYD POLYM, V78, P343, DOI 10.1016/j.carbpol.2009.04.013
   Lin Z., 2011, EVID-BASED COMPL ALT, V2011
   Luo ZG, 2009, PHYTOTHER RES, V23, P761, DOI 10.1002/ptr.2575
   Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x
   Mandal S., 2011, EVID-BASED COMPL ALT, V2011
   Mao XQ, 2009, PHYTOMEDICINE, V16, P416, DOI 10.1016/j.phymed.2008.12.011
   Musalmah M, 2005, LIPIDS, V40, P575, DOI 10.1007/s11745-005-1418-9
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Ohnishi ST, 2006, EVID-BASED COMPL ALT, V3, P475, DOI 10.1093/ecam/nel032
   Paradies G, 1997, FEBS LETT, V406, P136, DOI 10.1016/S0014-5793(97)00264-0
   PETRONILLI V, 1993, J BIOL CHEM, V268, P21939
   Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065
   Spiteller G, 2001, EXP GERONTOL, V36, P1425, DOI 10.1016/S0531-5565(01)00131-0
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Valls V, 2005, PROCESS BIOCHEM, V40, P903, DOI 10.1016/j.procbio.2004.02.025
   Viña J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194
   Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200
   Wang PC, 2003, MECH AGEING DEV, V124, P1025, DOI 10.1016/j.mad.2003.08.005
   Yin XL, 2010, BIOCHEM BIOPH RES CO, V397, P232, DOI 10.1016/j.bbrc.2010.05.090
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
   Yusuf MA, 2007, TRANSGENIC RES, V16, P109, DOI 10.1007/s11248-006-9028-0
   Zhang LJ, 2011, J AGR FOOD CHEM, V59, P1131, DOI 10.1021/jf103610j
   Zhao GR, 2006, FOOD CHEM, V99, P767, DOI 10.1016/j.foodchem.2005.09.002
   ZHENG XY, 2005, PHARMACOPOEIA PEOPLE, V1, P212
NR 57
TC 93
Z9 115
U1 4
U2 91
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB
PY 2012
VL 13
IS 2
BP 1747
EP 1761
DI 10.3390/ijms13021747
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 898DM
UT WOS:000300715700032
PM 22408421
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU PFLEIDERER, B
   XU, P
   ACKERMAN, JL
   GARRIDO, L
AF PFLEIDERER, B
   XU, P
   ACKERMAN, JL
   GARRIDO, L
TI STUDY OF AGING OF SILICONE-RUBBER BIOMATERIALS WITH NMR
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID SI-29 NMR; NETWORKS; MODEL; POLYDIMETHYLSILOXANE; IMPLANTS
AB Multinuclear nuclear magnetic resonance (NMR) spectroscopy (Si-29, C-13, H-1) is used to characterize the aging process of silicone rubber-based biomaterials in a rat model. H-1 NMR relaxation measurements (spin-lattice, T-1, and spin-spin, T-2, relaxation times) were performed to better understand the molecular dynamics of polysiloxane chains in implants. After 1 year of implantation in animals, changes in the H-1 T-2 relaxation times and the NMR spectra were observed in polydimethylsiloxane, Silastic(R) sheets and chin implants, while these measurements remain unchanged in finger joints. Very small amounts of fat were detected in all types of silicone rubber implants at the end of the implantation period. This work shows that free silicone migrates from the implants to adjacent tissues and distant sites, such as spleen or liver, and is chemically modified. (C) 1995 John Wiley and Sons, Inc.
C1 MASSACHUSETTS GEN HOSP,NMR CTR,DEPT RADIOL,BIOMAT LAB,BOSTON,MA 02129.
   HARVARD UNIV,SCH MED,BOSTON,MA 02129.
   UNIV CINCINNATI,DEPT CHEM,CINCINNATI,OH 45221.
C3 Harvard University; Massachusetts General Hospital; Harvard University;
   Harvard Medical School; University System of Ohio; University of
   Cincinnati
RI Garrido, Leoncio -/K-3092-2014; Ackerman, Jerome L./E-2646-2015
OI Garrido, Leoncio -/0000-0002-7587-1260; Ackerman, Jerome
   L./0000-0001-5176-7496
CR ALLWORK SP, 1976, THORAX, V31, P742, DOI 10.1136/thx.31.6.742
   [Anonymous], 1991, ANAL CHEM SILICONES
   BESHAH K, 1986, J POLYM SCI POL PHYS, V24, P1207, DOI 10.1002/polb.1986.090240602
   BRALEY S, 1970, J MACROMOL SCI CHEM, VA  4, P529, DOI 10.1080/00222337008074361
   CARMEN R, 1968, Journal of Biomedical Materials Research, V2, P457, DOI 10.1002/jbm.820020406
   CELLA JA, 1980, J ORGANOMET CHEM, V186, P13, DOI 10.1016/S0022-328X(00)93813-0
   CHAN S, 1973, J BIOMED MATER RES, V7, P485, DOI 10.1002/jbm.820070510
   CHIN H, 1971, CIRCULATION, V43, P151
   CHIN HP, 1971, CIRCULATION S1, V44, P151
   COHENADDAD JP, 1982, J CHEM PHYS, V76, P2744, DOI 10.1063/1.443260
   COHENADDAD JP, 1987, MACROMOLECULES, V20, P2146, DOI 10.1021/ma00175a017
   COHENADDAD JP, 1978, J CHEM PHYS, V68, P1194, DOI 10.1063/1.435810
   Colemman B., 1983, NMR NEWLY ACCESSIBLE, P197
   DOLEZEL B, 1980, BIOMATERILAS, V10, P387
   FOLLAND R, 1977, RADIAT PHYS CHEM, V10, P61, DOI 10.1016/0146-5724(77)90059-0
   FOLLAND R, 1978, J POLYM SCI POL PHYS, V16, P1041, DOI 10.1002/pol.1978.180160611
   GARRIDO L, 1993, MAGNET RESON MED, V29, P839, DOI 10.1002/mrm.1910290620
   GARRIDO L, 1994, MAGNET RESON MED, V31, P328, DOI 10.1002/mrm.1910310314
   GEBELEIN CG, 1987, POLYM SCI TECHNOLOGY, V35
   HARTMAN LC, 1988, J BIOMED MATER RES, V22, P475, DOI 10.1002/jbm.820220604
   MARK JE, 1982, ADV POLYM SCI, V44, P1
   NYILAS E, 1970, Journal of Biomedical Materials Research, V4, P369, DOI 10.1002/jbm.820040308
   PFLEIDERER B, 1995, MAGNET RESON MED, V33, P8, DOI 10.1002/mrm.1910330103
   PFLEIDERER B, 1993, MAGNET RESON MED, V30, P534, DOI 10.1002/mrm.1910300503
   PFLEIDERER B, 1991, POLYM PREP-ACS, V33, P767
   PICHA GJ, 1991, PLAST RECONSTR SURG, V87, P490, DOI 10.1097/00006534-199103000-00017
   PIERCE WS, 1983, J BIOMED MATER RES, V17, P389, DOI 10.1002/jbm.820170215
   QUESLEL JP, 1987, ENCY PHYSICAL SCI TE, V12, P385
   SWANSON JW, 1975, POLYM SCI TECHNOL, V7, P197
   THOMSEN JL, 1990, PLAST RECONSTR SURG, V85, P38, DOI 10.1097/00006534-199001000-00007
   TRUONG LD, 1988, AM J SURG PATHOL, V12, P484, DOI 10.1097/00000478-198806000-00009
   VANNOORT R, 1979, J MATER SCI, V14, P197, DOI 10.1007/BF01028344
   VANNOORT R, 1981, BIOCOMPATIBILITY CLI, P79
   WASSERBAUER R, 1987, PLASTY KAUCUK, V24, P169
   WILLIAMS JM, 1986, MAT RES SOC S P, V55
   WINDING O, 1984, SCAND J PLAST RECONS, V18, P311
NR 36
TC 25
Z9 29
U1 1
U2 14
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1995
VL 29
IS 9
BP 1129
EP 1140
DI 10.1002/jbm.820290913
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Materials Science
GA RR477
UT WOS:A1995RR47700012
PM 8567711
DA 2024-02-19
ER

PT S
AU Genova, ML
   Pich, MM
   Bernacchia, A
   Bianchi, C
   Biondi, A
   Bovina, C
   Falasca, AI
   Formiggini, G
   Castelli, GP
   Lenaz, G
AF Genova, ML
   Pich, MM
   Bernacchia, A
   Bianchi, C
   Biondi, A
   Bovina, C
   Falasca, AI
   Formiggini, G
   Castelli, GP
   Lenaz, G
BE Lee, HK
   DiMauro, S
   Tanaka, M
   Wei, YH
TI The mitochondrial production of reactive oxygen species in relation to
   aging and pathology
SO MITOCHONDRIAL PATHOGENESIS: FROM GENES AND APOPTOSIS TO AGING AND
   DISEASE
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 1st Scientific Meeting of the
   Asian-Society-for-Mitochondrial-Research-and-Medicine
CY FEB 05-06, 2003
CL Seoul, SOUTH KOREA
SP Asian Soc Mitochondrial Res & Med, Bukwang Pharmaceut, Dalim Pharmaceut, Mitocon Inc
DE mitochondria; oxidative stress; bioenergetic defects; aging; complex I;
   superoxide; coenzyme Q
ID COMPLEX-I; OXIDATIVE STRESS; COENZYME-Q; PLASMA-MEMBRANE; SUPEROXIDE
   RADICALS; LIVER-MITOCHONDRIA; ELECTRON-TRANSPORT; DNA; PHOSPHORYLATION;
   OXIDOREDUCTASE
AB Mitochondria are known to be strong producers of reactive oxygen species (ROS) and, at the same time, particularly susceptible to the oxidative damage produced by their action on lipids, proteins, and DNA. In particular, damage to mtDNA induces alterations to the polypeptides encoded by mtDNA in the respiratory complexes, with consequent decrease of electron transfer, leading to further production of ROS and thus establishing a vicious circle of oxidative stress and energetic decline. This deficiency in mitochondrial energetic capacity is considered the cause of aging and age-related degenerative diseases. Complex I would be the enzyme most affected by ROS, since it contains seven of the 13 subunits encoded by mtDNA. Accordingly, we found that complex I activity is significantly affected by aging in rat brain and liver mitochondria as well as in human platelets. Moreover, due to its rate control over aerobic respiration, such alterations are reflected on the entire oxidative phosphorylation system We also investigated the role of mitochondrial complex I in superoxide production anti found that the one-electron donor to oxygen is most probably the Fe-S cluster N2. Short chain coenzyme Q (CoQ) analogues enhance ROS formation, presumably by mediating electron transfer from N2 to oxygen, both in bovine heart SMP and in cultured HL60 cells. Nevertheless, we have accumulated much evidence of the antioxidant role of reduced CoQ(10) in several cellular systems and demonstrated the importance of DT diaphorase and other internal cellular reductases to reduce exogenous CoQ(10) after incorporation.
C1 Univ Bologna, Dipartimento Biochim G Moruzzi, I-40126 Bologna, Italy.
   Univ Parma, Dipartimento Sci Farmacol Biol & Chim Applicate, I-43100 Parma, Italy.
C3 University of Bologna; University of Parma
RP Lenaz, G (corresponding author), Univ Bologna, Dipartimento Biochim G Moruzzi, Via Irnerio 48, I-40126 Bologna, Italy.
EM lenaz@biocfarm.unibo.it
RI Genova, Maria Luisa/H-6921-2012; Lenaz, Giorgio/B-5751-2013
OI Genova, Maria Luisa/0000-0002-9176-3630; 
CR AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barogi S, 2000, MECH AGEING DEV, V113, P1, DOI 10.1016/S0047-6374(99)00089-5
   Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188
   BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202
   Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138
   Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528
   BEYER RE, 1990, HIGHLIGHTS IN UBIQUINONE RESEARCH, P191
   Biagini G, 1998, MECH AGEING DEV, V101, P269, DOI 10.1016/S0047-6374(97)00181-4
   Bianchi NO, 2001, MUTAT RES-REV MUTAT, V488, P9, DOI 10.1016/S1383-5742(00)00063-6
   BINDOLI A, 1990, BIOCHIM BIOPHYS ACTA, V1016, P349, DOI 10.1016/0005-2728(90)90168-4
   BOVERIS A, 1984, METHOD ENZYMOL, V105, P429
   Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7
   BRANDT U, 1998, BIOCHIM BIOPHYS ACTA, V1364, P285
   BROWN MD, 1992, GENETICS, V130, P163
   Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2
   Cavazzoni M, 1999, FEBS LETT, V449, P53, DOI 10.1016/S0014-5793(99)00400-7
   D'Aurelio M, 2001, MECH AGEING DEV, V122, P823, DOI 10.1016/S0047-6374(01)00239-1
   DiMauro S., 1993, Mitochondrial DNA in Human Pathology
   DIPLOCK AT, 1994, MOL ASPECTS MED, V15, P293, DOI 10.1016/0098-2997(94)90005-1
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   ERNSTER L, 1993, ACTIVE OXYGENS, LIPID PEROXIDES, AND ANTIOXIDANTS, P1
   Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2
   Esposti MD, 1996, ARCH BIOCHEM BIOPHYS, V330, P395, DOI 10.1006/abbi.1996.0267
   ESPOSTI MD, 1994, FEBS LETT, V352, P375, DOI 10.1016/0014-5793(94)00971-6
   FATO R, 1993, BIOCHEM J, V290, P225, DOI 10.1042/bj2900225
   Genova Maria Luisa, 2003, Ital J Biochem, V52, P58
   Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2
   Genova ML, 1997, FEBS LETT, V410, P467
   Genova MW, 2003, EXP BIOL MED, V228, P506, DOI 10.1177/15353702-0322805-14
   GILLIS JC, 1994, DRUG AGING, V5, P133, DOI 10.2165/00002512-199405020-00007
   GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8
   GREEN DE, 1966, COMPREHENSIVE BIOCH, P309
   HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010
   HANSEN M, 1964, BIOCHIM BIOPHYS ACTA, V81, P214, DOI 10.1016/0926-6569(64)90036-7
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   JAESCHKE H, 1991, CHEM-BIOL INTERACT, V79, P115, DOI 10.1016/0009-2797(91)90077-K
   Kacser H, 1979, BIOCHEM SOC T, V7, P1149, DOI 10.1042/bst0071149
   Kamp DW, 2002, MOL CELL BIOCHEM, V234, P153, DOI 10.1023/A:1015949118495
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   Lenaz G, 1998, BBA-BIOENERGETICS, V1364, P207, DOI 10.1016/S0005-2728(98)00028-0
   Lenaz G, 2002, BIOCHEM BIOPH RES CO, V290, P1589, DOI 10.1006/bbrc.2002.6392
   Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957
   Lenaz G, 2001, FEBS LETT, V509, P151, DOI 10.1016/S0014-5793(01)03172-6
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   Lenaz G, 1999, ACTA BIOCHIM POL, V46, P1
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Low PA, 1997, DIABETES, V46, pS38, DOI 10.2337/diab.46.2.S38
   Mashima R, 2001, CURR OPIN LIPIDOL, V12, P411, DOI 10.1097/00041433-200108000-00007
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mitchell P., 1968, Chemiosmotic coupling and energy transduction
   Navarro F, 1998, FASEB J, V12, P1665, DOI 10.1096/fasebj.12.15.1665
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   Paschen SA, 2001, IUBMB LIFE, V52, P101, DOI 10.1080/15216540152845894
   Pich MM, 2002, FREE RADICAL RES, V36, P429, DOI 10.1080/10715760290021289
   Pich MM, 1996, FEBS LETT, V380, P176, DOI 10.1016/0014-5793(96)00037-3
   RICEEVANS CA, 1993, FREE RADICAL BIO MED, V15, P77, DOI 10.1016/0891-5849(93)90127-G
   RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O
   Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Schägger H, 2001, J BIOL CHEM, V276, P37861
   SCHON EA, 1996, CELLULAR AGING CELL, P19
   Staniek K, 2000, BBA-BIOENERGETICS, V1460, P268, DOI 10.1016/S0005-2728(00)00152-3
   TAKAHASHI T, 1995, BIOCHEM J, V309, P883, DOI 10.1042/bj3090883
   TAYLOR DE, 1995, ARCH BIOCHEM BIOPHYS, V316, P70, DOI 10.1006/abbi.1995.1011
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   VILLALBA JM, 1995, P NATL ACAD SCI USA, V92, P4887, DOI 10.1073/pnas.92.11.4887
   Vinogradov AD, 2001, IUBMB LIFE, V52, P129, DOI 10.1080/15216540152845920
   Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1
   Yano T, 2001, J BIOENERG BIOMEMBR, V33, P213, DOI 10.1023/A:1010782903144
NR 72
TC 186
Z9 221
U1 0
U2 14
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-491-9; 1-57331-490-0
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1011
BP 86
EP 100
DI 10.1196/annals.1293.010
PG 15
WC Biochemistry & Molecular Biology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA BAE70
UT WOS:000221896100010
PM 15126287
DA 2024-02-19
ER

PT J
AU Majaw, T
   Sharma, R
AF Majaw, T.
   Sharma, R.
TI Long-term dietary restriction up-regulates activity and expression of
   renal arginase II in aging mice
SO JOURNAL OF BIOSCIENCES
LA English
DT Article
DE Aging; arginase II; dietary restriction; kidney; mice
ID CALORIC RESTRICTION; ARGININE METABOLISM; LIFE-SPAN; PROTEIN-SYNTHESIS;
   ENZYME-ACTIVITIES; KIDNEY; RAT; LIVER; AGE; LOCALIZATION
AB Arginase II is a mitochondrial enzyme that catalyses the hydrolysis of L-arginine into urea and ornithine. It is present in other extra-hepatic tissues that lack urea cycle. Therefore, it is plausible that arginase II has a physiological role other than urea cycle which includes polyamine, proline, glutamate synthesis and regulation of nitric oxide production. The high expression of arginase II in kidney, among extrahepatic tissues, might have an important role associated with kidney functions. The present study is aimed to determine the age-associated alteration in the activity and expression of arginase II in the kidney of mice of different ages. The effect of dietary restriction to modulate the age-dependent changes of arginase II was also studied. Results showed that renal arginase II activity declines significantly with the progression of age (p<0.01 and p<0.001 in 6-and 18-month-old mice, respectively as compared to 2-month old mice) and is due to the reduction in its protein as well as the mRNA level (p<0.001 in both 6-and 18-month-old mice as compared to 2-month-old mice). Long-term dietary restriction for three months has significantly up-regulated arginase II activity and expression level in both 2-and 18-month-old mice (p<0.01 and p<0.001, respectively as compared to AL group). These findings clearly indicate that the reducing level of arginase II during aging might have an impact on the declining renal functions. This age-dependent down-regulation of arginase II in the kidney can be attenuated by dietary restriction which may help in the maintenance of such functions.
C1 [Majaw, T.; Sharma, R.] North Eastern Hill Univ, Dept Biochem, Shillong 793022, Meghalayn, India.
C3 North Eastern Hill University
RP Sharma, R (corresponding author), North Eastern Hill Univ, Dept Biochem, Shillong 793022, Meghalayn, India.
EM sharamesh@gmail.com
FU Council of Scientific and Industrial Research (CSIR), New Delhi
   [09/347(0194)/2010-EMR-I]
FX We express our appreciation to the Department of Biochemistry,
   North-Eastern Hill University, Shillong, for assisting with the research
   facilities under UGC-UPE, SAP and DST-FIST, New Delhi. TM thanks the
   Council of Scientific and Industrial Research (CSIR), New Delhi, for the
   financial support as JRF and SRF (F.No: 09/347(0194)/2010-EMR-I).
CR Ahmad Abdullah Shafique, 2016, J Neurol Neurosci, V7
   Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476
   Bankir L, 1996, KIDNEY INT, V49, P1598, DOI 10.1038/ki.1996.232
   Bédard K, 2013, NEUROENDOCRINOLOGY, V97, P146, DOI 10.1159/000338411
   Belik J, 2008, AM J PHYSIOL-LUNG C, V294, pL498, DOI 10.1152/ajplung.00242.2007
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cederbaum SD, 2004, MOL GENET METAB, V81, pS38, DOI 10.1016/j.ymgme.2003.10.012
   Choi S, 2012, ACTA HISTOCHEM, V114, P487, DOI 10.1016/j.acthis.2011.09.002
   DHANAKOTI SN, 1992, BIOCHEM J, V282, P369, DOI 10.1042/bj2820369
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Goto S, 2013, J SPORT HEALTH SCI, V2, P75, DOI 10.1016/j.jshs.2013.03.004
   Goyary D, 2008, BIOGERONTOLOGY, V9, P11, DOI 10.1007/s10522-007-9112-8
   Hadem IKH, 2016, HORM METAB RES, V48, P201, DOI 10.1055/s-0035-1559770
   Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4
   Hartl FU, 2016, ANNU REV BIOCHEM, V85, P1, DOI 10.1146/annurev-biochem-011116-110806
   Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009
   Iwata S, 2002, HYPERTENS RES, V25, P411, DOI 10.1291/hypres.25.411
   Iyer R, 1998, J INHERIT METAB DIS, V21, P86, DOI 10.1023/A:1005313809037
   Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8
   Kaczor JJ, 2006, J GERONTOL A-BIOL, V61, P339, DOI 10.1093/gerona/61.4.339
   Kaji DM, 1997, AM J PHYSIOL-CELL PH, V272, pC615, DOI 10.1152/ajpcell.1997.272.2.C615
   Kanda H, 2008, ARCH TOXICOL, V82, P67, DOI 10.1007/s00204-007-0244-z
   Kanungo MS, 1980, BIOCH AGEING CHANGES, P79
   Kapahi P, 2010, ADV EXP MED BIOL, V694, P30
   Kern RM, 2007, MOL GENET METAB, V90, P37, DOI 10.1016/j.ymgme.2006.07.002
   Kielstein JT, 2003, NEPHROL DIAL TRANSPL, V18, P1245, DOI 10.1093/ndt/gfg183
   Levillain O, 2005, J HISTOCHEM CYTOCHEM, V53, P533, DOI 10.1369/jhc.4A6489.2005
   Levillain O, 2005, PFLUG ARCH EUR J PHY, V449, P491, DOI 10.1007/s00424-004-1336-8
   Levillain O, 2004, AM J PHYSIOL-RENAL, P727
   Levillain O, 2008, METABOLISM, V57, P9, DOI 10.1016/j.metabol.2007.06.001
   LEWIS SEM, 1985, EXP GERONTOL, V20, P253, DOI 10.1016/0531-5565(85)90050-6
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MacDonald L, 2011, AM J PHYSIOL-REG I, V301, pR172, DOI 10.1152/ajpregu.00057.2011
   Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059
   Majaw T, 2015, MOL CELL BIOCHEM, V407, P1, DOI 10.1007/s11010-015-2448-5
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   Ming XF, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000992
   Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x
   Morris SM, 1997, GENE, V193, P157, DOI 10.1016/S0378-1119(97)00099-1
   MORRISON RF, 1995, CARDIOVASC RES, V29, P841, DOI 10.1016/0008-6363(96)88621-4
   Musso CG, 2011, NEPHRON PHYSIOL, V119, P1, DOI 10.1159/000328010
   PATNAIK SK, 1989, BIOCHEM INT, V18, P709
   Pernow J, 2013, CARDIOVASC RES, V98, P334, DOI 10.1093/cvr/cvt036
   Qiu G, 2010, NEUROSCI BULL, V26, P55, DOI 10.1007/s12264-010-0716-7
   Romero MJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00480
   ROTH GS, 1982, MECH AGEING DEV, V20, P175, DOI 10.1016/0047-6374(82)90086-0
   Sands JM, 2007, J AM SOC NEPHROL, V18, P670, DOI 10.1681/ASN.2006121314
   Sands Jeff M, 2011, Trans Am Clin Climatol Assoc, V122, P82
   Sands Jeff M, 2003, Sci Aging Knowledge Environ, V2003, pPE15, DOI 10.1126/sageke.2003.24.pe15
   SATOH PS, 1968, ANAL BIOCHEM, V23, P219, DOI 10.1016/0003-2697(68)90353-9
   Soreq H, 1983, Brain Res, V312, P73
   Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001
   Tavernarakis N, 2002, MECH AGEING DEV, V123, P215, DOI 10.1016/S0047-6374(01)00341-4
   Tsang JPK, 2012, PEDIATR NEUROL, V47, P263, DOI 10.1016/j.pediatrneurol.2012.06.012
   Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001
   Xu WL, 2016, J CLIN INVEST, V126, P2465, DOI 10.1172/JCI82925
   Yang ZH, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00533
   Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006
NR 59
TC 2
Z9 2
U1 0
U2 2
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-5991
EI 0973-7138
J9 J BIOSCIENCES
JI J. Biosci.
PD JUN
PY 2017
VL 42
IS 2
BP 275
EP 283
DI 10.1007/s12038-017-9683-8
PG 9
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA EV6PU
UT WOS:000401893000007
PM 28569251
DA 2024-02-19
ER

PT J
AU Baek, JH
   Son, H
   Jeong, YH
   Park, SW
   Kim, HJ
AF Baek, Ji Hyeong
   Son, Hyeonwi
   Jeong, Young-Hoon
   Park, Sang Won
   Kim, Hyun Joon
TI Chronological Aging Standard Curves of Telomere Length and Mitochondrial
   DNA Copy Number in Twelve Tissues of C57BL/6 Male Mouse
SO CELLS
LA English
DT Article
DE telomere length; mitochondrial DNA copy number; aging; chronic stress;
   mouse
ID DEPRESSION; STRESS; DAMAGE; MUTATIONS; SEQUENCE; RISK; PCR; AGE
AB The changes in telomere length and mitochondrial DNA copy number (mtDNAcn) are considered to be aging markers. However, many studies have provided contradictory or only fragmentary information about changes of these markers in animal models, due to inaccurate analysis methods and a lack of objective aging standards. To establish chronological aging standards for these two markers, we analyzed telomere length and mtDNAcn in 12 tissues-leukocytes, prefrontal cortex, hippocampus, pituitary gland, adrenal gland, retina, aorta, liver, kidney, spleen, skeletal muscle, and skin-from a commonly used rodent model, C57BL/6 male mice aged 2-24 months. It was found that at least one of the markers changed age-dependently in all tissues. In the leukocytes, hippocampus, retina, and skeletal muscle, both markers changed age-dependently. As a practical application, the aging marker changes were analyzed after chronic immobilization stress (CIS) to see whether CIS accelerated aging or not. The degree of tissue-aging was calculated using each standard curve and found that CIS accelerated aging in a tissue-specific manner. Therefore, it is expected that researchers can use our standard curves to objectively estimate tissue-specific aging accelerating effects of experimental conditions for least 12 tissues in C57BL/6 male mice.
C1 [Baek, Ji Hyeong; Son, Hyeonwi; Kim, Hyun Joon] Gyeongsang Natl Univ, Sch Med, Dept Anat & Convergence Med Sci, Jinju 52727, South Korea.
   [Baek, Ji Hyeong; Son, Hyeonwi; Jeong, Young-Hoon; Park, Sang Won; Kim, Hyun Joon] Gyeongsang Natl Univ, Inst Hlth Sci, Bio Antiaging Med Res Ctr, Jinju 52727, South Korea.
   [Jeong, Young-Hoon] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Chang Won 51472, South Korea.
   [Jeong, Young-Hoon] Gyeongsang Natl Univ, Changwon Hosp, Cardiovasc Ctr, Chang Won 51472, South Korea.
   [Park, Sang Won] Gyeongsang Natl Univ, Sch Med, Dept Pharmacol & Convergence Med Sci, Jinju 52727, South Korea.
C3 Gyeongsang National University; Gyeongsang National University;
   Gyeongsang National University; Gyeongsang National University;
   Gyeongsang National University
RP Kim, HJ (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Anat & Convergence Med Sci, Jinju 52727, South Korea.; Kim, HJ (corresponding author), Gyeongsang Natl Univ, Inst Hlth Sci, Bio Antiaging Med Res Ctr, Jinju 52727, South Korea.
EM baekbaek@gnu.ac.kr; haeny@gnu.ac.kr; goodoctor@naver.com;
   parksw@gnu.ac.kr; kimhj@gnu.ac.kr
RI Baek, Ji Hyeong/GZA-9102-2022; Son, Hyeonwi/JLM-3096-2023; Jeong,
   Young-Hoon/F-3476-2015; Jeong, Young-Hoon/AAO-4401-2020
OI Baek, Ji Hyeong/0000-0001-5976-189X; Jeong,
   Young-Hoon/0000-0003-0403-3726; Park, Sang Won/0000-0002-6149-5284; Kim,
   Hyun Joon/0000-0003-4159-3888
FU Basic Research Program through the National Research Foundation of Korea
   [NRF-2015R1A5A2008833, NRF-2019R1A2C1005020]
FX This study was supported by a Basic Research Program through the
   National Research Foundation of Korea (NRF-2015R1A5A2008833 and
   NRF-2019R1A2C1005020).
CR Arai Y, 2015, EBIOMEDICINE, V2, P1549, DOI 10.1016/j.ebiom.2015.07.029
   Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003
   Bernal A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010294
   Bogenhagen DF, 2010, EXP GERONTOL, V45, P473, DOI 10.1016/j.exger.2009.12.002
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Cai N, 2015, CURR BIOL, V25, P1146, DOI 10.1016/j.cub.2015.03.008
   Calado RT, 2013, SEMIN HEMATOL, V50, P165, DOI 10.1053/j.seminhematol.2013.03.030
   Callicott RJ, 2006, COMPARATIVE MED, V56, P17
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chen N, 2016, SCI REP-UK, V6, DOI 10.1038/srep37404
   Deng YB, 2007, LAB INVEST, V87, P1071, DOI 10.1038/labinvest.3700673
   Fuke S, 2011, BBA-BIOENERGETICS, V1807, P270, DOI 10.1016/j.bbabio.2010.11.016
   Gilley D, 2005, INT J BIOCHEM CELL B, V37, P1000, DOI 10.1016/j.biocel.2004.09.003
   Gilley D, 2008, MECH AGEING DEV, V129, P27, DOI 10.1016/j.mad.2007.10.010
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962
   Hu LW, 2016, SCI REP-UK, V6, DOI 10.1038/srep35859
   Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0
   Joo Y, 2009, NEUROSCI LETT, V461, P121, DOI 10.1016/j.neulet.2009.06.025
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974
   Lin PY, 2016, J PSYCHIATR RES, V76, P84, DOI 10.1016/j.jpsychires.2016.01.015
   Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1673, DOI 10.1093/ije/dyu191
   Monroy-Jaramillo N, 2018, WORLD J BIOL PSYCHIA, V19, pS2, DOI 10.1080/15622975.2016.1273550
   Oikawa S, 2001, BIOCHEMISTRY-US, V40, P4763, DOI 10.1021/bi002721g
   Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72
   Otsuka I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03599-8
   Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Picard M, 2018, PSYCHOSOM MED, V80, P141, DOI 10.1097/PSY.0000000000000545
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   Rizvi Saliha, 2014, Curr Aging Sci, V7, P161
   Son H, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110406
   Son H, 2018, NEUROPHARMACOLOGY, V143, P143, DOI 10.1016/j.neuropharm.2018.09.040
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686
   Xia CY, 2017, CHINESE MED J-PEKING, V130, P2435, DOI 10.4103/0366-6999.216395
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Zgheib NK, 2018, AGING DIS, V9, P77, DOI 10.14336/AD.2017.0310
NR 43
TC 16
Z9 16
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAR 15
PY 2019
VL 8
IS 3
AR 247
DI 10.3390/cells8030247
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HS9QD
UT WOS:000464200900005
PM 30875959
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Li, C
   Fan, Y
   Li, S
   Zhou, XR
   Park, KY
   Zhao, X
   Liu, HZ
AF Li, Chong
   Fan, Yang
   Li, Shuang
   Zhou, Xianrong
   Park, Kun-Young
   Zhao, Xin
   Liu, Huazhi
TI Antioxidant Effect of Soymilk Fermented by <i>Lactobacillus
   plantarum</i> HFY01 on D-Galactose-Induced Premature Aging Mouse Model
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE Lactobacillus plantarum; antioxidant; D-galactose; fermented soymilk;
   isoflavone
ID OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; SOYBEAN ISOFLAVONE; SOD2;
   MAINTAINS; PATHWAY; FAMILY; ACID
AB The antioxidant effect of soymilk fermented by Lactobacillus plantarum HFY01 (screened from yak yogurt) was investigated on mice with premature aging induced by D-galactose. In vitro antioxidant results showed that L. plantarum HFY01-fermented soymilk (LP-HFY01-DR) had better ability to scavenge the free radicals 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2 '-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid) diammonium salt (ABTS) than unfermented soymilk and Lactobacillus bulgaricus-fermented soymilk. Histopathological observation showed that LP-HFY01-DR could protect the skin, spleen and liver, reduce oxidative damage and inflammation. Biochemical results showed that LP-HFY01-DR could effectively upregulate glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) levels and decrease malondialdehyde (MDA) content in the liver, brain, and serum. Real-time quantitative reverse transcription polymerase chain reaction further showed that LP-HFY01-DR could promote the relative expression levels of the genes encoding for cuprozinc superoxide dismutase (Cu/Zn-SOD, SOD1), manganese superoxide dismutase (Mn-SOD, SOD2), CAT, GSH, and GSH-Px in the liver, spleen, and skin. High-performance liquid chromatography results revealed daidzin, glycitin, genistin, daidzein, glycitein, and genistein in LP-HFY01-DR. In conclusion, LP-HFY01-DR could improve the antioxidant capacity in mice with premature aging induced by D-galactose.
C1 [Li, Chong; Li, Shuang; Zhou, Xianrong; Park, Kun-Young; Zhao, Xin] Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing, Peoples R China.
   [Li, Chong; Zhou, Xianrong; Park, Kun-Young; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing, Peoples R China.
   [Li, Chong; Zhou, Xianrong; Park, Kun-Young; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Lab Res & Dev Funct Food, Chongqing, Peoples R China.
   [Fan, Yang] Third Mil Med Univ, Dept Clin Nutr, Daping Hosp, Army Med Univ, Chongqing, Peoples R China.
   [Li, Shuang] Chongqing Univ Educ, Coll Biol & Chem Engn, Chongqing, Peoples R China.
   [Liu, Huazhi] Gannan Med Univ, Affiliated Hosp 1, Ganzhou, Peoples R China.
C3 Chongqing University of Education; Chongqing University of Education;
   Chongqing University of Education; Army Medical University; Chongqing
   University of Education; Gannan Medical University
RP Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing, Peoples R China.; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing, Peoples R China.; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Engn Lab Res & Dev Funct Food, Chongqing, Peoples R China.; Liu, HZ (corresponding author), Gannan Med Univ, Affiliated Hosp 1, Ganzhou, Peoples R China.
EM zhaoxin@cque.edu.cn; liuhuazhi8818@163.com
RI liu, xq/JDW-2596-2023
FU Chongqing University Innovation Research Group Project [CXQTP20033];
   Science and Technology Project of Chongqing Education Commission
   [KJQN202001604]; Scientific and Technological Innovation Project of
   Construction of Double City Economic Circle in Chengdu-Chongqing Area of
   Chongqing Education Commission [KJCX2020052]
FX This research was funded by Chongqing University Innovation Research
   Group Project (CXQTP20033), the Science and Technology Project of
   Chongqing Education Commission (KJQN202001604) and Scientific and
   Technological Innovation Project of Construction of Double City Economic
   Circle in Chengdu-Chongqing Area of Chongqing Education Commission
   (KJCX2020052), China.
CR Abo-elsoud MA, 2019, ANIM REPROD SCI, V203, P52, DOI 10.1016/j.anireprosci.2019.02.007
   Aguilar-Toalá JE, 2017, J DAIRY SCI, V100, P65, DOI 10.3168/jds.2016-11846
   Al-Dhabi NA, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8101461
   ARUOMA OI, 1987, BIOCHEM J, V248, P973, DOI 10.1042/bj2480973
   Babker, 2018, ASIAN J PHARM CLIN R, V11, P281, DOI DOI 10.22159/AJPCR.2018.V11I5.24548
   Baghbani-Arani F, 2020, NUTR CANCER, V72, P1390, DOI 10.1080/01635581.2019.1685674
   Berson DS, 2008, J DRUGS DERMATOL, V7, pS7
   Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340
   Cheng J, 2021, KOREAN J PHYSIOL PHA, V25, P131, DOI 10.4196/kjpp.2021.25.2.131
   CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093
   Choi IY, 2018, MULT SCLER J, V24, P1029, DOI 10.1177/1352458517711568
   Fatemi I, 2018, IRAN J BASIC MED SCI, V21, P19, DOI 10.22038/IJBMS.2017.24331.6071
   Floegel A, 2011, J FOOD COMPOS ANAL, V24, P1043, DOI 10.1016/j.jfca.2011.01.008
   Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013
   Gaucher C, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7050062
   Guimaraes A, 2018, INT J FOOD MICROBIOL, V264, P31, DOI 10.1016/j.ijfoodmicro.2017.10.025
   Guo Q, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004827.pub5
   Hara K, 2018, DATA BRIEF, V17, P870, DOI 10.1016/j.dib.2018.02.013
   Hwang CE, 2021, FOOD CHEM, V340, DOI 10.1016/j.foodchem.2020.128199
   Irshad M., 2002, Indian Journal of Experimental Biology, V40, P1233
   Kim YS, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040086
   Kumar V., 2018, ERAS J MED RES, V5, P59, DOI [10.24041/ejmr2018.63, DOI 10.24041/EJMR2018.63]
   Kuo CL, 2020, CANCER LETT, V474, P138, DOI 10.1016/j.canlet.2020.01.019
   Kwaw E, 2018, FOOD CHEM, V250, P148, DOI 10.1016/j.foodchem.2018.01.009
   Lee J, 2007, FOOD CHEM, V103, P662, DOI 10.1016/j.foodchem.2006.07.052
   Li C, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090381
   Li L, 2021, J ETHNOPHARMACOL, V271, DOI 10.1016/j.jep.2021.113810
   Lin XN, 2020, LWT-FOOD SCI TECHNOL, V126, DOI 10.1016/j.lwt.2020.109278
   Liu J, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9100575
   Lu MA, 2020, J FOOD SCI, V85, P1302, DOI 10.1111/1750-3841.14986
   Martinez RM, 2018, J DERMATOL SCI, V91, P164, DOI 10.1016/j.jdermsci.2018.04.014
   Mirmiranpour H, 2020, J DIABETES METAB DIS, V19, P53, DOI 10.1007/s40200-019-00474-3
   Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9
   Nakamoto M, 2018, EUR J CLIN NUTR, V72, P1458, DOI 10.1038/s41430-017-0061-2
   Nath A, 2020, BIOENGINEERING-BASEL, V7, DOI 10.3390/bioengineering7010005
   Ni YH, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900603
   Niamnuy C, 2019, DRY TECHNOL, V37, P1844, DOI 10.1080/07373937.2019.1596120
   Oshima A, 2016, BIOSCI BIOTECH BIOCH, V80, P2077, DOI 10.1080/09168451.2016.1196577
   Pablos MI, 1995, J PINEAL RES, V19, P111, DOI 10.1111/j.1600-079X.1995.tb00178.x
   Peña-Bautista C, 2019, CLIN CHIM ACTA, V491, P85, DOI 10.1016/j.cca.2019.01.021
   RAO GN, 1983, OPHTHALMIC RES, V15, P173, DOI 10.1159/000265254
   Sadigh-Eteghad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184122
   Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588
   Tao GR, 2019, ACTA BIOCH BIOPH SIN, V51, P1189, DOI 10.1093/abbs/gmz121
   Tsang CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4446
   Tseng WL, 2017, CELL TRANSPLANT, V26, P513, DOI 10.3727/096368916X694265
   Wang K, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13106
   Wang RR, 2020, FOOD FUNCT, V11, P2679, DOI 10.1039/c9fo02474c
   Xia YJ, 2020, J FUNCT FOODS, V67, DOI 10.1016/j.jff.2020.103854
   Xu FB, 2019, FOOD FUNCT, V10, P3868, DOI 10.1039/c8fo02300j
   Yamagata K, 2019, J CARDIOVASC PHARM, V74, P201, DOI 10.1097/FJC.0000000000000708
   Yang SQ, 2009, FOOD CHEM, V115, P1247, DOI 10.1016/j.foodchem.2009.01.038
   Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X
   Zhang FF, 2017, CANCER-AM CANCER SOC, V123, P2070, DOI 10.1002/cncr.30615
   Zhao X, 2018, J MED FOOD, V21, P575, DOI 10.1089/jmf.2017.4109
   Zhu RZ, 2012, HEPATOL RES, V42, P741, DOI 10.1111/j.1872-034X.2012.00996.x
NR 56
TC 11
Z9 13
U1 12
U2 56
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD MAY 17
PY 2021
VL 8
AR 667643
DI 10.3389/fnut.2021.667643
PG 17
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA SK2LJ
UT WOS:000656051000001
PM 34079813
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Shibata, A
   Maeda, D
   Ogino, H
   Tsutsumi, M
   Nohmi, T
   Nakagama, H
   Sugimura, T
   Teraoka, H
   Masutani, M
AF Shibata, Atsushi
   Maeda, Daisuke
   Ogino, Hideki
   Tsutsumi, Masahiro
   Nohmi, Takehiko
   Nakagama, Hitoshi
   Sugimura, Takashi
   Teraoka, Hirobumi
   Masutani, Mitsuko
TI Role of Parp-1 in suppressing spontaneous deletion mutation in the liver
   and brain of mice at adolescence and advanced age
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE Parp-1; Mutation; Deletion; gpt delta; Aging
ID DOUBLE-STRAND BREAKS; DELTA TRANSGENIC MOUSE; ION-INDUCED MUTATIONS;
   OXIDATIVE DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE; SOMATIC MUTATIONS;
   EFFICIENT METHOD; EXCISION-REPAIR; HEAVY-ION; ACCUMULATION
AB Poly(ADP-ribose) polymerase-1 knockout (Parp-1(-/-)) mice show increased frequency of spontaneous liver tumors compared to wild-type mice after aging. To understand the impact of Parp-1 deficiency on mutations during aging, in this study, we analyzed spontaneous mutations in Parp-1(-/-) aged mice. Parp-1(-/-) mice showed tendencies of higher mutation frequencies of the red/gam genes at 18 months of age, compared to Parp-1(+/+) mice, in the liver and brain. Complex-type deletions, accompanying small insertion were observed only in Parp-1(-/-) mice in the liver and brain. Further analysis in the liver showed that the frequency of single base deletion mutations at non-repeat or short repeat sequences was 5.8-fold higher in Parp-1(-/-) than in Parp-1(+/+) mice (p < 0.05). A 3.2-fold higher tendency of the deletion frequency of two bases or more was observed in Parp-1(-/-) mice compared to Parp-1(+/+) mice (p = 0.084). These results support the model that Parp-1 is involved in suppressing imprecise repair of endogenous DNA damage leading to deletion mutation during aging. The mutation frequencies of the gpt gene in the brain were found to be 3-fold lower in Parp-1(-/-) than in Parp-1(+/+) mice at 4 months of age (p < 0.01), implying that Parp-1 may be positively involved in imprecise DNA repair in the brain. On the other hand, the frequencies of gpt mutation showed an increase at 18 months of age in the Parp-1(-/-) (p < 0.05) but not in Parp-1 brains, suggesting that Parp-1 deficiency causes an increase of point mutations in the brain by aging. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Shibata, Atsushi; Maeda, Daisuke; Ogino, Hideki; Nakagama, Hitoshi; Sugimura, Takashi; Masutani, Mitsuko] Natl Canc Ctr, Res Inst, Div Biochem, Chuo Ku, Tokyo 1040045, Japan.
   [Shibata, Atsushi; Maeda, Daisuke; Ogino, Hideki; Masutani, Mitsuko] Natl Canc Ctr, Res Inst, ADP Ribosylat Oncol Project, Chuo Ku, Tokyo 1040045, Japan.
   [Shibata, Atsushi; Teraoka, Hirobumi] Tokyo Med & Dent Univ, Med Res Inst, Chiyoda Ku, Tokyo 1010062, Japan.
   [Tsutsumi, Masahiro] Saiseikai Chuwa Hosp, Sakurai City, Nara 6330054, Japan.
   [Nohmi, Takehiko] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan.
C3 National Cancer Center - Japan; National Cancer Center - Japan; Tokyo
   Medical & Dental University (TMDU); National Institute of Health
   Sciences - Japan
RP Masutani, M (corresponding author), Natl Canc Ctr, Res Inst, Div Biochem, Chuo Ku, 5-1-1 Chuo Ku, Tokyo 1040045, Japan.
EM mmasutan@ncc.go.jp
RI Shibata, Atsushi/AAX-1283-2021
OI Shibata, Atsushi/0000-0001-8912-6977
FU Ministry of Health, Labourand Welfare; Third Term Comprehensive 10-Year
   Strategy for Cancer Control; Ministry of Education, Science, Sports, and
   Culture of Japan [16-11804]
FX We are grateful to M. Abe for technical assistance, M. Yanagihara for
   maintenance of the animals and H. Suzuki and S. Gotoh for helpful
   suggestions on the manuscript. This work was supported in part by a
   Grant-in-Aid for the Cancer Research from the Ministry of Health,
   Labourand Welfare, a Grand-in-Aid from Third Term Comprehensive 10-Year
   Strategy for Cancer Control, and a Grant-in-Aid for Scientific Research
   from the Ministry of Education, Science, Sports, and Culture of Japan
   (16-11804).
CR deVries A, 1997, MOL CARCINOGEN, V19, P46, DOI 10.1002/(SICI)1098-2744(199705)19:1<46::AID-MC7>3.3.CO;2-O
   Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431
   Dollé MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403
   Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200
   Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521
   Giese H, 1999, ONCOGENE, V18, P1257, DOI 10.1038/sj.onc.1202404
   Gunji A, 2006, CANCER LETT, V241, P87, DOI 10.1016/j.canlet.2005.10.003
   Hill KA, 2004, ENVIRON MOL MUTAGEN, V43, P110, DOI 10.1002/em.20004
   Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015
   Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004
   KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849
   Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101
   Le Page F, 2003, J BIOL CHEM, V278, P18471, DOI 10.1074/jbc.M212905200
   Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003
   Li BM, 2004, J BIOL CHEM, V279, P13659, DOI 10.1074/jbc.M311606200
   Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172
   Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017
   Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563
   Masumura K, 1999, CANCER LETT, V143, P241, DOI 10.1016/S0304-3835(99)00132-9
   Masumura K, 1999, ENVIRON MOL MUTAGEN, V34, P1, DOI 10.1002/(SICI)1098-2280(1999)34:1<1::AID-EM1>3.0.CO;2-P
   Masumura K, 2002, ENVIRON MOL MUTAGEN, V40, P207, DOI 10.1002/em.10108
   Masumura K, 2009, J HEALTH SCI, V55, P40, DOI 10.1248/jhs.55.40
   Nohmi T, 1999, ENVIRON MOL MUTAGEN, V34, P9, DOI 10.1002/(SICI)1098-2280(1999)34:1<9::AID-EM2>3.0.CO;2-E
   Nohmi T, 1996, ENVIRON MOL MUTAGEN, V28, P465, DOI 10.1002/(SICI)1098-2280(1996)28:4<465::AID-EM24>3.0.CO;2-C
   Nozaki T, 2003, CANCER SCI, V94, P497, DOI 10.1111/j.1349-7006.2003.tb01472.x
   Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003
   Ono T, 2000, MUTAT RES-FUND MOL M, V447, P165, DOI 10.1016/S0027-5107(99)00200-6
   Russo MT, 2004, CANCER RES, V64, P4411, DOI 10.1158/0008-5472.CAN-04-0355
   Shibata A, 2005, ONCOGENE, V24, P1328, DOI 10.1038/sj.onc.1208289
   Shibata A, 2004, ENVIRON MOL MUTAGEN, V43, P204, DOI 10.1002/em.20008
   Shibata A, 2003, ENVIRON MOL MUTAGEN, V41, P370, DOI 10.1002/em.10159
   Swiger RR, 2001, ENVIRON MOL MUTAGEN, V37, P297, DOI 10.1002/em.1036
   Tong WM, 2003, AM J PATHOL, V162, P343, DOI 10.1016/S0002-9440(10)63825-4
   Tong WM, 2001, BBA-REV CANCER, V1552, P27, DOI 10.1016/S0304-419X(01)00035-X
   Tong WM, 2002, CANCER RES, V62, P6990
   Tsutsumi M, 2001, CARCINOGENESIS, V22, P1, DOI 10.1093/carcin/22.1.1
   Vispé S, 2000, J BIOL CHEM, V275, P27386
   von Kobbe C, 2004, NUCLEIC ACIDS RES, V32, P4003, DOI 10.1093/nar/gkh721
   von Kobbe C, 2003, MOL CELL BIOL, V23, P8601, DOI 10.1128/MCB.23.23.8601-8613.2003
   Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840
   Yatagai F, 2002, ENVIRON MOL MUTAGEN, V40, P216, DOI 10.1002/em.10107
NR 41
TC 17
Z9 22
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-1964
EI 1873-135X
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD MAY 12
PY 2009
VL 664
IS 1-2
BP 20
EP 27
DI 10.1016/j.mrfmmm.2009.02.001
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 449XM
UT WOS:000266364100004
PM 19428377
DA 2024-02-19
ER

PT J
AU Shi, C
   Xu, J
AF Shi, Chun
   Xu, Jie
TI Increased vulnerability of brain to estrogen withdrawal-induced
   mitochondrial dysfunction with aging
SO JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
LA English
DT Article
DE Mitochondrial dysfunction; COX; ATP; Ovariectomy; Aging;
   Neurodegeneration
ID CYTOCHROME-C-OXIDASE; ELECTRON-TRANSPORT CHAIN;
   OXIDATIVE-PHOSPHORYLATION; OVARIECTOMIZED RATS; LIVER-MITOCHONDRIA;
   NEURODEGENERATION; METABOLISM; MECHANISMS; EXPRESSION; GENISTEIN
AB In the present study, to determine whether aging could increase the vulnerability of the brain to estrogen withdrawal-induced mitochondrial dysfunction, we measured the cytochrome c oxidase (COX) activity and mitochondrial adenosine triphosphate (ATP) content in hippocampi of 2 groups of ovariectomized (OVX) Wistar rats aged 2 months (young) and 9 months (middle-aged), respectively. In addition, effects of genistein and estradiol benzoate (EB) were tested also. We observed only a transient alteration of COX activity and mitochondrial ATP content in hippocampi of young OVX rats but a prolonged lowering of COX activity and mitochondrial ATP content in hippocampi of middle-aged OVX rats. This suggested that with aging compensatory mechanisms of mitochondrial function were attenuated, thus exacerbated estrogen withdrawal-induced mitochondrial dysfunction in hippocampi. Significantly, EB/genistein treatment reversed this estrogen withdrawal-induced mitochondrial dysfunction in both young and middle-aged rats suggesting that genistein may be used as a substitute for estradiol to prevent age-related disease such as Alzheimer's disease in post-menopausal females.
C1 [Shi, Chun; Xu, Jie] Sun Yat Sen Univ, Zhongshan Med Coll, Dept Anat, Guangzhou 510080, Guangdong, Peoples R China.
C3 Sun Yat Sen University
RP Xu, J (corresponding author), Sun Yat Sen Univ, Zhongshan Med Coll, Dept Anat, Guangzhou 510080, Guangdong, Peoples R China.
EM x510y@yahoo.com.cn
FU GuangDong Provincial Natural Science Foundation [C04105332]; Key
   Guidance Project of GuangDong Provincial Science and Technology Planning
   [2005B33801004]
FX Many thanks for support from the GuangDong Provincial Natural Science
   Foundation (No. C04105332) and the Key Guidance Project of GuangDong
   Provincial Science and Technology Planning (No. 2005B33801004).
CR Abelenda M, 1999, EUR J ENDOCRINOL, V141, P630, DOI 10.1530/eje.0.1410630
   Aksenov MY, 1999, NEUROCHEM RES, V24, P767, DOI 10.1023/A:1020783614031
   ARENDT J, 1983, J REPROD FERTIL, V68, P213, DOI 10.1530/jrf.0.0680213
   ASSIMACOPOULOSJEANNET F, 1986, J BIOL CHEM, V261, P8799
   Beauvoit B, 2001, IUBMB LIFE, V52, P143, DOI 10.1080/152165401317316545
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   Borras C, 2007, FRONT BIOSCI, V12, P1008, DOI 10.2741/2120
   BRAND MD, 1990, ARCH BIOCHEM BIOPHYS, V283, P278, DOI 10.1016/0003-9861(90)90643-D
   Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003
   Garcia De La Asuncion Jose, 1996, FASEB Journal, V10, P333
   HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x
   Ho KP, 2003, MOL CELL BIOCHEM, V247, P219, DOI 10.1023/A:1024142004575
   Kacser H., 1973, RATE CONTROL BIOL PR, P65
   Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1
   Korzeniewski B, 2001, BBA-BIOENERGETICS, V1504, P31, DOI 10.1016/S0005-2728(00)00237-1
   Lecanu L, 2005, NEUROPHARMACOLOGY, V49, P86, DOI 10.1016/j.neuropharm.2005.01.028
   Liu Z, 1996, DEV BRAIN RES, V97, P178, DOI 10.1016/S0165-3806(96)00141-1
   Marks JD, 2000, DEV BRAIN RES, V124, P101, DOI 10.1016/S0165-3806(00)00096-1
   Miquel J, 2006, ARCH GERONTOL GERIAT, V42, P289, DOI 10.1016/j.archger.2005.08.005
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Nilsen J, 2004, CNS NEUROL DISORD-DR, V3, P297, DOI 10.2174/1568007043337193
   REDER C, 1988, J THEOR BIOL, V135, P175, DOI 10.1016/S0022-5193(88)80073-0
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Shi C, 2008, CELL BIOCHEM FUNCT, V26, P172, DOI 10.1002/cbf.1423
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Toescu EC, 2005, PHILOS T R SOC B, V360, P2347, DOI 10.1098/rstb.2005.1771
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   VINA J, 2005, SCI AGING KNOWLEDGE, V23, pPE17
   Xu J, 2007, J MOL NEUROSCI, V31, P101, DOI 10.1007/s12031-007-0010-y
   XU XW, 2008, CELL MOL NEUROBIOL
NR 31
TC 17
Z9 19
U1 0
U2 7
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0145-479X
EI 1573-6881
J9 J BIOENERG BIOMEMBR
JI J. Bioenerg. Biomembr.
PD DEC
PY 2008
VL 40
IS 6
BP 625
EP 630
DI 10.1007/s10863-008-9195-1
PG 6
WC Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Cell Biology
GA 411JP
UT WOS:000263646100009
PM 19139976
DA 2024-02-19
ER

PT J
AU KALINYAK, JE
   HOFFMAN, AR
   PERLMAN, AJ
AF KALINYAK, JE
   HOFFMAN, AR
   PERLMAN, AJ
TI ONTOGENY OF ANGIOTENSINOGEN MESSENGER-RNA AND ANGIOTENSIN-II RECEPTORS
   IN RAT-BRAIN AND LIVER
SO JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
LA English
DT Article
DE ANGIOTENSIN; ANGIOTENSINOGEN; MESSENGER RNA; RECEPTORS; RAT BRAIN; RAT
   LIVER
ID CONVERTING ENZYME; MULTIPLE TISSUES; RIBONUCLEIC-ACID; EXPRESSION; GENE;
   RENIN
AB The renin-angiotensin-system (RAS) is active in fetal and neonatal life.  This study was undertaken to examine the ontogenic regulation of angiotensinogen (AT) gene expression and angiotensin II (A II) receptors in liver and brain.  AT gene expression was studied in fetal, neonatal, adult and aged rats, using slot blot hybridization to quantify AT mRNA levels.  During fetal life (gestational days 15-20), AT mRNA was more abundant in brain than in liver.  Soon after birth, brain AT mRNA levels increased to a concentration 3 fold above fetal levels.  In contrast, liver AT mRNA abundance increased 30-fold within 12 h of birth.  Aging (3-20 months) resulted in a gradual decrease in AT mRNA in both the brain and liver.  Liver A II receptors in the neonate were 2-fold higher than in the fetus, but returned to fetal levels by 8 weeks of age.  In the brain, A II receptor abundance increased to a level 75% above fetal levels in 7 day old animals, but returned to fetal levels by 14 days of age.  These studies suggest than in the fetus, the liver is not the primary source of AT but that unknown factors at parturition result in a dramatic increase in liver AT mRNA.  In contrast, the more modest increases in brain AT mRNA parallel the gradual maturation of the CNS.  In both tissues, further aging resulted in a gradual decrease in AT mRNA, reflecting either increased sensitivity to feedback downregulation by A II or age related increases in other extrahepatic sites of AT synthesis.  Age related changes were also found in the A II receptor in both the liver and brain.
C1 DEPT VET AFFAIRS MED CTR,MED SERV 111,3801 MIRANDA AVE,PALO ALTO,CA 94304.
   STANFORD UNIV,MED CTR,SCH MED,DEPT MED,STANFORD,CA 94305.
C3 Stanford University
FU NHLBI NIH HHS [HL 35351] Funding Source: Medline; NIA NIH HHS [AG 01312]
   Funding Source: Medline
CR BENNETT JP, 1976, J BIOL CHEM, V251, P7423
   BOND JF, 1983, MOL CELL BIOL, V3, P1333, DOI 10.1128/MCB.3.8.1333
   CAMPBELL DJ, 1986, J CLIN INVEST, V78, P31, DOI 10.1172/JCI112566
   CHANG E, 1987, ENDOCRINOLOGY, V121, P513, DOI 10.1210/endo-121-2-513
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   EGGENA P, 1988, CLIN EXP HYPERTENS A, V10, P597, DOI 10.3109/10641968809033912
   FREID T, 1986, AM J PHYSIOL, V250, pF374
   GOMEZ RA, 1988, ENDOCRINOLOGY, V123, P2298, DOI 10.1210/endo-123-5-2298
   GUNTHER S, 1984, J BIOL CHEM, V259, P7622
   HARRIS PJ, 1985, AM J PHYSIOL, V248, P621
   IHARA Y, 1987, ENDOCRINOL JAPON, V34, P887
   KALINYAK JE, 1987, J BIOL CHEM, V262, P460
   KALINYAK JE, 1989, J CLIN INVEST, V84, P1843, DOI 10.1172/JCI114370
   KOTCHEN TA, 1972, J PEDIATR-US, V80, P938, DOI 10.1016/S0022-3476(72)80005-2
   LEE HU, 1987, ENDOCRINOLOGY, V121, P1335, DOI 10.1210/endo-121-4-1335
   LESHEM M, 1988, DEV PSYCHOBIOL, V21, P63, DOI 10.1002/dev.420210105
   LYNCH KR, 1986, HYPERTENSION, V8, P540, DOI 10.1161/01.HYP.8.6.540
   Maniatis T., 1982, MOL CLONING
   MCDONALD WJ, 1977, J CLIN ENDOCR METAB, V45, P1297, DOI 10.1210/jcem-45-6-1297
   MILLAN MA, 1989, SCIENCE, V244, P1340, DOI 10.1126/science.2734613
   MUNDAY KA, 1971, J PHYSIOL-LONDON, V215, P269, DOI 10.1113/jphysiol.1971.sp009468
   OHKUBO H, 1986, J BIOL CHEM, V261, P319
   POHLOVA I, 1974, PFLUG ARCH EUR J PHY, V351, P259, DOI 10.1007/BF00586922
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   SERNIA C, 1984, J ENDOCRINOL, V106, P103
   SINGH R, 1984, BRAIN RES, V303, P133, DOI 10.1016/0006-8993(84)90220-8
   SKEEGS LT, 1980, ADV EXP MED BIOL, V130, P1
   WALLACE KB, 1978, AM J PHYSIOL, V234, pR141, DOI 10.1152/ajpregu.1978.234.3.R141
   WALLACE KB, 1980, AM J PHYSIOL, V238, pR432, DOI 10.1152/ajpregu.1980.238.5.R432
   WALLACE KB, 1979, AM J PHYSIOL, V236, pR57, DOI 10.1152/ajpregu.1979.236.1.R57
   WILKES BM, 1985, AM J PHYSIOL, V243, pR619
NR 31
TC 28
Z9 28
U1 0
U2 0
PU EDITRICE KURTIS S R L
PI MILANO
PA VIA LUIGI ZOJA, 30-20153 MILANO, ITALY
SN 0391-4097
J9 J ENDOCRINOL INVEST
JI J. Endocrinol. Invest.
PD SEP
PY 1991
VL 14
IS 8
BP 647
EP 654
DI 10.1007/BF03347886
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA GJ597
UT WOS:A1991GJ59700003
PM 1723087
DA 2024-02-19
ER

PT J
AU Kitajima, Y
   Eguchi, Y
   Ishibashi, E
   Nakashita, S
   Aoki, S
   Toda, S
   Mizuta, T
   Ozaki, I
   Ono, N
   Eguchi, T
   Arai, K
   Iwakiri, R
   Fujimoto, K
AF Kitajima, Yoichiro
   Eguchi, Yuichiro
   Ishibashi, Eriko
   Nakashita, Shunya
   Aoki, Shigehisa
   Toda, Shuji
   Mizuta, Toshihiko
   Ozaki, Iwata
   Ono, Naofumi
   Eguchi, Takahisa
   Arai, Kohei
   Iwakiri, Ryuichi
   Fujimoto, Kazuma
TI Age-related fat deposition in multifidus muscle could be a marker for
   nonalcoholic fatty liver disease
SO JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Nonalcoholic steatohepatitis; Metabolic syndrome; Lifestyle modification
ID INSULIN SENSITIVITY; VISCERAL FAT; ABDOMINAL FAT; HEPATITIS-C;
   ACCUMULATION; RESISTANCE; WOMEN; VIRUS
AB Although nonalcoholic fatty liver disease (NAFLD) is associated with visceral obesity, the relationship between visceral fat accumulation and skeletal muscle steatosis in patients with NAFLD has not been established. We evaluated: (1) the relationship between multifidus muscular tissue steatosis, visceral fat accumulation, and biochemical data in a cross-sectional study, and (2) the influence of weight reduction on multifidus muscular tissue steatosis in a longitudinal study.
   Three hundred thirty-three NAFLD patients were enrolled. Hepatic steatosis, visceral fat area, and the multifidus muscle/subcutaneous fat attenuation ratio (MM/F ratio) were evaluated by computed tomography. To evaluate how weight reduction produced by diet and exercise affected the MM/F ratio, changes in the MM/F ratio were compared between weight reduction and non-weight reduction groups.
   There was a gender difference in MM/F ratios. The MM/F ratio was significantly correlated with age (male r = 0.613, P < 0.01; female r = 0.440, P < 0.01). The MM/F ratio was positively correlated with visceral fat area (male: r = 0.262, P < 0.01; female: r = 0.214, P < 0.01). A decrease in the MM/F ratio, concomitant with reduced visceral fat accumulation, led to alleviation of hepatic steatosis in 20 patients with weight reduction, but not in 22 patients without weight reduction.
   The MM/F ratio was closely related to aging and visceral fat accumulation. The MM/F ratio was improved by weight reduction, indicating that fat accumulation in the multifidus muscle evaluated by computed tomography might be a therapeutic indicator of NAFLD.
C1 [Kitajima, Yoichiro; Eguchi, Yuichiro; Ishibashi, Eriko; Nakashita, Shunya; Mizuta, Toshihiko; Ozaki, Iwata; Iwakiri, Ryuichi; Fujimoto, Kazuma] Saga Med Sch, Dept Internal Med, Saga 8498501, Japan.
   [Kitajima, Yoichiro; Ishibashi, Eriko; Nakashita, Shunya; Ono, Naofumi; Eguchi, Takahisa] Eguchi Hosp, Saga 8450032, Japan.
   [Aoki, Shigehisa; Toda, Shuji] Saga Med Sch, Dept Pathol, Saga 8498501, Japan.
   [Arai, Kohei] Saga Univ, Dept Engn, Saga 8408502, Japan.
C3 Saga University; Saga University; Saga University
RP Eguchi, Y (corresponding author), Saga Med Sch, Dept Internal Med, 5-1-1 Nabeshima, Saga 8498501, Japan.
EM eguchiyu@cc.saga-u.ac.jp
RI Aoki, Shigehisa/AFQ-9927-2022
OI Aoki, Shigehisa/0000-0002-1778-8944
CR Brunt E, 2000, AM J GASTROENTEROL, V95, P1370
   Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9
   Eguchi Y, 2009, LIVER INT, V29, P213, DOI 10.1111/j.1478-3231.2008.01853.x
   Eguchi Y, 2006, J GASTROENTEROL, V41, P462, DOI 10.1007/s00535-006-1790-5
   Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4
   Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579
   Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138
   HEYDRICK SJ, 1993, J CLIN INVEST, V91, P1358, DOI 10.1172/JCI116337
   Ishibashi E, 2008, J GASTROEN HEPATOL, V23, P908, DOI 10.1111/j.1440-1746.2008.05366.x
   Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402
   Kawaguchi Y, 2009, LIVER INT, V29, P871, DOI 10.1111/j.1478-3231.2009.01993.x
   Kim CS, 2004, YONSEI MED J, V45, P469, DOI 10.3349/ymj.2004.45.3.469
   Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8
   Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8
   PIEKARSKI J, 1980, RADIOLOGY, V137, P727, DOI 10.1148/radiology.137.3.6934563
   Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354
   SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930
   Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022
   Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959
   Thomas EL, 2006, WORLD J GASTROENTERO, V12, P5813, DOI 10.3748/wjg.v12.i36.5813
   Torriani M, 2003, J APPL PHYSIOL, V95, P1005, DOI 10.1152/japplphysiol.00366.2003
   Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x
   Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283
NR 23
TC 76
Z9 78
U1 0
U2 2
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 0944-1174
EI 1435-5922
J9 J GASTROENTEROL
JI J. Gastroenterol.
PD FEB
PY 2010
VL 45
IS 2
BP 218
EP 224
DI 10.1007/s00535-009-0147-2
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 555OF
UT WOS:000274521100011
PM 19882375
DA 2024-02-19
ER

PT J
AU Xiao, P
   Huang, HZ
   Li, X
   Chen, JW
   Duan, JA
AF Xiao, Ping
   Huang, Hongzhi
   Li, Xiang
   Chen, Jianwei
   Duan, Jin-ao
TI Characterization, evaluation of nutritional parameters of Radix isatidis
   protein and its antioxidant activity in D-galactose induced ageing mice
SO BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
DE Radix isatidis protein; Oxidative damage; Antioxidant activity; Protein
   composition; D-galactose
ID IN-VITRO; ANTIINFLAMMATORY ACTIVITIES; POLYSACCHARIDES; IDENTIFICATION;
   HYDROLYSATE; PEPTIDES; EXTRACT
AB BackgroundRadix isatidis (Isatis indigotica Fort.) is an ancient medicinal herb, which has been applied to the prevention and treatment of influenza virus since ancient times. In recent years, the antioxidant activity of Radix isatidis has been widely concerned by researchers. Our previous studies have shown that Radix isatidis protein (RIP) has good antioxidant activity in vitro. In this study, the composition of the protein was characterized and its antioxidant activity in vivo was evaluated.MethodsThe model of oxidative damage in mice was established by subcutaneous injection of D-galactose for 7weeks. Commercially available kits were used to determine the content of protein and several oxidation indexes in different tissues of mice. The tissue samples were stained with hematoxylin and eosin (H&E) and the pathological changes were observed by optical microscope. The molecular weight of RIP was analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The amino acid composition of RIP was determined by a non-derivative method developed by our research group.ResultsRIP significantly increased the activities of antioxidant enzymes such as SOD, CAT, GSH-Px and total antioxidant capability (TAOC) but decreased the MDA level in the serum, kidney and liver. H&E stained sections of liver and kidney revealed D-galactose could cause serious injury and RIP could substantially attenuate the injury. The analysis of SDS-PAGE showed that four bands with molecular weights of 19.2kDa, 21.5kDa, 24.8kDa and 40.0kDa were the main protein components of RIP.ConclusionsThe results suggested that RIP had excellent antioxidant activity, which could be explored as a health-care product to retard aging and a good source of protein nutrition for human consumption.
C1 [Xiao, Ping; Duan, Jin-ao] Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Natl & Local Collaborat Engn Ctr Chinese Med Reso, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing 210023, Jiangsu, Peoples R China.
   [Xiao, Ping; Duan, Jin-ao] Nanjing Univ Chinese Med, State Adm Tradit Chinese Med, Key Lab Chinese Med Resources Recycling Utilizat, Nanjing 210023, Jiangsu, Peoples R China.
   [Xiao, Ping; Huang, Hongzhi; Li, Xiang; Chen, Jianwei] Nanjing Univ Chinese Med, Coll Pharm, Nanjing 210023, Jiangsu, Peoples R China.
C3 Nanjing University of Chinese Medicine; Nanjing University of Chinese
   Medicine; Nanjing University of Chinese Medicine
RP Duan, JA (corresponding author), Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Natl & Local Collaborat Engn Ctr Chinese Med Reso, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing 210023, Jiangsu, Peoples R China.; Duan, JA (corresponding author), Nanjing Univ Chinese Med, State Adm Tradit Chinese Med, Key Lab Chinese Med Resources Recycling Utilizat, Nanjing 210023, Jiangsu, Peoples R China.; Li, X (corresponding author), Nanjing Univ Chinese Med, Coll Pharm, Nanjing 210023, Jiangsu, Peoples R China.
EM lixiang_8182@163.com; dja@njucm.edu.cn
RI .., What/IXW-6776-2023
FU National Natural Science Foundation of China [81703642]; Key Project of
   Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources
   Industrialization [ZDXM-3-19]; Top-notch Academic Programs Project of
   Jiangsu Higher Education Institutions [TAPP-PPZY2015A070]; Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   (PAPD)
FX The financial grants of this work have been supported by the National
   Natural Science Foundation of China (81703642), Key Project of Jiangsu
   Collaborative Innovation Center of Chinese Medicinal Resources
   Industrialization (ZDXM-3-19), Top-notch Academic Programs Project of
   Jiangsu Higher Education Institutions (TAPP-PPZY2015A070), and Project
   Funded by the Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD). The Funding bodies play no role in the
   design of the study and collection, analysis, and interpretation of data
   and in writing the manuscript.
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   [Anonymous], 1985, WHO TECH REP SER, P1
   Chavan UD, 2001, FOOD CHEM, V75, P145, DOI 10.1016/S0308-8146(01)00122-4
   Chen N, 2012, PEPTIDES, V38, P344, DOI 10.1016/j.peptides.2012.09.017
   Chen X, 2012, AFR J MICROBIOL RES, V6, P1001, DOI [10.5897/AJMR11.1220, 10.5897/AJMR-11-1220]
   Chung YC, 2011, INTEGR CANCER THER, V10, P201, DOI 10.1177/1534735410387420
   Du ZJ, 2013, INT J BIOL MACROMOL, V58, P329, DOI 10.1016/j.ijbiomac.2013.04.037
   Escudero E, 2013, FOOD CHEM, V138, P1282, DOI 10.1016/j.foodchem.2012.10.133
   Fang XB, 2012, FOOD BIOPROD PROCESS, V90, P676, DOI 10.1016/j.fbp.2012.04.001
   Ho YL, 2002, PHYTOMEDICINE, V9, P419, DOI 10.1078/09447110260571661
   Hu XC, 2000, CHINESE J NAT, V02, P122
   Ke CL, 2009, CARBOHYD POLYM, V75, P677, DOI 10.1016/j.carbpol.2008.09.008
   Lei LH, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1975-x
   Meydani M, 1999, MECH AGEING DEV, V111, P123, DOI 10.1016/S0047-6374(99)00067-6
   Delgado MCO, 2011, LWT-FOOD SCI TECHNOL, V44, P1752, DOI 10.1016/j.lwt.2011.04.002
   Pan YL, 2014, B KOREAN CHEM SOC, V35, P197, DOI 10.5012/bkcs.2014.35.1.197
   Prandi B, 2012, J CEREAL SCI, V56, P223, DOI 10.1016/j.jcs.2012.04.008
   Qiao DL, 2009, CARBOHYD POLYM, V78, P199, DOI 10.1016/j.carbpol.2009.03.018
   Sheih IC, 2009, BIORESOURCE TECHNOL, V100, P3419, DOI 10.1016/j.biortech.2009.02.014
   Xiao P., 2014, J FOOD NUTR RES, V11, P831, DOI DOI 10.12691/jfnr-2-11-12
   Xiao P, 2014, J ETHNOPHARMACOL, V157, P55, DOI 10.1016/j.jep.2014.09.005
   Xie NN, 2013, FOOD RES INT, V51, P114, DOI 10.1016/j.foodres.2012.12.001
   Zhou Jianwu, 2017, J Tradit Complement Med, V7, P178, DOI 10.1016/j.jtcme.2016.08.007
   Zhou W, 2013, AM J CHINESE MED, V41, P743, DOI 10.1142/S0192415X1350050X
NR 24
TC 11
Z9 12
U1 2
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6882
J9 BMC COMPLEM ALTERN M
JI BMC Complement. Altern. Med.
PD NOV 6
PY 2019
VL 19
IS 1
AR 297
DI 10.1186/s12906-019-2726-y
PG 9
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA JL5OZ
UT WOS:000495581600003
PM 31694618
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Petrosillo, G
   Matera, M
   Casanova, G
   Ruggiero, FM
   Paradies, G
AF Petrosillo, G.
   Matera, M.
   Casanova, G.
   Ruggiero, F. M.
   Paradies, G.
TI Mitochondrial dysfunction in rat brain with aging Involvement of complex
   I, reactive oxygen species and cardiolipin
SO NEUROCHEMISTRY INTERNATIONAL
LA English
DT Article
DE Complex I; ROS; Cardiolipin; Mitochondria; Brain; Aging
ID ELECTRON-TRANSPORT CHAIN; CYTOCHROME-C-OXIDASE; UBIQUINONE
   OXIDOREDUCTASE COMPLEX; HEART SUBMITOCHONDRIAL PARTICLES; OXIDATIVE
   STRESS; RESPIRATORY-CHAIN; NEURODEGENERATIVE DISEASES; PERMEABILITY
   TRANSITION; LIVER-MITOCHONDRIA; NITRIC-OXIDE
AB Reactive oxygen species (ROS) are considered a key factor in brain aging process. Mitochondrial respiration is an important site of ROS production and hence a potential contributor to brain functional changes with aging. In this study we examined the effect of aging on complex I activity, oxygen consumption, ROS production and phospholipid composition in rat brain mitochondria. The activity of complex I was reduced by 30% in brain mitochondria from 24 months aged rats relative to young animals. These changes in complex I activity were associated with parallel changes in state 3 respiration. H2O2 generation was significantly increased in mitochondria. isolated from aged rats. The mitochondrial content of cardiolipin, a phospholipid required for optimal activity of complex 1, decreased by 31% as function of aging, while there was a significant increase in the level of peroxidized cardiolipin. The age-related decrease in complex I activity in brain mitochondria could be reversed by exogenously added cardiolipin. This effect of cardiolipin could not be replaced by other phospholipids. It is proposed that aging causes brain mitochondrial complex I dysfunction which can be attributed to ROS-induced cardiolipin oxidation. These findings may prove useful in elucidating the mechanism underlying mitochondrial dysfunction associated with brain aging. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Petrosillo, G.; Matera, M.; Casanova, G.; Ruggiero, F. M.; Paradies, G.] Univ Bari, Inst Biomembranes & Bioenerget, CNR, Dept Biochem & Mol Biol, I-70126 Bari, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); Universita degli Studi di Bari
   Aldo Moro
RP Paradies, G (corresponding author), Univ Bari, Inst Biomembranes & Bioenerget, CNR, Dept Biochem & Mol Biol, Via E Orabona 4, I-70126 Bari, Italy.
EM g.paradies@biologia.uniba.it
OI PETROSILLO, GIUSEPPE/0000-0001-8035-8368
FU Italian Ministry for the University (MIUR) [PRIN 2005]
FX The authors thank Mr. G. De Vito for the expert management of
   experimental animals. This work was supported by grants National
   Research Project PRIN 2005 of the Italian Ministry for the University
   (MIUR).
CR BEAL MF, 1998, BIOCHIM BIOPHYS ACTA, V1366, P201
   Berman SB, 1999, J NEUROCHEM, V73, P1127, DOI 10.1046/j.1471-4159.1999.0731127.x
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bolanos JP, 1997, BIOCHEM SOC T, V25, P944, DOI 10.1042/bst0250944
   BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435
   BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x
   Brookes PS, 2002, METHOD ENZYMOL, V359, P305
   Cocco T, 2005, FREE RADICAL BIO MED, V38, P796, DOI 10.1016/j.freeradbiomed.2004.11.034
   Dröse S, 2002, BBA-BIOENERGETICS, V1556, P65, DOI 10.1016/S0005-2728(02)00307-9
   FERRANDIZ ML, 1994, BRAIN RES, V644, P335, DOI 10.1016/0006-8993(94)91699-3
   Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2
   FRY M, 1981, J BIOL CHEM, V256, P1874
   Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3
   McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3
   MIQUEL J, 1986, FREE RADICALS AGING, P51
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   OHTSUKA T, 1993, J BIOL CHEM, V268, P22914
   Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9
   Paradies G, 2001, MITOCHONDRION, V1, P151, DOI 10.1016/S1567-7249(01)00011-3
   Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64
   Paradies G, 1997, FEBS LETT, V406, P136, DOI 10.1016/S0014-5793(97)00264-0
   Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6
   PARINANDI NL, 1988, CHEM PHYS LIPIDS, V49, P215, DOI 10.1016/0009-3084(88)90009-6
   Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102
   Petrosillo G, 2004, J BIOL CHEM, V279, P53103, DOI 10.1074/jbc.M407500200
   Petrosillo G, 2007, BBA-BIOENERGETICS, V1767, P1260, DOI 10.1016/j.bbabio.2007.07.011
   RAGAN CI, 1978, BIOCHEM J, V172, P539, DOI 10.1042/bj1720539
   ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857
   RUGGIERO FM, 1984, LIPIDS, V19, P171, DOI 10.1007/BF02534794
   Sandhu SK, 2003, BIOGERONTOLOGY, V4, P19, DOI 10.1023/A:1022473219044
   Sanz A, 2005, J BIOENERG BIOMEMBR, V37, P83, DOI 10.1007/s10863-005-4131-0
   Sastre J, 2000, FREE RADICAL RES, V32, P189, DOI 10.1080/10715760000300201
   Schlame M, 1997, BBA-LIPID LIPID MET, V1348, P207, DOI 10.1016/S0005-2760(97)00119-7
   Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Sen T, 2007, NEUROCHEM INT, V50, P719, DOI 10.1016/j.neuint.2007.01.007
   Sharman EH, 2001, NEUROBIOL AGING, V22, P629, DOI 10.1016/S0197-4580(01)00226-3
   Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x
   SLATER TF, 1984, BIOCHEM J, V222, P1
   Toescu EC, 2000, CELL CALCIUM, V28, P329, DOI 10.1054/ceca.2000.0167
   Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   VIZIADAM V, 2005, ANTIOXID REDOX SIGN, V7, P1140
NR 52
TC 145
Z9 155
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0197-0186
EI 1872-9754
J9 NEUROCHEM INT
JI Neurochem. Int.
PD NOV
PY 2008
VL 53
IS 5
BP 126
EP 131
DI 10.1016/j.neuint.2008.07.001
PG 6
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 367JN
UT WOS:000260548400004
PM 18657582
DA 2024-02-19
ER

PT J
AU Kowald, A
AF Kowald, A
TI The mitochondrial theory of aging: Do damaged mitochondria accumulate by
   delayed degradation?
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE mitochondrial DNA; survival of the slowest; superoxide radicals;
   mitochondrial theory of aging; damaged mitochondria
ID FREE-RADICAL THEORY; DNA MUTATIONS; HUMAN TISSUES; OXYGEN RADICALS;
   SKELETAL-MUSCLE; HUMAN LIVER; DELETION; INCREASE; AGE; DISEASE
AB The mitochondrial theory of aging states that the slow accumulation of impaired mitochondria is the driving force of the aging process. In recent years, this theory has gained new support with the discovery of age-related mitochondrial DNA deletions. However, the underlying mechanism of the accumulation of defective mitochondria remained unclear. This has changed recently with the proposal of de Grey that damaged mitochondria have a decreased degradation rate. The resulting increase in biological half-life would be a strong selection advantage leading to the accumulation of defective mitochondria. In this article, I summarize current ideas on how damaged organelles can build up in a cell as well as the shortcomings of these ideas. Then the new hypothesis and its justification are described. It appears that de Grey's hypothesis is a very promising concept that elegantly solves inconsistencies of current models and is in accordance with experimental findings. (C) 1999 Elsevier Science Inc. All rights reserved.
C1 Humboldt Univ, Innovat Kolleg Theoret Biol, Berlin, Germany.
C3 Humboldt University of Berlin
RP Kowald, A (corresponding author), Humboldt Univ, Innovat Kolleg Theoret Biol, Berlin, Germany.
OI Kowald, Axel/0000-0001-6448-4364
CR Alberts B., 1994, MOL BIOL CELL
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Antunes F, 1996, FREE RADICAL BIO MED, V21, P917, DOI 10.1016/S0891-5849(96)00185-2
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BIELSKI BHJ, 1983, J BIOL CHEM, V258, P4759
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   De Grey A.D.N.J., 1998, EUR RESPIR J, V1, P53, DOI [10.1089/rej.1.1998.1.53, DOI 10.1089/REJ.1.1998.1.53]
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   GUIDOT DM, 1995, J CLIN INVEST, V96, P1131, DOI 10.1172/JCI118100
   Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   JOENJE H, 1989, MUTAT RES, V219, P193, DOI 10.1016/0921-8734(89)90001-5
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu VWS, 1997, HUM MUTAT, V9, P265, DOI 10.1002/(SICI)1098-1004(1997)9:3<265::AID-HUMU8>3.3.CO;2-6
   MENEGHINI R, 1988, MUTAT RES, V195, P215, DOI 10.1016/0165-1110(88)90001-2
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   Nicholls D.G., 1992, BIOENERGETICS
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   PRYOR WA, 1973, FED PROC, V32, P1862
   Randerath Kurt, 1996, P198
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   WOLFF SP, 1986, TRENDS BIOCHEM SCI, V11, P27, DOI 10.1016/0968-0004(86)90228-8
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Zhang CF, 1996, BIOCHEM BIOPH RES CO, V223, P450, DOI 10.1006/bbrc.1996.0914
NR 42
TC 36
Z9 42
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG
PY 1999
VL 34
IS 5
BP 605
EP 612
DI 10.1016/S0531-5565(99)00011-X
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 232MB
UT WOS:000082373600003
PM 10530786
DA 2024-02-19
ER

PT J
AU Karampatou, A
   Han, X
   Kondili, LA
   Taliani, G
   Ciancio, A
   Morisco, F
   Critelli, RM
   Baraldi, E
   Bernabucci, V
   Troshina, G
   Guarino, M
   Tagliavini, S
   D'Ambrosio, F
   Bristot, L
   Turco, L
   Rosato, S
   Vella, S
   Trenti, T
   Neri, I
   La Marca, A
   Manthena, S
   Goldstein, AS
   Bruno, S
   Bao, YJ
   Gonzalez, YS
   Villa, E
AF Karampatou, Aimilia
   Han, Xue
   Kondili, Loreta A.
   Taliani, Gloria
   Ciancio, Alessia
   Morisco, Filomena
   Critelli, Rosina Maria
   Baraldi, Enrica
   Bernabucci, Veronica
   Troshina, Giulia
   Guarino, Maria
   Tagliavini, Simonetta
   D'Ambrosio, Federica
   Bristot, Laura
   Turco, Laura
   Rosato, Stefano
   Vella, Stefano
   Trenti, Tommaso
   Neri, Isabella
   La Marca, Antonio
   Manthena, Shivaji
   Goldstein, Andrea S.
   Bruno, Savino
   Bao, Yanjun
   Gonzalez, Yuri Sanchez
   Villa, Erica
CA PITER Framework Investigators
TI Premature ovarian senescence and a high miscarriage rate impair
   fertility in women with HCV
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Anti-Mullerian hormone; Antiviral therapy; Sustained viral response;
   HBV; HCV
ID HEPATITIS-C VIRUS; IN-VITRO FERTILIZATION; ANTIMULLERIAN HORMONE;
   SPONTANEOUS-ABORTION; LIVER FIBROSIS; RISK-FACTORS; IGF SYSTEM;
   INFECTION; PREGNANCY; IVF
AB Background & Aims: Premenopausal women who are HCV positive (HCV+)have failing ovarian function, which is likely to impact their fertility. Thus, we investigated the reproductive history, risk of infertility, and pregnancy outcomes in women of childbearing age who were HCV+.
   Methods: Three different groups were studied: (1) Clinical cohort: 100 women who were HCV+ and also had chronic liver disease (CLD), age matched with 50 women who were HBV+ with CLD and with 100 healthy women; all women were consecutively observed in three gastroenterology units in hospitals in Italy; (2) 1,998 women who were HCV+ and enrolled in the Italian Platform for the Study of Viral Hepatitis Therapies (PITER); (3) 6,085 women, who were mono-infected with HCV, and 20,415 women, who were HCV , from a large deidentified insurance database from the USA. Measurements: total fertility rate (TFR) defined as the average number of children that a woman would bear during her lifetime. To define the reproductive stage of each participant, levels of anti-Mullerian hormone (AMH) and 17 beta-estradiol were measured.
   Results: Clinical cohort: women who were either HCV+ or HBV+ had similar CLD severity and age at first pregnancy. Based on a multivariate analysis, women who were HCV+ had a higher risk of miscarriage than those who were HBV+ (odds ratio [OR] 6,905; 95% CI 1.771-26.926). Among women who were HCV+, incidence of miscarriage was correlated with median AMH level (1.0 ng/ml). Achieving a sustained virologic response (SVR) after antiviral treatment reduced the risk of miscarriage (OR 0.255; 95% CI 0.090-0.723). In the PITER-HCV cohort, miscarriage occurred in 42.0% of women (44.6% had multiple miscarriages). TFR for women who were HCV+ and between 15 and 49 years of age was 0.7 vs. 1.37 of Italian population of the same age range. In the US cohort: compared with women who were HCV , women who were HCV+ positive were significantly more likely to have infertility (OR 2.439; 95% CI 2.130-2.794), premature birth (OR 1.34; 95% CI 1.060-1.690), gestational diabetes (OR 1.24; 95% CI 1.020-1.510), and pre-eclampsia (OR 1.206; 95% CI 0.935-1.556), and were less likely to have a live birth (OR 0.754; 95% CI 0.622-0.913).
   Conclusions: Ovarian senescence in women of childbearing age who are HCV+ is associated with a lower chance of live birth, greater risk of infertility, gestational diabetes, pre- eclampsia and miscarriage. Such risks could be positively influenced by successful HCV cure.
   Lay summary: Most new cases of HCV infection are among people who inject drugs, many of whom are young women in their childbearing years. Women of reproductive age who are HCV+ display markers of ovarian senescence. This is associated with an increased burden in terms of infertility and adverse pregnancy outcomes, including stillbirth, miscarriage, fewer live births, and gestational diabetes. Early viral suppression with therapy is likely to mitigate these risks. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V.
C1 [Karampatou, Aimilia; Critelli, Rosina Maria; Bernabucci, Veronica; D'Ambrosio, Federica; Bristot, Laura; Turco, Laura; Villa, Erica; PITER Framework Investigators] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin Modena, Div Gastroenterol, Modena, Italy.
   [Han, Xue] Univ Southern Calif, Leonard D Schaeffer Ctr, Los Angeles, CA USA.
   [Kondili, Loreta A.; Rosato, Stefano; Vella, Stefano] Ist Super Sanita, Ctr Global Hlth, Rome, Italy.
   [Taliani, Gloria] Univ Roma La Sapienza, Dept Clin Med, Rome, Italy.
   [Ciancio, Alessia; Troshina, Giulia] Univ Turin, Div Gastroenterol, Turin, Italy.
   [Morisco, Filomena; Guarino, Maria] Univ Naples Federico II, Gastroenterol Unit, Dept Clin Med & Surg, Naples, Italy.
   [Baraldi, Enrica; Tagliavini, Simonetta; Trenti, Tommaso] Osped S Agostino Estense, Clin Pathol Toxicol, Modena, Italy.
   [Neri, Isabella; La Marca, Antonio] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin Modena, Obstet & Gynecol, Modena, Italy.
   [Manthena, Shivaji; Goldstein, Andrea S.; Bao, Yanjun; Gonzalez, Yuri Sanchez] AbbVie Inc, N Chicago, IL USA.
   [Bruno, Savino] Humanitas Univ, Milan, Italy.
   [Bruno, Savino] Humanitas Res Hosp Rozzano, Milan, Italy.
C3 Universita di Modena e Reggio Emilia; Universita di Modena e Reggio
   Emilia Hospital; University of Southern California; Istituto Superiore
   di Sanita (ISS); Sapienza University Rome; University of Turin;
   University of Naples Federico II; Universita di Modena e Reggio Emilia;
   Universita di Modena e Reggio Emilia Hospital; AbbVie; Humanitas
   University
RP Villa, E (corresponding author), Univ Modena & Reggio Emilia, Gastroenterol Unit, Dept Internal Med, Via Pozzo 71, I-41124 Modena, Italy.; Villa, E (corresponding author), Azienda Osped Univ Modena, Via Pozzo 71, I-41124 Modena, Italy.
EM erica.villa@unimore.it
RI La Marca, Antonio/A-5940-2015; Chessa, Luchino/K-4255-2019; Simonetti,
   Giulia/W-7286-2018; Andreone, Pietro/K-8050-2016; Bruno,
   Raffaele/AAB-9491-2022; Vella, Stefano/GZM-0519-2022; Mondelli, Mario
   U/J-5375-2016; Morisco, Filomena/AHI-0851-2022; VELLA,
   STEFANO/V-8440-2019; guarino, maria/AAM-6001-2020; KONDILI,
   LORETA/J-8784-2016; Masarone, Mario/H-8633-2017; VELLA,
   STEFANO/ABI-3368-2020; Turco, Laura/AAZ-1790-2020; Villa,
   Erica/A-7576-2012; Trenti, Tommaso/K-8457-2016; Mallano,
   Alessandra/D-7959-2016; Gragnani, Laura/K-7751-2013
OI La Marca, Antonio/0000-0001-7921-9547; Chessa,
   Luchino/0000-0002-9474-0995; Simonetti, Giulia/0000-0001-8306-6133;
   Andreone, Pietro/0000-0002-4794-9809; Bruno,
   Raffaele/0000-0002-0235-9207; Mondelli, Mario U/0000-0003-1811-3153;
   VELLA, STEFANO/0000-0003-2347-5984; guarino, maria/0000-0002-0460-4122;
   KONDILI, LORETA/0000-0003-2656-224X; Masarone,
   Mario/0000-0003-0550-8201; Villa, Erica/0000-0001-6388-7022; Trenti,
   Tommaso/0000-0001-8093-4011; Turco, Laura/0000-0001-8148-3769; Persico,
   Marcello/0000-0002-1399-6498; DALLIO, MARCELLO/0000-0003-4153-815X;
   RUSSO, FRANCESCO PAOLO/0000-0003-4127-8941; BRUNETTO, MAURIZIA
   ROSSANA/0000-0001-8364-9152; Mazzella, Giuseppe/0000-0001-8656-8112;
   Rosato, Stefano/0000-0002-6690-5537; Mallano,
   Alessandra/0000-0003-2392-0769; Morisco, Filomena/0009-0006-1537-5034;
   Filomia, Roberto/0000-0002-8335-6816; Castelli,
   Francesco/0000-0001-9161-7804; Brancaccio,
   Giuseppina/0000-0001-5643-0139; Gragnani, Laura/0000-0001-6800-9149;
   Federico, Alessandro/0000-0002-0885-0793; Zanetto,
   Alberto/0000-0002-6734-7178; Puoti, Massimo/0000-0003-3278-7138;
   Toniutto, Pierluigi/0000-0002-2566-3041; Crisanti,
   Andrea/0000-0002-2406-4426; morisco, filomena/0000-0002-9059-8311
FU Programma di Ricerca Regione-Universita - Area 2 'Ricerca per il Governo
   Clinico' (Regione Emilia Romagna) [PRUa2-2013-00002033]
FX This work was supported by Programma di Ricerca Regione-Universita 2013
   - Area 2 'Ricerca per il Governo Clinico' (Regione Emilia Romagna), code
   PRUa2-2013-00002033 to EV and TT. The opinions, results, and conclusions
   reported in this paper are those of the authors and are independent from
   the funding sources.
CR Aboulghar M, 2014, FERTIL STERIL, V101, P134, DOI 10.1016/j.fertnstert.2013.09.028
   Al-Kubaisy W A, 2002, East Mediterr Health J, V8, P239
   [Anonymous], 2014, ISTAT
   Bonefeld K, 2011, LIVER INT, V31, P911, DOI 10.1111/j.1478-3231.2010.02428.x
   Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013
   Cacoub P, 2016, THER ADV INFECT DIS, V3, P3, DOI 10.1177/2049936115585942
   CAVALLO F, 1995, ALCOHOL ALCOHOLISM, V30, P195
   Codes L, 2007, GUT, V56, P390, DOI 10.1136/gut.2006.101931
   Connell LE, 2011, LIVER INT, V31, P1163, DOI 10.1111/j.1478-3231.2011.02556.x
   Cui AM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0884-1
   Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062
   Di Martino V, 2004, HEPATOLOGY, V40, P1426, DOI 10.1002/hep.20463
   Ditah I, 2014, J HEPATOL, V60, P691, DOI 10.1016/j.jhep.2013.11.014
   Durazzo M, 2006, WORLD J GASTROENTERO, V12, P3073, DOI 10.3748/wjg.v12.i19.3073
   Englert Y, 2007, FERTIL STERIL, V88, P607, DOI 10.1016/j.fertnstert.2006.11.177
   Furusyo N, 2012, J HEPATOL, V57, P1186, DOI 10.1016/j.jhep.2012.08.003
   García-Enguídanos A, 2002, EUR J OBSTET GYN R B, V102, P111, DOI 10.1016/S0301-2115(01)00613-3
   Hanafi NF, 2011, HUM REPROD, V26, P143, DOI 10.1093/humrep/deq317
   Hanson BM, 2017, AM J OBSTET GYNECOL, V384, P980
   Hanson BM, 2017, AM J OBSTET GYNECOL, V217, P4, DOI 10.1016/j.ajog.2017.02.012
   Hofny ERM, 2011, FERTIL STERIL, V95, P2557, DOI 10.1016/j.fertnstert.2011.05.014
   Huang QT, 2015, J VIRAL HEPATITIS, V22, P1033, DOI 10.1111/jvh.12430
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Iwase A, 2016, REPROD SCI, V23, P756, DOI 10.1177/1933719115618284
   Jabeen T, 2000, QJM-INT J MED, V93, P597, DOI 10.1093/qjmed/93.9.597
   Kondili LA, 2015, DIGEST LIVER DIS, V47, P741, DOI 10.1016/j.dld.2015.05.022
   La Marca A, 2016, GYNECOL ENDOCRINOL, V32, P1, DOI 10.3109/09513590.2015.1102879
   Lisovskaya TV, 2015, GYNECOL ENDOCRINOL, V31, P18, DOI 10.3109/09513590.2015.1085195
   MEDHAT A, 1993, INT J GYNECOL OBSTET, V40, P25, DOI 10.1016/0020-7292(93)90768-R
   Monget P, 2000, MOL CELL ENDOCRINOL, V163, P89, DOI 10.1016/S0303-7207(99)00244-0
   Morris MD, 2017, CLIN INFECT DIS, V64, P860, DOI 10.1093/cid/ciw869
   Nardo LG, 2009, FERTIL STERIL, V92, P1586, DOI 10.1016/j.fertnstert.2008.08.127
   Nie QH, 2012, J MED VIROL, V84, P1586, DOI 10.1002/jmv.23380
   Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983
   Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947
   Pergam SA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.052
   Rasch V, 2003, ACTA OBSTET GYN SCAN, V82, P182, DOI 10.1034/j.1600-0412.2003.00078.x
   Sifer C, 2002, HUM REPROD, V17, P1773, DOI 10.1093/humrep/17.7.1773
   Silva JRV, 2009, THERIOGENOLOGY, V71, P1193, DOI 10.1016/j.theriogenology.2008.12.015
   Sugiyama K, 1997, JPN J CANCER RES, V88, P925, DOI 10.1111/j.1349-7006.1997.tb00309.x
   Tal R, 2015, FERTIL STERIL, V103, P119, DOI 10.1016/j.fertnstert.2014.09.041
   Tracy D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004988
   Villa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044624
   Villa E, 2011, GASTROENTEROLOGY, V140, P818, DOI 10.1053/j.gastro.2010.12.027
   Wilcox A J, 1990, Epidemiology, V1, P382, DOI 10.1097/00001648-199009000-00008
NR 45
TC 15
Z9 15
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD JAN
PY 2018
VL 68
IS 1
BP 33
EP 41
DI 10.1016/j.jhep.2017.08.019
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA FR5HZ
UT WOS:000419098800008
PM 28882581
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Li, WQ
   Li, XN
   Miller, RA
AF Li, Weiquan
   Li, Xinna
   Miller, Richard A.
TI ATF4 activity: a common feature shared by many kinds of slow-aging mice
SO AGING CELL
LA English
DT Article
DE acarbose; caloric restriction; longevity; methionine restriction;
   rapamycin
ID EXTENDS LIFE-SPAN; ASPARAGINE SYNTHETASE; TARGETED DISRUPTION;
   RAPAMYCIN; TRANSCRIPTION; METABOLISM; RESISTANCE; EXTENSION; GLUCOSE;
   MTOR
AB ATF4, a DNA-binding factor that modulates responses to amino acid availability and ribosomal function, has been shown to be altered in both liver and fibroblasts from two strains of long-lived mice, i.e. Snell dwarf and PAPP-A knockout mice. New data now show elevated ATF4 levels, and elevation of ATF4-dependent proteins and mRNAs, in liver of mice treated with acarbose or rapamycin, calorically restricted mice, methionine-restricted mice, and mice subjected to litter crowding. Elevation of ATF4, at least in liver, thus seems to be a shared feature of diets, drugs, genes, and developmental alterations that extend maximum lifespan in mice.
C1 [Li, Weiquan; Li, Xinna; Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.
   [Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan
RP Miller, RA (corresponding author), BSRB 3001,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.
EM millerr@umich.edu
RI yang, qing/JBR-8440-2023
OI Li, Xinna/0000-0002-7461-5628
FU NIH [AG013283, AG024824, AG019899]; Ellison Medical Foundation
FX This work was supported by NIH grants AG013283, AG024824, and AG019899
   and by a Senior Scholar award from the Ellison Medical Foundation.
CR Al Sarraj J, 2005, BIOL CHEM, V386, P873, DOI 10.1515/BC.2005.102
   Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420
   Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559
   Conover CA, 2007, AGING CELL, V6, P727, DOI 10.1111/j.1474-9726.2007.00328.x
   Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050
   Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345
   Flurkey K, 2010, J GERONTOL A-BIOL, V65, P1275, DOI 10.1093/gerona/glq155
   Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9
   Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hinojosa CA, 2012, EXP GERONTOL, V47, P958, DOI 10.1016/j.exger.2012.08.013
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Li WQ, 2015, J GERONTOL A-BIOL, V70, P263, DOI 10.1093/gerona/glu040
   Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674
   Ren Y, 2004, ONCOGENE, V23, P3953, DOI 10.1038/sj.onc.1207498
   Sadagurski M, 2014, AM J PHYSIOL-ENDOC M, V306, pE1305, DOI 10.1152/ajpendo.00031.2014
   Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037
   Steinbaugh MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE488, DOI 10.1152/ajpendo.00110.2012
   Su N, 2009, HEPATOLOGY, V50, P282, DOI 10.1002/hep.22971
   SUGIYAMA RH, 1983, MOL CELL BIOL, V3, P1937, DOI 10.1128/MCB.3.11.1937
   Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051
   Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x
   Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4
   Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003
   Wang XQ, 2013, INVEST OPHTH VIS SCI, V54, P5995, DOI 10.1167/iovs.13-12117
   Weindruch R., 1988, RETARDATION AGING DI
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Yamamoto M, 2006, METABOLISM, V55, P533, DOI 10.1016/j.metabol.2005.11.007
   Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366
   Zhang Q, 2013, DIABETES, V62, P2230, DOI 10.2337/db12-1050
   Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200
   Zhu K, 2013, J BONE MINER RES, V28, P1870, DOI 10.1002/jbmr.1958
   Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3
NR 37
TC 53
Z9 56
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD DEC
PY 2014
VL 13
IS 6
BP 1012
EP 1018
DI 10.1111/acel.12264
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA AU2ON
UT WOS:000345457900005
PM 25156122
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Farahmand, SK
   Samini, F
   Samini, M
   Samarghandian, S
AF Farahmand, Seyed Kazem
   Samini, Fariborz
   Samini, Mohammad
   Samarghandian, Saeed
TI Safranal ameliorates antioxidant enzymes and suppresses lipid
   peroxidation and nitric oxide formation in aged male rat liver
SO BIOGERONTOLOGY
LA English
DT Article
DE Safranal; Antioxidant; Liver; Aging; Rat
ID CROCUS-SATIVUS L.; GLUTATHIONE-S-TRANSFERASE; PROOXIDANT SIGNALING
   SYSTEMS; FREE-RADICAL THEORY; OXIDATIVE STRESS; LIFE-SPAN; SAFFRON;
   BRAIN; EXTRACT; CONSTITUENT
AB Free radical production and oxidative stress are known to increase in liver during aging, and may contribute to oxidative damage. The objective of this study was to observe the changes in activities of antioxidant enzymes (superoxide dismutase, glutathione-S-transferase, catalase), lipid peroxidation levels and serum nitric oxide occurring in livers of rats of 2, 10 and 20 months old, and to see whether these changes are restored to those of the two month old control levels rats after administration of safranal. The aged rats (10 and 20 months) were given intraperitoneal injections of safranal (0.5 mg/kg day) daily for one month. The results obtained in the present work revealed that normal aging was associated with a significant decrease in the activities of antioxidant enzymes, and an increase in lipid peroxidation in livers and nitric oxide content in serum of aging rats. The results of the present study demonstrate that safranal could be a candidate to suppress the development of age-induced damage by protecting against oxidative stress and increasing antioxidant defenses. A likely mode of action of safranal can be its activity as a hormetin by inducing mild oxidative damage which leads to the activation of antioxidative enzymes.
C1 [Farahmand, Seyed Kazem; Samarghandian, Saeed] Neyshabur Med Fac Sci, Hlth Strateg Res Ctr, Neyshabur, Iran.
   [Samini, Fariborz; Samini, Mohammad] Mashhad Univ Med Sci, Dept Neurosurg, Fac Sci, Mashhad, Iran.
C3 Mashhad University Medical Science
RP Samini, F (corresponding author), Mashhad Univ Med Sci, Dept Neurosurg, Fac Sci, Mashhad, Iran.
EM saminif@mums.ac.ir; samarghandians@mums.ac.ir
FU Mashhad University of Medical Sciences
FX The authors would like to thank research affairs of Mashhad University
   of Medical Sciences for financially supporting this work.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Ali RE, 2006, ANN NY ACAD SCI, V1067, P394, DOI 10.1196/annals.1354.056
   Alonso GL, 1998, J FOOD PROTECT, V61, P1525, DOI 10.4315/0362-028X-61.11.1525
   Assimopoulou AN, 2005, PHYTOTHER RES, V19, P997, DOI 10.1002/ptr.1749
   Baquer NZ, 2009, BIOGERONTOLOGY, V10, P377, DOI 10.1007/s10522-009-9226-2
   BASKER D, 1983, ECON BOT, V37, P228, DOI 10.1007/BF02858789
   Bharti S, 2012, EUR J NUTR, V51, P719, DOI 10.1007/s00394-011-0251-y
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carrillo MC, 2002, MECH AGEING DEV, V123, P1617, DOI 10.1016/S0047-6374(02)00097-0
   CASTELLAR MR, 1993, J CHROMATOGR, V648, P187, DOI 10.1016/0021-9673(93)83301-8
   Chang VC, 1996, ANTICANCER RES, V765, P3603
   CHEN LH, 1994, ARCH GERONTOL GERIAT, V18, P191, DOI 10.1016/0167-4943(94)90013-2
   CONGY F, 1995, PRESSE MED, V24, P1115
   Dufresne C, 1997, PLANTA MED, V63, P150, DOI 10.1055/s-2006-957633
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   García-Olmo DC, 1999, NUTR CANCER, V35, P120, DOI 10.1207/S15327914NC352_4
   Genet S, 2002, MOL CELL BIOCHEM, V236, P7, DOI 10.1023/A:1016103131408
   Geromichalos GD, 2012, J AGR FOOD CHEM, V60, P6131, DOI 10.1021/jf300589c
   Gout B, 2010, NUTR RES, V30, P305, DOI 10.1016/j.nutres.2010.04.008
   Halataei BAS, 2011, PHYTOTHER RES, V25, P1833, DOI 10.1002/ptr.3495
   Hariri AT, 2010, FOOD CHEM TOXICOL, V48, P2803, DOI 10.1016/j.fct.2010.07.010
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Hashimoto M, 2001, EXP GERONTOL, V37, P89, DOI 10.1016/S0531-5565(01)00164-4
   Hayashi T, 2010, GERIATR GERONTOL INT, V10, P115, DOI 10.1111/j.1447-0594.2009.00581.x
   Hayes DP, 2007, EUR J CLIN NUTR, V61, P147, DOI 10.1038/sj.ejcn.1602507
   HORTELANO S, 1995, HEPATOLOGY, V21, P776
   Hosseinzadeh H, 2005, J PHARM PHARM SCI, V8, P394
   Hosseinzadeh H., 2002, Arch. Irn. Med, V5, P44
   Hosseinzadeh H, 2007, DNA CELL BIOL, V26, P841, DOI 10.1089/dna.2007.0631
   Hosseinzadeh H, 2009, EVID-BASED COMPL ALT, V6, P343, DOI 10.1093/ecam/nem125
   Kanakis CD, 2007, J AGR FOOD CHEM, V55, P970, DOI 10.1021/jf062638l
   Kitani K., 1989, LIFE CHEM REPORTS, V6, P143
   Kumar P, 2008, BIOGERONTOLOGY, V9, P235, DOI 10.1007/s10522-008-9133-y
   KURECHI T, 1980, CHEM PHARM BULL, V28, P2089
   Lamming DW, 2004, MOL MICROBIOL, V53, P1003, DOI 10.1111/j.1365-2958.2004.04209.x
   Linnane AW, 2006, ANN NY ACAD SCI, V1067, P47, DOI 10.1196/annals.1354.008
   Linnane AW, 2007, BIOGERONTOLOGY, V8, P445, DOI 10.1007/s10522-007-9096-4
   Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100
   Mantha AK, 2006, BIOGERONTOLOGY, V7, P19, DOI 10.1007/s10522-005-6044-z
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Mármol F, 2010, PHYSIOL RES, V59, P553, DOI 10.33549/physiolres.931768
   Martínez-Lara E, 2003, NEUROBIOL AGING, V24, P501, DOI 10.1016/S0197-4580(02)00139-2
   Mattson MP, 2008, AGEING RES REV, V7, P43, DOI 10.1016/j.arr.2007.08.004
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Melov S, 2001, J NEUROSCI, V21, P8348, DOI 10.1523/JNEUROSCI.21-21-08348.2001
   Papandreou MA, 2011, BEHAV BRAIN RES, V219, P197, DOI 10.1016/j.bbr.2011.01.007
   PIEPER GM, 1995, DIABETES, V44, P884, DOI 10.2337/diabetes.44.8.884
   Putics A, 2008, ANTIOXID REDOX SIGN, V10, P65, DOI 10.1089/ars.2007.1866
   Rattan SIS, 2008, AGEING RES REV, V7, P63, DOI 10.1016/j.arr.2007.03.002
   Rattan SIS, 2012, EXPERT OPIN DRUG DIS, V7, P439, DOI 10.1517/17460441.2012.677430
   Rattan SIS, 2012, BIOGERONTOLOGY, V13, P83, DOI 10.1007/s10522-011-9354-3
   RODRIGUEZMARTINEZ MA, 1992, MECH AGEING DEV, V66, P213, DOI 10.1016/0047-6374(92)90137-3
   Samarghandian S, 2011, APPL BIOCHEM BIOTECH, V164, P238, DOI 10.1007/s12010-010-9130-x
   Samarghandian S, 2010, PHARMACOGN MAG, V6, P309, DOI 10.4103/0973-1296.71799
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   Sheng L, 2006, EUR J PHARMACOL, V543, P116, DOI 10.1016/j.ejphar.2006.05.038
   Siddiqui MR, 2005, J BIOSCIENCES, V30, P483, DOI 10.1007/BF02703722
   SIMPSON JA, 1992, BIOCHEM J, V282, P621, DOI 10.1042/bj2820621
   Singh SP, 2002, J BIOL CHEM, V277, P4232, DOI 10.1074/jbc.M109678200
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sudheesh NP, 2010, CLIN NUTR, V29, P406, DOI 10.1016/j.clnu.2009.12.003
   Tew KD, 1999, DRUG RESIST UPDATE, V2, P143, DOI 10.1054/drup.1999.0086
   VANELLA A, 1982, GERONTOLOGY, V28, P108, DOI 10.1159/000212519
   Vendemiale G, 1999, INT J CLIN LAB RES, V29, P49, DOI 10.1007/s005990050063
NR 67
TC 72
Z9 75
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD FEB
PY 2013
VL 14
IS 1
BP 63
EP 71
DI 10.1007/s10522-012-9409-0
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 127HH
UT WOS:000317688400005
PM 23179288
DA 2024-02-19
ER

PT J
AU Sinha-Hikim, I
   Sinha-Hikim, AP
   Parveen, M
   Shen, RQ
   Goswami, R
   Tran, P
   Crum, A
   Norris, KC
AF Sinha-Hikim, Indrani
   Sinha-Hikim, Amiya P.
   Parveen, Meher
   Shen, Ruoqing
   Goswami, Rudrani
   Tran, Peter
   Crum, Albert
   Norris, Keith C.
TI Long-Term Supplementation With a Cystine-Based Antioxidant Delays Loss
   of Muscle Mass in Aging
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Antioxidant; Mice; Muscle cell apoptosis; Oxidative stress; Sarcopenia
ID JUN NH2-TERMINAL KINASE; OXIDATIVE STRESS; SKELETAL-MUSCLE; NUCLEAR
   TRANSLOCATION; RESVERATROL PREVENTS; HEPATIC STEATOSIS; APOPTOSIS;
   SARCOPENIA; CELLS; INHIBITION
AB Oxidative stress increases with age and is postulated to be a major causal factor for sarcopenia in aging. Here, we examined whether the administration of a cystine-based antioxidant (F1) can alleviate/delay age-specific changes in skeletal muscles. C57BL6 male mice aged 17 months (middle aged) were fed with normal diet with or without supplementation of F1 (3 mg/kg food) for 6 months. Compared with young (5 months old) mice old mice exhibited increased markers of oxidative stress, inflammation, and muscle cell apoptosis and decreased muscle weight. These age-related changes were further associated with inactivation of adenosine-5'-monophosphate-activated protein kinase (AMPK), increased lipogenesis, activation of c-Jun NH2-terminal kinase, and decreased expression of Delta 1, phospho-Akt, and proliferating cell nuclear antigen in aged skeletal muscle. Such alterations were significantly prevented by F1. These results demonstrate the beneficial effects of F1 to attenuate loss of muscle mass associated with aging.
C1 [Sinha-Hikim, Indrani; Sinha-Hikim, Amiya P.; Parveen, Meher; Shen, Ruoqing; Goswami, Rudrani; Tran, Peter; Norris, Keith C.] Charles R Drew Univ Med & Sci, Dept Internal Med, Los Angeles, CA USA.
   [Sinha-Hikim, Indrani; Norris, Keith C.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA.
   [Crum, Albert] Proimmune, Rhinebeck, NY USA.
C3 Charles R. Drew University of Medicine & Science; University of
   California System; University of California Los Angeles; University of
   California Los Angeles Medical Center; David Geffen School of Medicine
   at UCLA
RP Sinha-Hikim, I (corresponding author), Charles R Drew Univ Med & Sci, 1731 East 120th St, Los Angeles, CA USA.
EM indranisinhahikim@cdrewu.edu
FU American Federation of Aging Research; National Institutes of Health
   [U54MD007598, U54RR026138, P20MD00182, 3P30AG021684]
FX This work was supported by a grant from the American Federation of Aging
   Research (I. S-H.). Additional support was provided by the National
   Institutes of Health grants (U54MD007598, formerly U54RR026138 to K.C.N.
   and I. S-H., P20MD00182 to K.C.N., 3P30AG021684 to K.C.N.).
CR Alway SE, 2008, EXERC SPORT SCI REV, V36, P51, DOI 10.1097/JES.0b013e318168e9dc
   Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622
   Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520
   Bonetto A, 2009, FREE RADICAL BIO MED, V47, P906, DOI 10.1016/j.freeradbiomed.2009.07.002
   Braga M, 2008, APOPTOSIS, V13, P822, DOI 10.1007/s10495-008-0216-7
   Centeno-Baez C, 2011, AM J PHYSIOL-ENDOC M, V301, pE922, DOI 10.1152/ajpendo.00530.2010
   Chopra I, 2012, DIABETOLOGIA, V55, P783, DOI 10.1007/s00125-011-2407-y
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Crum A., 2007, US RE39734E, Patent No. [US. RE39734E, 39734]
   Doria E, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/830257
   Dupont-Versteegden EE, 2006, AM J PHYSIOL-REG I, V291, pR1730, DOI 10.1152/ajpregu.00176.2006
   Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x
   Hao YL, 2011, AM J PHYSIOL-REG I, V301, pR701, DOI 10.1152/ajpregu.00840.2010
   Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473
   Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003
   Jackson JR, 2011, J GERONTOL A-BIOL, V66, P751, DOI 10.1093/gerona/glr047
   Jackson JR, 2010, AM J PHYSIOL-REG I, V299, pR1572, DOI 10.1152/ajpregu.00489.2010
   Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2
   Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177
   Lieberthal W, 2011, AM J PHYSIOL-RENAL, V301, pF1177, DOI 10.1152/ajprenal.00034.2011
   Martin C, 2007, AGING CELL, V6, P165, DOI 10.1111/j.1474-9726.2007.00271.x
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   Marzetti E, 2012, GERONTOLOGY, V58, P99, DOI 10.1159/000330064
   McKiernan S, 2004, FASEB J, V18, P580, DOI 10.1096/fj.03-0667fje
   Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509
   Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260
   Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295
   Pallafacchina G, 2012, NUTR METAB CARDIOVAS
   Pinheiro CHJ, 2012, SCAND J MED SCI SPOR, V22, P24, DOI 10.1111/j.1600-0838.2010.01143.x
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595
   Ryan MJ, 2011, FREE RADICAL BIO MED, V51, P38, DOI 10.1016/j.freeradbiomed.2011.04.002
   Shadrach JL, 2011, PHILOS T R SOC B, V366, P2297, DOI 10.1098/rstb.2011.0027
   Sinha-Hikim I, 2007, APOPTOSIS, V12, P1965, DOI 10.1007/s10495-007-0120-6
   Sinha-Hikim I, 2011, EXP MOL PATHOL, V91, P419, DOI 10.1016/j.yexmp.2011.04.009
   Sinha-Hikim I, 2010, AM J PHYSIOL-CELL PH, V299, pC638, DOI 10.1152/ajpcell.00434.2009
   Sinha-Hikim I, 2010, CELL BIOL INT, V34, P503, DOI 10.1042/CBI20090349
   Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266
   United States Census Bureau, 2010, CENS BRIEFS OLD POP
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
NR 44
TC 45
Z9 51
U1 0
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JUL
PY 2013
VL 68
IS 7
BP 749
EP 759
DI 10.1093/gerona/gls334
PG 11
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 191WQ
UT WOS:000322446000001
PM 23459206
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU LOPEZTORRES, M
   PEREZCAMPO, R
   DEQUIROGA, GB
AF LOPEZTORRES, M
   PEREZCAMPO, R
   DEQUIROGA, GB
TI AGING IN BROWN FAT - ANTIOXIDANT DEFENSES AND OXIDATIVE STRESS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; BROWN FAT; SUPEROXIDE DISMUTASE; CATALASE; GLUTATHIONE;
   PEROXIDATION; FREE RADICALS
ID AGE-RELATED-CHANGES; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION;
   ADIPOSE-TISSUE; RAT-LIVER; GLUTATHIONE-PEROXIDASE; DRUG-TREATMENT;
   ENZYMES; BRAIN; SYSTEM
AB Brown adipose tissue (BAT) responds to physiological stimulation with high rates of mitochondrial O2 consumption, and with high rates of lipid turnover. These are the most susceptible molecules to peroxidation. Thus, it is important to elucidate the changes in antioxidant defenses and lipid peroxidation that occur in this tissue during the lifetime of the individual. It is shown for the first time that during development from young (3 months) to mature adults (9 months) quantitatively important increases of all the antioxidant enzymes (superoxide dismutase, catalase, selenium dependent and independent glutathione peroxidases and glutathione reductase) take place in BAT. This is concordant with the much higher aerobic capacity and sensitivity to in vitro peroxidation of the tissue in mature adults than in the young. During aging (from 9 to 28 months of age), aerobic capacity is clearly reduced. Nevertheless, the sensitivity of BAT to in vitro peroxidation is maintained in old animals and, accordingly, the antioxidant defensive systems do not show important changes either.
C1 COMPLUTENSE UNIV MADRID, FAC BIOL, DEPT ANIM BIOL ANIM PHYSIOL 2, E-28040 MADRID, SPAIN.
C3 Complutense University of Madrid
OI Barja, Gustavo/0000-0001-5736-4735
CR ANSARI KA, 1989, GROWTH DEVELOP AGING, V53, P117
   BALL EG, 1961, P NATL ACAD SCI USA, V47, P932, DOI 10.1073/pnas.47.7.932
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   BENZI G, 1988, NEUROBIOL AGING, V9, P371, DOI 10.1016/S0197-4580(88)80083-6
   BENZI G, 1988, NEUROCHEM RES, V13, P467, DOI 10.1007/BF01268883
   BERNARD T, 1980, BIOGENIC AMINES DEV, P391
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   DANH HC, 1983, J NEUROCHEM, V40, P1003, DOI 10.1111/j.1471-4159.1983.tb08084.x
   DEQUIROGA GB, 1988, J COMP PHYSIOL B, V158, P583, DOI 10.1007/BF00692567
   DEVASAGAYAM TPA, 1986, FEBS LETT, V205, P246, DOI 10.1016/0014-5793(86)80906-1
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HOTHERSALL JS, 1981, ENZYME, V26, P271, DOI 10.1159/000459190
   ISCHIROPOULOS H, 1990, MECH AGEING DEV, V52, P11, DOI 10.1016/0047-6374(90)90141-2
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   LAMMIKEEFE CJ, 1984, GERONTOLOGY, V30, P153, DOI 10.1159/000212623
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   MIZUNO Y, 1986, J NEUROCHEM, V46, P1344, DOI 10.1111/j.1471-4159.1986.tb01745.x
   NNODIM JO, 1988, ANAT REC, V220, P357, DOI 10.1002/ar.1092200403
   NNODIM JO, 1985, ANAT EMBRYOL, V173, P215, DOI 10.1007/BF00316302
   PAGLIA DE, 1967, J LAB CLIN MED, V276, P368
   PAOLETTI F, 1986, ANAL BIOCHEM, V154, P536, DOI 10.1016/0003-2697(86)90026-6
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   SEKHAR BS, 1987, J BIOENERG BIOMEMBR, V19, P397, DOI 10.1007/BF00768542
   SIMON G, 1965, HDB PHYSL 5, P101
   SKALA J, 1972, INT J BIOCHEM, V3, P229, DOI 10.1016/0020-711X(72)90084-5
   SMITH L, 1955, Methods Biochem Anal, V2, P427, DOI 10.1002/9780470110188.ch13
   Smith R. E., 1961, PHYSIOLOGIST, V4, P113
   TAYARANI I, 1989, J NEUROCHEM, V53, P817, DOI 10.1111/j.1471-4159.1989.tb11778.x
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   VITORICA J, 1984, J NEUROCHEM, V42, P351, DOI 10.1111/j.1471-4159.1984.tb02685.x
NR 36
TC 6
Z9 8
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN 14
PY 1991
VL 59
IS 1-2
BP 129
EP 137
DI 10.1016/0047-6374(91)90079-F
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FR468
UT WOS:A1991FR46800011
PM 1890877
DA 2024-02-19
ER

PT J
AU Cho, CG
   Kim, HJ
   Chung, SW
   Jung, KJ
   Shim, KH
   Yu, BP
   Yodoi, J
   Chung, HY
AF Cho, CG
   Kim, HJ
   Chung, SW
   Jung, KJ
   Shim, KH
   Yu, BP
   Yodoi, J
   Chung, HY
TI Modulation of glutathione and thioredoxin systems by calorie restriction
   during the aging process
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE thioredoxin; glutathione; aging; calorie restriction; Ref-1; GSH
   reductase; GSH peroxidase; GSH S-transferase
ID AGE-RELATED-CHANGES; OXIDATIVE STRESS; FISCHER-344 RATS; REDOX
   REGULATION; METABOLISM; REDUCTASE; LONGEVITY; CANCER; LIVER; INVOLVEMENT
AB Accumulating evidence strongly suggests that oxidative stress underlies aging processes and that calorie restriction (CR) retards aging processes, leading to an extended lifespan for various organisms. Recent studies revealed that the anti-aging action of CR depends on its antioxidative mechanism. However, at present, the status of glutathione (GSH) and thioredoxin (Trx) system, two major thiol redox systems in animal cells during aging and its modulation by CR has not fully been explored. The purpose of this study is two-fold: one, to determine whether these two systems in rat kidney are altered as a consequence of aging; two, to determine whether these systems can be modulated by anti-oxidative CR. The results of our study showed that GSH and GSH-related enzyme activities decreased with age in ad libitum (AL)-fed rats, while CR rats consistently showed resistance to decreases in these activities. Data from the present data further showed that while Trx and Trx reductase (TrxR) in cytoplasm decrease with age in AL-fed rats, CR prevents these decreases. In contrast, we also found that the nuclear translocation of the redox regulators, Trx and Ref-1, increase with age, which was suppressed in CR rats. Therefore, increases in nuclear Trx and Ref-1 during aging may result in the up-regulation of redox-sensitive transcription factors, such as NF-kappaB or AP-1, via the interaction of Ref-1 and Trx in a redox-dependent manner. Our conclusion is that a redox imbalance occurs during aging and that redox changes are minimized through the anti-oxidative action of CR. (C) 2003 Elsevier Science Inc. All rights reserved.
C1 Pusan Natl Univ, Coll Pharm, Dept Pharm, Gumjung gu, Pusan 609735, South Korea.
   Univ Texas, Hlth Sci Ctr, Dept Mol Pathol, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA.
   Kyoto Univ, Inst Virus Res, Dept Biol Responses, Kyoto 6068567, Japan.
C3 Pusan National University; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; Kyoto
   University
RP Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Dept Pharm, Gumjung gu, San 30,Jan Jun Dong,, Pusan 609735, South Korea.
EM hyjung@pusan.ac.kr
FU NIA NIH HHS [AG01188] Funding Source: Medline
CR Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x
   CASGRANDE S, 2002, P NATL ACAD SCI USA, V99, P9745
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   Chung HY, 2000, REV CLIN GERONTOL, V10, P207, DOI DOI 10.1017/S0959259800010327
   Demple B, 1998, SCIENCE, V279, P1655, DOI 10.1126/science.279.5357.1655
   DISIMPLICIO P, 1984, J APPL TOXICOL, V4, P227
   EKLOW L, 1984, EUR J BIOCHEM, V138, P459, DOI 10.1111/j.1432-1033.1984.tb07938.x
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   GASDASKA JR, 1995, CELL GROWTH DIFFER, V6, P1643
   HABIB A, 1993, J BIOL CHEM, V268, P23448
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841
   Harman D, 1973, Triangle, V12, P153
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891
   Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633
   HOLMGREN A, 1989, J BIOL CHEM, V264, P13963
   IWASAKI K, 1988, J GERONTOL, V43, pB5, DOI 10.1093/geronj/43.1.B5
   IWATA S, 1994, J IMMUNOL, V152, P5633
   JENKINSON SG, 1991, AM J MED SCI, V302, P347, DOI 10.1097/00000441-199112000-00004
   Kim HJ, 2002, J AM AGING ASSOC, V25, P123, DOI 10.1007/s11357-002-0011-2
   Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7
   Kim HJ, 2002, FREE RADICAL BIO MED, V32, P991, DOI 10.1016/S0891-5849(02)00798-0
   Kim JW, 2002, ARCH GERONTOL GERIAT, V34, P9, DOI 10.1016/S0167-4943(01)00178-9
   KUMAR A, 1995, CANCER LETT, V94, P107, DOI 10.1016/0304-3835(95)03832-H
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Liu RM, 2000, FREE RADICAL BIO MED, V28, P566, DOI 10.1016/S0891-5849(99)00269-5
   Lou MF, 1999, EXP EYE RES, V68, P547, DOI 10.1006/exer.1998.0638
   Lovell MA, 2000, FREE RADICAL BIO MED, V28, P418, DOI 10.1016/S0891-5849(99)00258-0
   MACDONALD CM, 1977, BIOCHEM PHARMACOL, V26, P1529, DOI 10.1016/0006-2952(77)90428-2
   MARIA CS, 1986, ARCH GERONTOL GERIAT, V5, P235, DOI 10.1016/0167-4943(86)90025-7
   MARIA CS, 1987, MECH AGEING DEV, V37, P183
   Masutani H, 2000, ANTIOXIDANT REDOX RE, P297
   MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   MirandaVizuete A, 1996, J BIOL CHEM, V271, P19099, DOI 10.1074/jbc.271.32.19099
   Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X
   Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661
   PUISSANT C, 1990, BIOTECHNIQUES, V8, P148
   QUIROGA GB, 1990, BIOCHEM J, V272, P247
   RICHIE JP, 1992, EXP GERONTOL, V27, P615, DOI 10.1016/0531-5565(92)90015-R
   Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163
   Rikans LE, 1998, GERONTOLOGY, V44, P72, DOI 10.1159/000021987
   Sasaki T, 2001, NUCL MED BIOL, V28, P25, DOI 10.1016/S0969-8051(00)00180-3
   SHIMODA R, 1994, CANCER RES, V54, P3171
   Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   STAAL FJT, 1992, LANCET, V339, P909, DOI 10.1016/0140-6736(92)90939-Z
   Tanaka T, 2000, FREE RADICAL RES, V33, P851, DOI 10.1080/10715760000301361
   Tappel A L, 1978, Methods Enzymol, V52, P506
   Tauskela JS, 2000, GLIA, V30, P329, DOI 10.1002/(SICI)1098-1136(200006)30:4<329::AID-GLIA20>3.3.CO;2-I
   TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B
   Yoshida S, 1999, J IMMUNOL, V163, P351
   Yu BP, 2001, DIABETES RES CLIN PR, V54, pS73, DOI 10.1016/S0168-8227(01)00338-2
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   YU BP, 2000, ANN NY ACAD SCI, V928, P39
NR 58
TC 85
Z9 95
U1 1
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAY
PY 2003
VL 38
IS 5
BP 539
EP 548
DI 10.1016/S0531-5565(03)00005-6
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 692CJ
UT WOS:000183642500009
PM 12742531
DA 2024-02-19
ER

PT J
AU Bae, HS
   Son, HY
   Son, Y
   Kim, S
   Hong, HS
   Park, JU
AF Bae, Hahn-Sol
   Son, Hye-Youn
   Son, Youngsook
   Kim, Sundong
   Hong, Hyun-Sook
   Park, Ji-Ung
TI Assessing biological aging following systemic administration of
   bFGF-supplemented adipose-derived stem cells with high efficacy in an
   experimental rat model
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE biologic aging; biochemical parameter; adipose-derived stem cell; basic
   fibroblast growth factor; rat model
ID AGE; BIOMARKERS; DISEASE
AB Biological aging (BA) is a tool for comprehensive assessment of individual health status. A rat model was developed for measuring BA by intravenously administering adipose-derived stem cells (ADSCs) into rats and evaluating several biochemical parameters. In addition, the effect of basic fibroblast growth factor (bFGF) on the differentiation potential of ADSCs was analyzed. A total of 12 male Sprague Dawley rats were divided into autologous ADSC administration (n=6) and saline administration (n=6) groups. The ADSC administration group was further divided into the bFGF supplemented (n=3) and bFGF non-supplemented (n=3) groups. Biochemical parameters and antioxidant potential were evaluated prior to fat harvest and ADSC administration, as well as 1, 3, and 5 weeks following ADSC administration. ADSC administration regulated inflammation, renal and hepatic functions, and levels of antioxidant enzymes. The cell doubling time of the bFGF-supplemented group was shorter (P=0.0001) than that of the bFGF non-supplemented group. Renal and hepatic functions were maintained with bFGF supplementation, which possibly enhanced the effect of ADSCs. The rat model developed in the present study may promote better understanding of BA in the context of bFGF-supplemented ADSC administration.
C1 [Bae, Hahn-Sol; Son, Hye-Youn; Park, Ji-Ung] Seoul Natl Univ, Boramae Med Ctr, Dept Plast & Reconstruct Surg, 20 Boraemae Ro, Seoul 07061, Sudogwon, South Korea.
   [Son, Youngsook] Kyung Hee Univ, Grad Sch Biotechnol, Dept Genet Engn, Yongin 16979, Gyeonggi, South Korea.
   [Kim, Sundong] Senior Sci Life Corp, Seoul 08594, South Korea.
   [Hong, Hyun-Sook] Kyung Hee Univ, Kyung Hee Inst Regenerat Med, Coll Med, Seoul 02447, South Korea.
C3 Seoul National University (SNU); Seoul National University Hospital;
   Kyung Hee University; Kyung Hee University
RP Park, JU (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Plast & Reconstruct Surg, 20 Boraemae Ro, Seoul 07061, Sudogwon, South Korea.
EM alfbskan@gmail.com
RI HONG, HYUN SOOK/AAI-3017-2020
OI HONG, HYUN SOOK/0000-0003-3659-1386
FU SNUH Research Fund [04-2016-0670]; Mi-Rae international consortium grant
   [BR16-0018]
FX The present study was supported by grant no. 04-2016-0670 from the SNUH
   Research Fund and a Mi-Rae international consortium grant (grant no.
   BR16-0018).
CR Bae CY, 2008, ARCH GERONTOL GERIAT, V47, P253, DOI 10.1016/j.archger.2007.08.009
   BORKAN GA, 1980, HUM BIOL, V52, P787
   Chandrasekaran A, 2017, REDOX BIOL, V11, P91, DOI 10.1016/j.redox.2016.11.005
   Crasto C, 2012, J AM GERIATR SOC, V60, P792, DOI 10.1111/j.1532-5415.2011.03879.x
   Davidovic M, 2010, AGING DIS, V1, P139
   Di Meo S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1245049
   Dong MH, 2012, CLIN GASTROENTEROL H, V10, P285, DOI 10.1016/j.cgh.2011.10.014
   Fan Y, 2015, J CRANIOFAC SURG, V26, pE467, DOI 10.1097/SCS.0000000000001902
   FINKEL D, 1995, J GERONTOL B-PSYCHOL, V50, pP104, DOI 10.1093/geronb/50B.2.P104
   Go YM, 2017, CLIN SCI, V131, P1669, DOI 10.1042/CS20160897
   Ighodaro OM, 2018, ALEX J MED, V54, P287, DOI 10.1016/j.ajme.2017.09.001
   Jackson SHD, 2003, ARCH GERONTOL GERIAT, V36, P103, DOI 10.1016/S0167-4943(02)00060-2
   Ji LL, 2015, ADV PHYSIOL EDUC, V39, P352, DOI 10.1152/advan.00106.2014
   JOBORN H, 1989, J INTERN MED, V225, P9, DOI 10.1111/j.1365-2796.1989.tb00029.x
   Kahya M, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00288
   Kapadia SR, 2001, J AM COLL CARDIOL, V38, P206, DOI 10.1016/S0735-1097(01)01337-7
   Kapoor N., 2012, INDIAN J ENDOCRIN S2, V16, P376
   Karasik D, 2005, J GERONTOL A-BIOL, V60, P574, DOI 10.1093/gerona/60.5.574
   Klemera P, 2006, MECH AGEING DEV, V127, P240, DOI 10.1016/j.mad.2005.10.004
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Lotz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056289
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56
   Nakamura E, 1998, EXP GERONTOL, V33, P421, DOI 10.1016/S0531-5565(97)00134-4
   Park BS, 2008, DERMATOL SURG, V34, P1323, DOI 10.1111/j.1524-4725.2008.34283.x
   Park J, 2009, ARCH GERONTOL GERIAT, V49, P7, DOI 10.1016/j.archger.2008.04.003
   Piantanelli L, 2001, MECH AGEING DEV, V122, P1461, DOI 10.1016/S0047-6374(01)00271-8
   Pinto A, 2003, CRIT REV ONCOL HEMAT, V48, pS3, DOI 10.1016/j.critrevonc.2003.06.006
   Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466
   RIES W, 1984, EXP GERONTOL, V19, P211, DOI 10.1016/0531-5565(84)90041-X
   Shaper AG, 2004, J CLIN EPIDEMIOL, V57, P195, DOI 10.1016/j.jclinepi.2003.07.001
   Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019
   Sprott RL, 2010, EXP GERONTOL, V45, P2, DOI 10.1016/j.exger.2009.07.008
   Stone NJ, 2005, AM J CARDIOL, V96, p53E, DOI 10.1016/j.amjcard.2005.06.006
   United Nations-Department of Economic and Social Affairs-Population Division, 2017, WORLD POP PROSP 2017
NR 35
TC 2
Z9 4
U1 0
U2 4
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD APR
PY 2019
VL 17
IS 4
BP 2407
EP 2416
DI 10.3892/etm.2019.7251
PG 10
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA HS3WQ
UT WOS:000463793600001
PM 30906427
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Kaneko, T
   Tahara, S
   Matsuo, M
AF Kaneko, T
   Tahara, S
   Matsuo, M
TI Non-linear accumulation of 8-hydroxy-2'-deoxyguanosine, a marker of
   oxidized DNA damage, during aging
SO MUTATION RESEARCH-DNAGING GENETIC INSTABILITY AND AGING
LA English
DT Article
DE aging; nuclear DNA; oxidative damage; free radical;
   8-hydroxydeoxyguanosine
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; OXIDATIVE DAMAGE; ELECTROCHEMICAL
   DETECTION; MITOCHONDRIAL-DNA; ESCHERICHIA-COLI; OXYGEN RADICALS; ORGAN
   DNA; VITAMIN-E; 8-HYDROXYGUANINE; 8-HYDROXYDEOXYGUANOSINE
AB Damage to DNA seems to be involved in aging and the etiology of age-associated degenerative diseases. The purpose of this study is to examine changes in DNA damage during aging. An oxidized nucleoside, 8-hydroxy-2'-deoxyguanosine (8-OHdG), is a proposed biomarker for DNA damaged by oxidative stress. The content of 8-OHdG in nuclear DNA isolated from brain, heart, liver, and kidneys of male Fischer 344 rats of different ages was measured. 8-OHdG can be detected selectively and sensitively at the fmol level by high performance liquid chromatography-electrochemical detection at an applied potential of + 350 mV. The amount of 8-OHdG, expressed as the ratio to deoxyguanosine in nuclear DNA, in heart, liver, and kidney remained steady from 2 to 24 months and then increased progressively. The content of 8-OHdG in the DNA in brain showed no changes from 2 to 27 months, but was significantly higher in 30 month-old rats. There was a significant 2-fold increase in the amount of 8-OHdG in the nuclear DNA of all organs tested in 30 month-old rats as compared to 2-24 month-old rats. These results indicate that the accumulation of 8-OHdG in the DNA of rat organs begins at ages above 24 months.
RP Kaneko, T (corresponding author), TOKYO METROPOLITAN INST GERONTOL,ITABASHI KU,35-2 SAKAECHO,TOKYO 173,JAPAN.
CR AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   BABIOR BM, 1984, BLOOD, V64, P959
   BESSHO T, 1993, J BIOL CHEM, V268, P19416
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHUNG MH, 1991, MUTAT RES, V254, P1, DOI 10.1016/0921-8777(91)90035-N
   CLAYCAMP HG, 1992, CARCINOGENESIS, V13, P1289, DOI 10.1093/carcin/13.7.1289
   CLAYCAMP HG, 1993, INT J RADIAT BIOL, V63, P597, DOI 10.1080/09553009314450781
   DIZDAROGLU M, 1985, ANAL BIOCHEM, V144, P593, DOI 10.1016/0003-2697(85)90158-7
   Floyd R A, 1986, Free Radic Res Commun, V1, P163, DOI 10.3109/10715768609083148
   FLOYD RA, 1988, ARCH BIOCHEM BIOPHYS, V262, P266, DOI 10.1016/0003-9861(88)90188-9
   FLOYD RA, 1990, CARCINOGENESIS, V11, P1447, DOI 10.1093/carcin/11.9.1447
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FREUND G, 1979, LIFE SCI, V24, P145, DOI 10.1016/0024-3205(79)90124-3
   GAJEWSKI E, 1990, BIOCHEMISTRY-US, V29, P7876, DOI 10.1021/bi00486a014
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HAYAKAWA M, 1993, MOL CELL BIOCHEM, V119, P95, DOI 10.1007/BF00926859
   HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230
   KAMIYA H, 1992, CANCER RES, V52, P3483
   KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137
   KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849
   KASAI H, 1987, CARCINOGENESIS, V8, P1959, DOI 10.1093/carcin/8.12.1959
   KASAI H, 1991, OXIDATIVE STRESS OXI, P99
   KIRKWOOD TBL, 1989, MUTAT RES, V219, P1, DOI 10.1016/0921-8734(89)90035-0
   KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0
   MACCUBBIN A, 1991, RADIAT RES, V126, P21, DOI 10.2307/3578166
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   PARK JW, 1989, CARCINOGENESIS, V10, P827, DOI 10.1093/carcin/10.5.827
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   SAI K, 1992, Journal of Environmental Pathology Toxicology and Oncology, V11, P139
   SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0
   SHIGENAGA MK, 1991, FREE RADICAL BIO MED, V10, P211, DOI 10.1016/0891-5849(91)90078-H
   SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697
   SHIGENAGA MK, 1990, METHOD ENZYMOL, V186, P521
   SONSONNTAG C, 1987, CHEM BASIS RAD BIOL
   SUMMERFIELD FW, 1984, ARCH BIOCHEM BIOPHYS, V233, P408, DOI 10.1016/0003-9861(84)90462-4
   WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011
   YAMAMOTO F, 1992, JPN J CANCER RES, V83, P351, DOI 10.1111/j.1349-7006.1992.tb00114.x
   YAMAMOTO F, 1993, JPN J CANCER RES, V84, P508, DOI 10.1111/j.1349-7006.1993.tb00168.x
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
NR 42
TC 167
Z9 173
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8734
J9 MUTAT RES-DNAGING G
JI Mutat. Res. DNAging Genet. Instabil. Aging
PD MAY
PY 1996
VL 316
IS 5-6
BP 277
EP 285
DI 10.1016/S0921-8734(96)90010-7
PG 9
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA UT588
UT WOS:A1996UT58800010
PM 8649461
DA 2024-02-19
ER

PT J
AU Wang, TN
   Tsui, B
   Kreisberg, JF
   Robertson, NA
   Gross, AM
   Yu, MK
   Carter, H
   Brown-Borg, HM
   Adams, PD
   Ideker, T
AF Wang, Tina
   Tsui, Brian
   Kreisberg, Jason F.
   Robertson, Neil A.
   Gross, Andrew M.
   Yu, Michael Ku
   Carter, Hannah
   Brown-Borg, Holly M.
   Adams, Peter D.
   Ideker, Trey
TI Epigenetic aging signatures in mice livers are slowed by dwarfism,
   calorie restriction and rapamycin treatment
SO GENOME BIOLOGY
LA English
DT Article
DE DNA methylation; Epigenomics; Aging; Epigenetic aging
ID GENOME BROWSER DATABASE; DNA METHYLATION AGE; LIFE-SPAN; EXTENDS LIFE;
   DEMETHYLATION; ALIGNMENT; INCREASE; DISTINCT; PACKAGE; TISSUES
AB Background: Global but predictable changes impact the DNA methylome as we age, acting as a type of molecular clock. This clock can be hastened by conditions that decrease lifespan, raising the question of whether it can also be slowed, for example, by conditions that increase lifespan. Mice are particularly appealing organisms for studies of mammalian aging; however, epigenetic clocks have thus far been formulated only in humans.
   Results: We first examined whether mice and humans experience similar patterns of change in the methylome with age. We found moderate conservation of CpG sites for which methylation is altered with age, with both species showing an increase in methylome disorder during aging. Based on this analysis, we formulated an epigenetic-aging model in mice using the liver methylomes of 107 mice from 0.2 to 26.0 months old. To examine whether epigenetic aging signatures are slowed by longevity-promoting interventions, we analyzed 28 additional methylomes from mice subjected to lifespan-extending conditions, including Prop1(df/df) dwarfism, calorie restriction or dietary rapamycin. We found that mice treated with these lifespan-extending interventions were significantly younger in epigenetic age than their untreated, wild-type age-matched controls.
   Conclusions: This study shows that lifespan-extending conditions can slow molecular changes associated with an epigenetic clock in mice livers.
C1 [Wang, Tina; Tsui, Brian; Kreisberg, Jason F.; Gross, Andrew M.; Yu, Michael Ku; Carter, Hannah; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Robertson, Neil A.; Adams, Peter D.] Beatson Inst Canc Res, Glasgow, Lanark, Scotland.
   [Robertson, Neil A.; Adams, Peter D.] Univ Glasgow, Glasgow, Lanark, Scotland.
   [Brown-Borg, Holly M.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA.
   [Adams, Peter D.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.
   [Tsui, Brian; Gross, Andrew M.; Yu, Michael Ku; Carter, Hannah] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA.
C3 University of California System; University of California San Diego;
   Beatson Institute; University of Glasgow; University of North Dakota
   Grand Forks; Sanford Burnham Prebys Medical Discovery Institute;
   University of California System; University of California San Diego
RP Ideker, T (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
EM tideker@ucsd.edu
RI Brown-Borg, Holly/IQV-8650-2023
OI Adams, Peter/0000-0002-0684-1770; Kreisberg, Jason/0000-0002-3616-079X;
   Ideker, Trey/0000-0002-1708-8454; Robertson, Neil/0000-0002-9509-1157
FU National Institutes of Health [P50 GM085764, GCIR-06673-B, AG034206,
   AG038509, P01 AG031862, DP5 OD017937, T32 GM008666]
FX This work is supported by the National Institutes of Health: P50
   GM085764 and GCIR-06673-B awarded to TI, AG034206 and AG038509 awarded
   to HMBB, P01 AG031862 awarded to PDA, DP5 OD017937 awarded to HC and T32
   GM008666 awarded to TW.
CR Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004
   [Anonymous], 2014, SEABORN V0 5 0
   Arum O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072255
   Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049
   Avrahami D, 2015, CELL METAB, V22, P619, DOI 10.1016/j.cmet.2015.07.025
   Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193
   Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7
   Bartke Andrzej, 2012, Frontiers in Genetics, V3, P288, DOI 10.3389/fgene.2012.00288
   Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Cannon MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090335
   Gravina S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1011-3
   Gross AM, 2016, MOL CELL, V62, P157, DOI 10.1016/j.molcel.2016.03.019
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hastie T, 2011, R PACKAGE VERSION
   Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144
   Horvath S, 2015, AGING CELL, V14, P491, DOI 10.1111/acel.12325
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Johansson Å, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067378
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Jones Eric, 2001, SciPy: Open source scientific tools for Python
   Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167
   Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maegawa S, 2014, GENOME RES, V24, P580, DOI 10.1101/gr.157529.113
   Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6
   Masternak MM, 2009, J GERONTOL A-BIOL, V64, P516, DOI 10.1093/gerona/glp024
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Orozco LD, 2015, CELL METAB, V21, P905, DOI 10.1016/j.cmet.2015.04.025
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Reizel Y, 2015, GENE DEV, V29, P923, DOI 10.1101/gad.259309.115
   Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177
   Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172
   Spiers H, 2016, MECH AGEING DEV, V154, P20, DOI 10.1016/j.mad.2016.02.001
   Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002
   Takasugi M, 2011, MECH AGEING DEV, V132, P65, DOI 10.1016/j.mad.2010.12.003
   Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680
   Urich MA, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.114
   Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157
   Zampieri M, 2015, MECH AGEING DEV, V151, P60, DOI 10.1016/j.mad.2015.02.002
   Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x
NR 53
TC 177
Z9 201
U1 3
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PD MAR 28
PY 2017
VL 18
AR 57
DI 10.1186/s13059-017-1186-2
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA EP7KP
UT WOS:000397557000002
PM 28351423
OA gold, Green Accepted, Green Published
DA 2024-02-19
ER

PT J
AU Garibyan, L
   Chiou, AS
   Elmariah, SB
AF Garibyan, Lilit
   Chiou, Albert S.
   Elmariah, Sarina B.
TI Advanced aging skin and itch: addressing an unmet need
SO DERMATOLOGIC THERAPY
LA English
DT Article
DE elderly; pruritus; Willan's itch; xerosis
ID EPIDERMAL PERMEABILITY BARRIER; TRIGEMINAL TROPHIC SYNDROME;
   HEMODIALYSIS-PATIENTS; NEUROPATHIC PRURITUS; GROVERS-DISEASE; WALLENBERG
   SYNDROME; CONTROLLED-TRIAL; UREMIC PRURITUS; LIVER-DISEASE; GABAPENTIN
AB Itch is the most common skin disorder in the elderly and frequently diminishes quality of life in this population. The high prevalence of pruritus in elderly patients is attributed in part to the decline in the normal physiology of the advanced aging skin, and reflects poor hydration, impaired skin barrier, and altered neural function, all ultimately contributing to inflammation and pruritus. As the elderly population continues to grow, practitioners need to be aware of how to evaluate and manage pruritus, recognizing the common conditions contributing to itch in elderly patients as well as the challenges of treatment in this group. Ultimately, management of pruritus will require an individually tailored approach that is guided by a patient's general health, severity of symptoms, and the potential adverse effects of itch therapies.
C1 [Garibyan, Lilit; Chiou, Albert S.; Elmariah, Sarina B.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.
C3 Harvard University; Massachusetts General Hospital
RP Elmariah, SB (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Dept Dermatol, 149 13th St, Charlestown, MA 02129 USA.
EM sbelmariah@partners.org
RI Garibyan, Lilit/AAR-1638-2020
OI Chiou, Albert/0000-0002-8436-0008
CR BEAUREGARD S, 1987, ARCH DERMATOL, V123, P1638, DOI 10.1001/archderm.123.12.1638
   Bergasa NV, 2006, HEPATOLOGY, V44, P1317, DOI 10.1002/hep.21370
   Bergasa NV, 2011, SEMIN CUTAN MED SURG, V30, P93, DOI 10.1016/j.sder.2011.04.009
   Berger TG, 2011, SEMIN CUTAN MED SURG, V30, P113, DOI 10.1016/j.sder.2011.04.002
   Berger TG, 2011, SEMIN CUTAN MED SURG, V30, P99, DOI 10.1016/j.sder.2011.04.005
   Berger TG, 2011, SEMIN CUTAN MED SURG, V30, P63, DOI 10.1016/j.sder.2011.04.007
   Bin Saif GA, 2011, EXP DERMATOL, V20, P959, DOI 10.1111/j.1600-0625.2011.01389.x
   Bouvresse S, 2010, CURR OPIN INFECT DIS, V23, P111, DOI 10.1097/QCO.0b013e328336821b
   Cassano N, 2010, AM J CLIN DERMATOL, V11, P399, DOI 10.2165/11317620-000000000-00000
   Chiang HC, 2011, SEMIN CUTAN MED SURG, V30, P107, DOI 10.1016/j.sder.2011.05.003
   Choi EH, 2007, J INVEST DERMATOL, V127, P2847, DOI 10.1038/sj.jid.5700913
   Conti A., 1996, International Journal of Cosmetic Science, V18, P1, DOI 10.1111/j.1467-2494.1996.tb00131.x
   Curtis AR, 2012, J DERMATOL TREAT, V23, P215, DOI 10.3109/09546634.2010.550912
   Curtis AR, 2012, AM J CLIN DERMATOL, V13, P125, DOI 10.2165/11594060-000000000-00000
   Ebrchen J, 2008, J AM ACAD DERMATOL, V58, pS36, DOI 10.1016/j.jaad.2007.07.017
   FLEISCHER AB, 1993, J AM ACAD DERMATOL, V28, P603, DOI 10.1016/0190-9622(93)70081-4
   GHADIALLY R, 1995, J CLIN INVEST, V95, P2281, DOI 10.1172/JCI117919
   Goodkin R, 2003, J AM ACAD DERMATOL, V48, P521, DOI 10.1067/mjd.2003.203
   Greaves Malcolm W, 2005, Dermatol Ther, V18, P323
   Hachem JP, 2003, J INVEST DERMATOL, V121, P345, DOI 10.1046/j.1523-1747.2003.12365.x
   Hashimoto K, 1996, J CUTAN PATHOL, V23, P151, DOI 10.1111/j.1600-0560.1996.tb01289.x
   Hong J, 2011, SEMIN CUTAN MED SURG, V30, P71, DOI 10.1016/j.sder.2011.05.002
   Irizarry E, 2007, ARCH DERMATOL, V143, P682, DOI 10.1001/archderm.143.5.682
   Jensen JM, 2005, EXP DERMATOL, V14, P609, DOI 10.1111/j.0906-6705.2005.00342.x
   Joly P, 2007, J INVEST DERMATOL, V127, P2766, DOI 10.1038/sj.jid.5701018
   Kimyai-Asadi A, 1999, STROKE, V30, P692, DOI 10.1161/01.STR.30.3.692
   Kini SP, 2011, ARCH DERMATOL, V147, P1153, DOI 10.1001/archdermatol.2011.178
   KRASOVEC M, 1993, DERMATOLOGY, V186, P248, DOI 10.1159/000247363
   LEWIECKI EM, 1976, JAMA-J AM MED ASSOC, V236, P2319, DOI 10.1001/jama.236.20.2319
   Li J, 2010, AUSTRALAS J DERMATOL, V51, P106, DOI 10.1111/j.1440-0960.2010.00629.x
   Lonsdale-Eccles A, 2003, DRUG AGING, V20, P197, DOI 10.2165/00002512-200320030-00004
   Mistik S, 2006, J EUR ACAD DERMATOL, V20, P672, DOI 10.1111/j.1468-3083.2006.01570.x
   Naini AE, 2007, SAUDI J KIDNEY DIS T, V18, P378
   Norman Robert A, 2003, Dermatol Ther, V16, P254, DOI 10.1046/j.1529-8019.2003.01635.x
   O'Donoghue Michael, 2005, Dermatol Ther, V18, P333
   Oaklander AL, 2009, NEUROLOGY, V73, P1605, DOI 10.1212/WNL.0b013e3181bd6c10
   Pacan P, 2009, ACTA DERM-VENEREOL, V89, P109, DOI 10.2340/00015555-0576
   Parsons JM, 1996, J AM ACAD DERMATOL, V35, P653, DOI 10.1016/S0190-9622(96)90715-X
   Patel Tejesh, 2010, Skin Therapy Lett, V15, P5
   Patel TS, 2007, AM J KIDNEY DIS, V50, P11, DOI 10.1053/j.ajkd.2007.03.010
   Pisoni RL, 2006, NEPHROL DIAL TRANSPL, V21, P3495, DOI 10.1093/ndt/gfl461
   POCHI PE, 1979, J INVEST DERMATOL, V73, P108, DOI 10.1111/1523-1747.ep12532792
   Raksha M Patel, 2008, Indian J Dermatol Venereol Leprol, V74, P80
   Rashid RM, 2007, J EUR ACAD DERMATOL, V21, P725, DOI 10.1111/j.1468-3083.2007.02250.x
   Rawlings A V, 2004, Dermatol Ther, V17 Suppl 1, P49, DOI 10.1111/j.1396-0296.2004.04S1006.x
   Razeghi E, 2009, RENAL FAILURE, V31, P85, DOI 10.1080/08860220802595476
   Reich A, 2010, CLIN EXP DERMATOL, V35, P2, DOI 10.1111/j.1365-2230.2009.03463.x
   Reich A, 2009, ACTA DERM-VENEREOL, V89, P236, DOI 10.2340/00015555-0650
   Rivard Jennifer, 2005, Dermatol Ther, V18, P344, DOI 10.1111/j.1529-8019.2005.00032.x
   Rogers J, 1996, ARCH DERMATOL RES, V288, P765, DOI 10.1007/s004030050138
   Saini KS, 2010, EUR J CLIN INVEST, V40, P828, DOI 10.1111/j.1365-2362.2010.02334.x
   Savk O, 2005, J AM ACAD DERMATOL, V52, P1085, DOI 10.1016/j.jaad.2005.01.138
   Scheinfeld N, 2006, J AM ACAD DERMATOL, V55, P263, DOI 10.1016/j.jaad.2006.01.029
   SCRIBNER M, 1977, JAMA-J AM MED ASSOC, V237, P1559, DOI 10.1001/jama.1977.03270420027007
   SCRIBNER MD, 1977, ARCH DERMATOL, V113, P1303, DOI 10.1001/archderm.1977.01640090151053
   Seo WK, 2009, NEUROLOGY, V72, P676, DOI 10.1212/01.wnl.0000342484.99298.52
   Smith DR, 2002, IND HEALTH, V40, P54, DOI 10.2486/indhealth.40.54
   SMITH L, 1989, CUTIS, V43, P414
   Solak Y, 2012, NEPHROLOGY, V17, P710, DOI 10.1111/j.1440-1797.2012.01655.x
   Ständer S, 2009, ACTA DERM-VENEREOL, V89, P45, DOI 10.2340/00015555-0553
   Steckelings UM, 2001, ACTA DERM-VENEREOL, V81, P321
   Tran B, 2011, INT J DERMATOL, V50, P1032, DOI 10.1111/j.1365-4632.2009.04445.x
   van Os-Medendorp H, 2007, BRIT J DERMATOL, V156, P1235, DOI 10.1111/j.1365-2133.2007.07919.x
   Wallengren J, 2002, J AM ACAD DERMATOL, V46, P215, DOI 10.1067/mjd.2002.118540
   Waller JM, 2006, SKIN RES TECHNOL, V12, P145, DOI 10.1111/j.0909-752X.2006.00146.x
   Wang H, 2010, INT J DERMATOL, V49, P1, DOI 10.1111/j.1365-4632.2009.04249.x
   Ward JR, 2005, INT J DERMATOL, V44, P267, DOI 10.1111/j.1365-4632.2004.02553.x
   White-Chu EF, 2011, CLIN DERMATOL, V29, P37, DOI 10.1016/j.clindermatol.2010.07.005
   Yalçin B, 2006, INT J DERMATOL, V45, P672, DOI 10.1111/j.1365-4632.2005.02607.x
   Yamaoka H, 2010, DIABETES CARE, V33, P150, DOI 10.2337/dc09-0632
   Yosipovitch G, 2008, DERMATOL THER, V21, P32, DOI 10.1111/j.1529-8019.2008.00167.x
   Zachariae R, 2012, ACTA DERM-VENEREOL, V92, P508, DOI 10.2340/00015555-1221
   Zylicz Z, 2003, J PAIN SYMPTOM MANAG, V26, P1105, DOI 10.1016/j.jpainsymman.2003.05.004
NR 73
TC 33
Z9 35
U1 1
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1396-0296
EI 1529-8019
J9 DERMATOL THER
JI Dermatol. Ther.
PD MAR-APR
PY 2013
VL 26
IS 2
SI SI
BP 92
EP 103
DI 10.1111/dth.12029
PG 12
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA 119WN
UT WOS:000317130100003
PM 23551366
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Alswat, K
   Alijumah, AA
   Sanai, FM
   Abaalkhail, F
   Alghamdi, M
   Al Hamoudi, WK
   Al Khathlan, A
   Al Quraishi, H
   Al Rifai, A
   Al Zaabi, M
   Babatin, MA
   Estes, C
   Hashim, A
   Razavi, H
AF Alswat, Khalid
   Alijumah, Abdulrahman A.
   Sanai, Faisal M.
   Abaalkhail, Faisal
   Alghamdi, Mohamed
   Al Hamoudi, Waleed K.
   Al Khathlan, Abdullah
   Al Quraishi, Huda
   Al Rifai, Ahmed
   Al Zaabi, Mohamed
   Babatin, Mohamed A.
   Estes, Chris
   Hashim, Almoutaz
   Razavi, Homie
TI Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab
   Emirates, 2017-2030
SO SAUDI JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Burden of disease; cardiovascular disease; cirrhosis; decompensated
   cirrhosis; healthcare resource utilization; hepatocellular; carcinoma;
   metabolic syndrome; nonalcoholic fatty liver; nonalcoholic fatty liver
   disease; nonalcoholic steatohepatitis; obesity; type 2 diabetes mellitus
ID LONG-TERM OUTCOMES; HEPATOCELLULAR-CARCINOMA; PREVALENCE; FIBROSIS;
   RISK; TRANSPLANTATION; STEATOHEPATITIS; HEALTH; NAFLD; EPIDEMIOLOGY
AB Background/Aim: Due to epidemic levels of obesity and type 2 diabetes mellitus (DM), nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH) will be driving factors in liver disease burden in the coming years in Saudi Arabia and United Arab Emirates (UAE).
   Materials and Methods: Models were used to estimate NAFLD and NASH disease progression, primarily based on changes in adult prevalence rates of adult obesity and DM. The published estimates and expert interviews were used to build and validate the model projections.
   Results: In both countries, the prevalence of NAFLD increased through 2030 parallel to projected increases in the prevalence of obesity and DM. By 2030, there were an estimated 12,534,000 NAFLD cases in Saudi Arabia and 372,000 cases in UAE. Increases in NASH cases were relatively greater than the NAFLD cases due to aging of the population and disease progression. likewise, prevalent cases of compensated cirrhosis and advanced liver disease are projected to at least double by 2030, while annual incident liver deaths increase in both countries to 4800 deaths in Saudi Arabia and 140 deaths in UAE.
   Conclusions: Continued high rates of adult obesity and DM, in combination with aging populations, suggest that advanced liver disease and mortality attributable to NAFLD/NASH will increase across both countries. Reducing the growth of the NAFLD population, along with potential therapeutic options, will be needed to reduce liver disease burden.
C1 [Alswat, Khalid; Sanai, Faisal M.; Al Hamoudi, Waleed K.] King Saud Univ, Coll Med, Liver Dis Res Ctr, 3 Riyadh, Saudi Arabia.
   [Alijumah, Abdulrahman A.] King Abdul Aziz Med City, Hepatol Div, Dept Hepatobiliary Sci, Riyadh, Saudi Arabia.
   [Alijumah, Abdulrahman A.] King Abdul Aziz Med City, Organ Transplant Ctr, Riyadh, Saudi Arabia.
   [Alijumah, Abdulrahman A.] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia.
   [Alijumah, Abdulrahman A.] Minist Natl Guard Hlth Affairs, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.
   [Sanai, Faisal M.] King Abdul Aziz Med City, Gastroenterol Unit, Dept Med, Jeddah, Saudi Arabia.
   [Abaalkhail, Faisal; Al Hamoudi, Waleed K.] King Faisal Specialist Hosp & Res Ctr, Div Organ Transplant Ctr, Dept Liver Transplantat & Hepatobiliary Pancreat, Riyadh, Saudi Arabia.
   [Abaalkhail, Faisal] Alfaisal Univ, Coll Med, Dept Med, Riyadh, Saudi Arabia.
   [Alghamdi, Mohamed] King Fahd Mil Med Complex, Gastroenterol Unit, Dept Med, Dhahran, Saudi Arabia.
   [Al Khathlan, Abdullah] King Fahad Med City, Gastroenterol Sect, Dept Med, Riyadh, Saudi Arabia.
   [Al Quraishi, Huda] Rashid Hosp, Gastroenterol Unit, Dubai, U Arab Emirates.
   [Al Rifai, Ahmed] Mafraq Hosp, Gastroenterol Div, Abu Dhabi, U Arab Emirates.
   [Al Zaabi, Mohamed] Zayed Mil Hosp, Dept Gastroenterol, Abu Dhabi, U Arab Emirates.
   [Babatin, Mohamed A.] King Fahad Hosp, Gastroenterol Unit, Dept Med, Jeddah, Saudi Arabia.
   [Estes, Chris; Razavi, Homie] Ctr Dis Anal, 1120 W South Boulder Rd,Ste 102, Lafayette, CA USA.
   [Hashim, Almoutaz] Jeddah Univ, Dept Internal Med, Jeddah, Saudi Arabia.
C3 King Saud University; King Abdulaziz Medical City; King Saud Bin
   Abdulaziz University for Health Sciences; King Abdulaziz Medical City -
   Riyadh; King Saud Bin Abdulaziz University for Health Sciences; King
   Abdulaziz Medical City - Riyadh; King Abdulaziz Medical City; King Saud
   Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz
   University for Health Sciences; Ministry of National Guard - Health
   Affairs; King Abdullah International Medical Research Center (KAIMRC);
   King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz
   Medical City - Jeddah; King Faisal Specialist Hospital & Research
   Center; Alfaisal University; King Fahd Military Medical Complex; King
   Fahad Medical City; University of Jeddah
RP Razavi, H (corresponding author), Ctr Dis Anal, 1120 W South Boulder Rd,Ste 102, Lafayette, CA USA.
EM hrazavi@cdafound.org
RI Al-Ghamdi, Mohammed. I./I-3651-2018; Alswat, Khalid A/ACK-5308-2022
OI Al-Ghamdi, Mohammed. I./0000-0002-9794-554X; Alswat, Khalid
   A/0000-0002-3521-8523; Aljumah, Abdulrahman/0000-0002-6156-4921; Razavi,
   Homie/0000-0002-2658-6930
CR Abuyassin B, 2016, WORLD J DIABETES, V7, P165, DOI 10.4239/wjd.v7.i8.165
   Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Ahmed MH, 2017, GASTROENTEROL RES, V10, P271, DOI 10.14740/gr913w
   Al Dawish MA, 2016, CURR DIABETES REV, V12, P359, DOI 10.2174/1573399811666150724095130
   Al-Hamoudi W, 2016, HEPATOL INT, V10, P347, DOI 10.1007/s12072-015-9664-7
   Al-hamoudi W, 2012, ANN SAUDI MED, V32, P288, DOI 10.5144/0256-4947.2012.288
   Al-Muhaimeed AA, 2015, ANN SAUDI MED, V35, P275, DOI 10.5144/0256-4947.2015.275
   Al-Rubeaan K, 2014, ANN SAUDI MED, V34, P465, DOI 10.5144/0256-4947.2014.465
   Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798
   Aljumah AA, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/1989045
   Alkhouri N, 2016, TRANSPL INT, V29, P418, DOI 10.1111/tri.12694
   Alotaibi A, 2017, J EPIDEMIOL GLOB HEA, V7, P211, DOI 10.1016/j.jegh.2017.10.001
   Alshumrani GA, 2013, MED J CAIRO U, V81, P205
   Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496
   Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057
   Bahijri SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152559
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Caballería L, 2010, EUR J GASTROEN HEPAT, V22, P24, DOI 10.1097/MEG.0b013e32832fcdf0
   Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
   Cheng YLJ, 2013, DIABETES CARE, V36, P2690, DOI 10.2337/dc12-2074
   DeNicola E, 2015, REV ENVIRON HEALTH, V30, P191, DOI 10.1515/reveh-2015-0008
   Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085
   EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y
   ELHASSAN AY, 1992, BRIT J RADIOL, V65, P774, DOI 10.1259/0007-1285-65-777-774
   Elmakki E., 2015, British Journal of Medicine and Medical Research, V5, P872, DOI 10.9734/BJMMR/2015/13077
   Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466
   Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010
   Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429
   Gasim Gasim Ibrahim, 2017, Open Access Maced J Med Sci, V5, P762, DOI 10.3889/oamjms.2017.187
   Grant Lafaine M, 2004, Ann Hepatol, V3, P93
   GROUND KEU, 1982, AVIAT SPACE ENVIR MD, V53, P14
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448
   Loomba R, 2014, HEPATOLOGY, V60, P1920, DOI 10.1002/hep.27362
   Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171
   MALCOLM DG, 1959, OPER RES, V7, P646, DOI 10.1287/opre.7.5.646
   Memish ZA, 2014, PREV CHRONIC DIS, V11
   Musaiger A O, 2004, East Mediterr Health J, V10, P789
   Musaiger AO, 2016, NUTR HOSP, V33, P1062
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135
   Sanyal A, 2010, CURR MED RES OPIN, V26, P2183, DOI 10.1185/03007995.2010.506375
   Shaikh MA, 2016, INT J HEALTH SCI-IJH, V10, P381
   Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014
   Stepanova M, 2013, DIGEST DIS SCI, V58, P3017, DOI 10.1007/s10620-013-2743-5
   Sulaiman N, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0287-0
   Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013
   United Nations. Department of Economic Social Affairs Population, 2018, WORLD POP PROSP 2015, V24
   Weinmann A, 2014, J CLIN GASTROENTEROL, V48, P279, DOI 10.1097/MCG.0b013e3182a8a793
   White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001
   Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038
   Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039
   Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986
   World Health Organization, 2013, WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020
   Yoneda M, 2008, DIGEST LIVER DIS, V40, P371, DOI 10.1016/j.dld.2007.10.019
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123
   Younossi ZM, 2015, PHARMACOECONOMICS, V33, P1245, DOI 10.1007/s40273-015-0316-5
   Younossi ZM, 2015, J CLIN GASTROENTEROL, V49, P222, DOI 10.1097/MCG.0000000000000071
   2010, B WORLD HEALTH ORGAN, V88, P86
NR 61
TC 72
Z9 72
U1 0
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 1319-3767
EI 1998-4049
J9 SAUDI J GASTROENTERO
JI Saudi J. Gastroenterol.
PD JUL-AUG
PY 2018
VL 24
IS 4
BP 211
EP 219
AR PMID 29956688
DI 10.4103/sjg.SJG_122_18
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA GP2CF
UT WOS:000440627500003
PM 29956688
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Javidnia, S
   Cranwell, S
   Mueller, SH
   Selman, C
   Tullet, JMA
   Kuchenbaecker, K
   Alic, N
AF Javidnia, Sara
   Cranwell, Stephen
   Mueller, Stefanie H.
   Selman, Colin
   Tullet, Jennifer M. A.
   Kuchenbaecker, Karoline
   Alic, Nazif
TI Mendelian randomization analyses implicate biogenesis of translation
   machinery in human aging
SO GENOME RESEARCH
LA English
DT Article
ID LIFE-SPAN EXTENSION; III CAUSE; DROSOPHILA; MUTATIONS; GROWTH; TISSUE;
   GENES; BRAIN; RATES; DFOXO
AB Reduced provision of protein translation machinery promotes healthy aging in a number of animal models. In humans, however, inborn impairments in translation machinery are a known cause of several developmental disorders, collectively termed ribosomopathies. Here, we use casual inference approaches in genetic epidemiology to investigate whether adult, tissue-specific biogenesis of translation machinery drives human aging. We assess naturally occurring variation in the expression of genes encoding subunits specific to the two RNA polymerases (Pols) that transcribe ribosomal and transfer RNAs, namely Pol I and III, and the variation in expression of ribosomal protein (RP) genes, using Mendelian randomization. We find each causally associated with human longevity (beta = -0.15 +/- 0.047, P = 9.6 x 10(-4), q = 0.015; beta = -0.13 +/- 0.040, P = 1.4 x 10(-3), q = 0.023; beta = -0.048 +/- 0.016, P = 3.5 x 10(-3), q = 0.056, respectively), and this does not appear to be mediated by altered susceptibility to a single disease. We find that reduced expression of Pol III, RPs, or Pol I promotes longevity from different organs, namely visceral adipose, liver, and skeletal muscle, echoing the tissue specificity of ribosomopathies. Our study shows the utility of leveraging genetic variation in expression to elucidate how essential cellular processes impact human aging. The findings extend the evolutionary conservation of protein synthesis as a critical process that drives animal aging to include humans.
C1 [Javidnia, Sara; Cranwell, Stephen; Alic, Nazif] UCL, Inst Hlth Ageing, Res Dept Genet Evolut & Environm, London WC1E 6BT, England.
   [Mueller, Stefanie H.] UCL, Inst Hlth Informat, London NW1 2DA, England.
   [Selman, Colin] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.
   [Tullet, Jennifer M. A.] Univ Kent, Sch Biosci, Canterbury CT2 7NZ, Kent, England.
   [Kuchenbaecker, Karoline] UCL, UCL Genet Inst, Res Dept Genet Evolut & Environm, London WC1E 6BT, England.
   [Kuchenbaecker, Karoline] UCL, Div Psychiat, London W1T 7NF, England.
C3 University of London; University College London; University of London;
   University College London; University of Glasgow; University of Kent;
   University of London; University College London; University of London;
   University College London
RP Alic, N (corresponding author), UCL, Inst Hlth Ageing, Res Dept Genet Evolut & Environm, London WC1E 6BT, England.; Kuchenbaecker, K (corresponding author), UCL, UCL Genet Inst, Res Dept Genet Evolut & Environm, London WC1E 6BT, England.; Kuchenbaecker, K (corresponding author), UCL, Div Psychiat, London W1T 7NF, England.
EM k.kuchenbaecker@ucl.ac.uk; n.alic@ucl.ac.uk
RI Tullet, Jennifer M A/C-1779-2008; Alic, Nazif/B-4665-2009
OI Alic, Nazif/0000-0003-0356-6600
FU Biotechnology and Biological Sciences Research Council [BB/R014507/1,
   BB/S014357/1]; Wellcome [212360/Z/18/Z]; Persia Mirzakhani Scholarship
   for Women; BBSRC [BB/S014357/1, BB/R014507/1] Funding Source: UKRI;
   Wellcome Trust [212360/Z/18/Z] Funding Source: Wellcome Trust
FX We thank J. Deelen for summary statistics with rsID mapping. This work
   was funded in part by Biotechnology and Biological Sciences Research
   Council grants BB/R014507/1 to N.A. and BB/S014357/1 to N.A., J.M.A.T.,
   and C.S. and Wellcome grant 212360/Z/18/Z to K.K. S.J. was a recipient
   of Persia Mirzakhani Scholarship for Women.
CR Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776
   Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bernard G, 2011, AM J HUM GENET, V89, P415, DOI 10.1016/j.ajhg.2011.07.014
   Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080
   Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102
   Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758
   Chen CY, 2018, CELL REP, V24, P1852, DOI 10.1016/j.celrep.2018.07.046
   Chen D, 2007, AGING CELL, V6, P525, DOI 10.1111/j.1474-9726.2007.00305.x
   Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Corrales GM, 2020, CELL REP, V30, P1661, DOI 10.1016/j.celrep.2020.01.017
   Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056
   Dauwerse JG, 2011, NAT GENET, V43, P20, DOI 10.1038/ng.724
   Deelen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11558-2
   Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007
   Farley-Barnes KI, 2019, TRENDS GENET, V35, P754, DOI 10.1016/j.tig.2019.07.004
   Filer D, 2017, NATURE, V552, P263, DOI 10.1038/nature25007
   Gay NR, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02113-0
   Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219
   Grewal SS, 2007, J CELL BIOL, V179, P1105, DOI 10.1083/jcb.200709044
   Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x
   Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408
   Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Khatter H, 2015, NATURE, V520, P640, DOI 10.1038/nature14427
   Kirby TJ, 2015, J APPL PHYSIOL, V119, P321, DOI 10.1152/japplphysiol.00296.2015
   Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4
   Lin JI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002408
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mannick JB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1564
   Marshall L, 2012, EMBO J, V31, P1916, DOI 10.1038/emboj.2012.33
   Martinez-Miguel VE, 2021, CELL METAB, V33, P2288, DOI 10.1016/j.cmet.2021.08.017
   Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216
   Meier S, 2016, J NEUROSCI, V36, P1001, DOI 10.1523/JNEUROSCI.3029-15.2016
   Mills EW, 2017, SCIENCE, V358, DOI 10.1126/science.aan2755
   Moens TG, 2019, ACTA NEUROPATHOL, V137, P487, DOI 10.1007/s00401-018-1946-4
   Ongen H, 2016, BIOINFORMATICS, V32, P1479, DOI 10.1093/bioinformatics/btv722
   Paolacci S, 2018, J MED GENET, V55, P837, DOI 10.1136/jmedgenet-2018-105528
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Partridge L, 2020, NAT REV DRUG DISCOV, V19, P513, DOI 10.1038/s41573-020-0067-7
   Sinturel F, 2017, CELL, V169, P651, DOI 10.1016/j.cell.2017.04.015
   Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x
   Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179
   Team RC, 2020, R: A Language and Environment for Statistical
   Templeman NM, 2017, CELL REP, V20, P451, DOI 10.1016/j.celrep.2017.06.048
   Thompson ACS, 2016, AGING CELL, V15, P118, DOI 10.1111/acel.12414
   Tiku V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16083
   Torres GG, 2021, J GERONTOL A-BIOL, V76, P786, DOI 10.1093/gerona/glab023
   Uhlén M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200
   Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023
   Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7
   Wang XL, 2020, P NATL ACAD SCI USA, V117, P15702, DOI 10.1073/pnas.1922821117
   Weaver KN, 2015, AM J HUM GENET, V96, P765, DOI 10.1016/j.ajhg.2015.03.011
   WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x
   Woodling NS, 2020, AGING CELL, V19, DOI 10.1111/acel.13137
   Yamada SB, 2019, NAT NEUROSCI, V22, P1383, DOI 10.1038/s41593-019-0455-7
NR 57
TC 3
Z9 3
U1 2
U2 11
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD FEB
PY 2022
VL 32
IS 2
BP 258
EP 265
DI 10.1101/gr.275636.121
PG 8
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA YQ8OQ
UT WOS:000749564500005
PM 35078808
OA hybrid, Green Published, Green Accepted
DA 2024-02-19
ER

PT J
AU Liu, BY
   Xie, YB
   Chen, J
   Xue, JL
   Zhang, XY
   Zhao, M
   Jia, XB
   Wang, YW
   Qin, SC
AF Liu, Boyan
   Xie, Yunbo
   Chen, Jun
   Xue, Junli
   Zhang, Xiaoyi
   Zhao, Min
   Jia, Xiubin
   Wang, Yiwei
   Qin, Shucun
TI Protective Effect of Molecular Hydrogen Following Different Routes of
   Administration on D-Galactose-Induced Aging Mice
SO JOURNAL OF INFLAMMATION RESEARCH
LA English
DT Article
DE molecular hydrogen; administration routes; oxidative stress; aging;
   D-galactose
ID MODEL; MALONDIALDEHYDE; ATORVASTATIN; ANTIOXIDANT; INHALATION
AB Background: Molecular hydrogen (H-2) has been recognized as an effective antioxidant with no or little side effects. While it is known that oxidative stress is closely associated with aging, the beneficial effect of H-2 on oxidative stress-related aging is still unclear. In this study, a mouse model of D-galactose-induced aging was employed to investigate the protective effects of H-2.
   Methods: The mice were administrated of H-2 via different routes (4% H-2 inhalation, H-2-rich water drinking, and H-2-rich saline injection), the aging-related biomarkers in plasma and the oxidative stress in different tissues were measured.
   Results: The results showed that H-2 improved aging-related biomarkers, ie, total antioxidant capacity, advanced glycation end products, tumor necrosis factor-alpha, free fatty acids, and alanine aminotransferase in plasma. Furthermore, H-2 alleviated oxidative stress in the liver, brain, and heart by reducing the levels of lipid peroxidation and malondialdehyde and increasing the activity of superoxide dismutase. In addition, it seems that 4% H-2 inhalation was the most effective regarding the amount of H-2 taken up and in reducing the markers of oxidative stress in some of the tissues; however, the other routes of administration resulted in the same efficacy in most indicators.
   Conclusion: H-2 can prevent oxidative stress in D-galactose-induced aging mice when administered by different routes.
C1 [Liu, Boyan; Xue, Junli; Qin, Shucun] Shandong First Med Univ, Affiliated Hosp 2, Tai An 271000, Shandong, Peoples R China.
   [Liu, Boyan; Xie, Yunbo; Xue, Junli; Zhang, Xiaoyi; Zhao, Min; Jia, Xiubin; Qin, Shucun] Shandong First Med Univ & Shandong Acad Med Sci, Taishan Inst Hydrogen Biomed, Tai An 271000, Shandong, Peoples R China.
   [Liu, Boyan; Xue, Junli] Shandong First Med Univ & Shandong Acad Med Sci, Coll Basic Med Sci, Jinan 250117, Peoples R China.
   [Xie, Yunbo; Chen, Jun; Wang, Yiwei] Chengde Med Univ, Affiliated Hosp, Dept Gen Practice, Chengde 067000, Peoples R China.
C3 Shandong First Medical University & Shandong Academy of Medical
   Sciences; Shandong First Medical University & Shandong Academy of
   Medical Sciences; Shandong First Medical University & Shandong Academy
   of Medical Sciences; Chengde Medical University
RP Qin, SC (corresponding author), Shandong First Med Univ, Affiliated Hosp 2, Tai An 271000, Shandong, Peoples R China.; Wang, YW (corresponding author), Chengde Med Univ, Affiliated Hosp, Dept Gen Practice, Chengde 067000, Peoples R China.
EM chengdewyw@126.com; scqin@sdfmu.edu.cn
RI XUE, JUNLI/ABE-8689-2021; Liu, Boyan/G-2138-2018
OI Liu, Boyan/0000-0001-7318-3555
FU National Natural Science Foundation of China [81770855]; Taishan
   Scholars Program of Shandong Province [ts201511057]; Shandong Provincial
   Natural Science Foundation [ZR2020QH020]; Academic Promotion Programme
   of Shandong First Medical University [2019QL010, 2019PT009]
FX This work was supported by the National Natural Science Foundation of
   China [grant number 81770855] , Taishan Scholars Program of Shandong
   Province [grant number ts201511057] , Shandong Provincial Natural
   Science Foundation (ZR2020QH020) , and Academic Promotion Programme of
   Shandong First Medical University [grant number 2019QL010, 2019PT009] .
CR Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Cai YS, 2020, CELL RES, V30, P574, DOI 10.1038/s41422-020-0314-9
   Chen JB, 2019, MED GAS RES, V9, P115, DOI 10.4103/2045-9912.266985
   Chen W, 2021, NEUROSCI BULL, V37, P389, DOI 10.1007/s12264-020-00597-1
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088
   Gil P, 2002, GERONTOLOGY, V48, P209, DOI 10.1159/000058352
   Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165
   Iketani M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35239-0
   Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8
   Ito M, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-15
   Kaviani E, 2017, BEHAV BRAIN RES, V334, P55, DOI 10.1016/j.bbr.2017.07.029
   Klichko VI, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01679
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Liu BY, 2021, LIFE SCI, V267, DOI 10.1016/j.lfs.2020.118945
   Liu BY, 2020, MOL MED REP, V22, P2860, DOI 10.3892/mmr.2020.11364
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   Matsumoto A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03273
   Middaugh LD, 1999, ALCOHOL, V17, P175, DOI 10.1016/S0741-8329(98)00055-X
   Miedema MD, 2014, AM J CARDIOL, V114, P843, DOI 10.1016/j.amjcard.2014.06.012
   Nicolaus ML, 2016, J AM ASSOC LAB ANIM, V55, P525
   Oharazawa H, 2010, INVEST OPHTH VIS SCI, V51, P487, DOI 10.1167/iovs.09-4089
   Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577
   Qin SC, 2021, CURR PHARM DESIGN, V27, P713, DOI 10.2174/1381612826666201124112152
   Retnaningtyas E, AIP C P, V2021
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Song GH, 2015, FREE RADICAL BIO MED, V87, P58, DOI 10.1016/j.freeradbiomed.2015.06.018
   Song GH, 2012, ATHEROSCLEROSIS, V221, P55, DOI 10.1016/j.atherosclerosis.2011.11.043
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Sun X., 2015, Hydrogen Molecular Biology and Medicine, DOI DOI 10.1007/978-94-017-9691-0
   Taghipour Z, 2019, PHYSIOL PHARMACOL, V23, P36
   Tao GR, 2019, ACTA BIOCH BIOPH SIN, V51, P1189, DOI 10.1093/abbs/gmz121
   Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Zhu QY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26388-3
NR 35
TC 9
Z9 9
U1 2
U2 12
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1178-7031
J9 J INFLAMM RES
JI J. Inflamm. Res.
PY 2021
VL 14
BP 5541
EP 5550
DI 10.2147/JIR.S332286
PG 10
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA WO6CT
UT WOS:000712541000005
PM 34737603
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wang, P
   Yang, X
   Zhou, N
   Wang, JY
   Li, Y
   Liu, YM
   Xu, XL
   Wei, WB
AF Wang, Ping
   Yang, Xuan
   Zhou, Nan
   Wang, Jinyuan
   Li, Yang
   Liu, Yueming
   Xu, Xiaolin
   Wei, Wenbin
TI Identifying a Potential Key Gene, TIMP1, Associated with Liver
   Metastases of Uveal Melanoma by Weight Gene Co-Expression Network
   Analysis
SO ONCOTARGETS AND THERAPY
LA English
DT Article
DE weighted gene co-expression network analysis; WGCNA; uveal melanoma;
   liver metastases; GO analysis; pathway analysis
ID HEPATOCYTE GROWTH-FACTOR; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES;
   PREMETASTATIC NICHE; SIGNALING PATHWAY; C-MET; EXPRESSION; PROGNOSIS;
   RECEPTOR; DISEASE
AB Purpose: Uveal melanoma (UM) is a primary intraocular tumor in adults, with a high percentage of metastases to the liver. Identifying potential key genes may provide informa-tion for early detection and prognosis of UM metastasis.
   Patients and Methods: Differentially expressed genes (DEGs) were identified using the GSE22138 dataset. Weighted gene co-expression network analysis was used to construct co expression modules. Functional enrichment analysis was performed for DEGs and genes of key modules. Hub genes were screened by co-expression network and protein-protein interaction network (PPI), and validated by survival analysis in The Cancer Genome Atlas database. Gene set enrichment analysis (GSEA) was used to explore the potential metastasis mechanism of UM. Transient transfection was used to investigate the effect of TIMP1 on the proliferation, migration, and invasion of UM cells.
   Results: In total, 552 DEGs were identified between primary and metastatic UM and mainly enriched in extracellular matrix, cellular senescence and focal adhesion pathway. A weighted gene co-expression network was built to identify key gene modules associated with UM metastasis (n=36). The turquoise module is positively correlated with metastasis and genes in this module were mainly enriched in peptidyl-tyrosine autophosphorylation and regulation of organ growth. The hub gene TIMP1 was screened out by co-expression network and PPI analysis. High expression of TIMP1 was related to p53 pathway by GSEA and short overall survival time. Experimental results indicated that overexpression of TIMP1 inhibited the proliferation and migration, while it had no significant effect on invasion of UM cells.
   Conclusion: Our study indicates that TIMP1 might be associated with metastasis in UM, which might have important significance for identifying patients with high risk of metastasis and predicting the prognosis of UM.
C1 [Wang, Ping; Yang, Xuan; Zhou, Nan; Wang, Jinyuan; Li, Yang; Liu, Yueming; Xu, Xiaolin; Wei, Wenbin] Capital Med Univ, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Med Artificial Intelligence Res & Verificat Key L, Beijing Ophthalmol & Visual Sci Key Lab,Minist In, Beijing 100730, Peoples R China.
C3 Capital Medical University
RP Wei, WB (corresponding author), Capital Med Univ, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Med Artificial Intelligence Res & Verificat Key L, Beijing Ophthalmol & Visual Sci Key Lab,Minist In, Beijing 100730, Peoples R China.
EM weiwenbintr@163.com
RI wei, wei/IQW-1347-2023; zhao, lin/JJF-0406-2023; li, zy/HZM-1892-2023;
   Liu, Gui/JHU-8707-2023; peng, jy/JMB-2297-2023; Liu,
   Yiming/ISU-3780-2023; Yang, Ying/ABD-2481-2022; Liu, Shao/JFK-0166-2023
OI peng, jy/0000-0001-9665-1059; Wang, Jinyuan/0000-0002-8378-1249
FU Capital Health Research and Development of Special [2020-1-2052];
   Science & Technology Project of Beijing Municipal Science & Technology
   Commission [Z181100001818003]; Beijing Municipal Administration of
   Hospitals' Ascent Plan [DFL20150201]
FX This research was supported by The Capital Health Research and
   Development of Special (2020-1-2052); Science & Technology Project of
   Beijing Municipal Science & Technology Commission (Z181100001818003);
   the Beijing Municipal Administration of Hospitals' Ascent Plan
   (DFL20150201).
CR Airola K, 1999, BRIT J CANCER, V80, P733, DOI 10.1038/sj.bjc.6690417
   All-Ericsson C, 2002, INVEST OPHTH VIS SCI, V43, P1
   AUGSBURGER JJ, 1990, CANCER, V66, P1596, DOI 10.1002/1097-0142(19901001)66:7<1596::AID-CNCR2820660726>3.0.CO;2-6
   Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2
   Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Botía JA, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0420-6
   Caley MP, 2015, ADV WOUND CARE, V4, P225, DOI 10.1089/wound.2014.0581
   Carvajal RD, 2017, BRIT J OPHTHALMOL, V101, P38, DOI 10.1136/bjophthalmol-2016-309034
   Clarke C, 2013, CARCINOGENESIS, V34, P2300, DOI 10.1093/carcin/bgt208
   Cree IA, 2000, J PATHOL, V191, P112
   Cruz-Munoz W, 2008, CRIT REV CL LAB SCI, V45, P291, DOI [10.1080/10408360801973244, 10.1080/10408360801973244 ]
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9
   Diener-West M, 2005, ARCH OPHTHALMOL-CHIC, V123, P1639
   Economou MA, 2008, ACTA OPHTHALMOL, V86, P930, DOI [10.1111/j.1755-3768.2008.01188.x, 10.1111/j.1755-3768.2008.01185.x, 10.1111/j.1755-3768.2008.01184.x, 10.1111/j.1755-3768.2008.01182.x]
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   El-Shabrawi Y, 2001, J PATHOL, V194, P201, DOI 10.1002/1096-9896(200106)194:2<201::AID-PATH840>3.0.CO;2-O
   Ewens KG, 2014, INVEST OPHTH VIS SCI, V55, P5160, DOI 10.1167/iovs.14-14550
   Field MG, 2014, CURR OPIN OPHTHALMOL, V25, P234, DOI 10.1097/ICU.0000000000000051
   Franco Renato, 2010, Front Biosci (Elite Ed), V2, P13, DOI 10.2741/e60
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Giulietti M, 2018, CARCINOGENESIS, V39, P1016, DOI 10.1093/carcin/bgy069
   GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995
   Gouyer V, 2005, CANCER-AM CANCER SOC, V103, P1676, DOI 10.1002/cncr.20965
   Grünwald B, 2016, GASTROENTEROLOGY, V151, P1011, DOI 10.1053/j.gastro.2016.07.043
   Honkavuori M, 2008, ANTICANCER RES, V28, P2715
   Hu Y, 2018, HELICOBACTER, V23, DOI 10.1111/hel.12530
   KHOKHA R, 1994, J NATL CANCER I, V86, P299, DOI 10.1093/jnci/86.4.299
   Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Laurent C, 2011, CANCER RES, V71, P666, DOI 10.1158/0008-5472.CAN-10-0605
   Li HC, 2009, INVEST OPHTH VIS SCI, V50, P5522, DOI 10.1167/iovs.09-3804
   Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241
   Liu JH, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118231
   Mallikarjuna K, 2007, CURR EYE RES, V32, P281, DOI 10.1080/02713680601161220
   Martin DC, 1996, ONCOGENE, V13, P569
   Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233
   Ni LH, 2020, ONCOTARGETS THER, V13, P6975, DOI 10.2147/OTT.S251000
   Nichols EE, 2016, SEMIN OPHTHALMOL, V31, P304, DOI 10.3109/08820538.2016.1154175
   Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750
   Onken MD, 2006, CANCER RES, V66, P4602, DOI 10.1158/0008-5472.CAN-05-4196
   Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Roeb E, 1999, J CELL BIOCHEM, V75, P346, DOI 10.1002/(SICI)1097-4644(19991101)75:2<346::AID-JCB16>3.0.CO;2-5
   Roy R, 2014, BRIT J CANCER, V111, P1772, DOI 10.1038/bjc.2014.462
   Schrohl AS, 2004, CLIN CANCER RES, V10, P2289, DOI 10.1158/1078-0432.CCR-03-0360
   Seubert B, 2015, HEPATOLOGY, V61, P238, DOI 10.1002/hep.27378
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426
   Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P989, DOI 10.1001/archophthalmol.2009.208
   Shields JA, 1996, SEMIN ONCOL, V23, P763
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tsai LH, 2014, ONCOGENE, V33, P3851, DOI 10.1038/onc.2013.353
   Wang JL, 2019, GYNECOL ONCOL, V152, P194, DOI 10.1016/j.ygyno.2018.10.002
   Woodward JKL, 2002, INVEST OPHTH VIS SCI, V43, P3144
   Xiao SS, 2015, INT J ONCOL, V46, P1677, DOI 10.3892/ijo.2015.2873
   Zheng JN, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00816
NR 59
TC 2
Z9 3
U1 0
U2 3
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6930
J9 ONCOTARGETS THER
JI OncoTargets Ther.
PY 2020
VL 13
BP 11923
EP 11934
DI 10.2147/OTT.S280435
PG 12
WC Biotechnology & Applied Microbiology; Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Oncology
GA OS8WI
UT WOS:000590438600005
PM 33239893
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU St-Onge, MP
AF St-Onge, MP
TI Relationship between body composition changes and changes in physical
   function and metabolic risk factors in aging
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Article
DE aging; body composition; metabolic risk; physical function
ID MUSCLE MASS; SKELETAL-MUSCLE; VISCERAL FAT; ELDERLY-MEN; OLDER MEN;
   WOMEN; STRENGTH; HEALTH; ASSOCIATION; PERFORMANCE
AB Purpose of review Several body composition changes are known to occur with aging. The purpose of this review is to evaluate recent literature examining body composition changes with aging and how these relate to changes in physical function and metabolic risk.
   Recent findings Cross-sectional and longitudinal studies have observed increases in fat mass and decreases in muscle mass or lean tissue mass in older adults, often in the absence of differences or changes in body weight. Cross-sectional studies have also reported increases in intramyocellular lipid and liver fat in older versus younger adults and related changes in body composition with changes in physical function and metabolic risk, but few longitudinal data are available. Furthermore, most longitudinal studies lack precise methods of assessing body fat distribution and muscle and organ quality, resulting in a lack of detailed and precise information on body composition changes with aging and their relationship to health.
   Summary Research to date has outlined a need for more detailed body composition measurements of aging adults. Absence of change in a total body compartment may mask a change in subcompartments that may impact health. Furthermore,, intervention studies to determine ways to maintain, body composition are consistent with healthy living throughout the aging process.
C1 Univ Alabama, Dept Nutr Sci, Div Physiol & Metab, Birmingham, AL 35226 USA.
C3 University of Alabama System; University of Alabama Birmingham
RP St-Onge, MP (corresponding author), Univ Alabama, Dept Nutr Sci, Div Physiol & Metab, 1530 3rd Ave S,Webb 404, Birmingham, AL 35226 USA.
EM mpstonge@uab.edu
RI St-Onge, Marie-Pierre/AAB-3523-2020
OI St-Onge, Marie-Pierre/0000-0003-1354-1749
CR Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986
   Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157
   Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372
   Haveman-Nies A, 2003, AGE AGEING, V32, P427, DOI 10.1093/ageing/32.4.427
   He Q, 2003, AM J CLIN NUTR, V78, P72, DOI 10.1093/ajcn/78.1.72
   Hernández-Ono A, 2002, INT J OBESITY, V26, P33, DOI 10.1038/sj.ijo.0801842
   Heymsfield SB, 2000, EUR J CLIN NUTR, V54, pS26, DOI 10.1038/sj.ejcn.1601022
   Hughes VA, 2004, AM J CLIN NUTR, V80, P475, DOI 10.1093/ajcn/80.2.475
   Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473
   Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209, DOI 10.1093/gerona/56.5.B209
   Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x
   Landers KA, 2001, J GERONTOL A-BIOL, V56, pB443, DOI 10.1093/gerona/56.10.B443
   LITTMAN AJ, 2005, INT J OBES, V11
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pi-Sunyer FX, 2004, NUTR REV, V62, pS120, DOI 10.1111/j.1753-4887.2004.tb00081.x
   Song MY, 2004, AM J CLIN NUTR, V79, P874
   St-Onge MP, 2004, J GERONTOL A-BIOL, V59, P796
   Stanforth PR, 2004, INT J OBESITY, V28, P925, DOI 10.1038/sj.ijo.0802563
   Sternfeld B, 2002, AM J EPIDEMIOL, V156, P110, DOI 10.1093/aje/kwf023
   Visser M, 2003, J APPL PHYSIOL, V94, P2368, DOI 10.1152/japplphysiol.00124.2002
   Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x
   Zamboni M, 2003, AGING CLIN EXP RES, V15, P321, DOI 10.1007/BF03324517
NR 22
TC 105
Z9 121
U1 1
U2 14
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD SEP
PY 2005
VL 8
IS 5
BP 523
EP 528
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 964LL
UT WOS:000231882500004
PM 16079623
DA 2024-02-19
ER

PT J
AU Rizvi, SI
   Jha, R
   Maurya, PK
AF Rizvi, Syed Ibrahim
   Jha, Rashmi
   Maurya, Pawan Kumar
TI Erythrocyte plasma membrane redox system in human aging
SO REJUVENATION RESEARCH
LA English
DT Article
ID TRANSMEMBRANE ELECTRON-TRANSFER; ASCORBIC-ACID; FREE-RADICALS;
   ANTIOXIDANT; NADH; OXIDOREDUCTASE; REDUCTION; DEHYDROGENASE; CELLS;
   LIVER
AB Eukaryotic cells display a plasma membrane redox system (PMRS) that transfers electrons from intracellular substrates to extracellular electron acceptors. The physiologic importance of PMRS is still not fully understood. The authors have carried out studies to determine the activity of PMRS in human erythrocytes as a function of age and correlate the activity with total plasma antioxidant capacity in an effort to understand the role of PMRS in human aging. The study was carried out on 80 normal healthy subjects of both genders between the ages of 18 and 85 years. The activity of erythrocyte PMRS was estimated by following the reduction of ferricyanide. The total antioxidant capacity of the plasma was estimated in terms of Ferric Reducing Ability of Plasma (FRAP) values. A significant (p < 0.0001) positive correlation (r = 0.7797) is observed between PMRS activity of erythrocytes and human age. There is an age-dependent decrease in total plasma antioxidant capacity measured in terms of FRAP values. A highly significant correlation is observed between PMRS activity and plasma FRAP values. The authors hypothesize that the increased PMRS in erythrocytes during aging may be a protective mechanism of the system for efficient extracellular DHA reduction and ascorbate recycling under condition of increased oxidative stress.
C1 Univ Allahabad, Dept Biochem, Allahabad 211002, Uttar Pradesh, India.
C3 University of Allahabad
RP Rizvi, SI (corresponding author), Univ Allahabad, Dept Biochem, Allahabad 211002, Uttar Pradesh, India.
EM rzv@rediffmail.com
CR Andriollo-Sanchez M, 2005, EUR J CLIN NUTR, V59, pS58, DOI 10.1038/sj.ejcn.1602300
   AVRON M, 1963, ANAL BIOCHEM, V6, P549, DOI 10.1016/0003-2697(63)90149-0
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   CRANE FL, 1976, FEBS LETT, V68, P153, DOI 10.1016/0014-5793(76)80425-5
   CRANE FL, 1991, J BIOENERG BIOMEMBR, V23, P773, DOI 10.1007/BF00786001
   De Cabo R, 2004, EXP GERONTOL, V39, P297, DOI 10.1016/j.exger.2003.12.003
   de Grey ADNJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P295, DOI 10.1006/abbi.1999.1509
   Demehin AA, 2001, FREE RADICAL RES, V34, P605, DOI 10.1080/10715760100300501
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Gil L, 2006, FREE RADICAL RES, V40, P495, DOI 10.1080/10715760600592962
   GREBING C, 1984, J BIOENERG BIOMEMBR, V16, P517, DOI 10.1007/BF00743243
   Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8
   JANQUEIRA VB, 2004, MOL ASPECTS MED, V25, P5
   JIALAL I, 1990, ATHEROSCLEROSIS, V82, P185, DOI 10.1016/0021-9150(90)90039-L
   Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7
   Kennett EC, 2003, IUBMB LIFE, V55, P375, DOI 10.1080/15216540310001592843
   LARM JA, 1994, J BIOL CHEM, V269, P30097
   LAWEN A, 1994, MOL ASPECTS MED, V15, P13
   Lenaz G, 2002, BIOCHEM BIOPH RES CO, V290, P1589, DOI 10.1006/bbrc.2002.6392
   López-Lluch G, 2005, AGE, V27, P153, DOI 10.1007/s11357-005-2726-3
   Lykkesfeldt J, 2003, FREE RADICAL BIO MED, V35, P1439, DOI 10.1016/j.freeradbiomed.2003.08.006
   Matteucci E, 2000, DIABETES CARE, V23, P994, DOI 10.2337/diacare.23.7.994
   May JM, 1999, BBA-BIOMEMBRANES, V1421, P19, DOI 10.1016/S0005-2736(99)00107-8
   May JM, 1996, J BIOL CHEM, V271, P10577, DOI 10.1074/jbc.271.18.10577
   May JM, 1999, FASEB J, V13, P995, DOI 10.1096/fasebj.13.9.995
   May JM, 2000, BIOCHEM BIOPH RES CO, V267, P118, DOI 10.1006/bbrc.1999.1906
   Van Duijn MM, 1998, J BIOL CHEM, V273, P13415, DOI 10.1074/jbc.273.22.13415
   VanDuijn MM, 2000, J BIOL CHEM, V275, P27720
   ZAMUDIO I, 1966, BIOCHIM BIOPHYS ACTA, V120, P165, DOI 10.1016/0926-6585(66)90290-1
   ZAMUDIO I, 1969, ARCH BIOCHEM BIOPHYS, V129, P336, DOI 10.1016/0003-9861(69)90184-2
NR 31
TC 98
Z9 104
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD WIN
PY 2006
VL 9
IS 4
BP 470
EP 474
DI 10.1089/rej.2006.9.470
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 105MI
UT WOS:000242033800010
PM 17105387
DA 2024-02-19
ER

PT J
AU LENTINI, A
   FALASCA, L
   AUTUORI, F
   DINI, L
AF LENTINI, A
   FALASCA, L
   AUTUORI, F
   DINI, L
TI THE SIMULTANEOUS EXPOSITION OF GALACTOSE AND MANNOSE-SPECIFIC RECEPTORS
   ON RAT-LIVER MACROPHAGES IS DEVELOPMENTALLY REGULATED
SO BIOSCIENCE REPORTS
LA English
DT Article
DE GALACTOSE-SPECIFIC RECEPTOR; MANNOSE-SPECIFIC RECEPTOR; KUPFFER CELLS;
   DEVELOPMENT; AGING
ID KUPFFER CELLS; ASIALOGLYCOPROTEIN RECEPTOR; N-ACETYLGLUCOSAMINE;
   LOCALIZATION; GLYCOPROTEINS; RECOGNITION; BINDING
AB We studied the simultaneous binding of galactose and mannose-exposing ligands in sinusoidal rat liver cells during development and aging. The galactose-specific receptors were visualized using 17 nm diameter colloidal gold particles coupled with Lactosylated bovine serum albumine (LacBSA), while mannose-specific receptors were localized by means of 5 nm diameter particles adsorbed with mannan. We observed the presence of four different classes of Kupffer cells in relation to the ligands bound. The percentage of each group of Kupffer cells varied in relation to the age of the subject from which the sample was taken. There were few double-labelled cells in the livers from newborn rats, with numbers increasing with age to adulthood, and decreasing again in the older animals. Cells without labelling were in the majority after birth, but they decreased in number up to adulthood and increased again during subsequent aging. The numbers of single-labelled cells did not change significantly during liver maturation. We hypothesize that the exposition of galactose and mannose-specific receptorial systems is regulated by developmental conditions.
C1 UNIV ROMA TOR VERGATA,DEPT BIOL,VIA E CARNEVALE,I-00173 ROME,ITALY.
C3 University of Rome Tor Vergata
RI Falasca, Laura/J-6459-2016
OI Falasca, Laura/0000-0001-8752-2415
CR [Anonymous], 1982, SINUSOIDAL LIVER CEL
   BARBERAGUILLEM E, 1986, J ULTRA MOL STRUCT R, V97, P197, DOI 10.1016/S0889-1605(86)80018-0
   BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430
   DINI L, 1987, EUR J CELL BIOL, V44, P144
   DINI L, 1992, FEBS LETT, V296, P174, DOI 10.1016/0014-5793(92)80373-O
   DINI L, 1989, MECH AGEING DEV, V50, P57, DOI 10.1016/0047-6374(89)90059-6
   DINI L, 1990, MECH AGEING DEV, V56, P117, DOI 10.1016/0047-6374(90)90003-X
   ESHDAT Y, 1984, BIOL CELL, V51, P259, DOI 10.1111/j.1768-322X.1984.tb00307.x
   FORSTER O, 1981, HETEROGENEITY MONONU
   HARDONK MJ, 1986, CELLS HEPATIC SINUSO, V2, P434
   HORISBERGER M, 1977, J HISTOCHEM CYTOCHEM, V25, P295, DOI 10.1177/25.4.323352
   JUNGERMANN K, 1988, SEMIN LIVER DIS, V8, P329, DOI 10.1055/s-2008-1040554
   KOLBBACHOFEN V, 1982, CELL, V29, P859, DOI 10.1016/0092-8674(82)90447-0
   MARAHAN PS, 1980, RETICULOENDOTHEL SOC, V27, P223
   NAITO M, 1991, CELLS HAPATIC SINUSO, V3, P497
   PRAANINGVANDALEN DP, 1987, HEPATOLOGY, V7, P672
   ROOS PH, 1985, BIOCHIM BIOPHYS ACTA, V847, P115, DOI 10.1016/0167-4889(85)90161-2
   SCHLESINGER PH, 1980, BIOCHEM J, V192, P597, DOI 10.1042/bj1920597
   SCHWARTZ AL, 1984, CRC CR REV BIOCH MOL, V16, P207, DOI 10.3109/10409238409108716
   SHERWOOD ER, 1988, SINUSOIDS HUMAN LIVE, P359
   SLEYSTER EC, 1982, LAB INVEST, V47, P484
   SPITZER JA, 1991, CELLS HEPATIC SINUSO, V3, P68
   STAHL PD, 1984, BIOL CELL, V51, P215, DOI 10.1111/j.1768-322X.1984.tb00301.x
   TABATA Y, 1988, BIOMATERIALS, V9, P356, DOI 10.1016/0142-9612(88)90033-6
   TAKEYA M, 1989, J HISTOCHEM CYTOCHEM, V37, P635, DOI 10.1177/37.5.2649558
   TELOPPELE M, 1990, AM J PHYSIOL, V259, pG814
   WARDLE EN, 1987, LIVER, V7, P63
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   WISSE E, 1989, CELLS HEPATIC SINUSO, V2, P1
NR 29
TC 5
Z9 5
U1 0
U2 0
PU PLENUM PUBL CORP
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013
SN 0144-8463
J9 BIOSCIENCE REP
JI Biosci. Rep.
PD DEC
PY 1992
VL 12
IS 6
BP 453
EP 461
DI 10.1007/BF01122033
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA KQ896
UT WOS:A1992KQ89600003
PM 1338496
DA 2024-02-19
ER

PT J
AU Macias, B
   Gomez-Pinilla, PJ
   Camello-Almaraz, C
   Pascua, P
   Af Tresguerres, J
   Camello, PJ
   Pozo, MJ
AF Macias, Beatriz
   Gomez-Pinilla, Pedro J.
   Camello-Almaraz, Cristina
   Pascua, Patricia
   Af Tresguerres, Jesus
   Camello, Pedro J.
   Pozo, Maria J.
TI Aging impairs Ca<SUP>2+</SUP> sensitization pathways in gallbladder
   smooth muscle
SO AGE
LA English
DT Article
DE Gallbladder; Bethanechol; CCK; Calcium sensitization; Aging; Oxidative
   stress; Melatonin
ID PROTEIN-KINASE; MELATONIN; CONTRACTILITY; LIVER; AGE; MECHANISMS;
   SENSITIVITY; GROWTH; MODEL
AB Calcium sensitization is an important physiological process in agonist-induced contraction of smooth muscle. In brief, calcium sensitization is a pathway that leads to smooth muscle contraction independently of changes in [Ca2+](i) by mean of inhibition of myosin light chain phosphatase. Aging has negative impacts on gallbladder contractile response due to partial impairment in calcium signaling and alterations in the contractile machinery. However, information regarding aging-induced alterations in calcium sensitization is scanty. We hypothesized that the calcium sensitization system is negatively affected by age. To investigate this, gallbladders were collected from adult (4 months old) and aged (22-24 months old) guinea pigs. To evaluate the contribution of calcium sensitization pathways we assayed the effect of the specific inhibitors Y-27632 and GF109203X on the "in vitro" isometric gallbladder contractions induced by agonist challenges. In addition, expression and phosphorylation (as activation index) of proteins participating in the calcium sensitization pathways were quantified by Western blotting. Aging reduced bethanechol- and cholecystokinin-evoked contractions, an effect associated with a reduction in MLC20 phosphorylation and in the effects of both Y-27632 and GF109203X. In addition, there was a drop in ROCK I, ROCK II, MYPT-1 and PKC expression and in the activation/phosphorylation of MYPT-1, PKC and CPI-17 in response to agonists. Interestingly, melatonin treatment for 4 weeks restored gallbladder contractile responses due to re-establishment of calcium sensitization pathways. These results demonstrate that age-related gallbladder hypocontractility is associated to alterations of calcium sensitization pathways and that melatonin treatment exerts beneficial effects in the recovery of gallbladder contractility.
C1 [Macias, Beatriz; Gomez-Pinilla, Pedro J.; Camello-Almaraz, Cristina; Pascua, Patricia; Camello, Pedro J.; Pozo, Maria J.] Univ Extremadura, Dept Physiol, Sch Nursing, Caceres 10003, Spain.
   [Af Tresguerres, Jesus] Univ Complutense Madrid, Sch Med, Dept Physiol, E-28040 Madrid, Spain.
C3 Universidad de Extremadura; Complutense University of Madrid
RP Pozo, MJ (corresponding author), Univ Extremadura, Dept Physiol, Sch Nursing, Avda Univ S-N, Caceres 10003, Spain.
EM mjpozo@unex.es
RI CAMELLO, PEDRO J J/K-8237-2014; Camello, Cristina/K-8238-2014; Pozo,
   Maria J/K-8277-2014; b, m/HPE-0989-2023; B, Macias-Garcia/H-7301-2013
OI CAMELLO, PEDRO J J/0000-0001-5026-7166; Camello,
   Cristina/0000-0003-0882-8497; Pozo, Maria J/0000-0002-4137-6798; B,
   Macias-Garcia/0000-0001-5331-9793
FU Spanish Ministery of Science and Education [BFU 2007-60563]; Junta de
   Extremadura [PRI07A069]; Instituto de Salud Carlos III [RETICEF
   RD06/0013/1012, RD06/0013/0002]
FX This work was supported by Spanish Ministery of Science and Education
   (BFU 2007-60563), Junta de Extremadura (PRI07A069) and Instituto de
   Salud Carlos III (RETICEF RD06/0013/1012 and RD06/0013/0002).
CR Camello-Almaraz C, 2008, J PINEAL RES, V45, P191, DOI 10.1111/j.1600-079X.2008.00576.x
   Camello-Almaraz C, 2009, AM J PHYSIOL-CELL PH, V296, pC783, DOI 10.1152/ajpcell.00452.2008
   Camilleri M, 2000, J AM GERIATR SOC, V48, P1142, DOI 10.1111/j.1532-5415.2000.tb04793.x
   Chen Q, 1999, GASTROENTEROLOGY, V116, P678, DOI 10.1016/S0016-5085(99)70190-3
   Chiba Y, 1999, BRIT J PHARMACOL, V127, P597, DOI 10.1038/sj.bjp.0702585
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   Cuesta S, 2010, EXP GERONTOL, V45, P950, DOI 10.1016/j.exger.2010.08.016
   ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993
   Forman K, 2010, J PINEAL RES, V49, P312, DOI 10.1111/j.1600-079X.2010.00800.x
   Gomez-Pinilla PJ, 2008, J PINEAL RES, V44, P416, DOI 10.1111/j.1600-079X.2007.00544.x
   Gomez-Pinilla PJ, 2007, BIOCHEM PHARMACOL, V74, P860, DOI 10.1016/j.bcp.2007.06.037
   Gomez-Pinilla PJ, 2006, J PHARMACOL EXP THER, V319, P847, DOI 10.1124/jpet.106.109256
   Gomez-Pinilla PJ, 2011, AGE, V33, P81, DOI 10.1007/s11357-010-9163-7
   Hirano Katsuya, 2004, Journal of Smooth Muscle Research, V40, P219, DOI 10.1540/jsmr.40.219
   Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967
   Karaki H, 1997, PHARMACOL REV, V49, P157
   Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x
   Kireev RA, 2008, J PINEAL RES, V45, P394, DOI 10.1111/j.1600-079X.2008.00606.x
   Kireev RA, 2007, J PINEAL RES, V42, P64, DOI 10.1111/j.1600-079X.2006.00385.x
   Kireev RA, 2007, BIOGERONTOLOGY, V8, P469, DOI 10.1007/s10522-007-9089-3
   Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707
   Pandi-Perumal SR, 2008, PROG NEUROBIOL, V85, P335, DOI 10.1016/j.pneurobio.2008.04.001
   PANG SF, 1990, J PINEAL RES, V8, P179, DOI 10.1111/j.1600-079X.1990.tb00678.x
   Pascua P, 2011, J PINEAL RES, DOI [10.1111/j.1600-079X.2011.00904.x.2011, DOI 10.1111/J.1600-079X.2011.00904.X.2011]
   Persson K, 1998, AM J PHYSIOL-REG I, V275, pR1366, DOI 10.1152/ajpregu.1998.275.4.R1366
   Pozo MJ, 2010, CURR MED CHEM, V17, P4150
   Pozo MJ, 2004, CURR MED CHEM, V11, P1801, DOI 10.2174/0929867043364955
   Puzianowska-Kuznicka M, 2009, AGEING RES REV, V8, P160, DOI 10.1016/j.arr.2009.05.002
   Rayner CK, 2000, SCAND J GASTROENTERO, V35, P1041
   Reiter RJ, 1999, ADV EXP MED BIOL, V467, P379
   Reiter RJ, 1999, MECH AGEING DEV, V110, P157, DOI 10.1016/S0047-6374(99)00058-5
   Reiter RJ, 2010, PROG BRAIN RES, V181, P127, DOI 10.1016/S0079-6123(08)81008-4
   Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003
   TOULLEC D, 1991, J BIOL CHEM, V266, P15771
   Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187
   Van de Heijning BJM, 1999, DIGEST DIS SCI, V44, P190, DOI 10.1023/A:1026635124115
   Wang H, 2002, J BIOL CHEM, V277, P30614, DOI 10.1074/jbc.M204262200
   Xu QW, 1996, GASTROENTEROLOGY, V110, P251, DOI 10.1053/gast.1996.v110.pm8536864
NR 38
TC 6
Z9 6
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD AUG
PY 2012
VL 34
IS 4
BP 881
EP 893
DI 10.1007/s11357-011-9285-6
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 979PP
UT WOS:000306832500008
PM 21748275
OA Green Published
DA 2024-02-19
ER

PT J
AU Chen, YT
   Pu, Q
   Ma, YY
   Zhang, H
   Ye, TH
   Zhao, CJ
   Huang, XJ
   Ren, YF
   Qiao, LN
   Liu, HM
   Esmon, CT
   Ding, BS
   Cao, ZW
AF Chen, Yutian
   Pu, Qiang
   Ma, Yongyuan
   Zhang, Hua
   Ye, Tinghong
   Zhao, Chengjian
   Huang, Xiaojuan
   Ren, Yafeng
   Qiao, Lina
   Liu, Han-Min
   Esmon, Charles T.
   Ding, Bi-Sen
   Cao, Zhongwei
TI Aging Reprograms the Hematopoietic-Vascular Niche to Impede Regeneration
   and Promote Fibrosis
SO CELL METABOLISM
LA English
DT Article; Early Access
AB Regenerative capacity is frequently impaired in aged organs. Stress to aged organs often causes scar formation (fibrosis) at the expense of regeneration. It remains to be defined how hematopoietic and vascular cells contribute to aging-induced regeneration to fibrotic transition. Here, we find that aging aberrantly reprograms the crosstalk between hematopoietic and vascular cells to impede the regenerative capacity and enhance fibrosis. In aged lung, liver, and kidney, induction of Neuropilin-1/hypoxia-inducible-factor 2 alpha (HIF2 alpha) suppresses anti-thrombotic and anti-inflammatory endothelial protein C receptor (EPCR) pathway, leading to formation of pro-fibrotic platelet-macrophage rosette. Activated platelets via supplying interleukin 1 alpha synergize with endothelial-produced angiocrine chemokine to recruit fibrogenic TIMP1(high) macrophages. In mouse models, genetic targeting of endothelial Neuropilin-1-HIF2 alpha, platelet interleukin 1 alpha, or macrophage TIMP1 normalized the pro-fibrotic hematopoietic-vascular niche and restored the regenerative capacity of old organs. Targeting of aberrant endothelial node molecules might help propel "regeneration without scarring'' in the repair of multiple organs.
C1 [Chen, Yutian; Ma, Yongyuan; Zhang, Hua; Ye, Tinghong; Zhao, Chengjian; Huang, Xiaojuan; Ren, Yafeng; Qiao, Lina; Liu, Han-Min; Ding, Bi-Sen; Cao, Zhongwei] Sichuan Univ, West China Second Univ Hosp, Key Lab Birth Defects MOE, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.
   [Pu, Qiang] Sichuan Univ, West China Hosp, Dept Thorac Surg, Natl Frontier Ctr Dis Mol Network, Chengdu 610041, Peoples R China.
   [Esmon, Charles T.] Oklahoma Med Res Fdn, Coagulat Biol Lab, 825 NE 13th St, Oklahoma City, OK 73104 USA.
   [Ding, Bi-Sen] Icahn Sch Med Mt Sinai, Div Pulm & Crit Care Med, Fibrosis Res Ctr, New York, NY 10029 USA.
   [Ding, Bi-Sen] Weill Cornell Med, Div Regenerat Med, New York, NY 10065 USA.
C3 Sichuan University; Sichuan University; Oklahoma Medical Research
   Foundation; Icahn School of Medicine at Mount Sinai; Cornell University;
   Weill Cornell Medicine
RP Cao, ZW (corresponding author), Sichuan Univ, West China Second Univ Hosp, Key Lab Birth Defects MOE, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.
EM zhongwei.cao@outlook.com
RI Liu, Hanlong/JPE-5810-2023; Liu, Han/HMD-9231-2023; ren,
   yafeng/ACV-4507-2022; Cao, Zhongwei/JYP-4941-2024
OI Liu, Han/0000-0002-5269-8477; Ma, Yongyuan/0000-0002-3865-2202
FU Key Research and Development Program focused on Stem Cell and
   Translational Research [2016YFA0101600]; National Natural Science
   Foundation of China [91639117, 81925005, 91839301, 81722005]; National
   Heart Lung and Blood Institute [UM1 HL120877]
FX We are grateful to Dr. Scott L. Friedman and Dr. Charles A. Powell
   (Icahn School of Medicine at Mount Sinai Hospital, NY) for their advice
   on liver and lung fibrosis study. We would also like to thank Dr. Naomi
   L. Esmon (Oklahoma Medical Research Foundation) for providing the EPCR
   blocking antibody. This work was supported by Key Research and
   Development Program focused on Stem Cell and Translational Research
   (2016YFA0101600) , National Natural Science Foundation of China
   (91639117, 81925005, 91839301, and 81722005) , and National Heart Lung
   and Blood Institute (UM1 HL120877) .
CR Augustin HG, 2017, SCIENCE, V357, DOI 10.1126/science.aal2379
   Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135
   Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525
   Bertozzi CC, 2010, ARTERIOSCL THROM VAS, V30, P2368, DOI 10.1161/ATVBAHA.110.217281
   Bry M, 2010, CIRCULATION, V122, P1725, DOI 10.1161/CIRCULATIONAHA.110.957332
   Cao YH, 2013, CELL METAB, V18, P478, DOI 10.1016/j.cmet.2013.08.008
   Cao ZW, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8710
   Cao ZW, 2016, NAT MED, V22, P154, DOI 10.1038/nm.4035
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007
   Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826
   Cho H, 2016, COLD SH Q B, V81, P113, DOI 10.1101/sqb.2016.81.030833
   De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001
   De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013
   Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930
   Dimmeler S, 2014, NAT MED, V20, P814, DOI 10.1038/nm.3627
   Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681
   Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003
   Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493
   Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956
   Doyle GAR, 1997, BIOCHEMISTRY-US, V36, P2492, DOI 10.1021/bi962161e
   Esmon CT, 2013, THROMB HAEMOSTASIS, V109, P416, DOI 10.1160/TH12-08-0634
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700
   Fuentes R, 2010, J CLIN INVEST, V120, P3917, DOI 10.1172/JCI43326
   Gaertner F, 2017, CELL, V171, P1368, DOI 10.1016/j.cell.2017.11.001
   Genschmer KR, 2019, CELL, V176, P113, DOI 10.1016/j.cell.2018.12.002
   Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223
   Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416
   Gur-Cohen S, 2015, NAT MED, V21, P1307, DOI 10.1038/nm.3960
   Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182
   Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282
   Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939
   Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012
   Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667
   Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400
   Jung K, 2017, P NATL ACAD SCI USA, V114, P10455, DOI 10.1073/pnas.1710754114
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183
   Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642
   Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004
   Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638
   Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780
   Lechner AJ, 2017, CELL STEM CELL, V21, P120, DOI 10.1016/j.stem.2017.03.024
   Lefrançais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706
   Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842
   Li W, 2005, J THROMB HAEMOST, V3, P1351, DOI 10.1111/j.1538-7836.2005.01385.x
   Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928
   Mantovani A, 2013, NAT IMMUNOL, V14, P768, DOI 10.1038/ni.2666
   Martinod K, 2017, J EXP MED, V214, P439, DOI 10.1084/jem.20160530
   Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323
   Rafii S, 2015, NAT CELL BIOL, V17, P123, DOI 10.1038/ncb3096
   Rayes J, 2019, J CLIN INVEST, V129, P12, DOI 10.1172/JCI122955
   Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013
   Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699
   Sanmamed MF, 2018, CELL, V175, P313, DOI 10.1016/j.cell.2018.09.035
   Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036
   Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428
   Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777
   Toricelli M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-22
   Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112
   Vaughan AE, 2013, BBA-MOL BASIS DIS, V1832, P922, DOI 10.1016/j.bbadis.2012.11.020
   Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016
   Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002
   Wei H, 2012, P NATL ACAD SCI USA, V109, pE841, DOI 10.1073/pnas.1202081109
   Welsh JD, 2017, J THROMB HAEMOST, V15, P526, DOI 10.1111/jth.13600
   Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498
   Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144
   Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613
   Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888
NR 75
TC 37
Z9 38
U1 5
U2 52
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD 2021 FEB 2
PY 2021
VL 33
IS 2
DI 10.1016/j.cmet.2020.11.019
EA FEB 2021
PG 21
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA RC2GD
UT WOS:000632621300002
PM 33357457
OA hybrid
DA 2024-02-19
ER

PT J
AU Rajakumari, S
   Srivastava, S
AF Rajakumari, Sona
   Srivastava, Simran
TI Aging and β3-adrenergic stimulation alter mitochondrial lipidome of
   adipose tissue
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
LA English
DT Article; Early Access
DE Thermogenesis; Adipose tissue; Mitochondrial lipidome; Aging; beta
   3-adrenergic stimulation; Acyl chain desaturation
ID BROWN ADIPOCYTES; PPAR-GAMMA; LIVER-MITOCHONDRIA; MEMBRANE-LIPIDS;
   BODY-WEIGHT; FATTY-ACIDS; WHITE; CARDIOLIPIN; THERMOGENESIS; PROTEIN
AB Mitochondrial abundance and thermogenic capacity are two imperative components that distinguish brown, beige and white adipose tissues. Most importantly, the lipid composition is vital for maintaining the quantity, quality and function of mitochondria. Therefore, we employed quantitative lipidomics to probe the mitochondrial lipidome of adipose tissues. The mitochondrial lipidome reveals beta 3-adrenergic stimulation and aging drastically altered the levels of phosphatidylcholine (PC)/phosphatidylethanolamine (PE) ratio and acyl chain desaturation. Precisely, PC36:2 and PE38:4 levels correlate with the increased brown and beige fat activity in young mice. While aging increased lysoPC species in white adipose tissue (WAT) mitochondria, CL-316,243 administration reduced lysoPC species and increased lyso-PE18:1 and 18:2 content during WAT browning. Also, non-thermogenic mitochondria accumulate sphingomyelin (SM), phosphatidylserine (PS), phosphatidic acid (PA) and ether-linked PC (ePC). Similarly, enrichment of phosphatidylglycerol (PG) and cardiolipin (CL) levels are associated with thermogenic mitochondria. Also, our in vitro experiment supports that blocking the de novo sphingolipid synthesis pathway by myriocin, SPT1 inhibitor increased the thermogenic capacity and oxygen consumption rate in mature adipocytes. Overall, our study suggests mitochondria of brown, beige and white adipose tissues own a unique pattern of lipid molecular species and their levels are altered by aging and CL-316,243 administration.
C1 [Rajakumari, Sona; Srivastava, Simran] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bengaluru 560012, India.
C3 Indian Institute of Science (IISC) - Bangalore
RP Rajakumari, S (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bengaluru 560012, India.
EM sona@iisc.ac.in
FU DBT-Innovative Young Biotechnologist Award, Ministry of Science and
   Technology [BT/09/IYBA/2015/02]; Early Career Research Award SERB
   [ECR/2015/000032]; CSIR Fellowship; DST-FIST [SR/FST/LS11-036/2014(C)];
   UGC-SAP [F.4.13/2018/DRS-III (SAP-II)]; DBT-IISc Partnership Program
   Phase-II [BT/PR27952-INF/22/212/2018]
FX We acknowledge Kansas Lipidomics Research Center for the quantitative
   lipidome analysis. This work was supported by the DBT-Innovative Young
   Biotechnologist Award, Ministry of Science and Technology
   (BT/09/IYBA/2015/02) and Early Career Research AwardSERB,
   ECR/2015/000032 (S. Rajakumari), and CSIR Fellowship (Simran
   Srivastava). We thank RGCB animal facility, Ms. Amoolya, Mr.
   Udayadithya, Ms. Dhanalakshmi and Mr. Rajprabu for technical help and
   all the lab members for reviewing the manuscript.; We also thank
   DST-FIST [SR/FST/LS11-036/2014(C)], UGC-SAP [F.4.13/2018/DRS-III
   (SAP-II)] and DBT-IISc Partnership Program Phase-II
   (BT/PR27952-INF/22/212/2018) for infrastructure and financial support.
CR AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X
   Arita K, 2001, BIOCHEM PHARMACOL, V62, P821, DOI 10.1016/S0006-2952(01)00723-7
   Baker RC, 2014, METHOD ENZYMOL, V538, P89, DOI 10.1016/B978-0-12-800280-3.00006-2
   BALL EG, 1965, ANN NY ACAD SCI, V131, P225, DOI 10.1111/j.1749-6632.1965.tb34791.x
   Ban T, 2017, NAT CELL BIOL, V19, P856, DOI 10.1038/ncb3560
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Böttinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001
   Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012
   Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339
   Caesar R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011525
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Chapkin RS, 2002, LIPIDS, V37, P193, DOI 10.1007/s11745-002-0880-8
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   Cohen Paul, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P271, DOI 10.2174/1568008033340117
   COUSIN B, 1992, J CELL SCI, V103, P931
   Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273
   Darcy J, 2020, GEROSCIENCE, V42, P1527, DOI 10.1007/s11357-020-00221-0
   DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4
   Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4
   Dean JM, 2018, PROTEIN CELL, V9, P196, DOI 10.1007/s13238-017-0423-5
   Di Paola M, 2000, BIOCHEM BIOPH RES CO, V277, P128, DOI 10.1006/bbrc.2000.3653
   Divakaran SJ, 2020, FASEB J, V34, P6854, DOI 10.1096/fj.201902124R
   Dobrzyn A, 2004, TRENDS CARDIOVAS MED, V14, P77, DOI 10.1016/j.tcm.2003.12.005
   FAWCETT DW, 1947, SCIENCE, V105, P123, DOI 10.1126/science.105.2718.123
   Fernández-Checa JC, 2003, BIOCHEM BIOPH RES CO, V304, P471, DOI 10.1016/S0006-291X(03)00619-3
   Florez-Duquet M, 1998, PHYSIOL REV, V78, P339, DOI 10.1152/physrev.1998.78.2.339
   FOSTER DO, 1979, CAN J PHYSIOL PHARM, V57, P257, DOI 10.1139/y79-039
   Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004
   Fruehan C, 2018, LIPIDS, V53, P1019, DOI 10.1002/lipd.12111
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   Graja A, 2015, GERONTOLOGY, V61, P211, DOI 10.1159/000366557
   Grzybek M, 2019, MOL METAB, V22, P12, DOI 10.1016/j.molmet.2019.01.009
   Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155
   Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107
   HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x
   Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670
   Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002
   HOVIUS R, 1993, FEBS LETT, V330, P71, DOI 10.1016/0014-5793(93)80922-H
   Indellicato R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133304
   Jesko H, 2019, MOL NEUROBIOL, V56, P3501, DOI 10.1007/s12035-018-1286-3
   Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011
   Levene PA, 1913, J EXP MED, V17, P679, DOI 10.1084/jem.17.6.679
   Li XY, 2016, ARTERIOSCL THROM VAS, V36, P1090, DOI 10.1161/ATVBAHA.115.306964
   LIN CS, 1980, FEBS LETT, V113, P299, DOI 10.1016/0014-5793(80)80613-2
   LINDBERG O, 1967, J CELL BIOL, V34, P293, DOI 10.1083/jcb.34.1.293
   Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598
   Lynes MD, 2018, CELL REP, V24, P781, DOI 10.1016/j.celrep.2018.06.073
   Marcher AB, 2015, CELL REP, V13, P2000, DOI 10.1016/j.celrep.2015.10.069
   May FJ, 2017, CELL REP, V18, P1558, DOI 10.1016/j.celrep.2017.01.038
   McDonald RB, 1999, J BIOENERG BIOMEMBR, V31, P507, DOI 10.1023/A:1005404708710
   Mejia EM, 2016, J BIOENERG BIOMEMBR, V48, P99, DOI 10.1007/s10863-015-9601-4
   MENSCHIK Z, 1953, ANAT REC, V116, P439, DOI 10.1002/ar.1091160405
   Modi HR, 2008, J MEMBRANE BIOL, V221, P51, DOI 10.1007/s00232-007-9086-0
   MONTI D, 1992, AM J CLIN NUTR, V55, P1208, DOI 10.1093/ajcn/55.6.1208S
   Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005
   NICHOLLS DG, 1976, EUR J BIOCHEM, V62, P223, DOI 10.1111/j.1432-1033.1976.tb10151.x
   Nicholls DG, 2001, BIOCHEM SOC T, V29, P751, DOI 10.1042/bst0290751
   NICHOLLS DG, 1974, EUR J BIOCHEM, V49, P573, DOI 10.1111/j.1432-1033.1974.tb03861.x
   Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942
   Pulli I, 2018, BBA-MOL CELL RES, V1865, P1668, DOI 10.1016/j.bbamcr.2018.04.012
   RAFAEL J, 1968, H-S Z PHYSIOL CHEM, V349, P1711, DOI 10.1515/bchm2.1968.349.2.1711
   RAFAEL J, 1969, H-S Z PHYSIOL CHEM, V350, P1121, DOI 10.1515/bchm2.1969.350.2.1121
   Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015
   RICQUIER D, 1979, FEBS LETT, V99, P203, DOI 10.1016/0014-5793(79)80279-3
   Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010
   Rosen ED, 2000, GENE DEV, V14, P1293
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012
   Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530
   SCARPACE PJ, 1992, AM J PHYSIOL, V262, pE185, DOI 10.1152/ajpendo.1992.262.2.E185
   Schenkel Laila Cigana, 2014, Int J Cell Biol, V2014, P709828, DOI 10.1155/2014/709828
   Schweizer S, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000412
   Shapira SN, 2017, GENE DEV, V31, P660, DOI 10.1101/gad.294405.116
   SPERKAGOTTLIEB CDM, 1988, BIOCHIM BIOPHYS ACTA, V946, P227, DOI 10.1016/0005-2736(88)90397-5
   Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308
   Sustarsic EG, 2018, CELL METAB, V28, P159, DOI 10.1016/j.cmet.2018.05.003
   TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628
   Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200
   Wriessnegger T, 2009, BBA-MOL CELL BIOL L, V1791, P166, DOI 10.1016/j.bbalip.2008.12.017
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Xiao S, 2010, PLANT CELL, V22, P1463, DOI 10.1105/tpc.110.075333
   Xu ZY, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0693-x
   Yu ZM, 2019, CLIN SCI, V133, P763, DOI 10.1042/CS20180911
   Zhang CC, 2015, ARCH MED SCI, V11, P1081, DOI 10.5114/aoms.2015.54865
   Zhou XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048889
   Zhou ZG, 2011, LIPIDS, V46, P879, DOI 10.1007/s11745-011-3575-8
NR 87
TC 8
Z9 8
U1 1
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1388-1981
EI 1879-2618
J9 BBA-MOL CELL BIOL L
JI Biochim. Biophys. Acta Mol. Cell Biol. Lipids
PD 2021 JUL
PY 2021
VL 1866
IS 7
AR 158922
DI 10.1016/j.bbalip.2021.158922
EA MAR 2021
PG 13
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA RV7RZ
UT WOS:000646027100001
PM 33713833
DA 2024-02-19
ER

PT J
AU Huertas, JR
   Martinez-Velasco, E
   Ibáñez, S
   López-Frias, M
   Ochoa, JJ
   Quiles, J
   Castelli, GP
   Mataix, J
   Lenaz, G
AF Huertas, JR
   Martinez-Velasco, E
   Ibáñez, S
   López-Frias, M
   Ochoa, JJ
   Quiles, J
   Castelli, GP
   Mataix, J
   Lenaz, G
TI Virgin olive oil and coenzyme Q<sub>10</sub> protect heart mitochondria
   from peroxidative damage during aging
SO BIOFACTORS
LA English
DT Article
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; LIPID-PEROXIDATION; OXIDATION; LIVER;
   RAT; DNA
AB The mitochondrial theory of aging suggests that this phenomenon is the consequence of random somatic mutations in mitochondrial DNA, induced by long-term exposure to free radical attack. There are two potential dietary means of delaying the effects of free radicals on cellular aging, i.e., enrichment of mitochondrial membranes with monounsaturated fatty acids and supplementation with antioxidants. We have performed a preliminary study on male rats, 6 or 12 month old, fed with diets differing in the nature of the fat (virgin olive oil or sunflower oil) and/or with antioxidant supplementation (coenzyme Q(10)), analysing hydroperoxide and coenzyme Qs and Q(10) in heart mitochondria. Preliminary results allow us to conclude that the CoQ(10) dietetic supplementation as well as the enrichment of the cellular membranes with monounsaturated fatty acids, successfully protect mitochondrial membranes from aged rats against the free radical insult.
C1 Univ Granada, Fac Pharm, Dept Physiol, Nutr Inst & Food Technol, E-18071 Granada, Spain.
   Univ Bologna, Dept Biochem G Moruzzi, I-40126 Bologna, Italy.
C3 University of Granada; University of Bologna
RP Huertas, JR (corresponding author), Univ Granada, Fac Pharm, Dept Physiol, Nutr Inst & Food Technol, E-18071 Granada, Spain.
RI Quiles, José L./C-6911-2013; Ochoa, Julio/L-8733-2014; /AAB-6832-2019;
   Huertas, Jesus Francisco Rodriguez/G-8188-2015
OI Quiles, José L./0000-0002-9048-9086; Ochoa, Julio/0000-0001-8976-6296;
   /0000-0002-8479-4658; Huertas, Jesus Francisco
   Rodriguez/0000-0002-7446-0857
CR BATTINO M, 1990, INT J TISSUE REACT, V12, P137
   BATTINO M, 1995, MECH AGEING DEV, V78, P173, DOI 10.1016/0047-6374(94)01535-T
   BATTINO M, 1993, FREE RADICALS ANTIOX, V6, P37
   CASTELLUCCIO C, 1994, MECH AGEING DEV, V76, P73, DOI 10.1016/0047-6374(94)91583-0
   Fleischer S, 1979, Methods Enzymol, V55, P32
   HUERTAS JR, 1991, BIOCHEM BIOPH RES CO, V181, P375, DOI 10.1016/S0006-291X(05)81429-9
   HUERTAS JR, 1991, FEBS LETT, V287, P89, DOI 10.1016/0014-5793(91)80022-U
   JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169
   LENAZ G, 1990, FREE RADICAL RES COM, V8, P317, DOI 10.3109/10715769009053365
   LEPAGE G, 1986, J LIPID RES, V27, P114
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mataix J., 1997, MOL ASPECTS MED, V18, P129
   MATAIX J, IN PRESS FREE RAD BI
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   RAUCHOVA H, 1992, J BIOENERG BIOMEMBR, V24, P235, DOI 10.1007/BF00762682
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SEVANIAN A, 1985, ANNU REV NUTR, V5, P365, DOI 10.1146/annurev.nu.05.070185.002053
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   TAKADA M, 1982, BIOCHIM BIOPHYS ACTA, V679, P308, DOI 10.1016/0005-2728(82)90301-2
   TSAI AL, 1985, ANAL BIOCHEM, V151, P131, DOI 10.1016/0003-2697(85)90062-4
NR 22
TC 40
Z9 46
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS
SN 0951-6433
J9 BIOFACTORS
JI Biofactors
PY 1999
VL 9
IS 2-4
BP 337
EP 343
DI 10.1002/biof.5520090233
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 284KW
UT WOS:000085332400033
PM 10416050
DA 2024-02-19
ER

PT J
AU Reyes-Toso, CF
   Rebagliati, IR
   Ricci, CR
   Linares, LM
   Albornoz, LE
   Cardinali, DP
   Zaninovich, A
AF Reyes-Toso, C. F.
   Rebagliati, I. R.
   Ricci, C. R.
   Linares, L. M.
   Albornoz, L. E.
   Cardinali, D. P.
   Zaninovich, A.
TI Effect of melatonin treatment on oxygen consumption by rat liver
   mitochondria
SO AMINO ACIDS
LA English
DT Article; Proceedings Paper
CT 9th International Congress on Amino Acids and Proteins
CY AUG 08-12, 2005
CL Vienna, AUSTRIA
DE melatonin; oxygen consumption; free radicals; liver mitochondria;
   beta-hydroxybutyrate; succinate
ID SENESCENCE-ACCELERATED MICE
AB The objective of this study was to examine the in vivo effect of melatonin on rat mitochondrial liver respiration. Two experiments were performed: For experiment 1, adult male rats received melatonin in the drinking water (16 or 50 mu g/ml) or vehicle during 45 days. For experiment 2, rats received melatonin in the drinking water (50 mu g/ml) for 45 days, or the same amount for 30 days followed by a 15 day-withdrawal period. At sacrifice, a liver mitochondrial fraction was prepared and oxygen consumption was measured polarographically in the presence of excess concentration of DL-3-beta-hydroxybutyrate or L-succinate. Melatonin treatment decreased Krebs' cycle substrate-induced respiration significantly at both examined doses. The stimulation of mitochondrial respiration caused by excess concentration of substrate recovered after melatonin withdrawal. Basal state 4 respiration was not modified by melatonin. Melatonin, by curtailing overstimulation of cellular respiration caused by excess Krebs' cycle substrates, can protect the mitochondria from oxidative damage.
C1 Univ Buenos Aires, Fac Med, Dept Fisiol, RA-1121 Buenos Aires, DF, Argentina.
   Univ Buenos Aires, Fac Med, Hosp Clin, RA-1121 Buenos Aires, DF, Argentina.
C3 University of Buenos Aires; University of Buenos Aires
RP Cardinali, DP (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, Paraguay 2155, RA-1121 Buenos Aires, DF, Argentina.
EM dcardinali@fmed.uba.ar
CR Brignone JA, 1996, DIABETES RES CLIN PR, V32, P141, DOI 10.1016/0168-8227(96)01264-8
   CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455
   Cardinali Daniel P., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P1, DOI 10.2174/1568008043340071
   León J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x
   Liochev SI, 2002, FREE RADICAL BIO MED, V33, P137, DOI 10.1016/S0891-5849(02)00864-X
   Okatani Y, 2002, J PINEAL RES, V32, P143, DOI 10.1034/j.1600-079x.2002.1o106.x
   Okatani Y, 2002, J PINEAL RES, V33, P127, DOI 10.1034/j.1600-079X.2002.02109.x
   Okatani Y, 2003, INT J BIOCHEM CELL B, V35, P367, DOI 10.1016/S1357-2725(02)00260-1
   Reiter RJ, 2005, EXP BIOL MED, V230, P104
   Reiter RJ, 2003, J PINEAL RES, V34, P79, DOI 10.1034/j.1600-079X.2003.2e114.x
   Ressmeyer AR, 2003, REDOX REP, V8, P205, DOI 10.1179/135100003225002709
   Reyes-Toso CF, 2003, NEUROENDOCRINOL LETT, V24, P341
   Srinivasan V, 2005, NEUROTOX RES, V7, P293, DOI 10.1007/BF03033887
NR 13
TC 21
Z9 23
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0939-4451
J9 AMINO ACIDS
JI Amino Acids
PD OCT
PY 2006
VL 31
IS 3
BP 299
EP 302
DI 10.1007/s00726-005-0280-z
PG 4
WC Biochemistry & Molecular Biology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 093LJ
UT WOS:000241169500009
PM 16554975
OA Green Published
DA 2024-02-19
ER

PT J
AU Pannérec, A
   Migliavacca, E
   De Castro, A
   Michaud, J
   Karaz, S
   Goulet, L
   Rezzi, S
   Ng, TP
   Bosco, N
   Larbi, A
   Feige, JN
AF Pannerec, Alice
   Migliavacca, Eugenia
   De Castro, Antonio
   Michaud, Joris
   Karaz, Sonia
   Goulet, Laurence
   Rezzi, Serge
   Tze Pin Ng
   Bosco, Nabil
   Larbi, Anis
   Feige, Jerome N.
TI Vitamin B12 deficiency and impaired expression of amnionless during
   aging
SO JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
LA English
DT Article
DE Aging; Frailty; Sarcopenia; Vitamin B12; Cobalamin; Amnionless;
   Methylmalonic acid
ID POLYUNSATURATED FATTY-ACIDS; QUALITY-OF-LIFE; OBSTRUCTIVE
   PULMONARY-DISEASE; NUTRITIONAL SUPPORT; WEIGHT-LOSS; CACHEXIA; COPD;
   THERAPY; CANCER; SUPPLEMENTATION
AB Background Physical frailty and loss of mobility in elderly individuals lead to reduced independence, quality of life, and increased mortality. Vitamin B12 deficiency has been linked to several age-related chronic diseases, including in the musculo-skeletal system, where vitamin B12 deficiency is generally believed to be linked to poor nutritional intake. In the present study, we asked whether aging and frailty associate with altered vitamin B12 homeostasis in humans and investigated the underlying molecular mechanisms using preclinical models.
   Methods We analysed a subset of the Singapore Longitudinal Aging Study and stratified 238 participants based on age and Fried frailty criteria. Levels of methyl-malonic acid (MMA), a marker for vitamin B12 deficiency, and amnionless, the vitamin B12 co-receptor that anchors the vitamin B12 transport complex to the membrane of epithelial cells, were measured in plasma. In addition, vitamin B12 levels and the molecular mechanisms of vitamin B12 uptake and excretion were analysed in ileum, kidney, liver, and blood using a rat model of natural aging where nutritional intake is fully controlled.
   Results We demonstrate that aging and frailty are associated with a higher prevalence of functional vitamin B12 deficiency that can be detected by increased levels of MMA in blood (rho = 0.25; P = 0.00013). The decline in circulating vitamin B12 levels is recapitulated in a rat model of natural aging where food composition and intake are stable. At the molecular level, these perturbations involve altered expression of amnionless in the ileum and kidney. Interestingly, we demonstrate that amnionless can be detected in serum where its levels increase during aging in both rodents and human (P = 3.3e-07 and 9.2e-07, respectively). Blood amnionless levels negatively correlate with vitamin B12 in rats (r(2) = 0.305; P = 0.0042) and positively correlate with the vitamin B12 deficiency marker MMA in humans (rho = 0.22; P = 0.00068).
   Conclusions Our results demonstrate that aging and frailty cause intrinsic vitamin B12 deficiencies, which can occur independently of nutritional intake. Mechanistically, vitamin B12 deficiency involves the physio-pathological decline of both the intestinal uptake and the renal reabsorption system for vitamin B12. Finally, amnionless is a novel biomarker which can detect perturbed vitamin B12 bioavailability during aging and physical frailty.
C1 [Pannerec, Alice; Migliavacca, Eugenia; Michaud, Joris; Karaz, Sonia; Goulet, Laurence; Rezzi, Serge; Feige, Jerome N.] Nestle Inst Hlth Sci, EPFL Innovat Pk,Bldg H1015, Lausanne, Switzerland.
   [De Castro, Antonio; Bosco, Nabil] Nestle Res Ctr, Singapore, Singapore.
   [Tze Pin Ng] Natl Univ Singapore, Young Loo Lin Sch Med, Dept Psychol Med, Gerontol Res Programme, Singapore, Singapore.
   [Tze Pin Ng] Minist Hlth, Geriatr Educ & Res Inst, Singapore, Singapore.
   [Larbi, Anis] Agcy Sci Technol & Res, Biopolis, Singapore Immunol Network, Singapore, Singapore.
C3 Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole
   Polytechnique Federale de Lausanne; National University of Singapore;
   Ministry of Health-Singapore; Agency for Science Technology & Research
   (A*STAR); A*STAR - Singapore Immunology Network (SIgN)
RP Feige, JN (corresponding author), Nestle Inst Hlth Sci, EPFL Innovat Pk,Bldg H, CH-1015 Lausanne, Switzerland.
EM jerome.feige@rd.nestle.com
RI Larbi, Anis/ABE-5868-2020; Bosco, Nabil/AAD-1579-2022
OI Rezzi, Serge/0000-0002-0691-2153
CR Abeywardena Mahinda Y., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P232
   Allaire J., 2016, AM J CLIN NUTR
   Balk EM, 2006, ATHEROSCLEROSIS, V189, P19, DOI 10.1016/j.atherosclerosis.2006.02.012
   Bernard S, 1998, AM J RESP CRIT CARE, V158, P629, DOI 10.1164/ajrccm.158.2.9711023
   Biswas S, 2013, CURR MED CHEM, V20, P1496, DOI 10.2174/0929867311320120004
   Broekhuizen R, 2005, THORAX, V60, P376, DOI 10.1136/thx.2004.030858
   Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x
   Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET
   Collins PF, 2013, RESPIROLOGY, V18, P616, DOI 10.1111/resp.12070
   Colomer R, 2007, BRIT J NUTR, V97, P823, DOI 10.1017/S000711450765795X
   Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111
   Creutzberg EC, 2000, AM J RESP CRIT CARE, V161, P745, DOI 10.1164/ajrccm.161.3.9808075
   CURTIS JR, 1994, THORAX, V49, P162, DOI 10.1136/thx.49.2.162
   Devries MC, 2015, J FOOD SCI, V80, pA8, DOI 10.1111/1750-3841.12802
   Ferreira IM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000998.pub3
   Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010
   Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017
   Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509
   Jones Paul W, 2005, COPD, V2, P75
   Malinovschi A, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0131-0
   Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702
   Mostert R, 2000, RESP MED, V94, P859, DOI 10.1053/rmed.2000.0829
   Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004
   Muscaritoli M, 2015, CRIT REV ONCOL HEMAT, V94, P251, DOI 10.1016/j.critrevonc.2014.10.014
   Onwuamaegbu ME, 2004, POSTGRAD MED J, V80, P642, DOI 10.1136/pgmj.2004.020891
   Ribaudo JM, 2000, QUAL LIFE RES, V9, P1137, DOI 10.1023/A:1016670403148
   Ries Andrew L, 2005, COPD, V2, P105
   Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53
   Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017
   SCHOLS AMWJ, 1995, AM J RESP CRIT CARE, V152, P1268, DOI 10.1164/ajrccm.152.4.7551381
   Schols AM, 2014, EUR RESPIR J, V44, P1504, DOI 10.1183/09031936.00070914
   Spruit MA, 2017, LANCET RESP MED
   Ställberg B, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-26
   Sugawara K, 2010, RESP MED, V104, P1883, DOI 10.1016/j.rmed.2010.05.008
   van der Meij BS, 2012, EUR J CLIN NUTR, V66, P399, DOI 10.1038/ejcn.2011.214
   van desBool C, J CACHEXIA SARCOPENI
   von Haehling S, 2015, J CACHEXIA SARCOPENI, V6, P315, DOI 10.1002/jcsm.12089
   Weed HG, 2011, HEAD NECK-J SCI SPEC, V33, P1027, DOI 10.1002/hed.21580
   Wigmore SJ, 1996, NUTRITION, V12, pS27
   Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074
NR 40
TC 26
Z9 27
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2190-5991
EI 2190-6009
J9 J CACHEXIA SARCOPENI
JI J. Caxhexia Sarcopenia Muscle
PD FEB
PY 2018
VL 9
IS 1
BP 41
EP 52
DI 10.1002/jcsm.12260
PG 12
WC Geriatrics & Gerontology; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; General & Internal Medicine
GA FV5SZ
UT WOS:000424644000004
PM 29159972
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Wernicke, C
   Pohrt, A
   Pletsch-Borba, L
   Apostolopoulou, K
   Hornemann, S
   Meyer, N
   Machann, J
   Gerbracht, C
   Tacke, F
   Pfeiffer, AF
   Spranger, J
   Mai, KT
AF Wernicke, Charlotte
   Pohrt, Anne
   Pletsch-Borba, Laura
   Apostolopoulou, Konstantina
   Hornemann, Silke
   Meyer, Nina
   Machann, Jurgen
   Gerbracht, Christiana
   Tacke, Frank
   Pfeiffer, Andreas F. H.
   Spranger, Joachim
   Mai, Knut
TI Effect of unsaturated fat and protein intake on liver fat in people at
   risk of unhealthy aging: 1-year results of a randomized controlled trial
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article; Early Access
DE nonalcoholic fatty liver disease; magnetic resonance spectroscopy;
   dietary proteins; MUFA; PUFA; diet; healthy aging; non-Mediterranean
   population
ID DIETARY; GLUCOSE; EPIDEMIOLOGY; INFLAMMATION; PREVALENCE; PLASMA
AB Background: Short-term trials indicate improvement of intrahepatic lipids (IHLs) and metabolism by dietary protein or unsaturated fatty acids (UFAs) beyond weight loss. Objectives: We aimed to assess the effect of a dietary intervention high in protein and UFAs on IHLs and metabolic outcome after 12 mo, as long-term effects of such a combined intervention are unknown. Methods: Within a 36-mo randomized controlled trial, eligible subjects (aged 50 to 80 y, >= 1 risk factor for unhealthy aging) were randomly assigned to either intervention group (IG) with high intake of mono-/poly-UFAs [15-20 percent of total energy (%E)/10%-15%E, respectively], plant protein (15%- 25%E), and fiber (>= 30 g/d), or control group [CG, usual care, dietary recommendations of the German Nutrition Society (fat 30%E/carbohydrates 55%E/ protein 15%E)]. Stratification criteria were sex, known cardiovascular disease, heart failure, arterial hypertension, type 2 diabetes, and cognitive or physical impairment. Nutritional counseling and supplementation of foods mirroring the intended dietary pattern were performed in the IG. Diet-induced effects on IHLs, analyzed by magnetic resonance spectroscopy, as well as on lipid and glucose metabolism were predefined secondary endpoints. Results: IHL content was analyzed in 346 subjects without significant alcohol consumption at baseline and in 258 subjects after 12 mo. Adjusted for weight loss, sex, and age, we observed a comparable decline of IHLs in IG and CG (-33.3%; 95% CI: -49.3, -12.3%; n = 128 compared with-21.8%; 95% CI: -39.7, 1.5%; n = 130; P = 0.179), an effect that became significant by comparing adherent IG subjects to adherent CG subjects (-42.1%; 95% CI: -58.1, -20.1%; n = 88 compared with-22.2%; 95% CI: -40.7, 2.0%; n = 121; P = 0.013). Compared with the CG, decline of LDL cholesterol (LDL-C) and total cholesterol (TC) was stronger in the IG (for LDL-C P = 0.019, for TC P = 0.010). Both groups decreased in triglycerides and insulin resistance (P for difference between groups P = 0.799 and P = 0.124, respectively). Conclusions: Diets enriched with protein and UFAs have beneficial long-term effects on liver fat and lipid metabolism in adherent older subjects. This study was registered at the German Clinical Trials Register, https://www.drks.de/drks_web/setLocale_EN.do, DRKS00010049. Am J Clin Nutr 20XX;xx:xx-xx.
C1 [Wernicke, Charlotte; Pohrt, Anne; Pletsch-Borba, Laura; Apostolopoulou, Konstantina; Meyer, Nina; Tacke, Frank; Pfeiffer, Andreas F. H.; Spranger, Joachim; Mai, Knut] Charite Univ Med Berlin, Berlin, Germany.
   [Wernicke, Charlotte; Pohrt, Anne; Pletsch-Borba, Laura; Apostolopoulou, Konstantina; Meyer, Nina; Tacke, Frank; Pfeiffer, Andreas F. H.; Spranger, Joachim; Mai, Knut] Free Univ Berlin, Berlin, Germany.
   [Wernicke, Charlotte; Pohrt, Anne; Pletsch-Borba, Laura; Apostolopoulou, Konstantina; Meyer, Nina; Tacke, Frank; Pfeiffer, Andreas F. H.; Spranger, Joachim; Mai, Knut] Humboldt Univ, Berlin, Germany.
   [Wernicke, Charlotte; Pletsch-Borba, Laura; Apostolopoulou, Konstantina; Meyer, Nina; Pfeiffer, Andreas F. H.; Spranger, Joachim; Mai, Knut] Berlin Inst Hlth, Dept Endocrinol & Metab, D-10117 Berlin, Germany.
   [Wernicke, Charlotte; Pletsch-Borba, Laura; Apostolopoulou, Konstantina; Hornemann, Silke; Meyer, Nina; Gerbracht, Christiana; Pfeiffer, Andreas F. H.; Spranger, Joachim; Mai, Knut] Nutri Act Competence Cluster Nutr Res Berlin, Potsdam, Germany.
   [Pohrt, Anne] Berlin Inst Hlth, Inst Biometry & Clin Epidemiol, Berlin, Germany.
   [Gerbracht, Christiana; Pfeiffer, Andreas F. H.] German Inst Human Nutr, Dept Clin Nutr, Potsdam, Germany.
   [Hornemann, Silke; Machann, Jurgen; Pfeiffer, Andreas F. H.] German Ctr Diabet Res, Neuherberg, Germany.
   [Machann, Jurgen] Univ Tubingen, Inst Diabet Res, Metab Dis IDM Helmholtz Ctr Munich, Tubingen, Germany.
   [Machann, Jurgen] Univ Hosp Tubingen, Dept Diagnost & Intervent Radiol, Sect Expt Radiol, Tubingen, Germany.
   [Tacke, Frank] Berlin Inst Hlth, Dept Hepatol & Gastroenterol, D-10117 Berlin, Germany.
   [Spranger, Joachim; Mai, Knut] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.
C3 Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Free University of Berlin; Humboldt
   University of Berlin; Berlin Institute of Health; Berlin Institute of
   Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke
   (DIfE); Eberhard Karls University of Tubingen; Eberhard Karls University
   of Tubingen; Eberhard Karls University Hospital; Berlin Institute of
   Health; German Centre for Cardiovascular Research
RP Spranger, J (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Spranger, J (corresponding author), Free Univ Berlin, Berlin, Germany.; Spranger, J (corresponding author), Humboldt Univ, Berlin, Germany.; Spranger, J (corresponding author), Berlin Inst Hlth, Dept Endocrinol & Metab, D-10117 Berlin, Germany.; Spranger, J (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.
EM joachim.spranger@charite.de
RI Tacke, Frank/ABF-2212-2020; Pfeiffer, Andreas F.H./AAJ-2311-2020; Mai,
   Knut/W-9904-2019
OI Pfeiffer, Andreas F.H./0000-0002-6887-0016; Mai,
   Knut/0000-0003-0126-3155; Meyer, Nina Marie Tosca/0000-0002-8208-0061;
   Pletsch-Borba, Laura/0000-0003-4872-6452; Pohrt,
   Anne/0000-0001-6104-622X
FU Competence Cluster Nutrition Research Berlin-Potsdam; Federal Ministry
   of Education and Research (BMBF) [01EA1408]; German Federal Ministry of
   Education and Research (BMBF) [01GI0925]; German Research
   Foundation[DFG] [CRC/TG 296]
FX This work was supported by the Competence Cluster Nutrition Research
   Berlin-Potsdam, funded by the Federal Ministry of Education and Research
   (BMBF funding code 01EA1408). In addition, KM and JS were supported by a
   grant (01GI0925) from the German Federal Ministry of Education and
   Research (BMBF) to the German Center for Diabetes Research (DZD e.V.).
   JS and FT were supported by acollaborative research center of the German
   Research Foundation[DFG; CRC/TG 296 (Locotact)]. The funding source had
   no role in the design of this study and does not have any role during
   its execution, analyses, interpretation of the data, or decision to
   submit results
CR Marin-Alejandre BA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102543
   Bauer J, 2013, J AM MED DIR ASSOC, V14, P542, DOI 10.1016/j.jamda.2013.05.021
   Bjermo H, 2012, AM J CLIN NUTR, V95, P1003, DOI 10.3945/ajcn.111.030114
   Bortolotti M, 2009, AM J CLIN NUTR, V90, P1002, DOI 10.3945/ajcn.2008.27296
   Bozzetto L, 2012, DIABETES CARE, V35, P1429, DOI 10.2337/dc12-0033
   Coughlin JW, 2016, OBESITY, V24, P1046, DOI 10.1002/oby.21454
   Cuthbertson DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050117
   Deutsche Gesellschaft fur Ernahrung Osterreichische Gesellschaft fur Ernahrung Schweizerische Gesellschaft fur Ernahrungsforschung and Schweizerische Vereinigung fur Ernahrung, D A CH REF NEHRSL 2
   EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y
   FREEDMAN LS, 1976, BIOMETRICS, V32, P691, DOI 10.2307/2529759
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gannon MC, 2003, AM J CLIN NUTR, V78, P734, DOI 10.1093/ajcn/78.4.734
   Gao C, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01214-w
   Gepner Y, 2019, J HEPATOL, V71, P379, DOI 10.1016/j.jhep.2019.04.013
   Hooper L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011737
   Imamura F, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002087
   Kruse M, 2015, MOL NUTR FOOD RES, V59, P507, DOI 10.1002/mnfr.201400446
   Linn T, 2000, DIABETOLOGIA, V43, P1257, DOI 10.1007/s001250051521
   Luukkonen PK, 2018, DIABETES CARE, V41, P1732, DOI 10.2337/dc18-0071
   Machann J, 2006, MAGN RESON MED, V55, P913, DOI 10.1002/mrm.20825
   Markova M, 2017, GASTROENTEROLOGY, V152, P571, DOI 10.1053/j.gastro.2016.10.007
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Meir AY, 2021, GUT, V70, P2085, DOI 10.1136/gutjnl-2020-323106
   Perumpail BJ, 2017, WORLD J GASTROENTERO, V23, P8263, DOI 10.3748/wjg.v23.i47.8263
   Pletsch-Borba L, 2021, CLIN NUTR, V40, P5457, DOI 10.1016/j.clnu.2021.09.022
   Rees K, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009825.pub3
   Reynolds AN, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003053
   Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748
   Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004
   Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620
   Wernicke C, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022381
   Wolfram G, 2015, ANN NUTR METAB, V67, P141, DOI [10.1159/00043724, 10.1159/000437243]
   Xu CC, 2020, LIVER INT, V40, P2982, DOI 10.1111/liv.14596
   Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577
   Yki-Järvinen H, 2021, NAT REV GASTRO HEPAT, V18, P770, DOI 10.1038/s41575-021-00472-y
   Younossi ZM, 2015, HEPATOLOGY, V62, p739A
NR 36
TC 1
Z9 1
U1 7
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD 2023 APR
PY 2023
VL 117
IS 4
BP 785
EP 793
DI 10.1016/j.ajcnut.2023.01.010
EA APR 2023
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA D4MH7
UT WOS:000968484200001
PM 36804020
OA Bronze
DA 2024-02-19
ER

PT J
AU Morel, JD
   Sauzéat, L
   Goeminne, LJE
   Jha, P
   Williams, E
   Houtkooper, RH
   Aebersold, R
   Auwerx, J
   Balter, V
AF Morel, Jean-David
   Sauzeat, Lucie
   Goeminne, Ludger J. E.
   Jha, Pooja
   Williams, Evan
   Houtkooper, Riekelt H.
   Aebersold, Ruedi
   Auwerx, Johan
   Balter, Vincent
TI The mouse metallomic landscape of aging and metabolism
SO NATURE COMMUNICATIONS
LA English
DT Article
ID IRON-METABOLISM; TRACE-ELEMENTS; COPPER; BLOOD; TRAFFICKING; CHEMISTRY;
   CU
AB The metallome is crucial for normal cell functioning but remains largely overlooked in mammals. Here the authors analyze the metallome and copper and zinc isotope compositions in aging mice and show networks of interactions that are organ-specific, age-dependent, isotopically-typified and associated with a wealth of clinical and molecular traits.
   Organic elements make up 99% of an organism but without the remaining inorganic bioessential elements, termed the metallome, no life could be possible. The metallome is involved in all aspects of life, including charge balance and electrolytic activity, structure and conformation, signaling, acid-base buffering, electron and chemical group transfer, redox catalysis energy storage and biomineralization. Here, we report the evolution with age of the metallome and copper and zinc isotope compositions in five mouse organs. The aging metallome shows a conserved and reproducible fingerprint. By analyzing the metallome in tandem with the phenome, metabolome and proteome, we show networks of interactions that are organ-specific, age-dependent, isotopically-typified and that are associated with a wealth of clinical and molecular traits. We report that the copper isotope composition in liver is age-dependent, extending the existence of aging isotopic clocks beyond bulk organic elements. Furthermore, iron concentration and copper isotope composition relate to predictors of metabolic health, such as body fat percentage and maximum running capacity at the physiological level, and adipogenesis and OXPHOS at the biochemical level. Our results shed light on the metallome as an overlooked omic layer and open perspectives for potentially modulating cellular processes using careful and selective metallome manipulation.
C1 [Morel, Jean-David; Goeminne, Ludger J. E.; Jha, Pooja; Williams, Evan; Houtkooper, Riekelt H.; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat Syst Physiol, Inst Bioengn, CH-1015 Lausanne, Switzerland.
   [Sauzeat, Lucie; Balter, Vincent] Univ Lyon, Ecole Normale Super Lyon, Univ Lyon 1, LGL TPE,CNRS, Lyon, France.
   [Aebersold, Ruedi] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland.
   [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland.
   [Sauzeat, Lucie] Univ Clermont Auvergne, CNRS, INSERM, Genet Reprod & Dev, F-63000 Clermont Ferrand, France.
   [Sauzeat, Lucie] Univ Clermont Auvergne, CNRS, IRD, OPGC,Lab Magmas & Volcans, F-63000 Clermont Ferrand, France.
   [Williams, Evan] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.
   [Houtkooper, Riekelt H.] Univ Amsterdam, Lab Genet Metab Dis, Amsterdam UMC, Amsterdam, Netherlands.
C3 Swiss Federal Institutes of Technology Domain; Ecole Polytechnique
   Federale de Lausanne; Ecole Normale Superieure de Lyon (ENS de LYON);
   Universite Claude Bernard Lyon 1; Centre National de la Recherche
   Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; ETH
   Zurich; University of Zurich; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre
   National de la Recherche Scientifique (CNRS); Institut de Recherche pour
   le Developpement (IRD); Centre National de la Recherche Scientifique
   (CNRS); Universite Clermont Auvergne (UCA); University of Luxembourg;
   University of Amsterdam
RP Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat Syst Physiol, Inst Bioengn, CH-1015 Lausanne, Switzerland.; Balter, V (corresponding author), Univ Lyon, Ecole Normale Super Lyon, Univ Lyon 1, LGL TPE,CNRS, Lyon, France.
EM admin.auwerx@epfl.ch; vincent.balter@ens-lyon.fr
RI Sauzeat, Lucie/HKE-2292-2023; Williams, Evan G/M-7539-2017
OI Sauzeat, Lucie/0000-0001-8723-1351; Williams, Evan
   G/0000-0002-9746-376X; Houtkooper, Riekelt/0000-0001-9961-0842; Morel,
   Jean-David/0000-0002-7122-9924; Goeminne, Ludger/0000-0002-8285-7766;
   balter, vincent/0000-0002-9236-4834; Auwerx, Johan/0000-0002-5065-5393;
   Jha, Pooja/0000-0002-0293-9287; Aebersold, Ruedi/0000-0002-9576-3267
FU CNRS through the MITI interdisciplinary programs; Bullukian Foundation;
   Ecole Polytechnique Federale de Lausanne (EPFL); European Research
   Council [ERC-AdG-787702]; Swiss National Science Foundation
   [31003A_179435]; National Research Foundation of Korea
   [2017K1A1A2013124]; EPFL; European Union Horizon 2020 Marie
   Skodowska-Curie Individual Fellowship "AmyloAge" [896042]; Swiss
   National Science Foundation (SNF) [31003A_179435] Funding Source: Swiss
   National Science Foundation (SNF); Marie Curie Actions (MSCA) [896042]
   Funding Source: Marie Curie Actions (MSCA)
FX We thank all members of J. Auwerx's laboratory for helpful discussions.
   This project has received financial support from the CNRS through the
   MITI interdisciplinary programs, the Bullukian Foundation, the Ecole
   Polytechnique Federale de Lausanne (EPFL), European Research Council
   (ERC-AdG-787702) and Swiss National Science Foundation (31003A_179435)
   and a Global Research Laboratory grant from the National Research
   Foundation of Korea (2017K1A1A2013124). L.S. was supported by EPFL and
   ENS de Lyon convention thanks to P. Gillet. L.J.E.G. was supported by
   the European Union Horizon 2020 Marie Skodowska-Curie Individual
   Fellowship "AmyloAge" (896042).
CR Adamson J, 1996, SEMIN HEMATOL, V33, P5
   Albarède F, 2017, REV MINERAL GEOCHEM, V82, P851, DOI 10.2138/rmg.2017.82.20
   Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651
   Auwerx J., PXD011142
   Balter V, 2015, P NATL ACAD SCI USA, V112, P982, DOI 10.1073/pnas.1415151112
   Balter V, 2013, METALLOMICS, V5, P1470, DOI 10.1039/c3mt00151b
   Balter V, 2010, RAPID COMMUN MASS SP, V24, P605, DOI 10.1002/rcm.4425
   Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794
   Barnham KJ, 2014, CHEM SOC REV, V43, P6727, DOI 10.1039/c4cs00138a
   Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330
   Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186
   BIGELEISEN J, 1949, J CHEM PHYS, V17, P675, DOI 10.1063/1.1747368
   BIGELEISEN J, 1947, J CHEM PHYS, V15, P261, DOI 10.1063/1.1746492
   Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101
   Büchl A, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-11
   Crabb E, 2010, METALS AND LIFE, P1
   Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77
   FIEVE RR, 1973, AM J PSYCHIAT, V130, P55, DOI 10.1176/ajp.130.1.55
   Garçon M, 2017, GEOSTAND GEOANAL RES, V41, P367, DOI 10.1111/ggr.12161
   Godt J, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-22
   Hahn P, 2009, EXP GERONTOL, V44, P594, DOI 10.1016/j.exger.2009.06.006
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Ishida S, 2013, P NATL ACAD SCI USA, V110, P19507, DOI 10.1073/pnas.1318431110
   Jaouen K, 2019, METALLOMICS, V11, P1049, DOI 10.1039/c8mt00286j
   Jaouen K, 2013, METALLOMICS, V5, P1016, DOI 10.1039/c3mt00085k
   Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865
   Li XY, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.4
   Lobinski R, 2010, PURE APPL CHEM, V82, P493, DOI 10.1351/PAC-REP-09-03-04
   Lobo L, 2017, TALANTA, V165, P92, DOI 10.1016/j.talanta.2016.12.007
   Ma SM, 2015, CELL REP, V13, P1319, DOI 10.1016/j.celrep.2015.10.014
   Malinouski M, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms4301, 10.1038/ncomms6167]
   Maréchal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0
   MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4
   Morgan JLL, 2012, P NATL ACAD SCI USA, V109, P9989, DOI 10.1073/pnas.1119587109
   MORITA A, 1994, BIOL TRACE ELEM RES, V42, P165, DOI 10.1007/BF02785387
   Moynier F, 2017, GEOCHEM PERSPECT LET, V3, P142, DOI 10.7185/geochemlet.1717
   Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942
   Sauzéat L, 2021, TALANTA, V221, DOI 10.1016/j.talanta.2020.121576
   Sauzéat L, 2018, METALLOMICS, V10, P496, DOI [10.1039/c7mt00318h, 10.1039/C7MT00318H]
   Sleiman MB, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108203
   Stich B, 2020, PLANT CELL ENVIRON, V43, P2095, DOI 10.1111/pce.13823
   Sticker A, 2020, MOL CELL PROTEOMICS, V19, P1209, DOI 10.1074/mcp.RA119.001624
   Takahashi S, 2001, BIOL TRACE ELEM RES, V80, P145, DOI 10.1385/BTER:80:2:145
   Telouk P, 2015, METALLOMICS, V7, P299, DOI 10.1039/c4mt00269e
   Vygodina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074436
   Walczyk T, 2002, SCIENCE, V295, P2065, DOI 10.1126/science.1069389
   Williams EG, 2018, MOL CELL PROTEOMICS, V17, P1766, DOI 10.1074/mcp.RA118.000554
   Wu Yibo, 2017, Curr Protoc Mouse Biol, V7, P130, DOI 10.1002/cpmo.28
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang BH, 2020, AGING CELL, V19, DOI 10.1111/acel.13119
NR 53
TC 15
Z9 15
U1 8
U2 29
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 1
PY 2022
VL 13
IS 1
AR 607
DI 10.1038/s41467-022-28060-x
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA YQ8DR
UT WOS:000749535300012
PM 35105883
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Fan, RR
   Kang, ZF
   He, L
   Chan, J
   Xu, G
AF Fan, Rongrong
   Kang, Zhanfang
   He, Lan
   Chan, Juliana
   Xu, Gang
TI Exendin-4 Improves Blood Glucose Control in Both Young and Aging Normal
   Non-Diabetic Mice, Possible Contribution of Beta Cell Independent
   Effects
SO PLOS ONE
LA English
DT Article
ID GLUCAGON-LIKE PEPTIDE-1; PERFUSED RAT PANCREAS; RECEPTOR AGONIST;
   INSULIN-RELEASE; GENE-EXPRESSION; PROTEIN-KINASE; DIABETIC-RATS; GLP-1;
   SOMATOSTATIN; TOLERANCE
AB Aims: Type 2 diabetes is highly prevalent in the elderly population. Glucagon like Peptide-1 mimetic such as exendin-4 augments post-prandial insulin secretion. However, the potential influence of aging on the therapeutic effects of this peptide has not been well studied. In this study, we examined the glucose regulatory effects of exendin-4 in mice with different ages.
   Methods: We treated 3-month and 20 to 22-month old C57/DBA mice with 10 nM/kg exendin-4 for 10 days with measurements of blood glucose and body weight. We performed OGTT and ITT to evaluate the glucose response and insulin sensitivity. Islet morphology and beta cell mass were measured by immuno-staining and beta cell proliferation was evaluated by BrdU incorporation and PCNA staining. Real-time PCR and western blot were used to measure protein changes in the liver tissue after exendin-4 treatment.
   Results: Exendin-4 treatment improved glycemic control in both 3-month and 20 to 22-month old mice. In both groups of mice, the blood glucose lowering effect was independent of beta cell function as indicated by unchanged beta cell proliferation, insulin secretion or beta cell mass. Moreover, we found that exendin-4 treatment increased hepatic AKT and FOXO1 phosphorylation and inhibited glucose-6-phosphotase (G6P) and Phosphoenolpyruvate carboxykinase (PEPCK) expression in young mice, but this effect was attenuated in aging mice while the insulin sensitivity showed no change in the young group but significantly improved in aging mice.
   Conclusion: Based on these data, we conclude that the glucose lowering effect of exendin-4 in normal non-diabetic mice was not blunted by aging. We further showed that although there was slight difference in the glucose modulating mechanism of exendin-4 therapy in young and aged mice, the improved glucose control seemed uncorrelated with increased beta cell mass or insulin secretion.
C1 [Fan, Rongrong; Kang, Zhanfang; He, Lan; Chan, Juliana; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.
   [Chan, Juliana; Xu, Gang] Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China.
   [Chan, Juliana; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China.
C3 Chinese University of Hong Kong; Prince of Wales Hospital; Chinese
   University of Hong Kong; Prince of Wales Hospital
RP Xu, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.
EM gangxu@cuhk.edu.hk
RI Fan, Rongrong/N-3446-2017; Fan, Rongrong/AAG-2200-2019; Messier,
   Claude/A-2322-2008; Chan, Juliana/B-7918-2016
OI Fan, Rongrong/0000-0002-5707-1497; Fan, Rongrong/0000-0002-5707-1497;
   Chan, Juliana/0000-0003-1325-1194; Kang, Zhanfang/0000-0001-7010-8701
FU CUHK; Liao Wun Yuk Diabetes Research Memorial Fund; Hong Kong Government
   Research Grant Committee [477008, 478110]; Chinese University of Hong
   Kong [2041569]
FX This work was supported by the CUHK Focused Investment Scheme and Liao
   Wun Yuk Diabetes Research Memorial Fund (grant number N/A); the Hong
   Kong Government Research Grant Committee (Grant Number: 477008 and
   478110) and Direct Grant from the Chinese University of Hong Kong (Grant
   Number: 2041569). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. No additional external funding was received for this study.
CR Ahren Bo, 2007, Curr Diab Rep, V7, P340, DOI 10.1007/s11892-007-0056-9
   Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054
   Barrera JG, 2009, DIABETES, V58, P2820, DOI 10.2337/db09-0281
   Barthel A, 2001, BIOCHEM BIOPH RES CO, V285, P897, DOI 10.1006/bbrc.2001.5261
   Dardevet D, 2004, AM J PHYSIOL-ENDOC M, V287, pE75, DOI 10.1152/ajpendo.00035.2004
   de Heer J, 2008, DIABETOLOGIA, V51, P2263, DOI 10.1007/s00125-008-1149-y
   DeOre K, 1997, J GERONTOL A-BIOL, V52, pB245, DOI 10.1093/gerona/52A.5.B245
   Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006
   Egido EM, 2004, HORM METAB RES, V36, P595, DOI 10.1055/s-2004-825921
   EISSELE R, 1994, LIFE SCI, V55, P629, DOI 10.1016/0024-3205(94)00489-7
   ENG J, 1992, J BIOL CHEM, V267, P7402
   Fan R, 2010, DIABETES OBES METAB, V12, P815, DOI 10.1111/j.1463-1326.2010.01238.x
   FERDAOUSSI M, 2008, DIABETES
   Heller RS, 2001, DIABETES, V50, P1553, DOI 10.2337/diabetes.50.7.1553
   Ihm SH, 2007, DIABETES RES CLIN PR, V77, pS150, DOI 10.1016/j.diabres.2007.01.049
   Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294
   Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103
   Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200
   Lee YS, 2007, DIABETES, V56, P1671, DOI 10.2337/db06-1182
   Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2
   Marzioni M, 2009, GUT, V58, P990, DOI 10.1136/gut.2008.150870
   Meneilly GS, 2003, DIABETES CARE, V26, P2835, DOI 10.2337/diacare.26.10.2835
   Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294
   MontroseRafizadeh C, 1997, J CELL PHYSIOL, V172, P275, DOI 10.1002/(SICI)1097-4652(199709)172:3<275::AID-JCP1>3.0.CO;2-L
   Nauck MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE981, DOI 10.1152/ajpendo.1997.273.5.E981
   Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198
   Samson SL, 2008, MOL THER, V16, P1805, DOI 10.1038/mt.2008.198
   Sancho V, 2005, J MOL ENDOCRINOL, V35, P27, DOI 10.1677/jme.1.01747
   Scrocchi LA, 1998, DIABETES, V47, P632, DOI 10.2337/diabetes.47.4.632
   Silvestre RA, 2003, EUR J PHARMACOL, V469, P195, DOI 10.1016/S0014-2999(03)01692-3
   Sinclair EM, 2008, GASTROENTEROLOGY, V135, P2096, DOI 10.1053/j.gastro.2008.07.075
   SORENSON RL, 1983, DIABETES, V32, P561, DOI 10.2337/diabetes.32.6.561
   STARKE A, 1987, J CLIN INVEST, V79, P20, DOI 10.1172/JCI112784
   Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734
   Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936
   TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848
   Tanigawa K, 1997, PANCREAS, V15, P53, DOI 10.1097/00006676-199707000-00008
   Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651
   Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0
   Wang YH, 1997, J CLIN INVEST, V99, P2883, DOI 10.1172/JCI119482
   Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270
   Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033
   Xu G, 2006, DIABETES RES CLIN PR, V73, P107, DOI 10.1016/j.diabres.2005.11.007
   Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200
   Zheng D, 2009, DIABETES, V58, P352, DOI 10.2337/db08-0875
NR 45
TC 27
Z9 33
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2011
VL 6
IS 5
AR e20443
DI 10.1371/journal.pone.0020443
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 770OP
UT WOS:000291097600070
PM 21655268
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Qiu, YH
   Gao, XX
   Chen, RX
   Lu, SY
   Wan, XZ
   Farag, MA
   Zhao, C
AF Qiu, Yinghui
   Gao, Xiaoxiang
   Chen, Ruoxin
   Lu, Suyue
   Wan, Xuzhi
   Farag, Mohamed A.
   Zhao, Chao
TI Metabolomics and biochemical insights on the regulation of aging-related
   diabetes by a low-molecular-weight polysaccharide from green microalga
   Chlorella pyrenoidosa
SO FOOD CHEMISTRY-X
LA English
DT Article; Early Access
DE Chlorella pyrenoidosa polysaccharide; Metabolomics; Type 2 diabetes;
   Antioxidant; Phenylpyruvic acid
ID INDUCED OXIDATIVE STRESS; BRAIN; RATS; INSULIN; MICROBIOTA; DECREASES;
   APOPTOSIS; PANCREAS; GROWTH; LIVER
AB Globally, aging and diabetes are considered prevalent threats to human health. Chlorella pyrenoidosa polysaccharide (CPP) is a natural active ingredient with multiple health benefits including antioxidant and hypolipidemic activities. In this study, the aging-related diabetic (AD) mice model was established to investigate the underlying hypoglycemic and antioxidant mechanisms of CPP. It improved superoxide dismutase, catalase (CAT), glutathione peroxidase (GSH-px), and malondialdehyde activities in liver and insulin secretion. CAT and GSH-px activity in the brain increased after CPP administration. In addition, through histopathological examinations, it was evident that injuries in the liver, brain, jejunum, and pancreas were restored by CPP. This restoration was likely mediated via the activation of glucagon-like peptide-1 receptor/FOXO-1 (forkhead box O1) pathway concurrent with the inhibition of interleukin-6 receptor/FOXO-1 pathway. Furthermore, metabolomics and correlation analysis revealed that CPP possibly relived AD through changes in insulin levels and declined oxidative stress as regulated by phenylpyruvic acid. These findings suggested that CPP exerted antioxidant and hypoglycemic roles in an AD mice model, thereby providing a sound scientific foundation for further development and utilization of CPP.
C1 [Qiu, Yinghui; Gao, Xiaoxiang; Chen, Ruoxin; Lu, Suyue; Wan, Xuzhi; Zhao, Chao] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Peoples R China.
   [Zhao, Chao] Minist Educ, Engn Res Ctr Fujian Taiwan Special Marine Food Pr, Fuzhou 350002, Peoples R China.
   [Zhao, Chao] Fujian Agr & Forestry Univ, Inst Oceanol, Key Lab Marine Biotechnol Fujian Prov, Fuzhou 350002, Peoples R China.
   [Farag, Mohamed A.] Cairo Univ, Fac Pharm, Dept Pharmacognosy, Cairo 11562, Egypt.
C3 Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry
   University; Egyptian Knowledge Bank (EKB); Cairo University
RP Zhao, C (corresponding author), Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Peoples R China.
EM zhchao@live.cn
RI wan, xuzhi/GVR-9836-2022; Zhao, Chao/P-1847-2017
OI Zhao, Chao/0000-0003-1096-632X; xiaoxiang, Gao/0000-0002-1658-4288
FU Key Project of the Natural Science Foundation of Fujian Province
   [2020J02032]; Fujian 'Young Eagle Program' Youth Top Talent Program
FX The project was funded by Key Project of the Natural Science Foundation
   of Fujian Province (2020J02032) and Fujian 'Young Eagle Program' Youth
   Top Talent Program.
CR Agunloye OM, 2022, FOOD FRONTIERS, V3, P161, DOI 10.1002/fft2.111
   Andersen JV, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/2107084
   Atella V, 2019, AGING CELL, V18, DOI 10.1111/acel.12861
   Aydin AF, 2016, METAB BRAIN DIS, V31, P337, DOI 10.1007/s11011-015-9755-0
   Benchoula K, 2021, EUR J PHARMACOL, V891, DOI 10.1016/j.ejphar.2020.173758
   Bikhazi AB, 2004, MOL PHARMACEUT, V1, P300, DOI 10.1021/mp049972u
   BOLLI GB, 1984, NEW ENGL J MED, V311, P1214, DOI 10.1056/NEJM198411083111904
   Chen L, 2020, eFood, V1, P77, DOI [10.2991/efood.k.191018.002, DOI 10.2991/EFOOD.K.191018.002]
   Rezende MSD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249487
   Fromenty B, 2009, J PHARMACOL EXP THER, V331, P23, DOI 10.1124/jpet.109.155168
   Fuster JJ, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108326
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Glauser DA, 2009, J RECEPT SIG TRANSD, V29, P293, DOI 10.3109/10799890903241824
   Huang DW, 2020, FOOD SCI NUTR, V8, P5710, DOI 10.1002/fsn3.1868
   Huang Y, 2014, ONCOL LETT, V8, P493, DOI 10.3892/ol.2014.2231
   Kazeem M, 2021, FOOD FRONTIERS, V2, P153, DOI 10.1002/fft2.71
   Kim CH, 2018, CELL MOL IMMUNOL, V15, P88, DOI 10.1038/cmi.2017.57
   Kim DY, 2015, CELL DEATH DIFFER, V22, P2034, DOI 10.1038/cdd.2015.123
   Lam DD, 2010, PHARMACOL BIOCHEM BE, V97, P84, DOI 10.1016/j.pbb.2010.09.003
   Lee CC, 2012, BIOPHYS J, V102, P1059, DOI 10.1016/j.bpj.2012.01.039
   Lennicke C, 2020, AGING-US, V12, P24479, DOI 10.18632/aging.104223
   Li YQ, 2021, J AGR FOOD CHEM, V69, P212, DOI 10.1021/acs.jafc.0c06456
   Liang XR, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03253-8
   Lin HT, 2021, FOOD FRONTIERS, V2, P208, DOI 10.1002/fft2.79
   Liu JP, 2015, ANAL BIOANAL CHEM, V407, P2569, DOI 10.1007/s00216-015-8481-0
   Liu P, 2021, J ALZHEIMERS DIS, V83, P609, DOI 10.3233/JAD-210461
   Longo M, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00045
   Malin SK, 2014, CURR OPIN ENDOCRINOL, V21, P323, DOI 10.1097/MED.0000000000000095
   Men LH, 2017, RSC ADV, V7, P16494, DOI 10.1039/c6ra28595c
   Metwally MMM, 2018, ACTA HISTOCHEM, V120, P828, DOI 10.1016/j.acthis.2018.09.008
   Oboh G, 2018, METAB BRAIN DIS, V33, P457, DOI 10.1007/s11011-018-0198-2
   Ouyang YZ, 2022, MOL NUTR FOOD RES, V66, DOI 10.1002/mnfr.202100564
   Prasad Shikha, 2014, J Pharmacovigil, V2, P125
   Price TO, 2006, EXP NEUROL, V201, P193, DOI 10.1016/j.expneurol.2006.03.030
   Rathinam A, 2014, J PHYSIOL BIOCHEM, V70, P935, DOI 10.1007/s13105-014-0362-z
   Rosa AP, 2012, CELL MOL NEUROBIOL, V32, P1113, DOI 10.1007/s10571-012-9834-2
   Rosemberg DB, 2010, NEUROSCIENCE, V171, P683, DOI 10.1016/j.neuroscience.2010.09.030
   Samaha MM, 2019, ENVIRON TOXICOL PHAR, V72, DOI 10.1016/j.etap.2019.103238
   Shen DD, 2021, NEUROSCI LETT, V746, DOI 10.1016/j.neulet.2020.135585
   Sivaraman Subash Chander, 2013, J Clin Med Res, V5, P92, DOI 10.4021/jocmr1201w
   Suthagar E, 2009, BIOMED PHARMACOTHER, V63, P43, DOI 10.1016/j.biopha.2008.01.002
   Wan XZ, 2020, J AGR FOOD CHEM, V68, P1186, DOI 10.1021/acs.jafc.9b06282
   Wan XZ, 2021, INT J BIOL MACROMOL, V168, P152, DOI 10.1016/j.ijbiomac.2020.12.010
   Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Yuan S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76249-1
   Zafar M, 2010, INT J MORPHOL, V28, P135, DOI 10.4067/S0717-95022010000100019
   Zhao C., 2020, EFOOD, V1, P107, DOI [10.2991/efood.k.200302.001, DOI 10.2991/EFOOD.K.200302.001]
NR 48
TC 11
Z9 11
U1 5
U2 27
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2590-1575
J9 FOOD CHEM X
JI Food Chem. X
PD 2022 JUN 30
PY 2022
VL 14
AR 100316
DI 10.1016/j.fochx.2022.100316
EA APR 2022
PG 10
WC Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology
GA 1J1SC
UT WOS:000797703100002
PM 35774637
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Leibing, T
   Riedel, A
   Xi, YN
   Adrian, M
   Krzistetzko, J
   Kirkamm, C
   Dormann, C
   Schledzewski, K
   Goerdt, S
   Geraud, C
AF Leibing, Thomas
   Riedel, Anna
   Xi, Yannick
   Adrian, Monica
   Krzistetzko, Jessica
   Kirkamm, Christof
   Dormann, Christof
   Schledzewski, Kai
   Goerdt, Sergij
   Geraud, Cyrill
TI Deficiency for scavenger receptors Stabilin-1 and Stabilin-2 leads to
   age-dependent renal and hepatic depositions of fasciclin domain proteins
   TGFBI and Periostin in mice
SO AGING CELL
LA English
DT Article; Early Access
DE aging; fasciclin; lifespan; mouse; POSTN; scavenger receptors; TGFBI
ID ATHEROSCLEROSIS; INFLAMMATION; BETA-IG-H3; BIOMARKER; GROWTH
AB Stabilin-1 (Stab1) and Stabilin-2 (Stab2) are two major scavenger receptors of liver sinusoidal endothelial cells that mediate removal of diverse molecules from the plasma. Double-knockout mice (Stab-DKO) develop impaired kidney function and a decreased lifespan, while single Stabilin deficiency or therapeutic inhibition ameliorates atherosclerosis and Stab1-inhibition is subject of clinical trials in immuno-oncology. Although POSTN and TFGBI have recently been described as novel Stabilin ligands, the dynamics and functional implications of these ligands have not been comprehensively studied. Immunofluorescence, Western Blotting and Simple Western (TM) as well as in situ hybridization (RNAScope (TM)) and qRT-PCR were used to analyze transcription levels and tissue distribution of POSTN and TGFBI in Stab-KO mice. Stab-POSTN-Triple deficient mice were generated to assess kidney and liver fibrosis and function in young and aged mice. TGFBI and POSTN protein accumulated in liver tissue in Stab-DKO mice and age-dependent in glomeruli of Stabilin-deficient mice despite unchanged transcriptional levels. Stab-POSTN-Triple KO mice showed glomerulofibrosis and a reduced lifespan comparable to Stab-DKO mice. However, alterations of the glomerular diameter and vascular density were partially normalized in Stab-POSTN-Triple KO. TGFBI and POSTN are Stabilin-ligands that are deposited in an age-dependent manner in the kidneys and liver due to insufficient scavenging in the liver. Functionally, POSTN might partially contribute to the observed renal phenotype in Stab-DKO mice. This study provides details on downstream effects how Stabilin dysfunction affects organ function on a molecular and functional level.
C1 [Leibing, Thomas; Riedel, Anna; Xi, Yannick; Adrian, Monica; Krzistetzko, Jessica; Kirkamm, Christof; Dormann, Christof; Schledzewski, Kai; Goerdt, Sergij; Geraud, Cyrill] Heidelberg Univ, Univ Med Ctr, Dept Dermatol Venereol & Allergol, Mannheim, Germany.
   [Leibing, Thomas; Riedel, Anna; Xi, Yannick; Adrian, Monica; Krzistetzko, Jessica; Kirkamm, Christof; Dormann, Christof; Schledzewski, Kai; Goerdt, Sergij; Geraud, Cyrill] Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany.
   [Leibing, Thomas; Riedel, Anna; Xi, Yannick; Adrian, Monica; Krzistetzko, Jessica; Kirkamm, Christof; Dormann, Christof; Geraud, Cyrill] Heidelberg Univ, Univ Med Ctr, Sect Clin & Mol Dermatol, Mannheim, Germany.
   [Goerdt, Sergij; Geraud, Cyrill] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, Mannheim, Germany.
   [Leibing, Thomas; Geraud, Cyrill] Heidelberg Univ, Univ Med Ctr, Dept Dermatol Venereol & Allergol, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.
   [Leibing, Thomas; Geraud, Cyrill] Heidelberg Univ, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.
C3 Ruprecht Karls University Heidelberg; Ruprecht Karls University
   Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls
   University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht
   Karls University Heidelberg
RP Leibing, T; Geraud, C (corresponding author), Heidelberg Univ, Univ Med Ctr, Dept Dermatol Venereol & Allergol, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.; Leibing, T; Geraud, C (corresponding author), Heidelberg Univ, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.
EM thomas.leibing@umm.de; cyrill.geraud@umm.de
OI Leibing, Thomas/0000-0002-7157-1201
FU Deutsche Forschungsgemeinschaft [INST 35/1503-1 FUGG, 259332240,
   394046768, 5454871, 5486332]; INST [35/1314-1]; Ministerium fur
   Wissenschaft, Forschung und Kunst Baden-Wuerttemberg [INST 35/1503-1
   FUGG]
FX Deutsche Forschungsgemeinschaft, Grant/Award Number: INST 35/1503-1
   FUGG, 259332240, 394046768, 5454871, 5486332 and INST 35/1314-1 FUGG;
   Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wuerttemberg,
   Grant/Award Number: INST 35/1503-1 FUGG
CR An JN, 2021, AGING-US, V13, P22649, DOI 10.18632/aging.203580
   An JN, 2019, AM J PHYSIOL-RENAL, V316, pF426, DOI 10.1152/ajprenal.00203.2018
   Bhandari S, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.757469
   Billings PC, 2002, J BIOL CHEM, V277, P28003, DOI 10.1074/jbc.M106837200
   Guerrot D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031974
   Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017
   Hanssen E, 2003, J BIOL CHEM, V278, P24334, DOI 10.1074/jbc.M303455200
   Harris EN, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9070273
   Harris VM, 2015, METHODS MOL BIOL, V1312, P465, DOI 10.1007/978-1-4939-2694-7_47
   Huang YM, 2015, AM J PATHOL, V185, P786, DOI 10.1016/j.ajpath.2014.11.002
   Kumar P, 2018, J BIOL CHEM, V293, P12781, DOI 10.1074/jbc.RA117.001601
   Lehallier B, 2019, NAT MED, V25, P1843, DOI 10.1038/s41591-019-0673-2
   Leibing T, 2018, HEPATOLOGY, V68, P707, DOI 10.1002/hep.29613
   Lück C, 2021, METHODS MOL BIOL, V2261, P481, DOI 10.1007/978-1-0716-1186-9_30
   Manta CP, 2022, CIRCULATION, V146, P1783, DOI 10.1161/CIRCULATIONAHA.121.058615
   Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047
   Olsavszky V, 2021, GENE, V768, DOI 10.1016/j.gene.2020.145284
   Patten DA, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9070283
   Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155
   PrabhuDas MR, 2017, J IMMUNOL, V198, P3775, DOI 10.4049/jimmunol.1700373
   Satirapoj B, 2014, TRANSPL P, V46, P135, DOI 10.1016/j.transproceed.2013.07.069
   Satirapoj B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124055
   Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schwanekamp JA, 2016, ARTERIOSCL THROM VAS, V36, P60, DOI 10.1161/ATVBAHA.115.306397
   Seifert GJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061628
   Virtakoivu R, 2021, CLIN CANCER RES, V27, P4205, DOI 10.1158/1078-0432.CCR-20-4862
   Wantanasiri P, 2015, LUPUS, V24, P835, DOI 10.1177/0961203314566634
   Yang YR, 2020, AGING-US, V12, P8652, DOI 10.18632/aging.103184
NR 29
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2023 SEP
PY 2023
VL 22
IS 9
DI 10.1111/acel.13914
EA JUN 2023
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA R8WT7
UT WOS:001019737900001
PM 37357460
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Jia, CJ
   Sun, H
   Dai, CL
AF Jia, Chang-jun
   Sun, Hao
   Dai, Chao-liu
TI Autophagy Contributes to Liver Regeneration After Portal Vein Ligation
   in Rats
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Autophagy; Liver Regeneration; Tetracycline
ID CYCLIN D1; EMBOLIZATION; HEPATECTOMY; INHIBITION; SENESCENCE; INDUCTION
AB Background: This study investigated the effect of 70% portal vein ligation (PVL), a widely used procedure for inducing rapid liver regeneration, on the expression of autophagy-related proteins in non-ligated liver lobes in rats.
   Material/Methods: Rats were subjected to either sham (n=30, major portal vein branches were exposed but kept intact) or PVL (n=30, major portal vein branches were double-ligated) operations. Liver samples were collected 12, 24, 48, 72, and 168 h after the operation. Liver volume, liver color, non-ligated liver percentage, and the expressions of light chain (LC) 3, beclin 1, and cyclin D1 in the non-ligated liver lobes were determined.
   Results: When compared to sham rats, increased (P<0.001) growth of the non-ligated liver lobes was observed in PVL rats as early as 12 h after surgery; an increased (P <= 0.001) LC3 II/I ratio was observed in the non-ligated lobes of PVL rats as early as 24 h after surgery. Increased expressions of beclin 1 (P <= 0.001) and cyclin D1 (P<0.001) were observed in the non-ligated lobes of PVL rats from 12 to 72 h after surgery and from 12 to 168 h after surgery, respectively, when compared to sham rats. In the non-ligated lobes, the expressions of beclin 1 and cyclin D1 were linearly and positively correlated with the LC3 II/I ratio.
   Conclusions: Autophagy is activated in the non-ligated liver after PVL. Both beclin 1 and cyclin D1 are linearly and positively correlated with autophagy activity in the PVL-induced rapid liver regeneration model.
C1 [Jia, Chang-jun; Sun, Hao; Dai, Chao-liu] China Med Univ, Dept Hepatobiliary Splen Surg, Gen Surg, Shengjing Hosp, Shenyang, Liaoning, Peoples R China.
C3 China Medical University
RP Dai, CL (corresponding author), China Med Univ, Dept Hepatobiliary Splen Surg, Gen Surg, Shengjing Hosp, Shenyang, Liaoning, Peoples R China.
EM daicl_sj@163.com
CR Abdalla EK, 2010, J SURG ONCOL, V102, P960, DOI 10.1002/jso.21654
   BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812
   Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005
   Brown NE, 2012, CANCER RES, V72, P6477, DOI 10.1158/0008-5472.CAN-11-4139
   Chae MS, 2018, ANN TRANSPL, V23, P481, DOI 10.12659/AOT.909112
   CHOJKIER M, 1981, AM J PHYSIOL, V240, pG371, DOI 10.1152/ajpgi.1981.240.5.G371
   Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063
   deBaere T, 1996, HEPATOLOGY, V24, P1386, DOI 10.1002/hep.510240612
   Ferraro E, 2007, ARCH BIOCHEM BIOPHYS, V462, P210, DOI 10.1016/j.abb.2007.02.006
   FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3
   KINOSHITA H, 1986, WORLD J SURG, V10, P803, DOI 10.1007/BF01655244
   Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029
   Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53
   Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257
   Lin CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15807
   Makuuchi M., 1984, J JPN PRACT SURG SOC, V45, P1558
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Oh SY, 2008, REPROD SCI, V15, P912, DOI 10.1177/1933719108319159
   Ravanan P, 2017, LIFE SCI, V188, P53, DOI 10.1016/j.lfs.2017.08.029
   Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009
   Song Dongda, 2017, Med Sci Monit, V23, P1471
   Toshima T, 2014, HEPATOLOGY, V60, P290, DOI 10.1002/hep.27140
   Wu S-Y, 2014, BIOMARK GENOMIC MED, V6, P187
   Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102
   Yokoyama Y, 2007, WORLD J SURG, V31, P367, DOI 10.1007/s00268-006-0526-2
   Zhu MJ, 2006, J PHYSIOL-LONDON, V575, P241, DOI 10.1113/jphysiol.2006.112110
NR 26
TC 6
Z9 6
U1 0
U2 2
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD JUL 31
PY 2019
VL 25
BP 5674
EP 5682
DI 10.12659/MSM.915404
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA IM4AK
UT WOS:000477936900002
PM 31364611
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Drvendzija, Z
   Stosic, S
   Galic, BS
   Radosevic, D
   Udicki, M
   Bodiroga, D
   Neskovic, N
AF Drvendzija, Zorka
   Stosic, Srdan
   Galic, Biljana Srdic
   Radosevic, Dragana
   Udicki, Mirjana
   Bodiroga, Danijel
   Neskovic, Natalija
TI Liver Size and its Correlation with Anthropometric Parameters and Age
SO INTERNATIONAL JOURNAL OF MORPHOLOGY
LA English
DT Article
DE Liver diameters; Body height; Body mass; Body surface area; Computed
   tomography
ID HEPATOBILIARY SCINTIGRAPHY; VOLUME; ULTRASOUND; WEIGHT
AB The liver has over 500 physiological and biochemical roles in our organism so checking of liver size and function is a part of every clinical examination. Aim of our research was to estimate liver size on computed tomography (CT) of the abdomen images and to determinate relations between liver dimensions and anthropometric parameters. The research included 99 patients, 49 men and 50 women, who were referred for CT of abdomen. We measured body height (BH) and body mass (BM), and calculated body mass index (BMI) and body surface area (BSA). Also, on CT images we measured anteroposterior (AP), laterolateral (LL) and two craniocaudal liver diameters (one at the level of midclavicular line CCmcl, and the other was maximal CCmax). Liver volume (LV) was calculated with formula. Our results showed that AP diameter positively correlated with BSA (r=0.30) in women. LL diameter positively correlated with BH (r=0.43), and BSA (0.31) in men. CCmcl diameter positively correlated with BH (r=0.33), BM (r=0.31), and BSA (r=0.34) in men, while in women it correlated only with BH (r=0.38). CCmax diameter positively correlated with BH (r=0.33) and BSA (r=0.33) in men. LV positively correlated with BH and BSA in both men (r=0.36, r=0.33, respectively) and women (r=0.42, r=0.31, respectively), and in men also with BM (r=0.34). LL, CCmcl, CCmax, and LV negatively correlated with aging in both sexes After the age of 60, there was a decrease in size of LL, CC diameters, as well as in LV. We concluded that liver dimensions decrease with aging, regardless of sex at the expanse of LL and CC diameters which are related to the size of body parameters, so that for a precise evaluation of liver size all three diameters should be measured, LV as well as BH, BM, and BSA.
C1 [Drvendzija, Zorka; Galic, Biljana Srdic; Radosevic, Dragana; Udicki, Mirjana] Univ Novi Sad, Fac Med, Dept Anat, Hajduk Veljkova 3, Novi Sad 21000, Serbia.
   [Stosic, Srdan] Univ Novi Sad, Fac Med, Dept Radiol, Novi Sad, Serbia.
   [Bodiroga, Danijel; Neskovic, Natalija] Univ Novi Sad, Fac Med, Novi Sad, Serbia.
C3 University of Novi Sad; University of Novi Sad; University of Novi Sad
RP Drvendzija, Z (corresponding author), Univ Novi Sad, Fac Med, Dept Anat, Hajduk Veljkova 3, Novi Sad 21000, Serbia.
EM zorka.drvendzija@mf.uns.ac.rs
CR Andersen V, 2000, ALCOHOL ALCOHOLISM, V35, P531, DOI 10.1093/alcalc/35.5.531
   [Anonymous], 2023, Obesity
   Blann Andrew, 2014, Nurs Times, V110, P17
   Chandramohan Anuradha, 2007, Indian J Gastroenterol, V26, P22
   Childs JT, 2014, J DIAGN MED SONOG, V30, P296, DOI 10.1177/8756479314549070
   Choukèr A, 2004, LIVER TRANSPLANT, V10, P678, DOI 10.1002/lt.20113
   de Graaf W, 2010, J NUCL MED, V51, P229, DOI 10.2967/jnumed.109.069724
   de Graaf W, 2010, J GASTROINTEST SURG, V14, P369, DOI 10.1007/s11605-009-1085-2
   Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002
   Ekpo E., 2013, J. Assoc. Radiogr. Niger., V27, P25
   Guyton A. C., 2004, Textbook of Medical Physiology, V11
   Ibrahim N. F. E. O, 2018, IOSR J. Dent. Med. Sci., V7, P16
   Ivkovic-Lazar T, 2013, Practicum of Physical Diagnostics with the Basics of Internal Propaedeutics, V9
   KENNEDY PA, 1977, SURG CLIN N AM, V57, P233
   Kratzer W, 2003, J ULTRAS MED, V22, P1155, DOI 10.7863/jum.2003.22.11.1155
   Lestra T, 2018, DIAGN INTERV IMAG, V99, P73, DOI 10.1016/j.diii.2017.12.009
   Linguraru MG, 2012, ACAD RADIOL, V19, P588, DOI 10.1016/j.acra.2012.01.015
   Nougaret S., 2011, Arch. Radiol. Soc. North Am., V17, P4
   Patzak M., 2021, Dev. Growth Differ., V63, P47
   Patzak M, 2014, J CLIN ULTRASOUND, V42, P399, DOI 10.1002/jcu.22151
   Seppelt D, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-04825-8
   Sharma M., 2016, Int. J. Res. Med. Sci., V4, P3020
   Singh H.R., 2019, Transl. Res. Anat, V14, P1, DOI [10.1016/j.tria.2018.11.004, DOI 10.1016/J.TRIA.2018.11.004]
   Sosna J, 2022, RADIOLOGY, V302, P343, DOI 10.1148/radiol.2021212010
   Trefts E, 2017, CURR BIOL, V27, pR1147, DOI 10.1016/j.cub.2017.09.019
   van Randen A, 2011, EUR RADIOL, V21, P1535, DOI 10.1007/s00330-011-2087-5
   van Wissen J, 2016, OBES SURG, V26, P251, DOI 10.1007/s11695-015-1769-5
   Vauthey JN, 2000, SURGERY, V127, P512, DOI 10.1067/msy.2000.105294
   Verma SK, 2010, CLIN RADIOL, V65, P315, DOI 10.1016/j.crad.2009.09.016
   Waelti S, 2021, BMC PEDIATR, V21, DOI 10.1186/s12887-021-02756-3
NR 30
TC 0
Z9 0
U1 0
U2 0
PU SOC CHILENA ANATOMIA
PI TEMUCO
PA CASILLA 54-D, TEMUCO, 00000, CHILE
SN 0717-9502
EI 0717-9367
J9 INT J MORPHOL
JI Int. J. Morphol.
PD DEC
PY 2023
VL 41
IS 6
BP 1679
EP 1686
PG 8
WC Anatomy & Morphology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology
GA DN2S7
UT WOS:001132665600039
DA 2024-02-19
ER

PT J
AU Pauk, M
   Kufner, V
   Rumenovic, V
   Dumic-Cule, I
   Farkas, V
   Milosevic, M
   Bordukalo-Niksic, T
   Vukicevic, S
AF Pauk, Martina
   Kufner, Vera
   Rumenovic, Viktorija
   Dumic-Cule, Ivo
   Farkas, Vladimir
   Milosevic, Milan
   Bordukalo-Niksic, Tatjana
   Vukicevic, Slobodan
TI Iron overload in aging <i>Bmp6</i><SUP>-/-</SUP> mice induces exocrine
   pancreatic injury and fibrosis due to acinar cell loss
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE bone morphogenetic protein 6; glucose homeostasis; pancreas; iron
   metabolism; diabetes
AB The relationship between hemochromatosis and diabetes has been well established, as excessive iron deposition has been reported to result in impaired function of the endocrine and exocrine pancreas. Therefore, the objective of the present study was to analyze the effects of iron accumulation on the pancreata and glucose homeostasis in a bone morphogenetic protein 6-knockout (Bmp6(-/-)) mouse model of hemochromatosis. The sera and pancreatic tissues of wild-type (WT) and Bmp6(-/-) mice (age, 3 and 10 months) were subjected to biochemical and histological analyses. In addition, F-18-fluorodeoxyglucose biodistribution was evaluated in the liver, muscle, heart, kidney and adipose tissue of both animal groups. The results demonstrated that 3-month-old Bmp6(-/-) mice exhibited iron accumulation preferentially in the exocrine pancreas, with no signs of pancreatic injury or fibrosis. No changes were observed in the glucose metabolism, as pancreatic islet diameter, insulin and glucagon secretion, blood glucose levels and glucose uptake in the liver, muscle and adipose tissue remained comparable with those in the WT mice. Aging Bmp6(-/-) mice presented with progressive iron deposits in the exocrine pancreas, leading to pancreatic degeneration and injury that was characterized by acinar atrophy, fibrosis and the infiltration of inflammatory cells. However, the aging mice exhibited unaltered blood glucose levels and islet structure, normal insulin secretion and moderately increased alpha-cell mass compared with those in the age-matched WT mice. Additionally, iron overload and pancreatic damage were not observed in the aging WT mice. These results supported a pathogenic role of iron overload in aging Bmp6(-/-) mice leading to iron-induced exocrine pancreatic deficiency, whereas the endocrine pancreas retained normal function.
C1 [Pauk, Martina; Kufner, Vera; Rumenovic, Viktorija; Dumic-Cule, Ivo; Bordukalo-Niksic, Tatjana; Vukicevic, Slobodan] Univ Zagreb, Ctr Translat & Clin Res, Sch Med, Lab Mineralized Tissues, 11 Salata St, HR-10000 Zagreb, Croatia.
   [Farkas, Vladimir] Rudjer Boskovic Inst, Mol Biol Dept, HR-10000 Zagreb, Croatia.
   [Milosevic, Milan] Univ Zagreb, Andrija Stampar Sch Publ Hlth, Sch Med, HR-10000 Zagreb, Croatia.
   [Dumic-Cule, Ivo] Childrens Hosp Srebrnjak, HR-10000 Zagreb, Croatia.
C3 University of Zagreb; Rudjer Boskovic Institute; University of Zagreb
RP Vukicevic, S (corresponding author), Univ Zagreb, Ctr Translat & Clin Res, Sch Med, Lab Mineralized Tissues, 11 Salata St, HR-10000 Zagreb, Croatia.
EM slobodan.vukicevic@mef.hr
RI /AFW-0958-2022; Farkas, Vladimir/JCE-6341-2023; /ABC-8179-2021;
   Vukicevic, Slobodan/AEG-2646-2022
OI /0000-0002-2005-6402; Farkas, Vladimir/0000-0003-0216-4706;
   /0000-0002-2005-6402; Vukicevic, Slobodan/0000-0003-4076-0285;
   Rumenovic, Viktorija/0000-0002-5982-2557; Milosevic,
   Milan/0000-0001-9008-7645; Kufner, Vera/0000-0002-1489-2981
FU Scientific Center of Excellence for Reproductive and Regenerative
   Medicine (project `Reproductive and regenerative medicineexplo-ration of
   new platforms and potentials') [KK.01.1.1.01.0008]; EU through the ERDF
FX The present study was supported by the Scientific Center of Excellence
   for Reproductive and Regenerative Medicine (project `Reproductive and
   regenerative medicineexplo-ration of new platforms and potentials';
   grant. no. GA KK.01.1.1.01.0008) funded by the EU through the ERDF.
CR Altamura S, 2014, CELL METAB, V20, P359, DOI 10.1016/j.cmet.2014.07.007
   Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335
   Bhatia M, 1998, P NATL ACAD SCI USA, V95, P4760, DOI 10.1073/pnas.95.8.4760
   Buysschaert M, 1997, DIABETES METAB, V23, P308
   Canali S, 2017, AM J HEMATOL, V92, P1204, DOI 10.1002/ajh.24888
   Cooksey RC, 2004, ENDOCRINOLOGY, V145, P5305, DOI 10.1210/en.2004-0392
   Corradini E, 2010, GASTROENTEROLOGY, V139, P1721, DOI 10.1053/j.gastro.2010.07.044
   Council of Europe, 1986, EUR CONV PROT VERT A
   Daher R, 2016, GASTROENTEROLOGY, V150, P672, DOI 10.1053/j.gastro.2015.10.049
   Dichmann DS, 2003, DEV DYNAM, V226, P663, DOI 10.1002/dvdy.10270
   Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967
   Guo QD, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01705-7
   Hansen JB, 2014, ACTA PHYSIOL, V210, P717, DOI 10.1111/apha.12256
   Hatunic M, 2010, METABOLISM, V59, P380, DOI 10.1016/j.metabol.2009.08.006
   Hramiak IM, 1997, CLIN INVEST MED, V20, P110
   Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049
   Jenkitkasemwong S, 2015, CELL METAB, V22, P138, DOI 10.1016/j.cmet.2015.05.002
   Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354
   Latour C, 2017, BLOOD, V130, P2339, DOI 10.1182/blood-2017-07-795658
   Latour C, 2016, HEPATOLOGY, V63, P126, DOI 10.1002/hep.28254
   Lunova M, 2017, J PATHOL, V241, P104, DOI 10.1002/path.4822
   Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200
   McClain DA, 2006, DIABETOLOGIA, V49, P1661, DOI 10.1007/s00125-006-0200-0
   Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4
   Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698
   Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320
   Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742
   Nguyen TQ, 2006, DIABETOLOGIA, V49, P1039, DOI 10.1007/s00125-006-0172-0
   Padda RS, 2015, AM J PHYSIOL-GASTR L, V308, pG251, DOI 10.1152/ajpgi.00137.2014
   Pauk M, 2019, ACTA DIABETOL, V56, P365, DOI 10.1007/s00592-018-1265-1
   Pauk M, 2015, INT ORTHOP, V39, P161, DOI 10.1007/s00264-014-2550-4
   Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013
   Piubelli C, 2017, AM J HEMATOL, V92, P562, DOI 10.1002/ajh.24730
   Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707
   Ramey G, 2007, FEBS LETT, V581, P1053, DOI 10.1016/j.febslet.2007.02.002
   Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178
   Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Roldan PS, 2007, NUCL INSTRUM METH A, V571, P498, DOI 10.1016/j.nima.2006.10.143
   Sampath KT, 2017, PROG INFLAMM RES SER, P15, DOI 10.1007/978-3-319-47507-3_2
   Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7
   Spasic MV, 2013, BBA-MOL BASIS DIS, V1832, P76, DOI 10.1016/j.bbadis.2012.08.013
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vinci MC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113864
   Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1
   Wagner J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221455
   Westerweel PE, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-55
   Xiao X, 2020, HEPATOLOGY, V72, P642, DOI 10.1002/hep.31048
   Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54
NR 49
TC 1
Z9 1
U1 0
U2 11
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD APR
PY 2021
VL 47
IS 4
AR 60
DI 10.3892/ijmm.2021.4893
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA QO6ML
UT WOS:000623255300001
PM 33649802
OA hybrid, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Zak, J
   Roy, K
   Dykova, I
   Mraz, J
   Reichard, M
AF Zak, Jakub
   Roy, Koushik
   Dykova, Iva
   Mraz, Jan
   Reichard, Martin
TI Starter feed for carnivorous species as a practical replacement of
   bloodworms for a vertebrate model organism in ageing, the turquoise
   killifish Nothobranchius furzeri
SO JOURNAL OF FISH BIOLOGY
LA English
DT Article; Early Access
DE African killifish; laboratory diet; nutritional ecology; practical diet
ID RAINBOW-TROUT; AMINO-ACID; ANNUAL FISH; LIFE-SPAN; DIET; NUTRITION;
   PROTEIN; GROWTH; METABOLISM; SYSTEM
AB The absence of a controlled diet is unfortunate in a promising model organism for ageing, the turquoise killifish (Nothobranchius furzeri Jubb, 1971). Currently captive N. furzeri are fed bloodworms but it is not known whether this is an optimal diet. Replacing bloodworms with a practical dry feed would reduce diet variability. In the present study, we estimated the nutritional value of the diet ingested by wild fish and determined the fish-body amino acid profile as a proxy for their nutritional requirements. We compared the performance of fish fed four commercial feeds containing 46%-64% protein to that achieved with bloodworms and that of wild fish. Wild fish target a high-protein (60%) diet and this is supported by their superior performance on high-protein diets in captivity. In contrast, feeds for omnivores led to slower growth, lower fecundity and unnatural liver size. In comparison to wild fish, a bloodworm diet led to lower body condition, overfeeding and male liver enlargement. Out of the four dry feeds tested, the fish fed Aller matched wild fish in body condition and liver size, and was comparable to bloodworms in terms of growth and fecundity. A starter feed for carnivorous species appears to be a practical replacement for bloodworms for N. furzeri. The use of dry feeds improved performance in comparison to bloodworms and thus may contribute to reducing response variability and improving research reproducibility in N. furzeri research.
C1 [Zak, Jakub; Reichard, Martin] Czech Acad Sci, Inst Vertebrate Biol, Kvetna 8, Brno 60300, Czech Republic.
   [Zak, Jakub] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.
   [Roy, Koushik; Mraz, Jan] Univ South Bohemia, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Ceske Budejovice, Czech Republic.
   [Dykova, Iva; Reichard, Martin] Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic.
   [Reichard, Martin] Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, Lodz, Poland.
C3 Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech
   Academy of Sciences; Charles University Prague; University of South
   Bohemia Ceske Budejovice; Masaryk University Brno; University of Lodz
RP Zak, J (corresponding author), Czech Acad Sci, Inst Vertebrate Biol, Kvetna 8, Brno 60300, Czech Republic.
EM fish.jakub.zak@gmail.com
RI Reichard, Martin/C-6563-2009; Žák, Jakub/HMO-7100-2023; Roy,
   Koushik/D-6015-2018; Mraz, Jan/F-7915-2015
OI Reichard, Martin/0000-0002-9306-0074; Žák, Jakub/0000-0003-2845-8323;
   Roy, Koushik/0000-0001-7205-9034; Mraz, Jan/0000-0003-3545-1269
FU Charles University Grant Agency [30121]; Czech Science Foundation
   [19-01781S]; Ministry of Education, Youth and Sports of the Czech
   Republic [LM2018099, CZ.02.1.01/0.0/0.0/16_025/0007370]
FX We thank Vaclav Homolka, Jiri Farkac, Matej Polacik and Milan Vrtilek
   for technical assistance during the course of feeding experiments, Adam
   Veleba and Barbora Pavlickova for help with body size measurements of
   experimental fish, and Rowena Spence for English correction. This
   research was supported by the Charles University Grant Agency (J.Z., Nr.
   30121) and the Czech Science Foundation M.R., 19-01781S). The study was
   also partly financed by the Ministry of Education, Youth and Sports of
   the Czech Republic, projects CENAKVA (J.M., J.Z., LM2018099;
   Biodiversity J.M., CZ.02.1.01/0.0/0.0/16_025/0007370).
CR Akiyama T, 1997, FISHERIES SCI, V63, P963, DOI 10.2331/fishsci.63.963
   [Anonymous], 1977, NUTR REQ WARMW FISH
   Armitage P.D., 1995, The Chironomidae : biology and ecology of non-biting midges
   Barnard DE, 2009, J AM ASSOC LAB ANIM, V48, P709
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Baumgart M, 2015, BIOGERONTOLOGY, V16, P63, DOI 10.1007/s10522-014-9535-y
   Bentley KT, 2013, T AM FISH SOC, V142, P747, DOI 10.1080/00028487.2013.769899
   Blazek R, 2017, EVOLUTION, V71, P386, DOI 10.1111/evo.13127
   Blazek R, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-24
   Butts IAE, 2020, AQUACULTURE, V518, DOI 10.1016/j.aquaculture.2019.734602
   Cellerino A, 2016, BIOL REV, V91, P511, DOI 10.1111/brv.12183
   CHELLAPPA S, 1995, J FISH BIOL, V47, P775, DOI 10.1111/j.1095-8649.1995.tb06002.x
   Cheng KC, 2008, ZEBRAFISH, V5, P237, DOI 10.1089/zeb.2008.0577
   CHO CY, 1992, AQUACULTURE, V100, P107, DOI 10.1016/0044-8486(92)90353-M
   Dabrowski Konrad, 2002, P309
   DABROWSKI KR, 1986, COMP BIOCHEM PHYS A, V85, P639, DOI 10.1016/0300-9629(86)90272-0
   Di Cicco E, 2011, EXP GERONTOL, V46, P249, DOI 10.1016/j.exger.2010.10.011
   Dodzian J, 2018, JOVE-J VIS EXP, DOI 10.3791/57073
   Evans DH, 1998, PHYSL FISHES
   Ferguson H. W., 1989, Systemic pathology of fish. A text and atlas of comparative tissue responses in diseases of teleosts.
   Fowler LA, 2019, ZEBRAFISH, V16, P508, DOI 10.1089/zeb.2019.1742
   Fox J., 2011, R COMPANION APPL REG
   Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x
   Harel I, 2015, COLD SH Q B, V80, P275, DOI 10.1101/sqb.2015.80.027524
   Hedrera MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069983
   Heger J., 2019, ABSORPTION UTILIZATI, P31, DOI DOI 10.1201/9780429487514-3
   Heikkinen J, 2006, AQUACULTURE, V261, P259, DOI 10.1016/j.aquaculture.2006.07.012
   Hemre GI, 2002, AQUACULT NUTR, V8, P175, DOI 10.1046/j.1365-2095.2002.00200.x
   Hu CK, 2018, AGING CELL, V17, DOI 10.1111/acel.12757
   Hua K, 2010, AQUACULTURE, V308, P152, DOI 10.1016/j.aquaculture.2010.07.040
   Jobling M, 2016, AQUACULT INT, V24, P767, DOI 10.1007/s10499-014-9875-2
   Jungheim ES, 2011, FERTIL STERIL, V96, P880, DOI 10.1016/j.fertnstert.2011.07.1115
   Kaushik SJ, 2010, AQUAC RES, V41, P322, DOI 10.1111/j.1365-2109.2009.02174.x
   Lahnsteiner F, 2009, J FISH BIOL, V75, P816, DOI 10.1111/j.1095-8649.2009.02317.x
   Lall SP, 2007, AQUACULTURE, V267, P3, DOI 10.1016/j.aquaculture.2007.02.053
   Lawrence C, 2012, COMP BIOCHEM PHYS C, V155, P160, DOI 10.1016/j.cbpc.2011.06.007
   Lenth RV, 2021, EMMEANS ESTIMATED MA, DOI DOI 10.1080/00031305.1980.10483031
   Ljubobratovic U, 2020, AQUACULT REP, V18, DOI 10.1016/j.aqrep.2020.100430
   Lugert V, 2016, REV AQUACULT, V8, P30, DOI 10.1111/raq.12071
   Mandal SC, 2012, FISH PHYSIOL BIOCHEM, V38, P573, DOI 10.1007/s10695-011-9539-3
   Marei WF, 2010, REPRODUCTION, V139, P979, DOI 10.1530/REP-09-0503
   Markovich ML, 2007, ZEBRAFISH, V4, P69, DOI 10.1089/zeb.2006.9993
   Marono S., 2015, Italian Journal of Animal Science, V14, P338
   McDonald J. H., 2014, Handbook of biological statistics, V3rd
   McKay A., 2021, AUTOMATED FEEDING SY, DOI 10.1101/2021.03.30.437790
   Meinelt T, 1999, J APPL ICHTHYOL, V15, P19, DOI 10.1046/j.1439-0426.1999.00121.x
   Moro J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051414
   Mráz J, 2009, FISH PHYSIOL BIOCHEM, V35, P615, DOI 10.1007/s10695-008-9291-5
   Muck J., 2018, SHORT LIVED AFRICAN
   Nüsslein-Volhard C, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600231
   PARKER GA, 1992, J FISH BIOL, V41, P1, DOI 10.1111/j.1095-8649.1992.tb03864.x
   Philippe C, 2018, JOVE-J VIS EXP, DOI 10.3791/57308
   Polacik M, 2014, J EVOLUTION BIOL, V27, P854, DOI 10.1111/jeb.12359
   Polacik M, 2010, J FISH BIOL, V77, P754, DOI 10.1111/j.1095-8649.2010.02717.x
   Polacik M, 2016, NAT PROTOC, V11, P1396, DOI 10.1038/nprot.2016.080
   Raubenheimer D, 2019, OBESITY, V27, P1225, DOI 10.1002/oby.22531
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Reichard M., 2022, LAB FISH BIOMEDICAL, P289, DOI DOI 10.1016/B978-0-12-821099-4.00001-8
   Reichard M, 2019, ELIFE, V8, DOI 10.7554/eLife.41548
   Riddle MR, 2021, DEV BIOL, V476, P101, DOI 10.1016/j.ydbio.2021.03.012
   Rollin X, 2003, BRIT J NUTR, V90, P865, DOI 10.1079/BJN2003973
   Ruohonen K, 2007, AQUACULTURE, V267, P147, DOI 10.1016/j.aquaculture.2007.02.051
   Salamanca N, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11010045
   Smith DL, 2013, ZEBRAFISH, V10, P439, DOI 10.1089/zeb.2012.0864
   Snellgrove DL, 2011, BRIT J NUTR, V106, pS110, DOI 10.1017/S0007114511002972
   Spitsbergen JM, 2012, ILAR J, V53, P114, DOI 10.1093/ilar.53.2.114
   Stephens D.W., 1971, FORAGING THEORY
   Surai PF, 2000, J REPROD FERTIL, V120, P257, DOI 10.1530/reprod/120.2.257
   Tacon A.G.J., 1985, P155
   Team RC, 2020, R: A Language and Environment for Statistical
   Terzibasi E, 2009, AGING CELL, V8, P88, DOI 10.1111/j.1474-9726.2009.00455.x
   Tozzini ET, 2020, EVODEVO, V11, DOI 10.1186/s13227-020-00170-x
   Therneau TM, 2000, Modeling Survival Data: Extending the Cox Model, DOI 10.1007/978-1-4757-3294-8_3
   Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226
   Turchini GM, 2019, N AM J AQUACULT, V81, P13, DOI 10.1002/naaq.10067
   Van Der Meer M. B., 1996, Aquaculture Research, V27, P487
   Verstraete F, 2013, TOXICOL APPL PHARM, V270, P230, DOI 10.1016/j.taap.2010.09.015
   Vrtilek M, 2019, J FISH BIOL, V95, P673, DOI 10.1111/jfb.14052
   Vrtílek M, 2018, SCI NAT-HEIDELBERG, V105, DOI 10.1007/s00114-018-1594-5
   Vrtílek M, 2016, ECOL EVOL, V6, P5921, DOI 10.1002/ece3.2337
   Vrtílek M, 2015, ECOL FRESHW FISH, V24, P616, DOI 10.1111/eff.12175
   Ward AJW, 2006, FISH FISH, V7, P231, DOI 10.1111/j.1467-2979.2006.00224.x
   Watts A., 2021, ANNU REV NUTR, V41, P1
   Watts SA, 2016, ZEBRAFISH, V13, pS72, DOI 10.1089/zeb.2016.1299
   Watts SA, 2012, ILAR J, V53, P144, DOI 10.1093/ilar.53.2.144
   Wheeler B., 2016, lmPerm: Permutation Tests for Linear Models, R Package Version 1.3-1
   Williams MB, 2019, GENES NUTR, V14, DOI 10.1186/s12263-019-0658-2
   Wolf JC, 2005, TOXICOL PATHOL, V33, P75, DOI 10.1080/01926230590890187
   Wood S. N., 2017, Generalized Additive Models: An Introduction with R
   Wu GY, 2011, AMINO ACIDS, V40, P1053, DOI 10.1007/s00726-010-0715-z
   Yamada S, 2009, COMP BIOCHEM PHYS B, V152, P282, DOI 10.1016/j.cbpb.2008.12.006
   Zák J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65930-0
   Zák J, 2019, BIOL J LINN SOC, V128, P435, DOI 10.1093/biolinnean/blz108
   Zandonà E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136079
NR 94
TC 3
Z9 3
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1112
EI 1095-8649
J9 J FISH BIOL
JI J. Fish Biol.
PD 2022 APR
PY 2022
VL 100
IS 4
BP 894
EP 908
DI 10.1111/jfb.15021
EA MAR 2022
PG 15
WC Fisheries; Marine & Freshwater Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Fisheries; Marine & Freshwater Biology
GA 0U6UV
UT WOS:000771139200001
PM 35195903
DA 2024-02-19
ER

PT J
AU Nomura, T
   Sakai, K
   Ogata, H
   Magae, J
AF Nomura, Takaharu
   Sakai, Kazuo
   Ogata, Hiromitsu
   Magae, Junji
TI Prolongation of Life Span in the Accelerated Aging <i>klotho</i> Mouse
   Model, by Low-Dose-Rate Continuous γ Irradiation
SO RADIATION RESEARCH
LA English
DT Article
ID X-RAY-IRRADIATION; IMMUNOLOGICAL MODIFICATION; OXIDATIVE STRESS; MICE;
   GENE; RADIATION; SUPPRESSION; REGULATOR; MUTATION; BIOLOGY
AB While lifespan studies provide basic information for estimating the risk of ionizing radiation, findings on the effect of low-dose/low-dose-rate irradiation on the lifespan of mammals are controversial. Here we evaluate the effect of continuous exposure to low-dose-rate gamma radiation on the lifespan of mice with accelerated aging caused by mutation of the klotho gene. While control mice died within 80 days after birth, more than 10% of mice exposed continuously to 0.35 or 0.7 or mGy/h gamma radiation from 40 days after birth survived for more than 80 days. Two of 50 mice survived for more than 100 days. Low-dose-rate irradiation significantly increased plasma calcium concentration in mutant mice, and concomitantly increased hepatic catalase activity. Although hepatic activity of superoxide dismutase in mutant mice decreased significantly compared to wild-type mice, continuous gamma irradiation decreased the activity in mutant mice significantly. These results suggest that low-dose-rate ionizing radiation can prolong the lifespan of mice in certain settings. (C) 2013 by Radiation Research Society
C1 [Nomura, Takaharu; Sakai, Kazuo; Magae, Junji] Cent Res Inst Elect Power Ind, Radiat Safety Res Ctr, Nucl Technol Res Lab, Komae, Tokyo 2018511, Japan.
   [Ogata, Hiromitsu; Magae, Junji] Natl Inst Publ Hlth, Wako, Saitama 3510197, Japan.
   [Magae, Junji] Magae Biosci Inst, Tsukuba, Ibaraki 3001263, Japan.
C3 Central Research Institute of Electric Power Industry - Japan; National
   Institute of Public Health - Japan
RP Magae, J (corresponding author), Magae Biosci Inst, 49-4 Fujimidai, Tsukuba, Ibaraki 3001263, Japan.
EM jmagae@sannet.ne.jp
CR Caratero A, 1998, GERONTOLOGY, V44, P272, DOI 10.1159/000022024
   Duport P., 2003, International Journal of Low Radiation, V1, P120, DOI 10.1504/IJLR.2003.003488
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Hoshi Y, 2000, J RADIAT RES, V41, P129, DOI 10.1269/jrr.41.129
   HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127
   Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901
   Ina Y, 2005, RADIAT RES, V163, P153, DOI 10.1667/RR3289
   Ina Y, 2005, RADIAT RES, V163, P418, DOI 10.1667/RR3316
   Ina Y, 2004, RADIAT RES, V161, P168, DOI 10.1667/RR3120
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kataoka Takahiro, 2005, Physiological Chemistry and Physics and Medical NMR, V37, P109
   Kawaguchi H, 1999, J CLIN INVEST, V104, P229, DOI 10.1172/JCI5705
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Kojima S, 1999, FREE RADICAL BIO MED, V26, P388, DOI 10.1016/S0891-5849(98)00200-7
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   Lacoste-Collin L, 2007, RADIAT RES, V168, P725, DOI 10.1667/RR1007.1
   Lloyd RD, 2004, HEALTH PHYS, V86, P629, DOI 10.1097/00004032-200406000-00009
   LORENZ E, 1955, J NATL CANCER I, V15, P1049
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUCKEY TD, 1982, HEALTH PHYS, V43, P771, DOI 10.1097/00004032-198212000-00001
   MACKLIS RM, 1991, J NUCL MED, V32, P350
   Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019
   MINE M, 1990, INT J RADIAT BIOL, V58, P1035, DOI 10.1080/09553009014552341
   Mori K, 2000, BIOCHEM BIOPH RES CO, V278, P665, DOI 10.1006/bbrc.2000.3864
   Nabeshima Y, 2002, AGEING RES REV, V1, P627, DOI 10.1016/S1568-1637(02)00027-2
   Nomura T, 1999, FREE RADICAL BIO MED, V27, P1324, DOI 10.1016/S0891-5849(99)00180-X
   Nomura T, 2011, RADIAT RES, V176, P356, DOI 10.1667/RR2559.1
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sasaki S, 2006, J RADIAT RES, V47, P135, DOI 10.1269/jrr.47.135
   Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081
   Taki K, 2009, J RADIAT RES, V50, P241, DOI 10.1269/jrr.09011
   Tanaka S, 2003, RADIAT RES, V160, P376, DOI 10.1667/RR3042
   Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048
   Tsuruga M, 2007, RADIAT RES, V167, P592, DOI 10.1667/RR0786.1
   Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang YH, 2009, AGEING RES REV, V8, P43, DOI 10.1016/j.arr.2008.10.002
   Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200
   Yamaoka K, 2004, J RADIAT RES, V45, P89, DOI 10.1269/jrr.45.89
   Yamaoka K, 2000, FREE RADICAL RES, V32, P213, DOI 10.1080/10715760000300221
NR 44
TC 22
Z9 23
U1 0
U2 21
PU RADIATION RESEARCH SOC
PI LAWRENCE
PA 810 E TENTH STREET, LAWRENCE, KS 66044 USA
SN 0033-7587
EI 1938-5404
J9 RADIAT RES
JI Radiat. Res.
PD JUN
PY 2013
VL 179
IS 6
BP 717
EP 724
DI 10.1667/RR2977.1
PG 8
WC Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology,
   Nuclear Medicine & Medical Imaging
GA AA3IQ
UT WOS:000330986500012
PM 23662650
DA 2024-02-19
ER

PT J
AU Wang, L
   Zhang, Y
   Zhu, ZL
   Zheng, FP
   Gao, RC
AF Wang, Lin
   Zhang, Yue
   Zhu, Zhiling
   Zheng, Fuping
   Gao, Ruichang
TI Food-derived collagen peptides: safety, metabolism, and anti-skin-aging
   effects
SO CURRENT OPINION IN FOOD SCIENCE
LA English
DT Article; Early Access
ID GLY-PRO-HYP; HYDROLYZED COLLAGEN; BIOACTIVE PEPTIDES; ABSORPTION;
   INGESTION
AB Collagen peptides (CPs) are a hot topic in the nutrition and health industries. This review summarizes their safety, metabolism, and anti-skin-aging effects, and addresses outstanding issues to guide further applications and research. CPs are safe, but the risks of excessive intake, harmful elements, and pathogenic agents should still be considered. Following gastrointestinal digestion, they are absorbed by the intestinal mucosa, pass through the liver, and enter the peripheral blood, where 25 types of hydroxyproline-containing peptides have been identified. These accumulate in the skin, improving its condition by alleviating oxidative stress, inhibiting inflammatory reaction, regulating cell behavior, and maintaining extracellular matrix homeostasis. However, questions remain concerning appropriate intake, evaluation methods, contrary findings, bioactive molecules, signaling pathways, and interactions with dietary components.
C1 [Wang, Lin; Zhang, Yue; Zhu, Zhiling; Gao, Ruichang] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang 212013, Peoples R China.
   [Zheng, Fuping] Beijing Technol & Business Univ, Beijing Lab Food Qual & Safety, Beijing 100048, Peoples R China.
C3 Jiangsu University; Beijing Technology & Business University
RP Gao, RC (corresponding author), Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang 212013, Peoples R China.
EM xiyuan2008@ujs.edu.cn
RI LIU, LIYING/KAM-4121-2024
FU China Agriculture Research System; National Natural Science Foundation
   of China [BE2022357]; Key Research and Development Program of Jiangsu
   Province [NY2021003]; Key Research and Development Program of Zhenjiang
   City [FQS-202109]; Beijing Laboratory of Food Quality and Safety
   [CARS-46-01A];  [32272324]
FX This research was supported by the China Agriculture Research System
   (CARS-46-01A), National Natural Science Foundation of China (32272324),
   Key Research and Development Program of Jiangsu Province (BE2022357) and
   Key Research and Development Program of Zhenjiang City (NY2021003), and
   Open Fund Project of Beijing Laboratory of Food Quality and Safety
   (FQS-202109).
CR Asai T, 2019, J AGR FOOD CHEM, V67, P2831, DOI 10.1021/acs.jafc.8b06896
   Cao CW, 2022, NUTRIENTS, V14, DOI 10.3390/nu14081622
   Chae M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094788
   Chen B, 2022, FRONT BIOENG BIOTECH, V10, DOI 10.3389/fbioe.2022.908033
   Chotphruethipong L, 2022, FISHES-BASEL, V7, DOI 10.3390/fishes7050265
   Chotphruethipong L, 2021, RSC ADV, V11, P18144, DOI 10.1039/d1ra03131g
   Csekes E, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222312641
   da Silva IJS, 2021, FOOD ANAL METHOD, V14, P1860, DOI 10.1007/s12161-021-02015-2
   de Miranda RB, 2021, INT J DERMATOL, V60, P1449, DOI 10.1111/ijd.15518
   Fu Y, 2022, J FUNCT FOODS, V93, DOI 10.1016/j.jff.2022.105101
   Gu YP, 2020, AGEING RES REV, V59, DOI 10.1016/j.arr.2020.101036
   Han K, 2022, PHOTOCHEM PHOTOBIOL, V98, P1172, DOI 10.1111/php.13618
   Han SH, 2022, MAR DRUGS, V20, DOI 10.3390/md20050308
   Han SB, 2021, J IND ENG CHEM, V98, P289, DOI 10.1016/j.jiec.2021.03.039
   hoon Kim, 2020, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V49, P454, DOI 10.3746/jkfn.2020.49.5.454
   Hu ZZ, 2022, LWT-FOOD SCI TECHNOL, V159, DOI 10.1016/j.lwt.2022.113205
   Hu ZZ, 2022, FOODS, V11, DOI 10.3390/foods11030391
   Hwang SJ, 2021, BMB REP, V54, P329, DOI 10.5483/BMBRep.2021.54.6.038
   Ilie D, 2022, FOOD TECHNOL BIOTECH, V60, P281, DOI 10.17113/ftb.60.03.22.7107
   Iwasaki Y, 2022, FOOD CHEM, V369, DOI 10.1016/j.foodchem.2021.130869
   Iwasaki Y, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10124066
   Jung K, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124372
   Kang MK, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22116137
   Kim D, 2022, J MED FOOD, V25, P192, DOI 10.1089/jmf.2021.K.0124
   Koutsoumanis K, 2020, EFSA J, V18, DOI 10.2903/j.efsa.2020.6267
   Larder CE, 2021, CURR ISSUES MOL BIOL, V43, P1592, DOI 10.3390/cimb43030113
   Li CY, 2022, FOOD SCI HUM WELL, V11, P218, DOI 10.1016/j.fshw.2021.11.003
   Lin P, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8031795
   Liu H, 2022, J FOOD BIOCHEM, V46, DOI 10.1111/jfbc.14122
   Miyanaga M, 2021, SKIN PHARMACOL PHYS, V34, P115, DOI 10.1159/000513988
   Oh SJ, 2022, J MICROBIOL BIOTECHN, V32, P1382, DOI 10.4014/jmb.2207.07018
   Park SJ, 2021, J MED FOOD, V24, P1313, DOI 10.1089/jmf.2021.K.0089
   Pfisterer K, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.682414
   Phipps KR, 2020, J FUNCT FOODS, V68, DOI 10.1016/j.jff.2020.103870
   Sato K, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.548975
   Sim Bo-ram, 2020, [Jounal of The Korean Society of cosmetology, 한국미용학회지], V26, P600
   Sivaraman K, 2022, CELL BIOL INT, V46, P391, DOI 10.1002/cbin.11737
   Sontakke SB, 2016, J AGR FOOD CHEM, V64, P7127, DOI 10.1021/acs.jafc.6b02955
   Taga Y, 2022, NPJ SCI FOOD, V6, DOI 10.1038/s41538-022-00144-4
   Walker M, 2022, INT J PHARMACEUT, V622, DOI 10.1016/j.ijpharm.2022.121850
   Wang L, 2019, FOOD FUNCT, V10, P3890, DOI [10.1039/C9FO00661C, 10.1039/c9fo00661c]
   Wang XF, 2019, J FUNCT FOODS, V63, DOI 10.1016/j.jff.2019.103574
   Watanabe-Kamiyama M, 2010, J AGR FOOD CHEM, V58, P835, DOI 10.1021/jf9031487
   Woonnoi W, 2021, POL J FOOD NUTR SCI, V71, P323, DOI 10.31883/pjfns/141515
   Xue WJ, 2022, J FOOD SCI, V87, P2744, DOI 10.1111/1750-3841.16160
   Yazaki M, 2017, J AGR FOOD CHEM, V65, P2315, DOI 10.1021/acs.jafc.6b05679
   Zhang L, 2020, FOOD FUNCT, V11, P5573, DOI [10.1039/d0fo00153h, 10.1039/D0FO00153H]
   Zhang SY, 2021, J COSMET DERMATOL-US, V20, P2277, DOI 10.1111/jocd.13805
   Zhang ZJ, 2020, J PHOTOCH PHOTOBIO B, V210, DOI 10.1016/j.jphotobiol.2020.111964
   Zmitek K, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030618
NR 50
TC 3
Z9 3
U1 32
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-7993
EI 2214-8000
J9 CURR OPIN FOOD SCI
JI Curr. Opin. Food Sci.
PD 2023 JUN
PY 2023
VL 51
AR 101012
DI 10.1016/j.cofs.2023.101012
EA MAR 2023
PG 7
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA A5FE8
UT WOS:000955371100001
DA 2024-02-19
ER

PT J
AU Shang, J
   Previs, SF
   Conarello, S
   Chng, K
   Zhu, YH
   Souza, SC
   Staup, M
   Chen, Y
   Xie, D
   Zycband, E
   Schlessinger, K
   Johnson, VP
   Arreaza, G
   Liu, F
   Levitan, D
   Wang, LS
   van Heek, M
   Erion, M
   Wang, YX
   Kelley, DE
AF Shang, Jin
   Previs, Stephen F.
   Conarello, Stacey
   Chng, Keefe
   Zhu, Yonghua
   Souza, Sandra C.
   Staup, Michael
   Chen, Ying
   Xie, Dan
   Zycband, Emanuel
   Schlessinger, Karni
   Johnson, Victoria Plamadeala
   Arreaza, Gladys
   Liu, Franklin
   Levitan, Diane
   Wang, Liangsu
   van Heek, Margaret
   Erion, Mark
   Wang, Yixin
   Kelley, David E.
TI Phenotyping of adipose, liver, and skeletal muscle insulin resistance
   and response to pioglitazone in spontaneously obese rhesus monkeys
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE insulin resistance; hyperinsulinemic-euglycemic clamp; rhesus monkey
ID SPONTANEOUS DIABETES-MELLITUS; GLUCOSE-TOLERANCE; TISSUE; SENSITIVITY;
   PROGRESSION; EXPRESSION
AB Insulin resistance and diabetes can develop spontaneously with obesity and aging in rhesus monkeys, highly similar to the natural history of obesity, insulin resistance, and progression to type 2 diabetes in humans. The current studies in obese rhesus were undertaken to assess hepatic and adipose contributions to systemic insulin resistance-currently, a gap in our knowledge-and to benchmark the responses to pioglitazone (PIO). A two-step hyperinsulinemic-euglycemic clamp, with tracer-based glucose flux estimates, was used to measure insulin resistance, and in an intervention study was repeated following 6 wk of PIO treatment (3 mg/kg). Compared with lean healthy rhesus, obese rhesus has a 60% reduction of glucose utilization during a high insulin infusion and markedly impaired suppression of lipolysis, which was evident at both low and high insulin infusion. However, obese dysmetabolic rhesus manifests only mild hepatic insulin resistance. Six-week PIO treatment significantly improved skeletal muscle and adipose insulin resistance (by similar to 50%). These studies strengthen the concept that insulin resistance in obese rhesus closely resembles human insulin resistance and indicate the value of obese rhesus for appraising new insulin-sensitizing therapeutics.
C1 [Shang, Jin; Previs, Stephen F.; Conarello, Stacey; Zhu, Yonghua; Souza, Sandra C.; Chen, Ying; Xie, Dan; Zycband, Emanuel; Schlessinger, Karni; Johnson, Victoria Plamadeala; Arreaza, Gladys; Liu, Franklin; Levitan, Diane; Wang, Liangsu; van Heek, Margaret; Erion, Mark; Kelley, David E.] Merck & Co Inc, Kenilworth, NJ USA.
   [Chng, Keefe; Staup, Michael; Wang, Yixin] Crown Biosci Inc, Kannapolis, NC USA.
C3 Merck & Company
RP Shang, J (corresponding author), Merck & Co Inc, Cardiometab Dis, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.
EM shangjin63@gmail.com
RI Zhou, Hong/JKJ-1067-2023; Previs, Stephen/JNE-8752-2023; Johnson,
   Victoria/GVU-7127-2022
FU Merck Co.
FX The study was funded by Merck & Co. J. Shang, S. F. Previs, S.
   Conarello, Y. Zhu, S. C. Souza, V. Plamadeala Johnson, Y. Chen, D. Xie,
   E. Zycband, K. Schlessinger, G. Arreaza, F. Liu, D. Levitan, L. Wang, M.
   van Heek, M. Erion, and D. Kelley were employees of Merck & Co. at the
   time when the work was performed and may hold stock or stock options of
   the company.
CR Bodkin N L, 1993, Obes Res, V1, P364
   BODKIN NL, 1989, AM J PHYSIOL, V256, pE676, DOI 10.1152/ajpendo.1989.256.5.E676
   Ciudin A, 2012, CURR TOP MED CHEM, V12, P585, DOI 10.2174/156802612799436632
   Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305
   Hammarstedt A, 2003, BIOCHEM BIOPH RES CO, V301, P578, DOI 10.1016/S0006-291X(03)00014-7
   Hansen B C, 1989, Nutrition, V5, P48
   Hansen B C, 1993, Obes Res, V1, P252
   Hansen BC, 2013, OBESITY, V21, P1643, DOI 10.1002/oby.20292
   HANSEN BC, 1986, DIABETOLOGIA, V29, P713, DOI 10.1007/BF00870281
   Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126
   Jocken JWE, 2013, DIABETOLOGIA, V56, P2255, DOI 10.1007/s00125-013-2995-9
   Koppaka S, 2013, DIABETES, V62, P1843, DOI 10.2337/db12-0868
   Liu GHF, 2009, STAT MED, V28, P2509, DOI 10.1002/sim.3639
   Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4
   Shankar SS, 2015, CURR THER RES CLIN E, V77, P83, DOI 10.1016/j.curtheres.2015.08.001
   Staup M, 2016, JOVE-J VIS EXP, DOI 10.3791/52895
   STOKES WS, 1986, LAB ANIM SCI, V36, P529
   SUGIYAMA Y, 1990, ARZNEIMITTEL-FORSCH, V40-1, P436
   Tardif SD, 2011, ILAR J, V52, P54, DOI 10.1093/ilar.52.1.54
   ter Horst KW, 2015, INT J OBESITY, V39, P1703, DOI 10.1038/ijo.2015.125
   ter Horst KW, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00182
   Tozzo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126642
   Wagner JD, 2001, TOXICOL PATHOL, V29, P142, DOI 10.1080/019262301301418955
   Wang SP, 2016, AM J PHYSIOL-ENDOC M, V311, pE911, DOI 10.1152/ajpendo.00182.2016
   Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16
   YASUDA M, 1988, J MED PRIMATOL, V17, P319
   Yeckel CW, 2008, J CLIN ENDOCR METAB, V93, P1285, DOI 10.1210/jc.2007-1875
NR 27
TC 1
Z9 1
U1 1
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD APR
PY 2017
VL 312
IS 4
BP E282
EP E290
DI 10.1152/ajpendo.00398.2016
PG 9
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA EQ2BA
UT WOS:000397872100001
OA Bronze
DA 2024-02-19
ER

PT J
AU Snyder, JM
   Snider, TA
   Ciol, MA
   Wilkinson, JE
   Imai, DM
   Casey, KM
   Vilches-Moure, JG
   Pettan-Brewer, C
   Pillai, SPS
   Carrasco, SE
   Salimi, S
   Ladiges, W
AF Snyder, Jessica M.
   Snider, Timothy A.
   Ciol, Marcia A.
   Wilkinson, John E.
   Imai, Denise M.
   Casey, Kerriann M.
   Vilches-Moure, Jose G.
   Pettan-Brewer, Christina
   Pillai, Smitha P. S.
   Carrasco, Sebastian E.
   Salimi, Shabnam
   Ladiges, Warren
TI Validation of a geropathology grading system for aging mouse studies
SO GEROSCIENCE
LA English
DT Article
DE Geropathology; Aging; Mouse; Histopathology; Lesion grades; Geroscience
ID NONPROLIFERATIVE LESIONS; LIFE-SPAN; MICE; RAT; PATHOLOGY; RELEVANCE;
   MODELS
AB An understanding of early-onset mechanisms underlying age-related changes can be obtained by evaluating changes that precede frailty and end of life using histological characterization of age-related lesions. Histopathology-based information as a component of aging studies in mice can complement and add context to molecular, cellular, and physiologic data, but there is a lack of information regarding scoring criteria and lesion grading guidelines. This report describes the validation of a grading system, designated as the geropathology grading platform (GGP), which generated a composite lesion score (CLS) for comparison of histological lesion scores in tissues from aging mice. To assess reproducibility of the scoring system, multiple veterinary pathologists independently scored the same slides from the heart, lung, liver, and kidney from two different strains (C57BL/6 and CB6F1) of male mice at 8, 16, 24, and 32 months of age. There was moderate to high agreement between pathologists, particularly when agreement within a 1-point range was considered. CLS for all organs was significantly higher in older versus younger mice, suggesting that the GGP was reliable for detecting age-related pathology in mice. The overall results suggest that the GGP guidelines reliably distinguish between younger and older mice and may therefore be accurate in distinguishing between experimental groups of mice with more, or less, age-related pathology.
C1 [Snyder, Jessica M.; Pettan-Brewer, Christina; Ladiges, Warren] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.
   [Snider, Timothy A.] Oklahoma State Univ, Dept Vet Pathobiol, Stillwater, OK 74078 USA.
   [Ciol, Marcia A.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA.
   [Wilkinson, John E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.
   [Imai, Denise M.] Univ Calif Davis, Dept Vet Pathol, Davis, CA USA.
   [Casey, Kerriann M.; Vilches-Moure, Jose G.] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA USA.
   [Pillai, Smitha P. S.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.
   [Carrasco, Sebastian E.] MIT, Div Comparat Med, Cambridge, MA 02139 USA.
   [Salimi, Shabnam] Univ Maryland, Sch Med, College Pk, MD 20742 USA.
C3 University of Washington; University of Washington Seattle; Oklahoma
   State University System; Oklahoma State University - Stillwater;
   University of Washington; University of Washington Seattle; University
   of Michigan System; University of Michigan; University of California
   System; University of California Davis; Stanford University; Fred
   Hutchinson Cancer Center; Massachusetts Institute of Technology (MIT);
   University System of Maryland; University of Maryland College Park
RP Ladiges, W (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.
EM wladiges@u.washington.edu
RI Wilkinson, John/JTV-0835-2023; Salimi, Shabnam/ABD-9552-2020
OI Salimi, Shabnam/0000-0002-5522-0305; Snider,
   Timothy/0000-0002-2659-835X; Casey, Kerriann/0000-0003-4228-928X; Imai,
   Denise/0000-0003-0667-2054; Ciol, Marcia/0000-0001-6406-4706;
   Vilches-Moure, Jose/0000-0003-3341-2258
FU NIA [AG047115, AG013280]
FX This work was financially supported by NIA grants AG047115 and AG013280.
CR Adissu HA, 2014, DIS MODEL MECH, V7, P515, DOI 10.1242/dmm.015263
   Berridge B. R., 2016, TOXICOL PATHOL, V29, P1, DOI DOI 10.1293/tox.29.3S-1
   Brayton CF, 2012, VET PATHOL, V49, P85, DOI 10.1177/0300985811430696
   Burch JB, 2014, J GERONTOL A-BIOL, V69, pS1, DOI 10.1093/gerona/glu041
   Eaton KA, 2007, COMPARATIVE MED, V57, P57
   Fayers PM, 2007, QUALITY LIFE ASSESSM, P77, DOI [10.1002/9780470024522.ch4, DOI 10.1002/9780470024522.CH4]
   Frazier KS, 2012, TOXICOL PATHOL, V40, P14, DOI 10.1177/0192623312438736
   Ge X, 2017, EXP GERONTOL, V91, P1, DOI 10.1016/j.exger.2017.02.001
   Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099
   Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291
   Kane AE, 2016, J GERONTOL A-BIOL, V71, P333, DOI 10.1093/gerona/glu315
   Koelink PJ, 2018, J CROHNS COLITIS, V12, P794, DOI 10.1093/ecco-jcc/jjy035
   Koks S, 2016, MECH AGEING DEV, V160, P41, DOI 10.1016/j.mad.2016.10.001
   Ladiges W, 2016, J GERONTOL A-BIOL, V71, P431, DOI 10.1093/gerona/glv079
   Ladiges W, 2009, AGING CELL, V8, P346, DOI 10.1111/j.1474-9726.2009.00491.x
   Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922
   Nadon NL, 2007, INT REV NEUROBIOL, V81, P15, DOI 10.1016/S0074-7742(06)81002-0
   Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674
   Pettan-Brewer C, 2012, PATHOBIOL AGING AGE, V2, DOI 10.3402/pba.v2i0.19182
   Ray MA, 2010, J AM ASSOC LAB ANIM, V49, P282
   Renne R, 2009, TOXICOL PATHOL, V37, p5S, DOI 10.1177/0192623309353423
   Sundberg JP, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7179
   Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499
   Treuting PM, 2016, VET PATHOL, V53, P244, DOI 10.1177/0300985815620629
   Vanhooren V, 2013, AGEING RES REV, V12, P8, DOI 10.1016/j.arr.2012.03.010
   Ward JM, 2011, TOXICOL PATHOL, V39, P745, DOI 10.1177/0192623311408622
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Yuan R, 2011, ILAR J, V52, P4, DOI 10.1093/ilar.52.1.4
NR 28
TC 12
Z9 13
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD AUG
PY 2019
VL 41
IS 4
BP 455
EP 465
DI 10.1007/s11357-019-00088-w
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA JH3IS
UT WOS:000492661900008
PM 31468322
OA Green Published
DA 2024-02-19
ER

PT J
AU de Cavanagh, EMV
   Flores, I
   Ferder, M
   Inserra, F
   Ferder, L
AF de Cavanagh, Elena M. V.
   Flores, Idhaliz
   Ferder, Marcelo
   Inserra, Felipe
   Ferder, Leon
TI Renin-angiotensin system inhibitors protect against age-related changes
   in rat liver mitochondrial DNA content and gene expression
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Mitochondria DNA; Reactive oxygen species; Gene expression;
   Anti-aging; Antioxidant
ID II RECEPTOR SUBTYPES; NITRIC-OXIDE SYNTHASE; MTDNA COPY NUMBER; DIETARY
   RESTRICTION; ENERGY-METABOLISM; SKELETAL-MUSCLES; SENESCENT RATS;
   ACE-INHIBITORS; NADPH OXIDASE; AGING PROCESS
AB Chronic renin-angiotensin system inhibition protects against liver fibrosis, ameliorates age-associated mitochondrial dysfunction and increases rodent lifespan. We hypothesized that life-long angiotensin-II-mediated stimulation of oxidant generation might participate in mitochondrial DNA "common deletion" formation, and the resulting impairment of bioenergetic capacity. Enalapril (10 mg/kg/d) or losartan (30 mg/kg/d) administered during 16.5 months were unable to prevent the age-dependent accumulation of rat liver mitochondrial DNA "common deletion", but attenuated the decrease of mitochondrial DNA content. This evidence - together with the enhancement of NRF-1 and PGC-1 mRNA contents - seems to explain why enalapril and losartan improved mitochondrial functioning and lowered oxidant production, since both the absolute number of mtDNA molecules and increased NRF-1 and PGC-1 transcription are positively related to mitochondrial respiratory capacity, and PGC-1 protects against increases in ROS production and damage. Oxidative stress evoked by abnormal respiratory function contributes to the pathophysiology of mitochondrial disease and human aging. If the present mitochondrial actions of renin-angiotensin system inhibitors are confirmed in humans they may modify the therapeutic significance of that strategy. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Ferder, Leon] Ponce Sch Med, Dept Physiol & Pharmacol, Ponce, PR 00732 USA.
   [de Cavanagh, Elena M. V.; Ferder, Marcelo; Inserra, Felipe] Univ Buenos Aires, Sch Med, Inst Cardiovasc Pathophysiol INFICA, RA-1122 Buenos Aires, DF, Argentina.
   [Flores, Idhaliz] Ponce Sch Med, Dept Microbiol, Ponce, PR 00716 USA.
C3 Instituto Cardiovascular de Buenos Aires (ICBA); University of Buenos
   Aires
RP Ferder, L (corresponding author), Ponce Sch Med, Dept Physiol & Pharmacol, POB 7004, Ponce, PR 00732 USA.
EM leferder@psm.edu
RI Flores, Idhaliz/AFG-3118-2022
OI Flores, Idhaliz/0000-0003-2130-4508
FU NIH/NCRR/RCMI [G12RR03050]
FX We thank Richard J. Noel Ph.D. for critical reading of the paper. We
   thank the Ponce School of Medicine Molecular Biology Core, RCMI Program.
   This work was partially supported by NIH/NCRR/RCMI/ Grant #G12RR03050.
CR Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002
   BAUMER A, 1994, AM J HUM GENET, V54, P618
   BELMIN J, 1994, DRUG AGING, V5, P391, DOI 10.2165/00002512-199405050-00007
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027
   Brookes PS, 2004, MITOCHONDRION, V3, P187, DOI 10.1016/j.mito.2003.10.001
   Casademont Jordi, 2002, Heart Fail Rev, V7, P131, DOI 10.1023/A:1015372407647
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Chan H, 2007, CLIN EXP PHARMACOL P, V34, P985, DOI 10.1111/j.1440-1681.2007.04669.x
   Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100
   de Cavanagh EMV, 2003, FASEB J, V17, P1096, DOI 10.1096/fj.02-0063fje
   Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200
   ENESCO HE, 1983, EXP GERONTOL, V18, P79, DOI 10.1016/0531-5565(83)90054-2
   Ernsberger P, 2007, CURR OPIN PHARMACOL, V7, P140, DOI 10.1016/j.coph.2006.11.008
   Estabrook R.W., 1967, METHOD ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
   FERDER L, 1993, AM J PHYSIOL, V265, pC15, DOI 10.1152/ajpcell.1993.265.1.C15
   Ferder LF, 2002, CURR OPIN PHARMACOL, V2, P189, DOI 10.1016/S1471-4892(02)00139-X
   Fernández-Alfonso MS, 1999, J HYPERTENS, V17, P1355, DOI 10.1097/00004872-199917100-00001
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   FLOHE L, 1984, METHOD ENZYMOL, V105, P93
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104
   Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005
   Halle JP, 1997, EUR J CELL BIOL, V74, P281
   HEYMES C, 1994, CIRCULATION, V90, P1328, DOI 10.1161/01.CIR.90.3.1328
   Heymes C, 1998, ENDOCRINOLOGY, V139, P2579, DOI 10.1210/en.139.5.2579
   Huang SZ, 2005, WORLD J GASTROENTERO, V11, P132, DOI 10.3748/wjg.v11.i1.132
   Janke J, 2006, J HYPERTENS, V24, P1809, DOI 10.1097/01.hjh.0000242405.68461.84
   JONES OTG, 1994, METHOD ENZYMOL, V233, P222
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   Kimura S, 2005, HYPERTENSION, V45, P438, DOI 10.1161/01.HYP.0000157169.27818.ae
   KITAMI Y, 1992, BIOCHEM BIOPH RES CO, V188, P446, DOI 10.1016/0006-291X(92)92405-M
   Knowles RG, 1998, METH MOL B, V100, P67
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Lanni A, 1996, INT J BIOCHEM CELL B, V28, P337, DOI 10.1016/1357-2725(95)00137-9
   Larkin JE, 2004, PHYSIOL GENOMICS, V18, P152, DOI 10.1152/physiolgenomics.00057.2004
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   Li JM, 2003, J BIOL CHEM, V278, P12094, DOI 10.1074/jbc.M209793200
   LLORENSCORTES C, 1994, HYPERTENSION, V24, P538, DOI 10.1161/01.HYP.24.5.538
   Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0
   Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Münzel T, 2001, CIRCULATION, V104, P1571, DOI 10.1161/hc3801.095585
   Nakada K, 2002, MITOCHONDRION, V2, P59, DOI 10.1016/S1567-7249(02)00007-7
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nakashima Hidekatsu, 2006, Current Vascular Pharmacology, V4, P67, DOI 10.2174/157016106775203126
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050
   Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368
   Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   OZAWA T, 1999, OXIDATIVE DAMAGE FRA
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   Piotrkowski B, 2007, AM J PHYSIOL-REG I, V292, pR1494, DOI 10.1152/ajpregu.00540.2006
   Ramanujan VK, 2007, J BIOL CHEM, V282, P19217, DOI 10.1074/jbc.M700572200
   SANBE A, 1995, J MOL CELL CARDIOL, V27, P2209, DOI 10.1016/S0022-2828(95)91551-6
   Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846
   Sechi LA, 1996, HYPERTENSION, V28, P403, DOI 10.1161/01.HYP.28.3.403
   Sersté T, 2006, ACTA GASTRO-ENT BELG, V69, P296
   Sorescu Dan, 2002, Congest Heart Fail, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x
   SPETH RC, 1990, BIOCHEM BIOPH RES CO, V169, P997, DOI 10.1016/0006-291X(90)91993-3
   Spiegelman BM, 2007, NOVART FDN SYMP, V286, P6
   Spiegelman BM, 2007, NOVART FDN SYMP, V286, P196, DOI DOI 10.1002/9780470985571.CH2
   Spiegelman BM, 2007, NOVART FDN SYMP, V286, P162
   Spiegelman Bruce M, 2007, Novartis Found Symp, V286, P3
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Strazzullo P, 2004, CURR OPIN NEPHROL HY, V13, P325, DOI 10.1097/00041552-200405000-00010
   Thompson MM, 2000, AM J PHYSIOL-REG I, V279, pR1787, DOI 10.1152/ajpregu.2000.279.5.R1787
   Toblli JE, 2002, J NEPHROL, V15, P358
   VINCENT M, 1976, CLIN SCI MOL MED, V50, P103, DOI 10.1042/cs0500103
   Wei Y H, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P259
   Yoshiji H, 2007, J GASTROEN HEPATOL, V22, pS93, DOI 10.1111/j.1440-1746.2006.04663.x
   Yowe DL, 1998, GENE, V209, P23, DOI 10.1016/S0378-1119(97)00628-8
   Zeviani M, 2005, J INHERIT METAB DIS, V28, P287, DOI 10.1007/s10545-005-0307-3
NR 78
TC 24
Z9 25
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT
PY 2008
VL 43
IS 10
BP 919
EP 928
DI 10.1016/j.exger.2008.08.007
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 373DN
UT WOS:000260951300006
PM 18765277
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Hu, YC
   Zhou, J
   Cao, YA
   Zhang, JM
   Zou, L
AF Hu, Yichen
   Zhou, Jie
   Cao, Yanan
   Zhang, Jinming
   Zou, Liang
TI Anti-aging effects of polysaccharides from quinoa (<i>Chenopodium
   </i>quinoa Willd.) in improving memory and cognitive function
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article; Early Access
DE Quinoa; Polysaccharide; Anti-aging; D-galactose; Cognitive function
ID D-GALACTOSE; MICE; NEUROINFLAMMATION; ANTIOXIDANT
AB Given that the polysaccharide of Quinoa (Chenopodium quinoa Willd., QP) exhibited preliminarily antioxidant activity in our previous studies, herein its anti-aging activities being associated with the antioxidant effect were evaluated in vitro and in vivo. A series of characterization including 1H NMR spectra, FT-IR spectra, and monosaccharide composition analysis, were implemented, indicated that homogalacturonans might exist as the major polysaccharide fraction in QP. The in vitro antioxidant assay demonstrated that QP had superior scavenging activities on DPPH and ABTS(+). Oral administration of QP (100, 400, and 800 mg.kg(-1)) to D-galactose induced mice significantly ameliorated the learning and memory of aging mice in the Morris water maze test. Meanwhile, QP could alleviate oxidative stress in brain and liver tissues, possibly related to an increase in antioxidant enzymes, reduction of lipid peroxidation, and restoration of lipid metabolism. The anti-aging effects of QP may involve the regulation of SITR1-associated target proteins including DBC1, p53, and Foxo3a in brain tissues. Overall, we demonstrate that QP would be a promising dietary supplement, which benefit to prevent aging and improve memory as well as cognitive function.
C1 [Hu, Yichen; Zhou, Jie; Cao, Yanan; Zou, Liang] Chengdu Univ, Sichuan Engn & Technol Res Ctr Coarse Cereal Indu, Sch Food & Biol Engn, Key Lab Coarse Cereal Proc,Minist Agr & Rural Aff, Chengdu 610106, Sichuan, Peoples R China.
   [Zhang, Jinming] Chengdu Univ Tradit Chinese Med, Coll Pharm, State Key Lab Southwestern Chinese Med Resources, 1166 Liutai Ave, Chengdu 611137, Sichuan, Peoples R China.
C3 Chengdu University; Ministry of Agriculture & Rural Affairs; Chengdu
   University of Traditional Chinese Medicine
RP Zhang, JM (corresponding author), Chengdu Univ Tradit Chinese Med, Coll Pharm, State Key Lab Southwestern Chinese Med Resources, 1166 Liutai Ave, Chengdu 611137, Sichuan, Peoples R China.; Zou, L (corresponding author), Chengdu Univ, Minist Agr & Rural Affairs, Key Lab Coarse Cereal Proc, 2025 Chengluo Ave, Chengdu 610106, Sichuan, Peoples R China.
EM zhangjinming1987@126.com; zouliang@cdu.edu.cn
FU project of Science & Technology Department of Sichuan Province
   [2019YFS0526]
FX Funding This study was supported by the project of Science & Technology
   Department of Sichuan Province (2019YFS0526) .
CR Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Bordet R, 2020, EUR J NEUROL, V27, P2111, DOI 10.1111/ene.14454
   Bosch AM, 2006, J INHERIT METAB DIS, V29, P516, DOI 10.1007/s10545-006-0382-0
   Cao YN, 2020, INT J BIOL MACROMOL, V163, P55, DOI 10.1016/j.ijbiomac.2020.06.241
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   Donehower LA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001081
   Fu J, 2020, FOOD CHEM, V325, DOI 10.1016/j.foodchem.2020.126761
   Garner B, 2010, BBA-MOL CELL BIOL L, V1801, P747, DOI 10.1016/j.bbalip.2010.06.003
   Gonzalez-Freire M, 2020, AGEING RES REV, V59, DOI 10.1016/j.arr.2020.101037
   Guo H, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11020215
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hernandez DF, 2021, CRIT REV FOOD SCI, V61, P3740, DOI 10.1080/10408398.2020.1805407
   Hu YC, 2017, INT J BIOL MACROMOL, V99, P622, DOI 10.1016/j.ijbiomac.2017.03.019
   Kang JH, 2012, ENDOCR REV, V33, P715, DOI 10.1210/er.2011-1049
   Lian WW, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00409
   Lin X, 2014, CARBOHYD POLYM, V101, P533, DOI 10.1016/j.carbpol.2013.09.037
   Loera-Valencia R, 2019, J STEROID BIOCHEM, V190, P104, DOI 10.1016/j.jsbmb.2019.03.003
   Luo J, 2020, AGEING RES REV, V57, DOI 10.1016/j.arr.2019.100982
   Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4
   Maradini AM, 2017, CRIT REV FOOD SCI, V57, P1618, DOI 10.1080/10408398.2014.1001811
   Noratto GD, 2019, FOOD CHEM, V287, P107, DOI 10.1016/j.foodchem.2019.02.061
   Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238
   Paraiso IL, 2020, MOL NUTR FOOD RES, V64, DOI [10.1002/mnfr.202000341, 10.1002/mnfr.202070034]
   Shen CY, 2017, BRIT J PHARMACOL, V174, P1395, DOI 10.1111/bph.13631
   Singh S, 2016, BEHAV BRAIN RES, V299, P141, DOI 10.1016/j.bbr.2015.11.023
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Wang HF, 2018, SCI CHINA LIFE SCI, V61, P24, DOI 10.1007/s11427-017-9207-x
   Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008
   Wu DT, 2021, FOODS, V10, DOI 10.3390/foods10102330
   Wu DT, 2022, FOOD HYDROCOLLOID, V122, DOI 10.1016/j.foodhyd.2021.107085
   Yao HYY, 2021, FOOD RES INT, V143, DOI 10.1016/j.foodres.2021.110290
   Yao Y, 2014, INT J MOL SCI, V15, P19307, DOI 10.3390/ijms151019307
   Yu C, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6635460
   Zhang SW, 2020, PHARM BIOL, V58, P959, DOI 10.1080/13880209.2020.1817102
   Zhang ZY, 2021, PHARM BIOL, V59, P347, DOI 10.1080/13880209.2021.1893347
NR 36
TC 4
Z9 4
U1 12
U2 47
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD 2022 JUL
PY 2022
VL 94
AR 105097
DI 10.1016/j.jff.2022.105097
EA MAY 2022
PG 10
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 1R9VJ
UT WOS:000803709100002
OA gold
DA 2024-02-19
ER

PT J
AU Barnaba, C
   Yadav, J
   Nagar, S
   Korzekwa, K
   Jones, JP
AF Barnaba, Carlo
   Yadav, Jaydeep
   Nagar, Swati
   Korzekwa, Ken
   Jones, Jeffrey P.
TI Mechanism-Based Inhibition of CYP3A4 by Podophyllotoxin: Aging of an
   Intermediate Is Important for in Vitro/in Vivo Correlations
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE methylenedioxyphenyl compounds; time-dependent inhibition; carbene;
   podophyllotoxin; mechanism-based inhibition
ID TIME-DEPENDENT INHIBITION; DRUG-DRUG INTERACTIONS; HUMAN CYTOCHROME-P450
   3A4; IN-VITRO; SPECTRAL INTERACTIONS; PIPERONYL BUTOXIDE; HEPATIC
   MICROSOMES; COMPLEX-FORMATION; LIVER-MICROSOMES; NUMERICAL-METHOD
AB An in vitro observation of time-dependent inhibition (TDI) of metabolic enzymes often results in removing a potential drug from the drug pipeline. However, the accepted method for,predicting TDIs of the important drug metabolizing cytochrome P450 enzymes often overestimates the drug interaction potential. Better models that take into account the complexities of the cytochrome P450 enzyme system will lead to better predictions. Herein we report the use of our previously described models for complex kinetics of podophyllotoxin. Spectral,characterization of the kinetics indicates that an intermediate MI complex is formed, which slowly progresses to an essentially irreversible MI complex. The intermediate MI complex can release free enzyme during the time course Of,a typical 30 min TDI experiment. This slow rate of MI complex conversion results in an overprediction of the k(inact) value if this process is not included in the analysis of the activity versus time profile. In vitro kinetic experiments in rat liver microsomes predicted a lack of drug interaction between podophyllotoxin and midazolam. In vivo tat pharmacokinetic studies confirmed this lack of drug interaction.
C1 [Barnaba, Carlo; Jones, Jeffrey P.] Washington State Univ, Dept Chem, Pullman, WA 99164 USA.
   [Yadav, Jaydeep; Nagar, Swati; Korzekwa, Ken] Temple Univ, Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19140 USA.
C3 Washington State University; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); Temple University
RP Jones, JP (corresponding author), Washington State Univ, Dept Chem, Pullman, WA 99164 USA.
EM jpj@wsu.edu
RI Jones, Jeffrey P/F-2801-2013; , Swati/AAC-3195-2020; Yadav,
   Jaydeep/ABB-2712-2021; Barnaba, Carlo/L-8681-2014
OI Barnaba, Carlo/0000-0003-2170-9695; Yadav, Jaydeep/0000-0003-1177-3976
FU NIH [R01-GM114369, R01-GM104178]
FX This work was supported by NIH Grants R01-GM114369 to K.K., S.N., and
   J.P.J. and R01-GM104178 to K.K. and S.N.
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Atkins WM, 2005, ANNU REV PHARMACOL, V45, P291, DOI 10.1146/annurev.pharmtox.45.120403.100004
   BEUMEL GA, 1985, GEN PHARMACOL-VASC S, V16, P193, DOI 10.1016/0306-3623(85)90068-0
   Chatterjee P, 2003, DRUG METAB DISPOS, V31, P1391, DOI 10.1124/dmd.31.11.1391
   CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029
   Correia M.A., 2005, CYTOCHROME P450 STRU, P247, DOI DOI 10.1007/0-387-27447-2_7
   CORREIA MA, 1991, METHOD ENZYMOL, V206, P315
   DAHL AR, 1979, CHEM-BIOL INTERACT, V27, P163, DOI 10.1016/0009-2797(79)90123-6
   Davydov DR, 2013, BIOCHEM J, V453, P219, DOI 10.1042/BJ20130398
   Davydov DR, 2010, BBA-BIOENERGETICS, V1797, P378, DOI 10.1016/j.bbabio.2009.12.008
   de Montellano P. R. O., 1995, Cytochrome P450: Structure, Mechanism, and Biochemistry, P305
   Denisov IG, 2006, J BIOL CHEM, V281, P23313, DOI 10.1074/jbc.M605511200
   DICKINS M, 1979, BIOCHEM PHARMACOL, V28, P231, DOI 10.1016/0006-2952(79)90509-4
   ELCOMBE CR, 1975, BIOCHEM PHARMACOL, V24, P1427, DOI 10.1016/0006-2952(75)90367-6
   Fahmi OA, 2009, DRUG METAB DISPOS, V37, P1658, DOI 10.1124/dmd.108.026252
   Gordaliza M, 2004, TOXICON, V44, P441, DOI 10.1016/j.toxicon.2004.05.008
   Greenblatt DJ, 2014, CLIN PHARMACOL THER, V95, P133, DOI 10.1038/clpt.2013.230
   Grimm SW, 2009, DRUG METAB DISPOS, V37, P1355, DOI 10.1124/dmd.109.026716
   HUANG MT, 1981, J BIOL CHEM, V256, P897
   Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0
   Keserü GM, 1999, INT J QUANTUM CHEM, V73, P123, DOI 10.1002/(SICI)1097-461X(1999)73:2<123::AID-QUA7>3.0.CO;2-5
   Korzekwa K, 2014, DRUG METAB DISPOS, V42, P1587, DOI 10.1124/dmd.114.058297
   Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627
   KULKARNI AP, 1976, PESTIC BIOCHEM PHYS, V6, P183, DOI 10.1016/0048-3575(76)90038-9
   KULKARNI AP, 1978, PESTIC BIOCHEM PHYS, V9, P75, DOI 10.1016/0048-3575(78)90068-8
   KULKARNI AP, 1984, ANNU REV PHARMACOL, V24, P19, DOI 10.1146/annurev.pa.24.040184.000315
   Lee SK, 2008, RAPID COMMUN MASS SP, V22, P52, DOI 10.1002/rcm.3325
   Mohutsky M, 2014, METHODS MOL BIOL, V1113, P57, DOI 10.1007/978-1-62703-758-7_5
   Murray M, 2012, J TOXICOL ENV HEAL B, V15, P365, DOI 10.1080/10937404.2012.705105
   Nagar S, 2014, DRUG METAB DISPOS, V42, P1575, DOI 10.1124/dmd.114.058289
   Obach RS, 2007, DRUG METAB DISPOS, V35, P246, DOI 10.1124/dmd.106.012633
   Obach RS, 2011, CURR TOP MED CHEM, V11, P334
   Orr STM, 2012, J MED CHEM, V55, P4896, DOI 10.1021/jm300065h
   PHILPOT RM, 1972, MOL PHARMACOL, V8, P204
   Roberts AG, 2005, BIOCHEMISTRY-US, V44, P1353, DOI 10.1021/bi0481390
   SCHENKMAN JB, 1973, DRUG METAB DISPOS, V1, P516
   Schenkman John B, 2006, Methods Mol Biol, V320, P11
   Silverman R., 1995, MECH BASED ENZYME IN
   Taxak N, 2013, INORG CHEM, V52, P5097, DOI 10.1021/ic400010d
   THUMMEL KE, 1994, J PHARMACOL EXP THER, V271, P549
   Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z
   Usia T, 2005, LIFE SCI, V76, P2381, DOI 10.1016/j.lfs.2004.12.005
   Vieiral MLT, 2014, CLIN PHARMACOL THER, V95, P189, DOI 10.1038/clpt.2013.187
   Wang YH, 2010, DRUG METAB DISPOS, V38, P1094, DOI 10.1124/dmd.110.032177
   Yan ZY, 2012, CURR TOP MED CHEM, V12, P1291, DOI 10.2174/156802612800672871
   Yang JS, 2008, CURR DRUG METAB, V9, P384, DOI 10.2174/138920008784746382
NR 46
TC 15
Z9 21
U1 0
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD AUG
PY 2016
VL 13
IS 8
BP 2833
EP 2843
DI 10.1021/acs.molpharmaceut.6b00436
PG 11
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA DS6AT
UT WOS:000380864800026
PM 27336918
OA Green Accepted
DA 2024-02-19
ER

PT J
AU González-Rodríguez, A
   Más-Gutierrez, JA
   Mirasierra, M
   Fernandez-Pérez, A
   Lee, YJ
   Ko, HJ
   Kim, JK
   Romanos, E
   Carrascosa, JM
   Ros, M
   Vallejo, M
   Rondinone, CM
   Valverde, AM
AF Gonzalez-Rodriguez, Agueda
   Mas-Gutierrez, Jose A.
   Mirasierra, Mercedes
   Fernandez-Perez, Antonio
   Lee, Yong J.
   Ko, Hwi J.
   Kim, Jason K.
   Romanos, Eduardo
   Carrascosa, Jose M.
   Ros, Manuel
   Vallejo, Mario
   Rondinone, Cristina M.
   Valverde, Angela M.
TI Essential role of protein tyrosine phosphatase 1B in obesity-induced
   inflammation and peripheral insulin resistance during aging
SO AGING CELL
LA English
DT Article
DE insulin resistance; type 2 diabetes; obesity; inflammation; PTP1B
ID ADIPOSE-TISSUE; IN-VIVO; METABOLIC SYNDROME; UP-REGULATION; MICE;
   SENSITIVITY; RECEPTOR; LIVER; HEPATOCYTES; EXPRESSION
AB Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of insulin signaling and a therapeutic target for type 2 diabetes (T2DM). In this study, we have evaluated the role of PTP1B in the development of aging-associated obesity, inflammation, and peripheral insulin resistance by assessing metabolic parameters at 3 and 16 months in PTP1B-/- mice maintained on mixed genetic background (C57Bl/6J x 129Sv/J). Whereas fat mass and adipocyte size were increased in wild-type control mice at 16 months, these parameters did not change with aging in PTP1B-/- mice. Increased levels of pro-inflammatory cytokines, crown-like structures, and hypoxia-inducible factor (HIF)-1a were observed only in adipose tissue from 16-month-old wild-type mice. Similarly, islet hyperplasia and hyperinsulinemia were observed in wild-type mice with aging-associated obesity, but not in PTP1B-/- animals. Leanness in 16-month-old PTP1B-/- mice was associated with increased energy expenditure. Whole-body insulin sensitivity decreased in 16-month-old control mice; however, studies with the hyperinsulinemiceuglycemic clamp revealed that PTP1B deficiency prevented this obesity-related decreased peripheral insulin sensitivity. At a molecular level, PTP1B expression and enzymatic activity were up-regulated in liver and muscle of 16-month-old wild-type mice as were the activation of stress kinases and the expression of p53. Conversely, insulin receptor-mediated Akt/Foxo1 signaling was attenuated in these aged control mice. Collectively, these data implicate PTP1B in the development of inflammation and insulin resistance associated with obesity during aging and suggest that inhibition of this phosphatase by therapeutic strategies might protect against age-dependent T2DM.
C1 [Gonzalez-Rodriguez, Agueda; Mirasierra, Mercedes; Fernandez-Perez, Antonio; Vallejo, Mario; Valverde, Angela M.] Inst Biomed Alberto Sols CSIC UAM, Madrid 28029, Spain.
   [Gonzalez-Rodriguez, Agueda; Mirasierra, Mercedes; Fernandez-Perez, Antonio; Vallejo, Mario; Valverde, Angela M.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain.
   [Mas-Gutierrez, Jose A.; Ros, Manuel] Univ Rey Juan Carlos, Fac Hlth Sci, Madrid 28922, Spain.
   [Lee, Yong J.; Ko, Hwi J.; Kim, Jason K.] Univ Massachusetts, Sch Med, Div Endocrinol Metab & Diabet, Program Mol Med, Worcester, MA 01605 USA.
   [Kim, Jason K.] Univ Massachusetts, Div Endocrinol, Sch Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA.
   [Romanos, Eduardo] IIS Aragon, Phenotyping Unit, Zaragoza, Spain.
   [Carrascosa, Jose M.] Ctr Mol Biol Severo Ochoa CSIC UAM, Madrid 28049, Spain.
   [Rondinone, Cristina M.] Abbott Labs, Global Pharmaceut Res Div, Dept 47R, Abbott Pk, IL 60064 USA.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro
   de Investigacion Biomedica en Red; CIBERDEM; Universidad Rey Juan
   Carlos; University of Massachusetts System; University of Massachusetts
   Worcester; University of Massachusetts System; University of
   Massachusetts Worcester; Consejo Superior de Investigaciones Cientificas
   (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Abbott
   Laboratories
RP Valverde, AM (corresponding author), Inst Biomed Alberto Sols CSIC UAM, C Arturo Duperier 4, Madrid 28029, Spain.
EM avalverde@iib.uam.es
RI Romanos, Eduardo/T-3794-2017; Carrascosa, Jose M/ABE-3526-2021;
   Mirasierra, Mercedes/ABG-6999-2020; Vallejo, Mario/ABG-4610-2020;
   Gonzalez-Rodriguez, Agueda/D-7651-2012
OI Romanos, Eduardo/0000-0002-9918-3374; Carrascosa, Jose
   M/0000-0002-3574-9076; Mirasierra, Mercedes/0000-0002-0023-8903;
   Vallejo, Mario/0000-0002-6422-0323; Gonzalez-Rodriguez,
   Agueda/0000-0003-2851-2318; Martinez Valverde,
   Angela/0000-0003-1192-9045; Gonzalez-Rodriguez,
   Agueda/0000-0001-6559-0847; Ros, Manuel/0000-0003-2982-513X;
   Fernandez-Perez, Antonio/0000-0001-6866-5824; Kim,
   Jason/0000-0002-7185-042X
FU Ministerio de Ciencia e Innovacion (Spain) [SAF2009-08114,
   BFU2008-04901-C03-02, BFU2008-04901-C03-03, BFU2008-01283]; Comunidad de
   Madrid [S2010/BMD-2423]; Centro de Investigacion Biomedica en Red de
   Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) (Instituto
   Salud Carlos III); UMass Diabetes and Endocrinology Research Center
   [DK32520]; EFSD/Amylin Programme;  [NIH-R01 DK080756];  [ADA
   7-07-RA-80];  [NIH U24-DK093000]
FX This work was supported by grants from Ministerio de Ciencia e
   Innovacion (Spain) SAF2009-08114 and (to A. M. V.), BFU2008-04901-C03-02
   and 03 (to M. R and J.M.C., respectively), BFU2008-01283 (to M. V),
   Comunidad de Madrid S2010/BMD-2423 and Centro de Investigacion Biomedica
   en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)
   (Instituto Salud Carlos III). CBMSO is recipient of institutional aid
   from Ramon Areces Foundation. We also acknowledge grants NIH-R01
   DK080756, ADA 7-07-RA-80, and NIH U24-DK093000 (to J.K.K.) and UMass
   Mouse Phenotyping Center supported by UMass Diabetes and Endocrinology
   Research Center Grant (DK32520) and EFSD/Amylin Programme 2011 grant (to
   A. M. V.). We would like to thank S. Kinicki and L. Li for assisting in
   the clamp study and D. Burks (CIPF, Spain) for critical reading of the
   manuscript and English editing. A.G.-R., A. F.-P and M. M. hold
   postdoctoral contracts from CIBERDEM. No potential conflicts of interest
   relevant to this article were reported.
CR Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047
   Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003
   Amati F, 2009, DIABETES CARE, V32, P1547, DOI 10.2337/dc09-0267
   Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620
   Barbieri M, 2001, DIABETES-METAB RES, V17, P19, DOI 10.1002/dmrr.178
   Benveniste RJ, 1998, DEVELOPMENT, V125, P4757
   Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133
   Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913
   Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544
   Escrivá F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   Gonzalez-Rodriguez A, 2007, ENDOCRINOLOGY, V148, P594, DOI 10.1210/en.2006-0644
   González-Rodríguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796
   González-Rodriguez A, 2009, HEPATOLOGY, V50, P216, DOI 10.1002/hep.22915
   Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200
   Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581
   Kasibhatla B, 2007, CURR OPIN INVEST DR, V8, P805
   Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060
   Kipfer-Coudreau S, 2004, DIABETOLOGIA, V47, P1278, DOI 10.1007/s00125-004-1432-5
   Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000
   Kushner JA, 2004, DIABETES, V53, P61, DOI 10.2337/diabetes.53.1.61
   Lechleitner M, 2008, GERONTOLOGY, V54, P253, DOI 10.1159/000161734
   Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Nieto-Vazquez I, 2007, DIABETES, V56, P404, DOI 10.2337/db06-0989
   Olefsky JM, 2008, CELL, V134, P914, DOI 10.1016/j.cell.2008.09.001
   Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846
   Quinn LS, 2010, EXP GERONTOL, V45, P106, DOI 10.1016/j.exger.2009.10.012
   Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744
   Regazzetti C, 2010, J BIOL CHEM, V285, P5157, DOI 10.1074/jbc.M109.047688
   Ruffolo SC, 2007, J BIOL CHEM, V282, P30423, DOI 10.1074/jbc.M700697200
   Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007
   Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4
   Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260
   Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Valverde AM, 1997, MOL ENDOCRINOL, V11, P595, DOI 10.1210/me.11.5.595
   Valverde AM, 2003, DIABETES, V52, P2239, DOI 10.2337/diabetes.52.9.2239
   Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388
   Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007
   Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200
   Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X
NR 44
TC 72
Z9 79
U1 1
U2 15
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1474-9718
J9 AGING CELL
JI Aging Cell
PD APR
PY 2012
VL 11
IS 2
BP 284
EP 296
DI 10.1111/j.1474-9726.2011.00786.x
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 908WF
UT WOS:000301523000014
PM 22221695
OA Green Submitted, Green Accepted, hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Choo, J
   Heo, G
   Kim, SJ
   Lee, Y
   Ishigami, A
   Maruyama, N
   Chung, HY
   Im, E
AF Choo, Jieun
   Heo, Gwangbeom
   Kim, Su Jin
   Lee, Yunna
   Ishigami, Akihito
   Maruyama, Naoki
   Chung, Hae Young
   Im, Eunok
TI Senescence marker protein 30 protects intestinal epithelial cells
   against inflammation-induced cell death by enhancing Nrf2 activity
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE SMP30; Nrf2; Keap1; Inflammatory bowel disease; Colitis-associated colon
   cancer
ID INCREASED SUSCEPTIBILITY; TRANSCRIPTION FACTOR; COLORECTAL-CANCER;
   ANTIOXIDANT RESPONSE; PROTEASOME ACTIVITY; ULCERATIVE-COLITIS; SIGNALING
   PATHWAY; KNOCKOUT MICE; SMP30; ACTIVATION
AB Senescence marker protein 30 (SMP30) is a calcium-binding protein whose expression decreases during senescence. SMP30 deficiency increases susceptibility to cytokine-induced apoptosis in the liver and to radiation induced apoptosis in the small intestine. Furthermore, colonic epithelial cell death is associated with the severity of colitis. Therefore, in the present study, we investigated the function of SMP30 during intestinal inflammation. In SMP30 deficient mice, colitis was significantly exacerbated as demonstrated by increased mortality (p = 0.001), body weight loss (p = 0.0105 at day 8), rectal bleeding (p = 0.0047 at day 8) and diarrhea (p = 0.0030 at day 8), histological scores (ulcers, p = 0.0002; edema, p = 0.0125; leukocyte infiltration, p = 0.0016) and productions of pro-inflammatory cytokines (IL-1 alpha, p = 0.0452; IL-6, p = 0.0074; G-CSF, p = 0.0036). In addition, greater proportions of apoptotic cells and lower levels of anti-apoptotic marker proteins (total PARP-1 and Bcl-2) were observed in the inflamed intestines of SMP30 deficient mice than in wild type controls. In vitro experiments on colonic epithelial cells showed that stable SMP30 expression inhibited but that SMP30 siRNA expression increased TNF-alpha-induced apoptosis. SMP30 inhibition decreased Nrf2 mRNA expression levels (p < 0.0001), but SMP30 overexpression increased Nrf2 mRNA expression levels (p = 0.0495). The underlying mechanism by which SMP30 protected cells appeared to be by inhibiting Nrf2 ubiquitination and Keap1 expression, and thus enhancing Nrf2 activity. Moreover, SMP30 deficiency increased the incidence of colitis-associated colon cancer as determined by increased mortality (p = 0.0572) and average polyp number (p = 0.0277). Collectively, these findings suggest that SMP30 protects intestinal epithelial cells from apoptosis and this can contribute to amelioration of colitis and colitis-associated colon cancer.
C1 [Choo, Jieun; Heo, Gwangbeom; Kim, Su Jin; Lee, Yunna; Chung, Hae Young; Im, Eunok] Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea.
   [Ishigami, Akihito; Maruyama, Naoki] Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo 1730015, Japan.
C3 Pusan National University; Tokyo Metropolitan Institute of Gerontology
RP Im, E (corresponding author), Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea.
EM eoim@pusan.ac.kr
OI Heo, Gwangbeom/0000-0001-5324-4074
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [2016R1D1A1B03932222]; MSIP
   through NRF [2009-0083538]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education (2016R1D1A1B03932222 to E.I.) and by MSIP (2009-0083538)
   through NRF.
CR Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647
   Ahmed SMU, 2017, BBA-MOL BASIS DIS, V1863, P585, DOI 10.1016/j.bbadis.2016.11.005
   Molodecky Natalie A, 2010, Gastroenterol Hepatol (N Y), V6, P339
   Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9
   Blander JM, 2016, FEBS J, V283, P2720, DOI 10.1111/febs.13771
   Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932
   Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   Choi YJ, 2010, J BIOL CHEM, V285, P37570, DOI 10.1074/jbc.M110.158394
   Choo J, 2015, J BIOL CHEM, V290, P25609, DOI 10.1074/jbc.M115.673046
   De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279
   Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Goo MJ, 2013, INT J MOL SCI, V14, P11084, DOI 10.3390/ijms140611084
   Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6
   Im E, 2010, GASTROENTEROLOGY, V138, P2457, DOI 10.1053/j.gastro.2010.02.055
   Ishigami A, 2005, CELL TISSUE RES, V320, P243, DOI 10.1007/s00441-004-1073-5
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004
   Iwama M, 2011, NUTRITION, V27, P471, DOI 10.1016/j.nut.2010.04.010
   Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113
   Jung KJ, 2015, J MOL MED, V93, P343, DOI 10.1007/s00109-014-1219-1
   Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001
   Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028
   Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562
   Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kruse ML, 2016, INFLAMM BOWEL DIS, V22, P2593, DOI 10.1097/MIB.0000000000000925
   Lakatos PL, 2008, WORLD J GASTROENTERO, V14, P3937, DOI 10.3748/wjg.14.3937
   Lu MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26585
   Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002
   Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161
   Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073
   Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200
   O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384
   Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280
   Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022
   Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902
   Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3
   Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790
   Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211
   Yamaguchi M, 2013, CELL TISSUE RES, V354, P331, DOI 10.1007/s00441-013-1665-z
   Yamaguchi M, 2013, APOPTOSIS, V18, P1145, DOI 10.1007/s10495-013-0859-x
NR 44
TC 6
Z9 6
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD DEC
PY 2018
VL 1864
IS 12
BP 3668
EP 3678
DI 10.1016/j.bbadis.2018.09.031
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA HA0LQ
UT WOS:000449899900011
PM 30266650
DA 2024-02-19
ER

PT J
AU van der Lugt, B
   Rusli, F
   Lute, C
   Lamprakis, A
   Salazar, E
   Boekschoten, MV
   Hooiveld, GJ
   Müller, M
   Vervoort, J
   Kersten, S
   Belzer, C
   Kok, DEG
   Steegenga, WT
AF van der Lugt, Benthe
   Rusli, Fenni
   Lute, Carolien
   Lamprakis, Andreas
   Salazar, Ethel
   Boekschoten, Mark V.
   Hooiveld, Guido J.
   Mueller, Michael
   Vervoort, Jacques
   Kersten, Sander
   Belzer, Clara
   Kok, Dieuwertje E. G.
   Steegenga, Wilma T.
TI Integrative analysis of gut microbiota composition, host colonic gene
   expression and intraluminal metabolites in aging C57BL/6J mice
SO AGING-US
LA English
DT Article
DE aging; gut microbiota; metabolites; colonic gene expression;
   host-microbe interactions
ID EPITHELIAL-MESENCHYMAL TRANSITION; INTESTINAL MICROBIOTA;
   AKKERMANSIA-MUCINIPHILA; COLORECTAL-CANCER; MOUSE MODELS; TGF-BETA;
   BACTERIA; LIVER; AGE; INDIVIDUALS
AB The aging process is associated with diminished colonic health. In this study, we applied an integrative approach to reveal potential interactions between determinants of colonic health in aging C57BL/6J mice. Analysis of gut microbiota composition revealed an enrichment of various potential pathobionts, including Desulfovibrio spp., and a decline of the health-promoting Akkermansia spp. and Lactobacillus spp. during aging. Intraluminal concentrations of various metabolites varied between ages and we found evidence for an increased gut permeability at higher age. Colonic gene expression analysis suggested that during the early phase of aging (between 6 and 12 months), expression of genes involved in epithelial-to-mesenchymal transition and (re) organization of the extracellular matrix were increased. Differential expression of these genes was strongly correlated with Bifidobacterium spp. During the later phase of aging (between 12 and 28 months), gene expression profiles pointed towards a diminished antimicrobial defense and were correlated with an uncultured Gastranaerophilales spp. This study demonstrates that aging is associated with pronounced changes in gut microbiota composition and colonic gene expression. Furthermore, the strong correlations between specific bacterial genera and host gene expression may imply that orchestrated interactions take place in the vicinity of the colonic wall and potentially mediate colonic health during aging.
C1 [van der Lugt, Benthe; Rusli, Fenni; Lute, Carolien; Lamprakis, Andreas; Salazar, Ethel; Boekschoten, Mark V.; Hooiveld, Guido J.; Kersten, Sander; Kok, Dieuwertje E. G.; Steegenga, Wilma T.] Wageningen Univ & Res, Div Human Nutr, NL-6708 WE Wageningen, Netherlands.
   [Mueller, Michael] Univ East Anglia, Norwich Med Sch, Nutrigen & Syst Nutr, Norwich NR4 7UA, Norfolk, England.
   [Vervoort, Jacques] Wageningen Univ & Res, Lab Biochem, NL-6708 WE Wageningen, Netherlands.
   [Belzer, Clara] Wageningen Univ & Res, Lab Microbiol, NL-6708 WE Wageningen, Netherlands.
C3 Wageningen University & Research; University of East Anglia; Wageningen
   University & Research; Wageningen University & Research
RP van der Lugt, B (corresponding author), Wageningen Univ & Res, Div Human Nutr, NL-6708 WE Wageningen, Netherlands.
EM benthe.vanderlugt@wur.nl
RI Hooiveld, Guido JEJ/F-4912-2010; Kersten, Sander/A-1116-2011; Muller,
   Michael/B-5795-2008; Muller, Michael/M-5724-2019; Belzer,
   Clara/P-6500-2018; Boekschoten, Mark/AAS-4597-2021; Kok,
   Dieuwertje/AFS-3371-2022
OI Hooiveld, Guido JEJ/0000-0003-1954-3542; Kersten,
   Sander/0000-0003-4488-7734; Muller, Michael/0000-0002-5930-9905; Muller,
   Michael/0000-0002-5930-9905; Belzer, Clara/0000-0001-6922-836X;
   Boekschoten, Mark/0000-0002-2139-0795; Kok,
   Dieuwertje/0000-0001-7154-8207
FU European Union's Seventh Framework Programme (FP7) IDEAL-aging [259679];
   Netherlands Organization for Scientific Research (NWO) through the
   Graduate Programme on Food Structure, Digestion and Health
FX This work was financially supported by the European Union's Seventh
   Framework Programme (FP7/2007-2011) IDEAL-aging under grant agreement no
   259679 and by the Netherlands Organization for Scientific Research (NWO)
   through the Graduate Programme on Food Structure, Digestion and Health.
CR Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020
   Alexopoulou A, 2017, ANN GASTROENTEROL, V30, P486, DOI 10.20524/aog.2017.0178
   Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016
   Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667
   Biagi E, 2012, AGE, V34, P247, DOI 10.1007/s11357-011-9217-5
   Braak C.J. F. ter., 2012, Canoco reference manual and user's guide: software for ordination
   Buford TW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0296-0
   Carbonero F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00448
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   Clavel T, 2014, GUT MICROBES, V5, P544, DOI 10.4161/gmic.29331
   Conley MN, 2016, PEERJ, V4, DOI 10.7717/peerj.1854
   Derrien M, 2017, MICROB PATHOGENESIS, V106, P171, DOI 10.1016/j.micpath.2016.02.005
   Earley H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135280
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191
   Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15
   Flurkey K, MOUSE BIOMEDICAL RES, P637
   Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005
   González I, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-19
   Han B, 2017, CELL, V169, P1249, DOI 10.1016/j.cell.2017.05.036
   Hippe B, 2011, FEMS MICROBIOL LETT, V316, P130, DOI 10.1111/j.1574-6968.2010.02197.x
   Hofman P, 2012, GUT MICROBES, V3, P176, DOI 10.4161/gmic.20288
   Hugenholtz F, 2018, CELL MOL LIFE SCI, V75, P149, DOI 10.1007/s00018-017-2693-8
   Hutchison N, 2013, BBA-MOL BASIS DIS, V1832, P962, DOI 10.1016/j.bbadis.2012.11.015
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kok DEG, 2018, J NUTR BIOCHEM, V56, P152, DOI 10.1016/j.jnutbio.2018.01.001
   Koks S, 2016, MECH AGEING DEV, V160, P41, DOI 10.1016/j.mad.2016.10.001
   Konturek PC, 2015, J PHYSIOL PHARMACOL, V66, P483
   Krämer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   Kumar Manish, 2016, Nutr Healthy Aging, V4, P3, DOI 10.3233/NHA-150002
   Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758
   Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9
   Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716
   Lepage P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x
   Mira-Pascual L, 2015, J GASTROENTEROL, V50, P167, DOI 10.1007/s00535-014-0963-x
   Morotomi M, 2012, INT J SYST EVOL MICR, V62, P144, DOI 10.1099/ijs.0.026989-0
   Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082
   Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738
   Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5
   Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608
   Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979
   Rusli F, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600677
   Rusli F, 2016, SCI REP-UK, V6, DOI 10.1038/srep30484
   Rusli F, 2015, MOL NUTR FOOD RES, V59, P533, DOI 10.1002/mnfr.201400621
   Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643
   Scott KA, 2017, BRAIN BEHAV IMMUN, V65, P20, DOI 10.1016/j.bbi.2017.02.004
   Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009
   Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974
   Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073
   Steegenga WT, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-38
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y
   Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109
   Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x
   Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5
   Yu H, 2015, NEOPLASMA, V62, P1, DOI 10.4149/neo_2015_002
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
   Zhao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11459
   Zhong L, 2014, WORLD J GASTROENTERO, V20, P7878, DOI 10.3748/wjg.v20.i24.7878
   Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002
NR 67
TC 40
Z9 44
U1 2
U2 27
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD MAY
PY 2018
VL 10
IS 5
BP 930
EP 950
DI 10.18632/aging.101439
PG 21
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GH7EB
UT WOS:000433605000009
PM 29769431
OA Green Submitted, Green Published, Green Accepted, gold
DA 2024-02-19
ER

PT J
AU BERTOLOTTI, M
   ABATE, N
   BERTOLOTTI, S
   LORIA, P
   CONCARI, M
   MESSORA, R
   CARUBBI, F
   PINETTI, A
   CARULLI, N
AF BERTOLOTTI, M
   ABATE, N
   BERTOLOTTI, S
   LORIA, P
   CONCARI, M
   MESSORA, R
   CARUBBI, F
   PINETTI, A
   CARULLI, N
TI EFFECT OF AGING ON CHOLESTEROL 7-ALPHA-HYDROXYLATION IN HUMANS
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE BILE ACID SYNTHESIS; CHOLESTEROL HOMEOSTASIS; PLASMA CHOLESTEROL; PLASMA
   TRIGLYCERIDES; BILE ACID POOL; CHOLESTYRAMINE
ID BILE-ACID METABOLISM; QUANTITATIVE ESTIMATION; URSODEOXYCHOLIC ACID;
   AGE; LIVER; SERUM; RAT; 7ALPHA-HYDROXYLASE; INVIVO
AB In order to investigate the alterations of bile acid synthesis in aging, we studied the rates of cholesterol 7alpha-hydroxylation, the rate-limiting step, in 28 patients of different ages (34-83 years old, 14 below and 14 above the age of 65) of both sexes. Hydroxylation rates were determined by tritium release assay after an intravenous bolus of [7alpha-H-3]cholesterol. Cholesterol 7alpha-hydroxylation was significantly decreased in the older age group, compared to middle-aged subjects, both in males and females; moreover, a significant inverse correlation between hydroxylation rates and age was found in the whole sample (r = -0.56; P < 0.01) and in females, but not in males. The percent concentration of deoxycholic acid in plasma (determined by gas-liquid chromatography) was increased in older subjects. Plasma cholesterol and triglyceride levels were not related with age even though triglyceride concentrations tended to be lower in the older age group. Triglyceride, but not cholesterol levels, were directly correlated with hydroxylation rates (r = 0.45, P < 0.05). After cholestyramine treatment (8-12 g/day for 4 weeks) a sharp increase in 7alpha-hydroxylation rates was observed in three elderly patients, accompanied by reduced levels of dihydroxylated bile acids.  Our data are consistent with a reduced rate of conversion of cholesterol to bile acids with aging, particularly in females, and suggest a coordinate reduction of triglyceride production. Alterations of the quantitative and/or qualitative pattern of the bile acid pool recirculating to the liver may be responsible, at least in part, for the changes observed.
C1 OSPED GIOVANNI 23,DIV GERIATRIA,I-42010 ALBINEA,ITALY.
   UNIV MODENA,IST PATOL MED,I-41100 MODENA,ITALY.
   UNIV MODENA,IST CHIM ORGAN,I-41100 MODENA,ITALY.
C3 Universita di Modena e Reggio Emilia; Universita di Modena e Reggio
   Emilia
RI Bertolotti, Marco/P-6040-2015; Carubbi, Francesca/P-3973-2015
OI Bertolotti, Marco/0000-0001-6908-1820; Carubbi,
   Francesca/0000-0001-7504-6407
CR ABBOTT RD, 1983, ARTERIOSCLEROSIS, V3, P260, DOI 10.1161/01.ATV.3.3.260
   AHLBERG J, 1977, GASTROENTEROLOGY, V73, P1377
   ALI SS, 1970, CAN J BIOCHEM CELL B, V48, P1054, DOI 10.1139/o70-166
   ANGELIN B, 1987, P NATL ACAD SCI USA, V84, P5434, DOI 10.1073/pnas.84.15.5434
   BERTOLOTTI M, 1991, HEPATOLOGY, V14, P830, DOI 10.1002/hep.1840140515
   BERTOLOTTI M, 1986, J LIPID RES, V27, P1278
   BJORKHEM I, 1985, STEROLS BILE ACIDS, P231
   CARULLI N, 1980, J LIPID RES, V21, P35
   COREY EJ, 1959, J AM CHEM SOC, V81, P3127, DOI 10.1021/ja01521a053
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   EINARSSON K, 1973, METABOLISM, V22, P1477, DOI 10.1016/0026-0495(73)90015-2
   ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034
   FRIEDMAN GD, 1966, J CHRON DIS, V19, P273, DOI 10.1016/0021-9681(66)90132-9
   HEISS G, 1980, CIRCULATION, V61, P302, DOI 10.1161/01.CIR.61.2.302
   HEUBI JE, 1983, J CLIN ENDOCR METAB, V57, P885, DOI 10.1210/jcem-57-5-885
   JELINEK DF, 1990, J BIOL CHEM, V265, P8190
   LINDSTEDT S, 1957, ACTA PHYSIOL SCAND, V40, P1, DOI 10.1111/j.1748-1716.1957.tb01473.x
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   MILLER NE, 1984, LANCET, V4, P263
   MYANT NB, 1977, J LIPID RES, V18, P135
   NAGENGAST FM, 1988, DIGEST DIS SCI, V33, P673, DOI 10.1007/BF01540429
   NUBER R, 1990, J LIPID RES, V31, P1517
   PANDAK WM, 1991, J BIOL CHEM, V266, P3416
   REIHNER E, 1989, GASTROENTEROLOGY, V97, P1498, DOI 10.1016/0016-5085(89)90395-8
   SCHOELLER DA, 1989, AM J CLIN NUTR, V50, P1176, DOI 10.1093/ajcn/50.5.1176
   SPADY DK, 1989, J LIPID RES, V30, P559
   STANGE EF, 1984, J LIPID RES, V25, P703
   STREET JM, 1983, J LIPID RES, V24, P491
   TINT GS, 1986, GASTROENTEROLOGY, V91, P1007, DOI 10.1016/0016-5085(86)90708-0
   TURLEY SD, 1988, LIVER BIOL PATHOBIOL, P617
   VALDIVIESO V, 1978, GASTROENTEROLOGY, V74, P871
   VANCANTFORT J, 1975, EUR J BIOCHEM, V55, P23
   VANDERWERF SDJ, 1981, EUR J CLIN INVEST, V11, P425, DOI 10.1111/j.1365-2362.1981.tb02009.x
   VLAHCEVIC ZR, 1991, HEPATOLOGY, V13, P590, DOI 10.1016/0270-9139(91)90317-O
   1984, AM J EPIDEMIOL, V119, P796
NR 35
TC 50
Z9 51
U1 0
U2 3
PU LIPID RESEARCH INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0022-2275
J9 J LIPID RES
JI J. Lipid Res.
PD JUN
PY 1993
VL 34
IS 6
BP 1001
EP 1007
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA LJ205
UT WOS:A1993LJ20500013
PM 8354947
DA 2024-02-19
ER

PT J
AU Hotta, K
   Kitamoto, A
   Kitamoto, T
   Ogawa, Y
   Honda, Y
   Kessoku, T
   Yoneda, M
   Imajo, K
   Tomeno, W
   Saito, S
   Nakajima, A
AF Hotta, Kikuko
   Kitamoto, Aya
   Kitamoto, Takuya
   Ogawa, Yuji
   Honda, Yasushi
   Kessoku, Takaomi
   Yoneda, Masato
   Imajo, Kento
   Tomeno, Wataru
   Saito, Satoru
   Nakajima, Atsushi
TI Identification of differentially methylated region (DMR) networks
   associated with progression of nonalcoholic fatty liver disease
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DNA; STEATOHEPATITIS; PNPLA3; GENES; PARVB; REVEALS; SAMM50
AB The progression of nonalcoholic fatty liver disease (NAFLD) is affected by epigenetics. We performed differentially methylated region (DMR) and co-methylation analyses to identify DMR networks associated with the progression of NAFLD. DMRs displaying differences in multiple consecutive differentially methylated CpGs between mild and advanced NAFLD were extracted. The average values of topological overlap measures for the CpG matrix combining two different DMRs were calculated and two DMR networks that strongly correlated with the stages of fibrosis were identified. The annotated genes of one network included genes involved in transcriptional regulation, cytoskeleton organization, and cellular proliferation. The annotated genes of the second network were primarily associated with metabolic pathways. The CpG methylation levels in these networks were strongly affected by age and fasting plasma glucose levels, which may be important co-regulatory factors. The methylation status of five DMRs in the second network was reversible following weight loss. Our results suggest that CpG methylation in DMR networks is regulated concomitantly via aging and hyperglycemia and plays important roles in hepatic metabolic dysfunction, fibrosis, and potential tumorigenesis, which occur during the progression of NAFLD. By controlling weight and blood glucose levels, the methylation of DMRs in the second network may be reduced.
C1 [Hotta, Kikuko] Osaka Univ Hosp, Dept Med Innovat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
   [Kitamoto, Aya; Kitamoto, Takuya] Hamamatsu Univ Sch Med, Adv Res Facil & Serv, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.
   [Ogawa, Yuji; Honda, Yasushi; Kessoku, Takaomi; Yoneda, Masato; Imajo, Kento; Tomeno, Wataru; Saito, Satoru; Nakajima, Atsushi] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.
   [Tomeno, Wataru] Int Univ Hlth & Welf Atami Hosp, Dept Gastroenterol, 13-1 Higashi Kaigancho, Atami, Shizuoka 4130012, Japan.
C3 Osaka University; Hamamatsu University School of Medicine; Yokohama City
   University; International University of Health & Welfare
RP Hotta, K (corresponding author), Osaka Univ Hosp, Dept Med Innovat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM hottakikuko@dmi.med.osaka-u.ac.jp
RI Imajo, Kento/AAF-5744-2020
OI Imajo, Kento/0000-0002-1931-6326; Hotta, Kikuko/0000-0003-2427-6354;
   Kitamoto, Takuya/0000-0002-4008-5497; Kitamoto, Aya/0000-0002-0223-3874
FU JSPS KAKENHI [16K09781]; Grants-in-Aid for Scientific Research
   [16K09781] Funding Source: KAKEN
FX This work was supported by JSPS KAKENHI (Grant Number 16K09781) to KH.
CR Ackerman SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7122
   Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P645, DOI 10.1038/nrgastro.2013.182
   Bartolini F, 2010, BBA-MOL CELL RES, V1803, P164, DOI 10.1016/j.bbamcr.2009.07.006
   Blom M, 2017, EXP CELL RES, V352, P255, DOI 10.1016/j.yexcr.2017.02.013
   Butcher LM, 2015, METHODS, V72, P21, DOI 10.1016/j.ymeth.2014.10.036
   Chakraborty S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7184
   Charpentier MS, 2013, DEV CELL, V25, P132, DOI 10.1016/j.devcel.2013.03.003
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909
   Farrell GC, 2003, J GASTROEN HEPATOL, V18, P124, DOI 10.1046/j.1440-1746.2003.02989.x
   Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006
   Flack JE, 2017, MOL CELL, V67, P181, DOI 10.1016/j.molcel.2017.06.009
   Hotta K, 2018, HEPATOL RES, V48, pE320, DOI 10.1111/hepr.12992
   Hotta K, 2017, HEPATOL RES, V47, P1445, DOI 10.1111/hepr.12877
   Hotta K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-172
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Kitamoto T, 2015, J HEPATOL, V63, P494, DOI 10.1016/j.jhep.2015.02.049
   Kitamoto T, 2014, J HUM GENET, V59, P241, DOI 10.1038/jhg.2014.17
   Kitamoto T, 2013, HUM GENET, V132, P783, DOI 10.1007/s00439-013-1294-3
   Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Lee JH, 2014, NUTRIENTS, V6, P3303, DOI 10.3390/nu6083303
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
   Meng G, 2010, J BIOL CHEM, V285, P39898, DOI 10.1074/jbc.M110.130781
   Miotto B, 2014, CELL REP, V7, P575, DOI 10.1016/j.celrep.2014.03.030
   Moreno M, 2014, CELL REP, V7, P575
   Morimoto A, 2017, J BIOL CHEM, V292, P10574, DOI 10.1074/jbc.M117.785592
   Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684
   Moylan CA, 2014, HEPATOLOGY, V59, P471, DOI 10.1002/hep.26661
   Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047
   Nilsson E, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0399-2
   Ohki T, 2012, BIOCHEM BIOPH RES CO, V425, P619, DOI 10.1016/j.bbrc.2012.07.134
   Okanoue T, 2011, J GASTROEN HEPATOL, V26, P153, DOI 10.1111/j.1440-1746.2010.06547.x
   Patel SB, 2014, CURR OPIN LIPIDOL, V25, P169, DOI 10.1097/MOL.0000000000000071
   Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6
   Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680
   van Unen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14693
   Vance DE, 2013, BBA-MOL CELL BIOL L, V1831, P626, DOI 10.1016/j.bbalip.2012.07.017
   Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449
NR 45
TC 31
Z9 35
U1 1
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 11
PY 2018
VL 8
AR 13567
DI 10.1038/s41598-018-31886-5
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GT1ZU
UT WOS:000444278400001
PM 30206277
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU MarinGarcia, J
   Ananthakrishnan, R
   Goldenthal, MJ
AF MarinGarcia, J
   Ananthakrishnan, R
   Goldenthal, MJ
TI Mitochondrial gene expression in rat heart and liver during growth and
   development
SO BIOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article
DE mitochondria; gene expression; cardiac growth and development
ID C-OXIDASE SUBUNITS; NUCLEOTIDE-SEQUENCE; SKELETAL-MUSCLE; DNA DELETION;
   NUCLEAR; RNA; COORDINATION; BIOGENESIS; SYNTHASE; TISSUES
AB The levels of mitochondrial enzyme activities involved in respiration and oxidative phosphorylation and of specific mitochondrial gene transcripts were examined in rat heart and liver tissues during early growth, development, and aging. Increases were shown in cardiac respiratory complex activities I, III, IV, and V and ATPase6 and CoxII transcript levels during the transition from neonate to young adult. This increased mitochondrial gene expression is not associated with a proportionate increase in mitochondrial number. In contrast, no significant changes in liver mitochondrial activities or transcripts were detected during this transition. Marked reductions in the activities of complexes I, III, IV, and V and in ATPase6 and COXII transcripts were demonstrated in older adult as compared with young adult cardiac tissue with no concomitant reduction in cardiac citrate synthase activity and content, and mtDNA copy number. No decline was noted in liver mitochondrial enzyme activity levels and transcripts of old adult rats. These findings suggest that cardiac mitochondrial gene expression is developmentally regulated at a pretranslational level. The pattern of increasing mitochondrial gene expression in the young adult and decreasing gene expression in the aging heart stands in clear contrast to liver mitochondrial gene expression or nuclear-encoded genes such as citrate synthase.
RP MarinGarcia, J (corresponding author), MOL CARDIOL INST, 75 RARITAN AVE, HIGHLAND PK, NJ 08904 USA.
CR ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   BARBU V, 1989, NUCLEIC ACIDS RES, V17, P7115, DOI 10.1093/nar/17.17.7115
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CANTATORE P, 1987, FEBS LETT, V213, P144, DOI 10.1016/0014-5793(87)81480-1
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Davis LG., 1986, Basic Methods in Molecular Biology
   EVANS CT, 1988, BIOCHEMISTRY-US, V27, P4680, DOI 10.1021/bi00413a015
   GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   GAGNON J, 1991, MOL CELL BIOCHEM, V107, P21, DOI 10.1007/BF02424572
   GARBOCZI DN, 1988, BIOCHEMISTRY-US, V27, P553, DOI 10.1021/bi00402a008
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   HOOD DA, 1989, EUR J BIOCHEM, V179, P275, DOI 10.1111/j.1432-1033.1989.tb14551.x
   IZQUIERDO JM, 1995, J BIOL CHEM, V270, P10342, DOI 10.1074/jbc.270.17.10342
   KELLY DP, 1989, J BIOL CHEM, V264, P18921
   KENNEDY JM, 1993, J MOL CELL CARDIOL, V25, P117, DOI 10.1006/jmcc.1993.1016
   MARINGARCIA J, 1994, J MOL CELL CARDIOL, V26, P1029, DOI 10.1006/jmcc.1994.1123
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   NAGLEY P, 1991, TRENDS GENET, V7, P1, DOI 10.1016/0168-9525(91)90002-8
   Ostronoff LK, 1995, BIOCHEM BIOPH RES CO, V217, P1094, DOI 10.1006/bbrc.1995.2881
   Ragan C.I., 1987, MITOCHONDRIA PRACTIC, P79
   Srere P.A., 1969, METHOD ENZYMOL, V13, P3, DOI DOI 10.1016/0076-6879(69)13005-0
   TAKASAWA M, 1993, EXP GERONTOL, V28, P269, DOI 10.1016/0531-5565(93)90034-B
   WIESNER RJ, 1994, AM J PHYSIOL, V267, pC229, DOI 10.1152/ajpcell.1994.267.1.C229
   WIESNER RJ, 1992, MOL ENDOCRINOL, V6, P1458, DOI 10.1210/me.6.9.1458
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P376
NR 28
TC 18
Z9 18
U1 0
U2 3
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0829-8211
EI 1208-6002
J9 BIOCHEM CELL BIOL
JI Biochem. Cell Biol.
PY 1997
VL 75
IS 2
BP 137
EP 142
DI 10.1139/bcb-75-2-137
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA XM212
UT WOS:A1997XM21200005
PM 9250361
DA 2024-02-19
ER

PT J
AU Guo, YL
   Hu, S
   Cao, F
   Liu, DB
   Li, F
AF Guo, Yulin
   Hu, Shun
   Cao, Feng
   Liu, Dongbin
   Li, Fei
TI Simultaneous resection of colorectal cancer and synchronous liver
   metastases is safe for properly selected elderly patients: A
   retrospective study
SO JOURNAL OF BUON
LA English
DT Article
DE colorectal cancer; elderly; liver metastases; Synchronous
ID LONG-TERM OUTCOMES; HEPATIC RESECTION; SURGERY; IMPACT; AGE
AB Purpose: The present study was conducted to evaluate the efficacy and safety of simultaneous resection of colorectal cancer (CRC) and synchronous liver metastases (SCRLM) in a group of elderly Chinese patients regarding the population aging in China.
   Methods: From January 1st 2010 to May 1st 2015, 24 out of 32 elderly patients who underwent simultaneous resection of CRC and SCRLM were matched with 24 out of 55 young patients based on the propensity scores. Perioperative results and survival outcomes were compared.
   Results: The demographic and cancer characteristics were comparable between the two groups. The postoperative duration of intensive nursing care in the elderly group was significantly longer than that in the young group [5.00 (4.00-6.75) vs. 6.50 (5.00-9.00) days, p=0.038]. No significant between group difference was observed with respect to time to first defecation, length of postoperative hospital stay, or postoperative complication rate. There was no significant difference with respect to 3-year overall and disease-free survival rates between the two groups.
   Conclusions: Simultaneous resection of CRC and SCRLM was safe and feasible in elderly patients, with reasonable 3-year survival rates. Age per se should not be considered as a contraindication for simultaneous resection of CRC and SCRLM.
C1 [Guo, Yulin; Cao, Feng; Liu, Dongbin; Li, Fei] Capital Med Univ, Dept Gen Surg, Xuanwu Hosp, Beijing 100053, Peoples R China.
   [Guo, Yulin; Hu, Shun; Cao, Feng; Liu, Dongbin; Li, Fei] Capital Med Univ, Natl Clin Res Ctr Geriatr Disorders, Xuanwu Hosp, Beijing 100053, Peoples R China.
   [Hu, Shun] Xiangnan Univ, Sch Publ Hlth, Chenzhou 423000, Hunan, Peoples R China.
C3 Capital Medical University; Capital Medical University; Xiangnan
   University
RP Li, F (corresponding author), Capital Med Univ, Dept Gen Surg, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Disorders, 45 Changchun St, Beijing 100053, Peoples R China.
EM feili36@ccmu.edu.cn
FU National Natural Science Foundation of China [81272756]; Beijing Natural
   Science Foundation [7162076]; Construction Project of Clinical Advanced
   Subjects of Capital Medical Univeristy [1192070312]
FX This study was supported by the National Natural Science Foundation of
   China (grant number 81272756), Beijing Natural Science Foundation (grant
   number 7162076), and Construction Project of Clinical Advanced Subjects
   of Capital Medical Univeristy (grant number 1192070312).
CR Adam R, 2015, CANCER TREAT REV, V41, P729, DOI 10.1016/j.ctrv.2015.06.006
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   de Santibañes E, 2010, WORLD J SURG, V34, P2133, DOI 10.1007/s00268-010-0654-6
   Hirokawa F, 2019, SURG TODAY, V49, P82, DOI 10.1007/s00595-018-1716-x
   Ke SB, 2018, J BUON, V23, P296
   Lee HS, 2014, J NUCL MED, V55, P582, DOI 10.2967/jnumed.113.128629
   Lindskog EB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-948
   Marusch F, 2005, WORLD J SURG, V29, P1013, DOI 10.1007/s00268-005-7711-6
   Nagano Y, 2005, J AM COLL SURGEONS, V201, P511, DOI 10.1016/j.jamcollsurg.2005.05.010
   Sui Kenta, 2019, Surg Technol Int, V34, P208
   Tanaka K, 2004, SURGERY, V136, P650, DOI 10.1016/j.surg.2004.02.012
   Tokuhara K, 2016, INT J SURG, V27, P66, DOI 10.1016/j.ijsu.2016.01.035
   Xu F, 2018, WORLD J CLIN CASES, V6, P716, DOI 10.12998/wjcc.v6.i14.716
   Zeng Y, 2016, J BUON, V21, P1146
   Zeng Y, 2012, CHINA ECON J, V5, P131, DOI 10.1080/17538963.2013.764677
NR 15
TC 0
Z9 0
U1 0
U2 4
PU IMPRIMATUR PUBLICATIONS
PI ATHENS
PA 30 DEM POLIORKETES ST, ATHENS, 136 76, GREECE
SN 1107-0625
EI 2241-6293
J9 J BUON
JI J. BUON
PD SEP-OCT
PY 2020
VL 25
IS 5
BP 2192
EP 2198
PG 7
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA PY4MM
UT WOS:000612020000011
PM 33277835
DA 2024-02-19
ER

PT J
AU Dollé, MET
   Snyder, WK
   Dunson, DB
   Vijg, J
AF Dollé, MET
   Snyder, WK
   Dunson, DB
   Vijg, J
TI Mutational fingerprints of aging
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID SOMATIC MUTATIONS; TRANSGENIC MICE; MISMATCH REPAIR; AGE; SPECTRA;
   CANCER; GENOME
AB Using a lacZ plasmid transgenic mouse model, spectra of spontaneous point mutations were determined in brain, heart, liver, spleen and small intestine in young and old mice. While similar at a young age, the mutation spectra among these organs were significantly different in old age. In brain and heart G:C-->A:T transitions at CpG sites were the predominant mutation, suggesting that oxidative damage is not a major mutagenic event in these tissues. Other base changes, especially those affecting A:T base pairs, positively correlated with increasing proliferative activity of the different tissues. A relatively high percentage of base changes at A:T base pairs and compound mutants were found in both spleen and spontaneous lymphoma, suggesting a possible role of the hypermutation process in splenocytes in carcinogenesis. The similar mutant spectra observed at a young age may reflect a common mutation mechanism for all tissues that could be driven by the rapid cell division that takes place during development. However, the spectra of the young tissues did not resemble that of the most proliferative aged tissue, implying that replicative history per se is not the underlying causal factor of age-related organ-specific differences in mutation spectra. Rather, differences in organ function, possibly in association with replicative history, may explain the divergence in mutation spectra during aging.
C1 Univ Texas, Hlth Sci Ctr, Sam & Ann Barshop Ctr Longev & Aging Studies, San Antonio, TX 78245 USA.
   NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; National Institutes of Health (NIH) - USA; NIH National
   Institute of Environmental Health Sciences (NIEHS)
RP Dollé, MET (corresponding author), Univ Texas, Hlth Sci Ctr, Sam & Ann Barshop Ctr Longev & Aging Studies, 15355 Lambda Dr,STCBM 2-200, San Antonio, TX 78245 USA.
FU NCI NIH HHS [1R01CA75653-03] Funding Source: Medline; NIA NIH HHS
   [1PO1AG17242-01, P30 AG013319, AG13319-05, P01 AG017242] Funding Source:
   Medline
CR Baross-Francis A, 2001, ONCOGENE, V20, P619, DOI 10.1038/sj.onc.1204138
   BOERRIGTER METI, 1995, NATURE, V377, P657, DOI 10.1038/377657a0
   Bult CJ, 2001, NUCLEIC ACIDS RES, V29, P95, DOI 10.1093/nar/29.1.95
   Cariello NF, 1996, NUCLEIC ACIDS RES, V24, P119, DOI 10.1093/nar/24.1.119
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431
   Dollé MET, 1999, ENVIRON MOL MUTAGEN, V34, P112, DOI 10.1002/(SICI)1098-2280(1999)34:2/3&lt;112::AID-EM9&gt;3.0.CO;2-W
   Dollé MET, 1999, MUTAGENESIS, V14, P287, DOI 10.1093/mutage/14.3.287
   Dollé MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403
   Dunson DB, 2000, GENETICS, V156, P1411
   EDWARDS JL, 1961, AM J PATHOL, V38, P437
   Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843
   HINRICHS HR, 1964, ARCH PATHOL, V78, P245
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Lee CM, 1997, FREE RADICAL BIO MED, V22, P1259, DOI 10.1016/S0891-5849(96)00546-1
   Loeb LA, 2001, CANCER RES, V61, P3230
   MACPHEE DG, 1995, CANCER RES, V55, P5489
   Meng QX, 2000, MUTAT RES-GEN TOX EN, V464, P169, DOI 10.1016/S1383-5718(99)00157-6
   Prolla TA, 1998, NAT GENET, V18, P276, DOI 10.1038/ng0398-276
   REID TM, 1994, ENVIRON HEALTH PERSP, V102, P57, DOI 10.2307/3431764
   Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X
   VIJG J, 1999, METHODS AGING RES D, P621
   VIJG J, 2001, HDB BIOL AGING, P84
   Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740
NR 26
TC 64
Z9 78
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 15
PY 2002
VL 30
IS 2
BP 545
EP 549
DI 10.1093/nar/30.2.545
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 516JY
UT WOS:000173551200015
PM 11788717
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Huang, EM
   Ma, T
   Zhou, JY
   Ma, N
   Yang, WS
   Liu, CX
   Hou, ZH
   Chen, S
   de Castria, TB
   Zeng, B
   Zong, Z
   Zhou, TC
AF Huang, Enmin
   Ma, Tao
   Zhou, Junyi
   Ma, Ning
   Yang, Weisheng
   Liu, Chuangxiong
   Hou, Zehui
   Chen, Shuang
   de Castria, Tiago Biachi
   Zeng, Bing
   Zong, Zhen
   Zhou, Taicheng
TI The development and validation of a novel senescence-related long-chain
   non-coding RNA (lncRNA) signature that predicts prognosis and the tumor
   microenvironment of patients with hepatocellular carcinoma
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Article; Early Access
DE Hepatocellular carcinoma (HCC); cellular senescence; long-chain
   non-coding RNA (lncRNA); prognosis; immunotherapy
ID CANCER; CELLS; P53
AB Background: The epigenetic regulators of cellular senescence, especially long non-coding RNAs (lncRNAs), remain unclear. The expression levels of lncRNA were previously known to be prognostic indicators for tumors. We hypothesized that lncRNAs regulating cellular senescence could also predict prognosis in patients with hepatocellular carcinoma (HCC) and developed a novel lncRNA predictive signature.
   Methods: Using RNA sequencing data from The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA-LIHC) database, a co-expression network of senescence-related messenger RNAs (mRNAs) and lncRNAs was constructed. Using univariate Cox regression analysis and a stepwise multiple Cox regression analysis, we constructed a prognostic HCC senescence-related lncRNA signature (HCCSenLncSig). Kaplan-Meier analysis was used to compare the overall survival (OS) of high- and low-risk groups stratified by the HCCSenLncSig. Furthermore, the HCCSenLncSig risk score and other clinical characteristics were included to develop an HCC prognostic nomogram. The accuracy of the model was evaluated by the time dependent receiver operating characteristic (ROC) and calibration curves, respectively.
   Results: We obtained a prognostic risk model consisting of 8 senescence-related lncRNAs: AL117336.3, AC103760.1, FOXD2-AS1, AC009283.1, AC026401.3, AC021491.4, AC124067.4, and RHPNI-AS1. The HCCSenLncSig high-risk group was associated with poor OS [hazard ratio (HR) =1.125, 95% confidence interval (CI): 1.082-1.169; P<0.001]. The accuracy of the model was further supported by ROC curves (the area under the curve is 0.783, sensitivity of 0.600, and specificity of 0.896 at the cut-off value of 1.447). The HCCScnLncSig was found to be an independent prognostic factor from other clinical factors in both univariate and multivariate Cox regression analyses. The prognostic nomogram shows HCCSenLncSig has a good prognostic effect for survival risk stratification. Finally, we found that a higher number of immunosuppressed Treg cells infiltrate in high-risk patients (P<0.001 compared to low-risk patients), possibly explaining why these patients have a poor prognosis. On the other hand, the expression of immunotherapy markers, such as CD276, PDCD1, and CTLA4, was also up-regulated in the high-risk patients, indicating potential immunotherapy response in these patients.
   Conclusions: The development of HCCSenLncSig allows us to better predict HCC patients' survival outcomes and disease risk, as well as contribute to the development of novel HCC anti-cancer therapeutic strategies.
C1 [Huang, Enmin; Ma, Tao; Ma, Ning; Yang, Weisheng; Liu, Chuangxiong; Hou, Zehui; Chen, Shuang; Zeng, Bing; Zhou, Taicheng] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Gastroenterol Surg, Guangzhou, Peoples R China.
   [Huang, Enmin; Ma, Tao; Ma, Ning; Yang, Weisheng; Liu, Chuangxiong; Hou, Zehui; Chen, Shuang; Zeng, Bing; Zhou, Taicheng] Sun Yat Sen Univ, Affiliated Hosp 6, Hernia Ctr, Guangzhou, Peoples R China.
   [Huang, Enmin; Ma, Tao; Zhou, Junyi; Ma, Ning; Yang, Weisheng; Liu, Chuangxiong; Hou, Zehui; Chen, Shuang; Zeng, Bing; Zhou, Taicheng] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou 510655, Peoples R China.
   [Zhou, Junyi] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Gastrointestinal Surg, Guangzhou, Peoples R China.
   [de Castria, Tiago Biachi] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.
   [Zong, Zhen] Nanchang Univ, Affiliated Hosp 2, Dept Gastroenterol Surg, Nanchang 330006, Jiangxi, Peoples R China.
C3 Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University;
   Sun Yat Sen University; Memorial Sloan Kettering Cancer Center; Nanchang
   University
RP Zeng, B; Zhou, TC (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou 510655, Peoples R China.; Zong, Z (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Gastroenterol Surg, Nanchang 330006, Jiangxi, Peoples R China.; Zeng, B; Zhou, TC (corresponding author), Sun Yat Sen Univ, Dept Gastroenterol Surg, Guangzhou 510655, Peoples R China.; Zeng, B; Zhou, TC (corresponding author), Sun Yat Sen Univ, Hernia Ctr, Guangzhou 510655, Peoples R China.
EM zengbing3@mail.sysu.edu.cn; zongzhenmd@126.com;
   zhoutch3@mail.sysu.edu.cn
RI zehui, hou/ABD-7065-2020; Liu, Zhiyu/JNR-8043-2023; Biachi de Castria,
   Tiago/AEQ-1042-2022
OI Liu, Zhiyu/0000-0001-8351-1268; Biachi de Castria,
   Tiago/0000-0001-6832-2485
FU National Key Clinical Discipline, the Basic and Applied Basic Research
   Fund Project of Guangdong Province [2021A1515410004]
FX This work was supported by National Key Clinical Discipline, the Basic
   and Applied Basic Research Fund Project of Guangdong Province (No.
   2021A1515410004 to TCZ).
CR Abou-Alfa GK, 2022, J CLIN ONCOL, V40, DOI 10.1200/JCO.2022.40.4_suppl.379
   Avelar RA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01990-9
   Bai Z, 2020, MEDICINE, V99
   Baj J, 2022, CANCERS, V14, DOI 10.3390/cancers14061493
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Birch J, 2020, GENE DEV, V34, P1565, DOI 10.1101/gad.343129.120
   Casella G, 2019, NUCLEIC ACIDS RES, V47, P7294, DOI 10.1093/nar/gkz555
   Chan TA, 2019, ANN ONCOL, V30, P44, DOI 10.1093/annonc/mdy495
   Chen W, 2021, J GASTROINTEST ONCOL, V12, P2985, DOI 10.21037/jgo-21-664
   Cheng Min, 2022, Yichuan, V44, P153, DOI 10.16288/j.yczz.21-416
   Cui Y, 2019, WORLD J GASTROENTERO, V25, P1890, DOI 10.3748/wjg.v25.i15.1890
   De Blander H, 2021, CANCERS, V13, DOI 10.3390/cancers13184561
   Deng BY, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020422
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   ELKHOUEIRY AB, 2018, J CLIN ONCOL, V36
   Fane M, 2020, NAT REV CANCER, V20, P89, DOI 10.1038/s41568-019-0222-9
   Feng YJ, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6640652
   Ferlay J, 2018, Cancer incidence in five continents, CI5plus: IARC CancerBase no. 9
   Fisher DT, 2014, SEMIN IMMUNOL, V26, P38, DOI 10.1016/j.smim.2014.01.008
   Georgakilas AG, 2017, TRENDS MOL MED, V23, P310, DOI 10.1016/j.molmed.2017.02.001
   Giraud J, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.655697
   Guo YG, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00576-z
   Hanahan D, 2022, CANCER DISCOV, V12, P31, DOI 10.1158/2159-8290.CD-21-1059
   Hu W, 2020, CANCER MED-US, V9, P5620, DOI 10.1002/cam4.3204
   Huang Z, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01188-4
   Hwang HJ, 2020, CANCER LETT, V490, P100, DOI 10.1016/j.canlet.2020.06.019
   Jafari-Oliayi A, 2019, CELL ONCOL, V42, P211, DOI 10.1007/s13402-019-00422-6
   Jemal A, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx030
   Jia Y, 2020, J CELL MOL MED, V24, P5304, DOI 10.1111/jcmm.15186
   Jia Y, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.608668
   Zhang JS, 2022, J GASTROINTEST ONCOL, V13, P298, DOI 10.21037/jgo-21-450
   Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1
   Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028
   Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015
   Kowald A, 2020, AGING CELL, V19, DOI 10.1111/acel.13270
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kugel CH, 2018, CLIN CANCER RES, V24, P5347, DOI 10.1158/1078-0432.CCR-18-1116
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Li XL, 2017, CELL REP, V20, P2408, DOI 10.1016/j.celrep.2017.08.041
   Lian JY, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00986-z
   Mang W, 2020, N-S ARCH PHARMACOL, V393, P2543, DOI 10.1007/s00210-020-01889-z
   Mayakonda A, 2018, GENOME RES, V28, P1747, DOI 10.1101/gr.239244.118
   Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025
   Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]
   Padron A, 2018, EXP GERONTOL, V105, P146, DOI 10.1016/j.exger.2017.12.025
   Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033
   Sangro B, 2013, J HEPATOL, V59, P81, DOI 10.1016/j.jhep.2013.02.022
   Shen SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38311
   Si LH, 2020, MENOPAUSE, V27, P1302, DOI 10.1097/GME.0000000000001655
   Tang PF, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.785185
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wang BS, 2020, TRENDS CANCER, V6, P838, DOI 10.1016/j.trecan.2020.05.004
   Wang DN, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01346-y
   Xiang XH, 2021, THERANOSTICS, V11, P4929, DOI 10.7150/thno.55672
   Zhang FJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08405-z
   Zhang GX, 2012, DIS MARKERS, V32, P265, DOI [10.1155/2012/964036, 10.3233/DMA-2011-0878]
   Zhao LJ, 2019, AGING-US, V11, P7098, DOI 10.18632/aging.102240
   Zhao XN, 2020, BIOMED RES INT-UK, V2020, DOI 10.1155/2020/8765461
   Zhu YM, 2021, THERANOSTICS, V11, P181, DOI 10.7150/thno.48206
   Zuo XL, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-019-0839-x
NR 62
TC 4
Z9 4
U1 3
U2 11
PU AME PUBLISHING COMPANY
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD 2022 JUL
PY 2022
VL 10
IS 14
AR 766
DI 10.21037/atm-22-3348
EA JUL 2022
PG 21
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA 5E1SI
UT WOS:000830782700001
PM 35965795
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Qamar, SH
   Zeng, QF
   Ding, XM
   Bai, SP
   Wang, JP
   Xuan, Y
   Zhou, QS
   Su, ZW
   Zhang, KY
AF Qamar, Sajid Hussain
   Zeng, Qiufeng
   Ding, Xuemei
   Bai, Shiping
   Wang, Jianping
   Xuan, Yue
   Zhou, Qiaoshun
   Su, Zhuowei
   Zhang, Keying
TI Effect of Oil Supplementation on Growth Performance, Meat Quality and
   Antioxidative Ability in Meat Ducks Fed a Diet Containing Aging Corn
SO INTERNATIONAL JOURNAL OF AGRICULTURE AND BIOLOGY
LA English
DT Article
DE Aging corn; Antioxidative ability; Duck; Oil; Liver; Meat quality
ID STORAGE; EXPRESSION; ENZYMES; ENERGY
AB This study investigated the effect of dietary aging corn with or without supplementation of soybean oil on performance, meat quality and antioxidative ability in meat ducks. A total of 768, one day old ducks were allotted randomly into 6 treatments with 8 replicates per treatment for 35 days as follow: T1 (0% aging corn and 0% oil), T2 (0% aging corn and 3% oil), T3 (50% aging corn and 0% oil), T4 (50% aging corn and 3% oil), T5 (100% aging corn and 0% oil), T6 (100% aging corn and 3% oil). Results showed that 50% aging corn or addition of 3% soybean oil did not affect on duck growth performance. Although 100% aging corn significantly (P < 0.05) decreased feed intake (FI) from 15 to 35 d. However, the oil addition in 100% aging corn diet increased FI during 15 to 35 d, FCR at 15 to 35 d and 1 to 35 d. In contrast, the oil addition in non-aging corn diet increased feed conversion ratio (FCR) significantly (P < 0.05) during 1 to 14 d, while significantly (P < 0.05) decreased from 15 to 35 d and 1 to 35 d. Aging corn levels with 50% and 100% resulted in breast meat color change with decreased of b* value at 35 d. Addition of oil in 100% aging corn significantly reduced the breast meat pH, a*, and b* value and skin L* value at 35 d. The aging corn and oil addition resulted in change of antioxidative enzymes e.g., CAT, SOD, TAOC and the level of MDA, may relate to the aging corn%, duck age, and the interaction of aging corn and oil. In conclusion, the aging corn reduced FI with 100% aging corn from 15-35d ,while decrease the breast meat and skin color b* value with 50% and 100% aging corn, it could be associated to the oxidative stress by aging corn. The oil addition perhaps increases the effects of aging corn on meat and skin color. (C) 2019 Friends Science Publishers
C1 [Qamar, Sajid Hussain; Zeng, Qiufeng; Ding, Xuemei; Bai, Shiping; Wang, Jianping; Xuan, Yue; Zhou, Qiaoshun; Su, Zhuowei; Zhang, Keying] Sichuan Agr Univ, Minist Educ, Key Lab Anim Dis Resistance Nutr China, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China.
C3 Sichuan Agricultural University
RP Zhang, KY (corresponding author), Sichuan Agr Univ, Minist Educ, Key Lab Anim Dis Resistance Nutr China, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China.
EM zkeying@sicau.edu.cn
RI zhang, ke/AAH-8217-2019; Ding, Xuemei/B-6619-2013
OI Ding, Xuemei/0000-0002-1830-1990
FU China Agriculture Research System [CARS-42-10]
FX This work was supported by China Agriculture Research System
   (CARS-42-10).
CR Ammouche A, 2002, ANN NUTR METAB, V46, P268, DOI 10.1159/000066496
   Anastassiades M, 2003, J AOAC INT, V86, P412
   Atapattu N. S. B. M., 2015, Journal of Agricultural Sciences (Sri Lanka), V10, P151, DOI 10.4038/jas.v10i3.8068
   Awada M., 2012, J LIPID RES, V2012, P1
   Baião NC, 2005, Rev. Bras. Cienc. Avic., V7, P129, DOI 10.1590/S1516-635X2005000300001
   Bailly C, 2002, SEED SCI RES, V12, P47, DOI 10.1079/SSR200197
   Barbour GW, 2006, J APPL POULTRY RES, V15, P190, DOI 10.1093/japr/15.2.190
   BUCK DF, 1981, J AM OIL CHEM SOC, V58, P275, DOI 10.1007/BF02582356
   Choct M., 2000, NEW SEASON GRAIN PHE, P1
   CHRASTIL J, 1990, J AGR FOOD CHEM, V38, P1804, DOI 10.1021/jf00099a005
   DHALIWAL YS, 1991, CEREAL CHEM, V68, P18
   Farhoosh R, 2009, FOOD CHEM, V115, P933, DOI 10.1016/j.foodchem.2009.01.035
   Fu CY, 2018, INT J AGRIC BIOL, V20, P1677, DOI 10.17957/IJAB/15.0706
   GALLIARD T, 1986, J CEREAL SCI, V4, P179, DOI 10.1016/S0733-5210(86)80020-0
   Hosseini-Vashan SJ, 2010, J ANIM VET ADV, V9, P2565
   Ivanovich FV, 2017, ANIM NUTR, V3, P258, DOI 10.1016/j.aninu.2017.06.005
   Koch A, 2007, J NUTR, V137, P2018, DOI 10.1093/jn/137.9.2018
   LIN CF, 1989, BRIT POULTRY SCI, V30, P855, DOI 10.1080/00071668908417212
   Liu Biyi, 2013, Chinese Journal of Animal Nutrition, V25, P1077
   Lü JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x
   McDonough CM, 2004, J CEREAL SCI, V39, P351, DOI 10.1016/j.jcs.2004.01.001
   MCFARLANE JM, 1989, POULTRY SCI, V68, P501, DOI 10.3382/ps.0680501
   MOH and SAC, 2012, 287162012 MOH SAC GB
   MOH and SAC, 2016, 50091682016 MOH SAC
   MOH and SAC, 2015, 205702015 MOH SAC GB
   MOH and SAC, 2014, 309552014 MOH SAC GB
   MOH and SAC, 2005, 15712005 MOH SAC SNT
   Pi ZK, 2005, SMALL RUMINANT RES, V56, P81, DOI 10.1016/j.smallrumres.2004.02.010
   Saeed M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020462
   Sahito HA, 2012, GLOB ADV RES J CHEM, V1, P23
   Salman H, 2007, CEREAL CHEM, V84, P600, DOI 10.1094/CCHEM-84-6-0600
   Swatland HJ, 2008, MEAT SCI, V80, P396, DOI 10.1016/j.meatsci.2008.01.002
   USDA, 2017, WORLD CORN PROD COUN
   Yin DF, 2017, ANIM NUTR, V3, P252, DOI 10.1016/j.aninu.2017.04.007
   Zhang T, 2015, LIVEST SCI, V180, P143, DOI 10.1016/j.livsci.2015.05.037
   Zhang WG, 2011, J AGR FOOD CHEM, V59, P969, DOI 10.1021/jf102918z
   Zhang Y. R., 2008, SCI AGR SIN, V10, P72
   Zhang YaRu, 2015, Chinese Journal of Animal Nutrition, V27, P1184
   Zhou X. Q., 2007, J MAIZE SCI, V3, P20
   Zia-Ur-Rehman, 2006, FOOD CHEM, V95, P53, DOI 10.1016/j.foodchem.2004.12.017
NR 40
TC 8
Z9 8
U1 1
U2 14
PU FRIENDS SCIENCE PUBL
PI FAISALABAD
PA 399-B, PEOPLES COLONY NO 1, FAISALABAD, 38090, PAKISTAN
SN 1560-8530
EI 1814-9596
J9 INT J AGRIC BIOL
JI Int. J. Agric. Biol.
PY 2019
VL 21
IS 1
BP 201
EP 208
DI 10.17957/IJAB/15.0882
PG 8
WC Agriculture, Multidisciplinary; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Life Sciences & Biomedicine - Other Topics
GA HG0AY
UT WOS:000454605700030
DA 2024-02-19
ER

PT J
AU VIDAL, H
   AUBOEUF, D
   BEYLOT, M
   RIOU, JP
AF VIDAL, H
   AUBOEUF, D
   BEYLOT, M
   RIOU, JP
TI REGULATION OF INSULIN-RECEPTOR MESSENGER-RNA SPLICING IN RAT-TISSUES -
   EFFECT OF FASTING, AGING, AND DIABETES
SO DIABETES
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; MESSENGER-RNA; SKELETAL-MUSCLE; 2 ISOFORMS;
   EXPRESSION; BINDING; VARIANTS; MELLITUS; GENE; CELLS
AB Recent findings suggested that alterations in insulin receptor isoform expression might be involved in the molecular mechanism of insulin resistance. Using reverse transcription reaction followed by competitive polymerase chain reaction, we measured the level of the receptor mRNA variants in rat insulin-sensitive tissues, under conditions of decreased insulin effectiveness (fasting, aging, and diabetes). The liver expressed the mRNA variant with exon II predominantly, and the hind limb skeletal muscles expressed the mRNA without exon II. The heart and epididymal adipose tissue expressed both variants. Fasting and streptozocin-induced diabetes increased the level of receptor mRNAs in the liver but did not modify the repartition between the two variants, The modification of the expression ratio, in favor of the form with exon 11, found by some authors in the skeletal muscle of insulin-resistant patients was not observed in rat muscles that expressed >99% of the form without exon 11 under all the conditions tested, In adipose tissue, the proportion of both mRNA variants was never altered (45% of exon 11-positive [Ex11(+)]), while the total receptor mRNA concentration changed markedly during fasting or aging, The only modification observed in the isoform distribution was a significant decrease in Ex11(+) mRNA concentration in the liver, muscle, and heart of old rats, We conclude that alternative splicing of insulin receptor mRNA is not involved in the impairment of insulin action during fasting or diabetes, Its potential role in the insulin resistance of old animals remains to be defined.
RP VIDAL, H (corresponding author), FAC MED ALEXIS CARREL,INSERM,U197,RUE G PARADIN,F-69373 LYON 08,FRANCE.
RI Vidal, Hubert/M-6674-2017; Auboeuf, Didier/M-4610-2014
OI Vidal, Hubert/0000-0002-9467-0317; Auboeuf, Didier/0000-0002-3757-0002
CR ANDERSON CM, 1993, J CLIN ENDOCR METAB, V76, P1380, DOI 10.1210/jc.76.5.1380
   BALAGE M, 1990, METABOLISM, V39, P366, DOI 10.1016/0026-0495(90)90250-G
   BENECKE H, 1992, J CLIN INVEST, V89, P2066, DOI 10.1172/JCI115819
   BOUABOULA M, 1992, J BIOL CHEM, V267, P21830
   BURANT CF, 1986, J CLIN INVEST, V77, P260, DOI 10.1172/JCI112285
   COTTREZ F, 1994, NUCLEIC ACIDS RES, V22, P2712, DOI 10.1093/nar/22.13.2712
   DARDEVET D, 1994, ENDOCRINOLOGY, V134, P1475, DOI 10.1210/en.134.3.1475
   DAVIDSON MB, 1977, J CLIN INVEST, V59, P22, DOI 10.1172/JCI108618
   GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725
   GOLDSTEIN BJ, 1990, MOL ENDOCRINOL, V4, P235, DOI 10.1210/mend-4-2-235
   GOLDSTEIN BJ, 1987, MOL ENDOCRINOL, V1, P759, DOI 10.1210/mend-1-11-759
   HANSEN T, 1993, J CLIN ENDOCR METAB, V77, P1500, DOI 10.1210/jc.77.6.1500
   HUANG Z, 1994, J CLIN INVEST, V94, P1289, DOI 10.1172/JCI117447
   KASUGA M, 1981, P NATL ACAD SCI-BIOL, V78, P6917, DOI 10.1073/pnas.78.11.6917
   KELLERER M, 1992, BIOCHEMISTRY-US, V13, P4588
   KIM YB, 1994, BIOCHEM BIOPH RES CO, V202, P519, DOI 10.1006/bbrc.1994.1959
   KOSAKI A, 1993, J BIOL CHEM, V268, P21990
   LEMARCHANDBRUST.Y, 1979, J CLIN INVEST, V64, P1505
   LUDWIG S, 1988, ENDOCRINOLOGY, V123, P594, DOI 10.1210/endo-123-1-594
   MCCLAIN DA, 1991, MOL ENDOCRINOL, V5, P734, DOI 10.1210/mend-5-5-734
   MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263
   MOSTHAF L, 1993, P NATL ACAD SCI USA, V90, P2633, DOI 10.1073/pnas.90.7.2633
   MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x
   MOSTHAF L, 1991, P NATL ACAD SCI USA, V88, P4728, DOI 10.1073/pnas.88.11.4728
   NADIV O, 1992, ENDOCRINOLOGY, V130, P1515, DOI 10.1210/en.130.3.1515
   NORGREN S, 1994, P NATL ACAD SCI USA, V91, P1465, DOI 10.1073/pnas.91.4.1465
   NORGREN S, 1994, J CLIN ENDOCR METAB, V78, P757, DOI 10.1210/jc.78.3.757
   NORGREN S, 1993, DIABETES, V42, P675, DOI 10.2337/diabetes.42.5.675
   NORGREN S, 1994, BIOCHEM BIOPH RES CO, V199, P277, DOI 10.1006/bbrc.1994.1225
   OLEFSKY JM, 1975, ENDOCRINOLOGY, V96, P1486, DOI 10.1210/endo-96-6-1486
   POSNER BI, 1974, ENDOCRINOLOGY, V95, P521, DOI 10.1210/endo-95-2-521
   ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814
   Sambrook J., 1989, MOL CLONING LABORATO, V2nd
   SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X
   SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114
   TOZZO E, 1992, DIABETES, V41, P1609, DOI 10.2337/diabetes.41.12.1609
   WHITE MF, 1994, J BIOL CHEM, V269, P1
   YAMAGUCHI Y, 1991, ENDOCRINOLOGY, V129, P2058, DOI 10.1210/endo-129-4-2058
   YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132
NR 39
TC 29
Z9 30
U1 0
U2 2
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1660 DUKE ST, ALEXANDRIA, VA 22314
SN 0012-1797
J9 DIABETES
JI Diabetes
PD OCT
PY 1995
VL 44
IS 10
BP 1196
EP 1201
DI 10.2337/diabetes.44.10.1196
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA TD624
UT WOS:A1995TD62400010
PM 7556957
DA 2024-02-19
ER

PT J
AU Yang, L
   Zhang, Y
   Wang, SS
   Zhang, W
   Shi, RL
AF Yang, Lei
   Zhang, Yu
   Wang, Shasha
   Zhang, Wei
   Shi, Ruling
TI Decreased liver peroxisomal β-oxidation accompanied by changes in brain
   fatty acid composition in aged rats
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE Brain aging; Very long chain fatty acids; Peroxisome; Fatty acid
   beta-oxidation; Acyl-CoA oxidase 1
ID ALZHEIMERS-DISEASE; DOCOSAHEXAENOIC ACID; FRONTAL-CORTEX; LIPID RAFTS;
   PPAR-ALPHA; HIPPOCAMPUS; METABOLISM; MICE
AB Peroxisomal beta-oxidation is primarily responsible for the degradation of very long chain fatty acids (VLCFAs), dicarboxylic acids, unsaturated fatty acids and branched fatty acids. The genes encoding beta-oxidation enzymes are transcriptionally regulated by peroxisome proliferator-activated receptor alpha (PPAR alpha). Age-related decreases in acyl-CoA oxidase 1 (ACOX1) activity, a key enzyme involved in peroxisomal beta-oxidation, have been found in aged rodents. To determine whether decreased peroxisomal beta-oxidation with aging affects brain fatty acid composition, 22-month-old (old) and 3-month-old (young) male Sprague-Dawley rats were used. We confirmed the decreased expression of liver ACOX1 and PPAR alpha in old rats. In addition, a gas chromatography assay showed significant changes in the percentage of fatty acids in the cerebral cortices between old and young rats. In the cerebral cortices of old rats, the increased fatty acids included VLCFAs (C20:0, C22:0, C24:0) and monounsaturated fatty acids (C16:1, C18:1, C20:1, C22:1, C24:1), whereas the decreased fatty acids included C18:0, C20:4 and C22:6. These results indicated that decreased liver peroxisomal beta-oxidation was accompanied by changes in brain fatty acid composition with aging and suggested that peroxisomal beta-oxidation dysfunction may play a potential role in the progression of brain aging.
C1 [Yang, Lei] Xinxiang Med Univ, Sch Nursing, Xinxiang, Peoples R China.
   [Zhang, Yu; Wang, Shasha; Zhang, Wei; Shi, Ruling] Xinxiang Med Univ, Dept Biochem & Mol Biol, Xinxiang 453003, Peoples R China.
C3 Xinxiang Medical University; Xinxiang Medical University
RP Shi, RL (corresponding author), Xinxiang Med Univ, Dept Biochem & Mol Biol, 601 Jinsui Ave, Xinxiang 453003, Peoples R China.
EM shrl1970@163.com
FU University Young Backbone Teacher Program of Henan Province
   [2010GGJS-121]; Key Area Research Project of Xinxiang Medical University
   [ZD2011-1]
FX This work was supported by the University Young Backbone Teacher Program
   of Henan Province (No. 2010GGJS-121) and Key Area Research Project of
   Xinxiang Medical University (No. ZD2011-1). We would like to thank
   Professor Ge Gao at the Gas Chromatographic Analysis and Test Center of
   Xinxiang Medical University for his scientific advice and technical
   assistance.
CR ALEXSON SEH, 1984, BIOCHIM BIOPHYS ACTA, V796, P1, DOI 10.1016/0005-2760(84)90231-5
   Bourre JM, 1997, BIOCHEM MOL BIOL INT, V41, P461
   Carver JD, 2001, BRAIN RES BULL, V56, P79, DOI 10.1016/S0361-9230(01)00551-2
   Cunnane SC, 2013, PROSTAG LEUKOTR ESS, V88, P61, DOI 10.1016/j.plefa.2012.04.006
   Cunnane SC, 2012, J ALZHEIMERS DIS, V29, P691, DOI 10.3233/JAD-2012-110629
   Fabelo N, 2011, MOL MED, V17, P1107, DOI 10.2119/molmed.2011.00119
   Fanelli F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-8
   Favrelière S, 2000, NEUROBIOL AGING, V21, P653, DOI 10.1016/S0197-4580(00)00170-6
   Ferdinandusse S, 2001, J LIPID RES, V42, P1987
   Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5
   Giusto NM, 2002, NEUROCHEM RES, V27, P1513, DOI 10.1023/A:1021604623208
   Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011
   Kou JQ, 2011, ACTA NEUROPATHOL, V122, P271, DOI 10.1007/s00401-011-0836-9
   Latruffe N, 2000, BIOCHEM PHARMACOL, V60, P1027, DOI 10.1016/S0006-2952(00)00416-0
   Martín V, 2010, J ALZHEIMERS DIS, V19, P489, DOI 10.3233/JAD-2010-1242
   Perichon R, 1996, MECH AGEING DEV, V87, P115, DOI 10.1016/0047-6374(96)01705-8
   PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7
   Sanguino E, 2005, BRIT J PHARMACOL, V145, P853, DOI 10.1038/sj.bjp.0706260
   Shi RL, 2012, NEUROSCI LETT, V528, P6, DOI 10.1016/j.neulet.2012.08.086
   Ulmann L, 2001, PROSTAG LEUKOTR ESS, V64, P189, DOI 10.1054/plef.2001.0260
   Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959
   Yetimler B, 2012, PHARMACOL BIOCHEM BE, V103, P53, DOI 10.1016/j.pbb.2012.07.009
NR 22
TC 14
Z9 16
U1 4
U2 15
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD FEB
PY 2014
VL 35
IS 2
BP 289
EP 293
DI 10.1007/s10072-013-1509-3
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AA3GE
UT WOS:000330980100021
PM 23892932
DA 2024-02-19
ER

PT J
AU Liu, BH
   Ma, RD
   Zhang, J
   Sun, P
   Yi, RK
   Zhao, X
AF Liu, Bihui
   Ma, Ruidong
   Zhang, Jing
   Sun, Peng
   Yi, Ruokun
   Zhao, Xin
TI Preventive Effect of Small-Leaved Kuding Tea (<i>Ligustrum robustum</i>
   (Roxb.) Bl.) Polyphenols on D-Galactose-Induced Oxidative Stress and
   Aging in Mice
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
AB Small-leaved Kuding tea is a traditional Chinese tea that is rich in polyphenols. In the current study, we investigated the preventive effect of small-leaved Kuding tea (SLKDT) on D-galactose-induced oxidative aging in mice. Changes in serum, skin, liver, and spleen of experimental animals were determined using biochemical and molecular biology techniques. Biochemical analysis demonstrated that polyphenol extract of SLKDT (PSLKDT) improved the indices of the thymus, brain, heart, liver, spleen, and kidney function in model mice. PSLKDT prevented a decrease in the levels of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and glutathione (GSH) as well as an increase in nitric oxide (NO) and malondialdehyde (MDA) levels in serum, liver, and spleen. Pathological assessment also showed that PSLKDT reduced oxidative damage induced by D-galactose in skin, liver, and spleen. We further found that PSLKDT upregulated neuronal nitric oxide synthase (nNOS), endothelial nitric oxide synthase (eNOS), Cu/Zn-SOD, Mn-SOD, catalase (CAT), heme oxygenase-1 (HO-1), nuclear factor (nuclear factor-erythroid 2 related factor 2 (Nrf2), -glutamylcysteine synthetase (-GCS), and NAD(P)H dehydrogenase [quinone] 1 (NQO1) mRNA expression and downregulated inducible nitric oxide synthase (iNOS) mRNA expression. Protein levels of SOD1 (Cu/Zn-SOD), SOD2 (Mn-SOD), CAT, GSH1 (-glutamate-cysteine ligase), and GSH2 (glutathione synthetase) in the liver and spleen were also increased by PSLKDT treatment. Collectively, these results indicate that PSLKDT is effective in preventing D-galactose-induced oxidative aging in mice, and its efficacy is significantly higher than antioxidant vitamin C. Because PSLKDT is a potent antioxidant and antiaging polyphenol, Kuding tea rich in PSLKDT should be considered an ideal drink with antioxidative and antiaging effects.
C1 [Liu, Bihui; Sun, Peng; Yi, Ruokun; Zhao, Xin] Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.
   [Liu, Bihui; Sun, Peng; Yi, Ruokun; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing 400067, Peoples R China.
   [Liu, Bihui; Sun, Peng; Yi, Ruokun; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Lab Res & Dev Funct Food, Chongqing 400067, Peoples R China.
   [Liu, Bihui; Sun, Peng] Chongqing Univ Educ, Coll Biol & Chem Engn, Chongqing 400067, Peoples R China.
   [Ma, Ruidong] Chengdu Med Coll, Affiliated Hosp 1, Dept Cardiothorac Surg, Chengdu 610500, Sichuan, Peoples R China.
   [Zhang, Jing] Chongqing Chem Ind Vocat Coll, Environm & Qual Inspect Coll, Chongqing 401228, Peoples R China.
C3 Chongqing University of Education; Chongqing University of Education;
   Chongqing University of Education; Chongqing University of Education;
   Chengdu Medical College
RP Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing 400067, Peoples R China.; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Engn Lab Res & Dev Funct Food, Chongqing 400067, Peoples R China.
EM zhaoxin@cque.edu.cn
FU Program for Innovation Team Building at Institutions of Higher Education
   in Chongqing [CXTDX201601040]; Introduction of High-level Personnel
   Research Start-Up Fund of Chongqing University of Education
   [2013BSRC001]; Scientific Research Foundation for Returned Overseas
   Chinese Scholars; State Education Ministry, China [1685]
FX This study was supported by the Program for Innovation Team Building at
   Institutions of Higher Education in Chongqing [CXTDX201601040], the
   Introduction of High-level Personnel Research Start-Up Fund of Chongqing
   University of Education [2013BSRC001], and the Scientific Research
   Foundation for Returned Overseas Chinese Scholars and the State
   Education Ministry [Jiaowaisiliu (2014) 1685], China.
CR Bao Y.F., 2018, NAT PROD RES DEV, V10, P1825, DOI [10.16333/j.1001-6880.2018.10.028, DOI 10.16333/J.1001-6880.2018.10.028]
   Berndt C, 2017, ANTIOXID REDOX SIGN, V27, P1235, DOI 10.1089/ars.2017.7132
   Bonthius DJ, 2015, NEUROTOXICOLOGY, V46, P60, DOI 10.1016/j.neuro.2014.11.009
   Bouayed J, 2007, J NEUROL SCI, V262, P77, DOI 10.1016/j.jns.2007.06.028
   Buford TW, 2016, AGEING RES REV, V26, P96, DOI 10.1016/j.arr.2016.01.007
   Carluccio MA, 2003, ARTERIOSCL THROM VAS, V23, P622, DOI 10.1161/01.ATV.0000062884.69432.A0
   Chard S, 2017, J GERONTOL B-PSYCHOL, V72, P319, DOI 10.1093/geronb/gbw119
   Che YY, 2016, MOLECULES, V21, DOI 10.3390/molecules21121728
   Delwing-Dal Magro D, 2016, BIOMED PHARMACOTHER, V83, P1422, DOI 10.1016/j.biopha.2016.08.057
   Fukai T., 2000, J CLIN INVEST, V105, P631
   Hohensinner PJ, 2018, OBES SURG, V28, P2804, DOI 10.1007/s11695-018-3247-3
   Hong C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10443-6
   HOSEN M, 2002, INT J REPROD BIOMED, V13, P525
   [侯彩平 Hou Caiping], 2017, [食品工业科技, Science & Technology of Food Industry], V38, P72
   Iwayama K, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0119-8
   Jiang XP, 2017, ENVIRON TOXICOL, V32, P1908, DOI 10.1002/tox.22413
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kitada M, 2016, AGING-US, V8, P2290, DOI 10.18632/aging.101068
   Kosenko EA, 2017, FREE RADICAL BIO MED, V113, P109, DOI 10.1016/j.freeradbiomed.2017.09.023
   Lee MH, 2001, J NEUROCHEM, V78, P32, DOI 10.1046/j.1471-4159.2001.00416.x
   Li GJ, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8050752
   Li HaoYang, 2013, Chinese Journal of Animal Nutrition, V25, P2529
   Li L, 2016, NEURAL REGEN RES, V11, P807, DOI 10.4103/1673-5374.182709
   [刘鑫 Liu Xin], 2017, [国际药学研究杂志, Journal of International Pharmaceutical Research], V44, P531
   Lu YQ, 2017, J MED FOOD, V20, P577, DOI 10.1089/jmf.2016.3910
   Manini TM, 2010, AGEING RES REV, V9, P1, DOI 10.1016/j.arr.2009.08.002
   Ou S. Y., 2002, GUANGZHOU FOOD SCI T, V18, P50
   Pan YN, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091280
   PAWLAK W, 2002, J GRAVIT PHYSL, V5, P163
   Qian Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23113026
   RAO K, 2002, INDIAN J BIOCHEM BIO, V46, P9
   Selvaratnam JS, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.141671
   Sharma S, 2016, HUM EXP TOXICOL, V35, P1264, DOI 10.1177/0960327115627689
   Shen ShengRong, 2000, Journal of Tea Science, V20, P19
   Sue YM, 2009, NEPHROL DIAL TRANSPL, V24, P769, DOI 10.1093/ndt/gfn545
   Tang T, 2013, AFR J TRADIT COMPLEM, V10, P12, DOI 10.4314/ajtcam.v10i4.3
   Tessari P, 2015, J NEPHROL, V28, P257, DOI 10.1007/s40620-014-0136-2
   Vázquez-Medina JP, 2011, J EXP BIOL, V214, P1294, DOI 10.1242/jeb.054320
   [王淑霞 WANG Shuxia], 2011, [食品科学, Food Science], V32, P196
   Wells SM, 2007, AM J RESP CELL MOL, V36, P520, DOI 10.1165/rcmb.2006-0302SM
   [伊利夏提·肖开提 Yilixiati·Xiaokaiti], 2012, [中国药学杂志, Chinese Pharmaceutical Journal], V47, P585
   Zhang J, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8091498
   Zhao X, 2018, FOOD FUNCT, V9, P1713, DOI [10.1039/C7FO01754E, 10.1039/c7fo01754e]
   Zhao X, 2018, MOLECULES, V23, DOI 10.3390/molecules23010204
   Zhou YL, 2015, SCI TECHNOL FOOD IND, V9, P339
NR 45
TC 20
Z9 25
U1 1
U2 41
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2019
VL 2019
AR 3152324
DI 10.1155/2019/3152324
PG 13
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA IB3LP
UT WOS:000470169300001
PM 31239856
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tomofuji, T
   Kawabata, Y
   Kasuyama, K
   Endo, Y
   Yoneda, T
   Yamane, M
   Azuma, T
   Ekuni, D
   Morita, M
AF Tomofuji, Takaaki
   Kawabata, Yuya
   Kasuyama, Kenta
   Endo, Yasumasa
   Yoneda, Toshiki
   Yamane, Mayu
   Azuma, Tetsuji
   Ekuni, Daisuke
   Morita, Manabu
TI Effects of hydrogen-rich water on aging periodontal tissues in rats
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POTENTIAL METABOLIC SYNDROME; OXIDATIVE STRESS; PREVENTS; MICE; AGE;
   CHOLESTEROL; LIVER; MODEL; INFLAMMATION; IMPAIRMENTS
AB Oxidative damage is involved in age-related inflammatory reactions. The anti-oxidative effects of hydrogen-rich water suppress oxidative damage, which may aid in inhibiting age-related inflammatory reactions. We investigated the effects of drinking hydrogen-rich water on aging periodontal tissues in healthy rats. Four-month-old male Fischer 344 rats (n = 12) were divided into two groups: the experimental group (hydrogen-rich water treatment) and the control group (distilled water treatment). The rats consumed hydrogen-rich water or distilled water until 16 months of age. The experimental group exhibited lower periodontal oxidative damage at 16 months of age than the control group. Although protein expression of interleukin-1 beta did not differ, gene expression of Nod-like receptor protein 3 inflammasomes was activated in periodontal tissues from the experimental group as compared with the control group. Drinking hydrogen-rich water is proposed to have anti-aging effects on periodontal oxidative damage, but not on inflammatory reactions in healthy rats.
C1 [Tomofuji, Takaaki; Kawabata, Yuya; Kasuyama, Kenta; Endo, Yasumasa; Yoneda, Toshiki; Yamane, Mayu; Azuma, Tetsuji; Ekuni, Daisuke; Morita, Manabu] Okayama Univ, Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Kita Ku, Okayama 7008558, Japan.
C3 Okayama University
RP Tomofuji, T (corresponding author), Okayama Univ, Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
EM tomofu@md.okayama-u.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology, Tokyo,
   Japan [24593153, 25463243]; Grants-in-Aid for Scientific Research
   [24593153, 25463243] Funding Source: KAKEN
FX This work was supported by Grants-in-Aid for Scientific Research
   (24593153 and 25463243) from the Ministry of Education, Culture, Sports,
   Science and Technology, Tokyo, Japan. The authors report no conflicts of
   interest related to this study.
CR Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613
   Bloemen V, 2011, J CELL BIOCHEM, V112, P1890, DOI 10.1002/jcb.23109
   Bullon P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074234
   Endo Y, 2013, J CLIN PERIODONTOL, V40, P33, DOI 10.1111/jcpe.12032
   Endo Y, 2010, J PERIODONTOL, V81, P520, DOI 10.1902/jop.2009.090574
   Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011
   Irie K, 2008, J DENT RES, V87, P456, DOI 10.1177/154405910808700511
   Kang KM, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-11
   Kasuyama K, 2011, J CLIN PERIODONTOL, V38, P1085, DOI 10.1111/j.1600-051X.2011.01801.x
   Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005
   Kawai D, 2012, HEPATOLOGY, V56, P912, DOI 10.1002/hep.25782
   Lee JH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/876316
   Leong NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035980
   Misawa Y, 2007, ARCH ORAL BIOL, V52, P44, DOI 10.1016/j.archoralbio.2006.06.012
   Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95
   Nakao A, 2010, J CLIN BIOCHEM NUTR, V46, P140, DOI 10.3164/jcbn.09-100
   Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133
   Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577
   Qian LR, 2010, J RADIAT RES, V51, P741, DOI 10.1269/jrr.10093
   Romano A. D., 2014, CURR PHARM IN PRESS
   Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0
   Sanbe T, 2007, J PERIODONTOL, V78, P2165, DOI 10.1902/jop.2007.070181
   Sanz Alberto, 2008, Curr Aging Sci, V1, P10
   Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020
   Shetty RA, 2013, AGE, V35, P1821, DOI 10.1007/s11357-012-9484-9
   Song GH, 2013, J LIPID RES, V54, P1884, DOI 10.1194/jlr.M036640
   Tomofuji T, 2006, FEBS LETT, V580, P3601, DOI 10.1016/j.febslet.2006.05.041
   Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069
   Xia CX, 2013, CTS-CLIN TRANSL SCI, V6, P372, DOI 10.1111/cts.12076
   Yoneda T, 2013, J DENT RES, V92, P735, DOI 10.1177/0022034513490959
   Yoritaka A, 2013, MOVEMENT DISORD, V28, P836, DOI 10.1002/mds.25375
NR 31
TC 25
Z9 29
U1 0
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 2
PY 2014
VL 4
AR 5534
DI 10.1038/srep05534
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AK4VA
UT WOS:000338421000007
PM 24985521
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ablise, M
   Mao, XM
   Kasim, R
AF Ablise, Mourboul
   Mao, Xin Min
   Kasim, Rena
TI Antioxidant activities of Uyghur medicinal tea in human HL-60 cell line
   and rat hepatic microsomes
SO JOURNAL OF MEDICINAL PLANTS RESEARCH
LA English
DT Article
DE Uyghur medicinal tea; antioxidant activity; HL 60 cells; hepatic
   microsomes
ID CYTOCHROME-P450 ENZYMES; MYELOPEROXIDASE; DISEASES
AB Uyghur medicinal tea (UMT) is preferably used as a common nutritional additive by Uyghur population, especially by the aged people including centenarians from southern part of Xinjiang, along the Silk Road of China. The study showed an evidence for the antioxidant properties of UMT extract by using two different oxidative systems in vitro: (1) the myeloperoxidase/H(2)O(2)/HOCl enzymatic system in human HL-60 cell line and (2) the cytochrome P450/NADPH reductase system in rat liver microsomes. The EGB 761 Ginkgo biloba extract was used as the reference. Reactive oxygen species (ROS) production was measured by fluorescence of 2',7'-dichlorofluorescein (DCF) originated from 2', 7'-dichlorofluorescein diacetate (DCFHDA) probe oxidation. UMT extract inhibited ROS formation by 81, 86 and 73% in the HL 60 cell line system (at the concentrations of 0.25, 0.50 and 0.75 mg/ml) and at similar rates in the microsomal system. In the same conditions, G. biloba extract inhibited ROS activity by 39, 78 and 81% in HL 60 cells, and by 78, 87 and 89% in the microsomal system. The present study shows that UMT possesses relatively high antioxidant activity, comparable to the free radical scavenger properties of EGB 761 extract. This effect could explain its benefic preventive action against age-related pathologies. Habitual consumption of UMT may provide beneficial effects in prevention of atherosclerosis and oxidative stress in aging process.
C1 [Ablise, Mourboul; Kasim, Rena] Xinjiang Med Univ, Coll Pharm, Urumqi 830054, Xinjiang, Peoples R China.
   [Mao, Xin Min] Xinjiang Med Univ, Coll Basic Med Sci, Urumqi 830054, Xinjiang, Peoples R China.
C3 Xinjiang Medical University; Xinjiang Medical University
RP Kasim, R (corresponding author), Xinjiang Med Univ, Coll Pharm, Urumqi 830054, Xinjiang, Peoples R China.
EM renakasimu@vip.sina.com
FU INSERM Unite 525 - Centre du Medicament, Faculte de Pharmacie,
   Universite Henri Poincare Nancy, France
FX This work was supported by Professor Gerard SIEST, Pr Vincent LOPPINET
   and Professor Sophie VISVIKIS at the INSERM Unite 525 - Centre du
   Medicament, Faculte de Pharmacie, Universite Henri Poincare Nancy 1,
   54000 Nancy, France. The authors wish also to thank for Mr. Mouhtar
   ANWAR (Pharmaceutical Laboratory of Kachgar Uygur Medicine, Xinjiang
   China) for providing UMT (a standardized commercial product) and Dr. Y.
   Christen (Beaufour-Ipsen, Paris, France), for providing EGB 761 G.
   biloba extract.
CR Bendjeddou D, 2003, J ETHNOPHARMACOL, V88, P155, DOI 10.1016/S0378-8741(03)00226-5
   Choi DW, 2002, FREE RADICAL RES, V36, P893, DOI 10.1080/1071576021000005339
   Christen Y, 2002, CELL MOL BIOL, V48, P601
   DUDAS SP, 1995, J GERONTOL A-BIOL, V50, pB117, DOI 10.1093/gerona/50A.3.B117
   EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9
   GUSTAVO B, 2002, FREE RADICAL BIO MED, V33, P1167
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Hoy A, 2002, CLIN CHEM LAB MED, V40, P2, DOI 10.1515/CCLM.2002.002
   Klapcinska B, 2000, ACTA BIOCHIM POL, V47, P281
   Kutter D, 2000, ACTA HAEMATOL-BASEL, V104, P10, DOI 10.1159/000041062
   Lin CC, 2003, PHYTOTHER RES, V17, P726, DOI 10.1002/ptr.1190
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MOHAMMED A, 2001, J XINJIANG MED U, V24, P62
   Orzechowski A, 2002, REPROD NUTR DEV, V42, P461, DOI [10.1051/rnd:2002037, 10.1051/rnd:2002034]
   Puntarulo S, 1998, FREE RADICAL BIO MED, V24, P1324, DOI 10.1016/S0891-5849(97)00463-2
   Rajbhandari I, 2001, J NAT PROD, V64, P693, DOI 10.1021/np0101346
   RANJINDAR SS, 2002, FREE RADICAL BIO MED, V33, P573
   Rimbach G, 2001, BIOFACTORS, V15, P39, DOI 10.1002/biof.5520150104
   Seo UK, 2005, J ETHNOPHARMACOL, V97, P101, DOI 10.1016/j.jep.2004.10.022
   Serron SC, 2000, TOXICOL APPL PHARM, V164, P305, DOI 10.1006/taap.2000.8910
   Zhang CX, 2003, AM J PHYSIOL-HEART C, V285, pH2563, DOI 10.1152/ajpheart.00435.2003
NR 21
TC 2
Z9 2
U1 0
U2 4
PU ACADEMIC JOURNALS
PI VICTORIA ISLAND
PA P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA
SN 1996-0875
J9 J MED PLANTS RES
JI J. Med. Plants Res.
PD JUL 4
PY 2011
VL 5
IS 13
BP 2677
EP 2681
PG 5
WC Chemistry, Medicinal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 853XW
UT WOS:000297460000012
DA 2024-02-19
ER

PT J
AU Li, SS
   Liu, M
   Zhang, C
   Tian, CY
   Wang, XX
   Song, XL
   Jing, HJ
   Gao, Z
   Ren, ZZ
   Liu, WR
   Zhang, JJ
   Jia, L
AF Li, Shangshang
   Liu, Min
   Zhang, Chen
   Tian, Chengye
   Wang, Xiuxiu
   Song, Xinling
   Jing, Huijuan
   Gao, Zheng
   Ren, Zhenzhen
   Liu, Weiru
   Zhang, Jianjun
   Jia, Le
TI Purification, <i>in vitro</i> antioxidant and <i>in vivo</i> anti-aging
   activities of soluble polysaccharides by enzyme-assisted extraction from
   <i>Agaricus bisporus</i>
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Agaricus bisporus; Polysaccharides; Enzyme-assisted extraction;
   Purification; Antioxidant activities; Anti-aging activities
ID AMELIORATES COGNITION DEFICITS; INTRACELLULAR POLYSACCHARIDE; OXIDATIVE
   STRESS; PROTEIN; OPTIMIZATION
AB In present study, the soluble polysaccharides by enzyme-assisted extraction from Agaricus bisporus (EnAPS) and its purified fractions of EnAPS-1. -2 and -3 were successfully obtained, and the antioxidant activities and anti-aging effects were investigated. The in vitro antioxidant assay demonstrated that EnAPS-2 had superior scavenging activities on DPPH and hydroxyl radicals, chelating activities of Fe2+ and reducing power. The in vivo animal experiments showed that both EnAPS and its purifies fractions had potential anti-aging effects against the D-galctose-induced aging diseases on liver, kidney, brain and skin, possibly by increasing the antioxidant enzymes, reducing the lipid peroxidation, improving the organ functions and remitting the lipid metabolism. The conclusions demonstrated that the polysaccharides by A. bisporus might be suitable for applying functional foods and natural drugs in preventing and delaying the aging and its complications. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Li, Shangshang; Liu, Min; Zhang, Chen; Wang, Xiuxiu; Song, Xinling; Jing, Huijuan; Gao, Zheng; Ren, Zhenzhen; Zhang, Jianjun; Jia, Le] Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.
   [Tian, Chengye] Comprehens Supervis & Enforcement Bur Sanitat & F, Tai An 271000, Shandong, Peoples R China.
   [Liu, Weiru] Second High Sch Taian, Tai An 271018, Shandong, Peoples R China.
C3 Shandong Agricultural University
RP Zhang, JJ; Jia, L (corresponding author), Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.
EM yyxf0315@163.com; jiale_1115@163.com
RI zhang, jian/HPD-1712-2023; zhan, y/ISA-2807-2023; Wang,
   Luyao/JLL-2001-2023; li, zhang/JHV-1750-2023; jin, li/IWU-4648-2023
FU Mushroom Technology System of Shandong Province [SDAIT-07-05]
FX This work was supported by grants from Mushroom Technology System of
   Shandong Province (SDAIT-07-05).
CR Aguirre MJ, 2009, CARBOHYD RES, V344, P1095, DOI 10.1016/j.carres.2009.03.024
   Butterfield DA, 2006, J NEUROCHEM, V98, P1697, DOI 10.1111/j.1471-4159.2006.03995.x
   Cao W, 2010, INT J BIOL MACROMOL, V46, P115, DOI 10.1016/j.ijbiomac.2009.11.005
   CARLBERG I, 1975, J BIOL CHEM, V250, P5475
   Cumby N, 2008, FOOD CHEM, V109, P144, DOI 10.1016/j.foodchem.2007.12.039
   Dröge W, 2005, PHILOS T R SOC B, V360, P2355, DOI 10.1098/rstb.2005.1770
   Finley JW, 2011, J AGR FOOD CHEM, V59, P6837, DOI 10.1021/jf2013875
   Fu W, 2010, J ETHNOPHARMACOL, V130, P521, DOI 10.1016/j.jep.2010.05.039
   Gan D, 2011, CARBOHYD POLYM, V84, P997, DOI 10.1016/j.carbpol.2010.12.058
   Gao CJ, 2013, CARBOHYD POLYM, V92, P2187, DOI 10.1016/j.carbpol.2012.12.011
   Govindan S, 2016, EXP TOXICOL PATHOL, V68, P329, DOI 10.1016/j.etp.2016.04.001
   Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hu WL, 2013, BIOTECHNOL LETT, V35, P1309, DOI 10.1007/s10529-013-1206-6
   Jeong SC, 2010, NUTR RES, V30, P49, DOI 10.1016/j.nutres.2009.12.003
   Jiao FP, 2017, INT J BIOL MACROMOL, V98, P469, DOI 10.1016/j.ijbiomac.2017.01.126
   Jin ML, 2012, CARBOHYD POLYM, V89, P713, DOI 10.1016/j.carbpol.2012.04.049
   Ke CL, 2009, CARBOHYD POLYM, V75, P677, DOI 10.1016/j.carbpol.2008.09.008
   Lan Z, 2012, J ETHNOPHARMACOL, V141, P386, DOI 10.1016/j.jep.2012.02.050
   Lin L, 2016, CARBOHYD POLYM, V146, P388, DOI 10.1016/j.carbpol.2016.03.071
   Liu J, 2015, INT J BIOL MACROMOL, V72, P1182, DOI 10.1016/j.ijbiomac.2014.08.058
   Liu M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43212
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Ma Z, 2015, INT J BIOL MACROMOL, V73, P236, DOI 10.1016/j.ijbiomac.2014.11.028
   Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001
   Mayolo-Deloisa K, 2009, PROCESS BIOCHEM, V44, P435, DOI 10.1016/j.procbio.2008.12.010
   Seven A, 2008, CLIN BIOCHEM, V41, P538, DOI 10.1016/j.clinbiochem.2008.01.029
   Sharma A, 2002, J AM OIL CHEM SOC, V79, P215, DOI 10.1007/s11746-002-0463-0
   Smiderle FR, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-58
   Sreelatha S, 2009, FOOD CHEM TOXICOL, V47, P702, DOI 10.1016/j.fct.2008.12.022
   Sun YX, 2010, CARBOHYD POLYM, V82, P510, DOI 10.1016/j.carbpol.2010.05.010
   Tian YT, 2012, CARBOHYD POLYM, V88, P522, DOI 10.1016/j.carbpol.2011.12.042
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
   Xiao JH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/273435
   Xiong QP, 2014, CARBOHYD POLYM, V108, P247, DOI 10.1016/j.carbpol.2014.02.068
   Ye CL, 2012, CARBOHYD POLYM, V89, P1131, DOI 10.1016/j.carbpol.2012.03.084
   Yuan JF, 2008, CARBOHYD POLYM, V74, P822, DOI 10.1016/j.carbpol.2008.04.040
   Zhang C, 2016, INT J BIOL MACROMOL, V91, P568, DOI 10.1016/j.ijbiomac.2016.05.104
   Zhang QB, 2003, PHARMACOL RES, V48, P151, DOI 10.1016/S1043-6618(03)00103-8
   Zhang ZS, 2014, CARBOHYD POLYM, V111, P762, DOI 10.1016/j.carbpol.2014.04.103
   Zhang ZF, 2013, CARBOHYD POLYM, V98, P1524, DOI 10.1016/j.carbpol.2013.07.052
   Zhao HJ, 2016, CARBOHYD POLYM, V151, P1227, DOI 10.1016/j.carbpol.2016.06.058
   Zhu KX, 2006, PROCESS BIOCHEM, V41, P1296, DOI 10.1016/j.procbio.2005.12.029
NR 45
TC 37
Z9 37
U1 7
U2 130
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2018
VL 109
BP 457
EP 466
DI 10.1016/j.ijbiomac.2017.12.108
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA GA1TI
UT WOS:000428099900048
PM 29274427
DA 2024-02-19
ER

PT J
AU EVERMAN, BW
   KOBLIN, DD
AF EVERMAN, BW
   KOBLIN, DD
TI AGING, CHRONIC ADMINISTRATION OF ETHANOL, AND ACUTE EXPOSURE TO
   NITROUS-OXIDE - EFFECTS ON VITAMIN-B12 AND FOLATE STATUS IN RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; ETHANOL; NITROUS OXIDE; FOLATE; VITAMIN-B12; METHIONINE SYNTHASE
ID FOLIC-ACID; METHIONINE SYNTHETASE; SERUM VITAMIN-B12; ELDERLY PATIENTS;
   TREATED RATS; METABOLISM; LIVER; INACTIVATION; EXCRETION; ALCOHOL
AB Elderly patients with alcoholism often require surgery and receive nitrous oxide (N2O) as a component of their anesthetic.  Since aging, ethanol, and N2O may all perturb folate and/or vitamin B-12 metabolism, we examined the combined influence of these parameters on vitamin B-12/folate status in a rodent model.  Aged male Fischer 344 rats (24 months old) were given a liquid ethanol diet (35% of calories as ethanol) and control rats were pair-fed a liquid diet with carbohydrate substituting for the caloric content of ethanol.  After receiving liquid diets for 7 weeks, rats were exposed to 60% N2O/40% O2 for 6 h.  Urinary excretion of formic acid, formiminoglutamic acid (FIGLU), and methylmalonic acid (MMA) were used as indirect markers of folate/vitamin B-12 status.  In both the aged ethanol-fed and control groups, excretion of formic acid and FIGLU markedly increased the first day after N2O exposure and returned towards background values by the second day.  No changes occurred in MMA excretion.  Exposure to N2O decreased methionine synthase activities in liver, kidney and brain, and recovery of methionine synthase activities occurred over a period of 4 days in both the aged ethanol-fed and control groups.  Ethanol treatment for 7 weeks combined with acute exposure to N2O did not deplete the aged rats of folate or vitamin B-12 in blood, liver, kidney or brain.  Thus, in this animal model, aging, chronic ethanol administration, and acute N2O exposure did not act synergistically to produce prolonged and sever disturbances in folate and vitamin B-12 metabolism.
C1 VET ADM MED CTR,DEPT ANESTHESIA,ANESTHESIOL SERV 129,4150 CLEMENT ST,SAN FRANCISCO,CA 94121.
   UNIV CALIF SAN FRANCISCO,DEPT ANESTHESIA,SAN FRANCISCO,CA 94143.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   University of California System; University of California San Francisco
FU NIA NIH HHS [P01 AG3104] Funding Source: Medline
CR AMOS RJ, 1982, LANCET, V2, P835
   BARAK AJ, 1990, J AM COLL NUTR, V9, P97
   BARAK AJ, 1987, BIOCHEM CELL BIOL, V65, P230, DOI 10.1139/o87-029
   BERGER JJ, 1988, ANESTH ANALG, V67, P197
   BLACK KA, 1984, HEPATOLOGY, V4, P871, DOI 10.1002/hep.1840040513
   BLOCKER DE, 1987, AM J CLIN NUTR, V46, P503, DOI 10.1093/ajcn/46.3.503
   BLUNDELL EL, 1985, J CLIN PATHOL, V38, P1179, DOI 10.1136/jcp.38.10.1179
   CURTIS JR, 1989, J AM GERIATR SOC, V37, P310, DOI 10.1111/j.1532-5415.1989.tb05496.x
   DEACON R, 1983, EUR J BIOCHEM, V129, P627
   DEACON R, 1978, LANCET, V2, P1023, DOI 10.1016/S0140-6736(78)92341-3
   GIMSING P, 1989, J NUTR, V119, P416, DOI 10.1093/jn/119.3.416
   GIORGIO AJ, 1965, J LAB CLIN MED, V66, P667
   GRADY S, 1986, J ANAL TOXICOL, V10, P1
   GREEN R, 1988, P WORKSHOP NATIONAL
   KOBLIN DD, 1991, ALCOHOL CLIN EXP RES, V15, P543, DOI 10.1111/j.1530-0277.1991.tb00557.x
   KOBLIN DD, 1990, ANESTHESIOLOGY, V73, P506, DOI 10.1097/00000542-199009000-00022
   KOBLIN DD, 1981, ANESTHESIOLOGY, V54, P318, DOI 10.1097/00000542-198104000-00012
   KOBLIN DD, 1982, ANESTH ANALG, V61, P75
   KOBLIN DD, 1990, ANESTH ANALG, V71, P610
   KONDO H, 1981, J CLIN INVEST, V67, P1270, DOI 10.1172/JCI110155
   LICHTIGFELD FJ, 1989, INT J NEUROSCI, V49, P83
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MATTHEWS JH, 1988, ACTA HAEMATOL-BASEL, V79, P84, DOI 10.1159/000205726
   MCMARTIN KE, 1983, BIOCHEM PHARMACOL, V32, P2549, DOI 10.1016/0006-2952(83)90017-5
   MOLLOY A M, 1986, P505
   NUNN JF, 1987, BRIT J ANAESTH, V59, P3, DOI 10.1093/bja/59.1.3
   RASK H, 1983, SCAND J HAEMATOL, V31, P45
   ROYSTON BD, 1988, ANESTHESIOLOGY, V68, P213, DOI 10.1097/00000542-198802000-00006
   SCHILLING RF, 1986, JAMA-J AM MED ASSOC, V255, P1605, DOI 10.1001/jama.255.12.1605
   STOKSTAD ELR, 1988, ARCH BIOCHEM BIOPHYS, V265, P407, DOI 10.1016/0003-9861(88)90143-9
   THOMPSON WG, 1989, ACTA HAEMATOL-BASEL, V82, P169, DOI 10.1159/000205371
   WEIR DG, 1985, BIOCHEM PHARMACOL, V34, P1, DOI 10.1016/0006-2952(85)90092-9
   ZINN SE, 1985, ANESTH ANALG, V64, P487
NR 33
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAR 1
PY 1992
VL 62
IS 3
BP 229
EP 243
DI 10.1016/0047-6374(92)90109-Q
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HH668
UT WOS:A1992HH66800002
PM 1583909
DA 2024-02-19
ER

PT J
AU Palomero, J
   Galán, AI
   Muñoz, ME
   Tuñón, MJ
   González-Gallego, J
   Jiménez, R
AF Palomero, J
   Galán, AI
   Muñoz, ME
   Tuñón, MJ
   González-Gallego, J
   Jiménez, R
TI Effects of aging and cyclosporin treatment on the hepatobiliary efflux
   of glutathione
SO LIFE SCIENCES
LA English
DT Article
DE aging; biliary glutathione; cyclosporin A; free radicals; liver
   glutathion
ID PHALLOIDIN-INDUCED CHOLESTASIS; BILIARY LIPID SECRETION; A-INDUCED
   ALTERATIONS; RAT-LIVER; REDUCED GLUTATHIONE; BILE FORMATION; TRANSPORT;
   INHIBITION; EXPORT; HEPATOTOXICITY
AB The aim of this study was to investigate the effects of cyclosporin (CyA) treatment on biliary glutathione efflux in rats of different ages (1, 2, 4, and 24 months). CyA treatment reduced the liver content of total glutathione in 1-, 2- and 24 month old rats (-30%, -43% and -30%, respectively). By contrast, oxidized glutathione (GSSG) concentration in liver tended to increase, although non significantly, in the rats aged 4 and 24 month (+36% and +28%, respectively). The oxidized-to-reduced glutathione ratio was significantly increased in 2-, 4- and 24 month old animals (+23%, +36% and >100%, respectively). Regarding biliary glutathione, our data indicate that efflux rates of total glutathione in control (untreated) rats increased to a maximum at 4 months, and decreased (-56%) in 24 month old rats, although values were still higher than those from young animals. CyA treatment significantly reduced biliary glutathione secretion except in 24 month old rats (-98%, -66% and -32%, at 1, 2 and 4 month, respectively). In addition, following inhibition of the intrabiliary catabolism of the tripeptide by acivicin, glutathione efflux rates into bile were significantly reduced by the drug only in 1- and 2 month old rats (-29% and -55%, respectively) and even tended to increase, although non significantly, in oldest animals. Our data indicate that inhibition of biliary glutathione efflux by CyA was greater in younger rats and support the view that increased intrabiliary catabolism of the tripeptide and inhibition of its canalicular transport could contribute to the decline in biliary glutathione secretion induced by the drug. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Salamanca, Dept Fisiol & Farmacol, Salamanca, Spain.
   Univ Leon, Dept Physiol, E-24071 Leon, Spain.
C3 University of Salamanca; Universidad de Leon
EM rajim@gugu.usal.es
RI JIMENEZ, RAFAEL/AAB-9656-2020; Gonzalez-Gallego, Javier/D-8219-2012;
   Hernández, Ana Isabel Galán/AAC-5862-2021; Tuñón, María
   Jesús/L-2456-2017; Palomero, Jesus/L-4783-2014
OI Gonzalez-Gallego, Javier/0000-0002-4386-9342; Hernández, Ana Isabel
   Galán/0000-0002-8879-4372; Palomero, Jesus/0000-0002-1013-9992; Tunon,
   Maria Jesus/0000-0001-7827-5918
CR BALLATORI N, 1988, AM J PHYSIOL, V254, pG1, DOI 10.1152/ajpgi.1988.254.1.G1
   Ballatori N, 1998, SEMIN LIVER DIS, V18, P377, DOI 10.1055/s-2007-1007171
   BALLATORI N, 1992, AM J PHYSIOL, V263, pG617, DOI 10.1152/ajpgi.1992.263.5.G617
   BALLATORI N, 1989, AM J PHYSIOL, V256, pG22, DOI 10.1152/ajpgi.1989.256.1.G22
   BALLATORI N, 1986, J BIOL CHEM, V261, P7860
   BOHME M, 1994, ADV ENZYME REGUL, V34, P371, DOI 10.1016/0065-2571(94)90023-X
   Borel J F, 1996, Adv Pharmacol, V35, P115, DOI 10.1016/S1054-3589(08)60276-8
   Bouchard G, 2000, J HEPATOL, V32, P550, DOI 10.1016/S0168-8278(00)80215-9
   BOUCHARD G, 1994, TOXICOL LETT, V74, P221, DOI 10.1016/0378-4274(94)90081-7
   Bramow S, 2001, PHARMACOL TOXICOL, V89, P133, DOI 10.1034/j.1600-0773.2001.d01-147.x
   Chan FKL, 1998, J HEPATOL, V28, P329, DOI 10.1016/0168-8278(88)80021-7
   DELEVE LD, 1990, SEMIN LIVER DIS, V10, P251, DOI 10.1055/s-2008-1040481
   Deters M, 1997, TOXICOLOGY, V123, P197, DOI 10.1016/S0300-483X(97)00123-6
   DURUIBE VA, 1989, PHARMACOLOGY, V39, P205, DOI 10.1159/000138599
   ELFERINK RPJO, 1995, J CLIN INVEST, V95, P31, DOI 10.1172/JCI117658
   FERNANDEZ E, 1995, J PHARMACOL EXP THER, V275, P442
   Galán AI, 1999, J PHARMACOL EXP THER, V290, P774
   GALAN AI, 1995, CLIN EXP PHARMACOL P, V22, P260, DOI 10.1111/j.1440-1681.1995.tb01991.x
   GALAN AI, 1991, ARCH INT PHYSIOL BIO, V99, P373
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   Keppler D, 1997, FASEB J, V11, P15, DOI 10.1096/fasebj.11.1.9034161
   KITANI K, 1988, LIFE CHEM REPORTS, V6, P143
   LAUTERBURG BH, 1991, PROGR PHARM CLIN PHA, V8, P201
   Morán D, 1998, J HEPATOL, V29, P68, DOI 10.1016/S0168-8278(98)80180-3
   Muller M, 1996, SEMIN LIVER DIS, V16, P211, DOI 10.1055/s-2007-1007233
   Ookhtens M, 1998, SEMIN LIVER DIS, V18, P313, DOI 10.1055/s-2007-1007167
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Paulusma CC, 1999, BIOCHEM J, V338, P393, DOI 10.1042/0264-6021:3380393
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Rikans LE, 1997, ENVIRON TOXICOL PHAR, V4, P339, DOI 10.1016/S1382-6689(97)10032-1
   ROMAN ID, 1990, HEPATOLOGY, V12, P83, DOI 10.1002/hep.1840120114
   Rost D, 1999, HEPATOLOGY, V29, P814, DOI 10.1002/hep.510290319
   SCHADE RR, 1983, TRANSPLANT P, V15, P2757
   Vendemiale G, 1999, INT J CLIN LAB RES, V29, P49, DOI 10.1007/s005990050063
   VERKADE HJ, 1995, HEPATOLOGY, V21, P1174
NR 35
TC 5
Z9 5
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD NOV 14
PY 2003
VL 73
IS 26
BP 3387
EP 3397
DI 10.1016/j.lfs.2003.06.019
PG 11
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 738BD
UT WOS:000186266100008
PM 14572880
DA 2024-02-19
ER

PT J
AU Nassar, K
   El-mekawey, D
   Elmasry, AE
   Refaey, MS
   Ghoneim, ME
   Elshaier, YAMM
AF Nassar, Khloud
   El-mekawey, Doaa
   Elmasry, Ahmed E.
   Refaey, Mohamed S.
   Ghoneim, Mai El-Sayed
   Elshaier, Yaseen A. M. M.
TI The significance of caloric restriction mimetics as anti-aging drugs
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article; Early Access
DE Aging; CRMs; Drug repurposing; Post COVID-19 syndrome; Autophagy
ID EXTENDS LIFE-SPAN; ACTIVATED PROTEIN-KINASE; SUPPRESSES HEPATIC
   GLUCONEOGENESIS; GREEN TEA POLYPHENOL; ALPHA-KETOGLUTARATE;
   EPIGALLOCATECHIN GALLATE; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS;
   GLUCOSE-METABOLISM; INSULIN-RESISTANCE
AB Aging is an intricate process characterized by the gradual deterioration of the physiological integrity of a living organism. This unfortunate phenomenon inevitably leads to a decline in functionality and a heightened susceptibility to the ultimate fate of mortality. Therefore, it is of utmost importance to implement interventions that possess the capability to reverse or preempt age-related pathology. Caloric restriction mimetics (CRMs) refer to a class of molecules that have been observed to elicit advantageous outcomes on both health and longevity in various model organisms and human subjects. Notably, these compounds offer a promising alternative to the arduous task of adhering to a caloric restriction diet and mitigate the progression of the aging process and extend the duration of life in laboratory animals and human population. A plethora of molecular signals have been linked to the practice of caloric restriction, encompassing Insulin-like Growth Factor 1 (IGF1), Mammalian Target of Rapamycin (mTOR), the Adenosine Monophosphate-Activated Protein Kinase (AMPK) pathway, and Sirtuins, with particular emphasis on SIRT1. Therefore, this review will center its focus on several compounds that act as CRMs, highlighting their molecular targets, chemical structures, and mechanisms of action. Moreover, this review serves to underscore the significant relationship between post COVID-19 syndrome, antiaging, and importance of utilizing CRMs. This particular endeavor will serve as a comprehensive guide for medicinal chemists and other esteemed researchers, enabling them to meticulously conceive and cultivate novel molecular entities with the potential to function as efficacious antiaging pharmaceutical agents.
C1 [Nassar, Khloud] Univ Sadat City, Fac Pharm, Dept Biochem, Menoufia 32897, Egypt.
   [El-mekawey, Doaa; Ghoneim, Mai El-Sayed] Univ Sadat City, Fac Pharm, Dept Pharmacol & Toxicol, Menoufia 32897, Egypt.
   [Elmasry, Ahmed E.; Elshaier, Yaseen A. M. M.] Univ Sadat City, Fac Pharm, Dept Organ & Med Chem, Menoufia 32897, Egypt.
   [Refaey, Mohamed S.] Univ Sadat City, Fac Pharm, Dept Pharmacognosy, Menoufia 32897, Egypt.
   [Ghoneim, Mai El-Sayed] Univ Sadat City USC, Fac Pharm, Dept Pharmacol & Toxicol, Sadat City, Egypt.
C3 Egyptian Knowledge Bank (EKB); University of Sadat City; Egyptian
   Knowledge Bank (EKB); University of Sadat City; Egyptian Knowledge Bank
   (EKB); University of Sadat City; Egyptian Knowledge Bank (EKB);
   University of Sadat City; Egyptian Knowledge Bank (EKB); University of
   Sadat City
RP Ghoneim, ME (corresponding author), Univ Sadat City USC, Fac Pharm, Dept Pharmacol & Toxicol, Sadat City, Egypt.
EM maielsaid89@yahoo.com
RI Refaey, Mohamed/AAM-1794-2020
OI Refaey, Mohamed/0000-0003-3879-104X; Elshaier,
   Yaseen/0000-0003-4332-6345
CR Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378
   Amalraj Augustine, 2017, J Tradit Complement Med, V7, P205, DOI 10.1016/j.jtcme.2016.05.005
   Anisimov VN, 2015, ONCOTARGET, V6, P39398, DOI 10.18632/oncotarget.6347
   Anisimov VN, 2013, CELL CYCLE, V12, P3483, DOI 10.4161/cc.26928
   Anisimov VN, 2013, CRIT REV ONCOL HEMAT, V87, P201, DOI 10.1016/j.critrevonc.2013.01.005
   Annunziata G, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00240
   Arefhosseini S, 2022, FOOD FUNCT, V13, P5124, DOI [10.1039/D1FO03685H, 10.1039/d1fo03685h]
   Asghar M, 2007, MOL CELL BIOCHEM, V304, P93, DOI 10.1007/s11010-007-9489-3
   Ayyadevara S, 2013, ANTIOXID REDOX SIGN, V18, P481, DOI 10.1089/ars.2011.4151
   Baky MH, 2022, ACS OMEGA, DOI 10.1021/acsomega.2c02838
   Banik K, 2020, PHARMACOL RES, V153, DOI 10.1016/j.phrs.2020.104635
   Bartke A, 2009, EXP GERONTOL, V44, P372, DOI 10.1016/j.exger.2009.04.001
   Basha NJ, 2023, POLYCYCL AROMAT COMP, DOI 10.1080/10406638.2023.2270116
   Bayliak MM, 2021, AGEING RES REV, V66, DOI 10.1016/j.arr.2020.101237
   Bayliak MM, 2017, COMP BIOCHEM PHYS A, V204, P28, DOI 10.1016/j.cbpa.2016.11.005
   Bellaver B, 2014, TOXICOL IN VITRO, V28, P479, DOI 10.1016/j.tiv.2014.01.006
   Benameur T, 2021, MOLECULES, V26, DOI 10.3390/molecules26164794
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Bernatova I, 2018, BIOTECHNOL ADV, V36, P666, DOI 10.1016/j.biotechadv.2018.01.009
   Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005
   Blagosklonny MV, 2020, AGING-US, V12, P10004, DOI 10.18632/aging.103493
   Bolfi F, 2018, EUR J ENDOCRINOL, V179, P59, DOI 10.1530/EJE-18-0255
   Bonkowski M.S., 2018, Innov. Aging, V2, P388
   Boo YC, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10081315
   Campbell J.M, 2023, Anti-Aging Pharmacol, P71
   Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981
   Carmona-Gutierrez D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08555-w
   Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345
   Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559
   Chen YF, 2020, EUR J MED CHEM, V208, DOI 10.1016/j.ejmech.2020.112820
   Chen YY, 2021, AGEING RES REV, V65, DOI 10.1016/j.arr.2020.101205
   Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Cordani M, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030361
   Cosín-Tomàs M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081764
   Coutinho DD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061812
   Cui ZF, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.943321
   D'Andrea G, 2015, FITOTERAPIA, V106, P256, DOI 10.1016/j.fitote.2015.09.018
   Das A, 2019, CELL, V176, P944, DOI 10.1016/j.cell.2019.01.026
   de Magalhaes JP, 2018, MECH AGEING DEV, V170, P2, DOI 10.1016/j.mad.2017.07.001
   Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919
   Diaz-Ruiz A, 2018, AGING CELL, V17, DOI 10.1111/acel.12767
   Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050
   Doan KV, 2015, ENDOCRINOLOGY, V156, P157, DOI 10.1210/en.2014-1354
   Dos Santos Ferreira C.I., 2016, Phenolic Compounds in Extracts from Eucalyptus Globulus Leaves and Calendula officinalis Flowers
   Ehninger D, 2014, CELL MOL LIFE SCI, V71, P4325, DOI 10.1007/s00018-014-1677-1
   Eid Hoda M, 2017, Pharm Biol, V55, P2026, DOI 10.1080/13880209.2017.1345952
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   Ekmekcioglu C, 2020, CRIT REV FOOD SCI, V60, P3063, DOI 10.1080/10408398.2019.1676698
   Fang EF, 2017, TRENDS MOL MED, V23, P899, DOI 10.1016/j.molmed.2017.08.001
   Fuellen G, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101091
   Garate-Carrillo A, 2020, EUR J PHARMACOL, V885, DOI 10.1016/j.ejphar.2020.173442
   Ge YC, 2022, BIOCHIMIE, V195, P100, DOI 10.1016/j.biochi.2021.11.008
   Ghasemi Fard S, 2019, CRIT REV FOOD SCI, V59, P1684, DOI 10.1080/10408398.2018.1425978
   Gillespie ZE, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00142
   Girsang E., 2020, Pharmaciana, V10, P147, DOI DOI 10.12928/PHARMACIANA.V10I2.13010
   Golubev AG, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.584248
   Gomes AP, 2012, BBA-MOL BASIS DIS, V1822, P185, DOI 10.1016/j.bbadis.2011.10.008
   Gu SH, 2013, INFECT GENET EVOL, V20, P118, DOI 10.1016/j.meegid.2013.08.016
   Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013
   He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016
   He L, 2017, ONCOTARGET, V8, P102974, DOI 10.18632/oncotarget.16875
   Heer CD, 2020, J BIOL CHEM, V295, P17986, DOI [10.1074/jbc.RA120.015138, 10.1101/2020.04.17.047480]
   Hofer SJ, 2022, NATURE AGING, V2, P1112, DOI 10.1038/s43587-022-00322-9
   Hofer SJ, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.717343
   Hu J, 2018, REGUL TOXICOL PHARM, V95, P412, DOI 10.1016/j.yrtph.2018.03.019
   Huang ZF, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.899633
   Husain A, 2020, CHEM-BIOL INTERACT, V331, DOI 10.1016/j.cbi.2020.109282
   Ingram DK, 2021, GEROSCIENCE, V43, P1159, DOI 10.1007/s11357-020-00298-7
   Ingram DK, 2015, AGEING RES REV, V20, P46, DOI 10.1016/j.arr.2014.11.005
   Ingram DK, 2011, EXP GERONTOL, V46, P148, DOI 10.1016/j.exger.2010.12.001
   Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Jokinen R, 2017, REDOX BIOL, V12, P246, DOI 10.1016/j.redox.2017.02.011
   Jung HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05303-2
   Jung SK, 2010, BIOCHEM PHARMACOL, V79, P1455, DOI 10.1016/j.bcp.2010.01.004
   Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67
   Kantor ED, 2018, CANCER CAUSE CONTROL, V29, P389, DOI 10.1007/s10552-018-1003-6
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Kim J, 2015, EUR J PHARMACOL, V748, P108, DOI 10.1016/j.ejphar.2014.12.010
   Kim MK, 2017, J DERMATOL SCI, V86, P252, DOI 10.1016/j.jdermsci.2017.03.019
   Kim YJ, 2006, LIFE SCI, V78, P2523, DOI 10.1016/j.lfs.2005.10.034
   Kitani K, 2007, BIOGERONTOLOGY, V8, P567, DOI 10.1007/s10522-007-9100-z
   Koff WC, 2020, NEW ENGL J MED, V383, P804, DOI 10.1056/NEJMp2006761
   Kumar R, 2020, ARCH GERONTOL GERIAT, V90, DOI 10.1016/j.archger.2020.104133
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Lan JR, 2015, J ETHNOPHARMACOL, V161, P69, DOI 10.1016/j.jep.2014.09.049
   Lane M., 1998, Journal of Anti-Aging Medicine, V1, P327, DOI [10.1089/rej.1.1998.1.327, DOI 10.1089/REJ.1.1998.1.327]
   Lee JH, 2015, ONCOTARGET, V6, P9701, DOI 10.18632/oncotarget.3832
   Lee SH, 2013, BMB REP, V46, P181, DOI 10.5483/BMBRep.2013.46.4.033
   Legeay S, 2015, NUTRIENTS, V7, P5443, DOI 10.3390/nu7075230
   Li ZH, 2020, ANN RHEUM DIS, V79, P829, DOI 10.1136/annrheumdis-2020-217176
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Liu CQ, 2015, CANCER LETT, V362, P8, DOI 10.1016/j.canlet.2015.03.019
   Liu PP, 2017, ACTA PHARMACOL SIN, V38, P488, DOI 10.1038/aps.2016.143
   López-Lluch G, 2016, J PHYSIOL-LONDON, V594, P2043, DOI 10.1113/JP270543
   López-Otin C, 2023, CELL, V186, P243, DOI 10.1016/j.cell.2022.11.001
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lundberg JO, 2018, CELL METAB, V28, P9, DOI 10.1016/j.cmet.2018.06.007
   Lushchak O, 2021, ADV EXP MED BIOL, V1286, P145, DOI 10.1007/978-3-030-55035-6_11
   Ma ZY, 2023, PLOS ONE, V18, DOI 10.1371/journal.pone.0282210
   Madeo F, 2019, CELL METAB, V29, P592, DOI 10.1016/j.cmet.2019.01.018
   Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788
   Mahmoodpoor A, 2022, GENE, V811, DOI 10.1016/j.gene.2021.146069
   Malavolta M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040909
   Marin TL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf7478
   Martel J, 2021, AGEING RES REV, V66, DOI 10.1016/j.arr.2020.101240
   Martin-Castillo B, 2010, CELL CYCLE, V9, P1057, DOI 10.4161/cc.9.6.10994
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063
   Menendez JA, 2020, AGING-US, V12, P8760, DOI 10.18632/aging.103347
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Mizusaki A, 2017, J FUNCT FOODS, V32, P176, DOI 10.1016/j.jff.2017.02.030
   Mlcek J, 2016, MOLECULES, V21, DOI 10.3390/molecules21050623
   Moretti CH, 2020, FREE RADICAL BIO MED, V160, P860, DOI 10.1016/j.freeradbiomed.2020.09.018
   Mouchiroud L, 2010, BIOFACTORS, V36, P377, DOI 10.1002/biof.127
   Mu HN, 2015, FREE RADICAL BIO MED, V85, P237, DOI 10.1016/j.freeradbiomed.2015.04.033
   Muhammad MH, 2018, J PHYSIOL SCI, V68, P681, DOI 10.1007/s12576-017-0582-4
   Navarrete-Yañez V, 2020, FOOD FUNCT, V11, P10351, DOI [10.1039/d0fo02438d, 10.1039/D0FO02438D]
   Ni YQ, 2021, AGING DIS, V12, P1948, DOI 10.14336/AD.2021.0603
   Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133
   Novotná R, 2023, MOLECULES, V28, DOI 10.3390/molecules28041728
   Okada Y, 2020, MOL BIOL REP, V47, P1021, DOI 10.1007/s11033-019-05194-8
   Omran HM, 2020, J INFECT PUBLIC HEAL, V13, P1196, DOI 10.1016/j.jiph.2020.06.004
   Pan MH, 2009, CARCINOGENESIS, V30, P1234, DOI 10.1093/carcin/bgp121
   Phillips T, 2004, REJUV RES, V7, P243, DOI 10.1089/rej.2004.7.243
   Pietrocola F, 2015, CELL DEATH DIFFER, V22, P509, DOI 10.1038/cdd.2014.215
   Pietrocola F, 2012, CELL CYCLE, V11, P3851, DOI 10.4161/cc.22027
   Proshkina E, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00505
   Quiles JL, 2020, ENVIRON RES, V191, DOI 10.1016/j.envres.2020.110053
   Rahmani Arshad Husain, 2018, Adv Biomed Res, V7, P38, DOI 10.4103/abr.abr_147_16
   Rai U, 2015, PHARMACOL THERAPEUT, V152, P98, DOI 10.1016/j.pharmthera.2015.05.007
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Roohbakhsh A, 2014, LIFE SCI, V113, P1, DOI 10.1016/j.lfs.2014.07.029
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Saccon TD, 2021, J GERONTOL A-BIOL, V76, P1895, DOI 10.1093/gerona/glab002
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Saraswat K, 2019, REJUV RES, V22, P377, DOI 10.1089/rej.2018.2125
   Saraswat K, 2017, EXPERT OPIN DRUG DIS, V12, P955, DOI 10.1080/17460441.2017.1349750
   Sataranatarajan K, 2016, J GERONTOL A-BIOL, V71, P850, DOI 10.1093/gerona/glv170
   Saul N, 2011, J NAT PROD, V74, P1713, DOI 10.1021/np200011a
   Sciarretta S, 2021, CARDIOVASC RES, V117, P1434, DOI 10.1093/cvr/cvaa297
   Shahmirzadi AA, 2020, CELL METAB, V32, P447, DOI 10.1016/j.cmet.2020.08.004
   Sharma P., 2021, Cent. Asian J. Med. Hypotheses Ethics, V2, P51
   Sharma S, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108183
   Sheng X, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.735483
   Shintani T, 2018, J APPL GLYOSCI, V65, P37, DOI 10.5458/jag.jag.JAG-2018_002
   Si HW, 2021, CURR MED CHEM, V28, P3, DOI 10.2174/0929867327666191230104958
   Si HW, 2019, FASEB J, V33, P965, DOI [10.1096/fj.201800554RR, 10.1096/fj.201800554rr]
   Singh A., 2023, Emerg. Anti-aging Strateg.=, P57
   Soda K, 2009, J NUTR SCI VITAMINOL, V55, P361, DOI 10.3177/jnsv.55.361
   Son DH, 2019, KOREAN J FAM MED, V40, P289, DOI 10.4082/kjfm.19.0087
   Song Q., 2023, Adv. Nutr
   Sorrenti V., 2023, Adv. Nutr
   Spindler SR, 2013, REJUV RES, V16, P143, DOI 10.1089/rej.2012.1386
   Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007
   Stanisic D, 2020, MOLECULES, V25, DOI 10.3390/molecules25194534
   Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Su Y, 2019, AGING-US, V11, P4183, DOI 10.18632/aging.102045
   Sun KY, 2012, BIOSCI BIOTECH BIOCH, V76, P640, DOI 10.1271/bbb.110535
   Sun LY, 2013, ELIFE, V2, DOI 10.7554/eLife.01098
   Sun PF, 2022, AESTHET PLAST SURG, V46, P192, DOI 10.1007/s00266-021-02335-y
   Surh YJ, 2016, ADV EXP MED BIOL, V928, P185, DOI 10.1007/978-3-319-41334-1_9
   Tucci P, 2012, AGING-US, V4, P525, DOI 10.18632/aging.100481
   Tyszka-Czochara M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020462
   Vaiserman A, 2020, PHARMANUTRITION, V14, DOI 10.1016/j.phanu.2020.100226
   Vaiserman AM, 2016, AGEING RES REV, V31, P9, DOI 10.1016/j.arr.2016.08.004
   Valerio A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00006
   Varoni EM, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00008
   Vitale G, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00027
   Wagner AE, 2015, ONCOTARGET, V6, P30568, DOI 10.18632/oncotarget.5215
   Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563
   Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014
   Xiao K, 2013, J PHARMACOL SCI, V123, P102, DOI 10.1254/jphs.13085FP
   Yamamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098972
   Yan J, 2019, BRIT J PHARMACOL, V176, P3126, DOI 10.1111/bph.14706
   Yanishlieva NV, 2001, EUR J LIPID SCI TECH, V103, P752, DOI 10.1002/1438-9312(200111)103:11<752::AID-EJLT752>3.0.CO;2-0
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Yu Y, 2018, J NUTR HEALTH AGING, V22, P710, DOI 10.1007/s12603-018-1015-7
   Zdzisinska B, 2017, ARCH IMMUNOL THER EX, V65, P21, DOI 10.1007/s00005-016-0406-x
   Zhang DX, 2016, METABOLISM, V65, P454, DOI 10.1016/j.metabol.2015.11.010
   Zhang JW, 2016, AGEING RES REV, V25, P55, DOI 10.1016/j.arr.2015.11.006
   Zhang M, 2012, MOL CELL ENDOCRINOL, V363, P122, DOI 10.1016/j.mce.2012.08.006
   Zhang T, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7861290
   Zhang Y, 2021, AGEING RES REV, V70, DOI 10.1016/j.arr.2021.101376
   Zhang YX, 2023, EXP GERONTOL, V179, DOI 10.1016/j.exger.2023.112248
   Zheng J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00472
   Zhou DD, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/9932218
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
   Zhu XF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123903
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
   Zhu Zongjian, 2011, J Carcinog, V10, P17
   Zia A, 2021, BIOMED PHARMACOTHER, V134, DOI 10.1016/j.biopha.2020.111119
   Zuhra K, 2022, NITRIC OXIDE-BIOL CH, V128, P12, DOI 10.1016/j.niox.2022.07.007
NR 197
TC 0
Z9 0
U1 3
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD 2024 JAN 15
PY 2024
VL 692
AR 149354
DI 10.1016/j.bbrc.2023.149354
EA DEC 2023
PG 16
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA EA8G0
UT WOS:001136267500001
PM 38091837
DA 2024-02-19
ER

PT J
AU Kregel, KC
AF Kregel, KC
TI Alterations in autonomic adjustments to acute hypoxia in conscious rats
   with aging
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE sympathetic nervous system; blood pressure; norepinephrine turnover;
   systemic hemodynamics
ID SYMPATHETIC ACTIVITY; RESPONSES; AGE; NOREPINEPHRINE; HYPOXEMIA; STRESS;
   NERVE; IMPAIRMENT; INCREASE; OXYGEN
AB The experimental objective was to determine whether sympathetic nervous system activity and cardiovascular adjustments to hypoxia are altered with advancing age. Norepinephrine (NE) synthesis was blocked with alpha-methyl-DL-p-tyrosine, and NE turnover rates were determined in the left ventricle of the heart, kidney, liver, and adrenal gland in groups of conscious unrestrained mature (12-mo-old) and senescent (24-mo-old) Fischer 344 rats in conditions of normoxia and acute hypocapnic hypoxia (10% O-2-90% N-2). Calculated NE turnover rates were similar in all four tissues sampled for both age groups in the normoxic condition. Thirty minutes of hypoxia produced elevations in NE turnover rates in the kidney, liver, and adrenal gland, but not in the heart, for both the mature and senescent groups. However, NE turnover rates were attenuated in the kidney (92 vs. 195%) and liver (119 vs. 190%) of senescent compared with mature rats. Hypoxia produced no change in mean arterial pressure from normoxic levels in the mature rats, whereas older rats had a progressive decline in mean arterial pressure (-24 +/- 3 mmHg from baseline) over the course of the hypoxic exposure. In contrast, heart rate responses were similar in the normoxic and hypoxic conditions for both age groups. These findings indicate that sympathetic nerve activity, as estimated from NE turnover rates, increases in a tissue-specific manner with moderate hypoxia, but this increase is markedly attenuated in the kidney and liver with advancing age. In addition, the ability to maintain MAP during a hypoxic challenge is impaired with aging, perhaps due, in part, to a reduced sympathetic vasoconstriction to selected internal organs.
RP Kregel, KC (corresponding author), UNIV IOWA,DEPT EXERCISE SCI,516 FIELD HOUSE,IOWA CITY,IA 52242, USA.
FU NIA NIH HHS [AG-12350] Funding Source: Medline
CR BHAGAT B, 1967, J PHARMACOL EXP THER, V157, P74
   BIESOLD D, 1989, JPN J PHYSIOL, V39, P511, DOI 10.2170/jjphysiol.39.511
   BRODIE BB, 1966, J PHARMACOL EXP THER, V154, P493
   CHIUEH CC, 1980, NEUROBIOL AGING, V1, P157, DOI 10.1016/0197-4580(80)90010-X
   DAUGHERTY RM, 1967, AM J PHYSIOL, V213, P1102
   ESLER MD, 1995, CIRCULATION, V91, P351, DOI 10.1161/01.CIR.91.2.351
   FUKUDA Y, 1989, J AUTONOM NERV SYST, V28, P61, DOI 10.1016/0165-1838(89)90008-8
   HAJDUCZOK G, 1991, AM J PHYSIOL, V260, pH1113, DOI 10.1152/ajpheart.1991.260.4.H1113
   HEISTAD DD, 1975, J PHARMACOL EXP THER, V193, P941
   HEISTAD DD, 1980, CIRCULATION, V61, P463, DOI 10.1161/01.CIR.61.3.463
   HENRY DP, 1986, LIFE SCI, V38, P1473, DOI 10.1016/0024-3205(86)90560-6
   IRIKI M, 1972, JPN J PHYSIOL, V22, P585
   JOHNSON TS, 1983, J CLIN INVEST, V71, P1263, DOI 10.1172/JCI110876
   KORNER PI, 1969, CIRC RES, V24, P671, DOI 10.1161/01.RES.24.5.671
   KREGEL KC, 1995, J APPL PHYSIOL, V79, P706, DOI 10.1152/jappl.1995.79.3.706
   KREGEL KC, 1994, J APPL PHYSIOL, V76, P1226, DOI 10.1152/jappl.1994.76.3.1226
   KREGEL KC, 1993, J APPL PHYSIOL, V74, P1988, DOI 10.1152/jappl.1993.74.4.1988
   KUWAHIRA I, 1993, J APPL PHYSIOL, V74, P211, DOI 10.1152/jappl.1993.74.1.211
   Lakatta Edward G., 1995, P413
   Levitzky M G, 1984, Physiologist, V27, P102
   LUGLIANI R, 1973, CHEST, V63, P744, DOI 10.1378/chest.63.5.744
   MAZZEO RS, 1989, J APPL PHYSIOL, V66, P1506, DOI 10.1152/jappl.1989.66.3.1506
   MCCARTY R, 1986, GERONTOLOGY, V32, P172, DOI 10.1159/000212785
   ROWELL LB, 1989, J APPL PHYSIOL, V66, P1736, DOI 10.1152/jappl.1989.66.4.1736
   ROWELL LB, 1987, CLIN PHYSIOL, V7, P349, DOI 10.1111/j.1475-097X.1987.tb00179.x
   SATO A, 1991, J AUTONOM NERV SYST, V32, P63, DOI 10.1016/0165-1838(91)90236-V
   SATO A, 1993, NEUROSCI LETT, V161, P97, DOI 10.1016/0304-3940(93)90149-F
   SEALS DR, 1994, MED SCI SPORT EXER, V26, P568
   SEALS DR, 1993, PERSPECTIVES EXERCIS, P257
   SOMERS VK, 1989, J APPL PHYSIOL, V67, P2095, DOI 10.1152/jappl.1989.67.5.2095
   SUN MK, 1992, AM J PHYSIOL, V262, pR182, DOI 10.1152/ajpregu.1992.262.2.R182
   TANABE S, 1989, AM J PHYSIOL, V256, pH1399, DOI 10.1152/ajpheart.1989.256.5.H1399
   WALKER BR, 1988, AM J PHYSIOL, V254, pR552, DOI 10.1152/ajpregu.1988.254.3.R552
NR 33
TC 12
Z9 12
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 8750-7587
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD FEB
PY 1996
VL 80
IS 2
BP 540
EP 546
DI 10.1152/jappl.1996.80.2.540
PG 7
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA UE824
UT WOS:A1996UE82400025
PM 8929596
DA 2024-02-19
ER

PT J
AU Almaida-Pagán, PF
   de Costa, J
   Mendiola, P
   Tocher, DR
AF Almaida-Pagan, Pedro F.
   de Costa, Jorge
   Mendiola, Pilar
   Tocher, Douglas R.
TI Changes in tissue and mitochondrial membrane composition during rapid
   growth, maturation and aging in rainbow trout, <i>Oncorhynchus
   mykiss</i>
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
DE Aging; Cardiolipin; Fish; Mitochondria; Oxidative stress
ID UNSATURATED FATTY-ACIDS; OXIDATIVE STRESS; LIFE-SPAN;
   LIPID-PEROXIDATION; TELEOST FISH; PHOSPHOLIPIDS; CARDIOLIPIN; RAT; AGE;
   MUSCLE
AB Membrane compositions, particularly of mitochondria, could be critical factors in the mechanisms of growth and aging processes, especially during phases of high oxidative stress that result in molecular damage. In the present study, liver and mitochondrial membrane phospholipid (PL) compositions were analyzed in rainbow trout during its four first years of life, a period characterized by rapid growth and high oxidative stress. Specifically, farmed fish of three ages (1-, 2- and 4-years) were studied, and PL compositions of whole liver and liver mitochondria, and fatty acid compositions of individual PL classes were determined. Liver mitochondrial membranes showed a PL composition different to that of the whole tissue suggesting adaptation of cell and subcellular membranes to specific functions. Individual PL had characteristic fatty acid compositions that were similar in whole liver and mitochondrial membranes. Whole liver and mitochondria showed increased lipid peroxidation with age along with changes in membrane PL fatty acid compositions. Most PL classes showed similar changes in fatty acid composition among the age groups, with reduced proportions of docosahexaenoic acid (DHA) and, generally, concomitantly increased levels of monounsaturated fatty acids, which together resulted in reduced peroxidation index (PIn). However, total polyunsaturated fatty acid (PUFA) content did not change significantly with age due to increased eicosapentaenoic acid, docosapentaenoic acid and, in most PI, increased n-6 PUFA. These results suggest there may be oxidation of PL DHA with compensatory mechanisms to maintain membrane fluidity and function. However, modification of fatty acid composition of specific PLs, such as cardiolipin, could affect the electron transport chain efficiency and propagate the oxidative reaction throughout the cell. In addition, both the content and fatty acid composition of sphingomyelin, which has been suggested as a possible mediator of cell dysfunction and apoptosis, changed with age differently to the other PL classes. Moreover, these changes showed different trends between mitochondria and whole liver. These data suggest there is marked oxidative stress associated with rapid growth and maturation in rainbow trout. Changes observed in membrane lipids point to their possible participation in the processes involved in this species response to oxidative stress and damage accumulation rate. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Almaida-Pagan, Pedro F.; Tocher, Douglas R.] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland.
   [de Costa, Jorge; Mendiola, Pilar] Univ Murcia, Fac Biol, Dept Physiol, E-30100 Murcia, Spain.
C3 University of Stirling; University of Murcia
RP Almaida-Pagán, PF (corresponding author), Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland.
EM pedro.almaida@stir.ac.uk
RI Tocher, Douglas R/C-5652-2011; ALMAIDA-PAGÁN, PEDRO
   FRANCISCO/A-9190-2019
OI Tocher, Douglas R/0000-0002-8603-9410; ALMAIDA-PAGÁN, PEDRO
   FRANCISCO/0000-0003-1965-3813
FU Fundacion Ramon Areces
FX This project was funded by a Fundacion Ramon Areces post-doctoral grant
   to P.F. Almaida-Pagan.
CR ACKMAN RG, 1980, ADV FISH SCI TECHNOL, P83
   Almroth BC, 2010, COMP BIOCHEM PHYS B, V155, P442, DOI 10.1016/j.cbpb.2010.01.012
   Alonso-Alvarez C, 2007, FUNCT ECOL, V21, P873, DOI 10.1111/j.1365-2435.2007.01300.x
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barceló-Coblijn G, 2008, LIPIDS, V43, P971, DOI 10.1007/s11745-008-3212-3
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   BIELSKI BHJ, 1983, J BIOL CHEM, V258, P4759
   BURK RF, 1980, BIOCHIM BIOPHYS ACTA, V618, P35, DOI 10.1016/0005-2760(80)90051-X
   Christie WW., 2003, LIPID ANAL ISOLATION
   Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Henderson R.J., 1992, Lipid Analysis: A Practical Approach, P65
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   Hsu CY, 2008, J GERONTOL A-BIOL, V63, P1267, DOI 10.1093/gerona/63.12.1267
   Hulbert AJ, 2008, COMP BIOCHEM PHYS A, V150, P196, DOI 10.1016/j.cbpa.2006.05.014
   Hulbert AJ, 2007, LIPIDS, V42, P811, DOI 10.1007/s11745-007-3058-0
   Inness CLW, 2008, P ROY SOC B-BIOL SCI, V275, P1703, DOI 10.1098/rspb.2008.0357
   Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6
   Kraffe E, 2007, J EXP BIOL, V210, P149, DOI 10.1242/jeb.02628
   Lucas-Sánchez A, 2011, EXP GERONTOL, V46, P970, DOI 10.1016/j.exger.2011.08.009
   Obeid LM, 1994, BIOCHEM SOC T, V25, P1171
   OLSEN RE, 1989, J EXP MAR BIOL ECOL, V129, P189, DOI 10.1016/0022-0981(89)90056-7
   Ostbye TK, 2011, AQUACULT NUTR, V17, P177, DOI 10.1111/j.1365-2095.2009.00721.x
   Otto DME, 1996, FISH PHYSIOL BIOCHEM, V15, P349, DOI 10.1007/BF02112362
   Pamplona R, 2011, BIOGERONTOLOGY, V12, P409, DOI 10.1007/s10522-011-9348-1
   Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9
   Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016
   Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020
   Paradies G, 2010, J PINEAL RES, V48, P297, DOI 10.1111/j.1600-079X.2010.00759.x
   Passi S, 2004, J AGR FOOD CHEM, V52, P2587, DOI 10.1021/jf030559t
   Rajapakse N, 2001, BRAIN RES PROTOC, V8, P176, DOI 10.1016/S1385-299X(01)00108-8
   Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Subbaiah PV, 1999, J BIOL CHEM, V274, P36409, DOI 10.1074/jbc.274.51.36409
   Tocher DR, 2008, AQUACULTURE, V280, P21, DOI 10.1016/j.aquaculture.2008.04.034
   TOCHER DR, 1988, FISH PHYSIOL BIOCHEM, V5, P229, DOI 10.1007/BF01874800
   Tsalouhidou S, 2006, J ANIM SCI, V84, P2818, DOI 10.2527/jas.2006-031
   WITTING LA, 1964, J NUTR, V82, P19, DOI 10.1093/jn/82.1.19
   Zabelinskii SA, 1999, COMP BIOCHEM PHYS B, V124, P187, DOI 10.1016/S0305-0491(99)00113-3
   Zar JH., 1998, BIOSTAT ANAL, V4th
NR 41
TC 14
Z9 14
U1 0
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1096-4959
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PD APR
PY 2012
VL 161
IS 4
BP 404
EP 412
DI 10.1016/j.cbpb.2012.01.006
PG 9
WC Biochemistry & Molecular Biology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Zoology
GA 910AJ
UT WOS:000301609300014
PM 22281523
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Williams, EG
   Pfister, N
   Roy, S
   Statzer, C
   Haverty, J
   Ingels, J
   Bohl, C
   Hasan, M
   Cuklina, J
   Bühlmann, P
   Zamboni, N
   Lu, L
   Ewald, CY
   Williams, RW
   Aebersold, R
AF Williams, Evan G.
   Pfister, Niklas
   Roy, Suheeta
   Statzer, Cyril
   Haverty, Jack
   Ingels, Jesse
   Bohl, Casey
   Hasan, Moaraj
   Cuklina, Jelena
   Buhlmann, Peter
   Zamboni, Nicola
   Lu, Lu
   Ewald, Collin Y.
   Williams, Robert W.
   Aebersold, Ruedi
TI Multiomic profiling of the liver across diets and age in a diverse mouse
   population
SO CELL SYSTEMS
LA English
DT Article; Early Access
ID LIFE-SPAN; CATHEPSIN-D; LONGEVITY; RESTRICTION
AB We profiled the liver transcriptome, proteome, and metabolome in 347 individuals from 58 isogenic strains of the BXD mouse population across age (7 to 24 months) and diet (low or high fat) to link molecular variations to metabolic traits. Several hundred genes are affected by diet and/or age at the transcript and protein levels. Orthologs of two aging-associated genes, St7 and Ctsd, were knocked down in C. elegans, reducing longevity in wild-type and mutant long-lived strains. The multiomics data were analyzed as segregating gene networks according to each independent variable, providing causal insight into dietary and aging effects. Candidates were cross-examined in an independent diversity outbred mouse liver dataset segregating for similar diets, with -80%-90% of diet-related candidate genes found in common across datasets. Together, we have developed a large multiomics resource for multivariate analysis of complex traits and demonstrate a methodology for moving from observational associations to causal connections.
C1 [Williams, Evan G.; Haverty, Jack] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.
   [Pfister, Niklas] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark.
   [Roy, Suheeta; Ingels, Jesse; Bohl, Casey; Lu, Lu; Williams, Robert W.] Univ Tennessee, Dept Genet Genom & Informat, Hlth Sci Ctr, Memphis, TN USA.
   [Statzer, Cyril; Ewald, Collin Y.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.
   [Hasan, Moaraj; Cuklina, Jelena; Zamboni, Nicola; Aebersold, Ruedi] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland.
   [Buhlmann, Peter] Swiss Fed Inst Technol, Dept Math, Seminar Stat, Zurich, Switzerland.
   [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland.
C3 University of Luxembourg; University of Copenhagen; University of
   Tennessee System; University of Tennessee Health Science Center; Swiss
   Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal
   Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of
   Technology Domain; ETH Zurich; University of Zurich
RP Williams, EG (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.
EM evan.williams@uni.lu
RI Bühlmann, Peter/A-2107-2013; lu, lu/HGA-0894-2022; Hasan,
   Moaraj/JLL-6646-2023; Ewald, Collin/K-6303-2015; Williams, Evan
   G/M-7539-2017; lu, lu/HII-7530-2022; Zamboni, Nicola/K-3042-2012; LU,
   LU/JEZ-4760-2023
OI Bühlmann, Peter/0000-0002-1782-6015; Ewald, Collin/0000-0003-1166-4171;
   Williams, Evan G/0000-0002-9746-376X; Zamboni,
   Nicola/0000-0003-1271-1021; Pfister, Niklas/0000-0001-6203-9777
FU EPFL; ETHZ; NIH [R01AG043930, F32GM119190]; European Research Council
   [670821, AdvG-233226]; SNSF [31003A-140780, 31003A-143914,
   CSRII3-136201, PP00P3_163898]; ERC [786461]; European Research Council
   (ERC) [670821, 786461] Funding Source: European Research Council (ERC);
   Swiss National Science Foundation (SNF) [PP00P3_163898] Funding Source:
   Swiss National Science Foundation (SNF)
FX Research was further supported by the EPFL, ETHZ, the NIH (R01AG043930
   to R.W.W.) , the European Research Council (Proteomics4D) (AdvG grant
   670821 and proteomics v3.0; AdvG-233226 to R.A.) , and SNSF
   (31003A-140780, 31003A-143914, and CSRII3-136201 to R.A., PP00P3_163898
   to C.S. and C.Y.E.) . N.P. and P.B. were supported by ERC no. 786461
   (Causal-Stats-ERC-2017-AdvG) . E.G.W. was supported by an NIH F32 Ruth
   Kirch-stein Fellowship (F32GM119190) . Thanks to Lorne Rose at the
   University of Tennessee Center of Excellence Sequencing Facility for
   transcriptomics; to Sebastien Lamy at the EPFL phenotyping unit (UDP)
   for clinical blood analysis; to Casey Chapman for BXD colony
   maintenance; and to Ludovic Gillet, Patrick Pedrioli, Odzgen Eren, Chloe
   Lee, and Yansheng Liu for proteomics discussions.
CR Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012
   Ashbrook DG, 2021, CELL SYST, V12, P235, DOI 10.1016/j.cels.2020.12.002
   Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Bate S.T., 2014, DESIGN STAT ANAL ANI
   Belknap JK, 1998, BEHAV GENET, V28, P29, DOI 10.1023/A:1021404714631
   Bell CG, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1824-y
   Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008
   Broman KW, 2019, GENETICS, V211, P495, DOI 10.1534/genetics.118.301595
   Cellerino A, 2017, SEMIN CELL DEV BIOL, V70, P177, DOI 10.1016/j.semcdb.2017.06.012
   Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270
   Cuklina J, 2021, MOL SYST BIOL, V17, DOI 10.15252/msb.202110240
   De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707
   Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80
   Ewald CY, 2020, GERONTOLOGY, V66, P266, DOI 10.1159/000504295
   Ewald CY, 2017, ELIFE, V6, DOI 10.7554/eLife.19493
   FENUKU RIA, 1975, CLIN CHIM ACTA, V60, P303, DOI 10.1016/0009-8981(75)90071-6
   Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k
   FUNGWE TV, 1994, J LIPID RES, V35, P311
   GELMAN R, 1988, GENETICS, V118, P693
   Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717
   Giurgiu M, 2019, NUCLEIC ACIDS RES, V47, pD559, DOI 10.1093/nar/gky973
   Harris TW, 2020, NUCLEIC ACIDS RES, V48, pD762, DOI 10.1093/nar/gkz920
   Hook M, 2018, BBA-MOL BASIS DIS, V1864, P2718, DOI 10.1016/j.bbadis.2018.01.026
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jazwinski SM, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00263
   Keele GR, 2021, CELL GENOM, V1, DOI 10.1016/j.xgen.2021.100003
   Kesmodel US, 2018, ACTA OBSTET GYN SCAN, V97, P388, DOI 10.1111/aogs.13331
   Kraja AT, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-41
   Kruse SE, 2016, AGING CELL, V15, P89, DOI 10.1111/acel.12412
   Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955
   Lancaster SM, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10121606
   Lang DH, 2010, AGING CLIN EXP RES, V22, P8, DOI 10.1007/BF03324809
   Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Liu YS, 2019, NAT BIOTECHNOL, V37, P314, DOI 10.1038/s41587-019-0037-y
   Ludwig C, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178126
   Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/NMETH.2016, 10.1038/nmeth.2016]
   Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432
   Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281
   Meinshausen N, 2016, P NATL ACAD SCI USA, V113, P7361, DOI 10.1073/pnas.1510493113
   Meinshausen N, 2010, J ROY STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x
   Mulligan MK, 2017, METHODS MOL BIOL, V1488, P75, DOI 10.1007/978-1-4939-6427-7_4
   Pfister N, 2021, ANN APPL STAT, V15, P1220, DOI 10.1214/21-AOAS1487
   Poulos RC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17641-3
   Rikke BA, 2010, EXP GERONTOL, V45, P691, DOI 10.1016/j.exger.2010.04.008
   Röst HL, 2014, NAT BIOTECHNOL, V32, P219, DOI 10.1038/nbt.2841
   Rosenberger G, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.31
   Roy S, 2021, NAT METAB, V3, P1217, DOI 10.1038/s42255-021-00449-w
   Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604
   Sadler NC, 2018, CHEM RES TOXICOL, V31, P308, DOI 10.1021/acs.chemrestox.8b00008
   Santra M, 2019, P NATL ACAD SCI USA, V116, P22173, DOI 10.1073/pnas.1906592116
   Sato Y, 2006, MECH AGEING DEV, V127, P771, DOI 10.1016/j.mad.2006.07.001
   Srivastava S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120398
   Stoeger T, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006643
   Stoka V, 2016, AGEING RES REV, V32, P22, DOI 10.1016/j.arr.2016.04.010
   Stroustrup N, 2013, NAT METHODS, V10, P665, DOI [10.1038/NMETH.2475, 10.1038/nmeth.2475]
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun YN, 2020, ELIFE, V9, DOI 10.7554/eLife.55745
   Templeman NM, 2018, CURR BIOL, V28, P753, DOI 10.1016/j.cub.2018.01.052
   Teuscher AC, 2019, METHODS MOL BIOL, V1944, P169, DOI 10.1007/978-1-4939-9095-5_13
   Vafaie F, 2014, AGING CELL, V13, P121, DOI 10.1111/acel.12155
   Visscher M, 2016, CELL REP, V16, P3041, DOI 10.1016/j.celrep.2016.08.025
   Vizcaíno JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145
   Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523
   White MC, 2014, AM J PREV MED, V46, pS7, DOI 10.1016/j.amepre.2013.10.029
   Whitelegge JP, 2013, ANAL CHEM, V85, P2558, DOI 10.1021/ac303064a
   WIEDERANDERS B, 1984, MECH AGEING DEV, V24, P265, DOI 10.1016/0047-6374(84)90112-X
   Williams EG, 2018, MOL CELL PROTEOMICS, V17, P1766, DOI 10.1074/mcp.RA118.000554
   Williams EG, 2016, SCIENCE, V352, DOI 10.1126/science.aad0189
   Wu Yibo, 2017, Curr Protoc Mouse Biol, V7, P130, DOI 10.1002/cpmo.28
NR 74
TC 15
Z9 15
U1 2
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2405-4712
EI 2405-4720
J9 CELL SYST
JI Cell Syst.
PD 2022 JAN 19
PY 2022
VL 13
IS 1
DI 10.1016/j.cels.2021.09.005
EA JAN 2022
PG 22
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA YM5TJ
UT WOS:000746636800001
PM 34666007
OA Green Submitted, Green Accepted, hybrid
DA 2024-02-19
ER

PT S
AU Yildirim, ZL
   Kiliç, N
   Ozer, Ç
   Babul, A
   Take, G
   Erdogan, D
AF Yildirim, Zuha L.
   Kilic, Nedret
   Ozer, Cigdem
   Babul, Aydan
   Take, Gulnur
   Erdogan, Deniz
BE Rattan, SIS
   Akman, S
TI Effects of taurine in cellular responses to oxidative stress in young
   and middle-aged rat liver
SO BIOGERONTOLOGY: MECHANISMS AND INTERVENTIONS
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 5th European Congress of Biogerontology
CY SEP 16-20, 2006
CL Istanbul, TURKEY
DE aging; taurine; liver; oxidative stress; rat
ID LIPID-PEROXIDATION; THIOREDOXIN REDUCTASE; ANTIOXIDANT; GLUTATHIONE;
   ENZYMES; MALONDIALDEHYDE; RADICALS; BRAIN; HEART; ACID
AB Aging is related with an increased cellular level of lipid peroxides and reactive oxygen species (ROS). The useful effects of taurine as an antioxidant in biological systems have been attributed to its capability to stabilize biomembranes, to scavenge ROS, and to decrease the peroxidation of unsaturated membrane lipids. The aim of the present study was to investigate the effects of taurine on malondialdehyde (MDA), glutathione (GSH), glutathione peroxidase (GPx), thioredoxin reductase (TR), and endothelial nitric oxide synthase (eNOS) in young and middle-aged rat liver. There was not a significant difference in liver MDA levels between the control groups of young and middle-aged rats (P > 0.05). However, liver GSH levels, and GPx and TR activities between the control groups of young and middle-aged rats were significantly different (P < 0.05). Liver MDA level was significantly lower in the taurine group of middle-aged rats (P < 0.05). Liver GSH levels, and GPx and TR activities were significantly increased in the taurine group of middle-aged rats when compared to the control group (P < 0.05). Liver MDA level was significantly lower in the taurine group of young rats than the ones in the control group (P < 0.05). Liver TR activity was significantly increased in the taurine group of young rats when compared to the control group (P < 0.05). Liver GPx activity was not statistically different between the taurine and the control groups in young rats (P > 0.05). Liver GSH levels were not different between the young taurine and the control groups (P > 0.05). Immunohistochernical studies exhibited no change in eNOS
C1 Gazi Univ, Fac Med, Dept Med Biochem, TR-06510 Besevler, Turkey.
C3 Gazi University
RP Yildirim, ZL (corresponding author), Gazi Univ, Fac Med, Dept Med Biochem, TR-06510 Besevler, Turkey.
EM zyildirim2004@yahoo.com
RI KILIÇ, NEDRET/AAK-5395-2021
OI KILIC, NEDRET/0000-0002-5747-9433
CR Akbulut H, 1997, DIGEST DIS SCI, V42, P1381
   Akbulut KG, 1999, GERONTOLOGY, V45, P67, DOI 10.1159/000022065
   Arivazhagan P, 2002, EXP GERONTOL, V37, P803, DOI 10.1016/S0531-5565(02)00015-3
   BANKS MA, 1992, ADV EXP MED BIOL, V315, P341
   Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x
   CONGY F, 1995, PRESSE MED, V24, P1115
   DE AK, 1991, MECH AGEING DEV, V59, P123, DOI 10.1016/0047-6374(91)90078-E
   DELAROSA J, 1985, COMP BIOCHEM PHYS B, V81, P565, DOI 10.1016/0305-0491(85)90367-0
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   Gomi F, 1998, J GERONTOL A-BIOL, V53, pB161, DOI 10.1093/gerona/53A.3.B161
   HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001
   HARADA H, 1990, BIOCHEM PHARMACOL, V39, P745, DOI 10.1016/0006-2952(90)90154-D
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Hill KE, 1997, BIOCHEM BIOPH RES CO, V234, P293, DOI 10.1006/bbrc.1997.6618
   HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101
   HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1
   Kim HG, 2003, MOL CELLS, V16, P278
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   Nandhini A. T. A., 2005, SMJ Singapore Medical Journal, V46, P82
   OHTA H, 1998, CARDIOVASC RES, V22, P407
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Penninckx M, 2000, ENZYME MICROB TECH, V26, P737, DOI 10.1016/S0141-0229(00)00165-4
   Pushpakiran G, 2004, AMINO ACIDS, V27, P91, DOI 10.1007/s00726-004-0066-8
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Rockey DC, 2003, HEPATOLOGY, V37, P4, DOI 10.1053/jhep.2003.50044
   RODRIGUEZMARTINEZ MA, 1992, MECH AGEING DEV, V66, P213, DOI 10.1016/0047-6374(92)90137-3
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Waters E, 2001, AM J PHYSIOL-GASTR L, V280, pG1274, DOI 10.1152/ajpgi.2001.280.6.G1274
NR 33
TC 40
Z9 41
U1 1
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER STREET, HOBOKEN, NJ, UNITED STATES
SN 0077-8923
BN 978-1-57331-679-8
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2007
VL 1100
BP 553
EP 561
DI 10.1196/annals.1395.061
PG 9
WC Biochemistry & Molecular Biology; Geriatrics & Gerontology;
   Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Geriatrics & Gerontology; Science &
   Technology - Other Topics
GA BGG91
UT WOS:000246733700061
PM 17460221
DA 2024-02-19
ER

PT J
AU FROLKIS, VV
   PARAMONOVA, GI
AF FROLKIS, VV
   PARAMONOVA, GI
TI CYTOCHROME-P-450 CATALYTIC ACTIVITY AND ISOFORM COMPOSITION FOLLOWING
   LIVER DENERVATION IN OLD MALE-RATS
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE LIVER MICROSOMAL OXIDATION; ADREN AND CHOLINERGIC REGULATION; AGING
ID DRUG-METABOLIZING-ENZYMES; FEMALE RATS; CYCLIC-AMP; INDUCTION;
   PHOSPHORYLATION; MICROSOMES; SYSTEM; AGE
AB A study was made concerning the role of adrenergic and cholinergic neural regulation in the functional activity of enzymes of microsomal oxidation in the liver. Experiments were performed on adult and old rats using surgical denervation of liver (vagotomy and sympathotomy). The results obtained showed changes that occurred in the monooxygenase activity (aminopyrine demethylase and aniline hydroxylase), as well as in the isoform composition and inductive synthesis of cytochrome P-450. The neural control over liver detoxication function was found to weaken in old age.
RP FROLKIS, VV (corresponding author), ACAD MED SCI USSR, INST GERONTOL, VYSHGORODSKAYA ST 67, KIEV 252655, UKRAINE, USSR.
RI Paramonova, Galina/T-3791-2019
OI Paramonova, Galina/0000-0001-6568-2434
CR BANHEGYI G, 1988, BIOCHEM PHARMACOL, V37, P849, DOI 10.1016/0006-2952(88)90171-2
   BIRNBAUM LS, 1980, EXP GERONTOL, V15, P259, DOI 10.1016/0531-5565(80)90030-3
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P299, DOI 10.1016/0531-5565(78)90038-4
   CARLSEN RC, 1975, J PHYSIOL-LONDON, V247, P343, DOI 10.1113/jphysiol.1975.sp010935
   DUBOVAJA K, 1987, CYTOCHROME P 450 ENV, P83
   FROLKIS VV, 1966, J GERONTOL, V21, P161, DOI 10.1093/geronj/21.2.161
   Frolkis VV, 1982, AGING LIFE PROLONGIN
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P1861, DOI 10.1016/0006-2952(85)90666-5
   IMAI Y, 1966, J BIOCHEM, V60, P417, DOI 10.1093/oxfordjournals.jbchem.a128453
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KITANI K, 1988, GERONTOLOGY, V34, P55, DOI 10.1159/000212931
   KITANI K, 1988, LIFE CHEM REPORTS, V6, P143
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASUDAMIKAWA R, 1979, J BIOCHEM-TOKYO, V86, P1383, DOI 10.1093/oxfordjournals.jbchem.a132655
   MATSUBARA T, 1977, JPN J PHARMACOL, V27, P127, DOI 10.1254/jjp.27.127
   MCMARTIN DN, 1980, TOXICOL APPL PHARM, V54, P411, DOI 10.1016/0041-008X(80)90168-4
   MESSNER B, 1984, PESTIC BIOCHEM PHYS, V21, P283, DOI 10.1016/0048-3575(84)90065-8
   NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   PALMER H, 1975, J CYCL NUCL RES, V1, P89
   PYERIN W, 1987, BIOCHEM BIOPH RES CO, V142, P885, DOI 10.1016/0006-291X(87)91496-3
   RIKANS LE, 1982, BIOCHEM PHARMACOL, V31, P2339, DOI 10.1016/0006-2952(82)90527-5
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   SHIMAZU T, 1965, BIOCHIM BIOPHYS ACTA, V105, P377, DOI 10.1016/S0926-6593(65)80163-1
   SHIMAZU T, 1986, LIVER AGING, P171
   SHIMAZU T, 1978, LIVER AGING 1978, P263
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   WELTON AF, 1974, BIOCHEM BIOPH RES CO, V56, P898, DOI 10.1016/S0006-291X(74)80273-1
NR 29
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JUL-AUG
PY 1992
VL 15
IS 1
BP 1
EP 11
DI 10.1016/0167-4943(92)90034-2
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA JH356
UT WOS:A1992JH35600001
PM 15374375
DA 2024-02-19
ER

PT J
AU Fujiwara, K
   Yasui, S
   Yonemitsu, Y
   Arai, M
   Kanda, T
   Nakano, M
   Oda, S
   Yokosuka, O
AF Fujiwara, Keiichi
   Yasui, Shin
   Yonemitsu, Yutaka
   Arai, Makoto
   Kanda, Tatsuo
   Nakano, Masayuki
   Oda, Shigeto
   Yokosuka, Osamu
TI Importance of the poor prognosis of severe and fulminant hepatitis in
   the elderly in an era of a highly aging society: Analysis in a Japanese
   center
SO HEPATOLOGY RESEARCH
LA English
DT Article
DE acute liver failure; fulminant hepatitis; old age; outcome; severe
   hepatitis
ID ACUTE LIVER-FAILURE; DISEASES STUDY-GROUP; EARLY INDICATORS;
   TRANSPLANTATION; ETIOLOGY; EXPERIENCE; CRITERIA; VOLUME; STAGE
AB AimOlder age has been widely believed to be associated with a poor prognosis of acute liver failure. We aimed to evaluate the impact of older age on outcomes of Japanese patients with severe and fulminant hepatitis in an era of a highly aging society.
   MethodsWe investigated 105 consecutive adult patients with fulminant hepatitis (FH) or severe hepatitis (SH) admitted to our liver unit between 2000 and 2013, consisting of 14 elderly patients (65 years) and 91 younger ones (<65 years).
   ResultsIn elderly patients, the proportion of women was greater (P<0.001), the levels of aspartate aminotransferase and lactate dehydrogenase on admission were lower (P=0.011 and P=0.010, respectively), and the survival rate without liver transplantation was lower (P=0.024) than younger ones. Two of seven SH and all seven FH elderly patients died, whereas all 45 SH and 16 of 46 FH younger patients recovered. Seventy-one percent of elderly patients had underlying diseases with medications, and 57% had additional complications after the start of treatment for acute liver failure. Patients aged 70 years or more showed even poorer prognoses than younger ones and those aged 65-69 years (P=0.0052 and P=0.036, respectively).
   ConclusionOlder age was associated with a poor prognosis of patients with SH and FH. One of the reasons other than complications and loss of organ reserve by aging would be that elderly patients consulted us at a more advanced stage of illness than younger ones.
C1 [Fujiwara, Keiichi; Yasui, Shin; Yonemitsu, Yutaka; Arai, Makoto; Kanda, Tatsuo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608670, Japan.
   [Oda, Shigeto] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba 2608670, Japan.
   [Nakano, Masayuki] Ofuna Chuo Hosp, Div Pathol, Kamakura, Kanagawa, Japan.
C3 Chiba University; Chiba University
RP Fujiwara, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.
EM fujiwara-cib@umin.ac.jp
RI Kanda, Tatsuo/AFA-8767-2022
OI Kanda, Tatsuo/0000-0002-1654-5385
FU Ministry of Health, Labor and Welfare of Japan by the Intractable
   Hepato-Biliary Disease Study Group of Japan
FX WE ARE INDEBTED to all our colleagues at the liver unit of our hospital
   who cared for the patients described herein. This study was supported in
   part by a Health Labor Sciences Research Grant from the Ministry of
   Health, Labor and Welfare of Japan as a project by the Intractable
   Hepato-Biliary Disease Study Group of Japan.
CR Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9
   Barshes NR, 2006, TRANSPLANTATION, V81, P195, DOI 10.1097/01.tp.0000188149.90975.63
   Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7
   Bernal W, 2009, J HEPATOL, V50, P306, DOI 10.1016/j.jhep.2008.09.012
   Dhiman RK, 2007, LIVER TRANSPLANT, V13, P814, DOI 10.1002/lt.21050
   Fujiwara K, 2002, GUT, V51, P82, DOI 10.1136/gut.51.1.82
   Fujiwara K, 2014, HEPATOL RES, V44, P491, DOI 10.1111/hepr.12148
   Fujiwara K, 2013, HEPATOL INT, V7, P335, DOI 10.1007/s12072-012-9402-3
   Fujiwara K, 2011, HEPATOL RES, V41, P133, DOI 10.1111/j.1872-034X.2010.00755.x
   Fujiwara K, 2008, HEPATOL RES, V38, P646, DOI 10.1111/j.1872-034X.2008.00322.x
   Germani G, 2012, J HEPATOL, V57, P288, DOI 10.1016/j.jhep.2012.03.017
   Lee WM, 2012, SEMIN RESP CRIT CARE, V33, P36, DOI 10.1055/s-0032-1301733
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Martin G. M., 2007, CECIL MED
   Mochida S, 2014, HEPATOL RES, V44, P365, DOI 10.1111/hepr.12295
   Mochida S, 2011, HEPATOL RES, V41, P805, DOI 10.1111/j.1872-034X.2011.00860.x
   O'Grady J, 2014, J HEPATOL, V60, P663, DOI 10.1016/j.jhep.2013.10.024
   OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4
   Oketani M, 2013, HEPATOL RES, V43, P97, DOI 10.1111/j.1872-034X.2012.01105.x
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Schiodt FV, 2009, LIVER TRANSPLANT, V15, P1481, DOI 10.1002/lt.21865
   Schiodt FV, 1999, LIVER TRANSPLANT SUR, V5, P29, DOI 10.1002/lt.500050102
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Trey C, 1970, Prog Liver Dis, V3, P282
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
NR 26
TC 9
Z9 9
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD AUG
PY 2015
VL 45
IS 8
BP 863
EP 871
DI 10.1111/hepr.12426
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CN7GA
UT WOS:000358601100006
PM 25238570
DA 2024-02-19
ER

PT J
AU Yan, SLS
   Hwang, IY
   Kamenyeva, O
   Kabat, J
   Kim, JS
   Park, C
   Kehrl, JH
AF Yan, Serena Li-Sue
   Hwang, Il-Young
   Kamenyeva, Olena
   Kabat, Juraj
   Kim, Ji Sung
   Park, Chung
   Kehrl, John H.
TI Unrestrained Gα<sub>i2</sub> Signaling Disrupts Neutrophil Trafficking,
   Aging, and Clearance
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE neutrophil; chemotaxis; trafficking; chemoattractants; G-protein;
   intravital; RGS protein
ID G-PROTEINS; PROGENITOR CELLS; RGS PROTEINS; REGULATOR; SUBUNIT;
   INFLAMMATION; ACTIVATION; MIGRATION; MUTATION; CASCADE
AB Neutrophil trafficking, homeostatic and pathogen elicited, depends upon chemoattractant receptors triggering heterotrimeric G-protein G alpha(i)beta gamma signaling, whose magnitude and kinetics are governed by RGS protein/G alpha(i) interactions. RGS proteins typically limit G alpha(i) signaling by reducing the duration that G alpha(i) subunits remain GTP bound and able to activate downstream effectors. Yet how in totality RGS proteins shape neutrophil chemoattractant receptor activated responses remains unclear. Here, we show that C57Bl/6 mouse neutrophils containing a genomic knock-in of a mutation that disables all RGS protein-G alpha(i2) interactions (G184S) cannot properly balance chemoattractant receptor signaling, nor appropriately respond to inflammatory insults. Mutant neutrophils accumulate in mouse bone marrow, spleen, lung, and liver; despite neutropenia and an intrinsic inability to properly mobilize from the bone marrow. In vitro they rapidly adhere to ICAM-1 coated plates, but in vivo they poorly adhere to blood vessel endothelium. Those few neutrophils that cross blood vessels and enter tissues migrate haphazardly. Following Concanavalin-A administration fragmented G184S neutrophils accumulate in liver sinusoids leading to thrombo-inflammation and perivasculitis. Thus, neutrophil G alpha(i2)/RGS protein interactions both limit and facilitate G alpha(i2) signaling thereby promoting normal neutrophil trafficking, aging, and clearance.
C1 [Yan, Serena Li-Sue; Hwang, Il-Young; Kim, Ji Sung; Park, Chung; Kehrl, John H.] NIAID, Lab Immunoregulat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Kamenyeva, Olena; Kabat, Juraj] NIAID, Biol Imaging, Res Technol Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Allergy & Infectious Diseases (NIAID); National Institutes of Health
   (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases
   (NIAID)
RP Kehrl, JH (corresponding author), NIAID, Lab Immunoregulat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM jkehrl@niaid.nih.gov
OI Park, Chung/0000-0002-7819-5333; Kim, Jisung/0009-0003-8943-5771
FU Intramural Research Program of National Institute of Allergy and
   Infectious Diseases
FX This work was supported by Intramural Research Program of National
   Institute of Allergy and Infectious Diseases.
CR Adrover JM, 2020, NAT IMMUNOL, V21, P135, DOI 10.1038/s41590-019-0571-2
   Adrover JM, 2019, IMMUNITY, V51, P966, DOI 10.1016/j.immuni.2019.11.001
   Adrover JM, 2016, TRENDS IMMUNOL, V37, P334, DOI 10.1016/j.it.2016.03.005
   Amulic B, 2017, DEV CELL, V43, P449, DOI 10.1016/j.devcel.2017.10.013
   Balenga NA, 2014, J ALLERGY CLIN IMMUN, V134, P451, DOI 10.1016/j.jaci.2014.01.019
   Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010
   Casanova-Acebes M, 2018, J EXP MED, V215, P2778, DOI 10.1084/jem.20181468
   Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040
   Chan EC, 2018, J BIOL CHEM, V293, P12690, DOI 10.1074/jbc.RA118.002404
   Cho H, 2012, MOL CELL BIOL, V32, P4561, DOI 10.1128/MCB.00651-12
   Cho H, 2009, PROG MOL BIOL TRANSL, V86, P249, DOI 10.1016/S1877-1173(09)86009-2
   Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649
   Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x
   George T, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0266-5
   George T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170269
   Girbl T, 2018, IMMUNITY, V49, P1062, DOI 10.1016/j.immuni.2018.09.018
   Grosse J, 2007, J CLIN INVEST, V117, P3540, DOI 10.1172/JCI32312
   Hidalgo A, 2019, TRENDS IMMUNOL, V40, P584, DOI 10.1016/j.it.2019.04.013
   Huang XY, 2006, MOL CELL BIOL, V26, P6870, DOI 10.1128/MCB.00314-06
   Hwang IY, 2017, J IMMUNOL, V198, P2721, DOI 10.4049/jimmunol.1601433
   Hwang IY, 2015, J IMMUNOL, V194, P2128, DOI 10.4049/jimmunol.1401952
   INOUE S, 1995, J BIOCHEM-TOKYO, V118, P650, DOI 10.1093/oxfordjournals.jbchem.a124959
   Kamenyeva O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004827
   Kamp ME, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010090
   Kehrl JH, 2006, IMMUNOL RES, V34, P211, DOI 10.1385/IR:34:3:211
   Kehrl JH, 2016, BIOCHEM PHARMACOL, V114, P40, DOI 10.1016/j.bcp.2016.04.005
   Lämmermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175
   Lamborn IT., 2016, PUBLICLY ACCESSIBLE, V2016, P160
   Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Liu Q, 2015, EUR J IMMUNOL, V45, P1855, DOI 10.1002/eji.201445245
   Lo Celso C, 2011, NAT PROTOC, V6, P1, DOI 10.1038/nprot.2010.168
   Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2
   MURRAYWHELAN R, 1995, EUR J BIOCHEM, V230, P164, DOI 10.1111/j.1432-1033.1995.tb20547.x
   Neubig RR, 2015, PROG MOL BIOL TRANSL, V133, P13, DOI 10.1016/bs.pmbts.2015.04.010
   Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179
   NISHINA H, 1995, J BIOCHEM-TOKYO, V118, P1083, DOI 10.1093/jb/118.5.1083
   Park C, 2019, ELIFE, V8, DOI 10.7554/eLife.47776
   Pillay J, 2020, J LEUKOCYTE BIOL, V107, P1175, DOI 10.1002/JLB.1MA0420-571RR
   Redpath AN, 2017, BLOOD ADV, V1, P1934, DOI 10.1182/bloodadvances.2017006064
   Siegmund K, 2013, IMMUNOL LETT, V153, P62, DOI 10.1016/j.imlet.2013.06.005
   Signarvic RS, 2010, BLOOD, V116, P6092, DOI 10.1182/blood-2010-05-283846
   Tomay F, 2018, IMMUNOL CELL BIOL, V96, P831, DOI 10.1111/imcb.12046
   Uhl B, 2016, BLOOD, V128, P2327, DOI 10.1182/blood-2016-05-718999
   Woodard GE, 2015, INT REV CEL MOL BIO, V317, P97, DOI 10.1016/bs.ircmb.2015.02.001
   Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062
   Xie ZH, 2016, AAPS J, V18, P294, DOI 10.1208/s12248-015-9847-0
   Yan SLS, 2019, ISCIENCE, V16, P283, DOI 10.1016/j.isci.2019.05.040
   Yu YRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150606
NR 49
TC 3
Z9 3
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAY 31
PY 2021
VL 12
AR 679856
DI 10.3389/fimmu.2021.679856
PG 17
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA SR6VK
UT WOS:000661180300001
PM 34135907
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Mizukami, S
   Yafune, A
   Watanabe, Y
   Nakajima, K
   Jin, ML
   Yoshida, T
   Shibutani, M
AF Mizukami, Sayaka
   Yafune, Atsunori
   Watanabe, Yousuke
   Nakajima, Kota
   Jin, Meilan
   Yoshida, Toshinori
   Shibutani, Makoto
TI Identification of epigenetically downregulated <i>Tmem70</i> and
   <i>Ube2e2</i> in rat liver after 28-day treatment with
   hepatocarcinogenic thioacetamide showing gene product downregulation in
   hepatocellular preneoplastic and neoplastic lesions produced by tumor
   promotion
SO TOXICOLOGY LETTERS
LA English
DT Article
DE Hepatocarcinogenesis; Methylation; Rat; Liver; Thioacetamide (TAA)
ID DNA METHYLATION; CELLULAR SENESCENCE; ABERRANT ACTIVATION; HEPATIC FOCI;
   EARLY-STAGE; EXPRESSION; CANCER; THRESHOLD; MODEL; MOUSE
AB The present study identified genes showing promoter region hypermethylation by CpG island microarrays in the liver of rats treated with hepatocarcinogen thioacetamide (TAA) for 28 days. Among 47 hypermethylated genes, Hist1h2aa, Tmem70, Ube2e2, and Slk were confirmed to show hypermethylation by methylation-specific quantitative polymerase chain reaction (PCR) and pyrosequencing analyses as well as downregulation of transcript levels by real-time reverse transcription-PCR analysis in the livers of rats treated with TAA. All gene products of the 4 selected genes showed decreased immunoreactivity forming negative liver cell foci in a subpopulation of glutathione S-transferase placental form (GST-P)(+) foci in TAA-promoted rat livers in a two-stage hepatocarcinogenesis model. Among them, TMEM70 and UBE2E2 showed increased incidences of negative foci in GST-P+ foci by promotion of all examined TAA, beta-naphthoflavone, piperonyl butoxide, fenbendazole and phenobarbital, while HIST1H2AA and SLK did not respond to all promotive treatments. In the late stage of tumor promotion by TAA, the incidence of GST-P+ proliferative lesions with downregulation of TMEM70 or UBE2E2 was higher in adenomas and carcinomas than liver cell foci. TMEM70 plays a role in mitochondrial oxidative phosphorylation, and UBE2E2 participates in the stabilization of cell cycle regulatory proteins. Therefore, our results indicate that aberrant epigenetic gene downregulation suggestive of a metabolic shift of cellular respiration from oxidative phosphorylation to glycolysis and aberrant cell cycle regulation facilitating cell proliferation from as early as 28 days after hepatocarcinogen treatment contribute to tumor development. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Mizukami, Sayaka; Yafune, Atsunori; Watanabe, Yousuke; Nakajima, Kota; Yoshida, Toshinori; Shibutani, Makoto] Tokyo Univ Agr & Technol, Lab Vet Pathol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.
   [Mizukami, Sayaka; Watanabe, Yousuke; Nakajima, Kota] Gifu Univ, United Grad Sch Vet Sci, Pathogenet Vet Sci, 1-1 Yanagido, Gifu, Gifu 5011193, Japan.
   [Jin, Meilan] Southwest Univ, Coll Anim Sci & Technol, Lab Vet Pathol, 2 Tiansheng Rd, Chongqing 400715, Peoples R China.
C3 Tokyo University of Agriculture & Technology; Gifu University; Southwest
   University - China
RP Shibutani, M (corresponding author), Tokyo Univ Agr & Technol, Lab Vet Pathol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.
EM smizuka@cc.tuat.ac.jp; yafune-atsunori@bozo.co.jp;
   ywatana@cc.tuat.ac.jp; knakaji@m2.tuat.ac.jp; meilan0622@swu.edu.cn;
   yoshida7@cc.tuat.ac.jp; mshibuta@cc.tuat.ac.jp
RI Shibutani, Makoto/C-2510-2013; Shibutani, Makoto/AGK-2801-2022; Yoshida,
   Toshinori/B-7255-2015
OI Shibutani, Makoto/0000-0003-3417-9697; Yoshida,
   Toshinori/0000-0003-2476-7794
FU Grants-in-Aid for Scientific Research [16J02009] Funding Source: KAKEN
CR Abe H, 2014, TOXICOL APPL PHARM, V280, P467, DOI 10.1016/j.taap.2014.08.013
   Al-Zahrani KN, 2013, CELL ADHES MIGR, V7, P1, DOI 10.4161/cam.22495
   BECKER FF, 1983, J NATL CANCER I, V71, P553
   BOITIER E, 1995, CANCER RES, V55, P3028
   BRANDEIS M, 1993, BIOESSAYS, V15, P709, DOI 10.1002/bies.950151103
   Chen Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11057
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950
   ENZMANN H, 1989, VIRCHOWS ARCH B, V57, P99, DOI 10.1007/BF02899070
   GERVASI PG, 1989, J CANCER RES CLIN, V115, P29, DOI 10.1007/BF00391596
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hayashi H, 2012, J TOXICOL SCI, V37, P517
   Hejzlarová K, 2011, BBA-BIOENERGETICS, V1807, P144, DOI 10.1016/j.bbabio.2010.10.005
   Hernández LG, 2009, MUTAT RES-REV MUTAT, V682, P94, DOI 10.1016/j.mrrev.2009.07.002
   HOLLIDAY R, 1989, CELL BIOPHYS, V15, P15, DOI 10.1007/BF02991575
   Houstek J, 1999, HUM MOL GENET, V8, P1967
   Ichimura R, 2010, TOXICOL APPL PHARM, V246, P128, DOI 10.1016/j.taap.2010.04.016
   Isidoro A, 2004, BIOCHEM J, V378, P17, DOI 10.1042/BJ20031541
   Ito Nobuyuki, 1998, Journal of Toxicological Sciences, V23, P103
   Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029
   Kimura M, 2016, J APPL TOXICOL, V36, P223, DOI 10.1002/jat.3163
   Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x
   Kitano M, 1998, CARCINOGENESIS, V19, P1475, DOI 10.1093/carcin/19.8.1475
   Kovatcheva M, 2015, ONCOTARGET, V6, P8226, DOI 10.18632/oncotarget.3364
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lujambio A, 2016, BIOESSAYS, V38, pS56, DOI 10.1002/bies.201670910
   Muguruma M, 2009, ARCH TOXICOL, V83, P183, DOI 10.1007/s00204-008-0340-8
   Nishida H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-108
   Palacios D, 2010, MOL CELL BIOL, V30, P3805, DOI 10.1128/MCB.00050-10
   Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893
   Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655
   Romanov VS, 2010, CELL CYCLE, V9, P3945, DOI 10.4161/cc.9.19.13160
   Roomi MW, 2006, EXP MOL PATHOL, V81, P8, DOI 10.1016/j.yexmp.2006.02.006
   Saretzki G, 2010, CURR PHARM DESIGN, V16, P79, DOI 10.2174/138161210789941874
   Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220
   Shibata E, 2011, MOL CELL BIOL, V31, P3136, DOI 10.1128/MCB.05496-11
   Shirai T, 1997, TOXICOL PATHOL, V25, P453, DOI 10.1177/019262339702500504
   Shoda T, 1999, TOXICOL PATHOL, V27, P553, DOI 10.1177/019262339902700509
   Taniai E, 2012, J TOXICOL SCI, V37, P1093, DOI 10.2131/jts.37.1093
   Taniai E, 2009, CANCER SCI, V100, P813, DOI 10.1111/j.1349-7006.2009.01120.x
   Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499
   Tsuchiya T, 2012, TOXICOLOGY, V299, P146, DOI 10.1016/j.tox.2012.05.018
   Uehara T, 2008, TOXICOLOGY, V250, P15, DOI 10.1016/j.tox.2008.05.013
   Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519
   Weinhold B, 2006, ENVIRON HEALTH PERSP, V114, pA160, DOI 10.1289/ehp.114-a160
   Yafune A, 2013, TOXICOL LETT, V219, P203, DOI 10.1016/j.toxlet.2013.03.012
   Zasadil LM, 2013, SEMIN CELL DEV BIOL, V24, P370, DOI 10.1016/j.semcdb.2013.02.001
   Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958
NR 49
TC 9
Z9 9
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD JAN 15
PY 2017
VL 266
BP 13
EP 22
DI 10.1016/j.toxlet.2016.11.022
PG 10
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA EJ9FG
UT WOS:000393531400002
PM 27914986
DA 2024-02-19
ER

PT J
AU Sukhodub, AL
   Padalko, VI
AF Sukhodub, AL
   Padalko, VI
TI Age-dependent changes in rat liver microsomal membrane structure and
   functions under benzene treatment
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE benzene; age; metabolism; microsomal membrane; cytochrome P-450;
   glucose-6-phosphatase; glucose dehydrogenase
ID ENDOPLASMIC-RETICULUM; METABOLISM; CYTOCHROME-P450; FLUIDITY; SYSTEM
AB The influence of benzene on 3 and 24 months old rat liver microsomes was studied. Some structural and functional changes occur under benzene treatment in the cytochrome P-450 system which are more pronounced in 3 months old rat microsomes than in the 24 months ones. Glucose-6-phosphatase and glucose dehydrogenase activities indicate that 3 months old rat microsomal vesicles are more stable against benzene injury than those, of 24 months old ones. In vitro benzene hydroxylation activation by NADPH addition decreased disruptive xenobiotic's effect on 3 but not on 24 months old rat liver microsomal vesicles. This fact suggests that the rate of benzene hydroxylation is important for its membrane damaging action effect. Thus, age-related differences in xenobiotic action on liver microsomes could be related to the decrease of benzene metabolism rate with senescence. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Res Inst Dermatol & Venerol, UA-310057 Kharkov, Ukraine.
   Kharkov State Univ, Res Inst Biol, UA-310077 Kharkov, Ukraine.
C3 National Academy of Medical Sciences of Ukraine; Institute of
   Dermatology & Venereology National Academy of Medical Sciences of
   Ukraine; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv
   National University
RP Sukhodub, AL (corresponding author), Res Inst Dermatol & Venerol, 7-9 Chernishevski St,PO Box 9601, UA-310057 Kharkov, Ukraine.
OI Padalko, Vladimir/0000-0002-0862-1317
CR ARINC E, 1991, ARCH TOXICOL, V65, P186, DOI 10.1007/BF02307307
   ARMBRECHT HJ, 1982, EXP GERONTOL, V17, P41, DOI 10.1016/0531-5565(82)90007-9
   BUBLITZ C, 1988, BIOCHIM BIOPHYS ACTA, V965, P90, DOI 10.1016/0304-4165(88)90155-9
   Buege J A, 1978, Methods Enzymol, V52, P302
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   DALLNER G, 1963, ACTA PATHOL MICROB S, V166, P94
   DENK H, 1979, PHARMACOL THERAPEUT, V6, P551, DOI 10.1016/0163-7258(79)90065-2
   ENGELKE M, 1993, XENOBIOTICA, V23, P71, DOI 10.3109/00498259309059363
   GERVASI PG, 1990, BIOL REACT INTERMED, V4, P285
   Gut I, 1996, ENVIRON HEALTH PERSP, V104, P1211, DOI 10.2307/3433165
   IMAI Y, 1966, J BIOCHEM, V60, P417, DOI 10.1093/oxfordjournals.jbchem.a128453
   KAMATH SA, 1972, ANAL BIOCHEM, V48, P53, DOI 10.1016/0003-2697(72)90169-8
   KARUZINA II, 1994, FREE RADICAL BIO MED, V17, P557, DOI 10.1016/0891-5849(94)90095-7
   Klinger W., 1996, EXP TOXICOL PATHOL, V48, P1
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   LEMESHKO VV, 1983, BIOFIZIKA+, V28, P985
   MILLER GL, 1959, ANAL CHEM, V31, P964, DOI 10.1021/ac60149a611
   NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416
   NELSON DH, 1979, J STEROID BIOCHEM, V11, P1381, DOI 10.1016/0022-4731(79)90109-2
   OMAHONY MS, 1994, PHARMACOL THERAPEUT, V61, P279, DOI 10.1016/0163-7258(94)90066-3
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   Parke DV, 1996, ENVIRON HEALTH PERSP, V104, P1123, DOI 10.1289/ehp.961041123
   Plewka A, 1993, Pol J Occup Med Environ Health, V6, P43
   RIKANS LE, 1989, DRUG METAB REV, V20, P87, DOI 10.3109/03602538908994145
   ROMANELLI A, 1994, BIOCHEM BIOPH RES CO, V200, P1491, DOI 10.1006/bbrc.1994.1619
   RUTTEN AAJJL, 1987, ARCH TOXICOL, V61, P27, DOI 10.1007/BF00324544
   SCHMUCKER DL, 1984, MECH AGEING DEV, V27, P207, DOI 10.1016/0047-6374(84)90046-0
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   Snyder R, 1996, ENVIRON HEALTH PERSP, V104, P1165, DOI 10.1289/ehp.961041165
   SOUCEK P, 1994, BIOCHEM PHARMACOL, V47, P2233, DOI 10.1016/0006-2952(94)90261-5
   Sukhodub A. L., 1997, Ukrainskii Biokhimicheskii Zhurnal, V69, P119
   WADDELL ID, 1991, BIOCHEM J, V275, P133, DOI 10.1042/bj2750133
   WAXMAN DJ, 1989, ENDOCRINOLOGY, V124, P2954, DOI 10.1210/endo-124-6-2954
   ZHANG ZH, 1995, BIOCHEM PHARMACOL, V50, P1607
NR 34
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JAN 15
PY 1999
VL 106
IS 3
BP 273
EP 282
DI 10.1016/S0047-6374(98)00120-1
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 168UE
UT WOS:000078710900005
PM 10100155
DA 2024-02-19
ER

PT J
AU Ertuglu, LA
   Afsar, B
   Yildiz, AB
   Demiray, A
   Ortiz, A
   Covic, A
   Kanbay, M
AF Ertuglu, Lale A.
   Afsar, Baris
   Yildiz, Abdullah B.
   Demiray, Atalay
   Ortiz, Alberto
   Covic, Adrian
   Kanbay, Mehmet
TI Substitution of Sugar-Sweetened Beverages for Other Beverages: Can It Be
   the Next Step Towards Healthy Aging?
SO CURRENT NUTRITION REPORTS
LA English
DT Article; Early Access
DE Healthy aging; Sugar-sweetened beverage; Inflammaging; Oxidative stress;
   Intestinal microbiota; Chronic kidney disease
ID CHRONIC KIDNEY-DISEASE; FRUCTOSE CORN SYRUP; FATTY LIVER-DISEASE;
   CALORIC RESTRICTION; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE;
   DIABETES-MELLITUS; ARTIFICIAL SWEETENERS; WEIGHT-LOSS; US ADULTS
AB Purpose of Review With the prolongation of life expectancy, the gap between lifespan and "health span," the disease-free lifespan, has been widening due to the massive burden of age-related chronic diseases and research on healthy aging has been gaining momentum. A growing body of evidence suggests that diet is a strong determinant of healthy aging and consumption of sugar-sweetened beverages (SSB), a major source of added sugars, predicts poor health outcomes in the aging population, including cardiovascular disease, diabetes, and cancer. Evidence further supports a link between sugar-sweetened beverages-triggered pathological processes and biologic factors of aging, including inflammaging, oxidative stress, and alterations in intestinal microbiota. At present, substitution of sugar-sweetened beverages with healthier alternative beverage remains the most robust strategy to limit the deleterious effects of sugar-sweetened beverages on health worldwide and may help achieve healthy longevity. The purpose of this review is to provide an overview of mechanisms by which sugar-sweetened beverages consumption may impact the physiological aging process and how a simple intervention of beverage replacement may promote healthy aging. Recent Findings Recent findings indicate that SSB are associated with accelerated aging phenotype and activate various adverse biological processes such as chronic inflammation, oxidative stress, insulin resistance, and gut dysbiosis. Summary Replacing SSB with healthier beverages may be a reasonable option to reduce the burden of chronic disease in the aging population and even prolong life and healthspan.
C1 [Ertuglu, Lale A.; Yildiz, Abdullah B.; Demiray, Atalay] Koc Univ, Dept Med, Sch Med, Istanbul, Turkey.
   [Afsar, Baris] Suleyman Demirel Univ, Dept Internal Med, Div Nephrol, Sch Med, Isparta, Turkey.
   [Ortiz, Alberto] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Sch Med, Dept Med, Madrid, Spain.
   [Covic, Adrian] Grigore T Popa Univ Med, Dept Nephrol, Iasi, Romania.
   [Kanbay, Mehmet] Koc Univ, Dept Med, Div Nephrol, Sch Med, Istanbul, Turkey.
C3 Koc University; Suleyman Demirel University; Fundacion Jimenez Diaz;
   Autonomous University of Madrid; Grigore T Popa University of Medicine &
   Pharmacy; Koc University
RP Afsar, B (corresponding author), Suleyman Demirel Univ, Dept Internal Med, Div Nephrol, Sch Med, Isparta, Turkey.
EM afsarbrs@yahoo.com
RI Ertuglu, Lale/AAE-6905-2020; 1, 1/IAO-4606-2023; Covic, Adrian
   C/G-5017-2016; ortiz, alberto/Y-7582-2018
OI Ertuglu, Lale/0000-0002-6318-4199; Covic, Adrian C/0000-0002-9985-2486;
   ortiz, alberto/0000-0002-9805-9523; Demiray, Atalay/0000-0001-5503-5305;
   Yildiz, Abdullah Burak/0000-0001-8921-2736
FU Presidency of Turkey, Presidency of Strategy and Budget
FX MK gratefully acknowledges the use of the services and facilities of the
   Koc University Research Center for Translational Medicine (KUTTAM),
   funded by the Presidency of Turkey, Presidency of Strategy and Budget.
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the Presidency of Strategy
   and Budget.
CR Aeberli I, 2011, AM J CLIN NUTR, V94, P479, DOI 10.3945/ajcn.111.013540
   Ahn H, 2021, NUTR J, V20, DOI 10.1186/s12937-021-00698-1
   An RP, 2016, J ACAD NUTR DIET, V116, P28, DOI 10.1016/j.jand.2015.08.009
   Anderson JJ, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01554-5
   Barzilay JI, 2007, ARCH INTERN MED, V167, P635, DOI 10.1001/archinte.167.7.635
   Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035
   Bernardes N, 2017, CAN J PHYSIOL PHARM, V95, P1078, DOI 10.1139/cjpp-2016-0663
   Bernstein AM, 2012, AM J CLIN NUTR, V95, P1190, DOI 10.3945/ajcn.111.030205
   Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016
   Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667
   Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   Burger KS, 2017, AM J CLIN NUTR, V105, P555, DOI 10.3945/ajcn.116.140145
   Cetiner O, 2021, J ACAD NUTR DIET, V121, P1721, DOI 10.1016/j.jand.2021.01.017
   Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240
   Cheungpasitporn W, 2015, CLIN EXP HYPERTENS, V37, P587, DOI 10.3109/10641963.2015.1026044
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Clément K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   DiNicolantonio JJ, 2018, PROG CARDIOVASC DIS, V61, P3, DOI 10.1016/j.pcad.2017.12.001
   Do MH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060761
   Drouin-Chartier JP, 2019, DIABETES CARE, V42, P2181, DOI 10.2337/dc19-0734
   Duffey KJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070395
   Duffey KJ, 2015, J ACAD NUTR DIET, V115, P1682, DOI 10.1016/j.jand.2015.05.005
   Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072
   Esposito K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008222
   Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997
   Farag MM, 2020, DUBAI MED J, V3, P76, DOI 10.1159/000506899
   Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Franceschi C, 2018, ANNU REV NUTR, V38, P329, DOI 10.1146/annurev-nutr-082117-051637
   Fulop T, 2018, SEMIN IMMUNOL, V40, P17, DOI 10.1016/j.smim.2018.09.003
   Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247
   Girard A, 2006, NUTRITION, V22, P758, DOI 10.1016/j.nut.2006.05.006
   Gorelick PB, 2010, ANN NY ACAD SCI, V1207, P155, DOI 10.1111/j.1749-6632.2010.05726.x
   Grummon AH, 2019, AM J PREV MED, V57, P601, DOI 10.1016/j.amepre.2019.06.019
   Hannou SA, 2018, J CLIN INVEST, V128, P545, DOI 10.1172/JCI96702
   Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539
   Hernández-Cordero S, 2014, J NUTR, V144, P1742, DOI 10.3945/jn.114.193490
   Hert KA, 2014, NUTR RES, V34, P58, DOI 10.1016/j.nutres.2013.10.005
   Hruby A, 2016, AM J PUBLIC HEALTH, V106, P1656, DOI 10.2105/AJPH.2016.303326
   Hu DQ, 2019, J AFFECT DISORDERS, V245, P348, DOI 10.1016/j.jad.2018.11.015
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Huang MN, 2017, AM J CLIN NUTR, V106, P614, DOI 10.3945/ajcn.116.145391
   Judah G, 2020, INT J BEHAV MED, V27, P623, DOI 10.1007/s12529-020-09906-4
   Kanbay M, 2021, HYPERTENSION, V77, P740, DOI 10.1161/HYPERTENSIONAHA.120.16635
   Kanbay M, 2009, BLOOD PURIFICAT, V27, P220, DOI 10.1159/000197562
   Kavanagh K, 2013, AM J CLIN NUTR, V98, P349, DOI 10.3945/ajcn.112.057331
   Kim Chan-Sik, 2017, J Exerc Nutrition Biochem, V21, P55, DOI 10.20463/jenb.2017.0027
   Koliaki C, 2013, MOL CELL ENDOCRINOL, V379, P35, DOI 10.1016/j.mce.2013.06.002
   Kumar Manish, 2016, Nutr Healthy Aging, V4, P3, DOI 10.3233/NHA-150002
   Kuzma JN, 2015, AM J CLIN NUTR, V102, P1373, DOI 10.3945/ajcn.115.116368
   Laclaustra M, 2018, AM J CLIN NUTR, V107, P772, DOI 10.1093/ajcn/nqy028
   Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899
   Leahy M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090928
   Leonardi GC, 2018, IMMUN AGEING, V15, DOI 10.1186/s12979-017-0112-5
   Liang R, 2014, ANTIOXID REDOX SIGN, V20, P1902, DOI 10.1089/ars.2013.5300
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41
   Lin WT, 2020, INT J PUBLIC HEALTH, V65, P45, DOI 10.1007/s00038-020-01330-5
   Luger M, 2017, OBESITY FACTS, V10, P674, DOI 10.1159/000484566
   Ma CH, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4849
   Ma JT, 2015, J HEPATOL, V63, P462, DOI 10.1016/j.jhep.2015.03.032
   Mai BH, 2019, DIABETES METAB SYNDR, V12, P821, DOI 10.2147/DMSO.S198968
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081840
   Malik VS, 2019, CIRCULATION, V139, P2113, DOI 10.1161/CIRCULATIONAHA.118.037401
   Mansouri M, 2020, EAT WEIGHT DISORD-ST, V25, P973, DOI 10.1007/s40519-019-00713-9
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Marsman D, 2018, EUR J NUTR, V57, pS15, DOI 10.1007/s00394-018-1723-0
   Martinez-Moreno JM, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00393
   Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063
   Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432
   Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492
   Most J, 2017, AGEING RES REV, V39, P36, DOI 10.1016/j.arr.2016.08.005
   Narain A, 2016, INT J CLIN PRACT, V70, P791, DOI 10.1111/ijcp.12841
   of USDoAaUSD and Services, 2020, HAH DIET GUID AMS
   Okazaki Y, 2016, FOOD SCI BIOTECHNOL, V25, P153, DOI 10.1007/s10068-016-0112-9
   Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016
   Pan A, 2012, AM J CLIN NUTR, V95, P1454, DOI 10.3945/ajcn.111.032698
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Pase MP, 2017, STROKE, V48, P1139, DOI 10.1161/STROKEAHA.116.016027
   Payne AN, 2012, OBES REV, V13, P799, DOI 10.1111/j.1467-789X.2012.01009.x
   Pereira MA, 2014, ADV NUTR, V5, P797, DOI 10.3945/an.114.007062
   Pifferi F, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0024-8
   Prasad K, 2014, INT J ANGIOL, V23, P217, DOI 10.1055/s-0034-1387169
   Prevention CfDCa, 2021, FASTST LIF EXP
   Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7
   Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721
   Ravussin E, 2015, J GERONTOL A-BIOL, V70, P1097, DOI 10.1093/gerona/glv057
   Rawshani A, 2018, LANCET, V392, P477, DOI 10.1016/S0140-6736(18)31506-X
   Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253
   Rehman K, 2017, J CELL BIOCHEM, V118, P3577, DOI 10.1002/jcb.26097
   Rivero-Gutiérrez B, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600622
   Rosinger A HK, 2017, 270 NCHS
   Ruanpeng D, 2017, QJM-INT J MED, V110, P513, DOI 10.1093/qjmed/hcx068
   Ruparelia N, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.185
   Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z
   Salimi S, 2018, J AM GERIATR SOC, V66, P804, DOI 10.1111/jgs.15268
   Schulze MB, 2005, AM J CLIN NUTR, V82, P675, DOI 10.1093/ajcn/82.3.675
   Schwingshackl L, 2015, CANCER MED-US, V4, P1933, DOI 10.1002/cam4.539
   Schwingshackl L, 2015, J ACAD NUTR DIET, V115, P780, DOI 10.1016/j.jand.2014.12.009
   Semchyshyn HM, 2011, CARBOHYD RES, V346, P933, DOI 10.1016/j.carres.2011.03.005
   Sikalidis AK, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56100490
   Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169
   Solfrizzi V, 2017, J ALZHEIMERS DIS, V59, P815, DOI [10.3233/JAD-170248, 10.3233/jad-170248]
   Soysal P, 2016, AGEING RES REV, V31, P1, DOI 10.1016/j.arr.2016.08.006
   Stanhope KL, 2015, AM J CLIN NUTR, V101, P1144, DOI 10.3945/ajcn.114.100461
   Stookey JD, 2007, OBESITY, V15, P3013, DOI 10.1038/oby.2007.359
   Struijk EA, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003453
   Suez Jotham, 2014, Nature, V514, P181, DOI 10.1038/nature13793
   Tamez M, 2018, J NUTR, V148, P117, DOI 10.1093/jn/nxx021
   Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009
   Taskinen MR, 2019, NUTRIENTS, V11, DOI 10.3390/nu11091987
   Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278
   van Dam RM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1440
   Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Widmer RJ, 2015, AM J MED, V128, P229, DOI 10.1016/j.amjmed.2014.10.014
   Willcox BJ, 2007, ANN NY ACAD SCI, V1114, P434, DOI 10.1196/annals.1396.037
   Willcox BJ, 2014, CURR OPIN CLIN NUTR, V17, P51, DOI 10.1097/MCO.0000000000000019
   Yan LJ, 2018, ANIM MODEL EXP MED, V1, P7, DOI 10.1002/ame2.12001
   Yang Q, 2021, FREE SUGARS INTAKE C, V13, DOI [10.3390/nu13030765, DOI 10.3390/NU13030765]
   Yerlikaya A, 2017, INT UROL NEPHROL, V49, P1611, DOI 10.1007/s11255-017-1544-8
   Yin JW, 2021, ADV NUTR, V12, P89, DOI 10.1093/advances/nmaa084
   Yu Z, 2018, BRIT J NUTR, V119, P570, DOI [10.1017/S0007114517003841, 10.1017/s0007114517003841]
   Yuzbashian E, 2016, NEPHROLOGY, V21, P608, DOI 10.1111/nep.12646
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
   Zhang SM, 2021, AM J CLIN NUTR, V113, P1265, DOI 10.1093/ajcn/nqaa380
   Zhang Y, 2011, NUTR METAB CARDIOVAS, V21, P418, DOI 10.1016/j.numecd.2009.10.020
   Zheng MB, 2015, J ACAD NUTR DIET, V115, P767, DOI 10.1016/j.jand.2015.01.006
NR 133
TC 4
Z9 4
U1 1
U2 18
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2161-3311
J9 CURR NUTR REP
JI Curr. Nutr. Rep.
PD 2021 DEC
PY 2021
VL 10
IS 4
BP 399
EP 412
DI 10.1007/s13668-021-00372-2
EA SEP 2021
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA XY1DS
UT WOS:000702191500001
PM 34595722
DA 2024-02-19
ER

PT J
AU Kahraman, AS
   Kahraman, B
   Ozdemir, ZM
   Karaca, L
   Sahin, N
   Yilmaz, S
AF Kahraman, A. S.
   Kahraman, B.
   Ozdemir, Z. M.
   Karaca, L.
   Sahin, N.
   Yilmaz, S.
TI Diffusion-weighted imaging of the liver in assessing chronic liver
   disease: effects of fat and iron deposition on ADC values
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE ADC measurements; Chronic liver disease; Diffusion-weighted MRI; Fat;
   Iron; Magnetic resonance im-aging
ID CHRONIC HEPATITIS; COEFFICIENT VALUES; FIBROSIS; CIRRHOSIS; MRI;
   DIAGNOSIS; BIOPSY; QUANTIFICATION; COMPLICATIONS; REGRESSION
AB OBJECTIVE: This study was de-signed to evaluate whether fat and iron affect the apparent diffusion coefficient (ADC) values of the liver parenchyma in the settings of fibro-sis and inflammation.PATIENTS AND METHODS: We evaluated the diffusion-weighted images (DWIs) of 58 pa-tients with chronic liver disease and 48 con-trol subjects. Liver specimens of patients were assessed for fibrosis, necroinflammation, iron, and steatosis. Liver ADCs, spleen ADCs, and normalized liver ADCs (defined as the ratio of the liver ADC to spleen ADC) values were an-alyzed after stratifying patients with either fi-brosis stages or histology activity index (HAI) scores. The relationship between ADC values and histopathological findings was studied us-ing multiple linear regression analysis.RESULTS: The median liver and normalized liver ADC values were significantly lower in higher stages of fibrosis and HAI scores. Com-pared to the control group, patients with the highest stages of fibrosis and inflammation had significantly higher spleen ADCs. The ef-fect of the fibrosis stage on liver ADC and nor-malized liver ADC values was significant in the setting of inflammation, whereas the degree of steatosis and iron grade did not affect these ADC values.CONCLUSIONS: ADC values can distinguish both later stages of liver fibrosis and inflam-mation. There is no significant effect of fat and iron on ADC values. Therefore, DWI may be re-liable in evaluating liver fibrosis and inflamma-tion.
C1 [Kahraman, A. S.; Ozdemir, Z. M.; Karaca, L.] Inonu Univ, Sch Med, Dept Radiol, Malatya, Turkey.
   [Kahraman, A. S.; Yilmaz, S.] Inonu Univ, Inst Liver Transplantat, Sch Med, Malatya, Turkey.
   [Kahraman, B.] Private Malatya Hosp, Dept Radiol, Malatya, Turkey.
   [Sahin, N.] Inonu Univ, Dept Pathol, Sch Med, Malatya, Turkey.
   [Yilmaz, S.] Inonu Univ, Dept Gen Surg, Sch Med, Malatya, Turkey.
C3 Inonu University; Inonu University; Special Malatya Hospital; Inonu
   University; Inonu University
RP Kahraman, AS (corresponding author), Inonu Univ, Sch Med, Dept Radiol, Malatya, Turkey.; Kahraman, AS (corresponding author), Inonu Univ, Inst Liver Transplantat, Sch Med, Malatya, Turkey.
EM mdasagir2003@hotmail.com
RI MARAŞ ÖZDEMİR, ZEYNEP/ABI-3319-2020; Kahraman, Aysegul
   Sagir/S-1526-2016; Karaca, Leyla/AAG-4002-2020; Kahraman,
   Bayram/HKM-4798-2023
OI MARAŞ ÖZDEMİR, ZEYNEP/0000-0003-1085-8978; Kahraman, Aysegul
   Sagir/0000-0002-2147-1181; Karaca, Leyla/0000-0001-9150-3823; Kahraman,
   Bayram/0000-0002-5447-1110
CR Anderson SW, 2011, J MAGN RESON IMAGING, V33, P882, DOI 10.1002/jmri.22481
   [Anonymous], 2005, COCHRANE DB SYST REV
   Bakan AA, 2012, EUR RADIOL, V22, P682, DOI 10.1007/s00330-011-2295-z
   Bonekamp S, 2011, J CLIN GASTROENTEROL, V45, P885, DOI 10.1097/MCG.0b013e318223bd2c
   Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706
   Bülow R, 2013, EUR RADIOL, V23, P1281, DOI 10.1007/s00330-012-2700-2
   Chandarana H, 2012, AM J ROENTGENOL, V199, P803, DOI 10.2214/AJR.11.7541
   Chandarana H, 2009, AM J ROENTGENOL, V193, P1261, DOI 10.2214/AJR.08.1996
   Charatcharoenwitthaya P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248024
   Do RKG, 2010, AM J ROENTGENOL, V195, P671, DOI 10.2214/AJR.09.3448
   Dufour JF, 1998, DIGEST DIS SCI, V43, P2573, DOI 10.1023/A:1026601904609
   Fujimoto K, 2011, RADIOLOGY, V258, P739, DOI 10.1148/radiol.10100853
   Girometti R, 2008, J MAGN RESON IMAGING, V28, P411, DOI 10.1002/jmri.21461
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Ito K, 1998, RADIOLOGY, V207, P729, DOI 10.1148/radiology.207.3.9609897
   Kim T, 1999, AM J ROENTGENOL, V173, P393, DOI 10.2214/ajr.173.2.10430143
   Klasen J, 2013, MAGN RESON IMAGING, V31, P1092, DOI 10.1016/j.mri.2013.01.003
   Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403
   Kohgo Y, 2008, J GASTROEN HEPATOL, V23, pS78, DOI 10.1111/j.1440-1746.2007.05290.x
   Koinuma M, 2005, J MAGN RESON IMAGING, V22, P80, DOI 10.1002/jmri.20344
   Lee JT, 2012, MAGN RESON IMAGING, V30, P572, DOI 10.1016/j.mri.2011.12.013
   Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747
   Malekzadeh R, 2004, AM J MED, V117, P125, DOI 10.1016/j.amjmed.2004.01.026
   Nasu Katsuhiro, 2006, Radiat Med, V24, P438, DOI 10.1007/s11604-006-0053-y
   Papanikolaou N, 2010, EUR J RADIOL, V73, P305, DOI 10.1016/j.ejrad.2008.10.023
   Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081
   PERRAULT J, 1978, GASTROENTEROLOGY, V74, P103
   Poyraz AK, 2012, J MAGN RESON IMAGING, V35, P1108, DOI 10.1002/jmri.23519
   Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084
   Safadi R, 2007, INT IMMUNOL, V19, P1021, DOI 10.1093/intimm/dxm069
   St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177
   Taouli B, 2003, RADIOLOGY, V226, P71, DOI 10.1148/radiol.2261011904
   Taouli B, 2008, J MAGN RESON IMAGING, V28, P89, DOI 10.1002/jmri.21227
   Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086
   Taouli B, 2010, RADIOLOGY, V254, P47, DOI 10.1148/radiol.09090021
   Thampanitchawong P, 1999, WORLD J GASTROENTERO, V5, P301
   Wanless IR, 2000, ARCH PATHOL LAB MED, V124, P1599
   Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003
   Yoshikawa T, 2006, AM J ROENTGENOL, V187, P1521, DOI 10.2214/AJR.05.0778
NR 39
TC 0
Z9 0
U1 1
U2 3
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PY 2022
VL 26
IS 18
BP 6620
EP 6631
PG 12
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 5I4DW
UT WOS:000868310400024
PM 36196712
DA 2024-02-19
ER

PT J
AU Liao, AM
   Lyu, X
   Ma, JR
   Hou, YC
   Hui, M
   Liu, N
   Zhao, Y
   Cui, YX
   Huang, JH
AF Liao, Aimei
   Lyu, Xing
   Ma, Jiarui
   Hou, Yinchen
   Hui, Ming
   Liu, Na
   Zhao, Yi
   Cui, Yixiang
   Huang, Jihong
TI Multi-protective effects of wheat embryo globulin on D-gal-induced aging
   mice
SO FOOD SCIENCE AND HUMAN WELLNESS
LA English
DT Article
DE Wheat embryo globulin; Antioxidant activity; Superoxide dismutase;
   Glutathione peroxidase; D-galactose
ID MORRIS WATER MAZE; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; RAT MODEL;
   GERM; ANTIOXIDANT; ESTABLISHMENT; EXTRACT
AB Wheat embryo globulin (WEG) has been proven to possess multiple biological activities, including antioxidative properties, immunomodulatory, and so on. Aged mouse model were established by subcutaneous injection of D-galactose (D-gal), and the effects of WEG on learning, memory, and antioxidant capacity in aging mice were explored through behavioural tests and antioxidant enzyme activities determination. Compared with the Model group, WEG improved the percentage of the platform quadrant, increased the number of crossing platforms, and enhanced the identifi cation indexs. WEG also increased total antioxidant capacity (T-AOC), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) activities in the liver and brains of aging mice, and reduced malondialdehyde (MDA) content. Pathological observations indicated that WEG protected against damage to brain in D-gal-induced aging mice. These results effectively revealed that WEG not only improved the abilities of learning and memory, and the cognitive impairment, but also delayed the aging process of the D-gal-induced mice.(c) 2023 Beijing Academy of Food Sciences. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Liao, Aimei; Lyu, Xing; Ma, Jiarui; Hui, Ming; Liu, Na; Zhao, Yi; Cui, Yixiang; Huang, Jihong] Henan Univ Technol, Coll Biol Engn, Luoyang 471000, Peoples R China.
   [Liao, Aimei; Hou, Yinchen; Huang, Jihong] Henan Prov Key Lab Biol Proc & Nutr Funct Wheat, Luoyang 471000, Peoples R China.
   [Lyu, Xing] Zhengzhou Synear Food Co Ltd, Zhengzhou 450000, Peoples R China.
   [Huang, Jihong] Xuchang Univ, Sch Food & Pharm, Xuchang 461000, Peoples R China.
   [Huang, Jihong] Henan Univ Technol, Coll Biol Engn, Zhengzhou 450000, Peoples R China.
C3 Henan University of Technology; Xuchang University; Henan University of
   Technology
RP Huang, JH (corresponding author), Henan Univ Technol, Coll Biol Engn, Zhengzhou 450000, Peoples R China.
EM huangjihong@haut.edu.cn
FU Zhongyuan Scholars in Henan Province [192101510004]; Major Science and
   Technology Projects for Public Welfare of Henan Province [201300110300];
   Innovation Demonstration Special Project of Henan Province
   [201111110100]; Key Project Foundation of Natural Science Research of
   Universities of Henan Province in China [20A550004]; Fundamental
   Research Funds for the Henan Provincial Colleges and Universities in
   Henan University of Technology (HAUT); High -Level Talents Research Fund
   of HAUT [2018QNJH13, 2018BS012]
FX This research was funded by Zhongyuan Scholars in Henan Province
   (192101510004) , Major Science and Technology Projects for Public
   Welfare of Henan Province (201300110300) , and Innovation Demonstration
   Special Project of Henan Province (201111110100) . This work was also
   financially supported by Key Project Foundation of Natural Science
   Research of Universities of Henan Province in China (20A550004) , and
   Fundamental Research Funds for the Henan Provincial Colleges and
   Universities in Henan University of Technology (HAUT) and High -Level
   Talents Research Fund of HAUT (2018QNJH13, and 2018BS012) . We also
   appreciate Editage ( www.editage.cn) for English language editing.
CR Abdel-Daim MM, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4179676
   Abdel-Daim MM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2098123
   Adler P, 2020, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00368
   Argyropoulou A, 2013, NAT PROD REP, V30, P1412, DOI 10.1039/c3np70031c
   Atallahi M, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.19503
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Battino M, 2018, BIOTECHNOL ADV, V36, P358, DOI 10.1016/j.biotechadv.2017.12.012
   Bell WR, 2019, ALZHEIMERS DEMENT, V15, P8, DOI 10.1016/j.jalz.2018.07.215
   Bougatef A, 2009, FOOD CHEM, V114, P1198, DOI 10.1016/j.foodchem.2008.10.075
   Brandolini A, 2012, INT J FOOD SCI NUTR, V63, P71, DOI 10.3109/09637486.2011.633898
   Budni J, 2016, BEHAV BRAIN RES, V302, P35, DOI 10.1016/j.bbr.2015.12.041
   Chen H, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6049083
   Chen WJ, 2021, FOOD FUNCT, V12, P2257, DOI [10.1039/d0fo03193c, 10.1039/D0FO03193C]
   Chikara S, 2018, CANCER LETT, V413, P122, DOI 10.1016/j.canlet.2017.11.002
   D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4
   Ding QY, 2016, INT J BIOL MACROMOL, V85, P133, DOI 10.1016/j.ijbiomac.2015.12.058
   Dolatshahi M, 2015, IRAN J BASIC MED SCI, V18, P38
   Elfawy HA, 2019, LIFE SCI, V218, P165, DOI 10.1016/j.lfs.2018.12.029
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Galkin F, 2019, AGEING RES REV, V49, P104, DOI 10.1016/j.arr.2018.11.008
   Ge YQ, 2000, J AGR FOOD CHEM, V48, P6215, DOI 10.1021/jf000478m
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   He RH, 2016, J FOOD PROCESS ENG, V39, P296, DOI 10.1111/jfpe.12224
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Ji XG, 2017, PROTEIN PEPTIDE LETT, V24, P1148, DOI 10.2174/0929866524666171026123054
   Ji ZH, 2015, J MOL NEUROSCI, V55, P678, DOI 10.1007/s12031-014-0407-3
   Lei LH, 2016, J CHIN MED ASSOC, V79, P205, DOI 10.1016/j.jcma.2015.06.023
   Li DD, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109204
   Lian WW, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00409
   Mackei M, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/3181202
   Miners JS, 2014, J ALZHEIMERS DIS, V40, P727, DOI 10.3233/JAD-132339
   Morroni F, 2018, AGING DIS, V9, P605, DOI 10.14336/AD.2017.0903
   Mure LS, 2018, SCIENCE, V359, P1232, DOI 10.1126/science.aao0318
   Pang YH, 2018, FOOD CHEM, V240, P212, DOI 10.1016/j.foodchem.2017.07.095
   Patel D, 2015, J AM COLL SURGEONS, V221, pS61, DOI 10.1016/j.jamcollsurg.2015.07.135
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Sha JY, 2019, J AGR FOOD CHEM, V67, P10342, DOI 10.1021/acs.jafc.9b04614
   Sun QA, 2011, J FOOD SCI TECH MYS, V48, P53, DOI 10.1007/s13197-010-0115-0
   Tabassum R, 2020, NEURAL REGEN RES, V15, P232, DOI 10.4103/1673-5374.265543
   Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116
   Wang C, 2020, J NUTR BIOCHEM, V75, DOI 10.1016/j.jnutbio.2019.108261
   Wang PP, 2017, J ETHNOPHARMACOL, V203, P252, DOI 10.1016/j.jep.2017.03.050
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Wu WJ, 2016, INT J FOOD SCI TECH, V51, P2556, DOI 10.1111/ijfs.13238
   Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411
   Xie ZJ, 2008, FOOD CHEM, V111, P370, DOI 10.1016/j.foodchem.2008.03.078
   Yang CR, 2021, FOOD CHEM TOXICOL, V153, DOI 10.1016/j.fct.2021.112240
   Yang RY, 2015, PHARMACOL BIOCHEM BE, V139, P15, DOI 10.1016/j.pbb.2015.10.009
   Yeung AWK, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8278454
   Zhang JJ, 2020, J FUNCT FOODS, V65, DOI 10.1016/j.jff.2019.103724
   Zhang YZ, 2019, J BIOBASED MATER BIO, V13, P269, DOI 10.1166/jbmb.2019.1845
   Zhao Fan-fan, 2017, Yaoxue Xuebao, V52, P347, DOI 10.16438/j.0513-4870.2016-0696
   Zhao Y, 2021, FOOD BIOSCI, V42, DOI 10.1016/j.fbio.2021.101182
NR 53
TC 2
Z9 2
U1 7
U2 53
PU TSINGHUA UNIV PRESS
PI BEIJING
PA B605D, XUE YAN BUILDING, BEIJING, 100084, PEOPLES R CHINA
EI 2213-4530
J9 FOOD SCI HUM WELL
JI Food Sci. Human Wellness
PD JUL
PY 2023
VL 12
IS 4
BP 1300
EP 1308
DI 10.1016/j.fshw.2022.10.012
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 6P2FX
UT WOS:000890749900001
OA gold
DA 2024-02-19
ER

PT J
AU Neill, US
AF Neill, Ushma S.
TI Skin care in the aging female: myths and truths
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID LYMPHATIC VESSELS; MASSAGE
AB I recently had the opportunity to visit a very relaxing and beautiful day spa during the middle-of-the-day break from the sessions at a Keystone meeting. I was having a very tranquil and restorative day, when I went in for my final treatment a facial. The very chipper and cheerful esthetician began examining my skin and applying various creams, when I then heard her say something that nearly ruined my experience: she claimed that the topical treatment she was about to apply would, in her words, "cleanse my liver."
C1 Journal Clin Invest, Ann Arbor, MI 48103 USA.
RP Neill, US (corresponding author), Journal Clin Invest, 15 Res Dr, Ann Arbor, MI 48103 USA.
EM editors@the-jci.org
CR [Anonymous], 2009, ISPA REL 2009 US SPA
   [Anonymous], 2010, WHY YOU SHOULD GET F
   Bello D, 2008, J ALTERN COMPLEM MED, V14, P387, DOI 10.1089/acm.2007.0660
   FUTORYAN T, 1994, NUTR REV, V52, P299, DOI 10.1111/j.1753-4887.1994.tb01461.x
   Kajiya K, 2007, J DERMATOL SCI, V47, P241, DOI 10.1016/j.jdermsci.2007.05.003
   Kajiya K, 2006, J INVEST DERMATOL, V126, P919, DOI 10.1038/sj.jid.5700126
   Moyer CA, 2011, J BODYW MOV THER, V15, P3, DOI 10.1016/j.jbmt.2010.06.001
   Rapaport MH, 2010, J ALTERN COMPLEM MED, V16, P1079, DOI 10.1089/acm.2009.0634
   Skin Care Industry News, SKIN CARE IND NEWS
NR 9
TC 8
Z9 9
U1 0
U2 9
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA
SN 0021-9738
J9 J CLIN INVEST
JI J. Clin. Invest.
PD FEB
PY 2012
VL 122
IS 2
BP 473
EP 477
DI 10.1172/JCI61978
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 885GF
UT WOS:000299765800009
PM 22293186
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Balounová, K
   Soták, M
   Ergang, P
   Vodicka, M
   Vagnerová, K
   Pácha, J
AF Balounova, Katerina
   Sotak, Matus
   Ergang, Peter
   Vodicka, Martin
   Vagnerova, Karla
   Pacha, Jiri
TI Effects of aging and tumorigenesis on coupling between the circadian
   clock and cell cycle in colonic mucosa
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Cell cycle; Aging; Tumorigenesis; Circadian rhythms; Colon
ID PERIPHERAL CLOCK; GENE-EXPRESSION; TUMOR-GROWTH; PER1; PROLIFERATION;
   BMAL1; RHYTHMS; PLAYS; LIVER
AB Aging and tumorigenesis are associated with decline and disruption of circadian rhythms in many tissues and accumulating evidence indicates molecular link between circadian clock and cell cycle. The aim of this study was to investigate the effect of aging and tumorigenesis on coupling between cell cycle and circadian clock oscillators in colon, which undergoes regular rhythmicity of cell cycle and expresses peripheral circadian clock. Using healthy 14-week-old mice and 33-week-old mice with and without colorectal tumors, we showed that the 24-h expression profiles of clock genes and clock-controlled genes were mostly unaffected by aging, whereas the genes of cell cycle and cell proliferation were rhythmic in the young colons but were silenced during aging. On the other hand, tumorigenesis completely silenced or dampened the circadian rhythmicity of the clock genes but only a few genes associated with cell cycle progression and cell proliferation. These results suggest that aging impacts the colonic circadian clock moderately but markedly suppresses the rhythms of cell cycle genes and appears to uncouple the cell cycle machinery from circadian clock control. Conversely, tumorigenesis predominantly affects the rhythms of colonic circadian clocks but is not associated with uncoupling of circadian clock and cell cycle.
C1 [Balounova, Katerina; Sotak, Matus; Ergang, Peter; Vodicka, Martin; Vagnerova, Karla; Pacha, Jiri] Czech Acad Sci, Inst Physiol, Prague, Czech Republic.
   [Balounova, Katerina; Pacha, Jiri] Charles Univ Prague, Fac Sci, Dept Physiol, Prague, Czech Republic.
C3 Czech Academy of Sciences; Institute of Physiology of the Czech Academy
   of Sciences; Charles University Prague
RP Pácha, J (corresponding author), Acad Sci Czech Republ, Inst Physiol, Videnska 1083, Prague 14220 4, Czech Republic.
EM jiri.pacha@fgu.cas.cz.cz
RI Pacha, Jiri/C-7094-2012; Ergang, Peter/H-2533-2014; Vodička,
   Martin/P-2117-2017; Vagnerova, Karla/AAD-3769-2020; Sotak,
   Matus/C-3407-2013
OI Pacha, Jiri/0000-0003-2335-6715; Ergang, Peter/0000-0002-7750-3541;
   Vodička, Martin/0000-0002-4508-9841; Vagnerova,
   Karla/0000-0002-1583-2219; Sotak, Matus/0000-0002-9984-9340
FU Czech Science Foundation [13-08304S]; Charles University [1075016]
FX The study was supported by the Czech Science Foundation (grant
   #13-08304S); and the Charles University (grant #1075016).
CR Bieler J, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145218
   Bonaconsa M, 2014, EXP GERONTOL, V55, P70, DOI 10.1016/j.exger.2014.03.011
   Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9
   Farshadi E, 2019, CELL CYCLE, V18, P16, DOI 10.1080/15384101.2018.1558638
   Feillet C, 2014, P NATL ACAD SCI USA, V111, P9828, DOI 10.1073/pnas.1320474111
   Filipski E, 2009, MUTAT RES-GEN TOX EN, V680, P95, DOI 10.1016/j.mrgentox.2009.10.002
   Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3
   Fu LN, 2013, PROG MOL BIOL TRANSL, V119, P221, DOI 10.1016/B978-0-12-396971-2.00009-9
   Fu XJ, 2016, ONCOTARGETS THER, V9, P2237, DOI 10.2147/OTT.S100952
   Gaucher J, 2018, TRENDS CELL BIOL, V28, P368, DOI 10.1016/j.tcb.2018.01.006
   Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038
   Gréchez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200
   Hood S, 2017, J CLIN INVEST, V127, P437, DOI 10.1172/JCI90328
   Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009
   Huisman SA, 2015, INT J CANCER, V136, P1024, DOI 10.1002/ijc.29089
   Kato Y, 2014, CURR TOP DEV BIOL, V110, P339, DOI 10.1016/B978-0-12-405943-6.00010-5
   Khapre RV, 2010, ANN MED, V42, P404, DOI 10.3109/07853890.2010.499134
   Kowalska E, 2013, P NATL ACAD SCI USA, V110, P1592, DOI 10.1073/pnas.1213317110
   Majumdar APN, 2007, AM J PHYSIOL-GASTR L, V293, pG1215, DOI 10.1152/ajpgi.00324.2007
   Matsu-ura T, 2016, MOL CELL, V64, P900, DOI 10.1016/j.molcel.2016.10.015
   Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271
   Mteyrek A, 2016, ONCOTARGET, V7, P85832, DOI 10.18632/oncotarget.11037
   Oishi K, 2011, EXP GERONTOL, V46, P994, DOI 10.1016/j.exger.2011.09.003
   Pagel R, 2017, FASEB J, V31, P4707, DOI 10.1096/fj.201700141RR
   Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6
   Papantoniou K, 2018, INT J CANCER, V143, P2709, DOI 10.1002/ijc.31655
   Peyric E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073209
   QIU JM, 1994, EPITHELIAL CELL BIOL, V3, P137
   Sato F, 2016, J CANCER, V7, P153, DOI 10.7150/jca.13748
   Scheving LA, 2000, GASTROENTEROLOGY, V119, P536, DOI 10.1053/gast.2000.9305
   Sellix MT, 2012, J NEUROSCI, V32, P16193, DOI 10.1523/JNEUROSCI.3559-12.2012
   Shostak A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11807
   Sládek M, 2007, GASTROENTEROLOGY, V133, P1240, DOI 10.1053/j.gastro.2007.05.053
   Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035
   Soták M, 2014, ANN MED, V46, P221, DOI 10.3109/07853890.2014.892296
   Soták M, 2013, INT J CANCER, V132, P1032, DOI 10.1002/ijc.27760
   Spörl F, 2012, P NATL ACAD SCI USA, V109, P10903, DOI 10.1073/pnas.1118641109
   Stokes K, 2017, CELL MOL GASTROENTER, V4, P95, DOI 10.1016/j.jcmgh.2017.03.011
   Svec J, 2010, INT J EXP PATHOL, V91, P44, DOI 10.1111/j.1365-2613.2009.00698.x
   Tan XM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09997
   Wood PA, 2008, MOL CANCER RES, V6, P1786, DOI 10.1158/1541-7786.MCR-08-0196
   Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499
   Yang XM, 2009, CHRONOBIOL INT, V26, P1323, DOI 10.3109/07420520903431301
   Yang YM, 2014, J BIOL RHYTHM, V29, P243, DOI 10.1177/0748730414544741
   Yang Y, 2017, CELL SIGNAL, V31, P58, DOI 10.1016/j.cellsig.2016.12.010
   Ye H, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S83710
   Yeom M, 2010, P NATL ACAD SCI USA, V107, P9665, DOI 10.1073/pnas.0914078107
   Yoshida D, 2015, CHRONOBIOL INT, V32, P1145, DOI 10.3109/07420528.2015.1065415
   Zeng ZL, 2010, J BIOCHEM, V148, P319, DOI 10.1093/jb/mvq069
NR 49
TC 2
Z9 2
U1 0
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP
PY 2020
VL 190
AR 111317
DI 10.1016/j.mad.2020.111317
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA NO3NQ
UT WOS:000569392800005
PM 32745473
DA 2024-02-19
ER

PT J
AU Puls, R
   Langner, S
   Rosenberg, C
   Hegenscheid, K
   Kuehn, JP
   Noeckler, K
   Hosten, N
AF Puls, Ralf
   Langner, Soenke
   Rosenberg, Christian
   Hegenscheid, Katrin
   Kuehn, Jens Peter
   Noeckler, Kai
   Hosten, Norbert
TI Laser Ablation of Liver Metastases from Colorectal Cancer with MR
   Thermometry: 5-Year Survival
SO JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
LA English
DT Article
ID PERCUTANEOUS RADIOFREQUENCY ABLATION; INDUCED INTERSTITIAL
   THERMOTHERAPY; INTENSITY FOCUSED ULTRASOUND; TUMOR-CONTROL RATE; HEPATIC
   METASTASES; CARCINOMA METASTASES; RESECTION; COMPLICATIONS; THERAPY;
   RECURRENCE
AB PURPOSE:To determine technical success, technique effectiveness, complications, and survival after laser ablation of liver metastases from colorectal cancer.
   MATERIALS AND METHODS: Eighty-seven consecutive patients (65 men. and 22 women; mean age, 62.8 years) with 180 liver metastases from colorectal carcinoma were included between 1998 and 2005. They underwent laser ablation with magnetic resonance (MR) in 170 sessions. Indications for laser ablation were locally unresectable tumors (1.6.1%), metastases in both liver lobes (34.5%), and refusal of surgery and/or general contraindications to surgery (49.4%). Technical success, technique effectiveness, and complication and survival rates were evaluated retrospectively.
   RESULTS: Technical success was achieved in 178 of 180 sessions (99%). Follow-up after 24-48 hours demonstrated an effectiveness rate of 85.6%. Local tumor progression rate was 10% after 6 months. Major complications included large pleural effusion, large, abscess, large pneumothorax, pleuritis with fever, intrahepatic hemorrhage, and biloma. Mean survival from the time of diagnosis of the primary tumor was 50.6 months for all patients treated (95% CI,44.9-56.3 months). Median survival time was 54 month, and survival rates were 95.7% at 1 year, 86.2% at 2 years, 72.4% at 3 years, 50.1% at 4 years, and 33.4% at 5 years. The mean survival time after the first treatment was 31.1 months (95% CI, 26.9-35.3 months).
   CONCLUSIONS: Laser ablation of liver metastases of colorectal cancer with MR thermometry appears safe and aging, direct comparison with other ablative modalities in a prospective efficacious. Although the are encouraging, direct comparison with other ablative modalities in prospective clinical trial would be necessary to definitely show one modality is superior.
C1 [Puls, Ralf; Langner, Soenke; Rosenberg, Christian; Hegenscheid, Katrin; Kuehn, Jens Peter; Noeckler, Kai; Hosten, Norbert] Ernst Moritz Arndt Univ Greifswald, Dept Diagnost Radiol & Neuroradiol, D-17487 Greifswald, Germany.
C3 Universitat Greifswald
RP Puls, R (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Diagnost Radiol & Neuroradiol, Friedrich Loeffler Str 23A, D-17487 Greifswald, Germany.
EM puls@uni-greifswald.de
RI Langner, Soenke/ABB-6744-2021
OI Langner, Soenke/0000-0001-7241-1173
CR Adam R, 2001, ANN SURG ONCOL, V8, P347
   ADSON MA, 1987, WORLD J SURG, V11, P511, DOI 10.1007/BF01655817
   Bleicher RJ, 2003, ANN SURG ONCOL, V10, P52, DOI 10.1245/ASO.2003.03.018
   Bremer C, 2002, EUR RADIOL, V12, P237, DOI 10.1007/s003300101118
   Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002
   de Baère T, 2003, AM J ROENTGENOL, V181, P695, DOI 10.2214/ajr.181.3.1810695
   Elias D, 1998, EUR J SURG ONCOL, V24, P174, DOI 10.1016/S0748-7983(98)92878-5
   Fong Y, 1996, SEMIN SURG ONCOL, V12, P219, DOI 10.1002/(SICI)1098-2388(199607/08)12:4<219::AID-SSU3>3.3.CO;2-O
   Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004
   Gillams AR, 2000, DIS COLON RECTUM, V43, P656, DOI 10.1007/BF02235582
   Gillams AR, 2004, EUR RADIOL, V14, P2261, DOI 10.1007/s00330-004-2416-z
   Goldberg SN, 2005, J VASC INTERV RADIOL, V16, P765, DOI 10.1097/01.RVI.0000170858.46668.65
   GREENWAY B, 1988, BRIT J SURG, V75, P513, DOI 10.1002/bjs.1800750605
   Hänsler J, 2007, J VASC INTERV RADIOL, V18, P405, DOI 10.1016/j.jvir.2006.12.729
   HUGHES KS, 1986, SURGERY, V100, P278
   Jakobs TF, 2006, ANTICANCER RES, V26, P671
   Kennedy JE, 2004, ULTRASONICS, V42, P931, DOI 10.1016/j.ultras.2004.01.089
   KOHNE CH, 2004, ANN SCI M AM SOC CLI
   Lencioni R, 2004, INVEST RADIOL, V39, P689, DOI 10.1097/00004424-200411000-00007
   Livraghi T, 2003, RADIOLOGY, V226, P441, DOI 10.1148/radiol.2262012198
   Mack MG, 2004, RADIOLOGY, V233, P400, DOI 10.1148/radiol.2332030454
   Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I
   Permpongkosol S, 2007, J VASC INTERV RADIOL, V18, P283, DOI 10.1016/j.jvir.2006.12.008
   Puls R, 2007, J MAGN RESON IMAGING, V25, P1174, DOI 10.1002/jmri.20936
   ROSEN CB, 1992, ANN SURG, V216, P439
   Sacks David, 2003, J Vasc Interv Radiol, V14, pS199
   SCHEELE J, 1991, SURGERY, V110, P13
   Seifert JK, 2004, EUR J SURG ONCOL, V30, P34, DOI 10.1016/j.ejso.2003.10.009
   Solazzo SA, 2007, RADIOLOGY, V242, P743, DOI 10.1148/radiol.2423052039
   Solbiati L, 2001, RADIOLOGY, V221, P159, DOI 10.1148/radiol.2211001624
   STEELE G, 1989, ANN SURG, V210, P127, DOI 10.1097/00000658-198908000-00001
   Tellez C, 1998, CANCER, V82, P1250, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1250::AID-CNCR7>3.0.CO;2-J
   Vogl TJ, 1999, EUR RADIOL, V9, P1479, DOI 10.1007/s003300050874
   Vogl TJ, 2004, RADIOLOGY, V230, P450, DOI 10.1148/radiol.2302020646
   Vogl TJ, 2002, RADIOLOGY, V225, P367, DOI 10.1148/radiol.2252011171
   Vogl TJ, 2002, EUR RADIOL, V12, P5, DOI 10.1007/s003300101117
   Wanebo HJ, 1996, ARCH SURG-CHICAGO, V131, P322
   Wood BJ, 2007, J VASC INTERV RADIOL, V18, P9, DOI 10.1016/j.jvir.2006.10.013
   Wood C B, 1976, Clin Oncol, V2, P285
   Wu F, 2005, RADIOLOGY, V235, P659, DOI 10.1148/radiol.2352030916
   Zagoria RJ, 2002, AM SURGEON, V68, P204
NR 41
TC 44
Z9 50
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1051-0443
J9 J VASC INTERV RADIOL
JI J. Vasc. Interv. Radiol.
PD FEB
PY 2009
VL 20
IS 2
BP 225
EP 234
DI 10.1016/j.jvir.2008.10.018
PG 10
WC Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular
   Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System &
   Cardiology
GA 403HZ
UT WOS:000263075000011
PM 19109037
DA 2024-02-19
ER

PT J
AU Li, Q
   Ceylan-Isik, AF
   Li, J
   Ren, J
AF Li, Qun
   Ceylan-Isik, Asli F.
   Li, Ji
   Ren, Jun
TI Deficiency of insulin-like growth factor 1 reduces sensitivity to
   aging-associated cardiomyocyte dysfunction
SO REJUVENATION RESEARCH
LA English
DT Article
ID GROWTH-FACTOR-I; VENTRICULAR MYOCYTES; OXIDATIVE STRESS; CONTRACTILE
   DYSFUNCTION; TRANSGENIC MICE; INSULIN; HORMONE; KLOTHO; IGF-1;
   OVEREXPRESSION
AB Circulating insulin-like growth factor-1 (IGF-1) levels are linked to cardiac performance and lifespan. However, the role of IGF-1 levels in aging-associated cardiac dysfunction has not been defined. This study was designed to evaluate the impact of severe liver IGF-1 deficiency (LID) on aging-induced cardiomyocyte contractile and intracellular Ca(++) dysfunction. Cardiomyocytes were isolated from young (2- to 4-month-old) and old (24- to 26-month-old) male C57BL/6 and LID mice. Cardiomyocyte contractile and intracellular Ca(++) transient properties were evaluated, including peak shortening (PS), maximal velocity of shortening/relengthening (+/-dL/dt), time-to-PS (TPS), time-to-90% relengthening (TR(90)), electrically stimulated change in fura-fluorescence intensity (Delta FFI), and intracellular Ca(++) decay rate. Aged C57BL/6 myocytes displayed reduced PS, +/-dL/dt and Delta FFI as well as prolonged TR(90) and intracellular Ca(++) decay. IGF-1 deficiency decreased +/-dL/dt, and prolonged TR(90) with little change in other mechanical indices. Interestingly, LID dampened aging-induced changes in cardiomyocyte function. Aging and IGF-1 deficiency both contributed to whole-body glucose intolerance. Aging downregulated expression of Akt, Klotho, and pAMPK, whereas it upregulated p53 expression, the effects of which were cancelled by IGF-1 deficiency. Aging and IGF-1 deficiency significantly reduced expression of the transcriptional factor Foxo3a without an overt effect on the mammalian target of rapamycin (mTOR) level. Collectively, these data depicted that IGF-1 deficiency may reduce the cardiomyocyte sensitivity to aging-induced mechanical dysfunction. Our data suggest that regulation of Akt, p53, adenosine monophosphate-activated protein kinase (AMPK) phosphorylation, and Klotho may play a role, at least in part, in IGF-1 deficiency-induced "desensitization" of cardiac aging.
C1 [Ren, Jun] Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.
   Univ Wyoming, Div Pharmaceut Sci, Laramie, WY 82071 USA.
C3 University of Wyoming; University of Wyoming
RP Ren, J (corresponding author), Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.
EM jren@uwyo.edu
RI Ren, Jun/ACG-5366-2022; Zhang, Yunxuan/IXD-9283-2023
OI Ren, Jun/0000-0002-0275-0783; 
FU American Heart Association Pacific Mountain Affiliate [0355521Z];
   National Institute of Aging [AG21324]; National Institutes of Health
   IDeA Networks of Biomedical Research Excellence (NTH INBRE) [P20
   RR016474]
FX The authors are grateful to Dr. Derek LeRoith from the Mount Sinai
   School of Medicine (New York, NY) for providing the LID founder mice.
   This work was supported in part by grants from American Heart
   Association Pacific Mountain Affiliate (#0355521Z), National Institute
   of Aging AG21324, and a pilot project from the National Institutes of
   Health IDeA Networks of Biomedical Research Excellence (NTH INBRE) P20
   RR016474 (J.R.).
CR Arvat E, 2000, DRUG AGING, V16, P29, DOI 10.2165/00002512-200016010-00003
   Bartke A, 2006, TRENDS ENDOCRIN MET, V17, P33, DOI 10.1016/j.tem.2006.01.002
   Colligan PB, 2002, J ENDOCRINOL, V173, P257, DOI 10.1677/joe.0.1730257
   Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399
   CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20
   Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104
   DESHMUKH AS, 2008, MOL ENDOCRINOL
   Fang CX, 2005, DIABETOLOGIA, V48, P2412, DOI 10.1007/s00125-005-1940-y
   Gola M, 2005, J ENDOCRINOL INVEST, V28, P759, DOI 10.1007/BF03347561
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Katic M, 2005, CELL MOL LIFE SCI, V62, P320, DOI 10.1007/s00018-004-4297-y
   Kinugawa S, 1999, CARDIOVASC RES, V43, P157, DOI 10.1016/S0008-6363(99)00058-9
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   Laron Z, 2005, MECH AGEING DEV, V126, P305, DOI 10.1016/j.mad.2004.08.022
   Laron Zvi, 2004, Novartis Found Symp, V262, P56
   Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206
   Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730
   Li Q, 2007, REJUV RES, V10, P501, DOI 10.1089/rej.2007.0552
   Li Q, 2007, AM J PHYSIOL-HEART C, V292, pH1398, DOI 10.1152/ajpheart.01036.2006
   Li Q, 2006, ALCOHOL ALCOHOLISM, V41, P585, DOI 10.1093/alcalc/agl080
   Lombardi G, 2000, ANN ENDOCRINOL-PARIS, V61, P16
   Ren J, 2002, GROWTH HORM IGF RES, V12, P99, DOI 10.1054/ghir.2002.0267
   Ren J, 1999, J MOL CELL CARDIOL, V31, P2049, DOI 10.1006/jmcc.1999.1036
   Ren J, 2000, CARDIOVASC RES, V46, P162, DOI 10.1016/S0008-6363(00)00011-0
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943
   Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105
   Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324
   Yakar Shoshana, 2005, Pediatr Endocrinol Rev, V3, P11
   Yang XP, 2006, FASEB J, V20, P1024, DOI 10.1096/fj.05-5288fje
NR 33
TC 52
Z9 57
U1 0
U2 2
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
J9 REJUV RES
JI Rejuv. Res.
PD AUG
PY 2008
VL 11
IS 4
BP 725
EP 733
DI 10.1089/rej.2008.0717
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 351XT
UT WOS:000259459900003
PM 18729805
OA Green Published
DA 2024-02-19
ER

PT J
AU Ye, Y
   Jia, RR
   Tang, L
   Chen, F
AF Ye, Yang
   Jia, Ran-ran
   Tang, Lin
   Chen, Fang
TI <i>In Vivo</i> Antioxidant and Anti-Skin-Aging Activities of Ethyl
   Acetate Extraction from <i>Idesia polycarpa</i> Defatted Fruit Residue
   in Aging Mice Induced by D-Galactose
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID NITRIC-OXIDE PRODUCTION; OXIDATIVE STRESS; DEFICITS; DAMAGE; MODEL
AB Two different concentrations of D-galactose (D-gal) induced organism and skin aging in Kunming mice were used to examine comprehensively the antioxidant and antiaging activities of ethyl acetate extraction (EAE) from Idesia polycarpa defatted fruit residue for the first time. The oxygen radical absorbance capacity (ORAC) of EAE was 13.09 +/- 0.11 mu mol Trolox equivalents (TE)/mg, which showed EAE had great in vitro free radical scavenging and antioxidant activity. Biochemical indexes and morphological analysis of all tested tissues showed that EAE could effectively improve the total antioxidant capacity (T-AOC) of the antioxidant defense system of the aging mice, enhance the activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) of tissues and serum, increase glutathione (GSH) content and decrease the malondialdehyde (MDA) content, and maintain the skin collagen, elastin, and moisture content. Meanwhile, EAE could effectively attenuate the morphological damage in brain, liver, kidney, and skin induced by D-gal and its effect was not less than that of the well-known L-ascorbic acid (VC) and alpha-tocopherol (VE). Overall, EAE is a potent natural antiaging agent with great antioxidant activity, which can be developed as a new medicine and cosmetic for the treatment of age-related conditions.
C1 [Ye, Yang; Jia, Ran-ran; Tang, Lin; Chen, Fang] Sichuan Univ, Natl & Local Joint Engn Lab Energe Plant Biooil P, Sichuan Key Lab Resource Biol & Biopharmaceut Eng, Key Lab Bioresources & Ecoenvironm,Minist Educ,Co, Chengdu 610064, Sichuan, Peoples R China.
C3 Sichuan University
RP Tang, L (corresponding author), Sichuan Univ, Natl & Local Joint Engn Lab Energe Plant Biooil P, Sichuan Key Lab Resource Biol & Biopharmaceut Eng, Key Lab Bioresources & Ecoenvironm,Minist Educ,Co, Chengdu 610064, Sichuan, Peoples R China.
EM tangl66127@gmail.com; 2359732804@qq.com
FU Innovation Projects of Science-Technology of Sichuan Province
   [2012ZZ028]
FX This work was supported by grants from Innovation Projects of
   Science-Technology of Sichuan Province (2012ZZ028).
CR Alañón ME, 2011, FOOD CHEM, V128, P997, DOI 10.1016/j.foodchem.2011.04.005
   Argyropoulou A, 2013, NAT PROD REP, V30, P1412, DOI 10.1039/c3np70031c
   Baek S, 2006, J MICROBIOL BIOTECHN, V16, P667
   Bruce S, 2013, J DRUGS DERMATOL, V12, pS27
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   Chou CJ, 1997, J NAT PROD, V60, P375, DOI 10.1021/np960335n
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Dulcy CP, 2012, J NEUROSCI RES, V90, P2053, DOI 10.1002/jnr.23080
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Jiang Ze-Qun, 2013, Zhong Yao Cai, V36, P85
   Jin SL, 2012, FOOD CHEM TOXICOL, V50, P3814, DOI 10.1016/j.fct.2012.07.046
   Kim SH, 2006, PLANTA MED, V72, P1007
   Kim SH, 2007, PLANTA MED, V73, P167, DOI 10.1055/s-2006-951771
   Lavanya G, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/535479
   Lephart ED, 2013, PHARM BIOL, V51, P1393, DOI 10.3109/13880209.2013.793720
   Li Zhan, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2435
   Liu CH, 2012, INT J BIOL MACROMOL, V50, P1075, DOI 10.1016/j.ijbiomac.2012.03.006
   Mamalis A, 2013, J DRUGS DERMATOL, V12, P780
   Palmer DM, 2010, J DRUGS DERMATOL, V9, P11
   Proksch E, 2014, SKIN PHARMACOL PHYS, V27, P47, DOI 10.1159/000351376
   Quanyi Wang, 2011, Advanced Materials Research, V396-398, P1222, DOI 10.4028/www.scientific.net/AMR.396-398.1222
   Ramos-e-Silva M, 2013, CLIN DERMATOL, V31, P750, DOI 10.1016/j.clindermatol.2013.05.013
   Rawlings AV., 2004, DERMATOL THER, V17, P43, DOI DOI 10.1111/J.1396-0296.2004.04S1005.X
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Sun Jiang-Hong, 2013, Shengli Xuebao, V65, P389
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Wang BS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/431081
   Wang DL, 2012, BIOL PHARM BULL, V35, P2128, DOI 10.1248/bpb.b12-00238
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Yang FX, 2009, IND CROP PROD, V29, P622, DOI 10.1016/j.indcrop.2008.12.004
   Zhao JG, 2013, NUTR RES PRACT, V7, P359, DOI 10.4162/nrp.2013.7.5.359
   Zhou XX, 2013, PHYTOCHEM LETT, V6, P372, DOI 10.1016/j.phytol.2013.05.002
   Zillich OV, 2013, INT J COSMETIC SCI, V35, P491, DOI 10.1111/ics.12072
NR 36
TC 18
Z9 22
U1 4
U2 52
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2014
VL 2014
AR 185716
DI 10.1155/2014/185716
PG 12
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA AJ0XA
UT WOS:000337378600001
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Youdim, KA
   Deans, SG
AF Youdim, KA
   Deans, SG
TI Effect of thyme oil and thymol dietary supplementation on the
   antioxidant status and fatty acid composition of the ageing rat brain
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE thyme oil; thymol; ageing; polyunsaturated fatty acids; docosahexaenoic
   acid
ID CENTRAL-NERVOUS-SYSTEM; SUPEROXIDE-DISMUTASE; MEMBRANE FLUIDITY; AGED
   RATS; ENZYMES; LIVER; RETINA; N-3; PEROXIDATION; ESSENTIALITY
AB The present study measured changes in antioxidant enzyme activity in, and the phospholipid fatty acid composition of the ageing rat brain and tested whether dietary supplementation with thyme oil or thymol could provide beneficial effects. There were significant declines in superoxide dismutase (EC 1.15.1.1) and glutathione peroxidase (EC 1.11.1.9) activities and the total antioxidant status in the untreated rats with age, while thyme-oil- and thymol-fed rats maintained significantly higher antioxidant enzyme activities and total antioxidant status. The proportions of 18:2n-6, 20:1n-9, 22:4n-6 and 22:5n-3 in the brain phospholipids resulting from all three dietary treatments were significantly higher in 28-month-old rats than in 7-month-old rats. Only 20 : 1n-9 levels in 28-month-old thyme-oil- and thymol-treated rats were significantly higher than in the age-matched control. The proportion of 22:6n-3 in brain phospholipids, which declined with age in control rats, was also significantly higher in rats given either supplement. This latter finding is particularly important as optimum levels of 22:6n-3 are required for normal brain function. These results highlight the potential benefit of thyme oil as a dietary antioxidant.
C1 Scottish Agr Coll, Aromat & Med Plant Grp, Auchincruive KA6 5HW, Ayr, Scotland.
C3 Scottish Agricultural College
RP Deans, SG (corresponding author), Scottish Agr Coll, Aromat & Med Plant Grp, Auchincruive KA6 5HW, Ayr, Scotland.
CR ANSARI KA, 1989, GROWTH DEVELOP AGING, V53, P117
   BENZI G, 1988, NEUROCHEM RES, V13, P467, DOI 10.1007/BF01268883
   BOURRE JM, 1993, PROSTAG LEUKOTR ESS, V48, P5, DOI 10.1016/0952-3278(93)90003-F
   Cao GH, 1996, P SOC EXP BIOL MED, V211, P359
   Chalon S, 1998, J NUTR, V128, P2512, DOI 10.1093/jn/128.12.2512
   Christie WW, 1982, LIPID ANAL
   Clark George S., 1995, Perfumer and Flavorist, V20, P41
   COHEN BM, 1985, LIFE SCI, V37, P1403, DOI 10.1016/0024-3205(85)90079-7
   DAHN HC, 1983, J NEUROCHEM, V40, P1003
   DEANS SG, 1993, AGE, V16, P71, DOI 10.1007/BF02435040
   DEANS SG, 1994, ASPECTS AGEING DIS, P173
   Deans SG, 1993, ROLE FREE RADICALS B, P159
   DEANS SG, 1990, COMMONWEALTH AGR BUR, V2, P211
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   DEQUIROGA GB, 1992, FREE RADICALS AGING, P109
   GURR MI, 1969, EUR J BIOCHEM, V9, P70, DOI 10.1111/j.1432-1033.1969.tb00577.x
   Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
   Harman D, 1995, AGE, V18, P51, DOI 10.1007/BF02432519
   Kaplan RJ, 1998, NEUROCHEM RES, V23, P615, DOI 10.1023/A:1022478503367
   KUROBE N, 1990, BIOMED RES-TOKYO, V11, P187, DOI 10.2220/biomedres.11.187
   LAMPTEY MS, 1976, J NUTR, V106, P86, DOI 10.1093/jn/106.1.86
   MIZUNO Y, 1986, J NEUROCHEM, V46, P1344, DOI 10.1111/j.1471-4159.1986.tb01745.x
   NEURINGER M, 1986, NUTR REV, V44, P285, DOI 10.1111/j.1753-4887.1986.tb07660.x
   NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505
   OKUYAMA H, 1992, P SOC EXP BIOL MED, V200, P174, DOI 10.3181/00379727-200-43412
   ONUMA Y, 1984, BIOCHIM BIOPHYS ACTA, V793, P80
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   Recsan Z., 1997, Journal of Essential Oil Research, V9, P53
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   Salem Jr N, 1989, NEW PROTECTIVE ROLES, P109
   SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   SOCCI DJ, 1995, BRAIN RES, V693, P88, DOI 10.1016/0006-8993(95)00707-W
   SPECTOR AA, 1985, J LIPID RES, V26, P1015
   STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4
   Suzuki H, 1998, MECH AGEING DEV, V101, P119, DOI 10.1016/S0047-6374(97)00169-3
   VANELLA A, 1989, J NEUROSCI RES, V22, P351, DOI 10.1002/jnr.490220316
   VITORICA J, 1984, J NEUROCHEM, V42, P351, DOI 10.1111/j.1471-4159.1984.tb02685.x
   WAHNON R, 1989, MECH AGEING DEV, V50, P249, DOI 10.1016/0047-6374(89)90103-6
   YAMAMOTO N, 1987, J LIPID RES, V28, P144
   YAMAMOTO N, 1991, J GERONTOL, V46, P17
   YOUDIM KA, 1997, THESIS U STRATHCLYDE
NR 42
TC 134
Z9 145
U1 2
U2 14
PU C A B INTERNATIONAL
PI WALLINGFORD
PA C/O PUBLISHING DIVISION, WALLINGFORD OX10 8DE, OXON, ENGLAND
SN 0007-1145
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JAN
PY 2000
VL 83
IS 1
BP 87
EP 93
DI 10.1017/S000711450000012X
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 291LC
UT WOS:000085734700012
PM 10703468
OA Bronze
DA 2024-02-19
ER

PT J
AU de Toda, IM
   Vida, C
   Ortega, E
   De La Fuente, M
AF Martinez de Toda, Irene
   Vida, Carmen
   Ortega, Eduardo
   De La Fuente, Monica
TI Hsp70 basal levels, a tissue marker of the rate of aging and longevity
   in mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Hsp70; Basal level; Aging; Longevity; Biomarker; Premature aging
ID HEAT-SHOCK-PROTEIN; OXIDATIVE STRESS; CRITICAL DETERMINANTS;
   SKELETAL-MUSCLE; MURINE MODEL; LIFE-SPAN; INFLAMMATION; VITAGENES;
   HEAT-SHOCK-PROTEIN-70; ADAPTATION
AB Under stressful conditions, the expression of the chaperone Hsp70 is induced, which acts as a cellular defense mechanism. The impairment in this induction has been related to aging, whereas an increased expression has been related to longevity. Nevertheless, it is still not known if the basal levels of Hsp70 can be indicative of the aging rate of different tissues. The aim of this study was to quantify the basal levels of Hsp70 in tissues from female mice throughout their aging process including long-lived mice, as well as from prematurely aging mice (PAM). Adult, old and long-lived (6, 18 and 30 months of age, respectively) female ICR-CD1 and Balb/C mice were used. Tissues with mainly mitotic (liver and renal medulla) or post-mitotic (heart, renal cortex, cerebral cortex, spleen) cells and peritoneal leukocytes from these animals as well as from adult PAM and non-prematurely aging mice (NPAM), were studied. Basal levels of Hsp70 were assessed using an ELISA method. The results showed that the aging-associated variation of the levels of Hsp70 followed a different pattern in post-mitotic and mitotic tissues, being lower or higher in old mice comparing to adults, respectively. In all the tissues analyzed the Hsp70 levels from long-lived mice were similar to those from adult animals. In addition, in adult PAM these Hsp70 levels were similar to those in chronologically old animals. In conclusion, Hsp70 basal levels show tissue-specific age-associated variations and are preserved in long-lived animals, demonstrating their role as markers of the rate of aging and longevity. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Martinez de Toda, Irene; Vida, Carmen; De La Fuente, Monica] Univ Complutense, Fac Biol, Dept Anim Physiol 2, Madrid, Spain.
   [Martinez de Toda, Irene; Vida, Carmen; De La Fuente, Monica] Hosp 12 Octubre, Inst Invest, Madrid, Spain.
   [Ortega, Eduardo] Univ Extremadura, Dept Physiol, Badajoz, Spain.
C3 Complutense University of Madrid; Hospital Universitario 12 de Octubre;
   Universidad de Extremadura
RP De La Fuente, M (corresponding author), Univ Complutense, Fac Biol, Dept Anim Physiol 2, Madrid, Spain.
EM mondelaf@bio.ucm.es
RI Ortega, Eduardo/GXN-2560-2022; Vida, Carmen CV/T-1243-2018; deToda,
   Irene Martinez/ABG-8061-2020; Ortega, Eduardo/H-9891-2016
OI Ortega, Eduardo/0000-0002-7007-7615
FU Ministerio de Economia y Competitividad (MINECO) [BFU2011-30336];
   Research group of UCM [910379]; FIS from the ISCIII-FEDER of the
   European Union [PI15/01787]; Red Tematica de Investigacion Cooperativa
   en Envejecimiento y Fragilidad (RETICEF) from the ISCIII-FEDER of the
   European Union [RD12/0043/0018]
FX This work was supported by grants of the Ministerio de Economia y
   Competitividad (MINECO) (BFU2011-30336), Research group of UCM (910379),
   FIS (PI15/01787) from the ISCIII-FEDER of the European Union, and Red
   Tematica de Investigacion Cooperativa en Envejecimiento y Fragilidad
   (RETICEF) (RD12/0043/0018) from the ISCIII-FEDER of the European Union.
CR Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503
   Ambra R, 2004, EXP GERONTOL, V39, P1475, DOI 10.1016/j.exger.2004.07.009
   Arranz L, 2010, J GERONTOL A-BIOL, V65, P941, DOI 10.1093/gerona/glq101
   Bonelli MA, 2008, BIOGERONTOLOGY, V9, P1, DOI 10.1007/s10522-007-9111-9
   Broome CS, 2006, FASEB J, V20, P1549, DOI 10.1096/fj.05-4935fje
   Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002
   Calabrese V, 2011, MOL ASPECTS MED, V32, P279, DOI 10.1016/j.mam.2011.10.007
   Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957
   Colotti C, 2005, BIOGERONTOLOGY, V6, P397, DOI 10.1007/s10522-005-4906-z
   Cornelius C, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-15
   De la Fuente M, 2009, CURR PHARM DESIGN, V15, P3003, DOI 10.2174/138161209789058110
   de Toda IM, 2015, BIOGERONTOLOGY, V16, P709, DOI 10.1007/s10522-015-9607-7
   Demirovic D., 2013, HORMESIS HUMAN HLTH, P227
   Demirovic D, 2013, EXP GERONTOL, V48, P94, DOI 10.1016/j.exger.2012.02.005
   Dmitriev LF, 2010, AGEING RES REV, V9, P200, DOI 10.1016/j.arr.2009.09.004
   Drew BG, 2014, DIABETES, V63, P1488, DOI 10.2337/db13-0665
   FABRIS N, 1991, ARCH GERONTOL GERIAT, V12, P219, DOI 10.1016/0167-4943(91)90029-P
   Fonager J, 2002, EXP GERONTOL, V37, P1223, DOI 10.1016/S0531-5565(02)00128-6
   Gaweda-Walerych K, 2013, ACTA NEUROBIOL EXP, V73, P199, DOI 10.55782/ane-2013-1931
   Gehrig SM, 2012, NATURE, V484, P394, DOI 10.1038/nature10980
   Guayerbas N, 2002, BEHAV BRAIN RES, V134, P41, DOI 10.1016/S0166-4328(01)00449-1
   Guzhova IV, 1997, CELL STRESS CHAPERON, V2, P132, DOI 10.1379/1466-1268(1997)002<0132:MSPHIW>2.3.CO;2
   Hall DM, 2001, J GERONTOL A-BIOL, V56, pB259, DOI 10.1093/gerona/56.6.B259
   Henstridge DC, 2014, DIABETES, V63, P1881, DOI 10.2337/db13-0967
   Kovalenko EI, 2014, ONCOTARGET, V5, P11800, DOI 10.18632/oncotarget.2856
   Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970
   LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443
   Murakami S, 2000, ANN NY ACAD SCI, V908, P40
   Nakanishi Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1302, DOI 10.1271/bbb.61.1302
   Nardai G, 2002, EXP GERONTOL, V37, P1257, DOI 10.1016/S0531-5565(02)00134-1
   Njemini R, 2002, J CLIN IMMUNOL, V22, P195, DOI 10.1023/A:1016036724386
   Oksala NKJ, 2014, REDOX BIOL, V3, P25, DOI 10.1016/j.redox.2014.10.003
   Ortega E, 2012, ANN NY ACAD SCI, V1261, P64, DOI 10.1111/j.1749-6632.2012.06619.x
   Pérez-Alvarez L, 2005, DEV COMP IMMUNOL, V29, P965, DOI 10.1016/j.dci.2005.02.008
   Rérole AL, 2011, METHODS MOL BIOL, V787, P205, DOI 10.1007/978-1-61779-295-3_16
   Soti C, 2000, BIOGERONTOLOGY, V1, P225, DOI 10.1023/A:1010082129022
   Spiró Z, 2012, ANTIOXID REDOX SIGN, V17, P890, DOI 10.1089/ars.2011.4161
   Unno K, 2000, J GERONTOL A-BIOL, V55, pB329, DOI 10.1093/gerona/55.7.B329
   Verbeke P, 2001, CELL BIOL INT, V25, P845, DOI 10.1006/cbir.2001.0789
   Vida C, 2014, CURR PHARM DESIGN, V20, P4656
   Viveros MP, 2007, NEUROIMMUNOMODULAT, V14, P157, DOI 10.1159/000110640
   Yenari MA, 1998, ANN NEUROL, V44, P584, DOI 10.1002/ana.410440403
   Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502
NR 43
TC 16
Z9 18
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD NOV
PY 2016
VL 84
BP 21
EP 28
DI 10.1016/j.exger.2016.08.013
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA DY9XU
UT WOS:000385490900003
PM 27582425
DA 2024-02-19
ER

PT J
AU Velasco, B
   Cacicedo, L
   Escalada, J
   Lopez-Fernandez, J
   Sanchez-Franco, F
AF Velasco, B
   Cacicedo, L
   Escalada, J
   Lopez-Fernandez, J
   Sanchez-Franco, F
TI Growth hormone gene expression and secretion in aging rats is age
   dependent and not age-associated weight increase related
SO ENDOCRINOLOGY
LA English
DT Article
ID FACTOR-I GENE; DIETARY-PROTEIN RESTRICTION; MESSENGER-RIBONUCLEIC-ACID;
   OBESE ZUCKER RATS; OLD MALE-RATS; BINDING PROTEIN-3; ENERGY STATUS;
   IGF-I; INSULIN; RECEPTOR
AB GH secretion declines with age in rats and humans and a reduction in GH gene expression has been demonstrated in aging rats. GH secretion also diminishes in obesity; thus, the aim of this study was to determine whether GH decrease in aging rats is clue to body weight gain or to aging. Three groups of male Wistar rats of different ages were studied (young, 3 months; middle-aged, 11 months; old, 27 months). The middle-aged group was established on a statistical analysis and corresponded to the youngest age at which body weight was not significantly different from the old (27 month) group. Thus, by using this group as control for comparison with animals with the same weight and an older age, the effects due to aging itself could be determined. Body weight (g, mean +/-SD) 3 months: 361 +/- 5.6; 11 months: 713 +/- 39; 27 months: 635 +/- 38. In comparison with 3-month-old rats, the 11-month-old animals showed no difference in pituitary GH messenger RNA (mRNA) accumulation and pituitary and serum IR-GH levels. Similarly IGF-La, IGF-Lb mRNA transcripts and IGFBP-3 mRNA accumulation in the liver showed no significant differences between the two groups. On the contrary, when the 27-month-old rats were compared with the 11-month-old animals, lower levels of pituitary GH mRNA and serum and pituitary IR-GH were found. Pituitary GH mRNA decreased 37.5 +/- 7.7% P < 0.001, pituitary IR-GH content diminished (5.2 +/- 3.4 vs. 55 +/- 10.7 ng/mg of protein, P < 0.001) and serum IR-GH decreased(3.5 +/- 1.8 vs. 12.5 +/- 4.2 ng/ml, P < 0.01). Liver IGF-La and IGF-Lb mRNA transcripts accumulation and serum IGF-I were significantly diminished. IGF-Lb mRNA accumulation decreased 35.8 +/- 1.2% P < 0.05 and IGF-La 36 +/- 5.6% P < 0.05; serum IR-IGF-I levels diminished (759 +/- 152 vs. 1327 +/- 67 ng/ml, P < 0.05). Liver IGFBP-3 mRNA accumulation decreased 79 +/- 4.2% P < 0.001.
   These results indicate that the decrease in GH gene expression and secretion, as well as the expression of genes induced by GH such as IGF-I and IGFBP-3, is due to aging and not to the increase in body weight that takes place with aging.
C1 Inst Salud Carlos III, Ctr Invest Clin, Serv Endocrinol, Madrid 28029, Spain.
   Hosp Ramon & Cajal, Serv Endocrinol, E-28034 Madrid, Spain.
C3 Instituto de Salud Carlos III; Hospital Universitario Ramon y Cajal
RP Sanchez-Franco, F (corresponding author), Inst Salud Carlos III, Ctr Invest Clin, Serv Endocrinol, C Sinesio Delgado 10, Madrid 28029, Spain.
RI Escalada, Javier/E-6330-2013
OI Escalada, Javier/0000-0001-5877-9465
CR ADAMO ML, 1991, MOL ENDOCRINOL, V5, P1677, DOI 10.1210/mend-5-11-1677
   ALBISTON AL, 1990, BIOCHEM BIOPH RES CO, V166, P892, DOI 10.1016/0006-291X(90)90894-S
   BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   BARZILAI N, 1996, AM J PHYSIOL, V193, pE390
   BAXTER RC, 1991, ACTA PAEDIATR SC   S, V372, P104
   BELL GI, 1986, NUCLEIC ACIDS RES, V14, P7873, DOI 10.1093/nar/14.20.7873
   BERCU BB, 1992, ENDOCRINOLOGY, V131, P2800, DOI 10.1210/en.131.6.2800
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x
   DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261
   DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68
   DCOSTA AP, 1993, J REPROD FERTIL, P87
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   DOMENE H, 1993, ENDOCRINOLOGY, V133, P675, DOI 10.1210/en.133.2.675
   EMLER CA, 1987, ENDOCRINOLOGY, V120, P832, DOI 10.1210/endo-120-2-832
   FINKELSTEIN JW, 1972, J CLIN ENDOCR METAB, V35, P665, DOI 10.1210/jcem-35-5-665
   FLORINI JR, 1980, J GERONTOL, V35, P23, DOI 10.1093/geronj/35.1.23
   FRAZE E, 1987, J AM GERIATR SOC, V35, P224, DOI 10.1111/j.1532-5415.1987.tb02313.x
   FRYSTYK J, 1995, METABOLISM, V44, P37, DOI 10.1016/0026-0495(95)90219-8
   GILMOUR RS, 1994, J ENDOCRINOL, V140, P1, DOI 10.1677/joe.0.1400001
   GOODMAN MN, 1983, AM J PHYSIOL, V244, pE93, DOI 10.1152/ajpendo.1983.244.1.E93
   GULVE EA, 1993, AM J PHYSIOL, V264, pE319, DOI 10.1152/ajpendo.1993.264.3.E319
   HEPLER JE, 1990, ENDOCRINOLOGY, V127, P1550, DOI 10.1210/endo-127-3-1550
   HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51
   *IFF CRED LAB AN, 1986, WIST RAT, P40
   LACKO AG, 1984, J GERONTOL, V39, P513, DOI 10.1093/geronj/39.5.513
   LEIDY JW, 1993, NEUROENDOCRINOLOGY, V57, P213, DOI 10.1159/000126362
   LopezFernandez J, 1996, ENDOCRINOLOGY, V137, P4384, DOI 10.1210/en.137.10.4384
   LOWE WL, 1989, J CLIN INVEST, V84, P619, DOI 10.1172/JCI114207
   LOWE WL, 1988, MOL ENDOCRINOL, V2, P528, DOI 10.1210/mend-2-6-528
   MARTIN A, 1985, BIOESTADISTICA CIENC, P57
   Martin J B, 1979, Physiologist, V22, P23
   MATHEWS LS, 1989, J BIOL CHEM, V264, P9905
   Melian E, 1997, ENDOCRINOLOGY, V138, P1066, DOI 10.1210/en.138.3.1066
   MOATSSTAATS BM, 1989, ENDOCRINOLOGY, V125, P2368, DOI 10.1210/endo-125-5-2368
   NARIMIYA M, 1983, AM J PHYSIOL, V244, pE93
   NGUYENYAMAMOTO L, 1994, ENDOCRINOLOGY, V134, P1382, DOI 10.1210/en.134.3.1382
   POSTELVINAY MC, 1990, HORM METAB RES, V22, P7, DOI 10.1055/s-2007-1004837
   PRINZ PN, 1983, J GERONTOL, V38, P519, DOI 10.1093/geronj/38.5.519
   REAVEN GM, 1995, DIABETOLOGIA, V38, P3, DOI 10.1007/BF02369347
   ROSEN T, 1994, CLIN ENDOCRINOL, V40, P111, DOI 10.1111/j.1365-2265.1994.tb02452.x
   ROSEN T, 1995, HORM RES, V43, P93, DOI 10.1159/000184245
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   RUDMAN D, 1976, NEUROENDOCRINOLOGY, V21, P193
   SCHWANDER JC, 1983, ENDOCRINOLOGY, V113, P297, DOI 10.1210/endo-113-1-297
   SEEBURG PH, 1977, NATURE, V270, P486, DOI 10.1038/270486a0
   SONNTAG WE, 1982, NEUROENDOCRINOLOGY, V34, P163, DOI 10.1159/000123295
   SONNTAG WE, 1980, ENDOCRINOLOGY, V107, P1875, DOI 10.1210/endo-107-6-1875
   STRAUS DS, 1991, J NUTR, V121, P1279, DOI 10.1093/jn/121.8.1279
   TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562, DOI 10.1210/endo-98-3-562
   THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80
   THISSEN JP, 1991, ENDOCRINOLOGY, V129, P429, DOI 10.1210/endo-129-1-429
   VERMEULEN A, 1987, J CLIN ENDOCR METAB, V64, P884, DOI 10.1210/jcem-64-5-884
   WELLER PA, 1994, AM J PHYSIOL, V266, pE776, DOI 10.1152/ajpendo.1994.266.5.E776
   WILLIAMS T, 1984, NEW ENGL J MED, V311, P1403, DOI 10.1056/NEJM198411293112203
   XU XO, 1995, ENDOCRINOLOGY, V136, P4551, DOI 10.1210/en.136.10.4551
   ZADIK Z, 1985, J CLIN ENDOCR METAB, V60, P513, DOI 10.1210/jcem-60-3-513
NR 59
TC 24
Z9 30
U1 0
U2 2
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD MAR
PY 1998
VL 139
IS 3
BP 1314
EP 1320
DI 10.1210/en.139.3.1314
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA YZ845
UT WOS:000072299800061
PM 9492067
OA Bronze
DA 2024-02-19
ER

PT J
AU Wu, J
   Bu, DD
   Wang, HQ
   Shen, D
   Chong, DY
   Zhang, TY
   Tao, WW
   Zhao, MF
   Zhao, Y
   Fang, L
   Li, P
   Xue, B
   Li, CJ
AF Wu, Jing
   Bu, Dandan
   Wang, Haiquan
   Shen, Di
   Chong, Danyang
   Zhang, Tongyu
   Tao, Weiwei
   Zhao, Mengfei
   Zhao, Yue
   Fang, Lei
   Li, Peng
   Xue, Bin
   Li, Chao-Jun
TI The rhythmic coupling of Egr-1 and Cidea regulates age-related metabolic
   dysfunction in the liver of male mice
SO NATURE COMMUNICATIONS
LA English
DT Article
ID PERIPHERAL CIRCADIAN OSCILLATORS; INSULIN SENSITIVITY; GROWTH;
   TRANSCRIPTION; PATHWAYS; BINDING; CLOCK; PROTEINS; DISEASE; CYCLE
AB The liver lipid metabolism of older individuals canbecome impaired and the circadian rhythm of genes involved in lipid metabolism is also disturbed. Although the link between metabolism and circadian rhythms is already recognized, how these processes are decoupled in liver during aging is still largely unknown. Here, we show that the circadian rhythm for the transcription factor Egr-1 expression is shifted forward with age in male mice. Egr-1 deletion accelerates liver age-related metabolic dysfunction, which associates with increased triglyceride accumulation, disruption of the opposite rhythmic coupling of Egr-1 and Cidea (Cell Death Inducing DFFA Like Effector A) at the transcriptional level and large lipid droplet formation. Importantly, adjustment of the central clock with light via a 4-hour forward shift in 6-month-old mice, leads to recovery the rhythm shift of Egr-1 during aging and largely ameliorated liver metabolic dysfunction. All our collected data suggest that liver Egr-1 might integrate the central and peripheral rhythms and regulate metabolic homeostasis in the liver.
   Many transcriptomic pathways in the liver show circadian rhythms, which have been reported to be disrupted in aged mice. Here the authors report that the expression of transcription factor Egr-1 decreases and its rhythm is shifted with age in the liver of male mice, and that deletion of Egr-1 results in increased liver fat accumulation.
C1 [Wu, Jing; Bu, Dandan; Wang, Haiquan; Shen, Di; Chong, Danyang; Zhang, Tongyu; Zhao, Mengfei; Zhao, Yue; Fang, Lei] Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ,Med Sch, Nanjing 210093, Jiangsu, Peoples R China.
   [Wu, Jing; Tao, Weiwei; Li, Chao-Jun] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing 211166, Peoples R China.
   [Wu, Jing; Tao, Weiwei; Li, Chao-Jun] Nanjing Med Univ, China Int Joint Res Ctr Environm & Human Hlth, Ctr Global Hlth, Sch Publ Hlth, Nanjing 211166, Peoples R China.
   [Wu, Jing; Xue, Bin] Nanjing Med Univ, Sir Run Run Hosp, Core Lab, Nanjing 211166, Jiangsu, Peoples R China.
   [Li, Peng] Fudan Univ, Inst Metab & Integrat Biol IMIB, Shanghai 200438, Peoples R China.
C3 Nanjing University; Nanjing Medical University; Nanjing Medical
   University; Nanjing Medical University; Fudan University
RP Li, CJ (corresponding author), Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing 211166, Peoples R China.; Li, CJ (corresponding author), Nanjing Med Univ, China Int Joint Res Ctr Environm & Human Hlth, Ctr Global Hlth, Sch Publ Hlth, Nanjing 211166, Peoples R China.; Xue, B (corresponding author), Nanjing Med Univ, Sir Run Run Hosp, Core Lab, Nanjing 211166, Jiangsu, Peoples R China.; Li, P (corresponding author), Fudan Univ, Inst Metab & Integrat Biol IMIB, Shanghai 200438, Peoples R China.
EM peng_li@fudan.edu.cn; xuebin@njmu.edu.cn; lichaojun@njmu.edu.cn
RI Li, Chao-Jun/G-3522-2019
OI Li, Chao-Jun/0000-0002-3859-8824; Fang, Lei/0000-0002-2582-4845; Li,
   Chaojun/0000-0001-9474-7321; ZHAO, YUE/0000-0002-3236-6360
FU National Natural Science Foundation of China [91857109, 32071142,
   31771572]; Natural Science Foundation of the Jiangsu Higher Education
   Institutions of China [20KJB180004]; Science and Technology Development
   Fund of Nanjing Medical University-General Project [NMUB2019079]; Social
   Development Fund of Jiangsu Province [BK20191356]
FX This work was supported by the National Natural Science Foundation of
   China (91857109 to C.-J.L., 32071142 to B.X., and 31771572 to B.X.) and
   the Natural Science Foundation of the Jiangsu Higher Education
   Institutions of China (20KJB180004 to J.W.), Science and Technology
   Development Fund of Nanjing Medical University-General Project
   (NMUB2019079 to J.W.), and the Social Development Fund of Jiangsu
   Province (BK20191356 to B.X.). We thank Peng Li (Institute of Metabolism
   & Integrative Biology (IMIB), Fudan University) for providing their
   Cidea plasmid and ShCidea adenovirus.
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048
   Cartee GD, 2016, CELL METAB, V23, P1034, DOI 10.1016/j.cmet.2016.05.007
   Casper RF, 2014, FERTIL STERIL, V102, P336, DOI 10.1016/j.fertnstert.2014.06.006
   Chaix A, 2019, CELL METAB, V29, P303, DOI 10.1016/j.cmet.2018.08.004
   Chakrabarti P, 2013, MOL CELL BIOL, V33, P3659, DOI 10.1128/MCB.01584-12
   CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x
   Davidson AJ, 2008, NEUROBIOL AGING, V29, P471, DOI 10.1016/j.neurobiolaging.2006.10.018
   Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011
   Gokey NG, 2011, J BIOL CHEM, V286, P29501, DOI 10.1074/jbc.M111.263509
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Guan DY, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI148278
   Hamilton TB, 1998, BIOCHEMISTRY-US, V37, P2051, DOI 10.1021/bi9717993
   Hofman MA, 2006, AGEING RES REV, V5, P33, DOI 10.1016/j.arr.2005.07.001
   Hood S, 2017, J CLIN INVEST, V127, P437, DOI 10.1172/JCI90328
   HUANG RP, 1995, CANCER RES, V55, P5054
   Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711
   Jakobsen JS, 2013, GENOME RES, V23, P592, DOI 10.1101/gr.146399.112
   Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747
   Kim K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00215-1
   Korencic A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05782
   Liu J, 2016, ENDOCRINOLOGY, V157, P2259, DOI 10.1210/en.2015-2027
   Liu ZJ, 2019, NAT METAB, V1, P1141, DOI 10.1038/s42255-019-0136-6
   Luo WY, 2012, AGING CELL, V11, P428, DOI 10.1111/j.1474-9726.2012.00800.x
   Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355
   Meyyappan M, 1999, J CELL PHYSIOL, V179, P29, DOI 10.1002/(SICI)1097-4652(199904)179:1<29::AID-JCP4>3.3.CO;2-4
   Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5
   Penner MR, 2016, HIPPOCAMPUS, V26, P1008, DOI 10.1002/hipo.22583
   Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190
   Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007
   Shen N, 2015, AM J PATHOL, V185, P513, DOI 10.1016/j.ajpath.2014.10.016
   Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231
   Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6
   Tao WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15212
   VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191
   Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603
   Wu J, 2018, FASEB J, V32, P4370, DOI 10.1096/fj.201701340R
   Xu WY, 2016, J BIOL CHEM, V291, P4282, DOI 10.1074/jbc.M115.701094
   Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499
   Yu X, 2011, EMBO J, V30, P3754, DOI 10.1038/emboj.2011.277
   Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611
   Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225
NR 44
TC 3
Z9 3
U1 14
U2 38
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 24
PY 2023
VL 14
IS 1
AR 1634
DI 10.1038/s41467-023-36775-8
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA C1VW6
UT WOS:000959887700026
PM 36964140
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU LOPEZTORRES, M
   PEREZCAMPO, R
   ROJAS, C
   DEQUIROGA, CB
AF LOPEZTORRES, M
   PEREZCAMPO, R
   ROJAS, C
   DEQUIROGA, CB
TI SENSITIVITY TO INVITRO LIPID-PEROXIDATION IN LIVER AND BRAIN OF AGED
   RATS
SO REVISTA ESPANOLA DE FISIOLOGIA
LA English
DT Article
DE AGING; LIPID PEROXIDATION; OXYGEN RADICALS; FREE RADICALS
ID ANTIOXIDANT ENZYMES; SUPEROXIDE-DISMUTASE; GLUTATHIONE SYSTEM;
   MICROSOMES; CATALASE; TISSUES; MALONALDEHYDE; INHIBITION; METABOLISM
AB Lipid peroxidation in rat liver and brain has been studied to see if it increases with old age. No significant differences in the level of endogenous, nonstimulated lipid peroxidation (TBA-RS) is found between 9 month-old (mature adults) and 28 month-old animals in liver or cerebral cortex. Liver homogenates subjected in vitro to an oxidative stress (ascorbate-Fe++), show a clearly slower peroxidation rate in old than in young animals. On the other hand, the in vitro peroxidation rate of cerebral homogenates was similar in young and old animals. The in vitro peroxidation rate was much higher in brain than in liver tissue. These results do not support the view that old rats liver and brain are more susceptible to free radical oxidative damage than those of young ones.
C1 UNIV COMPLUTENSE MADRID, FAC BIOL, DEPT BIOL ANIM 2, E-28040 MADRID, SPAIN.
C3 Complutense University of Madrid
CR ANSARI KA, 1989, GROWTH DEVELOP AGING, V53, P117
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   BOURRE JM, 1990, LIPIDS, V25, P354, DOI 10.1007/BF02544347
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CUTLER RG, 1985, P NATL ACAD SCI USA, V82, P4798, DOI 10.1073/pnas.82.14.4798
   DEQUIROGA GB, 1990, J NEUROSCI RES, V26, P370, DOI 10.1002/jnr.490260314
   DEVASAGAYAM TPA, 1986, MECH AGEING DEV, V34, P13, DOI 10.1016/0047-6374(86)90101-6
   DEVASAGAYAM TPA, 1986, FEBS LETT, V205, P246, DOI 10.1016/0014-5793(86)80906-1
   DEVASAGAYAM TPA, 1989, NEUROSCI LETT, V103, P92, DOI 10.1016/0304-3940(89)90491-6
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   LEVITSKY EL, 1989, BIOLET EKSPERIM BIOL, V6, P693
   LOPEZTORRES M, 1991, J COMP PHYSIOL B, V160, P655, DOI 10.1007/BF00571264
   MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I
   MIZUNO Y, 1986, J NEUROCHEM, V46, P1344, DOI 10.1111/j.1471-4159.1986.tb01745.x
   NUKOBO M, 1985, J GERONTOL, V40, P409
   PIKUL J, 1983, J AGR FOOD CHEM, V31, P1338, DOI 10.1021/jf00120a047
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S
   SOHAL RS, 1986, ADV FREE RADICAL BIO, V2, P117, DOI 10.1016/S8755-9668(86)80026-6
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   VATASSERY GT, 1984, J NEUROCHEM, V43, P409, DOI 10.1111/j.1471-4159.1984.tb00916.x
NR 23
TC 9
Z9 10
U1 0
U2 0
PU UNIV NAVARRA, SERVICIO PUBLICACIONES
PI PAMPLONA
PA CAMPUS UNIV, CARRETERA DEL SADAR S-N, APARTADO 177, 31080 PAMPLONA,
   SPAIN
SN 0034-9402
J9 REV ESP FISIOL
JI Rev. Esp. Fisiol.
PD SEP
PY 1992
VL 48
IS 3
BP 191
EP 196
PG 6
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA KP573
UT WOS:A1992KP57300008
PM 1301635
DA 2024-02-19
ER

PT J
AU Shabalina, IG
   Kolosova, NG
   Grishanova, AY
   Solovyov, VN
   Salganik, RI
   Solovyova, NA
AF Shabalina, IG
   Kolosova, NG
   Grishanova, AY
   Solovyov, VN
   Salganik, RI
   Solovyova, NA
TI Oxidative phosphorylation activity, F0F1-ATPase, and cytochrome content
   in liver mitochondria of rats with inherited hyperproduction of free
   radicals
SO BIOCHEMISTRY-MOSCOW
LA English
DT Article
DE mitochondria; oxidative phosphorylation; cytochromes; adenine
   nucleotides; hyperproduction of oxygen free radicals; lipid
   peroxidation; early aging; S-strain rats
ID DAMAGE; DNA
AB Liver mitochondria from S-strain rats with inherited hyperproduction of free radicals were studied at the age of 2-3 and 10-12 months. They are characterized by a lower rate of oxygen consumption with three types of oxidizing substrates (glutamate plus malate, succinate in the presence of rotenone, and ascorbate plus TMPD(5)) and a lower content of respiratory chain cytochrome a than that of control Wistar rats. At the age of 10-12 months changes were observed in the liver mitochondria of the S-strain rats: ADP/O ratio, phosphorylation rate, and F0F1-ATPase activity decreased. In liver the phosphate potential, ATP content, and the sum of adenine nucleotides decreased. These results may be relevant to the mechanisms occurring in degenerative diseases in man and are important for understanding the accelerated aging of S-strain rats.
C1 RUSSIAN ACAD MED SCI, SIBERIAN BRANCH, INST MOL PATHOL & ECOL BIOCHEM, NOVOSIBIRSK 630117, RUSSIA.
   RUSSIAN ACAD MED SCI, SIBERIAN BRANCH, INST BIOCHEM, NOVOSIBIRSK, RUSSIA.
   RUSSIAN ACAD SCI, SIBERIAN BRANCH, INST CYTOL & GENET, NOVOSIBIRSK 630090, RUSSIA.
C3 Russian Academy of Sciences; Russian Academy of Medical Sciences;
   Russian Academy of Sciences; Russian Academy of Medical Sciences;
   Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS
RI Grishanova, Alevtina/C-1759-2014; Shabalina, Irina G/A-4225-2011;
   Kolosova, Nataliya G/AAR-7409-2020; Shabalina, Irina/AAC-3720-2019;
   Kolosova, Nataliya G/P-3178-2015; Stecuk, Evgen/GQZ-6378-2022
OI Grishanova, Alevtina/0000-0002-5894-1159; Shabalina, Irina
   G/0000-0002-2915-6450; Kolosova, Nataliya G/0000-0003-2398-8544;
   Shabalina, Irina/0000-0002-2915-6450; Kolosova, Nataliya
   G/0000-0003-2398-8544; Stecuk, Evgen/0000-0002-4239-2618
CR ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   [Anonymous], USP SOVREM BIOL
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Chance B., 1967, METHODS ENZYMOL, V10, P641, DOI 10.1016/0076-6879(67)10106-7
   DILLARD CJ, 1984, METHOD ENZYMOL, V105, P337
   EVTODIENKO YV, 1967, MEKHANIZMY DYKHANIYA, P35
   HOHORST HJ, 1959, BIOCHEM Z, V332, P18
   KAGAN VE, 1986, ADV SCI TECHNOLOGY B, V18, P136
   Kappus H, 1985, OXIDATIVE STRESS, P273, DOI [DOI 10.1016/B978-0-12-642760-8.50016-8, 10.1016/b978-0-12-642760-8.50016-8]
   LESTIENNE P, 1994, BIOMED PHARMACOTHER, V48, P199, DOI 10.1016/0753-3322(94)90134-1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V254, P547, DOI 10.1016/0003-9861(87)90136-6
   Nohl H., 1986, FREE RADICALS AGING, P77
   OBERMAIERKUSSER B, 1990, BIOCHEM BIOPH RES CO, V169, P1007, DOI 10.1016/0006-291X(90)91994-4
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   SALGANIC RI, 1994, FREE RADICAL BIO MED, V16, P13, DOI 10.1016/0891-5849(94)90231-3
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V199, P726, DOI 10.1006/bbrc.1994.1289
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V205, P180, DOI 10.1006/bbrc.1994.2647
   Skulachev V. P., 1989, Energetics of Biological Membranes
   SOLOVEVA NA, 1975, GENETIKA+, V11, P63
   SOLOVYOVA NA, VOPR MED KHIM, V6, P41
   VALLE VGR, 1993, ARCH BIOCHEM BIOPHYS, V307, P1, DOI 10.1006/abbi.1993.1551
   VLADIMIROV YA, 1991, ADV SCI TECHNOLOGY B, V29, P252
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WEHMEIER KR, 1994, FREE RADICAL BIO MED, V17, P83, DOI 10.1016/0891-5849(94)90010-8
   WEILMAHLERBE H, 1951, BIOCHEM J, V7, P75
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   ZHANG Y, 1990, J BIOL CHEM, V265, P16330
NR 30
TC 8
Z9 8
U1 0
U2 2
PU PLENUM PUBL CORP
PI NEW YORK
PA CONSULTANTS BUREAU 233 SPRING ST, NEW YORK, NY 10013
SN 0006-2979
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD DEC
PY 1995
VL 60
IS 12
BP 1563
EP 1568
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA TX892
UT WOS:A1995TX89200011
DA 2024-02-19
ER

PT J
AU Sakai, Y
   Zhong, R
   Garcia, B
   Zhu, LF
   Wall, WJ
AF Sakai, Y
   Zhong, R
   Garcia, B
   Zhu, LF
   Wall, WJ
TI Assessment of the longevity of the liver using a rat transplant model
SO HEPATOLOGY
LA English
DT Article
ID GLUTATHIONE; RADICALS; DAMAGE; DONOR; AGE
AB To assess the longevity of the liver, arterialized, orthotopic liver grafts were performed using syngeneic male BN/BiRij rats, Young (5-month-old) livers were transplanted into B-month-old recipients (group I, n = 27), and old (28-month-old) livers were transplanted into 5-month-old rats (group II, n = 28). Recipient survival after transplantation was similar in both groups. The average age of the livers at the time of death was 16.7 months in group I and 39.1 months in group II, Four of the livers in group II survived for more than 4 years (48.1 to 52.4 months), Early deaths (less than 1 year) after transplantation were most commonly caused by biliary obstruction and cholangitis in both groups, Late deaths (more than 1 year) after grafting were mainly from heart failure or tumors, None of the animals died of liver failure or liver disease. Weight gain in the rats, total serum protein levels, and alanine transaminase levels after transplantation did not differ significantly between the two groups, There was a trend for the histological features of aging of the liver-fibrosis, bile duct proliferation, and pigment deposition-to become more prevalent as the livers became very old (mean age, 46 months). Nevertheless, typical aging changes, as individual findings, were absent in nearly half of the oldest organs, The alterations in morphology had no apparent effect on the ability of the livers to sustain the lives of the recipients, The liver of the BN/BiRij rat was capable of surviving far beyond the maximum life span of BN/BiRij rats, and rats in general, It did not become diseased in the process.
C1 UNIV WESTERN ONTARIO HOSP, DEPT SURG, LONDON, ON N6A 5A5, CANADA.
   UNIV WESTERN ONTARIO HOSP, DEPT PATHOL, LONDON, ON N6A 5A5, CANADA.
   JOHN P ROBARTS RES INST, LONDON, ON N6A 5K8, CANADA.
C3 Western University (University of Western Ontario); Western University
   (University of Western Ontario); Western University (University of
   Western Ontario)
CR ADAM R, 1991, TRANSPLANT P, V23, P2602
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   BROUWER A, 1988, AGING LIVER GASTROIN, P209
   BUCHER NLR, 1964, CANCER RES, V24, P509
   BUREK JD, 1978, PATHOLOGY AGING RATS, P58
   BUREK JD, 1978, PATHOLOGY AGING RATS, P3
   COHEN T, 1960, Geriatrics, V15, P824
   CUTLER RG, 1991, ANN NY ACAD SCI, V621, P1
   Detre K M, 1995, Liver Transpl Surg, V1, P311, DOI 10.1002/lt.500010507
   HIGAMI Y, 1994, LAB INVEST, V71, P650
   Hoffman H.J., 1979, DHEW NIH79161 PUBL, P19
   HOLLANDER CF, 1984, MECH AGEING DEV, V28, P249, DOI 10.1016/0047-6374(84)90025-3
   KAMPMANN JP, 1975, GERIATRICS, V30, P91
   MARTIN GR, 1993, ANNU REV MED, V44, P419, DOI 10.1146/annurev.me.44.020193.002223
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   MOONEY H, 1985, CLIN GASTROENTEROL, V14, P757
   MOS J, 1987, MECH AGEING DEV, V38, P89, DOI 10.1016/0047-6374(87)90113-8
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   RABES HM, 1987, AGING LIVER GASTROIN, P225
   RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734
   SAKAI Y, 1993, TRANSPLANTATION, V55, P18, DOI 10.1097/00007890-199301000-00005
   STEIN HJ, 1991, J SURG RES, V50, P398, DOI 10.1016/0022-4804(91)90209-5
   VANBEZOOIJEN KF, 1974, J GERONTOL, V29, P11
   WALL W, 1993, LANCET, V341, P121, DOI 10.1016/0140-6736(93)92604-R
   WALL WJ, 1990, TRANSPLANTATION, V49, P377, DOI 10.1097/00007890-199002000-00030
   ZHAO DL, 1995, HEPATOLOGY, V21, P1353, DOI 10.1016/0270-9139(95)90057-8
   ZHAO DL, 1993, HEPATOLOGY, V17, P310, DOI 10.1002/hep.1840170224
   ZURCHER C, 1982, LIVER AGING 1982, P19
NR 28
TC 18
Z9 19
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD FEB
PY 1997
VL 25
IS 2
BP 421
EP 425
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA WG103
UT WOS:A1997WG10300027
PM 9021957
DA 2024-02-19
ER

PT J
AU LIN, JL
   ASANO, T
   SHIBASAKI, Y
   TSUKUDA, K
   KATAGIRI, H
   ISHIHARA, H
   TAKAKU, F
   OKA, Y
AF LIN, JL
   ASANO, T
   SHIBASAKI, Y
   TSUKUDA, K
   KATAGIRI, H
   ISHIHARA, H
   TAKAKU, F
   OKA, Y
TI ALTERED EXPRESSION OF GLUCOSE TRANSPORTER ISOFORMS WITH AGING IN RATS -
   SELECTIVE DECREASE IN GLUT4 IN THE FAT TISSUE AND SKELETAL-MUSCLE
SO DIABETOLOGIA
LA English
DT Article
DE GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER MESSENGER RNA; AGING
ID INSULIN-RESPONSIVE TISSUES; MESSENGER-RNA; PROTEIN; SEQUENCE; CLONING;
   RESISTANCE; BRAIN; LIVER; CDNA; LOCALIZATION
AB To elucidate the cellular mechanisms of glucose intolerance associated with aging, both the protein and mRNA levels of glucose transporter isoforms were studied in the various tissues of young (7-week-old) and aged (20-month-old) rats.  GluT4 (adipose/muscle-type glucose transporter) protein, which is specifically expressed in insulin-responsive tissues, was selectively decreased per milligramme of cellular membrane protein in both the epididymal fat tissues and the gastrocnemius muscle of the aged rats compared with the young rats.  When the changes in total cellular membranes per gramme of tissue are taken into account, a further decrease in GluT4 protein per gramme of tissue was observed in the tissues of the aged rats compared with the young rats.  The decreased amount of GluT4 protein in the fat tissues of the aged rats is probably due to the decreased protein synthesis rather than the stability, since GluT4 mRNA/mu-g of cellular total RNA was also decreased.  In contrast, GluT4 mRNA in the gastrocnemium muscle was rather increased and a ratio of GluT4 protein/GluT4 mRNA was decreased by 70% in the aged rats, suggesting that the translational efficiency and/or stability of GluT4 protein is decreased in the skeletal muscle of the aged rats compared with the young rats.  GluT2 (liver-type glucose transporter) protein and mRNA in the liver were also decreased in the aged rats, while no apparent decrease in GluT1 (HepG2/brain-type glucose transporter) protein/mg of cellular membrane protein was observed in the skeletal muscle and fat tissues of the aged rats compared with the young rats.  Thus, the tissue and isoform-specific alterations of glucose transporter expression are associated with aging and may contribute to glucose intolerance observed with aging.
C1 UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,7-3-1,BUNKYO KU,TOKYO 113,JAPAN.
C3 University of Tokyo
CR ASANO T, 1989, NUCLEIC ACIDS RES, V17, P6386, DOI 10.1093/nar/17.15.6386
   ASANO T, 1988, BIOCHEM BIOPH RES CO, V154, P1204, DOI 10.1016/0006-291X(88)90268-9
   BAUER H, 1977, EUR J BIOCHEM, V74, P397
   BERGER J, 1989, NATURE, V340, P70, DOI 10.1038/340070a0
   BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9
   BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784
   BJORNTORP P, 1970, ACTA PHYSIOL SCAND, V80, P29, DOI 10.1111/j.1748-1716.1970.tb04766.x
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   FINK RI, 1986, ENDOCRINOLOGY, V118, P1139, DOI 10.1210/endo-118-3-1139
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FINK RI, 1986, J CLIN INVEST, V77, P2034, DOI 10.1172/JCI112533
   FINK RI, 1984, J CLIN ENDOCR METAB, V58, P721, DOI 10.1210/jcem-58-4-721
   FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776
   FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434
   GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408
   GOODMAN MN, 1983, AM J PHYSIOL, V244, pE93, DOI 10.1152/ajpendo.1983.244.1.E93
   JACKSON RA, 1988, DIABETES, V37, P119, DOI 10.2337/diabetes.37.1.119
   JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0
   JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0
   KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150
   KAYANO T, 1988, J BIOL CHEM, V263, P15245
   KLIP A, 1987, FEBS LETT, V224, P224, DOI 10.1016/0014-5793(87)80452-0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033
   LONNROTH P, 1986, J CLIN ENDOCR METAB, V62, P433
   MENEILLY GS, 1987, J GERONTOL, V42, P196, DOI 10.1093/geronj/42.2.196
   MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598
   NARIMIYA M, 1984, AM J PHYSIOL, V246, pE397, DOI 10.1152/ajpendo.1984.246.5.E397
   NISHIMURA H, 1988, AM J PHYSIOL, V254, pE92, DOI 10.1152/ajpendo.1988.254.1.E92
   OKA Y, 1990, DIABETES, V39, P441, DOI 10.2337/diabetes.39.4.441
   OKA Y, 1988, J BIOL CHEM, V263, P13432
   PAGANO G, 1984, METABOLISM, V33, P976, DOI 10.1016/0026-0495(84)90223-3
   SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059
   SIVITZ WI, 1989, NATURE, V340, P72, DOI 10.1038/340072a0
   THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7
   WHEELER TJ, 1985, ANNU REV PHYSIOL, V47, P503, DOI 10.1146/annurev.ph.47.030185.002443
   WILLIAMS TF, 1968, AM J PHYSIOL, V215, P1200, DOI 10.1152/ajplegacy.1968.215.5.1200
NR 39
TC 47
Z9 54
U1 0
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0012-186X
J9 DIABETOLOGIA
JI Diabetologia
PD JUL
PY 1991
VL 34
IS 7
BP 477
EP 482
DI 10.1007/BF00403283
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA FY115
UT WOS:A1991FY11500004
PM 1916052
OA Bronze
DA 2024-02-19
ER

PT J
AU Kasalka-Czarna, N
   Bieganska-Marecik, R
   Proch, J
   Orlowska, A
   Montowska, M
AF Kasalka-Czarna, Natalia
   Bieganska-Marecik, Roza
   Proch, Jedrzej
   Orlowska, Aleksandra
   Montowska, Magdalena
TI Effect of Dry, Vacuum, and Modified Atmosphere Ageing on Physicochemical
   Properties of Roe Deer Meat
SO POLISH JOURNAL OF FOOD AND NUTRITION SCIENCES
LA English
DT Article
DE roe deer; protein oxidation; lipid oxidation; vacuum; modified
   atmosphere; dry -ageing
ID CAPREOLUS L. BUCKS; PROTEIN OXIDATION; CHEMICAL-COMPOSITION;
   LONGISSIMUS-DORSI; PACKAGING SYSTEM; COLD-STORAGE; QUALITY; MUSCLES;
   VENISON; LIVER
AB Consumers around the world are choosing sustainable and unprocessed foods. Roe deer meat, due to the natural origin, is a source of organic and healthy meat. The selection of suitable storage conditions and times plays an important role in a deterioration of the meat's functional and nutritional values. The knowledge about oxidation processes in roe deer meat stored and packed deploying different methods is limited. The main aim of this study was therefore to investigate the effect of storage method on the physicochemical properties of musculus longissimus thoracis et lumborum (LTL), musculus biceps femoris (BF), and musculus vastus lateralis (VL) of roe deer. The muscles were stored either dry (DRY-AGED), vacuum--packed(VAC), or packed under modified atmosphere (MAP) for 21 days. The quality of roe deer meat was assessed based on chemical composition, technological properties, pH values, water activity, colour, and oxidation processes of proteins and lipids. Roe deer meat had high protein (216.5-228.6 g/kg) and low fat content (17.1-25.8 g/kg). Both DRY-AGED and VAC contributed to improving meat tenderness during storage, while the Warner-Bratzler shear force of the MAP muscles in-creased. The high-oxygen conditions during MAP storage strongly induced the oxidation processes; an average increase of 1,263% for thiobarbituric acid reactive substance (TBARS) level and 155% for protein carbonyl content on day 21. Vacuum packaging and dry-ageing are recommended methods for storing roe deer meat. The high oxygen atmosphere negatively affected the quality of this game species. It carries the risk of increased oxidation of proteins and lipids which may promote the formation of potentially detrimental compounds.
C1 [Kasalka-Czarna, Natalia; Montowska, Magdalena] Poznan Univ Life Sci, Dept Meat Technol, Wojska Polskiego 31, PL-60624 Poznan, Poland.
   [Bieganska-Marecik, Roza] Poznan Univ Life Sci, Dept Food Technol Plant Origin, Wojska Polskiego 31, PL-60624 Poznan, Poland.
   [Proch, Jedrzej; Orlowska, Aleksandra] Adam Mickiewicz Univ, Dept Analyt Chem, Uniwersytetu Poznanskiego 8, PL-61614 Poznan, Poland.
C3 Poznan University of Life Sciences; Poznan University of Life Sciences;
   Adam Mickiewicz University
RP Kasalka-Czarna, N (corresponding author), Poznan Univ Life Sci, Dept Meat Technol, Wojska Polskiego 31, PL-60624 Poznan, Poland.
EM natalia.czarna@up.poznan.pl
RI Proch, Jędrzej/AAB-9429-2020
OI Proch, Jędrzej/0000-0003-0023-044X; Kasalka-Czarna,
   Natalia/0000-0001-9062-0665; Proch, Aleksandra/0000-0003-2941-930X;
   Montowska, Magdalena/0000-0002-6331-5726; Bieganska-Marecik,
   Roza/0000-0002-3734-4806
FU Department of Meat Technology, Faculty of Food Science and Nutrition
   [506.753.03.00]
FX The study was financed by a grant (number 506.753.03.00) for the
   development of a young scientist or a doctoral student in the discipline
   of food technology and nutrition implemented as part of the doctoral
   dissertation at the Department of Meat Technology, Faculty of Food
   Science and Nutrition.
CR [Anonymous], 2004, OFFICIAL J EUROPEAN, pL139
   [Anonymous], 9371978 ISO
   Bao YL, 2019, CRIT REV FOOD SCI, V59, P3564, DOI 10.1080/10408398.2018.1498444
   Campo MM, 2006, MEAT SCI, V72, P303, DOI 10.1016/j.meatsci.2005.07.015
   Chaijan M., 2008, SJST, V30, P47
   Clausen I, 2009, PACKAG TECHNOL SCI, V22, P85, DOI 10.1002/pts.828
   Cygan-Szczegielniak D, 2012, POL J VET SCI, V15, P645, DOI 10.2478/v10181-012-0101-8
   Cygan-Szczegielniak D., 2012, FOOD SCI TECHNOL QUA, V6, P127
   Dashdorj Dashmaa, 2016, Journal of Animal Science and Technology, V58, P20, DOI 10.1186/s40781-016-0101-9
   Daszkiewicz T, 2011, POL J VET SCI, V14, P459, DOI 10.2478/v10181-011-0068-x
   Daszkiewicz Toman, 2008, Polish Journal of Food and Nutrition Sciences, V58, P331
   Daszkiewicz T, 2018, J FOOD QUALITY, DOI 10.1155/2018/4691542
   Dominguez R, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11010060
   Domínguez R, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100429
   Dominik P, 2012, POL J FOOD NUTR SCI, V62, P185, DOI 10.2478/v10222-012-0052-x
   Estévez M, 2004, MEAT SCI, V68, P551, DOI 10.1016/j.meatsci.2004.05.007
   Estévez M, 2019, J FOOD SCI, V84, P387, DOI 10.1111/1750-3841.14460
   Estévez M, 2011, MEAT SCI, V89, P259, DOI 10.1016/j.meatsci.2011.04.025
   Florek M, 2019, MED WETER, V75, P487, DOI 10.21521/mw.6214
   Fuentes V, 2010, MEAT SCI, V85, P506, DOI 10.1016/j.meatsci.2010.02.024
   Gill C. O., 1990, Food Control, V1, P74, DOI 10.1016/0956-7135(90)90088-T
   Hoffman LC, 2006, MEAT SCI, V74, P197, DOI 10.1016/j.meatsci.2006.04.005
   Ivanovic S, 2020, ANN ANIM SCI, V20, P245, DOI 10.2478/aoas-2019-0064
   Kasalka-Czarna N, 2022, J SCI FOOD AGR, V102, P5250, DOI 10.1002/jsfa.11878
   Kim YH, 2010, MEAT SCI, V85, P759, DOI 10.1016/j.meatsci.2010.04.001
   Klupsaite D, 2020, ANIM SCI J, V91, DOI 10.1111/asj.13346
   Krolikowski T., 2020, Technol. Prog. Food Process, V2, P125
   Kwiecinska K., 2018, ZESZYTY NAUKOWE SGGW, V121, P83, DOI DOI 10.22630/EIOGZ.2018.121.6
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   Li FF, 2020, FOOD RES INT, V133, DOI 10.1016/j.foodres.2020.109142
   Lindahl G, 2010, MEAT SCI, V85, P160, DOI 10.1016/j.meatsci.2009.12.020
   Lo Fiego DP, 2004, MEAT SCI, V67, P319, DOI 10.1016/j.meatsci.2003.11.004
   Lopacka J, 2016, MEAT SCI, V119, P147, DOI 10.1016/j.meatsci.2016.04.034
   Lund MN, 2007, MEAT SCI, V77, P295, DOI 10.1016/j.meatsci.2007.03.016
   Lund MN, 2011, MOL NUTR FOOD RES, V55, P83, DOI 10.1002/mnfr.201000453
   Moczkowska M, 2017, MEAT SCI, V130, P7, DOI 10.1016/j.meatsci.2017.03.008
   Niewiadomska K, 2020, FOODS, V9, DOI 10.3390/foods9101357
   PN-ISO, 14442000 PN ISO
   PN-ISO, 9362000 PN ISO
   PN-ISO, 14422000 PN ISO
   Razmaite V, 2015, ANN ANIM SCI, V15, P775, DOI 10.1515/aoas-2015-0012
   Soladoye OP, 2015, COMPR REV FOOD SCI F, V14, P106, DOI 10.1111/1541-4337.12127
   Sottero B, 2019, EUR J LIPID SCI TECH, V121, DOI 10.1002/ejlt.201700047
   Swiderski F., 2011, POSTEPY TECHNIKI PRZ, V1, P98
   Thogersen R, 2020, FOOD CHEM, V302, DOI 10.1016/j.foodchem.2019.125339
   Ventanas S, 2007, MEAT SCI, V77, P246, DOI 10.1016/j.meatsci.2007.03.010
   Vergara H, 2003, MEAT SCI, V65, P779, DOI 10.1016/S0309-1740(02)00282-6
   Wang C, 2019, MEAT SCI, V148, P189, DOI 10.1016/j.meatsci.2018.10.001
   Wazir H, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100486
   Zomborszky Z, 1996, J FOOD SCI, V61, P625, DOI 10.1111/j.1365-2621.1996.tb13172.x
   Zubaidi MA, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11094166
NR 51
TC 1
Z9 1
U1 6
U2 6
PU INST ANIMAL REPRODUCTION & FOOD RESEARCH POLISH ACAD SCIENCES OLSZTYN
PI OLSZTYN
PA UL J TUWIMA 10, OLSZTYN, 10-747, POLAND
SN 1230-0322
EI 2083-6007
J9 POL J FOOD NUTR SCI
JI Pol. J. food Nutr. Sci.
PY 2023
VL 73
IS 2
BP 175
EP 186
DI 10.31883/pjfns/163613
PG 12
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA K0RM0
UT WOS:001013606000007
OA gold
DA 2024-02-19
ER

PT J
AU Mahmoud, YI
   Mahmoud, AA
   Abo-Zeid, FS
   Fares, NH
AF Mahmoud, Yomna I.
   Mahmoud, Asmaa A.
   Abo-Zeid, Faten S.
   Fares, Nagui H.
TI Effect of dehydroepiandrosterone on the liver of perimenopausal rat:
   multiple doses study DHEA alters the liver of perimenopausal rats
SO ULTRASTRUCTURAL PATHOLOGY
LA English
DT Article
DE Dehydroepiandrosterone; lipids; liver; perimenopause; rat;
   ultrastructure
ID MITOCHONDRIAL PERMEABILITY; ENZYMATIC DETERMINATION; ELDERLY-WOMEN;
   CHOLESTEROL; PROLIFERATION; PARAMETERS; DISEASE; SUPPLEMENTATION;
   ACCUMULATION; TRIGLYCERIDE
AB Dehydroepiandrosterone (DHEA) is a widespread nutritional "anti-aging" supplement. Exogenous supplementation of DHEA is now being commonly used to augment ovarian stimulation in perimenopausal women with diminished ovarian reserve. Whether DHEA causes side effects in such age is, however, unknown. Thus, this study investigates the effects of pharmacological doses of DHEA supplementation on the liver of perimenopausal rats. DHEA supplementation to perimenopausal rats resulted in slight hepatomegaly and steatosis, hepatocytic hypertrophy, mitochondrial swelling, elevation in serum alanine aminotransaminase levels, in addition to the accumulation of lipid droplets and lipolysosomes in a dose-dependent manner. In conclusion, long-term administration of high doses of DHEA causes ultrastructural alterations and changes in the levels of cholesterol and triglyceride in hepatocytes of perimenopausal rats. DHEA at a dose of 50 mg/kg improves health and decreases the body weight, with the least side effects on the liver of perimenopausal rats.
C1 [Mahmoud, Yomna I.; Mahmoud, Asmaa A.; Abo-Zeid, Faten S.; Fares, Nagui H.] Ain Shams Univ, Zool Dept, Fac Sci, Cairo, Egypt.
C3 Egyptian Knowledge Bank (EKB); Ain Shams University
RP Mahmoud, YI (corresponding author), Ain Shams Univ, Zool Dept, Fac Sci, Cairo, Egypt.
EM yomna_ia@yahoo.com
RI Mahmoud, Yomna Ibrahim/H-6872-2019
OI Mahmoud, Yomna Ibrahim/0000-0002-9273-7661; Mahmoud,
   Asmaa/0000-0001-9655-5200; Abo-Zeid, Faten/0000-0002-3888-7503
CR ALLAIN CC, 1974, CLIN CHEM, V20, P470
   Almeida Felipe Natali, 2014, Acta Scientiarum Biological Sciences, V36, P223, DOI 10.4025/actascibiolsci.v36i2.19471
   ARAD Y, 1989, ARTERIOSCLEROSIS, V9, P159, DOI 10.1161/01.ATV.9.2.159
   Auchus RJ, 2004, SEMIN REPROD MED, V22, P281, DOI 10.1055/s-2004-861545
   Badriah Alabdulkarim, 2012, World Applied Sciences Journal, V17, P951
   Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279
   BELLEI M, 1992, J NUTR, V122, P967, DOI 10.1093/jn/122.4.967
   BERGMEYER HU, 1978, CLIN CHEM, V24, P58
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bovenberg SA, 2005, NETH J MED, V63, P300
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   BUCOLO G, 1973, CLIN CHEM, V19, P476
   Buvat J, 2003, WORLD J UROL, V21, P346, DOI 10.1007/s00345-003-0367-7
   Cahova M, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/757205
   Caldwell ASL, 2014, ENDOCRINOLOGY, V155, P3146, DOI 10.1210/en.2014-1196
   CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X
   Cecconello AL, 2015, ENDOCRINE, V48, P985, DOI 10.1007/s12020-014-0396-6
   Celec P, 2003, PHYSIOL RES, V52, P397, DOI 10.33549/physiolres.930385
   Chan DC, 2010, ARTERIOSCL THROM VAS, V30, P1043, DOI 10.1161/ATVBAHA.109.202275
   Correa F, 2003, J STEROID BIOCHEM, V87, P279, DOI 10.1016/j.jsbmb.2003.09.002
   Gleicher N, 2010, REPROD BIOMED ONLINE, V21, P360, DOI 10.1016/j.rbmo.2010.04.006
   Gleicher N, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-108
   Guzzaloni G, 2000, INT J OBESITY, V24, P772, DOI 10.1038/sj.ijo.0801224
   Holka-Pokorska J, 2015, PSYCHIATR POL, V49, P363, DOI 10.12740/PP/30180
   Hyman JH, 2013, EUR J OBSTET GYN R B, V168, P49, DOI 10.1016/j.ejogrb.2012.12.017
   Iancu TC, 2013, ULTRASTRUCT PATHOL, V37, P293, DOI 10.3109/01913123.2013.799625
   Kim SH, 2016, CLIN CHIM ACTA, V461, P47, DOI 10.1016/j.cca.2016.07.022
   Kopplow K, 2005, INT J ONCOL, V27, P1551
   Kuriwaki K, 1999, PATHOL INT, V49, P291, DOI 10.1046/j.1440-1827.1999.00862.x
   Kwak CS, 2000, J KOREAN MED SCI, V15, P533, DOI 10.3346/jkms.2000.15.5.533
   Labrie F, 2007, J STEROID BIOCHEM, V103, P178, DOI 10.1016/j.jsbmb.2006.09.034
   Lasco A, 2001, EUR J ENDOCRINOL, V145, P457, DOI 10.1530/eje.0.1450457
   Li SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep38134
   Liu L, 2016, MOL MED REP, V14, P705, DOI 10.3892/mmr.2016.5343
   Ma HT, 2008, VET MED-CZECH, V53, P543, DOI 10.17221/1963-VETMED
   Mahmoud YI, 2016, BIOTECH HISTOCHEM, V91, P86, DOI 10.3109/10520295.2015.1076578
   Mahmoud YI, 2018, LIFE SCI, V199, P131, DOI 10.1016/j.lfs.2018.03.021
   McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200
   METZGER C, 1995, TOXICOL PATHOL, V23, P591, DOI 10.1177/019262339502300505
   Miyazaki H, 2016, J CLIN BIOCHEM NUTR, V58, P223, DOI 10.3164/jcbn.15-133
   Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629
   Oberbeck R, 2010, CURR MED CHEM, V17, P1039
   Olech E, 2005, CLEV CLIN J MED, V72, P965, DOI 10.3949/ccjm.72.11.965
   Panjari M, 2009, MATURITAS, V63, P240, DOI 10.1016/j.maturitas.2009.03.020
   de Heredia FP, 2007, BRIT J NUTR, V97, P464, DOI 10.1017/S0007114507332546
   Pluchino N, 2015, J STEROID BIOCHEM, V145, P273, DOI 10.1016/j.jsbmb.2014.04.012
   Pratt DS, 2010, SLEISENGER FORDRANS, P118
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rutkowski K, 2014, DRUGS, V74, P1195, DOI 10.1007/s40265-014-0259-8
   Sadock BJ., 2008, KAPLAN SADOCKS CONCI
   Shen MQ, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/294278
   Shen XH, 2012, GEN COMP ENDOCR, V177, P177, DOI 10.1016/j.ygcen.2012.03.007
   Singh A., 2011, J CLIN TOXICOL S, VS4, P1, DOI [DOI 10.4172/2161-0495.S4-001, https://doi.org/10.4172/2161-0495.S4-001]
   Stárka L, 2015, J STEROID BIOCHEM, V145, P254, DOI 10.1016/j.jsbmb.2014.03.008
   Takitani K, 2016, J NUTR SCI VITAMINOL, V62, P12, DOI 10.3177/jnsv.62.12
   Traish AM, 2011, J SEX MED, V8, P2960, DOI 10.1111/j.1743-6109.2011.02523.x
   Villareal DT, 2000, CLIN ENDOCRINOL, V53, P561, DOI 10.1046/j.1365-2265.2000.01131.x
   Wiser A, 2010, HUM REPROD, V25, P2496, DOI 10.1093/humrep/deq220
   Xu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099858
NR 59
TC 0
Z9 1
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0191-3123
EI 1521-0758
J9 ULTRASTRUCT PATHOL
JI Ultrastruct. Pathol.
PY 2018
VL 42
IS 4
BP 333
EP 343
DI 10.1080/01913123.2018.1485806
PG 11
WC Microscopy; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microscopy; Pathology
GA HD2EF
UT WOS:000452323200002
PM 29932802
DA 2024-02-19
ER

PT J
AU Mao, L
   Zabel, C
   Nebrich, G
   Wacker, MA
   Sagi, D
   Schrade, P
   Bachman, S
   Kowald, A
   Klose, J
AF Mao, L
   Zabel, C
   Nebrich, G
   Wacker, MA
   Sagi, D
   Schrade, P
   Bachman, S
   Kowald, A
   Klose, J
TI Estimation of the mtDNA mutation rate in aging mice by proteome analysis
   and mathematical modeling
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE mitochondria; aging; proteome; large-gel 2D electrophoresis; mouse
   model; mathematical modeling
ID CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA MUTATIONS; HUMAN
   SKELETAL-MUSCLE; COMPLEX-I DEFICIENCY; 2-DIMENSIONAL ELECTROPHORESIS;
   DELAYED DEGRADATION; CATALYTIC-ACTIVITY; ENCODED SUBUNITS;
   GENE-EXPRESSION; PROTEINS
AB The accumulation of mitochondria containing mutated genomes was proposed to be an important factor involved in aging. Although the level of mutated mtDNA has shown to increase over time, it is currently not possible to directly measure the mtDNA mutation rate within living cells. The combination of mathematical modeling and controlled experiments is an alternative approach to obtain an estimate for the mutation rate in a well-defined system. In order to judge the relevance of mitochondrial mutations for the aging process, we used a mouse model to study age-related alterations of the mitochondrial proteins. Based on these experimental data we constructed a mathematical model of the mitochondrial population dynamics to estimate mtDNA mutation rates. Mitochondria were isolated from mouse brain and liver at six different ages (newborn to 24-months). A large-gel 2D-electrophoresis-based proteomics approach was used to analyze the mitochondrial proteins. The expression of two respiratory chain complex I subunits and one complex IV subunit decreased significantly with age. One subunit of complex III and one subunit of complex V increased in expression during aging. Together, these data indicate that complex I and IV deficiency in aged tissues might be accompanied by feedback regulation of other protein complexes in the respiratory chain. When we fitted our experimental data to the mathematical model, mtDNA mutation rate was estimated to be 2.7 x 10-8 per mtDNA per day for brain and 3.2 x 10-9 per mtDNA per day for liver. According to our model and in agreement with the mitochondrial theory of aging, mtDNA mutations could cause the detrimental changes seen in mitochondrial populations during the normal lifespan of mice, while at the same time ensure that the mitochondrial population remains functional during the developmental and reproductive period of mice.
C1 Humboldt Univ, Inst Human Genet, Bereich Med Charite, D-13353 Berlin, Germany.
   Humboldt Univ, Inst Anat, Bereich Med Charite, D-13353 Berlin, Germany.
   Max Planck Inst Mol Genet, Kinetic Model Group, D-14195 Berlin, Germany.
C3 Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin; Max Planck
   Society
RP Klose, J (corresponding author), Humboldt Univ, Inst Human Genet, Bereich Med Charite, Augustenburger Platz 1, D-13353 Berlin, Germany.
EM joachim.klose@charite.de
OI Kowald, Axel/0000-0001-6448-4364
CR Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Bachmann S, 2004, J AM SOC NEPHROL, V15, P892, DOI 10.1097/01.ASN.0000120389.09938.21
   Basu A, 1997, J BIOL CHEM, V272, P5899, DOI 10.1074/jbc.272.9.5899
   Bentlage HACM, 1996, NEUROLOGY, V47, P243, DOI 10.1212/WNL.47.1.243
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROWN GC, 1991, J THEOR BIOL, V153, P195, DOI 10.1016/S0022-5193(05)80422-9
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Challapalli KK, 2004, ELECTROPHORESIS, V25, P3040, DOI 10.1002/elps.200405979
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Coller HA, 2002, ANN NY ACAD SCI, V959, P434, DOI 10.1111/j.1749-6632.2002.tb02113.x
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   DALLMAN PR, 1967, J CLIN INVEST, V46, P1819, DOI 10.1172/JCI105672
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   DiMauro S, 2000, NEUROL SCI, V21, pS901
   diRago JP, 1997, J BIOL CHEM, V272, P4699, DOI 10.1074/jbc.272.8.4699
   Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5
   Giavalisco P, 2005, PROTEOMICS, V5, P1902, DOI 10.1002/pmic.200401062
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HOOD DA, 1989, EUR J BIOCHEM, V179, P275, DOI 10.1111/j.1432-1033.1989.tb14551.x
   JAEQUEZ JA, 1985, COMPART ANAL BIOL
   JOENJE H, 1985, LAB INVEST, V52, P420
   JUNGBLUT P, 1985, BIOCHEM GENET, V23, P227, DOI 10.1007/BF00504321
   Klose J, 1999, METH MOL B, V112, P147
   KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175
   Kopsidas G, 1998, MUTAT RES-FUND MOL M, V421, P27, DOI 10.1016/S0027-5107(98)00150-X
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   KOWALD A, 1993, MUTAT RES, V295, P93, DOI 10.1016/0921-8734(93)90011-Q
   Kowald A, 2000, J THEOR BIOL, V202, P145, DOI 10.1006/jtbi.1999.1046
   Kowald A, 1999, EXP GERONTOL, V34, P605, DOI 10.1016/S0531-5565(99)00011-X
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x
   Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6
   MOREADITH RW, 1984, J CLIN INVEST, V74, P685, DOI 10.1172/JCI111484
   NEUBERT D, 1966, NATURWISSENSCHAFTEN, V53, P23, DOI 10.1007/BF00607636
   NIJTMANS LGJ, 1995, BBA-MOL CELL RES, V1265, P117, DOI 10.1016/0167-4889(94)00203-Q
   Osiewacz HD, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1275
   PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T
   PIRT SJ, 1991, NATURE, V350, P104, DOI 10.1038/350104c0
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.0.CO;2-I
   Remacle C, 2004, CURR GENET, V45, P323, DOI 10.1007/s00294-004-0490-z
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   ROTILIO G, 1972, BIOCHIM BIOPHYS ACTA, V268, P605, DOI 10.1016/0005-2744(72)90359-2
   ROWLATT C, 1976, Laboratory Animals (London), V10, P419, DOI 10.1258/002367776780956917
   Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Shenkar R, 1996, AM J HUM GENET, V59, P772
   Stryer L., 1995, BIOCHEMISTRY
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   SWAT M, 2004, BIOINFORMATICS, V1, P1
   Toescu EC, 2000, CELL CALCIUM, V28, P329, DOI 10.1054/ceca.2000.0167
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vijayasarathy C, 2003, EUR J BIOCHEM, V270, P871, DOI 10.1046/j.1432-1033.2003.03447.x
   Vijayasarathy C, 1999, EUR J BIOCHEM, V266, P191, DOI 10.1046/j.1432-1327.1999.00843.x
   Vu TH, 2000, MUSCLE NERVE, V23, P80, DOI 10.1002/(SICI)1097-4598(200001)23:1<80::AID-MUS10>3.0.CO;2-V
   Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a
NR 63
TC 28
Z9 28
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN
PY 2006
VL 41
IS 1
BP 11
EP 24
DI 10.1016/j.exger.2005.09.012
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 004YN
UT WOS:000234788700002
PM 16307857
DA 2024-02-19
ER

PT J
AU Li, HY
   An, JH
   Wu, MY
   Zheng, QD
   Gui, X
   Li, TM
   Pu, H
   Lu, DD
AF Li, Haiyan
   An, Jiahui
   Wu, Mengying
   Zheng, Qidi
   Gui, Xin
   Li, Tianming
   Pu, Hu
   Lu, Dongdong
TI LncRNA HOTAIR promotes human liver cancer stem cell malignant growth
   through downregulation of SETD2
SO ONCOTARGET
LA English
DT Article
DE lncRNA HOTAIR; liver cancer stem cell; SETD2; DNA mismatch repair;
   microsatellite instability
ID LONG NONCODING RNA; DNA MISMATCH REPAIR; HOMOLOGOUS RECOMBINATION;
   ENDOMETRIAL CARCINOMA; EXPRESSION; IDENTIFICATION; PROGRESSION;
   METASTASIS; DAMAGE
AB Long non-coding RNA HOTAIR predicts negative tumor prognosis and exhibits oncogenic activity. Herein, we demonstrate HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2. Mechanistically, HOTAIR reduces the recuritment of the CREB, P300, RNA polII onto the SETD2 promoter region that inhibits SETD2 expression and its phosphorylation. Thereby, the SETD2 binding capacity to substrate histone H3 is weakened, triggering a reduction of trimethylation on histone H3 thirty-sixth lysine, and thereby the H3K36me3-hMSH2-hMSH6-SKP2 complex is also decreased. Strikingly, the complex occupancy on chromosome is depressed, preventing from mismatch DNA repair. While reducing the degradation capacity of Skp(2) for aging histone H3 bound to damaged DNA, the aging histone repair is impaired. Furthermore, that the damaged DNA escaped to repair can causes microsatellite instability(MSI) and abnormal expression of cell cycle related genes that may trigger the hepatocarcinogenesis. This study provides evidence for HOTAIR to promote tumorigenesis via downregulating SETD2 in liver cancer stem cells.
C1 [Li, Haiyan; An, Jiahui; Wu, Mengying; Zheng, Qidi; Gui, Xin; Li, Tianming; Pu, Hu; Lu, Dongdong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.
C3 Tongji University
RP Lu, DD (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.
EM ludongdong@tongji.edu.cn
RI jiang, lei/IWE-1124-2023; wu, jun/ISB-8607-2023
FU National Natural Science Fundation of China (NCSF) [81272291]; Science
   and Technology Commission of Shanghai Municipality
   [13JC1405500-13JC1405501]
FX This study was supported by grants from National Natural Science
   Fundation of China (NCSF No. 81272291) and Science and Technology
   Commission of Shanghai Municipality (No. 13JC1405500-13JC1405501).
CR Al Sarakbi W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-290
   Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796
   Bilbao-Sieyro C, 2014, ONCOTARGET, V5, P6206, DOI 10.18632/oncotarget.2187
   Cai B, 2014, NEOPLASMA, V61, P379, DOI 10.4149/neo_2014_075
   Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482
   Chen FJ, 2013, MOL CARCINOGEN, V52, P908, DOI 10.1002/mc.21944
   Ding C, INT J MOL SCI, V15, P1
   Du YQ, 2014, J BIOL CHEM, V289, P2711, DOI 10.1074/jbc.M113.525501
   Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120
   Edelbrock MA, 2013, MUTAT RES-FUND MOL M, V743, P53, DOI 10.1016/j.mrfmmm.2012.12.008
   Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077070
   Ge XS, 2013, CANCER SCI, V104, P1675, DOI 10.1111/cas.12296
   Gu MJ, 2012, HEPATO-GASTROENTEROL, V59, P2228, DOI 10.5754/hge11601
   Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975
   He XY, 2014, INT J MOL MED, V33, P325, DOI 10.3892/ijmm.2013.1570
   He Y, 2014, CANCER LETT, V344, P20, DOI 10.1016/j.canlet.2013.10.021
   Huang F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/216286
   Huang JM, 2014, INT J GYNECOL CANCER, V24, P635, DOI 10.1097/IGC.0000000000000121
   Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010
   Jha DK, 2014, NAT STRUCT MOL BIOL, V21, P655, DOI 10.1038/nsmb.2866
   Kaliyaperumal S, 2011, MUTAT RES-FUND MOL M, V706, P36, DOI 10.1016/j.mrfmmm.2010.10.008
   Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193
   Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021
   Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025
   Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92
   Liu Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060190, 10.1371/journal.pone.0066666]
   Lv XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063516
   Mohamadkhani A, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.18794
   Panganiban G, 2002, DEVELOPMENT, V129, P4371
   Park Ju Young, 2014, Brain Tumor Res Treat, V2, P1, DOI 10.14791/btrt.2014.2.1.1
   Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02
   Pei CS, 2014, ASIAN PAC J CANCER P, V15, P4239, DOI 10.7314/APJCP.2014.15.10.4239
   Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026
   Rega S, 2001, MOL CELL NEUROSCI, V18, P68, DOI 10.1006/mcne.2001.1004
   Sorensen KP, 2013, BREAST CANCER RES TR, V142, P529, DOI 10.1007/s10549-013-2776-7
   Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200
   Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107
   Valeri N, 2010, P NATL ACAD SCI USA, V107, P6982, DOI 10.1073/pnas.1002472107
   Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797
   Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045
   Wu L, 2013, BIOCHEMISTRY-US, V52, P9519, DOI 10.1021/bi401085h
   Yang O, 2004, ONCOGENE, V23, P3749, DOI 10.1038/sj.onc.1207462
   Zhang JS, 2014, ACTA BIOCH BIOPH SIN, V46, P1, DOI 10.1093/abbs/gmt117
   Zhang JX, 2013, NEURO-ONCOLOGY, V15, P1595, DOI 10.1093/neuonc/not131
   Zhang KL, 2015, ONCOTARGET, V6, P537, DOI 10.18632/oncotarget.2681
   Zhao W, 2014, EUR REV MED PHARMACO, V18, P1930
   Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894
   Zlatanou A, 2011, MOL CELL, V43, P649, DOI 10.1016/j.molcel.2011.06.023
NR 48
TC 133
Z9 142
U1 0
U2 19
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD SEP 29
PY 2015
VL 6
IS 29
BP 27847
EP 27864
DI 10.18632/oncotarget.4443
PG 18
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA CT9UE
UT WOS:000363161300105
PM 26172293
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Okada, D
AF Okada, Daigo
TI Plasma proteins as potential biomarkers of aging of single tissue and
   cell type
SO BIOGERONTOLOGY
LA English
DT Article; Early Access
DE Computational biology; Proteomics; Aging; biomarker
ID HEPATITIS-C
AB Plasma proteins serve as biomarkers of aging and various age-related diseases. While a number of plasma proteins have been identified that increase or decrease with age, the interpretation of each protein is challenging. This is due to the nature of plasma, which is a mixture of factors secreted by many different tissues and cells. Therefore, the catalog of age-related proteins secreted by a single cell type in a single tissue would be useful for understanding tissue-specific aging patterns. In this study, the author addressed this challenge by integrative data mining of the Human Protein Atlas and the recently published result of large-scale aging proteomics research. Finally, we identified the 17 age-related proteins produced by a single tissue and a single cell type: MBL2 and HP in the liver (hepatocytes), SFTPC in the lung (type II alveolar cells), PRL and POMC in the pituitary (anterior cells), GCG, CUZD1 and CPA2 in the pancreas (pancreatic cells), MYBPC1 in skeletal muscle (myocytes), PTH in the parathyroid gland (glandular cells), LPO and AMY1A in the salivary gland (glandular cells), INSL3 in the male testis (Leydig cells), KLK3 and KLK4 in the male prostate (glandular cells), MPO and ACP5 in immune cells. This list of proteins would be potentially useful for understanding age-related changes in the plasma proteome and inter-tissue networks.
C1 [Okada, Daigo] Kyoto Univ, Ctr Genom Med, Grad Sch Med, 53 Shogoin Kawaramachi, Kyoto 6068507, Japan.
C3 Kyoto University
RP Okada, D (corresponding author), Kyoto Univ, Ctr Genom Med, Grad Sch Med, 53 Shogoin Kawaramachi, Kyoto 6068507, Japan.
EM dokada@genome.med.kyoto-u.ac.jp
CR Enroth S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17282
   GRISHAM M B, 1988, American Journal of Physiology, V254, pH1017
   Ivell R, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.1016107
   Ivell R, 2018, HUM REPROD UPDATE, V24, P639, DOI 10.1093/humupd/dmy029
   Koutsounaki E, 2008, J CLIN IMMUNOL, V28, P495, DOI 10.1007/s10875-008-9201-8
   Lehallier B, 2019, NAT MED, V25, P1843, DOI 10.1038/s41591-019-0673-2
   Lu JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039726
   Maffei M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-87
   Martin FJ, 2023, NUCLEIC ACIDS RES, V51, pD933, DOI 10.1093/nar/gkac958
   Pedroso MLA, 2008, CLIN EXP IMMUNOL, V152, P258, DOI 10.1111/j.1365-2249.2008.03614.x
   Planque C, 2008, CLIN CANCER RES, V14, P1355, DOI 10.1158/1078-0432.CCR-07-4117
   Prakash A, 2023, J PROTEOME RES, V22, P729, DOI 10.1021/acs.jproteome.2c00406
   Raimondo S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18168833
   Ramachandra CJA, 2020, ANTIOXID REDOX SIGN, V32, P1135, DOI 10.1089/ars.2019.7971
   Vasconcelos LRS, 2011, INT J INFECT DIS, V15, pE551, DOI 10.1016/j.ijid.2011.04.008
   TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221, DOI 10.1177/39.9.1918940
   Tian YE, 2023, NAT MED, V29, P1221, DOI 10.1038/s41591-023-02296-6
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Xu R, 2020, J NUTR HEALTH AGING, V24, P846, DOI 10.1007/s12603-020-1392-6
NR 19
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD 2023 SEP 14
PY 2023
DI 10.1007/s10522-023-10065-8
EA SEP 2023
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA R6OJ9
UT WOS:001065527400002
PM 37707684
DA 2024-02-19
ER

PT J
AU Hiraoka, A
   Kumada, T
   Tsuji, K
   Takaguchi, K
   Itobayashi, E
   Kariyama, K
   Ochi, H
   Tajiri, K
   Hirooka, M
   Shimada, N
   Ishikawa, T
   Tachi, Y
   Tada, T
   Toyoda, H
   Nouso, K
   Joko, K
   Hiasa, Y
   Michitaka, K
   Kudo, M
AF Hiraoka, Atsushi
   Kumada, Takashi
   Tsuji, Kunihiko
   Takaguchi, Koichi
   Itobayashi, Ei
   Kariyama, Kazuya
   Ochi, Hironori
   Tajiri, Kazuto
   Hirooka, Masashi
   Shimada, Noritomo
   Ishikawa, Toru
   Tachi, Yoshihiko
   Tada, Toshifumi
   Toyoda, Hidenori
   Nouso, Kazuhiro
   Joko, Kouji
   Hiasa, Yoichi
   Michitaka, Kojiro
   Kudo, Masatoshi
CA RELPEC Study Grp
   HCC 48 Grp
TI Validation of Modified ALBI Grade for More Detailed Assessment of
   Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter
   Analysis
SO LIVER CANCER
LA English
DT Article
DE Hepatocellular carcinoma; Albumin-bilirubin grade; Modified ALBI; Japan
   Integrated Staging score; ALBI-T score; mALBI-T score; Prognosis
ID CONTRAST-ENHANCED ULTRASONOGRAPHY; PROGNOSTIC STAGING SYSTEM;
   ALBUMIN-BILIRUBIN GRADE; RADIOFREQUENCY ABLATION; JAPANESE PATIENTS;
   LIVER-FUNCTION; B-VIRUS; SCORE; CLIP; GUIDELINES
AB Background/Aim: The frequency of hepatocellular carcinoma (HCC) in patients with good hepatic reserve function has been increasing in Japan along with the progression of antiviral therapies and aging of the society. We evaluated the usefulness of modified albumin-bilirubin (ALBI) grade as a tool for assessment of hepatic reserve function. Materials/Methods: We enrolled 6,649 naive HCC patients treated from 2000 to 2017 and divided them into training (Ehime Prefecture group: E group, n = 2,357) and validation (validation group: V group, n = 4,292) cohorts. Child-Pugh classification and ALBI and modified ALBI (mALBI) grading were compared using with Japan Integrated Staging (JIS), ALBI-TNM (ALBI-T), and mALBI-T scores, which were calculated based on TNM stage and each assessment tool, retrospectively. Results: In the E group, Akaike's Information Criterion (AIC) and c-index values for mALBI-T (13,725.2/0.744) were better as compared to those of ALBI-T (13,772.6/0.733) and JIS score (13,874.7/0.720), with similar results observed in the V group (mALBI-T: 27,727.4/0.760; ALBI-T: 27,817.8/0.750; JIS: 27,807.5/0.748). Although there were some significant differences between the groups with regard to clinical background factors (age, etiology, tumor size, tumor number, treatment modalities), for all patients the AIC and c-index values of mALBI-T (45,327.1/0.755) were also better than those of ALBI-T (45,467.7/0.744) and JIS scores (45,555.8/0.739), indicating its superior stratification ability and prognostic predictive value in patients with HCC. Conclusion: The detailed stratification ability of mALBI grade for hepatic reserve function is suitable for the recent trend of HCC patients, while mALBI-T may provide a more accurate predictive value than existing total staging scoring systems. (C) 2018 S. Karger AG, Basel
C1 [Hiraoka, Atsushi; Michitaka, Kojiro] Ehime Prefectural Cent Hosp, Gastroenterol Ctr, 83 Kasuga Cho, Matsuyama, Ehime 7900024, Japan.
   [Kumada, Takashi; Tada, Toshifumi; Toyoda, Hidenori] Ogaki Municipal Hosp, Dept Gastroenterol & Hepatol, Gifu, Japan.
   [Tsuji, Kunihiko] Teine Keijinkai Hosp, Gastroenterol Ctr, Sapporo, Hokkaido, Japan.
   [Takaguchi, Koichi] Kagawa Prefectural Cent Hosp, Dept Hepatol, Takamatsu, Kagawa, Japan.
   [Itobayashi, Ei] Asahi Gen Hosp, Dept Gastroenterol, Asahi, Japan.
   [Kariyama, Kazuya; Nouso, Kazuhiro] Okayama City Hosp, Dept Gastroenterol, Okayama, Japan.
   [Ochi, Hironori; Joko, Kouji] Matsuyama Red Cross Hosp, Hepatobiliary Ctr, Matsuyama, Ehime, Japan.
   [Tajiri, Kazuto] Toyama Univ Hosp, Dept Gastroenterol, Toyama, Japan.
   [Hirooka, Masashi; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Matsuyama, Ehime, Japan.
   [Shimada, Noritomo] Ootakanomori Hosp, Div Gastroenterol & Hepatol, Kashiwa, Chiba, Japan.
   [Ishikawa, Toru] Saiseikai Niigata Daini Hosp, Dept Gastroenterol, Niigata, Japan.
   [Tachi, Yoshihiko] Komaki City Hosp, Dept Gastroenterol, Komaki, Japan.
   [Kudo, Masatoshi] Kindai Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka, Japan.
C3 Ogaki Municipal Hospital; Teine Keijinkai Hospital; Matsuyama Red Cross
   Hospital; University of Toyama; Ehime University; Kindai University
   (Kinki University)
RP Hiraoka, A (corresponding author), Ehime Prefectural Cent Hosp, Gastroenterol Ctr, 83 Kasuga Cho, Matsuyama, Ehime 7900024, Japan.
EM hirage@m.ehime-u.ac.jp
RI Hirooka, Masashi/JUF-2562-2023; Hiasa, Yoichi/ABD-2759-2021; Kudo,
   Masatoshi/AAA-9744-2019; Hiraoka, Atsushi/AFR-0440-2022
OI Hiasa, Yoichi/0000-0003-4117-339X; Kudo, Masatoshi/0000-0002-4102-3474;
   Hiraoka, Atsushi/0000-0003-1989-0480; Tajiri,
   Kazuto/0000-0002-2373-8601; Nouso, Kazuhiro/0000-0002-2018-0008;
   Kariyama, Kazuya/0000-0003-3996-7502
CR Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691
   Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933
   Chan AWH, 2016, J GASTROEN HEPATOL, V31, P1300, DOI 10.1111/jgh.13291
   Di Martino M, 2010, RADIOLOGY, V256, P806, DOI 10.1148/radiol.10091334
   GLOBOCAN, 2012, EST BREAST CANC INC
   Hiraoka A, 2005, ONCOL REP, V13, P1159
   Hiraoka A, 2018, HEPATOL RES, V48, pE61, DOI 10.1111/hepr.12927
   Hiraoka A, 2017, LIVER CANCER, V6, P377, DOI 10.1159/000481212
   Hiraoka A, 2017, LIVER CANCER, V6, P325, DOI 10.1159/000479984
   Hiraoka A, 2017, LIVER CANCER, V6, P204, DOI 10.1159/000452846
   Hiraoka A, 2016, J GASTROEN HEPATOL, V31, P1031, DOI 10.1111/jgh.13250
   Hiraoka A, 2016, J DIABETES, V8, P640, DOI 10.1111/1753-0407.12340
   Hiraoka A, 2012, HEPATO-GASTROENTEROL, V59, P1893, DOI 10.5754/hge11732
   Hiraoka A, 2011, J GASTROEN HEPATOL, V26, P616, DOI 10.1111/j.1440-1746.2011.06678.x
   Hiraoka A, 2010, ONCOL LETT, V1, P57, DOI 10.3892/ol_00000010
   Hiraoka A, 2008, HEPATO-GASTROENTEROL, V55, P2171
   Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180
   Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x
   Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151
   Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244
   Kokudo N, 2015, HEPATOL RES, V45, DOI 10.1111/hepr.12464
   Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038
   Kudo M, 2004, HEPATOLOGY, V40, P1396, DOI 10.1002/hep.20486
   Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x
   MIYAGAWA S, 1995, AM J SURG, V169, P589, DOI 10.1016/S0002-9610(99)80227-X
   Ogawa E, 2017, J GASTROENTEROL, V52, P845, DOI 10.1007/s00535-016-1290-1
   Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9
   Omata M, 2014, J VIRAL HEPATITIS, V21, P762, DOI 10.1111/jvh.12312
   PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817
   Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840
   Seyama Y, 2009, HEPATOL RES, V39, P107, DOI 10.1111/j.1872-034X.2008.00441.x
   Shao YY, 2016, J GASTROEN HEPATOL, V31, P1336, DOI 10.1111/jgh.13312
   Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425
   Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892
   The Liver Cancer Study Group of Japan, 2015, GEN RULES CLIN PATHO, P26
NR 35
TC 144
Z9 144
U1 0
U2 9
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 2235-1795
EI 1664-5553
J9 LIVER CANCER
JI Liver Cancer
PY 2019
VL 8
IS 2
BP 121
EP 129
DI 10.1159/000488778
PG 9
WC Oncology; Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Gastroenterology & Hepatology
GA HP9TO
UT WOS:000462036100005
PM 31019902
OA Green Published, gold
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Singhal, A
   Sezginsoy, B
   Ghuloom, AE
   Hutchinson, IV
   Cho, YW
   Jabbour, N
AF Singhal, Ashish
   Sezginsoy, Banu
   Ghuloom, Adel E.
   Hutchinson, Ian V.
   Cho, Yong W.
   Jabbour, Nicolas
TI Orthotopic Liver Transplant Using Allografts From Geriatric Population
   in the United States: Is There Any Age Limit?
SO EXPERIMENTAL AND CLINICAL TRANSPLANTATION
LA English
DT Article
DE Organ shortage; Donor age; Older donors; Octogenerian; Survival
ID HEPATITIS-C VIRUS; ELDERLY DONORS; GRAFT FUNCTION; OLDER; STEATOSIS;
   SURVIVAL; RECIPIENTS
AB Objectives: Observations of minimal pathophysiological changes in the liver with healthy aging represent the rationale for expanding the donor pool with older donors. However, a debate exists for their upper age limit. The aim of this study is to examine the outcomes of orthotopic liver transplants from older patients (>= 60 years).
   Materials and Methods: Using the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) data, we retrospectively analyzed graft and patient survivals of orthotopic liver transplants done with octogenarian grafts (n=197) and compared them with orthotopic liver transplants done with donors aged between 60 and 79 years (n=4003) and <60 years (n=21 290) during 2003 to 2007.
   Results: One- and 3-year graft and patient survival rates among recipients of hepatic allografts from donors < 60 years of age were significantly superior to recipients of octogenarian grafts (graft: 84% vs 75.5% at 1 year; 74.2% vs 61.2% at 3 years; P < .001; patient: 87.8% vs 81.0% at 1-year; 79.3% vs 69.1% at 3 years; P < .001). However, there was no survival difference between recipients of allografts from donors aged > 80 years and 60-79 years (graft: 75.5% vs 77.4% at 1 year; 61.2% vs 64.2% at 3 years; P=.564; patient: 81.0% vs 83.8% at 1 year; 69.1% vs 71.8% at 3 years; P=.494). It correlates well with hepatitis C virus-seronegativity and relatively lower model for end-stage liver disease score among recipients of octogenarian grafts (P < .001).
   Conclusions: Careful donor evaluation, avoidance of additional donor risk factors, and their pairing with appropriate recipients offer acceptable functional recovery, even with donors > 80 years.
C1 [Singhal, Ashish; Ghuloom, Adel E.; Jabbour, Nicolas] Baptist Med Ctr, Nazih Zuhdi Transplant Inst, INTEGRIS, Oklahoma City, OK 73112 USA.
   [Sezginsoy, Banu] Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Oklahoma City, OK USA.
   [Hutchinson, Ian V.; Cho, Yong W.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Southern California
RP Jabbour, N (corresponding author), Baptist Med Ctr, Nazih Zuhdi Transplant Inst, INTEGRIS, 3300 NW Expressway, Oklahoma City, OK 73112 USA.
EM nicolas.jabbour@integrisok.com
RI singhal, ashish/GRF-1377-2022
CR Amin MG, 2004, LIVER TRANSPLANT, V10, P1468, DOI 10.1002/lt.20304
   Berenguer M, 2008, LIVER TRANSPLANT, V14, pS45, DOI 10.1002/lt.21617
   Borchert D, 2005, TRANSPL INT, V18, P709, DOI 10.1111/j.1432-2277.2005.00128.x
   Briceño J, 2002, TRANSPLANTATION, V74, P522, DOI 10.1097/01.TP.0000026307.14572.8D
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Cuende N, 2002, TRANSPLANTATION, V73, P1360, DOI 10.1097/00007890-200204270-00033
   DEBAKEY ME, 1985, ANN SURG, V201, P115
   Doyle MBM, 2008, ARCH SURG-CHICAGO, V143, P679, DOI 10.1001/archsurg.143.7.679
   Emre S, 1996, TRANSPLANTATION, V62, P62, DOI 10.1097/00007890-199607150-00013
   Fiorini RN, 2004, CLIN TRANSPLANT, V18, P700, DOI 10.1111/j.1399-0012.2004.00282.x
   Fishbein TM, 1997, TRANSPLANTATION, V64, P248, DOI 10.1097/00007890-199707270-00012
   Franzén LE, 2005, MODERN PATHOL, V18, P912, DOI 10.1038/modpathol.3800370
   Grande L, 1997, TRANSPLANT P, V29, P3289, DOI 10.1016/S0041-1345(97)00914-7
   Grazi GL, 2001, AM J TRANSPLANT, V1, P61, DOI 10.1034/j.1600-6143.2001.010112.x
   Healey PJ, 1998, LANCET, V352, P2, DOI 10.1016/S0140-6736(98)22027-7
   Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172
   KAMPMANN JP, 1975, GERIATRICS, V30, P91
   Kim DY, 2005, TRANSPLANT INT, V18, P73, DOI 10.1111/j.1432-2277.2004.00017.x
   Lake JR, 2005, AM J TRANSPLANT, V5, P549, DOI 10.1111/j.1600-6143.2005.00741.x
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   MARINO IR, 1995, TRANSPLANT P, V27, P1184
   Mazziotti A, 1999, HEPATO-GASTROENTEROL, V46, P1819
   Merion RM, 2005, AM J TRANSPLANT, V5, P307, DOI 10.1111/j.1600-6143.2004.00703.x
   Nardo B, 2004, AM J TRANSPLANT, V4, P1139, DOI 10.1111/j.1600-6143.2004.00472.x
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Romero CJ, 1999, TRANSPLANTATION, V68, P572, DOI 10.1097/00007890-199908270-00021
   WALL W, 1993, LANCET, V341, P121, DOI 10.1016/0140-6736(93)92604-R
   WALL WJ, 1990, TRANSPLANTATION, V49, P377, DOI 10.1097/00007890-199002000-00030
   Washburn WK, 1996, TRANSPLANTATION, V61, P1062, DOI 10.1097/00007890-199604150-00013
NR 29
TC 28
Z9 28
U1 0
U2 0
PU BASKENT UNIV
PI ANKARA
PA TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY
SN 1304-0855
J9 EXP CLIN TRANSPLANT
JI Exp. Clin. Transplant.
PD SEP
PY 2010
VL 8
IS 3
BP 196
EP 201
PG 6
WC Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Transplantation
GA 657HN
UT WOS:000282403900002
PM 20716036
DA 2024-02-19
ER

PT J
AU Tian, WH
   Wu, BY
   Sun, LP
   Zhuang, YL
AF Tian, Wenhui
   Wu, Beiyi
   Sun, Liping
   Zhuang, Yongliang
TI Protective effect against d-gal-induced aging mice and components of
   polypeptides and polyphenols in defatted walnut kernel during simulated
   gastrointestinal digestion
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article; Early Access
DE antiaging; polypeptides; polyphenols; simulated gastrointestinal
   digestion; walnut kernel
ID LAPPACEUM PEEL PHENOLICS; ANTIOXIDANT PEPTIDES; PURIFICATION;
   IDENTIFICATION; JUGLANS
AB Defatted walnut kernel with pellicle (WKP) is an industrial byproduct during walnut oil extraction, which is rich in protein and polyphenols. WKP was hydrolyzed by simulated gastrointestinal digestion to obtain WKP hydrolysates (WKPHs). Results showed the protein recovery and hydrolysis degree of WKPH were 82.15 and 10.36%. The total phenol contents in WKP and WKPH were 4.90 and 40.70 mg gallic acid equivalent/g, respectively. The antiaging activity of WKPH was evaluated using a d-gal-induced aging mouse model. Results showed that WKPHs could recover the activities of SOD and T-AOC and the content of MDA in tissues and serum of the aging mice. The histological morphology of liver and kidney sections and the immunohistochemistry of TNF-alpha, IL-1 beta, and IL-6 in liver were observed. WKPH could effectively protect the tissue structure of the liver and kidney and reduce the inflammatory expression of liver in aging mice. The polypeptides and polyphenols in WKPH were further analyzed. Fifty polypeptides were identified and 12 of these peptides had Leu-Arg at the C-terminal. Forty-two polyphenols were detected, and most phenolic compounds belonged to ellagitannins. This study provided a theoretical basis for the improved processing and high-value utilization of walnut byproducts.
   Practical Application Defatted walnut kernel with pellicle was hydrolyzed by simulated gastrointestinal digestion to obtain its hydrolysates. The hydrolysates have good antiaging activity in vivo. Fifty polypeptides were identified and 12 of these peptides had Leu-Arg at the C-terminal. Forty-two polyphenols were detected, and most phenolic compounds belonged to ellagitannins. This study could provide a theoretical basis for high-value utilization of walnut byproducts.
C1 [Tian, Wenhui; Wu, Beiyi; Sun, Liping; Zhuang, Yongliang] Kunming Univ Sci & Technol, Inst Agr & Food, 727 South Jingming Rd, Kunming 650500, Yunnan, Peoples R China.
C3 Kunming University of Science & Technology
RP Zhuang, YL (corresponding author), Kunming Univ Sci & Technol, Inst Agr & Food, 727 South Jingming Rd, Kunming 650500, Yunnan, Peoples R China.
EM kmylzhuang@163.com
RI wu, by/GYA-2016-2022
OI Liping, Sun/0000-0002-4449-6146
FU National Natural Science Foundation of China [21767014]
FX National Natural Science Foundation of China, Grant/Award Number:
   21767014
CR Amaral JS, 2003, J AGR FOOD CHEM, V51, P7698, DOI 10.1021/jf030451d
   An L, 2018, FOOD FUNCT, V9, P4755, DOI 10.1039/c8fo00702k
   Arapitsas P, 2007, J AGR FOOD CHEM, V55, P48, DOI 10.1021/jf0622329
   Aydin S, 2015, TURK J BIOCHEM, V40, P241, DOI 10.1515/tjb-2015-0009
   Bi DD, 2016, NAT PROD COMMUN, V11, P869
   Chen N, 2012, PEPTIDES, V38, P344, DOI 10.1016/j.peptides.2012.09.017
   Chen YH, 2020, EUR FOOD RES TECHNOL, V246, P2029, DOI 10.1007/s00217-020-03553-5
   Fan J, 2012, MOLECULES, V17, P12836, DOI 10.3390/molecules171112836
   Feng L, 2019, FOOD RES INT, V116, P518, DOI 10.1016/j.foodres.2018.08.068
   Fujii T, 2013, J FUNCT FOODS, V5, P451, DOI 10.1016/j.jff.2012.11.018
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   Hong J, 2014, J FUNCT FOODS, V10, P144, DOI 10.1016/j.jff.2014.05.014
   Jahanban-Esfahlan A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163920
   Jahanban-Esfahlan A, 2019, MOLECULES, V24, DOI 10.3390/molecules24112133
   Jing S.Q., 2012, FOOD SCI TECH-BRAZIL, V3, P103
   Kim JM, 2019, FOOD SCI NUTR, V7, P1645, DOI 10.1002/fsn3.998
   Li XY, 2020, MOLECULES, V25, DOI 10.3390/molecules25061285
   Li YW, 2013, J THEOR BIOL, V318, P29, DOI 10.1016/j.jtbi.2012.10.029
   Li YJ, 2020, FOOD CHEM, V320, DOI 10.1016/j.foodchem.2020.126618
   Liu BT, 2020, J FOOD SCI, V85, P114, DOI 10.1111/1750-3841.14975
   Liu CL, 2019, FOOD FUNCT, V10, P3491, DOI 10.1039/c8fo02557f
   Liu D.D., 2019, FOOD CHEM, V311, P1
   Liu J, 2019, FOOD SCI NUTR, V7, P969, DOI 10.1002/fsn3.907
   Liu R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041138
   Mendis E, 2005, LIFE SCI, V77, P2166, DOI 10.1016/j.lfs.2005.03.016
   MILLER MD, 1989, J IMMUNOL, V143, P2907
   Mohammad T.G., 2008, J CLIN LAB ANAL, V24, P72
   MUNDAY R, 1989, BIOCHEM PHARMACOL, V38, P4349, DOI 10.1016/0006-2952(89)90641-2
   Nimalaratne C, 2015, FOOD CHEM, V188, P467, DOI 10.1016/j.foodchem.2015.05.014
   Oliveira I, 2008, FOOD CHEM TOXICOL, V46, P2326, DOI 10.1016/j.fct.2008.03.017
   Park JE, 2014, PHOTODERMATOL PHOTO, V30, P237, DOI 10.1111/phpp.12097
   Pereira JA, 2008, FOOD CHEM TOXICOL, V46, P2103, DOI 10.1016/j.fct.2008.02.002
   Pereira JA, 2007, FOOD CHEM TOXICOL, V45, P2287, DOI 10.1016/j.fct.2007.06.004
   Regueiro J, 2014, FOOD CHEM, V152, P340, DOI 10.1016/j.foodchem.2013.11.158
   Sheng JY, 2020, J AGR FOOD CHEM, V68, P751, DOI 10.1021/acs.jafc.9b05081
   Su C., 2020, FOOD CHEM, V331, P127
   Sun LP, 2018, J AGR FOOD CHEM, V66, P593, DOI 10.1021/acs.jafc.7b04196
   Sun LP, 2016, MAR DRUGS, V14, DOI 10.3390/md14100186
   Tavares L, 2012, FOOD CHEM, V131, P1443, DOI 10.1016/j.foodchem.2011.10.025
   Trandafir I., 2020, ERWERBS-OBSTBAU, V2, P1
   Wang C.L., 2017, CHINA FOOD ADDITIVES, V110, P110
   Wang J, 2020, J FUNCT FOODS, V69, DOI 10.1016/j.jff.2020.103944
   Wang M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100433
   Wang SG, 2020, J AGR FOOD CHEM, V68, P2381, DOI 10.1021/acs.jafc.9b07670
   Xiao JJ, 2019, FOOD CHEM TOXICOL, V129, P30, DOI 10.1016/j.fct.2019.04.020
   Xu DF, 2019, FOOD FUNCT, V10, P6792, DOI 10.1039/c8fo01833b
   Yan G, 2020, NAT PROD RES, V34, P2090, DOI 10.1080/14786419.2019.1573237
   Zhang YG, 2020, FOOD CHEM, V321, DOI 10.1016/j.foodchem.2020.126672
   Zhang YF, 2012, PEPTIDES, V38, P13, DOI 10.1016/j.peptides.2012.08.014
   Zhao HD, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1371
   [赵见军 Zhao Jianjun], 2014, [食品科学, Food Science], V35, P40
   Zheng Y.W., 2020, J FOOD MEAS CHARACT, V7, P1
   Zheng YJ, 2017, RSC ADV, V7, P54196, DOI 10.1039/c7ra11657h
   Zhou H.J., 2012, CEREALS OILS, V25, P28
   [周先艳 Zhou Xianyan], 2016, [食品科学, Food Science], V37, P221
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
   Zou J, 2016, J HUAZHONG U SCI-MED, V36, P21, DOI 10.1007/s11596-016-1536-4
NR 57
TC 8
Z9 8
U1 6
U2 66
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD 2021 JUN
PY 2021
VL 86
IS 6
BP 2736
EP 2752
DI 10.1111/1750-3841.15744
EA MAY 2021
PG 17
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA SU8SP
UT WOS:000648113700001
PM 33963555
DA 2024-02-19
ER

PT J
AU Cerrada-Gimenez, M
   Pietilä, M
   Loimas, S
   Pirinen, E
   Hyvönen, MT
   Keinänen, TA
   Jänne, J
   Alhonen, L
AF Cerrada-Gimenez, Marc
   Pietila, Marko
   Loimas, Suvikki
   Pirinen, Eija
   Hyvonen, Mervi T.
   Keinanen, Tuomo A.
   Janne, Juhani
   Alhonen, Leena
TI Continuous oxidative stress due to activation of polyamine catabolism
   accelerates aging and protects against hepatotoxic insults
SO TRANSGENIC RESEARCH
LA English
DT Article
DE Polyamines; Aging; Oxidative stress; p53; Carbon tetrachloride;
   Thioacetamide
ID HUMAN OVARIAN-CANCER; TRANSGENIC MICE; CARBON-TETRACHLORIDE;
   S-ADENOSYLMETHIONINE; L-METHIONINE; GLUTATHIONE; METABOLISM; EXPRESSION;
   SPERMIDINE; INDUCTION
AB Enhanced polyamine catabolism via polyamine acetylation-oxidation elevates the oxidative stress in an organism due to increased production of reactive oxygen species (ROS). We studied a transgenic mouse line overexpressing the rate limiting enzyme in the polyamine catabolism, spermidine/spermine N (1)-acetyltransferase (SSAT) that is characterized by increased putrescine and decreased spermidine and spermine pools. In order to protect the mice from the chronic oxidative stress produced by the activation of polyamine catabolism, the hepatic expression of the transcription factor p53 was found threefold elevated in the transgenic mice. In addition, the prolonged activation of p53 accelerated the aging of transgenic mice and reduced their lifespan (50%). Aging was associated with decreased antioxidant enzyme activities. In the transgenic mice the activities of catalase and Cu, Zn-superoxide dismutase (SOD) were 42 and 23% reduced respectively, while the expression of CYP450 2E1 was 60% decreased and oxidative stress measured as protein carbonyl content was tenfold elevated. In the transgenic mice, the age-related repression of the different antioxidant enzymes served as a protection against the hepatotoxic effects of carbon tetrachloride and thioacetamide.
C1 [Cerrada-Gimenez, Marc; Pietila, Marko; Loimas, Suvikki; Pirinen, Eija; Hyvonen, Mervi T.; Keinanen, Tuomo A.; Janne, Juhani; Alhonen, Leena] Univ Eastern Finland, Bioctr Kuopio, AI Virtanen Inst, Kuopio 70211, Finland.
C3 University of Eastern Finland
RP Cerrada-Gimenez, M (corresponding author), Univ Eastern Finland, Bioctr Kuopio, AI Virtanen Inst, Kuopio Campus,POB 1627, Kuopio 70211, Finland.
EM Marc.CerradaGimenez@uef.fi
RI Keinänen, Tuomo/AAC-5630-2019; Pirinen, Eija/H-9153-2015
OI Keinanen, Tuomo/0000-0002-0659-5573; Pirinen, Eija/0000-0003-1495-3972
FU Academy of Finland; North Savo regional fund from the Finnish Cultural
   Fund
FX We thank Ms Tuula Reponen, Ms Marita Heikkinen and Ms Sisko Juutinen for
   their skilful technical assistance. This work was supported by grants
   from Academy of Finland and the North Savo regional fund from the
   Finnish Cultural Fund.
CR AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X
   [Anonymous], 1984, METHOD ENZYMOL
   [Anonymous], AMINO ACIDS
   BAILEY HH, 1992, CANCER RES, V52, P5115
   Bauer JH, 2006, AGING CELL, V5, P437, DOI 10.1111/j.1474-9726.2006.00228.x
   Bernacki RJ, 1995, CLIN CANCER RES, V1, P847
   Brown-Borg HM, 2000, EXP GERONTOL, V35, P199, DOI 10.1016/S0531-5565(00)00079-6
   CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690
   Cerrada-Gimenez M, 2010, AMINO ACIDS, V38, P613, DOI 10.1007/s00726-009-0420-y
   Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   FINKELSTEIN JD, 1971, ARCH BIOCHEM BIOPHYS, V146, P84, DOI 10.1016/S0003-9861(71)80044-9
   GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070
   HYVONEN T, 1992, J CHROMATOGR-BIOMED, V574, P17, DOI 10.1016/0378-4347(92)80093-6
   JANNE J, 1971, J BIOL CHEM, V246, P1725
   Jänne J, 2004, EUR J BIOCHEM, V271, P877, DOI 10.1111/j.1432-1033.2004.04009.x
   JANNE J, 1971, BIOCHEM BIOPH RES CO, V42, P222
   KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112
   Kramer DL, 2001, CANCER RES, V61, P7754
   LEE FYF, 1989, BRIT J CANCER, V60, P291, DOI 10.1038/bjc.1989.273
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Manibusan MK, 2007, J ENVIRON SCI HEAL C, V25, P185, DOI 10.1080/10590500701569398
   Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851
   MATSUI I, 1981, J BIOL CHEM, V256, P2454
   Oredsson SM, 2003, BIOCHEM SOC T, V31, P366, DOI 10.1042/BST0310366
   Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008
   Pietilä M, 2005, J INVEST DERMATOL, V124, P596, DOI 10.1111/j.0022-202X.2005.23636.x
   Pietila M, 1997, J BIOL CHEM, V272, P18746, DOI 10.1074/jbc.272.30.18746
   Pietilä M, 2001, J INVEST DERMATOL, V116, P801, DOI 10.1046/j.1523-1747.2001.01330.x
   Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619
   SCALABRINO G, 1984, MECH AGEING DEV, V26, P149, DOI 10.1016/0047-6374(84)90090-3
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   Senft AP, 2000, ANAL BIOCHEM, V280, P80, DOI 10.1006/abio.2000.4498
   SHE QB, 1994, BIOCHEM BIOPH RES CO, V205, P1748, DOI 10.1006/bbrc.1994.2871
   Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013
   Suppola S, 1999, BIOCHEM J, V338, P311, DOI 10.1042/0264-6021:3380311
   Suzuki T, 2001, EXP GERONTOL, V36, P465, DOI 10.1016/S0531-5565(00)00223-0
   THOMAS T, 1994, CANCER RES, V54, P1077
   TROLIN CG, 1994, EUR NEUROPSYCHOPHARM, V4, P469, DOI 10.1016/0924-977X(94)90295-X
   VARELAMOREIRAS G, 1994, INT J VITAM NUTR RES, V64, P294
   Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327
   Wallace HM, 2003, BIOCHEM SOC T, V31, P354, DOI 10.1042/BST0310354
   Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981
   Wong FWY, 1998, TOXICOL APPL PHARM, V153, P109, DOI 10.1006/taap.1998.8547
   Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.10.2783S
NR 45
TC 18
Z9 20
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-8819
EI 1573-9368
J9 TRANSGENIC RES
JI Transgenic Res.
PD APR
PY 2011
VL 20
IS 2
BP 387
EP 396
DI 10.1007/s11248-010-9422-5
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 732GB
UT WOS:000288171900015
PM 20577801
DA 2024-02-19
ER

PT J
AU Son, M
   Chung, WJ
   Oh, S
   Ahn, H
   Choi, CH
   Hong, S
   Park, KY
   Son, KH
   Byun, K
AF Son, Myeongjoo
   Chung, Wook-Jin
   Oh, Seyeon
   Ahn, Hyosang
   Choi, Chang Hu
   Hong, Suntaek
   Park, Kook Yang
   Son, Kuk Hui
   Byun, Kyunghee
TI Age dependent accumulation patterns of advanced glycation end product
   receptor (RAGE) ligands and binding intensities between RAGE and its
   ligands differ in the liver, kidney, and skeletal muscle
SO IMMUNITY & AGEING
LA English
DT Article
DE RAGE; RAGE ligands; AGEs; Aging; Macrophage activation
ID GLYCOSYLATION; STRESS; INFLAMMATION; GLYOXALASE; RESISTANCE; PROTEINS;
   MICE
AB Background: Much evidence indicates receptor for advanced glycation end products (RAGE) related inflammation play essential roles during aging. However, the majority of studies have focused on advanced glycation end products (AGEs) and not on other RAGE ligands. In the present study, the authors evaluated whether the accumulation of RAGE ligands and binding intensities between RAGE and its ligands differ in kidney, liver, and skeletal muscle during aging.
   Results: In C57BL/6 N mice aged 12 weeks, 12 months, and 22 months, ligands accumulation, binding intensities between RAGE and its ligands, activated macrophage infiltration, M1/M2 macrophage expression, glyoxalase-1expression, and signal pathways related to inflammation were evaluated. The RAGE ligands age-associated accumulation patterns were found to be organ dependent. Binding intensities between RAGE and its ligands in kidney and liver increased with age, but those in skeletal muscle were unchanged. Infiltration of activated macrophages in kidney and liver increased with age, but infiltration in the skeletal muscle was unchanged. M1 expression increased and M2 and glyoxalase-1 expression decreased with age in kidney and liver, but their expressions in skeletal muscle were not changed.
   Conclusion: These findings indicate patterns of RAGE ligands accumulation, RAGE/ligands binding intensities, or inflammation markers changes during aging are organs dependent.
C1 [Son, Myeongjoo; Ahn, Hyosang; Byun, Kyunghee] Gachon Univ, Grad Sch Med, Dept Anat & Cell Biol, Incheon 21936, South Korea.
   [Son, Myeongjoo; Oh, Seyeon; Ahn, Hyosang; Byun, Kyunghee] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Funct Cellular Networks Lab, Incheon 21999, South Korea.
   [Chung, Wook-Jin] Gachon Univ, Dept Cardiovasc Med, Incheon 21999, South Korea.
   [Chung, Wook-Jin] Gachon Univ, Gachon Cardiovasc Res Inst, Incheon 21999, South Korea.
   [Choi, Chang Hu; Park, Kook Yang; Son, Kuk Hui] Gachon Univ, Gil Med Ctr, Dept Thorac & Cardiovasc Surg, Incheon 21565, South Korea.
   [Hong, Suntaek] Gachon Univ, Sch Med, Dept Biochem, Lab Canc Cell Biol, Incheon 21999, South Korea.
C3 Gachon University; Gachon University; Gachon University; Gachon
   University; Gachon University; Gachon University
RP Byun, K (corresponding author), Gachon Univ, Grad Sch Med, Dept Anat & Cell Biol, Incheon 21936, South Korea.; Byun, K (corresponding author), Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Funct Cellular Networks Lab, Incheon 21999, South Korea.; Son, KH (corresponding author), Gachon Univ, Gil Med Ctr, Dept Thorac & Cardiovasc Surg, Incheon 21565, South Korea.
EM dr632@gilhospital.com; khbyun1@gachon.ac.kr
RI Son, myeongjoo/GWQ-6808-2022; Chung, Wook-Jin/AAJ-5613-2021
OI Chung, Wook-Jin/0000-0002-9767-7098
FU Samsung Science and Technology Foundation [SSTF-BA1402-15]; Korea Health
   Industry Development Institute (KHIDI) [HI13C-1602-010015]
FX This work was supported by Samsung Science and Technology Foundation
   (grant no. SSTF-BA1402-15, KB) and Korea Health Industry Development
   Institute (KHIDI) (grant no. HI13C-1602-010015, KHS).
CR Alonso-Fernandez Patricia, 2011, Curr Aging Sci, V4, P78
   Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025
   Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792
   BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223
   Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2
   Enokido Y, 2008, BIOCHEM BIOPH RES CO, V376, P128, DOI 10.1016/j.bbrc.2008.08.108
   Falcone C, 2013, INT J MOL SCI, V14, P23203, DOI 10.3390/ijms141123203
   Feng Z, 2005, AM J PATHOL, V167, P355, DOI 10.1016/S0002-9440(10)62981-1
   Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007
   Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701
   Ikeda Y, 2011, AM J PATHOL, V179, P2810, DOI 10.1016/j.ajpath.2011.08.023
   Inagi R, 2016, GLYCOCONJUGATE J, V33, P619, DOI 10.1007/s10719-016-9689-8
   Jin X, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/732450
   Kawabata K, 2011, BBA-PROTEINS PROTEOM, V1814, P1246, DOI 10.1016/j.bbapap.2011.06.006
   Kimura T, 1996, NEUROSCI LETT, V208, P53, DOI 10.1016/0304-3940(96)12537-4
   Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474
   Kuhla A, 2011, EXP GERONTOL, V46, P868, DOI 10.1016/j.exger.2011.07.008
   Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017
   NEEPER M, 1992, J BIOL CHEM, V267, P14998
   Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x
   Qin QJ, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-37
   Rai V, 2012, J EXP MED, V209, P2339, DOI 10.1084/jem.20120873
   Sandu O, 2005, DIABETES, V54, P2314, DOI 10.2337/diabetes.54.8.2314
   Schinzel R, 2001, NEPHRON, V87, P295, DOI 10.1159/000045934
   SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987
   Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074
   Shim E, 2015, J PERIODONTAL RES, V50, P197, DOI 10.1111/jre.12194
   Snow LM, 2007, J GERONTOL A-BIOL, V62, P1204, DOI 10.1093/gerona/62.11.1204
   Tiu SC, 2000, DEV BRAIN RES, V119, P159, DOI 10.1016/S0165-3806(99)00151-0
   Vlassara H, 2009, SEMIN NEPHROL, V29, P594, DOI 10.1016/j.semnephrol.2009.07.013
   Yamamoto Y, 2013, FRONT ENDOCRINOL, V21, P21
   Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216
   Zheng F, 2003, AM J PATHOL, V162, P1339, DOI 10.1016/S0002-9440(10)63929-6
NR 33
TC 22
Z9 25
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4933
J9 IMMUN AGEING
JI Immun. Ageing
PD JUN 5
PY 2017
VL 14
AR 12
DI 10.1186/s12979-017-0095-2
PG 9
WC Geriatrics & Gerontology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Immunology
GA EX1AU
UT WOS:000402952700001
PM 28592983
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Snieckute, G
   Ryder, L
   Vind, AC
   Wu, ZZ
   Arendrup, FS
   Stoneley, M
   Chamois, S
   Martinez-Val, A
   Leleu, M
   Dreos, R
   Russell, A
   Gay, DM
   Genzor, AV
   Choi, BSY
   Basse, AL
   Sass, F
   Dall, M
   Dollet, LCM
   Blasius, M
   Willis, AE
   Lund, AH
   Treebak, JT
   Olsen, JV
   Poulsen, SS
   Pownall, ME
   Jensen, BAH
   Clemmensen, C
   Gerhart-Hines, Z
   Gatfield, D
   Bekker-Jensen, S
AF Snieckute, Goda
   Ryder, Laura
   Vind, Anna Constance
   Wu, Zhenzhen
   Arendrup, Frederic Schroder
   Stoneley, Mark
   Chamois, Sebastien
   Martinez-Val, Ana
   Leleu, Marion
   Dreos, Rene
   Russell, Alexander
   Gay, David Michael
   Genzor, Aitana Victoria
   Choi, Beatrice So-Yun
   Basse, Astrid Linde
   Sass, Frederike
   Dall, Morten
   Dollet, Lucile Chantal Marie
   Blasius, Melanie
   Willis, Anne E.
   Lund, Anders H.
   Treebak, Jonas T.
   Olsen, Jesper Velgaard
   Poulsen, Steen Seier
   Pownall, Mary Elizabeth
   Jensen, Benjamin Anderschou Holbech
   Clemmensen, Christoffer
   Gerhart-Hines, Zach
   Gatfield, David
   Bekker-Jensen, Simon
TI ROS-induced ribosome impairment underlies ZAKα-mediated metabolic
   decline in obesity and aging
SO SCIENCE
LA English
DT Article
ID INCREASED OXIDATIVE STRESS; QUALITY-CONTROL; ACTIVATION; JNK; RESPONSES;
   PATHWAYS; KINASES; IMPACT; INJURY; WHITE
AB The ribotoxic stress response (RSR) is a signaling pathway in which the p38- and c-Jun N-terminal kinase (JNK)-activating mitogen-activated protein kinase kinase kinase (MAP3K) ZAK alpha senses stalling and/or collision of ribosomes. Here, we show that reactive oxygen species (ROS)-generating agents trigger ribosomal impairment and ZAK alpha activation. Conversely, zebrafish larvae deficient for ZAK alpha are protected from ROS-induced pathology. Livers of mice fed a ROS-generating diet exhibit ZAK alpha-activating changes in ribosomal elongation dynamics. Highlighting a role for the RSR in metabolic regulation, ZAK-knockout mice are protected from developing high-fat high-sugar (HFHS) diet-induced blood glucose intolerance and liver steatosis. Finally, ZAK ablation slows animals from developing the hallmarks of metabolic aging. Our work highlights ROS-induced ribosomal impairment as a physiological activation signal for ZAK alpha that underlies metabolic adaptation in obesity and aging.
C1 [Snieckute, Goda; Ryder, Laura; Vind, Anna Constance; Wu, Zhenzhen; Genzor, Aitana Victoria; Blasius, Melanie; Bekker-Jensen, Simon] Univ Copenhagen, Ctr Hlth Aging, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark.
   [Snieckute, Goda; Ryder, Laura; Vind, Anna Constance; Wu, Zhenzhen; Genzor, Aitana Victoria; Blasius, Melanie; Bekker-Jensen, Simon] Univ Copenhagen, Ctr Gene Express, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark.
   [Arendrup, Frederic Schroder; Gay, David Michael; Lund, Anders H.] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark.
   [Stoneley, Mark; Willis, Anne E.] Univ Cambridge, MRC Toxicol Unit, Cambridge CB2 1QR, England.
   [Chamois, Sebastien; Gatfield, David] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.
   [Martinez-Val, Ana; Olsen, Jesper Velgaard] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Mass Spectrometry Quantitat Proteom,Proteom Progr, DK-2200 Copenhagen N, Denmark.
   [Leleu, Marion] Univ Lausanne, Bioinformat Competence Ctr, CH-1015 Lausanne, Switzerland.
   [Leleu, Marion] Univ Lausanne, Ecole Polytechn Fed Lausanne, CH-1015 Lausanne, Switzerland.
   [Russell, Alexander; Pownall, Mary Elizabeth] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.
   [Choi, Beatrice So-Yun; Jensen, Benjamin Anderschou Holbech] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen, Denmark.
   [Basse, Astrid Linde; Sass, Frederike; Dall, Morten; Dollet, Lucile Chantal Marie; Treebak, Jonas T.; Clemmensen, Christoffer; Gerhart-Hines, Zach] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark.
C3 University of Copenhagen; University of Copenhagen; University of
   Copenhagen; University of Cambridge; University of Lausanne; University
   of Copenhagen; University of Lausanne; University of Lausanne; Swiss
   Federal Institutes of Technology Domain; Ecole Polytechnique Federale de
   Lausanne; University of York - UK; University of Copenhagen; Novo
   Nordisk Foundation; University of Copenhagen
RP Bekker-Jensen, S (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark.; Bekker-Jensen, S (corresponding author), Univ Copenhagen, Ctr Gene Express, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark.
EM sbj@sund.ku.dk
RI ; Jensen, Benjamin/M-4661-2014; Clemmensen, Christoffer/N-4680-2017;
   Treebak, Jonas/B-4521-2017
OI Choi, Beatrice/0000-0001-8160-9448; Vind, Anna
   Constance/0000-0001-5074-2713; Jensen, Benjamin/0000-0001-6991-0828;
   Poulsen, Steen Seier/0000-0003-4419-4911; Gay, David
   Michael/0000-0002-7407-1245; Gerhart-Hines, Zachary/0000-0003-2981-4991;
   Clemmensen, Christoffer/0000-0003-2456-9667; Treebak,
   Jonas/0000-0003-1488-7012; Blasius, Melanie/0000-0001-5032-2209; Ryder,
   Laura/0000-0002-3753-6381; Lund, Anders/0000-0002-7407-3398; Dall,
   Morten/0000-0002-8577-3162; Willis, Anne/0000-0002-1470-8531
CR Akiyama Y, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232113100
   Arpat AB, 2020, GENOME RES, V30, P985, DOI 10.1101/gr.257741.119
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Burgoyne JR, 2011, BIOCHEM SOC T, V39, P1260, DOI 10.1042/BST0391260
   Canovas B, 2021, NAT REV MOL CELL BIO, V22, P346, DOI 10.1038/s41580-020-00322-w
   Challa TD, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810124
   Cicuéndez B, 2020, MOL METAB, V50, DOI 10.1016/j.molmet.2021.101190
   Craige SM, 2016, BBA-MOL BASIS DIS, V1862, P1581, DOI 10.1016/j.bbadis.2016.05.022
   Crespo M, 2023, HEPATOLOGY, V77, P874, DOI 10.1002/hep.32581
   Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138
   Damgaard MTF, 2018, J NUTR BIOCHEM, V54, P66, DOI 10.1016/j.jnutbio.2017.09.026
   Darnell AM, 2018, MOL CELL, V71, P229, DOI 10.1016/j.molcel.2018.06.041
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Garshott DM, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109642
   Garzia A, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109468
   Giansanti P, 2022, NAT METHODS, V19, P803, DOI 10.1038/s41592-022-01526-y
   Gobet C, 2022, METHODS, V203, P10, DOI 10.1016/j.ymeth.2021.10.004
   Gonçalves LF, 2017, INT J EXP PATHOL, V98, P100, DOI 10.1111/iep.12228
   Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015
   He ZY, 2022, J TRANSL MED, V20, DOI 10.1186/s12967-022-03734-8
   Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002
   Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373
   Juszkiewicz S, 2020, ELIFE, V9, DOI 10.7554/eLife.60038
   Juszkiewicz S, 2017, MOL CELL, V65, P743, DOI 10.1016/j.molcel.2016.11.039
   Keipert S, 2021, TRENDS ENDOCRIN MET, V32, P904, DOI 10.1016/j.tem.2021.08.008
   Kim KQ, 2022, TRENDS BIOCHEM SCI, V47, P82, DOI 10.1016/j.tibs.2021.09.001
   Leiva M, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.572089
   Lucchini FC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15483-7
   Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010
   McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775
   Meydan S, 2020, MOL CELL, V79, P588, DOI 10.1016/j.molcel.2020.06.010
   Mleleu, 2023, Zenodo, DOI 10.5281/ZENODO.8309532
   Müller TD, 2022, NAT REV DRUG DISCOV, V21, P201, DOI 10.1038/s41573-021-00337-8
   Nikolic I, 2020, NAT REV ENDOCRINOL, V16, P697, DOI 10.1038/s41574-020-00418-5
   Nordgaard C, 2022, EMBO J, V41, DOI 10.15252/embj.2022111650
   Ouyang DY, 2005, CELL MOL IMMUNOL, V2, P419
   Palmer AK, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI158451
   Patton EE, 2021, NAT REV DRUG DISCOV, V20, P611, DOI 10.1038/s41573-021-00210-8
   Pei JF, 2019, NAT CELL BIOL, V21, P1553, DOI 10.1038/s41556-019-0420-4
   Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038
   Ranea-Robles P, 2022, MOL METAB, V64, DOI 10.1016/j.molmet.2022.101573
   Reynolds TH, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.13995
   Robinson KS, 2022, SCIENCE, V377, P328, DOI 10.1126/science.abl6324
   Ronis MJJ, 2015, AM J PHYSIOL-GASTR L, V308, pG403, DOI 10.1152/ajpgi.00154.2014
   Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Schosserer M, 2018, GERONTOLOGY, V64, P229, DOI 10.1159/000485183
   Schwartz MW, 2017, ENDOCR REV, V38, P267, DOI 10.1210/er.2017-00111
   Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200
   Shields HJ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.628157
   Shiizaki Shigeru, 2013, Advances in Biological Regulation, V53, P135, DOI 10.1016/j.jbior.2012.09.006
   Silva J, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-32220-4
   Sinha NK, 2020, ELIFE, V9, DOI 10.7554/eLife.58828
   Smith RL, 2018, ENDOCR REV, V39, P489, DOI 10.1210/er.2017-00211
   Snieckute G, 2022, CELL METAB, V34, P2036, DOI 10.1016/j.cmet.2022.10.011
   Stein KC, 2022, NATURE, V601, P637, DOI 10.1038/s41586-021-04295-4
   Stein KC, 2019, MOL CELL, V75, P1117, DOI 10.1016/j.molcel.2019.06.036
   Stoneley M, 2022, MOL CELL, V82, P1557, DOI 10.1016/j.molcel.2022.01.019
   Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018
   Sundaramoorthy E, 2017, MOL CELL, V65, P751, DOI 10.1016/j.molcel.2016.12.026
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   Tudurí E, 2022, J GERONTOL A-BIOL, V77, P405, DOI 10.1093/gerona/glab276
   Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103
   Vasli N, 2017, BRAIN, V140, P37, DOI 10.1093/brain/aww257
   Vernia S, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2210434119
   Vernia S, 2014, CELL METAB, V20, P512, DOI 10.1016/j.cmet.2014.06.010
   Vind AC, 2020, NUCLEIC ACIDS RES, V48, P10648, DOI 10.1093/nar/gkaa757
   Vind AC, 2020, MOL CELL, V78, P700, DOI 10.1016/j.molcel.2020.03.021
   Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694
   Wang XS, 2005, J BIOL CHEM, V280, P19298, DOI 10.1074/jbc.M413059200
   Wu CCC, 2020, CELL, V182, P404, DOI 10.1016/j.cell.2020.06.006
   Yamamoto E, 2008, HYPERTENSION, V52, P573, DOI 10.1161/HYPERTENSIONAHA.108.112292
   Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106
   Zhao T, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-020-02256-0
NR 76
TC 1
Z9 1
U1 37
U2 37
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD DEC 8
PY 2023
VL 382
IS 6675
BP 1135
EP +
DI 10.1126/science.adf3208
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GX9M8
UT WOS:001156091000003
PM 38060659
DA 2024-02-19
ER

PT J
AU Lee, JS
   Oh, E
   Yoo, JY
   Choi, KS
   Yoon, MJ
   Yun, CO
AF Lee, Jung-Sun
   Oh, Eonju
   Yoo, Ji Young
   Choi, Kyeong Sook
   Yoon, Mi Jin
   Yun, Chae-Ok
TI Adenovirus expressing dual c-Met-specific shRNA exhibits potent
   antitumor effect through autophagic cell death accompanied by
   senescence-like phenotypes in glioblastoma cells
SO ONCOTARGET
LA English
DT Article
DE adenovirus; autophagic cell death; cancer gene therapy; c-Met; short
   hairpin RNA (shRNA)
ID MALIGNANT GLIOMA-CELLS; DOUBLE-STRANDED-RNA; IN-VITRO; TYROSINE KINASE;
   CYCLE ARREST; CANCER-CELLS; REPLICATING ADENOVIRUS; INHIBITS GROWTH;
   DOWN-REGULATION; TUMOR-GROWTH
AB c-Met, a cognate receptor tyrosine kinase of hepatocyte growth factor, is overexpressed and/or mutated in number of tumors. Therefore, abrogation of c-Met signaling may serve as potential therapeutic targets. In this study, we generated Ads expressing single shRNA specific to c-Met (shMet) (dl/shMet4 and dl/shMet5) or dual shRNAs specific to c-Met (dl/shMet4+ 5); and examined the therapeutic potential of these newly engineered Ads in targeting c-Met, and delineated their mechanism of action in vitro and in vivo. Ads expressing shMet induced knock-down in c-Met, and phenotypically resulted in autophagy-like features including appearance of membranousvacuoles, formation of acidic vesicular organelles, and cleavage and recruitment of microtubule-associated protein1 light chain 3 to autophagosomes. Ads expressing shMet also suppressed Akt phosphorylation and increased number of senescence-related gene products including SM22, TGase II, and PAI-1. These changes resulted in inhibition of cell proliferation and G(2)/M arrest of U343 cells. In vivo, intratumoral injection with dl/shMet4+ 5 resulted in a significant reduction of tumor growth with corresponding increasing overall survival. Histopathological analysis of these treated tumors revealed that Atg5 was highly up-regulated, indicating the therapeutic induction of autophagy. In sum, these results reveal that autophagic cell death induced by shMet-expressing Ads provide a novel strategy for targeting c-Met-expressing tumors through non-apoptotic mechanism of cell death.
C1 [Lee, Jung-Sun; Yoo, Ji Young] Yonsei Univ, Coll Med, Inst Canc Res, Seoul, South Korea.
   [Choi, Kyeong Sook; Yoon, Mi Jin] Ajou Univ, Dept Mol Sci & Technol, Inst Med Sci, Sch Med, Suwon 441749, South Korea.
   [Oh, Eonju; Yun, Chae-Ok] Hanyang Univ, Dept Bioengn, Coll Engn, Seoul 133791, South Korea.
C3 Yonsei University; Yonsei University Health System; Ajou University;
   Hanyang University
RP Yun, CO (corresponding author), Hanyang Univ, Dept Bioengn, Coll Engn, Seoul 133791, South Korea.
EM chaeok@hanyang.ac.kr
RI Yun, Chae-Ok/P-3698-2015
OI Yun, Chae-Ok/0000-0002-9466-4531; Choi, Kyeong Sook/0000-0003-2331-0856;
   Yoo, Ji Young/0000-0002-6767-1111
FU Korea Food and Drug Administration [KFDA-13172-306]; National Research
   Foundation of Korea [2010-0029220, 2013K1A1A2A02050188,
   2013M3A9D3045879]; National Institutes of Health, USA (CA)
FX This work was supported by grants from the Korea Food and Drug
   Administration (KFDA-13172-306 to Dr. C-O Yun), the National Research
   Foundation of Korea (2010-0029220, 2013K1A1A2A02050188,
   2013M3A9D3045879, Dr. C-O. Yun), and the National Institutes of Health,
   USA (CA 107070, Dr. C-O Yun).
CR Abounader R, 2001, FASEB J, V15, P108, DOI 10.1096/fj.01-0421fje
   Aoki H, 2008, AUTOPHAGY, V4, P467, DOI 10.4161/auto.5668
   Blagosklonny MV, 2013, AUTOPHAGY, V9, P260, DOI 10.4161/auto.22783
   Blagosklonny MV, 2012, AGING-US, V4, P159, DOI 10.18632/aging.100443
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Cao B, 2001, P NATL ACAD SCI USA, V98, P7443, DOI 10.1073/pnas.131200498
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Christensen JG, 2003, CANCER RES, V63, P7345
   Chu SH, 2006, SURG NEUROL, V65, P533, DOI 10.1016/j.surneu.2005.11.024
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863
   Davies G, 2004, PROSTATE, V60, P317, DOI 10.1002/pros.20068
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Firon M, 2000, ONCOGENE, V19, P2386, DOI 10.1038/sj.onc.1203557
   Hasinoff BB, 2010, TOXICOL APPL PHARM, V244, P190, DOI 10.1016/j.taap.2009.12.032
   Hayward RL, 2002, EUR J CANCER, V38, P2207, DOI 10.1016/S0959-8049(02)00476-8
   Herynk MH, 2003, CANCER RES, V63, P2990
   Hirose Y, 2005, CANCER RES, V65, P4861, DOI 10.1158/0008-5472.CAN-04-2633
   Ito H, 2006, JNCI-J NATL CANCER I, V98, P625, DOI 10.1093/jnci/djj161
   Kanzawa T, 2003, CANCER RES, V63, P2103
   Kim EH, 2007, CANCER RES, V67, P6314, DOI 10.1158/0008-5472.CAN-06-4217
   Kim J, 2007, HUM GENE THER, V18, P773, DOI 10.1089/hum.2006.167
   Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478
   Laird AD, 2003, EXPERT OPIN INV DRUG, V12, P51, DOI 10.1517/eoid.12.1.51.21253
   Li YC, 2012, LIFE SCI, V90, P962, DOI 10.1016/j.lfs.2012.04.044
   Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433
   Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926
   Ma PC, 2003, CANCER RES, V63, P6272
   Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842
   Mariño G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032
   Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728
   Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0
   Paglin S, 2001, CANCER RES, V61, P439
   Pirtoli L, 2009, AUTOPHAGY, V5, P930, DOI 10.4161/auto.5.7.9227
   Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039
   Sattler M, 2003, CANCER RES, V63, P5462
   Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993
   Son YG, 2007, CANCER RES, V67, P8274, DOI 10.1158/0008-5472.CAN-07-0407
   ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007
   Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191
   Wu Y, 2008, EUR J OBSTET GYN R B, V137, P198, DOI 10.1016/j.ejogrb.2007.02.014
   Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739
   Yoo JY, 2008, GENE THER, V15, P635, DOI 10.1038/gt.2008.3
   Yoo JY, 2007, MOL THER, V15, P295, DOI 10.1038/sj.mt.6300023
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100
   Yun CO, 2005, CANCER GENE THER, V12, P61, DOI 10.1038/sj.cgt.7700769
NR 49
TC 22
Z9 23
U1 0
U2 4
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD FEB 28
PY 2015
VL 6
IS 6
BP 4051
EP 4065
DI 10.18632/oncotarget.3018
PG 15
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA CF6WB
UT WOS:000352696200047
PM 25726528
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Ho, ST
   Hsieh, YT
   Wang, SY
   Chen, MJ
AF Ho, Shang-Tse
   Hsieh, Yueh-Tung
   Wang, Sheng-Yao
   Chen, Ming-Ju
TI Improving effect of a probiotic mixture on memory and learning abilities
   in D-galactose-treated aging mice
SO JOURNAL OF DAIRY SCIENCE
LA English
DT Article
DE aging; probiotic mixture; reactive oxygen species (ROS); antioxidant
ID CHAIN FATTY-ACIDS; INDUCED OXIDATIVE STRESS; IN-VIVO; ANTIOXIDANT;
   BRAIN; IMPAIRMENT; APOPTOSIS; PATHWAYS; CELLS; MODEL
AB The aim of this study was to evaluate the antiaging effect of a probiotic mixture using an in vivo mouse model in which aging was induced with D-galactose. Results of the Morris water maze test indicated that long-term administration of the probiotic mixture improved memory and learning abilities and ameliorated the apoptosis pattern in the hippocampus of aging mice treated with D-galactose. An antioxidation experiment indicated that administration of the probiotic mixture could restore activities of the antioxidant enzymes superoxide dismutase and catalase and inhibit the production of malondialdehyde. The antioxidant-related proteins nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) were upregulated in liver after treatment of D-galactose-treated aging mice with probiotics. Finally, the probiotic treatment did affect the production of short-chain fatty acids in D-galactose-treated aging mice. Our results highlighted a possible antioxidative effect triggered by short-chain fatty acids that contributed to improving the memory and learning abilities following treatment with the probiotic mixture and suggested that probiotics could serve as a therapy to modulate physiological function.
C1 [Ho, Shang-Tse; Hsieh, Yueh-Tung; Wang, Sheng-Yao; Chen, Ming-Ju] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10617, Taiwan.
   [Ho, Shang-Tse] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 11529, Taiwan.
C3 National Taiwan University; Academia Sinica - Taiwan
RP Chen, MJ (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10617, Taiwan.
EM cmj@ntu.edu.tw
FU Council of Agriculture, Executive Yuan (Taipei, Taiwan)
   [106AS-3.5.2AD-U1]
FX This work was supported by the project 106AS-3.5.2AD-U1 of the Council
   of Agriculture, Executive Yuan (Taipei, Taiwan). The authors declare no
   conflicts of interest.
CR Alam MN, 2013, SAUDI PHARM J, V21, P143, DOI 10.1016/j.jsps.2012.05.002
   Barja G, 2014, PROG MOL BIOL TRANSL, V127, P1, DOI 10.1016/B978-0-12-394625-6.00001-5
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Chen CL, 2016, J FUNCT FOODS, V21, P167, DOI 10.1016/j.jff.2015.12.017
   Chen PC, 2016, FOOD FUNCT, V7, P4576, DOI [10.1039/C6FO00628K, 10.1039/c6fo00628k]
   Chen ZX, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700313
   Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003
   Fontella FU, 2000, NEUROREPORT, V11, P541, DOI 10.1097/00001756-200002280-00023
   Fu W, 2017, BEHAV BRAIN RES, V328, P81, DOI 10.1016/j.bbr.2017.04.012
   Harman D, 2002, ANN NY ACAD SCI, V959, P384, DOI 10.1111/j.1749-6632.2002.tb02109.x
   Jan G, 2002, CELL DEATH DIFFER, V9, P179, DOI 10.1038/sj.cdd.4400935
   Jang MH, 2002, EUR J PHARMACOL, V449, P39, DOI 10.1016/S0014-2999(02)01973-8
   Khalil SR, 2015, NEUROTOXICOLOGY, V49, P121, DOI 10.1016/j.neuro.2015.05.011
   Lan YH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/178178
   LeBlanc JG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0691-z
   Li SY, 2012, FOOD CHEM, V135, P1914, DOI 10.1016/j.foodchem.2012.06.048
   Loboda A, 2008, ANTIOXID REDOX SIGN, V10, P1767, DOI 10.1089/ars.2008.2043
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   Ohira H, 2017, J ATHEROSCLER THROMB, V24, P660, DOI 10.5551/jat.RV17006
   Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016
   Parameshwaran K, 2010, REJUV RES, V13, P729, DOI 10.1089/rej.2010.1020
   Park J, 2016, J IMMUNOL, V196, P2388, DOI 10.4049/jimmunol.1502046
   Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3
   Pratico Domenico, 2002, Sci Aging Knowledge Environ, V2002, pre5
   Qu Z, 2016, PHYSIOL BEHAV, V154, P114, DOI 10.1016/j.physbeh.2015.11.016
   Raz N, 2018, GERONTOLOGY, V64, P49, DOI 10.1159/000479508
   Rottenberg H, 2017, AGING CELL, V16, P943, DOI 10.1111/acel.12650
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Spiteller G, 2001, EXP GERONTOL, V36, P1425, DOI 10.1016/S0531-5565(01)00131-0
   Tang W, 2016, APPL MICROBIOL BIOT, V100, P7193, DOI 10.1007/s00253-016-7581-x
   Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047
   Ward R, 2014, LANCET NEUROL, V13, P1045, DOI 10.1016/S1474-4422(14)70117-6
   Yu XM, 2016, J DAIRY SCI, V99, P903, DOI 10.3168/jds.2015-10265
   Zhao JC, 2017, J FUNCT FOODS, V39, P44, DOI 10.1016/j.jff.2017.09.055
   Zhong SZ, 2009, J NEUROL SCI, V277, P58, DOI 10.1016/j.jns.2008.10.008
NR 35
TC 34
Z9 35
U1 7
U2 31
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0022-0302
EI 1525-3198
J9 J DAIRY SCI
JI J. Dairy Sci.
PD MAR
PY 2019
VL 102
IS 3
BP 1901
EP 1909
DI 10.3168/jds.2018-15811
PG 9
WC Agriculture, Dairy & Animal Science; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Food Science & Technology
GA HL2FE
UT WOS:000458518700002
PM 30639021
OA hybrid
DA 2024-02-19
ER

PT J
AU Polo, ML
   Ghiglione, YA
   Salido, JP
   Urioste, A
   Poblete, G
   Sisto, AE
   Martinez, A
   Rolón, MJ
   Ojeda, DS
   Cahn, PE
   Turk, GJ
   Laufer, NL
AF Polo, Maria L.
   Ghiglione, Yanina A.
   Salido, Jimena P.
   Urioste, Alejandra
   Poblete, Gabriela
   Sisto, Alicia E.
   Martinez, Ana
   Rolon, Maria J.
   Ojeda, Diego S.
   Cahn, Pedro E.
   Turk, Gabriela J.
   Laufer, Natalia L.
TI Liver cirrhosis in HIV/HCV-coinfected individuals is related to NK cell
   dysfunction and exhaustion, but not to an impaired NK cell modulation by
   CD4<SUP>+</SUP> T-cells
SO JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
LA English
DT Article
DE HIV; hepatitis C virus; liver fibrosis; NK cells; CD4-positive
   T-lymphocytes; Immunology
ID NATURAL-KILLER-CELLS; HEPATIC STELLATE CELLS;
   HUMAN-IMMUNODEFICIENCY-VIRUS; ANTI-FIBROTIC ACTIVITY; TRANSIENT
   ELASTOGRAPHY; FIBROSIS; INFECTION; FREQUENCY; APOPTOSIS; BIOPSY
AB Introduction HIV worsens HCV-related liver disease by accelerating fibrosis progression; however, progression rates are extremely variable among HIV/HCV-coinfected individuals. NK cells are associated with modulation of liver fibrosis and are profoundly altered during HCV and HIV infections. CD4(+) T-cells modulate NK cell function, and are also affected by HIV infection. Here, we aim to characterize the association of hepatic fibrosis with both the phenotype and function of peripheral NK cells and their regulation by CD4(+) T-cells, in HIV/HCV-coinfected individuals. Methods Thirty-four HIV/HCV-coinfected individuals with minimal (n = 16) and advanced (n = 18) fibrosis (METAVIR F0/F1 and F4 scores respectively) and 20 healthy volunteers were enrolled. PBMC were obtained from peripheral blood samples and NK and CD4(+) T-cells were isolated and analysed. NK cell phenotype (CD25, CD69, Nkp46, NKG2D, PD-1), degranulation (CD107a) and IFN-gamma and TNF-alpha production, as well as CD4(+) T-cell activation (CD69, CD25 and CD38) were measured by flow cytometry. CD4(+) T-cell conditioned medium (CM) derived from F0/F1 or F4 individuals was assessed for IL-2 levels by ELISA. Modulation of NK cell functionality by these CMs was also analysed. Results When comparing to NK cells from individuals with minimal fibrosis, degranulation and cytokine secretion by NK cells from subjects with F4 scores was significantly impaired, while PD-1 expression was augmented. On the one hand, neither the expression of activation markers nor IL-2 secretion was distinctly induced in CD4(+) T-cells from subjects with F0/F1 or F4 METAVIR scores. Finally, NK cell degranulation and cytokine secretion were not differentially modulated by CD4(+) T-cell CM, whether CD4(+) T-cells derived from subjects with minimal or advanced fibrosis. Conclusions Low levels of NK and CD4(+) T-cells in HIV/HCV-coinfected individuals with advanced liver fibrosis have been previously described. Here, we show that advanced liver fibrosis in coinfected individuals is associated to a defective function of NK cells and an increased expression of the exhaustion/senescence marker PD-1. This NK signature could not be attributed to changes in the ability of CD4(+) T-cells to modulate NK cell function.
C1 [Polo, Maria L.; Ghiglione, Yanina A.; Salido, Jimena P.; Urioste, Alejandra; Ojeda, Diego S.; Turk, Gabriela J.; Laufer, Natalia L.] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina.
   [Poblete, Gabriela; Sisto, Alicia E.; Rolon, Maria J.; Laufer, Natalia L.] Hosp Gen Agudos Dr JA Fernandez, Infect Dis Unit, Buenos Aires, DF, Argentina.
   [Martinez, Ana] Hosp Gen Agudos Dr JA Fernandez, Gastroenterol Unit, Buenos Aires, DF, Argentina.
   [Cahn, Pedro E.] Fdn Huesped, Buenos Aires, DF, Argentina.
C3 Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET);
   University of Buenos Aires
RP Laufer, NL (corresponding author), Paraguay 2155,Piso 11, RA-1425 Buenos Aires, DF, Argentina.
EM nlaufer@fmed.ub.ar
RI Laufer, Natalia/AAB-7472-2022
OI Laufer, Natalia/0000-0002-5690-9454
FU Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyt)
   [PICT2015-2694, PICT2013/02229]; Fiorini Foundation
FX Grants of the Agencia Nacional de Promocion Cientifica y Tecnica
   (ANPCyt), PICT2015-2694 and PICT2013/02229, and Fiorini Foundation.
CR Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010
   Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008
   Alter G, 2011, J HEPATOL, V55, P278, DOI 10.1016/j.jhep.2010.11.030
   Baden R, 2014, J INFECT DIS, V209, pS81, DOI 10.1093/infdis/jiu057
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003
   Castéra L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018
   Collazos J, 2011, CURR HIV RES, V9, P339, DOI 10.2174/157016211797635982
   Collister M, 2019, GASTROENTEROL RES, V12, P8, DOI 10.14740/gr1081w
   Dharan NJ, 2019, HEPATOLOGY, V69, P1135, DOI 10.1002/hep.30296
   Eisenhardt M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038846
   Fasbender F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00019
   Gao B, 2013, BBA-MOL BASIS DIS, V1832, P1061, DOI 10.1016/j.bbadis.2012.09.008
   Gardiner CM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01061
   Glässner A, 2013, J HEPATOL, V59, P427, DOI 10.1016/j.jhep.2013.04.029
   Glässner A, 2012, LAB INVEST, V92, P967, DOI 10.1038/labinvest.2012.54
   Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400
   Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800
   Jeong WI, 2011, HEPATOLOGY, V53, P1342, DOI 10.1002/hep.24190
   Kaczmarek DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174465
   Kerdiles Y, 2013, J EXP MED, V210, P1065, DOI 10.1084/jem.20130960
   Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670
   Krämer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804
   Laufer N, 2017, WORLD J HEPATOL, V9, P1073, DOI 10.4254/wjh.v9.i25.1073
   Lichtfuss GF, 2012, J IMMUNOL, V189, P1491, DOI 10.4049/jimmunol.1200458
   Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926
   Lunemann S, 2014, J INFECT DIS, V209, P1362, DOI 10.1093/infdis/jit561
   McGovern BH, 2007, CLIN INFECT DIS, V44, P431, DOI 10.1086/509580
   Meier UC, 2005, J VIROL, V79, P12365, DOI 10.1128/JVI.79.19.12365-12374.2005
   Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025
   Mikulak J, 2017, AIDS, V31, P2317, DOI 10.1097/QAD.0000000000001645
   Mondelli MU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00351
   Morishima C, 2006, HEPATOLOGY, V43, P573, DOI 10.1002/hep.21073
   Muhanna N, 2011, GUT, V60, P90, DOI 10.1136/gut.2010.211136
   Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3
   Pembroke T, 2014, GUT, V63, P515, DOI 10.1136/gutjnl-2013-304472
   Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5
   Podhorzer Ariel, 2017, Front Immunol, V8, P1912, DOI 10.3389/fimmu.2017.01912
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   Rajasekaran K, 2013, NAT IMMUNOL, V14, P1127, DOI 10.1038/ni.2708
   Rehermann B, 2015, CELL MOL GASTROENTER, V1, P578, DOI 10.1016/j.jcmgh.2015.09.004
   Sánchez-Conde M, 2010, J VIRAL HEPATITIS, V17, P280, DOI 10.1111/j.1365-2893.2009.01180.x
   Sène D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001184
   Shi JJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44544
   Shoukry NH, 2011, GASTROENTEROLOGY, V141, P1144, DOI 10.1053/j.gastro.2011.08.025
   Sullivan T, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw060
   Tosello-Trampont A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00301
   Varchetta S, 2012, HEPATOLOGY, V56, P841, DOI 10.1002/hep.25723
   WHO, 2017, World Malaria Report 2017
   Zheng Q, 2015, CLIN EXP IMMUNOL, V180, P499, DOI 10.1111/cei.12597
NR 50
TC 10
Z9 12
U1 0
U2 2
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 1758-2652
J9 J INT AIDS SOC
JI J. Int. AIDS Soc.
PD SEP
PY 2019
VL 22
IS 9
AR e25375
DI 10.1002/jia2.25375
PG 9
WC Immunology; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases
GA JB3WC
UT WOS:000488486400001
PM 31536177
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Mizumoto, T
   Yoshizawa, T
   Sato, Y
   Ito, T
   Tsuyama, T
   Satoh, A
   Araki, S
   Tsujita, K
   Tamura, M
   Oike, Y
   Yamagata, K
AF Mizumoto, Tomoya
   Yoshizawa, Tatsuya
   Sato, Yoshifumi
   Ito, Takaaki
   Tsuyama, Tomonori
   Satoh, Akiko
   Araki, Satoshi
   Tsujita, Kenichi
   Tamura, Masaru
   Oike, Yuichi
   Yamagata, Kazuya
TI SIRT7 Deficiency Protects against Aging-Associated Glucose Intolerance
   and Extends Lifespan in Male Mice
SO CELLS
LA English
DT Article
DE SIRT7; knockout mouse; lifespan; FGF21
ID RNA-POLYMERASE-I; PPAR-ALPHA; FGF21; STRESS; METABOLISM; EXPRESSION;
   LONGEVITY; EXTENSION; SIRTUINS
AB Sirtuins (SIRT1-7 in mammals) are evolutionarily conserved nicotinamide adenine dinucleotide-dependent lysine deacetylases/deacylases that regulate fundamental biological processes including aging. In this study, we reveal that male Sirt7 knockout (KO) mice exhibited an extension of mean and maximum lifespan and a delay in the age-associated mortality rate. In addition, aged male Sirt7 KO mice displayed better glucose tolerance with improved insulin sensitivity compared with wild-type (WT) mice. Fibroblast growth factor 21 (FGF21) enhances insulin sensitivity and extends lifespan when it is overexpressed. Serum levels of FGF21 were markedly decreased with aging in WT mice. In contrast, this decrease was suppressed in Sirt7 KO mice, and the serum FGF21 levels of aged male Sirt7 KO mice were higher than those of WT mice. Activating transcription factor 4 (ATF4) stimulates Fgf21 transcription, and the hepatic levels of Atf4 mRNA were increased in aged male Sirt7 KO mice compared with WT mice. Our findings indicate that the loss of SIRT7 extends lifespan and improves glucose metabolism in male mice. High serum FGF21 levels might be involved in the beneficial effect of SIRT7 deficiency.
C1 [Mizumoto, Tomoya; Yoshizawa, Tatsuya; Sato, Yoshifumi; Tsuyama, Tomonori; Yamagata, Kazuya] Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto 8608556, Japan.
   [Ito, Takaaki] Kumamoto Hlth Sci Univ, Fac Hlth Sci, Dept Med Technol, Kumamoto 8615598, Japan.
   [Tsuyama, Tomonori; Tsujita, Kenichi; Oike, Yuichi; Yamagata, Kazuya] Kumamoto Univ, Fac Life Sci, Ctr Metab Regulat Hlth Aging, Kumamoto 8608556, Japan.
   [Satoh, Akiko] Natl Ctr Geriatr & Gerontol, Dept Integrat Physiol, Obu 4748511, Japan.
   [Satoh, Akiko] Tohoku Univ, Inst Dev Aging & Canc, Dept Integrat Physiol, Sendai, Miyagi 9808575, Japan.
   [Araki, Satoshi; Tsujita, Kenichi] Kumamoto Univ, Fac Life Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan.
   [Tamura, Masaru] RIKEN BioResource Res Ctr, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki 3050074, Japan.
   [Oike, Yuichi] Kumamoto Univ, Fac Life Sci, Dept Mol Genet, Kumamoto 8608556, Japan.
C3 Kumamoto University; Kumamoto Health Science University; Kumamoto
   University; National Center for Geriatrics & Gerontology; Tohoku
   University; Kumamoto University; RIKEN; Kumamoto University
RP Yamagata, K (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto 8608556, Japan.; Yamagata, K (corresponding author), Kumamoto Univ, Fac Life Sci, Ctr Metab Regulat Hlth Aging, Kumamoto 8608556, Japan.
EM k-yamaga@kumamoto-u.ac.jp
RI Sato, Yoshifumi/GYQ-7230-2022; Yoshizawa, Tatsuya/ISS-9836-2023;
   Yoshizawa, Tatsuya/IXW-7567-2023
OI Yoshizawa, Tatsuya/0000-0002-5728-1996; 
FU Japan Agency for Medical Research and Development [JP21gm5010002,
   JP20gm5010001s0604]; Naito Foundation; Takeda Science Foundation; 
   [19H03711];  [22H03129];  [20H04107];  [19K22639];  [19K09008]
FX This study was supported by a grant from the Japan Agency for Medical
   Research and Development under Grant Number (JP21gm5010002: K.Y. and
   JP20gm5010001s0604: A.S.); by Grantsin-Aid for Scientific Research (B)
   (19H03711 and 22H03129; K.Y. and 20H04107; T.Y.); by a Grantin-Aid for
   Challenging Research (Exploratory) (19K22639; K.Y.); by a Grant-in-Aid
   for Scientific Research (C) (19K09008; Y.S.); and by grants from the
   Naito Foundation (K.Y.) and Takeda Science Foundation (K.Y.)
CR Allard C, 2019, MOL METAB, V22, P62, DOI 10.1016/j.molmet.2019.02.002
   Bao XC, 2019, MOL CELL, V76, P660, DOI 10.1016/j.molcel.2019.08.018
   Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043
   Blank MF, 2017, TRANSCR-AUSTIN, V8, P67, DOI 10.1080/21541264.2016.1276658
   BonDurant LD, 2018, ANNU REV NUTR, V38, P173, DOI 10.1146/annurev-nutr-071816-064800
   Chen SF, 2013, MOL CELL, V52, P303, DOI 10.1016/j.molcel.2013.10.010
   de Magalhaes JP, 2005, GENETICS, V169, P265, DOI 10.1534/genetics.104.032292
   Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193
   Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706
   Fujita Y, 2016, BIOCHEM BIOPH RES CO, V469, P477, DOI 10.1016/j.bbrc.2015.12.045
   Fukuda M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05187-4
   Galore Trim, TRIM GALORE
   Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71
   GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9
   Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001
   Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x
   Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168
   Ladiges W, 2009, AGING CELL, V8, P346, DOI 10.1111/j.1474-9726.2009.00491.x
   Lagunas-Rangel FA, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-022-04342-x
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595
   Meller A, 2021, EXP CELL RES, V399, DOI 10.1016/j.yexcr.2021.112474
   Metcalf MG, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb9614
   Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002
   Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101
   Roichman A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23545-7
   Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001
   Sabath N, 2020, P NATL ACAD SCI USA, V117, P31902, DOI 10.1073/pnas.2018138117
   Salminen A, 2017, AGEING RES REV, V37, P79, DOI 10.1016/j.arr.2017.05.004
   Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013
   Simonet NG, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz2590
   Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558
   Vazquez BN, 2016, EMBO J, V35, P1488, DOI 10.15252/embj.201593499
   Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041
   Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001
   Wang WW, 2019, J AM CHEM SOC, V141, P2462, DOI 10.1021/jacs.8b12083
   Wodrich APK, 2022, FRONT MOL NEUROSCI, V15, DOI 10.3389/fnmol.2022.831116
   Wronska A, 2016, GERONTOLOGY, V62, P304, DOI 10.1159/000441603
   Wu D, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00652
   Yoshizawa T, 2014, CELL METAB, V19, P712, DOI 10.1016/j.cmet.2014.03.006
   Youm YH, 2016, P NATL ACAD SCI USA, V113, P1026, DOI 10.1073/pnas.1514511113
   Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065
NR 52
TC 2
Z9 2
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD NOV
PY 2022
VL 11
IS 22
AR 3609
DI 10.3390/cells11223609
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 6J7ZD
UT WOS:000887037900001
PM 36429037
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Qian, H
   Chao, XJ
   Wang, SG
   Li, Y
   Jiang, XX
   Sun, ZL
   Ruelicke, T
   Zatloukal, K
   Ni, HM
   Ding, WX
AF Qian, Hui
   Chao, Xiaojuan
   Wang, Shaogui
   Li, Yuan
   Jiang, Xiaoxiao
   Sun, Zhaoli
   Ruelicke, Thomas
   Zatloukal, Kurt
   Ni, Hong-Min
   Ding, Wen -Xing
TI Loss of SQSTM1/p62 Induces Obesity and Exacerbates Alcohol-Induced Liver
   Injury in Aged Mice
SO CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article; Early Access
DE Adipose Tissue; Adipokine; ALD; Autophagy; Steatosis
ID CHAPERONE-MEDIATED AUTOPHAGY; ADIPOSE-TISSUE LIPOLYSIS;
   MITOCHONDRIAL-FUNCTION; DISEASE PATHOGENESIS; CHRONIC ETHANOL; BROWN;
   ACTIVATION; PROTEIN; P62; TRANSCRIPTION
AB Loss of SQSTM1/p62 leads to adipose tissue dysfunction and mature-onset obesity in mice. Loss of SQSTM1/p62 leads to brown adipose tissue maladaptation to alcohol consumption resulting in more severe liver injury.BACKGROUND: Alcohol-associated liver disease (ALD) is a worldwide health problem, of which the effective treatment is still lacking. Both detrimental and protective roles of adipose tissue have been implicated in ALD. Although alcohol increases adipose tissue lipolysis to promote alcohol-induced liver injury, alcohol also activates brown adipose tissue (BAT) thermogen-esis as an adaptive response in protecting against alcohol -induced liver injury. Moreover, aging and obesity are also risk factors for ALD. In the present study, we investigated the effects of autophagy receptor protein SQSTM1/p62 on adipose tissue and obesity in alcohol-induced liver injury in both young and aged mice.METHODS: Young and aged whole-body SQSTM1/p62 knockout (KO) and their age-matched wild-type (WT) mice were subjected to chronic plus binge (Gao-binge) alcohol feeding. Blood, adipose and liver tissues were collected for biochemical and histologic analysis.RESULTS: Aged but not young SQSTM1/p62 KO mice had significantly increased body weight and fat mass compared with the matched WT mice. Gao-binge alcohol feeding induced white adipose atrophy and decreased levels of SQSTM1/p62 levels in adipose tissue in aged WT mice. SQSTM1/p62 KO aged mice were resistant to Gao-binge alcohol-induced white adipose atrophy. Alcohol feeding increased the expression of thermogenic genes in WT mouse BAT, which was significantly blunted in SQSTM1/p62 KO aged mice. Alcohol-fed aged SQSTM1/p62 KO mice showed significantly higher levels of serum alanine aminotransferase, hepatic triglyceride, and inflammation compared with young and aged WT mice fed with alcohol. Alcohol-fed SQSTM1/p62 KO mice also increased secretion of proinflammatory and angiogenic adipokines that may promote alcohol-induced liver injury.CONCLUSIONS: Loss of SQSTM1/p62 in aged mice leads to obesity and impairs alcohol-induced BAT adaptation, resulting in exacerbated alcohol-induced liver injury in mice. (Cell Mol Gastroenterol Hepatol 2023;15:1027-1049; https://doi.org/ 10.1016/j.jcmgh.2023.01.016)
C1 [Qian, Hui; Chao, Xiaojuan; Wang, Shaogui; Li, Yuan; Jiang, Xiaoxiao; Ni, Hong-Min; Ding, Wen -Xing] Univ Kansas, Dept Pharmacol Toxicol & Therapeut, Med Ctr, Kansas City, KS USA.
   [Sun, Zhaoli] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD USA.
   [Ruelicke, Thomas] Univ Vet Med Vienna, Dept Biomed Sci, Vienna, Austria.
   [Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Graz, Austria.
   [Ding, Wen -Xing] Univ Kansas, Dept Internal Med, Med Ctr, Kansas City, KS USA.
   [Ding, Wen -Xing] Univ Kansas Med Ctr, Dept Pharmacol, Toxicol & Therapeut, MS 1018, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.
   [Ding, Wen -Xing] Univ Kansas Med Ctr, Dept Pharmacol Toxicol & Therapeut, Med Ctr, MS 1018, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.
C3 University of Kansas; University of Kansas Medical Center; Johns Hopkins
   University; Johns Hopkins Medicine; University of Veterinary Medicine
   Vienna; Medical University of Graz; University of Kansas; University of
   Kansas Medical Center; University of Kansas; University of Kansas
   Medical Center; University of Kansas; University of Kansas Medical
   Center
RP Ding, WX (corresponding author), Univ Kansas, Dept Pharmacol Toxicol & Therapeut, Med Ctr, Kansas City, KS USA.; Ding, WX (corresponding author), Univ Kansas Med Ctr, Dept Pharmacol Toxicol & Therapeut, Med Ctr, MS 1018, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.
EM wxding@kumc.edu
RI Ding, Wen/JGD-3843-2023
FU National Institutes of Health (NIH) [R01 DK102142, R01 AG072895, R37
   AA020518]
FX Funding Supported in part by the National Institutes of Health (NIH)
   funds R01 DK102142, R01 AG072895, and R37 AA020518 (WXD) .
CR Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005
   Babu JR, 2008, J NEUROCHEM, V106, P107, DOI 10.1111/j.1471-4159.2008.05340.x
   Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485
   Bataller R, 2015, SEMIN LIVER DIS, V35, P146, DOI 10.1055/s-0035-1550054
   Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032
   Bitto A, 2014, AGE, V36, P1123, DOI 10.1007/s11357-014-9626-3
   Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002
   Blazer DG, 2009, AM J PSYCHIAT, V166, P1162, DOI 10.1176/appi.ajp.2009.09010016
   Bruha R, 2012, WORLD J HEPATOL, V4, P81, DOI 10.4254/wjh.v4.i3.81
   Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004
   Barbosa MC, 2019, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00790
   Chao XJ, 2022, AM J PATHOL, V192, P87, DOI 10.1016/j.ajpath.2021.10.004
   Chao XJ, 2018, GASTROENTEROLOGY, V155, P865, DOI 10.1053/j.gastro.2018.05.027
   Coelho M, 2013, ARCH MED SCI, V9, P191, DOI 10.5114/aoms.2013.33181
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Cursio R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/480508
   de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803
   Dolganiuc A, 2012, ALCOHOL CLIN EXP RES, V36, P1301, DOI 10.1111/j.1530-0277.2012.01742.x
   Du YF, 2009, FREE RADICAL BIO MED, V46, P492, DOI 10.1016/j.freeradbiomed.2008.11.003
   Fan MJ, 2022, CELL MOL GASTROENTER, V13, P809, DOI 10.1016/j.jcmgh.2021.12.001
   Fan XL, 2022, AGEING RES REV, V73, DOI 10.1016/j.arr.2021.101538
   Fernando R, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4908162
   Fischer K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16230-8
   Fu A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2107321118
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   Hayflick L, 2000, NATURE, V408, P267, DOI 10.1038/35041709
   Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007
   Kang L, 2007, J BIOL CHEM, V282, P28465, DOI 10.1074/jbc.M705503200
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kliewer SA, 2019, CELL METAB, V29, P246, DOI 10.1016/j.cmet.2019.01.004
   Komatsu M, 2022, IUBMB LIFE, V74, P1200, DOI 10.1002/iub.2689
   Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246
   Lahiri P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161083
   Li Y, 2020, AM J PATHOL, V190, P158, DOI 10.1016/j.ajpath.2019.09.023
   Li Yuan, 2017, Liver Res, V1, P54, DOI 10.1016/j.livres.2017.03.004
   Liang WJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13187
   Liu YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31026
   Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35
   Ma XW, 2023, HEPATOLOGY, V77, P159, DOI 10.1002/hep.32604
   Manley S, 2013, EXP BIOL MED, V238, P525, DOI 10.1177/1535370213489446
   Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3
   McCullough RL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02133
   Meier P, 2008, CURR OPIN CLIN NUTR, V11, P21, DOI 10.1097/MCO.0b013e3282f30564
   Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238
   Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023
   Müller TD, 2013, J CLIN INVEST, V123, P469, DOI 10.1172/JCI64209
   Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200
   Nagy LE, 2016, GASTROENTEROLOGY, V150, P1756, DOI 10.1053/j.gastro.2016.02.035
   Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120
   Ni HM, 2012, TOXICOL SCI, V127, P438, DOI 10.1093/toxsci/kfs133
   Orman ES, 2013, J GASTROEN HEPATOL, V28, P77, DOI 10.1111/jgh.12030
   Paik JM, 2020, HEPATOLOGY, V72, P1605, DOI 10.1002/hep.31173
   Parker R, 2019, EBIOMEDICINE, V45, P511, DOI 10.1016/j.ebiom.2019.03.046
   Peery AF, 2022, GASTROENTEROLOGY, V162, P621, DOI 10.1053/j.gastro.2021.10.017
   Prado V, 2016, ANN HEPATOL, V15, P463
   Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200
   Qian H, 2021, MOL ASPECTS MED, V82, DOI 10.1016/j.mam.2021.100973
   Reitman ML, 2007, CELL METAB, V5, P405, DOI 10.1016/j.cmet.2007.05.010
   Ren RX, 2022, HEPATOLOGY, V75, P646, DOI 10.1002/hep.32152
   Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011
   Sánchez-Martín P, 2019, FEBS J, V286, P8, DOI 10.1111/febs.14712
   Sasaki M, 2012, LIVER INT, V32, P487, DOI 10.1111/j.1478-3231.2011.02656.x
   Schneider JL, 2015, AGING CELL, V14, P249, DOI 10.1111/acel.12310
   Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009
   Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182
   Seitz HK, 2007, CLIN GERIATR MED, V23, P905, DOI 10.1016/j.cger.2007.06.010
   Shen H, 2019, J CLIN INVEST, V129, P2305, DOI 10.1172/JCI124376
   Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   STRALFORS P, 1983, J BIOL CHEM, V258, P5146
   Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674
   Thomes PG, 2015, ALCOHOL CLIN EXP RES, V39, P2354, DOI 10.1111/acer.12904
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Wang F, 2021, CELL MOL GASTROENTER, V11, P1369, DOI 10.1016/j.jcmgh.2021.01.007
   Wang L, 2016, ADV EXP MED BIOL, V854, P17, DOI 10.1007/978-3-319-17121-0_3
   Wang L, 2015, CLIN RES HEPATOL GAS, V39, pS2, DOI 10.1016/j.clinre.2015.05.023
   WHOMoSA Unit, 2018, GLOB STAT REP ALC HL
   Williams JA, 2020, FOOD CHEM TOXICOL, V136, DOI 10.1016/j.fct.2019.111075
   Williams JA, 2015, AM J PHYSIOL-GASTR L, V309, pG324, DOI 10.1152/ajpgi.00108.2015
   World Health Organization, AG 2020
   Yang H, 2016, J BIOL CHEM, V291, P18663, DOI 10.1074/jbc.M116.739821
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106
   Zhao CQ, 2015, J LIPID RES, V56, P1481, DOI 10.1194/jlr.M058610
   Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017
NR 87
TC 5
Z9 5
U1 3
U2 9
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2352-345X
J9 CELL MOL GASTROENTER
JI Cell. Mol. Gastroenterol. Hepatol.
PD 2023 
PY 2023
VL 15
IS 5
BP 1027
EP 1049
DI 10.1016/j.jcmgh.2023.01.016
EA MAR 2023
PG 23
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA A0XE7
UT WOS:000952440800001
PM 36754207
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Pamplona, R
   Barja, G
AF Pamplona, Reinald
   Barja, Gustavo
TI Mitochondrial oxidative stress, aging and caloric restriction: The
   protein and methionine connection
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT 14th European Bioenergetic Conference
CY JUL 22-27, 2006
CL Moscow, RUSSIA
DE mitochondria; methionine restriction; caloric restriction; free radical;
   aging; DNA damage
ID FREE-RADICAL PRODUCTION; MAXIMUM LIFE-SPAN; FATTY-ACID UNSATURATION;
   HYDROGEN-PEROXIDE PRODUCTION; RAT-LIVER MITOCHONDRIA; NADH-UBIQUINONE
   OXIDOREDUCTASE; OXYGEN SPECIES PRODUCTION; ELECTRON-TRANSPORT CHAIN;
   DOUBLE-STRAND-BREAKS; AGE-RELATED-CHANGES
AB Caloric restriction (CR) decreases aging rate and mitochondrial ROS (MitROS) production and oxidative stress in rat postmitotic tissues. Low levels of these parameters are also typical traits of long-lived mammals and birds. However, it is not known what dietary components are responsible for these changes during CR. It was recently observed that 40% protein restriction without strong CR also decreases MitROS generation and oxidative stress. This is interesting because protein restriction also increases maximum longevity (although to a lower extent than CR) and is a much more practicable intervention for humans than CR. Moreover, it was recently found that 80% methionine restriction substituting it for L-glutamate in the diet also decreases MitROS generation in rat liver. Thus, methionine restriction seems to be responsible for the decrease in ROS production observed in caloric restriction. This is interesting because it is known that exactly that procedure of methionine restriction also increases maximum longevity. Moreover, recent data show that methionine levels in tissue proteins negatively correlate with maximum longevity in mammals and birds. All these suggest that lowering of methionine levels is involved in the control of mitochondrial oxidative stress and vertebrate longevity by at least two different mechanisms: decreasing the sensitivity of proteins to oxidative damage, and lowering of the rate of ROS generation at mitochondria. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Lleida, Dept Basic Med Sci, Lleida 25008, Spain.
   Univ Complutense Madrid, Dept Fisiol Anim 2, Fac Ciencias Biol, E-28040 Madrid, Spain.
C3 Universitat de Lleida; Complutense University of Madrid
RP Barja, G (corresponding author), Univ Complutense Madrid, Dept Fisiol Anim 2, Fac Ciencias Biol, C Antonio Novais 2, E-28040 Madrid, Spain.
EM gbarja@bio.ucm.es
RI Barja, Gustavo/AAA-5903-2019; Pamplona, Reinald/A-7359-2010; Gustavo,
   Barja/B-5591-2012
OI Barja, Gustavo/0000-0001-5736-4735; Pamplona,
   Reinald/0000-0003-4337-6107; 
CR Archer VE, 2003, MED HYPOTHESES, V60, P924, DOI 10.1016/S0306-9877(03)00097-5
   Armeni T, 2003, J BIOENERG BIOMEMBR, V35, P181, DOI 10.1023/A:1023754305218
   Barja G, 1998, J BIOENERG BIOMEMBR, V30, P235, DOI 10.1023/A:1020592719405
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barja G, 2000, AGING CLIN EXP RES, V12, P342, DOI 10.1007/BF03339859
   BARJA G, 1994, COMP BIOCHEM PHYS B, V108, P501, DOI 10.1016/0305-0491(94)90103-1
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   BARROWS CH, 1975, GROWTH, V39, P525
   Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BENZI G, 1995, FREE RADICAL BIO MED, V19, P77, DOI 10.1016/0891-5849(94)00244-E
   Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004
   Blanchard JL, 2000, TRENDS GENET, V16, P315, DOI 10.1016/S0168-9525(00)02053-9
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Boveris A, 2000, IUBMB LIFE, V50, P245, DOI 10.1080/15216540051080912
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   CARP H, 1982, P NATL ACAD SCI-BIOL, V79, P2041, DOI 10.1073/pnas.79.6.2041
   Chang L, 2004, CLIN EXP PHARMACOL P, V31, P237, DOI 10.1111/j.1440-1681.2004.03983.x
   Ciorba MA, 1997, P NATL ACAD SCI USA, V94, P9932, DOI 10.1073/pnas.94.18.9932
   Davies SMK, 2001, FREE RADICAL BIO MED, V31, P181, DOI 10.1016/S0891-5849(01)00576-7
   DAVIS TA, 1983, EXP GERONTOL, V18, P427, DOI 10.1016/0531-5565(83)90021-9
   DE AK, 1983, MECH AGEING DEV, V21, P37, DOI 10.1016/0047-6374(83)90014-3
   de Grey ADNJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P295, DOI 10.1006/abbi.1999.1509
   Dean RT, 1997, BIOCHEM J, V324, P1
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   Doi SQ, 2001, AM J NEPHROL, V21, P331, DOI 10.1159/000046270
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Durand P, 2001, LAB INVEST, V81, P645, DOI 10.1038/labinvest.3780275
   FAU D, 1988, J NUTR, V118, P128, DOI 10.1093/jn/118.1.128
   FERNANDES G, 1976, P NATL ACAD SCI USA, V73, P1279, DOI 10.1073/pnas.73.4.1279
   Ferrari CKB, 2004, BIOGERONTOLOGY, V5, P275, DOI 10.1007/s10522-004-2566-z
   Foksinski M, 2004, FREE RADICAL BIO MED, V37, P1449, DOI 10.1016/j.freeradbiomed.2004.07.014
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200
   Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2
   GOODRICK CL, 1978, J GERONTOL, V33, P184, DOI 10.1093/geronj/33.2.184
   Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358
   Herrero A, 1999, AGING-CLIN EXP RES, V11, P294, DOI 10.1007/BF03339803
   Herrero A, 1998, MECH AGEING DEV, V103, P133, DOI 10.1016/S0047-6374(98)00035-9
   Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6
   Herrero A, 2001, J AM AGING ASSOC, V24, P45, DOI 10.1007/s11357-001-0006-4
   Herrero A, 2000, J BIOENERG BIOMEMBR, V32, P609, DOI 10.1023/A:1005626712319
   Hidiroglou N, 2004, J NUTR BIOCHEM, V15, P730, DOI 10.1016/j.jnutbio.2004.04.009
   Hirano T, 1996, J GERONTOL A-BIOL, V51, pB303, DOI 10.1093/gerona/51A.5.B303
   HORAKOVA M, 1988, MECH AGEING DEV, V45, P1, DOI 10.1016/0047-6374(88)90014-0
   Hulbert AJ, 2005, J THEOR BIOL, V234, P277, DOI 10.1016/j.jtbi.2004.11.024
   Judge S, 2004, AM J PHYSIOL-REG I, V286, pR254, DOI 10.1152/ajpregu.00502.2003
   Khrapko K, 2004, ANN NY ACAD SCI, V1019, P240, DOI 10.1196/annals.1297.040
   Kinoshita M, 2000, CLIN CHEM, V46, P822
   Krause F, 2004, J BIOL CHEM, V279, P26453, DOI 10.1074/jbc.M402756200
   KU HH, 1993, MECH AGEING DEV, V72, P67, DOI 10.1016/0047-6374(93)90132-B
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200
   Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121
   Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200
   Lambert AJ, 2004, MECH AGEING DEV, V125, P529, DOI 10.1016/j.mad.2004.06.002
   Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003
   Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297
   LEHNINGER AL, 2005, PRINCIPLES BIOCH, P721
   LETO S, 1976, J GERONTOL, V31, P144, DOI 10.1093/geronj/31.2.144
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   LOPEZTORRES M, 1993, MECH AGEING DEV, V70, P177, DOI 10.1016/0047-6374(93)90047-U
   LYNCH SM, 1988, FREE RADICAL RES COM, V5, P221, DOI 10.3109/10715768909074704
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223
   Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016
   MARK MCM, 1995, J GERONTOL A-BIOL, V50, pB148
   Marnett LJ, 2002, TOXICOLOGY, V181, P219, DOI 10.1016/S0300-483X(02)00448-1
   Matthias D, 1996, ATHEROSCLEROSIS, V122, P201, DOI 10.1016/0021-9150(95)05740-4
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Melov S, 1999, MUTAT RES-DNA REPAIR, V434, P233, DOI 10.1016/S0921-8777(99)00031-2
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MILLER DS, 1968, EXP GERONTOL, V3, P231, DOI 10.1016/0531-5565(68)90006-5
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201
   Miwa S, 2004, ANN NY ACAD SCI, V1019, P388, DOI 10.1196/annals.1297.069
   Miyazawa T, 1996, MECH AGEING DEV, V86, P145, DOI 10.1016/0047-6374(95)01687-2
   Mori N, 2004, J HEALTH SCI, V50, P277, DOI 10.1248/jhs.50.277
   Mori N, 2000, J NUTR, V130, P2349, DOI 10.1093/jn/130.9.2349
   Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998
   MULLER FL, 2003, AGING MOL LEVEL, P131
   Nakamura H, 2002, METHOD ENZYMOL, V347, P436
   Ninomiya T, 2004, AM J KIDNEY DIS, V44, P437, DOI [10.1016/S0272-6386(04)00813-3, 10.1053/j.ajkd.2004.05.024]
   Ohnishi T, 2005, FEBS LETT, V579, P500, DOI 10.1016/j.febslet.2004.11.107
   ORENTREICH N, 1993, J NUTR, V123, P269
   Ozawa T, 1999, J BIOENERG BIOMEMBR, V31, P377, DOI 10.1023/A:1005479920097
   Pamplona R, 2000, J GERONTOL A-BIOL, V55, pB286, DOI 10.1093/gerona/55.6.B286
   Pamplona R, 2004, EXP GERONTOL, V39, P725, DOI 10.1016/j.exger.2004.01.006
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Pamplona R, 2000, MECH AGEING DEV, V112, P169, DOI 10.1016/S0047-6374(99)00045-7
   Pamplona R, 2002, MECH AGEING DEV, V123, P1437, DOI 10.1016/S0047-6374(02)00076-3
   Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2
   Pamplona R, 2002, FREE RADICAL RES, V36, P47, DOI 10.1080/10715760210165
   Pamplona R, 1998, J LIPID RES, V39, P1989
   Pamplona R, 2005, AGE, V27, P267, DOI 10.1007/s11357-005-4562-x
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   PEREZCAMPO R, 1994, J COMP PHYSIOL B, V163, P682, DOI 10.1007/BF00369520
   Petzke KJ, 1999, J NUTR BIOCHEM, V10, P268, DOI 10.1016/S0955-2863(99)00006-6
   Portero-Otín M, 2004, EXP GERONTOL, V39, P1527, DOI 10.1016/j.exger.2004.08.001
   Portero-Otín M, 2001, LIPIDS, V36, P491, DOI 10.1007/s11745-001-0748-y
   Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002
   Quiles JL, 2004, EXP GERONTOL, V39, P189, DOI 10.1016/j.exger.2003.10.002
   Ramirez-Tortosa MC, 2004, BRIT J NUTR, V91, P943, DOI 10.1079/BJN20041146
   Ramsey JJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE31, DOI 10.1152/ajpendo.00283.2003
   Richie JP, 2004, NUTRITION, V20, P800, DOI 10.1016/j.nut.2004.05.009
   RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Robin S, 2004, BRIT J NUTR, V91, P857, DOI 10.1079/BJN20041116
   RODRIGUES MAM, 1991, FOOD CHEM TOXICOL, V29, P757, DOI 10.1016/0278-6915(91)90184-9
   ROSS MH, 1961, J NUTR, V75, P197, DOI 10.1093/jn/75.2.197
   ROSS MH, 1975, SCIENCE, V190, P165, DOI 10.1126/science.1166309
   Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199
   Ruiz MC, 2005, MECH AGEING DEV, V126, P1106, DOI 10.1016/j.mad.2005.04.005
   Sanz A, 2005, J BIOENERG BIOMEMBR, V37, P83, DOI 10.1007/s10863-005-4131-0
   Sanz A, 2005, BIOGERONTOLOGY, V6, P15, DOI 10.1007/s10522-004-7380-0
   Sanz A, 2004, J BIOENERG BIOMEMBR, V36, P545, DOI 10.1007/s10863-004-9001-7
   SANZ A, IN PRESS ANTIOXID RE
   SANZ A, 2005, ANN NEW YORK ACAD SC
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Slyshenkov VS, 2002, ACTA BIOCHIM POL, V49, P907
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010
   Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239
   Stadtman ER, 2004, CURR MED CHEM, V11, P1105, DOI 10.2174/0929867043365341
   STOLTZNER G, 1977, GROWTH, V41, P337
   STREHLER BL, 1962, TIME CELLS AGING, P456
   Stroikin Y, 2005, BIOGERONTOLOGY, V6, P39, DOI 10.1007/s10522-004-7382-y
   Tahara S, 2001, MECH AGEING DEV, V122, P415, DOI 10.1016/S0047-6374(00)00257-8
   TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129
   Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200
   Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9
   TOBOREK M, 1995, ATHEROSCLEROSIS, V115, P217, DOI 10.1016/0021-9150(94)05516-L
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   Wang ED, 1997, MUTAT RES-FUND MOL M, V377, P157, DOI 10.1016/S0027-5107(97)00091-2
   Weindruch R, 2003, CLIN NEUROSCI RES, V2, P279, DOI 10.1016/S1566-2772(03)00004-5
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   Yu BP, 1996, ANN NY ACAD SCI, V786, P44, DOI 10.1111/j.1749-6632.1996.tb39050.x
   Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3
NR 156
TC 186
Z9 215
U1 3
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD MAY-JUN
PY 2006
VL 1757
IS 5-6
BP 496
EP 508
DI 10.1016/j.bbabio.2006.01.009
PG 13
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics
GA 069XF
UT WOS:000239481800028
PM 16574059
OA hybrid
DA 2024-02-19
ER

PT J
AU Koo, YC
   Pyo, MC
   Nam, MH
   Hong, CO
   Yang, SY
   Lee, KW
AF Koo, Yun-Chang
   Pyo, Min Cheol
   Nam, Mi-Hyun
   Hong, Chung-Oui
   Yang, Sung-Yong
   Lee, Kwang-Won
TI Chebulic acid acid prevents hepatic fibrosis induced by advanced
   glycation end-products in LX-2 cell by modulating Nrf2 translocation
   <i>via</i> ERK pathway
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Chebulic acid; Human hepatic stellate cell; Advanced. glycation
   end-product; Hepatic fibrosis; Nuclear factor E2-related factor
ID TERMINALIA-CHEBULA; OXIDATIVE STRESS; STELLATE CELLS; HEME OXYGENASE-1;
   GENE-EXPRESSION; HEPG2 CELLS; RAT-LIVER; IN-VIVO; ACTIVATION; INDUCTION
AB Advanced glycation end-products (AGEs) are formed during normal aging, and at an accelerated rate in metaboll is syndrome patients. Nonalcoholic steatohepatitis (NASH) can be caused by the AGEs in plasma, while glyceraldehyde-derived AGEs (glycer-AGEs) are significantly higher in the serum of NASH patients. In this study, we investigated the molecular mechanisms of chebulic acid, isolated from Terminalia chebula Retz., in the inhibition of glycer-AGEs induced production of reactive oxygen species (ROS) and collagen accumulation using the LX-2 cell line. Chebulic acid significantly inhibited the induction of ROS and accumulation of collagen proteins by glycer-AGEs. ERK phosphorylation and total nuclear factor E2-related factor 2 (Nrf2) protein expression were induced by chebulic acid in a dose-dependent manner. Chebulic add was also found to induce trans location of Nrf2 into the nucleus, which was attenuated by inhibition of ERK phosphorylation through treatment with PD98059. Following translocation of Nrf2, chebulic acid induced the protein expressions of catalytic subunit of gamma-glutamylcysteine synthetase and glutathione synthesis. Collagen accumulation was also significantly reduced by chebulic add treatment. The observed effects of chebulic acid were all inhibited by PD98059 treatment. Taken together, these results suggest that chebulic acid prevents the glycer-AGEs-induced ROS formation of LX-2 cells and collagen accumulation by ERK-phosphorylation-mediated Nrf2 nuclear translocation, which causes up regulation of antioxidant protein production. (C) 2016 Published by Elsevier Ltd.
C1 [Koo, Yun-Chang; Pyo, Min Cheol; Nam, Mi-Hyun; Hong, Chung-Oui; Yang, Sung-Yong; Lee, Kwang-Won] Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 136701, South Korea.
   [Koo, Yun-Chang] Food Res Inst, Ourhome, Songnam 462819, Gyunggi Do, South Korea.
C3 Korea University; Korea Food Research Institute (KFRI)
RP Lee, KW (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Biotechnol, Seoul 136701, South Korea.
EM kwangwon@korea.ac.kr
RI Pyo, Min Cheol/C-6499-2019; 표, 민철/IAQ-7819-2023; Lee,
   Kwang-Won/V-5743-2019; Lee, Kwang-Won/F-2432-2013
OI Lee, Kwang-Won/0000-0001-5326-469X; Lee, Kwang-Won/0000-0001-5326-469X;
   Pyo, Min Cheol/0000-0002-9006-4475
FU Korea University Grant [K1420071]
FX This research was supported by a Korea University Grant (K1420071). The
   authors thank the Institute of Biomedical Science & Food Safety, Korea
   University Food Safety Hall, for providing the equipment and facilities.
CR Ahmad I, 1998, J ETHNOPHARMACOL, V62, P183, DOI 10.1016/S0378-8741(98)00055-5
   Bataille AM, 2012, CLIN PHARMACOL THER, V92, P340, DOI 10.1038/clpt.2012.110
   Castagnoli C, 2003, BURNS, V29, P759, DOI 10.1016/j.burns.2003.01.001
   Disthabanchong S, 2007, KIDNEY INT, V71, P201, DOI 10.1038/sj.ki.5002035
   Feng J, 2011, J CELL BIOCHEM, V112, P1524, DOI 10.1002/jcb.23065
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828
   Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683
   Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007
   Hyogo H, 2007, J GASTROEN HEPATOL, V22, P1112, DOI 10.1111/j.1440-1746.2007.04943.x
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Iwamoto K, 2008, J GASTROENTEROL, V43, P298, DOI 10.1007/s00535-007-2152-7
   Jeyapaul J, 2000, BIOCHEM PHARMACOL, V59, P1433, DOI 10.1016/S0006-2952(00)00256-2
   Kim JK, 2014, INT J MOL SCI, V15, P12149, DOI 10.3390/ijms150712149
   Koo YC, 2013, FOOD SCI BIOTECHNOL, V22, P871, DOI 10.1007/s10068-013-0158-x
   Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947
   Kweon MH, 2006, J BIOL CHEM, V281, P33761, DOI 10.1074/jbc.M604748200
   Lee HS, 2005, BIOL PHARM BULL, V28, P1639, DOI 10.1248/bpb.28.1639
   Lee HS, 2007, ARCH TOXICOL, V81, P211, DOI 10.1007/s00204-006-0139-4
   Lee HS, 2010, J ETHNOPHARMACOL, V131, P567, DOI 10.1016/j.jep.2010.07.039
   Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008
   Milliano MT, 2005, HEPATOL RES, V33, P225, DOI 10.1016/j.hepres.2005.08.007
   MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926
   Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x
   Pereira-Filho Gustavo, 2008, Arq. Gastroenterol., V45, P156, DOI 10.1590/S0004-28032008000200013
   Pietropaoli D, 2012, INT J IMMUNOPATH PH, V25, P9, DOI 10.1177/039463201202500102
   Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5
   Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798
   RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632
   Shin BY, 2012, FREE RADICAL BIO MED, V53, P834, DOI 10.1016/j.freeradbiomed.2012.06.026
   Shukla SK, 2006, ENVIRON TOXICOL PHAR, V22, P113, DOI 10.1016/j.etap.2006.01.001
   Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388
   Telli C, 1999, J ENDODONT, V25, P811, DOI 10.1016/S0099-2399(99)80303-3
   Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960
   White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X
   Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127
   Yang JH, 2014, TOXICOL APPL PHARM, V274, P293, DOI 10.1016/j.taap.2013.10.026
   Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200
   Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083
NR 39
TC 22
Z9 24
U1 0
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD AUG
PY 2016
VL 34
BP 8
EP 15
DI 10.1016/j.tiv.2016.03.013
PG 8
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA DQ5VR
UT WOS:000379273800002
PM 27021876
DA 2024-02-19
ER

PT J
AU Li, S
   Liu, C
   Li, N
   Hao, T
   Han, T
   Hill, DE
   Vidal, M
   Lin, JD
AF Li, Sinning
   Liu, Chang
   Li, Na
   Hao, Tong
   Han, Ting
   Hill, David E.
   Vidal, Marc
   Lin, Jiandie D.
TI Genome-wide coactivation analysis of PGC-1α identifies BAF60a as a
   regulator of hepatic lipid metabolism
SO CELL METABOLISM
LA English
DT Article
ID ACTIVATED RECEPTOR-ALPHA; CHROMATIN-REMODELING COMPLEX; OPEN READING
   FRAMES; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; NUCLEAR RECEPTORS;
   TRANSCRIPTIONAL COACTIVATORS; GAMMA COACTIVATOR-1; SWI/SNF COMPLEXES;
   RESPONSE ELEMENT
AB Impaired mitochondrial function has been implicated in the pathogenesis of type 2 diabetes, heart failure, and neurodegeneration as well as during aging. Studies with the PGC-1 transcriptional coactivators have demonstrated that these factors are central components of the regulatory network that controls mitochondrial function in mammalian cells. Here we describe a genome-wide coactivation assay to globally identify transcription factors and cofactors; in this pathway. These analyses revealed a molecular signature of the PGC-1 alpha transcriptional network and identified BAF60a (SMARCD1) as a molecular link between the SWI/SNF chromatin-remodeling complexes and hepatic lipid metabolism. Adenoviral-mediated expression of BAF60a stimulates fatty acid beta-oxidation in cultured hepatocytes and ameliorates hepatic steatosis in vivo. PGC-1 alpha mediates the recruitment of BAF60a to PPAR alpha-bincling sites, leading to transcriptional activation of peroxisomal and mitochondrial fat-oxidation genes. These results define a role for the SWI/SNF complexes in the regulation of lipid homeostasis.
C1 [Li, Sinning; Liu, Chang; Han, Ting; Lin, Jiandie D.] Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA.
   [Li, Sinning; Liu, Chang; Han, Ting; Lin, Jiandie D.] Univ Michigan, Med Ctr, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.
   [Li, Na; Hao, Tong; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, CCSB, Boston, MA 02115 USA.
   [Li, Na; Hao, Tong; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.
   [Li, Na; Hao, Tong; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; Harvard University; Harvard
   Medical School; Harvard University; Harvard Medical School; Dana-Farber
   Cancer Institute; Harvard University; Harvard Medical School
RP Lin, JD (corresponding author), Univ Michigan, Med Ctr, Inst Life Sci, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.
EM jdlin@umich.edu
RI Hill, David E/B-6617-2011
FU NIDDK NIH HHS [R01 DK077086, DK077086, R01 DK077086-01A1, K01
   DK065584-05, DK065584, R01 DK077086-02, K01 DK065584-04, K01 DK065584]
   Funding Source: Medline
CR Calfee-Mason KG, 2002, J NUTR, V132, P3178, DOI 10.1093/jn/131.10.3178
   Christian M, 2006, TRENDS ENDOCRIN MET, V17, P243, DOI 10.1016/j.tem.2006.06.008
   Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200
   Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8
   Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005
   Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X
   Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003
   Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200
   Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200
   Kanamori M, 2004, BIOCHEM BIOPH RES CO, V322, P787, DOI 10.1016/j.bbrc.2004.07.179
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000
   Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131
   Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010
   Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012
   Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013
   Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043
   Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767
   Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Nicolas-Frances V, 2000, BIOCHEM BIOPH RES CO, V269, P347, DOI 10.1006/bbrc.2000.2249
   Péterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193
   Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101
   Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514
   Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378
   Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6
   TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x
   Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X
   Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 57
TC 134
Z9 162
U1 0
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1550-4131
J9 CELL METAB
JI Cell Metab.
PD AUG 6
PY 2008
VL 8
IS 2
BP 105
EP 117
DI 10.1016/j.cmet.2008.06.013
PG 13
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA 335AH
UT WOS:000258262700004
PM 18680712
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Ballas, SK
AF Ballas, Samir K.
TI Comorbidities in aging patients with sickle cell disease
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Sickle cell disease; aging; comorbidities
ID SENSORINEURAL HEARING-LOSS; RENAL MEDULLARY CARCINOMA; OBSTRUCTIVE
   SLEEP-APNEA; ACOUSTIC NEUROMA MANAGEMENT; AUTOIMMUNE LIVER-DISEASE;
   CHRONIC HEPATITIS-C; QUALITY-OF-LIFE; SECONDARY GLAUCOMA; NIGERIAN
   CHILDREN; MULTIPLE-MYELOMA
AB Sickle cell disease (SCD) in general and sickle cell anemia in particular is a highly complex disorder both at the molecular and clinical levels. Although the molecular lesion is a single-point mutation, the sickle gene is pleiotropic in nature causing multiple phenotypic expressions that constitute the various complications of the disease. Moreover, despite the fact that SCD is a chronic malady, its manifestations are both acute and chronic. The former include, among other things, the recurrent vaso-occlusive crises (its hallmark) and acute chest syndrome. The chronic complications include most commonly avascular necrosis and leg ulcers. Currently, survival of patients with SCD has improved dramatically thanks to newborn screening, antibiotic prophylaxis, better vaccine, safer blood transfusion and the use of hydroxyurea. It is the advent of these therapies that improved the survival. This improvement, however, introduced a third dimension of the disease: comorbidities that occur in aging people in the general population. There is concern that the gain in survival may be offset by the comorbidities. Thus it is the purpose of this review to identify the comorbidities in the elderly with SCD and differentiate them from the basis disease to implement proper therapies so that better survival could be maintained.
C1 [Ballas, Samir K.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA.
C3 Jefferson University
RP Ballas, SK (corresponding author), Cardeza Fdn, 1020 Locust St,Suite 394, Philadelphia, PA 19107 USA.
EM samir.ballas@jefferson.edu
CR Acharya Sonu, 2015, Int J Clin Pediatr Dent, V8, P141, DOI 10.5005/jp-journals-10005-1301
   Adebamowo CA, 1996, E AFR MED J, V73, P489
   AJULO SO, 1993, J LARYNGOL OTOL, V107, P790, DOI 10.1017/S0022215100124442
   Akodu SO, 2012, PEDIATR HEMAT ONCOL, V29, P358, DOI 10.3109/08880018.2012.680682
   Al Zaman AS, 2013, SAUDI MED J, V34, P199
   Alabi S, 2008, INT J PEDIATR OTORHI, V72, P659, DOI 10.1016/j.ijporl.2008.01.024
   Aliyu ZY, 2008, AM J HEMATOL, V83, P63, DOI 10.1002/ajh.21057
   Amoah K G, 2015, Ghana Med J, V49, P214, DOI 10.4314/gmj.v49i3.13
   Ancel D, 2009, EUR J GASTROEN HEPAT, V21, P726, DOI 10.1097/MEG.0b013e3283097699
   ANDERSON IS, 1975, AM J MED, V59, P568, DOI 10.1016/0002-9343(75)90264-8
   Anim SO, 2011, EXPERT REV RESP MED, V5, P635, DOI [10.1586/ers.11.64, 10.1586/ERS.11.64]
   [Anonymous], 1992, Sickle cell disease
   Arlet JB, 2012, REV MED INTERNE, V33, P13, DOI 10.1016/j.revmed.2011.07.002
   Azar Justin M, 2014, J Pediatr Gastroenterol Nutr, V59, pe47, DOI 10.1097/MPG.0000000000000534
   Bagasra O, 1998, AM J HEMATOL, V59, P199, DOI 10.1002/(SICI)1096-8652(199811)59:3<199::AID-AJH4>3.3.CO;2-C
   Ballas S.K., 2014, J INTERDISCIPL MED D, V2, P6, DOI [10.4172/2376-032X.1000152, DOI 10.4172/2376-032X.1000152]
   Ballas Samir K, 2017, J Clin Med Res, V9, P889, DOI 10.14740/jocmr3137w
   Ballas SK, 2016, BLOOD
   Ballas SK, 2014, DIET FLUIDS SICKLE C, P431
   Ballas SK, 2014, Sickle Cell Pain, V2nd
   BARRETTCONNOR E, 1968, ANN INTERN MED, V69, P517, DOI 10.7326/0003-4819-69-3-517
   Baykul T, 2004, J CRANIOFAC SURG, V15, P1052, DOI 10.1097/00001665-200411000-00035
   Benner JD, 2000, AM J OPHTHALMOL, V130, P514, DOI 10.1016/S0002-9394(00)00578-X
   BERGREN RL, 1992, AM J OPHTHALMOL, V113, P718, DOI 10.1016/S0002-9394(14)74804-4
   BILECKOT R, 1994, PRESSE MED, V23, P1095
   Bille J, 2014, PEDIATR INT, V56, P400, DOI 10.1111/ped.12252
   Boyd JH, 2007, HAEMATOLOGICA, V92, P1115, DOI 10.3324/haematol.11213
   Browne I, 2005, INT J OBSTET ANESTH, V14, P66, DOI 10.1016/j.ijoa.2004.07.012
   Buchowski MS, 2000, J AM COLL NUTR, V19, P228, DOI 10.1080/07315724.2000.10718921
   Campos RP, 2013, RHEUMATOL INT, V33, P1419, DOI 10.1007/s00296-012-2568-0
   Caracas MD, 2013, OR SURG OR MED OR PA, V115, pE31, DOI 10.1016/j.oooo.2012.05.018
   Chuang E, 1997, J PEDIAT HEMATOL ONC, V19, P159, DOI 10.1097/00043426-199703000-00013
   Costa CP, 2015, BRAZ ORAL RES, V29
   Costa Cyrene Piazera Silva, 2016, Eur J Dent, V10, P356, DOI 10.4103/1305-7456.184149
   Costa Cyrene Piazera Silva, 2012, Rev. Bras. Hematol. Hemoter., V34, P60, DOI 10.5581/1516-8484.20120016
   Mendes PHC, 2011, QUINTESSENCE INT, V42, P701
   CROSBY WH, 1955, AM J MED, V18, P112, DOI 10.1016/0002-9343(55)90208-4
   Daher Paul, 2014, J Pediatr Hematol Oncol, V36, pe285, DOI 10.1097/MPH.0000000000000118
   Dawkins FW, 1997, AM J HEMATOL, V55, P188, DOI 10.1002/(SICI)1096-8652(199707)55:4<188::AID-AJH4>3.3.CO;2-N
   de Carvalho HLCC, 2016, J PERIODONTAL RES, V51, P622, DOI 10.1111/jre.12342
   Desai Payal, 2015, J Clin Med Res, V7, P189, DOI 10.14740/jocmr2028w
   DIAMOND HS, 1975, AM J MED, V59, P796, DOI 10.1016/0002-9343(75)90465-9
   DIAMOND HS, 1979, ANN INTERN MED, V90, P752, DOI 10.7326/0003-4819-90-5-752
   Donnelly J C, 2003, J Matern Fetal Neonatal Med, V14, P353, DOI 10.1080/jmf.14.5.353.355
   ELSABBAGH AM, 1989, CLIN RHEUMATOL, V8, P393, DOI 10.1007/BF02030354
   ElYounis CM, 1996, AM J GASTROENTEROL, V91, P1016
   Emre S, 2000, TRANSPLANTATION, V69, P675, DOI 10.1097/00007890-200002270-00036
   Emre S, 1999, LIVER TRANSPLANT SUR, V5, P161, DOI 10.1002/lt.500050315
   ESPINOZA LR, 1974, MEDICINE, V53, P295, DOI 10.1097/00005792-197407000-00003
   Ferraz M, 2015, J INTERDISCIPL MED D, V3, P4
   Fine PG, 2004, CLIN J PAIN, V20, P220, DOI 10.1097/00002508-200407000-00003
   Fisher E A, 1988, Va Med, V115, P80
   FORMAN DE, 1992, J AM GERIATR SOC, V40, P19, DOI 10.1111/j.1532-5415.1992.tb01823.x
   Gaine S, 2000, JAMA-J AM MED ASSOC, V284, P3160, DOI 10.1001/jama.284.24.3160
   Giamberardino MA, 2012, PAIN COMORBIDITIES
   Gilli SCO, 2002, TRANSPLANTATION, V74, P896, DOI 10.1097/00007890-200209270-00030
   GOLDBERG MF, 1979, OPHTHALMIC SURG LAS, V10, P32
   GOLDBERG MF, 1979, AM J OPHTHALMOL, V87, P43, DOI 10.1016/0002-9394(79)90190-9
   GOLDBERG MF, 1979, OPHTHALMIC SURG LAS, V10, P17
   GREENWALD MJ, 1985, OPHTHALMIC SURG LAS, V16, P170
   Grissinger Matthew, 2007, Consult Pharm, V22, P646, DOI 10.4140/TCP.n.2007.646
   Guarascio AJ, 2013, CLINICOECONOMIC OUTC, V5, P235, DOI 10.2147/CEOR.S34321
   Gupta E, 2012, BREAST J, V18, P647, DOI 10.1111/tbj.12036
   Hasan MF, 1996, AM J GASTROENTEROL, V91, P1204
   Isaacson JE, 2003, AM FAM PHYSICIAN, V68, P1125
   Javed F, 2013, AM J MED SCI, V345, P234, DOI 10.1097/MAJ.0b013e318265b146
   Jovanovic-Bateman L, 2006, J LARYNGOL OTOL, V120, P627, DOI 10.1017/S0022215106001678
   Kaleyias J, 2008, J PEDIAT HEMATOL ONC, V30, P659, DOI 10.1097/MPH.0b013e31817eb7ef
   Kaloterakis A, 2001, HAEMATOLOGIA, V31, P153, DOI 10.1163/15685590152492963
   Karanja Benson Wahome, 2014, BMC Res Notes, V7, P138, DOI 10.1186/1756-0500-7-138
   Kemp JS, 1996, J PEDIAT HEMATOL ONC, V18, P104, DOI 10.1097/00043426-199605000-00002
   Klings ES, 2006, AM J RESP CRIT CARE, V173, P1264, DOI 10.1164/rccm.200601-125OC
   Koduri PR, 2001, AM J HEMATOL, V68, P298, DOI 10.1002/ajh.10001
   Kordes U, 2011, PEDIATR BLOOD CANCER, V56, P323, DOI 10.1002/pbc.22820
   LABI M, 1989, AM J HEMATOL, V32, P222, DOI 10.1002/ajh.2830320312
   Lê PQ, 2015, PEDIATR BLOOD CANCER, V62, P1956, DOI 10.1002/pbc.25608
   LEFF RD, 1983, ARTHRITIS RHEUM, V26, P928, DOI 10.1002/art.1780260718
   Lemonne N, 2012, AM J HEMATOL, V87, pE129, DOI 10.1002/ajh.23312
   Liebmann JM, 1996, J GLAUCOMA, V5, P271
   Liptzin B., 2014, PSYCHIAT TIMES
   LORENZEN K, 1979, LANCET, V1, P922
   Lykavieris P, 2006, J PEDIATR GASTR NUTR, V42, P104, DOI 10.1097/01.MPG.0000162480.81900.AF
   MacKeith SAC, 2013, J NEUROL SURG PART B, V74, P194, DOI 10.1055/s-0033-1342919
   MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353
   Mariño-Enriquez A, 2011, GENE CHROMOSOME CANC, V50, P146, DOI 10.1002/gcc.20839
   Marsh A, 2014, PEDIATR BLOOD CANCER, V61, P567, DOI 10.1002/pbc.24795
   Martinez-Maldonado M, 1976, Perspect Nephrol Hypertens, V3, P77
   Fernandes MLMF, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0052-4
   Merino I, 2009, BRIT J ANAESTH, V102, P283, DOI 10.1093/bja/aen374
   Mgbor N, 2004, INT J PEDIATR OTORHI, V68, P1413, DOI 10.1016/j.ijporl.2004.05.009
   Mokhlesi B, 2016, NEW ENGL J MED, V375, P994, DOI 10.1056/NEJMe1609704
   MORABITO F, 1987, TUMORI, V73, P523, DOI 10.1177/030089168707300517
   Mulimani P, 2016, COCHRANE DB SYST REV, V4
   *NAT ASTHM ED PREV, 2007, NIH PUBL
   NEMOTO R, 1991, CANCER, V67, P643, DOI 10.1002/1097-0142(19910201)67:3<643::AID-CNCR2820670320>3.0.CO;2-W
   Newaskar M, 2011, THESCIENTIFICWORLDJO, V11, P1138, DOI 10.1100/tsw.2011.105
   NICHOLSON DH, 1976, ARCH OPHTHALMOL-CHIC, V94, P927
   Nicoleau A, 1999, AM J HEMATOL, V60, P250, DOI 10.1002/(SICI)1096-8652(199903)60:3<250::AID-AJH21>3.0.CO;2-K
   O'Rourke CA, 1998, BRIT DENT J, V185, P90, DOI 10.1038/sj.bdj.4809735
   Obaro S, 2012, SEX TRANSM INFECT, V88, P533, DOI 10.1136/sextrans-2012-050613
   Onakoya P A, 2002, Afr J Med Med Sci, V31, P21
   ONEILL WM, 1993, PAIN, V54, P3, DOI 10.1016/0304-3959(93)90093-5
   OROURKE C, 1990, BRIT DENT J, V169, P130, DOI 10.1038/sj.bdj.4807296
   Osafo-Kwaako A, 2011, EUR J OPHTHALMOL, V21, P484, DOI 10.5301/EJO.2010.5977
   Patel J, 2014, BRIT J NEUROSURG, V28, P20, DOI 10.3109/02688697.2013.815323
   PHILLIPS G, 1988, AM J MED, V85, P567
   Piltcher O, 2000, AM J OTOLARYNG, V21, P75, DOI 10.1016/S0196-0709(00)85001-2
   PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303
   REYNOLDS MD, 1983, SEMIN ARTHRITIS RHEU, V12, P404, DOI 10.1016/0049-0172(83)90020-3
   Roehrs T, 2013, SLEEP MED, V14, P109, DOI 10.1016/j.sleep.2012.09.020
   ROTHSCHILD BM, 1980, ANN RHEUM DIS, V39, P392, DOI 10.1136/ard.39.4.392
   Saito N, 2011, AM J NEURORADIOL, V32, P2160, DOI 10.3174/ajnr.A2720
   Sarma P S, 1986, J Assoc Physicians India, V34, P877
   Sathyamoorthy K, 2006, NAT CLIN PRACT UROL, V3, P279, DOI 10.1038/ncpuro0483
   Schlesinger N, 2004, J RHEUMATOL, V31, P598
   Schultz WH, 2003, AM J HEMATOL, V74, P249, DOI 10.1002/ajh.10427
   Ségbéna AY, 2005, TRANSFUS CLIN BIOL, V12, P423, DOI 10.1016/j.tracli.2005.12.003
   Sellier P, 2009, AIDS, V23, P2362, DOI 10.1097/QAD.0b013e32833298a7
   Shetty A, 2014, OCHSNER J, V14, P270
   Costa CPS, 2013, J ENDODONT, V39, P177, DOI 10.1016/j.joen.2012.10.024
   Simon MC, 2016, N ENGL J MED
   Smith NE, 2014, AM J SURG PATHOL, V38, P858, DOI 10.1097/PAS.0000000000000179
   Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699
   STEINBERG MH, 1995, BLOOD, V86, P3997, DOI 10.1182/blood.V86.10.3997.bloodjournal86103997
   Steiner RM, 1996, NAT SICKL CELL PROGR
   STEINMANN W, 1983, AM J EPIDEMIOL, V118, P288, DOI 10.1093/oxfordjournals.aje.a113635
   STRICKER RB, 1986, AM J HEMATOL, V21, P223, DOI 10.1002/ajh.2830210212
   TERRY SI, 1987, J CLIN GASTROENTEROL, V9, P55, DOI 10.1097/00004836-198702000-00014
   Thomas Hywel, 2013, Nurs Times, V109, P16
   TODD GB, 1973, ACTA OTO-LARYNGOL, V76, P268, DOI 10.3109/00016487309121507
   Torpy Janet M, 2005, JAMA, V294, P1986, DOI 10.1001/jama.294.15.1986
   Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840
   van den Hazel SJ, 2003, TRANSPLANT INT, V16, P434, DOI 10.1007/s00147-003-0567-5
   Wierenga KJJ, 2001, LANCET, V357, P680, DOI 10.1016/S0140-6736(00)04132-5
   Wilson S, 2000, ANN INTERN MED, V133, P925, DOI 10.7326/0003-4819-133-11-200012050-00029
   Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030
   Zizza CA, 2009, J GERONTOL A-BIOL, V64, P481, DOI 10.1093/gerona/gln045
NR 137
TC 11
Z9 11
U1 0
U2 6
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2018
VL 68
IS 2-3
BP 129
EP 145
DI 10.3233/CH-189003
PG 17
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA GB3CP
UT WOS:000428933100003
PM 29614628
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Wu, JL
   Wu, QP
   Peng, YP
   Zhang, JM
AF Wu, J. -L.
   Wu, Q. -P.
   Peng, Y. -P.
   Zhang, J. -M.
TI Effects of L-Malate on Mitochondrial Oxidoreductases in Liver of Aged
   Rats
SO PHYSIOLOGICAL RESEARCH
LA English
DT Article
DE L-malate; Aging; Electron transport chain; Mitochondria
ID ELECTRON-TRANSPORT CHAIN; HYDROGEN-PEROXIDE RELEASE; ALPHA-LIPOIC ACID;
   OXIDATIVE DAMAGE; RESPIRATORY-CHAIN; L-CARNITINE; COMPLEXES; MEMBRANE;
   ENZYMES; SUBSTRATE
AB Accumulation of oxidative damage has been implicated to be a major causative factor in the decline in physiological functions that occur during the aging process. The mitochondrial respiratory chain is a powerful source of reactive oxygen species (ROS), considered as the pathogenic agent of many diseases and aging. L-malate, a tricarboxylic acid cycle intermediate, plays an important role in transporting NADH from cytosol to mitochondria for energy production. Previous studies in our laboratory reported L-malate as a free radical scavenger in aged rats. In the present study we focused on the effect of L-malate on the activities of electron transport chain in young and aged rats. We found that mitochondrial membrane potential (MMP) and the activities of succinate dehydrogenase, NADH-cytochrome c oxidoreductase and cytochrome c oxidase in liver of aged rats were significantly decreased when compared to young control rats. Supplementation of L-malate to aged rats for 30 days slightly increased MMP and improved the activities of NADH-dehydrogenase, NADH-cytochrome c oxidoreductase and cytochrome c oxidase in liver of aged rats when compared with aged control rats. In young rats, L-malate administration increased only the activity of NADH-dehydrogenase. Our result suggested that L-malate could improve the activities of electron transport chain enzymes in aged rats
C1 [Wu, J. -L.; Wu, Q. -P.; Zhang, J. -M.] Guangdong Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou 510070, Guangdong, Peoples R China.
   [Peng, Y. -P.] S China Univ Technol, Guangzhou Wondfo Biotech Co Ltd, Guangzhou, Guangdong, Peoples R China.
C3 Guangdong Academy of Sciences; Institute of Microbiology, Guangdong
   Academy of Sciences; South China University of Technology
RP Wu, QP (corresponding author), Guangdong Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou 510070, Guangdong, Peoples R China.
EM microwjl@yahoo.com; wuqp203@yahoo.com.cn
FU Foundation for the Talents of Guangdong Academy of Science; National
   Natural Science Foundation of China [31000762]
FX This study was supported by grants from the Foundation for the Talents
   of Guangdong Academy of Science and National Natural Science Foundation
   of China (31000762).
CR Arivazhagan P, 2001, CHEM-BIOL INTERACT, V138, P189, DOI 10.1016/S0009-2797(01)00268-X
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bendahan D, 2002, BRIT J SPORT MED, V36, P282, DOI 10.1136/bjsm.36.4.282
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   BOBYLEVAGUARRIE.B, 1986, ARCH BIOCHEM BIOPHYS, V245, P270
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cervinková Z, 2009, ARCH TOXICOL, V83, P363, DOI 10.1007/s00204-008-0385-8
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHAPPELL JB, 1968, BRIT MED BULL, V24, P150, DOI 10.1093/oxfordjournals.bmb.a070618
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Drew B, 2002, ANN NY ACAD SCI, V959, P66, DOI 10.1111/j.1749-6632.2002.tb02084.x
   Drouet M, 1999, EXP GERONTOL, V34, P843, DOI 10.1016/S0531-5565(99)00058-3
   Endlicher R, 2009, PHYSIOL RES, V58, P685, DOI 10.33549/physiolres.931635
   Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130
   FERGUSON SM, 1966, J BIOL CHEM, V241, P3696
   FernandezCheca JC, 1996, SEMIN LIVER DIS, V16, P147, DOI 10.1055/s-2007-1007228
   GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hagen TM, 2002, P NATL ACAD SCI USA, V99, P7184
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990
   Kalaiselvi T, 1998, J NUTR BIOCHEM, V9, P575, DOI 10.1016/S0955-2863(98)00052-7
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Kwong LK, 1998, ARCH BIOCHEM BIOPHYS, V350, P118, DOI 10.1006/abbi.1997.0489
   Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   Sandhu SK, 2003, BIOGERONTOLOGY, V4, P19, DOI 10.1023/A:1022473219044
   Savitha S, 2005, CLIN NUTR, V24, P794, DOI 10.1016/j.clnu.2005.04.005
   Scholz TD, 2000, J MOL CELL CARDIOL, V32, P1, DOI 10.1006/jmcc.1999.1047
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SMITH JA, 1993, J IMMUNOL METHODS, V162, P261, DOI 10.1016/0022-1759(93)90391-J
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Wu JL, 2008, PHYSIOL RES, V57, P261, DOI 10.33549/physiolres.931161
   Wu JL, 2007, PHYSIOL RES, V56, P213, DOI 10.33549/physiolres.930937
NR 42
TC 15
Z9 22
U1 0
U2 15
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PY 2011
VL 60
IS 2
BP 329
EP 336
DI 10.33549/physiolres.931986
PG 8
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 771KF
UT WOS:000291154900016
PM 21114358
OA gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Sato, Y
   Suzuki, Y
   Ito, E
   Shimazaki, S
   Ishida, M
   Yamamoto, T
   Yamamoto, H
   Toda, T
   Suzuki, M
   Suzuki, A
   Endo, T
AF Sato, Yuji
   Suzuki, Yusuke
   Ito, Emi
   Shimazaki, Sayaka
   Ishida, Masami
   Yamamoto, Takaki
   Yamamoto, Haruhiko
   Toda, Tosifusa
   Suzuki, Minoru
   Suzuki, Akemi
   Endo, Tamao
TI Identification and characterization of an increased glycoprotein in
   aging: Age-associated translocation of cathepsin D
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Proceedings Paper
CT 78th Annual Meeting of the Japanese-Biochemical-Society
CY OCT   21, 2005
CL Kobe, JAPAN
SP Japanese Biochem Soc
DE glycoprotein; 2-D PAGE; lectin; cathepsin D; translocation; brain; CNS
ID I HEAVY-CHAINS; RAT-BRAIN; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY;
   OXIDATIVE STRESS; DEGRADATION; MEMBRANE; ADULT; CELLS; BIOSYNTHESIS
AB We found that 14 N-glycosylated proteins were accumulated in the rat cerebral cortex cytosolic fraction in the aging process by a comparative study with two-dimensional gel electrophoresis and concanavalin A staining. All proteins had high mannose and/or hybrid-type N-glycans, as indicated by the fact that they were sensitive to endoglycosidase H digestion. Three of these cytosolic glycoproteins were identified as cathepsin D, a lysosomal protease, by tryptic digestion and nano liquid chromatography electrospray ionization quadrupole time of flight mass spectrometry. The increase of cytosolic cathepsin D during aging was not due to lysosomal membrane disruption, as shown by the fact that the activities of beta-hexosaminidase and beta-glucuronidase, other lysosomal enzymes, did not increase in the cytosolic fraction. Although the total amount of cathepsin D increased during aging, the amount of cathepsin D in the microsomal fraction did not change, indicating a selective increase of cytosolic cathepsin D. This phenomenon was also observed in the hippocampus, cerebellum, kidney, liver, and spleen. Based on these results, we propose that cytosolic cathepsin D is a new biomarker of aging. (c) 2006 Published by Elsevier Ireland Ltd.
C1 Tokyo Metropolitan Inst Gerontol, Fdn Res Aging & Promot Human Welf, Res Team Funct Genom, Itabashi Ku, Tokyo 1730015, Japan.
   Tokyo Metropolitan Inst Gerontol, Fdn Res Aging & Promot Human Welf, Res Team Mol Biomarkers, Itabashi Ku, Tokyo 1730015, Japan.
   RIKEN, Inst Phys & Chem Res, Sphingolipid Express Lab, Wako, Saitama 3510198, Japan.
   Kanagawa Univ, Fac Sci, Dept Biol Sci, Hiratsuka, Kanagawa 2591293, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan
   Institute of Gerontology; RIKEN; Kanagawa University
RP Endo, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Fdn Res Aging & Promot Human Welf, Res Team Funct Genom, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.
EM endo@tmig.or.jp
CR BANAYSCHWARTZ M, 1992, J NEUROCHEM, V58, P2207, DOI 10.1111/j.1471-4159.1992.tb10965.x
   Bednarski E, 1996, J NEUROCHEM, V67, P1846, DOI 10.1046/j.1471-4159.1996.67051846.x
   BERNSTEIN HG, 1987, ACTA HISTOCHEM, V82, P25, DOI 10.1016/S0065-1281(87)80045-4
   CHAMBERS JP, 1982, BIOCHEM BIOPH RES CO, V107, P1490, DOI 10.1016/S0006-291X(82)80167-8
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021
   Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785
   GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1
   Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210
   Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896
   Jung H, 1999, BRAIN RES, V844, P43, DOI 10.1016/S0006-8993(99)01888-0
   Kågedal K, 2001, FASEB J, V15, P1592, DOI 10.1096/fj.00-0708fje
   KENNESSEY A, 1989, J NEUROSCI RES, V23, P454
   Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200
   Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MIYAGI T, 1993, J BIOL CHEM, V268, P26435
   NAKAMURA Y, 1989, MECH AGEING DEV, V50, P215, DOI 10.1016/0047-6374(89)90101-2
   NAKANISHI H, 1994, EXP NEUROL, V126, P119, DOI 10.1006/exnr.1994.1048
   Nakanishi H, 1997, J NEUROCHEM, V68, P739
   NIXON RA, 1984, J NEUROCHEM, V43, P507, DOI 10.1111/j.1471-4159.1984.tb00928.x
   PEDEMONTE CH, 1990, P NATL ACAD SCI USA, V87, P9789, DOI 10.1073/pnas.87.24.9789
   Roberg K, 1998, AM J PATHOL, V152, P1151
   Römisch K, 1999, J CELL SCI, V112, P4185
   Sato Y, 2005, NEUROSCI LETT, V382, P22, DOI 10.1016/j.neulet.2005.02.053
   Sato Y, 2001, FEBS LETT, V496, P152, DOI 10.1016/S0014-5793(01)02421-8
   Sato Y, 2001, J HISTOCHEM CYTOCHEM, V49, P1311, DOI 10.1177/002215540104901014
   Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev
   SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802
   Toda T, 2000, ELECTROPHORESIS, V21, P1814, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1814::AID-ELPS1814>3.0.CO;2-#
   WIEDERANDERS B, 1984, MECH AGEING DEV, V24, P265, DOI 10.1016/0047-6374(84)90112-X
   Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5
   YAMAMOTO K, 1995, ADV EXP MED BIOL, V362, P223
   Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800
NR 34
TC 26
Z9 29
U1 1
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD OCT
PY 2006
VL 127
IS 10
BP 771
EP 778
DI 10.1016/j.mad.2006.07.001
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 095DO
UT WOS:000241288600003
PM 16914181
DA 2024-02-19
ER

PT J
AU Monnerat, G
   Seara, FAC
   Evaristo, JAM
   Carneiro, G
   Evaristo, GPC
   Domont, G
   Nascimento, JHM
   Mill, JG
   Nogueira, FCS
   de Carvalho, ACC
AF Monnerat, Gustavo
   Seara, Fernando A. C.
   Medeiros Evaristo, Joseph Albert
   Carneiro, Gabriel
   Caprini Evaristo, Geisa Paulino
   Domont, Gilberto
   Matheus Nascimento, Jose Hamilton
   Mill, Jose Geraldo
   Souza Nogueira, Fabio Cesar
   Campos de Carvalho, Antonio Carlos
TI Aging-related compensated hypogonadism: Role of metabolomic analysis in
   physiopathological and therapeutic evaluation
SO JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE Aging; Hypogonadism; Endocrinology; Mass spectrometry; Metabolomics;
   Testosterone; Steroid biochemistry
ID TESTOSTERONE REPLACEMENT THERAPY; LEYDIG-CELL STRUCTURE; BROWN-NORWAY
   RAT; ELDERLY-MEN; OLDER MEN; LUTEINIZING-HORMONE; DEFICIENT MICE; LC-MS;
   RISK; FIBROBLASTS
AB Aging is a complex process that increases the risk of chronic disease development. Hormonal and metabolic alterations occur with aging, such as androgen activity decrease. Studies aim to understand the role of testosterone replacement therapy (TRT) in males, however biomarkers and the metabolic responses to TRT are not well characterized. Therefore, the present study investigated TRT effect in young adult and aged rats by metabolomics. Male Wistar rats were divided into four groups: adult and adult + testo (6months), old and old + testo (25-27months). TRT animals received daily testosterone propionate (1 mg/kg/subcutaneous). TRT changed the testicular weight index decrease induced by aging but did not change the body weight and liver weight index. Sera were analyzed by liquid chromatograph high resolution mass spectrometry (LC-MS/MS). Testosterone was quantified by target LC-MS/MS. A total of 126 metabolites were detected with known identification altered by TRT by non-target metabolomics analysis. Multivariate statistics shows that all groups segregated individually after principal component analysis. The treatment with testosterone induced several metabolic alterations in adult and old rats that were summarized by variable importance on projection score, metabolite interaction and pathway analysis. Aging-related hypogonadism induces a pattern of systemic metabolic alterations that can be partially reversed by TRT, however, this treatment in aged rats induces novel alterations in some metabolites that are possible new targets for monitoring in patients submitted to TRT.
C1 [Monnerat, Gustavo; Seara, Fernando A. C.; Matheus Nascimento, Jose Hamilton; Campos de Carvalho, Antonio Carlos] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Medeiros Evaristo, Joseph Albert; Carneiro, Gabriel; Caprini Evaristo, Geisa Paulino; Souza Nogueira, Fabio Cesar] Univ Fed Rio de Janeiro, Prote Lab, LADETEC, Inst Chem, Rio De Janeiro, Brazil.
   [Domont, Gilberto; Souza Nogueira, Fabio Cesar] Univ Fed Rio de Janeiro, Prote Unit, Inst Chem, Rio De Janeiro, Brazil.
   [Mill, Jose Geraldo] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Brazil.
C3 Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de
   Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do
   Espirito Santo
RP Monnerat, G (corresponding author), IBCCF UFRJ, Av Carlos Chagas Filho 373 CCS Bloco G, BR-21941902 Rio De Janeiro, Brazil.
EM gmc@biof.ufrj.br
RI Seara, Fernando Azevedo Cruz/T-7443-2019; de Carvalho, Antonio Carlos
   Campos/A-3152-2008; Monnerat, Gustavo/J-6907-2019; Nascimento, Jose
   Hamilton M/L-3722-2018; Seara, Fernando A. C./J-1366-2018; Nogueira,
   Fabio/G-9580-2011; monnerat, gustavo/E-3398-2015
OI Seara, Fernando Azevedo Cruz/0000-0003-4772-5618; de Carvalho, Antonio
   Carlos Campos/0000-0002-0062-3043; Nascimento, Jose Hamilton
   M/0000-0001-7052-254X; Seara, Fernando A. C./0000-0003-4772-5618;
   Nogueira, Fabio/0000-0001-5507-7142; monnerat,
   gustavo/0000-0002-1010-6314
FU Brazilian National Research Council (CNPq); Carlos Chagas Filho Rio de
   Janeiro State Research Foundation (FAPERJ); Regenerative Medicine
   National Institute of Science and Technology (INCT-Regenera); CNPq
FX This work was funded by the Brazilian National Research Council (CNPq),
   the Carlos Chagas Filho Rio de Janeiro State Research Foundation
   (FAPERJ) and Regenerative Medicine National Institute of Science and
   Technology (INCT-Regenera). GM has a postdoctoral fellowship from CNPq.
CR Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485
   Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376
   Chahal HS, 2007, J PATHOL, V211, P173, DOI 10.1002/path.2110
   Cheng S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7791
   Corona G, 2014, EXPERT OPIN DRUG SAF, V13, P1327, DOI 10.1517/14740338.2014.950653
   Dallmeyer S, 2017, EUR REV AGING PHYS A, V14, DOI 10.1186/s11556-017-0187-1
   Deda O., 2017, METABOLITES, V7
   Dohle GR, 2012, ACTAS UROL ESP, V36, P276, DOI 10.1016/j.acuro.2012.01.005
   Emwas Abdul-Hamid M, 2015, Methods Mol Biol, V1277, P161, DOI 10.1007/978-1-4939-2377-9_13
   EWING LL, 1983, RECENT PROG HORM RES, V39, P599
   EWING LL, 1983, ENDOCRINOLOGY, V112, P1763, DOI 10.1210/endo-112-5-1763
   Ferrando AA, 2003, J CLIN ENDOCR METAB, V88, P358, DOI 10.1210/jc.2002-021041
   Giavalisco P, 2009, ANAL CHEM, V81, P6546, DOI 10.1021/ac900979e
   Gooren L, 2003, J STEROID BIOCHEM, V85, P349, DOI 10.1016/S0960-0760(03)00206-1
   Grech A, 2014, THER ADV DRUG SAF, V5, P190, DOI 10.1177/2042098614548680
   Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701
   GRUENEWALD DA, 1994, J GERONTOL, V49, pB42, DOI 10.1093/geronj/49.2.B42
   Haring R, 2012, J ENDOCRINOL, V215, P3, DOI 10.1530/JOE-12-0119
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huber G, 2002, J CLIN ENDOCR METAB, V87, P3221, DOI 10.1210/jc.87.7.3221
   JOHNSEN S G, 1970, Hormones (Basel), V1, P2, DOI 10.1159/000178170
   Kelly DM, 2014, LIFE SCI, V109, P95, DOI 10.1016/j.lfs.2014.06.007
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395
   Leder BZ, 2007, J STEROID BIOCHEM, V106, P162, DOI 10.1016/j.jsbmb.2007.05.018
   Markley JL, 2017, CURR OPIN BIOTECH, V43, P34, DOI 10.1016/j.copbio.2016.08.001
   McBride JA, 2016, THER ADV UROL, V8, P47, DOI 10.1177/1756287215612961
   Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708
   Pitteloud N, 2008, J CLIN ENDOCR METAB, V93, P784, DOI 10.1210/jc.2007-2156
   Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395
   Pongkan W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122503
   Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958
   Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0
   Shen JJ, 2000, J INHERIT METAB DIS, V23, P27, DOI 10.1023/A:1005694712583
   Souza NS, 2016, CLIN EXP PHARMACOL P, V43, P476, DOI 10.1111/1440-1681.12543
   Spiekerkoetter U, 2004, EUR J CLIN INVEST, V34, P191, DOI 10.1111/j.1365-2362.2004.01308.x
   Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001
   Swerdloff R, 2011, J CLIN ENDOCR METAB, V96, P62, DOI 10.1210/jc.2010-2538
   Tresguerres JAF, 2008, J STEROID BIOCHEM, V108, P318, DOI 10.1016/j.jsbmb.2007.09.010
   van den Beld AW, 2000, J CLIN ENDOCR METAB, V85, P3276, DOI 10.1210/jc.85.9.3276
   WANG C, 1993, ENDOCRINOLOGY, V133, P2773, DOI 10.1210/en.133.6.2773
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   Wojtovich AP, 2008, BBA-BIOENERGETICS, V1777, P882, DOI 10.1016/j.bbabio.2008.03.025
   Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972
   Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101
   Wudy S.A., 2017, J STEROID BIOCH MOL
   Wudy SA, 2016, J STEROID BIOCHEM, V162, P1, DOI 10.1016/j.jsbmb.2016.05.010
   Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11
   Zhou B, 2012, MOL BIOSYST, V8, P470, DOI 10.1039/c1mb05350g
NR 50
TC 23
Z9 24
U1 1
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0760
J9 J STEROID BIOCHEM
JI J. Steroid Biochem. Mol. Biol.
PD OCT
PY 2018
VL 183
BP 39
EP 50
DI 10.1016/j.jsbmb.2018.05.005
PG 12
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA GU9YX
UT WOS:000445714300005
PM 29920416
DA 2024-02-19
ER

PT J
AU Gallone, A
   Sagliano, A
   Guida, G
   Ito, S
   Wakamatsu, K
   Capozzi, V
   Perna, G
   Zanna, P
   Cicero, R
AF Gallone, A.
   Sagliano, A.
   Guida, G.
   Ito, S.
   Wakamatsu, K.
   Capozzi, V.
   Perna, G.
   Zanna, P.
   Cicero, R.
TI The melanogenic system of the liver pigmented macrophages of <i>Rana
   esculenta</i> L. -: Tyrosinase activity
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Article
DE pigmented Kupffer cells; melanogenesis; tyrosine-hydroxylase activity;
   tyrosinase; melanins
ID DETERGENT-ACTIVATED TYROSINASE; KUPFFER CELLS; HEPATIC MELANOGENESIS;
   CHEMICAL DEGRADATION; COPPER TRANSFER; XENOPUS-LAEVIS; MELANIN;
   PEROXIDASE; EUMELANIN; HAIR
AB The enzyme system responsible for Amphibian Kupffer Cell ( KC) melanogenesis has not been entirely elucidated. This research demonstrates that the KC melanosomes of Rana esculenta L. possess a tyrosine- hydroxylase ( TH) activity, showing that a tyrosinase is the enzyme involved in the melanogenesis.
   The TH reaction depends on catalytic Dopa as a cofactor and is not affected by catalase or H2O2, showing that it is catalysed by the tyrosinase and not by the peroxidase present in the melanosomes. The TH reaction is activated by Cu2+ ions but not by other tyrosinase activators such as limited proteolysis, protein ageing, and Sodium Dodecyl Sulphate ( SDS). SDS inhibited the KC TH activity even below the critical micelle concentration. All these results suggest that the KC- tyrosinase differs in structure from other known tyrosinases.
   Using anti- KC- tyrosinase antobodies, we observed that the sites of the tyrosinase location within the cell are the same as those described in the melanocytes. In the immunoblots, the anti- KC- tyrosinase antibodies also recognised two protein bands, at the higher molecular weight ranges, in the protein electrophoretic pattern. Moreover, the tyrosinase activity was limited to the highest molecular weight band of about 260 kDa, suggesting that the enzyme activity could depend on a molecular aggregate. The melanin produced in the liver was found to be a 5,6- dihydroxyindole- rich eumelanin similar to the Sepia melanin.
C1 Univ Bari, Fac Med & Chirurg, Dipartimento Biochim Med Biol Med & Fis Med, I-70124 Bari, Italy.
   Univ Study Foggia, Fac Med & Chirurg, Dipartimento Sci Biomed, Foggia, Italy.
   Univ Study Foggia, Ctr Ric Interdept Bioagromed, Foggia, Italy.
   Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Toyoake, Aichi, Japan.
C3 Universita degli Studi di Bari Aldo Moro; University of Foggia;
   University of Foggia; Fujita Health University
RP Cicero, R (corresponding author), Univ Bari, Fac Med & Chirurg, Dipartimento Biochim Med Biol Med & Fis Med, PIazza Giulio Cesare, I-70124 Bari, Italy.
EM r.cicero@biolgene.uniba.it
RI Wakamatsu, Kazumasa/AAZ-5877-2020; Gallone, Anna/K-5384-2018; Perna,
   Giuseppe/AET-7080-2022
OI Wakamatsu, Kazumasa/0000-0003-1748-9001; Gallone,
   Anna/0000-0002-2252-9584; Guida, Gabriella/0000-0003-2345-2838; Ito,
   Shosuke/0000-0001-9182-5144; PERNA, GIUSEPPE/0000-0001-8315-0634
CR Agius C, 2003, J FISH DIS, V26, P499, DOI 10.1046/j.1365-2761.2003.00485.x
   Bani G., 1966, Bollettino di Zoologia, V33, P269
   Barni S, 1999, J ANAT, V195, P19, DOI 10.1046/j.1469-7580.1999.19510019.x
   BELTRAMINI M, 1982, FEBS LETT, V142, P219, DOI 10.1016/0014-5793(82)80138-5
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Capozzi V, 2005, J MOL STRUCT, V744, P717, DOI 10.1016/j.molstruc.2004.11.074
   CHEN LY, 1992, J BIOL CHEM, V267, P20100
   CICERO R, 1990, COMP BIOCHEM PHYS B, V96, P393, DOI 10.1016/0305-0491(90)90394-9
   CICERO R, 1982, COMP BIOCHEM PHYS A, V73, P477, DOI 10.1016/0300-9629(82)90188-8
   Cicero R, 1977, Boll Soc Ital Biol Sper, V53, P1772
   CICERO R, 1989, PIGM CELL RES, V2, P100, DOI 10.1111/j.1600-0749.1989.tb00169.x
   Clancy CMR, 2000, J PHYS CHEM B, V104, P7871, DOI 10.1021/jp001630q
   CORSARO C, 1975, B SOC ITAL BIOL SPER, V51, P1663
   CORSARO C, 1990, PIGM CELL RES, V3, P120, DOI 10.1111/j.1600-0749.1990.tb00331.x
   Corsaro C, 2000, J ANAT, V196, P249, DOI 10.1046/j.1469-7580.2000.19620249.x
   DAVID H, 1963, ACTA BIOL MED GER, V10, P663
   FITZPATRICK TB, 1966, SCIENCE, V152, P88, DOI 10.1126/science.152.3718.88
   Frangioni G, 2000, J EXP ZOOL, V287, P120, DOI 10.1002/1097-010X(20000701)287:2<120::AID-JEZ2>3.3.CO;2-Y
   Frangioni G, 2005, J EXP ZOOL PART A, V303A, P123, DOI 10.1002/jez.a.137
   Gallone A, 2002, PIGM CELL RES, V15, P32, DOI 10.1034/j.1600-0749.2002.00052.x
   GARCIABORRON JC, 1982, ANAL BIOCHEM, V125, P277, DOI 10.1016/0003-2697(82)90007-0
   GEREMIA E, 1984, COMP BIOCHEM PHYS B, V79, P67, DOI 10.1016/0305-0491(84)90078-6
   Guida G, 2004, PIGM CELL RES, V17, P128, DOI 10.1046/j.1600-0749.2003.00118.x
   Guida G, 2000, PIGM CELL RES, V13, P431, DOI 10.1034/j.1600-0749.2000.130604.x
   Guida G, 1998, IN VITRO CELL DEV-AN, V34, P393
   IMBERTY A, 1984, PLANT SCI LETT, V35, P103, DOI 10.1016/0304-4211(84)90182-2
   Ito S, 1998, PIGM CELL RES, V11, P120, DOI 10.1111/j.1600-0749.1998.tb00721.x
   ITO S, 1985, ANAL BIOCHEM, V144, P527, DOI 10.1016/0003-2697(85)90150-2
   Ito S, 1998, PIGMENTARY SYSTEM PH, P439
   Jiménez-Cervantes C, 1998, BIOCHEM BIOPH RES CO, V253, P761, DOI 10.1006/bbrc.1998.9817
   Kobayashi T, 1998, J BIOL CHEM, V273, P31801, DOI 10.1074/jbc.273.48.31801
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LERNER AB, 1949, J BIOL CHEM, V178, P185
   Liu Y, 2004, PIGM CELL RES, V17, P262, DOI 10.1111/j.1600-0749.2004.00140.x
   Liu Y, 2003, PIGM CELL RES, V16, P355, DOI 10.1034/j.1600-0749.2003.00059.x
   López-Serrano D, 2002, PIGM CELL RES, V15, P104
   MARTINEZ JH, 1987, BIOCHIM BIOPHYS ACTA, V923, P413, DOI 10.1016/0304-4165(87)90049-3
   MASON HS, 1948, J BIOL CHEM, V172, P83
   NICOLAUS RA, 1964, TETRAHEDRON, V20, P1163, DOI 10.1016/S0040-4020(01)98983-5
   Okun MR, 1997, PHYSIOL CHEM PHYS ME, V29, P15
   OKUN MR, 1974, LAB INVEST, V30, P681
   OKUN MR, 1982, PHYSIOL CHEM PHYS M, V14, P8
   ORLOW SJ, 1998, PIGMENTARY SYSTEM PH, P97
   OZEKI H, 1995, J INVEST DERMATOL, V105, P361, DOI 10.1111/1523-1747.ep12320792
   PALUMBO A, 1995, BBA-PROTEIN STRUCT M, V1247, P173, DOI 10.1016/0167-4838(94)00221-2
   PENAFIEL R, 1982, BIOCHEM J, V205, P397, DOI 10.1042/bj2050397
   Perna G, 2005, PHYS SCRIPTA, VT118, P89, DOI 10.1238/Physica.Topical.118a00089
   PIATTELLI M, 1962, TETRAHEDRON, V18, P941, DOI 10.1016/S0040-4020(01)92747-4
   PINTUCCI G, 1990, IN VITRO CELL DEV B, V26, P659, DOI 10.1007/BF02624421
   Powell BJ, 2004, J CHEM PHYS, V120, P8608, DOI 10.1063/1.1690758
   Purrello M, 2001, PIGM CELL RES, V14, P126, DOI 10.1034/j.1600-0749.2001.140208.x
   Raper HS, 1927, BIOCHEM J, V21, P89, DOI 10.1042/bj0210089
   SARNA T, 1986, BIOCHIM BIOPHYS ACTA, V883, P162, DOI 10.1016/0304-4165(86)90147-9
   SCALIA M, 1988, COMP BIOCHEM PHYS B, V89, P715, DOI 10.1016/0305-0491(88)90313-6
   SCALIA M, 1990, PIGM CELL RES, V3, P115, DOI 10.1111/j.1600-0749.1990.tb00330.x
   SCHRAERMEYER U, 1994, CELL TISSUE RES, V276, P273, DOI 10.1007/BF00306113
   SCIUTO S, 1988, COMP BIOCHEM PHYS B, V90, P397, DOI 10.1016/0305-0491(88)90095-8
   Sichel G, 1997, PIGM CELL RES, V10, P271, DOI 10.1111/j.1600-0749.1997.tb00687.x
   SICHEL G, 1988, PIGM CELL RES, V1, P250, DOI 10.1111/j.1600-0749.1988.tb00423.x
   SICHEL G, 1948, MONIT ZOOL ITAL S, V57, P3
   TAKASE M, 1992, GENE, V121, P359
   VALVERDE P, 1992, ARCH BIOCHEM BIOPHYS, V297, P221, DOI 10.1016/0003-9861(92)90665-J
   Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x
   Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x
   WITTENBERG C, 1985, J BIOL CHEM, V260, P2535
   WITTENBERG C, 1985, J BIOL CHEM, V260, P2542
   Zuasti A, 1998, ARCH HISTOL CYTOL, V61, P305, DOI 10.1679/aohc.61.305
NR 67
TC 16
Z9 19
U1 0
U2 4
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
EI 1699-5848
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD OCT
PY 2007
VL 22
IS 10
BP 1065
EP 1075
PG 11
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA 186CS
UT WOS:000247757300002
PM 17616933
DA 2024-02-19
ER

PT J
AU Valente, M
   Calabrese, F
AF Valente, M
   Calabrese, F
TI Liver and apoptosis
SO ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE apoptosis; liver
ID HUMAN HEPATOCELLULAR-CARCINOMA; NUCLEAR-DNA FRAGMENTATION; PRIMARY
   BILIARY-CIRRHOSIS; FAS ANTIGEN EXPRESSION; VIRUS CORE PROTEIN;
   HEPATITIS-C; CELL-DEATH; IMMUNOHISTOCHEMICAL DETECTION; MEDIATED
   APOPTOSIS; BCL-2 PROTEIN
AB Apoptosis is an energy-requiring mechanism of cell death which is a physiological event in organ morphogenesis, clone selection of lymphoid cells and cell turnover; but also occurs in many pathological conditions. It is under genetic control, bcl-2 being the major apoptosis suppressing gene, while p53 and c-myc are apoptosis promoting genes. Other factors, such as the Fas/Fas1 system, the caspases cascade, cytokines and enzymes also play a role in determining apoptosis.;The term apoptosis was introduced by Kerr to describe this type of death in ischaemic mt liver; and the same Councilman bodies are now considered an example of apoptotic death. Virus-infected hepatocytes bear Fas receptors and apoptosis is induced by binding to the Fas ligand which is expressed by activated T cells; this action is probably mediated by enzymes of the caspase family and/or by granzyme B. The Fas/Fas1 system is also involved in apoptosis occurring in chronic non suppurative destructive cholangitis, in transplant rejection and in other liver diseases, including neoplasms; in the latter Bcl-2 protein and mutations of p53 also seem to play an important role. Cytokines ape also frequently involved Toxins like alcohol probably induce apoptosis by producing active oxidants. Whether aging enhances apopstosis in liver is still controversial. Although many molecular mechanisms have been suggested to be involved the switch on/off of apoptosis of apoptosis is still poorly understood and will be a matter of further investigations.
C1 Univ Padua, Sch Med, Dept Pathol, Padua, Italy.
C3 University of Padua
RP Valente, M (corresponding author), Ist Anat Patol, Via A Gabelli 61, I-35121 Padua, Italy.
OI Valente, Marialuisa/0000-0002-3662-2878
CR AFFORD SC, 1995, J PATHOL, V176, P373, DOI 10.1002/path.1711760408
   Brown R, 1997, BRIT MED BULL, V53, P466
   Calabrese F, 1997, J PATHOL, V183, P477
   CALABRESE F, 1997, J HEPATOL, V26, pA90
   CHARLOTTE F, 1994, AM J PATHOL, V144, P460
   COLETTI LM, 1990, J CLIN INVEST, V85, P1936
   ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cellbio.7.1.663
   Feldmann G, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80491-6
   FESUS L, 1989, FEBS LETT, V245, P150, DOI 10.1016/0014-5793(89)80210-8
   GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223
   Gapany C, 1997, J HEPATOL, V26, P535, DOI 10.1016/S0168-8278(97)80418-7
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GraslKraupp B, 1997, HEPATOLOGY, V25, P906, DOI 10.1002/hep.510250420
   Halsted CH, 1996, HEPATOLOGY, V23, P497, DOI 10.1002/hep.510230314
   HARJIMOHAMADREZ.I, 1997, PROGR DRUG RES, V48, P55
   Higaki K, 1996, AM J PATHOL, V149, P429
   Higami Y, 1997, AM J PATHOL, V151, P659
   HIRAMATSU N, 1994, HEPATOLOGY, V19, P1354, DOI 10.1002/hep.1840190606
   Kano A, 1997, J BIOCHEM-TOKYO, V121, P677
   KAWAHARA H, 1994, INT HEPATOL COMMUN, V2, P321, DOI 10.1016/0928-4346(94)90027-2
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Koga H, 1997, HEPATOLOGY, V25, P1077, DOI 10.1002/hep.510250505
   Kuroki T, 1996, VIRCHOWS ARCH, V429, P119
   Kurose I, 1997, HEPATOLOGY, V25, P368
   MAJINO G, 1995, AM J PATHOL, V146, P3
   MITA E, 1994, BIOCHEM BIOPH RES CO, V204, P468, DOI 10.1006/bbrc.1994.2483
   Mochizuki K, 1996, J HEPATOL, V24, P1, DOI 10.1016/S0168-8278(96)80178-4
   Nagata S, 1996, Prog Mol Subcell Biol, V16, P87
   NARGY P, 1991, HEPATOLOGY, V14, P269
   PATEL T, 1995, HEPATOLOGY, V21, P1725, DOI 10.1002/hep.1840210635
   Ray RB, 1996, VIROLOGY, V226, P176, DOI 10.1006/viro.1996.0644
   Rouquet N, 1996, BIOCHEM BIOPH RES CO, V229, P27, DOI 10.1006/bbrc.1996.1753
   Ruggieri A, 1997, VIROLOGY, V229, P68, DOI 10.1006/viro.1996.8420
   Saile B, 1997, AM J PATHOL, V151, P1265
   Shimamatsu K, 1997, HEPATOLOGY, V26, P343, DOI 10.1002/hep.510260214
   Spengler U, 1996, CYTOKINE, V8, P864, DOI 10.1006/cyto.1996.0115
   Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361
   Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744
   Tang Dean G, 1996, Pathol Oncol Res, V2, P117
   TERADA T, 1995, AM J PATHOL, V146, P67
   Thornberry NA, 1997, BRIT MED BULL, V53, P478
   Tiegs G, 1997, ACTA GASTRO-ENT BELG, V60, P176
   Valente M, 1998, AM J PATHOL, V152, P479
   WANG XW, 1995, CANCER RES, V55, P6012
   Warner HR, 1997, CURR TOP CELL REGUL, V35, P107, DOI 10.1016/S0070-2137(97)80004-0
   Zhao M, 1997, J CLIN PATHOL, V50, P394, DOI 10.1136/jcp.50.5.394
NR 46
TC 14
Z9 14
U1 0
U2 1
PU PACINI EDITORE
PI OSPEDALETTO PISA
PA VIA DELLA GHERARDESCA-ZONA INDUSTRIALE, 56014 OSPEDALETTO PISA, ITALY
SN 1125-8055
J9 ITAL J GASTROENTEROL
JI Ital. J. Gastroenterol. Hepatol.
PD JAN-FEB
PY 1999
VL 31
IS 1
BP 73
EP 77
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 177KV
UT WOS:000079209900014
PM 10091108
DA 2024-02-19
ER

PT J
AU González-Hedström, D
   Amor, S
   de la Fuente-Fernández, M
   Tejera-Muñoz, A
   Priego, T
   Martín, AI
   López-Calderón, A
   Inarejos-García, AM
   García-Villalón, AL
   Granado, M
AF Gonzalez-Hedstrom, Daniel
   Amor, Sara
   de la Fuente-Fernandez, Maria
   Tejera-Munoz, Antonio
   Priego, Teresa
   Isabel Martin, Ana
   Lopez-Calderon, Asuncion
   Manuel Inarejos-Garcia, Antonio
   Luis Garcia-Villalon, Angel
   Granado, Miriam
TI A Mixture of Algae and Extra Virgin Olive Oils Attenuates the
   Cardiometabolic Alterations Associated with Aging in Male Wistar Rats
SO ANTIOXIDANTS
LA English
DT Article
DE aging; omega 3 fatty acids; extra virgin olive oil; insulin resistance;
   cardiovascular; inflammation; oxidative stress; endothelial dysfunction
ID AGE-RELATED INFLAMMATION; FATTY-ACID-COMPOSITION; NITRIC-OXIDE SYNTHASE;
   ENDOTHELIAL FUNCTION; INSULIN-RESISTANCE; DOCOSAHEXAENOIC ACID;
   METABOLIC SYNDROME; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; OMEGA-3
AB Aging is one of the major risk factors for suffering cardiovascular and metabolic diseases. Due to the increase in life expectancy, there is a strong interest in the search for anti-aging strategies to treat and prevent these aging-induced disorders. Both omega 3 polyunsaturated fatty acids (omega-3 PUFA) and extra virgin olive oil (EVOO) exert numerous metabolic and cardiovascular benefits in the elderly. In addition, EVOO constitutes an interesting ingredient to stabilize omega-3 PUFA and decrease their oxidation process due to its high content in antioxidant compounds. omega-3 PUFA are commonly obtained from fish. However, more ecological and sustainable sources, such as algae oil (AO) can also be used. In this study, we aimed to study the possible beneficial effect of an oil mixture composed by EVOO (75%) and AO (25%) rich in omega-3 PUFA (35% docosahexaenoic acid (DHA) and 20% eicosapentaenoic acid (EPA)) on the cardiometabolic alterations associated with aging. For this purpose; young (three months old) and old (24 months old) male Wistar rats were treated with vehicle or with the oil mixture (2.5 mL/kg) for 21 days. Treatment with the oil mixture prevented the aging-induced increase in the serum levels of saturated fatty acids (SFA) and the aging-induced decrease in the serum concentrations of mono-unsaturated fatty acids (MUFA). Old treated rats showed increased serum concentrations of EPA and DHA and decreased HOMA-IR index and circulating levels of total cholesterol, insulin and IL-6. Treatment with the oil mixture increased the mRNA levels of antioxidant and insulin sensitivity-related enzymes, as well as reduced the gene expression of pro-inflammatory markers in the liver and in cardiac and aortic tissues. In addition, the treatment also prevented the aging-induced endothelial dysfunction and vascular insulin resistance through activation of the PI3K/Akt pathway. Moreover, aortic rings from old rats treated with the oil mixture showed a decreased response to the vasoconstrictor AngII. In conclusion, treatment with a mixture of EVOO and AO improves the lipid profile, insulin sensitivity and vascular function in aged rats and decreases aging-induced inflammation and oxidative stress in the liver, and in the cardiovascular system. Thus, it could be an interesting strategy to deal with cardiometabolic alterations associated with aging.
C1 [Gonzalez-Hedstrom, Daniel; Amor, Sara; de la Fuente-Fernandez, Maria; Tejera-Munoz, Antonio; Luis Garcia-Villalon, Angel; Granado, Miriam] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid 28029, Spain.
   [Gonzalez-Hedstrom, Daniel; Manuel Inarejos-Garcia, Antonio] Pharmact Biotech Prod SL, Parque Cientif Madrid,Ave Doctor Severo Ochoa, Madrid 28108, Spain.
   [Priego, Teresa; Isabel Martin, Ana; Lopez-Calderon, Asuncion] Univ Complutense Madrid, Fac Med, Dept Fisiol, Madrid 28040, Spain.
   [Granado, Miriam] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid 28029, Spain.
C3 Autonomous University of Madrid; Complutense University of Madrid; CIBER
   - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud
   Carlos III
RP Granado, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid 28029, Spain.; Granado, M (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid 28029, Spain.
EM dgonzalez@pharmactive.eu; sara.amor@uam.es; maria.delafuente@uam.es;
   antonio.tejera@quironsalud.es; tpriegoc@med.ucm.es;
   anabelmartin@med.ucm.es; alc@med.ucm.es; aminarejos@hotmail.com;
   angeluis.villalon@uam.es; miriam.granado@uam.es
RI Tejera-Munoz, Antonio/R-8513-2017; Granado, Miriam/B-8978-2017; Martin,
   Ana Isabel/K-5301-2014; Lopez-Calderon, Asuncion/H-2442-2017
OI Tejera-Munoz, Antonio/0000-0002-7954-5753; Granado,
   Miriam/0000-0001-9178-8822; Gonzalez-Hedstrom,
   Daniel/0000-0001-9425-1115; Martin, Ana Isabel/0000-0002-4445-590X;
   Lopez-Calderon, Asuncion/0000-0003-0716-6276
FU Community of Madrid (Spain) [IND2017/BIO7701]; Community of Madrid
   [PEJ-2018-AI/SAL-11315]
FX This project was funded by the call "Doctorados Industriales 2017"
   (IND2017/BIO7701), a grant from Community of Madrid (Spain). This
   program aims to promote the effective collaboration between Universities
   and Companies and provides funding for the development of the research
   project at the University and, to hire a PhD student (Daniel
   Gonzalez-Hedstrom) by the Company (Pharmactive Biotech Products S.L.)
   over a three-year period. Community of Madrid also funded the contract
   of Maria de la Fuente-Fernandez through the Youth Employment Program
   (PEJ-2018-AI/SAL-11315).
CR Acharya P, 2019, INFLAMMATION, V42, P946, DOI 10.1007/s10753-018-0949-6
   Adarme-Vega TC, 2014, CURR OPIN BIOTECH, V26, P14, DOI 10.1016/j.copbio.2013.08.003
   Al-Shudiefat AAR, 2013, MOL CELL BIOCHEM, V372, P75, DOI 10.1007/s11010-012-1447-z
   Albracht-Schulte K, 2018, J NUTR BIOCHEM, V58, P1, DOI 10.1016/j.jnutbio.2018.02.012
   Amor S, 2018, EXP GERONTOL, V109, P126, DOI 10.1016/j.exger.2017.10.017
   Anderson Rozalyn M., 2007, V35, P18
   Arnold LE, 2017, J CHILD ADOL PSYCHOP, V27, P223, DOI 10.1089/cap.2016.0123
   Bhattacharjee B, 2020, LIFE SCI, V244, DOI 10.1016/j.lfs.2020.117324
   Buckland G, 2012, AM J CLIN NUTR, V96, P142, DOI 10.3945/ajcn.111.024216
   Chan SH, 2016, J BIOCHEM, V160, P217, DOI 10.1093/jb/mvw028
   CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
   Covas MI, 2015, BRIT J NUTR, V113, pS19, DOI 10.1017/S0007114515000136
   Craddock JC, 2017, J HUM NUTR DIET, V30, P693, DOI 10.1111/jhn.12474
   DAVDA RK, 1995, HYPERTENSION, V26, P764, DOI 10.1161/01.HYP.26.5.764
   DiNicolantonio James J, 2017, Mo Med, V114, P303
   Drenjancevic-Peric I, 2011, KIDNEY BLOOD PRESS R, V34, P1, DOI 10.1159/000320387
   Drews B, 2018, THERIOGENOLOGY, V114, P258, DOI 10.1016/j.theriogenology.2018.04.003
   Farooq MA, 2020, BIOCHEM PHARMACOL, V173, DOI 10.1016/j.bcp.2019.113749
   Flori L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11091962
   Food and Agriculture Organization of the United Nations, 2018, The State of World Fisheries and Aquaculture
   Gaertner S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030920
   Gao HQ, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0528-0
   Ghanbari R, 2012, INT J MOL SCI, V13, P3291, DOI 10.3390/ijms13033291
   Goldberg EL, 2015, IMMUNOL REV, V265, P63, DOI 10.1111/imr.12295
   Gonzalez-Hedstrom E.A.D., PROTECTIVE EFF UNPUB
   Goodfellow J, 2000, J AM COLL CARDIOL, V35, P265, DOI 10.1016/S0735-1097(99)00548-3
   Gorzynik-Debicka M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030686
   Granado M, 2019, NUTR METAB CARDIOVAS, V29, P97, DOI 10.1016/j.numecd.2018.09.005
   Gremmels H, 2015, EUR J PHARMACOL, V751, P67, DOI 10.1016/j.ejphar.2015.01.005
   Guarner V, 2012, AGING DIS, V3, P269
   Halade GV, 2010, J IMMUNOL, V184, P5280, DOI 10.4049/jimmunol.0903282
   Harris William S, 2010, Curr Cardiol Rep, V12, P503, DOI 10.1007/s11886-010-0141-6
   Hart CM, 1997, EXP LUNG RES, V23, P405, DOI 10.3109/01902149709039235
   Hellhammer J, 2012, NUTR RES, V32, P241, DOI 10.1016/j.nutres.2012.03.003
   Heshmati J, 2019, PHARMACOL RES, V149, DOI 10.1016/j.phrs.2019.104462
   Innes JK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041362
   Jimenez-Gomez Yolanda, 2009, Atherosclerosis, V204, pe70, DOI 10.1016/j.atherosclerosis.2008.09.011
   Kalupahana NS, 2011, ADV NUTR, V2, P304, DOI 10.3945/an.111.000505
   KENNY D, 1992, AM J CARDIOL, V70, P1347, DOI 10.1016/0002-9149(92)90773-R
   Khan F, 2003, CARDIOVASC RES, V59, P955, DOI 10.1016/S0008-6363(03)00395-X
   Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371
   Kim OY, 2013, NUTR METAB CARDIOVAS, V23, P366, DOI 10.1016/j.numecd.2011.06.006
   Kondo K, 2014, METABOLISM, V63, P930, DOI 10.1016/j.metabol.2014.04.005
   Lenihan-Geels G, 2013, NUTRIENTS, V5, P1301, DOI 10.3390/nu5041301
   Lennon-Edwards S, 2015, PHYSIOL RES, V64, P433, DOI 10.33549/physiolres.932891
   Limbu R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192484
   Liu TL, 2020, HYPERTENSION, V75, P680, DOI 10.1161/HYPERTENSIONAHA.119.14167
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   López-Lluch G, 2016, J PHYSIOL-LONDON, V594, P2043, DOI 10.1113/JP270543
   Maeda M, 2009, LIFE SCI, V84, P119, DOI 10.1016/j.lfs.2008.11.009
   Martínez-González MA, 2013, REV ENDOCR METAB DIS, V14, P265, DOI 10.1007/s11154-013-9264-6
   Mazzolai L, 2006, CURR HYPERTENS REP, V8, P47, DOI 10.1007/s11906-006-0040-9
   MCVEIGH GE, 1993, DIABETOLOGIA, V36, P33, DOI 10.1007/BF00399090
   Medeiros-de-Moraes IM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6053492
   Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319
   Miyashita K, 2019, J OLEO SCI, V68, P1, DOI 10.5650/jos.ess18144
   Mollace V, 2013, INT J CARDIOL, V170, pS8, DOI 10.1016/j.ijcard.2013.06.038
   Morgan DR, 2006, AM J CARDIOL, V97, P547, DOI 10.1016/j.amjcard.2005.08.075
   Muniyappa R, 2007, CURR OPIN CLIN NUTR, V10, P523, DOI 10.1097/MCO.0b013e32819f8ecd
   Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500
   Nobili V, 2016, CRIT REV CL LAB SCI, V53, P106, DOI 10.3109/10408363.2015.1092106
   Olmstead ILD, 2013, BIOTECHNOL BIOENG, V110, P2096, DOI 10.1002/bit.24844
   Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6
   Parkinson L, 2016, MOLECULES, V21, DOI 10.3390/molecules21121734
   Perdomo L, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0237-9
   Ruiz-Núñez B, 2016, J NUTR BIOCHEM, V36, P1, DOI 10.1016/j.jnutbio.2015.12.007
   Sametz W, 2000, PHARMACOLOGY, V60, P155, DOI 10.1159/000028360
   Sato K, 2014, PHARMACOLOGY, V93, P229, DOI 10.1159/000360543
   Sekikawa A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112599
   Serreli G, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020478
   Shi XJ, 2019, AM J CHINESE MED, V47, P97, DOI [10.1142/S0192415X19500058, 10.1142/s0192415x19500058]
   SHIMOKAWA H, 1989, AM J PHYSIOL, V256, pH968, DOI 10.1152/ajpheart.1989.256.4.H968
   Singh PK, 2020, CARDIOVASC TOXICOL, V20, P28, DOI 10.1007/s12012-019-09531-y
   Sloboda N, 2012, J GERONTOL A-BIOL, V67, P927, DOI 10.1093/gerona/glr236
   Soto-Alarcón SA, 2018, ENDOCR METAB IMMUNE, V18, P75, DOI 10.2174/1871530317666171114120552
   Summerhill V, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00188
   Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893
   Tapsell LC, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-100
   Thandapilly SJ, 2017, J PHYSIOL SCI, V67, P425, DOI 10.1007/s12576-016-0504-x
   Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620
   VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/s001250050215
   Villalpando DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142039
   Wang PS, 1997, J FORMOS MED ASSOC, V96, P792
   Wang QQ, 2012, ATHEROSCLEROSIS, V221, P536, DOI 10.1016/j.atherosclerosis.2012.01.006
   Yang W, 2020, J CELL PHYSIOL, V235, P6246, DOI 10.1002/jcp.29553
   Zanetti M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080895
   Zgheel F, 2019, EUR J PHARMACOL, V853, P41, DOI 10.1016/j.ejphar.2019.03.022
   Zgheel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105102
NR 88
TC 8
Z9 8
U1 4
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD JUN
PY 2020
VL 9
IS 6
AR 483
DI 10.3390/antiox9060483
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA MO0MR
UT WOS:000551231900001
PM 32503213
OA Green Published, gold, Green Accepted
DA 2024-02-19
ER

PT J
AU Leeuwenburgh, C
   Hansen, P
   Shaish, A
   Holloszy, JO
   Heinecke, JW
AF Leeuwenburgh, C
   Hansen, P
   Shaish, A
   Holloszy, JO
   Heinecke, JW
TI Markers of protein oxidation by hydroxyl radical and reactive nitrogen
   species in tissues of aging rats
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE nitric oxide; peroxynitrite; alpha-tocopherol; beta-carotene; ascorbic
   acid; oxidative stress
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; SKELETAL-MUSCLE; AMINO-ACIDS;
   6-AMINOQUINOLYL-N-HYDROXYSUCCINIMIDYL CARBAMATE; SUPEROXIDE-DISMUTASE;
   O-TYROSINE; PEROXYNITRITE; DITYROSINE; EXERCISE; MYELOPEROXIDASE
AB Many lines of evidence implicate oxidative damage in aging. Possible pathways include reactions that modify aromatic amino acid residues on proteins. o-Tyrosine is a stable marker for oxidation of protein-bound phenylalanine by hydroxyl radical, whereas 3-nitrotyrosine is a marker for oxidation of protein-bound tyrosine by reactive nitrogen species. To test the hypothesis that proteins damaged by hydroxyl radical and reactive nitrogen accumulate with aging, we used isotope dilution gas chromatography-mass spectrometry to measure levels of o-tyrosine and 3-nitrotyrosine in heart, skeletal muscle, and liver from young adult (9 mo) and old (24 mo) female Long-Evans/Wistar hybrid rats. We also measured these markers in young adult and old rats that received antioxidant supplements (alpha-tocopherol, beta-carotene, butylated hydroxytoluene, and ascorbic acid) from the age of 5 mo. We found that aging did not significantly increase levels of protein-bound o-tyrosine or 3-nitrotyrosine in any of the tissues. Antioxidant supplementation had no effect on the levels of protein-bound o-tyrosine and 3-nitrotyrosine in either young or old animals. These observations indicate that the o-tyrosine and 3-nitrotyrosine do not increase significantly in heart, skeletal muscle, and liver in old rats, suggesting that proteins damaged by hydroxyl radical and reactive nitrogen species do not accumulate in these tissues with advancing age.
C1 Washington Univ, Sch Med, Dept Internal Med, Div Atherosclerosis Nutr & Lipid Res, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.
C3 Washington University (WUSTL); Washington University (WUSTL)
RP Heinecke, JW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Atherosclerosis Nutr & Lipid Res, Box 8046,660 S Euclid Ave, St Louis, MO 63110 USA.
OI Leeuwenburgh, Christiaan/0000-0003-0826-4257
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303
   BALDWIN KM, 1973, AM J PHYSIOL, V225, P962, DOI 10.1152/ajplegacy.1973.225.4.962
   BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405
   BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229
   COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   Dougherty D.A., 1996, SCIENCE, V271, P163, DOI [10.1126/science.271.5246.163, DOI 10.1126/SCIENCE.271.5246.163]
   ESSER K, 1995, MOL ASPECT AGING
   HAZEN S, 1996, J BIOL CHEM, V26, P1861
   HEINECKE JW, 1993, J BIOL CHEM, V268, P4069
   HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281
   HUGGINS TG, 1993, J BIOL CHEM, V268, P12341
   ISHIMITSU S, 1990, CHEM PHARM BULL, V38, P1417
   KAUR H, 1994, METHOD ENZYMOL, V233, P67
   KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480
   KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017
   Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433
   LEEUWENBURGH C, 1995, ARCH BIOCHEM BIOPHYS, V316, P941, DOI 10.1006/abbi.1995.1125
   Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   LEIS JR, 1993, J CHEM SOC CHEM COMM, P1298, DOI 10.1039/c39930001298
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   LIU HJ, 1994, J CHROMATOGR A, V670, P59
   MASORO EJ, 1995, HDB PHYSL AGING
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   SAVENKOVA MI, 1994, J BIOL CHEM, V269, P20394
   SHAISH A, 1995, J CLIN INVEST, V96, P2075, DOI 10.1172/JCI118256
   SOLKOLOVSKY M, 1966, BIOCHEMISTRY-US, V5, P3582
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   URSINI F, 1990, PROTEIN METABOLISM A, P373
   Viner RI, 1996, FEBS LETT, V379, P286, DOI 10.1016/0014-5793(95)01530-2
   Viner RI, 1996, FREE RADICAL RES, V24, P243, DOI 10.3109/10715769609088022
   WELLSKNECHT MC, 1993, J BIOL CHEM, V268, P12348
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
NR 38
TC 97
Z9 104
U1 0
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD FEB
PY 1998
VL 274
IS 2
BP R453
EP R461
DI 10.1152/ajpregu.1998.274.2.R453
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA YW743
UT WOS:000071968700024
DA 2024-02-19
ER

PT J
AU Azuma, K
   Casey, SC
   Urano, T
   Horie-Inoue, K
   Ouchi, Y
   Blumberg, B
   Inoue, S
AF Azuma, Kotaro
   Casey, Stephanie C.
   Urano, Tomohiko
   Horie-Inoue, Kuniko
   Ouchi, Yasuyoshi
   Blumberg, Bruce
   Inoue, Satoshi
TI Pregnane X Receptor Knockout Mice Display Aging-Dependent Wearing of
   Articular Cartilage
SO PLOS ONE
LA English
DT Article
ID VITAMIN-K; AMELOGENESIS IMPERFECTA; OSTEOARTHRITIS; SXR; TRANSCRIPTION;
   ASSOCIATION; EXPRESSION; FRACTURES; FAM20A; HAND
AB Steroid and xenobiotic receptor (SXR) and its murine ortholog, pregnane X receptor (PXR), are nuclear receptors that are expressed at high levels in the liver and the intestine where they function as xenobiotic sensors that induce expression of genes involved in detoxification and drug excretion. Recent evidence showed that SXR and PXR are also expressed in bone tissue where they mediate bone metabolism. Here we report that systemic deletion of PXR results in aging-dependent wearing of articular cartilage of knee joints. Histomorphometrical analysis showed remarkable reduction of width and an enlarged gap between femoral and tibial articular cartilage in PXR knockout mice. We hypothesized that genes induced by SXR in chondrocytes have a protective effect on articular cartilage and identified Fam20a (family with sequence similarity 20a) as an SXR-dependent gene induced by the known SXR ligands, rifampicin and vitamin K2. Lastly, we demonstrated the biological significance of Fam20a expression in chondrocytes by evaluating osteoarthritis-related gene expression of primary articular chondrocytes. Consistent with epidemiological findings, our results indicate that SXR/PXR protects against aging-dependent wearing of articular cartilage and that ligands for SXR/PXR have potential role in preventing osteoarthritis caused by aging.
C1 [Azuma, Kotaro; Urano, Tomohiko; Ouchi, Yasuyoshi; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan.
   [Casey, Stephanie C.; Blumberg, Bruce] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.
   [Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo 1138655, Japan.
   [Horie-Inoue, Kuniko; Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Hidaka, Saitama 3501241, Japan.
   [Ouchi, Yasuyoshi] Toranomon Gen Hosp, Minato Ku, Tokyo 1058470, Japan.
C3 University of Tokyo; University of California System; University of
   California Irvine; University of Tokyo; Saitama Medical University;
   Toranomon Hospital
RP Inoue, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.
EM INOUE-GER@h.u-tokyo.ac.jp
RI Urano, Tomohiko/AFS-9574-2022
FU Cell Innovation Program from the Ministry of Education, Culture, Sports,
   Science and Technology; Japan Society for the Promotion of Science,
   Research [24659126]; Ministry of Health, Labor and Welfare; National
   Institute of Environmental Health Sciences [R01ES021832]; NIH
   Predoctoral Cancer Biology Training Grant [T32CA9054]; National Cancer
   Institute; Grants-in-Aid for Scientific Research [23249040, 24659126]
   Funding Source: KAKEN
FX This study was funded by: 1) Cell Innovation Program from the Ministry
   of Education, Culture, Sports, Science and Technology
   (http://cellinnovation.nig.ac.jp/mext-life/english/html/program/theme.ht
   ml) (SI); 2) Grants from the Japan Society for the Promotion of Science,
   Research Project number: 24659126
   (http://kaken.nii.ac.jp/d/p/24659126.en.html) (SI); 3) Grants-in-Aid
   from the Ministry of Health, Labor and Welfare
   (http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin-koubo16/0501.html)
   (SI); 4) Grant from the National Institute of Environmental Health
   Sciences, Grant number R01ES021832
   (http://tools.niehs.nih.gov/portfolio/index.cfm/portfolio/grantDetail/gr
   ant_number/R01ES021832) (BB); 5) NIH Predoctoral Cancer Biology Training
   Grant, T32CA9054, National Cancer Institute (SCC). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Azuma K, 2014, GERIATR GERONTOL INT, V14, P1, DOI 10.1111/ggi.12060
   Azuma K, 2010, J ENDOCRINOL, V207, P257, DOI 10.1677/JOE-10-0208
   Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195
   Cockayne S, 2006, ARCH INTERN MED, V166, P1256, DOI 10.1001/archinte.166.12.1256
   de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078
   Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Garnero P, 2002, ARTHRITIS RHEUM-US, V46, P2613, DOI 10.1002/art.10576
   GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0
   Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200
   Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0
   Misra D, 2013, AM J MED, V126, P243, DOI 10.1016/j.amjmed.2012.10.011
   Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11
   Neogi T, 2008, ANN RHEUM DIS, V67, P1570, DOI 10.1136/ard.2008.094771
   Neogi T, 2006, ARTHRITIS RHEUM, V54, P1255, DOI 10.1002/art.21735
   Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564
   O'Sullivan J, 2011, AM J HUM GENET, V88, P616, DOI 10.1016/j.ajhg.2011.04.005
   Oka H, 2009, J ORTHOP SCI, V14, P687, DOI 10.1007/s00776-009-1395-y
   Shiraki M, 2000, J BONE MINER RES, V15, P515, DOI 10.1359/jbmr.2000.15.3.515
   Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417
   Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912
   Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200
   Thirion S, 2004, METH MOLEC MED, V100, P1
   Urano T, 2007, GERIATR GERONTOL INT, V7, P104, DOI 10.1111/j.1447-0594.2007.00394.x
   VILLANUEVA AR, 1989, STAIN TECHNOL, V64, P129, DOI 10.3109/10520298909106985
   Vogel P, 2012, VET PATHOL, V49, P998, DOI 10.1177/0300985812453177
   Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116
   Zhou Changcheng, 2009, Nucl Recept Signal, V7, pe001, DOI 10.1621/nrs.07001
NR 28
TC 13
Z9 15
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 6
PY 2015
VL 10
IS 3
AR e0119177
DI 10.1371/journal.pone.0119177
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CC9KQ
UT WOS:000350689400055
PM 25749104
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zupo, R
   Castellana, F
   Donghia, R
   Lampignano, L
   Guerra, V
   De Pergola, G
   Lozupone, M
   Bortone, I
   De Nucci, S
   Tatoli, R
   Tirelli, S
   Sborgia, G
   Giannelli, G
   Panza, F
   Sardone, R
AF Zupo, Roberta
   Castellana, Fabio
   Donghia, Rossella
   Lampignano, Luisa
   Guerra, Vito
   De Pergola, Giovanni
   Lozupone, Madia
   Bortone, Ilaria
   De Nucci, Sara
   Tatoli, Rossella
   Tirelli, Sarah
   Sborgia, Giancarlo
   Giannelli, Gianluigi
   Panza, Francesco
   Sardone, Rodolfo
TI Liver frailty and all-cause mortality in the older participants of the
   Salus in Apulia Study
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Liver frailty; Aging phenotype; Primary care; Older population;
   Mortality
ID DISEASE; POPULATION; ASSOCIATION; MANAGEMENT; DIAGNOSIS; FIBROSIS; AGE
AB The liver contribution to the biological network underlying physical frailty in aging is underestimated. How best to measure this contribution magnitude and impact on health risk trajectories in frail individuals is not yet entirely clear. We analyzed the association of a novel liver frailty phenotype with the risk of death in older participants of the Salus in Apulia Study cohort. Clinical and physical examination, routine biomarkers, medical history, and anthropometry were analyzed in 1929 older adults (65 +). Physical frailty was classified by Cardiovascular Health Study criteria, and liver fibrosis risk by fibrosis-4 (FIB-4). The liver frailty phenotype was defined as physical frailty plus high-risk liver fibrosis (score > 2.67). Physical frailty, high-risk liver fibrosis, and liver frailty subjects were compared to subjects without these conditions (non-frail). Proportional Cox regression tested the adjusted association between liver frailty and all-cause mortality for each category. The liver frailty prevalence was relatively low (3.8%), but higher in men (58.1%). Compared to non-frail older subjects, liver frailty subjects were significantly older (effect size (ES) - 1.11, 95% confidence interval (CI) - 1.35 to - 0.87), with a lower education (ES 0.48, 95%CI 0.24 to 0.71) and higher multimorbidity (ES 15.81, 95%CI 4.20 to 27.41). Cox multivariate analyses showed a two-fold increased risk of overall mortality (hazard ratio 2.09, 95%CI 1.16-3.74) even after the adjustment for age, sex, education, and alcohol consumption. The liver frailty phenotype runs twice the risk of overall mortality compared with the non-frail population. This clinical tool, validated in a Southern Italian population, is based on simple sets of measures that can conveniently be assessed also in the primary care setting.
C1 [Zupo, Roberta; Castellana, Fabio; Donghia, Rossella; Lampignano, Luisa; Guerra, Vito; Lozupone, Madia; Bortone, Ilaria; De Nucci, Sara; Tatoli, Rossella; Tirelli, Sarah; Panza, Francesco; Sardone, Rodolfo] Res Hosp, Natl Inst Gastroenterol Saverio Bellis, Unit Data Sci & Technol Innovat Populat Hlth, Bari, Italy.
   [De Pergola, Giovanni] Res Hosp, Natl Inst Gastroenterol Saverio Bellis, Unit Geriatr & Internal Med, Bari, Italy.
   [Sborgia, Giancarlo] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy.
   [Giannelli, Gianluigi] Res Hosp, Natl Inst Gastroenterol Saverio Bellis, Sci Direct, Bari, Italy.
C3 IRCCS Saverio de Bellis; IRCCS Saverio de Bellis; Universita degli Studi
   di Bari Aldo Moro; IRCCS Saverio de Bellis
RP Panza, F; Sardone, R (corresponding author), Res Hosp, Natl Inst Gastroenterol Saverio Bellis, Unit Data Sci & Technol Innovat Populat Hlth, Bari, Italy.
EM f_panza@hotmail.com; rodolfo.sardone@irccsdebellis.it
RI Zupo, Roberta/AAO-9103-2020; Lampignano, Luisa/AAA-3108-2022;
   Castellana, Fabio/AAC-4919-2022; Bortone, Ilaria/O-3143-2019; Zupo,
   Roberta/GPT-3724-2022; Bortone, Ilaria/HPE-3696-2023; Sardone,
   Rodolfo/AAM-2727-2020; Lozupone, Madia/F-7262-2018
OI Zupo, Roberta/0000-0001-9885-1185; Castellana,
   Fabio/0000-0002-6439-8228; Bortone, Ilaria/0000-0002-4767-5334; Sardone,
   Rodolfo/0000-0003-1383-1850; Lozupone, Madia/0000-0002-1674-9724;
   Tirelli, Sarah/0000-0002-5521-2508; Sborgia,
   Giancarlo/0000-0001-7271-0536; Donghia, Rossella/0000-0002-9140-673X
FU Italian Ministry of Health; "Ricerca Corrente 2020" funds
FX Italian Ministry of Health with "Ricerca Corrente 2020" funds.
CR Bortone I, 2021, J CACHEXIA SARCOPENI, V12, P274, DOI 10.1002/jcsm.12667
   Burra P, 2013, LIVER TRANSPLANT, V19, P122, DOI 10.1002/lt.23574
   Carnovale E., 1987, EUROPEAN FOOD COMPOS, P63, DOI [10.1007/978-3-642-82989-5_11, DOI 10.1007/978-3-642-82989-5_11]
   Castellana F, 2021, J AM MED DIR ASSOC, V22, P598, DOI 10.1016/j.jamda.2020.12.026
   Chalasani NP, 2017, HEPATOLOGY, V66, p303A
   Chang AY, 2019, LANCET PUBLIC HEALTH, V4, pE159, DOI 10.1016/S2468-2667(19)30019-2
   Cozzolongo R, 2009, AM J GASTROENTEROL, V104, P2740, DOI 10.1038/ajg.2009.428
   EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Guy Jennifer, 2013, Gastroenterol Hepatol (N Y), V9, P633
   Jármay K, 2005, WORLD J GASTROENTERO, V11, P6422, DOI 10.3748/wjg.v11.i41.6422
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim J.J., 2005, EFFECT SIZES RES BRO
   Kurokawa T, 2017, WORLD J GASTROENTERO, V23, P3228, DOI 10.3748/wjg.v23.i18.3228
   Kurosawa T, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03353-5
   Laube R, 2018, LIVER INT, V38, P2117, DOI 10.1111/liv.13917
   McPherson S, 2017, AM J GASTROENTEROL, V112, P740, DOI 10.1038/ajg.2016.453
   Mitnitski A B, 2001, ScientificWorldJournal, V1, P323
   O'Caoimh R, 2021, AGE AGEING, V50, P96, DOI 10.1093/ageing/afaa219
   Paik JM, 2020, HEPATOLOGY, V72, P1605, DOI 10.1002/hep.31173
   Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7
   Sardone R, 2021, JAMA OTOLARYNGOL, V147, P561, DOI 10.1001/jamaoto.2020.5334
   Sardone R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020426
   Soysal P, 2016, AGEING RES REV, V31, P1, DOI 10.1016/j.arr.2016.08.006
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Stroffolini T, 2020, EUR J INTERN MED, V75, P55, DOI 10.1016/j.ejim.2020.01.008
   Upmeier E, 2011, AGE AGEING, V40, P280, DOI 10.1093/ageing/afq180
   Villén N, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01580-1
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   Zupo R, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101148
   Zupo R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041070
NR 33
TC 9
Z9 9
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2022 APR
PY 2022
VL 44
IS 2
SI SI
BP 835
EP 845
DI 10.1007/s11357-021-00434-x
EA AUG 2021
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 1U7PL
UT WOS:000683627000001
PM 34378088
OA Green Published
DA 2024-02-19
ER

PT J
AU DEVARAJ, B
   SCOTT, RQ
   ROSCHGER, P
   INABA, H
AF DEVARAJ, B
   SCOTT, RQ
   ROSCHGER, P
   INABA, H
TI ULTRAWEAK LIGHT-EMISSION FROM RAT-LIVER NUCLEI
SO PHOTOCHEMISTRY AND PHOTOBIOLOGY
LA English
DT Article
ID LEVEL CHEMI-LUMINESCENCE; SINGLET MOLECULAR-OXYGEN; LIPID-PEROXIDATION;
   HYDROPEROXIDE; DEPENDENCE; MEMBRANES; SYSTEMS; NADPH
AB An extremely weak native light emission from rat liver nuclei was detected and studied using a highly sensitive single photon counting system.  This emission is oxygen dependent and we attribute it to (per) oxidative processes.  The effects of deuterium oxide and 1,4-diazabicyclo-[2.2.2] octane on the light emission suggests the possible involvement of singlet oxygen.  The kinetic features of the underlying reactions including biphasic response to both oxygen and temperature changes, could be clearly discerned.  Further study of this light emission can serve as a useful adjunct to biochemical investigations of oxidative processes which play an important role in mutation, carcinogenesis and aging.
C1 TOHOKU UNIV,ELECT COMMUN RES INST,AOBA KU,SENDAI,MIYAGI 980,JAPAN.
C3 Tohoku University
RP DEVARAJ, B (corresponding author), RES DEV CORP JAPAN,BIOPHOTON PROJECT,2-1-1 YAGIYAMA MINAMI,TAIHAKU KU,SENDAI 982,JAPAN.
CR BAIRD MB, 1980, ARCH BIOCHEM BIOPHYS, V200, P108, DOI 10.1016/0003-9861(80)90337-9
   BOVERIS A, 1983, PHOTOCHEM PHOTOBIOL, V38, P99, DOI 10.1111/j.1751-1097.1983.tb08372.x
   BOVERIS A, 1978, ELECTRONS TISSUES FR, V2, P975
   CADENAS E, 1984, METHOD ENZYMOL, V105, P221
   CADENAS E, 1982, EUR J BIOCHEM, V124, P349
   CADENAS E, 1981, BIOCHEM J, V198, P645, DOI 10.1042/bj1980645
   CADENAS E, 1984, PHOTOCHEM PHOTOBIOL, V40, P823, DOI 10.1111/j.1751-1097.1984.tb04657.x
   CHWRIOT WB, 1985, CYTOBIOS, V44, P95
   CILENTO G, 1988, EXPERIENTIA, V44, P572, DOI 10.1007/BF01953304
   DENEKE CF, 1977, PHOTOCHEM PHOTOBIOL, V28, P803
   DIX TA, 1983, SCIENCE, V221, P77, DOI 10.1126/science.6304879
   EMERIT I, 1985, Journal of Free Radicals in Biology and Medicine, V1, P51, DOI 10.1016/0748-5514(85)90029-7
   Gurwitsch AG., 1959, MITOGENETISCHE STRAH
   HOWES RM, 1971, RES COMMUN CHEM PATH, V2, P619
   KEARNS DR, 1971, CHEM REV, V71, P395, DOI 10.1021/cr60272a004
   NAKANO M, 1976, J AM CHEM SOC, V98, P1974, DOI 10.1021/ja00423a060
   POPP F A, 1981, Collective Phenomena (London), V3, P187
   RATTEMEYER M, 1981, NATURWISSENSCHAFTEN, V68, P572, DOI 10.1007/BF00401671
   SCOTT RQ, 1989, APPL PHYS B-PHOTO, V48, P183, DOI 10.1007/BF00692144
   SVINGEN BA, 1978, PHOTOCHEM PHOTOBIOL, V28, P803, DOI 10.1111/j.1751-1097.1978.tb07022.x
   VACA CE, 1989, BIOCHIM BIOPHYS ACTA, V1001, P35, DOI 10.1016/0005-2760(89)90304-4
   VACA CE, 1988, BIOCHIM BIOPHYS ACTA, V958, P375, DOI 10.1016/0005-2760(88)90223-8
   WIDNELL CC, 1964, BIOCHEM J, V92, P313, DOI 10.1042/bj0920313
   WRIGHT JR, 1979, ARCH BIOCHEM BIOPHYS, V192, P344, DOI 10.1016/0003-9861(79)90102-4
NR 24
TC 33
Z9 33
U1 0
U2 0
PU AMER SOC PHOTOBIOLOGY
PI AUGUSTA
PA BIOTECH PARK, 1021 15TH ST, SUITE 9, AUGUSTA, GA 30901-3158
SN 0031-8655
J9 PHOTOCHEM PHOTOBIOL
JI Photochem. Photobiol.
PD AUG
PY 1991
VL 54
IS 2
BP 289
EP 293
DI 10.1111/j.1751-1097.1991.tb02018.x
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA FZ590
UT WOS:A1991FZ59000018
PM 1780363
DA 2024-02-19
ER

PT J
AU dos Reis, SRR
   Pinto, SR
   de Menezes, FD
   Martinez-Manez, R
   Ricci, E
   Alencar, LMR
   Helal-Neto, E
   de Barros, AOD
   Lisboa, PC
   Santos-Oliveira, R
AF dos Reis, Sara Rhaissa Rezende
   Pinto, Suyene Rocha
   de Menezes, Frederico Duarte
   Martinez-Manez, Ramon
   Ricci-Junior, Eduardo
   Alencar, Luciana Magalhaes Rebelo
   Helal-Neto, Edward
   da Silva de Barros, Aline Oiveira
   Lisboa, Patricia Cristina
   Santos-Oliveira, Ralph
TI Senescence and the Impact on Biodistribution of Different Nanosystems:
   the Discrepancy on Tissue Deposition of Graphene Quantum Dots,
   Polycaprolactone Nanoparticle and Magnetic Mesoporous Silica
   Nanoparticles in Young and Elder Animals
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE elderly; graphene; Mesoporous slica; biodistribution; nanomaterial;
   youth
ID AGE-RELATED-CHANGES; GOLD NANOPARTICLES; DRUG DEVELOPMENT; LIVER;
   METABOLISM; STRATEGIES; DELIVERY; PHARMACOKINETICS; CLEARANCE; KINETICS
AB Purposes Senescence is an inevitable and irreversible process, which may lead to loss in muscle and bone density, decline in brain volume and loss in renal clearance. Although aging is a well-known process, few studies on the consumption of nanodrugs by elderly people were performed. Methods We evaluated three different nanosystems: i) carbon based nanosystem (Graphene Quantum Dots, GQD), ii) polymeric nanoparticles and mesoporous silica (magnetic core mesoporous silica, MMSN). In previous studies, our group has already characterized GQD and MMSN nanoparticles by dynamic light scattering analysis, atomic force microscopy, transmission electron microscopy, X-ray diffraction, Raman analysis, fluorescence and absorbance. The polymeric nanoparticle has been characterized by AFM and DLS. All the nanosystems were radiolabeled with 99 m-Tc by. The in vivo biodistribution/tissue deposition analysis evaluation was done using elder (PN270) and young (PN90) mice injected with radioactive nanosystems. Results The nanosystems used in this study were well-formed as the radiolabeling processes were stable. Biodistribution analysis showed that there is a decrease in the uptake of the nanoparticles in elder mice when compared to young mice, showing that is necessary to increase the initial dose in elder people to achieve the same concentration when compared to young animals. Conclusion The discrepancy on tissue distribution of nanosystems between young and elder individuals must be monitored, as the therapeutic effect will be different in the groups. Noteworthy, this data is an alarm that some specific conditions must be evaluated before commercialization of nano-drugs.
   Changes between younger and elderly individuals are undoubtedly, especially in drug tissue deposition, biodistribution and pharmacokinetics. The same thought should be applied to nanoparticles. A comprehensive analysis on how age discrepancy change the biological behavior of nanoparticles has been performed.
C1 [dos Reis, Sara Rhaissa Rezende; Pinto, Suyene Rocha; Helal-Neto, Edward; da Silva de Barros, Aline Oiveira; Santos-Oliveira, Ralph] Brazilian Nucl Energy Commiss, Nucl Engn Inst, Rio De Janeiro, Brazil.
   [de Menezes, Frederico Duarte] Fed Inst Educ Sci & Technol, Recife, Pe, Brazil.
   [Martinez-Manez, Ramon] Univ Valencia, Univ Politecn Valencia, Inst Interuniv Invest Reconocimiento Mol & Desarr, Valencia, Spain.
   [Martinez-Manez, Ramon] Univ Politecn Valencia, Dept Quim, Valencia, Spain.
   [Martinez-Manez, Ramon] CIBER BBN, Valencia, Spain.
   [Ricci-Junior, Eduardo] Univ Fed Rio de Janeiro, Fac Pharm, Rio De Janeiro, Brazil.
   [Alencar, Luciana Magalhaes Rebelo] Univ Fed Maranhao, Dept Phys, Maranhao, Brazil.
   [Lisboa, Patricia Cristina] Univ Estado Rio De Janeiro, Roberto Alcantara Gomes Biol Inst, Dept Physiol Sci, Lab Endocrine Physiol, Rio De Janeiro, Brazil.
   [Santos-Oliveira, Ralph] Zona Oeste State Univ, Lab Radiopharm & Nanoradiopharmaceut, Rio De Janeiro, Brazil.
C3 Instituto Federal de Pernambuco (IFPE); Universitat Politecnica de
   Valencia; University of Valencia; Universitat Politecnica de Valencia;
   CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidade
   Federal do Rio de Janeiro; Universidade Federal do Maranhao;
   Universidade do Estado do Rio de Janeiro; Centro Universitario Estadual
   da Zona Oeste
RP Santos-Oliveira, R (corresponding author), Brazilian Nucl Energy Commiss, Nucl Engn Inst, Rio De Janeiro, Brazil.; Santos-Oliveira, R (corresponding author), Zona Oeste State Univ, Lab Radiopharm & Nanoradiopharmaceut, Rio De Janeiro, Brazil.
EM roliveira@ien.gov.br
RI de Menezes, Frederico Duarte/U-8888-2019; Moura, Egberto/ABA-6188-2021;
   Ricci-Junior, Eduardo/S-9969-2019; Alencar, Luciana Magalhães
   Rebelo/O-6736-2018; Santos-Oliveira, Ralph/J-3429-2016; Lisboa, Patricia
   C./H-8336-2015; Martinez-Manez, Ramon/O-8915-2014; santos-oliveira,
   ralph/J-8363-2013
OI de Menezes, Frederico Duarte/0000-0003-2186-1849; Ricci-Junior,
   Eduardo/0000-0002-2550-696X; Alencar, Luciana Magalhães
   Rebelo/0000-0001-8210-2016; Lisboa, Patricia C./0000-0002-2477-4364;
   Martinez-Manez, Ramon/0000-0001-5873-9674; santos-oliveira,
   ralph/0000-0002-0905-481X
CR Abdelhalim MAK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-163
   Adams DJ, 2012, TRENDS PHARMACOL SCI, V33, P173, DOI 10.1016/j.tips.2012.02.001
   Alexander A, 2019, INT J NANOMED, V14, P5895, DOI 10.2147/IJN.S210876
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   [Anonymous], BIOMED PHYS ENG
   Ben Haddada M, 2019, COLLOID SURFACE B, V184, DOI 10.1016/j.colsurfb.2019.110496
   Blechman MB, 1999, CLIN GERIATR MED, V15, P429
   Bu HJ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2398696
   CASTLEDEN CM, 1975, BRIT J CLIN PHARMACO, V2, P303, DOI 10.1111/j.1365-2125.1975.tb02774.x
   CASTLEDEN CM, 1979, BRIT J CLIN PHARMACO, V7, P49, DOI 10.1111/j.1365-2125.1979.tb00896.x
   Chiriacò M, 2019, HIGH BLOOD PRESS CAR, V26, P321, DOI 10.1007/s40292-019-00331-7
   Cho DS, 2019, ADV EXP MED BIOL, V1169, P179, DOI 10.1007/978-3-030-24108-7_9
   Choi Young Hee, 2018, Journal of Pharmaceutical Investigation, V48, P43
   DAVIES RO, 1984, BRIT J CLIN PHARMACO, V18, pS215, DOI 10.1111/j.1365-2125.1984.tb02601.x
   De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037
   de Menezes FD, 2019, MAT SCI ENG C-MATER, V102, P405, DOI 10.1016/j.msec.2019.04.058
   Dhas NL, 2015, POWDER TECHNOL, V283, P234, DOI 10.1016/j.powtec.2015.04.053
   DIVOLL M, 1982, J AM GERIATR SOC, V30, P240, DOI 10.1111/j.1532-5415.1982.tb07093.x
   Dodig S, 2019, BIOCHEM MEDICA, V29, DOI 10.11613/BM.2019.030501
   dos Santos SN, 2017, MICROPOR MESOPOR MAT, V251, P181, DOI 10.1016/j.micromeso.2017.06.005
   DREYFUSS D, 1986, J CLIN PSYCHIAT, V47, P511
   Fan CH, 2019, BIOCHEM BIOPH RES CO, V519, P378, DOI 10.1016/j.bbrc.2019.09.016
   Fatemikia H, 2017, MOL CELL BIOCHEM, V434, P163, DOI 10.1007/s11010-017-3046-5
   Faustino C, 2017, PHARMACOL RES, V120, P68, DOI 10.1016/j.phrs.2017.03.020
   Felismino CD, 2018, J CONTROL RELEASE, V281, P11, DOI 10.1016/j.jconrel.2018.05.003
   Forsberg A, 2019, PSYCHOL AGING, V34, P933, DOI 10.1037/pag0000391
   Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023
   FULOP T, 1985, GERONTOLOGY, V31, P6
   Gai LX, 2019, J PHOTOCH PHOTOBIO B, V194, P188, DOI 10.1016/j.jphotobiol.2019.03.014
   GAINSBOROUGH N, 1993, AGE AGEING, V22, P37, DOI 10.1093/ageing/22.1.37
   GREENBLATT DJ, 1991, NEW ENGL J MED, V324, P1691, DOI 10.1056/NEJM199106133242403
   He YJ, 2017, MAT SCI ENG C-MATER, V78, P12, DOI 10.1016/j.msec.2017.04.049
   Jackson SJ, 2017, LAB ANIM-UK, V51, P160, DOI 10.1177/0023677216653984
   Jain A, 2015, ACTA BIOMATER, V24, P140, DOI 10.1016/j.actbio.2015.06.027
   Kamakura R, 2019, EUR J PHARM BIOPHARM, V144, P132, DOI 10.1016/j.ejpb.2019.09.009
   KAMPMANN JP, 1975, GERIATRICS, V30, P91
   Kattumuri V, 2007, SMALL, V3, P333, DOI 10.1002/smll.200600427
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   KLAWANS HL, 1990, NEUROLOGY, V40, P5
   KOFF RS, 1973, GASTROENTEROLOGY, V65, P300
   Kounakis K, 2019, ADV EXP MED BIOL, V1178, P227, DOI 10.1007/978-3-030-25650-0_12
   Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556
   Lin YC, 2018, EUR J PHARM SCI, V122, P185, DOI 10.1016/j.ejps.2018.07.013
   Liu Y, 2019, J DERMATOL SCI, V96, P42, DOI 10.1016/j.jdermsci.2019.08.010
   MacParland SA, 2017, ACS NANO, V11, P2428, DOI 10.1021/acsnano.6b06245
   Maity R, 2019, MAT SCI ENG C-MATER, V104, DOI 10.1016/j.msec.2019.109909
   Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Ogrodnik M, 2019, AGING CELL, V18, DOI 10.1111/acel.12841
   Pan B, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016955
   Pappas LE, 2019, EUR J CLIN NUTR, V73, P172, DOI 10.1038/s41430-018-0324-6
   Pereira BI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10335-5
   Pibiri M, 2015, AGE, V37, DOI 10.1007/s11357-015-9796-7
   Pichette V, 2003, CURR DRUG METAB, V4, P91, DOI 10.2174/1389200033489532
   Portilho FL, 2018, ARTIF CELL NANOMED B, V46, pS1080, DOI 10.1080/21691401.2018.1443941
   REDOLFI A, 1979, EUR J CLIN PHARMACOL, V15, P257, DOI 10.1007/BF00618514
   ROBERTSON DRC, 1988, BRIT J CLIN PHARMACO, V25, P297, DOI 10.1111/j.1365-2125.1988.tb03307.x
   Rosa TG, 2017, PHARM RES-DORDR, V34, P2922, DOI 10.1007/s11095-017-2275-3
   Rostami-Hodjegan A, 1999, PHARMACOGENETICS, V9, P277, DOI 10.1097/00008571-199906000-00002
   Saez V, 2019, J MOL LIQ, V287, DOI 10.1016/j.molliq.2019.110949
   Shavlakadze T, 2019, CELL REP, V28, P3263, DOI 10.1016/j.celrep.2019.08.043
   Shi SJ, 2011, CURR DRUG METAB, V12, P601, DOI 10.2174/138920011796504527
   Song H, 2018, INT J NANOMED, V13, P1869, DOI 10.2147/IJN.S161237
   Sun XL, 2017, THERANOSTICS, V7, P319, DOI 10.7150/thno.18078
   Talevi A, 2012, MINI-REV MED CHEM, V12, P959, DOI 10.2174/138955712802762356
   TATEISHI T, 1995, INT J CLIN PHARM RES, V15, P95
   Rodrigues VST, 2018, J NUTR BIOCHEM, V55, P89, DOI 10.1016/j.jnutbio.2017.12.001
   Tchkonia T, 2018, JAMA-J AM MED ASSOC, V320, P1319, DOI 10.1001/jama.2018.12440
   Thomas N, 2019, ADV EXP MED BIOL, V1178, P57, DOI 10.1007/978-3-030-25650-0_4
   TODD PA, 1991, DRUGS, V42, P90, DOI 10.2165/00003495-199142010-00006
   Tsoi KM, 2016, NAT MATER, V15, P1212, DOI [10.1038/NMAT4718, 10.1038/nmat4718]
   Victorelli S, 2017, EBIOMEDICINE, V21, P14, DOI 10.1016/j.ebiom.2017.03.027
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Wynne Hilary, 2005, J Br Menopause Soc, V11, P51, DOI 10.1258/136218005775544589
   Xiao YQ, 2019, INT J NANOMED, V14, P5989, DOI 10.2147/IJN.S196794
   Yuan R, 2000, INT J CLIN PHARM TH, V38, P245
   Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829
   Zheng Z, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20082013
NR 78
TC 12
Z9 12
U1 3
U2 24
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD JAN 22
PY 2020
VL 37
IS 3
AR 40
DI 10.1007/s11095-019-2754-9
PG 12
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Pharmacology & Pharmacy
GA KJ4FL
UT WOS:000512013600001
PM 31970499
DA 2024-02-19
ER

PT J
AU VONZGLINICKI, T
   BRUNK, UT
AF VONZGLINICKI, T
   BRUNK, UT
TI INTRACELLULAR INTERACTIONS UNDER OXIDATIVE STRESS AND AGING - A
   HYPOTHESIS
SO ZEITSCHRIFT FUR GERONTOLOGIE
LA English
DT Article
DE OXIDATIVE STRESS; FREE RADICALS; MITOCHONDRIA; LYSOSOMES; AGING;
   INTERACTION HYPOTHESIS
ID HYDROGEN-PEROXIDE PRODUCTION; RAT-HEART MYOCYTES; LIPOFUSCIN
   ACCUMULATION; LIVER-MITOCHONDRIA; AMBIENT OXYGEN; BRAIN; WATER; TISSUES;
   CELLS
AB Oxygen-derived free radicals may result from various reactions, both intra- and extracellularly, but generation of oxygen free radicals from electrons escaping from the electron transport chain in mitochondria is by far the predominant process during the lifetime of a normal'', healthy cell.
   There is clear evidence that mitochondria are also an important target for oxygen-derived free radicals, and the resulting mitochondrial malfunction has long been suggested as the intracellular basis of aging. Moreover, there is clear evidence that free radical-dependent reactions lead to lipofuscin formation and its accumulation in Lysomes of post-mitotic cells. Lipofuscin accumulation was demonstrated to be dependent on the probability of iron-catalyzed Fenton reactions.
   A hypothesis is presented which assumes free radical dependent reactions in mitochondria and lysosomes to be interdependent. Production of hydrogen peroxide in mitochondria and its subsequent diffusion in the cytoplasm, and Fenton reactions in lysosomes, transferring hydrogen peroxide intralysosomally to the highly cytotoxic hydroxyl radical, are thought to be necessary intermediary steps in the generation of mitochondrial damage. On the other hand, damage to mitochondria increases both mitochondrial output of hydrogen peroxide and lipofuscin accumulation.
C1 UNIV LINKOPING, INST PATHOL, LINKOPING, SWEDEN.
C3 Linkoping University
RP VONZGLINICKI, T (corresponding author), CHARITE BERLIN, INST PATHOL, SCHUMANNSTR 20-21, D-10117 BERLIN, GERMANY.
OI von Zglinicki, Thomas/0000-0002-5939-0248
CR BACON BR, 1990, HEPATOLOGY, V11, P127, DOI 10.1002/hep.1840110122
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BEYER RE, 1990, FREE RADICAL BIO MED, V8, P545, DOI 10.1016/0891-5849(90)90154-B
   BRUN A, 1970, J HISTOCHEM CYTOCHEM, V18, P820, DOI 10.1177/18.11.820
   BRUNK U, 1988, APMIS, V96, P3, DOI 10.1111/j.1699-0463.1988.tb05261.x
   BRUNK UT, 1992, MUTAT RES, V275, P395, DOI 10.1016/0921-8734(92)90042-N
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHEVION M, 1991, FREE RADICAL RES COM, V12-3, P691, DOI 10.3109/10715769109145848
   CURTI D, 1990, MECH AGEING DEV, V55, P171, DOI 10.1016/0047-6374(90)90024-A
   DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4
   DIONISI O, 1975, BIOCHIM BIOPHYS ACTA, V403, P292, DOI 10.1016/0005-2744(75)90059-5
   DUQUEMAGALHAES MC, 1987, FEBS LETT, V210, P142, DOI 10.1016/0014-5793(87)81324-8
   Edelmann L., 1984, SCANNING ELECTRON MI, VII, P875
   ESSNER E, 1960, J ULTRA MOL STRUCT R, V3, P374, DOI 10.1016/S0022-5320(60)90016-2
   ESTERBAUER H, 1986, FREE RADICALS LIVER, P29
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GITOMER WL, 1987, BIOCHEM J, V248, P997, DOI 10.1042/bj2480997
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D., 1986, FREE RADICALS AGING, P3
   HONG Z, 1991, APMIS, V99, P1038, DOI 10.1111/j.1699-0463.1991.tb01297.x
   LEPRAT P, 1990, MECH AGEING DEV, V52, P149, DOI 10.1016/0047-6374(90)90121-U
   MARZABADI MR, 1988, MECH AGEING DEV, V46, P145, DOI 10.1016/0047-6374(88)90122-4
   MARZABADI MR, 1990, ANAL CELL PATHOL, V2, P333
   MARZABADI MR, 1991, APMIS, V99, P416, DOI 10.1111/j.1699-0463.1991.tb05170.x
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   MICHAEL LH, 1980, SCIENCE, V208, P1267, DOI 10.1126/science.6246584
   MIQUEL J, 1986, FREE RADICALS AGING, P51
   MIYAWAKI H, 1965, JNCI-J NATL CANCER I, V34, P601
   Oberley LW, 1986, Free radicals, aging, and degenerative diseases, P325
   PETRUZELLA V, 1993, IN PRESS ARCH GERONT
   PRYOR WA, 1990, FREE RADICAL BIO MED, V8, P541, DOI 10.1016/0891-5849(90)90153-A
   RAGUSA N, 1989, NEUROCHEM RES, V14, P415, DOI 10.1007/BF00964854
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SOHAL RS, 1991, MECH AGEING DEV, V60, P189, DOI 10.1016/0047-6374(91)90130-R
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1989, FREE RADICAL BIO MED, V6, P23, DOI 10.1016/0891-5849(89)90155-X
   SOHAL RS, 1990, LIPOFUSCIN CEROID PI, P17
   STREHLER BERNARD L., 1964, ADVANCE GERONTOL RES, V1, P343
   THAW HH, 1984, MECH AGEING DEV, V24, P211, DOI 10.1016/0047-6374(84)90072-1
   TURRENS JF, 1991, FREE RADICAL RES COM, V12-3, P681, DOI 10.3109/10715769109145847
   VLADIMIROV YA, 1980, ADV LIPID RES, V17, P173
   VONZGLINICKI T, 1988, GEN PHYSIOL BIOPHYS, V7, P495
   VONZGLINICKI T, 1989, SCANNING MICROSCOPY, V3, P1231
   VONZGLINICKI T, 1991, J MICROSC-OXFORD, V161, P149, DOI 10.1111/j.1365-2818.1991.tb03079.x
   VONZGLINICKI T, 1988, SCANNING MICROSCOPY, V2, P1791
   VONZGLINICKI T, 1991, MECH AGEING DEV, V58, P49, DOI 10.1016/0047-6374(91)90119-K
   VONZGLINICKI T, 1991, MECH AGEING DEV, V57, P233, DOI 10.1016/0047-6374(91)90049-6
   ZDOLSEK JM, 1993, IN PRESS FREE RAD RE
   ZHANG H, 1992, APMIS, V100, P317, DOI 10.1111/j.1699-0463.1992.tb00878.x
   ZHANG H, 1992, APMIS, V100, P309, DOI 10.1111/j.1699-0463.1992.tb00877.x
NR 51
TC 17
Z9 17
U1 0
U2 0
PU DR DIETRICH STEINKOPFF VERLAG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, 69121 HEIDELBERG, GERMANY
SN 0044-281X
J9 Z GERONTOL
PD JUL-AUG
PY 1993
VL 26
IS 4
BP 215
EP 220
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA LV881
UT WOS:A1993LV88100003
PM 8212789
DA 2024-02-19
ER

PT J
AU Dong, Y
   Cui, PF
   Li, ZJ
   Zhang, SC
AF Dong, Yuan
   Cui, Pengfei
   Li, Zhijian
   Zhang, Shicui
TI Aging asymmetry: systematic survey of changes in age-related biomarkers
   in the annual fish <i>Nothobranchius guentheri</i>
SO FISH PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Aging asymmetry; Age-related markers; Annual fish; Nothobranchius;
   Reactive oxygen species; ercc1
ID NEMATODE CAENORHABDITIS-ELEGANS; DNA-DAMAGE; PROTEIN OXIDATION; MODEL
   SYSTEM; EXPRESSION; LONGEVITY; BRAIN; MICE; GLUTATHIONE; SKELETAL
AB Aging asymmetry is the observation that different tissues age in different ways and at different rates. This has not been assessed in a single organism using multiple biomarkers of aging. Here we clearly demonstrated that the levels of protein oxidation and lipid peroxidation as well as CAT, SOD and GPX activities all showed a tissue-dependent change with advancing age; and DNA repair ability, as revealed by the expression of ercc1 and its protein levels, also exhibited a tissue-specific variation with age. We also found that protein oxidation and lipid peroxidation levels remained relatively stable in the liver, intestine, skin and testis as well as in the brain, eye and heart of young, adult and aged fishes; SOD and GPX activities displayed little variation in the intestine, eye and skin as well as in the brain and skin of young, adult and aged fishes; and low and stable expression of ercc1 was observed in the spleen, eye and heart of young, adult and aged fishes. Collectively, these results indicate that aging is tissue specific and asymmetric in N. guentheri. The observation of aging asymmetry may have practical implications for the application of non-intrusion intervention approaches to prolong lifespan.
C1 [Dong, Yuan; Cui, Pengfei; Li, Zhijian; Zhang, Shicui] Ocean Univ China, Inst Evolut & Marine Biodivers, Dept Marine Biol, Lab Evolut & Dev, Qingdao 266003, Peoples R China.
C3 Ocean University of China
RP Zhang, SC (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Dept Marine Biol, Lab Evolut & Dev, Qingdao 266003, Peoples R China.
EM sczhang@ouc.edu.cn
RI Dong, Yuan/HHZ-3455-2022
OI Dong, Yuan/0000-0001-6579-6466
FU Natural Science Foundation of China [31372505, U1401211]
FX This work was supported by the grants of Natural Science Foundation of
   China (31372505; U1401211). No competing financial interests exist. S.C.
   Zhang designed the research and wrote the manuscript; Y. Dong performed
   the research, analyzed the data and wrote the manuscript; P.F. Cui and
   Z.J. Li participated in the research.
CR Akintola AD, 2008, AM J PHYSIOL-RENAL, V294, pF170, DOI 10.1152/ajprenal.00285.2007
   Almeida Maria, 2012, Bonekey Rep, V1
   Anson RM, 2000, J AM AGING ASSOC, V23, P199, DOI 10.1007/s11357-000-0020-y
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Çakatay U, 2003, CLIN BIOCHEM, V36, P51, DOI 10.1016/S0009-9120(02)00407-1
   Cellerino A, 2016, BIOL REV, V91, P511, DOI 10.1111/brv.12183
   Di Cicco E, 2011, EXP GERONTOL, V46, P249, DOI 10.1016/j.exger.2010.10.011
   Facista Alexander, 2012, Genome Integr, V3, P3, DOI 10.1186/2041-9414-3-3
   Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x
   GENSLER HL, 1981, Q REV BIOL, V56, P279, DOI 10.1086/412317
   Gregg SQ, 2011, DNA REPAIR, V10, P781, DOI 10.1016/j.dnarep.2011.04.026
   HARMAN D, 1965, J GERONTOL, V20, P151, DOI 10.1093/geronj/20.2.151
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Helen O, 2003, EUR J HEART FAIL, V5, P427, DOI [10.1016/S1388-9842(03)00011-4, DOI 10.1016/S1388-9842(03)00011-4]
   Hsu CY, 2008, J GERONTOL A-BIOL, V63, P1267, DOI 10.1093/gerona/63.12.1267
   Jin JL, 2009, AGING-US, V1, P582, DOI 10.18632/aging.100060
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9
   Koutsouleris N, 2014, SCHIZOPHRENIA BULL, V40, P1140, DOI 10.1093/schbul/sbt142
   Latimer CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026812
   Li XL, 2011, AGING-US, V3, P985, DOI 10.18632/aging.100371
   Liu CS, 2012, BIOGERONTOLOGY, V13, P501, DOI 10.1007/s10522-012-9395-2
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lucas-Sánchez A, 2014, AGING DIS, V5, P281, DOI 10.14336/AD.2014.0500281
   MARKOFSKY J, 1972, EXP GERONTOL, V7, P131, DOI 10.1016/0531-5565(72)90007-1
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Montine TJ, 2002, FREE RADICAL BIO MED, V33, P620, DOI 10.1016/S0891-5849(02)00807-9
   Ng'oma E, 2014, AGING-US, V6, P468, DOI 10.18632/aging.100660
   Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8
   SCHISLER NJ, 1987, GENOME, V29, P748, DOI 10.1139/g87-127
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9
   URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5
   Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x
   Van Voorhies WA, 2002, AGING CELL, V1, P91, DOI 10.1046/j.1474-9728.2002.00022.x
   VANMANEN R, 1983, MECH AGEING DEV, V22, P159, DOI 10.1016/0047-6374(83)90109-4
   Wang GF, 2009, FISH SHELLFISH IMMUN, V26, P33, DOI 10.1016/j.fsi.2008.09.018
   WEGLICKI WB, 1969, NATURE, V221, P185, DOI 10.1038/221185a0
   Weisleder N, 2008, AGEING RES REV, V7, P177, DOI 10.1016/j.arr.2007.12.003
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030
   Zhu YG, 2006, BRAIN RES, V1090, P35, DOI 10.1016/j.brainres.2006.03.063
NR 44
TC 17
Z9 17
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-1742
EI 1573-5168
J9 FISH PHYSIOL BIOCHEM
JI Fish Physiol. Biochem.
PD APR
PY 2017
VL 43
IS 2
BP 309
EP 319
DI 10.1007/s10695-016-0288-1
PG 11
WC Biochemistry & Molecular Biology; Fisheries; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Fisheries; Physiology
GA ER7TW
UT WOS:000399017500002
PM 27614442
DA 2024-02-19
ER

PT J
AU Jadzic, J
   Milovanovic, PD
   Cvetkovic, D
   Zivkovic, V
   Nikolic, S
   Tomanovic, N
   Djuric, MP
   Djonic, D
AF Jadzic, Jelena
   Milovanovic, Petar D.
   Cvetkovic, Danica
   Zivkovic, Vladimir
   Nikolic, Slobodan
   Tomanovic, Nada
   Djuric, Marija P.
   Djonic, Danijela
TI The altered osteocytic expression of connexin 43 and sclerostin in human
   cadaveric donors with alcoholic liver cirrhosis: Potential treatment
   targets
SO JOURNAL OF ANATOMY
LA English
DT Article; Early Access
DE alcoholic liver cirrhosis; bone marrow adipose tissue; connexin 43;
   osteocytes; sclerostin
ID GAP-JUNCTION; BONE; APOPTOSIS; MECHANISMS; DENSITY; DISEASE
AB Previous studies suggested that osteocyte lacunar network disruption could play a role in the complex pathophysiology of bone changes in aging and disease. Considering that particular research interest is lacking, we aimed to assess alcoholic liver cirrhosis (ALC)-induced changes in osteocyte lacunar network and bone marrow adiposity. Immunohistochemistry was conducted to assess changes in the micro-morphology of osteocyte lacunar network and bone marrow adiposity, and expression of connexin 43 and sclerostin in vertebral and femoral samples collected from 40 cadaveric men (age range between 44 and 70 years) divided into ALC group (n = 20) and control group (n = 20). Furthermore, the assessment of the potential association between bone changes and the severity of the hepatic disorder (given by Knodell's pathohistologic scoring) was conducted. Our data revealed fewer connexin 43-positive osteocytes per vertebral and femoral bone area (p < 0.01), suggesting defective signal transduction among osteocytes in ALC individuals. Moreover, we found an ALC-induced increase in the number of adipocytes in the vertebral bone marrow (p = 0.038). Considering significant associations between the severity of liver tissue disturbances and impaired functionality of osteocyte lacunar network (Pearson's correlation analyses, p < 0.05), we may assume that timely treatment of the liver disease may delay bone impairment. ALC induced an increase in osteocytic sclerostin expression (p < 0.001), suggesting its role in mediating low bone formation among ALC individuals. Hence, medicaments targeting low bone formation may be beneficial to attenuate the bone changes among ALC patients. However, future clinical studies are required to verify the therapeutic utility of these findings.
C1 [Jadzic, Jelena; Milovanovic, Petar D.; Djuric, Marija P.; Djonic, Danijela] Univ Belgrade, Fac Med, Inst Anat, Lab Bone Biol & Bioanthropol, Dr Subotica 4-2, Belgrade 11000, Serbia.
   [Cvetkovic, Danica; Zivkovic, Vladimir; Nikolic, Slobodan] Univ Belgrade, Fac Med, Inst Forens Med, Belgrade, Serbia.
   [Tomanovic, Nada] Univ Belgrade, Fac Med, Inst Pathol, Belgrade, Serbia.
C3 University of Belgrade; University of Belgrade; University of Belgrade
RP Djonic, D (corresponding author), Univ Belgrade, Fac Med, Inst Anat, Lab Bone Biol & Bioanthropol, Dr Subotica 4-2, Belgrade 11000, Serbia.
EM ddjonic@yahoo.com
RI Milovanovic, Petar/AAH-9358-2020; Jadzic, Jelena/GWU-6755-2022
OI Milovanovic, Petar/0000-0003-1461-8437; Jadzic,
   Jelena/0000-0002-3124-1400; Djonic, Danijela/0000-0003-1043-1077;
   Djukic, Danica/0000-0001-6276-8566; Tomanovic, Nada/0009-0009-9216-4566;
   Nikolic, Slobodan/0000-0001-5501-423X; Djuric,
   Marija/0000-0001-6267-827X
FU Science Fund of the Republic of Serbia; Ministry of Education and
   Science of the Republic of Serbia [III 45005/7]; Alexander von Humboldt
   Foundation [3.4-1162414-SRB-IP]
FX This study received financial support from the Science Fund of the
   Republic of Serbia (IDEAS program, BoFraM group and PROMIS program,
   DiaBoNet group), the Ministry of Education and Science of the Republic
   of Serbia (no. III 45005/7), and from Alexander von Humboldt Foundation
   (Research linkage program, no. 3.4-1162414-SRB-IP).
CR Albakheet SS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234096
   Alvisa-Negrín J, 2009, ALCOHOL ALCOHOLISM, V44, P468, DOI 10.1093/alcalc/agp038
   Balasubramaniyan V, 2013, J HEPATOL, V58, P1194, DOI 10.1016/j.jhep.2013.01.023
   Callaci JJ, 2009, CALCIFIED TISSUE INT, V84, P474, DOI 10.1007/s00223-009-9240-z
   Chakkalakal DA, 2005, ALCOHOL CLIN EXP RES, V29, P2077, DOI 10.1097/01.alc.0000192039.21305.55
   Cooreman A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186534
   Cui QJ, 2006, J BONE JOINT SURG AM, V88A, P148, DOI 10.2106/JBJS.F.00534
   Culafic D, 2015, OSTEOPOROSIS INT, V26, P253, DOI 10.1007/s00198-014-2849-4
   Davis HM, 2018, JBMR PLUS, V2, P206, DOI 10.1002/jbm4.10035
   De Maré A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122027
   Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
   Ehnert S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102555
   Emkey G.R., 2018, ENCY ENDOCRINE DIS, V39, P253, DOI [10.1016/B978-0-12-801238-3.65820-8, DOI 10.1016/B978-0-12-801238-3.65820-8]
   González-Reimers E, 2013, ALCOHOL ALCOHOLISM, V48, P278, DOI 10.1093/alcalc/ags136
   Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006
   Guañabens N, 2018, LIVER INT, V38, P776, DOI 10.1111/liv.13730
   Guañabens N, 2016, J BONE MINER RES, V31, P1725, DOI 10.1002/jbmr.2845
   Hernández-Guerra M, 2019, J HEPATOL, V70, P759, DOI 10.1016/j.jhep.2018.12.023
   Jadzic J, 2020, OSTEOPOROSIS INT, V31, P2209, DOI 10.1007/s00198-020-05509-7
   Jadzic J, 2021, BONE, V150, DOI 10.1016/j.bone.2021.116020
   Jadzic J, 2021, EXP GERONTOL, V150, DOI 10.1016/j.exger.2021.111375
   Jadzic J, 2021, MICROSC RES TECHNIQ, V84, P840, DOI 10.1002/jemt.23642
   Jeong HM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174270
   López-Larramona G, 2013, REV ESP ENFERM DIG, V105, P609, DOI 10.4321/s1130-01082013001000006
   Luo ZH, 2017, CELL MOL LIFE SCI, V74, P4443, DOI 10.1007/s00018-017-2585-y
   Maddalozzo GF, 2009, OSTEOPOROSIS INT, V20, P1529, DOI 10.1007/s00198-009-0836-y
   Maurel DB, 2011, BONE, V49, P543, DOI 10.1016/j.bone.2011.06.001
   Maurel DB, 2014, J CELL MOL MED, V18, P1680, DOI 10.1111/jcmm.12113
   Maurel DB, 2012, ALCOHOL ALCOHOLISM, V47, P413, DOI 10.1093/alcalc/ags057
   Milovanovic P, 2019, CURR OSTEOPOROS REP, V17, P105, DOI 10.1007/s11914-019-00508-y
   Mitchell R, 2011, WORLD J HEPATOL, V3, P157, DOI 10.4254/wjh.v3.i6.157
   Otete H, 2018, J HEPATOL, V69, P697, DOI 10.1016/j.jhep.2018.04.002
   Plotkin LI, 2011, ACTUAL OSTEOL, V7, P79
   Power J, 2001, CALCIFIED TISSUE INT, V69, P13, DOI 10.1007/s00223-001-0013-6
   Rhee Y, 2014, J BONE MINER METAB, V32, P545, DOI 10.1007/s00774-013-0524-z
   Rolvien T, 2018, BONE, V112, P187, DOI 10.1016/j.bone.2018.04.018
   Santori C, 2008, J ENDOCRINOL INVEST, V31, P321, DOI 10.1007/BF03346365
   Schmidt C, 2021, J BONE MINER RES, V36, P1316, DOI 10.1002/jbmr.4289
   Sens C, 2017, J BONE MINER RES, V32, P70, DOI 10.1002/jbmr.2916
   Stains JP, 2014, CALCIFIED TISSUE INT, V94, P55, DOI 10.1007/s00223-013-9742-6
   Stains JP., 2020, PRINCIPLES BONE BIOL, P423, DOI DOI 10.1016/B978-0-12-814841-9.00018-X
   Tratwal J, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00065
   Wakolbinger R, 2019, OSTEOPOROSIS INT, V30, P1195, DOI 10.1007/s00198-019-04870-6
   Wakolbinger R, 2020, WIEN KLIN WOCHENSCHR, V132, P19, DOI 10.1007/s00508-019-01595-8
   Wölfel EM, 2020, BONE, V140, DOI 10.1016/j.bone.2020.115556
   Woods GN, 2020, J BONE MINER RES, V35, P326, DOI 10.1002/jbmr.3895
   Yanguas SC, 2016, EXCLI J, V15, P177, DOI 10.17179/excli2016-119
   Yousry WA., 2016, IOSR J DENT MED SCI, V15, P59, DOI [10.9790/0853-1508065964, DOI 10.9790/0853-1508065964]
   Yu NY, 2017, CLIN RADIOL, V72, DOI 10.1016/j.crad.2016.11.017
NR 49
TC 4
Z9 4
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8782
EI 1469-7580
J9 J ANAT
JI J. Anat.
PD 2022 JUN
PY 2022
VL 240
IS 6
BP 1162
EP 1173
DI 10.1111/joa.13621
EA JAN 2022
PG 12
WC Anatomy & Morphology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology
GA 1J1KY
UT WOS:000737215600001
PM 34978341
DA 2024-02-19
ER

PT J
AU Toda, A
   Uehara, S
   Inoue, T
   Utoh, M
   Kusama, T
   Shimizu, M
   Uno, Y
   Mogi, M
   Sasaki, E
   Yamazaki, H
AF Toda, Akiko
   Uehara, Shotaro
   Inoue, Takashi
   Utoh, Masahiro
   Kusama, Takashi
   Shimizu, Makiko
   Uno, Yasuhiro
   Mogi, Masayuki
   Sasaki, Erika
   Yamazaki, Hiroshi
TI Effects of aging and rifampicin pretreatment on the pharmacokinetics of
   human cytochrome P450 probes caffeine, warfarin, omeprazole, metoprolol
   and midazolam in common marmosets genotyped for <i>cytochrome</i> P450
   2C19
SO XENOBIOTICA
LA English
DT Article
DE Hepatic clearance; human; induction; marmoset; P450 substrates
ID HUMAN PLASMA-CONCENTRATIONS; HUMAN LIVER-MICROSOMES; CYNOMOLGUS MONKEYS;
   IN-VIVO; DRUG-METABOLISM; S-WARFARIN; AGE; ENZYMES; 3A; ALPRAZOLAM
AB 1. The pharmacokinetics were investigated for human cytochrome P450 probes after single intravenous and oral administrations of 0.20 and 1.0 mg/kg, respectively, of caffeine, warfarin, omeprazole, metoprolol and midazolam to aged (10-14 years old, n=4) or rifampicin-treated/young (3 years old, n=3) male common marmosets all genotyped as heterozygous for a cytochrome P450 2C19 variant.
   2. Slopes of the plasma concentration-time curves after intravenous administration of warfarin and midazolam were slightly, but significantly (two-way analysis of variance), decreased in aged marmosets compared with young marmosets. The mean hepatic clearances determined by in silico fitting for individual pharmacokinetic models of warfarin and midazolam in the aged group were, respectively, 23% and 56% smaller than those for the young group.
   3. Significantly enhanced plasma clearances of caffeine, warfarin, omeprazole and midazolam were evident in young marmosets pretreated with rifampicin (25 mg/kg daily for 4days). Two- to three-fold increases in hepatic intrinsic clearance values were observed in the individual pharmacokinetic models.
   4. The in vivo dispositions of multiple simultaneously administered drugs in old, young and P450-enzyme-induced marmosets were elucidated. The results suggest that common marmosets could be experimental models for aged, induced or polymorphic P450 enzymes in P450-dependent drug metabolism studies.
C1 [Toda, Akiko; Utoh, Masahiro; Uno, Yasuhiro; Mogi, Masayuki] Shin Nippon Biomed Labs Ltd, Kainan, Japan.
   [Uehara, Shotaro; Utoh, Masahiro; Kusama, Takashi; Shimizu, Makiko; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Tokyo, Japan.
   [Inoue, Takashi] Cent Inst Expt Anim, Marmoset Res Dept, Kawasaki, Kanagawa, Japan.
   [Sasaki, Erika] Cent Inst Expt Anim, Ctr Appl Dev Biol, Kawasaki, Kanagawa, Japan.
   [Sasaki, Erika] Keio Univ, Keio Adv Res Ctr, Tokyo, Japan.
C3 Shin Nippon Biomedical Laboratories Ltd.; Showa Pharmaceutical
   University; Keio University
RP Yamazaki, H (corresponding author), Showa Pharmaceut Univ, 3-3165 Higashi Tamagawa Gakuen, Machida, Tokyo 1948543, Japan.
EM hyamazak@ac.shoyaku.ac.jp
RI Yamazaki, Hiroshi/A-6081-2011; 井上, 貴史/HPD-0092-2023
OI Yamazaki, Hiroshi/0000-0002-1068-4261; 井上, 貴史/0000-0003-4691-7255;
   Uehara, Shotaro/0000-0002-1359-8828; Uno, Yasuhiro/0000-0001-9040-1681;
   Shimizu, Makiko/0000-0002-2508-4031
CR Birkett DJ, 1996, METHOD ENZYMOL, V272, P132, DOI 10.1016/S0076-6879(96)72016-5
   COMBALBERT J, 1989, DRUG METAB DISPOS, V17, P197
   Corsonello A, 2010, CURR MED CHEM, V17, P571, DOI 10.2174/092986710790416326
   Gorski JC, 2003, CLIN PHARMACOL THER, V74, P275, DOI 10.1016/S0009-9236(03)00187-5
   Ishizawa Y, 2005, CLIN PHARMACOKINET, V44, P1179, DOI 10.2165/00003088-200544110-00005
   Jensen BP, 2012, BRIT J CLIN PHARMACO, V74, P797, DOI 10.1111/j.1365-2125.2012.04259.x
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Koyanagi T, 2015, XENOBIOTICA, V45, P312, DOI 10.3109/00498254.2014.979271
   Koyanagi T, 2014, XENOBIOTICA, V44, P893, DOI 10.3109/00498254.2014.903532
   LARSSON M, 1984, EUR J CLIN PHARMACOL, V27, P217, DOI 10.1007/BF00544048
   McLachlan AJ, 2012, J GERONTOL A-BIOL, V67, P175, DOI 10.1093/gerona/glr118
   Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479
   Ohtsuka T, 2010, DRUG METAB DISPOS, V38, P1806, DOI 10.1124/dmd.110.032656
   Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010
   Qato DM, 2008, JAMA-J AM MED ASSOC, V300, P2867, DOI 10.1001/jama.2008.892
   Shida S, 2016, XENOBIOTICA, V46, P759, DOI 10.3109/00498254.2015.1118650
   Shida S, 2015, XENOBIOTICA, V45, P881, DOI 10.3109/00498254.2015.1028511
   Turpault S, 2009, BRIT J CLIN PHARMACO, V68, P928, DOI 10.1111/j.1365-2125.2009.03548.x
   Uehara S, 2017, DRUG METAB DISPOS, V45, P896, DOI 10.1124/dmd.117.075630
   Uehara Shotaro, 2017, Drug Metab Lett, V10, P244, DOI 10.2174/1872312810666161114144412
   Uehara S, 2017, DRUG METAB DISPOS, V45, P457, DOI 10.1124/dmd.116.074898
   Uehara S, 2016, DRUG METAB DISPOS, V44, P911, DOI 10.1124/dmd.116.070383
   Uehara S, 2016, XENOBIOTICA, V46, P573, DOI 10.3109/00498254.2015.1096980
   Uehara S, 2016, XENOBIOTICA, V46, P163, DOI 10.3109/00498254.2015.1057270
   Uehara S, 2015, DRUG METAB DISPOS, V43, P1408, DOI 10.1124/dmd.115.066100
   Uno Y, 2016, BIOCHEM PHARMACOL, V121, P1, DOI 10.1016/j.bcp.2016.06.008
   Utoh M, 2018, XENOBIOTICA, V48, P206, DOI 10.1080/00498254.2017.1288945
   Utoh M, 2016, XENOBIOTICA, V46, P1049, DOI 10.3109/00498254.2016.1147102
   Utoh M, 2015, BIOCHEM PHARMACOL, V95, P110, DOI 10.1016/j.bcp.2015.03.008
   Yamazaki H, 1997, J PHARMACOL EXP THER, V283, P434
   Yamazaki H, 2016, CHEM RES TOXICOL, V29, P1903, DOI 10.1021/acs.chemrestox.6b00136
NR 31
TC 6
Z9 6
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0049-8254
EI 1366-5928
J9 XENOBIOTICA
JI Xenobiotica
PY 2018
VL 48
IS 7
BP 720
EP 726
DI 10.1080/00498254.2017.1353716
PG 7
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA GF8KZ
UT WOS:000432221300008
PM 28686070
DA 2024-02-19
ER

PT J
AU Koike, K
   Kondo, Y
   Sekiya, M
   Sato, Y
   Tobino, K
   Iwakami, S
   Goto, S
   Takahashi, K
   Maruyama, N
   Seyama, K
   Ishigami, A
AF Koike, Kengo
   Kondo, Yoshitaka
   Sekiya, Mitsuaki
   Sato, Yasunori
   Tobino, Kazunori
   Iwakami, Shin-iciro
   Goto, Sataro
   Takahashi, Kazuhisa
   Maruyama, Naoki
   Seyama, Kuniaki
   Ishigami, Akihito
TI Complete lack of vitamin C intake generates pulmonary emphysema in
   senescence marker protein-30 knockout mice
SO AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
LA English
DT Article
DE chronic obstructive pulmonary disease; collagen
ID NECROSIS-FACTOR-ALPHA; HEP G2 CELLS; ASCORBIC-ACID; RAT-LIVER; IN-VIVO;
   OXIDATIVE STRESS; TOBACCO-SMOKE; SENILE LUNG; DISEASE; MOUSE
AB Koike K, Kondo Y, Sekiya M, Sato Y, Tobino K, Iwakami S, Goto S, Takahashi K, Maruyama N, Seyama K, Ishigami A. Complete lack of vitamin C intake generates pulmonary emphysema in senescence marker protein-30 knockout mice. Am J Physiol Lung Cell Mol Physiol 298: L784-L792, 2010. First published February 19, 2010; doi:10.1152/ajplung.00256.2009.-Vitamin C (VC) is a potent antioxidant and plays an essential role in collagen synthesis. As we previously reported, senescence marker protein-30 (SMP30) knockout (KO) mice cannot synthesize VC due to the genetic disruption of gluconolactonase (i.e., SMP30). Here, we utilized SMP30 KO mice deprived of VC and found that VC depletion caused pulmonary emphysema due to oxidative stress and a decrease of collagen synthesis by the third month of age. We grew SMP30 KO mice and wild-type (WT) mice on VC-free chow and either VC water [VC(+)] or plain water [VC(-)] after weaning at 4 wk of age. Morphometric findings and reactive oxygen species (ROS) in the lungs were evaluated at 3 month of age. No VC was detected in the lungs of SMP30 KO VC(-) mice, but their ROS increased 50.9% over that of the VC(+) group. Moreover, their collagen content in the lungs markedly decreased, and their collagen I mRNA decreased 82.2% compared with that of the WT VC(-) group. In the SMP30 KO VC(-) mice, emphysema developed [21.6% increase of mean linear intercepts (MLI) and 42.7% increase of destructive index compared with VC(+) groups], and the levels of sirtuin 1 (Sirt1) decreased 16.8%. However, VC intake increased the MLI 16.2% and thiobarbituric acid reactive substances 22.2% in WT mice, suggesting that an excess of VC can generate oxidative stress and may be harmful during this period of lung development. These results suggest that VC plays an important role in lung development through affecting oxidant-antioxidant balance and collagen synthesis.
C1 [Seyama, Kuniaki] Juntendo Univ, Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo 1138421, Japan.
   [Kondo, Yoshitaka; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Dept Aging Regulat, Tokyo, Japan.
   [Sato, Yasunori; Ishigami, Akihito] Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Chiba 2748510, Japan.
   [Iwakami, Shin-iciro] Juntendo Univ, Shizuoka Hosp, Dept Resp Med, Shizuoka, Japan.
   [Goto, Sataro] Juntendo Univ, Grad Sch, Inst Hlth & Sports Sci & Med, Chiba, Japan.
C3 Juntendo University; Tokyo Metropolitan Institute of Gerontology; Toho
   University; Juntendo University; Juntendo University
RP Seyama, K (corresponding author), Juntendo Univ, Sch Med, Dept Resp Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.
EM kseyama@juntendo.ac.jp
RI Yoshitaka, Kondo/AFK-7721-2022
OI Yoshitaka, Kondo/0000-0002-0046-9429; Koike, Kengo/0000-0003-4677-3589
FU High Technology Research Center, Ministry of Education, Culture, Sports,
   Science, and Technology; Smoking Science Foundation; Respiratory Failure
   Research Group, Ministry of Health, Labour, and Welfare, Japan;
   Institute for Environmental and Gender-Specific Medicine, Juntendo
   University, Graduate School of Medicine; Grants-in-Aid for Scientific
   Research [21590974] Funding Source: KAKEN
FX This study was supported in part by the High Technology Research Center
   Grant from the Ministry of Education, Culture, Sports, Science, and
   Technology, the Smoking Science Foundation, the Respiratory Failure
   Research Group from the Ministry of Health, Labour, and Welfare, Japan,
   and the Institute for Environmental and Gender-Specific Medicine,
   Juntendo University, Graduate School of Medicine.
CR Arai KY, 2009, BIOCHEM BIOPH RES CO, V385, P478, DOI 10.1016/j.bbrc.2009.05.104
   BIELSKI BHJ, 1975, ANN NY ACAD SCI, V258, P231, DOI 10.1111/j.1749-6632.1975.tb29283.x
   Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651
   BODANNES RS, 1979, FEBS LETT, V105, P195, DOI 10.1016/0014-5793(79)80609-2
   Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104
   DARMIENTO J, 1992, CELL, V71, P955, DOI 10.1016/0092-8674(92)90391-O
   Duarte TL, 2007, FREE RADICAL BIO MED, V43, P1165, DOI 10.1016/j.freeradbiomed.2007.07.017
   EIDELMAN DH, 1990, LUNG, V168, P159, DOI 10.1007/BF02719687
   Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Furusawa H, 2008, BIOL PHARM BULL, V31, P1673, DOI 10.1248/bpb.31.1673
   GEESIN JC, 1988, J INVEST DERMATOL, V90, P420, DOI 10.1111/1523-1747.ep12460849
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158
   Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901
   Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419
   Izumi T, 2004, J CELL BIOCHEM, V92, P296, DOI 10.1002/jcb.20056
   Izumi T, 2003, J CELL BIOCHEM, V89, P800, DOI 10.1002/jcb.10544
   Kasagi S, 2006, AM J PHYSIOL-LUNG C, V290, pL396, DOI 10.1152/ajplung.00483.2004
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   MacNee William, 2009, Proc Am Thorac Soc, V6, P527, DOI 10.1513/pats.200905-027DS
   Manya H, 2002, J BIOL CHEM, V277, P35503, DOI 10.1074/jbc.M206033200
   Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161
   McKeever TM, 2002, AM J RESP CRIT CARE, V165, P1299, DOI 10.1164/rccm.2109030
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   MYLLYLA R, 1978, BIOCHEM BIOPH RES CO, V83, P441, DOI 10.1016/0006-291X(78)91010-0
   NISHIKIMI M, 1975, BIOCHEM BIOPH RES CO, V63, P463, DOI 10.1016/0006-291X(75)90710-X
   Nusgens BV, 2001, J INVEST DERMATOL, V116, P853, DOI 10.1046/j.0022-202x.2001.01362.x
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PARAIDATHATHU T, 1992, FREE RADICAL BIO MED, V13, P289, DOI 10.1016/0891-5849(92)90176-H
   PETERKOFSKY B, 1991, AM J CLIN NUTR, V54, pS1135, DOI 10.1093/ajcn/54.6.1135s
   Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC
   Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X
   Sargeant LA, 2000, EUR RESPIR J, V16, P397, DOI 10.1034/j.1399-3003.2000.016003397.x
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   Sie H, 1991, AM J MED, V9, P31, DOI DOI 10.1016/0002-9343(91)90281-2
   Siedlinski M, 2008, AM J RESP CRIT CARE, V178, P13, DOI 10.1164/rccm.200711-1749OC
   Takubo Y, 2002, AM J RESP CRIT CARE, V166, P1596, DOI 10.1164/rccm.2202001
   TERAMOTO S, 1994, AM J RESP CRIT CARE, V150, P238, DOI 10.1164/ajrccm.150.1.8025756
   THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P765
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Tricon S., 2006, Clinical and Experimental Allergy Reviews, V6, P117, DOI 10.1111/j.1365-2222.2006.00114.x
   Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC
   Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006
NR 52
TC 36
Z9 44
U1 0
U2 8
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1040-0605
EI 1522-1504
J9 AM J PHYSIOL-LUNG C
JI Am. J. Physiol.-Lung Cell. Mol. Physiol.
PD JUN
PY 2010
VL 298
IS 6
BP L784
EP L792
DI 10.1152/ajplung.00256.2009
PG 9
WC Physiology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Respiratory System
GA 596ZG
UT WOS:000277724200008
PM 20172953
DA 2024-02-19
ER

PT J
AU Nicolas, G
   Stefano, B
   Andreas, C
   Jean-Francoisd, D
   Francois, RJ
   Joachim, M
   Alberto, M
   Beat, M
   Francescoa, N
   Homie, R
   David, S
   Chris, E
AF Nicolas, Goossens
   Stefano, Bellentani
   Andreas, Cerny
   Jean-Francoisd, Dufour
   Francois, Jornayvaz R.
   Joachim, Mertens
   Alberto, Moriggia
   Beat, Muellhaupt
   Francescoa, Negro
   Homie, Razavi
   David, Semela
   Chris, Estes
TI Nonalcoholic fatty liver disease burden - Switzerland 2018-2030
SO SWISS MEDICAL WEEKLY
LA English
DT Article
DE metabolic syndrome; non-alcoholic fatty liver disease; liver cirrhosis;
   liver neoplasms; carcinoma; hepatocellular
ID HEPATOCELLULAR-CARCINOMA INCIDENCE; LONG-TERM OUTCOMES; QUALITY-OF-LIFE;
   INCREASED RISK; UNITED-STATES; HEPATITIS-C; POPULATION; FIBROSIS;
   STEATOHEPATITIS; PREVALENCE
AB As a result of epidemic levels of obesity and diabetes mellitus, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) will contribute to increases in the liver-related disease burden in Switzerland.
   A Markov model was built to quantify fibrosis progression among the NAFLD and NASH populations, and predict disease burden up to 2030. Long-term trending of NAFLD prevalence was based on changes in the prevalence of adult obesity. Published estimates and surveillance data were applied to build and validate the model projections.
   The prevalence of NAFLD increased up to 2030 in tandem with projected increases in adult obesity. By 2030, there were an estimated 2,234,000 (1,918,000-2,553,000) NAFLD cases, or 24.3% (20.9-27.8%) of the total Swiss population (all ages). Increases in NASH cases were relatively greater than NAFLD cases. Incident cases of advanced liver disease are projected to increase by approximately 40% by 2030, and incident NAFLD liver deaths to increase from 580 deaths in 2018 to 820 deaths in 2030.
   Continued growth in obesity, in combination with an aging population, will result in increasing number of cases of advanced liver disease and mortality related to NAFLD and NASH. Slowing the growth in obesity and metabolic syndrome, along with future potential therapies, are required to reduce liver disease burden.
C1 [Nicolas, Goossens; Francescoa, Negro] Geneva Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland.
   [Stefano, Bellentani] Clin Santa Chiara, Gastroenterol & Hepatol Serv, Locarno, Switzerland.
   [Andreas, Cerny; Alberto, Moriggia] Epatoctr Ticino Fdn, Lugano, Switzerland.
   [Jean-Francoisd, Dufour] Univ Bern, Univ Clin Visceral Surg & Med, Inselspital, Bern, Switzerland.
   [Jean-Francoisd, Dufour] Univ Bern, Dept Biomed Res, Bern, Switzerland.
   [Francois, Jornayvaz R.] Lausanne Univ Hosp, Lausanne, Switzerland.
   [Joachim, Mertens; Beat, Muellhaupt] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland.
   [Joachim, Mertens] Univ Zurich, Zurich, Switzerland.
   [Beat, Muellhaupt] Univ Hosp Zurich, Swiss Hepatopancreato Biliary Ctr, Zurich, Switzerland.
   [Francescoa, Negro] Univ Hosp, Div Clin Pathol, Geneva, CO, Switzerland.
   [Homie, Razavi; Chris, Estes] Ctr Dis Anal, Lafayette, CO USA.
   [David, Semela] Hosp St Gallen, Div Gastroenterol & Hepatol, St Gallen, Switzerland.
C3 University of Geneva; University of Bern; University Hospital of Bern;
   University of Bern; University of Lausanne; Centre Hospitalier
   Universitaire Vaudois (CHUV); University of Zurich; University Zurich
   Hospital; University of Zurich; University of Zurich; University Zurich
   Hospital; University of Geneva; Kantonsspital St. Gallen
RP Homie, R (corresponding author), Ctr Dis Anal Fdn, 1120 W South Boulder Rd, Lafayette, CO 80026 USA.
EM Hrazavi@cdafound.org
RI Jornayvaz, François/AAL-2134-2020
OI Jornayvaz, Francois/0000-0001-9425-3137; Goossens,
   Nicolas/0000-0002-8698-4690; Razavi, Homie/0000-0002-2658-6930;
   Bellentani, Stefano/0000-0003-2836-8870
FU Gilead Sciences
FX Funding for this project was provided by Gilead Sciences. The funders
   had no role in the study design, data collection, analysis,
   interpretation of data, or preparation of the manuscript. The experts
   consulted in the Delphi process did not receive financial compensation.
CR Al Hasani F, 2014, ANN HEPATOL, V13, P204
   Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798
   Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11
   Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496
   Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057
   [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006
   [Anonymous], 2014, ROBERT KOCH I ASS PO
   [Anonymous], 2018, WORLD POP PROSP 2017
   Bernfort L, 2006, SCAND J INFECT DIS, V38, P497, DOI 10.1080/00365540500532803
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Caballería L, 2018, CLIN GASTROENTEROL H, V16, P1138, DOI 10.1016/j.cgh.2017.12.048
   Caballería L, 2010, EUR J GASTROEN HEPAT, V22, P24, DOI 10.1097/MEG.0b013e32832fcdf0
   Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
   Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI [10.1016/S0002-9270(02)06054-9, 10.1111/j.1572-0241.2003.07332.x]
   Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/s0140-6736(16)30054-x
   Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085
   Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011
   EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y
   Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036
   Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3
   Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010
   Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429
   Hong TP, 2016, HEPATOLOGY, V63, P1205, DOI 10.1002/hep.28267
   Huber CA, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-44
   Koehler EM, 2016, HEPATOLOGY, V63, P138, DOI 10.1002/hep.27981
   Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020
   Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171
   MALCOLM DG, 1959, OPER RES, V7, P646, DOI 10.1287/opre.7.5.646
   McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034
   Petta S, 2018, LIVER INT, V38, P2060, DOI 10.1111/liv.13743
   Pfeil AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126984
   Pimpin L, 2018, J HEPATOL, V69, P718, DOI 10.1016/j.jhep.2018.05.011
   Piscaglia F, 2016, HEPATOLOGY, V63, P827, DOI 10.1002/hep.28368
   Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084
   Ratziu V, 2016, J HEPATOL, V65, P249, DOI 10.1016/j.jhep.2016.05.021
   Ries L. A. G., 2007, SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, V076215, P193
   Sanyal A, 2010, CURR MED RES OPIN, V26, P2183, DOI 10.1185/03007995.2010.506375
   Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103
   Singh S, 2016, EUR RADIOL, V26, P1431, DOI 10.1007/s00330-015-3949-z
   Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014
   Stepanova M, 2013, DIGEST DIS SCI, V58, P3017, DOI 10.1007/s10620-013-2743-5
   Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013
   Weinmann A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1197-x
   Weinmann A, 2014, J CLIN GASTROENTEROL, V48, P279, DOI 10.1097/MCG.0b013e3182a8a793
   White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001
   Wiegand S, 2010, INT J OBESITY, V34, P1468, DOI 10.1038/ijo.2010.106
   Williams R, 2018, LANCET, V391, P1097, DOI 10.1016/S0140-6736(17)32866-0
   Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986
   World Health Organization, 2013, WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020
   Younossi ZM, 2015, HEPATOLOGY, V62, p739A
   Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123
   Younossi ZM, 2015, PHARMACOECONOMICS, V33, P1245, DOI 10.1007/s40273-015-0316-5
   Younossi ZM, 2015, J CLIN GASTROENTEROL, V49, P222, DOI 10.1097/MCG.0000000000000071
   Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8
NR 57
TC 12
Z9 12
U1 0
U2 2
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
EI 1424-3997
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD DEC 17
PY 2019
VL 149
AR w20152
DI 10.4414/smw.2019.20152
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA JX0NI
UT WOS:000503440400004
PM 31846507
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Gorraiz, C
   Beriain, MJ
   Chasco, J
   Insausti, K
AF Gorraiz, C
   Beriain, MJ
   Chasco, J
   Insausti, K
TI Effect of aging time on volatile compounds, odor, and flavor of cooked
   beef from Pirenaica and Friesian bulls and heifers
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE beef; volatile compounds; flavor; aging
ID INSTRUMENTAL ANALYSES; MEAT; IDENTIFICATION; MUSCLE
AB Volatile compounds, odor, and flavor produced by beef from bulls and heifers of the Pirenaica and Friesian breeds were studied during 7 d of aging. The Friesian breed beef had stronger fatty flavor and aftertaste than the Pirenaica, as well as differences in the content of several volatile compounds. Bull beef had stronger liver-like odor and flavor, and bloody flavor that were related to a higher 2-propanone content, while beef from heifers had stronger characteristic flavor. Aging of meat increased characteristic flavor and aftertaste. Ethanal showed a positive correlation with livery flavor and a negative correlation with the characteristic odor. The hexane seems to contribute to fatty flavor, 2-propanone was related to livery and bloody notes, and 2,2,4,6,6-pentamethylheptane to characteristic flavor.
C1 Univ Publ Navarra, Escuela Tecn Super Ingenieros Agron, Pamplona 31006, Spain.
C3 Universidad Publica de Navarra
RP Beriain, MJ (corresponding author), Univ Publ Navarra, Escuela Tecn Super Ingenieros Agron, Pamplona 31006, Spain.
RI Insausti, Kizkitza/AAH-8956-2021; Beriain, Maria Jose/AAA-7466-2020
OI Insausti, Kizkitza/0000-0002-3821-814X; Beriain, Maria
   Jose/0000-0002-6662-6394
CR ACREE I, 1997, FLAVORNET
   ALZUETA MJ, 2000, THESIS U PUBLICA NAV
   AMSA, 1978, GUID COOK SENS EV ME
   Baines D. A., 1983, RECENT ADV CHEM MEAT, P119
   *BOE, 1993, B OF EST
   Denoyelle C., 1995, Viandes et Produits Carnes, V16, P89
   Dikeman ME., 1987, P RECIP MEAT C, V40, P93
   GOLOVNJA RV, 1980, NAHRUNG, V24, P141, DOI 10.1002/food.19800240205
   Gorraiz C, 2000, J SENS STUD, V15, P137, DOI 10.1111/j.1745-459X.2000.tb00261.x
   GUTH H, 1994, J AGR FOOD CHEM, V42, P2862, DOI 10.1021/jf00048a039
   HOOD RL, 1971, J FOOD SCI, V36, P786, DOI 10.1111/j.1365-2621.1971.tb03306.x
   JEREMIAH LE, 1991, J MUSCLE FOODS, V2, P191
   Kondjoyan N., 1996, COMPILATION RELATIVE
   LARICK DK, 1989, J FOOD SCI, V54, P521, DOI 10.1111/j.1365-2621.1989.tb04641.x
   Lawrie R. A., 1985, Meat science, V4th ed.
   LIZASO G, 1998, THESIS U PUBLICA NAV
   MACLEOD G, 1981, CRC CR REV FOOD SCI, V14, P309, DOI 10.1080/10408398109527309
   MacLeod G., 1986, Flavour and Fragrance Journal, V1, P91, DOI 10.1002/ffj.2730010302
   MOIO L, 1993, J DAIRY RES, V60, P199, DOI 10.1017/S0022029900027515
   Mottram DS, 1998, FOOD CHEM, V62, P415, DOI 10.1016/S0308-8146(98)00076-4
   Mottram DS, 1994, Flavor of meat and meat products, P210
   RESURRECCION AVA, 1988, FOOD TECHNOL-CHICAGO, V42, P128
   SHAHIDI F, 1986, CRIT REV FOOD SCI, V24, P141, DOI 10.1080/10408398609527435
   SINK JD, 1979, J FOOD SCI, V44, P1, DOI 10.1111/j.1365-2621.1979.tb09992.x
   SPANIER AM, 1992, J FOOD SCI, V57, P10, DOI 10.1111/j.1365-2621.1992.tb05413.x
   SPECHT K, 1994, J AGR FOOD CHEM, V42, P2246, DOI 10.1021/jf00046a031
   *SPSS, 1998, US GUID
   STANGELO AJ, 1987, J FOOD SCI, V52, P1163, DOI 10.1111/j.1365-2621.1987.tb14034.x
   STANGELO AJ, 1987, WARMED OVER FLAVOR M
   Touraille C., 1985, B TECH CRZV, V60, P83
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P194
   VEJAPHAN W, 1988, J FOOD SCI, V53, P1669
   WHITFIELD FB, 1992, CRIT REV FOOD SCI, V31, P1, DOI 10.1080/10408399209527560
NR 33
TC 88
Z9 100
U1 1
U2 43
PU INST FOOD TECHNOLOGISTS
PI CHICAGO
PA 525 WEST VAN BUREN, STE 1000, CHICAGO, IL 60607-3814 USA
SN 0022-1147
J9 J FOOD SCI
JI J. Food Sci.
PD APR
PY 2002
VL 67
IS 3
BP 916
EP 922
DI 10.1111/j.1365-2621.2002.tb09428.x
PG 7
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 555LB
UT WOS:000175794600004
DA 2024-02-19
ER

PT J
AU Goto, S
   Nakamura, A
   Radak, Z
   Nakamoto, H
   Takahashi, R
   Yasuda, K
   Sakurai, Y
   Ishii, N
AF Goto, S
   Nakamura, A
   Radak, Z
   Nakamoto, H
   Takahashi, R
   Yasuda, K
   Sakurai, Y
   Ishii, N
TI Carbonylated proteins in aging and exercise: immunoblot approaches
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Proceedings Paper
CT 2nd International NILS Workshop on Longevity Sciences - Roles of Protein
   in Aging and Age-Associated Disorders
CY NOV 29-30, 1997
CL OBU, JAPAN
SP NILS
DE protein oxidation; protein carbonyl; aging; exercise; nematode;
   vitellogenin
ID OXIDATIVELY MODIFIED PROTEINS; CAENORHABDITIS-ELEGANS; SKELETAL-MUSCLE;
   FREE-RADICALS; SENSITIVE MUTANT; LIFE EXPECTANCY; RAT-KIDNEY; DAMAGE;
   ANTIOXIDANT; ACCUMULATION
AB Protein carbonyls were studied in aging and exercise by immunoblot followed by one- or two-dimensional polyacrylamide gel electrophoresis using antibodies against 2,4-dinitrophenylhydrazones. Proteins of rat kidneys exhibited significant age-related increase in the amount of carbonyl while those of the brain and liver did not. Major carbonylated proteins in the kidney included serum albumin. In nematodes in which protein carbonyls increased with age, one of the carbonylated proteins was identified as vitellogenin, an egg-yolk protein. A possible biological significance of this protein present in abundance even after egg-laying stages is discussed in terms of protection against oxidative stress. Exhaustive exercise induced significant increase in the carbonylation of selected but unidentified proteins in the lung. This oxidative stress might be caused by xanthine oxidase in this tissue and hypoxanthine derived from ATP-depleted muscles. Exercise at high altitude caused higher carbonylation of the skeletal muscle proteins, most notably a protein likely to be actin, than that at sea level but no significant difference was observed in lipid peroxidation. These studies emphasize the value of immunoblot analysis of tissue protein carbonyls in a variety of situations where oxidative stress is likely involved. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Toho Univ, Sch Pharmaceut Sci, Dept Biochem, Funabashi, Chiba 2748510, Japan.
   Hungarian Univ Phys Educ, H-1123 Budapest, Hungary.
   Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 2570811, Japan.
C3 Toho University; University of Physical Education; Tokai University
RP Goto, S (corresponding author), Toho Univ, Sch Pharmaceut Sci, Dept Biochem, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.
EM goto@phar.toho-u.ac.jp
RI Yasuda, Kayo/ABA-5867-2021
OI Yasuda, Kayo/0000-0002-6205-9249; Radak, Zsolt/0000-0003-1297-6804
CR Adachi H, 1998, J GERONTOL A-BIOL, V53, pB240, DOI 10.1093/gerona/53A.4.B240
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P79515
   BAKALA H, 1995, MECH AGEING DEV, V78, P63, DOI 10.1016/0047-6374(94)01527-S
   BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093
   Booth FW, 1998, ACTA PHYSIOL SCAND, V162, P343, DOI 10.1046/j.1365-201X.1998.0326e.x
   BURNETT VL, 1989, J HISTOCHEM CYTOCHEM, V37, P813, DOI 10.1177/37.6.2470808
   Caraceni P, 1997, FREE RADICAL BIO MED, V23, P339, DOI 10.1016/S0891-5849(96)00571-0
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9902
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Friedman D.B., 1988, Journals of Gerontology, V43, P102
   Goto S, 1997, AGE, V20, P81, DOI 10.1007/s11357-997-0008-y
   HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8
   HAYASE F, 1989, J BIOL CHEM, V264, P3758
   HOLLOSZY JO, 1993, J GERONTOL, V48, pB97, DOI 10.1093/geronj/48.3.B97
   HOSOKAWA H, 1994, MECH AGEING DEV, V74, P161, DOI 10.1016/0047-6374(94)90087-6
   ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   KINNULA VL, 1992, EXP LUNG RES, V18, P655, DOI 10.3109/01902149209031700
   KRISTAL BS, 1992, J GERONTOL, V47, pB107, DOI 10.1093/geronj/47.4.B107
   LANE SE, 1972, BIOCHIM BIOPHYS ACTA, V263, P433, DOI 10.1016/0005-2795(72)90095-5
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Liggins J, 1997, BBA-MOL BASIS DIS, V1361, P123, DOI 10.1016/S0925-4439(97)00023-9
   Loban A, 1997, CLIN SCI, V93, P445, DOI 10.1042/cs0930445
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   NAKAMOTO H, 1994, INT CONGR SER, V1062, P137
   Nakamura A, 1996, J BIOCHEM, V119, P768
   Oliver C.N., 1985, MODIFICATION PROTEIN, P39
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144
   Radák Z, 1998, PFLUG ARCH EUR J PHY, V435, P439, DOI 10.1007/s004240050537
   RADAK Z, 1995, J APPL PHYSIOL, V79, P129, DOI 10.1152/jappl.1995.79.1.129
   RADAK Z, 1994, EUR J APPL PHYSIOL, V69, P392, DOI 10.1007/BF00865401
   Radak Z, 1997, FREE RADICAL BIO MED, V22, P1109, DOI 10.1016/S0891-5849(96)00350-4
   REZNICK AZ, 1992, BIOCHEM BIOPH RES CO, V189, P801, DOI 10.1016/0006-291X(92)92273-Z
   Reznick AZ PL, 1998, OXIDATIVE STRESS SKE
   RICHARDS MP, 1987, J EXP ZOOL, P39
   SARNA S, 1993, MED SCI SPORT EXER, V25, P237
   SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   SOHAL RS, 1995, MECH AGEING DEV, V81, P15, DOI 10.1016/0047-6374(94)01578-A
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   TAKAHASHI R, 1990, ARCH BIOCHEM BIOPHYS, V277, P228, DOI 10.1016/0003-9861(90)90573-H
   UCHIDA K, 1995, ARCH BIOCHEM BIOPHYS, V317, P405, DOI 10.1006/abbi.1995.1181
   VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605
   VONHEUSDEN MC, 1991, PROTEIN EXPRES PURIF, V2, P24
   WITT EH, 1992, J NUTR, V122, P766, DOI 10.1093/jn/122.suppl_3.766
   Zhao GC, 1997, AM J PHYSIOL-LUNG C, V273, pL1112, DOI 10.1152/ajplung.1997.273.6.L1112
NR 53
TC 85
Z9 92
U1 1
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR 15
PY 1999
VL 107
IS 3
BP 245
EP 253
DI 10.1016/S0047-6374(98)00133-X
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cell Biology; Geriatrics & Gerontology
GA 192VC
UT WOS:000080099400004
PM 10360680
DA 2024-02-19
ER

PT J
AU Hagiwara, K
   Watanabe, A
   Harimoto, N
   Araki, K
   Yokobori, T
   Muranushi, R
   Hoshino, K
   Ishii, N
   Tsukagoshi, M
   Shirabe, K
AF Hagiwara, Kei
   Watanabe, Akira
   Harimoto, Norifumi
   Araki, Kenichiro
   Yokobori, Takehiko
   Muranushi, Ryo
   Hoshino, Kouki
   Ishii, Norihiro
   Tsukagoshi, Mariko
   Shirabe, Ken
TI Liver regeneration after hepatectomy is significantly suppressed in a
   muscular atrophy mouse model
SO JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
LA English
DT Article; Early Access
DE branched-chain amino acid; liver regeneration; peroxisome
   proliferator-activated receptor gamma coactivator-1 alpha; sarcopenia
ID CHAIN AMINO-ACIDS; HEPATOCELLULAR-CARCINOMA; MUSCLE MASS;
   SUPPLEMENTATION; GLUCOSE; OVEREXPRESSION; METABOLISM; SENESCENCE;
   DEPLETION
AB Background: Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength. As reported in previous studies, the loss of skeletal muscle mass is associated with poor liver regeneration after hepatectomy. It is considered important to clarify the effect of sarcopenia on liver regeneration; however, there are no reports about model animals for sarcopenia. We focused on the peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1 alpha) transgenic mice that overexpressed PGC-1 alpha, specifically for skeletal muscle, and showed significant atrophy of type 2B fiber-rich muscles like sarcopenia.Methods: We performed 70% hepatectomy using PGC-1 alpha transgenic mice and examined the liver regeneration rate and the effects of branched-chain amino acids (BCAA) after hepatectomy.Results: Liver regeneration after 70% hepatectomy was significantly suppressed in the PGC-1 alpha transgenic mice. In addition, a decrease in the blood BCAA concentration and a decrease in the liver glycogen content after 70% hepatectomy were observed in the PGC-1 alpha transgenic mice. By administering BCAA before and after surgery, it was clarified that a significant increase in the blood BCAA concentration was observed and the liver regeneration rate was improved in the PGC-1 alpha transgenic mice.Conclusions: BCAA administration may improve the suppression of liver regeneration in patients with sarcopenia.
C1 [Hagiwara, Kei; Watanabe, Akira; Harimoto, Norifumi; Araki, Kenichiro; Muranushi, Ryo; Hoshino, Kouki; Ishii, Norihiro; Tsukagoshi, Mariko; Shirabe, Ken] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Div Hepatobiliary & Pancreat Surg, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.
   [Yokobori, Takehiko] Gunma Univ Initiat Adv Res GIAR, Div Integrated Oncol Res, Maebashi, Gunma, Japan.
C3 Gunma University; Gunma University
RP Harimoto, N (corresponding author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Div Hepatobiliary & Pancreat Surg, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.
EM nharimotoh1@gmail.com
FU We thank the staff of Bioresource Center, Gunma University Graduate
   School of Medicine for their technical help. This work was carried out
   in part at the Bioresource Center, Gunma University Graduate School of
   Medicine. We also thank Dolgormaa Gantumur and; Gunma University
   Graduate School of Medicine; Pancreatic Surgery, Department of General
   Surgical Science
FX We thank the staff of Bioresource Center, Gunma University Graduate
   School of Medicine for their technical help. This work was carried out
   in part at the Bioresource Center, Gunma University Graduate School of
   Medicine. We also thank Dolgormaa Gantumur and the staff of Division of
   Hepatobiliary and Pancreatic Surgery, Department of General Surgical
   Science, Gunma University Graduate School of Medicine, for providing
   technical support for this experiment.
CR Beppu T, 2015, J GASTROENTEROL, V50, P1197, DOI 10.1007/s00535-015-1067-y
   Cardiff Robert D, 2014, Cold Spring Harb Protoc, V2014, P655, DOI 10.1101/pdb.prot073411
   Chang CF, 2010, INT J BIOCHEM CELL B, V42, P1708, DOI 10.1016/j.biocel.2010.06.025
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   de Araujo JA, 2006, LIFE SCI, V79, P1343, DOI 10.1016/j.lfs.2006.03.045
   Derave W, 2005, EXP GERONTOL, V40, P562, DOI 10.1016/j.exger.2005.05.005
   Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017
   Fernandez-Rojo MA, 2012, HEPATOLOGY, V55, P1574, DOI 10.1002/hep.24810
   Ichikawa K, 2013, SURG TODAY, V43, P720, DOI 10.1007/s00595-012-0288-4
   Jeong JH, 2017, MED SCI SPORT EXER, V49, P1562, DOI 10.1249/MSS.0000000000001286
   Kim SJ, 2011, HEPATO-GASTROENTEROL, V58, P1280, DOI 10.5754/hge10389
   Kurokawa T, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-99
   LAI HS, 1992, JPEN-PARENTER ENTER, V16, P152, DOI 10.1177/0148607192016002152
   LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11
   Li XL, 2004, LIVER TRANSPLANT, V10, P1173, DOI 10.1002/lt.20240
   Mert S, 2021, J BURN CARE RES, V42, P269, DOI 10.1093/jbcr/iraa145
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200
   Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034
   Nie CX, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040954
   Obayashi Y, 2012, AMINO ACIDS, V43, P2371, DOI 10.1007/s00726-012-1317-8
   Porter C, 2013, INT J BURNS TRAUMA, V3, P9
   Pravisani R, 2020, HEPATOBIL SURG NUTR, V9, P183, DOI 10.21037/hbsn.2019.11.08
   Shirabe K, 2013, SCAND J SURG, V102, P101, DOI 10.1177/1457496913482250
   TABUCCHI A, 1987, BIOCHIM BIOPHYS ACTA, V926, P177, DOI 10.1016/0304-4165(87)90235-2
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   Tomiya T, 2004, BIOCHEM BIOPH RES CO, V313, P411, DOI 10.1016/j.bbrc.2003.07.017
   Tsunoda T, 2003, AM J PATHOL, V162, P1857, DOI 10.1016/S0002-9440(10)64320-9
   Wei XY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091075
   Whitson BA, 2021, CURR OPIN PHARMACOL, V59, P26, DOI 10.1016/j.coph.2021.04.005
   Yamanaka T, 2020, BRIT J CANCER, V122, P986, DOI 10.1038/s41416-020-0744-7
NR 31
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1868-6974
EI 1868-6982
J9 J HEPATO-BIL-PAN SCI
JI J. Hepato-Biliary-Pancreat. Sci.
PD 2023 NOV 1
PY 2023
DI 10.1002/jhbp.1386
EA NOV 2023
PG 10
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery
GA W8XS7
UT WOS:001094409600001
PM 37909250
DA 2024-02-19
ER

PT J
AU Bauernfeind, F
   Niepmann, S
   Knolle, PA
   Hornung, V
AF Bauernfeind, Franz
   Niepmann, Sven
   Knolle, Percy A.
   Hornung, Veit
TI Aging-Associated TNF Production Primes Inflammasome Activation and
   NLRP3-Related Metabolic Disturbances
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID NECROSIS-FACTOR-ALPHA; NLRP3 INFLAMMASOME; URIC-ACID; OBESITY; GLUCOSE;
   ETANERCEPT; MECHANISMS; INDUCTION; CELLS
AB Accumulating evidence suggests that the activation of the innate branch of the immune system plays a pivotal role in the induction and perpetuation of metabolic and aging-related diseases. In this context, the NLRP3 inflammasome pathway has been identified as an important driver of sterile inflammatory processes. De novo protein synthesis of NLRP3 induced by signals such as TLR ligands or TNF is a prerequisite for sustained NLRP3 mediated caspase-1 cleavage and inflammasome activation. Here, we demonstrate in aged mice that spontaneously elevated TNF represents a critical priming signal that functions to control NLRP3 inflammasome activation. Elevated systemic TNF levels were responsible for increased NLRP3 expression and caspase-1 activity in adipose tissues and liver. TNF dependent, spontaneous inflammasome activity in aged mice resulted in impaired glucose tolerance that could be attributed to peripheral insulin resistance. Altogether, these results implicate that TNF-driven NLRP3 expression constitutes an important checkpoint that regulates inflammasome activation, presumably by additional signals such as aging-associated DAMPs.
C1 [Bauernfeind, Franz; Niepmann, Sven; Hornung, Veit] Univ Bonn, Univ Hosp, Inst Mol Med, Sigmund Freud Str 25, D-53127 Bonn, Germany.
   [Bauernfeind, Franz] Univ Bonn, Univ Hosp, Dept Internal Med 3, D-53127 Bonn, Germany.
   [Knolle, Percy A.] Univ Bonn, Univ Hosp, Inst Expt Immunol, D-53127 Bonn, Germany.
   [Hornung, Veit] Univ Munich, Dept Biochem, Gene Ctr, D-81377 Munich, Germany.
C3 University of Bonn; University of Bonn; University of Bonn; University
   of Munich
RP Bauernfeind, F; Hornung, V (corresponding author), Univ Bonn, Univ Hosp, Inst Mol Med, Sigmund Freud Str 25, D-53127 Bonn, Germany.
EM bauernfeind@uni-bonn.de; veit.hornung@uni-bonn.de
RI Hornung, Veit/C-3565-2012; Bauernfeind, Franz-Georg/ABF-1148-2020
OI Hornung, Veit/0000-0002-4150-194X; Knolle, Percy A./0000-0003-2983-0414
CR Araújo EP, 2007, ENDOCRINOLOGY, V148, P5991, DOI 10.1210/en.2007-0132
   Bartok E, 2013, NAT METHODS, V10, P147, DOI [10.1038/nmeth.2327, 10.1038/NMETH.2327]
   Bauernfeind F, 2013, EMBO MOL MED, V5, P814, DOI 10.1002/emmm.201201771
   Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363
   Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8
   Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357
   Chandrasekera PC, 2014, ALTEX-ALTERN ANIM EX, V31, P157, DOI 10.14573/altex.1309231
   Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101
   Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261
   Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938
   Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681
   Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173
   Grant RW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00050
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x
   Hegenbarth S, 2000, HUM GENE THER, V11, P481, DOI 10.1089/10430340050015941
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130
   Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040
   Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188
   Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515
   Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516
   McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278
   Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960
   Orr JS, 2013, JOVE-J VIS EXP, DOI 10.3791/50707
   Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294
   Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705
   Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879
   Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878
   Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170
   Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108
   Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759
   Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725
   Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279
   von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022
   Yazdani-Biuki B, 2004, EUR J CLIN INVEST, V34, P641, DOI 10.1111/j.1365-2362.2004.01390.x
   Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010
NR 39
TC 90
Z9 97
U1 3
U2 8
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD OCT 1
PY 2016
VL 197
IS 7
BP 2900
EP 2908
DI 10.4049/jimmunol.1501336
PG 9
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA DY3OX
UT WOS:000385004600038
PM 27566828
DA 2024-02-19
ER

PT J
AU Kitano, S
   Bohr, VA
   Reed, TD
   Haggerty, CM
   May, A
   Roth, GS
AF Kitano, S
   Bohr, VA
   Reed, TD
   Haggerty, CM
   May, A
   Roth, GS
TI Effect of aging on EGF-stimulated replication of specific genes in rat
   hepatocytes
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID DNA-POLYMERASE-ALPHA; MITOCHONDRIAL-DNA; CELLS; DELTA
AB EGF-stimulated replication of specific genes was examined in primary hepatocyte cultures from mature (6 months) and senescent (24 months) rats. Basal and EGF-stimulated [H-3]thymidine incorporation and DNA polymerase a activities, as well as total cellular DNA, were also assessed. The genes examined were dihydrofolate reductase (DHFR) and c-myc, as well as total mitochondrial DNA (mt DNA). Although [H-3]thymidine incorporation, DNA polymerase alpha activity, total cellular DNA, DHFR, and c-myc gene specific DNA replication stimulated by EGF are reduced with age, mt DNA replication is not affected by either EGF or age. Chromosomal DNA replication is mediated mainly by DNA polymerase alpha while mt DNA replication is mediated by its own DNA polymerase gamma. Thus, the age-related decline in stimulated DNA replication appears to be associated mainly with the DNA polymerase alpha activation pathway. (C) 1998 Wiley-Liss, Inc.
C1 NIA, Mol Physiol & Genet Sect, Cellular & Mol Biol Lab, Gerontol Res Ctr,Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA.
   NIA, Mol Genet Lab, Gerontol Res Ctr, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA.
C3 Johns Hopkins University; Johns Hopkins Medicine; National Institutes of
   Health (NIH) - USA; NIH National Institute on Aging (NIA); National
   Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA);
   Johns Hopkins University; Johns Hopkins Medicine
RP Roth, GS (corresponding author), NIA, Mol Physiol & Genet Sect, Cellular & Mol Biol Lab, Gerontol Res Ctr,Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA.
RI Bohr, Vilhelm/AAP-5931-2020
OI Haggerty, Cynthia/0000-0002-6019-2724
CR BUCHER NLR, 1964, CANCER RES, V24, P509
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CRISTOFA.VJ, 1969, MED EXP, V19, P313
   CRISTOFALO VJ, 1985, CRC HDB CELL BIOL AG
   CROUSE GF, 1985, MOL CELL BIOL, V5, P1847, DOI 10.1128/MCB.5.8.1847
   CRUTE JJ, 1986, BIOCHEMISTRY-US, V25, P26, DOI 10.1021/bi00349a005
   DEPAMPHILIS ML, 1993, ANNU REV BIOCHEM, V62, P29
   Dijkwel PA, 1996, J CELL BIOCHEM, V62, P210, DOI 10.1002/(SICI)1097-4644(199608)62:2<210::AID-JCB9>3.3.CO;2-T
   DIJKWEL PA, 1995, MOL CELL BIOL, V15, P3023
   DOWNEY KM, 1988, CANCER CELLS EUKARYO, V6, P403
   DUTARTRE P, 1991, MECH AGEING DEV, V59, P275, DOI 10.1016/0047-6374(91)90138-P
   FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES
   FRIEDMAN HS, 1994, CANCER RES, V54, P3487
   FRY M, 1986, ANIMAL CELL DNA POLY
   HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877
   ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232
   ISHIGAMI A, 1994, J CELL PHYSIOL, V158, P231, DOI 10.1002/jcp.1041580204
   KOKKONEN GC, 1997, IN PRESS EXP CELL RE
   KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965
   Liu YS, 1996, J BIOL CHEM, V271, P3604
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   PENDERGRASS WR, 1985, J CELL PHYSIOL, V124, P331, DOI 10.1002/jcp.1041240224
   SAWADA N, 1988, CANCER RES, V48, P1618
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664
NR 28
TC 5
Z9 5
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9541
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD JUL
PY 1998
VL 176
IS 1
BP 32
EP 39
DI 10.1002/(SICI)1097-4652(199807)176:1<32::AID-JCP4>3.0.CO;2-9
PG 8
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA ZP476
UT WOS:000073757300004
PM 9618142
DA 2024-02-19
ER

PT J
AU Treviño, LS
   Dong, JR
   Kaushal, A
   Katz, TA
   Jangid, RK
   Robertson, MJ
   Grimm, SL
   Ambati, CSR
   Putluri, V
   Cox, AR
   Kim, KH
   May, TD
   Gallo, MR
   Moore, DD
   Hartig, SM
   Foulds, CE
   Putluri, N
   Coarfa, C
   Walker, CL
AF Trevino, Lindsey S.
   Dong, Jianrong
   Kaushal, Ahkilesh
   Katz, Tiffany A.
   Jangid, Rahul Kumar
   Robertson, Matthew J.
   Grimm, Sandra L.
   Ambati, Chandra Shekar R.
   Putluri, Vasanta
   Cox, Aaron R.
   Kim, Kang Ho
   May, Thaddeus D.
   Gallo, Morgan R.
   Moore, David D.
   Hartig, Sean M.
   Foulds, Charles E.
   Putluri, Nagireddy
   Coarfa, Cristian
   Walker, Cheryl Lyn
TI Epigenome environment interactions accelerate epigenomic aging and
   unlock metabolically restricted epigenetic reprogramming in adulthood
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ENDOCRINE-DISRUPTING CHEMICALS; BISPHENOL-A; DNA METHYLATION;
   DEVELOPMENTAL ORIGINS; GENE-EXPRESSION; EARLY-LIFE; INSULIN-RESISTANCE;
   IN-UTERO; EXPOSURE; LIVER
AB Our early-life environment has a profound influence on developing organs that impacts metabolic function and determines disease susceptibility across the life-course. Using a rat model for exposure to an endocrine disrupting chemical (EDC), we show that early-life chemical exposure causes metabolic dysfunction in adulthood and reprograms histone marks in the developing liver to accelerate acquisition of an adult epigenomic signature. This epigenomic reprogramming persists long after the initial exposure, but many reprogrammed genes remain transcriptionally silent with their impact on metabolism not revealed until a later life exposure to a Western-style diet. Diet-dependent metabolic disruption was largely driven by reprogramming of the Early Growth Response 1 (EGR1) transcriptome and production of metabolites in pathways linked to cholesterol, lipid and one-carbon metabolism. These findings demonstrate the importance of epigenome:environment interactions, which early in life accelerate epigenomic aging, and later in adulthood unlock metabolically restricted epigenetic reprogramming to drive metabolic dysfunction. Early life exposure to environmental stressors, including endocrine disrupting chemicals (EDCs), can impact health later in life. Here, the authors show that neonatal EDC exposure in rats causes epigenetic reprogramming in the liver, which is transcriptionally silent until animals are placed on a Western-style diet.
C1 [Trevino, Lindsey S.; Kaushal, Ahkilesh; Katz, Tiffany A.; Jangid, Rahul Kumar; Gallo, Morgan R.; Foulds, Charles E.; Coarfa, Cristian; Walker, Cheryl Lyn] Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX 77030 USA.
   [Trevino, Lindsey S.; Dong, Jianrong; Katz, Tiffany A.; Jangid, Rahul Kumar; Ambati, Chandra Shekar R.; Kim, Kang Ho; Moore, David D.; Hartig, Sean M.; Foulds, Charles E.; Putluri, Nagireddy; Coarfa, Cristian; Walker, Cheryl Lyn] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
   [Trevino, Lindsey S.] City Hope Natl Med Ctr, Dept Populat Sci, Div Hlth Equ, Duarte, CA 91010 USA.
   [Robertson, Matthew J.; Grimm, Sandra L.; Putluri, Vasanta] Baylor Coll Med, Adv Technol Cores, Houston, TX 77030 USA.
   [Cox, Aaron R.; Hartig, Sean M.; Walker, Cheryl Lyn] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [May, Thaddeus D.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Foulds, Charles E.; Coarfa, Cristian; Walker, Cheryl Lyn] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.
   [Walker, Cheryl Lyn] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; City of Hope;
   Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Baylor College of Medicine; Baylor College of Medicine
RP Coarfa, C; Walker, CL (corresponding author), Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX 77030 USA.; Coarfa, C; Walker, CL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Walker, CL (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.; Coarfa, C; Walker, CL (corresponding author), Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.; Walker, CL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
EM coarfa@bcm.edu; cheryl.walker@bcm.edu
RI Hartig, Sean/HKN-8506-2023; ambati, chandra shekar reddy/G-1908-2017;
   Kaushal, Akhilesh/AAE-7352-2021
OI ambati, chandra shekar reddy/0000-0001-5413-6745; Trevino,
   Lindsey/0000-0003-3810-4895; , Akhilesh/0000-0002-5137-0461
FU NIH [U01ES026719, 1P30ES030285, R01ES023206, R01DK114356, U24DK097748,
   P30 CA125123]; American Diabetes Association grant [1-18-IBS-105]; CPRIT
   Proteomics and Metabolomics Core Facility funding [RP170005]; Dan L.
   Duncan Cancer Center at Baylor College of Medicine; CPRIT Core Facility
   Support grants [RP120348, RP170002]
FX This work was supported in part by NIH grants U01ES026719, 1P30ES030285,
   and R01ES023206 to CLW, American Diabetes Association grant
   #1-18-IBS-105 and NIH grant R01DK114356 to S.M.H., and a subaward from
   NIH grant U24DK097748 to C.E.F. Lipidomics and metabolomics sample
   processing and analysis were conducted by the Metabolomics Core at
   Baylor College of Medicine, supported by CPRIT Proteomics and
   Metabolomics Core Facility funding (RP170005), the NIH (P30 CA125123),
   and the Dan L. Duncan Cancer Center at Baylor College of Medicine.
   ChIP-sequencing and RNAsequencing were conducted by the MD Anderson
   Cancer Center Science Park Next Generation Sequencing Core, supported by
   CPRIT Core Facility Support grants (RP120348 and RP170002). Figure 1a
   was created with Biorender.com.
CR Al-Hamad D, 2017, TRANSL PEDIATR, V6, P397, DOI 10.21037/tp.2017.10.02
   Austin MK, 2018, PSYCHONEUROENDOCRINO, V97, P131, DOI 10.1016/j.psyneuen.2018.07.007
   Bacalini MG, 2019, J GERONTOL A-BIOL, V74, P1, DOI 10.1093/gerona/gly048
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   Barouki R, 2018, ENVIRON INT, V114, P77, DOI 10.1016/j.envint.2018.02.014
   Barrès R, 2016, NAT REV ENDOCRINOL, V12, P441, DOI 10.1038/nrendo.2016.87
   Bommarito PA, 2017, EPIGENOMICS-UK, V9, P333, DOI 10.2217/epi-2016-0112
   Bysani M, 2017, EPIGENOMICS-UK, V9, P105, DOI 10.2217/epi-2016-0087
   Cole JJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1185-3
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Duque-Guimaraes DE, 2013, TRENDS ENDOCRIN MET, V24, P525, DOI 10.1016/j.tem.2013.05.006
   Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906
   Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906
   Fiorito G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16391-5
   Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]
   Foulds C, 2017, NAT REV ENDOCRINOL, V13, P445, DOI 10.1038/nrendo.2017.42
   Fries GR, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0048-8
   Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088
   García-Arévalo M, 2016, ENDOCRINOLOGY, V157, P4158, DOI 10.1210/en.2016-1390
   Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010
   Greathouse KL, 2008, REPROD SCI, V15, P765, DOI 10.1177/1933719108322440
   Hahn O, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1187-1
   Heindel JJ, 2017, REPROD TOXICOL, V68, P3, DOI 10.1016/j.reprotox.2016.10.001
   Heo HJ, 2016, AGING CELL, V15, P964, DOI 10.1111/acel.12505
   Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004
   Hoffman DJ, 2017, NUTR REV, V75, P951, DOI 10.1093/nutrit/nux053
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Khalil N, 2014, SCI TOTAL ENVIRON, V470, P726, DOI 10.1016/j.scitotenv.2013.09.088
   Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126
   Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265
   Kochmanski J, 2018, EPIGENETICS-US, V13, P779, DOI 10.1080/15592294.2018.1507198
   Kochmanski J, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvy017
   Kojima H, 2019, TOXICOLOGY, V413, P48, DOI 10.1016/j.tox.2018.12.001
   Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466
   Lee S, 2018, ENVIRON RES, V161, P195, DOI 10.1016/j.envres.2017.11.007
   Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260
   Lizio M, 2017, NUCLEIC ACIDS RES, V45, pD737, DOI 10.1093/nar/gkw995
   Loomba R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96685
   Ma Y, 2013, DIABETOLOGIA, V56, P2059, DOI 10.1007/s00125-013-2944-7
   MacKay H, 2018, HORM BEHAV, V101, P59, DOI 10.1016/j.yhbeh.2017.11.001
   Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109
   Magee Nancy, 2017, Hepatoma Res, V3, P268, DOI 10.20517/2394-5079.2017.36
   Masuyama H, 2015, ENDOCRINOLOGY, V156, P2482, DOI 10.1210/en.2014-2020
   Nadal A, 2017, NAT REV ENDOCRINOL, V13, P536, DOI 10.1038/nrendo.2017.51
   Nahar MS, 2014, ENVIRON MOL MUTAGEN, V55, P184, DOI 10.1002/em.21823
   Najar RA, 2018, J NUTR BIOCHEM, V53, P121, DOI 10.1016/j.jnutbio.2017.10.007
   Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021
   Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931
   Rosen AD, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0233-4
   Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100
   Sales VM, 2017, CELL METAB, V25, P559, DOI 10.1016/j.cmet.2017.02.016
   Sargent J, 2015, NAT REV ENDOCRINOL, V11, P256, DOI [10.1038/nrendo.2014.198, 10.1038/nrendo.2015.35]
   Shimpi PC, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP664, 10.1289/ehp664]
   Slenter DN, 2018, NUCLEIC ACIDS RES, V46, pD661, DOI 10.1093/nar/gkx1064
   Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784
   Snykers S, 2009, STEM CELLS, V27, P577, DOI 10.1634/stemcells.2008-0963
   Strakovsky RS, 2015, TOXICOL APPL PHARM, V284, P101, DOI 10.1016/j.taap.2015.02.021
   Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5
   Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195
   Tarry-Adkins JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22383-w
   Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x
   Treviño LS, 2018, ENDOCRINOLOGY, V159, P20, DOI 10.1210/en.2017-00887
   Treviño LS, 2015, PROG BIOPHYS MOL BIO, V118, P8, DOI 10.1016/j.pbiomolbio.2015.02.013
   Verstraete SG, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0356-3
   Walker CL, 2016, MOL ENDOCRINOL, V30, P848, DOI 10.1210/me.2016-1086
   Walker CL, 2012, NAT REV CANCER, V12, P479, DOI 10.1038/nrc3220
   Wang Q, 2016, MOL ENDOCRINOL, V30, P856, DOI 10.1210/me.2015-1310
   Wang TN, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1186-2
   Wang T, 2018, NAT BIOTECHNOL, V36, P225, DOI 10.1038/nbt.4099
   Wesolowski SR, 2017, NAT REV GASTRO HEPAT, V14, P81, DOI 10.1038/nrgastro.2016.160
   Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Zannas AS, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1441-1
NR 76
TC 36
Z9 41
U1 1
U2 13
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 8
PY 2020
VL 11
IS 1
AR 2316
DI 10.1038/s41467-020-15847-z
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA LO9IB
UT WOS:000533936800040
PM 32385268
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Hu, MJ
   Bai, Y
   Zhang, CX
   Liu, F
   Cui, ZB
   Chen, J
   Peng, JR
AF Hu, Minjie
   Bai, Yun
   Zhang, Chunxia
   Liu, Feng
   Cui, Zongbin
   Chen, Jun
   Peng, Jinrong
TI Liver-Enriched Gene 1, a Glycosylated Secretory Protein, Binds to FGFR
   and Mediates an Anti-stress Pathway to Protect Liver Development in
   Zebrafish
SO PLOS GENETICS
LA English
DT Article
ID ENDODERM FORMATION; NADPH OXIDASE; SPECIFICATION; ACTIVATION;
   ORGANOGENESIS; PANCREAS; BMP; INITIATION; EXPRESSION; HEDGEHOG
AB Unlike mammals and birds, teleost fish undergo external embryogenesis, and therefore their embryos are constantly challenged by stresses from their living environment. These stresses, when becoming too harsh, will cause arrest of cell proliferation, abnormal cell death or senescence. Such organisms have to evolve a sophisticated anti-stress mechanism to protect the process of embryogenesis/organogenesis. However, very few signaling molecule(s) mediating such activity have been identified. liver-enriched gene 1 (leg1) is an uncharacterized gene that encodes a novel secretory protein containing a single domain DUF781 (domain of unknown function 781) that is well conserved in vertebrates. In the zebrafish genome, there are two copies of leg1, namely leg1a and leg1b. leg1a and leg1b are closely linked on chromosome 20 and share high homology, but are differentially expressed. In this report, we generated two leg1a mutant alleles using the TALEN technique, then characterized liver development in the mutants. We show that a leg1a mutant exhibits a stress-dependent small liver phenotype that can be prevented by chemicals blocking the production of reactive oxygen species. Further studies reveal that Leg1a binds to FGFR3 and mediates a novel anti-stress pathway to protect liver development through enhancing Erk activity. More importantly, we show that the binding of Leg1a to FGFR relies on the glycosylation at the 70th asparagine (Asn(70) or N-70), and mutating the Asn(70) to Ala(70) compromised Leg1' s function in liver development. Therefore, Leg1 plays a unique role in protecting liver development under different stress conditions by serving as a secreted signaling molecule/modulator.
C1 [Hu, Minjie; Bai, Yun; Peng, Jinrong] Zhejiang Univ, Coll Anim Sci, MOE Key Lab Mol Anim Nutr, Hangzhou 310003, Zhejiang, Peoples R China.
   [Zhang, Chunxia; Liu, Feng] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China.
   [Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China.
   [Chen, Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.
C3 Zhejiang University; Chinese Academy of Sciences; Institute of Zoology,
   CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS;
   Zhejiang University
RP Peng, JR (corresponding author), Zhejiang Univ, Coll Anim Sci, MOE Key Lab Mol Anim Nutr, Hangzhou 310003, Zhejiang, Peoples R China.; Chen, J (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.
EM chenjun2009@zju.edu.cn; pengjr@zju.edu.c
RI Hu, Minjie/AAP-4915-2020; Liu, Feng/B-9985-2015
OI Liu, Feng/0000-0003-3228-0943; Zhang, Chunxia/0000-0003-0063-9181; Peng,
   Jinrong/0000-0002-0793-4848
FU Ministry of Science and Technology of China [2015CB942802,
   2012CB944500]; National Natural Science Foundation of China [31330050,
   30825025]
FX This work was funded by the "973 Program" of the Ministry of Science and
   Technology of China (http://www.most.gov.cn/) (2015CB942802,
   2012CB944500) and the National Natural Science Foundation of China
   (http://www.nsfc.gov.cn/) (31330050, 30825025) to JP. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008
   [Anonymous], PLOS ONE
   Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8
   Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006
   Chang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022910
   Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609
   Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018
   Deutsch G, 2001, DEVELOPMENT, V128, P871
   Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3
   ELLIS JA, 1989, BIOCHEM J, V262, P575, DOI 10.1042/bj2620575
   Enjapoori AK, 2014, GENOME BIOL EVOL, V6, P2754, DOI 10.1093/gbe/evu209
   Gilbert SF, 2012, EVOL DEV, V14, P20, DOI 10.1111/j.1525-142X.2011.00519.x
   Ginestet C, 2011, J ROY STAT SOC A, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x
   Goldfarb M, 2001, Sci STKE, V2001, ppe37, DOI 10.1126/stke.2001.106.pe37
   GONZALEZ J, 1992, ANAL BIOCHEM, V205, P151, DOI 10.1016/0003-2697(92)90592-U
   Gordillo M, 2015, DEVELOPMENT, V142, P2094, DOI 10.1242/dev.114215
   GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603
   Gupta R., 2004, PREDICTION N GLYCOSY
   HAUGG M, 1992, NUCLEIC ACIDS RES, V20, P612, DOI 10.1093/nar/20.3.612
   Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406
   Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939
   Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998
   Kim BM, 2015, COMP BIOCHEM PHYS C, V167, P15, DOI 10.1016/j.cbpc.2014.08.003
   Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069
   Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813
   Krzywinski M, 2013, NAT METHODS, V10, P921, DOI 10.1038/nmeth.2659
   Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649
   Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101
   LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679
   Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81
   Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148
   Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880
   Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383
   Negishi T, 2010, HEPATOLOGY, V51, P1037, DOI 10.1002/hep.23387
   Niu XB, 2012, DEV BIOL, V367, P197, DOI 10.1016/j.ydbio.2012.05.004
   Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1
   Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888
   Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667
   Poulain M, 2006, DEVELOPMENT, V133, P2189, DOI 10.1242/dev.02387
   Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840
   Rian H, 2013, ISRN CELL BIOL, V2013, P1
   Rossi A, 2015, NATURE
   Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580
   Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601
   Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281
   Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996
   Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6
   Stainier DYR, 2002, GENE DEV, V16, P893, DOI 10.1101/gad.974902
   STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341
   Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6
   Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018
   Walker SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029916
   Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9
   Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497
   Wilkinson RN, 2009, DEV CELL, V16, P909, DOI 10.1016/j.devcel.2009.04.014
   Yang SL, 2011, ENDOCRINOLOGY, V152, P4706, DOI 10.1210/en.2011-1306
   Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837
   Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005
NR 58
TC 17
Z9 20
U1 0
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD FEB
PY 2016
VL 12
IS 2
AR e1005881
DI 10.1371/journal.pgen.1005881
PG 23
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA DH1OI
UT WOS:000372554100052
PM 26901320
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Honka, MJ
   Latva-Rasku, A
   Bucci, M
   Virtanen, KA
   Hannukainen, JC
   Kalliokoski, KK
   Nuutila, P
AF Honka, Miikka-Juhani
   Latva-Rasku, Aino
   Bucci, Marco
   Virtanen, Kirsi A.
   Hannukainen, Jarna C.
   Kalliokoski, Kari K.
   Nuutila, Pirjo
TI Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and
   liver: a positron emission tomography study
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID RESISTANCE; OBESE; INFLAMMATION; METABOLISM; NONOBESE; HEART; RATES
AB Objective: Insulin resistance is reflected by the rates of reduced glucose uptake (GU) into the key insulin-sensitive tissues, skeletal muscle, liver and adipose tissue. It is unclear whether insulin resistance occurs simultaneously in all these tissues or whether insulin resistance is tissue specific.
   Design and methods: We measured GU in skeletal muscle, adipose tissue and liver and endogenous glucose production (EGP), in a single session using F-18-fluorodeoxyglucose with positron emission tomography (PET) and euglycemic-hyperinsulinemic clamp. The study population consisted of 326 subjects without diabetes from the CMgene study cohort.
   Results: Skeletal muscle GU less than 33 mu mol/kg tissue/min and subcutaneous adipose tissue GU less than 11.5 mu mol/kg tissue/min characterized insulin-resistant individuals. Men had considerably worse insulin suppression of EGP compared to women. By using principal component analysis (PCA), BMI inversely and skeletal muscle, adipose tissue and liver GU positively loaded on same principal component explaining one-third of the variation in these measures. The results were largely similar when liver GU was replaced by EGP in PCA Liver GU and EGP were positively associated with aging.
   Conclusions: We have provided threshold values, which can be used to identify tissue-specific insulin resistance. In addition, we found that insulin resistance measured by GU was only partially similar across all insulin-sensitive tissues studied, skeletal muscle, adipose tissue and liver and was affected by obesity, aging and gender.
C1 [Honka, Miikka-Juhani; Latva-Rasku, Aino; Virtanen, Kirsi A.; Hannukainen, Jarna C.; Kalliokoski, Kari K.; Nuutila, Pirjo] Univ Turku, Turku PET Ctr, Turku, Finland.
   [Bucci, Marco] Abo Akad Univ, Turku, Finland.
   [Virtanen, Kirsi A.] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.
   [Nuutila, Pirjo] Turku Univ Hosp, Dept Endocrinol, Turku, Finland.
C3 University of Turku; Abo Akademi University; University of Eastern
   Finland; University of Turku
RP Nuutila, P (corresponding author), Univ Turku, Turku PET Ctr, Turku, Finland.; Nuutila, P (corresponding author), Turku Univ Hosp, Dept Endocrinol, Turku, Finland.
EM pirjo.nuutila@utu.fi
RI Virtanen, Kirsi/HME-1983-2023; Nuutila, Pirjo/J-2087-2012; Honka,
   Miikka/AAR-7971-2021; Kalliokoski, Kari K/B-8891-2015; Bucci,
   Marco/C-5130-2009
OI Honka, Miikka/0000-0001-9875-5863; Bucci, Marco/0000-0002-5206-8651;
   Kalliokoski, Kari/0000-0002-8893-7126; Nuutila,
   Pirjo/0000-0001-9597-338X; Latva-Rasku, Aino/0000-0001-8786-9160;
   Hannukainen, Jarna/0000-0002-8692-4049
FU Academy of Finland; University of Turku; Turku University Hospital; Abo
   Akademi University; Finnish Cultural Foundation; Varsinais-Suomi
   Regional fund; Yrjo Jahnsson Foundation; Turku University Foundation;
   Combined Research Fund; Oskar Oflund Stiftelse
FX The study has been conducted at the Center of Excellence in
   Cardiovascular and Metabolic Diseases, supported by the Academy of
   Finland, the University of Turku, Turku University Hospital and Abo
   Akademi University. It was supported also by the Finnish Cultural
   Foundation, Varsinais-Suomi Regional fund, Yrjo Jahnsson Foundation,
   Turku University Foundation, University of Turku, Combined Research Fund
   and Oskar Oflund Stiftelse.
CR Alenius S, 1997, EUR J NUCL MED, V24, P258, DOI 10.1007/BF01728761
   [Anonymous], 2000, APPL LOGISTIC REGRES
   Choi KM, 2016, ENDOCRINOL METAB, V31, P1, DOI 10.3803/EnM.2016.31.1.1
   Conte C, 2012, DIABETES CARE, V35, P1316, DOI 10.2337/dc11-1951
   Dadson P, 2016, DIABETES CARE, V39, P292, DOI 10.2337/dc15-1447
   DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
   DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028
   GJEDDE A, 1982, BRAIN RES REV, V4, P237, DOI 10.1016/0165-0173(82)90018-2
   HAMACHER K, 1986, J NUCL MED, V27, P235
   Iozzo P, 2006, J NUCL MED, V47, P1016
   Iozzo P, 2004, DIABETOLOGIA, V47, P1149, DOI 10.1007/s00125-004-1443-2
   Iozzo P, 2003, J NUCL MED, V44, P682
   Iozzo P, 2003, J CLIN ENDOCR METAB, V88, P2055, DOI 10.1210/jc.2002-021446
   Iozzo P, 2007, GASTROENTEROLOGY, V132, P531, DOI 10.1053/j.gastro.2006.12.040
   Jolliffe I. T, 2002, PRINCIPAL COMPONENT, P488, DOI [10.1007/b98835, DOI 10.1007/B98835]
   KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116
   Korenblat KM, 2008, GASTROENTEROLOGY, V134, P1369, DOI 10.1053/j.gastro.2008.01.075
   Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189
   Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861
   Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539
   Mitrou P, 2009, J CLIN ENDOCR METAB, V94, P2958, DOI 10.1210/jc.2008-2297
   Molina SA, 2017, AM J PHYSIOL-LUNG C, V312, P1688, DOI 10.1152/ajplung.00364.2016
   NUUTILA P, 1992, J CLIN INVEST, V89, P1767, DOI 10.1172/JCI115780
   PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87
   Peltoniemi P, 2000, AM J PHYSIOL-ENDOC M, V279, pE1122, DOI 10.1152/ajpendo.2000.279.5.E1122
   Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012
   R Core Team, 2017, R LANG ENV STAT COMP, DOI DOI 10.1007/B98835
   Rask-Madsen C, 2012, ARTERIOSCL THROM VAS, V32, P2052, DOI 10.1161/ATVBAHA.111.241919
   */* S  81, 2014, DIABETES CARE S1, V37, pS8, DOI DOI 10.2337/DC14-S081
   Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812
   Schinner S, 2005, DIABETIC MED, V22, P674, DOI 10.1111/j.1464-5491.2005.01566.x
   Sharabi K, 2015, MOL ASPECTS MED, V46, P21, DOI 10.1016/j.mam.2015.09.003
   Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333
   ter Horst KW, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00182
   ter Horst KW, 2016, METABOLISM, V65, P757, DOI 10.1016/j.metabol.2016.02.010
   Utriainen T, 1998, DIABETOLOGIA, V41, P555, DOI 10.1007/s001250050946
   Virtanen KA, 2005, DIABETES, V54, P2720, DOI 10.2337/diabetes.54.9.2720
   Virtanen KA, 2001, DIABETOLOGIA, V44, P2171, DOI 10.1007/s001250100026
   Virtanen KA, 2002, J CLIN ENDOCR METAB, V87, P3902, DOI 10.1210/jc.87.8.3902
   Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806
   Wan M, 2013, CELL METAB, V18, P99, DOI 10.1016/j.cmet.2013.06.001
   WICKHAM H, 2009, ELEGANT GRAPHICS DAT, P1, DOI DOI 10.1007/978-0-387-98141-3
   Winnick JJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE358, DOI 10.1152/ajpendo.00043.2009
NR 43
TC 82
Z9 93
U1 0
U2 4
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD MAY
PY 2018
VL 178
IS 5
BP 523
EP 531
DI 10.1530/EJE-17-0882
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA GL4GL
UT WOS:000437107600014
PM 29535167
OA hybrid, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Marotta, F
   Harada, M
   Minelli, E
   Ono-Nita, SK
   Marandola, P
AF Marotta, Francesco
   Harada, Masatoshi
   Minelli, Emilio
   Ono-Nita, Suzanne K.
   Marandola, Paulo
TI "Accelerating aging" chemotherapy on aged animals: Protective effect
   from nutraceutical modulation
SO REJUVENATION RESEARCH
LA English
DT Article; Proceedings Paper
CT 3rd Conference on Strategies for Engineered Negligible Senescence (SENS)
CY SEP 06-10, 2007
CL Queens Coll, Cambridge, ENGLAND
HO Queens Coll
ID IN-VIVO
AB The aim of this study was to test a novel phytocompound in an experimental model of antitumor-induced immunosuppression. Five groups of mice were considered: young (Y) and aged (A) that were given intraperitoneally 10 doses of cyclophosphamide (CPX, 25mg/kg/bw) or CPX plus (150 mg/kg/bw) of the nutraceutical DTS (Denshichi-Tochiu-Sen), and control. After sacrifice, macrophage chemotaxis and serum levels of IFN-gamma, IL-2, and GM-CSF were determined. Liver and urinary bladder were examined histologically, as were the liver and kidney for redox enzymes. CPX significantly decreased macrophage chemotaxis and all cytokines (p < 0.05, A >> Y). DTS restored macrophage function and cytokine concentration (p < 0.001) and partly improved the necro-inflammatory score and substance P receptor expression in the bladder and the redox status in liver and kidney (p < 0.05). Such data suggest that DTS effectively prevents CPX-induced immune suppression and oxidative-inflammatory damage, which are particularly enhanced in aged organisms.
C1 [Marotta, Francesco; Minelli, Emilio] Univ Milan, WHO, Ctr Biotechnol & Tradit Med, I-20122 Milan, Italy.
   [Harada, Masatoshi] MCH Hosp, Tokyo, Japan.
   [Ono-Nita, Suzanne K.] Univ Sao Paulo, Hepatogastroenterol Dept, BR-05508 Sao Paulo, Brazil.
   [Marotta, Francesco; Marandola, Paulo] GAIA Age Management Fdn, Pavia, Italy.
C3 University of Milan; World Health Organization; Universidade de Sao
   Paulo
RP Marotta, F (corresponding author), Piazza Firenze 12, I-20154 Milan, Italy.
EM fmarchimede@libero.it
RI Marotta, Francesco/ABI-1960-2020; Ono, Suzane K/I-3107-2012
OI Marotta, Francesco/0000-0002-6016-1864; 
CR Balducci L, 2000, Oncologist, V5, P224, DOI 10.1634/theoncologist.5-3-224
   Castillo J, 2000, J AGR FOOD CHEM, V48, P1738, DOI 10.1021/jf990665o
   Daniel D, 2006, SEMIN ONCOL, V33, P74, DOI 10.1053/j.seminoncol.2005.11.003
   DEVI PU, 1990, NUTR CANC, V13, P201
   Hashimoto Kazuyuki, 2007, J Toxicol Sci, V32, P249, DOI 10.2131/jts.32.249
   Hsu HY, 1999, J ETHNOPHARMACOL, V64, P101, DOI 10.1016/S0378-8741(98)00115-9
   Kopjar N, 2006, CLIN EXP MED, V6, P177, DOI 10.1007/s10238-006-0113-8
   KUTTAN G, 1993, TUMORI, V79, P74, DOI 10.1177/030089169307900116
   Marotta F, 2006, ANN NY ACAD SCI, V1067, P408, DOI 10.1196/annals.1354.058
   Moallem SA, 1998, DEVELOPMENT, V125, P3225
   Prakash J, 2000, J ETHNOPHARMACOL, V72, P29, DOI 10.1016/S0378-8741(00)00194-X
   Schröder CP, 2001, BRIT J CANCER, V84, P1348, DOI 10.1054/bjoc.2001.1803
   Yoshikawa M, 2001, CHEM PHARM BULL, V49, P1452, DOI 10.1248/cpb.49.1452
   Zhang HY, 2005, CANCER BIOL THER, V4, P207
NR 14
TC 4
Z9 4
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD APR
PY 2008
VL 11
IS 2
BP 513
EP 517
DI 10.1089/rej.2008.0681
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Geriatrics & Gerontology
GA 299RR
UT WOS:000255773200038
PM 18442331
DA 2024-02-19
ER

PT J
AU Conconi, M
   Friguet, B
AF Conconi, M
   Friguet, B
TI Proteasome inactivation upon aging and on oxidation-effect of HSP 90
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE aging; heat shock protein 90; multicatalytic proteinase; oxidative
   damage; proteasome
ID MULTICATALYTIC PROTEINASE COMPLEX; MODIFIED GLUTAMINE-SYNTHETASE;
   ENDOGENOUS INHIBITOR; PROTEOLYSIS; LIVER;
   GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; PURIFICATION; ASSOCIATION; STRESS;
   CELLS
AB Increases of oxidatively modified protein in the eel have been associated with the aging process. Such an accumulation of damaged protein may be the result of increase in the rate of protein oxidation and/or decrease in the rate of degradation of oxidized protein. The multicatalytic proteinase or proteasome is known to be the major proteolytic system involved in the removal of oxidized protein. We have reported that, after isolation of the 20S proteasome from the liver of young and old male Fischer 344 rat, out of the three peptidase activities (chymotrypsin-like, trypsin-like and peptidyl-glutamyl peptide hydrolase) we assayed with fluorogenic peptides, the peptidyl-glutamyl peptide hydrolase activity was declining with age to a value approximately 50% of that observed for protease purified from young rats. The proteasome was subjected to metal catalyzed oxidation to determine the susceptibility of the different peptidase activities to oxidative inactivation. Both trypsin-like and peptidyl-glutamyl peptide hydrolase activities were found sensitive to oxidation. Treatment of the proteasome with 4-hydroxy-2-nonenal, a major lipid peroxidation product, was also found to inactivate the trypsin-like activity. However, the trypsin-like activity was protected from inactivation by metal catalyzed oxidation in proteasome preparations contaminated with HSP 90, a protein that often copurifies with the proteasome. Upon addition of HSP 90 to pure 20S active proteasome, the trypsin-like activity was protected from inactivation by metal catalyzed oxidation and from inactivation by treatment with 4-hydroxy-2-nonenal. These results suggest a possible intervention of HSP 90 in response to oxidative stress in preventing the inactivation of the proteasome by oxidative damage.
RP Conconi, M (corresponding author), INST PASTEUR, UNITE BIOCHIM CELLULAIRE, 28 RUE DOCTEUR ROUX, F-75724 PARIS 15, FRANCE.
OI Friguet, Bertrand/0000-0001-8085-1961
CR AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x
   ARRIBAS J, 1990, J BIOL CHEM, V265, P13969
   Cohn JA, 1996, ARCH BIOCHEM BIOPHYS, V328, P158, DOI 10.1006/abbi.1996.0156
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   DAS DK, 1993, CARDIOVASC RES, V27, P578, DOI 10.1093/cvr/27.4.578
   DJABALLAH H, 1992, BIOCHEMISTRY-US, V31, P4133, DOI 10.1021/bi00131a033
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   FRIGUET B, 1994, J BIOL CHEM, V269, P21639
   Fukuda A, 1996, BIOCHEM BIOPH RES CO, V219, P76, DOI 10.1006/bbrc.1996.0184
   GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344
   Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095
   MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995
   ORLOWSKI M, 1991, BIOCHEMISTRY-US, V30, P5999, DOI 10.1021/bi00238a025
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PACIFICI RE, 1989, FREE RADICAL BIO MED, V7, P521, DOI 10.1016/0891-5849(89)90028-2
   REALINI C, 1994, FEBS LETT, V348, P109, DOI 10.1016/0014-5793(94)00569-9
   REALINI C, 1995, J BIOL CHEM, V270, P29664
   RIVETT AJ, 1985, J BIOL CHEM, V260, P2600
   SAHAKIAN JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P411, DOI 10.1006/abbi.1995.1248
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB175, DOI 10.1093/gerona/51A.2.B175
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   SZWEDA LI, 1993, J BIOL CHEM, V268, P3342
   TSUBUKI S, 1994, FEBS LETT, V344, P229, DOI 10.1016/0014-5793(94)00388-2
   WAGNER BJ, 1995, ARCH BIOCHEM BIOPHYS, V323, P455, DOI 10.1006/abbi.1995.0067
NR 31
TC 95
Z9 98
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD MAR
PY 1997
VL 24
IS 1-2
BP 45
EP 50
DI 10.1023/A:1006852506884
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA XJ409
UT WOS:A1997XJ40900008
PM 9228280
DA 2024-02-19
ER

PT J
AU Chen, LQ
   Hu, TG
   Wu, RQ
   Wang, H
   Wu, H
   Wen, P
AF Chen, Lingqi
   Hu, Tenggen
   Wu, Ruiqing
   Wang, Hong
   Wu, Hong
   Wen, Peng
TI <i>In vivo</i> antioxidant activity of <i>Cinnamomum cassia</i> leaf
   residues and their effect on gut microbiota of d-galactose-induced aging
   model mice
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article; Early Access
DE Cinnamomum cassia leaf residues; antioxidant; anti-inflammatory;
   anti-aging; gut microbiota
ID INDUCED LIVER; BY-PRODUCTS; INFLAMMATION; ACID; POLYSACCHARIDES;
   CYTOKINES
AB BACKGROUND To thoroughly explore the values of Cinnamomum cassia leaf residues (CcLR), their antioxidant activity in vivo and the relationship with gut microbiota were investigated using d-galactose-induced aging mice. RESULTS Results showed that CcLR extract treatment exerted antioxidant activity by increasing the levels of superoxide dismutase (P < 0.01) and glutathione peroxidase (P < 0.05), as well as inhibiting the formation of malondialdehyde (P < 0.01). Meanwhile, the inflammatory response was also alleviated as the ratio of pro-inflammatory tumor necrosis factor-alpha (P < 0.01) and interleukin-1 beta (P < 0.01))/anti-inflammatory cytokines (interleukin-10; P < 0.05) in serum was decreased and the contents of inflammatory markers (induced nitrogen monoxide synthase and nitric oxide) in brain and liver tissues (P < 0.01) were reduced. Moreover, through inhibiting acetylcholinesterase activity and improving choline acetyltransferase activity, the cholinergic system in aging mice recovered to levels comparable to the normal control group. In addition, 16S rRNA sequencing results demonstrated that CcLR extract promoted the growth of beneficial bacteria. In particular, Spearman correlation analysis revealed that the abundance of Colidextribacter was negatively correlated with serum superoxide dismutase (P < 0.05, R = -0.943), and Helicobacter displayed a positive correlation with the content of brain nitric oxide (P < 0.05, R = 0.899), suggesting that regulating gut microbiota might be one of the mechanisms for reducing oxidative stress, thus postponing the aging process. CONCLUSION It is suggested that CcLR extract could be used as a novel antioxidant and anti-aging resource in the pharmaceutical and food industries. (c) 2022 Society of Chemical Industry.
C1 [Chen, Lingqi; Wang, Hong; Wen, Peng] South China Agr Univ, Coll Food Sci, Guangdong Prov Key Lab Food Qual & Safety, Guangzhou 510642, Peoples R China.
   [Hu, Tenggen] Guangdong Acad Agr Sci, Sericultural & Agrifood Res Inst, Key Lab Funct Foods, Minist Agr,Guangdong Key Lab Agr Prod Proc, Guangzhou, Peoples R China.
   [Wu, Ruiqing; Wu, Hong] South China Univ Technol, Guangdong Prov Key Lab Green Proc Nat Prod & Prod, Sch Food Sci & Engn, Guangzhou, Peoples R China.
C3 South China Agricultural University; Guangdong Academy of Agricultural
   Sciences; Ministry of Agriculture & Rural Affairs; South China
   University of Technology
RP Wen, P (corresponding author), South China Agr Univ, Coll Food Sci, Guangdong Prov Key Lab Food Qual & Safety, Guangzhou 510642, Peoples R China.
EM pwen@scau.edu.cn
RI Wu, Rui/JWP-7623-2024
FU National Natural Science Foundation of China [32001631]; Guangdong Basic
   and Applied Basic Research Foundation [2020A151511019]
FX We acknowledge the National Natural Science Foundation of China, grant
   number 32001631, and Guangdong Basic and Applied Basic Research
   Foundation, grant number 2020A151511019, for financial support.
CR Abeysekera WPKM, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/2693795
   Bohnen NI, 2011, BEHAV BRAIN RES, V221, P564, DOI 10.1016/j.bbr.2009.12.048
   Chen P, 2019, AGING-US, V11, P7339, DOI 10.18632/aging.101733
   Chu SH, 2021, BIOORG MED CHEM LETT, V40, DOI 10.1016/j.bmcl.2021.127913
   Cui XJ, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00209
   Di Benedetto S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040990
   dos Santos ÉM, 2021, TRENDS FOOD SCI TECH, V111, P280, DOI 10.1016/j.tifs.2021.02.064
   Fan J, 2017, CARBOHYD POLYM, V157, P629, DOI 10.1016/j.carbpol.2016.10.040
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Ge HF, 2021, FOOD CHEM, V360, DOI 10.1016/j.foodchem.2021.129981
   Hu SW, 2019, FOOD FUNCT, V10, P1736, DOI 10.1039/c8fo02364f
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Lahmass I, 2017, J FUNCT FOODS, V35, P341, DOI 10.1016/j.jff.2017.05.057
   Leal C, 2020, IND CROP PROD, V154, DOI 10.1016/j.indcrop.2020.112675
   Lee J, 2021, J ETHNOPHARMACOL, V278, DOI 10.1016/j.jep.2021.114209
   Lei LH, 2016, J CHIN MED ASSOC, V79, P205, DOI 10.1016/j.jcma.2015.06.023
   Li L, 2005, LIFE SCI, V77, P230, DOI 10.1016/j.lfs.2004.12.024
   Ling ZX, 2022, CRIT REV FOOD SCI, V62, P3509, DOI 10.1080/10408398.2020.1867054
   Liu BH, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3152324
   Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002
   Lu J, 2010, NEUROBIOL LEARN MEM, V93, P157, DOI 10.1016/j.nlm.2009.09.006
   Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312
   Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586
   Rodrigues F, 2015, IND CROP PROD, V70, P116, DOI 10.1016/j.indcrop.2015.03.027
   Salminen A, 2021, AGEING RES REV, V67, DOI 10.1016/j.arr.2021.101280
   Saraswati S, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00764
   Tauffenberger A, 2021, NEUROCHEM RES, V46, P77, DOI 10.1007/s11064-020-03208-7
   Tian Y, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.103464
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Wang MY, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.645099
   Wang R, 2009, INNOV FOOD SCI EMERG, V10, P289, DOI 10.1016/j.ifset.2008.12.002
   Woods JA, 2012, AGING DIS, V3, P130
   Wu RQ, 2022, J FOOD PROCESS PRES, V46, DOI 10.1111/jfpp.16454
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Zeng L, 2020, EXP GERONTOL, V131, DOI 10.1016/j.exger.2019.110823
   Zhang DJ, 2018, J AGR FOOD CHEM, V66, P5510, DOI 10.1021/acs.jafc.8b00446
   Zhang XL, 2013, FOOD CHEM TOXICOL, V58, P50, DOI 10.1016/j.fct.2013.04.006
   Zhu YL, 2020, INT J BIOL MACROMOL, V157, P394, DOI 10.1016/j.ijbiomac.2020.04.163
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
   Zuo L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184472
NR 41
TC 1
Z9 1
U1 12
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD 2023 JAN 30
PY 2023
VL 103
IS 2
BP 590
EP 598
DI 10.1002/jsfa.12170
EA AUG 2022
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 6Z2BX
UT WOS:000844246300001
PM 36054514
DA 2024-02-19
ER

PT J
AU Polyzos, SA
   Vachliotis, ID
   Mantzoros, CS
AF Polyzos, Stergios A.
   Vachliotis, Ilias D.
   Mantzoros, Christos S.
TI Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article; Early Access
DE Adipose tissue; Nonalcoholic fatty liver disease; Nonalcoholic
   steatohepatitis; Sarcopenia; Sarcopenic obesity; Treatment
ID SKELETAL-MUSCLE MASS; CHRONIC KIDNEY-DISEASE; VITAMIN-D; PROTEIN-INTAKE;
   INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; BODY-COMPOSITION; GROWTH-HORMONE;
   AREA RATIO; ASSOCIATION
AB Nonalcoholic fatty liver disease (NAFLD), sarcopenia and sarcopenic obesity (SO) are highly prevalent conditions that may coexist, especially in the aging population, without any approved pharmacologic treatment for all of them. There are multiple pathophysiologic mechanisms suggested to explain an association between NAFLD and sarcopenia or SO, including alterations in the adipokines, cytokines, hepatokines and myokines, which may interplay with other factors, such as aging, diet and physical inactivity. In clinical terms, most observational studies support an association between NAFLD and sarcopenia or SO; importantly, there are few cohort studies indicating higher mortality in patients with NAFLD and sarcopenia. Their association also bears some treatment considerations: for example, pioglitazone or vitamin E, suggested as off label treatment for selected patients with nonalcoholic steatohepatitis, may be recommended in the coexistence of sarcopenia or SO, since limited evidence did not show adverse effects of them on sarcopenia and abdominal obesity. In this review, evidence linking sarcopenia and SO with NAFLD is summarized, with a special focus on clinical data. A synopsis of the major pathophysiological links between NAFLD and sarcopenia/SO is initially presented, followed by selected clinical studies and, finally, treatment considerations in patients with NAFLD and sarcopenia or SO are discussed.
C1 [Polyzos, Stergios A.; Vachliotis, Ilias D.] Aristotle Univ Thessaloniki, Med Sch, Dept Pharmacol 1, Thessaloniki, Greece.
   [Mantzoros, Christos S.] Harvard Med Sch, Dept Internal Med, Beth Israel Deaconess Med Ctr, Boston, MA USA.
   [Mantzoros, Christos S.] Harvard Med Sch, Dept Internal Med, Boston VA Healthcare Syst, Boston, MA USA.
   [Polyzos, Stergios A.] Sch Med, Lab Pharmacol 1, Campus Aristotle Univ Thessaloniki, Thessaloniki 54124, Greece.
C3 Aristotle University of Thessaloniki; Harvard University; Beth Israel
   Deaconess Medical Center; Harvard Medical School; Harvard University;
   Harvard Medical School; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); VA Boston Healthcare System
RP Polyzos, SA (corresponding author), Sch Med, Lab Pharmacol 1, Campus Aristotle Univ Thessaloniki, Thessaloniki 54124, Greece.
EM spolyzos@auth.gr
CR Altajar S, 2020, J CLIN TRANSL HEPATO, V8, P414, DOI 10.14218/JCTH.2020.00065
   Angelidi AM, 2022, METABOLISM, V129, DOI 10.1016/j.metabol.2022.155136
   Athyros VG, 2020, CURR VASC PHARMACOL, V18, P172, DOI 10.2174/1570161117666190405164313
   Athyros VG, 2017, METABOLISM, V71, P17, DOI 10.1016/j.metabol.2017.02.014
   Axelrod CL, 2023, Metabolism, V146
   Barazzoni R, 2023, METABOLISM, V143, DOI 10.1016/j.metabol.2023.155558
   Becker C, 2015, LANCET DIABETES ENDO, V3, P948, DOI 10.1016/S2213-8587(15)00298-3
   Benton MJ, 2011, AM J NURS, V111, P38, DOI 10.1097/01.NAJ.0000408184.21770.98
   Besora-Moreno M, 2022, CLIN NUTR, V41, P2308, DOI 10.1016/j.clnu.2022.07.035
   Buzga M, 2023, BIOMOL BIOMED, V23, P191, DOI 10.17305/bjbms.2022.7786
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Cai CZ, 2020, HEPATOL INT, V14, P115, DOI 10.1007/s12072-019-09964-1
   Carias S, 2016, J GASTROEN HEPATOL, V31, P628, DOI 10.1111/jgh.13166
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Chang JS, 2017, GERIATR GERONTOL INT, V17, P2266, DOI 10.1111/ggi.13030
   Chen YF, 2022, FRONT CELL DEV BIOL, V10, DOI 10.3389/fcell.2022.948819
   Cho Y, 2022, HEPATOL COMMUN, V6, P2238, DOI 10.1002/hep4.1975
   Choe HJ, 2023, J CACHEXIA SARCOPENI, V14, P260, DOI 10.1002/jcsm.13125
   Chun HS, 2022, HEPATOLOGY, V76, pS791
   Chun HS, 2023, CLIN GASTROENTEROL H, V21, P358, DOI 10.1016/j.cgh.2021.12.043
   Chung GE, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-30833-3
   Chung Goh Eun, 2022, Metabolism, V133, P155222, DOI 10.1016/j.metabol.2022.155222
   Coelho HJ, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19148718
   Colleluori G, 2021, EXP GERONTOL, V155, DOI 10.1016/j.exger.2021.111561
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
   De Spiegeleer A, 2018, DRUG AGING, V35, P719, DOI 10.1007/s40266-018-0566-y
   Diago-Galmés A, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10020093
   Dongiovanni P, 2016, METABOLISM, V65, P1026, DOI 10.1016/j.metabol.2015.08.018
   Donini LM, 2022, CLIN NUTR, V41, P990, DOI 10.1016/j.clnu.2021.11.014
   Donneyong MM, 2016, NUTR METAB CARDIOVAS, V26, P735, DOI 10.1016/j.numecd.2016.02.008
   Drey M, 2017, ENDOCRINE, V57, P481, DOI 10.1007/s12020-017-1370-x
   EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y
   Eglseer D, 2023, ADV NUTR, V14, P516, DOI 10.1016/j.advnut.2023.04.001
   Ferrari U, 2021, J CLIN ENDOCR METAB, V106, pE1698, DOI 10.1210/clinem/dgaa972
   Fulgoni VL, 2008, AM J CLIN NUTR, V87, p1554S, DOI 10.1093/ajcn/87.5.1554S
   Gao F, 2021, BRIT J NUTR, V126, P813, DOI 10.1017/S0007114520004559
   Garito T, 2018, CLIN ENDOCRINOL, V88, P908, DOI 10.1111/cen.13601
   Gkekas NK, 2021, MATURITAS, V145, P56, DOI 10.1016/j.maturitas.2021.01.002
   Golabi P, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100171
   Granic A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040745
   Guo A, 2021, J CELL MOL MED, V25, P3585, DOI 10.1111/jcmm.16448
   Guo MW, 2023, J CACHEXIA SARCOPENI, V14, P391, DOI 10.1002/jcsm.13141
   Guo W, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.883015
   Gustafsson T, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.688526
   Ha J, 2023, CLIN GASTROENTEROL H, V21, P2496, DOI 10.1016/j.cgh.2022.11.019
   Ha NB, 2023, LIVER TRANSPLANT, V29, P476, DOI 10.1097/LVT.0000000000000010
   Hajhashemy Z, 2022, NUTR REV, V80, P1105, DOI 10.1093/nutrit/nuab070
   Han E, 2023, GUT LIVER, V17, P456, DOI 10.5009/gnl220133
   Han E, 2020, AM J GASTROENTEROL, V115, P584, DOI 10.14309/ajg.0000000000000572
   Harring M, 2023, CLIN GASTROENTEROL H, V21, P2876, DOI 10.1016/j.cgh.2023.02.013
   Henry L, 2022, ALIMENT PHARM THER, V56, P942, DOI 10.1111/apt.17158
   Heymsfield SB, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.33457
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Hong J, 2022, METAB SYNDR RELAT D, V20, P210, DOI 10.1089/met.2021.0106
   Hong J, 2021, METAB SYNDR RELAT D, DOI 10.1089/met.2021.0011
   Hsieh YC, 2023, CLIN GASTROENTEROL H, V21, P388, DOI 10.1016/j.cgh.2022.01.020
   Hsieh YC, 2021, LIVER INT, V41, P494, DOI 10.1111/liv.14719
   Huang QB, 2022, CLIN ENDOCRINOL, V97, P612, DOI 10.1111/cen.14732
   Jo IH, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-34263-z
   Kang MK, 2019, J GASTROEN HEPATOL, V34, P1633, DOI 10.1111/jgh.14607
   Kanno H, 2016, CLIN EXP NEPHROL, V20, P258, DOI 10.1007/s10157-015-1164-5
   Kashiwagi K, 2020, CLIN NUTR ESPEN, V38, P86, DOI 10.1016/j.clnesp.2020.05.025
   Katsiki N, 2022, CLIN INVEST ARTERIOS, V34, pS24, DOI 10.1016/j.arteri.2021.10.001
   Katsiki N, 2018, ANGIOLOGY, V69, P841, DOI 10.1177/0003319718776528
   Katsiki N, 2016, METABOLISM, V65, P1109, DOI 10.1016/j.metabol.2016.05.003
   Kechagias S, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154183
   Khazaei Yasaman, 2023, Clin Nutr Res, V12, P29, DOI 10.7762/cnr.2023.12.1.29
   Kim D, 2023, LIVER INT, V43, P513, DOI 10.1111/liv.15498
   Kim D, 2021, LIVER INT, V41, P1832, DOI 10.1111/liv.14852
   Kim D, 2020, HEPATOLOGY, V72, P1556, DOI 10.1002/hep.31158
   Kim G, 2018, HEPATOLOGY, V68, P1755, DOI 10.1002/hep.30049
   Kim YJ, 2022, GERIATR GERONTOL INT, V22, P695, DOI 10.1111/ggi.14442
   Koo BK, 2017, J HEPATOL, V66, P123, DOI 10.1016/j.jhep.2016.08.019
   Koutoukidis DA, 2021, METABOLISM, V115, DOI 10.1016/j.metabol.2020.154455
   Kouvari M, 2022, CLIN NUTR, V41, P1281, DOI 10.1016/j.clnu.2022.03.022
   Kouvari M, 2022, METABOLISM, V128, DOI 10.1016/j.metabol.2021.154893
   Kumagai H, 2021, AM J PHYSIOL-ENDOC M, V320, pE680, DOI 10.1152/ajpendo.00275.2020
   Lee JH, 2021, CLIN NUTR, V40, P5252, DOI 10.1016/j.clnu.2021.08.012
   Lee MJ, 2019, GUT LIVER, V13, P67, DOI 10.5009/gnl18070
   Lee SB, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19031675
   Lee YK, 2023, ALIMENT PHARM THER, V58, P322, DOI 10.1111/apt.17601
   Lindström I, 2021, J VASC SURG, V74, P1651, DOI 10.1016/j.jvs.2021.04.054
   Linge J, 2023, JHEP REP, V5, DOI 10.1016/j.jhepr.2022.100663
   Liu T, 2020, EUR J GASTROEN HEPAT, V32, P140, DOI 10.1097/MEG.0000000000001486
   Liu ZQ, 2022, METABOLISM, V127, DOI 10.1016/j.metabol.2021.154955
   Luo J, 2018, ASIA PAC J CLIN NUTR, V27, P1258, DOI 10.6133/apjcn.201811_27(6).0013
   Makri E, 2021, ARCH MED RES, V52, P25, DOI 10.1016/j.arcmed.2020.11.010
   Makri ES, 2021, EUR J PHARMACOL, V907, DOI 10.1016/j.ejphar.2021.174272
   Mantovani A, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154170
   Mantovani A, 2018, METABOLISM, V79, P64, DOI 10.1016/j.metabol.2017.11.003
   Maseroli E, 2021, J ENDOCRINOL INVEST, V44, P819, DOI 10.1007/s40618-020-01381-8
   Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56
   Messier V, 2011, MATURITAS, V68, P331, DOI 10.1016/j.maturitas.2011.01.014
   Michalakis K, 2013, METABOLISM, V62, P1341, DOI 10.1016/j.metabol.2013.05.019
   Montano-Loza AJ, 2016, J CACHEXIA SARCOPENI, V7, P126, DOI 10.1002/jcsm.12039
   Monterrosa-Castro A, 2022, MENOPAUSE, V29, P664, DOI 10.1097/GME.0000000000001960
   Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075
   Muscariello E, 2016, CLIN INTERV AGING, V11, DOI 10.2147/CIA.S96017
   Muzurovic E, 2021, METABOLISM, V119, DOI 10.1016/j.metabol.2021.154770
   Nunan E, 2022, GEROSCIENCE, V44, P1393, DOI 10.1007/s11357-022-00567-7
   Nunes EA, 2022, J CACHEXIA SARCOPENI, V13, P795, DOI 10.1002/jcsm.12922
   Oh C, 2017, NUTRITION, V33, P169, DOI 10.1016/j.nut.2016.06.004
   Osaka T, 2023, CLIN MED INSIGHTS-EN, V16, DOI 10.1177/11795514231161885
   Pafili K, 2022, J ENDOCRINOL INVEST, V45, P1609, DOI 10.1007/s40618-022-01766-x
   Pan CS, 2021, CLIN ENDOCRINOL, V94, P183, DOI 10.1111/cen.14344
   Pan RZ, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0279889
   Pan XY, 2018, DIGEST DIS, V36, P427, DOI 10.1159/000491015
   Papanastasiou L, 2017, MINERVA ENDOCRINOL, V42, P151, DOI 10.23736/S0391-1977.16.02583-9
   Parahiba SM, 2020, EXP GERONTOL, V142, DOI 10.1016/j.exger.2020.111106
   Paris MT, 2020, CURR OPIN PHARMACOL, V52, P61, DOI 10.1016/j.coph.2020.06.003
   Park HY, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.706259
   Park MJ, 2023, METABOLISM, V144, DOI 10.1016/j.metabol.2023.155577
   Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x
   Petta S, 2017, ALIMENT PHARM THER, V45, P510, DOI 10.1111/apt.13889
   Poggiogalle E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145811
   Polyzos SA, 2022, HORM-INT J ENDOCRINO, V21, P375, DOI 10.1007/s42000-022-00369-8
   Polyzos SA, 2022, CURR OBES REP, V11, P166, DOI 10.1007/s13679-022-00474-0
   Polyzos SA, 2020, METABOLISM, V113, DOI 10.1016/j.metabol.2020.154413
   Polyzos SA, 2020, DIABETES METAB SYND, V14, P1571, DOI 10.1016/j.dsx.2020.07.049
   Polyzos SA, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154203
   Polyzos SA, 2020, HORM-INT J ENDOCRINO, V19, P61, DOI 10.1007/s42000-019-00127-3
   Polyzos SA, 2019, METABOLISM, V96, P66, DOI 10.1016/j.metabol.2019.05.001
   Polyzos SA, 2019, METABOLISM, V92, P82, DOI 10.1016/j.metabol.2018.11.014
   Polyzos SA, 2018, HORM-INT J ENDOCRINO, V17, P321, DOI 10.1007/s42000-018-0049-x
   Polyzos SA, 2018, ENDOCRINE, V59, P260, DOI 10.1007/s12020-017-1476-1
   Polyzos SA, 2017, MINERVA ENDOCRINOL, V42, P92, DOI 10.23736/S0391-1977.16.02563-3
   Polyzos SA, 2016, METABOLISM, V65, P1297, DOI 10.1016/j.metabol.2016.05.013
   Polyzos SA, 2016, METABOLISM, V65, P1062, DOI 10.1016/j.metabol.2015.11.006
   Polyzos SA, 2016, J BONE MINER METAB, V34, P447, DOI 10.1007/s00774-015-0687-x
   Polyzos SA, 2012, J CLIN GASTROENTEROL, V46, P272, DOI 10.1097/MCG.0b013e31824587e0
   Polyzos SA, 2009, CURR MOL MED, V9, P299, DOI 10.2174/156652409787847191
   Prokopidis K, 2022, J CACHEXIA SARCOPENI, V13, P1642, DOI 10.1002/jcsm.12976
   Raptis D, 2023, THER CLIN RISK MANAG, V19, P77, DOI 10.2147/TCRM.S352008
   Ren QJ, 2022, DRUG DES DEV THER, V16, P3723, DOI 10.2147/DDDT.S381546
   Roh E, 2022, HEPATOL INT, V16, P545, DOI 10.1007/s12072-021-10258-8
   Rolland Y, 2023, Metabolism, DOI [10.1016/j.metabol.2023.155597:155597, DOI 10.1016/J.METABOL.2023.155597:155597]
   Schmitz SMT, 2021, J CLIN MED, V10, DOI 10.3390/jcm10153445
   Seko Y, 2019, HEPATOL RES, V49, P627, DOI 10.1111/hepr.13321
   Seo JY, 2022, J CACHEXIA SARCOPENI, V13, P2953, DOI 10.1002/jcsm.13099
   Shi YX, 2021, SCAND J GASTROENTERO, V56, P312, DOI 10.1080/00365521.2021.1879244
   Shida T, 2019, DIABET METAB SYND OB, V12, P495, DOI 10.2147/DMSO.S185705
   Shida T, 2018, J GASTROENTEROL, V53, P535, DOI 10.1007/s00535-017-1377-3
   Sindhughosa DA, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-11950-x
   Sinn DH, 2022, HEPATOLOGY, V76, P1746, DOI 10.1002/hep.32578
   Song WL, 2023, GUT LIVER, V17, P130, DOI 10.5009/gnl220041
   Steffl M, 2017, CLIN INTERV AGING, V12, P835, DOI 10.2147/CIA.S132940
   Su XY, 2019, BMC ENDOCR DISORD, V19, DOI 10.1186/s12902-019-0404-1
   Tabrizi R, 2017, DIAB MET SYND CLIN R, V11, pS975, DOI 10.1016/j.dsx.2017.07.025
   Tanaka M, 2020, LIVER INT, V40, P120, DOI 10.1111/liv.14253
   Targher G, 2006, CLIN ENDOCRINOL, V64, P337, DOI 10.1111/j.1365-2265.2006.02466.x
   Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008
   Tian SM, 2016, GERIATR GERONTOL INT, V16, P155, DOI 10.1111/ggi.12579
   Vachliotis I, 2022, HORM-INT J ENDOCRINO, V21, P41, DOI 10.1007/s42000-021-00339-6
   Valdiviesso R, 2022, BMC CARDIOVASC DISOR, V22, DOI 10.1186/s12872-022-02804-5
   Veldhuis JD, 2005, EUR J ENDOCRINOL, V153, P669, DOI 10.1530/eje.1.02019
   Waters DL, 2008, J GERONTOL A-BIOL, V63, P536, DOI 10.1093/gerona/63.5.536
   White HK, 2009, J CLIN ENDOCR METAB, V94, P1198, DOI 10.1210/jc.2008-0632
   Wijarnpreecha K, 2021, J GASTROINTEST LIVER, V30, P227, DOI 10.15403/jgld-3323
   Wijarnpreecha K, 2019, EUR J GASTROEN HEPAT, V31, P1121, DOI 10.1097/MEG.0000000000001397
   Wijarnpreecha K, 2018, SAUDI J GASTROENTERO, V24, P12, DOI 10.4103/sjg.SJG_237_17
   Wu YX, 2023, EUR J PHARMACOL, V939, DOI 10.1016/j.ejphar.2022.175476
   Xia L, 2020, CANCER MED-US, V9, P7964, DOI 10.1002/cam4.3428
   Xiao P, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.1057261
   Yan MY, 2022, METABOLISM, V134, DOI 10.1016/j.metabol.2022.155264
   Yokota T, 2017, J DIABETES INVEST, V8, P535, DOI 10.1111/jdi.12606
   Yu R, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0776-0
   Zanker J, 2023, J CACHEXIA SARCOPENI, V14, P142, DOI 10.1002/jcsm.13115
   Zelber-Sagi S, 2018, J HEPATOL, V68, P1239, DOI 10.1016/j.jhep.2018.01.015
   Zhang XX, 2022, J DIABETES RES, V2022, DOI 10.1155/2022/2229139
   Zhu XP, 2023, HEPATOL INT, V17, P313, DOI 10.1007/s12072-022-10439-z
NR 170
TC 5
Z9 5
U1 5
U2 5
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 1532-8600
J9 METABOLISM
JI Metab.-Clin. Exp.
PD 2023 OCT
PY 2023
VL 147
AR 155676
DI 10.1016/j.metabol.2023.155676
EA AUG 2023
PG 14
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA S4WP5
UT WOS:001071190000001
PM 37544590
DA 2024-02-19
ER

PT J
AU Guo, YN
   Tang, ZH
   Yan, BJ
   Yin, H
   Tai, S
   Peng, J
   Cui, YT
   Gui, Y
   Belke, D
   Zhou, SH
   Zheng, XL
AF Guo, Yanan
   Tang, Zhihan
   Yan, Binjie
   Yin, Hao
   Tai, Shi
   Peng, Juan
   Cui, Yuting
   Gui, Yu
   Belke, Darrell
   Zhou, Shenghua
   Zheng, Xi-Long
TI PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Triggers Vascular
   Smooth Muscle Cell Senescence and Apoptosis: Implication of Its Direct
   Role in Degenerative Vascular Disease
SO ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
LA English
DT Article
DE apoptosis; plaque vulnerability; polyploidy; senescence; smooth muscle
   cells
ID MYOCARDIAL-INFARCTION; NEOINTIMAL FORMATION; CYCLE ARREST; CROSS-TALK;
   RECEPTOR; ATHEROSCLEROSIS; HYPERTROPHY; INFLAMMATION; HYPERPLOIDY;
   POLYPLOIDY
AB Objective: PCSK9 (proprotein convertase subtilisin/kexin type 9) plays a critical role in cholesterol metabolism via the PCSK9-LDLR (low-density lipoprotein receptor) axis in the liver; however, evidence indicates that PCSK9 directly contributes to the pathogenesis of various diseases through mechanisms independent of its LDL-cholesterol regulation. The objective of this study was to determine how PCSK9 directly acts on vascular smooth muscle cells (SMCs), contributing to degenerative vascular disease. Approach and Results: We first examined the effects of PCSK9 on cultured human aortic SMCs. Overexpression of PCSK9 downregulated the expression of ApoER2 (apolipoprotein E receptor 2), a known target of PCSK9. Treatment with soluble recombinant human ApoER2 or the DNA synthesis inhibitor, hydroxyurea, inhibited PCSK9-induced polyploidization and other cellular responses of human SMCs. Treatment with antibodies against ApoER2 resulted in similar effects to those observed with PCSK9 overexpression. Inducible, SMC-specific knockout of Pcsk9 accelerated neointima formation in mouse carotid arteries and reduced age-related arterial stiffness. PCSK9 was expressed in SMCs of human atherosclerotic lesions and abundant in the "shoulder" regions of vulnerable atherosclerotic plaques. PCSK9 was also expressed in SMCs of abdominal aortic aneurysm, which was inversely related to the expression of smooth muscle alpha-actin. Conclusions: Our findings demonstrate that PCSK9 inhibits proliferation and induces polyploidization, senescence, and apoptosis, which may be relevant to various degenerative vascular diseases.
C1 [Guo, Yanan; Tang, Zhihan; Yan, Binjie; Yin, Hao; Gui, Yu; Zheng, Xi-Long] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada.
   [Guo, Yanan; Tang, Zhihan; Yan, Binjie; Yin, Hao; Gui, Yu; Zheng, Xi-Long] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada.
   [Belke, Darrell] Univ Calgary, Cumming Sch Med, Dept Cardiac Sci, Calgary, AB, Canada.
   [Yin, Hao] Western Univ, Robarts Res Inst, Schulich Sch Med & Dent, London, ON, Canada.
   [Guo, Yanan; Tai, Shi; Zhou, Shenghua] Cent South Univ, Dept Cardiol, Xiangya Hosp 2, Changsha, Peoples R China.
   [Tang, Zhihan; Yan, Binjie; Peng, Juan; Cui, Yuting] Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Sch Basic Med Sci,Hengyang Med Sch,Hunan Int Sci, Hengyang, Hunan, Peoples R China.
C3 University of Calgary; University of Calgary; University of Calgary;
   Western University (University of Western Ontario); Central South
   University; University of South China
RP Zhou, SH (corresponding author), 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China.; Zheng, XL (corresponding author), GAA12-HRIC 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.
EM guoyanan@csu.edu.cn; tangzhihan98@163.com; simple_3531@163.com;
   hyin@robarts.ca; taishi2017@csu.edu.cn; 2106456725@qq.com;
   936634621@qq.com; ygui@ucalgary.ca; darrellbelke@gmail.com;
   zhoushenghua@csu.edu.cn; xlzheng@ucalgary.ca
RI cui, yuting/HZL-2925-2023; TAI, SHI/HOC-0563-2023; zhou,
   sheng/GYJ-6012-2022
OI TAI, SHI/0000-0002-5802-2910; Guo, Yanan/0000-0003-1070-7774; Zhou,
   Shenghua/0000-0001-5388-7766; Belke, Darrell/0009-0002-4418-7201
FU Canadian Institutes of Health Research (CIHR) [PJT-178010, PJT-165941];
   Natural Sciences and Engineering Research Council of Canada
   [RGPIN-2020-04592]; International Atherosclerosis Society; China
   Scholarship Council (CSC); CSC Studentship
FX This study was supported by the Canadian Institutes of Health Research
   (CIHR, PJT-178010 to X.-L. Zheng, PJT-165941 to X.-L. Zheng) and the
   Natural Sciences and Engineering Research Council of Canada
   (RGPIN-2020-04592 to X.-L. Zheng). Z. Tang was the recipient of a
   Visiting Fellowship Award from the International Atherosclerosis Society
   and a visiting scholarship from the China Scholarship Council (CSC). Y.
   Guo and B. Yan were supported by CSC Studentship.
CR Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161
   Andreassen PR, 1996, MUTAT RES-FUND MOL M, V372, P181, DOI 10.1016/S0027-5107(96)00138-8
   Aranzulla TC, 2021, CATHETER CARDIO INTE, V97, pE835, DOI 10.1002/ccd.29231
   Asif M, 2018, GENE, V642, P225, DOI 10.1016/j.gene.2017.10.037
   BARRETT TB, 1983, P NATL ACAD SCI-BIOL, V80, P882, DOI 10.1073/pnas.80.3.882
   Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200
   Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361
   Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095
   Bown MJ, 2011, AM J HUM GENET, V89, P619, DOI 10.1016/j.ajhg.2011.10.002
   Buj R, 2021, AGING-US, V13, P3290, DOI 10.18632/aging.202640
   Cariou B, 2016, ATHEROSCLEROSIS, V253, P275, DOI 10.1016/j.atherosclerosis.2016.08.007
   Chakraborty R, 2019, ARTERIOSCL THROM VAS, V39, P603, DOI 10.1161/ATVBAHA.119.312449
   Cheng JM, 2016, ATHEROSCLEROSIS, V248, P117, DOI 10.1016/j.atherosclerosis.2016.03.010
   CHOBANIAN AV, 1987, CIRCULATION, V75, P102
   Cui Q, 2010, ATHEROSCLEROSIS, V213, P632, DOI 10.1016/j.atherosclerosis.2010.09.027
   Davis FM, 2015, ARTERIOSCL THROM VAS, V35, P155, DOI 10.1161/ATVBAHA.114.304683
   DEVLIN AM, 1995, J HUM HYPERTENS, V9, P497
   Ding ZF, 2018, CARDIOVASC RES, V114, P1145, DOI 10.1093/cvr/cvy079
   Ding ZF, 2016, ANTIOXID REDOX SIGN, V25, P997, DOI 10.1089/ars.2016.6631
   Ding ZF, 2015, CARDIOVASC RES, V107, P556, DOI 10.1093/cvr/cvv178
   Ding ZF, 2015, ANTIOXID REDOX SIGN, V22, P760, DOI 10.1089/ars.2014.6054
   Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249
   ENGELMANN GL, 1986, CIRC RES, V58, P137, DOI 10.1161/01.RES.58.1.137
   Ferri N, 2016, ATHEROSCLEROSIS, V253, P214, DOI 10.1016/j.atherosclerosis.2016.07.910
   Ferri N, 2012, ATHEROSCLEROSIS, V220, P381, DOI 10.1016/j.atherosclerosis.2011.11.026
   Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923
   Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115
   GORDON D, 1986, CIRC RES, V59, P633, DOI 10.1161/01.RES.59.6.633
   Grootaert MOJ, 2021, CARDIOVASC RES, V117, P2326, DOI 10.1093/cvr/cvab046
   Gui Y, 2006, HYPERTENSION, V47, P271, DOI 10.1161/01.HYP.0000199656.99448.dc
   Gui Y, 2003, J BIOL CHEM, V278, P53017, DOI 10.1074/jbc.M309640200
   Gui Y, 2007, AM J PHYSIOL-LUNG C, V293, pL702, DOI 10.1152/ajplung.00016.2007
   Guo YN, 2021, J CELL PHYSIOL, V236, P2333, DOI 10.1002/jcp.30025
   Haas ME, 2016, CIRCULATION, V134, P61, DOI 10.1161/CIRCULATIONAHA.115.020912
   Hixon ML, 2003, CELL CYCLE, V2, P105, DOI 10.4161/cc.2.2.341
   Hixon ML, 2000, J BIOL CHEM, V275, P40434, DOI 10.1074/jbc.M005059200
   Iida Y, 2018, ANN VASC SURG, V48, P195, DOI 10.1016/j.avsg.2017.10.005
   Jones MR, 2004, J BIOL CHEM, V279, P5306, DOI 10.1074/jbc.M308406200
   Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200
   KAMENTSKY LA, 1991, CYTOMETRY, V12, P381, DOI 10.1002/cyto.990120502
   Kamentsky LA, 2001, METHOD CELL BIOL, V63, P51
   Kockx MM, 1998, EUR HEART J, V19, pG23
   Komaravolu RK, 2019, ARTERIOSCL THROM VAS, V39, P2132, DOI 10.1161/ATVBAHA.119.313194
   Kysenius K, 2012, CELL MOL LIFE SCI, V69, P1903, DOI 10.1007/s00018-012-0977-6
   Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383
   Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114
   Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009
   Liberale L, 2018, INT J CARDIOL, V263, P138, DOI 10.1016/j.ijcard.2018.03.081
   Lupo MG, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22084114
   Martinelli N, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-41
   Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101
   Mccrann DJ, 2008, J CELL PHYSIOL, V215, P588, DOI 10.1002/jcp.21363
   Miranda MX, 2015, EUR HEART J, V36, P51, DOI 10.1093/eurheartj/ehu095
   Moura R, 2007, ARTERIOSCL THROM VAS, V27, P2163, DOI 10.1161/ATVBAHA.107.151282
   Najjar SS, 2005, HYPERTENSION, V46, P454, DOI 10.1161/01.HYP.0000177474.06749.98
   O'Rourke MF, 2010, VASC MED, V15, P461, DOI 10.1177/1358863X10382946
   Omori H, 2020, JACC-CARDIOVASC IMAG, V13, P1639, DOI 10.1016/j.jcmg.2020.02.019
   Owens Gary K, 2007, Novartis Found Symp, V283, P174
   OWENS GK, 1989, AM J PHYSIOL, V257, pH1755, DOI 10.1152/ajpheart.1989.257.6.H1755
   OWENS GK, 1985, CIRC RES, V56, P525, DOI 10.1161/01.RES.56.4.525
   OWENS GK, 1981, P NATL ACAD SCI-BIOL, V78, P7759, DOI 10.1073/pnas.78.12.7759
   OWENS GK, 1983, CIRC RES, V53, P491, DOI 10.1161/01.RES.53.4.491
   OWENS GK, 1982, CIRC RES, V51, P280, DOI 10.1161/01.RES.51.3.280
   Park M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019143
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Ruscica M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005764
   Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100
   Shen GQ, 2007, AM J HUM GENET, V81, P780, DOI 10.1086/521581
   Shi WB, 2004, J LIPID RES, V45, P2008, DOI 10.1194/jlr.M400254-JLR200
   Shtutman M, 2017, METHODS MOL BIOL, V1534, P31, DOI 10.1007/978-1-4939-6670-7_3
   Strickland DK, 2014, ARTERIOSCL THROM VAS, V34, P487, DOI 10.1161/ATVBAHA.113.301924
   Tanaka H, 2018, J OLEO SCI, V67, P1355, DOI 10.5650/jos.ess18131
   Tang ZH, 2017, ATHEROSCLEROSIS, V262, P113, DOI 10.1016/j.atherosclerosis.2017.04.023
   Tao RY, 2013, J BIOL CHEM, V288, P29252, DOI 10.1074/jbc.M113.481473
   Umar S, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.012063
   Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003
   Virmani R, 1998, EUR HEART J, V19, P678
   Waltmann MD, 2014, BBA-MOL BASIS DIS, V1842, P1395, DOI 10.1016/j.bbadis.2014.05.009
   Wang L, 2018, INT J MOL MED, V42, P2098, DOI 10.3892/ijmm.2018.3797
   Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560
   YAMORI Y, 1987, CIRCULATION, V75, P92
   Yan L, 2021, EXP THER MED, V21, DOI 10.3892/etm.2020.9457
   Yoshida K, 2018, THROMB RES, V163, P30, DOI 10.1016/j.thromres.2018.01.001
   YOUNG CW, 1967, CANCER RES, V27, P535
   Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200
NR 86
TC 28
Z9 28
U1 16
U2 66
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1079-5642
EI 1524-4636
J9 ARTERIOSCL THROM VAS
JI Arterioscler. Thromb. Vasc. Biol.
PD JAN
PY 2022
VL 42
IS 1
BP 67
EP 86
DI 10.1161/ATVBAHA.121.316902
PG 20
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA XR1NK
UT WOS:000732004900014
PM 34809446
OA Bronze
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Parra, CA
   Duarte, A
   Luna, RS
   Wolcott, DM
   Weckerly, FW
AF Parra, Claire A.
   Duarte, Adam
   Luna, Ryan S.
   Wolcott, Daniel M.
   Weckerly, Floyd W.
TI Body mass, age, and reproductive influences on liver mass of
   white-tailed deer (<i>Odocoileus virginianus</i>)
SO CANADIAN JOURNAL OF ZOOLOGY
LA English
DT Article
DE Odocoileus virginianus; ruminant; scaling relationships; visceral organ;
   white-tailed deer
ID RED DEER; WEIGHT; LACTATION; ALLOMETRY; METABOLISM; SENESCENCE;
   NUTRITION; CAPACITY; ONTOGENY; RESERVES
AB Previous research into the liver has mainly examined liver function and liver response to energy restriction. There have been few investigations into how liver mass is coupled to body mass, body condition, age, and reproductive events like lactation. Therefore, we examined the scaling relationship between body mass and liver mass and the influences of age, sex, body condition (back fat), and lactation on liver mass to gain insight into liver-mass variation in white-tailed deer (Odocoileus virginianus (Zimmermann, 1780)). Deer from two sites in Texas (89 males, 70 females) were sampled; one site was sampled before the mating season (premating) and the other site was sampled during the mating season. There was an allometric relationship between body mass and liver mass (scalars 0.59-0.80) at both sites. Also, sex and age were predictors of liver mass at one site, whereas lactation was influential at the other location. Controlling for body mass, males had heavier livers than females during the mating but not the premating season and age was positively related to liver mass. Our findings indicate that sex and lactation status were coupled to liver masses, but the effect of these two factors differed between premating and mating seasons. It appears that animals in situations where metabolic demands might be higher than current nutrient intake, such as mature males during the rut or lactating females, have heavier liver masses when body mass is controlled.
C1 [Parra, Claire A.; Duarte, Adam; Luna, Ryan S.; Wolcott, Daniel M.; Weckerly, Floyd W.] Texas State Univ San Marcos, Dept Biol, San Marcos, TX 78666 USA.
C3 Texas State University System; Texas State University San Marcos
RP Weckerly, FW (corresponding author), Texas State Univ San Marcos, Dept Biol, San Marcos, TX 78666 USA.
EM fw11@txstate.edu
FU Houston Safari Club
FX We thank Texas Parks and Wildlife and Kerr Wildlife Management Area, as
   well as the south Texas ranch, for allowing us to collect data and for
   their assistance. We also thank K. Cummings, J. Duarte, A. Julian, J.
   Lattanzio, A. Munters, and V. Pina for helping in data collection.
   Funding was provided by the Houston Safari Club.
CR Asmus J, 2011, J WILDLIFE MANAGE, V75, P1194, DOI 10.1002/jwmg.133
   Barboza P.S., 2009, INT WILDL NUTR
   Barboza PS, 2004, J COMP PHYSIOL B, V174, P309, DOI 10.1007/s00360-004-0416-6
   Barboza PS, 2000, J MAMMAL, V81, P473, DOI 10.1644/1545-1542(2000)081&lt;0473:SSIDDA&gt;2.0.CO;2
   Bollo E, 1999, J WILDLIFE DIS, V35, P770, DOI 10.7589/0090-3558-35.4.770
   Burnham K.P., 2002, MODEL SELECTION MULT
   Carranza J, 2004, NATURE, V432, P215, DOI 10.1038/nature03004
   Christians JK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P250, DOI 10.1086/316661
   Duarte A, 2011, EUR J WILDLIFE RES, V57, P1131, DOI 10.1007/s10344-011-0525-y
   EMERY RS, 1992, J NUTR, V122, P832, DOI 10.1093/jn/122.suppl_3.832
   Ericsson G, 2001, ECOLOGY, V82, P1613, DOI 10.1890/0012-9658(2001)082[1613:ARREAS]2.0.CO;2
   Franz R, 2009, P ROY SOC B-BIOL SCI, V276, P1731, DOI 10.1098/rspb.2008.1735
   Gerhart KL, 1996, CAN J ZOOL, V74, P136, DOI 10.1139/z96-018
   Gross JJ, 2013, J DAIRY SCI, V96, P5008, DOI 10.3168/jds.2012-6245
   Hewison AJM, 2011, OIKOS, V120, P1217, DOI 10.1111/j.1600-0706.2011.19316.x
   HOLTER JB, 1977, J ANIM SCI, V45, P365, DOI 10.2527/jas1977.452365x
   Isaac NJB, 2010, ECOL LETT, V13, P728, DOI 10.1111/j.1461-0248.2010.01461.x
   JOHNSON DE, 1990, J NUTR, V120, P649, DOI 10.1093/jn/120.6.649
   KENNEDY GC, 1958, J ENDOCRINOL, V17, P158, DOI 10.1677/joe.0.0170158
   LEADERWILLIAMS N, 1982, OIKOS, V38, P27, DOI 10.2307/3544564
   Lindstedt SL, 2002, LAB ANIM-UK, V36, P1, DOI 10.1258/0023677021911731
   Lockwood MA, 2007, J WILDLIFE MANAGE, V71, P2732, DOI 10.2193/2005-517
   Luna RS, 2012, CAN J ZOOL, V90, P1351, DOI 10.1139/cjz-2012-0122
   McCullough D.R., 1979, The George Reserve deer herd
   Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008
   MITCHELL B, 1976, J ZOOL, V180, P107, DOI 10.1111/j.1469-7998.1976.tb04667.x
   Monteith KL, 2013, J ANIM ECOL, V82, P377, DOI 10.1111/1365-2656.12016
   Müller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022732
   Naya DE, 2008, PHYSIOL BIOCHEM ZOOL, V81, P186, DOI 10.1086/527453
   PROTHERO JW, 1982, COMP BIOCHEM PHYS A, V71, P567, DOI 10.1016/0300-9629(82)90205-5
   Ramsey JJ, 2006, J NUTR, V136, p1958S, DOI 10.1093/jn/136.7.1958S
   Ramzinski DM, 2007, J MAMMAL, V88, P415, DOI 10.1644/06-MAMM-A-213R1.1
   Ribeiro TR, 2001, REV BRAS ZOOTECN, V30, P2163, DOI 10.1590/S1516-35982001000800027
   ROBINSON R. M., 1965, J WILDLIFE MANAGE, V29, P53, DOI 10.2307/3798631
   Rohlf, 2012, BIOMETRY PRINCIPLES
   Rule DC, 1998, COMP BIOCHEM PHYS B, V119, P563, DOI 10.1016/S0305-0491(98)00029-7
   SEVERINGHAUS CW, 1949, J WILDLIFE MANAGE, V13, P195, DOI 10.2307/3796089
   Therrien JF, 2008, ANIM BEHAV, V75, P235, DOI 10.1016/j.anbehav.2007.04.030
   THOMPSON CB, 1973, J WILDLIFE MANAGE, V37, P301, DOI 10.2307/3800120
   Van Soest PJ., 1994, Nutritional ecology of the ruminant, p476p, DOI 10.7591/9781501732355
   Wang ZM, 2001, J NUTR, V131, P2967, DOI 10.1093/jn/131.11.2967
   Webb SL, 2007, J WILDLIFE MANAGE, V71, P555, DOI 10.2193/2006-189
   Weckerly FW, 2013, J MAMMAL, V94, P120, DOI 10.1644/12-MAMM-A-066.1
   Weckerly FW, 2003, J MAMMAL, V84, P659, DOI 10.1644/1545-1542(2003)084&lt;0659:BWARRC&gt;2.0.CO;2
   WHEATON C, 1983, J WILDLIFE MANAGE, V47, P442, DOI 10.2307/3808517
   WOLKERS H, 1994, CAN J ZOOL, V72, P1837, DOI 10.1139/z94-248
NR 46
TC 8
Z9 8
U1 0
U2 9
PU CANADIAN SCIENCE PUBLISHING
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4301
EI 1480-3283
J9 CAN J ZOOL
JI Can. J. Zool.
PD APR
PY 2014
VL 92
IS 4
BP 273
EP 278
DI 10.1139/cjz-2013-0201
PG 6
WC Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Zoology
GA AT4ZQ
UT WOS:000344953600001
DA 2024-02-19
ER

PT J
AU OhIshi, S
   Kizaki, T
   Yamashita, H
   Nagata, N
   Suzuki, K
   Taniguchi, N
   Ohno, H
AF OhIshi, S
   Kizaki, T
   Yamashita, H
   Nagata, N
   Suzuki, K
   Taniguchi, N
   Ohno, H
TI Alterations of superoxide dismutase iso-enzyme activity, content, and
   mRNA expression with aging in rat skeletal muscle
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; skeletal muscle; Mn-superoxide dismutase; Cu,Zn-superoxide
   dismutase
ID ANTIOXIDANT ENZYMES; LIVER; RNA; FRAGMENTS; COPPER; BRAIN; HEART; MICE
AB The alterations of superoxide dismutase iso-enzyme (Cu,Zn-SOD and Mn-SOD) activities, contents, and mRNA expressions with aging were studied in rat soleus muscle (SO) and extensor digitorum longus muscle (EDL). The activity and content of Cu,Zn-SOD in both muscles were significantly higher in old rats (24 months old) than in young rats (4 months old), whereas those of Mn-SOD showed no difference between young and old rats. After normalization to citrate synthase (CS) activity, however Mn-SOD/CS ratio in SO also showed the age-related increase. Moreover, the activities of other major antioxidant enzymes, glutathione peroxidase (GPX) and catalase (CAT), indicated age-related increases only in SO. As for the expressions of mRNAs for SOD iso-enzymes, that of Cu,Zn-SOD in either muscle showed no significant change with aging, unlike its activity and content, although that of Mn-SOD was decreased with aging only in EDL. Thus, aging appeared to raise the level of antioxidant enzyme system in rat skeletal muscle. However, the resistance of Cu,Zn-SOD and Mn-SOD to oxidative stress accompanied by aging was different, the former being obviously greater than the latter. Such changes also differed in muscle fiber type suggesting that fast-twitch fibers are more susceptible to age-related oxidative stress than slow-twitch fibers.
C1 NATL DEF MED COLL, DEPT INTERNAL MED 3, TOKOROZAWA, SAITAMA 359, JAPAN.
   OSAKA UNIV, SCH MED, DEPT BIOCHEM, SUITA, OSAKA 565, JAPAN.
C3 National Defense Medical College - Japan; Osaka University
RP OhIshi, S (corresponding author), NATL DEF MED COLL, DEPT HYG, 3-2 NAMIKI, TOKOROZAWA, SAITAMA 359, JAPAN.
RI Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014
OI Taniguchi, Naoyuki/0000-0001-5889-5968; Yamashita,
   Hitoshi/0000-0002-5785-5208
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Crapo J D, 1978, Methods Enzymol, V53, P382
   DANH HC, 1983, J NEUROCHEM, V40, P1003, DOI 10.1111/j.1471-4159.1983.tb08084.x
   DELEEUW WJF, 1989, NUCLEIC ACIDS RES, V17, P10137, DOI 10.1093/nar/17.23.10137
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   GOLAN R, 1994, EXERCISE OXYGEN TOXI, P235
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HO YS, 1987, NUCLEIC ACIDS RES, V15, P10070, DOI 10.1093/nar/15.23.10070
   HO YS, 1987, NUCLEIC ACIDS RES, V15, P6746, DOI 10.1093/nar/15.16.6746
   JENKINS RR, 1984, INT J SPORTS MED, V5, P11, DOI 10.1055/s-2008-1025872
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JI LL, 1991, AM J PHYSIOL, V261, pR386, DOI 10.1152/ajpregu.1991.261.2.R386
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P137, DOI 10.1016/0003-9861(88)90622-4
   JORNOT L, 1993, AM J PHYSIOL, V264, pL482, DOI 10.1152/ajplung.1993.264.5.L482
   LAWLER JM, 1993, AM J PHYSIOL, V265, pR1344, DOI 10.1152/ajpregu.1993.265.6.R1344
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUHTALA TA, 1994, J GERONTOL, V49, pB231, DOI 10.1093/geronj/49.5.B231
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   Ohno H., 1994, EXERCISE OXYGEN TOXI, P127
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   SCOTT MD, 1987, J BIOL CHEM, V262, P3640
   SHARMA HK, 1980, J BIOL CHEM, V255, P5043
   Shepherd D., 1969, CITRATE SYNTHASE RAT, V13, P11
   SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0
   SUZUKI K, 1993, CARCINOGENESIS, V14, P1881, DOI 10.1093/carcin/14.9.1881
   TANIGUCHI N, 1992, ADV CLIN CHEM, V29, P1, DOI 10.1016/S0065-2423(08)60221-8
   Tappel A L, 1978, Methods Enzymol, V52, P506
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TOLMASOFF JM, 1980, P NATL ACAD SCI-BIOL, V77, P2777, DOI 10.1073/pnas.77.5.2777
   VERTECHY M, 1989, EXP GERONTOL, V24, P211, DOI 10.1016/0531-5565(89)90012-0
NR 33
TC 68
Z9 68
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP 29
PY 1995
VL 84
IS 1
BP 65
EP 76
DI 10.1016/0047-6374(95)01637-F
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA TK942
UT WOS:A1995TK94200006
PM 8719778
DA 2024-02-19
ER

PT J
AU Katsuta, N
   Takahashi, H
   Nagai, M
   Sugawa, H
   Nagai, R
AF Katsuta, Nana
   Takahashi, Himeno
   Nagai, Mime
   Sugawa, Hikari
   Nagai, Ryoji
TI Changes in <i>S</i>-(2-succinyl)cysteine and advanced glycation
   end-products levels in mouse tissues associated with aging
SO AMINO ACIDS
LA English
DT Article; Early Access
DE S-(2-succinyl)cysteine; Advanced glycation end-products; Aging-related
   changes; Liquid chromatography-tandem mass spectrometry; Brain
   metabolite levels
ID CHEMICAL-MODIFICATION; MITOCHONDRIAL STRESS; PROTEIN; DISEASE;
   SUCCINATION; AGE; IDENTIFICATION; BIOMARKER;
   N-EPSILON-(CARBOXYETHYL)LYSINE; METHYLGLYOXAL
AB Cysteine is non-enzymatically modified by fumarate, which is an intermediate of the tricarboxylic acid cycle, leading to the formation of S-(2-succinyl)cysteine (2SC). Post-translational modification of physiological proteins by fumarate causes enzyme dysfunction. The aim of the study was to evaluate the changes in 2SC accumulation in physiological tissues associated with aging. Brain, liver, kidney, and serum samples were collected from 4-, 12-, and 96-week-old male C57BL/6J mice, and the level of 2SC was determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) after pretreatment, including delipidation, protein precipitation, and hydrolysis using hydrochloric acid. The 2SC level in the brain was higher than that in other tissues, and its accumulation significantly increased with age. Similarly, N-epsilon-(carboxymethyl)lysine levels, an advanced glycation end-products (AGEs) that accumulates in tissues in an age-dependent manner, was found to be increased in the brain and kidneys of elderly mice. Accumulation of N-delta-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine increased significantly with age, but only in the kidneys. The fumarate content in the brain was similar to that in the liver and kidney at 4 and 12 weeks of age. Furthermore, fumarate contents increased in the liver and kidney at 96 weeks of age, whereas its level did not change in the brain. Our results demonstrated that the changes in 2SC and AGEs levels in tissues reflected differing metabolism and enhanced oxidative stress in each organ; in particular, the metabolism in the brain and kidneys is highly affected by aging.
C1 [Katsuta, Nana; Nagai, Ryoji] Tokai Univ, Grad Sch Biosci, Lab Food & Regulat Biol, Kumamoto, Japan.
   [Takahashi, Himeno; Nagai, Mime; Sugawa, Hikari; Nagai, Ryoji] Tokai Univ, Sch Agr, Dept Biosci, Lab Food & Regulat Biol,Higashi Ku, Toroku 9-1-1, Kumamoto, Kumamoto 8628652, Japan.
C3 Tokai University; Tokai University
RP Nagai, R (corresponding author), Tokai Univ, Grad Sch Biosci, Lab Food & Regulat Biol, Kumamoto, Japan.; Nagai, R (corresponding author), Tokai Univ, Sch Agr, Dept Biosci, Lab Food & Regulat Biol,Higashi Ku, Toroku 9-1-1, Kumamoto, Kumamoto 8628652, Japan.
EM nagai-883@umin.ac.jp
FU JSPS KAKENHI [20K05895]; Japan Science and Technology Agency, Adaptable
   and Seamless Technology Transfer Program through Target-Driven R and D
   [AS3015118U]; Grants-in-Aid for Scientific Research [20K05895] Funding
   Source: KAKEN
FX This work was supported by a JSPS KAKENHI grant (grant no. 20K05895)
   provided to Ryoji Nagai. This work was also supported in part by the
   YJapan Science and Technology Agency, Adaptable and Seamless Technology
   Transfer Program through Target-Driven R and D (number AS3015118U).
CR Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565
   Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005
   Bardella C, 2011, J PATHOL, V225, P4, DOI 10.1002/path.2932
   Bélanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016
   Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983
   Blatnik M, 2008, DIABETES, V57, P41, DOI 10.2337/db07-0838
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Cabré R, 2017, FREE RADICAL BIO MED, V103, P14, DOI 10.1016/j.freeradbiomed.2016.12.010
   Fang YD, 2020, AGEING RES REV, V63, DOI 10.1016/j.arr.2020.101151
   Frizzell N, 2012, BIOCHEM J, V445, P247, DOI 10.1042/BJ20112142
   Frizzell N, 2009, J BIOL CHEM, V284, P25772, DOI 10.1074/jbc.M109.019257
   Giorgi C, 2018, INT REV CEL MOL BIO, V340, P209, DOI 10.1016/bs.ircmb.2018.05.006
   Grimm A, 2017, J NEUROCHEM, V143, P418, DOI 10.1111/jnc.14037
   Hyogo H, 2007, J GASTROEN HEPATOL, V22, P1112, DOI 10.1111/j.1440-1746.2007.04943.x
   Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244
   Kawas C, 2000, NEUROLOGY, V54, P2072, DOI 10.1212/WNL.54.11.2072
   Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737
   López-González I, 2015, J NEUROPATH EXP NEUR, V74, P975, DOI 10.1097/NEN.0000000000000241
   Merkley ED, 2014, MASS SPECTROM REV, V33, P98, DOI 10.1002/mas.21382
   Nagai R, 2003, J CHROMATOGR B, V788, P75, DOI 10.1016/S1570-0232(02)01019-X
   Nagai R, 2002, J BIOL CHEM, V277, P48905, DOI 10.1074/jbc.M205688200
   Nagai R, 2007, J BIOL CHEM, V282, P34219, DOI 10.1074/jbc.M703551200
   Nagai R, 2014, J CLIN BIOCHEM NUTR, V55, P1, DOI 10.3164/jcbn.13-112
   Naudí A, 2017, BBA-MOL CELL BIOL L, V1862, P485, DOI 10.1016/j.bbalip.2017.02.001
   O'Connor PM, 2006, CLIN EXP PHARMACOL P, V33, P961, DOI 10.1111/j.1440-1681.2006.04475.x
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Piroli GG, 2016, MOL CELL PROTEOMICS, V15, P445, DOI 10.1074/mcp.M115.051516
   Piroli GG, 2014, BIOCHEM J, V462, P231, DOI 10.1042/BJ20131581
   Postma M, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000202
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917
   Thomas SA, 2012, OBESITY, V20, P263, DOI 10.1038/oby.2011.340
   Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763
   Toriumi K, 2021, REDOX BIOL, V45, DOI 10.1016/j.redox.2021.102057
   Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200
   Yamanaka M, 2016, J CLIN BIOCHEM NUTR, V58, P130, DOI 10.3164/jcbn.15-131
   Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044
   Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513
NR 38
TC 5
Z9 5
U1 0
U2 5
PU SPRINGER WIEN
PI Vienna
PA Prinz-Eugen-Strasse 8-10, A-1040 Vienna, AUSTRIA
SN 0939-4451
EI 1438-2199
J9 AMINO ACIDS
JI Amino Acids
PD 2022 APR
PY 2022
VL 54
IS 4
SI SI
BP 653
EP 661
DI 10.1007/s00726-022-03130-y
EA FEB 2022
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 1I9RG
UT WOS:000755403700001
PM 35166937
DA 2024-02-19
ER

PT J
AU Guarasci, F
   D'Aquila, P
   Mandalà, M
   Garasto, S
   Lattanzio, F
   Corsonello, A
   Passarino, G
   Bellizzi, D
AF Guarasci, Francesco
   D'Aquila, Patrizia
   Mandala, Maurizio
   Garasto, Sabrina
   Lattanzio, Fabrizia
   Corsonello, Andrea
   Passarino, Giuseppe
   Bellizzi, Dina
TI Aging and nutrition induce tissue-specific changes on global DNA
   methylation status in rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Global DNA methylation; Aging; Tissue specificity; Nutrition;
   Low-calorie diet; Maternal pre-gestational/gestational diet
ID GENE-EXPRESSION; EPIGENETICS; AGE; METHYLTRANSFERASES; METABOLISM; DIET;
   LIFE; HYPOMETHYLATION; SUPPLEMENTATION; MECHANISMS
AB A number of epigenetic studies have demonstrated that DNA methylation patterns exhibit a tissue specificity, but not much has been done to highlight the extent of this phenomenon. Moreover, it is unknown how external factors modulate the plasticity of the tissue specific epigenetic profile. We examined global DNA methylation profiles in tissues from rats of different age, fed with standard or low-calorie diet, and evaluated their association with aging and nutrition. Tissue-specific variations occur during aging with hyper-methylation taking place in all tissues except for liver. The expression of enzymes involved in methylation reactions (DNMTs and TETs) was consistent with the methylation patterns. Nutrition affects global DNA methylation status throughout lifespan. Interestingly, the differences among different tissues are magnified in 96 weeks old rats fed with low calorie diet. Moreover, the low-calorie diet appears to affect the offspring's epigenetic status more strongly if administered during the maternal pre-gestational period than the gestational and lactation time.
   Therefore, we propose that changes in the global DNA methylation status may represent an epigenetic mechanism by which age and nutrition intersect each other and, in turn, influence the aging plasticity.
C1 [Guarasci, Francesco; D'Aquila, Patrizia; Mandala, Maurizio; Passarino, Giuseppe; Bellizzi, Dina] Univ Calabria, Dept Biol Ecol & Earth Sci DiBEST, I-87036 Arcavacata Di Rende, Italy.
   [Garasto, Sabrina; Corsonello, Andrea] Italian Natl Res Ctr Aging, I-87100 Cosenza, Italy.
   [Lattanzio, Fabrizia] Italian Natl Res Ctr Aging, Sci Direct, I-60124 Ancona, Italy.
C3 University of Calabria; IRCCS INRCA; IRCCS INRCA
RP Passarino, G; Bellizzi, D (corresponding author), Univ Calabria, Dept Biol Ecol & Earth Sci DiBEST, I-87036 Arcavacata Di Rende, Italy.
EM giuseppe.passarino@unical.it; dina.bellizzi@unical.it
RI Passarino, Giuseppe/ISB-6758-2023; Lattanzio, Fabrizia/D-2896-2018;
   D'Aquila, Patrizia/AAC-3468-2022; Andrea, Corsonello/AAC-1845-2022;
   Guarasci, Francesco/AAB-9790-2020
OI Lattanzio, Fabrizia/0000-0003-4051-1289; Guarasci,
   Francesco/0000-0003-3891-226X; D'Aquila, Patrizia/0000-0001-5740-4733
CR Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003
   Bacalini MG, 2017, MECH AGEING DEV, V165, P156, DOI 10.1016/j.mad.2017.01.006
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017
   Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005
   Bellizzi D, 2012, AGE, V34, P169, DOI 10.1007/s11357-011-9216-6
   Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877
   Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003
   Bormann F, 2016, AGING CELL, V15, P563, DOI 10.1111/acel.12470
   Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909
   Chango A, 2015, NUTRIENTS, V7, P2748, DOI 10.3390/nu7042748
   Chmurzynska A, 2010, NUTR REV, V68, P87, DOI 10.1111/j.1753-4887.2009.00265.x
   Craciunescu CN, 2010, J NUTR, V140, P1162, DOI 10.3945/jn.110.122044
   D'Aquila P, 2017, AGING CELL, V16, P966, DOI 10.1111/acel.12603
   D'Aquila P, 2015, BIOGERONTOLOGY, V16, P569, DOI 10.1007/s10522-015-9562-3
   D'Aquila P, 2013, MATURITAS, V74, P130, DOI 10.1016/j.maturitas.2012.11.005
   Dominguez-Salas P, 2012, P NUTR SOC, V71, P154, DOI 10.1017/S0029665111003338
   Farias N, 2015, J NUTR BIOCHEM, V26, P818, DOI 10.1016/j.jnutbio.2015.02.002
   Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   Geraghty AA, 2015, NUTR METAB INSIGHTS, V8, P41, DOI 10.4137/NMI.S29527
   Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105
   Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109
   Hino S, 2013, J HUM GENET, V58, P410, DOI 10.1038/jhg.2013.57
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86
   Jang Hyeran, 2014, Clin Nutr Res, V3, P1, DOI 10.7762/cnr.2014.3.1.1
   Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009
   Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286
   Kim KC, 2009, J NUTR BIOCHEM, V20, P917, DOI 10.1016/j.jnutbio.2009.06.008
   Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069
   Lee HS, 2015, NUTRIENTS, V7, P9492, DOI 10.3390/nu7115467
   Lee WJ, 2005, MOL PHARMACOL, V68, P1018, DOI 10.1124/mol.104.008367
   Li CCY, 2010, EPIGENOMICS-UK, V2, P539, DOI 10.2217/EPI.10.33
   Li X, 2015, EUR J NUTR, V54, P1201, DOI 10.1007/s00394-014-0799-4
   Li YY, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-98
   Lillycrop KA, 2014, P NUTR SOC, V73, P413, DOI 10.1017/S0029665114000081
   Lim Unhee, 2012, Methods Mol Biol, V863, P359, DOI 10.1007/978-1-61779-612-8_23
   Lopatina N, 2002, J CELL BIOCHEM, V84, P324, DOI 10.1002/jcb.10015
   Maegawa S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00607-3
   Mckay JA, 2011, ACTA PHYSIOL, V202, P103, DOI 10.1111/j.1748-1716.2011.02278.x
   Mehedint MG, 2010, P NATL ACAD SCI USA, V107, P12834, DOI 10.1073/pnas.0914328107
   Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003
   Pauwels S, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0321-y
   Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021
   Pogribny IP, 2008, BRAIN RES, V1237, P25, DOI 10.1016/j.brainres.2008.07.077
   Pogribny IP, 2006, MUTAT RES-FUND MOL M, V593, P80, DOI 10.1016/j.mrfmmm.2005.06.028
   Poirier LA, 2001, CANCER EPIDEM BIOMAR, V10, P649
   Qian H, 2014, EXP DERMATOL, V23, P357, DOI 10.1111/exd.12375
   Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895
   Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5
   Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   Takasugi M, 2011, MECH AGEING DEV, V132, P65, DOI 10.1016/j.mad.2010.12.003
   Tan QH, 2013, AGEING RES REV, V12, P182, DOI 10.1016/j.arr.2012.06.004
   Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353
   Vickers MH, 2014, NUTRIENTS, V6, P2165, DOI 10.3390/nu6062165
   Wanders D, 2014, BIOFACTORS, V40, P13, DOI 10.1002/biof.1111
   Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100
   Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24
   Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004
   Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949
   Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226
   Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230
   Zhang NF, 2015, ANIM NUTR, V1, P144, DOI 10.1016/j.aninu.2015.09.002
NR 67
TC 22
Z9 23
U1 1
U2 16
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP
PY 2018
VL 174
SI SI
BP 47
EP 54
DI 10.1016/j.mad.2018.02.001
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GQ9ED
UT WOS:000442067800005
PM 29427568
DA 2024-02-19
ER

PT J
AU Saghir, SA
   Ansari, RA
   Dorato, MA
AF Saghir, Shakil Ahmed
   Ansari, Rais Ahmad
   Dorato, Michael A.
TI Rethinking toxicity testing: Influence of aging on the outcome of
   long-term toxicity testing and possible remediation
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Aging-related; Changes in systemic dose; Dose non-proportionality; Late
   occurring toxicity; Long-term studies
ID AGE-RELATED-CHANGES; GENERATION REPRODUCTIVE TOXICITY; HEPATIC
   GLUTATHIONE CONTENT; GLYCOL MONOMETHYL ETHER; KIDNEY-FUNCTION;
   BODY-COMPOSITION; RISK-FACTORS; CLINICAL-PHARMACOLOGY; CALORIC
   RESTRICTION; GLOMERULAR FUNCTION
AB Traditionally, toxicity testing is conducted at fixed dose rates (i.e., mg/kg/day) without considering life-changing events, e.g., stress, sickness, aging- and/or pregnancy-related changes in physical, physiological and biochemical parameters. In humans, life-changing events may cause systemic dose non-proportionality requiring modulation of drug dosage; similar changes occur in animals altering systemic dose during chronic/carcinogenic testing leading to "late-occurring" effects in some studies. For example, propylene monomethyl ether, an industrial chemical, initially induced sedation in rats and mice with recovery upon induction of hepatic CYPs after similar to 1 week. Sedation reappeared in rats but not in mice after similar to 12 months of exposure due to decreased CYP activity in rats, elderly mice were able to maintain slightly higher CYP activity avoiding recurrence of sedation. The systemic dose of two pharmaceuticals (doxazosin and brimonidine tartrate) increased up to 6-fold in >= 12-month old rats with no toxicity. In a rat reproductive toxicity study, systemic dose of 2,4-D, an herbicide, rapidly increased due to increased consumption of 2,4-D-fortified diet during pregnancy, lactation and neonatal growth, requiring adjustment to maintain the targeted systemic dose. Ideally, toxicological studies should be based on systemic dose with the option of modulating external dose rates to maintain the targeted systemic dose. Systemic dose can easily be monitored in selected core study animals at desired intervals considering recent developments in sampling and analysis at a fraction of the overall cost of a study.
C1 [Saghir, Shakil Ahmed] Scotts Miracle Gro, 14111 Scottslawn Rd, Marysville, OH 43041 USA.
   [Saghir, Shakil Ahmed] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.
   [Saghir, Shakil Ahmed] ToxInternational Inc, 5057 Stonecroft Ct, Hilliard, OH 43026 USA.
   [Ansari, Rais Ahmad] Nova Southeastern Univ, Coll Pharm, Dept Pharmaceut Sci, Hlth Profess Div, 3200 S Univ Dr, Ft Lauderdale, FL 33328 USA.
   [Dorato, Michael A.] Inotiv, 13 Firstfield Rd,Suite 110, Gaithersburg, MD 20878 USA.
C3 Aga Khan University; Nova Southeastern University
RP Saghir, SA (corresponding author), Scotts Miracle Gro, 14111 Scottslawn Rd, Marysville, OH 43041 USA.
EM shakil.saghir@scotts.com; ra557@nova.edu; mdorato@inotivco.com
CR Abdi R, 1998, AM J KIDNEY DIS, V32, P43, DOI 10.1053/ajkd.1998.v32.pm9669422
   Acgih (American Conference of Governmental Industrial Hygienists), 2008, DOC TLVS BEIS
   Acquavella JF, 2004, ENVIRON HEALTH PERSP, V112, P321, DOI 10.1289/ehp.6667
   Alexander BH, 2007, ENVIRON HEALTH PERSP, V115, P370, DOI 10.1289/ehp.8869
   Alexander BH, 2006, J EXPO SCI ENV EPID, V16, P447, DOI 10.1038/sj.jes.7500475
   ALTURK WA, 1981, DRUG CHEM TOXICOL, V4, P37, DOI 10.3109/01480548109066370
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   ANDERSON S, 1986, AM J MED, V80, P435, DOI 10.1016/0002-9343(86)90718-7
   [Anonymous], 1969, Physiology of the human kidney
   Azuma K., 2017, HLTH RISK ASSESSMENT
   Bales CW, 2002, ANNU REV NUTR, V22, P309, DOI 10.1146/annurev.nutr.22.010402.102715
   Baum B, 2007, WORLD J GASTROENTERO, V13, P152, DOI 10.3748/wjg.v13.i1.152
   Bax L, 2003, EUR J CLIN INVEST, V33, P34, DOI 10.1046/j.1365-2362.2003.01091.x
   Baylis C, 1998, J AM SOC NEPHROL, V9, P699
   Boothe D.M., 2012, AUGUSTS CONSULTATION, V7, P1004
   BRANDIS A, 1986, LAB INVEST, V55, P234
   Butler JM, 2008, CLIN PHARMACOKINET, V47, P297, DOI 10.2165/00003088-200847050-00002
   CDER (Center for Drug Evaluation and Research), 2012, APPL NUMB 204708ORIG
   CHARUEL C, 1992, J APPL TOXICOL, V12, P7, DOI 10.1002/jat.2550120104
   Cohen SM, 2019, REGUL TOXICOL PHARM, V103, P100, DOI 10.1016/j.yrtph.2019.01.017
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   Creton S, 2012, REGUL TOXICOL PHARM, V62, P241, DOI 10.1016/j.yrtph.2011.12.005
   DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286
   Denic A, 2016, ADV CHRONIC KIDNEY D, V23, P19, DOI 10.1053/j.ackd.2015.08.004
   Dodman N., 2015, EFFECTS AGING DOGS
   DODMAN NH, 1984, COMP CONT EDUC PRACT, V6, P1106
   Doe JE, 2019, REGUL TOXICOL PHARM, V103, P124, DOI 10.1016/j.yrtph.2019.01.024
   Elmadfa I, 2008, ANN NUTR METAB, V52, P2, DOI 10.1159/000115339
   Elsherbiny HE, 2014, CLIN J AM SOC NEPHRO, V9, P1892, DOI 10.2215/CJN.02560314
   EMAMIAN SA, 1993, AM J ROENTGENOL, V160, P83, DOI 10.2214/ajr.160.1.8416654
   eMC, 2017, EL MED COMP
   Erden-Inal M, 2002, CELL BIOCHEM FUNCT, V20, P61, DOI 10.1002/cbf.937
   FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Fulladosa X, 2003, J AM SOC NEPHROL, V14, P2662, DOI 10.1097/01.ASN.0000088025.33462.B0
   Giroux M.C., 2016, PHYSL PHARMACOKINETI
   GOURTSOYIANNIS N, 1990, AM J ROENTGENOL, V155, P541, DOI 10.2214/ajr.155.3.2117353
   GOYAL VK, 1982, EXP GERONTOL, V17, P321, DOI 10.1016/0531-5565(82)90032-8
   Grantham JJ, 2012, AM J KIDNEY DIS, V59, P593, DOI 10.1053/j.ajkd.2012.02.002
   Gurley BJ, 2005, DRUG AGING, V22, P525, DOI 10.2165/00002512-200522060-00006
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   He X, 2011, CURR GERONTOL GERIAT, V2011
   Hijazi Y, 2002, DRUG METAB DISPOS, V30, P853, DOI 10.1124/dmd.30.7.853
   Hilmer S. N., 2009, HAZZARDS GERIATRIC M, P99
   Hilmer SN, 2008, EXPERT OPIN DRUG MET, V4, P1321, DOI 10.1517/17425255.4.10.1321 
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   HOLLENBERG NK, 1974, CIRC RES, V34, P309, DOI 10.1161/01.RES.34.3.309
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Hoy Wendy E, 2003, Kidney Int Suppl, pS31
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Johns Hopkins Animal Care and Use Program, 2017, SURVIVAL SURG PROCED
   KAPLAN C, 1975, AM J PATHOL, V80, P227
   Keenan KP, 2000, TOXICOL PATHOL, V28, P788, DOI 10.1177/019262330002800604
   Khojasteh SC, 2011, DRUG METABOLISM AND PHARMACOKINETICS QUICK GUIDE, P1, DOI 10.1007/978-1-4419-5629-3
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kremers WK, 2015, NEPHROL DIAL TRANSPL, V30, P2034, DOI 10.1093/ndt/gfv072
   Lamb EJ, 2003, CLIN CHIM ACTA, V334, P25, DOI 10.1016/S0009-8981(03)00246-8
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   LECOUTEUR D, 1995, INT HEPATOL COMMUN, V3, P244, DOI 10.1016/0928-4346(94)00186-9
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   Lichtman Stuart M, 2003, Cancer Control, V10, P445
   Lichtman SM, 2008, CURR TREAT OPTION ON, V9, P191, DOI 10.1007/s11864-008-0060-6
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   Luckey AE, 2003, ARCH SURG-CHICAGO, V138, P1055, DOI 10.1001/archsurg.138.10.1055
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111
   Martul EV, 2003, TRANSPL P, V35, P1658, DOI 10.1016/S0041-1345(03)00573-6
   Marty MS, 2013, TOXICOL SCI, V136, P527, DOI 10.1093/toxsci/kft213
   Massoud N, 1984, PHARMACOKINETIC BASI
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Mitchell Sarah J, 2011, Curr Gerontol Geriatr Res, V2011, P624156, DOI 10.1155/2011/624156
   Mitchell SJ, 2009, REV CLIN GERONTOL, V19, P103, DOI 10.1017/S0959259809990232
   Mitchell SJ, 2011, J GERONTOL A-BIOL, V66, P400, DOI 10.1093/gerona/glq221
   MORGOTT DA, 1987, TOXICOL APPL PHARM, V89, P19, DOI 10.1016/0041-008X(87)90172-4
   Munar MY, 2007, AM FAM PHYSICIAN, V75, P1487
   National Research Council, 2011, GUIDE CARE USE LAB A, DOI DOI 10.17226/12910
   OECD, 2012, ENVJMMONO201147 OECD, V2nd
   OECD, 2009, COMB CHRON TOX CARC
   OWEN R A, 1986, Toxicologic Pathology, V14, P158
   Preisser L, 2000, AM J PHYSIOL-RENAL, V279, pF144, DOI 10.1152/ajprenal.2000.279.1.F144
   RIKANS LE, 1991, ARCH GERONTOL GERIAT, V13, P263, DOI 10.1016/0167-4943(91)90048-U
   RIKANS LE, 1992, DRUG DEVELOP RES, V26, P461, DOI 10.1002/ddr.430260409
   ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155
   Rule AD, 2011, MAYO CLIN PROC, V86, P282, DOI 10.4065/mcp.2010.0821
   Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006
   Saghir S.A., 2018, COMPREHENSIVE TOXICO, V9, P95
   Saghir SA, 2006, TOXICOL APPL PHARM, V211, P245, DOI 10.1016/j.taap.2005.06.010
   Saghir SA, 2003, XENOBIOTICA, V33, P1059, DOI 10.1080/00498250310001602711
   Saghir SA, 2016, REGUL TOXICOL PHARM, V79, P110, DOI 10.1016/j.yrtph.2016.03.023
   Saghir SA, 2013, TOXICOL SCI, V136, P294, DOI 10.1093/toxsci/kft212
   Saghir SA, 2012, REGUL TOXICOL PHARM, V63, P321, DOI 10.1016/j.yrtph.2012.03.004
   Saghir SA, 2015, REGUL TOXICOL PHARM, V72, P423, DOI 10.1016/j.yrtph.2015.05.009
   Sawhney R, 2005, CANCER J, V11, P449, DOI 10.1097/00130404-200511000-00004
   SCHMUCKER DL, 1985, GASTROENTEROLOGY, V88, P436, DOI 10.1016/0016-5085(85)90504-9
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Sotaniemi EA, 1997, CLIN PHARMACOL THER, V61, P331, DOI 10.1016/S0009-9236(97)90166-1
   Speakman JR, 2003, AGING CELL, V2, P265, DOI 10.1046/j.1474-9728.2003.00061.x
   Spencer PJ, 2002, TOXICOL PATHOL, V30, P570, DOI 10.1080/01926230290105848
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Tan JC, 2010, KIDNEY INT, V78, P686, DOI 10.1038/ki.2010.128
   Tan JC, 2009, J AM SOC NEPHROL, V20, P181, DOI 10.1681/ASN.2008030306
   Tchambaz L, 2006, DRUG SAFETY, V29, P509, DOI 10.2165/00002018-200629060-00004
   Terry C, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2014.910753
   Toornvliet R, 2006, CLIN PHARMACOL THER, V79, P540, DOI 10.1016/j.clpt.2006.02.004
   U.S. EPA (United States Environmental Protection Agency), 1991, 107982 US EPA CASRN
   Veilleux-Lemieux D, 2013, J AM ASSOC LAB ANIM, V52, P567
   Wang XL, 2014, KIDNEY INT, V85, P677, DOI 10.1038/ki.2013.359
   Wasil T, 2005, ONCOLOGIST, V10, P602, DOI 10.1634/theoncologist.10-8-602
   Wauthier V, 2004, ARCH TOXICOL, V78, P131, DOI 10.1007/s00204-003-0526-z
   Wolden-Hanson T, 2010, INTERD TOP GERONTOL, V37, P64, DOI 10.1159/000319995
   Wolf DC, 2019, REGUL TOXICOL PHARM, V103, P86, DOI 10.1016/j.yrtph.2019.01.021
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1989, AGE AGEING, V18, P415, DOI 10.1093/ageing/18.6.415
   YATES MS, 1979, EXPERIENTIA, V35, P78, DOI 10.1007/BF01917888
   Zhang YKJ, 2010, DRUG METAB DISPOS, V38, P1122, DOI 10.1124/dmd.110.032599
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 123
TC 0
Z9 1
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD JUL
PY 2020
VL 141
AR 111327
DI 10.1016/j.fct.2020.111327
PG 10
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA LZ3EP
UT WOS:000541110800004
PM 32380075
DA 2024-02-19
ER

PT J
AU Wang, X
   Huo, XZ
   Liu, Z
   Yang, R
   Zeng, HJ
AF Wang, Xia
   Huo, Xiu-zhu
   Liu, Zhe
   Yang, Ran
   Zeng, Hua-jin
TI Investigations on the anti-aging activity of polysaccharides from
   Chinese yam and their regulation on klotho gene expression in mice
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article
DE Chinese yam (Dioscorea opposita thunb.); Polysaccharide; Anti-aging
   activity; Klotho gene; Anti-aging mechanism
ID ANTIOXIDANT ACTIVITIES; PURIFICATION
AB In this study, Chinese yam polysaccharides (CYP) were extracted from the tuber of Dioscorea opposita Thunb. by hot-water extraction and ethanol precipitation. After deproteinized by the Sevag method, the content of CYP was determined to be 91.77%. The anti-aging activities of the CYP were evaluated in aging mice induced by D-galactose in vitro and in vivo. The results indicated that the CYP not only could enhance the learning ability of mice, but alleviate the spatial memory impairment of mice. Furthermore, the CYP could effectively inhibit the formation of malondialdehyde and enhance the activities of superoxide dismutase, catalase and glutathione peroxidase in brain, liver and kidney tissues of mice. The histological analysis indicated that CYP could significantly alleviate the damages induced by D-galactose in the above tissues. Gene expression studies showed that the CYP could up-regulate the expression of anti-aging klotho gene in brain and kidney. Therefore, it can be concluded that the anti-aging effect of Chinese yam may be achieved by repairing the function of organs and improving the expression of klotho gene in mice. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Wang, Xia; Huo, Xiu-zhu; Liu, Zhe; Zeng, Hua-jin] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China.
   [Yang, Ran] Zhengzhou Univ, Coll Chem & Mol Engn, Zhengzhou 450001, Peoples R China.
C3 Zhengzhou University; Zhengzhou University
RP Zeng, HJ (corresponding author), Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China.
EM zenghuajin@sina.com
FU Henan Provincial Natural Science Foundation [162300410293]; Henan
   Provincial Education Department Project [14B360013, 17A350014]; National
   Natural Science Foundation of China [U1304832]
FX This work was financially supported by Henan Provincial Natural Science
   Foundation (162300410293), Henan Provincial Education Department Project
   (14B360013, 17A350014) and National Natural Science Foundation of China
   (U1304832).
CR [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   BARKER SA, 1954, J CHEM SOC, P171, DOI 10.1039/jr9540000171
   Cerná M, 2003, CARBOHYD POLYM, V51, P383, DOI 10.1016/S0144-8617(02)00259-X
   Chen L, 2018, INT J BIOL MACROMOL, V108, P408, DOI 10.1016/j.ijbiomac.2017.12.034
   Cui Y, 2017, J TAIWAN INST CHEM E, V76, P10, DOI 10.1016/j.jtice.2017.03.040
   D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4
   Halliwell B., 2015, Free radicals in biology and medicine
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hsu SC, 2014, INT J BIOCHEM CELL B, V53, P361, DOI 10.1016/j.biocel.2014.06.002
   Huang SQ, 2012, INT J BIOL MACROMOL, V50, P1183, DOI 10.1016/j.ijbiomac.2012.03.019
   Ju Y, 2014, INT J BIOL MACROMOL, V66, P81, DOI 10.1016/j.ijbiomac.2014.01.070
   Kim DB, 2016, FOOD CHEM, V194, P920, DOI 10.1016/j.foodchem.2015.08.094
   Kong XF, 2009, J SCI FOOD AGR, V89, P2039, DOI 10.1002/jsfa.3688
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   Li M, 2017, J FUNCT FOODS, V37, P491, DOI 10.1016/j.jff.2017.08.025
   Ling S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3128235
   Liu QW, 2018, INT J BIOL MACROMOL, V107, P2262, DOI 10.1016/j.ijbiomac.2017.10.095
   MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5
   Ou ZQ, 2015, MOLECULES, V20, P4548, DOI 10.3390/molecules20034548
   Pan J, 2011, TUMOR BIOL, V32, P729, DOI 10.1007/s13277-011-0174-5
   Sun YX, 2010, CARBOHYD POLYM, V82, P510, DOI 10.1016/j.carbpol.2010.05.010
   Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010
   Wang PP, 2017, J ETHNOPHARMACOL, V203, P252, DOI 10.1016/j.jep.2017.03.050
   Xue HY, 2019, INT J BIOL MACROMOL, V121, P1186, DOI 10.1016/j.ijbiomac.2018.10.126
   Yang WF, 2015, CARBOHYD POLYM, V117, P1021, DOI 10.1016/j.carbpol.2014.09.082
   Yu WJ, 2008, FREE RADICAL RES, V42, pS100
   Yuan JF, 2008, CARBOHYD POLYM, V74, P822, DOI 10.1016/j.carbpol.2008.04.040
   Zeng HJ, 2018, INT J BIOL MACROMOL, V119, P470, DOI 10.1016/j.ijbiomac.2018.07.157
   Zhao GH, 2005, CARBOHYD POLYM, V61, P125, DOI 10.1016/j.carbpol.2005.04.020
NR 31
TC 16
Z9 18
U1 3
U2 82
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-2860
EI 1872-8014
J9 J MOL STRUCT
JI J. Mol. Struct.
PD MAY 15
PY 2020
VL 1208
AR 127895
DI 10.1016/j.molstruc.2020.127895
PG 10
WC Chemistry, Physical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA KT7JK
UT WOS:000519189500045
DA 2024-02-19
ER

PT J
AU Pahlavani, MA
   Vargas, DA
AF Pahlavani, MA
   Vargas, DA
TI Aging but not dietary restriction alters the activation-induced
   apoptosis in rat T cells
SO FEBS LETTERS
LA English
DT Article
DE activation-induced cell death; T cell; aging; dietary restriction; rat
ID DNA FRAGMENTATION; HEPATOCYTE PROLIFERATION; FAS ANTIGEN; DEATH;
   EXPRESSION; LYMPHOCYTES; LIGAND; MICE; AGE; ENDONUCLEASE
AB The aim of this study was to determine if aging or dietary restriction (DR) alters activation-induced cell death, which is known to regulate cell proliferation and eliminate the high number of activated cells during an immune response, Splenic T cells were isolated from young (4-6 months) and old (25-26 months) Fischer 344 rats that had free access to food, ad libitum (AL), and from dietary-restricted (DR) old (25-26 months) rats that beginning at 6 weeks of age mere fed 60% (40% food-restricted) of the diet consume by the AL rats, T cells were incubated with anti-CD3 antibody, or staphylococcal enterotoxin B (primary stimulus) for 72-96 h, followed by restimulation with anti-CD3 (secondary stimulus) for 72 h, Activation-induced apoptosis was assessed by DNA fragmentation and the expression of Fas/CD95 receptor and Fas ligand (Fas-L) was measured by flow cytometry, We found that the amount of DNA fragmentation was significantly (P < 0.05) higher in the stimulated and restimulated T cells from AL old rats and DR old rats compared to young rats. The increase in DNA fragmentation with age was paralleled by an increase in the proportion of the cells expressing Fas and Fas-L, However, DR had no significant effect on the age-related increase in DNA fragmentation or the expression of Fas or Fas-L, We also measured the levels of Bcl-2 and Bas protein and found that the level of Bcl-2 decreased and Pax increased with age and that DR had no effect on the age-related changes in the level of Bcl-2 or Bax protein. These results demonstrate that aging but not DR alters activation-induced apoptosis in rat T cells. (C) 2001 Federation of European Biochemical Societies, Published by Elsevier Science B.V. All rights reserved.
C1 S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr 182, San Antonio, TX 78284 USA.
   Audie L Murphy Mem Vet Adm Med Ctr, San Antonio, TX 78284 USA.
   Univ Texas, Dept Physiol, Ctr Hlth Sci, San Antonio, TX 78284 USA.
C3 Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy
   Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital;
   University of Texas System; University of Texas Health Science Center at
   San Antonio
RP Pahlavani, MA (corresponding author), S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr 182, 7400 Merton Minter Blvd, San Antonio, TX 78284 USA.
EM pahlavani@uthscsa.edu
CR Afford S, 2000, J CLIN PATHOL-MOL PA, V53, P55, DOI 10.1136/mp.53.2.55
   AKBAR AN, 1993, J EXP MED, V178, P427, DOI 10.1084/jem.178.2.427
   [Anonymous], [No title captured]
   ARENDS MJ, 1990, AM J PATHOL, V136, P593
   Avula CPR, 1999, FEBS LETT, V458, P231, DOI 10.1016/S0014-5793(99)01163-1
   BENEDETTI A, 1995, HEPATOLOGY, V22, P1488, DOI 10.1016/0270-9139(95)90157-4
   CANMAN CE, 1994, COLD SPRING HARB SYM, V59, P277, DOI 10.1101/SQB.1994.059.01.032
   CHREST FJ, 1995, CYTOMETRY, V20, P33, DOI 10.1002/cyto.990200107
   COHEN JJ, 1984, J IMMUNOL, V132, P38
   DUKE RC, 1983, P NATL ACAD SCI-BIOL, V80, P6361, DOI 10.1073/pnas.80.20.6361
   Ferlini C, 1996, CYTOMETRY, V24, P106
   GANTNER F, 1995, GASTROENTEROLOGY, V109, P166, DOI 10.1016/0016-5085(95)90282-1
   HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506
   Higami Y, 1997, CELL TISSUE RES, V288, P69, DOI 10.1007/s004410050793
   Higami Y, 2000, CELL TISSUE RES, V299, P363, DOI 10.1007/s004410050034
   James SJ, 1998, ENVIRON HEALTH PERSP, V106, P307, DOI 10.2307/3433932
   JONES LA, 1990, SCIENCE, V250, P1726, DOI 10.1126/science.2125368
   Kabelitz Dieter, 1997, Frontiers in Bioscience (online), V2, pD61
   KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0
   KERR JFR, 1972, J PATHOL, V107, P41, DOI 10.1002/path.1711070107
   Kong J, 1996, CANCER LETT, V105, P241, DOI 10.1016/0304-3835(96)04291-7
   Lechner H, 1996, INT ARCH ALLERGY IMM, V110, P238, DOI 10.1159/000237293
   LEE JM, 1995, CANCER METAST REV, V14, P149, DOI 10.1007/BF00665797
   Masoro EJ, 1996, TOXICOL PATHOL, V24, P738, DOI 10.1177/019262339602400617
   MASORO EJ, 1995, EXP GERONTOL, V30, P291, DOI 10.1016/0531-5565(94)00028-2
   MCCONKEY DJ, 1990, IMMUNOL TODAY, V11, P120, DOI 10.1016/0167-5699(90)90048-E
   MCDONNELL TJ, 1993, MOL CARCINOGEN, V8, P209, DOI 10.1002/mc.2940080402
   MEIKRANTZ W, 1995, J CELL BIOCHEM, V58, P160, DOI 10.1002/jcb.240580205
   Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29
   OWENSCHAUB LB, 1992, CELL IMMUNOL, V140, P197, DOI 10.1016/0008-8749(92)90187-T
   PAHLAVANI M A, 1987, Drugs of Today, V23, P611
   Pahlavani MA, 2000, P SOC EXP BIOL MED, V223, P163, DOI 10.1046/j.1525-1373.2000.22322.x
   Pahlavani MA, 1996, J NUTR, V126, P2069, DOI 10.1093/jn/126.9.2069
   PAHLAVANI MA, 1994, MECH AGEING DEV, V74, P171, DOI 10.1016/0047-6374(94)90088-4
   Pahlavani MA, 1998, CELL IMMUNOL, V185, P39, DOI 10.1006/cimm.1998.1274
   Pahlavani MA, 2000, INT ARCH ALLERGY IMM, V122, P182, DOI 10.1159/000024395
   Pahlavani Mohammad A., 1998, Frontiers in Bioscience, V3, pD125
   PAHLKAVANI MA, 1998, FRONT BIOSCI, V5, pD580
   PAWELEC G, 1998, FRONT BIOSCI, V3, P59
   Phelouzat MA, 1996, MECH AGEING DEV, V88, P25, DOI 10.1016/0047-6374(96)01714-9
   Pinkoski MJ, 1999, CELL DEATH DIFFER, V6, P1174, DOI 10.1038/sj.cdd.4400611
   Potestio M, 1998, MECH AGEING DEV, V102, P221, DOI 10.1016/S0047-6374(98)00020-7
   RADVANYI LG, 1993, J IMMUNOL, V150, P5704
   Roberts AD, 1998, INFECT IMMUN, V66, P5036, DOI 10.1128/IAI.66.10.5036-5040.1998
   RUSSELL JH, 1995, CURR OPIN IMMUNOL, V7, P382, DOI 10.1016/0952-7915(95)80114-6
   SALMON M, 1994, EUR J IMMUNOL, V24, P892, DOI 10.1002/eji.1830240417
   SCHULTEHERMANN R, 1994, INT ARCH ALLERGY IMM, V105, P363, DOI 10.1159/000236784
   SCHWEIGERT FJ, 1993, COMP BIOCHEM PHYS A, V105, P347, DOI 10.1016/0300-9629(93)90219-T
   Vaux DL, 1998, SPRINGER SEMIN IMMUN, V19, P271, DOI 10.1007/BF00787224
   WARNER HR, 1995, J GERONTOL A-BIOL, V50, pB107, DOI 10.1093/gerona/50A.3.B107
   WITTY JP, 1995, CANCER RES, V55, P1401
   YOSHINO T, 1994, BLOOD, V83, P1856
NR 52
TC 24
Z9 26
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD FEB 23
PY 2001
VL 491
IS 1-2
BP 114
EP 118
DI 10.1016/S0014-5793(01)02184-6
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 407AC
UT WOS:000167248400025
PM 11226431
DA 2024-02-19
ER

PT J
AU KWEON, SH
   OKA, T
   ITO, M
   MORITA, M
   NATORI, Y
AF KWEON, SH
   OKA, T
   ITO, M
   MORITA, M
   NATORI, Y
TI MONOCLONAL-ANTIBODY-BASED ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR HMG 2B
   NONHISTONE PROTEIN IN CHICK LIVER
SO JOURNAL OF IMMUNOASSAY
LA English
DT Article
DE HIGH MOBILITY GROUP PROTEIN; CHICK LIVER; MONOCLONAL-ANTIBODY-BASED
   ELISA
ID MOBILITY GROUP PROTEIN; CHROMATIN
AB Monoclonal antibodies were prepared against the high mobility group (HMG) protein 2b from chick liver chromatin and a monoclonal-antibody-based enzyme-linked immunosorbent assay (ELISA) was developed for chick HMG 2b. The sensitivity of the assay is about ten times that of the previously described radioimmunoassay and solid-phase enzyme immunoassay for HMG proteins. With the use of ELISA technique, the amount of HMG 2b (mu-g protein/mg DNA) in the livers of 1-day old and 70-day old chicks was found to be 2.56 +/- 0.4, and 1.20 +/- 0.2, respectively. The age-dependent change in the level of HMG proteins probably reflects changes in the functional state of chromatin during ageing.
C1 UNIV TOKUSHIMA,SCH MED,DEPT NUTR CHEM,TOKUSHIMA 770,JAPAN.
C3 Tokushima University
CR BUCCI LR, 1984, J BIOL CHEM, V259, P8840
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   GOODWIN GH, 1982, HMG CHROMOSOMAL PROT, P193
   LEPP WA, 1989, J IMMUNOASSAY, V10, P449, DOI 10.1080/01971528908053252
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MATHEW CGP, 1979, BIOCHEM BIOPH RES CO, V87, P1243, DOI 10.1016/S0006-291X(79)80040-6
   Mathis D, 1980, Prog Nucleic Acid Res Mol Biol, V24, P1
   NATORI Y, 1989, SEITAINO KAGAKU, V40, P575
   OKA T, 1985, J NUTR, V115, P1504, DOI 10.1093/jn/115.11.1504
   PRASAD S, 1990, BIOCHEM INT, V20, P687
   REECK GR, 1985, PROGR NONHISTONE PRO, V1, P1
   ROMANI M, 1980, J BIOL CHEM, V255, P468
   SEYEDIN SM, 1979, J BIOL CHEM, V254, P1264
   TENG CS, 1987, GERONTOLOGY, V33, P287, DOI 10.1159/000212892
NR 14
TC 4
Z9 4
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0197-1522
J9 J IMMUNOASSAY
JI J. Immunoass.
PY 1991
VL 12
IS 4
BP 487
EP 499
DI 10.1080/01971529108053276
PG 13
WC Biochemistry & Molecular Biology; Immunology; Medical Laboratory
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Immunology; Medical Laboratory
   Technology
GA GQ758
UT WOS:A1991GQ75800003
PM 1806585
DA 2024-02-19
ER

PT J
AU ARNHEIM, N
   CORTOPASSI, G
AF ARNHEIM, N
   CORTOPASSI, G
TI DELETERIOUS MITOCHONDRIAL-DNA MUTATIONS ACCUMULATE IN AGING HUMAN
   TISSUES
SO MUTATION RESEARCH
LA English
DT Article
DE MITOCHONDRIAL DNA; MITOCHONDRIAL DNA DELETION; HUMAN TISSUE
ID KEARNS-SAYRE SYNDROME; POLYMERASE CHAIN-REACTION; ENZYMATIC
   AMPLIFICATION; EXTERNAL OPHTHALMOPLEGIA; OXIDATIVE DAMAGE; NUCLEAR-DNA;
   HUMAN-HEART; HELA-CELLS; RAT-LIVER; DELETION
AB This paper reviews the current state of knowledge of the contribution of mitochondrial DNA (mtDNA) mutations to the phenotype of aging. Its major focus is on the discovery of deletions of mtDNA which previously were thought to occur only in individuals with neuromuscular disease. One particular deletion (mtDNA4977) accumulates with age primarily in non-dividing cells such as muscle and brain of normal individuals. The level of the deletion rises with age by more than 1000 fold in heart and brain and to a lesser extent in other tissues. In the brain, different regions have substantially different levels of the deletion. High levels of accumulation of the deletion in tissues are correlated with high oxygen consumption. We speculate that oxidative damage to mtDNA may be 'catastrophic'; mutations affecting mitochondrially encoded polypeptides involved in electron transport could increase free radical generation leading to more mtDNA damage.
C1 UNIV SO CALIF,INST TOXICOL,LOS ANGELES,CA 90033.
C3 University of Southern California
RP ARNHEIM, N (corresponding author), UNIV SO CALIF,MOLEC BIOL SECT,LOS ANGELES,CA 90089, USA.
OI Arnheim, Norman/0000-0003-1247-1347
FU NIGMS NIH HHS [GM36745] Funding Source: Medline
CR ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706
   ALLEN JA, 1980, NATURE, V287, P244, DOI 10.1038/287244a0
   AMES BN, 1989, MUTAT RES, V214, P41, DOI 10.1016/0027-5107(89)90196-6
   BACKER JM, 1980, SCIENCE, V209, P297, DOI 10.1126/science.6770466
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991
   Boveris A, 1982, SUPEROXIDE DISMUTASE, VII
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   BULPITT KJ, 1984, BRAIN RES, V300, P41, DOI 10.1016/0006-8993(84)91339-8
   Burnet FM, 1974, INTRINSIC MUTAGENESI
   CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   CORTOPASSI GA, 1992, IN PRESS PROGR PARKI, V2
   DOMENA JD, 1988, BIOCHEMISTRY-US, V27, P6742, DOI 10.1021/bi00418a015
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   FORMAN HJ, 1982, FREE RADICALS BIOL, V5
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   GROSSMAN LI, 1990, AM J HUM GENET, V46, P415
   GUPTA KP, 1990, MUTAT RES, V237, P17, DOI 10.1016/0921-8734(90)90028-P
   HARDING AE, 1991, TRENDS NEUROSCI, V14, P132, DOI 10.1016/0166-2236(91)90081-5
   HARDING AE, 1989, NUCLEIC ACIDS RES, V17, P4465
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HRUSZKEWYCZ AM, 1988, BIOCHEM BIOPH RES CO, V153, P191, DOI 10.1016/S0006-291X(88)81207-5
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   JOHNS DR, 1989, GENOMICS, V5, P623, DOI 10.1016/0888-7543(89)90032-3
   JOHNS DR, 1989, LANCET, V1, P393
   JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KIRKWOOD TBL, 1989, MUTAT RES, V219, P1, DOI 10.1016/0921-8734(89)90035-0
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   LESTIENNE P, 1988, LANCET, V1, P885
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LUBIN MB, 1991, MOL CELL PROBE, V5, P307, DOI 10.1016/0890-8508(91)90054-N
   MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLIS KB, 1987, METHOD ENZYMOL, V155, P335
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   NELSON I, 1989, NUCLEIC ACIDS RES, V17, P8117, DOI 10.1093/nar/17.20.8117
   PAABO S, 1990, J BIOL CHEM, V265, P4718
   PETTEPHER CC, 1991, J BIOL CHEM, V266, P3113
   PIKO L, 1984, MECH AGEING DEV, V26, P113, DOI 10.1016/0047-6374(84)90170-2
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   PIKO L, 1978, MECH AGEING DEV, V7, P351, DOI 10.1016/0047-6374(78)90077-5
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0
   SYVANEN AC, 1988, NUCLEIC ACIDS RES, V16, P11327, DOI 10.1093/nar/16.23.11327
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P35
   TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532
   TOMKINSON AE, 1990, NUCLEIC ACIDS RES, V18, P929, DOI 10.1093/nar/18.4.929
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
NR 70
TC 181
Z9 186
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
PD SEP
PY 1992
VL 275
IS 3-6
BP 157
EP 167
DI 10.1016/0921-8734(92)90020-P
PG 11
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA JV302
UT WOS:A1992JV30200006
PM 1383758
DA 2024-02-19
ER

PT J
AU Aumailley, L
   Warren, A
   Garand, C
   Dubois, MJ
   Paquet, ER
   Le Couteur, DG
   Marette, A
   Cogger, VC
   Lebel, M
AF Aumailley, Lucie
   Warren, Alessandra
   Garand, Chantal
   Dubois, Marie Julie
   Paquet, Eric R.
   Le Couteur, David G.
   Marette, Andre
   Cogger, Victoria C.
   Lebel, Michel
TI Vitamin C modulates the metabolic and cytokine profiles, alleviates
   hepatic endoplasmic reticulum stress, and increases the life span of
   <i>Gulo</i><SUP>-/-</SUP> mice
SO AGING-US
LA English
DT Article
DE vitamin C; gulonolactone oxidase; metabolomic; inflammation; endoplasmic
   reticulum stress; aging
ID CHROMATOGRAPHY-MASS SPECTROMETRY; SYNTHESIZE ASCORBIC-ACID; OXIDATIVE
   STRESS; EIF2-ALPHA PHOSPHORYLATION; GENETIC-VARIATION; DEFICIENCY;
   ANTIOXIDANT; CANCER; PREVENTION; RESISTIN
AB Suboptimal intake of dietary vitamin C (ascorbate) increases the risk of several chronic diseases but the exact metabolic pathways affected are still unknown. In this study, we examined the metabolic profile of mice lacking the enzyme gulonolactone oxidase (Gulo) required for the biosynthesis of ascorbate. Gulo(-/-) mice were supplemented with 0%, 0.01%, and 0.4% ascorbate (w/v) in drinking water and serum was collected for metabolite measurements by targeted mass spectrometry. We also quantified 42 serum cytokines and examined the levels of different stress markers in liver. The metabolic profiles of Gulo(-/-) mice treated with ascorbate were different from untreated Gulo(-/-) and normal wild type mice. The cytokine profiles of Gulo(-/-) mice, in return, overlapped the profile of wild type animals upon 0.01% or 0.4% vitamin C supplementation. The life span of Gulo(-/-) mice increased with the amount of ascorbate in drinking water. It also correlated significantly with the ratios of serum arginine/lysine, tyrosine/phenylalanine, and the ratio of specific species of saturated/unsaturated phosphatidylcholines. Finally, levels of hepatic phosphorylated endoplasmic reticulum associated stress markers IRE1 alpha and eIF2 alpha correlated inversely with serum ascorbate and life span suggesting that vitamin C modulates endoplasmic reticulum stress response and longevity in Gulo(-/-) mice.
C1 [Aumailley, Lucie; Garand, Chantal; Lebel, Michel] Univ Laval, Fac Med, Ctr Rech CHU Quebec, Quebec City, PQ G1K 7P4, Canada.
   [Warren, Alessandra; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, Ctr Educ & Res Aging, Sydney, NSW 2006, Australia.
   [Warren, Alessandra; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, ANZAC Res Inst, Sydney, NSW 2006, Australia.
   [Warren, Alessandra; Le Couteur, David G.; Cogger, Victoria C.] Concord Hosp, Concord, NSW, Australia.
   [Dubois, Marie Julie; Marette, Andre] Univ Laval, Fac Med, Quebec Heart & Lung Inst, Quebec City, PQ G1K 7P4, Canada.
   [Paquet, Eric R.] Univ Laval, Hop Hotel Dieu, Ctr Rech Canc, Quebec City, PQ, Canada.
C3 Laval University; University of Sydney; University of Sydney; ANZAC
   Research Institute; Concord Repatriation General Hospital; Quebec Heart
   & Lung Institute; Laval University; Laval University
RP Lebel, M (corresponding author), Univ Laval, Fac Med, Ctr Rech CHU Quebec, Quebec City, PQ G1K 7P4, Canada.
EM michel.lebel@crchudequebec.ulaval.ca
RI Research Institute, ANZAC/CAE-9030-2022; Ekanayake,
   Kanchana/P-8817-2016; Marette, Andre/E-9342-2013
OI Garand, Chantal/0000-0003-0716-6487; Le Couteur,
   David/0000-0002-4227-5817; Paquet, Eric/0000-0001-9194-1655; Marette,
   Andre/0000-0003-3950-5973
FU Canadian Institutes of Health Research
FX This work was supported by the Canadian Institutes of Health Research to
   M.L. E.R.P. is supported by a Doctoral scholarship from the Canadian
   Institutes of Health Research.
CR Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   Baltzis D, 2004, J VIROL, V78, P12747, DOI 10.1128/JVI.78.23.12747-12761.2004
   Bánhegyi G, 2014, BBA-MOL CELL RES, V1843, P1909, DOI 10.1016/j.bbamcr.2014.05.016
   Beydoun MA, 2012, J NUTR, V142, P1693, DOI 10.3945/jn.112.160416
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Bleys J, 2006, AM J CLIN NUTR, V84, P880, DOI 10.1093/ajcn/84.4.880
   Bo Simona, 2007, PLoS Clin Trials, V2, pe17, DOI 10.1371/journal.pctr.0020017
   Carr AC, 1999, AM J CLIN NUTR, V69, P1086
   Castello-Cros R, 2011, CELL CYCLE, V10, P2021, DOI 10.4161/cc.10.12.16002
   Chen Y, 2012, GENES BRAIN BEHAV, V11, P269, DOI 10.1111/j.1601-183X.2011.00762.x
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025
   Coulter ID, 2006, J GEN INTERN MED, V21, P735, DOI 10.1111/j.1525-1497.2006.00483.x
   Danhauser K, 2012, AM J HUM GENET, V91, P1082, DOI 10.1016/j.ajhg.2012.10.006
   Daugherty CC, 1996, PEDIATR PATHOL LAB M, V16, P263, DOI 10.1080/107710496175741
   Duggan GE, 2011, J BIOMOL NMR, V49, P165, DOI 10.1007/s10858-011-9485-5
   Frikke-Schmidt H, 2009, BASIC CLIN PHARMACOL, V104, P419, DOI 10.1111/j.1742-7843.2009.00420.x
   Garcia-Bailo B, 2011, BIOL-TARGETS THER, V5, P7, DOI 10.2147/BTT.S14417
   Gempel K, 2002, J INHERIT METAB DIS, V25, P17, DOI 10.1023/A:1015109127986
   Harrison FE, 2008, J NEUROCHEM, V106, P1198, DOI 10.1111/j.1471-4159.2008.05469.x
   Harrison FE, 2010, BRAIN RES, V1349, P143, DOI 10.1016/j.brainres.2010.06.037
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Jenab M, 2006, CARCINOGENESIS, V27, P2250, DOI 10.1093/carcin/bgl096
   Ji YL, 2012, REPROD TOXICOL, V34, P357, DOI 10.1016/j.reprotox.2012.04.011
   Kim Hyemin, 2012, Immune Netw, V12, P18, DOI 10.4110/in.2012.12.1.18
   Kim H, 2013, FREE RADICAL BIO MED, V65, P573, DOI 10.1016/j.freeradbiomed.2013.07.023
   Koponen T, 2012, AMINO ACIDS, V42, P427, DOI 10.1007/s00726-011-1013-0
   Krishnamoorthy J, 2014, CELL CYCLE, V13, P801, DOI 10.4161/cc.27726
   Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Lebel M, 2003, AM J PATHOL, V162, P1559, DOI 10.1016/S0002-9440(10)64290-3
   Lee AH, 2009, CELL MOL LIFE SCI, V66, P2835, DOI 10.1007/s00018-009-0049-8
   Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x
   Lou PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087205
   Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003
   Luiking YC, 2007, J NUTR, V137, p1662S, DOI 10.1093/jn/137.6.1662S
   Lynam-Lennon N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-907
   Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841
   Martinez-Cruz F, 2002, J NEUROSCI RES, V69, P550, DOI 10.1002/jnr.10307
   Mashima R, 2003, ANAL BIOCHEM, V313, P28, DOI 10.1016/S0003-2697(02)00537-7
   Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133
   Michels AJ, 2013, ANNU REV NUTR, V33, P45, DOI 10.1146/annurev-nutr-071812-161246
   Ogawa K, 2004, ANAT REC PART A, V278A, P533, DOI 10.1002/ar.a.20024
   Ostan R, 2013, AGE, V35, P1995, DOI 10.1007/s11357-012-9483-x
   Panda K, 1999, FREE RADICAL BIO MED, V27, P1064, DOI 10.1016/S0891-5849(99)00154-9
   Pfister R, 2011, AM HEART J, V162, P246, DOI 10.1016/j.ahj.2011.05.007
   Rigoglio N.N., 2012, CURRENT MICROSCOPY C, P309
   SAUBERLICH HE, 1994, ANNU REV NUTR, V14, P371, DOI 10.1146/annurev.nu.14.070194.002103
   Schleicher RL, 2009, AM J CLIN NUTR, V90, P1252, DOI 10.3945/ajcn.2008.27016
   Sell DR, 2008, ANN NY ACAD SCI, V1126, P205, DOI 10.1196/annals.1433.065
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Unterwurzacher I, 2008, CLIN CHEM LAB MED, V46, P1589, DOI 10.1515/CCLM.2008.323
   Vendrell J, 2004, OBES RES, V12, P962, DOI 10.1038/oby.2004.118
   Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74
   Ward MS, 2013, J NEUROCHEM, V124, P363, DOI 10.1111/jnc.12069
   Wrieden WL, 2000, J EPIDEMIOL COMMUN H, V54, P355, DOI 10.1136/jech.54.5.355
   Yu R, 2013, J NUTR, V143, P1, DOI 10.3945/jn.112.168690
   Yuan W, 2011, J PROTEOME RES, V10, P5242, DOI 10.1021/pr200815c
   Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010
NR 61
TC 20
Z9 23
U1 0
U2 12
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD MAR
PY 2016
VL 8
IS 3
BP 458
EP 483
DI 10.18632/aging.100902
PG 26
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA DL2GA
UT WOS:000375450300008
PM 26922388
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sahoo, A
   Chainy, GBN
AF Sahoo, A
   Chainy, GBN
TI Alterations in the activities of cerebral antioxidant enzymes of rat are
   related to aging
SO INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
LA English
DT Article
DE oxidative stress; lipid peroxidation; antioxidant enzymes; glutathione;
   ascorbic acid; brain aging
ID SUPEROXIDE-DISMUTASE ACTIVITY; GLUTATHIONE-PEROXIDASE;
   LIPID-PEROXIDATION; OXIDATIVE DAMAGE; CATALASE; BRAIN; SYSTEM; LIVER;
   ACID; DNA
AB Developmental profiles of antioxidant enzymes and lipid peroxidation were investigated in rat cerebral hemisphere from birth to 600 days of age. Lipid peroxidation level decreased in the crude homogenate from birth until 15 days and, thereafter increased gradually up to 600 days. However, susceptibility of sub-cellular fractions to lipid peroxidation displayed an increasing trend with increasing age. Superoxide dismutase activity decreased gradually with age, whereas activities of catalase, glutathione peroxidase and glutathione reductase exhibited an elevation up to 90 days followed by either a stagnancy or diminution in the later life. No linearity was observed in the contents of glutathione, ascorbic acid and H2O2 in the tissue. The results suggest that free radicals could be the causative agents of the aging process in which antioxidant enzymes have a definite regulatory contribution. (C) 1997 ISDN. Published by Elsevier Science Ltd. All rights reserved.
C1 SVM Coll, Dept Zool, Jagatsinghpur 754103, Orissa, India.
   Utkal Univ, Dept Zool, Biochem Unit, Bhubaneswar 751004, Orissa, India.
C3 Utkal University
RP Chainy, GBN (corresponding author), SVM Coll, Dept Zool, Jagatsinghpur 754103, Orissa, India.
RI Chainy, Gagan B N/G-7020-2012
OI Chainy, Gagan B N/0000-0002-6418-0480
CR Aebi H., 1974, Methods of enzymatic analysis, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   [Anonymous], [No title captured]
   BENZI G, 1995, FREE RADICAL BIO MED, V19, P77, DOI 10.1016/0891-5849(94)00244-E
   BENZI G, 1988, NEUROCHEM RES, V13, P467, DOI 10.1007/BF01268883
   BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6
   BOEHME DH, 1977, BRAIN RES, V136, P11, DOI 10.1016/0006-8993(77)90127-5
   Bus J. S., 1979, REV BIOCH TOXICOLOGY, P125
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CHEN LH, 1989, DIETARY RESTRICTION, P247
   Cotman CW, 1989, BASIC NEUROCHEMISTRY, P382
   DEHAAN JB, 1992, MOL BRAIN RES, V13, P179, DOI 10.1016/0169-328X(92)90025-7
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Halliwell B., 2007, FREE RADICAL BIO MED, DOI [10.1016/0748-5514(85)90140-0, DOI 10.1016/0748-5514(85)90140-0]
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARRIS ED, 1992, FASEB J, V6, P2675, DOI 10.1096/fasebj.6.9.1612291
   HAZELTON GA, 1985, MECH AGEING DEV, V29, P71, DOI 10.1016/0047-6374(85)90048-X
   Hussain S, 1995, INT J DEV NEUROSCI, V13, P811, DOI 10.1016/0736-5748(95)00071-2
   KAMATH SA, 1972, ANAL BIOCHEM, V48, P53, DOI 10.1016/0003-2697(72)90169-8
   KONO Y, 1982, J BIOL CHEM, V257, P5751
   KORUBE N, 1990, BIOMED RES, V11, P187
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARIUCCI G, 1990, EXPERIENTIA, V46, P753, DOI 10.1007/BF01939957
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   MITSUI A, 1961, PLANT CELL PHYSIOL, V2, P31, DOI 10.1093/oxfordjournals.pcp.a077661
   MIZUNO Y, 1986, J NEUROCHEM, V46, P1344, DOI 10.1111/j.1471-4159.1986.tb01745.x
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Okabe T, 1996, J NEUROL SCI, V141, P100, DOI 10.1016/0022-510X(96)00160-8
   PACIFICI RE, 1991, GERONTOLOGY, V37, P166
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PAOLETTI F, 1990, METHOD ENZYMOL, V186, P209
   PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3
   PRZEDBORSKI S, 1992, J NEUROCHEM, V58, P1760, DOI 10.1111/j.1471-4159.1992.tb10051.x
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   ROSENTHAL HL, 1957, J LAB CLIN MED, V50, P318
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Schulze-Osthoff K, 1991, Trends Cell Biol, V1, P150, DOI 10.1016/0962-8924(91)90003-R
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   WINKLER BS, 1994, FREE RADICAL BIO MED, V17, P333, DOI 10.1016/0891-5849(94)90019-1
   ZOLLNER N., 1962, ZEIT GES EXPTL MED, V135, P545, DOI 10.1007/BF02045455
NR 43
TC 38
Z9 40
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-5748
EI 1873-474X
J9 INT J DEV NEUROSCI
JI Int. J. Dev. Neurosci.
PD DEC
PY 1997
VL 15
IS 8
BP 939
EP 948
DI 10.1016/S0736-5748(97)00049-X
PG 10
WC Developmental Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology; Neurosciences & Neurology
GA ZQ610
UT WOS:000073885300003
PM 9641525
DA 2024-02-19
ER

PT J
AU Gershon, D
AF Gershon, D
TI The mitochondrial theory of aging: Is the culprit a faulty disposal
   system rather than indigenous mitochondrial alterations?
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE survival of the slowest; damaged mitochondria; mitochondrial theory of
   aging; mitochondrial DNA; effete mitochondria
ID SUPEROXIDE-DISMUTASE; PURIFICATION; LIVER; AGE
AB Mitochondrial damage and the proportion of effete mitochondria in cells increase with age. According to the mitochondrial theory of aging, this phenomenon is mostly due to oxidative damage and is a major (and, some argue, the main) determinant of aging. It will be argued briefly that this phenomenon plays a role that is not exclusively crucial in aging. It will also be contended, essentially on theoretical grounds (for lack of sufficient current information), that there is low probability that the accumulation of reduced degradation of affected mitochondria is due to diminished production of hydroxyl radicals, as suggested by Aubrey and de Grey (1997) and expanded by Kowald (in this issue). What seems more likely is that the phagolysosomal disposal system of effete mitochondria is considerably altered in cells of aging organisms. Also, in view of the significant role of damaged mitochondria in the initial steps in apoptosis and the lack of evidence of massive apoptosis of cells in senescent individuals, the damage that exists may be milder than anticipated by the mitochondrial theory of aging. A brief fundamental summary on the biology of mitochondria is included for the sake of better understanding the arguments presented in this article. Also, suggestions are made for experimental testing of the hypotheses presented by Aubrey and de Grey (1997) and Kowald (1999). (C) 1999 Elsevier Science Inc. All rights reserved.
C1 Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.
C3 Technion Israel Institute of Technology
RP Gershon, D (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.
CR Alberts B., 1994, MOL BIOL CELL
   AUBREY D, 1997, BIOESSAYS, V19, P161
   COHEN G, 1979, CHEM BIOCH ASPECTS S, P27
   DOVRAT A, 1981, EXP EYE RES, V33, P651, DOI 10.1016/S0014-4835(81)80105-4
   Gershon D, 1997, BIOESSAYS, V19, P533, DOI 10.1002/bies.950190614
   GLASS GA, 1984, BIOCHEM J, V218, P531, DOI 10.1042/bj2180531
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099
   KOWALD A, 1999, EXP GERONTOL, V34
   Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   REISS U, 1976, EUR J BIOCHEM, V63, P617, DOI 10.1111/j.1432-1033.1976.tb10266.x
   REISS U, 1978, LIVER AGING 1978, P55
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217
NR 16
TC 25
Z9 26
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG
PY 1999
VL 34
IS 5
BP 613
EP 619
DI 10.1016/S0531-5565(99)00010-8
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 232MB
UT WOS:000082373600004
PM 10530787
DA 2024-02-19
ER

PT J
AU Xia, MF
   Li, WR
   Lin, HD
   Zeng, HL
   Ma, S
   Wu, Q
   Ma, H
   Li, XM
   Pan, BS
   Gao, J
   Hu, Y
   Liu, Y
   Wang, SJ
   Gao, X
AF Xia, Mingfeng
   Li, Wenran
   Lin, Huandong
   Zeng, Hailuan
   Ma, Shuai
   Wu, Qi
   Ma, Hui
   Li, Xiaoming
   Pan, Baishen
   Gao, Jian
   Hu, Yu
   Liu, Yun
   Wang, Sijia
   Gao, Xin
TI DNA methylation age acceleration contributes to the development and
   prediction of non-alcoholic fatty liver disease
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Non-alcoholic fatty liver disease; Horvath age; DNA methylation age
   acceleration; Body fat distribution
ID CELL PROGENITORS; EXPRESSION; GENE; DIFFERENTIATION; SUSCEPTIBILITY
AB Non-alcoholic fatty liver disease (NAFLD) is prevalent in the aging society. Despite body weight reduction, the prevalence of NAFLD has been increasing with aging for unknown reasons. Here, we investigate the association of DNA methylation age acceleration, a hallmark of aging, with risk of NAFLD. Genome-wide DNA methylation profiles were measured in 95 participants who developed type 2 diabetes during 4-year follow-up, and 356 randomly sampled participants from Shanghai Changfeng Study. DNA methylation age was calculated using the Horvath's method, and liver fat content (LFC) was measured using a quantitative ultrasound method. Subjects with highest tertile of DNA methylation age acceleration (>= 9.5 years) had significantly higher LFC (7.2% vs 3.1%, P = 0.008) but lower body fat percentage (29.7% vs 33.0%, P = 0.032) than those with lowest tertile of DNA methylation age acceleration (< 4.0 years). After adjustment for age, sex, alcohol drinking, cigarette smoking, BMI, waist circumference, and different type blood cell counts, the risk of NAFLD was still significantly increased in the highest tertile group (OR, 4.55; 95% CI, 1.06-19.61). Even in subjects with similar LFC at baseline, DNA methylation age acceleration was associated with higher increase in LFC (4.0 +/- 10.7% vs 0.9 +/- 9.5%, P = 0.004) after a median of 4-year follow-up. Further analysis found that 6 CpGs of Horvath age predictors were associated with longitudinal changes in LFC after multivariate adjustment and located on genes that might lead to fat redistribution from peripheral adipose to liver. Combination of the key CpG methylation related to liver fat content with conventional risk factors improves the performance for NAFLD prediction.
C1 [Xia, Mingfeng; Lin, Huandong; Zeng, Hailuan; Ma, Shuai; Wu, Qi; Li, Xiaoming; Gao, Xin] Fudan Univ, Zhongshan Hosp, Fudan Inst Metab Dis, Dept Endocrinol & Metab, 180 Fenglin Rd, Shanghai 200032, Peoples R China.
   [Xia, Mingfeng; Lin, Huandong; Zeng, Hailuan; Ma, Shuai; Wu, Qi; Li, Xiaoming; Gao, Xin] Fudan Univ, Human Phenome Inst, Shanghai 201203, Peoples R China.
   [Li, Wenran; Wang, Sijia] Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Chinese Acad Sci, CAS Key Lab Computat Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.
   [Ma, Hui; Hu, Yu] Fudan Univ, Zhongshan Hosp, Dept Geriatr, Shanghai 200032, Peoples R China.
   [Pan, Baishen] Fudan Univ, Zhongshan Hosp, Dept Lab Med, Shanghai 200032, Peoples R China.
   [Gao, Jian] Fudan Univ, Dept Nutr, Zhongshan Hosp, Shanghai 200032, Peoples R China.
   [Liu, Yun] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai, Peoples R China.
   [Liu, Yun] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China.
   [Wang, Sijia] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming 650223, Peoples R China.
C3 Fudan University; Fudan University; Chinese Academy of Sciences;
   Shanghai Institute of Nutrition & Health, CAS; University of Chinese
   Academy of Sciences, CAS; Fudan University; Fudan University; Fudan
   University; Fudan University; Fudan University; Chinese Academy of
   Sciences
RP Gao, X (corresponding author), Fudan Univ, Zhongshan Hosp, Fudan Inst Metab Dis, Dept Endocrinol & Metab, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Wang, SJ (corresponding author), Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Chinese Acad Sci, CAS Key Lab Computat Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.
EM wangsijia@picb.ac.cn; zhongshan_endo@126.com
OI Liu, Yun/0000-0001-5753-1265
FU National Key Research and Development Program of China [2021YFC2700403];
   "Strategic Priority Research Program" of the Chinese Academy of Sciences
   [XDB38020400]; National Natural Science Foundation of China [81873660,
   32200472]; Shanghai Municipal Science and Technology Major Project
   [2017SHZDZX01]; Shanghai Municipal Science and Technology Commission
   Foundation [16JC1400500, 16411954800]; Shanghai Pujiang Talent Project
   [20PJ1402300]; CAS Project for Young Scientists in Basic Research
   [YSBR-077]; China Postdoctoral Science Foundation [2021M693274,
   BX2021336]
FX We have obtained financial support from the National Key Research and
   Development Program of China (2021YFC2700403), "Strategic Priority
   Research Program" of the Chinese Academy of Sciences (XDB38020400),
   National Natural Science Foundation of China (81873660, 32200472),
   Shanghai Municipal Science and Technology Major Project (2017SHZDZX01),
   Shanghai Municipal Science and Technology Commission Foundation
   (16JC1400500, 16411954800), Shanghai Pujiang Talent Project
   (20PJ1402300), CAS Project for Young Scientists in Basic Research
   (YSBR-077), and China Postdoctoral Science Foundation (2021M693274 and
   BX2021336).
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Arendt BM, 2015, HEPATOLOGY, V61, P1565, DOI 10.1002/hep.27695
   Bacalini MG, 2019, J GERONTOL A-BIOL, V74, P1, DOI 10.1093/gerona/gly048
   Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343
   Chen Q, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-03066-z
   Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200
   Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Gao X, 2010, EUR J EPIDEMIOL, V25, P885, DOI 10.1007/s10654-010-9525-6
   Guo W, 2007, AM J PHYSIOL-ENDOC M, V292, pE1041, DOI 10.1152/ajpendo.00557.2006
   Hansen K.D., 2017, ILLUMINAHUMANMETHYLA
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Kagansky N, 2004, LIVER INT, V24, P588, DOI 10.1111/j.1478-3231.2004.0969.x
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kim JY, 2007, ARCH BIOCHEM BIOPHYS, V464, P100, DOI 10.1016/j.abb.2007.04.018
   Kirchner H, 2016, MOL METAB, V5, P171, DOI 10.1016/j.molmet.2015.12.004
   Lausberg E, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143078
   Loomba R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96685
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Marchetti B, 2020, AGING CELL, V19, DOI 10.1111/acel.13101
   Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684
   Morrison FG, 2019, AGING-US, V11, P3487, DOI 10.18632/aging.101992
   Nannini DR, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0767-1
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Ou HL, 2018, BLOOD, V131, P488, DOI 10.1182/blood-2017-07-746396
   Owusu D, 2017, J PSYCHIATR RES, V84, P27, DOI 10.1016/j.jpsychires.2016.09.015
   Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Ryczko MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23043
   Sepe A, 2011, GERONTOLOGY, V57, P66, DOI 10.1159/000279755
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Targher G, 2021, LANCET GASTROENTEROL, V6, pS78, DOI 10.1016/S2468-1253(21)00020-0
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Teschendorff AE, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1511-5
   Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680
   Xia MF, 2012, OBESITY, V20, P444, DOI 10.1038/oby.2011.302
   Xia MF, 2021, J HEPATOL, V74, P974, DOI 10.1016/j.jhep.2020.10.019
   Meir AY, 2021, CLIN EPIGENETICS, V13, DOI 10.1186/s13148-021-01038-0
   Younes R, 2022, GUT, V71, P382, DOI 10.1136/gutjnl-2020-322564
   Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033
   Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785
   Zhou WD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw967
   Zhu J., 2017, Chin J Health Manag, V11, P7
NR 46
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2023 AUG 22
PY 2023
DI 10.1007/s11357-023-00903-5
EA AUG 2023
PG 18
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA P7NU4
UT WOS:001052512300001
PM 37605101
OA hybrid
DA 2024-02-19
ER

PT J
AU Yoshida, Y
   Itoh, N
   Hayakawa, M
   Habuchi, Y
   Saito, Y
   Tsukamoto, Y
   Cynshi, O
   Jishage, K
   Arai, H
   Niki, E
AF Yoshida, Yasukazu
   Itoh, Nanako
   Hayakawa, Mieko
   Habuchi, Yoko
   Saito, Yoshiro
   Tsukamoto, Yoshitane
   Cynshi, Osamu
   Jishage, Kou-ichi
   Arai, Hiroyuki
   Niki, Etsuo
TI The role of α-tocopherol in motor hypofunction with aging in
   α-tocopherol transfer protein knockout mice as assessed by oxidative
   stress biomarkers
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Aging; Motor activity; Lipid peroxidation; Total hydroxyoctadecadienoic
   acid (tHODE); Stereoisomer ratio
ID PEROXIDATION IN-VIVO; TOTAL HYDROXYOCTADECADIENOIC ACID; PC12 CELL
   TOLERANCE; LIPID-PEROXIDATION; VITAMIN-E; ADAPTIVE RESPONSE;
   HYPERLIPIDEMIC MICE; ANTIOXIDANT; 7-HYDROXYCHOLESTEROL; ATHEROSCLEROSIS
AB It has been hypothesized that oxidative stress plays a key role in aging. In order to elucidate the role of the antioxidant network including alpha-atocopherol (alpha T) and alpha T transfer protein - in aging in vivo, alpha-tocopherol transfer protein knockout (alpha TTP(-/-)) mice were fed a vitamin-E-depleted diet, and wild-type (WT) trice were fed a diet containing 0.002 wt.% alpha T from the age of 3 months to 1 1/2 years. The lipid oxidation markers total hydroxyoctadecadienoic acid (tHODE) and 8-iso-prostaglandin F(2)alpha, and antioxidant levels in the blood, liver and brain were measured at 3, 6, 12 and 18 months. thHODE levels in the plasma of alpha TTP(-/-) mice were elevated at 6 months compared to 3 months, and were significantly higher those in WT mice, although they decreased thereafter. On the other hand, tHODE levels in the liver and brain were constantly higher in alpha TTP(-/-) mice than in WT mice. Motor activities decreased with aging in both mouse types; however, those in the alpha TTP(-/-) mice were lower than those in the WT mice. It is intriguing to note that motor activities were significantly correlated with the stereoisomer ratio (Z,E/E,E) of HODE, which is a measure of antioxidant capacity in vivo, in the plasma, in the liver and even in the brain, but not with other factors such as antioxidant levels. In summary, using the biomarker tHODE and its stereoisomer ratio, we demonstrated that alpha T depletion was associated with a decrease in motor function, and that this may be primarily attributable to a decrease in the total antioxidant capacity in vivo. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Yoshida, Yasukazu; Itoh, Nanako; Hayakawa, Mieko; Habuchi, Yoko; Saito, Yoshiro; Niki, Etsuo] Natl Inst Adv Ind Sci & Technol, Hlth Technol Res Ctr, Osaka 5638577, Japan.
   [Tsukamoto, Yoshitane] Hyogo Med Univ, Nishinomiya, Hyogo 6638501, Japan.
   [Cynshi, Osamu; Jishage, Kou-ichi] Chugai Pharmaceut Co Ltd, Fujigotemba Res Labs, Shizuoka 4128513, Japan.
   [Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130031, Japan.
C3 National Institute of Advanced Industrial Science & Technology (AIST);
   Hyogo College of Medicine; University of Hyogo; Roche Holding; Chugai
   Pharmaceutical Co., Ltd.; University of Tokyo
RP Yoshida, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Hlth Technol Res Ctr, Osaka 5638577, Japan.
EM yoshida-ya@aist.go.jp
RI Saito, Yoshiro/H-4597-2019; YOSHIDA, YASUKAZU/H-8510-2016
OI Saito, Yoshiro/0000-0002-0559-5889; YOSHIDA,
   YASUKAZU/0000-0001-6034-2502
FU Ministry of Education, Science, Sports and Culture [19300256];
   Grants-in-Aid for Scientific Research [19300256] Funding Source: KAKEN
FX We gratefully acknowledge Eisai Co., Ltd. for providing us the natural
   form of alpha T. This study was partially supported by a donation from
   Eisai Food and Chemical Co., Ltd. and a Grant-in-Aid for Scientific
   Research (B) from the Ministry of Education, Science, Sports and Culture
   (19300256; 2007).
CR Azzi A, 2007, FREE RADICAL BIO MED, V43, P16, DOI 10.1016/j.freeradbiomed.2007.03.013
   Basu S, 2004, FREE RADICAL RES, V38, P105, DOI 10.1080/10715760310001646895
   Chen ZH, 2006, FEBS LETT, V580, P479, DOI 10.1016/j.febslet.2005.12.045
   Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200
   Chen ZH, 2006, J BIOL CHEM, V281, P14440, DOI 10.1074/jbc.M600260200
   Cyrus T, 2001, CIRCULATION, V103, P2277
   Girotti AW, 1998, J LIPID RES, V39, P1529
   Gohil K, 2004, ANN NY ACAD SCI, V1031, P109, DOI 10.1196/annals.1331.012
   Leonarduzzi G, 2000, FREE RADICAL BIO MED, V28, P1370, DOI 10.1016/S0891-5849(00)00216-1
   Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821
   Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072
   Niki E, 2004, BIOCHEM SOC T, V32, P156, DOI 10.1042/BST0320156
   PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034
   Roberts LJ, 2007, FREE RADICAL BIO MED, V43, P1388, DOI 10.1016/j.freeradbiomed.2007.06.019
   Suarna C, 2006, FREE RADICAL BIO MED, V41, P722, DOI 10.1016/j.freeradbiomed.2006.05.013
   Tang DG, 2002, BIOL CHEM, V383, P425, DOI 10.1515/BC.2002.046
   Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697
   Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024
   Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098
   Yoshida Y, 2005, BIOFACTORS, V24, P7, DOI 10.1002/biof.5520240102
   Yoshida Y, 2005, TOXICOL APPL PHARM, V208, P87, DOI 10.1016/j.taap.2005.01.015
   Yoshida Y, 2004, FREE RADICAL RES, V38, P787, DOI 10.1080/10715760410001700460
   YOSHIDA Y, 2006, HODE NUTR, V22, P303
   YOSHIDA Y, 2006, BIOCHIM BIOPHYS ACTA, V1760, P1559
   Yoshida Y, 2007, BIOCHEM PHARMACOL, V74, P1010, DOI 10.1016/j.bcp.2007.07.020
   Yoshida Y, 2007, LIPIDS, V42, P463, DOI 10.1007/s11745-007-3043-7
   Yoshida Y, 2007, LIPIDS, V42, P439, DOI 10.1007/s11745-007-3037-5
   Yoshida Y, 2006, BIOFACTORS, V27, P195, DOI 10.1002/biof.5520270117
NR 28
TC 23
Z9 27
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0955-2863
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JAN
PY 2010
VL 21
IS 1
BP 66
EP 76
DI 10.1016/j.jnutbio.2008.10.006
PG 11
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 533EN
UT WOS:000272806600007
PM 19157826
DA 2024-02-19
ER

PT J
AU Montgomery, MK
   Hulbert, AJ
   Buttemer, WA
AF Montgomery, Magdalene K.
   Hulbert, A. J.
   Buttemer, William A.
TI Does the oxidative stress theory of aging explain longevity differences
   in birds? I. Mitochondrial ROS production
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Parrots; Maximum lifespan; Reactive oxygen species (ROS);
   Antimycin A; Free radical leak
ID HYDROGEN-PEROXIDE PRODUCTION; FREE-RADICAL PRODUCTION; RAT-LIVER
   MITOCHONDRIA; HEART-MITOCHONDRIA; COMPLEX-I; SKELETAL-MUSCLE;
   METABOLIC-RATE; LIFE-SPAN; SUPEROXIDE-PRODUCTION; CALORIC RESTRICTION
AB Mitochondrial reactive oxygen species (ROS) production rates are reported to be inversely related to maximum lifespan potential (MLSP) in mammals and also to be higher in short-living mammals compared to short-living birds. The mammal-bird comparison, however, is mainly based on studies of rats and pigeons. To date, there has been no systematic examination of ROS production in birds that differ in MLSP. Here we report a comparison of mitochondria! ROS production in two short-living (quails) and three long-living bird species (parrots) that exhibit, on average, a 5-fold longevity difference. Mitochondrial ROS production was determined both in isolated mitochondria (heart, skeletal muscle and liver) as traditionally done and also in intact erythrocytes. In all four tissues, mitochondrial ROS production was similar in quails and parrots and showed no correspondence with known longevity differences. The lack of a consistent difference between quails and parrots was not due to differences in mitochondrial content as ROS production in relation to oxygen consumption (determined as the free radical leak) showed a similar pattern. These findings cast doubt on the robustness of the oxidative stress theory of aging. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Montgomery, Magdalene K.] St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Res Program, Darlinghurst, NSW 2010, Australia.
   [Montgomery, Magdalene K.; Hulbert, A. J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia.
   [Buttemer, William A.] Deakin Univ, Ctr Integrat Ecol, Waurn Ponds, Vic 3217, Australia.
C3 Garvan Institute of Medical Research; NSW Health; St Vincents Hospital
   Sydney; University of Wollongong; Deakin University
RP Montgomery, MK (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Res Program, Darlinghurst, NSW 2010, Australia.
EM m.montgomery@garvan.org.au; hulbert@uow.edu.au; buttemer@deakin.edu.au
RI Buttemer, William A/F-9573-2019
OI Buttemer, William A/0000-0003-3176-4452; Montgomery,
   Magdalene/0000-0003-2551-4174
FU Australian Research Council
FX We gratefully acknowledge the assistance on diet formulation provided by
   Kirk C. Klasing and Ron Newman. This research was supported by funding
   from the Australian Research Council. The study was conceived and
   planned by all three authors; the experiments were carried out by M.K.
   Montgomery and the manuscript was written by all three authors.
CR Alberio SO, 2005, TISSUE CELL, V37, P193, DOI 10.1016/j.tice.2004.12.006
   Azad MAK, 2010, COMP BIOCHEM PHYS A, V157, P266, DOI 10.1016/j.cbpa.2010.07.011
   Barja G, 1998, J BIOENERG BIOMEMBR, V30, P235, DOI 10.1023/A:1020592719405
   Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x
   Barja G, 2002, J BIOENERG BIOMEMBR, V34, P227, DOI 10.1023/A:1016039604958
   BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584
   Brown JCL, 2009, MECH AGEING DEV, V130, P467, DOI 10.1016/j.mad.2009.05.002
   DARGEL R, 1974, FEBS LETT, V42, P57, DOI 10.1016/0014-5793(74)80278-4
   FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325
   Gomez J, 2009, J BIOENERG BIOMEMBR, V41, P309, DOI 10.1007/s10863-009-9229-3
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   Herrero A, 1998, MECH AGEING DEV, V103, P133, DOI 10.1016/S0047-6374(98)00035-9
   Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6
   HINKLE PC, 1979, J BIOL CHEM, V254, P2450
   KALOMENOPOULOU M, 1989, COMP BIOCHEM PHYS A, V92, P215, DOI 10.1016/0300-9629(89)90156-4
   Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616
   KU HH, 1993, MECH AGEING DEV, V72, P67, DOI 10.1016/0047-6374(93)90132-B
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   Lambert AJ, 2007, AGING CELL, V6, P607, DOI 10.1111/j.1474-9726.2007.00312.x
   Lambert AJ, 2010, AGING CELL, V9, P78, DOI 10.1111/j.1474-9726.2009.00538.x
   Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Montgomery M.K., EXP GERONTO IN PRESS
   Montgomery MK, 2012, J COMP PHYSIOL B, V182, P127, DOI 10.1007/s00360-011-0603-1
   Montgomery MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024138
   Mujahid A, 2009, AM J PHYSIOL-REG I, V297, pR690, DOI 10.1152/ajpregu.90974.2008
   Olsson M, 2008, J EXP BIOL, V211, P1257, DOI 10.1242/jeb.015065
   Olsson M, 2009, NATURWISSENSCHAFTEN, V96, P845, DOI 10.1007/s00114-009-0530-0
   Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033
   REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1
   RODNAN GP, 1957, BLOOD, V12, P355, DOI 10.1182/blood.V12.4.355.355
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Trzcionka M, 2008, J EXP BIOL, V211, P1911, DOI 10.1242/jeb.016519
   Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026
NR 38
TC 36
Z9 41
U1 1
U2 64
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAR
PY 2012
VL 47
IS 3
BP 203
EP 210
DI 10.1016/j.exger.2011.11.006
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 911BR
UT WOS:000301692800001
PM 22123429
DA 2024-02-19
ER

PT J
AU MANIONGUI, C
   BLOND, JP
   ULMANN, L
   DURAND, G
   POISSON, JP
   BEZARD, J
AF MANIONGUI, C
   BLOND, JP
   ULMANN, L
   DURAND, G
   POISSON, JP
   BEZARD, J
TI AGE-RELATED-CHANGES IN DELTA-6 AND DELTA-5 DESATURASE ACTIVITIES IN
   RAT-LIVER MICROSOMES
SO LIPIDS
LA English
DT Article
ID FATTY-ACID COMPOSITION; GAMMA-LINOLENIC ACID; DELTA-6-DESATURASE
   ACTIVITY; DIETARY-PROTEIN; AGING INFLUENCE; SERUM-LIPIDS; CHOLESTEROL;
   METABOLISM
AB Age-related changes in A6 desaturation of [1-C-14]alpha-linolenic acid and [1-C-14]linoleic acid and in DELTA5 desaturation of [2-C-14]dihomo-gamma-linolenic acid were studied in liver microsomes from Wistar male rats at various ages ranging from 1.5 to 24 mon. Desaturase activities were expressed both as specific activity of liver microsomes and as the capacity of whole liver to desaturate by taking into account the total amount of liver microsomal protein. A6 Desaturation of alpha-linolenic acid increased from 1.5 to 3 mon and then decreased linearly up to 24 mon to reach the same desaturation capacity of liver measured at 1.5 mon. The capacity of liver to desaturate linoleic acid increased up to 6 mon and then remained constant, whereas microsomal specific activity was equal at 1.5 and 24 mon of age. The capacity of liver to convert dihomo-gamma-linolenic acid to arachidonic acid by DELTA5 desaturation decreased markedly from 1.5 to 3 mon. It then increased to reach, at 24 mon, the same level as that observed at 1.5 mon. Age-related changes in the fatty acid composition of liver microsomal phospholipids at the seven time points studied and of erythrocyte lipids at 1.5 and 24 mon were consistent with the variations in desaturation capacity of liver. In particular, arachidonic acid content in old rats was slightly higher than in young rats whereas contents in linoleic and docosahexaenoic acids varied little throughout the life span. The results suggest that, in liver, the activity of desaturases may be regulated in the course of aging to maintain a constant level of polyunsaturated fatty acids in cellular membranes.
C1 UNIV BOURGOGNE,FAC SCI MIRANDE,UNITE RECH NUTR CELLULAIRE & METAB,BP 138,F-21004 DIJON,FRANCE.
   INRA,NUTR & SECUR ALIMENTAIRE LAB,F-78350 JOUY EN JOSAS,FRANCE.
C3 Universite de Bourgogne; Universite Paris Saclay; INRAE
RI Ulmann, Lionel/AAC-6561-2019
OI Ulmann, Lionel/0000-0002-9009-2791
CR ASCIUTTIMOURA LS, 1988, AM J CLIN NUTR, V48, P980, DOI 10.1093/ajcn/48.4.980
   BIAGI PL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P187, DOI 10.1016/0005-2760(91)90041-F
   BLOND JP, 1981, CR ACAD SCI III-VIE, V292, P911
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   BOURRE JM, 1990, LIPIDS, V25, P354, DOI 10.1007/BF02544347
   BRENNER RR, 1974, MOL CELL BIOCHEM, V3, P41, DOI 10.1007/BF01660076
   CHOI YS, 1989, LIPIDS, V24, P45, DOI 10.1007/BF02535263
   CHOI YS, 1989, BRIT J NUTR, V61, P531, DOI 10.1079/BJN19890141
   de Gomez Dumm I, 1975, LIPIDS, V10, P315
   . Delsal J. L., 1944, BULL SOC CHIM BIOL, V26, P99
   DRISS F, 1988, CLIN HEMORHEOL, V8, P679
   DUMM INT, 1976, LIPIDS, V11, P833
   HIRSCH J, 1958, J BIOL CHEM, V233, P311
   HOLMAN RT, 1979, AM J CLIN NUTR, V32, P2390, DOI 10.1093/ajcn/32.12.2390
   HORROBIN DF, 1981, MED HYPOTHESES, V7, P1211, DOI 10.1016/0306-9877(81)90064-5
   HRELIA S, 1989, BIOCHEM BIOPH RES CO, V163, P348, DOI 10.1016/0006-291X(89)92142-6
   Jeffcoat R, 1979, Essays Biochem, V15, P1
   LAYNE E, 1957, METHOD ENZYMOL, V3, P447, DOI 10.1016/S0076-6879(57)03413-8
   MIMOUNI V, 1991, BIOCHIM BIOPHYS ACTA, V1086, P349, DOI 10.1016/0005-2760(91)90180-P
   NARCE M, 1988, J CHROMATOGR, V448, P250
   PELUFFO RO, 1974, J NUTR, V104, P894, DOI 10.1093/jn/104.7.894
   RAO GA, 1979, LIPIDS, V14, P30, DOI 10.1007/BF02533563
   SLOVER HT, 1979, J AM OIL CHEM SOC, V56, P933, DOI 10.1007/BF02674138
   SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6
   STONE KJ, 1979, LIPIDS, V14, P174, DOI 10.1007/BF02533869
   TAKAHASHI R, 1988, LIPIDS, V23, P885, DOI 10.1007/BF02536210
   ULMANN L, 1991, LIPIDS, V26, P127, DOI 10.1007/BF02544006
   VERICEL E, 1988, THROMB RES, V49, P451, DOI 10.1016/S0049-3848(98)90002-0
NR 28
TC 64
Z9 64
U1 0
U2 4
PU AMER OIL CHEMISTS SOC
PI CHAMPAIGN
PA 1608 BROADMOOR DRIVE, CHAMPAIGN, IL 61821-0489
SN 0024-4201
J9 LIPIDS
JI Lipids
PD APR
PY 1993
VL 28
IS 4
BP 291
EP 297
DI 10.1007/BF02536313
PG 7
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA KW586
UT WOS:A1993KW58600005
PM 8487621
DA 2024-02-19
ER

PT J
AU Keith, D
   Finlay, L
   Butler, J
   Gómez, L
   Smith, E
   Moreau, R
   Hagen, T
AF Keith, Dove
   Finlay, Liam
   Butler, Judy
   Gomez, Luis
   Smith, Eric
   Moreau, Regis
   Hagen, Tory
TI Lipoic acid entrains the hepatic circadian clock and lipid metabolic
   proteins that have been desynchronized with advanced age
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Aging; Circadian; Entrainment; Peroxisome proliferator-activated
   receptor; Corticosterone; Dyslipidemia
ID PPAR-ALPHA; LIVER; GENE; CARBOXYLASE; EXPRESSION; PREVENTION; OBESITY;
   RHYTHM; MICE
AB It is well established that lipid metabolism is controlled, in part, by circadian clocks. However, circadian clocks lose temporal precision with age and correlates with elevated incidence in dyslipidemia and metabolic syndrome in older adults. Because our lab has shown that lipoic acid (LA) improves lipid homeostasis in aged animals, we hypothesized that LA affects the circadian clock to achieve these results. We fed 24 month old male F344 rats a diet supplemented with 0.2% (w/w) LA for 2 weeks prior to sacrifice and quantified hepatic circadian clock protein levels and clock-controlled lipid metabolic enzymes. LA treatment caused a significant phase-shift in the expression patterns of the circadian clock proteins Period (Per) 2, Brain and Muscle Arnt-Like1 (BMAL1), and Reverse Erythroblastosis virus (Rev-erb) beta without altering the amplitude of protein levels during the light phase of the day. LA also significantly altered the oscillatory patterns of clock-controlled proteins associated with lipid metabolism. The level of peroxisome proliferator-activated receptor (PPAR) a was significantly increased and acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS) were both significantly reduced, suggesting that the LA-supplemented aged animals are in a catabolic state. We conclude that LA remediates some of the dyslipidemic processes associated with advanced age, and this mechanism may be at least partially through entrainment of circadian clocks. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Keith, Dove; Finlay, Liam; Butler, Judy; Gomez, Luis; Smith, Eric; Moreau, Regis; Hagen, Tory] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.
   [Gomez, Luis; Smith, Eric; Hagen, Tory] Oregon State Univ, Dept Biochem Biophys, Corvallis, OR 97331 USA.
C3 Oregon State University; Oregon State University
RP Hagen, T (corresponding author), Oregon State Univ, Linus Pauling Inst, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA.
EM Tory.Hagen@oregonstate.edu
RI Gómez, Luis A./AAD-6660-2021
OI Gomez, Luis/0000-0002-5829-406X; Moreau, Regis/0000-0003-0532-9887
FU NCCAM [T32AT002688, AT002034]
FX This work was funded in part by NCCAM T32AT002688 for D.K. and NCCAM
   AT002034.
CR Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344
   Buijs RM, 2003, J ENDOCRINOL, V177, P17, DOI 10.1677/joe.0.1770017
   Butler JA, 2009, ARCH BIOCHEM BIOPHYS, V485, P63, DOI 10.1016/j.abb.2009.01.024
   Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052
   CHAWLA A, 1993, J BIOL CHEM, V268, P16265
   DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x
   Dufour CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002143
   El Midaoui A, 2002, HYPERTENSION, V39, P303, DOI 10.1161/hy0202.104345
   Fernández-Alvarez A, 2011, J BIOL CHEM, V286, P21466, DOI 10.1074/jbc.M110.209973
   Finlay LA, 2012, AM J PHYSIOL-REG I, V302, pR587, DOI 10.1152/ajpregu.00393.2011
   Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444
   FUKUDA H, 1991, BIOCHIM BIOPHYS ACTA, V1086, P261, DOI 10.1016/0005-2760(91)90168-H
   Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108
   Gibson EM, 2009, EXP GERONTOL, V44, P51, DOI 10.1016/j.exger.2008.05.007
   GREGUS Z, 1992, TOXICOL APPL PHARM, V114, P88, DOI 10.1016/0041-008X(92)90100-7
   Guillou Herve, 2008, V49, P3, DOI 10.1007/978-1-4020-8831-5_1
   Guo Q, 2001, BBA-MOL CELL BIOL L, V1533, P220, DOI 10.1016/S1388-1981(01)00156-1
   Hagen TM, 2000, ANTIOXID REDOX SIGN, V2, P473, DOI 10.1089/15230860050192251
   Keith DJ, 2012, PHARMACOL RES, V66, P199, DOI 10.1016/j.phrs.2012.05.002
   Knight BL, 2005, BIOCHEM J, V389, P413, DOI 10.1042/BJ20041896
   Levay EA, 2010, NUTR RES, V30, P366, DOI 10.1016/j.nutres.2010.05.001
   Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200
   Mendoza J, 2008, J PHYSIOL-LONDON, V586, P5901, DOI 10.1113/jphysiol.2008.159566
   Mensah GA, 2004, CARDIOL CLIN, V22, P485, DOI 10.1016/j.ccl.2004.06.005
   Nakagawa H, 2010, P JPN ACAD B-PHYS, V86, P391, DOI 10.2183/pjab.86.391
   Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001
   Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496
   Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417
   Raspé E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200
   Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248
   Sumida K, 1996, CHEMOSPHERE, V33, P2201, DOI 10.1016/0045-6535(96)00331-1
   Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750
   Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957
   Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499
   Yang ST, 2009, ENDOCRINOLOGY, V150, P2153, DOI 10.1210/en.2008-0705
   Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08
   ZARDOYA R, 1994, REV ESP FISIOL, V50, P239
   Ziegler D, 1999, EXP CLIN ENDOCR DIAB, V107, P421, DOI 10.1055/s-0029-1212132
NR 38
TC 3
Z9 4
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 18
PY 2014
VL 450
IS 1
BP 324
EP 329
DI 10.1016/j.bbrc.2014.05.112
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA AR5RK
UT WOS:000343641000053
PM 24944020
OA Green Accepted, Green Published
DA 2024-02-19
ER

PT J
AU Roh, E
   Hwang, SY
   Yoo, HJ
   Baik, SH
   Lee, JH
   Son, SJ
   Kim, HJ
   Park, YS
   Lee, SG
   Cho, BL
   Jang, HC
   Kim, BJ
   Kim, M
   Won, CW
   Choi, KM
AF Roh, Eun
   Hwang, Soon Young
   Yoo, Hye Jin
   Baik, Sei Hyun
   Lee, Jin-Hee
   Son, Sang Joon
   Kim, Hyeon Ju
   Park, Yong Soon
   Lee, Sam-Gyu
   Cho, Be Long
   Jang, Hak Chul
   Kim, Bong Jo
   Kim, Miji
   Won, Chang Won
   Choi, Kyung Mook
TI Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a
   nationwide multicenter prospective study
SO HEPATOLOGY INTERNATIONAL
LA English
DT Article; Early Access
DE Muscle; Skeletal; Muscle strength; Sarcopenia; Nonalcoholic fatty liver
   disease; Cohort
ID INSULIN-RESISTANCE; ASSOCIATION; STRENGTH; OBESITY; HEALTH
AB Background and aims Despite the association between sarcopenia and non-alcoholic fatty liver disease (NAFLD), no study has evaluated the predictive role of NAFLD in sarcopenia. We investigated impact of NAFLD on the risk of low muscle mass (LMM) and low muscle strength (LMS) in a nationwide multicenter study.
   Methods A total of 1595 community-dwelling people aged 70-84 years were followed for 2 years in the Korean Frailty and Aging Cohort Study. Muscle mass was estimated by dividing appendicular skeletal muscle mass (ASM) by body mass index (BMI). Muscle strength was measured as handgrip strength (HGS) divided by BMI. The sex-specific lowest quintiles of ASM/BMI and HGS/BMI of the study population were used as cutoffs for LMM and LMS, respectively. The risk of LMM and LMS were assessed according to hepatic steatosis index (HSI) and fatty liver index (FLI) quartiles.
   Results As HSI quartiles increased, the LMM risk increased gradually, after adjusting for age, sex, lifestyle factors, comorbidities, and several causative factors (insulin resistance, inflammation, and vitamin D) (Q4 vs. Q1 OR [95% CI] 3.46 [2.23-5.35]). The increased risk of LMS was even higher according to HSI quartiles (Q4 vs. Q1 5.81 [3.67-9.21]). Multivariate analyses based on FLI showed similar results. People with NAFLD (HSI> 36) were at higher risk of developing LMM and LMS compared to those without (1.65 [1.19-2.31] and 2.29 [1.61-3.26], respectively).
   Conclusions The presence of NAFLD may predict future risk of LMM and LMS, with greater impact on LMS than on LMM.
   [GRAPHICS]
   .
C1 [Roh, Eun; Yoo, Hye Jin; Baik, Sei Hyun; Choi, Kyung Mook] Korea Univ, Dept Internal Med, Div Endocrinol & Metab, Coll Med, Seoul, South Korea.
   [Hwang, Soon Young] Korea Univ, Dept Biostat, Coll Med, Seoul, South Korea.
   [Lee, Jin-Hee] Catholic Univ Korea, Catholic Inst U Healthcare, Seoul, South Korea.
   [Son, Sang Joon] Ajou Univ, Dept Psychiat, Sch Med, Suwon, South Korea.
   [Kim, Hyeon Ju] Jeju Natl Univ, Dept Family Med, Sch Med, Jeju, South Korea.
   [Park, Yong Soon] Hallym Univ, Dept Family Med, Chuncheon Sacred Heart Hosp, Chunchon, South Korea.
   [Lee, Sam-Gyu] Chonnam Natl Univ, Dept Phys & Rehabil Med, Med Sch, Gwangju, South Korea.
   [Cho, Be Long] Seoul Natl Univ, Ctr Hlth Promot & Optimal Aging, Dept Family Med, Coll Med, Seoul, South Korea.
   [Jang, Hak Chul] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.
   [Kim, Bong Jo] Gyeongsang Natl Univ, Dept Psychiat, Coll Med, Jinju, South Korea.
   [Kim, Miji] Kyung Hee Univ, East West Med Res Inst, Seoul, South Korea.
   [Won, Chang Won] Kyung Hee Univ, Coll Med, Dept Family Med, Seoul, South Korea.
C3 Korea University; Korea University Medicine (KU Medicine); Korea
   University; Korea University Medicine (KU Medicine); Catholic University
   of Korea; Ajou University; Jeju National University; Hallym University;
   Chonnam National University; Seoul National University (SNU); Seoul
   National University (SNU); Gyeongsang National University; Kyung Hee
   University; Kyung Hee University
RP Choi, KM (corresponding author), Korea Univ, Dept Internal Med, Div Endocrinol & Metab, Coll Med, Seoul, South Korea.; Won, CW (corresponding author), Kyung Hee Univ, Coll Med, Dept Family Med, Seoul, South Korea.
EM chunwon62@naver.com; medica7@gmail.com
RI Choi, Kyung Mook/C-4195-2018; Cho, Belong/GLU-3443-2022
OI Choi, Kyung Mook/0000-0001-6175-0225; Cho, Belong/0000-0001-9558-689X;
   Hwang, Soon Young/0000-0001-7474-1803
FU Korea Health Technology R&D Project through the Korean Health Industry
   Development Institute (KHIDI) - Ministry of Health and Welfare of Korea
   [HI15C3153]; National Research Foundation of Korea (NRF) - Ministry of
   Education of Korea [2020R1I1A1A01070499]; Korea University Guro Hospital
   (Korea Research-Driven Hospital); Korea University Medicine [K2115701]
FX This study was supported by grant from the Korea Health Technology R&D
   Project through the Korean Health Industry Development Institute (KHIDI)
   funded by the Ministry of Health and Welfare of Korea (grant number:
   HI15C3153) and grant from the National Research Foundation of Korea
   (NRF) funded by the Ministry of Education of Korea (grant number:
   2020R1I1A1A01070499) This work was also supported by Korea University
   Guro Hospital (Korea Research-Driven Hospital) and grant funded by Korea
   University Medicine (K2115701).
CR Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
   Gan D, 2020, CLIN NUTR, V39, P1124, DOI 10.1016/j.clnu.2019.04.023
   Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019
   Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716
   Kang S, 2020, J CACHEXIA SARCOPENI, V11, P1232, DOI 10.1002/jcsm.12598
   Kim D, 2021, LIVER INT, V41, P1832, DOI 10.1111/liv.14852
   Kim G, 2018, HEPATOLOGY, V68, P1755, DOI 10.1002/hep.30049
   Kim JA, 2019, HEPATOL INT, V13, P674, DOI 10.1007/s12072-019-09996-7
   Kim KM, 2016, KOREAN J INTERN MED, V31, P643, DOI 10.3904/kjim.2016.015
   Kim TN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06831-7
   Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005
   Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002
   Lee MJ, 2019, GUT LIVER, V13, P67, DOI 10.5009/gnl18070
   Lee YH, 2015, J HEPATOL, V63, P486, DOI 10.1016/j.jhep.2015.02.051
   Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6
   Li DX, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00059
   Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107
   Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171
   Mathews ST, 2000, MOL CELL ENDOCRINOL, V164, P87, DOI 10.1016/S0303-7207(00)00237-9
   McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012
   Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56
   Meng G, 2016, SCI REP-UK, V6, DOI 10.1038/srep33255
   Moon JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166344
   Roh E, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00332
   Shafiee G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0299-1
   Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805
   Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005
   Valenti L, 2016, LIVER INT, V36, P1563, DOI 10.1111/liv.13185
   Won CW, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035573
   Wu HT, 2016, DIABETOLOGIA, V59, P1732, DOI 10.1007/s00125-016-3991-7
NR 31
TC 17
Z9 17
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1936-0533
EI 1936-0541
J9 HEPATOL INT
JI Hepatol. Int.
PD 2022 JUN
PY 2022
VL 16
IS 3
BP 545
EP 554
DI 10.1007/s12072-021-10258-8
EA NOV 2021
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 1X6CV
UT WOS:000718703800001
PM 34780030
DA 2024-02-19
ER

PT J
AU Hamrick, MW
   Dukes, A
   Arounleut, P
   Davis, C
   Periyasamy-Thandavan, S
   Mork, S
   Herberg, S
   Johnson, MH
   Isales, CM
   Hill, WD
   Otvos, L
   de Chantemèle, EJB
AF Hamrick, M. W.
   Dukes, A.
   Arounleut, P.
   Davis, C.
   Periyasamy-Thandavan, S.
   Mork, S.
   Herberg, S.
   Johnson, M. H.
   Isales, C. M.
   Hill, W. D.
   Otvos, L., Jr.
   de Chantemele, E. J. Belin
TI The adipokine leptin mediates muscle- and liver-derived IGF-1 in aged
   mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Calorie restriction; Food intake; Longevity
ID GROWTH-HORMONE; CALORIE RESTRICTION; ANTAGONIST PEPTIDE; IN-VIVO; MASS;
   BONE; LIFE; EXPRESSION; RECEPTORS; AXIS
AB Muscle- and liver-derived IGF-1 play important roles in muscle anabolism throughout growth and aging. Yet, prolonged food restriction is thought to increase longevity in part by lowering levels of IGF-1, which in turn reduces the risk for developing various cancers. The dietary factors that modulate IGF-1 levels are, however, poorly understood. We tested the hypothesis that the adipokine leptin, which is elevated with food intake and suppressed during fasting, is a key mediator of IGF-1 levels with aging and food restriction. First, leptin levels in peripheral tissues were measured in young mice fed ad libitum, aged mice fed ad libitum, and aged calorie-restricted (CR) mice. A group of aged CR mice were also treated with recombinant leptin for 10 days. Later, aged mice fed ad libitum were treated with saline (VEH) or with a novel leptin receptor antagonist peptide (Allo-aca) and tissue-specific levels of IGF-1 were determined. On one hand, recombinant leptin induced a three-fold increase in liver-derived IGF-1 and a two-fold increase in muscle-derived IGF-1 in aged, CR mice. Leptin also significantly increased serum growth hormone levels in the aged, CR mice. On the other, the leptin receptor antagonist Allo-aca did not alter body weight or muscle mass in treated mice compared to VEH mice. Allo-aca did, however, produce a significant (20%) decline in liver-derived IGF-1 as well as an even more pronounced (>50%) decrease in muscle-derived IGF-1 compared to VEH-treated mice. The reduced IGF-1 levels in Allo-aca treated mice were not accompanied by any significant change in growth hormone levels compared to VEH mice. These findings suggest that leptin receptor antagonists may represent novel therapeutic agents for attenuating IGF-1 signaling associated with aging, and could potentially mimic some of the positive effects of calorie restriction on longevity. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Hamrick, M. W.; Dukes, A.; Davis, C.; Periyasamy-Thandavan, S.; Mork, S.; Johnson, M. H.; Isales, C. M.; Hill, W. D.; de Chantemele, E. J. Belin] Georgia Regents Univ, Med Coll Georgia, Augusta, GA 30912 USA.
   [Arounleut, P.] Wake Forest Sch Med, Winston Salem, NC USA.
   [Herberg, S.] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Otvos, L., Jr.] Temple Univ, Philadelphia, PA 19122 USA.
C3 University System of Georgia; Augusta University; Wake Forest
   University; University System of Ohio; Case Western Reserve University;
   Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple
   University
RP Hamrick, MW (corresponding author), Georgia Regents Univ, Dept Cellular Biol & Anat, Laney Walker Blvd, Augusta, GA 30912 USA.
EM mhamrick@gru.edu
RI Herberg, Samuel/I-3811-2019; de Chantemele, Eric J Belin/H-8923-2019;
   Hamrick, Mark/K-1131-2016; Davis, Catherine L/A-7522-2011; Isales,
   Carlos/J-9902-2013
OI Herberg, Samuel/0000-0001-7196-2010; de Chantemele, Eric J
   Belin/0000-0002-0184-3830; Isales, Carlos/0000-0002-4480-3484; Davis,
   Catherine Lucy/0000-0002-2942-8233
FU National Institutes of Health [NIA-AG036675-01]
FX This work was supported by the National Institutes of Health
   (NIA-AG036675-01). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ajuwon KM, 2003, J NUTR BIOCHEM, V14, P522, DOI 10.1016/S0955-2863(03)00103-7
   Arounleut P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072330
   Bartell SM, 2011, J BONE MINER RES, V26, P1710, DOI 10.1002/jbmr.406
   Barzilai N, 2009, J GERONTOL A-BIOL, V64, P187, DOI 10.1093/gerona/gln061
   Carro E, 1997, ENDOCRINOLOGY, V138, P2203, DOI 10.1210/en.138.5.2203
   Carter CS, 2002, TRENDS GENET, V18, P295, DOI 10.1016/S0168-9525(02)02696-3
   Chan JL, 2008, J CLIN ENDOCR METAB, V93, P2819, DOI 10.1210/jc.2008-0056
   Gat-Yablonski G, 2004, ENDOCRINOLOGY, V145, P343, DOI 10.1210/en.2003-0910
   Gertler A, 2014, CURR PHARM DESIGN, V20, P659, DOI 10.2174/13816128113199990014
   Gesing A, 2014, EXP GERONTOL, V58, P219, DOI 10.1016/j.exger.2014.08.010
   Guerra B, 2007, J APPL PHYSIOL, V102, P1786, DOI 10.1152/japplphysiol.01313.2006
   Hamrick MW, 2008, J BONE MINER RES, V23, P870, DOI 10.1359/JBMR.080213
   Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011
   Hamrick MW, 2010, BIOCHEM BIOPH RES CO, V400, P379, DOI 10.1016/j.bbrc.2010.08.079
   Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361
   Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67
   Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006
   Luo L, 2013, EXP GERONTOL, V48, P427, DOI 10.1016/j.exger.2013.02.009
   Luque RM, 2007, AM J PHYSIOL-ENDOC M, V292, pE891, DOI 10.1152/ajpendo.00258.2006
   Otvos L, 2014, AMINO ACIDS, V46, P873, DOI 10.1007/s00726-013-1650-6
   Otvos L, 2011, PEPTIDES, V32, P1567, DOI 10.1016/j.peptides.2011.06.015
   Otvos L, 2011, EUR J CANCER, V47, P1578, DOI 10.1016/j.ejca.2011.01.018
   Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Watanobe H, 2002, J NEUROSCI, V22, P6265
NR 25
TC 20
Z9 21
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT
PY 2015
VL 70
BP 92
EP 96
DI 10.1016/j.exger.2015.07.014
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA CV4QV
UT WOS:000364252500013
PM 26220769
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Baburina, Y
   Odinokova, I
   Azarashvili, T
   Akatov, V
   Lemasters, JJ
   Krestinina, O
AF Baburina, Yulia
   Odinokova, Irina
   Azarashvili, Tamara
   Akatov, Vladimir
   Lemasters, John J.
   Krestinina, Olga
TI 2′,3′-Cyclic nucleotide 3′-phosphodiesterase as a messenger of
   protection of the mitochondrial function during melatonin treatment in
   aging
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE Melatonin; Rat liver mitochondria; Permeability transition pore; Aging;
   2 ',3 '-Cyclic nucleotide 3 '-phosphodiesterase
ID PERMEABILITY TRANSITION PORE; RAT-BRAIN MITOCHONDRIA; CYTOCHROME-C
   RELEASE; AGE; RECEPTOR; HEART; LOCALIZATION; APOPTOSIS; CELL; CNP
AB The process of aging is considered to be tightly related to mitochondrial dysfunction. One of the causes of aging is an increased sensitivity to the induction of mitochondrial permeability transition pore (mPTP) opening in the inner membrane of mitochondria. Melatonin, a natural antioxidant, is a hormone produced by the pineal gland. The role of melatonin whose level decreases with aging is well understood. In the present study, we demonstrated that long-term treatment of aged rats with melatonin improved the functional state of mitochondria; thus, the Ca2+ capacity was enhanced and mitochondrial swelling was deaccelerated in mitochondria. Melatonin prevented mPTP and impaired the release of cytochrome c and 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) from mitochondria of both young and aged rats. Our data suggest that melatonin retains CNPase inside mitochondria, thereby providing the protection of the protein against deleterious effects of 2',3'-cAMP in aging. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Baburina, Yulia; Odinokova, Irina; Azarashvili, Tamara; Akatov, Vladimir; Lemasters, John J.; Krestinina, Olga] Russian Acad Sci, Inst Theoret & Expt Biophys, Inst Skaya 3, RU-142290 Pushchino, Moscow Region, Russia.
   [Lemasters, John J.] Med Univ South Carolina, Ctr Cell Death Injury & Regenerat, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.
   [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.
C3 Russian Academy of Sciences; Pushchino Scientific Center for Biological
   Research (PSCBI) of the Russian Academy of Sciences; Institute of
   Theoretical & Experimental Biophysics; Medical University of South
   Carolina; Medical University of South Carolina
RP Krestinina, O (corresponding author), Russian Acad Sci, Inst Theoret & Expt Biophys, Inst Skaya 3, RU-142290 Pushchino, Moscow Region, Russia.
EM ovkres@mail.ru
RI Odinokova, Irina V./A-5656-2014
OI Odinokova, Irina V./0000-0002-6331-0191; Krestinina,
   Olga/0000-0001-5676-6919; Baburina, Yulia/0000-0003-1661-3154
FU Russian Federation Government [N14.Z50.0028]; RFBR [14-04-00625,
   16-04-00927]
FX The work was supported by grants from the Russian Federation Government
   (N14.Z50.0028 to J.L.) and RFBR (14-04-00625, 16-04-00927).
CR Castroviejo DA, 2011, CURR TOP MED CHEM, V11, P221
   ALLSHIRE A, 1985, BIOCHIM BIOPHYS ACTA, V807, P202, DOI 10.1016/0005-2728(85)90123-9
   ANVERSA P, 1990, CIRC RES, V67, P871, DOI 10.1161/01.RES.67.4.871
   Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004
   Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009
   Baburina YL, 2014, BIOCHEMISTRY-MOSCOW+, V79, P555, DOI 10.1134/S0006297914060091
   Baburina Y, 2015, NEUROCHEM INT, V90, P46, DOI 10.1016/j.neuint.2015.07.012
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095
   Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x
   Cheshchevik VT, 2012, TOXICOL APPL PHARM, V261, P271, DOI 10.1016/j.taap.2012.04.007
   Cheshchevik VT, 2011, CELL BIOCHEM FUNCT, V29, P481, DOI 10.1002/cbf.1775
   Costa EJX, 1997, FEBS LETT, V416, P103, DOI 10.1016/S0014-5793(97)01178-2
   Coto-Montes A, 2003, J PINEAL RES, V34, P297, DOI 10.1034/j.1600-079X.2003.00049.x
   Crompton M, 2004, AGING CELL, V3, P3, DOI 10.1046/j.1474-9728.2003.00073.x
   Di Lisa F, 2005, CARDIOVASC RES, V66, P222, DOI 10.1016/j.cardiores.2005.02.009
   Drew JE, 2001, J NEUROENDOCRINOL, V13, P453, DOI 10.1046/j.1365-2826.2001.00651.x
   Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101
   García JJ, 1999, J BIOENERG BIOMEMBR, V31, P609, DOI 10.1023/A:1005425213253
   Gonzalez-Arto M, 2016, ANDROLOGY-US, V4, P163, DOI 10.1111/andr.12117
   Goodell S, 1998, MECH AGEING DEV, V101, P245, DOI 10.1016/S0047-6374(97)00182-6
   Hardeland R, 2003, J PINEAL RES, V34, P233, DOI 10.1034/j.1600-079X.2003.00040.x
   Hardeland R, 2008, CELL MOL LIFE SCI, V65, P2001, DOI 10.1007/s00018-008-8001-x
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156
   Hofer T, 2009, MECH AGEING DEV, V130, P297, DOI 10.1016/j.mad.2009.01.004
   Jackson EK, 2011, AM J PHYSIOL-RENAL, V301, pF1160, DOI 10.1152/ajprenal.00450.2011
   Jackson EK, 2009, J BIOL CHEM, V284, P33097, DOI 10.1074/jbc.M109.053876
   Jimenéz-Aranda A, 2014, J PINEAL RES, V57, P103, DOI 10.1111/jpi.12147
   Jou MJ, 2011, J PINEAL RES, V50, P427, DOI 10.1111/j.1600-079X.2011.00861.x
   Karasek M, 2004, EXP GERONTOL, V39, P1723, DOI 10.1016/j.exger.2004.04.012
   Krestinina OV, 2015, BIOCHEM MOSC SUPPL S, V9, P116, DOI 10.1134/S1990747814020032
   Krestinina OV, 2013, BIOL MEMBRANY, V30, P304, DOI 10.7868/S0233475513040051
   Krestinina OV, 2010, BIOL MEMBRANY, V27, P177
   Krestinina O, 2015, NEUROCHEM INT, V80, P41, DOI 10.1016/j.neuint.2014.09.008
   Lee J, 2006, MOL CELL NEUROSCI, V31, P446, DOI 10.1016/j.mcn.2005.10.017
   Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009
   Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1
   Maldonado MD, 2010, PHARMACOL RES, V62, P282, DOI 10.1016/j.phrs.2009.11.014
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054
   MENENDEZPELAEZ A, 1993, J PINEAL RES, V15, P59, DOI 10.1111/j.1600-079X.1993.tb00511.x
   Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412
   Myllykoski M., 2015, BRAIN RES
   Paredes SD, 2009, J EXP BOT, V60, P57, DOI 10.1093/jxb/ern284
   Petrosillo G, 2010, J PINEAL RES, V48, P340, DOI 10.1111/j.1600-079X.2010.00758.x
   Petrosillo G, 2009, AM J PHYSIOL-HEART C, V297, pH1487, DOI 10.1152/ajpheart.00163.2009
   Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001
   POEGGELER B, 1993, EXPERIENTIA, V49, P611, DOI 10.1007/BF01923940
   Poloni JD, 2011, FUNCT INTEGR GENOMIC, V11, P383, DOI 10.1007/s10142-011-0221-8
   Pozo D, 2004, J PINEAL RES, V37, P48, DOI 10.1111/j.1600-079X.2004.00135.x
   Reiter R J, 1981, Prog Clin Biol Res, V59C, P223
   Reiter RJ, 2014, PHYSIOLOGY, V29, P325, DOI 10.1152/physiol.00011.2014
   SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235
   STRICKER R, 1994, BIOL CHEM H-S, V375, P205
   Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349
   Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443
   Tan DX, 2003, J PINEAL RES, V34, P75, DOI 10.1034/j.1600-079X.2003.02111.x
   THOMPSON JE, 1994, BIOCHEMISTRY-US, V33, P7408, DOI 10.1021/bi00189a047
   Turgut M, 2011, RECENT PATENTS ENDOC, V5, P100, DOI 10.2174/187221411799015336
   Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x
   Verrier JD, 2012, J NEUROCHEM, V122, P115, DOI 10.1111/j.1471-4159.2012.07705.x
   Villapol S, 2011, PEDIATR RES, V69, P51, DOI 10.1203/PDR.0b013e3181fcb40b
   Williams LM, 2001, J NEUROENDOCRINOL, V13, P94, DOI 10.1046/j.1365-2826.2001.00595.x
   Witt-Enderby PA, 2006, J PINEAL RES, V41, P297, DOI 10.1111/j.1600-079X.2006.00369.x
   Zavodnik IB, 2011, J PHYSIOL PHARMACOL, V62, P421
NR 65
TC 26
Z9 30
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD JAN
PY 2017
VL 1859
IS 1
BP 94
EP 103
DI 10.1016/j.bbamem.2016.11.003
PG 10
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA EG0MQ
UT WOS:000390727300010
PM 27836641
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Chang, J
   Cornell, JE
   Van Remmen, H
   Hakala, K
   Ward, WF
   Richardson, A
AF Chang, Jinsook
   Cornell, John E.
   Van Remmen, Holly
   Hakala, Kevin
   Ward, Walter F.
   Richardson, Arlan
TI Effect of aging and caloric restriction on the mitochondrial proteome
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID RESPIRATORY-CHAIN ACTIVITY; AGE-DEPENDENT IMPAIRMENT; FREE FATTY-ACIDS;
   OXIDATIVE STRESS; OXYGEN-CONSUMPTION; DIETARY RESTRICTION; RADICAL
   GENERATION; LIVER-MITOCHONDRIA; GENE-EXPRESSION; SENESCENT RAT
AB The rat mitochondrial proteome was analyzed using two-dimensional polyacrylamide gel electrophoresis (2-D PAGE), and proteins altered by age or caloric restriction (CR) were identified using mass spectrometry. Of 2061 mitochondrial proteins analyzed in the three tissues, a significant change with age occurred in 25 liver proteins (19 increased, 6 decreased), 3 heart proteins (1 increased, 2 decreased), and 5 skeletal muscle proteins (all increased). CR prevented the age-related change in the level of one liver mitochondrial protein, altered the levels of four proteins (one increased, three decreased) from heart, and one protein (decreased) from skeletal muscle. Identification of the proteins that changed with age or CR revealed that they were varied among the three tissues, that is, not one mitochondrial protein was changed, in common, by age or CR in any tissue studied. Thus, the effect of age on the mitochondrial proteome appears to be tissue-specific, and CR has a minor effect on age-related protein changes.
C1 Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA.
   Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA.
   Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA.
   Univ Texas, Hlth Sci Ctr, Barshop Inst Longev & Aging Studies, San Antonio, TX 78284 USA.
   S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; University of
   Texas System; University of Texas Health Science Center at San Antonio;
   US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education
   & Clinical Center
RP Ward, WF (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Physiol, 7703 Floyd Curl Dr,MSC 7756, San Antonio, TX 78229 USA.
EM wardw@uthscsa.edu
FU NCI NIH HHS [CA54174] Funding Source: Medline; NIA NIH HHS [R01 AG23843,
   R01 AG025362-01] Funding Source: Medline
CR Andreu AL, 1998, BIOCHEM BIOPH RES CO, V252, P577, DOI 10.1006/bbrc.1998.9703
   [Anonymous], MODERN BIOL THEORIES
   BAILEY LB, 1995, FOLATES HLTH DIS, P23
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x
   BYRNE E, 1991, MECH AGEING DEV, V60, P295, DOI 10.1016/0047-6374(91)90042-X
   Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200
   CHAMPION KM, 1994, P NATL ACAD SCI USA, V91, P11338, DOI 10.1073/pnas.91.24.11338
   Chang JS, 2003, MECH AGEING DEV, V124, P33, DOI 10.1016/S0047-6374(02)00167-7
   Chevallet M, 1998, ELECTROPHORESIS, V19, P1901, DOI 10.1002/elps.1150191108
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Craig EE, 1997, AM J PHYSIOL-HEART C, V272, pH2983, DOI 10.1152/ajpheart.1997.272.6.H2983
   Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003
   Ellis RJ, 1996, FASEB J, V10, P20, DOI 10.1096/fasebj.10.1.8566542
   FARMER KJ, 1989, FREE RADICAL BIO MED, V7, P23, DOI 10.1016/0891-5849(89)90096-8
   Feuers RJ, 1998, ANN NY ACAD SCI, V854, P192, DOI 10.1111/j.1749-6632.1998.tb09902.x
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   Goodell S, 1998, MECH AGEING DEV, V101, P245, DOI 10.1016/S0047-6374(97)00182-6
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Hoppel CL, 2002, BIOGERONTOLOGY, V3, P41, DOI 10.1023/A:1015251212039
   JOENJE H, 1989, MUTAT RES, V219, P193, DOI 10.1016/0921-8734(89)90001-5
   Johnson D., 1967, Methods Enzymol, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9
   Korvald C, 2000, AM J PHYSIOL-HEART C, V278, pH1345, DOI 10.1152/ajpheart.2000.278.4.H1345
   Kristal BS, 1998, FREE RADICAL BIO MED, V24, P1269, DOI 10.1016/S0891-5849(97)00444-9
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   Lesnefsky EJ, 2003, ARCH BIOCHEM BIOPHYS, V420, P287, DOI 10.1016/j.abb.2003.09.046
   MARCILLAT O, 1988, BIOCHEM J, V254, P677, DOI 10.1042/bj2540677
   MARTINEZ M, 1994, NEUROSCI LETT, V170, P121, DOI 10.1016/0304-3940(94)90254-2
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   Mela L, 1979, Methods Enzymol, V55, P39
   MERLO PM, 2004, FEBS LETT, V558, P19
   Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x
   Merry BJ, 2000, ANN NY ACAD SCI, V908, P180
   Mitsumoto A, 2002, FREE RADICAL BIO MED, V32, P22, DOI 10.1016/S0891-5849(01)00755-9
   MJOS OD, 1971, J CLIN INVEST, V50, P1386, DOI 10.1172/JCI106621
   MullerHocker J, 1996, MECH AGEING DEV, V86, P197, DOI 10.1016/0047-6374(95)01692-9
   MUSCARI C, 1990, BASIC RES CARDIOL, V85, P172, DOI 10.1007/BF01906970
   Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Paradies G, 1996, ANN NY ACAD SCI, V786, P252, DOI 10.1111/j.1749-6632.1996.tb39068.x
   RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0
   Sabbah HN, 2001, J AM COLL CARDIOL, V37, p173A
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SCHATZ G, 1995, BBA-MOL BASIS DIS, V1271, P123, DOI 10.1016/0925-4439(95)00018-Y
   SIMONSEN S, 1978, CIRCULATION, V58, P484, DOI 10.1161/01.CIR.58.3.484
   Smyth GK., 2004, Stat Appl Genet Mol Biol, V3, P1, DOI DOI 10.2202/1544-6115.1027
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Stanley William C, 2002, Heart Fail Rev, V7, P115, DOI 10.1023/A:1015320423577
   THURMAN JD, 1994, TOXICOL PATHOL, V22, P1, DOI 10.1177/019262339402200101
   Torres-Mendoza CE, 1999, MOL CELL BIOCHEM, V195, P133
   Van Remmen H, 2001, Novartis Found Symp, V235, P221
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
   Weindruch R., 1988, RETARDATION AGING DI
   Wolff Andrew A, 2002, Heart Fail Rev, V7, P187, DOI 10.1023/A:1015384710373
   Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x
NR 67
TC 30
Z9 32
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAR
PY 2007
VL 62
IS 3
BP 223
EP 234
DI 10.1093/gerona/62.3.223
PG 12
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 228WM
UT WOS:000250763300001
PM 17389719
OA Bronze
DA 2024-02-19
ER

PT J
AU Karagiannides, I
   Thomou, T
   Tchkonia, T
   Pirtskhalava, T
   Kypreos, KE
   Cartwright, A
   Dalagiorgou, G
   Lash, TL
   Farmer, SR
   Timchenko, NA
   Kirkland, JL
AF Karagiannides, Iordanes
   Thomou, Thomas
   Tchkonia, Tamara
   Pirtskhalava, Tamar
   Kypreos, Kyriakos E.
   Cartwright, Andrew
   Dalagiorgou, Georgia
   Lash, Timothy L.
   Farmer, Stephen R.
   Timchenko, Nikolai A.
   Kirkland, James L.
TI Increased CUG triplet repeat-binding protein-1 predisposes to impaired
   adipogenesis with aging
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ACTIVATED RECEPTOR-GAMMA; TUMOR-NECROSIS-FACTOR; TRANSCRIPTIONAL
   INHIBITORY PROTEIN; ADIPOCYTE PRECURSOR CLONES; C/EBP-BETA;
   ADIPOSE-TISSUE; PPAR-GAMMA; ANATOMIC SITE; MESSENGER-RNA;
   DIFFERENTIATION
AB Preadipocyte differentiation capacity declines between middle and old age. Expression of the adipogenic transcription factors, CCAAT/enhancer-binding protein (C/EBP) alpha and peroxisome proliferator-activated receptor gamma (PPAR gamma), is lower in differentiating preadipocytes from old than young animals, although no age-related changes occur in C/EBP beta mRNA, which is upstream of C/EBP alpha and PPAR gamma. C/EBP beta-liver-enriched inhibitory protein (C/EBP beta-LIP), a truncated C/EBP beta isoform that is a dominant inhibitor of differentiation, increases with aging in rat fat tissue and preadipocytes. CUG triplet repeat-binding protein-1 (CUGBP1) binds to C/EBP beta mRNA, increasing C/EBP beta-LIP translation. Abundance and nucleotide binding activity of CUGBP1 increased with aging in preadipocytes. CUGBP1 overexpression in preadipocytes from young animals increased C/EB beta-LIP and impaired adipogenesis. Decreasing CUGBP1 in preadipocytes from old rats by RNA interference reduced C/EB beta-LIP abundance and promoted adipogenesis. Tumor necrosis factor-alpha, levels of which are elevated in fat tissue with aging, increased CUGBP1 protein, CUGBP1 binding activity, and C/EBP beta-LIP in preadipocytes from young rats. Thus, CUGBP1 contributes to regulation of adipogenesis in primary preadipocytes and is responsive to tumor necrosis factor-alpha. With aging, preadipocyte CUGBP1 abundance and activity increases, resulting in enhanced translation of the C/EBP beta-LIP isoform, thereby blocking effects of adipogenic transcription factors, predisposing preadipocytes from old animals to resist adipogenesis. Altered translational processing, possibly related to changes in cytokine milieu and activation of stress responses, may contribute to changes in progenitor differentiation and tissue function with aging.
C1 Boston Univ, Dept Med, Boston, MA 02118 USA.
   Boston Univ, Dept Biochem, Boston, MA 02118 USA.
   Baylor Coll Med, Huffington Ctr Aging, Dept Pathol, Houston, TX 77030 USA.
C3 Boston University; Boston University; Baylor College of Medicine
RP Kirkland, JL (corresponding author), Boston Univ, Dept Med, 88 E Newton St,Robinson 2, Boston, MA 02118 USA.
EM kirkland@bu.edu
RI KYPREOS, KYRIAKOS/AAN-4485-2020; Kypreos, Kyriakos/AAG-1745-2020;
   Kirkland, James/F-9159-2016
OI Kypreos, Kyriakos/0000-0001-6784-2710; Tchkonia,
   Tamar/0000-0003-4623-7145; Farmer, Stephen/0000-0003-2483-2795
FU NIA NIH HHS [AG13925] Funding Source: Medline
CR [Anonymous], 2004, Design and analysis: A researcher's handbook
   [Anonymous], 1986, STAT ANAL
   Bae EJ, 2005, MOL PHARMACOL, V68, P660, DOI 10.1124/mol.105.012997
   Baer M, 2000, J BIOL CHEM, V275, P26582, DOI 10.1074/jbc.M004268200
   Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004
   BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x
   BAUMANN H, 1991, J BIOL CHEM, V266, P20390
   BECKER TC, 1994, METHOD CELL BIOL, V43, P161
   BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827
   BERTRAND HA, 1978, SCIENCE, V201, P1234, DOI 10.1126/science.151328
   Chae GN, 2003, EXP MOL MED, V35, P431, DOI 10.1038/emm.2003.56
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593
   COOPER C, 1995, NUCLEIC ACIDS RES, V23, P4371, DOI 10.1093/nar/23.21.4371
   Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285
   Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057
   DATAR KV, 1993, NUCLEIC ACIDS RES, V21, P439, DOI 10.1093/nar/21.3.439
   DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3
   DJIAN P, 1983, J CLIN INVEST, V72, P1200, DOI 10.1172/JCI111075
   DJIAN P, 1985, METABOLISM, V34, P880, DOI 10.1016/0026-0495(85)90114-3
   Fajas L, 1999, MOL CELL BIOL, V19, P5495
   Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215
   Garcia E, 1999, J ENDOCRINOL, V161, P89, DOI 10.1677/joe.0.1610089
   GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9
   GREGERMAN RI, 1994, J GERONTOL, V49, pB135, DOI 10.1093/geronj/49.4.B135
   GRUNFELD C, 1991, BIOTHERAPY, V3, P143, DOI 10.1007/BF02172087
   Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200
   HAZZARD DG, 1988, EXP AGING RES, V14, P59, DOI 10.1080/03610738808259727
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   HOLLENBERG CH, 1968, J CLIN INVEST, V47, P2485, DOI 10.1172/JCI105930
   HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854
   Hughes KA, 2002, P NATL ACAD SCI USA, V99, P14286, DOI 10.1073/pnas.222326199
   Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052
   Kang KW, 2003, J NATL CANCER I, V95, P53, DOI 10.1093/jnci/95.1.53
   Karagiannides I, 2001, AM J PHYSIOL-REG I, V280, pR1772, DOI 10.1152/ajpregu.2001.280.6.R1772
   Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333
   KIRKLAND JL, 1990, AM J PHYSIOL, V258, pC206, DOI 10.1152/ajpcell.1990.258.2.C206
   Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1
   KIRKLAND JL, 1992, ENDOCRINOLOGY, V131, P2769, DOI 10.1210/en.131.6.2769
   Kirkland JL, 1996, INT J OBESITY, V20, pS102
   KIRKLAND JL, 1994, J GERONTOL, V49, pB31, DOI 10.1093/geronj/49.1.B31
   KLYDE BJ, 1979, J LIPID RES, V20, P691
   Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382
   MILLER WH, 1984, J LIPID RES, V25, P336
   Morin CL, 1997, J GERONTOL A-BIOL, V52, pB190, DOI 10.1093/gerona/52A.4.B190
   Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737
   Poleev A, 2000, EUR J BIOCHEM, V267, P4002, DOI 10.1046/j.1432-1327.2000.01431.x
   Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221
   SAMBROOKJ, 2001, MOL CLONING LAB MANU
   Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704
   SHENG Y, 1995, NUCLEIC ACIDS RES, V23, P1990, DOI 10.1093/nar/23.11.1990
   Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003
   Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004
   Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001
   Tchkonia T, 2006, ENDOCR UPDAT, V26, P105
   Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407
   Timchenko LT, 1996, HUM MOL GENET, V5, P115, DOI 10.1093/hmg/5.1.115
   Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517
   Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200
   Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200
   WANG H, 1989, J CLIN INVEST, V83, P1741, DOI 10.1172/JCI114075
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Welm AL, 2000, J BIOL CHEM, V275, P27406
   WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350
   Wu ZD, 1996, MOL CELL BIOL, V16, P4128
   Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776
   YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168
   YKIJARVINEN H, 1986, ACTA ENDOCRINOL-COP, V113, P88, DOI 10.1530/acta.0.1130088
   Zapata JM, 1998, J BIOL CHEM, V273, P6916, DOI 10.1074/jbc.273.12.6916
NR 69
TC 56
Z9 63
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 11
PY 2006
VL 281
IS 32
BP 23025
EP 23033
DI 10.1074/jbc.M513187200
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 070RY
UT WOS:000239542600065
PM 16754681
OA hybrid
DA 2024-02-19
ER

PT J
AU Ohshima, T
   Schiffmann, R
   Murray, GJ
   Kopp, J
   Quirk, JM
   Stahl, S
   Chan, CC
   Zerfas, P
   Tao-Cheng, JH
   Ward, JM
   Brady, RO
   Kulkarni, AB
AF Ohshima, T
   Schiffmann, R
   Murray, GJ
   Kopp, J
   Quirk, JM
   Stahl, S
   Chan, CC
   Zerfas, P
   Tao-Cheng, JH
   Ward, JM
   Brady, RO
   Kulkarni, AB
TI Aging accentuates and bone marrow transplantation ameliorates metabolic
   defects in Fabry disease mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID ALPHA-GALACTOSIDASE-A; GENE; EXPRESSION; THERAPY; CELLS
AB Fabry disease is an X-linked metabolic disorder caused by a deficiency of cu-galactosidase A (alpha-Gal A). The enzyme defect leads to the systemic accumulation of glycosphingolipids with Lu-galactosyl moieties consisting predominantly of globotriaosylceramide (Gb3). In patients with this disorder, glycolipid deposition in endothelial cells leads to renal failure and cardiac and cerebrovascular disease. Recently, we generated alpha-Gal A gene knockout mouse lines and described the phenotype of 10-week-old mice. In the present study, we characterize the progression of the disease with aging and explore the effects of bone marrow transplantation (BMT) on the phenotype. Histopathological analysis of alpha-Gal A-/0 mice revealed subclinical lesions in the Kupffer cells in the liver and macrophages in the skin with no gross lesions in the endothelial cells. Gb3 accumulation and pathological lesions in the affected organs increased with age. Treatment with BMT from the wild-type mice resulted in the clearance of accumulated Gb3 in the liver, spleen, and heart with concomitant elevation of alpha-Gal A activity. These findings suggest that BMT may have a potential role in the management of patients with Fabry disease.
C1 Natl Inst Dent & Craniofacial Res, Funct Genomics Unit, NIH, Bethesda, MD 20892 USA.
   NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD USA.
   NIDDK, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA.
   NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA.
   NINDS, Electron Microscope Facil, NIH, Bethesda, MD 20892 USA.
   NCI, Vet & Tumor Pathol Sect, Off Lab Anim Sci, NIH, Frederick, MD 21702 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Dental & Craniofacial Research (NIDCR); National Institutes of Health
   (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke
   (NINDS); National Institutes of Health (NIH) - USA; NIH National
   Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National
   Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI);
   National Institutes of Health (NIH) - USA; NIH National Institute of
   Neurological Disorders & Stroke (NINDS); National Institutes of Health
   (NIH) - USA; NIH National Cancer Institute (NCI)
RP Kulkarni, AB (corresponding author), Natl Inst Dent & Craniofacial Res, Funct Genomics Unit, NIH, Bldg 30,Room 529,30 Convent Dr, Bethesda, MD 20892 USA.
RI Kopp, Jeffrey B/O-2681-2015
OI Kopp, Jeffrey B/0000-0001-9052-186X
CR BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101
   BRADY RO, 1973, NEW ENGL J MED, V289, P9, DOI 10.1056/NEJM197307052890103
   Desnick R.J., 1995, The Metabolic and Molecular Bases of Inherited Disease, P2741
   DESNICK RJ, 1983, METABOLIC BASIS INHE, P906
   HOZUMI I, 1990, J LIPID RES, V31, P335
   KARLSSON S, 1991, BLOOD, V78, P2481
   KAY MA, 1994, TRENDS GENET, V10, P253, DOI 10.1016/0168-9525(94)90173-2
   KRIVIT W, 1992, BONE MARROW TRANSPL, V10, P87
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAYES JS, 1981, CLIN CHIM ACTA, V112, P247, DOI 10.1016/0009-8981(81)90384-3
   MAYES JS, 1982, AM J HUM GENET, V34, P602
   Medin JA, 1996, P NATL ACAD SCI USA, V93, P7917, DOI 10.1073/pnas.93.15.7917
   Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540
   SCHIFFMANN R, 1995, BLOOD, V86, P1218
   SIAKOTOS AN, 1965, J AM OIL CHEM SOC, V42, P913, DOI 10.1007/BF02632444
   TALLMAN JF, 1974, J BIOL CHEM, V249, P3489
   ULLMAN MD, 1977, J LIPID RES, V18, P371
NR 17
TC 83
Z9 97
U1 0
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 25
PY 1999
VL 96
IS 11
BP 6423
EP 6427
DI 10.1073/pnas.96.11.6423
PG 5
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 200ER
UT WOS:000080527100092
PM 10339603
OA Green Published
DA 2024-02-19
ER

PT J
AU Márquez-Mota, CC
   Rodriguez-Gaytan, C
   Adjibade, P
   Mazroui, R
   Gálvez, A
   Granados, O
   Tovar, AR
   Torres, N
AF Marquez-Mota, Claudia C.
   Rodriguez-Gaytan, Cinthya
   Adjibade, Pauline
   Mazroui, Rachid
   Galvez, Amanda
   Granados, Omar
   Tovar, Armando R.
   Torres, Nimbe
TI The mTORC1-Signaling Pathway and Hepatic Polyribosome Profile Are
   Enhanced after the Recovery of a Protein Restricted Diet by a
   Combination of Soy or Black Bean with Corn Protein
SO NUTRIENTS
LA English
DT Article
DE soy protein; black bean protein; SNAT2; mTORC1-signaling pathway;
   polysome profiling; protein rehabilitation
ID AMINO-ACID TRANSPORTERS; SKELETAL-MUSCLE; TRANSLATION INITIATION;
   RAT-LIVER; MTORC1; MIXTURES; ENERGY; GROWTH; MALNUTRITION; CONSUMPTION
AB Between 6% and 11% of the world's population suffers from malnutrition or undernutrition associated with poverty, aging or long-term hospitalization. The present work examined the effect of different types of proteins on the mechanistic target of rapamycin (mTORC1)-signaling pathway in: (1) healthy; and (2) protein restricted rats. (1) In total, 200 rats were divided into eight groups and fed one of the following diets: 20% casein (C), soy (S), black bean (B), B + Corn (BCr), Pea (P), spirulina (Sp), sesame (Se) or Corn (Cr). Rats fed C or BCr had the highest body weight gain; rats fed BCr had the highest pS6K1/S6K1 ratio; rats fed B, BCr or P had the highest eIF4G expression; (2) In total, 84 rats were fed 0.5% C for 21 day and protein rehabilitated with different proteins. The S, soy + Corn (SCr) and BCr groups had the highest body weight gain. Rats fed SCr and BCr had the highest eIF4G expression and liver polysome formation. These findings suggest that the quality of the dietary proteins modulate the mTORC1-signaling pathway. In conclusion, the combination of BCr or SCr are the best proteins for dietary protein rehabilitation due to the significant increase in body weight, activation of the mTORC1-signaling pathway in liver and muscle, and liver polysome formation.
C1 [Marquez-Mota, Claudia C.; Rodriguez-Gaytan, Cinthya; Granados, Omar; Tovar, Armando R.; Torres, Nimbe] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Fisiol Nutr, Mexico City 14080, DF, Mexico.
   [Adjibade, Pauline; Mazroui, Rachid] Univ Laval, Fac Med, Dept Biol Mol Biochim Med & Pathol, Ctr Rech,Chu Quebec, Quebec City, PQ G1V 0A6, Canada.
   [Galvez, Amanda] Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, DF, Mexico.
C3 Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran -
   Mexico; Laval University; Universidad Nacional Autonoma de Mexico
RP Torres, N (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Fisiol Nutr, Mexico City 14080, DF, Mexico.
EM claudia.qa@gmail.com; citzelg@hotmail.com; pauline.adjibade@gmail.com;
   Rachid.Mazroui@crchudequebec.ulaval.ca; galvez@unam.mx;
   ograpo@yahoo.com; tovar.ar@gmail.com; nimbester@gmail.com
RI Torres, Nimbe/AAY-8821-2020; Torres, Nimbe/AAI-4340-2020
OI Torres, Nimbe/0000-0002-1741-0984; Marquez Mota, Claudia
   Cecilia/0000-0002-4311-381X
FU Programa de Apoyo a la Investigacion y Posgrado (PAIP) from the Faculty
   of Chemistry, National Autonomous University of Mexico (UNAM)
   [5000-9096]; Natural Sciences and Engineering Council of Canada
   [1256477]
FX This work was supported in part by the Programa de Apoyo a la
   Investigacion y Posgrado (PAIP), grant No. 5000-9096 to (AG) from the
   Faculty of Chemistry, National Autonomous University of Mexico (UNAM)
   and by the Natural Sciences and Engineering Council of Canada # 1256477)
   to (RM). Pilot plant production of black bean concentrate was performed
   at the Instituto de Biotecnologia-UNAM with the help of Leobardo
   Serrano, Mario Caro and Raunel Tinoco.
CR [Anonymous], 2006, DIETARY REFERENCE IN
   [Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD001914.PUB2
   Ascencio C, 2004, J NUTR, V134, P522, DOI 10.1093/jn/134.3.522
   Averous J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27698
   Bai XC, 2010, CELL MOL LIFE SCI, V67, P239, DOI 10.1007/s00018-009-0163-7
   Baldwin C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002008.pub3
   Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003
   Barker LA, 2011, INT J ENV RES PUB HE, V8, P514, DOI 10.3390/ijerph8020514
   Blum A, 2007, CLIN INVEST MED, V30, P21, DOI 10.25011/cim.v30i1.445
   Bonetti F, 2016, NEURODEGENER DIS MAN, V6, P133, DOI 10.2217/nmt-2015-0008
   BRESSANI R, 1959, J NUTR, V69, P351, DOI 10.1093/jn/69.4.351
   Bressani R, 2010, FOOD NUTR BULL, V31, P95, DOI 10.1177/156482651003100110
   Brör S, 2014, PFLUG ARCH EUR J PHY, V466, P155, DOI 10.1007/s00424-013-1393-y
   Butteiger DN, 2013, CLIN NUTR, V32, P585, DOI 10.1016/j.clnu.2012.10.001
   Carrillo MC, 1996, MECH AGEING DEV, V91, P55, DOI 10.1016/0047-6374(96)01779-4
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Chotechuang N, 2009, AM J PHYSIOL-ENDOC M, V297, pE1313, DOI 10.1152/ajpendo.91000.2008
   Dickinson JM, 2013, CURR OPIN CLIN NUTR, V16, P638, DOI 10.1097/MCO.0b013e3283653ec5
   Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011
   Düvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   Eberlé D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190
   Food and Agriculture Organization, 2015, STAT FOOD SEC WORLD
   GARLICK PJ, 1976, BIOCHEM J, V156, P657, DOI 10.1042/bj1560657
   Gorissen SHM, 2016, J NUTR, V146, P1651, DOI 10.3945/jn.116.231340
   Grover Z, 2009, PEDIATR CLIN N AM, V56, P1055, DOI 10.1016/j.pcl.2009.07.001
   Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002
   Hernandez M, 1996, J NUTR, V126, P574, DOI 10.1093/jn/126.2.574
   Iadevaia V, 2014, SEMIN CELL DEV BIOL, V36, P113, DOI 10.1016/j.semcdb.2014.08.004
   Kanda A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060339
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Le LT, 2014, NUTRIENTS, V6, P2131, DOI 10.3390/nu6062131
   Mensa-Wilmot Y, 2001, NUTR RES, V21, P849, DOI 10.1016/S0271-5317(01)00302-5
   MILLWARD DJ, 1975, BIOCHEM J, V150, P235, DOI 10.1042/bj1500235
   Norton LE, 2006, J NUTR, V136, p533S, DOI 10.1093/jn/136.2.533S
   Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289
   Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x
   Proud CG, 2011, MOL CELL, V44, P7, DOI 10.1016/j.molcel.2011.09.004
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Richter CK, 2015, ADV NUTR, V6, P712, DOI 10.3945/an.115.009654
   SCRIMSHAW NS, 1958, J NUTR, V66, P485, DOI 10.1093/jn/66.4.485
   Tan VP, 2016, J MOL CELL CARDIOL, V95, P31, DOI 10.1016/j.yjmcc.2016.01.005
   Tanaka K, 2005, NEUROSCI LETT, V378, P70, DOI 10.1016/j.neulet.2004.12.030
   TANPHAICHITR V, 1976, J NUTR, V106, P111, DOI 10.1093/jn/106.1.111
   Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086
   Torres N, 2006, J NUTR BIOCHEM, V17, P365, DOI 10.1016/j.jnutbio.2005.11.005
   Toyoshima Y, 2010, J MOL ENDOCRINOL, V45, P329, DOI 10.1677/JME-10-0102
   Trabal J, 2015, NUTR REV, V73, P624, DOI 10.1093/nutrit/nuv023
   van Vliet S, 2015, J NUTR, V145, P1981, DOI 10.3945/jn.114.204305
   Yoshizawa F, 1998, AM J PHYSIOL-ENDOC M, V275, pE814, DOI 10.1152/ajpendo.1998.275.5.E814
NR 52
TC 10
Z9 10
U1 1
U2 14
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD SEP
PY 2016
VL 8
IS 9
AR 573
DI 10.3390/nu8090573
PG 24
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DZ0MM
UT WOS:000385534000054
PM 27657118
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Rao, RP
   Scheffer, L
   Srideshikan, SM
   Parthibane, V
   Kosakowska-Cholody, T
   Masood, MA
   Nagashima, K
   Gudla, P
   Lockett, S
   Acharya, U
   Acharya, JK
AF Rao, Raghavendra Pralhada
   Scheffer, Luana
   Srideshikan, Sargur M.
   Parthibane, Velayoudame
   Kosakowska-Cholody, Teresa
   Masood, M. Athar
   Nagashima, Kunio
   Gudla, Prabhakar
   Lockett, Stephen
   Acharya, Usha
   Acharya, Jairaj K.
TI Ceramide Transfer Protein Deficiency Compromises Organelle Function and
   Leads to Senescence in Primary Cells
SO PLOS ONE
LA English
DT Article
ID ENDOPLASMIC-RETICULUM; STRUCTURAL BASIS; RAT-LIVER; LIFE-SPAN; GOLGI;
   TRAFFICKING; CERT; GLUCOSYLCERAMIDE; APOPTOSIS; TRANSPORT
AB Ceramide transfer protein (CERT) transfers ceramide from the endoplasmic reticulum (ER) to the Golgi complex. Its deficiency in mouse leads to embryonic death at E11.5. CERT deficient embryos die from cardiac failure due to defective organogenesis, but not due to ceramide induced apoptotic or necrotic cell death. In the current study we examined the effect of CERT deficiency in a primary cell line, namely, mouse embryonic fibroblasts (MEFs). We show that in MEFs, unlike in mutant embryos, lack of CERT does not lead to increased ceramide but causes an accumulation of hexosylceramides. Nevertheless, the defects due to defective sphingolipid metabolism that ensue, when ceramide fails to be trafficked from ER to the Golgi complex, compromise the viability of the cell. Therefore, MEFs display an incipient ER stress. While we observe that ceramide trafficking from ER to the Golgi complex is compromised, the forward transport of VSVG-GFP protein is unhindered from ER to Golgi complex to the plasma membrane. However, retrograde trafficking of the plasma membrane-associated cholera toxin B to the Golgi complex is reduced. The dysregulated sphingolipid metabolism also leads to increased mitochondrial hexosylceramide. The mitochondrial functions are also compromised in mutant MEFs since they have reduced ATP levels, have increased reactive oxygen species, and show increased glutathione reductase activity. Live-cell imaging shows that the mutant mitochondria exhibit reduced fission and fusion events. The mitochondrial dysfunction leads to an increased mitophagy in the CERT mutant MEFs. The compromised organelle function compromise cell viability and results in premature senescence of these MEFs.
C1 [Rao, Raghavendra Pralhada; Scheffer, Luana; Srideshikan, Sargur M.; Parthibane, Velayoudame; Kosakowska-Cholody, Teresa; Acharya, Jairaj K.] NCI, Lab Cell & Dev Signaling, Frederick, MD 21701 USA.
   [Masood, M. Athar] Frederick Natl Lab Canc Res, Lab Prote & Analyt Technol, Frederick, MD USA.
   [Nagashima, Kunio] Frederick Natl Lab Canc Res, Electron Microscopy Lab, Frederick, MD USA.
   [Gudla, Prabhakar; Lockett, Stephen] Frederick Natl Lab Canc Res, Opt Microscopy & Anal Lab, Frederick, MD USA.
   [Acharya, Usha] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer
   Institute (NCI); Frederick National Laboratory for Cancer Research;
   National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); Frederick National Laboratory for Cancer Research; National
   Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI);
   Frederick National Laboratory for Cancer Research; University of
   Massachusetts System; University of Massachusetts Worcester
RP Acharya, JK (corresponding author), NCI, Lab Cell & Dev Signaling, Frederick, MD 21701 USA.
EM acharyaj@mail.nih.gov
RI Madabushi, Srideshikan Sargur/AAG-1208-2020
OI Madabushi, Srideshikan Sargur/0000-0002-1087-6044; Acharya, U
   Rajendra/0000-0003-2689-8552; Acharya, Jairaj/0000-0001-7366-4228
FU intramural division of the National Cancer Institute, National
   Institutes of Health, Department of Health and Human Resources
FX This project has been funded in whole by the intramural division of the
   National Cancer Institute, National Institutes of Health, Department of
   Health and Human Resources. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   Fisher R, 2010, HIPR2 ADAPTIVE THRES
   Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017
   Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354
   FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295
   Goldenberg NM, 2007, MOL BIOL CELL, V18, P4762, DOI 10.1091/mbc.E06-11-0991
   HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7
   Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091
   Hanada K, 2010, P JPN ACAD B-PHYS, V86, P426, DOI 10.2183/pjab.86.426
   HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6
   Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329
   Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200
   Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105
   Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029
   Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200
   MEISTER A, 1988, J BIOL CHEM, V263, P17205
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Obeid LM, 2003, SCI AGING KNOWLEDGE, V2003, pPE27
   PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267
   PAGANO RE, 1989, METHOD CELL BIOL, V29, P75
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001
   Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104
   Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   SIES H, 1991, KLIN WOCHENSCHR, V69, P965, DOI 10.1007/BF01645140
   SIXMA TK, 1993, BIOCHEMISTRY-US, V32, P191, DOI 10.1021/bi00052a025
   Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880
   Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730
   Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779
   Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176
   White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309
NR 36
TC 51
Z9 55
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 18
PY 2014
VL 9
IS 3
AR e92142
DI 10.1371/journal.pone.0092142
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AD4ZE
UT WOS:000333259900093
PM 24642596
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU SIMONETTI, S
   CHEN, X
   DIMAURO, S
   SCHON, EA
AF SIMONETTI, S
   CHEN, X
   DIMAURO, S
   SCHON, EA
TI ACCUMULATION OF DELETIONS IN HUMAN MITOCHONDRIAL-DNA DURING NORMAL AGING
   - ANALYSIS BY QUANTITATIVE PCR
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
DE MITOCHONDRION; MTDNA; RESPIRATORY CHAIN; KEARNS-SAYRE SYNDROME; COMMON
   DELETION; AGING
ID KEARNS-SAYRE SYNDROME; DEGENERATIVE DISEASES; SENESCENT RAT;
   HUMAN-HEART; INCREASE; CARDIOMYOCYTES; POLYMERASE; DEPLETION; MUTATIONS;
   STRIATUM
AB We have developed a quantitative PCR technique to measure the amount of a specific mitochondrial DNA deletion (DELTAmtDNA), the so-called 'common deletion', in human tissues. Using this method, we estimate that there is a 10000-fold increase in this DELTAmtDNA species in muscle during the course of the normal human lifespan. The maximum amount of common deletion observed in aged muscle was approx. 0.1%. Tissues that turn-over slowly, such as skeletal muscle and heart, contained more DELTAmtDNA than more rapidly dividing tissues, such as liver, in agreement with studies performed by others.
C1 COLUMBIA UNIV,DEPT NEUROL,ROOM 4-431,630 W 168TH ST,NEW YORK,NY 10032.
   COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032.
C3 Columbia University; Columbia University
RP SCHON, EA (corresponding author), COLUMBIA UNIV,DEPT NEUROL,ROOM 4-431,630 W 168TH ST,NEW YORK,NY 10032, USA.
RI Simonetti, Simonetta/IAQ-0244-2023
FU NIA NIH HHS [P50-AG08702] Funding Source: Medline; NINDS NIH HHS
   [P01-NS11766, R01-NS28828] Funding Source: Medline
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
   BYRNE E, 1991, REV NEUROL, V147, P532
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   DARLEYUSMAR VM, 1990, BIOCHEM SOC T, V18, P526, DOI 10.1042/bst0180526
   DAVIS LG, 1986, BASIC METHODS MOL BI, P47
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   FERNANDEZSILVA P, 1991, BIOCHEM BIOPH RES CO, V176, P645, DOI 10.1016/S0006-291X(05)80233-5
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   Hauswirth W., 1985, ACHIEVEMENTS PERSPEC, V2, P49
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   KADENBACH B, 1990, NATURWISSENSCHAFTEN, V77, P221, DOI 10.1007/BF01138485
   KADENBACH B, 1969, BIOCHIM BIOPHYS ACTA, V186, P399, DOI 10.1016/0005-2787(69)90021-5
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, MOL CELL BIOL, V11, P1631, DOI 10.1128/MCB.11.3.1631
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   ROTIG A, 1991, GENOMICS, V10, P502, DOI 10.1016/0888-7543(91)90342-C
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   Sambrook J., 1989, MOL CLONING LABORATO, V2nd
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Walton J, 1988, DISORDERS VOLUNTARY
   WILSON GN, 1978, P NATL ACAD SCI USA, V75, P5367, DOI 10.1073/pnas.75.11.5367
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
NR 44
TC 206
Z9 215
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PD DEC 10
PY 1992
VL 1180
IS 2
BP 113
EP 122
DI 10.1016/0925-4439(92)90059-V
PG 10
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA KC874
UT WOS:A1992KC87400001
PM 1463763
DA 2024-02-19
ER

PT J
AU Jeon, TI
   Lim, BO
   Yu, BP
   Lim, Y
   Jeon, EJ
   Park, DK
AF Jeon, TI
   Lim, BO
   Yu, BP
   Lim, Y
   Jeon, EJ
   Park, DK
TI Effect of dietary restriction on age-related increase of liver
   susceptibility to peroxidation in rats
SO LIPIDS
LA English
DT Article
ID LIPID-PEROXIDATION; FOOD RESTRICTION; FLOW-INJECTION; LONGEVITY;
   MODULATION; PHOSPHATIDYLCHOLINE; HYDROPEROXIDE; MECHANISMS; GENERATION;
   BRAIN
AB Dietary restriction (DR) increases life span and decreases age-related diseases in experimental animals. It has received a great deal of attention in connection with the relationship between aging, nutrition, and oxidative stress because oxidative injury in several organ systems is a prominent feature in aging. We investigated the possibility that DR can protect vulnerable liver lipids against age-related increases of peroxidation. Male Fischer 344 rats fed ad libitum (AL) or dietarily restricted (maintained on 60% of AL food intake) were killed by decapitation at 4 (young) or 12 mon (adult) of age. Phosphatidylcholine hydroperoxide (PCOOH) concentration of liver was determined using a chemiluminescent high-performance liquid chromatographic method. Liver PCOOH increased with age in adult rats, but less of an increase of PCOOH was seen in DR rats, which is consistent with results on production of thiobarbituric acid-reactive substances and oxygen-derived free radicals. No significant differences were found in liver superoxide dismutase and catalase activity between AL and DR groups of young and adult rats. Liver triglyceride and cholesterol contents were lower in DR than AL rats at 12 mon. Fatty acid compositions of phosphatidylcholine and phosphatidylethanolamine indicated that the ratio of (20:3n-6 + 20:4n-6)/18:2n-6, an index of linoleic acid (18:2n-6) desaturation, was lower in DR than in AL rats. We concluded that DR suppresses age-related oxidative damage in liver by modulating the amount of lipid as well as fatty acid composition.
C1 Konkuk Univ, Dept Appl Biol & Chem, Seoul 143701, South Korea.
   Kyung Hee Univ, Grad Sch E W Med Sci, Seoul, South Korea.
   Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78284 USA.
C3 Konkuk University; Kyung Hee University; University of Texas System;
   University of Texas Health Science Center at San Antonio
RP Park, DK (corresponding author), Konkuk Univ, Dept Appl Biol & Chem, 1 Hwayang Dong, Seoul 143701, South Korea.
EM parks@konkuk.ac.kr
RI Lim, Beong Ou/AAS-5184-2021
OI Lim, Beong Ou/0000-0002-9618-5956
CR Aebi H, 1984, Catalase in vitro. Meth Enzymol, V105, P121, DOI [10.1016/S0076-6879(84)05016-3, DOI 10.1016/S0076-6879(84)05016-3]
   ALBRECHT R, 1992, TOXICOL LETT, V63, P91, DOI 10.1016/0378-4274(92)90111-V
   Baek BS, 1999, ARCH PHARM RES, V22, P361, DOI 10.1007/BF02979058
   BAKER GT, 1994, J AGING PHYS ACTIV, V2, P304
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Buege J A, 1978, Methods Enzymol, V52, P302
   Choi HY, 2000, PHYTOTHER RES, V14, P250, DOI 10.1002/1099-1573(200006)14:4&lt;250::AID-PTR587&gt;3.0.CO;2-J
   Choi HY, 1998, ANAL BIOCHEM, V264, P291, DOI 10.1006/abio.1998.2864
   CHOI JH, 1989, AGE, V12, P133, DOI 10.1007/BF02432350
   CLAUDE L, 1987, J CHROMATOGR, V420, P411
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gu JY, 1995, BIOSCI BIOTECH BIOCH, V59, P2198, DOI 10.1271/bbb.59.2198
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   Kim JD, 1996, FREE RADICAL BIO MED, V20, P83, DOI 10.1016/0891-5849(95)02023-3
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   Lane M A, 1999, J Nutr Health Aging, V3, P69
   Lee D W, 1990, Aging (Milano), V2, P357
   Lee J, 1999, FREE RADICAL BIO MED, V26, P260, DOI 10.1016/S0891-5849(98)00195-6
   MIYAZAWA T, 1992, J LIPID RES, V33, P1051
   MIYAZAWA T, 1990, J BIOCHEM-TOKYO, V107, P689, DOI 10.1093/oxfordjournals.jbchem.a123109
   Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2
   PIERI C, 1991, ANN NY ACAD SCI, V621, P353
   REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461
   Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x
   Song JH, 2000, J NUTR, V130, P3028, DOI 10.1093/jn/130.12.3028
   TERAO J, 1994, ARCH BIOCHEM BIOPHYS, V308, P278, DOI 10.1006/abbi.1994.1039
   TERAO J, 1985, LIPIDS, V20, P312, DOI 10.1007/BF02534264
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
   Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 35
TC 26
Z9 30
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0024-4201
EI 1558-9307
J9 LIPIDS
JI Lipids
PD JUN
PY 2001
VL 36
IS 6
BP 589
EP 593
DI 10.1007/s11745-001-0761-1
PG 5
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 454YZ
UT WOS:000170000500006
PM 11485162
DA 2024-02-19
ER

PT J
AU Stowe, HD
   Lawler, DF
   Kealy, RD
AF Stowe, Howard D.
   Lawler, Dennis F.
   Kealy, Richard D.
TI Antioxidant status of pair-fed Labrador Retrievers is affected by diet
   restriction and aging
SO JOURNAL OF NUTRITION
LA English
DT Article; Proceedings Paper
CT Purina-Pet-Institute Symposium on Advancing Life Through Diet
   Restriction
CY SEP 20-21, 2002
CL St Louis, MO
SP Purina Pet Inst
DE diet restriction; dogs; antioxidants; aging
ID VITAMIN-A; LIFE-SPAN; RETARDED GROWTH; SELENIUM STATUS; BLOOD-PLASMA;
   SERUM; ASCORBATE; URATE; ACID; DOGS
AB Twenty-four sibling pairs of 8-wk-old Labrador Retrievers were assigned to an experiment to determine the effects of diet restriction (75% of control-fed pair mate) on the quality and span of canine life and to identify biological markers of aging in dogs. The antioxidnt status of these dogs was monitored by annual assays for serum retinol (RT), retinyl palmitate (RP), total vitamin A (VA), vitamin E (VE), selenium (Se), copper (Cu), and ceruloplasmin (Cp), plasma ascorbic acid (AA), uric acid (UA), and total peroxyl-radical trapping activity (TRAP), and whole-blood glutathione peroxidase (Gpx). Data in this report are for the 6-y period of the experiment when the dogs were between 5 and 10 y of age. Diet restriction reduced RT, VE, Cu, and Cp. Aging was associated with decreased RP, VA, VE, Se, and Cu and with increased FIT, Cp, and Gpx. Female dogs had lower RP, VA, Cu, and Cp than male dogs. Litter effects were observed for VE, Cu, UA, and Gpx. Treatment effects on serum RT and Cu suggest that these variables are not as regulated homeostatically by hepatic storage as in most other species. Although the antioxidant profiles did not elucidate how diet restriction contributes to longevity, they have the potential to enhance our understanding of canine clinical nutrition and to have practical applications in formulating canine diets.
C1 Michigan State Univ, Owosso, MI 48867 USA.
   Nestle Purina Petcare Co, St Louis, MO 63164 USA.
C3 Michigan State University
RP Stowe, HD (corresponding author), Michigan State Univ, Owosso, MI 48867 USA.
EM hdstowe@msu.edu
CR AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x
   ANDERSON PH, 1979, VET REC, V104, P235, DOI 10.1136/vr.104.11.235
   [Anonymous], Z IMMUNITATSFORSCH
   [Anonymous], 1989, SAS STAT US GUID VER
   BAKER H, 1986, AM J VET RES, V47, P1468
   BARTGES JW, 1995, AM J VET RES, V56, P60
   BERGE G E, 1990, Norsk Veterinaertidsskrift, V102, P579
   CHEVALIER S, 1995, NUTR RES, V15, P859, DOI 10.1016/0271-5317(95)00051-J
   Chevalier S, 1996, FASEB J, V10, P1085, DOI 10.1096/fasebj.10.9.8801171
   DENNISON DB, 1977, J FOOD SCI, V42, P1376, DOI 10.1111/j.1365-2621.1977.tb14502.x
   Felice Lawrence J., 1990, Vet Clin Pathol, V19, P86, DOI 10.1111/j.1939-165X.1990.tb00549.x
   FERLAND G, 1992, J GERONTOL, V47, pB3, DOI 10.1093/geronj/47.1.B3
   FERREIRA H, 1987, Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, V39, P905
   Food and Drug Administration (FDA), 1987, FED REGISTER, V52, P10887
   Frei B, 1992, Molecular Biology of Free Radical Scavenging Systems, P23
   GILBERT PA, 1992, J AM ANIM HOSP ASSOC, V28, P407
   INGRAM DK, 1990, J GERONTOL, V45, pB148, DOI 10.1093/geronj/45.5.B148
   KEALY RD, 1992, J AM VET MED ASSOC, V201, P857
   Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315
   KEMNITZ JW, 1993, J GERONTOL, V48, pB17, DOI 10.1093/geronj/48.1.B17
   Lopez-Aguilar E, 1998, ARCH MED RES, V29, P313
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   McCay CM, 1939, J NUTR, V18, P1
   MONTASER A, 1992, P SOC EXP BIOL MED, V200, P321, DOI 10.3181/00379727-200-43437
   *NAT RES COUNC, 1985, COMM AN NUTR NUTR RE
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PFALZGRAF A, 1995, FETT WISS TECHNOL, V97, P159, DOI 10.1002/lipi.19950970408
   PIERI C, 1990, Bollettino Societa Italiana Biologia Sperimentale, V66, P909
   PILLAI SR, 1992, J COMP PATHOL, V107, P399, DOI 10.1016/0021-9975(92)90014-L
   REAMER DC, 1983, ANAL CHEM, V55, P1605, DOI 10.1021/ac00260a037
   Rous P, 1914, J EXP MED, V20, P433, DOI 10.1084/jem.20.5.433
   SANKARI S, 1985, ACTA VET SCAND, P1
   SCHOSINSKY KH, 1974, CLIN CHEM, V20, P1556
   SCHWEIGERT FJ, 1990, COMP BIOCHEM PHYS A, V95, P573, DOI 10.1016/0300-9629(90)90741-A
   SCHWEIGERT FJ, 1990, J VET MED A, V37, P605, DOI 10.1111/j.1439-0442.1990.tb00951.x
   SCHWEIGERT FJ, 1991, J VET MED A, V38, P35, DOI 10.1111/j.1439-0442.1991.tb00981.x
   STOWE HD, 1992, J ANIM SCI, V70, P3928, DOI 10.2527/1992.70123928x
   STOWE HD, 1985, J ANIM SCI, V60, P200, DOI 10.2527/jas1985.601200x
   TAYLOR A, 1995, EXP EYE RES, V61, P55, DOI 10.1016/S0014-4835(95)80058-1
   WASHKO PW, 1989, ANAL BIOCHEM, V181, P276, DOI 10.1016/0003-2697(89)90243-1
   WAYNER DDM, 1985, FEBS LETT, V187, P33, DOI 10.1016/0014-5793(85)81208-4
   WAYNER DDM, 1987, BIOCHIM BIOPHYS ACTA, V924, P408, DOI 10.1016/0304-4165(87)90155-3
   Weindruch R., 1988, RETARDATION AGING DI
   WHETTER PA, 1978, J ASSOC OFF ANA CHEM, V61, P927
   ZENTEK J, 1995, J VET MED A, V42, P69, DOI 10.1111/j.1439-0442.1995.tb00357.x
NR 45
TC 21
Z9 22
U1 3
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD JUL
PY 2006
VL 136
IS 7
BP 1844
EP 1848
DI 10.1093/jn/136.7.1844
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics
GA 057VV
UT WOS:000238624200015
PM 16772447
OA hybrid
DA 2024-02-19
ER

PT J
AU Wandt, VK
   Winkelbeiner, N
   Lossow, K
   Kopp, JF
   Schwarz, M
   Alker, W
   Nicolai, MM
   Simon, L
   Dietzel, C
   Hertel, B
   Pohl, G
   Ebert, F
   Schomburg, L
   Bornhorst, J
   Haase, H
   Kipp, AP
   Schwerdtle, T
AF Wandt, Viktoria K.
   Winkelbeiner, Nicola
   Lossow, Kristina
   Kopp, Johannes F.
   Schwarz, Maria
   Alker, Wiebke
   Nicolai, Merle M.
   Simon, Luise
   Dietzel, Caroline
   Hertel, Barbara
   Pohl, Gabriele
   Ebert, Franziska
   Schomburg, Lutz
   Bornhorst, Julia
   Haase, Hajo
   Kipp, Anna P.
   Schwerdtle, Tanja
TI Ageing-associated effects of a long-term dietary modulation of four
   trace elements in mice
SO REDOX BIOLOGY
LA English
DT Article; Early Access
DE Trace elements; Ageing; Sex; Redox status; Genome stability
   (maintenance)
ID BASE EXCISION-REPAIR; DNA-DAMAGE; OXIDATIVE STRESS; GENOMIC STABILITY;
   GENE-EXPRESSION; SELENIUM; IRON; AGE; ZINC; NRF2
AB Trace elements (TEs) are essential for diverse processes maintaining body function and health status. The complex regulation of the TE homeostasis depends among others on age, sex, and nutritional status. If the TE homeostasis is disturbed, negative health consequences can result, e.g., caused by impaired redox homeostasis and genome stability maintenance. Based on age-related shifts in TEs which have been described in mice wellsupplied with TEs, we aimed to understand effects of a long-term feeding with adequate or suboptimal amounts of four TEs in parallel. As an additional intervention, we studied mice which received an age-adapted diet with higher concentrations of selenium and zinc to counteract the age-related decline of both TEs. We conducted comprehensive analysis of diverse endpoints indicative for the TE and redox status, complemented by analysis of DNA (hydroxy)methylation and markers denoting genomic stability maintenance. TE concentrations showed age-specific alterations which were relatively stable and independent of their nutritional supply. In addition, hepatic DNA hydroxymethylation was significantly increased in the elderly mice and markers indicative for the redox status were modulated. The reduced nutritional supply with TEs inconsistently affected their status, with most severe effects regarding Fe deficiency. This may have contributed to the sex-specific differences observed in the alterations related to the redox status and DNA repair activity. Overall, our results highlight the complexity of factors impacting on the TE status and its physiological consequences. Alterations in TE supply, age, and sex proved to be important determinants that need to be taken into account when considering TE interventions for improving general health and supporting convalescence in the clinics.
C1 [Wandt, Viktoria K.; Winkelbeiner, Nicola; Kopp, Johannes F.; Simon, Luise; Hertel, Barbara; Pohl, Gabriele; Ebert, Franziska; Schwerdtle, Tanja] Univ Potsdam, Inst Nutr Sci, Dept Food Chem, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.
   [Wandt, Viktoria K.; Winkelbeiner, Nicola; Lossow, Kristina; Kopp, Johannes F.; Schwarz, Maria; Alker, Wiebke; Simon, Luise; Ebert, Franziska; Schomburg, Lutz; Bornhorst, Julia; Haase, Hajo; Kipp, Anna P.; Schwerdtle, Tanja] TraceAge DFG Res Unit Interact Essential Trace El, Berlin, Germany.
   [Lossow, Kristina; Schwarz, Maria; Kipp, Anna P.] Friedrich Schiller Univ Jena, Inst Nutr Sci, Dept Mol Nutr Physiol, Dornburger Str 24, D-07743 Jena, Germany.
   [Lossow, Kristina] German Inst Human Nutr, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.
   [Alker, Wiebke; Dietzel, Caroline; Haase, Hajo] Tech Univ Berlin, Chair Food Chem & Toxicol, Str 17 Juni 135, D-10623 Berlin, Germany.
   [Nicolai, Merle M.; Bornhorst, Julia] Univ Wuppertal, Fac Math & Nat Sci, Food Chem, Gaussstr 20, D-42119 Wuppertal, Germany.
   [Schomburg, Lutz] Charite Univ Med Berlin, Inst Expt Endocrinol, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Schomburg, Lutz] Free Univ Berlin, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Schomburg, Lutz] Humboldt Univ, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Schomburg, Lutz] Berlin Inst Hlth, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Schwerdtle, Tanja] German Fed Inst Risk Assessment BfR, Max Dohrn Str 8-10, D-10589 Berlin, Germany.
C3 University of Potsdam; Friedrich Schiller University of Jena; Deutsches
   Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Technical
   University of Berlin; University of Wuppertal; Free University of
   Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin
   Institute of Health; Federal Institute for Risk Assessment
RP Schwerdtle, T (corresponding author), Univ Potsdam, Inst Nutr Sci, Ur Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.
EM vwandt@uni-potsdam.de; winkelbeiner@uni-potsdam.de;
   kristina.lossow@uni-jena.de; research.jfkopp@posteo.de;
   schwarz.maria@uni-jena.de; alker@tu-berlin.de;
   merle.nicolai@uni-wuppertal.de; Luisesimon@gmx.net;
   carolinedietzel@gmx.de; bhertel@uni-potsdam.de; gpohl@uni-potsdam.de;
   fraebert@uni-potsdam.de; lutz.schomburg@charite.de;
   bornhorst@uni-wuppertal.de; haase@tu-berlin.de; anna.kipp@uni-jena.de;
   tanja.schwerdtle@uni-potsdam.de
RI Schomburg, Lutz/D-8096-2013; Nicolai, Merle/GRO-3615-2022; Haase,
   Hajo/B-9280-2009; Schwarz, Maria/KBA-4119-2024; Kopp, Johannes
   Florian/G-9269-2016
OI Schomburg, Lutz/0000-0001-9445-1555; Haase, Hajo/0000-0002-1622-8718;
   Kopp, Johannes Florian/0000-0001-9929-6937; Nicolai, Merle
   Marie/0000-0002-0950-4841; Kipp, Anna Patricia/0000-0002-3307-1038
FU German Research Foundation (DFG) Research Unit TraceAge [2558]; German
   Federal Ministry of Education and Research [FKS: 01EA1806B]
FX This research was funded by the German Research Foundation (DFG)
   Research Unit TraceAge (FOR 2558) and by the German Federal Ministry of
   Education and Research for the Competence Cluster NutriAct Nutrition
   Research Berlin-Potsdam (FKS: 01EA1806B).
CR Alker W, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20164006
   [Anonymous], 1973, World Health Organ Tech Rep Ser, V532, P1
   [Anonymous], 2011, INT J ALZHEIMERS DIS
   Aslan M, 2006, MUTAT RES-FUND MOL M, V601, P144, DOI 10.1016/j.mrfmmm.2006.06.013
   Azqueta A, 2013, ARCH TOXICOL, V87, P949, DOI 10.1007/s00204-013-1070-0
   Baudry J, 2020, EUR J NUTR, V59, P3045, DOI 10.1007/s00394-019-02143-w
   Bayele HK, 2015, FREE RADICAL BIO MED, V89, P1192, DOI 10.1016/j.freeradbiomed.2015.11.001
   Bornhorst J, 2018, TRAC-TREND ANAL CHEM, V104, P183, DOI 10.1016/j.trac.2017.11.007
   Brigelius-Flohé R, 2013, METHOD ENZYMOL, V527, P65, DOI 10.1016/B978-0-12-405882-8.00004-0
   Bürkle A, 2000, ANN NY ACAD SCI, V908, P126
   Cabelof DC, 2002, MUTAT RES-FUND MOL M, V500, P135, DOI 10.1016/S0027-5107(02)00003-9
   Cai ZL, 2019, AGING CLIN EXP RES, V31, P1035, DOI 10.1007/s40520-018-1086-7
   Cao L, 2017, J NUTR, V147, P1858, DOI 10.3945/jn.117.247775
   Cassandri M, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.71
   Chandrasena REP, 2008, CHEM RES TOXICOL, V21, P1324, DOI 10.1021/tx8000797
   Chen J, 2020, PFLUG ARCH EUR J PHY, V472, P1415, DOI 10.1007/s00424-020-02412-2
   Chen Y, 2020, BIOL TRACE ELEM RES, V195, P142, DOI 10.1007/s12011-019-01821-4
   Chhetri J, 2018, CURR ALZHEIMER RES, V15, P56, DOI 10.2174/1567205014666170203095802
   Combs GF, 2001, BRIT J NUTR, V85, P517, DOI 10.1079/BJN2000280
   Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019
   Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275
   Ferreira GC, 1999, INT J BIOCHEM CELL B, V31, P995, DOI 10.1016/S1357-2725(99)00066-7
   Finke H, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.202000325
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Florian S, 2010, FREE RADICAL BIO MED, V49, P1694, DOI 10.1016/j.freeradbiomed.2010.08.029
   Fu ZD, 2012, DRUG METAB DISPOS, V40, P1216, DOI 10.1124/dmd.111.044461
   Gaier ED, 2012, EXP GERONTOL, V47, P491, DOI 10.1016/j.exger.2012.03.014
   Giacconi R, 2017, EUR J NUTR, V56, P2457, DOI 10.1007/s00394-016-1281-2
   Gkouvatsos K, 2012, BBA-GEN SUBJECTS, V1820, P188, DOI 10.1016/j.bbagen.2011.10.013
   Gorniak JP, 2013, MUTAGENESIS, V28, P673, DOI 10.1093/mutage/get047
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   Gu JL, 2017, DIABETES, V66, P529, DOI 10.2337/db15-1274
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Hackler J, 2020, J TRACE ELEM MED BIO, V58, DOI 10.1016/j.jtemb.2019.126437
   Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002
   Hedrich HJ, 2012, LABORATORY MOUSE, P1
   Heitland P, 2018, INT J HYG ENVIR HEAL, V221, P564, DOI 10.1016/j.ijheh.2018.02.006
   Hill KE, 2007, J BIOL CHEM, V282, P10972, DOI 10.1074/jbc.M700436200
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811
   Hu R, 2004, J PHARMACOL EXP THER, V310, P263, DOI 10.1124/jpet.103.064261
   Jacob KD, 2013, MECH AGEING DEV, V134, P139, DOI 10.1016/j.mad.2013.02.008
   Jones DP, 2015, REDOX BIOL, V5, P71, DOI 10.1016/j.redox.2015.03.004
   Kerins MJ, 2018, ANTIOXID REDOX SIGN, V29, P1756, DOI 10.1089/ars.2017.7176
   Kopp JF, 2019, J TRACE ELEM MED BIO, V54, P221, DOI 10.1016/j.jtemb.2019.04.015
   Krehl S, 2012, CARCINOGENESIS, V33, P620, DOI 10.1093/carcin/bgr288
   Krezel A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061237
   Lima CF, 2005, J ETHNOPHARMACOL, V97, P383, DOI 10.1016/j.jep.2004.11.029
   Linder MC, 2001, MUTAT RES-FUND MOL M, V475, P141, DOI 10.1016/S0027-5107(01)00076-8
   Livingstone C, 2015, NUTR CLIN PRACT, V30, P371, DOI 10.1177/0884533615570376
   Ljubojevic M, 2019, J TRACE ELEM MED BIO, V53, P98, DOI 10.1016/j.jtemb.2019.02.010
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lossow K, 2020, AGING-US, V12, P13762, DOI 10.18632/aging.103572
   Lovell MA, 1998, NEUROLOGY, V51, P1562, DOI 10.1212/WNL.51.6.1562
   Lymbury R, 2008, BIOL TRACE ELEM RES, V126, pS1, DOI 10.1007/s12011-008-8208-6
   Ma SM, 2015, CELL REP, V13, P1319, DOI 10.1016/j.celrep.2015.10.014
   Malavolta M, 2010, BIOGERONTOLOGY, V11, P309, DOI 10.1007/s10522-009-9251-1
   Malbohan I M, 1997, Cas Lek Cesk, V136, P356
   Mangerich A, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/321653
   Maret W, 2013, ADV NUTR, V4, P82, DOI 10.3945/an.112.003038
   Martello R, 2013, ACS CHEM BIOL, V8, P1567, DOI 10.1021/cb400170b
   Maslov AY, 2013, AGING CELL, V12, P467, DOI 10.1111/acel.12071
   Massie H., 1979, CHANGES AGE COPPER C
   Méplan C, 2011, J TRACE ELEM MED BIO, V25, pS11, DOI 10.1016/j.jtemb.2010.10.002
   MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654
   Meyer S, 2018, J TRACE ELEM MED BIO, V49, P157, DOI 10.1016/j.jtemb.2018.05.012
   Mikkelsen L, 2009, FREE RADICAL BIO MED, V47, P608, DOI 10.1016/j.freeradbiomed.2009.05.030
   Minelli A, 2009, BBA-REV CANCER, V1795, P83, DOI 10.1016/j.bbcan.2008.11.001
   Mocchegiani E, 2013, AGE, V35, P839, DOI 10.1007/s11357-011-9377-3
   Mocchegiani E, 2012, AGE, V34, P539, DOI 10.1007/s11357-011-9252-2
   Moller P, 2020, NAT PROTOC, V15, P3817, DOI 10.1038/s41596-020-0398-1
   Müller M, 2010, GENES NUTR, V5, P297, DOI 10.1007/s12263-010-0168-8
   Müller SM, 2018, ARCH TOXICOL, V92, P1751, DOI 10.1007/s00204-018-2194-z
   Neumann C, 2020, J TRACE ELEM MED BIO, V57, P21, DOI 10.1016/j.jtemb.2019.09.001
   Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890
   OECD, 2016, TEST 489 VIV MAMM 4
   Ou HL, 2018, BLOOD, V131, P488, DOI 10.1182/blood-2017-07-746396
   Ozturk P, 2013, J TRACE ELEM MED BIO, V27, P312, DOI 10.1016/j.jtemb.2013.04.002
   Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919
   Prá D, 2012, MUTAT RES-FUND MOL M, V733, P92, DOI 10.1016/j.mrfmmm.2012.02.001
   Riese C, 2006, ENDOCRINOLOGY, V147, P5883, DOI 10.1210/en.2006-0689
   Ross David, 2018, Current Opinion in Toxicology, V7, P67, DOI 10.1016/j.cotox.2017.10.005
   Ross D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00595
   Schiesser S, 2013, J AM CHEM SOC, V135, P14593, DOI 10.1021/ja403229y
   Schmidlin CJ, 2019, FREE RADICAL BIO MED, V134, P702, DOI 10.1016/j.freeradbiomed.2019.01.016
   Schomburg L, 2007, BIOL CHEM, V388, P1035, DOI 10.1515/BC.2007.128
   Schwarz M, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101746
   Schwarz M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092112
   Schwerdtle T, 2007, MOL NUTR FOOD RES, V51, P201, DOI 10.1002/mnfr.200600107
   Seale LA, 2018, FREE RADICAL BIO MED, V127, P198, DOI 10.1016/j.freeradbiomed.2018.03.036
   Seo YA, 2013, NEUROTOXICOLOGY, V38, P67, DOI 10.1016/j.neuro.2013.06.002
   Sharif R, 2012, MUTAT RES-FUND MOL M, V733, P111, DOI 10.1016/j.mrfmmm.2011.08.009
   Shawki A, 2015, AM J PHYSIOL-GASTR L, V309, pG635, DOI 10.1152/ajpgi.00160.2015
   Speckmann B, 2017, J NUTR BIOCHEM, V48, P112, DOI 10.1016/j.jnutbio.2017.07.002
   Sun Q, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061894
   Swain U, 2011, MECH AGEING DEV, V132, P374, DOI 10.1016/j.mad.2011.04.012
   Takahashi S, 2015, MOL MED REP, V12, P795, DOI 10.3892/mmr.2015.3459
   Tammen Stephanie A, 2014, J Cancer Prev, V19, P301, DOI [10.15430/JCP.2014.19.4.301, 10.15430/JCP.2014.19.2.301]
   Tian F, 2009, REJUV RES, V12, P209, DOI 10.1089/rej.2009.0849
   Vermeij WP, 2016, ANNU REV PHARMACOL, V56, P427, DOI 10.1146/annurev-pharmtox-010814-124316
   VUORI E, 1978, SCAND J WORK ENV HEA, V4, P167, DOI 10.5271/sjweh.2712
   Wandt VK, 2021, REDOX BIOL, V41, DOI 10.1016/j.redox.2021.101877
   Wedler N, 2021, CHEM RES TOXICOL, V34, P839, DOI 10.1021/acs.chemrestox.0c00452
   Winkelbeiner N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186600
   Wong CP, 2013, J NUTR BIOCHEM, V24, P353, DOI 10.1016/j.jnutbio.2012.07.005
   WOODWARD WD, 1984, J GERONTOL, V39, P521, DOI 10.1093/geronj/39.5.521
   World Health Organization, 2015, The Global prevalence of Anaemia in 2011
   Ye Q, 2017, METALLOMICS, V9, P1028, DOI 10.1039/c7mt00079k
   Yiannikourides Andronicos, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6030085
   Zhang Dan, 2012, J Circadian Rhythms, V10, P5, DOI 10.1186/1740-3391-10-5
   Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P2038, DOI 10.1016/j.freeradbiomed.2012.02.042
   Zhang QR, 2020, BIOL TRACE ELEM RES, V194, P203, DOI 10.1007/s12011-019-01762-y
   Zhao BL, 2014, NUCLEIC ACIDS RES, V42, P1593, DOI 10.1093/nar/gkt1090
   Zhou L, 2018, REDOX BIOL, V14, P35, DOI 10.1016/j.redox.2017.08.014
   Zhou XD, 2012, J NUTR BIOCHEM, V23, P532, DOI 10.1016/j.jnutbio.2011.02.008
NR 117
TC 4
Z9 4
U1 0
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
J9 REDOX BIOL
JI Redox Biol.
PD 2021 OCT
PY 2021
VL 46
AR 102083
DI 10.1016/j.redox.2021.102083
EA AUG 2021
PG 16
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA WA4HJ
UT WOS:000702847500003
PM 34371368
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhu, M
   de Cabo, R
   Anson, RM
   Ingram, DK
   Lane, MA
AF Zhu, M
   de Cabo, R
   Anson, RM
   Ingram, DK
   Lane, MA
TI Caloric restriction modulates insulin receptor signaling in liver and
   skeletal muscle of rat
SO NUTRITION
LA English
DT Article
DE caloric restriction; tyrosine phosphorylation; insulin receptor; protein
   tyrosine phosphatase-1B
ID PROTEIN-TYROSINE PHOSPHATASE-1B; COMPLEMENT-RELATED PROTEIN; LIFE-SPAN;
   CAENORHABDITIS-ELEGANS; METABOLIC SYNDROME; DIABETES-MELLITUS;
   ADIPOSE-TISSUE; RHESUS-MONKEYS; MICE LACKING; RESISTANCE
AB Objective: We investigated how the insulin/insulin-like growth factor-1 signaling pathway is involved in the robust antiaging effects produced by caloric restriction.
   Methods: We subjected male rats to feeding ad libitum or calorie restriction, i.e., 60% of the ad libitum amount, for 2 and 25 mo and then assessed the effects of calorie restriction on insulin receptor (IR) signaling in liver and skeletal muscle.
   Results: The results indicated that aging was accompanied by a significant decrease in IR tyrosine phosphorylation after insulin stimulation in live and skeletal muscle, which was associated with a significant increase in the activity of protein tyrosine phosphatase-1B. However, these age-related alterations were attenuated by long-term calorie restriction. Expression profile of mRNA showed an increased expression of mRNAs for IR and insulin-like growth factor-1 receptor in both tissues of calorie-restricted rats, but increased expression of IR mRNA was dissociated with the IR gene product in rats maintained on long-term calorie-restricted diet.
   Conclusion: IR signaling may play an important role in aging and its retardation by calorie restriction, and normal function of IR in liver and skeletal muscle is required for healthy aging and extending lifespan in mammals. (C) 2005 Elsevier Inc. All rights reserved.
C1 NIA, Lab Expt Gerontol, Gerontol Res Ctr, Intramural Res Program, Baltimore, MD 21224 USA.
   Merck & Co Inc, Rahway, NJ 07065 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); Merck & Company
RP Ingram, DK (corresponding author), NIA, Lab Expt Gerontol, Gerontol Res Ctr, Intramural Res Program, Baltimore, MD 21224 USA.
EM ingramd@grc.nia.nih.gov
RI de Cabo, Rafael Carlos/E-7996-2010; de Cabo, Rafael/J-5230-2016
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo,
   Rafael/0000-0002-3354-2442; Anson, Robert/0000-0002-7913-3644
CR Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106
   Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1
   Baudry A, 2002, EMBO REP, V3, P323, DOI 10.1093/embo-reports/kvf078
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Blüher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5
   Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0
   BUTLER RN, 2003, J GERONTOL A-BIOL, V58, pB581
   Byon JCH, 1998, MOL CELL BIOCHEM, V182, P101, DOI 10.1023/A:1006868409841
   Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120
   Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662
   Dreyfuss G, 1996, CELL, V85, P963, DOI 10.1016/S0092-8674(00)81298-2
   Egawa K, 2001, J BIOL CHEM, V276, P10207, DOI 10.1074/jbc.M009489200
   Elahi D, 2002, NOVART FDN SYMP, V242
   Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544
   Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407
   Friedman JE, 1997, AM J PHYSIOL-ENDOC M, V273, pE1014, DOI 10.1152/ajpendo.1997.273.5.E1014
   Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798
   GULVE EA, 1993, AM J PHYSIOL, V264, pE319, DOI 10.1152/ajpendo.1993.264.3.E319
   HANSEN BC, 1993, DIABETES, V42, P1809, DOI 10.2337/diabetes.42.12.1809
   Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126
   Hribal ML, 2002, AM J PHYSIOL-ENDOC M, V282, pE977, DOI 10.1152/ajpendo.00561.2001
   Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kennedy BP, 2000, BIOCHEM PHARMACOL, V60, P877, DOI 10.1016/S0006-2952(00)00305-1
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   Kirkland JL, 2002, CLIN GERIATR MED, V18, P383, DOI 10.1016/S0749-0690(02)00023-X
   Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000
   Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2
   LARSEN PL, 1995, GENETICS, V139, P1567
   Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2
   Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139
   MADISON LL, 1960, METABOLISM, V9, P97
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x
   MCCAY CM, 1989, NUTRITION, V5, P155
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   MULLERWIELAND D, 1993, EXP CLIN ENDOCRINOL, V101, P17
   NADIV O, 1994, BIOCHEM J, V298, P443, DOI 10.1042/bj2980443
   OKAUCHI N, 1995, DIABETES RES CLIN PR, V27, P97, DOI 10.1016/0168-8227(95)01029-D
   Pender C, 2002, METABOLISM, V51, P465, DOI 10.1053/meta.2002.31327
   Perls T, 2002, J MOL NEUROSCI, V19, P233, DOI 10.1007/s12031-002-0039-x
   REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473
   Rondinone CM, 2002, DIABETES, V51, P2405, DOI 10.2337/diabetes.51.8.2405
   Roth GS, 2001, ANN NY ACAD SCI, V928, P305
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   WERTHEIMER E, 1993, NAT GENET, V5, P71, DOI 10.1038/ng0993-71
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Ye JM, 2003, AM J PHYSIOL-ENDOC M, V284, pE531, DOI 10.1152/ajpendo.00299.2002
   Youngren JF, 2001, J APPL PHYSIOL, V91, P2240, DOI 10.1152/jappl.2001.91.5.2240
   Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199
NR 58
TC 26
Z9 32
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD MAR
PY 2005
VL 21
IS 3
BP 378
EP 388
DI 10.1016/j.nut.2004.06.030
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 915DH
UT WOS:000228277400015
PM 15797682
DA 2024-02-19
ER

PT J
AU Martínez-Lara, E
   Siles, E
   Hernández, R
   Cañuelo, AR
   del Moral, ML
   Jiménez, A
   Blanco, S
   López-Ramos, JC
   Esteban, FJ
   Pedrosa, JA
   Peinado, MA
AF Martínez-Lara, E
   Siles, E
   Hernández, R
   Cañuelo, AR
   del Moral, ML
   Jiménez, A
   Blanco, S
   López-Ramos, JC
   Esteban, FJ
   Pedrosa, JA
   Peinado, MA
TI Glutathione <i>S</i>-transferase isoenzymatic response to aging in rat
   cerebral cortex and cerebellum
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE aging; glutathione transferase isoenzymes; cerebral cortex; cerebellum;
   glia; oxidative stress
ID LIPID-PEROXIDATION; OXIDATIVE DAMAGE; BRAIN; BINDING; LIVER;
   LOCALIZATION; NEURONS; AGE; IDENTIFICATION; CONJUGATION
AB Aging is associated with increased oxidant generation. One mechanism involved in the defense of oxidative products is the family of glutathione transferases (GST). We have analyzed the activity, distribution and expression of GSTP1 and GSTA4 isoenzymes in the cerebral cortex and cerebellum of young, adult and aged rats. The total GST activity, measured with the universal substrate 1-chloro-2,4-dinitrobenzene (CDNB), increased only with the maturation process; however GSTA4 activity, using the specific substrate 4-hydroxynonenal (HNE), did show an age-dependent increase in both brain regions. Cellular location of GSTA4 in astrocytes was not changed except for young cerebral cortex and adult/aged cerebellum that also showed immunoreactivity in layer III pyramidal neurons and Bergman radial glia, respectively. Distribution of GSTP1 was similar among groups and only an increased number of positive oligodendrocytes was found in the Purkinje and granular layer of adult/aged cerebellum. The GSTA4 and GSTP1 expression increased from young to adult/aged brain and GSTA4 even augmented in the aged cerebral cortex. These results suggest a GST isoenzymatic response with aging, but above all with the maturation process. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Univ Jaen, Dept Expt Biol, Jaen 23071, Spain.
C3 Universidad de Jaen
RP Peinado, MA (corresponding author), Univ Jaen, Dept Expt Biol, Paraje Lagunillas S-N, Jaen 23071, Spain.
EM apeinado@ujaen.es
RI Esteban, Francisco J./H-5504-2015; Pedrosa, Juan Ángel/G-9951-2015;
   Blanco, Santos/R-9080-2019; Ramos, Juan Carlos López/K-9336-2014;
   Martínez-Lara, Esther/ABG-3428-2020
OI Esteban, Francisco J./0000-0002-7135-2973; Blanco,
   Santos/0000-0002-4686-5320; Martínez-Lara, Esther/0000-0002-4962-3634;
   Pedrosa Raya, Juan Angel/0000-0003-1752-2799; Peinado, Maria
   Angeles/0000-0003-3136-0706; Lopez Ramos, Juan
   Carlos/0000-0003-0943-8802; Siles Rivas, Eva/0000-0003-4192-7008;
   Canuelo Navarro, Ana Rosa/0000-0001-5626-4484
CR ABRAMOVITZ M, 1988, J NEUROCHEM, V50, P50, DOI 10.1111/j.1471-4159.1988.tb13228.x
   Ahlgren-Beckendorf JA, 1999, GLIA, V25, P131, DOI 10.1002/(SICI)1098-1136(19990115)25:2<131::AID-GLIA4>3.0.CO;2-6
   ALIN P, 1985, FEBS LETT, V179, P267, DOI 10.1016/0014-5793(85)80532-9
   ARIAS IM, 1980, MOL CELL BIOCHEM, V29, P71
   Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915
   BERHANE K, 1994, P NATL ACAD SCI USA, V91, P1480, DOI 10.1073/pnas.91.4.1480
   BLANCO S, UNPUB MECH AGING DEV
   Board PG, 1997, BIOCHEM J, V328, P929
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURGESS JR, 1987, BIOCHEM BIOPH RES CO, V142, P441, DOI 10.1016/0006-291X(87)90294-4
   CAMMER W, 1989, J NEUROCHEM, V52, P876, DOI 10.1111/j.1471-4159.1989.tb02536.x
   Chung YH, 2000, BRAIN RES, V885, P137, DOI 10.1016/S0006-8993(00)02979-6
   DANH HC, 1983, J NEUROCHEM, V40, P1003, DOI 10.1111/j.1471-4159.1983.tb08084.x
   DANIELSON UH, 1987, BIOCHEM J, V247, P707, DOI 10.1042/bj2470707
   DAS M, 1981, J NEUROCHEM, V36, P1439, DOI 10.1111/j.1471-4159.1981.tb00584.x
   Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X
   Fukuda A, 1997, BIOCHEM BIOPH RES CO, V236, P505, DOI 10.1006/bbrc.1997.6585
   Gopal PV, 2000, GERONTOLOGY, V46, P7, DOI 10.1159/000022126
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001
   Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491
   Hiratsuka A, 1997, ANAL BIOCHEM, V252, P229, DOI 10.1006/abio.1997.2316
   Hollensworth SB, 2000, FREE RADICAL BIO MED, V28, P1161, DOI 10.1016/S0891-5849(00)00214-8
   HOMMA H, 1986, BIOCHEM J, V235, P763, DOI 10.1042/bj2350763
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JOHNSON JA, 1993, J NEUROSCI, V13, P2013
   JUUNRLINK BHJ, 1996, BRAIN RES, V710, P229
   JUUNRLINK BHJ, 1997, NEUROSCI BIOBEHAV R, V21, P151
   Kaur J, 2001, NEUROSCI LETT, V301, P1, DOI 10.1016/S0304-3940(01)01576-2
   Ketterer B., 1988, P73
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LISTOWSKY I, 1988, DRUG METAB REV, V19, P305, DOI 10.3109/03602538808994138
   MANNERVIK B, 1984, FEBS LETT, V175, P289, DOI 10.1016/0014-5793(84)80753-X
   MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202
   MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226
   MARUYAMA H, 1984, J BIOL CHEM, V259, P2449
   MEYER DJ, 1982, FEBS LETT, V150, P499, DOI 10.1016/0014-5793(82)80798-9
   MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409
   MO JQ, 1995, MECH AGEING DEV, V81, P73, DOI 10.1016/0047-6374(95)01586-O
   Nakaso K, 2000, NEUROSCI LETT, V282, P57, DOI 10.1016/S0304-3940(00)00836-3
   Peinado MA, 1997, ANAT REC, V247, P420
   Peinado MA, 2000, REV NEUROLOGIA, V31, P1054, DOI 10.33588/rn.3111.2000382
   PEINADO MA, 1988, MICROSC RES TECHNIQ, V43, P1
   Peinado Maria Angeles, 2002, P3
   Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749
   PHILBERT MA, 1991, TOXICOL APPL PHARM, V107, P215, DOI 10.1016/0041-008X(91)90204-R
   PINTO RE, 1969, BIOCHEM J, V112, P109, DOI 10.1042/bj1120109
   SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1
   SINGHAL SS, 1994, ARCH BIOCHEM BIOPHYS, V311, P242, DOI 10.1006/abbi.1994.1233
   SLIVKA A, 1987, BRAIN RES, V409, P275, DOI 10.1016/0006-8993(87)90712-8
   Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/S0361-9230(96)00159-1
   TANSEY FA, 1991, J NEUROCHEM, V57, P95, DOI 10.1111/j.1471-4159.1991.tb02104.x
   Tjalkens RB, 1998, ARCH BIOCHEM BIOPHYS, V359, P42, DOI 10.1006/abbi.1998.0895
   TSUCHIDA S, 1987, EUR J BIOCHEM, V170, P159, DOI 10.1111/j.1432-1033.1987.tb13681.x
   VERTECHY M, 1993, EXP GERONTOL, V28, P77, DOI 10.1016/0531-5565(93)90022-6
   Wilson E, 1997, CHEM ENG NEWS, V75, P10
   Xie CS, 2001, FREE RADICAL BIO MED, V31, P73, DOI 10.1016/S0891-5849(01)00553-6
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
NR 59
TC 30
Z9 32
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0197-4580
EI 1558-1497
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD MAY-JUN
PY 2003
VL 24
IS 3
BP 501
EP 509
AR PII S0197-4580(02)00139-2
DI 10.1016/S0197-4580(02)00139-2
PG 9
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA 654FT
UT WOS:000181484100011
PM 12600725
DA 2024-02-19
ER

PT J
AU Kalaiselvi, T
   Panneerselvam, C
AF Kalaiselvi, T
   Panneerselvam, C
TI Effect of L-carnitine on the status of lipid peroxidation and
   antioxidants in aging rats
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE L-carnitine; aging; antioxidants; lipid peroxidation
ID ANIMAL-TISSUES; GLUTATHIONE; ASSAY; LIVER; HEART; AGE; DECREASE
AB The effect of L-carnitine on lipid peroxidation and antioxidant status has been studied in blood, liver, and kidney of young and aged mts. In the aged rats, level of lipid peroxidation was considerably high, while the antioxidants superoxide dismutase, catalase, glutathione peroxidase, vitamin C, and vitamin E reduced glutathione, and total thiols were low. The L-carnitine was administered by i.p. injection (300 mg/kg body weight/day) for 7, 14, and 21 days. Supplementation of aged rats with L-carnitine demonstrated a time-dependent normalization of abnormally elevated lipid peroxides and of subnormal antioxidant status. Carnitine administration to young rats has brought reduction in lipid peroxidation and elevation in glutathione peroxidase activity and ascorbic acid content. From our observations we conclude that as carnitine is very effective in normalizing age-associated alterations, it can be implemented in the aged to minimize age-associated disorders where free radicals are the major cause. (C) Elsevier Science Inc. 1998.
C1 Univ Madras, Dr ALM Postgrad Inst Basic Med Sci, Dept Med Biochem, Madras 600113, Tamil Nadu, India.
C3 University of Madras
RP Panneerselvam, C (corresponding author), Univ Madras, Dr ALM Postgrad Inst Basic Med Sci, Dept Med Biochem, Madras 600113, Tamil Nadu, India.
CR ALVAREZ E, 1995, BIOCHEM J, V312, P555, DOI 10.1042/bj3120555
   ARDUINI A, 1992, AM HEART J, V123, P1726, DOI 10.1016/0002-8703(92)90850-U
   BELLEI M, 1989, BIOCHEM BIOPH RES CO, V158, P181, DOI 10.1016/S0006-291X(89)80195-0
   BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420
   CELINE VJ, 1992, BIOMEDICINE, V12, P22
   CHIU D, 1982, FREE RADICALS BIOL, P115
   CONTI P, 1994, MOL CELL BIOCHEM, V131, P1, DOI 10.1007/BF01075718
   COSTELL M, 1989, BIOCHEM BIOPH RES CO, V161, P1135, DOI 10.1016/0006-291X(89)91360-0
   DELIONARDIS V, 1985, INT J CLIN PHARM RES, V5, P137
   DESAI ID, 1984, METHOD ENZYMOL, V105, P138, DOI 10.1016/S0076-6879(84)05019-9
   Haber F., 1935, P ROYAL SOC LONDON, VA147, P332, DOI [DOI 10.1098/rspa.1934.0221, 10.1098/rspa.1934.0221]
   HALLIWELL B, 1992, J LAB CLIN MED, V119, P598
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Jayachandran M, 1996, J NUTR BIOCHEM, V7, P270, DOI 10.1016/0955-2863(96)00027-7
   KHAIRALLAH EA, 1965, J NUTR, V87, P469, DOI 10.1093/jn/87.4.469
   LOEPER J, 1983, IRCS MED SCI-BIOCHEM, V11, P1034
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Omaye S. T., 1979, METHOD ENZYMOL, P3, DOI [DOI 10.1016/0076-6879(79)62181-X, 10.1016/0076-6879(79)62181-X, 10.1016/0076-6879(79)62181-x]
   PAULSON DJ, 1992, MOL CELL BIOCHEM, V116, P131, DOI 10.1007/BF01270580
   PEARSON DT, 1977, METHOD ENZYMAT AN, V4, P1758
   QUIST EE, 1980, BIOCHEM BIOPH RES CO, V92, P631, DOI 10.1016/0006-291X(80)90380-0
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   REBOUCHE CJ, 1991, AM J CLIN NUTR, V54, pS1147, DOI 10.1093/ajcn/54.6.1147s
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7
   SOM S, 1981, METABOLISM, V30, P573
   SUSHAMAKUMARI S, 1989, INDIAN J EXP BIOL, V27, P134
   YU PB, 1994, PHYSIOL REV, V74, P134
NR 33
TC 115
Z9 127
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0955-2863
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD OCT
PY 1998
VL 9
IS 10
BP 575
EP 581
DI 10.1016/S0955-2863(98)00052-7
PG 7
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 126NR
UT WOS:000076300500005
DA 2024-02-19
ER

PT J
AU Abenavoli, L
   Peta, V
   Milic, N
AF Abenavoli, Ludovico
   Peta, Valentina
   Milic, Natasa
TI Lifestyle changes associated with a new antioxidant formulation in
   non-alcoholic fatty liver disease: a case series
SO ANNALS OF HEPATOLOGY
LA English
DT Article
DE Non-alcoholic fatty liver disease; Steatosis; Mediterranean diet;
   Antioxidant; Insulin resistance
ID MILK THISTLE; STEATOHEPATITIS; EPIDEMIOLOGY; GUIDELINES; MANAGEMENT;
   PROTOPINE; SEVERITY; DIET
AB Non-alcoholic fatty liver disease (NAFLD) is a relevant issue in public health owing to its epidemiological burden. It represents the most common chronic liver disease in the general population and is expected to increase in future as a result of an ageing population. The only currently recommended treatment for NAFLD is lifestyle modification. However, literature reports pre-clinical and clinical studies on the use of antioxidant supplementation in NAFLD. A new antioxidant complex, called Bilirel (BIL) (Pharmaluce, Republic of San Marino), have recently introduced in the Italian market. However no data are reported on his effects on liver steatosis. Here we report on a cases series of seven overweight patients with NAFLD, in which the association of an Italian Mediterranean diet, increased physical activity, and daily administration of two pills of BIL for 6 weeks, have induced the rapid improvement of fatty liver accumulation, glucose and lipid metabolism, and weight reduction.
C1 [Abenavoli, Ludovico; Peta, Valentina] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy.
   [Milic, Natasa] Univ Novi Sad, Dept Pharm, Novi Sad 21000, Serbia.
C3 Magna Graecia University of Catanzaro; University of Novi Sad
RP Abenavoli, L (corresponding author), Magna Graecia Univ Catanzaro, Dept Hlth Sci, Viate Europa Germaneto, I-88100 Catanzaro, Italy.
EM l.abenavoli@unicz.it
RI Abenavoli, Ludovico/J-4394-2019
OI Abenavoli, Ludovico/0000-0002-5922-1524; Milic,
   Natasa/0000-0002-8595-6065
CR Abenavoli L, 2014, PANMINERVA MED, V56, P189
   Abenavoli L, 2013, ANN HEPATOL, V12, P357, DOI 10.1016/S1665-2681(19)30997-4
   Abenavoli L, 2010, PHYTOTHER RES, V24, P1423, DOI 10.1002/ptr.3207
   Bae DS, 2012, BMB REP, V45, P108, DOI 10.5483/BMBRep.2012.45.2.108
   Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080
   Cacciapuoti F, 2013, WORLD J HEPATOL, V5, P109, DOI 10.4254/wjh.v5.i3.109
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   De Lorenzo A, 2010, CURR PHARM DESIGN, V16, P814, DOI 10.2174/138161210790883561
   Fan JG, 2011, J DIGEST DIS, V12, P38, DOI 10.1111/j.1751-2980.2010.00476.x
   Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x
   Fruci B, 2013, INT J MOL SCI, V14, P22933, DOI 10.3390/ijms141122933
   Guerrero-Romero F, 2010, J CLIN ENDOCR METAB, V95, P3347, DOI 10.1210/jc.2010-0288
   Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x
   Kalhan SC, 2011, CLIN SCI, V121, P179, DOI 10.1042/CS20110060
   Loguercio C, 2012, FREE RADICAL BIO MED, V52, P1658, DOI 10.1016/j.freeradbiomed.2012.02.008
   Loria P, 2010, DIGEST LIVER DIS, V42, P272, DOI 10.1016/j.dld.2010.01.021
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/702196, 10.1155/2013/801457]
   Milic N, 2013, NAT PROD COMMUN, V8, P1801
   Milic S, 2012, DIGEST DIS, V30, P158, DOI 10.1159/000336669
   Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044
   Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10
   Oni ET, 2013, ATHEROSCLEROSIS, V230, P258, DOI 10.1016/j.atherosclerosis.2013.07.052
   Paz G, 2013, J MOL ENDOCRINOL, V51, P167, DOI 10.1530/JME-13-0072
   Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008
   Rouabhia S, 2014, EXPERT REV GASTROENT, V8, P343, DOI 10.1586/17474124.2014.894880
   Sofi F, 2014, WORLD J GASTROENTERO, V20, P7339, DOI 10.3748/wjg.v20.i23.7339
   Tarantino G, 2013, WORLD J GASTROENTERO, V19, P3375, DOI 10.3748/wjg.v19.i22.3375
   Vrba J, 2011, TOXICOL LETT, V203, P135, DOI 10.1016/j.toxlet.2011.03.015
   Williams KH, 2013, ENDOCR REV, V34, P84, DOI 10.1210/er.2012-1009
NR 31
TC 3
Z9 3
U1 0
U2 5
PU MEXICAN ASSOC HEPATOLOGY
PI MEXICO
PA PUNTE DE PIEDRA 150, COLONIA TORIELLO GUERRA, MEXICO, DF CP 14040,
   MEXICO
SN 1665-2681
J9 ANN HEPATOL
JI Ann. Hepatol.
PD JAN-FEB
PY 2015
VL 14
IS 1
BP 121
EP 126
DI 10.1016/S1665-2681(19)30809-9
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CD2JM
UT WOS:000350903700014
PM 25536650
OA hybrid
DA 2024-02-19
ER

PT J
AU Kilic, N
   Yildirim, Z
AF Kilic, Nedret
   Yildirim, Zuhal
TI Effects of Taurine and Age on Liver Antioxidant Status and Protein
   Oxidation
SO TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
LA English
DT Article; Proceedings Paper
CT 5th European Congress of Biogerontology
CY SEP 16-20, 2006
CL Istanbul, TURKEY
DE Aging; Taurine; Oxidative stress; Antioxidants
ID LIPID-PEROXIDATION; SKELETAL-MUSCLE; STRESS; COPPER; ZINC; GLUTATHIONE;
   ENZYMES; DAMAGE; BRAIN; BIOSYNTHESIS
AB Purpose: The aim of the study was to investigate the effects of taurine on advanced oxidation protein products, protein carbonyl groups, superoxide dismutase, zinc and copper in young and middle-aged rat liver. Materials and
   Methods: Middle-aged (13-14 months of age) male albino Wistar rats were divided into two groups as the middle-aged control and the middle-aged taurine groups. Young (6-7 weeks of age) male albino Wistar rats were divided into two groups as the young control and the young taurine groups. While the rats in the control groups were given 0.5 mL of isotonic sodium chloride, the others were given taurine intraperitonally at a single dose of 200 mg/kg/day for 7 days.
   Results: Liver protein carbonyl group levels were significantly lower in the taurine group of middle-aged rats when compared to the middle-aged control group (p<0.05). The liver advanced oxidation protein product levels were decreased in the taurine group of middle-aged rats when compared to the middle-aged control group. However, the liver advanced oxidation protein product levels between the taurine group of middle-aged rats and the control group of middle-aged rats was not significant (p>0.05). The liver superoxide dismutase activity was significantly increased in taurine group of middle-aged rats when compared to the control group of middle-aged rats (p<0.05).
   Conclusion: The results of the present study suggested that exogenous taurine may delay the aging process of tissues by means of its free radical scavenging effects.
C1 [Kilic, Nedret; Yildirim, Zuhal] Gazi Univ, Fac Med, Dept Med Biochem, TR-06500 Ankara, Turkey.
C3 Gazi University
RP Kilic, N (corresponding author), Gazi Univ, Fac Med, Dept Med Biochem, TR-06500 Ankara, Turkey.
EM nedretk@gazi.edu.tr
RI KILIÇ, NEDRET/AAK-5395-2021
CR BANKS MA, 1992, ADV EXP MED BIOL, V315, P341
   Butterfield DA, 2001, MECH AGEING DEV, V122, P945, DOI 10.1016/S0047-6374(01)00249-4
   Cai QY, 1996, EXP GERONTOL, V31, P373, DOI 10.1016/0531-5565(95)02027-6
   Çakatay U, 2003, CLIN BIOCHEM, V36, P51, DOI 10.1016/S0009-9120(02)00407-1
   Çakatay U, 2001, EXP GERONTOL, V36, P221, DOI 10.1016/S0531-5565(00)00197-2
   CEBALLOSPICOT I, 1992, MUTAT RES, V275, P281, DOI 10.1016/0921-8734(92)90032-K
   Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006
   Coudray C, 2006, J TRACE ELEM MED BIO, V20, P73, DOI 10.1016/j.jtemb.2005.10.007
   DAVIES KJ, 1995, BIOCH SOC S, V61, P31
   DELAROSA J, 1985, COMP BIOCHEM PHYS B, V81, P565, DOI 10.1016/0305-0491(85)90367-0
   Domínguez C, 1999, DIABETES CARE, V22, P871
   DURSUN N, 1995, JPN J PHYSIOL, V45, P197, DOI 10.2170/jjphysiol.45.197
   Eppler B, 2001, BIOCHEM PHARMACOL, V62, P29, DOI 10.1016/S0006-2952(01)00647-5
   FLAGG EW, 1993, BRIT J NUTR, V70, P797, DOI 10.1079/BJN19930175
   Gomi F, 1998, J GERONTOL A-BIOL, V53, pB161, DOI 10.1093/gerona/53A.3.B161
   Halliwell B, 1997, NUTR REV, V55, pS44, DOI 10.1111/j.1753-4887.1997.tb06100.x
   Kim HG, 2003, MOL CELLS, V16, P278
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   Koti RS, 2005, FASEB J, V19, P1155, DOI 10.1096/fj.04-3220fje
   Kowluru RA, 1997, FREE RADICAL BIO MED, V22, P587, DOI 10.1016/S0891-5849(96)00347-4
   Lallemand F, 2004, AMINO ACIDS, V26, P111, DOI 10.1007/s00726-003-0058-0
   LEEUWENBURGH C, 1995, ARCH BIOCHEM BIOPHYS, V316, P941, DOI 10.1006/abbi.1995.1125
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martín-Gallán P, 2003, FREE RADICAL BIO MED, V34, P1563, DOI 10.1016/S0891-5849(03)00185-0
   Matés JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1
   Mezzetti A, 1998, FREE RADICAL BIO MED, V25, P676, DOI 10.1016/S0891-5849(98)00109-9
   MILNE DB, 1990, NUTR RES, V10, P975, DOI 10.1016/S0271-5317(05)80039-9
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   Mosoni L, 2004, EXP GERONTOL, V39, P203, DOI 10.1016/j.exger.2003.10.014
   NAKASHIMA T, 1982, JPN J PHARMACOL, V32, P583, DOI 10.1254/jjp.32.583
   Olivares-Corichi IM, 2005, FRONT BIOSCI-LANDMRK, V10, P838, DOI 10.2741/1577
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   Pansarasa O, 2000, FREE RADICAL RES, V33, P287, DOI 10.1080/10715760000301451
   PONCZEK MB, 2005, INTERACTION REACTIVE, V51, P140
   Pushpakiran G, 2004, AMINO ACIDS, V27, P91, DOI 10.1007/s00726-004-0066-8
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Schmuck A, 1996, J AM COLL NUTR, V15, P462
   SOHAL RS, 1995, MECH AGEING DEV, V81, P15, DOI 10.1016/0047-6374(94)01578-A
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   Stadtman ER, 2004, CURR MED CHEM, V11, P1105, DOI 10.2174/0929867043365341
   SUN Y, 1988, CLIN CHEM, V34, P497
   Tas S, 2006, CELL BIOCHEM FUNCT, V24, P153, DOI 10.1002/cbf.1198
   TERAMOTO S, 1994, LUNG, V172, P223, DOI 10.1007/BF00164439
   Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018
   Waters E, 2001, AM J PHYSIOL-GASTR L, V280, pG1274, DOI 10.1152/ajpgi.2001.280.6.G1274
   WEISSMAN N, 1974, CLIN CHEM PRINCIPLES, P699
   WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186
   Yildirim ZL, 2007, ANN NY ACAD SCI, V1100, P553, DOI 10.1196/annals.1395.061
   ZHANG JR, 1993, J NEUROCHEM, V61, P1640, DOI 10.1111/j.1471-4159.1993.tb09798.x
NR 51
TC 10
Z9 10
U1 0
U2 3
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0250-4685
EI 1303-829X
J9 TURK J BIOCHEM
JI Turk. J. Biochem.
PY 2008
VL 33
IS 4
BP 169
EP 174
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology
GA 426YZ
UT WOS:000264746100007
DA 2024-02-19
ER

PT J
AU Guan, YL
   Zhao, X
   Song, N
   Cui, Y
   Chang, Y
AF Guan, Yalin
   Zhao, Xia
   Song, Nuan
   Cui, Yuan
   Chang, Ying
TI Albicanol antagonizes Cd-induced apoptosis through a NO/iNOS-regulated
   mitochondrial pathway in chicken liver cells
SO FOOD & FUNCTION
LA English
DT Article
AB Cadmium (Cd) induces hepatocyte injury by oxidative stress. Albicanol is a sesquiterpenoid extracted from the medicinal plant Dryopteris fragrans that has previously been shown to exhibit anti-aging and antioxidant activity. In this study, we explored the mechanism of albicanol inhibition of the Cd-induced apoptosis of chicken hepatoma cells (LMH) by treating these cells with CdCl2 (25 mu M) and/or albicanol (2.5 x 10(-5) mu g mL(-1)) for 24 h. Under Cd treatment, the research results showed that the apoptosis rate markedly increased in LMH cells. In addition, the iNOS activity and NO content increased significantly, which promoted the expressions of genes associated with the mitochondrial apoptosis pathway (Bax, CytC, Caspase-3 and Caspase-9) and inhibited the expression of Bcl-2 in this pathway. However, Cd + albicanol co-treatment significantly reduced the apoptosis rate and the expressions of iNOS and genes associated with the mitochondrial apoptosis pathway (Bax, CytC, Caspase-3 and Caspase-9), and promoted the expression of Bcl-2 in this pathway. In addition, molecular docking supported a link between the albicanol ligand and the iNOS receptor. These results indicated that albicanol can inhibit Cd-induced apoptosis by regulating the NO/iNOS-mediated mitochondrial pathway.
C1 [Guan, Yalin; Chang, Ying] Northeast Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China.
   [Zhao, Xia; Song, Nuan; Cui, Yuan] Northeast Agr Univ, Coll Vet Med, Harbin 150030, Peoples R China.
C3 Northeast Agricultural University - China; Northeast Agricultural
   University - China
RP Chang, Y (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China.
EM changying@neau.edu.cn
FU National Natural Science Foundation of China [31870313]
FX This study was supported by the National Natural Science Foundation of
   China (No. 31870313).
CR Aitio A, 2004, BIOMETALS, V17, P491, DOI 10.1023/B:BIOM.0000045832.13400.02
   Bakary I, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4976-6
   Bao RK, 2017, ENVIRON SCI POLLUT R, V24, P20342, DOI 10.1007/s11356-017-9422-6
   Bensassi F, 2012, FOOD CHEM TOXICOL, V50, P1680, DOI 10.1016/j.fct.2012.01.015
   Berges A, 2003, ACTA CARDIOL, V58, P119, DOI 10.2143/AC.58.2.2005264
   BERLINER AF, 1975, BIOL REPROD, V13, P240, DOI 10.1095/biolreprod13.2.240
   Chae IH, 2004, CLIN CHIM ACTA, V341, P83, DOI 10.1016/j.cccn.2003.11.009
   Chen DJ, 2019, BIOMED PHARMACOTHER, V111, P791, DOI 10.1016/j.biopha.2018.12.151
   Chen Long, 2003, Sheng Li Xue Bao, V55, P535
   Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554
   Crowell JA, 2003, MOL CANCER THER, V2, P815
   Cui Y, 2021, J HAZARD MATER, V402, DOI 10.1016/j.jhazmat.2020.123527
   Cui Y, 2020, ECOTOX ENVIRON SAFE, V206, DOI 10.1016/j.ecoenv.2020.111151
   Davey DD, 2007, J MED CHEM, V50, P1146, DOI 10.1021/jm061319i
   Dawn B, 2002, ANN NY ACAD SCI, V962, P18, DOI 10.1111/j.1749-6632.2002.tb04053.x
   Fouad AA, 2011, LIFE SCI, V89, P29, DOI 10.1016/j.lfs.2011.04.019
   Gao C, 2016, ARCH DERMATOL RES, V308, P79, DOI 10.1007/s00403-015-1603-x
   Gao R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35061-8
   Guo Li-Min, 2018, Zhongguo Zhong Yao Za Zhi, V43, P3989, DOI 10.19540/j.cnki.cjcmm.20180726.013
   He L, 2017, Zhonghua Yi Xue Za Zhi, V97, P57, DOI 10.3760/cma.j.issn.0376-2491.2017.01.014
   Huang YH, 2014, MOLECULES, V19, P507, DOI 10.3390/molecules19010507
   Ito H, 2000, CHEM PHARM BULL, V48, P1190
   Jan R, 2019, ADV PHARM BULL, V9, P205, DOI 10.15171/apb.2019.024
   Jin X, 2018, J HAZARD MATER, V357, P355, DOI 10.1016/j.jhazmat.2018.06.003
   Kumar A, 2014, FREE RADICAL BIO MED, V73, P51, DOI 10.1016/j.freeradbiomed.2014.04.014
   Li J., 2020, PROTECTIVE MECH ALBI
   Li JL, 2013, ECOTOX ENVIRON SAFE, V96, P103, DOI 10.1016/j.ecoenv.2013.07.007
   Li XJ, 2012, FOOD CHEM, V133, P437, DOI 10.1016/j.foodchem.2012.01.056
   Lin YS, 2013, BIOCHEM PHARMACOL, V86, P242, DOI 10.1016/j.bcp.2013.05.009
   Liu CM, 2010, ENVIRON TOXICOL PHAR, V29, P158, DOI 10.1016/j.etap.2009.12.006
   Liu LL, 2014, BIOL TRACE ELEM RES, V159, P199, DOI 10.1007/s12011-014-0007-7
   Liu W, 2014, TOXICOL LETT, V224, P1, DOI 10.1016/j.toxlet.2013.10.009
   Liu XT, 2018, ENVIRON SCI POLLUT R, V25, P15609, DOI 10.1007/s11356-018-1758-z
   Long J, 2010, CONT ECO AGR, P60
   Ma JG, 2019, ENVIRON POLLUT, V252, P1288, DOI 10.1016/j.envpol.2019.06.040
   Miao Y.Q., 2016, ENV SUSTAINABLE DEV, V41, P170
   Miltonprabu S, 2016, TOXICOL REP, V3, P63, DOI 10.1016/j.toxrep.2015.11.010
   Mohajeri M, 2017, BIOFACTORS, V43, P645, DOI 10.1002/biof.1376
   Morán JM, 2010, NITRIC OXIDE-BIOL CH, V23, P51, DOI 10.1016/j.niox.2010.04.002
   Nawrot TS, 2010, BIOMETALS, V23, P769, DOI 10.1007/s10534-010-9343-z
   Nordberg GF, 2004, BIOMETALS, V17, P485, DOI 10.1023/B:BIOM.0000045726.75367.85
   Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018
   Peng B, 2016, J ASIAN NAT PROD RES, V18, P59, DOI 10.1080/10286020.2015.1121853
   Pitocco Dario, 2010, Rev Diabet Stud, V7, P15, DOI 10.1900/RDS.2010.7.15
   Qi X., 2020, SCI TOTAL ENVIRON
   Ren HT, 2019, ARCH ORAL BIOL, V101, P108, DOI 10.1016/j.archoralbio.2019.03.006
   Shen R, 2017, FOOD FUNCT, V8, P3636, DOI [10.1039/c7fo00495h, 10.1039/C7FO00495H]
   Siddiqui WA, 2015, ARCH TOXICOL, V89, P289, DOI 10.1007/s00204-014-1448-7
   Song Y.T., 2018, J XICHANG U, V32, P87
   Soyupek S, 2012, TOXICOL IND HEALTH, V28, P624, DOI 10.1177/0748233711420467
   Su HL, 2020, J HAZARD MATER, V400, DOI 10.1016/j.jhazmat.2020.123204
   Szuster-Ciesielska A, 2009, BIOCHEM PHARMACOL, V78, P301, DOI 10.1016/j.bcp.2009.04.009
   Wan DQ, 2015, ANTI-CANCER DRUG, V26, P931, DOI 10.1097/CAD.0000000000000269
   Wang GW, 2014, EXPERT OPIN INV DRUG, V23, P317, DOI 10.1517/13543784.2014.868882
   Wang J, 2002, J AGR FOOD CHEM, V50, P850, DOI 10.1021/jf010976a
   Wang J., 2013, PROTECTIVE EFFECT ME
   Wang JC, 2014, BIOL TRACE ELEM RES, V161, P180, DOI 10.1007/s12011-014-0105-6
   Wang KW, 2011, CELL SIGNAL, V23, P1677, DOI 10.1016/j.cellsig.2011.06.003
   Wang L, 2015, ENVIRON SCI POLLUT R, V22, P16441, DOI 10.1007/s11356-015-5273-1
   Wang Y, 2013, FOOD CHEM TOXICOL, V58, P61, DOI 10.1016/j.fct.2013.04.013
   Wang Y, 2018, TOXICOL APPL PHARM, V353, P23, DOI 10.1016/j.taap.2018.06.003
   Wu SW, 2016, SCI TOTAL ENVIRON, V560, P141, DOI 10.1016/j.scitotenv.2016.03.228
   Xie WQ, 2017, MOLECULES, V22, DOI 10.3390/molecules22101610
   Xu S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.7
   Zhang C, 2017, TOXICOL IN VITRO, V44, P349, DOI 10.1016/j.tiv.2017.07.027
   Zhang H.M., 2015, J HUBEI U MED, V34, P55
   Zhang JY, 2020, ECOTOX ENVIRON SAFE, V204, DOI 10.1016/j.ecoenv.2020.111049
   Zhang RX, 2017, BIOL TRACE ELEM RES, V178, P310, DOI 10.1007/s12011-016-0925-7
   Zhang T, 2018, MOLECULES, V23, DOI 10.3390/molecules23071652
   Zhao DD, 2014, MOLECULES, V19, P3345, DOI 10.3390/molecules19033345
   Zheng SF, 2020, J HAZARD MATER, V389, DOI 10.1016/j.jhazmat.2019.121885
   Zhou XL, 2019, BIOMED PHARMACOTHER, V115, DOI 10.1016/j.biopha.2019.108929
   Zou H, 2020, BIOL TRACE ELEM RES, V198, P206, DOI 10.1007/s12011-020-02045-7
NR 73
TC 13
Z9 15
U1 3
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD FEB 21
PY 2021
VL 12
IS 4
BP 1757
EP 1768
DI 10.1039/d0fo03270k
PG 12
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA QP6PH
UT WOS:000623956200030
PM 33502412
DA 2024-02-19
ER

PT J
AU Xie, XX
   Chen, YY
   Ma, LY
   Shen, QC
   Huang, LF
   Zhao, BG
   Wu, T
   Fu, ZW
AF Xie, Xiaoxian
   Chen, Yangyang
   Ma, Lingyan
   Shen, Qichen
   Huang, Liangfeng
   Zhao, Binggong
   Wu, Tao
   Fu, Zhengwei
TI Major depressive disorder mediates accelerated aging in rats subjected
   to chronic mild stress
SO BEHAVIOURAL BRAIN RESEARCH
LA English
DT Article
DE Major depressive disorder; Accelerated aging; Oxidative damage; Telomere
   length; Mitochondria; Chronic mild stress
ID SHORTENED TELOMERE LENGTH; CALORIE RESTRICTION; METABOLISM; ACTIVATION;
   LONGEVITY; DISEASE; MODEL; PCR
AB Major depressive disorder (MDD) has a complex etiology and is characterized by a change in mood and psychophysiological state. MDD has been shown to mediate accelerated biological aging in patients, although the underlying mechanism is not well understood. In the present study, we used a chronic mild stress (CMS) paradigm to induce anhedonia, one of the main symptoms of MDD. CMS induced depression-like symptoms in rats, including reduced sucrose preference and increased immobility time in the forced swim test. Moreover, stressed rats travelled a shorter total distance, had fewer grid line crossings, and spent less time in the outer zone in the open field test than controls. CMS altered the levels of 5-hydroxytryptophan, dopamine, and corticosterone in the serum and hippocampus (P < 0.05); these rats also exhibited impaired liver function, decreased telomerase activity, and telomere shortening, which was associated with increased oxidative damage along with decreased superoxide dismutase and glutathione reductase activities. Mitochondria in CMS-treated rats showed ultrastructural damage as well as reduced DNA content and integrity. These findings provide physiological and cellular evidence that the MDD can mediate accelerated aging in rats.
C1 [Xie, Xiaoxian; Chen, Yangyang; Ma, Lingyan; Shen, Qichen; Huang, Liangfeng; Zhao, Binggong; Wu, Tao; Fu, Zhengwei] Zhejiang Univ Technol, Coll Biotechnol & Bioengn, 6 Dist, Hangzhou 310032, Zhejiang, Peoples R China.
C3 Zhejiang University of Technology
RP Fu, ZW (corresponding author), Zhejiang Univ Technol, Coll Biotechnol & Bioengn, 6 Dist, Hangzhou 310032, Zhejiang, Peoples R China.
EM azwfu@zjut.edu.cn
RI Wu, Tao/A-7783-2012; shen, qichen/GOG-8043-2022; Fu,
   Zhengwei/G-3162-2011
OI Fu, Zhengwei/0000-0003-3351-3075; Shen, Qichen/0000-0002-2834-2059
FU National Natural Science Foundation of China [31200890]; Program for
   Changjiang Scholars and Innovative Research Team in University
   [IRT13096]
FX This work was supported by the National Natural Science Foundation of
   China (grant number 31200890) and Program for Changjiang Scholars and
   Innovative Research Team in University (IRT13096).
CR Abdelaziz RR, 2015, ENVIRON TOXICOL PHAR, V40, P259, DOI 10.1016/j.etap.2015.06.019
   Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Beery AK, 2012, BIOL LETTERS, V8, P1063, DOI 10.1098/rsbl.2012.0747
   Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]
   Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500
   Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5
   Cai N, 2015, CURR BIOL, V25, P1146, DOI 10.1016/j.cub.2015.03.008
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Che Y, 2015, NEUROSCI LETT, V584, P208, DOI 10.1016/j.neulet.2014.10.031
   Christiansen SL, 2016, NEUROSCI RES, V110, P43, DOI 10.1016/j.neures.2016.03.002
   Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107
   Dorfman KE, 2016, P NATL ACAD SCI USA, V113, P10001, DOI 10.1073/pnas.1610729113
   Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101
   Faggioni R, 2001, FASEB J, V15, P2565, DOI 10.1096/fj.01-0431rev
   Gong Y, 2011, NEUROSCI LETT, V488, P76, DOI 10.1016/j.neulet.2010.11.006
   Gotlib IH, 2015, MOL PSYCHIATR, V20, P615, DOI 10.1038/mp.2014.119
   Hartmann N, 2010, DEPRESS ANXIETY, V27, P1111, DOI 10.1002/da.20749
   Henningsen K, 2009, BEHAV BRAIN RES, V198, P136, DOI 10.1016/j.bbr.2008.10.039
   Hoen PW, 2011, PSYCHOSOM MED, V73, P541, DOI 10.1097/PSY.0b013e31821b1f6e
   Karabatsiakis A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-192
   Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301
   Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8
   Lin PY, 2016, J PSYCHIATR RES, V76, P84, DOI 10.1016/j.jpsychires.2016.01.015
   Lucca G, 2009, J PSYCHIATR RES, V43, P864, DOI 10.1016/j.jpsychires.2008.11.002
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104
   Otsuka T, 2014, PSYCHONEUROENDOCRINO, V40, P37, DOI 10.1016/j.psyneuen.2013.10.013
   Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021
   Patel R, 2002, J NEUROCHEM, V82, P118, DOI 10.1046/j.1471-4159.2002.00948.x
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Ridout KK, 2016, J AFFECT DISORDERS, V191, P237, DOI 10.1016/j.jad.2015.11.052
   Santos J.H., 2014, METHOD MOL BIOL, V314, P183
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schutte NS, 2015, DEPRESS ANXIETY, V32, P229, DOI 10.1002/da.22351
   Sebastian C, 2010, CELL, V143, P667, DOI 10.1016/j.cell.2010.11.009
   Shay JW, 2007, J PATHOL, V211, P114, DOI 10.1002/path.2090
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Spencer RL, 2000, BRAIN RES, V868, P275, DOI 10.1016/S0006-8993(00)02341-6
   Szebeni A, 2014, INT J NEUROPSYCHOPH, V17, P1579, DOI 10.1017/S1461145714000698
   Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013
   Verhoeven JE, 2014, MOL PSYCHIATR, V19, P895, DOI 10.1038/mp.2013.151
   von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034
   Wikgren M, 2012, BIOL PSYCHIAT, V71, P294, DOI 10.1016/j.biopsych.2011.09.015
   Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837
   Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686
   Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385
   Xie X., 2014, PLOS ONE, V9
   Xu LZ, 2016, BEHAV BRAIN RES, V300, P38, DOI 10.1016/j.bbr.2015.12.002
   Zhang DD, 2010, BEHAV GENET, V40, P250, DOI 10.1007/s10519-010-9338-0
   Zhang L, 2014, MED HYPOTHESES, V83, P182, DOI 10.1016/j.mehy.2014.04.033
   Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44
   Zhou QG, 2011, J NEUROSCI, V31, P12258, DOI 10.1523/JNEUROSCI.0805-11.2011
NR 60
TC 34
Z9 36
U1 0
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-4328
EI 1872-7549
J9 BEHAV BRAIN RES
JI Behav. Brain Res.
PD JUN 30
PY 2017
VL 329
BP 96
EP 103
DI 10.1016/j.bbr.2017.04.022
PG 8
WC Behavioral Sciences; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Behavioral Sciences; Neurosciences & Neurology
GA EY4YV
UT WOS:000403985100013
PM 28442351
DA 2024-02-19
ER

PT J
AU Lin, YS
   Feng, XC
   Cao, X
   Miao, R
   Sun, YH
   Li, R
   Ye, JZ
   Zhong, BH
AF Lin, Yansong
   Feng, Xiongcai
   Cao, Xu
   Miao, Rong
   Sun, Yanhong
   Li, Rui
   Ye, Junzhao
   Zhong, Bihui
TI Age patterns of nonalcoholic fatty liver disease incidence:
   heterogeneous associations with metabolic changes
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Nonalcoholic fatty liver disease; Incidence rate; Aging; Risk factors;
   Metabolic disorder
ID WEIGHT-GAIN; PREVALENCE; RISK
AB Background As the nonalcoholic fatty liver disease (NAFLD) epidemic matures, understanding how metabolic changes in NAFLD development vary over the age distribution is important to guide precise prevention. We aimed to clarify metabolic trends in age-specific NAFLD incidence. Methods We conducted a 4-year longitudinal retrospective cohort study enrolling 10,240 consecutive healthy individuals who received annual physical examination during 2012-2019. Baseline and dynamic changes in metabolism and hepatic steatosis determined with ultrasound were collected and analyzed stratified by age into the following groups: 20-34, 35-49, 50-64, and over 65 years. Results Overall, 1701 incident NAFLD participants (16.6%) were identified. Adjusted Cox regression analysis showed that the baseline and increased body mass index were the main risk factors for NAFLD in people <= 65 years old. Baseline high-density lipoprotein (HR = 0.56; 95% CI 0.39-0.78) was a protective factor for newly onset NAFLD in the 50-to-64-year-old group, while baseline SBP (HR = 1.03; 95% CI 1.01-1.05), baseline uric acid (HR = 1.04; 95% CI 1.01-1.07), triglyceride increase (HR = 4.76; 95% CI 3.69-6.14), fasting blood glucose increase (HR = 1.32; 95% CI 1.06-1.65) were independently associated with incident NAFLD in over-65-year-old group. Conclusions NAFLD incidence attributable to potentially metabolic risk factors varied substantially across age groups in a cohort of Chinese people. The adoption of age targeted metabolic prevention strategies might reduce the burden of NAFLD.
C1 [Lin, Yansong; Feng, Xiongcai; Li, Rui; Ye, Junzhao; Zhong, Bihui] Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, 58 Zhongshan 2 Rd, Guangzhou 510080, Peoples R China.
   [Cao, Xu; Miao, Rong] Sen Univ, East Div, Phys Examinat Ctr, Affiliated Hosp 1, Guangzhou 510700, Guangdong, Peoples R China.
   [Sun, Yanhong] Sen Univ, Affiliated Hosp Sun Yat 1, Dept Clin Lab, Guangzhou, Peoples R China.
RP Ye, JZ; Zhong, BH (corresponding author), Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, 58 Zhongshan 2 Rd, Guangzhou 510080, Peoples R China.
EM yejzh@mail2.sysu.edu.cn; zhongbh@mail.sysu.edu.cn
RI Lin, Ginger/IAN-3925-2023
FU Chinese Foundation for Hepatitis Prevention and Control [TQGB20140083];
   National Natural Science Foundation of China [81870404, 81670518,
   81170392, 82100648]; Medical Scientific Research Foundation of Guangdong
   Province [A2019496]; Postdoctoral Research Foundation of China
   [2020M683128]
FX This work was supported by Chinese Foundation for Hepatitis Prevention
   and Control (TQGB20140083), National Natural Science Foundation of China
   (81870404, 81670518, 81170392, 82100648), Medical Scientific Research
   Foundation of Guangdong Province (A2019496) and Postdoctoral Research
   Foundation of China (2020M683128).
CR Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x
   Aneni EC, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0266505
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Ciardullo S, 2022, EUR J GASTROEN HEPAT, V34, P365, DOI 10.1097/MEG.0000000000002299
   Ciardullo S, 2021, DIGEST LIVER DIS, V53, P866, DOI 10.1016/j.dld.2021.02.010
   Eslam M, 2020, HEPATOL INT, V14, P889, DOI 10.1007/s12072-020-10094-2
   Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039
   Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036
   Hua Y., 2007, CHIN J GASTROENTEROL, V16, P347
   Li J, 2019, LANCET GASTROENTEROL, V4, P389, DOI 10.1016/S2468-1253(19)30039-1
   Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105
   Liu YX, 2021, HEPATOB PANCREAT DIS, V20, P409, DOI 10.1016/j.hbpd.2021.08.004
   Marchesini G, 2015, J HEPATOL, V62, P15, DOI 10.1016/j.jhep.2014.10.023
   Meynial-Denis D, 2016, NUTR REV, V74, P225, DOI 10.1093/nutrit/nuv052
   National Workshop on Fatty Liver and Alcoholic Liver Disease Chinese Society of Hepatology Chinese Medical Association, 2018, Zhonghua Gan Zang Bing Za Zhi, V26, P195, DOI 10.3760/cma.j.issn.1007-3418.2018.03.008
   Polyzos SA, 2019, METABOLISM, V92, P82, DOI 10.1016/j.metabol.2018.11.014
   Pontzer H, 2021, SCIENCE, V373, P808, DOI 10.1126/science.abe5017
   Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006
   Rim JH, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.637241
   Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033
   Shen L, 2003, WORLD J GASTROENTERO, V9, P1106
   Shi L, 2012, BIOMED ENVIRON SCI, V25, P383, DOI 10.3967/0895-3988.2012.04.002
   [石晓东 Shi Xiaodong], 2011, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V37, P379
   Sung KC, 2014, J HEPATOL, V60, P1040, DOI 10.1016/j.jhep.2014.01.009
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Wang B, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa112
   Wang JH, 2018, J GASTROEN HEPATOL, V33, P1518, DOI 10.1111/jgh.14105
   Wei FJ, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00179
   Westeneng HJ, 2021, LANCET NEUROL, V20, P373, DOI 10.1016/S1474-4422(21)00042-9
   Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088
   Wu WT, 2022, FRONT CARDIOVASC MED, V9, DOI 10.3389/fcvm.2022.891963
   Wu YK, 2020, HEPATOL INT, V14, P259, DOI 10.1007/s12072-020-10023-3
   Yamada G, 2021, AM J GASTROENTEROL, V116, P733, DOI 10.14309/ajg.0000000000001030
   Yu Xin-yan, 2014, Zhejiang Da Xue Xue Bao Yi Xue Ban, V43, P546
   Zhao YC, 2020, HYPERTENSION, V75, P275, DOI 10.1161/HYPERTENSIONAHA.119.13419
   Zhou JH, 2020, HEPATOLOGY, V71, P1851, DOI 10.1002/hep.31150
   Zhou M, 2019, Zhonghua Liu Xing Bing Xue Za Zhi, V40, P510, DOI 10.3760/cma.j.issn.0254-6450.2019.05.004
NR 37
TC 6
Z9 7
U1 1
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD NOV 28
PY 2022
VL 14
IS 1
AR 181
DI 10.1186/s13098-022-00930-w
PG 12
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 6N4GL
UT WOS:000889516300003
PM 36443867
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Mikkelsen, L
   Bialkowski, K
   Risom, L
   Lohr, M
   Loft, S
   Moller, P
AF Mikkelsen, Lone
   Bialkowski, Karol
   Risom, Lotte
   Lohr, Mille
   Loft, Steffen
   Moller, Peter
TI Aging and defense against generation of
   8-oxo-7,8-dihydro-2′-deoxyguanosine in DNA
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Aging; DNA repair; FPG sites; Nudt1; Ogg1
ID OXIDATIVELY DAMAGED DNA; DIESEL EXHAUST PARTICLES; BASE-EXCISION-REPAIR;
   FORMAMIDOPYRIMIDINE DNA; ANTIOXIDANT PROTECTION; 8-OXO-DGTPASE ACTIVITY;
   MITOCHONDRIAL-DNA; LIVER-TISSUE; RAT-LIVER; GLYCOSYLASE
AB The imbalance between the formation of 8-oxo-7,8-dihydro-2 '-deoxyguanosine (8-oxodG) in DNA and the efficiency of cellular systems of DNA protection and repair is considered an important factor in the age-dependent development of cancer. This study investigated the relationship between oxidatively damaged DNA and the activity of the DNA repair system and 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate pyrophosphohydrolase (8-oxodGTPase) activity in liver and lung tissue from mice at 10-100 weeks of age. The level of 8-oxodG increased with age, whereas the level of formamidopyrimidine DNA glycosylase sites was unaltered. The enzyme activity toward single oxygen-induced DNA damage and mRNA expression levels of Ercc1, Neil1, and Ogg1 remained unaltered with age. However, the 8-oxodGTPase activity in the liver was 18% (95% CI: 0.2-37%) lower in mice at 25 and 50 weeks than in 10-week-old mice. The 10- and 100-week-old mice had similar 8-oxodGTPase activity. In contrast, the mRNA expression of Nudt1 was statistically unaltered that likely resulted from higher variation of measurements. The accumulation of 8-oxodG with age is not a direct consequence of decreased enzyme activity toward singlet oxygen-induced substrate DNA. An age-related higher level of 8-oxodG even occurs concomitantly with high 8-oxodGTPase activity. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Mikkelsen, Lone; Risom, Lotte; Lohr, Mille; Loft, Steffen; Moller, Peter] Univ Copenhagen, Inst Publ Hlth, Oster Farimagsgade 5,2 Floor, DK-1014 Copenhagen K, Denmark.
   [Bialkowski, Karol] Nicholas Copernicus Univ, Coll Med, Dept Clin Biochem, PL-85092 Bydgoszcz, Poland.
C3 University of Copenhagen; Nicolaus Copernicus University; Ludwik
   Rydygier Collegium Medicum
RP Moller, P (corresponding author), Univ Copenhagen, Inst Publ Hlth, Oster Farimagsgade 5,2 Floor, DK-1014 Copenhagen K, Denmark.
EM p.moller@pubhealth.ku.dk
RI Bialkowski, Karol/E-2328-2014
OI Bialkowski, Karol/0000-0002-3836-8076; Loft, Steffen/0000-0001-9552-8518
FU Hoffmann-LaRoche, Basel, Switzerland [Ro19-8022]; Danish Research
   Councils; ECNIS (Environmental Cancer Risk, Nutrition and Individual
   Susceptibility); European Union 6th Framework Program; Food Quality and
   Safety [513943]; Danish Cancer Society.
FX Thanks to Professor Andrew Collins, University of Oslo, Norway, for the
   FPG enzyme. The Ro19-8022 photosensitizer was provided as a gift from F.
   Hoffmann-LaRoche, Basel, Switzerland. This study was supported by Danish
   Research Councils, ECNIS (Environmental Cancer Risk, Nutrition and
   Individual Susceptibility), a network of excellence operating within the
   European Union 6th Framework Program, Priority 5: "Food Quality and
   Safety" (Contract No. 513943), including a travel grant to Lone
   Mikkelsen, and by a scholarship from The Danish Cancer Society.
CR Asagoshi K, 2000, J BIOL CHEM, V275, P4956, DOI 10.1074/jbc.275.7.4956
   Badouard C, 2008, ZYGOTE, V16, P9, DOI 10.1017/S0967199407004340
   Bialkowski K, 2004, FREE RADICAL BIO MED, V37, P1534, DOI 10.1016/j.freeradbiomed.2004.07.018
   Bialkowski K, 1998, NUCLEIC ACIDS RES, V26, P3194, DOI 10.1093/nar/26.13.3194
   Bialkowski K, 1999, FREE RADICAL BIO MED, V27, P90, DOI 10.1016/S0891-5849(99)00040-4
   BRUNBORG G, 1990, PROG CLIN BIOL RES, V340, P43
   Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001
   CHENEY KE, 1980, EXP GERONTOL, V15, P237, DOI 10.1016/0531-5565(80)90029-7
   Choi JY, 1999, FREE RADICAL BIO MED, V27, P848, DOI 10.1016/S0891-5849(99)00141-0
   Collins A, 2003, FREE RADICAL BIO MED, V34, P1089, DOI 10.1016/s0891-5849(03)00041-8
   Collins A, 2002, CARCINOGENESIS, V23, P2129, DOI 10.1093/carcin/23.12.2129
   Collins AR, 2004, ARCH BIOCHEM BIOPHYS, V423, P57, DOI 10.1016/j.abb.2003.12.022
   Collins AR, 2001, MUTAGENESIS, V16, P297, DOI 10.1093/mutage/16.4.297
   Cooke MS, 2007, P NATL ACAD SCI USA, V104, P13535, DOI 10.1073/pnas.0706878104
   Cooke MS, 2006, CLIN CHIM ACTA, V365, P30, DOI 10.1016/j.cca.2005.09.009
   de Souza-Pinto NC, 2001, FREE RADICAL BIO MED, V30, P916, DOI 10.1016/S0891-5849(01)00483-X
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033
   Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001
   Folkmann JK, 2007, MUTAGENESIS, V22, P105, DOI 10.1093/mutage/gel059
   Gackowski D, 2003, CANCER RES, V63, P4899
   Gedik CM, 2005, FASEB J, V19, P82, DOI 10.1096/fj.04-1767fje
   Gedik CM, 2005, EUR J NUTR, V44, P263, DOI 10.1007/s00394-004-0520-0
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   Guarnieri S, 2008, BRIT J NUTR, V99, P1018, DOI 10.1017/S0007114507842796
   Haghdoost S, 2006, FREE RADICAL BIO MED, V41, P620, DOI 10.1016/j.freeradbiomed.2006.05.003
   Hah SS, 2007, P NATL ACAD SCI USA, V104, P11203, DOI 10.1073/pnas.0701733104
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Hasty P, 2005, MECH AGEING DEV, V126, P71, DOI 10.1016/j.mad.2004.09.036
   Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200
   Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799
   Humphreys V, 2007, AGE AGEING, V36, P521, DOI 10.1093/ageing/afm107
   Jaruga P, 2004, BIOCHEMISTRY-US, V43, P15909, DOI 10.1021/bi048162l
   Jaruga P, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.6.e16
   Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137
   Kaneko T, 2003, ARCH GERONTOL GERIAT, V36, P23, DOI 10.1016/S0167-4943(02)00056-0
   Karakaya A, 1997, NUCLEIC ACIDS RES, V25, P474, DOI 10.1093/nar/25.3.474
   Kemeleva EA, 2006, MUTAT RES-FUND MOL M, V599, P88, DOI 10.1016/j.mrfmmm.2006.01.008
   Loft S, 2006, CARCINOGENESIS, V27, P1245, DOI 10.1093/carcin/bgi313
   Meyer F, 2000, TOXICOLOGY, V146, P83, DOI 10.1016/S0300-483X(00)00140-2
   Moller P, 2004, FREE RADICAL RES, V38, P1207, DOI 10.1080/10715760400016824
   Moller P, 2006, FREE RADICAL BIO MED, V41, P388, DOI 10.1016/j.freeradbiomed.2006.04.001
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Nakamoto H, 2007, EXP GERONTOL, V42, P287, DOI 10.1016/j.exger.2006.11.006
   Osterod M, 2001, CARCINOGENESIS, V22, P1459, DOI 10.1093/carcin/22.9.1459
   Parsons JL, 2005, NUCLEIC ACIDS RES, V33, P4849, DOI 10.1093/nar/gki816
   Paz-Elizur T, 2003, J NATL CANCER I, V95, P1312, DOI 10.1093/jnci/djg033
   Paz-Elizur T, 2006, CANCER RES, V66, P11683, DOI 10.1158/0008-5472.CAN-06-2294
   Pouget JP, 2002, RADIAT RES, V157, P589, DOI 10.1667/0033-7587(2002)157[0589:FOMDBI]2.0.CO;2
   Riis B, 2002, DNA REPAIR, V1, P419, DOI 10.1016/S1568-7864(02)00018-6
   Riis B, 2002, DNA REPAIR, V1, P709, DOI 10.1016/S1568-7864(02)00077-0
   Risom L, 2003, FREE RADICAL RES, V37, P957, DOI 10.1080/1071576031000150788
   Risom L, 2007, TOXICOL LETT, V175, P16, DOI 10.1016/j.toxlet.2007.09.003
   Risom L, 2007, FREE RADICAL RES, V41, P172, DOI 10.1080/10715760601024122
   Russo MT, 2004, CANCER RES, V64, P4411, DOI 10.1158/0008-5472.CAN-04-0355
   Sakumi K, 2003, CANCER RES, V63, P902
   Schmerold I, 2001, EXP GERONTOL, V36, P1375, DOI 10.1016/S0531-5565(01)00103-6
   Selfridge J, 2001, NUCLEIC ACIDS RES, V29, P4541, DOI 10.1093/nar/29.22.4541
   Seo AY, 2006, ANTIOXID REDOX SIGN, V8, P529, DOI 10.1089/ars.2006.8.529
   Servais S, 2005, FREE RADICAL RES, V39, P305, DOI 10.1080/10715760400011098
   Speina E, 2005, JNCI-J NATL CANCER I, V97, P384, DOI 10.1093/jnci/dji058
   Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798
   Turturro A, 2002, J GERONTOL A-BIOL, V57, pB379, DOI 10.1093/gerona/57.11.B379
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   Wellejus A, 2002, J TOXICOL ENV HEAL A, V65, P813, DOI 10.1080/00984100290071126
   Wellejus A, 2002, FASEB J, V16, P195, DOI 10.1096/fj.01-0385com
   Will O, 1999, MUTAT RES-DNA REPAIR, V435, P89, DOI 10.1016/S0921-8777(99)00039-7
   Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017
   Wolf FI, 2005, EXP GERONTOL, V40, P181, DOI 10.1016/j.exger.2004.11.002
NR 69
TC 40
Z9 44
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD SEP 1
PY 2009
VL 47
IS 5
BP 608
EP 615
DI 10.1016/j.freeradbiomed.2009.05.030
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 483VF
UT WOS:000268995900016
PM 19500668
DA 2024-02-19
ER

PT S
AU Hansford, RG
   Tsuchiya, N
   Pepe, S
AF Hansford, RG
   Tsuchiya, N
   Pepe, S
BE Brown, GC
   Nicholls, DG
   Cooper, CE
TI Mitochondria in heart ischaemia and aging
SO MITOCHONDRIA AND CELL DEATH
SE Biochemical Society Symposia
LA English
DT Article; Proceedings Paper
CT Biochemical-Society Symposium on Mitochondria and Cell Death
CY JUL, 1998
CL SHEFFIELD UNIV, SHEFFIELD, ENGLAND
SP Biochem Soc
HO SHEFFIELD UNIV
ID RAT-LIVER MITOCHONDRIA; CYTOCHROME-C; PYRUVATE-DEHYDROGENASE;
   ELECTRON-TRANSPORT; OXIDATIVE DAMAGE; APOPTOSIS; DNA; ACTIVATION;
   RELEASE; CALCIUM
AB We have examined the effect of dietary polyunsaturated fatty acids (PUFAs) upon mitochondrial Ca2+ content and dehydrogenase activation in the rat heart. Diets were either a conventional low-fat chow (Ref) or were rich in n-3 PUFAs from fish oils (n-3) or n-6 PUFAs from animal fat (n-6). We found that the n-3 diet minimized the rise in mitochondrial Ca2+ seen in response to positive inotropic intervention with noradrenaline, and also minimized the activation of pyruvate dehydrogenase, which is Ca2+ dependent. As the work output of all three groups of hearts was the same, this observation may explain the previous finding of increased thermodynamic efficiency of the n-3 heart relative to the n-6 heart. When hearts were subjected to low-flow ischaemia (15 min), followed by 5 min of reperfusion, increases of mitochondrial Ca2+ were less in the n-3 group than in the n-6 group. In more prolonged ischaemia and reperfusion, n-3 feeding may confer protection against mitochondrial Ca2+ overload, opening of the permeability transition pore and cell death. Notably, the effects of n-3 feeding on mitochondrial functioning were most apparent in hearts from senescent rats (23 months). This is consistent with our finding that the decrease in mitochondrial membrane cardiolipin content, and increase in phosphatidylcholine, which occurred with aging in the Ref and n-6 groups, was totally prevented by n-3 feeding. Thus there are a number of reasons to regard an n-3-rich diet as being protective of the heart in aging mammals.
C1 NIA, Genet Mol Lab, Mitochondria & Aging Sect, Gerontol Res Ctr,NIH, Baltimore, MD 21224 USA.
   Kitasato Univ Hosp, Dept Cardiol, Sagamihara, Kanagawa 228, Japan.
   Baker Med Res Inst, Cardiac Surg Res & Transplantat Unit, Melbourne, Vic 3181, Australia.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); Kitasato University; Baker Heart and Diabetes Institute
RP Hansford, RG (corresponding author), NIA, Genet Mol Lab, Mitochondria & Aging Sect, Gerontol Res Ctr,NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.
CR BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37
   BROWN GC, 1986, BIOCHEM J, V234, P75, DOI 10.1042/bj2340075
   BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543
   Filburn CR, 1996, MECH AGEING DEV, V87, P35, DOI 10.1016/0047-6374(96)01696-X
   GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755
   HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HANSFORD RG, 1991, J BIOENERG BIOMEMBR, V23, P823, DOI 10.1007/BF00786004
   HANSFORD RG, 1994, J BIOENERG BIOMEMBR, V26, P495, DOI 10.1007/BF00762734
   HANSFORD RG, 1982, J BIOENERG BIOMEMBR, V14, P361, DOI 10.1007/BF00743064
   HANSFORD RG, 1985, REV PHYSIOL BIOCH P, V102, P1, DOI 10.1007/BFb0034084
   Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155
   Hudson EK, 1998, MECH AGEING DEV, V103, P179, DOI 10.1016/S0047-6374(98)00043-8
   Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132
   KOBAYASHI K, 1983, J MOL CELL CARDIOL, V15, P359, DOI 10.1016/0022-2828(83)90320-6
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MCCORMACK JG, 1984, BIOCHEM J, V218, P235, DOI 10.1042/bj2180235
   MCCORMACK JG, 1989, BIOCHIM BIOPHYS ACTA, V973, P420, DOI 10.1016/S0005-2728(89)80384-6
   NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x
   NOEL H, 1986, EUR J BIOCHEM, V155, P99, DOI 10.1111/j.1432-1033.1986.tb09463.x
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   PARADIES G, 1992, BIOCHIM BIOPHYS ACTA, V1103, P324, DOI 10.1016/0005-2736(92)90103-S
   PEPE S, 1992, Journal of Molecular and Cellular Cardiology, V24, pS115
   Pepe S, 1996, J NUTR, V126, P34, DOI 10.1093/jn/126.1.34
   Pepe Salvatore, 1997, Journal of Molecular and Cellular Cardiology, V29, pA263
   PIETROBON D, 1981, EUR J BIOCHEM, V117, P389, DOI 10.1111/j.1432-1033.1981.tb06350.x
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   WAN B, 1993, AM J PHYSIOL, V265, pH453, DOI 10.1152/ajpheart.1993.265.2.H453
   WAN B, 1989, J BIOL CHEM, V264, P13430
   Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129
   Zamzami N, 1998, ONCOGENE, V16, P1055, DOI 10.1038/sj.onc.1201864
NR 39
TC 21
Z9 23
U1 0
U2 0
PU PORTLAND PRESS LTD
PI LONDON
PA 59 PORTLAND PL, LONDON W1N 3AJ, ENGLAND
SN 0067-8694
BN 1-85578-125-5
J9 BIOCHEM SOC SYMP
JI Biochem. Soc. Symp.
PY 1999
VL 66
BP 141
EP 147
DI 10.1042/bss0660141
PG 7
WC Biochemistry & Molecular Biology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA BP10N
UT WOS:000084132600013
PM 10989664
DA 2024-02-19
ER

PT J
AU Jiang, Z
   Wang, J
   Imai, D
   Snider, T
   Klug, J
   Mangalindan, R
   Morton, J
   Zhu, LD
   Salmon, AB
   Wezeman, J
   Hu, JY
   Menon, V
   Marka, N
   Neidernhofer, L
   Ladiges, W
AF Jiang, Zhou
   Wang, Juan
   Imai, Denise
   Snider, Tim
   Klug, Jenna
   Mangalindan, Ruby
   Morton, John
   Zhu, Lida
   Salmon, Adam B.
   Wezeman, Jackson
   Hu, Jiayi
   Menon, Vinal
   Marka, Nicholas
   Neidernhofer, Laura
   Ladiges, Warren
TI Short term treatment with a cocktail of rapamycin, acarbose and
   phenylbutyrate delays aging phenotypes in mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LIFE-SPAN; ACID; PARADIGM
AB Pharmaceutical intervention of aging requires targeting multiple pathways, thus there is rationale to test combinations of drugs targeting different but overlapping processes. In order to determine if combining drugs shown to extend lifespan and healthy aging in mice would have greater impact than any individual drug, a cocktail diet containing 14 ppm rapamycin, 1000 ppm acarbose, and 1000 ppm phenylbutyrate was fed to 20-month-old C57BL/6 and HET3 4-way cross mice of both sexes for three months. Mice treated with the cocktail showed a sex and strain-dependent phenotype consistent with healthy aging including decreased body fat, improved cognition, increased strength and endurance, and decreased age-related pathology compared to mice treated with individual drugs or control. The severity of age-related lesions in heart, lungs, liver, and kidney was consistently decreased in mice treated with the cocktail compared to mice treated with individual drugs or control, suggesting an interactive advantage of the three drugs. This study shows that a combination of three drugs, each previously shown to enhance lifespan and health span in mice, is able to delay aging phenotypes in middle-aged mice more effectively than any individual drug in the cocktail over a 3-month treatment period.
C1 [Jiang, Zhou; Klug, Jenna; Mangalindan, Ruby; Morton, John; Wezeman, Jackson; Ladiges, Warren] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA.
   [Wang, Juan] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA 99352 USA.
   [Imai, Denise] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Snider, Tim] Oklahoma State Univ, Coll Vet Med, Dept Vet Pathobiol, Stillwater, OK 74078 USA.
   [Zhu, Lida] HD Biosci Co Ltd, In Vivo Pharmacol, Shanghai, Peoples R China.
   [Salmon, Adam B.] Univ Texas Hlth Sci Ctr San Antonio, Geriatr Res Educ & Clin Ctr, San Antonio Sam & Ann Barshop Inst Longev & Aging, South Texas Vet Hlth Care Syst,Dept Mol Med, San Antonio, TX 78229 USA.
   [Hu, Jiayi; Menon, Vinal; Neidernhofer, Laura] Univ Minnesota, Inst Biol Aging & Metab, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA.
   [Marka, Nicholas] Univ Minnesota, Biostat Design & Anal Ctr, Clin & Translat Sci Inst, Minneapolis, MN USA.
C3 University of Washington; University of Washington Seattle; United
   States Department of Energy (DOE); Pacific Northwest National
   Laboratory; University of California System; University of California
   Davis; Oklahoma State University System; Oklahoma State University -
   Stillwater; University of Texas System; University of Texas Health
   Science Center at San Antonio; Geriatric Research Education & Clinical
   Center; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Audie L. Murphy Memorial Veterans Hospital;
   University of Minnesota System; University of Minnesota Twin Cities;
   University of Minnesota System; University of Minnesota Twin Cities
RP Ladiges, W (corresponding author), Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA.
EM wladiges@uw.edu
OI Snider, Timothy/0000-0002-2659-835X
FU National Institutes of Health [R56 AG058543, R01 AG057381, R01 AG057431]
FX This study was funded by National Institutes of Health (Grant Nos. R56
   AG058543, R01 AG057381, R01 AG057431).
CR Anderson RM, 2012, AM J HUM BIOL, V24, P101, DOI 10.1002/ajhb.22243
   BALFOUR JA, 1993, DRUGS, V46, P1025, DOI 10.2165/00003495-199346060-00007
   Bitto A, 2016, ELIFE, V5, DOI 10.7554/eLife.16351
   Brewer Rachel A, 2016, Nutr Healthy Aging, V4, P31, DOI 10.3233/NHA-160007
   Camell CD, 2021, SCIENCE, V373, DOI 10.1126/science.abe4832
   Cowan P A, 2000, Nephrol Nurs J, V27, P623
   Darvas Martin, 2020, Curr Protoc Mouse Biol, V10, pe68, DOI 10.1002/cpmo.68
   Flynn JM, 2013, AGING CELL, V12, P851, DOI 10.1111/acel.12109
   Garratt M, 2017, AGING CELL, V16, P1256, DOI 10.1111/acel.12656
   Ge X, 2017, EXP GERONTOL, V91, P1, DOI 10.1016/j.exger.2017.02.001
   Ge X, 2016, PATHOBIOL AGING AGE, V6, DOI 10.3402/pba.v6.32981
   Hara Y, 2019, NEUROLOGY, V92, P84, DOI 10.1212/WNL.0000000000006745
   Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170
   Khan S, 2017, EPIGENOMICS-UK, V9, P711, DOI 10.2217/epi-2016-0160
   Klug J., 2021, J TRANSL SCI, V7, P458
   Kolb PS, 2015, INT J BIOCHEM CELL B, V61, P45, DOI 10.1016/j.biocel.2015.01.015
   Ladiges W, 2017, PATHOBIOL AGING AGE, V8, DOI 10.1080/20010001.2017.1407203
   Ladiges W, 2014, PATHOBIOL AGING AGE, V4, DOI 10.3402/pba.v4.24835
   Ladiges W, 2017, J GERONTOL A-BIOL, V72, P760, DOI 10.1093/gerona/glx019
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Phelps M, 2013, BIOGERONTOLOGY, V14, P729, DOI 10.1007/s10522-013-9447-2
   Ren J, 2018, TRENDS PHARMACOL SCI, V39, P1064, DOI 10.1016/j.tips.2018.10.005
   Snyder JM, 2019, GEROSCIENCE, V41, P455, DOI 10.1007/s11357-019-00088-w
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Touzot M, 2012, CURR OPIN ORGAN TRAN, V17, P626, DOI 10.1097/MOT.0b013e32835a4be2
   Van Skike CE, 2019, AGING-US, V11, P1331, DOI 10.18632/aging.101869
   Wiley JC, 2011, AGING CELL, V10, P418, DOI 10.1111/j.1474-9726.2011.00680.x
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
NR 29
TC 2
Z9 5
U1 0
U2 2
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 4
PY 2022
VL 12
IS 1
AR 7300
DI 10.1038/s41598-022-11229-1
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 0Z2YF
UT WOS:000790941900039
PM 35508491
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Musicco, C
   Capelli, V
   Pesce, V
   Timperio, AM
   Calvani, M
   Mosconi, L
   Zolla, L
   Cantatore, P
   Gadaleta, MN
AF Musicco, Clara
   Capelli, Valentina
   Pesce, Vito
   Timperio, Anna Maria
   Calvani, Menotti
   Mosconi, Luigi
   Zolla, Lello
   Cantatore, Palmiro
   Gadaleta, Maria Nicola
TI Accumulation of overoxidized Peroxiredoxin III in aged rat liver
   mitochondria
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article
DE Peroxiredoxin III; Aging; Rat liver mitochondria; Protein oxidation;
   Mass spectrometry; Two-dimensional electrophoresis
ID ACETYL-L-CARNITINE; ACTIVE-SITE CYSTEINE; OXIDATIVE STRESS; LON
   PROTEASE; PROTECTIVE ROLE; SOLEUS MUSCLE; SULFINIC ACID; IN-VIVO;
   MECHANISMS; OVEROXIDATION
AB Overoxidation and subsequent inactivation of Peroxiredoxin III (PrxIII), a mitochondrial H2O2 scavenging enzyme, have been reported in oxidative stress conditions. No data are available in the literature about the presence of overoxidized forms of PrxIII in aged tissues. Liver mitochondria from 12-month-old rats and 28-month-old rats were here analyzed by two-dimensional gel electrophoresis. A spot corresponding to the native form of PrxIII was present in adult and old rats with the same volume, whereas an additional, more acidic spot, of the same molecular weight of the native form, accumulated only in old rats. The acidic spot was identified, by MALDI-MS analysis, as a form of PrxIII bearing the cysteine of the catalytic site overoxidized to sulphonic acid. This modified PrxIII form corresponds to the irreversibly inactivated enzyme, here reported, for the first time, in aging. Three groups of 28-month-old rats treated with acetyl-L-carnitine were also examined. Reduced accumulation of the overoxidized PrxIII form was found in all ALCAR-treated groups. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Capelli, Valentina; Pesce, Vito; Cantatore, Palmiro; Gadaleta, Maria Nicola] Univ Bari, Dept Biochem & Mol Biol Ernesto Quagliariello, I-70125 Bari, Italy.
   [Musicco, Clara; Cantatore, Palmiro; Gadaleta, Maria Nicola] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy.
   [Timperio, Anna Maria; Zolla, Lello] Univ Tuscia, Dept Environm Sci, Viterbo, Italy.
   [Calvani, Menotti; Mosconi, Luigi] Sigma Tau Ind Farmaceut Riunite SpA, Rome, Italy.
C3 Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle
   Ricerche (CNR); Tuscia University
RP Gadaleta, MN (corresponding author), Univ Bari, Dept Biochem & Mol Biol Ernesto Quagliariello, Via Orabona 4, I-70125 Bari, Italy.
EM m.n.gadaleta@biologia.uniba.it
RI Musicco, Clara/B-9480-2015; Timperio, Anna Maria/AAN-4248-2020
OI Timperio, Anna Maria/0000-0001-8457-042X; PESCE,
   VITO/0000-0002-9148-3129; Musicco, Clara/0000-0003-4359-4403
CR Araki M, 1999, J BIOL CHEM, V274, P2271, DOI 10.1074/jbc.274.4.2271
   AURELI T, 1994, BRAIN RES, V643, P92, DOI 10.1016/0006-8993(94)90013-2
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Calabrese V, 2003, NEUROCHEM RES, V28, P1321, DOI 10.1023/A:1024984013069
   Cassano P, 2006, BBA-BIOENERGETICS, V1757, P1421, DOI 10.1016/j.bbabio.2006.05.019
   Cesaratto L, 2005, FREE RADICAL RES, V39, P255, DOI 10.1080/10715760400029603
   Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200
   Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200
   Cox AG, 2008, FREE RADICAL BIO MED, V44, P1001, DOI 10.1016/j.freeradbiomed.2007.11.017
   Dhitavat S, 2002, NEUROCHEM RES, V27, P501, DOI 10.1023/A:1019800703683
   Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GADALETA MN, 1994, ANN NY ACAD SCI, V717, P150, DOI 10.1111/j.1749-6632.1994.tb12082.x
   Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com
   Greenawalt J W, 1974, Methods Enzymol, V31, P310
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562
   Iossa S, 2002, J NUTR, V132, P636, DOI 10.1093/jn/132.4.636
   Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452
   Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200
   LIU YB, 1993, FREE RADICAL BIO MED, V15, P667, DOI 10.1016/0891-5849(93)90171-P
   Mansour HH, 2006, PHARMACOL RES, V54, P165, DOI 10.1016/j.phrs.2006.04.003
   Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7
   Mollica MP, 2001, CELL MOL LIFE SCI, V58, P477, DOI 10.1007/PL00000871
   Moriggi M, 2008, PROTEOMICS, V8, P3588, DOI 10.1002/pmic.200701176
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603
   Ngo JK, 2007, ANN NY ACAD SCI, V1119, P78, DOI 10.1196/annals.1404.015
   NOH YH, 2009, J BIOL CHEM     0128
   PARADIES G, 1992, BIOCHIM BIOPHYS ACTA, V1103, P324, DOI 10.1016/0005-2736(92)90103-S
   PARADIES G, 1994, FEBS LETT, V350, P213, DOI 10.1016/0014-5793(94)00763-2
   Paradies G, 1995, MECH AGEING DEV, V84, P103, DOI 10.1016/0047-6374(95)01636-8
   Pesce V, 2004, ANN NY ACAD SCI, V1019, P430, DOI 10.1196/annals.1297.077
   PETRUZZELLA V, 1992, ARCH GERONTOL GERIAT, V14, P131, DOI 10.1016/0167-4943(92)90048-9
   Poon HF, 2006, ANTIOXID REDOX SIGN, V8, P381, DOI 10.1089/ars.2006.8.381
   Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200
   Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Sinha P, 2001, PROTEOMICS, V1, P835, DOI 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.0.CO;2-2
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5
   Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026
   Virmani MA, 2001, ANN NY ACAD SCI, V939, P162
   Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525
   Wang E, 1999, FASEB J, V13, pS167
   Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200
   Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Zanelli SA, 2005, ANN NY ACAD SCI, V1053, P153, DOI 10.1196/annals.1344.013
NR 54
TC 54
Z9 58
U1 0
U2 12
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD JUL
PY 2009
VL 1787
IS 7
BP 890
EP 896
DI 10.1016/j.bbabio.2009.03.002
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 467VU
UT WOS:000267772000016
PM 19272351
DA 2024-02-19
ER

PT J
AU Dallaire, A
   Garand, C
   Paquet, ER
   Mitchell, SJ
   de Cabo, R
   Simard, MJ
   Lebel, M
AF Dallaire, Alexandra
   Garand, Chantal
   Paquet, Eric R.
   Mitchell, Sarah J.
   de Cabo, Rafael
   Simard, Martin J.
   Lebel, Michel
TI Down regulation of miR-124 in both Werner syndrome DNA helicase mutant
   mice and mutant <i>Caenorhabditis elegans wrn</i>-<i>1</i> reveals the
   importance of this microRNA in accelerated aging
SO AGING-US
LA English
DT Article
DE Werner syndrome; aging; microRNA; liver; mouse; nematode
ID SYNDROME PROTEIN; SYNDROME GENE; LIFE-SPAN; RECQ HELICASE; MOUSE LUNG;
   ELEGANS; EXPRESSION; EXONUCLEASE; INSULIN; CELLS
AB Small non-coding microRNAs are believed to be involved in the mechanism of aging but nothing is known on the impact of microRNAs in the progeroid disorder Werner syndrome (WS). WS is a premature aging disorder caused by mutations in a RecQ-like DNA helicase. Mice lacking the helicase domain of the WRN ortholog exhibit many phenotypic features of WS, including a pro-oxidant status and a shorter mean life span. Caenorhabditis elegans (C. elegans) with a nonfunctional wrn-1 DNA helicase also exhibit a shorter life span. Thus, both models are relevant to study the expression of microRNAs involved in WS. In this study, we show that miR-124 expression is lost in the liver of Wrn helicase mutant mice. Interestingly, the expression of this conserved miR-124 in whole wrn-1 mutant worms is also significantly reduced. The loss of mir-124 in C. elegans increases reactive oxygen species formation and accumulation of the aging marker lipofuscin, reduces whole body ATP levels and results in a reduction in life span. Finally, supplementation of vitamin C normalizes the median life span of wrn-1 and mir-124 mutant worms. These results suggest that biological pathways involving WRN and miR-124 are conserved in the aging process across different species.
C1 [Dallaire, Alexandra; Garand, Chantal; Paquet, Eric R.; Simard, Martin J.; Lebel, Michel] Univ Laval, Ctr Rech Cancerol, Hop Hotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada.
   [Mitchell, Sarah J.; de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA.
   [Mitchell, Sarah J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
C3 Laval University; National Institutes of Health (NIH) - USA; NIH
   National Institute on Aging (NIA); University of Sydney
RP Lebel, M (corresponding author), Univ Laval, Ctr Rech Cancerol, Hop Hotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada.
EM michel.lebel@crhdq.ulaval.ca
RI de Cabo, Rafael Carlos/E-7996-2010; de Cabo, Rafael/J-5230-2016
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; Garand,
   Chantal/0000-0003-0716-6487; de Cabo, Rafael/0000-0002-3354-2442;
   Simard, Martin/0000-0002-3189-9309; Dallaire,
   Alexandra/0000-0003-1097-7766; Paquet, Eric/0000-0001-9194-1655
FU National Institute of Health National Center for Research Resources;
   Canadian Institutes of Health Research; National Institute on Aging of
   the National Institutes of Health, USA; National Health and Medical
   Research Council of Australia CJ Martin Early Career Fellowship (RIMS
   Project) [2010-01671]
FX We would like to thank Dr. Patrick Laprise (Centre de Recherche en
   Cancerologie de l'Universite Laval, Canada) for allowing us to use his
   COPAS Biosort instrument. Nematode strains were provided by the
   Caenorhabditis Genetics Center, which is funded by the National
   Institute of Health National Center for Research Resources. This work
   was supported by the Canadian Institutes of Health Research to M. L. and
   M.J.S. R.d.C. is supported by the Intramural Research Program of the
   National Institute on Aging of the National Institutes of Health, USA.
   S.J.M. is supported by a National Health and Medical Research Council of
   Australia CJ Martin Early Career Fellowship (RIMS Project ID
   2010-01671). M.J.S. is a Junior II scholar from the Fonds de la
   Recherche en Sante du Quebec.
CR Balajee AS, 1999, MOL BIOL CELL, V10, P2655, DOI 10.1091/mbc.10.8.2655
   Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200
   Bates DJ, 2010, AGING CELL, V9, P1, DOI 10.1111/j.1474-9726.2009.00529.x
   Bates DJ, 2009, BBA-GEN SUBJECTS, V1790, P970, DOI 10.1016/j.bbagen.2009.03.028
   BRENNER S, 1974, GENETICS, V77, P71
   Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294
   Clark AM, 2010, NUCLEIC ACIDS RES, V38, P3780, DOI 10.1093/nar/gkq083
   Cooper MP, 2000, GENE DEV, V14, P907
   Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619
   EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001
   FRIEDMAN DB, 1988, GENETICS, V118, P75
   Grillari J, 2010, EXP GERONTOL, V45, P302, DOI 10.1016/j.exger.2010.01.007
   Hamrick MW, 2010, BIOCHEM BIOPH RES CO, V400, P379, DOI 10.1016/j.bbrc.2010.08.079
   Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043
   Huang JZ, 2009, J MOL BIOL, V387, P559, DOI 10.1016/j.jmb.2009.02.028
   Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396
   Hyun M, 2008, BIOCHEMISTRY-US, V47, P7583, DOI 10.1021/bi800197m
   Ibáñez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x
   Ibáñez-Ventoso C, 2009, CURR GENOMICS, V10, P144, DOI 10.2174/138920209788185243
   Izzotti A, 2009, FASEB J, V23, P3243, DOI 10.1096/fj.09-135251
   Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Khanna A, 2011, AGING-US, V3, P223, DOI 10.18632/aging.100276
   Kipling D, 2004, SCIENCE, V305, P1426, DOI 10.1126/science.1102587
   Labbé A, 2011, J GERONTOL A-BIOL, V66, P264, DOI 10.1093/gerona/glq184
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Lebel M, 2003, AM J PATHOL, V162, P1559, DOI 10.1016/S0002-9440(10)64290-3
   Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097
   Lee SJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000801
   Lee SJ, 2004, DEVELOPMENT, V131, P2565, DOI 10.1242/dev.01136
   Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004
   Li N, 2011, NEUROBIOL AGING, V32, P944, DOI 10.1016/j.neurobiolaging.2009.04.020
   Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   Massip L, 2006, EXP GERONTOL, V41, P157, DOI 10.1016/j.exger.2005.10.011
   Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133
   Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215
   Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020
   Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002
   SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598
   Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8
   Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139
   Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200
   Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172
   Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X
   Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258
NR 46
TC 28
Z9 32
U1 0
U2 5
PU IMPACT JOURNALS LLC
PI ALBANY
PA 6211 TIPTON HOUSE, STE 6, ALBANY, NY 12203 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD SEP
PY 2012
VL 4
IS 9
BP 636
EP 647
DI 10.18632/aging.100489
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 024SD
UT WOS:000310128000006
PM 23075628
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Parentini, H
   Cavallini, G
   Donati, A
   Gori, Z
   Bergamini, E
AF Parentini, H
   Cavallini, G
   Donati, A
   Gori, Z
   Bergamini, E
TI Accumulation of dolichol in older tissues satisfies the proposed
   criteria to be qualified a biomarker of aging
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID AGE-RELATED-CHANGES; RAT-LIVER; DIETARY RESTRICTION; LIPID COMPOSITIONS;
   SERUM DOLICHOLS; METABOLISM; CELLS; PHOSPHATE; PLASMA; BRAIN
AB Criteria for defining biomarkers have been suggested. Accumulation of dolichol in tissues of older animals meets the following criteria: (a) levels of dolichol exhibit a quantitative correlation with age in all tissues and are not altered by several age-dependent diseases in the same direction as that of aging; (b) accumulation is not secondary to metabolic changes of aging and is altered appropriately by factors that modulate the aging rate like caloric restriction and physical exercise; (c) biomarker is applicable to different tissues across mammalian species, including humans, and to trisomy 21 and its hypothalamic digoxin-mediated model. Reliable changes in tissue dolichol levels are seen in relatively short intervals of time compared to over a life span, and levels can be tested on a small amount of tissue without causing death of the animal. In this article, we show applications to the study of host-graft interaction and detection of gender-related differences in biological age, and we discuss mechanism(s) of accumulation.
C1 Univ Pisa, Ctr Ric Biol & Patol Invecchiamento, I-56126 Pisa, Italy.
C3 University of Pisa
RP Bergamini, E (corresponding author), Univ Pisa, Ctr Ric Biol & Patol Invecchiamento, Via Roma 55, I-56126 Pisa, Italy.
EM ebergami@med.unipi.it
CR Andersson M, 1995, MECH AGEING DEV, V85, P1, DOI 10.1016/0047-6374(95)01642-2
   BAKER GT, 1988, EXP GERONTOL, V23, P223, DOI 10.1016/0531-5565(88)90025-3
   BERG JM, 2002, BIOCHEMISTRY-US, P736
   Bergamini E, 2004, J ALZHEIMERS DIS, V6, P129
   Bizzarri R, 2003, BIOGERONTOLOGY, V4, P353, DOI 10.1023/B:BGEN.0000006555.87407.04
   BROOKSBANK BWL, 1989, MOL CHEM NEUROPATHOL, V11, P157, DOI 10.1007/BF03160049
   BURGOS J, 1963, BIOCHEM J, V88, P470, DOI 10.1042/bj0880470
   CARROLL KK, 1992, BIOCHEM CELL BIOL, V70, P382, DOI 10.1139/o92-059
   Casu A, 2002, BBA-MOL CELL BIOL L, V1583, P266, DOI 10.1016/S1388-1981(02)00251-2
   Cavallini G, 2003, BIOGERONTOLOGY, V4, P347, DOI 10.1023/B:BGEN.0000006554.23397.a0
   Cavallini G, 2003, BIOGERONTOLOGY, V4, P341, DOI 10.1023/B:BGEN.0000006553.13232.a5
   Cavallini G, 2002, AGING CLIN EXP RES, V14, P152
   Cavallini G, 2002, LIPIDS, V37, P913, DOI 10.1007/s11745-002-0979-y
   CAVALLINI G, 2002, BIOGERONTOLOGY S1, V3, P4
   CERAMI A, 1985, J AM GERIATR SOC, V33, P626, DOI 10.1111/j.1532-5415.1985.tb06319.x
   CHOJNACKI T, 1988, BIOCHEM J, V251, P1
   DANIELS I, 1990, LIPIDS, V25, P586, DOI 10.1007/BF02536006
   De Cabo R, 2004, EXP GERONTOL, V39, P297, DOI 10.1016/j.exger.2003.12.003
   Di Stefano R, 2001, TRANSPLANT P, V33, P901, DOI 10.1016/S0041-1345(00)02369-1
   Dini B, 2001, EXP GERONTOL, V37, P99, DOI 10.1016/S0531-5565(01)00156-5
   Dolfi C, 2003, BIOGERONTOLOGY, V4, P113, DOI 10.1023/A:1023304021679
   DOLFI C, 1999, GIORNALE GERONTOL, V47, P275
   Duffy PH, 2001, AGING-CLIN EXP RES, V13, P263
   EDLUND C, 1994, NEUROCHEM INT, V25, P35, DOI 10.1016/0197-0186(94)90050-7
   EGGENS I, 1988, BRIT J EXP PATHOL, V69, P671
   EGGENS I, 1983, BIOCHIM BIOPHYS ACTA, V751, P355, DOI 10.1016/0005-2760(83)90294-1
   ELMBERGER PG, 1989, LIPIDS, V24, P919, DOI 10.1007/BF02544535
   GRONAR Y, 1997, ENCY HUMAN BIOL, P463
   Humaloja K, 1999, J HEPATOL, V31, P1014, DOI 10.1016/S0168-8278(99)80313-4
   Humaloja K, 1997, LIPIDS, V32, P1169, DOI 10.1007/s11745-997-0150-9
   HUMALOJA K, 1991, SCAND J CLIN LAB INV, V51, P705, DOI 10.3109/00365519109104584
   Ishinaga M, 1996, BIOCHEM CELL BIOL, V74, P265, DOI 10.1139/o96-028
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   Keller RK, 1996, BBA-LIPID LIPID MET, V1303, P169, DOI 10.1016/0005-2760(96)00081-1
   KOTHAPALLI R, 1994, BIOCHEM CELL BIOL, V72, P62, DOI 10.1139/o94-011
   Kurup RK, 2003, PEDIATR PATHOL MOL M, V22, P411, DOI 10.1080/15227950390223721
   MARINARI UM, 1995, ITAL J BIOCHEM, V44, P1
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   Marino M, 2002, MECH AGEING DEV, V123, P1183, DOI 10.1016/S0047-6374(02)00009-X
   MOORADIAN AD, 1990, J GERONTOL, V45, pB183, DOI 10.1093/geronj/45.6.B183
   Nanni G, 2000, LIFE SCI, V67, P2293, DOI 10.1016/S0024-3205(00)00819-5
   PALLOTTINI V, 2004, P 55 C SOC FIS, P96
   Parentini I, 2003, BIOGERONTOLOGY, V4, P365, DOI 10.1023/B:BGEN.0000006556.76899.29
   PULLARKAT RK, 1982, J BIOL CHEM, V257, P5991
   PULLARKAT RK, 1984, BIOCHIM BIOPHYS ACTA, V793, P494, DOI 10.1016/0005-2760(84)90269-8
   RIP JW, 1985, PROG LIPID RES, V24, P269, DOI 10.1016/0163-7827(85)90008-6
   SAKAKIHARA Y, 1989, CLIN CHIM ACTA, V184, P333, DOI 10.1016/0009-8981(89)90068-5
   SCHEDIN S, 1995, J NEUROCHEM, V65, P670
   SHARMA C, 1987, P SOC EXP BIOL MED, V185, P347
   TAMBURINI I, IN PRESS AGING CLIN
   THELIN A, 1994, MECH AGEING DEV, V76, P165, DOI 10.1016/0047-6374(94)91591-1
   YAMADA K, 1985, ANAL BIOCHEM, V150, P26, DOI 10.1016/0003-2697(85)90437-3
   YASUGI E, 1994, BBA-LIPID LIPID MET, V1211, P107, DOI 10.1016/0005-2760(94)90144-9
   Zhang YY, 1996, NEUROBIOL AGING, V17, P869, DOI 10.1016/S0197-4580(96)00076-0
NR 54
TC 29
Z9 35
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JAN
PY 2005
VL 60
IS 1
BP 39
EP 43
DI 10.1093/gerona/60.1.39
PG 5
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 902MF
UT WOS:000227360500006
PM 15741281
OA Bronze
DA 2024-02-19
ER

PT S
AU Kovalenko, SA
   Kopsidas, G
   Kelso, J
   Rosenfeldt, F
   Linnane, AW
AF Kovalenko, SA
   Kopsidas, G
   Kelso, J
   Rosenfeldt, F
   Linnane, AW
BE Harman, D
   Holliday, R
   Meydani, M
TI Tissue-specific distribution of multiple mitochondrial DNA
   rearrangements during human aging
SO TOWARDS PROLONGATION OF THE HEALTHY LIFE SPAN: PRACTICAL APPROACHES TO
   INTERVENTION
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT Conference on Towards Prolongation of the Healthy Life Span - Practical
   Approaches to Intervention
CY AUG 15-18, 1997
CL ADELAIDE, AUSTRALIA
SP 7th Congress Int Assoc Biomed Gerontol
ID DEGENERATIVE DISEASES; OXIDATIVE DAMAGE; HUMAN BRAIN; AGE; MUTATIONS;
   DELETIONS; OXYGEN; DECAY; PCR; ACCUMULATION
AB Mitochondria, according to the free radical theory of aging, are the major source of reactive oxygen species (ROS), The results, presented in this paper, question the role of reactive oxygen species in contributing significantly to the extent of mitochondrial bioenergy degradation of the tissues, which can be correlated with mtDNA rearrangements, We report here that mtDNA rearrangements, including deletions and duplications, in tissues from human aged subjects, occur in levels ranging from very low in liver, to considerable in cardiac muscle, to almost total in skeletal muscle, The extent of mtDNA rearrangements is correlated at both the individual tissue and cell level with cytochrome oxidase (COX) activity as the exemplifier of cellular bioenergy capacity. Thus, the ROS proposal in its simplest form as it affects mtDNA and mitochondrial electron transport system is not supported by the available data.
C1 Epworth Hosp, Ctr Mol Biol & Med, Melbourne, Vic 3121, Australia.
   Baker Inst, Cardiac Res Unit, Melbourne, Vic, Australia.
C3 Baker Heart and Diabetes Institute
RP Kovalenko, SA (corresponding author), Epworth Hosp, Ctr Mol Biol & Med, 185-187 Hoddle St, Melbourne, Vic 3121, Australia.
EM tlinnane@cmbm.com.au
RI Linnane, Anthony W/A-6546-2011
CR BAUMER A, 1994, AM J HUM GENET, V54, P618
   Beckman K B, 1996, Methods Enzymol, V264, P442, DOI 10.1016/S0076-6879(96)64040-3
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   FRAGA CG, 1988, BIOCHEM J, V252, P893, DOI 10.1042/bj2520893
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   HAYAKAWA M, 1995, BIOCHEM BIOPH RES CO, V215, P952, DOI 10.1006/bbrc.1995.2556
   KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W
   KOPSIDAS G, 1998, IN PRESS MUTAT RES
   Kovalenko SA, 1997, BIOCHEM BIOPH RES CO, V232, P147, DOI 10.1006/bbrc.1997.6251
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   LEE CM, 1993, J GERONTOL, V48, P201
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   LINNANE AW, 1992, MUTAT RES, V275, P195, DOI 10.1016/0921-8734(92)90023-I
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   Linnane AW, 1997, FASEB J, V11, pA1450
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu VWS, 1997, HUM MUTAT, V9, P265, DOI 10.1002/(SICI)1098-1004(1997)9:3<265::AID-HUMU8>3.3.CO;2-6
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Nagley Phillip, 1993, P137
   NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   SOONG NW, 1992, NAT GENET, V2, P318
   Stadtman E R, 1992, EXS, V62, P64
   TANAKA M, 1991, BIOCHEM BIOPH RES CO, V174, P861, DOI 10.1016/0006-291X(91)91497-Z
   TAPPEL AL, 1973, FED PROC, V32, P1870
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   ZHANG C, 1992, FEBS LETT, V297, P4
   Zhang CF, 1997, BIOCHEM BIOPH RES CO, V230, P630, DOI 10.1006/bbrc.1996.6020
NR 42
TC 28
Z9 30
U1 0
U2 4
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-108-1
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 1998
VL 854
BP 171
EP 181
DI 10.1111/j.1749-6632.1998.tb09900.x
PG 11
WC Geriatrics & Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Science & Technology - Other Topics
GA BM29P
UT WOS:000078303400016
PM 9928428
DA 2024-02-19
ER

PT J
AU CHOI, JH
   YU, BP
AF CHOI, JH
   YU, BP
TI BRAIN SYNAPTOSOMAL AGING - FREE-RADICALS AND MEMBRANE FLUIDITY
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE SYNAPTOSOMES; MEMBRANE FLUIDITY; FREE RADICALS; HYDROGEN PEROXIDE;
   CHOLESTEROL/PHOSPHOLIPID; AGE; DIETARY RESTRICTION
ID CHRONIC FOOD RESTRICTION; DIETARY RESTRICTION; RAT-BRAIN;
   LIPID-PEROXIDATION; AGED RATS; DAMAGE; LIVER; MODULATION; RECEPTORS;
   INVIVO
AB Dietary restriction was used in this study as a modulator of free radical reactions to examine the effects of age on the physico-biochemical property of synaptosomal membranes. Synaptosomal membranes were isolated from the frontal cortices of 6- and 24-month-old barrier-reared male Fischer 344 rats maintained on either an ad lib (AL) or a 40% diet restricted (DR) feeding schedule. The age-related production of reactive oxygen species (ROS) was only seen in the AL group, and dietary restriction suppressed the amount of the reactive species at both ages. Although membrane fluidity significantly decreased with age in AL fed rats, no change occurred in DR rats. Because age-related increases in cholesterol/phospholipid occurred in both At and DR groups, fluidity loss may be influenced by factors other than cholesterol. We suggest that lipid peroxidation may be a major factor in the change in fluidity during the aging process.
C1 UNIV TEXAS, HLTH SCI CTR, DEPT PHYSIOL, SAN ANTONIO, TX 78284 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
FU NIA NIH HHS [AG01188] Funding Source: Medline
CR ANDO S, 1990, NEUROSCI LETT, V113, P199, DOI 10.1016/0304-3940(90)90303-Q
   APRIKYAN GV, 1988, GERONTOLOGY, V34, P35, DOI 10.1159/000212928
   ARAI H, 1987, BIOCHEM INT, V14, P741
   BENZI G, 1989, NEUROCHEM RES, V14, P473, DOI 10.1007/BF00964863
   BONDY SC, 1992, NEUROTOXICOLOGY, V13, P87
   CADENAS E, 1981, BIOCHEM J, V198, P645, DOI 10.1042/bj1980645
   CALDERINI G, 1983, NEUROCHEM RES, V8, P483, DOI 10.1007/BF00965104
   CHOI JH, 1992, GERONTOLOGIST, V32, P30
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   FLOYD RA, 1984, FREE RADICALS MOL BI, P143
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   GOVONI S, 1980, MECH AGEING DEV, V12, P39, DOI 10.1016/0047-6374(80)90027-5
   HABIB MP, 1990, J APPL PHYSIOL, V68, P2588, DOI 10.1152/jappl.1990.68.6.2588
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78
   JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5
   JOSEPH JA, 1983, NEUROBIOL AGING, V4, P191, DOI 10.1016/0197-4580(83)90020-9
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   LEBEL CP, 1989, BIOCHEM BIOPH RES CO, V163, P860, DOI 10.1016/0006-291X(89)92301-2
   LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O
   Lee D W, 1990, Aging (Milano), V2, P357
   LEE DW, 1991, INT CONGR SER, V940, P17
   LONDON ED, 1985, NEUROBIOL AGING, V6, P199, DOI 10.1016/0197-4580(85)90050-8
   MAGUIRE PA, 1989, BRAIN RES BULL, V22, P431, DOI 10.1016/0361-9230(89)90070-1
   MASORO EJ, 1991, NEUROBIOL AGING, V12, P639, DOI 10.1016/0197-4580(91)90114-Y
   OLAFSON RW, 1969, CAN J BIOCHEM CELL B, V47, P961, DOI 10.1139/o69-151
   PORTA EA, 1988, CELLULAR ANTIOXIDANT, V3, P1
   ROTH GS, 1984, BRAIN RES, V300, P27, DOI 10.1016/0006-8993(84)91337-4
   SCHROEDER F, 1984, NEUROBIOL AGING, V5, P323, DOI 10.1016/0197-4580(84)90010-1
   STRONG R, 1984, J PHARMACOL EXP THER, V229, P726
   VIANI P, 1991, J NEUROCHEM, V56, P253, DOI 10.1111/j.1471-4159.1991.tb02589.x
   VOLICER L, 1990, NEUROBIOL AGING, V11, P567, DOI 10.1016/0197-4580(90)90119-K
   VORBECK ML, 1982, ARCH BIOCHEM BIOPHYS, V217, P351, DOI 10.1016/0003-9861(82)90511-2
   WEINDRUCH R, 1988, RETARDATION AGING DI
   WHEELER DD, 1983, EXP GERONTOL, V18, P125, DOI 10.1016/0531-5565(83)90005-0
   WOOD WG, 1984, LIFE SCI, V35, P1947, DOI 10.1016/0024-3205(84)90475-2
   WOOD WG, 1985, HOMEOSTATIC FUNCTION, P125
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   YU BP, 1990, REV BIOL RES AGING, V4, P349
   ZHAN H, 1992, MECH AGEING DEV, V62, P111, DOI 10.1016/0047-6374(92)90047-H
NR 44
TC 134
Z9 145
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD FEB
PY 1995
VL 18
IS 2
BP 133
EP 139
DI 10.1016/0891-5849(94)00106-T
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA QF074
UT WOS:A1995QF07400001
PM 7744296
DA 2024-02-19
ER

PT J
AU CHIARPOTTO, E
   BIASI, F
   SCAVAZZA, A
   CAMANDOLA, S
   DIANZANI, MU
   POLI, G
AF CHIARPOTTO, E
   BIASI, F
   SCAVAZZA, A
   CAMANDOLA, S
   DIANZANI, MU
   POLI, G
TI METABOLISM OF 4-HYDROXY-2-NONENAL AND AGING
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID ISOLATED RAT HEPATOCYTES; LIPID-PEROXIDATION; CARBON-TETRACHLORIDE;
   ALDEHYDIC PRODUCTS; GLUTATHIONE TRANSFERASES; OXYGEN RADICALS; PROTEIN
   DAMAGE; LIVER; MITOCHONDRIAL; SEPARATION
AB Hepatocytes isolated from male Wistar rats of 2-3 and 20-24 months of age were compared as regards concentration and metabolism of 4-hydroxy-2-nonenal, one of the major aldehyde products of n-6 fatty acid oxidative breakdown. A significant accumulation of fluorescent 4-hydroxy-2-nonenal-membrane lipid adducts was found in the cells from the old rats. The mechanism mainly responsible for such aldehyde accumulation was shown to be the impairment of its enzymatic metabolism. In fact, while endogenous, that is non-stimulated, aldehyde production was not impaired, the reductive pathway of 4-hydroxy-2-nonenal metabolism in hepatocytes from old rats was strongly depressed. The decrease of 4-hydroxy-2-nonenal consumption with age was confirmed in homogenates from liver and kidney, while there were no differences between young and old animals in heart, lung or brain. (C) 1995 Academic Press, Inc.
C1 UNIV TURIN,DEPT EXPTL MED & ONCOL,GEN PATHOL SECT,I-10125 TURIN,ITALY.
   CNR,CTR IMMUNOGENET & EXPTL ONCOL,I-10126 TURIN,ITALY.
C3 University of Turin; Consiglio Nazionale delle Ricerche (CNR)
CR [Anonymous], 1982, FREE RADIC LIPID PER
   BERNHEIM F, 1948, J BIOL CHEM, V174, P257
   BIASI F, 1991, CELL BIOCHEM FUNCT, V9, P111, DOI 10.1002/cbf.290090208
   CARINI R, 1988, ADV BIOSCI, V71, P61
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   DAVIES KJA, 1988, LIPOFUSCIN 1987 STAT, P109
   DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P334, DOI 10.1016/0003-9861(84)90206-6
   ESTERBAUER H, 1986, BIOCHEM J, V239, P405, DOI 10.1042/bj2390405
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   ESTERBAUER H, 1982, BIOCHEM J, V208, P129, DOI 10.1042/bj2080129
   ESTERBAUER H, 1985, BIOCHEM J, V22, P363
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HUNT JV, 1988, BIOCHEM J, V256, P205, DOI 10.1042/bj2560205
   KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849
   MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226
   MITCHELL DY, 1987, TOXICOL APPL PHARM, V87, P403, DOI 10.1016/0041-008X(87)90245-6
   PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4
   POLI G, 1987, CHEM PHYS LIPIDS, V45, P117, DOI 10.1016/0009-3084(87)90063-6
   POLI G, 1985, BIOCHEM J, V227, P629, DOI 10.1042/bj2270629
   POLI G, 1979, EXP MOL PATHOL, V30, P116, DOI 10.1016/0014-4800(79)90086-8
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   SLATER TF, 1972, FREE RADICAL MECHANI
   SPEARMAN ME, 1984, BIOCHEM PHARMACOL, V33, P1309, DOI 10.1016/0006-2952(84)90185-0
   WARHOLM M, 1985, METHOD ENZYMOL, V113, P499
   WOLFF SP, 1986, BIOCHEM J, V234, P399, DOI 10.1042/bj2340399
NR 25
TC 19
Z9 22
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD FEB 15
PY 1995
VL 207
IS 2
BP 477
EP 484
DI 10.1006/bbrc.1995.1213
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA QG836
UT WOS:A1995QG83600001
PM 7864834
DA 2024-02-19
ER

PT J
AU King, TL
   Underwood, KB
   Hansen, KK
   Kinter, MT
   Schneider, A
   Masternak, MM
   Mason, JB
AF King, Tristin L.
   Underwood, Kaden B.
   Hansen, Kindra K.
   Kinter, Michael T.
   Schneider, Augusto
   Masternak, Michal M.
   Mason, Jeffrey B.
TI Chronological and reproductive aging-associated changes in resistance to
   oxidative stress in post-reproductive female mice
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Menopause; Oxidative stress; Estradiol; Follicle; Ovarian
ID YOUNG OVARIES; SUPEROXIDE; CELLS; TRANSPLANTATION; POSTMENOPAUSAL;
   RESTORATION; ACTIVATION; REDUCTION; LONGEVITY; MENOPAUSE
AB Effort toward reproduction is often thought to negatively influence health and survival. Reproduction has been shown to influence metabolism, but the pathways and mechanisms have yet to be thoroughly elucidated. In the current experiments, our aim was to dissect the role of young and old ovarian tissues in the response to oxidative stress, through changes in liver oxidative stress response proteins. Liver proteins were analyzed in control mice at 4, 13, and 27 months of age and compared to 23-month-old mice which received young ovarian tissue transplants (intact or follicle-depleted) at 13 months of age. In control mice, of the 29 oxidative stress response proteins measured, 31% of the proteins decreased, 52% increased, and 17% were unchanged from 13 to 27 months. The greatest changes were seen during the period of reproductive failure, from 4 to 13 months of age. In transplanted mice, far more proteins were decreased from 13 to 23 months (93% in follicle-containing young ovary recipients; 62% in follicle-depleted young ovary recipients). Neither transplant group reflected changes seen in control mice between 13 and 27 months. Estradiol levels in transplant recipient mice were not increased compared with age-matched control mice. The current results suggest the presence of a germ cell- and estradiol-independent ovarian influence on aging-associated changes in the response to oxidative stress, which is manifest differently in reproductive-aged adults and post-reproductive-aged mice. The results presented here separate chronological and ovarian aging and the influence of estradiol in the response to aging-associated oxidative stress and support a novel, estradiol-independent role for the ovary in female health and survival.
C1 [King, Tristin L.; Underwood, Kaden B.; Hansen, Kindra K.; Mason, Jeffrey B.] Utah State Univ, Coll Vet Med, Ctr Integrated Biosyst, Dept Vet Clin & Life Sci, Logan, UT 84322 USA.
   [Kinter, Michael T.] Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK USA.
   [Schneider, Augusto] Univ Fed Pelotas, Fac Nutricao, Pelotas, Rio Grande do S, Brazil.
   [Masternak, Michal M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL USA.
   [Masternak, Michal M.] Poznan Univ Med Sci, Dept Head & Neck Surg, Poznan, Poland.
C3 Utah System of Higher Education; Utah State University; Oklahoma Medical
   Research Foundation; Universidade Federal de Pelotas; State University
   System of Florida; University of Central Florida; Poznan University of
   Medical Sciences
RP Mason, JB (corresponding author), Utah State Univ, Coll Vet Med, Ctr Integrated Biosyst, Dept Vet Clin & Life Sci, Logan, UT 84322 USA.
EM jeff.mason@usu.edu
RI Schneider, Augusto/B-5011-2014; Mason, Jeffrey/I-8601-2017
OI Schneider, Augusto/0000-0002-3410-2860; Mason,
   Jeffrey/0000-0003-2459-1186
FU National Institute on Aging of the National Institutes of Health
   [R15AG061795, R56AG074499]; Nathan Shock Center Pilot Funding Program;
   Oklahoma Nathan Shock Center core facility [P30 AG050911]; Utah
   Agricultural Experiment Station [UTA01159]; Utah State University;
   College of Veterinary Medicine, Department of Animal, Dairy and
   Veterinary Sciences, Utah State University
FX Research reported in this publication was supported by the National
   Institute on Aging of the National Institutes of Health under award
   number R15AG061795 to J.B.M. and R56AG074499 to M.M.M and J.B.M. This
   work was also supported by the Nathan Shock Center Pilot Funding Program
   and the Oklahoma Nathan Shock Center core facility under award number
   P30 AG050911, the Utah Agricultural Experiment Station, grant number
   UTA01159, Utah State University, and by the College of Veterinary
   Medicine, Department of Animal, Dairy and Veterinary Sciences, Utah
   State University.
CR Ansere VA, 2021, MECH AGEING DEV, V194, DOI 10.1016/j.mad.2020.111425
   Barnett KR, 2006, HUM REPROD UPDATE, V12, P537, DOI 10.1093/humupd/dml022
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Bridgeman SC, 2018, DIABETES OBES METAB, V20, P1553, DOI 10.1111/dom.13262
   CASALINO SM, 1994, PROSTAG LEUKOTR ESS, V51, P41, DOI 10.1016/0952-3278(94)90176-7
   Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA
   Csiszar A, 2007, AGING CELL, V6, P783, DOI 10.1111/j.1474-9726.2007.00339.x
   Csiszar A, 2014, AM J PHYSIOL-HEART C, V307, pH292, DOI 10.1152/ajpheart.00307.2014
   Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004
   Dalal PK, 2015, INDIAN J PSYCHIAT, V57, pS222, DOI 10.4103/0019-5545.161483
   de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528
   Duan SR, 2020, DRUG DES DEV THER, V14, P3143, DOI [10.2147/DDDT.S255628, 10.2147/DDDT.S255828]
   Eppig JJ, 2000, BIOL REPROD, V63, P1014, DOI 10.1095/biolreprod63.4.1014
   Eshkoor SA, 2012, GENET MOL RES, V11, P1486, DOI 10.4238/2012.May.21.5
   FADDY MJ, 1987, CELL TISSUE KINET, V20, P551, DOI 10.1111/j.1365-2184.1987.tb01364.x
   Fang EF, 2017, TRENDS MOL MED, V23, P899, DOI 10.1016/j.molmed.2017.08.001
   Finch CE, 2014, J STEROID BIOCHEM, V142, P132, DOI 10.1016/j.jsbmb.2013.03.010
   Francisco S, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23063232
   Fryar Cheryl D, 2012, NCHS Data Brief, P1
   Garcia DN, 2019, GEROSCIENCE, V41, P395, DOI 10.1007/s11357-019-00087-x
   GOSDEN RG, 1978, EXP GERONTOL, V13, P159, DOI 10.1016/0531-5565(78)90008-6
   Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200
   GSELL W, 1995, J NEUROCHEM, V64, P1216
   Habermehl T.L., 2019, OBSTET GYNECOLOGY OP, DOI [10.29011/2577-2236/100031, DOI 10.29011/2577-2236/100031]
   Habermehl TL, 2022, GEROSCIENCE, V44, P2157, DOI 10.1007/s11357-022-00549-9
   Habermehl TL, 2019, GEROSCIENCE, V41, P25, DOI 10.1007/s11357-018-0049-4
   Habermehl TL, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010040
   Henderson VW, 2009, COGN BEHAV NEUROL, V22, P205, DOI 10.1097/WNN.0b013e3181a74ce7
   Hense JD, 2022, GEROSCIENCE, V44, P1747, DOI 10.1007/s11357-022-00573-9
   Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006
   Ho HY, 2007, REDOX REP, V12, P109, DOI 10.1179/135100007X200209
   Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250
   Hoyer PB, 1996, ANNU REV PHARMACOL, V36, P307, DOI 10.1146/annurev.pa.36.040196.001515
   Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003
   Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299
   Jacobsen BK, 1999, J CLIN EPIDEMIOL, V52, P303, DOI 10.1016/S0895-4356(98)00170-X
   Jin Z, 2020, INT IMMUNOPHARMACOL, V78, DOI 10.1016/j.intimp.2019.105946
   JONES EC, 1961, J ENDOCRINOL, V21, P469, DOI 10.1677/joe.0.0210469
   Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391
   Kruk J, 2019, FREE RADICAL RES, V53, P497, DOI 10.1080/10715762.2019.1612059
   Labinskyy N, 2006, AM J PHYSIOL-HEART C, V291, pH2698, DOI 10.1152/ajpheart.00534.2006
   Lee JY, 2021, J CANCER, V12, P2825, DOI 10.7150/jca.55553
   Lohff JC, 2005, COMPARATIVE MED, V55, P523
   Mason JB, 2022, J GERONTOL A-BIOL, V77, P75, DOI 10.1093/gerona/glab252
   Mason JB, 2018, JOVE-J VIS EXP, DOI 10.3791/56638
   Mason JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145821
   Mason JB, 2011, AGING CELL, V10, P448, DOI 10.1111/j.1474-9726.2011.00691.x
   Mason JB, 2010, EXP GERONTOL, V45, P435, DOI 10.1016/j.exger.2010.03.010
   Mason JB, 2009, J GERONTOL A-BIOL, V64, P1207, DOI 10.1093/gerona/glp134
   McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101
   McLean Robert R, 2009, Curr Osteoporos Rep, V7, P134
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Nilsen J, 2008, FRONT NEUROENDOCRIN, V29, P463, DOI 10.1016/j.yfrne.2007.12.005
   Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003
   Nunes ADC, 2022, GEROSCIENCE, V44, P503, DOI 10.1007/s11357-021-00490-3
   Olson E, 2019, J HYPERTENS, V37, P985, DOI 10.1097/HJH.0000000000001960
   Papa L, 2014, J BIOL CHEM, V289, P5412, DOI 10.1074/jbc.C113.526475
   PARKENING TA, 1985, BIOL REPROD, V32, P989, DOI 10.1095/biolreprod32.5.989
   Parkinson KC, 2017, EXP GERONTOL, V92, P28, DOI 10.1016/j.exger.2017.03.002
   Peterson RL, 2017, REPROD FERT DEVELOP, V29, P2052, DOI [10.1071/RD16333, 10.1071/rd16333]
   Peterson RL, 2016, J TRANSPLANT, V2016, DOI 10.1155/2016/4570842
   Pinto YM, 1998, CARDIOVASC RES, V39, P77, DOI 10.1016/S0008-6363(98)00077-7
   Piotrowski I, 2021, CANCERS, V13, DOI 10.3390/cancers13163980
   Rivera Z, 2009, BIOL REPROD, V80, P328, DOI 10.1095/biolreprod.108.070359
   Robert H, 2021, JOVE-J VIS EXP, DOI 10.3791/62884
   Santo Signorelli S, 2006, MATURITAS, V53, P77, DOI 10.1016/j.maturitas.2005.03.001
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]
   Shuster LT, 2010, MATURITAS, V65, P161, DOI 10.1016/j.maturitas.2009.08.003
   Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105
   Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600
   THUNG PJ, 1956, ACTA ENDOCRINOL-COP, V23, P8, DOI 10.1530/acta.0.0230008
   Tyler KA, 2019, EXP GERONTOL, V126, DOI 10.1016/j.exger.2019.110686
   Umanskaya A, 2014, P NATL ACAD SCI USA, V111, P15250, DOI 10.1073/pnas.1412754111
   Ungvari Z, 2003, CIRCULATION, V108, P1253, DOI 10.1161/01.CIR.0000079165.84309.4D
   Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, pH363, DOI 10.1152/ajpheart.01134.2010
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Victoria B, 2017, MOL CELL ENDOCRINOL, V455, P131, DOI 10.1016/j.mce.2016.12.021
   WEXLER BC, 1976, CIRC RES, V38, P494, DOI 10.1161/01.RES.38.6.494
   Yamaza H, 2010, AGING CELL, V9, P372, DOI 10.1111/j.1474-9726.2010.00563.x
   Yao SR, 2020, CANCER MED-US, V9, P5989, DOI 10.1002/cam4.3248
   Zhang YQ, 2017, REDOX BIOL, V11, P30, DOI 10.1016/j.redox.2016.10.014
   Zhou Y, 2022, HUM REPROD, V37, P2635, DOI 10.1093/humrep/deac204
NR 82
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2023 JUL 15
PY 2023
DI 10.1007/s11357-023-00865-8
EA JUL 2023
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA M3GT2
UT WOS:001029103300001
PM 37454002
DA 2024-02-19
ER

PT J
AU Tian, Y
   Wen, Z
   Lei, L
   Li, FH
   Zhao, JC
   Zhi, Q
   Li, FX
   Yin, R
   Ming, J
AF Tian, Yong
   Wen, Zhen
   Lei, Lin
   Li, Fuhua
   Zhao, Jichun
   Zhi, Qi
   Li, Fuxiang
   Yin, Ran
   Ming, Jian
TI <i>Coreopsis tinctoria</i> flowers extract ameliorates
   <i>D</i>-galactose induced aging in mice <i>via</i> regulation of
   Sirtl-Nrf2 signaling pathway
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Coreopsis tinctoria flowers; UPLC/Q-TOF-MS; Antioxidant; Anti-aging;
   Sirtl-Nrf2 signaling pathway
ID ANTIOXIDANT ACTIVITY; ANTIAGING ACTIVITIES; OXIDATIVE STRESS; NUTT.;
   IDENTIFICATION; POLYPHENOLS; FLAVONOIDS; PHENOLICS; CELLS; SIRT1
AB The aim of this study was to investigate the protective effects and its underlying signaling pathways of Coreopsis tinctoria flowers extract (CTE) on D-galactose induced aging in mice. UPLC/Q-TOF-MS analysis of CTE identified 12 active compounds, including three phenolic acids and nine flavonoids. The extract showed superior antioxidant activities in vitro using DPPH, FRAP, and ORAC assay. Administration with CTE remarkably improved body weight, organ indexes of aging mice, and liver histological injury as well as decreased oxidative stress markers levels of aged mice. Further studies showed CTE treatment significantly enhanced Sirtl expression and activated the Nrf2 signaling pathway by the increase of Nrf2 nuclear translocation, NQO-1 and HO-1 expression. Furthermore, CTE treatment resulted in the increase of Sirt3 and the suppression of p53. These results demonstrated that the promising anti-aging effects of Coreopsis tinctoria flowers extract might be related to up regulation of Sirtl-Nrf2 signaling pathway.
C1 [Tian, Yong; Lei, Lin; Li, Fuhua; Zhao, Jichun; Zhi, Qi; Li, Fuxiang; Ming, Jian] Southwest Univ, Coll Food Sci, Tiansheng Rd 2, Chongqing 400715, Peoples R China.
   [Wen, Zhen] Chengdu Third Peoples Hosp, Dept Gen Surg, Chengdu 610031, Sichuan, Peoples R China.
   [Li, Fuhua; Zhao, Jichun; Ming, Jian] Chongqing Engn Res Ctr Special Foods, Chongqing 400715, Peoples R China.
   [Yin, Ran] Rutgers State Univ, Ernest Mario Sch Pharm, 160 Frelinghuysen Rd, Piscataway, NJ 08855 USA.
C3 Southwest University - China; Rutgers University System; Rutgers
   University New Brunswick
RP Ming, J (corresponding author), Southwest Univ, Coll Food Sci, Tiansheng Rd 2, Chongqing 400715, Peoples R China.
EM food_mj@swu.edu.cn
RI zhi, qi/AAP-1218-2020; Zhao, Jichun/ABG-6369-2021; yang,
   peng/JEZ-8452-2023
FU National Key R&D Program of China [2016YFD0400203]; Fundamental Research
   Funds for the Central Universities [XDJK2017B050]
FX This research was supported by National Key R&D Program of China
   (2016YFD0400203) and Fundamental Research Funds for the Central
   Universities (XDJK2017B050).
CR [Anonymous], MITOCHONDRIA
   Ardestani A, 2007, FOOD CHEM, V104, P21, DOI 10.1016/j.foodchem.2006.10.066
   Chen LX, 2016, J CHROMATOGR A, V1428, P134, DOI 10.1016/j.chroma.2015.10.037
   Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3
   Dias T, 2010, J ETHNOPHARMACOL, V132, P483, DOI 10.1016/j.jep.2010.08.048
   Ding QY, 2016, INT J BIOL MACROMOL, V85, P133, DOI 10.1016/j.ijbiomac.2015.12.058
   Du D, 2018, J ETHNOPHARMACOL, V224, P261, DOI 10.1016/j.jep.2018.06.003
   Engel N, 2008, INT J MOL MED, V21, P223
   Farag MA, 2013, PHYTOCHEMISTRY, V95, P177, DOI 10.1016/j.phytochem.2013.07.003
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Gouveia S, 2011, FOOD CHEM, V129, P333, DOI 10.1016/j.foodchem.2011.04.078
   Govindan S, 2016, EXP TOXICOL PATHOL, V68, P329, DOI 10.1016/j.etp.2016.04.001
   Gu LN, 2016, TOXICOL APPL PHARM, V292, P19, DOI 10.1016/j.taap.2015.12.024
   Guo LM, 2015, J FUNCT FOODS, V13, P11, DOI 10.1016/j.jff.2014.11.011
   HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hossain S., 2014, AM J BIOSCI, V2, P222
   Huang KP, 2018, EUR J PHARMACOL, V832, P138, DOI 10.1016/j.ejphar.2018.05.017
   Huang KP, 2015, MOL CELL ENDOCRINOL, V399, P178, DOI 10.1016/j.mce.2014.08.014
   Jeong H, 2017, EXP GERONTOL, V95, P16, DOI 10.1016/j.exger.2017.05.004
   Ji DB, 2009, PHYTOTHER RES, V23, P116, DOI 10.1002/ptr.2576
   Jiao JJ, 2017, J FUNCT FOODS, V30, P63, DOI 10.1016/j.jff.2016.12.039
   Kim DB, 2016, FOOD CHEM, V194, P920, DOI 10.1016/j.foodchem.2015.08.094
   Kulkarni SR, 2014, ANTIOXID REDOX SIGN, V20, P15, DOI 10.1089/ars.2012.5082
   Lee DY, 2012, J MED FOOD, V15, P399, DOI 10.1089/jmf.2011.1905
   Li N, 2015, J FUNCT FOODS, V17, P837, DOI 10.1016/j.jff.2015.06.027
   Lin LZ, 2018, J FUNCT FOODS, V47, P11, DOI 10.1016/j.jff.2018.05.033
   Liu CS, 2013, BIOSCI BIOTECH BIOCH, V77, P1682, DOI 10.1271/bbb.130236
   Ma ZY, 2016, J FUNCT FOODS, V20, P575, DOI 10.1016/j.jff.2015.11.023
   Do MT, 2014, FREE RADICAL BIO MED, V74, P21, DOI [10.1016/j.freeradbiomed.2014.06.010, 10.1016/j.freeradbiomed2014.06.010]
   Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005
   Shah SA, 2017, CNS NEUROSCI THER, V23, P33, DOI 10.1111/cns.12588
   Sosnowska B, 2017, ATHEROSCLEROSIS, V265, P275, DOI 10.1016/j.atherosclerosis.2017.08.027
   Sun JZ, 2018, INT IMMUNOPHARMACOL, V58, P94, DOI 10.1016/j.intimp.2018.03.017
   Sun J, 2018, FOOD CHEM TOXICOL, V121, P495, DOI 10.1016/j.fct.2018.09.042
   Sun LP, 2013, J FUNCT FOODS, V5, P154, DOI 10.1016/j.jff.2012.09.006
   Sun Y, 2017, J FUNCT FOODS, V30, P179, DOI 10.1016/j.jff.2017.01.004
   Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013
   Tomobe K, 2012, ARCH GERONTOL GERIAT, V54, pE1, DOI 10.1016/j.archger.2011.06.006
   Tsai JC, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1604-8
   Wang W, 2015, J AGR FOOD CHEM, V63, P200, DOI 10.1021/jf504289g
   Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8418, DOI 10.1021/jf801381y
   Yang DQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37157
   Yang YJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21101307
   Zalaru C, 2014, CENT EUR J CHEM, V12, P858, DOI 10.2478/s11532-014-0539-x
   Zhang WX, 2016, INDIAN J ANIM RES, V50, P769, DOI 10.18805/ijar.9630
   Zhi Q, 2018, J FUNCT FOODS, V44, P201, DOI 10.1016/j.jff.2018.03.019
   Zhou XX, 2013, PHYTOCHEM LETT, V6, P372, DOI 10.1016/j.phytol.2013.05.002
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
NR 49
TC 19
Z9 19
U1 1
U2 58
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD SEP
PY 2019
VL 60
AR 103464
DI 10.1016/j.jff.2019.103464
PG 8
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA IN7JW
UT WOS:000478858700058
DA 2024-02-19
ER

PT J
AU Courlet, P
   Decosterd, LA
   Saldanha, SA
   Cavassini, M
   Stader, F
   Stoeckle, M
   Buclin, T
   Marzolini, C
   Csajka, C
   Guidi, M
AF Courlet, Perrine
   Decosterd, Laurent A.
   Saldanha, Susana Alves
   Cavassini, Matthias
   Stader, Felix
   Stoeckle, Marcel
   Buclin, Thierry
   Marzolini, Catia
   Csajka, Chantal
   Guidi, Monia
CA Swiss HIV Cohort Study
TI Influence of Drug-Drug Interactions on the Pharmacokinetics of
   Atorvastatin and Its Major Active Metabolite
   <i>ortho</i>-OH-Atorvastatin in Aging People Living with HIV
SO CLINICAL PHARMACOKINETICS
LA English
DT Article; Early Access
ID COA REDUCTASE INHIBITORS; POPULATION PHARMACOKINETICS; MODEL; ACID;
   LACTONE; RHABDOMYOLYSIS; PATIENT; QUANTIFICATION; POLYMORPHISM;
   DISPOSITION
AB Background People living with HIV (PLWH) are aging and experience age-related physiological changes and comorbidities. Atorvastatin is a widely prescribed lipid-lowering agent metabolized by cytochrome P450 (CYP) 3A4, whose hepatocyte uptake is facilitated by organic anion transporting polypeptide (OATP) 1B1/1B3. Inhibition or induction of this enzyme and hepatic transporter can increase or decrease atorvastatin exposure, respectively. Objective This study aimed to describe the pharmacokinetic profile of atorvastatin and its major metabolite, and to evaluate drug-drug interactions (DDIs) with antiretrovirals (ARVs). Methods The atorvastatin pharmacokinetic profile was best described by a two-compartment model with first-order absorption and elimination. Metabolite concentrations were described by considering both linear metabolism from atorvastatin and presystemic metabolism. The influence of demographic and clinical covariates on drug and metabolite pharmacokinetics was assessed using NONMEM(R). Model-based simulations were performed to evaluate the magnitude of DDIs with ARVs. Results Full pharmacokinetic profiles (98 atorvastatin + 62 o-OH-atorvastatin concentrations) and sparse concentrations (78 and 53 for atorvastatin and o-OH-atorvastatin, respectively) were collected in 59 PLWH. Interindividual variability was high. The coadministration of boosted ARVs decreased atorvastatin clearance by 58% and slowed down o-OH-atorvastatin formation by 88%. Atorvastatin clearance increased by 78% when coadministered with CYP3A4 inducers. Simulations revealed a 180% increase and 44% decrease in atorvastatin exposure (area under the curve) in the presence of ARVs with inhibiting and inducing properties, respectively. Conclusion This study showed an important interindividual variability in atorvastatin pharmacokinetics that remains largely unexplained after the inclusion of covariates. Since boosted ARVs double atorvastatin exposure, the initial dosage might be reduced by half, and titrated based on individual clinical targets.
C1 [Courlet, Perrine; Decosterd, Laurent A.; Saldanha, Susana Alves; Buclin, Thierry; Guidi, Monia] Lausanne Univ Hosp, Serv Clin Pharmacol, Lausanne, Switzerland.
   [Courlet, Perrine; Decosterd, Laurent A.; Saldanha, Susana Alves; Cavassini, Matthias; Buclin, Thierry; Csajka, Chantal; Guidi, Monia] Univ Lausanne, Lausanne, Switzerland.
   [Cavassini, Matthias] Lausanne Univ Hosp, Serv Infect Dis, Lausanne, Switzerland.
   [Stader, Felix; Stoeckle, Marcel; Marzolini, Catia] Univ Hosp Basel, Div Infect Dis, Basel, Switzerland.
   [Stader, Felix; Stoeckle, Marcel; Marzolini, Catia] Univ Hosp Basel, Hosp Epidemiol, Basel, Switzerland.
   [Stader, Felix; Marzolini, Catia] Univ Basel, Basel, Switzerland.
   [Csajka, Chantal; Guidi, Monia] Univ Hosp, Ctr Res & Innovat Clin Pharmaceut Sci, Lausanne, Switzerland.
   [Csajka, Chantal; Guidi, Monia] Univ Geneva, Univ Lausanne, Inst Pharmaceut Sci Western Switzerland, Geneva, Switzerland.
   [Csajka, Chantal] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
C3 University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV);
   University of Lausanne; University of Lausanne; Centre Hospitalier
   Universitaire Vaudois (CHUV); University of Basel; University of Basel;
   University of Basel; University of Lausanne; Centre Hospitalier
   Universitaire Vaudois (CHUV); University of Lausanne; University of
   Geneva; University of Geneva
RP Csajka, C (corresponding author), Univ Lausanne, Lausanne, Switzerland.; Csajka, C (corresponding author), Univ Hosp, Ctr Res & Innovat Clin Pharmaceut Sci, Lausanne, Switzerland.; Csajka, C (corresponding author), Univ Geneva, Univ Lausanne, Inst Pharmaceut Sci Western Switzerland, Geneva, Switzerland.; Csajka, C (corresponding author), Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
EM chantal.csajka@chuv.ch
RI cavassini, matthias/F-8987-2017; Buclin, Thierry/P-1640-2014; Marzolini,
   Catia/C-8253-2019; Decosterd, Laurent/E-8494-2019
OI cavassini, matthias/0000-0003-0933-7833; Buclin,
   Thierry/0000-0003-0639-5536; Decosterd, Laurent/0000-0002-9840-1325;
   Courlet, Perrine/0000-0001-9114-7793; Csajka,
   Chantal/0000-0002-0660-082X; Guidi, Monia/0000-0002-6419-9317
FU Swiss National Science Foundation [324730-165956, 324730-166204]; OPO
   Foundation; Isaac Dreyfus Foundation; 2017 SHCS Abbvie Award [815];
   Swiss National Science Foundation (SNF) [324730_166204, 324730_165956]
   Funding Source: Swiss National Science Foundation (SNF)
FX This work was supported by two Swiss National Science Foundation grants
   (Grant SNF No. 324730-165956 to LAD (Lausanne) and Grant No.
   324730-166204 to CM (Basel), as well as Grants from the OPO and Isaac
   Dreyfus Foundations to CM (Basel). The SHCS #815 study received the 2017
   SHCS Abbvie Award (awarded to LAD and CM).
CR Annaert P, 2010, XENOBIOTICA, V40, P163, DOI 10.3109/00498250903509375
   Arab-Alameddine M, 2014, J ANTIMICROB CHEMOTH, V69, P2489, DOI 10.1093/jac/dku131
   Backman JT, 2005, CLIN PHARMACOL THER, V78, P154, DOI 10.1016/j.clpt.2005.04.007
   Barry M, 1999, CLIN PHARMACOKINET, V36, P289, DOI 10.2165/00003088-199936040-00004
   Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260
   Bergstrand M, 2011, AAPS J, V13, P143, DOI 10.1208/s12248-011-9255-z
   Bergstrand M, 2009, AAPS J, V11, P371, DOI 10.1208/s12248-009-9112-5
   Bhaskaruni D, 2018, INT C PATT RECOG, P49, DOI 10.1109/ICPR.2018.8545706
   Bouzom F, 2000, J PHARM SCI, V89, P603, DOI 10.1002/(SICI)1520-6017(200005)89:5<603::AID-JPS6>3.0.CO;2-E
   Bullman J, 2011, EPILEPSIA, V52, P1351, DOI 10.1111/j.1528-1167.2011.03118.x
   Chauvin B, 2013, CLIN PHARMACOKINET, V52, P815, DOI 10.1007/s40262-013-0075-4
   Courlet P, 2020, AIDS, V34, P103, DOI 10.1097/QAD.0000000000002372
   Courlet P, 2019, J CHROMATOGR B, V1125, DOI 10.1016/j.jchromb.2019.121733
   Custodio JM, 2017, 18 INT WORKSH CLIN P
   DeGorter MK, 2013, CIRC-CARDIOVASC GENE, V6, P400, DOI 10.1161/CIRCGENETICS.113.000099
   European Medicine Agency, AT SUMM PROD CHAR
   Fayet A, 2009, J CHROMATOGR B, V877, P1057, DOI 10.1016/j.jchromb.2009.02.057
   Gerber JG, 2005, JAIDS-J ACQ IMM DEF, V39, P307, DOI 10.1097/01.qai.0000167156.44980.33
   Gibson DM, 1996, J CLIN PHARMACOL, V36, P242, DOI 10.1002/j.1552-4604.1996.tb04194.x
   Heerey A, 2000, IRISH J MED SCI, V169, P176, DOI 10.1007/BF03167690
   Hermann M, 2006, CLIN PHARMACOL THER, V79, P532, DOI 10.1016/j.clpt.2006.02.014
   Hsiao SH, 2016, J CLIN PHARM THER, V41, P575, DOI 10.1111/jcpt.12425
   Jacobsen W, 2000, DRUG METAB DISPOS, V28, P1369
   Janssen-Cilag, 2012, PREZ SUMM PROD CHAR
   Jonsson EN, 1999, COMPUT METH PROG BIO, V58, P51, DOI 10.1016/S0169-2607(98)00067-4
   Kahri J, 2005, EUR J CLIN PHARMACOL, V60, P905, DOI 10.1007/s00228-004-0858-5
   Kantola T, 1998, CLIN PHARMACOL THER, V64, P58, DOI 10.1016/S0009-9236(98)90023-6
   Keizer RJ, 2011, COMPUT METH PROG BIO, V101, P72, DOI 10.1016/j.cmpb.2010.04.018
   Keskitalo JE, 2009, CLIN PHARMACOL THER, V86, P197, DOI 10.1038/clpt.2009.79
   Knebel W, 2013, J CLIN PHARMACOL, V53, P505, DOI 10.1002/jcph.66
   Lau YY, 2007, CLIN PHARMACOL THER, V81, P194, DOI 10.1038/sj.clpt.6100038
   Lennernäs H, 2003, CLIN PHARMACOKINET, V42, P1141, DOI 10.2165/00003088-200342130-00005
   Li R, 2018, CLIN PHARMACOKINET, V57, P491, DOI 10.1007/s40262-017-0568-7
   Lindbom L, 2005, COMPUT METH PROG BIO, V79, P241, DOI 10.1016/j.cmpb.2005.04.005
   Macwan JS, 2013, J PHARMACOKINET PHAR, V40, pS73
   Ming JBM, 2003, AIDS PATIENT CARE ST, V17, P207, DOI 10.1089/108729103321655854
   Nandy A, 2016, CASE REP MED, V2016, DOI 10.1155/2016/4705492
   Narwal R, 2010, CLIN PHARMACOKINET, V49, P693, DOI 10.2165/11535980-000000000-00000
   Neuvonen PJ, 2006, CLIN PHARMACOL THER, V80, P565, DOI 10.1016/j.clpt.2006.09.003
   Niemi M, 2010, CLIN PHARMACOL THER, V87, P130, DOI 10.1038/clpt.2009.197
   Pham PA, 2009, ANTIMICROB AGENTS CH, V53, P4385, DOI 10.1128/AAC.00449-09
   Scholler-Gyure M, 2007, IAS C HIV PATH TREAT
   Schwartz JB, 2009, CLIN PHARMACOL THER, V86, P497, DOI 10.1038/clpt.2009.100
   Shitara Y, 2013, BIOPHARM DRUG DISPOS, V34, P45, DOI 10.1002/bdd.1823
   Skottheim IB, 2008, EUR J PHARM SCI, V33, P317, DOI 10.1016/j.ejps.2007.12.009
   Swiss Medic, INF MED
   Tsamandouras N, 2017, PHARMACOGENET GENOM, V27, P27, DOI 10.1097/FPC.0000000000000252
   U.S. Food and Drug Administration, DRUG DEV DRUG INT TA
   Ucar M, 2000, DRUG SAFETY, V22, P441, DOI 10.2165/00002018-200022060-00003
   Vandenberghe F, 2015, CLIN PHARMACOKINET, V54, P1259, DOI 10.1007/s40262-015-0289-8
   Woo HI, 2017, DRUG DES DEV THER, V11, P1135, DOI 10.2147/DDDT.S131487
   Wu XC, 2000, PHARMACEUT RES, V17, P209, DOI 10.1023/A:1007525616017
NR 52
TC 6
Z9 6
U1 1
U2 6
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 0312-5963
EI 1179-1926
J9 CLIN PHARMACOKINET
JI Clin. Pharmacokinet.
PD 2020 AUG
PY 2020
VL 59
IS 8
BP 1037
EP 1048
DI 10.1007/s40262-020-00876-0
EA APR 2020
PG 12
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA MU9LF
UT WOS:000525331900001
PM 32281059
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Alexaki, A
   Gupta, SD
   Majumder, S
   Kono, M
   Tuymetova, G
   Harmon, JM
   Dunn, TM
   Proia, RL
AF Alexaki, Aikaterini
   Gupta, Sita D.
   Majumder, Saurav
   Kono, Mari
   Tuymetova, Galina
   Harmon, Jeffrey M.
   Dunn, Teresa M.
   Proia, Richard L.
TI Autophagy regulates sphingolipid levels in the liver
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE ceramide; lipids; endoplasmic reticulum; triglycerides; lipophagy
ID CERAMIDE SYNTHASE 2; INSULIN-RESISTANCE; SERINE PALMITOYLTRANSFERASE;
   MEDIATED AUTOPHAGY; CELL-DEATH; ER STRESS; BIOSYNTHESIS; DISEASE;
   METABOLISM; INHIBITION
AB Sphingolipid levels are tightly regulated to maintain cellular homeostasis. During pathologic conditions such as in aging, inflammation, and metabolic and neurodegenerative diseases, levels of some sphingolipids, including the bioactive metabolite ceramide, are elevated. Sphingolipid metabolism has been linked to autophagy, a critical catabolic process in both normal cell function and disease; however, the in vivo relevance of the interaction is not well-understood. Here, we show that blocking autophagy in the liver by deletion of the Atg7 gene, which is essential for autophagosome formation, causes an increase in sphingolipid metabolites including ceramide. We also show that overexpression of serine palmitoyltransferase to elevate de novo sphingolipid biosynthesis induces autophagy in the liver. The results reveal autophagy as a process that limits excessive ceramide levels and that is induced by excessive elevation of de novo sphingolipid synthesis in the liver. Dysfunctional autophagy may be an underlying mechanism causing elevations in ceramide that may contribute to pathogenesis in diseases.
C1 [Alexaki, Aikaterini; Majumder, Saurav; Kono, Mari; Tuymetova, Galina; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA.
   [Gupta, Sita D.; Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20184 USA.
   [Harmon, Jeffrey M.] Uniformed Serv Univ Hlth Sci, Dept Mol Biol & Pharmacol, Bethesda, MD 20184 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Diabetes & Digestive & Kidney Diseases (NIDDK); Uniformed Services
   University of the Health Sciences - USA; Uniformed Services University
   of the Health Sciences - USA
RP Proia, RL (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA.
EM richardp@intra.niddk.nih.gov
RI Proia, Richard L/A-7908-2012
OI Kono, Mari/0000-0003-2447-4350; Harmon, Jeffrey/0000-0001-7833-931X;
   Proia, Richard/0000-0003-0456-1270; Alexaki,
   Aikaterini/0000-0003-2511-8569; Majumder, Saurav/0000-0002-5067-1190
FU Intramural Research Program of the National Institutes of Health,
   National Institute of Diabetes and Digestive and Kidney Diseases; USU
   [CO75PI]; National Institutes of Health [R01NS072446, R21HD080181];
   Lipidomics Shared Resource, Hollings Cancer Center, Medical University
   of South Carolina [P30 CA138313]; Lipidomics Core in the South Carolina
   Lipidomics and Pathobiology COBRE [P20 RR017677]
FX This research was supported by the Intramural Research Program of the
   National Institutes of Health, National Institute of Diabetes and
   Digestive and Kidney Diseases, the USU Grant CO75PI and National
   Institutes of Health Grants R01NS072446 and R21HD080181, the Lipidomics
   Shared Resource, Hollings Cancer Center, Medical University of South
   Carolina (P30 CA138313), and the Lipidomics Core in the South Carolina
   Lipidomics and Pathobiology COBRE (P20 RR017677).
CR [Anonymous], INT J CELL BIOL
   Arboleda G, 2009, BRAIN RES REV, V59, P333, DOI 10.1016/j.brainresrev.2008.10.001
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Bedia C, 2011, ANTI-CANCER AGENT ME, V11, P844, DOI 10.2174/187152011797655131
   Ben-David O, 2010, NEUROMOL MED, V12, P341, DOI 10.1007/s12017-010-8114-x
   Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423
   Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930
   Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144
   Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005
   Chang CL, 2009, AM J PHYSIOL-CELL PH, V297, pC451, DOI 10.1152/ajpcell.00586.2008
   Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002
   Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158
   Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101
   Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084
   de la Monte SM, 2012, J ALZHEIMERS DIS, V30, pS231, DOI 10.3233/JAD-2012-111727
   Gable K, 2002, J BIOL CHEM, V277, P10194, DOI 10.1074/jbc.M107873200
   Gable K, 2010, J BIOL CHEM, V285, P22844, DOI 10.1074/jbc.M110.122259
   Ge L, 2013, ELIFE, V2, DOI 10.7554/eLife.00947
   Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105
   Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106
   Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200
   Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200
   Harmon JM, 2013, J BIOL CHEM, V288, P10144, DOI 10.1074/jbc.M113.451526
   Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017
   Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025
   Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002
   Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378
   Huang XH, 2014, BBA-MOL CELL BIOL L, V1841, P657, DOI 10.1016/j.bbalip.2013.08.006
   Jiang WH, 2014, BBA-MOL CELL BIOL L, V1841, P783, DOI 10.1016/j.bbalip.2013.09.005
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Lavieu G, 2007, AUTOPHAGY, V3, P45, DOI 10.4161/auto.3416
   Lépine S, 2011, J BIOL CHEM, V286, P44380, DOI 10.1074/jbc.M111.257519
   Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200
   Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1
   Molano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047650
   Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398
   Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86
   Obeid Lina M, 2003, Sci Aging Knowledge Environ, V2003, pPE27, DOI 10.1126/sageke.2003.39.pe27
   Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200
   Peralta ER, 2009, AUTOPHAGY, V5, P407, DOI 10.4161/auto.5.3.7809
   Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com
   Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610
   Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594
   Rivas DA, 2012, J APPL PHYSIOL, V113, P1727, DOI 10.1152/japplphysiol.00412.2012
   Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802
   Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888
   Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624
   Saddoughi SA, 2013, ADV CANCER RES, V117, P37, DOI 10.1016/B978-0-12-394274-6.00002-9
   Samad F, 2011, ADV EXP MED BIOL, V721, P67, DOI 10.1007/978-1-4614-0650-1_5
   Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200
   Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211
   Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059
   Silva LC, 2012, J LIPID RES, V53, P430, DOI 10.1194/jlr.M022715
   Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020
   Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699
   Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831
   Truman JP, 2014, BBA-MOL CELL BIOL L, V1841, P1174, DOI 10.1016/j.bbalip.2013.12.013
   WRIGHT R, 1988, J CELL BIOL, V107, P101, DOI 10.1083/jcb.107.1.101
   Xiong YQ, 2013, J BIOL CHEM, V288, P32563, DOI 10.1074/jbc.M113.483750
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
   Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009
NR 67
TC 40
Z9 41
U1 1
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-2275
EI 1539-7262
J9 J LIPID RES
JI J. Lipid Res.
PD DEC
PY 2014
VL 55
IS 12
BP 2521
EP 2531
DI 10.1194/jlr.M051862
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AU3NH
UT WOS:000345519900009
PM 25332431
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Ikeyama, S
   Kokkonen, G
   Martindale, JL
   Wang, XT
   Gorospe, M
   Holbrook, NJ
AF Ikeyama, S
   Kokkonen, G
   Martindale, JL
   Wang, XT
   Gorospe, M
   Holbrook, NJ
TI Effects of aging and calorie restriction of Fischer 344 rats on
   hepatocellular response to proliferative signals
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE hepatocytes; aging; oxidative stress; proliferation; epidermal growth
   factor
ID ACTIVATED PROTEIN-KINASE; LIFE-SPAN EXTENSION; AGE-RELATED DECLINE;
   GROWTH-FACTOR RECEPTOR; DIETARY RESTRICTION; LIVER-REGENERATION;
   DNA-SYNTHESIS; CELL-PROLIFERATION; REGULATED KINASES; OXIDATIVE STRESS
AB It is well established that the proliferative potential of the liver declines with aging. Epidermal growth factor (EGF)-stimulated DNA synthesis is reduced in hepatocytes from aged rats relative to young rats, and this reduction correlates with diminished activation of the extracellular signal-regulated kinase (ERK) pathway and lower phosphorylation of the EGF receptor on residue Y1173. Calorie restriction (CR) can increase rodent life span and retard many age-associated declines in physiologic function, but its influence on cell proliferation is unknown. Here, we investigated the effects of long-term CR on proliferation of hepatocytes derived from young and aged rats following in vitro stimulation with either low-dose hydrogen peroxide or EGF. CR reduced the proliferative response of hepatocytes derived from young hosts, but long-term CR was associated with enhanced proliferation in aged cells relative to that of ad libitum (AL)-fed animals. ERK activation mirrored the effects of CR on proliferation, in that young CR cells exhibited lower ERK activation than young AL cells, but old Ck cells showed higher ERK activation than old AL cells. Finally, a decline in EGF receptor phosphorylation on Y1173, which normally occurs with aging, was absent in cells of old hosts maintained on long-term CR, supporting the view that alterations in this early signaling event underlie the age-related decline in proliferative potential in rat hepatocytes. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 NIA, Cellular & Mol Biol Lab, Gerontol Res Ctr, Intramural Res Program,NIH,Cell Stress & Aging Se, Baltimore, MD 21224 USA.
   Yale Univ, Sch Med, Sect Geriatr, New Haven, CT 06520 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); Yale University
RP Ikeyama, S (corresponding author), NIA, Cellular & Mol Biol Lab, Gerontol Res Ctr, Intramural Res Program,NIH,Cell Stress & Aging Se, Box 12,5600 Nathan Shock Dr, Baltimore, MD 21224 USA.
EM ikeyamash@grc.nia.nih.gov
RI Martindale, Jennifer Luethy/AAD-1963-2022
OI Martindale, Jennifer Luethy/0000-0002-3234-6861
CR Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709
   Alvarez E, 2001, CLIN EXP IMMUNOL, V124, P95, DOI 10.1046/j.1365-2249.2001.01490.x
   [Anonymous], HDB BIOL AGING
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S
   CHOU MW, 1995, CANCER LETT, V91, P191, DOI 10.1016/0304-3835(95)03750-Q
   COBB MH, 1994, SEMIN CANCER BIOL, V5, P261
   Cuenca AG, 2001, EXP BIOL MED, V226, P1061, DOI 10.1177/153537020122601114
   Elias PM, 2002, CLIN GERIATR MED, V18, P103, DOI 10.1016/S0749-0690(03)00037-5
   Fausto N, 2001, LIVER TRANSPLANT, V7, P835, DOI 10.1053/jlts.2001.27865
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604
   Hart RW, 1998, EXP GERONTOL, V33, P53, DOI 10.1016/S0531-5565(97)00063-6
   Higami Y, 1997, CELL TISSUE RES, V288, P69, DOI 10.1007/s004410050793
   HIMENO Y, 1992, P NATL ACAD SCI USA, V89, P5497, DOI 10.1073/pnas.89.12.5497
   Holbrook NJ, 2002, BIOCHEM PHARMACOL, V64, P999, DOI 10.1016/S0006-2952(02)01169-3
   HORNSBY PJ, 2001, HDB BIOL AGING, P207
   Hu YH, 1998, EXP GERONTOL, V33, P601, DOI 10.1016/S0531-5565(98)00034-5
   Hutter D, 2000, J GERONTOL A-BIOL, V55, pB125, DOI 10.1093/gerona/55.3.B125
   Ikeyama S, 2001, FASEB J, V15, P114, DOI 10.1096/fj.01-0409fje
   ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232
   Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x
   Liu YS, 1996, J BIOL CHEM, V271, P3604
   Lu MH, 2002, MECH AGEING DEV, V123, P391, DOI 10.1016/S0047-6374(01)00397-9
   Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119
   Masoro EJ, 1998, EXP GERONTOL, V33, P61, DOI 10.1016/S0531-5565(97)00071-5
   Meydani M, 2001, ANN NY ACAD SCI, V928, P226
   MILLER RA, 2001, HDB BIOL AGING, P369
   MOOLTEN FL, 1967, SCIENCE, V158, P272, DOI 10.1126/science.158.3798.272
   Pahlavani MA, 2000, P SOC EXP BIOL MED, V223, P163, DOI 10.1046/j.1525-1373.2000.22322.x
   Pahlavani MA, 1998, FRONT BIOSCI, V3, P1120
   Palmer HJ, 1999, J BIOL CHEM, V274, P11424, DOI 10.1074/jbc.274.16.11424
   Park WY, 2001, ANN NY ACAD SCI, V928, P79
   PENDERGRASS WR, 1995, EXP CELL RES, V217, P309, DOI 10.1006/excr.1995.1091
   PIGNOLO RJ, 1992, EXP CELL RES, V201, P16, DOI 10.1016/0014-4827(92)90343-7
   Podolin DA, 2001, AM J PHYSIOL-ENDOC M, V281, pE516, DOI 10.1152/ajpendo.2001.281.3.E516
   Roka F, 2000, EXP GERONTOL, V35, P133, DOI 10.1016/S0531-5565(99)00092-3
   Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.0.CO;2-6
   Rozga Jacek, 2002, Med Sci Monit, V8, pRA32
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Shaddock JG, 1996, MUTAGENESIS, V11, P281, DOI 10.1093/mutage/11.3.281
   Spiteller G, 2002, ANN NY ACAD SCI, V959, P30, DOI 10.1111/j.1749-6632.2002.tb02080.x
   Taguchi T, 2001, MECH AGEING DEV, V122, P141, DOI 10.1016/S0047-6374(00)00226-8
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   Van Remmen H, 2001, Novartis Found Symp, V235, P221
   VOLICER L, 1983, MECH AGEING DEV, V21, P283, DOI 10.1016/0047-6374(83)90047-7
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   WOLF NS, 1995, EXP CELL RES, V217, P317, DOI 10.1006/excr.1995.1092
   Zanella CL, 1996, CANCER RES, V56, P5334
NR 49
TC 19
Z9 19
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR
PY 2003
VL 38
IS 4
BP 431
EP 439
AR PII S0531-5565(02)00239-5
DI 10.1016/S0531-5565(02)00239-5
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 673AK
UT WOS:000182556200011
PM 12670630
DA 2024-02-19
ER

PT J
AU Konkle, BA
AF Konkle, Barbara A.
TI Clinical challenges within the aging hemophilia population
SO THROMBOSIS RESEARCH
LA English
DT Article
DE Hemophilia; Geriatrics; Cardiovascular disease; Osteoporosis; Hepatitis;
   Kidney disease
ID HEPATOCELLULAR-CARCINOMA; HEPATITIS-C; OSTEOPOROSIS; MORTALITY; ADULTS;
   LIFE; PREVALENCE; DISEASE; MALES; OLDER
AB Older patients with hemophilia face many challenges related not only to hemophilia but also to general comorbidity associated with aging. Patients with hemophilia often have known risk factors for cardiovascular disease, such as hypertension and hepatitis C virus (HCV) infection, which may counteract any protective effects bestowed by the hypocoagulable state. Arthritis and joint disease are common and contribute to disability and pain. The high prevalence of chronic HCV infection has led to an increased risk for liver failure and hepatocellular carcinoma. Renal function and urological disorders are a concern in these patients, and issues related to sexuality are an important but often-overlooked issue. The use of routine procedures for general health maintenance in the elderly (e. g. colonoscopy) can be more complex in patients with hemophilia due to the inherent risk of bleeding, and serious disorders such as malignancy can be overlooked if signs of abnormal bleeding are attributed to hemophilia, rather than to cancer. Prospective studies are needed to address these challenges so that evidence-based guidance can be given to clinicians who treat older patients with hemophilia. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Konkle, Barbara A.] Puget Sound Blood Ctr, Seattle, WA 98104 USA.
   [Konkle, Barbara A.] Univ Washington, Sch Med, Seattle, WA USA.
C3 Puget Sound Blood Center; University of Washington; University of
   Washington Seattle
RP Konkle, BA (corresponding author), Puget Sound Blood Ctr, 921 Terry Ave, Seattle, WA 98104 USA.
EM barbarak@psbc.org
RI Konkle, Barbara A/AAD-7712-2022; Konkle, Barbara/GPX-3325-2022
OI Konkle, Barbara A/0000-0002-3959-8797; 
FU CSL Behring; Baxter
FX Research support from CSL Behring and Baxter; consultancy for CSL
   Behring, Baxter, Bayer, Novo Nordisk, Inspiration Biopharmaceuticals.
CR Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753
   Darby SC, 2007, BLOOD, V110, P815, DOI 10.1182/blood-2006-10-050435
   Diamond TH, 1997, MED J AUSTRALIA, V167, P412, DOI 10.5694/j.1326-5377.1997.tb126646.x
   Dolan G, 2009, HAEMOPHILIA, V15, P20, DOI 10.1111/j.1365-2516.2008.01949.x
   Eyster ME, 2007, HAEMOPHILIA, V13, P279, DOI 10.1111/j.1365-2516.2007.01453.x
   Franchini M, 2010, BRIT J HAEMATOL, V148, P522, DOI 10.1111/j.1365-2141.2009.08005.x
   Gerstner G, 2009, HAEMOPHILIA, V15, P559, DOI 10.1111/j.1365-2516.2008.01963.x
   Gianotten WL, 2009, HAEMOPHILIA, V15, P55, DOI 10.1111/j.1365-2516.2008.01914.x
   Goedert JJ, 2005, HAEMOPHILIA, V11, P516, DOI 10.1111/j.1365-2516.2005.01138.x
   Hermans CR, 2008, BLOOD, P112
   High KP, 2010, J AM GERIATR SOC, V58, P765, DOI 10.1111/j.1532-5415.2010.02772.x
   Hill K, 2010, HAEMOPHILIA, V16, P162, DOI 10.1111/j.1365-2516.2009.02110.x
   INWOOD MJ, 1983, BLOOD, V61, P709
   Kiebzak GM, 2002, ARCH INTERN MED, V162, P2217, DOI 10.1001/archinte.162.19.2217
   Konkle BA, 2009, HAEMOPHILIA, V15, P1197, DOI 10.1111/j.1365-2516.2009.02066.x
   Kulkarni R, 2003, HAEMOPHILIA, V9, P703, DOI 10.1046/j.1351-8216.2003.00821.x
   Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107
   Mannucci PM, 2009, BLOOD, V114, P5256, DOI 10.1182/blood-2009-07-215665
   Mauser-Bunschoten EP, 2009, HAEMOPHILIA, V15, P853, DOI 10.1111/j.1365-2516.2009.01987.x
   Miesbach W, 2009, HAEMOPHILIA, V15, P894, DOI 10.1111/j.1365-2516.2009.02030.x
   Nair AP, 2007, AM J HEMATOL, V82, P453, DOI 10.1002/ajh.20877
   National Center for Health Statistics, 2010, LIM ACT CAUS CHRON C
   Quon DV, 2010, HAEMOPHILIA, V16, P683, DOI 10.1111/j.1365-2516.2009.02171.x
   Siboni SM, 2009, J THROMB HAEMOST, V7, P780, DOI 10.1111/j.1538-7836.2009.03318.x
   Soucie JM, 2000, BLOOD, V96, P437
   Street A, 2006, HAEMOPHILIA, V12, P8, DOI 10.1111/j.1365-2516.2006.01254.x
   Thabut D, 2006, AM J GASTROENTEROL, V101, P1260, DOI 10.1111/j.1572-0241.2006.00556.x
   Theodore D, 2004, HAEMOPHILIA, V10, P413, DOI 10.1111/j.1365-2516.2004.00919.x
   Tradati F, 1998, BLOOD, V91, P1173
   Tuinenburg A, 2009, J THROMB HAEMOST, V7, P247, DOI 10.1111/j.1538-7836.2008.03201.x
   Wallny TA, 2007, HAEMOPHILIA, V13, P79, DOI 10.1111/j.1365-2516.2006.01405.x
   Yano M, 1996, HEPATOLOGY, V23, pP273
   Zakarija A, 2009, HAEMOPHILIA, V15, P1308, DOI 10.1111/j.1365-2516.2009.02060.x
NR 33
TC 22
Z9 24
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PD JAN
PY 2011
VL 127
SU 1
BP S10
EP S13
DI 10.1016/j.thromres.2010.10.004
PG 4
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA 705LV
UT WOS:000286134600004
PM 21056901
DA 2024-02-19
ER

PT J
AU GAUBATZ, JW
   ARCEMENT, B
   CUTLER, RG
AF GAUBATZ, JW
   ARCEMENT, B
   CUTLER, RG
TI GENE-EXPRESSION OF AN ENDOGENOUS RETROVIRUS-LIKE ELEMENT DURING MURINE
   DEVELOPMENT AND AGING
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE INTRACISTERNAL A-PARTICLE; GENE EXPRESSION; RETROVIRUS-LIKE ELEMENTS;
   AGING; DEVELOPMENT; MOUSE TISSUES
ID A-PARTICLE GENES; EARLY MOUSE EMBRYOS; DNA METHYLATION; C57BL-6J MICE;
   CELL-LINES; RNA; AGE; VIRUS; LIVER; SEQUENCE
AB We have measured intracisternal A-particle (IAP) RNA levels during development and aging in C57BL/6J mouse tissues to determine possible age-dependent changes in gene expression of these retrovirus-like sequences. Total RNA was isolated from tissues of embryonic and new born mice and mice ranging in age from 2 months to 32 months of age. RNA samples were either slot-blotted directly or fractionated on denaturing agarose gels and transferred to nylon membranes. Hybridization with cloned, P-32-labeled IAP sequences showed that both the mass amounts and the relative proportions of IAP transcripts varied between tissues and as a function of age. IAP gene products were higher in brain kidney tissues than in liver and heart tissues. The relative proportion of transcripts increased in embryonic tissues until birth and following birth, was highest in neonatal or 2-month-old tissues. The adult levels of IAP-related RNAs did not change significantly from 6 to 24 months of age. However, 32-month-old tissues exhibited the lowest content of IAP transcripts, with the exception of heart tissue which did not change with age. A 5.4-kb RNa was the predominant IAP transcript in most samples, but each tissue had a characteristic size distribution of IAP-related transcripts. These results demonstrate that transcription of IAP genes continues throughout the life span of this mouse strain with tissue-specific and age-dependent regulation of expression.
C1 NIA, GERONTOL RES CTR, BALTIMORE, MD 21224 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA)
RP GAUBATZ, JW (corresponding author), UNIV SO ALABAMA, COLL MED, DEPT BIOCHEM, MOBILE, AL 36688 USA.
FU NIA NIH HHS [AG07860] Funding Source: Medline
CR BENNETT KL, 1984, MOL CELL BIOL, V4, P1561, DOI 10.1128/MCB.4.8.1561
   BENSON RW, 1978, J GERONTOL, V33, P323, DOI 10.1093/geronj/33.3.323
   CANAANI E, 1983, P NATL ACAD SCI-BIOL, V80, P7118, DOI 10.1073/pnas.80.23.7118
   CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5
   CHATTOPADHYAY SK, 1974, COLD SPRING HARB SYM, V39, P1085, DOI 10.1101/SQB.1974.039.01.124
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   COLE MD, 1982, J VIROL, V42, P123, DOI 10.1128/JVI.42.1.123-130.1982
   DEAN RG, 1985, ARCH GERONTOL GERIAT, V4, P43, DOI 10.1016/0167-4943(85)90017-2
   DEOCA FH, 1983, J VIROL, V46, P307, DOI 10.1128/JVI.46.1.307-310.1983
   DRAGANI TA, 1986, CANCER RES, V46, P1915
   FEENSTRA A, 1986, NUCLEIC ACIDS RES, V14, P4343, DOI 10.1093/nar/14.10.4343
   FLORES SC, 1988, NUCLEIC ACIDS RES, V16, P3889, DOI 10.1093/nar/16.9.3889
   FLORINE DL, 1980, CANCER RES, V40, P519
   GAUBATZ JW, 1990, MUTAT RES, V237, P29, DOI 10.1016/0921-8734(90)90029-Q
   GETZ MJ, 1985, HDB BIOL AGING, P255
   GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025
   HOWLETT D, 1989, MUTAT RES, V219, P101, DOI 10.1016/0921-8734(89)90020-9
   KAMEROV DA, 1985, BIOCHIM BIOPHYS ACTA, V824, P84
   KAMEROV DA, 1985, BIOCHIM BIOPHYS ACTA, V826, P20
   KELLY F, 1982, BIOCHIM BIOPHYS ACTA, V651, P105, DOI 10.1016/0304-419X(82)90009-9
   KRAYEV AS, 1980, NUCLEIC ACIDS RES, V8, P1201, DOI 10.1093/nar/8.6.1201
   KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7
   KUFF EL, 1985, MOL CELL BIOL, V5, P474, DOI 10.1128/MCB.5.3.474
   KUFF EL, 1983, P NATL ACAD SCI-BIOL, V80, P1992, DOI 10.1073/pnas.80.7.1992
   KUFF EL, 1981, MOL CELL BIOL, V1, P216, DOI 10.1128/MCB.1.3.216
   KUNSTYR I, 1975, J GERONTOL, V30, P157, DOI 10.1093/geronj/30.2.157
   LUEDERS K, 1989, PROG NUCLEIC ACID RE, V36, P173
   LUEDERS KK, 1977, CELL, V12, P963, DOI 10.1016/0092-8674(77)90161-1
   LUEDERS KK, 1980, P NATL ACAD SCI-BIOL, V77, P3571, DOI 10.1073/pnas.77.6.3571
   Maniatis T., 1982, MOL CLONING
   MAYSHOOPES LL, 1983, MOL CELL BIOL, V3, P1371, DOI 10.1128/MCB.3.8.1371
   MORGAN RA, 1987, DEV GENET, V8, P125, DOI 10.1002/dvg.1020080302
   MORGAN RA, 1988, DEVELOPMENT, V102, P23
   ONO M, 1980, CELL, V21, P465, DOI 10.1016/0092-8674(80)90483-3
   ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   PIKO L, 1984, P NATL ACAD SCI-BIOL, V81, P488, DOI 10.1073/pnas.81.2.488
   SEMSEI I, 1989, ONCOGENE, V4, P465
   SHENONG GLC, 1982, J VIROL, V42, P411, DOI 10.1128/JVI.42.2.411-421.1982
   STUHLMANN H, 1981, CELL, V26, P221, DOI 10.1016/0092-8674(81)90305-6
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
   WUJCIK KM, 1984, J VIROL, V52, P29, DOI 10.1128/JVI.52.1.29-36.1984
   YOTSUYANAGI Y, 1981, J NATL CANCER I, V67, P677
NR 43
TC 17
Z9 18
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JAN
PY 1991
VL 57
IS 1
BP 71
EP 85
DI 10.1016/0047-6374(91)90025-U
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EQ278
UT WOS:A1991EQ27800006
PM 1900553
DA 2024-02-19
ER

PT J
AU Ko, KM
   Chen, N
   Leung, HY
   Leong, EPK
   Poon, MKT
   Chiu, PY
AF Ko, Kam Ming
   Chen, Na
   Leung, Hoi Yan
   Leong, Eriol P. K.
   Poon, Michel K. T.
   Chiu, Po Yee
TI Long-term schisandrin B treatment mitigates age-related impairments in
   mitochondrial antioxidant status and functional ability in various
   tissues, and improves the survival of aging C57BL/6J mice
SO BIOFACTORS
LA English
DT Article; Proceedings Paper
CT 4th International Niigata Symposium on Diet and Health
CY NOV 29-30, 2008
CL Niigata, JAPAN
DE Schisandrin B; aging; mitochondria; glutathione; alpha-tocopherol;
   Mn-superoxide dismutase; reactive oxygen species; ATP generation; brain;
   heart; kidney; liver
ID INDUCED PERMEABILITY TRANSITION; RESPIRATORY-CHAIN FUNCTION; STRUCTURAL
   INTEGRITY; OXIDATIVE STRESS; SKELETAL-MUSCLE; LIFE-SPAN; PROTECTS;
   GLUTATHIONE; LONGEVITY; INJURY
AB Mitochondrial decay is a major cause of aging, leading to the subsequent death of aerobic organisms including humans. In the present study, we examined the effects of supplementation with schisandrin B (Sch B, a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis), administered at 0.012% (w/w) of diet, starting from the age of 36 weeks, on age-dependent changes in mouse mitochondrial antioxidant status and functional ability in various tissues (brain, heart, liver, and kidney) up to the age of 120 weeks. We also monitored survival of male and female C57BL/6J mice. Aging caused progressive impairment in mitochondrial antioxidant status in various tissues, as evidenced by decreases in reduced glutathione and alpha-tocopherol levels, and Mn-superoxide dismutase activity. Impairments in mitochondrial antioxidant status were invariably associated with increases in mitochondria-driven reactive oxygen species (ROS) production in tissue homogenates, as well as decreased mitochondrial ATP-generation capacities (ATP-GCs), in all tested tissues. Diet supplementation with Sch B ameliorated impairment in mitochondrial antioxidant status during aging. The effects were more pronounced in younger than in older mice, when compared to age-matched non-supplemented controls. Sch B supplementation also suppressed mitochondria-driven ROS production and enhanced mitochondrial ATP-GC in various tissues during aging. The beneficial effects of Sch B supplementation on mitochondrial antioxidant status and functional ability were paralleled by survival improvement in aging male mice, when compared with controls. Sch B supplementation also improved the survival in female mice. In conclusion, long-term Sch B supplementation mitigated age-dependent impairments in mitochondrial antioxidant capacity and functional ability, thereby retarding the aging process in mice, particularly during early aging.
C1 [Ko, Kam Ming; Chen, Na; Leung, Hoi Yan; Leong, Eriol P. K.; Poon, Michel K. T.; Chiu, Po Yee] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.
C3 Hong Kong University of Science & Technology
RP Ko, KM (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.
EM bcrko@ust.hk
OI Leung, Hoi Yan/0000-0002-2216-1150
CR Ali SS, 2006, AGING CELL, V5, P565, DOI 10.1111/j.1474-9726.2006.00252.x
   Bezlepkin VG, 1996, MECH AGEING DEV, V92, P227, DOI 10.1016/S0047-6374(96)01840-4
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chaudière J, 1999, FOOD CHEM TOXICOL, V37, P949, DOI 10.1016/S0278-6915(99)00090-3
   Chen N, 2008, BIOL PHARM BULL, V31, P1387, DOI 10.1248/bpb.31.1387
   Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200
   Chiu PY, 2008, BIOL PHARM BULL, V31, P602, DOI 10.1248/bpb.31.602
   Chiu PY, 2008, REJUV RES, V11, P43, DOI 10.1089/rej.2007.0577
   Chiu PY, 2007, BIOL PHARM BULL, V30, P1108, DOI 10.1248/bpb.30.1108
   Chiu PY, 2006, BIOGERONTOLOGY, V7, P199, DOI 10.1007/s10522-006-9017-y
   Choksi KB, 2008, FREE RADICAL BIO MED, V44, P1795, DOI 10.1016/j.freeradbiomed.2008.01.032
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hipkiss AR, 2008, BIOGERONTOLOGY, V9, P49, DOI 10.1007/s10522-007-9110-x
   Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003
   Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200
   IP SP, 1995, PLANTA MED, V61, P398, DOI 10.1055/s-2006-958123
   Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006
   KO RKM, 2004, OXIDAT STRESS DIS, P289
   Leung HY, 2005, REJUV RES, V8, P238, DOI 10.1089/rej.2005.8.238
   Linford NJ, 2006, CANCER RES, V66, P2497, DOI 10.1158/0008-5472.CAN-05-3163
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lipman RD, 1998, MECH AGEING DEV, V103, P269, DOI 10.1016/S0047-6374(98)00048-7
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Meng QY, 2007, MECH AGEING DEV, V128, P286, DOI 10.1016/j.mad.2006.12.008
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Chiu PY, 2007, ACTA PHARMACOL SIN, V28, P1559, DOI 10.1111/j.1745-7254.2007.00614.x
   Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010
   Quick KL, 2008, NEUROBIOL AGING, V29, P117, DOI 10.1016/j.neurobiolaging.2006.09.014
   Rebrin I, 2008, ADV DRUG DELIVER REV, V60, P1545, DOI 10.1016/j.addr.2008.06.001
   SADRZADEH SMH, 1994, BIOCHEM PHARMACOL, V47, P2005, DOI 10.1016/0006-2952(94)90075-2
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Ungvari Z, 2008, AGE, V30, P121, DOI 10.1007/s11357-008-9059-y
   Yu BP, 2006, MECH AGEING DEV, V127, P436, DOI 10.1016/j.mad.2006.01.023
NR 36
TC 23
Z9 25
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-6433
EI 1872-8081
J9 BIOFACTORS
JI Biofactors
PY 2008
VL 34
IS 4
BP 331
EP 342
DI 10.1002/biof.5520340408
PG 12
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 509NT
UT WOS:000271025400008
PM 19850987
DA 2024-02-19
ER

PT J
AU Zhou, S
   Gu, J
   Liu, R
   Wei, S
   Wang, Q
   Shen, HB
   Dai, YF
   Zhou, HM
   Zhang, F
   Lu, L
AF Zhou, Shun
   Gu, Jian
   Liu, Rui
   Wei, Song
   Wang, Qi
   Shen, Hongbing
   Dai, Yifan
   Zhou, Haoming
   Zhang, Feng
   Lu, Ling
TI Spermine Alleviates Acute Liver Injury by Inhibiting Liver-Resident
   Macrophage Pro-Inflammatory Response Through ATG5-Dependent Autophagy
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE liver injury; thioacetamide; spermine; Kupffer cell; polarization;
   autophagy; ATG5
ID ENDOPLASMIC-RETICULUM STRESS; ISCHEMIA/REPERFUSION INJURY;
   IMMUNE-RESPONSE; MICE; POLARIZATION; POLYAMINES; CELLS; INDUCTION;
   PATHWAY; DISEASE
AB Liver-resident macrophages (Kupffer cells, KCs) and autophagy play critical roles in the pathogenesis of toxin-induced liver injury. Recent evidence indicates that autophagy can regulate macrophage M1/M2 polarization under different inflammatory conditions. Polyamines, including putrescine, spermidine, and spermine (SPM), are polycations with anti-oxidative, anti-aging, and cell autophagy induction properties. This study aimed to determine the mechanisms by which SPM protects against thioacetamide (TAA)-induced acute liver injury in a mouse model. Pretreatment with SPM significantly alleviated liver injury and reduced intrahepatic inflammation in TAA-induced liver injury compared to controls. SPM markedly inhibited M1 polarization, but promoted M2 polarization of KCs obtained from TAA-exposed livers, as evidenced by decreased IL-1 beta and iNOS gene induction but increased Arg-1 and Mrc-1 gene induction accompanied by decreased STAT1 activation and increased STAT6 activation. Furthermore, pretreatment with SPM enhanced autophagy, as revealed by increased LC3B-II levels, decreased p62 protein expression, and increased ATG5 protein expression in TAA-treated KCs. Knockdown of ATG5 in SPM-pretreated KCs by siRNA resulted in a significant increase in pro-inflammatory TNF-alpha and IL-6 secretion and decreased anti-inflammatory IL-10 secretion after TAA treatment, while no significant changes were observed in cytokine production in the TAA treatment alone. Additionally, the effect of SPM on regulation of KC M1/M2 polarization was abolished by ATG5 knockdown in TAA-exposed KCs. Finally, in vivo ATG5 knockdown in KCs abrogated the protective effect of SPM against TAA-induced acute liver injury. Our results indicate that SPM-mediated autophagy inhibits M1 polarization, while promoting M2 polarization of KCs in TAA-treated livers via upregulation of ATG5 expression, leading to attenuated liver injury. This study provides a novel target for the prevention of acute liver injury.
C1 [Zhou, Shun; Gu, Jian; Liu, Rui; Wei, Song; Wang, Qi; Zhou, Haoming; Zhang, Feng; Lu, Ling] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.
   [Zhou, Shun] Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.
   [Zhou, Shun; Shen, Hongbing] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China.
   [Dai, Yifan] Nanjing Med Univ, Jiangsu Key Lab Xenotransplantat, Nanjing, Jiangsu, Peoples R China.
C3 Nanjing Medical University; Nanjing Medical University; Nanjing Medical
   University; Nanjing Medical University
RP Zhou, HM; Zhang, F; Lu, L (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.
EM hmzhou@njmu.edu.cn; zhangfeng1958@hotmail.com; lvling@njmu.edu.cn
RI LU, LU/JEZ-4760-2023; lu, lu/HGA-0894-2022; shen, hong/HTQ-6147-2023;
   zhou, haoming/HMV-1715-2023; lu, lu/HII-7530-2022; 古, 鉴/HGD-2083-2022
OI Shen, Hongbing/0000-0002-2581-5906
FU National Natural Science Foundation of China [81521004, 81100270,
   1310108001, 81210108017, 81600450, 31700791]; National Science
   Foundation of Jiangsu Province [BK20131024, BE2016766]; 863 Young
   Scientists Special Fund grant [SS2015AA0209322]; Foundation of Jiangsu
   Collaborative Innovation Center of Biomedical Functional Materials;
   Dumont Research Foundation; PAPD
FX This study was supported by the National Natural Science Foundation of
   China 81521004, 81100270, 1310108001, 81210108017, 81600450, 31700791,
   National Science Foundation of Jiangsu Province BK20131024, BE2016766,
   863 Young Scientists Special Fund grant SS2015AA0209322 and the
   Foundation of Jiangsu Collaborative Innovation Center of Biomedical
   Functional Materials (LL), The Dumont Research Foundation and a project
   Funded by the PAPD.
CR Amanzada A, 2014, LAB INVEST, V94, P235, DOI 10.1038/labinvest.2013.134
   Babbar N, 2007, BIOCHEM SOC T, V35, P300, DOI 10.1042/BST0350300
   Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834
   Chae YB, 2014, INT J BIOL MACROMOL, V63, P56, DOI 10.1016/j.ijbiomac.2013.10.041
   Chaturvedi R, 2012, AMINO ACIDS, V42, P627, DOI 10.1007/s00726-011-1038-4
   Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060
   Do THT, 2013, AMINO ACIDS, V44, P869, DOI 10.1007/s00726-012-1413-9
   Duan QJ, 2016, AM J TRANSL RES, V8, P3976
   Eisenberg T, 2017, AUTOPHAGY, V13, P767, DOI 10.1080/15548627.2017.1280225
   Ghosh S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00481
   Hai Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15368
   Han J, 2016, AUTOPHAGY, V12, P2326, DOI 10.1080/15548627.2016.1235124
   Hernández-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044
   Hyvönen MT, 2010, AMINO ACIDS, V38, P575, DOI 10.1007/s00726-009-0418-5
   Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104
   Ke BB, 2010, MOL THER, V18, P1019, DOI 10.1038/mt.2009.285
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11
   Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088
   Li C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01289-7
   Li PZ, 2014, IMMUNOL LETT, V158, P52, DOI 10.1016/j.imlet.2013.12.002
   Liu K, 2015, AUTOPHAGY, V11, P271, DOI 10.1080/15548627.2015.1009787
   Lu L, 2018, HEPATOLOGY, V67, P1041, DOI 10.1002/hep.29593
   Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788
   Madeo F, 2010, AUTOPHAGY, V6, P160, DOI 10.4161/auto.6.1.10600
   McDonald B, 2016, GASTROENTEROLOGY, V151, P1087, DOI 10.1053/j.gastro.2016.09.048
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011
   Okumura S, 2016, LIVER TRANSPLANT, V22, P1231, DOI 10.1002/lt.24471
   Park JK, 2017, HEPATOLOGY, V65, P1720, DOI 10.1002/hep.29051
   Patanè S, 2009, INT J CARDIOL, V132, P140, DOI 10.1016/j.ijcard.2007.07.153
   Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230
   Rao ZQ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01299
   Shan MH, 2017, FREE RADICAL BIO MED, V110, P432, DOI 10.1016/j.freeradbiomed.2017.05.021
   SZABO C, 1994, BRIT J PHARMACOL, V112, P355, DOI 10.1111/j.1476-5381.1994.tb13078.x
   Tacke F, 2017, J HEPATOL, V66, P1300, DOI 10.1016/j.jhep.2017.02.026
   ter Steege JCA, 1999, SHOCK, V11, P115, DOI 10.1097/00024382-199902000-00008
   Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852
   Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701
   Van den Bossche J, 2012, J LEUKOCYTE BIOL, V91, P685, DOI 10.1189/jlb.0911453
   Wang Y, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00691
   Wei C, 2016, CELL PHYSIOL BIOCHEM, V38, P531, DOI 10.1159/000438648
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Zhang C, 2018, CELL MOL IMMUNOL, V15, P973, DOI 10.1038/cmi.2017.22
   Zhang MH, 2000, CRIT CARE MED, V28, pN60, DOI 10.1097/00003246-200004001-00007
   Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759
   Zhao EP, 2017, HEPATOLOGY, V66, P922, DOI 10.1002/hep.29244
   Zhou HM, 2016, TRANSPLANTATION, V100, P365, DOI 10.1097/TP.0000000000001032
   Zhu S, 2009, MOL MED, V15, P275, DOI 10.2119/molmed.2009.00062
NR 52
TC 60
Z9 67
U1 0
U2 25
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAY 2
PY 2018
VL 9
AR 948
DI 10.3389/fimmu.2018.00948
PG 12
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA GE4PK
UT WOS:000431198000001
PM 29770139
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Schmidt, H
   Malik, A
   Bicker, A
   Poetzsch, G
   Avivi, A
   Shams, I
   Hankeln, T
AF Schmidt, Hanno
   Malik, Assaf
   Bicker, Anne
   Poetzsch, Gesa
   Avivi, Aaron
   Shams, Imad
   Hankeln, Thomas
TI Hypoxia tolerance, longevity and cancer-resistance in the mole rat
   <i>Spalax</i> - a liver transcriptomics approach
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; GENE-EXPRESSION; CELLS; MTOR; OVEREXPRESSION;
   ENVIRONMENT; INTEGRATION; ACTIVATION; WEBGESTALT; CYTOSCAPE
AB The blind subterranean mole rat Spalax shows a remarkable tolerance to hypoxia, cancer-resistance and longevity. Unravelling the genomic basis of these adaptations will be important for biomedical applications. RNA-Seq gene expression data were obtained from normoxic and hypoxic Spalax and rat liver tissue. Hypoxic Spalax broadly downregulates genes from major liver function pathways. This energy-saving response is likely a crucial adaptation to low oxygen levels. In contrast, the hypoxia-sensitive rat shows massive upregulation of energy metabolism genes. Candidate genes with plausible connections to the mole rat's phenotype, such as important key genes related to hypoxia-tolerance, DNA damage repair, tumourigenesis and ageing, are substantially higher expressed in Spalax than in rat. Comparative liver transcriptomics highlights the importance of molecular adaptations at the gene regulatory level in Spalax and pinpoints a variety of starting points for subsequent functional studies.
C1 [Schmidt, Hanno; Bicker, Anne; Poetzsch, Gesa; Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut, Mol Genet & Genome Anal, Johann Joachim Becher Weg 30 A, D-55128 Mainz, Germany.
   [Schmidt, Hanno] Senckenberg Biodivers & Climate Res Ctr SBiK F, Gen Evolut & Climate, D-60325 Frankfurt, Germany.
   [Malik, Assaf; Avivi, Aaron; Shams, Imad] Univ Haifa, Inst Evolut, IL-31905 Haifa, Israel.
C3 Johannes Gutenberg University of Mainz; Senckenberg Gesellschaft fur
   Naturforschung (SGN); Senckenberg Biodiversitat & Klima-
   Forschungszentrum (BiK-F); University of Haifa
RP Hankeln, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut, Mol Genet & Genome Anal, Johann Joachim Becher Weg 30 A, D-55128 Mainz, Germany.; Shams, I (corresponding author), Univ Haifa, Inst Evolut, IL-31905 Haifa, Israel.
EM imadshams@univ.haifa.ac.il; hankeln@uni-mainz.de
RI Schmidt, Hanno/H-3345-2018
OI Schmidt, Hanno/0000-0001-8915-891X; Shams, Imad/0000-0001-6496-2928;
   Bicker, Dr. Anne/0000-0003-4364-9777; , Assaf Malik/0000-0001-6878-1569
FU University of Mainz Center for Computational Sciences (SRFN); Stiftung
   Innovation Rhineland-Palatinate [1049]; John Templeton Foundation, USA
   [53057]
FX H.S. and T.H. acknowledge financial support by the University of Mainz
   Center for Computational Sciences (SRFN) and the Stiftung Innovation
   Rhineland-Palatinate (1049). A. A., I.S. and A.M. acknowledge financial
   support from the John Templeton Foundation, USA (grant #53057) and the
   donation of Mr. Peter Kadas, UK. We thank Bettina Weich for performing
   RNA preparation, Dr. Steffen Rapp for operating the Illumina HiSeq
   machine and Dr. Dennis Strand (University Medical School Mainz) for
   critical reading of the manuscript.
CR Aggarwal M, 2013, CANCER RES, V73, P5497, DOI 10.1158/0008-5472.CAN-12-2975
   Anisimov VN, 2005, NAT REV CANCER, V5, P807, DOI 10.1038/nrc1715
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Avivi A, 2007, ONCOGENE, V26, P2507, DOI 10.1038/sj.onc.1210045
   Avivi A, 2005, FASEB J, V19, P1314, DOI 10.1096/fj.04-3414fje
   Avivi A, 2006, PHYSIOL GENOMICS, V27, P54, DOI 10.1152/physiolgenomics.00001.2006
   Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107
   Azpurua Jorge, 2013, Frontiers in Genetics, V3, P319, DOI 10.3389/fgene.2012.00319
   Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048
   Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081
   Baze MM, 2010, PHYSIOL GENOMICS, V41, P275, DOI 10.1152/physiolgenomics.00075.2009
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244
   de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Fang XD, 2014, CELL REP, V8, P1354, DOI 10.1016/j.celrep.2014.07.030
   Fang XD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4966
   Ghosh AP, 2015, ONCOTARGET, V6, P17895, DOI 10.18632/oncotarget.4963
   Gorbunova V, 2012, P NATL ACAD SCI USA, V109, P19392, DOI 10.1073/pnas.1217211109
   Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493
   Jha AR, 2016, MOL BIOL EVOL, V33, P501, DOI 10.1093/molbev/msv248
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988
   Kim TM, 2015, NUCLEIC ACIDS RES, V43, P893, DOI 10.1093/nar/gku1334
   Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Lewis SH, 2016, GENOME BIOL EVOL, V8, P507, DOI 10.1093/gbe/evw018
   Lindner I, 2010, CANCER RES, V70, P277, DOI 10.1158/0008-5472.CAN-09-1462
   MacRae SL, 2015, AGING-US, V7, P1171, DOI 10.18632/aging.100866
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   Maity J, 2014, BBA-MOL BASIS DIS, V1842, P2387, DOI 10.1016/j.bbadis.2014.09.007
   Malik A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38624
   Malik A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-615
   Manov I, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-91
   McCarty M. F, 2015, HORM MOL BIOL CLIN I, V30
   Miyawaki S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11471
   Mori C, 2013, GENES CELLS, V18, P278, DOI 10.1111/gtc.12034
   Mori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088891
   Nasser NJ, 2009, P NATL ACAD SCI USA, V106, P2253, DOI 10.1073/pnas.0812846106
   Nevo E., 2001, ADAPTIVE RAD BLIND S
   Orman MA, 2011, J THEOR BIOL, V272, P131, DOI 10.1016/j.jtbi.2010.11.042
   Pawaria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050365
   Rosmorduc O, 2010, SEMIN LIVER DIS, V30, P258, DOI 10.1055/s-0030-1255355
   Scanlon SE, 2014, MOL CANCER RES, V12, P1016, DOI 10.1158/1541-7786.MCR-13-0628
   Schmidt H, 2016, GENE, V577, P293, DOI 10.1016/j.gene.2015.11.038
   Schülke S, 2012, GENE, V500, P199, DOI 10.1016/j.gene.2012.03.019
   Semenza GL, 2014, ANNU REV PHYSIOL, V76, P39, DOI 10.1146/annurev-physiol-021113-170322
   Shams I, 2005, COMP BIOCHEM PHYS A, V142, P376, DOI 10.1016/j.cbpa.2005.09.003
   Shams I, 2004, P NATL ACAD SCI USA, V101, P9698, DOI 10.1073/pnas.0403540101
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shigechi T, 2012, CANCER RES, V72, P1149, DOI 10.1158/0008-5472.CAN-11-2904
   Shimokawa I, 2015, AGING CELL, V14, P707, DOI 10.1111/acel.12340
   Stein B, 2000, LIFE UNDERGROUND BIO
   Su FT, 2016, ONCOTARGET, V7, P46, DOI 10.18632/oncotarget.6659
   Sugitani N, 2016, DNA REPAIR, V44, P123, DOI 10.1016/j.dnarep.2016.05.018
   Tacutu R., 2012, NUCLEIC ACIDS RES
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tekin S, 2016, ULTRASTRUCT PATHOL, V40, P51, DOI 10.3109/01913123.2015.1088909
   Thieme R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130470
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59
   Voloch Carolina M., 2013, BMC Research Notes, V6, P160, DOI 10.1186/1756-0500-6-160
   WAHRMAN J, 1969, SCIENCE, V164, P82, DOI 10.1126/science.164.3875.82
   Wang CQ, 2014, FREE RADICAL RES, V48, P435, DOI [10.3109/10715762.2014.885116, 10.3109/10715762.2014.936431]
   Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439
   Wang JX, 1998, CANCER RES, V58, P3538
   Williams S. A., 2015, P R SOC LONDON B, V282
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Yu CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026729
   Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475
   Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
   박우현, 2006, Blood Research, V41, P1
NR 78
TC 34
Z9 38
U1 0
U2 8
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 30
PY 2017
VL 7
AR 14348
DI 10.1038/s41598-017-13905-z
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FL3OC
UT WOS:000414131700041
PM 29084988
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU TANHAUSER, SM
   LAIPIS, PJ
AF TANHAUSER, SM
   LAIPIS, PJ
TI MULTIPLE DELETIONS ARE DETECTABLE IN MITOCHONDRIAL-DNA OF AGING MICE
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID RESPIRATORY-CHAIN FUNCTION; DEGENERATIVE DISEASES; SKELETAL-MUSCLE;
   EXTERNAL OPHTHALMOPLEGIA; HUMAN BRAIN; SEQUENCE; MUTATION; TISSUES;
   ACCUMULATION; MYOPATHIES
AB Mutational damage to human mitochondrial DNA (mtDNA) can cause disorders in oxidative phosphorylation; speculation that such damage is involved in degenerative diseases and aging is common. We have detected deletions in mouse mtDNA which resemble those found in elderly humans or patients with certain mtDNA disorders. Five different mtDNA deletions, predicted from the positions of short, direct DNA repeats, were present in aged, but not young, mice. Deleted regions were surrounded by either exact or inexact repeats and occurred in both the major and minor regions of the mtDNA genome, The abundance of a particular deletion was generally related to the thermodynamic stability of the bounding repeat sequence. Deletions in aged mice were present at low levels (less than 0.01% of total mtDNA). However, in contrast to results from aged humans, deletions were more abundant in liver than in brain, heart, or skeletal muscle. These results make it possible to predict the location and relative abundance of deletions in any sequenced mtDNA, including inbred mouse strains differing in inherent natural lifespan. The inbred mouse model will allow a critical examination of the relationship between the presence and abundance of mtDNA deletions and the aging process.
C1 UNIV FLORIDA, COLL MED, DEPT BIOCHEM & MOLEC BIOL, GAINESVILLE, FL 32610 USA.
C3 State University System of Florida; University of Florida
FU NIGMS NIH HHS [GM33537] Funding Source: Medline
CR ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811
   ARNOLD FH, 1987, BIOCHEMISTRY-US, V26, P4068, DOI 10.1021/bi00387a049
   BAKER GT, 1988, EXP GERONTOL, V23, P223, DOI 10.1016/0531-5565(88)90025-3
   BAUMER A, 1994, AM J HUM GENET, V54, P618
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   BLOCH W, 1992, AMPLIFICATIONS, V8, P1
   BOURSOT P, 1987, MOL BIOL EVOL, V4, P46
   BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746
   BROSSAS JY, 1994, BIOCHEM BIOPH RES CO, V202, P654, DOI 10.1006/bbrc.1994.1980
   CHUNG SS, 1994, AGING-CLIN EXP RES, V6, P193, DOI 10.1007/BF03324239
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387
   GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   LINNANE AW, 1992, MUTAT RES, V275, P195, DOI 10.1016/0921-8734(92)90023-I
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   MASORO EJ, 1992, LAB ANIM SCI, V42, P132
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   NEWSHOLME EA, 1983, BIOCH MED SCI, P146
   PERITZ AE, 1991, BIOCHEMISTRY-US, V30, P6428, DOI 10.1021/bi00240a013
   PIKO L, 1992, ANN NY ACAD SCI, V663, P450, DOI 10.1111/j.1749-6632.1992.tb38698.x
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Sambrook J., 1989, MOL CLONING LABORATO, V2nd
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SOONG NW, 1992, NAT GENET, V2, P318
   SPROTT RL, 1991, NEUROBIOL AGING, V12, P635, DOI 10.1016/0197-4580(91)90113-X
   SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
NR 49
TC 129
Z9 146
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 20
PY 1995
VL 270
IS 42
BP 24769
EP 24775
DI 10.1074/jbc.270.42.24769
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA TB465
UT WOS:A1995TB46500028
PM 7559594
OA hybrid
DA 2024-02-19
ER

PT J
AU Yarian, CS
   Sohal, RS
AF Yarian, CS
   Sohal, RS
TI In the aging housefly aconitase is the only citric acid cycle enzyme to
   decline significantly
SO JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
LA English
DT Article
DE citric acid cycle; aconitase; aging
ID CYTOCHROME-OXIDASE ACTIVITY; HYDROGEN-PEROXIDE RELEASE; OXIDATIVE
   STRESS; DEHYDROGENASE; PURIFICATION; LIVER; MITOCHONDRIA; RESTRICTION;
   DROSOPHILA; COMPLEXES
AB The main objective of this study was to determine if the activities of the mitochondrial citric acid cycle enzymes are altered during the normal aging process. Flight muscle mitochondria of houseflies of different ages were used as a model system because of their apparent age-related decline in bioenergetic efficiency, evident as a failure of flying ability. The maximal activities of each of the citric acid cycle enzymes were determined in preparations of mitochondria from flies of relatively young, middle, and old age. Aconitase was the only enzyme exhibiting altered activity during aging. The maximal activity of aconitase from old flies was decreased by 44% compared to that from young flies while the other citric acid cycle enzymes showed no change in activity with age. It is suggested that the selective age-related decrease in aconitase activity is likely to contribute to a decline in the efficiency of mitochondrial bioenergetics, as well as result in secondary effects associated with accumulation of citrate and redox-active iron.
C1 Univ So Calif, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA.
C3 University of Southern California
RP Sohal, RS (corresponding author), Univ So Calif, Dept Mol Pharmacol & Toxicol, 1985 Zonal Ave, Los Angeles, CA 90033 USA.
EM sohal@usc.edu
FU NIA NIH HHS [R01 AG 17077] Funding Source: Medline
CR Ackrell B A, 1978, Methods Enzymol, V53, P466
   Bayne ACV, 2002, FREE RADICAL BIO MED, V32, P1229, DOI 10.1016/S0891-5849(02)00849-3
   CHA S, 1964, J BIOL CHEM, V239, P1961
   Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209
   Eaton P, 2002, ANN NY ACAD SCI, V973, P529, DOI 10.1111/j.1749-6632.2002.tb04694.x
   Feuers RJ, 1998, ANN NY ACAD SCI, V854, P192, DOI 10.1111/j.1749-6632.1998.tb09902.x
   Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   HENSON CP, 1967, J BIOL CHEM, V242, P3833
   KANSKI J, 2004, AM J PHYSL HEART CIR
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200
   Li H, 2001, J NEURAL TRANSM, V108, P1363, DOI 10.1007/s007020100013
   Morel F, 1995, MECH AGEING DEV, V84, P171, DOI 10.1016/0047-6374(95)01653-8
   Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200
   Robinson, 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135
   ROSE IA, 1967, J BIOL CHEM, V242, P1870
   Rouault TA, 2002, BLOOD CELL MOL DIS, V29, P309, DOI 10.1006/bcmd.2002.0571
   Schwarze SR, 1998, FREE RADICAL BIO MED, V25, P740, DOI 10.1016/S0891-5849(98)00153-1
   SOHAL RS, 1993, FREE RADICAL BIO MED, V14, P583, DOI 10.1016/0891-5849(93)90139-L
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   SPENCER AF, 1967, BIOCHEM J, V103, P342, DOI 10.1042/bj1030342
   STADTMAN ER, 1991, J BIOL CHEM, V266, P17201
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
   Zahavi M., 1965, Journal of Insect Physiology, V11, P811, DOI 10.1016/0022-1910(65)90160-5
NR 28
TC 24
Z9 25
U1 0
U2 9
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0145-479X
EI 1573-6881
J9 J BIOENERG BIOMEMBR
JI J. Bioenerg. Biomembr.
PD APR
PY 2005
VL 37
IS 2
BP 91
EP 96
DI 10.1007/s10863-005-4132-z
PG 6
WC Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Cell Biology
GA 928JH
UT WOS:000229267200005
PM 15906154
DA 2024-02-19
ER

PT J
AU de Goyet, JD
   Baumann, U
   Karam, V
   Adam, R
   Nadalin, S
   Heaton, N
   Reding, R
   Branchereau, S
   Mirza, D
   Klempnauer, JL
   Fischer, L
   Kalicinski, P
   Colledan, M
   Santamaria, ML
   de Kleine, RH
   Chardot, C
   Yilmaz, S
   Kilic, M
   Boillot, O
   di Francesco, F
   Polak, WG
   Verkade, HJ
   Liver, E
AF de Goyet, Jean de Ville
   Baumann, Ulrich
   Karam, Vincent
   Adam, Rene
   Nadalin, Silvio
   Heaton, Nigel
   Reding, Raymond
   Branchereau, Sophie
   Mirza, Darius
   Klempnauer, Juergen L.
   Fischer, Lutz
   Kalicinski, Piotr
   Colledan, Michele
   Lopez Santamaria, Manuel
   de Kleine, Ruben H.
   Chardot, Christophe
   Yilmaz, Sezai
   Kilic, Murat
   Boillot, Olivier
   di Francesco, Fabrizio
   Polak, Wojciech G.
   Verkade, Henkjan J.
   Liver, European
TI European Liver Transplant Registry: Donor and transplant surgery aspects
   of 16,641 liver transplantations in children
SO HEPATOLOGY
LA English
DT Article; Early Access
ID RECIPIENTS; SURVIVAL; COMPLICATIONS
AB Background and Aims The European Liver Transplant Registry (ELTR) has collected data on liver transplant procedures performed in Europe since 1968. Approach and Results Over a 50-year period (1968-2017), clinical and laboratory data were collected from 133 transplant centers and analyzed retrospectively (16,641 liver transplants in 14,515 children). Data were analyzed according to three successive periods (A, before 2000; B, 2000-2009; and C, since 2010), studying donor and graft characteristics and graft outcome. The use of living donors steadily increased from A to C (A, n = 296 [7%]; B, n = 1131 [23%]; and C, n = 1985 [39%]; p = 0.0001). Overall, the 5-year graft survival rate has improved from 65% in group A to 75% in group B (p < 0.0001) and to 79% in group C (B versus C, p < 0.0001). Graft half-life was 31 years, overall; it was 41 years for children who survived the first year after transplant. The late annual graft loss rate in teenagers is higher than that in children aged Pediatric liver transplantation has reached a high efficacy as a cure or treatment for severe liver disease in infants and children. Grafts that survived the first year had a half-life similar to standard human half-life. Transplantation before or after puberty may be the pivot-point for lower long-term outcome in children. Further studies are necessary to revisit some old concepts regarding transplant benefit (survival time) for small children, the role of recipient pathophysiology versus graft aging, and risk at transition to adult age.
C1 [de Goyet, Jean de Ville; di Francesco, Fabrizio] Ist Ricovero & Cura Carattere Sci, Dept Treatment & Study Pediat Abdominal Dis & Abd, Palermo, Italy.
   [Baumann, Ulrich] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.
   [Baumann, Ulrich] Hannover Med Sch, Paediat Gastroenterol & Hepatol, Hannover, Germany.
   [Baumann, Ulrich; Adam, Rene; Polak, Wojciech G.; Verkade, Henkjan J.] European Liver & Intestine Transplant Assoc, Padua, Italy.
   [Karam, Vincent; Adam, Rene; Liver, European] Univ Paris Sud, Hop Paul Brousse, AP HP, European Liver Transplant Registry,Inserm U 935, Villejuif, France.
   [Nadalin, Silvio] Univ Hosp Tubingen, Dept Gen Visceral & Transplant Surg, Tubingen, Germany.
   [Heaton, Nigel] Kings Coll Hosp London, London, England.
   [Reding, Raymond] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium.
   [Branchereau, Sophie] Bicetre Univ Hosp, AP HP, Serv Chirurg Viscerale Pediat, Fac Med Paris Sud, Le Kremlin Bicetre, France.
   [Mirza, Darius] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Liver Unit, Birmingham, W Midlands, England.
   [Klempnauer, Juergen L.] Hannover Med Sch, Klin Viszeral & Transplantat Chirurg, Hannover, Germany.
   [Fischer, Lutz] Univ Med Ctr Hamburg Eppendorf, Dept Visceral Transplantat, Hamburg, Germany.
   [Kalicinski, Piotr] Childrens Mem Hlth Inst, Dept Pediat & Transplant Surg, Warsaw, Poland.
   [Colledan, Michele] Univ Milano Bicocca, Dept Organ Failure & Transplantat, ASST Giovanni XXIII, Bergamo, Italy.
   [Lopez Santamaria, Manuel] Hosp Infantil Univ La Paz, Pediat Surg Dept, Madrid, Spain.
   [de Kleine, Ruben H.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect HepatoPancreat Biliary Surg, Groningen, Netherlands.
   [Chardot, Christophe] Hop Necker Enfants Malad, Serv Chirurg Pediat, Paris, France.
   [Yilmaz, Sezai] Inonu Univ, Liver Transplantat Inst, Malatya, Turkey.
   [Kilic, Murat] Izmir Kent Hosp, Liver Transplant Program, Izmir, Turkey.
   [Boillot, Olivier] Hop Edouard Herriot, Pediat Liver Transplant Surg, Lyon, France.
   [Polak, Wojciech G.] Univ Med Ctr Rotterdam, Transplant Inst, Dept Surg, Div Hepatopancreatobiliary & Transplant Surg,Eras, Rotterdam, Netherlands.
   [Verkade, Henkjan J.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.
C3 University of Birmingham; Hannover Medical School; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP;
   Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP;
   Universite Paris Saclay; Eberhard Karls University of Tubingen; Eberhard
   Karls University Hospital; King's College Hospital NHS Foundation Trust;
   King's College Hospital; Universite Catholique Louvain; Cliniques
   Universitaires Saint-Luc; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Bicetre - APHP; Universite Paris Cite; Hopital
   Universitaire Hotel-Dieu - APHP; Universite Paris Saclay; Hopital
   Universitaire Paul-Brousse - APHP; University of Birmingham; Hannover
   Medical School; University of Hamburg; University Medical Center
   Hamburg-Eppendorf; Children's Memorial Health Institute; University of
   Milano-Bicocca; University of Groningen; Assistance Publique Hopitaux
   Paris (APHP); Universite Paris Cite; Hopital Universitaire
   Necker-Enfants Malades - APHP; Inonu University; Kent Hospital; CHU
   Lyon; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Transplant
   Institute; University of Groningen
RP de Goyet, JD (corresponding author), ISMETT, Dept Treatment & Study Pediat Abdominal Dis & Abd, Via Ernesto Tric 5, I-90127 Palermo, Italy.
EM Jdeville@ismett.edu
RI Colledan, Michele/JGM-6908-2023; Kalicinski, Piotr/AEN-1920-2022;
   Yilmaz, Sezai/ABI-2323-2020; Verkade, Heather/J-2401-2013; de Ville de
   Goyet, Jean/I-6913-2019; Polak, Wojciech/AAM-6937-2021; Karam,
   Vincent/HLQ-6211-2023
OI Colledan, Michele/0000-0002-3880-4763; Kalicinski,
   Piotr/0000-0003-0555-2229; Yilmaz, Sezai/0000-0002-8044-0297; de Ville
   de Goyet, Jean/0000-0001-7681-6178; Polak, Wojciech/0000-0002-3096-4893;
   Verkade, Henkjan J/0000-0002-7034-2861
CR Adam R, 2018, TRANSPL INT, V31, P1293, DOI 10.1111/tri.13358
   Angelico R, 2019, AM J TRANSPLANT, V19, P2029, DOI 10.1111/ajt.15300
   Angelico R, 2018, TRANSPL INT, V31, P739, DOI 10.1111/tri.13147
   Bezinover D, 2019, HPB, V21, P370, DOI 10.1016/j.hpb.2018.08.014
   Bowring MG, 2020, J PEDIATR GASTR NUTR, V70, P356, DOI 10.1097/MPG.0000000000002592
   Dharnidharka VR, 2015, PEDIATR TRANSPLANT, V19, P471, DOI 10.1111/petr.12464
   Ekong UD, 2019, PEDIATR TRANSPLANT, V23, DOI 10.1111/petr.13523
   Elisofon SA, 2020, PEDIATR TRANSPLANT, V24, DOI 10.1111/petr.13605
   Emond J, 2012, AM J TRANSPLANT, V12, P2267, DOI 10.1111/j.1600-6143.2012.04208.x
   Englesbe MJ, 2012, AM J TRANSPLANT, V12, P2301, DOI 10.1111/j.1600-6143.2012.04204.x
   Grimaldi C, 2018, PEDIATR TRANSPLANT, V22, DOI 10.1111/petr.13288
   Jean-St-Michel E, 2015, PEDIATR TRANSPLANT, V19, P439, DOI 10.1111/petr.12528
   Kasahara M, 2018, AM J TRANSPLANT, V18, P659, DOI 10.1111/ajt.14489
   Loirat C, 2001, PEDIATR NEPHROL, V16, P964, DOI 10.1007/s004670100004
   McDiarmid SV, 2011, ANN SURG, V254, P145, DOI 10.1097/SLA.0b013e31821ad86a
   McDiarmid SV, 2000, TRANSPLANTATION, V70, P1283, DOI 10.1097/00007890-200011150-00005
   Neto JS, 2020, LIVER TRANSPLANT, V26, P1644, DOI 10.1002/lt.25875
   Perito ER, 2019, TRANSPLANTATION, V103, P552, DOI 10.1097/TP.0000000000002249
   Sagar N, 2015, AM J TRANSPLANT, V15, P1864, DOI 10.1111/ajt.13184
   STARZL TE, 1968, ANN SURG, V168, P392, DOI 10.1097/00000658-196809000-00009
   US Department of Health and Human Services, 2018, SCI REG TRANSPL REC
   Valentino PL, 2019, AM J TRANSPLANT, V19, P3114, DOI 10.1111/ajt.15481
NR 22
TC 30
Z9 30
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2022 MAR
PY 2022
VL 75
IS 3
BP 634
EP 645
DI 10.1002/hep.32223
EA DEC 2021
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA YY3YH
UT WOS:000730929100001
PM 34724224
OA Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU Nahálková, J
AF Nahalkova, Jarmila
TI Focus on Molecular Functions of Anti-Aging Deacetylase SIRT3
SO BIOCHEMISTRY-MOSCOW
LA English
DT Article
DE SIRT3; NAD(+)-dependent protein deacetylase; protein interaction
   network; pathway enrichment analysis; aging; respiratory electron
   transport chain; mitochondria; age-related disease
ID PYRUVATE-DEHYDROGENASE ACTIVITY; CALORIE RESTRICTION; DNA-PK;
   MITOCHONDRIAL; ACTIVATION; KINASE; CLOCK; PGC-1-ALPHA; METABOLISM;
   MECHANISMS
AB SIRT3 is a protein lysine deacetylase with a prominent role in the maintenance of mitochondrial integrity, which is a vulnerable target in many diseases. Intriguingly, cellular aging is reversible just by SIRT3 overexpression, which raises many questions about the role of SIRT3 in the molecular anti-aging mechanisms. Therefore, functions of SIRT3 were analyzed through the interaction network of 407 substrates collected by data mining. Results of the pathway enrichment and gene function prediction confirmed functions in the primary metabolism and mitochondrial ATP production. However, it also suggested involvement in thermogenesis, brain-related neurodegenerative diseases Alzheimer's (AD), Parkinson's, Huntington's disease (HD), and non-alcoholic fatty liver disease. The protein node prioritization analysis identified subunits of the complex I of the mitochondrial respiratory chain (MRC) as the nodes with the main regulatory effect within the entire interaction network. Additional high-ranked nodes were succinate dehydrogenase subunit B (SDHB), complex II, and ATP5F1, complex V of MRC. The analysis supports existence of the NADH/NAD(+) driven regulatory feedback loop between SIRT3, complex I (MRC), and acetyl-CoA synthetases, and existence of the nuclear substrates of SIRT3. Unexplored functions of SIRT3 substrates such as LMNA and LMNB; HIF-1a, p53, DNA-PK, and PARK7 are highlighted for further scientific advances. SIRT3 acts as a repressor of BACE1 through the SIRT3-LKB1-AMPK-CREB-PGC1A-PPARG-BACE1 (SIRT3-BACE1), which functions are fitted the best by the Circadian Clock pathway. It forms a new working hypothesis as the therapeutical target for AD treatment. Other important pathways linked to SIRT3 activity are highlighted for therapeutical interventions.
C1 [Nahalkova, Jarmila] Biochemworld Co, Biochem Mol & Cell Biol Unit, S-74394 Skyttorp, Uppsala County, Sweden.
RP Nahálková, J (corresponding author), Biochemworld Co, Biochem Mol & Cell Biol Unit, S-74394 Skyttorp, Uppsala County, Sweden.
EM jarmila.nahalkova@biochemworld.net
FU Biochemworld Co., Uppsala County, Sweden
FX The research was financially supported by the Biochemworld Co., Uppsala
   County, Sweden.
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Amberger JS, 2019, NUCLEIC ACIDS RES, V47, pD1038, DOI 10.1093/nar/gky1151
   Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2
   Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924
   Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009
   Bateman A, 2021, NUCLEIC ACIDS RES, V49, pD480, DOI 10.1093/nar/gkaa1100
   Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354
   Braidy N, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00167
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474
   Chaplin AK, 2021, NAT STRUCT MOL BIOL, V28, DOI 10.1038/s41594-020-00517-x
   Chaves I, 2014, CURR BIOL, V24, P1248, DOI 10.1016/j.cub.2014.04.018
   Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254
   Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11
   Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u
   Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624
   Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575
   Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295
   Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094
   Franz M, 2018, NUCLEIC ACIDS RES, V46, pW60, DOI 10.1093/nar/gky311
   Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200
   Fukumura S, 2015, J HUM GENET, V60, P509, DOI 10.1038/jhg.2015.57
   Galmiche L, 2012, MITOCHONDRION, V12, P242, DOI 10.1016/j.mito.2011.09.007
   Gurd BJ, 2012, METABOLISM, V61, P733, DOI 10.1016/j.metabol.2011.09.016
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Jacobs KM, 2008, INT J BIOL SCI, V4, P291
   Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650
   Joo HY, 2015, BIOCHEM BIOPH RES CO, V462, P294, DOI 10.1016/j.bbrc.2015.04.119
   Katsouri L, 2011, J ALZHEIMERS DIS, V25, P151, DOI 10.3233/JAD-2011-101356
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Kutmon Martina, 2014, F1000Res, V3, P152, DOI 10.12688/f1000research.4254.2
   Laemmle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033433
   Lee J, 2018, AGING CELL, V17, DOI 10.1111/acel.12679
   Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767
   Liu L, 2015, NEUROCHEM RES, V40, P600, DOI 10.1007/s11064-014-1507-8
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430
   Lu ZP, 2015, J BIOL CHEM, V290, P2466, DOI 10.1074/jbc.M114.606228
   Mauvoisin D, 2017, CELL REP, V20, P1729, DOI 10.1016/j.celrep.2017.07.065
   Maynard S, 2019, NUCLEIC ACIDS RES, V47, P11709, DOI 10.1093/nar/gkz912
   McDonnell E, 2015, TRENDS ENDOCRIN MET, V26, P486, DOI 10.1016/j.tem.2015.06.001
   Murray-Nerger LA, 2021, NUCLEIC ACIDS RES, V49, P2044, DOI 10.1093/nar/gkab019
   Nakamura Y, 2008, BIOCHEM BIOPH RES CO, V366, P174, DOI 10.1016/j.bbrc.2007.11.122
   Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376
   Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001
   Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075
   Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060
   Park SJ, 2017, CELL METAB, V25, P1135, DOI [10.1016/j.cmet.2017.04.008, 10.1016/j.cmet.2017.07.005]
   Perli E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41483-9
   Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271
   Polischouk AG, 1999, INT J RADIAT ONCOL, V43, P191, DOI 10.1016/S0360-3016(98)00362-9
   Poulose N, 2015, BBA-MOL BASIS DIS, V1852, P2442, DOI 10.1016/j.bbadis.2015.08.017
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Ramesh S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190350
   Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110
   Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327
   Redwood AB, 2011, CELL CYCLE, V10, P2549, DOI 10.4161/cc.10.15.16531
   Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13
   Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307
   Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048
   Schrader M, 2020, J INHERIT METAB DIS, V43, P71, DOI 10.1002/jimd.12083
   Sengupta A, 2018, DNA REPAIR, V61, P1, DOI 10.1016/j.dnarep.2017.11.003
   Shi HJ, 2012, PATHOLOGY, V44, P506, DOI 10.1097/PAT.0b013e3283559cbe
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003
   Sol EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050545
   Song C., 2017, SIRT3 DEPENDENT MITO, DOI [10.1101/107813, DOI 10.1101/107813]
   Stacpoole PW, 2012, AGING CELL, V11, P371, DOI 10.1111/j.1474-9726.2012.00805.x
   Sui JD, 2020, CELL MOL BIOL LETT, V25, DOI 10.1186/s11658-020-0199-0
   Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Tomita Taisuke, 2017, Advances in Biological Regulation, V64, P33, DOI 10.1016/j.jbior.2017.01.001
   Tong WX, 2016, HEPATOL RES, V46, P933, DOI 10.1111/hepr.12634
   Tseng AHH, 2013, FREE RADICAL BIO MED, V63, P222, DOI 10.1016/j.freeradbiomed.2013.05.002
   Van Dongen S., 2000, THESIS
   Vassilopoulos A, 2014, ANTIOXID REDOX SIGN, V21, P551, DOI 10.1089/ars.2013.5420
   Vedrenne V, 2012, AM J HUM GENET, V91, P912, DOI 10.1016/j.ajhg.2012.09.001
   Wang ZW, 2012, ONCOTARGET, V3, P1294
   Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519
   Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537
   Weir HJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048225
   Xiong YL, 2018, J CANCER RES CLIN, V144, P189, DOI 10.1007/s00432-017-2537-9
   Xue L, 2012, FEBS LETT, V586, P137, DOI 10.1016/j.febslet.2011.11.031
   Yang H, 2015, EMBO J, V34, P1110, DOI 10.15252/embj.201591041
   Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016
   Yang YJ, 2010, J BIOL CHEM, V285, P7417, DOI 10.1074/jbc.M109.053421
   Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206
   Zhou QQ, 2009, FEBS LETT, V583, P1132, DOI 10.1016/j.febslet.2009.02.043
   Zhu YM, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-15
   Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533
NR 94
TC 8
Z9 8
U1 0
U2 1
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0006-2979
EI 1608-3040
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD JAN
PY 2022
VL 87
IS 1
BP 21
EP 34
DI 10.1134/S0006297922010035
PG 14
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA YJ4QF
UT WOS:000744517800003
PM 35491023
DA 2024-02-19
ER

PT J
AU KANUNGO, MS
   SARAN, S
AF KANUNGO, MS
   SARAN, S
TI METHYLATION OF DNA OF THE BRAIN AND LIVER OF YOUNG AND OLD RATS
SO INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS
LA English
DT Article
ID GENE-EXPRESSION; CELLS; 5-METHYLCYTOSINE; INVITRO; TISSUE;
   DEMETHYLATION; INHERITANCE; SEQUENCES; CHROMATIN; MAMMALS
AB In vitro methylation of purified DNA and chromatin-DNA in nuclei of the liver and brain of young (18 week) and old (120 week) female rats has been studied using H-3-SAM as the -CH3 group donor. Incorporation of -CH3 group is higher in old liver and brain, but it is far higher in the latter. 5 mC is 11% lower in the old brain, but there is no difference in the liver. Methylation by Hpa II methylase does not show any difference in the incorporation of -CH3 group into DNA of the liver of the two ages. However, its incorporation is lower in the old brain. Methylation by Msp I methylase causes slightly higher incorporation of -CH3 groups in the old brain. This shows a higher percentage of unmethylated external cytosines in the 5'-CCGG-3' sequences. On the contrary, methylation by Eco RI methylase is considerably higher in the old brain. These studies show alterations in the methylation status of the DNA during ageing which may cause changes in the expression of genes.
C1 BANARAS HINDU UNIV, DEPT ZOOL, MOLEC BIOL LAB, VARANASI 221005, UTTAR PRADESH, INDIA.
C3 Banaras Hindu University (BHU)
CR AXEL R, 1973, P NATL ACAD SCI USA, V70, P2029, DOI 10.1073/pnas.70.7.2029
   BENVENISTY N, 1984, DNA METHYLATION BIOC, P353
   BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0
   BUSSLINGER M, 1983, CELL, V34, P197, DOI 10.1016/0092-8674(83)90150-2
   CHATURVEDI MM, 1985, BIOCHEM BIOPH RES CO, V127, P604, DOI 10.1016/S0006-291X(85)80203-5
   CUTLER RG, 1985, MOL BIOL AGING GENE, P307
   DOERFLER W, 1983, ANNU REV BIOCHEM, V52, P93, DOI 10.1146/annurev.bi.52.070183.000521
   DUERRE JA, 1977, J BIOL CHEM, V252, P5981
   EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709
   EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918
   FAIRWEATHER DS, 1987, EXP CELL RES, V168, P153, DOI 10.1016/0014-4827(87)90424-1
   FELSENFELD G, 1982, NATURE, V296, P602, DOI 10.1038/296602a0
   GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9
   GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P3087, DOI 10.1093/nar/11.10.3087
   HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7
   HOLLIDAY R, 1979, BRIT J CANCER, V40, P513, DOI 10.1038/bjc.1979.216
   HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230
   Holliday R., 1985, MOL BIOL AGEING, P269
   JAENISCH R, 1984, BIOCHIM BIOPHYS ACTA, V782, P1, DOI 10.1016/0167-4781(84)90099-X
   JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8
   KANUNGO MS, 1975, J THEOR BIOL, V53, P253, DOI 10.1016/S0022-5193(75)80002-6
   KANUNGO MS, 1980, BIOCH AGEING, P242
   KASTAN MB, 1982, CELL, V30, P509, DOI 10.1016/0092-8674(82)90248-3
   KORBA BE, 1985, SCIENCE, V228, P1103, DOI 10.1126/science.2581318
   LEY TJ, 1984, P NATL ACAD SCI-BIOL, V81, P6618, DOI 10.1073/pnas.81.21.6618
   LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9
   LYON SB, 1987, MOL CELL BIOL, V7, P1759, DOI 10.1128/MCB.7.5.1759
   MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8
   MAYHOOPES LL, 1989, INT REV CYTOL, V114, P181
   PARK JW, 1988, P NATL ACAD SCI USA, V85, P7467, DOI 10.1073/pnas.85.20.7467
   PRASHAD N, 1976, BIOCHIM BIOPHYS ACTA, V418, P1, DOI 10.1016/0005-2787(76)90322-1
   RATH PC, 1989, FEBS LETT, V244, P193, DOI 10.1016/0014-5793(89)81191-3
   RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144
   REIS RJS, 1980, CELL, V21, P739, DOI 10.1016/0092-8674(80)90437-7
   RIGGS AD, 1983, ADV CANCER RES, V40, P1, DOI 10.1016/S0065-230X(08)60678-8
   SANO H, 1982, P NATL ACAD SCI-BIOL, V79, P3584, DOI 10.1073/pnas.79.11.3584
   SHWETA S, 1989, THESIS BANARAS HINDU
   SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6
   STURM KS, 1981, NUCLEIC ACIDS RES, V9, P4537, DOI 10.1093/nar/9.18.4537
   VEDEL M, 1983, NUCLEIC ACIDS RES, V11, P4335, DOI 10.1093/nar/11.13.4335
   WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7
   YISRAELI J, 1984, DNA METHYLATION BIOC, P353
NR 42
TC 3
Z9 3
U1 0
U2 1
PU NATL INST SCIENCE COMMUNICATION-NISCAIR
PI NEW DELHI
PA DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA
SN 0301-1208
EI 0975-0959
J9 INDIAN J BIOCHEM BIO
JI Indian J. Biochem. Biophys.
PD FEB
PY 1992
VL 29
IS 1
BP 49
EP 53
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA HA650
UT WOS:A1992HA65000008
PM 1592415
DA 2024-02-19
ER

PT J
AU Harrison, DE
   Strong, R
   Alavez, S
   Astle, CM
   DiGiovanni, J
   Fernandez, E
   Flurkey, K
   Garratt, M
   Gelfond, JAL
   Javors, MA
   Levi, M
   Lithgow, GJ
   Macchiarini, F
   Nelson, JF
   Rizzo, SJS
   Slaga, TJ
   Stearns, T
   Wilkinson, JE
   Miller, RA
AF Harrison, David E.
   Strong, Randy
   Alavez, Silvestre
   Astle, Clinton Michael
   DiGiovanni, John
   Fernandez, Elizabeth
   Flurkey, Kevin
   Garratt, Michael
   Gelfond, Jonathan A. L.
   Javors, Martin A.
   Levi, Moshe
   Lithgow, Gordon J.
   Macchiarini, Francesca
   Nelson, James F.
   Rizzo, Stacey J. Sukoff
   Slaga, Thomas J.
   Stearns, Tim
   Wilkinson, John Erby
   Miller, Richard A.
TI Acarbose improves health and lifespan in aging HET3 mice
SO AGING CELL
LA English
DT Article
DE acarbose; health measures; heterogeneous mice; lifespan
ID FARNESOID X RECEPTOR; GLUCOSIDASE INHIBITOR; ALPHA-GLUCOSIDASE;
   NORDIHYDROGUAIARETIC ACID; RAPAMYCIN TREATMENT; BILE-ACIDS; AGE; DIET;
   RESTRICTION; RESVERATROL
AB To follow-up on our previous report that acarbose (ACA), a drug that blocks postprandial glucose spikes, increases mouse lifespan, we studied ACA at three doses: 400, 1,000 (the original dose), and 2,500 ppm, using genetically heterogeneous mice at three sites. Each dose led to a significant change (by log-rank test) in both sexes, with larger effects in males, consistent with the original report. There were no significant differences among the three doses. The two higher doses produced 16% or 17% increases in median longevity of males, but only 4% or 5% increases in females. Age at the 90th percentile was increased significantly (8%-11%) in males at each dose, but was significantly increased (3%) in females only at 1,000 ppm. The sex effect on longevity is not explained simply by weight or fat mass, which were reduced by ACA more in females than in males. ACA at 1,000 ppm reduced lung tumors in males, diminished liver degeneration in both sexes and glomerulosclerosis in females, reduced blood glucose responses to refeeding in males, and improved rotarod performance in aging females, but not males. Three other interventions were also tested: ursolic acid, 2-(2-hydroxyphenyl) benzothiazole (HBX), and INT-767; none of these affected lifespan at the doses tested. The acarbose results confirm and extend our original report, prompt further attention to the effects of transient periods of high blood glucose on aging and the diseases of aging, including cancer, and should motivate studies of acarbose and other glucose-control drugs in humans.
C1 [Harrison, David E.; Astle, Clinton Michael; Flurkey, Kevin; Rizzo, Stacey J. Sukoff; Stearns, Tim] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.
   [Strong, Randy; Fernandez, Elizabeth; Nelson, James F.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   [Strong, Randy; Fernandez, Elizabeth] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA.
   [Strong, Randy] South Texas Vet Hlth Care Syst, Res Serv, San Antonio, TX USA.
   [Strong, Randy; Fernandez, Elizabeth; Slaga, Thomas J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.
   [Alavez, Silvestre; Lithgow, Gordon J.] Buck Inst Res Aging, Novato, CA USA.
   [Alavez, Silvestre] Metropolitan Autonomous Univ, Lerma, Mexico.
   [DiGiovanni, John] Univ Texas Austin, Austin, TX 78712 USA.
   [Garratt, Michael; Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.
   [Garratt, Michael] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA.
   [Gelfond, Jonathan A. L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA.
   [Javors, Martin A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA.
   [Levi, Moshe] Georgetown Univ, Washington, DC USA.
   [Macchiarini, Francesca] NIA, Div Aging Biol, Bethesda, MD 20892 USA.
   [Nelson, James F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.
   [Wilkinson, John Erby] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA.
   [Wilkinson, John Erby] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.
C3 Jackson Laboratory; University of Texas System; University of Texas
   Health Science Center at San Antonio; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans
   Hospital; Geriatric Research Education & Clinical Center; US Department
   of Veterans Affairs; Veterans Health Administration (VHA); Audie L.
   Murphy Memorial Veterans Hospital; University of Texas System;
   University of Texas Health Science Center at San Antonio; Buck Institute
   for Research on Aging; Universidad Autonoma Metropolitana - Mexico;
   University of Texas System; University of Texas Austin; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan; University of Texas System; University of Texas
   Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; Georgetown
   University; National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA); University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Michigan
   System; University of Michigan; University of Michigan System;
   University of Michigan
RP Harrison, DE (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.
EM david.harrison@jax.org
RI Wilkinson, John/JTV-0835-2023; Alavez, Silvestre/AAM-4894-2021; Rizzo,
   Stacey/AAU-1145-2021
OI Rizzo, Stacey/0000-0002-1460-8127; Stearns, Timothy/0000-0002-5533-6076;
   Alavez, Silvestre/0000-0002-9220-0696
FU NIA [AG022308, AG022303, AG022307, AG013319]; NCI [CA034196]; Glenn
   Foundation for Medical Research; Department of Veterans Affairs Office
   of Research and Development
FX NIA, Grant/Award Number: AG022308, AG022303, AG022307, AG013319; NCI,
   Grant/Award Number: CA034196; Glenn Foundation for Medical Research;
   Department of Veterans Affairs Office of Research and Development
CR Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873
   Archer VE, 2003, MED HYPOTHESES, V60, P924, DOI 10.1016/S0306-9877(03)00097-5
   BALFOUR JA, 1993, DRUGS, V46, P1025, DOI 10.2165/00003495-199346060-00007
   Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001
   Flurkey K, 2010, J GERONTOL A-BIOL, V65, P1275, DOI 10.1093/gerona/glq155
   Frantz S, 2005, FASEB J, V19, P591, DOI 10.1096/fj.04-2459fje
   Garratt M, 2018, AGING CELL, V17, DOI 10.1111/acel.12786
   Garratt M, 2017, AGING CELL, V16, P1256, DOI 10.1111/acel.12656
   Gems D, 2007, AGING CELL, V6, P421, DOI 10.1111/j.1474-9726.2007.00309.x
   Gong H, 2015, ONCOTARGET, V6, P15882, DOI 10.18632/oncotarget.4137
   Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200
   JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x
   Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332
   Lamming DW, 2013, AGING CELL, V12, P712, DOI 10.1111/acel.12097
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Miyamura M, 2010, J PHARMACOL SCI, V114, P32, DOI 10.1254/jphs.10014FP
   Reifsnyder PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119748
   Reifsnyder PC, 2018, ANN NY ACAD SCI, V1418, P106, DOI 10.1111/nyas.13557
   Reifsnyder PC, 2016, AGING-US, V8, P3120, DOI 10.18632/aging.101117
   Reifsnyder PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114324
   Rizzo G, 2010, MOL PHARMACOL, V78, P617, DOI 10.1124/mol.110.064501
   RODERICK TH, 1963, GENETICS, V48, P205
   RUPPIN H, 1988, GASTROENTEROLOGY, V95, P93, DOI 10.1016/0016-5085(88)90295-8
   Smith B.J., 2018, BIORXIV, P311456, DOI DOI 10.1101/311456
   Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Strong R, 2013, J GERONTOL A-BIOL, V68, P6, DOI 10.1093/gerona/gls070
   Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003
   Wang XXX, 2017, J BIOL CHEM, V292, P12018, DOI 10.1074/jbc.C117.794982
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Yamamoto M, 2006, METABOLISM, V55, P533, DOI 10.1016/j.metabol.2005.11.007
   Yuan R, 2012, P NATL ACAD SCI USA, V109, P8224, DOI 10.1073/pnas.1121113109
NR 37
TC 67
Z9 75
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD APR
PY 2019
VL 18
IS 2
AR e12898
DI 10.1111/acel.12898
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HO5JY
UT WOS:000460963500025
PM 30688027
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kireev, RA
   Tresguerres, ACF
   Garcia, C
   Ariznavarreta, C
   Vara, E
   Tresguerres, JAF
AF Kireev, R. A.
   Tresguerres, A. C. F.
   Garcia, C.
   Ariznavarreta, C.
   Vara, E.
   Tresguerres, Jesus A. F.
TI Melatonin is able to prevent the liver of old castrated female rats from
   oxidative and pro-inflammatory damage
SO JOURNAL OF PINEAL RESEARCH
LA English
DT Article
DE aging; inflammation; lipid peroxidation; melatonin; ovariectomizes
ID NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; OXYGENASE-1 EXPRESSION;
   DEGENERATIVE DISEASES; INHIBITS EXPRESSION; HUMAN HEPATOCYTES;
   GENE-EXPRESSION; REACTIVE OXYGEN; CARBON-MONOXIDE; GROWTH-HORMONE
AB The aim of this study was to investigate the effect of aging and ovariectomy on various physiological parameters related to inflammation and oxidative stress in livers obtained from old female rats, and the influence of chronic administration of melatonin on these animals. Twenty-four female Wistar rats of 22 months of age were used. Animals were divided into four experimental groups: two intact groups that were untreated or given melatonin (1 mg/kg/day), and two ovariectomized groups that also untreated and treated with melatonin (1 mg/kg/day). After 10 wk of treatment, rats were sacrificed by decapitation, and livers were collected and homogenized. A group of 2-month-old female rats was used as young controls. Protein expression of inducible nitric oxide synthase (iNOS), heme oxygenase-1 (HO-1), IL-6, TNF-alpha and IL-1 beta were determined by Western blot analysis. The levels of nitric oxide metabolites (NOx), lipid hydroperoxide (LPO), TNF-alpha, IL-1 beta, IL-6 and IL-10 were determined. Levels of LPO in the liver homogenates as well as iNOS protein expression and NOx levels were increased in old rats as compared with young animals; this effect was more evident in ovariectomized animals. Pro-inflammatory cytokines TNF-alpha, IL-1 beta and IL-6 were significantly increased and anti-inflammatory IL-10 decreased during aging and after ovariectomy. Aging also significantly increased the expression of HO-1 protein, and ovariectomized rats showed an additional increase. Administration of melatonin, both to intact and to the ovariectomized animals significantly reduced NOx, LPO levels and pro-inflammatory cytokines in the liver as compared with untreated rats. Significant rice in IL-10 and reductions in the iNOS, HO-1, IL-6, TNF-alpha and IL-1 beta protein expression were also found in rats treated with melatonin. Oxidative stress and inflammation induced during aging in the liver are more marked in castrated than in intact females. Administration of melatonin reduces both these situations.
C1 [Tresguerres, Jesus A. F.] Univ Complutense, Lab Expt Endocrinol, Dept Physiol, Sch Med, E-28040 Madrid, Spain.
   [Kireev, R. A.] Res Inst Gen Pathol & Pathophysiol, Moscow, Russia.
   [Garcia, C.; Vara, E.] Univ Complutense, Sch Med, Dept Biochem & Mol Biol, E-28040 Madrid, Spain.
C3 Complutense University of Madrid; Russian Academy of Medical Sciences;
   Institute of General Pathology & Pathophysiology, RAMS; Complutense
   University of Madrid
RP Tresguerres, JAF (corresponding author), Univ Complutense, Lab Expt Endocrinol, Dept Physiol, Sch Med, Avda Complutense S-N, E-28040 Madrid, Spain.
EM guerres@med.ucm.es
OI Kireev, Roman/0000-0002-6105-2440
FU (FIS) Instituto Carlos III [RETICEF RD 06/0013]; Ministerio de ASUNTOS
   EXTERIORES [AECI 3309/05]; Nutricia Research Foundation; International
   Training Fellowship [2007-T4]
FX This work was supported by grants: RETICEF RD 06/0013 (FIS) Instituto
   Carlos III, AECI 3309/05 Ministerio de ASUNTOS EXTERIORES. Dr Kireev
   Roman was supported by Nutricia Research Foundation, International
   Training Fellowship (2007-T4).
CR Alm P, 1999, DIABETOLOGIA, V42, P978, DOI 10.1007/s001250051256
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   An Y, 2007, EUR J CARDIO-THORAC, V31, P1037, DOI 10.1016/j.ejcts.2007.01.077
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   Borrego F, 1999, EXP GERONTOL, V34, P253, DOI 10.1016/S0531-5565(98)00076-X
   Brigelius-Flohé R, 2004, ARCH BIOCHEM BIOPHYS, V423, P66, DOI 10.1016/j.abb.2003.12.008
   Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   CAROLEO M C, 1992, Pharmacological Research, V26, P34, DOI 10.1016/1043-6618(92)90587-2
   Carrillo-Vico A, 2004, FASEB J, V18, P537, DOI 10.1096/fj.03-0694fje
   Castillo C, 2005, J PINEAL RES, V38, P240, DOI 10.1111/j.1600-079X.2004.00199.x
   CHOI SY, 1996, J PARODONTOL IMPLANT, V15, P19
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Corda S, 2001, AM J RESP CELL MOL, V24, P762, DOI 10.1165/ajrcmb.24.6.4228
   Crespo E, 1999, FASEB J, V13, P1537, DOI 10.1096/fasebj.13.12.1537
   Escames G, 2006, J PINEAL RES, V40, P71, DOI 10.1111/j.1600-079X.2005.00281.x
   Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007
   García-Mauriño S, 1999, LIFE SCI, V65, P2143, DOI 10.1016/S0024-3205(99)00479-8
   Gilad E, 1998, FASEB J, V12, P685, DOI 10.1096/fasebj.12.9.685
   GONZALEZAMARO R, 1994, J EXP MED, V179, P841, DOI 10.1084/jem.179.3.841
   Grisham MB, 1999, AM J PHYSIOL-GASTR L, V276, pG315, DOI 10.1152/ajpgi.1999.276.2.G315
   Guerrero Juan M., 2002, Current Topics in Medicinal Chemistry, V2, P167, DOI 10.2174/1568026023394335
   Gupta S, 2003, MECH AGEING DEV, V124, P503, DOI 10.1016/S0047-6374(03)00028-9
   Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119
   Helenius M, 2001, ANTIOXID REDOX SIGN, V3, P147, DOI 10.1089/152308601750100669
   Ho KMT, 1999, J UROLOGY, V161, P1968, DOI 10.1016/S0022-5347(05)68865-9
   Hon WM, 2002, ANN NY ACAD SCI, V962, P275, DOI 10.1111/j.1749-6632.2002.tb04074.x
   HUETHER G, 1992, LIFE SCI, V51, P945, DOI 10.1016/0024-3205(92)90402-B
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kireev RA, 2007, J PINEAL RES, V42, P64, DOI 10.1111/j.1600-079X.2006.00385.x
   Kireev RA, 2007, BIOGERONTOLOGY, V8, P469, DOI 10.1007/s10522-007-9089-3
   Koyuncu FM, 2006, HISTOL HISTOPATHOL, V21, P367, DOI 10.14670/HH-21.367
   Lardone PJ, 2006, J PINEAL RES, V40, P153, DOI 10.1111/j.1600-079X.2005.00289.x
   Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Lee YM, 2005, FREE RADICAL BIO MED, V39, P108, DOI 10.1016/j.freeradbiomed.2005.02.033
   Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517
   Martinez-Cruz F, 2002, NEUROSCI LETT, V331, P208, DOI 10.1016/S0304-3940(02)00884-4
   Masilamoni JG, 2005, FREE RADICAL RES, V39, P603, DOI 10.1080/10715760500117373
   McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007
   Meki ARMA, 2001, NEUROENDOCRINOL LETT, V22, P417
   MESTER M, 1994, SURGERY, V115, P588
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   NUSSLER AK, 1992, J EXP MED, V176, P261, DOI 10.1084/jem.176.1.261
   Okatani Y, 2003, EUR J PHARMACOL, V469, P145, DOI 10.1016/S0014-2999(03)01643-1
   PACIFICI R, 1993, J CLIN ENDOCR METAB, V77, P1135, DOI 10.1210/jc.77.5.1135
   PANG SF, 1983, HORM RES, V17, P228, DOI 10.1159/000179702
   Patriarca S, 2007, BIOGERONTOLOGY, V8, P365, DOI 10.1007/s10522-006-9079-x
   Pévet P, 2002, CELL TISSUE RES, V309, P183, DOI 10.1007/s00441-002-0584-1
   Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90
   Qi WB, 2000, J PINEAL RES, V29, P54, DOI 10.1034/j.1600-079X.2000.290108.x
   RADAK Z, 2000, FREE RADICALS EXERCI, P177
   RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7
   Raghavendra V, 2001, MOL CELL BIOCHEM, V221, P57, DOI 10.1023/A:1010968611716
   Raghavendra V, 2001, CLIN EXP IMMUNOL, V124, P414, DOI 10.1046/j.1365-2249.2001.01519.x
   REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947
   Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237
   REITER RJ, 1986, J NEURAL TRANSM, P35
   Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697
   Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E
   Rodríguez MI, 2007, J PINEAL RES, V42, P272, DOI 10.1111/j.1600-079X.2006.00416.x
   SALGO MG, 1995, ARCH BIOCHEM BIOPHYS, V322, P500, DOI 10.1006/abbi.1995.1493
   SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x
   Tan DX, 2003, J PINEAL RES, V34, P75, DOI 10.1034/j.1600-079X.2003.02111.x
   Tan DX, 1999, BBA-GEN SUBJECTS, V1472, P206, DOI 10.1016/S0304-4165(99)00125-7
   Tekbas OF, 2008, J PINEAL RES, V44, P222, DOI 10.1111/j.1600-079X.2007.00516.x
   Touitou Y, 2001, EXP GERONTOL, V36, P1083, DOI 10.1016/S0531-5565(01)00120-6
   Tsukamoto H, 1999, ALCOHOL CLIN EXP RES, V23, P911, DOI 10.1111/j.1530-0277.1999.tb04202.x
   Urata Y, 1999, FREE RADICAL BIO MED, V27, P838, DOI 10.1016/S0891-5849(99)00131-8
   Warskulat U, 2002, GLIA, V40, P324, DOI 10.1002/glia.10128
   WINWOOD PJ, 1993, SEMIN LIVER DIS, V13, P50, DOI 10.1055/s-2007-1007337
   Wu CC, 2001, J PINEAL RES, V30, P147, DOI 10.1034/j.1600-079X.2001.300303.x
   Yasui T, 2007, MATURITAS, V56, P396, DOI 10.1016/j.maturitas.2006.11.002
   Yoo YM, 2002, J PINEAL RES, V33, P146, DOI 10.1034/j.1600-079X.2002.02899.x
   Zeeh J, 2001, ARCH GERONTOL GERIAT, V32, P255, DOI 10.1016/S0167-4943(01)00090-5
NR 75
TC 65
Z9 66
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3098
EI 1600-079X
J9 J PINEAL RES
JI J. Pineal Res.
PD NOV
PY 2008
VL 45
IS 4
BP 394
EP 402
DI 10.1111/j.1600-079X.2008.00606.x
PG 9
WC Endocrinology & Metabolism; Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology; Physiology
GA 358XV
UT WOS:000259951700006
PM 18573161
DA 2024-02-19
ER

PT J
AU Laitakari, A
   Huttunen, R
   Kuvaja, P
   Hannuksela, P
   Szabo, Z
   Heikkilä, M
   Kerkelä, R
   Myllyharju, J
   Dimova, EY
   Serpi, R
   Koivunen, P
AF Laitakari, Anna
   Huttunen, Riikka
   Kuvaja, Paula
   Hannuksela, Pauliina
   Szabo, Zoltan
   Heikkila, Minna
   Kerkela, Risto
   Myllyharju, Johanna
   Dimova, Elitsa Y.
   Serpi, Raisa
   Koivunen, Peppi
TI Systemic long-term inactivation of hypoxia-inducible factor prolyl
   4-hydroxylase 2 ameliorates aging-induced changes in mice without
   affecting their life span
SO FASEB JOURNAL
LA English
DT Article; Early Access
DE anemia; HCC; hypoxia response; metabolism
ID CORONARY-HEART-DISEASE; SERUM URIC-ACID; CELL-PROLIFERATION; ROXADUSTAT
   FG-4592; ENDOTHELIAL-CELLS; PHD2; ACTIVATION; INHIBITION; MORTALITY;
   PROTECTS
AB Hypoxia inactivates hypoxia-inducible factor (HIF) prolyl 4-hydroxylases (HIF-P4Hs), which stabilize HIF and upregulate genes to restore tissue oxygenation. HIF-P4Hs can also be inhibited by small molecules studied in clinical trials for renal anemia. Knowledge of systemic long-term inactivation of HIF-P4Hs is limited but crucial, since HIF overexpression is associated with cancers. We aimed to determine the effects of systemic genetic inhibition of the most abundant isoenzyme HIF prolyl 4-hydroxylase-2 (HIF-P4H-2)/PHD2/EglN1 on life span and tissue homeostasis in aged mice. Our data showed no difference between wild-type and HIF-P4H-2-deficient mice in the average age reached. There were several differences, however, in the primary causes of death and comorbidities, the HIF-P4H-2-deficient mice having less inflammation, liver diseases, including cancer, and myocardial infarctions, and not developing anemia. No increased cancer incidence was observed due to HIF-P4H-2-deficiency. These data suggest that chronic inactivation of HIF-P4H-2 is not harmful but rather improves the quality of life in senescence.
C1 [Laitakari, Anna; Huttunen, Riikka; Hannuksela, Pauliina; Heikkila, Minna; Myllyharju, Johanna; Dimova, Elitsa Y.; Serpi, Raisa; Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Bioctr Oulu, Aapistie 7C, FIN-90014 Oulu, Finland.
   [Kuvaja, Paula] Univ Oulu, Oulu Univ Hosp, Med Res Ctr Oulu, Canc & Translat Med Res Unit, Oulu, Finland.
   [Kuvaja, Paula] Oulu Univ Hosp, Dept Pathol, Oulu, Finland.
   [Szabo, Zoltan; Kerkela, Risto] Univ Oulu, Dept Pharmacol & Toxicol, Res Unit Biomed, Oulu, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University
   of Oulu
RP Koivunen, P (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Bioctr Oulu, Aapistie 7C, FIN-90014 Oulu, Finland.
EM peppi.koivunen@oulu.fi
OI Szabo, Zoltan/0000-0003-0778-1113; Serpi, Raisa/0000-0002-8207-4673
FU Academy of Finland (Suomen Akatemia) [266719, 308009, 296498, 251314];
   Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse); Finnish Cancer
   Foundation; Jane ja Aatos Erkon Saatio (JAE); FibroGen (FibroGen Inc.);
   Academy of Finland (AKA) [296498, 251314, 266719, 308009] Funding
   Source: Academy of Finland (AKA)
FX Academy of Finland (Suomen Akatemia), Grant/Award Number: 266719,
   308009, 296498 and 251314; Sigrid Juseliuksen Saatio (Sigrid Juselius
   Stiftelse); Finnish Cancer Foundation; Jane ja Aatos Erkon Saatio (J &
   AE); FibroGen (FibroGen Inc.)
CR Acker T, 2005, CANCER CELL, V8, P131, DOI 10.1016/j.ccr.2005.07.003
   Amiiants V I, 1997, Klin Med (Mosk), V75, P26
   Andersen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023847
   Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019
   Bagherniya M, 2018, AGEING RES REV, V47, P183, DOI 10.1016/j.arr.2018.08.004
   Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6
   Bogaerts E, 2016, EXCLI J, V15, P687, DOI 10.17179/excli2016-607
   Callicott RJ, 2006, COMPARATIVE MED, V56, P17
   Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002
   Chen N, 2017, NEPHROL DIAL TRANSPL, V32, P1373, DOI 10.1093/ndt/gfx011
   Dai ZY, 2016, CIRCULATION, V133, P2447, DOI 10.1161/CIRCULATIONAHA.116.021494
   Dhillon S, 2019, DRUGS, V79, P563, DOI 10.1007/s40265-019-01077-1
   Di Conza G, 2017, CELL REP, V18, P2836, DOI 10.1016/j.celrep.2017.02.081
   Dovell F, 2018, EUR J CANCER PREV, V27, P399, DOI [10.1097/cej.0000000000000440, 10.1097/CEJ.0000000000000440]
   Durkin ME, 2013, BIO PROTOC, V3, pe908, DOI [DOI 10.21769/BI0PR0T0C.908, DOI 10.21769/BioProtoc.908]
   Ezzati M, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112938
   Faeh D, 2009, CIRCULATION, V120, P495, DOI 10.1161/CIRCULATIONAHA.108.819250
   Farese RV, 1996, P NATL ACAD SCI USA, V93, P6393, DOI 10.1073/pnas.93.13.6393
   Flamme I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111838
   Folgueras AR, 2018, CIRC RES, V123, P905, DOI 10.1161/CIRCRESAHA.118.312204
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Guralnik Jack M, 2005, Hematology Am Soc Hematol Educ Program, P528
   Haase VH, 2017, HEMODIAL INT, V21, pS110, DOI 10.1111/hdi.12567
   Hawley JA, 2018, CELL METAB, V27, P962, DOI 10.1016/j.cmet.2018.04.014
   Hirsilä M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200
   Hwang AB, 2012, CURR GENOMICS, V13, P519, DOI 10.2174/138920212803251427
   Hyvärinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855
   Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009
   Kaelin William G Jr, 2017, Trans Am Clin Climatol Assoc, V128, P298
   Karsikas S, 2016, J MOL MED, V94, P301, DOI 10.1007/s00109-015-1349-0
   Kerkelä R, 2013, MOL CELL BIOL, V33, P3321, DOI 10.1128/MCB.00432-13
   Klotzsche-von Ameln A, 2011, CANCER RES, V71, P3306, DOI 10.1158/0008-5472.CAN-10-3838
   Koivunen P, 2018, TRENDS MOL MED, V24, P1021, DOI 10.1016/j.molmed.2018.10.004
   Koivunen P, 2016, PHARMACOL RES, V114, P265, DOI 10.1016/j.phrs.2016.11.003
   Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898
   Kozlova N, 2017, ONCOTARGET, V8, P9885, DOI 10.18632/oncotarget.14241
   Kuchnio A, 2015, CELL REP, V12, P992, DOI 10.1016/j.celrep.2015.07.010
   Laitakari A, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101145
   Laitala A, 2012, BLOOD, V120, P3336, DOI 10.1182/blood-2012-07-441824
   Li Z, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000179
   Liu ZW, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00477
   Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812
   MIRRAKHIMOV MM, 1991, KARDIOLOGIYA, V31, P8
   MKRTCHYAN RI, 1989, KARDIOLOGIYA, V29, P22
   Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594
   Myllymäki MNM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00529-16
   Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256
   Olson E, 2014, VASC MED, V19, P473, DOI 10.1177/1358863X14557151
   Provenzano R, 2016, CLIN J AM SOC NEPHRO, V11, P982, DOI 10.2215/CJN.06890615
   Provenzano R, 2016, AM J KIDNEY DIS, V67, P912, DOI 10.1053/j.ajkd.2015.12.020
   Rahtu-Korpela L, 2016, ARTERIOSCL THROM VAS, V36, P608, DOI 10.1161/ATVBAHA.115.307136
   Rahtu-Korpela L, 2014, DIABETES, V63, P3324, DOI 10.2337/db14-0472
   Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09
   Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016
   Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008
   Snyder JM, 2016, VET PATHOL, V53, P233, DOI 10.1177/0300985815610391
   Song LP, 2008, ONCOGENE, V27, P519, DOI 10.1038/sj.onc.1210670
   Strasak AM, 2007, CANCER CAUSE CONTROL, V18, P1021, DOI 10.1007/s10552-007-9043-3
   Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561
   Tao YF, 2016, INT J BIOCHEM CELL B, V77, P129, DOI 10.1016/j.biocel.2016.05.022
   Véniant MM, 1998, J CLIN INVEST, V102, P1559, DOI 10.1172/JCI4164
   Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5
   Xie C, 2017, NAT MED, V23, P1298, DOI 10.1038/nm.4412
   Yeh TL, 2017, CHEM SCI, V8, P7651, DOI 10.1039/c7sc02103h
   Zhao G, 2013, ATHEROSCLEROSIS, V231, P61, DOI 10.1016/j.atherosclerosis.2013.08.023
NR 73
TC 7
Z9 7
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD 2020 APR
PY 2020
VL 34
IS 4
BP 5590
EP 5609
DI 10.1096/fj.201902331R
EA FEB 2020
PG 20
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA LJ5ZA
UT WOS:000517899100001
PM 32100354
OA Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Halade, GV
   Rahman, MM
   Fernandes, G
AF Halade, Ganesh V.
   Rahman, Md. M.
   Fernandes, Gabriel
TI Effect of CLA isomers and their mixture on aging C57Bl/6J mice
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Obesity; Conjugated linoleic acid; Fat mass; Glucose; Insulin
ID CONJUGATED LINOLEIC-ACID; BETA-CELL FUNCTION; INSULIN-RESISTANCE;
   BODY-FAT; GLUCOSE-TOLERANCE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; LEPTIN
   LEVELS; SUPPLEMENTATION; OBESITY
AB Dietary supplements containing conjugated linoleic acid (CLA) are widely promoted for weight loss management over the counter. Recently, FDA approved the CLA as Generally Recognized as Safe category so that it can be used in various food and beverages. The combined effect of CLA isomers have been studied extensively in animals and humans, however, the role of individual isomers remains unraveled.
   The present investigation addresses the effects of CLA isomers on body composition and body weight as well as safety using female C57Bl/6J aging mice.
   Two main CLA isomers and their mixture were fed to 12-months-old female C57Bl/6J mice. Ten percent corn oil (CO) based fat diet supplemented with 0.5% purified cis 9 trans 11 (c9,t11) CLA or trans 10 cis 12 (t10,c12) CLA or their mixture (CLA mix, 50:50) for 6 months. The lean mass, fat mass, glucose, non-esterified fatty acids, and insulin were examined at the end of study.
   As a result of 6 months dietary intervention, both t10,c12 CLA and CLA mix groups showed increased lean mass and reduced fat mass compared to that of c9,t11 CLA and CO group. However, insulin resistance and liver hypertrophy were observed in t10,c12 CLA and CLA mix groups based on the results of homeostasis model assessment, revised quantitative insulin-sensitivity check index (R-QUICKI), intravenous glucose tolerance test, and liver histology. Liver histology revealed that increased liver weight was due to hypertrophy.
   In conclusion, the major CLA isomers have a distinct effect on fat mass, glucose, and insulin metabolism. The t10,c12 isomer was found to reduce the fat mass and to increase the lean mass but significantly contributed to increase insulin resistance and liver hypertrophy, whereas c9,t11 isomer prevented the insulin resistance. Between the two major CLA isomers, the t10,c12 was attributed to reduce fat mass whereas, c9,t11 improves the insulin sensitivity.
C1 [Halade, Ganesh V.; Rahman, Md. M.; Fernandes, Gabriel] Univ Texas Hlth Sci Ctr San Antonio, Div Clin Immunol & Rheumatol, Dept Med, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
RP Fernandes, G (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Clin Immunol & Rheumatol, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.
EM fernandes@uthscsa.edu
FU NIH [R21 AG027562]
FX The authors would like to thank Paul J Williams for his critical review
   of this manuscript and to Nishu Kazi for her help in diet preparation,
   animal feeding, and care. This work was supported by NIH grant R21
   AG027562.
CR Akahoshi A, 2002, BIOSCI BIOTECH BIOCH, V66, P916, DOI 10.1271/bbb.66.916
   Azain MJ, 2000, J NUTR, V130, P1548
   Bhattacharya A, 2005, J NUTR, V135, P1124, DOI 10.1093/jn/135.5.1124
   Bhattacharya A, 2006, J NUTR BIOCHEM, V17, P789, DOI 10.1016/j.jnutbio.2006.02.009
   Bhattacharya A, 2006, LIPIDS, V41, P437, DOI 10.1007/s11745-006-5117-3
   Brodie AE, 1999, J NUTR, V129, P602
   Cesari M, 2005, AM J CLIN NUTR, V82, P428, DOI 10.1093/ajcn/82.2.428
   Delany JP, 1999, AM J PHYSIOL-REG I, V276, pR1172, DOI 10.1152/ajpregu.1999.276.4.R1172
   DESPRES JP, 1989, DIABETES, V38, P304, DOI 10.2337/diabetes.38.3.304
   Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002
   FIELD CJ, 1990, J BIOL CHEM, V265, P11143
   HA YL, 1987, CARCINOGENESIS, V8, P1881, DOI 10.1093/carcin/8.12.1881
   HA YL, 1990, CANCER RES, V50, P1097
   Hargrave KM, 2004, OBES RES, V12, P1435, DOI 10.1038/oby.2004.180
   Inoue N, 2004, BIOCHEM BIOPH RES CO, V323, P679, DOI 10.1016/j.bbrc.2004.08.139
   IP C, 1994, CANCER RES, V54, P1212
   Kelley DS, 2001, LIPIDS, V36, P669, DOI 10.1007/s11745-001-0771-z
   KEPLER CR, 1966, J BIOL CHEM, V241, P1350
   KISSEBAH AH, 1991, INT J OBESITY, V15, P109
   Larsen TM, 2006, AM J CLIN NUTR, V83, P606, DOI 10.1093/ajcn.83.3.606
   Larsen TM, 2003, J LIPID RES, V44, P2234, DOI 10.1194/jlr.R300011-JLR200
   LEE KN, 1994, ATHEROSCLEROSIS, V108, P19, DOI 10.1016/0021-9150(94)90034-5
   Lin H, 1995, J DAIRY SCI, V78, P2358, DOI 10.3168/jds.S0022-0302(95)76863-1
   LIU S, 1994, BIOCHEM J, V299, P831, DOI 10.1042/bj2990831
   MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Medina EA, 2000, LIPIDS, V35, P783, DOI 10.1007/s11745-000-0586-y
   MILLER CC, 1994, BIOCHEM BIOPH RES CO, V198, P1107, DOI 10.1006/bbrc.1994.1157
   Moulias R, 1999, Z GERONTOL GERIATR, V32, P425, DOI 10.1007/s003910050140
   Ohashi A, 2004, J NUTR SCI VITAMINOL, V50, P416, DOI 10.3177/jnsv.50.416
   Ostrowska E, 1999, J NUTR, V129, P2037, DOI 10.1093/jn/129.11.2037
   Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x
   Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8
   Perseghin G, 2001, J CLIN ENDOCR METAB, V86, P4776, DOI 10.1210/jc.86.10.4776
   Rahman MM, 2007, J NUTR BIOCHEM, V18, P467, DOI 10.1016/j.jnutbio.2006.08.002
   Risérus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516
   Risérus U, 2002, CIRCULATION, V106, P1925, DOI 10.1161/01.CIR.0000033589.15413.48
   Roche HM, 2002, DIABETES, V51, P2037, DOI 10.2337/diabetes.51.7.2037
   Ryder JW, 2001, DIABETES, V50, P1149, DOI 10.2337/diabetes.50.5.1149
   Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406
   Staiger H, 2005, EXP CLIN ENDOCR DIAB, V113, P67, DOI 10.1055/s-2004-830555
   Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359/jbmr.2003.18.7.1206
   SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163
   Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534
   Wallace TM, 2004, DIABETIC MED, V21, P568, DOI 10.1111/j.1464-5491.2004.01218.x
   WANG YC, 2007, OBESITY SILVER SPRIN, V15, P5
   West DB, 1998, AM J PHYSIOL-REG I, V275, pR667
   Whigham LD, 2004, FOOD CHEM TOXICOL, V42, P1701, DOI 10.1016/j.fct.2004.06.008
   Whigham LD, 2000, PHARMACOL RES, V42, P503, DOI 10.1006/phrs.2000.0735
   Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215
   Yamasaki M, 2003, NUTRITION, V19, P30, DOI 10.1016/S0899-9007(02)00842-0
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Yu Y, 2002, BBA-MOL CELL BIOL L, V1581, P89, DOI 10.1016/S1388-1981(02)00126-9
   Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005
   Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002
NR 55
TC 27
Z9 30
U1 0
U2 8
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT
PY 2009
VL 48
IS 7
BP 409
EP 418
DI 10.1007/s00394-009-0029-7
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 495TH
UT WOS:000269917400004
PM 19424653
DA 2024-02-19
ER

PT J
AU Andric, A
   Wagner, E
   Heberle, A
   Holzknecht, M
   Weiss, AKH
AF Andric, Andreas
   Wagner, Eva
   Heberle, Anne
   Holzknecht, Max
   Weiss, Alexander K. H.
TI Extraction and Purification of FAHD1 Protein from Swine Kidney and Mouse
   Liver
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
ID FUMARYLACETOACETATE HYDROLASE; CRYSTAL-STRUCTURE; SENESCENCE;
   IDENTIFICATION
AB Fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1) is the first identified member of the FAH superfamily in eukaryotes, acting as oxaloacetate decarboxylase in mitochondria. This article presents a series of methods for the extraction and purification of FAHD1 from swine kidney and mouse liver. Covered methods are ionic exchange chromatography with fast protein liquid chromatography (FPLC), preparative and analytical gel filtration with FPLC, and proteomic approaches. After total protein extraction, ammonium sulfate precipitation and ionic exchange chromatography were explored, and FAHD1 was extracted via a sequential strategy using ionic exchange and size-exclusion chromatography. This representative approach may be adapted to other proteins of interest (expressed at significant levels) and modified for other tissues. Purified protein from tissue may support the development of high-quality antibodies, and/or potent and specific pharmacological inhibitors.
C1 [Andric, Andreas; Wagner, Eva; Heberle, Anne; Holzknecht, Max; Weiss, Alexander K. H.] Univ Innsbruck, Res Inst Biomed Aging Res, Innsbruck, Austria.
C3 University of Innsbruck
RP Weiss, AKH (corresponding author), Univ Innsbruck, Res Inst Biomed Aging Res, Innsbruck, Austria.
EM alexander.weiss@uibk.ac.at
OI Weiss, Alexander/0000-0002-0166-8630
CR Ahmed U., 2011, EFFECT PH PROTEIN SI
   Amer H.E.A., 2019, Proteomics Technologies and Applications, P41
   [Anonymous], CYTIVA LIFE FUNDAMEN
   Bateman RL, 2001, J BIOL CHEM, V276, P15284, DOI 10.1074/jbc.M007621200
   Etemad S, 2019, MECH AGEING DEV, V177, P22, DOI 10.1016/j.mad.2018.07.007
   Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600
   Gallagher SR., 2012, CURR PROTOC ESSENT L, V20, P20, DOI [10.1002/9780470089941.et0703s00, DOI 10.1002/9780470089941.ET0703S00]
   GORDON JA, 1991, METHOD ENZYMOL, V201, P477
   Hong H, 2020, ENVIRON MICROBIOL, V22, P270, DOI 10.1111/1462-2920.14844
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Lee CH, 2017, ENDOCRINOL METAB, V32, P18, DOI 10.3803/EnM.2017.32.1.18
   Mizutani H, 2007, ACTA CRYSTALLOGR F, V63, P792, DOI 10.1107/S1744309107039590
   Niu LJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00802
   Petit M, 2017, EXP GERONTOL, V92, P7, DOI 10.1016/j.exger.2017.03.004
   Pircher H, 2015, J BIOL CHEM, V290, P6755, DOI 10.1074/jbc.M114.609305
   Pircher H, 2011, J BIOL CHEM, V286, P36500, DOI 10.1074/jbc.M111.264770
   Rosano GL, 2019, PROTEIN SCI, V28, P1412, DOI 10.1002/pro.3668
   Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172
   Sorensen BK, 2002, ANAL BIOCHEM, V304, P33, DOI 10.1006/abio.2001.5604
   Timm DE, 1999, STRUCTURE, V7, P1023, DOI 10.1016/S0969-2126(99)80170-1
   Weiss AKH, 2021, MOLECULES, V26, DOI 10.3390/molecules26165009
   Weiss AKH, 2020, MECH AGEING DEV, V190, DOI 10.1016/j.mad.2020.111284
   Weiss AKH, 2019, JOVE-J VIS EXP, DOI 10.3791/59729
   Weiss AKH, 2018, BIOCHEM J, V475, P3561, DOI 10.1042/BCJ20180750
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
NR 25
TC 0
Z9 0
U1 0
U2 3
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD FEB
PY 2022
IS 180
AR e63333
DI 10.3791/63333
PG 22
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 1Q2DS
UT WOS:000802505600062
PM 35253790
DA 2024-02-19
ER

PT J
AU Abdelmegeed, MA
   Choi, Y
   Ha, SK
   Song, BJ
AF Abdelmegeed, Mohamed A.
   Choi, Youngshim
   Ha, Seung-Kwoon
   Song, Byoung-Joon
TI Cytochrome P450-2E1 is involved in aging-related kidney damage in mice
   through increased nitroxidative stress
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Kidney; Aging; CYP2E1; Apoptosis; Fibrosis; Oxidative stress
ID MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; INDUCED NEPHROTOXICITY;
   FEMALE MICE; HIGH-FAT; CYP2E1; LIVER; INJURY; METABOLISM; APOPTOSIS
AB The aim of this study was to investigate the role of cytochrome P450-2E1 (CYP2E1) in aging-dependent kidney damage since it is poorly understood. Young (7 weeks) and aged female (16-17 months old) wild type (WT) and Cyp2el-null mice were used. Kidney histology showed that aged WT mice exhibited typical signs of kidney aging such as cell vacuolation, inflammatory cell infiltration, cellular apoptosis, glomerulonephropathy, and fibrosis, along with significantly elevated levels of renal TNF-alpha and serum creatinine than all other groups. Furthermore, the highest levels of renal hydrogen peroxide, protein carbonylation and nitration were observed in aged WT mice. These increases in the aged WT mice were accompanied by increased levels of iNOS and mitochondrial nitroxidative stress through altered amounts and activities of the mitochondrial complex proteins and significantly reduced levels of the antioxidant glutathione (GSH). In contrast, the aged Cyp2el-null mice exhibited significantly higher antioxidant capacity with elevated heme oxygenase-1 and catalase activities compared to all other groups, while maintaining normal GSH levels with significantly less mitochondrial nitroxidative stress compared to the aged WT mice. Thus, CYP2E1 is important in causing aging-related kidney damage most likely through increasing nitroxidative stress and that CYP2E1 could be a potential target in preventing aging-related kidney diseases. Published by Elsevier Ltd.
C1 [Abdelmegeed, Mohamed A.; Choi, Youngshim; Ha, Seung-Kwoon; Song, Byoung-Joon] NIAAA, Sect Mol Pharmacol & Toxicol, Lab Membrane Biochem & Biophys, 9000 Rockville Pike, Bethesda, MD 20849 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Alcohol Abuse & Alcoholism (NIAAA)
RP Abdelmegeed, MA; Song, BJ (corresponding author), NIAAA, Sect Mol Pharmacol & Toxicol, Lab Membrane Biochem & Biophys, 9000 Rockville Pike, Bethesda, MD 20849 USA.
EM abdelmegeedm@mail.nih.gov; bj.song@nih.gov
FU National Institute on Alcohol Abuse and Alcoholism
FX This research was supported by the Intramural Research Program of
   National Institute on Alcohol Abuse and Alcoholism. We are thankful to
   Dr. Frank J. Gonzalez (National Cancer Institute, NIH, Bethesda, MD,
   USA) and Dr. James P. Hardwick (Northeastern Ohio University College of
   Medicine, Rootstown, OH, USA) for providing the WT and Cyp2el-null mice
   and the polyclonal antibodies to different P450 isoforms, respectively.
   We also thank Dr. Klaus Gawrisch for supporting this study.
CR Abdelmegeed MA, 2017, CURR MOL PHARMACOL, V10, P207, DOI 10.2174/1874467208666150817111114
   Abdelmegeed MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep39764
   Abdelmegeed MA, 2016, FREE RADICAL BIO MED, V91, P188, DOI 10.1016/j.freeradbiomed.2015.12.016
   Abdelmegeed MA, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/149627
   Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V60, P211, DOI 10.1016/j.freeradbiomed.2013.02.018
   Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210
   Abdelmegeed MA, 2010, BIOCHEM PHARMACOL, V79, P57, DOI 10.1016/j.bcp.2009.07.016
   Akbar M, 2016, BRAIN RES, V1637, P34, DOI 10.1016/j.brainres.2016.02.016
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704
   Carroll MA, 1997, KIDNEY INT, V51, P1696, DOI 10.1038/ki.1997.234
   Chakravarti B., 2017, CURR AGING SCI
   Chanas B, 2003, TOXICOL APPL PHARM, V193, P293, DOI 10.1016/j.taap.2003.08.006
   Choi Y, 2017, FOOD CHEM TOXICOL, V103, P111, DOI 10.1016/j.fct.2017.02.039
   Choi Y, 2016, J NUTR BIOCHEM, V38, P70, DOI 10.1016/j.jnutbio.2016.08.013
   Curhan GC, 2004, ARCH INTERN MED, V164, P1519, DOI 10.1001/archinte.164.14.1519
   Fan F, 2015, CURR OPIN NEPHROL HY, V24, P37, DOI 10.1097/MNH.0000000000000088
   Fortepiani LA, 2003, HYPERTENSION, V41, P640, DOI 10.1161/01.HYP.0000046924.94886.EF
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Gross ML, 2005, KIDNEY INT, V67, P849, DOI 10.1111/j.1523-1755.2005.00149.x
   GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008
   Hardwick JP, 2009, PPAR RES, V2009, DOI 10.1155/2009/952734
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HIRT DL, 1991, SEMIN NEPHROL, V11, P148
   Hodgin JB, 2015, J AM SOC NEPHROL, V26, P3162, DOI 10.1681/ASN.2014080752
   Hosohata K., 2016, INT J MOL SCI, P17
   Jang S, 2015, REDOX BIOL, V6, P552, DOI 10.1016/j.redox.2015.09.040
   Kim SK, 2014, CLIN TRANSPLANT, V28, P707, DOI 10.1111/ctr.12369
   Ko JW, 2017, FOOD CHEM TOXICOL, V102, P156, DOI 10.1016/j.fct.2017.02.021
   Konstandi M, 2013, AM J PHYSIOL-ENDOC M, V304, pE1118, DOI 10.1152/ajpendo.00585.2012
   Lambert AJ, 2007, AGING CELL, V6, P607, DOI 10.1111/j.1474-9726.2007.00312.x
   Latchoumycandane C, 2014, FREE RADICAL BIO MED, V69, P403, DOI 10.1016/j.freeradbiomed.2014.01.001
   Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063
   Liu H, 2003, KIDNEY INT, V63, P1687, DOI 10.1046/j.1523-1755.2003.00908.x
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   Moon KH, 2008, GASTROENTEROLOGY, V135, P1344, DOI 10.1053/j.gastro.2008.06.048
   Moon KH, 2006, HEPATOLOGY, V44, P1218, DOI 10.1002/hep.21372
   Novak RF, 2000, ARCH PHARM RES, V23, P267, DOI 10.1007/BF02975435
   Ortuño-Sahagún D, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/573208
   Pedraza-Chaverri J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6043601
   Percy C, 2005, ADV CHRONIC KIDNEY D, V12, P78, DOI 10.1053/j.ackd.2004.10.006
   Percy CJ, 2008, NEPHROLOGY, V13, P147, DOI 10.1111/j.1440-1797.2008.00924.x
   Poulianiti KP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8598253
   Reeg S, 2015, ANTIOXID REDOX SIGN, V23, P239, DOI 10.1089/ars.2014.6062
   REINKE LA, 1985, DRUG METAB DISPOS, V13, P548
   Sasso AF, 2013, TOXICOL SCI, V131, P360, DOI 10.1093/toxsci/kfs320
   Sataranatarajan K, 2012, AGING CELL, V11, P1065, DOI 10.1111/acel.12008
   Sergiev PV, 2015, ACTA NATURAE, V7, P9, DOI 10.32607/20758251-2015-7-1-9-18
   Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726
   Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   Song BJ, 1996, ALCOHOL CLIN EXP RES, V20, pA138, DOI 10.1111/j.1530-0277.1996.tb01764.x
   Song BJ, 2014, REDOX BIOL, V3, P109, DOI 10.1016/j.redox.2014.10.004
   Song BJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/781050
   Wang Z, 2014, KIDNEY INT, V86, P338, DOI 10.1038/ki.2014.65
NR 57
TC 13
Z9 17
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD NOV
PY 2017
VL 109
BP 48
EP 59
DI 10.1016/j.fct.2017.08.022
PN 1
PG 12
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA FN3PN
UT WOS:000415911400005
PM 28843596
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Kemeleva, EA
   Sinitsyna, OI
   Kolosova, NG
   Vasyunina, EA
   Zharkov, DO
   Conlon, KA
   Berrios, M
   Nevinsky, GA
AF Kemeleva, Eugenia A.
   Sinitsyna, Olga I.
   Kolosova, Nataliya G.
   Vasyunina, Elena A.
   Zharkov, Dmitry O.
   Conlon, Kimberly A.
   Berrios, Miguel
   Nevinsky, Georgy A.
TI Immunofluorescent detection of 8-oxoguanine DNA lesions in liver cells
   from aging OXYS rats, a strain prone to overproduction of free radicals
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE immunofluorescent; OXYS rats; 8-oxoguanine
ID OXIDATIVE DAMAGE; HEREDITARY GALACTOSEMIA; POINT MUTATIONS;
   IMMUNE-RESPONSE; 8-HYDROXYGUANINE; MITOCHONDRIA; WISTAR; ANTIOXIDANTS;
   GENERATION; CATARACT
AB Production of free radicals in animals is accompanied with a number of pathologic conditions, some of which may be manifested through DNA damage. Studies of mechanisms of oxidative DNA damage by free radicals in vivo are hindered by the lack of good animal models with significant overgeneration of or increased sensitivity to free radicals. An inbred rat strain (OXYS) is characterized by inherited overgeneration of free radicals, lipid peroxidation, protein oxidation, DNA rearrangements, and pathological conditions paralleling several human degenerative diseases. We have used monoclonal antibodies against a common pre-mutagenic base lesion 8-oxoguanine (8-oxoG) in combination with indirect immunofluorescence microscopy and image analysis to follow the relative age-dependent amounts and distribution of 8-oxoG in liver cells from OXYS and Wistar rats. 8-OxoG increased with age in both strains of rats, with OXYS rats always displaying statistically significantly higher levels of oxidative DNA damage than Wistar rats. Statistical analysis indicates that 8-oxoG does not uniformly accumulate in all cells with advancing age or increasing free radical load, but rather concentrates in a minor fraction of cells with a high damage level. (c) 2006 Elsevier B.V. All rights reserved.
C1 RAS, SD, Inst Cytol & Genet, Novosibirsk 630090, Russia.
   RAS, SD, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia.
   Novosibirsk State Univ, Novosibirsk 630090, Russia.
   SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.
   SUNY Stony Brook, Microscopy Imaging Ctr, Stony Brook, NY 11794 USA.
C3 Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB
   RAS; Institute of Chemical Biology & Fundamental Medicine, Siberian
   Branch of the RAS; Russian Academy of Sciences; Novosibirsk State
   University; State University of New York (SUNY) System; State University
   of New York (SUNY) Stony Brook; State University of New York (SUNY)
   System; State University of New York (SUNY) Stony Brook
RP Nevinsky, GA (corresponding author), RAS, SD, Inst Cytol & Genet, Novosibirsk 630090, Russia.
EM nevinsky@niboch.nsc.ru
RI Nevinsky, Georgy/E-6053-2012; Kolosova, Nataliya G/P-3178-2015; Zharkov,
   Dmitry/K-2158-2012; Sinitsyna, Olga/U-3682-2019; Kolosova, Nataliya
   G/AAR-7409-2020
OI Kolosova, Nataliya G/0000-0003-2398-8544; Zharkov,
   Dmitry/0000-0001-5013-0194; Kolosova, Nataliya G/0000-0003-2398-8544
FU NCI NIH HHS [CA8403301] Funding Source: Medline
CR Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Collins A, 2002, CARCINOGENESIS, V23, P2129, DOI 10.1093/carcin/23.12.2129
   Conlon KA, 2003, DNA REPAIR, V2, P1337, DOI 10.1016/j.dnarep.2003.08.002
   Conlon KA, 2000, J HISTOTECHNOL, V23, P37
   DEGAN P, 1991, CARCINOGENESIS, V12, P865, DOI 10.1093/carcin/12.5.865
   DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O
   DIZDAROGLU M, 1985, BIOCHEMISTRY-US, V24, P4476, DOI 10.1021/bi00337a032
   Frank A, 2004, CARCINOGENESIS, V25, P1027, DOI 10.1093/carcin/bgh089
   GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z
   Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141
   Ishchenko A, 2003, MED SCI MONITOR, V9, pBR16
   KAMIYA H, 1992, CANCER RES, V52, P3483
   KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137
   Kolosova NG, 2002, B EXP BIOL MED+, V133, P171, DOI 10.1023/A:1015507107763
   Kolosova NG, 2001, B EXP BIOL MED+, V132, P814, DOI 10.1023/A:1013014919721
   Kolosova NG, 2004, B EXP BIOL MED+, V137, P249, DOI 10.1023/B:BEBM.0000031561.71977.85
   Kolosova NG, 2003, B EXP BIOL MED+, V136, P415, DOI 10.1023/B:BEBM.0000010967.24302.78
   Kolosova NG, 2003, B EXP BIOL MED+, V135, P593, DOI 10.1023/A:1025445822566
   Loskutova LV, 2000, B EXP BIOL MED+, V130, P746, DOI 10.1007/BF02766083
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Markova EV, 2003, B EXP BIOL MED+, V136, P588, DOI 10.1023/B:BEBM.0000020212.10768.9a
   Markova EV, 2003, B EXP BIOL MED+, V136, P377, DOI 10.1023/B:BEBM.0000010957.87077.ae
   Marsili S, 2004, EXP EYE RES, V79, P595, DOI 10.1016/j.exer.2004.06.008
   Men'shchikova EB, 2002, B EXP BIOL MED+, V133, P175, DOI 10.1023/A:1015559124601
   PARK EM, 1992, P NATL ACAD SCI USA, V89, P3375, DOI 10.1073/pnas.89.8.3375
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V199, P726, DOI 10.1006/bbrc.1994.1289
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V205, P180, DOI 10.1006/bbrc.1994.2647
   SHABALINA IG, 2004, EKSP KLIN FARMAKOL, V64, P34
   SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOLOVEVA NA, 1975, GENETIKA+, V11, P63
   SOLOVYOVA NA, 1987, VOP MED KHIM, V33, P41
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   von Sonntag C., 1987, CHEM BASIS RAD BIOL
   Yelinova V, 1996, BIOCHEM BIOPH RES CO, V221, P300, DOI 10.1006/bbrc.1996.0590
   Yoon SH, 2005, BIOCHEM BIOPH RES CO, V327, P342, DOI 10.1016/j.bbrc.2004.12.013
NR 41
TC 16
Z9 19
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-1964
EI 1873-135X
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD JUL 25
PY 2006
VL 599
IS 1-2
BP 88
EP 97
DI 10.1016/j.mrfmmm.2006.01.008
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 071BH
UT WOS:000239571400010
PM 16574166
DA 2024-02-19
ER

PT J
AU Stevnsner, T
   Thorslund, T
   de Souza-Pinto, NC
   Bohr, VA
AF Stevnsner, T
   Thorslund, T
   de Souza-Pinto, NC
   Bohr, VA
TI Mitochondrial repair of 8-oxoguanine and changes with aging
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Proceedings Paper
CT 2nd Euroconference on Biological Ageing
CY MAY 18-22, 2002
CL SPETSES ISL, GREECE
DE mitochondria; base excision repair; 8-oxoG; aging
ID TRANSCRIPTION-COUPLED REPAIR; RETRACTED ARTICLE. SEE; DNA-REPAIR;
   COCKAYNE-SYNDROME; OXIDATIVE DAMAGE; FINE-STRUCTURE; RAT-LIVER; DHFR
   GENE; NUCLEAR; CELLS
AB Reactive oxygen species (ROS) are formed in all living organisms as a by-product of normal metabolism (endogenous sources) and:as a consequence of exposure to environmental compounds (exogenous sources). Endogenous ROS are largely formed during oxidative phosphorylation in the mitochondria and, therefore, mitochondrial DNA (mtDNA) is at particularly high risk of ROS-induced damage. Mitochondria are essential for cell viability, and oxidative damage to mtDNA has been implicated as a causative factor in a wide variety of degenerative diseases, and in cancer and aging. One of the most common oxidative DNA lesions is 7,8-dihydro-8-oxoguanine (8-oxoG) which can introduce G/C to T/A transversions after DNA replication. Oxidative DNA base lesions, including 8-oxoG, are repaired primarily by the base excision repair (BER) pathway. While we know much about how this pathway functions in processing the nuclear DNA lesions, little is yet known about BER in mitochondria. We have used a number of different approaches to explore the mechanisms of DNA damage processing in the mtDNA. We have been able to demonstrate that mammalian mitochondria efficiently remove 8-oxoG from their genome, and that the efficiency of 8-oxoG incision increases with age in rats and mice. Yet 8-oxoG accumulates in mtDNA during aging. Changes in mitochondrial function with age have been observed in several organisms and accumulation of DNA lesions in mtDNA with age may be an underlying cause for numerous age-associated diseases including cancer. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Danish Ctr Mol Gerontol, Dept Mol Biol, DK-8000 Aarhus, Denmark.
   NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.
C3 Aarhus University; National Institutes of Health (NIH) - USA; NIH
   National Institute on Aging (NIA)
RP Stevnsner, T (corresponding author), Danish Ctr Mol Gerontol, Dept Mol Biol, CF Mollers Alle Bldg 130, DK-8000 Aarhus, Denmark.
EM tvs@mb.au.dk
RI Souza-Pinto, Nadja/T-3050-2019; Souza-Pinto, Nadja C./C-3462-2013; Bohr,
   Vilhelm/AAP-5931-2020
OI Souza-Pinto, Nadja/0000-0003-4206-964X; Souza-Pinto, Nadja
   C./0000-0003-4206-964X; Thorslund, Tina/0000-0001-9207-0070; Stevnsner,
   Tinna/0000-0003-1007-0427
CR Anson RM, 1998, NUCLEIC ACIDS RES, V26, P662, DOI 10.1093/nar/26.2.662
   Anson RM, 1999, FREE RADICAL BIO MED, V27, P456, DOI 10.1016/S0891-5849(99)00091-X
   Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314
   BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3
   Bohr VA, 1995, CARCINOGENESIS, V16, P2885, DOI 10.1093/carcin/16.12.2885
   BOHR VA, 1995, MUTAT RES-DNAGING G, V338, P25, DOI 10.1016/0921-8734(95)00008-T
   BOHR VA, 1994, IARC SCI PUBL, V125, P361
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990
   Croteau DL, 1997, J BIOL CHEM, V272, P27338, DOI 10.1074/jbc.272.43.27338
   Cullinane C, 1998, CANCER RES, V58, P1400
   de Souza-Pinto NC, 2001, FREE RADICAL BIO MED, V30, P916, DOI 10.1016/S0891-5849(01)00483-X
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Dianov G, 1999, NUCLEIC ACIDS RES, V27, P1365, DOI 10.1093/nar/27.5.1365
   DIZDAROGLU M, 1993, CHEM FREE RADICAL DA, P18
   DOMENA JD, 1985, BIOCHEMISTRY-US, V24, P7320, DOI 10.1021/bi00346a045
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   Friedberg EC, 1996, ANNU REV BIOCHEM, V65, P15
   Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611
   Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300
   Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2
   LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967
   MALINS DC, 1991, CANCER RES, V51, P5430
   Mambo E, 2002, CANCER RES, V62, P1349
   MYERS KA, 1988, CARCINOGENESIS, V9, P285, DOI 10.1093/carcin/9.2.285
   NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115
   Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750
   OLINSKI R, 1992, FEBS LETT, V309, P193, DOI 10.1016/0014-5793(92)81093-2
   Parker A, 2000, NUCLEIC ACIDS RES, V28, P3206, DOI 10.1093/nar/28.17.3206
   Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   PETTEPHER CC, 1991, J BIOL CHEM, V266, P3113
   PIRSEL M, 1993, CARCINOGENESIS, V14, P2105, DOI 10.1093/carcin/14.10.2105
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010
   SATOH MS, 1988, J BIOL CHEM, V263, P6854
   SNYDERWINE EG, 1992, CANCER RES, V52, P4183
   Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935
   Stierum RH, 1999, J BIOL CHEM, V274, P7128, DOI 10.1074/jbc.274.11.7128
   Sunesen M, 2002, ONCOGENE, V21, P3571, DOI 10.1038/sj.onc.1205443
   Taffe BG, 1996, MUTAT RES-DNA REPAIR, V364, P183, DOI 10.1016/S0921-8777(96)00031-6
   Thorslund T, 2002, DNA REPAIR, V1, P261, DOI 10.1016/S1568-7864(02)00003-4
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   WALLACE DC, 1999, P A BENZON S MUNK CO, V44
   Wallace Douglas C., 1998, Biofactors, V7, P187
   WISEMAN H, 1995, CANCER LETT, V93, P113, DOI 10.1016/0304-3835(95)03792-U
NR 46
TC 56
Z9 59
U1 2
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT-NOV
PY 2002
VL 37
IS 10-11
BP 1189
EP 1196
AR PII S0531-5565(02)00142-0
DI 10.1016/S0531-5565(02)00142-0
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Geriatrics & Gerontology
GA 623UW
UT WOS:000179722100007
PM 12470830
DA 2024-02-19
ER

PT J
AU Zhang, YY
   Appelkvist, EL
   Kristensson, K
   Dallner, G
AF Zhang, YY
   Appelkvist, EL
   Kristensson, K
   Dallner, G
TI The lipid compositions of different regions of rat brain during
   development and aging
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE rat brain; aging; cholesterol; ubiquinone; dolichol
ID VITAMIN-E; DOLICHYL PHOSPHATE; ALZHEIMERS-DISEASE; HUMAN-TISSUES;
   MEMBRANES; LIVER; ANTIOXIDANT; UBIQUINONE; BIOSYNTHESIS; PEROXIDATION
AB The lipid contents in different regions of the rat brain were analyzed from birth to the age of 2 years. The total brain phospholipid content increased threefold during the first 20 postnatal days. The cholesterol content elevated extensively during the first 2 months of life and, after this period, remained unchanged. The level of dolichol increased almost 100-fold during the first 10 months of life and continued to increase thereafter. Some modifications in the dolichol isoprenoid pattern were also observed. An increase in the brain ubiquinone level occurred during the first few months of life, but no further change was observed after this period. Ubiquinone-9 and -10 constituted 70 and 30%, respectively, of the total ubiquinone in all regions and all subcellular fractions. The alpha-tocopherol content increased during the first 3 weeks of life and was unchanged thereafter. These results demonstrate characteristic changes in the lipid contents of various regions of rat brain during development and aging. Copyright (C) 1996 Elsevier Science Inc.
C1 KAROLINSKA INST, DEPT NEUROSCI, DIV NEURODEGENERAT DIS RES, S-17177 STOCKHOLM, SWEDEN.
C3 Karolinska Institutet
RP Zhang, YY (corresponding author), KAROLINSKA INST, NOVUM, CLIN RES CTR, DIV MED CELL BIOL, S-14186 HUDDINGE, SWEDEN.
CR ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T
   ABERG F, 1994, CHEM-BIOL INTERACT, V91, P1, DOI 10.1016/0009-2797(94)90002-7
   ANDERSSON M, 1990, FEBS LETT, V269, P15, DOI 10.1016/0014-5793(90)81107-Y
   ANDERSSON M, 1987, J NEUROCHEM, V49, P685, DOI 10.1111/j.1471-4159.1987.tb00948.x
   ANSELL GB, 1964, PHOSPHOLIPIDS, P278
   BEYER RE, 1987, CHEM SCR, V27, P143
   BLOCH K, 1991, BIOCH LIPIDS LIPOPRO, P363
   BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005
   BURTON GW, 1990, ANNU REV NUTR, V10, P357, DOI [10.1146/annurev.nu.10.070190.002041, 10.1146/annurev.nutr.10.1.357]
   CONNOR JR, 1982, EXP NEUROL, V76, P35, DOI 10.1016/0014-4886(82)90099-1
   CULLIS PR, 1991, BIOCH LIPIDS LIPOPRO, P1
   DEGIER J, 1969, P 4 INT C PHARM, V4, P102
   DEROPP JS, 1985, J BIOL CHEM, V260, P5669
   DESOUSA BN, 1979, DEV NEUROSCI, V2, P122
   EDLUND C, 1992, BIOCHEM CELL BIOL, V70, P422, DOI 10.1139/o92-065
   ERICSSON J, 1992, J BIOL CHEM, V267, P18708
   Ericsson Johan, 1993, V21, P229
   ERNSTER L, 1992, BIOFACTORS, V3, P241
   ERNSTER L, 1993, ACTIVE OXYGENS, LIPID PEROXIDES, AND ANTIOXIDANTS, P1
   ERNSTER L, 1993, CLIN INVESTIGATOR, V71, pS60, DOI 10.1007/BF00226842
   FARIELLO RG, 1988, NEUROPHARMACOLOGY, V27, P1077, DOI 10.1016/0028-3908(88)90071-8
   FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879
   HARMAN D, 1984, AGE, V7, P111, DOI 10.1007/BF02431866
   Horrocks L. A., 1981, MOL BASIS NEUROPATHO, P601
   KAGAN V, 1990, BIOCHEM BIOPH RES CO, V169, P851, DOI 10.1016/0006-291X(90)91971-T
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   LOW P, 1992, LIPIDS, V27, P1, DOI 10.1007/BF02537050
   MATSURA T, 1991, BIOCHIM BIOPHYS ACTA, V1083, P277, DOI 10.1016/0005-2760(91)90083-T
   MCILWAIN H, 1985, BIOCH CENTRAL NERVOU, P371
   MITCHELL P, 1990, HIGHLIGHTS IN UBIQUINONE RESEARCH, P77
   ROGERS J, 1984, BRAIN RES, V292, P23, DOI 10.1016/0006-8993(84)90886-2
   Rouser G, 1972, Adv Lipid Res, V10, P261
   SAKAKIHARA Y, 1985, J NEUROCHEM, V44, P1535, DOI 10.1111/j.1471-4159.1985.tb08792.x
   SODERBERG M, 1992, J NEUROCHEM, V59, P1646
   SODERBERG M, 1990, J NEUROCHEM, V54, P415, DOI 10.1111/j.1471-4159.1990.tb01889.x
   STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646
   VALTERSSON C, 1982, J LIPID RES, V23, P868
   VALTERSSON C, 1985, J BIOL CHEM, V260, P2742
   VATASSERY GT, 1984, J NEUROCHEM, V43, P409, DOI 10.1111/j.1471-4159.1984.tb00916.x
NR 39
TC 77
Z9 80
U1 1
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0197-4580
EI 1558-1497
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD NOV-DEC
PY 1996
VL 17
IS 6
BP 869
EP 875
DI 10.1016/S0197-4580(96)00076-0
PG 7
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA VY127
UT WOS:A1996VY12700008
PM 9363798
DA 2024-02-19
ER

PT J
AU Bader, A
   Petters, O
   Keller, M
   Pavlica, S
AF Bader, Augustinus
   Petters, Oliver
   Keller, Mario
   Pavlica, Sanja
TI Paracetamol treatment increases telomerase activity in rat embryonic
   liver cells
SO PHARMACOLOGICAL REPORTS
LA English
DT Article
DE paracetamol; hepatotoxicity; telomerase activity; liver progenitors
ID ACETAMINOPHEN OVERDOSE; INDUCED HEPATOTOXICITY; HEPATOCYTES; STRESS;
   MICE
AB Although paracetamol is known to have a damaging effect, this pharmaceutical is widely applied to pregnant and lactating women. Despite substantial progress in our understanding of its hepatotoxicity, some mechanisms, particularly of its embryonal and developmental toxicity, are still unknown. Thus, cell culture assays that investigate its toxicity are of particular interest. We assessed the effects of acute paracetamol treatment on cell viability (LDH assay, MTT assay), glutathione content (GSH assay), metabolic status (albumin and urea assays) and telomerase activity using rat embryonic liver cells (RLC-18 cells).
   Incubation with low (6 mmol/l) and high (15 mmol/l) concentrations of toxin for 24 h leads to 20% and 50% cytotoxicity, respectively. Paracetamol exerted its toxicity in a similar pathway (depletion of GSH stores) as in adult liver cells, producing damage at the cellular level. Interestingly, paracetamol treatment significantly enhanced telomerase activity. Mechanisms involved in paracetamol-induced inhibition of cell senescence should be further elucidated. Telomerase activity in RLC-18 cells offers unique opportunities for examining basic biologic mechanisms. Our findings should encourage further studies to investigate a link between telomerase activity and toxicity, implying a role of impaired telomerase activity in human pathology.
C1 [Bader, Augustinus; Petters, Oliver; Keller, Mario; Pavlica, Sanja] Univ Leipzig, Biotechnol Biomed Ctr, Dept Cell Tech & Stem Cell Biol, D-04103 Leipzig, Germany.
C3 Leipzig University
RP Pavlica, S (corresponding author), Univ Leipzig, Biotechnol Biomed Ctr, Dept Cell Tech & Stem Cell Biol, Deutsch Pl 5, D-04103 Leipzig, Germany.
EM sanja.pavlica@bbz.uni-leipzig.de
FU EU [NMP3-CT-013653]
FX The work was funded by EU through the EU-project LIVEBIOMAT
   NMP3-CT-013653, Mrs. Angela Hennig (BBZ, University of Leipzig) is
   acknowledged for technical assistance. We are grateful to Prof. Dr.
   Michaela Schulz-Siegmund (Department of Pharmaceutical Technologies,
   University of Leipzig) for allowing us to perform RT-PCR at her lab.
CR Adams ML, 2001, MOL PHARMACOL, V60, P907, DOI 10.1124/mol.60.5.907
   BYER AJ, 1982, JAMA-J AM MED ASSOC, V247, P3114, DOI 10.1001/jama.247.22.3114
   Farkas D, 2005, TOXICOL SCI, V85, P927, DOI 10.1093/toxsci/kfi145
   Harley CB, 2005, CURR MOL MED, V205, P11
   Kitteringham NR, 2000, HEPATOLOGY, V32, P321, DOI 10.1053/jhep.2000.9602
   Larson Anne M, 2007, Clin Liver Dis, V11, P525, DOI 10.1016/j.cld.2007.06.006
   LEVY G, 1975, PEDIATRICS, V55, P895
   LUDMIR J, 1986, OBSTET GYNECOL, V67, P750, DOI 10.1097/00006250-198605000-00028
   Morishita Katsumi, 2006, Journal of Toxicological Sciences, V31, P491, DOI 10.2131/jts.31.491
   Pavlica S, 2005, FREE RADICAL RES, V39, P1377, DOI 10.1080/09670260500197660
   Pavlica S, 2012, J TISSUE ENG REGEN M, V6, P486, DOI 10.1002/term.453
   Pavlica S, 2009, BIOMATERIALS, V30, P6514, DOI 10.1016/j.biomaterials.2009.08.024
   ROLLINS DE, 1979, SCIENCE, V205, P1414, DOI 10.1126/science.38505
   Rousar T, 2009, PHYSIOL RES, V58, P239, DOI 10.33549/physiolres.931437
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   SARKAR G, 1995, SCIENCE, V268, P1115, DOI 10.1126/science.7761821
   Shen C, 2006, CHEM-BIOL INTERACT, V162, P53, DOI 10.1016/j.cbi.2006.05.005
   TAKAOKA T, 1975, JPN J EXP MED, V45, P317
   WEEKS BS, 1990, TERATOGEN CARCIN MUT, V10, P361, DOI 10.1002/tcm.1770100502
   Wege Henning, 2007, Curr Stem Cell Res Ther, V2, P31, DOI 10.2174/157488807779317062
NR 20
TC 7
Z9 9
U1 0
U2 3
PU POLISH ACAD SCIENCES INST PHARMACOLOGY
PI KRAKOW
PA SMETNA 12, 31-343 KRAKOW, POLAND
SN 1734-1140
J9 PHARMACOL REP
JI Pharmacol. Rep.
PD NOV-DEC
PY 2011
VL 63
IS 6
BP 1435
EP 1441
DI 10.1016/S1734-1140(11)70707-1
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 929BR
UT WOS:000303036700014
PM 22358091
DA 2024-02-19
ER

PT S
AU Narasimhan, M
   Rajasekaran, NS
AF Narasimhan, Madhusudhanan
   Rajasekaran, Namakkal-Soorappan
BE Xiao, J
TI Cardiac Aging - Benefits of Exercise, Nrf2 Activation and Antioxidant
   Signaling
SO EXERCISE FOR CARDIOVASCULAR DISEASE PREVENTION AND TREATMENT: FROM
   MOLECULAR TO CLINICAL, PT 1
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Cardiovascular dysfunction; Aging; Exercise
ID TRANSCRIPTION FACTOR NRF2; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY;
   INDUCED OXIDATIVE STRESS; MN SUPEROXIDE-DISMUTASE; CHRONIC
   HEART-FAILURE; CUL3-BASED E3 LIGASE; SMALL MAF PROTEINS;
   QUALITY-OF-LIFE; GROWTH-FACTOR-I; PHYSICAL-ACTIVITY
AB Cardiovascular dysfunction and heart failure associated with aging not only impairs the cardiac function but also the quality of life eventually decreasing the life expectancy of the elderly. Notably, cardiac tissue can prematurely age under certain conditions such as genetic mutation, persistent redox stress and overload, aberrant molecular signaling, DNA damage, telomere attrition, and other pathological insults. While cardiovascular-related morbidity and mortality is on the rise and remains a global health threat, there has been only little to moderate improvements in its medical management. This is due to the fact that the lifestyle changes to molecular mechanisms underlying age-related myocardial structure and functional remodeling are multifactorial and intricately operate at different levels. Along these lines, the intrinsic redox mechanisms and oxidative stress (OS) are widely studied in the myocardium. The accumulation of reactive oxygen species (ROS) with age and the resultant oxidative damage has been shown to increase the susceptibility of the myocardium to multiple complications such as atherosclerosis, hypertension, ischemic heart disease, cardiac myopathy, and heart failure. There has been growing interest in trying to enhance the mechanisms that neutralize the ROS and curtailing OS as a possible anti-aging intervention and as a treatment for age-related disorders. Natural defense system to fight against OS involves a master transcription factor named nuclear erythroid-2-p45-related factor-2 (Nrf2) that regulates several antioxidant genes. Compelling evidence exists on the Nrf2 gain of function through pharmacological interventions in counteracting the oxidative damage and affords cytoprotection in several organs including but not limited to lung, liver, kidney, brain, etc. Nevertheless, thus far, only a few studies have described the potential role of Nrf2 and its non-pharmacological induction in cardiac aging. This chapter explores the effects of various modes of exercise on Nrf2 signaling along with its responses and ramifications on the cascade of OS in the aging heart.
C1 [Narasimhan, Madhusudhanan] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA.
   [Rajasekaran, Namakkal-Soorappan] Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA.
   [Rajasekaran, Namakkal-Soorappan] Univ Utah, Sch Med, Coll Hlth, Dept Med, Salt Lake City, UT 84132 USA.
   [Rajasekaran, Namakkal-Soorappan] Univ Utah, Sch Med, Coll Hlth, Dept Exercise Physiol, Salt Lake City, UT 84132 USA.
C3 Texas Tech University System; Texas Tech University Health Science
   Center; University of Alabama System; University of Alabama Birmingham;
   Utah System of Higher Education; University of Utah; Utah System of
   Higher Education; University of Utah
RP Narasimhan, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA.; Rajasekaran, NS (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA.; Rajasekaran, NS (corresponding author), Univ Utah, Sch Med, Coll Hlth, Dept Med, Salt Lake City, UT 84132 USA.; Rajasekaran, NS (corresponding author), Univ Utah, Sch Med, Coll Hlth, Dept Exercise Physiol, Salt Lake City, UT 84132 USA.
EM madhu.narasimhan@ttuhsc.edu; rajnsr@uabmc.edu
FU NHLBI NIH HHS [R01 HL118067, HL118067] Funding Source: Medline; NIA NIH
   HHS [AG042860] Funding Source: Medline
CR ANDREWS NC, 1993, P NATL ACAD SCI USA, V90, P11488, DOI 10.1073/pnas.90.24.11488
   [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1
   Arbab-Zadeh A, 2014, CIRCULATION, V130, P2152, DOI 10.1161/CIRCULATIONAHA.114.010775
   Barboza CA, 2013, EUR J APPL PHYSIOL, V113, P1137, DOI 10.1007/s00421-012-2533-3
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Bartlo P, 2007, J CARDIOPULM REHABIL, V27, P368, DOI 10.1097/01.HCR.0000300263.07764.4a
   Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006
   Bean JF, 2004, ARCH PHYS MED REHAB, V85, pS31, DOI 10.1016/j.apmr.2004.03.010
   Belardinelli R, 1999, CIRCULATION, V99, P1173, DOI 10.1161/01.CIR.99.9.1173
   Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003
   Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303
   Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Berzosa C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/540458
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Blair SN, 2009, ANN EPIDEMIOL, V19, P253, DOI 10.1016/j.annepidem.2009.01.019
   Bocalini DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087106
   Brassard P, 2007, MED SCI SPORT EXER, V39, P1896, DOI 10.1249/mss.0b013e318145b642
   Buffenstein R, 2008, AGE, V30, P99, DOI 10.1007/s11357-008-9058-z
   Buggisch M, 2007, J CELL SCI, V120, P885, DOI 10.1242/jcs.03386
   Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216
   Buttar Harpal S, 2005, Exp Clin Cardiol, V10, P229
   Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020
   Capell BC, 2007, CIRC RES, V101, P13, DOI 10.1161/CIRCRESAHA.107.153692
   Chandra N, 2013, J AM COLL CARDIOL, V61, P1027, DOI 10.1016/j.jacc.2012.08.1032
   Chicco AJ, 2006, J APPL PHYSIOL, V100, P519, DOI 10.1152/japplphysiol.00148.2005
   Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006
   Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF
   Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771
   Conraads VM, 2004, EUR HEART J, V25, P1797, DOI 10.1016/j.ehj.2004.07.022
   Conraads VM, 2002, EUR HEART J, V23, P1854, DOI 10.1053/euhj.2002.3239
   Coronary Blood Flow and Myocardial Ischemia, 2001, HEART DIS TEXTB CARD
   Costa E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/871656
   Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004
   Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018
   Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004
   Deschenes MR, 1999, MED SCI SPORT EXER, V31, P1599, DOI 10.1097/00005768-199911000-00016
   Domenighetti AA, 2005, HYPERTENSION, V46, P426, DOI 10.1161/01.HYP.0000173069.53699.d9
   Eaton C B, 1992, J Am Board Fam Pract, V5, P157
   Eijsvogels TMH, 2016, PHYSIOL REV, V96, P99, DOI 10.1152/physrev.00029.2014
   Elahi MM, 2009, OXID MED CELL LONGEV, V2, P259, DOI 10.4161/oxim.2.5.9441
   Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101
   Fagard RH, 2001, MED SCI SPORT EXER, V33, pS484, DOI 10.1097/00005768-200106001-00018
   Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459
   FLEG JL, 1994, J APPL PHYSIOL, V77, P1500, DOI 10.1152/jappl.1994.77.3.1500
   Forman HJ, 2016, FREE RADICAL BIO MED, V97, P398, DOI 10.1016/j.freeradbiomed.2016.07.003
   Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355
   Frantz S, 2014, CARDIOVASC RES, V102, P240, DOI 10.1093/cvr/cvu025
   Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005
   Gounder SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045697
   Green DJ, 2008, J APPL PHYSIOL, V105, P766, DOI 10.1152/japplphysiol.01028.2007
   Gregg EW, 2003, ARCH INTERN MED, V163, P1440, DOI 10.1001/archinte.163.12.1440
   Haddad JJE, 2000, J BIOL CHEM, V275, P21130, DOI 10.1074/jbc.M000737200
   Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008
   Halverstadt A, 2007, METABOLISM, V56, P444, DOI 10.1016/j.metabol.2006.10.019
   Hamacher-Brady A, 2006, CARDIOVASC DRUG THER, V20, P445, DOI 10.1007/s10557-006-0583-7
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Harvey R. P., 1999, HEART DEV
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   Haykowsky MJ, 2012, J AM COLL CARDIOL, V60, P120, DOI 10.1016/j.jacc.2012.02.055
   He F, 2015, INT J MOL SCI, V16, P27770, DOI 10.3390/ijms161126059
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156
   Hoffman MD, 2009, MED SCI SPORT EXER, V41, P2191, DOI 10.1249/MSS.0b013e3181a8d553
   Hollenberg M, 2006, J GERONTOL A-BIOL, V61, P851, DOI 10.1093/gerona/61.8.851
   Hu FB, 2001, ANN INTERN MED, V134, P96, DOI 10.7326/0003-4819-134-2-200101160-00009
   Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5
   Hurt Ryan T, 2010, Gastroenterol Hepatol (N Y), V6, P780
   Jackson AS, 2009, ARCH INTERN MED, V169, P1781, DOI 10.1001/archinternmed.2009.312
   Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976
   James SE, 2000, MECH AGEING DEV, V121, P139
   Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100
   Janicki JS, 2015, METHODS MOL BIOL, V1220, P121, DOI 10.1007/978-1-4939-1568-2_8
   Jennings JR, 1997, PSYCHOL AGING, V12, P225, DOI 10.1037/0882-7974.12.2.225
   Ji L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082627
   Johnson ML, 2015, J GERONTOL A-BIOL, V70, P1386, DOI 10.1093/gerona/glu221
   Joyner MJ, 2009, J PHYSIOL-LONDON, V587, P5551, DOI 10.1113/jphysiol.2009.179432
   Kadaja L, 2010, EXP CLIN CARDIOL, V15, pE116
   Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215, DOI 10.1152/ajpheart.1996.271.3.H1215
   Karavidas A, 2010, HELL J CARDIOL, V51, P421
   Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005
   Katzmarzyk PT, 2004, CAN J APPL PHYSIOL, V29, P90, DOI 10.1139/h04-008
   Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046
   Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007
   Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007
   KING DS, 1985, J APPL PHYSIOL, V59, P1350, DOI 10.1152/jappl.1985.59.5.1350
   Kitzman D., 2017, HAZZARDS GERIATRIC M
   Kitzman DW, 2013, J AM COLL CARDIOL, V62, P584, DOI 10.1016/j.jacc.2013.04.033
   Knechtle B, 2011, SCAND J MED SCI SPOR, V21, pE82, DOI 10.1111/j.1600-0838.2010.01160.x
   Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004
   KRAUS WE, 2002, NEW ENGL J MED, V347, P1483, DOI [DOI 10.1056/NEJMOA020194, DOI 10.1056/NEJMoa020194, 10.1056/NEJMoa020194]
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Kumar RR, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0839-3
   Kunapuli S, 2006, J CARD FAIL, V12, P381, DOI 10.1016/j.cardfail.2006.02.002
   Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002
   La Gerche A, 2008, HEART, V94, P860, DOI 10.1136/hrt.2006.101063
   Lakatta Edward, 1994, Am J Geriatr Cardiol, V3, P11
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   LAUGHLIN MH, 1992, J APPL PHYSIOL, V73, P2209, DOI 10.1152/jappl.1992.73.6.2209
   Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09
   Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013
   Lewis KN, 2015, P NATL ACAD SCI USA, V112, P3722, DOI 10.1073/pnas.1417566112
   Lewis KN, 2012, GERONTOLOGY, V58, P453, DOI 10.1159/000335966
   Li J, 2014, ANTIOXID REDOX SIGN, V20, P2290, DOI 10.1089/ars.2013.5715
   Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480
   Ludlow AT, 2017, EXP PHYSIOL, V102, P397, DOI 10.1113/EP086189
   Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271
   Mampuya WM, 2012, CARDIOVASC DIAGN THE, V2, P38, DOI 10.3978/j.issn.2223-3652.2012.01.02
   Marí M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]
   Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705
   Middleton N, 2006, MED SCI SPORT EXER, V38, P681, DOI 10.1249/01.mss.0000210203.10200.12
   Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939
   Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101
   Mourkioti F, 2013, NAT CELL BIOL, V15, P895, DOI 10.1038/ncb2790
   Mozaffarian D, 2015, CIRCULATION, V131, P434, DOI 10.1161/CIR.0000000000000157
   Mukaigasa K, 2012, MOL CELL BIOL, V32, P4455, DOI 10.1128/MCB.00481-12
   Murillo OB, 2016, OXID MED CELL LONGEV, V2016
   Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440
   Myers J, 2003, CIRCULATION, V107, pE2, DOI 10.1161/01.CIR.0000048890.59383.8D
   Nadel ER, 1983, BIOCH EXERCISE
   Narasimhan M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00241
   Narasimhan M, 2014, FREE RADICAL BIO MED, V71, P402, DOI 10.1016/j.freeradbiomed.2014.02.023
   Narasimhan M, 2011, MOL PHARMACOL, V80, P988, DOI 10.1124/mol.111.073262
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   Valcarcel-Ares MN, 2012, J GERONTOL A-BIOL, V67, P821, DOI 10.1093/gerona/glr229
   North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876
   Okumura S, 2007, CIRCULATION, V116, P1776, DOI 10.1161/CIRCULATIONAHA.107.698662
   OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560
   ORI A, 2015, MECH AGEING DEV, V1, P224
   Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006
   Padilla J, 2011, PHYSIOLOGY, V26, P132, DOI 10.1152/physiol.00052.2010
   PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145
   Postiglione A, 1996, NEUROBIOL AGING, V17, P325, DOI 10.1016/0197-4580(96)00033-4
   Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768
   Prysyazhna O, 2012, NAT MED, V18, P286, DOI 10.1038/nm.2603
   Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081
   Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10
   Radak Z, 2001, EXERC IMMUNOL REV, V7, P90
   Radak Z, 2009, FREE RADICAL BIO MED, V46, P238, DOI 10.1016/j.freeradbiomed.2008.10.022
   Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264
   Ramos GC, 2017, P NATL ACAD SCI USA, V114, pE2420, DOI 10.1073/pnas.1621047114
   Rebrin I, 2008, ADV DRUG DELIVER REV, V60, P1545, DOI 10.1016/j.addr.2008.06.001
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010
   SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803
   Sawka MN, 1990, PERSPECTIVES EXERCIS
   SEALS DR, 1984, JAMA-J AM MED ASSOC, V252, P645, DOI 10.1001/jama.252.5.645
   Sharma S, 2015, EUR HEART J, V36, P1445, DOI 10.1093/eurheartj/ehv090
   Singh MAF, 1999, AM J PHYSIOL-ENDOC M, V277, pE135
   SOBEL H, 1970, LANCET, V2, P1191
   Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809
   Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011
   STRATTON JR, 1994, CIRCULATION, V89, P1648, DOI 10.1161/01.CIR.89.4.1648
   Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162
   Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3
   Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164
   Tanasescu M, 2003, CIRCULATION, V107, P2435, DOI 10.1161/01.CIR.0000066906.11109.1F
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094
   Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197
   Thompson PD, 2001, MED SCI SPORT EXER, V33, pS438, DOI 10.1097/00005768-200106001-00012
   Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006
   Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50
   Tremblay MS, 2007, APPL PHYSIOL NUTR ME, V32, pS218, DOI 10.1139/H07-125
   Treuting PM, 2008, J GERONTOL A-BIOL, V63, P813, DOI 10.1093/gerona/63.8.813
   Tyni-Lenne R, 1998, J Card Fail, V4, P9, DOI 10.1016/S1071-9164(98)90503-6
   TyniLenne R, 1997, AM J CARDIOL, V80, P1025, DOI 10.1016/S0002-9149(97)00597-3
   Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, pH363, DOI 10.1152/ajpheart.01134.2010
   Ursini F, 2016, REDOX BIOL, V8, P205, DOI 10.1016/j.redox.2016.01.010
   van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012
   van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z
   Viña J, 2007, IUBMB LIFE, V59, P249, DOI 10.1080/15216540601178067
   Vitiello D, 2011, J APPL PHYSIOL, V111, P1242, DOI 10.1152/japplphysiol.00449.2011
   Wang SL, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0578-x
   Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043
   West JB, 1981, CARDIAC ENERGETICS M
   Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006
   Whyte JJ, 2010, ACTA PHYSIOL, V199, P441, DOI 10.1111/j.1748-1716.2010.02127.x
   Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837
   Wonders KY, 2008, INTEGR CANCER THER, V7, P147, DOI 10.1177/1534735408322848
   Wu JZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/615312
   Xu XH, 2010, EXP PHYSIOL, V95, P1008, DOI 10.1113/expphysiol.2010.054221
   Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038
   Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132
   Zhang ZhengFeng, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P1
   Zhou SS, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/260429
   Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523
   Zoccali C, 2004, J AM SOC NEPHROL, V15, P1029, DOI 10.1097/01.ASN.0000117977.14912.91
NR 196
TC 10
Z9 12
U1 0
U2 5
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-4307-9; 978-981-10-4306-2
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2017
VL 999
BP 231
EP 255
DI 10.1007/978-981-10-4307-9_13
D2 10.1007/978-981-10-4307-9
PG 25
WC Cardiac & Cardiovascular Systems; Medicine, Research & Experimental;
   Physiology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Research & Experimental Medicine;
   Physiology
GA BK5CK
UT WOS:000438271500013
PM 29022266
DA 2024-02-19
ER

PT J
AU Debata, PR
   Panda, H
   Supakar, PC
AF Ranjan Debata, Priya
   Panda, Harekrushna
   Supakar, Prakash C.
TI Altered expression of trefoil factor 3 and cathepsin L gene in rat
   kidney during aging
SO BIOGERONTOLOGY
LA English
DT Article
DE aging; DD-PCR; differential gene expression; trefoil factor 3; cathepsin
   L
ID ANDROGEN RECEPTOR GENE; AGE-RELATED-CHANGES; FACTOR-KAPPA-B;
   DIFFERENTIAL DISPLAY; LIVER; BRAIN
AB Alterations in a wide array of physiological functions are normal consequences of aging. It is likely that, decline in cellular and physiological functions that occur during aging are the net result of age related differential gene expression and their consequent down stream effects. In this report we demonstrate that in aged kidney there is a decrease in the expression of trefoil factor 3 gene and an age-related increase in the expression of cathepsin L gene as revealed by differential display PCR (DD-PCR) and northern blot analysis. Trefoil factor 3 is mainly expressed in the alimentary canal and protects it from the degradative effect of HCl by stimulating the goblet cells to synthesize mucin. Though the exact role of trefoil factor 3 in kidney is not known, we speculate that it has a protective role in kidney. Cathepsin L is a cysteine protease which degrades connective tissue proteins like collagen, elastin and fibronectin. Increase in the expression of cathepsin L in aged kidney leading to considerable loss of organ function in old age. Down regulation of trefoil factor 3 and up regulation of cathepsin L may contribute to lack of protection and increased age related tissue damage to kidney in aging.
C1 Inst Life Sci, Bhubaneswar 751023, Orissa, India.
C3 Department of Biotechnology (DBT) India; Institute of Life Sciences
   India (ILS)
RP Supakar, PC (corresponding author), Inst Life Sci, Bhubaneswar 751023, Orissa, India.
EM pcsupakar@hotmail.com
RI Debata, Priya Ranjan/AAY-7142-2021
CR Anderson S, 1997, NEPHROL DIAL TRANSPL, V12, P1093, DOI 10.1093/ndt/12.6.1093
   [Anonymous], MOL CLONING
   Baus-Loncar M, 2004, PEPTIDES, V25, P849, DOI 10.1016/j.peptides.2003.11.019
   CHRISTIANE D, 2001, BIOCHEM J, V360, P143
   Goyns MH, 1998, MECH AGEING DEV, V101, P73, DOI 10.1016/S0047-6374(97)00166-8
   Ishidoh K, 1998, BIOL CHEM, V379, P131
   Kim CH, 2004, EXP GERONTOL, V39, P1155, DOI 10.1016/j.exger.2004.04.003
   KIRSCHKE H, 1998, LYSOSOMAL CYSTEINE P, V2
   Lavery LW, 2002, BIOGERONTOLOGY, V3, P207, DOI 10.1023/A:1016251929165
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   MEYER BR, 1989, J AM GERIATR SOC, V37, P791, DOI 10.1111/j.1532-5415.1989.tb02244.x
   Mühlberg W, 1999, GERONTOLOGY, V45, P243, DOI 10.1159/000022097
   NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205
   Panda H, 2004, J BIOMED SCI, V11, P528, DOI 10.1159/000077903
   Salehi M, 1996, EXPERIENTIA, V52, P888, DOI 10.1007/BF01938876
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   Takeda T, 1996, Nihon Jinzo Gakkai Shi, V38, P555
NR 21
TC 12
Z9 13
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1389-5729
J9 BIOGERONTOLOGY
JI Biogerontology
PD FEB
PY 2007
VL 8
IS 1
BP 25
EP 30
DI 10.1007/s10522-006-9032-z
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 123UO
UT WOS:000243321800003
PM 16865413
DA 2024-02-19
ER

PT J
AU Wu, B
   Xiao, X
   Li, SS
   Zuo, GQ
AF Wu, Bin
   Xiao, Xue
   Li, Shasha
   Zuo, Guoqing
TI Transcriptomics and metabonomics of the anti-aging properties of total
   flavones of <i>Epimedium</i> in relation to lipid metabolism
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Total flavone of Epimedium; Anti-aging; Lipid metabolism;
   Transcriptomics; Metabonomics
ID ICARIIN; METABOLOMICS; EXPRESSION; METSCAPE
AB Ethnopharmacological relevance: Total flavones of Epimedium (TFE) is the main active ingredient in Herba Epimedii, which is a well-known Chinese herbal medicine that is widely used to treat certain age-related diseases in oriental countries.
   Aim of the study: The aim of this work was to investigate the anti-aging properties of TFE related to lipid metabolism.
   Materials and methods: Both transcriptomics and metabonomics were applied in this work to investigate the anti aging properties of TFE. Microarray and LC MS analysis were conducted on liver samples of three groups of rats, including young (4 months), old (24 months), and old rats administrated TFE.
   Results: Transcriptomics analysis highlighted 287 transcripts related to the anti-aging effect of TFE, in which the expression ratio of 18 genes regulating lipid metabolism, including HMGCS1 and NR1H3, returned to normal levels after TFE treatment. In addition, 24 aging-related metabolites were discovered in a metabonomics study, and 15 of these were structurally identified, including palmitic amide, linoleamide, and oleamide. Bioinformatics and integral data analysis on the results of the transcriptomics and metabonomics suggest the involvement of 12 key metabolic pathways, half of which are highly related to lipid metabolism.
   Conclusions: This study demonstrates that the role played by TFE in the lipid metabolism of aging rats is multifaceted and multi-layered.
C1 [Wu, Bin; Zuo, Guoqing] Chongqing Hosp Tradit Chinese Med, Dept Rheumatol, 6 Panxiqizhi Rd, Chongqing 400021, Peoples R China.
   [Xiao, Xue] Guangdong Pharmaceut Univ, Guangzhou, Guangdong, Peoples R China.
   [Li, Shasha] Guangdong Prov Hosp Chinese Med, 111 Dade Rd, Guangzhou 510120, Guangdong, Peoples R China.
C3 Guangdong Pharmaceutical University; Guangzhou University of Chinese
   Medicine
RP Zuo, GQ (corresponding author), Chongqing Hosp Tradit Chinese Med, Dept Rheumatol, 6 Panxiqizhi Rd, Chongqing 400021, Peoples R China.; Li, SS (corresponding author), Guangdong Prov Hosp Chinese Med, 111 Dade Rd, Guangzhou 510120, Guangdong, Peoples R China.
EM happylishasha@163.com; cqzgqly@163.com
RI Wu, Bin/AAA-9378-2019
FU National Natural Science Foundation of China [81673724, 30600794];
   Chongqing Science and Technology Commission [cstc2015-shmszx120105,
   cstc2016shmszd10001, cstc2013jcsf10012]
FX This study was financially supported by grants from the National Natural
   Science Foundation of China (nos.: 81673724 and 30600794) and Chongqing
   Science and Technology Commission (no.: cstc2015-shmszx120105,
   cstc2016shmszd10001 and cstc2013jcsf10012).
CR Bang CN, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0461-4
   Barash Y, 2004, BIOINFORMATICS, V20, P839, DOI 10.1093/bioinformatics/btg487
   Cai WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028835
   Eichler GS, 2012, METHODS MOL BIOL, V823, P347, DOI 10.1007/978-1-60327-216-2_22
   Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009
   Fresno C, 2013, BIOINFORMATICS, V29, P2810, DOI 10.1093/bioinformatics/btt487
   Galvan Yuliana P, 2017, Curr Aging Sci, V10, P56
   Gao J, 2010, BIOINFORMATICS, V26, P971, DOI 10.1093/bioinformatics/btq048
   Gao YJ, 2017, AGING DIS, V8, P778, DOI 10.14336/AD.2017.0725
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Gribble KE, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3540-x
   Han S, 2017, NATURE, V544, P185, DOI 10.1038/nature21686
   Han YY, 2016, CHIN J NAT MEDICINES, V14, P671, DOI 10.1016/S1875-5364(16)30079-6
   Harper S, 2014, SCIENCE, V346, P587, DOI 10.1126/science.1254405
   Hu Zuo-Wei, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P1094
   Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661
   Liu P, 2017, AGING DIS, V8, P868, DOI 10.14336/AD.2017.0816
   Liu XY, 2011, CHIN J INTEGR MED, V17, P704, DOI 10.1007/s11655-011-0848-2
   Ma HP, 2011, J ETHNOPHARMACOL, V134, P519, DOI 10.1016/j.jep.2011.01.001
   Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
   Russo D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101732
   Sala A, 2010, PHARMACOL REP, V62, P503, DOI 10.1016/S1734-1140(10)70306-6
   Sapir A, 2014, P NATL ACAD SCI USA, V111, pE3880, DOI 10.1073/pnas.1414748111
   Schosserer M, 2018, GERONTOLOGY, V64, P229, DOI 10.1159/000485183
   [沈自尹 Shen Ziyun], 2005, [中国老年学杂志, Chinese Journal of Gerontology], V25, P1061
   Singh P, 2012, J NEUROCHEM, V123, P716, DOI 10.1111/jnc.12008
   Sood S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0750-x
   Sun M, 2018, MOLECULES, V23
   Sutphin GL, 2017, AGING CELL, V16, P672, DOI 10.1111/acel.12595
   Tan Xiaohou, 1998, Hunan Yike Daxue Xuebao, V23, P450
   Ulbricht Catherine E., 2016, Journal of Dietary Supplements, V13, P136, DOI 10.3109/19390211.2015.1008817
   Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329
   Vijg J, 2013, ANNU REV PHYSIOL, V75, P645, DOI 10.1146/annurev-physiol-030212-183715
   Wan QL, 2017, AGING-US, V9, P447, DOI 10.18632/aging.101170
   Wu B, 2008, MOL BIOSYST, V4, P855, DOI 10.1039/b800923f
   Wu B, 2012, J ETHNOPHARMACOL, V142, P746, DOI 10.1016/j.jep.2012.05.056
   Wu JF, 2016, J PROTEOME RES, V15, P2299, DOI 10.1021/acs.jproteome.6b00336
   Xue LM, 2016, J ETHNOPHARMACOL, V192, P370, DOI 10.1016/j.jep.2016.07.037
   Yan FF, 2008, PHYTOTHER RES, V22, P1224, DOI 10.1002/ptr.2451
   Yan SK, 2009, MOL BIOSYST, V5, P1204, DOI 10.1039/b816407j
   Yeo R, 2016, CELL METAB, V23, P395, DOI 10.1016/j.cmet.2016.02.018
   Zhang B, 2016, PROCEEDINGS OF 2016 INTERNATIONAL CONFERENCE ON CYBERNETICS, ROBOTICS AND CONTROL (CRC), P99, DOI [10.1109/CRC.2016.030, 10.1109/CRC.2016.9]
   Zhang SQ, 2015, EXP GERONTOL, V69, P226, DOI 10.1016/j.exger.2015.06.020
   Zhao L, 2014, EXP GERONTOL, V56, P3, DOI 10.1016/j.exger.2014.02.001
NR 44
TC 16
Z9 17
U1 21
U2 174
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD JAN 30
PY 2019
VL 229
BP 73
EP 80
DI 10.1016/j.jep.2018.09.039
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA HD2LZ
UT WOS:000452343400007
PM 30278205
DA 2024-02-19
ER

PT J
AU Akhtar, S
AF Akhtar, Shamsuddin
TI Preoperative evaluation of geriatric patients undergoing liver
   transplantation
SO CURRENT OPINION IN ANESTHESIOLOGY
LA English
DT Article
DE cirrhosis; geriatrics; liver transplantation; perioperative period;
   preoperative evaluation
ID RISK; ASSOCIATION; SARCOPENIA; MORTALITY; SURVIVAL; HEART
AB Purpose of review As the population of the world is aging the number of geriatric patients undergoing liver transplantation (LT) is also increasing. They pose a unique challenge for the caregivers, as they have age-related physiological changes, multiple comorbidities and cirrhosis-related pathologies. Recent findings Twenty-two percent of patients who undergo LT are older than 65 years. Many patients suffer from nonalcoholic steatohepatitis (NASH), hepatocellular carcinoma and hepatitis-C virus. Incidence of NASH tends to increase with age, obesity, diabetes and metabolic syndrome. Elderly patients require comprehensive cognitive, cardiac and pulmonary evaluation prior to LT. Cirrhotic cardiomyopathy, hepatopulmonary syndrome, portopulmonary hypertension and frailty are of specific concern. Proportion of elderly patients who are undergoing LT continues to increase. These patients require comprehensive cardiopulmonary and frailty evaluation. Consensus-based practice advisories need to be developed to standardize preoperative evaluation of geriatric patients awaiting LT.
C1 [Akhtar, Shamsuddin] Yale Sch Med, Dept Anesthesiol & Pharmacol, New Haven, CT 06510 USA.
C3 Yale University
RP Akhtar, S (corresponding author), Yale Sch Med, Dept Anesthesiol & Pharmacol, New Haven, CT 06510 USA.
EM shamsuddin.akhtar@yale.edu
FU National Institute on Aging [R01AG059607]
FX This work was supported in part by grant R01AG059607 from the National
   Institute on Aging. The content is solely the responsibility of the
   authors and does not necessarily represent the policy or views of the
   NIH, NIA, or the United States Government.
CR Akhtar S, 2021, CURR ANESTHESIOL REP, V11, P381, DOI 10.1007/s40140-021-00497-8
   Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055
   [Anonymous], 2021, ORG PROC TRANSPL NET
   Avolio AW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211678
   Balp M-M., 2021, ENDOCR METAB SCI, P3
   Barman PM, 2021, HEPATOLOGY, V73, P2564, DOI 10.1002/hep.31647
   Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI [10.1161/CIR.0000000000000659, 10.1161/CIR.0000000000000746]
   Blok JJ, 2015, LIVER TRANSPLANT, V21, P1486, DOI 10.1002/lt.24308
   Botello-Manilla AE, 2021, ANN HEPATOL, V24, DOI 10.1016/j.aohep.2021.100320
   Caspers S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00149
   Chen W, 2010, HEART FAIL REV, V15, P415, DOI 10.1007/s10741-010-9161-y
   Cheng Y, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0114-21.2021
   De Gasperi A, 2020, BEST PRAC RES-CL ANA, V34, P51, DOI 10.1016/j.bpa.2020.02.002
   Demertzi A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat7603
   Dolnikov S, 2020, SURG TODAY, V50, P533, DOI 10.1007/s00595-020-01996-7
   Durand F, 2019, J HEPATOL, V70, P745, DOI 10.1016/j.jhep.2018.12.009
   Dutkowski P, 2011, ANN SURG, V254, P745, DOI 10.1097/SLA.0b013e3182365081
   Edde M, 2021, J NEUROSCI RES, V99, P236, DOI 10.1002/jnr.24669
   Edwin N, 2011, POSTGRAD MED J, V87, P605, DOI 10.1136/pgmj.2010.108985
   Egeli T, 2019, TRANSPL P, V51, P1143, DOI 10.1016/j.transproceed.2019.01.090
   El Hadi H, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030567
   Erdo F, 2017, J CEREBR BLOOD F MET, V37, P4, DOI 10.1177/0271678X16679420
   Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944
   Frost A, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01904-2018
   Galiè N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Kandiah PA., HEPATIC CRIT CARE
   Kwong AJ, 2020, LIVER TRANSPLANT, V26, P1492, DOI 10.1002/lt.25863
   Lai JC, 2019, AM J TRANSPLANT, V19, P1896, DOI 10.1111/ajt.15392
   Lattanzi B, 2019, J CLIN EXP HEPATOL, V9, P125, DOI 10.1016/j.jceh.2018.04.007
   Liu HQ, 2017, LIVER TRANSPLANT, V23, P826, DOI 10.1002/lt.24768
   MAGGIONI AP, 1993, NEW ENGL J MED, V329, P1442, DOI 10.1056/NEJM199311113292002
   Martin P, 2014, HEPATOLOGY, V59, P1144, DOI 10.1002/hep.26972
   Martinez-Palli G, 2011, ANN HEPATOL, V10, P421, DOI 10.1016/S1665-2681(19)31508-X
   Mashour GA, 2018, ANESTHESIOLOGY, V129, P869, DOI 10.1097/ALN.0000000000002385
   Matt SM, 2016, CURR OPIN PHARMACOL, V26, P96, DOI 10.1016/j.coph.2015.10.009
   McIsaac DI, 2016, JAMA SURG, V151, P538, DOI 10.1001/jamasurg.2015.5085
   Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393
   Moller S, 2013, EUR HEART J, V34, P2804, DOI 10.1093/eurheartj/eht246
   Montgomery J, 2019, CURR TRANSPLANT REP, V6, P7, DOI 10.1007/s40472-019-0223-3
   Rana A, 2013, CLIN TRANSPLANT, V27, P627, DOI 10.1111/ctr.12181
   Rich NE, 2020, CLIN GASTROENTEROL H, V18, P242, DOI 10.1016/j.cgh.2019.04.043
   Robertson M, 2021, LIVER TRANSPLANT, V27, P1007, DOI 10.1002/lt.26025
   Savale L, 2019, EUR HEART J SUPPL, V21, P37, DOI 10.1093/eurheartj/suz221
   Sprung J, 2006, CAN J ANAESTH, V53, P1244, DOI 10.1007/BF03021586
   Sutton MS, 1997, CIRCULATION, V96, P3294
   Thomas C, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.569413
   Valery PC, 2018, HEPATOLOGY, V67, P600, DOI 10.1002/hep.29498
   von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124
   Wiese S, 2014, NAT REV GASTRO HEPAT, V11, P177, DOI 10.1038/nrgastro.2013.210
   Zhai MM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84577-z
   Zonneveld HI, 2019, NEUROIMAGE, V189, P432, DOI 10.1016/j.neuroimage.2019.01.041
NR 51
TC 1
Z9 1
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0952-7907
EI 1473-6500
J9 CURR OPIN ANESTHESIO
JI Curr. Opin. Anesthesiol.
PD FEB
PY 2022
VL 35
IS 1
BP 96
EP 104
DI 10.1097/ACO.0000000000001084
PG 9
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA XR8DL
UT WOS:000732452500016
PM 34878418
DA 2024-02-19
ER

PT J
AU Yang, WH
   Heithoff, DM
   Aziz, PV
   Haslund-Gourley, B
   Westman, JS
   Narisawa, S
   Pinkerton, AB
   Millan, JL
   Nizet, V
   Mahan, MJ
   Marth, JD
AF Yang, Won Ho
   Heithoff, Douglas M.
   Aziz, Peter V.
   Haslund-Gourley, Benjamin
   Westman, Julia S.
   Narisawa, Sonoko
   Pinkerton, Anthony B.
   Millan, Jose Luis
   Nizet, Victor
   Mahan, Michael J.
   Marth, Jamey D.
TI Accelerated Aging and Clearance of Host Anti-inflammatory Enzymes by
   Discrete Pathogens Fuels Sepsis
SO CELL HOST & MICROBE
LA English
DT Article
ID INTESTINAL ALKALINE-PHOSPHATASE; MORTALITY; LIPOPOLYSACCHARIDE;
   ENDOTOXIN; MICE; EXPRESSION; TOXICITY
AB Sepsis is a life-threatening inflammatory syndrome accompanying a bloodstream infection. Frequently secondary to pathogenic bacterial infections, sepsis remains difficult to treat as a singular disease mechanism. We compared the pathogenesis of murine sepsis experimentally elicited by five bacterial pathogens and report similarities among host responses to Gram-negative Salmonella and E. coli. We observed that a host protective mechanism involving de-toxification of lipopolysaccharide by circulating alkaline phosphatase (AP) isozymes was incapacitated during sepsis caused by Salmonella or E. coli through activation of host Toll-like receptor 4, which triggered Neul and Neu3 neuraminidase induction. Elevated neuraminidase activity accelerated the molecular aging and clearance of AP isozymes, thereby intensifying disease. Mice deficient in the sialyltransferase ST3Gal6 displayed increased disease severity, while deficiency of the endocytic lectin hepatic Ashwell-Morell receptor was protective. AP augmentation or neuraminidase inhibition diminished inflammation and promoted host survival. This study illuminates distinct routes of sepsis pathogenesis, which may inform therapeutic development.
C1 [Yang, Won Ho; Heithoff, Douglas M.; Aziz, Peter V.; Haslund-Gourley, Benjamin; Westman, Julia S.; Mahan, Michael J.; Marth, Jamey D.] Univ Calif Santa Barbara, Ctr Nanomed, Santa Barbara, CA 93106 USA.
   [Yang, Won Ho; Aziz, Peter V.; Haslund-Gourley, Benjamin; Westman, Julia S.; Narisawa, Sonoko; Pinkerton, Anthony B.; Millan, Jose Luis; Marth, Jamey D.] Univ Calif Santa Barbara, Sanford Burham Prebys Med Discovery Inst, Santa Barbara, CA 93106 USA.
   [Heithoff, Douglas M.; Aziz, Peter V.; Haslund-Gourley, Benjamin; Mahan, Michael J.; Marth, Jamey D.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.
   [Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.
   [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
C3 University of California System; University of California Santa Barbara;
   University of California System; University of California Santa Barbara;
   University of California System; University of California Santa Barbara;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego
RP Marth, JD (corresponding author), Univ Calif Santa Barbara, Ctr Nanomed, Santa Barbara, CA 93106 USA.; Marth, JD (corresponding author), Univ Calif Santa Barbara, Sanford Burham Prebys Med Discovery Inst, Santa Barbara, CA 93106 USA.; Marth, JD (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.
EM jmarth@sbpdiscovery.org
RI Nizet, Victor/AAF-3190-2019
OI Haslund-Gourley, Benjamin/0000-0002-8488-0759; Pinkerton,
   Anthony/0000-0003-4571-152X
FU NIH [HL125352, HL131474]; Swedish Research Council [2017-00192]; Vinnova
   [2017-00192] Funding Source: Vinnova; Swedish Research Council
   [2017-00192] Funding Source: Swedish Research Council
FX This research was funded by NIH grants HL125352 (J.D.M. and V.N.) and
   HL131474 (J.D.M., M.J.M., and V.N.). Additional support was provided by
   the Swedish Research Council 2017-00192 (J.S.W.).
CR [Anonymous], 2006, MAMMALIAN ALKALINE P
   Ashwell G, 1974, Biochem Soc Symp, P117
   Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010
   Bentala H, 2002, SHOCK, V18, P561, DOI 10.1097/00024382-200212000-00013
   Beumer C, 2003, J PHARMACOL EXP THER, V307, P737, DOI 10.1124/jpet.103.056606
   Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6
   Chang Huan J, 2010, JAMA, V304, P1856, DOI 10.1001/jama.304.16.1856
   Chaudhry H, 2013, IN VIVO, V27, P669
   Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005
   Cross AS, 2012, J BIOL CHEM, V287, P15966, DOI 10.1074/jbc.M112.346817
   D'Elia RV, 2013, CLIN VACCINE IMMUNOL, V20, P319, DOI 10.1128/CVI.00636-12
   Dahl R, 2009, J MED CHEM, V52, P6919, DOI 10.1021/jm900383s
   Davis MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3916
   de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933
   Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001
   Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099
   Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2
   Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x
   Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC
   Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8
   Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105
   Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760
   Grewal PK, 2013, P NATL ACAD SCI USA, V110, P20218, DOI 10.1073/pnas.1313905110
   Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad
   Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08
   Hawiger J, 2011, CRIT CARE, V15, DOI 10.1186/cc10482
   Heemskerk S, 2009, CRIT CARE MED, V37, P417, DOI 10.1097/CCM.0b013e31819598af
   Heithoff DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002647
   ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803
   Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553
   Kats S, 2009, RECENT PATENTS INFLA, V3, P214, DOI 10.2174/187221309789257388
   Kiffer-Moreira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089374
   Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2
   Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961
   Lin JN, 2010, ACAD EMERG MED, V17, P1072, DOI 10.1111/j.1553-2712.2010.00871.x
   Lukas M, 2010, INFLAMM BOWEL DIS, V16, P1180, DOI 10.1002/ibd.21161
   Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007
   Narisawa S, 1997, DEV DYNAM, V208, P432, DOI 10.1002/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1
   Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003
   Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414
   Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194
   Orban JC, 2017, ANESTHESIOLOGY, V126, P882, DOI 10.1097/ALN.0000000000001612
   Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830
   Parlato M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708483
   Peters E, 2015, INT J PHARMACEUT, V495, P122, DOI 10.1016/j.ijpharm.2015.08.090
   Pettengill M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175936
   Pickkers P, 2012, CRIT CARE, V16, DOI 10.1186/cc11159
   Pinkerton AB, 2018, BIOORG MED CHEM LETT, V28, P31, DOI 10.1016/j.bmcl.2017.11.024
   Poelstra K, 1997, LAB INVEST, V76, P319
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Poolman JT, 2016, J INFECT DIS, V213, P6, DOI 10.1093/infdis/jiv429
   Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9
   RUSSO TA, 1990, J BACTERIOL, V172, P2594, DOI 10.1128/jb.172.5.2594-2600.1990
   Schromm AB, 1998, J IMMUNOL, V161, P5464
   Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974
   Sheen CR, 2015, J BONE MINER RES, V30, P824, DOI 10.1002/jbmr.2420
   Singleton KD, 2003, EUR SURG RES, V35, P486, DOI 10.1159/000073387
   Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327
   Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111
   Tuin A, 2006, AM J PHYSIOL-GASTR L, V290, pG377, DOI 10.1152/ajpgi.00147.2005
   van Sorge NM, 2013, J BIOL CHEM, V288, P6417, DOI 10.1074/jbc.M112.448738
   VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985
   Vincent JL, 2009, CRIT CARE CLIN, V25, P665, DOI 10.1016/j.ccc.2009.07.001
   Yang WH, 2017, SCIENCE, V358, DOI 10.1126/science.aao5610
   Yang WH, 2015, P NATL ACAD SCI USA, V112, P13657, DOI 10.1073/pnas.1515464112
   Yang WH, 2012, BLOOD, V120, P1015, DOI 10.1182/blood-2012-04-424366
NR 66
TC 30
Z9 32
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD OCT 10
PY 2018
VL 24
IS 4
BP 500
EP +
DI 10.1016/j.chom.2018.09.011
PG 19
WC Microbiology; Parasitology; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology; Parasitology; Virology
GA GW4MJ
UT WOS:000446888300009
PM 30308156
OA hybrid, Green Accepted
DA 2024-02-19
ER

PT J
AU ADRIAN, GS
   HERBERT, DC
   ROBINSON, LK
   WALTER, CA
   BUCHANAN, JM
   ADRIAN, EK
   WEAKER, FJ
   EDDY, CA
   YANG, FM
   BOWMAN, BH
AF ADRIAN, GS
   HERBERT, DC
   ROBINSON, LK
   WALTER, CA
   BUCHANAN, JM
   ADRIAN, EK
   WEAKER, FJ
   EDDY, CA
   YANG, FM
   BOWMAN, BH
TI EXPRESSION OF A HUMAN CHIMERIC TRANSFERRIN GENE IN SENESCENT TRANSGENIC
   MICE REFLECTS THE DECREASE OF TRANSFERRIN LEVELS IN AGING HUMANS
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
DE TRANSGENIC MICE; TOTAL IRON BINDING CAPACITY; TRANSFERRIN; ALBUMIN;
   SERUM AMYLOID PROTEIN; C3; AGING; ACUTE PHASE REACTION
ID IRON-DEFICIENCY; PROTEIN GENES; MESSENGER-RNA; CHICK LIVER; RAT;
   ESTROGEN; TISSUES; EVOLUTION; DIAGNOSIS; FRAGMENTS
AB Transgenic mice provide a means to study human gene expression in vivo throughout the aging process. A DNA sequence containing 668 bp of the 5' regulatory region of the human transferrin gene was fused to the bacterial reporter gene chloramphenicol acetyl transferase (TF-CAT) and introduced into the mouse genome. Expression of the human chimeric transferrin gene was similar to the tissue patterns of mouse and human transferrin. In aging transgenic mice, expression of the human chimeric transferrin gene was found to diminish 40% in livers between 18 and 26 months of age. Transferrin levels and serum iron levels in aging humans also diminish, as observed from measurements of total iron binding capacity and percent iron saturation in sera from 701 individuals ranging from 0 to 99 years of age. In contrast, in transgenic mice and nontransgenic mice, the mouse endogenous plasma transferrin and endogenous Tf mRNA increase significantly during aging. Neither the decrease of human TF-CAT nor the increase of mouse transferrin during aging appears to be part of a typical inflammatory reaction. Although the 5' regions of the human transferrin and mouse transferrin genes are homologous, sequence diversities exist which could account for the different responses to inflammation and aging observed.
C1 UNIV TEXAS, HLTH SCI CTR, DEPT OBSTET & GYNECOL, SAN ANTONIO, TX 78284 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
RP ADRIAN, GS (corresponding author), UNIV TEXAS, HLTH SCI CTR, DEPT CELLULAR & STRUCT BIOL, 7703 FLOYD CURL DR, SAN ANTONIO, TX 78284 USA.
FU NIA NIH HHS [1 T32 AG00165, AG 06872] Funding Source: Medline
CR Adrian G S, 1990, SAAS Bull Biochem Biotechnol, V3, P97
   ADRIAN GS, 1990, UCLA SYM BI, V123, P365
   ADRIAN GS, 1990, EXP CELL RES, V186, P385, DOI 10.1016/0014-4827(90)90321-Z
   ADRIAN GS, 1990, J BIOL CHEM, V265, P13344
   ADRIAN GS, 1986, GENE, V49, P167, DOI 10.1016/0378-1119(86)90277-5
   ADRIAN GS, 1990, IN PRESS BIOTECHNOLO
   ALDRED AR, 1987, J BIOL CHEM, V262, P5293
   BOWMAN BH, 1990, BIOESSAYS, V12, P317, DOI 10.1002/bies.950120703
   BOWMAN BH, 1988, ADV GENET, V25, P1
   BRINSTER RL, 1982, TRENDS BIOCHEM SCI, V7, P438, DOI 10.1016/S0968-0004(82)80012-1
   BRUNEL F, 1988, J BIOL CHEM, V263, P10180
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   COHN C, 1971, TXB CLIN PATHOLOGY, P264
   DYBKAER R, 1981, ACTA MED SCAND, V209, P1
   FISCHBACH K, 1990, J NEUROSCI RES, V27, P633, DOI 10.1002/jnr.490270424
   GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044
   HAMMER RE, 1986, MOL CELL BIOL, V6, P1010, DOI 10.1128/MCB.6.4.1010
   HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032
   HOGAN B, 1986, MANIPULATING MOUSE E, P81
   HORNE CHW, 1972, J ENDOCRINOL, V54, P47, DOI 10.1677/joe.0.0540047
   IDZERDA RL, 1989, MOL CELL BIOL, V9, P5154, DOI 10.1128/MCB.9.11.5154
   IDZERDA RL, 1986, P NATL ACAD SCI USA, V83, P3723, DOI 10.1073/pnas.83.11.3723
   KAFATOS FC, 1979, NUCLEIC ACIDS RES, V7, P1541, DOI 10.1093/nar/7.6.1541
   KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x
   LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6
   LEE DC, 1978, J BIOL CHEM, V253, P3494
   LEVIN MJ, 1984, BIOCHEM BIOPH RES CO, V122, P212, DOI 10.1016/0006-291X(84)90461-3
   LUM JB, 1986, J CLIN INVEST, V77, P841, DOI 10.1172/JCI112381
   MACGILLIVRAY RTA, 1983, J BIOL CHEM, V258, P3543
   MARKUS HS, 1989, BRIT J CLIN PRACT, V43, P451
   MCKNIGHT GS, 1980, J BIOL CHEM, V255, P148
   MCKNIGHT GS, 1983, CELL, V34, P335
   MCKNIGHT GS, 1980, J BIOL CHEM, V255, P144
   MEEK J, 1985, J EMBRYOL EXP MORPH, V86, P205
   MORGAN EH, 1983, PLASMA PROTEIN SECRE, P331
   PARK I, 1985, P NATL ACAD SCI USA, V82, P3149, DOI 10.1073/pnas.82.10.3149
   POWELL DEB, 1969, GERONTOL CLIN, V11, P36, DOI 10.1159/000245213
   SCHAEFFER E, 1989, J BIOL CHEM, V264, P7153
   SCHAEFFER E, 1985, PROTEINS IRON STORAG, P361
   SCHREIBER G, 1983, PLASMA PROTEIN SECRE, P423
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Walter C A, 1989, Biotechniques, V7, P1065
   WILLIAMS J, 1982, TRENDS BIOCHEM SCI, V7, P394, DOI 10.1016/0968-0004(82)90183-9
   YANG F, 1990, MECH AGEING DEV, V56, P187, DOI 10.1016/0047-6374(90)90009-5
   YANG FM, 1984, P NATL ACAD SCI-BIOL, V81, P2752, DOI 10.1073/pnas.81.9.2752
   YEOH GCT, 1974, BIOCHEM J, V144, P215, DOI 10.1042/bj1440215
   YIP R, 1984, AM J CLIN NUTR, V39, P427, DOI 10.1093/ajcn/39.3.427
NR 48
TC 7
Z9 7
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
JI Biochim. Biophys. Acta
PD SEP 24
PY 1992
VL 1132
IS 2
BP 168
EP 176
DI 10.1016/0167-4781(92)90008-N
PG 9
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA JQ425
UT WOS:A1992JQ42500008
PM 1382606
DA 2024-02-19
ER

PT J
AU Buddhan, S
   Sivakumar, R
   Dhandapani, N
   Ganesan, B
   Anandan, R
AF Buddhan, S.
   Sivakumar, R.
   Dhandapani, N.
   Ganesan, B.
   Anandan, R.
TI Protective effect of dietary squalene supplementation on mitochondrial
   function in liver of aged rats
SO PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
LA English
DT Article
ID INDUCED MYOCARDIAL-INFARCTION; LIPID-PEROXIDATION; ACID; TISSUES; ASSAY;
   ANTIOXIDANTS; PRODUCTS; MUTATION; SQUALANE; DAMAGE
AB Mitochondria are an important intracellular source and target of reactive oxygen species. The life span of a species is thought to be determined, in part, by the rate of mitochondrial damage inflicted by oxygen free radicals during the course of normal cellular metabolism. In the present study, we have investigated the protective effect of squalene supplementation for 15 days and 30 days on energy status and antioxidant defense system in liver mitochondria of 18 young and IS aged rats. The dietary supplementation of 2% squalene significantly minimized aging associated alterations in mitochondrial energy status by maintaining the activities of TCA cycle enzymes (isocitrate dehydrogenase, a-ketoglutarate dehydrogenase, succinate dehydrogenase and malate dehydrogenase) and respiratory marker enzymes (NADH dehydrogenase and cytochrome-c-oxidase) at higher level in the liver mitochondria of aged rats compared with unsupplemented controls. It exerted an antioxidant effect by inhibiting mitochondrial lipid peroxidation (malondialdehyde) in liver of young and aged rats. Supplementation with squalene also maintained the mitochondrial antioxidant defense system at higher rate by increasing the level of reduced glutathione and the activities of glutathione-dependent antioxidant enzymes (glutathione peroxidase and glutathione-S-transferase) and antiperoxidative enzymes (superoxide dismutase and catalase) in the liver of young and aged rats. The results of this study provide evidence that dietary supplementation with squalene can improve liver mitochondrial function during aging and minimize the age-associated disorders in which reactive oxygen species are a major cause. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Cent Inst Fisheries Technol, Biochem & Nutr Div, Cochin 682029, Kerala, India.
   RVS Coll Pharmaceut Sci, Dept Pharmaceut Chem, Coimbatore 641402, Tamil Nadu, India.
   Vinayaka Missions Res Fdn Deemed Univ, Dept Biochem, Salem 636308, Tamil Nadu, India.
C3 Indian Council of Agricultural Research (ICAR); ICAR - Central Institute
   of Fisheries Technology; Vinayaka Mission's Research Foundation
RP Anandan, R (corresponding author), Cent Inst Fisheries Technol, Biochem & Nutr Div, Matsyaouri PO, Cochin 682029, Kerala, India.
EM kranandan@email.com
OI Anandan, Rangasamy/0000-0003-0759-2064
CR Arivazhagan P, 2002, EXP GERONTOL, V37, P1489, DOI 10.1016/S0531-5565(02)00122-5
   Arivazhagan P, 2001, J NUTR BIOCHEM, V12, P2, DOI 10.1016/S0955-2863(00)00138-8
   ARNES BN, 1993, P NATL ACAD SCI USA, V90, P7915
   BARNETT YA, 1995, MUTAT RES-DNAGING G, V338, P115, DOI 10.1016/0921-8734(95)00017-Z
   BELL JL, 1960, CLIN CHIM ACTA, V5, P740, DOI 10.1016/0009-8981(60)90017-6
   Chan P, 1996, J CLIN PHARMACOL, V36, P422, DOI 10.1002/j.1552-4604.1996.tb05029.x
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   Desai KN, 1996, CANCER LETT, V101, P93, DOI 10.1016/0304-3835(96)04122-5
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Fan SR, 1996, MUTAT RES-GENET TOX, V368, P165, DOI 10.1016/S0165-1218(96)90058-0
   Farvin KHS, 2005, J CLIN BIOCHEM NUTR, V37, P55, DOI 10.3164/jcbn.37.55
   Farvin KHS, 2004, PHARMACOL RES, V50, P231, DOI 10.1016/j.phrs.2004.03.004
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   IKEKAWA T, 1986, YAKUGAKU ZASSHI, V106, P578, DOI 10.1248/yakushi1947.106.7_578
   IVASHKEVICH S P, 1981, Biokhimiya, V46, P1420
   Jahangir A, 2001, MECH AGEING DEV, V122, P1073, DOI 10.1016/S0047-6374(01)00242-1
   Johnson D., 1967, Methods Enzymol, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9
   Kalous M, 1996, PHYSIOL RES, V45, P351
   KAMIMURA H, 1992, J PHARMACOBIO-DYNAM, V15, P215, DOI 10.1248/bpb1978.15.215
   KOHNO Y, 1995, BBA-LIPID LIPID MET, V1256, P52, DOI 10.1016/0005-2760(95)00005-W
   MEHLER AH, 1948, J BIOL CHEM, V174, P961
   MINAKAMI S, 1962, J BIOL CHEM, V237, P569
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PEARL W, 1963, J HISTOCHEM CYTOCHEM, V11, P102, DOI 10.1177/11.1.102
   Rao CV, 1998, CARCINOGENESIS, V19, P287, DOI 10.1093/carcin/19.2.287
   Reed LJ, 1969, METHOD ENZYMOL, V14, P53
   RICHTER E, 1982, J ENVIRON SCI HEAL B, V17, P195, DOI 10.1080/03601238209372313
   Romero FJ, 1998, ENVIRON HEALTH PERSP, V106, P1229, DOI 10.2307/3433990
   RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SLATER EC, 1952, BIOCHEM J, V52, P185, DOI 10.1042/bj0520185
   Smith TJ, 1998, CARCINOGENESIS, V19, P703, DOI 10.1093/carcin/19.4.703
   SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S
   Stahl V, 1997, DIABETES, V46, pS14, DOI 10.2337/diab.46.2.S14
   TAKAHARA S, 1960, J CLIN INVEST, V39, P610, DOI 10.1172/JCI104075
   Wei YH, 1996, ANN NY ACAD SCI, V786, P24, DOI 10.1111/j.1749-6632.1996.tb39049.x
   Wei YH, 1998, CURR SCI INDIA, V74, P887
   Yarian CS, 2006, MECH AGEING DEV, V127, P79, DOI 10.1016/j.mad.2005.09.028
   Zarchin N, 2002, COMP BIOCHEM PHYS A, V132, P117, DOI 10.1016/S1095-6433(01)00537-2
NR 41
TC 28
Z9 31
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0952-3278
EI 1532-2823
J9 PROSTAG LEUKOTR ESS
JI Prostaglandins Leukot. Essent. Fatty Acids
PD JUN
PY 2007
VL 76
IS 6
BP 349
EP 355
DI 10.1016/j.plefa.2007.05.001
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Endocrinology &
   Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Endocrinology &
   Metabolism
GA 206MY
UT WOS:000249188800006
PM 17574827
DA 2024-02-19
ER

PT J
AU Ichiba, M
   Yamada, S
   Ishii, K
   Gonda, K
   Murai, R
   Shimomura, T
   Saeki, T
   Kanbe, T
   Tanabe, Y
   Yoshida, Y
   Tsuchiya, H
   Hoshikawa, Y
   Kurimasa, A
   Kishimoto, Y
   Kawasaki, H
   Shiota, G
AF Ichiba, Miho
   Yamada, Sadako
   Ishii, Kyoko
   Gonda, Kazue
   Murai, Rie
   Shimomura, Takashi
   Saeki, Toshiya
   Kanbe, Takamasa
   Tanabe, Yoshitada
   Yoshida, Yoko
   Tsuchiya, Hiroyuki
   Hoshikawa, Yoshiko
   Kurimasa, Akihiro
   Kishimoto, Yukihiro
   Kawasaki, Hironaka
   Shiota, Goshi
TI Significance of urinary excretion of 8-hydroxy-2′-deoxyguanosine in
   healthy subjects and liver disease patients
SO HEPATO-GASTROENTEROLOGY
LA English
DT Article
DE 8-hydroxy-2 '-deoxyguanosine; urinary excretion; liver disease; aging;
   smoking; BMI
ID OXIDATIVE DNA-DAMAGE; NON-HODGKINS-LYMPHOMA; BIOMARKER EVIDENCE;
   8-HYDROXYDEOXYGUANOSINE; 8-HYDROXY-2-DEOXYGUANOSINE; STRESS; RISK;
   8-OXO-2'-DEOXYGUANOSINE; SMOKING; PLASMA
AB Background/Aims: Although the importance of reactive oxygen species (ROS) in the pathogenesis of various diseases is stressed, clinical significance of the markers reflecting DNA oxidation such as 8hydroxy-2'-deoxyguanosine (8-OHdG) remains to be clarified.
   Methodology: To examine clinical usefulness of 8OHdG in healthy individuals in comparison with liver disease patients, urinary excretion of 8-OHdG was measured in 336 healthy individuals and 110 patients with liver disease.
   Results: In healthy persons, the 8-OHdG excretion was increased in an age-dependent manner. It was positively correlated with cigarettes smoked a day and negatively correlated with body mass index (BMI) (P<0.05, each). Age, smoking and BMI were independent predictors of urinary 8-OHdG excretion (P<0.01, P<0.01 and P<0.05, respectively). In liver disease, the excretion of 8-OHdG was not changed, as compared with healthy individuals. However, the liver disease patients under the age of 40 had higher values of 8-OHdG than healthy persons. In addition, the urinary excretion of 8-OHdG was higher in patients with hepatitis C virus (HCV) infection than those with hepatitis B virus (HBV) infection.
   Conclusions: The results of the present study suggest that measurement of urinary 8-OHdG excretion is useful in assessing DNA oxidation caused by aging, smoking, body composition and liver disease.
C1 Tottori Univ, Grad Sch Med, Dept Gene & Regenerat Med, Div Mol & Genet Med, Tottori, Japan.
   Tottori Univ, Sch Hlth Sci, Dept Pathol Sci & Technol, Tottori, Japan.
   San In Rosal Hosp, Dept Internal Med, Yonago, Tottori, Japan.
C3 Tottori University; Tottori University
RP Shiota, G (corresponding author), Tottori Univ, Grad Sch Med, Dept Genet Med & Regenerat Therapeut, Yonago, Tottori 6838504, Japan.
EM gshiota@grape.med.tottori-u.ac.jp
CR BERGTOLD DS, 1991, PROG CLIN BIOL RES, V372, P21
   Cardin R, 2001, J HEPATOL, V34, P587, DOI 10.1016/S0168-8278(00)00098-2
   Cooke MS, 2000, FREE RADICAL RES, V32, P381, DOI 10.1080/10715760000300391
   DENDA A, 1994, CARCINOGENESIS, V15, P1279, DOI 10.1093/carcin/15.6.1279
   Erhola M, 1997, FEBS LETT, V409, P287, DOI 10.1016/S0014-5793(97)00523-1
   Evans MD, 1999, BIOCHEM BIOPH RES CO, V259, P374, DOI 10.1006/bbrc.1999.0801
   Farinati F, 1999, FREE RADICAL BIO MED, V27, P1284, DOI 10.1016/S0891-5849(99)00161-6
   Floyd R A, 1986, Free Radic Res Commun, V1, P163, DOI 10.3109/10715768609083148
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FREI B, 1991, BIOCHEM J, V277, P133, DOI 10.1042/bj2770133
   Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5
   KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137
   Kitada T, 2001, J HEPATOL, V35, P613, DOI 10.1016/S0168-8278(01)00171-4
   Kondo S, 2000, CLIN CANCER RES, V6, P1394
   LEANDERSON P, 1992, CHEM-BIOL INTERACT, V81, P197, DOI 10.1016/0009-2797(92)90034-I
   LEANDERSON P, 1990, CHEM-BIOL INTERACT, V75, P71, DOI 10.1016/0009-2797(90)90023-G
   Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6
   Leinonen J, 1997, FEBS LETT, V417, P150, DOI 10.1016/S0014-5793(97)01273-8
   LOFT S, 1993, J TOXICOL ENV HEALTH, V40, P391, DOI 10.1080/15287399309531806
   LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241
   Moriya K, 2001, CANCER RES, V61, P4365
   Musarrat J, 1996, EUR J CANCER, V32A, P1209, DOI 10.1016/0959-8049(96)00031-7
   Ohsawa M, 1999, INT J CANCER, V80, P237, DOI 10.1002/(SICI)1097-0215(19990118)80:2&lt;237::AID-IJC12&gt;3.0.CO;2-I
   PARK EM, 1992, P NATL ACAD SCI USA, V89, P3375, DOI 10.1073/pnas.89.8.3375
   Rasul I, 1999, HEPATOLOGY, V29, P543, DOI 10.1002/hep.510290224
   RIEMERSMA RA, 1991, LANCET, V337, P1, DOI 10.1016/0140-6736(91)93327-6
   ROTH M, 1989, EXP CELL RES, V180, P171, DOI 10.1016/0014-4827(89)90221-8
   SHAH M, 1988, EUR J CLIN NUTR, V42, P741
   SHIGENAGA MK, 1991, FREE RADICAL BIO MED, V10, P211, DOI 10.1016/0891-5849(91)90078-H
   SHIMODA R, 1994, CANCER RES, V54, P3171
   SHIOTA G, 1995, HEPATOLOGY, V21, P106, DOI 10.1016/0270-9139(95)90416-6
   Tagesson C, 1996, INT ARCH OCC ENV HEA, V69, P5
   YAMAMOTO T, 1999, J OBSTET CYNAECOL RE, V22, P359
   ZIEGLER RG, 1989, J NUTR, V119, P116, DOI 10.1093/jn/119.1.116
NR 34
TC 8
Z9 9
U1 0
U2 2
PU H G E UPDATE MEDICAL PUBLISHING S A
PI ATHENS
PA PO BOX 17257, ATHENS GR-10024, GREECE
SN 0172-6390
J9 HEPATO-GASTROENTEROL
JI Hepato-Gastroenterol.
PD SEP
PY 2007
VL 54
IS 78
BP 1736
EP 1740
PG 5
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery
GA 225CV
UT WOS:000250495600034
PM 18019707
DA 2024-02-19
ER

PT J
AU MIYA, T
   SASAKI, Y
   KARATO, A
   SAIJO, N
AF MIYA, T
   SASAKI, Y
   KARATO, A
   SAIJO, N
TI PHARMACOKINETIC STUDY OF MITOMYCIN-C WITH EMPHASIS ON THE INFLUENCE OF
   AGING
SO JAPANESE JOURNAL OF CANCER RESEARCH
LA English
DT Article
DE MITOMYCIN-C; PHARMACOKINETICS; INFLUENCE OF AGING; INTERPATIENT
   VARIATION
ID CLINICAL PHARMACOKINETICS; ACTIVATION; REDUCTASE; HUMANS
AB Mitomycin C (MMC) at a dose of 8 mg/m2 was administered by short intravenous infusion to 14 cancer patients. All patients had normal renal, hepatic, cardiac and bone marrow functions. The plasma level of MMC, which was determined by high-performance liquid chromatography over a 24-h period after the infusion, fitted the 2-compartment model curve except for one patient. There was a significant correlation between the area under the time versus concentration curve (AUC) of MMC and the age of patients (r=0.558, P<0.05). Pharmacokinetic parameters in one of the older (a 69-year-old male) patients were extremely different from those of the other 13 patients. This patient experienced severe myelosuppression, probably due to the markedly increased AUC of MMC. Our results suggest that a patient's age has a significant influence on the pharmacokinetics of MMC in patients with normal major organ functions and that in some patients, MMC pharmacokinetics may be altered, possibly due to interpatient variation in the activation or metabolic pathway of MMC.
C1 NATL CANC CTR,DEPT INTERNAL MED,CHUO KU,TOKYO 104,JAPAN.
   NATL CANC CTR,RES INST,DIV PHARMACOL,CHUO KU,TOKYO 104,JAPAN.
C3 National Cancer Center - Japan; National Cancer Center - Japan
CR ABDALLAH HY, 1991, J CLIN PHARMACOL, V31, P380, DOI 10.1002/j.1552-4604.1991.tb03722.x
   BLIGH HFJ, 1990, CANCER RES, V50, P7789
   DENHARTIGH J, 1981, ANAL CHIM ACTA, V127, P47, DOI 10.1016/S0003-2670(01)83960-X
   DENHARTIGH J, 1983, CANCER RES, V43, P5017
   EGORIN MJ, 1989, CANCER RES, V49, P3129
   EVANS WE, 1989, CLIN PHARMACOKINET, V16, P327, DOI 10.2165/00003088-198916060-00001
   FUKUOKA E, 1988, J J S H P, V24, P1201
   HASHIDA M, 1990, J PHARMACOBIO-DYNAM, V13, P441, DOI 10.1248/bpb1978.13.441
   HOBAN PR, 1990, CANCER RES, V50, P4692
   Mayersohn M., 1986, APPLIED PHARMACOKINE, P229
   RATAIN MJ, 1991, J CLIN ONCOL, V9, P871, DOI 10.1200/JCO.1991.9.5.871
   SASAKI Y, 1990, JPN J CANCER RES, V81, P196, DOI 10.1111/j.1349-7006.1990.tb02548.x
   SCHILCHER RB, 1984, CANCER CHEMOTH PHARM, V13, P186, DOI 10.1007/BF00269026
   VERWEIJ J, 1986, J CANCER RES CLIN, V112, P283, DOI 10.1007/BF00395925
   WAKAKI S., 1958, ANTIBIOT AND CHEMOTHER, V8, P228
   Zubrod CG., 1960, J CHRON DIS, V11, P7, DOI DOI 10.1016/0021-9681(60)90137-5
NR 16
TC 15
Z9 15
U1 0
U2 5
PU JAPANESE CANCER ASSOCIATION
PI TOKYO
PA EDITORIAL OFFICE 7TH FLOOR, JOHKOH BLDG 2-23-11, KOISHIKAWA, TOKYO 112,
   JAPAN
SN 0910-5050
J9 JPN J CANCER RES
JI Jpn. J. Cancer Res.
PD DEC
PY 1992
VL 83
IS 12
BP 1382
EP 1385
DI 10.1111/j.1349-7006.1992.tb02773.x
PG 4
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA KD921
UT WOS:A1992KD92100023
PM 1336497
OA Green Published
DA 2024-02-19
ER

PT J
AU Guo, MW
   Zhang, J
   Ma, Y
   Zhu, ZZ
   Zuo, H
   Yao, J
   Wu, X
   Wang, DM
   Yu, J
   Meng, MY
   Liu, CZ
   Zhang, Y
   Chen, JR
   Lu, J
   Ding, SZ
   Hu, C
   Ma, XR
   Xu, LY
AF Guo, Mingwei
   Zhang, Jun
   Ma, Ying
   Zhu, Zhenzhong
   Zuo, Hui
   Yao, Jing
   Wu, Xia
   Wang, Dongmei
   Yu, Jian
   Meng, Meiyao
   Liu, Caizhi
   Zhang, Yi
   Chen, Jiangrong
   Lu, Jian
   Ding, Shuzhe
   Hu, Cheng
   Ma, Xinran
   Xu, Lingyan
TI AAV-Mediated nuclear localized PGC1α4 delivery in muscle ameliorates
   sarcopenia and aging-associated metabolic dysfunctions
SO AGING CELL
LA English
DT Article; Early Access
DE aging; metabolic dysfunctions; nuclear localization; PGC1 & alpha;4;
   sarcopenia
ID SKELETAL-MUSCLE; GENE-EXPRESSION; EXERCISE; HYPERTROPHY; ATROPHY;
   OBESITY; FAMILY; YOUNG; MASS
AB Sarcopenia is characterized of muscle mass loss and functional decline in elder individuals which severely affects human physical activity, metabolic homeostasis, and life quality. Physical exercise is considered effective in combating muscle atrophy and sarcopenia, yet it is not feasible to elders with limited mobility. PGC-1a4, a short isoform of PGC-1a, is strongly induced in muscle under resistance training, and promotes muscle hypertrophy. In the present study, we showed that the transcriptional levels and nuclear localization of PGC1a4 was reduced during aging, accompanied with muscle dystrophic morphology, and gene programs. We thus designed NLS-PGC1a4 and ectopically express it in myotubes to enhance PGC1a4 levels and maintain its location in nucleus. Indeed, NLS-PGC1a4 overexpression increased muscle sizes in myotubes. In addition, by utilizing AAV-NLS-PGC1a4 delivery into gastrocnemius muscle, we found that it could improve sarcopenia with grip strength, muscle weights, fiber size and molecular phenotypes, and alleviate age-associated adiposity, insulin resistance and hepatic steatosis, accompanied with altered gene signatures. Mechanistically, we demonstrated that NLS-PGC-1a4 improved insulin signaling and enhanced glucose uptake in skeletal muscle. Besides, via RNA-seq analysis, we identified myokines IGF1 and METRNL as potential targets of NLS-PGC-1a4 that possibly mediate the improvement of muscle and adipose tissue functionality and systemic energy metabolism in aged mice. Moreover, we found a negative correlation between PGC1a4 and age in human skeletal muscle. Together, our results revealed that NLS-PGC1a4 overexpression improves muscle physiology and systematic energy homeostasis during aging and suggested it as a potent therapeutic strategy against sarcopenia and aging-associated metabolic diseases.
C1 [Guo, Mingwei; Zhang, Jun; Ma, Ying; Zuo, Hui; Yao, Jing; Wu, Xia; Wang, Dongmei; Yu, Jian; Meng, Meiyao; Chen, Jiangrong; Ma, Xinran; Xu, Lingyan] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China.
   [Guo, Mingwei; Zhang, Jun; Ma, Ying; Zuo, Hui; Yao, Jing; Wu, Xia; Wang, Dongmei; Yu, Jian; Meng, Meiyao; Chen, Jiangrong; Ma, Xinran; Xu, Lingyan] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China.
   [Zhu, Zhenzhong] Shanghai Jiao Tong Univ, Peoples Hosp 6, Sch Med, Dept Orthoped, Shanghai, Peoples R China.
   [Yu, Jian; Liu, Caizhi; Hu, Cheng; Ma, Xinran] Southern Med Univ, Fengxian Cent Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China.
   [Liu, Caizhi; Zhang, Yi; Hu, Cheng] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Shanghai Clin Ctr Diabet, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China.
   [Lu, Jian; Ding, Shuzhe] East China Normal Univ, Coll Phys Educ & Hlth, Key Lab Adolescent Hlth Assessment & Exercise Inte, Minist Educ, Shanghai, Peoples R China.
   [Ma, Xinran] East China Normal Univ, Shanghai Frontiers Sci Ctr Genome Editing & Cell T, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China.
   [Ma, Xinran] East China Normal Univ, Chongqing Key Lab Precis Opt, Chongqing Inst, Chongqing, Peoples R China.
C3 East China Normal University; East China Normal University; Shanghai
   Jiao Tong University; Southern Medical University - China; Shanghai Jiao
   Tong University; East China Normal University; East China Normal
   University; East China Normal University
RP Ma, XR; Xu, LY (corresponding author), East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China.; Hu, C (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Shanghai Clin Ctr Diabet, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China.; Ma, XR (corresponding author), East China Normal Univ, Chongqing Key Lab Precis Opt, Chongqing Inst, Chongqing, Peoples R China.
EM alfredhc@sjtu.edu.cn; xrma@bio.ecnu.edu.cn; lyxu@bio.ecnu.edu.cn
RI wang, xi/JNT-5162-2023; Lin, Kuan-Yu/JXM-6653-2024; xu,
   lingzhi/JVZ-8748-2024; Hu, Cheng/C-3346-2008
OI Guo, Mingwei/0000-0001-8081-6912; Zhang, Yi/0009-0007-7340-3619; Hu,
   Cheng/0000-0003-4314-2386
FU Fundamental Research Funds for the Central Universities, ECNU public
   platform for Innovation [011]; National Key Research and~Development
   Program of China [2019YFA0904500]; National Natural Science Foundation
   of China [32022034, 32071148, 32222024, 32271224]; Natural Science
   Foundation of Chongqing, China [CSTB2022NSCQ-JQX0033]; Science and
   Technology Commission of Shanghai Municipality [21140904300]
FX Fundamental Research Funds for the Central Universities, ECNU public
   platform for Innovation, Grant/Award Number: 011; National Key Research
   and & nbsp;Development Program of China, Grant/Award Number:
   2019YFA0904500; National Natural Science Foundation of China,
   Grant/Award Number: 32022034, 32071148, 32222024 and 32271224; Natural
   Science Foundation of Chongqing, China, Grant/Award Number:
   CSTB2022NSCQ-JQX0033; Science and Technology Commission of Shanghai
   Municipality, Grant/Award Number: 21140904300
CR Al Saif A, 2015, J PHYS THER SCI, V27, P1697, DOI 10.1589/jpts.27.1697
   Bordeaux R, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00535
   Brown JL, 2017, ACTA PHYSIOL, V220, P275, DOI 10.1111/apha.12826
   Bulaklak K, 2018, MOL THER-NUCL ACIDS, V12, P283, DOI 10.1016/j.omtn.2018.05.011
   Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106
   Colleluori G, 2019, CELL METAB, V30, P261, DOI 10.1016/j.cmet.2019.06.008
   Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9
   Dasarathy S, 2016, J HEPATOL, V65, P1232, DOI 10.1016/j.jhep.2016.07.040
   Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78
   Gundersen K, 2011, BIOL REV, V86, P564, DOI 10.1111/j.1469-185X.2010.00161.x
   Hu YP, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.642000
   Koh JH, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-30056-6
   Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017
   Léveillé M, 2020, MOL METAB, V34, P72, DOI 10.1016/j.molmet.2020.01.004
   Li J, 2021, MOL THER, V29, P1102, DOI 10.1016/j.ymthe.2020.12.002
   Li J, 2020, MOL THER, V28, P1359, DOI 10.1016/j.ymthe.2020.03.005
   Li ZQ, 2023, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1098570
   Lim CKW, 2020, MOL THER, V28, P1177, DOI 10.1016/j.ymthe.2020.01.005
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   Martinez-Redondo V, 2016, J BIOL CHEM, V291, P15169, DOI 10.1074/jbc.M115.705822
   Martínez-Redondo V, 2015, DIABETOLOGIA, V58, P1969, DOI 10.1007/s00125-015-3671-z
   Miller Karl N, 2019, Curr Opin Endocr Metab Res, V5, P37, DOI 10.1016/j.coemr.2019.02.002
   Nance ME, 2019, MOL THER, V27, P1568, DOI 10.1016/j.ymthe.2019.06.012
   Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49
   Petrocelli JJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228650
   Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2
   Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065
   Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009
   Rodríguez-Fdez S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19489-z
   Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   Sakuma K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721219
   Sartori R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20123-1
   Tabebordbar M, 2021, CELL, V184, P4919, DOI 10.1016/j.cell.2021.08.028
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   Vainshtein A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134759
   Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104
   Wei YD, 2016, MOL THER, V24, P1889, DOI 10.1038/mt.2016.192
   Wen XY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/402175
   White JP, 2014, P NATL ACAD SCI USA, V111, P15756, DOI 10.1073/pnas.1417898111
   Winbanks CE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac4976
   Yoshida T, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9091970
   Yoshioka T, 2009, BIOCHEM BIOPH RES CO, V381, P537, DOI 10.1016/j.bbrc.2009.02.077
   Yu G, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abf3136
   Yue YP, 2015, HUM MOL GENET, V24, P5880, DOI 10.1093/hmg/ddv310
   Zhang AQ, 2018, J CACHEXIA SARCOPENI, V9, P755, DOI 10.1002/jcsm.12296
   Zhang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29551
   Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556
   Zhou WH, 2018, ANGEW CHEM INT EDIT, V57, P10268, DOI 10.1002/anie.201806941
NR 50
TC 0
Z9 0
U1 10
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2023 OCT
PY 2023
VL 22
IS 10
DI 10.1111/acel.13961
EA AUG 2023
PG 17
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA U5HL2
UT WOS:001049910100001
PM 37584432
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Costa, E
   Fernandes, J
   Ribeiro, S
   Sereno, J
   Garrido, P
   Rocha-Pereira, P
   Coimbra, S
   Catarino, C
   Belo, L
   Bronze-da-Rocha, E
   Vala, H
   Alves, R
   Reis, F
   Santos-Silva, A
AF Costa, Elisio
   Fernandes, Joao
   Ribeiro, Sandra
   Sereno, Jose
   Garrido, Patricia
   Rocha-Pereira, Petronila
   Coimbra, Susana
   Catarino, Cristina
   Belo, Luis
   Bronze-da-Rocha, Elsa
   Vala, Helena
   Alves, Rui
   Reis, Flavio
   Santos-Silva, Alice
TI Aging is Associated with Impaired Renal Function, INF-gamma Induced
   Inflammation and with Alterations in Iron Regulatory Proteins Gene
   Expression
SO AGING AND DISEASE
LA English
DT Article
DE Anemia; older population; elderly; renal failure; inflammation;
   erythropoietic disturbances
ID ANEMIA; ERYTHROPOIETIN; OLDER; HEPCIDIN; AGE
AB Our aim was to contribute to a better understanding of the pathophysiology of anemia in elderly, by studying how aging affects renal function, iron metabolism, erythropoiesis and the inflammatory response, using an experimental animal model. The study was performed in male Wistar, a group of young rats with 2 months age and an old one with 18 months age. Old rats presented a significant higher urea, creatinine, interferon (INF)-gamma, ferritin and soluble transferrin receptor serum levels, as well as increased counts of reticulocytes and RDW. In addition, these rats showed significant lower erythropoietin (EPO) and iron serum levels. Concerning gene expression of iron regulatory proteins, old rats presented significantly higher mRNA levels of hepcidin (Hamp), transferrin (TF), transferrin receptor 2 (TfR2) and hemojuvelin (HJV); divalent metal transporter 1 (DMT1) mRNA levels were significantly higher in duodenal tissue; EPO gene expression was significantly higher in liver and lower in kidney, and the expression of the EPOR was significantly higher in both liver and kidney. Our results showed that aging is associated with impaired renal function, which could be in turn related with the inflammatory process and with a decline in EPO renal production. Moreover, we also propose that aging may be associated with INF-gamma-induced inflammation and with alterations upon iron regulatory proteins gene expression.
C1 [Costa, Elisio; Ribeiro, Sandra; Catarino, Cristina; Belo, Luis; Bronze-da-Rocha, Elsa; Santos-Silva, Alice] Univ Porto, Fac Farm, Dept Ciencias Biol, Lab Bioquim, P-4050313 Oporto, Portugal.
   [Costa, Elisio; Fernandes, Joao; Ribeiro, Sandra; Rocha-Pereira, Petronila; Coimbra, Susana; Catarino, Cristina; Belo, Luis; Bronze-da-Rocha, Elsa; Santos-Silva, Alice] Univ Porto, Inst Biol Mol & Celular, P-4050313 Oporto, Portugal.
   [Fernandes, Joao; Sereno, Jose; Garrido, Patricia; Reis, Flavio] Univ Coimbra, Fac Med, Inst Imagem Biomed & Ciencias Vida, Lab Farmacol & Terapeut Expt, Coimbra, Portugal.
   [Rocha-Pereira, Petronila] Univ Beira Interior, Ctr Invest Ciencias Saude, Covilha, Portugal.
   [Coimbra, Susana] Inst Res & Adv Training Hlth Sci & Technol, CESPU, Gandhinagar Prd, Portugal.
   [Vala, Helena] Inst Politecn Viseu, Escola Super Agr Viseu, Viseu, Portugal.
   [Vala, Helena] Inst Politecn Viseu, Ctr Estudos Educ Tecnol & Saude, Viseu, Portugal.
   [Alves, Rui] CHUC, Dept Nefrol, Coimbra, Portugal.
   [Alves, Rui] Univ Coimbra, Fac Med, Coimbra, Portugal.
C3 Universidade do Porto; Universidade do Porto; Universidade de Coimbra;
   Universidade da Beira Interior; Instituto Politecnico de Viseu;
   Instituto Politecnico de Viseu; Universidade de Coimbra; Universidade de
   Coimbra
RP Costa, E (corresponding author), Univ Porto, Fac Farm, Dept Ciencias Biol, Lab Bioquim, P-4050313 Oporto, Portugal.
EM emcosta@ff.up.pt
RI Coimbra, Susana/K-4466-2013; Santos-Silva, Alice/AAC-7082-2020;
   Santos-Silva, Alice/K-2326-2013; Catarino, Cristina/K-5492-2013; Alves,
   Rui/N-2759-2013; Reis, Flávio/E-7077-2016; Rocha-Pereira,
   Petronila/K-3102-2013; Bronze-da-Rocha, Elsa M R/K-2723-2013; Fernandes,
   Joao C/AAF-2091-2019; Fernandes, João/IUN-2117-2023; Belo, Luís
   FBA/K-5878-2013; Catarino, Cristina/AFM-2226-2022; Costa, Elisio
   MS/K-1990-2013
OI Coimbra, Susana/0000-0001-8411-8038; Santos-Silva,
   Alice/0000-0002-2565-3169; Santos-Silva, Alice/0000-0002-2565-3169;
   Catarino, Cristina/0000-0002-3229-1434; Alves, Rui/0000-0003-3922-3618;
   Reis, Flávio/0000-0003-3401-9554; Rocha-Pereira,
   Petronila/0000-0002-7985-1494; Bronze-da-Rocha, Elsa M
   R/0000-0002-3571-2513; Fernandes, Joao C/0000-0003-1556-1698; Belo, Luís
   FBA/0000-0002-3941-6850; Costa, Elisio MS/0000-0003-1158-1480; Sereno,
   Jose/0000-0002-9607-6653; Vala, Helena/0000-0001-6829-4867; Garrido,
   Patricia/0000-0002-0457-6790
CR Beerman I, 2010, CURR OPIN IMMUNOL, V22, P500, DOI 10.1016/j.coi.2010.06.007
   Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046
   Ble A, 2005, ARCH INTERN MED, V165, P2222, DOI 10.1001/archinte.165.19.2222
   Dukkipati R, 2008, DRUG AGING, V25, P241, DOI 10.2165/00002512-200825030-00006
   Feng Q, 2012, AM J PHYSIOL-GASTR L, V302, pG1397, DOI 10.1152/ajpgi.00020.2012
   Ferrucci L, 2008, SEMIN HEMATOL, V45, P242, DOI 10.1053/j.seminhematol.2008.06.001
   Ferrucci L, 2007, BRIT J HAEMATOL, V136, P849, DOI 10.1111/j.1365-2141.2007.06502.x
   Ferrucci Luigi, 2005, Am J Med, V118, P1288
   Ferrucci L, 2010, BLOOD, V115, P3810, DOI 10.1182/blood-2009-02-201087
   Fleming RE, 2006, P NATH ACAD US, V98, P8160
   Friedman J, 2008, BLOOD, V112, P1182, DOI 10.1182/blood.V112.11.3445.3445
   Garrido P, 2010, OPEN DRUG DISCOVERY, V2, P25
   GOODNOUGH LT, 1995, J LAB CLIN MED, V126, P57
   Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812
   Hediger MA, 2002, NATURE, V417, P393, DOI 10.1038/417393a
   KARIO K, 1991, GERONTOLOGY, V37, P345
   KARIO K, 1992, AM J HEMATOL, V41, P252, DOI 10.1002/ajh.2830410406
   Libregts SF, 2011, BLOOD, V118, P2578, DOI 10.1182/blood-2010-10-315218
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111
   Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945
   Patel KV, 2008, SEMIN HEMATOL, V45, P210, DOI 10.1053/j.seminhematol.2008.06.006
   Riva E, 2009, HAEMATOL-HEMATOL J, V94, P22, DOI 10.3324/haematol.13449
   ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155
   Teixeira M, 2012, J PHARM BIOALLIED SC, V4, P76, DOI 10.4103/0975-7406.92743
   Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631
   Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214
NR 27
TC 17
Z9 18
U1 0
U2 8
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
J9 AGING DIS
JI Aging Dis.
PD DEC
PY 2014
VL 5
IS 6
BP 356
EP 365
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AW5BR
UT WOS:000346291500001
PM 25489488
DA 2024-02-19
ER

PT J
AU Tachibana, M
   Shinohara, M
   Yamazaki, Y
   Liu, CC
   Rogers, J
   Bu, GJ
   Kanekiyo, T
AF Tachibana, Masaya
   Shinohara, Mitsuru
   Yamazaki, Yu
   Liu, Chia-Chen
   Rogers, Justin
   Bu, Guojun
   Kanekiyo, Takahisa
TI Rescuing effects of RXR agonist bexarotene on aging-related synapse loss
   depend on neuronal LRP1
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Aging; apoE; Synapse; Retinoid; Nuclear receptor; LRP1; RXR agonist;
   Bexarotene
ID AD MOUSE MODELS; T-CELL LYMPHOMA; RECEPTOR-RELATED PROTEIN-1;
   APOLIPOPROTEIN-E; REVERSE DEFICITS; ALZHEIMERS-DISEASE; X-RECEPTOR;
   NUCLEAR RECEPTORS; SPATIAL MEMORY; IN-VIVO
AB Apolipoprotein E (apoE) plays a critical role in maintaining synaptic integrity by transporting cholesterol to neurons through the low-density lipoprotein receptor related protein-1 (LRP1). Bexarotene, a retinoid X receptor (RXR) agonist, has been reported to have potential beneficial effects on cognition by increasing brain apoE levels and lipidation. To investigate the effects of bexarotene on aging-related synapse loss and the contribution of neuronal LRP1 to the pathway, forebrain neuron-specific LRP1 knockout (nLrp1(-/-)) and littermate control mice were administered with bexarotene-formulated diet (100 mg/kg/day) or control diet at the age of 20-24 months for 8 weeks. Upon bexarotene treatment, levels of brain apoE and ATP-binding cassette sub-family A member 1 (ABCA1) were significantly increased in both mice. While levels of PSD95, glutamate receptor 1 (GluR1), and N-methyl-D-aspartate receptor NR1 subunit (NR1), which are key postsynaptic proteins that regulate synaptic plasticity, were decreased with aging, they were restored by bexarotene treatment in the brains of control but not nLrp1(-/-) mice. These results indicate that the beneficial effects of bexarotene on synaptic integrity depend on the presence of neuronal LRP1. However, we also found that bexarotene treatment led to the activation of glial cells, weight loss and hepatomegaly, which are likely due to hepatic failure. Taken together, our results demonstrate that apoE-targeted treatment through the RXR pathway has a potential beneficial effect on synapses during aging; however, the therapeutic application of bexarotene requires extreme caution due to its toxic side effects. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Tachibana, Masaya; Shinohara, Mitsuru; Yamazaki, Yu; Liu, Chia-Chen; Rogers, Justin; Bu, Guojun; Kanekiyo, Takahisa] Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.
C3 Mayo Clinic
RP Bu, GJ; Kanekiyo, T (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.
EM bu.guojun@mayo.edu; kanekiyo.takahisa@mayo.edu
RI Tachibana, Masaya/AAW-3526-2020; Yamazaki, Yu/HSG-5881-2023; Bu,
   Guojun/JCO-1472-2023
OI Tachibana, Masaya/0000-0002-6761-7158; Yamazaki, Yu/0000-0002-0806-4960;
   Liu, Chia-Chen/0000-0001-7203-3926
FU NIH [R01AG035355, R01AG046205, R01AG027924, P50AG016574, P01NS074969];
   Alzheimer's Association [2014NIRG304190]
FX This work was supported by NIH grants R01AG035355, R01AG046205,
   R01AG027924, P50AG016574 and P01NS074969 (to G.B.), and a New
   Investigator Research Grant from the Alzheimer's Association
   2014NIRG304190 (to T. K). The authors thank Mary D. Davis for careful
   reading of the manuscript.
CR A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018
   BAHR BA, 1992, BRAIN RES, V589, P320, DOI 10.1016/0006-8993(92)91293-N
   Bardou I, 2013, NEUROBIOL AGING, V34, P2293, DOI 10.1016/j.neurobiolaging.2013.03.034
   Bezprozvanny I, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-23
   Boehm-Cagan A, 2014, J NEUROSCI, V34, P7293, DOI 10.1523/JNEUROSCI.5198-13.2014
   Brothers HM, 2013, J NEUROIMMUNE PHARM, V8, P1098, DOI 10.1007/s11481-013-9476-2
   Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620
   Butterworth RF, 2013, NAT REV GASTRO HEPAT, V10, P522, DOI 10.1038/nrgastro.2013.99
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Clayton DA, 2002, J BIOL CHEM, V277, P14367, DOI 10.1074/jbc.C200074200
   Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697
   Cruchaga C, 2012, HUM MOL GENET, V21, P4558, DOI 10.1093/hmg/dds296
   Ledesma MD, 2012, PROG LIPID RES, V51, P23, DOI 10.1016/j.plipres.2011.11.004
   Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010
   Duvic M, 2001, J CLIN ONCOL, V19, P2456, DOI 10.1200/JCO.2001.19.9.2456
   Elgamal SA, 2011, CAN GERIATR J, V14, P66, DOI 10.5770/cgj.v14i3.17
   Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012
   Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809
   Gan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113237
   Gong JS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-9
   Gregoriou S, 2013, J CUTAN MED SURG, V17, P52, DOI 10.2310/7750.2012.12022
   Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323
   Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040
   Jayakumar AR, 2015, J CLIN EXP HEPATOL, V5, pS21, DOI 10.1016/j.jceh.2014.07.006
   Kanekiyo T, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00093
   Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045
   Kang BY, 2000, BRIT J PHARMACOL, V130, P581, DOI 10.1038/sj.bjp.0703345
   LaClair KD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-18
   Lefterov I, 2015, NEUROBIOL DIS, V82, P132, DOI 10.1016/j.nbd.2015.05.019
   Liang Y, 2004, J NEUROCHEM, V88, P623, DOI 10.1111/j.1471-4159.2004.02183.x
   Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263
   Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008
   Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010
   Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354
   May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004
   Mehta N, 2012, CL LYMPH MYELOM LEUK, V12, P20, DOI 10.1016/j.clml.2011.06.016
   Nakajima C, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444364
   Pereira AC, 2014, P NATL ACAD SCI USA, V111, P18733, DOI 10.1073/pnas.1421285111
   Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x
   Petralia RS, 2014, AGEING RES REV, V14, P31, DOI 10.1016/j.arr.2014.01.003
   Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089
   Reinvang I, 2010, NEUROPSYCHOLOGIA, V48, P566, DOI 10.1016/j.neuropsychologia.2009.10.018
   Scarisbrick JJ, 2013, BRIT J DERMATOL, V168, P192, DOI 10.1111/bjd.12042
   Shinohara M, 2013, ACTA NEUROPATHOL, V125, P535, DOI 10.1007/s00401-013-1086-9
   Sodero AO, 2011, J NEUROCHEM, V116, P747, DOI 10.1111/j.1471-4159.2010.07079.x
   Sonntag WE, 2000, BRAIN RES BULL, V51, P331, DOI 10.1016/S0361-9230(99)00259-2
   Sparkman NL, 2008, NEUROIMMUNOMODULAT, V15, P323, DOI 10.1159/000156474
   Sussman F, 2005, J MED CHEM, V48, P6212, DOI 10.1021/jm050285w
   Szanto A, 2004, CELL DEATH DIFFER, V11, pS126, DOI 10.1038/sj.cdd.4401533
   Tai LM, 2014, J BIOL CHEM, V289, P30538, DOI 10.1074/jbc.M114.600833
   Tesseur I, 2013, SCIENCE, V340, DOI 10.1126/science.1233937
   Tesseur I, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt218
   Uchimura K, 2001, HEPATOLOGY, V33, P91, DOI 10.1053/jhep.2001.21145
   Ulrich JD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-13
   Väkevä L, 2012, ACTA DERM-VENEREOL, V92, P258, DOI 10.2340/00015555-1359
   van Vliet P, 2012, J ALZHEIMERS DIS, V30, pS147, DOI 10.3233/JAD-2011-111028
   VanGuilder HD, 2010, J NEUROCHEM, V113, P1577, DOI 10.1111/j.1471-4159.2010.06719.x
   Veeraraghavalu K, 2013, SCIENCE, V340, DOI 10.1126/science.1235505
   von Bohlen und Halbach O, 2006, J NEUROSCI RES, V83, P525, DOI 10.1002/jnr.20759
   WHO, 2014, WORLD HLTH STAT 2014
   Zehnder AE, 2009, INT J GERIATR PSYCH, V24, P132, DOI 10.1002/gps.2080
   Zhao J, 2014, J BIOL CHEM, V289, P11282, DOI 10.1074/jbc.M113.526095
NR 62
TC 42
Z9 43
U1 0
U2 14
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD MAR
PY 2016
VL 277
BP 1
EP 9
DI 10.1016/j.expneurol.2015.12.003
PG 9
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DF2ST
UT WOS:000371194800001
PM 26688581
OA Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Puech, A
   Dupressoir, A
   Loireau, MP
   Mattei, MG
   Heidmann, T
AF Puech, A
   Dupressoir, A
   Loireau, MP
   Mattei, MG
   Heidmann, T
TI Characterization of two age-induced intracisternal A-particle-related
   transcripts in the mouse liver - Transcriptional read-through into an
   open reading frame with similarities to the yeast CCR4 transcription
   factor
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HUMAN ENDOGENOUS RETROVIRUS; MESSENGER-RNAS; SACCHAROMYCES-CEREVISIAE;
   INDUCED ERYTHROBLASTOSIS; DEPENDENT EXPRESSION; NUCLEOTIDE-SEQUENCE;
   GENE-EXPRESSION; ACTIVATION; VIRUS; METHYLATION
AB Intracisternal A-particle (IAP) sequences are endogenous retrovirus-like elements present at 1,000 copies in the mouse genome, We had previously identified IAP-related transcripts of unusual size (6 and 10 kilobases (kb)), which are observed exclusively in the liver of the aging mouse. In this report, using cDNA libraries that we have constructed from the liver mRNAs of an aged DBA/2 mouse, we have cloned and entirely sequenced the corresponding cDNAs, Both are initiated within the 5' long terminal repeat of a type I Delta 1 IAP sequence, and correspond to a read-through into a unique flanking cellular sequence containing a 966-nucleotide open reading frame, located 3' to the IAP sequence, The 6-kb IAP-related transcript corresponds to a post-transcriptional modification of the 10-kb mRNA, and is generated by a splicing event with the donor site in the IAP sequence, and the acceptor site 5' to the open reading frame. This open reading frame is located on chromosome 3, is evolutionarily conserved, and discloses significant similarity to the yeast CCR4 transcription factor at the amino acid level, The specific expression of these age-induced transcripts, which account for more than 50% of the IAP-related transcripts in the liver of old mice, is therefore entirely consistent with the induction of a single genomic locus, thus strengthening the importance of position effects for the expression of transposable elements, Characterization of this locus should now allow studies on its chromatin and methylation status, and on the ''molecular factors of senescence'' possibly involved in its induction.
C1 INST GUSTAVE ROUSSY,UNITE PHYSICOCHIM & PHARMACOL MACROMOL BIOL,CNRS URA 147,F-94805 VILLEJUIF,FRANCE.
   FAC MED MARSEILLE,INSERM U406,UNITE GENET MED & DEV,F-13385 MARSEILLE,FRANCE.
C3 UNICANCER; Gustave Roussy; Aix-Marseille Universite; Institut National
   de la Sante et de la Recherche Medicale (Inserm)
RI PUECH, Anne/A-7470-2013; Dupressoir, Anne/M-5280-2018
OI Dupressoir, Anne/0000-0002-3464-8513
CR [Anonymous], 1989, MOL CLONING LAB MANU
   BENSON S A, 1984, Biotechniques, V2, P66
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   Coffin J.M., 1992, RETROVIRIDAE, P19
   DEAN RG, 1985, ARCH GERONTOL GERIAT, V4, P43, DOI 10.1016/0167-4943(85)90017-2
   DESSEN P, 1990, COMPUT APPL BIOSCI, V6, P355
   DRAPER MP, 1994, MOL CELL BIOL, V14, P4522, DOI 10.1128/MCB.14.7.4522
   DRAPER MP, 1995, MOL CELL BIOL, V15, P3487
   Dupressoir A, 1996, MOL CELL BIOL, V16, P4495
   Dupressoir A, 1995, BBA-GENE STRUCT EXPR, V1264, P397, DOI 10.1016/0167-4781(95)00181-6
   FEUCHTERMURTHY AE, 1993, NUCLEIC ACIDS RES, V21, P135, DOI 10.1093/nar/21.1.135
   FLORINE DL, 1980, CANCER RES, V40, P519
   GAUBATZ JW, 1991, MECH AGEING DEV, V57, P71, DOI 10.1016/0047-6374(91)90025-U
   GONDA TJ, 1987, J VIROL, V61, P2754, DOI 10.1128/JVI.61.9.2754-2763.1987
   GOODWIN RG, 1986, MOL CELL BIOL, V6, P3128, DOI 10.1128/MCB.6.9.3128
   HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M
   Jazwinski SM, 1996, SCIENCE, V273, P54, DOI 10.1126/science.273.5271.54
   KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3
   KASS SU, 1993, MOL CELL BIOL, V13, P7372, DOI 10.1128/MCB.13.12.7372
   KATO N, 1990, MOL CELL BIOL, V10, P4401, DOI 10.1128/MCB.10.8.4401
   KATO N, 1987, J VIROL, V61, P2182, DOI 10.1128/JVI.61.7.2182-2191.1987
   KRAYEV AS, 1980, NUCLEIC ACIDS RES, V8, P1201, DOI 10.1093/nar/8.6.1201
   KRAYEV AS, 1982, NUCLEIC ACIDS RES, V10, P7461, DOI 10.1093/nar/10.23.7461
   KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7
   KUFF EL, 1990, CANCER CELL-MON REV, V2, P398
   LESLIE KB, 1991, MOL CELL BIOL, V11, P5562, DOI 10.1128/MCB.11.11.5562
   LIU AY, 1991, CANCER RES, V51, P4107
   LUEDERS KK, 1986, NUCLEIC ACIDS RES, V14, P1495, DOI 10.1093/nar/14.3.1495
   LUEDERS KK, 1993, MOL CELL BIOL, V13, P7439, DOI 10.1128/MCB.13.12.7439
   LUEDERS KK, 1987, GENE, V52, P139, DOI 10.1016/0378-1119(87)90040-0
   MALVAR T, 1992, GENETICS, V132, P951
   MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038
   MAYSHOOPES L, 1986, DEV GENET, V7, P65, DOI 10.1002/dvg.1020070202
   MAYSHOOPES LL, 1983, MOL CELL BIOL, V3, P1371, DOI 10.1128/MCB.3.8.1371
   MIETZ JA, 1992, MOL CELL BIOL, V12, P220, DOI 10.1128/MCB.12.1.220
   MOUNTZ JD, 1993, IMMUNOL TODAY, V14, P532, DOI 10.1016/0167-5699(93)90182-K
   NILSEN TW, 1985, CELL, V41, P719, DOI 10.1016/S0092-8674(85)80052-0
   REUSS FU, 1991, J VIROL, V65, P5702, DOI 10.1128/JVI.65.11.5702-5709.1991
   SHENONG GLC, 1982, J VIROL, V42, P411, DOI 10.1128/JVI.42.2.411-421.1982
   SHENONG GLC, 1986, MOL CELL BIOL, V6, P380, DOI 10.1128/MCB.6.2.380
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   VOJTA PJ, 1995, BBA-REV CANCER, V1242, P29, DOI 10.1016/0304-419X(95)00002-W
   YMER S, 1986, NUCLEIC ACIDS RES, V14, P5901, DOI 10.1093/nar/14.14.5901
NR 45
TC 18
Z9 22
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 28
PY 1997
VL 272
IS 9
BP 5995
EP 6003
DI 10.1074/jbc.272.9.5995
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA WK747
UT WOS:A1997WK74700089
PM 9038221
OA hybrid
DA 2024-02-19
ER

PT J
AU Suzui, N
   Yoshimi, N
   Kawabata, K
   Mori, H
AF Suzui, N
   Yoshimi, N
   Kawabata, K
   Mori, H
TI The telomerase activities in several organs and strains of rats with
   ageing
SO LABORATORY ANIMALS
LA English
DT Article
DE rat; telomerase; TRAP assay
ID HUMAN SKIN; CELLS; TISSUES; ACTIVATION; CARCINOMA; MOUSE;
   CARCINOGENESIS; LYMPHOCYTES; REPEAT; COLON
AB Telomerase activity is known to be implicated both in cell immortalization and carcinogenesis. Telomerase activity has not been detected in most human somatic tissues. However, we previously confirmed that the activity is present both in methylazoxymethanol acetate-induced rat colonic adenocarcinoma and non-treated colonic mucosa, presumably indicating the tissue-specific activity of the enzyme in rats. To determine the standard activity of rat telomerase in various organs in relation to differences in sex, age and strain, we examined the activity by using the telomeric repeat amplification protocol (TRAP) assay. The testis, liver, and colon mucosa showed the activity. The brain had very low or negative activity in 5-week-old male rats of the F344, SD, Wistar, Donryu or ACI strains. Age (5-week-old and 9-month-old) or sex difference for the activity was not apparent in rats of these strains. In general, telomerase activity in the fetal brain, liver and kidney was stronger than in the adult organ. The telomerase activity of each organ was different from that of human. This difference may indicate that the rat has a specific mechanism for maintaining the telomeric repeats of the chromosome even in somatic tissues. The basic information resulting from this study may be useful for the study of the role of telomerase in tumorigenesis in animal experiment models.
C1 Gifu Univ, Sch Med, Dept Pathol 1, Gifu 5008705, Japan.
C3 Gifu University
RP Suzui, N (corresponding author), Gifu Univ, Sch Med, Dept Pathol 1, 40 Tsukasamachi, Gifu 5008705, Japan.
CR ALLSHIRE RC, 1988, NATURE, V332, P656, DOI 10.1038/332656a0
   BEDNAREK A, 1995, CANCER RES, V55, P1566
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   CHADENEAU C, 1995, ONCOGENE, V11, P893
   COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   GUTMANN HR, 1972, CANCER RES, V32, P1554
   HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hiyama E, 1996, INT J ONCOL, V9, P453
   HIYAMA K, 1995, J IMMUNOL, V155, P3711
   Igarashi H, 1996, BIOCHEM BIOPH RES CO, V219, P649, DOI 10.1006/bbrc.1996.0288
   ITO N, 1991, CARCINOGENESIS, V12, P1503, DOI 10.1093/carcin/12.8.1503
   KAKUNAGA T, 1978, P NATL ACAD SCI USA, V75, P1334, DOI 10.1073/pnas.75.3.1334
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kinosita R, 1937, Transactions of the Japanese Society for Pathology, V27, P665
   KITAGAWA T, 1973, ANAL EXPT EPIDEMIOLO
   LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393
   MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P
   MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4
   Mutirangura A, 1996, CANCER RES, V56, P3530
   Nakatani K, 1997, CANCER, V80, P471, DOI 10.1002/(SICI)1097-0142(19970801)80:3<471::AID-CNCR15>3.0.CO;2-U
   Poole TB., 1987, UFAW HDB CARE MANAGE
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   REUBER MD, 1976, J NATL CANCER I, V57, P111, DOI 10.1093/jnci/57.1.111
   Shay Jerry W., 1996, Current Opinion in Oncology, V8, P66, DOI 10.1097/00001622-199601000-00012
   SKORYNA SC, 1951, P SOC EXP BIOL MED, V78, P62
   STARLING JA, 1990, NUCLEIC ACIDS RES, V18, P6881, DOI 10.1093/nar/18.23.6881
   TAHARA H, 1995, CANCER RES, V55, P2734
   Taylor RS, 1996, J INVEST DERMATOL, V106, P759, DOI 10.1111/1523-1747.ep12345811
   Ueda M, 1997, CANCER RES, V57, P370
   WEISBURGER JH, 1972, CANCER RES, V32, P491
   Wright WE, 1996, DEV GENET, V18, P173
   Yashima K, 1997, CANCER RES, V57, P2373
   Yoshimi N, 1996, MOL CARCINOGEN, V16, P1, DOI 10.1002/(SICI)1098-2744(199605)16:1<1::AID-MC1>3.0.CO;2-N
NR 37
TC 6
Z9 6
U1 0
U2 1
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1M 8AE, ENGLAND
SN 0023-6772
J9 LAB ANIM
JI Lab. Anim.
PD APR
PY 1999
VL 33
IS 2
BP 149
EP 154
DI 10.1258/002367799780578408
PG 6
WC Veterinary Sciences; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences; Zoology
GA 196AQ
UT WOS:000080287200007
PM 10780818
DA 2024-02-19
ER

PT J
AU Blalock, EM
   Phelps, JT
   Pancani, T
   Searcy, JL
   Anderson, KL
   Gant, JC
   Popovic, J
   Avdiushko, MG
   Cohen, DA
   Chen, KC
   Porter, NM
   Thibault, O
AF Blalock, Eric M.
   Phelps, Jeremiah T.
   Pancani, Tristano
   Searcy, James L.
   Anderson, Katie L.
   Gant, John C.
   Popovic, Jelena
   Avdiushko, Margarita G.
   Cohen, Don A.
   Chen, Kuey-Chu
   Porter, Nada M.
   Thibault, Olivier
TI Effects of Long-Term Pioglitazone Treatment on Peripheral and Central
   Markers of Aging
SO PLOS ONE
LA English
DT Article
ID ACTIVATED-RECEPTOR-GAMMA; NITRIC-OXIDE SYNTHASE; MILD COGNITIVE
   IMPAIRMENT; TRANSIENT FOCAL ISCHEMIA; PPAR-GAMMA; ALZHEIMERS-DISEASE;
   HIPPOCAMPAL-NEURONS; INSULIN-RESISTANCE; SYNAPTIC PLASTICITY; CALCIUM
   HOMEOSTASIS
AB Background: Thiazolidinediones (TZDs) activate peroxisome proliferator-activated receptor gamma (PPAR gamma) and are used clinically to help restore peripheral insulin sensitivity in Type 2 diabetes (T2DM). Interestingly, long-term treatment of mouse models of Alzheimer's disease (AD) with TZDs also has been shown to reduce several well-established brain biomarkers of AD including inflammation, oxidative stress and A beta accumulation. While TZD's actions in AD models help to elucidate the mechanisms underlying their potentially beneficial effects in AD patients, little is known about the functional consequences of TZDs in animal models of normal aging. Because aging is a common risk factor for both AD and T2DM, we investigated whether the TZD, pioglitazone could alter brain aging under non-pathological conditions.
   Methods and Findings: We used the F344 rat model of aging, and monitored behavioral, electrophysiological, and molecular variables to assess the effects of pioglitazone (PIO-Actos (R) a TZD) on several peripheral (blood and liver) and central (hippocampal) biomarkers of aging. Starting at 3 months or 17 months of age, male rats were treated for 4-5 months with either a control or a PIO-containing diet (final dose approximately 2.3 mg/kg body weight/day). A significant reduction in the Ca2+-dependent afterhyperpolarization was seen in the aged animals, with no significant change in long-term potentiation maintenance or learning and memory performance. Blood insulin levels were unchanged with age, but significantly reduced by PIO. Finally, a combination of microarray analyses on hippocampal tissue and serum-based multiplex cytokine assays revealed that age-dependent inflammatory increases were not reversed by PIO.
   Conclusions: While current research efforts continue to identify the underlying processes responsible for the progressive decline in cognitive function seen during normal aging, available medical treatments are still very limited. Because TZDs have been shown to have benefits in age-related conditions such as T2DM and AD, our study was aimed at elucidating PIO's potentially beneficial actions in normal aging. Using a clinically-relevant dose and delivery method, long-term PIO treatment was able to blunt several indices of aging but apparently affected neither age-related cognitive decline nor peripheral/central age-related increases in inflammatory signaling.
C1 [Blalock, Eric M.; Phelps, Jeremiah T.; Pancani, Tristano; Searcy, James L.; Anderson, Katie L.; Gant, John C.; Popovic, Jelena; Chen, Kuey-Chu; Porter, Nada M.; Thibault, Olivier] Univ Kentucky, Med Ctr, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.
   [Avdiushko, Margarita G.; Cohen, Don A.] Univ Kentucky, Med Ctr, Dept Microbiol & Immunol, Lexington, KY 40536 USA.
C3 University of Kentucky; University of Kentucky
RP Blalock, EM (corresponding author), Univ Kentucky, Med Ctr, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.
EM othibau@uky.edu
RI Anderson, katie/JEF-4235-2023; Thibault, Olivier/AAY-7614-2020
OI Thibault, Olivier/0000-0002-3548-3466
FU Neurosciences Education and Research Foundation [AG029268, AG0033649,
   NCRR-P20-RR15592]
FX Funding for this work was provided in part by a gift from the
   Neurosciences Education and Research Foundation (OT), and research
   grants AG029268 (OT), AG0033649 (OT) and NCRR-P20-RR15592 (OT). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aenlle KK, 2009, NEUROBIOL AGING, V30, P932, DOI 10.1016/j.neurobiolaging.2007.09.004
   [Anonymous], [No title captured]
   Aoun P, 2003, EUR J PHARMACOL, V472, P65, DOI 10.1016/S0014-2999(03)01867-3
   Arikawa M, 2004, J CARDIOVASC PHARM, V44, P109, DOI 10.1097/00005344-200407000-00015
   Asano M, 1999, BRIT J PHARMACOL, V128, P673, DOI 10.1038/sj.bjp.0702818
   Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875
   Barnes CA, 1996, LEARN MEMORY, V3, P124, DOI 10.1101/lm.3.2-3.124
   BARNES CA, 1985, BEHAV NEUROSCI, V99, P1040, DOI 10.1037/0735-7044.99.6.1040
   Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002
   BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   Bellelli G, 2009, J AM GERIATR SOC, V57, P178, DOI 10.1111/j.1532-5415.2009.02067.x
   Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2
   Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018
   Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003
   Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100
   Blalock EM, 2003, J NEUROSCI, V23, P3807
   BONINI JA, 1995, AM J PHYSIOL-ENDOC M, V269, pE759, DOI 10.1152/ajpendo.1995.269.4.E759
   Boyle PJ, 2002, CLIN THER, V24, P378, DOI 10.1016/S0149-2918(02)85040-8
   Breidert T, 2002, J NEUROCHEM, V82, P615, DOI 10.1046/j.1471-4159.2002.00990.x
   Brunton L., 2005, Goodman and Gilman's The Pharmacological Basis of Therapeutics, VEleventh
   Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006
   Burger C, 2007, NEUROBIOL LEARN MEM, V87, P21, DOI 10.1016/j.nlm.2006.05.003
   Churi SB, 2008, J PAIN, V9, P639, DOI 10.1016/j.jpain.2008.02.002
   Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000
   Dasu MR, 2009, ENDOCRINOLOGY, V150, P3457, DOI 10.1210/en.2008-1757
   de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89
   Deeg MA, 2007, DIABETES CARE, V30, P2458, DOI 10.2337/dc06-1903
   Dehmer T, 2004, J NEUROCHEM, V88, P494, DOI 10.1046/j.1471-4159.2003.02210.x
   DETOLEDOMORRELL L, 1988, NEUROBIOL AGING, V9, P581, DOI 10.1016/S0197-4580(88)80117-9
   DEUPREE DL, 1993, NEUROBIOL AGING, V14, P249, DOI 10.1016/0197-4580(93)90009-Z
   Disterhoft JF, 1996, LIFE SCI, V59, P413, DOI 10.1016/0024-3205(96)00320-7
   Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x
   DRAZNIN B, 1989, ENDOCRINOLOGY, V125, P2341, DOI 10.1210/endo-125-5-2341
   Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071
   Feinstein Douglas L, 2003, Diabetes Technol Ther, V5, P67, DOI 10.1089/152091503763816481
   Fishel MA, 2005, ARCH NEUROL-CHICAGO, V62, P1539, DOI 10.1001/archneur.62.10.1539
   Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x
   GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618
   Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006
   GANT JC, 2008, NEUROBIOL AGING
   García-Bueno B, 2005, BIOL PSYCHIAT, V57, P885, DOI 10.1016/j.biopsych.2005.01.007
   Gemma C, 2004, NEUROREPORT, V15, P2255, DOI 10.1097/00001756-200410050-00023
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gillies PS, 2000, DRUGS, V60, P333, DOI 10.2165/00003495-200060020-00009
   Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje
   Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547
   GOODMAN DG, 1979, TOXICOL APPL PHARM, V48, P237, DOI 10.1016/0041-008X(79)90029-2
   GRADMAN TJ, 1993, J AM GERIATR SOC, V41, P1305, DOI 10.1111/j.1532-5415.1993.tb06480.x
   Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174
   Hauner H, 2002, DIABETES-METAB RES, V18, pS10, DOI 10.1002/dmrr.249
   Heneka MT, 2000, J NEUROSCI, V20, P6862, DOI 10.1523/JNEUROSCI.20-18-06862.2000
   Heneka MT, 1999, J NEUROIMMUNOL, V100, P156, DOI 10.1016/S0165-5728(99)00192-7
   HENEKA MT, 2005, BRAIN
   Heppner TJ, 2005, PHARMACOLOGY, V73, P15, DOI 10.1159/000081070
   HOFMANN C, 1994, ENDOCRINOLOGY, V134, P264, DOI 10.1210/en.134.1.264
   Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016
   Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183
   Huang TJ, 2005, MOL CELL NEUROSCI, V28, P42, DOI 10.1016/j.mcn.2004.08.009
   Huang TJ, 2002, DIABETOLOGIA, V45, P560, DOI 10.1007/s00125-002-0785-x
   Hunter RL, 2008, NEUROSCI LETT, V432, P198, DOI 10.1016/j.neulet.2007.12.019
   Ikeda S, 1998, EUR J PHARMACOL, V357, P243, DOI 10.1016/S0014-2999(98)00557-3
   Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032
   Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184
   Jiang QG, 2008, CNS DRUGS, V22, P1, DOI 10.2165/00023210-200822010-00001
   Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009
   Kamal A, 2003, NEUROSCIENCE, V118, P577, DOI 10.1016/S0306-4522(02)00874-6
   Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802
   KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293
   Kruglikov I, 2004, PFLUG ARCH EUR J PHY, V448, P395, DOI 10.1007/s00424-004-1263-8
   Lacombe P, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-11
   LANDFIELD PW, 1984, SCIENCE, V226, P1089, DOI 10.1126/science.6494926
   Landreth GE, 2001, NEUROBIOL AGING, V22, P937, DOI 10.1016/S0197-4580(01)00296-2
   LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   LEVIN BE, 1983, AM J PHYSIOL, V245, pR364, DOI 10.1152/ajpregu.1983.245.3.R364
   Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000
   Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634
   Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29
   Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210
   Messier C, 2005, NEUROBIOL AGING, V26, pS26, DOI 10.1016/j.neurobiolaging.2005.09.014
   MORGENWECK J, 2009, NEUROPHARMACOLOGY
   Moyer JR, 1996, J NEUROSCI, V16, P5536
   MOYER JR, 1992, J NEUROPHYSIOL, V68, P2100, DOI 10.1152/jn.1992.68.6.2100
   Nakajima T, 1999, CIRCULATION, V99, P2942, DOI 10.1161/01.CIR.99.22.2942
   Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008
   Pancani T, 2009, J NEUROCHEM, V109, P1800, DOI 10.1111/j.1471-4159.2009.06107.x
   Parachikova A, 2007, NEUROBIOL AGING, V28, P1821, DOI 10.1016/j.neurobiolaging.2006.08.014
   Pedersen WA, 2004, NEUROBIOL DIS, V17, P500, DOI 10.1016/j.nbd.2004.08.003
   Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018
   Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668
   Prolla TA, 2002, CHEM SENSES, V27, P299, DOI 10.1093/chemse/27.3.299
   Reagan LP, 2002, INT REV NEUROBIOL, V51, P289, DOI 10.1016/S0074-7742(02)51009-6
   Rex CS, 2005, J NEUROSCI, V25, P5956, DOI 10.1523/JNEUROSCI.0880-05.2005
   Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178
   Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369
   Romera C, 2007, J CEREBR BLOOD F MET, V27, P1327, DOI 10.1038/sj.jcbfm.9600438
   Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0
   Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007
   Ryan CM, 2000, DIABETES-METAB RES, V16, P308, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR141>3.0.CO;2-X
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x
   Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334
   Song JB, 1997, DIABETES, V46, P659, DOI 10.2337/diabetes.46.4.659
   Spanheimer R, 2009, AM J CARDIOL, V104, P234, DOI 10.1016/j.amjcard.2009.03.023
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107
   Storozhevykh TP, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-84
   Stranahan AM, 2008, NEUROBIOL AGING
   Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021
   Szapary PO, 2006, ARTERIOSCL THROM VAS, V26, P182, DOI 10.1161/01.ATV.0000195790.24531.4f
   Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017
   Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x
   Tombaugh GC, 2002, J NEUROSCI, V22, P9932
   Tureyen K, 2007, J NEUROCHEM, V101, P41, DOI 10.1111/j.1471-4159.2006.04376.x
   Uryu S, 2002, BRAIN RES, V924, P229, DOI 10.1016/S0006-8993(01)03242-5
   Victor NA, 2006, EUR J NEUROSCI, V24, P1653, DOI 10.1111/j.1460-9568.2006.05037.x
   Wang XK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-12
   Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950
   Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003
   Yan Q, 2003, J NEUROSCI, V23, P7504
   Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5
   Zhao XR, 2006, BRAIN RES, V1073, P460, DOI 10.1016/j.brainres.2005.12.061
NR 121
TC 36
Z9 40
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 29
PY 2010
VL 5
IS 4
AR e10405
DI 10.1371/journal.pone.0010405
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 590PU
UT WOS:000277240100015
PM 20454453
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU FUJIMOTO, S
   KIKUGAWA, M
   KANEKO, M
   TAMAKI, N
AF FUJIMOTO, S
   KIKUGAWA, M
   KANEKO, M
   TAMAKI, N
TI ROLE OF DIHYDROPYRIMIDINE DEHYDROGENASE IN THE URIDINE
   NUCLEOTIDE-METABOLISM IN THE RAT-LIVER
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE DIHYDROPYRIMIDINE DEHYDROGENASE; URIDINE NUCLEOTIDE POOL; URIDINE;
   PYRIMIDINE METABOLISM; 5-FLUOROURIDINE
ID CELLS
AB The activity of dihydropyrimidine dehydrogenase, which is the rate-limiting enzyme in the catabolism of pyrimidine, in livers of 5-day-old rats increased 48 h after glucocorticoid injection. The increase in the activity of dihydropyrimidine dehydrogenase by glucocorticoid administration and by aging did not decrease the uridine, uracil and SIGMA-UMP (the sum of acid-soluble uracil 5'-nucleotides) pool in liver. The increase of liver uracil by a uridine diet not increase dihydropyrimidine dehydrogenase activity. The increase of liver uracil did not increase dihydropyrimidine dehydrogenase activity. However, dihydropyrimidine dehydrogenase activity which increased after glucocorticoid treatment increased the pyrimidine-degradation rate in rat livers and hepatocytes. Pyrimidine catabolism pathway in liver may play an important role in degradation of dietary pyrimidines and pyrimidines which are administered in the form of medicines as 5-fluorouridine.
RP FUJIMOTO, S (corresponding author), KOBE GAKUIN UNIV,FAC NUTR,NISHI KU,KOBE 65121,JAPAN.
CR BRONK JR, 1988, J PHYSIOL-LONDON, V395, P349, DOI 10.1113/jphysiol.1988.sp016923
   FRITZSON P, 1957, J BIOL CHEM, V226, P223
   FRITZSON P, 1961, J BIOL CHEM, V237, P150
   FUJIMOTO S, 1991, J NUTR SCI VITAMINOL, V37, P89, DOI 10.3177/jnsv.37.89
   Granner D. K., 1970, METHODS ENZYMOL    A, V17, P633
   IIGO M, 1980, BIOCHEM PHARMACOL, V38, P1885
   KARLE JM, 1984, J BIOL CHEM, V259, P67
   KILLMANN SA, 1964, ACTA MED SCAND, V175, P489
   MARIJNEN YMT, 1989, BIOCHIM BIOPHYS ACTA, V1012, P148, DOI 10.1016/0167-4889(89)90088-8
   MONKS A, 1982, AM J PHYSIOL, V242, pR465, DOI 10.1152/ajpregu.1982.242.5.R465
   NAGUIB FNM, 1985, CANCER RES, V45, P5405
   ORENGO A, 1969, J BIOL CHEM, V244, P2204
   ROTH GS, 1975, FED PROC, V34, P183
   SONODA T, 1978, BIOCHIM BIOPHYS ACTA, V521, P55, DOI 10.1016/0005-2787(78)90248-4
   TAMAKI N, 1990, EUR J BIOCHEM, V189, P39, DOI 10.1111/j.1432-1033.1990.tb15457.x
   TANAKA K, 1978, J BIOCHEM-TOKYO, V84, P937, DOI 10.1093/oxfordjournals.jbchem.a132207
   Tatibana M, 1972, Adv Enzyme Regul, V10, P249, DOI 10.1016/0065-2571(72)90017-9
   Weber G, 1970, Adv Enzyme Regul, V9, P63
NR 18
TC 4
Z9 4
U1 0
U2 2
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 4-16 YAYOI 2-CHOME, BUNKYO-KU, TOKYO 113, JAPAN
SN 0301-4800
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PD FEB
PY 1992
VL 38
IS 1
BP 39
EP 48
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HU302
UT WOS:A1992HU30200004
PM 1629785
DA 2024-02-19
ER

PT J
AU Bonaconsa, M
   Malpeli, G
   Montaruli, A
   Carandente, F
   Grassi-Zucconi, G
   Bentivoglio, M
AF Bonaconsa, Marta
   Malpeli, Giorgio
   Montaruli, Angela
   Carandente, Franca
   Grassi-Zucconi, Gigliola
   Bentivoglio, Marina
TI Differential modulation of clock gene expression in the suprachiasmatic
   nucleus, liver and heart of aged mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Peripheral oscillators; Circadian pacemaker; Bmal1; Period genes;
   Cryptochrome genes; Rev-erb alpha; Dbp; Dec1
ID MESSENGER-RNA EXPRESSION; REV-ERB-ALPHA; CIRCADIAN CLOCK;
   PERIPHERAL-TISSUES; DBP GENE; TRANSCRIPTION; RHYTHMS; BMAL1; DEC1;
   SYSTEM
AB Studies on the molecular clockwork during aging have been hitherto addressed to core clock genes. These previous investigations indicate that circadian profiles of core clock gene expression at an advanced age are relatively preserved in the master circadian pacemaker and the hypothalamic suprachiasmatic nucleus (SCN), and relatively impaired in peripheral tissues. It remains to be clarified whether the effects of aging are confined to the primary loop of core clock genes, or also involve secondary clock loop components, including Rev-erb alpha and the clock-controlled genes Dbp and Dec1. Using quantitative real-time RT-PCR, we here report a comparative analysis of the circadian expression of canonical core clock genes (Per1, Per2, Cry1, Cry2, Clock and Bmal1) and non-core clock genes (Rev-erb alpha, Dbp and Dec1) in the SCN, liver, and heart of 3 month-old vs 22 month-old mice. The results indicate that circadian clock gene expression is significantly modified in the SCN and peripheral oscillators of aged mice. These changes are not only highly tissue- specific, but also involve different clock gene loops. In particular, we here report changes of secondary clock loop components in the SCN, changes of the primary clock loop in the liver, and minor changes of clock gene expression in the heart of aged mice. The present findings outline a track to further understanding of the role of primary and secondary clock loop components and their crosstalk in the impairment of circadian output which characterizes aging. (C) 2014 Published by Elsevier Inc.
C1 [Bonaconsa, Marta; Grassi-Zucconi, Gigliola; Bentivoglio, Marina] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy.
   [Malpeli, Giorgio] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy.
   [Montaruli, Angela; Carandente, Franca] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.
C3 University of Verona; University of Verona; University of Milan
RP Bonaconsa, M (corresponding author), Sch Med, Dept Neurol & Movement Sci, Str Le Grazie 8, I-35134 Verona, Italy.
EM marta.bonaconsa@gmail.com
RI Bentivoglio, Marina/K-1008-2016
OI Bentivoglio, Marina/0000-0003-4958-9795; Malpeli,
   Giorgio/0000-0002-2996-2903; MONTARULI, ANGELA/0000-0003-4296-066X
FU University of Verona
FX The authors are grateful to E. Moccheggiani (INRCCA, Ancona, Italy) for
   his help in obtaining aged animals, and to anonymous Experimental
   Gerontology reviewers for their helpful criticisms. The support of
   intramural funds of the University of Verona is gratefully acknowledged.
   Thanks are due to Valeria Colavito for her help in statistical analyses.
CR Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006
   Asai M, 2001, J NEUROSCI RES, V66, P1133, DOI 10.1002/jnr.10010
   Aujard F, 2001, NEUROSCIENCE, V106, P255, DOI 10.1016/S0306-4522(01)00285-8
   Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X
   Bonaconsa M, 2013, CURR ALZHEIMER RES, V10, P597
   Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007
   Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1
   Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104
   Claustrat F, 2005, PATHOL BIOL, V53, P257, DOI 10.1016/j.patbio.2004.12.028
   Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086
   Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104
   Deng XH, 2010, CHRONOBIOL INT, V27, P742, DOI 10.3109/07420521003681498
   Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821
   Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009
   Duncan MJ, 2013, BRAIN RES, V1491, P44, DOI 10.1016/j.brainres.2012.11.008
   Durgan DJ, 2011, CHRONOBIOL INT, V28, P187, DOI 10.3109/07420528.2010.550406
   Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005
   Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012
   Franken P, 2000, J NEUROSCI, V20, P617, DOI 10.1523/JNEUROSCI.20-02-00617.2000
   Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404
   Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015
   Gast H, 2012, ANN NY ACAD SCI, V1261, P79, DOI 10.1111/j.1749-6632.2012.06640.x
   Gibson EM, 2009, EXP GERONTOL, V44, P51, DOI 10.1016/j.exger.2008.05.007
   Gréchez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200
   Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232
   Hofman MA, 2006, AGEING RES REV, V5, P33, DOI 10.1016/j.arr.2005.07.001
   Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123
   Jucker M, 1997, BEHAV BRAIN RES, V85, P1, DOI 10.1016/S0166-4328(96)02243-7
   Kato Y., 2010, HIROSAKI MED J, V61, pS34
   Kawakami F, 1997, NEUROSCI LETT, V222, P99, DOI 10.1016/S0304-3940(97)13355-9
   Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099
   Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207
   Kolker DE, 2003, J BIOL RHYTHM, V18, P159, DOI 10.1177/0748730403251802
   Kornmann B, 2007, COLD SPRING HARB SYM, V72, P319, DOI 10.1101/sqb.2007.72.041
   Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loh DH, 2011, J BIOL RHYTHM, V26, P200, DOI 10.1177/0748730411401740
   LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762
   Martino T, 2004, J MOL MED, V82, P256, DOI 10.1007/s00109-003-0520-1
   Mongrain V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026622
   Monk TH, 2005, J BIOL RHYTHM, V20, P366, DOI 10.1177/0748730405277378
   Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011
   Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07
   NELSON W, 1979, CHRONOBIOLOGIA, V6, P305
   Nishide S, 2006, GENES CELLS, V11, P1173, DOI 10.1111/j.1365-2443.2006.01015.x
   Noshiro M, 2009, GENES CELLS, V14, P29, DOI 10.1111/j.1365-2443.2008.01247.x
   Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200
   Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779
   Oishi K, 2011, EXP GERONTOL, V46, P994, DOI 10.1016/j.exger.2011.09.003
   Palomba M, 2008, J BIOL RHYTHM, V23, P220, DOI 10.1177/0748730408316998
   Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5
   Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965
   Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738
   ROOZENDAAL B, 1987, BRAIN RES, V409, P259, DOI 10.1016/0006-8993(87)90710-4
   Sadki A, 2007, NEUROBIOL AGING, V28, P296, DOI 10.1016/j.neurobiolaging.2005.12.007
   Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x
   Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745
   Schmutz I, 2012, MOL CELL ENDOCRINOL, V349, P38, DOI 10.1016/j.mce.2011.05.007
   Sitzmann BD, 2010, NEUROBIOL AGING, V31, P696, DOI 10.1016/j.neurobiolaging.2008.05.024
   Sothern RB., 2009, SCRIPTA MED, V82, P133
   Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810
   Takahashi JS, 2008, SCIENCE, V322, P909, DOI 10.1126/science.1158822
   Takekida S, 2000, EUR J NEUROSCI, V12, P4557, DOI 10.1046/j.0953-816X.2000.01324.x
   Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303
   Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469
   Weinert D, 2000, CHRONOBIOL INT, V17, P261, DOI 10.1081/CBI-100101048
   Weinert H, 2001, CHRONOBIOL INT, V18, P559, DOI 10.1081/CBI-100103976
   Wyse CA, 2010, BRAIN RES, V1337, P21, DOI 10.1016/j.brainres.2010.03.113
   Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542
   Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000
   Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499
   Yan L, 1999, NEUROSCIENCE, V94, P141, DOI 10.1016/S0306-4522(99)00223-7
   Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005
   Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4
   Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4
NR 75
TC 67
Z9 77
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUL
PY 2014
VL 55
BP 70
EP 79
DI 10.1016/j.exger.2014.03.011
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AH2CW
UT WOS:000335929300010
PM 24674978
DA 2024-02-19
ER

PT J
AU Sharma, R
   Nakamura, A
   Takahashi, R
   Nakamoto, H
   Goto, S
AF Sharma, R
   Nakamura, A
   Takahashi, R
   Nakamoto, H
   Goto, S
TI Carbonyl modification in rat liver histones: Decrease with age and
   increase by dietary restriction
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE histones; carbonylation; rat liver; aging; dietary restriction;
   posttranslational modification; free radicals
ID OXIDATIVELY MODIFIED PROTEINS; CALORIC RESTRICTION; IN-VITRO; CHROMATIN;
   BRAIN; ACCUMULATION; DEGRADATION; LONGEVITY; MICE; LIFE
AB We studied carbonylation, a form of oxidative modification of proteins, of histones in rat livers. Histories HI, H2B/H2A, and H3 were significantly carbonylated but the modification was almost undetectable in H4. Contrary to the generally accepted view of increased protein carborylation with age, the modification of histories was significantly lower in old (30-month-old) than in young (5-month-old) animals. Dietary restriction of older animals for 2 months resulted in increase in carbonylation comparable to that at the young level. These findings may have physiological implications in chromatin structure/function in aging and beneficial effects of DR by influencing transcription, replication, and/or repair activities. (c) 2005 Elsevier Inc. All rights reserved.
C1 Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Funabashi, Chiba 2748510, Japan.
C3 Toho University
RP Goto, S (corresponding author), Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Miyama 2-2-1, Funabashi, Chiba 2748510, Japan.
EM goto@phar.toho-u.ac.jp
CR AXEL R, 1973, P NATL ACAD SCI USA, V70, P2029, DOI 10.1073/pnas.70.7.2029
   Burzynski SR, 2003, MED HYPOTHESES, V60, P578, DOI 10.1016/S0306-9877(03)00050-1
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969
   CHATURVEDI MM, 1983, BIOCHEM INT, V6, P357
   DONNE ID, 2003, TRENDS MOL MED, V9, P169
   EBERHARDT NL, 1978, ENDOCRINOLOGY, V102, P556, DOI 10.1210/endo-102-2-556
   ENRIGHT HU, 1992, NUCLEIC ACIDS RES, V20, P3341, DOI 10.1093/nar/20.13.3341
   Goto S, 2002, ANN NY ACAD SCI, V959, P50, DOI 10.1111/j.1749-6632.2002.tb02082.x
   Goto S, 1997, AGE, V20, P81, DOI 10.1007/s11357-997-0008-y
   Hoffmann P, 1978, Methods Cell Biol, V17, P1, DOI 10.1016/S0091-679X(08)61130-9
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V283, P362, DOI 10.1016/0003-9861(90)90655-I
   KANUNGO MS, 1994, GENES AGING
   LENZ AG, 1989, ANAL BIOCHEM, V177, P419, DOI 10.1016/0003-2697(89)90077-8
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444
   MASORO EJ, 2003, SCI AGING KNOWLEDG R, V2
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   MORIMOTO S, 1993, ARCH GERONTOL GERIAT, V16, P217, DOI 10.1016/0167-4943(93)90033-E
   MOZZHUKHINA TG, 1991, GERONTOLOGY, V37, P181
   Nagai M, 2000, BIOGERONTOLOGY, V1, P321, DOI 10.1023/A:1026590819033
   Nakamura A, 1996, J BIOCHEM, V119, P768
   QUESADA P, 1990, BIOCHEM BIOPH RES CO, V170, P900, DOI 10.1016/0006-291X(90)92176-Z
   Radák Z, 2002, EXP GERONTOL, V37, P1423, DOI 10.1016/S0531-5565(02)00116-X
   Ranhotra HS, 2001, BIOGERONTOLOGY, V2, P245, DOI 10.1023/A:1013218528102
   Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Spindler SR, 2005, MECH AGEING DEV, V126, P960, DOI 10.1016/j.mad.2005.03.016
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   TAKAHASHI R, 1987, ARCH BIOCHEM BIOPHYS, V257, P200, DOI 10.1016/0003-9861(87)90559-5
   Takahashi R, 2002, MICROSC RES TECHNIQ, V59, P278, DOI 10.1002/jemt.10205
   Thomas J O, 1978, Methods Cell Biol, V18, P429
   VAQUERO A, 2003, AGING KNOWLEDGE EN E, V4
   VONHOLT C, 1989, METHOD ENZYMOL, V170, P431
   Weindruch R, 1996, SCI AM, V274, P46, DOI 10.1038/scientificamerican0196-46
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   Wolffe A., 1998, CHROMATIN STRUCTURE
   Wondrak GT, 2000, BIOCHEM J, V351, P769, DOI 10.1042/0264-6021:3510769
NR 40
TC 41
Z9 45
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD APR 1
PY 2006
VL 40
IS 7
BP 1179
EP 1184
DI 10.1016/j.freeradbiomed.2005.11.013
PG 6
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 028KJ
UT WOS:000236485800009
PM 16545685
DA 2024-02-19
ER

PT J
AU Valls, V
   Peiro, C
   Muñiz, P
   Saez, GT
AF Valls, V
   Peiro, C
   Muñiz, P
   Saez, GT
TI Age-related changes in antioxidant status and oxidative damage to lipids
   and dna in mitochondria of rat liver
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE antioxidant enzymes; GSH; lipid peroxidation; DNA damage; membrane
   potential
ID PEROXIDATION; HEPATOCYTES; GLUTATHIONE; APOPTOSIS; ORIGIN; BRAIN
AB To investigate the correlation between oxidative stress and mitochondrial damage with aging, antioxidant system, levels of oxidative DNA damage and as an index of the loss of plasma membrane integrity lipid peroxidation and membrane potential were studied. Results showed that the activities of antioxidant enzymes superoxide dismutase (SOD) and catalase significantly decreased during aging, however glutathione peroxidase (GSH-PX) increased in the aged mitochondria and glutathione (GSH) did not change during aging. No statistical difference was observed in the lipid peroxidation of mitochondria between young and old animals. The level of oxidative DNA damage (measured as 8oxo-dG) tended to increase during aging. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Burgos, Fac Ciencias, Area Bioquim & Biol Mol, Burgos 09001, Spain.
   Univ Valencia, Fac Med, Dpto Pediat Ginecol & Obstet, Valencia, Spain.
   Univ Valencia, Fac Med, Dpto Bioquim & Biol Mol, Valencia, Spain.
C3 Universidad de Burgos; University of Valencia; University of Valencia
RP Univ Burgos, Fac Ciencias, Area Bioquim & Biol Mol, Pl Misael Banuelos S-N, Burgos 09001, Spain.
EM pmuniz@ubu.es
RI Muñiz, Pilar/N-1255-2017
OI Muñiz, Pilar/0000-0002-9306-0082; Saez, Guillermo/0000-0002-8164-4048
CR ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   Anson RM, 1999, FREE RADICAL BIO MED, V27, P456, DOI 10.1016/S0891-5849(99)00091-X
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BRIGELIUS R, 1983, BIOCHEM PHARMACOL, V32, P2529, DOI 10.1016/0006-2952(83)90014-X
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   CHOI JH, 1995, FREE RADICAL BIO MED, V18, P133, DOI 10.1016/0891-5849(94)00106-T
   Claiborne A., 1986, HDB METHODS OXYGEN R, P283
   de Souza-Pinto NC, 2001, FREE RADICAL BIO MED, V30, P916, DOI 10.1016/S0891-5849(01)00483-X
   EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X
   FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0
   Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029
   GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0
   LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649
   MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P7185, DOI 10.1073/pnas.87.18.7185
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MIGUEL J, 1993, BIOL AGING, P51
   MUNIZ P, 1995, FREE RADICAL BIO MED, V18, P747, DOI 10.1016/0891-5849(94)00200-4
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   RICKWOD D, 1987, MITOCHONDRIA PRACTIC, pCH1
   RITCHER C, 1988, P NATL ACAD SCI USA, V8, P6465
   Salvioli S, 2001, FEBS LETT, V492, P9, DOI 10.1016/S0014-5793(01)02199-8
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   STACEY N, 1978, TOXICOL APPL PHARM, V45, P41, DOI 10.1016/0041-008X(78)90026-1
   Tahara S, 2001, MECH AGEING DEV, V122, P415, DOI 10.1016/S0047-6374(00)00257-8
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Zamzami N, 1997, J BIOENERG BIOMEMBR, V29, P185, DOI 10.1023/A:1022694131572
NR 35
TC 18
Z9 28
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD FEB
PY 2005
VL 40
IS 2
BP 903
EP 908
DI 10.1016/j.procbio.2004.02.025
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA 872UY
UT WOS:000225235400053
DA 2024-02-19
ER

PT J
AU Chan, CYK
   Yuen, VWH
   Chiu, DKC
   Goh, CC
   Thu, KL
   Cescon, DW
   Soria-Bretones, I
   Law, CT
   Cheu, JWS
   Lee, D
   Tse, APW
   Tan, KV
   Zhang, MS
   Wong, BPY
   Wong, CM
   Khong, PL
   Ng, IOL
   Bray, MR
   Mak, TW
   Yau, TCC
   Wong, CCL
AF Chan, Cerise Yuen-Ki
   Yuen, Vincent Wai-Hin
   Chiu, David Kung-Chun
   Goh, Chi-Ching
   Thu, Kelsie L.
   Cescon, David W.
   Soria-Bretones, Isabel
   Law, Cheuk-Ting
   Cheu, Jacinth Wing-Sum
   Lee, Derek
   Tse, Aki Pui-Wah
   Tan, Kel Vin
   Zhang, Misty Shuo
   Wong, Bowie Po-Yee
   Wong, Chun-Ming
   Khong, Pek-Lan
   Ng, Irene Oi-Lin
   Bray, Mark R.
   Mak, Tak Wah
   Yau, Thomas Chung-Cheung
   Wong, Carmen Chak-Lui
TI Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through
   cell cycle perturbation and eliciting antitumor immunity
SO HEPATOLOGY
LA English
DT Article; Early Access
ID CGAS-STING PATHWAY; SENESCENCE; RESPONSES
AB Background and Aims Prognosis of HCC remains poor due to lack of effective therapies. Immune checkpoint inhibitors (ICIs) have delayed response and are only effective in a subset of patients. Treatments that could effectively shrink the tumors within a short period of time are idealistic to be employed together with ICIs for durable tumor suppressive effects. HCC acquires increased tolerance to aneuploidy. The rapid division of HCC cells relies on centrosome duplication. In this study, we found that polo-like kinase 4 (PLK4), a centrosome duplication regulator, represents a therapeutic vulnerability in HCC. Approach and Results An orally available PLK4 inhibitor, CFI-400945, potently suppressed proliferating HCC cells by perturbing centrosome duplication. CFI-400945 induced endoreplication without stopping DNA replication, causing severe aneuploidy, DNA damage, micronuclei formation, cytosolic DNA accumulation, and senescence. The cytosolic DNA accumulation elicited the DEAD box helicase 41-stimulator of interferon genes-interferon regulatory factor 3/7-NF-kappa beta cytosolic DNA sensing pathway, thereby driving the transcription of senescence-associated secretory phenotypes, which recruit immune cells. CFI-400945 was evaluated in liver-specific p53/phosphatase and tensin homolog knockout mouse HCC models established by hydrodynamic tail vein injection. Tumor-infiltrated immune cells were analyzed. CFI-400945 significantly impeded HCC growth and increased infiltration of cluster of differentiation 4-positive (CD4(+)), CD8(+) T cells, macrophages, and natural killer cells. Combination therapy of CFI-400945 with anti-programmed death-1 showed a tendency to improve HCC survival. Conclusions We show that by targeting a centrosome regulator, PLK4, to activate the cytosolic DNA sensing-mediated immune response, CFI-400945 effectively restrained tumor progression through cell cycle inhibition and inducing antitumor immunity to achieve a durable suppressive effect even in late-stage mouse HCC.
C1 [Chan, Cerise Yuen-Ki; Yuen, Vincent Wai-Hin; Chiu, David Kung-Chun; Goh, Chi-Ching; Law, Cheuk-Ting; Cheu, Jacinth Wing-Sum; Lee, Derek; Tse, Aki Pui-Wah; Zhang, Misty Shuo; Wong, Bowie Po-Yee; Wong, Chun-Ming; Ng, Irene Oi-Lin; Wong, Carmen Chak-Lui] Univ Hong Kong, Dept Pathol, Hong Kong, Peoples R China.
   [Chan, Cerise Yuen-Ki; Yuen, Vincent Wai-Hin; Cheu, Jacinth Wing-Sum; Lee, Derek; Tse, Aki Pui-Wah; Zhang, Misty Shuo; Mak, Tak Wah; Wong, Carmen Chak-Lui] Ctr Oncol & Immunol, Hong Kong Sci Pk, Hong Kong, Peoples R China.
   [Thu, Kelsie L.; Cescon, David W.; Soria-Bretones, Isabel; Bray, Mark R.; Mak, Tak Wah] Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada.
   [Tan, Kel Vin; Khong, Pek-Lan] Univ Hong Kong, Dept Diagnost Radiol, Hong Kong, Peoples R China.
   [Wong, Chun-Ming; Ng, Irene Oi-Lin; Yau, Thomas Chung-Cheung; Wong, Carmen Chak-Lui] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China.
   [Yau, Thomas Chung-Cheung] Univ Hong Kong, Dept Med, Hong Kong, Peoples R China.
   [Wong, Carmen Chak-Lui] Sun Yat Sen Univ, Guangdong Hong Kong Joint Lab RNA Med, Guangzhou, Peoples R China.
C3 University of Hong Kong; University of Toronto; University Health
   Network Toronto; Princess Margaret Cancer Centre; University of Hong
   Kong; University of Hong Kong; University of Hong Kong; Sun Yat Sen
   University
RP Yau, TCC (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, 102 Pokfulam Rd, Hong Kong, Peoples R China.; Wong, CCL (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, T810 Block T, Hong Kong, Peoples R China.
EM tyaucc@hku.hk; carmencl@pathology.hku.hk
RI Tan, Kel Vin/IAN-0904-2023; Yau, Thomas Chung Cheung/B-3429-2011; Wong,
   Carmen Chak Lui/C-4660-2009; Khong, Pek Lan/C-4292-2009; WONG,
   Chun-Ming/A-6739-2009; Chiu, David Kung-Chun/JYP-6176-2024
OI Tan, Kel Vin/0000-0002-5762-6958; Ng, Irene Oi-lin/0000-0001-7532-2029;
   Thu, Kelsie/0000-0001-9262-7238; Chiu, David
   Kung-Chun/0000-0002-9700-4707
FU University of Hong Kong Outstanding Young Researcher Award; Croucher
   Foundation Croucher Innovation Award; Health and Medical Research Fund
   [08192516]
FX Supported by The University of Hong Kong Outstanding Young Researcher
   Award (to C. C. L. W.) and the Croucher Foundation Croucher Innovation
   Award (to C. C. L. W.), Health and Medical Research Fund (08192516) (to
   D. L. and C. C. L. W.)
CR Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039
   Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558
   Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   De Cecco M, 2019, NATURE, V572, pE5, DOI [10.1038/s41586-019-1350-9, 10.1038/s41586-018-0784-9]
   Dunphy G, 2018, MOL CELL, V71, P745, DOI 10.1016/j.molcel.2018.07.034
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Elbekai RH, 2004, CURR DRUG METAB, V5, P157, DOI 10.2174/1389200043489054
   Finn RS, 2020, NEW ENGL J MED, V382, P1894, DOI 10.1056/NEJMoa1915745
   Frey N, 2018, NAT REV GASTRO HEPAT, V15, P81, DOI 10.1038/nrgastro.2017.146
   Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123
   Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320
   Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470
   Jilkova ZM, 2019, CANCERS, V11, DOI 10.3390/cancers11101487
   Kawakami M, 2018, P NATL ACAD SCI USA, V115, P1913, DOI 10.1073/pnas.1719760115
   Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605
   KOCH AE, 1994, J CLIN INVEST, V94, P1012, DOI 10.1172/JCI117414
   Kwon J, 2020, CANCER DISCOV, V10, P26, DOI 10.1158/2159-8290.CD-19-0761
   Lang H, 2005, ANN SURG, V241, P134, DOI 10.1097/01.sla.0000149426.08580.a1
   Liu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041293
   Lohse I, 2017, ONCOTARGET, V8, P3064, DOI 10.18632/oncotarget.13619
   Maseda D, 2018, J IMMUNOL, V200, P725, DOI 10.4049/jimmunol.1601808
   Mason JM, 2014, CANCER CELL, V26, P163, DOI 10.1016/j.ccr.2014.05.006
   Nakayama T, 2010, J IMMUNOL, V185, P6472, DOI 10.4049/jimmunol.0904126
   Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924
   Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345
   Pantelidou C, 2019, CANCER DISCOV, V9, P722, DOI 10.1158/2159-8290.CD-18-1218
   Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138
   Ruscetti M, 2018, SCIENCE, V362, P1416, DOI 10.1126/science.aas9090
   Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315
   Shibata T, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.6
   WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612
NR 33
TC 11
Z9 11
U1 2
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2023 MAR
PY 2023
VL 77
IS 3
BP 729
EP 744
DI 10.1002/hep.32461
EA APR 2022
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 9N8PO
UT WOS:000778846300001
PM 35302667
DA 2024-02-19
ER

PT J
AU Navarro, M
   Morales, FJ
   Ramos, S
AF Navarro, Marta
   Morales, Francisco J.
   Ramos, Sonia
TI Olive leaf extract concentrated in hydroxytyrosol attenuates protein
   carbonylation and the formation of advanced glycation end products in a
   hepatic cell line (HepG2)
SO FOOD & FUNCTION
LA English
DT Article
ID TANDEM MASS-SPECTROMETRY; PHENOLIC-COMPOUNDS; OXIDATIVE STRESS;
   IN-VITRO; OIL; ENDPRODUCTS; POLYPHENOLS; METABOLISM; METHYLGLYOXAL;
   FLAVONOIDS
AB Glycation takes place both at the cellular level and at the extracellular matrix level and generates, consequently, advanced glycation end-products (AGEs) associated with chronic diseases and the aging process. Two olive leaf extracts concentrated in (i) oleuropein (OLE-A; 93.9 mg oleuropein g(-1)) and (ii) hydroxytyrosol (OLE-B; 54.5 mg hydroxytyrosol g(-1)) were evaluated according to their antiglycative and antioxidant capacity in vitro. OLE-B exerted the highest anti-AGE effect in different glycation models (IC50: 0.25-0.29 mg mL(-1)). OLE-B showed the highest antioxidant capacity and methylglyoxal-trapping capacity (IC50 0.16 mg mL(-1)). OLE-B showed a significant inhibitory effect against protein carbonylation (21%) and generation of argpyrimidine (26%) in a hepatocyte cellular carbonyl stress model evoked by methylglyoxal (MGO). OLE-B was further fractionated by solid phase-extraction, and the protective effect against protein carbonylation was only exerted by the fraction containing hydroxytyrosol. However, hydroxytyrosol standard, at the same concentration in the extract, inhibited the protein carbonylation below 10% but not significantly. The results indicate that the antiglycative activity of OLE in cells could be due to a synergic effect of hydroxytyrosol and other minor compounds with similar polarity. The research of the antiglycative activity in vivo could confirm these promising results and to propose OLE as a natural anti-AGE agent.
C1 [Navarro, Marta; Morales, Francisco J.; Ramos, Sonia] Inst Food Sci Technol & Nutr ICTAN CSIC, Madrid, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN)
RP Morales, FJ (corresponding author), Inst Food Sci Technol & Nutr ICTAN CSIC, Madrid, Spain.
EM fjmorales@ictan.csic.es
RI Morales, Francisco J./N-1941-2019; Morales, Francisco J./F-5523-2010;
   Ramos, Sonia/K-4594-2012
OI Morales, Francisco J./0000-0003-3984-7009; Morales, Francisco
   J./0000-0003-3984-7009; Ramos, Sonia/0000-0003-2649-2616
FU Comunidad of Madrid [S2013/ABI-3028-AVANSECAL]; European funding from
   FEDER program (European Regional Development Fund)
   [S2013/ABI-3028-AVANSECAL]; Spanish National Research Council
   [CSIC-201370E027]
FX This work was funded by projects S2013/ABI-3028-AVANSECAL from Comunidad
   of Madrid and European funding from FEDER program (European Regional
   Development Fund) and CSIC-201370E027 (Spanish National Research
   Council). M. Navarro received grants from the JAE program (Spanish
   National Research Council).
CR Ados S. Rosa, 2014, WOUND REPAIR REGEN, V22, P537
   Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3
   Granado-Serrano AB, 2007, J AGR FOOD CHEM, V55, P2020, DOI 10.1021/jf062556x
   Bulotta S, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0219-9
   Cicerale S, 2010, INT J MOL SCI, V11, P458, DOI 10.3390/ijms11020458
   Cordero-Herrera I, 2015, MOL NUTR FOOD RES, V59, P597, DOI 10.1002/mnfr.201400492
   Cumaoglu A, 2011, ACTA BIOCHIM POL, V58, P45
   de Bock M, 2013, MOL NUTR FOOD RES, V57, P2079, DOI 10.1002/mnfr.201200795
   Donato-Trancoso A, 2016, J DERMATOL SCI, V83, P60, DOI 10.1016/j.jdermsci.2016.03.012
   Dong Q, 2010, CHEM-BIOL INTERACT, V185, P101, DOI 10.1016/j.cbi.2010.03.003
   Ergin V, 2013, AGING DIS, V4, P276, DOI 10.14336/AD.2013.0400276
   Goya L, 2007, EUR J NUTR, V46, P70, DOI 10.1007/s00394-006-0633-8
   Hamden K, 2009, CHEM-BIOL INTERACT, V180, P421, DOI 10.1016/j.cbi.2009.04.002
   Handl M, 2007, PHYSIOL RES, V56, P235, DOI 10.33549/physiolres.930934
   Hayes JE, 2011, FOOD CHEM, V126, P948, DOI 10.1016/j.foodchem.2010.11.092
   Jemai H, 2009, J AGR FOOD CHEM, V57, P8798, DOI 10.1021/jf901280r
   Kawaguchi K, 2011, CURR TOP MED CHEM, V11, P1767, DOI 10.2174/156802611796235152
   Kontogianni VG, 2013, J MED FOOD, V16, P817, DOI [10.1089/jmf.2013.0016, 10.1094/jmf.2013.0016]
   Kroon PA, 2004, AM J CLIN NUTR, V80, P15
   Lee OH, 2009, BIORESOURCE TECHNOL, V100, P6107, DOI 10.1016/j.biortech.2009.06.059
   Mateos R, 2005, J AGR FOOD CHEM, V53, P9897, DOI 10.1021/jf051721q
   Mesias M, 2013, J SCI FOOD AGR, V93, P2037, DOI 10.1002/jsfa.6012
   Miyata T, 1999, PERITON DIALYSIS INT, V19, pS58
   Morales FJ, 2009, EUR FOOD RES TECHNOL, V228, P345, DOI 10.1007/s00217-008-0940-9
   Munch G, 1997, BRAIN RES REV, V23, P134, DOI 10.1016/S0165-0173(96)00016-1
   Navarro M, 2016, EUR FOOD RES TECHNOL, V242, P1101, DOI 10.1007/s00217-015-2614-8
   Navarro M, 2015, FOOD FUNCT, V6, P574, DOI 10.1039/c4fo01049c
   Navarro M, 2015, FOOD CHEM, V175, P92, DOI 10.1016/j.foodchem.2014.11.117
   Nowotny K, 2015, BIOMOLECULES, V5, P194, DOI 10.3390/biom5010194
   Pashikanti S, 2010, FREE RADICAL BIO MED, V48, P656, DOI 10.1016/j.freeradbiomed.2009.11.019
   Peng XF, 2011, FOOD FUNCT, V2, P289, DOI 10.1039/c1fo10034c
   Peralbo-Molina A, 2012, J AGR FOOD CHEM, V60, P11542, DOI 10.1021/jf302896m
   Perez-Herrera A, 2012, MOL NUTR FOOD RES, V56, P510, DOI 10.1002/mnfr.201100533
   Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052
   Quirantes-Piné R, 2013, PHYTOCHEM ANALYSIS, V24, P213, DOI 10.1002/pca.2401
   Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140
   Shangari N, 2004, BIOCHEM PHARMACOL, V68, P1433, DOI 10.1016/j.bcp.2004.06.013
   Shao X, 2014, J AGR FOOD CHEM, V62, P3202, DOI 10.1021/jf500204s
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763
   Tuck KL, 2002, J NUTR BIOCHEM, V13, P636, DOI 10.1016/S0955-2863(02)00229-2
   Visioli F, 2000, FEBS LETT, V468, P159, DOI 10.1016/S0014-5793(00)01216-3
   Yang K, 2011, CHEM-BIOL INTERACT, V191, P322, DOI 10.1016/j.cbi.2011.02.012
NR 43
TC 20
Z9 21
U1 0
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD MAR 1
PY 2017
VL 8
IS 3
BP 944
EP 953
DI 10.1039/c6fo01738j
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA ER4OQ
UT WOS:000398780200006
PM 28229142
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Thomson, JA
   Wang, WC
   Browning, C
   Kendig, HL
AF Thomson, Jennifer A.
   Wang, Wei C.
   Browning, Colette
   Kendig, Hal L.
TI Self-reported medication side effects in an older cohort living
   independently in the community - the Melbourne Longitudinal Study on
   Healthy Ageing (MELSHA): cross-sectional analysis of prevalence and risk
   factors
SO BMC GERIATRICS
LA English
DT Article
ID ADVERSE DRUG EVENTS; AUSTRALIANS; AGREEMENT; ADMISSION; ACCURACY;
   PEOPLE; ERRORS; ENOUGH
AB Background: Medication side effects are an important cause of morbidity, mortality and costs in older people. The aim of our study was to examine prevalence and risk factors for self-reported medication side effects in an older cohort living independently in the community.
   Methods: The Melbourne Longitudinal Study on Healthy Ageing (MELSHA), collected information on those aged 65 years or older living independently in the community and commenced in 1994. Data on medication side effects was collected from the baseline cohort (n = 1000) in face-to-face baseline interviews in 1994 and analysed as cross-sectional data. Risk factors examined were: socio-demographics, health status and medical conditions; medication use and health service factors. Analysis included univariate logistic regression to estimate unadjusted risk and multivariate logistic regression analysis to assess confounding and estimate adjusted risk.
   Results: Self-reported medication side effects were reported by approximately 6.7% (67/1000) of the entire baseline MELSHA cohort, and by 8.5% (65/761) of those on medication. Identified risk factors were increased education level, co-morbidities and health service factors including recency of visiting the pharmacist, attending younger doctors, and their doctor's awareness of their medications. The greatest increase in risk for medication side effects was associated with liver problems and their doctor's awareness of their medications. Aging and gender were not risk factors.
   Conclusion: Prevalence of self-reported medication side effects was comparable with that reported in adults attending General Practices in a primary care setting in Australia. The prevalence and identified risk factors provide further insight and opportunity to develop strategies to address the problem of medication side effects in older people living independently in the community setting.
C1 [Thomson, Jennifer A.; Wang, Wei C.; Browning, Colette] Monash Univ, Sch Primary Hlth Care, Melbourne, Vic 3004, Australia.
   [Kendig, Hal L.] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia.
C3 Monash University; University of Sydney
RP Thomson, JA (corresponding author), Monash Univ, Sch Primary Hlth Care, Melbourne, Vic 3004, Australia.
EM jennifer.thomson@med.monash.edu.au
RI Browning, Colette/AAD-3387-2020; Browning, Colette J/H-9903-2013; Wang,
   Wei Chun C/I-1444-2016
OI Browning, Colette/0000-0001-6739-0152; Browning, Colette
   J/0000-0001-6739-0152; Wang, Wei Chun C/0000-0003-4287-1704; Kendig,
   Hal/0000-0002-0353-3182
FU Victorian Health Promotion Foundation; National Health and Medical
   Research Council; Australian Research Council
FX We thank the study participants for their long-term commitment to the
   project. The Melbourne Longitudinal Studies on Healthy Ageing (MELSHA)
   program has been funded by a large number of grants and supporting
   agencies. They include the Victorian Health Promotion Foundation, the
   National Health and Medical Research Council and the Australian Research
   Council. Funding bodies had no role in the design and conduct of the
   study; collection, management, analysis, and interpretation of the data;
   and preparation, review, or approval of the manuscript. The program is
   jointly led by Professor Colette Browning at Monash University and
   Professor Hal Kendig from the University of Sydney and includes
   associates from La Trobe University. The baseline data were collected
   with funding from the Victorian Health Promotion Foundation for the
   Health Status of Older People project. The MELSHA data were collected
   and the data files prepared with the collaboration of a number of Chief
   Investigators and staff, with particularly important contributions by
   Professor Shane Thomas in the latest rounds and Professor Yvonne Wells
   in earlier rounds. In addition, we thank Ms Sylvie Niele for her reading
   and comments on the manuscript and Mr Sean Colishaw for helpful advice.
CR AIHW Australian GP Statistics and Classification Center, 2004, SAND ABSTR 56 BEACH
   Akici A, 2007, CURR DRUG SAF, V2, P65, DOI 10.2174/157488607779315408
   [Anonymous], 2009, Medication safety in the community: a review of the literature
   Bar-Oz B, 2008, ISR MED ASSOC J, V10, P771
   Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553
   Chan M, 2001, INTERN MED J, V31, P199, DOI 10.1046/j.1445-5994.2001.00044.x
   Evans RS, 2005, ANN PHARMACOTHER, V39, P1161, DOI 10.1345/aph.1E642
   Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526
   Franceschi M, 2008, DRUG SAFETY, V31, P545, DOI 10.2165/00002018-200831060-00009
   Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x
   Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703
   Kendig H, 1998, AUST NZ J PUBL HEAL, V22, P808, DOI 10.1111/j.1467-842X.1998.tb01498.x
   Kendig H., 1996, Health status of older people project: preliminary findings from a survey of the health and lifestyles of older Australians: Victorian Health Promotion Foundation
   Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037
   Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200
   Miller GC, 2006, MED J AUSTRALIA, V184, P321, DOI 10.5694/j.1326-5377.2006.tb00263.x
   Miller GC, 2006, MED J AUSTRALIA, V184, P646
   Morris M, 2004, AUST J PHYSIOTHER, V50, P153, DOI 10.1016/S0004-9514(14)60153-7
   O'Mahony D, 2008, AGE AGEING, V37, P138, DOI [10.1093/ageing/afm189, 10.1093/ageing/Afm189]
   Pirmohamed M, 1998, BRIT MED J, V316, P1295, DOI 10.1136/bmj.316.7140.1295
   Pit S, 2010, J CLIN EPIDEMIOL, V63, P428, DOI 10.1016/j.jclinepi.2009.07.008
   Pit SW, 2008, J EVAL CLIN PRACT, V14, P203, DOI 10.1111/j.1365-2753.2007.00833.x
   Pit SW, 2008, DRUG AGING, V25, P71, DOI 10.2165/00002512-200825010-00008
   Riedl MA, 2003, AM FAM PHYSICIAN, V68, P1781
   Roughead EE, 2006, MED J AUSTRALIA, V184, P315, DOI 10.5694/j.1326-5377.2006.tb00260.x
   Roughead EE, 2005, MED J AUSTRALIA, V182, P264, DOI 10.5694/j.1326-5377.2005.tb06697.x
   Roughead EE, 2004, PHARMACOEPIDEM DR S, V13, P83, DOI 10.1002/pds.912
   Runciman WB, 2003, INT J QUAL HEALTH C, V15, pI49, DOI 10.1093/intqhc/mzg085
   Sandhiya S, 2008, J Assoc Physicians India, V56, P525
   Steven I D, 1999, J Qual Clin Pract, V19, P47, DOI 10.1046/j.1440-1762.1999.00302.x
   Tam-McDevitt J, 2008, ONCOLOGY-NY, V22, P1052
   van den Bemt PMLA, 2000, PHARM WORLD SCI, V22, P62, DOI 10.1023/A:1008721321016
   Vervloet D, 1998, BRIT MED J, V316, P1511, DOI 10.1136/bmj.316.7143.1511
   Vestal RE, 1997, CANCER, V80, P1302, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1302::AID-CNCR16>3.0.CO;2-B
   Wilke RA, 2007, NAT REV DRUG DISCOV, V6, P904, DOI 10.1038/nrd2423
   Zed PJ, 2008, CAN MED ASSOC J, V178, P1563, DOI 10.1503/cmaj.071594
   Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6
NR 38
TC 7
Z9 8
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2318
J9 BMC GERIATR
JI BMC Geriatr.
PY 2010
VL 10
AR 37
DI 10.1186/1471-2318-10-37
PG 11
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA V29EL
UT WOS:000208731600037
PM 20537140
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tsai, YC
   Lin, YC
   Huang, CC
   Villaflores, OB
   Wu, TY
   Huang, SM
   Chin, TY
AF Tsai, Yun-Chieh
   Lin, Yu-Chen
   Huang, Chun-Chih
   Villaflores, Oliver B.
   Wu, Tzong-Yuan
   Huang, Shih-Ming
   Chin, Ting-Yu
TI <i>Hericium erinaceus</i> Mycelium and Its Isolated Compound, Erinacine
   A, Ameliorate High-Fat High-Sucrose Diet-Induced Metabolic Dysfunction
   and Spatial Learning Deficits in Aging Mice
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE Hericium erinaceus; erinacine A; metabolic dysfunction; cognitive
   impairment; neuroinflammation; nerve growth factor
ID GROWTH-FACTOR (NGF)-SYNTHESIS; COGNITIVE IMPAIRMENT; OXIDATIVE STRESS;
   NEUROTROPHIC FACTOR; RECOGNITION MEMORY; ADIPOSE-TISSUE; LIVER-DISEASE;
   OBESITY; CHOLESTEROL; EXPRESSION
AB Aging and lifestyle factors, including high-sugar and high-fat diets, promote a systemic metabolic imbalance that promotes neurodegeneration. Hericium erinaceus has long been used in traditional Chinese medicine. Recently, its functional activities, such as antimetabolic dysfunction, antineuroinflammatory activities, and stimulation of nerve growth factor (NGF) synthesis, have been revealed. This study demonstrated that Hericium erinaceus mycelium (HEM) and an isolated diterpenoid derivative, erinacine A (EA), may reverse spatial learning disabilities in aging mice (15 months old) fed with a high-fat and high-sucrose diet (HFSD). Aging mice were randomly assigned to one of four treatment groups: (1) a chow diet (control), (2) an HFSD, and an HFSD supplemented with either (3) HEM or (4) EA for 18 weeks. The Morris water maze (MWM) and Y-maze were used for behavioral assessments. Both HEM- and EA-treated mice had shorter mean daily escape latencies than HFSD-treated mice in the MWM. In addition, HEM-treated mice had a slightly increased exploratory time and frequency in the novel arm in the Y-maze. Quantitative PCR revealed that both HEM- and EA-treated mice exhibited reduced messenger RNA (mRNA) expression of tumor necrosis factor-alpha, interleukin-1 beta, and HEM-treated mice exhibited increased mRNA expression of NGF and NeuN in the hippocampus. Moreover, HEM and EA also decreased body weight, abdominal fat, plasma glucose, serum and liver total cholesterol, and liver triacylglycerol. Thus, HEM may be a potential health-promoting supplement for minimizing the progression of aging and obesity-induced neurodegeneration by reducing metabolic abnormalities and neuroinflammatory cytokines and increasing neurogenesis factors.
C1 [Tsai, Yun-Chieh; Huang, Shih-Ming] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.
   [Lin, Yu-Chen; Wu, Tzong-Yuan; Chin, Ting-Yu] Chung Yuan Christian Univ, Dept Biosci Technol, Taoyuan 320, Taiwan.
   [Wu, Tzong-Yuan] Chung Yuan Christian Univ, Dept Chem, Taoyuan, Taiwan.
   [Huang, Chun-Chih] New Bellus Enterprise Co Ltd, Tainan, Taiwan.
   [Villaflores, Oliver B.] Univ Santo Tomas, Dept Chem, Manila, Philippines.
   [Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei 114, Taiwan.
C3 National Defense Medical Center; Chung Yuan Christian University; Chung
   Yuan Christian University; University of Santo Tomas; National Defense
   Medical Center
RP Wu, TY (corresponding author), Chung Yuan Christian Univ, Dept Biosci Technol, Taoyuan 320, Taiwan.; Huang, SM (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei 114, Taiwan.; Chin, TY (corresponding author), Chung Yuan Christian Univ, Dept Biosci Technol, 200 Chung Pei Rd, Taoyuan 32023, Taiwan.
EM tywu@cycu.edu.tw; shihming7102@gmail.com; tychin@cycu.edu.tw
OI Chin, Ting-Yu/0000-0001-5492-1794
CR Allen SJ, 2006, CLIN SCI, V110, P175, DOI 10.1042/CS20050161
   Badowska-Szalewska E, 2011, BRAIN RES, V1384, P97, DOI 10.1016/j.brainres.2011.01.112
   Bailey-Downs LC, 2013, J GERONTOL A-BIOL, V68, P780, DOI 10.1093/gerona/gls238
   Birch AM, 2013, NEUROPHARMACOLOGY, V75, P255, DOI 10.1016/j.neuropharm.2013.07.023
   Cano-Ramírez D, 2012, J BIOCHEM MOL TOXIC, V26, P206, DOI 10.1002/jbt.21404
   Cuadrado-Tejedor M, 2011, J ALZHEIMERS DIS, V23, P195, DOI 10.3233/JAD-2010-100966
   Eskelinen MH, 2008, INT J GERIATR PSYCH, V23, P741, DOI 10.1002/gps.1969
   Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0
   Frielingsdorf H, 2007, NEUROBIOL DIS, V26, P47, DOI 10.1016/j.nbd.2006.11.015
   Gong M, 2004, ACTA BIOCH BIOPH SIN, V36, P343, DOI 10.1093/abbs/36.5.343
   Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017
   Harvey J, 2003, ANN MED, V35, P197, DOI 10.1080/07853890310008251
   Harvey J, 2003, NEUROPHARMACOLOGY, V44, P845, DOI 10.1016/S0028-3908(03)00076-5
   Hiwatashi K, 2010, BIOSCI BIOTECH BIOCH, V74, P1447, DOI 10.1271/bbb.100130
   Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3
   Kawagishi H, 1996, TETRAHEDRON LETT, V37, P7399, DOI 10.1016/0040-4039(96)01687-5
   KAWAGISHI H, 1994, TETRAHEDRON LETT, V35, P1569, DOI 10.1016/S0040-4039(00)76760-8
   Kuo PH, 2015, BRIT J NUTR, V113, P1550, DOI 10.1017/S0007114515000732
   Lee EW, 2000, BIOSCI BIOTECH BIOCH, V64, P2402, DOI 10.1271/bbb.64.2402
   Lee JS, 2010, CANCER LETT, V297, P144, DOI 10.1016/j.canlet.2010.05.006
   Lee KF, 2014, INT J MOL SCI, V15, P15073, DOI 10.3390/ijms150915073
   Li G, 2014, J ETHNOPHARMACOL, V153, P521, DOI 10.1016/j.jep.2014.03.003
   Liu Qing Yan, 2016, Am J Neurodegener Dis, V5, P74
   Liu Y, 2014, BEHAV BRAIN RES, V267, P178, DOI 10.1016/j.bbr.2014.02.040
   Ma BingJi, 2010, Mycology - An International Journal on Fungal Biology, V1, P92
   Ma MX, 2007, NEUROSCIENCE, V147, P1059, DOI 10.1016/j.neuroscience.2007.05.020
   Malinowska E, 2009, J IND MICROBIOL BIOT, V36, P1513, DOI 10.1007/s10295-009-0640-x
   Mizuno T., 1999, International Journal of Medicinal Mushrooms, V1, P105
   Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9
   Mori K, 2009, PHYTOTHER RES, V23, P367, DOI 10.1002/ptr.2634
   Morrison CD, 2010, J NEUROCHEM, V114, P1581, DOI 10.1111/j.1471-4159.2010.06865.x
   Nakamura A, 2013, INT J MOL SCI, V14, P21240, DOI 10.3390/ijms141121240
   Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149
   Obara Y, 2002, DRUG NEWS PERSPECT, V15, P290, DOI 10.1358/dnp.2002.15.5.840042
   Pasinetti GM, 2008, J NEUROCHEM, V106, P1503, DOI 10.1111/j.1471-4159.2008.05454.x
   Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010
   Portiansky EL, 2006, EXP NEUROL, V202, P519, DOI 10.1016/j.expneurol.2006.07.014
   Prins JB, 2002, BEST PRACT RES CL EN, V16, P639, DOI 10.1053/beem.2002.0222
   Razay G, 2006, DEMENT GERIATR COGN, V22, P173, DOI 10.1159/000094586
   Ross AP, 2012, PHYSIOL BEHAV, V106, P133, DOI 10.1016/j.physbeh.2012.01.008
   Schönknecht P, 2002, NEUROSCI LETT, V324, P83, DOI 10.1016/S0304-3940(02)00164-7
   Shimbo M, 2005, NUTR RES, V25, P617, DOI 10.1016/j.nutres.2005.06.001
   Singh VK, 1997, J PSYCHIAT RES, V31, P657, DOI 10.1016/S0022-3956(97)00023-X
   Smine S, 2017, BBA-PROTEINS PROTEOM, V1865, P578, DOI 10.1016/j.bbapap.2017.03.001
   Stranahan AM, 2016, J CEREBR BLOOD F MET, V36, P2108, DOI 10.1177/0271678X16642233
   Sun H, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0370-9
   TAKEI N, 1989, J NEUROCHEM, V53, P1405, DOI 10.1111/j.1471-4159.1989.tb08531.x
   Taylor VH, 2007, OBES REV, V8, P409, DOI 10.1111/j.1467-789X.2007.00401.x
   Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x
   Tucsek Z, 2014, J GERONTOL A-BIOL, V69, P1212, DOI 10.1093/gerona/glt177
   Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061
   Xie WD, 2008, EUR J PHARMACOL, V599, P159, DOI 10.1016/j.ejphar.2008.09.042
   Yang BK, 2003, BIOSCI BIOTECH BIOCH, V67, P1292, DOI 10.1271/bbb.67.1292
   Yim MH, 2007, ACTA PHARMACOL SIN, V28, P901, DOI 10.1111/j.1745-7254.2007.00577.x
   Zhang YT, 2018, J ANTIBIOT, V71, P818, DOI 10.1038/s41429-018-0065-8
NR 55
TC 17
Z9 18
U1 2
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD MAY 1
PY 2019
VL 22
IS 5
BP 469
EP 478
DI 10.1089/jmf.2018.4288
PG 10
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition &
   Dietetics
GA HY2PC
UT WOS:000467964100005
PM 31084539
DA 2024-02-19
ER

PT J
AU Utiyama, SRD
   Nisihara, RM
   Nass, FR
   Oliveira, NP
   Fiedler, PT
   de Messias-Reason, IT
AF da Rosa Utiyama, Shirley Ramos
   Nisihara, Renato Mitsunori
   Nass, Flavia Raphaela
   Oliveira, Nanci P.
   Fiedler, Patricia T.
   de Messias-Reason, Iara Taborda
TI Autoantibodies in patients with Down Syndrome: Early senescence of the
   immune system or precocious markers for immunological diseases?
SO JOURNAL OF PAEDIATRICS AND CHILD HEALTH
LA English
DT Article
DE autoantibody; Down syndrome; rheumatoid factor
ID LUPUS-ERYTHEMATOSUS; ANTIBODIES; ARTHRITIS; GLOMERULONEPHRITIS;
   ASSOCIATION; ARTHROPATHY; PREVALENCE; DEFICIENCY; MORTALITY; HEPATITIS
AB Down syndrome (DS) patients present several immunological disturbances, with high rates of infections, malignancies and autoimmune phenomena. The present study aims to evaluate the prevalence of autoantibodies in children and adolescents with DS that are not usually investigated, and to establish possible clinical and laboratory associations.
   One hundred and fifty Caucasoid DS patients from southern Brazil (93M, 57F; median age 4 years) and 105 healthy children (58M, 47F; median age 8 years) were evaluated for the presence of anti-mitochondrial (AMA), smooth-muscle (SMA), liver-kidney microsomal (LKM), nuclear (ANA), gastric parietal cell (GPC) and neutrophil cytoplasmic (ANCA) antibodies, by indirect immunofluorescence, and rheumatoid factor (RF), by turbidimetry.
   Forty-three DS patients (28.6%) showed positivity to at least one autoantibody, in comparison with eight of the controls (7.6%; P < 0.001). RF was detected in 28% of the patients and 6.7% of the controls (P < 0.001). ANCA, SMA and ANA were positive in 0.66% of the patients, while AMA, GPC and LKM were negative in all the samples. Currently, none of the RF positive patients has clinical evidence of rheumatic disease.
   Data from the present study suggest that the high incidence of positive RF observed in DS patients might be related to the senescence of the immune system or could be an earlier marker of rheumatic diseases in these patients.
C1 [da Rosa Utiyama, Shirley Ramos; Nisihara, Renato Mitsunori; Nass, Flavia Raphaela; de Messias-Reason, Iara Taborda] Univ Fed Parana, Immunopathol Lab, Dept Med Pathol, Clin Hosp, BR-80060240 Curitiba, Parana, Brazil.
   [Oliveira, Nanci P.; Fiedler, Patricia T.] Univ Fed Parana, Clin Hosp, Down Syndrome Clin, BR-80060240 Curitiba, Parana, Brazil.
   [de Messias-Reason, Iara Taborda] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
C3 Universidade Federal do Parana; Universidade Federal do Parana; Eberhard
   Karls University of Tubingen
RP Utiyama, SRD (corresponding author), Univ Fed Parana, Immunopathol Lab, Dept Med Pathol, Clin Hosp, Rua Padre Camargo 280, BR-80060240 Curitiba, Parana, Brazil.
EM shirley@ufpr.br
RI Nisihara, Renato RN/I-9654-2016
OI Nisihara, Renato RN/0000-0002-1234-8093; Jose de Messias Reason,
   Iara/0000-0002-5573-260X
CR Agrawal S, 2007, CLIN RHEUMATOL, V26, P201, DOI 10.1007/s10067-006-0275-5
   Anwar AJ, 1998, DIABETIC MED, V15, P160, DOI 10.1002/(SICI)1096-9136(199802)15:2<160::AID-DIA537>3.0.CO;2-J
   Ates A, 2007, CLIN RHEUMATOL, V26, P499, DOI 10.1007/s10067-006-0309-z
   AVANZINI MA, 1988, SCAND J IMMUNOL, V28, P465, DOI 10.1111/j.1365-3083.1988.tb01477.x
   BAKKALOGLU A, 1994, CLIN GENET, V46, P322
   Bigazzi PE, 1984, LAB IMMUNOLOGIA CLIN, P968
   Bonamico M, 2001, J PEDIATR GASTR NUTR, V33, P139, DOI 10.1097/00005176-200108000-00008
   COSSARIZZA A, 1990, AM J MED GENET, P213
   Cuadrado E, 1996, CLIN IMMUNOL IMMUNOP, V78, P209, DOI 10.1006/clin.1996.0031
   Day SM, 2005, DEV MED CHILD NEUROL, V47, P171, DOI 10.1017/S0012162205000319
   Feingold M, 1995, CLIN GENET, V48, P277
   Haseyama T, 1998, NEPHROL DIAL TRANSPL, V13, P2142, DOI 10.1093/ndt/13.8.2142
   Hill DA, 2003, ARCH INTERN MED, V163, P705, DOI 10.1001/archinte.163.6.705
   HUANG YP, 1992, J GERONTOL, V47, pM50, DOI 10.1093/geronj/47.2.M50
   Kaushik SP, 2000, J CLIN GASTROENTEROL, V30, P330, DOI 10.1097/00004836-200004000-00029
   Manavalan JS, 1998, AUTOIMMUNE DISEASES, THIRD EDITION, P783
   NESPOLI L, 1993, J INTELL DISABIL RES, V37, P543
   Nisihara Renato M., 2005, J. Pediatr. (Rio J.), V81, P373, DOI 10.1590/S0021-75572005000600006
   OLSON JC, 1990, PEDIATRICS, V86, P931
   Padmakumar B, 2002, RHEUMATOLOGY, V41, P1191, DOI 10.1093/rheumatology/41.10.1191
   PHILIP R, 1996, J IMMUNOL, V136, P166
   Ribeiro Luciana M.A., 2003, J. Pediatr. (Rio J.), V79, P141, DOI 10.1590/S0021-75572003000200009
   RIZZETTO M, 1973, CLIN EXP IMMUNOL, V15, P331
   ROBSON WLM, 1995, PEDIATR NEPHROL, V9, P204, DOI 10.1007/BF00860750
   ROITZEN NJ, 2003, LANCET, V361, P1281
   Rosso C, 1997, Minerva Pediatr, V49, P483
   Shalitin S, 2002, J PEDIATR ENDOCR MET, V15, P649
   UGAZIO AG, 1977, EUR J PEDIATR, V126, P139, DOI 10.1007/BF00442195
   UGAZIO AG, 1990, AM J MED GENET, P204
   Wiik A, 1989, APMIS Suppl, V6, P12
   YANCEY CL, 1984, ARTHRITIS RHEUM, V27, P929, DOI 10.1002/art.1780270813
NR 31
TC 23
Z9 24
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1034-4810
EI 1440-1754
J9 J PAEDIATR CHILD H
JI J. Paediatr. Child Health
PD APR
PY 2008
VL 44
IS 4
BP 182
EP 186
DI 10.1111/j.1440-1754.2007.01229.x
PG 5
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 281MG
UT WOS:000254501100006
PM 17927730
DA 2024-02-19
ER

PT J
AU CRISTIANO, F
   DEHAAN, JB
   IANNELLO, RC
   KOLA, I
AF CRISTIANO, F
   DEHAAN, JB
   IANNELLO, RC
   KOLA, I
TI CHANGES IN THE LEVELS OF ENZYMES WHICH MODULATE THE ANTIOXIDANT BALANCE
   OCCUR DURING AGING AND CORRELATE WITH CELLULAR-DAMAGE
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; LIPID
   PEROXIDATION; AGING
ID CU/ZN-SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; GLUTATHIONE-PEROXIDASE;
   OXYGEN RADICALS; TRANSPORT; LIVER; PERMEABILITY; INVITRO; CELLS; BRAIN
AB Oxidative metabolism produces a flux of superoxide anions that must be removed from the cellular environment if the cell is to survive. The levels of antioxidant enzyme involved in the elimination of superoxide anions and/or hydrogen peroxide were investigated in an attempt to correlate any changes in the levels of these enzymes during aging with changes in free radical mediated cellular damage. Cu/Zn superoxide dismutase (Sod1), glutathione peroxidase (Gpx1) and catalase levels were measured in a number of organs during murine aging. Sod1 enzyme activity rose during aging in all organs studied, while the levels of both Gpx1 and catalase showed organ specific profiles. Both organs in which lipid peroxidation damage (which was used as a marker of free radical mediated damage) increased with age, namely the brain and small intestine, also showed a significant increase in the ratio of Sod1 to Gpx1 enzyme activity. In organs where either the ratio of Sod1/Gpx1 activity or Sod1/catalase levels (in the lung only) ratios were maintained during aging, no increased lipid peroxidation damage was detected. In the lung where Sod1/Gpx1 ratio did increase, Sod1/catalase remained constant and this was able to provide protection during aging. Thus our data shows that alterations in the balance between first and second steps of the antioxidant pathway correlate with cellular damage, and that this may contribute to the aging changes seen in some organs.
C1 MONASH UNIV,INST REPROD & DEV,MOLEC EMBRYOL & BIRTH DEFECTS LAB,CLAYTON,VIC 3168,AUSTRALIA.
C3 Monash University
RI de Haan, Judy B/E-8778-2010; Kola, Ismail/C-5254-2013
OI de Haan, Judy B./0000-0002-2749-7833
CR ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682
   AMSTAD P, 1991, BIOCHEMISTRY-US, V30, P9305, DOI 10.1021/bi00102a024
   BROOKSBANK BWL, 1984, DEV BRAIN RES, V16, P37, DOI 10.1016/0165-3806(84)90060-9
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHEN TS, 1990, J GERONTOL, V45, pB129, DOI 10.1093/geronj/45.4.B129
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DAHN HC, 1983, J NEUROCHEM, V40, P1003
   DEHAAN JB, 1994, PEDIATR RES, V35, P188, DOI 10.1203/00006450-199402000-00013
   DEHAAN JB, 1992, MOL BRAIN RES, V13, P179, DOI 10.1016/0169-328X(92)90025-7
   ELROYSTEIN O, 1986, EMBO J, V5, P615, DOI 10.1002/j.1460-2075.1986.tb04255.x
   FERRARIS RP, 1993, J NUTR, V123, P502, DOI 10.1093/jn/123.3.502
   FREEMAN HJ, 1986, AM J PHYSIOL, V251, pG208, DOI 10.1152/ajpgi.1986.251.2.G208
   GETZOFF ED, 1989, PROTEINS, V5, P322, DOI 10.1002/prot.340050408
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821
   KATZ D, 1987, DIGEST DIS SCI, V32, P285, DOI 10.1007/BF01297055
   KUROBE N, 1991, BIOMED RES-TOKYO, V12, P97, DOI 10.2220/biomedres.12.97
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   MARIUCCI G, 1990, EXPERIENTIA, V46, P735
   MCCOY EE, 1978, PEDIATR RES, V12, P685, DOI 10.1203/00006450-197806000-00001
   MULDER TPJ, 1991, GUT, V32, P1146, DOI 10.1136/gut.32.10.1146
   OTAMIRI T, 1991, DIGEST DIS, V9, P133, DOI 10.1159/000171299
   PARKS DA, 1984, AM J PHYSIOL, V247, pG167, DOI 10.1152/ajpgi.1984.247.2.G167
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   RESNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   SMITH JR, 1989, GENOME, V31, P386, DOI 10.1139/g89-058
   SUN SC, 1992, J SURG RES, V52, P583, DOI 10.1016/0022-4804(92)90133-K
   VINARDELL MP, 1987, COMP BIOCHEM PHYS A, V86, P617, DOI 10.1016/0300-9629(87)90611-6
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
NR 30
TC 42
Z9 44
U1 0
U2 5
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAY 12
PY 1995
VL 80
IS 2
BP 93
EP 105
DI 10.1016/0047-6374(94)01561-Y
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA RB321
UT WOS:A1995RB32100003
PM 7564567
DA 2024-02-19
ER

PT J
AU Puche, JE
   Fernández, MG
   Muntané, J
   Rioja, J
   Gonzalez-Barón, S
   Cortazar, IC
AF Puche, Juan E.
   Garcia Fernandez, Maria
   Muntane, Jordi
   Rioja, Jose
   Gonzalez-Baron, Salvador
   Castilla Cortazar, Inma
TI Low doses of insulin-like growth factor-I induce mitochondrial
   protection in aging rats
SO ENDOCRINOLOGY
LA English
DT Article
ID PERMEABILITY TRANSITION; PROTON LEAK; CELL-DEATH; ACTIVATION; APOPTOSIS;
   TRANSPORT; CIRRHOSIS; MEMBRANE; BINDING; IMPACT
AB Serum IGF-I levels decline with age. We have recently reported that in aging rats the exogenous administration of IGF-I restores IGF-I circulating levels and age relatedchanges, improving glucose and lipid metabolisms, increasing testosterone levels and serum total antioxidant capability, and reducing oxidative damage in the brain and liver associated with a normalization of antioxidant enzyme activities. Understanding that mitochondria are one of the most important cellular targets of IGF-I, the aims of this study were to characterize mitochondrial dysfunction and study the effect of IGF-I therapy on mitochondria, leading to cellular protection in the following experimental groups: young controls, untreated old rats, and aging rats treated with IGF-I. Compared with young controls, untreated aging rats showed an increase of oxidative damage in isolated mitochondria with a mitochondrial dysfunction characterized by: depletion of membrane potential with increased proton leak rates and intramitochondrial free radical production, and a significant reduction of ATPase and complex IV activities. In addition, mitochondrial respiration from untreated aging rats was atractyloside insensitive, suggesting that the adenine nucleotide translocator was uncoupled. The adenine nucleotide translocator has been shown to be one of the most sensitive locations for pore opening. Accordingly, untreated aging rats showed a significant overexpression of the active fragment of caspases 3 and 9. IGF-I therapy corrected these parameters of mitochondrial dysfunction and reduced caspase activation. In conclusion, these results show that the cytoprotective effect of IGF-I is closely related to a mitochondrial protection, leading to reduce free radical production, oxidative damage, and apoptosis, and to increased ATP production.
C1 [Puche, Juan E.; Castilla Cortazar, Inma] Univ San Pablo, Sch Med, Univ CEU, Dept Med Physiol, Madrid 28668, Spain.
   [Puche, Juan E.; Garcia Fernandez, Maria; Rioja, Jose; Gonzalez-Baron, Salvador; Castilla Cortazar, Inma] Univ Malaga, Sch Med, Dept Med Physiol, E-29071 Malaga, Spain.
   [Muntane, Jordi] Univ Cordoba, Liver Unit, Dept Internal Med, E-14080 Cordoba, Spain.
C3 San Pablo CEU University; Universidad de Malaga; Universidad de Cordoba
RP Cortazar, IC (corresponding author), Univ San Pablo, Sch Med, Univ CEU, Dept Med Physiol, Madrid 28668, Spain.
EM iccortazar@uma.es
RI María, garcia-fernandez/H-8196-2017; Castilla-Cortazar,
   Inma/K-7883-2017; Puche, Juan/L-9132-2014; Puche, Juan E/HMP-2853-2023
OI María, garcia-fernandez/0000-0002-6436-1361; Castilla-Cortazar,
   Inma/0000-0002-2230-5927; RIOJA VILLODRES, JOSE/0000-0002-1196-0352
CR Arab K, 2004, ANAL BIOCHEM, V325, P158, DOI 10.1016/j.ab.2003.10.022
   Barger JL, 2006, J APPL PHYSIOL, V101, P339, DOI 10.1152/japplphysiol.01260.2005
   Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890
   BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S
   BRAND MD, 1995, BIOENERGETICS PRACTI, P39
   Bras M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P231, DOI 10.1007/s10541-005-0105-4
   Cardoso SM, 1999, FREE RADICAL BIO MED, V26, P3, DOI 10.1016/S0891-5849(98)00205-6
   Castilla-Cortazar I, 2000, HEPATOLOGY, V31, P592, DOI 10.1002/hep.510310308
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1180, DOI 10.1053/gast.1997.v113.pm9322513
   Cemborain A, 1998, J HEPATOL, V28, P122, DOI 10.1016/S0168-8278(98)80211-0
   CORTESE JD, 1995, BBA-BIOENERGETICS, V1228, P216, DOI 10.1016/0005-2728(94)00178-8
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383
   GARCIFERNANDEZ M, 2007, ENDOCRINOLOGY
   Gu YP, 2004, FEBS LETT, V577, P357, DOI 10.1016/j.febslet.2004.10.040
   Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346
   Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008
   Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Laron Z, 1996, NEW ENGL J MED, V334, P463, DOI 10.1056/NEJM199602153340711
   Leinninger GM, 2004, CELL DEATH DIFFER, V11, P885, DOI 10.1038/sj.cdd.4401429
   Maggio M, 2005, J ENDOCRINOL INVEST, V28, P711, DOI 10.1007/BF03347554
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   MILLER NJ, 1993, NEW METHOD MEASURING, V21, pS95
   Mirpuri E, 2002, INT J BIOCHEM CELL B, V34, P242, DOI 10.1016/S1357-2725(01)00123-6
   Monemdjou S, 1999, AM J PHYSIOL-ENDOC M, V276, pE1073, DOI 10.1152/ajpendo.1999.276.6.E1073
   Muguerza B, 2001, BBA-MOL BASIS DIS, V1536, P185, DOI 10.1016/S0925-4439(01)00045-X
   *NAT AC SCI, 1991, GUIDING PRINCIPLES R
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Ness JK, 2004, GLIA, V46, P183, DOI 10.1002/glia.10360
   OCONNOR JE, 1988, BIOCHEM BIOPH RES CO, V151, P568, DOI 10.1016/0006-291X(88)90632-8
   Perez R, 2001, J HEPATOL, V34, P79
   Ritz P, 2005, DIABETES METAB, V31, pS67, DOI 10.1016/S1262-3636(05)73654-5
   SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591
   SCHNEIDER WC, 1950, JNCI-J NATL CANCER I, V10, P969
   Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254
   VELDHUIS JD, 1995, J CLIN ENDOCR METAB, V80, P3209, DOI 10.1210/jc.80.11.3209
   Vieira HLA, 2000, CELL DEATH DIFFER, V7, P1146, DOI 10.1038/sj.cdd.4400778
   Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859
   WU A, 1974, CLIN SCI MOL MED, V47, P359, DOI 10.1042/cs0470359
   Yamamura T, 2001, AM J PHYSIOL-HEART C, V280, pH1191, DOI 10.1152/ajpheart.2001.280.3.H1191
NR 42
TC 89
Z9 98
U1 0
U2 13
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD MAY
PY 2008
VL 149
IS 5
BP 2620
EP 2627
DI 10.1210/en.2007-1563
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 291LX
UT WOS:000255200000063
PM 18276748
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Chung, SI
   Moon, H
   Ju, HL
   Kim, DY
   Cho, KJ
   Ribback, S
   Dombrowski, F
   Calvisi, DF
   Ro, SW
AF Chung, Sook In
   Moon, Hyuk
   Ju, Hye-Lim
   Kim, Dae Yeong
   Cho, Kyung Joo
   Ribback, Silvia
   Dombrowski, Frank
   Calvisi, Diego F.
   Ro, Simon Weonsang
TI Comparison of liver oncogenic potential among human RAS isoforms
SO ONCOTARGET
LA English
DT Article
DE RAS isoform; liver cancer; hydrodynamic transfection; KRAS splicing
   variant; P16-INK4A
ID K-RAS; EXON 4A; CANCER; PROLIFERATION; SPECIFICITY; SENESCENCE;
   PROTEINS; MODELS
AB Mutation in one of three RAS genes (i.e., HRAS, KRAS, and NRAS) leading to constitutive activation of RAS signaling pathways is considered a key oncogenic event in human carcinogenesis. Whether activated RAS isoforms possess different oncogenic potentials remains an unresolved question. Here, we compared oncogenic properties among RAS isoforms using liver-specific transgenesis in mice. Hydrodynamic transfection was performed using transposons expressing short hairpin RNA downregulating p53 and an activated RAS isoform, and livers were harvested at 23 days after gene delivery. No differences were found in the hepatocarcinogenic potential among RAS isoforms, as determined by both gross examination of livers and liver weight per body weight ratio (LW/BW) of mice expressing HRAS(Q61L), KRAS4B(G12V) and NRAS(Q61K). However, the tumorigenic potential differed significantly between KRAS splicing variants. The LW/BW ratio in KRAS4A(G12V) mice was significantly lower than in KRAS4B(G12V) mice (p < 0.001), and KRAS4A(G12V) mice lived significantly longer than KRRAS4B(G12V) mice (p < 0.0001). Notably, tumors from KRAS4A(G12V) mice displayed higher expression of the p16(INK4A) tumor suppressor when compared with KRAS4B(G12V) tumors. Forced overexpression of p16(INK4A) significantly reduced tumor growth in KRAS4B(G12V) mice, suggesting that upregulation of p16(INK4A) by KRAS4A(G12V) presumably delays tumor development driven by the latter oncogene.
C1 [Chung, Sook In; Moon, Hyuk; Kim, Dae Yeong; Cho, Kyung Joo; Ro, Simon Weonsang] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea.
   [Ju, Hye-Lim; Ro, Simon Weonsang] Yonsei Univ, Coll Med, Liver Cirrhosis Clin Res Ctr, Seoul, South Korea.
   [Ribback, Silvia; Dombrowski, Frank; Calvisi, Diego F.] Univ Med Greifswald, Inst Pathol, Greifswald, Germany.
C3 Yonsei University; Yonsei University Health System; Yonsei University;
   Yonsei University Health System; Greifswald Medical School
RP Ro, SW (corresponding author), Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea.; Ro, SW (corresponding author), Yonsei Univ, Coll Med, Liver Cirrhosis Clin Res Ctr, Seoul, South Korea.
EM simonr@yuhs.ac
RI Ro, Simon Weonsang/AAK-7198-2020
OI Ro, Simon Weonsang/0000-0003-2187-3698; CHUNG, SOOK
   IN/0000-0002-7915-9203
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education [NRF-2011-0021830]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea, which is funded by
   the Ministry of Education (NRF-2011-0021830 to S.W.R.).
CR Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021
   Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35
   BOS JL, 1989, CANCER RES, V49, P4682
   Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102
   Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081
   Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969
   Downward J, 1997, CURR BIOL, V7, pR258, DOI 10.1016/S0960-9822(06)00116-3
   Figueiredo ML, 2012, LIVER INT, V32, P582, DOI 10.1111/j.1478-3231.2011.02732.x
   FIORUCCI G, 1988, BIOCHIM BIOPHYS ACTA, V950, P81, DOI 10.1016/0167-4781(88)90076-0
   Frith C H, 1994, IARC Sci Publ, P223
   Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0
   Hackett PB, 2005, ADV GENET, V54, P189, DOI 10.1016/S0065-2660(05)54009-4
   Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115
   Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105
   Ju HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059869
   Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lau KS, 2009, MOL CELLS, V28, P315, DOI 10.1007/s10059-009-0143-7
   Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750
   LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223
   Luo FJ, 2010, J PATHOL, V220, P542, DOI 10.1002/path.2672
   Millán O, 2003, ONCOGENE, V22, P477, DOI 10.1038/sj.onc.1206179
   Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8
   Pells S, 1997, ONCOGENE, V15, P1781, DOI 10.1038/sj.onc.1201354
   Plowman SJ, 2006, J EXP CLIN CANC RES, V25, P259
   Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612
   Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106
   Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X
   To MD, 2008, NAT GENET, V40, P1240, DOI 10.1038/ng.211
   Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40
   Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6
NR 35
TC 10
Z9 13
U1 0
U2 4
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD FEB 9
PY 2016
VL 7
IS 6
BP 7354
EP 7366
DI 10.18632/oncotarget.6931
PG 13
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA DM1RE
UT WOS:000376123100073
PM 26799184
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Videan, EN
   Fritz, J
   Murphy, J
AF Videan, Elaine N.
   Fritz, Jo
   Murphy, James
TI Effects of aging on hematology and serum clinical chemistry in
   chimpanzees <i>(Pan troglodytes</i>)
SO AMERICAN JOURNAL OF PRIMATOLOGY
LA English
DT Article
DE gerontology; clinical chemistry; longitudinal; chimpanzee; sex
   difference
ID BLOOD-CHEMISTRY; CAPTIVE CHIMPANZEES; BIOCHEMICAL VARIABLES; REFERENCE
   INTERVALS; RHESUS-MONKEYS; AGE; VALUES; HEMOGLOBIN; MATURATION;
   BIOMARKERS
AB A number of age-related changes in physiological functions have been identified in macaques and humans. However, few studies have examined physiological aging in chimpanzees, despite the increasing age of the chimpanzee population. We documented age-related changes in seven hematology and 17 clinical chemistry parameters in 49 adult chimpanzees (17 males, 32 females) as a comparative viewpoint with human and macaque aging. Longitudinal data were analyzed using weighted linear and quadratic mixed effects regression models. Male chimpanzees exhibited a significant age-related increase in anemia risk, based on significant decreases in hemoglobin (F-1,F-49 = 12.45, P = 0.0009) and hematocrit (F-1,F-49 = 15.42, P = 0.0003). Both sexes exhibited significant age-related decreases in both kidney and liver function. Decreases in kidney function were noted by significant increases in blood urea nitrogen (F-1,F-45 = 3.92, P = 0.036) and creatinine (F-1,F-50 = 5.63, P = 0.022) as well as changes in electrolyte (i.e., sodium, potassium, phosphorous, chloride) balance. Declining liver function was based on significant increases in globulin (F-1,F-46 = 32.34, P < 0.0001) and decreases in albumin (F-1,F-48 = 23.42, P < 0.0001). These changes were most evident beginning at 25-30 years of age in males and 30-35 years of age in females. We recommend amending chimpanzee age classes to categorize males over 25 years and females over 30 years as aged.
C1 [Videan, Elaine N.; Fritz, Jo; Murphy, James] Primate Fdn Arizona, Mesa, AZ USA.
RP Videan, EN (corresponding author), Alamogordo Primate Facil, POB 965, Holloman AFB, NM 88330 USA.
EM elaine.videan@crl.com
FU NCRR NIH HHS [U42 RR015090 05 S1] Funding Source: Medline
CR ANEMONE RL, 1991, AM J PHYS ANTHROPOL, V86, P229, DOI 10.1002/ajpa.1330860211
   [Anonymous], 2004, US INT PROJ AG SEX R
   Baker KC, 2000, ZOO BIOL, V19, P111, DOI 10.1002/1098-2361(2000)19:2<111::AID-ZOO2>3.0.CO;2-5
   Blain H, 2001, PRESSE MED, V30, P779
   BOHNEN N, 1992, Z GERONTOL, V25, P339
   Boulat O, 1998, CLIN CHIM ACTA, V272, P127, DOI 10.1016/S0009-8981(98)00017-5
   Bryk A.S., 1992, Hierarchical Models: Applications and Data Analysis Methods
   Caprari P, 1999, EXP GERONTOL, V34, P47, DOI 10.1016/S0531-5565(98)00055-2
   Chan PC, 1999, J AM COLL NUTR, V18, P358
   Coppola L, 2000, ARCH GERONTOL GERIAT, V31, P35, DOI 10.1016/S0167-4943(00)00063-7
   Erwin JM, 2002, INTERD T GERONT GERI, V31, P1
   Gavan J. A., 1953, Human Biology, V25, P93
   GEARING M, 1994, P NATL ACAD SCI USA, V91, P9382, DOI 10.1073/pnas.91.20.9382
   Goodall J., 1986, CHIMPANZEES GOMBE PA
   Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310
   HAINSEY BM, 1993, LAB ANIM SCI, V43, P236
   Hamada Y, 2003, PRIMATES, V44, P259, DOI 10.1007/s10329-003-0039-7
   Herndon JG, 1999, J COMP NEUROL, V409, P567
   Herndon JG, 2001, COMPARATIVE MED, V51, P60
   Hof PR, 2002, INTERD T GERONT GERI, V31, P130
   Howell S, 2003, COMPARATIVE MED, V53, P413
   Huffman M.A., 1990, P237
   Ihrig M, 2001, COMPARATIVE MED, V51, P30
   Kuykendall KL, 1996, AM J PHYS ANTHROPOL, V99, P159, DOI 10.1002/(SICI)1096-8644(199601)99:1<159::AID-AJPA9>3.0.CO;2-W
   Kuzuya M, 2002, ATHEROSCLEROSIS, V163, P313, DOI 10.1016/S0021-9150(02)00009-6
   Leigh SR, 1996, AM J PHYS ANTHROPOL, V99, P43, DOI 10.1002/(SICI)1096-8644(199601)99:1<43::AID-AJPA3>3.0.CO;2-0
   Littleton J, 2005, AM J PRIMATOL, V67, P281, DOI 10.1002/ajp.20185
   MARSON J, 1991, BIOL REPROD, V44, P448, DOI 10.1095/biolreprod44.3.448
   MCCLURE HM, 1973, CHIMPANZEE ANATOMY P, V1, P121
   METELOVSKI E, 1997, CHIMPANZOO C P PROF, P44
   NAKAMURA E, 1994, EXP GERONTOL, V29, P151, DOI 10.1016/0531-5565(94)90048-5
   Nakamura E, 1998, EXP GERONTOL, V33, P421, DOI 10.1016/S0531-5565(97)00134-4
   Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319
   Nilsson-Ehle H, 2000, EUR J HAEMATOL, V65, P297, DOI 10.1034/j.1600-0609.2000.065005297.x
   Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068
   REIBNEGGER G, 1988, MECH AGEING DEV, V46, P67, DOI 10.1016/0047-6374(88)90115-7
   Roof KA, 2005, AM J PRIMATOL, V67, P199, DOI 10.1002/ajp.20177
   Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541
   Schalk BWM, 2005, J AM GERIATR SOC, V53, P1331, DOI 10.1111/j.1532-5415.2005.53417.x
   Skjelbakken T, 2005, EUR J HAEMATOL, V74, P381, DOI 10.1111/j.1600-0609.2004.00392.x
   Smith B. Holly, 1994, Yearbook of Physical Anthropology, V37, P177
   Smucny DA, 2004, J MED PRIMATOL, V33, P48, DOI 10.1111/j.1600-0684.2003.00052.x
   Smucny DA, 2001, J MED PRIMATOL, V30, P161, DOI 10.1111/j.1600-0684.2001.tb00005.x
   Stone GA, 2000, J MED PRIMATOL, V29, P324, DOI 10.1034/j.1600-0684.2000.290503.x
   Tarou LR, 2002, INTERDISC TOPICS GER, V31, P209
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
NR 46
TC 34
Z9 35
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0275-2565
EI 1098-2345
J9 AM J PRIMATOL
JI Am. J. Primatol.
PD APR
PY 2008
VL 70
IS 4
BP 327
EP 338
DI 10.1002/ajp.20494
PG 12
WC Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Zoology
GA 277MW
UT WOS:000254218000003
PM 17943981
DA 2024-02-19
ER

PT J
AU Bellavista, E
   Martucci, M
   Vasuri, F
   Santoro, A
   Mishto, M
   Kloss, A
   Capizzi, E
   Degiovanni, A
   Lanzarini, C
   Remondini, D
   Dazzi, A
   Pellegrini, S
   Cescon, M
   Capri, M
   Salvioli, S
   D'Errico-Grigioni, A
   Dahlmann, B
   Grazi, GL
   Franceschi, C
AF Bellavista, Elena
   Martucci, Morena
   Vasuri, Francesco
   Santoro, Aurelia
   Mishto, Michele
   Kloss, Alexander
   Capizzi, Elisa
   Degiovanni, Alessio
   Lanzarini, Catia
   Remondini, Daniel
   Dazzi, Alessandro
   Pellegrini, Sara
   Cescon, Matteo
   Capri, Miriam
   Salvioli, Stefano
   D'Errico-Grigioni, Antonia
   Dahlmann, Burkhardt
   Grazi, Gian Luca
   Franceschi, Claudio
TI Lifelong maintenance of composition, function and cellular/subcellular
   distribution of proteasomes in human liver
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Aging; Human liver; Standard proteasome; Immunoproteasome; PA28 alpha
   beta regulator; Gender
ID DIFFERENT ENZYMATIC-PROPERTIES; RAT-LIVER; 20S PROTEASOME; STRUCTURAL
   MODEL; OXIDATIVE-STRESS; KAPPA-B; IMMUNOPROTEASOME; AGE; DONORS;
   TRANSPLANTATION
AB Owing to organ shortage, livers from old donors are increasingly used for transplantation. The function and duration of such transplanted livers are apparently comparable to those from young donors, suggesting that, despite some morphological and structural age-related changes, no major functional changes do occur in liver with age. We tested this hypothesis by performing a comprehensive study on proteasomes, major cell organelles responsible for proteostasis, in liver biopsies from heart-beating donors. Oxidized and poly-ubiquitin conjugated proteins did not accumulate with age and the three major proteasome proteolytic activities were similar in livers from young and old donors. Analysis of proteasomes composition showed an age-related increased of beta 5i/alpha 4 ratio, suggesting a shift toward proteasomes containing inducible subunits and a decreased content of PA28 alpha subunit, mainly in the cytosol of hepatocytes. Thus our data suggest that, proteasomes activity is well preserved in livers from aged donors, concomitantly with subtle changes in proteasome subunit composition which might reflect the occurrence of a functional remodelling to maintain an efficient proteostasis. Gender differences are emerging and they deserve further investigations owing to the different aging trajectories between men and women. Finally, our data support the safe use of livers from old donors for transplantation. (C) 2014 The Authors. Published by Elsevier Ireland Ltd.
C1 [Bellavista, Elena; Remondini, Daniel; Capri, Miriam; Salvioli, Stefano; Franceschi, Claudio] Univ Bologna, Alma Mater Studiorum, Interdept Ctr L Galvani Integrated Studies Biophy, I-40126 Bologna, Italy.
   [Bellavista, Elena; Martucci, Morena; Santoro, Aurelia; Lanzarini, Catia; Capri, Miriam; Salvioli, Stefano; Franceschi, Claudio] Univ Bologna, Alma Mater Studiorum, Dept Expt Diagnost & Specialty Med DIMES, I-40126 Bologna, Italy.
   [Vasuri, Francesco; Capizzi, Elisa; Degiovanni, Alessio; D'Errico-Grigioni, Antonia] St Orsola Marcello Malpighi Hosp, Dept Expt Diagnost & Specialty Med DIMES, F Addarii Inst Oncol & Transplant Pathol, I-40138 Bologna, Italy.
   [Mishto, Michele; Kloss, Alexander; Dahlmann, Burkhardt] Charite, Inst Biochem, D-10117 Berlin, Germany.
   [Mishto, Michele] Univ Bologna, Ctr Interdipartimentale Ric Canc Giorgio Prodi CI, I-40126 Bologna, Italy.
   [Remondini, Daniel] Univ Bologna, Alma Mater Studiorum, Dept Phys & Astron DIFA, I-40127 Bologna, Italy.
   [Remondini, Daniel] Univ Bologna, Alma Mater Studiorum, Ist Nazl Fis Nucl, Sez Bologna, I-40127 Bologna, Italy.
   [Dazzi, Alessandro; Pellegrini, Sara; Cescon, Matteo] St Orsola Marcello Malpighi Hosp, Dept Gen Surg & Organ Transplantat, I-40138 Bologna, Italy.
   [Grazi, Gian Luca] Ist Nazl Tumori Regina Elena, I-00144 Rome, Italy.
   [Franceschi, Claudio] IRCCS Inst Neurol Sci, I-40139 Bologna, Italy.
   [Franceschi, Claudio] CNR, Natl Res Council Italy, Inst Organ Synth & Photoreact ISOF, I-40129 Bologna, Italy.
   [Franceschi, Claudio] CNR, Natl Res Council Italy, Inst Mol Genet, Unit Bologna IOR, I-40136 Bologna, Italy.
C3 University of Bologna; University of Bologna; IRCCS Azienda
   Ospedaliero-Universitaria di Bologna; Free University of Berlin;
   Humboldt University of Berlin; Charite Universitatsmedizin Berlin;
   University of Bologna; University of Bologna; University of Bologna;
   Istituto Nazionale di Fisica Nucleare (INFN); IRCCS Azienda
   Ospedaliero-Universitaria di Bologna; IRCCS Istituti Fisioterapici
   Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituto delle Scienze
   Neurologiche di Bologna (ISNB); Consiglio Nazionale delle Ricerche
   (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR);
   Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica
   Molecolare (IGM-CNR)
RP Bellavista, E (corresponding author), Univ Bologna, Alma Mater Studiorum, Interdept Ctr L Galvani, I-40126 Bologna, Italy.
EM elena.bellavista2@unibo.it; morena.martucci3@unibo.it;
   francesco.vasuri@aosp.bo.it; aurelia.santoro@unibo.it;
   michele.mishto@charite.de; alex.kloss@charite.de;
   elisa.capizzi@libero.it; alessio.degiovanni@gmail.com;
   catia.lanzarini2@unibo.it; daniel.remondini@unibo.it; alled78@yahoo.it;
   sarapellegrini@hotmail.com; matteo.cescon@aosp.bo.it;
   miriam.capri@unibo.it; stefano.salvioli@unibo.it; derrico@aosp.bo.it;
   burkhardt.dahlmann@charite.de; grazi@ifo.it; claudio.franceschi@unibo.it
RI Capri, Miriam/K-4700-2016; Franceschi, Claudio/L-4484-2017; D'ERRICO,
   ANTONIETTA/HGU-1912-2022; Salvioli, Stefano/K-6663-2016; Remondini,
   Daniel/ABA-9971-2020; Vasuri, Francesco/K-5418-2016; Grazi, Gian
   Luca/J-7215-2018; mishto, michele/A-5592-2010
OI Capri, Miriam/0000-0001-9077-0401; D'ERRICO,
   ANTONIETTA/0000-0003-2747-3732; Salvioli, Stefano/0000-0002-6191-1225;
   Vasuri, Francesco/0000-0002-1145-6025; Grazi, Gian
   Luca/0000-0002-3279-0313; mishto, michele/0000-0003-3042-2792; Santoro,
   Aurelia/0000-0002-7187-1116; Cescon, Matteo/0000-0003-1715-3794;
   Remondini, Daniel/0000-0003-3185-7456
FU MIUR [prot. 2008WRBYPE]; European Commission Integrated Project
   PROTEOMAGE [FP6-518230]; IDEAL [FP7-259679]; Italian Ministry of
   Economic Development project MIAO50 [00088 MI01]; Fondazione Italiana
   Sclerosi Multipla fellowship [2011/B/5]
FX This work was financed in part by MIUR (prot. 2008WRBYPE) project
   PRIN2008 to GLG, by the European Commission Integrated Project
   PROTEOMAGE (FP6-518230) and IDEAL (FP7-259679), by Italian Ministry of
   Economic Development project MIAO50 (00088 MI01) to CF. Morena Martucci
   was supported by Fondazione Italiana Sclerosi Multipla fellowship
   (2011/B/5).
CR Bellavista E, 2008, REJUV RES, V11, P73, DOI 10.1089/rej.2007.0559
   Bellavista E, 2013, CURR PHARM DESIGN, V19, P702, DOI 10.2174/138161213804581927
   Böttcher JP, 2011, DIGEST DIS, V29, P384, DOI 10.1159/000329801
   Breusing N, 2009, MECH AGEING DEV, V130, P748, DOI 10.1016/j.mad.2009.09.004
   Broering R., 2001, CLIN SCI, V121, P415
   Cescon M, 2003, LIVER TRANSPLANT, V9, P1174, DOI 10.1053/jlts.2003.50234
   Cescon M, 2008, LIVER TRANSPLANT, V14, P672, DOI 10.1002/lt.21433
   Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13
   Chondrogianni N, 2010, ADV EXP MED BIOL, V694, P38
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185
   Dasuri K, 2009, MECH AGEING DEV, V130, P777, DOI 10.1016/j.mad.2009.10.003
   Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P130, DOI 10.1089/ars.2006.8.130
   Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2543, DOI 10.1007/s00018-012-0938-0
   Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1
   Fiorentino M, 2009, LIVER TRANSPLANT, V15, P1821, DOI 10.1002/lt.21948
   Franceschi C, 2000, EXP GERONTOL, V35, P879, DOI 10.1016/S0531-5565(00)00172-8
   Franceschi C, 2000, AGING-CLIN EXP RES, V12, P77, DOI 10.1007/BF03339894
   Gohlke S, 2014, ANN HEPATOL, V13, P429, DOI 10.1016/S1665-2681(19)30850-6
   Gohlke S, 2014, AGE, V36, P57, DOI 10.1007/s11357-013-9543-x
   Grazi GL, 2001, AM J TRANSPLANT, V1, P61, DOI 10.1034/j.1600-6143.2001.010112.x
   Grimm S, 2012, BIOCHEM J, V448, P127, DOI 10.1042/BJ20120298
   Hansen TO, 2012, BIOGERONTOLOGY, V13, P429, DOI 10.1007/s10522-012-9387-2
   Harring TR, 2011, CLIN LIVER DIS, V15, P879, DOI 10.1016/j.cld.2011.08.006
   Hayashi T, 1999, MOL CELL BIOL, V19, P8646
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425
   Huber N, 2009, HEPATOLOGY, V49, P1718, DOI 10.1002/hep.22840
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3
   Mishto M, 2006, BIOL CHEM, V387, P417, DOI 10.1515/BC.2006.056
   Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004
   Mishto M, 2011, BIOCHEM BIOPH RES CO, V408, P65, DOI 10.1016/j.bbrc.2011.03.117
   Mishto M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009287
   Petersen A., 2010, CURR GERONTOL GERIAT, DOI [10.1155/2010/, DOI 10.1155/2010]
   Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878
   Ravaioli M, 2009, TRANSPL INT, V22, P423, DOI 10.1111/j.1432-2277.2008.00812.x
   Rodriguez KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035890
   Rodriguez KA, 2010, MECH AGEING DEV, V131, P144, DOI 10.1016/j.mad.2010.01.002
   Schmeding M, 2010, ANN TRANSPL, V15, P5
   Schmidt F, 2006, PROTEOMICS, V6, P4622, DOI 10.1002/pmic.200500920
   Schmucker DL, 2011, CURR GERONTOL GERIAT, V2011, DOI [10.1155/2011/526379, DOI 10.1155/2011/526379]
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   Shibatani T, 2006, MOL BIOL CELL, V17, P4962, DOI 10.1091/mbc.E06-04-0311
   Sixt SU, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/204250
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Thi KDV, 2011, EXP GERONTOL, V46, P257, DOI 10.1016/j.exger.2010.10.012
   Tomaru U, 2012, AM J PATHOL, V180, P963, DOI 10.1016/j.ajpath.2011.11.012
   Vasuri F, 2010, BIOCHEM BIOPH RES CO, V397, P301, DOI 10.1016/j.bbrc.2010.05.104
NR 50
TC 13
Z9 15
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD NOV-DEC
PY 2014
VL 141
BP 26
EP 34
DI 10.1016/j.mad.2014.09.003
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA AX8BK
UT WOS:000347135400005
PM 25265087
OA hybrid
DA 2024-02-19
ER

PT J
AU Donati, A
   Cavallini, G
   Bergamini, E
AF Donati, Alessio
   Cavallini, Gabriella
   Bergamini, Ettore
TI Effects of aging, antiaging calorie restriction and in vivo stimulation
   of autophagy on the urinary excretion of 8OHdG in male Sprague-Dawley
   rats
SO AGE
LA English
DT Article
DE Caloric restriction; Autophagy; Antilipolytic drugs; 8OHdG; Urine
ID OXIDATIVE DNA-DAMAGE; MITOCHONDRIAL-DNA; LIVER; CELLS; MACROAUTOPHAGY;
   HUMANS; DEGRADATION; PROTEOLYSIS; NUCLEAR; REPAIR
AB 8-Hydroxy-2-deoxyguanosine (8OHdG) excreted into the urine is considered a marker of oxidative stress effect on DNA, and it is reported to be mainly produced by the DNA repair system. In previous works, we showed that autophagy was also involved in 8OHdG disposal through the degradation of oxidatively altered mitochondria. Here, we show that aging in Sprague-Dawley male rats is associated with a decline in the in vitro function of liver autophagy and a slight and not significant decrease in the urinary excretion of 8OHdG. In addition, we demonstrate that anti-aging caloric restriction maintains levels of both liver autophagy and urinary excretion of 8OHdG at very high levels throughout life. Finally, we show the in vivo stimulation of autophagy by the administration of an antilipolytic agent or everolimus, which rescues rats from the accumulation of 8OHdG in the liver mtDNA, also causes a dramatic increase in the urinary excretion of 8OHdG. The intensification of autophagy by the administration of the antilipolytic drugs to fasting rats faded progressively with increasing age, together with a reduced increase in 8OHdG output into the urine. It is concluded that the process of autophagy may play a major role in the disposal of 8OHdG with urine, and that the assay of 8OHdG levels in the urine before and after the stimulation of autophagy may provide a novel, non-invasive and safe procedure to monitor the in vivo functioning of the process.
C1 [Donati, Alessio; Cavallini, Gabriella; Bergamini, Ettore] Univ Pisa, Ctr Interdipartimentale Biol & Patol Invecchiamen, I-56126 Pisa, Italy.
C3 University of Pisa
RP Donati, A (corresponding author), Univ Pisa, Ctr Interdipartimentale Biol & Patol Invecchiamen, Via Roma 55, I-56126 Pisa, Italy.
EM a.donati@med.unipi.it
CR Bergamini E, 2004, INT J BIOCHEM CELL B, V36, P2392, DOI 10.1016/j.biocel.2004.05.007
   Bergamini E, 1995, AGING-CLIN EXP RES, V7, P473, DOI 10.1007/BF03324374
   BERGAMINI E, 1993, EXP MOL PATHOL, V59, P13, DOI 10.1006/exmp.1993.1023
   Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020
   BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2
   Burtis CA, 2009, TIETZ TXB CLIN CHEM
   Cavallini G, 2007, AUTOPHAGY, V3, P26, DOI 10.4161/auto.3268
   Cooke MS, 2008, CANCER EPIDEM BIOMAR, V17, P3, DOI 10.1158/1055-9965.EPI-07-0751
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   Donati A, 2008, BIOCHEM BIOPH RES CO, V366, P786, DOI 10.1016/j.bbrc.2007.12.023
   Donati Alessio, 2006, Molecular Aspects of Medicine, V27, P455, DOI 10.1016/j.mam.2006.08.003
   Donati A, 2006, REJUV RES, V9, P408, DOI 10.1089/rej.2006.9.408
   Donati A, 2009, METHOD ENZYMOL, V452, P441, DOI 10.1016/S0076-6879(08)03626-4
   Evans MD, 2010, MUTAGENESIS, V25, P433, DOI 10.1093/mutage/geq031
   FEUERS RJ, 1993, MUTAT RES, V295, P191, DOI 10.1016/0921-8734(93)90020-4
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Hartford CM, 2007, CLIN PHARMACOL THER, V82, P381, DOI 10.1038/sj.clpt.6100317
   Heydari AR, 2007, NUCLEIC ACIDS RES, V35, P7485, DOI 10.1093/nar/gkm860
   Hofer T, 2008, REJUV RES, V11, P793, DOI 10.1089/rej.2008.0712
   Jin SK, 2006, AUTOPHAGY, V2, P80, DOI 10.4161/auto.2.2.2460
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204
   LOFT S, 1995, CANCER EPIDEM BIOMAR, V4, P515
   LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241
   Masoro EJ, 2009, BBA-GEN SUBJECTS, V1790, P1040, DOI 10.1016/j.bbagen.2009.02.011
   MCCARTER R, 1985, AM J PHYSIOL, V248, pE488
   Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3
   MORTIMOR.GE, 1970, J BIOL CHEM, V245, P2375
   MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543
   Nakamoto H, 2007, EXP GERONTOL, V42, P287, DOI 10.1016/j.exger.2006.11.006
   PFEIFER U, 1978, J CELL BIOL, V78, P152, DOI 10.1083/jcb.78.1.152
   Priemé H, 1998, CARCINOGENESIS, V19, P347, DOI 10.1093/carcin/19.2.347
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   SIMIC MG, 1991, MUTAT RES, V250, P17, DOI 10.1016/0027-5107(91)90158-K
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   van Zutphen T, 2011, AUTOPHAGY, V7, P863, DOI 10.4161/auto.7.8.15697
   VERHAGEN H, 1995, CARCINOGENESIS, V16, P969, DOI 10.1093/carcin/16.4.969
   Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010
NR 44
TC 16
Z9 19
U1 0
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
J9 AGE
JI Age
PD APR
PY 2013
VL 35
IS 2
BP 261
EP 270
DI 10.1007/s11357-011-9346-x
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 105JX
UT WOS:000316065200001
PM 22351421
OA Green Published
DA 2024-02-19
ER

PT J
AU D'Souza, T
   Sherman-Baust, CA
   Poosala, S
   Mullin, JM
   Morin, PJ
AF D'Souza, Theresa
   Sherman-Baust, Cheryl A.
   Poosala, Suresh
   Mullin, James M.
   Morin, Patrice J.
TI Age-Related Changes of Claudin Expression in Mouse Liver, Kidney, and
   Pancreas
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Claudin; Aging; Tight junction; Immunohistochemistry
ID JUNCTION BARRIER FUNCTION; OVARIAN-CANCER CELLS; TIGHT JUNCTIONS;
   PROTEINS; MICE; PERMEABILITY; PHOSPHORYLATION; EPIDIDYMIS; OCCLUDIN;
   PATHWAY
AB Tight junctions (TJs) play crucial roles in tissue homeostasis and inflammation through their roles in the control of paracellular transport and barrier function. There is evidence that these functions are compromised in older organisms, but the exact mechanisms leading to TJ deterioration are not well understood. Claudin proteins are a family of membrane proteins that constitute the structural barrier elements of TJs and therefore play a major role in their formation and function. Using immunohistochemistry and immunoblotting, we have Studied the expression of six different claudin proteins (claudin-1, -2, -3, -4, -5, and -7) in three tissues (liver, kidney, and pancreas) of aging male and female mice. In general, we find an age-dependent decrease in the expression of several claudin proteins in all three tissues observed, although the exact changes are tissue specific. Our findings provide a possible basis for the decrease in tissue barrier function in older organisms.
C1 [Morin, Patrice J.] NIA, Cellular & Mol Biol Lab, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA.
   [Poosala, Suresh] NIA, Res Resource Branch, Baltimore, MD 21224 USA.
   [Mullin, James M.] Lankenau Inst Med Res, Wynnewood, PA USA.
   [Morin, Patrice J.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA); Lankenau Medical Center; Lankenau Institute
   for Medical Research; Johns Hopkins University; Johns Hopkins Medicine
RP Morin, PJ (corresponding author), NIA, Cellular & Mol Biol Lab, NIH, Biomed Res Ctr, 251 Bayview Blvd,Suite 100,Room 6C228, Baltimore, MD 21224 USA.
EM morinp@mail.nih.gov
RI Mullin, James M./AAD-9348-2020
OI Mullin, James/0000-0001-5285-7530
FU National Institutes of Health, National Institute on Aging
FX This research was supported entirely by the Intramural Research Program
   of the National Institutes of Health, National Institute on Aging.
CR BACALLAO R, 1994, J CELL SCI, V107, P3301
   Balkovetz DF, 2009, BBA-BIOMEMBRANES, V1788, P858, DOI 10.1016/j.bbamem.2008.07.004
   BURNS EM, 1981, NEUROBIOL AGING, V2, P285, DOI 10.1016/0197-4580(81)90037-3
   Campbell SJ, 2007, NEUROPATH APPL NEURO, V33, P108, DOI 10.1111/j.1365-2990.2006.00773.x
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen YH, 2000, MOL BIOL CELL, V11, P849, DOI 10.1091/mbc.11.3.849
   Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002
   D'Souza T, 2005, J BIOL CHEM, V280, P26233, DOI 10.1074/jbc.M502003200
   D'Souza T, 2007, EXP CELL RES, V313, P3364, DOI 10.1016/j.yexcr.2007.06.026
   De Melo MR, 2006, J MOL HISTOL, V37, P321, DOI 10.1007/s10735-006-9056-3
   Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006
   Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122
   Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6
   Gregory M, 2001, ENDOCRINOLOGY, V142, P854, DOI 10.1210/en.142.2.854
   Haddad M, 2005, PEDIATR RES, V57, P453, DOI 10.1203/01.PDR.0000151354.07752.9B
   Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022
   Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186
   Hough CD, 2000, CANCER RES, V60, P6281
   Imamura M, 2007, EXP CELL RES, V313, P1951, DOI 10.1016/j.yexcr.2007.03.010
   Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875
   Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018
   Lechpammer M, 2008, MODERN PATHOL, V21, P1320, DOI 10.1038/modpathol.2008.116
   Levy S, 1999, BIOL REPROD, V60, P1392, DOI 10.1095/biolreprod60.6.1392
   Mitic LL, 2000, AM J PHYSIOL-GASTR L, V279, pG250, DOI 10.1152/ajpgi.2000.279.2.G250
   Mooradian AD, 2003, MECH AGEING DEV, V124, P143, DOI 10.1016/S0047-6374(02)00041-6
   Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782
   Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9
   Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070
   Pummi KP, 2004, J HISTOCHEM CYTOCHEM, V52, P1037, DOI 10.1369/jhc.3a6217.2004
   Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736
   Reyes JL, 2002, KIDNEY INT, V62, P476, DOI 10.1046/j.1523-1755.2002.00479.x
   Skrovanek S, 2007, AM J PHYSIOL-REG I, V293, pR1046, DOI 10.1152/ajpregu.00072.2007
   Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200
   Tankersley CG, 2003, J APPL PHYSIOL, V95, P1681, DOI 10.1152/japplphysiol.00190.2003
   Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088
   Turksen K, 2002, DEVELOPMENT, V129, P1775
   Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404
   VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x
   Virgintino D, 2004, HISTOCHEM CELL BIOL, V122, P51, DOI 10.1007/s00418-004-0665-1
   Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
NR 41
TC 33
Z9 37
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV
PY 2009
VL 64
IS 11
BP 1146
EP 1153
DI 10.1093/gerona/glp118
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 509UU
UT WOS:000271044900006
PM 19692671
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Samarghandian, S
   Nezhad, MA
   Farkhondeh, T
AF Samarghandian, Saeed
   Nezhad, Mohsen Azimi
   Farkhondeh, Tahereh
TI Preventive effect of carvacrol against oxidative damage in aged rat
   liver
SO INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
LA English
DT Article
DE Carvacrol; oxidative stress; aging; rat; liver
ID GLUTATHIONE-S-TRANSFERASE; LIPID-PEROXIDATION; ANTIOXIDANT ENZYMES;
   INDUCED TOXICITY; NITRIC-OXIDE; STRESS; TRIGONELLA
AB The present study was designed to investigate the changes in activities of antioxidant enzymes and lipid peroxidation level in the liver of 2, 10- and 20-months old rats, and to see whether these changes are restored to those of the two month old rats after carvacrol treatment. Male rats of 2, 10, and 20 months (n = 10 for each group) were used for all the experiments. The aged rats (10 and 20 months old) were given carvacrol (15 mg/day per body weight) for 30 days. Control animals received an equal volume of vehicle. After the treatment, livers were removed for estimation of superoxide dismutase-SOD, glutathione-S-transferase-GST, catalase-CAT activities and lipid peroxidation level. The present findings determined that normal aging was associated with a significant decrease in the activities of antioxidant enzymes (SOD; 11.87 +/- 0.6 (2 months old) vs 7.56 +/- 0.1 (20 months old); p < 0.001) in liver, as well as an increase in lipid peroxidation level (MDA; 0.15 +/- 0.01 (2 months old) vs 0.41 +/- 0.01 (20 months old); p < 0.001) in aged rats. Also, the results of this study indicated that carvacrol treatment increased the activities of the antioxidant enzymes in 20 months old animals versus the aged matched control group (SOD; 9.87 +/- 0.4; p < 0.01). Furthermore, carvacrol decreased lipid peroxidation content in 10- and 20-months old animals compared with the aged matched control (MDA; 9.87 +/- 0.4; p < 0.001). Our data shows that carvacrol could be a candidate to inhibit the development of age-induced liver damage through inhibition of oxidative stress and also increasing antioxidant defenses.
C1 [Samarghandian, Saeed] Neyshabur Univ Med Sci, Dept Basic Med Sci, Neyshabur, Iran.
   [Nezhad, Mohsen Azimi] Mashhad Univ Med Sci, Fac Med, Dept Genet, Mashhad, Razavi Khorasan, Iran.
   [Farkhondeh, Tahereh] Mashhad Univ Med Sci, BuAli Res Inst, Dept Immunogenet, Mashhad, Razavi Khorasan, Iran.
C3 Mashhad University Medical Science; Mashhad University Medical Science
RP Samarghandian, S (corresponding author), Neyshabur Univ Med Sci, Dept Basic Med Sci, Neyshabur, Iran.
EM samarghandians@mums.ac.ir
RI Farkhondeh, Tahereh/Y-2083-2018
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   AESCHBACH R, 1994, FOOD CHEM TOXICOL, V32, P31, DOI 10.1016/0278-6915(84)90033-4
   Aristatile B, 2011, J NAT MED-TOKYO, V65, P568, DOI 10.1007/s11418-011-0544-8
   Aristatile B, 2015, J BIOCHEM MOL TOXIC, V29, P497, DOI 10.1002/jbt.20355
   Aristatile B, 2009, FUND CLIN PHARMACOL, V23, P757, DOI 10.1111/j.1472-8206.2009.00721.x
   Aristatile Balakrishnan, 2009, Journal of Basic and Clinical Physiology and Pharmacology, V20, P15
   Arunasree KM, 2010, PHYTOMEDICINE, V17, P581, DOI 10.1016/j.phymed.2009.12.008
   Aydin E, 2014, CYTOTECHNOLOGY, V66, P149, DOI 10.1007/s10616-013-9547-5
   Aydin Y, 2007, PLANTA MED, V73, P1365, DOI 10.1055/s-2007-990236
   Baquer NZ, 2009, BIOGERONTOLOGY, V10, P377, DOI 10.1007/s10522-009-9226-2
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carrillo MC, 2002, MECH AGEING DEV, V123, P1617, DOI 10.1016/S0047-6374(02)00097-0
   Melo FHC, 2011, FUND CLIN PHARMACOL, V25, P362, DOI 10.1111/j.1472-8206.2010.00850.x
   Melo FHC, 2010, FUND CLIN PHARMACOL, V24, P437, DOI 10.1111/j.1472-8206.2009.00788.x
   Celik F, 2013, EUR REV MED PHARMACO, V17, P2988
   CHEN LH, 1994, ARCH GERONTOL GERIAT, V18, P191, DOI 10.1016/0167-4943(94)90013-2
   Cho S, 2012, J NUTR BIOCHEM, V23, P192, DOI 10.1016/j.jnutbio.2010.11.016
   CONGY F, 1995, PRESSE MED, V24, P1115
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   Genet S, 2002, MOL CELL BIOCHEM, V236, P7, DOI 10.1023/A:1016103131408
   Guimaraes AG, 2010, BASIC CLIN PHARMACOL, V107, P949, DOI 10.1111/j.1742-7843.2010.00609.x
   Hariri AT, 2010, FOOD CHEM TOXICOL, V48, P2803, DOI 10.1016/j.fct.2010.07.010
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Hashimoto M, 2001, EXP GERONTOL, V37, P89, DOI 10.1016/S0531-5565(01)00164-4
   Hayashi T, 2010, GERIATR GERONTOL INT, V10, P115, DOI 10.1111/j.1447-0594.2009.00581.x
   Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200
   Kitani K., 1989, LIFE CHEM REPORTS, V6, P143
   Kumar P, 2008, BIOGERONTOLOGY, V9, P235, DOI 10.1007/s10522-008-9133-y
   Mantha AK, 2006, BIOGERONTOLOGY, V7, P19, DOI 10.1007/s10522-005-6044-z
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Mármol F, 2010, PHYSIOL RES, V59, P553, DOI 10.33549/physiolres.931768
   Martínez-Lara E, 2003, NEUROBIOL AGING, V24, P501, DOI 10.1016/S0197-4580(02)00139-2
   Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724
   PIEPER GM, 1995, DIABETES, V44, P884, DOI 10.2337/diabetes.44.8.884
   RODRIGUEZMARTINEZ MA, 1992, MECH AGEING DEV, V66, P213, DOI 10.1016/0047-6374(92)90137-3
   Samarghandian S., 2014, SCI WORLD J, V2014, P6
   Samarghandian S., PROTECTIVE EFFECTS C
   Samarghandian Saeed, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P231
   Samarghandian S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/417928
   Samarghandian Saeed, 2013, Indian J Urol, V29, P177, DOI 10.4103/0970-1591.117278
   Samarghandian S, 2013, J PHARM PHARM SCI, V16, P352, DOI 10.18433/J3ZS3Q
   Samarghandian S, 2011, APPL BIOCHEM BIOTECH, V164, P238, DOI 10.1007/s12010-010-9130-x
   Samarghandian S, 2010, PHARMACOGN MAG, V6, P309, DOI 10.4103/0973-1296.71799
   Samini F, 2013, PHARMACOL BIOCHEM BE, V110, P238, DOI 10.1016/j.pbb.2013.07.019
   Siddiqui MR, 2005, J BIOSCIENCES, V30, P483, DOI 10.1007/BF02703722
   SIMPSON JA, 1992, BIOCHEM J, V282, P621, DOI 10.1042/bj2820621
   Singh SP, 2002, J BIOL CHEM, V277, P4232, DOI 10.1074/jbc.M109678200
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sudheesh NP, 2010, CLIN NUTR, V29, P406, DOI 10.1016/j.clnu.2009.12.003
   Tew KD, 1999, DRUG RESIST UPDATE, V2, P143, DOI 10.1054/drup.1999.0086
   VANELLA A, 1982, GERONTOLOGY, V28, P108, DOI 10.1159/000212519
   Vendemiale G, 1999, INT J CLIN LAB RES, V29, P49, DOI 10.1007/s005990050063
NR 56
TC 7
Z9 7
U1 0
U2 3
PU HOGREFE AG-HOGREFE AG SUISSE
PI BERN
PA LANGGASSSTRASSE 76, BERN, SWITZERLAND
SN 0300-9831
EI 1664-2821
J9 INT J VITAM NUTR RES
JI Int. J. Vitam. Nutr. Res.
PD MAR
PY 2017
VL 87
IS 1-2
BP 59
EP 65
DI 10.1024/0300-9831/a000393
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA VI2TN
UT WOS:000467332200007
PM 27866466
DA 2024-02-19
ER

PT J
AU Kondo, H
   Ono, H
   Hamano, H
   Sone-Asano, K
   Ohno, T
   Takeda, K
   Ochiai, H
   Matsumoto, A
   Takasaki, A
   Hiraga, C
   Kumagai, J
   Maezawa, Y
   Yokote, K
AF Kondo, Hiroya
   Ono, Hiraku
   Hamano, Hiiro
   Sone-Asano, Kanako
   Ohno, Tomohiro
   Takeda, Kenji
   Ochiai, Hidetoshi
   Matsumoto, Ai
   Takasaki, Atsushi
   Hiraga, Chihiro
   Kumagai, Jin
   Maezawa, Yoshiro
   Yokote, Koutaro
TI Insulin Sensitivity Initially Worsens but Later Improves With Aging in
   Male C57BL/6N Mice
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article; Early Access
DE Biology of aging; Fat; Hyperinsulinemic-euglycemic clamp; Muscle
ID RESISTANCE; GLUCOSE; AGE; RECEPTOR; PROTECTS; OBESITY
AB Aging is believed to induce insulin resistance in humans. However, when and how insulin sensitivity changes with aging remains unclear in both humans and mice. In this study, groups of male C57BL/6N mice at 9-19 weeks (young), 34-67 weeks (mature adult), 84-85 weeks (presenile), and 107-121 weeks of age underwent hyperinsulinemic-euglycemic clamp studies with somatostatin infusion under awake and nonrestrained conditions. The glucose infusion rates for maintaining euglycemia were 18.4 +/- 2.9, 5.9 +/- 1.3, 20.3 +/- 7.2, and 25.3 +/- 4.4 mg/kg/min in young, mature adult, presenile, and aged mice, respectively. Thus, compared with young mice, mature adult mice exhibited the expected insulin resistance. In contrast, presenile and aged mice showed significantly higher insulin sensitivity than mature adult mice. These age-related changes were mainly observed in glucose uptake into adipose tissue and skeletal muscle (rates of glucose disappearance were 24.3 +/- 2.0, 17.1 +/- 1.0, 25.5 +/- 5.2, and 31.8 +/- 2.9 mg/kg/min in young, mature adult, presenile, and aged mice, respectively). Epididymal fat weight and hepatic triglyceride levels were higher in mature adult mice than those in young and aged mice. Our observations indicate that, in male C57BL/6N mice, insulin resistance appears at the mature adult stage of life but subsequently improves markedly. These alterations in insulin sensitivity are attributable to changes in visceral fat accumulations and age-related factors.
C1 [Kondo, Hiroya; Hamano, Hiiro] Chiba Univ, Sch Med, Chiba, Japan.
   [Ono, Hiraku; Sone-Asano, Kanako; Ohno, Tomohiro; Takeda, Kenji; Ochiai, Hidetoshi; Matsumoto, Ai; Takasaki, Atsushi; Hiraga, Chihiro; Kumagai, Jin; Maezawa, Yoshiro; Yokote, Koutaro] Chiba Univ, Grad Sch Med, Dept Endocrinol Hematol & Gerontol, Chiba, Japan.
   [Ono, Hiraku] Chiba Univ, Grad Sch Med, Dept Endocrinol Hematol & Gerontol, 1-8-1 Inohana, Chuo Ku, Chiba, Chiba, Japan.
C3 Chiba University; Chiba University; Chiba University
RP Ono, H (corresponding author), Chiba Univ, Grad Sch Med, Dept Endocrinol Hematol & Gerontol, 1-8-1 Inohana, Chuo Ku, Chiba, Chiba, Japan.
EM hono@chiba-u.jp
OI Kondo, Hiroya/0000-0001-9090-1168
CR Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686
   Ayala JE, 2008, DIABETES, V57, P288, DOI 10.2337/db07-0704
   Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188
   Ayala JE, 2010, ENDOCRINOLOGY, V151, P4678, DOI 10.1210/en.2010-0289
   Barbieri M, 2001, DIABETES-METAB RES, V17, P19, DOI 10.1002/dmrr.178
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Blüher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5
   BROUGHTON DL, 1987, GERONTOLOGY, V33, P357, DOI 10.1159/000212903
   BUCOLO G, 1973, CLIN CHEM, V19, P476
   Cha HN, 2019, J GERONTOL A-BIOL, V74, P147, DOI 10.1093/gerona/gly113
   Chakraborty G, 2009, LAB ANIMAL, V38, P364, DOI 10.1038/laban1109-364
   Close AF, 2021, DIABETOLOGIA, V64, P2550, DOI 10.1007/s00125-021-05548-7
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   Ehrhardt N, 2019, OBESITY, V27, P434, DOI 10.1002/oby.22418
   Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   Fischer KE, 2016, AGING-US, V8, P2370, DOI 10.18632/aging.101059
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fueger PT, 2004, AM J PHYSIOL-ENDOC M, V286, pE77, DOI 10.1152/ajpendo.00309.2003
   González-Rodríguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034
   KOHRT WM, 1993, DIABETES, V42, P273, DOI 10.2337/diabetes.42.2.273
   KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353
   LEITER EH, 1988, FASEB J, V2, P2807, DOI 10.1096/fasebj.2.12.3044905
   Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160
   Luo P, 2013, DIABETOLOGIA, V56, P901, DOI 10.1007/s00125-012-2814-8
   Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141
   Mohamad M, 2016, AGING CELL, V15, P706, DOI 10.1111/acel.12481
   Oh YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159689
   Palliyaguru DL, 2021, CELL METAB, V33, P2189, DOI 10.1016/j.cmet.2021.08.013
   Rodríguez-Morán M, 2003, J ENDOCRINOL INVEST, V26, P42, DOI 10.1007/BF03345121
   Ropelle ER, 2013, DIABETES, V62, P466, DOI 10.2337/db12-0339
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   Sakai G, 2017, ENDOCRINOLOGY, V158, P2659, DOI 10.1210/en.2016-1969
   Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82
   SLAVIN BG, 1990, ANAT REC, V228, P53, DOI 10.1002/ar.1092280109
   SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163
NR 38
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD 2023 OCT 9
PY 2023
VL 78
IS 10
BP 1785
EP 1792
DI 10.1093/gerona/glad126
EA MAY 2023
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA X6US7
UT WOS:001006384400001
PM 37205871
DA 2024-02-19
ER

PT J
AU Johnson, WT
   Newman, SM
AF Johnson, WT
   Newman, SM
TI Copper deficiency: A potential model for determining the role of
   mitochondria in cardiac aging
SO JOURNAL OF THE AMERICAN AGING ASSOCIATION
LA English
DT Article
ID ELECTRON-TRANSPORT SYSTEM; C-OXIDASE ACTIVITY; DIETARY COPPER;
   LIPID-PEROXIDATION; ANTIOXIDANT ENZYMES; CYTOCHROME-OXIDASE; OXIDATIVE
   STRESS; FOOD RESTRICTION; RAT-LIVER; AGE
AB Heart mitochondria experience age-related declines in cytochrome c oxidase (CCO) activity and increases in the generation of reactive oxygen species (ROS) that may contribute to loss of cardiac function and the development of disease that occur with advancing age. In a manner similar to aging, copper, deficiency also suppresses heart CCO activity and has cardiovascular consequences related to increased peroxidation. Food restriction is often used as a tool to study oxidative mechanisms of aging and the present study examines the potential of copper deficiency to model the role of mitochondria in cardiac aging by determining if the effect of food restriction on CCO activity and oxidative stress in heart mitochondria parallels its effect on cardiac mitochondria during aging. Overall, copper deficiency severely inhibited CCO activity and increased both Mn superoxide dismutase (MnSOD) and glutathione peroxidase (GPX) in isolated heart mitochondria. However, a 20% reduction in food intake by copper-deficient rats increased CCO activity by 65% and decreased MnSOD activity by 25% but had no effect in rats fed adequate copper. Copper deficiency also reduced the carbonyl content of 80-100 kDa mitochondrial proteins, but the reduction in carbonyl content was unaffected by food restriction. Food restriction did, however, completely prevent the enlargement of cardiac mitochondria in copper-deficient rats. Together, these findings indicate that copper deficiency induces mitochondrial antioxidant enzyme activity and hypertrophy in cardiac tissue in response to reduced CCO activity and that food restriction may counteract these changes by reducing oxidative stress. Because the action of food restriction on CCO activity and mitochondrially generated oxidative stress are similar in copper deficiency and aging, copper deficiency may serve as a short-term model for studying the potential roles of mitochondria in cardiac aging.
C1 ARS, USDA, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA.
C3 United States Department of Agriculture (USDA)
RP Johnson, WT (corresponding author), ARS, USDA, Grand Forks Human Nutr Res Ctr, POB 9034, Grand Forks, ND 58202 USA.
EM tjohnson@gfhnrc.ars.usda.gov
CR AHERNE WA, 1982, MORPHOLOGY
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BALEVSKA PS, 1981, INT J BIOCHEM, V13, P489, DOI 10.1016/0020-711X(81)90122-1
   BALEVSKA PS, 1985, BIOL TRACE ELEM RES, V8, P211, DOI 10.1007/BF02917460
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   BODE AM, 1992, J NUTR BIOCHEM, V3, P668, DOI 10.1016/0955-2863(92)90088-Z
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Brambilla L, 1997, FEBS LETT, V418, P247, DOI 10.1016/S0014-5793(97)01393-8
   CHAO JCJ, 1994, J NUTR, V124, P789, DOI 10.1093/jn/124.6.789
   CHAUDIERE J, 1984, J BIOL CHEM, V259, P1043
   DALLMAN PR, 1970, BLOOD-J HEMATOL, V35, P496, DOI 10.1182/blood.V35.4.496.496
   Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375
   Desai VG, 2000, NUTR CANCER, V36, P42, DOI 10.1207/S15327914NC3601_7
   FIELDS M, 1984, BIOL TRACE ELEM RES, V6, P379, DOI 10.1007/BF02989255
   GHADIALLY FN, 1988, MITOCHONDRIA, V1, P254
   GREDILLA R, 2001, FASEB J         0509, DOI DOI 10.1096/F4.00-0764FJE
   HALLIWELL B, 1989, FREE RADICAL BIO MED, P416
   JOHNSON WT, 1993, NUTR RES, V13, P1153, DOI 10.1016/S0271-5317(05)80739-0
   JOHNSON WT, 1987, J NUTR, V117, P1085, DOI 10.1093/jn/117.6.1085
   LAWRENCE CB, 1985, BIOCHIM BIOPHYS ACTA, V809, P351, DOI 10.1016/0005-2728(85)90185-9
   Lee J, 1999, FREE RADICAL BIO MED, V26, P260, DOI 10.1016/S0891-5849(98)00195-6
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   MEDEIROS DM, 1993, BIOL TRACE ELEM RES, V36, P271, DOI 10.1007/BF02783961
   MEDEIROS DM, 1991, J NUTR, V121, P815, DOI 10.1093/jn/121.6.815
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Paradies G, 1997, FEBS LETT, V406, P136, DOI 10.1016/S0014-5793(97)00264-0
   PAYNTER DI, 1980, BIOL TRACE ELEM RES, V2, P121, DOI 10.1007/BF02798591
   PROHASKA JR, 1974, J NEUROCHEM, V23, P91, DOI 10.1111/j.1471-4159.1974.tb06920.x
   PROHASKA JR, 1983, J NUTR, V113, P2048, DOI 10.1093/jn/113.10.2048
   PROHASKA JR, 1991, J NUTR, V121, P355, DOI 10.1093/jn/121.3.355
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   Saari JT, 2000, CAN J PHYSIOL PHARM, V78, P848, DOI 10.1139/cjpp-78-10-848
   SAARI JT, 1990, P SOC EXP BIOL MED, V195, P30, DOI 10.3181/00379727-195-43114
   SAARI JT, 1993, AM J CLIN NUTR, V58, P891, DOI 10.1093/ajcn/58.6.891
   SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Singal PK, 1998, CARDIOVASC RES, V40, P426, DOI 10.1016/S0008-6363(98)00244-2
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SOHAL RS, 1993, FREE RADICAL BIO MED, V14, P583, DOI 10.1016/0891-5849(93)90139-L
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   TAYLOR CG, 1988, J NUTR, V118, P613, DOI 10.1093/jn/118.5.613
   VENABLE JH, 1965, J CELL BIOL, V25, P407, DOI 10.1083/jcb.25.2.407
   WAN XS, 1993, ARCH BIOCHEM BIOPHYS, V304, P89, DOI 10.1006/abbi.1993.1325
   Warner BB, 1996, AM J PHYSIOL-LUNG C, V271, pL150, DOI 10.1152/ajplung.1996.271.1.L150
   WILDMAN REC, 1995, J TRACE ELEM EXP MED, V8, P11
   WILDMAN REC, 1994, BIOL TRACE ELEM RES, V46, P51, DOI 10.1007/BF02790067
NR 50
TC 7
Z9 7
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
J9 J AM AGING ASSOC
JI J. Am. Aging Assoc.
PD JAN-APR
PY 2003
VL 26
IS 1-2
BP 19
EP 28
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 877EA
UT WOS:000225549400003
PM 23604915
OA Green Published
DA 2024-02-19
ER

PT J
AU Costa-Machado, LF
   Garcia-Dominguez, E
   McIntyre, RL
   Lopez-Aceituno, JL
   Ballesteros-Gonzalez, A
   Tapia-Gonzalez, A
   Fabregat-Safont, D
   Eisenberg, T
   Gomez, J
   Plaza, A
   Sierra-Ramirez, A
   Perez, M
   Villanueva-Bermejo, D
   Fornari, T
   Loza, MI
   Herradon, G
   Hofer, SJ
   Magnes, C
   Madeo, F
   Duerr, JS
   Pozo, OJ
   Galindo, MI
   del Pino, I
   Houtkooper, RH
   Megias, D
   Vina, J
   Gomez-Cabrera, MC
   Fernandez-Marcos, PJ
AF Filipe Costa-Machado, Luis
   Garcia-Dominguez, Esther
   McIntyre, Rebecca L.
   Luis Lopez-Aceituno, Jose
   Ballesteros-Gonzalez, Alvaro
   Tapia-Gonzalez, Andrea
   Fabregat-Safont, David
   Eisenberg, Tobias
   Gomez, Jesus
   Plaza, Adrian
   Sierra-Ramirez, Aranzazu
   Perez, Manuel
   Villanueva-Bermejo, David
   Fornari, Tiziana
   Isabel Loza, Maria
   Herradon, Gonzalo
   Hofer, Sebastian J.
   Magnes, Christoph
   Madeo, Frank
   Duerr, Janet S.
   Pozo, Oscar J.
   Galindo, Maximo-Ibo
   del Pino, Isabel
   Houtkooper, Riekelt H.
   Megias, Diego
   Vina, Jose
   Gomez-Cabrera, Mari Carmen
   Fernandez-Marcos, Pablo J.
TI Peripheral modulation of antidepressant targets MAO-B and GABAAR by
   harmol induces mitohormesis and delays aging in preclinical models
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SKELETAL-MUSCLE MITOCHONDRIA; BETA-CARBOLINE; LIFE-SPAN; COFFEE
   CONSUMPTION; MONOAMINE-OXIDASE; BIOGENIC-AMINES; RECEPTOR; EXERCISE;
   HARMANE; HEALTH
AB Reversible mitochondrial stress leading to improved mitochondrial function (mitohormesis) has been reported as an anti-aging mechanism. Here the authors report that harmol (a beta-carboline compound) induces mitohormesis in peripheral organs, alleviates aging-related phenotypes in mice, and extends lifespan in invertebrate models.
   Reversible and sub-lethal stresses to the mitochondria elicit a program of compensatory responses that ultimately improve mitochondrial function, a conserved anti-aging mechanism termed mitohormesis. Here, we show that harmol, a member of the beta-carbolines family with anti-depressant properties, improves mitochondrial function and metabolic parameters, and extends healthspan. Treatment with harmol induces a transient mitochondrial depolarization, a strong mitophagy response, and the AMPK compensatory pathway both in cultured C2C12 myotubes and in male mouse liver, brown adipose tissue and muscle, even though harmol crosses poorly the blood-brain barrier. Mechanistically, simultaneous modulation of the targets of harmol monoamine-oxidase B and GABA-A receptor reproduces harmol-induced mitochondrial improvements. Diet-induced pre-diabetic male mice improve their glucose tolerance, liver steatosis and insulin sensitivity after treatment with harmol. Harmol or a combination of monoamine oxidase B and GABA-A receptor modulators extend the lifespan of hermaphrodite Caenorhabditis elegans or female Drosophila melanogaster. Finally, two-year-old male and female mice treated with harmol exhibit delayed frailty onset with improved glycemia, exercise performance and strength. Our results reveal that peripheral targeting of monoamine oxidase B and GABA-A receptor, common antidepressant targets, extends healthspan through mitohormesis.
C1 [Filipe Costa-Machado, Luis; Luis Lopez-Aceituno, Jose; Plaza, Adrian; Sierra-Ramirez, Aranzazu; Fernandez-Marcos, Pablo J.] Madrid Inst Adv Studies IMDEA Food, Metab Syndrome Grp, CEI UAM??, BIOPROMET,CSIC, Madrid E-28049, Spain.
   [Filipe Costa-Machado, Luis; Isabel Loza, Maria] Kaertor Fdn, EMPRENDIA Bldg,Floor 2,Off 4,Campus Vida, Santiago De Compostela E-15706, Spain.
   [Filipe Costa-Machado, Luis; Isabel Loza, Maria] Univ Santiago Compostela, Ctr Res Mol Med & Chron Dis, BioFarma Res Grp, CIMUS, Santiago De Compostela, Spain.
   [Garcia-Dominguez, Esther; Vina, Jose; Gomez-Cabrera, Mari Carmen] Univ Valencia, Fdn Invest Hosp Clin Univ, Fac Med, Dept Physiol,CIBERFES,INCLIVA,Freshage Res Grp, Valencia, Spain.
   [McIntyre, Rebecca L.; Houtkooper, Riekelt H.] Univ Amsterdam, Lab Genet Metab Dis, Amsterdam Gastroenterol, Endocrinol,Metab,Amsterdam Cardiovasc Sci, Amsterdam, Netherlands.
   [Ballesteros-Gonzalez, Alvaro; Galindo, Maximo-Ibo] Ctr Invest Principe Felipe, Dev Biol & Dis Models Grp, Valencia 46012, Spain.
   [Tapia-Gonzalez, Andrea; del Pino, Isabel] Ctr Invest Principe Felipe, Neural Plast Grp, Valencia 46012, Spain.
   [Fabregat-Safont, David; Pozo, Oscar J.] Hosp Mar Med Res Inst, Appl Metabol Res Grp, IMIM, Barcelona, Spain.
   [Fabregat-Safont, David] Univ Jaume 1, Res Inst Pesticides & Water, Environm & Publ Hlth Analyt Chem, Castellon de La Plana 12006, Castellon, Spain.
   [Eisenberg, Tobias; Hofer, Sebastian J.; Madeo, Frank] Karl Franzens Univ Graz, Inst Mol Biosci, NAWI Graz, Humboldtstr 50, A-8010 Graz, Austria.
   [Eisenberg, Tobias; Hofer, Sebastian J.; Madeo, Frank] BioTechMed Graz, A-8010 Graz, Austria.
   [Eisenberg, Tobias; Hofer, Sebastian J.; Madeo, Frank] Karl Franzens Univ Graz, Field Excellence Biohlth, Graz, Austria.
   [Gomez, Jesus; Perez, Manuel; Megias, Diego] Spanish Natl Canc Res Ctr, Biotechnol Programme, Confocal Microscopy Unit, CNIO, Melchor Fernandez Almagro 3, Madrid 28029, Spain.
   [Villanueva-Bermejo, David; Fornari, Tiziana] CSIC, Inst Food Sci Res, Dept Prod & Characterizat Novel Foods, CIAL UAM, C Nicolas Cabrera 9, Madrid 28049, Spain.
   [Herradon, Gonzalo] Univ CEU San Pablo, Fac Pharm, Lab Pharmacol, Urb Monteprincipe, Boadilla Del Monte 28668, Madrid, Spain.
   [Magnes, Christoph] Inst Biomed & Hlth Sci, HEALTH, Joanneum Res Forsch Gesell mbH, A-8010 Graz, Austria.
   [Duerr, Janet S.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.
   [Galindo, Maximo-Ibo] Univ Valencia, Univ Politecn Valencia, Inst Interuniv Invest Reconocimiento Mol & Desarro, IDM, Valencia 46022, Spain.
   [Galindo, Maximo-Ibo] Ctr Invest Principe Felipe, Joint Res Unit Dis Mech & Nanomed, UPV, CIPF, Valencia 46012, Spain.
   [del Pino, Isabel] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Campus Sant Joan, Alicante 03550, Spain.
C3 IMDEA Food Institute; Consejo Superior de Investigaciones Cientificas
   (CSIC); Universidade de Santiago de Compostela; University of Valencia;
   CIBER - Centro de Investigacion Biomedica en Red; CIBERFES; University
   of Amsterdam; Prince Felipe Research Center; Prince Felipe Research
   Center; Hospital del Mar Research Institute; Hospital del Mar;
   Universitat Jaume I; University of Graz; University of Graz; Centro
   Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de
   Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de
   Investigacion en Ciencias de la Alimentacion (CIAL); San Pablo CEU
   University; University System of Ohio; Ohio University; University of
   Valencia; Universitat Politecnica de Valencia; Prince Felipe Research
   Center; Consejo Superior de Investigaciones Cientificas (CSIC);
   Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de
   Neurociencias de Alicante (IN)
RP Fernandez-Marcos, PJ (corresponding author), Madrid Inst Adv Studies IMDEA Food, Metab Syndrome Grp, CEI UAM??, BIOPROMET,CSIC, Madrid E-28049, Spain.
EM pablojose.fernandez@imdea.org
RI Alonso, Jesús Gómez/S-1834-2019; del Pino, Isabel/KAM-2441-2024; Pozo,
   Oscar J./I-1615-2019
OI Alonso, Jesús Gómez/0000-0002-8567-8907; del Pino,
   Isabel/0000-0002-8672-926X; Pozo, Oscar J./0000-0002-1735-9728; Plaza,
   Adrian/0000-0002-5316-5090; Megias, Diego/0000-0003-0755-0518;
   Fabregat-Safont, David/0000-0002-2918-227X; Magnes,
   Christoph/0000-0002-5153-7444; Perez-Martinez,
   Manuel/0000-0001-8839-6895; Eisenberg, Tobias/0000-0003-3559-1130;
   Garcia-Dominguez, Esther/0000-0001-6276-4944
FU IMDEA Food institute; Ramon Areces Foundation [CIVP18A3891]; Portuguese
   Foundation for Science and Technology (FCT-MCTES); Ramon Areces
   Foundation; AECC (SIRTBIO); MICINN - European Regional Development Fund;
   Ramon y Cajal Fellowship (MICINN); Spanish Ministry of Science and
   Innovation (MICINN); Instituto de Salud Carlos III from the Spanish
   Ministry of Innovation and Science; FGCSIC/PSLINTERREG/FEDER;
   Conselleria de Sanitat de la Generalitat Valenciana; EU; Generalitat
   Valenciana; ERDF funds (OP ERDF of Comunitat Valenciana); Ramon Areces
   Fundation; Soria Melguizo Foundation; Spanish Ministry
   [SFRH/BD/124022/2016]; MICINN [CIVP18A3891]; PlaGenT excellence research
   program of the Valencian regional government [LABAE18008FERN];
   Conselleria, de Sanitat de la Generalitat Valenciana [SAF2017-85766-R,
   PRPPID2020-114077RB-I00]; Generalitat Valenciana [RYC-2017-22335]; ERDF
   funds (OP ERDF of Comunitat Valenciana 2014-2020) [PTA2017-14689-I];
   Austrian Science Fund FWF [CB16/10/00435,
   PID2019-110906RB-I00/AEI/10.13039/501100011033]; Austrian Federal
   Ministry of Education, Science and Research; University of Graz
   [PROMETEO/2019/097]; NAWI Graz, the BioTechMed-Graz agship project
   EPIAge [825546]; VIDI grant from ZonMw; Ohio University; Ministerio de
   Universidades in Spain; NIH Office of Research Infrastructure Programs; 
   [FPU18/05350];  [RTI2018-100872-J-I00];  [CIDENGENT/2019/044]; 
   [PROMETEU/2018/135];  [SFB-LIPOTOX F3007];  [F3012];  [W1226]; 
   [P29203];  [P29262];  [P27893];  [P31727];  [P 33957];  [TAI 602 1000]; 
   [BMWFW-80.109/0001-WF/V/3b/2015];  [91715305];  [MGS/2021/15];  [P40
   OD010440]
FX We thank Manuel Serrano for his unfaltering support and advice; Fernando
   Pelaez, Isabel Blanco and Alejo Efeyan for their help in the CNIO
   facilities; Rosa Serrano and Concepcion Timon for their help with animal
   procedures; Marta Barradas for her help and support in the laboratory
   tasks; Laura Formentini and Jose Antonio Enriquez for their kind
   technical and scientific support; and the Caenorhabditis Genetics Center
   (CGC) at the University of Minnesota for providing C. elegans strains.
   L.F.C.-M. was supported by the IMDEA Food institute and by a PhD
   Fellowship from the Portuguese Foundation for Science and Technology
   (FCT-MCTES, SFRH/BD/124022/2016). Work in the laboratory of P.J.F.-M.
   was funded by the IMDEA Food Institute, the Ramon Areces Foundation
   (CIVP18A3891), the AECC (SIRTBIO, LABAE18008FERN), the MICINN
   (SAF2017-85766-R and PRPPID2020-114077RB-I00) co-funded by the European
   Regional Development Fund, and a Ramon y Cajal Fellowship (MICINN,
   RYC-2017-22335). J.L.L.-A. was funded by the Spanish Ministry of Science
   and Innovation (MICINN) (PTA2017-14689-I). Work in Fresh Age laboratory
   was funded by: Instituto de Salud Carlos III CB16/10/00435 (CIBERFES),
   (PID2019-110906RB-I00/AEI/10.13039/501100011033) from the Spanish
   Ministry of Innovation and Science; FGCSIC/PSLINTERREG/FEDER;
   PROMETEO/2019/097 de "Conselleria de Sanitat de la Generalitat
   Valenciana" and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546). Part of
   the equipment employed in this work has been funded by Generalitat
   Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat
   Valenciana). Support from Ramon Areces Fundation and Soria Melguizo
   Foundation is also acknowledged. E.G.-D. was a recipient of a
   predoctoral grant financed by the Spanish Ministry (FPU18/05350). Work
   in the laboratory of IdP was funded by the MICINN (RTI2018-100872-J-I00)
   and PlaGenT excellence research program of the Valencian regional
   government (CIDENGENT/2019/044). Work in the laboratory of M.-I.G. was
   funded by PROMETEU/2018/135 from "Conselleria, de Sanitat de la
   Generalitat Valenciana" and part of the equipment employed in this work
   has been funded by Generalitat Valenciana and co-financed with ERDF
   funds (OP ERDF of Comunitat Valenciana 2014-2020). F.M. is grateful to
   the Austrian Science Fund FWF (SFB-LIPOTOX F3007 & F3012, W1226, P29203,
   P29262, P27893, and P31727); the Austrian Federal Ministry of Education,
   Science and Research and the University of Graz for grants
   Unkonventionelle Forschung-InterFast and ysleep
   (BMWFW-80.109/0001-WF/V/3b/2015) and the field of excellence program
   BioHealth. We acknowledge support from NAWI Graz, the BioTechMed-Graz
   agship project EPIAge. T.E. acknowledges support from Austrian Science
   Fund FWF (P 33957 and TAI 602 1000). Work in the laboratory of R.H.H.
   was financially supported by a VIDI grant from ZonMw (no. 91715305).
   J.S.D. was supported by Ohio University. D.F.-S. acknowledges Ministerio
   de Universidades in Spain for his Margarita Salas postdoctoral grant
   (Ref. MGS/2021/15). The CGC group is funded by NIH Office of Research
   Infrastructure Programs (P40 OD010440).
CR Abe A, 2013, ONCOL REP, V29, P1333, DOI 10.3892/or.2013.2242
   Abe A, 2011, BIOL PHARM BULL, V34, P1264, DOI 10.1248/bpb.34.1264
   Aleidi S, 2015, SAUDI PHARM J, V23, P250, DOI 10.1016/j.jsps.2014.11.011
   Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797
   Bansal Y, 2016, CURR NEUROPHARMACOL, V14, P610, DOI 10.2174/1570159X14666160229114755
   Barettino C, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.770458
   Bellantuono I, 2020, NAT PROTOC, V15, P540, DOI 10.1038/s41596-019-0256-1
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   BRENNER S, 1974, GENETICS, V77, P71
   Burroughs S., 2007, CURR ANAESTH CRIT CA, V18, P4, DOI [DOI 10.1016/J.CACC.2007.01.007, 10.1016/j.cacc.2007.01, DOI 10.1016/J.CACC.2007.01, 10.1016/j.cacc.2007.01.007]
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Gomez-Cabrera MC, 2017, J GERONTOL A-BIOL, V72, P885, DOI 10.1093/gerona/glw337
   Celikyurt IK, 2013, PHARMACOL BIOCHEM BE, V103, P666, DOI 10.1016/j.pbb.2012.10.011
   Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245
   Chaput E, 2000, BIOCHEM BIOPH RES CO, V271, P445, DOI 10.1006/bbrc.2000.2647
   Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007
   Chun L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9828
   Corona JC, 2016, FREE RADICAL BIO MED, V100, P153, DOI 10.1016/j.freeradbiomed.2016.06.023
   Dahlmans D, 2017, MOL METAB, V6, P1429, DOI 10.1016/j.molmet.2017.08.007
   De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111
   Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503
   DEWHURST SA, 1972, COMP BIOCHEM PHYSIOL, V43, P975, DOI 10.1016/0305-0491(72)90241-6
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   Farzin D, 2006, EUR NEUROPSYCHOPHARM, V16, P324, DOI 10.1016/j.euroneuro.2005.08.005
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Gaweska Helena, 2011, Biomol Concepts, V2, P365
   Ghose S, 2011, BRIT J PHARMACOL, V162, P1, DOI 10.1111/j.1476-5381.2010.01004.x
   GLOVER V, 1982, J NEURAL TRANSM, V54, P209, DOI 10.1007/BF01254930
   Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142
   Gonzalez-Freire M, 2018, AGING CELL, V17, DOI 10.1111/acel.12725
   Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420
   Herraiz T, 2010, FOOD CHEM TOXICOL, V48, P839, DOI 10.1016/j.fct.2009.12.019
   Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104
   Hill LE, 2010, J PSYCHOPHARMACOL, V24, P745, DOI 10.1177/0269881108096983
   Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002
   Jakobsen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060519
   KAUR G, 1990, MOL CHEM NEUROPATHOL, V13, P175, DOI 10.1007/BF03159920
   Kim JK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06487-5
   Knoll J, 2016, LIFE SCI, V167, P32, DOI 10.1016/j.lfs.2016.10.023
   Kobayashi M, 2006, BIOSCI BIOTECH BIOCH, V70, P677, DOI 10.1271/bbb.70.677
   Konopka AR, 2011, J GERONTOL A-BIOL, V66, P835, DOI 10.1093/gerona/glr088
   Kulkarni AD, 2016, EXPERT OPIN DRUG DEL, V13, P85, DOI 10.1517/17425247.2016.1092519
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lin LF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030263
   Little D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27058-0
   Liu JJ, 2016, J NUTR, V146, P1373, DOI 10.3945/jn.116.230490
   Liu PF, 2019, HEPATOLOGY, V70, P372, DOI 10.1002/hep.30616
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Louis ED, 2014, NEUROTOXICOLOGY, V40, P52, DOI 10.1016/j.neuro.2013.11.005
   Louis ED, 2013, NEUROTOXICOLOGY, V38, P131, DOI 10.1016/j.neuro.2013.07.002
   Magnes C, 2014, J CHROMATOGR A, V1331, P44, DOI 10.1016/j.chroma.2013.12.061
   MALATYNSKA E, 1989, BRAIN RES BULL, V22, P845, DOI 10.1016/0361-9230(89)90028-2
   Martin CA, 2014, NEUROCHEM INT, V73, P71, DOI 10.1016/j.neuint.2014.03.015
   de Toda IM, 2018, J GERONTOL A-BIOL, V73, P1323, DOI 10.1093/gerona/gly064
   Martínez-Abundis E, 2010, MITOCHONDRION, V10, P151, DOI 10.1016/j.mito.2009.12.140
   Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314
   McColl G, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-57
   McIntyre RL, 2021, AGING CELL, V20, DOI 10.1111/acel.13381
   Misiewicz RZ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008358
   Moorwood C, 2013, J BIOMOL SCREEN, V18, P400, DOI 10.1177/1087057112465648
   Morales-García JA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05407-9
   Müller J, 2015, EUR J PHARM SCI, V79, P53, DOI 10.1016/j.ejps.2015.08.019
   Musci RV, 2019, SPORTS, V7, DOI 10.3390/sports7070170
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858
   Nakagawa Y, 2010, CHEM-BIOL INTERACT, V188, P393, DOI 10.1016/j.cbi.2010.09.004
   Navarro AM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091333
   Nesterov SV, 2018, CHEM-BIOL INTERACT, V291, P40, DOI 10.1016/j.cbi.2018.06.004
   Nwabuo CC, 2020, ESC HEART FAIL, V7, P1510, DOI 10.1002/ehf2.12684
   Ortega-Molina A, 2015, CELL METAB, V21, P558, DOI 10.1016/j.cmet.2015.02.017
   Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021
   Parker L, 2011, GENETICS, V187, P523, DOI 10.1534/genetics.110.123299
   Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610
   Piechowska P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040814
   Plana-Ripoll O, 2019, LANCET, V394, P1827, DOI 10.1016/S0140-6736(19)32316-5
   Qiu BY, 2010, DIABETES, V59, P256, DOI 10.2337/db09-0223
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Robinson MM, 2019, AM J PHYSIOL-CELL PH, V317, pC339, DOI 10.1152/ajpcell.00343.2018
   Roelofs J, 2001, NATURE, V411, P1013, DOI 10.1038/35082627
   Rong JX, 2011, PPAR RES, V2011, DOI 10.1155/2011/179454
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Saito E, 2015, AM J CLIN NUTR, V101, P1029, DOI 10.3945/ajcn.114.104273
   Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0
   Schroeder S, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108985
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x
   SEILER N, 1975, BIOCHEM J, V152, P201, DOI 10.1042/bj1520201
   Shu C, 2019, SKELET MUSCLE, V9, DOI 10.1186/s13395-019-0218-x
   Solfrizzi V, 2015, J ALZHEIMERS DIS, V47, P889, DOI 10.3233/JAD-150333
   Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143
   Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2
   Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138
   Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4
   Tapia PC, 2006, MED HYPOTHESES, V66, P832, DOI 10.1016/j.mehy.2005.09.009
   Tarpley M, 2021, EUR J PHARM SCI, V162, DOI 10.1016/j.ejps.2021.105821
   Tian J, 2021, AGING-US, V13, P22629, DOI 10.18632/aging.203597
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wang Z, 2011, J NEUROCHEM, V119, P1294, DOI 10.1111/j.1471-4159.2011.07517.x
   Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563
   Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851
NR 110
TC 3
Z9 3
U1 10
U2 14
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 15
PY 2023
VL 14
IS 1
AR 2779
DI 10.1038/s41467-023-38410-y
PG 22
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA H2PU2
UT WOS:000994445900020
PM 37188705
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhao, G
   Cui, J
   Zhang, JG
   Qin, Q
   Chen, Q
   Yin, T
   Deng, SC
   Liu, Y
   Liu, L
   Wang, B
   Tian, K
   Wang, GB
   Wang, CY
AF Zhao, G.
   Cui, J.
   Zhang, J-G
   Qin, Q.
   Chen, Q.
   Yin, T.
   Deng, S-C
   Liu, Y.
   Liu, L.
   Wang, B.
   Tian, K.
   Wang, G-B
   Wang, C-Y
TI SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion
   and enhances chemosensitivity in pancreatic cancer cells
SO GENE THERAPY
LA English
DT Article
DE SIRT1; RNAi; pancreatic cancer; proliferation; apoptosis
ID FORKHEAD TRANSCRIPTION FACTORS; HISTONE DEACETYLASES; CALORIE
   RESTRICTION; PROSTATE-CANCER; GENE-EXPRESSION; POOR-PROGNOSIS;
   TUMOR-CELLS; SIRTUINS; P53; PROTEIN
AB The NAD+-dependent deacetylase, sirtuin 1 (SIRT1), has been recently been suspected to have a role in tumorigenesis. We investigated the expression of SIRT1 in pancreatic cancer and the effect of SIRT1-targeted RNA interference (RNAi) on cell proliferation and tumor formation in a pancreatic cancer cell line, PANC1. The expression of SIRT1 was investigated in 49 specimens of pancreatic cancer and adjacent normal pancreatic tissues. SIRT1 was overexpressed in pancreatic cancer tissues at both the mRNA and protein levels, with increased SIRT1 positivity associated with tumors from patients over 60 years old, tumors larger than 4 cm, higher TNM (extent of tumor (T), the extent of spread to lymph nodes (N), and presence of distant metastasis (M)) stage or the presence of lymph node or hepatic metastases. The PANC-1 was stably transfected with a SIRT1 small hairpin RNA (shRNA) expression plasmid and compared with untransfected and PANC-1-negative RNAi cells. Proliferation of PANC-1-SIRT1-RNAi cells was significantly reduced, accompanied by increased rates of apoptosis, G1 arrest and senescence. Furthermore, FOXO3a expression was markedly upregulated in PANC-1-SIRT1-RNAi cells, but no significant difference in p53 expression was observed. The invasive ability of PANC-1-SIRT1-RNAi cells was markedly reduced in vitro, which was linked to increased E-cadherin and reduced-MMP expression. Additionally, PANC-1-SIRT1-RNAi cells had a significantly reduced capacity to form tumors in vivo compared with untransfected and PANC-1-negative RNAi cells. These results suggest that SIRT1 may promote cell proliferation and tumor formation in pancreatic cancer, and downregulation of SIRT1 using shRNA could provide a novel therapeutic treatment. Gene Therapy (2011) 18, 920-928; doi:10.1038/gt.2011.81; published online 16 June 2011
C1 [Zhao, G.] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Pancreat Surg Ctr,Pancreat Dis Inst, Wuhan 430022, Hubei Province, Peoples R China.
   [Wang, G-B] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430022, Hubei Province, Peoples R China.
C3 Huazhong University of Science & Technology; Huazhong University of
   Science & Technology
RP Zhao, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Pancreat Surg Ctr,Pancreat Dis Inst, Jiefang Ave 1277, Wuhan 430022, Hubei Province, Peoples R China.
EM zhaogang1427@yahoo.com.cn; chunyouwang52@126.com
RI Li, Jiaai/JCO-0168-2023; ZHAO, GANG/IUS-4473-2023
OI ZHAO, GANG/0000-0001-9391-6242
FU National Science Foundation Committee (NSFC) of China [30600594,
   30972900]; National Natural Science Foundation of China [30600594,
   30972900]
FX This study was funded by grants from the National Science Foundation
   Committee (NSFC) of China (Grant number: 30600594 and 30972900).; Grant
   sponsor: National Natural Science Foundation of China; Grant number
   30600594 and 30972900.
CR Bihani T, 2004, CELL CYCLE, V3, P1201
   Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200
   Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329
   Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923
   Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610
   Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486
   Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506
   Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617
   Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001
   Hisahara S, 2005, J PHARMACOL SCI, V98, P200, DOI 10.1254/jphs.FMJ05001X2
   Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085
   Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478
   Jang KY, 2009, PATHOLOGY, V41, P366, DOI 10.1080/00313020902884451
   Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010
   Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816
   Jung-Hynes B, 2009, J BIOL CHEM, V284, P3823, DOI 10.1074/jbc.M807869200
   Jung-Hynes B, 2009, CELL CYCLE, V8, P1478, DOI 10.4161/cc.8.10.8408
   Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034
   Keleg Shereen, 2003, Mol Cancer, V2, P14, DOI 10.1186/1476-4598-2-14
   Kim JH, 2008, J SURG ONCOL, V97, P125, DOI 10.1002/jso.20937
   Kobayashi D, 2001, PANCREAS, V22, P255, DOI 10.1097/00006676-200104000-00005
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023
   Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1
   Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219
   Lim CS, 2006, MED HYPOTHESES, V67, P341, DOI 10.1016/j.mehy.2006.01.050
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mahmud DL, 2002, ONCOGENE, V21, P1556, DOI 10.1038/sj.onc.1205230
   McBurney MW, 2003, MOL CANCER RES, V1, P402
   Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140
   Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6
   Nosho K, 2009, MODERN PATHOL, V22, P922, DOI 10.1038/modpathol.2009.49
   Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049
   Ouaïssi M, 2008, ANN SURG ONCOL, V15, P2318, DOI 10.1245/s10434-008-9940-z
   Qiao AM, 2006, ACTA PHARMACOL SIN, V27, P1622, DOI 10.1111/j.1745-7254.2006.00444.x
   Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867
   Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616
   Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087
   Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972
   Tsutsumi S, 2004, CLIN CANCER RES, V10, P7775, DOI 10.1158/1078-0432.CCR-04-1015
   van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663
   Yu-Pei Z, 2007, CHINESE MED J-PEKING, V120, P1743, DOI 10.1097/00029330-200710020-00003
NR 50
TC 91
Z9 103
U1 0
U2 22
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0969-7128
EI 1476-5462
J9 GENE THER
JI Gene Ther.
PD SEP
PY 2011
VL 18
IS 9
BP 920
EP 928
DI 10.1038/gt.2011.81
PG 9
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Research & Experimental Medicine
GA 817PC
UT WOS:000294685300009
PM 21677689
DA 2024-02-19
ER

PT J
AU Davis, GL
   Alter, MJ
   El-Serag, H
   Poynard, T
   Jennings, LW
AF Davis, Gary L.
   Alter, Miriam J.
   El-Serag, Hashem
   Poynard, Thierry
   Jennings, Linda W.
TI Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States:
   A Multiple Cohort Model of HCV Prevalence and Disease Progression
SO GASTROENTEROLOGY
LA English
DT Article
ID CHRONIC LIVER-DISEASE; NON-B-HEPATITIS; SUSTAINED VIROLOGICAL RESPONSE;
   HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; FIBROSIS PROGRESSION;
   FOLLOW-UP; NON-A; COMPENSATED CIRRHOSIS; CLINICAL-OUTCOMES
AB BACKGROUND & AIMS: The prevalence of chronic hepatitis C (CH-C) remains high and the complications of infection are common. Our goal was to project the future prevalence of CH-C and its complications. METHODS: We developed a multicohort natural history model to overcome limitations of previous models for predicting disease outcomes and benefits of therapy. RESULTS: Prevalence of CH-C peaked in 2001 at 3.6 million. Fibrosis progression was inversely related to age at infection, so cirrhosis and its complications were most common after the age of 60 years, regardless of when infection occurred. The proportion of CH-C with cirrhosis is projected to reach 25% in 2010 and 45% in 2030, although the total number with cirrhosis will peak at 1.0 million (30.5% higher than the current level) in 2020 and then decline. Hepatic decompensation and liver cancer will continue to increase for another 10 to 13 years. Treatment of all infected patients in 2010 could reduce risk of cirrhosis, decompensation, cancer, and liver-related deaths by 16%, 42%, 31%, and 36% by 2020, given current response rates to antiviral therapy. CONCLUSIONS: Prevalence of hepatitis C cirrhosis and its complications will continue to increase through the next decade and will mostly affect those older than 60 years of age. Current treatment patterns will have little effect on these complications, but wider application of antiviral treatment and better responses with new agents could significantly reduce the impact of this disease in coming years.
C1 [Davis, Gary L.; Jennings, Linda W.] Baylor Univ, Med Ctr, Div Hepatol, Dallas, TX 75246 USA.
   [Davis, Gary L.; Jennings, Linda W.] Baylor Reg Transplant Inst, Dallas, TX USA.
   Univ Texas Med Branch, Infect Dis Epidemiol Program, Galveston, TX USA.
   [El-Serag, Hashem] Baylor Coll Med, Houston, TX 77030 USA.
   [El-Serag, Hashem] Michael E DeBakey VA Med Ctr, Houston, TX USA.
   [Poynard, Thierry] Univ Paris 06, Ctr Liver, AP HP, Paris, France.
C3 Baylor University; Baylor University Medical Center; Baylor University
   Medical Center; University of Texas System; University of Texas Medical
   Branch Galveston; Baylor College of Medicine; Baylor College of
   Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Paul-Brousse - APHP; Sorbonne Universite; Universite Paris
   Cite; Hopital Universitaire Hotel-Dieu - APHP
RP Davis, GL (corresponding author), Baylor Univ, Med Ctr, Div Hepatol, 4 Roberts,3500 Gaston Ave, Dallas, TX 75246 USA.
EM GaryDav@BaylorHealth.edu
RI Poynard, Thierry/C-1355-2010
OI Poynard, Thierry/0000-0002-3726-7230; Poynard,
   Thierry/0000-0002-2050-640X
FU Vertex Pharmaceutical Inc.
FX Sponsored by an unrestricted grant from Vertex Pharmaceutical Inc.
CR Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753
   ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702
   Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802
   Alter MJ, 2004, ANN INTERN MED, V141, P715, DOI 10.7326/0003-4819-141-9-200411020-00013
   ALTER MJ, 1990, JAMA-J AM MED ASSOC, V264, P2231, DOI 10.1001/jama.264.17.2231
   Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332
   Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004
   Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492
   Centers for Disease Control and Prevention, MORT TABL
   Chiaramonte M, 1999, CANCER-AM CANCER SOC, V85, P2132, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2132::AID-CNCR6>3.0.CO;2-H
   Cruts G, 2008, SUBST USE MISUSE, V43, P733, DOI 10.1080/10826080701202643
   D'Souza R, 2005, CLIN GASTROENTEROL H, V3, P910, DOI 10.1016/S1542-3565(05)00527-6
   Datz C, 1999, GUT, V44, P563, DOI 10.1136/gut.44.4.563
   Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020
   Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073
   Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131
   Deuffic S, 1999, HEPATOLOGY, V29, P1596, DOI 10.1002/hep.510290528
   DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A
   El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x
   El-Serag HB, 2002, HEPATOLOGY, V36, pS74, DOI 10.1053/jhep.2002.36807
   El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007
   El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013
   El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001
   Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038
   Farci P, 1996, NEW ENGL J MED, V335, P631, DOI 10.1056/NEJM199608293350904
   Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300
   Ferenci P, 2007, J HEPATOL, V47, P31, DOI 10.1016/j.jhep.2007.01.023
   Franchini M, 2001, BLOOD, V98, P1836, DOI 10.1182/blood.V98.6.1836
   Freeman AJ, 2003, J VIRAL HEPATITIS, V10, P285, DOI 10.1046/j.1365-2893.2003.00436.x
   Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047
   Guiltinan AM, 2008, AM J EPIDEMIOL, V167, P743, DOI 10.1093/aje/kwm370
   Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032
   Irving WL, 2006, J VIRAL HEPATITIS, V13, P264, DOI 10.1111/j.1365-2893.2005.00698.x
   Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602
   Kim WR, 2004, GASTROENTEROLOGY, V127, P749, DOI 10.1053/j.gastro.2004.06.052
   Kim WR, 2001, HEPATOLOGY, V33, P201, DOI 10.1053/jhep.2001.20798
   Levine RA, 2006, CLIN GASTROENTEROL H, V4, P1271, DOI 10.1016/j.cgh.2006.05.028
   Manos MM, 2008, HEPATOLOGY, V47, P1150, DOI 10.1002/hep.22181
   Mindikoglu AL, 2009, CLIN GASTROENTEROL H, V7, P128, DOI 10.1016/j.cgh.2008.07.017
   Missiha SB, 2008, GASTROENTEROLOGY, V134, P1699, DOI 10.1053/j.gastro.2008.02.069
   Morrill JA, 2005, J GEN INTERN MED, V20, P754, DOI 10.1111/j.1525-1497.2005.0161.x
   Neal KR, 2007, GUT, V56, P1098, DOI 10.1136/gut.2006.113217
   Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Pradat P, 2007, LIVER INT, V27, P335, DOI 10.1111/j.1478-3231.2006.01430.x
   Russmann S, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-5
   Ryder SD, 2004, GUT, V53, P451, DOI 10.1136/gut.2003.021691
   Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176
   Seeff LB, 2005, CLIN GASTROENTEROL H, V3, P840, DOI 10.1016/S1542-3565(05)00535-5
   SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703
   Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806
   Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003
   Sersté T, 2006, ACTA GASTRO-ENT BELG, V69, P296
   Shehab TM, 2003, AM J GASTROENTEROL, V98, P639, DOI 10.1111/j.1572-0241.2003.07331.x
   Snowberger N, 2007, ALIMENT PHARM THER, V26, P1187, DOI 10.1111/j.1365-2036.2007.03498.x
   Thabut D, 2006, AM J GASTROENTEROL, V101, P1260, DOI 10.1111/j.1572-0241.2006.00556.x
   Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375
   Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003
   Vong S, 2004, HEPATOLOGY, V39, P476, DOI 10.1002/hep.20049
   Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165
   Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562
   Wright M, 2003, GUT, V52, P574, DOI 10.1136/gut.52.4.574
   Yi Q, 2004, J VIRAL HEPATITIS, V11, P166, DOI 10.1046/j.1365-2893.2003.00484.x
   Yoshida H, 2004, GUT, V53, P425, DOI 10.1136/gut.2003.030353
   YOUSUF M, 1992, SCAND J GASTROENTERO, V27, P812, DOI 10.3109/00365529209011189
   Zarski JP, 2003, J HEPATOL, V38, P307, DOI 10.1016/S0168-8278(02)00387-2
   DIS BURDEN HEPATITIS
NR 67
TC 717
Z9 772
U1 1
U2 38
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD FEB
PY 2010
VL 138
IS 2
BP 513
EP U141
DI 10.1053/j.gastro.2009.09.067
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 552OB
UT WOS:000274300900019
PM 19861128
OA hybrid
DA 2024-02-19
ER

PT J
AU Collison, LW
   Kannan, L
   Onorato, TA
   Knudsen, J
   Haldar, D
   Jolly, CA
AF Collison, LW
   Kannan, L
   Onorato, TA
   Knudsen, J
   Haldar, D
   Jolly, CA
TI Aging reduces glycerol-3-phosphate acyltransferase activity in activated
   rat splenic T-lymphocytes
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
LA English
DT Article
DE T-lymphocyte; phosphatidic acid; acyl-CoA binding protein; mitochondria;
   aging
ID COA-BINDING PROTEINS; GLYCEROPHOSPHATE ACYLTRANSFERASE;
   SIGNAL-TRANSDUCTION; KINASE CK2; LIVER; BIOSYNTHESIS; CELLS;
   STIMULATION; MODULATION; AGE
AB T-lymphocyte proliferation declines with age. Phosphatidic acid (PA) is the precursor to all glycerophospholipids, which serve as important membrane structural components and signaling molecules. Therefore, we tested the hypothesis that aged T-lymphocyte proliferation may be reduced, in part, suppressing phosphatidic acid (PA) biosynthesis. We showed, for the first time, that anti-CD3 stimulation in rat splenic T-lymphocytes selectively increased mitochondrial glycerol-3-phosphate acyltransferase (GPAT) activity. GPAT activity could be further increased by the addition of recombinant acyl-CoA binding protein (rACBP), but the amplification of GPAT activity was blunted by aging. This is important because PA is the precursor lipid for phospholipid synthesis and GPAT is the rate-limiting enzyme in PA biosynthesis. The mechanism by which stimulation and rACBP increased GPAT activity may involve phosphorylation since incubating Jurkat T-lymphocyte mitochondria with casein kinase 2 in vitro significantly increased GPAT activity. The data presented here suggest a novel mechanism by which aging may reduce activation-dependent mitochondrial GPAT activity. This age-induced alteration would result in reduced PA biosynthesis and could explain, in part, the diminished phospholipid content of the membrane and subsequent loss of proliferative capacity in the aged T-lymphocyte. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Texas, Div Nutr Sci, Austin, TX 78712 USA.
   Univ Texas, Inst Cell & Mol Biol, Austin, TX 78712 USA.
   St Johns Hosp, Jamaica, NY USA.
   Odense Univ, Inst Biochem, DK-5230 Odense, Denmark.
C3 University of Texas System; University of Texas Austin; University of
   Texas System; University of Texas Austin; University of Southern Denmark
RP Jolly, CA (corresponding author), Univ Texas, Div Nutr Sci, 1 Univ Stn A2700, Austin, TX 78712 USA.
EM jolly@mail.utexas.edu
OI Onorato, Thomas/0000-0001-5901-7956
FU NIA NIH HHS [AG19990-01, AG20651] Funding Source: Medline
CR BOVOLIN P, 1990, REGUL PEPTIDES, V29, P267, DOI 10.1016/0167-0115(90)90089-F
   Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806
   Courageot J, 1999, EUR J BIOCHEM, V260, P482, DOI 10.1046/j.1432-1327.1999.00193.x
   Dircks L, 1999, PROG LIPID RES, V38, P461, DOI 10.1016/S0163-7827(99)00012-0
   Dircks LK, 1997, BBA-LIPID LIPID MET, V1348, P17, DOI 10.1016/S0005-2760(97)00106-9
   Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256
   Færgeman NJ, 2002, BIOCHEM J, V368, P679, DOI 10.1042/BJ20021413
   Fulop T, 2001, MECH AGEING DEV, V122, P1413, DOI 10.1016/S0047-6374(01)00274-3
   Gossett RE, 1997, LIPIDS, V32, P577, DOI 10.1007/s11745-997-0073-5
   Gossett RE, 1996, LIPIDS, V31, P895, DOI 10.1007/BF02522684
   Guthmann F, 2003, FREE RADICAL BIO MED, V34, P663, DOI 10.1016/S0891-5849(02)01376-X
   JAMDAR SC, 1986, LIPIDS, V21, P460, DOI 10.1007/BF02536404
   Jolly CA, 2002, LIPIDS, V37, P475, DOI 10.1007/s11745-002-0920-4
   Jolly CA, 1997, ARCH BIOCHEM BIOPHYS, V341, P112, DOI 10.1006/abbi.1997.9957
   Jolly CA, 1998, BBA-LIPID LIPID MET, V1390, P258, DOI 10.1016/S0005-2760(97)00186-0
   Jolly CA, 2000, BBA-MOL CELL BIOL L, V1483, P185, DOI 10.1016/S1388-1981(99)00170-5
   JOLLY CA, 2002, LIPIDS GLYCEROLIPID, P29
   Kannan L, 2003, BBA-MOL CELL BIOL L, V1631, P12, DOI 10.1016/S1388-1981(02)00367-0
   Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469
   Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70
   Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783
   Onorato TM, 2002, BIOCHEM BIOPH RES CO, V296, P1091, DOI 10.1016/S0006-291X(02)02064-8
   Pahlavani MA, 2000, P SOC EXP BIOL MED, V223, P163, DOI 10.1046/j.1525-1373.2000.22322.x
   Rifkin IR, 1998, J IMMUNOL, V161, P5164
   Tamir A, 2000, J IMMUNOL, V165, P1243, DOI 10.4049/jimmunol.165.3.1243
   Uchida T, 1996, BBA-LIPID LIPID MET, V1304, P89, DOI 10.1016/S0005-2760(96)00109-9
   Wang GQ, 2001, J BIOL CHEM, V276, P34307, DOI 10.1074/jbc.M103526200
   Woods MJ, 1996, BIOCHEM PHARMACOL, V51, P1283, DOI 10.1016/0006-2952(96)00034-2
   YANG SY, 1994, AGE RELATED MEMBRANE
NR 29
TC 19
Z9 20
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1388-1981
EI 0006-3002
J9 BBA-MOL CELL BIOL L
JI Biochim. Biophys. Acta Mol. Cell Biol. Lipids
PD FEB 21
PY 2005
VL 1687
IS 1-3
BP 164
EP 172
DI 10.1016/j.bbalip.2004.11.013
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 900XI
UT WOS:000227247200017
PM 15708364
DA 2024-02-19
ER

PT J
AU González-Hedström, D
   García-Villalón, AL
   Amor, S
   de la Fuente-Fernández, M
   Almodóvar, P
   Prodanov, M
   Priego, T
   Martín, AI
   Inarejos-García, AM
   Granado, M
AF Gonzalez-Hedstrom, Daniel
   Luis Garcia-Villalon, Angel
   Amor, Sara
   de la Fuente-Fernandez, Maria
   Almodovar, Paula
   Prodanov, Marin
   Priego, Teresa
   Isabel Martin, Ana
   Manuel Inarejos-Garcia, Antonio
   Granado, Miriam
TI Olive leaf extract supplementation improves the vascular and metabolic
   alterations associated with aging in Wistar rats
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AGE
AB Olive leaves are rich in bioactive substances which exert anti-inflammatory, antioxidant, insulin-sensitizing and antihypertensive effects. The aim of this study was to analyze the possible beneficial effects of an olive leaf extract (OLE) rich in secoiridoids and phenolic compounds on the aging-induced metabolic and vascular alterations. Three experimental groups of rats were used: 3-month-old rats, 24-month-old rats and 24-month-old rats supplemented 21 days with OLE (100 mg/kg). Administration of OLE to aged rats decreased the weight of adrenal glands and prevented the aging-induced loss of body weight and muscle mass. In the serum, OLE reduced the circulating levels of LDL-cholesterol and IL-6 and increased the concentrations of leptin and adiponectin. In the liver OLE attenuated the decreased gene expression of SOD-1, GSR, GCK and GSK-3 beta and reduced the aging-induced overexpression of NOX-4, Alox-5, iNOS and TNF-alpha. In aorta segments, OLE prevented endothelial dysfunction and vascular insulin resistance and improved vasoconstriction in response to KCl and NA. Improvement in vascular function was associated with the attenuation of the alterations in the gene expression of COX-2, IL-6, GPx, NOX-1 and IL-10. In conclusion, OLE exerts anti-inflammatory and antioxidant effects in aged rats and attenuates the alterations in vascular function associated with aging.
C1 [Gonzalez-Hedstrom, Daniel; Luis Garcia-Villalon, Angel; Amor, Sara; de la Fuente-Fernandez, Maria; Granado, Miriam] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.
   [Gonzalez-Hedstrom, Daniel; Almodovar, Paula; Manuel Inarejos-Garcia, Antonio] Pharmact Biotech Prod SL Parque Cient Madrid, Ave Doctor Severo Ochoa,37 Local 4J, Madrid 28108, Spain.
   [Prodanov, Marin] Univ Autonoma Madrid, Fac Ciencias, Dept Quim Fis Aplicada, CIAL CEI,CSIC UAM, Madrid, Spain.
   [Priego, Teresa; Isabel Martin, Ana] Univ Complutense Madrid, Fac Med, Dept Fisiol, Madrid, Spain.
   [Granado, Miriam] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain.
C3 Autonomous University of Madrid; Consejo Superior de Investigaciones
   Cientificas (CSIC); Autonomous University of Madrid; Complutense
   University of Madrid; Instituto de Salud Carlos III; CIBER - Centro de
   Investigacion Biomedica en Red; CIBEROBN
RP Granado, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.; Granado, M (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain.
EM miriam.granado@uam.es
RI Martín, Ana Isabel/K-5301-2014
OI Gonzalez-Hedstrom, Daniel/0000-0001-9425-1115
FU Community of Madrid (Spain) [IND2017/BIO7701]; Community of Madrid
   [PEJ-2018-AI/SAL-11315]
FX This project was funded by the call "Doctorados Industriales 2017"
   (IND2017/BIO7701), a grant from Community of Madrid (Spain). This
   program aims to promote the effective collaboration between Universities
   and Companies and provides funding for both, the development of the
   research project in the University and the Company, and to hire a PhD
   student (Daniel Gonzalez-Hedstrom) over a three-year period by the
   Company (Pharmactive Biotech Products S.L.). Community of Madrid also
   funded the contract of Maria de la Fuente-Fernandez through the Youth
   Employment Program (PEJ-2018-AI/SAL-11315).
CR Abunab H, 2017, J DIABETES, V9, P947, DOI 10.1111/1753-0407.12508
   Acar-Tek N, 2020, ANN NUTR METAB, V76, P10, DOI 10.1159/000505508
   Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321
   Amor S, 2018, EXP GERONTOL, V109, P126, DOI 10.1016/j.exger.2017.10.017
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Aslam M, 2017, ENDOCRINE, V58, P59, DOI 10.1007/s12020-017-1403-5
   Aziz N, 2018, J ETHNOPHARMACOL, V225, P342, DOI 10.1016/j.jep.2018.05.019
   Barzi F, 2003, EUR J CLIN NUTR, V57, P1034, DOI 10.1038/sj.ejcn.1601575
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Buckley BM, 2001, EUR HEART J SUPPL, V3, pN6, DOI 10.1016/S1520-765X(01)90131-2
   Burja B, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00056
   Casamenti F, 2017, EXPERT REV NEUROTHER, V17, P345, DOI 10.1080/14737175.2017.1245617
   Cheurfa M, 2019, FOOD CHEM TOXICOL, V123, P98, DOI 10.1016/j.fct.2018.10.002
   CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P996, DOI 10.1111/ggi.12192
   De la Ossa JG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235918
   Dominguez LJ, 2016, CURR OPIN CLIN NUTR, V19, P5, DOI 10.1097/MCO.0000000000000243
   Efentakis P, 2015, PLANTA MED, V81, P648, DOI 10.1055/s-0035-1546017
   El SN, 2009, NUTR REV, V67, P632, DOI 10.1111/j.1753-4887.2009.00248.x
   Elgebaly HA, 2018, BIOMED PHARMACOTHER, V98, P446, DOI 10.1016/j.biopha.2017.12.101
   Fki I, 2020, BIOMED RES INT-UK, V2020, DOI 10.1155/2020/1315202
   Fleg JL, 2012, HEART FAIL REV, V17, P545, DOI 10.1007/s10741-011-9270-2
   Ghadge AA, 2017, DIABETES METAB SYND, V11, pS481, DOI 10.1016/j.dsx.2017.03.041
   Gocmez Semil S, 2016, J Exerc Nutrition Biochem, V20, P41, DOI 10.20463/jenb.2016.03.20.1.2
   Gong DZ, 2012, PHYTOTHER RES, V26, P397, DOI 10.1002/ptr.3567
   González-Hedström D, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9060483
   Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332
   Hansen K, 1996, PHYTOMEDICINE, V2, P319, DOI 10.1016/S0944-7113(96)80076-6
   Huang C, 2016, AGE AGEING, V45, P366, DOI 10.1093/ageing/afw043
   Ivanov M, 2018, EXCLI J, V17, P29, DOI 10.17179/excli2017-1002
   Javadi Hamidreza, 2019, Pak J Biol Sci, V22, P342, DOI 10.3923/pjbs.2019.342.348
   Jemai H, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4398924
   Johansson H, 2012, J BONE MINER RES, V27, P1390, DOI 10.1002/jbmr.1591
   Keane KN, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/181643
   Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371
   Khayyal MT, 2002, ARZNEIMITTEL-FORSCH, V52, P797
   Kmiec Z, 2005, GERONTOLOGY, V51, P357, DOI 10.1159/000088698
   Komorita Y, 2017, DIABETOLOGIA, V60, P1922, DOI 10.1007/s00125-017-4369-1
   Li FH, 2018, EXP GERONTOL, V113, P150, DOI 10.1016/j.exger.2018.10.006
   Li YX, 2018, INT ARCH ALLERGY IMM, V175, P220, DOI 10.1159/000486958
   Liu YN, 2014, NUTR RES, V34, P450, DOI 10.1016/j.nutres.2014.04.007
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lockyer S, 2017, EUR J NUTR, V56, P1421, DOI 10.1007/s00394-016-1188-y
   Lockyer S, 2015, BRIT J NUTR, V114, P75, DOI 10.1017/S0007114515001269
   Luo SY, 2019, MOLECULES, V24, DOI 10.3390/molecules24040704
   Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707
   Ma HB, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.921276
   MacNee W, 2014, EUR RESPIR J, V44, P1332, DOI 10.1183/09031936.00134014
   Mahmoudi A, 2018, FOOD FUNCT, V9, P3220, DOI [10.1039/c8fo00248g, 10.1039/C8FO00248G]
   Silvan JM, 2019, INNOV FOOD SCI EMERG, V51, P177, DOI 10.1016/j.ifset.2018.05.013
   Martel J, 2019, TRENDS ENDOCRIN MET, V30, P335, DOI 10.1016/j.tem.2019.04.001
   Mattioli S, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10020274
   Mehraein F, 2016, HISTOL HISTOPATHOL, V31, P425, DOI 10.14670/HH-11-687
   Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319
   Motlagh S. V.M, 2020, TRENDS PHARM SCI, P43, DOI 10.30476/TIPS.2020.82251.1038
   Olmez E, 2015, PHYTOTHER RES, V29, P1652, DOI 10.1002/ptr.5445
   Park JH, 2013, NUTR RES, V33, P942, DOI 10.1016/j.nutres.2013.07.011
   Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6
   Pérez-López FR, 2009, MATURITAS, V64, P67, DOI 10.1016/j.maturitas.2009.07.013
   Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812
   Richter-Stretton GL, 2020, DIABETES METAB SYND, V14, P867, DOI 10.1016/j.dsx.2020.06.006
   Romero M, 2016, FOOD FUNCT, V7, P584, DOI [10.1039/c5fo01101a, 10.1039/C5FO01101A]
   Saibandith B, 2017, MOLECULES, V22, DOI 10.3390/molecules22071082
   Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308
   Speciale A, 2011, CURR MOL MED, V11, P770, DOI 10.2174/156652411798062395
   Susalit E, 2011, PHYTOMEDICINE, V18, P251, DOI 10.1016/j.phymed.2010.08.016
   Talhaoui N, 2014, LWT-FOOD SCI TECHNOL, V58, P28, DOI 10.1016/j.lwt.2014.03.014
   Tuchweber B, 1975, Methods Achiev Exp Pathol, V7, P167
   Tuomilehto J, 2004, ATHEROSCLEROSIS SUPP, V5, P9, DOI 10.1016/j.atherosclerosissup.2004.03.006
   Vezza T, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104487
   Villani A, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-017-0700-4
   Virruso C, 2014, REJUV RES, V17, P217, DOI 10.1089/rej.2013.1532
   Wainstein J, 2012, J MED FOOD, V15, P605, DOI 10.1089/jmf.2011.0243
   Wang HH, 2020, PEDIATR GASTROENTERO, V23, P189
   Wilson D, 2017, AGEING RES REV, V36, P1, DOI 10.1016/j.arr.2017.01.006
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Yoon L, 2015, J MED FOOD, V18, P738, DOI 10.1089/jmf.2014.3287
   Zuntar I, 2019, FOODS, V8, DOI 10.3390/foods8070248
NR 78
TC 9
Z9 9
U1 0
U2 7
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 14
PY 2021
VL 11
IS 1
AR 8188
DI 10.1038/s41598-021-87628-7
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA RN8LF
UT WOS:000640601800022
PM 33854149
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Pamplona, R
   Prat, J
   Cadenas, S
   Rojas, C
   PerezCampo, R
   Torres, ML
   Barja, G
AF Pamplona, R
   Prat, J
   Cadenas, S
   Rojas, C
   PerezCampo, R
   Torres, ML
   Barja, G
TI Low fatty acid unsaturation protects against lipid peroxidation in liver
   mitochondria from long-lived species: The pigeon and human case
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; longevity; mitochondria; free radicals; fatty acids;
   unsaturation; lipid peroxidation; membranes; liver
ID GLUTATHIONE-REDUCTASE; LIFE-SPAN; ACCUMULATION; RESTRICTION; LONGEVITY;
   ASCORBATE; INDUCTION; SURVIVAL; TISSUES; DNA
AB Birds have a much higher maximum longevity (MLSP) than mammals of similar metabolic rate. Recent data showed that pigeon mitochondria produce oxygen radicals at a rate much slower than rat mitochondria, in spite of showing similar levels of oxygen consumption (Free Rad Res., 21 (1994) 317-328). Since oxidative damage from and to mitochondria seems important in relation to aging and longevity, and mitochondrial membranes are situated at the place where oxygen radicals are generated, we studied protein and lipid peroxidation and fatty acid composition of the three main membrane phospholipids of liver mitochondria from rats (MLSP = 4 years) and pigeons (MLSP = 35 years). It was found that pigeon mitochondria show lower levels of fatty acid unsaturation than rat mitochondria in the three lipid fractions, mainly due to a substitution of highly unsaturated fatty acids (20:4 and 22:6) by linoleic acid (18:2), and that these mitochondria are more resistant to lipid peroxidation. Previous research has also obtained exactly the same major difference in fatty acid composition in human mitochondria when compared to those of rat. Thus, present information suggests that the liver mitochondrial membranes of especially long-lived species show both a low level of free radical production and a low degree of fatty acid unsaturation as important constitutive protective traits to slow down aging.
C1 UNIV COMPLUTENSE MADRID,FAC BIOL,DEPT ANIM BIOL ANIM PHYSIOL 2,E-28040 MADRID,SPAIN.
C3 Complutense University of Madrid
RI Barja, Gustavo/AAA-5903-2019; Gustavo, Barja/B-5591-2012; Pamplona,
   Reinald/A-7359-2010; Cadenas, Susana/D-1523-2016
OI Barja, Gustavo/0000-0001-5736-4735; Pamplona,
   Reinald/0000-0003-4337-6107; Cadenas, Susana/0000-0003-0726-0369
CR ARSLAN P, 1984, BIOCHEM J, V217, P419, DOI 10.1042/bj2170419
   BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584
   BARJA G, 1994, FREE RADICAL BIO MED, V17, P105, DOI 10.1016/0891-5849(94)90108-2
   BARJA G, UNPUB MECH AGEING DE
   BENGA G, 1978, EUR J BIOCHEM, V84, P625, DOI 10.1111/j.1432-1033.1978.tb12205.x
   BRUNI A, 1975, BIOCHIM BIOPHYS ACTA, V406, P315, DOI 10.1016/0005-2736(75)90013-9
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4
   Griminger P., 1986, P345
   Halliwell B., 1989, Free radicals in biology and medicine, V2nd
   HARMAN D, 1994, AGE, V17, P119, DOI 10.1007/BF02435819
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   KU HH, 1993, MECH AGEING DEV, V72, P67, DOI 10.1016/0047-6374(93)90132-B
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   LIDSTEDT SL, 1976, CONDOR, V78, P91
   LOPEZTORRES M, 1993, MECH AGEING DEV, V70, P177, DOI 10.1016/0047-6374(93)90047-U
   LOPEZTORRES M, 1993, J NEUROSCI RES, V34, P233, DOI 10.1002/jnr.490340211
   LOPEZTORRES M, 1993, FREE RADICAL BIO MED, V15, P133, DOI 10.1016/0891-5849(93)90052-V
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NORTH JA, 1994, AM J PHYSIOL, V267, pC177, DOI 10.1152/ajpcell.1994.267.1.C177
   Pearl R., 1928, RATE LIVING
   PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0
   PRINZINGER R, 1993, COMP BIOCHEM PHYS A, V105, P609, DOI 10.1016/0300-9629(93)90260-B
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   ROJAS C, 1993, ARCH BIOCHEM BIOPHYS, V306, P59, DOI 10.1006/abbi.1993.1480
   Rubner M., 1908, PROBLEM LEBENSDAUER
   SHIGENAGA MK, 1994, NATURAL ANTIOXIDANTS, P63
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
NR 37
TC 117
Z9 126
U1 0
U2 13
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JAN 5
PY 1996
VL 86
IS 1
BP 53
EP 66
DI 10.1016/0047-6374(95)01673-2
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA TX129
UT WOS:A1996TX12900005
PM 8866736
DA 2024-02-19
ER

PT J
AU Lysek-Gladysinska, M
   Wieczorek, A
   Józwik, A
   Walaszczyk, A
   Jelonek, K
   Szczukiewicz-Markowska, G
   Horbanczuk, OK
   Pietrowska, M
   Widlak, P
   Gabrys, D
AF Lysek-Gladysinska, Malgorzata
   Wieczorek, Anna
   Jozwik, Artur
   Walaszczyk, Anna
   Jelonek, Karol
   Szczukiewicz-Markowska, Grazyna
   Horbanczuk, Olaf K.
   Pietrowska, Monika
   Widlak, Piotr
   Gabrys, Dorota
TI Aging-Related Changes in the Ultrastructure of Hepatocytes and
   Cardiomyocytes of Elderly Mice Are Enhanced in ApoE-Deficient Animals
SO CELLS
LA English
DT Article
DE aging; hepatocytes; cardiomyocytes; lysosomes; mitochondrion; lipids
AB Biological aging is associated with various morphological and functional changes, yet the mechanisms of these phenomena remain unclear in many tissues and organs. Hyperlipidemia is among the factors putatively involved in the aging of the liver and heart. Here, we analyzed morphological, ultrastructural, and biochemical features in adult (7-month-old) and elderly (17-month-old) mice, and then compared age-related features between wild type (C57Bl/6 strain) and ApoE-deficient (transgenic ApoE(-/-)) animals. Increased numbers of damaged mitochondria, lysosomes, and lipid depositions were observed in the hepatocytes of elderly animals. Importantly, these aging-related changes were significantly stronger in hepatocytes from ApoE-deficient animals. An increased number of damaged mitochondria was observed in the cardiomyocytes of elderly animals. However, the difference between wild type and ApoE-deficient mice was expressed in the larger size of mitochondria detected in the transgenic animals. Moreover, a few aging-related differences were noted between wild type and ApoE-deficient mice at the level of plasma biochemical markers. Levels of cholesterol and HDL increased in the plasma of elderly ApoE(-/-) mice and were markedly higher than in the plasma of elderly wild type animals. On the other hand, the activity of alanine transaminase (ALT) decreased in the plasma of elderly ApoE(-/-) mice and was markedly lower than in the plasma of elderly wild type animals.
C1 [Lysek-Gladysinska, Malgorzata; Wieczorek, Anna] Univ Jan Kochanowski, Inst Biol, Div Med Biol, Univ 7, PL-25406 Kielce, Poland.
   [Jozwik, Artur] Inst Genet & Anim Biotechnol PAS, Postepu 36A, PL-05552 Magdalenka, Poland.
   [Walaszczyk, Anna] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Jelonek, Karol; Pietrowska, Monika; Widlak, Piotr] Maria Sklodowska Curie Natl Res Inst Oncol, Ctr Translat Res & Mol Biol Canc, Gliwice Branch, Wybrzeze Armii Krajowej 15, PL-44101 Gliwice, Poland.
   [Szczukiewicz-Markowska, Grazyna] Univ Jan Kochanowski, Dept Surg Med, Coll Med, Lab Med Genet, Al IX Wiekow Kielc 19A, PL-25317 Kielce, Poland.
   [Horbanczuk, Olaf K.] Warsaw Univ Life Sci, Fac Human Nutr, Nowoursynowska 159 C, PL-02776 Warsaw, Poland.
   [Gabrys, Dorota] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Radiotherapy, Gliwice Branch, Wybrzeze Armii Krajowej 15, PL-44101 Gliwice, Poland.
C3 Jan Kochanowski University; Newcastle University - UK; Jan Kochanowski
   University; Warsaw University of Life Sciences
RP Lysek-Gladysinska, M (corresponding author), Univ Jan Kochanowski, Inst Biol, Div Med Biol, Univ 7, PL-25406 Kielce, Poland.; Józwik, A (corresponding author), Inst Genet & Anim Biotechnol PAS, Postepu 36A, PL-05552 Magdalenka, Poland.
EM malgorzata.lysek-gladysinska@ujk.edu.pl; anna.wieczorek@ujk.edu.pl;
   aa.jozwik@ighz.pl; walaszczyk.anna@gmail.com;
   Karol.Jelonek@io.gliwice.pl; grazyna.szczukiewicz-markowska@ujk.edu.pl;
   olaf_horbanczuk@sggw.edu.pl; Monika.Pietrowska@io.gliwice.pl;
   Piotr.Widlak@io.gliwice.pl; dorota.gabrys@io.gliwice.pl
RI Jozwik, Artur/HJY-6775-2023; Widlak, Piotr/HPD-6080-2023
OI Jozwik, Artur/0000-0001-5546-9891; Widlak, Piotr/0000-0001-5099-4726;
   Lysek-Gladysinska, Malgorzata/0000-0002-0327-3202; Wieczorek,
   Anna/0000-0002-3530-1335; Horbanczuk, Olaf/0000-0002-1746-9134; Jelonek,
   Karol/0000-0002-7233-7695; Gabrys, Dorota/0000-0001-9096-2788;
   Pietrowska, Monika/0000-0001-9317-7822
FU European Atomic Energy Community's Seventh Framework Programme
   (FP7/2007-2011) [211403]; National Science Center, Poland [N-402685640]
FX The research received funding from the European Atomic Energy
   Community's Seventh Framework Programme (FP7/2007-2011) under the grant
   agreement no. 211403 (CARDIORISK) and from the National Science Center,
   Poland under grant no. N-402685640.
CR Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031
   Alvarez AM, 2011, INT J ANGIOL, V20, P135, DOI 10.1055/s-0031-1284434
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Barrett AJ, 1977, LYSOSOMES LABORATORY, P19
   Bonomini F, 2013, BIOGERONTOLOGY, V14, P209, DOI 10.1007/s10522-013-9424-9
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Brandt T, 2017, ELIFE, V6, DOI 10.7554/eLife.24662
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Buzello M, 2003, J AM SOC NEPHROL, V14, P311, DOI 10.1097/01.ASN.0000045048.71975.FC
   Fouad YM, 2014, WORLD J HEPATOL, V6, P41, DOI 10.4254/wjh.v6.i1.41
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Gouras P, 2016, GRAEF ARCH CLIN EXP, V254, P1221, DOI 10.1007/s00417-016-3342-x
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Gude NA, 2018, NAT REV CARDIOL, V15, P523, DOI 10.1038/s41569-018-0061-5
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hoppel CL, 2009, INT J BIOCHEM CELL B, V41, P1949, DOI 10.1016/j.biocel.2009.05.004
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Kaneva AM, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-43
   Khraiwesh H, 2014, EXP GERONTOL, V56, P77, DOI 10.1016/j.exger.2014.03.023
   KIRSCHKE H, 1984, METHODEN AKTIVITATSB, P11
   Koks S, 2016, MECH AGEING DEV, V160, P41, DOI 10.1016/j.mad.2016.10.001
   Leonova Elena I, 2017, Open Biochem J, V11, P77, DOI 10.2174/1874091X01711010077
   Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lysek-Gladysinska M, 2018, RADIAT ENVIRON BIOPH, V57, P123, DOI 10.1007/s00411-018-0734-9
   Marcos R, 2016, CELL TISSUE RES, V366, P639, DOI 10.1007/s00441-016-2490-y
   MARZELLA L, 1980, LAB INVEST, V42, P8
   MARZELLA L, 1980, LAB INVEST, V42, P18
   Pendse AA, 2009, J LIPID RES, V50, pS178, DOI 10.1194/jlr.R800070-JLR200
   Premoli A, 2009, Minerva Gastroenterol Dietol, V55, P71
   Rockwood K, 2019, MECH AGEING DEV, V180, P107, DOI 10.1016/j.mad.2019.04.005
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Shah S, 2015, LIVER RES OPEN J, V1, P1, DOI [10.17140/1roj-1-101, DOI 10.17140/1ROJ-1-101, 10.17140/lroj-1-101]
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Son HG, 2019, AGING CELL, V18, DOI 10.1111/acel.12853
   Spazzafumo L, 2017, ONCOTARGET, V8, P93338, DOI 10.18632/oncotarget.21848
   Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011
   Stroikin Y, 2005, BIOGERONTOLOGY, V6, P39, DOI 10.1007/s10522-004-7382-y
   Tandler B, 2002, ULTRASTRUCT PATHOL, V26, P177, DOI 10.1080/01913120290076847
   Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094
   Tewari D, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092552
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   Wieczorek A, 2018, INT J RADIAT BIOL, V94, P443, DOI 10.1080/09553002.2018.1451005
   Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008
   Yeung AWK, 2020, ANIM SCI PAP REP, V38, P5
   Yeung AWK, 2018, ANIM SCI PAP REP, V36, P345
NR 49
TC 7
Z9 8
U1 1
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAR
PY 2021
VL 10
IS 3
AR 502
DI 10.3390/cells10030502
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA RD4QF
UT WOS:000633464000001
PM 33652838
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Page, MM
   Stuart, JA
AF Page, Melissa M.
   Stuart, Jeffrey A.
TI Activities of DNA base excision repair enzymes in liver and brain
   correlate with body mass, but not lifespan
SO AGE
LA English
DT Article
DE Base excision repair (BER); DNA repair; Maximum lifespan; Body mass;
   Polymerase beta; AP endonuclease; APE1
ID HYDROGEN-PEROXIDE PRODUCTION; MAMMALIAN-CELLS; INDEPENDENT CONTRASTS;
   CALORIC RESTRICTION; RADICAL PRODUCTION; MITOCHONDRIAL-DNA; OXIDATIVE
   DAMAGE; PHYLOGENY; EVOLUTION; BIRDS
AB Accumulation of DNA lesions compromises replication and transcription and is thus toxic to cells. DNA repair deficiencies are generally associated with cellular replicative senescence and premature aging syndromes, suggesting that efficient DNA repair is required for normal longevity. It follows that the evolution of increasing lifespan amongst animal species should be associated with enhanced DNA repair capacities. Although UV damage repair has been shown to correlate positively with mammalian species lifespan, we lack similar insight into many other DNA repair pathways, including base excision repair (BER). DNA is continuously exposed to reactive oxygen species produced during aerobic metabolism, resulting in the occurrence of oxidative damage within DNA. Short-patch BER plays an important role in repairing the resultant oxidative lesions. We therefore tested whether an enhancement of BER enzyme activities has occurred concomitantly with the evolution of increased maximum lifespan (MLSP). We collected brain and liver tissue from 15 vertebrate endotherm species ranging in MLSP over an order of magnitude. We measured apurinic/apyrimidinic (AP) endonuclease activity, as well as the rates of nucleotide incorporation into an oligonucleotide containing a single nucleotide gap (catalyzed by BER polymerase beta) and subsequent ligation of the oligonucleotide. None of these activities correlated positively with species MLSP. Rather, nucleotide incorporation and oligonucleotide ligation activities appeared to be primarily (and negatively) correlated with species body mass.
C1 [Page, Melissa M.; Stuart, Jeffrey A.] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.
C3 Brock University
RP Stuart, JA (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.
EM jstuart@brocku.ca
OI Page, Melissa/0000-0001-5750-8962
FU Ontario Graduate Scholarship; Natural Sciences and Engineering Research
   Council; Canada Foundation for Innovation; Ontario Ministry of Research
   and Innovation
FX MMP was supported by an Ontario Graduate Scholarship. Work at Brock
   University was supported by the Natural Sciences and Engineering
   Research Council, the Canada Foundation for Innovation and an Early
   Researcher Award from the Ontario Ministry of Research and Innovation to
   JAS. We thank Gary Burness, Esther Tiedke, and Paul Faure for providing
   bird, livestock, and bat samples.
CR Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x
   Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448
   Cabelof DC, 2003, CANCER RES, V63, P5799
   Cabelof DC, 2003, DNA REPAIR, V2, P295, DOI 10.1016/S1568-7864(02)00219-7
   Cabelof DC, 2002, CARCINOGENESIS, V23, P1419, DOI 10.1093/carcin/23.9.1419
   Cabelof DC, 2002, MUTAT RES-FUND MOL M, V500, P135, DOI 10.1016/S0027-5107(02)00003-9
   Cabelof DC, 2006, CANCER RES, V66, P7460, DOI 10.1158/0008-5472.CAN-06-1177
   Chaudhry MA, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-15
   Cortopassi GA, 1996, MECH AGEING DEV, V91, P211, DOI 10.1016/S0047-6374(96)01788-5
   Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409
   de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017
   ELSE PL, 1985, AM J PHYSIOL, V248, pR415, DOI 10.1152/ajpregu.1985.248.4.R415
   FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325
   Foksinski M, 2004, FREE RADICAL BIO MED, V37, P1449, DOI 10.1016/j.freeradbiomed.2004.07.014
   FRANCIS AA, 1981, MECH AGEING DEV, V16, P181, DOI 10.1016/0047-6374(81)90094-4
   GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503
   GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464
   GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759
   Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704
   HALL KY, 1984, MECH AGEING DEV, V24, P163, DOI 10.1016/0047-6374(84)90068-X
   HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169
   Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385
   Izumi T, 2000, CARCINOGENESIS, V21, P1329, DOI 10.1093/carcin/21.7.1329
   Karahalil B, 2002, FASEB J, V16, P1895, DOI 10.1096/fj.02-0463com
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   Lambert AJ, 2007, AGING CELL, V6, P607, DOI 10.1111/j.1474-9726.2007.00312.x
   Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11
   LICASTRO F, 1985, MECH AGEING DEV, V31, P171, DOI 10.1016/S0047-6374(85)80028-2
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   Lorenzini A, 2009, MECH AGEING DEV, V130, P784, DOI 10.1016/j.mad.2009.10.004
   MARTINS EP, 1991, EVOLUTION, V45, P534, DOI 10.1111/j.1558-5646.1991.tb04328.x
   Meira LB, 2001, CANCER RES, V61, P5552
   Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104
   Page MM, 2009, COMP BIOCHEM PHYS A, V152, P115, DOI 10.1016/j.cbpa.2008.09.032
   PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213
   Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104
   Price T, 1997, PHILOS T ROY SOC B, V352, P519, DOI 10.1098/rstb.1997.0036
   Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z
   Salway KD, 2011, AGE, V33, P33, DOI 10.1007/s11357-010-9157-5
   Seluanov A, 2007, AGING CELL, V6, P45, DOI 10.1111/j.1474-9726.2006.00262.x
   Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   Speakman JR, 2005, AGING CELL, V4, P167, DOI 10.1111/j.1474-9726.2005.00162.x
   Springer MS, 2007, BIOL REV, V82, P375, DOI 10.1111/j.1469-185X.2007.00016.x
   Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203
   Stuart GW, 2002, MOL BIOL EVOL, V19, P554, DOI 10.1093/oxfordjournals.molbev.a004111
   Stuart JA, 2004, FASEB J, V18, P595, DOI 10.1096/fj.03-0890fje
   Stuart JA, 2010, MECH AGEING DEV, V131, P591, DOI 10.1016/j.mad.2010.08.005
   Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448
NR 51
TC 20
Z9 21
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
J9 AGE
JI Age
PD OCT
PY 2012
VL 34
IS 5
BP 1195
EP 1209
DI 10.1007/s11357-011-9302-9
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 011NB
UT WOS:000309170600012
PM 21853261
OA Green Published
DA 2024-02-19
ER

PT J
AU Weinstein, G
   Zelber-Sagi, S
   Preis, SR
   Beiser, AS
   DeCarli, C
   Speliotes, EK
   Satizabal, CL
   Vasan, RS
   Seshadri, S
AF Weinstein, Galit
   Zelber-Sagi, Shira
   Preis, Sarah R.
   Beiser, Alexa S.
   DeCarli, Charles
   Speliotes, Elizabeth K.
   Satizabal, Claudia L.
   Vasan, Ramachandran S.
   Seshadri, Sudha
TI Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume
   in Healthy Middle-aged Adults in the Framingham Study
SO JAMA NEUROLOGY
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; RISK-FACTOR;
   INSULIN-RESISTANCE; COGNITIVE DECLINE; ABDOMINAL OBESITY;
   PHYSICAL-ACTIVITY; VISCERAL FAT; STROKE; NAFLD
AB IMPORTANCE Nonalcoholic fatty liver disease (NAFLD) is a common condition that is most often asymptomatic. It is associated with metabolic syndrome, incident diabetes, carotid atherosclerosis, and endothelial dysfunction, conditions that in turn are strongly linked with brain damage and cognitive impairment. However, it is not known whether NAFLD is associated with structural brain measures in humans.
   OBJECTIVE To assess the association between prevalent NAFLD and brain magnetic resonance imaging (MRI) measures.
   DESIGN, SETTING, AND PARTICIPANTS The cross-sectional association between NAFLD and brain MRI measures was assessed from November 6, 2002, to March 16, 2011, in 766 individuals from the Offspring cohort of the Framingham Study. Participants were included if they did not have excessive alcohol intake and were free of stroke and dementia. Data analysis was conducted from December 30, 2015, to June 15, 2016.
   EXPOSURES Nonalcoholic fatty liver disease was assessed by multidetector computed tomographic scans of the abdomen.
   MAIN OUTCOMES AND MEASURES Linear or logistic regression models were used to evaluate the cross-sectional association between NAFLD and brain MRI measures, adjusting for age, sex, alcohol consumption, visceral adipose tissue, body mass index, menopausal status, systolic blood pressure, hypertension, current smoking, high-density lipoprotein and low-density lipoprotein cholesterol levels, lipid treatment, type 2 diabetes, cardiovascular disease, physical activity, insulin resistance, C-reactive protein levels, and plasma homocysteine values. Brain MRI measures included total cerebral brain volume, hippocampal and white matter hyperintensity volumes, and presence or absence of covert brain infarcts.
   RESULTS Of the 766 individuals in the study sample (410 women and 356 men; mean [SD] age at the time of brain MRI, 67 [9] years), 137 (17.9%) had NAFLD. Nonalcoholic fatty liver disease was significantly associated with smaller total cerebral brain volume even after adjustment for all the covariates included in the study (beta [SE], -0.26 [0.11]; P=.02). Differences in total cerebral brain volume between those with and without NAFLD corresponded to 4.2 years of brain aging in the general sample and to 7.3 years in individuals younger than 60 years of age. No statistically significant associations were observed between NAFLD and hippocampal or white matter hyperintensity volumes or covert brain infarcts.
   CONCLUSIONS AND RELEVANCE Nonalcoholic fatty liver disease is associated with a smaller total cerebral brain volume, independent of visceral adipose tissue and cardiometabolic risk factors, pointing to a possible link between hepatic steatosis and brain aging.
C1 [Weinstein, Galit; Zelber-Sagi, Shira] Univ Haifa, Sch Publ Hlth, 199 Aba Khoushy Ave, IL-3498838 Haifa, Israel.
   [Zelber-Sagi, Shira] Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol, Liver Unit, Tel Aviv, Israel.
   [Preis, Sarah R.; Beiser, Alexa S.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA.
   [Preis, Sarah R.; Beiser, Alexa S.; Satizabal, Claudia L.; Vasan, Ramachandran S.; Seshadri, Sudha] Framingham Study, Framingham, MA USA.
   [Beiser, Alexa S.; Satizabal, Claudia L.; Vasan, Ramachandran S.; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.
   [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA.
   [Speliotes, Elizabeth K.] Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA.
   [Speliotes, Elizabeth K.] Broad Inst Harvard, Dept Med & Populat Genet, Cambridge, MA USA.
   [Speliotes, Elizabeth K.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Vasan, Ramachandran S.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
C3 University of Haifa; Sackler Faculty of Medicine; Boston University;
   Boston University; University of California System; University of
   California Davis; Harvard University; Massachusetts General Hospital;
   Harvard University; Massachusetts Institute of Technology (MIT); Broad
   Institute; Massachusetts Institute of Technology (MIT); Boston
   University
RP Weinstein, G (corresponding author), Univ Haifa, Sch Publ Hlth, 199 Aba Khoushy Ave, IL-3498838 Haifa, Israel.
EM gweinstei@univ.haifa.ac.il
RI Ramachandran, Vasan/Y-2527-2019; DeCarli, Charles/B-5541-2009
OI Ramachandran, Vasan/0000-0001-7357-5970; Beiser,
   Alexa/0000-0001-8551-7778; Preis, Sarah/0000-0002-9360-4166; Satizabal,
   Claudia L/0000-0002-1115-4430; Seshadri, Sudha/0000-0001-6135-2622
FU NIA NIH HHS [P30 AG010129] Funding Source: Medline; NIDDK NIH HHS [R01
   DK106621, R01 DK107904] Funding Source: Medline; NINDS NIH HHS [R01
   NS017950] Funding Source: Medline
CR Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Das RR, 2008, STROKE, V39, P2929, DOI 10.1161/STROKEAHA.108.516575
   Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227
   Debette S, 2014, NEUROBIOL AGING, V35, P378, DOI 10.1016/j.neurobiolaging.2013.07.022
   Debette S, 2010, ANN NEUROL, V68, P136, DOI 10.1002/ana.22062
   Debette S, 2010, STROKE, V41, P600, DOI 10.1161/STROKEAHA.109.570044
   DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004
   Doycheva I, 2017, DIGEST DIS SCI, V62, P1373, DOI 10.1007/s10620-017-4492-3
   FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7
   Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355
   Francque SM, 2016, J HEPATOL, V65, P425, DOI 10.1016/j.jhep.2016.04.005
   Franzosi MG, 2006, LANCET, V368, P624, DOI 10.1016/S0140-6736(06)69222-2
   Fukuda T, 2016, LIVER INT, V36, P275, DOI 10.1111/liv.12912
   Ghareeb DA, 2011, METAB BRAIN DIS, V26, P253, DOI 10.1007/s11011-011-9261-y
   Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496
   Jack CR, 2005, NEUROLOGY, V65, P1227, DOI 10.1212/01.wnl.0000180958.22678.91
   Jakobsen MU, 2007, EPIDEMIOL REV, V29, P77, DOI 10.1093/epirev/mxm002
   Jeerakathil T, 2004, STROKE, V35, P1857, DOI 10.1161/01.STR.0000135226.53499.85
   Jefferson AL, 2007, NEUROLOGY, V68, P1032, DOI 10.1212/01.wnl.0000257815.20548.df
   KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857
   Kim DG, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0467-5
   Lockhart SN, 2014, NEUROPSYCHOL REV, V24, P271, DOI 10.1007/s11065-014-9268-3
   Lonardo A, 2016, METABOLISM, V65, P1136, DOI 10.1016/j.metabol.2015.09.017
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020
   Long MT, 2015, ARTERIOSCL THROM VAS, V35, P1284, DOI 10.1161/ATVBAHA.114.305200
   Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171
   Ma JT, 2015, J HEPATOL, V63, P462, DOI 10.1016/j.jhep.2015.03.032
   Mellinger JL, 2015, J HEPATOL, V63, P470, DOI 10.1016/j.jhep.2015.02.045
   Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253
   Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509
   Sapmaz F, 2016, MEDICINE, V95, pe3280
   Seo SW, 2016, NEUROLOGY, V86, P1136, DOI 10.1212/WNL.0000000000002498
   Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642
   Sookoian S, 2008, J HEPATOL, V49, P600, DOI 10.1016/j.jhep.2008.06.012
   Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593
   Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258
   Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009
   Sung KC, 2012, DIABETES CARE, V35, P717, DOI 10.2337/dc11-1853
   Sung KC, 2011, J CLIN ENDOCR METAB, V96, P1093, DOI 10.1210/jc.2010-2190
   Takahashi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174169
   Tan ZS, 2011, DIABETES CARE, V34, P1766, DOI 10.2337/dc11-0308
   Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005
   Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418
   Weinstein G, 2013, STROKE, V44, P2787, DOI 10.1161/STROKEAHA.113.000947
   Willette AA, 2015, AGEING RES REV, V20, P86, DOI 10.1016/j.arr.2014.03.007
   Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038
   Wu SQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33386
   Yamada T, 2010, J GASTROEN HEPATOL, V25, P352, DOI 10.1111/j.1440-1746.2009.05998.x
   Yamazaki H, 2015, DIABETES CARE, V38, P1673, DOI 10.2337/dc15-0140
   Yilmaz Y, 2009, HEPATOLOGY, V49, P698, DOI 10.1002/hep.22752
   Zelber-Sagi S, 2013, LIVER INT, V33, P1406, DOI 10.1111/liv.12200
   Zelber-Sagi S, 2011, WORLD J GASTROENTERO, V17, P3377, DOI 10.3748/wjg.v17.i29.3377
NR 56
TC 93
Z9 97
U1 0
U2 18
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD JAN
PY 2018
VL 75
IS 1
BP 97
EP 104
DI 10.1001/jamaneurol.2017.3229
PG 8
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA FS1FC
UT WOS:000419519100017
PM 29159396
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU STAELS, B
   AUWERX, J
AF STAELS, B
   AUWERX, J
TI PERTURBATION OF DEVELOPMENTAL GENE-EXPRESSION IN RAT-LIVER BY FIBRIC
   ACID-DERIVATIVES - LIPOPROTEIN-LIPASE AND ALPHA-FETOPROTEIN AS MODELS
SO DEVELOPMENT
LA English
DT Article
DE GENE REGULATION; TRANSCRIPTION FACTORS; STEROID HORMONE RECEPTORS; PPAR;
   FIBRATES; HNF
ID ENHANCER BINDING-PROTEIN; ALPHA-1-FETOPROTEIN MESSENGER-RNA; HORMONE
   RECEPTOR SUPERFAMILY; TISSUE-SPECIFIC EXTINGUISHER; NUCLEAR FACTOR-I;
   PEROXISOME PROLIFERATORS; MOLECULAR-CLONING; INVITRO TRANSCRIPTION;
   REGULATORY SUBUNIT; HEPATOMA-CELLS
AB Liver lipoprotein lipase (LPL) and alpha-fetoprotein (AFP) gene expression show similar developmental patterns. Both mRNAs are abundantly expressed in neonatal rat liver and gradually disappear upon ageing. Treatment with fibric acid derivatives, such as fenofibrate, not only delays the developmental extinction of the LPL gene, but also increases LPL mRNA levels in neonatal rat liver. Similarly, the developmental extinction of the AFP gene in the liver is clearly delayed after fenofibrate. In adult rat liver, fibric acid derivatives transcriptionally reinduce a mRNA with similar size as LPL, but no effect on AFP mRNA was detected. Sequence comparison of clones isolated from a fenofibrate-induced cDNA library demonstrates that the fenofibrate-(re)induced mRNA in adult rat liver is encoding for LPL. The induction of LPL after fenofibrate is tissue-specific, since heart and adipose tissue LPL mRNA levels remain unchanged. In conclusion, fibric acid derivatives modulate developmental expression patterns in rat liver, and may selectively reinduce the expression of extinct genes in adult rat liver.
C1 CATHOLIC UNIV LEUVEN,DEPT DEV BIOL,EXPTL GENEESKUNDE ENDOCRINOL LAB,B-3000 LOUVAIN,BELGIUM.
   CNRS,CTR BIOCHIM,BIOL REGULAT EUCARYOTES LAB,NICE,FRANCE.
C3 KU Leuven; Centre National de la Recherche Scientifique (CNRS)
RI Staels, Bart/N-9497-2016; Auwerx, Johan/ABE-9307-2021; Staels,
   Bart/JAZ-0644-2023
OI Staels, Bart/0000-0002-3784-1503; Staels, Bart/0000-0002-3784-1503;
   Auwerx, Johan/0000-0002-5065-5393
CR Abelev G I, 1971, Adv Cancer Res, V14, P295, DOI 10.1016/S0065-230X(08)60523-0
   AUWERX J, 1990, ARTERIOSCLEROSIS, V10, pA826
   AUWERX JH, 1988, BIOCHEMISTRY-US, V27, P2651, DOI 10.1021/bi00408a003
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   BARS RGC, 1991, GENE EXPRESSION LIVE, P218
   BELANGER L, 1979, CANCER RES, V39, P2141
   BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146
   BOSHART M, 1991, CELL, V66, P849, DOI 10.1016/0092-8674(91)90432-X
   BURGAYA F, 1989, BIOCHEM J, V259, P159, DOI 10.1042/bj2590159
   CAMPER SA, 1989, GENE DEV, V3, P537, DOI 10.1101/gad.3.4.537
   CEREGHINI S, 1988, GENE DEV, V2, P957, DOI 10.1101/gad.2.8.957
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323
   CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X
   COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415
   COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668
   COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937
   DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7
   ECKEL RH, 1987, LIPOPROTEIN LIPASE, P79
   ENERBACK S, 1987, GENE, V58, P1, DOI 10.1016/0378-1119(87)90023-0
   EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
   FEUERMAN MH, 1989, MOL CELL BIOL, V9, P4204, DOI 10.1128/MCB.9.10.4204
   FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314
   GARFINKEL AS, 1987, PLASMA LIPOPROTEINS, P335
   GOLDBERG AP, 1979, NEW ENGL J MED, V301, P1073, DOI 10.1056/NEJM197911153012001
   GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2
   GREEN S, 1986, NATURE, V324, P615, DOI 10.1038/324615a0
   GUERTIN M, 1983, BIOCHEMISTRY-US, V22, P4296, DOI 10.1021/bi00287a021
   HARDON EM, 1988, EMBO J, V7, P1711, DOI 10.1002/j.1460-2075.1988.tb03000.x
   ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
   JAGODZINSKI LL, 1981, P NATL ACAD SCI-BIOL, V78, P3521, DOI 10.1073/pnas.78.6.3521
   JONES KW, 1991, CELL, V66, P861, DOI 10.1016/0092-8674(91)90433-Y
   KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463
   KUO CJ, 1990, P NATL ACAD SCI USA, V87, P9838, DOI 10.1073/pnas.87.24.9838
   LIAO WSL, 1980, J BIOL CHEM, V255, P36
   LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6
   LLOBERA M, 1979, BIOCHEM BIOPH RES CO, V91, P272, DOI 10.1016/0006-291X(79)90613-2
   MONACI P, 1988, EMBO J, V7, P2075, DOI 10.1002/j.1460-2075.1988.tb03047.x
   NEVINS JR, 1987, METHOD ENZYMOL, V152, P234
   NIKKILA EA, 1977, METABOLISM, V26, P179, DOI 10.1016/0026-0495(77)90053-1
   NIKKILA EA, 1976, P ROY SOC MED, V69, P58
   Olivecrona T., 1987, LIPOPROTEIN LIPASE, P15
   PEINADOONSURBE J, 1992, IN PRESS BIOCH BIOPH
   PETROPOULOS C, 1983, J BIOL CHEM, V258, P4901
   REDDY JK, 1982, ANN NY ACAD SCI, V386, P81, DOI 10.1111/j.1749-6632.1982.tb21409.x
   REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHORPP M, 1988, J MOL BIOL, V199, P83, DOI 10.1016/0022-2836(88)90380-4
   SENDA M, 1987, P NATL ACAD SCI USA, V84, P4369, DOI 10.1073/pnas.84.13.4369
   SIRTORI CR, 1988, PHARMACOL THERAPEUT, V37, P167, DOI 10.1016/0163-7258(88)90024-1
   STAELS B, 1989, J LIPID RES, V30, P1137
   SVOBODA DJ, 1966, J CELL BIOL, V30, P442, DOI 10.1083/jcb.30.2.442
   TILGHMAN SM, 1982, P NATL ACAD SCI-BIOL, V79, P5254, DOI 10.1073/pnas.79.17.5254
   TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x
   TURCOTTE B, 1985, NUCLEIC ACIDS RES, V13, P2387, DOI 10.1093/nar/13.7.2387
   VACHER J, 1990, SCIENCE, V250, P1732, DOI 10.1126/science.1702902
   VESSBY B, 1980, ATHEROSCLEROSIS, V37, P257, DOI 10.1016/0021-9150(80)90011-8
   VOGT TF, 1987, SCIENCE, V236, P301, DOI 10.1126/science.2436297
   WILSON GN, 1991, PEDIATR RES, V29, P256, DOI 10.1203/00006450-199103000-00007
   WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907
   ZHANG XK, 1991, J BIOL CHEM, V266, P828
NR 61
TC 74
Z9 78
U1 0
U2 1
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE, CAMBS,
   ENGLAND CB4 4DL
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD AUG
PY 1992
VL 115
IS 4
BP 1035
EP &
PG 0
WC Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology
GA JK993
UT WOS:A1992JK99300013
PM 1280557
DA 2024-02-19
ER

PT J
AU Kwak, MS
   Kim, KW
   Seo, H
   Chung, GE
   Yim, JY
   Kim, D
AF Kwak, Min-Sun
   Kim, Kyung Won
   Seo, Hyobin
   Chung, Goh-Eun
   Yim, Jeong Yoon
   Kim, Donghee
TI Non-obese fatty liver disease is associated with lacunar infarct
SO LIVER INTERNATIONAL
LA English
DT Article
DE atherosclerosis; cerebral infarct; hepatic steatosis; lacunar infarct
ID TYPE-2 DIABETIC-PATIENTS; SMALL VESSEL DISEASE; CARDIOVASCULAR-DISEASE;
   INSULIN-RESISTANCE; RISK-FACTOR; METABOLIC SYNDROME; ISCHEMIC-STROKE;
   ECTOPIC FAT; FIBROSIS; POPULATION
AB Background/AimsLacunar infarct, a small subcortical ischaemic lesion, is a known risk factor for future cognitive impairment, dementia and stroke. We evaluated the relationship between fatty liver disease (FLD) and lacunar infarct in a healthy general population.
   MethodsSubjects who underwent brain magnetic resonance imaging (MRI) and abdominal ultrasonography (US) during health check-ups from 2007 to 2009 were included. FLD was diagnosed by US. Subjects with a history of cerebrovascular disease, radiological findings consistent with cerebrovascular stenosis or cerebral small vessel disease were excluded.
   ResultsOf the 1277 subjects, 54 (4.2%) exhibited lacunar infarct, and 514 (40.3%) had FLD. Subjects with lacunar infarct had a higher prevalence of FLD (59.3% vs 39.4%, P=.004). There was significant interaction between obesity (BMI<25kg/m(2) vs 25 kg/m(2)) and FLD for lacunar infarct (P for interaction=.024). Subgroup analysis revealed that non-obese FLD was more common in the subjects with lacunar infarct than those without (51.7% vs 23.5%, P=.001). However, there was no significant difference in the obese FLD prevalence between these 2 groups. In multivariate models adjusted by age, sex, smoking, alcohol, hypertension and diabetes, FLD was significantly associated with lacunar infarct (odds ratio [OR] 1.97; 95% confidence interval [CI] 1.08-3.58; P=.027). Non-obese FLD was associated with lacunar infarct (OR 3.58; 95% CI 1.63-7.89; P=.002); however, this association remained insignificant in obese FLD. Instead, ageing and hypertension were independent risk factors for lacunar infarct in the obese population.
   ConclusionsFLD is significantly associated with lacunar infarct, independent of traditional risk factors. This association was prominent in the non-obese population.
C1 [Kwak, Min-Sun; Kim, Kyung Won; Chung, Goh-Eun; Yim, Jeong Yoon; Kim, Donghee] Seoul Natl Univ Hosp, Healthcare Res Inst, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea.
   [Seo, Hyobin] Seoul Natl Univ Hosp, Healthcare Res Inst, Dept Radiol, Healthcare Syst Gangnam Ctr, Seoul, South Korea.
   [Seo, Hyobin] Korea Univ, Hlth Promot Ctr, Anam Hosp, Seoul, South Korea.
   [Kim, Donghee] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.
C3 Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU); Seoul National University Hospital;
   Korea University; Korea University Medicine (KU Medicine); Stanford
   University
RP Kim, D (corresponding author), Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.
EM messmd@chol.com
RI Kim, Donghee/C-4288-2013
OI Kim, Donghee/0000-0003-1919-6800; Chung, Goh Eun/0000-0001-8344-7737
CR Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   Adams LA, 2017, GUT, V66, P1138, DOI 10.1136/gutjnl-2017-313884
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496
   Arboix A, 2014, ACTA NEUROL BELG, V114, P107, DOI 10.1007/s13760-013-0257-8
   Arboix A, 2009, EXPERT REV NEUROTHER, V9, P179, DOI 10.1586/14737175.9.2.179
   Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3
   Byrne CD, 2014, ARTERIOSCL THROM VAS, V34, P1155, DOI 10.1161/ATVBAHA.114.303034
   Caplan LR, 2015, J STROKE, V17, P2, DOI 10.5853/jos.2015.17.1.2
   Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
   Dearborn JL, 2015, STROKE, V46, P3131, DOI 10.1161/STROKEAHA.115.010060
   Dela Cruz AC, 2014, GASTROENTEROLOGY, V146, pS909
   Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327
   Evans TE, 2016, STROKE, V47, P2756, DOI 10.1161/STROKEAHA.116.014651
   Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579
   Jackson C, 2005, STROKE, V36, P891, DOI 10.1161/01.STR.0000157949.34986.30
   Kim DG, 2016, HEPATOLOGY, V64, p537A
   Kim KW, 2017, INT J OBESITY, V41, P683, DOI 10.1038/ijo.2017.13
   Kim SU, 2017, ATHEROSCLEROSIS, V260, P156, DOI 10.1016/j.atherosclerosis.2017.02.005
   Lastella M, 2006, CLIN EXP HYPERTENS, V28, P205, DOI 10.1080/10641960600549082
   Lee JE, 2016, STROKE, V47, P2938, DOI 10.1161/STROKEAHA.116.014097
   Lee SS, 2014, WORLD J GASTROENTERO, V20, P7392, DOI 10.3748/wjg.v20.i23.7392
   Lim S, 2014, ARTERIOSCL THROM VAS, V34, P1820, DOI 10.1161/ATVBAHA.114.303035
   Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P1217, DOI 10.1001/archneur.55.9.1217
   Lv P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149605
   MACDONALD RL, 1995, STROKE, V26, P1247, DOI 10.1161/01.STR.26.7.1247
   Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018
   Mok V, 2015, J STROKE, V17, P111, DOI 10.5853/jos.2015.17.2.111
   Moshayedi H, 2014, IRAN J NEUROL, V13, P144
   Salamone F, 2010, J HEPATOL, V53, P1146, DOI 10.1016/j.jhep.2010.06.013
   Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033
   Tanizaki Y, 2000, STROKE, V31, P2616, DOI 10.1161/01.STR.31.11.2616
   Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541
   Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349
   Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247
   Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669
   Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3
   Ying I, 2011, EPIDEMIOLOGY, V22, P129, DOI 10.1097/EDE.0b013e3181feb50a
   Yoshitaka H, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006712
NR 39
TC 12
Z9 12
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD JUL
PY 2018
VL 38
IS 7
BP 1292
EP 1299
DI 10.1111/liv.13663
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA GK2GT
UT WOS:000435946000017
PM 29220869
DA 2024-02-19
ER

PT J
AU Charlton, MA
   Merry, BJ
   Goyns, MH
AF Charlton, MA
   Merry, BJ
   Goyns, MH
TI Differential display analysis can reveal patterns of gene expression in
   immortalised hepatoma cells which are similar to those observed in young
   adult but not old adult liver cells
SO CANCER LETTERS
LA English
DT Article
DE differential display; gene expression; immortalisation; liver; hepatoma
ID EUKARYOTIC MESSENGER-RNA; AGE-RELATED-CHANGES; CLONING
AB We used the differential display technique to examine whether there were any patterns of gene expression which were characteristic of both young adult rat liver and of immortalised rat hepatoma cell lines, but not of old adult rat liver. No genes were detected which appeared to be clearly expressed in young liver and immortalised cell lines, but not in old liver, However, 14 genes were detected in old liver which were down-regulated in young liver and the hepatoma cell lines. This observation lends support to the idea that immortalisation of malignant cells may involve, at least in some aspects, a reversal of the ageing process in these cells and that the genes involved have a recessive action. (C) 1999 Elsevier Science ireland Ltd. All rights reserved.
C1 Univ Sunderland, Mol Gerontol Unit, Sch Sci, Sunderland SR2 3SD, Durham, England.
   Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield, S Yorkshire, England.
   Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.
C3 University of Sunderland; University of Sheffield; University of
   Liverpool
RP Goyns, MH (corresponding author), Univ Sunderland, Mol Gerontol Unit, Sch Sci, Fleming Bldg,Warncliffe St, Sunderland SR2 3SD, Durham, England.
EM malcolm.goyns@sunderland.ac.uk
CR Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5
   CARTER D, 1999, IN PRESS LEUK LYMPH
   Goyns MH, 1998, MECH AGEING DEV, V101, P73, DOI 10.1016/S0047-6374(97)00166-8
   GRONINGEN JJM, 1995, CANCER RES, V55, P6237
   HOLEHAN AM, 1986, BIOL REV, V61, P329, DOI 10.1111/j.1469-185X.1986.tb00658.x
   HUANG LR, 1995, CANCER RES, V55, P4717
   KAR S, 1995, BIOCHEM BIOPH RES CO, V212, P21, DOI 10.1006/bbrc.1995.1930
   KOECHNER P, 1995, CLIN CANCER RES, V1, P1209
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   LIANG P, 1995, CURR OPIN IMMUNOL, V7, P274, DOI 10.1016/0952-7915(95)80015-8
   LIANG P, 1994, NUCLEIC ACIDS RES, V22, P5763, DOI 10.1093/nar/22.25.5763
   LIANG P, 1995, SCIENCE, V267, P1186, DOI 10.1126/science.267.5201.1186-a
   MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040
   Salehi M, 1996, EXPERIENTIA, V52, P888, DOI 10.1007/BF01938876
   SAN RHC, 1979, CANCER RES, V39, P4441
   STROUS JAM, 1980, CELL, V22, P709, DOI 10.1016/0092-8674(80)90547-4
   THOMPSON EB, 1966, P NATL ACAD SCI USA, V56, P296, DOI 10.1073/pnas.56.1.296
   UCHIYAMA CM, 1995, NEUROSURGERY, V37, P464, DOI 10.1227/00006123-199509000-00014
   UTANS U, 1994, P NATL ACAD SCI USA, V91, P6463, DOI 10.1073/pnas.91.14.6463
   WATSON JB, 1993, DEV NEUROSCI-BASEL, V15, P77, DOI 10.1159/000111319
   WynfordThomas D, 1997, EUR J CANCER, V33, P716, DOI 10.1016/S0959-8049(97)00064-6
NR 21
TC 8
Z9 8
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3835
EI 1872-7980
J9 CANCER LETT
JI Cancer Lett.
PD AUG 23
PY 1999
VL 143
IS 1
BP 45
EP 50
DI 10.1016/S0304-3835(99)00173-1
PG 6
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 221NA
UT WOS:000081732100007
PM 10465336
DA 2024-02-19
ER

PT J
AU Gao, HT
   Cheng, WZ
   Xu, Q
   Shao, LX
AF Gao, Hai-tao
   Cheng, Wen-zhao
   Xu, Qian
   Shao, Lin-xiang
TI Dietary restriction reduces blood lipids and ameliorates liver function
   of mice with hyperlipidemia
SO JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL
   SCIENCES
LA English
DT Article
DE dietary restriction; high-fat diet; hyperlipidemia; hypolipidemic
   action; liver function; SIRT1; PPAR gamma
ID OXIDATIVE STRESS; PPAR-GAMMA; INDUCED OBESITY; APOPTOSIS; SIRT1;
   SUSCEPTIBILITY; HOMEOSTASIS; MANAGEMENT; RAPAMYCIN; PROTECTS
AB Dietary restriction (DR) can delay senescence, prolong lifespan of mammals and improve their learning-memory activity. The purpose of the study was to explore the effects of DR on hypolipidemic action and liver function of mice with hyperlipidemia. To investigate these effects, hyperlipidemia mouse models were established with high-fat diet (HFD) (34% of energy), then randomly divided into HFD group, DR30% group and DR50% group. Mice in DR30% and DR50% group were respectively supplied with HFD as much as about 70% and 50% of the consumption of HFD in the mice of HFD group. Rats in control group were fed routinely. After DR for 5 weeks, the average body weight, liver weight, liver index, serum lipids and glucose levels in both DR groups decreased significantly as compared with the HFD group (P < 0.05 or P < 0.01), so did alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH) levels and the ratio of LDL-C/HDL-C in the DR50% group (P < 0.05 or P < 0.01). Histopathology examination of liver tissues further proved ameliorative effect of DR on liver function. Western blotting showed that DR significantly increased the expression of silent mating type information regulation 2 homolog 1 (SIRT1) in liver and adipose, while notably decreased the expression of peroxisome proliferators-activated receptors-gamma (PPAR gamma) in adipose (P < 0.05 or P < 0.01). The increase of SIRT1 and decrease of PPAR gamma may be a mechanism by which DR reduces blood lipids and ameliorates liver function.
C1 [Gao, Hai-tao; Xu, Qian] Southeast Univ, Key Lab Environm Med Engn, Minist Educ, Nanjing 210009, Peoples R China.
   [Gao, Hai-tao; Cheng, Wen-zhao; Shao, Lin-xiang] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua 321004, Peoples R China.
   [Cheng, Wen-zhao] Huaqiao Univ, Inst Mol Med, Quanzhou 362021, Peoples R China.
C3 Southeast University - China; Zhejiang Normal University; Huaqiao
   University
RP Xu, Q (corresponding author), Southeast Univ, Key Lab Environm Med Engn, Minist Educ, Nanjing 210009, Peoples R China.; Shao, LX (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua 321004, Peoples R China.
EM gaohaitaosky@163.com; q_xu68@163.com; shaolinxiang@zjnu.cn
RI Gao, Hai-Tao/JXL-3133-2024
OI Gao, Haitao/0000-0003-3986-7261
FU Social Development Research Program of Science and Technology Agency of
   Jiangsu Province [BE2015646]
FX This project was supported by a grant from the Social Development
   Research Program of Science and Technology Agency of Jiangsu Province
   (No. BE2015646).
CR [Anonymous], 2010, GB1492432010
   Aydin C, 2007, CELL BIOCHEM FUNCT, V25, P129, DOI 10.1002/cbf.1279
   Baek JH, 2015, ENDOCRINOLOGY, V156, P147, DOI 10.1210/en.2014-1374
   Beltaifa L, 2011, OBESITY FACTS, V4, P45, DOI 10.1159/000324579
   Chen SM, 2013, FLUCT NOISE LETT, V12, DOI 10.1142/S021947751350017X
   Devassy JG, 2015, APPL PHYSIOL NUTR ME, V40, DOI 10.1139/apnm-2014-0399
   Fok WC, 2014, AGING CELL, V13, P311, DOI 10.1111/acel.12175
   Gao HaiTao, 2014, Acta Nutrimenta Sinica, V36, P168
   Gao HT, 2014, J ZHEJIANG NORM U NA, V37, P99
   Gao HT, 2013, J ZHEJIANG NORM U NA, V36, P337
   Gao HT, 2013, ZHEJIANG PREV MED, V25, P1
   Gao X, 2010, BRIT J NUTR, V103, P608, DOI 10.1017/S0007114509992108
   Gong WH, 2012, WORLD J GASTROENTERO, V18, P4934, DOI 10.3748/wjg.v18.i35.4934
   Grattagliano I, 2004, EXP GERONTOL, V39, P1323, DOI 10.1016/j.exger.2004.06.001
   Grattagliano I, 2008, J NUTR BIOCHEM, V19, P491, DOI 10.1016/j.jnutbio.2007.06.011
   Gu M., 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/34256123533476
   Hamelet J, 2007, J HEPATOL, V46, P151, DOI 10.1016/j.jhep.2006.07.028
   Hinnouho GM, 2015, EUR HEART J, V36, P551, DOI 10.1093/eurheartj/ehu123
   Hipkiss AR, 2006, MECH AGEING DEV, V127, P8, DOI 10.1016/j.mad.2005.09.006
   Hong Y, 2012, J HUAZHONG U SCI-MED, V32, P872, DOI 10.1007/s11596-012-1050-2
   Huang YH, 2010, BRIT J NUTR, V104, P1297, DOI 10.1017/S0007114510002291
   Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070
   Jeon TI, 2001, LIPIDS, V36, P589, DOI 10.1007/s11745-001-0761-1
   Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102
   Kitada M, 2011, EXP DIABETES RES, DOI 10.1155/2011/908185
   Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006
   Kuo YH, 2015, J AGR FOOD CHEM, V63, P2479, DOI 10.1021/acs.jafc.5b00073
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Li XR, 2011, EUR J PHARMACOL, V660, P468, DOI 10.1016/j.ejphar.2011.03.027
   Lin BQ, 2013, LUNG CANCER, V79, P111, DOI 10.1016/j.lungcan.2012.11.001
   Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   Linden MA, 2015, APPL PHYSIOL NUTR ME, V40, P1038, DOI 10.1139/apnm-2015-0236
   Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016
   Moore JB, 2010, P NUTR SOC, V69, P211, DOI 10.1017/S0029665110000030
   Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Raval J, 2006, FREE RADICAL BIO MED, V41, P1645, DOI 10.1016/j.freeradbiomed.2006.07.023
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Samartín S, 2001, NUTR RES, V21, P243, DOI 10.1016/S0271-5317(00)00255-4
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Tanaka K, 2004, EXP GERONTOL, V39, P195, DOI 10.1016/j.exger.2003.10.013
   Wen H, 2013, MOL CELL PROTEOMICS, V12, P575, DOI 10.1074/mcp.M112.021352
   Wu YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092618
   Yang XR, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/783860
   Yu Z, 2015, J GERONTOL A-BIOL, V70, P410, DOI 10.1093/gerona/glu053
NR 46
TC 12
Z9 16
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1672-0733
EI 1993-1352
J9 J HUAZHONG U SCI-MED
JI J. Huazhong Univ. Sci. Tech.-Med.
PD FEB
PY 2017
VL 37
IS 1
BP 79
EP 86
DI 10.1007/s11596-017-1698-8
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA EM6AO
UT WOS:000395395400013
PM 28224418
DA 2024-02-19
ER

PT J
AU Pérez, H
   Finocchietto, PV
   Alippe, Y
   Rebagliati, I
   Elguero, ME
   Villalba, N
   Poderoso, JJ
   Carreras, MC
AF Perez, Hernan
   Vanesa Finocchietto, Paola
   Alippe, Yael
   Rebagliati, Ines
   Eugenia Elguero, Maria
   Villalba, Nerina
   Jose Poderoso, Juan
   Cecilia Carreras, Maria
TI p66<SUP>Shc</SUP> Inactivation Modifies RNS Production, Regulates Sirt3
   Activity, and Improves Mitochondrial Homeostasis, Delaying the Aging
   Process in Mouse Brain
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE; OXIDATIVE STRESS;
   SKELETAL-MUSCLE; LIFE-SPAN; EXPRESSION; PROMOTES; HOMOLOG; LIVER; GENE
AB Programmed and damage aging theories have traditionally been conceived as stand-alone schools of thought. However, the p66(Shc) adaptor protein has demonstrated that aging-regulating genes and reactive oxygen species (ROS) are closely interconnected, since its absence modifies metabolic homeostasis by providing oxidative stress resistance and promoting longevity. p66(Shc(-/-)) mice are a unique opportunity to further comprehend the bidirectional relationship between redox homeostasis and the imbalance of mitochondrial biogenesis and dynamics during aging. This study shows that brain mitochondria of p66(Shc(-/-)) aged mice exhibit a reduced alteration of redox balance with a decrease in both ROS generation and its detoxification activity. We also demonstrate a strong link between reactive nitrogen species (RNS) and mitochondrial function, morphology, and biogenesis, where low levels of ONOO- formation present in aged p66(Shc(-/-)) mouse brain prevent protein nitration, delaying the loss of biological functions characteristic of the aging process. Sirt3 modulates age-associated mitochondrial biology and function via lysine deacetylation of target proteins, and we show that its regulation depends on its nitration status and is benefited by the improved NAD(+)/NADH ratio in aged p66(Shc(-/-)) brain mitochondria. Low levels of protein nitration and acetylation could cause the metabolic homeostasis maintenance observed during aging in this group, thus increasing its lifespan.
C1 [Perez, Hernan; Vanesa Finocchietto, Paola; Alippe, Yael; Rebagliati, Ines; Eugenia Elguero, Maria; Villalba, Nerina; Jose Poderoso, Juan; Cecilia Carreras, Maria] INIGEM UBA CONICET, Lab Oxygen Metab, Buenos Aires, DF, Argentina.
   [Vanesa Finocchietto, Paola] Univ Buenos Aires, Fac Med, Dept Med, Buenos Aires, DF, Argentina.
   [Cecilia Carreras, Maria] Univ Buenos Aires, Fac Farm & Bioquim, Dept Bioquim Clin, Buenos Aires, DF, Argentina.
C3 University of Buenos Aires; University of Buenos Aires
RP Carreras, MC (corresponding author), INIGEM UBA CONICET, Lab Oxygen Metab, Buenos Aires, DF, Argentina.
EM carreras@ffyb.uba.ar
FU Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT) [PICT
   02418]; Universidad de Buenos Aires [UBACyT 20020130100574BA]
FX This work was supported by the Agencia Nacional de Promocion Cientifica
   y Tecnologica (FONCyT, Grant PICT 02418) and Universidad de Buenos Aires
   (UBACyT 20020130100574BA).
CR Afanas'ev IB, 2005, BIOGERONTOLOGY, V6, P283, DOI 10.1007/s10522-005-2626-z
   Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866
   Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200
   Berry A, 2008, EXP GERONTOL, V43, P200, DOI 10.1016/j.exger.2007.10.016
   Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   Cardoso SM, 1999, FREE RADICAL BIO MED, V26, P3, DOI 10.1016/S0891-5849(98)00205-6
   Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006
   Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255
   Carreras MC, 2002, METHOD ENZYMOL, V359, P413
   Carreras MC, 2001, AM J PHYSIOL-HEART C, V281, pH2282, DOI 10.1152/ajpheart.2001.281.6.H2282
   Cerqueira FM, 2012, FREE RADICAL BIO MED, V52, P1236, DOI 10.1016/j.freeradbiomed.2012.01.011
   Chance B., 1954, ASSAY CATALASE PEROX, P408
   Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091
   Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613
   Estabrook R.W., 1967, METHOD ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
   Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024
   Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D
   Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gonzalez AS, 2014, FREE RADICAL RES, V48, P769, DOI 10.3109/10715762.2014.906592
   Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070
   Gounden S, 2015, METAB SYNDR RELAT D, V13, P255, DOI 10.1089/met.2014.0140
   Halaschek-Wiener J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006641
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200
   Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje
   Jin QR, 2004, BIOCHEM BIOPH RES CO, V315, P555, DOI 10.1016/j.bbrc.2004.01.093
   Kincaid B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00048
   Knapp LT, 2000, J BIOL CHEM, V275, P24136, DOI 10.1074/jbc.M002043200
   Knott AB, 2010, DIABETES OBES METAB, V12, P126, DOI 10.1111/j.1463-1326.2010.01267.x
   Knowles RG, 1998, METH MOL B, V100, P67
   Koltai E, 2012, AM J PHYSIOL-REG I, V303, pR127, DOI 10.1152/ajpregu.00337.2011
   Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707
   Lam PY, 2009, FREE RADICAL RES, V43, P431, DOI 10.1080/10715760902849813
   Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041
   Liu ZX, 2011, MOL BIOSYST, V7, P1197, DOI 10.1039/c0mb00279h
   Lizana L, 2008, P NATL ACAD SCI USA, V105, P4099, DOI 10.1073/pnas.0709932105
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Mannella CA, 2013, J MOL CELL CARDIOL, V62, P51, DOI 10.1016/j.yjmcc.2013.05.001
   MCCORD JM, 1969, J BIOL CHEM, V244, P6056
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Pelicci PG, 2005, FEBS J, V272, P319
   Perez H., 2016, MEDICINA S1, V76, P105
   Pérez-Gallardo RV, 2014, J BIOENERG BIOMEMBR, V46, P511, DOI 10.1007/s10863-014-9594-4
   Poderoso JJ, 1999, J BIOL CHEM, V274, P37709, DOI 10.1074/jbc.274.53.37709
   Puri PL, 2010, PHARMACOL RES, V62, P1, DOI 10.1016/j.phrs.2010.04.003
   Qiang W, 2007, EXP MOL MED, V39, P535, DOI 10.1038/emm.2007.59
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Raffaello A, 2011, BBA-MOL CELL RES, V1813, P260, DOI 10.1016/j.bbamcr.2010.10.007
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2
   Sacksteder CA, 2006, BIOCHEMISTRY-US, V45, P8009, DOI 10.1021/bi060474w
   Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13
   Sánchez-Villamil JP, 2016, INT J BIOCHEM CELL B, V81, P323, DOI 10.1016/j.biocel.2016.08.045
   Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057
   Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103
   Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sone K, 2012, ARCH GERONTOL GERIAT, V55, P744, DOI 10.1016/j.archger.2011.11.001
   Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200
   Telford JE, 2009, J BIOL CHEM, V284, P9109, DOI 10.1074/jbc.M809101200
   Venegas V., 2011, CURRENT PROTOCOLS HU, V68
   Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006
NR 72
TC 16
Z9 17
U1 0
U2 9
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2018
VL 2018
AR 8561892
DI 10.1155/2018/8561892
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GA4ZY
UT WOS:000428343100001
PM 29721150
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Greenberg, JA
   Wei, HC
   Ward, K
   Boozer, CN
AF Greenberg, JA
   Wei, HC
   Ward, K
   Boozer, CN
TI Whole-body metabolic rate appears to determine the rate of DNA oxidative
   damage and glycation involved in aging
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE caloric restriction; metabolic rate; DNA oxidative damage; glycation;
   theories of aging
ID FISCHER-344 RATS; DIETARY RESTRICTION; CALORIC RESTRICTION;
   8-HYDROXY-2'-DEOXYGUANOSINE; LONGEVITY; AGE; 8-HYDROXYDEOXYGUANOSINE;
   HYPOTHESIS; PROTECTION; BIOMARKER
AB While aging has been found to be a multifactorial process, it seems logical that different aging parameters which reflect the deleterious effects of normal basal metabolism should be directly related. Three such putative aging parameters were therefore measured in adult male Fischer 344 rats on three different long-term diets which have been shown to yield different lifespans. It was found that the dairy caloric intake per unit organ weight, a measure of whole-body metabolic rate, was directly proportional to: (1) the level of 8-hydroxydeoxyguanosine in skin dermal cells, used as a measure of the rate of DNA oxidative damage; (2) the proportion of hemoglobin that was glycated, used as a measure of the rate of glycation. This appears to be the first evidence suggesting that whole-body metabolic rate plays a role in determining both the rate of DNA oxidative damage and the rate of glycation involved in aging, because whole-body metabolic rate was the only one of these three variables manipulated in the study. The study also found that then were no significant between-group differences in brain, kidney and liver 8-hydroxydeoxyguanosine, suggesting that DNA oxidative damage in non-mitotic and slow-dividing cells is not a reliable linear biomarker of aging. (C) 2000 Elsevier Science ireland Ltd. All rights reserved.
C1 CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, Brooklyn, NY 11210 USA.
   Mt Sinai Med Ctr, Dept Dermatol, New York, NY 10029 USA.
   Amer Soc Clin Pathologists, Board Registry, Chicago, IL USA.
   St Lukes Roosevelt Hosp, New York Obes Res Ctr, New York, NY USA.
C3 City University of New York (CUNY) System; Brooklyn College (CUNY);
   Icahn School of Medicine at Mount Sinai; Mount Sinai St. Luke's; Mount
   Sinai West
RP Greenberg, JA (corresponding author), CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, Brooklyn, NY 11210 USA.
EM james@brooklyn.cuny.edu
CR ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706
   ALLISON DB, 1995, INT J OBESITY, V19, P644
   [Anonymous], P S SME NONTR MACH F
   CERAMI A, 1985, J AM GERIATR SOC, V33, P626, DOI 10.1111/j.1532-5415.1985.tb06319.x
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   DUNNETT CW, 1991, STAT MED, V10, P939, DOI 10.1002/sim.4780100614
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Greenberg JA, 1999, METABOLISM, V48, P1272, DOI 10.1016/S0026-0495(99)90267-6
   GREENBERG JA, 2000, IN PRESS MECH AGEING
   HALL DA, 1984, BIOMEDICAL BASIS GER, P2
   HART RW, 1983, REV BIOL RES AGING, P5
   HOLLOSZY JO, 1986, J APPL PHYSIOL, V61, P1656, DOI 10.1152/jappl.1986.61.5.1656
   HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826
   JAIN NC, 1986, SCHALMS VET HEMATOLO, P549
   Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3
   KRISTAL BS, 1992, J GERONTOL, V47, pB107, DOI 10.1093/geronj/47.4.B107
   LOFT S, 1993, J TOXICOL ENV HEALTH, V40, P391, DOI 10.1080/15287399309531806
   LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241
   MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   MONNIER VM, 1991, GERONTOLOGY, V37, P152
   Pearl R., 1928, RATE LIVING
   SAI K, 1992, Journal of Environmental Pathology Toxicology and Oncology, V11, P139
   SHIGENAGA MK, 1991, FREE RADICAL BIO MED, V10, P211, DOI 10.1016/0891-5849(91)90078-H
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SIMIC MG, 1994, CANCER RES, V54, pS1918
   SIMIC MG, 1991, MUTAT RES, V250, P17, DOI 10.1016/0027-5107(91)90158-K
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   TAKASAWA M, 1993, EXP GERONTOL, V28, P269, DOI 10.1016/0531-5565(93)90034-B
   Te Koppele J. M., 1996, Neurobiology of Aging, V17, P819, DOI 10.1016/S0197-4580(96)00165-0
   Wei HC, 1998, BIOCHEMISTRY-US, V37, P6485, DOI 10.1021/bi972702f
   WEI HC, 1991, CANCER RES, V51, P4443
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 34
TC 16
Z9 16
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAY 18
PY 2000
VL 115
IS 1-2
BP 107
EP 117
DI 10.1016/S0047-6374(00)00108-1
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 322JM
UT WOS:000087506500008
PM 10854633
DA 2024-02-19
ER

PT J
AU FRAEYMAN, N
   VANERMEN, A
AF FRAEYMAN, N
   VANERMEN, A
TI INFLUENCE OF AGING ON THE BETA-RECEPTOR AND GLUCAGON-RECEPTOR-MEDIATED
   GLYCOGENOLYSIS IN RAT HEPATOCYTES
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; BETA-RECEPTOR; GLUCAGON-RECEPTOR; GLYCOGENOLYSIS; PROTEIN
   KINASE-C; CALCIUM
ID NUCLEOTIDE REGULATORY PROTEIN; ADENYLATE-CYCLASE; SIGNAL-TRANSDUCTION;
   ALPHA-1-ADRENERGIC ACTION; ADRENERGIC REGULATION; POSSIBLE INVOLVEMENT;
   PHORBOL ESTERS; CA-2+ INFLUX; KINASE-C; LIVER
AB The influence of aging on beta-receptor and glucagon-receptor control of glycogenolysis was investigated in rat hepatocytes. The beta-receptor-induced glucose output was detectable only in senescent rats, was partly dependent on extracellular Ca2+, and was inhibited by 4beta-phorbol 12-myristate 13-acetate (PMA), insulin, and the Ca2+-antagonists, verapamil and nifedipine. Chelation of extracellular Ca2+ potentiated the effect of nifedipine only. In contrast, glucagon-stimulated glycogenolysis, similar in mature and senescent rats, was independent on extracellular Ca2+ and was unaffected by PMA. Verapamil, in senescent rats only, and nifedipine, in mature and senescent rats, inhibited glucagon-stimulated glucose output on y in the presence of Ca2+.  Insulin inhibited glucagon-induced glucose output, irrespective of the age of the rat and the presence of Ca2+. We conclude that the beta-receptor component in the adrenergic regulation of glycogenolysis in senescent rats consists of a major Ca2+-independent and a minor Ca2+-dependent part, displaying different sensitivity towards protein kinase C (PKC), Ca2+-antagonists, and insulin. Aging does not change the capacity of glucagon to induce a full glycogenolytic response in the absence of extracellular Ca2+; Ca2+-influx, however, seems to be involved when extracellular Ca2+ is present, and this sensitivity is increased on aging.
RP FRAEYMAN, N (corresponding author), STATE UNIV GHENT,HEYMANS INST PHARMACOL,DE PINTELAAN 185,B-9000 GHENT,BELGIUM.
CR ASHENDEL CL, 1985, BIOCHIM BIOPHYS ACTA, V822, P219, DOI 10.1016/0304-4157(85)90009-7
   BELL JD, 1985, J BIOL CHEM, V260, P2625
   BENDECK JL, 1985, PEDIATR RES, V19, P862, DOI 10.1203/00006450-198508000-00018
   BERGMEYER HU, 1965, METHOD ENZYMAT AN, V3, P1205
   BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   BLACKMOR PF, 1979, J BIOL CHEM, V258, P2828
   BLAIR JB, 1979, J BIOL CHEM, V254, P7579
   BORST S, 1988, LIFE SCI, V43, P1021, DOI 10.1016/0024-3205(88)90196-8
   CHAREST R, 1983, J BIOL CHEM, V258, P8769
   COMBETTES L, 1986, BIOCHEM J, V237, P675, DOI 10.1042/bj2370675
   CORVERA S, 1984, BIOCHIM BIOPHYS ACTA, V803, P95, DOI 10.1016/0167-4889(84)90060-0
   GARCIASAINZ JA, 1985, BIOCHEM J, V228, P277, DOI 10.1042/bj2280277
   GUSOVSKY F, 1991, MOL PHARMACOL, V39, P124
   HALLAM TJ, 1989, TRENDS PHARMACOL SCI, V10, P8, DOI 10.1016/0165-6147(89)90092-8
   HELMREICH EJM, 1985, TRENDS PHARMACOL SCI, V6, P438, DOI 10.1016/0165-6147(85)90208-1
   HERNANDEZSOTOMAYOR SMT, 1988, BIOCHIM BIOPHYS ACTA, V972, P311, DOI 10.1016/0167-4889(88)90207-8
   HERNANDEZSOTOMAYOR SMT, 1984, FEBS LETT, V166, P385, DOI 10.1016/0014-5793(84)80118-0
   HEYWORTH CM, 1983, BIOCHEM J, V214, P547, DOI 10.1042/bj2140547
   HOUSLAY MD, 1991, EUR J BIOCHEM, V195, P9, DOI 10.1111/j.1432-1033.1991.tb15671.x
   HUGHES BP, 1986, BIOCHEM PHARMACOL, V35, P3045, DOI 10.1016/0006-2952(86)90384-9
   JOHNSON JA, 1990, MOL PHARMACOL, V38, P289
   JOIS M, 1990, BIOCHEM CELL BIOL, V68, P543, DOI 10.1139/o90-077
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KOENIG H, 1988, BIOCHEM BIOPH RES CO, V153, P1179, DOI 10.1016/S0006-291X(88)81352-4
   MALBON CC, 1980, J BIOL CHEM, V255, P8692
   MCKINNEY JS, 1988, BIOCHEM PHARMACOL, V37, P4433, DOI 10.1016/0006-2952(88)90657-0
   MEURS H, 1986, BIOCHEM PHARMACOL, V35, P4217, DOI 10.1016/0006-2952(86)90698-2
   MORAND C, 1988, BIOCHIM BIOPHYS ACTA, V968, P192, DOI 10.1016/0167-4889(88)90008-0
   POGGIOLI J, 1986, BIOCHEM J, V235, P663, DOI 10.1042/bj2350663
   PYNE NJ, 1989, FEBS LETT, V243, P77, DOI 10.1016/0014-5793(89)81221-9
   SAVAGE AL, 1989, BIOCHEM J, V260, P821, DOI 10.1042/bj2600821
   VANERMEN A, 1992, MOL PHARMACOL, V42, P649
   VANERMEN A, UNPUB INFLUENCE AGIN
   WAKELAM MJO, 1986, NATURE, V323, P68, DOI 10.1038/323068a0
   YOSHIMASA T, 1987, NATURE, V327, P67, DOI 10.1038/327067a0
   ZERNIG G, 1990, TRENDS PHARMACOL SCI, V11, P38, DOI 10.1016/0165-6147(90)90040-F
NR 37
TC 7
Z9 7
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD AUG 1
PY 1993
VL 70
IS 1-2
BP 115
EP 126
DI 10.1016/0047-6374(93)90063-W
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA LT099
UT WOS:A1993LT09900009
PM 8231283
DA 2024-02-19
ER

PT J
AU VENKATRAMAN, JT
   CHANDRASEKAR, B
   KIM, JD
   FERNANDES, G
AF VENKATRAMAN, JT
   CHANDRASEKAR, B
   KIM, JD
   FERNANDES, G
TI EFFECTS OF N-3 AND N-6 FATTY-ACIDS ON THE ACTIVITIES AND EXPRESSION OF
   HEPATIC ANTIOXIDANT ENZYMES IN AUTOIMMUNE-PRONE NZBXNZW F1-MICE
SO LIPIDS
LA English
DT Article
ID LIPID-PEROXIDATION; DIETARY-FAT; FOOD RESTRICTION; RAT-LIVER;
   GENE-EXPRESSION; VITAMIN-E; EICOSAPENTAENOIC ACID; SUPEROXIDE-DISMUTASE;
   FREE-RADICALS; AGING RATS
AB Menhaden fish oil (FO) containing n-3 fatty acids dramatically extends the life span and delays the onset and progression of autoimmune disease in (NZBxNZW)F-1 (B/W) female mice as compared to those fed corn oil (CO) rich in n-6 lipids. As an inefficient antioxidant defense system has been linked to autoimmune diseases, the present study was undertaken to determine whether the protective action of n-3 lipids is mediated through their antioxidant defense system. Weanling B/W mice were fed a nutritionally adequate, semipurified diet containing CO or krill oil (KO) or FO at 10% level (w/w) ad libitum until the mice were 6.5 months old. All diets contained the same level of vitamin E (21.5 mg/100 g diet). We compared the effects of feeding n-6 and n-3 lipids on survival, kidney disease, hepatic microsomal lipid composition, peroxidation, and on the activity and mRNA expression of the antioxidant enzymes catalase, glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) in 6.5-month-old B/W mice. The results showed that when compared to livers from CO-fed mice, livers from KO- and FO-fed mice showed: (i) significantly higher (P < 0.001) activities and expression of CAT, GSH-Px and SOD; (ii) significantly lower (P < 0.001) arachidonic acid (20:4n-6) and linoleic acid (18:2n-6) and higher (P < 0.001) eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3) levels in hepatic microsomes; and (iii) significantly lower (P < 0.001) estimated peroxidation indices and thiobarbituric acid reactive substances generation. The data indicate that one of the mechanisms through which the n-3 lipids delay the onset of autoimmune diseases in B/W mice may be through maintenance of higher activities and expression of hepatic antioxidant enzymes.
C1 UNIV TEXAS, HLTH SCI CTR, DEPT MED, SAN ANTONIO, TX 78284 USA.
   UNIV TEXAS, HLTH SCI CTR, DEPT PHYSIOL, SAN ANTONIO, TX 78284 USA.
   UNIV TEXAS, HLTH SCI CTR, DEPT MICROBIOL, SAN ANTONIO, TX 78284 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; University of Texas System; University of
   Texas Health Science Center at San Antonio
CR Aebi H., 1974, Methods of enzymatic analysis, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]
   ALLEN RG, 1992, J NUTR, V122, P631, DOI 10.1093/jn/122.suppl_3.631
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   [Anonymous], 2012, FREE RADICALS BIOL
   AWAD AB, 1991, J NUTR, V121, P771, DOI 10.1093/jn/121.6.771
   BENDICH A, 1990, ADV EXP MED BIOL, V262, P1
   BENDICH A, 1988, NUTRITION IMMUNOLOGY, P125
   CAMERON RG, 1986, CANCER LETT, V30, P175, DOI 10.1016/0304-3835(86)90086-8
   CHANDRASEKAR B, 1994, BIOCHEM BIOPH RES CO, V200, P893, DOI 10.1006/bbrc.1994.1534
   CHEN LC, 1993, LIPIDS, V28, P657, DOI 10.1007/BF02536062
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Chow CK, 1988, CELLULAR ANTIOXIDANT, VII, P217
   CLARKE SD, 1992, FASEB J, V6, P3146, DOI 10.1096/fasebj.6.13.1397836
   CULP BR, 1979, PROSTAG LEUKOTR ESS, V3, P269, DOI 10.1016/0161-4630(79)90068-5
   DANGVU AP, 1987, J IMMUNOL, V138, P1757
   DAS UN, 1991, PROSTAG LEUKOTR ESS, V44, P201, DOI 10.1016/0952-3278(91)90018-Z
   DRAPER HH, 1984, LIPIDS, V19, P836, DOI 10.1007/BF02534512
   ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501
   FERNANDES G, 1990, P SOC EXP BIOL MED, V193, P16, DOI 10.3181/00379727-193-42983
   FERNANDES G, 1994, J IMMUNOL, V152, P5979
   FERNANDES G, 1976, P NATL ACAD SCI USA, V73, P1279, DOI 10.1073/pnas.73.4.1279
   FERNANDES G, 1978, P NATL ACAD SCI USA, V75, P1500, DOI 10.1073/pnas.75.3.1500
   FERNANDES G, 1989, HEALTH EFFECTS OF FISH AND FISH OILS, P409
   FERNANDES G, 1993, NUTR RES, V13, pS19, DOI 10.1016/S0271-5317(05)80282-9
   FERNANDES G, 1973, INT ARCH ALLER A IMM, V44, P770, DOI 10.1159/000230981
   FERNANDES G, 1990, POTENTIAL NUTRITIONA, P263
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   HORBACH GJMJ, 1990, BIOCHEM INT, V20, P725
   HU ML, 1989, J NUTR, V119, P1574, DOI 10.1093/jn/119.11.1574
   HU ML, 1992, LIPIDS, V27, P42, DOI 10.1007/BF02537057
   HUANG CJ, 1993, J NUTR, V123, P803, DOI 10.1093/jn/123.5.803
   IRITANI N, 1992, EUR J BIOCHEM, V205, P433, DOI 10.1111/j.1432-1033.1992.tb16797.x
   Jeng K C, 1991, Proc Natl Sci Counc Repub China B, V15, P105
   JENG KC, 1989, INT J IMMUNOPATHOL I, V126, P1999
   JOHNSTON PV, 1985, ADV LIPID RES, V21, P103
   KAASGAARD SG, 1992, LIPIDS, V27, P740, DOI 10.1007/BF02535843
   KELLEY VE, 1983, AM J PATHOL, V111, P288
   KEPPEL G, 1982, DESIGN ANAL RES HDB, P146
   KINSELLA JE, 1990, J NUTR BIOCHEM, V1, P123, DOI 10.1016/0955-2863(90)90011-9
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   KORC M, 1992, J CLIN INVEST, V90, P1352, DOI 10.1172/JCI116001
   KORELUK RG, 1984, J BIOL CHEM, V259, P13819
   KORNBRUST DJ, 1980, LIPIDS, V15, P315, DOI 10.1007/BF02533546
   KREMER JM, 1990, OMEGA3 POLYUNSATURAT, P367
   LABBE MR, 1991, J NUTR, V121, P1331, DOI 10.1093/jn/121.9.1331
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1990, ADV EXP MED BIOL, V262, P95
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LANDS WEM, 1973, ADV BIOSCI, V9, P15
   LEIBOVITZ B, 1990, J NUTR, V120, P97, DOI 10.1093/jn/120.1.97
   LIEMANHURWITZ J, 1982, P NATL ACAD SCI-BIOL, V79, P2808, DOI 10.1073/pnas.79.9.2808
   LOKESH BR, 1981, J LIPID RES, V22, P905
   MACHLIN LJ, 1987, FASEB J, V1, P441, DOI 10.1096/fasebj.1.6.3315807
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MEYDANI SN, 1987, LIPIDS, V22, P345, DOI 10.1007/BF02534004
   MORROW WJW, 1985, J IMMUNOL, V135, P3857
   MULLENBACH GT, 1987, NUCLEIC ACIDS RES, V15, P5484, DOI 10.1093/nar/15.13.5484
   PRICKETT JD, 1981, J CLIN INVEST, V68, P556, DOI 10.1172/JCI110288
   PUIGPARELLADA P, 1978, BIOCHEM PHARMACOL, V27, P535, DOI 10.1016/0006-2952(78)90390-8
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   ROKUTAN K, 1988, INT ARCH ALLER A IMM, V87, P113, DOI 10.1159/000234660
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SPALLHOLZ JE, 1990, ADV EXP MED BIOL, V262, P145
   Talal N, 1974, Curr Top Microbiol Immunol, V64, P79
   TIWARI RK, 1988, IMMUNOL LETT, V17, P151, DOI 10.1016/0165-2478(88)90084-3
   TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485
   VENKATRAMAN JT, 1988, BIOCHIM BIOPHYS ACTA, V940, P33, DOI 10.1016/0005-2736(88)90005-3
   VENKATRAMAN JT, 1994, IN PRESS BIOCH BIOPH
   VENKATRAMAN JT, 1991, NUTRITION IMMUNOLOGY, P309
   WEINDRUCH R, 1984, FREE RADICALS MOL BI, P181
   Wills E.D., 1985, OXIDATIVE STRESS, P197
   YAMAZAKI RK, 1987, BIOCHIM BIOPHYS ACTA, V920, P62, DOI 10.1016/0005-2760(87)90311-0
   Yu B.P., 1993, FREE RADICALS AGING, P57
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
NR 74
TC 120
Z9 125
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0024-4201
EI 1558-9307
J9 LIPIDS
JI Lipids
PD AUG
PY 1994
VL 29
IS 8
BP 561
EP 568
DI 10.1007/BF02536628
PG 8
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA PB784
UT WOS:A1994PB78400006
PM 7990663
DA 2024-02-19
ER

PT J
AU Brewer, GJ
AF Brewer, George J.
TI The Risks of Copper Toxicity Contributing to Cognitive Decline in the
   Aging Population and to Alzheimer's Disease
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article; Proceedings Paper
CT 50th Annual Meeting of the American-College-of-Nutrition
CY OCT 01-04, 2009
CL Orlando, FL
SP Amer Coll Nutr
ID AMYLOID PRECURSOR PROTEIN; SERUM COPPER; OXIDATION; EXCESS; WATER
AB It is a pleasure and an honor to contribute a paper to a special issue of the Journal of the American College of Nutrition honoring Stanley Wallach and Pearl Small. In this brief review I advance the hypothesis that copper toxicity is the major cause of the epidemic of mild cognitive impairment and Alzheimer's disease engulfing our aging population. This epidemic is recent, exploding in the last 50-60 years. The disease was virtually unknown 100 years ago. And it involves only developed countries that use copper plumbing. Something in our environment associated with development is poisoning the minds of our aged. The epidemic is associated with the use of copper plumbing, and the taking of copper in multi-mineral supplements. Food copper (organic copper) is processed by the liver and is transported and sequestered in a safe manner. Inorganic copper, such as that in drinking water and copper supplements, largely bypasses the liver and enters the free copper pool of the blood directly. This copper is potentially toxic because it may penetrate the blood/brain barrier. I review a web of animal and human data that tightens the noose around the hypothesis that copper toxicity is causing the epidemic of Alzheimer's disease and loss of cognition in our aging population.
C1 [Brewer, George J.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48103 USA.
   [Brewer, George J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48103 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan
RP Brewer, GJ (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, 3820 Gensley Rd, Ann Arbor, MI 48103 USA.
EM brewergj@umich.edu
CR Angeletti B, 2005, J BIOL CHEM, V280, P17930, DOI 10.1074/jbc.M412034200
   [Anonymous], DYING HAMBURGER MODE
   BREWER GJ, 2009, COPPER PROOF CHRONIC
   HILL GM, 1986, AM J MED SCI, V292, P344, DOI 10.1097/00000441-198612000-00002
   Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520
   LIEBMAN B, 2009, COMMUNICATION    JUN
   Ma QF, 2006, PEPTIDES, V27, P841, DOI 10.1016/j.peptides.2005.09.002
   Morris MC, 2006, ARCH NEUROL-CHICAGO, V63, P1085, DOI 10.1001/archneur.63.8.1085
   Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406
   NAKANO E, 2004, BIOCHIM BIOPHYS ACTA, V1688, P3342
   Nelson TJ, 2005, J BIOL CHEM, V280, P7377, DOI 10.1074/jbc.M409071200
   Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613
   Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6
   Sparks DL, 2006, J NUTR HEALTH AGING, V10, P247
   Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100
   Squitti R, 2006, NEUROLOGY, V67, P76, DOI 10.1212/01.wnl.0000223343.82809.cf
   Squitti R, 2005, NEUROLOGY, V64, P1040, DOI 10.1212/01.WNL.0000154531.79362.23
   Squitti R, 2009, NEUROLOGY, V72, P50, DOI 10.1212/01.wnl.0000338568.28960.3f
   White AR, 2002, J NEUROSCI, V22, P365, DOI 10.1523/JNEUROSCI.22-02-00365.2002
NR 19
TC 106
Z9 120
U1 0
U2 29
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD JUN
PY 2009
VL 28
IS 3
BP 238
EP 242
DI 10.1080/07315724.2009.10719777
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics
GA 539PV
UT WOS:000273270000004
PM 20150596
DA 2024-02-19
ER

PT J
AU Kamkwalala, AR
   Garg, A
   Roy, U
   Matthews, A
   Castillo-Mancilla, J
   Lake, JE
   Sebastiani, G
   Yin, M
   Brown, TT
   Kamer, AR
   Jabs, DA
   Ellis, RJ
   Boffito, M
   Greene, M
   Schmalzle, S
   Siegler, E
   Erlandson, KM
   Moore, DJ
AF Kamkwalala, Asante R.
   Garg, Ankita
   Roy, Upal
   Matthews, Avery
   Castillo-Mancilla, Jose
   Lake, Jordan E.
   Sebastiani, Giada
   Yin, Michael
   Brown, Todd T.
   Kamer, Angela R.
   Jabs, Douglas A.
   Ellis, Ronald J.
   Boffito, Marta
   Greene, Meredith
   Schmalzle, Sarah
   Siegler, Eugenia
   Erlandson, Kristine M.
   Moore, David J.
TI Current Considerations for Clinical Management and Care of People with
   HIV: Findings from the 11th Annual International HIV and Aging Workshop
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article; Early Access
DE neuroscience; aging; HIV; antiretroviral therapy; clinical outcomes
ID HUMAN-IMMUNODEFICIENCY-VIRUS; BONE-MINERAL DENSITY; FATTY LIVER-DISEASE;
   ACTIVE ANTIRETROVIRAL THERAPY; POPULATION PHARMACOKINETIC ANALYSIS;
   NEVIRAPINE PLASMA-CONCENTRATION; TENOFOVIR DISOPROXIL FUMARATE; INFECTED
   PATIENTS; FRACTURE RISK; SYSTEMIC INFLAMMATION
AB The number of people with HIV (PWH) aged 50 years or older continues to steadily increase. The convergence of age- and HIV-related complications in these individuals presents a challenge for both patients and clinicians alike. New findings continue to emerge, as numerous researchers evaluate the combined impact of these two factors on quality of life, physiological systems, and mental health in PWH. Since its first occurrence in 2009, the International Workshop on HIV and Aging has served as a multidisciplinary meeting to share basic biomedical data, clinical trial results, treatment strategies, and epidemiological recommendations, toward better understanding and outcomes among like-minded scientific professionals. In this article, we share a selection of key findings presented in plenary talks at the 11th Annual International Workshop on HIV and Aging, held virtually from September 30, 2020 to October 2, 2020. We will also address the future directions of HIV and aging research, to further assess how the aging process intersects with chronic HIV.
C1 [Kamkwalala, Asante R.] Johns Hopkins Univ, Dept Neurol, 600 N Wolfe St,Osler 668, Baltimore, MD 21287 USA.
   [Garg, Ankita] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.
   [Roy, Upal] Univ Texas Rio Grande Valley, Dept Hlth & Biomed Sci, Brownsville, TX USA.
   [Matthews, Avery] Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Care Syst, Dept Psychiat, San Antonio, TX 78229 USA.
   [Castillo-Mancilla, Jose; Erlandson, Kristine M.] Univ Colorado, Div Infect Dis, Dept Med, Anschutz Med Campus, Aurora, CO USA.
   [Lake, Jordan E.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA.
   [Sebastiani, Giada] McGill Univ, Dept Med, Hlth Ctr, Montreal, PQ, Canada.
   [Yin, Michael] Columbia Univ, Dept Infect Dis, New York, NY USA.
   [Brown, Todd T.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21287 USA.
   [Kamer, Angela R.] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY USA.
   [Jabs, Douglas A.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA.
   [Jabs, Douglas A.] Johns Hopkins Univ, Wilmer Eye Inst, Dept Ophthalmol, Sch Med, Baltimore, MD 21287 USA.
   [Ellis, Ronald J.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.
   [Ellis, Ronald J.; Moore, David J.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.
   [Boffito, Marta] Chelsea & Westminster Hosp, Dept HIV Serv, London, England.
   [Greene, Meredith] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA.
   [Schmalzle, Sarah] Univ Maryland, Dept Infect Dis, Baltimore, MD 21201 USA.
   [Siegler, Eugenia] Weill Cornell Med, Div Geriatr & Palliat Med, New York, NY USA.
C3 Johns Hopkins University; University System of Georgia; University of
   Georgia; University of Texas System; University of Texas Rio Grande
   Valley; University of Texas System; University of Texas Health Science
   Center at San Antonio; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital;
   University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Texas System; University of Texas Health Science
   Center Houston; McGill University; Columbia University; Johns Hopkins
   University; New York University; Johns Hopkins University; Johns Hopkins
   Bloomberg School of Public Health; Johns Hopkins University; Johns
   Hopkins Medicine; University of California System; University of
   California San Diego; University of California System; University of
   California San Diego; Imperial College London; University of California
   System; University of California San Francisco; University System of
   Maryland; University of Maryland Baltimore; Cornell University; Weill
   Cornell Medicine
RP Kamkwalala, AR (corresponding author), Johns Hopkins Univ, Dept Neurol, 600 N Wolfe St,Osler 668, Baltimore, MD 21287 USA.
EM akamkwa1@jhmi.edu
OI Yin, Michael T/0000-0002-9346-9056; Moore, David/0000-0001-9699-318X
FU NIMH/NIH [R25MH108389, R01AG048650]; NIAID/NIH [R01AI145453]; Gilead
   Sciences; Pfizer; OncoImmune; CytoDyn; Fonds de la Recherche en Santedu
   Quebec [27127, 267806]; K24 AI120834; NIH [DE023139]; Alzheimer's
   Association [NIRG-12-173937]; NEI/NIH [EY025093]; NIA/NIH
   [K76AG064545-01]; Wayen Family Charitable Foundation; NIA [AG066562]
FX A.R. Kamkwalala, A.G., U.R., and A.M. are supported by funding from the
   NIMH/NIH (R25MH108389). J.C.-M. is supported in part by NIAID/NIH
   (R01AI145453). J.E.L. receives research support from Gilead Sciences,
   Pfizer, OncoImmune, and CytoDyn. G.S. is supported by a Junior 1 and 2
   Salary Award from Fonds de la Recherche en Sante ' du Quebe ' c (Nos.
   27127 and 267806). T.T.B. is supported in part by K24 AI120834. A.R.
   Kamer is supported by funding from the NIH (DE023139) and the
   Alzheimer's Association (NIRG-12-173937). D.A.J. is supported by funding
   from the NEI/NIH (EY025093). R.J.E. is supported by funding from the
   NIH/NIMH (R01AG048650). M.G. receives funding from the NIA/NIH
   (K76AG064545-01). S.S. is supported by funding from Gilead Sciences.
   E.S. is supported by funding from the Wayen Family Charitable
   Foundation. K.M.E. is supported by NIA AG066562.
CR Abara WE, 2016, AIDS BEHAV, V20, P2674, DOI 10.1007/s10461-016-1325-x
   Agarwal N, 2015, ADIPOCYTE, V4, P55, DOI 10.4161/adip.29852
   Agarwal N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007148
   Alisky JM, 2007, MED HYPOTHESES, V69, P1140, DOI 10.1016/j.mehy.2007.02.030
   Ances BM, 2007, SEMIN NEUROL, V27, P86, DOI 10.1055/s-2006-956759
   Ances BM, 2012, JAIDS-J ACQ IMM DEF, V59, P469, DOI 10.1097/QAI.0b013e318249db17
   Ances BM, 2010, J INFECT DIS, V201, P336, DOI 10.1086/649899
   Arab-Alameddine M, 2009, CLIN PHARMACOL THER, V85, P485, DOI 10.1038/clpt.2008.271
   Back D, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25449
   Benaboud S, 2012, ANTIMICROB AGENTS CH, V56, P857, DOI 10.1128/AAC.05244-11
   Beraldo Rebeca Antunes, 2017, Rev. bras. epidemiol., V20, P526, DOI 10.1590/1980-5497201700030014
   Bernardino JI, 2015, LANCET HIV, V2, pE464, DOI 10.1016/S2352-3018(15)00181-2
   Bhatia R, 2012, J NEUROVIROL, V18, P247, DOI 10.1007/s13365-011-0073-y
   Boccara F, 2010, ANTIVIR THER, V15, P363, DOI 10.3851/IMP1533
   Borderi M, 2014, NEW MICROBIOL, V37, P25
   Borges AH, 2017, CLIN INFECT DIS, V64, P1413, DOI 10.1093/cid/cix167
   Bourgi K, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25484
   Bouwman FH, 1998, NEUROLOGY, V50, P1814, DOI 10.1212/WNL.50.6.1814
   Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x
   Byrd KK, 2019, JAIDS-J ACQ IMM DEF, V82, P245, DOI 10.1097/QAI.0000000000002142
   Caballero J, 2019, ANN PHARMACOTHER, V53, P151, DOI 10.1177/1060028018798327
   Carmo FB, 2017, BRAZ J INFECT DIS, V21, P270, DOI 10.1016/j.bjid.2017.03.005
   Castillo-Mancilla JR, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25297
   Castillo-Mancilla JR, 2018, JAIDS-J ACQ IMM DEF, V77, P507, DOI 10.1097/QAI.0000000000001629
   Castillo-Mancilla JR, 2016, CLIN INFECT DIS, V63, P1661, DOI 10.1093/cid/ciw650
   Castillo-Mancilla JR., OPEN FORUM INFECT DI
   Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd
   Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
   Chang L, 2011, NEUROIMAGE, V58, P1017, DOI 10.1016/j.neuroimage.2011.07.010
   Cheru LT, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy288
   Cole JH, 2017, NEUROLOGY, V88, P1349, DOI [10.1212/WNL.0000000000003790, 10.1212/wnl.0000000000003790]
   Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2
   Couturier J, 2018, ANTIVIR RES, V154, P140, DOI 10.1016/j.antiviral.2018.04.002
   Croxford S, 2017, LANCET PUBLIC HEALTH, V2, pE35, DOI 10.1016/S2468-2667(16)30020-2
   Custodio JM, 2016, J CLIN PHARMACOL, V56, P723, DOI 10.1002/jcph.657
   Dailly E, 2004, EUR J CLIN PHARMACOL, V60, P343, DOI 10.1007/s00228-004-0769-5
   Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756
   Deeks Steven G, 2009, Top HIV Med, V17, P118
   Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4
   Dickinson L., 2010, J INT AIDS SOC, V13, pP184
   Diker-Cohen T, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz322
   Ding YY, 2017, J NEUROIMMUNE PHARM, V12, P661, DOI 10.1007/s11481-017-9748-3
   Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333
   Dumond JB, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00177-20
   Edelman EJ, 2020, CURR OPIN HIV AIDS, V15, P126, DOI 10.1097/COH.0000000000000608
   Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520
   Elliot ER, 2019, CLIN INFECT DIS, V68, P87, DOI 10.1093/cid/ciy426
   Ellis RJ, 2020, ANN CLIN TRANSL NEUR, V7, P1166, DOI 10.1002/acn3.51097
   Erlandson KM, 2018, JAIDS-J ACQ IMM DEF, V77, P288, DOI [10.1097/QAI.0000000000001591, 10.1097/qai.0000000000001591]
   Erlandson KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114166
   Erlandson KM, 2013, JAIDS-J ACQ IMM DEF, V63, P209, DOI 10.1097/QAI.0b013e318289bb7e
   Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036
   Foley JM, 2012, APPL NEUROPSYCH-ADUL, V19, P16, DOI 10.1080/09084282.2011.595601
   Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
   Gallant J, 2017, J INFECT DIS, V216, P1525, DOI 10.1093/infdis/jix518
   Ghidei L, 2013, DRUG AGING, V30, P809, DOI 10.1007/s40266-013-0107-7
   Grant PM, 2016, J INFECT DIS, V214, P607, DOI 10.1093/infdis/jiw204
   Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191
   Guaraldi G, 2008, CLIN INFECT DIS, V47, P250, DOI 10.1086/589294
   Guaraldi G, 2017, VIRULENCE, V8, P504, DOI 10.1080/21505594.2017.1306622
   Guaraldi G, 2017, AIDS, V31, pS147, DOI [10.1097/qad.0000000000001483, 10.1097/QAD.0000000000001483]
   Güerri-Fernández R, 2014, ARQ BRAS ENDOCRINOL, V58, P478, DOI 10.1590/0004-2730000003323
   Haffajee AD, 2006, PERIODONTOL 2000, V42, P7, DOI 10.1111/j.1600-0757.2006.00190.x
   Hajishengallis G, 2014, MOL ORAL MICROBIOL, V29, P248, DOI 10.1111/omi.12065
   Hajishengallis G, 2016, TRENDS MICROBIOL, V24, P477, DOI 10.1016/j.tim.2016.02.010
   Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001
   Halloran MO, 2019, ANTIVIR THER, V24, P193, DOI 10.3851/IMP3293
   Hines LJ, 2016, BRAIN IMAGING BEHAV, V10, P640, DOI 10.1007/s11682-015-9441-1
   Hinkin CH, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200418001-00004
   Hirakawa H, 2017, J INFECT DIS, V215, P1893, DOI 10.1093/infdis/jix246
   Hoy JF, 2017, J BONE MINER RES, V32, P1945, DOI 10.1002/jbmr.3183
   Ilievski V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204941
   Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0
   Jha S, 2015, J BONE MINER RES, V30, P2179, DOI 10.1002/jbmr.2565
   Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004
   Kamer AR, 2020, PERIODONTOL 2000, V83, P242, DOI 10.1111/prd.12327
   Kamer AR, 2015, NEUROBIOL AGING, V36, P627, DOI 10.1016/j.neurobiolaging.2014.10.038
   Kannisto K, 2003, AIDS, V17, P1753, DOI 10.1097/00002030-200308150-00004
   Kile DA, 2012, AIDS RES HUM RETROV, V28, P1227, DOI 10.1089/aid.2011.0378
   Kissel EC, 2005, J NEUROPSYCH CLIN N, V17, P180, DOI 10.1176/appi.neuropsych.17.2.180
   Kobin AB, 2011, ANN PHARMACOTHER, V45, P372, DOI 10.1345/aph.1P587
   Kohli R, 2006, J URBAN HEALTH, V83, P31, DOI 10.1007/s11524-005-9005-6
   Krahn T, 2020, J INFECT DIS, V222, P787, DOI 10.1093/infdis/jiaa170
   Krishnan K, 2017, ORAL DIS, V23, P276, DOI 10.1111/odi.12509
   Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005
   Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503
   Lagathu C, 2019, EXPERT OPIN DRUG SAF, V18, P829, DOI 10.1080/14740338.2019.1644317
   Lima ALLM, 2011, HIV AIDS-RES PALLIAT, V3, P117, DOI 10.2147/HIV.S6617
   Letendre Scott, 2006, Top HIV Med, V14, P21
   Levine AJ, 2016, J NEUROVIROL, V22, P366, DOI 10.1007/s13365-015-0406-3
   Lombardi R, 2016, DIGEST LIVER DIS, V48, P1471, DOI 10.1016/j.dld.2016.08.117
   Lubomirov R, 2010, PHARMACOGENET GENOM, V20, P217, DOI 10.1097/FPC.0b013e328336eee4
   Macías J, 2017, CLIN INFECT DIS, V65, P1012, DOI 10.1093/cid/cix467
   Maia BS, 2005, CLIN NUTR, V24, P971, DOI 10.1016/j.clnu.2005.06.012
   Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x
   Mann SC, 2020, CURR OPIN HIV AIDS, V15, P134, DOI 10.1097/COH.0000000000000615
   Martin GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055279
   Mayer KH, 2020, LANCET, V396, P239, DOI 10.1016/S0140-6736(20)31065-5
   Mazzitelli M, 2019, AIDS, V33, P2439, DOI 10.1097/QAD.0000000000002403
   McDermott AY, 2001, AM J CLIN NUTR, V74, P679
   McMurtray A, 2007, CEREBROVASC DIS, V24, P236, DOI 10.1159/000104484
   Milic J, 2020, AIDS, V34, P1915, DOI 10.1097/QAD.0000000000002650
   Mohr R, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000010462, 10.1097/md.0000000000010462]
   Moltó J, 2013, CLIN PHARMACOKINET, V52, P543, DOI 10.1007/s40262-013-0057-6
   Morgan EE, 2012, JAIDS-J ACQ IMM DEF, V61, P341, DOI 10.1097/QAI.0b013e31826bfc53
   Musinguzi N, 2019, JAIDS-J ACQ IMM DEF, V82, P386, DOI 10.1097/QAI.0000000000002148
   Nachega Jean B, 2012, AIDS, V26 Suppl 1, pS39
   Offenbacher S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05940-9
   Panhard X, 2007, EUR J CLIN PHARMACOL, V63, P1019, DOI 10.1007/s00228-007-0337-x
   Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x
   Pembroke T, 2017, J HEPATOL, V67, P801, DOI 10.1016/j.jhep.2017.05.011
   Perazzo H, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25201
   Perazzo H, 2017, LANCET HIV, V4, pE236, DOI 10.1016/S2352-3018(17)30030-9
   Pereira B, 2020, JAIDS-J ACQ IMM DEF, V85, P98, DOI 10.1097/QAI.0000000000002400
   Petoumenos K, 2014, HIV MED, V15, P595, DOI 10.1111/hiv.12162
   Pfefferbaum A, 2014, NEUROBIOL AGING, V35, P1755, DOI 10.1016/j.neurobiolaging.2014.01.008
   Price JC, 2017, HEPATOLOGY, V65, P853, DOI 10.1002/hep.28968
   Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276
   Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008
   Ryom L, 2020, HIV MED, V21, P617, DOI 10.1111/hiv.12878
   Saag MS, 2018, JAMA-J AM MED ASSOC, V320, P379, DOI 10.1001/jama.2018.8431
   Sánchez A, 2011, ANTIMICROB AGENTS CH, V55, P5314, DOI 10.1128/AAC.00194-11
   Sax PE, 2015, LANCET, V385, P2606, DOI 10.1016/S0140-6736(15)60616-X
   Scherzer R, 2011, AIDS, V25, P1405, DOI 10.1097/QAD.0b013e32834884e6
   Schifitto G, 2002, NEUROLOGY, V58, P1764, DOI 10.1212/WNL.58.12.1764
   Schoen JC, 2013, EXPERT OPIN DRUG MET, V9, P573, DOI 10.1517/17425255.2013.781153
   Sebastiani G, 2020, AIDS, V34, P237, DOI 10.1097/QAD.0000000000002412
   Seider TR, 2016, J NEUROVIROL, V22, P201, DOI 10.1007/s13365-015-0386-3
   Seifert SM, 2018, JAIDS-J ACQ IMM DEF, V77, P295, DOI [10.1097/QAI.0000000000001596, 10.1097/qai.0000000000001596]
   Sheppard DP, 2017, J NEUROVIROL, V23, P492, DOI 10.1007/s13365-017-0523-2
   Shiau S, 2020, JAIDS-J ACQ IMM DEF, V84, P101, DOI 10.1097/QAI.0000000000002309
   Siccardi M, 2012, THER DRUG MONIT, V34, P232, DOI 10.1097/FTD.0b013e31824aa50a
   Siefried KJ, 2018, AIDS, V32, P35, DOI [10.1097/QAD.0000000000001685, 10.1097/qad.0000000000001685]
   Socransky S S, 1997, Ann Periodontol, V2, P3
   Soomro N, 2019, AIDS BEHAV, V23, P445, DOI 10.1007/s10461-018-2196-0
   Srinivasa S, 2015, J CLIN ENDOCR METAB, V100, P2873, DOI 10.1210/jc.2015-1461
   Stanley TL, 2019, LANCET HIV, V6, pE821, DOI 10.1016/S2352-3018(19)30338-8
   Stephens KI, 2016, ENDOCR PRACT, V22, P440, DOI 10.4158/EP15958.OR
   Stöhr W, 2008, ANTIVIR THER, V13, P675
   Stoff DM, 2017, CURR HIV-AIDS REP, V14, P184, DOI 10.1007/s11904-017-0364-x
   Tan DHS, 2017, HIV CLIN TRIALS, V18, P28, DOI 10.1080/15284336.2016.1266074
   Thomas JB, 2013, NEUROLOGY, V80, P1186, DOI 10.1212/WNL.0b013e318288792b
   Tiliscan C, 2018, ENDOCR RES, V43, P149, DOI 10.1080/07435800.2018.1439058
   Valcour V, 2011, J INT NEUROPSYCH SOC, V17, P190, DOI 10.1017/S1355617710001438
   van Welzen BJ, 2019, JAIDS-J ACQ IMM DEF, V82, P439, DOI 10.1097/QAI.0000000000002177
   van Wijk JPH, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/201027
   Verheggen ICM, 2020, GEROSCIENCE, V42, P1183, DOI 10.1007/s11357-020-00211-2
   Viswanathan S, 2015, JAIDS-J ACQ IMM DEF, V69, P493, DOI 10.1097/QAI.0000000000000643
   Viswanathan S, 2015, AIDS BEHAV, V19, P601, DOI 10.1007/s10461-014-0927-4
   Waters L., BHIVA GUIDELINES TRE
   Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632
   World Health Organization, WHOCDSHIV1915
   ZHOU M, 2020, BRIT J OPHTHALMOL
NR 153
TC 1
Z9 1
U1 3
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD 2021 NOV 1
PY 2021
VL 37
IS 11
BP 807
EP 820
DI 10.1089/aid.2021.0059
EA SEP 2021
PG 14
WC Immunology; Infectious Diseases; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Virology
GA XB1RV
UT WOS:000697258800001
PM 34405689
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Pereira, BF
   Alves, AL
   Senhorini, JA
   Rocha, RDGD
   Pitol, DL
   Caetano, FH
AF Pereira, Bruno Fiorelini
   Alves, Anderson Luis
   Senhorini, Jose Algusto
   Gimenes de Alcantara Rocha, Rita de Cassia
   Pitol, Dimitrius Leonardo
   Caetano, Flavio Henrique
TI Effects of Biodegradable Detergents in the Accumulation of Lipofuscin
   (Age Pigment) in Gill and Liver of Two Neotropical Fish Species
SO INTERNATIONAL JOURNAL OF MORPHOLOGY
LA English
DT Article
DE Lipofuscin; Liver; Gill; Prochilodus; Astyanax
ID CRUSTACEA; POLLUTION; STRESS; GLAND
AB Currently there is a growing concern, in both population and governments, to identify the effects of substances commonly disposed of into rivers and lakes, on aquatic fauna and flora. Thus the objective of the present study was to verify effects of biodegradable detergents and water from an urban lake on gills and liver of two neotropical fish species of great economic importance, Astyanax altiparanae and Prochilodus lineatus. In order to do so, lipofuscin, also called the ageing pigment, was used as bioindicator. After one and five months of experiment both tissues accumulated this pigment. These data are discussed from physiological points of view, related with lipid peroxidation and mitochondrial damage.
C1 [Pereira, Bruno Fiorelini] Univ Fed Oeste Bahia, Barreiras, BA, Brazil.
   [Alves, Anderson Luis] EMBRAPA, Palmas, Tocantins, Brazil.
   [Senhorini, Jose Algusto; Gimenes de Alcantara Rocha, Rita de Cassia] ICMBio CEPTA, Pirassununga, SP, Brazil.
   [Pitol, Dimitrius Leonardo] Univ Sao Paulo, Fac Odontol Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Caetano, Flavio Henrique] Univ Estadual Paulista, UNESP, Sao Paulo, Brazil.
C3 Universidade Federal do Oeste da Bahia; Empresa Brasileira de Pesquisa
   Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade Estadual
   Paulista
RP Pitol, DL (corresponding author), Univ Sao Paulo, Dept Morfol Fisiol & Patol Basica, Fac Odontol Ribeirao Preto, Ave Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM dimitrius@forp.usp.br
RI Pereira, Bruno F/J-6223-2012; Rocha, Rita/IWL-9676-2023; Alves, Anderson
   L/E-9325-2013; Pitol, Dimitrius Loenardo/B-5524-2016; Augusto, José
   Senhorini/S-2419-2016; Calado, Leonardo/H-1346-2016
OI Pitol, Dimitrius Loenardo/0000-0001-5943-2359; Augusto, José
   Senhorini/0000-0002-5120-448X; Calado, Leonardo/0000-0003-2328-5267
FU FAPESP [2009/17118-9]; Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [09/17118-9] Funding Source: FAPESP
FX The authors are thankful to FAPESP, process number: 2009/17118-9, for
   financial support and to ICMBio/CEPTA - Institute Chico Mendes for
   providing the specimens used in this experiment.
CR [Anonymous], 2004, PLOS ONE
   [Anonymous], 2009, PLOS ONE
   [Anonymous], 2011, PLOS ONE
   [Anonymous], 2004, PLOS ONE
   [Anonymous], 2009, PLOS ONE
   [Anonymous], 1998, PLOS ONE
   [Anonymous], 2008, PLOS ONE
   [Anonymous], 2003, PLOS ONE
   [Anonymous], 2003, PLOS ONE, V26, P499
   [Anonymous], 1996, PLOS ONE
   Ding LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013287
   Han JA, 2010, AQUAT TOXICOL, V99, P281, DOI 10.1016/j.aquatox.2010.05.010
   Hödl E, 2010, CELL TISSUE RES, V341, P159, DOI 10.1007/s00441-010-0980-x
   Jordanova M, 2008, MICROSC RES TECHNIQ, V71, P822, DOI 10.1002/jemt.20626
   Junqueira L.C.U., 1983, TECNICAS BASICAS CIT
   Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152
   Kodama K, 2005, FISHERIES SCI, V71, P141, DOI 10.1111/j.1444-2906.2005.00941.x
   Machella N, 2005, AQUAT TOXICOL, V71, P335, DOI 10.1016/j.aquatox.2004.12.002
   MOORE MN, 1991, PROG HISTOCHEM CYTOC, V23, P1
   Peixoto S, 2002, BRAZ J BIOL, V62, P871, DOI 10.1590/S1519-69842002000500017
   Pinto AL, 2010, ENVIRON MONIT ASSESS, V169, P569, DOI 10.1007/s10661-009-1197-x
   Radwan MA, 2010, ARCH ENVIRON CON TOX, V58, P828, DOI 10.1007/s00244-009-9380-1
   Schutt F, 2003, INVEST OPHTH VIS SCI, V44, P3663, DOI 10.1167/iovs.03-0172
   Silva M. M., 2005, ARQ MED ABC, V30, P11
   Teh SJ, 1997, AQUAT TOXICOL, V37, P51, DOI 10.1016/S0166-445X(96)00808-9
   Terman A, 1998, APMIS, V106, P265, DOI 10.1111/j.1699-0463.1998.tb01346.x
   Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866
   Vaschenko MA, 2012, ARCH ENVIRON CON TOX, V62, P599, DOI 10.1007/s00244-011-9733-4
   Viarengo A, 2007, ARCH ENVIRON CON TOX, V53, P607, DOI 10.1007/s00244-005-0209-2
   Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063
NR 30
TC 4
Z9 4
U1 1
U2 17
PU SOC CHILENA ANATOMIA
PI TEMUCO
PA CASILLA 54-D, TEMUCO, 00000, CHILE
SN 0717-9502
EI 0717-9367
J9 INT J MORPHOL
JI Int. J. Morphol.
PD SEP
PY 2014
VL 32
IS 3
BP 773
EP 781
PG 9
WC Anatomy & Morphology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology
GA AW7DG
UT WOS:000346424200005
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU López-Avalos, MD
   Fernández-Llebrez Zayas, R
   Cifuentes, M
   De Andrés, MV
   Fernández-Llebrez Del Rey, P
   Grondona, J
   Pérez-Martín, M
   Pedraza, C
AF Lopez-Avalos, M. D.
   Fernandez-Llebrez Zayas, R.
   Cifuentes, M.
   De Andres, M. V.
   Fernandez-Llebrez Del Rey, P.
   Grondona, J. M.
   Perez-Martin, M.
   Pedraza, C.
TI Mente ActivaA® improves impaired spatial memory in aging rats
SO JOURNAL OF NUTRITION HEALTH & AGING
LA English
DT Article
DE Aging; prevention; cognitive decline; dietary supplements
ID MORRIS WATER MAZE; MILD COGNITIVE IMPAIRMENT; AGE-RELATED DECLINE;
   INDIVIDUAL-DIFFERENCES; LEARNING-STRATEGIES; BRAIN; DEFICITS;
   PERFORMANCE; MICE; RECEPTORS
AB Aging is accompanied by a decline in several aspects of the cognitive function, having negative personal and socioeconomic impacts. Dietary supplements could be beneficial for preventing age-related cognitive decline. In this context, we examined whether the nutritional supplement Mente ActivaA (R) has beneficial effects on aging-related cognitive deficits without inducing side effects.
   Mente ActivaA (R) was administered to old rats (n= 30 treated rats and n= 30 control rats) during 5 months, and the Morris water maze was used to test the learning capacities of the animals. The first assessment was conducted before the nutritional intervention (age of 18-19 months), to determine the baseline of the performance of animals on this test, and the second assessment was performed at the end of the treatment (23-24 moths). In order to examine possible secondary effects of this nutritional supplement, plasma, heart anatomy and liver parameters were evaluated.
   Our data indicate that supplemented rats showed less escape latency, distance swum, higher use of spatial search strategies, and crossed the former platform location with higher frequency than control rats. These effects were specific of the treatment, indicating that this nutritional supplement has a beneficial effect on spatial memory. On the other hand, the regular intake of Mente ActivaA (R) did not induce any negative effects in plasma parameters and heart size.
   Aged rats under a sustained dietary intake of the nutritional supplement Mente ActivaA (R) displayed improved learning and memory abilities compared to the non-treated rats. These results suggest the therapeutic potential and safety of use of Mente ActivaA (R) for age-related cognitive deficits, particularly, in the onset of the first cognitive dysfunction symptoms.
C1 [Lopez-Avalos, M. D.; Fernandez-Llebrez Zayas, R.; Cifuentes, M.; Fernandez-Llebrez Del Rey, P.; Grondona, J. M.; Perez-Martin, M.] Univ Malaga, Fac Ciencias, Dept Biol Celular Genet & Fisiol, E-29071 Malaga, Spain.
   [De Andres, M. V.] Univ Malaga, Fac Ciencias, Dept Biol Anim, E-29071 Malaga, Spain.
   [Pedraza, C.] Univ Malaga, Fac Psicol, Dept Psicobiol & Metodol CC, E-29071 Malaga, Spain.
   [Lopez-Avalos, M. D.; Cifuentes, M.; Fernandez-Llebrez Del Rey, P.; Grondona, J. M.; Perez-Martin, M.; Pedraza, C.] Inst Invest Biomed Malaga IBIMA, Malaga, Spain.
C3 Universidad de Malaga; Universidad de Malaga; Universidad de Malaga;
   Universidad de Malaga; Instituto de Investigacion Biomedica de Malaga y
   Plataforma en Nanomedicina (IBIMA)
RP Pedraza, C (corresponding author), Univ Malaga, Fac Psicol, Dept Psicobiol & Metodol CC, Campus Teatinos S-N, E-29071 Malaga, Spain.
EM mdpedraza@uma.es
RI Benitez, Carmen Pedraza/K-2328-2017; Martin, Margarita
   Perez/L-1556-2017; Martin, Margarita Perez/AAS-9326-2021; Grondona,
   Jesus M./F-1650-2011; Lopez-Avalos, Maria D./AAS-5327-2021; Cifuentes
   Rueda, Manuel/I-6922-2018
OI Benitez, Carmen Pedraza/0000-0002-0011-2817; Martin, Margarita
   Perez/0000-0001-8791-3862; Martin, Margarita Perez/0000-0001-8791-3862;
   Grondona, Jesus M./0000-0003-1781-1486; Cifuentes Rueda,
   Manuel/0000-0003-1414-469X; Lopez Avalos, Maria de los
   Dolores/0000-0002-9022-2381
FU University of Malaga; Laboratorios Fernandez y Canivell S.A. (Malaga,
   Spain)
FX We thank J.E. Casares-Mira for his help in animal handling, L.J. Santin
   for his critic review of the manuscript, and E. Castilla-Ortega for her
   methodological suggestions. This work was supported by a Research
   Contract between the University of Malaga and Laboratorios Fernandez y
   Canivell S.A. (Malaga, Spain).
CR Bañuelos C, 2014, J NEUROSCI, V34, P3457, DOI 10.1523/JNEUROSCI.5192-13.2014
   Bañuelos C, 2013, NEUROBIOL AGING, V34, P845, DOI 10.1016/j.neurobiolaging.2012.06.013
   Barrientos RM, 2011, J NEUROSCI, V31, P11578, DOI 10.1523/JNEUROSCI.2266-11.2011
   Bayley PJ, 2006, J NEUROSCI, V26, P13311, DOI 10.1523/JNEUROSCI.4262-06.2006
   Begega A, 2012, NEUROBIOL LEARN MEM, V97, P346, DOI 10.1016/j.nlm.2012.02.007
   Berchtold NC, 2013, NEUROBIOL AGING, V34, P1653, DOI 10.1016/j.neurobiolaging.2012.11.024
   Bimonte-Nelson HA, 2010, MOLECULES, V15, P6050, DOI 10.3390/molecules15096050
   Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983
   Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020
   BURWELL RD, 1993, NEUROBIOL AGING, V14, P57, DOI 10.1016/0197-4580(93)90023-5
   Carman AJ, 2014, J NUTR HEALTH AGING, V18, P383, DOI 10.1007/s12603-014-0021-7
   Champagne D, 2002, NEUROSCIENCE, V114, P641, DOI 10.1016/S0306-4522(02)00313-5
   Dangour AD, 2012, BRIT J NUTR, V107, pS152, DOI 10.1017/S0007114512001547
   Devore EE, 2010, AM J CLIN NUTR, V92, P1157, DOI 10.3945/ajcn.2010.29634
   Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100
   Driscoll I, 2003, CEREB CORTEX, V13, P1344, DOI 10.1093/cercor/bhg081
   Einvik G, 2010, EUR J CARDIOV PREV R, V17, P588, DOI 10.1097/HJR.0b013e328339cc70
   El Idrissi A, 2008, NEUROSCI LETT, V436, P19, DOI 10.1016/j.neulet.2008.02.070
   Foster TC, 2012, PROG NEUROBIOL, V96, P283, DOI 10.1016/j.pneurobio.2012.01.007
   Fujiwara H, 2011, COGN PROCESS, V12, P151, DOI 10.1007/s10339-010-0375-7
   GALLAGHER M, 1993, BEHAV BRAIN RES, V57, P155, DOI 10.1016/0166-4328(93)90131-9
   Gallagher M, 2006, AGE, V28, P221, DOI 10.1007/s11357-006-9017-5
   Gao SJ, 2014, AM J GERIAT PSYCHIAT, V22, P670, DOI 10.1016/j.jagp.2013.02.015
   Gauthie S, 2011, LANCET, V367, P1262
   Goh JOS, 2011, AGING DIS, V2, P30
   Gomez-Pinilla Fernando, 2011, Nutrition and Health (Bicester), V20, P165
   Graziano A, 2003, J NEUROSCI METH, V130, P33, DOI 10.1016/S0165-0270(03)00187-0
   Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659
   Hilgier W, 2005, BRAIN RES, V1043, P242, DOI 10.1016/j.brainres.2005.02.066
   Hirayama S, 2014, J HUM NUTR DIET, V27, P284, DOI 10.1111/jhn.12090
   Hok V, 2012, J NEUROSCI, V32, P3540, DOI 10.1523/JNEUROSCI.6449-11.2012
   Kato-Kataoka A, 2010, J CLIN BIOCHEM NUTR, V47, P246, DOI 10.3164/jcbn.10-62
   Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x
   Koepsell TD, 2012, NEUROLOGY, V79, P1591, DOI 10.1212/WNL.0b013e31826e26b7
   Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998
   Kumar A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.023
   Lee B, 2010, PROG NEURO-PSYCHOPH, V34, P1085, DOI 10.1016/j.pnpbp.2010.05.031
   Leggio MG, 2003, BRAIN RES PROTOC, V12, P83, DOI 10.1016/j.brainresprot.2003.08.001
   Lieb W, 2009, DIABETES CARE, V32, P612, DOI 10.2337/dc08-1596
   Lindner MD, 1997, NEUROBIOL LEARN MEM, V68, P203, DOI 10.1006/nlme.1997.3782
   Liu SH, 2012, BRAIN RES, V1451, P19, DOI 10.1016/j.brainres.2012.02.060
   Ménard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028666
   MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0
   Newman MC, 2000, AGING NEUROPSYCHOL C, V7, P86, DOI 10.1076/1382-5585(200006)7:2;1-U;FT086
   Park HR, 2011, ANN NY ACAD SCI, V1229, P23, DOI 10.1111/j.1749-6632.2011.06089.x
   Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985
   Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044
   Roberts RO, 2014, NEUROLOGY, V82, P317, DOI 10.1212/WNL.0000000000000055
   Robitsek RJ, 2008, J NEUROSCI, V28, P8945, DOI 10.1523/JNEUROSCI.1893-08.2008
   Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0
   Sachdev PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059649
   Santin LJ, 2009, GENES BRAIN BEHAV, V8, P772, DOI 10.1111/j.1601-183X.2009.00524.x
   Schwab S, 2014, J NUTR HEALTH AGING, V18, P510, DOI 10.1007/s12603-013-0418-8
   Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026
   Song NY, 2012, BRAIN RES, V1472, P1, DOI 10.1016/j.brainres.2012.07.001
   Stark SM, 2010, LEARN MEMORY, V17, P284, DOI 10.1101/lm.1768110
   Stranahan AM, 2012, NAT REV NEUROSCI, V13, P209, DOI 10.1038/nrn3151
   Tsai LH, 2014, NATURE, V507, P439, DOI 10.1038/nature13214
   Warburton EC, 1999, BEHAV BRAIN RES, V98, P27
   Winocur G, 2010, NEUROBIOL AGING, V31, P143, DOI 10.1016/j.neurobiolaging.2008.03.016
   Wyss JM, 2003, CLIN EXP HYPERTENS, V25, P455, DOI 10.1081/CEH-120024988
NR 61
TC 1
Z9 1
U1 0
U2 10
PU SPRINGER FRANCE
PI PARIS
PA 22 RUE DE PALESTRO, PARIS, 75002, FRANCE
SN 1279-7707
EI 1760-4788
J9 J NUTR HEALTH AGING
JI J. Nutr. Health Aging
PD OCT
PY 2015
VL 19
IS 8
BP 819
EP 827
DI 10.1007/s12603-015-0546-4
PG 9
WC Geriatrics & Gerontology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Nutrition & Dietetics
GA CT3CL
UT WOS:000362683900004
PM 26412286
DA 2024-02-19
ER

PT J
AU Argikar, UA
   Remmel, RP
AF Argikar, Upendra A.
   Remmel, Rory P.
TI Effect of Aging on Glucuronidation of Valproic Acid in Human Liver
   Microsomes and the Role of UDP-Glucuronosyltransferase UGT1A4, UGT1A8,
   and UGT1A10
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
ID CHEMICAL-SYNTHESIS; THERAPEUTIC CONSIDERATIONS; CLINICAL
   PHARMACOKINETICS; AGE; XENOBIOTICS; METABOLISM; KINETICS; DRUG;
   ENDOBIOTICS; DISPOSITION
AB Valproic acid (VPA) is a widely used anticonvulsant that is also approved for mood disorders, bipolar depression, and migraine. In vivo, valproate is metabolized oxidatively by cytochromes P450 and beta-oxidation, as well as conjugatively via glucuronidation. The acyl glucuronide conjugate (valproate-glucuronide or VPAG) is the major urinary metabolite (30-50% of the dose). It has been hypothesized that glucuronidation of antiepileptic drugs is spared over age, despite a known decrease in liver mass. The formation rates of VPAG in a bank of elderly ( 65 years onward) human liver microsomes (HLMs) were measured by liquid chromatography/ tandem mass spectrometry and compared with those in a younger ( 2 - 56 years) HLM bank. In vitro kinetic studies with recombinant UDP-glucuronosyltransferases (UGTs) were completed. A 5- to 8-fold variation for the formation of VPAG was observed within the microsomal bank obtained from elderly and younger donors. VPAG formation ranged from 6.0 to 53.4 nmol/min/mg protein at 1 mM substrate concentration (n = 36). The average velocities at 0.25, 0.5, and 1 mM VPA were 7.0, 13.4, and 25.4 nmol/min/mg protein, respectively, in the elderly HLM bank. Rates of VPAG formation were not significantly different in the HLM bank obtained from younger subjects. Intrinsic clearances (V-max/K-m) for several cloned, expressed UGTs were determined. UGT1A4, UGT1A8, and UGT1A10 also were found to catalyze the formation of VPAG in vitro. This is the first reported activity of these UGTs toward VPA glucuronidation. UGT2B7 had the highest intrinsic clearance, whereas UGT1A1 demonstrated no activity. In conclusion, our investigation revealed no differences in VPAG formation in younger versus elderly HMLs and revealed three other UGTs that form VPAG in vitro.
C1 [Argikar, Upendra A.; Remmel, Rory P.] Univ Minnesota, Dept Med Chem, Coll Pharm, Minneapolis, MN 55414 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities
RP Remmel, RP (corresponding author), Univ Minnesota, Dept Med Chem, Coll Pharm, 8-101 WDH,308 Harvard St SE, Minneapolis, MN 55414 USA.
EM remme001@umn.edu
RI Remmel, Rory P/N-2453-2015
FU National Institute of Neurological Disorders and Stroke; National
   Institutes of Health [P50 NS16308]
FX This study was funded by National Institute of Neurological Disorders
   and Stroke, National Institutes of Health [ Grant P50 NS16308].
CR Becker B, 1996, BIOCHEM J, V314, P249, DOI 10.1042/bj3140249
   Burchell B, 1998, Adv Pharmacol, V42, P335
   Chen SJ, 2005, J BIOL CHEM, V280, P37547, DOI 10.1074/jbc.M506683200
   DICKINSON RG, 1989, THER DRUG MONIT, V11, P127, DOI 10.1097/00007691-198903000-00002
   DICKINSON RG, 1985, J PHARMACOL EXP THER, V233, P214
   DICKINSON RG, 1984, DRUG METAB DISPOS, V12, P247
   DIVOLL M, 1981, J PHARM SCI, V70, P1104, DOI 10.1002/jps.2600701004
   DURNAS C, 1990, CLIN PHARMACOKINET, V19, P359, DOI 10.2165/00003088-199019050-00002
   Dutton G. J., 1966, GLUCURONIC ACID FREE
   Ethell BT, 2003, BIOCHEM PHARMACOL, V65, P1441, DOI 10.1016/S0006-2952(03)00076-5
   Fattore C, 2006, EPILEPSY RES, V70, P153, DOI 10.1016/j.eplepsyres.2006.04.002
   Green MD, 1996, DRUG METAB DISPOS, V24, P356
   Green MD, 1998, DRUG METAB DISPOS, V26, P507
   GREENBLATT DJ, 1981, BRIT J CLIN PHARMACO, V12, P631, DOI 10.1111/j.1365-2125.1981.tb01281.x
   GREENBLATT DJ, 1991, CLIN PHARMACOKINET, V21, P262, DOI 10.2165/00003088-199121040-00003
   GREENBLATT DJ, 1991, CLIN PHARMACOKINET, V21, P165, DOI 10.2165/00003088-199121030-00002
   GREENBLATT DJ, 1981, CLIN PHARMACOL THER, V30, P475, DOI 10.1038/clpt.1981.191
   GREENBLATT DJ, 1980, J PHARMACOL EXP THER, V215, P86
   KASPERSEN FM, 1987, XENOBIOTICA, V17, P1451, DOI 10.3109/00498258709044005
   Kolwankar D, 2005, DRUG METAB DISPOS, V33, P524, DOI 10.1124/dmd.104.002261
   Levy RH., 2002, Antiepileptic drugs
   Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001
   Mackenzie PI, 2000, CLIN CHEM LAB MED, V38, P889, DOI 10.1515/CCLM.2000.129
   Nelson MH, 2001, EPILEPSY RES, V44, P71, DOI 10.1016/S0920-1211(00)00203-5
   PANFIL I, 1992, BIOCHIM BIOPHYS ACTA, V1126, P221, DOI 10.1016/0005-2760(92)90294-6
   PERUCCA E, 1984, BRIT J CLIN PHARMACO, V17, P665, DOI 10.1111/j.1365-2125.1984.tb02401.x
   REMMEL RP, 2008, DRUG DRUG INTERACTIO
   Stachulski AV, 1998, NAT PROD REP, V15, P173
   Tephly T R, 1998, Adv Pharmacol, V42, P343
   Tukey RH, 2001, MOL PHARMACOL, V59, P405, DOI 10.1124/mol.59.3.405
   VAZ ADN, 1992, DRUG METAB DISPOS, V20, P108
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
NR 32
TC 104
Z9 112
U1 1
U2 17
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0090-9556
EI 1521-009X
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD JAN
PY 2009
VL 37
IS 1
BP 229
EP 236
DI 10.1124/dmd.108.022426
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 387CA
UT WOS:000261928100030
PM 18838507
OA Green Published
DA 2024-02-19
ER

PT J
AU ALTERMAN, MA
   CARVAN, MJ
   BUSBEE, DL
AF ALTERMAN, MA
   CARVAN, MJ
   BUSBEE, DL
TI ETHOXYRESORUFIN AND PENTOXYRESORUFIN O-DEALKYLATION BY HEPATIC
   MICROSOMES FROM FEMALE FISCHER-344 RATS - EFFECTS OF AGE AND DIET
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE CYTOCHROME P450; AGING; CALORIE RESTRICTION
ID DRUG-METABOLIZING-ENZYMES; SEX-SPECIFIC FORMS; CALORIC RESTRICTION;
   LIVER-MICROSOMES; CYTOCHROME-P-450; INDUCTION; SYSTEM; EXPRESSION;
   UPDATE
AB Ethoxyresorufin (EROD) and pentoxyresorufin (PROD) O-dealkylase activities, and contributions of the P450 cytochromes CYP1A1, CYP2B1 and 2, CYP2C6 and CYP2C12 to these metabolic activities, were evaluated in hepatic microsomes from ad libitum and calorie restricted female Fischer 344 rats across an age continuum from 1 to 26 months, The presence of CYP1A in microsome preparations was confirmed by western blot analysis. Uninduced levels of EROD and PROD peak in very young animals, decline to about 3 months,of age, and do not exhibit an additional substantive decline after about 3 months of age. Monoclonal antibody (MAb) 1-7-1 (anti-CYP1A) strongly inhibited EROD activity in all microsome preparations, with the highest levels of inhibition in microsomes from 1- and 3-month-old AL animals, PROD activity in 1-month uninduced animals was apparently not attributable solely to CYP2B1 and 2, since it was inhibited by about 30% in both 1- and 26-month-old AL rats by an MAb specific for CYP2C12, However, in CR rats, CYP2C12 did not contribute to PROD activity. Approximately 40% of PROD activity in old AL rats and 20% of PROD activity in old CR rats was inhibited by an MAb specific for CYP2C6. These data indicate that long-term calorie restriction modulates either the expression or post-translational modification patterns of constitutive P450 isozymes in rats as they age, with P450 patterns in calorie restricted rats more closely resembling those found-in young animals.
C1 TEXAS A&M UNIV, COLL VET MED, DEPT ANAT & PUBL HLTH, COLLEGE STN, TX 77843 USA.
   UNIV KANSAS, COLL PHARM, DEPT MED CHEM, LAWRENCE, KS 66045 USA.
   UNIV CINCINNATI, MED CTR, KETTERING LAB, DEPT ENVIRONM HLTH, CINCINNATI, OH 45267 USA.
C3 Texas A&M University System; Texas A&M University College Station;
   University of Kansas; University System of Ohio; University of
   Cincinnati
OI Carvan, Michael/0000-0002-9190-9417
FU NIA NIH HHS [AG 06347, AG 07739] Funding Source: Medline
CR ALTERMAN M, 1993, AGE, V16, P1, DOI 10.1007/BF02436124
   BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243
   DUFFY PH, 1989, MECH AGEING DEV, V48, P117, DOI 10.1016/0047-6374(89)90044-4
   GORSKI JR, 1985, CARCINOGENESIS, V6, P617, DOI 10.1093/carcin/6.4.617
   HIETANEN E, 1987, BIOCHEM PHARMACOL, V36, P3973, DOI 10.1016/0006-2952(87)90466-7
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KATO R, 1986, J BIOCHEM-TOKYO, V100, P895, DOI 10.1093/oxfordjournals.jbchem.a121802
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   MORGAN ET, 1987, BIOCHEMISTRY-US, V26, P4193, DOI 10.1021/bi00388a003
   MORGAN ET, 1987, STEROIDS, V49, P213
   NAKAJIMA T, 1990, BIOCHEM PHARMACOL, V40, P1255
   NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1
   OKEY AB, 1990, PHARMACOL THERAPEUT, V45, P241, DOI 10.1016/0163-7258(90)90030-6
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   PINEAU T, 1991, EUR J BIOCHEM, V197, P145, DOI 10.1111/j.1432-1033.1991.tb15893.x
   POHL RJ, 1980, ANAL BIOCHEM, V107, P150, DOI 10.1016/0003-2697(80)90505-9
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   SCHWEIZER M, 1991, ARCH BIOCHEM BIOPHYS, V288, P64, DOI 10.1016/0003-9861(91)90165-F
   SKETT P, 1988, PHARMACOL THERAPEUT, V38, P269, DOI 10.1016/0163-7258(88)90007-1
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023
   YANG CS, 1988, PHARMACOL THERAPEUT, V38, P53, DOI 10.1016/0163-7258(88)90102-7
   ZAPHIROPOULOS PG, 1989, TRENDS PHARMACOL SCI, V10, P149, DOI 10.1016/0165-6147(89)90167-3
NR 25
TC 7
Z9 8
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD NOV 25
PY 1994
VL 77
IS 1
BP 1
EP 11
DI 10.1016/0047-6374(94)90042-6
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA PZ472
UT WOS:A1994PZ47200001
PM 7731269
DA 2024-02-19
ER

PT J
AU Braidy, N
   Guillemin, GJ
   Mansour, H
   Chan-Ling, T
   Grant, R
AF Braidy, Nady
   Guillemin, Gilles J.
   Mansour, Hussein
   Chan-Ling, Tailoi
   Grant, Ross
TI Changes in kynurenine pathway metabolism in the brain, liver and kidney
   of aged female Wistar rats
SO FEBS JOURNAL
LA English
DT Article
DE aging; indoleamine 2; 3-dioxygenase (IDO); kynurenine pathway; NAD;
   tryptophan
ID NICOTINAMIDE ADENINE-DINUCLEOTIDE; EXCITOTOXIN QUINOLINIC ACID;
   CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; INDOLEAMINE 2,3-DIOXYGENASE;
   TRYPTOPHAN-METABOLISM; LIFE-SPAN; IMMUNE ACTIVATION; DRUG DISCOVERY;
   HUMAN NEURONS
AB The kynurenine pathway of tryptophan catabolism plays an important role in several biological systems affected by aging. We quantified tryptophan and its metabolites kynurenine (KYN), kynurenine acid (KYNA), picolinic acid (PIC) and quinolinic acid (QUIN), and activity of the kynurenine pathway enzymes indoleamine 2,3-dioxygenase (IDO), tryptophan 2,3-dioxygenase (TDO) and quinolinic acid phosphoribosyltransferase (QPRTase), in the brain, liver and kidney of young, middle-aged and old female Wistar rats. Tryptophan levels and TDO activity decreased in all tissues with age. In contrast, brain IDO activity increased with age, while liver and kidney IDO activity decreased with age. The levels of KYN, KYNA, QUIN and PIC in brain all increased with age, while the levels of KYN in the liver and kidney showed a tendency to decrease. The levels of KYNA in the liver did not change, but the levels of KYNA in the kidney increased. The levels of PIC and QUIN increased significantly in the liver but showed a tendency to decrease in the kidney. QPRTase activity in both brain and liver decreased with age but was elevated in the kidney in middle-aged (12-month-old) rats. These age-associated changes in tryptophan metabolism have the potential to impact upon major biological processes, including lymphocyte function, pyridine (NAD(P)(H)) synthesis and N-methyl-d-aspartate (NMDA)-mediated synaptic transmission, and may therefore contribute to several degenerative changes of the elderly.
C1 [Guillemin, Gilles J.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia.
   [Mansour, Hussein; Chan-Ling, Tailoi] Univ Sydney, Sch Med Sci, Retinal & Dev Neurobiol Lab, Discipline Anat & Histol, Sydney, NSW 2006, Australia.
   [Grant, Ross] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia.
   [Braidy, Nady; Guillemin, Gilles J.; Grant, Ross] Univ New S Wales, Fac Med, Dept Pharmacol, Sydney, NSW 2052, Australia.
C3 University of Sydney; Sydney Adventist Hospital; University of New South
   Wales Sydney
RP Grant, R (corresponding author), Univ New S Wales, Fac Med, Dept Pharmacol, Sydney, NSW 2052, Australia.
EM r.grant@unsw.edu.au
RI Mansour, Hussein/S-2883-2019; Chan-Ling, Tailoi/A-2177-2008; Chan-Ling,
   Tailoi/X-2718-2019; Grant, Ross/H-1805-2015; Braidy, Nady/G-4928-2012;
   GUILLEMIN, Gilles J./C-3878-2015
OI Mansour, Hussein/0000-0002-9559-3229; Chan-Ling,
   Tailoi/0000-0002-8225-3671; GUILLEMIN, Gilles J./0000-0001-8105-4470;
   Braidy, Nady/0000-0002-0497-5572
FU National Health and Medical Research Council of Australia [571100]; NSW
   Optometrist Registration Board; Rebecca Cooper Medical Research
   Foundation (Sydney, Australia); University of New South Wales;
   University of Sydney Medical Foundation/Bluesand Research Scholarship;
   National Health and Medical Research Council of Australia [571100]
   Funding Source: NHMRC
FX This work was supported by grants to Prof Tailoi Chan-Ling from the
   National Health and Medical Research Council of Australia, the National
   Health and Medical Research Council of Australia Principal Research
   Fellowship (571100), and the NSW Optometrist Registration Board Best
   Practice Grant. Dr Gilles J Guillemin and Professor Tailoi Chan-Ling
   also received support from the Rebecca Cooper Medical Research
   Foundation (Sydney, Australia). Nady Braidy is the recipient of an
   Australian Postgraduate Award at the University of New South Wales.
   Hussein Mansour is the recipient of a University of Sydney Medical
   Foundation/Bluesand Research Scholarship. The authors like to thank the
   staff from the Bioanalytical Mass Spectrometry Facility at the
   University of New South Wales for assistance with GC-MS experiments.
CR Baran H, 1999, J NEURAL TRANSM, V106, P165, DOI 10.1007/s007020050149
   Bari F, 2006, BRAIN RES, V1069, P39, DOI 10.1016/j.brainres.2005.11.033
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   BEAL MF, 1991, J NEUROSCI, V11, P1649
   BEAL MF, 1992, DEV BRAIN RES, V68, P136
   BENINGER RJ, 1994, NEUROSCIENCE, V61, P603, DOI 10.1016/0306-4522(94)90438-3
   Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007
   Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200
   Blagosklonny MV, 2007, DRUG DISCOV TODAY, V12, P218, DOI 10.1016/j.drudis.2007.01.004
   Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785
   Boeck CR, 2004, EPILEPSIA, V45, P745, DOI 10.1111/j.0013-9580.2004.65203.x
   Braidy N, 2009, INT J TRYPTOPHAN RES, V2, P61
   Braidy N, 2009, NEUROTOX RES, V16, P77, DOI 10.1007/s12640-009-9051-z
   BURKE F, 1995, INT J CANCER, V60, P115, DOI 10.1002/ijc.2910600117
   Bürkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x
   Bürkle A, 2004, EXP GERONTOL, V39, P1599, DOI 10.1016/j.exger.2004.07.010
   COLEMAN PD, 1989, NEUROBIOL AGING, V10, P115, DOI 10.1016/0197-4580(89)90019-5
   COLLIER TJ, 1991, NEUROBIOL AGING, V12, P685, DOI 10.1016/0197-4580(91)90122-Z
   Comai S, 2005, CLIN CHIM ACTA, V360, P67, DOI 10.1016/j.cccn.2005.04.013
   CREPALDI G, 1975, ACTA VITAMINOL ENZYM, V29, P140
   DECASTRO FT, 1956, J AM CHEM SOC, V78, P2904, DOI 10.1021/ja01593a069
   FEIGELSON P, 1961, J BIOL CHEM, V236, P153
   Frick B, 2004, CLIN BIOCHEM, V37, P684, DOI 10.1016/j.clinbiochem.2004.02.007
   Frumento Guido, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P223, DOI 10.2174/187153006778250019
   FUCHS D, 1988, ANN NEUROL, V24, P289, DOI 10.1002/ana.410240227
   Fujigaki S, 2001, EUR J IMMUNOL, V31, P2313, DOI 10.1002/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S
   GRAMSBERGEN JBP, 1992, BRAIN RES, V588, P1, DOI 10.1016/0006-8993(92)91337-E
   Grant RS, 2000, J VIROL, V74, P4110, DOI 10.1128/JVI.74.9.4110-4115.2000
   Guillemin G.J., 2001, J NEUROIMMUNOL, V118, P112
   Guillemin G.J., 2007, INT C SERIES, P324, DOI DOI 10.1016/J.ICS.2007.07.031
   Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007
   Guillemin GJ, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-16
   Guillemin GJ, 2005, NEUROPATH APPL NEURO, V31, P395, DOI 10.1111/j.1365-2990.2005.00655.x
   Guillemin GJ, 2005, NEUROTOX RES, V7, P103, DOI 10.1007/BF03033781
   Guillemin GJ, 2002, REDOX REP, V7, P199, DOI 10.1179/135100002125000550
   Guillemin GJ, 2001, J NEUROIMMUNOL, V118, P336
   Guillemin GJ., 2007, Int Congress Ser, V1304, P404, DOI [10.1016/j.ics.2007.07.012, DOI 10.1016/J.ICS.2007.07.012]
   Hansson E, 2000, NEUROCHEM INT, V37, P317, DOI 10.1016/S0197-0186(00)00033-4
   Hartai Z, 2007, NEUROCHEM INT, V50, P308, DOI 10.1016/j.neuint.2006.08.012
   HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249
   HEYES MP, 1988, J CHROMATOGR-BIOMED, V428, P340, DOI 10.1016/S0378-4347(00)83925-0
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   KAPOOR V, 1994, CLIN EXP PHARMACOL P, V21, P891, DOI 10.1111/j.1440-1681.1994.tb02460.x
   Kepplinger B, 2005, NEUROSIGNALS, V14, P126, DOI 10.1159/000086295
   Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695
   Kiefmann R, 2004, INTENS CARE MED, V30, P1421, DOI 10.1007/s00134-004-2301-x
   Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758
   Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690
   Lamming DW, 2004, MOL MICROBIOL, V53, P1003, DOI 10.1111/j.1365-2958.2004.04209.x
   Leung JC, 2004, KIDNEY INT, V66, P167, DOI 10.1111/j.1523-1755.2004.00718.x
   Lin H, 2007, ORG BIOMOL CHEM, V5, P2541, DOI 10.1039/b706887e
   Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x
   Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5
   Magni G, 1999, ADV ENZYMOL RELAT AR, V73, pxi
   MORONI F, 1984, NEUROSCI LETT, V47, P51, DOI 10.1016/0304-3940(84)90385-9
   OWENS MJ, 1994, CLIN CHEM, V40, P288
   Oxenkrug G, 2010, J NEURAL TRANSM, V117, P23, DOI 10.1007/s00702-009-0341-7
   PATNEAU DK, 1990, J NEUROSCI, V10, P2385
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344
   Ruddick Jon P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000068
   Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019
   Smythe GA, 2002, ANAL BIOCHEM, V301, P21, DOI 10.1006/abio.2001.5490
   STONE TW, 1985, NEUROSCIENCE, V15, P597, DOI 10.1016/0306-4522(85)90063-6
   Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870
   TAKIKAWA O, 1986, J BIOL CHEM, V261, P3648
   Widner B, 1999, ADV EXP MED BIOL, V467, P133
   Widner B, 2000, J NEURAL TRANSM, V107, P343, DOI 10.1007/s007020050029
   Ying WH, 2007, FRONT BIOSCI-LANDMRK, V12, P1863, DOI 10.2741/2194
   Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038
NR 70
TC 82
Z9 90
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD NOV
PY 2011
VL 278
IS 22
BP 4425
EP 4434
DI 10.1111/j.1742-4658.2011.08366.x
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 849WI
UT WOS:000297155600025
PM 22032336
DA 2024-02-19
ER

PT J
AU Li, C
   He, JC
   Yang, Y
   Gou, YT
   Wang, ZY
   Chen, H
   Zhao, X
AF Li, Chong
   He, Jianchun
   Yang, Yue
   Gou, Yuting
   Wang, Zhiying
   Chen, Hong
   Zhao, Xin
TI White Tip Silver Needle (Slightly Fermented White Tea) Flavonoids Help
   Prevent Aging via Antioxidative and Anti-Inflammatory Effects
SO DRUG DESIGN DEVELOPMENT AND THERAPY
LA English
DT Article
DE white tip silver needle flavonoids; D-galactose/lipopolysaccharide;
   oxidation; inflammation
ID OXIDATIVE STRESS; NITRIC-OXIDE; QUERCETIN; TOXICITY; GREEN; CELLS; ACID;
   MICE
AB Aim: White tip silver needle, a slightly fermented white tea, is abundant in flavonoids, and it has great significance in terms of D-galactose/lipopolysaccharide-induced aging in mice.
   Methods: We analyzed the antioxidant capacity of white tip silver needle flavonoids (WTSNF) in vitro, assessed the effects of WTSNF on organ indexes, pathological changes, liver function indexes, biochemical indicators, molecular biological indicators, and genes related to oxidation and inflammation.
   Results: Ultra-high performance liquid chromatography-tandem mass spectrometry results showed that WTSNF contained baicalin, kaempferol, kaempferide, quercetin, isorhamnetin, lespenephryl, and rutin. WTSNF showed strong scavenging ability for both 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) free radicals. Pathological analysis results showed that WTSNF reduced liver, kidney, and lung damage in mice with induced aging. In the serum and liver tissue, WTSNF effectively increased the antioxidant-related levels of superoxide dismutase, catalase, glutathione peroxidase, glutathione, and total antioxidant capacity and reduced the levels of aspartate aminotransferase, alanine aminotransferase, malondialdehyde and nitric oxide. WTSNF also reduced the inflammation-related levels of interleukin-6, interleukin-1 beta, tumor necrosis factor alpha (TNF alpha), and interferon gamma (IFN-gamma) and increased the levels of interleukin-10 and interleukin-12. Furthermore, WTSNF upregulated the mRNA expression levels of cupro-zinc superoxide dismutase, manganese superoxide dismutase, catalase, glutathione peroxidase, interleukin-10, neuronal nitric oxide synthase, endothelial nitric oxide synthase, nuclear factor erythroid 2-related factor, heme oxygenase 1, NAD(P)H dehydrogenase [quinone] 1, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (I kappa B-alpha), and thioredoxin, while it downregulated the mRNA expression levels of interleukin-6, interleukin-18, interleukin-1 beta, TNF alpha, IFN-gamma, inducible nitric oxide synthase, cyclooxygenase-2, and nuclear factor kappa-light chain-enhancer of activated B cells (NF-kappa B).
   Conclusion: WTSNF is a high-quality natural product with antioxidative and anti-inflammatory properties that can inhibits D-galactose/lipopolysaccharide-induced aging in mice.
C1 [Li, Chong; Yang, Yue; Gou, Yuting; Zhao, Xin] Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.
   [Li, Chong; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing 400067, Peoples R China.
   [Li, Chong; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Lab Res & Dev Funct Food, Chongqing 400067, Peoples R China.
   [He, Jianchun] Chongqing Dazu Dist Peoples Hosp, Dept Lab Med, Chongqing 402360, Peoples R China.
   [Yang, Yue; Gou, Yuting] Chongqing Univ Educ, Coll Biol & Chem Engn, Chongqing 400067, Peoples R China.
   [Wang, Zhiying] Heilongjiang Univ Tradit Chinese Med, Sch Pharm, Harbin 150040, Peoples R China.
   [Chen, Hong] Chongqing Tradit Chinese Med Hosp, Dept Orthopaed Surg 1, Chongqing 400021, Peoples R China.
C3 Chongqing University of Education; Chongqing University of Education;
   Chongqing University of Education; Chongqing University of Education;
   Heilongjiang University of Chinese Medicine
RP Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing 400067, Peoples R China.; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Engn Lab Res & Dev Funct Food, Chongqing 400067, Peoples R China.; Chen, H (corresponding author), Chongqing Tradit Chinese Med Hosp, Dept Orthopaed Surg 1, Chongqing 400021, Peoples R China.
EM 1528779302@qq.com; zhaoxin@cque.edu.cn
FU Chongqing University Innovation Research Group Project [CXQTP20033];
   Science and Technology Project of the Chongqing Education Commission
   [KJQN202001604]; Chongqing Science and Health Joint Medical Research
   Project, China [2020MSXM072]
FX This research was funded by the Chongqing University Innovation Research
   Group Project (CXQTP20033), the Science and Technology Project of the
   Chongqing Education Commission (KJQN202001604) and Chongqing Science and
   Health Joint Medical Research Project (2020MSXM072), China.
CR Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593
   Almajano MP, 2011, NEUROTOX RES, V20, P372, DOI 10.1007/s12640-011-9252-0
   BAI SC, 1992, FISH PHYSIOL BIOCHEM, V10, P183, DOI 10.1007/BF00004512
   Bhandari V, 2006, P NATL ACAD SCI USA, V103, P11021, DOI 10.1073/pnas.0601057103
   Biharee A, 2020, FITOTERAPIA, V146, DOI 10.1016/j.fitote.2020.104720
   Boesch-Saadatmandi C, 2011, J NUTR BIOCHEM, V22, P293, DOI 10.1016/j.jnutbio.2010.02.008
   Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008
   Calderón-Montaño JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335
   Carloni P, 2013, FOOD RES INT, V53, P900, DOI 10.1016/j.foodres.2012.07.057
   CeballosPicot I, 1996, FREE RADICAL BIO MED, V21, P845, DOI 10.1016/0891-5849(96)00233-X
   Chaves-López C, 2018, FOOD FUNCT, V9, P2725, DOI [10.1039/c7fo01542a, 10.1039/C7FO01542A]
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Cui WJ, 2020, NAT PROD COMMUN, V15, DOI 10.1177/1934578X20915018
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   Donadu M, 2018, J INFECT DEV COUNTR, V12, P9, DOI 10.3855/jidc.9920
   Donadu MG, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9060334
   FOX P, 1989, MILBANK Q, V67, P58, DOI 10.2307/3350070
   Fukao T, 2000, J IMMUNOL, V164, P64, DOI 10.4049/jimmunol.164.1.64
   Gau H P, 1969, Med Welt, V44, P2426
   Hardbower DM, 2013, GUT MICROBES, V4, P475, DOI 10.4161/gmic.25583
   Herrmann K., 1976, Journal of Food Technology, V11, P433, DOI 10.1108/09566160010378107
   Hilal Y, 2007, J VERBRAUCH LEBENSM, V2, P414, DOI 10.1007/s00003-007-0250-3
   Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535
   Felices MJ, 2019, J PHYSIOL BIOCHEM, V75, P329, DOI 10.1007/s13105-019-00682-8
   Lawrence Toby, 2009, Cold Spring Harb Perspect Biol, V1, pa001651, DOI 10.1101/cshperspect.a001651
   Le NT, 2020, J INFECT DEV COUNTR, V14, P1054, DOI 10.3855/jidc.12469
   Li C, 2020, RSC ADV, V10, P34276, DOI 10.1039/d0ra06977a
   Li C, 2019, J FOOD QUALITY, V2019, DOI 10.1155/2019/2465341
   MIHAS AA, 1981, J MED, V12, P237
   MONK LS, 1989, PHYSIOL PLANTARUM, V76, P456, DOI 10.1111/j.1399-3054.1989.tb06219.x
   Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016
   Olatunji OJ, 2017, BIOMED PHARMACOTHER, V93, P895, DOI 10.1016/j.biopha.2017.07.013
   Ozer JS, 2010, REGUL TOXICOL PHARM, V56, P237, DOI 10.1016/j.yrtph.2009.11.001
   Santana-Rios G, 2001, MUTAT RES-GEN TOX EN, V495, P61, DOI 10.1016/S1383-5718(01)00200-5
   Shen YC, 2003, EUR J PHARMACOL, V465, P171, DOI 10.1016/S0014-2999(03)01378-5
   Tambewagh UU, 2017, INT IMMUNOPHARMACOL, V52, P110, DOI 10.1016/j.intimp.2017.09.001
   Thaipong K, 2006, J FOOD COMPOS ANAL, V19, P669, DOI 10.1016/j.jfca.2006.01.003
   Wang F, 2017, CELL REP, V19, P2331, DOI 10.1016/j.celrep.2017.05.065
   [汪光华 Wang Guanghua], 2017, [食品与机械, Food and Machinery], V33, P168
   Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025
   Zhang LG, 2019, METAB BRAIN DIS, V34, P1325, DOI 10.1007/s11011-019-00440-1
NR 43
TC 7
Z9 8
U1 3
U2 19
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1177-8881
J9 DRUG DES DEV THER
JI Drug Des. Dev. Ther.
PY 2021
VL 15
BP 1441
EP 1457
DI 10.2147/DDDT.S304885
PG 17
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA RN0RD
UT WOS:000640061800001
PM 33833503
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU WOODHOUSE, K
   HERD, B
AF WOODHOUSE, K
   HERD, B
TI THE EFFECT OF AGE AND GENDER ON GLUCURONIDATION AND SULFATION IN
   RAT-LIVER - A STUDY USING PARACETAMOL AS A MODEL SUBSTRATE
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE AGING; PARACETAMOL; METABOLISM
ID DRUG DISPOSITION; METABOLISM; ACETAMINOPHEN
AB The effect of age and sex on glucuronidation and sulphation was studied in vitro in rat liver fractions, using paracetamol (acetaminophen) as substrate. Glucuronidation was more rapid in females; sulphation in males. Age was not a determinant of either metabolic pathway in either sex.
C1 UNIV NEWCASTLE UPON TYNE,DEPT MED GERIATR,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND.
   UNIV NEWCASTLE UPON TYNE,WOLFSON UNIT CLIN PHARMACOL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND.
C3 Newcastle University - UK; Newcastle University - UK
RP WOODHOUSE, K (corresponding author), UNIV WALES COLL CARDIFF,COLL MED,CARDIFF ROYAL INFIRM W WING,NEWPORT RD,CARDIFF CF2 1SZ,WALES.
CR ALI M, 1979, 1979 P BPS, P498
   BORGHOFF SJ, 1985, DRUG METAB DISPOS, V13, P62
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1225, DOI 10.3109/00498258809042246
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V237, P107
   GREEN MD, 1981, LIFE SCI, V29, P2421, DOI 10.1016/0024-3205(81)90479-3
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   HOWIE D, 1977, J PHARM PHARMACOL, V29, P235, DOI 10.1111/j.2042-7158.1977.tb11295.x
   KNOX JH, 1977, J CHROMATOGR, V149, P297
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARIA CS, 1988, MECH AGEING DEV, V44, P115
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   SWEENY DJ, 1985, DRUG METAB DISPOS, V13, P377
   WOODHOUSE KW, 1990, BRIT MED BULL, V46, P22, DOI 10.1093/oxfordjournals.bmb.a072387
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
   1984, J R COLL PHYSICIANS, V18, P7
NR 15
TC 6
Z9 6
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAR-APR
PY 1993
VL 16
IS 2
BP 111
EP 115
DI 10.1016/0167-4943(93)90002-Y
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LL395
UT WOS:A1993LL39500002
PM 15374341
DA 2024-02-19
ER

PT J
AU Caramés, B
   Olmer, M
   Kiosses, WB
   Lotz, MK
AF Carames, Beatriz
   Olmer, Merissa
   Kiosses, William B.
   Lotz, Martin K.
TI The Relationship of Autophagy Defects to Cartilage Damage During Joint
   Aging in a Mouse Model
SO ARTHRITIS & RHEUMATOLOGY
LA English
DT Article
ID ARTICULAR-CARTILAGE; EXPERIMENTAL OSTEOARTHRITIS; MAMMALIAN AUTOPHAGY;
   CELL-DEATH; RAPAMYCIN; MICE; DISEASE; HEALTH; HISTOPATHOLOGY;
   HOMEOSTASIS
AB Objective. Aging is a main risk factor for osteo arthritis (OA), the most prevalent musculoskeletal disorder. Defects in autophagy, an essential cellular homeostasis mechanism, have recently been observed in OA articular cartilage. The objectives of this study were to establish the constitutive level of autophagy activation in normal cartilage and to monitor the temporal relationship between changes in autophagy and aging-related degradation of cartilage in a mouse model.
   Methods. In GFP-LC3-transgenic mice, green fluo rescent protein (GFP)-light chain 3 (LC3) is ubiquitously expressed, and the accumulation of GFP puncta, repre senting autophagosomes, was quantified by confocal microscopy as a measure of autophagy activation. Expression of the autophagy proteins autophagy-related protein 5 (ATG-5) and microtubule-associated protein 1 light chain 3 (LC3) was analyzed by immunohistochemistry. Cartilage cellularity, apoptotic cell death, and cartilage structural damage and changes in synovium and bone were examined by histology and immunohistochemistry.
   Results. Basal autophagy activation was detected in liver and knee articular cartilage from young (6-month-old) mice, with higher levels in cartilage than in liver in the same animals. In 28-month-old mice, there was a statistically significant reduction in the total number of autophagic vesicles per cell (P<0.01) and in the total area of vesicles per cell (P<0.01) in the articular cartilage as compared to that from young 6-month-old mice. With increasing age, the expression of ATG-5 and LC3 decreased, and this was followed by a reduction in cartilage cellularity and an increase in the apoptosis marker poly(ADP-ribose) polymerase p85. Cartilage structural damage progressed in an age-dependent manner subsequent to the autophagy changes.
   Conclusion. Autophagy is constitutively activated in normal cartilage. This is compromised with aging and precedes cartilage cell death and structural damage.
C1 [Carames, Beatriz; Olmer, Merissa; Kiosses, William B.; Lotz, Martin K.] Scripps Res Inst, La Jolla, CA 92037 USA.
   [Carames, Beatriz] SER GAS, Complexo Hosp Univ A Coruna, Inst Invest Biomed A Coruna, La Coruna, Spain.
   [Carames, Beatriz] Univ A Coruna, La Coruna, Spain.
C3 Scripps Research Institute; Complejo Hospitalario Universitario A
   Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de
   A Coruna (INIBIC); Universidade da Coruna
RP Lotz, MK (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, MEM-161,10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.
EM mlotz@scripps.edu
OI Carames, Beatriz/0000-0002-8353-6526
FU NIH [AG-007996]; Sam and Rose Stein Endowment Fund; Miguel Servet
   Program, Instituto de Salud Carlos III [CP11/00095]
FX Supported by the NIH (grant AG-007996) and the Sam and Rose Stein
   Endowment Fund. Dr. Carames' work was supported by the Miguel Servet
   Program, Instituto de Salud Carlos III (grant CP11/00095).
CR Akasaki Y, 2014, OSTEOARTHR CARTILAGE, V22, P162, DOI 10.1016/j.joca.2013.11.004
   Alirezaei M, 2010, AUTOPHAGY, V6, P702, DOI 10.4161/auto.6.6.12376
   Bohensky J, 2007, AUTOPHAGY, V3, P207, DOI 10.4161/auto.3708
   Bohensky J, 2010, PEDIATR NEPHROL, V25, P633, DOI 10.1007/s00467-009-1310-y
   Bohensky J, 2009, ARTHRITIS RHEUM-US, V60, P1406, DOI 10.1002/art.24444
   Caramés B, 2012, ARTHRITIS RHEUM-US, V64, P1182, DOI 10.1002/art.33444
   Caramés B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557
   Caramés B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305
   Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025
   Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357
   Krenn V, 2002, PATHOL RES PRACT, V198, P317, DOI 10.1078/0344-0338-5710261
   Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529
   Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453
   Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023
   Lotz MK, 2011, NAT REV RHEUMATOL, V7, P579, DOI 10.1038/nrrheum.2011.109
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Mahr S, 2003, ANN RHEUM DIS, V62, P1234, DOI 10.1136/ard.2002.005041
   Matsuzaki T, 2014, BIOMATERIALS, V35, P9904, DOI 10.1016/j.biomaterials.2014.08.041
   McNulty MA, 2012, OSTEOARTHR CARTILAGE, V20, P949, DOI 10.1016/j.joca.2012.05.001
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3
   Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049
   Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021
   Nguyen QT, 2010, J BIOMECH, V43, P1787, DOI 10.1016/j.jbiomech.2010.02.014
   Pan T, 2009, NEUROSCIENCE, V164, P541, DOI 10.1016/j.neuroscience.2009.08.014
   Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146
   Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979
   Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P1181, DOI 10.1073/pnas.0806062106
   Terkeltaub R, 2011, ARTHRITIS RHEUM-US, V63, P1928, DOI 10.1002/art.30333
   Vellai T, 2009, TRENDS CELL BIOL, V19, P487, DOI 10.1016/j.tcb.2009.07.007
   Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215
   Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153
   Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang Y, 2014, ANN RHEUM DIS
   Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]
   Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093
NR 42
TC 151
Z9 168
U1 1
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2326-5191
EI 2326-5205
J9 ARTHRITIS RHEUMATOL
JI Arthritis Rheumatol.
PD JUN
PY 2015
VL 67
IS 6
BP 1568
EP 1576
DI 10.1002/art.39073
PG 9
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA CJ2QA
UT WOS:000355328400019
PM 25708836
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Wang, J
   Clauson, CL
   Robbins, PD
   Niedernhofer, LJ
   Wang, YS
AF Wang, Jin
   Clauson, Cheryl L.
   Robbins, Paul D.
   Niedernhofer, Laura J.
   Wang, Yinsheng
TI The oxidative DNA lesions 8,5'-cyclopurines accumulate with aging in a
   tissue-specific manner
SO AGING CELL
LA English
DT Article
DE aging; progeria; DNA damage; nucleotide excision repair; oxidative DNA
   lesion
ID HUMAN-CELLS; REPAIR ENDONUCLEASE; MAMMALIAN-CELLS;
   8-OXO-7,8-DIHYDROGUANINE; PATHWAY; DAMAGE; MOUSE
AB Accumulation of DNA damage is implicated in aging. This is supported by the fact that inherited defects in DNA repair can cause accelerated aging of tissues. However, clear-cut evidence for DNA damage accumulation in old age is lacking. Numerous studies report measurement of DNA damage in nuclear and mitochondrial DNA from tissues of young and old organisms, with variable outcomes. Variability results from genetic differences between specimens or the instability of some DNA lesions. To control these variables and test the hypothesis that elderly organisms have more oxidative DNA damage than young organisms, we measured 8,5'-cyclopurine-2'-deoxynucleosides (cPu), which are relatively stable, in tissues of young and old wild-type and congenic progeroid mice. We found that cPu accumulate spontaneously in the nuclear DNA of wild-type mice with age and to a greater extent in DNA repairdeficient progeroid mice, with a similar tissue-specific pattern (liver > kidney > brain). These data, generated under conditions where genetic and environmental variables are controlled, provide strong evidence that DNA repair mechanisms are inadequate to clear endogenous lesions over the lifespan of mammals. The similar, although exaggerated, results obtained from progeroid, DNA repairdeficient mice and old normal mice support the conclusion that DNA damage accumulates with, and likely contributes to, aging.
C1 [Wang, Jin; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.
   [Clauson, Cheryl L.; Robbins, Paul D.; Niedernhofer, Laura J.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA.
C3 University of California System; University of California Riverside;
   Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh
RP Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.
EM yinsheng.wang@ucr.edu
RI Wang, Yin/HCI-9352-2022; Wang, Jin/AAE-3809-2022; zhang,
   shuai/IVU-7877-2023
OI Wang, Jin/0000-0001-5511-3983; 
FU National Institutes of Health (NIH) [R01CA101864, R01ES016114,
   P30AG024827, P30CA047904]; Hartwell Foundation
FX This work was supported by the National Institutes of Health (NIH)
   (R01CA101864, R01ES016114, P30AG024827, P30CA047904). C. L. C. is
   supported by a Biomedical Research Fellowship from the Hartwell
   Foundation.
CR Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200
   Chatgilialoglu C, 2011, CHEM SOC REV, V40, P1368, DOI 10.1039/c0cs00061b
   Collins AR, 2004, ARCH BIOCHEM BIOPHYS, V423, P57, DOI 10.1016/j.abb.2003.12.022
   Gregg SQ, 2011, DNA REPAIR, V10, P781, DOI 10.1016/j.dnarep.2011.04.026
   Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161
   Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005
   Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597
   Loft S, 2012, ARCH BIOCHEM BIOPHYS, V518, P142, DOI 10.1016/j.abb.2011.12.026
   Marietta C, 2007, EMBO REP, V8, P388, DOI 10.1038/sj.embor.7400932
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   OCALLAGHAN JP, 1991, NEUROBIOL AGING, V12, P171, DOI 10.1016/0197-4580(91)90057-Q
   Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5
   Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s
   Yuan BF, 2011, NUCLEIC ACIDS RES, V39, P5945, DOI 10.1093/nar/gkr159
NR 16
TC 115
Z9 132
U1 0
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
J9 AGING CELL
JI Aging Cell
PD AUG
PY 2012
VL 11
IS 4
BP 714
EP 716
DI 10.1111/j.1474-9726.2012.00828.x
PG 3
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 973ZY
UT WOS:000306400600018
PM 22530741
OA hybrid, Green Accepted
DA 2024-02-19
ER

PT J
AU Huang, CC
   Tsai, SC
   Lin, WT
AF Huang, Chi-Chang
   Tsai, Shiow-Chwen
   Lin, Wan-Teng
TI Potential ergogenic effects of L-arginine against oxidative and
   inflammatory stress induced by acute exercise in aging rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE L-arginine; exhaustive exercise; oxidative stress; inflammation; aging
ID XANTHINE-OXIDASE; SKELETAL-MUSCLE; NITRIC-OXIDE; EXHAUSTIVE EXERCISE;
   REACTIVE OXYGEN; ANTIOXIDANT SYSTEM; VITAMIN-E; HEART; MYELOPEROXIDASE;
   TISSUE
AB In this study, we report protective effects of dietary L-arginine (L-Arg) supplementation against oxidative stress and inflammation in aging rats during exhaustive exercise. Thirty 18-month-old male Sprague-Dawley rats were randomly divided into four groups: sedentary control (SC); sedentary control with L-Arg treatment (SC+Arg); exhaustive exercise (E); and exhaustive exercise with L-Arg treatment (E + Arg). Rats in groups SC + Arg and E + Arg received a 2% L-Arg diet. Rats in groups E and E + Arg performed an exhaustive running test on a treadmill. The mean duration of exercise differed significantly between groups E and E + Arg (51 +/- 6 versus 63 +/- 3 min). Results showed significant increases in xanthine oxidase (XO) and myeloperoxidase (MPO) activities and in lipid peroxidation end-product (malondialdehyde, MDA) levels of myocardial, muscular, hepatic, pulmonary, and renal tissues of exercised rats compared with SC and SC + Arg rats. The increased XO and MPO activities and MDA levels significantly decreased in exercised rats that were fed a diet supplemented with L-Arg. We also found that L-Arg supplementation prevented exhaustive exercise-induced elevations of plasma aminotransferase activity, and lactate and uric acid levels in aging rats. These findings suggest that L-Arg supplementation enhances exercise capacity and protects against oxidative damage and inflammatory responses caused by exhaustive exercise in aging rats. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Lin, Wan-Teng] Tunghai Univ, Dept Hospitality Management, Coll Agr, Taichung 40704, Taiwan.
   [Huang, Chi-Chang] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.
   [Tsai, Shiow-Chwen] Shin Kong Wu Ho Su Mem Hosp, Dept Med Educ & Res, Taipei, Taiwan.
   [Lin, Wan-Teng] Fu Jen Catholic Univ, Dept Nutr Sci, Taipei, Taiwan.
C3 Tunghai University; Academia Sinica - Taiwan; Shin Kong Wu Ho Su
   Memorial Hospital; Fu Jen Catholic University
RP Lin, WT (corresponding author), Tunghai Univ, Dept Hospitality Management, Coll Agr, Taichung 40704, Taiwan.
EM 040770@thu.edu.tw
RI Huang, Chi-Chang/A-3280-2013
OI Lin, Wan-Teng/0000-0001-7700-3398; Huang, Chi-Chang/0000-0003-1446-6787
CR Ashton T, 1998, EUR J APPL PHYSIOL O, V77, P498, DOI 10.1007/s004210050366
   Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   Belcastro AN, 1996, J APPL PHYSIOL, V80, P1331, DOI 10.1152/jappl.1996.80.4.1331
   BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009
   Campbell WW, 2004, NUTRITION, V20, P603, DOI 10.1016/j.nut.2004.04.004
   Clarkson PM, 2000, AM J CLIN NUTR, V72, p637S, DOI 10.1093/ajcn/72.2.637S
   Cuzzolin L, 2000, INT J SPORTS MED, V21, P289, DOI 10.1055/s-2000-13308
   de Oliveira SL, 2003, BRIT J NUTR, V89, P89, DOI 10.1079/BJN2002749
   FIELDING RA, 1993, AM J PHYSIOL, V265, pR166, DOI 10.1152/ajpregu.1993.265.1.R166
   FrankiewiczJozko A, 1996, EUR J APPL PHYSIOL, V74, P470
   FUKAHORI M, 1994, FREE RADICAL RES, V21, P203, DOI 10.3109/10715769409056572
   Gomez-Cabrera MC, 2005, J PHYSIOL-LONDON, V567, P113, DOI 10.1113/jphysiol.2004.080564
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   HASSOUN PM, 1995, AM J PHYSIOL-LUNG C, V268, pL809, DOI 10.1152/ajplung.1995.268.5.L809
   Hellsten Y, 1997, J PHYSIOL-LONDON, V498, P239, DOI 10.1113/jphysiol.1997.sp021855
   JI LL, 1991, AM J PHYSIOL, V261, pR386, DOI 10.1152/ajpregu.1991.261.2.R386
   Ji LL, 2001, ANN NY ACAD SCI, V928, P236
   JI LL, 1994, BIOCHEM PHARMACOL, V47, P877
   Jolitha AB, 2006, EXP GERONTOL, V41, P753, DOI 10.1016/j.exger.2006.04.007
   Judge AR, 2004, AM J PHYSIOL-HEART C, V286, pH252, DOI 10.1152/ajpheart.00684.2003
   Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006
   Kakarla P, 2005, J EXP ZOOL PART A, V303A, P203, DOI 10.1002/jez.a.149
   KUMAR CT, 1992, MOL CELL BIOCHEM, V111, P109
   Lewis B, 2000, J NUTR, V130, P1827
   Lin WT, 2006, BRIT J NUTR, V95, P67, DOI 10.1079/BJN20051602
   Lin WT, 2005, ACTA PHARMACOL SIN, V26, P992, DOI 10.1111/j.1745-7254.2005.00155.x
   Maxwell AJ, 2001, J APPL PHYSIOL, V90, P933, DOI 10.1152/jappl.2001.90.3.933
   McConell GK, 2006, AM J PHYSIOL-ENDOC M, V290, pE60, DOI 10.1152/ajpendo.00263.2005
   MCCORD JM, 1985, NEW ENGL J MED, V312, P159
   Morozov VI, 2003, EUR J APPL PHYSIOL, V89, P257, DOI 10.1007/s00421-002-0755-5
   Morozov VI, 2006, EUR J APPL PHYSIOL, V97, P716, DOI 10.1007/s00421-006-0193-x
   Navarro-Arévalo A, 1998, MECH AGEING DEV, V104, P91, DOI 10.1016/S0047-6374(98)00061-X
   Paddon-Jones D, 2004, J NUTR, V134, p2888S, DOI 10.1093/jn/134.10.2888S
   Radák Z, 1998, PFLUG ARCH EUR J PHY, V435, P439, DOI 10.1007/s004240050537
   RADAK Z, 1995, J APPL PHYSIOL, V79, P129, DOI 10.1152/jappl.1995.79.1.129
   Reid MB, 2002, ANN NY ACAD SCI, V959, P108, DOI 10.1111/j.1749-6632.2002.tb02087.x
   Schaefer A, 2002, INT J SPORTS MED, V23, P403, DOI 10.1055/s-2002-33743
   SCHIERWAGEN C, 1990, J PHARMACOL METHOD, V23, P179, DOI 10.1016/0160-5402(90)90061-O
   Siomek A, 2007, ANTIOXID REDOX SIGN, V9, P143, DOI 10.1089/ars.2007.9.143
   SOMANI SM, 1995, PHARMACOL BIOCHEM BE, V51, P627, DOI 10.1016/0091-3057(94)00427-K
   Suzuki J, 2006, J PHYSIOL SCI, V56, P39, DOI 10.2170/physiolsci.RP000505
   Suzuki K, 1996, J APPL PHYSIOL, V81, P1213, DOI 10.1152/jappl.1996.81.3.1213
   Tiidus PM, 1998, CAN J PHYSIOL PHARM, V76, P533, DOI 10.1139/cjpp-76-5-533
   Viña J, 2000, IUBMB LIFE, V49, P539
   WESTERFELD WW, 1959, J BIOL CHEM, V234, P1897
   WESTING YH, 1989, ACTA PHYSIOL SCAND, V137, P341, DOI 10.1111/j.1748-1716.1989.tb08762.x
   Xiao DS, 2003, MOL CELL BIOCHEM, V252, P65, DOI 10.1023/A:1025517216681
   Yamada M, 2000, LUMINESCENCE, V15, P15, DOI 10.1002/(SICI)1522-7243(200001/02)15:1<15::AID-BIO570>3.0.CO;2-O
   Yeh CL, 2007, SHOCK, V28, P39, DOI 10.1097/shk.0b013e31802f0190
NR 51
TC 65
Z9 76
U1 1
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUN
PY 2008
VL 43
IS 6
BP 571
EP 577
DI 10.1016/j.exger.2008.03.002
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 317KL
UT WOS:000257019000008
PM 18424033
DA 2024-02-19
ER

PT J
AU VENUGOPAL, J
   RAO, KS
AF VENUGOPAL, J
   RAO, KS
TI GENE-EXPRESSION IN DIFFERENT CELL-TYPES OF AGING RAT-BRAIN
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE AGING; RNA POLYMERASE; CHROMATIN; DNA; RAT BRAIN
ID RIBONUCLEIC-ACID SYNTHESIS; AGE-ASSOCIATED CHANGES; RNA-POLYMERASE;
   DEOXYRIBONUCLEIC-ACID; POSTNATAL-DEVELOPMENT; POLYADENYLATED RNA; LIVER
   NUCLEI; MOUSE-BRAIN; OLD RATS; TRANSCRIPTION
AB "Bound" and "free" RNA polymerase activities were assessed in the nuclear fraction of cerebral cortical, neuronal, astroglial, and oligodendroglial cells obtained from rats of young, adult, and old ages.  Significant decreases in both the bound and free polymerase II activities were noticed in old brain, as compared to adult brain, in neuronal and oligodendroglial nuclei.  In astroglia, only the free polymerase II was found to be affected.  No effect of aging could be seen on the activity of bound RNA polymerase I + III.  The free RNA polymerase I + III activity was increased from adult to old age in neuronal nuclei, but unchanged in oligodendroglial and astroglial nuclei.  The age-dependent reduction in RNA polymerase II was maximum in oligodendroglial cells, whereas it was least, although still significant, in neuronal cells.  DNA isolated from old brain was unable to enhance the transcriptional activity when added to chromatin preparations obtained from rat brains of any of the above ages, and the "old" chromatin was unable to accept even the "young" DNA as additional exogenous template.  It is concluded that the reduced gene expression noticed in old brain nuclei is due to both altered chromatin/DNA structure and inadequate levels of free RNA polymerase II.
C1 UNIV HYDERABAD,SCH LIFE SCI,HYDERABAD 500134,ANDHRA PRADESH,INDIA.
C3 University of Hyderabad
CR BANTLE JA, 1976, CELL, V8, P139, DOI 10.1016/0092-8674(76)90195-1
   BERKOWITZ EM, 1983, J NEUROCHEM, V41, P516, DOI 10.1111/j.1471-4159.1983.tb04769.x
   BROWN IR, 1972, DEV BIOL, V29, P73, DOI 10.1016/0012-1606(72)90045-0
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   CASTLE T, 1978, MECH AGEING DEV, V8, P383, DOI 10.1016/0047-6374(78)90037-4
   CHATURVEDI MM, 1985, MOL BIOL REP, V10, P215
   CHAUDHARI N, 1983, SCIENCE, V220, P924, DOI 10.1126/science.6189184
   CHETSANGA CJ, 1977, BIOCHIM BIOPHYS ACTA, V474, P180, DOI 10.1016/0005-2787(77)90192-7
   CUTLER RG, 1975, EXP GERONTOL, V10, P37, DOI 10.1016/0531-5565(75)90014-5
   DAS BR, 1987, MOL BIOL REP, V12, P43, DOI 10.1007/BF00580649
   DAVIS LG, 1986, BASIC METHODS MOL BI, P47
   DEVI PLA, 1966, NATURE, V212, P474
   FONG TC, 1988, MECH AGEING DEV, V46, P219, DOI 10.1016/0047-6374(88)90126-1
   GENSLER HL, 1981, Q REV BIOL, V56, P279, DOI 10.1086/412317
   GIBAS MA, 1970, J GERONTOL, V25, P105, DOI 10.1093/geronj/25.2.105
   GIUFFRIDA AM, 1975, J NEUROCHEM, V24, P749
   GROUSE L, 1972, BIOCHEMISTRY-US, V11, P798, DOI 10.1021/bi00755a019
   GROUSE L, 1973, J NEUROCHEM, V20, P1063, DOI 10.1111/j.1471-4159.1973.tb00077.x
   HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169
   KANUNGO MS, 1975, J THEOR BIOL, V53, P253, DOI 10.1016/S0022-5193(75)80002-6
   KANUNGO MS, 1980, BIOCH AGEING, P242
   KORR H, 1980, ADV ANATOMICAL EMBRY, V61
   Lajtha A., 1982, HDB NEUROCHEMISTRY, V1
   LEWIN B, 1980, GENE EXPRESSION, V2
   Lindahl T., 1977, DNA REPAIR PROCESS, P225
   LINDELL TJ, 1982, MECH AGEING DEV, V19, P63, DOI 10.1016/0047-6374(82)90051-3
   LINDHOLM DB, 1986, J NEUROCHEM, V47, P1503
   MARZLUFF WF, 1975, P NATL ACAD SCI USA, V72, P1082, DOI 10.1073/pnas.72.3.1082
   Menzies RA, 1972, MECH AGEING DEV, V1, P117, DOI 10.1016/0047-6374(72)90059-0
   MILLER JK, 1980, BIOCHEM J, V188, P55, DOI 10.1042/bj1880055
   MURTHY MR, 1976, NEUROPSYCHOPHARMACOL, P1615
   PATNAIK SK, 1984, INDIAN J BIOCHEM BIO, V21, P178
   PRICE GB, 1971, SCIENCE, V171, P917, DOI 10.1126/science.171.3974.917
   RATTAN SIS, 1988, TRENDS BIOTECHNOL, V6, P58, DOI 10.1016/0167-7799(88)90092-3
   SERRA I, 1984, NEUROCHEM RES, V9, P1051, DOI 10.1007/BF00964801
   TAS S, 1980, MECH AGEING DEV, V12, P65, DOI 10.1016/0047-6374(80)90030-5
   VENUGOPAL J, 1989, BIOCHEM INT, V19, P787
   YU FL, 1974, NATURE, V251, P344, DOI 10.1038/251344a0
NR 38
TC 16
Z9 16
U1 0
U2 0
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0022-3042
J9 J NEUROCHEM
JI J. Neurochem.
PD MAR
PY 1991
VL 56
IS 3
BP 812
EP 817
DI 10.1111/j.1471-4159.1991.tb01996.x
PG 6
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA EX981
UT WOS:A1991EX98100013
PM 1993896
DA 2024-02-19
ER

PT J
AU Nakamura, S
   Oba, M
   Suzuki, M
   Takahashi, A
   Yamamuro, T
   Fujiwara, M
   Ikenaka, K
   Minami, S
   Tabata, N
   Yamamoto, K
   Kubo, S
   Tokumura, A
   Akamatsu, K
   Miyazaki, Y
   Kawabata, T
   Hamasaki, M
   Fukui, K
   Sango, K
   Watanabe, Y
   Takabatake, Y
   Kitajima, TS
   Okada, Y
   Mochizuki, H
   Isaka, Y
   Antebi, A
   Yoshimori, T
AF Nakamura, Shuhei
   Oba, Masaki
   Suzuki, Mari
   Takahashi, Atsushi
   Yamamuro, Tadashi
   Fujiwara, Mari
   Ikenaka, Kensuke
   Minami, Satoshi
   Tabata, Namine
   Yamamoto, Kenichi
   Kubo, Sayaka
   Tokumura, Ayaka
   Akamatsu, Kanako
   Miyazaki, Yumi
   Kawabata, Tsuyoshi
   Hamasaki, Maho
   Fukui, Koji
   Sango, Kazunori
   Watanabe, Yoshihisa
   Takabatake, Yoshitsugu
   Kitajima, Tomoya S.
   Okada, Yukinori
   Mochizuki, Hideki
   Isaka, Yoshitaka
   Antebi, Adam
   Yoshimori, Tamotsu
TI Suppression of autophagic activity by Rubicon is a signature of aging
SO NATURE COMMUNICATIONS
LA English
DT Article
ID LIFE-SPAN EXTENSION; ALPHA-SYNUCLEIN; CAENORHABDITIS-ELEGANS;
   LIPID-METABOLISM; LONGEVITY; MITOPHAGY; RAPAMYCIN; CELLS; LIVER;
   NEURODEGENERATION
AB Autophagy, an evolutionarily conserved cytoplasmic degradation system, has been implicated as a convergent mechanism in various longevity pathways. Autophagic activity decreases with age in several organisms, but the underlying mechanism is unclear. Here, we show that the expression of Rubicon, a negative regulator of autophagy, increases in aged worm, fly and mouse tissues at transcript and/or protein levels, suggesting that an age-dependent increase in Rubicon impairs autophagy over time, and thereby curtails animal healthspan. Consistent with this idea, knockdown of Rubicon extends worm and fly lifespan and ameliorates several age-associated phenotypes. Tissue-specific experiments reveal that Rubicon knockdown in neurons has the greatest effect on lifespan. Rubicon knockout mice exhibits reductions in interstitial fibrosis in kidney and reduced a-synuclein accumulation in the brain. Rubicon is suppressed in several long-lived worms and calorie restricted mice. Taken together, our results suggest that suppression of autophagic activity by Rubicon is one of signatures of aging.
C1 [Nakamura, Shuhei; Yamamuro, Tadashi; Fujiwara, Mari; Kubo, Sayaka; Tokumura, Ayaka; Akamatsu, Kanako; Miyazaki, Yumi; Kawabata, Tsuyoshi; Hamasaki, Maho; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Med, Dept Genet, Osaka 5650871, Japan.
   [Nakamura, Shuhei; Kubo, Sayaka; Miyazaki, Yumi; Hamasaki, Maho; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Frontier Biosci, Dept Intracellular Membrane Dynam, Osaka 5650871, Japan.
   [Nakamura, Shuhei; Takabatake, Yoshitsugu] Osaka Univ, Inst Adv Cocreat Studies, Osaka 5650871, Japan.
   [Oba, Masaki; Suzuki, Mari; Sango, Kazunori] Tokyo Metropolitan Inst Med Sci, Dept Sensory & Motor Syst, Diabet Neuropathy Project, Setagaya Ku, Tokyo 1568506, Japan.
   [Oba, Masaki; Fukui, Koji] Shibaura Inst Technol, Dept Biosci & Engn, Saitama 3378570, Japan.
   [Takahashi, Atsushi; Minami, Satoshi; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Nephrol, Osaka 5650871, Japan.
   [Ikenaka, Kensuke; Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka 5650871, Japan.
   [Tabata, Namine; Kitajima, Tomoya S.] RIKEN, Ctr Biosyst Dynam Res BDR, Lab Chromosome Segregat, Kobe, Hyogo 6500047, Japan.
   [Tabata, Namine; Kitajima, Tomoya S.] Kyoto Univ, Grad Sch Biostudies, Lab Mol Cell Biol & Dev, Kyoto 6068501, Japan.
   [Tabata, Namine; Kitajima, Tomoya S.] Osaka Univ, Grad Sch Sci, Lab Biomol Informat, Osaka 5600043, Japan.
   [Yamamoto, Kenichi; Okada, Yukinori] Osaka Univ, Grad Sch Med, Dept Stat Genet, Osaka 5650871, Japan.
   [Kawabata, Tsuyoshi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Stem Cell Biol, Nagasaki 8528523, Japan.
   [Watanabe, Yoshihisa] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Basic Geriatr, Kyoto 6028566, Japan.
   [Antebi, Adam] Max Planck Inst Biol Ageing, Dept Mol Genet Ageing, D-50931 Cologne, Germany.
   [Antebi, Adam] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.
C3 Osaka University; Osaka University; Osaka University; Tokyo Metropolitan
   Institute of Medical Science; Shibaura Institute of Technology; Osaka
   University; Osaka University; RIKEN; Kyoto University; Osaka University;
   Osaka University; Nagasaki University; Kyoto Prefectural University of
   Medicine; Max Planck Society; University of Cologne
RP Yoshimori, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Genet, Osaka 5650871, Japan.; Yoshimori, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Dept Intracellular Membrane Dynam, Osaka 5650871, Japan.
EM tamyoshi@fbs.osaka-u.ac.jp
RI Nakamura, Shuhei/JVO-2543-2024; Kitajima, Tomoya S/A-7049-2016; Minami,
   Satoshi/GMW-8861-2022; Shuhei, Nakamura/AGZ-2173-2022
OI Kitajima, Tomoya S/0000-0002-6486-7143; Minami,
   Satoshi/0000-0001-5043-3435; Shuhei, Nakamura/0000-0002-1488-8317;
   Fukui, Koji/0000-0003-2748-3228; Hamasaki, Maho/0000-0002-5646-5136;
   Yamamuro, Tadashi/0000-0002-0610-5204
FU AMED-PRIME [17gm6110003h0001]; JSPS KAKENHI; Senri Life Science
   Foundation; Takeda Science Foundation; Nakajima Foundation; MSD Life
   Science Foundation; Ichiro Kanehara Foundation; AMED [JP17gm5010001,
   JP17gm0610005]; JST CREST [JPMJCR17H6]; HFSP grant; MEXT/JSPS KAKENHI
FX We thank Prof. Dr. Hansen and Dr. Kumsta (Sanford-Burnham Medical
   Research Institute) for let-363/TOR RNAi clone, bafilomycin injection
   protocol and MAH215 strain. We thank Prof. Grant for providing hTFR::
   GFP transgenic worms. Many thanks to C. elegans Genetic Center (CGC) at
   the University of Minnesota. S.N. is supported by AMED-PRIME
   (17gm6110003h0001), JSPS KAKENHI, the Senri Life Science Foundation, the
   Takeda Science Foundation, the Nakajima Foundation, and the MSD Life
   Science Foundation. M.S. is supported by JSPS KAKENHI and the Ichiro
   Kanehara Foundation. T.Y. is supported by AMED under grant number
   JP17gm5010001 and JP17gm0610005, MEXT/JSPS KAKENHI, JST CREST
   (JPMJCR17H6) and HFSP grant.
CR Banreti A, 2014, DEV CELL, V28, P56, DOI 10.1016/j.devcel.2013.11.024
   Bejarano E, 2018, AGING CELL, V17, DOI 10.1111/acel.12777
   Burkewitz K, 2015, CELL, V160, P842, DOI 10.1016/j.cell.2015.02.004
   Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]
   Chang JT, 2017, ELIFE, V6, DOI 10.7554/eLife.18459
   Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787
   Cheng XW, 2017, MOL CELL, V65, P1029, DOI 10.1016/j.molcel.2017.02.010
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   Fang EF, 2017, SCI REP-UK, V7, DOI 10.1038/srep46208
   Fernández AF, 2018, NATURE, V558, P136, DOI 10.1038/s41586-018-0162-7
   Friedman LG, 2012, J NEUROSCI, V32, P7585, DOI 10.1523/JNEUROSCI.5809-11.2012
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Hahm JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9919
   Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024
   Hansen M, 2018, NAT REV MOL CELL BIO, V19, P579, DOI 10.1038/s41580-018-0033-y
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989
   Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Lapierre LR, 2012, AUTOPHAGY, V8, P144, DOI 10.4161/auto.8.1.18722
   Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042
   Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157
   Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846
   Meléndez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099
   Nezis IP, 2010, J CELL BIOL, V190, P523, DOI 10.1083/jcb.201002035
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016
   Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300
   Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200
   Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009
   Suzuki M, 2015, HUM MOL GENET, V24, P6675, DOI 10.1093/hmg/ddv372
   Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]
   Tanaka S, 2016, HEPATOLOGY, V64, P1994, DOI 10.1002/hep.28820
   Tóth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9
   Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006
   Watanabe Y, 2017, AUTOPHAGY, V13, P133, DOI 10.1080/15548627.2016.1248018
   Wilhelm T, 2017, GENE DEV, V31, P1561, DOI 10.1101/gad.301648.117
   Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113
   Yamamoto T, 2016, AUTOPHAGY, V12, P801, DOI 10.1080/15548627.2016.1159376
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhang YL, 2017, NATURE, V548, P52, DOI 10.1038/nature23282
   Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854
NR 53
TC 102
Z9 109
U1 0
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 19
PY 2019
VL 10
AR 847
DI 10.1038/s41467-019-08729-6
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics
GA HL9IL
UT WOS:000459056400004
PM 30783089
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sczelecki, S
   Besse-Patin, A
   Abboud, A
   Kleiner, S
   Laznik-Bogoslavski, D
   Wrann, CD
   Ruas, JL
   Haibe-Kains, B
   Estall, JL
AF Sczelecki, Sarah
   Besse-Patin, Aurele
   Abboud, Alexandra
   Kleiner, Sandra
   Laznik-Bogoslavski, Dina
   Wrann, Christiane D.
   Ruas, Jorge L.
   Haibe-Kains, Benjamin
   Estall, Jennifer L.
TI Loss of <i>Pgc</i>-<i>1</i>α expression in aging mouse muscle
   potentiates glucose intolerance and systemic inflammation
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE aging; mitochondria; peroxisome proliferator-activated receptor-gamma
   coactivator-1; muscle; diabetes; inflammation
ID NF-KAPPA-B; SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; PGC-1
   COACTIVATORS; INSULIN-RESISTANCE; ENERGY-METABOLISM; GENE-EXPRESSION;
   MITOCHONDRIAL; EXERCISE; OBESITY
AB Diabetes risk increases significantly with age and correlates with lower oxidative capacity in muscle. Decreased expression of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (Pgc-1 alpha) and target gene pathways involved in mitochondrial oxidative phosphorylation are associated with muscle insulin resistance, but a causative role has not been established. We sought to determine whether a decline in Pgc-1 alpha and oxidative gene expression occurs during aging and potentiates the development of age-associated insulin resistance. Muscle-specific Pgc-1 alpha knockout (MKO) mice and wild-type littermate controls were aged for 2 yr. Genetic signatures of skeletal muscle (microarray and mRNA expression) and metabolic profiles (glucose homeostasis, mitochondrial metabolism, body composition, lipids, and indirect calorimetry) of mice were compared at 3, 12, and 24 mo of age. Microarray and gene set enrichment analysis highlighted decreased function of the electron transport chain as characteristic of both aging muscle and loss of Pgc-1 alpha expression. Despite significant reductions in oxidative gene expression and succinate dehydrogenase activity, young mice lacking Pgc-1 alpha in muscle had lower fasting glucose and insulin. Consistent with loss of oxidative capacity during aging, Pgc-1 alpha and Pgc-1 beta expression were reduced in aged wild-type mouse muscle. Interestingly, the combination of age and loss of muscle Pgc-1 alpha expression impaired glucose tolerance and led to increased fat mass, insulin resistance, and inflammatory markers in white adipose and liver tissues. Therefore, loss of Pgc-1 alpha expression and decreased mitochondrial oxidative capacity contribute to worsening glucose tolerance and chronic systemic inflammation associated with aging.
C1 [Sczelecki, Sarah; Besse-Patin, Aurele; Abboud, Alexandra; Estall, Jennifer L.] Inst Rech Clin Montreal, Div Cardiovasc & Metab Dis, Montreal, PQ H2W 1R7, Canada.
   [Haibe-Kains, Benjamin] Inst Rech Clin Montreal, Div Syst Biol & Med Chem, Montreal, PQ H2W 1R7, Canada.
   [Sczelecki, Sarah; Estall, Jennifer L.] McGill Univ, Dept Expt Med, Montreal, PQ, Canada.
   [Besse-Patin, Aurele; Estall, Jennifer L.] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada.
   [Kleiner, Sandra; Laznik-Bogoslavski, Dina; Wrann, Christiane D.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.
   [Ruas, Jorge L.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.
C3 Institut de Recherche Clinique de Montreal (IRCM); Universite de
   Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite
   de Montreal; McGill University; Universite de Montreal; Harvard
   University; Dana-Farber Cancer Institute; Karolinska Institutet
RP Estall, JL (corresponding author), IRCM, 110 Ave Des Pins Ouest, Montreal, PQ H2W 1R7, Canada.
EM jennifer.estall@ircm.qc.ca
RI Ruas, Jorge L/T-3040-2017; Haibe-Kains, Benjamin/D-3702-2011
OI Ruas, Jorge L/0000-0002-1110-2606; Haibe-Kains,
   Benjamin/0000-0002-7684-0079; Estall, Jennifer/0000-0002-9838-1440;
   Besse-Patin, Aurele/0000-0002-1475-8723
FU National Research Council of Canada; Canadian Diabetes Association;
   Institut de Recherches Cliniques de Montreal; Novo Nordisk Fonden
   [NNF12OC1016062] Funding Source: researchfish
FX This research was funded by grants from the National Research Council of
   Canada (H. L. Holmes Award) and Canadian Diabetes Association to J. L.
   Estall and the Institut de Recherches Cliniques de Montreal to J. L.
   Estall and B. Haibe-Kains.
CR Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080
   Barrès R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001
   Barrès R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011
   Bergman BC, 2012, J CLIN ENDOCR METAB, V97, P1663, DOI 10.1210/jc.2011-3172
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105
   Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179
   Dillon LM, 2012, IUBMB LIFE, V64, P231, DOI 10.1002/iub.608
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253
   Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Ghosh S, 2011, DIABETES, V60, P2051, DOI 10.2337/db11-0121
   Goodpaster BH, 2002, OBES RES, V10, P575, DOI 10.1038/oby.2002.78
   Goodpaster BH, 2013, DIABETES, V62, P1032, DOI 10.2337/db12-1612
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Hadjiyanni I, 2008, ENDOCRINOLOGY, V149, P1338, DOI 10.1210/en.2007-1137
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Holloszy JO, 2013, DIABETES, V62, P1036, DOI 10.2337/db12-1107
   Hernández-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305
   Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003
   Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109
   Lanza IR, 2009, AM J CLIN NUTR, V89, p467S, DOI 10.3945/ajcn.2008.26717D
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Ma D, 2010, J BIOL CHEM, V285, P39087, DOI 10.1074/jbc.M110.151688
   Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Mormeneo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029985
   Olesen J, 2013, EXP GERONTOL, V48, P1274, DOI 10.1016/j.exger.2013.07.015
   Park SW, 2009, DIABETES CARE, V32, P1993, DOI 10.2337/dc09-0264
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Peterson Courtney M, 2012, J Aging Res, V2012, P194821, DOI 10.1155/2012/194821
   Phielix E, 2011, GERONTOLOGY, V57, P387, DOI 10.1159/000317691
   Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047
   Ringholm S, 2013, EXP GERONTOL, V48, P1311, DOI 10.1016/j.exger.2013.08.012
   Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001
   Summermatter S, 2012, INT J OBESITY, V36, P1428, DOI 10.1038/ijo.2012.12
   Summermatter S, 2013, DIABETES, V62, P85, DOI 10.2337/db12-0291
   Summermatter S, 2011, BIOCHEM BIOPH RES CO, V408, P180, DOI 10.1016/j.bbrc.2011.04.012
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029
   Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
   Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008
NR 56
TC 73
Z9 82
U1 1
U2 21
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD JAN
PY 2014
VL 306
IS 2
BP E157
EP E167
DI 10.1152/ajpendo.00578.2013
PG 11
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 291VW
UT WOS:000329860600004
PM 24280126
OA Green Published
DA 2024-02-19
ER

PT J
AU Khaidakov, M
   Heflich, RH
   Manjanatha, MG
   Myers, MB
   Aidoo, A
AF Khaidakov, M
   Heflich, RH
   Manjanatha, MG
   Myers, MB
   Aidoo, A
TI Accumulation of point mutations in mitochondrial DNA of aging mice
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE aging; D-loop region; mitochondrial DNA; mutation frequency; PCR
ID EPITHELIAL-CELLS; OXIDATIVE DAMAGE; SOMATIC MUTATION; HUMAN BRAIN;
   IN-VIVO; HPRT; AGE; FREQUENCY; LIVER; RATS
AB Mitochondrial DNA (mtDNA) exists in a highly genotoxic environment created by exposure to reactive oxygen species, somewhat deficient DNA repair, and the relatively low fidelity of polymerase gamma. Given the severity of the environment, it was anticipated that mutation accumulation in the mtDNA of aging animals should exceed that of nuclear genes by several orders of magnitude. We have analyzed fragments amplified from the D-loop region of mtDNA from 2 to 22-month-old mice. The amplified 432 bp fragments were cloned into plasmid vectors, and plasmid DNAs from individual clones were purified and sequenced. None of 110 fragments from young mice contained a mutation, while 9 of 87 clones originating from old animals contained base substitutions (chi square = 11.9, P < 0.001). The estimated mutation frequency in mtDNA from old mice was 11.6 +/- 2.7 or 25.4 +/- 7.8 per 10(5) nucleotides (depending on assumptions of clonality), which exceeds existing estimates for mutation frequencies for nuclear genes by approximately 1000-fold. Our data suggest that at 22 months of age, which roughly corresponds to 3/4 of the mouse natural life span, most mtDNA molecules carry multiple point mutations. Published by Elsevier Science B.V.
C1 US FDA, Div Genet & Reprod Toxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.
   Univ Arkansas Med Sci, Little Rock, AR 72205 USA.
   Dept Geriatr, Little Rock, AR 72205 USA.
   Univ Arkansas Med Sci Hosp, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA.
C3 US Food & Drug Administration (FDA); University of Arkansas System;
   University of Arkansas Medical Sciences; University of Arkansas System;
   University of Arkansas Medical Sciences
RP Aidoo, A (corresponding author), US FDA, Div Genet & Reprod Toxicol, Natl Ctr Toxicol Res, 3900 NCTR Rd, Jefferson, AR 72079 USA.
OI Myers, Meagan/0000-0001-5404-578X; Khaidakov,
   Magomed/0000-0003-4834-1077
CR AIDOO A, 1993, MUTAT RES, V298, P169, DOI 10.1016/0165-1218(93)90038-F
   ALVI NK, 1992, MUTAT RES, V265, P283, DOI 10.1016/0027-5107(92)90057-9
   AMES C, 1988, P NATL ACAD SCI USA, V85, P64655
   AMMENHEUSER MM, 1991, ENVIRON MOL MUTAGEN, V18, P126, DOI 10.1002/em.2850180208
   Anson RM, 2000, FASEB J, V14, P355, DOI 10.1096/fasebj.14.2.355
   BODENTEICH A, 1991, GENE, V108, P305, DOI 10.1016/0378-1119(91)90451-G
   BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Cariello NF, 1996, NUCLEIC ACIDS RES, V24, P119, DOI 10.1093/nar/24.1.119
   Casado A, 1998, Gac Med Mex, V134, P539
   Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256
   Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11
   Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546
   Coller HA, 1998, CANCER RES, V58, P1268
   Cormio A, 2000, ANN NY ACAD SCI, V908, P299
   DEMPSEY JL, 1993, MUTAT RES, V291, P141, DOI 10.1016/0165-1161(93)90153-Q
   Dollé MET, 2000, RES PRO CEL, V29, P165
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9
   FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015
   HAKODA M, 1995, HUM GENET, V96, P674, DOI 10.1007/BF00210298
   Herman JP, 1998, NEUROBIOL AGING, V19, P581, DOI 10.1016/S0197-4580(98)00099-2
   INAMIZU T, 1986, P NATL ACAD SCI USA, V83, P2488, DOI 10.1073/pnas.83.8.2488
   Jang I, 1998, EXP ANIM TOKYO, V47, P247, DOI 10.1538/expanim.47.247
   Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382
   JI LL, 1991, AM J PHYSIOL, V261, pR386, DOI 10.1152/ajpregu.1991.261.2.R386
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Kirches E, 2001, INT J CANCER, V93, P534, DOI 10.1002/ijc.1375
   KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965
   Lanza RP, 2001, SCIENCE, V294, P1893, DOI 10.1126/science.1063440
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu VWS, 1998, HUM MUTAT, V11, P191, DOI 10.1002/(SICI)1098-1004(1998)11:3<191::AID-HUMU2>3.0.CO;2-L
   Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Manjanatha MG, 1996, MUTAT RES-FUND MOL M, V357, P89, DOI 10.1016/0027-5107(96)00086-3
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011
   Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580
   STEEN AM, 1993, MUTAT RES, V286, P209, DOI 10.1016/0027-5107(93)90185-I
   Stuart GR, 2000, GENETICS, V154, P1291
   Todd R, 1999, ANTICANCER RES, V19, P4729
   Turker MS, 2000, MECH AGEING DEV, V117, P1, DOI 10.1016/S0047-6374(00)00133-0
   WALDREN C, 1986, P NATL ACAD SCI USA, V83, P4839, DOI 10.1073/pnas.83.13.4839
   Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   Yeh JJ, 2000, ONCOGENE, V19, P2060, DOI 10.1038/sj.onc.1203537
   Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497
   ZHANG CF, 1993, BIOCHEM BIOPH RES CO, V195, P1104, DOI 10.1006/bbrc.1993.2158
   ZHANG XB, 1995, MUTAT RES-DNAGING G, V338, P189, DOI 10.1016/0921-8734(95)00024-Z
NR 52
TC 88
Z9 108
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0027-5107
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD MAY 15
PY 2003
VL 526
IS 1-2
BP 1
EP 7
DI 10.1016/S0027-5107(03)00010-1
PG 7
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 676HX
UT WOS:000182746200001
PM 12714177
DA 2024-02-19
ER

PT J
AU Das, N
   Levine, RL
   Orr, WC
   Sohal, RS
AF Das, N
   Levine, RL
   Orr, WC
   Sohal, RS
TI Selectivity of protein oxidative damage during aging in <i>Drosophila
   melanogaster</i>
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE aconitase; hyperoxia; mitochondria; protein carbonylation; protein
   oxidation; oxidative stress
ID LIFE-SPAN; CALORIC RESTRICTION; ESCHERICHIA-COLI; FLUOROACETATE;
   HYPEROXIA; LIVER; FLUOROCITRATE; INACTIVATION; EXPECTANCY; MECHANISM
AB The purpose of the present study was to determine whether oxidation of various proteins during the aging process occurs selectively or randomly, and whether the same proteins are damaged in different species. Protein oxidative damage to the proteins, present in the matrix of mitochondria in the flight muscles of Drosophila melanogaster and manifested as carbonyl modifications, was detected immunochemically with anti-dinitrophenyl-group antibodies. Aconitase was found to be the only protein in the mitochondrial matrix that exhibited an age-associated increase in carbonylation. The accrual of oxidative damage was accompanied by an approx. 50% loss in aconitase activity. An increase in ambient temperature, which elevates the rate of metabolism and shortens the life span of flies, caused an elevation in the amount of aconitase carbonylation and an accelerated loss in its activity. Exposure to 100% ambient oxygen showed that aconitase was highly susceptible to undergo oxidative damage and loss of activity under oxidative stress. Administration of fluoroacetate, a competitive inhibitor of aconitase activity, resulted in a dose-dependent decrease in the life span of the flies. Results of the present study demonstrate that protein oxidative damage during aging is a selective phenomenon, and might constitute a mechanism by which oxidative stress causes age-associated losses in specific biochemical functions.
C1 Univ So Calif, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA.
   NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA.
   So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.
C3 University of Southern California; National Institutes of Health (NIH) -
   USA; NIH National Heart Lung & Blood Institute (NHLBI); Southern
   Methodist University
RP Sohal, RS (corresponding author), Univ So Calif, Dept Mol Pharmacol & Toxicol, 1985 Zonal Ave, Los Angeles, CA 90033 USA.
EM sohal@usc.edu
RI Levine, Rodney L/D-9885-2011
FU NIA NIH HHS [R01 AG17077] Funding Source: Medline
CR AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Bollag D.M., 1996, PROTEIN METHODS, P173
   BRAND MD, 1973, BIOCHEM J, V134, P217, DOI 10.1042/bj1340217
   CLARKE DD, 1991, NEUROCHEM RES, V16, P1055, DOI 10.1007/BF00965850
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9914
   Dean RT, 1997, BIOCHEM J, V324, P1
   Eisenstein RS, 1997, CH MICROBIOL SER, P157
   GAFNI A, 1990, REV BIOL RES AGING, V4, P315
   GARDNER PR, 1992, J BIOL CHEM, V267, P8757
   GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248
   GARDNER PR, 1991, J BIOL CHEM, V266, P19328
   Ghezzo-Schöneich E, 2001, FREE RADICAL BIO MED, V30, P858, DOI 10.1016/S0891-5849(01)00473-7
   KENNEDY MC, 1983, J BIOL CHEM, V258, P1098
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Ma YS, 1999, ARCH BIOCHEM BIOPHYS, V363, P129, DOI 10.1006/abbi.1998.1076
   Merker K, 2000, EXP GERONTOL, V35, P779, DOI 10.1016/S0531-5565(00)00140-6
   MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   Rothstein M., 1982, BIOCH APPROACHES AGI
   SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SOHAL RS, 1982, AGE, V5, P21, DOI 10.1007/BF02431719
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SPENCER AF, 1967, BIOCHEM J, V103, P342, DOI 10.1042/bj1030342
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5
   TAYLOR WM, 1977, CAN J BIOCHEM CELL B, V55, P982, DOI 10.1139/o77-146
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5
   TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P411, DOI 10.1016/0003-9861(82)90519-7
   van den Bergh S., 1967, METHODS ENZYMOL, V10, P117
   Winn LM, 1997, FREE RADICAL BIO MED, V22, P607, DOI 10.1016/S0891-5849(96)00340-1
   Yan LJ, 2000, FREE RADICAL BIO MED, V29, P1143, DOI 10.1016/S0891-5849(00)00423-8
   Yan LJ, 1998, ANAL BIOCHEM, V265, P176, DOI 10.1006/abio.1998.2868
   Yan LJ, 2000, FREE RADICAL BIO MED, V29, P90, DOI 10.1016/S0891-5849(00)00323-3
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
   Zahavi M., 1965, Journal of Insect Physiology, V11, P811, DOI 10.1016/0022-1910(65)90160-5
   Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o
   1991, FREE RADICAL BIOL ME, V10, P249
NR 46
TC 150
Z9 188
U1 1
U2 15
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD NOV 15
PY 2001
VL 360
BP 209
EP 216
DI 10.1042/0264-6021:3600209
PN 1
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 497QL
UT WOS:000172466900024
PM 11696009
OA Green Published
DA 2024-02-19
ER

PT J
AU Kolomeichuk, SN
   Gurov, EV
   Piskunova, TS
   Tyndyk, ML
   Anisimov, VN
AF Kolomeichuk, S. N.
   Gurov, E. V.
   Piskunova, T. S.
   Tyndyk, M. L.
   Anisimov, V. N.
TI Expression of Circadian <i>Per1</i> and <i>Per2</i> Genes in the Liver
   and Breast Tumor Tissues of HER2/neu Transgenic Mice of Different Age
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE circadian genes; liver; breast tumor; aging
ID LIFE-SPAN; IN-VIVO; CANCER; DNA; METFORMIN; GROWTH; PLAYS; LIGHT
AB The expression of Per1, Per2, and Cry1 circadian genes in the liver and breast tumors were studied by real-time PCR in FVB/N mice of different age transfected with HER-2/neu gene. The expression of Per1 and Per2 genes in breast tumor tissue decreased in comparison with their expression in the lever. The expression of these genes decreased with age in both the liver and tumor tissue.
C1 [Piskunova, T. S.; Tyndyk, M. L.; Anisimov, V. N.] Minist Hlth Care & Social Dev Russian Fed, NN Petrov Inst Oncol, St Petersburg, Russia.
   [Kolomeichuk, S. N.; Gurov, E. V.] Russian Acad Sci, Inst Biol, Karelian Res Ctr, Petrozavodsk, Russia.
C3 Ministry of Health of the Russian Federation; N.N. Petrov Research
   Institute of Oncology; Russian Academy of Sciences; Karelian Research
   Centre of the Russian Academy of Sciences; Institute of Biology of
   Karelian Research Centre RAS
RP Anisimov, VN (corresponding author), Minist Hlth Care & Social Dev Russian Fed, NN Petrov Inst Oncol, St Petersburg, Russia.
EM aging@mail.ru
RI Kolomeichuk, Sergey N/K-3674-2017; Kolomeychuk, Sergey/L-5800-2019;
   Margarita, Tyndyk/AAA-8919-2020
OI Kolomeichuk, Sergey N/0000-0003-3104-3639; Kolomeychuk,
   Sergey/0000-0003-3104-3639; Margarita, Tyndyk/0000-0002-4755-9317
FU Russian Federation "The Leading Scientific Schools" [NSh-306.2008.4];
   Foundation for Russian Science Promotion "Young Candidates of Sciences
   in the Russian Academy of Sciences"; Russian Foundation for Basic
   Research [09-04-90779 mob_st]
FX The study was partially supported by the Program of the President of the
   Russian Federation "The Leading Scientific Schools" (NSh-306.2008.4),
   Foundation for Russian Science Promotion "Young Candidates of Sciences
   in the Russian Academy of Sciences" 20082009, and Russian Foundation for
   Basic Research (Program "Mobility of Young Scientists", grant No.
   09-04-90779 mob_st).
CR Anisimov V. N., 2008, Uspekhi Fiziologicheskikh Nauk, V39, P40
   Anisimov VN, 2006, NEUROENDOCRINOL LETT, V27, P35
   Anisimov VN, 2010, CELL CYCLE, V9, P188, DOI 10.4161/cc.9.1.10407
   Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007
   Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075
   Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3
   Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038
   Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177
   Keith LG, 2001, INT J FERTIL WOMEN M, V46, P238
   Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263
   Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965
   Stevens RG, 2001, CANCER CAUSE CONTROL, V12, P279, DOI 10.1023/A:1011237000609
   Winter SL, 2007, NEOPLASIA, V9, P797, DOI 10.1593/neo.07595
NR 13
TC 2
Z9 3
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4888
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD JUN
PY 2011
VL 151
IS 2
BP 227
EP 229
DI 10.1007/s10517-011-1295-y
PG 3
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 782VU
UT WOS:000292041600016
PM 22238756
DA 2024-02-19
ER

PT J
AU Hayasaka, S
   Kimura, F
   Kato, S
   Shimizu, N
   Ito, J
   Higuchi, O
   Izumisawa, K
   Miyazawa, T
   Nakagawa, K
AF Hayasaka, Saki
   Kimura, Fumiko
   Kato, Shunji
   Shimizu, Naoki
   Ito, Junya
   Higuchi, Oki
   Izumisawa, Katsuhiro
   Miyazawa, Teruo
   Nakagawa, Kiyotaka
TI High-fat Diet Increases Phospholipid Peroxidation in the Liver of Mature
   Fischer 344 Rats
SO JOURNAL OF OLEO SCIENCE
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Rice Bran Oil (ICRBO)
CY OCT 24-25, 2016
CL Univ Tokyo, ITO Int Res Ctr, Bunkyo, JAPAN
HO Univ Tokyo, ITO Int Res Ctr
DE antioxidant; liver; oxidative stress; phosphatidylcholine hydroperoxide;
   rat
ID PHOSPHATIDYLCHOLINE HYDROPEROXIDE; CARBON-TETRACHLORIDE; METABOLIC
   SYNDROME; ALPHA-TOCOPHEROL; LIPID-METABOLISM; PLASMA; MALONDIALDEHYDE;
   OBESITY; CHROMATOGRAPHY; ACCUMULATION
AB Phospholipid peroxidation is considered to be involved in the pathophysiology of various diseases. While dietary antioxidants are believed to help prevent these diseases via inhibition of phospholipid peroxidation, further evaluation is needed to prove this hypothesis. For this, it is crucial to establish an animal model with accelerated phospholipid peroxidation. In this study, we hypothesized that a combination of aging and high-fat diet feeding may accelerate phospholipid peroxidation in vivo. High-fat diets were fed to mature and juvenile Fischer 344 rats for 12 weeks. The mature rats in particular accumulated body fat and liver phosphatidylcholine hydroperoxide (PCOOH). Interestingly, the increase in PCOOH levels was abrogated by the co-administration of antioxidants to mature rats. This may be attributed to factors including the decrease in body fat, functions of vitamin E, and/or the involvement of antioxidant-related genes, each caused by antioxidant administration. These results indicate that the high-fat diet-fed aging animal model may be suitable for investigation of the relationship between phospholipid peroxidation, oxidative stress-related diseases, and dietary antioxidants.
C1 [Hayasaka, Saki; Kato, Shunji; Shimizu, Naoki; Ito, Junya; Miyazawa, Teruo; Nakagawa, Kiyotaka] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi, Japan.
   [Kimura, Fumiko] Shokei Gakuin Univ, Dept Human Hlth & Nutr, Natori, Miyagi, Japan.
   [Higuchi, Oki] Biodynam Plant Inst CO Ltd, Sapporo, Hokkaido, Japan.
   [Izumisawa, Katsuhiro] Eisai & Co Ltd, Tokyo, Japan.
   [Miyazawa, Teruo] Tohoku Univ, NICHe, Food Biotechnol Innovat Project, Sendai, Miyagi, Japan.
C3 Tohoku University; Eisai Co Ltd; Tohoku University
RP Nakagawa, K (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi, Japan.
EM nkgw@biochem.tohoku.ac.jp
RI Shimizu, Naoki/HPE-8265-2023; Shimizu, Naoki/AAF-3554-2020; Kato,
   Shunji/ABG-8440-2021
OI Shimizu, Naoki/0000-0002-1892-5795; Kato, Shunji/0000-0003-4659-9541
FU JSPS KAKENHI [15H04497, 15K14726]; Grants-in-Aid for Scientific Research
   [15K14726, 15H04497] Funding Source: KAKEN
FX This study was partly supported by a JSPS KAKENHI Grant (Number 15H04497
   and 15K14726).
CR Bardag-Gorce F, 2011, EXP MOL PATHOL, V90, P123, DOI 10.1016/j.yexmp.2010.10.013
   BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   Burdeos GC, 2014, FOOD FUNCT, V5, P2221, DOI [10.1039/c4fo00463a, 10.1039/C4FO00463A]
   Burdeos GC, 2012, LIPIDS, V47, P471, DOI 10.1007/s11745-012-3659-0
   CHO S, 1978, J NUTR SCI VITAMINOL, V24, P221, DOI 10.3177/jnsv.24.221
   Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003
   Djuric Z, 2001, NUTR CANCER, V39, P214, DOI 10.1207/S15327914nc392_9
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S
   Giriwono PE, 2010, FOOD RES INT, V43, P118, DOI 10.1016/j.foodres.2009.09.008
   JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2
   Kato S, 2015, ANAL BIOCHEM, V471, P51, DOI 10.1016/j.ab.2014.10.017
   Kato S, 2014, J OLEO SCI, V63, P431, DOI 10.5650/jos.ess13225
   Khoschsorur GA, 2000, CHROMATOGRAPHIA, V52, P181, DOI 10.1007/BF02490453
   Kiko T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049620
   Kiko T, 2012, J ALZHEIMERS DIS, V28, P593, DOI 10.3233/JAD-2011-111493
   Kinoshita M, 2000, CLIN CHEM, V46, P822
   Kitano-Okada T, 2012, J SCI FOOD AGR, V92, P2644, DOI 10.1002/jsfa.5680
   Konrad D, 2014, PHYSIOLOGY, V29, P304, DOI 10.1152/physiol.00014.2014
   LEE JH, 1989, J NUTR, V119, P1893, DOI 10.1093/jn/119.12.1893
   Levy JR, 2000, AM J PHYSIOL-ENDOC M, V279, pE1088, DOI 10.1152/ajpendo.2000.279.5.E1088
   Liu CM, 2010, ENVIRON TOXICOL PHAR, V29, P158, DOI 10.1016/j.etap.2009.12.006
   Martínez-Fernández L, 2015, PROSTAG OTH LIPID M, V121, P24, DOI 10.1016/j.prostaglandins.2015.07.003
   MCDONALD RB, 1989, J NUTR, V119, P1472, DOI 10.1093/jn/119.10.1472
   Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737
   MIYAZAWA T, 1992, J LIPID RES, V33, P1051
   MIYAZAWA T, 1990, J BIOCHEM-TOKYO, V107, P689, DOI 10.1093/oxfordjournals.jbchem.a123109
   MIYAZAWA T, 1993, LIPIDS, V28, P789, DOI 10.1007/BF02536232
   Miyazawa T, 1988, Basic Life Sci, V49, P191
   Miyazawa T., 1989, BIOL MED, V7, P209
   Nagashima T, 2002, DIABETES RES CLIN PR, V56, P19, DOI 10.1016/S0168-8227(01)00353-9
   Nakagawa K, 1999, J AGR FOOD CHEM, V47, P3967, DOI 10.1021/jf981195l
   Nakashima Y, 2010, J NUTR SCI VITAMINOL, V56, P380, DOI 10.3177/jnsv.56.380
   STEINBERG D, 1989, NEW ENGL J MED, V320, P915
   Suzuki K, 2015, BIOSCI BIOTECH BIOCH, V79, P1669, DOI 10.1080/09168451.2015.1039481
   Xiong QA, 2010, J BIOCHEM MOL TOXIC, V24, P361, DOI 10.1002/jbt.20347
   YANG NYJ, 1977, J NUTR, V107, P1418, DOI 10.1093/jn/107.8.1418
NR 37
TC 2
Z9 3
U1 0
U2 2
PU JAPAN OIL CHEMISTS SOC
PI TOKYO
PA YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO,
   103-0027, JAPAN
SN 1345-8957
EI 1347-3352
J9 J OLEO SCI
JI J. Oleo Sci.
PD JUN
PY 2017
VL 66
IS 6
SI SI
BP 607
EP 614
DI 10.5650/jos.ess16225
PG 8
WC Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Chemistry; Food Science & Technology
GA EW6AR
UT WOS:000402588100010
PM 28515377
OA gold
DA 2024-02-19
ER

PT J
AU Sun, L
   Xu, H
   Zhang, J
   Li, W
   Nie, J
   Qiu, Q
   Liu, YY
   Fang, Y
   Yang, Z
   Li, X
   Xiao, SF
AF Sun, Lin
   Xu, Hua
   Zhang, Jie
   Li, Wei
   Nie, Jing
   Qiu, Qi
   Liu, Yuanyuan
   Fang, Yuan
   Yang, Zhi
   Li, Xia
   Xiao, Shifu
TI Alcohol Consumption and Subclinical Findings on Cognitive Function,
   Biochemical Indexes, and Cortical Anatomy in Cognitively Normal Aging
   Han Chinese Population
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Article
DE alcohol consumption; light-to-moderated alcohol; cognitive function;
   biochemical markers; left superiortemporal gyrus
ID ASSOCIATION; LIGHT; AGE
AB Background: Binge drinking of alcohol is associated with brain damage, but less is known about relationship of light-to-moderate alcohol consumption with cognitive function, biochemical indexes, and cortical anatomy. Previous findings have debated on whether light-to-moderate drinking has any health benefits. We investigated cortical thickness and its association with alcohol consumption and cognitive functions in a non-dementia aging Han Chinese population.
   Methods: 940 non-dementia aging subjects were included in our study (alcohol n = 149; non-alcohol n = 791). Among them, 572 received blood biochemical tests including liver function and lipid metabolism (alcohol n = 100; non-alcohol n = 472) and 141 had brain magnetic resonance imaging (alcohol n = 27; non-alcohol n = 114). The Beijing version of the Montreal Cognitive Assessment and the Chinese version of the neuropsychological test battery were used to assess cognitive functions.
   Results: There was no significant difference in cognitive functions between alcohol and non-alcohol groups in the overall database. Similarly, there was no significant difference in liver function and lipid metabolism between two groups in the sub-database. The left superiortemporal gyrus was one of age sensitive regions and alcohol consumption was significantly associated with thinner cortex of the left superiotemporal cluster in the sub-database.
   Conclusion: Alcohol consumption was not significantly associated with better or worse cognitive function and biochemical indexes abnormality, however, significantly associated with thinner cortex of the left superiortemporal gyrus in cognitively normal aging Han Chinese population.
C1 [Sun, Lin; Xu, Hua; Li, Wei; Nie, Jing; Qiu, Qi; Liu, Yuanyuan; Fang, Yuan; Yang, Zhi; Li, Xia; Xiao, Shifu] Shanghai Jiao Tong Univ, Alzheimers Dis & Related Disorders Ctr, Shanghai Mental Hlth Ctr, Sch Med,Dept Geriatr Psychiat, Shanghai, Peoples R China.
   [Zhang, Jie] Tong Ji Univ Sch Med, Shanghai East Hosp, Key Lab Anhythmias, Minist Educ, Shanghai, Peoples R China.
C3 Shanghai Jiao Tong University
RP Yang, Z; Li, X; Xiao, SF (corresponding author), Shanghai Jiao Tong Univ, Alzheimers Dis & Related Disorders Ctr, Shanghai Mental Hlth Ctr, Sch Med,Dept Geriatr Psychiat, Shanghai, Peoples R China.
EM yangz@smhc.org.cn; ja_1023@hotmail.com; xiaoshifu@msn.com
RI Yang, Zhi/W-6459-2019; liu, yuanyuan/HSG-8372-2023; liu,
   pu/HOH-6399-2023; liu, yang/HQY-7531-2023; LIU, YANG/HWQ-4615-2023; liu,
   园园/HJI-4438-2023; liu, yuanyuan/IQS-2755-2023; Liu, Yang/HNJ-6693-2023
OI Yang, Zhi/0000-0002-2222-2312; 
FU Western medical guidance project of Shanghai Science and Technology
   Commission [17411970100, 15411961400]; National Natural Science
   Foundation of China [81301139, 81270023, 81571756]; National Key R&D
   Program of China [2017YFC1310501500]; Precision medical research project
   of Shanghai Jiao Tong University School of Medicine [15ZH4010];
   SHSMU-ION Research Center for brain disorders [2015NKX003, 2015NKX001,
   2015NKX004]; Shanghai Municipal Education Commission - Gaofeng clinical
   medicine grant support [20171929]; Startup fund from Shanghai Mental
   Health Center [13dz2260500]
FX This study was supported by grants of Western medical guidance project
   of Shanghai Science and Technology Commission (Grant Nos. 17411970100
   and 15411961400), National Natural Science Foundation of China (Grant
   Nos. 81301139, 81270023, and 81571756), National Key R&D Program of
   China (Grant No. 2017YFC1310501500), Precision medical research project
   of Shanghai Jiao Tong University School of Medicine (Grant No.
   15ZH4010). SHSMU-ION Research Center for brain disorders (Grant Nos.
   2015NKX003, 2015NKX001, and 2015NKX004), Shanghai Municipal Education
   Commission - Gaofeng clinical medicine grant support (Grant No.
   20171929), and Startup fund from Shanghai Mental Health Center
   (13dz2260500, start-up fund to ZY).
CR Cho YE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172463
   Clarke TK, 2017, MOL PSYCHIATR, V22, P1376, DOI 10.1038/mp.2017.153
   Corley J, 2011, NEUROPSYCHOLOGY, V25, P166, DOI 10.1037/a0021571
   Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018
   Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395
   Davis BJK, 2014, J GERONTOL A-BIOL, V69, P1528, DOI 10.1093/gerona/glu092
   Degerud E, 2018, PSYCHOL MED, V48, P2011, DOI 10.1017/S0033291717003543
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Lang I, 2007, AGE AGEING, V36, P256, DOI 10.1093/ageing/afm001
   Lange EH, 2017, PSYCHOL MED, V47, P655, DOI 10.1017/S0033291716002920
   Liu Y Y., 2011, Zhonghua Linchuang Yishi Zazhi (Dianzi Ban), V5, P1339
   Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
   O'Malley SS, 2015, DRUG ALCOHOL DEPEN, V149, P87, DOI 10.1016/j.drugalcdep.2015.01.023
   Paul CA, 2008, ARCH NEUROL-CHICAGO, V65, P1363, DOI 10.1001/archneur.65.10.1363
   Pilatti A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01452
   Reid MC, 2006, J GERIATR PSYCH NEUR, V19, P98, DOI 10.1177/0891988706286513
   Shokri-Kojori E, 2017, MOL PSYCHIATR, V22, P1185, DOI 10.1038/mp.2016.25
   Topiwala A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2353
   Vetreno RP, 2017, ADDICT BIOL, V22, P712, DOI 10.1111/adb.12364
   Vetreno RP, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00035
   Vinader-Caerols C, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01720
   Wallon D, 2012, J ALZHEIMERS DIS, V30, P847, DOI 10.3233/JAD-2012-120172
   Xiao Shifu, 2013, Shanghai Arch Psychiatry, V25, P91, DOI 10.3969/j.issn.1002-0829.2013.02.005
NR 23
TC 6
Z9 7
U1 1
U2 21
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-4365
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD JUN 19
PY 2018
VL 10
AR 182
DI 10.3389/fnagi.2018.00182
PG 7
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA GJ9ZT
UT WOS:000435766000001
PM 29970998
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wang, L
   Sheng, YL
   Xu, WL
   Sun, MN
   Lv, S
   Yu, J
   Wang, XD
   Ding, GX
   Duan, Y
AF Wang, Li
   Sheng, Yunlu
   Xu, Wenli
   Sun, Minne
   Lv, Shan
   Yu, Jing
   Wang, Xiaodong
   Ding, Guoxian
   Duan, Yu
TI Mechanism of thyroid hormone signaling in skeletal muscle of aging mice
SO ENDOCRINE
LA English
DT Article; Early Access
DE Aging; Skeletal muscle; Thyroid hormone signaling; Mice
ID PITUITARY; EXPRESSION; RECEPTOR; KIDNEY; LIVER
AB Background and aim Skeletal muscle (SM) has been shown as a target of thyroid hormones (THs). However, the status of TH signaling in aged SM remains unclear. This study aimed to explore the mechanism of TH signaling in SM of aging mice. Methods Thirty C57BL/6J male mice were divided into 6-, 15- and 22-month (6, 15 and 22M) groups according to different age. Physical parameters were evaluated by analytical balance, grip strength test and histological analysis. Thyroid function was detected by enzyme-linked immunosorbent assay. TH signaling was compared among the three groups by real-time PCR and western blotting analysis. Results p16, p21, and p53 mRNA levels in SM increased in age-dependent manner. The muscle weight and strength decreased in 22M group compared to 6 and 15M groups. Concentrations of thyroid hormones, including free triiodothyronine (FT3), free thyroxine (FT4) and thyroid-stimulating hormone (TSH) in 22 M mice were not shown significant difference compared to 6M or 15M mice, although FT3 showed slightly decrease and TSH appeared a mild increase accompanying with age. mRNA levels of TH transporters, including MCT8 and MCT10, as well as iodothyronine deiodinase type 2 (DIO2) and type 3 (DIO3), were higher in 22M, while TH receptor alpha (TR alpha) mRNA and protein expression was lower in 22M, compared to the other groups. Type-I myosin heavy chain (MyHC I), MyHC IIx, and MyHC IIa were upregulated and Type-IIb MyHC (MyHC IIb) was downregulated in SM with advancing age. Conclusions TH signaling in SM changes with aging.
C1 [Wang, Li; Sheng, Yunlu; Xu, Wenli; Sun, Minne; Lv, Shan; Yu, Jing; Wang, Xiaodong; Ding, Guoxian; Duan, Yu] Nanjing Med Univ, Affiliated Hosp 1, Div Geriatr Endocrinol, 300 Guangzhou Rd, Nanjing 210029, Peoples R China.
C3 Nanjing Medical University
RP Ding, GX; Duan, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Div Geriatr Endocrinol, 300 Guangzhou Rd, Nanjing 210029, Peoples R China.
EM dinggx@njmu.edu.cn; duanyujsph@163.com
RI Yu, Jing/AAL-5498-2021
OI Yu, Jing/0000-0002-5062-7069; Duan, Yu/0000-0002-0035-5915
FU National Natural Science Foundation of China [81670724]
FX This study was supported by the National Natural Science Foundation of
   China (No. 81670724) to Y.D.
CR Ambrosio R, 2017, MOL CELL ENDOCRINOL, V459, P79, DOI 10.1016/j.mce.2017.06.014
   Bianco AC, 2019, ENDOCR REV, V40, P1000, DOI 10.1210/er.2018-00275
   Bloise FF, 2018, J ENDOCRINOL, V236, pR57, DOI 10.1530/JOE-16-0611
   Boelen A, 2017, J ENDOCRINOL, V233, P25, DOI 10.1530/JOE-16-0483
   Brent GA, 2014, THYROID, V24, P1, DOI 10.1089/thy.2013.0679
   Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047
   Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
   da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005
   Di Cosmo C, 2010, J CLIN INVEST, V120, P3377, DOI 10.1172/JCI42113
   [段宇 DUAN Yu], 2008, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V24, P275
   Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112
   Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y
   Kadoguchi T, 2020, GERIATR GERONTOL INT, V20, P78, DOI 10.1111/ggi.13818
   Locquet M, 2019, J AM MED DIR ASSOC, V20, P384, DOI 10.1016/j.jamda.2018.11.027
   Mebis L, 2009, EUR J ENDOCRINOL, V161, P243, DOI 10.1530/EJE-09-0290
   OPPENHEIMER JH, 1974, ENDOCRINOLOGY, V95, P897, DOI 10.1210/endo-95-3-897
   Ortiga-Carvalho TM, 2016, COMPR PHYSIOL, V6, P1387, DOI 10.1002/cphy.c150027
   Rolland Y, 2008, J NUTR HEALTH AGING, V12, P433, DOI 10.1007/BF02982704
   Salvatore D, 2014, NAT REV ENDOCRINOL, V10, P206, DOI 10.1038/nrendo.2013.238
   Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Sheng YL, 2019, AGING CLIN EXP RES, V31, P1113, DOI 10.1007/s40520-018-1057-z
   SILVA JE, 1978, ENDOCRINOLOGY, V103, P1196, DOI 10.1210/endo-103-4-1196
   Simonides WS, 2008, THYROID, V18, P205, DOI 10.1089/thy.2007.0256
   Tylki-Szymanska A, 2015, J MED GENET, V52, P312, DOI 10.1136/jmedgenet-2014-102936
   Yu FS, 2000, AM J PHYSIOL-REG I, V278, pR1545, DOI 10.1152/ajpregu.2000.278.6.R1545
   Zhang D, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0141-y
NR 28
TC 6
Z9 6
U1 1
U2 11
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
PD 2021 APR
PY 2021
VL 72
IS 1
BP 132
EP 139
DI 10.1007/s12020-020-02428-9
EA JUL 2020
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA RV6FB
UT WOS:000553652400001
PM 32720201
DA 2024-02-19
ER

PT J
AU Bauer, M
   Hamm, AC
   Bonaus, M
   Jacob, A
   Jaekel, J
   Schorle, H
   Pankratz, MJ
   Katzenberger, JD
AF Bauer, M
   Hamm, AC
   Bonaus, M
   Jacob, A
   Jaekel, J
   Schorle, H
   Pankratz, MJ
   Katzenberger, JD
TI Starvation response in mouse liver shows strong correlation with
   life-span-prolonging processes
SO PHYSIOLOGICAL GENOMICS
LA English
DT Article
DE microarray analysis; nutrient response; caloric restriction; metabolic
   signaling; aging/longevity
ID GENE-EXPRESSION; CALORIC RESTRICTION; BINDING-PROTEIN;
   MOLECULAR-CLONING; DOWN-REGULATION; SYNTHASE GENE; INSULIN; RAT;
   LONGEVITY; MICE
AB We have monitored global changes in gene expression in mouse liver in response to fasting and sugar- fed conditions using high- density microarrays. From similar to 20,000 different genes, the significantly regulated ones were grouped into specific signaling and metabolic pathways. Striking changes in lipid signaling cascade, insulin and dehydroepiandrosterone ( DHEA) hormonal pathways, urea cycle and S- adenosylmethionine- based methyl transfer systems, and cell apoptosis regulators were observed. Since these pathways have been implicated to play a role in the aging process, and since we observe significant overlap of genes regulated upon starvation with those regulated upon caloric restriction, our analysis suggests that starvation may elicit a stress response that is also elicited during caloric restriction. Therefore, many of the signaling and metabolic components regulated during fasting may be the same as those which mediate caloric restriction- dependent life- span extension.
C1 Forschungszentrum Karlsruhe, Inst Genet, D-76021 Karlsruhe, Germany.
   Univ Bonn, Inst Pathol, D-53127 Bonn, Germany.
   Forschungszentrum Karlsruhe, Inst Angew Informat, D-76021 Karlsruhe, Germany.
C3 Helmholtz Association; Karlsruhe Institute of Technology; University of
   Bonn; Helmholtz Association; Karlsruhe Institute of Technology
RP Jaekel, J (corresponding author), Forschungszentrum Karlsruhe, Inst Genet, Postfach 3640, D-76021 Karlsruhe, Germany.
RI Schorle, Hubert/M-5001-2016; Schorle, Hubert/S-1713-2019
OI Schorle, Hubert/0000-0001-8272-0076; Jaekel, Jens/0000-0003-1569-3543
CR Allolio B, 2002, TRENDS ENDOCRIN MET, V13, P288, DOI 10.1016/S1043-2760(02)00617-3
   Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578
   Antebi A, 2000, GENE DEV, V14, P1512
   Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811
   BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X
   Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082
   BRUSILOW SW, 1984, NEW ENGL J MED, V310, P1630, DOI 10.1056/NEJM198406213102503
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4
   Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A
   DANESCH U, 1992, J BIOL CHEM, V267, P7185
   Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   Di Bacco A, 2003, ONCOGENE, V22, P5436, DOI 10.1038/sj.onc.1206670
   Figge A, 2004, J BIOL CHEM, V279, P2790, DOI 10.1074/jbc.M307363200
   Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435
   FITZPATRICK DR, 1995, GENOMICS, V27, P457, DOI 10.1006/geno.1995.1077
   Ford ES, 2002, INT J EPIDEMIOL, V31, P59, DOI 10.1093/ije/31.1.59
   Forestier M, 2003, BBA-MOL BASIS DIS, V1638, P29, DOI 10.1016/S0925-4439(03)00037-1
   Fujino T, 2001, J BIOL CHEM, V276, P35961, DOI 10.1074/jbc.M106651200
   Fujita T, 1999, MECH AGEING DEV, V107, P271, DOI 10.1016/S0047-6374(98)00136-5
   Gasmi L, 2001, BIOCHEM J, V357, P33, DOI 10.1042/0264-6021:3570033
   Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5
   Hertzel AV, 1998, GENE, V221, P235, DOI 10.1016/S0378-1119(98)00446-6
   Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857
   Holla VR, 2001, P NATL ACAD SCI USA, V98, P5211, DOI 10.1073/pnas.081627898
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200
   Inubushi T, 1996, BIOL CHEM, V377, P539
   Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999
   KAPPAS A, 1989, METABOLIC BASIS INHE
   Karlic H, 2003, J MOL MED, V81, P435, DOI 10.1007/s00109-003-0447-6
   Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2
   Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3
   Kikuta Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P225, DOI 10.1006/abbi.2000.2078
   Kurtz DM, 1998, MAMM GENOME, V9, P361, DOI 10.1007/s003359900770
   Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   Longo VD, 1999, NEUROBIOL AGING, V20, P479, DOI 10.1016/S0197-4580(99)00089-5
   Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398
   Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev
   Mazat L, 2001, P NATL ACAD SCI USA, V98, P8145, DOI 10.1073/pnas.121177998
   Meléndez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   MICHAL M, 1999, BIOCH PATHWAYS
   MOZIER NM, 1988, J BIOL CHEM, V263, P4527
   Muoio DM, 2002, BEST PRACT RES CL EN, V16, P653, DOI 10.1053/beem.2002.0223
   Murata T, 1997, MOL CELL BIOCHEM, V173, P127, DOI 10.1023/A:1006887929369
   Nadal A, 2002, BIOCHEM J, V366, P289, DOI 10.1042/BJ20020598
   Ntambi JM, 2003, CURR OPIN LIPIDOL, V14, P255, DOI 10.1097/00041433-200306000-00005
   Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699
   Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439
   Ren S, 2003, METABOLISM, V52, P636, DOI 10.1053/meta.2003.50106
   Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986
   Scassa ME, 1998, EXP CELL RES, V244, P460, DOI 10.1006/excr.1998.4206
   Schaefer EJ, 2002, AM J CLIN NUTR, V75, P191, DOI 10.1093/ajcn/75.2.191
   SCISLOWSKI PWD, 1994, BIOCHEM J, V300, P887, DOI 10.1042/bj3000887
   Scriver C. R., 1989, METABOLIC BASIS INHE
   Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564
   Shu ZG, 1999, MOL CELL BIOL, V19, P8686
   Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650
   Stypmann J, 2002, P NATL ACAD SCI USA, V99, P6234, DOI 10.1073/pnas.092637699
   Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   Taubes G, 2003, SCIENCE, V301, P40, DOI 10.1126/science.301.5629.40
   Taubes G, 2001, SCIENCE, V291, P2536, DOI 10.1126/science.291.5513.2536
   Tillman JB, 1996, J BIOL CHEM, V271, P3500, DOI 10.1074/jbc.271.7.3500
   Uthus EO, 2003, EXP GERONTOL, V38, P491, DOI 10.1016/S0531-5565(03)00008-1
   Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140
   VANDEVELDE C, MOL CELL BIOL, V15, P5454
   Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698
   Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200
   WATANABE R, 1994, BIOCHEM BIOPH RES CO, V200, P253, DOI 10.1006/bbrc.1994.1442
   Waters C, 2000, NEUROLOGY, V55, pS57
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
   Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15
   Yen SSC, 2001, P NATL ACAD SCI USA, V98, P8167, DOI 10.1073/pnas.161278698
   Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200
   Zhao WQ, 2001, EXP NEUROL, V171, P127, DOI 10.1006/exnr.2001.7726
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
   Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600
   Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546
NR 86
TC 135
Z9 154
U1 0
U2 17
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1094-8341
EI 1531-2267
J9 PHYSIOL GENOMICS
JI Physiol. Genomics
PD APR 13
PY 2004
VL 17
IS 2
BP 230
EP 244
DI 10.1152/physiolgenomics.00203.2003
PG 15
WC Cell Biology; Genetics & Heredity; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity; Physiology
GA 829YR
UT WOS:000222088800016
PM 14762175
DA 2024-02-19
ER

PT J
AU Hillje, R
   Luzi, L
   Amatori, S
   Persico, G
   Casciaro, F
   Rusin, M
   Fanelli, M
   Pelicci, P
   Giorgio, M
AF Hillje, Roman
   Luzi, Lucilla
   Amatori, Stefano
   Persico, Giuseppe
   Casciaro, Francesca
   Rusin, Martina
   Fanelli, Mirco
   Pelicci, Piergiuseppe
   Giorgio, Marco
TI Time makes histone H3 modifications drift in mouse liver
SO AGING-US
LA English
DT Article
DE epigenetics; aging; histones; ChIP-seq; diet
ID LIFE-SPAN; CHROMATIN MODIFICATIONS; DIETARY RESTRICTION; STEM-CELLS;
   GENOME; ACETYLATION; METHYLATION; AGE
AB To detect the epigenetic drift of time passing, we determined the genome-wide distributions of mono- and trimethylated lysine 4 and acetylated and tri-methylated lysine 27 of histone H3 in the livers of healthy 3, 6 and 12 months old C57BL/6 mice. The comparison of different age profiles of histone H3 marks revealed global redistribution of histone H3 modifications with time, in particular in intergenic regions and near transcription start sites, as well as altered correlation between the profiles of different histone modifications. Moreover, feeding mice with caloric restriction diet, a treatment known to retard aging, reduced the extent of changes occurring during the first year of life in these genomic regions.
C1 [Hillje, Roman; Luzi, Lucilla; Persico, Giuseppe; Rusin, Martina; Pelicci, Piergiuseppe; Giorgio, Marco] IRCCS European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy.
   [Amatori, Stefano; Rusin, Martina; Fanelli, Mirco] Univ Urbino Carlo Bo, Dept Biomol Sci, Mol Pathol Lab, I-61032 Fano, Italy.
   [Casciaro, Francesca; Pelicci, Piergiuseppe] Univ Milan, Dept Oncol & Hematooncol, I-20122 Milan, Italy.
   [Giorgio, Marco] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.
C3 IRCCS European Institute of Oncology (IEO); University of Urbino;
   University of Milan; University of Padua
RP Giorgio, M (corresponding author), IRCCS European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy.; Giorgio, M (corresponding author), Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.
EM marco.giorgio@unipd.it
RI Pelicci, Pier Giuseppe/AAL-6572-2020; Fanelli, Mirco/F-2665-2011
OI Fanelli, Mirco/0000-0002-9649-8661; Rusin, Martina/0000-0002-3012-2653;
   PELICCI, PIER GIUSEPPE/0000-0002-5076-2316
FU National Institute on Aging NIH U.S. grant [1R56AG057163-01A1]
FX This work was funded by National Institute on Aging NIH U.S. grant
   #1R56AG057163-01A1.
CR Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808
   Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009
   Benayoun BA, 2019, GENOME RES, V29, P697, DOI 10.1101/gr.240093.118
   Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027
   Blanco E, 2020, TRENDS GENET, V36, P118, DOI 10.1016/j.tig.2019.11.004
   Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048
   Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107
   Cheutin T, 2014, CURR OPIN GENET DEV, V25, P30, DOI 10.1016/j.gde.2013.11.016
   Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107
   Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511
   Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609
   Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906
   Fanelli M, 2011, NAT PROTOC, V6, P1905, DOI 10.1038/nprot.2011.406
   Gong H, 2015, ONCOTARGET, V6, P15882, DOI 10.18632/oncotarget.4137
   Goodell MA, 2015, SCIENCE, V350, P1199, DOI 10.1126/science.aab3388
   Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Kawakami K, 2009, BIOGERONTOLOGY, V10, P415, DOI 10.1007/s10522-008-9176-0
   Li YY, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-98
   Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101
   Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043
   Maures TJ, 2011, AGING CELL, V10, P980, DOI 10.1111/j.1474-9726.2011.00738.x
   Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112
   Nakamura A, 2013, GERONTOLOGY, V59, P542, DOI 10.1159/000354087
   Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108
   Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016
   Price AJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13092
   Ramsey JJ, 2014, J GERONTOL A-BIOL, V69, P1177, DOI 10.1093/gerona/glt198
   Ryu SH, 2011, EXP GERONTOL, V46, P811, DOI 10.1016/j.exger.2011.07.001
   Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243
   Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422
   Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107
   Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002
   Tsurumi A, 2012, EPIGENETICS-US, V7, P680, DOI 10.4161/epi.20540
   Veitia RA, 2017, TRENDS CELL BIOL, V27, P299, DOI 10.1016/j.tcb.2016.11.006
   Wang CM, 2010, BIOGERONTOLOGY, V11, P87, DOI 10.1007/s10522-009-9231-5
   Wood JG, 2010, AGING CELL, V9, P971, DOI 10.1111/j.1474-9726.2010.00624.x
   Zhang WQ, 2020, NAT REV MOL CELL BIO, V21, P137, DOI 10.1038/s41580-019-0204-5
   Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905
NR 39
TC 0
Z9 0
U1 1
U2 4
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUN 30
PY 2022
VL 14
IS 12
BP 4959
EP 4975
PG 17
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 3E1MS
UT WOS:000829754900005
PM 35687897
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Otano, I
   Escors, D
   Schurich, A
   Singh, H
   Robertson, F
   Davidson, BR
   Fusai, G
   Vargas, FA
   Tan, ZMD
   Aw, JYJ
   Hansi, N
   Kennedy, PTF
   Xue, SA
   Stauss, HJ
   Bertoletti, A
   Pavesi, A
   Maini, MK
AF Otano, Itziar
   Escors, David
   Schurich, Anna
   Singh, Harsimran
   Robertson, Francis
   Davidson, Brian R.
   Fusai, Giuseppe
   Vargas, Frederick A.
   Tan, Zhi M. D.
   Aw, Jia Y. J.
   Hansi, Navjyot
   Kennedy, Patrick T. F.
   Xue, Shao-An
   Stauss, Hans J.
   Bertoletti, Antonio
   Pavesi, Andrea
   Maini, Mala K.
TI Molecular Recalibration of PD-1+Antigen-Specific T Cells from Blood and
   Liver
SO MOLECULAR THERAPY
LA English
DT Article
ID MULTIPLE INHIBITORY RECEPTORS; PD-1 BLOCKADE; ANTI-PD-1 ANTIBODY;
   IMMUNOTHERAPY; LYMPHOCYTES; EXPRESSION; RESPONSES; IMMUNITY; THERAPY;
   TRANSCRIPTION
AB Checkpoint inhibitors and adoptive cell therapy provide promising options for treating solid cancers such as HBV-related HCC, but they have limitations. We tested the potential to combine advantages of each approach, genetically reprogramming T cells specific for viral tumor antigens to overcome exhaustion by down-modulating the co-inhibitory receptor PD-1. We developed a novel lentiviral transduction protocol to achieve preferential targeting of endogenous or TCR-redirected, antigen-specific CD8 T cells for shRNA knockdown of PD-1 and tested functional consequences for antitumor immunity. Antigen-specific and intrahepatic CD8 T cells transduced with lentiviral (LV)-shPD-1 consistently had a marked reduction in PD-1 compared to those transduced with a control lentiviral vector. PD-1 knockdown of human T cells rescued antitumor effector function and promoted killing of hepatoma cells in a 3D microdevice recapitulating the pro-inflammatory PD-L1(hi) liver microenvironment. However, upon repetitive stimulation, PD-1 knockdown drove T cell senescence and induction of other co-inhibitory pathways. We provide the proof of principle that T cells with endogenous or genetically engineered specificity for HBV-associated HCC viral antigens can be targeted for functional genetic editing. We show that PD-1 knockdown enhances immediate tumor killing but is limited by compensatory engagement of alternative co-inhibitory and senescence program upon repetitive stimulation.
C1 [Otano, Itziar; Escors, David; Schurich, Anna; Singh, Harsimran; Xue, Shao-An; Stauss, Hans J.; Maini, Mala K.] UCL, Inst Immun & Transplantat, Div Infect & Immun, Rayne Bldg,5 Univ St, London WC1E 6JF, England.
   [Robertson, Francis; Davidson, Brian R.; Fusai, Giuseppe] UCL, Dept Surg & Intervent Sci, London, England.
   [Vargas, Frederick A.] UCL, Inst Canc Res, London, England.
   [Otano, Itziar] Ctr Appl Med Res, Div Immun & Immunotherapy, Pamplona, Spain.
   [Otano, Itziar; Tan, Zhi M. D.; Aw, Jia Y. J.; Bertoletti, Antonio; Pavesi, Andrea] Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, Singapore.
   [Escors, David] IdiSNA, Navarrabiomed Biomed Res Ctr, Pamplona, Spain.
   [Schurich, Anna] Kings Coll London, Sch Immunol & Microbial Sci, London, England.
   [Hansi, Navjyot; Kennedy, Patrick T. F.] QMUL, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunobiol, London, England.
   [Xue, Shao-An] Xian Univ, Sch Biol & Environm Engn, Genet Engn Lab, Xian, Shaanxi, Peoples R China.
   [Bertoletti, Antonio] Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore.
C3 University of London; University College London; University of London;
   University College London; University of London; Institute of Cancer
   Research - UK; Royal Marsden NHS Foundation Trust; University College
   London; University of Navarra; Agency for Science Technology & Research
   (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB);
   Navarrabiomed; University of London; King's College London; University
   of London; Queen Mary University London; Xi'an University; National
   University of Singapore
RP Maini, MK (corresponding author), UCL, Inst Immun & Transplantat, Div Infect & Immun, Rayne Bldg,5 Univ St, London WC1E 6JF, England.; Pavesi, A (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, Singapore.
EM andreap@imcb.a-star.edu.sg; m.maini@ucl.ac.uk
RI Otano, Itziar/N-1410-2016; Xue, Shao-An/A-2735-2011; Escors,
   David/C-1549-2008
OI Otano, Itziar/0000-0002-1433-1711; Escors, David/0000-0003-2828-4458;
   Schurich, Anna/0000-0002-2525-3114; Maini, Mala/0000-0001-6384-1462
FU Wellcome Senior Investigator Award [101849/Z/13/Z]; Medical Research
   Council UK [G0801213]; EASL post-doctoral fellowship; Miguel Servet
   Fellowship (Insituto de Salud Carlos III, Spain) [CP12/03114]; LRF
   Programme grant; National Research Foundation (NRF) [NRF-CRP17-2017-06];
   Wellcome Trust [101849/Z/13/Z] Funding Source: Wellcome Trust; MRC
   [G0801213] Funding Source: UKRI
FX This work was funded by a Wellcome Senior Investigator Award
   (101849/Z/13/Z) and Medical Research Council UK grant (G0801213) to
   M.K.M. I.O. was funded by an EASL post-doctoral fellowship, D.E. is
   funded by a Miguel Servet Fellowship (CP12/03114, Insituto de Salud
   Carlos III, Spain), H.S. is funded by an LRF Programme grant, and A.P.
   is funded by a National Research Foundation (NRF) grant
   (NRF-CRP17-2017-06). We are grateful to all patients and control
   volunteers who participated in this study and to all clinical staff who
   helped with participant recruitment, including Amir Gander and the
   Tissue Access for Patient Benefit project at The Royal Free Hospital.
CR Abate-Daga D, 2013, BLOOD, V122, P1399, DOI 10.1182/blood-2013-04-495531
   Adriani G, 2016, DRUG DISCOV TODAY, V21, P1472, DOI 10.1016/j.drudis.2016.05.006
   Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001
   Beane JD, 2015, MOL THER, V23, P1380, DOI 10.1038/mt.2015.71
   Bengsch B, 2014, J HEPATOL, V61, P1212, DOI 10.1016/j.jhep.2014.07.005
   Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711
   Bertoletti A, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008354
   Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679
   Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06
   Boussiotis VA, 2016, NEW ENGL J MED, V375, P1767, DOI 10.1056/NEJMra1514296
   Cherkassky L, 2016, J CLIN INVEST, V126, P3130, DOI 10.1172/JCI83092
   Di Scala M, 2016, J VIROL, V90, P8563, DOI 10.1128/JVI.01030-16
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005
   El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2
   Escors D, 2008, BLOOD, V111, P3050, DOI 10.1182/blood-2007-11-122408
   Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052
   Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604
   Gane E, 2017, J HEPATOL, V66, pS26, DOI 10.1016/S0168-8278(17)30315-X
   Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775
   Gardiner D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063818
   Gargett T, 2016, MOL THER, V24, P1135, DOI 10.1038/mt.2016.63
   Gehring AJ, 2011, J HEPATOL, V55, P103, DOI 10.1016/j.jhep.2010.10.025
   Gehring AJ, 2009, GASTROENTEROLOGY, V137, P682, DOI 10.1053/j.gastro.2009.04.045
   Georgiadis C, 2018, MOL THER, V26, P1215, DOI 10.1016/j.ymthe.2018.02.025
   Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988
   Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011
   Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005
   Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235
   John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458
   Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010
   Kah J, 2017, J CLIN INVEST, V127, P3177, DOI 10.1172/JCI93024
   Kassel R, 2009, HEPATOLOGY, V50, P1625, DOI 10.1002/hep.23173
   Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052
   Koh S, 2018, GASTROENTEROLOGY, V155, P180, DOI 10.1053/j.gastro.2018.03.027
   Koh S, 2016, METHODS MOL BIOL, V1428, P285, DOI 10.1007/978-1-4939-3625-0_19
   Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998
   Lee SWL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00416
   Menger L, 2016, CANCER RES, V76, P2087, DOI 10.1158/0008-5472.CAN-15-3352
   Naidoo J, 2015, ANN ONCOL, V26, P2375, DOI 10.1093/annonc/mdv383
   Nebbia G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047648
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237
   Pallett LJ, 2017, J EXP MED, V214, P1567, DOI 10.1084/jem.20162115
   Pavesi A, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89762
   Qasim W, 2015, J HEPATOL, V62, P486, DOI 10.1016/j.jhep.2014.10.001
   Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300
   Rivino L, 2018, J CLIN INVEST, V128, P668, DOI [10.1172/JCI92812, 10.1172/jci92812]
   Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348
   Schmidt N, 2016, DIGEST DIS, V34, P429, DOI 10.1159/000444558
   Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112
   Schurich A, 2011, HEPATOLOGY, V53, P1494, DOI 10.1002/hep.24249
   Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491
   Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172
   Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070
   Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690
   Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954
   Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606
   Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862
   Zehn D, 2016, CURR OPIN VIROL, V16, P49, DOI 10.1016/j.coviro.2016.01.002
NR 60
TC 19
Z9 23
U1 1
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD NOV 7
PY 2018
VL 26
IS 11
BP 2553
EP 2566
DI 10.1016/j.ymthe.2018.08.013
PG 14
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA HF1ER
UT WOS:000453909200005
PM 30217730
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Lupp, A
   Glöckner, R
   Etzrodt, J
   Möller, D
AF Lupp, Amelie
   Gloeckner, Reinhild
   Etzrodt, Joachim
   Moeller, Dieter
TI Precision-cut liver slices from rats of different ages: basal cytochrome
   P450-dependent monooxygenase activities and inducibility
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE Rat; Liver slices; Precision-cut; Age dependency; Cytochrome P450;
   Induction
ID DRUG-METABOLIZING-ENZYMES; MIXED-FUNCTION OXIDASES; FETAL LIVER; WISTAR
   RATS; IN-VIVO; EXPRESSION; INDUCTION; ONTOGENY; ISOFORMS; CYP3A
AB The biotransformation capacity - of the cytochrome P450 (CYP) system for example - is lower but inducibility is more pronounced in neonates than in adults. On the other hand, both enzyme activities and inducibility decline with senescence. Precision-cut rat liver slices are widely used as an in vitro tool for the examination of drug toxicity, xenobiotic metabolism or enzyme induction. The aim of the present study was to assess whether age-related changes in CYP activities and induction observed in vivo are also mirrored in vitro in liver slices. For this purpose, different CYP model reactions were measured in precision-cut liver slices from one-day-old, 40-day-old and one-year-old rats after in vitro exposure to various inducers. Similar to the in vivo situation, basal CYP activities were distinctly lower and inducibility was much more pronounced in liver slices from neonatal than in those from adult animals. Also, enzyme activities were mostly somewhat lower in liver slices from aged rats compared to those from 40-day-old rats. However, CYP inducibility was less pronounced than with younger animals too. Thus, precision-cut rat liver slices are a suitable in vitro tool for investigating age-related changes in CYP activities and induction as well as developmental differences in drug metabolism and toxicity.
C1 [Lupp, Amelie; Gloeckner, Reinhild; Etzrodt, Joachim; Moeller, Dieter] Univ Jena, Inst Pharmacol & Toxicol, D-07743 Jena, Germany.
   [Etzrodt, Joachim] Univ Jena, Dept Gen Visceral & Vasc Surg, D-07747 Jena, Germany.
C3 Friedrich Schiller University of Jena; Friedrich Schiller University of
   Jena
RP Lupp, A (corresponding author), Univ Jena, Inst Pharmacol & Toxicol, Nonnenplan 4, D-07743 Jena, Germany.
EM amelie.lupp@mti.uni-jena.de
CR Alcorn J, 2002, CLIN PHARMACOKINET, V41, P1077, DOI 10.2165/00003088-200241130-00005
   Benedetti MS, 2007, DRUG DISCOV TODAY, V12, P599, DOI 10.1016/j.drudis.2007.06.011
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P299, DOI 10.1016/0531-5565(78)90038-4
   Blake MJ, 2005, SEMIN FETAL NEONAT M, V10, P123, DOI 10.1016/j.siny.2004.11.001
   BORLAKOGLU JT, 1993, INT J BIOCHEM, V25, P1659, DOI 10.1016/0020-711X(93)90525-J
   CORREIAMA, 1995, CYTOCHROME P450 STRU, P607
   Graaf IAM, 2007, EXPERT OPIN DRUG MET, V3, P879, DOI 10.1517/17425255.3.6.879
   Elbarbry FA, 2007, J BIOCHEM MOL TOXIC, V21, P41, DOI 10.1002/jbt.20156
   Farkas D, 2005, CURR DRUG METAB, V6, P111, DOI 10.2174/1389200053586118
   Fisher RL, 2001, CELL BIOL TOXICOL, V17, P179, DOI 10.1023/A:1011944531257
   Gebhardt R, 2003, DRUG METAB REV, V35, P145, DOI 10.1081/DMR-120023684
   Glöckner R, 1999, TOXICOL IN VITRO, V13, P531, DOI 10.1016/S0887-2333(99)00021-1
   Groneberg DA, 2002, TOXICOL PATHOL, V30, P394, DOI 10.1080/01926230252929972
   HART A, 1983, IN VITRO CELL DEV B, V19, P841
   Hines RN, 2007, J BIOCHEM MOL TOXIC, V21, P169, DOI 10.1002/jbt.20179
   Iwai M, 2002, CELL BIOL TOXICOL, V18, P147, DOI 10.1023/A:1015500219572
   Johnson TN, 2000, BIOCHEM PHARMACOL, V60, P1601, DOI 10.1016/S0006-2952(00)00485-8
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   Kinirons MT, 2004, BRIT J CLIN PHARMACO, V57, P540, DOI 10.1111/j.1365-2125.2004.02096.x
   Klinger W, 2005, EUR J DRUG METAB PH, V30, P3, DOI 10.1007/BF03226403
   KLINGER W, 1974, Z VERSUCHSTIERKD, V16, P149
   Lake BG, 1998, TOXICOLOGY, V131, P9, DOI 10.1016/S0300-483X(98)00085-7
   LEE PC, 1994, BIOCHEM MOL BIOL INT, V34, P861
   Lerche-Langrand C, 2000, TOXICOLOGY, V153, P221, DOI 10.1016/S0300-483X(00)00316-4
   Lewis DFV., 2001, GUIDE CYTOCHROMES P4
   LUM PY, 1985, TOXICOLOGY, V35, P307, DOI 10.1016/0300-483X(85)90064-2
   Lupp A, 2005, TOXICOLOGY, V206, P427, DOI 10.1016/j.tox.2004.08.011
   Lupp A, 1998, EXP TOXICOL PATHOL, V50, P41, DOI 10.1016/S0940-2993(98)80064-X
   Martin H, 2003, PHARMACEUT RES, V20, P557, DOI 10.1023/A:1023234429596
   MCMARTIN DN, 1980, TOXICOL APPL PHARM, V54, P411, DOI 10.1016/0041-008X(80)90168-4
   MULLER D, 1985, BIOMED BIOCHIM ACTA, V44, P1171
   MULLER D, 1990, EXP PATHOL-JENA, V39, P187
   Müller D, 1998, EXP TOXICOL PATHOL, V50, P507
   Oinonen T, 1998, BIOCHEM J, V329, P17, DOI 10.1042/bj3290017
   Olinga P, 1998, DRUG METAB DISPOS, V26, P5
   Olinga P, 1998, TOXICOL IN VITRO, V12, P77, DOI 10.1016/S0887-2333(97)00097-0
   Persson KP, 2006, PHARM RES, V23, P56, DOI 10.1007/s11095-005-8812-5
   Renwick AB, 2000, DRUG METAB DISPOS, V28, P1202
   RIBEIRO V, 1992, ARCH BIOCHEM BIOPHYS, V293, P147, DOI 10.1016/0003-9861(92)90377-9
   Rich KJ, 1997, MICROSC RES TECHNIQ, V39, P424, DOI 10.1002/(SICI)1097-0029(19971201)39:5<424::AID-JEMT5>3.0.CO;2-G
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   Tanaka E, 1998, J CLIN PHARM THER, V23, P247
   VandenBranden M, 1998, DRUG METAB DISPOS, V26, P1063
   Vermeir Marc, 2005, Expert Opin Drug Metab Toxicol, V1, P75, DOI 10.1517/17425255.1.1.75
   Verrill C, 2002, J PHARMACOL TOX MET, V48, P103, DOI 10.1016/S1056-8719(03)00042-X
   Warrington JS, 2004, J PHARMACOL EXP THER, V309, P720, DOI 10.1124/jpet.103.061077
   WATANABE J, 1993, J HISTOCHEM CYTOCHEM, V41, P397, DOI 10.1177/41.3.8429202
   Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981
   Wauthier V, 2004, TOXICOL IN VITRO, V18, P879, DOI 10.1016/j.tiv.2004.04.013
   Wauthier V, 2004, ARCH TOXICOL, V78, P131, DOI 10.1007/s00204-003-0526-z
NR 50
TC 7
Z9 8
U1 0
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
EI 1618-2650
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD NOV
PY 2008
VL 392
IS 6
BP 1173
EP 1184
DI 10.1007/s00216-008-2253-z
PG 12
WC Biochemical Research Methods; Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 364YS
UT WOS:000260372500014
PM 18629480
DA 2024-02-19
ER

PT J
AU Atia, A
   Alrawaiq, NS
   Abdullah, A
AF Atia, Ahmed
   Alrawaiq, Nadia Salem
   Abdullah, Azman
TI Effect of Tocotrienol-Rich Fraction on Superoxide Dismutase 3 Expression
   in Mice Liver
SO INTERNATIONAL JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Superoxide dismutase 3; SOD3; liver; mice; tocotrienols; TRF;
   anti-ageing
ID VITAMIN-E; GAMMA-TOCOTRIENOL; OXIDATIVE STRESS; GENE-EXPRESSION; HEALTH;
   NRF2; ANTIOXIDANTS; CANCER; DAMAGE; LUNG
AB Background and Objective: Superoxide Dismutase (SOD) is responsible for the dismutation of superoxide radicals and protect cells from toxic impairment due to excessive oxygen exposure. Overexpression of the superoxide dismutase 3 isoenzyme (SOD3) had been suggested to prevent cancer growth. Tocotrienols are the more potent members of the vitamin E family. The objective of this study was to investigate the dose-dependent effect of Tocotrienol Rich Fraction (TRF) supplementation on liver SOD3 gene and protein expression. Materials and Methods: Thirty male ICR white mice were divided into five groups [control, TRF-treated groups (T200, T500, T1000) and BHA (the positive control)]. After 14 days of treatment, the animals were sacrificed. Liver RNA and protein were extracted for qPCR and Western blotting to determine SOD3 gene and protein expressions and analysed using one-way ANOVA and Student's t-test. Results: TRF oral administration significantly increased liver SOD3 gene and protein expressions dose-dependently, compared to controls. Liver SOD3 gene and protein expressions are significantly correlated with the doses of TRF administered. SOD3 gene expression is significantly highly correlated with SOD3 protein expression. Conclusion: In conclusion, TRF oral treatment for 14 days resulted in increased SOD3 gene and protein expression in mice liver in a dose-dependent manner, with the highest expression seen in mice treated with 1000 mg kg(-1) TRF.
C1 [Atia, Ahmed; Alrawaiq, Nadia Salem; Abdullah, Azman] Univ Kebangsaan Malaysia, Fac Med, Dept Pharmacol, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.
   [Atia, Ahmed] Tripoli Univ, Fac Med Technol, Dept Anesthesia & Intens Care, Tripoli, Libya.
   [Alrawaiq, Nadia Salem] Sebha Univ, Fac Pharm, Dept Pharmacol, Sebha, Libya.
C3 Universiti Kebangsaan Malaysia; University of Tripoli; Sebha University
RP Abdullah, A (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Pharmacol, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.
RI Atia, Ahmed/B-2078-2015; Abdullah, Azman/HOF-6275-2023
OI Atia, Ahmed/0000-0002-9951-1921; 
FU Universiti Kebangsaan Malaysia (UKM) [UKM-GGPM-TKP-051-2010,
   FF-176-2013]
FX The authors would like to thank Universiti Kebangsaan Malaysia (UKM) for
   providing the financial assistance to conduct this study through the
   conferment of research grants UKM-GGPM-TKP-051-2010 and FF-176-2013.
CR Abdullah A, 2012, PHARMACOL REP, V64, P680, DOI 10.1016/S1734-1140(12)70863-0
   Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043
   Ahsan H, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-52
   Almazroo OA, 2017, CLIN LIVER DIS, V21, P1, DOI 10.1016/j.cld.2016.08.001
   Atla A, 2018, SAINS MALAYS, V47, P2799, DOI 10.17576/jsm-2018-4711-23
   Che MX, 2016, DRUG DISCOV TODAY, V21, P143, DOI 10.1016/j.drudis.2015.10.001
   Chin SF, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-42
   Feng ZH, 2010, J NUTR BIOCHEM, V21, P1222, DOI 10.1016/j.jnutbio.2009.10.010
   Gongora MC, 2008, AM J PATHOL, V173, P915, DOI 10.2353/ajpath.2008.080119
   Griess B, 2017, FREE RADICAL BIO MED, V112, P464, DOI 10.1016/j.freeradbiomed.2017.08.013
   Hsieh TC, 2008, INT J ONCOL, V33, P851, DOI 10.3892/ijo_00000073
   Kanchi MM, 2017, DRUG DISCOV TODAY, V22, P1765, DOI 10.1016/j.drudis.2017.08.001
   Khor SC, 2015, CLIN TER, V166, pE81, DOI [10.7417/CT.2015.1825, 10.7417/T.2015.1825]
   Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO
   Kong L, 2007, J NEUROCHEM, V101, P1041, DOI 10.1111/j.1471-4159.2007.04481.x
   Lee SP, 2009, EUR J APPL PHYSIOL, V107, P587, DOI 10.1007/s00421-009-1159-6
   Li GX, 2012, FREE RADICAL BIO MED, V52, P1151, DOI 10.1016/j.freeradbiomed.2011.12.005
   Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Pall Martin L., 2015, Shengli Xuebao, V67, P1
   Peh HY, 2017, FREE RADICAL BIO MED, V110, P332, DOI 10.1016/j.freeradbiomed.2017.06.023
   Peh HY, 2016, PHARMACOL THERAPEUT, V162, P152, DOI 10.1016/j.pharmthera.2015.12.003
   Peh HY, 2015, J IMMUNOL, V195, P437, DOI 10.4049/jimmunol.1500362
   Rosa AC, 2021, MOLECULES, V26, DOI 10.3390/molecules26071844
   Sailo BL, 2018, PHARMACOL RES, V130, P259, DOI 10.1016/j.phrs.2018.02.017
   Saso L, 2014, CURR DRUG TARGETS, V15, P1177, DOI 10.2174/1389450115666141024113925
   Sen CK, 2010, J AM COLL NUTR, V29, p314S, DOI 10.1080/07315724.2010.10719846
   Seta F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023439
   Singh B, 2012, CARCINOGENESIS, V33, P2601, DOI 10.1093/carcin/bgs300
   Sundram K, 2003, ASIA PAC J CLIN NUTR, V12, P355
   Wang YD, 2015, MOL ENDOCRINOL, V29, P322, DOI 10.1210/me.2014-1225
   Wong WY, 2012, NUTRIENTS, V4, P1527, DOI 10.3390/nu4101527
   Zhang JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122175
NR 33
TC 0
Z9 0
U1 0
U2 5
PU ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET
PI FAISALABAD
PA 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN
SN 1811-7775
EI 1812-5700
J9 INT J PHARMACOL
JI Int. J. Pharmacol.
PY 2021
VL 17
IS 8
BP 531
EP 540
DI 10.3923/ijp.2021.532.540
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA WM6IM
UT WOS:000711187000002
OA Bronze
DA 2024-02-19
ER

PT J
AU Barbot, W
   Dupressoir, A
   Lazar, V
   Heidmann, T
AF Barbot, W
   Dupressoir, A
   Lazar, V
   Heidmann, T
TI Epigenetic regulation of an IAP retrotransposon in the aging mouse:
   progressive demethylation and de-silencing of the element by its
   repetitive induction
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID INTRACISTERNAL-A-PARTICLES; AGE-RELATED REACTIVATION; X-LINKED GENE; DNA
   METHYLATION; TRANSCRIPTION FACTOR; CYTOSINE METHYLATION; BINDING;
   EXPRESSION; PROMOTER; CELLS
AB The recent insertion of a murine intracisternal A-particle (IAP) retrotransposon within one of the introns of a housekeeping gene, the circadian m. nocturnin gene, revealed a singular expression profile, both throughout the daytime and the mouse life span. Measurement of the levels of transcripts from this element by quantitative real-time RT-PCR, in organs of 1-24-month-old mice, disclosed that the inserted element-which is part of a large family of otherwise severely repressed mobile elements-becomes active upon aging, specifically in the liver where the m. nocturnin housekeeping gene is expressed in a circadian manner and induces a circadian expression of the IAP sequence. This age-dependent induction is cell-autonomous, as it persists in hepatocytes in primary culture. We further show, using methylation-sensitive enzymes, a correlation between the life-time kinetics of this process and a liver-specific demethylation of the IAP promoter. These results strongly support a model whereby the progressive demethylation and turning on of the IAP sequence is the sole result of the transient, daily activation-throughout the mouse life span-of its promoter. This phenomenon, which develops on a timescale of months to years in the aging mouse, might reveal a general epigenetic-and stochastic-process, which could account for a large series of events associated with cell and animal aging.
C1 Inst Gustave Roussy, Unite Retrovirus Endogenes & Elements Retroides E, CNRS, UMR 1573, F-94805 Villejuif, France.
   Inst Gustave Roussy, Unite Genom Fonct, F-94805 Villejuif, France.
C3 UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique
   (CNRS); UNICANCER; Gustave Roussy
RP Heidmann, T (corresponding author), Inst Gustave Roussy, Unite Retrovirus Endogenes & Elements Retroides E, CNRS, UMR 1573, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.
RI Dupressoir, Anne/M-5280-2018; Lazar, Vladimir/AAQ-2086-2020; Lazar,
   Vladimir/AAV-2087-2020
OI Dupressoir, Anne/0000-0002-3464-8513; 
CR BARBOT W, 2002, IN PRESS BIOCH BIOPH
   BEDNARIK DP, 1990, EMBO J, V9, P1157, DOI 10.1002/j.1460-2075.1990.tb08222.x
   BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x
   BROWN S, 1988, GENET RES, V52, P151, DOI 10.1017/S0016672300027531
   Chen C, 2001, J BIOL CHEM, V276, P320, DOI 10.1074/jbc.M007096200
   DEAN RG, 1985, ARCH GERONTOL GERIAT, V4, P43, DOI 10.1016/0167-4943(85)90017-2
   DEOCA FHM, 1984, BIOL CELL, V52, P199
   Deragon JM, 1996, PLANT MOL BIOL, V32, P869, DOI 10.1007/BF00020484
   Dupressoir A, 1999, J BIOL CHEM, V274, P31068, DOI 10.1074/jbc.274.43.31068
   Dupressoir A, 1996, MOL CELL BIOL, V16, P4495
   Dupressoir A, 1995, BBA-GENE STRUCT EXPR, V1264, P397, DOI 10.1016/0167-4781(95)00181-6
   ENVER T, 1988, GENE DEV, V2, P698, DOI 10.1101/gad.2.6.698
   FALZON M, 1991, MOL CELL BIOL, V11, P117, DOI 10.1128/MCB.11.1.117
   FEENSTRA A, 1986, NUCLEIC ACIDS RES, V14, P4343, DOI 10.1093/nar/14.10.4343
   FLORINE DL, 1980, CANCER RES, V40, P519
   HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M
   HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127
   HSIAO WLW, 1986, J VIROL, V57, P1119, DOI 10.1128/JVI.57.3.1119-1126.1986
   Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997
   KANUNGO MS, 1994, GENES AGING
   Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7
   KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7
   KUFF EL, 1990, CANCER CELL-MON REV, V2, P398
   LUEDERS KK, 1993, MOL CELL BIOL, V13, P7439, DOI 10.1128/MCB.13.12.7439
   Matsuo K, 1998, EMBO J, V17, P1446, DOI 10.1093/emboj/17.5.1446
   MAYSHOOPES L, 1986, DEV GENET, V7, P65, DOI 10.1002/dvg.1020070202
   MIETZ JA, 1992, MOL CELL BIOL, V12, P220, DOI 10.1128/MCB.12.1.220
   MIETZ JA, 1990, P NATL ACAD SCI USA, V87, P2269, DOI 10.1073/pnas.87.6.2269
   Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3
   Puech A, 1997, J BIOL CHEM, V272, P5995, DOI 10.1074/jbc.272.9.5995
   SIEGFRIED Z, 1997, CURR BIOL, V7, P305
   SILKE J, 1995, FEBS LETT, V370, P170, DOI 10.1016/0014-5793(95)00830-3
   Wade PA, 2001, ONCOGENE, V20, P3166, DOI 10.1038/sj.onc.1204340
   Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413
   Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9
   WAREHAM KA, 1987, NATURE, V327, P725, DOI 10.1038/327725a0
   WEISSHAAR B, 1988, J MOL BIOL, V202, P255, DOI 10.1016/0022-2836(88)90456-1
   WILKS A, 1984, NUCLEIC ACIDS RES, V12, P1163, DOI 10.1093/nar/12.2.1163
   Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5
NR 39
TC 87
Z9 96
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUN 1
PY 2002
VL 30
IS 11
BP 2365
EP 2373
DI 10.1093/nar/30.11.2365
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 563LE
UT WOS:000176256500012
PM 12034823
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Fu, CX
   Xi, L
   Wu, YM
   McCarter, R
   Richardson, A
   Hickey, M
   Han, ES
AF Fu, CX
   Xi, L
   Wu, YM
   McCarter, R
   Richardson, A
   Hickey, M
   Han, ES
TI Hepatic genes altered in expression by food restriction are not
   influenced by the low plasma glucose level in young male GLUT4
   transgenic mice
SO JOURNAL OF NUTRITION
LA English
DT Article
DE gene expression; food restriction; GLUT4 transgenic mouse; GeneChip
   array
ID CALORIC RESTRICTION; DIETARY RESTRICTION; MOUSE-LIVER; AGE; PROFILE;
   MICROARRAYS; RESPONSES; MUSCLE; ARRAYS
AB Because food restriction (FR) has a profound effect on most tissues, it is plausible that the modulation of aging by FR occurs through cellular processes such as gene expression. The effect of FR in lowering plasma glucose levels has been demonstrated in mice, rats, and nonhuman primates. The consistency of this finding suggests that decreased plasma glucose may be an important consequence of FR. Indeed, lowering plasma glucose in the absence of FR would be expected to change the expression of some of the same genes as seen with FR. GLUT4 transgenic (TG) mice were particularly suited to this examination because they have low plasma glucose levels like FR mice. We investigated altered gene expression by FR and the effect of low plasma glucose levels caused by genetic manipulation by measuring mRNA expression in liver tissues of 4- to 6-mo-old mice with 2.5-4.5 mo of FR using microarrays and 4 groups: GLUT4 TG (C57BL/6 background) consumed food ad libitum (AL), GLUT4 TG FR, wild-type littermates AL, and wild-type littermates FR. The 3 statistical analysis methods commonly indicated that FR altered the expression of 1277 genes; however, none of these genes was altered by additional GLUT4 expression. In fact, the low plasma glucose level in GLUT4 TG mice did not affect gene expression. Some results were confirmed by real-time quantitative RT-PCR. We conclude that a low plasma glucose level does not contribute to or coincide with the effect of FR on gene expression in the liver.
C1 Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.
   Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   S Texas Vet Hlth Care Syst San Antonio, San Antonio, TX 78229 USA.
C3 University of Tulsa; University of Texas System; University of Texas
   Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio
RP Han, ES (corresponding author), Univ Tulsa, Dept Biol Sci, 600 S Coll Ave, Tulsa, OK 74104 USA.
EM eun-han@utulsa.edu
FU NIA NIH HHS [AG 14674-04S1, AG 00746] Funding Source: Medline
CR *AFF INC, 2004, STAT ALG DESCR DOC
   Blalock EM, 2003, J NEUROSCI, V23, P3807
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   CEFALU WT, 1995, J GERONTOL A-BIOL, V50, pB337, DOI 10.1093/gerona/50A.6.B337
   Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101
   Edwards MG, 2003, PHYSIOL GENOMICS, V13, P119, DOI 10.1152/physiolgenomics.00172.2002
   Falls JG, 1997, ARCH BIOCHEM BIOPHYS, V342, P212, DOI 10.1006/abbi.1997.9965
   Falls JG, 1997, ARCH BIOCHEM BIOPHYS, V347, P9, DOI 10.1006/abbi.1997.0322
   Han ES, 2004, J GERONTOL A-BIOL, V59, P306
   Han ES, 1998, J NUTR, V128, P1415, DOI 10.1093/jn/128.9.1415
   Han ES, 2000, MECH AGEING DEV, V115, P157, DOI 10.1016/S0047-6374(00)00119-6
   HARRIS SB, 1994, MECH AGEING DEV, V73, P209, DOI 10.1016/0047-6374(94)90053-1
   Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321
   Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609
   INOUYE C, 1994, DNA CELL BIOL, V13, P731, DOI 10.1089/dna.1994.13.731
   Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930
   Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898
   KEMNITZ JW, 1994, AM J PHYSIOL, V266, pE540, DOI 10.1152/ajpendo.1994.266.4.E540
   LAKSO M, 1991, EUR J BIOCHEM, V195, P477, DOI 10.1111/j.1432-1033.1991.tb15728.x
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098
   LIU ML, 1992, J BIOL CHEM, V267, P11673
   LIU ML, 1993, P NATL ACAD SCI USA, V90, P11346, DOI 10.1073/pnas.90.23.11346
   Marino JH, 2003, J IMMUNOL METHODS, V283, P291, DOI 10.1016/S0022-1759(03)00103-0
   MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202
   MASORO EJ, 1990, P SOC EXP BIOL MED, V193, P31, DOI 10.3181/00379727-193-42985
   Masoro EJ, 1996, J GERONTOL A-BIOL, V51, pB387, DOI 10.1093/gerona/51A.6.B387
   MASORO EJ, 1992, ANN NY ACAD SCI, V673, P29, DOI 10.1111/j.1749-6632.1992.tb27433.x
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   McCarthy EM, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0053
   RICHARDSON A, 1987, J BIOL CHEM, V262, P12821
   Ripp SL, 1999, DRUG METAB DISPOS, V27, P46
   Sambrook J, 1989, MOL CLONING LAB MANU
   Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744
   Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Wedemeyer N, 2000, FEBS LETT, V477, P49, DOI 10.1016/S0014-5793(00)01766-X
   WEINDRUCH R, 1988, RETARDATION AGING DI, P436
   Wong JS, 2002, TOXICOL APPL PHARM, V185, P180, DOI 10.1006/taap.2002.9540
   Wong JS, 2002, BIOCHEM BIOPH RES CO, V293, P549, DOI 10.1016/S0006-291X(02)00235-8
   Young KA, 2000, BIOL REPROD, V62, P347, DOI 10.1095/biolreprod62.2.347
   HDB NUTR AGED
NR 44
TC 9
Z9 9
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD NOV
PY 2004
VL 134
IS 11
BP 2965
EP 2974
DI 10.1093/jn/134.11.2965
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 870HB
UT WOS:000225047100014
PM 15514260
OA hybrid
DA 2024-02-19
ER

PT J
AU RAEDERSTORFF, D
   LOECHLEITER, V
   MOSER, U
AF RAEDERSTORFF, D
   LOECHLEITER, V
   MOSER, U
TI POLYUNSATURATED FATTY-ACID METABOLISM OF HUMAN SKIN FIBROBLASTS DURING
   CELLULAR AGING
SO INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
LA English
DT Article
ID GAMMA-LINOLENIC ACID; RAT-LIVER MICROSOMES; DELTA-6-DESATURASE ACTIVITY;
   DESATURATION; CELLS
AB The linoleic acid metabolism was studied in serially cultured human skin fibroblasts during 30 passages. Confluent cells were incubated with [U-C-14]linoleic acid in serum free medium for 4 h after 3, 6, 12, 18, 24 and 30 passages. The labeled linoleic acid was rapidly incorporated in cell lipids, preferentially into phospholipids (80%), and the distribution within the lipid classes remained constant during the cell cycles. The rate of conversion of [C-14] linoleic acid into long chain fatty acids varied with the number of passages. The formation of diho-mo-gamma-linolenic acid and of arachidonic acid decreased significantly from 12% to 5% (as % of incorporated linoleic acid) between. 3 and 30 serial passages whereas the linoleic acid content increased in the cells from 68% to 83%. The results indicate that the desaturase activities decreased significantly during cellular aging of human skin fibroblasts.
C1 F HOFFMANN LA ROCHE & CO LTD,DEPT VITAMIN & NUTR RES,CH-4002 BASEL,SWITZERLAND.
C3 Roche Holding
CR AEBERHARD EE, 1978, LIPIDS, V13, P758, DOI 10.1007/BF02533473
   BIAGI PL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P187, DOI 10.1016/0005-2760(91)90041-F
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   BOURRE JM, 1990, LIPIDS, V25, P354, DOI 10.1007/BF02544347
   BRENNER R R, 1981, Progress in Lipid Research, V20, P41, DOI 10.1016/0163-7827(81)90012-6
   BRENNER RR, 1974, MOL CELL BIOCHEM, V3, P41, DOI 10.1007/BF01660076
   BRENNER RR, 1971, LIPIDS, V6, P567, DOI 10.1007/BF02531137
   FAAS FH, 1980, LIPIDS, V15, P953, DOI 10.1007/BF02534421
   HAMILTON JG, 1988, LIPIDS, V23, P1146, DOI 10.1007/BF02535281
   HOLLIDAY R, 1972, NATURE, V238, P26, DOI 10.1038/238026a0
   HORROBIN DF, 1992, PROG LIPID RES, V31, P163, DOI 10.1016/0163-7827(92)90008-7
   HRELIA S, 1989, BIOCHEM BIOPH RES CO, V163, P348, DOI 10.1016/0006-291X(89)92142-6
   HRELIA S, 1990, BIOCHEM INT, V22, P659
   JIMENEZ JAL, 1993, BIOCHEM BIOPH RES CO, V192, P1037, DOI 10.1006/bbrc.1993.1521
   KANG JX, 1992, BIOCHIM BIOPHYS ACTA, V1128, P267, DOI 10.1016/0005-2760(92)90317-O
   LEWIS CM, 1972, NATURE, V239, P316, DOI 10.1038/239316a0
   MAEDA M, 1978, BIOCHIM BIOPHYS ACTA, V530, P153
   NARCE M, 1988, J CHROMATOGR, V448, P249, DOI 10.1016/S0021-9673(01)84587-8
   POLGAR P, 1984, NUTRITION GERONTOLOG, P119
   RAEDERSTORFF D, 1991, LIPIDS, V26, P781, DOI 10.1007/BF02536158
   RAMSEY PH, 1978, J AM STAT ASSOC, V73, P479, DOI 10.2307/2286584
   ROSENTHAL MD, 1987, PROG LIPID RES, V26, P87, DOI 10.1016/0163-7827(87)90009-9
   SMITH PK, 1985, ANAL BIOCHEM, V193, P265
   Spector A A, 1980, Prog Lipid Res, V19, P155
   SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6
NR 26
TC 9
Z9 10
U1 2
U2 5
PU VERLAG HANS HUBER
PI BERN 9
PA LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND
SN 0300-9831
J9 INT J VITAM NUTR RES
JI Int. J. Vitam. Nutr. Res.
PY 1995
VL 65
IS 1
BP 51
EP 55
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA QX517
UT WOS:A1995QX51700008
PM 7657482
DA 2024-02-19
ER

PT J
AU Zhang, YQ
   Liu, YH
   Walsh, M
   Bokov, A
   Ikeno, Y
   Jang, YC
   Perez, VI
   Van Remmen, H
   Richardson, A
AF Zhang, Yiqiang
   Liu, Yuhong
   Walsh, Michael
   Bokov, Alex
   Ikeno, Yuji
   Jang, Young C.
   Perez, Viviana I.
   Van Remmen, Holly
   Richardson, Arlan
TI Liver specific expression of Cu/ZnSOD extends the lifespan of
   <i>Sod1</i> null mice
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE CuZnSOD; Oxidative stress; Lifespan; Liver-specific transgenic mice
ID SUPEROXIDE-DISMUTASE; MUSCLE ATROPHY; OXIDATIVE STRESS; AGE; DEFICIENT;
   CUZNSOD; LEADS; PEROXIDATION; REDUCTION; PATHOLOGY
AB Genetic ablation of CuZn-superoxide dismutase (Sod1) in mice (Sod1(-/-) mice) leads to shortened lifespan with a dramatic increase in hepatocellular carcinoma and accelerated aging phenotypes, including early onset sarcopenia. To study the tissue specific effects of oxidative stress in the Sod1(-/-) mice, we generated mice that only express the human SOD1 gene specifically in the liver of Sod1(-/-) mice (Sod1(-/-)/hSOD1(alb) mice). Expression of hSOD1 in the liver of Sod1(-/-) mice improved liver function, reduced oxidative damage in liver, and partially restored the expression of several genes involved in tumorigenesis, which are abnormally expressed in the livers of the Sod1(-/-) mice. However, liver specific expression of hSOD1 did not prevent the loss of body weight and muscle mass and alterations in the structure of neuromuscular junctions. The expression of hSOD1 in the liver of Sod1(-/-) mice significantly improved the lifespan of Sod1(-/-) mice; however, the lifespan of the Sod1(-/-)/hSOD1(alb) mice was still significantly shorter than wild type mice. Published by Elsevier Ireland Ltd
C1 [Zhang, Yiqiang] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.
   [Liu, Yuhong; Walsh, Michael] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular Biol, San Antonio, TX 78229 USA.
   [Liu, Yuhong; Walsh, Michael] Univ Texas Hlth Sci Ctr San Antonio, Dept Biol Struct, San Antonio, TX 78229 USA.
   [Bokov, Alex] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol, San Antonio, TX 78229 USA.
   [Bokov, Alex] Univ Texas Hlth Sci Ctr San Antonio, Dept Biostat, San Antonio, TX 78229 USA.
   [Ikeno, Yuji] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA.
   [Ikeno, Yuji] South Texas Vet Hlth Care Syst, GRECC, San Antonio, TX USA.
   [Jang, Young C.] Georgia Inst Technol, Sch Appl Physiol, Atlanta, GA 30332 USA.
   [Perez, Viviana I.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.
   [Van Remmen, Holly] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.
   [Van Remmen, Holly; Richardson, Arlan] Oklahoma City VA Med Ctr, Oklahoma City, OK USA.
   [Richardson, Arlan] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA.
C3 University of Texas System; University of Texas Southwestern Medical
   Center Dallas; University of Texas System; University of Texas Health
   Science Center at San Antonio; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; University of
   Texas System; University of Texas Health Science Center at San Antonio;
   University of Texas System; University of Texas Health Science Center at
   San Antonio; Geriatric Research Education & Clinical Center; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital; University System of
   Georgia; Georgia Institute of Technology; Oregon State University;
   Oklahoma Medical Research Foundation; University of Oklahoma System;
   University of Oklahoma Health Sciences Center; University of Oklahoma
   System; University of Oklahoma Health Sciences Center
RP Richardson, A (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA.
EM LiuY2@uthscsa.edu; walshme125@gmail.com; BOKOV@uthscsa.edu;
   youngjang@gatech.edu; Viviana.Perez@oregonstate.edu;
   Holly-VanRemmen@omrf.org; arlan-richardson@ouhsc.edu
RI Zhang, Yiqiang/AAA-3143-2019; Bokov, Alex/O-9952-2014
OI Bokov, Alex/0000-0002-0511-9815
FU National Institute on Aging [AG-020591]; VA Merit Grants
FX This study was funded as part of a program project grant from the
   National Institute on Aging (AG-020591) and VA Merit Grants to HVR and
   AR.
CR [Anonymous], 2012, R LANG ENV STAT COMP
   Argilés JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829
   Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Elchuri S, 2007, PROTEOMICS, V7, P2121, DOI 10.1002/pmic.200601011
   Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791
   Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Huang TT, 1997, ARCH BIOCHEM BIOPHYS, V344, P424, DOI 10.1006/abbi.1997.0237
   Jang Y.C., 2012, AGING CELL
   Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308
   Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006
   Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Matsuda Y, 2013, MED MOL MORPHOL, V46, P185, DOI 10.1007/s00795-013-0047-7
   McFadden SL, 1999, J COMP NEUROL, V413, P101
   McFadden SL, 1999, NEUROBIOL AGING, V20, P1, DOI 10.1016/S0197-4580(99)00018-4
   Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X
   Morrow JD, 1999, METHOD ENZYMOL, V300, P3
   Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006
   Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036
   Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847
   Olofsson EM, 2005, EXP EYE RES, V81, P639, DOI 10.1016/j.exer.2005.03.022
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Ran QT, 2003, FREE RADICAL BIO MED, V35, P1101, DOI 10.1016/S0891-5849(03)00466-0
   Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43
   RITZ E, 1977, CLIN NEPHROL, V7, P231
   Roberts LJ, 2002, CELL MOL LIFE SCI, V59, P808, DOI 10.1007/s00018-002-8469-8
   Sakellariou GK, 2014, FASEB J, V28, P1666, DOI 10.1096/fj.13-240390
   Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415
   Sataranatarajan K, 2015, REDOX BIOL, V5, P140, DOI 10.1016/j.redox.2015.04.005
   Therneau TM., 2000, Modeling Survival Data: Extending the Cox Model, DOI DOI 10.1007/978-1-4757-3294-8
   Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060
   Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847
   Zhang Y, 2013, FREE RADIC BIOL MED
   Zhang YQ, 2013, FASEB J, V27, P3536, DOI 10.1096/fj.13-228130
   Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132
NR 37
TC 13
Z9 15
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR
PY 2016
VL 154
BP 1
EP 8
DI 10.1016/j.mad.2016.01.005
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA DH6YN
UT WOS:000372938100001
PM 26839948
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Thakur, MK
   Asaithambi, A
   Mukherjee, S
AF Thakur, MK
   Asaithambi, A
   Mukherjee, S
TI Sex-specific alterations in chromatin conformation of the brain of aging
   mouse
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE aging; chromatin conformation; nuclease digestion; mouse brain
ID AGE-RELATED-CHANGES; RAT-LIVER; MICROCOCCAL NUCLEASE; GENE-EXPRESSION;
   SATELLITE DNA; OLD RATS; NUCLEOSOME; ENDONUCLEASE; ORGANIZATION;
   PERIODICITY
AB Chromatin conformation has been analysed in the brain cortex of adult (24 +/- 2 weeks) and old (65 +/- 4 weeks) male and female mice. Nuclei purified from different groups of mice were digested with MNase and DNase I for varying time periods (0-90 min), and with endogenous endonucleases for 1 h. MNase and DNase I digestion kinetics showed that the percentage of acid solubility of chromatin was relatively lower in old than adult and in female than male. This was further supported by electrophoretic analysis of nuclease digested DNA fragments. When the nuclei were incubated with only Ca2+ or mg(2+), no endonuclease digestion was observed. However, under similar conditions, the liver DNA was cleaved substantially. When divalent cations were added together, they activated endogenous endonucleases and digested the brain chromatin. The activity of Ca2+/Mg2+-dependent endogenous endonucleases was higher in male than female. Thus the accessibility of chromatin to MNase, DNase I and endogenous endonucleases was higher in male than female, and MNase as well as DNase I were more active in adult than old. Such sex- and age-dependent conformation of chromatin may attribute to differential expression of genes in the mouse brain.
C1 Banaras Hindu Univ, Ctr Adv Study Bot, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
C3 Banaras Hindu University (BHU)
RP Thakur, MK (corresponding author), Banaras Hindu Univ, Ctr Adv Study Bot, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
CR Anderson B, 1996, BRAIN, V119, P1983, DOI 10.1093/brain/119.6.1983
   [Anonymous], 1977, COMPUTATIONAL HDB ST
   ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688
   ARENDS MJ, 1990, AM J PATHOL, V136, P593
   Ausubel FM, 1995, SHORT PROTOCOLS MOL
   BURGOYNE LA, 1978, CELL NUCLEUS, V4, P48
   CHATURVEDI MM, 1983, BIOCHEM INT, V6, P357
   CHATURVEDI MM, 1985, MOL BIOL REP, V10, P215
   Chaurasia P, 1997, MECH AGEING DEV, V95, P63, DOI 10.1016/S0047-6374(96)01843-X
   Chaurasia P, 1998, MOL BIOL REP, V25, P63, DOI 10.1023/A:1006835732729
   COLEMAN PD, 1987, NEUROBIOL AGING, V8, P521, DOI 10.1016/0197-4580(87)90127-8
   FILIPSKI J, 1990, EMBO J, V9, P1319, DOI 10.1002/j.1460-2075.1990.tb08241.x
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   Gahr Manfred, 1994, P273
   GAUBATZ J, 1979, J GERONTOL, V34, P672, DOI 10.1093/geronj/34.5.672
   Gavin IM, 1998, J BIOL CHEM, V273, P2429, DOI 10.1074/jbc.273.4.2429
   HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405
   IGOKEMENES T, 1982, ANNU REV BIOCHEM, V51, P89, DOI 10.1146/annurev.bi.51.070182.000513
   JACGER AW, 1982, EMBO J, V1, P811
   KANUNGO MS, 1995, MOL BASIS AGING, P184
   KANUNGO MS, 1994, GENES AGING
   Kawabata H, 1996, LEUKEMIA, V10, P67
   KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435
   MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343
   Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701
   Mukherjee S, 1996, MOL BIOL REP, V22, P59, DOI 10.1007/BF00996306
   NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063
   NOLL M, 1974, NATURE, V251, P249, DOI 10.1038/251249a0
   NOLL M, 1974, NUCLEIC ACIDS RES, V1, P1573, DOI 10.1093/nar/1.11.1573
   NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3
   PETERS AL, 1997, INT TXB DIABETES MEL, P1151
   SEMESI I, 1989, BIOCHEM BIOPH RES CO, V164, P620
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   SINGH S, 1993, BIOCHEM BIOPH RES CO, V193, P440, DOI 10.1006/bbrc.1993.1643
   SINGH S, 1991, BIOCHEM BIOPH RES CO, V182, P131
   SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349
   SRIVASTAVA A, 1985, J BIOL CHEM, V260, P6404
   STAYNOV DZ, 1983, INT J BIOL MACROMOL, V5, P3, DOI 10.1016/0141-8130(83)90071-5
   THAKUR MK, 1993, MECH AGEING DEV, V66, P283, DOI 10.1016/0047-6374(93)90015-J
   THAKUR MK, 1984, MECH AGEING DEV, V27, P263, DOI 10.1016/0047-6374(84)90052-6
   THAKUR MK, 1996, AGING INDIAN PERSPEC, P413
   TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x
   Upadhyay R, 1996, BIOCHEM BIOPH RES CO, V226, P356, DOI 10.1006/bbrc.1996.1361
   VANDERBILT JN, 1982, J BIOL CHEM, V257, P3009
   WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749
   Wickelgren I, 1996, SCIENCE, V273, P48
NR 46
TC 4
Z9 4
U1 0
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0301-4851
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD DEC
PY 1999
VL 26
IS 4
BP 239
EP 247
DI 10.1023/A:1007042321521
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 268CC
UT WOS:000084395900004
PM 10634506
DA 2024-02-19
ER

PT J
AU Yamamoto, Y
   Zolfaghari, R
   Ross, AC
AF Yamamoto, Y
   Zolfaghari, R
   Ross, AC
TI Regulation of CYP26 (cytochrome P450RAI) mRNA expression and retinoic
   acid metabolism by retinoids and dietary vitamin A in liver of mice and
   rats
SO FASEB JOURNAL
LA English
DT Article
DE retinoic acid oxidation; vitamin A status; aging
ID AGING LEWIS RATS; ALL-TRANS; BINDING PROTEINS; MESSENGER-RNA; IN-VIVO;
   MOUSE; CELLS; 4-HYDROXYLASE; MICROSOMES; RECEPTORS
AB Retinoic acid (RA), through nuclear retinoid receptors, regulates the expression of numerous genes. However, little is known of the biochemical mechanisms that regulate RA concentration in vivo. CYP26 (P450RAI), a novel cytochrome P450, is expressed during embryonic development, induced by all-trans RA, and capable of catalyzing the oxidation of [H-3]RA to polar retinoids including 4-oxo-RA. Here we report that CYP26 expression in adult liver is regulated by all-trans RA and dietary vitamin A, and is correlated with the metabolism of all-trans RA to polar metabolites. In normal mouse and rat liver, CYP26 mRNA was barely detectable; however, after acute treatment with all-trans RA CYP26 mRNA and RA metabolism by liver microsomes were significantly induced. Aqueous-soluble RA metabolites were detected, but their formation was not induced. The expression of retinoid receptors, RAR-gamma and RXR-alpha, was not changed after RA treatment in vivo. In a model of chronic vitamin A ingestion during aging, CYP26 mRNA expression, determined by Northern blot and RT-PCR analysis, increased progressively with dietary vitamin A (P<0.0001; marginal < control < supplemented) and age (P<0.003). The relative expression of CYP26 mRNA was positively correlated with liver total retinol (log(10)), ranging from undetectable CYP26 expression at liver retinol concentrations below similar to 20 nmol/g to a three- to fourfold elevation at concentrations >10,000 nmol/g (r=0.90, P<0.0001). We conclude that CYP26 expression and RA metabolism are regulated in adult liver not only acutely by RA administration, as may be relevant to retinoid therapy but under chronic dietary conditions relevant to vitamin A nutrition in humans.
C1 Penn State Univ, Dept Nutr, University Pk, PA 16802 USA.
   Penn State Univ, Dept Vet Sci, University Pk, PA 16802 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park
RP Ross, AC (corresponding author), Penn State Univ, Dept Nutr, 126-S Henderson Bldg, University Pk, PA 16802 USA.
EM acr6@psu.edu
FU NIA NIH HHS [AG09839] Funding Source: Medline; NIDDK NIH HHS [DK46869]
   Funding Source: Medline
CR Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409
   Blaner William S., 1994, P229
   BLOMHOFF R, 1982, P NATL ACAD SCI-BIOL, V79, P7326, DOI 10.1073/pnas.79.23.7326
   BLOMHOFF R, 1992, ANNU REV NUTR, V12, P37, DOI 10.1146/annurev.nu.12.070192.000345
   Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176
   Dawson HD, 2000, J NUTR, V130, P1280, DOI 10.1093/jn/130.5.1280
   Dawson HD, 1999, J NUTR, V129, P1510, DOI 10.1093/jn/129.8.1510
   de Roos K, 1999, MECH DEVELOP, V82, P205, DOI 10.1016/S0925-4773(99)00016-7
   DECICCO KL, 2000, J INFECT DIS, V130, P1280
   Duester G, 1996, BIOCHEMISTRY-US, V35, P12221, DOI 10.1021/bi961176+
   DUNAGIN PE, 1966, BIOCHIM BIOPHYS ACTA, V124, P71, DOI 10.1016/0304-4165(66)90314-X
   EDWARDS RB, 1992, EXP EYE RES, V54, P481, DOI 10.1016/0014-4835(92)90126-D
   FIORELLA PD, 1994, J BIOL CHEM, V269, P10538
   Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163
   Gaemers IC, 1996, ENDOCRINOLOGY, V137, P479, DOI 10.1210/en.137.2.479
   GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61
   HARRISON EH, 1995, J LIPID RES, V36, P1498
   Kang S, 1996, J INVEST DERMATOL, V107, P183, DOI 10.1111/1523-1747.ep12329579
   KATO S, 1992, BIOCHEM J, V286, P755, DOI 10.1042/bj2860755
   KURLANDSKY SB, 1995, J BIOL CHEM, V270, P17850, DOI 10.1074/jbc.270.30.17850
   LEO MA, 1989, J NUTR, V119, P993, DOI 10.1093/jn/119.7.993
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MUINDI JRF, 1994, LEUKEMIA, V8, P1807
   Nadin L, 1999, BIOCHEM PHARMACOL, V58, P1201, DOI 10.1016/S0006-2952(99)00192-6
   NAPOLI JL, 1987, ARCH BIOCHEM BIOPHYS, V255, P95, DOI 10.1016/0003-9861(87)90298-0
   NAPOLI JL, 1991, BIOMED PHARMACOTHER, V45, P131, DOI 10.1016/0753-3322(91)90101-X
   Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1
   OLSON JA, 1984, J NATL CANCER I, V73, P1439
   Ong David E., 1994, P283
   Raner GM, 1996, MOL PHARMACOL, V49, P515
   Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   RIAZULHAQ, 1991, P NATL ACAD SCI USA, V88, P8272, DOI 10.1073/pnas.88.18.8272
   ROBERTS AB, 1980, ARCH BIOCHEM BIOPHYS, V199, P374, DOI 10.1016/0003-9861(80)90293-3
   ROBERTS ES, 1992, MOL PHARMACOL, V41, P427
   ROSS AC, 1993, FASEB J, V7, P317, DOI 10.1096/fasebj.7.2.8440409
   ROSS AC, 1982, J BIOL CHEM, V257, P2453
   Ross AC, 2000, MODERN NUTR HLTH DIS, P305
   SCHWARTZ EL, 1995, BIOCHEM PHARMACOL, V50, P923, DOI 10.1016/0006-2952(95)00213-J
   Sonneveld E, 1999, DEV BIOL, V213, P390, DOI 10.1006/dbio.1999.9381
   Teerlink T, 1997, J CHROMATOGR B, V694, P83, DOI 10.1016/S0378-4347(97)00109-6
   VECCHINI F, 1994, BIOCHEM BIOPH RES CO, V201, P1205, DOI 10.1006/bbrc.1994.1833
   Westin S, 1997, MOL CELL ENDOCRINOL, V129, P169, DOI 10.1016/S0303-7207(97)04055-0
   White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538
   White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922
   ZACHMAN RD, 1966, J LIPID RES, V7, P3
   ZOLFAGHARI R, 1995, ARCH BIOCHEM BIOPHYS, V323, P258, DOI 10.1006/abbi.1995.9966
NR 48
TC 67
Z9 86
U1 0
U2 4
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD OCT
PY 2000
VL 14
IS 13
BP 2119
EP 2127
DI 10.1096/fj.00-0061com
PG 9
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 359WE
UT WOS:000089634400031
PM 11023996
DA 2024-02-19
ER

PT J
AU Esfahani, NS
   Wu, Q
   Kumar, N
   Ganesan, LP
   Lafuse, WP
   Rajaram, MVS
AF Esfahani, Noushin Saljoughian
   Wu, Qian
   Kumar, Naresh
   Ganesan, Latha Prabha
   Lafuse, William P.
   Rajaram, Murugesan V. S.
TI Aging influences the cardiac macrophage phenotype and function during
   steady state and during inflammation
SO AGING CELL
LA English
DT Article; Early Access
DE aging; cardiac macrophages; infection and inflammation
ID HEART-FAILURE; OXIDATIVE STRESS; AGE; DYSFUNCTION; SEPSIS; GAMMA;
   ACTIVATION; RECEPTORS; PATHWAYS; BIOLOGY
AB Aging-mediated immune dysregulation affects the normal cardiac immune cell phenotypes and functions, resulting in cardiac distress. During cardiac inflammation, immune activation is critical for mounting the regenerative responses to maintain normal heart function. We investigated the impact of aging on myeloid cell phenotype and function during cardiac inflammation induced by a sub-lethal dose of LPS. Our data show that hearts of old mice contain more myeloid cells than the hearts of young mice. However, while the number of monocytic-derived suppressor cells did not differ between young and old mice, monocytic-derived suppressor cells from old mice were less able to suppress T-cell proliferation. Since cardiac resident macrophages (CRMs) are important for immune surveillance, clearance of dead cells, and tissue repair, we focused our studies on CRMs phenotype and function during steady state and LPS treatment. In the steady state, we observed significantly more MHC-IIlow and MHC-IIhigh CRMs in the hearts of old mice; however, these populations were decreased in both young and aged mice upon LPS treatment and the decrease in CRM populations correlated with defects in cardiac electrical activity. Notably, mice treated with a liver X receptor (LXR) agonist showed an increase in MerTK expression in CRMs of both young and old mice, which resulted in the reversal of cardiac electrical dysfunction caused by lipopolysaccharide (LPS). We conclude that aging alters the phenotype of CRMs, which contributes to the dysregulation of cardiac electrical dysfunction during infection in aged mice.
C1 [Esfahani, Noushin Saljoughian; Wu, Qian; Kumar, Naresh; Lafuse, William P.; Rajaram, Murugesan V. S.] Ohio State Univ, Wexner Med Ctr, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.
   [Ganesan, Latha Prabha] Ohio State Univ, Wexner Med Ctr, Coll Med, Dept Internal Med, Columbus, OH 43210 USA.
C3 University System of Ohio; Ohio State University; University System of
   Ohio; Ohio State University
RP Rajaram, MVS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, 712 Biomed Res Tower,460 West 12 Ave, Columbus, OH 43210 USA.
EM Murugesan.Rajaram@osumc.edu
RI Rajaram, Murugesan/E-5203-2013
OI Kumar, Naresh/0000-0001-9920-9143; Rajaram,
   Murugesan/0000-0002-1515-1122
FU National Institute of Allergy and Infectious Diseases [A146252];
   American Heart Association [AHA-17GRNT33420101]
FX National Institute of Allergy and Infectious Diseases, Grant/Award
   Number: AI146690; American Heart Association, Grant/Award Number:
   AHA-17GRNT33420101; National Institute of Allergy and Infectious
   Diseases, Grant/Award Number: A146252
CR A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018
   Aprahamian T, 2008, CLIN EXP IMMUNOL, V152, P448, DOI 10.1111/j.1365-2249.2008.03658.x
   Brüünsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5
   Calder PC, 2017, AGEING RES REV, V40, P95, DOI 10.1016/j.arr.2017.09.001
   Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13
   Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019
   Costantino S, 2016, J PHYSIOL-LONDON, V594, P2061, DOI 10.1113/JP270538
   Cuervo H, 2011, J IMMUNOL, V187, P2656, DOI 10.4049/jimmunol.1002928
   de Almeida AJPO, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1954398
   DeBerge M, 2017, CIRC RES, V121, P930, DOI 10.1161/CIRCRESAHA.117.311327
   Demissei BG, 2016, INT J CARDIOL, V204, P164, DOI 10.1016/j.ijcard.2015.11.141
   Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001
   Díez-Villanueva P, 2016, J GERIATR CARDIOL, V13, P115, DOI 10.11909/j.issn.1671-5411.2016.02.009
   Dorhoi A, 2019, CANCER IMMUNOL IMMUN, V68, P673, DOI 10.1007/s00262-018-2277-y
   Drosatos K, 2013, CIRC-HEART FAIL, V6, P550, DOI 10.1161/CIRCHEARTFAILURE.112.000177
   Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800
   Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019
   Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020
   Fessler MB, 2018, PHARMACOL THERAPEUT, V181, P1, DOI 10.1016/j.pharmthera.2017.07.010
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Fresno M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00351
   Gao MM, 2013, AAPS J, V15, P258, DOI 10.1208/s12248-012-9429-3
   Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419
   Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486
   Han SH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00135
   Headley CA, 2019, AGING CELL, V18, DOI 10.1111/acel.12926
   Hüsecken Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13019-6
   Izgüt-Uysal V, 2004, IMMUNOL INVEST, V33, P287, DOI 10.1081/IMM-120037276
   Kovacic JC, 2011, CIRCULATION, V123, P1900, DOI 10.1161/CIRCULATIONAHA.110.009118
   Lafuse WP, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010051
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Loffredo FS, 2014, CIRC RES, V115, P97, DOI 10.1161/CIRCRESAHA.115.302929
   Ma YG, 2018, TRANSL RES, V191, P15, DOI 10.1016/j.trsl.2017.10.001
   Makara MA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003820
   Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA
   Mayr FB, 2010, JAMA-J AM MED ASSOC, V303, P2495, DOI 10.1001/jama.2010.851
   Meeson A, 2013, STEM CELL REV REP, V9, P731, DOI 10.1007/s12015-013-9440-9
   Meschiari CA, 2017, GEROSCIENCE, V39, P7, DOI 10.1007/s11357-017-9959-9
   Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885
   Oh YJ, 2017, AMINO ACIDS, V49, P695, DOI 10.1007/s00726-016-2295-z
   Panth Nisha, 2016, Adv Med, V2016, P9152732
   Papaconstantinou J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111383
   PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483
   Pawelec G, 2014, CURR OPIN IMMUNOL, V29, P23, DOI 10.1016/j.coi.2014.03.007
   Penberthy KK, 2016, IMMUNOL REV, V269, P44, DOI 10.1111/imr.12376
   Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x
   Ramos GC, 2017, P NATL ACAD SCI USA, V114, pE2420, DOI 10.1073/pnas.1621047114
   Romero-Bermejo FJ, 2011, CURR CARDIOL REV, V7, P163, DOI 10.2174/157340311798220494
   Ryzhov S, 2011, J IMMUNOL, V187, P6120, DOI 10.4049/jimmunol.1101225
   Salminen A, 2019, CELL MOL LIFE SCI, V76, P1901, DOI 10.1007/s00018-019-03048-x
   Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002
   Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002
   Smit J, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1570-7
   UNDESA, 2017, WORLD POP AG 2017 HI
   van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36
   Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198
   Wang WJ, 2014, CRIT CARE, V18, DOI 10.1186/cc13181
   Wu JZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/615312
   Zhou L, 2018, CIRCULATION, V138, P181, DOI 10.1161/CIRCULATIONAHA.117.030811
   Zizzo G, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0081-4
NR 60
TC 14
Z9 15
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2021 AUG
PY 2021
VL 20
IS 8
AR e13438
DI 10.1111/acel.13438
EA AUG 2021
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA UB5AD
UT WOS:000680308400001
PM 34342127
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Li, SX
   Liu, W
   Wang, LH
   Huang, R
   Chen, Q
   Wu, YH
   Cai, YT
AF Li, Shengxian
   Liu, Wei
   Wang, Lihua
   Huang, Rong
   Chen, Qi
   Wu, Yihua
   Cai, Yiting
TI Effects of menopause on hepatic 11β-hydroxysteroid dehydrogenase type 1
   activity and adrenal sensitivity to adrenocorticotropin in healthy
   non-obese women
SO GYNECOLOGICAL ENDOCRINOLOGY
LA English
DT Article
DE Menopause; aging; HPA axis activity; cortisol; 11 beta-HSD1
ID BETA-HYDROXYSTEROID DEHYDROGENASE; ADIPOSE-TISSUE; POSTMENOPAUSAL WOMEN;
   METABOLIC SYNDROME; SEXUAL-DIMORPHISM; VISCERAL OBESITY; GROWTH-HORMONE;
   IN-VIVO; DEHYDROEPIANDROSTERONE; RAT
AB Menopause is associated with central obesity, dyslipidemia, hypertension and insulin resistance, which are also shown in the patients with excess of glucocorticoids. However, the interaction of hypothalamic-pituitary-adrenal (HPA) axis activity and menopause has not been fully understood. In this study, 55 healthy non-obese women were recruited, and then divided into two groups, premenopausal group (n = 24) and postmenopausal group (n = 31). HPA axis function was evaluated by using dexamethasone suppression test (DST; 0.25 mg), and adrenocorticotrophic hormone (ACTH)-stimulation test. Moreover, 25 mg cortisone acetate test was applied to evaluate the hepatic 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) activity. We found that hepatic 11 beta-HSD1 activity and adrenal response to ACTH were increased in the postmenopausal group compared with the premenopausal group, whereas the negative feedback effect of dexamethasone did not show significant difference between pre- and postmenopausal women. These findings suggest that the adrenal sensitivity to ACTH and hepatic 11 beta-HSD1 activity are increased. The increased cortisol conversion and/or synthesis may be contributed to the dysmetabolic features in the postmenopausal women.
C1 [Li, Shengxian; Liu, Wei; Wang, Lihua; Huang, Rong; Chen, Qi; Wu, Yihua; Cai, Yiting] Shanghai Jiao Tong Univ, Renji Hosp, Dept Endocrinol, Sch Med, Shanghai 200127, Peoples R China.
C3 Shanghai Jiao Tong University
RP Liu, W (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Endocrinol, Sch Med, 1630 Dongfang Rd, Shanghai 200127, Peoples R China.
EM sue_liuwei@163.com
RI Li, Shengxian/AFT-2979-2022; Lin, Kuan-Yu/JXM-6653-2024
FU Nature Science Foundation of China (NSFC) [30570882]
FX This study was supported by the Nature Science Foundation of China (NSFC
   30570882). We thank the research volunteers for their participation in
   this study. We thank our study nurses Chen Ya-wen and Jia Yun for
   excellent assistance with recruiting the subjects and the clinical
   measurements, and the staff of the Shanghai Institute of Endocrine and
   Metabolic Disease for their invaluable help with this project.
CR Andersson T, 2010, OBESITY, V18, P470, DOI 10.1038/oby.2009.294
   Apostolova G, 2005, AM J PHYSIOL-ENDOC M, V288, pE957, DOI 10.1152/ajpendo.00442.2004
   Atanasov AG, 2004, FEBS LETT, V571, P129, DOI 10.1016/j.febslet.2004.06.065
   Atanasov Atanas G., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P125, DOI 10.2174/187153007780832082
   Balazs Z, 2008, J AM SOC NEPHROL, V19, P92, DOI 10.1681/ASN.2007030263
   Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242
   Cohen PG, 2005, MED HYPOTHESES, V64, P989, DOI 10.1016/j.mehy.2004.11.004
   COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608
   De Leo V, 1998, EUR J ENDOCRINOL, V138, P430, DOI 10.1530/eje.0.1380430
   de Oliveira APL, 2004, NEUROIMMUNOMODULAT, V11, P20, DOI 10.1159/000072965
   Dieudonné MN, 2006, J STEROID BIOCHEM, V99, P189, DOI 10.1016/j.jsbmb.2006.01.007
   Escher G, 1997, J EXP MED, V186, P189, DOI 10.1084/jem.186.2.189
   Genazzani AR, 2006, GYNECOL ENDOCRINOL, V22, P627, DOI 10.1080/09513590601024681
   GENAZZANI AR, 1975, J CLIN ENDOCR METAB, V41, P431, DOI 10.1210/jcem-41-3-431
   Gu S, 2003, MOL PHARMACOL, V63, P722, DOI 10.1124/mol.63.3.722
   HAMMAMI MM, 1991, J CLIN ENDOCR METAB, V73, P326, DOI 10.1210/jcem-73-2-326
   Hennebert O, 2007, J STEROID BIOCHEM, V104, P326, DOI 10.1016/j.jsbmb.2007.03.026
   Jamieson A, 1999, J CLIN ENDOCR METAB, V84, P3570, DOI 10.1210/jc.84.10.3570
   Kim SB, 2004, J STEROID BIOCHEM, V92, P383, DOI 10.1016/j.jsbmb.2004.09.005
   KITAY JI, 1963, ENDOCRINOLOGY, V73, P253, DOI 10.1210/endo-73-2-253
   Kudielka BM, 1999, NEUROENDOCRINOLOGY, V70, P422, DOI 10.1159/000054504
   Lavery GG, 2006, J BIOL CHEM, V281, P6546, DOI 10.1074/jbc.M512635200
   LIU CH, 1990, J CLIN ENDOCR METAB, V71, P900, DOI 10.1210/jcem-71-4-900
   LOW SC, 1993, J ENDOCRINOL, V139, P27, DOI 10.1677/joe.0.1390027
   LOW SC, 1994, J ENDOCRINOL, V143, P541, DOI 10.1677/joe.0.1430541
   Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI200317845
   Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285
   Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062
   Moore JS, 1999, J CLIN ENDOCR METAB, V84, P4172, DOI 10.1210/jc.84.11.4172
   Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931
   Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101
   Paulsen SK, 2008, OBESITY, V16, P731, DOI 10.1038/oby.2008.2
   ROELFSEMA F, 1993, J CLIN ENDOCR METAB, V77, P234, DOI 10.1210/jc.77.1.234
   Shen W, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-17
   Stomati M, 2000, GYNECOL ENDOCRINOL, V14, P342, DOI 10.3109/09513590009167703
   Sun K, 1997, J CLIN ENDOCR METAB, V82, P300, DOI 10.1210/jc.82.1.300
   Walker BR, 2006, ANN NY ACAD SCI, V1083, P165, DOI 10.1196/annals.1367.012
   White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135
   WHORWOOD CB, 1993, J STEROID BIOCHEM, V46, P539, DOI 10.1016/0960-0760(93)90180-5
   Zallocchi M, 2004, CAN J PHYSIOL PHARM, V82, P422, DOI 10.1139/Y04-035
   Zuckerman-Levin N, 2001, J CLIN ENDOCR METAB, V86, P5920, DOI 10.1210/jc.86.12.5920
NR 41
TC 3
Z9 3
U1 1
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0951-3590
EI 1473-0766
J9 GYNECOL ENDOCRINOL
JI Gynecol. Endocrinol.
PD OCT
PY 2011
VL 27
IS 10
BP 794
EP 799
DI 10.3109/09513590.2010.507288
PG 6
WC Endocrinology & Metabolism; Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Obstetrics & Gynecology
GA 829WW
UT WOS:000295617600012
PM 21736538
DA 2024-02-19
ER

PT J
AU Quiles, JL
   Ochoa, JJ
   Ramirez-Tortosa, MC
   Huertas, JR
   Mataix, J
AF Quiles, JL
   Ochoa, JJ
   Ramirez-Tortosa, MC
   Huertas, JR
   Mataix, J
TI Age-related mitochondrial DNA deletion in rat liver depends on dietary
   fat unsaturation
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID OXIDATIVE STRESS; VITAMIN-E; GENE-EXPRESSION; OLIVE OIL; PLASMA-LIPIDS;
   VIRGIN OLIVE; OLEIC-ACID; COENZYME-Q; DAMAGE; PEROXIDATION
AB We fed male Wistar rats lifelong on virgin olive (rich in the monounsaturated oleic acid) or sunflower (rich in the polyunsaturated linoleic acid) oil-based diets. At 6 and 24 months. liver mitochondria were analyzed for a mitochondrial DNA (mtDNA) deletion, reactive oxygen species, antioxidants, and ultrastructural alterations. An aging-related increase in the relative amount of the deletion was observed for both dietary groups, being higher in animals fed sunflower oil. Oxidative stress was lower in vir-in olive oil-fed animals. Aging led to hi-her superoxide dismutase, catalase, and glutathione peroxidase activities and increased alpha-tocopherol and coenzyme Q. Mitochondria from aged animals fed sunflower oil exhibited a lower number of cristae and a higher circularity. Results suggest that the age-related increase of the relative amount of deleted mtDNA depends on fat unsaturation. Moreover, the studied mtDNA deletion was con-elated with mitochondrial oxidative stress and ultrastructural alterations.
C1 Univ Granada, Inst Nutr & Food Technol, Dept Physiol, E-18071 Granada, Spain.
   Univ Granada, Inst Nutr & Food Technol, Dept Biochem & Mol Biol, E-18071 Granada, Spain.
C3 University of Granada; University of Granada
RP Quiles, JL (corresponding author), Inst Nutr & Tecnol Alimentos, C Ramon & Cajal 4, Granada 18071, Spain.
EM jlquiles@urg.es
RI Ochoa, Julio/L-8733-2014; Huertas, Jesus Francisco
   Rodriguez/G-8188-2015; Quiles, José L./C-6911-2013
OI Ochoa, Julio/0000-0001-8976-6296; Huertas, Jesus Francisco
   Rodriguez/0000-0002-7446-0857; Quiles, José L./0000-0002-9048-9086
CR Aebi H, 1984, Methods Enzymol, V105, P121
   Aejmelaeus RT, 1997, FREE RADICAL BIO MED, V23, P69, DOI 10.1016/S0891-5849(96)00591-6
   AGREN JJ, 1992, J LIPID RES, V33, P1871
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   ASHA DS, 2003, EXP GERONTOL, V38, P285
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barja G, 2002, FREE RADICAL BIO MED, V33, P1167, DOI 10.1016/S0891-5849(02)00910-3
   Battino M, 2002, FREE RADICAL RES, V36, P479, DOI 10.1080/10715760290021351
   Battino M, 2002, J BIOENERG BIOMEMBR, V34, P127, DOI 10.1023/A:1015128009826
   Camougrand N, 2001, RESP PHYSIOL, V128, P393, DOI 10.1016/S0034-5687(01)00314-0
   Chevanne M, 2003, BIOGERONTOLOGY, V4, P97, DOI 10.1023/A:1023399820770
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Crapo J D, 1978, Methods Enzymol, V53, P382
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fleischer S, 1979, Methods Enzymol, V55, P32
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   Hardy RW, 2002, J NUTR, V132, P3172, DOI 10.1093/jn/131.10.3172
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HUERTAS JR, 1991, BIOCHEM BIOPH RES CO, V181, P375, DOI 10.1016/S0006-291X(05)81429-9
   HUERTAS JR, 1991, FEBS LETT, V287, P89, DOI 10.1016/0014-5793(91)80022-U
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   KOLAROVIC L, 1986, ANAL BIOCHEM, V156, P244, DOI 10.1016/0003-2697(86)90179-X
   LANG JK, 1987, J CHROMATOGR, V385, P109, DOI 10.1016/S0021-9673(01)94626-6
   LENAZ G, 1998, BIOCHIM BIOPHYS ACTA, V1366, P63
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marino M, 2002, MECH AGEING DEV, V123, P1183, DOI 10.1016/S0047-6374(02)00009-X
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Mataix J, 1998, FREE RADICAL BIO MED, V24, P511, DOI 10.1016/S0891-5849(97)00288-8
   NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   Ochoa JJ, 2002, NUTRITION, V18, P60, DOI 10.1016/S0899-9007(01)00732-8
   Ochoa-Herrera JJ, 2001, J NUTR BIOCHEM, V12, P357, DOI 10.1016/S0955-2863(01)00150-4
   ORRENIUS S, 1977, MICROSOMES DRUGS OXI
   Quiles JL, 1999, BRIT J NUTR, V81, P21, DOI 10.1017/S0007114599000094
   Quiles JL, 2002, J BIOENERG BIOMEMBR, V34, P517, DOI 10.1023/A:1022530512096
   Quiles JL, 2002, BRIT J NUTR, V88, P57, DOI [10.1079/BJN2002588, 10.1079/BJNBJN2002588]
   Quiles JL, 1999, BIOFACTORS, V9, P331, DOI 10.1002/biof.5520090232
   Quiles JL, 2001, J BIOENERG BIOMEMBR, V33, P127, DOI 10.1023/A:1010700515071
   Quiles JL, 1999, FREE RADICAL RES, V31, pS129, DOI 10.1080/10715769900301421
   Ramírez-Tortosa C, 1999, BRIT J NUTR, V82, P31, DOI 10.1017/S0007114599001099
   Reeves P G, 1997, J Nutr, V127, p838S, DOI 10.1093/jn/127.5.838S
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   STAHLBERG D, 1991, LIPIDS, V26, P349, DOI 10.1007/BF02537197
   THELIN A, 1994, MECH AGEING DEV, V76, P165, DOI 10.1016/0047-6374(94)91591-1
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033
   van der Loo B, 2002, CIRCULATION, V105, P1635, DOI 10.1161/01.CIR.0000014986.29834.71
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   VanTuyle GC, 1996, MUTAT RES-FUND MOL M, V349, P95, DOI 10.1016/0027-5107(95)00165-4
NR 57
TC 42
Z9 42
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD FEB
PY 2006
VL 61
IS 2
BP 107
EP 114
DI 10.1093/gerona/61.2.107
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 018TB
UT WOS:000235786600001
PM 16510854
OA Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU Spencer, RP
AF Spencer, RP
TI Organ body weight loss with aging: Evidence for co-ordinated involution
SO MEDICAL HYPOTHESES
LA English
DT Article
AB Loss of body weight, during later stages of aging, is a phenomenon recognized in all human populations studied. Reduction of body weight is accompanied by a loss of internal organ weight and volume. The usual approach is to describe organ weight versus age. However, organ weight can be related to overall body weight, by means of the allometric equation. This general expression can be used to relate the weight of each of several organs to that of the body, and offered a good description of data for a reported Japanese autopsy study on males and females over the age of 60 years. The equations were also used in describing the ratio of organ weights (such as the spleen/liver weight). A further extension was in examining the terms of the allometric equation (a constant and an exponent for each organ), and noting a close coupling between male and female values. The allometric description of organ weights versus body weight, suggests a 'co-ordinated involution', and appears worthy of further investigation.
RP Spencer, RP (corresponding author), UNIV CONNECTICUT, CTR HLTH, DEPT NUCL MED, 263 FARMINGTON AVE, FARMINGTON, CT 06030 USA.
CR GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x
   Huxley J. S., 1932, PROBLEMS RELATIVE GR, P276
   INOUE T, 1987, ACTA PATHOL JAPON, V37, P343
   OYAMA S, 1987, AM J PHYS ANTHROPOL, V73, P179
   SHEA BT, 1987, ENDOCRINOLOGY, V121, P1924, DOI 10.1210/endo-121-6-1924
NR 5
TC 6
Z9 6
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD FEB
PY 1996
VL 46
IS 2
BP 59
EP 62
DI 10.1016/S0306-9877(96)90000-6
PG 4
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA TX132
UT WOS:A1996TX13200001
PM 8692044
DA 2024-02-19
ER

PT J
AU Liu, WX
   Zhao, HK
   Su, YQ
   Wang, KF
   Li, J
   Xue, S
   Sun, XP
   Qiu, ZG
AF Liu, Wenxiong
   Zhao, Haikang
   Su, Yuqiang
   Wang, Kefeng
   Li, Jing
   Xue, Sha
   Sun, Xiaopeng
   Qiu, Zhengguo
TI Senescence marker protein 30 confers neuroprotection in oxygen-glucose
   deprivation/reoxygenation-injured neurons through modulation of
   Keap1/Nrf2 signaling: Role of SMP30 in OGD/R-induced neuronal injury
SO HUMAN & EXPERIMENTAL TOXICOLOGY
LA English
DT Article; Early Access
DE Ischemia; oxygen-glucose deprivation; reoxygenation; Keap1; Nrf2; SMP30
ID INCREASED OXIDATIVE STRESS; KNOCKOUT MICE; VITAMIN-C; DEFICIENCY; NRF2;
   EXPRESSION; LIVER; MODEL
AB Senescence marker protein 30 (SMP30) is a senescence marker molecule and identified as a calcium regulatory protein. Currently, SMP30 has emerged as a cytoprotective protein in a wide range of cell types. However, the role of SMP30 in regulating neuronal survival during cerebral ischemia/reperfusion injury remains unclear. In the present study, we aimed to investigate the biological function and regulatory mechanism of SMP30 on neuronal survival using a cellular model induced by oxygen-glucose deprivation/reoxygenation (OGD/R). The results showed that SMP30 expression was significantly decreased by OGD/R exposure in neurons. Functional experiments demonstrated that SMP30 overexpression significantly rescued the decreased cell viability and attenuated the apoptosis and reactive oxygen species generation in OGD/R-exposed neurons. By contrast, SMP30 knockdown exhibited the opposite effect. Mechanism research revealed that SMP30 overexpression contributed to the activation of nuclear factor erythroid 2-related factor (Nrf2)/antioxidant response element (ARE) signaling associated with downregulation of Kelch-like ECH-associated protein (Keap1). Keap1 overexpression or Nrf2 silencing significantly reversed SMP30-mediated neuroprotection against OGD/R-induced injury. Overall, these findings demonstrate that SMP30 overexpression protects neurons from OGD/R-induced apoptosis and oxidative stress by enhancing Nrf2/ARE antioxidant signaling via inhibition of Keap1. These data highlight the importance of the SMP30/Keap1/Nrf2/ARE signaling axis in regulating neuronal survival during cerebral ischemia/reperfusion injury.
C1 [Liu, Wenxiong] Hosp Xidian Grp, Dept Anesthesiol, Xian, Shaanxi, Peoples R China.
   [Zhao, Haikang] Xian Med Univ, Dept Neurosurg, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China.
   [Su, Yuqiang; Li, Jing; Xue, Sha; Qiu, Zhengguo] Xian Med Univ, Dept Anesthesiol, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China.
   [Wang, Kefeng] Xian Med Univ, Clin Training Ctr, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China.
   [Sun, Xiaopeng] Xian Med Univ, Dept Otolaryngol, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China.
C3 Xi'an Medical University; Xi'an Medical University; Xi'an Medical
   University; Xi'an Medical University
RP Qiu, ZG (corresponding author), Shaanxi Univ Tradit Chinese Med, Dept Anesthesiol, Affiliated Hosp, 2 Weiyang West Rd, Xianyang 712000, Shaanxi, Peoples R China.
EM qiuzhengguo_xmu@163.com
RI wang, jian/HRB-9588-2023; Zhang, Lijun/JEZ-7925-2023
OI Qiu, Zhengguo/0000-0003-0013-911X
CR Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI [10.1161/CIR.0000000000000530, 10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485]
   Chen X, 2018, INT J OPHTHALMOL-CHI, V11, P553, DOI 10.18240/ijo.2018.04.03
   Choo J, 2018, BIOCH BIOPHYS ACTA M, V12, P26
   Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019
   Du JX, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/3243906
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645
   Inoue H, 2018, BIOSCI BIOTECH BIOCH, V82, P900, DOI 10.1080/09168451.2018.1440190
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023
   Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76
   Kadowaki S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040542
   KAPLAN B, 1991, STROKE, V22, P1032, DOI 10.1161/01.STR.22.8.1032
   Kashio A, 2009, BIOCHEM BIOPH RES CO, V390, P394, DOI 10.1016/j.bbrc.2009.09.003
   Kim HS, 2013, NEUROBIOL AGING, V34, P1177, DOI 10.1016/j.neurobiolaging.2012.10.008
   Koizumi M, 2016, NUTR RES, V36, P1379, DOI 10.1016/j.nutres.2016.11.006
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2014, FEBS OPEN BIO, V4, P522, DOI 10.1016/j.fob.2014.05.003
   Li SN, 2017, MOL MED REP, V16, P4022, DOI 10.3892/mmr.2017.7106
   Lin PH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32085
   Liu L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00153
   Misaka T, 2013, BIOCHEM BIOPH RES CO, V439, P142, DOI 10.1016/j.bbrc.2013.08.002
   Misaka T, 2013, CARDIOVASC RES, V99, P461, DOI 10.1093/cvr/cvt122
   Miyata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079093
   Morán J, 2017, CELL MOL NEUROBIOL, V37, P405, DOI 10.1007/s10571-016-0372-1
   Okada H, 2015, J DIABETES INVEST, V6, P35, DOI 10.1111/jdi.12252
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Sun ML, 2015, NEUROCHEM INT, V80, P99, DOI 10.1016/j.neuint.2014.09.006
   Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006
   Takahashi K, 2019, ARCH BIOCHEM BIOPHYS, V663, P120, DOI 10.1016/j.abb.2019.01.003
   Vijayan M, 2019, MOL NEUROBIOL, V56, P6976, DOI 10.1007/s12035-019-1562-x
   Wu MY, 2018, CELL PHYSIOL BIOCHEM, V46, P1650, DOI 10.1159/000489241
   Yamaguchi M, 2013, APOPTOSIS, V18, P1145, DOI 10.1007/s10495-013-0859-x
   Yamauchi H, 2016, FREE RADICAL BIO MED, V94, P66, DOI 10.1016/j.freeradbiomed.2016.02.020
NR 38
TC 2
Z9 2
U1 0
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0960-3271
EI 1477-0903
J9 HUM EXP TOXICOL
JI Hum. Exp. Toxicol.
PD 2021 MAR
PY 2021
VL 40
IS 3
BP 472
EP 482
AR 0960327120954243
DI 10.1177/0960327120954243
EA SEP 2020
PG 11
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA QP7UA
UT WOS:000568539800001
PM 32909858
DA 2024-02-19
ER

PT J
AU Zhong, WZ
   Rao, ZQ
   Xu, J
   Sun, Y
   Hu, HR
   Wang, P
   Xia, YX
   Pan, XX
   Tang, WW
   Chen, ZY
   Zhou, HM
   Wang, XH
AF Zhong, Weizhe
   Rao, Zhuqing
   Xu, Jian
   Sun, Yu
   Hu, Haoran
   Wang, Ping
   Xia, Yongxiang
   Pan, Xiongxiong
   Tang, Weiwei
   Chen, Ziyi
   Zhou, Haoming
   Wang, Xuehao
TI Defective mitophagy in aged macrophages promotes mitochondrial DNA
   cytosolic leakage to activate STING signaling during liver sterile
   inflammation
SO AGING CELL
LA English
DT Article; Early Access
DE aging; macrophage; mitochondrial DNA; mitophagy; sterile inflammation;
   stimulator of interferon genes
ID ISCHEMIA-REPERFUSION INJURY; MECHANISMS; AUTOPHAGY
AB Macrophage-stimulator of interferon genes (STING) signaling mediated sterile inflammation has been implicated in various age-related diseases. However, whether and how macrophage mitochondrial DNA (mtDNA) regulates STING signaling in aged macrophages remains largely unknown. We found that hypoxia-reoxygenation (HR) induced STING activation in macrophages by triggering the release of macrophage mtDNA into the cytosol. Aging promoted the cytosolic leakage of macrophage mtDNA and enhanced STING activation, which was abrogated upon mtDNA depletion or cyclic GMP-AMP Synthase (cGAS) inhibition. Aged macrophages exhibited increased mitochondrial injury with impaired mitophagy. Mechanistically, a decline in the PTEN-induced kinase 1 (PINK1)/Parkin-mediated polyubiquitination of mitochondria was observed in aged macrophages. Pink1 overexpression reversed the inhibition of mitochondrial ubiquitination but failed to promote mitolysosome formation in the aged macrophages. Meanwhile, aging impaired lysosomal biogenesis and function in macrophages by modulating the mTOR/transcription factor EB (TFEB) signaling pathway, which could be reversed by Torin-1 treatment. Consequently, Pink1 overexpression in combination with Torin-1 treatment restored mitophagic flux and inhibited mtDNA/cGAS/STING activation in aged macrophages. Moreover, besides HR-induced metabolic stress, other types of oxidative and hepatotoxic stresses inhibited mitophagy and promoted the cytosolic release of mtDNA to activate STING signaling in aged macrophages. STING deficiency protected aged mice against diverse types of sterile inflammatory liver injuries. Our findings suggest that aging impairs mitophagic flux to facilitate the leakage of macrophage mtDNA into the cytosol and promotes STING activation, and thereby provides a novel potential therapeutic target for sterile inflammatory liver injury in aged patients.
C1 [Zhong, Weizhe; Xu, Jian; Sun, Yu; Hu, Haoran; Wang, Ping; Xia, Yongxiang; Tang, Weiwei; Chen, Ziyi; Zhou, Haoming; Wang, Xuehao] Nanjing Med Univ, Affiliated Hosp 1, Hepatobiliary Liver Transplantat Ctr, Nanjing 210029, Peoples R China.
   [Zhong, Weizhe; Xu, Jian; Sun, Yu; Hu, Haoran; Wang, Ping; Xia, Yongxiang; Tang, Weiwei; Chen, Ziyi; Zhou, Haoming; Wang, Xuehao] Chinese Acad Med Sci, Key Lab Liver Transplantat, Nanjing, Peoples R China.
   [Zhong, Weizhe; Xu, Jian; Sun, Yu; Hu, Haoran; Wang, Ping; Xia, Yongxiang; Tang, Weiwei; Chen, Ziyi; Zhou, Haoming; Wang, Xuehao] Nanjing Med Univ, NHC Key Lab Living Donor Liver Transplantat, Nanjing, Peoples R China.
   [Rao, Zhuqing; Pan, Xiongxiong] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing, Peoples R China.
C3 Nanjing Medical University; Chinese Academy of Medical Sciences - Peking
   Union Medical College; Nanjing Medical University; Nanjing Medical
   University
RP Zhou, HM; Wang, XH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Hepatobiliary Liver Transplantat Ctr, Nanjing 210029, Peoples R China.
EM hmzhou@njmu.edu.cn; wangxh@njmu.edu.cn
RI zhou, haoming/HMV-1715-2023; xiongxiong, pan/GPP-4500-2022; tang,
   wei/HZH-5205-2023; luo, yuan/JLS-6416-2023; Tang, Wei/IZQ-1283-2023
OI xiongxiong, pan/0000-0002-2747-3241; 
FU Major Program of the National Natural Science Foundation of China
   [81530048, 31930020]; National Science and Technology Major Project
   [2018AD18]; Key Laboratory of Liver Transplantation, Chinese Academy of
   Medical Sciences [2019PT320015]; National Natural Science Foundation of
   China [82071798, 81870448, 81470901, 81901628]; CAMS Innovation Fund for
   Medical Sciences [2019-I2 M-5-035]; Jiangsu Provincial Natural Science
   Foundation [BK20191490]; Six Talent Peaks Project in Jiangsu Province
   [2018-WSN-011]; Jiangsu Science and Technology Association Young Science
   and Technology Talents Lifting Project [DG000D4007]; Postgraduate
   Research & Practice Innovation Program of Jiangsu Province
   [KYCX21_1606]; PAPD
FX This study was supported by the Major Program of the National Natural
   Science Foundation of China (Grant No. 81530048, 31930020), National
   Science and Technology Major Project (2018AD18), Key Laboratory of Liver
   Transplantation, Chinese Academy of Medical Sciences (Grant No.
   2019PT320015), National Natural Science Foundation of China (No.
   82071798, 81870448, 81470901, 81901628), the CAMS Innovation Fund for
   Medical Sciences (No.2019--I2 M--5-035), Jiangsu Provincial Natural
   Science Foundation (No. BK20191490), Six Talent Peaks Project in Jiangsu
   Province (No. 2018--WSN--011), Jiangsu Science and Technology
   Association Young Science and Technology Talents Lifting Project (No.
   DG000D4007), Postgraduate Research & Practice Innovation Program of
   Jiangsu Province (KYCX21_1606), and A Project Funded by the PAPD
CR Aarreberg LD, 2019, MOL CELL, V74, P801, DOI 10.1016/j.molcel.2019.02.038
   Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657
   Bai JL, 2017, P NATL ACAD SCI USA, V114, P12196, DOI 10.1073/pnas.1708744114
   Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942
   Chakraborty J, 2020, PHARMACOL RES, V160, DOI 10.1016/j.phrs.2020.105097
   Chen G, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00200
   Chen Y, 2019, J HEPATOL, V70, P66, DOI 10.1016/j.jhep.2018.09.022
   Decout A, 2021, NAT REV IMMUNOL, V21, P548, DOI 10.1038/s41577-021-00524-z
   Duan KZ, 2021, NEURON, V109, P3793, DOI 10.1016/j.neuron.2021.09.008
   Han D, 2013, TRENDS PHARMACOL SCI, V34, P243, DOI 10.1016/j.tips.2013.01.009
   Harper JW, 2018, NAT REV MOL CELL BIO, V19, P93, DOI 10.1038/nrm.2017.129
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   Hopfner KP, 2020, NAT REV MOL CELL BIO, V21, P501, DOI 10.1038/s41580-020-0244-x
   Huang DD, 2019, EXP GERONTOL, V119, P61, DOI 10.1016/j.exger.2019.01.022
   Kan CY, 2018, TRANSPLANTATION, V102, P368, DOI 10.1097/TP.0000000000001999
   Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Khaminets A, 2016, TRENDS CELL BIOL, V26, P6, DOI 10.1016/j.tcb.2015.08.010
   Kitapma S, 2019, CANCER DISCOV, V9, P34, DOI 10.1158/2159-8290.CD-18-0689
   Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886
   Kondratskyi A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.156
   Kong WN, 2022, AM J TRANSPLANT, V22, P130, DOI 10.1111/ajt.16757
   Lei Z, 2018, AM J PHYSIOL-GASTR L, V314, pG655, DOI 10.1152/ajpgi.00326.2017
   Li N, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.228
   Lin QS, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101254
   Moehlman AT, 2020, ANNU REV CELL DEV BI, V36, P265, DOI 10.1146/annurev-cellbio-021820-101354
   Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1
   Nyfeler B, 2011, MOL CELL BIOL, V31, P2867, DOI 10.1128/MCB.05430-11
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Paul BD, 2021, TRENDS NEUROSCI, V44, P83, DOI 10.1016/j.tins.2020.10.008
   Rai P, 2021, NAT IMMUNOL, V22, P312, DOI 10.1038/s41590-020-00859-0
   Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799
   Sato Y, 2019, NAT REV NEPHROL, V15, P625, DOI 10.1038/s41581-019-0185-9
   Shen A, 2020, BIOCHEM BIOPH RES CO, V522, P47, DOI 10.1016/j.bbrc.2019.10.182
   Shen YJ, 2015, CELL REP, V11, P460, DOI 10.1016/j.celrep.2015.03.041
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   STOCCO DM, 1978, J GERONTOL, V33, P802, DOI 10.1093/geronj/33.6.802
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sunny NE, 2017, TRENDS ENDOCRIN MET, V28, P250, DOI 10.1016/j.tem.2016.11.006
   Tang CY, 2021, NAT REV NEPHROL, V17, P299, DOI 10.1038/s41581-020-00369-0
   Tyrrell DJ, 2021, NAT REV CARDIOL, V18, P58, DOI 10.1038/s41569-020-0431-7
   Xu DW, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.682736
   Xu Y, 2022, CANCER LETT, V529, P19, DOI 10.1016/j.canlet.2021.12.032
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yin KL, 2021, CELL DEATH DIFFER, V28, P2421, DOI 10.1038/s41418-021-00760-9
   Zhang XW, 2020, IMMUNITY, V53, P43, DOI 10.1016/j.immuni.2020.05.013
   Zhong WZ, 2020, AGING CELL, V19, DOI 10.1111/acel.13186
   Zhou HM, 2018, J HEPATOL, V69, P99, DOI 10.1016/j.jhep.2018.01.036
NR 49
TC 33
Z9 34
U1 9
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2022 JUN
PY 2022
VL 21
IS 6
AR e13622
DI 10.1111/acel.13622
EA MAY 2022
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 2C2HG
UT WOS:000798532600001
PM 35599014
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhao, JC
   Tian, FW
   Yan, S
   Zhai, QX
   Zhang, H
   Chen, W
AF Zhao, Jichun
   Tian, Fengwei
   Yan, Shuang
   Zhai, Qixiao
   Zhang, Hao
   Chen, Wei
TI <i>Lactobacillus plantarum</i> CCFM10 alleviating oxidative stress and
   restoring the gut microbiota in D-galactose-induced aging mice
SO FOOD & FUNCTION
LA English
DT Article
ID BALB/CJ MICE; MOUSE-LIVER; PLASMA; RATS; METABOLISM; ACTIVATION;
   TOXICITY; CAPACITY; INJURY
AB Oxidative stress and its correlation with degenerative diseases have been attracting wide attention. In the present study, Lactobacillus plantarum (L. plantarum) CCFM10 and RS15-3 were examined for their abilities to resist oxidative stress in D-galactose (D-gal)-exposed mice. Both strains significantly reversed the changes of hepatic total antioxidant capacity, catalase activity and glutathione content induced by D-gal. The antioxidative abilities of CCFM10 were higher than those of RS15-3. Moreover, the composition of the mice microbiota was changed by D-gal injection, which was characterized by the up-regulated ratio of Firmicutes/Bacteroidetes. At the genus level, the relative abundance of Lactobacillus reduced and the proportion of one genus of Clostridiales increased. However, in probiotic groups, the composition of the microbiota was similar to that of the control group at the phylum and the genus levels, suggesting that probiotic administration can restore the microbiota. Our study suggests that the protective effects of L. plantarum strains on the host microbiota could be one of the mechanisms of their resistance to oxidative stress. Besides this, through comparing the antioxidative capacity of two strains, we also found that the antioxidative capacity of L. plantarum might be strain-specific.
C1 [Zhao, Jichun; Tian, Fengwei; Yan, Shuang; Zhai, Qixiao; Zhang, Hao; Chen, Wei] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.
   [Zhao, Jichun; Tian, Fengwei; Yan, Shuang; Zhai, Qixiao; Zhang, Hao; Chen, Wei] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.
   [Tian, Fengwei; Zhai, Qixiao] Jiangnan Univ, Int Joint Res Lab Probiot, Wuxi 214122, Jiangsu, Peoples R China.
   [Zhang, Hao; Chen, Wei] Jiangnan Univ, Natl Engn Res Ctr Funct Food, Wuxi 214122, Jiangsu, Peoples R China.
   [Chen, Wei] BTBU, Beijing Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China.
C3 Jiangnan University; Jiangnan University; Jiangnan University; Jiangnan
   University; Beijing Technology & Business University
RP Chen, W (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.; Chen, W (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.; Chen, W (corresponding author), Jiangnan Univ, Natl Engn Res Ctr Funct Food, Wuxi 214122, Jiangsu, Peoples R China.; Chen, W (corresponding author), BTBU, Beijing Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China.
EM chenwei66@jiangnan.edu.cn
RI Chen, Wei/GZK-7348-2022; Wang, Luyao/JLL-2001-2023; Zhang,
   Hao/HHM-1940-2022; Zhao, Jichun/ABG-6369-2021
OI chen, weidong/0009-0006-1337-808X; Zhao, Jichun/0000-0003-1269-5922
FU National Natural Science Foundation of China [31371721, 31530056];
   Program of Collaborative Innovation Center of Food Safety and Quality
   Control in Jiangsu Province
FX This work was supported by the National Natural Science Foundation of
   China (no. 31371721 and 31530056) and the Program of Collaborative
   Innovation Center of Food Safety and Quality Control in Jiangsu
   Province.
CR Achuthan AA, 2012, MOL BIOL REP, V39, P7887, DOI 10.1007/s11033-012-1633-9
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104
   Gao DW, 2013, FOOD FUNCT, V4, P982, DOI 10.1039/c3fo30316k
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hsia CH, 2012, BRIT J NUTR, V107, P1787, DOI 10.1017/S0007114511005150
   Li C, 2014, FOOD FUNCT, V5, P3216, DOI 10.1039/c4fo00549j
   Lin MY, 1999, J AGR FOOD CHEM, V47, P1460, DOI 10.1021/jf981149l
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033
   Mao BY, 2016, J AGR FOOD CHEM, V64, P6240, DOI 10.1021/acs.jafc.6b02305
   Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9
   Peng XY, 2014, INFLAMMATION, V37, P1599, DOI 10.1007/s10753-014-9886-1
   Peng XY, 2014, INT DAIRY J, V34, P80, DOI 10.1016/j.idairyj.2013.08.004
   Qiao Y, 2013, APPL MICROBIOL BIOT, V97, P1689, DOI 10.1007/s00253-012-4323-6
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Serrano LM, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-29
   Tang W, 2017, FOOD CHEM, V221, P1642, DOI 10.1016/j.foodchem.2016.10.124
   Tang W, 2016, APPL MICROBIOL BIOT, V100, P7193, DOI 10.1007/s00253-016-7581-x
   Tian FW, 2012, BIOL TRACE ELEM RES, V150, P264, DOI 10.1007/s12011-012-9462-1
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   van der Loo B, 2003, BIOCHEM BIOPH RES CO, V303, P483, DOI 10.1016/S0006-291X(03)00360-7
   Wang LX, 2013, WORLD J GASTROENTERO, V19, P3150, DOI 10.3748/wjg.v19.i20.3150
   Wang LL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020318
   Wu JL, 2008, PHYSIOL RES, V57, P261, DOI 10.33549/physiolres.931161
   Yeh SL, 2014, EUR J NUTR, V53, P449, DOI 10.1007/s00394-013-0545-3
   Zhai QX, 2013, APPL ENVIRON MICROB, V79, P1508, DOI 10.1128/AEM.03417-12
   Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27
   Zhang XL, 2008, FOOD CHEM TOXICOL, V46, P2888, DOI 10.1016/j.fct.2008.05.032
   Zhang ZF, 2009, J AGR FOOD CHEM, V57, P7731, DOI 10.1021/jf9012357
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
   Zhao JC, 2017, J FUNCT FOODS, V39, P44, DOI 10.1016/j.jff.2017.09.055
NR 32
TC 63
Z9 69
U1 7
U2 94
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD FEB
PY 2018
VL 9
IS 2
BP 917
EP 924
DI 10.1039/c7fo01574g
PG 8
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA GC6GB
UT WOS:000429887000020
PM 29313548
DA 2024-02-19
ER

PT J
AU Zou, JW
   Zhang, HS
   Huang, Y
   Xu, WJ
   Huang, YJ
   Zuo, SY
   Li, ZH
   Zhou, HL
AF Zou, Junwei
   Zhang, Hesong
   Huang, Yong
   Xu, Wenjing
   Huang, Yujin
   Zuo, Siyuan
   Li, Zhenhan
   Zhou, Hailang
TI Multi-Omics Analysis of the Tumor Microenvironment in Liver Metastasis
   of Colorectal Cancer Identified FJX1 as a Novel Biomarker
SO FRONTIERS IN GENETICS
LA English
DT Article
DE colorectal cancer; liver metastasis; bioinformatics analysis; FJX1;
   tumor microenvironment
ID SURVIVAL; EXPRESSION
AB Colorectal cancer incidence and mortality have increased in recent years, with more than half of patients who died of colorectal cancer developing liver metastases. Consequently, colorectal cancer liver metastasis is the focus of clinical treatment, as well as being the most difficult. The primary target genes related to colorectal cancer liver metastasis were via bioinformatics analysis. First, five prognosis-related genes, CTAG1A, CSTL1, FJX1, IER5L, and KLHL35, were identified through screening, and the prognosis of the CSTL1, FJX1, IER5L, and KLHL35 high expression group was considerably poorer than that of the low expression group. Furthermore, the clinical correlation analysis revealed that in distinct pathological stages T, N, and M, the mRNA expression levels of CSTL1, IER5L, and KLHL35 were higher than in normal tissues. Finally, a correlation study of the above genes and clinical manifestations revealed that FJX1 was strongly linked to colorectal cancer liver metastasis. FJX1 is thought to affect chromogenic modification enzymes, the Notch signaling system, cell senescence, and other signaling pathways, according to KEGG enrichment analysis. FJX1 may be a critical target in colorectal cancer metastasis, and thus has the potential as a new biomarker to predict and treat colorectal cancer liver metastases.
C1 [Zou, Junwei; Huang, Yong] Second Affiliated Hosp Wannan Med Coll, Dept Gastrointestinal Surg, Wuhu, Peoples R China.
   [Zhang, Hesong] Second Peoples Hosp Wuhu, Dept Hepatobiliary Surg, Wuhu, Peoples R China.
   [Xu, Wenjing; Zuo, Siyuan; Li, Zhenhan] Wannan Med Coll, Sch Clin Med, Wuhu, Peoples R China.
   [Huang, Yujin] Wannan Med Coll, Sch Pharm, Wuhu, Peoples R China.
   [Zhou, Hailang] Nanjing Med Univ, Lianshui Peoples Hosp, Kangda Coll, Dept Gastroenterol, Huaian, Peoples R China.
C3 Wannan Medical College; Wannan Medical College; Nanjing Medical
   University
RP Li, ZH (corresponding author), Wannan Med Coll, Sch Clin Med, Wuhu, Peoples R China.; Zhou, HL (corresponding author), Nanjing Med Univ, Lianshui Peoples Hosp, Kangda Coll, Dept Gastroenterol, Huaian, Peoples R China.
EM a18756476231@126.com; zhouhl198779@163.com
RI li, fei/JYP-3334-2024; Zou, Junwei/HLG-6333-2023; Li,
   Xinyue/JVN-4601-2024; Liu, Jinyu/JYQ-6274-2024; li,
   zhenhan/HKM-6439-2023; Xu, Wenjing/N-6924-2018
OI Zou, Junwei/0000-0002-9575-5347; Xu, Wenjing/0000-0002-3046-2535
CR Al-Greene NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069660
   Alghandour R, 2020, J EGYPT NATL CANCER, V32, DOI 10.1186/s43046-020-00040-6
   Balacescu O, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123711
   Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193
   Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003
   Brody H, 2015, NATURE, V526, pS1, DOI [10.1038/526S1a, 10.1038/521S1a]
   Cassetta L, 2020, CURR BIOL, V30, pR246, DOI 10.1016/j.cub.2020.01.031
   Castells Antoni, 2016, Gastroenterol Hepatol, V39 Suppl 1, P62, DOI 10.1016/S0210-5705(16)30176-5
   Chai SJ, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/3857853
   Chakedis J, 2018, SURG ONCOL CLIN N AM, V27, P377, DOI 10.1016/j.soc.2017.11.010
   Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002
   Chandrashekar DS, 2022, NEOPLASIA, V25, P18, DOI 10.1016/j.neo.2022.01.001
   Chang HJ, 2018, REPROD SCI, V25, P207, DOI 10.1177/1933719117716780
   Cui MF, 2021, COMB CHEM HIGH T SCR, V24, P1736, DOI 10.2174/1386207323666201110154142
   Dang W, 2020, J GENE MED, V22, DOI 10.1002/jgm.3183
   de la Pinta C, 2021, CANCERS, V13, DOI 10.3390/cancers13215547
   Engstrand J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3925-x
   Hänzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7
   Hou JY, 2017, SEMIN CELL DEV BIOL, V64, P58, DOI 10.1016/j.semcdb.2016.08.034
   House MG, 2010, J AM COLL SURGEONS, V210, P744, DOI 10.1016/j.jamcollsurg.2009.12.040
   Huang XM, 2013, J GASTROINTEST SURG, V17, P1283, DOI 10.1007/s11605-013-2194-5
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Jin KT, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107041
   Lai H, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019265
   Larionova I, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.566511
   Li ZJ, 2016, ONCOL REP, V35, P1403, DOI 10.3892/or.2016.4546
   Liu F, 2020, CANCER MANAG RES, V12, P8773, DOI 10.2147/CMAR.S260537
   Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052
   Moeini A, 2012, LIVER CANCER, V1, P83, DOI 10.1159/000342405
   Nasseri Y, 2017, SURG CLIN N AM, V97, P503, DOI 10.1016/j.suc.2017.01.002
   Palaga T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00652
   Pan YY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.583084
   Pretzsch E, 2019, J ONCOL, V2019, DOI 10.1155/2019/7407190
   Roncucci L, 2015, EUR J INTERN MED, V26, P752, DOI 10.1016/j.ejim.2015.08.019
   Stewart CL, 2018, CURR PROB SURG, V55, P330, DOI 10.1067/j.cpsurg.2018.08.004
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tao Y, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7269150
   Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Vivian J, 2017, NAT BIOTECHNOL, V35, P314, DOI 10.1038/nbt.3772
   Wang J, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2020.11723
   Xiong Z, 2022, NUCLEIC ACIDS RES, V50, pD1004, DOI 10.1093/nar/gkab972
   Xiong Z, 2020, NUCLEIC ACIDS RES, V48, pD890, DOI 10.1093/nar/gkz840
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhou FY, 2021, UPDATES SURG, V73, P391, DOI 10.1007/s13304-021-00978-9
NR 45
TC 4
Z9 4
U1 3
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JUL 19
PY 2022
VL 13
AR 960954
DI 10.3389/fgene.2022.960954
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 3L9MF
UT WOS:000835083700001
PM 35928453
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU PIERI, C
   FALASCA, M
   MARCHESELLI, F
   MORONI, F
   RECCHIONI, R
   MARMOCCHI, F
   LUPIDI, G
AF PIERI, C
   FALASCA, M
   MARCHESELLI, F
   MORONI, F
   RECCHIONI, R
   MARMOCCHI, F
   LUPIDI, G
TI FOOD RESTRICTION IN FEMALE WISTAR RATS .5. LIPID-PEROXIDATION AND
   ANTIOXIDANT ENZYMES IN THE LIVER
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE UNDERNUTRITION; LIVER; PEROXIDATION; ANTIOXIDANT ENZYMES
ID LONGEVITY
AB The activities of antioxidant enzymes as well as the levels of basal and enzyme induced peroxidation have been investigated in liver of female Wistar undernourished rats. Food restriction was applied starting from the age of 3.5 months by feeding the animals on every-other-day schedule (EOD). Diet restriction prevented the age-dependent increase of basal and enzyme induced lipid peroxidation in both mitochondrial and microsomal liver membrane preparations.
   The activities of antioxidant enzyme, i.e. superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) of liver decreased during aging in ad libitum fed rats. In the diet conditioned animals, a small increase of SOD and a complete recovery of CAT activities were observed.
   Present data support that food restriction improved the protection against peroxidation, and this may be in close relationship with the life prolonging effect of such a treatment.
C1 UNIV CAMERINO,DEPT CELLULAR BIOL,I-62032 CAMERINO,ITALY.
C3 University of Camerino
RP PIERI, C (corresponding author), IST NAZL RIPOSA & CURA ANZIANI,CTR CYTOL,DEPT GERONTOL RES,VIA BIRARELLI 8,I-60121 ANCONA,ITALY.
RI Marcheselli, Fiorella/AAB-4170-2021; Recchioni, Rina/ABH-7802-2020;
   Falasca, Marco/S-4020-2016
OI Marcheselli, Fiorella/0000-0003-1188-1651; Recchioni,
   Rina/0000-0002-7596-3077; Falasca, Marco/0000-0002-9801-7235; Lupidi,
   Giulio/0000-0001-9452-0741
CR COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   KITAHARA A, 1982, LIVER AGING 1982, P135
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LOWRY DH, 1976, J BIOL CHEM, V71, P952
   LUCK H, 1974, METHOD ENZYMAT AN, P886
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MERRY JB, 1988, PHYSL BASIS AGING GE, P392
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PIERI C, 1990, ARCH GERONTOL GERIAT, V11, P117, DOI 10.1016/0167-4943(90)90003-O
   PIERI C, 1991, ARCH GERONTOL GERIAT, V12, P179, DOI 10.1016/0167-4943(91)90026-M
   PIERI C, 1990, ARCH GERONTOL GERIAT, V11, P99, DOI 10.1016/0167-4943(90)90001-M
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P520
   SVINGEN BA, 1979, J BIOL CHEM, V254, P5892
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 18
TC 38
Z9 41
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JAN-FEB
PY 1992
VL 14
IS 1
BP 93
EP 99
DI 10.1016/0167-4943(92)90010-2
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA HK365
UT WOS:A1992HK36500009
PM 15374413
DA 2024-02-19
ER

PT J
AU Wang, XY
   Oishi, N
   Shimakami, T
   Yamashita, T
   Honda, M
   Murakami, S
   Kaneko, S
AF Wang, Xuyang
   Oishi, Naoki
   Shimakami, Tetsuro
   Yamashita, Taro
   Honda, Masao
   Murakami, Seishi
   Kaneko, Shuichi
TI Hepatitis B virus X protein induces hepatic stem cell-like features in
   hepatocellular carcinoma by activating KDM5B
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Hepatitis B virus X protein; Hepatocellular carcinoma; KDM5B; Progenitor
   cell; Tumorigenesis
ID HISTONE DEMETHYLASE KDM5B; PROLIFERATION; CANCER; JARID1B; ROLES
AB AIM
   To determine the role of hepatitis B virus X protein (HBx), HBx in regulating hepatic progenitor cell (HPC)-like features in hepatocellular carcinoma (HCC) and the underlying molecular mechanisms.
   METHODS
   We used a retrovirus vector to introduce wild type HBx or empty vector into HepG2 cells. We then used these cells to analyze cell proliferation, senescence, transformation, and stem-like features. Gene expression profiling was carried out on Affymetrix GeneChip Human U133A2.0 ver. 2 arrays according to the manufacturer's protocol. Unsupervised hierarchical clustering analysis and Class Comparison analysis were performed by BRB-Array Tools software Version 4.2.2. A total of 238 hepatitis B virus (HBV)-related HCC patients' array data were used for analyzing clinical features.
   RESULTS
   The histone demethylase KDM5B was significantly highly expressed in HBV-related HCC cases (P < 0.01). In HBV proteins, only HBx up-regulated KDM5B by activating c-myc. Hepatic stem cell (HpSC) markers (EpCAM, AFP, PROM1, and NANOG) were significantly highly expressed in KDM5B-high HCC cases (P < 0.01). KDM5B played an important role in maintaining HpSC-like features and was associated with a poor prognosis. Moreover, inhibition of KDM5B suppressed spheroid formation and cell invasion in vitro.
   CONCLUSION
   HBx activates the histone demethylase KDM5B and induces HPC-like features in HCC. Histone demethylases KDM5B may be an important therapeutic target against HBV-related HCC cases.
C1 [Wang, Xuyang; Oishi, Naoki; Shimakami, Tetsuro; Yamashita, Taro; Honda, Masao; Murakami, Seishi; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan.
C3 Kanazawa University
RP Oishi, N (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan.
EM ooishi@m-kanazawa.jp
FU KAKENHI [15K08992]; Japan Society for the Promotion of Science;
   Grants-in-Aid for Scientific Research [15K08992, 15K08492, 15H04809]
   Funding Source: KAKEN
FX Supported by Grant-in-Aid for Scientific Research (KAKENHI) (C), No.
   15K08992 (to Oishi N); and Core-to-Core Program, B. Asia-Africa Science
   Platforms, the Japan Society for the Promotion of Science (to Kaneko S).
CR Buendia MA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021444
   Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59
   Hirata A, 2017, HEPATOL RES, V47, P283, DOI 10.1111/hepr.12714
   Hu XM, 2016, HEPATOL RES, V46, P804, DOI 10.1111/hepr.12618
   Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025
   Kuo YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125343
   Lakhtakia R, 2003, J GASTROEN HEPATOL, V18, P80, DOI 10.1046/j.1440-1746.2003.02902.x
   Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377
   Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021
   Li X, 2014, P NATL ACAD SCI USA, V111, P7096, DOI 10.1073/pnas.1324036111
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633
   Matsuda Y, 2009, MED MOL MORPHOL, V42, P138, DOI 10.1007/s00795-009-0457-8
   Oishi N, 2007, CANCER SCI, V98, P1540, DOI 10.1111/j.1349-7006.2007.00579.x
   Okitsu T, 2004, DIABETES, V53, P105
   PFEIFER AMA, 1993, P NATL ACAD SCI USA, V90, P5123, DOI 10.1073/pnas.90.11.5123
   Saitta C, 2015, LIVER INT, V35, P2311, DOI 10.1111/liv.12807
   Secombe J, 2007, CELL CYCLE, V6, P1324, DOI 10.4161/cc.6.11.4269
   Shen XD, 2015, TUMOR BIOL, V36, P7133, DOI 10.1007/s13277-015-3418-y
   Shinoda M, 2007, J SURG RES, V137, P130, DOI 10.1016/j.jss.2006.08.009
   Shirasaki T, 2014, HEPATOLOGY, V60, P1519, DOI 10.1002/hep.27277
   Shukla SK, 2012, FEBS J, V279, P3859, DOI 10.1111/j.1742-4658.2012.08745.x
   Stalker L, 2012, METHODS MOL BIOL, V809, P411, DOI 10.1007/978-1-61779-376-9_27
   Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488
   Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x
   Terradillos O, 1997, ONCOGENE, V14, P395, DOI 10.1038/sj.onc.1200850
   Wang D, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0311-5
   Wang ZR, 2015, AM J CANCER RES, V5, P87
   Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104
   Xie LQ, 2011, EMBO J, V30, P1473, DOI 10.1038/emboj.2011.91
   Yamamoto S, 2014, CANCER CELL, V25, P762, DOI 10.1016/j.ccr.2014.04.024
   Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168
   Zhang WY, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-128
   Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003
   Zhang Y, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0366-3
NR 35
TC 12
Z9 18
U1 0
U2 7
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD MAY 14
PY 2017
VL 23
IS 18
BP 3252
EP 3261
DI 10.3748/wjg.v23.i18.3252
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA EU8XD
UT WOS:000401320900006
PM 28566884
OA Green Published, Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU Mathews, ST
   Rakhade, S
   Zhou, XH
   Parker, GC
   Coscina, DV
   Grunberger, G
AF Mathews, Suresh T.
   Rakhade, Sanjay
   Zhou, Xiaohua
   Parker, Graham C.
   Coscina, Donald V.
   Grunberger, George
TI Fetuin-null mice are protected against obesity and insulin resistance
   associated with aging
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE alpha 2-HS glycoprotein; Ahsg; fetuin; fetuin-A; insulin sensitivity;
   aging
ID RECEPTOR TYROSINE KINASE; GLUCOSE-TRANSPORT; RAT ADIPOCYTES; AHSG GENE;
   MUSCLE; SENSITIVITY; AGE; AUTOPHOSPHORYLATION; INHIBITOR; BINDING
AB alpha 2-HS glycoprotein (AHSG), also known as fetuin-A, inhibits insulin receptor autophosphorylation and tyrosine kinase activity in vitro and in vivo. Earlier we have shown that fetuin-null (KO) mice demonstrate improved insulin sensitivity and resistance to diet-induced obesity. Since aging is associated with insulin resistance and impaired glucose handling, we tested the hypothesis that fetuin-null (KO) mice are resilient to changes in insulin sensitivity associated with aging. Aged (80-week-old) fetuin-null mice were leaner and demonstrated significantly lower body weights compared to age- and sex-matched wild-type (WT) littermates. Leanness in aged fetuin KO mice was accompanied by a significant increase in dark-onset energy expenditure, without marked alteration of respiratory quotient. In comparison to WT mice, fetuin KO mice demonstrated a lower fasting insulin resistance index, and significantly lower blood glucose and insulin levels, following a 4 h fast. Interestingly, despite significantly decreased insulin levels during a glucose tolerance test, aged fetuin-null mice demonstrated a similar glucose excursion as WT mice, indicative of improved insulin sensitivity. Analysis of aldehyde-fuchsin stained pancreas from aged fetuin KO mice indicated no difference in islet P-cell size or number. An insulin tolerance test confirmed the increased insulin sensitivity of aged fetuin KO mice. Further, compared to WT mice, aged fetuin-null mice demonstrated increased skeletal muscle and liver IR autophosphorylation and TK activity. Taken together, this study suggests that the absence of fetuin may contribute to the improvement of insulin sensitivity associated with aging. (c) 2006 Elsevier Inc. All rights reserved.
C1 Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA.
   Wayne State Univ, Sch Med, Dept Psychol, Detroit, MI 48201 USA.
C3 Wayne State University; Wayne State University
RP Mathews, ST (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA.
EM smathews@auburn.edu
CR Ahmad F, 1997, J CLIN INVEST, V100, P449, DOI 10.1172/JCI119552
   AUBERGER P, 1989, CELL, V58, P631, DOI 10.1016/0092-8674(89)90098-6
   Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639
   BARNARD RJ, 1992, AM J PHYSIOL, V262, pE619, DOI 10.1152/ajpendo.1992.262.5.E619
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   CHOU CK, 1987, J BIOL CHEM, V262, P1842
   Cintron V J, 2001, Int J Exp Diabetes Res, V1, P249
   EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704
   Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FRAZE E, 1987, J AM GERIATR SOC, V35, P224, DOI 10.1111/j.1532-5415.1987.tb02313.x
   Fulop T, 2003, PATHOL BIOL, V51, P574, DOI 10.1016/j.patbio.2003.09.007
   Goldfine ID, 1999, ANN NY ACAD SCI, V892, P204, DOI 10.1111/j.1749-6632.1999.tb07797.x
   GOODMAN MN, 1983, AM J PHYSIOL, V244, pE93, DOI 10.1152/ajpendo.1983.244.1.E93
   GRUNBERGER G, 1984, SCIENCE, V223, P932, DOI 10.1126/science.6141638
   Ix JH, 2006, CIRCULATION, V113, P1760, DOI 10.1161/CIRCULATIONAHA.105.588723
   JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496
   Kalabay L, 1998, HORM METAB RES, V30, P1, DOI 10.1055/s-2007-978822
   Kalabay L, 2002, EUR J ENDOCRINOL, V147, P243, DOI 10.1530/eje.0.1470243
   Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000
   Lavebratt C, 2005, HUM GENET, V117, P54, DOI 10.1007/s00439-005-1286-z
   Lempiäinen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123
   Mathews ST, 2000, MOL CELL ENDOCRINOL, V164, P87, DOI 10.1016/S0303-7207(00)00237-9
   Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450
   MATTHAEI S, 1990, J ENDOCRINOL, V126, P99, DOI 10.1677/joe.0.1260099
   Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484
   Olivier E, 2000, BIOCHEM J, V350, P589, DOI 10.1042/0264-6021:3500589
   REAVEN GM, 1985, J AM GERIATR SOC, V33, P286, DOI 10.1111/j.1532-5415.1985.tb07118.x
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   RUIZ P, 1992, ARCH BIOCHEM BIOPHYS, V296, P231, DOI 10.1016/0003-9861(92)90567-G
   Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938
   Tabarin A, 2005, DIABETES, V54, P3510, DOI 10.2337/diabetes.54.12.3510
   TOLLEFSBOL TO, 1986, J AM GERIATR SOC, V34, P282, DOI 10.1111/j.1532-5415.1986.tb04225.x
   Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887
   Youngren JF, 2001, J APPL PHYSIOL, V91, P2240, DOI 10.1152/jappl.2001.91.5.2240
   Youngren JF, 1997, AM J PHYSIOL-ENDOC M, V273, pE276, DOI 10.1152/ajpendo.1997.273.2.E276
NR 36
TC 103
Z9 114
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 17
PY 2006
VL 350
IS 2
BP 437
EP 443
DI 10.1016/j.bbrc.2006.09.071
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 096PS
UT WOS:000241389900027
PM 17011519
DA 2024-02-19
ER

PT J
AU Meir, AY
   Keller, M
   Bernhart, SH
   Rinott, E
   Tsaban, G
   Zelicha, H
   Kaplan, A
   Schwarzfuchs, D
   Shelef, I
   Gepner, Y
   Li, J
   Lin, YF
   Blüher, M
   Ceglarek, U
   Stumvoll, M
   Stadler, PF
   Stampfer, MJ
   Kovacs, P
   Liang, LM
   Shai, I
AF Yaskolka Meir, Anat
   Keller, Maria
   Bernhart, Stephan H.
   Rinott, Ehud
   Tsaban, Gal
   Zelicha, Hila
   Kaplan, Alon
   Schwarzfuchs, Dan
   Shelef, Ilan
   Gepner, Yftach
   Li, Jun
   Lin, Yifei
   Blueher, Matthias
   Ceglarek, Uta
   Stumvoll, Michael
   Stadler, Peter F.
   Stampfer, Meir J.
   Kovacs, Peter
   Liang, Liming
   Shai, Iris
TI Lifestyle weight-loss intervention may attenuate methylation aging: the
   CENTRAL MRI randomized controlled trial
SO CLINICAL EPIGENETICS
LA English
DT Article
DE Age prediction; Intrahepatic fat; DNA methylation; Aging; Weight loss
ID EPIGENETIC CLOCK ANALYSIS; FATTY LIVER-DISEASE; ALL-CAUSE MORTALITY; DNA
   METHYLATION; VISCERAL FAT; AGE; CONSEQUENCES; EXERCISE; OBESITY; CANCER
AB Background: DNA methylation age (mAge), a methylation biomarker for the aging process, might serve as a more accurate predictor of morbidity and aging status than chronological age. We evaluated the role of multiple factors, including fat deposition, cardiometabolic risk factors and lifestyle weight-loss intervention, on the deviation of mAge from chronological age (mAge deviation) or 18-month change in mAge (Delta mAge). In this sub-study of the CENTRAL magnetic resonance imaging weight-loss trial, we evaluated mAge by a validated 240-CpG-based prediction formula at baseline and after 18-month intervention of either low fat (LF) or mediterranean/low carbohydrate (MED/LC) diets.
   Results: Among 120 CENTRAL participants with abdominal obesity or dyslipidemia, mAge (mean +/- SD: 60.3 +/- 7.5 years) was higher than the chronological age (48.6 +/- 9.3 years) but strongly correlated (r = 0.93; p = 3.1 x 10(-53)). Participants in the lowest tertile of mAge deviation from their chronological age had significantly lower waist-circumference, visceral adipose tissue, intrahepatic fat (IHF) content, fasting-glucose and HOMA-IR, as compared with participants in the highest sex-specific residual tertile (p < 0.05 for all). IHF% remained associated with greater mAge deviation after further adjustments (beta = 0.23; p = 0.02). After 18-month weight-loss lifestyle intervention, mAge remained significantly correlated with chronological age (r = 0.94, p = 1.5 x 10(-55)). mAging occurred, with no difference between lifestyle intervention groups (Delta = 0.9 +/- 1.9 years in MED/LC vs. Delta = 1.3 +/- 1.9 years in LF; p = 0.2); however, we observed a mAging attenuation in successful weight losers (> 5% weight loss) vs. weight-loss failures (Delta = 0.6 years vs. Delta = 1.1 years; p = 0.04), and in participants who completed the trial with healthy liver fat content (< 5% IHF) vs. participants with fatty liver (Delta = 0.6 years vs. Delta = 1.8 years; p = 0.003). Overall, 18 months of weight-loss lifestyle intervention attenuated the mAging of the men, mainly the older, by 7.1 months than the expected (p < 0.05).
   Conclusions: Lifestyle weight-loss intervention may attenuate mAging. Deviation of mAge from chronological age might be related to body fat distribution and glycemic control and could indicate biological age, health status and the risk for premature cardiometabolic diseases.
C1 [Yaskolka Meir, Anat; Rinott, Ehud; Tsaban, Gal; Zelicha, Hila; Kaplan, Alon; Shai, Iris] Ben Gurion Univ Negev, Dept Publ Hlth, Fac Hlth Sci, IL-84105 Beer Sheva, Israel.
   [Lin, Yifei; Stampfer, Meir J.; Liang, Liming] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Keller, Maria; Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, Helmholtz Ctr Munich, Helmholtz Inst Metab Obes & Vasc Res HI MAG, D-04103 Leipzig, Germany.
   [Keller, Maria; Blueher, Matthias; Stumvoll, Michael] Univ Hosp Leipzig, D-04103 Leipzig, Germany.
   [Keller, Maria; Stumvoll, Michael; Kovacs, Peter] Univ Leipzig, Med Ctr, Med Dept Endocrinol Nephrol Rheumatol 3, D-04103 Leipzig, Germany.
   [Bernhart, Stephan H.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany.
   [Bernhart, Stephan H.; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04107 Leipzig, Germany.
   [Bernhart, Stephan H.] Univ Leipzig, LIFE Res Ctr Civilizat Dis, Transcriptome Bioinformat, D-04107 Leipzig, Germany.
   [Schwarzfuchs, Dan; Shelef, Ilan] Soroka Univ, Med Ctr, IL-84101 Beer Sheva, Israel.
   [Gepner, Yftach] Tel Aviv Univ, Sch Publ Hlth, Sackler Fac Med, Dept Epidemiol & Prevent Med, IL-6997801 Tel Aviv, Israel.
   [Gepner, Yftach] Tel Aviv Univ, Sylvan Adams Sports Inst, IL-6997801 Tel Aviv, Israel.
   [Li, Jun; Stampfer, Meir J.; Shai, Iris] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Ceglarek, Uta] Univ Leipzig, Inst Lab Med, Med Ctr, D-04103 Leipzig, Germany.
   [Stumvoll, Michael; Kovacs, Peter] Deutsch Zentrum Diabet Forsch, D-85764 Neuherberg, Germany.
   [Stadler, Peter F.] Univ Leipzig, German Ctr Integrat Biodivers Res iDiv, Competence Ctr Scalable Data Serv & Solut Dresden, D-04109 Leipzig, Germany.
   [Stadler, Peter F.] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany.
   [Stadler, Peter F.] Max Planck Inst Math Sci, D-04103 Leipzig, Germany.
   [Stadler, Peter F.] Fraunhofer Inst Cell Therapy & Immunol, D-04103 Leipzig, Germany.
   [Stadler, Peter F.] Univ Vienna, Dept Theoret Chem, A-1090 Vienna, Austria.
   [Stadler, Peter F.] Univ Copenhagen, Ctr RNA Technol & Hlth, DK-1871 Frederiksberg, Denmark.
   [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA.
   [Stampfer, Meir J.] Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA 02115 USA.
   [Stampfer, Meir J.] Harvard Med Sch, Boston, MA 02115 USA.
   [Liang, Liming] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
C3 Ben Gurion University; Harvard University; Harvard T.H. Chan School of
   Public Health; Helmholtz Association; Helmholtz-Center Munich - German
   Research Center for Environmental Health; Leipzig University; Leipzig
   University; Leipzig University; Leipzig University; Leipzig University;
   Leipzig University; Ben Gurion University; Soroka Medical Center;
   Sackler Faculty of Medicine; Tel Aviv University; Harvard University;
   Harvard T.H. Chan School of Public Health; Leipzig University; Leipzig
   University; Leipzig University; Max Planck Society; Fraunhofer
   Gesellschaft; University of Vienna; University of Copenhagen; The Santa
   Fe Institute; Harvard University; Brigham & Women's Hospital; Harvard
   University; Harvard Medical School; Harvard University; Harvard T.H.
   Chan School of Public Health
RP Shai, I (corresponding author), Ben Gurion Univ Negev, Dept Publ Hlth, Fac Hlth Sci, IL-84105 Beer Sheva, Israel.; Liang, LM (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Shai, I (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.; Liang, LM (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
EM lliang@hsph.harvard.edu; irish@bgu.ac.il
RI Kovacs, Peter/JYP-2384-2024; Lin, Yifei/AAF-6606-2022; Lin,
   Yifei/ACO-6658-2022; Ceglarek, Uta/GOE-5561-2022; Stadler, Peter
   F./L-7857-2015; Stumvoll, Michael/HJZ-3437-2023; Meir, Anat
   Yaskolka/AAK-7469-2021; wang, xiao/HZI-9156-2023; Keller,
   Maria/AAD-4877-2020; SHAI, IRIS/HJO-8533-2023; Stumvoll,
   Michael/ABE-1121-2021
OI Kovacs, Peter/0000-0002-0290-5423; Lin, Yifei/0000-0002-3184-9213; Lin,
   Yifei/0000-0002-3184-9213; Stadler, Peter F./0000-0002-5016-5191;
   Stumvoll, Michael/0000-0001-6225-8240; Keller,
   Maria/0000-0003-4026-8530; SHAI, IRIS/0000-0001-9050-4605; Stumvoll,
   Michael/0000-0001-6225-8240; , Stephan/0000-0002-5928-9449
FU Free State of Saxony; Deutsche Forschungsgemeinschaft (DFG)
   [209933838-SFB 1052]; German Diabetes Association; Deutsches Zentrum fur
   Diabetesforschung; Israel Science Foundation (ISF); Israel Ministry of
   Science and Technology [3-13604]; Dr. Robert C. and Veronica Atkins
   Research Foundation
FX This work has been supported by the Free State of Saxony and grants from
   the Deutsche Forschungsgemeinschaft (DFG, German Research
   Foundation-Projektnummer 209933838-SFB 1052; B01, B03, B11, Z04), from
   the German Diabetes Association and Deutsches Zentrum fur
   Diabetesforschung. The CENTRAL RCT was supported by the Israel Science
   Foundation (ISF), Israel Ministry of Science and Technology (grant
   #3-13604) and the Dr. Robert C. and Veronica Atkins Research Foundation.
CR Arpón A, 2016, J PHYSIOL BIOCHEM, V73, P445, DOI 10.1007/s13105-017-0552-6
   Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049
   Balducci L, 2000, HEMATOL ONCOL CLIN N, V14, P1, DOI 10.1016/S0889-8588(05)70274-4
   Bettio LEB, 2017, NEUROSCI BIOBEHAV R, V79, P66, DOI 10.1016/j.neubiorev.2017.04.030
   Britton KA, 2011, CIRCULATION, V124, pE837, DOI 10.1161/CIRCULATIONAHA.111.077602
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Byrne CD, 2009, CLIN SCI, V116, P539, DOI 10.1042/CS20080253
   Capurso C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010035
   Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020
   Chen L, 2019, J GERONTOL A-BIOL, V74, P91, DOI 10.1093/gerona/gly223
   Christiansen L, 2016, AGING CELL, V15, P149, DOI 10.1111/acel.12421
   Denic A, 2016, ADV CHRONIC KIDNEY D, V23, P19, DOI 10.1053/j.ackd.2015.08.004
   Dugué PA, 2018, AM J EPIDEMIOL, V187, P529, DOI 10.1093/aje/kwx291
   Fortin JP, 2017, BIOINFORMATICS, V33, P558, DOI 10.1093/bioinformatics/btw691
   Fraga MF, 2009, CURR OPIN IMMUNOL, V21, P446, DOI 10.1016/j.coi.2009.04.003
   Gensous N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20082022
   Gepner Y, 2019, J HEPATOL, V71, P379, DOI 10.1016/j.jhep.2019.04.013
   Gepner Y, 2018, CIRCULATION, V137, P1143, DOI 10.1161/CIRCULATIONAHA.117.030501
   Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Jylhävä J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046
   Käräjämäki AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142937
   Keller M, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00794-7
   Li J, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP2773
   Lind L, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12872
   Liu JK, 2011, ARTERIOSCL THROM VAS, V31, P2715, DOI 10.1161/ATVBAHA.111.234062
   Marioni RE, 2019, J GERONTOL A-BIOL, V74, P57, DOI 10.1093/gerona/gly060
   Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6
   Mckay JA, 2011, ACTA PHYSIOL, V202, P103, DOI 10.1111/j.1748-1716.2011.02278.x
   Moore JB, 2010, P NUTR SOC, V69, P211, DOI 10.1017/S0029665110000030
   Nasabian PJ, 2017, J ENDOCRINOL, V234, pR37, DOI 10.1530/JOE-16-0603
   Perna L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0228-z
   Quach A, 2017, AGING-US, V9, P419, DOI 10.18632/aging.101168
   Roetker NS, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.117.001937
   Scorletti E, 2011, ENDOCRINE, V40, P332, DOI 10.1007/s12020-011-9530-x
   Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593
   Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009
   Tammen SA, 2013, MOL ASPECTS MED, V34, P753, DOI 10.1016/j.mam.2012.07.018
   Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011
   Teven CM, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/201371
   van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636
   van Iterson M, 2014, BIOINFORMATICS, V30, P3435, DOI 10.1093/bioinformatics/btu566
   Voisin S, 2015, ACTA PHYSIOL, V213, P39, DOI 10.1111/apha.12414
   Williamson DA, 2015, OBESITY, V23, P2319, DOI 10.1002/oby.21358
   Zelber-Sagi S, 2016, THER ADV GASTROENTER, V9, P392, DOI 10.1177/1756283X16638830
NR 47
TC 18
Z9 18
U1 3
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1868-7075
EI 1868-7083
J9 CLIN EPIGENETICS
JI Clin. Epigenetics
PD MAR 4
PY 2021
VL 13
IS 1
AR 48
DI 10.1186/s13148-021-01038-0
PG 10
WC Oncology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Genetics & Heredity
GA QT4TD
UT WOS:000626580700002
PM 33663610
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wang, LP
   Chen, QW
   Zhuang, SQ
   Wen, YY
   Cheng, WQ
   Zeng, ZJ
   Jiang, T
   Tang, CP
AF Wang, Liping
   Chen, Qiangwei
   Zhuang, Suqi
   Wen, Yuying
   Cheng, Wanqiu
   Zeng, Zhijun
   Jiang, Tao
   Tang, Chunping
TI Effect of <i>Anoectochilus roxburghii</i> flavonoids extract on
   H<sub>2</sub>O<sub>2</sub>- Induced oxidative stress in LO2 cells and
   D-gal induced aging mice model
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Anoectochilus roxburghii flavonoids Extract; Oxidative stress;
   D-galactose; Aging; Hydrogen peroxide
ID ANTIAGING ACTIVITIES; CELLULAR-PROTECTION; ANTIOXIDANT; POLYSACCHARIDES;
   BRAIN; IMPAIRMENT; APOPTOSIS; DAMAGE; INJURY; RATS
AB Ethnopharmacological relevance: Anoectochilus roxburghii (A. roxburghii) is a popular folk medicine in many Asian countries, which has been used traditionally for treatment of some diseases such as diabetes, tumors, hyperlipemia, and hepatitis. The ethanol extract from A. roxburghii was recently shown to exert better ability to scavenge free radicals in vitro and possess antioxidant on natural aging mice in vivo.
   Aim of the study: This study is to characterize the chemical composition, and investigate the protective effect of the A. roxburghii flavonoids extract (ARF) against hydrogen peroxide (H2O2)-induced oxidative stress in LO2 cells in vitro and D-galactose (D-gal)-induced aging mice model in vivo, and explore the underlying mechanisms.
   Materials and methods: The chemical components of the flavonoids extract from A. roxburghii were detected by ul-traperformance lipid chromatography coupled with quadrupole-time-of-flight mass spectrometry (UPLC-QTOF-MS/MS). H(2)O(2 )was used to establish an oxidative stress model in LO2 cells. Cytotoxic and protective effects of ARF on the LO2 cells were determined using 3-(4,5-dimethylthiazol 2 yl) 2,5 diphenyltetrazolium bromide (MTT) method. Moreover, the levels of superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), and malondialdehyde (MDA) in cell supernatants were measured by commercial reagent kits. Kun-Ming mice were induced to aging with D-gal (400 mg/kg, BW) by subcutaneous injection for 58 days. From the 28th day to the 58th day of D-gal treatment, ARF (122.5, 245 and 490 mg/kg, BW) and vitamin E (100 mg/kg, BW) were orally administrated to aging mice once a day for consecutive 30 days. After 25 days of the treatment with ARF, learning and memory were assessed using Morris Water Maze (MWM). At the end of the test period, the animals were euthanized by cervical dislocation, and the levels of SOD, GSH-PX, and MDA in serum, liver homogenates and brain homogenates were measured. The levels of monoamine oxidase (MAO) and acetylcholinesterase (AchE) were determined in brain homogenates. Skin and liver histopatholo-gical morphology were observed by H&E staining. Furthermore, antioxidant-related gene expression levels in the liver were carried out by quantitative real-time polymerase chain reaction (qRT-PCR).
   Results: Nine flavonoids were identified in the extracts of A. roxburghii. In vitro assay, a high concentration of ARF ( > 612.5 mu g/ml) reduced the survival rate and had toxic effects on LO2 cells. In addition, ARF (245 mu g/ml, 490 mu g/ml) and Vitamin C (200 mu g/ml) markedly inhibited generations of MDA and increased activities of SOD, GSH-PX in H2O2-induced LO2 cells supernatants. In vivo assay, ARF (122.5 mg/kg, 245 mg/kg and 490 mg/kg) and Vitamin E (100 mg/kg) not only ameliorated learning and memory ability but also improved skin and liver pathological alterations. Strikingly, ARF significantly decreased MDA and MAO levels, markedly enhanced an-tioxidant enzyme (SOD and GSH-PX) activities. Further, compared to the D-gal group, ARF could obviously up-regulate glutathione peroxidase-1 (GPx-1) and glutathione peroxidase-4 (GPx-4) mRNA levels.
   Conclusions: These findings suggested that ARF protects LO2 cells against H2O2-induced oxidative stress and exerts the potent anti-aging effects in D-gal aging mice model, which may be related to the inhibition of oxi-dative stress. Flavonoid compounds may contribute to the anti-oxidative capability and modulating aging.
C1 [Wang, Liping; Chen, Qiangwei; Zhuang, Suqi; Wen, Yuying; Cheng, Wanqiu; Zeng, Zhijun; Tang, Chunping] Guangdong Pharmaceut Univ, Coll Chinese Mat Med, Guangzhou 510006, Peoples R China.
   [Jiang, Tao] Guangdong Pharmaceut Univ, Lab Anim Ctr, Guangzhou 510006, Peoples R China.
   [Jiang, Tao] Guangzhou Key Lab Construct & Applicat New Drug S, Guangzhou 510006, Peoples R China.
   [Tang, Chunping] Guangdong Pharmaceut Univ, Guangdong Prov Engn Ctr Top Precise Drug Delivery, Guangzhou 510006, Guangdong, Peoples R China.
C3 Guangdong Pharmaceutical University; Guangdong Pharmaceutical
   University; Guangdong Pharmaceutical University
RP Tang, CP (corresponding author), Guangzhou Key Lab Construct & Applicat New Drug S, Guangzhou 510006, Peoples R China.; Jiang, T (corresponding author), Guangdong Pharmaceut Univ, Guangdong Prov Engn Ctr Top Precise Drug Delivery, Guangzhou 510006, Guangdong, Peoples R China.; Jiang, T (corresponding author), Guangdong Pharmaceut Univ, Sch Tradit Chinese Med, Guangzhou 510006, Guangdong, Peoples R China.
EM jiangtao@gdpu.edu.cn; tangchunping@gdpu.edu.cn
RI Zeng, Zhijun/JMQ-4495-2023
FU National Scientific and Technological Project of Traditional Chinese
   Medicine Industry [201507004]
FX This work was supported by National Scientific and Technological Project
   of Traditional Chinese Medicine Industry(NO. 201507004), thanks for the
   help of the Experimental Animal Center of Guangdong Pharmaceutical
   University and teacher Tang's language guidance.
CR Abdollahi M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/876834
   Alara OR, 2018, FOOD BIOPROD PROCESS, V107, P36, DOI 10.1016/j.fbp.2017.10.007
   Ambikar DB, 2013, ORIENTAL PHARM EXP M, V13, P301, DOI 10.1007/s13596-013-0110-x
   [Anonymous], 2018, OXID MED CELL LONGEV, DOI DOI 10.1038/NRC3916
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   Aydin AF, 2016, METAB BRAIN DIS, V31, P337, DOI 10.1007/s11011-015-9755-0
   Bartlett DE, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072139
   Cao ST, 2018, INNATE IMMUN-LONDON, V24, P221, DOI 10.1177/1753425918769372
   Carocho M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1472708
   Chen Ping, 2013, Journal of Chinese Pharmaceutical Sciences, V22, P106
   Chen QiangWei, 2017, Journal of Guangdong Pharmaceutical University, V33, P352
   Cheng BH, 2013, NEUROCHEM INT, V62, P620, DOI 10.1016/j.neuint.2012.09.011
   Choudhry QN, 2019, J GINSENG RES, V43, P179, DOI 10.1016/j.jgr.2017.10.003
   Cui SC, 2013, EXP TOXICOL PATHOL, V65, P485, DOI 10.1016/j.etp.2012.02.003
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   Ding QY, 2016, INT J BIOL MACROMOL, V85, P133, DOI 10.1016/j.ijbiomac.2015.12.058
   Ferlazzo N, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/957031
   Gray NE, 2016, J ETHNOPHARMACOL, V180, P78, DOI 10.1016/j.jep.2016.01.013
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   Harris CJ, 2014, J ALZHEIMERS DIS, V41, P179, DOI 10.3233/JAD-131703
   Jian WJ, 2018, FOOD RES INT, V107, P93, DOI 10.1016/j.foodres.2018.02.014
   Jian WJ, 2017, FOOD CHEM, V231, P42, DOI 10.1016/j.foodchem.2017.03.121
   Jiménez-Sánchez C, 2016, J FOOD COMPOS ANAL, V46, P78, DOI 10.1016/j.jfca.2015.11.004
   Kolniak-Ostek J, 2016, J FOOD COMPOS ANAL, V49, P65, DOI 10.1016/j.jfca.2016.04.004
   Koyama H, 2013, MOLECULES, V18, P1383, DOI 10.3390/molecules18021383
   Kumar S, 2015, IND CROP PROD, V69, P143, DOI 10.1016/j.indcrop.2015.02.012
   Lan Z, 2012, J ETHNOPHARMACOL, V141, P386, DOI 10.1016/j.jep.2012.02.050
   Lei LH, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1975-x
   [李桂兰 Li Guilan], 2014, [中国细胞生物学学报, Chinese Journal of Cell Biology], V36, P785
   Li SS, 2018, INT J BIOL MACROMOL, V106, P1297, DOI 10.1016/j.ijbiomac.2017.08.135
   Liu SS, 2015, INT J MOL SCI, V16, P30190, DOI 10.3390/ijms161226224
   Liu X, 2018, SKIN RES TECHNOL, V24, P31, DOI 10.1111/srt.12387
   Ma J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40953-4
   Ma KS, 2014, PAK J ZOOL, V46, P215
   Merksamer PI, 2013, AGING-US, V5, P144, DOI 10.18632/aging.100544
   Mladenov M, 2015, PHYSIOL RES, V64, P891, DOI 10.33549/physiolres.932890
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Nam SM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010176
   Perruchot MH, 2019, PEERJ, V7, DOI 10.7717/peerj.6565
   Qian Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23113026
   Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68
   Ruijters E, 2012, FREE RADICAL BIO MED, V53, pS87, DOI 10.1016/j.freeradbiomed.2012.10.348
   Saeidnia S, 2013, TOXICOL APPL PHARM, V273, P442, DOI 10.1016/j.taap.2013.09.031
   Shao QS, 2014, IND CROP PROD, V60, P104, DOI 10.1016/j.indcrop.2014.06.009
   Simirgiotis MJ, 2013, FOOD CHEM, V139, P289, DOI 10.1016/j.foodchem.2013.01.089
   Sun KY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7108604
   Tang JY, 2016, BIOL TRACE ELEM RES, V173, P71, DOI 10.1007/s12011-016-0653-z
   Tang TT, 2018, INT J BIOL MACROMOL, V112, P882, DOI 10.1016/j.ijbiomac.2018.02.042
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Wang PP, 2016, PHYTOMEDICINE, V23, P460, DOI 10.1016/j.phymed.2016.02.014
   Xiao JH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/273435
   Ye SW, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01298
   Ye SY, 2017, J ETHNOPHARMACOL, V209, P184, DOI 10.1016/j.jep.2017.07.032
   Zeng BY, 2017, J ETHNOPHARMACOL, V200, P124, DOI 10.1016/j.jep.2017.02.018
   Zeng BY, 2016, CARBOHYD POLYM, V153, P391, DOI 10.1016/j.carbpol.2016.07.067
   Zhang HY, 2017, J ETHNOPHARMACOL, V196, P225, DOI 10.1016/j.jep.2016.11.042
   Zhang HY, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00187
   Zhang JG, 2015, J ETHNOPHARMACOL, V164, P180, DOI 10.1016/j.jep.2015.01.050
   Zhang SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097573
   Zhen YZ, 2016, EXP THER MED, V11, P303, DOI 10.3892/etm.2015.2858
   Zhu SY, 2017, BIOMED ENVIRON SCI, V30, P623, DOI 10.3967/bes2017.083
NR 73
TC 49
Z9 51
U1 8
U2 76
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD MAY 23
PY 2020
VL 254
AR 112670
DI 10.1016/j.jep.2020.112670
PG 14
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA KZ9SX
UT WOS:000523600200013
PM 32135242
DA 2024-02-19
ER

PT J
AU Esselun, C
   Dilberger, B
   Silaidos, CV
   Koch, E
   Schebb, NH
   Eckert, GP
AF Esselun, Carsten
   Dilberger, Benjamin
   Silaidos, Carmina, V
   Koch, Elisabeth
   Schebb, Nils Helge
   Eckert, Gunter P.
TI A Walnut Diet in Combination with Enriched Environment Improves
   Cognitive Function and Affects Lipid Metabolites in Brain and Liver of
   Aged NMRI Mice
SO NEUROMOLECULAR MEDICINE
LA English
DT Article; Early Access
DE Mitochondrial function; Brain; Liver; Oxylipins; Cognition; Behaviour;
   NMRI; Ageing; Neurodegeneration
ID ALPHA-LINOLENIC ACID; POLYUNSATURATED FATTY-ACIDS; MITOCHONDRIAL
   DYSFUNCTION; DOCOSAHEXAENOIC ACID; MEDITERRANEAN DIET; EICOSAPENTAENOIC
   ACID; NERVOUS-SYSTEM; SPATIAL MEMORY; NITRIC-OXIDE; LIFE-SPAN
AB This in vivo study aimed to test if a diet enriched with 6% walnuts alone or in combination with physical activity supports healthy ageing by changing the oxylipin profile in brain and liver, improving motor function, cognition, and cerebral mitochondrial function. Female NMRI mice were fed a 6% walnut diet starting at an age of 12 months for 24 weeks. One group was additionally maintained in an enriched environment, one group without intervention served as control. After three months, one additional control group of young mice (3 weeks old) was introduced. Motor and cognitive functions were measured using Open Field, Y-Maze, Rotarod and Passive Avoidance tests. Lipid metabolite profiles were determined using RP-LC-ESI(-)-MS/MS in brain and liver tissues of mice. Cerebral mitochondrial function was characterized by the determination of ATP levels, mitochondrial membrane potential and mitochondrial respiration. Expression of genes involved with mito- and neurogenesis, inflammation, and synaptic plasticity were determined using qRT-PCR. A 6% walnut-enriched diet alone improved spatial memory in a Y-Maze alternation test (p < 0.05) in mice. Additional physical enrichment enhanced the significance, although the overall benefit was virtually identical. Instead, physical enrichment improved motor performance in a Rotarod experiment (p* < 0.05) which was unaffected by walnuts alone. Bioactive oxylipins like hydroxy-polyunsaturated fatty acids (OH-PUFA) derived from linoleic acid (LA) were significantly increased in brain (p** < 0.01) and liver (p*** < 0.0001) compared to control mice, while OH-PUFA of alpha-linolenic acid (ALA) could only be detected in the brains of mice fed with walnuts. In the brain, walnuts combined with physical activity reduced arachidonic acid (ARA)-based oxylipin levels (p < 0.05). Effects of walnut lipids were not linked to mitochondrial function, as ATP production, mitochondrial membrane potential and mitochondrial respiration were unaffected. Furthermore, common markers for synaptic plasticity and neuronal growth, key genes in the regulation of cytoprotective response to oxidative stress and neuronal growth were unaffected. Taken together, walnuts change the oxylipin profile in liver and brain, which could have beneficial effects for healthy ageing, an effect that can be further enhanced with an active lifestyle. Further studies may focus on specific nutrient lipids that potentially provide preventive effects in the brain.
C1 [Esselun, Carsten; Dilberger, Benjamin; Silaidos, Carmina, V; Eckert, Gunter P.] Justus Liebig Univ, Biomed Res Ctr Seltersberg BFS, Inst Nutr Sci, Lab Nutr Prevent & Therapy, Schubertstr 81, D-35392 Giessen, Germany.
   [Koch, Elisabeth; Schebb, Nils Helge] Univ Wuppertal, Fac Math & Nat Sci, Chair Food Chem, Gaussstr 20, D-42119 Wuppertal, Germany.
C3 Justus Liebig University Giessen; University of Wuppertal
RP Eckert, GP (corresponding author), Justus Liebig Univ, Biomed Res Ctr Seltersberg BFS, Inst Nutr Sci, Lab Nutr Prevent & Therapy, Schubertstr 81, D-35392 Giessen, Germany.
EM eckert@uni-giessen.de
OI Esselun, Carsten/0000-0003-1193-8347; Eckert, Gunter
   Peter/0000-0002-8002-9983; Schebb, Nils Helge/0000-0003-1299-6629
FU California Walnut Commission
FX Open Access funding enabled and organized by Projekt DEAL. This research
   was funded by a grant from the California Walnut Commission.
CR Afshordel S, 2015, PROSTAG LEUKOTR ESS, V92, P23, DOI 10.1016/j.plefa.2014.05.008
   Ali W, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030667
   Amtul Z, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.014
   Ashley S, 2021, NUTR NEUROSCI, V24, P795, DOI 10.1080/1028415X.2019.1681066
   Asseburg H, 2016, NEUROMOL MED, V18, P378, DOI 10.1007/s12017-016-8428-4
   Baraldi T, 2013, EXP GERONTOL, V48, P831, DOI 10.1016/j.exger.2013.05.055
   Blondeau N, 2009, NEUROPSYCHOPHARMACOL, V34, P2548, DOI 10.1038/npp.2009.84
   Bourre JM, 2006, J NUTR HEALTH AGING, V10, P386
   Bourre JM, 2006, J NUTR HEALTH AGING, V10, P377
   Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com
   Carey AN, 2013, NUTR NEUROSCI, V16, P13, DOI 10.1179/1476830512Y.0000000023
   Cole GM, 2009, PROSTAG LEUKOTR ESS, V81, P213, DOI 10.1016/j.plefa.2009.05.015
   Coras R, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040827
   Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009
   Cutuli D, 2017, CURR NEUROPHARMACOL, V15, P534, DOI 10.2174/1570159X14666160614091311
   DeMar JC, 2005, J NEUROCHEM, V94, P1063, DOI 10.1111/j.1471-4159.2005.03258.x
   Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4
   Dilberger B, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6840540
   Dilberger B, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081886
   Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052
   Eckert GP, 2013, PROSTAG LEUKOTR ESS, V88, P105, DOI 10.1016/j.plefa.2012.05.006
   Eckert GP, 2011, BBA-BIOMEMBRANES, V1808, P236, DOI 10.1016/j.bbamem.2010.10.014
   Eckert GP, 2010, PHARMACOL RES, V61, P234, DOI 10.1016/j.phrs.2010.01.005
   Emendato A, 2016, FEBS LETT, V590, P582, DOI 10.1002/1873-3468.12082
   Ferdouse A, 2019, LIPIDS, V54, P67, DOI 10.1002/lipd.12122
   Franke C, 2007, NEUROBIOL DIS, V25, P438, DOI 10.1016/j.nbd.2006.10.004
   Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732
   Gnaiger E., 2020, BIOENERG COMMUN, V5, P23, DOI DOI 10.26124/BEC:2020-0002
   Gong Z, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1450-3
   Grimm A, 2016, BIOGERONTOLOGY, V17, P281, DOI 10.1007/s10522-015-9618-4
   Hagl S, 2016, NEUROMOL MED, V18, P347, DOI 10.1007/s12017-016-8420-z
   Haider S, 2011, PLANT FOOD HUM NUTR, V66, P335, DOI 10.1007/s11130-011-0260-2
   Hatchard T, 2014, BEHAV BRAIN RES, V273, P177, DOI 10.1016/j.bbr.2014.06.043
   Hayes D, 2016, CRIT REV FOOD SCI, V56, P1231, DOI 10.1080/10408398.2012.760516
   Herbst EAF, 2014, J PHYSIOL-LONDON, V592, P1341, DOI 10.1113/jphysiol.2013.267336
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Intlekofer KA, 2013, NEUROBIOL DIS, V57, P47, DOI 10.1016/j.nbd.2012.06.011
   Jiménez-Jiménez FJ, 2016, CURR MED CHEM, V23, P2666, DOI 10.2174/0929867323666160812151356
   Kim D, 2019, BEHAV BRAIN RES, V374, DOI 10.1016/j.bbr.2019.112105
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Koch E, 2020, TALANTA, V217, DOI 10.1016/j.talanta.2020.121074
   Kutzner L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00169
   Kutzner L, 2017, BBA-MOL CELL BIOL L, V1862, P666, DOI 10.1016/j.bbalip.2017.04.001
   Leng S, 2018, J NUTR BIOCHEM, V57, P228, DOI 10.1016/j.jnutbio.2018.04.002
   Leng S, 2017, J LIPID RES, V58, P1702, DOI 10.1194/jlr.M078097
   Litwiniuk A, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8908901
   Liu J, 2019, FOOD SCI NUTR, V7, P969, DOI 10.1002/fsn3.907
   Lores-Arnaiz S, 2010, BRAIN RES, V1319, P44, DOI 10.1016/j.brainres.2010.01.017
   Lu DY, 2010, NEUROPSYCHOPHARMACOL, V35, P2238, DOI 10.1038/npp.2010.98
   Lynch AM, 2007, NEUROBIOL AGING, V28, P845, DOI 10.1016/j.neurobiolaging.2006.04.006
   Maesako M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.028
   Martínez-Lapiscina EH, 2013, J NEUROL NEUROSUR PS, V84, P1318, DOI 10.1136/jnnp-2012-304792
   Mawhinney LJ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-123
   McKay DL, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-21
   Mejias NH, 2018, J INFLAMM-LOND, V15, DOI 10.1186/s12950-018-0198-3
   Mendonça AM, 2018, PROSTAG LEUKOTR ESS, V129, P13, DOI 10.1016/j.plefa.2017.12.004
   Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3
   Minogue AM, 2007, J NEUROCHEM, V103, P914, DOI 10.1111/j.1471-4159.2007.04848.x
   Moon DO, 2007, INT IMMUNOPHARMACOL, V7, P222, DOI 10.1016/j.intimp.2006.10.001
   Muthaiyah B, 2014, J ALZHEIMERS DIS, V42, P1397, DOI 10.3233/JAD-140675
   Naoe S, 2019, METABOLITES, V9, DOI 10.3390/metabo9100241
   Nayeem MA, 2018, ACTA PHARMACOL SIN, V39, P1142, DOI 10.1038/aps.2018.24
   Neves J, 2020, FEBS J, V287, P43, DOI 10.1111/febs.15061
   Nuernberg K, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-56
   Official Methods of Analysis of AOAC International, 1995, 96315 AOAC OFF METH
   Ostermann AI, 2020, PROSTAG OTH LIPID M, V146, DOI 10.1016/j.prostaglandins.2019.106384
   Ostermann AI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184470
   Ostermann AI, 2017, FOOD FUNCT, V8, P2355, DOI [10.1039/C7FO00403F, 10.1039/c7fo00403f]
   Ostermann AI, 2017, PROSTAG OTH LIPID M, V133, P79, DOI 10.1016/j.prostaglandins.2017.06.001
   Pandareesh MD, 2018, J ALZHEIMERS DIS, V64, P1295, DOI [10.3233/JAD-180361, 10.3233/jad-180361]
   Poulose SM, 2014, J NUTR, V144, p561S, DOI 10.3945/jn.113.184838
   Poulose SM, 2013, J NUTR BIOCHEM, V24, P912, DOI 10.1016/j.jnutbio.2012.06.009
   Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001
   Ren DY, 2018, J SCI FOOD AGR, V98, P5142, DOI 10.1002/jsfa.9060
   Reutzel M, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4060769
   Rey C, 2019, BRAIN BEHAV IMMUN, V76, P17, DOI 10.1016/j.bbi.2018.07.025
   Ros E, 2009, AM J CLIN NUTR, V89, pS1649, DOI 10.3945/ajcn.2009.26736R
   Rosales-Martínez P, 2014, J MEX CHEM SOC, V58, P185
   Rossignoli CP, 2018, J NUTR BIOCHEM, V60, P16, DOI 10.1016/j.jnutbio.2018.07.001
   Rund Katharina M, 2019, Prostaglandins Other Lipid Mediat, V144, P106334, DOI 10.1016/j.prostaglandins.2019.04.004
   Rund KM, 2018, ANAL CHIM ACTA, V1037, P63, DOI 10.1016/j.aca.2017.11.002
   Sala-Vila A, 2020, AM J CLIN NUTR, V111, P590, DOI 10.1093/ajcn/nqz328
   Sales-Campos H, 2013, MINI-REV MED CHEM, V13, P201
   Samson AL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16171
   Schaffer S, 2012, MOL NEUROBIOL, V46, P161, DOI 10.1007/s12035-012-8282-9
   Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434
   Shashikumar S, 2015, PHYSIOL BEHAV, V151, P563, DOI 10.1016/j.physbeh.2015.08.025
   Signini ÉF, 2020, METABOLITES, V10, DOI 10.3390/metabo10060264
   Smarr B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218935
   Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011
   Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010
   Thomas J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/172801
   Valencak TG, 2011, J COMP PHYSIOL B, V181, P289, DOI 10.1007/s00360-010-0520-8
   Valls-Pedret C, 2015, JAMA INTERN MED, V175, P1094, DOI 10.1001/jamainternmed.2015.1668
   Valls-Pedret C, 2012, J ALZHEIMERS DIS, V29, P773, DOI 10.3233/JAD-2012-111799
   Verret L, 2013, NEUROBIOL AGING, V34, P211, DOI 10.1016/j.neurobiolaging.2012.05.013
   Vinson JA, 2012, FOOD FUNCT, V3, P134, DOI 10.1039/c2fo10152a
   Wang LM, 2019, FOOD SCI NUTR, V7, P293, DOI 10.1002/fsn3.889
   Weiser MJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020099
   Willis LM, 2009, BRIT J NUTR, V101, P1140, DOI 10.1017/S0007114508059369
NR 100
TC 10
Z9 10
U1 1
U2 15
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1535-1084
EI 1559-1174
J9 NEUROMOL MED
JI Neuromol. Med.
PD 2021 MAR
PY 2021
VL 23
IS 1
SI SI
BP 140
EP 160
DI 10.1007/s12017-020-08639-7
EA DEC 2020
PG 21
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA QR3ZQ
UT WOS:000602292900001
PM 33367957
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Schachtschneider, KM
   Schook, LB
   Meudt, JJ
   Shanmuganayagam, D
   Zoller, JA
   Haghani, A
   Li, CZ
   Zhang, JS
   Yang, A
   Raj, K
   Horvath, S
AF Schachtschneider, Kyle M.
   Schook, Lawrence B.
   Meudt, Jennifer J.
   Shanmuganayagam, Dhanansayan
   Zoller, Joseph A.
   Haghani, Amin
   Li, Caesar Z.
   Zhang, Joshua
   Yang, Andrew
   Raj, Ken
   Horvath, Steve
TI Epigenetic clock and DNA methylation analysis of porcine models of aging
   and obesity
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Porcine; Pig; Minipigs; Aging; Development; Epigenetic clock; DNA
   methylation
ID LARGE ANIMAL-MODELS; PIG; MINIPIG; ATHEROSCLEROSIS; DISEASE; TISSUE; AGE
AB DNA-methylation profiles have been used successfully to develop highly accurate biomarkers of age, epigenetic clocks, for many species. Using a custom methylation array, we generated DNA methylation data from n = 238 porcine tissues including blood, bladder, frontal cortex, kidney, liver, and lung, from domestic pigs (Sus scrofa domesticus) and minipigs (Wisconsin Miniature Swine (TM)). Samples used in this study originated from Large White X Landrace crossbred pigs, Large White X Minnesota minipig crossbred pigs, and Wisconsin Miniature Swine (TM). We present 4 epigenetic clocks for pigs that are distinguished by their compatibility with tissue type (pan-tissue and blood clock) and species (pig and human). Two dual-species human-pig pan-tissue clocks accurately measure chronological age and relative age, respectively. We also characterized CpGs that differ between minipigs and domestic pigs. Strikingly, several genes implicated by our epigenetic studies of minipig status overlap with genes (ADCY3, TFAP2B, SKOR1, and GPR61) implicated by genetic studies of body mass index in humans. In addition, CpGs with different levels of methylation between the two pig breeds were identified proximal to genes involved in blood LDL levels and cholesterol synthesis, of particular interest given the minipig's increased susceptibility to cardiovascular disease compared to domestic pigs. Thus, breed-specific differences of domestic and minipigs may potentially help to identify biological mechanisms underlying weight gain and aging-associated diseases. Our porcine clocks are expected to be useful for elucidating the role of epigenetics in aging and obesity, and the testing of anti-aging interventions.
C1 [Schachtschneider, Kyle M.; Schook, Lawrence B.] Univ Illinois, Dept Radiol, Chicago, IL USA.
   [Schachtschneider, Kyle M.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA.
   [Schachtschneider, Kyle M.] Univ Illinois, Natl Ctr Supercomp Applicat, Urban, IL USA.
   [Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL USA.
   [Meudt, Jennifer J.; Shanmuganayagam, Dhanansayan] Univ Wisconsin, Dept Anim & Dairy Sci, Biomed & Genom Res Grp, Madison, WI USA.
   [Shanmuganayagam, Dhanansayan] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA.
   [Zoller, Joseph A.; Haghani, Amin; Li, Caesar Z.; Yang, Andrew; Horvath, Steve] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA.
   [Zhang, Joshua; Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda Bldg,695 Charles Young Dr South, Los Angeles, CA 90095 USA.
   [Raj, Ken] Publ Hlth England, Radiat Effects Dept, Ctr Radiat Chem & Environm Hazards, Didcot, Oxon, England.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison;
   University of California System; University of California Los Angeles;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; Public Health England
RP Horvath, S (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA.
EM kschach2@uic.edu; schook@illinois.edu; jjmeudt@wisc.edu;
   dshanmug@wisc.edu; ahaghani@g.ucla.edu; lizexuan@g.ucla.edu;
   joshuazhang@g.ucla.edu; andy.yang@yale.edu; ken.raj@phe.gov.uk;
   shorvath@mednet.ucla.edu
RI ; Haghani, Amin/C-5543-2015
OI ZHANG, JOSHUA/0000-0002-4488-1175; Schachtschneider,
   Kyle/0000-0002-7293-8642; Haghani, Amin/0000-0002-6052-8793; Zoller,
   Joseph/0000-0001-6309-0291; Horvath, Steve/0000-0002-4110-3589
FU Paul G. Allen Frontiers Group
FX This work was supported by the Paul G. Allen Frontiers Group (SH).
CR Al-Mashhadi RH, 2015, DIABETOLOGIA, V58, P1926, DOI 10.1007/s00125-015-3637-1
   Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853
   Arneson A, 2021, MAMMALIAN METHYLATIO, DOI DOI 10.1101/2021.01.07.425637
   Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Caliebe A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44550
   Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020
   Choi M, 2015, DNA RES, V22, P343, DOI 10.1093/dnares/dsv017
   Coronel R, 2007, CARDIOVASC RES, V73, P386, DOI 10.1016/j.cardiores.2006.10.006
   Crisóstomo V, 2016, LAB ANIMAL, V45, P67, DOI 10.1038/laban.935
   de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149
   de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017
   Dixon JA, 2009, CIRC-HEART FAIL, V2, P262, DOI 10.1161/CIRCHEARTFAILURE.108.814459
   Ekelof S, 2014, J CARDIOVASC TRANSL, V7, P570, DOI 10.1007/s12265-014-9574-4
   Elmadhun NY, 2013, J THORAC CARDIOV SUR, V145, P258, DOI 10.1016/j.jtcvs.2012.09.028
   Felix JF, 2016, HUM MOL GENET, V25, P389, DOI 10.1093/hmg/ddv472
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Gaba Ron C, 2020, Oncotarget, V11, P2686, DOI 10.18632/oncotarget.27647
   Ganderup NC, 2012, INT J TOXICOL, V31, P507, DOI 10.1177/1091581812462039
   Goni L, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060789
   Grarup N, 2018, NAT GENET, V50, P172, DOI 10.1038/s41588-017-0022-7
   Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622
   Gutierrez K, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00293
   He J, 2015, INT J BIOL SCI, V11, P361, DOI 10.7150/ijbs.10858
   Heino TJ, 2012, J ORTHOP RES, V30, P1019, DOI 10.1002/jor.22049
   Hoffe B, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00838
   Horvath S, 2018, AIDS, V32, P1465, DOI [10.1097/QAD.0000000000001854, 10.1097/qad.0000000000001854]
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Horvath S, 2015, J INFECT DIS, V212, P1563, DOI 10.1093/infdis/jiv277
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Ito T, 2018, CELL REP, V22, P3480, DOI 10.1016/j.celrep.2018.03.002
   Kabacik S, 2018, AGING-US, V10, P2800, DOI 10.18632/aging.101588
   Kaewsutthi S, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028311
   Kalla D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020488
   Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Levine ME, 2016, P NATL ACAD SCI USA, V113, P9327, DOI 10.1073/pnas.1604558113
   Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684
   Lu AT, 2021, UNIVERSAL DNA METHYL, V2021, DOI [DOI 10.1101/2021.01.18.426733, 10.1101/2021.01.18, DOI 10.1101/2021.01.18]
   Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6
   McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630
   Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028
   Morgello S, 2001, NEUROPATH APPL NEURO, V27, P326, DOI 10.1046/j.0305-1846.2001.00334.x
   Nambu H, 2011, LIFE SCI, V89, P765, DOI 10.1016/j.lfs.2011.09.002
   Saeed S, 2018, NAT GENET, V50, P175, DOI 10.1038/s41588-017-0023-6
   Santulli G, 2015, TRANSL MED UNISA, V13, P4
   Schachtschneider KM, 2017, ONCOTARGET, V8, P63620, DOI 10.18632/oncotarget.18872
   Schachtschneider KM, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00190
   Schachtschneider KM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1938-x
   Schook LB, 2008, DEV BIOLOGICALS, V132, P15, DOI 10.1159/000317140
   Schook LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128864
   Schook LB, 2015, ANNU REV ANIM BIOSCI, V3, P219, DOI 10.1146/annurev-animal-022114-110815
   Schwartz RS, 2008, CIRC-CARDIOVASC INTE, V1, P143, DOI 10.1161/CIRCINTERVENTIONS.108.789974
   Shim J, 2016, J PATHOL, V238, P257, DOI 10.1002/path.4646
   Stocks T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043212
   Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846
   Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015
   Wege Henning, 2007, Comp Hepatol, V6, P6, DOI 10.1186/1476-5926-6-6
   Weigl R., 2005, Longevity of mammals in captivity; from the living collections of the world
   Wolf E, 2014, TRANSGENIC RES, V23, P27, DOI 10.1007/s11248-013-9755-y
   Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271
   Zhou WD, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky691
NR 62
TC 20
Z9 21
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2021 OCT
PY 2021
VL 43
IS 5
SI SI
BP 2467
EP 2483
DI 10.1007/s11357-021-00439-6
EA SEP 2021
PG 17
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA WZ5BL
UT WOS:000695767600001
PM 34523051
OA Green Published, Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU Pamplona, R
   Portero-Otín, M
   Riba, D
   Ledo, F
   Gredilla, R
   Herrero, A
   Barja, G
AF Pamplona, R
   Portero-Otín, M
   Riba, D
   Ledo, F
   Gredilla, R
   Herrero, A
   Barja, G
TI Heart fatty acid unsaturation and lipid peroxidation, and aging rate,
   are lower in the canary and the parakeet than in the mouse
SO AGING CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
DE aging; birds; fatty acids; lipid peroxidation; longevity; unsaturation
ID FREE-RADICAL PRODUCTION; LIVER-MITOCHONDRIA; MAMMALIAN LIVER;
   METABOLIC-RATE; BODY-MASS; LONGEVITY; FLUIDITY; TISSUES; DNA; PIGEON
AB Despite their high metabolic rates. birds have a much higher maximum longevity (MLSP) than mammals of similar body size, and thus represent ideal models for identifying longevity characteristics not linked to lour metabolic rates. This study shows that the fatty acid double bond content of both canary (MLSP=24 years) and parakeet (MLSP=21 years) hearts is intrinsically lower than in mouse (MLSP=3.5 years) heart. This is caused by a redistribution between types of unsaturated fatty acids, mainly due to a lower content of the most highly unsaturated docosahexaenoic acid (22:6n-3) in the two birds in relation to the mammal. The lower double bond content leads to a lower sensitivity to lipid peroxidation, and to a lower level of in vivo lipid peroxidation in the heart of parakeets and canaries than in that of mice. Similar results have been previously found comparing liver mitochondria of rats and pigeons and tissues of different mammalian species. All these results taken together suggest that a low degree of fatty acid unsaturation is a general characteristic of longevous homeothermic vertebrate animals, both when they have low metabolic rates (mammals of large body size) or high metabolic rates (the studied birds); this constitutive trait protects their tissues and organelles against free radical mediated lipid peroxidation, and can contribute to their slow aging rate.
C1 Univ Complutense Madrid, Fac Biol, Dept Biol Anim 2, E-28040 Madrid, Spain.
C3 Complutense University of Madrid
RP Barja, G (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Biol Anim 2, E-28040 Madrid, Spain.
RI Pamplona, Reinald/A-7359-2010; Barja, Gustavo/AAA-5903-2019; Gustavo,
   Barja/B-5591-2012; Portero-Otin, Manuel/B-7122-2009
OI Pamplona, Reinald/0000-0003-4337-6107; Barja,
   Gustavo/0000-0001-5736-4735; Portero-Otin, Manuel/0000-0002-1823-0299;
   GREDILLA, RICARDO/0000-0003-4501-1355
CR ALTMAN P, 1972, BIOL DATA BOOK, P229
   BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584
   BONDY SC, 1995, FEBS LETT, V375, P53, DOI 10.1016/0014-5793(95)01173-C
   Box HC, 1997, NUTRITION, V13, P920, DOI 10.1016/S0899-9007(97)00260-8
   BRAND MD, 1994, COMP BIOCHEM PHYS B, V108, P181, DOI 10.1016/0305-0491(94)90064-7
   CHAUDHARY AK, 1994, SCIENCE, V265, P1580, DOI 10.1126/science.8079172
   Chen JJ, 1996, AGING CLIN EXP RES, V8, P334, DOI 10.1007/BF03339590
   Cortopassi GA, 1996, MECH AGEING DEV, V91, P211, DOI 10.1016/S0047-6374(96)01788-5
   COUTURE P, 1995, J MEMBRANE BIOL, V148, P27
   COUTURE P, 1995, AM J PHYSIOL, V268, pR645
   CUTLER RG, 1985, P NATL ACAD SCI USA, V82, P4798, DOI 10.1073/pnas.82.14.4798
   DRAPER HH, 1995, LIPIDS, V30, P959, DOI 10.1007/BF02537489
   Flower SS, 1938, P ZOOL SOC LOND A-GE, V108, P195
   GUDBJARNASON S, 1989, J INTERN MED, V225, P117, DOI 10.1111/j.1365-2796.1989.tb01445.x
   Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6
   Jeffcoat R, 1979, Essays Biochem, V15, P1
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   LAGANIERE S, 1990, ADV EXP MED BIOL, V262, P95
   LEE AG, 1991, PROG LIPID RES, V30, P323, DOI 10.1016/0163-7827(91)90002-M
   MARESCA B, 1993, NATURE, V365, P606, DOI 10.1038/365606a0
   NORTH JA, 1994, AM J PHYSIOL, V267, pC177, DOI 10.1152/ajpcell.1994.267.1.C177
   Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2
   Pearl R., 1928, RATE LIVING
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0
   PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213
   STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
NR 28
TC 62
Z9 72
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1594-0667
EI 1720-8319
J9 AGING CLIN EXP RES
JI Aging Clin. Exp. Res.
PD FEB
PY 1999
VL 11
IS 1
BP 44
EP 49
DI 10.1007/BF03399636
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 182BF
UT WOS:000079478100008
PM 10337442
DA 2024-02-19
ER

PT J
AU Li, XN
   Hager, M
   McPherson, M
   Lee, M
   Hagalwadi, R
   Skinner, ME
   Miller, RA
   Lombard, D
AF Li, Xinna
   Hager, Mary
   McPherson, Madaline
   Lee, Michael
   Hagalwadi, Riha
   Skinner, Mary E.
   Miller, Richard
   Lombard, David A.
TI Recapitulation of anti-aging phenotypes by global, but not by
   muscle-specific, deletion of PAPP-A in mice
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Pregnancy-associated plasma protein-A (PAPP-a); Uncoupling protein 1
   (UCP1); Fibronectin type III domain-containing protein 5 (FNDC5)/IRISIN;
   Glycosylphosphatidylinositol-specific phospholipase D1 (GPLD1);
   Brain-derived neurotrophic factor (BDNF); Doublecortin (DCX)
ID PLASMA-PROTEIN-A; LONG-LIVED MICE; MICROTUBULE-ASSOCIATED PROTEIN;
   ADIPOSE-TISSUE; GENE-EXPRESSION; LIFE-SPAN; BROWN-FAT; NEUROGENESIS;
   RESISTANCE; DEFICIENT
AB Deletion of pregnancy-associated plasma protein-A (PAPP-A), a protease that cleaves some but not all IGF1 binding proteins, postpones late-life diseases and extends lifespan in mice, but the mechanism of this effect is unknown. Here we show that PAPP-A knockout (PKO) mice display a set of changes, in multiple tissues, that are characteristic of other varieties of slow-aging mice with alterations in GH production or GH responsiveness, including Ames dwarf, Snell dwarf, and GHRKO mice. PKO mice have elevated UCP1 in brown and white adipose tissues (WAT), and a change in fat-associated macrophage subsets that leads to diminished production of inflammatory cytokines. PKO mice also show increased levels of muscle FNDC5 and its cleavage product, the myokine irisin, thought to cause changes in fat cell differentiation. PKO mice have elevated production of hepatic GPLD1 and plasma GPLD1, consistent with their elevation of hippocampal BDNF and DCX, used as indices of neurogenesis. In contrast, disruption of PAPP-A limited to muscle ( "muPKO " mice) produces an unexpectedly complex set of changes, in most cases opposite in direction from those seen in PKO mice. These include declines in WAT UCP1, increases in inflammatory macrophages and cytokines in WAT, and a decline in muscle FNDC5 and plasma irisin. muPKO mice do, however, resemble global PKO mice in their elevation of hippocampal BDNF and DCX. The data for the PKO mice support the idea that these changes in fat, macrophages, liver, muscle, plasma, and brain are consistent and biologically significant features of the slow-aging phenotype in mice. The results on the muPKO mice provide a foundation for further investigation of the complex, local, and global circuits by which PAPP-A modulates signals ordinarily controlled by GH and/or IGF1.
C1 [Li, Xinna; Skinner, Mary E.; Miller, Richard; Lombard, David A.] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA.
   [Hager, Mary; McPherson, Madaline; Lee, Michael; Hagalwadi, Riha] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA.
   [Lombard, David A.] Univ Miami, Sylvester Canc Ctr, Miller Sch Med, Miami, FL 33136 USA.
   [Miller, Richard] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Miami; University
   of Michigan System; University of Michigan
RP Li, XN (corresponding author), Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA.
EM xinna@umich.edu
RI yang, qing/JBR-8440-2023
OI Li, Xinna/0000-0002-7461-5628; Lombard, David/0000-0002-4292-0185
FU Glenn Foundation for Medical Research; NIH;  [AG023122];  [AG024824]
FX AcknowledgementsWe thank Lori Roberts, Natalie Perry, Roxann Alonzo,
   Jacob Sheets, and Ilkim Erturk for expert assistance in animal care. We
   thank Dr. Cheryl Conover for her gift of breeding stock for the PKO
   mutant mice. The work was supported by a grant from the Glenn Foundation
   for Medical Research and by NIH grants AG023122 and AG024824.
CR Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Boss Olivier, 2012, Front Endocrinol (Lausanne), V3, P14, DOI 10.3389/fendo.2012.00014
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Conover CA, 2004, DEVELOPMENT, V131, P1187, DOI 10.1242/dev.00997
   Conover CA, 2008, J ENDOCRINOL, V198, P599, DOI 10.1677/JOE-08-0179
   Conover CA, 2013, ENDOCRINOLOGY, V154, P2734, DOI 10.1210/en.2013-1320
   Conover CA, 2010, AGING CELL, V9, P647, DOI 10.1111/j.1474-9726.2010.00589.x
   Conover CA, 2010, J GERONTOL A-BIOL, V65, P590, DOI 10.1093/gerona/glq032
   Costantini A, 2018, AGING-US, V10, P1268, DOI 10.18632/aging.101465
   Dominick G, 2017, AGING CELL, V16, P52, DOI 10.1111/acel.12525
   Dun SL, 2013, NEUROSCIENCE, V240, P155, DOI 10.1016/j.neuroscience.2013.02.050
   Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516
   Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014
   Ferrer-Martínez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099
   Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1
   Fuentes L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/219583
   Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008
   Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3
   Grohmann U, 2001, J IMMUNOL, V167, P221, DOI 10.4049/jimmunol.167.1.221
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Harrington SC, 2007, CIRC RES, V100, P1696, DOI 10.1161/CIRCRESAHA.106.146183
   Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170
   Horowitz AM, 2020, SCIENCE, V369, P167, DOI 10.1126/science.aaw2622
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002
   Inokuma K, 2005, DIABETES, V54, P1385, DOI 10.2337/diabetes.54.5.1385
   Itoh M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/720926
   Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654
   Kraakman MJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00470
   Li XN, 2022, AGING CELL, V21, DOI 10.1111/acel.13685
   Li XN, 2022, FASEB J, V36, DOI 10.1096/fj.202200143R
   Li XN, 2020, AGING-US, V12, P8766, DOI 10.18632/aging.103380
   Lichtnekert J, 2013, CURR OPIN PHARMACOL, V13, P555, DOI 10.1016/j.coph.2013.05.013
   Liu P, 2015, RESTOR NEUROL NEUROS, V33, P143, DOI 10.3233/RNN-140446
   LONCAR D, 1988, J ULTRA MOL STRUCT R, V101, P199, DOI 10.1016/0889-1605(88)90010-9
   Mader JR, 2013, J ENDOCRINOL, V219, P51, DOI 10.1530/JOE-13-0167
   Mahbub S, 2012, J INTERF CYTOK RES, V32, P18, DOI 10.1089/jir.2011.0058
   Matsuo Y, 2015, J CACHEXIA SARCOPENI, V6, P62, DOI 10.1002/jcsm.12006
   Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001
   Mazur-Bialy AI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040701
   Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Nyegaard M, 2010, BIOL REPROD, V82, P1129, DOI 10.1095/biolreprod.109.079517
   Patsouris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110653
   Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x
   RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4
   Sharma S, 2012, AGE, V34, P609, DOI 10.1007/s11357-011-9253-1
   Shatsky IN, 2018, TRENDS BIOCHEM SCI, V43, P882, DOI 10.1016/j.tibs.2018.04.011
   Shen ZQ, 2021, AGING CELL, V20, DOI 10.1111/acel.13345
   Shetty AK, 2011, HIPPOCAMPUS, V21, P631, DOI 10.1002/hipo.20776
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Sun LY, 2007, J GERONTOL A-BIOL, V62, P117, DOI 10.1093/gerona/62.2.117
   Swindell WR, 2010, EXP GERONTOL, V45, P366, DOI 10.1016/j.exger.2010.02.009
   Tanner SJ, 2008, J BONE MINER RES, V23, P655, DOI 10.1359/JBMR.071210
   Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4
   Vallejo AN, 2009, P NATL ACAD SCI USA, V106, P11252, DOI 10.1073/pnas.0807025106
   Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Wrann Christiane D, 2015, Brain Plast, V1, P55, DOI 10.3233/BPL-150019
   Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Xiong XQ, 2018, METABOLISM, V83, P31, DOI 10.1016/j.metabol.2018.01.013
   YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4
   Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377
NR 65
TC 3
Z9 3
U1 1
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2023 APR
PY 2023
VL 45
IS 2
BP 931
EP 948
DI 10.1007/s11357-022-00692-3
EA DEC 2022
PG 18
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 8I9UK
UT WOS:000900100800001
PM 36542300
OA Green Published
DA 2024-02-19
ER

PT J
AU Conte, M
   Medici, V
   Malagoli, D
   Chiariello, A
   Cirrincione, A
   Davin, A
   Chikhladze, M
   Vasuri, F
   Legname, G
   Ferrer, I
   Vanni, S
   Marcon, G
   Poloni, TE
   Guaita, A
   Franceschi, C
   Salvioli, S
AF Conte, Maria
   Medici, Valentina
   Malagoli, Davide
   Chiariello, Antonio
   Cirrincione, Alice
   Davin, Annalisa
   Chikhladze, Maia
   Vasuri, Francesco
   Legname, Giuseppe
   Ferrer, Isidre
   Vanni, Silvia
   Marcon, Gabriella
   Poloni, Tino Emanuele
   Guaita, Antonio
   Franceschi, Claudio
   Salvioli, Stefano
TI Expression pattern of perilipins in human brain during aging and in
   Alzheimer's disease
SO NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
LA English
DT Article; Early Access
DE brain; human aging; inflammation; neurodegenerative diseases; perilipins
ID HUMAN SKELETAL-MUSCLE; LIPID DROPLETS; HEPATIC STEATOSIS; AGE;
   METFORMIN; PROTEIN; INFLAMMATION; DEGRADATION; METABOLISM; ASSOCIATION
AB Aims Perilipins are conserved proteins that decorate intracellular lipid droplets and are essential for lipid metabolism. To date, there is limited knowledge on their expression in human brain or their involvement in brain aging and neurodegeneration. The aim of this study was to characterise the expression levels of perilipins (Plin1-Plin5) in different cerebral areas from subjects of different age, with or without signs of neurodegeneration. Methods We performed real-time RT-PCR, western blotting, immunohistochemistry and confocal microscopy analyses in autoptic brain samples of frontal and temporal cortex, cerebellum and hippocampus from subjects ranging from 33 to 104 years of age, with or without histological signs of neurodegeneration. To test the possible relationship between Plins and inflammation, correlation analysis with IL-6 expression was also performed. Results Plin2, Plin3 and Plin5, but not Plin1 and Plin4, are expressed in the considered brain areas with different intensities. Plin2 appears to be expressed more in grey matter, particularly in neurons in all the areas analysed, whereas Plin3 and Plin5 appear to be expressed more in white matter. Plin3 seems to be expressed more in astrocytes. Only Plin2 expression is higher in old subjects and patients with early tauopathy or Alzheimer's disease and is associated with IL-6 expression. Conclusions Perilipins are expressed in human brain but only Plin2 appears to be modulated with age and neurodegeneration and linked to an inflammatory state. We propose that the accumulation of lipid droplets decorated with Plin2 occurs during brain aging and that this accumulation may be an early marker and initial step of inflammation and neurodegeneration.
C1 [Conte, Maria; Chiariello, Antonio; Salvioli, Stefano] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy.
   [Conte, Maria; Salvioli, Stefano] Univ Bologna, Interdept Ctr Alma Mater Res Inst Global, Bologna, Italy.
   [Medici, Valentina; Cirrincione, Alice; Davin, Annalisa; Chikhladze, Maia; Poloni, Tino Emanuele; Guaita, Antonio] GolgiCenci Fdn, Dept Neurol & Neuropathol, Milan, Italy.
   [Malagoli, Davide] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy.
   [Chikhladze, Maia] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.
   [Vasuri, Francesco] S Orsola Malpighi Bologna Author Hosp, Pathol Unit, Bologna, Italy.
   [Legname, Giuseppe] Scuola Int Super Studi Avanzati SISSA, Dept Neurosci, Lab Prion Biol, Trieste, Italy.
   [Ferrer, Isidre] Univ Barcelona, Inst Neurosci, Dept Pathol & Expt Therapeut, Barcelona, Spain.
   [Ferrer, Isidre] Bellvitge Univ Hosp, Bellvitge Biomed Res Inst IDIBELL, Dept Pathol Anat, Barcelona, Spain.
   [Ferrer, Isidre] Inst Carlos III, Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Minist Hlth, Hosp Llobregat, Barcelona, Spain.
   [Vanni, Silvia] IRCCS Ist Romagnolo Studio Tumori IRST Dino Ama, Osteoncol & Rare Tumors Ctr, Meldola, Italy.
   [Marcon, Gabriella] Univ Udine, DAME, Udine, Italy.
   [Marcon, Gabriella] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
   [Franceschi, Claudio] Lobachevsky Univ, Inst Informat Technol Math & Mech, Nizhnii Novgorod, Russia.
C3 University of Bologna; University of Bologna; Universita di Modena e
   Reggio Emilia; University of Milan; IRCCS Azienda
   Ospedaliero-Universitaria di Bologna; International School for Advanced
   Studies (SISSA); University of Barcelona; Institut d'Investigacio
   Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital;
   University of Udine; University of Trieste; Lobachevsky State University
   of Nizhni Novgorod
RP Conte, M (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy.
EM m.conte@unibo.it
RI Vanni, Silvia/AAA-7149-2021; Legname, Giuseppe/C-1723-2012; Davin,
   Annalisa/AAB-8602-2022; Vasuri, Francesco/K-5418-2016
OI Vanni, Silvia/0000-0003-1192-7322; Legname,
   Giuseppe/0000-0003-0716-4393; Davin, Annalisa/0000-0002-5597-7586;
   Vasuri, Francesco/0000-0002-1145-6025; Medici,
   Valentina/0000-0001-9385-3384; Conte, Maria/0000-0002-4621-9898;
   CHIARIELLO, ANTONIO/0000-0002-7920-9100; GUAITA,
   ANTONIO/0000-0003-3954-5932; Poloni, Tino Emanuele/0000-0002-8463-6879;
   Ferrer, Isidro/0000-0001-9888-8754
FU Ministry of Science and Higher Education at the Lobachevsky State
   University of Nizhny Novgorod [075-15-2019-871]; Roberto and Cornelia
   Pallotti Legacy for Cancer Research
FX Ministry of Science and Higher Education at the Lobachevsky State
   University of Nizhny Novgorod, Grant/Award Number: 075-15-2019-871;
   Roberto and Cornelia Pallotti Legacy for Cancer Research
CR American Psychiatric Association, 2013, Diagnostic and statistical manual of mental disorders, P50
   Bickel PE., 1791, BIOCH BIOPHYS ACTA, V2009, p419
   Chappus-McCendie H, 2019, PROG NEURO-PSYCHOPH, V94, DOI 10.1016/j.pnpbp.2019.109662
   Chen FL, 2010, MOL CELL BIOCHEM, V337, P193, DOI 10.1007/s11010-009-0299-7
   Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200
   Conte M, 2019, J CACHEXIA SARCOPENI, V10, P95, DOI 10.1002/jcsm.12355
   Conte M, 2016, TRENDS ENDOCRIN MET, V27, P893, DOI 10.1016/j.tem.2016.09.001
   Conte M, 2015, BIOGERONTOLOGY, V16, P329, DOI 10.1007/s10522-014-9549-5
   Conte M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073709, 10.1371/journal.pone.0081064]
   Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101
   Czubowicz K, 2019, MOL NEUROBIOL, V56, P5436, DOI 10.1007/s12035-018-1448-3
   Farmer BC, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00742
   Farokhian F, 2017, AGING DIS, V8, P899, DOI 10.14336/AD.2017.0502
   Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061
   Gasparini L, 1998, FASEB J, V12, P17, DOI 10.1096/fasebj.12.1.17
   GIUGLIANO D, 1993, DIABETES CARE, V16, P1387, DOI 10.2337/diacare.16.10.1387
   Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069
   Hafkemeijer A, 2014, AGING CELL, V13, P1068, DOI 10.1111/acel.12271
   Hamilton LK, 2018, BIOL CELL, V110, P6, DOI 10.1111/boc.201700037
   Horvath S, 2015, AGING-US, V7, P1159, DOI 10.18632/aging.100861
   Hussain G, 2020, CRIT REV FOOD SCI, V60, P351, DOI 10.1080/10408398.2018.1529653
   Ioannou MS, 2019, CELL, V177, P1522, DOI 10.1016/j.cell.2019.04.001
   Itabe H, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0473-y
   Ji J, 2019, J CELL MOL MED, V23, P2890, DOI 10.1111/jcmm.14172
   Kao YC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041505
   Kaushik S, 2016, AUTOPHAGY, V12, P432, DOI 10.1080/15548627.2015.1124226
   Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166
   Kim HS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70347-w
   Kinney Jefferson W, 2018, Alzheimers Dement (N Y), V4, P575, DOI 10.1016/j.trci.2018.06.014
   Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671
   Kwon YH, 2017, FEBS LETT, V591, P1742, DOI 10.1002/1873-3468.12691
   Liu F, 2014, INT J MOL MED, V33, P51, DOI 10.3892/ijmm.2013.1560
   Marschallinger J, 2020, NAT NEUROSCI, V23, P194, DOI 10.1038/s41593-019-0566-1
   Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011
   Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3
   Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015
   Olzmann JA, 2019, NAT REV MOL CELL BIO, V20, P137, DOI 10.1038/s41580-018-0085-z
   Onal G, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0521-7
   Palikaras K, 2017, J LIPID RES, V58, P72, DOI 10.1194/jlr.M069385
   Pennetta G, 2018, DEV CELL, V45, P427, DOI 10.1016/j.devcel.2018.05.002
   Perez MJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00553
   Phillips SA, 2005, OBES RES, V13, P1321, DOI 10.1038/oby.2005.160
   Poloni TE, 2020, JOVE-J VIS EXP, DOI 10.3791/60296
   Rothaug M., 1863, BIOCH BIOPHYS ACTA, V2016, p1218
   Saisho Y, 2015, ENDOCR METAB IMMUNE, V15, P196, DOI 10.2174/1871530315666150316124019
   Sato S, 2019, AM J PHYSIOL-ENDOC M, V317, pE1193, DOI 10.1152/ajpendo.00227.2019
   Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Shimabukuro MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23795
   Shimeng Xu, 2019, Biophysics Reports, V5, P145, DOI 10.1007/s41048-019-0091-5
   Spassieva SD, 2016, P NATL ACAD SCI USA, V113, P5928, DOI 10.1073/pnas.1522071113
   Takahashi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20975
   Tan YM, 2017, DNA CELL BIOL, V36, P1159, DOI 10.1089/dna.2017.3706
   Teixeira V., 1866, BIOCH BIOPHYS ACTA M, V2021
   van der Kant R, 2019, CELL STEM CELL, V24, P363, DOI 10.1016/j.stem.2018.12.013
   Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008
   Wang NH, 2016, DIABETES RES CLIN PR, V122, P170, DOI 10.1016/j.diabres.2016.10.006
   Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49
   Wu YY, 2015, DEMENT GER COGN D EX, V5, P424, DOI 10.1159/000439214
   Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005
   Zhang PP, 2018, CURR GENOMICS, V19, P247, DOI 10.2174/1389202918666170915155948
NR 61
TC 13
Z9 13
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1846
EI 1365-2990
J9 NEUROPATH APPL NEURO
JI Neuropathol. Appl. Neurobiol.
PD 2022 FEB
PY 2022
VL 48
IS 1
DI 10.1111/nan.12756
EA AUG 2021
PG 14
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA YH4SM
UT WOS:000681331600001
PM 34312912
OA Green Published, hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Papachristou, F
   Anninou, N
   Koukoulis, G
   Paraskakis, S
   Sertaridou, E
   Tsalikidis, C
   Pitiakoudis, M
   Simopoulos, C
   Tsaroucha, A
AF Papachristou, Fotini
   Anninou, Nikolia
   Koukoulis, Georgios
   Paraskakis, Stefanos
   Sertaridou, Eleni
   Tsalikidis, Christos
   Pitiakoudis, Michael
   Simopoulos, Constantinos
   Tsaroucha, Alexandra
TI Differential effects of cisplatin combined with the flavonoid apigenin
   on HepG2, Hep3B, and Huh7 liver cancer cell lines
SO MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
LA English
DT Article; Early Access
DE Cisplatin; Apigenin; Senescence-like Phenotype; Migration; Genotoxicity;
   Sister Chromatid Exchanges
ID EPITHELIAL-MESENCHYMAL TRANSITION; DNA-DAMAGE; P53 GENE; IN-VITRO;
   HOMOLOGOUS RECOMBINATION; HUMAN-LYMPHOCYTES; APOPTOTIC INDUCTION;
   ANTITUMOR-ACTIVITY; REACTIVE OXYGEN; HEPATOMA-CELLS
AB The potential of apigenin (APG) to enhance cisplatin's (CDDP) chemotherapeutic efficacy was investigated in HepG2, Hep3B, and Huh7 liver cancer cell lines. The presence of 20 mu M APG sensitized all cell lines to CDDP treatment (degree of sensitization based on the MTT assay: HepG2>Huh7>Hep3B). As reflected by sister chromatid exchange levels, the degree of genetic instability as well as DNA repair by homologous recombination differed among cell lines. CDDP and 20 mu M APG cotreatment exhibited a synergistic genotoxic effect on Hep3B cells and a less than additive effect on HepG2 and Huh7 cells. Cell cycle delays were noticed during the first mitotic division in Hep3B and Huh7 cells and the second mitotic division in HepG2 cells. CDDP and CDDP + APG treatments reduced the clonogenic capacity of all cell lines; however, there was a discordance in drug sensitivity compared with the MMT assay. Furthermore, a senescence-like phenotype was induced, especially in Hep3B and Huh7 cells. Unlike CDDP monotherapy, the combined treatment exhibited a significant anti-invasive and antimigratory action in all cancer cell lines. The fact that the three liver cancer cell lines responded differently, yet positively, to CDDP + APG cotreatment could be attributed to variations they present in gene expression. Complex mechanisms seem to influence cellular responses and cell fate.
C1 [Papachristou, Fotini; Anninou, Nikolia; Simopoulos, Constantinos; Tsaroucha, Alexandra] Democritus Univ Thrace, Fac Med, Lab Expt Surg & Surg Res, Dragana 68100, Alexandroupolis, Greece.
   [Papachristou, Fotini; Koukoulis, Georgios; Paraskakis, Stefanos; Sertaridou, Eleni; Tsalikidis, Christos; Pitiakoudis, Michael; Simopoulos, Constantinos; Tsaroucha, Alexandra] Democritus Univ Thrace, Fac Med, Dept Surg 2, Postgrad Program Hepatobiliary & Pancreat Surg, Alexandroupolis 68100, Greece.
C3 Democritus University of Thrace; Democritus University of Thrace
RP Papachristou, F (corresponding author), Democritus Univ Thrace, Fac Med, Lab Expt Surg & Surg Res, Dragana 68100, Alexandroupolis, Greece.
EM fpapachr@med.duth.gr
FU Postgraduate Program in Hepatobiliary and Pancreatic Surgery, 2nd
   Department of Surgery, Faculty of Medicine, Democritus University of
   Thrace
FX This work was supported by the Postgraduate Program in Hepatobiliary and
   Pancreatic Surgery, 2nd Department of Surgery, Faculty of Medicine,
   Democritus University of Thrace.
CR Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0
   Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121
   Amsterdam JD, 2012, ALTERN THER HEALTH M, V18, P44
   [Anonymous], 1981, IARC Monogr Eval Carcinog Risk Chem Hum, V26, P151
   Arango D, 2012, BIOCHEM PHARMACOL, V84, P1571, DOI 10.1016/j.bcp.2012.09.005
   Avkin S, 2006, MOL CELL, V22, P407, DOI 10.1016/j.molcel.2006.03.022
   Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627
   Beg T, 2012, J YOUNG PHARM, V4, P124, DOI 10.4103/0975-1483.96628
   Bhardwaj B, 1999, J HEPATOL, V31, P386, DOI 10.1016/S0168-8278(99)80245-1
   Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022
   Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711
   BLASKO M, 1987, NEOPLASMA, V34, P235
   Borges HL, 2008, CELL RES, V18, P17, DOI 10.1038/cr.2007.110
   BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973
   Brozovic A, 2010, CRIT REV TOXICOL, V40, P347, DOI 10.3109/10408441003601836
   Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208
   Bulusu KC, 2016, DRUG DISCOV TODAY, V21, P225, DOI 10.1016/j.drudis.2015.09.003
   Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497
   CAO SS, 1989, CANCER CHEMOTH PHARM, V24, P181, DOI 10.1007/BF00300240
   Cevik D, 2015, WORLD J GASTROENTERO, V21, P311, DOI 10.3748/wjg.v21.i1.311
   Chan KT, 2004, CANCER CHEMOTH PHARM, V53, P519, DOI 10.1007/s00280-004-0767-4
   Chan LP, 2012, BBA-GEN SUBJECTS, V1820, P1081, DOI 10.1016/j.bbagen.2012.04.013
   Charette N, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-256
   Chen YW, 2006, MOL CANCER RES, V4, P257, DOI 10.1158/1541-7786.MCR-05-0118
   Chiang LC, 2006, CANCER LETT, V237, P207, DOI 10.1016/j.canlet.2005.06.002
   CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517
   Chung YL, 2013, FASEB J, V27, P2316, DOI 10.1096/fj.12-226639
   Crespo I, 2008, FOOD CHEM TOXICOL, V46, P1555, DOI 10.1016/j.fct.2007.12.014
   Datta K, 2004, CANCER GENE THER, V11, P525, DOI 10.1038/sj.cgt.7700724
   Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088
   Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627
   Eot-Houllier G, 2009, CANCER LETT, V274, P169, DOI 10.1016/j.canlet.2008.06.005
   Erdogan S, 2017, BIOMED PHARMACOTHER, V88, P210, DOI 10.1016/j.biopha.2017.01.056
   Farshid M, 1994, J Viral Hepat, V1, P45, DOI 10.1111/j.1365-2893.1994.tb00061.x
   Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937
   Friedman SL, 1997, ONCOGENE, V15, P63, DOI 10.1038/sj.onc.1201149
   Fuertes MA, 2003, CHEM REV, V103, P645, DOI 10.1021/cr020010d
   Galati G, 2000, Drug Metabol Drug Interact, V17, P311
   Gewirtz DA, 2009, AUTOPHAGY, V5, P1232, DOI 10.4161/auto.5.8.9896
   Guégan JP, 2013, CARCINOGENESIS, V34, P38, DOI 10.1093/carcin/bgs317
   Guo J, 2019, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00661
   Gurpinar E, 2015, TRENDS CELL BIOL, V25, P486, DOI 10.1016/j.tcb.2015.04.001
   Hassana SM, 2017, PHARM BIOL, V55, P766, DOI 10.1080/13880209.2016.1275704
   HAYASHI K, 1975, HUMANGENETIK, V29, P201, DOI 10.1007/BF00297624
   He J, 2012, INT J MOL SCI, V13, P7271, DOI 10.3390/ijms13067271
   He XX, 2016, EUR J PHARMACOL, V789, P215, DOI 10.1016/j.ejphar.2016.07.003
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Hirano S, 2005, EMBO J, V24, P418, DOI 10.1038/sj.emboj.7600534
   HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987
   Ishikawa T, 2009, WORLD J HEPATOL, V1, P8, DOI 10.4254/wjh.v1.i1.8
   Iwadate Y, 1998, BRIT J CANCER, V77, P547, DOI 10.1038/bjc.1998.88
   Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935
   Kasai F, 2018, HUM CELL, V31, P261, DOI 10.1007/s13577-018-0212-3
   Kashif M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14118
   Kawamura Y, 2013, GUT LIVER, V7, P576, DOI 10.5009/gnl.2013.7.5.576
   Kikuchi K, 2005, MOL CELL BIOL, V25, P6948, DOI 10.1128/MCB.25.16.6948-6955.2005
   Kim BR, 2011, FOOD CHEM TOXICOL, V49, P1626, DOI 10.1016/j.fct.2011.04.015
   Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341
   Knapp DW, 2000, CANCER CHEMOTH PHARM, V46, P221, DOI 10.1007/s002800000147
   KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960
   Korga-Plewko A, 2020, MOLECULES, V25, DOI 10.3390/molecules25194421
   Kovatcheva M, 2015, ONCOTARGET, V6, P8226, DOI 10.18632/oncotarget.3364
   Kwon SM, 2019, BMB REP, V52, P5, DOI 10.5483/BMBRep.2019.52.1.291
   Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77
   Lee WJ, 2008, TOXICOL APPL PHARM, V226, P178, DOI 10.1016/j.taap.2007.09.013
   Lehmann BD, 2008, CELL CYCLE, V7, P1262, DOI 10.4161/cc.7.9.5945
   Li CH, 2013, J NUTR BIOCHEM, V24, P1766, DOI 10.1016/j.jnutbio.2013.03.006
   Li XC, 2018, THERANOSTICS, V8, P1740, DOI 10.7150/thno.22010
   Li XC, 2013, TOXICOL LETT, V221, P197, DOI 10.1016/j.toxlet.2013.06.233
   Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004
   Liu JP, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.165
   Liu R, 2017, ONCOL LETT, V13, P1024, DOI 10.3892/ol.2016.5495
   Lou ZK, 2006, EXP CELL RES, V312, P2641, DOI 10.1016/j.yexcr.2006.06.009
   Maeta Y, 2005, TUMOR BIOL, V26, P300, DOI 10.1159/000089288
   Mao JJ, 2016, PHYTOMEDICINE, V23, P1735, DOI 10.1016/j.phymed.2016.10.012
   Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447
   MATSUMURA T, 1979, J GERONTOL, V34, P328, DOI 10.1093/geronj/34.3.328
   Mikula-Pietrasik J, 2020, CELL MOL LIFE SCI, V77, P213, DOI 10.1007/s00018-019-03261-8
   Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899
   Mirzayans R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071460
   Mirzayans R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020360
   Mirzayans R, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/951574
   Mirzayans R, 2010, J CELL PHYSIOL, V223, P57, DOI 10.1002/jcp.22002
   Miyoshi N, 2007, ARCH BIOCHEM BIOPHYS, V466, P274, DOI 10.1016/j.abb.2007.07.026
   Mjelle R, 2015, DNA REPAIR, V30, P53, DOI 10.1016/j.dnarep.2015.03.007
   Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x
   Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174
   Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059
   NAKABAYASHI H, 1982, CANCER RES, V42, P3858
   Nessa MU, 2011, ANTICANCER RES, V31, P3789
   Noel S, 2006, TOXICOL IN VITRO, V20, P1168, DOI 10.1016/j.tiv.2006.03.007
   Osaki A, 2013, CANCER MED-US, V2, P86, DOI 10.1002/cam4.55
   Palagyi A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-127
   Pandey M, 2012, MOL CARCINOGEN, V51, P952, DOI 10.1002/mc.20866
   Papachristou F, 2006, ASIAN J ANDROL, V8, P199, DOI 10.1111/j.1745-7262.2006.00084.x
   Papachristou F, 2013, CHIN MED-UK, V8, DOI 10.1186/1749-8546-8-9
   Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032
   Piantelli M, 2006, J CELL PHYSIOL, V207, P23, DOI 10.1002/jcp.20510
   PLESKOVA I, 1984, NEOPLASMA, V31, P655
   Qin LF, 2002, CANCER LETT, V175, P27, DOI 10.1016/S0304-3835(01)00720-0
   Qin Y, 2016, ONCOTARGET, V7, P41421, DOI 10.18632/oncotarget.9404
   Qiu GH, 2015, CYTOTECHNOLOGY, V67, P1, DOI 10.1007/s10616-014-9761-9
   Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4
   Rocha CRR, 2018, CLINICS, V73
   Rich JN, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004764
   Sanchez-Gonzalez PD, 2011, NEPHROL DIAL TRANSPL, V26, P3484, DOI 10.1093/ndt/gfr195
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Schuler PJ, 2010, EUR J MED RES, V15, P337, DOI 10.1186/2047-783X-15-8-337
   Schulze K, 2016, J HEPATOL, V65, P1031, DOI 10.1016/j.jhep.2016.05.035
   Senturk Emir, 2013, Methods Mol Biol, V962, P49, DOI 10.1007/978-1-62703-236-0_4
   Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x
   Sharma Haripaul, 2014, PLoS One, V9, pe91588, DOI 10.1371/journal.pone.0091588
   Sharma NK, 2013, J RADIAT RES, V54, P789, DOI 10.1093/jrr/rrs117
   Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111
   Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7
   Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933
   Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4
   Sohn BH, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.174
   Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571
   Tang B, 2012, ONCOL REP, V27, P1090, DOI 10.3892/or.2011.1580
   Telles Elphine, 2012, Front Biosci (Schol Ed), V4, P831
   TOMINAGA K, 1984, JPN J CLIN ONCOL, V14, P659
   Visconti R, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0433-9
   Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136
   Volkmann M, 2001, J MOL MED-JMM, V79, P594, DOI 10.1007/s001090100244
   Wang H, 2014, EUR J PHARMACOL, V723, P156, DOI 10.1016/j.ejphar.2013.12.004
   Wang XH, 1998, CANCER RES, V58, P5019
   Wang YC, 2013, MOL CELL, V49, P997, DOI 10.1016/j.molcel.2012.12.010
   Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072846
   WIENCKE JK, 1979, MUTAT RES, V68, P69, DOI 10.1016/0165-1218(79)90079-X
   Wu XT, 1999, P NATL ACAD SCI USA, V96, P1303, DOI 10.1073/pnas.96.4.1303
   Xie CH, 2016, MOL MED REP, V13, P386, DOI 10.3892/mmr.2015.4567
   Xing J, 2020, CANCERS, V12, DOI 10.3390/cancers12030615
   Xu SP, 2007, ACTA PHARMACOL SIN, V28, P869, DOI 10.1111/j.1745-7254.2007.00564.x
   Xu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029169
   Yang LX, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.49
   Yazici ZM, 2012, EUR ARCH OTO-RHINO-L, V269, P45, DOI 10.1007/s00405-011-1582-2
   Zannini L, 2014, J MOL CELL BIOL, V6, P442, DOI 10.1093/jmcb/mju045
   Zeng Sulin, 2018, Cancer Transl Med, V4, P70, DOI 10.4103/ctm.ctm_22_18
   Zhang RJ, 2017, CELL PHYSIOL BIOCHEM, V43, P465, DOI 10.1159/000480473
   Zhang SF, 2015, SPECTROCHIM ACTA A, V136, P1666, DOI 10.1016/j.saa.2014.10.062
   Zhang WH, 2011, CANCER-AM CANCER SOC, V117, P4092, DOI 10.1002/cncr.26021
   Zhang YY, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/2514090
   Zhao W, 2013, MOL CELL BIOCHEM, V382, P243, DOI 10.1007/s11010-013-1740-5
   Zick SM, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-78
   Zimmermann A., 2016, TUMORS TUMOR LIKE LE, V1st
NR 147
TC 11
Z9 10
U1 3
U2 17
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1383-5718
EI 1879-3592
J9 MUTAT RES-GEN TOX EN
JI Mutat. Res. Genet. Toxicol. Environ. Mutagen.
PD 2021 JUN
PY 2021
VL 866
AR 503352
DI 10.1016/j.mrgentox.2021.503352
EA APR 2021
PG 13
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA SA0CO
UT WOS:000648967700007
PM 33985696
DA 2024-02-19
ER

PT J
AU Kim, JY
   Kim, SJ
   Bae, MA
   Kim, JR
   Cho, KH
AF Kim, Jae-Yong
   Kim, Suk-Jeong
   Bae, Myung Ae
   Kim, Jae-Ryong
   Cho, Kyung-Hyun
TI Cadmium exposure exacerbates severe hyperlipidemia and fatty liver
   changes in zebrafish via impairment of high-density lipoproteins
   functionality
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Cadmium; Lipoprotein; Zebrafish; Hyperlipidemia; Cholesteryl ester
   transfer protein; Embryo
ID ESTER TRANSFER PROTEIN; ANTIATHEROSCLEROTIC ACTIVITY; ATHEROSCLEROSIS;
   DEFORMITIES; ASPARTAME; SACCHARIN; OXIDATION; CANCER; RISK; HDL
AB Cadmium (Cd) is a heavy metal with several toxicities that have destructive effect on most organ systems. However, its toxic effects on human lipoproteins are largely remained unknown especially in hyperlipidemic zebrafish model. Treatment of human high-density lipoprotein (HDL) with cadmium chloride (CdCl2, final 12 and 24 mu M) caused spontaneous formation of multimeric apoA-I as well as increased production of glycated extent products. Cd-HDL3 accelerated uptake of oxidized LDL (oxLDL) into macrophages and induced severe senescence in human dermal fibroblast (HDF) cells. Microinjection of Cd-HDL3 into zebrafish embryos resulted in acute embryonic toxicity with high mortality. Exposure of zebrafish embryos to water containing CdCl2 (final 12 and 24 mu M) caused early embryonic death along with increased production of oxidized products and impairment of skeletal development. Consumption of CdCl2 (12 and 24 mu M) by zebrafish for 4 weeks resulted in severe elevation of plasma total cholesterol (TC) and triglyceride (TG) levels as well as cholesteryl ester (CE) transfer activity. Furthermore, consumption of CdCl2 resulted in acceleration of fatty liver changes and increased production of reactive oxygen species (ROS). In conclusion, CdCl2 caused structural modification of HDL3 and impaired the beneficial functions of HDL3, including anti-oxidation, anti-atherosclerosis, and anti-senescence effects. Consumption of CdCl2 also resulted in exacerbated hyperlipidemia and fatty liver changes in zebrafish via enhancement of cholesteryl ester transfer protein (CETP) activity.
C1 [Kim, Jae-Yong; Kim, Suk-Jeong; Cho, Kyung-Hyun] Yeungnam Univ, Dept Med Biotechnol, Gyongsan 712749, South Korea.
   [Kim, Jae-Yong; Kim, Suk-Jeong; Cho, Kyung-Hyun] Yeungnam Univ, Res Inst Prot Sensor, Gyongsan 712749, South Korea.
   [Kim, Jae-Yong; Kim, Suk-Jeong; Cho, Kyung-Hyun] Yeungnam Univ, Serum Biomed Res & Educ Team BK21plus, Gyongsan 712749, South Korea.
   [Bae, Myung Ae] Korea Res Inst Chem Technol, Drug Discovery Platform Technol Team, Taejon 305343, South Korea.
   [Kim, Jae-Ryong] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Daegu 705717, South Korea.
C3 Yeungnam University; Yeungnam University; Yeungnam University; Korea
   Research Institute of Chemical Technology (KRICT); Yeungnam University
RP Cho, KH (corresponding author), Yeungnam Univ, Dept Med Biotechnol, Gyongsan 712749, South Korea.
EM chok@yu.ac.kr
OI Kim, Suk-Jeong/0000-0002-3465-5481
FU Ministry of Trade, Industry and Energy, Korea [2016-10063396]; Medical
   Research Center Program through the National Research Foundation (NRF) -
   Ministry of Science, ICT and Future Planning of Korea [2015R1A5A2009124,
   NRF-2017R1A6A3A11033480]
FX This work was supported by a grant from the Ministry of Trade, Industry
   and Energy, Korea (grant no. 2016-10063396) and Medical Research Center
   Program (2015R1A5A2009124) and NRF-2017R1A6A3A11033480 through the
   National Research Foundation (NRF), funded by the Ministry of Science,
   ICT and Future Planning of Korea.
CR Åkesson A, 2014, ENVIRON HEALTH PERSP, V122, P431, DOI 10.1289/ehp.1307110
   Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13
   Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64
   Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6
   BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0
   Chen C., 2016, SCI REP, V13, P6
   Cho KH, 2009, BMB REP, V42, P393, DOI 10.5483/BMBRep.2009.42.7.393
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Edwards JR, 2009, TOXICOL APPL PHARM, V238, P289, DOI 10.1016/j.taap.2009.03.007
   ESTERBAUER H, 1989, FREE RADICAL RES COM, V6, P67, DOI 10.3109/10715768909073429
   HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182
   Houston MC, 2007, ALTERN THER HEALTH M, V13, P128
   Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111
   Il'yasova D, 2005, TOXICOL APPL PHARM, V207, P179, DOI 10.1016/j.taap.2004.12.005
   Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009
   JAKUBOWSKI M, 1987, INT ARCH OCC ENV HEA, V59, P567, DOI 10.1007/BF00377920
   Jin S, 2011, FOOD CHEM TOXICOL, V49, P1521, DOI 10.1016/j.fct.2011.03.043
   Kim JY, 2015, CARDIOVASC TOXICOL, V15, P79, DOI 10.1007/s12012-014-9273-z
   Kim JY, 2011, FOOD CHEM TOXICOL, V49, P2899, DOI 10.1016/j.fct.2011.08.001
   Kim JH, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201500954
   Kim SM, 2015, TOXICOL IN VITRO, V30, P383, DOI 10.1016/j.tiv.2015.09.026
   Kim SM, 2015, CARDIOVASC TOXICOL, V15, P300, DOI 10.1007/s12012-014-9294-7
   Lawrence C, 2012, ILAR J, V53, P179, DOI 10.1093/ilar.53.2.179
   Lin JB, 2016, CANCER EPIDEMIOL, V42, P101, DOI 10.1016/j.canep.2016.04.002
   Lin YS, 2009, ANN EPIDEMIOL, V19, P592, DOI 10.1016/j.annepidem.2009.02.005
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   Mitra S, 2011, AM J MED SCI, V342, P135, DOI 10.1097/MAJ.0b013e318224a147
   Morton RE, 1999, CURR OPIN LIPIDOL, V10, P321, DOI 10.1097/00041433-199908000-00006
   NOBLE RP, 1968, J LIPID RES, V9, P693
   Nordberg GF, 2006, LANCET ONCOL, V7, P99, DOI 10.1016/S1470-2045(06)70548-4
   Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL
   Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50
   Park KH, 2014, TOXICOL SCI, V140, P16, DOI 10.1093/toxsci/kfu076
   Park KH, 2011, FISH SHELLFISH IMMUN, V31, P904, DOI 10.1016/j.fsi.2011.08.006
   Park KH, 2011, J GERONTOL A-BIOL, V66, P511, DOI 10.1093/gerona/glr016
   Park KH, 2010, BIOCHEM BIOPH RES CO, V392, P295, DOI 10.1016/j.bbrc.2009.12.179
   PRAGATHEESWARAN V, 1987, P INDIAN AS-ANIM SCI, V96, P389, DOI 10.1007/BF03179592
   Samarghandian Saeed, 2015, Interdiscip Toxicol, V8, P151, DOI 10.1515/intox-2015-0023
   Sassi A, 2010, FISH PHYSIOL BIOCHEM, V36, P403, DOI 10.1007/s10695-009-9307-9
   Selderslaghs IWT, 2009, REPROD TOXICOL, V28, P308, DOI 10.1016/j.reprotox.2009.05.004
   Strähle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121
   Trede NS, 2001, TRENDS IMMUNOL, V22, P302, DOI 10.1016/S1471-4906(01)01939-1
   Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26
NR 43
TC 32
Z9 36
U1 1
U2 36
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
EI 1879-3177
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD MAR
PY 2018
VL 47
BP 249
EP 258
DI 10.1016/j.tiv.2017.11.007
PG 10
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA FX9HO
UT WOS:000426409400026
PM 29197506
DA 2024-02-19
ER

PT J
AU Yang, GR
   Chen, LH
   Grant, GR
   Paschos, G
   Song, WL
   Musiek, ES
   Lee, V
   McLoughlin, SC
   Grosser, T
   Cotsarelis, G
   FitzGerald, GA
AF Yang, Guangrui
   Chen, Lihong
   Grant, Gregory R.
   Paschos, Georgios
   Song, Wen-Liang
   Musiek, Erik S.
   Lee, Vivian
   McLoughlin, Sarah C.
   Grosser, Tilo
   Cotsarelis, George
   FitzGerald, Garret A.
TI Timing of expression of the core clock gene <i>Bmal1</i> influences its
   effects on aging and survival
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID CIRCADIAN CLOCK; DIFFERENTIAL EXPRESSION; SUPRACHIASMATIC NUCLEUS;
   MUTANT MICE; MAMMALS; DISRUPTION; COMPONENT; PROTEINS; PATTERNS; RHYTHMS
AB The absence of Bmal1, a core clock gene, results in a loss of circadian rhythms, an acceleration of aging, and a shortened life span in mice. To address the importance of circadian rhythms in the aging process, we generated conditional Bmal1 knockout mice that lacked the BMAL1 protein during adult life and found that wild-type circadian variations in wheel-running activity, heart rate, and blood pressure were abolished. Ocular abnormalities and brain astrogliosis were conserved irrespective of the timing of Bmal1 deletion. However, life span, fertility, body weight, blood glucose levels, and age-dependent arthropathy, which are altered in standard Bmal1 knockout mice, remained unaltered, whereas atherosclerosis and hair growth improved, in the conditional adult-life Bmal1 knockout mice, despite abolition of clock function. Hepatic RNA-Seq revealed that expression of oscillatory genes was dampened in the adult-life Bmal1 knockout mice, whereas overall gene expression was largely unchanged. Thus, many phenotypes in conventional Bmal1 knockout mice, hitherto attributed to disruption of circadian rhythms, reflect the loss of properties of BMAL1 that are independent of its role in the clock. These findings prompt reevaluation of the systemic consequences of disruption of the molecular clock.
C1 [Yang, Guangrui; Chen, Lihong; Grant, Gregory R.; Paschos, Georgios; Song, Wen-Liang; McLoughlin, Sarah C.; Grosser, Tilo; FitzGerald, Garret A.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.
   [Grant, Gregory R.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.
   [Musiek, Erik S.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA.
   [Lee, Vivian] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA.
   [Cotsarelis, George] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; University of Pennsylvania; Washington
   University (WUSTL); University of Pennsylvania; Pennsylvania Medicine;
   University of Pennsylvania
RP FitzGerald, GA (corresponding author), Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.
EM garret@upenn.edu
RI Grant, Gregory Robert/I-3599-2019; YANG, GUANGRUI/F-9693-2013; Grosser,
   Tilo/A-1057-2007; Paschos, Georgios K/F-2802-2011
OI Grant, Gregory Robert/0000-0002-0139-7658; YANG,
   GUANGRUI/0000-0002-8310-8257; Grosser, Tilo/0000-0001-8569-8396; 
FU NIH [HL097800]; University of Pennsylvania Genomics Frontiers
   Institute's Translational and Personalized Genomics Centers Initiative
FX This work was supported by a grant from the NIH (HL097800) and the
   University of Pennsylvania Genomics Frontiers Institute's Translational
   and Personalized Genomics Centers Initiative. G.A.F. is the McNeil
   Professor of Translational Medicine and Therapeutics.
CR Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010
   Ansari N, 2009, EUR J NEUROSCI, V29, P477, DOI 10.1111/j.1460-9568.2008.06605.x
   Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7
   Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1
   Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102
   Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540
   Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dolatshad H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009855
   Grant GR, 2005, BIOINFORMATICS, V21, P2684, DOI 10.1093/bioinformatics/bti407
   Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215
   HARRISON DE, 1988, EXP GERONTOL, V23, P309, DOI 10.1016/0531-5565(88)90034-4
   Johnson BP, 2014, P NATL ACAD SCI USA, V111, P18757, DOI 10.1073/pnas.1421708111
   Johnson Martin H, 2002, Reprod Biomed Online, V4, P140
   Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105
   Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386
   Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573
   Maia LF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006446
   Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253
   McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430
   Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317
   Pan XY, 2013, CIRCULATION, V128, P1758, DOI 10.1161/CIRCULATIONAHA.113.002885
   Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5
   Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377
   Rüger M, 2009, REV ENDOCR METAB DIS, V10, P245, DOI 10.1007/s11154-009-9122-8
   Sládek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051
   Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957
   Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004
   Westgate EJ, 2008, CIRCULATION, V117, P2087, DOI 10.1161/CIRCULATIONAHA.107.739227
   Yang GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038117
   Yu Z, 2012, P NATL ACAD SCI USA, V109, P6727, DOI 10.1073/pnas.1115313109
   Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111
NR 36
TC 105
Z9 119
U1 4
U2 37
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD FEB 3
PY 2016
VL 8
IS 324
AR 324ra16
DI 10.1126/scitranslmed.aad3305
PG 10
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA DC4CC
UT WOS:000369166600005
OA Bronze, Green Accepted
DA 2024-02-19
ER

PT J
AU Moore, RM
   Sun, ZF
   Juran, BD
   Lazaridis, KN
AF Moore, Raymond M.
   Sun, Zhifu
   Juran, Brian D.
   Lazaridis, Konstantinos N.
TI Genome-wide resolution peripheral blood methylome profiling reveals
   signatures for cholestatic liver disease
SO EPIGENOMICS
LA English
DT Article; Early Access
DE differentially methylated CpG; differentially methylated region;
   methylation biomarker; peripheral blood; primary biliary cholangitis;
   primary sclerosing cholangitis; reduced representation bisulfite
   sequencing
ID PRIMARY SCLEROSING CHOLANGITIS; ASSOCIATION; SENESCENCE
AB Aim:To profile DNA methylation changes of primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).Materials & methods:Patients with: PBC, PSC with inflammatory bowel disease (IBD), PSC without IBD, and age-, sex-matched controls were profiled for methylomes of peripheral blood by reduced representation bisulfite sequencing. Differentially methylated CpG (DMC) and differentially methylated region (DMR) were detected and compared.Results:We identified consistently altered DMCs and DMRs across diseases with involvement in key pathways. Many similarities noted between two subtypes of PSC, interestingly few existed between PBC and PSC. DMRs were highly enriched with transcription factor binding. Top DMC changes were validated in liver tissue of an independent cohort.Conclusion:Methylome profiling provides insights to PBC and PSC.
C1 [Moore, Raymond M.; Sun, Zhifu] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA.
   [Juran, Brian D.; Lazaridis, Konstantinos N.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic
RP Lazaridis, KN (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.
EM Lazaridis.Konstantinos@mayo.edu
OI Lazaridis, Konstantinos/0000-0002-0437-681X
FU Catharine Nicole Jockisch Carlos Endowment Fund in primary sclerosing
   cholangitis (PSC) [RC2 DK118619]
FX This study was supported by RC2 DK118619 (KN Lazaridis) and the
   ChrisMCarlos and Catharine Nicole Jockisch Carlos Endowment Fund in
   primary sclerosing cholangitis (PSC) (KN Lazaridis). The authors have no
   other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023
   Beery RMM, 2014, J CLIN TRANSL HEPATO, V2, P266, DOI 10.14218/JCTH.2014.00024
   Chèneby J, 2020, NUCLEIC ACIDS RES, V48, pD180, DOI 10.1093/nar/gkz945
   Chèneby J, 2018, NUCLEIC ACIDS RES, V46, pD267, DOI 10.1093/nar/gkx1092
   Cheung AC, 2017, 68 ANN M A A S L D O
   Cheung AC, 2017, SEMIN LIVER DIS, V37, P159, DOI 10.1055/s-0037-1603324
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Folseraas T, 2015, CLIN REV ALLERG IMMU, V48, P154, DOI 10.1007/s12016-014-8417-z
   Guicciardi ME, 2020, HEPATOLOGY, V71, P741, DOI 10.1002/hep.31067
   Gulamhusein AF, 2015, SEMIN LIVER DIS, V35, P392, DOI 10.1055/s-0035-1567831
   Holbrook JD, 2017, EPIGENOMICS-UK, V9, P1143, DOI 10.2217/epi-2017-0032
   Invernizzi P, 2004, LANCET, V363, P533, DOI 10.1016/S0140-6736(04)15541-4
   Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31
   Ji SG, 2017, NAT GENET, V49, P269, DOI 10.1038/ng.3745
   Kim W, 2019, P NATL ACAD SCI USA, V116, P12952, DOI 10.1073/pnas.1821552116
   Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018
   Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Lazaridis KN, 2007, HEPATOLOGY, V46, P785, DOI 10.1002/hep.21749
   Lazaridis KN, 2016, NEW ENGL J MED, V375, P1161, DOI 10.1056/NEJMra1506330
   Lleo A, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0098-9
   Miozzo M, 2007, HEPATOLOGY, V46, P456, DOI 10.1002/hep.21696
   Morchikh M, 2017, MOL CELL, V67, P387, DOI 10.1016/j.molcel.2017.06.020
   Oliva-Vilarnau N, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00192
   Park Y, 2016, BIOINFORMATICS, V32, P1446, DOI 10.1093/bioinformatics/btw026
   Qian YC, 2010, CELL MOL IMMUNOL, V7, P328, DOI 10.1038/cmi.2010.27
   Rodrigues MA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123913
   Sauer K, 2010, NAT REV IMMUNOL, V10, P257, DOI 10.1038/nri2745
   Selmi C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00128
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Teschendorff AE, 2017, EPIGENOMICS-UK, V9, P757, DOI 10.2217/epi-2016-0153
   Weerachayaphorn J, 2015, GASTROENTEROLOGY, V149, P211, DOI 10.1053/j.gastro.2015.03.014
   Zimmermann MT, 2019, PEERJ, V7, DOI 10.7717/peerj.6994
NR 33
TC 3
Z9 3
U1 0
U2 2
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1750-1911
EI 1750-192X
J9 EPIGENOMICS-UK
JI Epigenomics
PD 2020 AUG
PY 2020
VL 12
IS 16
DI 10.2217/epi-2020-0048
EA SEP 2020
PG 14
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA NR5OR
UT WOS:000568279700001
PM 32914644
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU El-Horany, HE
   Gaballah, HH
   Helal, DS
AF El-Horany, Hemat El-Sayed
   Gaballah, Hanaa Hibishy
   Helal, Duaa Samir
TI Berberine ameliorates renal injury in a rat model of D-galactose-induced
   aging through a PTEN/Akt-dependent mechanism
SO ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE D-galactose; berberine; aging; oxidative stress; PTEN; Akt
ID NRF2 NUCLEAR TRANSLOCATION; OXIDATIVE STRESS; SIGNALING PATHWAY; KIDNEY
   INJURY; INDUCED LIVER; INDUCED APOPTOSIS; MESANGIAL CELLS; EXPRESSION;
   PROTECTS; MICE
AB This study aimed to investigate the protective effects of berberine (BBR) against D-galactose (D-gal)-induced renal aging in rats, pointing to its ability to modulate phosphatase and tensin homolog deleted on chromosome ten (PTEN)/Akt signalling, and to attenuate oxidative stress, inflammation and apoptosis. Renal aging was induced by subcutaneous injection of D-gal for six consecutive weeks along with simultaneous oral administration of BBR and compared to control rats and rats received individual doses of either drug. BBR treatment significantly reduced the serum levels of urea and creatinine, retrieved the alterations in kidney histopathology, and restored redox balance evidenced by alleviations of the level of malondialdehyde, 8-hydroxy-2 '-deoxyguanosine and activating heme oxygenase-1 enzyme. Moreover, it markedly reduced the serum levels of pro-inflammatory mediators, along with down-regulation of PTEN expression, enhanced Akt activity, as well as significantly higher immunostaining of the anti-apoptotic marker (Bcl-2). These findings hold a great promise for the use of BBR as a protecting agent against renal aging.
C1 [El-Horany, Hemat El-Sayed; Gaballah, Hanaa Hibishy] Tanta Univ, Dept Med Biochem, Fac Med, Tanta, Egypt.
   [Helal, Duaa Samir] Tanta Univ, Dept Histopathol, Fac Med, Tanta, Egypt.
C3 Egyptian Knowledge Bank (EKB); Tanta University; Egyptian Knowledge Bank
   (EKB); Tanta University
RP El-Horany, HE (corresponding author), Tanta Univ, Dept Med Biochem, Fac Med, Tanta, Egypt.
EM hematelhorany@yahoo.com
RI Elhorany, Hemat/ABF-9705-2021; El-Horany, Hemat/AAR-4094-2021; Gaballah,
   Hanaa/R-2671-2018
OI Helal, Duaa/0000-0001-5748-1480; Gaballah, Hanaa/0000-0003-1774-5482
CR Abdelmegeed MA, 2017, FOOD CHEM TOXICOL, V109, P48, DOI 10.1016/j.fct.2017.08.022
   Adil M, 2016, RENAL FAILURE, V38, P1007, DOI 10.3109/0886022X.2016.1163998
   [Anonymous], 2014, INT J ANTENNAS PROPA
   Aziz MTA, 2007, ASIAN J ANDROL, V9, P377, DOI 10.1111/j.1745-7262.2007.00241.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cao ZJ, 2013, BBA-MOL BASIS DIS, V1832, P96, DOI 10.1016/j.bbadis.2012.08.008
   Chang YM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040466
   Chen JX, 2015, GENET MOL RES, V14, P17373, DOI 10.4238/2015.December.21.6
   Chitra P, 2015, J MOL MED, V93, P1015, DOI 10.1007/s00109-015-1283-1
   Dai PF, 2015, EXP THER MED, V10, P869, DOI 10.3892/etm.2015.2585
   Dang LTH, 2017, BIOMATERIALS, V141, P314, DOI 10.1016/j.biomaterials.2017.07.010
   Dinh QN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/406960
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Gaballah HH, 2017, TOXICOL APPL PHARM, V316, P27, DOI 10.1016/j.taap.2016.12.012
   Gao HY, 2017, EUR REV MED PHARMACO, V21, P3634
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   Hasanein P, 2018, ENVIRON SCI POLLUT R, V25, P4896, DOI 10.1007/s11356-017-0702-y
   Hsu YY, 2012, EUR J PHARM SCI, V46, P415, DOI 10.1016/j.ejps.2012.03.004
   Jeong H, 2017, EXP GERONTOL, V95, P16, DOI 10.1016/j.exger.2017.05.004
   Lan RP, 2012, AM J PHYSIOL-RENAL, V302, pF1210, DOI 10.1152/ajprenal.00660.2011
   Li HH, 2016, J ALZHEIMERS DIS, V50, P1083, DOI 10.3233/JAD-150741
   Li K, 2009, CELL RES, V19, P1006, DOI 10.1038/cr.2009.76
   Lin CC, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00387
   Lin JS, 2015, J PATHOL, V236, P30, DOI 10.1002/path.4508
   Liu C, 2017, CLIN INTERV AGING, V12, P593, DOI 10.2147/CIA.S132277
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mahmoud AM, 2017, BIOMED PHARMACOTHER, V94, P280, DOI 10.1016/j.biopha.2017.07.101
   Milella M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00024
   Mohamed AF, 2017, INFLAMMATION, V40, P1742, DOI 10.1007/s10753-017-0617-2
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Orrenius S, 2015, BIOCHEM BIOPH RES CO, V460, P72, DOI 10.1016/j.bbrc.2015.01.137
   Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001
   Park S, 2013, ACTA HISTOCHEM CYTOC, V46, P111, DOI 10.1267/ahc.13012
   Pourrajab Fatemeh, 2015, Mol Cell Ther, V3, P4
   Qiu YY, 2017, MOL CELL ENDOCRINOL, V443, P89, DOI 10.1016/j.mce.2017.01.009
   Schmitt R, 2017, KIDNEY INT, V92, P569, DOI 10.1016/j.kint.2017.02.036
   Sergiev PV, 2015, ACTA NATURAE, V7, P9, DOI 10.32607/20758251-2015-7-1-9-18
   Tait IS, 2015, INT J MOL MED, V35, P277, DOI 10.3892/ijmm.2014.1999
   Tang LQ, 2016, J DIABETES, V8, P693, DOI 10.1111/1753-0407.12349
   Tarnawski AS, 2010, BIOCHEM BIOPH RES CO, V394, P291, DOI 10.1016/j.bbrc.2010.02.161
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Visnagri A, 2015, RENAL FAILURE, V37, P482, DOI 10.3109/0886022X.2014.996843
   Wang BH, 2011, CLIN ENDOCRINOL, V74, P705, DOI 10.1111/j.1365-2265.2011.03979.x
   Wang CM, 2015, ENVIRON TOXICOL, V30, P793, DOI 10.1002/tox.21958
   Xie YQ, 2017, EXP THER MED, V13, P1321, DOI 10.3892/etm.2017.4152
   Xiong YY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00682
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Xu X, 2015, MEDIAT INFLAMM, V2015, DOI [10.1155/2015/810798, 10.1155/2015/380218]
   Yang GN, 2017, DRUG DES DEV THER, V11, P1065, DOI 10.2147/DDDT.S124971
   Ying WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048715
   Yu YH, 2015, PHARMACOL BIOCHEM BE, V133, P122, DOI 10.1016/j.pbb.2015.03.020
   Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6
   Zahran MH, 2015, INT UROL NEPHROL, V47, P1907, DOI 10.1007/s11255-015-1099-5
   Zeng Y, 2016, AGING CLIN EXP RES, V28, P69, DOI 10.1007/s40520-015-0371-y
   Zhang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129527
   Zhang M, 2017, J FOOD DRUG ANAL, V25, P976, DOI 10.1016/j.jfda.2016.12.013
   Zhang W, 2009, BIOL PHARM BULL, V32, P1335, DOI 10.1248/bpb.32.1335
   Zhang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081327
   Zhang XL, 2016, APOPTOSIS, V21, P721, DOI 10.1007/s10495-016-1234-5
   Zhang Y, 2017, REJUV RES, V20, P462, DOI 10.1089/rej.2017.1960
   Zhang YQ, 2017, REDOX BIOL, V11, P30, DOI 10.1016/j.redox.2016.10.014
   Zhang YH, 2015, INT J CLIN EXP MED, V8, P7535
   Zhou J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10336-8
   Zhu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101291
NR 64
TC 11
Z9 11
U1 0
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1381-3455
EI 1744-4160
J9 ARCH PHYSIOL BIOCHEM
JI Arch. Physiol. Biochem.
PD MAR 14
PY 2020
VL 126
IS 2
BP 157
EP 165
DI 10.1080/13813455.2018.1499117
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
GA KI1KR
UT WOS:000511106400007
PM 30145915
DA 2024-02-19
ER

PT J
AU Lal, SB
   Ramsey, JJ
   Monemdjou, S
   Weindruch, R
   Harper, ME
AF Lal, SB
   Ramsey, JJ
   Monemdjou, S
   Weindruch, R
   Harper, ME
TI Effects of caloric restriction on skeletal muscle mitochondrial proton
   leak in aging rats
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID UNCOUPLING PROTEIN HOMOLOG; ATP TURNOVER REACTIONS; LIVER-MITOCHONDRIA;
   OXIDATIVE STRESS; FOOD RESTRICTION; INNER MEMBRANE; AGE; HEPATOCYTES;
   DAMAGE; MODULATION
AB Long-term caloric restriction (CR) retards aging processes and increases maximum life span. We investigated the influence of CR on mitochondrial proton leaks in rat skeletal muscle. Because CR lowers oxidative damage to mitochondrial membrane lipids and proteins, we hypothesized that leak would be lower in mitochondria from old CR rats than in age-matched controls. Three groups (n = 12) were studied: 4-month-old "young" control rats (body weight: 404 g +/- 7 SEM), 33-month-old CR rats (body weight: 262 g +/- 3), and 33-month-old control rats (body weight: 446 g +/- 5). CR rats received 67% of the energy intake of old control rats, with adequate intakes of all essential nutrients. Maximum leak-dependent O-2 consumption (State 3) was 23% lower in CR rats than in age-matched controls, whereas protonmotive force values were similar, supporting our hypothesis. The overall kinetics of leak were similar between the two groups of old rats; in the young, kinetics indicated higher protonmotive force values. The latter indication is consistent with aging-induced alterations in proton leak kinetics that are independent of dietary intervention. There was no influence of age or diet on serum T-4 level, whereas T-3 was lower in young than in old control rats. These results support and extend the oxidative stress hypothesis of aging.
C1 Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
   Univ Wisconsin, Wisconsin Reg Primate Res Ctr, Madison, WI 53706 USA.
   Univ Wisconsin, Dept Med, Madison, WI 53706 USA.
   Vet Adm Geriatr Res Educ & Clin Ctr, Madison, WI USA.
C3 University of Ottawa; University of Wisconsin System; University of
   Wisconsin Madison; University of Wisconsin System; University of
   Wisconsin Madison; Geriatric Research Education & Clinical Center
RP Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.
EM mharper@uottawa.ca
RI Harper, Mary-Ellen/C-3103-2009
OI Harper, Mary-Ellen/0000-0003-3864-5886; Monemdjou,
   Shadi/0000-0002-5809-595X
FU NIA NIH HHS [T32 AG 00213, P01 AG 11915] Funding Source: Medline
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BHATTACHARYA SK, 1991, ANAL BIOCHEM, V192, P344, DOI 10.1016/0003-2697(91)90546-6
   Boss O, 1998, EUR J ENDOCRINOL, V139, P1, DOI 10.1530/eje.0.1390001
   Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0
   BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081
   Brookes PS, 1998, J NEUROCHEM, V70, P2195
   BROWN GC, 1985, BIOCHEM J, V225, P399, DOI 10.1042/bj2250399
   CHEN RF, 1967, J BIOL CHEM, V242, P173
   Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001
   Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269
   Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900
   HAFNER RP, 1988, EUR J BIOCHEM, V178, P511, DOI 10.1111/j.1432-1033.1988.tb14477.x
   HAFNER RP, 1989, FEBS LETT, V248, P175, DOI 10.1016/0014-5793(89)80455-7
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harper ME, 1998, AM J PHYSIOL-ENDOC M, V275, pE197, DOI 10.1152/ajpendo.1998.275.2.E197
   HARPER ME, 1993, J BIOL CHEM, V268, P14850
   HARPER ME, 1994, CAN J PHYSIOL PHARM, V72, P899, DOI 10.1139/y94-127
   HERLIHY JT, 1990, MECH AGEING DEV, V53, P9, DOI 10.1016/0047-6374(90)90030-J
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   HORRUM MA, 1985, MOL CELL ENDOCRINOL, V41, P163, DOI 10.1016/0303-7207(85)90019-X
   HOTTA H, 1991, JPN J PHYSIOL, V41, P75, DOI 10.2170/jjphysiol.41.75
   KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X
   NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366
   PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0
   Sanchis D, 1998, J BIOL CHEM, V273, P34611, DOI 10.1074/jbc.273.51.34611
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740
   WEINDRUCH R, 1995, J GERONTOL A-BIOL, V50, P157
   Weindruch R., 1988, RETARDATION AGING DI
   Wilson P D, 1975, Adv Exp Med Biol, V53, P171
   Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 41
TC 69
Z9 77
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAR
PY 2001
VL 56
IS 3
BP B116
EP B122
DI 10.1093/gerona/56.3.B116
PG 7
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 407WP
UT WOS:000167294000003
PM 11253148
OA Bronze
DA 2024-02-19
ER

PT J
AU Ruiz, CE
   Cabrera, L
   López-Jiménez, JA
   Zamora, S
   Pérez-Llamas, F
AF Espinosa Ruiz, Cristobal
   Cabrera, Lorena
   Angel Lopez-Jimenez, Jose
   Zamora, Salvador
   Perez-Llamas, Francisca
TI Effects of long-term ingestion of white tea on oxidation produced by
   aging and acute oxidative damage in rats
SO JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Antioxidant; White tea; Adriamycin; Rats; Oxidative stress; Experimental
   model
ID GREEN TEA; LIPID-PEROXIDATION; CHRONIC EXPOSURE; GENE-EXPRESSION;
   ANTIOXIDANT; CONSUMPTION; BLACK; ADRIAMYCIN; IMPROVES; SUPPLEMENTATION
AB The infusion tea extracted from the leaves of the plant Camellia sinensis can be used in the prevention of cancer, cardiovascular and neurodegenerative diseases, and aging, while adriamycin (ADR) is an anticancer drug that increases oxidative stress in cells. The present study evaluated the protective effect of the long-term consumption of white tea used at two different doses against the oxidative stress produced by aging and acute oxidation caused ADR treatment. At wearing, rats received distilled water (control), or 0.15 (dose 1) or 0.45 mg (dose 2) of solid tea extract/kilogram body weight in their drink. At 12 months, about half of the rats of each group were injected with a bolus of ADR, and six rats of the control group with an injection of saline solution and sacrificed. The rest of the animals continued in their cages until 24 months of age, when they were sacrificed. Lipid and protein oxidation of liver and brain microsomes was analyzed by measuring hydroperoxide and carbonyl levels. White tea consumption for 12 months at a non-pharmacological dose was seen to reverse the oxidative damage caused by ADR in both liver and brain, while the consumption of white tea for 20 months at a non-pharmacological dose had no effect on carbonyl or hydroperoxides in these tissues. The long-term ingestion of white tea protected tissues from acute oxidative stress but did not affect chronic oxidative agents such aging.
C1 [Espinosa Ruiz, Cristobal] Univ Murcia, Fac Biol, Dept Cell Biol & Histol, Fish Innate Immune Syst Grp, Campus Espinardo, E-30100 Murcia, Spain.
   [Cabrera, Lorena; Angel Lopez-Jimenez, Jose; Zamora, Salvador; Perez-Llamas, Francisca] Univ Murcia, Fac Biol, Physiol Dept, Nutr Lab, Campus Espinardo, E-30100 Murcia, Spain.
C3 University of Murcia; University of Murcia
RP Ruiz, CE (corresponding author), Univ Murcia, Fac Biol, Dept Cell Biol & Histol, Fish Innate Immune Syst Grp, Campus Espinardo, E-30100 Murcia, Spain.
EM cespinosa31416@gmail.com
RI , Paquita/ABG-4122-2020; Jimenez, Jose Angel Lopez/AAA-2321-2019;
   Espinosa-Ruiz, Cristóbal/C-2555-2019
OI , Paquita/0000-0003-0080-6592; Espinosa-Ruiz,
   Cristóbal/0000-0002-3063-1634
FU "Ministerio de Ciencia y Tecnologia" of Spain [AGL2005-08088-C02-01];
   Beca FPU [AP2006-02642]
FX This study was funded by "Ministerio de Ciencia y Tecnologia" of Spain
   with the project AGL2005-08088-C02-01 and Beca FPU (AP2006-02642). The
   authors would like to thank M<SUP>a</SUP> Pilar Almajano for extract of
   the white tea and Rebeca Martinez-Tomas and Daniel Gonzalez for
   technical support.
CR Almajano MP, 2011, NEUROTOX RES, V20, P372, DOI 10.1007/s12640-011-9252-0
   Almajano MP, 2008, FOOD CHEM, V108, P55, DOI 10.1016/j.foodchem.2007.10.040
   Alves MG, 2015, J FUNCT FOODS, V14, P102, DOI 10.1016/j.jff.2015.01.019
   Azman NAM, 2014, J AGR FOOD CHEM, V62, P5743, DOI 10.1021/jf501707p
   BAILEY PJ, 1991, J ORGANOMET CHEM, V420, pC21, DOI 10.1016/0022-328X(91)86471-2
   Carloni P, 2012, FOOD RES INT
   Catalá A, 2007, J PINEAL RES, V42, P43, DOI 10.1111/j.1600-079X.2006.00354.x
   Coimbra S, 2006, NUTR RES, V26, P604, DOI 10.1016/j.nutres.2006.09.014
   Dean RT, 1997, BIOCHEM J, V324, P1
   Dias TR, 2016, J NUTR BIOCHEM, V37, P83, DOI 10.1016/j.jnutbio.2016.07.018
   Duthie GG, 2000, NUTR RES REV, V13, P79, DOI 10.1079/095442200108729016
   Espinosa C, 2014, J PHYSIOL BIOCHEM, V70, P891, DOI 10.1007/s13105-014-0357-9
   Espinosa C, 2015, J SCI FOOD AGR
   Espinosa C, 2012, FOOD CHEM, V134, P1780, DOI 10.1016/j.foodchem.2012.03.083
   Esterbauer H, 1996, PATHOL BIOL, V44, P25
   Firuzi O, 2006, J CLIN LAB ANAL, V20, P139, DOI 10.1002/jcla.20122
   GOODMAN J, 1977, BIOCHEM BIOPH RES CO, V77, P797, DOI 10.1016/S0006-291X(77)80048-X
   Halliwell B, 1989, FREE RADIC BIOL MED, V12, P93
   JACOB RA, 1995, NUTR RES, V15, P755, DOI 10.1016/0271-5317(95)00041-G
   JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N
   Juskiewicz J, 2008, NUTR RES, V28, P343, DOI 10.1016/j.nutres.2008.03.004
   Khan SA, 2007, NUTRITION, V23, P687, DOI 10.1016/j.nut.2007.06.007
   Kim MJ, 2002, NUTR RES, V22, P733, DOI 10.1016/S0271-5317(02)00365-2
   Koutelidakis AE, 2010, FOOD CHEM, V120, P895, DOI 10.1016/j.foodchem.2009.10.064
   Koutelidakis AE, 2009, NUTRITION, V25, P453, DOI 10.1016/j.nut.2008.10.007
   Larsson SC, 2013, ANN EPIDEMIOL, V23, P157, DOI 10.1016/j.annepidem.2012.12.006
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mohamadin AM, 2005, PHARMACOL RES, V51, P51, DOI 10.1016/j.phrs.2004.04.007
   Nunes AR, 2015, BRIT J NUTR, V113, P832, DOI 10.1017/S0007114514004395
   Oliveira PF, 2015, REPROD BIOMED ONLINE, V31, P544, DOI 10.1016/j.rbmo.2015.06.021
   Pérez-Llamas F, 2011, J PHYSIOL BIOCHEM, V67, P331, DOI 10.1007/s13105-011-0079-1
   PHILIPP BW, 1979, J LIPID RES, V20, P588
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   RICEEVANS C, 1993, PROG LIPID RES, V32, P71, DOI 10.1016/0163-7827(93)90006-I
   Rusak G, 2008, FOOD CHEM, V110, P852, DOI 10.1016/j.foodchem.2008.02.072
   Schimmel KJM, 2004, CANCER TREAT REV, V30, P181, DOI 10.1016/j.ctrv.2003.07.003
   Serafini M, 2002, GASTROENTEROLOGY, V123, P985, DOI 10.1053/gast.2002.35957
   Singleton V. L., 1965, American Journal of Enology and Viticulture, V16, P144, DOI [10.5344/ajev.1965.16.3.144, DOI 10.12691/IJEBB-2-1-5]
   Soleas GJ, 2002, CLIN BIOCHEM, V35, P119, DOI 10.1016/S0009-9120(02)00275-8
   Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r
   Suzuki E, 2009, ANN EPIDEMIOL, V19, P732, DOI 10.1016/j.annepidem.2009.06.003
   Tenore GC, 2015, FOOD CHEM, V169, P320, DOI 10.1016/j.foodchem.2014.08.006
   Tomaszewska E, 2015, EXP TOXICOL PATHOL, V67, P331, DOI 10.1016/j.etp.2015.02.005
   Verstraeten SV, 2003, FREE RADICAL BIO MED, V34, P84, DOI 10.1016/S0891-5849(02)01185-1
   Wang D, 2011, J ETHNOPHARMACOL, V134, P156, DOI 10.1016/j.jep.2010.11.068
   Winiarska-Mieczan A, 2015, REGUL TOXICOL PHARM, V73, P521, DOI 10.1016/j.yrtph.2015.10.007
   Zhang Y, 2016, ENVIRON TOXICOL PHAR, V46, P183, DOI 10.1016/j.etap.2016.07.016
NR 47
TC 2
Z9 4
U1 0
U2 34
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1138-7548
EI 1877-8755
J9 J PHYSIOL BIOCHEM
JI J. Physiol. Biochem.
PD FEB
PY 2018
VL 74
IS 1
SI SI
BP 171
EP 177
DI 10.1007/s13105-017-0591-z
PG 7
WC Biochemistry & Molecular Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Physiology
GA FV6LN
UT WOS:000424692600018
PM 28929453
DA 2024-02-19
ER

PT J
AU Rifai, K
   Sebagh, M
   Karam, V
   Saliba, F
   Azoulay, D
   Adam, R
   Castaing, D
   Bismuth, H
   Reynès, M
   Samuel, D
   Féray, C
AF Rifai, K
   Sebagh, M
   Karam, V
   Saliba, F
   Azoulay, D
   Adam, R
   Castaing, D
   Bismuth, H
   Reynès, M
   Samuel, D
   Féray, C
TI Donor age influences 10-year liver graft histology independently of
   hepatitis C virus infection
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE ABO blood-group system; adult; age factors; follow-up studies; graft
   rejection; graft survival; human; liver transplantation pathology; liver
   transplantation; tissue donors
ID REPLICATIVE SENESCENCE; TRANSPLANTATION; IMPACT; RECURRENCE; CIRRHOSIS;
   SURVIVAL; PATIENT
AB Background/Aims: Factors influencing the long-term histological outcome of liver graft are not known. We conducted a prospective study based on a 10-year liver biopsy in order to identify the main factors influencing long-term graft histology.
   Methods: 270 of 423 patients who still had their first functional graft 10 years after liver transplantation accepted to undergo routine liver biopsy. All slides were blindly reviewed by two pathologists.
   Results: Main histological findings were fibrosis in 143 patients (54%) and ductopenia in 76 patients (29%). Ductopenia was independently related to higher donor age (32 +/- 12 vs 28 +/- 13 years; P < 0.02). Severity of fibrosis was influenced by hepatitis C virus (HCV) infection (P < 0.001), hepatitis B virus (HBV) recurrence (P = 0.001) and higher donor age (P = 0.03). Eighty biopsies (30%) showed minimal-change lesions which were associated with the absence of HCV infection (24/80 vs 99/185; P < 0.001) or of HBV infection (1/80 vs 15/185; P = 0.03) and lower donor age (25 +/- 11 vs 31 +/- 13 years; P < 0.001).
   Conclusions: Post-transplant infection by HCV or HBV are main factors influencing the histological course of liver graft. Donor age was also a strong factor in HCV infected patients as well as in HCV-negative patients. This variable should be taken into account, particularly for candidate recipients with long life, expectancy. (C) 2004 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 Univ Paris Sud, Villejuif Assistance Publ Hop Paris, Hop Paul Brousse, Ctr Hepatobiliaire, F-94800 Villejuif, France.
   Univ Paris Sud, Villejuif Assistance Publ Hop Paris, Hop Paul Brousse, Unite Propre Rech Enseignement Super 3541, F-94800 Villejuif, France.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Paul-Brousse - APHP; Universite Paris Saclay; Universite Paris Saclay;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Paul-Brousse - APHP
RP Univ Paris Sud, Villejuif Assistance Publ Hop Paris, Hop Paul Brousse, Ctr Hepatobiliaire, 12-14 Ave Paul Vaillant Couturier, F-94800 Villejuif, France.
EM feray@noos.fr
RI SEBAGH, Mylène/T-7464-2018; Feray, Cyrille/S-2559-2018; SALIBA,
   Faouzi/T-7456-2018; Karam, Vincent/HLQ-6211-2023; FERAY,
   Cyrille/T-7370-2018; Samuel, Didier/U-5265-2018
OI cyrille, feray/0000-0002-8627-9676; Karam, Vincent/0000-0002-7391-0190;
   Samuel, Didier/0000-0001-9481-3616
CR Adam R, 2000, LANCET, V356, P621, DOI 10.1016/S0140-6736(00)02603-9
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   BEDOSSA P, 1994, HEPATOLOGY, V20, P15
   Berenguer M, 2003, HEPATOLOGY, V38, P34, DOI 10.1053/jhep.2003.50278
   Berenguer M, 2000, HEPATOLOGY, V32, P852, DOI 10.1053/jhep.2000.17924
   Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993
   Boker KHW, 1997, HEPATOLOGY, V25, P203, DOI 10.1053/jhep.1997.v25.pm0008985291
   Burak KW, 2002, LIVER TRANSPLANT, V8, P362, DOI 10.1053/jlts.2002.32282
   Busquets J, 2001, TRANSPLANTATION, V71, P1765, DOI 10.1097/00007890-200106270-00011
   Demetris A, 2000, Hepatology, V31, P792
   Deschênes M, 1999, LIVER TRANSPLANT SUR, V5, P357, DOI 10.1002/lt.500050501
   Detre K M, 1995, Liver Transpl Surg, V1, P311, DOI 10.1002/lt.500010507
   FERAY C, 1994, HEPATOLOGY, V20, P1137, DOI 10.1002/hep.1840200506
   Féray C, 1999, GASTROENTEROLOGY, V117, P619, DOI 10.1016/S0016-5085(99)70454-3
   Hoofnagle JH, 1996, HEPATOLOGY, V24, P89, DOI 10.1053/jhep.1996.v24.pm0008707288
   Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Marino IR, 1995, HEPATOLOGY, V22, P1754, DOI 10.1002/hep.1840220622
   Markmann JF, 2001, TRANSPLANTATION, V72, P1113, DOI 10.1097/00007890-200109270-00023
   Oh CK, 2000, CLIN TRANSPLANT, V14, P386, DOI 10.1034/j.1399-0012.2000.14040502.x
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Ratziu V, 1999, J HEPATOL, V30, P131, DOI 10.1016/S0168-8278(99)80017-8
   Roche B, 2003, HEPATOLOGY, V38, P86, DOI 10.1053/jhep.2003.50294
   Sakai Y, 1997, HEPATOLOGY, V25, P421
   SAMUEL D, 1991, LANCET, V337, P813, DOI 10.1016/0140-6736(91)92515-4
   Sebagh M, 1998, TRANSPLANTATION, V65, P1328, DOI 10.1097/00007890-199805270-00008
   Sebagh M, 2003, HEPATOLOGY, V37, P1293, DOI 10.1053/jhep.2003.50231
   YERSIZ H, 1995, TRANSPLANTATION, V60, P790, DOI 10.1097/00007890-199510270-00005
NR 28
TC 53
Z9 54
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD SEP
PY 2004
VL 41
IS 3
BP 446
EP 453
DI 10.1016/j.jhep.2004.05.013
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 855YI
UT WOS:000224010400012
PM 15336448
DA 2024-02-19
ER

PT J
AU Giroux, MC
   Santamaria, R
   Hélie, P
   Burns, P
   Beaudry, F
   Vachon, P
AF Giroux, Marie-Chantal
   Santamaria, Raphael
   Helie, Pierre
   Burns, Patrick
   Beaudry, Francis
   Vachon, Pascal
TI Physiological, pharmacokinetic and liver metabolism comparisons between
   3-, 6-, 12-and 18-month-old male Sprague Dawley rats under
   ketamine-xylazine anesthesia
SO EXPERIMENTAL ANIMALS
LA English
DT Article
DE anesthesia; ketamine; liver metabolism; pharmacokinetics; xylazine
ID BLOOD-BRAIN-BARRIER; MASS-SPECTROMETRY; IN-VITRO; KETAMINE/XYLAZINE
   ANESTHESIA; CYTOCHROME-P450 ENZYMES; NORKETAMINE ENANTIOMERS;
   DRUG-METABOLISM; CYP3A ACTIVITY; MICROSOMES; PHARMACOLOGY
AB The main objective of this study was to compare the physiological changes (withdrawal and corneal reflexes, respiratory and cardiac frequency, blood oxygen saturation, and rectal temperature) following intraperitoneal administration of ketamine (80 mg/kg) and xylazine (10 mg/kg) to 3-, 6-, 12- and 18-month-old male Sprague Dawley rats (n=6/age group). Plasma pharmacokinetics, liver metabolism, and blood biochemistry were examined for a limited number of animals to better explain anesthetic drug effects. Selected organs were collected for histopathology. The results for the withdrawal and corneal reflexes suggest a shorter duration and decreased depth of anesthesia with aging. Significant cardiac and respiratory depression, as well as decreased blood oxygen saturation, occurred in all age groups however, cardiac frequency was the most affected parameter with aging, since the 6-, 12-, and 18-month-old animals did not recuperate to normal values during recovery from anesthesia. Pharmacokinetic parameters (T-1/2 and AUC) increased and drug clearance decreased with aging, which strongly suggests that drug exposure is associated with the physiological results. The findings for liver S9 fractions of 18-month-old rats compared with the other age groups suggest that following a normal ketamine anesthetic dose (80 mg/kg), drug metabolism is impaired, leading to a significant increase of drug exposure. In conclusion, age and related factors have a substantial effect on ketamine and xylazine availability, which is reflected by significant changes in pharmacokinetics and liver metabolism of these drugs, and this translates into shorter and less effective anesthesia with increasing age.
C1 [Giroux, Marie-Chantal; Santamaria, Raphael; Beaudry, Francis; Vachon, Pascal] Univ Montreal, Dept Vet Biomed, St Hyacinthe, PQ, Canada.
   [Helie, Pierre] Univ Montreal, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada.
   [Burns, Patrick] Univ Montreal, Fac Vet Med, Deterinary Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada.
   [Vachon, Pascal] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada.
C3 Universite de Montreal; Universite de Montreal; Universite de Montreal
RP Vachon, P (corresponding author), Fac Vet, Dept Vet Med Biomed, 3200 Sicotte, St Hyacinthe, PQ J2S 2M2, Canada.
RI Burns, Patrick/C-5943-2013; Beaudry, Francis/A-9462-2012
OI Burns, Patrick/0000-0001-5229-3886; Beaudry, Francis/0000-0001-5403-7333
FU CALAM/CALAS research fund; Fond du Centenaire de la Faculty de Medecine
   Veterinaire; Fond de Recherche pour la Medecine des Animaux de
   Laboratoire; National Sciences and Engineering Research Council of
   Canada [386637-2010, 439748-2013]
FX The authors would like to thank Dr. Guy Beauchamp, a statistician in the
   Faculty of Veterinary Medicine, University of Montreal, for the
   statistical analyses. This study was funded by the CALAM/CALAS 2014
   research fund (Pascal Vachon) as well as the Fond du Centenaire de la
   Faculty de Medecine Veterinaire (Marie-Chantal Giroux and Raphael
   Santamaria) and the Fond de Recherche pour la Medecine des Animaux de
   Laboratoire (Pascal Vachon). This project was also funded by the
   National Sciences and Engineering Research Council of Canada (Francis
   Beaudry; Discovery Grant no. 386637-2010). The HPLC-MS/MS analyses were
   performed on instruments funded by the National Sciences and Engineering
   Research Council of Canada (Francis Beaudry; Research Tools and
   Instruments Grants no. 439748-2013).
CR AMOUZADEH HR, 1993, TOXICOL PATHOL, V21, P562, DOI 10.1177/019262339302100607
   AMOUZADEH HR, 1989, VET HUM TOXICOL, V31, P532
   Choi SO, 1991, ARCH PHARM RES, V14, P346, DOI [10.1007/BF02876882, DOI 10.1007/BF02876882]
   DAYTON PG, 1983, EUR J CLIN PHARMACOL, V24, P825, DOI 10.1007/BF00607095
   Dittmar MS, 2004, COMPARATIVE MED, V54, P652
   Ebert B, 1997, EUR J PHARMACOL, V333, P99, DOI 10.1016/S0014-2999(97)01116-3
   Edwards SR, 2001, LIFE SCI, V69, P2051, DOI 10.1016/S0024-3205(01)01287-5
   Fitzgibbon EJ, 2002, J PAIN SYMPTOM MANAG, V23, P165, DOI 10.1016/S0885-3924(01)00393-1
   Flecknell P., 1996, LAB ANIMAL ANESTHESI
   Giroux MC, 2015, EXP ANIM TOKYO, V64, P253, DOI 10.1538/expanim.14-0088
   GREENE SA, 1988, J VET PHARMACOL THER, V11, P295, DOI 10.1111/j.1365-2885.1988.tb00189.x
   Halama B, 2013, CLIN PHARMACOL THER, V93, P564, DOI 10.1038/clpt.2013.27
   Hijazi Y, 2002, DRUG METAB DISPOS, V30, P853, DOI 10.1124/dmd.30.7.853
   Holtman JR, 2008, PHARMACOL BIOCHEM BE, V90, P676, DOI 10.1016/j.pbb.2008.05.011
   Karch SB, 2007, PHARMACOKINETICS PHA, P21
   Knobloch M, 2006, TOXICOL APPL PHARM, V216, P373, DOI 10.1016/j.taap.2006.06.011
   Krinke G., 1994, PATHOBIOLOGY AGING R, V2, P3
   Lavoie DSG, 2013, BIOMED CHROMATOGR, V27, P882, DOI 10.1002/bmc.2875
   Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X
   LEUNG LY, 1986, J MED CHEM, V29, P2396, DOI 10.1021/jm00161a043
   MADSEN NB, 1952, J BIOL CHEM, V195, P741
   Meyer RE, 2008, AM COLL LAB, P27
   Mézière A, 2013, PRESSE MED, V42, P197, DOI 10.1016/j.lpm.2012.07.040
   Michaelis L, 1913, BIOCHEM Z, V49, P333
   Mössner LD, 2011, AM J VET RES, V72, P1505, DOI 10.2460/ajvr.72.11.1505
   Mooiman KD, 2013, BIOMED CHROMATOGR, V27, P1107, DOI 10.1002/bmc.2913
   MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7
   Olfert E.D., 1993, GUIDE CARE USE EXPT, V1
   Plumb D. C., 2008, PLUMBS VET DRUG HDB, P935
   Portmann S, 2010, J CHROMATOGR A, V1217, P7942, DOI 10.1016/j.chroma.2010.06.028
   Ramasamy K., INT J PHARM SCI RES, V2, P205
   Richardson CA, 2005, ATLA-ALTERN LAB ANIM, V33, P119, DOI 10.1177/026119290503300207
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   Rodrigues SF, 2006, LIFE SCI, V79, P1630, DOI 10.1016/j.lfs.2006.05.019
   Rowland M., 1995, CLIN PHARMACOKINET, P367
   Saha JK, 2005, EXP BIOL MED, V230, P777, DOI 10.1177/153537020523001012
   Santamaria R, 2014, BIOMED CHROMATOGR, V28, P1660, DOI 10.1002/bmc.3199
   Schwenke DO, 2004, COMPARATIVE MED, V54, P77
   SHARP PE, 1998, LAB RAT, P14
   Shimizu M, 2007, J CHROMATOGR B, V847, P275, DOI 10.1016/j.jchromb.2006.10.018
   Singh NS, 2014, EXPERT REV NEUROTHER, V14, P1239, DOI 10.1586/14737175.2014.971760
   Song G, 2012, J LIPOSOME RES, V22, P177, DOI 10.3109/08982104.2012.655285
   Struck MB, 2011, J AM ASSOC LAB ANIM, V50, P344
   Sumitra M, 2004, LIFE SCI, V75, P1887, DOI 10.1016/j.lfs.2004.05.009
   Sun H, 2010, CHEM BIOL DRUG DES, V75, P3, DOI 10.1111/j.1747-0285.2009.00899.x
   Swindle M. M., 2002, Laboratory animal medicine, P956
   Tucsek Z, 2014, J GERONTOL A-BIOL, V69, P1212, DOI 10.1093/gerona/glt177
   Uhing MR, 2004, DRUG METAB DISPOS, V32, P1325, DOI 10.1124/dmd.104.000927
   Veilleux-Lemieux D, 2013, J AM ASSOC LAB ANIM, V52, P567
   Veilleux-Lemieux D, 2012, VET MED-RES REP, V3, P99, DOI 10.2147/VMRR.S35666
   Vesa N., 2007, IRANIAN J VET RES U, V8
   WATERMAN AE, 1978, BRIT J ANAESTH, V50, P885, DOI 10.1093/bja/50.9.885
   Zanger Ulrich M., 2013, Frontiers in Genetics, V4, P24, DOI 10.3389/fgene.2013.00024
NR 53
TC 19
Z9 20
U1 0
U2 12
PU INT PRESS EDITING CENTRE INC
PI TOKYO
PA 1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN
SN 1341-1357
EI 1881-7122
J9 EXP ANIM TOKYO
JI Exp. Anim.
PD JAN
PY 2016
VL 65
IS 1
BP 63
EP 75
DI 10.1538/expanim.15-0039
PG 13
WC Veterinary Sciences; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences; Zoology
GA DD1JX
UT WOS:000369679100008
PM 26489361
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Pomatto, LCD
   Cline, M
   Woodward, N
   Pakbin, P
   Sioutas, C
   Morgan, TE
   Finch, CE
   Forman, HJ
   Davies, KJA
AF Pomatto, Laura C. D.
   Cline, Mayme
   Woodward, Nicholas
   Pakbin, Payam
   Sioutas, Constantinos
   Morgan, Todd E.
   Finch, Caleb E.
   Forman, Henry Jay
   Davies, Kelvin J. A.
TI Aging attenuates redox adaptive homeostasis and proteostasis in female
   mice exposed to traffic-derived nanoparticles ('vehicular smog')
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Adaptive homeostasis; Nrf2; Bach1; c-Myc; Lon protease; Proteasome;
   Proteostasis; Immunoproteasome; Aging; Nanoparticulate-matter; Air
   pollution
ID OXIDATIVE STRESS-ADAPTATION; DIESEL EXHAUST PARTICLES; HUMAN BJ
   FIBROBLASTS; OXIDIZED PROTEINS; 20S PROTEASOME; AIR-POLLUTION;
   GENE-EXPRESSION; LON PROTEASE; TRANSCRIPTIONAL REPRESSOR; TRANSIENT
   ADAPTATION
AB Environmental toxicants are catalysts for protein damage, aggregation, and the aging process. Fortunately, evolution selected adaptive homeostasis as a system to mitigate such damage by expanding the normal capacity to cope with toxic stresses. Little is known about the subcellular degradative responses to proteins oxidatively damaged by air pollution. To better understand the impact of environmental toxicants upon the adaptive homeostatic response, female C57BL/6 mice were exposed for 10 weeks to filtered air or reaerosolized vehicular-derived nano-scale particulate matter (nPM), at which point tissues from young (6 month) and middle-aged (21 month) mice were studied. We found significant increases of proteolytic capacity in lung, liver, and heart. Up to two-fold increases were seen in the 20S Proteasome, the Immunoproteasome, the mitochondrial Lon protease, and NF-E2-related factor 2 (Nrf2), a major transcriptional factor for these and other stress-responsive genes. The responses were equivalent in all organs, despite the indirect input of inhaled particles to heart and liver which are downstream of lung. To our knowledge, this is the first exploration of proteostatic responses to oxidative damage by air pollution. Although, middle-aged mice had higher basal levels, their Nrf2-responsive-genes exhibited no response to nanoparticulate exposure. We also found a parallel age-associated rise in the Nrf2 transcriptional inhibitors, Bach1 and c-Myc which appear to attenuate adaptive responses in older mammals, possibly explaining the 'age-ceiling effect.' This report extends prior findings in male mice by demonstrating the involvement of proteolytic responses to traffic-related air pollution in lung, liver, and heart of female mice, with an age-dependent loss of adaptive homeostasis.
C1 [Pomatto, Laura C. D.; Cline, Mayme; Woodward, Nicholas; Morgan, Todd E.; Finch, Caleb E.; Forman, Henry Jay; Davies, Kelvin J. A.] Univ Southern Calif, Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA.
   [Pakbin, Payam; Sioutas, Constantinos] Univ Southern Calif, Dept Civil & Environm Engn, Viterbi Sch Engn, Los Angeles, CA 90089 USA.
   [Finch, Caleb E.; Davies, Kelvin J. A.] Univ Southern Calif, Mol & Computat Biol Program, Dept Biol Sci, Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA.
   [Davies, Kelvin J. A.] Univ Southern Calif, Dept Biochem & Mol Med, Keck Sch Med, Los Angeles, CA 90089 USA.
   [Pomatto, Laura C. D.] Natl Inst Gen Med Sci, 45 Ctr Dr MSC 6200, Bethesda, MD 20892 USA.
   [Pakbin, Payam] South Coast Air Qual Management Dist, 21865 Copley Dr, Diamond Bar, CA 91765 USA.
C3 University of Southern California; University of Southern California;
   University of Southern California; University of Southern California;
   National Institutes of Health (NIH) - USA; NIH National Institute of
   General Medical Sciences (NIGMS)
RP Davies, KJA (corresponding author), Univ Southern Calif, Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA.
EM kelvin@usc.edu
RI Finch, Caleb/AAA-7250-2022; Sioutas, Constantinos/R-1968-2019
OI Sioutas, Constantinos/0000-0001-5146-0857
FU USA National Science Foundation [DGE-1418060]; National Institute of
   Environmental Health Sciences of the US National Institutes of Health
   [ES003598, ES023864]; National Institute on Aging of the US National
   Institutes of Health [AG052374, AG-040753]
FX This work was supported by grant #DGE-1418060 of the USA National
   Science Foundation to LCDP; by grant #ES003598 from the National
   Institute of Environmental Health Sciences of the US National Institutes
   of Health to KJAD, by grant #AG052374 from the National Institute on
   Aging of the US National Institutes of Health to KJAD, by grant
   #ES023864 From the National Institute of Environmental Health Sciences
   of the US National Institutes of Health to HJF, and by grant #AG-040753
   from the National Institute on Aging of the US National Institutes of
   Health to CEF. The authors declare no conflict of interest.
CR Agarwal NK, 2017, MED SCI, V21, P270, DOI 10.1161/CIR.0b013e3181dbece1
   Alam J, 2003, CURR PHARM DESIGN, V9, P2499, DOI 10.2174/1381612033453730
   [Anonymous], J PHYSL
   Araujo JA, 2008, CIRC RES, V102, P589, DOI 10.1161/CIRCRESAHA.107.164970
   Attaix D, 2005, INT J BIOCHEM CELL B, V37, P1962, DOI 10.1016/j.biocel.2005.04.009
   BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664
   Barford A, 2006, BMJ-BRIT MED J, V332, P808, DOI 10.1136/bmj.332.7545.808
   Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Cacciottolo M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.280
   Campbell A, 2009, J NANOSCI NANOTECHNO, V9, P5099, DOI 10.1166/jnn.2009.GR07
   Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021
   CHEN W, 1995, MOL CELL BIOL, V15, P3424
   Chevion M, 2000, FREE RADICAL RES, V33, pS99
   Cho HY, 2015, FREE RADICAL BIO MED, V88, P362, DOI 10.1016/j.freeradbiomed.2015.06.012
   Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794
   Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2
   Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5
   Dalton TP, 2004, FREE RADICAL BIO MED, V37, P1511, DOI 10.1016/j.freeradbiomed.2004.06.040
   DAVIES JMS, 1995, ARCH BIOCHEM BIOPHYS, V317, P1, DOI 10.1006/abbi.1995.1128
   Davies KJA, 2016, MOL ASPECTS MED, V49, P1, DOI 10.1016/j.mam.2016.04.007
   Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0
   Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200
   Di Q, 2017, NEW ENGL J MED, V376, P2513, DOI 10.1056/NEJMoa1702747
   Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2543, DOI 10.1007/s00018-012-0938-0
   Fanò G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060
   Farout L, 2006, ANTIOXID REDOX SIGN, V8, P205, DOI 10.1089/ars.2006.8.205
   Gems D, 2014, AGING-US, V6, P84, DOI 10.18632/aging.100640
   Gillespie P, 2013, NEUROTOXICOLOGY, V36, P112, DOI 10.1016/j.neuro.2011.10.006
   Goven D, 2009, FEBS LETT, V583, P3508, DOI 10.1016/j.febslet.2009.10.010
   Goven D., 2008, THORAX
   Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97
   Grimble RF, 2003, CURR OPIN CLIN NUTR, V6, P21, DOI 10.1097/00075197-200301000-00005
   Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020
   Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   Grune T, 2011, FREE RADICAL BIO MED, V51, P1355, DOI 10.1016/j.freeradbiomed.2011.06.015
   Gvozdeva OV, 2016, NUCLEOS NUCLEOT NUCL, V35, P389, DOI 10.1080/15257770.2016.1184275
   Heusinkveld HJ, 2016, NEUROTOXICOLOGY, V56, P94, DOI 10.1016/j.neuro.2016.07.007
   Hotzi B, 2018, AGING CELL, V17, DOI 10.1111/acel.12724
   Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x
   Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8
   Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021
   Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074
   Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011
   Jentoft N, 1979, LABELING PROTEINS RE
   Ji L., 1990, AM J PHYSIOL-REG I, V258, pR218
   Johnston-Carey HK, 2016, CRIT REV BIOCHEM MOL, V51, P268, DOI 10.3109/10409238.2016.1172554
   Kane A. E., 2018, CURR OPIN PHYSL
   Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kipen HM, 2011, ENVIRON HEALTH PERSP, V119, P658, DOI 10.1289/ehp.1002784
   Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004
   Lai CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33727
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Levy S, 2010, IUBMB LIFE, V62, P237, DOI 10.1002/iub.314
   Li N, 2000, J IMMUNOL, V165, P3393, DOI 10.4049/jimmunol.165.6.3393
   McCullough LD, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0015-5
   Meiners S, 2012, EUR RESPIR J, V40, P1260, DOI 10.1183/09031936.00208511
   Miller MR, 2016, OXID STRESS APPL BAS, P133, DOI 10.1007/978-3-319-33486-8_8
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Morgan TE, 1997, FREE RADICAL BIO MED, V23, P524, DOI 10.1016/S0891-5849(97)00120-2
   Morgan TE, 2011, ENVIRON HEALTH PERSP, V119, P1003, DOI 10.1289/ehp.1002973
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Mühlfeld C, 2008, AM J PHYSIOL-LUNG C, V294, pL817, DOI 10.1152/ajplung.00442.2007
   Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752
   Ngo JK, 2011, J GERONTOL A-BIOL, V66, P1178, DOI 10.1093/gerona/glr145
   Ngo JK, 2009, FREE RADICAL BIO MED, V46, P1042, DOI 10.1016/j.freeradbiomed.2008.12.024
   NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P
   Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   Opitz E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002233
   Oyake T, 1996, MOL CELL BIOL, V16, P6083
   Pajares M, 2017, REDOX BIOL, V11, P543, DOI 10.1016/j.redox.2017.01.006
   Pardue M-L, 2001, Exploring the biological contributions to human health: does sex matter?
   Pettit AP, 2012, INHAL TOXICOL, V24, P172, DOI 10.3109/08958378.2012.654856
   Pickering AM, 2015, J CLIN INVEST, V125, P2059, DOI 10.1172/JCI80514
   Pickering AM, 2013, FREE RADICAL BIO MED, V55, P109, DOI 10.1016/j.freeradbiomed.2012.11.001
   Pickering AM, 2013, J EXP BIOL, V216, P543, DOI 10.1242/jeb.074757
   Pickering AM, 2012, ARCH BIOCHEM BIOPHYS, V523, P181, DOI 10.1016/j.abb.2012.04.018
   Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145
   Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878
   Pomatto LCD, 2018, DATA BRIEF, V17, P653, DOI 10.1016/j.dib.2018.01.044
   Pomatto LCD, 2018, J GERONTOL A-BIOL, V73, P141, DOI 10.1093/gerona/glx083
   Pomatto LCD, 2017, ARCH BIOCHEM BIOPHYS, V636, P57, DOI 10.1016/j.abb.2017.10.021
   Pomatto LCD, 2017, AGING-US, V9, P1153, DOI 10.18632/aging.101218
   Racca JD, 2016, J BIOL CHEM, V291, P22173, DOI 10.1074/jbc.M116.741959
   García-Niño WR, 2014, FOOD CHEM TOXICOL, V69, P182, DOI 10.1016/j.fct.2014.04.016
   RAYNES R, 2016, J GERONTOL A-BIOL
   Raynes R, 2016, MOL ASPECTS MED, V50, P41, DOI 10.1016/j.mam.2016.05.001
   Reeg S, 2016, FREE RADICAL BIO MED, V99, P153, DOI 10.1016/j.freeradbiomed.2016.08.002
   Reis-Rodrigues P, 2012, AGING CELL, V11, P120, DOI 10.1111/j.1474-9726.2011.00765.x
   Rodriguez K. A., 2014, FRONT MOL NEUROSCI, P7
   SAGAI M, 1993, FREE RADICAL BIO MED, V14, P37, DOI 10.1016/0891-5849(93)90507-Q
   Shenvi SV, 2012, AGING CELL, V11, P297, DOI 10.1111/j.1474-9726.2011.00788.x
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   Sitte N, 2000, FASEB J, V14, P2503, DOI 10.1096/fj.00-0210com
   Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516
   Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200
   Tanaka K, 1998, IMMUNOL REV, V163, P161
   Thimmulappa RK, 2002, CANCER RES, V62, P5196
   Tsakiri EN, 2013, FASEB J, V27, P2407, DOI 10.1096/fj.12-221408
   Verheyen GR, 2004, TOXICOL IN VITRO, V18, P377, DOI 10.1016/j.tiv.2003.10.007
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
   WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225
   Woodward NC, 2017, NEUROBIOL AGING, V53, P48, DOI 10.1016/j.neurobiolaging.2017.01.007
   Yang LE, 2017, LANCET PLANET HEALTH, V1, pE132, DOI 10.1016/S2542-5196(17)30067-0
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
   Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P2038, DOI 10.1016/j.freeradbiomed.2012.02.042
   Zhang HQ, 2010, BBA-GENE REGUL MECH, V1799, P496, DOI 10.1016/j.bbagrm.2010.05.003
   Zhu H, 2008, EXP BIOL MED, V233, P463, DOI 10.3181/0711-RM-304
NR 114
TC 34
Z9 35
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JUN
PY 2018
VL 121
BP 86
EP 97
DI 10.1016/j.freeradbiomed.2018.04.574
PG 12
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA GH2CC
UT WOS:000433208200010
PM 29709705
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Ma, XH
   Muzumdar, R
   Gabriely, I
   Atzmon, G
   Barzilai, N
AF Ma, XH
   Muzumdar, R
   Gabriely, I
   Atzmon, G
   Barzilai, N
TI Does the brain lead the metabolic decline in aging? Lessons from animal
   models and human centenarians
SO CLINICAL NEUROSCIENCE RESEARCH
LA English
DT Article; Proceedings Paper
CT 82nd Annual Conference of the
   Association-for-Research-in-Nerous-and-Mental-Disease
CY DEC 06-07, 2002
CL NEW YORK, NY
SP Assoc Res Nervous & Ment Dis
DE leptin; visceral fat; HDL cholesterol; cognitive function; centarians
ID HIGH-DENSITY-LIPOPROTEIN; LEPTIN RESISTANCE; CALORIC RESTRICTION;
   VISCERAL ADIPOSITY; INSULIN-RESISTANCE; APOLIPOPROTEIN AI; WEIGHT-LOSS;
   FAT; AGE; PROTEIN
AB We hypothesize that age-related metabolic alterations originate in the brain (studies in rodents), and that the functional decline of the brain may be protected by a favorable metabolic profile (studies in human centenarians). The metabolic decline with aging is associated with a progressive increase in fat mass in mammals and caloric restriction enhances life span in rodents. Here we show that a diminished biological response to leptin is a feature of aging. Leptin is a fat derived peptide that decreases body weight, fat mass, improves insulin sensitivity and energy expenditure through its receptors in the hypothalamus. We examined the effects of exogenous leptin on several metabolic parameters as a function of aging in rats. A prolonged elevation in plasma leptin levels in aging rats failed to decrease food intake, total fat mass, and intra-abdominal fat. Furthermore, the effects of leptin on liver triglyceride content, on insulin action and insulin secretion were markedly decreased in these animals compared to young controls. Leptin's failure in this aging model suggests its role in age-associated body fat accumulation, fat distribution and insulin resistance. We propose that a central nervous system resistance to leptin is probably a primary event that leads to the metabolic syndrome of aging, especially when availability of calories is unrestricted. Families of centenarians often have extremely high levels of high-density lipoprotein (HDL), which may have neurological as well as cardiovascular protective effects during aging. Because HDL level declines with aging, we tested if centenarians with higher HDL levels have greater cognitive protection. HDL levels correlated significantly with mini-mental state score (MMSE) of the centenarian, and each decrease in HDL tertile was associated with significant decrease in MMSE. These data suggests that the appearance of cognitive dysfunction in centenarians is associated with a decline in HDL cholesterol. This underscores the protective effects of increased HDL cholesterol, and its role in longevity. Taken together, these data suggest a determinant role for brain in the metabolic decline of aging, and highlight the advantage of favorable metabolic profile on the protection of brain from age-related cognitive decline. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Albert Einstein Coll Med, Inst Aging Res, Dept Med, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Inst Aging Res, Dept Mol Genet, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine
RP Barzilai, N (corresponding author), Albert Einstein Coll Med, Inst Aging Res, Dept Med, Belfer Bldg 701,1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM barzilai@aecom.yu.edu
CR Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113
   Atzmon G, 2002, J GERONTOL A-BIOL, V57, pM712, DOI 10.1093/gerona/57.11.M712
   Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137
   Barnes CA, 2001, INT REV NEUROBIOL, V45, P339
   Barzilai N, 1999, J GERONTOL A-BIOL, V54, pB89, DOI 10.1093/gerona/54.3.B89
   Barzilai N, 1999, AM J PHYSIOL-ENDOC M, V277, pE291, DOI 10.1152/ajpendo.1999.277.2.E291
   Barzilai N, 2001, J AM GERIATR SOC, V49, P76, DOI 10.1046/j.1532-5415.2001.49013.x
   Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Barzilai N, 2001, J GERONTOL A-BIOL, V56, pM83, DOI 10.1093/gerona/56.2.M83
   Barzilai N, 1999, ANN NY ACAD SCI, V892, P58, DOI 10.1111/j.1749-6632.1999.tb07785.x
   BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488
   Bjorbæk C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501
   Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   FRAZE E, 1987, J AM GERIATR SOC, V35, P224, DOI 10.1111/j.1532-5415.1987.tb02313.x
   Gabriely I, 2002, DIABETES, V51, P1016, DOI 10.2337/diabetes.51.4.1016
   Griffin JH, 1999, J CLIN INVEST, V103, P219, DOI 10.1172/JCI5006
   HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777
   Hazzard William R., 1995, Am J Geriatr Cardiol, V4, P16
   Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568
   KAWANO M, 1995, CLIN CHIM ACTA, V239, P209, DOI 10.1016/0009-8981(95)06115-T
   Kotz CM, 1999, CLIN GERIATR MED, V15, P391
   KOUDINOV A, 1994, BIOCHEM BIOPH RES CO, V205, P1164, DOI 10.1006/bbrc.1994.2788
   KURIYAMA M, 1994, JPN J PSYCHIAT NEUR, V48, P589
   Li H, 1997, DIABETES, V46, P2035, DOI 10.2337/diabetes.46.12.2035
   Li H, 1998, AM J PHYSIOL-ENDOC M, V275, pE405, DOI 10.1152/ajpendo.1998.275.3.E405
   Ma XH, 2002, J GERONTOL A-BIOL, V57, pB225, DOI 10.1093/gerona/57.6.B225
   Maresh GA, 2001, LIFE SCI, V69, P67, DOI 10.1016/S0024-3205(01)01093-1
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7
   Perls TT, 1998, LANCET, V351, P1560, DOI 10.1016/S0140-6736(05)61126-9
   Qiu J, 2001, ENDOCRINOLOGY, V142, P348, DOI 10.1210/en.142.1.348
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   RENTSCH J, 1995, BIOCHEM BIOPH RES CO, V214, P131, DOI 10.1006/bbrc.1995.2266
   Rinn W E, 1988, J Geriatr Psychiatry Neurol, V1, P144, DOI 10.1177/089198878800100304
   Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074/jbc.272.44.27758
   Sánchez-Rodríguez M, 2000, ARCH MED RES, V31, P425, DOI 10.1016/S0188-4409(99)00079-X
   Scarpace PJ, 2000, NEUROPHARMACOLOGY, V39, P1872, DOI 10.1016/S0028-3908(00)00014-9
   SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66
   TORRE JC, 2000, BRAIN RES REV, V34, P119
   Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118
   *US DEP HHS, 1998, CD ROM SER CTR DIS C, V11
   Wang ZW, 2000, BIOCHEM BIOPH RES CO, V277, P20, DOI 10.1006/bbrc.2000.3615
   Wang ZW, 2001, FASEB J, V15, P108, DOI 10.1096/fj.00-0310com
   WILLIAMSON DF, 1995, AM J EPIDEMIOL, V141, P1128, DOI 10.1093/oxfordjournals.aje.a117386
   WILSON PWF, 1994, J GERONTOL, V49, pM252, DOI 10.1093/geronj/49.6.M252
   Xia P, 1999, J BIOL CHEM, V274, P33143, DOI 10.1074/jbc.274.46.33143
NR 49
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1566-2772
J9 CLIN NEUROSCI RES
JI Clin. Neurosci. Res.
PD JAN-FEB
PY 2003
VL 2
IS 5-6
BP 339
EP 344
DI 10.1016/S1566-2772(03)00011-2
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)
SC Neurosciences & Neurology
GA 713HV
UT WOS:000184852300010
DA 2024-02-19
ER

PT J
AU STAHLBERG, D
   ANGELIN, B
   EINARSSON, K
AF STAHLBERG, D
   ANGELIN, B
   EINARSSON, K
TI AGE-RELATED-CHANGES IN THE METABOLISM OF CHOLESTEROL IN RAT-LIVER
   MICROSOMES
SO LIPIDS
LA English
DT Article
ID LIPID-METABOLISM; 3-HYDROXY-3-METHYLGLUTARYL COENZYME;
   SERUM-CHOLESTEROL; INACTIVE FORMS; BILE-SALT; ABSORPTION; REDUCTASE
AB The effects of aging on the hepatic metabolism of cholesterol were studied in 1-, 6- and 24-month-old male Sprague-Dawley rats.  Microsomal 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity, which regulates cholesterol biosynthesis, decreased from 835 +/- 144 (SEM) pmol/min/mg protein in the youngest group to 219 +/- 34 and 205 +/- 53 pmol/min/mg protein (p < 0.001) in the 6- and 24-month-old groups, respectively.  Cholesterol 7-alpha-hydroxylase activity, which governs bile acid synthesis, was gradually reduced from 70 +/- 14 pmol/min/mg protein in the 1-month-old group to 32 +/- 7 and 16 +/- 3 pmol/min/mg protein (p < 0.05) in the 6- and 24-month-old groups, respectively.  Acyl coenzyme Axcholesterol acyltransferase activity, which catalyzes the esterification of cholesterol, averaged 431 +/- 47 and 452 +/- 48 pmol/min/mg protein in the 1- and 6-month-old groups, respectively, and was increased to 585 +/- 55 pmol/min/mg protein (p < 0.05) in the 24-month-old group.  The level of total cholesterol showed an age-related increase from 1.56 +/- 0.16 mg/g liver in the 1-month-old group to 1.70 +/- 0.15 and 2.20 +/- 0.19 mg/g liver (p < 0.05) in the 6- and 24-month-old groups, respectively.  The increase was mainly caused by an accumulation of esterified cholesterol.  We conclude that a marked decrease in HMG-CoA reductase occurs between 1 and 6 months of age; thereafter the enzyme activity stays unchanged.  The activity of cholesterol 7-alpha-hydroxylase decreases progressively and drastically with age, whereas the capacity for esterifying cholesterol increases slightly.  We speculate that the reduced conversion of cholesterol to bile acids may be one explanation of the age-related increase of plasma cholesterol seen in rats.
RP STAHLBERG, D (corresponding author), KAROLINSKA INST,HUDDINGE UNIV HOSP,DEPT MED,S-14186 HUDDINGE,SWEDEN.
CR ANGELIN B, 1984, J LIPID RES, V25, P1159
   ANGELIN B, 1987, AGING LIVER GASTROIN, P161
   BILLHEIMER JT, 1981, ANAL BIOCHEM, V111, P331, DOI 10.1016/0003-2697(81)90570-4
   BJORKHEM I, 1976, J LIPID RES, V17, P360
   BJORKHEM I, 1974, CLIN CHIM ACTA, V54, P185, DOI 10.1016/0009-8981(74)90236-8
   BJORKHEM I, 1985, COMPREHENSIVE BIOCH, P231
   BROWN MS, 1979, J BIOL CHEM, V254, P5144
   CARLSON LA, 1968, GERONTOLOGY, V14, P65, DOI 10.1159/000211644
   CHOI YS, 1987, MECH AGEING DEV, V41, P149, DOI 10.1016/0047-6374(87)90059-5
   CHOI YS, 1987, EXP GERONTOL, V22, P339, DOI 10.1016/0531-5565(87)90032-5
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   LESTER R, 1977, J CLIN INVEST, V59, P1009, DOI 10.1172/JCI108723
   LITTLE JM, 1980, AM J PHYSIOL, V239, pG319, DOI 10.1152/ajpgi.1980.239.4.G319
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MORISAKI N, 1984, GERONTOLOGY, V30, P13, DOI 10.1159/000212601
   SCHAFFER R, 1982, CLIN CHEM, V28, P5
   STAHLBERG D, 1989, J LIPID RES, V30, P953
   STANGE EF, 1984, J LIPID RES, V25, P703
   STORY JA, 1981, LIPIDS, V16, P87, DOI 10.1007/BF02535679
   STORY JA, 1976, LIPIDS, V11, P623, DOI 10.1007/BF02532876
   YAMAMOTO M, 1971, ATHEROSCLEROSIS, V13, P365, DOI 10.1016/0021-9150(71)90079-7
NR 21
TC 30
Z9 30
U1 0
U2 0
PU AMER OIL CHEMISTS SOC
PI CHAMPAIGN
PA 1608 BROADMOOR DRIVE, CHAMPAIGN, IL 61821-0489
SN 0024-4201
J9 LIPIDS
JI Lipids
PD MAY
PY 1991
VL 26
IS 5
BP 349
EP 352
DI 10.1007/BF02537197
PG 4
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA FM582
UT WOS:A1991FM58200004
PM 1895880
DA 2024-02-19
ER

PT J
AU Tsutsumi, T
   Nakano, D
   Kawaguchi, M
   Hashida, R
   Yoshinaga, S
   Takahashi, H
   Anzai, K
   Kawaguchi, T
AF Tsutsumi, Tsubasa
   Nakano, Dan
   Kawaguchi, Machiko
   Hashida, Ryuki
   Yoshinaga, Shinobu
   Takahashi, Hirokazu
   Anzai, Keizo
   Kawaguchi, Takumi
TI MAFLD associated with COPD via systemic inflammation independent of
   aging and smoking in men
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Metabolic associated fatty liver disease; Chronic obstructive pulmonary
   disease; Systemic inflammation; CRP; albumin ratio; Steatosis
ID OBSTRUCTIVE PULMONARY-DISEASE; FATTY LIVER-DISEASE; LUNG AGE;
   PREVALENCE; UPDATE; RISK
AB Background and aim Metabolic dysfunction and associated systemic inflammation are risk factors for chronic obstructive pulmonary disease (COPD) and COPD is highly prevalent in men. We investigated the impact of metabolic-associated fatty liver disease (MAFLD) and MAFLD-related systemic inflammation on COPD in men. Methods We enrolled 2,041 men with fatty liver. Patients were classified into the COPD (n = 420/2041) and non-COPD (n = 1621/2041) groups. COPD and its high-risk group were diagnosed using the Japanese Respiratory Society Disease statement. Systemic inflammation was evaluated using the C-reactive protein (CRP)/albumin ratio. Independent factors for COPD were investigated by multivariate analysis and decision-tree analysis. Results The prevalence of MAFLD was significantly higher in the COPD group than in the non-COPD group. In multivariable analysis, in addition to heavy smoking and aging, MAFLD was identified as an independent factor for COPD (OR 1.46, 95% CI 1.020-2.101, P = 0.0385). Decision-tree analysis showed that MAFLD, rather than heavy smoking, was the most influential classifier for COPD in non-elderly men (14% in MAFLD vs 6% in non-MAFLD groups). MAFLD was also the second most influential factor in elderly men who were not heavy smokers. In both groups, the CRP/albumin ratio was the first classifier for COPD (16% in the high CRP/albumin ratio group vs 3% in the low CRP/albumin ratio group of non-elderly men). Conclusions MAFLD is an independent predictor of COPD in men. MAFLD had a significant impact on COPD through systemic inflammation in men of all ages who were not heavy smokers. MAFLD may be useful to broadly identify COPD in men.
C1 [Tsutsumi, Tsubasa; Nakano, Dan; Kawaguchi, Machiko; Kawaguchi, Takumi] Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, Kurume, Fukuoka, Japan.
   [Hashida, Ryuki] Kurume Univ, Dept Orthoped, Sch Med, Kurume, Fukuoka, Japan.
   [Yoshinaga, Shinobu] Saga Prefectural Hlth Promot Fdn, Med Examinat Sect, Med Examinat Part Facil, Publ Util Fdn, Saga, Japan.
   [Takahashi, Hirokazu; Anzai, Keizo] Saga Univ, Fac Med, Div Metab & Endocrinol, Saga, Japan.
C3 Kurume University; Kurume University; Saga University
RP Tsutsumi, T (corresponding author), Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, Kurume, Fukuoka, Japan.
EM tsutsumi_tsubasa@med.kurume-u.ac.jp
RI 中野, 暖/IYJ-2642-2023
FU Research Program on Hepatitis from the Japan Agency for Medical Research
   and Development, AMED [JP21fk0210090]
FX This research was supported by the Research Program on Hepatitis from
   the Japan Agency for Medical Research and Development, AMED under Grant
   Number JP21fk0210090.
CR Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   Alcaraz-Quiles J, 2018, HEPATOLOGY, V68, P1937, DOI 10.1002/hep.30135
   [Anonymous], 2019, J Hypertens, V37, P456, DOI [DOI 10.1097/HJH.0000000000001961, 10.1097/HJH.0000000000002026, DOI 10.1097/HJH.0000000000002026]
   Bilgin S, 2021, PRIM CARE DIABETES, V15, P1071, DOI 10.1016/j.pcd.2021.08.015
   Brassington K, 2022, CLIN SCI, V136, P405, DOI 10.1042/CS20210835
   Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996
   Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC
   Chan SMH, 2019, PHARMACOL THERAPEUT, V198, P160, DOI 10.1016/j.pharmthera.2019.02.013
   Çolak Y, 2020, AM J RESP CRIT CARE, V201, P671, DOI 10.1164/rccm.201908-1644OC
   COPD guideline committee of the Japanese Respiratory Society, 2018, GUID DIAGN TRAETM CO
   Cosentino F, 2020, EUR HEART J, V41, P255, DOI 10.1093/eurheartj/ehz486
   Díez-Manglano J, 2014, INTERN EMERG MED, V9, P419, DOI 10.1007/s11739-013-0945-7
   Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC
   Dixon AE, 2008, LUNG, V186, P361, DOI 10.1007/s00408-008-9119-1
   Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x
   Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588
   Graham BL, 2019, AM J RESP CRIT CARE, V200, pE70, DOI 10.1164/rccm.201908-1590ST
   Haruki T, 2010, RESPIROLOGY, V15, P495, DOI 10.1111/j.1440-1843.2010.01708.x
   Hong KS, 2020, INT J CHRONIC OBSTR, V15, P1005, DOI 10.2147/COPD.S249534
   Kalyan S, 2010, PHARMACOTHERAPY, V30, P442, DOI 10.1592/phco.30.5.442
   Kawaguchi T, 2021, HEPATOL RES, V51, P1207, DOI 10.1111/hepr.13714
   Kawaguchi T, 2022, HEPATOL RES, V52, P422, DOI 10.1111/hepr.13706
   Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938
   Li HR, 2021, CLIN LAB, V67, P755, DOI 10.7754/Clin.Lab.2020.200630
   Liang YB, 2022, J CLIN ENDOCR METAB, V107, P88, DOI 10.1210/clinem/dgab641
   Lipovec NC, 2016, COPD, V13, P399, DOI 10.3109/15412555.2016.1140732
   Lonardo A, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00546-2017
   Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1016/j.atherosclerosis.2019.08.014, 10.1093/eurheartj/ehz455]
   Minakata Y, 2010, INTERNAL MED, V49, P2687, DOI 10.2169/internalmedicine.49.3948
   Mitsumune T, 2009, RESPIROLOGY, V14, P757, DOI 10.1111/j.1440-1843.2009.01541.x
   Moon SW, 2018, INT J CHRONIC OBSTR, V13, P2603, DOI 10.2147/COPD.S166902
   Naseem S, 2019, J FAM MED PRIM CARE, V8, P3393, DOI 10.4103/jfmpc.jfmpc_482_19
   Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO
   Ritchie AI, 2021, AM J RESP CRIT CARE, V204, P14, DOI 10.1164/rccm.202102-0253UP
   Shiha G, 2021, LANCET GASTROENTEROL, V6, P73, DOI 10.1016/S2468-1253(20)30294-6
   Soriano JB, 2000, THORAX, V55, P789, DOI 10.1136/thorax.55.9.789
   Starzer AM, 2021, BRIT J CANCER, V124, P1294, DOI 10.1038/s41416-020-01254-0
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Sun DQ, 2021, METABOLISM, V115, DOI 10.1016/j.metabol.2020.154433
   Tokushige K, 2021, J GASTROENTEROL, V56, P951, DOI 10.1007/s00535-021-01796-x
   Tsutsumi T, 2021, HEPATOL RES, V51, P1115, DOI 10.1111/hepr.13685
   Viglino D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01923-2016
   Yamamura S, 2020, LIVER INT, V40, P3018, DOI 10.1111/liv.14675
   Yamamura S, 2020, HEPATOL RES, V50, P199, DOI 10.1111/hepr.13436
   Ye LY, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181199
   ZHOU T, 2015, SCI REP-UK, V5, DOI DOI 10.1038/SREP10481
   Zhou W, 2020, CLIN RESPIR J, V14, P1159, DOI 10.1111/crj.13253
   Zinellu E, 2021, J CLIN MED, V10, DOI 10.3390/jcm10020269
NR 50
TC 4
Z9 4
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD AUG 16
PY 2022
VL 14
IS 1
AR 115
DI 10.1186/s13098-022-00887-w
PG 14
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 3U8TG
UT WOS:000841236700001
PM 35974418
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU CAPOZZA, G
   GUERRIERI, F
   VENDEMIALE, G
   ALTOMARE, E
   PAPA, S
AF CAPOZZA, G
   GUERRIERI, F
   VENDEMIALE, G
   ALTOMARE, E
   PAPA, S
TI AGE-RELATED-CHANGES OF THE MITOCHONDRIAL ENERGY-METABOLISM IN RAT-LIVER
   AND HEART
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE ATP SYNTHASE; OXIDATIVE PHOSPHORYLATION; FREE RADICALS; GLUTATHIONE
ID HYDROGEN-PEROXIDE; GENERATION; INACTIVATION; GLUTATHIONE; OXYGEN; ATPASE
AB The influence of aging on mitochondrial energy metabolism of rat liver and rat heart has been studied by analysis of (i) respiratory rate of succinate-supplemented mitochondria in state III (coupled state in the presence of ADP + Pi); (ii) the rate of synthesis of ATP in succinate-supplemented mitochondria; (iii) the ATP hydrolase activity of sonicated submitochondrial particles. The results indicate a decrease of the F0F1-ATP synthase activity in mitochondria isolated from both organs of aged (24-month-old) as compared to young (3-month-old) rats which was accompanied by a decrease of immunodetected amount of the beta-F-1 (subunit of the catalytic F-1 sector of F0F1-ATP synthase). These effects were more evident in heart than in liver mitochondria. Analysis of the mitochondrial content of glutathione (GSH), an essential intracellular antioxidant agent, shows a decrease in mitochondria of both tissues of aged animals. Exposure of submitochondrial particles to free radicals, produced either by Co-60 or by respirtory chain (in presence of the inhibitor antimycin A) mimicked the alterations of F0F1 ATP synthase observed in submitochondrial particles of aged rats. The possible relationship between aging process, free radical production and alteration of mitochondrial oxidative phosphorylation is discussed.
C1 UNIV BARI, INST CLIN MED, I-70124 BARI, ITALY.
   POLICLIN BARI, CNR, CTR STUDY MITOCHONDRIA & ENERGY METAB, I-70124 BARI, ITALY.
C3 Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle
   Ricerche (CNR); Universita degli Studi di Bari Aldo Moro
RP CAPOZZA, G (corresponding author), POLICLIN BARI, CNR, INST MED BIOCHEM & CHEM, PIAZZA G CESARE, I-70124 BARI, ITALY.
OI Papa, Sergio/0000-0002-4417-1763
CR BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435
   BRANDY B, 1990, FREE RADIC BIOL MED, V8, P523
   BUSTAMANTE E, 1977, ANAL BIOCHEM, V80, P401, DOI 10.1016/0003-2697(77)90661-3
   Emerit I., 1992, FREE RADICALS AGING
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   GUERRIERI F, 1989, ORGANELLES IN EUKARYOTIC CELLS, P197
   GUERRIERI F, 1992, ANN NY ACAD SCI, V671, P395, DOI 10.1111/j.1749-6632.1992.tb43813.x
   GUERRIERI F, 1992, ARCH GERONTOL GERIAT, V14, P299, DOI 10.1016/0167-4943(92)90029-4
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   KIM JH, 1988, MECH AGEING DEV, V46, P279, DOI 10.1016/0047-6374(88)90130-3
   LEE CP, 1968, EUR J BIOCHEM, V3, P391, DOI 10.1111/j.1432-1033.1967.tb19542.x
   LIPPE G, 1991, BIOCHEM BIOPH RES CO, V181, P764, DOI 10.1016/0006-291X(91)91256-C
   LOW H, 1963, BIOCHIM BIOPHYS ACTA, V69, P361, DOI 10.1016/0006-3002(63)91269-1
   MASINI A, 1992, BIOCHIM BIOPHYS ACTA, V1101, P84, DOI 10.1016/0167-4838(92)90471-O
   MIQUEL J, 1986, FREE RADICALS AGING, P51
   NOHL H, 1986, BIOCHEM BIOPH RES CO, V138, P533, DOI 10.1016/S0006-291X(86)80529-0
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   PAPA S, 1969, BIOCHIM BIOPHYS ACTA, V172, P184, DOI 10.1016/0005-2728(69)90106-6
   RICHIE JP, 1992, EXP GERONTOL, V27, P615, DOI 10.1016/0531-5565(92)90015-R
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   ZHANG Y, 1990, J BIOL CHEM, V265, P16330
   ZSNAGY I, 1978, J THEOR BIOL, V75, P189, DOI 10.1016/0022-5193(78)90230-8
NR 25
TC 7
Z9 8
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PY 1994
SU 4
BP 31
EP 38
DI 10.1016/S0167-4943(05)80045-7
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA NK652
UT WOS:A1994NK65200005
PM 18649840
DA 2024-02-19
ER

PT J
AU Tang, XL
   Xu, MJ
   Li, ZH
   Pan, Q
   Fu, JH
AF Tang, Xue-Lian
   Xu, Min-Jun
   Li, Zhi-Hua
   Pan, Qing
   Fu, Jing-Hua
TI Effects of vitamin E on expressions of eight microRNAs in the liver of
   Nile tilapia (<i>Oreochromis niloticus</i>)
SO FISH & SHELLFISH IMMUNOLOGY
LA English
DT Article
DE Vitamin E; Antioxidant responses; microRNA; Target; Nile tilapia
ID OXIDATIVE STRESS; FREE-RADICALS; IN-VIVO; MECHANISMS; ANTIOXIDANTS;
   SENESCENCE; DISEASE; HEALTH
AB Currently, microRNAs (miRNAs) are known to regulate cellular processes such as apoptosis, differentiation, cell cycle, and immune functions, and their expression can be altered by distinct stress conditions, such as oxidative stress. In immune systems of fish, vitamin E (VE) has a defined role as an antioxidant. In order to understand the molecular mechanism of vitamin E defending from oxidative stress, three groups of juvenile Nile tilapia (Oreochromis niloticus) (initial weight 3.25 +/- 0.02 g) were fed to satiation with 3 semi-purified diets containing VE (DL-alpha-tocopherol acetate) of 0, 50, and 2500 mg/kg supplementation, respectively, with the expressions of eight miRNAs (miR-21, miR-223, miR-146a, miR-125b, miR-181a, miR-16, miR-155 and miR-122) in the liver of tilapia subsequently detected after 8-week growth experiment. Results showed that VE-deficient (0 mg/kg supplementation) decreased the activity of superoxide dismutase (SOD), and decreased the expressions of miR-223, miR-146a, miR-16 and miR-122, while excessive supplementation of VE (2500 mg/kg) decreased SOD activity and increased the expressions of all the eight miRNAs. The targets of the eight miRNAs were further predicated with bioinformatic approach and the possible regulating mechanisms of VE via miRNAs were analyzed. The present study confirmed that the differences in dietary VE affected expression of hepatic miRNAs which may partly demonstrate the molecular mechanism of VE, and the new idea of introducing miRNAs into research will provide the basic data for researches of molecular nutrition. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Tang, Xue-Lian; Li, Zhi-Hua; Pan, Qing; Fu, Jing-Hua] South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China.
   [Xu, Min-Jun] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, Lanzhou 730046, Gansu, Peoples R China.
C3 South China Agricultural University; Chinese Academy of Agricultural
   Sciences; Lanzhou Veterinary Research Institute, CAAS
RP Fu, JH (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China.
EM mjxu@yahoo.cn; fujinghua@scau.edu.cn
FU National Natural Science Foundation of China [31001117]; Project on the
   Integration of Industry, Education and Research of Guangdong Province;
   Education Ministry of China [2012B091100421]
FX This work was supported by grants from the National Natural Science
   Foundation of China (31001117) and the Project on the Integration of
   Industry, Education and Research of Guangdong Province and the Education
   Ministry of China (2012B091100421).
CR [Anonymous], 5009822003 GBT
   [Anonymous], 1989, VITAMIN
   Bai XY, 2011, J AM SOC NEPHROL, V22, P1252, DOI 10.1681/ASN.2010040367
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bollati V, 2010, ENVIRON HEALTH PERSP, V118, P763, DOI 10.1289/ehp.0901300
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Chan AC, 1998, J NUTR, V128, P1593, DOI 10.1093/jn/128.10.1593
   Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178
   Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008
   Combs GF, 2012, VITAMINS: FUNDAMENTAL ASPECTS IN NUTRITION AND HEALTH, 4TH EDITION, P181, DOI 10.1016/B978-0-12-381980-2.00007-4
   Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832
   Devaraj S, 1996, J CLIN INVEST, V98, P756, DOI 10.1172/JCI118848
   DRAPER HH, 1993, FREE RADICAL BIO MED, V15, P353, DOI 10.1016/0891-5849(93)90035-S
   Elamin BK, 2011, MUTAT RES-FUND MOL M, V717, P67, DOI 10.1016/j.mrfmmm.2011.03.015
   Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005
   Fu JH, 2007, J SHELLFISH RES, V26, P809, DOI 10.2983/0730-8000(2007)26[809:EOVEOA]2.0.CO;2
   Gaedicke S, 2008, FEBS LETT, V582, P3542, DOI 10.1016/j.febslet.2008.09.032
   Hou LF, 2011, MUTAT RES-FUND MOL M, V714, P105, DOI 10.1016/j.mrfmmm.2011.05.004
   Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384
   Kiron V, 2004, AQUACULTURE, V234, P361, DOI 10.1016/j.aquaculture.2003.11.026
   Kovacic P, 2001, CURR MED CHEM, V8, P773, DOI 10.2174/0929867013373084
   Krüger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243
   Krützfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154
   Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027
   Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200
   Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42
   Manca S, 2011, EXP DERMATOL, V20, P932, DOI 10.1111/j.1600-0625.2011.01359.x
   Marchioli R, 1999, PHARMACOL RES, V40, P227, DOI 10.1006/phrs.1999.0480
   Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512
   MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5
   National Research Council (NRC), 1993, NUTR REQ FISH, P7
   NRC, 2011, NUTR REQ FISH SHRIMP, DOI [10.1007/s10499-011-9480-6, DOI 10.1007/S10499-011-9480-6, 10.17226/13039, DOI 10.17226/13039]
   Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012
   Pogue AI, 2009, J INORG BIOCHEM, V103, P1591, DOI 10.1016/j.jinorgbio.2009.05.012
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Vasu VT, 2007, FEBS LETT, V581, P1572, DOI 10.1016/j.febslet.2007.03.017
   Wang Z, 2010, BRAIN RES, V1346, P14, DOI 10.1016/j.brainres.2010.05.059
   WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6
   Xu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-521
NR 41
TC 33
Z9 38
U1 0
U2 49
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1050-4648
EI 1095-9947
J9 FISH SHELLFISH IMMUN
JI Fish Shellfish Immunol.
PD JUN
PY 2013
VL 34
IS 6
BP 1470
EP 1475
DI 10.1016/j.fsi.2013.03.353
PG 6
WC Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences
GA 154BI
UT WOS:000319646100010
PM 23542605
DA 2024-02-19
ER

PT J
AU de Grey, ADNJ
AF de Grey, ADNJ
TI Noncorrelation between maximum life span and antioxidant enzyme levels
   among homeotherms: Implications for retarding human aging
SO JOURNAL OF ANTI-AGING MEDICINE
LA English
DT Article
ID EXTRACELLULAR-SUPEROXIDE-DISMUTASE; MITOCHONDRIAL RESPIRATORY-CHAIN;
   FREE-RADICAL PRODUCTION; HUMAN SKELETAL-MUSCLE; CAENORHABDITIS-ELEGANS;
   OXIDATIVE STRESS; RAT-LIVER; HEART-MITOCHONDRIA; DNA MUTATIONS;
   MOTOR-NEURONS
AB A series of studies over many years has conclusively disproved the hypothesis that longevity in warm-blooded animals (homeotherms) correlates with high levels of antioxidant enzymes: in fact, these variables generally exhibit a strong negative cross-species correlation. in flies and nematodes, however, substantial extension of maximum life span has resulted from genetic manipulations that increase antioxidant enzyme levels; these manipulations have always been associated with increased resistance to oxidative challenge, indicating that the life span extension is directly caused by the raised antioxidant capacity. This stark contrast merits careful analysis because it casts doubt on the value of short-lived invertebrates as models for the investigation of mammalian aging. Here is it shown that these results imply the existence, in homeotherms but not in flies or worms, of life span-limiting pathways of oxidative damage that are impervious to enzymatic antioxidants. This is shown to lend weight to the currently controversial theory that somatic mitochondrial DNA mutations contribute significantly to determining the rate of aging of homeotherms, and thereby suggests a feasible intervention to retard human aging.
C1 Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England.
C3 University of Cambridge
RP de Grey, ADNJ (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.
EM ag24@gen.cam.ac.uk
CR ALTMAN PL, 1972, BIOL DATA BOOK, P1804
   AUSTAD SN, 1991, J GERONTOL, V46, pB47, DOI 10.1093/geronj/46.2.B47
   AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x
   Balzan R, 1999, BIOCHEM BIOPH RES CO, V256, P63, DOI 10.1006/bbrc.1999.0285
   BARJA G, 1994, COMP BIOCHEM PHYS B, V108, P501, DOI 10.1016/0305-0491(94)90103-1
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   CALLEJA M, 1993, J BIOL CHEM, V268, P18891
   CARLSSON LM, 1995, P NATL ACAD SCI USA, V92, P6264, DOI 10.1073/pnas.92.14.6264
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cutler R G, 1985, Basic Life Sci, V35, P15
   CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S
   Cutler RG, 1986, PHYSL OXYGEN RADICAL, P251
   De Grey A.D.N.J., 1998, EUR RESPIR J, V1, P53, DOI [10.1089/rej.1.1998.1.53, DOI 10.1089/REJ.1.1998.1.53]
   de Grey ADNJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P295, DOI 10.1006/abbi.1999.1509
   DEGREY ADN, 1999, SYMBIOSIS EUKARYOTIS, V7, P489
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   DEJONG AMP, 1994, EUR J BIOCHEM, V222, P975
   ECHEVERRIA M, 1991, PLANT MOL BIOL, V16, P301, DOI 10.1007/BF00020561
   EDNEY EB, 1968, NATURE, V220, P281, DOI 10.1038/220281a0
   EDRIS W, 1994, MUTAT RES-DNAGING G, V316, P69, DOI 10.1016/0921-8734(94)90009-4
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   GELLER BL, 1982, J BIOL CHEM, V257, P8945
   Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hayakawa M, 1996, BIOCHEM BIOPH RES CO, V226, P369, DOI 10.1006/bbrc.1996.1363
   Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6
   HOEBEN P, 1993, MED HYPOTHESES, V41, P131, DOI 10.1016/0306-9877(93)90058-X
   HOLMES DJ, 1995, J GERONTOL A-BIOL, V50, pB59, DOI 10.1093/gerona/50A.2.B59
   Kappus H, 1985, OXIDATIVE STRESS, P273, DOI [DOI 10.1016/B978-0-12-642760-8.50016-8, 10.1016/b978-0-12-642760-8.50016-8]
   Kerver ED, 1997, HISTOCHEM J, V29, P229, DOI 10.1023/A:1026453926517
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083
   KOBAYASHI K, 1995, ENDOCR J, V42, P461, DOI 10.1507/endocrj.42.461
   Kovalenko SA, 1997, BIOCHEM BIOPH RES CO, V232, P147, DOI 10.1006/bbrc.1997.6251
   Kowald A, 1999, EXP GERONTOL, V34, P605, DOI 10.1016/S0531-5565(99)00011-X
   KU HH, 1993, MECH AGEING DEV, V72, P67, DOI 10.1016/0047-6374(93)90132-B
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Lightowlers RH, 1999, TRENDS GENET, V15, P91, DOI 10.1016/S0168-9525(98)01684-9
   Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943
   LIOU W, 1993, FREE RADICAL BIO MED, V14, P201, DOI 10.1016/0891-5849(93)90011-I
   Long MY, 1996, P NATL ACAD SCI USA, V93, P7727, DOI 10.1073/pnas.93.15.7727
   LOPEZTORRES M, 1993, MECH AGEING DEV, V70, P177, DOI 10.1016/0047-6374(93)90047-U
   MARKLUND SL, 1984, BIOCHEM J, V222, P649, DOI 10.1042/bj2220649
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6
   MONNIER VM, 1991, GERONTOLOGY, V37, P152
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   MullerHocker J, 1996, MECH AGEING DEV, V86, P197, DOI 10.1016/0047-6374(95)01692-9
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2
   Pamplona R, 1998, J LIPID RES, V39, P1989
   Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534
   Pearl R., 1928, RATE LIVING
   PEREZCAMPO R, 1994, J COMP PHYSIOL B, V163, P682, DOI 10.1007/BF00369520
   PEREZCAMPO R, 1993, COMP BIOCHEM PHYS B, V105, P749, DOI 10.1016/0305-0491(93)90116-M
   Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43
   Rubner M., 1908, PROBLEM LEBENSDAUER
   Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Sun JT, 1999, MOL CELL BIOL, V19, P216
   TOLMASOFF JM, 1980, P NATL ACAD SCI-BIOL, V77, P2777, DOI 10.1073/pnas.77.5.2777
   TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0
   Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887
   VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wallace DC, 1995, LIFE SCI R, V56, P199
   WEISIGER RA, 1973, J BIOL CHEM, V248, P4793
NR 78
TC 10
Z9 10
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1094-5458
J9 J ANTI-AGING MED
JI J. Anti-Aging Med.
PD SPR
PY 2000
VL 3
IS 1
BP 25
EP 36
DI 10.1089/rej.1.2000.3.25
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 344LZ
UT WOS:000088761500005
DA 2024-02-19
ER

PT J
AU Peng, FC
   Jian, WC
   Edwards, RJ
AF Peng, FC
   Jian, WC
   Edwards, RJ
TI Profile of territrem metabolism and cytochrome P-450 3A expression in
   liver microsomes from Wistar rats of both genders as a function of age
SO JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; SEX-RELATED CHANGES; DRUG-METABOLISM;
   DEPENDENT EXPRESSION; ASPERGILLUS-TERREUS; FEMALE RATS; HEPATIC
   CYTOCHROME-P-450; TREMORGENIC MYCOTOXINS; ENZYME SYSTEMS; MESSENGER-RNAS
AB This study determined territrem metabolites after incubation of territrem A, B, or C with NADPH and liver microsomes from Wistar rat of both genders aged 2 to 76 wk. The liver microsomal cytochrome P-450 content, NADPH-cytochrome P-450 reductase activity, and CYP3A1 and CYP3A2 protein and mRNA levels were also analyzed. Male rats had significantly higher liver microsomal cytochrome P-450 content and NADPH-cytochrome P-450 reductase activities than females at 14 to 26 wk. Microsomal cytochrome P-450 content was decreased in senescence in both genders compared with postpubertal and adulthood stages. The activity of 6 beta-testosterone hydroxylase in male rats, which was significantly higher than those in females at all ages, decreased after 52 wk. After 26 wk, the levels of CYP3A1 protein markely declined in both genders, which resulted in a large gender difference (male greater than female). The protein levels and mRNA of CYP3A2 were constitutively expressed in 2- to 52-wk-old male rats, but they decreased after 76 wk, and decreased in females after 6 wk. The expression of CYP3A1 or CYP3A2 in males are generally higher than in females. The metabolites of territrems MA(1), MAX, MA(2), MB2, MB4, and MC were measured by high-performance chromatography (HPLC). Formation of MA(1), MAX, and MA(2) decreased after 52 wk in males, and MAX and MA, were not formed after 6 wk in females. The amount of MB2 formed in females was less than in males, but the amount of MC (TRC metabolites) formed in females was higher than in males. The gender differences in metabolism of TRA were related to the protein and mRNA expression of CYP3A2. The protein levels and mRNA expression of CYP3A2 and efficiency of territrems metabolism were decreased after 76 wk. The results suggested that the effects of age and gender on territrem metabolism are due to differences in CYP3A1 and CYP3A2 expression in the liver microsomes.
C1 Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10018, Taiwan.
   Imperial Coll Sch Med, London, England.
C3 National Taiwan University; Imperial College London
RP Peng, FC (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, 1,Sect 1 Jen Ai Rd, Taipei 10018, Taiwan.
EM fcpeng@ha.mc.ntu.edu.tw
OI PENG, FU-CHUO/0000-0003-4385-8499
CR ALEXANDER WW, 1983, J BIOL CHEM, V258, P8839
   ALVARES AP, 1970, MOL PHARMACOL, V6, P206
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P299, DOI 10.1016/0531-5565(78)90038-4
   BONATE PL, 1991, J CLIN PHARMACOL, V31, P684, DOI 10.1002/j.1552-4604.1991.tb03760.x
   Burczynski ME, 2001, DRUG METAB DISPOS, V29, P1243
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1211, DOI 10.3109/00498258809042245
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   GONZALEZ FJ, 1986, MOL CELL BIOL, V6, P2969, DOI 10.1128/MCB.6.8.2969
   GONZALEZ FJ, 1985, J BIOL CHEM, V260, P7435
   HSEU TH, 1982, CRYST STRUCT COMMUN, V11, P199
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KATO R, 1968, JPN J PHARMACOL, V18, P389, DOI 10.1254/jjp.18.389
   KATO R, 1982, XENOBIOTICA, V12, P787, DOI 10.3109/00498258209038950
   KATO R, 1968, JPN J PHARMACOL, V18, P381, DOI 10.1254/jjp.18.381
   KIRITA S, 1993, ARCH BIOCHEM BIOPHYS, V307, P253, DOI 10.1006/abbi.1993.1587
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   KOMORI M, 1994, J BIOCHEM-TOKYO, V116, P114, DOI 10.1093/oxfordjournals.jbchem.a124482
   LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X
   LEE SS, 1992, J NAT PROD, V55, P251
   Lin J, 2003, J AAPOS, V7, P66, DOI 10.1016/S1091-8531(02)42006-X
   LING KH, 1991, DRUG METAB DISPOS, V19, P587
   LING KH, 1994, J TOXICOL-TOXIN REV, V13, P243, DOI 10.3109/15569549409089963
   LING KH, 1984, APPL ENVIRON MICROB, V47, P98, DOI 10.1128/AEM.47.1.98-100.1984
   LING KH, 1979, APPL ENVIRON MICROB, V37, P355, DOI 10.1128/AEM.37.3.355-357.1979
   LING KH, 1988, J BIOMED LAB SCI, V1, P28
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAEDA K, 1984, BIOCHEM PHARMACOL, V33, P509, DOI 10.1016/0006-2952(84)90252-1
   Mahnke Z, 1997, ARCH BIOCHEM BIOPHYS, V337, P62, DOI 10.1006/abbi.1996.9752
   Matsubara T, 2004, J PHARMACOL EXP THER, V309, P1282, DOI 10.1124/jpet.103.061671
   Morris DL, 1996, BIOCHEM PHARMACOL, V52, P781, DOI 10.1016/0006-2952(96)00390-5
   Nagata K, 1996, PHARMACOGENETICS, V6, P103, DOI 10.1097/00008571-199602000-00009
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   Peng FC, 2003, J TOXICOL ENV HEAL A, V66, P1237, DOI 10.1080/15287390306408
   Peng FC, 2002, J TOXICOL ENV HEAL A, V65, P2163, DOI 10.1080/00984100290071531
   Peng FC, 1997, J NAT PROD, V60, P842, DOI 10.1021/np9701236
   Peng FC, 2001, J TOXICOL ENV HEAL A, V64, P661, DOI 10.1080/152873901753246250
   Peng FC, 2001, J TOXICOL ENV HEAL A, V64, P579, DOI 10.1080/15287390152627255
   Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013
   PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652
   RIBEIRO V, 1992, ARCH BIOCHEM BIOPHYS, V293, P147, DOI 10.1016/0003-9861(92)90377-9
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   ROBINSON RC, 1990, ARCH BIOCHEM BIOPHYS, V277, P42, DOI 10.1016/0003-9861(90)90547-C
   Sakuma T, 2002, ARCH BIOCHEM BIOPHYS, V404, P234, DOI 10.1016/S0003-9861(02)00329-6
   SCHENKMAN JB, 1989, DRUG METAB REV, V20, P557, DOI 10.3109/03602538909103562
   SCHMUCKER DL, 1978, PHARMACOL REV, V30, P445
   SHIMADA M, 1989, J BIOCHEM-TOKYO, V106, P1030, DOI 10.1093/oxfordjournals.jbchem.a122959
   Shimamoto A, 1999, RES COMMUN MOL PATH, V104, P265
   SOUCEK P, 1992, XENOBIOTICA, V22, P83
   STROTKAMP D, 1995, BBA-GENE STRUCT EXPR, V1260, P341, DOI 10.1016/0167-4781(94)00244-W
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Wang HM, 1996, BIOCHEM BIOPH RES CO, V221, P157, DOI 10.1006/bbrc.1996.0562
   Warrington JS, 2000, J PHARMACOL EXP THER, V292, P1024
   WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023
   Xu ZM, 2001, BIOCHEM PHARMACOL, V62, P1283, DOI 10.1016/S0006-2952(01)00776-6
   Yamane H, 2000, MATER SCI RES INT, V6, P104
NR 56
TC 4
Z9 6
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1528-7394
EI 1087-2620
J9 J TOXICOL ENV HEAL A
JI J. Toxicol. Env. Health Part A
PD NOV 12
PY 2005
VL 68
IS 21
BP 1871
EP 1888
DI 10.1080/15287390500226763
PG 18
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 972UR
UT WOS:000232479200004
PM 16207635
DA 2024-02-19
ER

PT J
AU CORBISIER, P
   REMACLE, J
AF CORBISIER, P
   REMACLE, J
TI INFLUENCE OF THE ENERGETIC PATTERN OF MITOCHONDRIA IN CELL AGING
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE MITOCHONDRIA; ENERGY; MICROINJECTION; HOMEOSTASIS
ID LIVER-MITOCHONDRIA; LIPID-COMPOSITION; DNA MUTATION; RESPIRATION; RAT;
   HEART; DEGENERATION; SEQUENCE; CARRIER; BRAIN
AB Injections of mitochondria isolated from liver of young or old rats have been performed in young or old WI-38 human fibroblasts and the survival of the injected cells was followed with time. Cells having received young mitochondria behave as the control non-injected cells while cells having received old mitochondria showed signs of degeneration after a few days. Such a behaviour could however be obtained with young mitochondria when partially uncoupled. The negative effect of the presence of uncoupled mitochondria could be overcome by addition of a ketone body: D(-)beta-hydroxybutyrate. When comparisons were performed between injected young and old fibroblasts, old cells were found less efficient in counteracting the presence of uncoupled mitochondria. These results clearly indicate that old cells contain partly altered mitochondria which are less able to fulfil their energy requirement so that a general lowering of homeostasis but also an increased susceptibility, toward unfavorable situations is obtained.
C1 FAC UNIV NOTRE DAME PAIX,61 RUE BRUXELLES,B-5000 NAMUR,BELGIUM.
C3 University of Namur
CR ABUERREISH GM, 1978, MECH AGEING DEV, V7, P425, DOI 10.1016/0047-6374(78)90083-0
   ANSORGE W, 1982, EXP CELL RES, V140, P31, DOI 10.1016/0014-4827(82)90152-5
   ARHEIM N, 1992, MUTAT RES, V275, P157
   ASANO K, 1991, MECH AGEING DEV, V60, P275, DOI 10.1016/0047-6374(91)90040-7
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BENZI G, 1990, NEUROCHEM RES, V16, P659
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   CHANCE B, 1955, NATURE, V175, P1120, DOI 10.1038/1751120a0
   CHEN JC, 1972, J CELL PHYSIOL, V80, P141, DOI 10.1002/jcp.1040800115
   CHIU YJD, 1980, EXP GERONTOL, V15, P511, DOI 10.1016/0531-5565(80)90003-0
   CORBISIER P, 1990, EUR J CELL BIOL, V51, P173
   DARNOLD JR, 1990, MECH AGEING DEV, V53, P157, DOI 10.1016/0047-6374(90)90067-P
   FARMER KJ, 1989, FREE RADICAL BIO MED, V7, P23, DOI 10.1016/0891-5849(89)90096-8
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   GUPTA KP, 1990, MUTAT RES, V237, P17, DOI 10.1016/0921-8734(90)90028-P
   HRUSZKEWYCZ AM, 1992, MUTAT RES, V275, P243, DOI 10.1016/0921-8734(92)90028-N
   JI LL, 1990, AM J PHYSIOL, V258, P918
   JI LL, 1991, AM J PHYSIOL, V261, P386
   KATAYAMA M, 1991, BIOCH INT, V25, P45
   LEPRAT P, 1990, MECH AGEING DEV, V52, P149, DOI 10.1016/0047-6374(90)90121-U
   LINNANE AW, 1992, MUTAT RES, V275, P195, DOI 10.1016/0921-8734(92)90023-I
   MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510X(90)90006-9
   NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x
   PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H
   PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2
   REMACLE J, 1979, BIOCHIM BIOPHYS ACTA, V630, P57
   REMACLE J, 1990, THEORETICAL BASIS AG
   RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   TAUCHI H, 1980, MECH AGEING DEV, V12, P7, DOI 10.1016/0047-6374(80)90023-8
   TORII K, 1992, AM J RESP CELL MOL, V6, P88, DOI 10.1165/ajrcmb/6.1.88
   TOUSSAINT O, 1991, MECH AGEING DEV, V61, P45, DOI 10.1016/0047-6374(91)90006-L
   TUMMINO PJ, 1991, MECH AGEING DEV, V59, P177, DOI 10.1016/0047-6374(91)90083-C
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
   WILSON PD, 1975, GERONTOLOGY, V21, P81, DOI 10.1159/000212035
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P944
NR 43
TC 18
Z9 18
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD OCT 1
PY 1993
VL 71
IS 1-2
BP 47
EP 58
DI 10.1016/0047-6374(93)90034-O
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA MD032
UT WOS:A1993MD03200005
PM 8309283
DA 2024-02-19
ER

PT J
AU Navarro, A
   Gómez, C
   Sánchez-Pino, MJ
   González, H
   Bández, MJ
   Boveris, AD
   Boveris, A
AF Navarro, A
   Gómez, C
   Sánchez-Pino, MJ
   González, H
   Bández, MJ
   Boveris, AD
   Boveris, A
TI Vitamin E at high doses improves survival, neurological performance, and
   brain mitochondrial function in aging male mice
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE mitochondrial nitric oxide synthase; mitochondrial respiration; complex
   I; complex IV; oxidative damage
ID NITRIC-OXIDE; OXIDATIVE STRESS; LIPID-PEROXIDATION; COGNITIVE FUNCTION;
   ALPHA-TOCOPHEROL; ANTIOXIDANT; LIVER; OXYGEN; DAMAGE; TRIAL
AB Male mice receiving vitamin E (5.0 g alpha-tocopherol acetate/kg of food) from 28 wk of age showed a 40% increased median life span, from 61 +/- 4 wk to 85 +/- 4 wk, and 17% increased maximal life span, whereas female mice equally supplemented exhibited only 14% increased median life span. The alpha-tocopherol content of brain and liver was 2.5-times and 7-times increased in male mice, respectively. Vitamin E-supplemented male mice showed a better performance in the tightrope ( neuromuscular function) and the T-maze ( exploratory activity) tests with improvements of 9-24% at 52 wk and of 28-45% at 78 wk. The rates of electron transfer in brain mitochondria, determined as state 3 oxygen uptake and as NADH-cytochrome c reductase and cytochrome oxidase activities, were 16-25% and 35-38% diminished at 52-78 wk. These losses of mitochondrial function were ameliorated by vitamin E supplementation by 37-56% and by 60-66% at the two time points considered. The activities of mitochondrial nitric oxide synthase and Mn-SOD decreased 28-67% upon aging and these effects were partially (41-68%) prevented by vitamin E treatment. Liver mitochondrial activities showed similar effects of aging and of vitamin E supplementation, although less marked. Brain mitochondrial enzymatic activities correlated negatively with the mitochondrial content of protein and lipid oxidation products (r(2) = 0.58 - 0.99, P < 0.01), and the rates of respiration and of complex I and IV activities correlated positively (r(2) = 0.74 - 0.80, P < 0.01) with success in the behavioral tests and with maximal life span.
C1 Univ Cadiz, Sch Med, Dept Biochem & Mol Biol, Cadiz, Spain.
   Univ Buenos Aires, Sch Pharm & Biochem, Lab Free Rad Biol, Buenos Aires, DF, Argentina.
C3 Universidad de Cadiz; University of Buenos Aires
RP Navarro, A (corresponding author), Fac Med, Dept Bioquim & Biol Mol, Plaza Fragela 9, Cadiz 11003, Spain.
EM ana.navarro@uca.es
RI Gómez-Gómez, Carmen/AAN-2273-2020
OI Bandez Ruiz, Manuel Jesus/0000-0002-6128-8752; Gomez Gomez,
   Carmen/0000-0002-9619-5927
CR AZNAIZ MR, 2004, EUR J NUTR S1, V43, pI18
   Azzi A, 2002, FEBS LETT, V519, P8, DOI 10.1016/S0014-5793(02)02706-0
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bickford PC, 1999, MECH AGEING DEV, V111, P141, DOI 10.1016/S0047-6374(99)00063-9
   Blackett A D, 1981, Age Ageing, V10, P191, DOI 10.1093/ageing/10.3.191
   Boveris A, 2003, ANTIOXID REDOX SIGN, V5, P265, DOI 10.1089/152308603322110841
   Boveris A, 2002, METHOD ENZYMOL, V359, P328
   Boveris A, 1999, METHOD ENZYMOL, V301, P188
   Boveris A, 2000, IUBMB LIFE, V50, P245, DOI 10.1080/15216540051080912
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919
   Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200
   Ferrari R, 1983, Acta Vitaminol Enzymol, V5, P11
   FINCH CE, 1990, LONGEVITY SENESENCE
   Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765
   FRAGA CG, 1988, FREE RADICAL BIO MED, V4, P155, DOI 10.1016/0891-5849(88)90023-8
   GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623
   Ghafourifar P, 1997, FEBS LETT, V418, P291, DOI 10.1016/S0014-5793(97)01397-5
   GILAD GM, 1995, MECH AGEING DEV, V78, P75, DOI 10.1016/0047-6374(94)01529-U
   Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038
   GONZALEZFLECHA B, 1993, J CLIN INVEST, V91, P456, DOI 10.1172/JCI116223
   Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Ibrahim WH, 2000, J NUTR, V130, P2343, DOI 10.1093/jn/130.9.2343
   INGOLD KU, 1987, ARCH BIOCHEM BIOPHYS, V259, P224, DOI 10.1016/0003-9861(87)90489-9
   Junqueira VBC, 2000, FREE RADICAL RES, V33, P313, DOI 10.1080/10715760000301481
   Liu JK, 2002, P NATL ACAD SCI USA, V99, P1876, DOI 10.1073/pnas.261709098
   LORESARNAIZ S, 2004, MOL ASPECTS MED, V25, P91
   Maniam J, 2004, FREE RADICAL BIO MED, V36, pS146
   MIQUEL J, 1978, EXP GERONTOL, V13, P389, DOI 10.1016/0531-5565(78)90049-9
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Morley AA, 2001, BIOGERONTOLOGY, V2, P109, DOI 10.1023/A:1011589218219
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Navarro Ana, 2004, Molecular Aspects of Medicine, V25, P37, DOI 10.1016/j.mam.2004.02.007
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151
   Poderoso JJ, 1999, J BIOL CHEM, V274, P37709, DOI 10.1074/jbc.274.53.37709
   Reckelhoff JF, 1998, AM J PHYSIOL-REG I, V274, pR767, DOI 10.1152/ajpregu.1998.274.3.R767
   Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704
   Sies H, 1992, J Nutr Sci Vitaminol (Tokyo), VSpec No, P27
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   Vatassery GT, 1999, AM J CLIN NUTR, V70, P793
   Viña J, 2005, FEBS LETT, V579, P2541, DOI 10.1016/j.febslet.2005.03.090
   Zingg JM, 2004, CURR MED CHEM, V11, P1113, DOI 10.2174/0929867043365332
NR 48
TC 171
Z9 181
U1 2
U2 19
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD NOV
PY 2005
VL 289
IS 5
BP R1392
EP R1399
DI 10.1152/ajpregu.00834.2004
PG 8
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 973MZ
UT WOS:000232528200022
PM 16020519
DA 2024-02-19
ER

PT J
AU Yang, J
   Sáinz, N
   Félix-Soriano, E
   Gil-Iturbe, E
   Castilla-Madrigal, R
   Fernández-Galilea, M
   Martínez, JA
   Moreno-Aliaga, MJ
AF Yang, Jinchunzi
   Sainz, Neira
   Felix-Soriano, Elisa
   Gil-Iturbe, Eva
   Castilla-Madrigal, Rosa
   Fernandez-Galilea, Marta
   Martinez, J. Alfredo
   Moreno-Aliaga, Maria J.
TI Effects of Long-Term DHA Supplementation and Physical Exercise on
   Non-Alcoholic Fatty Liver Development in Obese Aged Female Mice
SO NUTRIENTS
LA English
DT Article
DE obesity; aging; non-alcoholic fatty liver; omega-3 fatty acids;
   exercise; lipogenesis; fatty acid oxidation; inflammation; ER stress;
   autophagy
ID ENDOPLASMIC-RETICULUM STRESS; ACTIVATION
AB Obesity and aging are associated to non-alcoholic fatty liver disease (NAFLD) development. Here, we investigate whether long-term feeding with a docosahexaenoic acid (DHA)-enriched diet and aerobic exercise, alone or in combination, are effective in ameliorating NAFLD in aged obese mice. Two-month-old female C57BL/6J mice received control or high fat diet (HFD) for 4 months. Then, the diet-induced obese (DIO) mice were distributed into four groups: DIO, DIO + DHA (15% dietary lipids replaced by a DHA-rich concentrate), DIO + EX (treadmill running), and DIO + DHA + EX up to 18 months. The DHA-rich diet reduced liver steatosis in DIO mice, decreasing lipogenic genes (Dgat2, Scd1, Srebp1c), and upregulated lipid catabolism genes (Hsl/Acox) expression. A similar pattern was observed in the DIO + EX group. The combination of DHA + exercise potentiated an increase in Cpt1a and Ppara genes, and AMPK activation, key regulators of fatty acid oxidation. Exercise, alone or in combination with DHA, significantly reversed the induction of proinflammatory genes (Mcp1, Il6, Tnf alpha, Tlr4) in DIO mice. DHA supplementation was effective in preventing the alterations induced by the HFD in endoplasmic reticulum stress-related genes (Ern1/Xbp1) and autophagy markers (LC3II/I ratio, p62, Atg7). In summary, long-term DHA supplementation and/or exercise could be helpful to delay NAFLD progression during aging in obesity.
C1 [Yang, Jinchunzi; Sainz, Neira; Felix-Soriano, Elisa; Gil-Iturbe, Eva; Castilla-Madrigal, Rosa; Fernandez-Galilea, Marta; Martinez, J. Alfredo; Moreno-Aliaga, Maria J.] Univ Navarra, Ctr Nutr Res, Pamplona 31008, Spain.
   [Yang, Jinchunzi; Sainz, Neira; Felix-Soriano, Elisa; Gil-Iturbe, Eva; Castilla-Madrigal, Rosa; Fernandez-Galilea, Marta; Martinez, J. Alfredo; Moreno-Aliaga, Maria J.] Univ Navarra, Dept Nutr Food Sci & Physiol, Pamplona 31008, Spain.
   [Fernandez-Galilea, Marta; Martinez, J. Alfredo; Moreno-Aliaga, Maria J.] Navarras Hlth Res Inst IdiSNA, Pamplona 31008, Spain.
   [Martinez, J. Alfredo; Moreno-Aliaga, Maria J.] Carlos III Hlth Inst, CIBERobn Physiopathol Obes & Nutr, Madrid 28029, Spain.
C3 University of Navarra; University of Navarra; CIBER - Centro de
   Investigacion Biomedica en Red; CIBEROBN
RP Moreno-Aliaga, MJ (corresponding author), Univ Navarra, Ctr Nutr Res, Pamplona 31008, Spain.; Moreno-Aliaga, MJ (corresponding author), Univ Navarra, Dept Nutr Food Sci & Physiol, Pamplona 31008, Spain.; Moreno-Aliaga, MJ (corresponding author), Navarras Hlth Res Inst IdiSNA, Pamplona 31008, Spain.; Moreno-Aliaga, MJ (corresponding author), Carlos III Hlth Inst, CIBERobn Physiopathol Obes & Nutr, Madrid 28029, Spain.
EM jyang@alumni.unav.es; nsainz@unav.es; efelix@alumni.unav.es;
   egil.5@alumni.unav.es; rcastilla@alumni.unav.es; mfgalilea@unav.es;
   jalfmtz@unav.es; mjmoreno@unav.es
RI Yang, Jinchunzi/ABC-4058-2021; Moreno-Aliaga, Maria J/M-7015-2018;
   Gil-Iturbe, Eva/C-4387-2018; Martinez Hernandez, J Alfredo/K-8709-2014
OI Yang, Jinchunzi/0000-0002-8519-2878; Moreno-Aliaga, Maria
   J/0000-0002-2018-6434; Gil-Iturbe, Eva/0000-0002-4046-5756; Felix
   Soriano, Elisa/0000-0003-4633-1289; Sainz, Neira/0000-0003-0298-3031;
   Martinez Hernandez, J Alfredo/0000-0001-5218-6941
FU Government of Spain (MINECO/FEDER) [BFU2015-65937-R]; CIBERobn
   (Physiopathology of Obesity and Nutrition) [CB12/03/3002]; "Juan de la
   Cierva" Grant [IJCI-2016-30025]; Center for Nutrition Research
   (University of Navarra)
FX This research was funded by the Government of Spain (MINECO/FEDER,
   BFU2015-65937-R) and CIBERobn (Physiopathology of Obesity and Nutrition)
   (CB12/03/3002). A "Juan de la Cierva" Grant was provided to M.F.-G.
   (IJCI-2016-30025). During the study, E.F.-S. and E.G.-I. were supported
   by a predoctoral grant from the Center for Nutrition Research
   (University of Navarra).
CR Albracht-Schulte K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030599
   Alex S, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0026-1
   Aoi W, 2011, BIOCHEM BIOPH RES CO, V413, P330, DOI 10.1016/j.bbrc.2011.08.097
   Asrih M, 2013, J ENDOCRINOL, V218, pR25, DOI 10.1530/JOE-13-0201
   Balakrishnan M, 2021, CLIN GASTROENTEROL H, V19, P61, DOI 10.1016/j.cgh.2020.04.067
   Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1
   Batatinha HAP, 2017, J CELL PHYSIOL, V232, P1008, DOI 10.1002/jcp.25440
   Berná G, 2020, LIVER INT, V40, P102, DOI 10.1111/liv.14360
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Bozaykut P, 2016, MECH AGEING DEV, V157, P17, DOI 10.1016/j.mad.2016.07.001
   Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727
   Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955
   Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263
   Caldwell SH, 1999, J HEPATOL, V31, P430, DOI 10.1016/S0168-8278(99)80033-6
   Barbosa MC, 2019, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00790
   Carotti S, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00850
   Chapados NA, 2010, CELL BIOCHEM FUNCT, V28, P202, DOI 10.1002/cbf.1643
   Chen Y, 2015, NUTRITION, V31, P1423, DOI 10.1016/j.nut.2015.05.022
   Cho Jinkyung, 2014, J Exerc Nutrition Biochem, V18, P339, DOI 10.5717/jenb.2014.18.4.339
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   Cintra DE, 2012, LIFE SCI, V91, P395, DOI 10.1016/j.lfs.2012.08.002
   Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013
   Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659
   Czaja MJ, 2016, DIGEST DIS SCI, V61, P1304, DOI 10.1007/s10620-015-4025-x
   Dasgupta D, 2020, GASTROENTEROLOGY, V159, P1487, DOI 10.1053/j.gastro.2020.06.031
   Deng X, 2015, BBA-MOL CELL BIOL L, V1851, P1521, DOI 10.1016/j.bbalip.2015.08.007
   Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322
   Ding H, 2020, ANN HEPATOL, V19, P516, DOI 10.1016/j.aohep.2020.06.001
   Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224
   Echeverría F, 2019, FOOD FUNCT, V10, P6170, DOI [10.1039/C9FO01373C, 10.1039/c9fo01373c]
   Echeverría F, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/5109503
   Estébanez B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01744
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Fukunaga K, 2016, LIPIDS, V51, P279, DOI 10.1007/s11745-016-4118-0
   Fun XH, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.04.009
   Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525
   Gao Y, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101635
   Garcia D, 2019, CELL REP, V26, P192, DOI 10.1016/j.celrep.2018.12.036
   Ghareghani P, 2018, OBES RES CLIN PRACT, V12, P80, DOI 10.1016/j.orcp.2017.01.004
   Gil-Iturbe E, 2020, APPL PHYSIOL NUTR ME, V45, P957, DOI 10.1139/apnm-2019-0721
   Gonçalves NB, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e150
   González-Rodríguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162
   Green CJ, 2014, NUTRIENTS, V6, P5018, DOI 10.3390/nu6115018
   Guarino M, 2020, CANCERS, V12, DOI 10.3390/cancers12061407
   Hallsworth K, 2015, FRONTLINE GASTROENTE, V6, P44, DOI 10.1136/flgastro-2014-100432
   Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009
   Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P237, DOI 10.3748/wjg.v18.i3.237
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hashida R, 2017, J HEPATOL, V66, P142, DOI 10.1016/j.jhep.2016.08.023
   Heintz MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229896
   Hernández-Rodas MC, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700479
   Hirotani Y, 2015, INT J FOOD SCI NUTR, V66, P569, DOI 10.3109/09637486.2015.1042848
   Hong LN, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040917
   Jang M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30977-7
   Jordy AB, 2015, AM J PHYSIOL-ENDOC M, V308, pE778, DOI 10.1152/ajpendo.00547.2014
   Junjappa RP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01289
   Kandeil MA, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.13076
   Kawanishi N, 2012, BRAIN BEHAV IMMUN, V26, P931, DOI 10.1016/j.bbi.2012.04.006
   Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892
   Kim JK, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.90
   Kim Y, 2010, BRAIN RES, V1317, P13, DOI 10.1016/j.brainres.2009.12.062
   Kobori M, 2020, J AGR FOOD CHEM, V68, P13267, DOI 10.1021/acs.jafc.0c02984
   Kotronen A, 2009, DIABETES, V58, P203, DOI 10.2337/db08-1074
   Kristensen CM, 2018, PFLUG ARCH EUR J PHY, V470, P1431, DOI 10.1007/s00424-018-2159-3
   Laiglesia LM, 2018, INT J OBESITY, V42, P572, DOI 10.1038/ijo.2017.226
   Lavoie JM, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/914938
   Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008
   Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042
   Lee AH, 2009, CELL MOL LIFE SCI, V66, P2835, DOI 10.1007/s00018-009-0049-8
   Li HL, 2014, BBA-MOL BASIS DIS, V1842, P1844, DOI 10.1016/j.bbadis.2014.07.002
   Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63
   Liu L, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6256802
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Bargut TCL, 2014, LIPIDS, V49, P431, DOI 10.1007/s11745-014-3892-9
   López-Yoldi M, 2014, J LIPID RES, V55, P2634, DOI 10.1194/jlr.M055335
   Lytle KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173376
   Mancuso P, 2019, FRONT ENDOCRINOL, V10, DOI [10.3389/fendo.2019.00137, 10.3389/fendo.019.00137]
   Mao Y.Q, 2015, WORLD CHIN J DIG, V23, P5107, DOI [10.11569/wcjd.v23.i32.5107, DOI 10.11569/WCJD.V23.I32.5107]
   Marques CMM, 2010, BRAZ J MED BIOL RES, V43, P467, DOI 10.1590/S0100-879X2010007500030
   Martínez-Fernández L, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900358
   McLaren DG, 2018, CELL METAB, V27, P1236, DOI 10.1016/j.cmet.2018.04.004
   McMullan Rachel C, 2016, Physiol Rep, V4
   Miotto PM, 2017, AM J PHYSIOL-ENDOC M, V312, pE461, DOI 10.1152/ajpendo.00438.2016
   Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823
   Mu J., 2019, J TRADITI CHIN MED S, V6, P315, DOI [10.1016/J.JTCMS.2019.08.001, DOI 10.1016/J.JTCMS.2019.08.001, 10.1016/j.jtcms.2019.08.001]
   Musa-Veloso K, 2018, NUTR REV, V76, P581, DOI 10.1093/nutrit/nuy022
   Nakamoto K, 2018, EUR J PHARMACOL, V820, P31, DOI 10.1016/j.ejphar.2017.11.046
   Norheim F, 2017, J LIPID RES, V58, P178, DOI 10.1194/jlr.M071522
   Nunes-Souza V, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1987960
   Ok DP, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0852-z
   Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132
   Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039
   Pettinelli P, 2011, NUTR HOSP, V26, P441, DOI [10.1590/S0212-16112011000300003, 10.3305/nh.2011.26.3.5119]
   Pino-de la Fuente F, 2019, BBA-MOL CELL BIOL L, V1864, DOI 10.1016/j.bbalip.2019.158519
   Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295
   Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007
   Rietman A, 2018, EUR J CLIN NUTR, V72, P117, DOI 10.1038/ejcn.2017.148
   Romero-Gómez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016
   Rosa-Caldwell ME, 2017, APPL PHYSIOL NUTR ME, V42, P148, DOI 10.1139/apnm-2016-0280
   Sanders FWB, 2016, BIOL REV, V91, P452, DOI 10.1111/brv.12178
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schultz A, 2012, EXP TOXICOL PATHOL, V64, P273, DOI 10.1016/j.etp.2010.08.019
   Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028
   Serviddio G, 2008, EUR J CLIN INVEST, V38, P245, DOI 10.1111/j.1365-2362.2008.01936.x
   Shang TT, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0461-2
   Shiwa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135554
   Sicari D, 2020, FEBS J, V287, P27, DOI 10.1111/febs.15107
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Singh RK, 2012, INT J OPT, V2012, DOI [10.1155/2012/282041, 10.1155/2012/832086]
   Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016
   Sozio MS, 2011, AM J PHYSIOL-GASTR L, V301, pG739, DOI [10.1152/ajpgi.00432.2010, 10.1152/ajpgi.00161.2011]
   Spooner MH, 2019, CURR OPIN CLIN NUTR, V22, P103, DOI 10.1097/MCO.0000000000000539
   Spruss A, 2012, MOL MED, V18, P1346, DOI 10.2119/molmed.2012.00223
   Stahl EC, 2020, AM J PATHOL, V190, P372, DOI 10.1016/j.ajpath.2019.10.016
   Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500
   Suzuki-Kemuriyama N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157580
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Ukropec J, 2003, LIPIDS, V38, P1023, DOI 10.1007/s11745-006-1156-z
   Valenzuela R, 2016, FOOD FUNCT, V7, P140, DOI [10.1039/c5fo01086a, 10.1039/C5FO01086A]
   van der Windt Dirk J., 2018, Gene Expression, V18, P89, DOI 10.3727/105221617X15124844266408
   Velazquez KT, 2019, WORLD J HEPATOL, V11, P619, DOI 10.4254/wjh.v11.i8.619
   Vieira VJ, 2009, CYTOKINE, V46, P339, DOI 10.1016/j.cyto.2009.03.006
   Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506
   Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110
   Whitsett M, 2015, WORLD J HEPATOL, V7, P2041, DOI 10.4254/wjh.v7.i16.2041
   Wu H, 2015, BIOCHEM BIOPH RES CO, V458, P862, DOI 10.1016/j.bbrc.2015.02.046
   Wu R, 2015, DNA CELL BIOL, V34, P6, DOI 10.1089/dna.2014.2552
   Yang JCZ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040872
   Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785
   Zhang XQ, 2014, WORLD J GASTROENTERO, V20, P1768, DOI 10.3748/wjg.v20.i7.1768
   Zhao G, 2015, NEUROSCIENCE, V298, P357, DOI 10.1016/j.neuroscience.2015.04.038
   Zheng JY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010055
   Zheng W, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0370-1
NR 135
TC 17
Z9 18
U1 3
U2 22
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD FEB
PY 2021
VL 13
IS 2
AR 501
DI 10.3390/nu13020501
PG 19
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA QO0YW
UT WOS:000622875200001
PM 33546405
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kubo, S
   Tokunaga, I
   Yamamoto, A
   Gotohda, T
   Morita, K
AF Kubo, S
   Tokunaga, I
   Yamamoto, A
   Gotohda, T
   Morita, K
TI Relevance of heat-shock protein 70 expression as histological marker of
   paraquat-induced damage to rat liver cells
SO ACTA HISTOCHEMICA ET CYTOCHEMICA
LA English
DT Article
DE HSP70 expression; histological marker; paraquat treatment; oxidative
   damage; rat liver
ID GENE-EXPRESSION; STRESS; HSP70; ISCHEMIA; BRAIN; INDUCTION; INJURY
AB Heat-shock protein 70 (HSP70) is expressed in response to various stressful stimuli, and generally used as a histological marker of cell damage. While paraquat has previously been shown to cause HSP70 expression as a result of the oxidative cell damage, recent study has shown that HSP70 expression induced by paraquat poisoning is no longer observed at 18 hr after the drug administration in the senescence-accelerated mouse liver, thereby raising the question whether the cell damage is always accompanied by elevated HSP70 expression. To affirm the relevance of HSP70 expression as a marker of the cell damage, the expression of HSP70 immunoreactivity and lipid peroxidation in paraquat-poisoned rat liver were examined, The immunostaining of HSP70 was still clearly detected at 24 hr after the drug administration. Lipid peroxidation, a biochemical maker of the oxidative cell damage, was also elevated by the same treatment, suggesting that the expression of HSP70 immunoreactivity observed here may reflect the oxidative-damage to liver cells. These results seem to provide evidence supporting the relevance of HSP70 expression as a histological marker of paraquat-induced damage to rat liver cells.
C1 Univ Tokushima, Sch Med, Dept Legal Med, Tokushima 7708503, Japan.
   Univ Tokushima, Sch Med, Dept Pharmacol, Tokushima 7708503, Japan.
C3 Tokushima University; Tokushima University
RP Kubo, S (corresponding author), Univ Tokushima, Sch Med, Dept Legal Med, 03-18-15 Kuramoto, Tokushima 7708503, Japan.
CR CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   COHEN DM, 1991, AM J PHYSIOL, V261, pC594, DOI 10.1152/ajpcell.1991.261.4.C594
   Ding XZ, 1996, MOL CELL BIOCHEM, V158, P189
   DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2
   Gaspary H, 1995, MOL BRAIN RES, V34, P327, DOI 10.1016/0169-328X(95)00195-X
   Kubo S, 1999, ACTA HISTOCHEM CYTOC, V32, P373, DOI 10.1267/ahc.32.373
   LONGO FM, 1993, J NEUROSCI RES, V36, P325, DOI 10.1002/jnr.490360310
   LOWENSTEIN DH, 1991, NEURON, V7, P1053, DOI 10.1016/0896-6273(91)90349-5
   Matz P, 1996, STROKE, V27, P504, DOI 10.1161/01.STR.27.3.504
   Nakanishi Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1302, DOI 10.1271/bbb.61.1302
   NOWAK TS, 1990, CEREBROVAS BRAIN MET, V2, P345
   NOWAK TS, 1994, BRAIN PATHOL, V4, P67
   Schiaffonati L, 1997, LIVER, V17, P183
   Sharp F. R., 1995, Society for Neuroscience Abstracts, V21, P512
   SHARP FR, 1993, STROKE S, V24, P172
   Tokunaga I, 1997, BIOCHEM MOL BIOL INT, V43, P73
   TWOMEY BM, 1993, LUPUS, V2, P297, DOI 10.1177/096120339300200504
   WILBUR KM, 1949, ARCH BIOCHEM, V24, P305
NR 18
TC 3
Z9 3
U1 0
U2 2
PU JAPAN SOC HISTOCHEMISTRY & CYTOCHEMISTRY
PI KYOTO
PA C/O NAKANISHI PRINTING CO LTD, SHIMODACHIURI-OGAWA, KAMIGYO-KU, KYOTO,
   602-8048, JAPAN
SN 0044-5991
EI 1347-5800
J9 ACTA HISTOCHEM CYTOC
JI Acta Histochem. Cytochem.
PY 1999
VL 32
IS 5
BP 381
EP 386
DI 10.1267/ahc.32.381
PG 6
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 276WN
UT WOS:000084901500001
OA Bronze
DA 2024-02-19
ER

PT J
AU Zhang, H
   Chen, SR
   Liu, MT
   Wang, YC
   Xin, C
   Ma, J
   Zheng, XD
   Huang, YD
   Zhang, B
   Zhang, XJ
   Sun, LD
   Yang, S
AF Zhang, Hui
   Chen, Shirui
   Liu, Mengting
   Wang, Yaochi
   Xin, Cong
   Ma, Jing
   Zheng, Xiaodong
   Huang, Yuandi
   Zhang, Bo
   Zhang, Xuejun
   Sun, Liangdan
   Yang, Sen
TI Data-independent acquisition mass spectrometry quantitative proteomic
   analysis reveals that skin aging-related proteins differ between men and
   women
SO BIOCELL
LA English
DT Article
DE Epidermal protein; Mass spectrometer; Skin barrier; Gender-related skin
   aging; Proteome
ID FATTY LIVER-DISEASE; ARACHIDONIC-ACID; OXIDATIVE STRESS; BARRIER
   FUNCTION; EXPRESSION; INFLAMMATION; COX-2; IDENTIFICATION;
   KERATINOCYTES; METABOLISM
AB The skin is the largest organ of the human body, and its aging is visible to the naked eye. The aging rate of men and women is slightly different. This study compared the protein expression of skin samples on the curved forearms of 11 healthy women and 9 healthy men. Quantitative proteomics analysis found that the expression of epidermal proteins in men and women of the same age group was different. Compared with female skin, in male skin, 20 proteins were upregulated, and 7 proteins were downregulated. These data suggest that men and women have differences in the speed of skin aging. For the first time in this experiment, a non-invasive mass spectrometer was used to detect 27 different-related epidermal proteins between men and women. Compared with women, among the 20 epidermal proteins upregulated in men, their functions can be classified into antioxidants, epidermal lipid metabolism, signal transduction, membrane transport, and cell biological processes; the 7 downregulated proteins are involved in a variety of biological processes and inflammatory reactions. Our experiments have discovered epidermal proteins related to the differences between men and women, enriching the library of epidermal differential proteins between men and women and enriching the mechanism of skin aging between men and women from the perspective of epidermal differential proteins.
C1 [Zhang, Hui; Chen, Shirui; Liu, Mengting; Wang, Yaochi; Xin, Cong; Ma, Jing; Zheng, Xiaodong; Huang, Yuandi; Zhang, Xuejun; Sun, Liangdan; Yang, Sen] Anhui Med Univ, 1 Hosp, Dept Dermatol, Hefei 230022, Peoples R China.
   [Liu, Mengting; Wang, Yaochi; Xin, Cong; Zheng, Xiaodong; Huang, Yuandi; Zhang, Xuejun; Sun, Liangdan] Anhui Med Univ, Inst Dermatol, Hefei 230032, Peoples R China.
   [Zhang, Hui; Chen, Shirui; Ma, Jing; Zhang, Bo; Yang, Sen] Anhui Ferry Dermotol Inst, Hefei 230031, Peoples R China.
   [Zhang, Bo] Anhui Med Univ, Affiliated Hosp 2, Dept Oncol, Hefei 230601, Peoples R China.
C3 Anhui Medical University; Anhui Medical University; Anhui Medical
   University
RP Sun, LD; Yang, S (corresponding author), Anhui Med Univ, 1 Hosp, Dept Dermatol, Hefei 230022, Peoples R China.; Sun, LD (corresponding author), Anhui Med Univ, Inst Dermatol, Hefei 230032, Peoples R China.; Yang, S (corresponding author), Anhui Ferry Dermotol Inst, Hefei 230031, Peoples R China.
EM ahmusld@163.com; yang2004sen@163.com
RI Chen, Shirui/GXN-1041-2022
FU Science and Technology Action Plan for Prevention and Treatment of Major
   Diseases; National Health and Family Planning Commission of the People's
   Republic of China [2017ZX-01E-002]; Anhui Institute of Translational
   Medicine [ZHYX2020A005]
FX This research was funded by the Science and Technology Action Plan for
   Prevention and Treatment of Major Diseases sponsored by the National
   Health and Family Planning Commission of the People's Republic of China
   (Grant No. 2017ZX-01E-002) and Anhui Institute of Translational Medicine
   (ZHYX2020A005) .
CR Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   AKED D, 1986, BRIT J PHARMACOL, V89, P431, DOI 10.1111/j.1476-5381.1986.tb10277.x
   Arjmandi N., 2018, J BIOMED PHYS ENG, V8, P447, DOI DOI 10.31661/JBPE.V0I0.599
   Bäsler K, 2016, J CONTROL RELEASE, V242, P105, DOI 10.1016/j.jconrel.2016.08.007
   Baumann L, 2018, FACIAL PLAST SURG CL, V26, P407, DOI 10.1016/j.fsc.2018.06.002
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990
   Brandt SL, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120220
   Breitenbach JS, 2015, AGING-US, V7, P389, DOI 10.18632/aging.100755
   Bruderer R, 2016, PROTEOMICS, V16, P2246, DOI 10.1002/pmic.201500488
   Chambers DM, 2018, J BIOL CHEM, V293, P15867, DOI 10.1074/jbc.RA118.003658
   Chang HS, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0556-6
   Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305
   Chun KS, 2007, MOL CARCINOGEN, V46, P699, DOI 10.1002/mc.20354
   Clatici Victor Gabriel, 2017, Maedica (Bucur), V12, P191
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Dabrowska M, 2018, SKIN RES TECHNOL, V24, P614, DOI 10.1111/srt.12473
   Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002
   Farage M. A., 2008, International Journal of Cosmetic Science, V30, P87, DOI 10.1111/j.1468-2494.2007.00415.x
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Gruber JV, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/230450
   Gu YP, 2020, AGEING RES REV, V59, DOI 10.1016/j.arr.2020.101036
   Guimaraes FR, 2018, CLIN IMMUNOL, V190, P74, DOI 10.1016/j.clim.2017.08.022
   Han A, 2014, DERMATOL CLIN, V32, P291, DOI 10.1016/j.det.2014.03.015
   Hao D, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1261-y
   Holly AC, 2013, MECH AGEING DEV, V134, P356, DOI 10.1016/j.mad.2013.05.006
   Ibarrola-Villava M, 2015, INT J CANCER, V136, P2109, DOI 10.1002/ijc.29257
   IKAI K, 1988, INT J DERMATOL, V27, P141, DOI 10.1111/j.1365-4362.1988.tb04917.x
   Jeong H, 2019, BIOMOL THER, V27, P553, DOI 10.4062/biomolther.2019.125
   Kammeyer A, 2015, AGEING RES REV, V21, P16, DOI 10.1016/j.arr.2015.01.001
   Kamsteeg M, 2007, J INVEST DERMATOL, V127, P1786, DOI 10.1038/sj.jid.5700752
   Kim SK, 2012, ADV FOOD NUTR RES, V65, P223, DOI 10.1016/B978-0-12-416003-3.00014-7
   Kitamura T, 2017, P NATL ACAD SCI USA, V114, pE2616, DOI 10.1073/pnas.1700138114
   Kobayashi M, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0385-2
   Lai JL, 2017, INFLAMMATION, V40, P1, DOI 10.1007/s10753-016-0447-7
   Langston PK, 2019, NAT IMMUNOL, V20, P1186, DOI 10.1038/s41590-019-0453-7
   Lee DH, 2016, J DERMATOL SCI, V83, P174, DOI 10.1016/j.jdermsci.2016.05.016
   Lephart ED, 2018, J COSMET DERMATOL-US, V17, P282, DOI 10.1111/jocd.12508
   Li YF, 2018, THERANOSTICS, V8, P5713, DOI 10.7150/thno.28778
   Ma J, 2019, SKIN RES TECHNOL, V25, P424, DOI 10.1111/srt.12668
   Makrantonaki E, 2009, CURR OPIN ENDOCRINOL, V16, P240, DOI 10.1097/MED.0b013e32832b71dc
   Masuya T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233087
   McDaniel D, 2018, J COSMET DERMATOL-US, V17, P124, DOI 10.1111/jocd.12518
   Megna M, 2017, GIORN ITAL DERMAT V, V152, P302, DOI 10.23736/S0392-0488.17.05567-5
   Nguyen Gloria, 2012, J Drugs Dermatol, V11, pe1
   Niehues H, 2018, EXP DERMATOL, V27, P501, DOI 10.1111/exd.13531
   Niki E, 2015, FREE RADICAL RES, V49, P827, DOI 10.3109/10715762.2014.976213
   NUGTEREN DH, 1987, BIOCHIM BIOPHYS ACTA, V921, P135, DOI 10.1016/0005-2760(87)90179-2
   Pham DM, 2015, INT J COSMETIC SCI, V37, P357, DOI 10.1111/ics.12208
   Pullar JM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080866
   Quan TH, 2015, GERONTOLOGY, V61, P427, DOI 10.1159/000371708
   RAMSING D, 1995, ACTA DERM-VENEREOL, V75, P198
   Reina S, 2010, FEBS LETT, V584, P2837, DOI 10.1016/j.febslet.2010.04.066
   Rinnerthaler M, 2015, BIOMOLECULES, V5, P545, DOI 10.3390/biom5020545
   RUZICKA T, 1984, REV PHYSIOL BIOCH P, V100, P121
   Sator PG, 2004, EXP DERMATOL, V13, P36, DOI 10.1111/j.1600-0625.2004.00259.x
   Seibt TM, 2019, FREE RADICAL BIO MED, V133, P144, DOI 10.1016/j.freeradbiomed.2018.09.014
   Sengupta A, 2013, J INVEST DERMATOL, V133, P1731, DOI 10.1038/jid.2013.52
   Setkowicz M, 2015, BRIT J DERMATOL, V172, P337, DOI [10.1111/bjd.13225, 10.1111/b]
   Sheffer R, 2016, AM J MED GENET A, V170, P1603, DOI 10.1002/ajmg.a.37624
   Sochorová M, 2019, J COLLOID INTERF SCI, V535, P227, DOI 10.1016/j.jcis.2018.09.104
   Stacey SN, 2008, NAT GENET, V40, P1313, DOI 10.1038/ng.234
   Steck A, 2011, REV NEUROL-FRANCE, V167, P927, DOI 10.1016/j.neurol.2011.09.002
   Stuart Jeffrey A, 2014, Longev Healthspan, V3, P4, DOI 10.1186/2046-2395-3-4
   Subramanya RD, 2010, GENOMICS, V96, P146, DOI 10.1016/j.ygeno.2010.05.002
   Suggs Amanda, 2014, Inflammation & Allergy Drug Targets, V13, P168
   Surowiak P, 2014, J COSMET DERMATOL-US, V13, P195, DOI 10.1111/jocd.12103
   Taïeb A, 2018, PEDIATR DERMATOL, V35, pS5, DOI 10.1111/pde.13482
   Tang SC, 2017, J DERMATOL SCI, V86, P238, DOI 10.1016/j.jdermsci.2017.03.004
   Tobin DJ, 2017, J TISSUE VIABILITY, V26, P37, DOI 10.1016/j.jtv.2016.03.002
   Wang LQ, 2020, J APPL GERONTOL, V39, P627, DOI 10.1177/0733464819865415
   Wu ST, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00379
   Xian HF, 2020, AUTOPHAGY, V16, P408, DOI 10.1080/15548627.2019.1615303
   Xiong TF, 2019, MELANOMA RES, V29, P23, DOI 10.1097/CMR.0000000000000512
   Yang YF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14324-x
   ZIBOH VA, 1973, J LIPID RES, V14, P377
   Zouboulis CC, 2007, HORM METAB RES, V39, P85, DOI 10.1055/s-2007-961807
NR 78
TC 0
Z9 0
U1 1
U2 9
PU TECH SCIENCE PRESS
PI HENDERSON
PA 871 CORONADO CENTER DR, SUTE 200, HENDERSON, NV 89052 USA
SN 0327-9545
EI 1667-5746
J9 BIOCELL
JI Biocell
PY 2021
VL 45
IS 5
BP 1321
EP 1335
DI 10.32604/biocell.2021.016524
PG 15
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA TI4WH
UT WOS:000672801900015
OA gold
DA 2024-02-19
ER

PT J
AU Malhi, H
   Irani, AN
   Gagandeep, S
   Gupta, S
AF Malhi, H
   Irani, AN
   Gagandeep, S
   Gupta, S
TI Isolation of human progenitor liver epithelial cells with extensive
   replication capacity and differentiation into mature hepatocytes
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE stem; progenitor; cells; epithelial; fetal; human; liver
ID TRANSPLANTED HEPATOCYTES; RAT-LIVER; BONE-MARROW; OVAL CELLS; IN-VIVO;
   EXPRESSION; CULTURES; GROWTH; REPOPULATION; INTEGRATION
AB The liver can regenerate itself through the progenitor cells it harbors. Here we demonstrate isolation of epithelial progenitor/stem cells from the fetal human liver, which contains a large number of hepatoblasts. Progenitor liver cells displayed clonogenic capacity, expressed genes observed in hepatocytes, bile duct cells and oval cells, and incorporated genes transferred by adenoviral or lentiviral vectors. Under culture conditions, progenitor cells proliferated for several months, with each cell undergoing more than forty divisions, but they retained normal karyotypes. Progenitor cells differentiated into mature hepatocytes in mice with severe combined immunodeficiency, both when in an ectopic location and when in the liver itself. Cells integrated in the liver parenchyma and proliferated following liver injury. An abundance of progenitor cells in the fetal human liver is consistent with models indicating depletion of progenitor/stem cells during aging and maturation of organs. The studies indicate that isolation of progenitor cells from fetal organs will be appropriate for establishing novel systems to investigate basic mechanisms and for cell and gene therapy.
C1 Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Canc Res Ctr, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Gen Clin Res Ctr, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Yeshiva University; Albert Einstein
   College of Medicine
RP Gupta, S (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM sanjvgupta@pol.net
FU NCI NIH HHS [P30 CA13330] Funding Source: Medline; NIDDK NIH HHS [P30
   DK41296, R01 DK46952] Funding Source: Medline
CR Alison M, 1998, CURR OPIN CELL BIOL, V10, P710, DOI 10.1016/S0955-0674(98)80111-7
   Badve S, 2000, PATHOBIOLOGY, V68, P76, DOI 10.1159/000028117
   Bisgaard HC, 1998, LAB INVEST, V78, P237
   Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133
   Coleman WB, 1997, AM J PATHOL, V151, P353
   Dabeva MD, 1997, P NATL ACAD SCI USA, V94, P7356, DOI 10.1073/pnas.94.14.7356
   EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737
   FARBER E, 1956, CANCER RES, V16, P142
   Farwell DG, 2000, AM J PATHOL, V156, P1537, DOI 10.1016/S0002-9440(10)65025-0
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004
   Gagandeep S, 1999, GENE THER, V6, P729, DOI 10.1038/sj.gt.3300871
   Gorla GR, 2001, J CELL SCI, V114, P2943
   Grompe M, 1999, SEMIN LIVER DIS, V19, P7, DOI 10.1055/s-2007-1007093
   GUPTA S, 1992, HEPATOLOGY, V15, P485, DOI 10.1002/hep.1840150322
   Gupta S, 1999, HEPATOLOGY, V29, P509, DOI 10.1002/hep.510290213
   Gupta S, 1999, J BIOL CHEM, V274, P2157, DOI 10.1074/jbc.274.4.2157
   Gupta S, 1999, AM J PHYSIOL-GASTR L, V276, pG629, DOI 10.1152/ajpgi.1999.276.3.G629
   GUPTA S, 1995, P NATL ACAD SCI USA, V92, P5860, DOI 10.1073/pnas.92.13.5860
   Haruna Y, 1996, HEPATOLOGY, V23, P476
   HERRING AS, 1983, IN VITRO CELL DEV B, V19, P576, DOI 10.1007/BF02619606
   HOSHI H, 1987, IN VITRO CELL DEV B, V23, P723
   Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258
   Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Ott M, 1999, GENE EXPRESSION, V8, P175
   Ott M, 1998, J BIOL CHEM, V273, P11954, DOI 10.1074/jbc.273.19.11954
   Ott M, 1999, J PATHOL, V187, P365, DOI 10.1002/(SICI)1096-9896(199902)187:3<365::AID-PATH237>3.0.CO;2-Z
   Overturf K, 1997, AM J PATHOL, V151, P1273
   Papoff P, 1998, ARCH DIS CHILD-FETAL, V78, pF67, DOI 10.1136/fn.78.1.F67
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Rajvanshi P, 1996, GASTROENTEROLOGY, V111, P1092, DOI 10.1016/S0016-5085(96)70078-1
   REID LM, 1984, HEPATOLOGY, V4, P548, DOI 10.1002/hep.1840040332
   Rogler LE, 1997, AM J PATHOL, V150, P591
   Runge D, 2000, BIOCHEM BIOPH RES CO, V269, P46, DOI 10.1006/bbrc.2000.2215
   Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9
   SIGAL SH, 1995, DIFFERENTIATION, V59, P35, DOI 10.1046/j.1432-0436.1995.5910035.x
   SIGAL SH, 1995, CELL MOL BIOL RES, V41, P39
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   TAHARA H, 1995, CANCER RES, V55, P2734
   Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135
   Wieder R, 1999, PRACT APPROACH SER, V215, P1
   Yasui O, 1997, HEPATOLOGY, V25, P329
   Zahler MH, 2000, J GENE MED, V2, P186
NR 44
TC 155
Z9 188
U1 0
U2 7
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD JUL 1
PY 2002
VL 115
IS 13
BP 2679
EP 2688
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 575RK
UT WOS:000176961600007
PM 12077359
DA 2024-02-19
ER

PT J
AU Qin, ZP
   Worthen, CA
   Quan, TH
AF Qin, Zhaoping
   Worthen, Christal A.
   Quan, Taihao
TI Cell-size-dependent upregulation of HGF expression in dermal
   fibroblasts: Impact on human skin connective tissue aging
SO JOURNAL OF DERMATOLOGICAL SCIENCE
LA English
DT Article
DE HGF; Cell size; c-Jun; TGF-beta; Skin aging
ID HEPATOCYTE GROWTH-FACTOR; AGED HUMAN SKIN; PHOTODAMAGED HUMAN SKIN;
   PHOTOAGED HUMAN SKIN; EXTRACELLULAR-MATRIX; IN-VIVO; FACTOR GENE;
   ULTRAVIOLET-IRRADIATION; COLLAGEN FRAGMENTATION; RETINOIC ACID
AB Background: Aged human skin is primarily attributable to loss of collagen, the main structural component of skin. Hepatocyte growth factor (HGF) acts as an anti-fibrotic factor by suppression of collagen production. It is not known whether HGF is involved in age-related collagen deficit in human skin.
   Objective: The objective of this study was to investigate the expression of HGF in human skin, and the underlying mechanisms of age-related elevation of HGF expression.
   Methods: The expression of HGF in young (25 +/- 5 years, six subjects) and aged (75 +/- 6 years, six subjects) human skin was determined by laser capture microdissection (LCM) coupled real-time PCR and immunohistology. The underlying mechanisms of age-related elevation of HGF were investigated by reducing dermal fibroblast size, which is a prominent feature of aged skin fibroblast in vivo.
   Results: HGF is predominantly expressed in human skin dermal fibroblasts, the major cells responsible for collagen production, and is significantly elevated in aged human skin in vivo. Mechanistically, reduced fibroblast size, which is a prominent feature of aged skin fibroblasts in vivo, is responsible for age-related elevation of HGF expression. Cell-size-dependent upregulation of HGF expression is driven by increased c-Jun and impaired TGF-beta signaling. Restoration of fibroblast size normalizes increased c-Jun expression and impaired TGF-beta signaling, and thus reversed the elevated HGF expression. Finally, we confirmed that application of retinoid (ROL), which has been shown to improve aged human skin, significantly reduced elevated HGF mRNA expression in aged human skin in vivo (78 +/- 4 years, six subjects).
   Conclusion: These data reveal a novel mechanism by which reduction of fibroblast size upregulates HGF expression, which in turn contributes to loss of collagen, a prominent feature of aged skin. (C) 2017 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Qin, Zhaoping; Worthen, Christal A.; Quan, Taihao] Univ Michigan, Med Sch, Dept Dermatol, 1301 Catherine,Med Sci 1,Room 6447, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan
RP Quan, TH (corresponding author), Univ Michigan, Med Sch, Dept Dermatol, 1301 Catherine,Med Sci 1,Room 6447, Ann Arbor, MI 48109 USA.
EM thquan@umich.edu
OI Quan, Taihao/0000-0002-0954-5109
FU National Institute of Health [AG19364, ES014697]
FX We express our appreciation to Dr. Gary J Fisher for his thoughtful
   advice. This work was supported by the National Institute of Health
   (AG19364 to T Quan and GJ Fisher and ES014697 to T Quan).
CR Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395
   ASHCROFT GS, 1995, J ANAT, V187, P1
   Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922
   Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013
   Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328
   Chattopadhyay N, 2004, MOL BRAIN RES, V121, P146, DOI 10.1016/j.molbrainres.2003.11.008
   Cheng N, 2008, MOL CANCER RES, V6, P1521, DOI 10.1158/1541-7786.MCR-07-2203
   Cheng N, 2007, CANCER RES, V67, P4869, DOI 10.1158/0008-5472.CAN-06-3381
   Chung JH, 2000, J INVEST DERMATOL, V115, P177, DOI 10.1046/j.1523-1747.2000.00009.x
   Eaglstein W H, 1989, Clin Geriatr Med, V5, P183
   Fisher GJ, 2008, ARCH DERMATOL, V144, P666, DOI 10.1001/archderm.144.5.666
   Fisher GJ, 2016, AGING CELL, V15, P67, DOI 10.1111/acel.12410
   Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599
   Fisher GJ, 2000, J CLIN INVEST, V106, P663, DOI 10.1172/JCI9362
   FISHER GJ, 1991, J INVEST DERMATOL, V96, P699, DOI 10.1111/1523-1747.ep12470632
   Gieni RS, 2008, J CELL BIOCHEM, V104, P1964, DOI 10.1002/jcb.21364
   Imamura R., 2017, CYTOKINE IN PRESS
   Jacob MP, 2003, BIOMED PHARMACOTHER, V57, P195, DOI 10.1016/S0753-3322(03)00065-9
   Jiang JG, 1997, MOL CELL BIOL, V17, P5758, DOI 10.1128/MCB.17.10.5758
   Jinnin M, 2005, J INVEST DERMATOL, V124, P324, DOI 10.1111/j.0022-202X.2004.23601.x
   Joseph H, 1999, MOL BIOL CELL, V10, P1221, DOI 10.1091/mbc.10.4.1221
   Kafi R, 2007, ARCH DERMATOL, V143, P606, DOI 10.1001/archderm.143.5.606
   Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568
   LAVKER RM, 1979, J INVEST DERMATOL, V73, P59, DOI 10.1111/1523-1747.ep12532763
   Li JJ, 2000, MOL CARCINOGEN, V29, P159, DOI 10.1002/1098-2744(200011)29:3<159::AID-MC5>3.0.CO;2-W
   LIU YH, 1994, J BIOL CHEM, V269, P4152
   NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0
   Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x
   Nejak-Bowen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059836
   Phaneuf D, 2004, DNA CELL BIOL, V23, P592, DOI 10.1089/1044549041939250
   Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246
   Purohit T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173191
   Qin Z., 2017, BR J DERMAT IN PRESS
   Qin ZP, 2014, AGING CELL, V13, P1028, DOI 10.1111/acel.12265
   Qin ZP, 2014, AGE, V36, P353, DOI 10.1007/s11357-013-9565-4
   Quan TH, 2006, AM J PATHOL, V169, P482, DOI 10.2353/ajpath.2006.060128
   Quan TH, 2015, GERONTOLOGY, V61, P427, DOI 10.1159/000371708
   Quan TH, 2013, J INVEST DERMATOL, V133, P1362, DOI 10.1038/jid.2012.509
   Quan TH, 2013, J INVEST DERMATOL, V133, P658, DOI 10.1038/jid.2012.364
   Quan TH, 2011, J CELL COMMUN SIGNAL, V5, P201, DOI 10.1007/s12079-011-0144-0
   Quan TH, 2010, J INVEST DERMATOL, V130, P1697, DOI 10.1038/jid.2010.29
   Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224
   Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8
   Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187
   Schievenbusch S, 2009, BIOCHEM BIOPH RES CO, V385, P55, DOI 10.1016/j.bbrc.2009.05.010
   SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0
   Schnickmann S, 2009, J INVEST DERMATOL, V129, P1140, DOI 10.1038/jid.2008.350
   Shao Y, 2017, INT J COSMETIC SCI, V39, P56, DOI 10.1111/ics.12348
   Shin MH, 2005, J INVEST DERMATOL, V125, P221, DOI 10.1111/j.0022-202X.2005.23823.x
   Sprenger CC, 2010, INT J CANCER, V127, P2739, DOI 10.1002/ijc.25615
   Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183
   Thomas DR, 2001, DRUG AGING, V18, P607, DOI 10.2165/00002512-200118080-00005
   UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0
   Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593
   Uitto J, 1998, J Investig Dermatol Symp Proc, V3, P41
   Varani J, 2004, J INVEST DERMATOL, V122, P1471, DOI 10.1111/j.0022-202X.2004.22614.x
   Vas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042080
   Wang F, 2007, ARCH DERMATOL, V143, P155, DOI 10.1001/archderm.143.2.155
NR 58
TC 13
Z9 15
U1 4
U2 12
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0923-1811
EI 1873-569X
J9 J DERMATOL SCI
JI J. Dermatol. Sci.
PD DEC
PY 2017
VL 88
IS 3
BP 289
EP 297
DI 10.1016/j.jdermsci.2017.08.003
PG 9
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA FS1LP
UT WOS:000419537600004
PM 28826691
OA Bronze
DA 2024-02-19
ER

PT J
AU SODERBERG, M
   EDLUND, C
   KRISTENSSON, K
   DALLNER, G
AF SODERBERG, M
   EDLUND, C
   KRISTENSSON, K
   DALLNER, G
TI FATTY-ACID COMPOSITION OF BRAIN PHOSPHOLIPIDS IN AGING AND IN
   ALZHEIMERS-DISEASE
SO LIPIDS
LA English
DT Article
ID MICROSOMAL-MEMBRANES; RAT-LIVER; PHOSPHATIDYLETHANOLAMINE; ETHANOLAMINE;
   DEMENTIA; PROTEINS
AB The two major phospholipid classes, namely, phosphatidylethanolamines (PE) and phosphatidylcholines (PC), were studied in four different regions of human brain, i.e., in frontal gray matter, frontal white matter, hippocampus and in pons. The fatty acid (FA) compositions of these phospholipids were found to be specific for the different regions. PC contains mostly saturated and 18:1 FA, while PE is rich in polyunsaturated FA. Aging has no influence on the FA compositions, while in Alzheimer's disease (AD) PE is modified in all four regions, particularly in frontal gray matter and in hippocampus. The abundance of the major monounsaturated FA of PE, 18:1, is not significantly altered in Alzheimer's disease, but there is a substantial increase in the relative amounts of the saturated components 14:0, 16:0 and 18:0. This is paralleled by a decrease in the polyunsaturated FA 20:4, 22:4 and 22:6. It is not clear whether the changes observed are specific for AD. Changes in saturated/polyunsaturated FA ratio are likely to influence cellular function, which in turn may cause certain neural deficiencies. The findings do not support the hypothesis that AD reflects an accelerated aging process.
RP SODERBERG, M (corresponding author), KAROLINSKA INST, HUDDINGE UNIV HOSP, CLIN RES CTR, DIV MED CELL & NEUROBIOL, S-14186 HUDDINGE, SWEDEN.
CR BOWEN DM, 1973, BRAIN, V96, P849, DOI 10.1093/brain/96.4.849
   BROOKSBANK BWL, 1989, MOL CHEM NEUROPATHOL, V11, P157, DOI 10.1007/BF03160049
   COTMAN C, 1969, BIOCHEMISTRY-US, V8, P4606, DOI 10.1021/bi00839a056
   Cullis P. R., 1985, BIOCH LIPIDS MEMBRAN, P25
   Dhopeshwarkar G A, 1973, Adv Lipid Res, V11, P109
   ELLISON DW, 1987, BRAIN RES, V417, P389, DOI 10.1016/0006-8993(87)90471-9
   GOTTFRIES CG, 1986, PROG BRAIN RES, V70, P133
   HIDALGO C, 1977, J BIOL CHEM, V252, P8446
   Horrocks L. A., 1981, MOL BASIS NEUROPATHO, P601
   Jeffcoat R, 1979, Essays Biochem, V15, P1
   KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029
   KISHIMOTO Y, 1969, J NEUROCHEM, V16, P397, DOI 10.1111/j.1471-4159.1969.tb10380.x
   MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X
   MORRISON WR, 1964, J LIPID RES, V5, P600
   PULLARKAT RK, 1978, J NEUROCHEM, V31, P707, DOI 10.1111/j.1471-4159.1978.tb07844.x
   SCHEIBEL ME, 1975, AGING-US, V1, P11
   SCHEIBEL ME, 1969, CLIN MORPHOLOGIC NEU, V8, P4606
   SODERBERG M, 1990, J NEUROCHEM, V54, P415, DOI 10.1111/j.1471-4159.1990.tb01889.x
   STIER A, 1973, BIOCHIM BIOPHYS ACTA, V311, P400, DOI 10.1016/0005-2736(73)90320-9
   STOKES CE, 1987, J NEUROCHEM, V48, P1018, DOI 10.1111/j.1471-4159.1987.tb05619.x
   STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565
   SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x
   VALTERSSON C, 1982, J LIPID RES, V23, P868
   VALTERSSON C, 1985, J BIOL CHEM, V260, P2742
   VANDERKOOI G, 1974, BIOCHIM BIOPHYS ACTA, V344, P307, DOI 10.1016/0304-4157(74)90011-2
   VANDIJCK PWM, 1976, BIOCHIM BIOPHYS ACTA, V455, P576, DOI 10.1016/0005-2736(76)90326-6
NR 26
TC 548
Z9 609
U1 4
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0024-4201
EI 1558-9307
J9 LIPIDS
JI Lipids
PD JUN
PY 1991
VL 26
IS 6
BP 421
EP 425
DI 10.1007/BF02536067
PG 5
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA FQ560
UT WOS:A1991FQ56000003
PM 1881238
DA 2024-02-19
ER

PT J
AU Bulteau, AL
   Petropoulos, I
   Friguet, B
AF Bulteau, AL
   Petropoulos, I
   Friguet, B
TI Age-related alterations of proteasome structure and function in aging
   epidermis
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Proceedings Paper
CT Biological Aging - Euroconference on Molecular, Cellular and Tissue
   Gerontology
CY MAY 06-10, 2000
CL SPA, BELGIUM
SP Int Assoc Gerontol, UN Programme Ageing
DE aging; human epidermal cells; protein oxidation; proteolysis; proteasome
   structure and function
ID MULTICATALYTIC PROTEINASE; OXIDATIVE INACTIVATION; 20S PROTEASOME;
   LIVER; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; HEAT-SHOCK-PROTEIN-90;
   RESTRICTION; PROTECTION
AB Recent studies on the effect of aging in epidermal cells have evidenced a decrease of proteasome activity and content, suggesting that proteasome is down-regulated in aged cells. The 20S proteasome is the major proteolytic system that has been implicated in removal of abnormal and oxidatively damaged proteins. Therefore, a decreased proteasome content may explain, at least in part, the well-documented age-related accumulation of oxidized proteins. To gain further insight in other mechanisms that may be implicated in a decreased activity of the proteasome with age, 20S proteasome has been purified from the epidermis from donors of different ages: young, middle-aged and old. The patterns of proteasome subunits have been analyzed by 2D gel electrophoresis to determine whether its structure is also affected with age. The 2D gel pattern of proteasome subunits was found to be modified for four subunits, indicating that the observed decline in proteasome activity with age may also be related to alterations of its subunits. These subunit alterations are likely to be involved in the age-related decrease of proteasome activity since the specific peptidase activities of the purified proteasome were found to be decreased with age. (C) 2000 Elsevier Science Inc. All rights reserved.
C1 Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, F-75251 Paris 05, France.
C3 Universite Paris Cite
RP Friguet, B (corresponding author), Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, CC 1728,2 Pl Jussieu, F-75251 Paris 05, France.
RI bulteau, anne-laure/AAN-4004-2020
OI Friguet, Bertrand/0000-0001-8085-1961; Petropoulos,
   Isabelle/0000-0001-9205-7458
CR Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173, DOI 10.1093/gerona/53A.3.B173
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   CHONDROGIANNI N, 2000, EXP GERONTOL, V35
   Conconi M, 1998, BIOCHEM J, V333, P407, DOI 10.1042/bj3330407
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   Friedrich C, 1997, MICROSYST TECHNOL, V4, P21, DOI 10.1007/s005420050085
   FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222
   FRIGUET B, 1994, J BIOL CHEM, V269, P21639
   Friguet B, 2000, ANN NY ACAD SCI, V908, P143
   Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0
   HANDIL KB, 1995, BIOCHEM J, V305, P242
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   HENDIL KB, 1991, J BIOCHEM BIOPH METH, V22, P159, DOI 10.1016/0165-022X(91)90028-U
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Merker K, 2000, ARCH BIOCHEM BIOPHYS, V375, P50, DOI 10.1006/abbi.1999.1657
   MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199
   Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   WAGNER BJ, 1995, ARCH BIOCHEM BIOPHYS, V323, P455, DOI 10.1006/abbi.1995.0067
NR 23
TC 142
Z9 150
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD SEP
PY 2000
VL 35
IS 6-7
SI SI
BP 767
EP 777
DI 10.1016/S0531-5565(00)00136-4
PG 11
WC Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 367ZQ
UT WOS:000090093100013
PM 11053667
DA 2024-02-19
ER

PT J
AU Li, NN
   Cui, JY
   Wen, CY
   Huang, KX
AF Li, Nannan
   Cui, Jiayue
   Wen, Chunyan
   Huang, Kexin
TI Different cellular properties and loss of nuclear signalling of porcine
   epidermal growth factor receptor with aging
SO GENERAL AND COMPARATIVE ENDOCRINOLOGY
LA English
DT Article
DE EGFR; EGF; Signalling pathway; Cell behaviour; Aging
ID EGF RECEPTOR; LOCALIZATION; PHOSPHORYLATION; TRAFFICKING; TRANSLOCON;
   CAVEOLIN-1; NETWORK; LIVER
AB Epidermal growth factor (EGF) has important physiological functions that are mediated by the epidermal growth factor receptor (EGFR); however, to date, the changes in cellular behaviours and signalling properties of EGF/EGFR with aging remain unclear in the pig tissue models. Hence, the present study used porcine hepatocytes as a model to explore this issue. The study revealed the following results: 1) EGF could activate the intra-cellular signalling pathways in a time- and dose-dependent manner both in the young- and aged-pig hepatocytes, EGF induced tyrosine phosphorylation of EGFR, signal transducers and activators of transcription 3 (STAT3), protein kinase B (AKT) and extra-cellular signal-regulated kinase 1/2 (ERK1/2). Nevertheless, the EGF's signalling ability in the aged-pig hepatocytes was significantly reduced compared with that of the young-pig hepatocytes; 2) although EGF/EGFR can still be internalised into cells in a time-dependent manner with aging, the endocytic pathway differs between the young- and aged-pig hepatocytes. Furthermore, the results of the present study indicated that caveolin may play a pivotal role in the endocytosis of EGF/EGFR in the aged-pig hepatocytes, which is different from that of EGF/EGFR's endocytosis in young-pig hepatocytes; 3) It is well-known that EGFR carried out its biological effects via two signalling pathways, cytoplasmic pathway (traditional) and nuclear pathway; however, we found that the nuclear localisation of EGFR was significantly reduced in the aged-pig hepatocytes, which indicated that EGFR may lose its nuclear pathway with aging. Collectively, the present study lays the foundation for further study regarding the biological functional changes occurring in EGF/EGFR with aging.
C1 [Li, Nannan] Jilin Univ, Sch Stomatol, Changchun 130021, Peoples R China.
   [Cui, Jiayue; Huang, Kexin] Jilin Univ, Coll Basic Med, Dept Histol & Embryol, Changchun 130021, Peoples R China.
   [Wen, Chunyan] Jilin Univ, Dept Pathol, China Japan Union Hosp, Changchun 130033, Peoples R China.
C3 Jilin University; Jilin University; Jilin University
RP Huang, KX (corresponding author), Jilin Univ, Coll Basic Med, Dept Histol & Embryol, Changchun 130021, Peoples R China.
EM tougaoJL@163.com
FU Effect of Er:YAG laser on dentin bond strength under selfetching
   adhesive systems of Jilin Provincial Finance Department [:20180536]
FX This work was supported by the Effect of Er:YAG laser on dentin bond
   strength under selfetching adhesive systems of Jilin Provincial Finance
   Department (Grant:20180536).
CR Agelaki S, 2009, CANCER BIOL THER, V8, P1470, DOI 10.4161/cbt.8.15.8939
   Babitha V, 2014, GEN COMP ENDOCR, V198, P1, DOI 10.1016/j.ygcen.2013.12.004
   Brand TM, 2011, DISCOV MED, V12, P419
   Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263
   Cho KA, 2005, MECH AGEING DEV, V126, P105, DOI 10.1016/j.mad.2004.09.029
   Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004
   Geller SA, 2008, ARCH PATHOL LAB MED, V132, P490, DOI 10.1043/1543-2165(2008)132[490:AOITLA]2.0.CO;2
   Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005
   Hinrichs A, 2018, MOL METAB, V11, P113, DOI 10.1016/j.molmet.2018.03.006
   Lan HN, 2017, DOMEST ANIM ENDOCRIN, V61, P39, DOI 10.1016/j.domaniend.2017.05.003
   Lan HN, 2019, J CLIN ENDOCR METAB, V104, P1887, DOI 10.1210/jc.2018-02063
   Lan HN, 2018, GEN COMP ENDOCR, V266, P101, DOI 10.1016/j.ygcen.2018.05.002
   Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802
   Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802
   Liu KC, 2013, GEN COMP ENDOCR, V181, P288, DOI 10.1016/j.ygcen.2012.07.032
   Lo HW, 2010, DISCOV MED, V10, P44
   Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007
   MARTI U, 1989, HEPATOLOGY, V9, P126, DOI 10.1002/hep.1840090122
   MARTI U, 1991, HEPATOLOGY, V13, P15, DOI 10.1016/0270-9139(91)90210-M
   Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005
   Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018
   Reenstra WR, 1996, EXP CELL RES, V227, P252, DOI 10.1006/excr.1996.0274
   Wang YN, 2012, J BIOL CHEM, V287, P16869, DOI 10.1074/jbc.M111.314799
   Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659
   Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4
NR 25
TC 2
Z9 2
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0016-6480
EI 1095-6840
J9 GEN COMP ENDOCR
JI Gen. Comp. Endocrinol.
PY 2020
VL 290
AR 113415
DI 10.1016/j.ygcen.2020.113415
PG 16
WC Endocrinology & Metabolism; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Zoology
GA KW1QO
UT WOS:000520946200005
PM 32001323
DA 2024-02-19
ER

PT J
AU Ashpole, NM
   Herron, JC
   Mitschelen, MC
   Farley, JA
   Logan, S
   Yan, H
   Ungvari, Z
   Hodges, EL
   Csiszar, A
   Ikeno, Y
   Humphrey, MB
   Sonntag, WE
AF Ashpole, Nicole M.
   Herron, Jacquelyn C.
   Mitschelen, Matthew C.
   Farley, Julie A.
   Logan, Sreemathi
   Yan, Han
   Ungvari, Zoltan
   Hodges, Erik L.
   Csiszar, Anna
   Ikeno, Yuji
   Humphrey, Mary Beth
   Sonntag, William E.
TI IGF-1 Regulates Vertebral Bone Aging Through Sex-Specific and
   Time-Dependent Mechanisms
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
DE AGING; IGF-1; BONE mu CT; BONE HISTOMORPHOMETRY; OSTEOPROTEGERIN
ID GROWTH-FACTOR-I; MINERAL DENSITY; POSTNATAL-GROWTH; SERUM IGF-1;
   IDIOPATHIC OSTEOPOROSIS; ADVANCING AGE; ELDERLY-MEN; LIFE-SPAN; INSULIN;
   MICE
AB Advanced aging is associated with increased risk of bone fracture, especially within the vertebrae, which exhibit significant reductions in trabecular bone structure. Aging is also associated with a reduction in circulating levels of insulin-like growth factor (IGF-1). Studies have suggested that the reduction in IGF-1 compromises healthspan, whereas others report that loss of IGF-1 is beneficial because it increases healthspan and lifespan. To date, the effect of decreases in circulating IGF-1 on vertebral bone aging has not been thoroughly investigated. Here, we delineate the consequences of a loss of circulating IGF-1 on vertebral bone aging in male and female Igf(f/f) mice. IGF-1 was reduced at multiple specific time points during the mouse lifespan: early in postnatal development (crossing albumin-cyclic recombinase [Cre] mice with Igf(f/f) mice); and in early adulthood and in late adulthood using hepatic-specific viral vectors (AAV8-TBG-Cre). Vertebrae bone structure was analyzed at 27 months of age using micro-computed tomography (CT) and quantitative bone histomorphometry. Consistent with previous studies, both male and female mice exhibited age-related reductions in vertebral bone structure. In male mice, reduction of circulating IGF-1 induced at any age did not diminish vertebral bone loss. Interestingly, early-life loss of IGF-1 in females resulted in a 67% increase in vertebral bone volume fraction, as well as increased connectivity density and increased trabecular number. The maintenance of bone structure in the early-life IGF-1-deficient females was associated with increased osteoblast surface and an increased ratio of osteoprotegerin/receptor-activator of NF-B-ligand (RANKL) levels in circulation. Within 3 months of a loss of IGF-1, there was a 2.2-fold increase in insulin receptor expression within the vertebral bones of our female mice, suggesting that local signaling may compensate for the loss of circulating IGF-1. Together, these data suggest the age-related loss of vertebral bone density in females can be reduced by modifying circulating IGF-1 levels early in life. (c) 2015 American Society for Bone and Mineral Research.
C1 [Ashpole, Nicole M.; Mitschelen, Matthew C.; Farley, Julie A.; Logan, Sreemathi; Yan, Han; Ungvari, Zoltan; Hodges, Erik L.; Csiszar, Anna; Sonntag, William E.] Univ Oklahoma, Hlth Sci Ctr, Donald W Reynolds Dept Geriatr Med, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK USA.
   [Herron, Jacquelyn C.; Humphrey, Mary Beth] Univ Oklahoma, Hlth Sci Ctr, Dept Immunol Rheumatol Allergy Med, Oklahoma City, OK USA.
   [Ikeno, Yuji] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Dept Pathol, San Antonio, TX 78229 USA.
   [Humphrey, Mary Beth] Dept Vet Affairs, Oklahoma City, OK USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Oklahoma System; University of Oklahoma Health
   Sciences Center; University of Texas System; University of Texas Health
   Science Center at San Antonio
RP Sonntag, WE (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, 975 NE 10th St,SLY BRC 1303, Oklahoma City, OK 73104 USA.
EM william-sonntag@ouhsc.edu
RI Hodges, Erik Lewis/AAO-2927-2020; Ungvari, Zoltan/GZK-8127-2022; Wrong,
   Wrong/ADU-0095-2022; Logan, Sreemathi/AAV-1098-2021
OI Hodges, Erik Lewis/0000-0002-6123-3540; sonntag,
   William/0000-0003-1850-2407; Logan, Sreemathi/0000-0001-9160-0383
FU NIH [R01AG038747]; OAIC [P30 AG028718]; Donald W. Reynolds Foundation
FX This work was supported by NIH R01AG038747 (to WES), OAIC grant P30
   AG028718, and the Donald W. Reynolds Foundation. We thank the
   Histomorphometry and Molecular Analysis Core in the Department of
   Pathology at the University of Alabama at Birmingham for their
   assistance.
CR Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120
   Ashpole NM, 2015, EXP GERONTOL, V68, P76, DOI 10.1016/j.exger.2014.10.002
   BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
   BANDO H, 1991, ACTA ENDOCRINOL-COP, V124, P31, DOI 10.1530/acta.0.1240031
   Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7
   Bartke A, 2003, BIOGERONTOLOGY, V4, P1, DOI 10.1023/A:1022448532248
   Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603
   Bikle D, 2001, J BONE MINER RES, V16, P2320, DOI 10.1359/jbmr.2001.16.12.2320
   Birkhold AI, 2014, BIOMATERIALS, V35, P9290, DOI 10.1016/j.biomaterials.2014.07.051
   Böni-Schnetzler M, 1999, DIABETOLOGIA, V42, P160, DOI 10.1007/s001250051134
   Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]
   CORPAS E, 1993, J CLIN ENDOCR METAB, V76, P134, DOI 10.1210/jc.76.1.134
   Courtland HW, 2013, AGE, V35, P1691, DOI 10.1007/s11357-012-9469-8
   Courtland HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014762
   Courtland HW, 2011, J BONE MINER RES, V26, P761, DOI 10.1002/jbmr.265
   Crane JL, 2014, J MOL MED, V92, P107, DOI 10.1007/s00109-013-1084-3
   Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
   Eckstein F, 2007, J BONE MINER RES, V22, P817, DOI 10.1359/JBMR.070301
   Frenkel B, 2010, J CELL PHYSIOL, V224, P305, DOI 10.1002/jcp.22159
   Fulzele K, 2007, J BIOL CHEM, V282, P25649, DOI 10.1074/jbc.M700651200
   Fulzele K, 2012, BONE, V50, P452, DOI 10.1016/j.bone.2011.06.018
   Gillberg P, 2002, CALCIFIED TISSUE INT, V70, P22, DOI 10.1007/s002230020048
   Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507
   Gong ZW, 2014, AGING CELL, V13, P408, DOI 10.1111/acel.12188
   Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044
   HAYDEN JM, 1995, BONE, V17, pS93, DOI 10.1016/8756-3282(95)00186-H
   He JN, 2006, BONE, V38, P826, DOI 10.1016/j.bone.2005.11.021
   Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367
   Janssen JAMJL, 1998, EUR J ENDOCRINOL, V138, P627, DOI 10.1530/eje.0.1380627
   Khosla S, 2012, TRENDS ENDOCRIN MET, V23, P576, DOI 10.1016/j.tem.2012.03.008
   Kubota T, 2013, ACTA ASTRONAUT, V92, P73, DOI 10.1016/j.actaastro.2012.08.007
   Kurland ES, 1997, J CLIN ENDOCR METAB, V82, P2799, DOI 10.1210/jc.82.9.2799
   Langlois JA, 1998, J CLIN ENDOCR METAB, V83, P4257, DOI 10.1210/jc.83.12.4257
   List EO, 2014, ENDOCRINOLOGY, V155, P1793, DOI 10.1210/en.2013-2086
   Liu JM, 2008, J BONE MINER METAB, V26, P159, DOI 10.1007/s00774-007-0799-z
   LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4
   Lochmüller EM, 2008, J BONE MINER RES, V23, P1964, DOI [10.1359/jbmr.080709, 10.1359/JBMR.080709]
   Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385
   Mócsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101
   Mohamad MI, 2015, ARCH GERONTOL GERIAT, V60, P124, DOI 10.1016/j.archger.2014.08.011
   Niblock MM, 1998, BRAIN RES, V804, P79, DOI 10.1016/S0006-8993(98)00645-3
   Paccou J, 2012, JOINT BONE SPINE, V79, P78, DOI 10.1016/j.jbspin.2011.06.002
   Rhee EJ, 2004, J BONE MINER METAB, V22, P392, DOI 10.1007/s00774-003-0500-0
   Riggs BL, 2004, J BONE MINER RES, V19, P1945, DOI 10.1359/JBMR.040916
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   Seeman E, 2008, RHEUMATOLOGY, V47, P2, DOI 10.1093/rheumatology/ken177
   Seeman E, 2003, OSTEOPOROSIS INT, V14, pS2, DOI 10.1007/s00198-002-1340-9
   Sheng Matilda H C, 2014, J Bone Metab, V21, P41, DOI 10.11005/jbm.2014.21.1.41
   Sjögren K, 2002, J BONE MINER RES, V17, P1977, DOI 10.1359/jbmr.2002.17.11.1977
   SMITH CP, 1989, J CLIN ENDOCR METAB, V68, P932, DOI 10.1210/jcem-68-5-932
   Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001
   Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058
   Sugimoto T, 1997, J BONE MINER RES, V12, P1272, DOI 10.1359/jbmr.1997.12.8.1272
   Szulc P, 2004, CALCIFIED TISSUE INT, V74, P322, DOI 10.1007/s00223-003-0090-9
   Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006
   Torchia EC, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-11
   Toth P, 2014, J CEREBR BLOOD F MET, V34, P1887, DOI 10.1038/jcbfm.2014.156
   Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734
   Wang YM, 2006, ENDOCRINOLOGY, V147, P4753, DOI 10.1210/en.2006-0196
   Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805
   Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324
   Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763
   Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110
   Yakar S, 2009, J BONE MINER RES, V24, P1481, DOI [10.1359/JBMR.090226, 10.1359/jbmr.090226]
   Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200
NR 67
TC 36
Z9 40
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD FEB
PY 2016
VL 31
IS 2
BP 443
EP 454
DI 10.1002/jbmr.2689
PG 12
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA DD8NE
UT WOS:000370182900021
PM 26260312
OA Bronze, Green Accepted
DA 2024-02-19
ER

PT J
AU Zhao, XJ
   Zhuo, HX
AF Zhao, Xiu-Ju
   Zhuo, Hexian
TI ECR-MAPK Regulation in Liver Early Development
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID GENE-EXPRESSION; CANCER; ACTIVATION; CXCL13; MODEL
AB Early growth is connected to a key link between embryonic development and aging. In this paper, liver gene expression profiles were assayed at postnatal day 22 and week 16 of age. Meanwhile another independent animal experiment and cell culture were carried out for validation. Significance analysis of microarrays, qPCR verification, drug induction/inhibition assays, and metabonomics indicated that alpha-2u globulin (extracellular region)-socs2 (-SH2-containing signals/receptor tyrosine kinases)-ppp2r2a/pik3c3 (MAPK signaling)-hsd3b5/cav2 (metabolism/organization) plays a vital role in early development. Taken together, early development of male rats is ECR and MAPK-mediated coordination of cancer-like growth and negative regulations. Our data represent the first comprehensive description of early individual development, which could be a valuable basis for understanding the functioning of the gene interaction network of infant development.
C1 [Zhao, Xiu-Ju] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Collaborat Innovat Ctr Proc Agr Prod Hubei Prov, Wuhan 430023, Peoples R China.
   [Zhao, Xiu-Ju] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan 430071, Peoples R China.
   [Zhuo, Hexian] Xinxiang Inst Drug Control, Xinxiang 453000, Peoples R China.
C3 Wuhan Polytechnic University; Chinese Academy of Sciences; Wuhan
   Institute of Physics & Mathematics, CAS
RP Zhao, XJ (corresponding author), Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Collaborat Innovat Ctr Proc Agr Prod Hubei Prov, 68 South Xuefu Rd, Wuhan 430023, Peoples R China.
EM dzrdez@163.com
RI zhao, xiu-ju/A-6529-2012
OI zhao, xiu-ju/0000-0003-4962-6285
FU Natural Science Foundation of Hubei Province [2012FFB04802]; Wuhan
   Polytechnic University [2012RZ06]
FX The authors would like to acknowledge KR Shockley. This work was
   supported in part by Natural Science Foundation of Hubei Province
   (2012FFB04802), Wuhan Polytechnic University (2012RZ06).
CR AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450
   AUE WP, 1976, J CHEM PHYS, V64, P4226, DOI 10.1063/1.431994
   Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837
   Becker D, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-55
   Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314
   BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3
   CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518
   Conforto TL, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-9
   Dey BR, 1998, J BIOL CHEM, V273, P24095, DOI 10.1074/jbc.273.37.24095
   Doncic A, 2013, MOL CELL, V50, P856, DOI 10.1016/j.molcel.2013.04.014
   Dunnick JK, 2012, TOXICOL PATHOL, V40, P93, DOI 10.1177/0192623311429973
   Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504
   Guillén N, 2009, PHYSIOL GENOMICS, V37, P187, DOI 10.1152/physiolgenomics.90339.2008
   Hastie T., 2008, ELEMENTS STAT LEARNI
   Henegar C, 2006, LECT NOTES COMPUT SC, V4212, P186
   Jenh CH, 2001, CYTOKINE, V15, P113, DOI 10.1006/cyto.2001.0923
   Li TT, 2009, GENOMICS, V93, P235, DOI 10.1016/j.ygeno.2008.10.006
   Lindgren F, 1996, J CHEMOMETR, V10, P521
   Lui JC, 2013, P NATL ACAD SCI USA, V110, P6181, DOI 10.1073/pnas.1219079110
   Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Rodrigues FCC, 2003, CANCER GENET CYTOGEN, V142, P92, DOI 10.1016/S0165-4608(02)00839-7
   ROY AK, 1987, J STEROID BIOCHEM, V27, P1129, DOI 10.1016/0022-4731(87)90199-3
   ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345
   Rupprecht TA, 2007, INFECT IMMUN, V75, P4351, DOI 10.1128/IAI.01642-06
   Spear BT, 2006, CELL MOL LIFE SCI, V63, P2922, DOI 10.1007/s00018-006-6258-5
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Todorov V, 2010, COMPUT STAT DATA AN, V54, P37, DOI 10.1016/j.csda.2009.08.015
   Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695
   Tsai CA, 2003, BIOMETRICS, V59, P1071, DOI 10.1111/j.0006-341X.2003.00123.x
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67
   Wang J, 2013, CANCER BIOL THER, V14, P262, DOI 10.4161/cbt.23299
   Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200
   Wang WB, 2009, MOL BIOTECHNOL, V43, P221, DOI 10.1007/s12033-009-9199-z
   Zhao XJ, 2011, J PROTEOME RES, V10, P5183, DOI 10.1021/pr2006457
NR 36
TC 6
Z9 8
U1 0
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
VL 2014
AR 850802
DI 10.1155/2014/850802
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AY8HA
UT WOS:000347793700001
PM 25580437
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Kolgiri, V
   Patil, VW
AF Kolgiri, Vaishali
   Patil, Vinayak Wamanrao
TI Protein carbonyl content: a novel biomarker for aging in HIV/AIDS
   patients
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Carbonyl content; DNA damage; Human immunodeficiency virus; (HIV)
   infection; 8-OH-dG ROS
ID OXIDATIVE STRESS; HIV-INFECTION
AB Background: The major complications of "treated" Human Immunodeficiency Virus (HIV) infection are cardiovascular disease, malignancy, renal disease, liver disease, bone disease, and perhaps neurological complications, which are phenomena of the normal aging process occurring at an earlier age in the HIV-infected population. The present study is aimed to explore protein carbonyl content as a biomarker for detecting oxidative DNA damage induced ART toxicity and/or accelerated aging in HIV/AIDS patients.
   Objective: To investigate the potential of carbonyl content as a biomarker for detecting oxidative Deoxyribonucleic acid (DNA) damage induced Antiretroviral Theraphy (ART) toxicity and/or accelerated aging in HIV/AIDS patients.
   Methods: In this case control study a total 600 subjects were included. All subjects were randomly selected and grouped as HIV-negative (control group) (n = 300), HIV-infected ART naive (n = 100), HIV-infected on first line ART (n = 100), and HIV-infected on second line ART (n = 100). Seronegative control subjects were age-and sex-matched with the ART naive patients and the two other groups. Carbonyl protein was determined by the method described in Levine et al. DNA damage marker 8-OH-dG was determined using 8-hydroxy-2-deoxy Guanosine StressXpress ELA Kit by StressMarq Biosciences.
   Results: Protein carbonyl content levels and oxidative DNA damage were significantly higher (p <0.05) in HIV-infected patients on second line ART and HIV-infected patients on first line ART than ART naive patients and controls. In a linear regression analysis, increased protein carbonyl content was positively associated with increased DNA damage (OR: 0.356; 95% CI: 0.287-0.426) p <0.05.
   Conclusions: Carbonyl content may has a role as a biomarker for detecting oxidative DNA damage induced ART toxicity and/or accelerated aging in HIV/AIDS patients. Larger studies are warranted to elucidate the role of carbonyl content as a biomarker for premature aging in HIV/AIDS patients. (C) 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.
C1 [Kolgiri, Vaishali] Grant Govt Med Coll Hosp, Dept Biochem, Mumbai, Maharashtra, India.
   Sir JJ Grp Hosp, Dept Biochem, Mumbai, Maharashtra, India.
RP Kolgiri, V (corresponding author), Grant Govt Med Coll Hosp, Dept Biochem, Mumbai, Maharashtra, India.
EM vaishali.h@gmail.com
CR Aukrust P, 2005, BLOOD, V105, P4730, DOI 10.1182/blood-2004-11-4272
   Dalle-Donne I, CLIN CHIM ACTA
   Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756
   Hiraku, 2010, ANN NY ACAD SCI, V1203, P15
   Höhn A, 2013, J PROTEOMICS, V92, P132, DOI 10.1016/j.jprot.2013.01.004
   Horvath S, J INFECT DIS
   Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Olinski R, 2006, ANTIOXID REDOX SIGN, V8, P1011, DOI 10.1089/ars.2006.8.1011
   Pandey G, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0159-9
   Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168
   Perrin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041129
   Reeg S, 2015, ANTIOXID REDOX SIGN, V23, P239, DOI 10.1089/ars.2014.6062
   Rickabaugh TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119201
   Rodriguez Song, 2013, PLOS GENET, V9
   Sedelnikova OA, 2010, MUTAT RES-REV MUTAT, V704, P152, DOI 10.1016/j.mrrev.2009.12.005
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Stadtman ER, CHEM RES TOXICOL
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887
   Thanan R, 2015, INT J MOL SCI, V16, P193, DOI 10.3390/ijms16010193
   Tones RA, 2014, LAB INVEST, V94, P120
   Vajpayee M, 2011, INDIAN J MED RES, V134, P801, DOI 10.4103/0971-5916.92627
   Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684
   van Melis Steeg, ANTIOXID REDOX SIGNA
   Wendelken LA, 2012, J NEUROVIROL, V18, P256, DOI 10.1007/s13365-012-0094-1
   YERMILOV V, 1995, CARCINOGENESIS, V16, P2045, DOI 10.1093/carcin/16.9.2045
NR 28
TC 17
Z9 22
U1 0
U2 9
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD JAN-FEB
PY 2017
VL 21
IS 1
BP 35
EP 41
DI 10.1016/j.bjid.2016.09.007
PG 7
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA EL7WE
UT WOS:000394831200006
PM 27821249
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Umezawa, M
   Tatematsu, K
   Korenaga, T
   Fu, XY
   Matushita, T
   Okuyama, H
   Hosokawa, M
   Takeda, T
   Higuchi, K
AF Umezawa, M
   Tatematsu, K
   Korenaga, T
   Fu, XY
   Matushita, T
   Okuyama, H
   Hosokawa, M
   Takeda, T
   Higuchi, K
TI Dietary fat modulation of apoA-II metabolism and prevention of senile
   amyloidosis in the senescence-accelerated mouse
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE apolipoprotein A-II; apolipoprotein A-II amyloid fibril; high density
   lipoprotein
ID APOLIPOPROTEIN-A-II; HIGH-DENSITY-LIPOPROTEIN; UNLABELED
   IMMUNOPEROXIDASE METHOD; AGE-ASSOCIATED AMYLOIDOSIS; FISH OIL;
   ALZHEIMERS-DISEASE; SAFFLOWER OIL; MICE; CHOLESTEROL; SAM
AB Senescence-accelerated mouse-prone (SAMP1; SAMP1@Umz) is an animal model of senile amyloidosis with apolipoprotein A-II (apoA-II) amyloid fibril (AApoAII) deposits. This study was undertaken to investigate the effects of dietary fats on AApoAII deposits in SAMP1 mice when purified diets containing 4% fat as butter, safflower oil, or fish oil were fed to male mice for 26 weeks. The serum HDL cholesterol was significantly lower (P < 0.01) in mice on the diet containing fish oil (7.4 +/- 3.0 mg/dl) than in mice on the butter diet (38.7 +/- 12.5 mg/dl), which in turn had significantly lower (P < 0.01) HDL levels than mice on the safflower oil diet (51.9 +/- 5.6 mg/dI). ApoA-II was also significantly lower (P < 0.01) in mice on the fish oil diet (7.6 +/- 2.7 mg/dl) than on the butter (26.9 +/- 7.3 mg/dl) or safflower oil (21.6 +/- 3.7 mg/dl) diets. The mice fed fish oil had a significantly greater ratio (P < 0.01) of apoA-I to apoA-II, and a smaller HDL particle size than those fed butter and safflower oil. Severe AApoAII deposits in the spleen, heart, skin, liver, and stomach were shown in the fish oil group compared with those in the butter and safflower oil groups (fish oil > butter > safflower oil group, P < 0.05).jlr These findings suggest that dietary fats differ in their effects on serum lipoprotein metabolism, and that dietary lipids may modulate amyloid deposition in SAMP1 mice.
C1 Koshien Univ, Dept Nutr, Takarazuka, Hyogo 6650006, Japan.
   Nagoya City Univ, Grad Sch Pharmaceut Biol Chem, Dept Prevent Nutraceut Sci, Nagoya, Aichi 4678603, Japan.
   Kyoto Univ, Inst Frontier Med Sci, Field Regenerat Control, Kyoto 6068397, Japan.
   Shinshu Univ, Sch Med, Res Ctr Aging & Adapt, Dept Aging Angiol, Matsumoto, Nagano 3908621, Japan.
C3 Nagoya City University; Kyoto University; Shinshu University
RP Umezawa, M (corresponding author), Koshien Univ, Dept Nutr, 10-1 Momijigaoka, Takarazuka, Hyogo 6650006, Japan.
EM umezawa@koshien.ac.jp
CR AHN YS, 1994, J NUTR, V124, P2147, DOI 10.1093/jn/124.11.2147
   BABIAK J, 1988, ARTERIOSCLEROSIS, V8, P22, DOI 10.1161/01.ATV.8.1.22
   BEER F, 1993, J LIPID RES, V34, P1275
   BERDANIER CD, 1992, FATTY ACIDS FOODS TH, P531
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   CATHCART ES, 1987, J IMMUNOL, V139, P1850
   Chiba T, 1999, AM J PATHOL, V155, P1319, DOI 10.1016/S0002-9440(10)65234-0
   CHOI YS, 1989, LIPIDS, V24, P45, DOI 10.1007/BF02535263
   COX C, 1995, J LIPID RES, V36, P1787
   DOOLITTLE MH, 1990, J BIOL CHEM, V265, P16380
   Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098
   FUJIHARA S, 1980, LAB INVEST, V43, P358
   HALMINSKI MA, 1991, J NUTR, V121, P1554, DOI 10.1093/jn/121.10.1554
   HANG A, 1987, J NUTR, V117, P1011
   HIGUCHI K, 1983, LAB INVEST, V48, P231
   HIGUCHI K, 1993, FEBS LETT, V317, P207, DOI 10.1016/0014-5793(93)81277-7
   HIGUCHI K, 1983, J EXP MED, V158, P1600, DOI 10.1084/jem.158.5.1600
   HIGUCHI K, 1991, BIOCHEM J, V279, P427, DOI 10.1042/bj2790427
   HIGUCHI K, 1995, LAB INVEST, V72, P75
   Higuchi K, 1999, METHOD ENZYMOL, V309, P674
   HIGUCHI K, 1986, J BIOL CHEM, V261, P2834
   Higuchi K, 1997, EXP GERONTOL, V32, P129, DOI 10.1016/S0531-5565(96)00060-5
   HIGUCHI K, 1991, VIRCHOWS ARCH B, V60, P231, DOI 10.1007/BF02899551
   HIGUCHI K, 1986, FEBS LETT, V207, P23, DOI 10.1016/0014-5793(86)80006-0
   IKEDA I, 1994, J NUTR, V124, P1898, DOI 10.1093/jn/124.10.1898
   Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X
   KOHNO A, 1985, J NUTR, V115, P1259, DOI 10.1093/jn/115.10.1259
   Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998
   LI JJ, 1984, SCAND J IMMUNOL, V20, P219, DOI 10.1111/j.1365-3083.1984.tb00995.x
   MATSUMURA A, 1982, LAB INVEST, V47, P270
   Mehrabian M, 1992, MOL GENETICS CORONAR, P363
   NAIKI H, 1993, LAB INVEST, V68, P332
   NAIKI H, 1988, AM J PATHOL, V130, P579
   PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355
   PURCELLHUYNH DA, 1995, J CLIN INVEST, V96, P1845, DOI 10.1172/JCI118230
   ROACH PD, 1987, FEBS LETT, V222, P159, DOI 10.1016/0014-5793(87)80211-9
   Simons M, 2001, NEUROLOGY, V57, P1089, DOI 10.1212/WNL.57.6.1089
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKEDA T, 1988, AMYLOID AMYLOIDOSIS, P985
   TAKESHITA S, 1982, MECH AGEING DEV, V20, P13, DOI 10.1016/0047-6374(82)90070-7
   UMEZAWA M, 1990, J NUTR, V120, P1393, DOI 10.1093/jn/120.11.1393
   Umezawa M, 2000, J NUTR, V130, P221, DOI 10.1093/jn/130.2.221
   Westermark GT, 2000, UPSALA J MED SCI, V105, P97, DOI 10.1517/03009734000000057
   WILLIAMS RC, 1965, ANN INTERN MED, V62, P1000, DOI 10.7326/0003-4819-62-5-1000
   Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439
   Wolozin B, 2001, P NATL ACAD SCI USA, V98, P5371, DOI 10.1073/pnas.101123198
   YAMAMOTO N, 1987, J LIPID RES, V28, P144
   YONEZU T, 1986, FEBS LETT, V203, P149, DOI 10.1016/0014-5793(86)80732-3
NR 48
TC 17
Z9 17
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-2275
EI 1539-7262
J9 J LIPID RES
JI J. Lipid Res.
PD APR
PY 2003
VL 44
IS 4
BP 762
EP 769
DI 10.1194/jlr.M200405-JLR200
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 667DA
UT WOS:000182214500012
PM 12562830
OA hybrid
DA 2024-02-19
ER

PT J
AU Alabarse, PVG
   Salomon, TB
   Medeiros, TM
   Hackenhaar, FS
   Schüller, AK
   Ehrenbrink, G
   Benfato, MS
AF Alabarse, Paulo V. G.
   Salomon, Tiago B.
   Medeiros, Tassia M.
   Hackenhaar, Fernanda S.
   Schueller, Artur K.
   Ehrenbrink, Guilherme
   Benfato, Mara S.
TI Oxidative stress in the kidney of reproductive male rats during aging
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Reproduction; Antioxidant enzymes; Antioxidant compounds; Hormones;
   Oxidative damage
ID GLUTATHIONE-PEROXIDASE; ENERGY-METABOLISM; PROTEIN DAMAGE;
   ASCORBIC-ACID; LIVER; TESTOSTERONE; COST; SEX; ACONITASE; BRAIN
AB Reproduction alters the male physiology. We performed a comprehensive examination of oxidative stress in the kidneys of male rats with (experienced) or without (naive) reproductive activity during aging. Oxidative stress was assessed by measuring the activity of catalase, glutathione peroxidase, glutathione S-transferase, and superoxide dismutase, and by measuring protein carbonylation, lipid peroxidation, nitrite and nitrate levels, vitamin C levels, and glutathione (total, reduced, and oxidized forms) levels, and metabolism was accessed by aconitase activity in kidney tissue, as well as testosterone and estradiol levels in serum. Reproductively active animals exhibited increased testosterone levels and altered metabolism. Aging affects tissues and organs and contributes to their functional decline. Elderly naive rats showed high nitrite and nitrate levels. The experienced rats had less damage in elderly ages, probably because they had higher antioxidant amount and antioxidant enzyme activities at earlier ages, which would have avoided oxidative damage seen in naive group, and because of the metabolism decline. Glutathione increase in naive elder rats probably was induced for direct protection against oxidative damage and indirect protection by higher glutathione peroxidase and glutathione S-transferase activities. Linear regression shows that lipid peroxidation levels explained vitamin C levels (B standardized value of 0.42), indicating that vitamin C was properly produced or recruited into kidneys to combat lipid peroxidation. Catalase activity reflected the protein carbonylation and lipid peroxidation levels (B standardized values of 0.28 and 0.48). These results add comprehensive data regarding changes in oxidative stress during aging, and suggest an explanation for the costs of reproduction. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Benfato, Mara S.] Univ Fed Rio Grande do Sul, Dept Biofis, IB, Programa Posgrad Biol Celular & Mol, BR-91501970 Porto Alegre, RS, Brazil.
   [Salomon, Tiago B.; Medeiros, Tassia M.; Schueller, Artur K.; Ehrenbrink, Guilherme] Univ Fed Rio Grande do Sul, Dept Biofis, IB, Lab Estresse Oxidat, BR-91501970 Porto Alegre, RS, Brazil.
C3 Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio
   Grande do Sul
RP Benfato, MS (corresponding author), Univ Fed Rio Grande do Sul, Dept Biofis, IB, Programa Posgrad Biol Celular & Mol, Av Bento Goncalves 9500,Predio 43431, BR-91501970 Porto Alegre, RS, Brazil.
EM mara.benfato@ufrgs.br
RI Salomon, Tiago/L-9319-2015; Alabarse, Paulo VG/C-3122-2013; Salomon,
   Tiago/T-8230-2019; Hackenhaar, Fernanda Schäfer/R-7660-2016; Benfato,
   Mara S/G-4873-2012
OI Salomon, Tiago/0000-0002-6095-8291; Alabarse, Paulo
   VG/0000-0002-9721-9302; Salomon, Tiago/0000-0002-6095-8291; Benfato,
   Mara S/0000-0001-5997-1926; Hackenhaar, Fernanda/0000-0002-9395-2216
FU PPGBCM - Programa de Pos-Graduacao em Biologia Celular e Molecular;
   CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
FX We thank Z. Almeida for technical assistance. This research was
   supported by grants from PPGBCM - Programa de Pos-Graduacao em Biologia
   Celular e Molecular, and from CAPES - Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (Brazilian agencies for research support).
CR Abdallah GM, 2010, FOOD CHEM TOXICOL, V48, P1753, DOI 10.1016/j.fct.2010.04.006
   Abegg MA, 2010, MYCOPATHOLOGIA, V170, P11, DOI 10.1007/s11046-010-9294-5
   Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x
   Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764
   [Anonymous], 2000, EXPT PROTOCOLS REACT
   Arenas-Ríos E, 2007, COMP BIOCHEM PHYS A, V148, P150, DOI 10.1016/j.cbpa.2007.04.003
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brewer GJ, 2010, EXP GERONTOL, V45, P173, DOI 10.1016/j.exger.2009.11.007
   Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669
   Buemi M, 2005, REJUV RES, V8, P101, DOI 10.1089/rej.2005.8.101
   Costantini D, 2008, COMP BIOCHEM PHYS A, V151, pS49, DOI 10.1016/j.cbpa.2008.05.163
   Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x
   Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791
   Ehrenbrink G, 2006, EXP GERONTOL, V41, P368, DOI 10.1016/j.exger.2006.02.007
   Floccari F, 2005, MED RES REV, V25, P473, DOI 10.1002/med.20028
   GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248
   GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343
   Gatson JW, 2007, ENDOCRINOLOGY, V148, P2458, DOI 10.1210/en.2006-1443
   Alabarse PVG, 2011, EXP GERONTOL, V46, P241, DOI 10.1016/j.exger.2010.10.009
   Gobe G, 2010, TOXICOL LETT, V198, P49, DOI 10.1016/j.toxlet.2010.04.013
   Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378
   Grisham MB, 1996, METHOD ENZYMOL, V268, P237
   Guevara R, 2009, FREE RADICAL BIO MED, V46, P169, DOI 10.1016/j.freeradbiomed.2008.09.035
   Hackenhaar FS, 2009, CELL BIOCHEM FUNCT, V27, P378, DOI 10.1002/cbf.1585
   Halliwell B, 2007, FREE RADICALS BIOL M
   HAMILTON JB, 1969, J GERONTOL, V24, P395, DOI 10.1093/geronj/24.4.395
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008
   Herlein JA, 2009, ENDOCRINOLOGY, V150, P46, DOI 10.1210/en.2008-0404
   Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030
   Ikeda Y, 2009, ENDOCRINOLOGY, V150, P2857, DOI 10.1210/en.2008-1254
   Imaizumi N, 2006, LIFE SCI, V78, P2998, DOI 10.1016/j.lfs.2005.11.026
   Irnaten M, 2009, STEROIDS, V74, P642, DOI 10.1016/j.steroids.2009.02.002
   Jankauskas SS, 2010, BBA-BIOENERGETICS, V1797, P59, DOI 10.1016/j.bbabio.2010.04.194
   Karatepe M, 2004, LC GC N AM, V22, P362
   KIMURA H, 1992, J NUTR, V122, P1904, DOI 10.1093/jn/122.9.1904
   Krinke G. J., 2000, HDB EXPT ANIMALS LAB
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Matsumoto K, 2009, MOLECULES, V14, P4440, DOI 10.3390/molecules14114440
   Medvedeva LV, 2002, BIOL BULL+, V29, P426, DOI 10.1023/A:1020401423790
   Miles DB, 2007, FUNCT ECOL, V21, P653, DOI 10.1111/j.1365-2435.2007.01304.x
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Mladenov M, 2008, J THERM BIOL, V33, P431, DOI 10.1016/j.jtherbio.2008.07.001
   Musci G, 2006, MECH AGEING DEV, V127, P544, DOI 10.1016/j.mad.2006.01.012
   NIESCHLAG E, 1993, NATURE, V366, P215, DOI 10.1038/366215a0
   Percy CJ, 2008, NEPHROLOGY, V13, P147, DOI 10.1111/j.1440-1797.2008.00924.x
   Pérez-Torres I, 2010, METABOLISM, V59, P414, DOI 10.1016/j.metabol.2009.08.014
   Pham VV, 2009, NITRIC OXIDE-BIOL CH, V21, P210, DOI 10.1016/j.niox.2009.09.001
   PINTO RE, 1969, BIOCHEM J, V112, P109, DOI 10.1042/bj1120109
   Prabhakar R, 2006, BIOCHEMISTRY-US, V45, P6967, DOI 10.1021/bi060456e
   Ramara A, 2007, BRAIN RES, V1176, P71, DOI 10.1016/j.brainres.2007.08.036
   Reckelhoff JF, 2005, AM J PHYSIOL-RENAL, V289, pF941, DOI 10.1152/ajprenal.00034.2005
   Requintina PJ, 2005, ANN NY ACAD SCI, V1053, P400, DOI 10.1196/annals.1344.035
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145
   Tsuchida S., 2000, EXPT PROTOCOLS REACT, P83
   Verma Y, 2008, INDIAN J EXP BIOL, V46, P568
   Viña J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006
   Wadey AL, 2009, J NEUROCHEM, V109, P101, DOI 10.1111/j.1471-4159.2009.05936.x
   Wang Y, 2001, EXP GERONTOL, V36, P1349, DOI 10.1016/S0531-5565(01)00095-X
   Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171
   Wikelski M, 1999, J COMP PHYSIOL A, V185, P463, DOI 10.1007/s003590050407
   Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yi S, 2009, CLIN ENDOCRINOL, V71, P246, DOI 10.1111/j.1365-2265.2008.03455.x
   Yoshioka I, 2010, UROLOGY, V75, P907, DOI 10.1016/j.urology.2009.09.094
NR 69
TC 5
Z9 8
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT
PY 2011
VL 46
IS 10
BP 773
EP 780
DI 10.1016/j.exger.2011.05.006
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 825WO
UT WOS:000295313000001
PM 21619925
DA 2024-02-19
ER

PT J
AU Yamano, T
   Kosanke, SD
   Rikans, LE
AF Yamano, T
   Kosanke, SD
   Rikans, LE
TI Attenuation of cadmium-induced liver injury in senescent male Fischer
   344 rats: Role of metallothionein and glutathione
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE cadmium; hepatotoxicity; aging; metallothionein; glutathione
ID AGE-RELATED-CHANGES; INDUCED HEPATOTOXICITY; LIPID-PEROXIDATION;
   TRANSGENIC MICE; EXPRESSION; TOXICITY; CELLS; GALACTOSAMINE;
   HEPATOCYTES; RESTRICTION
AB The influence of aging on the sensitivity of the liver to the acute toxicity of cadmium has not been studied previously in adult rats. In this study hepatotoxicity caused by a single sc injection of CdCl2 was compared in 5-, 18-, and 28-month-old male Fischer 344 rats. Doses of Cd were adjusted on the basis of the mean lean body mass for each age group of rats, and liver injury was evaluated 24 h after treatment. Cd treatment produced substantial increases in serum alanine aminotransferase (ALT) and sorbitol dehydrogenase (SDH) activities in 5- and 18-month-old rats, whereas no significant increases were observed in 28-month-old rats. Histologic examination of representative livers from each age group confirmed the findings for serum enzyme activity; hepatocellular necrosis was observed only in livers from 5- and 18-month-old rats, The attenuation of Cd hepatotoxicity in senescent rats did not appear to be related to pretreatment levels of metallothionein or glutathione. Likewise, resistance to Cd could not be explained on the basis of metallothionein induction, which decreased as a function of aging. Thus, the mechanisms that account for the postmaturational decline in sensitivity to Cd do not appear to be associated with alterations in levels of the major factors that protect against Cd-induced hepatotoxicity, (C) 1999 Academic Press.
C1 Osaka City Inst Publ Hlth & Environm Sci, Osaka 543, Japan.
   Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA.
   Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Oklahoma System; University of Oklahoma Health
   Sciences Center
RP Yamano, T (corresponding author), Osaka City Inst Publ Hlth & Environm Sci, Osaka 543, Japan.
FU NIA NIH HHS [AG04984] Funding Source: Medline
CR ABDULHUSSAIN SK, 1991, TOXICOL APPL PHARM, V107, P504, DOI 10.1016/0041-008X(91)90313-4
   Bagchi D, 1996, BIOL TRACE ELEM RES, V52, P143, DOI 10.1007/BF02789456
   BORGHOFF SJ, 1986, DRUG METAB DISPOS, V14, P417
   Conrad CC, 1997, J TOXICOL ENV HEALTH, V52, P527
   Dong WM, 1998, TOXICOL APPL PHARM, V151, P359, DOI 10.1006/taap.1998.8481
   DUDLEY RE, 1984, TOXICOL APPL PHARM, V72, P530, DOI 10.1016/0041-008X(84)90130-3
   EATON DL, 1982, TOXICOL APPL PHARM, V66, P134, DOI 10.1016/0041-008X(82)90068-0
   GOERING PL, 1984, TOXICOL APPL PHARM, V74, P321, DOI 10.1016/0041-008X(84)90285-0
   Hassoun EA, 1996, TOXICOLOGY, V112, P219, DOI 10.1016/0300-483X(96)03404-X
   Klaassen CD, 1997, DRUG METAB REV, V29, P79, DOI 10.3109/03602539709037574
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LI WD, 1993, TOXICOLOGY, V77, P65
   LI WD, 1994, TOXICOL APPL PHARM, V126, P114, DOI 10.1006/taap.1994.1097
   Liu YP, 1995, TOXICOL APPL PHARM, V135, P222, DOI 10.1006/taap.1995.1227
   MANCA D, 1991, TOXICOLOGY, V67, P303, DOI 10.1016/0300-483X(91)90030-5
   NOLAN CV, 1986, LIFE SCI, V39, P1403, DOI 10.1016/0024-3205(86)90543-6
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   RIKANS LE, 1992, J PHARMACOL EXP THER, V262, P271
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   Rikans LE, 1998, GERONTOLOGY, V44, P72, DOI 10.1159/000021987
   RIKANS LE, 1984, TOXICOL APPL PHARM, V73, P243, DOI 10.1016/0041-008X(84)90329-6
   RIKANS LE, 1984, DRUG CHEM TOXICOL, V7, P595, DOI 10.3109/01480548409042822
   RIKANS LE, 1993, MECH AGEING DEV, V71, P155, DOI 10.1016/0047-6374(93)90043-Q
   Rikans LE, 1996, MECH AGEING DEV, V91, P165, DOI 10.1016/S0047-6374(96)01784-8
   Sauer JM, 1997, TOXICOLOGY, V121, P155, DOI 10.1016/S0300-483X(97)00062-0
   SCHOEFFNER DJ, 1996, TOXICOLOGIST, V30, P289
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   SINGHAL RK, 1987, FASEB J, V1, P220, DOI 10.1096/fasebj.1.3.2887478
   WORMSER U, 1988, ARCH TOXICOL, V62, P392, DOI 10.1007/BF00293629
   Yamano T, 1998, TOXICOL APPL PHARM, V151, P9, DOI 10.1006/taap.1998.8401
   Zheng H, 1996, TOXICOL APPL PHARM, V136, P229, DOI 10.1006/taap.1996.0029
NR 32
TC 14
Z9 14
U1 0
U2 2
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD DEC 15
PY 1999
VL 161
IS 3
BP 225
EP 230
DI 10.1006/taap.1999.8813
PG 6
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 282RY
UT WOS:000085233400002
PM 10620479
DA 2024-02-19
ER

PT J
AU Zhang, WG
   Li, Z
   Niu, Y
   Zhe, F
   Liu, WC
   Fu, SH
   Wang, B
   Jin, XY
   Zhang, J
   Sun, D
   Li, H
   Luo, Q
   Zhao, YL
   Chen, XM
   Chen, YZ
AF Zhang, Weiguang
   Li, Zhe
   Niu, Yue
   Zhe, Feng
   Liu, Weicen
   Fu, Shihui
   Wang, Bin
   Jin, Xinye
   Zhang, Jie
   Sun, Ding
   Li, Hao
   Luo, Qing
   Zhao, Yali
   Chen, Xiangmei
   Chen, Yizhi
TI The biological age model for evaluating the degree of aging in
   centenarians
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE Aging; Biological age; Centenarians; Longevity markers; Chronological
   age; Machine learning
ID BODY-SURFACE AREA; PHYSICAL-FITNESS; PULSE PRESSURE; BIOMARKERS; OLDER;
   ASSOCIATION; POPULATION; DISABILITY; MORBIDITY; MORTALITY
AB Background: Biological age (BA) has been used to assess individuals' aging conditions. However, few studies have evaluated BA models' applicability in centenarians.
   Methods: Important organ function examinations were performed in 1798 cases of the longevity population (80 similar to 115 years old) in Hainan, China. Eighty indicators were selected that responded to nutritional status, cardiovascular function, liver and kidney function, bone metabolic function, endocrine system, hematological system, and immune system. BA models were constructed using multiple linear regression (MLR), principal component analysis (PCA), Klemera and Doubal method (KDM), random forest (RF), support vector machine (SVM), extreme gradient boosting (XGBoost), and light gradient boosting machine (lightGBM) methods. A tenfold crossover validated the efficacy of models.
   Results: A total of 1398 participants were enrolled, of whom centenarians accounted for 49.21%. Seven aging markers were obtained, including estimated glomerular filtration rate, albumin, pulse pressure, calf circumference, body surface area, fructosamine, and complement 4. Eight BA models were successfully constructed, namely MLR, PCA, KDM1, KDM2, RF, SVM, XGBoost and lightGBM, which had the worst R-2 of 0.45 and the best R-2 of 0.92. The best R-2 for cross-validation was KDM2 (0.89), followed by PCA (0.62).
   Conclusion: In this study, we successfully applied eight methods, including traditional methods and machine learning, to construct models of biological age, and the performance varied among the models.
C1 [Zhang, Weiguang; Li, Zhe; Niu, Yue; Zhe, Feng; Liu, Weicen; Chen, Xiangmei; Chen, Yizhi] Chinese Peoples Liberat Army Gen Hosp, Nephrol Inst Chinese Peoples Liberat Army, State Key Lab Kidney Dis,Dept Nephrol, Natl Clin Res Ctr Kidney Dis,Beijing Key Lab Kidn, Beijing, Peoples R China.
   [Fu, Shihui; Wang, Bin; Jin, Xinye; Zhang, Jie; Sun, Ding; Li, Hao; Luo, Qing; Zhao, Yali; Chen, Yizhi] Chinese Peoples Liberat Army Gen Hosp, Hainan Hosp, Hainan Academician Team Innovat Ctr, Dept Nephrol, Sanya, Peoples R China.
   [Li, Zhe] Henan Univ Sci & Technol, Affiliated Hosp 1, Luoyang, Peoples R China.
   [Li, Zhe] Henan Univ Sci & Technol, Coll Clin Med, Luoyang, Peoples R China.
C3 Chinese People's Liberation Army General Hospital; Chinese People's
   Liberation Army General Hospital; Henan University of Science &
   Technology; Henan University of Science & Technology
RP Chen, XM; Chen, YZ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Nephrol Inst Chinese Peoples Liberat Army, State Key Lab Kidney Dis,Dept Nephrol, Natl Clin Res Ctr Kidney Dis,Beijing Key Lab Kidn, Beijing, Peoples R China.; Zhao, YL; Chen, YZ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hainan Hosp, Hainan Academician Team Innovat Ctr, Dept Nephrol, Sanya, Peoples R China.
EM zhaoyl301@163.com; xmchen301@126.com; yizchen@126.com
FU National Key Research and Development Program of China [2022YFC3602900,
   2022YFC3602903, 2022YFC3602902]; Innovation Platform for Academicians of
   Hainan Province (Academician Chen Xiangmei of Hainan Province Kidney
   Diseases Team Innovation Center); Specialized Scientific Program of the
   Innovation Platform for Academicians of Hainan Province [YSPTZX202026];
   Specialized Scientific Research Project of Military Health Care
   [21BJZ37]; National Natural Science Foundation of China [82030025,
   81601211]
FX This study was supported by the National Key Research and Development
   Program of China (2022YFC3602900, 2022YFC3602903, 2022YFC3602902), the
   Innovation Platform for Academicians of Hainan Province (Academician
   Chen Xiangmei of Hainan Province Kidney Diseases Team Innovation
   Center), the Specialized Scientific Program of the Innovation Platform
   for Academicians of Hainan Province (YSPTZX202026), the Specialized
   Scientific Research Project of Military Health Care (21BJZ37), and the
   National Natural Science Foundation of China (82030025, 81601211).
CR Andersen SL, 2012, J GERONTOL A-BIOL, V67, P395, DOI 10.1093/gerona/glr223
   [Anonymous], 2023, Xinhua
   Aviv A, 2001, HYPERTENSION, V37, P1060, DOI 10.1161/01.HYP.37.4.1060
   Bai XJ, 2010, GERONTOLOGY, V56, P129, DOI 10.1159/000262449
   BAKER J, 1988, DIABETES CARE, V11, P239, DOI 10.2337/diacare.11.3.239
   Barrio-Cortes J, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02217-7
   Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE4104, DOI 10.1073/pnas.1506264112
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Brown PJ, 2018, J GERONTOL A-BIOL, V73, P1370, DOI 10.1093/gerona/glx162
   Butler RN, 2004, J GERONTOL A-BIOL, V59, P560
   Chen LK, 2020, J AM MED DIR ASSOC, V21, P300, DOI 10.1016/j.jamda.2019.12.012
   Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Cohen E, 2014, J NEPHROL, V27, P635, DOI 10.1007/s40620-014-0077-9
   Davagdorj K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186513
   DUBINA TL, 1984, EXP GERONTOL, V19, P133, DOI 10.1016/0531-5565(84)90016-0
   Economic U. N. D. of & Social Affairs P. D.., 2022, World population prospects 2022: Summary of results
   Fu SH, 2020, CELL MOL IMMUNOL, V17, P1196, DOI 10.1038/s41423-020-0386-y
   Fuhrman P, 2004, J AM DIET ASSOC, V104, P1258, DOI 10.1016/j.jada.2004.05.213
   Gellert P, 2018, J GERONTOL A-BIOL, V73, P1357, DOI 10.1093/gerona/glx136
   Gibson S, 2003, ANAESTHESIA, V58, P50, DOI 10.1046/j.1365-2044.2003.02788_1.x
   Hamczyk MR, 2020, J AM COLL CARDIOL, V75, P919, DOI 10.1016/j.jacc.2019.11.062
   He Y, 2018, INT J EPIDEMIOL, V47, P694, DOI 10.1093/ije/dyy017
   Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428
   Hirata T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17636-0
   Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X
   Hollingswort J.H.W., 1965, physiologic age
   Huang SJ, 2018, CANCER GENOM PROTEOM, V15, P41, DOI 10.21873/cgp.20063
   Innes KE, 2011, DIABETES METAB SYND, V5, P179, DOI 10.1016/j.dsx.2010.12.007
   Jee H, 2012, GERONTOLOGY, V58, P344, DOI 10.1159/000335738
   Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006
   Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7
   Kang YG, 2017, CLIN INTERV AGING, V12, P253, DOI 10.2147/CIA.S123316
   Khaltourina D, 2020, MECH AGEING DEV, V189, DOI 10.1016/j.mad.2020.111230
   Kitamura Kaori, 2012, Environmental Health and Preventive Medicine, V17, P164, DOI 10.1007/s12199-011-0233-y
   Klemera P, 2006, MECH AGEING DEV, V127, P240, DOI 10.1016/j.mad.2005.10.004
   Lack JA, 1997, BRIT J ANAESTH, V78, P601, DOI 10.1093/bja/78.5.601
   Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233
   Li Z, 2023, FRONT PUBLIC HEALTH, V11, DOI 10.3389/fpubh.2023.1074274
   Mitnitski A, 2017, J GERONTOL A-BIOL, V72, P877, DOI 10.1093/gerona/glw089
   Moskalev A, 2019, HEALTHY AGEING LONG, V10, P1, DOI 10.1007/978-3-030-24970-0_1
   Mrowka R, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13086
   NAKAMURA E, 1989, EUR J APPL PHYSIOL O, V58, P778, DOI 10.1007/BF00637391
   NAKAMURA E, 1988, MECH AGEING DEV, V46, P1, DOI 10.1016/0047-6374(88)90109-1
   O'Rourke M, 1999, HYPERTENSION, V34, P372, DOI 10.1161/01.HYP.34.3.372
   Organization W. H., 2015, World report on ageing and healgh
   Ota A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155022
   Parker DC, 2020, J GERONTOL A-BIOL, V75, P1671, DOI 10.1093/gerona/glz219
   Putin E, 2016, AGING-US, V8, P1021, DOI 10.18632/aging.100968
   Qi M., 2017, Neural Information Processing Systems
   Rahman SA, 2020, IEEE J BIOMED HEALTH, V24, P1226, DOI 10.1109/JBHI.2019.2930938
   Ratain MJ, 1998, J CLIN ONCOL, V16, P2297, DOI 10.1200/JCO.1998.16.7.2297
   Rudnicka E, 2020, MATURITAS, V139, P6, DOI 10.1016/j.maturitas.2020.05.018
   Rutledge J, 2022, NAT REV GENET, V23, P715, DOI 10.1038/s41576-022-00511-7
   Ryan LM, 2019, BURNS, V45, P1827, DOI 10.1016/j.burns.2019.07.029
   Solovev I, 2020, MECH AGEING DEV, V185, DOI 10.1016/j.mad.2019.111192
   Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415
   Taniguchi Y, 2014, J GERONTOL A-BIOL, V69, P1276, DOI 10.1093/gerona/glt286
   Terry DF, 2008, ARCH INTERN MED, V168, P277, DOI 10.1001/archinternmed.2007.75
   Volpi E, 2004, CURR OPIN CLIN NUTR, V7, P405, DOI 10.1097/01.mco.0000134362.76653.b2
   Wei J, 2022, EUR GERIATR MED, V13, P597, DOI 10.1007/s41999-021-00603-3
   Wu XY, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.927344
   Xiong MF, 2022, J CLIN DENSITOM, V25, P630, DOI 10.1016/j.jocd.2022.02.001
   Zeng Y, 2017, LANCET, V389, P1619, DOI 10.1016/S0140-6736(17)30548-2
   Zhang W, 2017, J NUTR HEALTH AGING, V21, P1233, DOI 10.1007/s12603-017-0874-7
   Zhang WG, 2014, J NUTR HEALTH AGING, V18, P137, DOI 10.1007/s12603-013-0345-8
   Zhang WG, 2014, AGE, V36, P1201, DOI 10.1007/s11357-014-9639-y
   Zheng RZ, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23158689
   Zhou JH, 2022, J GERONTOL A-BIOL, V77, P1673, DOI 10.1093/gerona/glab339
NR 69
TC 1
Z9 1
U1 6
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD FEB
PY 2024
VL 117
AR 105175
DI 10.1016/j.archger.2023.105175
EA SEP 2023
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA U3BF1
UT WOS:001083579300001
PM 37688921
OA hybrid
DA 2024-02-19
ER

PT J
AU Leeuwenburgh, C
   Wagner, P
   Holloszy, JO
   Sohal, RS
   Heinecke, JW
AF Leeuwenburgh, C
   Wagner, P
   Holloszy, JO
   Sohal, RS
   Heinecke, JW
TI Caloric restriction attenuates dityrosine cross-linking of cardiac and
   skeletal muscle proteins in aging mice
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE hydroxyl radical; tyrosyl radical; protein oxidation; oxidative stress;
   o-tyrosine
ID OXIDATIVE STRESS; DIETARY RESTRICTION; CATALYZED OXIDATION;
   DENSITY-LIPOPROTEIN; TYROSINE; MYELOPEROXIDASE; PROTEOLYSIS; RADICALS;
   WALL
AB Oxidative damage, particularly to proteins, has been widely postulated to be a major causative factor in the loss of functional capacity during senescence. The nature of the various mechanisms that may contribute to protein oxidation is only partially understood. In this study, concentrations of two markers for oxidative damage, o,o'-dityrosine and o-tyrosine, were determined using stable isotope dilution gas chromatography-mass spectrometry in four tissues of the mouse, namely heart, skeletal muscle, brain, and liver, during youth (4 months old), adulthood (14 months old), and old (30 months old) age. A comparison was made between mice that had access to unlimited calories with those that were restricted to 60% of the caloric intake of the ad libitum regimen. Caloric restriction of this magnitude extends the average and maximum life span of mice by similar to 40%. In vitro studies demonstrated that o,o'-dityrosine was generated selectively in proteins exposed to tyrosyl radical, o-Tyrosine increased in proteins oxidized with hydroxyl radical, which also resulted in a variable increase in o,o'-dityrosine. In mice fed ad libitum, levels of o,o'-dityrosine increased with age in cardiac and skeletal muscle but not in liver or brain, In contrast, o-tyrosine levels did not rise with age in any of the tissues examined. These results suggest that tyrosyl radical-induced protein oxidation increases selectively with age in skeletal muscle and heart, Caloric restriction prevented the increase in o,o'-dityrosine levels in cardiac and skeletal muscle but did not influence o-tyrosine levels in any of the four tissues. This selective increase in o,o'-dityrosine levels and its prevention by a life-prolonging caloric restriction regimen raise the possibility that oxidation of muscle proteins by tyrosyl radical contributes to the deterioration of cardiac and skeletal muscle function with advancing age. (C) 1997 Academic Press.
C1 WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63110.
   WASHINGTON UNIV,SCH MED,DEPT MOL BIOL & PHARMACOL,ST LOUIS,MO 63110.
   SO METHODIST UNIV,DEPT BIOL SCI,DALLAS,TX 75275.
C3 Washington University (WUSTL); Washington University (WUSTL); Southern
   Methodist University
OI Leeuwenburgh, Christiaan/0000-0003-0826-4257
FU NCRR NIH HHS [RR00954] Funding Source: Medline; NIA NIH HHS [AG13563,
   AG00425] Funding Source: Medline
CR AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   AMADO R, 1984, METHOD ENZYMOL, V107, P377
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   [Anonymous], AM J PHYSIOL
   BAYSE GS, 1972, BIOCHIM BIOPHYS ACTA, V284, P34
   BRIZA P, 1986, J BIOL CHEM, V261, P4288
   BRIZA P, 1990, GENE DEV, V4, P1775, DOI 10.1101/gad.4.10.1775
   CATALONO CE, 1989, J BIOL CHEM, V264, P10530
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   FOERDER CA, 1977, P NATL ACAD SCI USA, V74, P4214, DOI 10.1073/pnas.74.10.4214
   FRANCIS GA, 1993, P NATL ACAD SCI USA, V90, P6631, DOI 10.1073/pnas.90.14.6631
   FREUERS RI, 1993, MUTAT RES, V295, P191
   GIULIVI C, 1993, J BIOL CHEM, V268, P8752
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531
   HEINECKE JW, 1993, J BIOL CHEM, V268, P4069
   HUGGINS TG, 1993, J BIOL CHEM, V268, P12341
   KANGHWA K, 1985, J BIOL CHEM, V260, P15394
   KAUR H, 1994, METHOD ENZYMOL, V233, P67
   Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433
   Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   MARGOLIASH E, 1960, BIOCHEM J, V74, P339, DOI 10.1042/bj0740339
   MASORO EJ, 1995, HDB PHYSL 2
   MATSUO M, 1993, FREE RADICALS AGING, P144
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   SAVENKOVA MI, 1994, J BIOL CHEM, V269, P20394
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 34
TC 126
Z9 134
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 1997
VL 346
IS 1
BP 74
EP 80
DI 10.1006/abbi.1997.0297
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA YA566
UT WOS:A1997YA56600010
PM 9328286
DA 2024-02-19
ER

PT J
AU Estes, C
   Razavi, H
   Loomba, R
   Younossi, Z
   Sanyal, AJ
AF Estes, Chris
   Razavi, Homie
   Loomba, Rohit
   Younossi, Zobair
   Sanyal, Arun J.
TI Modeling the epidemic of nonalcoholic fatty liver disease demonstrates
   an exponential increase in burden of disease
SO HEPATOLOGY
LA English
DT Article
ID NUTRITION EXAMINATION SURVEY; UNITED-STATES; HEPATOCELLULAR-CARCINOMA;
   NATURAL-HISTORY; ADVANCED FIBROSIS; NATIONAL-HEALTH; HEPATITIS-C;
   STEATOHEPATITIS; PREVALENCE; NAFLD
AB Nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH) are highly prevalent in the United States, where they are a growing cause of cirrhosis and hepatocellular carcinoma (HCC) and increasingly an indicator for liver transplantation. A Markov model was used to forecast NAFLD disease progression. Incidence of NAFLD was based on historical and projected changes in adult prevalence of obesity and type 2 diabetes mellitus (DM). Assumptions were derived from published literature where available and validated using national surveillance data for incidence of NAFLD-related HCC. Projected changes in NAFLD-related cirrhosis, advanced liver disease, and liver-related mortality were quantified through 2030. Prevalent NAFLD cases are forecasted to increase 21%, from 83.1 million (2015) to 100.9 million (2030), while prevalent NASH cases will increase 63% from 16.52 million to 27.00 million cases. Overall NAFLD prevalence among the adult population (aged 15 years) is projected at 33.5% in 2030, and the median age of the NAFLD population will increase from 50 to 55 years during 2015-2030. In 2015, approximately 20% of NAFLD cases were classified as NASH, increasing to 27% by 2030, a reflection of both disease progression and an aging population. Incidence of decompensated cirrhosis will increase 168% to 105,430 cases by 2030, while incidence of HCC will increase by 137% to 12,240 cases. Liver deaths will increase 178% to an estimated 78,300 deaths in 2030. During 2015-2030, there are projected to be nearly 800,000 excess liver deaths. Conclusion: With continued high rates of adult obesity and DM along with an aging population, NAFLD-related liver disease and mortality will increase in the United States. Strategies to slow the growth of NAFLD cases and therapeutic options are necessary to mitigate disease burden. (Hepatology 2018;67:123-133).
C1 [Estes, Chris; Razavi, Homie] Ctr Dis Anal, Lafayette, CO USA.
   [Loomba, Rohit] Univ Calif San Diego, Dept Internal Med, Div Gastroenterol, San Diego, CA 92103 USA.
   [Younossi, Zobair] Inova Fairfax Hosp, Dept Med, Falls Church, VA USA.
   [Sanyal, Arun J.] Virginia Commonwealth Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA.
C3 University of California System; University of California San Diego;
   Inova Fairfax Hospital; Virginia Commonwealth University
RP Estes, C (corresponding author), 1120 W South Boulder Rd 102, Lafayette, CO 80026 USA.
EM chris.estes@centerforda.com
RI Loomba, Rohit/AAE-7831-2019; Younossi, Zobair M./JRY-9916-2023
OI Loomba, Rohit/0000-0002-4845-9991; Razavi, Homie/0000-0002-2658-6930
FU Intercept Pharmaceuticals; Gilead Sciences; Boehringer Ingelheim
FX Supported by Intercept Pharmaceuticals, Gilead Sciences, and Boehringer
   Ingelheim. The funders had no role in the study design, data collection,
   analysis, interpretation of data, or preparation of the manuscript.
CR Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496
   Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491
   Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
   Goossens N, 2016, CLIN GASTROENTEROL H, V14, P1619, DOI 10.1016/j.cgh.2015.10.010
   Grant Lafaine M, 2004, Ann Hepatol, V3, P93
   Gregg EW, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-18
   GROUND KEU, 1982, AVIAT SPACE ENVIR MD, V53, P14
   Kabbany MN, 2017, AM J GASTROENTEROL, V112, P581, DOI 10.1038/ajg.2017.5
   Kanwal F, 2016, CLIN GASTROENTEROL H, V14, P301
   Kim YS, 2013, CLIN MOL HEPATOL, V19, P120, DOI 10.3350/cmh.2013.19.2.120
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Koehler EM, 2016, HEPATOLOGY, V63, P138, DOI 10.1002/hep.27981
   Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448
   Lazo M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6891
   Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171
   McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077
   National Cancer Institute, Surveillance, Epidemiology, and End Results Program. About the SEER Registries
   National Cancer Institute, Surveillance, Epidemiology, and End Results Program. SEER*Explorer: Explore Our Statistics, DOI DOI 11/44679/INDEX.HTM
   Neff Guy W, 2011, Gastroenterol Hepatol (N Y), V7, P661
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Organ Procurement and Transplantation Network, OPTN DAT OCT 28 2016
   Portillo-Sanchez P, 2015, J CLIN ENDOCR METAB, V100, P2231, DOI 10.1210/jc.2015-1966
   Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370
   Rinella ME, 2011, HEPATOLOGY, V54, P1118, DOI 10.1002/hep.24634
   Sanyal A, 2010, CURR MED RES OPIN, V26, P2183, DOI 10.1185/03007995.2010.506375
   Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103
   Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033
   Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014
   Stepanova M, 2013, DIGEST DIS SCI, V58, P3017, DOI 10.1007/s10620-013-2743-5
   Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013
   United Nations, 2016, DEP EC SOC AFF POP D
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Wattacheril J, 2012, HEPATOLOGY, V56, P1580, DOI 10.1002/hep.26031
   Whalley S, 2007, CLIN MED, V7, P119, DOI 10.7861/clinmedicine.7-2-119
   White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001
   Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038
   Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039
   Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986
   Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123
   Younossi ZM, 2015, PHARMACOECONOMICS, V33, P1245, DOI 10.1007/s40273-015-0316-5
NR 47
TC 1250
Z9 1350
U1 19
U2 144
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JAN
PY 2018
VL 67
IS 1
BP 123
EP 133
DI 10.1002/hep.29466
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA FQ5MM
UT WOS:000418404900015
PM 28802062
OA hybrid, Green Published
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Warrington, JS
   von Moltke, LL
   Harmatz, JS
   Shader, RI
   Greenblatt, DJ
AF Warrington, JS
   von Moltke, LL
   Harmatz, JS
   Shader, RI
   Greenblatt, DJ
TI The effect of age on sildenafil biotransformation in rat and mouse liver
   microsomes
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
ID IN-VITRO BIOTRANSFORMATION; THERAPEUTIC CONSIDERATIONS; CLINICAL
   PHARMACOKINETICS; ERECTILE FUNCTION; FEMALE RATS; METABOLISM;
   IDENTIFICATION; ANXIOLYTICS; CYTOCHROMES; HYPNOTICS
AB Sildenafil [SIL (Viagra); Pfizer, New York, NY] is a widely prescribed agent for erectile dysfunction in men older than 65 years. The present study evaluated experimental models to assess age-dependent changes in SIL biotransformation using hepatic microsomes from male rats and mice ranging from 6 weeks to 26 months of age. The role of specific isoforms in the conversion of SIL to its primary circulating metabolite, UK-103,320 ( piperazine N-desmethyl sildenafil) in the mouse was also investigated using immunoinhibitory antibodies. Although CYP2C11 largely mediated UK-103,320 formation in the rat, UK-103,320 formation was principally inhibited by a CYP3A antibody in the mouse. An age-related decrement in metabolite formation rate was observed for both species, although this effect was more pronounced in the old rats (reduced to 7% of young) than in the old mice ( reduced to 51% of young). CYP2C expression was assessed by Western blot analysis in rat and mouse livers. Age-related differences in hepatic CYP3A expression in the mouse were also compared with metabolite formation rates in the mouse model. Decrements with age in CYP2C and - 3A expression in the aging rodents paralleled the decrements in SIL biotransformation, suggesting that age-related differences in SIL metabolic rate may, in part, reflect differences in expression. Although the role of specific CYP enzymes and the clearance values for this reaction may differ among species, age-related changes in these rodent models are consistent with the reduced clearance of SIL observed in human studies.
C1 Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA.
   Tufts New England Med Ctr, Boston, MA USA.
C3 Tufts University; Tufts Medical Center
RP Greenblatt, DJ (corresponding author), Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, 136 Harrison Ave, Boston, MA 02111 USA.
OI Shader, Richard/0000-0002-1888-7565
FU NCRR NIH HHS [RR-00054] Funding Source: Medline; NIA NIH HHS [AG-17880]
   Funding Source: Medline; NIDA NIH HHS [DA-05258, DA-13209, DA-13834]
   Funding Source: Medline; NIDDK NIH HHS [DK/AI-58496] Funding Source:
   Medline; NIMH NIH HHS [MH-58435] Funding Source: Medline
CR Agrawal AK, 2003, DRUG METAB DISPOS, V31, P612, DOI 10.1124/dmd.31.5.612
   BARNHILL JG, 1990, J PHARMACOL EXP THER, V253, P1153
   COTREAU MM, 2003, IN PRESS CLIN PHARM
   Eagling VA, 1998, BRIT J CLIN PHARMACO, V45, P107, DOI 10.1046/j.1365-2125.1998.00679.x
   FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1
   GREENBLATT DJ, 1991, CLIN PHARMACOKINET, V21, P262, DOI 10.2165/00003088-199121040-00003
   GREENBLATT DJ, 1991, CLIN PHARMACOKINET, V21, P165, DOI 10.2165/00003088-199121030-00002
   GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P6019, DOI 10.1021/bi00266a045
   Hyland R, 2001, BRIT J CLIN PHARMACO, V51, P239, DOI 10.1046/j.1365-2125.2001.00318.x
   IMAOKA S, 1990, ARCH BIOCHEM BIOPHYS, V278, P168, DOI 10.1016/0003-9861(90)90245-T
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   LANG PL, 2000, GROWTH DEV LIFE SPAN
   MAUREL P, 1996, CYTOCHROMES P450 MET, P241
   Muirhead G J, 1996, BR J CLIN PHARM, V42
   Muirhead GJ, 2002, BRIT J CLIN PHARMACO, V53, p21S, DOI 10.1046/j.0306-5251.2001.00029.x
   Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618
   Rhoden EL, 2002, J UROLOGY, V167, P1745, DOI 10.1016/S0022-5347(05)65191-9
   RING BJ, 1994, DRUG METAB DISPOS, V22, P352
   SCHMUCKER DL, 1990, CLIN PHARMACOL THER, V48, P365, DOI 10.1038/clpt.1990.164
   Transon C, 1996, EUR J CLIN PHARMACOL, V51, P79, DOI 10.1007/s002280050164
   Venkatakrishnan K, 2001, J CLIN PHARMACOL, V41, P1149, DOI 10.1177/00912700122012724
   von Moltke LL, 1999, ANNU REV GERONTOL, V19, P53
   VONMOLTKE LL, 1993, PHARMACOLOGY, V47, P268, DOI 10.1159/000139107
   Wagner G, 2001, J GERONTOL A-BIOL, V56, pM113, DOI 10.1093/gerona/56.2.M113
   Walker DK, 1999, XENOBIOTICA, V29, P297, DOI 10.1080/004982599238687
   Warrington JS, 2000, DRUG METAB DISPOS, V28, P392
   Warrington JS, 2000, J PHARMACOL EXP THER, V292, P1024
   Warrington JS, 2002, DRUG METAB DISPOS, V30, P655, DOI 10.1124/dmd.30.6.655
NR 29
TC 11
Z9 12
U1 0
U2 8
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0090-9556
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD NOV
PY 2003
VL 31
IS 11
BP 1306
EP 1309
DI 10.1124/dmd.31.11.1306
PG 4
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 734UK
UT WOS:000186076200007
PM 14570760
DA 2024-02-19
ER

PT J
AU Xu, SF
   Ji, LL
   Wu, Q
   Li, J
   Liu, J
AF Xu, Shang-Fu
   Ji, Li-Li
   Wu, Qin
   Li, Jin
   Liu, Jie
TI Ontogeny and aging of Nrf2 pathway genes in livers of rats
SO LIFE SCIENCES
LA English
DT Article
DE Nrf2/Keap1; Nqo1; Ho-1; Rat liver; Development; Aging; Sex-difference
ID GLUTATHIONE ANTIOXIDANT SYSTEM; AGE-RELATED-CHANGES; OXIDATIVE STRESS;
   HEME OXYGENASE-1; YOUNG MICE; EXPRESSION; RESPONSES; SEX;
   HEPATOTOXICITY; INFLAMMATION
AB The Nrf2/Keap1 antioxidant system plays important roles in protecting against oxidative stress and toxic stimuli, which may vary in infants, elderly, and females.
   Aim: The constitutive expression of the Nrf2 genes during development and aging in both sexes would help our understanding of the Nrf2/Keap1 pathway in toxicological studies.
   Main methods: Sprague Dawley rat livers were collected at 11 age points from prenatal (- 2 d), neonatal (1, 7, 14 and 21 d), at puberty (28 and 35 d), at adulthood (60 and 180 d), to aging (540 and 800 d) from both sexes. Total RNA and proteins were extracted for real-time RT-PCR and Western-blot analysis.
   Key findings: The abundant mRNA expression was in the order of Nrf2, Gclm, Nqo1, Gclc, Ho-1, and Keap1. The expression of these genes except Gclc was high in fetal livers, decreased at birth, reached the first peak at 7 days of age, and gradually decreased to adult levels till 180 days of age. All these genes remained high at 540 days of age, but declined at 800 days of age, with more increases with Nqo1 and Ho-1. Females had lower fetal, neonatal, and aged levels than males. Protein expressions of Nrf2, Nqo1, Ho-1, GCLC and GCLM agree with mRNA analysis.
   Significance: This study characterized the age-and sex-related changes of Nrf2-related gene/proteins in livers of rats, and higher expressions in newborns and aged rats could cope with increased oxidative stress in infants and elderly.
C1 [Xu, Shang-Fu; Wu, Qin; Liu, Jie] Zunyi Med Univ, Minist Educ, Key Lab Basic Pharmacol, Zunyi, Peoples R China.
   [Xu, Shang-Fu; Wu, Qin; Liu, Jie] Zunyi Med Univ, Joint Int Res Lab Ethnomed, Zunyi, Peoples R China.
   [Xu, Shang-Fu; Ji, Li-Li] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China.
   [Li, Jin] Zunyi Med Univ, Res Ctr Med & Biol, Zunyi, Peoples R China.
C3 Zunyi Medical University; Zunyi Medical University; Shanghai University
   of Traditional Chinese Medicine; Zunyi Medical University
RP Liu, J (corresponding author), Zunyi Med Univ, Minist Educ, Key Lab Basic Pharmacol, Zunyi, Peoples R China.; Liu, J (corresponding author), Zunyi Med Univ, Joint Int Res Lab Ethnomed, Zunyi, Peoples R China.
EM Jie@liuonline.com
RI Xu, Shangfu/JLG-2773-2023; 季, 季莉莉/HNQ-7703-2023
OI 季, 季莉莉/0000-0001-6159-2626; Liu, Jie/0000-0002-4530-1443
FU National Natural Science Foundation of China [81560682, 81360661]
FX This study is supported by the National Natural Science Foundation of
   China (81560682 and 81360661).
CR Al-Sawaf O, 2015, CLIN SCI, V129, P989, DOI 10.1042/CS20150436
   Barnes CJ, 1998, AGE, V21, P123, DOI 10.1007/s11357-998-0019-3
   Bello RI, 2005, EXP GERONTOL, V40, P694, DOI 10.1016/j.exger.2005.07.003
   Cheng ML, 2015, HEPATOB PANCREAT DIS, V14, P485, DOI 10.1016/S1499-3872(15)60425-8
   Cui JY, 2012, TOXICOL SCI, V127, P592, DOI 10.1093/toxsci/kfs107
   Davinelli S, 2014, BIOGERONTOLOGY, V15, P449, DOI 10.1007/s10522-014-9511-6
   Davis JM, 2010, SEMIN FETAL NEONAT M, V15, P191, DOI 10.1016/j.siny.2010.04.001
   Hanna D, 2016, TOXICOLOGY, V373, P30, DOI 10.1016/j.tox.2016.10.006
   Hou W. Y., 2014, ZUNYI YIXUEYUAN XUEB, V37, P72
   Hou WY, 2014, TOXICOL APPL PHARM, V280, P370, DOI 10.1016/j.taap.2014.08.020
   Jiang P, 2013, TOXICOL MECH METHOD, V23, P396, DOI 10.3109/15376516.2013.769655
   Kamzalov S, 2004, EXP GERONTOL, V39, P1199, DOI 10.1016/j.exger.2004.04.007
   Kane AE, 2016, EXP GERONTOL, V73, P95, DOI 10.1016/j.exger.2015.11.013
   Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046
   Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013
   Kurzawski M, 2012, ENVIRON TOXICOL PHAR, V34, P87, DOI 10.1016/j.etap.2012.03.001
   Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   Lee JS, 2012, MECH AGEING DEV, V133, P467, DOI 10.1016/j.mad.2012.05.006
   Lee JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-33
   Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381
   Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09
   Lewis KN, 2015, P NATL ACAD SCI USA, V112, P3722, DOI 10.1073/pnas.1417566112
   Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034
   Liang QN, 2011, ARCH TOXICOL, V85, P1267, DOI 10.1007/s00204-011-0664-7
   Liu J, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/305861
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   Mach J, 2014, J GERONTOL A-BIOL, V69, P387, DOI 10.1093/gerona/glt095
   Manoharan S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8590578
   Meng J, 2017, REDOX BIOL, V11, P365, DOI 10.1016/j.redox.2016.12.026
   Mimoto T, 2012, BRAIN RES, V1446, P109, DOI 10.1016/j.brainres.2011.12.064
   Muñiz P, 2000, IUBMB LIFE, V49, P497
   Narasimhan M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00241
   Nie B, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/303181
   Ozsurekci Y, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2768365
   Poggi C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/721043
   Pomatto LCD, 2018, J GERONTOL A-BIOL, V73, P141, DOI 10.1093/gerona/glx083
   Poulianiti KP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8598253
   Ramadori P, 2016, FREE RADICAL BIO MED, V91, P114, DOI 10.1016/j.freeradbiomed.2015.12.014
   Rohrer PR, 2014, DRUG METAB DISPOS, V42, P1663, DOI 10.1124/dmd.114.059006
   Sanchez-Roman I, 2012, BIOGERONTOLOGY, V13, P399, DOI 10.1007/s10522-012-9384-5
   Schippers JHM, 2012, CELL MOL LIFE SCI, V69, P3245, DOI 10.1007/s00018-012-1092-4
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   Smith EJ, 2015, FREE RADICAL BIO MED, V89, P1184, DOI 10.1016/j.freeradbiomed.2015.11.003
   Taguchi K, 2010, MOL CELL BIOL, V30, P3016, DOI 10.1128/MCB.01591-09
   Tomobe K, 2012, ARCH GERONTOL GERIAT, V54, pE1, DOI 10.1016/j.archger.2011.06.006
   Vyskocilová E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/408573
   Watanabe T, 2003, ARCH HISTOL CYTOL, V66, P155, DOI 10.1679/aohc.66.155
   Wu KC, 2011, TOXICOL SCI, V123, P590, DOI 10.1093/toxsci/kfr183
   Xu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037182
   Yang Wei, 2015, EXCLI J, V14, P1273, DOI 10.17179/excli2015-734
   Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P2038, DOI 10.1016/j.freeradbiomed.2012.02.042
   Zhu QN, 2017, LIFE SCI, V170, P108, DOI 10.1016/j.lfs.2016.11.022
   Zhu RZ, 2012, HEPATOL RES, V42, P741, DOI 10.1111/j.1872-034X.2012.00996.x
   Zuo L, 2016, ONCOTARGET, V7, P25010, DOI 10.18632/oncotarget.7075
NR 55
TC 10
Z9 12
U1 3
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD JUN 15
PY 2018
VL 203
BP 99
EP 104
DI 10.1016/j.lfs.2018.04.018
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA GG6ZF
UT WOS:000432846600012
PM 29689272
DA 2024-02-19
ER

PT J
AU Qiu, J
   Ren, CZ
   Fan, JF
   Li, ZG
AF Qiu, Ju
   Ren, Changzhong
   Fan, Junfeng
   Li, Zaigui
TI Antioxidant activities of aged oat vinegar <i>in vitro</i> and in mouse
   serum and liver
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE oat (Avena sativa L.) vinegar; antioxidant; in vitro; in vivo
ID ACETIC-ACID; PHENOLIC ANTIOXIDANTS; RATS; MECHANISMS; EXTRACTION;
   PRODUCTS; CAPACITY; ASSAY; RICE; VIVO
AB BACKGROUND: The present study focused on the antioxidant activities of aged oat (Avena sativa L.) vinegar. The antioxidant activities of oat and vinegar have been proved by many previous research studies. It should be noted that oat vinegar, as a novel seasoning, has antioxidant activity.
   RESULTS: Oat vinegar showed stronger radical scavenging activities, reducing power, and inhibition of lipid peroxidation than rice vinegar. The concentrations of polyphenols and flavonoids in oat vinegar were higher than those in rice vinegar. Ethyl acetate extract of oat vinegar possessed the most varieties of phenolic acids and showed the strongest antioxidant activity compared with ethanol and water extracts. At suitable doses of oat vinegar, the malondialdehyde value was decreased, activities of superoxide dismutase and glutathione peroxidase were promoted, and hepatic damage induced by Co-60 gamma-irradiation was ameliorated in aging mice.
   CONCLUSION: Oat vinegar manifested antioxidant activity which was stronger than that of rice vinegar in vitro and the same as that of vitamin E in vivo. (C) 2010 Society of Chemical Industry
C1 [Qiu, Ju; Li, Zaigui] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.
   [Ren, Changzhong] China Agr Univ, Dept Agron, Beijing 100094, Peoples R China.
   [Ren, Changzhong] Oat Engn & Tech Res Ctr Jilin Prov, Baicheng 137000, Jilin, Peoples R China.
   [Fan, Junfeng] Beijing Forestry Univ, Coll Biosci & Biotechnol, Beijing 100083, Peoples R China.
C3 China Agricultural University; China Agricultural University; Beijing
   Forestry University
RP Li, ZG (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Box 40,17 Qinghua Dong Lu, Beijing 100083, Peoples R China.
EM lizg@cau.edu.cn
RI fan, Junfeng/AGH-6782-2022; Barnier, Alejandro/JHT-2596-2023; Xiang,
   Li/JQI-6805-2023
FU Ministry of Agriculture [nyhyzx07-009]; earmarked fund for Modern
   Agro-industry Technology Research System [nycytx07-14]
FX This study was supported by nyhyzx07-009 (public industry project of the
   Ministry of Agriculture) and nycytx07-14 (the earmarked fund for Modern
   Agro-industry Technology Research System).
CR Albano E, 2002, FREE RADICAL BIO MED, V32, P110, DOI 10.1016/S0891-5849(01)00773-0
   Alonso AM, 2004, FOOD RES INT, V37, P715, DOI 10.1016/j.foodres.2004.03.007
   Amarowicz R, 2004, FOOD CHEM, V84, P551, DOI 10.1016/S0308-8146(03)00278-4
   Andreucetti NA, 1998, RADIAT PHYS CHEM, V52, P177, DOI 10.1016/S0969-806X(98)00135-2
   Ashizuka S, 2005, PEPTIDES, V26, P2610, DOI 10.1016/j.peptides.2005.05.007
   Bissell DM, 2001, HEPATOLOGY, V33, P1009, DOI 10.1053/jhep.2001.23505
   Cerezo AB, 2008, FOOD CHEM, V109, P606, DOI 10.1016/j.foodchem.2008.01.013
   Cerezo AB, 2010, J FOOD COMPOS ANAL, V23, P175, DOI 10.1016/j.jfca.2009.08.008
   Chou ST, 2003, J FOOD SCI, V68, P21, DOI 10.1111/j.1365-2621.2003.tb14108.x
   Chun RL, 2007, INT J BIOCHEM CELL B, V39, P426, DOI 10.1016/j.biocel.2006.09.011
   Chung HC, 2001, TOXICOLOGY, V161, P79, DOI 10.1016/S0300-483X(01)00332-8
   ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407
   Fardet A, 2008, J CEREAL SCI, V48, P258, DOI 10.1016/j.jcs.2008.01.002
   Fushimi T, 2001, J NUTR, V131, P1973, DOI 10.1093/jn/131.7.1973
   Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2
   Kondo S, 2001, BIOSCI BIOTECH BIOCH, V65, P2690, DOI 10.1271/bbb.65.2690
   Liljeberg H, 1998, EUR J CLIN NUTR, V52, P368, DOI 10.1038/sj.ejcn.1600572
   López F, 2005, J FOOD ENG, V68, P133, DOI 10.1016/j.jfoodeng.2004.05.021
   Mikula RJ, 2007, J CAN PETROL TECHNOL, V46, P50
   OYANAGUI Y, 1984, ANAL BIOCHEM, V142, P290
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Peterson DM, 2002, FOOD CHEM, V79, P473, DOI 10.1016/S0308-8146(02)00219-4
   Peterson DM, 2001, J CEREAL SCI, V33, P97, DOI 10.1006/jcrs.2000.0347
   Peterson DM, 2001, J CEREAL SCI, V33, P115, DOI 10.1006/jcrs.2000.0349
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Rumbaoa RGO, 2009, FOOD CHEM, V113, P1133, DOI 10.1016/j.foodchem.2008.08.088
   Shimoji Y, 2002, J AGR FOOD CHEM, V50, P6501, DOI 10.1021/jf020458f
   Stalikas CD, 2007, J SEP SCI, V30, P3268, DOI 10.1002/jssc.200700261
   Tian S, 2004, J AGR FOOD CHEM, V52, P4808, DOI 10.1021/jf049446f
   Tsujihata S, 1998, INT J FOOD MICROBIOL, V43, P135, DOI 10.1016/S0168-1605(98)00093-2
   Verzelloni E, 2007, FOOD CHEM, V105, P564, DOI 10.1016/j.foodchem.2007.04.014
   Wang D, 2008, FOOD CHEM, V107, P1421, DOI 10.1016/j.foodchem.2007.09.072
   Wen CY, 2002, LIFE SCI, V70, P2997, DOI 10.1016/S0024-3205(02)01552-7
   [徐清萍 Xu Qingping], 2005, [食品与发酵工业, Food and Fermentation Industries], V31, P33
   Zin ZM, 2002, FOOD CHEM, V78, P227, DOI 10.1016/S0308-8146(01)00402-2
NR 35
TC 31
Z9 35
U1 1
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD AUG 30
PY 2010
VL 90
IS 11
BP 1951
EP 1958
DI 10.1002/jsfa.4040
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 633ES
UT WOS:000280482900024
PM 20564418
DA 2024-02-19
ER

PT J
AU Mukai, R
   Okunuki, Y
   Husain, D
   Kim, CB
   Lambris, JD
   Connor, KM
AF Mukai, Ryo
   Okunuki, Yoko
   Husain, Deeba
   Kim, Clifford B.
   Lambris, John D.
   Connor, Kip M.
TI The Complement System Is Critical in Maintaining Retinal Integrity
   during Aging
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Article
DE aging; complement system; retina; ERG; OCT; EM
ID MACULAR DEGENERATION; INNATE IMMUNITY; INHIBITION; C5A; IMMUNOLOGY;
   ACTIVATION; EXPRESSION; THERAPY; PROTEIN; C5L2
AB The complement system is a key component of innate immunity comprised of soluble components that form a proteolytic cascade leading to the generation of effector molecules involved in cellular clearance. This system is highly activated not only under general inflammatory conditions such as infections, collagen diseases, nephritis, and liver diseases, but also in focal ocular diseases. However, little is known about the role of the complement system in retinal homeostasis during aging. Using young (6-week-old) and adult (6-month-old) mice in wild type (C57BL/6) and complement knockout strains (C1q(-/-), Mbl a/c(-/-), Fb(-/-), C3(-/-), and C5(-/-)), we compared amplitudes of electroretinograms (ERG) and thicknesses of retinal layers in spectral domain optical coherence tomography between young and adult mice. The ERG amplitudes in adult mice were significantly decreased (p < 0.001, p < 0.0001) compared to that of young mice in all complement knockout strains, and there were significant decreases in the inner nuclear layer (INL) thickness in adultmice compared to youngmice in all complement knockout strains (p < 0.0001). There were no significant differences in ERG amplitude or thickness of the INL between young and adult control mice. These data suggest that the complement system plays an important role in maintaining normal retinal integrity over time.
C1 [Mukai, Ryo; Okunuki, Yoko; Husain, Deeba; Kim, Clifford B.; Connor, Kip M.] Harvard Univ, Harvard Med Sch, Massachusetts Eye & Ear Infirm, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02115 USA.
   [Mukai, Ryo] Gunma Univ, Grad Sch Med, Dept Ophthalmol, Maebashi, Gunma, Japan.
   [Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA.
C3 Harvard University; Harvard Medical School; Massachusetts Eye & Ear
   Infirmary; Gunma University; University of Pennsylvania
RP Connor, KM (corresponding author), Harvard Univ, Harvard Med Sch, Massachusetts Eye & Ear Infirm, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02115 USA.
EM kip_connor@meei.harvard.edu
RI Okunuki, Yoko/ABE-8090-2020; husain, dordaneh/I-9325-2018; Lambris,
   John/O-8507-2019
OI Okunuki, Yoko/0000-0002-1612-7925; husain, dordaneh/0000-0003-2163-5155;
   Lambris, John/0000-0002-9370-5776; Connor, Kip/0000-0002-2048-9080;
   Husain, Deeba/0000-0002-8494-0950
FU NIH [R01EY022084-01/S1]; Harvard Department of Ophthalmology;
   Massachusetts Eye and Ear Infirmary; Research to Prevent Blindness
   Medical Student Fellowship Grant; Massachusetts Lions Eye Research Fund
FX The authors are grateful to G. Stahl at Brigham and Women's Hospital,
   who gave us Mbl A/C<SUP>-/-</SUP> mice. This study was supported by NIH
   grants R01EY022084-01/S1 (KC); Special thanks to the Harvard Department
   of Ophthalmology and Massachusetts Eye and Ear Infirmary for supporting
   this research (KC); Research to Prevent Blindness Medical Student
   Fellowship Grant (to CK); as well as to the Massachusetts Lions Eye
   Research Fund (KC).
CR Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003
   Barnum SR, 2017, PHARMACOL THERAPEUT, V172, P63, DOI 10.1016/j.pharmthera.2016.11.014
   Bosmann M, 2013, EUR J IMMUNOL, V43, P1907, DOI 10.1002/eji.201243075
   Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P8108, DOI 10.1167/iovs.10-6418
   Copland DA, 2010, CLIN EXP IMMUNOL, V159, P303, DOI 10.1111/j.1365-2249.2009.04070.x
   Ding JD, 2015, AM J PATHOL, V185, P29, DOI 10.1016/j.ajpath.2014.08.026
   Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108
   Guo MZ, 2005, MICROCIRCULATION, V12, P223, DOI 10.1080/10739680590905251
   Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x
   Hogan M, 1971, HISTOLOGY HUMAN EYE
   Kam JH, 2013, AM J PATHOL, V183, P480, DOI 10.1016/j.ajpath.2013.04.008
   Kim C, 2016, FASEB J, V30, P1300, DOI 10.1096/fj.15-280834
   Kondo N, 2011, OPHTHALMOLOGY, V118, P339, DOI 10.1016/j.ophtha.2010.06.040
   Langer HF, 2010, BLOOD, V116, P4395, DOI 10.1182/blood-2010-01-261503
   Li CB, 2001, OPTOMETRY VISION SCI, V78, P425, DOI 10.1097/00006324-200106000-00015
   Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509
   LINDER JC, 1987, NEUROSCI LETT, V82, P221, DOI 10.1016/0304-3940(87)90134-0
   Luo C, 2011, MOL VIS, V17, P1588
   Lyzogubov VV, 2016, AM J PATHOL, V186, P2088, DOI 10.1016/j.ajpath.2016.03.021
   McGeer PL, 2017, NEUROBIOL AGING, V52, P12, DOI 10.1016/j.neurobiolaging.2016.12.017
   McHarg S, 2015, MOL IMMUNOL, V67, P43, DOI 10.1016/j.molimm.2015.02.032
   Melis JPM, 2015, MOL IMMUNOL, V67, P117, DOI 10.1016/j.molimm.2015.01.028
   Reis ES, 2011, BRAIN BEHAV IMMUN, V25, P1416, DOI 10.1016/j.bbi.2011.04.011
   Richard S. S., 2001, SYSTEMIC EVALUATION
   Ricklin D, 2016, SEMIN IMMUNOL, V28, P208, DOI 10.1016/j.smim.2016.06.001
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Sjöberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003
   SOMOGYI G, 1977, CELL TISSUE RES, V182, P455
   Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Sweigard JH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1482
   Sweigard JH, 2014, FASEB J, V28, P3171, DOI 10.1096/fj.14-251041
   Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406
   Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506
   Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541
   Wang X, 2016, J NEUROSCI, V36, P2827, DOI 10.1523/JNEUROSCI.3575-15.2016
   Ward PA, 2010, J INNATE IMMUN, V2, P439, DOI 10.1159/000317194
   Ward PA, 2009, J MOL MED, V87, P375, DOI 10.1007/s00109-009-0442-7
   Wert KJ, 2014, DEV OPHTHALMOL, V53, P33, DOI 10.1159/000357294
   Xu HP, 2016, EUR J PHARMACOL, V787, P94, DOI 10.1016/j.ejphar.2016.03.001
   Yanai R, 2012, ADV EXP MED BIOL, V946, P161, DOI 10.1007/978-1-4614-0106-3_10
   Yu MZ, 2012, INVEST OPHTH VIS SCI, V53, P7684, DOI 10.1167/iovs.12-10069
   Zhuang Yong, 2014, Inflammation & Allergy Drug Targets, V13, P153
NR 43
TC 35
Z9 38
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-4365
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD FEB 15
PY 2018
VL 10
AR 15
DI 10.3389/fnagi.2018.00015
PG 12
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA FW2OH
UT WOS:000425142700001
PM 29497373
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kim, L
   Il Kwak, J
   Kim, SA
   An, YJ
AF Kim, Lia
   Il Kwak, Jin
   Kim, Sang A.
   An, Youn-Joo
TI Potential effects of natural aging process on the characteristics and
   toxicity of facial masks: A zebrafish-based study
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article; Early Access
DE Weathering; Disposable mask; Aquatic organism; Behavior
ID EXPOSURE; REPRODUCTION; ENVIRONMENT; AGGRESSION; BEHAVIORS; IMPACTS;
   GILL
AB The use of facial masks has increased and is therefore being recognized as a large source of environmental microplastics. Herein, we naturally aged disposable masks in a lake for eight weeks and compared the toxicity of mask-derived microplastics depending on the aging process using zebrafish (Danio rerio). Zebrafish were exposed to virgin and aged mask fragments (VF and AF, respectively) for eight weeks. The aging process induced cracks on the surface of mask fragments and chemical adsorption. Both VF and AFs damaged the zebrafish's liver, gills, and intestine and adversely affected their digestive ability, and their movement-aggression was decreased. These observations highlight the consequences of indiscriminately discarding masks or AFs following consumption. In conclusion, personal protective equipment waste in the environment should be appropriately managed to pre-vent negative impacts on aquatic organisms and, consequently, on humans via the food chain.
C1 [Kim, Lia; Il Kwak, Jin; Kim, Sang A.; An, Youn-Joo] Konkuk Univ, Dept Environm Hlth Sci, 120 Neungdong ro, Seoul 05029, South Korea.
C3 Konkuk University
RP An, YJ (corresponding author), Konkuk Univ, Dept Environm Hlth Sci, 120 Neungdong ro, Seoul 05029, South Korea.
EM anyjoo@konkuk.ac.kr
OI KWAK, JIN IL/0000-0002-6755-8493
FU Basic Science Research Program of the National Research Foundation of
   Korea (NRF) - Ministry of Science, ICT and future planning
   [2020R1A2B5B02001734]
FX This research was supported by the Basic Science Research Program of the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Science, ICT and future planning (2020R1A2B5B02001734) .
CR Allouche J, 2021, CELL, V184, P4268, DOI 10.1016/j.cell.2021.06.022
   Alnajar N, 2021, CHEMOSPHERE, V262, DOI 10.1016/j.chemosphere.2020.128290
   Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373
   Batel A, 2018, ENVIRON POLLUT, V235, P918, DOI 10.1016/j.envpol.2018.01.028
   Bergmeyer H.-U., 2012, Methods of Enzymatic Analysis
   Bernfeld P., 1955, Methods in enzymology, V1, P149, DOI [10.1016/0076-6879(55)01021-5, DOI 10.1016/0076-6879(55)01021-5]
   BLOCKI FA, 1992, NATURE, V360, P269, DOI 10.1038/360269a0
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bredeck G, 2022, ENVIRON INT, V158, DOI 10.1016/j.envint.2021.106921
   Brion F, 2004, AQUAT TOXICOL, V68, P193, DOI 10.1016/j.aquatox.2004.01.022
   Chen XCA, 2021, ENVIRON POLLUT, V285, DOI 10.1016/j.envpol.2021.117485
   Choi D, 2021, SCI TOTAL ENVIRON, V752, DOI 10.1016/j.scitotenv.2020.142242
   Cole M, 2020, MAR POLLUT BULL, V160, DOI 10.1016/j.marpolbul.2020.111552
   Araújo APD, 2020, J HAZARD MATER, V382, DOI 10.1016/j.jhazmat.2019.121066
   Dawson AL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03465-9
   Duan ZH, 2022, J HAZARD MATER, V429, DOI 10.1016/j.jhazmat.2022.128332
   Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003
   Fan XL, 2021, J HAZARD MATER, V401, DOI [10.1016/j.jhazmat.2020.123363, 10.1016/j.jhazmal.2020.123363]
   Feng SB, 2021, SCI TOTAL ENVIRON, V759, DOI 10.1016/j.scitotenv.2020.143558
   Gao L, 2021, MAR POLLUT BULL, V169, DOI 10.1016/j.marpolbul.2021.112480
   Gewert B, 2015, ENVIRON SCI-PROC IMP, V17, P1513, DOI 10.1039/c5em00207a
   Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012
   Godoy V, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113363
   Griffitt RJ, 2007, ENVIRON SCI TECHNOL, V41, P8178, DOI 10.1021/es071235e
   Gunasekaran K, 2022, MAR POLLUT BULL, V180, DOI 10.1016/j.marpolbul.2022.113769
   Hu LL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229962
   Pizarro-Ortega CI, 2022, MAR POLLUT BULL, V176, DOI 10.1016/j.marpolbul.2022.113474
   Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197
   Jemec Kokalj Anita, 2022, Microplast nanoplast, V2, P1, DOI 10.1186/s43591-021-00020-0
   Jimoh JO, 2023, ENVIRON POLLUT, V317, DOI 10.1016/j.envpol.2022.120769
   Jin YX, 2019, SCI TOTAL ENVIRON, V649, P308, DOI 10.1016/j.scitotenv.2018.08.353
   Ju H, 2019, ENVIRON POLLUT, V247, P890, DOI 10.1016/j.envpol.2019.01.097
   Junaid M, 2021, WATER RES, V201, DOI 10.1016/j.watres.2021.117319
   Kang HM, 2021, J HAZARD MATER, V405, DOI 10.1016/j.jhazmat.2020.124207
   Kim D, 2021, AQUAT TOXICOL, V240, DOI 10.1016/j.aquatox.2021.105968
   Kim L, 2021, AQUAT TOXICOL, V232, DOI 10.1016/j.aquatox.2021.105748
   Kim SA, 2022, MAR POLLUT BULL, V185, DOI 10.1016/j.marpolbul.2022.114279
   Kim SK, 2021, J HAZARD MATER, V418, DOI 10.1016/j.jhazmat.2021.125971
   Koelmans AA, 2016, ENVIRON SCI TECHNOL, V50, P3315, DOI 10.1021/acs.est.5b06069
   Kokalj AJ, 2022, J HAZARD MATER, V438, DOI 10.1016/j.jhazmat.2022.129440
   Koutnik VS, 2021, ENVIRON POLLUT, V274, DOI 10.1016/j.envpol.2021.116552
   Kulkeaw K, 2011, GENES CELLS, V16, P358, DOI 10.1111/j.1365-2443.2011.01498.x
   Kwak JI, 2021, J HAZARD MATER, V416, DOI 10.1016/j.jhazmat.2021.126169
   Kwak JI, 2021, J HAZARD MATER, V402, DOI [10.1016/j.hazmat.2020.124034, 10.1016/j.jhazmat.2020.124034]
   Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020
   Leclercq E, 2010, FISH FISH, V11, P159, DOI 10.1111/j.1467-2979.2009.00346.x
   LeMoine CMR, 2018, ENVIRON POLLUT, V243, P591, DOI 10.1016/j.envpol.2018.08.084
   Leusch FDL, 2021, ENVIRON SCI TECHNOL, V55, P11470, DOI 10.1021/acs.est.1c04093
   Lin LJ, 2022, CHEM ENG J, V439, DOI 10.1016/j.cej.2022.135613
   Liu JB, 2021, ENVIRON POLLUT, V269, DOI 10.1016/j.envpol.2020.116186
   Liu YX, 2021, ENVIRON SCI TECHNOL, V55, P1885, DOI 10.1021/acs.est.0c06479
   Lu YF, 2016, ENVIRON SCI TECHNOL, V50, P4054, DOI 10.1021/acs.est.6b00183
   Ma J, 2022, J HAZARD MATER, V436, DOI 10.1016/j.jhazmat.2022.129084
   Ma ML, 2023, J HAZARD MATER, V443, DOI 10.1016/j.jhazmat.2022.130146
   Marks C, 2005, COPEIA, P901, DOI 10.1643/0045-8511(2005)005[0901:DEACAI]2.0.CO;2
   Mateos-Cárdenas A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69635-2
   McGivney E, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00205
   Moretz JA, 2007, ENVIRON BIOL FISH, V80, P91, DOI 10.1007/s10641-006-9122-4
   O'Brien CJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253802
   OECD, 2019, EFF BIOT SYST OECD G
   Peng YM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2111530118
   Pham M., 2012, Zebrafish Protocols for Neurobehavioral Research, P231
   Qiao RX, 2019, CHEMOSPHERE, V236, DOI 10.1016/j.chemosphere.2019.07.065
   Quadros VA, 2016, BEHAV PROCESS, V122, P1, DOI 10.1016/j.beproc.2015.10.014
   Rathinamoorthy R, 2022, SCI TOTAL ENVIRON, V816, DOI 10.1016/j.scitotenv.2021.151562
   Sarasamma S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041410
   Sendra M, 2022, J HAZARD MATER, V428, DOI 10.1016/j.jhazmat.2021.128186
   Signoret C, 2020, J POLYM ENVIRON, V28, P2055, DOI 10.1007/s10924-020-01741-8
   Sorensen L, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.143170
   Sun JJ, 2021, ENVIRON SCI TECH LET, V8, P1065, DOI 10.1021/acs.estlett.1c00748
   Sun T, 2021, SCI TOTAL ENVIRON, V783, DOI 10.1016/j.scitotenv.2021.147076
   Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6
   Trestrail C, 2021, SCI TOTAL ENVIRON, V779, DOI 10.1016/j.scitotenv.2021.146418
   Wang XH, 2020, ENVIRON POLLUT, V258, DOI 10.1016/j.envpol.2019.113691
   WHO, 2021, 2021 WHO INF PREV CO
   World Health Organization, 2020, Rational use of personal protective equipment for COVID-1 9 and considerations during severe shortages
   Yang H, 2020, J HAZARD MATER, V388, DOI 10.1016/j.jhazmat.2020.122058
   Yang YY, 2021, CHEMOSPHERE, V271, DOI 10.1016/j.chemosphere.2020.129512
   Zabegalov KN, 2019, BEHAV PROCESS, V158, P200, DOI 10.1016/j.beproc.2018.11.010
   Zhang X, 2021, ENVIRON INT, V151, DOI 10.1016/j.envint.2021.106452
   Zhao Y, 2021, ENVIRON POLLUT, V282, DOI 10.1016/j.envpol.2021.117039
   Zheng JL, 2022, SCI TOTAL ENVIRON, V806, DOI 10.1016/j.scitotenv.2021.150213
NR 82
TC 3
Z9 3
U1 24
U2 37
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD 2023 JUL 5
PY 2023
VL 453
AR 131425
DI 10.1016/j.jhazmat.2023.131425
EA APR 2023
PG 12
WC Engineering, Environmental; Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Environmental Sciences & Ecology
GA F6RL7
UT WOS:000983596700001
PM 37084512
DA 2024-02-19
ER

PT J
AU Poynard, T
   Mathurin, P
   Lai, CL
   Guyader, D
   Poupon, R
   Tainturier, MH
   Myers, RP
   Muntenau, M
   Ratziu, V
   Manns, M
   Vogel, A
   Capron, F
   Chedid, A
   Bedossa, P
AF Poynard, T
   Mathurin, P
   Lai, CL
   Guyader, D
   Poupon, R
   Tainturier, MH
   Myers, RP
   Muntenau, M
   Ratziu, V
   Manns, M
   Vogel, A
   Capron, F
   Chedid, A
   Bedossa, P
CA Panfibrosis Grp
TI A comparison of fibrosis progression in chronic liver diseases
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE chronic liver diseases; liver fibrosis; fibrosis progression
ID CHRONIC HEPATITIS-C; URSODEOXYCHOLIC ACID; CIRRHOSIS; MORTALITY; VIRUS;
   RISK; INTERFERON-ALPHA-2B; RIBAVIRIN; MEDICINE; SURVIVAL
AB Background/Aims: No study has compared the liver fibrosis progression rates among chronic liver diseases and the risk factors in order to better organize screening strategies.
   Methods: A total of 4852 patients were retrospectively studied (chronic hepatitis C (HCV) [n = 2313], human immunodeficiency virus (HIV)-HCV co-infection (HIV-HCV [n = 180]), hepatitis B (HBV [n = 777]), alcoholic liver disease (ALD [n = 701]), primary biliary cirrhosis (PBC [n = 406]), genetic hemochromatosis (GH [n = 383]) autoimmune hepatitis (AIH [n = 57]) and delta hepatitis (n = 35). The fibrosis progression rates were estimated from birth and from the date of exposure, when known, to the first biopsy.
   Results: There were highly significant differences in the rates of fibrosis progression, the most rapid being HIV-HCV co-infection (50% cirrhosis percentile at 52 years of age) and the slowest being PBC (50% cirrhosis percentile at 81 years). There was an acceleration of fibrosis progression with aging. Fibrosis progression was slower in females compared with males for HCV, HBV, GH, and PBC. In contrast, in ALD, the fibrosis progression was more rapid in females.
   Conclusions: Rates of fibrosis progression differ markedly between the predominant causes of chronic liver disease, and according to age and gender. Patients with HIV-HCV co-infection are at particularly high risk of fibrosis progression. (C) 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
C1 Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75651 Paris 13, France.
   CNRS, UPRESA 8067, F-75651 Paris 13, France.
   Hop Antoine Beclere, Serv Hepatogastroenterol, F-92141 Clamart, France.
   Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.
   Univ Hosp Pontchaillou, Clin Malad Foie & Liver Res Unit, INSERM, U522, Rennes, France.
   Fac Med Necker Enfants Malad, INSERM, Unit 370, F-75571 Paris, France.
   Hop St Antoine, Serv Hepatogastroenterol, F-75571 Paris, France.
   Hannover Med Sch, Div Gastroenterol & Hepatol, D-3000 Hannover, Germany.
   Hop Antoine Beclere, Serv Anat Pathol, Clamart, France.
   Finch Univ Hlth Sci Chicago Med Sch, Dept Pathol, N Chicago, IL 60064 USA.
   Finch Univ Hlth Sci Chicago Med Sch, Dept Med, N Chicago, IL 60064 USA.
   Hop Bicetre, Serv Anat Pathol, Le Kremlin Bicetre, France.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Sorbonne Universite; Centre National de la
   Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Antoine-Beclere - APHP; University of Hong
   Kong; CHU Rennes; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite de Rennes; Institut National de la Sante
   et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance
   Publique Hopitaux Paris (APHP); Sorbonne Universite; Hopital
   Universitaire Saint-Antoine - APHP; Hannover Medical School; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere -
   APHP; Chicago Medical School; Chicago Medical School; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP;
   Hopital Universitaire Antoine-Beclere - APHP; Universite Paris Saclay
RP Poynard, T (corresponding author), Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, 47-83 Blvd Hop, F-75651 Paris 13, France.
EM tpoynard@teaser.fr
RI Poynard, Thierry/C-1355-2010; Mathurin, Philippe/A-9121-2018; Lai, Ching
   Lung/C-4298-2009; Vogel, Arndt/A-8437-2012
OI Poynard, Thierry/0000-0002-3726-7230; Mathurin,
   Philippe/0000-0003-3447-2025; Vogel, Arndt/0000-0003-0560-5538;
   Munteanu, Mona/0000-0003-4517-2757; Lai, Ching-Lung/0000-0002-5927-2436;
   Guyader, Dominique/0000-0001-8912-6950; Poynard,
   Thierry/0000-0002-2050-640X; Bedossa, Pierre/0000-0002-8487-7322
CR Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   BEDOSSA P, 1994, HEPATOLOGY, V20, P15
   Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409
   Bissell DM, 1999, HEPATOLOGY, V29, P988, DOI 10.1002/hep.510290351
   Corpechot C, 2000, HEPATOLOGY, V32, P1196, DOI 10.1053/jhep.2000.20240
   Corrao G, 1997, INT J EPIDEMIOL, V26, P100, DOI 10.1093/ije/26.1.100
   Deuffic S, 1999, HEPATOLOGY, V29, P1596, DOI 10.1002/hep.510290528
   FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828
   Gu X, 2001, Zhonghua Gan Zang Bing Za Zhi, V9, P34
   Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3
   HINTZE JL, 2001, NCSS 2001 USER GUIDE
   Howel D, 1999, GUT, V45, P756, DOI 10.1136/gut.45.5.756
   Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6
   Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leifman H, 1997, ADDICTION, V92, P1523
   LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310
   LIEBER CS, 1995, NEW ENGL J MED, V333, P1058, DOI 10.1056/NEJM199510193331607
   Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5
   Mc Rosenberg W, 2000, HEPATOLOGY, V32, p183A
   Moirand R, 1999, GASTROENTEROLOGY, V116, P372, DOI 10.1016/S0016-5085(99)70134-4
   NAGEL JE, 1991, J IMMUNOL, V191, P599
   Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120
   Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000
   Oberti F, 1997, GASTROENTEROLOGY, V113, P1609, DOI 10.1053/gast.1997.v113.pm9352863
   Poupon RE, 1999, HEPATOLOGY, V29, P1668, DOI 10.1002/hep.510290603
   Poupon RE, 1997, GASTROENTEROLOGY, V113, P884, DOI 10.1016/S0016-5085(97)70183-5
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Poynard T, 1999, J HEPATOL, V30, P1130, DOI 10.1016/S0168-8278(99)80269-4
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023
   Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833
   Sobesky R, 1999, GASTROENTEROLOGY, V116, P378, DOI 10.1016/S0016-5085(99)70135-6
   Tainturier-Sayeg MH, 2000, HEPATOLOGY, V32, p452A
   TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202
   Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
NR 38
TC 335
Z9 369
U1 0
U2 16
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD MAR
PY 2003
VL 38
IS 3
BP 257
EP 265
DI 10.1016/S0168-8278(02)00413-0
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 653YK
UT WOS:000181464500002
PM 12586290
OA hybrid
DA 2024-02-19
ER

PT J
AU Petropoulos, I
   Mary, J
   Perichon, M
   Friguet, B
AF Petropoulos, I
   Mary, J
   Perichon, M
   Friguet, B
TI Rat peptide methionine sulphoxide reductase: cloning of the cDNA, and
   down-regulation of gene expression and enzyme activity during aging
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE post-translational modification; protein oxidation; protein repair
ID SULFOXIDE REDUCTASE; CATALYTIC MECHANISM; OXIDATIVE STRESS;
   ESCHERICHIA-COLI; PROTEINS; RESIDUES; CELLS; STEREOSPECIFICITY;
   BIOCHEMISTRY; DEGRADATION
AB Peptide methionine sulphoxide reductase (PRMSR, EC 1.8,4,6), the msrA or pmsR gene product, is a ubiquitous enzyme catalysing the reduction of methionine sulphoxide to methionine in proteins. Decreased expression and/or activity of the PMSR with age could explain, at least in part, the accumulation of oxidized protein observed upon aging. In test this hypothesis, the rat pmsR cDNA was cloned and sequenced. The recombinant protein was expressed, its catalytic activity checked with a synthetic substrate and polyclonal antibodies were raised against recombinant PMSR. The expression of the pmsR gene and protein as well as its catalytic activity wire then analysed as a function of age in the rat brain and in two organs that express the most PMSR, liver and kidney. It appears that pmsR gene expression decreases with age in liver and kidney as early as 18 months, whereas protein level and protein activity are reduced in the three organs at the very end of the life of the rat (26 months). These results suggest that the down-regulation of PMSR can contribute to the accumulation of oxidized protein that has been associated with the aging process.
C1 Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, CC 7128, F-75251 Paris 05, France.
C3 Universite Paris Cite
RP Friguet, B (corresponding author), Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, CC 7128, 2 Pl Jussieu, F-75251 Paris 05, France.
RI Mary, Jean/H-2344-2011
OI Mary, Jean/0000-0002-2438-8383; Friguet, Bertrand/0000-0001-8085-1961;
   Petropoulos, Isabelle/0000-0001-9205-7458
CR ABRAMS WR, 1981, P NATL ACAD SCI-BIOL, V78, P7483, DOI 10.1073/pnas.78.12.7483
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200
   BROT N, 1991, BIOFACTORS, V3, P91
   BROT N, 1983, ARCH BIOCHEM BIOPHYS, V223, P271, DOI 10.1016/0003-9861(83)90592-1
   Ciorba MA, 1997, P NATL ACAD SCI USA, V94, P9932, DOI 10.1073/pnas.94.18.9932
   Cohn E.J., 1943, PROTEINS AMINO ACIDS, P370
   Friguet B, 2000, ANN NY ACAD SCI, V908, P143
   Gabbita SP, 1999, J NEUROCHEM, V73, P1660, DOI 10.1046/j.1471-4159.1999.0731660.x
   GARNER MH, 1980, P NATL ACAD SCI-BIOL, V77, P1274, DOI 10.1073/pnas.77.3.1274
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   HOLMGREN A, 1989, J BIOL CHEM, V264, P13963
   Kozak M, 1979, Methods Enzymol, V60, P360
   Kuschel L, 1999, FEBS LETT, V456, P17, DOI 10.1016/S0014-5793(99)00917-5
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036
   Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3
   Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269
   Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   MINETTI G, 1994, ITAL J BIOCHEM, V43, P273
   Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585
   Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071
   Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095
   Moskovitz J, 2000, J BIOL CHEM, V275, P14167, DOI 10.1074/jbc.275.19.14167
   Moskovitz J, 1999, METHOD ENZYMOL, V300, P239
   MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995
   Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P3205, DOI 10.1073/pnas.93.8.3205
   Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268
   PACIFICI RE, 1989, FREE RADICAL BIO MED, V7, P521, DOI 10.1016/0891-5849(89)90028-2
   RIVETT AJ, 1985, J BIOL CHEM, V260, P2600
   Sun HY, 1999, BIOCHEMISTRY-US, V38, P105, DOI 10.1021/bi981295k
   Tête-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8
   VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G
NR 36
TC 118
Z9 136
U1 0
U2 4
PU PORTLAND PRESS
PI LONDON
PA 59 PORTLAND PLACE, LONDON W1N 3AJ, ENGLAND
SN 0264-6021
J9 BIOCHEM J
JI Biochem. J.
PD MAY 1
PY 2001
VL 355
BP 819
EP 825
DI 10.1042/bj3550819
PN 3
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 431MY
UT WOS:000168636200032
PM 11311146
OA Green Published
DA 2024-02-19
ER

PT J
AU Li, DM
   Li, J
   Wang, GP
   Qin, YL
   Niu, ZP
   Li, ZW
   Xu, CS
AF Li, Deming
   Li, Jun
   Wang, Gaiping
   Qin, Yanli
   Niu, Zhipeng
   Li, Ziwei
   Xu, Cunshuan
TI Delayed Liver Regeneration after Partial Hepatectomy in Aged <i>Nos2</i>
   Knockout Mice
SO CELL JOURNAL
LA English
DT Article
DE Aged; Liver Regeneration; Proliferation; Apoptosis
ID NITRIC-OXIDE SYNTHASE; RAT-LIVER; RAPID ACTIVATION; AGING LIVER; CYCLIN
   D1; KAPPA-B; EXPRESSION; DIFFERENTIATION; PROLIFERATION; HEPATOCYTES
AB Objective: Patients over 60 years of age have higher mortality and morbidity after major liver resections. Nitric oxide (NO) derived from the catalytic activity of Nos2 plays a beneficial role in liver regeneration (LR) after partial hepatectomy (PH). In this experiment, we evaluated the effect of Nos2 knockout (KO) on LR in aged mice after PH.
   Materials and Methods: In this experimental study, 52 two-year-old Nos2 KO and 46 the same age wild-type (WT) C57BL/6J mice were subjected to 2/3 PH. Liver tissues were collected at 11 time points after PH. Mice survival ratio and liver coefficient (liver-weight/ body-weight) was calculated. Transcript and protein levels were estimated by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) and Western blot, respectively.
   Results: The aged Nos2 KO mice had lower survival ratio (P=0.039) and liver coefficient (P=0.002) at the termination phase. Nos2 transcript level was obviously increased after PH in WT mice and undetected in the Nos2 KO mice. During LR, the expression at the transcript level of Cyclin D1, Cyclin A2 and Cyclin B1 and protein expression level of proliferation marker Ki67 and proliferation-associated transcription factors JNK1, NF-kB and STAT3 were decreased or delayed. The expression of pro-apoptotic proteins, CAS-PASE3, CASPASE9 and BAX, was increased in the Nos2 KO mice.
   Conclusion: Decreased survival ratio and impaired LR in aged Nos2 KO mice is probably due to decreased liver cell proliferation and increased liver cell apoptosis.
C1 [Li, Deming; Li, Jun; Wang, Gaiping; Qin, Yanli; Niu, Zhipeng; Li, Ziwei; Xu, Cunshuan] Key Lab Cell Differentiat Regulat, Xinxiang, Peoples R China.
   [Li, Deming; Li, Jun; Wang, Gaiping; Qin, Yanli; Niu, Zhipeng; Li, Ziwei; Xu, Cunshuan] Henan Normal Univ, Coll Life Sci, 46 East Construct Rd, Xinxiang 453007, Henan, Peoples R China.
C3 Henan Normal University
RP Xu, CS (corresponding author), Henan Normal Univ, Coll Life Sci, 46 East Construct Rd, Xinxiang 453007, Henan, Peoples R China.
EM cellkeylab@126.com
RI ZHAO, S/IWV-4219-2023
FU Natural Science Foundation of China [31572270]; Natural Science
   Foundation of Henan [112300413204, 142300413227]; Biology key discipline
   of Henan province
FX This work was supported by grants from the Natural Science Foundation of
   China (No. 31572270), Natural Science Foundation of Henan (No.
   112300413204 and 142300413227) and Biology key discipline of Henan
   province. The authors have no competing interests to declare.
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088
   Carnovale CE, 2000, J HEPATOL, V32, P798, DOI 10.1016/S0168-8278(00)80249-4
   Chou TC, 1998, HYPERTENSION, V31, P643, DOI 10.1161/01.HYP.31.2.643
   Clavien PA, 1997, HEPATOLOGY, V25, P1294, DOI 10.1002/hep.510250544
   Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034
   CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3
   CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429
   Diehl AM, 1996, J GASTROEN HEPATOL, V11, P466, DOI 10.1111/j.1440-1746.1996.tb00292.x
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Gallucci RM, 2000, J IMMUNOL, V164, P872, DOI 10.4049/jimmunol.164.2.872
   García-Trevijano ER, 2002, GASTROENTEROLOGY, V122, P1355, DOI 10.1053/gast.2002.33020
   Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424
   Guttridge DC, 1999, MOL CELL BIOL, V19, P5785
   HORTELANO S, 1995, HEPATOLOGY, V21, P776
   IJtsma AJC, 2008, J GASTROINTEST SURG, V12, P2196, DOI 10.1007/s11605-008-0563-2
   Kohjima M, 2013, J HEPATOL, V59, P1246, DOI 10.1016/j.jhep.2013.07.025
   LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688
   Li JR, 1999, AM J PHYSIOL-GASTR L, V276, pG1069, DOI 10.1152/ajpgi.1999.276.5.G1069
   Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055
   Liu Y, 2015, J HEPATOL, V62, P590, DOI 10.1016/j.jhep.2014.10.022
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   MORELLO D, 1990, ONCOGENE, V5, P1511
   Muriel P, 2000, J APPL TOXICOL, V20, P189, DOI 10.1002/(SICI)1099-1263(200005/06)20:3<189::AID-JAT632>3.3.CO;2-#
   OBOLENSKAYA MY, 1994, BIOCHEM BIOPH RES CO, V202, P571, DOI 10.1006/bbrc.1994.1966
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Rai RM, 1998, P NATL ACAD SCI USA, V95, P13829, DOI 10.1073/pnas.95.23.13829
   Ronco MT, 2004, BBA-MOL BASIS DIS, V1690, P70, DOI 10.1016/j.bbadis.2004.05.004
   Schaefer FM, 2015, BBA-MOL BASIS DIS, V1852, P137, DOI 10.1016/j.bbadis.2014.10.011
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135
   Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004
   Tabernero A, 2000, BRIT J PHARMACOL, V131, P1227, DOI 10.1038/sj.bjp.0703696
   VANTHIEL DH, 1987, GASTROENTEROLOGY, V93, P1414, DOI 10.1016/0016-5085(87)90274-5
   Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299
   Yin S, 2011, AM J PATHOL, V178, P1614, DOI 10.1016/j.ajpath.2011.01.001
   YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D
   Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829
   Zeini M, 2005, FASEB J, V19, P995, DOI 10.1096/fj.04-3233fje
   Zeini M, 2004, J HEPATOL, V40, P926, DOI 10.1016/j.jhep.2004.02.016
   Zhang BC, 2015, J SURG RES, V193, P795, DOI 10.1016/j.jss.2014.07.042
   Zhang SB, 2015, CANCER RES, V75, P1936, DOI 10.1158/0008-5472.CAN-14-3303
NR 45
TC 3
Z9 4
U1 0
U2 6
PU ROYAN INST
PI TEHRAN
PA PO BOX 19395-4644, TEHRAN, 00000, IRAN
SN 2228-5806
EI 2228-5814
J9 CELL J
JI Cell J.
PD SUM
PY 2017
VL 19
IS 2
BP 218
EP 230
DI 10.22074/cellj.2016.4878
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA ES3DT
UT WOS:000399409000005
PM 28670514
DA 2024-02-19
ER

PT J
AU RICHIE, JP
   LANG, CA
   CHEN, TS
AF RICHIE, JP
   LANG, CA
   CHEN, TS
TI ACETAMINOPHEN-INDUCED DEPLETION OF GLUTATHIONE AND CYSTEINE IN THE AGING
   MOUSE KIDNEY
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
ID INDUCED HEPATIC NECROSIS; ACUTE-RENAL-FAILURE; INDUCED NEPHROTOXICITY;
   COVALENT BINDING; N-ACETYLCYSTEINE; YOUNG-ADULT; LIFE-SPAN; RATS; AGE;
   METABOLISM
AB Glutathione (GSH) plays an essential role in the detoxification of acetaminophen (APAP) and the prevention of APAP-induced toxicity in the kidney. Our previous results demonstrated that a GSH deficiency is a general property of aging tissues, including the kidney, suggesting a hypothesis that senescent organisms are at greater risk to APAP-induced renal damage. To test this, C57BL/6NIA mice of different ages through the life span were injected with various doses of APAP, and the extent of GSH and cysteine (Cys) depletion and recovery were determined. At time intervals up to 24 hr, kidney cortex samples were obtained, processed and analyzed for glutathione status, namely GSH, glutathione disulfide (GSSG), Cys and cystine, using an HPLC method with dual electrochemical detection. In the uninjected controls, GSH and Cys concentrations decreased about 30% in the aging mouse, but the GSSG and cystine levels were unchanged during the life span. APAP administration depleted the kidney GSH and Cys contents in a dose- and time-dependent manner. Four hours after APAP administration, GSH levels of the young, growing (3- to 6-month) and the mature (12-month) mice decreased 34 and 58%, respectively, and recovered to near control values by 24 hr (95 and 98%). In contrast, the extent of depletion in old (31-month) mice was greater (64%) and the 24-hr recovery was less, returning only to 56%. Likewise, Cys levels of the young and mature mice decreased 49 and 65%, respectively, 4 hr following APAP, and increased to 99 and 85% by 24 hr. In contrast, in old mice, there was a 78% depletion after 4 hr followed by a recovery of only 65% by 24 hr. These results demonstrated clearly that in the aging mouse kidney, a GSH and Cys deficiency occurs that is accompanied by an impaired APAP detoxification capacity.
C1 UNIV LOUISVILLE,DEPT BIOCHEM,LOUISVILLE,KY 40292.
   UNIV LOUISVILLE,DEPT PHARMACOL & TOXICOL,LOUISVILLE,KY 40292.
C3 University of Louisville; University of Louisville
RP RICHIE, JP (corresponding author), AMER HLTH FDN,1 DANA RD,VALHALLA,NY 10595, USA.
OI Richie, John/0000-0001-8239-2850
CR ABRAHAM EC, 1978, BIOCHEM J, V174, P819, DOI 10.1042/bj1740819
   BEIERSCHMITT WP, 1986, ARCH TOXICOL, V59, P206, DOI 10.1007/BF00290539
   BEIERSCHMITT WP, 1986, LIFE SCI, V39, P2335, DOI 10.1016/0024-3205(86)90664-8
   BENEDETTI MS, 1975, J PHARM PHARMACOL, V27, P629, DOI 10.1111/j.2042-7158.1975.tb09524.x
   BJORCK S, 1988, NEPHRON, V49, P45, DOI 10.1159/000184985
   BOYER TD, 1971, J AMER MED ASSOC, V218, P440, DOI 10.1001/jama.218.3.440
   CANALESE J, 1981, BRIT MED J, V282, P199, DOI 10.1136/bmj.282.6259.199
   CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399
   CHEN TS, 1990, DRUG METAB DISPOS, V18, P882
   CROOKS J, 1983, J CHRON DIS, V36, P85, DOI 10.1016/0021-9681(83)90047-4
   FISCHER LJ, 1985, DRUG METAB DISPOS, V13, P121
   GABRIEL R, 1982, ACUTE RENAL FAILURE, P125
   GALINSKY RE, 1986, PHARMACOLOGY, V32, P313, DOI 10.1159/000138186
   HARDING JJ, 1970, BIOCHEM J, V117, P957, DOI 10.1042/bj1170957
   HART SGE, 1991, TOXICOL APPL PHARM, V107, P1
   HAZELTON GA, 1984, P SOC EXP BIOL MED, V176, P249
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   Jollow D J, 1980, Arch Toxicol Suppl, V3, P95
   KEATON MR, 1988, SOUTHERN MED J, V81, P1163
   KLEINMAN JG, 1980, CLIN NEPHROL, V14, P201
   LANG CA, 1989, DIETARY RESTRICTION, P241
   LAUTERBURG BH, 1987, J HEPATOL, V4, P206, DOI 10.1016/S0168-8278(87)80081-8
   LAUTERBURG BH, 1983, J CLIN INVEST, V71, P980, DOI 10.1172/JCI110853
   MCMURTRY RJ, 1978, TOXICOL APPL PHARM, V46, P87, DOI 10.1016/0041-008X(78)90139-4
   MINERS JO, 1988, EUR J CLIN PHARMACOL, V35, P157, DOI 10.1007/BF00609245
   MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211
   MUDGE GH, 1978, J PHARMACOL EXP THER, V206, P218
   NARYSHKIN S, 1981, FED PROC, V40, P3179
   NEWTON JF, 1985, TOXICOL APPL PHARM, V78, P39, DOI 10.1016/0041-008X(85)90302-3
   NEWTON JF, 1986, J PHARMACOL EXP THER, V237, P519
   PRESCOTT LF, 1979, BRIT MED J, V2, P1097, DOI 10.1136/bmj.2.6198.1097
   PRICE VF, 1989, TOXICOL APPL PHARM, V101, P356, DOI 10.1016/0041-008X(89)90283-4
   PROUDFOOT AT, 1970, BMJ-BRIT MED J, V3, P557, DOI 10.1136/bmj.3.5722.557
   REICKS M, 1989, J NUTR, V119, P1042, DOI 10.1093/jn/119.7.1042
   RICHIE JP, 1985, DRUG METAB DISPOS, V13, P14
   RICHIE JP, 1988, P SOC EXP BIOL MED, V187, P235
   RICHIE JP, 1987, ANAL BIOCHEM, V163, P9, DOI 10.1016/0003-2697(87)90085-6
   SCHNEIDER D, 1982, FED PROC, V41, P7671
   SLATTERY JT, 1987, CLIN PHARMACOL THER, V41, P413, DOI 10.1038/clpt.1987.50
   Snedecor G.W., 1980, STATISTICAL METHODS
   SOHAL RS, 1984, MECH AGEING DEV, V24, P185, DOI 10.1016/0047-6374(84)90070-8
   STANDEVEN AM, 1991, TOXICOL APPL PHARM, V107, P269, DOI 10.1016/0041-008X(91)90208-V
   STOHS SJ, 1980, AGE, V3, P11, DOI 10.1007/BF02435000
   TARLOFF JB, 1991, P SOC EXP BIOL MED, V197, P297
NR 44
TC 39
Z9 42
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-2952
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD JUL 7
PY 1992
VL 44
IS 1
BP 129
EP 135
DI 10.1016/0006-2952(92)90046-L
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA JF160
UT WOS:A1992JF16000017
PM 1632827
DA 2024-02-19
ER

PT J
AU Boleman, CT
   McKenna, DR
   Ramsey, WS
   Peel, RK
   Savell, JW
AF Boleman, CT
   McKenna, DR
   Ramsey, WS
   Peel, RK
   Savell, JW
TI Influence of feeding vitamin D<sub>3</sub> and aging on the tenderness
   of four lamb muscles
SO MEAT SCIENCE
LA English
DT Article
DE carcass; lamb; meat tenderness; vitamin D-3
ID CALCIUM-CHLORIDE; POSTMORTEM TENDERIZATION; INFUSION; ACCELERATION;
   LONGISSIMUS; CARCASSES
AB In Trial 1, rams (n = 26) were fed different levels (0, 250,000, 500,000 or 750,000 IU) of vitamin D-3 for 4 days to determine the most effective dose to increase blood calcium concentrations. Trial 2 consisted of feeding feedlot lambs (n 40) different levels (0 or 750,000 IU) of vitamin D3 for 14 days to determine if vitamin D3 could improve the tenderness of lamb muscles. Lambs were slaughtered and the M. longissimus lumborum, M. biceps femoris, M. semitendinosus, and M. semimembranosus were removed after chilling, cut into chops, and assigned to an aging period (5, 10 or 15 days) for Warner-Bratzler shear force (WBS) determination. In Trial 1, feed intake and weight gain were lower for rams supplemented with 500,000 IU of vitamin D3 compared to all Other groups. Blood calcium concentrations were not different between groups, although the 750,000 1 U group tended (P < 0.10) to have higher blood calcium concentrations on day 5 of the trial compared to controls. In Trial 2, blood calcium concentrations were not different between the treated and control groups, however, treated lambs had higher (P < 0.01) calcium concentrations in both the liver and kidneys. Control chops from the M. longissimus lumborum had lower (P < 0.05) WBS values than chops from vitamin D3 fed lambs, but no other muscles were affected by vitamin D3 feeding. An interaction between treatment and aging was observed for the M. biceps femoris, with chops from vitamin D3 fed lambs having lower WBS values at 5 days aging, but chops from control lambs having lower WBS values at 15 days aging. WBS values decreased for the M. longissimus lumborum, M. semitendinosus, and M. semimembranosus with increasing aging time. Vitamin D3 supplementation was not an effective means of improving the tenderness characteristics of lamb muscles. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Texas A&M Univ, Texas Agr Expt Stn, Dept Anim Sci, Meat Sci Sect, College Stn, TX 77843 USA.
C3 Texas A&M University System; Texas A&M University College Station; Texas
   A&M AgriLife Research
RP Savell, JW (corresponding author), Texas A&M Univ, Texas Agr Expt Stn, Dept Anim Sci, Meat Sci Sect, 2471 TAMU, College Stn, TX 77843 USA.
EM j-savell@tamu.edu
RI Savell, Jeffrey Wyatt/C-2434-2008
OI Savell, Jeffrey Wyatt/0000-0003-0354-1286
CR *AMSA, 1995, RES GUID COOK SENS F
   Belew JB, 2003, MEAT SCI, V64, P507, DOI 10.1016/S0309-1740(02)00242-5
   CARPENTER Z. L., 1965, FOOD TECHNOL, V19, P102
   Clare TL, 1997, J ANIM SCI, V75, P377
   DELUCA HF, 1976, ANNU REV BIOCHEM, V45, P631, DOI 10.1146/annurev.bi.45.070176.003215
   DUCKETT SK, 1998, J ANIMAL SCI S1, V76, P156
   HIBBS JW, 1946, J DAIRY SCI, V29, P767, DOI 10.3168/jds.S0022-0302(46)92536-2
   HIBBS JW, 1955, J DAIRY SCI, V38, P65, DOI 10.3168/jds.S0022-0302(55)94939-0
   HIBBS JW, 1951, J DAIRY SCI, V34, P855, DOI 10.3168/jds.S0022-0302(51)91793-6
   HILL R, 1977, URBAN LEAGUE REV, V1, P18
   JEREMIAH LE, 1971, J FOOD SCI, V35, P45
   KOOHMARAIE M, 1991, J ANIM SCI, V69, P2463
   Koohmaraie M, 2002, MEAT SCI, V62, P345, DOI 10.1016/S0309-1740(02)00127-4
   KOOHMARAIE M, 1989, J ANIM SCI, V67, P934, DOI 10.2527/jas1989.674934x
   KOOHMARAIE M, 1990, J ANIM SCI, V68, P1278
   McDowell L.R., 1989, Vitamins in Animal Nutrition
   MONTGOMERY JL, 1997, P 50 REC MEAT C AM I, P168
   North American Meat Processor Association (NAMP), 1997, The Meat Buyers Guide
   RAMSBOTTOM JM, 1945, FOOD RES, V10, P497
   SCANGA JA, 1999, P 52 REC MEAT C SAV, P120
   Swanek SS, 1999, J ANIM SCI, V77, P874
   *USDA, 1996, IMPS FRESH LAMB MUTT
   *USDA, 1992, US STAND GRAD CARC L
   Wheeler TL, 1999, J ANIM SCI, V77, P2444
   Wiegand BR, 2001, J ANIM SCI, V79, P2086
NR 25
TC 14
Z9 16
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0309-1740
EI 1873-4138
J9 MEAT SCI
JI Meat Sci.
PD JUN
PY 2004
VL 67
IS 2
BP 185
EP 190
DI 10.1016/j.meatsci.2003.09.010
PG 6
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 806FH
UT WOS:000220419300001
PM 22061312
DA 2024-02-19
ER

PT J
AU Lu, Y
   Ye, M
   Song, S
   Li, L
   Shaikh, F
   Li, JH
AF Lu, Ying
   Ye, Ming
   Song, Sheng
   Li, Lan
   Shaikh, Farnaz
   Li, Junhong
TI Isolation, Purification, and Anti-Aging Activity of Melanin from
   <i>Lachnum singerianum</i>
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE Lachnum singerianum melanin; Microwave-assisted extraction;
   Fractionation; Anti-aging activity
ID PHYSICOCHEMICAL CHARACTERIZATION; STRUCTURAL CHARACTERISTICS;
   ANTIOXIDANT ACTIVITY; D-GALACTOSE; POLYSACCHARIDE; PIGMENT; STRAIN
AB Intracellular melanin from Lachnum singerianum YM296 (LIM) was obtained by the method of microwave-assisted extraction. On the basis of single factor experiment, the optimum microwave-assisted extraction conditions of LIM using Box-Behnken design were as follows: NaOH concentration, 1.05 mol/L; ratio of raw material to liquid ratio, 1:14.72 (g/mL); microwave time, 118.70 s; and microwave power, 320 W. Under these conditions, the extraction yield of LIM was 11.08 %, and 40.43 % higher than that of extraction by alkali extraction and acid precipitation. The results showed that microwave-assisted extraction could increase the extraction yield of LIM. Three homogeneous components were fractionated from LIM by Sephadex G-15 column. LIM-a was the main homogeneous component, accounting for 75.7 % of the total content of the homogeneous components. Aged mice model were induced by injecting d-galactose, and the aged mice were given LIM-a of different dosages, respectively. The results showed that LIM-a can significantly increase body weight, thymus indexes, and spleen indexes of the aged mice; effectively elevate the levels of SOD, GSH-PX, and CAT; and decrease the level of MDA in mice liver homogenate, brain homogenate, and serum, indicating that LIM-a had significant anti-aging activity.
C1 [Lu, Ying; Ye, Ming; Song, Sheng; Li, Lan; Shaikh, Farnaz; Li, Junhong] Hefei Univ Technol, Coll Biotechnol & Food Engn, Hefei 230009, Peoples R China.
C3 Hefei University of Technology
RP Ye, M (corresponding author), Hefei Univ Technol, Coll Biotechnol & Food Engn, Hefei 230009, Peoples R China.
EM yeming123@sina.com
FU National Natural Science Foundation of China [31270060]; Annual Research
   Projects of Anhui Province [12070303037]; SME Technology Innovation
   Foundation [12C26213403307]
FX This work was financially supported by the National Natural Science
   Foundation of China (31270060), Annual Research Projects of Anhui
   Province (12070303037), and the SME Technology Innovation Foundation
   (12C26213403307).
CR Aghajanyan AE, 2005, PIGM CELL RES, V18, P130, DOI 10.1111/j.1600-0749.2005.00211.x
   Argyropoulou A, 2013, NAT PROD REP, V30, P1412, DOI 10.1039/c3np70031c
   Bonnefoy M, 2002, PRESSE MED, V31, P1174
   Choi Yuen-Wah, 1999, Fungal Diversity, V3, P29
   Dong CH, 2012, J BIOSCI BIOENG, V113, P474, DOI 10.1016/j.jbiosc.2011.12.001
   Dong H. Q., 2012, FOOD RES DEV, V33, P140
   El-Obeid A, 2006, PHYTOMEDICINE, V13, P324, DOI 10.1016/j.phymed.2005.03.007
   Gómez-Marín AM, 2010, J NON-CRYST SOLIDS, V356, P1576, DOI 10.1016/j.jnoncrysol.2010.05.054
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   [胡志杰 Hu Zhijie], 2007, [中国野生植物资源, Chinese Wild Plant Resources], V26, P52
   [李军 Li Jun], 2012, [食品工业科技, Science & Technology of Food Industry], V33, P295
   Lin X, 2014, CARBOHYD POLYM, V101, P533, DOI 10.1016/j.carbpol.2013.09.037
   Liu Y, 2003, PIGM CELL RES, V16, P72, DOI 10.1034/j.1600-0749.2003.00009.x
   Manninga J. T., 2006, J THEOR BIOL, V223, P131
   Meng J. X., 2010, CHINESE J GERONTOLOG, V30, P216
   Olennikov DN, 2011, APPL BIOCHEM MICRO+, V47, P298, DOI 10.1134/S0003683811030094
   Sava VM, 2003, FOOD RES INT, V36, P505, DOI 10.1016/S0963-9969(02)00199-0
   Song R., 2009, J ZHEJIANG OCEAN U N, V28, P95
   Tu YG, 2009, FOOD CHEM, V114, P1345, DOI 10.1016/j.foodchem.2008.11.015
   Uddin MN, 2010, J IMMUNOTOXICOL, V7, P165, DOI 10.3109/15476910903510806
   Wang HS, 2006, LWT-FOOD SCI TECHNOL, V39, P496, DOI 10.1016/j.lwt.2005.04.001
   Wang Y, 2013, J PURE APPL MICROBIO, V7, P285
   Xing HJ, 2012, CHEMOSPHERE, V88, P377, DOI 10.1016/j.chemosphere.2012.02.049
   Ye M, 2014, INT J BIOL MACROMOL, V63, P170, DOI 10.1016/j.ijbiomac.2013.10.046
   Ye M, 2012, FOOD CHEM, V135, P2490, DOI 10.1016/j.foodchem.2012.06.120
   Ye M, 2011, ADV MATER RES-SWITZ, V284-286, P1742, DOI 10.4028/www.scientific.net/AMR.284-286.1742
   Ye M, 2012, FOOD CHEM, V132, P338, DOI 10.1016/j.foodchem.2011.10.087
   Zhang QA, 2009, FOOD CHEM, V116, P513, DOI 10.1016/j.foodchem.2009.02.071
   Zhang ZF, 2012, INT J BIOL MACROMOL, V51, P1140, DOI 10.1016/j.ijbiomac.2012.09.002
   Zhen Tianyuan, 2012, Journal of Chinese Institute of Food Science and Technology, V12, P61
   Zhuang W. Y., 2004, HYALOSCYPHACEAE SARC, V21, P75
NR 31
TC 41
Z9 53
U1 0
U2 74
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0273-2289
EI 1559-0291
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD SEP
PY 2014
VL 174
IS 2
BP 762
EP 771
DI 10.1007/s12010-014-1110-0
PG 10
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AO6EZ
UT WOS:000341443900027
PM 25091327
DA 2024-02-19
ER

PT J
AU IVY, GO
   IHARA, Y
   KITANI, K
AF IVY, GO
   IHARA, Y
   KITANI, K
TI THE PROTEASE INHIBITOR LEUPEPTIN INDUCES SEVERAL SIGNS OF AGING IN
   BRAIN, RETINA AND INTERNAL ORGANS OF YOUNG-RATS
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article; Proceedings Paper
CT INTERNATIONAL SYMP : FRITZ VERZAR PROJECT - 2000
CY SEP 30-OCT 03, 1990
CL ANCONA, ITALY
SP IST NAZL RICOVERO & CURA ANZIANI, SANDOZ FDN GERONTOL RES, BIOGAL PHARM WORKS
DE LEUPEPTIN; AGING; PROTEOLYSIS; LIPOFUSCIN; PROTEASE INHIBITOR; UBIQUITIN
ID PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; CEROID-LIPOFUSCINOSIS;
   UBIQUITIN; ACCUMULATION; TAU; COMPONENT; DOLICHOLS; PROTEINS
AB The protease inhibitor leupeptin was administered to brain, retina and internal organs of young rats for up to two weeks in order to determine if specifically decreased proteolysis could cause symptoms of cellular aging in a variety of tissues. Electron microscopy showed that leupeptin induced the formation of dense substances with fine morphologies similar to and, in many cases, apparently identical with those of natural lipofuscin from aged tissues. Leupeptin also caused increased immunoreactivity to ubiquitin in cerebellar Purkinje cells and presumed Bergmann glia perikarya of brain tissue as well as in hepatocytes of liver tissue. Both of these effects were found in aged tissues as well. Finally, both leupeptin treatment and normal aging led to the onset of immunoreactivity in Purkinje cells to antibodies to the abnormal tau molecule of paired helical filaments from Alzheimer's disease brain.
   Together, these results indicate that inhibition of thiol (and possibly some serine) proteases by leupeptin is sufficient to cause obvious morphological manifestations of aging in several tissues, and are thus consistent with the hypothesis that lipofuscinogenesis as well as a build-up of ubiquitinated proteins with age is caused by decreased or defective proteolysis. These effects are likely secondary to the mechanism(s) interfering with proteolysis itself.
C1 TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT NEUROPHYSIOL,ITABASHI KU,TOKYO 173,JAPAN.
   TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT CLIN PHYSIOL,ITABASHI KU,TOKYO 173,JAPAN.
RP IVY, GO (corresponding author), UNIV TORONTO,DEPT PSYCHOL,DIV LIFE SCI,1265 MIL TRAIL,TORONTO M5S 1A4,ONTARIO,CANADA.
RI Toschi, Isabella/ABC-5408-2020
OI Toschi, Isabella/0000-0002-6602-529X
CR AOYAGI T, 1969, J ANTIBIOT, V22, P558, DOI 10.7164/antibiotics.22.558
   BARRETT AJ, 1980, FED PROC, V39, P9
   BHACHATARRYA TK, 1983, BIOCHEM PHARMACOL, V32, P2965
   BJORKERUD SOREN, 1964, ADVANCE GERONTOL RES, V1, P257
   CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861
   CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3
   GERSHON D, 1988, AGING LIVER GASTROIN, P31
   GERSHON H, 1970, NATURE, V227, P1214, DOI 10.1038/2271214a0
   GERSHON H, 1973, Mechanisms of Ageing and Development, V2, P33, DOI 10.1016/0047-6374(73)90006-7
   HENDLEY DD, 1963, J GERONTOL, V18, P144, DOI 10.1093/geronj/18.2.144
   IHARA Y, 1983, NATURE, V304, P727, DOI 10.1038/304727a0
   Ivy G.O., 1988, Lipofuscin-1987: State of the Art, V1st ed., P83
   IVY GO, 1989, BRAIN RES, V498, P360, DOI 10.1016/0006-8993(89)91117-7
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   IVY GO, 1990, IN PRESS MECH AGEING
   IVY GO, 1990, LIPOFUSCIN CEROID PI, P31
   KATZ ML, 1989, MECH AGEING DEV, V49, P23, DOI 10.1016/0047-6374(89)90065-1
   KIN NMKNY, 1983, J NEUROCHEM, V40, P1465, DOI 10.1111/j.1471-4159.1983.tb13592.x
   KITANI K, 1989, LIPOFUSCIN CEROID PI, P75
   KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4
   LOWE J, 1988, J PATHOL, V155, P1
   MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875
   NAGY K, 1984, MECH AGEING DEV, V28, P171, DOI 10.1016/0047-6374(84)90017-4
   PALMER DN, 1986, J BIOL CHEM, V261, P1773
   PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033
   REZNICK AZ, 1985, MODIFICATION PROTEIN, P69
   TOYOOKA T, 1978, BIOCHEM BIOPH RES CO, V82, P484, DOI 10.1016/0006-291X(78)90900-2
   WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506
   WOLFE LS, 1987, CHEM SCRIPTA, V27, P79
   FREE RAD BIOL
NR 30
TC 11
Z9 11
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAR-JUN
PY 1991
VL 12
IS 2-3
BP 119
EP 131
DI 10.1016/0167-4943(91)90023-J
PG 13
WC Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA FT598
UT WOS:A1991FT59800004
PM 15374443
DA 2024-02-19
ER

PT J
AU Sakurai, H
   Tsuji, A
   Sano, Y
   Masuyama, N
   Asano, H
   Suzuki, K
   Nakajima, K
AF Sakurai, H
   Tsuji, A
   Sano, Y
   Masuyama, N
   Asano, H
   Suzuki, K
   Nakajima, K
TI Dietary copper (Cu)- and age-dependent changes of Cu-metallothionein in
   relation to the level of nitric oxide (NO) in the liver of LEC
   (Long-Evans cinnamon) rats
SO JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE
LA English
DT Article
DE LEC rat; dietary copper; age; metallothionein; nitric oxide (NO)
ID HEREDITARY HEPATITIS; INDUCTION; ACCUMULATION; MODEL; CELLS; BRAIN
AB To understand the unique pathophysiological process of LEC rats (Long-Evans rats with a cinnamon-like coat color), which develop hereditary and spontaneous hepatic injury similar to 4 months after birth, the levels of four biometals, such as Cu, Fe, Zn, and Mn together with metallothionein (MT) and nitric oxide (NO as NO2- plus NO3-), were determined in the liver of male and female animals given normal (Cu level: 0.9-1.0 mg/100 g solid) or Cu-deficient (Cu level: <0.1 mg/100 g solid) diet by atomic absorption spectrometry, radioimmunoassay, and the Griess method, respectively. Levels of Cu and MT, which in turn form Cu-MT, increased, whereas the NO level was decreased in the aging process of both male and female rats given a normal diet. Therefore, the accumulated Cu-MT was proposed to scavenge NO, since NO levels in the liver of LEC rats were lowered compared with those of normal Wistar rats given the same diet. In female LEC rats, enhancements of both Cu and MT accumulations were proposed to relate closely to the development of hepatoma as estimated by histochemical staining. In addition, alterations of Fe, Zn, and Mn levels in the liver were obtained, which map contribute the development of jaundice, hepatitis, and hepatoma of LEC rats. (C) 1997 Wiley-Liss, Inc.
C1 CHARLES RIVER JAPAN, SHIGA, JAPAN.
   GUNMA UNIV, SCH HLTH SCI, DEPT LAB SCI, MAEBASHI, GUMMA 371, JAPAN.
   JAPAN IMMUNORES LAB, TAKASAKI, GUMMA, JAPAN.
C3 Gunma University
RP Sakurai, H (corresponding author), KYOTO PHARMACEUT UNIV, DEPT ANALYT & BIOINORGAN CHEM, YAMASHIMA KU, NAKAUCHI CHO, KYOTO 607, JAPAN.
OI Nakajima, Katsuyuki/0000-0002-0896-8070
CR ARIZONO K, 1995, RES COMMUN MOL PATH, V90, P49
   FELDMAN PL, 1993, CHEM ENG NEWS, V71, P26
   FEND Q, 1990, CLIN PHYSL, V10, P407
   HABU H, 1994, NEUROREPORT, V5, P1571, DOI 10.1097/00001756-199408150-00007
   KAWANO K, 1991, J GASTROEN HEPATOL, V6, P377, DOI 10.1111/j.1440-1746.1991.tb00875.x
   LANCASTER JR, 1992, AM SCI, V80, P248
   LI Y, 1991, J CLIN INVEST, V87, P1858, DOI 10.1172/JCI115208
   LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0
   MASUDA R, 1988, JPN J CANCER RES, V79, P828, DOI 10.1111/j.1349-7006.1988.tb00044.x
   Misra RR, 1996, CHEM RES TOXICOL, V9, P326, DOI 10.1021/tx950109y
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   NAKAJIMA K, 1991, METHOD ENZYMOL, V205, P387
   NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691
   PRYOR WA, 1982, J ORG CHEM, V47, P156, DOI 10.1021/jo00340a038
   SAKURAI H, 1992, BIOCHEM BIOPH RES CO, V185, P548, DOI 10.1016/0006-291X(92)91659-E
   SAKURAI H, 1992, BIOCHEM BIOPH RES CO, V184, P1393, DOI 10.1016/S0006-291X(05)80037-3
   SAKURAI H, 1993, BIOCHEM BIOPH RES CO, V192, P893, DOI 10.1006/bbrc.1993.1499
   SAKURAI H, 1994, BIOCHEM BIOPH RES CO, V199, P313, DOI 10.1006/bbrc.1994.1230
   SASAKI M, 1985, RAT NEWS LETT, V14, P4
   SAWAKI M, 1990, CARCINOGENESIS, V11, P1857, DOI 10.1093/carcin/11.10.1857
   SCHWARZ MA, 1995, P NATL ACAD SCI USA, V92, P4452, DOI 10.1073/pnas.92.10.4452
   STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444
   SUGAWARA N, 1992, PHARMACOL TOXICOL, V71, P321, DOI 10.1111/j.1600-0773.1992.tb00554.x
   SUGAWARA N, 1991, EXPERIENTIA, V47, P1060, DOI 10.1007/BF01923342
   SUZUKI K, 1992, ACTA HISTOCHEM CYTOC, V25, P609
   TAKEICHI N, 1988, ACTA PATHOL JAPON, V38, P1369
   YOSHIDA MC, 1987, J HERED, V78, P361, DOI 10.1093/oxfordjournals.jhered.a110416
NR 27
TC 5
Z9 5
U1 0
U2 0
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0896-548X
J9 J TRACE ELEM EXP MED
JI J. Trace Elem. Exp. Med.
PY 1997
VL 10
IS 2
BP 89
EP 100
PG 12
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA XN336
UT WOS:A1997XN33600006
DA 2024-02-19
ER

PT J
AU John, CM
   Mallat, RK
   Mishra, RC
   George, G
   Singh, V
   Turnbull, JD
   Umeshappa, CS
   Kendrick, DJ
   Kim, T
   Fauzi, FM
   Visser, F
   Fedak, PWM
   Wulff, H
   Braun, AP
AF John, Cini Mathew
   Mallat, Rayan Khaddaj
   Mishra, Ramesh C.
   George, Grace
   Singh, Vikrant
   Turnbull, Jeannine D.
   Umeshappa, Channakeshava S.
   Kendrick, Dylan J.
   Kim, Taeyeob
   Fauzi, Fazlin M.
   Visser, Frank
   Fedak, Paul W. M.
   Wulff, Heike
   Braun, Andrew P.
TI SKA-31, an activator of Ca<SUP>2+</SUP>-activated K<SUP>+</SUP>
   channels, improves cardiovascular function in aging
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Aging; Ca2+-activated K+ channels; Arteries; Heart; Immune system
ID VASCULAR ENDOTHELIAL FUNCTION; T-CELL-ACTIVATION; REAL-TIME PCR;
   PHARMACOLOGICAL ACTIVATOR; POTASSIUM CHANNELS; CORONARY FLOW; ARTERIES;
   RAT; AGE; INFLAMMATION
AB Aging represents an independent risk factor for the development of cardiovascular disease, and is associated with complex structural and functional alterations in the vasculature, such as endothelial dysfunction. Small- and intermediate-conductance, Ca2+-activated K+ channels (KCa2.3 and KCa3.1, respectively) are prominently expressed in the vascular endothelium, and pharmacological activators of these channels induce robust vasodilation upon acute exposure in isolated arteries and intact animals. However, the effects of prolonged in vivo administration of such compounds are unknown. In our study, we hypothesized that such treatment would ameliorate aging-related cardiovascular deficits. Aged (-18 months) male Sprague Dawley rats were treated daily with either vehicle or the KCa channel activator SKA-31 (10 mg/kg, intraperitoneal injection; n = 6/group) for 8 weeks, followed by echocardiography, arterial pressure myography, immune cell and plasma cytokine characterization, and tissue histology. Our results show that SKA-31 administration improved endothelium-dependent vasodilation, reduced agonist-induced vascular contractility, and prevented the aging-associated declines in cardiac ejection fraction, stroke volume and fractional shortening, and further improved the expression of endothelial KCa channels and associated cell signalling components to levels similar to those observed in young male rats (similar to 5 months at end of study). SKA-31 administration did not promote pro-inflammatory changes in either T cell populations or plasma cytokines/chemokines, and we observed no overt tissue histopathology in heart, kidney, aorta, brain, liver and spleen. SKA-31 treatment in young rats had little to no effect on vascular reactivity, select protein expression, tissue histology, plasma cytokines/chemokines or immune cell properties. Collectively, these data demonstrate that administration of the KCa channel activator SKA-31 improved aging-related cardiovascular function, without adversely affecting the immune system or promoting tissue toxicity.
C1 [John, Cini Mathew; Mallat, Rayan Khaddaj; Mishra, Ramesh C.; George, Grace; Kendrick, Dylan J.; Kim, Taeyeob; Braun, Andrew P.] Univ Calgary, Dept Physiol & Pharmacol, Cumming Sch Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
   [Turnbull, Jeannine D.; Fedak, Paul W. M.] Univ Calgary, Dept Cardiac Sci, Cumming Sch Med, Calgary, AB, Canada.
   [Umeshappa, Channakeshava S.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Cumming Sch Med, Calgary, AB, Canada.
   [John, Cini Mathew; Mallat, Rayan Khaddaj; Mishra, Ramesh C.; George, Grace; Turnbull, Jeannine D.; Kendrick, Dylan J.; Kim, Taeyeob; Fedak, Paul W. M.; Braun, Andrew P.] Univ Calgary, Libin Cardiovasc Inst, Cumming Sch Med, Calgary, AB, Canada.
   [Visser, Frank] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada.
   [Fauzi, Fazlin M.] Univ Teknol MARA, Dept Pharmacol & Chem, Shah Alam, Malaysia.
   [Singh, Vikrant; Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.
C3 University of Calgary; University of Calgary; University of Calgary;
   Libin Cardiovascular Institute Of Alberta; University of Calgary;
   University of Calgary; Universiti Teknologi MARA; University of
   California System; University of California Davis
RP Braun, AP (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Cumming Sch Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
EM abraun@ucalgary.ca
RI Khaddaj-Mallat, Rayan/W-8228-2019
OI Khaddaj-Mallat, Rayan/0000-0002-8850-6342
FU Canadian Institutes of Health Research [MOP-142467]; Natural Sciences
   and Engineering Research Council of Canada [RGPIN-201704116]; NIH [R21
   NS101876]; Libin Cardiovascular Institute; Cumming School of Medicine,
   University of Calgary
FX This study was supported by research funding to APB from the Canadian
   Institutes of Health Research (MOP-142467) and the Natural Sciences and
   Engineering Research Council of Canada (RGPIN-201704116), and to HW from
   the NIH (R21 NS101876). CMJ and RKM were supported in part by
   post-doctoral fellowship awards from the Libin Cardiovascular Institute
   and the Cumming School of Medicine, University of Calgary.
CR Anderson TJ, 2011, CIRCULATION, V123, P163, DOI 10.1161/CIRCULATIONAHA.110.953653
   Behnke BJ, 2010, J APPL PHYSIOL, V108, P14, DOI 10.1152/japplphysiol.00970.2009
   Behringer EJ, 2012, CIRC RES, V110, P1311, DOI 10.1161/CIRCRESAHA.111.262592
   Brähler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634
   Brondum E, 2010, BRIT J PHARMACOL, V159, P154, DOI 10.1111/j.1476-5381.2009.00525.x
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cao YJ, 2002, EUR J PHARMACOL, V449, P47, DOI 10.1016/S0014-2999(02)01987-8
   Chiang EY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14644
   Cifra A, 2013, NEUROSCIENTIST, V19, P137, DOI 10.1177/1073858412444932
   Dai ZH, 2012, J CARDIOL, V60, P416, DOI 10.1016/j.jjcc.2012.06.009
   Damkjaer M, 2012, BRIT J PHARMACOL, V165, P223, DOI 10.1111/j.1476-5381.2011.01546.x
   Dienz O, 2007, P NATL ACAD SCI USA, V104, P7175, DOI 10.1073/pnas.0610442104
   Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021
   El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003
   Félétou M, 2011, BRIT J PHARMACOL, V164, P894, DOI 10.1111/j.1476-5381.2011.01276.x
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212
   Fleg JL, 2012, HEART FAIL REV, V17, P545, DOI 10.1007/s10741-011-9270-2
   Gates PE, 2009, EXP PHYSIOL, V94, P311, DOI 10.1113/expphysiol.2008.043349
   Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200
   Goldberg EL, 2015, IMMUNOL REV, V265, P63, DOI 10.1111/imr.12295
   Grundy D, 2015, J PHYSIOL-LONDON, V593, P2547, DOI 10.1113/JP270818
   Grunnet M, 2001, NEUROPHARMACOLOGY, V40, P879, DOI 10.1016/S0028-3908(01)00028-4
   Harwani SC, 2012, CIRC RES, V111, P1190, DOI 10.1161/CIRCRESAHA.112.277475
   Hemmeryckx B, 2013, THROMB HAEMOSTASIS, V110, P785, DOI 10.1160/TH13-01-0022
   Hilgers RHP, 2006, AM J PHYSIOL-HEART C, V291, pH216, DOI 10.1152/ajpheart.01383.2005
   Houghton D, 2016, MECH AGEING DEV, V153, P1, DOI 10.1016/j.mad.2015.11.001
   Jin LW, 2019, ANN CLIN TRANSL NEUR, V6, P723, DOI 10.1002/acn3.754
   John CM, 2011, CELL IMMUNOL, V271, P474, DOI 10.1016/j.cellimm.2011.08.017
   John CM, 2018, CHANNELS, V12, P126, DOI 10.1080/19336950.2018.1454814
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kasumu AW, 2012, CHEM BIOL, V19, P1340, DOI 10.1016/j.chembiol.2012.07.013
   Khaddaj-Mallat R, 2018, EUR J PHARMACOL, V831, P60, DOI 10.1016/j.ejphar.2018.05.006
   Köhler R, 2016, ADV PHARMACOL, V77, P65, DOI 10.1016/bs.apha.2016.04.002
   Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009
   Kunnath-Velayudhan S, 2018, J IMMUNOL METHODS, V456, P77, DOI 10.1016/j.jim.2018.02.008
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Mishra RC, 2016, VASC PHARMACOL, V79, P24, DOI 10.1016/j.vph.2015.07.016
   Mishra RC, 2015, J CARDIOVASC PHARM, V66, P118, DOI 10.1097/FJC.0000000000000252
   Mishra RC, 2014, J MOL CELL CARDIOL, V72, P364, DOI 10.1016/j.yjmcc.2014.04.013
   Mishra RC, 2013, CARDIOVASC RES, V97, P339, DOI 10.1093/cvr/cvs326
   Nanjundappa RH, 2017, CELL, V171, P655, DOI 10.1016/j.cell.2017.09.022
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Radtke J, 2013, BRIT J PHARMACOL, V170, P293, DOI 10.1111/bph.12267
   Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425
   Seals DR, 2014, J APPL PHYSIOL, V117, P425, DOI 10.1152/japplphysiol.00362.2014
   Seals DR, 2014, PHYSIOLOGY, V29, P250, DOI 10.1152/physiol.00059.2013
   Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476
   Seibert TA, 2013, J AM COLL CARDIOL, V62, P1446, DOI 10.1016/j.jacc.2013.05.041
   Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011
   Swayze RD, 2001, J BIOL CHEM, V276, P19729, DOI 10.1074/jbc.M005711200
   Triggle CR, 2012, CAN J PHYSIOL PHARM, V90, P713, DOI [10.1139/Y2012-073, 10.1139/y2012-073]
   Vanhoutte PM, 2017, ACTA PHYSIOL, V219, P22, DOI 10.1111/apha.12646
   Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531
   Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015
   Veerasamy M, 2015, CARDIOL REV, V23, P119, DOI 10.1097/CRD.0000000000000047
   Wang MY, 2014, TRENDS ENDOCRIN MET, V25, P72, DOI 10.1016/j.tem.2013.10.002
   Wang ZJ, 2014, NAT NANOTECHNOL, V9, P204, DOI [10.1038/NNANO.2014.17, 10.1038/nnano.2014.17]
   Wernimont SA, 2011, J IMMUNOL, V187, P6256, DOI 10.4049/jimmunol.1102028
   Wheeler JB, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001744
   Zhu BH, 2001, ACTA PHARMACOL SIN, V22, P445
NR 61
TC 14
Z9 14
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
EI 1096-1186
J9 PHARMACOL RES
JI Pharmacol. Res.
PD JAN
PY 2020
VL 151
AR 104539
DI 10.1016/j.phrs.2019.104539
PG 17
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA LE8US
UT WOS:000527002000034
PM 31707036
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Sipos, F
   Galamb, O
   Herszényi, L
   Molnár, B
   Solymosi, N
   Zágoni, T
   Berczi, L
   Tulassay, Z
AF Sipos, Ferenc
   Galamb, Orsolya
   Herszenyi, Laszlo
   Molnar, Bela
   Solymosi, Norbert
   Zagoni, Tamas
   Berczi, Lajos
   Tulassay, Zsolt
TI Elevated insulin-like growth factor 1 receptor, hepatocyte growth factor
   receptor and telomerase protein expression in mild ulcerative colitis
SO SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE epithelial cell; HGFR; IGF1R; TERT; TP-1; ulcerative colitis
ID INFLAMMATORY-BOWEL-DISEASE; EPITHELIAL-CELL PROLIFERATION; NITRIC-OXIDE
   SYNTHASE; ABERRANT CRYPT FOCI; COLORECTAL-CANCER; C-MET; PREMALIGNANT
   LESIONS; MAMMALIAN TELOMERASE; HUNGARIAN COHORT; CROHNS-DISEASE
AB Objective. The risk of development of colorectal carcinoma is elevated in chronic, long-standing ulcerative colitis (UC). The changes in regenerative and immortalizing pathways caused by the inflammatory process, and that have been proved to be carcinogenic in other human tissues, have not been fully and uniformly described. We assayed the expression alterations of regenerative signal receptors and cell-aging inhibitory systems within colonic crypts by considering the histological activity of the disease. Methods. I-type insulin-like growth factor receptor (IGF1R), hepatocyte growth factor receptor (HGFR), telomerase reverse transcriptase (TERT) and telomerase associated protein (TP-1) expression were evaluated immunohistochemically on biopsy specimens from 11 mild, 11 moderate and 12 severe active inflammation of UC cases and from 10 normal colonic tissue cases. Independent colonic biopsies from 5 healthy and 7 severe UC cases were used for TaqMan real-time RT-PCR validation. Results. In mild inflammation, all observed parameters showed significantly elevated epithelial protein expression (IGF1R: 22.3 +/- 9.46%; HGFR: 35.3 +/- 22.8%; TERT/TP-1: 2.1 +/- 1.87%/2 +/- 1.32%) compared to normal (p < 0.005). In moderately active inflammation, only IGF1R expression was significantly higher (50.2 +/- 8.6%) compared to normal and mild inflammation (p < 0.005). In severe inflammation, all parameters showed decreased epithelial expression; IGF1R showed decreased mRNA expression, while HGFR was overexpressed and TERT showed a decreased tendency. Conclusions. The epithelial expression of IGF1R, HGFR and TERT/TP-1 is elevated in mildly active UC. This phenomenon may allow the epithelial cells that collected genetic defects during severe inflammatory episodes pathologically to survive and proliferate.
C1 [Sipos, Ferenc; Herszenyi, Laszlo; Molnar, Bela; Solymosi, Norbert; Zagoni, Tamas; Tulassay, Zsolt] Semmelweis Univ, Dept Internal Med 2, H-1088 Budapest, Hungary.
   [Galamb, Orsolya; Molnar, Bela; Tulassay, Zsolt] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary.
   [Berczi, Lajos] Semmelweis Univ, Dept Pathol & Canc Res 1, H-1085 Budapest, Hungary.
C3 Semmelweis University; Hungarian Academy of Sciences; Semmelweis
   University
RP Sipos, F (corresponding author), Semmelweis Univ, Dept Internal Med 2, Szentkiralyi Str 46, H-1088 Budapest, Hungary.
EM sipos.ferenc@freemail.hu
RI Solymosi, Norbert/B-5428-2012; Sipos, Ferenc/GYV-6182-2022
OI Solymosi, Norbert/0000-0003-1783-2041
CR Alrawi SJ, 2006, ANTICANCER RES, V26, P107
   Artandi SE, 2005, BIOCHEM BIOPH RES CO, V331, P881, DOI 10.1016/j.bbrc.2005.03.211
   Chakravarti A, 2002, CANCER RES, V62, P200
   Cheng L, 2003, WORLD J GASTROENTERO, V9, P2642
   Chowdhury A, 1996, J GASTROENTEROL, V31, P353, DOI 10.1007/BF02355024
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0
   DIGNASS AU, 1994, BIOCHEM BIOPH RES CO, V202, P701, DOI 10.1006/bbrc.1994.1987
   Dignass AU, 2001, EUR J GASTROEN HEPAT, V13, P763, DOI 10.1097/00042737-200107000-00002
   Ding XH, 2005, CANCER SCI, V96, P157, DOI 10.1111/j.1349-7006.2005.00024.x
   DIRENZO MF, 1995, CLIN CANCER RES, V1, P147
   El Yafi F, 2005, CLIN EXP IMMUNOL, V139, P526, DOI 10.1111/j.1365-2249.2004.02724.x
   Engelhardt M, 1997, CLIN CANCER RES, V3, P1931
   Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843
   GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0
   Goodman JE, 2004, ENVIRON MOL MUTAGEN, V44, P3, DOI 10.1002/em.20024
   Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005
   Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780
   Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973
   Holzmann K, 2000, ANTICANCER RES, V20, P3951
   KANDA H, 1993, ONCOGENE, V8, P3047
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   KIPLING D, 1995, NAT GENET, V9, P104, DOI 10.1038/ng0295-104
   Kipling D., 1995, TELOMERE
   Kitamura S, 2000, INFLAMM RES, V49, P320, DOI 10.1007/PL00000212
   Kleideiter E, 2003, DIGEST DIS SCI, V48, P2328, DOI 10.1023/B:DDAS.0000007871.86129.4a
   Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554
   Lakatos L, 2006, INFLAMM BOWEL DIS, V12, P205, DOI 10.1097/01.MIB.0000217770.21261.ce
   Lakatos Laszlo, 2006, Orvosi Hetilap, V147, P175
   Lakatos L, 2004, WORLD J GASTROENTERO, V10, P404
   Lala PK, 2001, LANCET ONCOL, V2, P149, DOI 10.1016/S1470-2045(00)00256-4
   Levine AD, 2000, INFLAMM BOWEL DIS, V6, P191, DOI 10.1097/00054725-200008000-00006
   LIU C, 1992, ONCOGENE, V7, P181
   Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3
   Myung SJ, 2005, J GASTROEN HEPATOL, V20, P1578, DOI 10.1111/j.1440-1746.2005.03877.x
   Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955
   Nakayama JI, 1997, CELL, V88, P875, DOI 10.1016/S0092-8674(00)81933-9
   NALDINI L, 1991, ONCOGENE, V6, P501
   Noffsinger A, 1998, MODERN PATHOL, V11, P1198
   PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379
   PRAT M, 1991, INT J CANCER, V49, P323, DOI 10.1002/ijc.2910490302
   Rao CV, 2004, MUTAT RES-FUND MOL M, V555, P107, DOI 10.1016/j.mrfmmm.2004.05.022
   Sipos F, 2005, DIS COLON RECTUM, V48, P775, DOI 10.1007/s10350-004-0831-5
   Tahara Y, 2003, J PHARMACOL EXP THER, V307, P146, DOI 10.1124/jpet.103.054106
   TAKAHASHI M, 1995, J CLIN INVEST, V95, P1994, DOI 10.1172/JCI117884
   Takayama T, 2006, J GASTROENTEROL, V41, P185, DOI 10.1007/s00535-006-1801-6
   TULASSAY Z, 2005, GASTROENTEROLOGY GUI
   Usselmann B, 2001, AM J GASTROENTEROL, V96, P1106
   Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318
   Yagihashi N, 2000, VIRCHOWS ARCH, V436, P109, DOI 10.1007/PL00008208
   Zeeh JM, 1997, AM J PHYSIOL-GASTR L, V272, pG481, DOI 10.1152/ajpgi.1997.272.3.G481
NR 51
TC 19
Z9 22
U1 0
U2 0
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0036-5521
J9 SCAND J GASTROENTERO
JI Scand. J. Gastroenterol.
PY 2008
VL 43
IS 3
BP 289
EP 298
DI 10.1080/00365520701714434
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 261RG
UT WOS:000253097100006
PM 18938767
DA 2024-02-19
ER

PT J
AU UGARKOVIC, D
   KUCHINO, Y
   MIZUSHIMA, H
   NEMOTO, F
   MULLER, WEG
   SCHRODER, HC
AF UGARKOVIC, D
   KUCHINO, Y
   MIZUSHIMA, H
   NEMOTO, F
   MULLER, WEG
   SCHRODER, HC
TI RETROVIRUS INFECTION AND AGING - INCREASE IN UAG SUPPRESSOR TRANSFER-RNA
   EXPRESSION IN AGED MICE
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article; Proceedings Paper
CT 5th International Congress of the
   International-Association-of-Biomedical-Gerontology
CY JUL 01-03, 1993
CL BUDAPEST, HUNGARY
SP INT ASSOC BIOMED GERONTOL, VERZIR INT LAB EXPTL GERONTOL, BIOGAL PHARM WORKSLTD, GLENN FDN MED RES, SANDOZ FDN GERONTOL RES
DE RETROVIRUS; UAG CODON; MOUSE; GLUTAMINE SUPPRESSOR TRANSFER-RNA;
   RETROVIRAL PROTEASE GENE
ID MURINE LEUKEMIA-VIRUS; GLUTAMINE TRANSFER-RNA; TERMINATION CODON;
   ACTIVE-SITE; CELLS; GENE; SELENOCYSTEINE; INHIBITION; AVAROL; LIVER
AB The effect of aging on expression of a natural glutamine suppressor tRNA (tRNA(Gln(UmUG))) was studied in different tissues of mice; this tRNA recognizes UAG and inserts glutamine at the site of the termination codon. The level of tRNA(Gln(UmUG)) was found to be strongly increased in aged mice, compared to newborn and mature animals. An elevated expression of tRNA(Gln(UmUG)) has also been found in retrovirus-infected cells; in Moloney virus-infected cells the suppressor tRNA allows to read-through the UAG codon within the retroviral protease gene. We suggest that the increase in the level of tRNA(Gln(UmUG)) may influence retroviral gene expression with age.
C1 NATL CANC CTR,RES INST,DIV BIOPHYS,CHUO KU,TOKYO 104,JAPAN.
C3 National Cancer Center - Japan
RP UGARKOVIC, D (corresponding author), UNIV MAINZ,INST PHYSIOL CHEM,DUESBERGWEG 6,D-55099 MAINZ,GERMANY.
RI Müller, W. E. G./AAR-8651-2020
OI Müller, W. E. G./0000-0002-8223-3689
CR Andron L.A. II, 1973, Mechanisms Ageing Dev, V2, P97, DOI 10.1016/0047-6374(73)90009-2
   CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x
   DINGERMANN T, 1987, EUR J BIOCHEM, V170, P217, DOI 10.1111/j.1432-1033.1987.tb13689.x
   FLORINE DL, 1980, CANCER RES, V40, P519
   FRAZER JM, 1972, ARCH BIOCHEM BIOPHYS, V153, P610, DOI 10.1016/0003-9861(72)90380-3
   GELLER AI, 1980, NATURE, V283, P41, DOI 10.1038/283041a0
   HATFIELD D, 1988, BIOCHEMISTRY-US, V27, P1179, DOI 10.1021/bi00404a017
   KUCHINO Y, 1988, VIROLOGY, V165, P518, DOI 10.1016/0042-6822(88)90596-X
   KUCHINO Y, 1987, P NATL ACAD SCI USA, V84, P2668, DOI 10.1073/pnas.84.9.2668
   LEE BJ, 1989, J BIOL CHEM, V264, P9724
   MAYS LL, 1979, FED PROC, V38, P1984
   MULLENBACH GT, 1987, NUCLEIC ACIDS RES, V15, P5484, DOI 10.1093/nar/15.13.5484
   MULLER WEG, 1988, AIDS RES HUM RETROV, V4, P279, DOI 10.1089/aid.1988.4.279
   ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431
   SCHRODER HC, 1992, EUR J GERONTOL, V1, P452
   STREHLER B, 1971, J THEOR BIOL, V33, P429, DOI 10.1016/0022-5193(71)90091-9
   STREHLER BL, 1979, TIME CELLS AGING
   YOSHINAKA Y, 1985, P NATL ACAD SCI USA, V82, P1618, DOI 10.1073/pnas.82.6.1618
NR 18
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PY 1994
SU 4
BP 257
EP 263
PG 7
WC Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA NK652
UT WOS:A1994NK65200031
DA 2024-02-19
ER

PT J
AU Tresguerres, JAF
   Kireev, R
   Tresguerres, AR
   Borras, C
   Vara, E
   Ariznavarreta, C
AF Tresguerres, Jesus A. F.
   Kireev, Roman
   Tresguerres, Ana R.
   Borras, Consuelo
   Vara, Elena
   Ariznavarreta, Carmen
TI Molecular mechanisms involved in the hormonal prevention of aging in the
   rat
SO JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article; Proceedings Paper
CT 12th International Congress on Hormonal Steroids and Hormones and Cancer
CY SEP 13-16, 2006
CL Athens, GREECE
ID GROWTH-FACTOR-I; AGE-RELATED-CHANGES; GENE-EXPRESSION; CYTOCHROME-C;
   HYDROGEN-PEROXIDE; OXIDATIVE DAMAGE; BODY-COMPOSITION; CARBON-MONOXIDE;
   HEME OXYGENASE; NITRIC-OXIDE
AB Previous data from our group have provided support for the role of GH, melatonin and estrogens in the prevention of aging of several physiological parameters from bone, liver metabolism, vascular activity, the central nervous system (CNS), the immune system and the skin. In the present work data on the molecular mechanisms involved are presented. A total of 140 male and female rats have been submitted to different treatments over 10 weeks, between 22 and 24 months of age. Males have been treated with GH and melatonin. Females were divided in two groups: intact and castrated at 12 months of age. The first group was treated with GH and melatonin and the second with the two latter compounds and additionally with estradiol and Phytosoya((R)). Aging was associated with a reduction in the number of neurons of the hylus of the dentate gyrus of the hippocampus and with a reduction of neurogenesis. GH treatment increased the number of neurons but did not increase neurogenesis thus suggesting a reduction of apoptosis. This was supported by the reduction in nucleosomes and the increase in Bcl2 observed in cerebral homogenates together with an increase in sirtuin2 and a reduction of caspases 9 and 3. Melatonin, estrogen and Phytosoya((R)) treatments increased neurogenesis but did not enhance the total number of neurons. Aging induced a significant increase in mitochondrial nitric oxide in the hepatocytes, together with a reduction in the mitochondrial fraction content in cytochrome C and an increase of this compound in the cytosolic fraction. Reductions of glutathione peroxidase and glutathione S-transferase were also detected, thus indicating oxidative stress and possibly apoptosis. Treatment for 2.5 months of old rats with GH and melatonin were able to significantly and favourably affect age-induced deteriorations, thus reducing oxidative damage. Keratinocytes obtained from old rats in primary culture showed an increase in lipoperoxides, caspases 8 and 3 as well as a reduction in Bcl2 leading to enhanced number of nucleosomes that was also restored upon treatments with GH and melatonin. In conclusion, GH and melatonin treatment seem to have beneficial effects against age-induced damage in the CNS the liver and the skin through molecular mechanisms reducing oxidative stress and apoptosis. (c) 2007 Published by Elsevier Ltd.
C1 [Tresguerres, Jesus A. F.; Tresguerres, Ana R.; Ariznavarreta, Carmen] UCM, Dept Physiol, Fac Med, Madrid, Spain.
   [Vara, Elena] UCM, Fac Med, Dept Biochem, Madrid, Spain.
   [Borras, Consuelo] Univ Valencia, Fac Med, Dept Physiol, E-46003 Valencia, Spain.
   [Kireev, Roman] Inst Gen Pathol & Pathophysiol, Moscow, Russia.
C3 Complutense University of Madrid; Complutense University of Madrid;
   University of Valencia; Russian Academy of Medical Sciences; Institute
   of General Pathology & Pathophysiology, RAMS
RP Tresguerres, JAF (corresponding author), Univ Complutense, Dept Physiol, Lab Experimental Endocrinol, Sch Med, Avda,Complutense S-N, E-28040 Madrid, Spain.
EM querres@med.ucm.es
RI borras, consuelo/Y-3407-2019
OI borras, consuelo/0000-0003-4606-1792; Kireev, Roman/0000-0002-6105-2440
CR ACUNACASTROVIEJ.D, 2004, LONGEVIDAD TRATADO I, P216
   Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209
   Azcoitia I, 1999, J NEUROSCI RES, V58, P815, DOI 10.1002/(SICI)1097-4547(19991215)58:6<815::AID-JNR8>3.0.CO;2-R
   Azcoitia I, 2005, NEUROBIOL AGING, V26, P697, DOI 10.1016/j.neurobiolaging.2004.06.007
   Barañano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298
   Barros MH, 2003, FREE RADICAL BIO MED, V35, P179, DOI 10.1016/S0891-5849(03)00307-1
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   BRINCAT M, 1983, BRIT MED J, V287, P1337, DOI 10.1136/bmj.287.6402.1337
   BROWN GC, 1995, EUR J BIOCHEM, V232, P188, DOI 10.1111/j.1432-1033.1995.tb20798.x
   Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7
   BROWN GC, 1992, BIOCHEM J, V284, P1
   BROWN SD, 1992, J CLIN INVEST, V89, P666, DOI 10.1172/JCI115633
   Brown-Borg HM, 2003, MECH AGEING DEV, V124, P1013, DOI 10.1016/j.mad.2003.07.001
   Brown-Borg HM, 2002, EXP BIOL MED, V227, P94, DOI 10.1177/153537020222700203
   Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001
   Castillo C, 2005, BIOGERONTOLOGY, V6, P303, DOI 10.1007/s10522-005-4805-3
   Castillo C, 2004, ENDOCRINE, V25, P33, DOI 10.1385/ENDO:25:1:33
   Castillo C, 2005, J PINEAL RES, V38, P240, DOI 10.1111/j.1600-079X.2004.00199.x
   Castillo C, 2005, BIOGERONTOLOGY, V6, P49, DOI 10.1007/s10522-004-7383-x
   Castillo C, 2003, EXP GERONTOL, V38, P971, DOI 10.1016/S0531-5565(03)00156-6
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   Chernyak BV, 1997, BIOSCIENCE REP, V17, P293, DOI 10.1023/A:1027384628678
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   De la Fuente M, 2004, BIOGERONTOLOGY, V5, P389
   Dubal DB, 1999, J NEUROSCI, V19, P6385
   Dykens JA, 1997, NEURODEGENER DIS, P29
   Erden-Inal M, 2002, CELL BIOCHEM FUNCT, V20, P61, DOI 10.1002/cbf.937
   Esteve JM, 1999, FASEB J, V13, P1055, DOI 10.1096/fasebj.13.9.1055
   Frago LM, 2002, ENDOCRINOLOGY, V143, P4113, DOI 10.1210/en.2002-220261
   Frankel D, 2000, J CELL PHYSIOL, V185, P80, DOI 10.1002/1097-4652(200010)185:1<80::AID-JCP7>3.0.CO;2-W
   Garcia-Segura LM, 2000, J NEUROCYTOL, V29, P425, DOI 10.1023/A:1007125626308
   Gilad E, 1997, LIFE SCI, V60, pPL169, DOI 10.1016/S0024-3205(97)00008-8
   Guo X, 2001, LIFE SCI, V69, P3113, DOI 10.1016/S0024-3205(01)01417-5
   Gustafson K, 1999, PEDIATR RES, V45, P318, DOI 10.1203/00006450-199903000-00005
   Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851
   Ignarro LJ, 1999, BIOSCIENCE REP, V19, P51, DOI 10.1023/A:1020150124721
   Jeon TI, 2001, LIPIDS, V36, P589, DOI 10.1007/s11745-001-0761-1
   Kanda N, 2005, J DERMATOL SCI, V38, P1, DOI 10.1016/j.jdermsci.2004.10.011
   Kim HG, 2003, MOL CELLS, V16, P278
   KIREEV RA, IN PRESS J PINEAL RE
   Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132
   Koehler RC, 2002, ANTIOXID REDOX SIGN, V4, P279, DOI 10.1089/152308602753666334
   Kunduzova OR, 2003, FASEB J, V17, P872, DOI 10.1096/fj.02-0504fje
   LAUTIER D, 1992, CARCINOGENESIS, V13, P227, DOI 10.1093/carcin/13.2.227
   Leon J, 2004, LIFE SCI, V75, P765, DOI 10.1016/j.lfs.2004.03.003
   LopezFernandez J, 1996, ENDOCRINOLOGY, V137, P4384, DOI 10.1210/en.137.10.4384
   Ma YX, 1999, FREE RADICAL BIO MED, V27, P227, DOI 10.1016/S0891-5849(99)00083-0
   Miyamoto Y, 2003, BIOL CHEM, V384, P567, DOI 10.1515/BC.2003.064
   Mosoni L, 2004, EXP GERONTOL, V39, P203, DOI 10.1016/j.exger.2003.10.014
   Neill J.D., 1994, PHYSL REPROD
   Nyberg F, 2002, AMINO ACIDS, V23, P231, DOI 10.1007/s00726-001-0134-2
   Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Perez-Martin M, 2005, EXP GERONTOL, V40, P450, DOI 10.1016/j.exger.2005.03.003
   Phillips TJ, 2001, CLIN GERIATR MED, V17, P661, DOI 10.1016/S0749-0690(05)70092-6
   PIANTADOSI CA, 1995, FREE RADICAL BIO MED, V18, P603, DOI 10.1016/0891-5849(95)00168-W
   Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146
   Poderoso JJ, 1998, AM J PHYSIOL-CELL PH, V274, pC112, DOI 10.1152/ajpcell.1998.274.1.C112
   Reiter R, 1997, LIFE SCI, V60, P2255, DOI 10.1016/S0024-3205(97)00030-1
   Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5
   Reiter RJ, 1999, BIOL SIGNAL RECEPT, V8, P56
   Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x
   Rollo CD, 1996, CAN J ZOOL, V74, P606, DOI 10.1139/z96-070
   Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924
   Sasaki M, 2001, MECH AGEING DEV, V122, P1695, DOI 10.1016/S0047-6374(01)00281-0
   Sastre J, 2000, IUBMB LIFE, V49, P427
   Scheepens A, 2000, J PEDIATR ENDOCR MET, V13, P1483
   Scheepens A, 2001, NEUROSCIENCE, V104, P677, DOI 10.1016/S0306-4522(01)00109-9
   Shen YX, 2002, J PINEAL RES, V32, P163, DOI 10.1034/j.1600-079x.2002.1o839.x
   Shetty AK, 1999, EXP NEUROL, V158, P491, DOI 10.1006/exnr.1999.7107
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9
   STUBBS WA, 1978, LANCET, V2, P1225
   Takuma K, 2001, J BIOL CHEM, V276, P48093, DOI 10.1074/jbc.M108622200
   Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   TRESGUERRES ACF, 2006, THESIS U COMPLUTENSE
   Viña J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194
   Wallace D C, 2001, Novartis Found Symp, V235, P247
   WATERLOW JC, 1984, Q J EXP PHYSIOL CMS, V69, P409, DOI 10.1113/expphysiol.1984.sp002829
   Wise PM, 2000, J NEUROCYTOL, V29, P401, DOI 10.1023/A:1007169408561
   Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177
   Yin ZM, 2000, CANCER RES, V60, P4053
   Yoo YM, 2002, J PINEAL RES, V33, P146, DOI 10.1034/j.1600-079X.2002.02899.x
   Youn YK, 1998, J BURN CARE REHABIL, V19, P542, DOI 10.1097/00004630-199811000-00015
   ZHANG J, 1992, J CLIN INVEST, V90, P1193, DOI 10.1172/JCI115980
   Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200
NR 89
TC 40
Z9 44
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0760
J9 J STEROID BIOCHEM
JI J. Steroid Biochem. Mol. Biol.
PD FEB
PY 2008
VL 108
IS 3-5
BP 318
EP 326
DI 10.1016/j.jsbmb.2007.09.010
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 273XD
UT WOS:000253964600020
PM 18252241
DA 2024-02-19
ER

PT J
AU Cordery, DV
   Cooper, DA
AF Cordery, Damien V.
   Cooper, David A.
TI Optimal antiretroviral therapy for aging
SO SEXUAL HEALTH
LA English
DT Article
DE highly active antiretroviral therapy; HIV
ID HUMAN-IMMUNODEFICIENCY-VIRUS; BONE-MINERAL DENSITY; RISK-FACTORS;
   HIV-INFECTION; DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; METABOLIC
   SYNDROME; AGE; OLDER; AIDS
AB The introduction of highly active antiretroviral therapy (HAART) has irrevocably changed the nature of the HIV epidemic in developed countries. Although the use of HAART does not completely restore health in HIV-infected individuals, it has dramatically reduced morbidity and mortality. Increases in life expectancy resulting from effective longterm treatment mean that the proportion of older people living with HIV has increased substantially in the past 15 years. Increasing age is associated with many complications including cardiovascular disease, neurological complications, kidney and liver dysfunction, and metabolic complications such as dyslipidaemia and diabetes. HIV infection and antiretroviral drugs have also been associated with similar complications to those seen with increasing age. The increase in HIV prevalence in older age groups has not been accompanied by the development of treatment guidelines or recommendations for appropriate antiretroviral therapy or clinical management in these patients.
C1 [Cordery, Damien V.; Cooper, David A.] Univ New S Wales, Kirby Inst, Sydney, NSW 2010, Australia.
C3 University of New South Wales Sydney; Kirby Institute
RP Cooper, DA (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW 2010, Australia.
EM dcooper@kirby.unsw.edu.au
CR Aberg JA, 2009, ENDOCRIN METAB CLIN, V38, P207, DOI 10.1016/j.ecl.2008.11.009
   [Anonymous], 2010, MAPP HIV OUTC GEOGR
   Appay V, 2002, TRENDS IMMUNOL, V23, P580, DOI 10.1016/S1471-4906(02)02338-4
   Arnsten JH, 2006, CLIN INFECT DIS, V42, P1014, DOI 10.1086/501015
   Arnsten JH, 2007, AIDS, V21, P617, DOI 10.1097/QAD.0b013e3280148c05
   Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76
   Bhavan Kavita P, 2008, Curr HIV/AIDS Rep, V5, P150, DOI 10.1007/s11904-008-0023-3
   Blanch J, 2001, J ACQ IMMUN DEF SYND, V27, P336, DOI 10.1097/00126334-200108010-00003
   Bolland MJ, 2007, J CLIN ENDOCR METAB, V92, P4522, DOI 10.1210/jc.2007-1660
   Bonfanti P, 2007, JAIDS-J ACQ IMM DEF, V45, P426, DOI 10.1097/QAI.0b013e318074ef83
   BORKAN GA, 1983, J GERONTOL, V38, P673, DOI 10.1093/geronj/38.6.673
   Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb
   Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28
   Carr A, 2003, AIDS, V17, pS141, DOI 10.1097/00002030-200304001-00017
   Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2
   Carr A, 2001, AIDS, V15, P703, DOI 10.1097/00002030-200104130-00005
   CARRE N, 1994, AIDS, V8, P797, DOI 10.1097/00002030-199406000-00012
   Centers for Disease Control (CDC), 2008, CDC HIV SURV REP 200
   Chu KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009183
   Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, 2008, AIDS, V22, P1463, DOI 10.1097/QAD.0b013e3282f88d02
   Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681
   Costagliola Dominique, 2010, Curr HIV/AIDS Rep, V7, P127, DOI 10.1007/s11904-010-0047-3
   Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172
   Dolan SE, 2006, J CLIN ENDOCR METAB, V91, P2938, DOI 10.1210/jc.2006-0127
   Fontas E, 2004, J INFECT DIS, V189, P1056, DOI 10.1086/381783
   Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218
   Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744
   Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191
   Gan SK, 2002, DIABETES, V51, P3163, DOI 10.2337/diabetes.51.11.3163
   Gebo KA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1460
   Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577
   Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792
   Grunfeld C, 2009, TOP HIV MED, V18, P112
   Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541
   Hansen ABE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000738
   Herlitz LC, 2010, KIDNEY INT, V78, P1171, DOI 10.1038/ki.2010.318
   Hinkin CH, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200418001-00004
   Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7
   Jones S, 2008, OSTEOPOROSIS INT, V19, P913, DOI 10.1007/s00198-007-0524-8
   Kearney F, 2010, AGE AGEING, V39, P536, DOI 10.1093/ageing/afq083
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31
   Letendre Scott L, 2010, Top HIV Med, V18, P45
   Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003
   Mallon PWG, 2010, CURR OPIN INFECT DIS, V23, P1, DOI 10.1097/QCO.0b013e328334fe9a
   Marraa CM, 2009, AIDS, V23, P1359, DOI 10.1097/QAD.0b013e32832c4152
   McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412
   Moodie EEM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004517
   Mussini C, 2008, AIDS, V22, P2461, DOI 10.1097/QAD.0b013e328314b5f1
   *NCHECR, 2010, HIV VIR HEP SEX TRAN
   Noor MA, 2002, AIDS, V16, pF1, DOI 10.1097/00002030-200203290-00002
   Noor MA, 2006, AIDS, V20, P1813, DOI 10.1097/01.aids.0000244200.11006.55
   Papaioannou A, 2009, OSTEOPOROSIS INT, V20, P507, DOI 10.1007/s00198-008-0720-1
   Perazella MA, 2010, KIDNEY INT, V78, P1060, DOI 10.1038/ki.2010.344
   PHILLIPS AN, 1991, J ACQ IMMUN DEF SYND, V4, P970
   Rhee MS, 2008, J CLIN PHARMACOL, V48, P1212, DOI 10.1177/0091270008322177
   Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7
   Salles N, 2007, DIGEST DIS, V25, P112, DOI 10.1159/000099474
   Samaras K, 2008, J ANTIMICROB CHEMOTH, V61, P238, DOI 10.1093/jac/dkm475
   Schwartz EJ, 2005, J AM SOC NEPHROL, V16, P2412, DOI 10.1681/ASN.2005040340
   Shah SS, 2002, CLIN INFECT DIS, V35, P1238, DOI 10.1086/343048
   Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684
   Tien PC, 2007, AIDS, V21, P1739, DOI 10.1097/QAD.0b013e32827038d0
   van Leth F, 2005, AIDS, V19, P463, DOI 10.1097/01.aids.0000162334.12815.5b
   Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9
   Wand H, 2007, AIDS, V21, P2445, DOI 10.1097/QAD.0b013e3282efad32
   Waugh EJ, 2009, OSTEOPOROSIS INT, V20, P1, DOI 10.1007/s00198-008-0643-x
   Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632
   White D A, 1995, J Int Neuropsychol Soc, V1, P304
   Winston A, 2010, CLIN INFECT DIS, V50, P920, DOI 10.1086/650743
NR 70
TC 5
Z9 5
U1 0
U2 5
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1448-5028
EI 1449-8987
J9 SEX HEALTH
JI Sex Health
PY 2011
VL 8
IS 4
SI SI
BP 534
EP 540
DI 10.1071/SH11026
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 844UM
UT WOS:000296774000013
PM 22127040
DA 2024-02-19
ER

PT J
AU Liu, C
   Jia, YL
   Qiu, Y
AF Liu, Chang
   Jia, Yanli
   Qiu, Yan
TI Ethyl Acetate Fraction of <i>Abelmoschus manihot</i> (L.) Medic Flowers
   Exerts Inhibitory Effects Against Oxidative Stress in
   H<sub>2</sub>O<sub>2</sub>-Induced HepG2 Cells and D-Galactose-Induced
   Aging Mice
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE Abelmoschus manihot (L; ) Medic flowers; antioxidative activity; ethyl
   acetate fraction; HepG2 cells; mice
ID ANTIOXIDANT PEPTIDES; INDUCED LIVER; IN-VITRO; DISEASE; INFLAMMATION;
   MECHANISMS; CAPACITY; EXTRACT; PATHWAY; DAMAGE
AB Oxidative stress has been demonstrated to be associated with numerous aging-related diseases. Ethyl acetate fraction of Abelmoschus manihot (L.) Medic (EA) had been reported to possess strong radical-scavenging activity due to its rich content of flavonoids. This work aimed to determine the protective effects of EA against oxidative injuries in vivo and in vitro, as well as to explore the relevant mechanisms behind these effects. Pretreatment with EA significantly elevated cell viability of H2O2-induced HepG2 cells, reduced the reactive oxygen species level, decreased apoptotic cells, and inhibited activities of caspase 3/9. Meanwhile, EA pretreatment elevated the levels of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), while reduced malondialdehyde (MDA) generation and lactate dehydrogenase (LDH) release dose-dependently. In addition, EA modulated key marker genes expression of antioxidation and apoptosis-related signaling pathways at the messenger RNA (mRNA) and protein levels. In the animal studies, EA also significantly enhanced the antioxidant activity and reduced MDA generation in serum, liver, and brain of the D-galactose (D-gal)-induced mice. Furthermore, the histological analysis indicated that EA effectively alleviated liver and brain injury of mice induced by D-gal, dose-dependently. EA as a potential antioxidant agent promoted health and reduced the risk of aging-associated diseases.
C1 [Liu, Chang; Jia, Yanli; Qiu, Yan] Hebei Univ Sci & Technol, Coll Food Sci & Biol, 26 Yuxiang St, Shijiazhuang 050018, Hebei, Peoples R China.
C3 Hebei University of Science & Technology
RP Qiu, Y (corresponding author), Hebei Univ Sci & Technol, Coll Food Sci & Biol, 26 Yuxiang St, Shijiazhuang 050018, Hebei, Peoples R China.
EM qiuyan@hebust.edu.cn
CR Brosché M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004112
   Byun K, 2017, PHARMACOL THERAPEUT, V177, P44, DOI 10.1016/j.pharmthera.2017.02.030
   Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021
   Chang SK, 2015, J FUNCT FOODS, V14, P63, DOI 10.1016/j.jff.2015.01.011
   Chen ZT, 2012, FOOD CHEM, V135, P2119, DOI 10.1016/j.foodchem.2012.07.041
   Diem S, 2016, BRIT J CANCER, V114, P256, DOI 10.1038/bjc.2015.467
   Dinkova-Kostova AT, 2010, J BIOL CHEM, V285, P33747, DOI 10.1074/jbc.M110.163485
   Gao XD, 2019, FOOD CHEM TOXICOL, V130, P130, DOI 10.1016/j.fct.2019.05.021
   Gómez LJ, 2019, FOOD RES INT, V120, P52, DOI 10.1016/j.foodres.2019.02.029
   Halliwell B, 1996, FREE RADICAL RES, V25, P57, DOI 10.3109/10715769609145656
   Huang BX, 2018, J FUNCT FOODS, V45, P452, DOI 10.1016/j.jff.2018.04.018
   Jiang CP, 2012, WORLD J GASTROENTERO, V18, P1753, DOI 10.3748/wjg.v18.i15.1753
   Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740
   Lai XY, 2009, J CHROMATOGR SCI, V47, P206, DOI 10.1093/chromsci/47.3.206
   Lee MS, 2012, FITOTERAPIA, V83, P1060, DOI 10.1016/j.fitote.2012.05.007
   Liang R, 2019, FOOD RES INT, V121, P336, DOI 10.1016/j.foodres.2019.03.049
   Lin CM, 2020, J FOOD DRUG ANAL, V28, P147, DOI 10.1016/j.jfda.2019.10.004
   Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x
   Oyebode OT, 2020, J FUNCT FOODS, V69, DOI 10.1016/j.jff.2020.103957
   Palma-Duran SA, 2018, METABOLISM, V83, P120, DOI 10.1016/j.metabol.2018.01.023
   Qiu Y., 2006, J HEBEI NORMAL U NAT, V30, P713
   [仇燕 Qiu Yan], 2017, [精细化工, Fine Chemicals], V34, P786
   Qiu Y, 2017, J MED FOOD, V20, P557, DOI 10.1089/jmf.2016.3870
   [仇燕 Qiu Yan], 2016, [精细化工, Fine Chemicals], V33, P890
   Saleh DO, 2019, EUR J PHARMACOL, V855, P40, DOI 10.1016/j.ejphar.2019.04.043
   Sreelatha S, 2009, FOOD CHEM TOXICOL, V47, P702, DOI 10.1016/j.fct.2008.12.022
   Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x
   Tong J, 2015, J ETHNOPHARMACOL, V174, P355, DOI 10.1016/j.jep.2015.08.045
   Tu Y, 2013, J ETHNOPHARMACOL, V147, P311, DOI 10.1016/j.jep.2013.03.006
   Veiko AG, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183442
   Wang D, 2020, FREE RADICAL BIO MED, V153, P122, DOI 10.1016/j.freeradbiomed.2020.04.018
   Wang FX, 2016, INT J BIOL MACROMOL, V87, P222, DOI 10.1016/j.ijbiomac.2016.02.011
   Wang LY, 2016, FOOD RES INT, V90, P33, DOI 10.1016/j.foodres.2016.10.023
   Wang P, 2017, FOOD CHEM TOXICOL, V102, P129, DOI 10.1016/j.fct.2017.02.016
   Wang YX., 2003, NONG YE KE JI YU XIN, V12, P23
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Zaplatic E, 2019, LIFE SCI, V224, P109, DOI 10.1016/j.lfs.2019.03.055
   Zhang BS, 2020, KOREAN J PHYSIOL PHA, V24, P373, DOI 10.4196/kjpp.2020.24.5.373
   Zhang L, 2014, AM J KIDNEY DIS, V64, P57, DOI 10.1053/j.ajkd.2014.01.431
   Zhou L., 2012, J LIAONING U TRADIT, V14, P44
   Zhou ZY, 2019, SCI TOTAL ENVIRON, V656, P778, DOI 10.1016/j.scitotenv.2018.11.306
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
   Zou LY, 2017, EXP TOXICOL PATHOL, V69, P451, DOI 10.1016/j.etp.2017.04.001
NR 43
TC 5
Z9 5
U1 1
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD SEP 1
PY 2021
VL 24
IS 9
BP 997
EP 1009
DI 10.1089/jmf.2021.K.0053
PG 13
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition &
   Dietetics
GA UQ4FM
UT WOS:000696021000012
PM 34524027
DA 2024-02-19
ER

PT J
AU Hu, KC
   Chu, CH
   Wang, HY
   Chang, WH
   Lin, SC
   Liu, CC
   Liao, WC
   Liu, CJ
   Wu, MS
   Shih, SC
AF Hu, Kuang-Chun
   Chu, Cheng-Hsin
   Wang, Horng-Yuan
   Chang, Wen-Hsiung
   Lin, Shee-Chan
   Liu, Chuan-Chuan
   Liao, Wei-Chih
   Liu, Chun-Jen
   Wu, Ming-Shiang
   Shih, Shou-Chuan
TI How Does Aging Affect Presentation and Management of Biliary Stones?
SO JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
LA English
DT Article
DE biliary stone disease; elderly; effects of aging; presentation;
   management
ID BILE-DUCT STONES; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;
   BALLOON DILATION; RISK-FACTORS; CHOLEDOCHOLITHIASIS; CHOLECYSTECTOMY;
   SPHINCTEROTOMY; COMPLICATIONS; PREDICTORS; ELEVATION
AB Common bile duct (CBD) stones are common in elderly adults, but the effect of aging on the presentation of CBD stones remains to be evaluated. Recent studies have demonstrated that the clinical presentation of CBD stones may vary with age. Younger adults may present with classical biliary colic symptoms, whereas elderly adults may have no unapparent clinical features. Younger adults with CBD stones were significantly more likely to have abnormal liver function tests than those without. The sensitivity and accuracy of transabdominal ultrasound scans in screening for CBD stones increases with age. Antibiotic agents should be promptly administered to individuals with CBD stones complicated by cholangitis, but the effects of pharmacotherapy on renal function should be considered in elderly adults. Endoscopic retrograde cholangiopancreatography (ERCP) is considered to be first-line treatment for CBD stones, and endoscopic biliary sphincterotomy (EST) or endoscopic papillary balloon dilation (EPBD) along with ERCP is an adequate biliary drainage method in individuals with CBD stones. EPBD has a lower bleeding risk but higher post-ERCP risk of pancreatitis than EST. Longer-duration (>1 minute) EPBD may be preferred over EST because it is associated with a comparable risk of pancreatitis but a lower rate of overall complications, although recurrent cholangitis or unfavorable outcomes will increase during CBD dilation or in the presence of residual CBD stones.
C1 [Hu, Kuang-Chun; Chu, Cheng-Hsin; Wang, Horng-Yuan; Chang, Wen-Hsiung; Lin, Shee-Chan; Shih, Shou-Chuan] MacKay Mem Hosp, Div Gastroenterol, Dept Internal Med, 92,Sec 2,Chung Shan North Rd, Taipei, Taiwan.
   [Hu, Kuang-Chun; Liu, Chuan-Chuan; Shih, Shou-Chuan] MacKay Mem Hosp, Healthy Evaluat Ctr, Taipei, Taiwan.
   [Hu, Kuang-Chun; Chu, Cheng-Hsin; Wang, Horng-Yuan; Chang, Wen-Hsiung; Lin, Shee-Chan; Shih, Shou-Chuan] Natl Taiwan Univ, MacKay Med Nursing & Management Coll, Taipei, Taiwan.
   [Hu, Kuang-Chun; Liu, Chun-Jen; Wu, Ming-Shiang] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.
   [Liao, Wei-Chih; Liu, Chun-Jen; Wu, Ming-Shiang] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Coll Med, Taipei, Taiwan.
   [Shih, Shou-Chuan] MacKay Med Coll, Taipei, Taiwan.
C3 Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Junior
   College of Medicine, Nursing & Management; National Taiwan University;
   National Taiwan University; National Taiwan University; National Taiwan
   University Hospital; Mackay Medical College
RP Shih, SC (corresponding author), MacKay Mem Hosp, Div Gastroenterol, Dept Internal Med, 92,Sec 2,Chung Shan North Rd, Taipei, Taiwan.
EM shihshou@gmail.com
RI zhang, luyu/JJC-4227-2023; LIU, YU/HTR-1607-2023; Chu, Chu/T-6038-2019;
   Hu, Kuang-Chun/L-9095-2019
OI Wu, Ming-Shiang/0000-0002-1940-6428; LIU, CHUN-JEN/0000-0002-6202-0993;
   LIAO, WEI-CHIH/0000-0001-5362-6953
CR Abboud PAC, 1996, GASTROINTEST ENDOSC, V44, P450, DOI 10.1016/S0016-5107(96)70098-6
   ANCIAUX ML, 1986, DIGEST DIS SCI, V31, P449, DOI 10.1007/BF01320306
   Anderson MA, 2009, GASTROINTEST ENDOSC, V70, P1060, DOI 10.1016/j.gie.2009.09.040
   [Anonymous], 2014, SANFORD GUIDE ANTIMI
   Bachar GN, 2003, J ULTRAS MED, V22, P879, DOI 10.7863/jum.2003.22.9.879
   BARKUN AN, 1994, ANN SURG, V220, P32, DOI 10.1097/00000658-199407000-00006
   Baron TH, 2004, AM J GASTROENTEROL, V99, P1455, DOI 10.1111/j.1572-0241.2004.30151.x
   Boustière C, 2011, ENDOSCOPY, V43, P445, DOI 10.1055/s-0030-1256317
   BUGLIOSI TF, 1990, ANN EMERG MED, V19, P1383, DOI 10.1016/S0196-0644(05)82602-2
   Caddy GR, 2006, BEST PRACT RES CL GA, V20, P1085, DOI 10.1016/j.bpg.2006.03.002
   Chang WH, 2007, INT J GERONTOL, V1, P83, DOI 10.1016/S1873-9598(08)70027-9
   COBDEN I, 1984, LANCET, V1, P1062
   Collins C, 2004, ANN SURG, V239, P28, DOI 10.1097/01.sla.0000103069.00170.9c
   CSENDES A, 1988, ARCH SURG-CHICAGO, V123, P697
   Day LW, 2014, ENDOSC INT OPEN, V2, pE28, DOI 10.1055/s-0034-1365281
   Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301
   Freeman ML, 2001, GASTROINTEST ENDOSC, V54, P425, DOI 10.1067/mge.2001.117550
   Guda NM, 2007, ENDOSCOPY, V39, P833, DOI 10.1055/s-2007-966771
   Halldestam I, 2004, BRIT J SURG, V91, P734, DOI 10.1002/bjs.4547
   Hu KC, 2014, J GASTROEN HEPATOL, V29, P1614, DOI 10.1111/jgh.12581
   Hu KC, 2009, J AM GERIATR SOC, V57, P1839, DOI 10.1111/j.1532-5415.2009.02477.x
   JOHNSON AG, 1987, BRIT J SURG, V74, P555, DOI 10.1002/bjs.1800740703
   Kelly K, 2012, BLUMGARTS SURG LIVER, P487
   Kialian G P, 1995, Morfologiia, V108, P10
   Kondo S, 2005, EUR J RADIOL, V54, P271, DOI 10.1016/j.ejrad.2004.07.007
   Kumar V, 2009, EXPERT CONSULT ONLIN
   Lai JH, 2012, J LAPAROENDOSC ADV S, V22, P324, DOI 10.1089/lap.2011.0353
   Lee TH, 2011, GASTROINTEST ENDOSC, V74, P96, DOI 10.1016/j.gie.2011.03.005
   Lehman GA, 2008, MED CLIN N AM, V92, P925, DOI 10.1016/j.mcna.2008.03.001
   Liao WC, 2012, CLIN GASTROENTEROL H, V10, P1101, DOI 10.1016/j.cgh.2012.05.017
   Liao WC, 2010, GASTROINTEST ENDOSC, V72, P1154, DOI 10.1016/j.gie.2010.07.009
   Marco CA, 1998, ACAD EMERG MED, V5, P1163, DOI 10.1111/j.1553-2712.1998.tb02689.x
   Möller M, 2014, JAMA SURG, V149, P1008, DOI 10.1001/jamasurg.2014.249
   Nathwani RA, 2005, AM J GASTROENTEROL, V100, P295, DOI 10.1111/j.1572-0241.2005.40793.x
   Onken JE, 1996, AM J GASTROENTEROL, V91, P762
   Park TY, 2014, J GASTROEN HEPATOL, V29, P1943, DOI 10.1111/jgh.12608
   Rosseland AR, 2000, EUR J GASTROEN HEPAT, V12, P1171, DOI 10.1097/00042737-200012110-00001
   SALVIOLI G, 1983, GUT, V24, P609, DOI 10.1136/gut.24.7.609
   Sharara AI, 2010, CLIN GASTROENTEROL H, V8, P1077, DOI 10.1016/j.cgh.2010.08.021
   Tanaka A, 2007, J HEPATO-BILIARY-PAN, V14, P59, DOI 10.1007/s00534-006-1157-6
   TOOULI J, 1982, GASTROENTEROLOGY, V82, P111
   TOYOTA N, 1984, LAB INVEST, V50, P536
   Watanabe N, 2007, J GASTROEN HEPATOL, V22, P1983, DOI 10.1111/j.1440-1746.2006.04623.x
   Yoshikawa TT, 2000, CLIN INFECT DIS, V30, P931, DOI 10.1086/313792
NR 44
TC 5
Z9 7
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-8614
EI 1532-5415
J9 J AM GERIATR SOC
JI J. Am. Geriatr. Soc.
PD NOV
PY 2016
VL 64
IS 11
BP 2330
EP 2335
DI 10.1111/jgs.14481
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA EC7QO
UT WOS:000388335600050
PM 27676699
DA 2024-02-19
ER

PT S
AU Friguet, B
   Bulteau, AL
   Chondrogianni, N
   Conconi, M
   Petropoulos, I
AF Friguet, B
   Bulteau, AL
   Chondrogianni, N
   Conconi, M
   Petropoulos, I
BE Toussaint, O
   Osiewacz, HD
   Lithgow, GJ
   Brack, C
TI Protein degradation by the proteasome and its implications in aging
SO MOLECULAR AND CELLULAR GERONTOLOGY
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT EMBO Workshop on Molecular and Cellular Gerontology
CY SEP 18-22, 1999
CL SERPIANO, SWITZERLAND
SP European Molec Biol Org, AETAS, Biogerontology, Kluwer Acad Publishers, Clontech AG, Crossair Ltd Co Reg European Air Transport, F Hoffmann La Roche AG, Freiwillege Akad Gesell, Geriatr Univ Clin, Novartis Pharma AG, Psychiat Univ Clin, Res Into Aging, London, Swiss Acad Med Sci, Verum, Fdn Behav & Environm
ID METHIONINE SULFOXIDE RESIDUES; OXIDATIVELY MODIFIED PROTEINS;
   LIPOFUSCIN-LIKE SUBSTANCES; CROSS-LINKED PROTEIN; AGE-RELATED-CHANGES;
   RED BLOOD-CELLS; MULTICATALYTIC PROTEINASE; 20S PROTEASOME; RAT-LIVER;
   THERMOPLASMA-ACIDOPHILUM
AB Free radical damage to cellular components is believed to contribute to the aging process. Studies on proteins have shown both an age-related decline in several enzyme activities and an age-related accumulation of oxidized forms of protein. Oxidized forms of protein are generally degraded more rapidly than their native counterparts. Indeed, the normal functions of the cell involve the regular elimination of these altered molecules. The proteasome, a multienzymatic proteolytic complex, is the major enzymatic system in charge of cellular "cleansing"' and plays a key role in the degradation of damaged proteins. Consequently, proteasome function is very important in controlling the level of altered proteins in eukaryotic cells. Because the steady-state level of oxidized protein reflects the balance between the rate of protein oxidation and the rate of protein degradation, age-related accumulation of altered protein can be due to an increase of free radical-mediated damage, a loss of protease activity, or the combination of both mechanisms. One of the hypotheses put forward to explain the accumulation of altered proteins is the decrease of proteasome activity with age. In this paper, the importance of oxidative damage to proteins and that of their elimination by the proteasome are first described. Then, evidence for a decline of proteasome activity upon aging and upon oxidative stress is provided by studies from our and other laboratories.
C1 Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, F-75251 Paris 05, France.
C3 Universite Paris Cite
RP Friguet, B (corresponding author), Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, CC 7128,2 Pl Jussieu, F-75251 Paris 05, France.
RI bulteau, anne-laure/AAN-4004-2020
OI Petropoulos, Isabelle/0000-0001-9205-7458; Friguet,
   Bertrand/0000-0001-8085-1961
CR AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173, DOI 10.1093/gerona/53A.3.B173
   Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156
   Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0
   BAUMEISTER W, 1988, FEBS LETT, V241, P239, DOI 10.1016/0014-5793(88)81069-X
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   BROT N, 1982, TRENDS BIOCHEM SCI, V7, P137, DOI 10.1016/0968-0004(82)90204-3
   BROT N, 1983, ARCH BIOCHEM BIOPHYS, V223, P271, DOI 10.1016/0003-9861(83)90592-1
   BRUNK UT, 1992, MUTAT RES, V275, P395, DOI 10.1016/0921-8734(92)90042-N
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   CHIO KS, 1969, BIOCHEMISTRY-US, V8, P2821, DOI 10.1021/bi00835a019
   Conconi M, 1998, BIOCHEM J, V333, P407, DOI 10.1042/bj3330407
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Conconi M, 1999, ARCH BIOCHEM BIOPHYS, V362, P325, DOI 10.1006/abbi.1998.1037
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813
   DAVIES KJA, 1987, J BIOL CHEM, V262, P8220
   DAVIES KJA, 1987, J BIOL CHEM, V262, P8227
   DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123
   DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8
   DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267
   DJABALLAH H, 1993, BIOCHEM J, V292, P857, DOI 10.1042/bj2920857
   DUBIEL W, 1992, J BIOL CHEM, V267, P22369
   FALKENBURG PE, 1989, J BIOL CHEM, V264, P6660
   FIGUEIREDOPEREIRA ME, 1995, ARCH BIOCHEM BIOPHYS, V317, P69, DOI 10.1006/abbi.1995.1137
   Friedman D.B., 1988, Journals of Gerontology, V43, P102
   Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8
   FRIGUET B, 1994, J BIOL CHEM, V269, P21639
   FRUH K, 1994, EMBO J, V13, P3236, DOI 10.1002/j.1460-2075.1994.tb06625.x
   Fukuda A, 1996, BIOCHEM BIOPH RES CO, V219, P76, DOI 10.1006/bbrc.1996.0184
   Gaczynska M, 1996, J BIOL CHEM, V271, P17275, DOI 10.1074/jbc.271.29.17275
   Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738
   Goldberg AL, 1997, BIOL CHEM, V378, P131
   Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0
   GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344
   Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504
   GRZIWA A, 1991, FEBS LETT, V290, P186, DOI 10.1016/0014-5793(91)81256-8
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   Hekimi S, 1998, TRENDS GENET, V14, P14, DOI 10.1016/S0168-9525(97)01299-7
   HOLMGREN A, 1989, J BIOL CHEM, V264, P13963
   IVY GO, 1991, MECH AGEING DEV, V57, P213, DOI 10.1016/0047-6374(91)90048-5
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   KIRKWOOD TB, 1987, LIFE SCI, V42, P209
   KLEINSCHMIDT JA, 1983, EUR J CELL BIOL, V32, P143
   Kuehn L, 1996, ARCH BIOCHEM BIOPHYS, V329, P87, DOI 10.1006/abbi.1996.0195
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097
   MA CP, 1992, J BIOL CHEM, V267, P10515
   MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2
   MEHLEN P, 1995, J IMMUNOL, V154, P363
   MELLONI E, 1989, TRENDS NEUROSCI, V12, P438, DOI 10.1016/0166-2236(89)90093-3
   MORTIMORE GE, 1987, LYSOSOMES THEIR ROLE, P415
   Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001
   ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PACIFICI RE, 1989, FREE RADICAL BIO MED, V7, P521, DOI 10.1016/0891-5849(89)90028-2
   PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0
   PETROPOULOS I, IN PRESS J GERONTOL
   PUHLER G, 1992, EMBO J, V11, P1607, DOI 10.1002/j.1460-2075.1992.tb05206.x
   Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637
   RIVETT AJ, 1985, J BIOL CHEM, V260, P2600
   RIVETT AJ, 1985, J BIOL CHEM, V260, P300
   RIVETT AJ, 1989, J BIOL CHEM, V264, P12215
   ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6
   SAITOH Y, 1989, BIOCHEM BIOPH RES CO, V162, P334, DOI 10.1016/0006-291X(89)92000-7
   SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107
   SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB175, DOI 10.1093/gerona/51A.2.B175
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   SOHAL RS, 1981, EXP GERONTOL, V16, P347, DOI 10.1016/0531-5565(81)90055-3
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   Strack PR, 1996, BIOCHEMISTRY-US, V35, P7142, DOI 10.1021/bi9518048
   Tanaka K, 1998, BIOCHEM BIOPH RES CO, V247, P537, DOI 10.1006/bbrc.1998.8617
   TAPPEL AL, 1980, FREE RADICALS BIOL, V4, P2
   TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3
   TOKUMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P1106, DOI 10.1006/bbrc.1993.1531
   TSUCHIDA M, 1987, CHEM PHYS LIPIDS, V44, P297, DOI 10.1016/0009-3084(87)90055-7
   Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223
   VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605
   WAGNER BJ, 1995, ARCH BIOCHEM BIOPHYS, V323, P455, DOI 10.1006/abbi.1995.0067
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
NR 93
TC 139
Z9 156
U1 0
U2 7
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-271-1
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2000
VL 908
BP 143
EP 154
PG 12
WC Biochemistry & Molecular Biology; Cell Biology; Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Geriatrics & Gerontology
GA BQ53H
UT WOS:000088671200014
PM 10911955
DA 2024-02-19
ER

PT J
AU Nagata, T
AF Nagata, Tetsuji
TI Electron microscopic radioautographic study on mitochondrial DNA
   synthesis in adrenal cortical cells of developing and aging mice
SO THESCIENTIFICWORLDJOURNAL
LA English
DT Article
DE mitochondria; mouse adrenal cortex; EM radioautography; DNA synthesis
ID DRY-MOUNTING AUTORADIOGRAPHY; NUCLEIC-ACID SYNTHESIS;
   MACROMOLECULAR-SYNTHESIS; RNA-SYNTHESIS; LIGHT; HEPATOCYTES; THYMIDINE;
   CULTURE; LIVER
AB In order to study the aging changes of intramitochondrial DNA synthesis of mouse adrenal cortical cells, eight groups of developing mice, each consisting of three individuals (total 24), from fetal day 19 to postnatal newborn at days 1, 3, 9, 14, to adult at months 1, 2, and 6, were injected with H-3-thymidine, sacrificed 1 h later, and the adrenal tissues were fixed and processed for electron microscopic (EM) radioautography. On EM radioautograms obtained from each animal, the number of mitochondria and the mitochondrial labeling index labeled with H-3-thymidine showing DNA synthesis in each adrenal cortical cell, in three zones, were counted and the results in respective developing groups were compared. From the results, it was demonstrated that the numbers of mitochondria in the three zones, the zona glomerulosa, fasciculata, and reticularis, of mice at various ages increased from fetal day 19 to postnatal month 6 due to development and aging of animals, respectively, while the number of labeled mitochondria and the labeling index of intramitochondrial DNA syntheses incorporating 3H-thymidine increased from fetal day 19 to postnatal month 2, reaching the maxima, and decreased to month 6. It was shown that the activity of intramitochondrial DNA synthesis in the adrenal cortical cells in developing and aging mice changed due to aging.
C1 [Nagata, Tetsuji] Shinshu Univ, Sch Med, Dept Anat & Cell Biol, Matsumoto, Nagano 3908621, Japan.
   [Nagata, Tetsuji] Shinshu Inst Alternat Med & Welf, Dept Anat, Nagano 3800816, Japan.
C3 Shinshu University
RP Nagata, T (corresponding author), Shinshu Univ, Sch Med, Dept Anat & Cell Biol, Matsumoto, Nagano 3908621, Japan.
EM nagatas@po.cnet.ne.jp
CR Chevremont M., 1963, Symp Int Soc Cell Biol, V2, P323
   Cui H, 1996, P 4 CHIN JAP JOINT H, P111
   GAHAN P. B., 1965, INT REV CYTOL, V18, P223, DOI 10.1016/S0074-7696(08)60555-0
   GAO FL, 1995, CELL MOL BIOL, V41, P145
   Gao Fulu, 1994, Medical Electron Microscopy, V27, P360, DOI 10.1007/BF02349697
   GIBOR A, 1964, SCIENCE, V145, P890, DOI 10.1126/science.145.3635.890
   Gunarso W, 1997, CELL MOL BIOL, V43, P189
   Gunarso W, 1996, ACTA HISTOCHEM, V98, P309, DOI 10.1016/S0065-1281(96)80024-9
   Gunarso W., 1984, SHINSHU MED J, V32, P241
   GUTTES E, 1964, SCIENCE, V145, P1057, DOI 10.1126/science.145.3636.1057
   Hanai Toru, 1994, Medical Electron Microscopy, V27, P355, DOI 10.1007/BF02349695
   Ito M, 1996, CELL MOL BIOL, V42, P279
   Ito Masayuki, 1996, Medical Electron Microscopy, V29, P145, DOI 10.1007/BF02348068
   Kong Yongli, 1994, Medical Electron Microscopy, V27, P366, DOI 10.1007/BF02349699
   Korr H, 1997, ACTA NEUROPATHOL, V94, P557, DOI 10.1007/s004010050750
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   MA H, 1988, Japanese Journal of Clinical Electron Microscopy, V21, P335
   MA H, 1988, Japanese Journal of Clinical Electron Microscopy, V21, P715
   Ma H., 2005, ANN MICROSC, V5, P4
   Ma H, 1994, MED ELECT MICROSC, V27, P349
   MURATA F, 1979, ACTA HISTOCHEM CYTOC, V12, P443, DOI 10.1267/ahc.12.443
   Nadler NJ, 1971, J CELL BIOL, V49, P377
   Nagata T, 1997, HISTOL HISTOPATHOL, V12, P1091
   Nagata T, 1996, J ELECTRON MICROSC, V45, P258, DOI 10.1093/oxfordjournals.jmicro.a023442
   Nagata T, 2003, CELL MOL BIOL, V49, P591
   Nagata T, 2002, PROG HISTOCHEM CYTO, V37, P67, DOI 10.1016/S0079-6336(02)80003-1
   Nagata T, 1977, J Electron Microsc (Tokyo), V26 Suppl, P347
   NAGATA T, 1972, Acta Histochemica et Cytochemica, V5, P201
   NAGATA T, 1977, ACTA PHARMACOL TOX, V41, P64
   Nagata T, 2001, INT REV CYTOL, V211, P33, DOI 10.1016/S0074-7696(01)11017-X
   NAGATA T, 1979, ACTA HISTOCHEM CYTOC, V12, P610
   NAGATA T, 1977, HISTOCHEMISTRY, V54, P75, DOI 10.1007/BF00493331
   NAGATA T, 1977, ACTA PHARMACOL TOX, V41, P62
   NAGATA T, 1982, HISTOCHEM J, V14, P197, DOI 10.1007/BF01041214
   NAGATA T, 1972, HISTOCHEMISTRY, V32, P163, DOI 10.1007/BF00303731
   NAGATA T, 1967, HISTOCHEMISTRY, V10, P305, DOI 10.1007/BF00304312
   NAGATA T, 1976, P 5 INT C HIST CYT B, P242
   Nagata T, 2000, ANN MICROSC, V1, P13
   Nagata T., 2008, J CELL TIS RES, V8, P1303
   NAGATA T, 2007, MODERN RES ED TOPICS, V1, P245
   Nagata T, 2007, ANN MICROSC, V7, P36
   Nagata T., 2007, TRENDS CELL MOL BIOL, V2, P19
   Nagata T., 1984, J CLIN ELECT MICROSC, V17, P589
   NAGATA T, 1972, P 4 INT C HIST CYT K, P43
   NAGATA T, 1974, P 8 INT C EL MICR CA, V2, P346
   NAGATA T, 1984, P 11 INT C EL MICR, V3, P2281
   Nagata T., 1967, ARCH HISTOL JAPON, V28, P540
   Nagata T, 2006, ANN MICROSC, V6, P42
   NAGATA T, 1992, RECENT ADV CELLULAR, V6, P9
   Nagata T., 1982, P 10 INT C EL MICR, V2, P305
   Nagata T., 2007, J CELL TISSUE RES, V7, P1019
   NAGATA T, 1975, P 10 INT C AN TOK, P474
   Nagata Tetsuji, 2007, ARBS Annual Review of Biomedical Sciences, V9, P30
   Nagata Tetsuji, 2006, ARBS Annual Review of Biomedical Sciences, V8, P33
   Nagata T, 2007, THESCIENTIFICWORLDJO, V7, P1008, DOI 10.1100/tsw.2007.140
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   SALPETER MM, 1969, J CELL BIOL, V41, P1, DOI 10.1083/jcb.41.1.1
   SCHATZ G, 1970, MEMBRANES MITOCHONDR, P251
   Schmitz C, 1999, ACTA NEUROPATHOL, V97, P71, DOI 10.1007/s004010050957
   Schmitz Christoph, 1999, J Alzheimers Dis, V1, P387
   SCHUSTER FL, 1965, EXP CELL RES, V39, P329, DOI 10.1016/0014-4827(65)90038-8
   SINCLAIR JH, 1966, P NATL ACAD SCI USA, V56, P508, DOI 10.1073/pnas.56.2.508
   STONE GE, 1965, EXP ZOOL, V159, P33
   Sun L, 1997, ACTA HISTOCHEM CYTOC, V30, P211, DOI 10.1267/ahc.30.211
   Uchida K, 1970, Arch Histol Jpn, V31, P291
   VANBRUGGEN EF, 1966, BIOCHIM BIOPHYS ACTA, V119, P437, DOI 10.1016/0005-2787(66)90210-3
   YAMADA AT, 1993, CELL MOL BIOL, V39, P221
   Yamada Aureo T., 1992, Cellular and Molecular Biology (Noisy-Le-Grand), V38, P763
NR 69
TC 8
Z9 8
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1537-744X
J9 THESCIENTIFICWORLDJO
JI TheScientificWorldJOURNAL
PY 2008
VL 8
BP 683
EP 697
DI 10.1100/tsw.2008.93
PG 15
WC Environmental Sciences; Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Science & Technology - Other Topics
GA 324VA
UT WOS:000257546300006
PM 18661056
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Annamalai, K
   Nanda, A
AF Annamalai, Kalyan
   Nanda, Arnab
TI Biological Aging and Life Span Based on Entropy Stress via Organ and
   Mitochondrial Metabolic Loading
SO ENTROPY
LA English
DT Article
DE biological aging; entropy stress; mitochondria; life span; bio-markers
ID RESTING ENERGY-EXPENDITURE; MAMMALS; TISSUE; LEVEL; MASS
AB The energy for sustaining life is released through the oxidation of glucose, fats, and proteins. A part of the energy released within each cell is stored as chemical energy of Adenosine Tri-Phosphate molecules, which is essential for performing life-sustaining functions, while the remainder is released as heat in order to maintain isothermal state of the body. Earlier literature introduced the availability concepts from thermodynamics, related the specific irreversibility and entropy generation rates to metabolic efficiency and energy release rate of organ k, computed whole body specific entropy generation rate of whole body at any given age as a sum of entropy generation within four vital organs Brain, Heart, Kidney, Liver (BHKL) with 5th organ being the rest of organs (R5) and estimated the life span using an upper limit on lifetime entropy generated per unit mass of body, sigma(M),(life). The organ entropy stress expressed in terms of lifetime specific entropy generated per unit mass of body organs (kJ/(K kg of organ k)) was used to rank organs and heart ranked highest while liver ranked lowest. The present work includes the effects of (1) two additional organs: adipose tissue (AT) and skeletal muscles (SM) which are of importance to athletes; (2) proportions of nutrients oxidized which affects blood temperature and metabolic efficiencies; (3) conversion of the entropy stress from organ/cellular level to mitochondrial level; and (4) use these parameters as metabolism-based biomarkers for quantifying the biological aging process in reaching the limit of sigma(M life). Based on the 7-organ model and Elia constants for organ metabolic rates for a male of 84 kg steady mass and using basic and derived allometric constants of organs, the lifetime energy expenditure is estimated to be 2725 MJ/kg body mass while lifetime entropy generated is 6050 kJ/(K kg body mass) with contributions of 190; 1835.0; 610; 290; 700; 1470 and 95 kJ/K contributed by AT-BHKL-SM-R7 to 1 kg body mass over life time. The corresponding life time entropy stresses of organs are: 1.2; 60.5; 110.5; 110.5; 50.5; 3.5; 3.0 MJ/K per kg organ mass. Thus, among vital organs highest stress is for heart and kidney and lowest stress is for liver. The 5-organ model (BHKL and R5) also shows similar ranking. Based on mitochondrial volume and 5-organ model, the entropy stresses of organs expressed in kJ/K per cm(3) of Mito volume are: 12,670; 5465; 2855; 4730 kJ/cm(3) of Mito for BHKL indicating brain to be highly stressed and liver to be least stressed. Thus, the organ entropy stress ranking based on unit volume of mitochondria within an organ (kJ/(K cm(3) of Mito of organ k)) differs from entropy stress based on unit mass of organ. Based on metabolic loading, the brains of athletes already under extreme mitochondrial stress and facing reduced metabolic efficiency under concussion are subjected to more increased stress. In the absence of non-intrusive measurements for estimating organ-based metabolic rates which can serve as metabolism-based biomarkers for biological aging (BA) of whole body, alternate methods are suggested for estimating the biological aging rate.
C1 [Annamalai, Kalyan; Nanda, Arnab] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.
C3 Texas A&M University System; Texas A&M University College Station
RP Annamalai, K (corresponding author), Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.
EM kannamalai@tamu.edu; arnab229@gmail.com
FU Texas AM University
FX The authors wish to thank (1) three anonymous reviewers for bringing
   attention to review articles in this area, a few more pertinent
   references and many useful discussions which have been incorporated in
   the manuscript; and (2) Jothi Sukkawala MD for bringing attention to
   recent aging research of Mayo Clinic [47]. The principal author close to
   retirement recently started translating results from combustion and
   thermodynamics to biology and hence wish to acknowledge the funding
   provided through Paul Pepper Professorship and the James J. Cain Chair
   in Mechanical Engineering at Texas A&M University, which partially
   supported the graduate student(s) and the open access fees for the
   publication of this manuscript.
CR ABRAHAMS S, 1991, AM J PHYSIOL, V261, pR719, DOI 10.1152/ajpregu.1991.261.3.R719
   Andresen B, 2002, P NATL ACAD SCI USA, V99, P5822, DOI 10.1073/pnas.082633699
   Annamalai K., 2017, P 10 US NAT COMB M C
   Annamalai K., 2006, COMBUSTION SCI ENG, DOI DOI 10.1201/9781420003789
   Annamalai K., 2011, ADV THERMODYNAMICS E
   Annamalai K., 2017, J COMBUST IN PRESS
   Annamalai K, 2012, ENTROPY-SWITZ, V14, P2550, DOI 10.3390/e14122550
   [Anonymous], 1980, NEW AGE SCALE HUMANS
   AOKI I, 1994, AGE, V17, P29, DOI 10.1007/BF02435047
   CALDER WA, 1981, ANNU REV PHYSIOL, V43, P301, DOI 10.1146/annurev.ph.43.030181.001505
   DAVIES M, 1961, J CELL COMPAR PHYSL, V57, P135, DOI 10.1002/jcp.1030570302
   ELIA M, 1992, ENERGY METABOLISM, P61
   ELSE PL, 1985, AM J PHYSIOL, V248, pR415, DOI 10.1152/ajpregu.1985.248.4.R415
   Flatt Thomas, 2012, Frontiers in Genetics, V3, P148, DOI 10.3389/fgene.2012.00148
   Floyd RA, 2001, EXP GERONTOL, V36, P619, DOI 10.1016/S0531-5565(00)00231-X
   Gemma C., 2007, BRAIN AGING MODELS M
   Guachalla LM, 2009, AGING-US, V1, P303, DOI 10.18632/aging.100030
   Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034
   HOPPELER H, 1984, RESP PHYSIOL, V55, P131, DOI 10.1016/0034-5687(84)90018-5
   Huaxiong H., RETIREMENT SPENDING
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kummitha CM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12159
   Lee CP, 1996, FASEB J, V10, P345, DOI 10.1096/fasebj.10.2.8641569
   Lee D, 2015, AGING CELL, V14, P8, DOI 10.1111/acel.12277
   Longevity Sacher G., 1978, GERONTOLOGIST, V18, p[112, 120], DOI [10.1093/geront/18.2.112640450, DOI 10.1093/GERONT/18.2.112640450]
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   Miller J., 2014, THESIS
   Mostafavi H, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002458
   Nanda N., 2017, THESIS
   Pinker S., 2016, WALL STREET J
   PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213
   Segolene M., 2012, ANESTHESIOL RES PRAC, V2012, p[1, 13]
   Silva C.A., 2009, J. Thermodyn, V2009, P1, DOI [10.1155/2009/186723, DOI 10.1155/2009/186723]
   Silva C, 2008, ENTROPY-SWITZ, V10, P100, DOI 10.3390/entropy-e10020100
   Singer D, 2006, THERMOCHIM ACTA, V446, P20, DOI 10.1016/j.tca.2006.05.006
   Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8
   Wang Z., 2012, ISRN ZOOL, V9, DOI [DOI 10.5402/2012/673050, 10.5402/2012/673050]
   Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885
   Wang ZM, 2000, AM J PHYSIOL-ENDOC M, V279, pE539, DOI 10.1152/ajpendo.2000.279.3.E539
   Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003
   Wenger B. C., TEMPERATURE REGULATI
NR 41
TC 5
Z9 5
U1 0
U2 16
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1099-4300
J9 ENTROPY-SWITZ
JI Entropy
PD OCT
PY 2017
VL 19
IS 10
AR 566
DI 10.3390/e19100566
PG 36
WC Physics, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physics
GA FM2QQ
UT WOS:000414845100060
OA Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Kawakami, K
   Nakamura, A
   Goto, S
AF Kawakami, Kyojiro
   Nakamura, Akihiro
   Goto, Sataro
TI Dietary restriction increases site-specific histone H3 acetylation in
   rat liver: Possible modulation by sirtuins
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Dietary (calorie) restriction; Aging; Histone modification; Acetylation;
   Epigenetics; Sirtuin
ID CALORIE RESTRICTION; LIFE-SPAN; PROTEIN; SIR2; DEACETYLASE; CHROMATIN;
   NAD; AGE; TRANSCRIPTION; EPIGENETICS
AB We studied dietary restriction (DR) related changes of site-specific acetylation of histone H3 in rat livers to explore a possible link to histone modifications and sirtuin levels with anti-aging effects of DR. The acetylation at lysine residue 9, 27 and 56 in H3 was 20-30% higher in DR animals compared with ad libitum fed counterparts. SIRT6, one of histone deacetylases, was significantly decreased by DR and thereby may be involved in an increase in the histone acetylation. Our findings suggest that upregulation of chromatin activities through increased histone acetylation is a mechanism of anti-aging effects of DR. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Kawakami, Kyojiro; Goto, Sataro] Juntendo Univ, Grad Sch, Inst Hlth & Sports Sci & Med, Inzai, Chiba 2701695, Japan.
   [Nakamura, Akihiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat Cardiol & Nephrol, Kamigyou Ku, Kyoto 6028566, Japan.
C3 Juntendo University; Kyoto Prefectural University of Medicine
RP Goto, S (corresponding author), Juntendo Univ, Grad Sch, Inst Hlth & Sports Sci & Med, Hiragagakuendai 1-1, Inzai, Chiba 2701695, Japan.
EM gotosataro@sakura.juntendo.ac.jp
OI Kawakami, Kyojiro/0000-0002-2822-3252
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   Ministry of Education, Science, Sports and Culture of Japan [22800062];
   Juntendo University Graduate School, Institute of Health and Sports
   Science Medicine; Grants-in-Aid for Scientific Research [22800062]
   Funding Source: KAKEN
FX This study was supported, in part, by Grant-in Aid for the High-Tech
   Research Project (2005-2009) to SG from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan; Grants-in-Aid for
   Scientific Research (22800062) to KK from the Ministry of Education,
   Science, Sports and Culture of Japan. KK is grateful for receiving
   Postdoctoral Fellowship from Juntendo University Graduate School,
   Institute of Health and Sports Science & Medicine.
CR BESSHO M, 1989, ANAL BIOCHEM, V182, P304, DOI 10.1016/0003-2697(89)90599-X
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608
   Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2
   Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706
   Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008
   Goto S, 2002, ANN NY ACAD SCI, V959, P50, DOI 10.1111/j.1749-6632.2002.tb02082.x
   Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250
   Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]
   Kawakami K, 2009, BIOGERONTOLOGY, V10, P415, DOI 10.1007/s10522-008-9176-0
   Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005
   Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804
   Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126
   Matsumura H., 1980, METHODS ENZYMOLOGY
   Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736
   Nakamoto H, 2007, EXP GERONTOL, V42, P287, DOI 10.1016/j.exger.2006.11.006
   Nakamura A, 2010, ANN NY ACAD SCI, V1197, P33, DOI 10.1111/j.1749-6632.2009.05374.x
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026
   Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698
   Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101
   Roy AK, 2002, AGEING RES REV, V1, P367, DOI 10.1016/S1568-1637(02)00006-5
   Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x
   Sedivy JM, 2008, EXP CELL RES, V314, P1909, DOI 10.1016/j.yexcr.2008.02.023
   Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114
   Sharma R, 2006, FREE RADICAL BIO MED, V40, P1179, DOI 10.1016/j.freeradbiomed.2005.11.013
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031
   WEINDRUCH R, 1989, J GERONTOL, V44, P67, DOI 10.1093/geronj/44.6.67
   Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011
   Xu G, 2008, MECH AGEING DEV, V129, P366, DOI 10.1016/j.mad.2008.03.001
   Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620
NR 39
TC 14
Z9 15
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD FEB 24
PY 2012
VL 418
IS 4
BP 836
EP 840
DI 10.1016/j.bbrc.2012.01.120
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 906GE
UT WOS:000301332100043
PM 22321393
DA 2024-02-19
ER

PT J
AU Li, W
   Wang, JQ
   Zhou, YD
   Hou, JG
   Liu, Y
   Wang, YP
   Gong, XJ
   Lin, XH
   Jiang, S
   Wang, Z
AF Li, Wei
   Wang, Jian-Qiang
   Zhou, Yan-Dan
   Hou, Jin-Gang
   Liu, Ying
   Wang, Ying-Ping
   Gong, Xiao-Jie
   Lin, Xiang-Hui
   Jiang, Shuang
   Wang, Zi
TI Rare Ginsenoside 20(R)-Rg3 Inhibits D-Galactose-Induced Liver and Kidney
   Injury by Regulating Oxidative Stress-Induced Apoptosis
SO AMERICAN JOURNAL OF CHINESE MEDICINE
LA English
DT Article
DE 20(R)-Ginsenoside Rg3; D-Galactose; Liver and Kidney; Oxidative Stress;
   Apoptosis; PI3K/Akt Pathway
ID ACETAMINOPHEN-INDUCED HEPATOTOXICITY; ENDOTHELIAL DYSFUNCTION; ADVANCED
   GLYCATION; RED GINSENG; RAT MODEL; RG3; EXPRESSION; PATHWAY; MICE;
   INFLAMMATION
AB Oxidative stress is considered as a major factor in aging and exacerbates aging process through a variety of molecular mechanisms. D-galactose, a normal reducing sugar with high dose can cause the accumulation of reactive oxygen species (ROS) or stimulate free radical production indirectly by the formation of advanced glycation end products in tissues, finally resulting in oxidative stress. 20(R)-ginsenoside Rg3 (20(R)-Rg3), a major and representative component isolated from red ginseng (Panax ginseng C.A Meyer), has been shown to observably have an anti-oxidative effect. We thereby investigated the beneficial effects of 20(R)-Rg3 on D-galactose-induced oxidative stress injury and its underlying mechanisms. Our results showed that continuous injection of D-galactose with 800 mg/kg/ day for 8 weeks increased the levels of alanine aminotransferase (ALT) and blood urea nitrogen (BUN). However, such increases were attenuated by the treatment of 20(R)-Rg3 for 4 weeks. Meanwhile, 20(R)-Rg3 markedly inhibited D-galactose-caused oxidative stress in liver and kidney. The anti-oxidants, including catalase (CAT) and superoxide dismutase (SOD), were elevated in the mice from 20(R)-Rg3-treated group compared with that from D-galactose group. In contrast, a significant decrease in levels of cytochrome P450 E1 (CYP2E1) and the lipid peroxidation product malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) were observed in the 20(R)-Rg3-treated group. These effects were associated with a significant increase of AGEs. More importantly, 20(R)-Rg3 effectively attenuated D-galactose induced apoptosis in liver and kidney via restoring the upstream PI3K/AKT signaling pathway. Taken together, our study suggests that 20(R)-Rg3 may be a novel and promising anti-oxidative therapeutic agent to prevent aging-related injuries in liver and kidney.
C1 [Li, Wei; Wang, Jian-Qiang; Zhou, Yan-Dan; Hou, Jin-Gang; Liu, Ying; Wang, Ying-Ping; Jiang, Shuang; Wang, Zi] Jilin Agr Univ, Coll Chinese Med Mat, 2888 Xincheng St, Changchun 130118, Peoples R China.
   [Li, Wei; Wang, Ying-Ping; Jiang, Shuang; Wang, Zi] Res Ctr Ginseng Breeding & Dev, Natl & Local Joint Engn, Changchun 130118, Peoples R China.
   [Hou, Jin-Gang] Intelligent Synthet Biol Ctr, Daejeon 34141, South Korea.
   [Gong, Xiao-Jie] Dalian Univ, Coll Med, Dalian 116622, Peoples R China.
   [Lin, Xiang-Hui] Liaoning Xifeng Pharmaceut Grp Co Ltd, Huanren 117200, Peoples R China.
C3 Jilin Agricultural University; Dalian University
RP Jiang, S; Wang, Z (corresponding author), Jilin Agr Univ, Coll Chinese Med Mat, 2888 Xincheng St, Changchun 130118, Peoples R China.
EM jiangshuang0503@hotmail.com; wangzi8020@126.com
RI wang, KiKi/JFZ-3334-2023
OI , wei/0000-0002-2988-4298
FU Scientific Research Foundation for the Returned Overseas Chinese
   Scholars (Jilin Province, 2015); Jilin Science & Technology Development
   Plan [20180201083YY, 20191102051YY, 20200301037RQ, 20190304003YY,
   20190103092JH]; Program for the Young Top-notch and Innovative Talents
   of Jilin Agricultural University (2016-2018)
FX This work was supported by the grants of the Scientific Research
   Foundation for the Returned Overseas Chinese Scholars (Jilin Province,
   2015), Jilin Science & Technology Development Plan (No. 20180201083YY,
   20191102051YY, 20190103092JH, 20200301037RQ and 20190304003YY), and the
   Program for the Young Top-notch and Innovative Talents of Jilin
   Agricultural University (2016-2018).
CR Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x
   [Anonymous], 2008, CHIN J INTEGR MED, V14, P33, DOI [10.1007/s11655-007-9002-6, 10.1007/s11655-007-9002]
   [Anonymous], CHIN MED
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Chiu YJ, 2018, AM J CHINESE MED, V46, P1535, DOI 10.1142/S0192415X18500799
   Conti V, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00024
   Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025
   Dong ZY, 2017, EXP THER MED, V14, P616, DOI 10.3892/etm.2017.4514
   Fan YL, 2016, PHARM BIOL, V54, P1815, DOI 10.3109/13880209.2015.1129543
   Gao J, 2015, BEHAV BRAIN RES, V293, P27, DOI 10.1016/j.bbr.2015.06.045
   Ghatei N, 2017, IRAN J BASIC MED SCI, V20, P1037, DOI 10.22038/IJBMS.2017.9273
   Gong YS, 2008, BEHAV BRAIN RES, V194, P100, DOI 10.1016/j.bbr.2008.06.029
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   Ham J, 2018, AM J CHINESE MED, V46, P1333, DOI 10.1142/S0192415X18500702
   Hou J, 2017, MOLECULES, V22, DOI 10.3390/molecules22091516
   Hu JN, 2017, MOLECULES, V22, DOI 10.3390/molecules22040664
   Jandeleit-Dahm K, 2008, CURR PHARM DESIGN, V14, P979, DOI 10.2174/138161208784139684
   Jeong H, 2017, EXP GERONTOL, V95, P16, DOI 10.1016/j.exger.2017.05.004
   Jian Jie, 2015, Drug Des Devel Ther, V9, P5933, DOI 10.2147/DDDT.S92549
   Joo SS, 2008, BIOL PHARM BULL, V31, P1392, DOI 10.1248/bpb.31.1392
   Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59
   Kubo E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14520-8
   Lee DY, 2019, AM J CHINESE MED, V47, P823, DOI [10.1142/S0192415X19500435, 10.1142/s0192415x19500435]
   Lee HJ, 2017, J KOREAN MED SCI, V32, P679, DOI 10.3346/jkms.2017.32.4.679
   Lei LH, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1975-x
   Lei LH, 2016, J CHIN MED ASSOC, V79, P205, DOI 10.1016/j.jcma.2015.06.023
   Li RY, 2019, J AGR FOOD CHEM, V67, P5754, DOI 10.1021/acs.jafc.9b00540
   Li X, 2018, AM J CHINESE MED, V46, P1915, DOI [10.1142/S0192415X18500969, 10.1142/s0192415x18500969]
   Li YH, 2011, BIOMATERIALS, V32, P9068, DOI 10.1016/j.biomaterials.2011.08.001
   Liman N, 2013, REPROD DOMEST ANIM, V48, P33, DOI 10.1111/j.1439-0531.2012.02021.x
   Mi XJ, 2019, J AGR FOOD CHEM, V67, P1392, DOI 10.1021/acs.jafc.8b05943
   Mo ZZ, 2017, REJUV RES, V20, P231, DOI 10.1089/rej.2016.1870
   Mu XY, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3508907
   Oh DR, 2018, AM J CHINESE MED, V46, P1499, DOI [10.1142/S0192415X18500775, 10.1142/s0192415x18500775]
   Ou HC, 2019, AM J CHINESE MED, V47, P541, DOI [10.1142/S0192415X19500289, 10.1142/s0192415x19500289]
   Qu Z, 2016, PHYSIOL BEHAV, V154, P114, DOI 10.1016/j.physbeh.2015.11.016
   Raina AK, 2000, CLIN CHEM LAB MED, V38, P93, DOI 10.1515/CCLM.2000.015
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Sha JY, 2019, J AGR FOOD CHEM, V67, P10342, DOI 10.1021/acs.jafc.9b04614
   Shirato T, 2017, ARCH TOXICOL, V91, P1319, DOI 10.1007/s00204-016-1785-9
   Song E.K, 2018, NUTR RES
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Su EY, 2019, AM J CHINESE MED, V47, P237, DOI [10.1142/S0192415X19500125, 10.1142/s0192415x19500125]
   Sun JZ, 2018, INT IMMUNOPHARMACOL, V58, P94, DOI 10.1016/j.intimp.2018.03.017
   Tian LL, 2016, ONCOTARGET, V7, P1619, DOI 10.18632/oncotarget.6451
   Vlassara H, 1997, DIABETES, V46, pS19, DOI 10.2337/diab.46.2.S19
   Wang XY, 2015, PHYTOMEDICINE, V22, P875, DOI 10.1016/j.phymed.2015.06.010
   Wang Z, 2017, J AGR FOOD CHEM, V65, P9226, DOI 10.1021/acs.jafc.7b03361
   Xiao H, 2019, AM J CHINESE MED, V47, P1737, DOI 10.1142/S0192415X19500885
   Ying A, 2018, AM J CHINESE MED, V46, P137, DOI 10.1142/S0192415X18500088
   Zhang JY, 2017, INT IMMUNOPHARMACOL, V45, P26, DOI 10.1016/j.intimp.2017.01.028
   Zhang WJ, 2019, AM J CHINESE MED, V47, P1523, DOI 10.1142/S0192415X19500782
   Zhao HD, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1371
   Zhou YD, 2018, INT IMMUNOPHARMACOL, V59, P21, DOI 10.1016/j.intimp.2018.03.030
NR 55
TC 27
Z9 27
U1 5
U2 28
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0192-415X
EI 1793-6853
J9 AM J CHINESE MED
JI Am. J. Chin. Med.
PY 2020
VL 48
IS 5
BP 1141
EP 1157
DI 10.1142/S0192415X20500561
PG 17
WC Integrative & Complementary Medicine; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; General & Internal Medicine
GA MO4QP
UT WOS:000551513000007
PM 32668974
DA 2024-02-19
ER

PT J
AU Kim, SH
   Shishido, Y
   Sogabe, H
   Rachadech, W
   Yorita, K
   Kato, Y
   Fukui, K
AF Kim, Soo Hyeon
   Shishido, Yuji
   Sogabe, Hirofumi
   Rachadech, Wanitcha
   Yorita, Kazuko
   Kato, Yusuke
   Fukui, Kiyoshi
TI Age- and gender-dependent D-amino acid oxidase activity in mouse brain
   and peripheral tissues: implication for aging and neurodegeneration
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE age- and gender-dependence; D-amino acid oxidase; epididymis; kidney;
   spinal cord
ID AMYOTROPHIC-LATERAL-SCLEROSIS; D-SERINE; D-CYCLOSERINE; D-ASPARTATE;
   RAT-BRAIN; KIDNEY; EXPRESSION; MUTATION; RACEMASE
AB D-amino acid oxidase (DAO) is a flavoenzyme, catalysing oxidative deamination of D-amino acids to produce corresponding alpha-keto acids, ammonia and hydrogen peroxide. In our search for DAO activity among various tissues, we developed a sensitive assay based on hydrogen peroxide production involving enzyme-coupled colorimetric assay with peroxidase. We first optimized buffer components to extract DAO protein from mouse tissues. Here we show that DAO activity was detected in kidney, cerebellum, medulla oblongata, midbrain and spinal cord, but not in liver. In addition, we observed that DAO activity and expression were decreased in thoracic and lumbar regions of spinal cord in aged mice when compared with young mice, indicating that decreased DAO is involved in motoneuron degeneration during senescence. We also found gender difference in DAO activity in the kidney, suggesting that DAO activity is influenced by sexual dimorphism. We newly detected DAO activity in the epididymis, although undetected in testis. Furthermore, DAO activity was significantly higher in the caput region than corpus and cauda regions of epididymis, indicating that D-amino acids present in the testis are eliminated in epididymis. Taken together, age-and gender-dependent DAO activity in each organ may underlie the human pathophysiology regulated by D-amino acid metabolism.
C1 [Kim, Soo Hyeon; Shishido, Yuji; Sogabe, Hirofumi; Rachadech, Wanitcha; Yorita, Kazuko; Kato, Yusuke; Fukui, Kiyoshi] Tokushima Univ, Inst Enzyme Res, Div Enzyme Pathophysiol, 3-18-15 Kuramoto, Tokushima 7708503, Japan.
C3 Tokushima University
RP Fukui, K (corresponding author), Tokushima Univ, Inst Enzyme Res, Div Enzyme Pathophysiol, 3-18-15 Kuramoto, Tokushima 7708503, Japan.
EM kiyo.fukui@tokushima-u.ac.jp
FU Japan Science and Technology Agency, CREST (Core Research for
   Evolutionary Science and Technology); grant for Enzyme Research from the
   Japan Foundation for Applied Enzymology; Japanese Government
   (MONBUKAGAKUSHO: MEXT) Scholarship
FX This work was supported in part by Japan Science and Technology Agency,
   CREST (Core Research for Evolutionary Science and Technology) and a
   grant for Enzyme Research from the Japan Foundation for Applied
   Enzymology. A Japanese Government (MONBUKAGAKUSHO: MEXT) Scholarship was
   awarded to S. H. K.
CR Bardaweel SK, 2013, ACTA PHARMACEUT, V63, P467, DOI 10.2478/acph-2013-0032
   Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055
   Fischer L, 1996, ANN NY ACAD SCI, V799, P683, DOI 10.1111/j.1749-6632.1996.tb33274.x
   FUKUI K, 1988, BIOCHEMISTRY-US, V27, P6693, DOI 10.1021/bi00418a008
   Gill SS, 2000, TOXICOL PATHOL, V28, P277, DOI 10.1177/019262330002800207
   Gispert S, 1995, Am J Hum Genet, V57, P972
   GOECKERMANN JA, 1975, J HISTOCHEM CYTOCHEM, V23, P957, DOI 10.1177/23.12.440
   GOLDSTEIN DB, 1966, J NEUROCHEM, V13, P1011, DOI 10.1111/j.1471-4159.1966.tb10299.x
   GOSSRAU R, 1991, ACTA HISTOCHEM, V90, P27, DOI 10.1016/S0065-1281(11)80153-4
   Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1
   HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2
   Horio M, 2011, NEUROCHEM INT, V59, P853, DOI 10.1016/j.neuint.2011.08.017
   Job V, 2002, J BIOL CHEM, V277, P6985, DOI 10.1074/jbc.M111095200
   Kapoor R, 1997, BRAIN RES, V771, P351, DOI 10.1016/S0006-8993(97)00886-X
   Kayalioglu G, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P17
   Kimura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26137
   KONNO R, 1984, J NEUROCHEM, V42, P584, DOI 10.1111/j.1471-4159.1984.tb02718.x
   Konno R, 1997, BBA-GEN SUBJECTS, V1335, P173, DOI 10.1016/S0304-4165(96)00136-5
   KONNO R, 1983, GENETICS, V103, P277
   Kozaki A, 2012, BIOSCI TRENDS, V6, P241, DOI 10.5582/bst.2012.v6.5.241
   KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1620
   Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52
   Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002
   McCombe PA, 2010, GENDER MED, V7, P557, DOI 10.1016/j.genm.2010.11.010
   Mitchell J, 2010, P NATL ACAD SCI USA, V107, P7556, DOI 10.1073/pnas.0914128107
   Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926
   NAGATA Y, 1991, EXPERIENTIA, V47, P835, DOI 10.1007/BF01922467
   Nakade Y, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97957
   Nakamura H, 2012, INFECT IMMUN, V80, P1546, DOI 10.1128/IAI.06214-11
   NEIMS AH, 1966, J NEUROCHEM, V13, P163, DOI 10.1111/j.1471-4159.1966.tb07508.x
   Ogawa M, 2003, J NEUROL SCI, V210, P53, DOI 10.1016/S0022-510X(03)00009-1
   Ono K, 2009, J NEURAL TRANSM, V116, P1335, DOI 10.1007/s00702-009-0289-7
   Onozato M, 2016, LIFE SCI, V158, P98, DOI 10.1016/j.lfs.2016.06.021
   Paul P, 2014, NEUROBIOL AGING, V35, P876, DOI 10.1016/j.neurobiolaging.2013.09.005
   Pilone MS, 2000, CELL MOL LIFE SCI, V57, P1732, DOI 10.1007/PL00000655
   Rosini E, 2018, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00102
   Sacchi S, 2004, PROTEIN ENG DES SEL, V17, P517, DOI 10.1093/protein/gzh064
   Sacchi S, 2008, J BIOL CHEM, V283, P22244, DOI 10.1074/jbc.M709153200
   Saigoh K, 1998, BRAIN RES, V808, P42, DOI 10.1016/S0006-8993(98)00810-5
   Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840
   Sasabe J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.125, 10.1038/nmicrobiol.2016.125]
   Sasabe Jumpei, 2014, Front Synaptic Neurosci, V6, P14, DOI 10.3389/fnsyn.2014.00014
   Sasabe J, 2012, P NATL ACAD SCI USA, V109, P627, DOI 10.1073/pnas.1114639109
   SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948
   Shibuya N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2371
   TADA M, 1990, GENE, V90, P293, DOI 10.1016/0378-1119(90)90193-U
   Tsukahara A, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0425-4
   VANBEKKUM DW, 1954, ACTA ENDOCRINOL-COP, V15, P9, DOI 10.1530/acta.0.0150009
   Verrall L, 2010, MOL PSYCHIATR, V15, P122, DOI 10.1038/mp.2009.99
   Wang LZ, 2003, ACTA PHARMACOL SIN, V24, P965
   Watanabe S, 2015, J BIOTECHNOL, V199, P9, DOI 10.1016/j.jbiotec.2015.01.026
NR 51
TC 10
Z9 10
U1 1
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0021-924X
EI 1756-2651
J9 J BIOCHEM
JI J. Biochem.
PD AUG
PY 2019
VL 166
IS 2
BP 187
EP 196
DI 10.1093/jb/mvz025
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA IV7WT
UT WOS:000484478300009
PM 30938755
DA 2024-02-19
ER

PT J
AU Coudray, C
   Feillet-Coudray, C
   Rambeau, M
   Tressol, JC
   Gueux, E
   Mazur, A
   Rayssiguier, Y
AF Coudray, Charles
   Feillet-Coudray, Christine
   Rambeau, Mathieu
   Tressol, Jean Claude
   Gueux, Elyett
   Mazur, Andrzej
   Rayssiguier, Yves
TI The effect of aging on intestinal absorption and status of calcium,
   magnesium, zinc, and copper in rats: A stable isotope study
SO JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE aging; intestinal absorption; minerals; rats; status
ID SERUM COPPER; VITAMIN-D; PARATHYROID-HORMONE; DIETARY MAGNESIUM; ELDERLY
   SUBJECTS; TRACE-ELEMENTS; RED-CELL; AGE; YOUNG; POPULATION
AB Many investigators have reported changes in mineral status with age but conflicting observations were done concerning mineral absorption. This study was conducted to clarify the effect of aging on intestinal absorption and status of minerals, using a stable isotope approach. To do so. 40 rats of different ages: 9, 22. 44. and 88 weeks were fed with a semi-purified diet for a total of 30 days. At the beginning of the 4th week. the rats received a stable isotope solution containing Ca-44, Mg-25, Zn-67, and Cu-65. Individual feces and urine were then collected during 4 consecutive days in order to measure stable isotopes by inductively coupled plasma/mass spectrometry (ICP/MS) and blood and tissues were sampled for mineral status determination. Intestinal absorption of Ca-44 and Zn-67 considerably decreased with age, whereas intestina Mg-25 absorption decreased only moderately and intestina Cu-65 absorption was unaffected. Plasma and bone calcium (Ca) were not modified with age whereas urinary Ca excretion considerably increased. Plasma and erythrocyte magnesium (Mg) levels were unaffected with age whereas urinary Mg excretion and Mg bone level decreased. Plasma zinc (Zn) level decreased and bone Zn level increased with age whereas red blood cell and liver Zn level and urinary Zn excretion remained unchanged. Plasma Cu level increased with age whereas liver and bone Cu levels and urinary Cu excretion remained unchanged. These results show that the effect of aging on the intestinal mineral absorption and status differ largely according to the mineral considered. Further studies are required under different nutritional conditions to explore the underlying mechanisms during aging and to adjust a better nutrition of the elderly. (c) 2005 Elsevier GmbH. All rights reserved.
C1 INRA, Ctr Rech Nutr Humaine Auvergne, Unite Malad Metab & Micronutr, F-63122 St Genes Champanelle, France.
C3 INRAE
RP Coudray, C (corresponding author), INRA, Ctr Rech Nutr Humaine Auvergne, Unite Malad Metab & Micronutr, F-63122 St Genes Champanelle, France.
EM coudray@clermont.inra.fr
RI COUDRAY, Charles/AGG-4757-2022; Mazur, Andre/AAG-9751-2020
OI Mazur, Andre/0000-0002-1067-5066; Coudray, Charles/0000-0003-2680-7796
CR AMBRECHT HJ, 1990, MINER ELECTROLYTE ME, V16, P159
   AUGUST D, 1989, AM J CLIN NUTR, V50, P1457, DOI 10.1093/ajcn/50.6.1457
   BALES CW, 1986, AM J CLIN NUTR, V44, P664, DOI 10.1093/ajcn/44.5.664
   CHAN ELP, 1992, CLIN ENDOCRINOL, V36, P375, DOI 10.1111/j.1365-2265.1992.tb01463.x
   Coudray C, 1999, MAGNESIUM RES, V12, P109
   Coudray C, 2002, J NUTR, V132, P2043, DOI 10.1093/jn/132.7.2043
   COUZY F, 1993, AM J CLIN NUTR, V58, P690, DOI 10.1093/ajcn/58.5.690
   Couzy F, 1998, BRIT J NUTR, V80, P177, DOI 10.1017/S0007114598001081
   Czernichow S, 2004, INT J VITAM NUTR RES, V74, P123, DOI 10.1024/0300-9831.74.2.123
   DEBIEVRE P, 1993, INT J MASS SPECTROM, V123, P149, DOI 10.1016/0168-1176(93)87009-H
   Durlach J, 1998, MAGNESIUM RES, V11, P25
   EASTELL R, 1991, J BONE MINER RES, V6, P125
   Fairweather-Tait SJ, 2002, FOOD ADDIT CONTAM A, V19, P939, DOI 10.1080/02652030110087474
   FairweatherTait SJ, 1997, EUR J CLIN NUTR, V51, pS24
   Ford D, 2004, P NUTR SOC, V63, P21, DOI 10.1079/PNS2003320
   GRANDJEAN P, 1992, SCAND J CLIN LAB INV, V52, P321, DOI 10.3109/00365519209088366
   GUEUX E, 1988, MAGNESIUM-B, V10, P77
   HARDWICK LL, 1990, MINER ELECTROL METAB, V16, P174
   HARMAN D, 1965, J GERONTOL, V20, P151, DOI 10.1093/geronj/20.2.151
   JOHNSON PE, 1992, AM J CLIN NUTR, V56, P917, DOI 10.1093/ajcn/56.5.917
   KANT AK, 1989, NUTR RES, V9, P717, DOI 10.1016/S0271-5317(89)80015-6
   KAYNE LH, 1993, MINER ELECTROL METAB, V19, P210
   Kim J, 2004, J AM COLL NUTR, V23, P309, DOI 10.1080/07315724.2004.10719373
   King JC, 2000, J NUTR, V130, p1360S, DOI 10.1093/jn/130.5.1360S
   Kinyamu HK, 1997, AM J CLIN NUTR, V65, P790, DOI 10.1093/ajcn/65.3.790
   Krebs NF, 2000, J NUTR, V130, p1374S, DOI 10.1093/jn/130.5.1374S
   LINDEMAN RD, 1982, J AM COLL NUTR, V1, P49
   LINDEMAN RD, 1971, J GERONTOL, V26, P358, DOI 10.1093/geronj/26.3.358
   Lonnerdal B, 1996, AM J CLIN NUTR, V63, P821
   MADARIC A, 1994, PHYSIOL RES, V43, P107
   MCMASTER D, 1992, AM J CLIN NUTR, V56, P440, DOI 10.1093/ajcn/56.2.440
   MERTZ W, 1987, J NUTR, V117, P1811, DOI 10.1093/jn/117.11.1811
   MILNE DB, 1993, CLIN CHEM, V39, P883
   Pannemans DLE, 1997, BRIT J NUTR, V77, P721, DOI 10.1079/BJN19970070
   PAYETTE H, 1991, AM J CLIN NUTR, V54, P478, DOI 10.1093/ajcn/54.3.478
   Praet JP, 1998, J ENDOCRINOL INVEST, V21, P263, DOI 10.1007/BF03347313
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   RUDNICKI M, 1993, J INTERN MED, V234, P195, DOI 10.1111/j.1365-2796.1993.tb00730.x
   Russell RM, 2000, AM J CLIN NUTR, V72, p529S, DOI 10.1093/ajcn/72.2.529S
   Saltzman JR, 1998, GASTROENTEROL CLIN N, V27, P309, DOI 10.1016/S0889-8553(05)70005-4
   Sandstrom B, 1997, EUR J CLIN NUTR, V51, pS17
   SCHAAFSMA G, 1997, EUR J CLIN NUTR, V81, pS13
   TEILLET L, 1995, MECH AGEING DEV, V79, P151, DOI 10.1016/0047-6374(94)01556-2
   TURNLUND JR, 1989, AM J CLIN NUTR, V49, P870, DOI 10.1093/ajcn/49.5.870
   TURNLUND JR, 1986, J NUTR, V116, P1239, DOI 10.1093/jn/116.7.1239
   TURNLUND JR, 1988, NUTR RES, V8, P333, DOI 10.1016/S0271-5317(88)80028-9
   TURNLUND JR, 1989, J NUTR, V119, P7, DOI 10.1093/jn/119.1.7
   Vaquero M P, 2002, J Nutr Health Aging, V6, P147
   Wapnir RA, 1998, AM J CLIN NUTR, V67, p1054S, DOI 10.1093/ajcn/67.5.1054S
   WEAVER CM, 1994, J NUTR, V124, pS1418, DOI 10.1093/jn/124.suppl_8.1418S
   Woudstra T, 2002, BEST PRACT RES CL GA, V16, P1, DOI 10.1053/bega.2001.0262
   YANG XY, 1990, J AM COLL NUTR, V9, P308
NR 52
TC 53
Z9 56
U1 0
U2 26
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0946-672X
J9 J TRACE ELEM MED BIO
JI J. Trace Elem. Med. Biol.
PY 2006
VL 20
IS 2
BP 73
EP 81
DI 10.1016/j.jtemb.2005.10.007
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 064OV
UT WOS:000239099900001
PM 16785046
DA 2024-02-19
ER

PT J
AU LEEUWENBURGH, C
   FIEBIG, R
   CHANDWANEY, R
   JI, LL
AF LEEUWENBURGH, C
   FIEBIG, R
   CHANDWANEY, R
   JI, LL
TI AGING AND EXERCISE TRAINING IN SKELETAL-MUSCLE - RESPONSES OF
   GLUTATHIONE AND ANTIOXIDANT ENZYME-SYSTEMS
SO AMERICAN JOURNAL OF PHYSIOLOGY
LA English
DT Article
DE LIPID PEROXIDATION; OXIDATIVE STRESS; SOLEUS; VASTUS LATERALIS
ID RAT; DAMAGE; DISULFIDE; HEART; LIVER
AB Glutathione (GSH) content and antioxidant enzyme activities were investigated in skeletal muscle of young, adult, and old male Fischer 344 rats. Furthermore, the effect of 10 wk of exercise training on these antioxidant systems was evaluated at all ages. In the soleus muscle, GSH concentration increased markedly with age, with no significant change in glutathione disulfide (GSSG) content. Training caused a 30% decrease of GSH (P < 0.05) in the soleus of young rats and a reduction of the GSH-to-GSSG ratio at all ages. Activity of gamma-glutamyl transpeptidase (GGT), a key enzyme for GSH uptake by muscle, was also significantly decreased with training. GSH, GSSG, and the GSH-to-GSSG ratio were not altered with aging or training in the deep portion of vastus lateralis muscle (DVL). Activities of GSH peroxidase (GPX), GSSG reductase (GR), superoxide dismutase (SOD), catalase (CAT), and GSH sulfur-transferase were increased significantly with aging in both soleus and DVL. In DVL, training increased GPX and SOD activities in the young rats, whereas in soleus, training decreased GR and CAT activities in the adult rats and GGT and CAT activities in the old rats. Muscle lipid peroxidation was significantly increased with aging in both DVL and soleus but was not affected by training. These data indicate that aging may cause not only an overall elevation of antioxidant enzyme activities but also a fiber-specific adaptation of GSH system in skeletal muscle. Exercise training, although increasing selective antioxidant enzymes in the young rats, does not offer additional protection against oxidative stress in the senescent muscle.
C1 UNIV ILLINOIS, DEPT KINESIOL, URBANA, IL 61801 USA.
   UNIV ILLINOIS, DIV NUTR SCI, URBANA, IL 61801 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign
OI Leeuwenburgh, Christiaan/0000-0003-0826-4257
CR ADAMS JD, 1983, J PHARMACOL EXP THER, V227, P749
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   AMELINK GJ, 1991, PFLUG ARCH EUR J PHY, V419, P304, DOI 10.1007/BF00371111
   BAR PR, 1988, LIFE SCI, V42, P2677, DOI 10.1016/0024-3205(88)90243-3
   BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   CECONI C, 1988, J MOL CELL CARDIOL, V20, P5, DOI 10.1016/S0022-2828(88)80174-3
   DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HAMMEREN J, 1992, INT J SPORTS MED, V13, P412, DOI 10.1055/s-2007-1021290
   Harman D., 1986, FREE RADICALS AGING, P3
   JENKINS RR, 1988, SPORTS MED, V5, P156, DOI 10.2165/00007256-198805030-00003
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JI LL, 1993, MED SCI SPORT EXER, V25, P225
   JI LL, 1992, J APPL PHYSIOL, V73, P1854, DOI 10.1152/jappl.1992.73.5.1854
   JI LL, 1992, J APPL PHYSIOL, V72, P549, DOI 10.1152/jappl.1992.72.2.549
   JI LL, 1991, GERONTOLOGY, V37, P317
   JOHNSON JE, 1986, BIOLOGY AGING, pR9
   KRETZSCHMAR M, 1991, INT J SPORTS MED, V12, P218, DOI 10.1055/s-2007-1024671
   LUHTALA T, IN PRESS GERONTOLOGY
   Matsuo M., 1993, FREE RADICALS AGING, P143
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   Meister A, 1981, Methods Enzymol, V77, P237
   MEYDANI M, 1993, FREE RADICALS AGING, P183
   Miquel J., 1986, FREE RADICALS AGING, P51
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   REED DJ, 1986, BIOCHEM PHARMACOL, V35, P7, DOI 10.1016/0006-2952(86)90545-9
   REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9
   SALMINEN A, 1988, COMP BIOCHEM PHYS B, V89, P695, DOI 10.1016/0305-0491(88)90310-0
   SEN CK, 1992, J APPL PHYSIOL, V73, P1265, DOI 10.1152/jappl.1992.73.4.1265
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   VERTECHY M, 1989, EXP GERONTOL, V24, P211, DOI 10.1016/0531-5565(89)90012-0
   YU BP, 1993, FREE RADICALS AGING, P58
   ZERBA E, 1990, AM J PHYSIOL, V258, pC429, DOI 10.1152/ajpcell.1990.258.3.C429
NR 36
TC 224
Z9 252
U1 0
U2 11
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0002-9513
J9 AM J PHYSIOL
JI Am. J. Physiol.
PD AUG
PY 1994
VL 267
IS 2
BP R439
EP R445
DI 10.1152/ajpregu.1994.267.2.R439
PN 2
PG 7
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA PC441
UT WOS:A1994PC44100067
PM 8067452
DA 2024-02-19
ER

PT J
AU LAUC, G
   SEVE, AP
   HUBERT, J
   FLOGELMRSIC, M
   MULLER, WEG
   SCHRODER, HC
AF LAUC, G
   SEVE, AP
   HUBERT, J
   FLOGELMRSIC, M
   MULLER, WEG
   SCHRODER, HC
TI HNRNP CBP35.CBP67 INTERACTION DURING STRESS-RESPONSE AND AGING
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE HNRNP; NUCLEAR LECTIN; TRANSPORT; CBP35 AND CBP67; RAT LIVER
ID ENVELOPE NUCLEOSIDE TRIPHOSPHATASE; CARBOHYDRATE-BINDING PROTEIN-35;
   RNA-TRANSLOCATION SYSTEM; MESSENGER-RNA; RIBONUCLEOPROTEIN COMPLEX;
   ENDOGENOUS LECTINS; CULTURED-CELLS; NUCLEAR; TRANSPORT; LOCALIZATION
AB Previous studies have demonstrated the existence of nuclear carbohydrate binding proteins in a variety of mammalian cells with molecular masses of 35 000, 67 000, and 70 000 (CBP35, CBP67, and CBP70), which are associated with nuclear ribonucleoprotein (RNP) complexes. CBP35 consists of two domains, an amino-terminal portion that is homologous to certain regions of proteins of the heterogeneous nuclear RNP complex, and a carboxyl-terminal portion homologous to beta-galactoside-specific lectins. CBP35 it has been proposed, like the glucose-specific lectin, CBP67, to guide RNP complexes through the nuclear pore. Here we show that the exposure of mature rats to stress induces an increase in nuclear CBP35 bound to CBP67 and retained on immobilized glucose. Nuclear extracts from the livers of old rats displayed no detectable stress response. This CBP35.CBP67 association detected in rat liver is considered with respect to the CBP35.CBP70 association recently observed in HL60 cell nuclear extracts.
C1 UNIV MAINZ, INST PHYSIOL CHEM, ANGEW MOLEK BIOL ABT, DUESBERGWEG 6, D-55099 MAINZ, GERMANY.
   UNIV ZAGREB, FAC PHARM & BIOCHEM, DEPT MED BIOCHEM, 41000 ZAGREB, CROATIA.
   UFR BIOMED ST PERES, GLYCOBIOL & RECONNAISSANCE CELLULAIRE LAB, INSERM, U180, F-75270 PARIS 06, FRANCE.
C3 Johannes Gutenberg University of Mainz; University of Zagreb; Institut
   National de la Sante et de la Recherche Medicale (Inserm)
RI Müller, W. E. G./AAR-8651-2020; Lauc, Gordan/K-5864-2012
OI Müller, W. E. G./0000-0002-8223-3689; Lauc, Gordan/0000-0003-1840-9560;
   Schroder, Heinz C./0000-0003-0992-6427
CR AGRWAL N, 1989, J BIOL CHEM, V264, P17236
   AGUTTE PS, 1976, NATURE, V263, P165, DOI 10.1038/263165a0
   [Anonymous], NUCLEUS CYTOPLASM
   BERND A, 1984, J INVEST DERMATOL, V83, P20, DOI 10.1111/1523-1747.ep12261641
   BERND A, 1982, MECH AGEING DEV, V20, P331, DOI 10.1016/0047-6374(82)90100-2
   BERND A, 1983, GERONTOLOGY, V29, P394, DOI 10.1159/000213150
   BERND A, 1982, EUR J BIOCHEM, V129, P43, DOI 10.1111/j.1432-1033.1982.tb07018.x
   BOURGEOIS CA, 1987, EXP CELL RES, V172, P365, DOI 10.1016/0014-4827(87)90394-6
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   COWLES EA, 1990, J BIOL CHEM, V265, P17706
   CUELLO AC, 1983, IMMUNOHISTOCHEMISTRY, P214
   DEKLOET ER, 1992, ANN NY ACAD SCI, V663, P357, DOI 10.1111/j.1749-6632.1992.tb38679.x
   DRICKAMER K, 1988, J BIOL CHEM, V263, P9557
   FACY P, 1990, EXP CELL RES, V190, P151, DOI 10.1016/0014-4827(90)90179-E
   FINCH EC, 1985, HDB BIOL AGING, P567
   HUBERT J, 1989, CELL DIFFER DEV, V27, P69, DOI 10.1016/0922-3371(89)90737-5
   HUBERT J, 1985, BIOL CELL, V55, P15, DOI 10.1111/j.1768-322X.1985.tb00404.x
   JIA SH, 1988, J BIOL CHEM, V263, P6009
   KALB VF, 1977, ANAL BIOCHEM, V82, P362, DOI 10.1016/0003-2697(77)90173-7
   KARN J, 1991, CURR OPIN IMMUNOL, V3, P526, DOI 10.1016/0952-7915(91)90016-T
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAING JG, 1988, BIOCHEMISTRY-US, V27, P5329, DOI 10.1021/bi00414a057
   MONSIGNY M, 1984, BIOL CELL, V51, P187, DOI 10.1111/j.1768-322X.1984.tb00298.x
   MONSIGNY M, 1988, ANAL BIOCHEM, V175, P525, DOI 10.1016/0003-2697(88)90578-7
   MOUTSATSOS IK, 1987, P NATL ACAD SCI USA, V84, P6452, DOI 10.1073/pnas.84.18.6452
   PFEIFER K, 1991, EUR J BIOCHEM, V199, P53, DOI 10.1111/j.1432-1033.1991.tb16091.x
   PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0
   ROFF CF, 1983, J BIOL CHEM, V258, P657
   SCHRODER HC, 1986, BIOCHIM BIOPHYS ACTA, V868, P108, DOI 10.1016/0167-4781(86)90013-8
   SCHRODER HC, 1990, BIOCHEMISTRY-US, V29, P2368, DOI 10.1021/bi00461a022
   SCHRODER HC, 1992, EUR J BIOCHEM, V205, P1017, DOI 10.1111/j.1432-1033.1992.tb16869.x
   SCHRODER HC, 1988, BIOCHEM J, V252, P777, DOI 10.1042/bj2520777
   SCHRODER HC, 1986, J BIOL CHEM, V261, P663
   SCHRODER HC, 1987, PROG NUCLEIC ACID RE, V34, P89, DOI 10.1016/S0079-6603(08)60494-8
   SCHRODER HC, 1989, METHODS INVESTIGATIN
   SEVE AP, 1985, EXP CELL RES, V157, P533, DOI 10.1016/0014-4827(85)90138-7
   SEVE AP, 1986, P NATL ACAD SCI USA, V83, P5997, DOI 10.1073/pnas.83.16.5997
   SEVE AP, 1993, GLYCOBIOLOGY, V3, P23, DOI 10.1093/glycob/3.1.23
   VERHEIJEN R, 1988, J CELL SCI, V90, P11
   WANG J L, 1991, Glycobiology, V1, P243, DOI 10.1093/glycob/1.3.243
   WANG JL, 1992, BIOCHEM SOC T, V20, P269, DOI 10.1042/bst0200269
   YANNARELL A, 1977, MECH AGEING DEV, V6, P259, DOI 10.1016/0047-6374(77)90026-4
NR 42
TC 15
Z9 17
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD AUG 15
PY 1993
VL 70
IS 3
BP 227
EP 237
DI 10.1016/0047-6374(93)90050-2
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA LV100
UT WOS:A1993LV10000005
PM 8246636
DA 2024-02-19
ER

PT J
AU Cheng, W
   Zhou, Y
   Chen, HE
   Wu, Q
   Li, Y
   Wang, H
   Feng, Y
   Wang, Y
AF Cheng, Wei
   Zhou, Yue
   Chen, Hange
   Wu, Qian
   Li, Yan
   Wang, Hui
   Feng, Yan
   Wang, Yan
TI The iron matters: Aged microplastics disrupted the iron homeostasis in
   the liver organoids
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article; Early Access
DE Aged microplastics; Hepatocytotoxicity; Alternative test; Iron
   homeostasis; MDA; GPX4
ID FERRITIN
AB Plastic products undergo artificial and unintentional aging during daily use, causing the presence of aged microplastics (aMP). Humans are inevitably exposed to aMP. Liver is one of the critical target organs of MP through oral intake, however, limited research has focused on the hepatic toxicity of aMP compared to pristine MP (pMP). We utilized the human pluripotent stem cells-derived liver organoids (LOs) to compare the cyto-toxicity of pristine polystyrene microplastics (pPS) (1 mu m, carbonyl index 0.08) and aged polystyrene micro -plastics (aPS) (1 mu m, carbonyl index 0.20) ranged from 20 to 200 ng/mL. Our findings indicate that aPS was more cytotoxic than pPS. We explored the disrupted iron homeostasis in terms of the [Fe2+] and [Fe3+] levels, iron storage and transport. A "vector-like effect" induced by aPS has been preliminarily suggested by the correlated change in total iron level and co-localization of PS and ferritin light chain (FTL) in the LOs following exposure to aPS and ferric ammonium citrate (FAC) individually and com-binedly. In addition, we observed abnormal mitochondrial morphology, elevated lipid peroxidation, and declined GSH peroxidase activity, together with the declined expression of transferrin receptor (TFRC) and elevated expressions of SLC7A11, FTL. The gene handled iron transport and iron use were disrupted by aPS. Moreover, we employed FAC to introduce iron overload and Nacetylcysteine (NAC) to protect the lipid perox-idation. In aPS + FAC group, aggravated effects could be observed in aspects of [Fe2+] level, lipid peroxidation, and compromised expression levels of iron homeostasis-related markers, in contrast, in aPS + NAC group, most of changes recovered but the hepatocytoxicity remained. Specifically, a dimorphic change in elevated FTL and decreased ferritin heavy chain (FTH1) caused by 50 ng/mL aMP (57.33 +/- 3.57 items/mL, equivalent to human intake level), indicated a specific response to low-dose aMP.
C1 [Cheng, Wei; Zhou, Yue; Chen, Hange; Wu, Qian; Li, Yan; Feng, Yan] Shanghai Jiao Tong Univ, Sch Publ Hlth, Sch Med, Shanghai, Peoples R China.
   [Wang, Hui] Shanghai Jiao Tong Univ, Ctr Single Cell Om, Sch Publ Hlth, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China.
   [Wang, Yan] Shanghai Jiao Tong Univ, Collaborat Innovat Ctr Clin & Translat Sci, Minist Educ & Shanghai, Peoples Hosp 9,Sch Publ Hlth,Sch Med, Shanghai, Peoples R China.
   [Wang, Yan] Bld 8,639 Zhizaoju Rd, Shanghai 200011, Peoples R China.
   [Cheng, Wei] 280 South Chongqing Rd, Shanghai 200025, Peoples R China.
C3 Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai
   Jiao Tong University
RP Wang, Y (corresponding author), Bld 8,639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Cheng, W (corresponding author), 280 South Chongqing Rd, Shanghai 200025, Peoples R China.
EM wcheng@shsmu.edu.cn; yjszhouyue@sjtu.edu.cn; c122711910097@sjtu.edu.cn;
   wuqianqian@sjtu.edu.cn; huiwang@shsmu.edu.cn; fy_575@sjtu.edu.cn;
   wangyan@shsmu.edu.cn
OI Cheng, Wei/0000-0003-4708-2966
FU National Natural Science Foundation of China [82204076]; Shanghai
   Science & Technology Development Foundation [22140901300]; Shanghai Jiao
   Tong University [21X010501060, YG2021QN03]
FX This work was supported by the National Natural Science Foundation of
   China (82204076), Shanghai Science & Technology Development Foundation
   (22140901300), the Start-up Program (21X010501060), and the
   Interdisciplinary Program (YG2021QN03) of Shanghai Jiao Tong University.
CR Bain A, 2021, ENVIRON SCI TECHNOL, V55, P11775, DOI 10.1021/acs.est.1c04272
   Bao RQ, 2022, J HAZARD MATER, V439, DOI 10.1016/j.jhazmat.2022.129686
   Bauten W, 2023, SCI TOTAL ENVIRON, V860, DOI 10.1016/j.scitotenv.2022.160450
   Chen X, 2021, CELL DEATH DIFFER, V28, P1135, DOI 10.1038/s41418-020-00728-1
   Cheng W, 2022, SCI TOTAL ENVIRON, V806, DOI 10.1016/j.scitotenv.2021.150328
   Brito WAD, 2023, SCI TOTAL ENVIRON, V854, DOI 10.1016/j.scitotenv.2022.158731
   de Souza SS, 2022, J HAZARD MATER, V434, DOI 10.1016/j.jhazmat.2022.128814
   Di Fiore C, 2023, FOOD CHEM, V404, DOI 10.1016/j.foodchem.2022.134682
   Du FN, 2020, J HAZARD MATER, V399, DOI 10.1016/j.jhazmat.2020.122969
   Duan L, 2023, SCI TOTAL ENVIRON, V869, DOI 10.1016/j.scitotenv.2023.161800
   Fabra M, 2021, SCI TOTAL ENVIRON, V797, DOI 10.1016/j.scitotenv.2021.149217
   Fisher J, 2007, AM J PHYSIOL-CELL PH, V293, pC641, DOI 10.1152/ajpcell.00599.2006
   Fournier E, 2023, J HAZARD MATER, V442, DOI 10.1016/j.jhazmat.2022.130010
   Fritsche E, 2021, SMALL, V17, DOI 10.1002/smll.202006252
   Giansily-Blaizot M, 2013, HAEMATOLOGICA, V98, pE42, DOI 10.3324/haematol.2012.077198
   Guo JY, 2021, ADV SCI, V8, DOI 10.1002/advs.202004680
   Hatinoglu MD, 2023, SCI TOTAL ENVIRON, V860, DOI 10.1016/j.scitotenv.2022.160524
   He YJ, 2022, CHEMOSPHERE, V307, DOI 10.1016/j.chemosphere.2022.135662
   Hu JY, 2023, WATER RES, V232, DOI 10.1016/j.watres.2023.119628
   Laine F, 2017, HEPATOLOGY, V65, P465, DOI 10.1002/hep.28856
   Li YR, 2022, J CONTROL RELEASE, V342, P201, DOI 10.1016/j.jconrel.2022.01.006
   Lin LJ, 2022, CHEM ENG J, V439, DOI 10.1016/j.cej.2022.135613
   Liu P, 2022, CHEMOSPHERE, V287, DOI 10.1016/j.chemosphere.2021.132412
   Mamun AA, 2023, SCI TOTAL ENVIRON, V858, DOI 10.1016/j.scitotenv.2022.159834
   Mattos BD, 2017, J CONTROL RELEASE, V262, P139, DOI 10.1016/j.jconrel.2017.07.025
   Meng K, 2023, J HAZARD MATER, V447, DOI 10.1016/j.jhazmat.2023.130765
   Mu YW, 2022, CHEMOSPHERE, V291, DOI 10.1016/j.chemosphere.2021.132944
   Muhib MI, 2023, SCI TOTAL ENVIRON, V865, DOI 10.1016/j.scitotenv.2022.161274
   Ossmann BE, 2018, WATER RES, V141, P307, DOI 10.1016/j.watres.2018.05.027
   Ren XA, 2023, WATER RES, V233, DOI 10.1016/j.watres.2023.119786
   Rushworth GF, 2014, PHARMACOL THERAPEUT, V141, P150, DOI 10.1016/j.pharmthera.2013.09.006
   Sahoo K, 2023, APOPTOSIS, V28, P277, DOI 10.1007/s10495-022-01806-0
   Sewwandi M, 2023, ENVIRON POLLUT, V317, DOI 10.1016/j.envpol.2022.120747
   Shinozawa T, 2021, GASTROENTEROLOGY, V160, P831, DOI 10.1053/j.gastro.2020.10.002
   Song W, 2023, ENVIRON POLLUT, V318, DOI 10.1016/j.envpol.2022.120925
   Sturm MT, 2021, ANAL BIOANAL CHEM, V413, P1059, DOI 10.1007/s00216-020-03066-w
   Tang J, 2023, ACS NANO, DOI 10.1021/acsnano.2c09729
   Wang LX, 2023, ENVIRON POLLUT, V334, DOI 10.1016/j.envpol.2023.122250
   Wang SC, 2021, SCI TOTAL ENVIRON, V797, DOI 10.1016/j.scitotenv.2021.149180
   Wu PF, 2022, J HAZARD MATER, V437, DOI 10.1016/j.jhazmat.2022.129361
   Wu YL, 2023, SCI TOTAL ENVIRON, V855, DOI 10.1016/j.scitotenv.2022.158851
   Xie MW, 2021, SCI TOTAL ENVIRON, V797, DOI 10.1016/j.scitotenv.2021.149108
   Yan ZH, 2022, ENVIRON SCI TECHNOL, V56, P414, DOI 10.1021/acs.est.1c03924
   Zhang P, 2022, ENVIRON INT, V169, DOI 10.1016/j.envint.2022.107540
   Zhang XL, 2022, ENVIRON INT, V158, DOI 10.1016/j.envint.2021.106922
   Zheng JS, 2020, CELL METAB, V32, P920, DOI 10.1016/j.cmet.2020.10.011
   Zhong YH, 2023, ENVIRON POLLUT, V316, DOI 10.1016/j.envpol.2022.120617
NR 47
TC 0
Z9 0
U1 16
U2 16
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-9697
EI 1879-1026
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD 2024 JAN 1
PY 2024
VL 906
AR 167529
DI 10.1016/j.scitotenv.2023.167529
EA OCT 2023
PG 10
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology
GA Y1HS6
UT WOS:001102854200001
PM 37788777
DA 2024-02-19
ER

PT J
AU van der Loo, B
   Bachschmid, M
   Spitzer, V
   Brey, L
   Ullrich, V
   Lüscher, TF
AF van der Loo, B
   Bachschmid, M
   Spitzer, V
   Brey, L
   Ullrich, V
   Lüscher, TF
TI Decreased plasma and tissue levels of vitamin C in a rat model of
   aging:: implications for antioxidative defense
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE aging; vitamin C; oxidative stress
ID ASCORBIC-ACID; MORTALITY
AB Aging is an independent risk factor for the development of cardiovascular and many other diseases. The aging process is known to be associated with increased oxidative stress, possibly related to an age-inherent loss of antioxidant capacity. Vitamin C is a major naturally occurring antioxidant. Thus, we investigated its role in a rat model of aging. Vitamin C in plasma and tissues as well as malondialdehyde in the heart were measured in young (6 months old) and old (27-30 months old) F1 (F344 x BN) healthy male rats fed a normal diet. In old rats, vitamin C plasma levels were found to be decreased (p < 0.02) as compared with young animals. Furthermore, there was a tissue-specific distribution: in the heart, liver, kidney, lungs, and skeletal muscle, vitamin C decreased with age (p < 0.005 to p < 0.05), while no significant differences could be observed in the aortic wall and in the brain. Organs of the digestive tract rather showed an increase of vitamin C levels with, age. Oxidative stress, determined representatively in the heart by measuring malondialdehyde tissue levels, exhibited an age-dependent increase (p < 0.05). A distinct pattern of specific tissue distribution of vitamin C suggests a differential age-associated regulation. As vitamin C decreased concomitantly to an increase in cardiac lipid peroxidation, its supplementation may be useful to prevent age-related oxidative stress and tissue aging. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 Univ Zurich Hosp, Div Cardiol, Ctr Cardiovasc, CH-8091 Zurich, Switzerland.
   Univ Zurich Irchel, Div Cardiovasc Res, Inst Physiol, Zurich, Switzerland.
   Univ Konstanz, Dept Biol, D-7750 Constance, Germany.
   Roche Vitamins Ltd, Dept Vitamin Res, Basel, Switzerland.
C3 University of Zurich; University Zurich Hospital; University of Zurich;
   University of Konstanz; Roche Holding
EM cardiotfl@gmx.ch
OI Bachschmid, Markus Michael/0000-0002-0748-5528
CR FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377
   Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3
   Lakatta EG, 2001, CIRC RES, V88, P984, DOI 10.1161/hh1001.091963
   Loria CM, 2000, AM J CLIN NUTR, V72, P139
   LUSCHER TF, 1995, HEART DIS, V3, P1
   Nakata Y, 2002, CIRCULATION, V105, P1485, DOI 10.1161/01.CIR.0000012142.69612.25
   OHKAWA H, 1978, J LIPID RES, V19, P1053
   PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0
   REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461
   Russell RM, 2000, AM J CLIN NUTR, V72, p529S, DOI 10.1093/ajcn/72.2.529S
   Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986
   Umegaki K, 2001, FREE RADICAL RES, V34, P427, DOI 10.1080/10715760100300361
   Upston JM, 1999, FASEB J, V13, P977, DOI 10.1096/fasebj.13.9.977
   van der Loo B, 2002, CIRCULATION, V105, P1635, DOI 10.1161/01.CIR.0000014986.29834.71
   VUILLEUMIER JP, 1989, J MICRONUTR ANAL, V5, P25
NR 15
TC 53
Z9 55
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD APR 4
PY 2003
VL 303
IS 2
BP 483
EP 487
DI 10.1016/S0006-291X(03)00360-7
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 666LB
UT WOS:000182177800015
PM 12659843
DA 2024-02-19
ER

PT J
AU Augustyniak, A
   Waszkiewicz, E
   Skrzydlewska, M
AF Augustyniak, A
   Waszkiewicz, E
   Skrzydlewska, M
TI Preventive action of green tea from changes in the liver antioxidant
   abilities of different aged rats intoxicated with ethanol
SO NUTRITION
LA English
DT Article
DE green tea; ethanol; antioxidants; lipid peroxidation; protein oxidation
ID LIPID-PEROXIDATION; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE;
   MEMBRANE-FLUIDITY; ALPHA-TOCOPHEROL; BLACK TEA; IN-VITRO; GLUTATHIONE;
   POLYPHENOLS; FLAVONOIDS
AB Objective: The present study investigated the influence of green tea as a source of water-soluble antioxidants on the liver antioxidant potential of different aged rats chronically intoxicated with ethanol.
   Methods: Rats (2, 12, and 24 mo old) were fed for 5 wk on a control or an ethanol Lieber-DeCarli diet with and without green tea (7 g/L). The activity and level of enzymatic and non-enzymatic antioxidants and the level of markers of protein and lipid oxidation in the liver of rats were examined.
   Results: The activities of superoxide dismutase and catalase and levels of vitamins C, E, A, and beta-carotene were significantly decreased, whereas activities of glutathione peroxidase and glutathione reductase and the level of reduced glutathione significantly increased during aging. The ethanol diet caused a significant decrease in activity of antioxidant enzymes and in the level of nonenzymatic antioxidants tested. Administration of green tea to ethanol-treated rats of different ages partly normalized the activity of enzymes and the level of non-enzymatic antioxidants. Changes in antioxidant ability observed during aging were accompanied by increased levels of markers of lipid and protein modifications that also were intensified by ethanol. Green tea caused a decrease in lipid and protein oxidation in aged and ethanol-treated rats. The protective effect of green tea was confirmed by the significantly lower activity of biomarkers of liver damage (alanine and aspartate aminotransferases) in the serum of rats that received green tea with ethanol compared with rats from the control ethanol group.
   Conclusions: The use of green tea appears to be beneficial to rat liver by decreasing oxidative stress caused by ethanol and/or aging. (c) 2005 Elsevier Inc. All rights reserved.
C1 Med Univ Bialystok, Dept Analyt Chem, Bialystok, Poland.
C3 Medical University of Bialystok
RP Skrzydlewska, M (corresponding author), Med Univ Bialystok, Dept Analyt Chem, Bialystok, Poland.
EM skrzydle@amb.edu.pl
RI Tarasiuk, Ewa/Y-1757-2018
OI Tarasiuk, Ewa/0000-0002-0614-1352; Skrzydlewska,
   Elzbieta/0000-0001-5397-7139
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Arora A, 2000, ARCH BIOCHEM BIOPHYS, V373, P102, DOI 10.1006/abbi.1999.1525
   Aucamp J, 1997, ANTICANCER RES, V17, P4381
   BRIEN JF, 1983, CAN J PHYSIOL PHARM, V61, P1, DOI 10.1139/y83-001
   BUNKER VW, 1992, MED LAB SCI, V49, P299
   Chen LJ, 2002, TOXICOL SCI, V69, P149, DOI 10.1093/toxsci/69.1.149
   Cherubini A, 1999, FREE RADICAL BIO MED, V27, P381, DOI 10.1016/S0891-5849(99)00064-7
   COSTAGLIOLA C, 1990, CLIN PHYSIOL BIOCH, V8, P140
   CUTLER RG, 2003, ADV BASIC SCI DIAGNO, P1523
   DELEENHEER AP, 1979, J CHROMATOGR, V162, P408, DOI 10.1016/S0378-4347(00)81528-5
   ELINDER LS, 1992, J LIPID RES, V33, P131
   Erden-Inal M, 2002, CELL BIOCHEM FUNCT, V20, P61, DOI 10.1002/cbf.937
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Guo QN, 1996, BBA-LIPID LIPID MET, V1304, P210, DOI 10.1016/S0005-2760(96)00122-1
   HARATA J, 1983, BIOCHEM PHARMACOL, V32, P1795
   HENNING SM, 1991, J NUTR, V121, P1969, DOI 10.1093/jn/121.12.1969
   Husain K, 2001, ALCOHOL, V25, P89, DOI 10.1016/S0741-8329(01)00176-8
   Ivanovic D, 1999, J PHARMACEUT BIOMED, V18, P999, DOI 10.1016/S0731-7085(98)00109-5
   Junqueira Virginia B. C., 2004, Molecular Aspects of Medicine, V25, P5, DOI 10.1016/j.mam.2004.02.003
   KHAN SG, 1992, CANCER RES, V52, P4050
   Kinter M, 1996, FREE RADICAL BIO MED, V21, P457, DOI 10.1016/0891-5849(96)00128-1
   KUKIELKA E, 1994, BIOCHEM J, V302, P773, DOI 10.1042/bj3020773
   Kurose I, 1996, ALCOHOL CLIN EXP RES, V20, pA77, DOI 10.1111/j.1530-0277.1996.tb01736.x
   LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393
   Li C, 2000, CHEM RES TOXICOL, V13, P177, DOI 10.1021/tx9901837
   LIEBER CS, 1970, J BIOL CHEM, V245, P2505
   Liu RM, 2000, FREE RADICAL BIO MED, V28, P566, DOI 10.1016/S0891-5849(99)00269-5
   Londero D, 1996, J CHROMATOGR A, V729, P207, DOI 10.1016/0021-9673(95)00959-0
   Maiani G, 1997, J CHROMATOGR B, V692, P311, DOI 10.1016/S0378-4347(97)00009-1
   MAUCH TJ, 1986, HEPATOLOGY, V6, P263, DOI 10.1002/hep.1840060218
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   MIZE CE, 1962, J BIOL CHEM, V237, P1589
   NADKARNI DV, 1995, CHEM RES TOXICOL, V8, P284, DOI 10.1021/tx00044a014
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Ponnappa BC, 2000, ALCOHOL RES HEALTH, V24, P93
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   RICEEVANS CA, 1991, TECHNIQUES FREE RADI, P207
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Rouach H, 1997, HEPATOLOGY, V25, P351
   SAIJA A, 1995, FREE RADICAL BIO MED, V19, P481, DOI 10.1016/0891-5849(94)00240-K
   Scott, 2000, Pathophysiology, V7, P25, DOI 10.1016/S0928-4680(99)00034-6
   Skrzydlewska E, 2002, PHYTOMEDICINE, V9, P232, DOI 10.1078/0944-7113-00119
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   SOHN OS, 1994, XENOBIOTICA, V24, P119, DOI 10.3109/00498259409043226
   SOMVILLE M, 1985, MECH AGEING DEV, V29, P35, DOI 10.1016/0047-6374(85)90045-4
   STONER GD, 1995, J CELL BIOCHEM, P169
   STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352
   SYKES JA, 1978, CANCER RES, V38, P2759
   TOKUMARU S, 1995, ANAL CHIM ACTA, V307, P97, DOI 10.1016/0003-2670(95)00045-2
   YOSHINO K, 1986, CHEM PHARM BULL, V34, P1694
   Zhu QY, 1999, J AGR FOOD CHEM, V47, P2020, DOI 10.1021/jf9809941
NR 51
TC 70
Z9 76
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD SEP
PY 2005
VL 21
IS 9
BP 925
EP 932
DI 10.1016/j.nut.2005.01.006
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 959LS
UT WOS:000231519800007
PM 16084066
DA 2024-02-19
ER

PT J
AU Mu, JF
   Yang, FP
   Tan, F
   Zhou, XR
   Pan, YN
   Long, XY
   Zhao, X
AF Mu, Jianfei
   Yang, Fuping
   Tan, Fang
   Zhou, Xianrong
   Pan, Yanni
   Long, Xingyao
   Zhao, Xin
TI Determination of Polyphenols in <i>Ilex kudingcha</i> and <i>Insect
   Tea</i> (Leaves Altered by Animals) by Ultra-high-performance Liquid
   Chromatography-Triple Quadrupole Mass Spectrometry (UHPLC-QqQ-MS) and
   Comparison of Their Anti-Aging Effects
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE ilex kudingcha; insect tea; polyphenols; aging; UHPLC-QqQ-MS
AB Ilex kudingcha C.J. Tseng tea and insect tea, as traditional Chinese teas, are favored for their original craftsmanship, unique flavor, and biological functionality. In this study, ultra high-performance liquid chromatography-triple quadrupole mass spectrometry (UHPLC-QqQ-MS) was used to analyze the bioactive components of the extracts of Ilex kudingcha and insect tea, and D-galactose-induced aging mice were used to compare the in vivo anti-aging effects of Ilex kudingcha and insect tea extracts. The results were remarkable, UHPLC-QqQ-MS analysis showed that ITP contains 29 ingredients, while IKDCP contains 26 ingredients. However, due to the large differences in the content of the main chemical components in IKDCP and ITP, the effects are equally different. At the same time, the in vivo research results suggesting that the anti-aging effects of IKDCP and ITP (500 mg/kg) include the regulation of viscera indices of major organs; improvement in liver, skin, and spleen tissue morphology; decreased production of inflammatory cytokines; up regulation of SOD, CAT, GSH, GSH-PX, and T-AOC and down regulation of NO and MDA levels in serum and liver tissue; reductions in the concentration of pro-inflammatory factors, and increases in the concentration of anti-inflammatory factor. RT-qPCR and western blot assay also showed that IKDCP and ITP affect anti-aging by regulating the gene and protein expression of GSH-PX, GSH1, SOD1, SOD2, and CAT. The overall results indicate that ITP is more effective in treating oxidative damage in aging mice induced by D-galactose. Thus, ITP appears to be an effective functional drink owing to its rich nutritional components and anti-aging activities.
C1 [Mu, Jianfei; Zhou, Xianrong; Pan, Yanni; Long, Xingyao; Zhao, Xin] Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing, Peoples R China.
   [Mu, Jianfei] Southwest Univ, Coll Food Sci, Chongqing, Peoples R China.
   [Yang, Fuping] Chongqing Publ Hlth Med Treatment Ctr, TB Sect 3, Chongqing, Peoples R China.
   [Tan, Fang] Our Lady Fatima Univ, Dept Publ Hlth, Valenzuela, Philippines.
   [Pan, Yanni; Long, Xingyao] Cha Univ, Dept Food Sci & Biotechnol, Seongnam, South Korea.
C3 Chongqing University of Education; Southwest University - China; Our
   Lady of Fatima University; Pochon Cha University
RP Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing, Peoples R China.
EM zhaoxin@cque.edu.cn
OI Tan, Fang/0000-0003-2406-129X
FU Chongqing University Innovation Research Group Project [CXQTP20033];
   Introduction of High-level Person-nel Research Start-up Fund of
   Chongqing University of Education [2013BSRC001]
FX This research was funded by Chongqing University Innovation Research
   Group Project (CXQTP20033) and the Introduction of High-level Person-nel
   Research Start-up Fund of Chongqing University of Education
   (2013BSRC001), China.
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491
   Bo-Htay C, 2018, J CELL MOL MED, V22, P1392, DOI 10.1111/jcmm.13472
   Cheng X, 2018, INT IMMUNOPHARMACOL, V56, P29, DOI 10.1016/j.intimp.2018.01.002
   Clement MV, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.201800400
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209
   El-naseery NI, 2020, LIFE SCI, V241, DOI 10.1016/j.lfs.2019.117168
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Forman K, 2020, J CELL PHYSIOL, V235, P9773, DOI 10.1002/jcp.29791
   Funaguchi N, 2007, CLIN EXP PHARMACOL P, V34, P766, DOI 10.1111/j.1440-1681.2007.04636.x
   Gan RY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111682
   Giardino R, 2002, ARTIF CELL BLOOD SUB, V30, P189, DOI 10.1081/BIO-120004339
   Guo H, 2020, EXP THER MED, V19, P557, DOI 10.3892/etm.2019.8261
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   He CQ, 2020, J NUTR BIOCHEM, V78, DOI 10.1016/j.jnutbio.2019.108326
   Hsu CC, 2005, GYNECOL ONCOL, V96, P415, DOI 10.1016/j.ygyno.2004.10.010
   Isanga J, 2008, FOOD REV INT, V24, P252, DOI 10.1080/87559120801926351
   Jin X, 2020, RSC ADV, V10, P3329, DOI 10.1039/c9ra06105c
   Kono Y, 1997, BBA-GEN SUBJECTS, V1335, P335, DOI 10.1016/S0304-4165(96)00151-1
   Kumar R, 2020, CURR MOL PHARMACOL, V13, P7, DOI 10.2174/1874467212666190716145210
   Lebel M., 2011, CURR GERONTOL GERIAT, V2011, P1, DOI [DOI 10.1155/2011/859415, 10.1155/2011/859415]
   Li C, 2019, J FOOD QUALITY, V2019, DOI 10.1155/2019/2465341
   Li C, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090381
   Li JJ, 2019, NAT PROD COMMUN, V14, DOI 10.1177/1934578X19896676
   Li X, 2020, CLIN INTERV AGING, V15, P97, DOI 10.2147/CIA.S237601
   Liao YJ, 2016, FOOD SCI BIOTECHNOL, V25, P581, DOI 10.1007/s10068-016-0081-z
   Lin Chun-Song, 2018, Bulletin of Botanical Research, V38, P453, DOI 10.7525/j.issn.1673-5102.2018.03.018
   Lin LZ, 2018, J FUNCT FOODS, V47, P11, DOI 10.1016/j.jff.2018.05.033
   Liu LX, 2009, FOOD CHEM, V112, P35, DOI 10.1016/j.foodchem.2008.05.038
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu HJ, 2020, COMPR REV FOOD SCI F, V19, P3130, DOI 10.1111/1541-4337.12620
   Lu YR, 2000, FOOD CHEM, V68, P81, DOI 10.1016/S0308-8146(99)00167-3
   Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x
   Maczurek A, 2008, ANN NY ACAD SCI, V1126, P147, DOI 10.1196/annals.1433.026
   Mao X, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.03087
   Mao X, 2019, MITOCHONDRIAL DNA B, V4, P3850, DOI 10.1080/23802359.2019.1687030
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Noblanc A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9020151
   Qian Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23112848
   Ren K, 2019, CHIN HERB MED, V11, P119, DOI 10.1016/j.chmed.2019.04.001
   Rocchetti G, 2018, J FUNCT FOODS, V40, P564, DOI 10.1016/j.jff.2017.11.042
   Sánchez-Rodríguez MA, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4128152
   Shang A, 2022, CRIT REV FOOD SCI, V62, P917, DOI 10.1080/10408398.2020.1830363
   Si LH, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182254
   Song CW, 2016, J FOOD SCI, V81, pH1313, DOI 10.1111/1750-3841.13299
   Song JL, 2013, MOL MED REP, V8, P1256, DOI 10.3892/mmr.2013.1635
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Thuong PT, 2009, FOOD CHEM, V113, P139, DOI 10.1016/j.foodchem.2008.07.041
   Tian Y, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.103464
   Wang C, 2020, BRIT J NUTR, V123, P975, DOI 10.1017/S0007114519003088
   Wang Y, 2016, INT DAIRY J, V62, P28, DOI 10.1016/j.idairyj.2016.07.001
   Wang YJ, 2019, MECH AGEING DEV, V184, DOI 10.1016/j.mad.2019.111160
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Woo JY, 2014, ANAEROBE, V27, P22, DOI 10.1016/j.anaerobe.2014.03.003
   Wu Y, 2020, FOOD SCI NUTR, V8, P4512, DOI 10.1002/fsn3.1758
   Wüpper S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092796
   Xia JX, 2019, J PHARMACEUT BIOMED, V175, DOI 10.1016/j.jpba.2019.06.031
   Xie MH, 2019, J AGR FOOD CHEM, V67, P171, DOI 10.1021/acs.jafc.8b05444
   Xu LJ, 2013, FOOD RES INT, V53, P629, DOI 10.1016/j.foodres.2013.01.005
   Yang CL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112655
   Yi RK, 2019, MOLECULES, V24, DOI 10.3390/molecules24061016
   Zeng L, 2020, EXP GERONTOL, V131, DOI 10.1016/j.exger.2019.110823
   Zhai XC, 2017, FOOD FUNCT, V8, P2536, DOI [10.1039/C7FO00490G, 10.1039/c7fo00490g]
   Zhang J, 2020, RSC ADV, V10, P4984, DOI 10.1039/c9ra09641h
   Zhang WH, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13279
   Zhang ZY, 2020, J FUNCT FOODS, V65, DOI 10.1016/j.jff.2019.103729
   Zhao X, 2018, MOLECULES, V23, DOI 10.3390/molecules23010204
   Zhou J, 2018, J PHARMACEUT BIOMED, V155, P15, DOI 10.1016/j.jpba.2018.02.037
   Zhu F, 2009, J AGR FOOD CHEM, V57, P6082, DOI 10.1021/jf901020h
   Zhu K, 2019, FOOD SCI NUTR, V7, P4105, DOI 10.1002/fsn3.1278
NR 71
TC 6
Z9 6
U1 0
U2 55
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD JAN 21
PY 2021
VL 11
AR 600219
DI 10.3389/fphar.2020.600219
PG 16
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA QC0HI
UT WOS:000614514300001
PM 33551806
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Tuell, JR
   Nondorf, MJ
   Abdelhaseib, M
   Setyabrata, D
   Barker, S
   Legako, JF
   Kim, YHB
AF Tuell, Jacob R.
   Nondorf, Mariah J.
   Abdelhaseib, Maha
   Setyabrata, Derico
   Barker, Samantha
   Legako, Jerrad F.
   Kim, Yuan H. Brad
TI Beef quality, biochemical attributes, and descriptive sensory scores of
   <i>gluteus medius, biceps femoris</i>, and <i>tensor fasciae latae</i>
   muscles subjected to combined tumbling and postmortem aging
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article; Early Access
DE beef sirloin muscles; fresh beef tumbling; meat quality attributes
ID BRATZLER SHEAR FORCE; PANEL RATINGS; PALATABILITY; TENDERNESS; TRAITS;
   COLOR; TENDERIZATION; STEAKS; CHOICE; FLAVOR
AB This study assessed how fresh beef tumbling without brine inclusion combined with aging would affect quality, biochemical attributes, and descriptive sensory scores of sirloin muscles. Paired gluteus medius (GM), biceps femoris (BF), and tensor fasciae latae (TFL) muscles from beef carcasses (n = 16) at 5 days postmortem were assigned to 0 or 120 min of tumbling, after which sections were aged 0 or 10 days. Tumbled GM (p < 0.001) and TFL (p < 0.01) muscles had increased objective tenderness compared to respective controls. Greater cook and initial purge losses were induced in all muscles with tumbling (p < 0.05), while thawing loss and purge loss with aging were similar (p > 0.05). Fragmentation of myofibrils was increased with tumbling and aging main effects (p < 0.001), although degradation of troponin T and desmin were primarily affected by aging only. In general, neither tumbling nor aging affected properties of collagen. Trained panelists assessed muscles aged 10 days for descriptive sensory scores including tenderness (myofibrillar, connective tissue, and overall), flavor (beef flavor identity, bloody/serumy, fat-like, liver-like, oxidized, umami, metallic, and sour), and juiciness (overall). Tumbled GM had greater myofibrillar tenderness than the control group (p < 0.05). Most sensory scores were unaffected by tumbling; however, tumbling increased oxidized and liver-like flavors of GM and TFL, respectively, as well as decreased overall juiciness of BF (p < 0.05). These findings indicate tumbling combined with postmortem aging can improve tenderness of certain sirloin muscles like GM, although some impairments to flavor and juiciness could also occur. Practical Application The findings of this study are applicable to the beef industry to develop postharvest strategies to ensure sufficient tenderization of fresh beef sirloin muscles is achieved. However, the effectiveness of this process would differ between individual cuts, and minimizing possible impairments to flavor and juiciness would be critical.
C1 [Tuell, Jacob R.; Nondorf, Mariah J.; Abdelhaseib, Maha; Setyabrata, Derico; Kim, Yuan H. Brad] Purdue Univ, Dept Anim Sci, Meat Sci & Muscle Biol Lab, W Lafayette, IN 47907 USA.
   [Barker, Samantha; Legako, Jerrad F.] Texas Tech Univ, Dept Anim & Food Sci, Lubbock, TX 79409 USA.
C3 Purdue University System; Purdue University West Lafayette Campus;
   Purdue University; Texas Tech University System; Texas Tech University
RP Kim, YHB (corresponding author), CRTN Room 2056,270 S Russell St, W Lafayette, IN 47907 USA.
EM bradkim@purdue.edu
RI Setyabrata, Derico/ISV-2248-2023; Tuell, Jacob/ITT-9571-2023; Legako,
   Jerrad/J-6191-2015
OI Setyabrata, Derico/0000-0002-7284-0346; Legako,
   Jerrad/0000-0001-5384-4248; Tuell, Jacob/0000-0002-2554-0551
FU Beef Checkoff
FX This work was supported by The Beef Checkoff.
CR Adhikari K, 2011, J SENS STUD, V26, P413, DOI 10.1111/j.1745-459X.2011.00356.x
   AMSA, 2016, Research guidelines for cookery, sensory evaluation, and instrumental tenderness measurements of meat, V2nd
   Anderson MJ, 2012, MEAT SCI, V91, P247, DOI 10.1016/j.meatsci.2012.01.022
   [Anonymous], 2012, MEAT COLOR MEASUREME, P1
   Ardeshiri A, 2019, MEAT SCI, V157, DOI 10.1016/j.meatsci.2019.06.004
   Asioli D, 2017, FOOD RES INT, V99, P58, DOI 10.1016/j.foodres.2017.07.022
   Beyer E. S., 2021, Meat and Muscle Biology, V5, DOI 10.22175/mmb.12424
   Bhat ZF, 2018, COMPR REV FOOD SCI F, V17, P841, DOI 10.1111/1541-4337.12356
   Cheng JH, 2003, MEAT SCI, V65, P1353, DOI 10.1016/S0309-1740(03)00057-3
   Chun CKY, 2020, MEAT SCI, V170, DOI 10.1016/j.meatsci.2020.108247
   Colle MJ, 2015, MEAT SCI, V110, P32, DOI 10.1016/j.meatsci.2015.06.013
   CROSS HR, 1973, J FOOD SCI, V38, P998, DOI 10.1111/j.1365-2621.1973.tb02133.x
   CULLER RD, 1978, J FOOD SCI, V43, P1177, DOI 10.1111/j.1365-2621.1978.tb15263.x
   Daudin JD, 2016, J FOOD ENG, V170, P83, DOI 10.1016/j.jfoodeng.2015.09.020
   Garmyn A, 2020, FOODS, V9, DOI 10.3390/foods9020177
   Guelker MR, 2013, J ANIM SCI, V91, P1005, DOI 10.2527/jas.2012-5785
   Hosch J.J., 2013, NEBRASKA BEEF CATTLE, V748, P4
   Hughes JM, 2014, MEAT SCI, V98, P520, DOI 10.1016/j.meatsci.2014.05.022
   Hunt MR, 2014, MEAT SCI, V98, P1, DOI 10.1016/j.meatsci.2014.04.004
   Jeremiah LE, 2003, MEAT SCI, V65, P1013, DOI 10.1016/S0309-1740(02)00309-1
   Jeremiah LE, 2003, MEAT SCI, V65, P985, DOI 10.1016/S0309-1740(02)00308-X
   Jeremiah LE, 1999, FOOD RES INT, V32, P585, DOI [10.1016/S0963-9969(99)00134-9, 10.1016/S0963-9969(99)00077-0]
   Kim YHB, 2018, MEAT SCI, V144, P74, DOI 10.1016/j.meatsci.2018.04.031
   King D. A., 2021, Meat and Muscle Biology, V5, DOI 10.22175/mmb.10939
   Ma DY, 2017, J AGR FOOD CHEM, V65, P6708, DOI 10.1021/acs.jafc.7b02175
   Martinez H. A., 2017, Meat and Muscle Biology, V1, P138, DOI 10.22175/mmb2017.05.0028
   Miller R. K., 2019, Meat and Muscle Biology, V3, DOI [10.22175/mmb2018.07.0020, DOI 10.22175/MMB2018.07.0020]
   Molina ME, 2005, MEAT SCI, V71, P52, DOI 10.1016/j.meatsci.2005.04.004
   Morrow S. J., 2019, Meat and Muscle Biology, V3, P457, DOI [10.22175/mmb2019.07.0030, DOI 10.22175/MMB2019.07.0030]
   N'Gatta KCA, 2021, FOODS, V10, DOI 10.3390/foods10112802
   Nondorf MJ, 2022, INT J FOOD SCI TECH, V57, P3021, DOI 10.1111/ijfs.15627
   O'Quinn TG, 2018, TRANSL ANIM SCI, V2, P26, DOI 10.1093/tas/txx008
   Rhee MS, 2004, J ANIM SCI, V82, P534
   Setyabrata, 2019, MEAT MUSCLE BIOL, V3, P488, DOI [10.22175/mmb2019.08.0034, DOI 10.22175/MMB2019.08.0034]
   Stolowski GD, 2006, MEAT SCI, V73, P475, DOI 10.1016/j.meatsci.2006.01.006
   Sullivan GA, 2011, J FOOD QUALITY, V34, P195, DOI 10.1111/j.1745-4557.2011.00386.x
   Tuell J.R., 2021, MEAT MUSCLE BIOL, DOI [10.22175/mmb.13044, DOI 10.22175/MMB.13044]
   Tuell JR, 2022, J ANIM SCI, V100, DOI 10.1093/jas/skac062
   USDA, 2021, NAT RET REP BEEF ADV
   USDA, 2014, I MEAT PURCH SPEC FR, P71
   USDA, 2017, United States standards for grades of carcass beef
   Warner R., 2021, Meat and Muscle Biology, V4, DOI 10.22175/mmb.10489
   Warner R.D., 2017, LAWRIES MEAT SCI, VEighth, P419, DOI DOI 10.1016/B978-0-08-100694-8.00014-5
   Wyrwisz J, 2016, MEAT SCI, V122, P48, DOI 10.1016/j.meatsci.2016.07.018
   Yang L, 2021, FOOD CONTROL, V120, DOI 10.1016/j.foodcont.2020.107505
   Yu QQ, 2021, FOODS, V10, DOI 10.3390/foods10030668
NR 46
TC 0
Z9 0
U1 5
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD 2022 SEP
PY 2022
VL 87
IS 9
BP 3781
EP 3796
DI 10.1111/1750-3841.16298
EA AUG 2022
PG 16
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 4P0RY
UT WOS:000842791400001
PM 35986923
DA 2024-02-19
ER

PT J
AU Fujii, N
   Uta, S
   Kobayashi, M
   Sato, T
   Okita, N
   Higami, Y
AF Fujii, Namiki
   Uta, Seira
   Kobayashi, Masaki
   Sato, Tsugumichi
   Okita, Naoyuki
   Higami, Yoshikazu
TI Impact of aging and caloric restriction on fibroblast growth factor 21
   signaling in rat white adipose tissue
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Caloric restriction; White adipose tissue; Fibroblast growth factor 21;
   beta-Klotho; Glucose transporter 1
ID BETA-KLOTHO; INSULIN-RESISTANCE; METABOLIC-ACTIVITY; FGF21; EXPRESSION;
   PGC-1-ALPHA; RECEPTOR; OBESITY; PROTEIN-1; FGF-21
AB Caloric restriction (CR) suppresses age-related pathophysiology and extends lifespan. We recently reported that metabolic remodeling of white adipose tissue (WAT) plays an important role in the beneficial actions of CR; however, the detailed molecular mechanisms of this remodeling remain to be established. In the present study, we aimed to identify CR-induced alterations in the expression of fibroblast growth factor 21 (FGF21), a regulator of lipid and glucose metabolism, and of its downstream signaling mediators in liver and WAT, across the lifespan of rats. We evaluated groups of rats that had been either fed ad libitum or calorie restricted from 3 months of age and were euthanized at 3.5, 9, or 24 months of age, under fed and fasted conditions. The expression of FGF21 mRNA and/or protein increased with age in liver and WAT. Interestingly, in the WAT of 9-month-old fed rats, CR further upregulated FGF21 expression and eliminated the aging-associated reductions in the expression of FGFR1 and beta-klotho (KLB; FGF21 receptor complex). It also enhanced the expression of FGF21 targets, including glucose transporter 1 and peroxisome proliferator-activated receptor (PPAR)gamma coactivator-1 alpha. The analysis of transcriptional regulators of Fgf21 suggested that aging and CR might upregulate Fgf21 expression via different mechanisms. In adipocytes in vitro, constitutive FGF21 overexpression upregulated the FGF21 receptor complex and FGF21 targets at the mRNA or protein level. Thus, both aging and CR induced FGF21 expression in rat WAT; however, only CR activated FGF21 signaling. Our results suggest that FGF21 signaling contributes to the CR-induced metabolic remodeling of WAT, likely activating glucose uptake and mitochondrial biogenesis.
C1 [Fujii, Namiki; Uta, Seira; Kobayashi, Masaki; Higami, Yoshikazu] Tokyo Univ Sci, Fac Pharmaceut Sci, Lab Mol Pathol & Metab Dis, 2641 Yamazaki, Noda, Chiba 2788510, Japan.
   [Kobayashi, Masaki; Sato, Tsugumichi; Okita, Naoyuki; Higami, Yoshikazu] Tokyo Univ Sci, Res Inst Sci & Technol, Translat Res Ctr, 2641 Yamazaki, Noda, Chiba 2788510, Japan.
   [Sato, Tsugumichi] Tokyo Univ Sci, Fac Pharmaceut Sci, Lab Drug Informat, 2641 Yamazaki, Noda, Chiba 2788510, Japan.
   [Okita, Naoyuki] Sanyo Onoda City Univ, Fac Pharmaceut Sci, Div Pathol Biochem, 1-1-1 Daigakudori, Yamaguchi 7560884, Japan.
C3 Tokyo University of Science; Tokyo University of Science; Tokyo
   University of Science
RP Higami, Y (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Lab Mol Pathol & Metab Dis, 2641 Yamazaki, Noda, Chiba 2788510, Japan.
EM 3b16710@ed.tus.ac.jp; 3B18508@ed.tus.ac.jp; kobayashim@rs.tus.ac.jp;
   tsugusato@rs.tus.ac.jp; nokita7@rs.socu.ac.jp; higami@rs.noda.tus.ac.jp
RI Okita, Naoyuki/B-9600-2012
OI Okita, Naoyuki/0000-0002-1694-2129; Kobayashi,
   Masaki/0000-0002-0985-0322; Higami, Yoshikazu/0000-0003-1381-0777
FU Japan Society for the Promotion of Science [17H02179]; MEXT-Supported
   Program for the Strategic Research Foundation at Private Universities;
   Grants-in-Aid for Scientific Research [17H02179] Funding Source: KAKEN
FX This work was supported by Grants-in-Aid for Scientific Research (B)
   (No. 17H02179) from the Japan Society for the Promotion of Science, and
   the MEXT-Supported Program for the Strategic Research Foundation at
   Private Universities, 2014-2018.
CR Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977
   Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x
   Gómez-Sámano MA, 2017, REDOX BIOL, V11, P335, DOI 10.1016/j.redox.2016.12.024
   [Anonymous], R LANG ENV STAT COMP
   Argmann C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000752
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107
   Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104
   Chujo Y, 2013, AGE, V35, P1143, DOI 10.1007/s11357-012-9439-1
   Chung KW, 2013, EXP GERONTOL, V48, P1049, DOI 10.1016/j.exger.2012.11.007
   Díaz-Delfín J, 2012, ENDOCRINOLOGY, V153, P4238, DOI 10.1210/en.2012-1193
   Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002
   Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062
   Fabbiano S, 2016, CELL METAB, V24, P434, DOI 10.1016/j.cmet.2016.07.023
   Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001
   Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111
   Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193
   Fujii N, 2017, AGING CELL, V16, P508, DOI 10.1111/acel.12576
   Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005
   Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591
   Gesing A, 2014, EXP GERONTOL, V58, P219, DOI 10.1016/j.exger.2014.08.010
   Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113
   Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Kim AM, 2017, DIABETES OBES METAB, V19, P1762, DOI 10.1111/dom.13023
   Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200
   Li K, 2012, MOL CELL ENDOCRINOL, V348, P21, DOI 10.1016/j.mce.2011.07.026
   Ma XR, 2014, P NATL ACAD SCI USA, V111, P14289, DOI 10.1073/pnas.1407640111
   Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595
   Mikami K, 2012, BIOCHEM BIOPH RES CO, V427, P758, DOI 10.1016/j.bbrc.2012.09.134
   Min X., 2018, J BIOL CHEM, V21, DOI [10.1074/jbc.RA118.004343.jbc.RA118.004343, DOI 10.1074/JBC.RA118.004343.JBC.RA118.004343]
   Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826
   Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1
   Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104
   Oishi K, 2011, BIOCHEM BIOPH RES CO, V412, P396, DOI 10.1016/j.bbrc.2011.07.125
   Okita N, 2015, EXP GERONTOL, V63, P59, DOI 10.1016/j.exger.2015.01.043
   Okita N, 2012, MECH AGEING DEV, V133, P255, DOI 10.1016/j.mad.2012.02.003
   Pagliassotti MJ, 2016, METABOLISM, V65, P1238, DOI 10.1016/j.metabol.2016.05.002
   Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6
   Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106
   Qiao LP, 2011, AM J PHYSIOL-ENDOC M, V300, pE809, DOI 10.1152/ajpendo.00004.2011
   Sánchez J, 2009, ENDOCRINOLOGY, V150, P5341, DOI 10.1210/en.2009-0466
   Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019
   Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182
   Stelmanska E, 2004, ACTA BIOCHIM POL, V51, P805
   Sun B, 2012, CYTOKINE, V59, P131, DOI 10.1016/j.cyto.2012.03.030
   Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142
   Vandanmagsar B, 2016, CELL REP, V15, P1686, DOI 10.1016/j.celrep.2016.04.057
   Véniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164
   Wan XS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807874
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476
   Zhang Y, 2011, MOL CELL ENDOCRINOL, V342, P41, DOI 10.1016/j.mce.2011.05.003
   Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065
NR 54
TC 19
Z9 22
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR
PY 2019
VL 118
BP 55
EP 64
DI 10.1016/j.exger.2019.01.001
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA HL2DK
UT WOS:000458513200009
PM 30620889
OA hybrid
DA 2024-02-19
ER

PT J
AU Chimienti, G
   Picca, A
   Fracasso, F
   Russo, F
   Orlando, A
   Riezzo, G
   Leeuwenburgh, C
   Pesce, V
   Lezza, AMS
AF Chimienti, Guglielmina
   Picca, Anna
   Fracasso, Flavio
   Russo, Francesco
   Orlando, Antonella
   Riezzo, Giuseppe
   Leeuwenburgh, Christiaan
   Pesce, Vito
   Lezza, Angela Maria Serena
TI The Age-Sensitive Efficacy of Calorie Restriction on Mitochondrial
   Biogenesis and mtDNA Damage in Rat Liver
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE rat liver; aging; calorie restriction; mitochondrial biogenesis; mtDNA
   damage; age-sensitive efficacy of CR
ID DNA COPY NUMBER; LON PROTEASE; OXIDATIVE STRESS; SKELETAL-MUSCLE; TFAM;
   PHOSPHORYLATION; ACCUMULATION; DEGRADATION; EXPRESSION; HALLMARKS
AB Calorie restriction (CR) is the most efficacious treatment to delay the onset of age-related changes such as mitochondrial dysfunction. However, the sensitivity of mitochondrial markers to CR and the age-related boundaries of CR efficacy are not fully elucidated. We used liver samples from ad libitum-fed (AL) rats divided in: 18-month-old (AL-18), 28-month-old (AL-28), and 32-month-old (AL-32) groups, and from CR-treated (CR) 28-month-old (CR-28) and 32-month-old (CR-32) counterparts to assay the effect of CR on several mitochondrial markers. The age-related decreases in citrate synthase activity, in TFAM, MFN2, and DRP1 protein amounts and in the mtDNA content in the AL-28 group were prevented in CR-28 counterparts. Accordingly, CR reduced oxidative mtDNA damage assessed through the incidence of oxidized purines at specific mtDNA regions in CR-28 animals. These findings support the anti-aging effect of CR up to 28 months. Conversely, the protein amounts of LonP1, Cyt c, OGG1, and APE1 and the 4.8 Kb mtDNA deletion content were not affected in CR-28 rats. The absence of significant differences between the AL-32 values and the CR-32 counterparts suggests an age-related boundary of CR efficacy at this age. However, this only partially curtails the CR benefits in counteracting the generalized aging decline and the related mitochondrial involvement.
C1 [Chimienti, Guglielmina; Fracasso, Flavio; Pesce, Vito; Lezza, Angela Maria Serena] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.
   [Picca, Anna] Fdn Policlin Univ Agostino Gemelli IRCCS, Lgo F Vito 8, I-00168 Rome, Italy.
   [Picca, Anna] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, S-11330 Stockholm, Sweden.
   [Picca, Anna] Stockholm Univ, S-11330 Stockholm, Sweden.
   [Russo, Francesco; Orlando, Antonella; Riezzo, Giuseppe] Res Hosp, Natl Inst Gastroenterol S de Bellis, Lab Nutr Pathophysiol, I-70013 Castellana Grotte, Italy.
   [Leeuwenburgh, Christiaan] Univ Florida, Inst Aging, Div Biol Aging, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA.
C3 Universita degli Studi di Bari Aldo Moro; Catholic University of the
   Sacred Heart; IRCCS Policlinico Gemelli; Karolinska Institutet;
   Stockholm University; State University System of Florida; University of
   Florida
RP Lezza, AMS (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.
EM guglielminaalessandra.chimienti@uniba.it; anna.picca1@gmail.com;
   flavio.fracasso@uniba.it; francesco.russo@irccsdebellis.it;
   antonella.orlando@irccsdebellis.it; giuseppe.riezzo@irccsdebellis.it;
   cleeuwen@ufl.edu; vito.pesce@uniba.it; angelamariaserena.lezza@uniba.it
RI Riezzo, Giuseppe/AAC-1753-2022; Picca, Anna/K-2305-2018; Chimienti,
   Guglielmina/H-3122-2016
OI Picca, Anna/0000-0001-7032-3487; PESCE, VITO/0000-0002-9148-3129;
   Orlando, Antonella/0000-0001-8255-4776; Chimienti,
   Guglielmina/0000-0002-4403-2317; Lezza, Angela Maria
   Serena/0000-0002-2006-1076
FU MIUR-FFABR; Istituto Banco di Napoli-Fondazione; UniBa Fondi d'Ateneo
FX This work was partly supported by MIUR-FFABR 2018 to V.P., MIUR-FFABR
   2018 to A.M.S.L., Istituto Banco di Napoli-Fondazione 2015 to A.M.S.L.,
   UniBa Fondi d'Ateneo 2014 to A.M.S.L., UniBa Fondi d'Ateneo 2015/2016 to
   A.M.S.L.
CR Akbari M, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100940
   López-Domínguez JA, 2015, J GERONTOL A-BIOL, V70, P399, DOI 10.1093/gerona/glu045
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031
   Chimienti G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133302
   Chimienti G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102601
   Chimienti G, 2018, FREE RADICAL BIO MED, V124, P447, DOI 10.1016/j.freeradbiomed.2018.06.041
   de Souza-Pinto NC, 2001, FREE RADICAL BIO MED, V30, P916, DOI 10.1016/S0891-5849(01)00483-X
   Duszka K, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071708
   Ferrucci L, 2020, AGING CELL, V19, DOI 10.1111/acel.13080
   Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003
   Folgueras AR, 2018, CIRC RES, V123, P905, DOI 10.1161/CIRCRESAHA.118.312204
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Gaziev AI, 2014, BIOGERONTOLOGY, V15, P417, DOI 10.1007/s10522-014-9515-2
   Green DR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006080
   Guarasci F, 2018, MECH AGEING DEV, V174, P47, DOI 10.1016/j.mad.2018.02.001
   Gutiérrez-Casado E, 2019, J GERONTOL A-BIOL, V74, P760, DOI 10.1093/gerona/gly161
   Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024
   Ingram DK, 2017, AGEING RES REV, V39, P15, DOI 10.1016/j.arr.2017.05.008
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kondadi AK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174311
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338
   López-Lluch G, 2016, J PHYSIOL-LONDON, V594, P2043, DOI 10.1113/JP270543
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Martin-Montalvo A, 2013, ANTIOXID REDOX SIGN, V19, P310, DOI 10.1089/ars.2012.4866
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008
   Ngo JK, 2013, REDOX BIOL, V1, P258, DOI 10.1016/j.redox.2013.01.015
   Orlando A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081862
   Pastukh VM, 2016, FREE RADICAL BIO MED, V96, P78, DOI 10.1016/j.freeradbiomed.2016.04.011
   Pesce V, 2005, J GERONTOL A-BIOL, V60, P715, DOI 10.1093/gerona/60.6.715
   Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014
   Picca A, 2017, CLIN INTERV AGING, V12, P1887, DOI 10.2147/CIA.S126458
   Picca A, 2016, EXP GERONTOL, V85, P33, DOI 10.1016/j.exger.2016.09.010
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Picca A, 2014, BBA-GEN SUBJECTS, V1840, P2184, DOI 10.1016/j.bbagen.2014.03.004
   Picca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074644
   Picca A, 2013, AGE, V35, P1607, DOI 10.1007/s11357-012-9465-z
   Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005
   Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002
   Shinmura K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/528935
   Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935
   Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001
   Wang HY, 2017, J GERONTOL A-BIOL, V72, P1638, DOI 10.1093/gerona/glx099
   Yowe DL, 1998, GENE, V209, P23, DOI 10.1016/S0378-1119(97)00628-8
NR 53
TC 14
Z9 14
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB
PY 2021
VL 22
IS 4
AR 1665
DI 10.3390/ijms22041665
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Biochemistry & Molecular Biology; Chemistry
GA QP4FZ
UT WOS:000623793400001
PM 33562258
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kim, DH
   Park, MH
   Chung, KW
   Kim, MJ
   Park, D
   Lee, B
   Lee, EK
   Choi, YJ
   Kim, ND
   Yu, BP
   Chung, HY
AF Kim, Dae Hyun
   Park, Min Hi
   Chung, Ki Wung
   Kim, Min Jo
   Park, Daeui
   Lee, Bonggi
   Lee, Eun Kyeong
   Choi, Yeon Ja
   Kim, Nam Deuk
   Yu, Byung Pal
   Chung, Hae Young
TI Suppression of FoxO6 by lipopolysaccharide in aged rat liver
SO ONCOTARGET
LA English
DT Article
DE FoxO6; Pak1 pathway; aging; NF-kappa B; Akt; Gerotarget
ID NF-KAPPA-B; P21-ACTIVATED KINASE PAK1; CELL-SURVIVAL; LIFE-SPAN;
   ACTIVATION; PHOSPHORYLATION; ORGANIZATION; MODULATION; RECEPTOR; INSULIN
AB The beneficial role of FoxO during aging has been proposed for its promotion of resistance to oxidative stress and inhibition of pro-inflammatory mediators. On the other hand, NF-kappa B is a pro-inflammatory transcription factor which is a key mediator of inflammatory cytokine generation. However, the correlation between FoxO6 and NF-kappa B during aging has not fully been explored.
   The main purpose of the present study was to elucidate mechanisms underlying the protective role of FoxO6 in the maintenance of cellular homeostasis under potent pro-inflammatory conditions induced by LPS. Initial experimentation revealed that reduced FoxO6 activity during aging was caused by its phosphorylation, which suppressed its transcriptional activity in aged livers. Transfection with FoxO6-wt virus and FoxO6-siRNA in HepG2 cells revealed that FoxO6 phosphorylation by LPS leads to NF-kappa B activation via Akt and Pak1 pathways. Furthermore, Pak1 activity was increased in a phosphatidylinositol 3-kinase independent manner, and LPS-induced FoxO6 phosphorylation and FoxO6 inactivation were Pak1-dependent in nuclear fractions of cells. Further revealed Pak1 phosphorylation by LPS permitted interaction between FoxO6 and Akt.
   Current study suggests FoxO6 phosphorylation facilitates the nuclear translocation of NF-kappa B via Akt and Pak1 pathways induced by LPS in aged rats.
C1 [Kim, Dae Hyun; Park, Min Hi; Chung, Ki Wung; Kim, Min Jo; Lee, Bonggi; Lee, Eun Kyeong; Choi, Yeon Ja; Kim, Nam Deuk; Chung, Hae Young] Pusan Natl Univ, Mol Inflammat Res Ctr Aging Intervent MRCA, Coll Pharm, Busan, South Korea.
   [Park, Daeui] Korea Inst Toxicol, Silico Toxicol Res Ctr, Daejeon, South Korea.
   [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.
C3 Pusan National University; Korea Institute of Toxicology; University of
   Texas System; University of Texas Health Science Center at San Antonio
RP Chung, HY (corresponding author), Pusan Natl Univ, Mol Inflammat Res Ctr Aging Intervent MRCA, Coll Pharm, Busan, South Korea.
EM hyjung@pusan.ac.kr
RI Park, Min Hi/AAL-9880-2020; Park, Daeui/HOH-1179-2023
OI Park, Daeui/0000-0002-9452-5849
FU National Research Foundation (NRF) grant - Korean government (MSIP)
   [2009-0083538]; Basic Science Research Program through the National
   Research Foundation of Korea (NRF) - Ministry of Education
   [NRF-2015R1D1A4A01019409]
FX This work was supported by a National Research Foundation (NRF) grant
   funded by the Korean government (MSIP) (Grant no. 2009-0083538). In
   addition, this research was supported by the Basic Science Research
   Program through the National Research Foundation of Korea (NRF) funded
   by the Ministry of Education (Grant no. NRF-2015R1D1A4A01019409). We
   also take this opportunity to thank the Aging Tissue Bank (Busan, Korea)
   for supplying research materials.
CR Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0
   Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238
   Affò S, 2014, GUT, V63, P1782, DOI 10.1136/gutjnl-2013-306098
   Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Bektas A, 2014, AGING-US, V6, P957, DOI 10.18632/aging.100705
   Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292
   Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629
   Carré JE, 2008, BBA-BIOENERGETICS, V1777, P763, DOI 10.1016/j.bbabio.2008.04.024
   Chen X, 2011, J PINEAL RES, V51, P416, DOI 10.1111/j.1600-079X.2011.00905.x
   Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794
   Chung SY, 2013, BIOSCI REP IN PRESS, V33
   Dadke D, 2003, CANCER RES, V63, P8837
   de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510
   Foo NP, 2011, TOXICOLOGY, V282, P39, DOI 10.1016/j.tox.2011.01.009
   Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199
   Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003
   Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200
   Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536
   Hsu HY, 2000, J BIOL CHEM, V275, P41035, DOI 10.1074/jbc.M003464200
   Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007
   Karger S, 2009, ENDOCR-RELAT CANCER, V16, P189, DOI 10.1677/ERC-07-0283
   Kennedy LM, 2013, CELL REP, V4, P996, DOI 10.1016/j.celrep.2013.07.045
   Kenyon C, 2010, ANN NY ACAD SCI, V1204, P156, DOI 10.1111/j.1749-6632.2010.05640.x
   KERR LD, 1995, METHOD ENZYMOL, V254, P619
   Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6
   Kim DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059316
   Kim DH, 2011, DIABETES, V60, P2763, DOI 10.2337/db11-0548
   Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7
   Kim HS, 2005, FASEB J, V19, P1042, DOI 10.1096/fj.04-2841fje
   Kimura K, 2014, NUTR RES, V34, P368, DOI 10.1016/j.nutres.2014.02.003
   King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200
   Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319
   MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0
   Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA
   Mazumdar A, 2003, FEBS LETT, V535, P6, DOI 10.1016/S0014-5793(02)03846-2
   Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848
   Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007
   Osorio FG, 2012, AGING-US, V4, P726, DOI 10.18632/aging.100502
   Ozes ON, 1999, NATURE, V401, P82
   Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200
   Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002
   Schürmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000
   Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5
   Sizemore N, 1999, MOL CELL BIOL, V19, P4798
   Steckelings UM, 2011, CURR OPIN PHARMACOL, V11, P187, DOI 10.1016/j.coph.2010.11.002
   Sung B, 2004, J GERONTOL A-BIOL, V59, P997
   Sylow L, 2013, DIABETES, V62, P1865, DOI 10.2337/db12-1148
   Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106
   Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1
   Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a
   Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200
   van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167
   Wang QH, 1999, MOL CELL BIOL, V19, P4008
   Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565
   Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153
NR 62
TC 11
Z9 13
U1 0
U2 7
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD OCT 27
PY 2015
VL 6
IS 33
BP 34143
EP 34157
DI 10.18632/oncotarget.6219
PG 15
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA CY0PE
UT WOS:000366107200022
PM 26506521
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU He, SD
   Yu, M
   Sun, HJ
   Zhang, ZY
   Zhu, YC
   Zhao, JL
   Tang, MM
   Cao, YP
AF He, Shudong
   Yu, Min
   Sun, Hanju
   Zhang, Zuoyong
   Zhu, Yuchen
   Zhao, Jinlong
   Tang, Mingming
   Cao, Yanping
TI Potential effects of dietary Maillard reaction products derived from 1
   to 3 kDa soybean peptides on the aging ICR mice
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Maillard reaction products; Soybean peptides; Aging mice; Food intake;
   Antioxidant activity; Bacterial abundance
ID AMELIORATES COGNITION DEFICITS; OXIDATIVE STRESS; GUT MICROBIOTA; BREAD
   CRUST; IN-VITRO; ANTIOXIDANT; DAMAGE; BRAIN; MELANOIDINS; METABOLISM
AB Effects of Maillard reaction products derived from 1 to 3 kDa soybean peptides (MRPF3) on aging ICR mice were investigated. Seven animal groups were established for 5 weeks, including one normal group and six D-galactose (1000 mg kg(-1)/day) treated groups. Aging control was D-galactose + saline solution, and positive controls were D-galactose + ascorbic acid (Vc) (400 mg kg(-1)/day) and oligofructose (400 mg kg(-1)/day), respectively, while the test groups are D-galactose + high (800 mg kg(-1)/day), medium (400 mg kg(-1)/day) and low (200 mg kg(-1)/ day) doses of MRPF3. Compared with the aging controls, food intake, body weights and organ indexes returned to normal after feeding with MRPF3, and the color of feces as well as the fluorescence intensity of urine increased. The content of malondialdehyde (MDA) in the liver significantly decreased with the intake of MRPF3, and the activities of SOD and GSH-Px and the total antioxidant capacity of serum significantly increased. The abundance ratio of Bacteroidetes and Firmicutes significantly decreased in MRPF3 groups, and the abundance of Lactobacillus significantly increased, while potentially pathogenic bacteria such as Porphyromonadaceae significantly decreased. Our results showed that MRPF3 might offer a potent retardation potential for aging.
C1 [He, Shudong; Zhu, Yuchen; Cao, Yanping] BTBU, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China.
   [He, Shudong; Yu, Min; Sun, Hanju; Zhang, Zuoyong; Zhao, Jinlong; Tang, Mingming] Hefei Univ Technol, Sch Food & Biol Engn, Hefei 230009, Anhui;, Peoples R China.
   [He, Shudong; Sun, Hanju] Anhui Qiangwang Seasoning Food Co Ltd, Anhui Prov Key Lab Funct Compound Seasoning, Jieshou 236500, Anhui, Peoples R China.
   [Zhu, Yuchen; Cao, Yanping] BTBU, Beijing Key Lab Flavor Chem, Beijing Higher Inst Engn Res Ctr Food Addit & Ing, Beijing 100048, Peoples R China.
   [Zhu, Yuchen; Cao, Yanping] BTBU, Beijing Lab Food Qual & Safety, Beijing 100048, Peoples R China.
C3 Beijing Technology & Business University; Hefei University of
   Technology; Beijing Technology & Business University; Beijing Technology
   & Business University
RP Sun, HJ (corresponding author), Hefei Univ Technol, Hefei 230009, Anhui, Peoples R China.; Cao, YP (corresponding author), BTBU, Beijing 100048, Peoples R China.
EM sunhanjv@163.com; caoyp@th.btbu.edu.cn
RI He, Shudong/ABF-4582-2021; cao, yanping/E-3381-2010; He,
   Shudong/H-4396-2014
OI He, Shudong/0000-0002-1155-4928; Zhao, Jinlong/0000-0002-5467-4866
FU National Natural Science Foundation of China [31701524, 31701728]; Anhui
   Provincial Natural Science Foundation [1708085MC70]; Fundamental
   Research Funds for the Central Universities [JZ2018HGTB0245]; Anhui
   Provincial Science and Technology Major Project [16030701084]; China
   Postdoctoral Science Foundation [2017M611208, 2018T11021]; Open
   Foundation of Beijing Advanced Innovation Center for Food Nutrition and
   Human Health, Beijing Technology and Business University (BTBU)
   [20181017]
FX The authors are grateful for the financial support from the National
   Natural Science Foundation of China (No. 31701524, No. 31701728), the
   Anhui Provincial Natural Science Foundation (No. 1708085MC70), the
   Fundamental Research Funds for the Central Universities (No.
   JZ2018HGTB0245), the Anhui Provincial Science and Technology Major
   Project (No. 16030701084), the Financial Grant from China Postdoctoral
   Science Foundation (No. 2017M611208, No. 2018T11021), and the Open
   Foundation of Beijing Advanced Innovation Center for Food Nutrition and
   Human Health, Beijing Technology and Business University (BTBU) (No.
   20181017). The authors would like to thank Mr. Yongsheng Zhu, Mr. Lijun
   Tu, Mr. Xianbao Sun and Mrs. Qian He, School of Food and Biological
   Engineering, Hefei University of Technology, for helping in animal
   feeding and treatments. The authors thank LC Sciences, LLC, Hangzhou,
   China, for the technical assistance in gut microbial analysis.
CR Ames JM, 1999, BRIT J NUTR, V82, P489, DOI 10.1017/S0007114599001749
   Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x
   Aydin AF, 2016, METAB BRAIN DIS, V31, P337, DOI 10.1007/s11011-015-9755-0
   Borrelli RC, 2005, MOL NUTR FOOD RES, V49, P673, DOI 10.1002/mnfr.200500011
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   Delgado-Andrade C, 2013, FOOD FUNCT, V4, P1016, DOI 10.1039/c2fo30288h
   Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661
   Domínguez R, 2014, MEAT SCI, V97, P223, DOI 10.1016/j.meatsci.2014.01.023
   Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6
   Ferrández MD, 1999, EXP GERONTOL, V34, P675, DOI 10.1016/S0531-5565(99)00009-1
   Forman HJ, 2016, FREE RADICAL BIO MED, V97, P398, DOI 10.1016/j.freeradbiomed.2016.07.003
   Förster A, 2005, ANN NY ACAD SCI, V1043, P474, DOI 10.1196/annals.1333.054
   Giannelli V, 2014, WORLD J GASTROENTERO, V20, P16795, DOI 10.3748/wjg.v20.i45.16795
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Jaeger H, 2010, PATHOL BIOL, V58, P207, DOI 10.1016/j.patbio.2009.09.016
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Jiménez-Escrig A, 2013, J APPL PHYCOL, V25, P503, DOI 10.1007/s10811-012-9884-3
   Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5
   Kumar A, 2011, J ASIAN NAT PROD RES, V13, P42, DOI 10.1080/10286020.2010.544253
   Lan Z, 2012, J ETHNOPHARMACOL, V141, P386, DOI 10.1016/j.jep.2012.02.050
   Liu HY, 2018, FOOD AGR IMMUNOL, V29, P316, DOI 10.1080/09540105.2017.1376037
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Lykkesfeldt J, 1998, FASEB J, V12, P1183, DOI 10.1096/fasebj.12.12.1183
   Monente C, 2015, J FUNCT FOODS, V12, P365, DOI 10.1016/j.jff.2014.12.006
   Na S., 2014, FOOD CHEM, V136, P144
   Naughton V, 2011, APPL PHYSIOL NUTR ME, V36, P161, DOI 10.1139/H10-088
   Nguyen CV, 2006, MOL NUTR FOOD RES, V50, P1140, DOI 10.1002/mnfr.200600144
   Ogasawara M, 2006, FOOD CHEM, V99, P600, DOI 10.1016/j.foodchem.2005.08.040
   Pan L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00519
   Patrignani M, 2016, FOOD CHEM, V196, P204, DOI 10.1016/j.foodchem.2015.09.038
   Rufián-Henares JA, 2007, FOOD RES INT, V40, P995, DOI 10.1016/j.foodres.2007.05.002
   Sadigh-Eteghad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184122
   Saulnier DAA, 2007, APPL ENVIRON MICROB, V73, P1753, DOI 10.1128/AEM.01151-06
   Shen YX, 2002, J PINEAL RES, V32, P173, DOI 10.1034/j.1600-079x.2002.1o850.x
   Sirivarasai J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/856319
   Somoza V, 2005, MOL NUTR FOOD RES, V49, P663, DOI 10.1002/mnfr.200500034
   Sönmez M, 2005, THERIOGENOLOGY, V63, P2063, DOI 10.1016/j.theriogenology.2004.10.003
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Strober W, 2010, NAT MED, V16, P1195, DOI 10.1038/nm1110-1195
   Sun SW, 2007, NUTR RES, V27, P169, DOI 10.1016/j.nutres.2007.01.010
   Tropek R, 2016, ENVIRON SCI POLLUT R, V23, P13653, DOI 10.1007/s11356-015-4382-1
   Tuohy KM, 2006, MOL NUTR FOOD RES, V50, P847, DOI 10.1002/mnfr.200500126
   Valls-Bellés V, 2004, J SCI FOOD AGR, V84, P1701, DOI 10.1002/jsfa.1859
   Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x
   Wu FF, 2018, CEREAL CHEM, V95, P98, DOI 10.1002/cche.10019
   Wu SP, 2014, FOOD CHEM, V148, P196, DOI 10.1016/j.foodchem.2013.10.044
   Xia T, 2017, RSC ADV, V7, P17377, DOI 10.1039/c6ra27789f
   Yeh SL, 2014, EUR J NUTR, V53, P449, DOI 10.1007/s00394-013-0545-3
   Yu M, 2018, FOOD CHEM, V243, P249, DOI 10.1016/j.foodchem.2017.09.139
   Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129
NR 51
TC 12
Z9 15
U1 2
U2 52
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD MAR
PY 2019
VL 125
BP 62
EP 70
DI 10.1016/j.fct.2018.12.045
PG 9
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA HR7AT
UT WOS:000463305000008
PM 30597219
DA 2024-02-19
ER

PT J
AU Cokan, KB
   Urlep, Z
   Lorbek, G
   Matz-Soja, M
   Skubic, C
   Perse, M
   Jeruc, J
   Juvan, P
   Rezen, T
   Rozman, D
AF Cokan, Kaja Blagotinsek
   Urlep, Ziga
   Lorbek, Gregor
   Matz-Soja, Madlen
   Skubic, Cene
   Perse, Martina
   Jeruc, Jera
   Juvan, Peter
   Rezen, Tadeja
   Rozman, Damjana
TI Chronic Disruption of the Late Cholesterol Synthesis Leads to
   Female-Prevalent Liver Cancer
SO CANCERS
LA English
DT Article
DE cholesterol biosynthesis; hepatocellular carcinoma; lanosterol 14&#945;
   -demethylase (CYP51); sex dimorphism
ID HORMONE-BINDING GLOBULIN; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION
   FACTOR; ROR-GAMMA; GENES; MOUSE; IDENTIFICATION; METABOLISM; EXPRESSION;
   GENERATION
AB Simple Summary
   Hepatocellular carcinoma is a disease with a variety of molecular triggers and is usually reported to prevail in males. However, after the menopause, the disease is also increasing in the female population. Herein, we discovered that chronic depletion of cholesterol synthesis due to the knock-out of the gene Cyp51 from this pathway leads to female prevalent hepatocarcinogenesis in aging mice. There is a high similarity between our mouse model and the situation in humans. Multiple deregulated pathways of hepatocarcinogenesis are shared. A female-dependent metabolic reprogramming leading to this type of liver cancer is exposed for the first time and reflects on deregulated cholesterol synthesis as the metabolic trigger. These data are of crucial importance. Despite the higher overall prevalence of hepatocellular carcinoma in males, we need tools and biomarkers to further stratify patients and offer better diagnosis and treatment options to both sexes.
   While the role of cholesterol in liver carcinogenesis remains controversial, hepatocellular carcinoma generally prevails in males. Herein, we uncover pathways of female-prevalent progression to hepatocellular carcinoma due to chronic repression of cholesterogenic lanosterol 14 alpha-demethylase (CYP51) in hepatocytes. Tumors develop in knock-out mice after year one, with 2:1 prevalence in females. Metabolic and transcription factor networks were deduced from the liver transcriptome data, combined by sterol metabolite and blood parameter analyses, and interpreted with relevance to humans. Female knock-outs show increased plasma cholesterol and HDL, dampened lipid-related transcription factors FXR, LXR alpha:RXR alpha, and importantly, crosstalk between reduced LXR alpha and activated TGF-beta signalling, indicating a higher susceptibility to HCC in aging females. PI3K/Akt signalling and ECM-receptor interaction are common pathways that are disturbed by sex-specific altered genes. Additionally, transcription factors (SOX9)2 and PPAR alpha were recognized as important for female hepatocarcinogenesis, while overexpressed Cd36, a target of nuclear receptor RORC, is a new male-related regulator of ECM-receptor signalling in hepatocarcinogenesis. In conclusion, we uncover the sex-dependent metabolic reprogramming of cholesterol-related pathways that predispose for hepatocarcinogenesis in aging females. This is important in light of increased incidence of liver cancers in post-menopausal women.
C1 [Cokan, Kaja Blagotinsek; Urlep, Ziga; Lorbek, Gregor; Skubic, Cene; Juvan, Peter; Rezen, Tadeja; Rozman, Damjana] Univ Ljubljana, Fac Med, Inst Biochem, Ctr Funct Genom & Biochips, SI-1000 Ljubljana, Slovenia.
   [Matz-Soja, Madlen] Univ Leipzig, Div Gen Biochem, Rudol Schonheimer Inst Biochem, Fac Med, D-04103 Leipzig, Germany.
   [Perse, Martina] Univ Ljubljana, Inst Pathol, Med Expt Ctr, Fac Med, SI-1000 Ljubljana, Slovenia.
   [Jeruc, Jera] Univ Ljubljana, Inst Pathol, Fac Med, SI-1000 Ljubljana, Slovenia.
   [Matz-Soja, Madlen] Univ Clin Leipzig, Sect Hepatol Clin & Polyclin Gastroenterol, Hepatol, Infectiol,Pneumol, D-04103 Leipzig, Germany.
C3 University of Ljubljana; Leipzig University; University of Ljubljana;
   University of Ljubljana; Leipzig University
RP Rozman, D (corresponding author), Univ Ljubljana, Fac Med, Inst Biochem, Ctr Funct Genom & Biochips, SI-1000 Ljubljana, Slovenia.
EM kaja.blagotinsek@mf.uni-lj.si; zigaurlep@gmail.com;
   greg.lorbek@gmail.com; madlen.matz@medizin.uni-leipzig.de;
   cene.skubic@mf.uni-lj.si; martina.perse@mf.uni-lj.si;
   jera.jeruc@mf.uni-lj.si; peter.juvan@mf.uni-lj.si;
   tadeja.rezen@mf.uni-lj.si; damjana.rozman@mf.uni-lj.si
RI Jeruc, Jera/AAL-5258-2021; Perse, Martina/AAS-2898-2020; Matz-Soja,
   Madlen/D-8021-2014
OI Rezen, Tadeja/0000-0001-6210-7370; Blagotinsek Cokan,
   Kaja/0000-0002-7779-8036; Perse, Martina/0000-0001-9397-9366; Matz-Soja,
   Madlen/0000-0002-5929-3704; Skubic, Cene/0000-0002-2601-2291
FU Slovenian Research Agency (ARRS) program [P1-0104, P1-0390, J1-9176,
   BI-DE/17-19-8]; ARRS
FX This research was funded by the Slovenian Research Agency (ARRS) program
   grants P1-0104, P1-0390, and projects J1-9176 and BI-DE/17-19-8. Kaja
   Blagotinsek Cokan, Gregor Lorbek, and Ziga Urlep were supported by the
   graduate fellowship of ARRS.
CR Acimovic J, 2013, MOLECULES, V18, P4002, DOI 10.3390/molecules18044002
   Acimovic J, 2009, J CHROMATOGR B, V877, P2081, DOI 10.1016/j.jchromb.2009.05.050
   Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496
   [Anonymous], 2001, International Classification of Rodent Tumors
   Athwal VS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36037-4
   Athwal VS, 2017, EMBO MOL MED, V9, P1696, DOI 10.15252/emmm.201707860
   Burra P, 2013, LIVER TRANSPLANT, V19, P122, DOI 10.1002/lt.23574
   Caldwell JD, 2009, HORM METAB RES, V41, P173, DOI 10.1055/s-0028-1093351
   Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431
   Che L, 2020, GUT, V69, P177, DOI 10.1136/gutjnl-2018-317581
   Chen L, 2019, J LIPID RES, V60, P1765, DOI 10.1194/jlr.RA119000201
   Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082
   Cruz PMR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00119
   Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y
   Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312
   Fang CH, 2004, WORLD J GASTROENTERO, V10, P2482, DOI 10.3748/wjg.v10.i17.2482
   Furge K., 2006, PGSEA: parametric gene set enrichment analysis
   Gabitova L, 2015, CELL REP, V12, P1927, DOI 10.1016/j.celrep.2015.08.023
   Gillespie RL, 2016, OPHTHALMOLOGY, V123, P217, DOI 10.1016/j.ophtha.2015.06.035
   Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200
   Guy Jennifer, 2013, Gastroenterol Hepatol (N Y), V9, P633
   Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1
   Hartwell HJ, 2014, P NATL ACAD SCI USA, V111, P11455, DOI 10.1073/pnas.1404267111
   Hautanen A, 2000, INT J OBESITY, V24, pS64, DOI 10.1038/sj.ijo.0801281
   Horvat S, 2011, DRUG METAB REV, V43, P69, DOI 10.3109/03602532.2010.540580
   Huang BL, 2020, NAT METAB, V2, P132, DOI 10.1038/s42255-020-0174-0
   Hubler Z, 2018, NATURE, V560, P372, DOI 10.1038/s41586-018-0360-3
   Infantino V, 2019, BBA-MOL BASIS DIS, V1865, P38, DOI 10.1016/j.bbadis.2018.10.018
   Jiang Jing-ting, 2007, Journal of Zhejiang University-Science B, V8, P398, DOI 10.1631/jzus.2007.B0398
   Jiang NN, 2020, MOL BIOL REP, V47, P4587, DOI 10.1007/s11033-020-05435-1
   Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647
   Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245
   Kohi MP, 2016, J VASC INTERV RADIOL, V27, P1338, DOI 10.1016/j.jvir.2016.06.035
   Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60
   Kovac U, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00483
   Kurokawa T, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-167
   Leung CON, 2016, ONCOTARGET, V7, P29371, DOI 10.18632/oncotarget.8835
   Lewinska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082554
   Li CH, 2018, CANCER RES, V78, P5527, DOI 10.1158/0008-5472.CAN-18-0362
   Li L, 2016, INT J ONCOL, V48, P1457, DOI 10.3892/ijo.2016.3355
   Liu DB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9840
   Lonardo A, 2019, HEPATOLOGY, V70, P1457, DOI 10.1002/hep.30626
   Lorbek G, 2016, PHARMACOGENOMICS, V17, P1273, DOI 10.2217/pgs-2016-0047
   Lorbek G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08777
   Lu M, 2013, J MOL CELL BIOL, V5, P404, DOI 10.1093/jmcb/mjt039
   Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411
   Matheu A, 2012, CANCER RES, V72, P1301, DOI 10.1158/0008-5472.CAN-11-3660
   Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143
   Mello T, 2016, PPAR RES, V2016, DOI 10.1155/2016/7403230
   Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284
   Morén A, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0140-4
   Nakagawa H, 2018, CANCERS, V10, DOI 10.3390/cancers10110447
   Nath A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14752
   Chua NK, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat3741
   Niavarani SR, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6045-y
   Oh TG, 2016, EBIOMEDICINE, V6, P59, DOI 10.1016/j.ebiom.2016.02.028
   Patel N, 2017, HUM GENET, V136, P205, DOI 10.1007/s00439-016-1747-6
   Pelikan RC, 2013, J CELL BIOCHEM, V114, P796, DOI 10.1002/jcb.24417
   Phillips RE, 2019, P NATL ACAD SCI USA, V116, P7957, DOI 10.1073/pnas.1820989116
   Rezen T, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00417
   RUSSELL DW, 1992, CARDIOVASC DRUG THER, V6, P103, DOI 10.1007/BF00054556
   Salleng KJ, 2015, COMPARATIVE MED, V65, P398
   Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004
   Skubic C, 2020, MOLECULES, V25, DOI 10.3390/molecules25184116
   Smeuninx B, 2020, CANCERS, V12, DOI 10.3390/cancers12071714
   Smyth GK., 2004, Stat Appl Genet Mol Biol, V3, P1, DOI DOI 10.2202/1544-6115.1027
   Steensels S, 2020, METABOLITES, V10, DOI 10.3390/metabo10070283
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Takeda Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004331
   Tint GS, 2014, DEV NEUROSCI-BASEL, V36, P132, DOI 10.1159/000362363
   Tomas TC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00360
   Urlep Z, 2017, SCI REP-UK, V7, DOI 10.1038/srep40775
   Vaidya D, 2008, FUTURE LIPIDOL, V3, P603, DOI 10.2217/17460875.3.6.603
   Vervoort SJ, 2018, NUCLEIC ACIDS RES, V46, P9578, DOI 10.1093/nar/gky755
   Vizcaíno C, 2015, PHARMACOL THERAPEUT, V152, P111, DOI 10.1016/j.pharmthera.2015.05.008
   Walker C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103028
   Wang SH, 2012, DIGEST DIS SCI, V57, P3184, DOI 10.1007/s10620-012-2255-8
   Wilson MA, 2020, CANCER RES, V80, P27, DOI 10.1158/0008-5472.CAN-19-2634
   Wu XZ, 2006, J GASTROEN HEPATOL, V21, P1093, DOI 10.1111/j.1440-1746.2006.04485.x
   Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443
   Xiao YB, 2018, CANCER MANAG RES, V10, P1781, DOI 10.2147/CMAR.S166971
   Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007
   Yashin AI, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00122
   Zhu WW, 2020, GENES DIS, V7, P299, DOI 10.1016/j.gendis.2020.01.016
NR 84
TC 7
Z9 7
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6694
J9 CANCERS
JI Cancers
PD NOV
PY 2020
VL 12
IS 11
AR 3302
DI 10.3390/cancers12113302
PG 24
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA OW3KU
UT WOS:000592790900001
PM 33182326
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Bray, EE
   Zheng, ZH
   Tolbert, MK
   McCoy, BM
   Kaeberlein, M
   Kerr, KF
AF Bray, Emily E.
   Zheng, Zihan
   Tolbert, M. Katherine
   McCoy, Brianah M.
   Kaeberlein, Matt
   Kerr, Kathleen F.
CA Dog Aging Project Consortium
TI Once-daily feeding is associated with better health in companion dogs:
   results from the Dog Aging Project
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Canine; Canine cognitive dysfunction; Feeding frequency; Healthy aging;
   Time-restricted feeding
ID POLYUNSATURATED FATTY-ACIDS; REDUCED MEAL FREQUENCY; CALORIC
   RESTRICTION; KETOGENIC DIET; FISH-OIL; COGNITIVE FUNCTION;
   CONTROLLED-TRIAL; IMPROVES MEMORY; NORMAL-WEIGHT; TIME
AB A variety of diets have been studied for possible anti-aging effects. In particular, studies of intermittent fasting and time-restricted feeding in laboratory rodents have found evidence of beneficial health outcomes. Companion dogs represent a unique opportunity to study diet in a large mammal that shares human environments. The Dog Aging Project has been collecting data on thousands of companion dogs of all different ages, sizes, and breeds since 2019. We leveraged this diverse cross-sectional dataset to investigate associations between feeding frequency and cognitive function (n = 10,474) as well as nine broad categories of health conditions (n = 24,238). Controlling for sex, age, breed, and other potential confounders, we found that dogs fed once daily rather than more frequently had lower mean scores on a cognitive dysfunction scale, and lower odds of having gastrointestinal, dental, orthopedic, kidney/urinary, and liver/pancreas disorders. Therefore, we find that once-daily feeding is associated with better health in multiple domains. Future research with longitudinal data can provide stronger evidence for a possible causal effect of feeding frequency on health in companion dogs.
C1 [Bray, Emily E.] Univ Arizona, Sch Anthropol, Arizona Canine Cognit Ctr, Tucson, AZ 85721 USA.
   [Bray, Emily E.] Canine Compan Independence, Natl Headquarters, Santa Rosa, CA USA.
   [Zheng, Zihan; Kerr, Kathleen F.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Tolbert, M. Katherine] Texas A&M Univ, Coll Vet Med, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA.
   [McCoy, Brianah M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA.
   [Kaeberlein, Matt] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA.
C3 University of Arizona; University of Washington; University of
   Washington Seattle; Texas A&M University System; Texas A&M University
   College Station; Arizona State University; Arizona State
   University-Tempe; University of Washington; University of Washington
   Seattle
RP Bray, EE (corresponding author), Univ Arizona, Sch Anthropol, Arizona Canine Cognit Ctr, Tucson, AZ 85721 USA.
EM ebray@email.arizona.edu
RI Bray, Emily/J-8145-2019; Fajt, Virginia/AAN-8785-2020
OI Bray, Emily/0000-0002-3230-0636; Fajt, Virginia/0000-0003-0697-7149;
   Akey, Joshua/0000-0002-4411-1330; Ma, Jing/0000-0001-6294-227X;
   Snyder-Mackler, Noah/0000-0003-3026-6160; Castelhano,
   Marta/0000-0003-2497-1939
FU National Institute on Aging, a part of the National Institutes of Health
   [U19AG057377, R24AG073137]
FX The Dog Aging Project is supported by U19AG057377 and R24AG073137 from
   the National Institute on Aging, a part of the National Institutes of
   Health, and by additional grants and private donations. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR Anderson RM, 2012, AM J HUM BIOL, V24, P101, DOI 10.1002/ajhb.22243
   [Anonymous], 2001, REGRESSION MODELING
   Bostock ECS, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00043
   Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012
   Brown SA, 1998, J LAB CLIN MED, V131, P447, DOI 10.1016/S0022-2143(98)90146-9
   Carlson O, 2007, METABOLISM, V56, P1729, DOI 10.1016/j.metabol.2007.07.018
   Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001
   Cienfuegos S, 2020, CELL METAB, V32, P366, DOI 10.1016/j.cmet.2020.06.018
   Comblain F, 2016, J VET PHARMACOL THER, V39, P1, DOI 10.1111/jvp.12251
   Cotman CW, 2007, ALZHEIMERS DEMENT, V3, pS30, DOI 10.1016/j.jalz.2007.01.013
   Creevy KE, 2022, NATURE, V602, P51, DOI 10.1038/s41586-021-04282-9
   de Cabo R, 2019, NEW ENGL J MED, V381, P2541, DOI 10.1056/NEJMra1905136
   Dog Aging Project, 2021, DOG AG PROJ 2020
   Freeman LM, 2006, J VET INTERN MED, V20, P1116, DOI 10.1892/0891-6640(2006)20[1116:EODMID]2.0.CO;2
   Fritsch D, 2010, J VET INTERN MED, V24, P1020, DOI 10.1111/j.1939-1676.2010.0572.x
   Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682
   Hadley KB, 2017, PROSTAG LEUKOTR ESS, V118, P10, DOI 10.1016/j.plefa.2017.01.011
   Harder-Lauridsen NM, 2017, NUTRITION, V37, P92, DOI 10.1016/j.nut.2016.12.015
   Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Harvey ND, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.643085
   Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019
   Hickman MA, 1998, CLIN TECH SMALL AN P, V13, P211, DOI 10.1016/S1096-2867(98)80005-4
   Hill CM, 2021, NATURE, V589, DOI 10.1038/d41586-020-03662-x
   Hoffman JM, 2018, AGING CELL, V17, DOI 10.1111/acel.12737
   Kaeberlein M, 2016, MAMM GENOME, V27, P279, DOI 10.1007/s00335-016-9638-7
   Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315
   Lawler DF, 2008, BRIT J NUTR, V99, P793, DOI 10.1017/S0007114507871686
   Leclerc E, 2020, CNS SPECTRUMS, V25, P2, DOI 10.1017/S1092852918001566
   Lee JH, 2020, PHYSIOLOGY, V35, P185, DOI 10.1152/physiol.00030.2019
   Lee MB, 2021, SCIENCE, V374, P953, DOI 10.1126/science.abe7365
   Leung YB, 2020, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00480
   Li LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066069
   Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001
   Martinez-Lopez N, 2017, CELL METAB, V26, P856, DOI 10.1016/j.cmet.2017.09.020
   Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063
   Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005
   Milgram NW, 2006, AGEING RES REV, V5, P354, DOI 10.1016/j.arr.2006.04.004
   Mirzaei H, 2016, CURR OPIN CLIN NUTR, V19, P74, DOI 10.1097/MCO.0000000000000239
   Mitchell SJ, 2019, CELL METAB, V29, P221, DOI 10.1016/j.cmet.2018.08.011
   Mueller RS, 2005, AM J VET RES, V66, P868, DOI 10.2460/ajvr.2005.66.868
   Newman JC, 2017, CELL METAB, V26, P547, DOI 10.1016/j.cmet.2017.08.004
   Ogilvie GK, 2000, CANCER, V88, P1916, DOI 10.1002/(SICI)1097-0142(20000415)88:8&lt;1916::AID-CNCR22&gt;3.0.CO;2-F
   Packer RMA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192182
   Packer RMA, 2016, EPILEPSY BEHAV, V55, P62, DOI 10.1016/j.yebeh.2015.11.014
   Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3
   Perri AR, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2010083118
   Qasrawi SO, 2017, SLEEP BREATH, V21, P577, DOI 10.1007/s11325-017-1473-x
   Raghavan M, 2004, J AM ANIM HOSP ASSOC, V40, P192, DOI 10.5326/0400192
   Regmi P, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101161
   Roberts MN, 2017, CELL METAB, V26, P539, DOI 10.1016/j.cmet.2017.08.005
   Salvin HE, 2011, VET J, V188, P331, DOI 10.1016/j.tvjl.2010.05.014
   Shin BK, 2018, EXP BIOL MED, V243, P334, DOI 10.1177/1535370217751610
   Simpson M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209131
   Singh R, 2012, AGE, V34, P917, DOI 10.1007/s11357-011-9289-2
   Stote KS, 2007, AM J CLIN NUTR, V85, P981, DOI 10.1093/ajcn/85.4.981
   Studzinski CM, 2006, NEUROBIOL LEARN MEM, V86, P197, DOI 10.1016/j.nlm.2006.02.005
   Team RC, 2020, R: A Language and Environment for Statistical
   Vasconcelos AR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-85
   Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700
   Weindruch R., 1988, RETARDATION AGING DI
   Witte AV, 2009, P NATL ACAD SCI USA, V106, P1255, DOI 10.1073/pnas.0808587106
   Yang FY, 2014, BEHAV BRAIN RES, V264, P82, DOI 10.1016/j.bbr.2014.02.005
   Zicker SC, 2012, JAVMA-J AM VET MED A, V241, P583, DOI 10.2460/javma.241.5.583
   Zlotnick M, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00334
NR 65
TC 7
Z9 9
U1 7
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2022 JUN
PY 2022
VL 44
IS 3
BP 1779
EP 1790
DI 10.1007/s11357-022-00575-7
EA APR 2022
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 2I3KY
UT WOS:000788416300002
PM 35484470
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Wang, X
   Shang, XM
   Luan, J
   Zhang, SC
AF Wang, Xia
   Shang, Xiaomei
   Luan, Jing
   Zhang, Shicui
TI Identification, expression and function of apolipoprotein E in annual
   fish <i>Nothobranchius guentheri</i>: implication for an aging marker
SO BIOGERONTOLOGY
LA English
DT Article
DE Annual fish; Nothobranchius guentheri; Apolipoprotein E; Aging;
   Antioxidation
ID RECEPTOR-BINDING DOMAIN; CELL-SURFACE RECEPTORS; ALZHEIMERS-DISEASE;
   ALLELE; RISK; APOE; AGE; ATHEROSCLEROSIS; LIPOPROTEINS; ASSOCIATION
AB Apolipoprotein E (apoE) is a lipid-associated protein present in both plasma and in central nervous system. Variation in apoE gene has been reported to be associated with longevity in humans as well as with aged diseases such as atherosclerosis, Alzheimer's disease, and Parkinson's disease. However, information regarding the function and structure-activity relationship of apoE in lower vertebrates is rather limited. In this study we show that the apoE gene from the annual fish Nothobranchius guentheri, NapoE, encodes a protein of 262 amino acids, which shares common structural features characteristic of mammalian apoE. We also show that like human apoE, recombinant NapoE is able to inhibit LDL oxidation, and it is the N-terminal domain of NapoE with lysine or arginine residues that plays a key role in inhibition of LDL oxidation. NapoE is predominantly expressed in the liver of N. guentheri, consistent with that in mammalian species. More importantly, we demonstrate an age-dependent down-regulation of NapoE gene, rendering it a suitable biomarker of aging. This lays a foundation for further study of the role of apoE in the aging process of fish.
C1 [Wang, Xia; Shang, Xiaomei; Zhang, Shicui] Ocean Univ China, Dept Marine Biol, Qingdao 266003, Peoples R China.
   [Wang, Xia; Shang, Xiaomei; Zhang, Shicui] Ocean Univ China, Lab Evolut & Dev, Qingdao 266003, Peoples R China.
   [Luan, Jing] Shandong Entry Exit Inspect & Quarantine Bur, Qingdao 266001, Peoples R China.
C3 Ocean University of China; Ocean University of China
RP Zhang, SC (corresponding author), Ocean Univ China, Dept Marine Biol, Qingdao 266003, Peoples R China.
EM sczhang@ouc.edu.cn
FU Science and Technology Department of Shandong Province [BS2010SW035];
   Science and Technology Bureau of Yantai, Shandong Province [2010155]
FX This work was supported by the grants of Science and Technology
   Department of Shandong Province (BS2010SW035) and Science and Technology
   Bureau of Yantai, Shandong Province (2010155).
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622
   Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620
   Caselli R J, 2004, Neurology, V62, P1990
   Caselli RJ, 1999, NEUROLOGY, V53, P201, DOI 10.1212/WNL.53.1.201
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   Croy JE, 2004, BIOCHEMISTRY-US, V43, P7328, DOI 10.1021/bi036208p
   DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1
   Durliat M, 2000, EUR J BIOCHEM, V267, P549, DOI 10.1046/j.1432-1327.2000.01033.x
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Havel R J, 1975, Adv Exp Med Biol, V63, P37
   Hsu CY, 2009, AGING CELL, V8, P726, DOI 10.1111/j.1474-9726.2009.00525.x
   Ihara Y, 2000, ACTA NEUROL SCAND, V102, P346, DOI 10.1034/j.1600-0404.2000.102006346.x
   INNERARITY TL, 1983, J BIOL CHEM, V258, P2341
   Itabe H, 2003, BIOL PHARM BULL, V26, P1, DOI 10.1248/bpb.26.1
   Kasap M, 2008, CELL BIOCHEM FUNCT, V26, P43, DOI 10.1002/cbf.1396
   Kim KY, 2009, MITOCHONDR DNA, V20, P119, DOI 10.3109/19401730903176896
   Kondo Jiro, 2005, Nucleic Acids Symp Ser (Oxf), P253
   Lahoz C, 2001, ATHEROSCLEROSIS, V154, P529, DOI 10.1016/S0021-9150(00)00570-0
   Lauderback CM, 2002, BRAIN RES, V924, P90, DOI 10.1016/S0006-8993(01)03228-0
   Letters JM, 1999, J LIPID RES, V40, P1104
   Li CJ, 2011, COMP BIOCHEM PHYS B, V158, P64, DOI 10.1016/j.cbpb.2010.09.008
   Li DY, 2003, ARTERIOSCL THROM VAS, V23, P816, DOI 10.1161/01.ATV.0000066685.13434.FA
   Li YJ, 2004, NEUROLOGY, V62, P2005, DOI 10.1212/01.WNL.0000128089.53030.AC
   Liu CS, 2012, BIOGERONTOLOGY, V13, P501, DOI 10.1007/s10522-012-9395-2
   Liu MY, 2009, BIOSCIENCE REP, V29, P385, DOI 10.1042/BSR20080173
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507
   Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003
   MAHLEY RW, 1977, J BIOL CHEM, V252, P7279
   MARKOFSKY J, 1972, EXP GERONTOL, V7, P131, DOI 10.1016/0531-5565(72)90007-1
   McKay GJ, 2011, HUM MUTAT, V32, P1407, DOI 10.1002/humu.21577
   Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55
   Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673
   Nyyssönen K, 2012, ATHEROSCLEROSIS, V225, P231, DOI 10.1016/j.atherosclerosis.2012.08.030
   PAIK YK, 1985, P NATL ACAD SCI USA, V82, P3445, DOI 10.1073/pnas.82.10.3445
   Pham T, 2005, BIOCHEMISTRY-US, V44, P7577, DOI 10.1021/bi0472696
   Poupard G, 2000, CELL TISSUE RES, V300, P251, DOI 10.1007/s004419900158
   Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387
   Small GW, 1999, AM J PSYCHIAT, V156, P1035
   Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Toikka JO, 2000, HYPERTENSION, V36, P929, DOI 10.1161/01.HYP.36.6.929
   Valenzano DR, 2006, CELL CYCLE, V5, P1027, DOI 10.4161/cc.5.10.2739
   Watanabe T, 1982, Nihon Kyobu Geka Gakkai Zasshi, V30, P1796
   WEISGRABER KH, 1983, J BIOL CHEM, V258, P2348
   WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053
   WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194
NR 50
TC 10
Z9 10
U1 1
U2 8
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD JUN
PY 2014
VL 15
IS 3
BP 233
EP 243
DI 10.1007/s10522-014-9493-4
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AH3NB
UT WOS:000336029500003
PM 24573419
DA 2024-02-19
ER

PT J
AU Li, XT
   Li, HC
   Li, CB
   Dou, DQ
   Gao, MB
AF Li, Xing-Tai
   Li, Hong-Cheng
   Li, Chun-Bin
   Dou, De-Qiang
   Gao, Ming-Bo
TI Protective Effects on Mitochondria and Anti-Aging Activity of
   Polysaccharides from Cultivated Fruiting Bodies of <i>Cordyceps
   militaris</i>
SO AMERICAN JOURNAL OF CHINESE MEDICINE
LA English
DT Article
DE Cordyceps militaris Polysaccharides; Mitochondria; Anti-Aging; Reactive
   Oxygen Species; Antioxidase
ID FREE-RADICAL THEORY; OXIDATIVE STRESS; ANTIOXIDANT ACTIVITIES;
   LIPID-PEROXIDATION; PERMEABILITY TRANSITION; CYTOCHROME-C; OXYGEN;
   SINENSIS; DAMAGE; GENERATION
AB Cordyceps militaris (L.) Link is an entomopathogenic fungus parasitic to Lepidoptera larvae, and is widely used as a folk tonic or invigorant for longevity in China. Although C. militaris has been used in traditional Chinese medicine for millennia, there is still a lack convincing evidence for its anti-aging activities. This study was performed to investigate the effects of polysaccharides from cultivated fruiting bodies of C. militaris (CMP) on mitochondrial injury, antioxidation and anti-aging activity. Fruiting bodies of C. militaris were cultivated artificially under optimized conditions. The spectrophotometric method was used to measure thiobarbituric acid reactive substances (TBARS), mitochondrial swelling, and activities of scavenging superoxide anions in vitro. D-galactose (100 mg/kg/day) was injected subcutaneously into back of the neck of mice for 7 weeks to induce an aging model. The effects of CMP on the activities of catalase (CAT), surperoxide dismutase (SOD), glutathione peroxidase (GPx) and anti-hydroxyl radicals were assayed in vivo using commercial monitoring kits. The results showed that CMP could inhibit mitochondrial injury and swelling induced by Fe2+-L-Cysteine in a concentration-dependent manner and it also had a significant superoxide anion scavenging effect. Moreover, the activities of CAT, SOD, GPx and anti-hydroxyl radicals in mice liver were increased significantly by CMP. These results indicate that CMP protects mitochondria by scavenging reactive oxygen species (ROS), inhibiting mitochondrial swelling, and increasing the activities of antioxidases. Therefore, CMP may have pharmaceutical values for mitochondrial protection and anti-aging. CMP was the major bioactive component in C. militaris.
C1 [Li, Xing-Tai; Li, Chun-Bin; Gao, Ming-Bo] Dalian Nationalities Univ, Coll Life Sci, Dalian 116600, Peoples R China.
   [Li, Hong-Cheng] GeneSci Pharmaceut Co Ltd, Res & Dev Dept, High Tech Dev Zone, Changchun 130012, Peoples R China.
   [Dou, De-Qiang] Liaoning Univ Tradit Chinese Med, Coll Pharm, Dalian 116600, Peoples R China.
C3 Dalian Minzu University; Liaoning University of Traditional Chinese
   Medicine
RP Li, XT (corresponding author), Dalian Nationalities Univ, Coll Life Sci, 18 Liaohe W Rd, Dalian 116600, Peoples R China.
EM xtli@dlnu.edu.cn
RI Dou, Deqiang/GLR-4592-2022
FU Scientific Research Item for Institutions of Higher Learning of the
   Education Department of Liaoning Province in China [994421792]
FX This work was supported by the Scientific Research Item for Institutions
   of Higher Learning of the Education Department of Liaoning Province in
   China (Grant No. 994421792).
CR Abuja PM, 2001, CLIN CHIM ACTA, V306, P1, DOI 10.1016/S0009-8981(01)00393-X
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Armstrong JS, 2006, MITOCHONDRION, V6, P225, DOI 10.1016/j.mito.2006.07.006
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chen GT, 2007, J SCI FOOD AGR, V87, P357, DOI 10.1002/jsfa.2744
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   Chen YJ, 1997, LIFE SCI, V60, P2349, DOI 10.1016/S0024-3205(97)00291-9
   Chitra S, 2008, Indian J Med Sci, V62, P141
   Cuddihy SL, 2008, J BIOL CHEM, V283, P6915, DOI 10.1074/jbc.M702572200
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Feng K, 2009, J PHARMACEUT BIOMED, V50, P522, DOI 10.1016/j.jpba.2009.04.029
   Fink BD, 2005, AM J PHYSIOL-ENDOC M, V288, pE71, DOI 10.1152/ajpendo.00332.2004
   GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399
   Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408
   Gülçin I, 2005, ACTA VET HUNG, V53, P425, DOI 10.1556/AVet.53.2005.4.3
   Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   HRUSZKEWYCZ AM, 1992, MUTAT RES, V275, P243, DOI 10.1016/0921-8734(92)90028-N
   HUNTER FE, 1963, J BIOL CHEM, V238, P828
   Kiho T, 1999, BIOL PHARM BULL, V22, P966
   Koh JH, 2003, BIOL PHARM BULL, V26, P84, DOI 10.1248/bpb.26.84
   Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619
   Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896
   LI X, 1997, J MICROBIOL, V17, P13
   Liu CS, 2006, ACTA PHARMACOL SIN, V27, P1137, DOI 10.1111/j.1745-7254.2006.00378.x
   Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x
   Nakamura K, 1999, JPN J PHARMACOL, V79, P505, DOI 10.1254/jjp.79.505
   Navarro A, 2005, AM J PHYSIOL-REG I, V289, pR1392, DOI 10.1152/ajpregu.00834.2004
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9
   Ohta Y, 2007, J AGR FOOD CHEM, V55, P10194, DOI 10.1021/jf0721287
   Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122
   Paradies G, 1997, FEBS LETT, V406, P136, DOI 10.1016/S0014-5793(97)00264-0
   Park NS, 2005, MYCOLOGIA, V97, P130, DOI 10.3852/mycologia.97.1.130
   Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Shimada T, 2008, AM J PHYSIOL-ENDOC M, V295, pE859, DOI 10.1152/ajpendo.90373.2008
   Shin KH, 2001, ANN NY ACAD SCI, V928, P261
   SHUN Y, 1999, J LIAONING TEACHERS, V1, P86
   Suji G, 2004, BIOGERONTOLOGY, V5, P365, DOI 10.1007/s10522-004-3189-0
   Tsiapali E, 2001, FREE RADICAL BIO MED, V30, P393, DOI 10.1016/S0891-5849(00)00485-8
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Valls V, 2005, PROCESS BIOCHEM, V40, P903, DOI 10.1016/j.procbio.2004.02.025
   Viña J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194
   Wang BJ, 2005, FOOD CHEM TOXICOL, V43, P543, DOI 10.1016/j.fct.2004.12.008
   WANG Q, 2002, J LIAONING TEACHERS, V4, P43
   WANG Q, 2008, J ANHUI AGR SCI, V36, P8722
   [王奇 WANG Qi], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36
   Wu ZL, 2000, CELL BIOCHEM FUNCT, V18, P93
   Xiao Jian-hui, 2002, Yaoxue Xuebao, V37, P589
   Yang FQ, 2009, J PHARMACEUT BIOMED, V50, P307, DOI 10.1016/j.jpba.2009.04.027
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
   Zhan Y, 2006, J INTEGR PLANT BIOL, V48, P1365, DOI 10.1111/j.1744-7909.2006.00345.x
   Zhou XX, 2008, AM J CHINESE MED, V36, P967, DOI 10.1142/S0192415X08006387
   刘建华, 1999, [中国食用菌, Edible Fungl of China], V18, P18
NR 60
TC 42
Z9 45
U1 2
U2 68
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0192-415X
EI 1793-6853
J9 AM J CHINESE MED
JI Am. J. Chin. Med.
PY 2010
VL 38
IS 6
BP 1093
EP 1106
DI 10.1142/S0192415X10008494
PG 14
WC Integrative & Complementary Medicine; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; General & Internal Medicine
GA 676SM
UT WOS:000283938800007
PM 21061463
DA 2024-02-19
ER

PT J
AU Yoo, H
   Kim, HS
AF Yoo, Hyoeun
   Kim, Hyun-Sook
TI Cacao powder supplementation attenuates oxidative stress, cholinergic
   impairment, and apoptosis in d-galactose-induced aging rat brain
SO SCIENTIFIC REPORTS
LA English
DT Article
ID COGNITIVE IMPAIRMENT; MITOCHONDRIAL DYSFUNCTION; COCOA; DAMAGE; MOUSE;
   MICE; DIET; RICH; POLYPHENOLS; OXIDANTS
AB Aging, a critical risk factor of several diseases, including neurodegenerative disorders, affects an ever-growing number of people. Cacao supplementation has been suggested to improve age-related neuronal deficits. Therefore, this study investigated the protective effects of raw cacao powder on oxidative stress-induced aging. Male Sprague-Dawley rats were divided into 4 groups: Control (C), d-galactose-induced aging (G), d-galactose injection with 10% (LC), and 16% (HC) cacao powder mixed diet. d-galactose (300 mg/3 mL/kg) was intraperitoneally injected into all but the control group for 12 weeks. Cacao supplemented diets were provided for 8 weeks. The levels of serum Malondialdehyde (MDA), Advanced Glycation End-products (AGEs), brain and liver MDA, the indicators of the d-galactose induced oxidative stress were significantly decreased in LC and HC but increased in G. The Acetylcholinesterase (AChE) activity of brain showed that the cholinergic impairment was significantly lower in LC, and HC than G. Furthermore, the expression levels of catalase (CAT), phospho-Akt/Akt, and procaspase-3 were significantly increased in LC and HC. In conclusion, cacao consumption attenuated the effects of oxidative stress, cholinergic impairment and apoptosis, indicating its potential in future clinical studies.
C1 [Yoo, Hyoeun; Kim, Hyun-Sook] Sookmyung Womens Univ, Grad Sch Life & Sci, Food & Nutr, Seoul, South Korea.
C3 Sookmyung Women's University
RP Kim, HS (corresponding author), Sookmyung Womens Univ, Grad Sch Life & Sci, Food & Nutr, Seoul, South Korea.
EM hskim@sookmyung.ac.kr
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Banji OJF, 2014, FOOD CHEM TOXICOL, V74, P51, DOI 10.1016/j.fct.2014.08.020
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Granado-Serrano AB, 2009, FOOD CHEM TOXICOL, V47, P2499, DOI 10.1016/j.fct.2009.07.007
   Cady RJ, 2010, BRAIN RES, V1323, P18, DOI 10.1016/j.brainres.2010.01.081
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Choi YJ, 2012, AGE, V34, P317, DOI 10.1007/s11357-011-9235-3
   Deepa SS, 2017, GEROSCIENCE, V39, P187, DOI 10.1007/s11357-017-9975-9
   Dei R, 2002, ACTA NEUROPATHOL, V104, P113, DOI 10.1007/s00401-002-0523-y
   Deng S, 2019, BIOMED PHARMACOTHER, V112, DOI 10.1016/j.biopha.2019.108696
   Fernández-Fernández L, 2012, BEHAV BRAIN RES, V228, P261, DOI 10.1016/j.bbr.2011.11.014
   Fernández-Millán E, 2015, MOL NUTR FOOD RES, V59, P820, DOI [10.1002/mnfr, 10.1002/mnfr.201400746]
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Gary DS, 2003, J NEUROCHEM, V84, P878, DOI 10.1046/j.1471-4159.2003.01579.x
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   He M, 2009, BIOL PHARM BULL, V32, P55, DOI 10.1248/bpb.32.55
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Jeong H, 2017, EXP GERONTOL, V95, P16, DOI 10.1016/j.exger.2017.05.004
   Kawakami K, 1999, TOHOKU J EXP MED, V187, P157, DOI 10.1620/tjem.187.157
   Kitagishi Y, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt265
   Kumar A, 2009, N-S ARCH PHARMACOL, V380, P431, DOI 10.1007/s00210-009-0442-8
   Lee KW, 2003, J AGR FOOD CHEM, V51, P7292, DOI 10.1021/jf0344385
   Li YN, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/320513
   Liang J, 2019, INT J BIOL MACROMOL, V126, P414, DOI 10.1016/j.ijbiomac.2018.12.230
   Magrone T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00677
   Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Oracz J, 2015, CRIT REV FOOD SCI, V55, P1176, DOI 10.1080/10408398.2012.686934
   Ou Y, 2012, TOXICOL LETT, V215, P25, DOI 10.1016/j.toxlet.2012.09.017
   Patel AK, 2008, INT J CLIN EXP MED, V1, P181
   Perez-Lloret S, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2016.1
   Perrone A, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/3818196
   Piao Y, 2013, J TOXICOL PATHOL, V26, P29, DOI 10.1293/tox.26.29
   Prakash A, 2013, CLIN EXP PHARMACOL P, V40, P644, DOI 10.1111/1440-1681.12144
   Qu Z, 2016, PHYSIOL BEHAV, V154, P114, DOI 10.1016/j.physbeh.2015.11.016
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Rozan P, 2007, J FOOD SCI, V72, pS203, DOI 10.1111/j.1750-3841.2007.00297.x
   Rusconi M, 2010, PHARMACOL RES, V61, P5, DOI 10.1016/j.phrs.2009.08.008
   Shah SA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.538
   Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Turgut NH, 2016, PHARM BIOL, V54, P1052, DOI 10.3109/13880209.2015.1101476
   Minh Doan V, 2015, FOOD FUNCT, V6, P1712, DOI [10.1039/C5FO00238A, 10.1039/c5fo00238a]
   Vauzour D, 2008, GENES NUTR, V3, P115, DOI 10.1007/s12263-008-0091-4
   Yamade T, 2009, J NUTR BIOCHEM, V20, P948, DOI 10.1016/j.jnutbio.2008.08.007
   Zhao MH, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00071
   Zhu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101291
NR 51
TC 3
Z9 3
U1 2
U2 12
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 9
PY 2021
VL 11
IS 1
AR 17914
DI 10.1038/s41598-021-96800-y
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA UP3GW
UT WOS:000695272000005
PM 34504131
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Taner, CB
   Ung, RL
   Rosser, BG
   Aranda-Michel, J
AF Taner, C. Burcin
   Ung, Ryan L.
   Rosser, Barry G.
   Aranda-Michel, Jaime
TI Age is not a contraindication for orthotopic liver transplantation: a
   single institution experience with recipients older than 75 years
SO HEPATOLOGY INTERNATIONAL
LA English
DT Article
DE Liver transplantation; Outcome; Recipient age
ID OUTCOMES; MODEL
AB Introduction Transplant community has arbitrary age limit for liver transplantation based on the increased comorbidities in aging population. There has been an increased demand to consider older patients to have access to liver transplantation as the US population continues to live longer with better health.
   Methods This is a single institution, retrospective review of patients, who were age 75 or over underwent liver transplantation.
   Results There were 13 patients, who were 75 years or older at the time of orthotopic liver transplantation. There were no intraoperative or perioperative deaths. Seven of 13 patients are still alive (53.8%) with a mean survival of 65 months.
   Conclusion Our study demonstrates that a with proper evaluation and careful consideration of risk factors, individuals older than 75 years of age can undergo this life-saving procedure with acceptable long-term survival.
C1 [Taner, C. Burcin; Ung, Ryan L.; Rosser, Barry G.; Aranda-Michel, Jaime] Mayo Clin Florida, Dept Transplantat, Jacksonville, FL 32224 USA.
C3 Mayo Clinic
RP Taner, CB (corresponding author), Mayo Clin Florida, Dept Transplantat, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.
EM taner.burcin@mayo.edu
CR Aduen JF, 2009, MAYO CLIN PROC, V84, P973, DOI 10.1016/S0025-6196(11)60667-8
   Aloia TA, 2010, LIVER TRANSPLANT, V16, P950, DOI 10.1002/lt.22098
   Avolio AW, 2008, TRANSPL P, V40, P1899, DOI 10.1016/j.transproceed.2008.05.070
   Berg CL, 2009, AM J TRANSPLANT, V9, P907, DOI 10.1111/j.1600-6143.2009.02567.x
   BROMLEY PN, 1994, TRANSPLANTATION, V58, P800, DOI 10.1097/00007890-199410150-00009
   Carithers RL, 2000, LIVER TRANSPLANT, V6, P122
   Collins BH, 2000, TRANSPLANTATION, V70, P780, DOI 10.1097/00007890-200009150-00012
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Futagawa Y, 2004, CLIN TRANSPL, P325
   Garcia CE, 2001, TRANSPLANTATION, V72, P679, DOI 10.1097/00007890-200108270-00021
   Herrero JI, 2003, AM J TRANSPLANT, V3, P1407, DOI 10.1046/j.1600-6143.2003.00227.x
   Keswani RN, 2004, LIVER TRANSPLANT, V10, P957, DOI 10.1002/lt.20155
   Levy MF, 2001, ANN SURG, V233, P107, DOI 10.1097/00000658-200101000-00016
   PIRSCH JD, 1991, TRANSPLANTATION, V51, P431, DOI 10.1097/00007890-199102000-00031
   Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016
NR 15
TC 24
Z9 25
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1936-0533
EI 1936-0541
J9 HEPATOL INT
JI Hepatol. Int.
PD JAN
PY 2012
VL 6
IS 1
BP 403
EP 407
DI 10.1007/s12072-011-9286-7
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 893NO
UT WOS:000300362800011
PM 21688082
DA 2024-02-19
ER

PT J
AU Zumsteg, D
   Wieser, HG
AF Zumsteg, D
   Wieser, HG
TI Effects of aging and sex on middle-latency somatosensory evoked
   potentials: normative data
SO CLINICAL NEUROPHYSIOLOGY
LA English
DT Article
DE somatosensory evoked potential; middle-latency; aging; development;
   gender
ID HUMAN HEAD TRAUMA; HEPATIC-ENCEPHALOPATHY; SCALP TOPOGRAPHY;
   BRAIN-FUNCTION; DOWNS-SYNDROME; YOUNG-ADULTS; INJURY; STIMULATION;
   DYSFUNCTION; PREDICTION
AB Objectives: To investigate the exact relationship of middle-latency somatosensory evoked potential (SEP) components (in particular the third negative component N60) to age and sex in a normal population. Middle-latency SEPs are believed to show a considerable inter-individual variability and there is little published information on normative data of these components.
   Methods: Eighty-three healthy subjects aged 13-80 years were investigated using a standard SEP procedure.
   Results: Both latency and amplitude of N60 increased substantially with age. Least square polynomial regression analysis showed that a quadratic curve best described its relationship (r(2) = 0.67 for the latency, r(2) = 0.18 for the amplitude). Data did not differ significantly with reference to sex or side of stimulation.
   Conclusions: The use of polynomial regression analysis for the determination of the normal range of N60 latencies and amplitudes has to be highly recommended. It might improve the accuracy with which abnormal results are detected in studies investigating the value of middle-latency SEPs in various diseases. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.
C3 University of Zurich; University Zurich Hospital
RP Zumsteg, D (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin 26, CH-8091 Zurich, Switzerland.
CR BOSCH EP, 1985, MUSCLE NERVE, V8, P556, DOI 10.1002/mus.880080703
   DESMEDT JE, 1980, ELECTROEN CLIN NEURO, V50, P404, DOI 10.1016/0013-4694(80)90007-3
   DRECHSLER F, 1978, J NEUROL, V218, P197, DOI 10.1007/BF00313013
   Eisenhuber E, 1997, INTENS CARE MED, V23, P587, DOI 10.1007/s001340050377
   Ferri R, 1996, NEUROPHYSIOL CLIN, V26, P321, DOI 10.1016/S0987-7053(97)85099-X
   FERRI R, 1994, NEUROPHYSIOL CLIN, V24, P413, DOI 10.1016/S0987-7053(05)80074-7
   FERRI R, 1994, NEUROPHYSIOL CLIN, V24, P357, DOI 10.1016/S0987-7053(05)80249-7
   Ferri R, 1996, NEUROPHYSIOL CLIN, V26, P311, DOI 10.1016/S0987-7053(97)85098-8
   GOFF GD, 1977, ELECTROEN CLIN NEURO, V42, P57, DOI 10.1016/0013-4694(77)90151-1
   GOFF WR, 1966, ELECTROEN CLIN NEURO, V21, P1, DOI 10.1016/0013-4694(66)90053-8
   GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150
   GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227
   GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163
   GRIMM G, 1991, INTENS CARE MED, V17, P94, DOI 10.1007/BF01691430
   HE FS, 1993, ENVIRON RES, V60, P213, DOI 10.1006/enrs.1993.1029
   KAKIGI R, 1991, J CLIN NEUROPHYSIOL, V8, P320, DOI 10.1097/00004691-199107010-00008
   Kitamura Y, 1996, COGNITIVE BRAIN RES, V4, P275, DOI 10.1016/S0926-6410(96)00066-3
   Kramer L, 2000, HEPATOLOGY, V31, P30, DOI 10.1002/hep.510310107
   KULLMANN F, 1995, J HEPATOL, V22, P101, DOI 10.1016/0168-8278(95)80267-3
   LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796
   LUDERS H, 1970, ELECTROEN CLIN NEURO, V29, P450, DOI 10.1016/0013-4694(70)90062-3
   MADL C, 1994, HEPATOLOGY, V20, P1487, DOI 10.1002/hep.1840200618
   Madl C, 2000, CRIT CARE MED, V28, P721, DOI 10.1097/00003246-200003000-00020
   MADL C, 1993, LANCET, V341, P855, DOI 10.1016/0140-6736(93)93061-5
   MOULTON RJ, 1994, CLIN INVEST MED, V17, P187
   PFURTSCHELLER G, 1985, ELECTROEN CLIN NEURO, V62, P88, DOI 10.1016/0168-5597(85)90020-6
   SHAGASS C, 1965, SCIENCE, V148, P1359, DOI 10.1126/science.148.3675.1359
   SHAGASS C, 1984, BIOL PSYCHIAT, V19, P1507
   SHAGASS C, 1978, BIOL PSYCHIAT, V13, P163
   SHAGASS C, 1985, BIOL PSYCHIAT, V20, P701, DOI 10.1016/0006-3223(85)90150-7
   YAMADA T, 1982, ARCH NEUROL-CHICAGO, V39, P88, DOI 10.1001/archneur.1982.00510140022006
   YAMADA T, 1985, J NEUROL SCI, V68, P31, DOI 10.1016/0022-510X(85)90048-6
   YANG SS, 1985, GASTROENTEROLOGY, V89, P625, DOI 10.1016/0016-5085(85)90460-3
   Yang SS, 1998, HEPATOLOGY, V27, P357, DOI 10.1002/hep.510270207
   Zauner C, 2000, CRIT CARE MED, V28, P1310, DOI 10.1097/00003246-200005000-00009
NR 35
TC 20
Z9 21
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 1388-2457
J9 CLIN NEUROPHYSIOL
JI Clin. Neurophysiol.
PD MAY
PY 2002
VL 113
IS 5
BP 681
EP 685
AR PII S1388-2457(02)00054-8
DI 10.1016/S1388-2457(02)00054-8
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 554NL
UT WOS:000175742000006
PM 11976047
DA 2024-02-19
ER

PT J
AU Chen, ZQ
   Xiao, J
   Liu, H
   Yao, KF
   Hou, XN
   Cao, Y
   Liu, XJ
AF Chen, Zhiqing
   Xiao, Jie
   Liu, Han
   Yao, Kangfei
   Hou, Xiaoning
   Cao, Yong
   Liu, Xiaojuan
TI Astaxanthin attenuates oxidative stress and immune impairment
   ind-galactose-induced aging in rats by activating the Nrf2/Keap1 pathway
   and suppressing the NF-κB pathway
SO FOOD & FUNCTION
LA English
DT Article
ID INDUCED LIVER; ANTIOXIDANT; MODEL; ACID; NRF2; MICE; APOPTOSIS;
   PROTECTS; INJURY
AB As a potential antioxidant, astaxanthin (AST) exhibits anti-aging effects. However, its relationships to oxidative stress and immunity have yet to be sufficiently investigated. In this research, integrated analysis of oxidative stress and immunosenescence was performed to elucidate the efficacy and potential mechanisms of AST ind-galactose-induced aging in rats. The results showed that AST significantly decreased malonaldehyde (MDA) levels and increased antioxidase activity, in addition to demonstrating the ability to repair histopathological injuries to the liver, thereby attenuating oxidative stress. Nuclear factor erythroid 2-related factor 2 (Nrf2) expression was up-regulated by 117.95%, whereas Kelch-like ECH-associated protein-1 (Keap1) expression was simultaneously down-regulated by 51.22%. Moreover, AST significantly reduced interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) levels, as well as expression of nuclear factor-kappa B (NF-kappa B) (p65) and i-kappa-B-alpha (I kappa B alpha) proteins. Findings of repair of immune organs, as well as elevated levels of interleukin-2 (IL-2), immunoglobulin M (IgM) and immunoglobulin G (IgG), suggest a novel mechanism by which AST could regulate cellular immunity and humoral immunity to attenuate immunosenescence. The anti-aging effects of AST were shown to be due in part to the Nrf2/Keap1 and NF-kappa B pathways, and AST treatment ameliorated oxidative stress and immune impairment overall.
C1 [Chen, Zhiqing; Xiao, Jie; Liu, Han; Yao, Kangfei; Hou, Xiaoning; Cao, Yong; Liu, Xiaojuan] South China Agr Univ, Coll Food Sci, Guangdong Prov Key Lab Nutraceut & Funct Foods, Guangzhou 510642, Peoples R China.
   [Chen, Zhiqing; Xiao, Jie; Liu, Han; Yao, Kangfei; Hou, Xiaoning; Cao, Yong; Liu, Xiaojuan] Guangdong Lab Lingnan Modern Agr, Guangzhou 510642, Peoples R China.
C3 South China Agricultural University; Guangdong Laboratory for Lingnan
   Modern Agriculture
RP Liu, XJ (corresponding author), South China Agr Univ, Coll Food Sci, Guangdong Prov Key Lab Nutraceut & Funct Foods, Guangzhou 510642, Peoples R China.; Liu, XJ (corresponding author), Guangdong Lab Lingnan Modern Agr, Guangzhou 510642, Peoples R China.
EM liuxj@scau.edu.cn
OI Chen, Zhiqing/0000-0002-0040-5599
FU Natural Science Foundation of Guangdong Province [2019A1515011391,
   2017A030313150]; Guangzhou Science and Technology Plan Project
   [201707010035]; Program for Guangdong Introducing Innovative and
   Entrepreneurial Teams [2019ZT08N291]
FX This work was financially supported by the Natural Science Foundation of
   Guangdong Province (2019A1515011391; 2017A030313150), the Guangzhou
   Science and Technology Plan Project (201707010035), and the Program for
   Guangdong Introducing Innovative and Entrepreneurial Teams
   (2019ZT08N291).
CR [Anonymous], 2012, EVID BASED COMPLEMEN, DOI DOI 10.1016/J.TRAC.2011.08.009
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Banji OJF, 2014, FOOD CHEM TOXICOL, V74, P51, DOI 10.1016/j.fct.2014.08.020
   Bo-Htay C, 2018, J CELL MOL MED, V22, P1392, DOI 10.1111/jcmm.13472
   Che HX, 2018, J AGR FOOD CHEM, V66, P4948, DOI 10.1021/acs.jafc.8b00988
   Chen BF, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1974-z
   Chen SS, 2019, J AGR FOOD CHEM, V67, P3140, DOI 10.1021/acs.jafc.8b06402
   Chogtu B, 2018, CLIN PSYCHOPHARM NEU, V16, P153, DOI 10.9758/cpn.2018.16.2.153
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P490, DOI 10.1111/ggi.12096
   Dehghani A, 2019, AGING CLIN EXP RES, V31, P1195, DOI 10.1007/s40520-018-1075-x
   Du HM, 2019, BIOCHEMISTRY-MOSCOW+, V84, P617, DOI 10.1134/S000629791906004X
   El-Baz FK, 2018, ADV PHARM BULL, V8, P523, DOI 10.15171/apb.2018.061
   Fakhri S, 2019, MOLECULES, V24, DOI 10.3390/molecules24142640
   Farruggia C, 2018, J NUTR BIOCHEM, V62, P202, DOI 10.1016/j.jnutbio.2018.09.005
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Grimmig B, 2019, GEROSCIENCE, V41, P77, DOI 10.1007/s11357-019-00051-9
   Guo B, 2020, BIOGERONTOLOGY, V21, P311, DOI 10.1007/s10522-020-09859-x
   Guo H, 2020, EXP THER MED, V19, P557, DOI 10.3892/etm.2019.8261
   Guo L, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2019.11.005
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   Jeong H, 2017, EXP GERONTOL, V95, P16, DOI 10.1016/j.exger.2017.05.004
   Ji MS, 2017, EXP THER MED, V14, P5881, DOI 10.3892/etm.2017.5327
   Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007
   Kim SH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091137
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Lee E., 2020, J WOMEN AGING, V3, P1
   Li C, 2020, DEV COMP IMMUNOL, V103, DOI 10.1016/j.dci.2019.103526
   Li DD, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109204
   Li J, 2019, PROPAG ORNAM PLANTS, V19, P3
   Liu C, 2019, J AGR FOOD CHEM, V67, P10059, DOI 10.1021/acs.jafc.9b03847
   Liu GT, 2000, REPROD TOXICOL, V14, P377, DOI 10.1016/S0890-6238(00)00096-4
   Liu HY, 2018, FOOD AGR IMMUNOL, V29, P316, DOI 10.1080/09540105.2017.1376037
   Lopes-Paciencia S, 2019, CYTOKINE, V117, P15, DOI 10.1016/j.cyto.2019.01.013
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40953-4
   Mladenov M, 2015, PHYSIOL RES, V64, P891, DOI 10.33549/physiolres.932890
   Mohammadi E, 2018, AVICENNA J PHYTOMEDI, V8, P14
   Ni YH, 2018, ENDOCR J, V65, P569, DOI [10.1507/endocrj.ej17-0500, 10.1507/endocrj.EJ17-0500]
   O'Meara S, 2020, NATURE, V578, pS1, DOI 10.1038/d41586-020-00279-y
   Pall Martin L., 2015, Shengli Xuebao, V67, P1
   Parra MA, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020310
   Qi X, 2019, CLIN NUTR ESPEN, V33, P18, DOI 10.1016/j.clnesp.2019.07.004
   Rahimi VB, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116595
   Saber S, 2020, CANCER CHEMOTH PHARM, V85, P331, DOI 10.1007/s00280-020-04033-z
   Saleh DO, 2019, EUR J PHARMACOL, V855, P40, DOI 10.1016/j.ejphar.2019.04.043
   Shin JS, 2019, INFLAMMATION, V42, P342, DOI 10.1007/s10753-018-0898-0
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Song C., 2020, BIOL TRACE ELEM RES, P3
   Song EK, 2019, NUTR RES, V70, P60, DOI 10.1016/j.nutres.2018.09.011
   Song LL, 2020, MOL IMMUNOL, V117, P160, DOI 10.1016/j.molimm.2019.10.019
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Sun JZ, 2018, INT IMMUNOPHARMACOL, V58, P94, DOI 10.1016/j.intimp.2018.03.017
   Tang J, 2016, J ANIM PHYSIOL AN N, V100, P768, DOI 10.1111/jpn.12385
   Tarantini S, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101192
   Uddin MN, 2010, J IMMUNOTOXICOL, V7, P165, DOI 10.3109/15476910903510806
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Van Minh D., 2015, FOOD FUNCT, V6, P1712
   Wang JJ, 2019, NEUROSCI LETT, V704, P106, DOI 10.1016/j.neulet.2019.04.002
   Wu WQ, 2014, FOOD FUNCT, V5, P158, DOI 10.1039/c3fo60400d
   Xie JJ, 2020, AQUACULTURE, V518, DOI 10.1016/j.aquaculture.2019.734657
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yang X, 2019, MAR DRUGS, V17, DOI 10.3390/md17010024
   Zeng L, 2020, EXP GERONTOL, V131, DOI 10.1016/j.exger.2019.110823
   Zhang ZF, 2009, J AGR FOOD CHEM, V57, P7731, DOI 10.1021/jf9012357
   Zhao DR, 2019, J AGR FOOD CHEM, V67, P1230, DOI 10.1021/acs.jafc.8b06263
   Zhao FF, 2018, FOOD FUNCT, V9, P4814, DOI 10.1039/c8fo00740c
   Zhu K, 2019, FOOD SCI NUTR, V7, P4105, DOI 10.1002/fsn3.1278
   Zhuang W, 2019, AGING DIS, V10, P134, DOI 10.14336/AD.2018.0511
NR 69
TC 27
Z9 31
U1 3
U2 54
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD SEP 1
PY 2020
VL 11
IS 9
BP 8099
EP 8111
DI 10.1039/d0fo01663b
PG 13
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA NS8ZN
UT WOS:000572544200061
PM 32857080
DA 2024-02-19
ER

PT J
AU FRAEYMAN, N
   VANSCHEEUWIJCK, P
   DEWOLF, M
   QUATACKER, J
AF FRAEYMAN, N
   VANSCHEEUWIJCK, P
   DEWOLF, M
   QUATACKER, J
TI INFLUENCE OF AGING ON FLUIDITY AND COUPLING BETWEEN BETA-RECEPTORS AND
   G-PROTEINS IN RAT LUNG MEMBRANES
SO LIFE SCIENCES
LA English
DT Article
ID ADRENERGIC TRANSDUCTION SYSTEM; ADENYLATE-CYCLASE ACTIVITY;
   AGE-RELATED-CHANGES; PLASMA-MEMBRANES; AUTORADIOGRAPHIC LOCALIZATION;
   PHYSICOCHEMICAL PROPERTIES; SIGNAL TRANSDUCTION; HORMONE RECEPTORS;
   LIPID-COMPOSITION; LATERAL MOBILITY
AB We tested the hypothesis that in rat lung membranes, the age-related decline in the percentage of beta-receptors coupled with high affinity to G-proteins, is due to limitation of the diffusion caused by a decrease in membrane fluidity. We measured both parameters simultaneously in a crude membrane preparation from lungs of rat of different age. In contrast to what is found in crude membrane preparations from rat liver and brain, in rat lung fluidity was increased upon aging. We conclude that the age-related alteration in coupling between receptor and G-protein is difficult to explain by alterations of membrane fluidity.
C1 STATE UNIV GHENT,GOORMACHTIGH INST PATHOL,B-9000 GHENT,BELGIUM.
   RUCA,HUMAN BIOCHEM LAB,ANTWERP,BELGIUM.
C3 Ghent University; University of Antwerp
RP FRAEYMAN, N (corresponding author), STATE UNIV GHENT,HEYMANS INST PHARMACOL,DE PINTELAAN 185,B-9000 GHENT,BELGIUM.
CR ARMBRECHT HJ, 1982, EXP GERONTOL, V17, P41, DOI 10.1016/0531-5565(82)90007-9
   BARNES PJ, 1983, AM REV RESPIR DIS, V127, P758
   BARNES PJ, 1982, NATURE, V299, P444, DOI 10.1038/299444a0
   BENEDETTI A, 1988, BIOCHEM BIOPH RES CO, V156, P840, DOI 10.1016/S0006-291X(88)80920-3
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   BLOOM W, 1975, TXB HISTOLOGY, P748
   BRASITUS TA, 1985, BIOCHIM BIOPHYS ACTA, V812, P460, DOI 10.1016/0005-2736(85)90321-9
   BRASITUS TA, 1984, BIOCHIM BIOPHYS ACTA, V778, P341, DOI 10.1016/0005-2736(84)90378-X
   BRIGGS MM, 1980, BIOCHEMISTRY-US, V19, P4461, DOI 10.1021/bi00560a012
   CALDERINI G, 1983, NEUROCHEM RES, V8, P483, DOI 10.1007/BF00965104
   CIMINO M, 1984, LIFE SCI, V34, P2029, DOI 10.1016/0024-3205(84)90367-9
   DAVE JR, 1983, MECH AGEING DEV, V23, P235, DOI 10.1016/0047-6374(83)90023-4
   DEPAUW H, 1985, BIOCHIM BIOPHYS ACTA, V644, P623
   ENGELS F, 1989, EUR J PHARMACOL, V164, P139, DOI 10.1016/0014-2999(89)90240-9
   FELDMAN RD, 1984, NEW ENGL J MED, V310, P815, DOI 10.1056/NEJM198403293101303
   FELDMAN RD, 1988, MOL PHARMACOL, V35, P304
   FRAEYMAN N, 1991, NATO ASI SERIES H, V52, P193
   FREUND G, 1986, EXP GERONTOL, V21, P37, DOI 10.1016/0531-5565(86)90016-1
   HANEL HK, 1955, ACTA CHEM SCAND, V9, P677, DOI 10.3891/acta.chem.scand.09-0677
   HELMREICH EJM, 1985, TRENDS PHARMACOL SCI, V6, P438, DOI 10.1016/0165-6147(85)90208-1
   HENIS YI, 1989, TRENDS PHARMACOL SCI, V10, P95, DOI 10.1016/0165-6147(89)90201-0
   MALONEY AG, 1986, HEPATOLOGY, V6, P282, DOI 10.1002/hep.1840060221
   MCMURCHIE EJ, 1988, BIOCHIM BIOPHYS ACTA, V942, P324, DOI 10.1016/0005-2736(88)90034-X
   MOTULSKY HJ, 1987, GRAPHPAD
   MURIANA FJG, 1992, BIOCHIMIE, V74, P551, DOI 10.1016/0300-9084(92)90153-6
   NAGATOMO T, 1984, BIOCHEM MED METAB B, V32, P122, DOI 10.1016/0006-2944(84)90014-0
   Nagy K, 1983, Arch Gerontol Geriatr, V2, P23, DOI 10.1016/0167-4943(83)90014-6
   NOKUBO M, 1985, J GERONTOL, V40, P409, DOI 10.1093/geronj/40.4.409
   PETERS R, 1988, FEBS LETT, V234, P1, DOI 10.1016/0014-5793(88)81290-0
   PETKOVA DH, 1986, EXP GERONTOL, V21, P187, DOI 10.1016/0531-5565(86)90072-0
   POPPSNIJDERS C, 1986, BIOCHIM BIOPHYS ACTA, V854, P31, DOI 10.1016/0005-2736(86)90061-1
   RAND ML, 1988, LIPIDS, V23, P1019, DOI 10.1007/BF02535646
   RASENICK MM, 1981, NATURE, V294, P560, DOI 10.1038/294560a0
   RAYMOND JR, 1990, HYPERTENSION, V15, P119, DOI 10.1161/01.HYP.15.2.119
   RIMON G, 1978, NATURE, V276, P394, DOI 10.1038/276394a0
   ROUSER G, 1970, METHODS DIAGNOSTICS, P691
   SCARPACE P J, 1991, Drugs and Aging, V1, P116
   SCARPACE PJ, 1986, FASEB J, V45, P51
   SCHMUCKER DL, 1984, MECH AGEING DEV, V27, P207, DOI 10.1016/0047-6374(84)90046-0
   STORCH J, 1984, BIOCHIM BIOPHYS ACTA, V798, P137, DOI 10.1016/0304-4165(84)90021-7
   VANSCHEEUWIJCK P, 1989, EUR J PHARM-MOLEC PH, V172, P373, DOI 10.1016/0922-4106(89)90018-7
   VANSCHEEUWIJCK P, 1990, BIOCHEM PHARMACOL, V39, P2035, DOI 10.1016/0006-2952(90)90626-V
   VANSCHEEUWIJCK P, 1990, EUR J PHARM-MOLEC PH, V188, P129, DOI 10.1016/0922-4106(90)90048-3
   VIANI P, 1991, J NEUROCHEM, V56, P253, DOI 10.1111/j.1471-4159.1991.tb02589.x
   WINCE LC, 1981, J PHARMACOL EXP THER, V219, P625
   YEGUTKIN GG, 1991, MECH AGEING DEV, V59, P1, DOI 10.1016/0047-6374(91)90069-C
   YU BP, 1984, MECH AGEING DEV, V24, P67
NR 47
TC 14
Z9 14
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0024-3205
J9 LIFE SCI
JI Life Sci.
PY 1993
VL 53
IS 2
BP 153
EP 160
DI 10.1016/0024-3205(93)90662-M
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA LF441
UT WOS:A1993LF44100008
PM 8390597
DA 2024-02-19
ER

PT J
AU Gredilla, R
   Sánchez-Román, I
   Gómez, A
   López-Torres, M
   Barja, G
AF Gredilla, Ricardo
   Sanchez-Roman, Ines
   Gomez, Alexia
   Lopez-Torres, Monica
   Barja, Gustavo
TI Mitochondrial base excision repair positively correlates with longevity
   in the liver and heart of mammals
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Mitochondria; DNA repair; AP endonuclease; DNA glycosylases; Aging
ID DNA-POLYMERASE-BETA; MAXIMUM LIFE-SPAN; CALORIC RESTRICTION;
   ALZHEIMERS-DISEASE; BRAIN; DAMAGE; DEFICIENCY; AGE; HAPLOINSUFFICIENCY;
   INFLAMMATION
AB Damage to DNA is especially important for aging. High DNA repair could contribute, in principle, to lower such damage in long-lived species. However, previous studies showed that repair of endogenous damage to nuclear DNA (base excision repair, BER) is negatively or not correlated with mammalian longevity. However, we hypothesize here that mitochondrial, instead of nuclear, BER is higher in long-lived than in short-lived mammals. We have thus measured activities and/or protein levels of various BER enzymes including DNA glycosylases, NTHL1 and NEIL2, and the APE endonuclease both in total and mitochondrial liver and heart fractions from up to eight mammalian species differing by 13-fold in longevity. Our results show, for the first time, a positive correlation between (mitochondrial) BER and mammalian longevity. This suggests that the low steady-state oxidative damage in mitochondrial DNA of long-lived species would be due to both their lower mitochondrial ROS generation and their higher mitochondrial BER. Long-lived mammals do not need to continuously maintain high nuclear BER levels because they release less mitROS to the cytosol. This can be the reason why they tend to show lower nuclear BER values. The higher mitochondrial BER of long-lived mammals contributes to their superior longevity, agrees with the updated version of the mitochondrial free radical theory of aging, and indicates the special relevance of mitochondria and mitROS for aging.
C1 [Gredilla, Ricardo] Univ Complutense Madrid, Fac Med, Dept Physiol, Madrid, Spain.
   [Sanchez-Roman, Ines; Gomez, Alexia; Lopez-Torres, Monica; Barja, Gustavo] Univ Complutense Madrid, Fac Biol Sci, Dept Genet Physiol & Microbiol, Jose Antonio Novais S-N, E-28040 Madrid, Spain.
   [Sanchez-Roman, Ines] Univ Europea Madrid, Fac Biomed & Hlth Sci, Dept Basic Biomed Sci, Madrid, Spain.
C3 Complutense University of Madrid; Complutense University of Madrid;
   European University of Madrid
RP Barja, G (corresponding author), Univ Complutense Madrid, Fac Biol Sci, Dept Genet Physiol & Microbiol, Jose Antonio Novais S-N, E-28040 Madrid, Spain.
EM gredilla@ucm.es; Ines.sanchezroman@universidadeuropea.es;
   alexiagomezrguez@gmail.com; mltorres@ucm.es; gbarja@bio.ucm.es
RI Gustavo, Barja/B-5591-2012
OI Sanchez-Roman, Ines/0000-0003-4844-5781; GREDILLA,
   RICARDO/0000-0003-4501-1355; Barja, Gustavo/0000-0001-5736-4735
FU Spanish Ministry of Economy and Competitiveness [BFU2011-23888, [19] BIO
   MET 0155]
FX This investigation was supported in part by a grant from the Spanish
   Ministry of Economy and Competitiveness (BFU2011-23888) and PR[19] BIO
   MET 0155.
CR Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barja G, 2019, EXP GERONTOL, V124, DOI 10.1016/j.exger.2019.05.016
   Barja G, 2013, ANTIOXID REDOX SIGN, V19, P1420, DOI 10.1089/ars.2012.5148
   Brown MF, 2007, MECH AGEING DEV, V128, P696, DOI 10.1016/j.mad.2007.10.004
   Cabelof DC, 2003, CANCER RES, V63, P5799
   Cabelof DC, 2003, DNA REPAIR, V2, P295, DOI 10.1016/S1568-7864(02)00219-7
   Cabelof DC, 2006, CANCER RES, V66, P7460, DOI 10.1158/0008-5472.CAN-06-1177
   Canugovi C, 2014, NEUROBIOL AGING, V35, P1293, DOI 10.1016/j.neurobiolaging.2014.01.004
   Cortopassi GA, 1996, MECH AGEING DEV, V91, P211, DOI 10.1016/S0047-6374(96)01788-5
   FRANCIS AA, 1981, MECH AGEING DEV, V16, P181, DOI 10.1016/0047-6374(81)90094-4
   Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070
   Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756
   Gredilla R, 2017, BASE EXCISION REPAIR PATHWAY: MOLECULAR MECHANISMS AND ROLE IN DISEASE DEVELOPMENT AND THERAPEUTIC DESIGN, P773
   Gredilla R, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/282438
   Gredilla Ricardo, 2012, Methods Mol Biol, V920, P289, DOI 10.1007/978-1-61779-998-3_20
   Gredilla R, 2010, EXP GERONTOL, V45, P478, DOI 10.1016/j.exger.2010.01.017
   GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759
   HALL KY, 1984, MECH AGEING DEV, V24, P163, DOI 10.1016/0047-6374(84)90068-X
   HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169
   Hou YJ, 2017, MECH AGEING DEV, V161, P83, DOI 10.1016/j.mad.2016.04.005
   Huamani J, 2004, MOL CELL BIOL, V24, P8145, DOI 10.1128/MCB.24.18.8145-8153.2004
   Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006
   Iida T, 2002, ACTA NEUROPATHOL, V103, P20, DOI 10.1007/s004010100418
   Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013
   Kisby GE, 2010, EXP GERONTOL, V45, P208, DOI 10.1016/j.exger.2009.12.003
   Leclère R, 2013, BIOGERONTOLOGY, V14, P383, DOI 10.1007/s10522-013-9431-x
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   López-Lluch G, 2015, BIOGERONTOLOGY, V16, P599, DOI 10.1007/s10522-015-9585-9
   Lorenzini A, 2009, MECH AGEING DEV, V130, P784, DOI 10.1016/j.mad.2009.10.004
   Macedo JC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05258-6
   Meira LB, 2001, CANCER RES, V61, P5552
   Miwa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4837
   Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001
   Munro D, 2019, AGING CELL, V18, DOI 10.1111/acel.13009
   Munro D, 2019, AGING CELL, V18, DOI 10.1111/acel.12916
   Naudí A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00372
   Page MM, 2012, AGE, V34, P1195, DOI 10.1007/s11357-011-9302-9
   Page MM, 2010, AGE, V32, P255, DOI 10.1007/s11357-010-9131-2
   Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   Picca A, 2018, REJUV RES, V21, P350, DOI 10.1089/rej.2017.1989
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Shaposhnikov M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15299
   Soltys DT, 2019, NEUROBIOL AGING, V73, P161, DOI 10.1016/j.neurobiolaging.2018.09.015
   Stuart JA, 2004, FASEB J, V18, P595, DOI 10.1096/fj.03-0890fje
   Swain U, 2016, NEUROCHEM RES, V41, P270, DOI 10.1007/s11064-015-1787-7
   Sykora P, 2015, NUCLEIC ACIDS RES, V43, P943, DOI 10.1093/nar/gku1356
   Torregrosa-Muñmer R, 2016, BIOGERONTOLOGY, V17, P325, DOI 10.1007/s10522-015-9612-x
   TRETON JA, 1982, CELL BIOL INT REP, V6, P253, DOI 10.1016/0309-1651(82)90077-7
   Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605
   Zárate S, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00430
   Zsurka G, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040175
NR 52
TC 12
Z9 14
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2020 APR
PY 2020
VL 42
IS 2
SI SI
BP 653
EP 665
DI 10.1007/s11357-020-00158-4
EA JAN 2020
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LK7KR
UT WOS:000508724700001
PM 31970600
OA Green Published
DA 2024-02-19
ER

PT J
AU Hu, HR
   Cheng, XY
   Li, F
   Guan, Z
   Xu, J
   Wu, DM
   Gao, YY
   Zhan, XY
   Wang, P
   Zhou, HM
   Rao, ZQ
   Cheng, F
AF Hu, Haoran
   Cheng, Xuyu
   Li, Fei
   Guan, Zhu
   Xu, Jian
   Wu, Dongming
   Gao, Yiyun
   Zhan, Xinyu
   Wang, Ping
   Zhou, Haoming
   Rao, Zhuqing
   Cheng, Feng
TI Defective efferocytosis by aged macrophages promotes STING signaling
   mediated inflammatory liver injury
SO CELL DEATH DISCOVERY
LA English
DT Article
ID ISCHEMIA-REPERFUSION INJURY; RECEPTOR TYROSINE KINASE; MERTK CLEAVAGE;
   BLOCKADE; REPAIR
AB Aged livers have shown aggravated liver ischemia and reperfusion (IR) injury. Timely efferocytosis of apoptotic cells is a key mechanism for avoiding excessive inflammation and tissue injury. Here, we investigated the alteration of efferocytosis by aged macrophages and its role in regulating macrophage STING (stimulator of interferon genes) signaling and liver IR injury. Aged and young mice were subjected to liver partial IR model. Liver injury and inflammation were measured. Efferocytosis by aged macrophages and the underlying regulatory mechanism were analyzed as well. Aged macrophages exhibited impaired efferocytosis with decreased MerTK (c-mer proto-oncogene tyrosine kinase) activation, which was reversed by treatment of the MerTK CRISPR activation plasmid. Increased MerTK cleavage by ADAM17 (a disintegrin and metalloproteinase 17) due to enhanced ROS (reactive oxygen species) levels contributed to defective efferocytosis by aged macrophages. MerTK activation by suppressing ADAM17 or ROS improved aged macrophage efferocytosis, leading to reduced inflammatory liver injury. Moreover, increased apoptotic hepatocytes, DNA accumulation, and macrophage STING activation were observed in aged ischemic livers. Improvement in efferocytosis by aged macrophages via MerTK activation suppressed STING activation and inflammatory liver injury. Our study demonstrates that aging suppresses MerTK- mediated macrophage efferocytosis to promote macrophage STING activation and inflammatory liver IR injury, suggesting a new mechanism and potential therapy to promote inflammation resolution and efferocytosis in aged livers.
C1 [Hu, Haoran; Xu, Jian; Wu, Dongming; Gao, Yiyun; Zhan, Xinyu; Wang, Ping; Zhou, Haoming; Cheng, Feng] Nanjing Med Univ, Affiliated Hosp 1, Hepatobiliary Ctr, Nanjing 210029, Jiangsu Provinc, Peoples R China.
   [Hu, Haoran; Xu, Jian; Wu, Dongming; Gao, Yiyun; Zhan, Xinyu; Wang, Ping; Zhou, Haoming; Cheng, Feng] Chinese Acad Med Sci, Res Unit Liver Transplantat & Transplant Immunol, Key Lab Liver Transplantat, Nanjing 210029, Jiangsu Provinc, Peoples R China.
   [Hu, Haoran; Xu, Jian; Wu, Dongming; Gao, Yiyun; Zhan, Xinyu; Wang, Ping; Zhou, Haoming; Cheng, Feng] Nanjing Med Univ, NHC Key Lab Living Donor Liver Transplantat, Nanjing 210029, Jiangsu Provinc, Peoples R China.
   [Cheng, Xuyu] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing 210029, Jiangsu, Peoples R China.
   [Li, Fei; Guan, Zhu; Rao, Zhuqing] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing 210029, Jiangsu, Peoples R China.
C3 Nanjing Medical University; Chinese Academy of Medical Sciences - Peking
   Union Medical College; Nanjing Medical University; Nanjing Medical
   University; Nanjing Medical University
RP Zhou, HM; Cheng, F (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Hepatobiliary Ctr, Nanjing 210029, Jiangsu Provinc, Peoples R China.; Zhou, HM; Cheng, F (corresponding author), Chinese Acad Med Sci, Res Unit Liver Transplantat & Transplant Immunol, Key Lab Liver Transplantat, Nanjing 210029, Jiangsu Provinc, Peoples R China.; Zhou, HM; Cheng, F (corresponding author), Nanjing Med Univ, NHC Key Lab Living Donor Liver Transplantat, Nanjing 210029, Jiangsu Provinc, Peoples R China.; Rao, ZQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing 210029, Jiangsu, Peoples R China.
EM hmzhou@njmu.edu.cn; zhuqingraojsph@163.com; docchengfeng@njmu.edu.cn
RI Yun, Ji/KAL-9759-2024; luo, yuan/JLS-6416-2023
FU National Natural Science Foundation of China [82071798, 81901628]; CAMS
   Innovation Fund for Medical Sciences [2019-I2M-5-035]; Medical research
   project of Jiangsu Provincial Health Commission [ZD2021022]; Jiangsu
   Provincial Medical Innovation Center [CXZX202203]; Jiangsu Provincial
   Medical Key Laboratory [ZDXYS202201]
FX AcknowledgementsThis study was supported by the National Natural Science
   Foundation of China (No. 82071798 and 81901628), CAMS Innovation Fund
   for Medical Sciences (No. 2019-I2M-5-035), Medical research project of
   Jiangsu Provincial Health Commission (ZD2021022), Jiangsu Provincial
   Medical Innovation Center (CXZX202203) and Jiangsu Provincial Medical
   Key Laboratory (ZDXYS202201).
CR Akalu YT, 2017, IMMUNOL REV, V276, P165, DOI 10.1111/imr.12522
   Boada-Romero E, 2020, NAT REV MOL CELL BIO, V21, P398, DOI 10.1038/s41580-020-0232-1
   Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033
   Cai BS, 2020, CELL METAB, V31, P406, DOI 10.1016/j.cmet.2019.11.013
   Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113
   Cai W, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131355
   De Maeyer RPH, 2021, IMMUNOL LETT, V230, P1, DOI 10.1016/j.imlet.2020.12.003
   DeBerge M, 2017, CIRC RES, V121, P930, DOI 10.1161/CIRCRESAHA.117.311327
   Dickson KM, 2020, TRANSPLANT REV-ORLAN, V34, DOI 10.1016/j.trre.2020.100549
   Doran AC, 2020, NAT REV IMMUNOL, V20, P254, DOI 10.1038/s41577-019-0240-6
   Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4
   Höhn A, 2017, REDOX BIOL, V11, P482, DOI 10.1016/j.redox.2016.12.001
   Hopfner KP, 2020, NAT REV MOL CELL BIO, V21, P501, DOI 10.1038/s41580-020-0244-x
   Horst AK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02670
   Howangyin KY, 2016, CIRCULATION, V133, P826, DOI 10.1161/CIRCULATIONAHA.115.020857
   Huang HT, 2022, LIVER INT, V42, P2620, DOI 10.1111/liv.15380
   Huang W, 2022, JCI INSIGHT, V7, DOI 10.1172/jci.insight.158571
   Jia DL, 2022, CIRCULATION, V145, P1542, DOI 10.1161/CIRCULATIONAHA.121.057549
   Kadono K, 2022, J HEPATOL, V76, P896, DOI 10.1016/j.jhep.2021.11.026
   Kan CY, 2018, TRANSPLANTATION, V102, P368, DOI 10.1097/TP.0000000000001999
   Kang JW, 2016, BBA-MOL CELL BIOL L, V1861, P1025, DOI 10.1016/j.bbalip.2016.06.002
   Linehan E, 2014, AGING CELL, V13, P699, DOI 10.1111/acel.12223
   Liu Z, 2022, REDOX BIOL, V52, DOI 10.1016/j.redox.2022.102305
   Lu L, 2016, TRANSPLANTATION, V100, P2601, DOI 10.1097/TP.0000000000001411
   Mehrotra P, 2022, NAT REV DRUG DISCOV, V21, P601, DOI 10.1038/s41573-022-00470-y
   Myers KV, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1022-2
   Ni M, 2021, HEPATOLOGY, V74, P2118, DOI 10.1002/hep.31906
   Rymut N, 2020, FASEB J, V34, P597, DOI 10.1096/fj.201902126R
   Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634
   Shi SJ, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.890353
   Tang DL, 2019, CELL RES, V29, P347, DOI 10.1038/s41422-019-0164-5
   Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020
   Tummers B, 2022, PHYSIOL REV, V102, DOI 10.1152/physrev.00002.2021
   Uehara T, 2005, J HEPATOL, V42, P850, DOI 10.1016/j.jhep.2005.01.030
   Vago JP, 2021, PHARMACOL THERAPEUT, V227, DOI 10.1016/j.pharmthera.2021.107893
   Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198
   Wang Q, 2022, J HEPATOL, V77, P312, DOI 10.1016/j.jhep.2022.02.031
   Yamada N, 2020, AM J TRANSPLANT, V20, P1606, DOI 10.1111/ajt.15773
   Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225
   Zhang Y, 2019, AM J PHYSIOL-CELL PH, V317, pC776, DOI 10.1152/ajpcell.00145.2019
   Zhao Y, 2023, NAT REV IMMUNOL, V23, P75, DOI 10.1038/s41577-022-00751-y
   Zhong WZ, 2022, AGING CELL, V21, DOI 10.1111/acel.13622
   Zhong WZ, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2822
   Zhong WZ, 2020, AGING CELL, V19, DOI 10.1111/acel.13186
   Zhou HM, 2021, AM J TRANSPLANT, V21, P1453, DOI 10.1111/ajt.16327
   Zhou HM, 2018, J HEPATOL, V69, P99, DOI 10.1016/j.jhep.2018.01.036
   Zhou Y, 2020, IMMUNITY, V52, P357, DOI 10.1016/j.immuni.2020.01.014
NR 47
TC 3
Z9 3
U1 8
U2 10
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2058-7716
J9 CELL DEATH DISCOV
JI Cell Death Discov.
PD JUL 8
PY 2023
VL 9
IS 1
AR 236
DI 10.1038/s41420-023-01497-9
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA L7MZ1
UT WOS:001025076800003
PM 37422464
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Gloux, A
   Le Roy, N
   Même, N
   Piketty, ML
   Prié, D
   Benzoni, G
   Gautron, J
   Nys, Y
   Narcy, A
   Duclos, MJ
AF Gloux, A.
   Le Roy, N.
   Meme, N.
   Piketty, M. L.
   Prie, D.
   Benzoni, G.
   Gautron, J.
   Nys, Y.
   Narcy, A.
   Duclos, M. J.
TI Increased expression of fibroblast growth factor 23 is the signature of
   a deteriorated Ca/P balance in ageing laying hens
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VITAMIN-D METABOLISM; CHOLECALCIFEROL METABOLISM; ORGANIC MATRIX; AGE;
   QUALITY; OSTEOPOROSIS; POPULATIONS; PHOSPHORUS; SHELL; PUMP
AB The present study concerned the effect of ageing in laying hens, from 23 to 90 weeks of age, on the regulation of Ca metabolism related to the requirement for eggshell mineralization. Samples were collected from parathyroid gland (PG), liver, jejunum, medullary bone (MB) and kidney for a quantitative study of candidate gene expression. Although parathyroid hormone (PTH) gene expression in the PG did not vary with age, a stronger challenge to Ca homeostasis was suggested in aged hens. Indeed gene expression of Ca transporters, Vitamin D Receptor (VDR) in the jejunum, and that of transient receptor potential channel subfamily V member 5 (TRPV5) in the kidney decreased. This could exacerbate bone resorption and impair bone accretion, as attested by a higher expression of the Carbonic Anhydrase 2 (CA2) gene and a lower expression of collagen type I alpha 1 chain (COL1A1) in the MB. The increased expression of Fibroblast Growth Factor 23 (FGF23) in the MB likely contributed to the decreased plasma levels of 1.25(OH)(2)D-3 and the altered expression of target genes under its regulation. Our data highlights the molecular mechanisms underlying the osteoporotic syndrome previously documented in aged laying hens, thus providing new perspectives for future interventions.
C1 [Gloux, A.; Le Roy, N.; Meme, N.; Gautron, J.; Nys, Y.; Narcy, A.; Duclos, M. J.] Univ Tours, INRAE, UMR BOA, F-37380 Nouzilly, France.
   [Piketty, M. L.; Prie, D.] Univ Paris 05, Serv Explorat Fonct, GH Necker Enfants Malades, Fac Med,INSERM,U11513, F-75743 Paris 15, France.
   [Benzoni, G.] ADM Anim Nutr, F-56250 Talhouet, St Nolff, France.
C3 Universite de Tours; INRAE; Universite Paris Cite; Institut National de
   la Sante et de la Recherche Medicale (Inserm)
RP Duclos, MJ (corresponding author), Univ Tours, INRAE, UMR BOA, F-37380 Nouzilly, France.
EM michel.duclos@inrae.fr
RI Gautron, Joel/A-1753-2017; DUCLOS, Michel/AAQ-3957-2021
OI Gautron, Joel/0000-0001-7800-0578; DUCLOS, Michel/0000-0002-9305-3982;
   Le Roy, Nathalie/0000-0002-7840-0018; GLOUX, Audrey/0000-0001-7717-3725
FU Institut Carnot "France Futur Elevage"
FX The authors are grateful to Maryse Leconte, Jacky Ezagal and Jean-Eudes
   Bavay (INRAE Universite de Tours, UMR BOA, France) for their technical
   assistance, to Christelle Hennequet-Antier for expert advice on
   statistical analysis, and to Philippe Didier for the care of
   experimental birds at INRAE Poultry Experimental Facility (2018,
   https://doi.org/10.15454/1.5572326250887292E12).The research was
   supported by a research grant from Institut Carnot "France Futur
   Elevage", and was part of the PhD project of Audrey Gloux.
CR ABE E, 1982, J NUTR, V112, P436, DOI 10.1093/jn/112.3.436
   ALBATSHAN HA, 1994, POULTRY SCI, V73, P1590, DOI 10.3382/ps.0731590
   Bain MM, 2016, BRIT POULTRY SCI, V57, P330, DOI 10.1080/00071668.2016.1161727
   Bain MM, 1990, THESIS U GLASGOW
   Balla B, 2008, CALCIFIED TISSUE INT, V82, P12, DOI 10.1007/s00223-007-9092-3
   BAR A, 1987, J NUTR, V117, P1775, DOI 10.1093/jn/117.10.1775
   BAR A, 1988, J NUTR, V118, P1018, DOI 10.1093/jn/118.8.1018
   Bar A, 2009, COMP BIOCHEM PHYS A, V152, P447, DOI [10.1016/j.cbpa.2008.07.006, 10.1016/j.cbpa.2008.11.020]
   Braw-Tal R, 2004, BRIT POULTRY SCI, V45, P815, DOI 10.1080/00071660400012782
   Celik E, 2013, MINERVA MED, V104, P497
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Erben RG, 2017, BONE, V100, P62, DOI 10.1016/j.bone.2016.09.010
   Eusemann BK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194974
   Franco-Jimenez D. J., 2005, International Journal of Poultry Science, V4, P518
   Gattineni J., 2019, AM J PHYSIOL, V297, P282
   Gloux A, 2020, DOMEST ANIM ENDOCRIN, V72, DOI 10.1016/j.domaniend.2019.106407
   Gloux A, 2019, POULTRY SCI, V98, P6005, DOI 10.3382/ps/pez407
   Hansen KK, 2003, POULTRY SCI, V82, P1624, DOI 10.1093/ps/82.10.1624
   HORST RL, 1990, ENDOCRINOLOGY, V126, P1053, DOI 10.1210/endo-126-2-1053
   Johnson JA, 1995, EXP GERONTOL, V30, P631, DOI 10.1016/0531-5565(95)00014-3
   Kerschnitzki M, 2014, BONE, V69, P109, DOI 10.1016/j.bone.2014.08.019
   Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050
   Kim WK, 2012, WORLD POULTRY SCI J, V68, P71, DOI 10.1017/S0043933912000086
   KNOTT L, 1995, BIOCHEM J, V310, P1045, DOI 10.1042/bj3101045
   Kogawa M, 2010, J STEROID BIOCHEM, V121, P277, DOI 10.1016/j.jsbmb.2010.03.048
   Kuro-o M, 2008, TRENDS ENDOCRIN MET, V19, P239, DOI 10.1016/j.tem.2008.06.002
   Lanske B, 2014, KIDNEY INT, V86, P1071, DOI 10.1038/ki.2014.316
   Moor MB, 2016, AM J PHYSIOL-RENAL, V310, pF1337, DOI 10.1152/ajprenal.00273.2015
   Nys Y, 2010, PROD ANIM, V23, P143
   Nys Y., 2001, P 13 EUR S POULTR NU, P45
   Nys Y, 2017, VITAMIN VOLUME 1 PHY, V1, P361
   Panheleux M, 2000, POULTRY SCI, V79, P580, DOI 10.1093/ps/79.4.580
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Ren ZZ, 2017, POULTRY SCI, V96, P127, DOI 10.3382/ps/pew189
   Riihonen R, 2007, BONE, V40, P1021, DOI 10.1016/j.bone.2006.11.028
   Roberts J, 2017, BURL DODDS AGR SCI, V17, P29, DOI 10.19103/AS.2016.0012.33
   Rutkovskiy A, 2016, MED SCI MONIT BASIC, V22, P95, DOI 10.12659/MSMBR.901142
   SAAREM K, 1987, BIOCHEM J, V247, P73, DOI 10.1042/bj2470073
   SAUVEUR B, 1983, REPROD NUTR DEV, V23, P755, DOI 10.1051/rnd:19830508
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   Tumová E, 2014, CZECH J ANIM SCI, V59, P435, DOI 10.17221/7655-CJAS
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   VANDEVELDE JP, 1984, METAB BONE DIS RELAT, V5, P191, DOI 10.1016/0221-8747(84)90029-8
   Veldurthy V, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.41
   WASSERMAN RH, 1992, GASTROENTEROLOGY, V102, P886, DOI 10.1016/0016-5085(92)90174-W
   Whitehead CC, 2000, POULTRY SCI, V79, P1033, DOI 10.1093/ps/79.7.1033
   Whitehead CC, 2004, POULTRY SCI, V83, P193, DOI 10.1093/ps/83.2.193
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
   ZELINSKI JM, 1991, BIOCHEM BIOPH RES CO, V179, P749, DOI 10.1016/0006-291X(91)91880-L
NR 49
TC 6
Z9 7
U1 0
U2 11
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 3
PY 2020
VL 10
IS 1
AR 21124
DI 10.1038/s41598-020-78106-7
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA QD2ZZ
UT WOS:000615394300124
PM 33273568
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Han, WM
   Apornpong, T
   Gatechompol, S
   Ubolyam, S
   Chattranukulchai, P
   Wattanachanya, L
   Siwamogsatham, S
   Kerr, SJ
   Erlandson, KM
   Avihingsanon, A
AF Han, Win Min
   Apornpong, Tanakorn
   Gatechompol, Sivaporn
   Ubolyam, Sasiwimol
   Chattranukulchai, Pairoj
   Wattanachanya, Lalita
   Siwamogsatham, Sarawut
   Kerr, Stephen J.
   Erlandson, Kristine M.
   Avihingsanon, Anchalee
TI Association of Phenotypic Aging Marker with comorbidities, frailty and
   inflammatory markers in people living with HIV
SO BMC GERIATRICS
LA English
DT Article
DE Phenotypic aging marker; Phenotypic age acceleration; HIV/AIDS; Frailty;
   Aging; Comorbidities; Thailand
ID COGNITIVE IMPAIRMENT; AGE ACCELERATION; DNA METHYLATION; INFECTION;
   OLDER; MORTALITY; ADULTS; BIOMARKER; INDEX
AB Background: Aging characteristics in people living with HIV (PLWH) are heterogeneous, and the identification of risk factors associated with aging-related comorbidities such as neurocognitive impairment (NCI) and frailty is important. We evaluated predictors of novel aging markers, phenotypic age (PhenoAge) and phenotypic age acceleration (PAA) and their association with comorbidities, frailty, and NCI. Methods: In a cohort of PLWH and age- and sex-matched HIV-negative controls, we calculated PhenoAge using chronological age and 9 biomarkers from complete blood counts, inflammatory, metabolic-, liver- and kidney-related parameters. PAA was calculated as the difference between chronological age and PhenoAge. Multivariate logistic regression models were used to identify the factors associated with higher (> median) PAA. Area under the receiver operating characteristics curve (AUROC) was used to assess model discrimination for frailty. Results: Among 333 PLWH and 102 HIV-negative controls (38% female), the median phenotypic age (49.4 vs. 48.5 years, p = 0.54) and PAA (- 6.7 vs. -7.5, p = 0.24) was slightly higher and PAA slightly less in PLWH although this did not reach statistical significance. In multivariate analysis, male sex (adjusted odds ratio = 1.68 [95%CI = 1.03-2.73]), current smoking (2.74 [1.30-5.79]), diabetes mellitus (2.97 [1.48-5.99]), hypertension (1.67 [1.02-2.72]), frailty (3.82 [1.33-10.93]), and higher IL-6 levels (1.09 [1.04-1.15]), but not HIV status and NCI, were independently associated with higher PAA. PhenoAge marker discriminated frailty better than chronological age alone (AUROC: 0.75 [0.66-0.85] vs. 0.65 [0.55-0.77], p = 0.04). In the analysis restricted to PLWH, PhenoAge alone predicted frailty better than chronological age alone (AUROC: 0.7412 vs. 0.6499, P = 0.09) and VACS index (AUROC: 0.7412 vs. 0.6811, P = 0.34) despite not statistically significant. Conclusions: While PLWH did not appear to have accelerated aging in our cohort, the phenotypic aging marker was significantly associated with systemic inflammation, frailty, and cardiovascular disease risk factors. This simple aging marker could be useful to identify high-risk PLWH within a similar chronological age group.
C1 [Han, Win Min; Apornpong, Tanakorn; Gatechompol, Sivaporn; Ubolyam, Sasiwimol; Kerr, Stephen J.; Avihingsanon, Anchalee] HIV Netherlands Australia Thailand Res Collaborat, Thai Red Cross AIDS Res Ctr, Bangkok, Thailand.
   [Han, Win Min; Gatechompol, Sivaporn; Ubolyam, Sasiwimol; Avihingsanon, Anchalee] Chulalongkorn Univ, Fac Med, Ctr Excellence TB, Dept Med, Bangkok, Thailand.
   [Chattranukulchai, Pairoj] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Div Cardiovasc Med, Bangkok, Thailand.
   [Wattanachanya, Lalita] Chulalongkorn Univ, Fac Med, Dept Med, Div Endocrinol & Metab, Bangkok, Thailand.
   [Wattanachanya, Lalita] King Chulalongkorn Mem Hosp, Excellence Ctr Diabet Hormone & Metab, Bangkok, Thailand.
   [Siwamogsatham, Sarawut] Chulalongkorn Univ, Hosp Med, Fac Med, Div Ambulatory, Bangkok, Thailand.
   [Siwamogsatham, Sarawut] Chulalongkorn Univ, Fac Med, Chula Clin Res Ctr, Bangkok, Thailand.
   [Kerr, Stephen J.] UNSW Sydney, Kirby Inst, Sydney, Australia.
   [Kerr, Stephen J.] Chulalongkorn Univ, Fac Med, Biostat Excellence Ctr, Bangkok, Thailand.
   [Erlandson, Kristine M.] Univ Colorado Anschutz Med Campus, Sch Med, Div Infect Dis, Aurora, CO USA.
C3 Thai Red Cross Society; Chulalongkorn University; Chulalongkorn
   University; Chulalongkorn University; Chulalongkorn University;
   Chulalongkorn University; Chulalongkorn University; University of New
   South Wales Sydney; Kirby Institute; Chulalongkorn University;
   University of Colorado System; University of Colorado Anschutz Medical
   Campus
RP Han, WM (corresponding author), HIV Netherlands Australia Thailand Res Collaborat, Thai Red Cross AIDS Res Ctr, Bangkok, Thailand.; Han, WM (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence TB, Dept Med, Bangkok, Thailand.
EM win.m@hivnat.org
RI Kerr, Stephen/J-6126-2012; Han, Win Min/ABB-5988-2020
OI Kerr, Stephen/0000-0002-1919-4525; 
FU Thai government through the National Research Council of Thailand;
   Chulalongkorn University; Office of the Higher Education Commission
   (Health Cluster) [GRB_APS_04_16_30_03, GRB_APS_12_58_30_09,
   GRB_APS_04_59_30_03]; Ratchadapiseksompotch Fund, Faculty of Medicine,
   Chulalongkorn University [RA61/008]; National Research University (NRU),
   Health Cluster [NRU59-014-HR]
FX The study was funded by the Thai government through the National
   Research Council of Thailand and Chulalongkorn University under the
   Fiscal Year Budget 2014 to 2016, the National Research University (NRU),
   Health Cluster, grant number NRU59-014-HR, the Office of the Higher
   Education Commission (Health Cluster) grant number GRB_APS_04_16_30_03,
   GRB_APS_12_58_30_09 (year 2015) and GRB_APS_04_59_30_03 (year 2016), and
   the Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn
   University under the grant number RA61/008.
CR Aberg Judith A, 2020, Top Antivir Med, V27, P102
   Aita SL, 2021, J NEUROVIROL, V27, P568, DOI 10.1007/s13365-021-00991-z
   Alonso A, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012241
   Arunpongpaisal Suwanna, 2013, Journal of the Medical Association of Thailand, V96, P860
   Borges AH, 2016, J INFECT DIS, V214, P408, DOI 10.1093/infdis/jiw173
   Esteban-Cantos A, 2021, LANCET HIV, V8, pe197, DOI 10.1016/S2352-3018(21)00006-0
   Gross AM, 2016, MOL CELL, V62, P157, DOI 10.1016/j.molcel.2016.03.019
   Han WM, 2018, AIDS RES THER, V15, DOI 10.1186/s12981-018-0200-4
   Hiransuthikul A, 2019, AIDS RES HUM RETROV, V35, P1170, DOI [10.1089/aid.2019.0139, 10.1089/AID.2019.0139]
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Horvath S, 2015, J INFECT DIS, V212, P1563, DOI 10.1093/infdis/jiv277
   Justice A., 2022, LANCET HEALTH LONGEV, V3, pS4
   Justice AC, 2013, JAIDS-J ACQ IMM DEF, V62, P149, DOI 10.1097/QAI.0b013e31827df36c
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Levine AJ, 2016, J NEUROVIROL, V22, P366, DOI 10.1007/s13365-015-0406-3
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Liu Zuyun, 2018, PLoS Med, V15, pe1002718, DOI 10.1371/journal.pmed.1002718
   Maciel RA, 2018, INT J INFECT DIS, V70, P30, DOI 10.1016/j.ijid.2018.02.009
   Milanini B, 2014, JAIDS-J ACQ IMM DEF, V67, P67, DOI 10.1097/QAI.0000000000000220
   Montano Monty, 2022, Lancet Healthy Longev, V3, pe194, DOI 10.1016/s2666-7568(21)00278-6
   Nelson KN, 2017, AIDS, V31, P571, DOI 10.1097/QAD.0000000000001360
   Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158
   Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163
   Rodés B, 2022, EBIOMEDICINE, V77, DOI 10.1016/j.ebiom.2022.103896
   Sánchez-Conde M, 2019, EPIGENOMICS-UK, V11, P501, DOI 10.2217/epi-2018-0130
   Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701
   Serrano-Villar S, 2015, LANCET HIV, V2, pE76, DOI 10.1016/S2352-3018(15)00018-1
   Shiau S, 2021, CLIN INFECT DIS, V73, P1982, DOI 10.1093/cid/ciab563
   Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f
   Tumkosit M, 2022, AIDS, V36, P1073, DOI 10.1097/QAD.0000000000003204
   Zhang XY, 2016, EPIGENETICS-US, V11, P750, DOI 10.1080/15592294.2016.1221569
NR 31
TC 2
Z9 2
U1 2
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2318
J9 BMC GERIATR
JI BMC Geriatr.
PD DEC 31
PY 2022
VL 22
IS 1
AR 1010
DI 10.1186/s12877-022-03720-1
PG 12
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 7L8FM
UT WOS:000906194500002
PM 36585655
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU den Hartigh, LJ
   Goodspeed, L
   Wang, SA
   Kenerson, HL
   Omer, M
   O'Brien, KD
   Ladiges, W
   Yeung, R
   Subramanian, S
AF den Hartigh, Laura J.
   Goodspeed, Leela
   Wang, Shari A.
   Kenerson, Heidi L.
   Omer, Mohamed
   O'Brien, Kevin D.
   Ladiges, Warren
   Yeung, Raymond
   Subramanian, Savitha
TI Chronic oral rapamycin decreases adiposity, hepatic triglycerides and
   insulin resistance in male mice fed a diet high in sucrose and saturated
   fat
SO EXPERIMENTAL PHYSIOLOGY
LA English
DT Article
DE browning; insulin sensitivity; mTORC1; white adipose tissue
ID GENETICALLY HETEROGENEOUS MICE; KIDNEY-TRANSPLANT RECIPIENTS; EXTENDS
   LIFE-SPAN; MAMMALIAN TARGET; OBESE MICE; GLUCOSE-INTOLERANCE; MTOR
   INHIBITION; METABOLISM; PATHWAY; TISSUE
AB Excess adiposity is commonly associated with insulin resistance, which can increase the risk of cardiovascular disease. However, the exact molecular mechanisms by which obesity results in insulin resistance are yet to be understood clearly. The intracellular nutrient-sensing protein, mechanistic target of rapamycin (mTOR), is a crucial signalling component in the development of obesity-associated insulin resistance. Given that increased tissue activation of mTOR complex-1 (mTORC1) occurs in obesity, diabetes and ageing, we hypothesized that pharmacological inhibition of mTORC1 would improve metabolic dysregulation in diet-induced obesity. We administered continuous rapamycin, a specific mTORC1 inhibitor, orally to C57BL/6J mice concurrently with a high-fat, high-sucrose (HFHS) diet for 20 weeks. The control group received placebo microcapsules. Rapamycin-treated mice showed significantly reduced weight gain and adiposity (33.6 +/- 4.9 versus 40.4 +/- 3.0% body fat, P < 0.001, n = 8 mice per group), despite increased or equivalent food intake compared with the placebo group. The rapamycin-fed mice also demonstrated reduced plasma glucose (252 +/- 57 versus 297 +/- 67 mg dl(-1), P < 0.001) and improved insulin sensitivity during insulin and glucose tolerance testing. Rapamycin-treated mice also had lower plasma triglycerides (48 +/- 13 versus 67 +/- 11 mg/dL, P < 0.01) and hepatic triglyceride content (89 +/- 15 versus 110 +/- 19 mg/g liver, P < 0.05) compared with the placebo group. A moderately low dose of rapamycin decreased adiposity and improved the metabolic profile in a model of diet-induced obesity. These data suggest that low-grade chronic mTORC1 inhibition might be a potential strategy for anti-obesity therapies.
C1 [den Hartigh, Laura J.; Goodspeed, Leela; Wang, Shari A.; Omer, Mohamed; Subramanian, Savitha] Univ Washington, Div Metab Endocrinol & Nutr, Dept Med, Seattle, WA 98019 USA.
   [den Hartigh, Laura J.; Goodspeed, Leela; Wang, Shari A.; Omer, Mohamed; O'Brien, Kevin D.; Subramanian, Savitha] Univ Washington, Diabet Inst, Seattle, WA 98019 USA.
   [Kenerson, Heidi L.; Yeung, Raymond] Univ Washington, Dept Surg, Seattle, WA 98019 USA.
   [O'Brien, Kevin D.] Univ Washington, Div Cardiol, Seattle, WA 98019 USA.
   [Ladiges, Warren] Univ Washington, Dept Comparat Med, Seattle, WA 98019 USA.
C3 University of Washington; University of Washington Seattle; University
   of Washington; University of Washington Seattle; University of
   Washington; University of Washington Seattle; University of Washington;
   University of Washington Seattle; University of Washington; University
   of Washington Seattle
RP den Hartigh, LJ (corresponding author), Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, 850 Republican St,Box 358055, Seattle, WA 98109 USA.
EM lauradh@u.washington.edu
RI O'Brien, Kevin/CAH-4638-2022; O'Brien, Kevin Douglas/HDO-1461-2022
OI O'Brien, Kevin/0000-0002-2293-9196; O'Brien, Kevin
   Douglas/0000-0002-2293-9196; Subramanian, Savitha/0000-0002-4866-2009;
   Kenerson, Heidi/0000-0002-4497-4101
FU National Institutes of Health [DK017047, DK035816, AT007177, HL092969]
FX This work was supported by National Institutes of Health in parts by
   grantsDK017047, DK035816, AT007177 and HL092969.
CR Aggarwal D, 2006, METABOLISM, V55, P794, DOI 10.1016/j.metabol.2006.01.017
   Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486
   Apelo SIA, 2016, AGING CELL, V15, P28, DOI 10.1111/acel.12405
   Bae EJ, 2012, J BIOL CHEM, V287, P18769, DOI 10.1074/jbc.M112.365544
   BAEDER WL, 1992, CLIN EXP IMMUNOL, V89, P174
   Chang GR, 2009, BASIC CLIN PHARMACOL, V105, P188, DOI 10.1111/j.1742-7843.2009.00427.x
   Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP
   Cruzado Josep M, 2008, Transplant Rev (Orlando), V22, P73, DOI 10.1016/j.trre.2007.09.003
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002
   Deepa Sathyaseelan S, 2013, J Biochem Pharmacol Res, V1, P114
   den Hartigh LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172912
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324
   Jiang HF, 2014, DIABETOLOGIA, V57, P2393, DOI 10.1007/s00125-014-3350-5
   Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202
   Kasiske BL, 2008, AM J TRANSPLANT, V8, P1384, DOI 10.1111/j.1600-6143.2008.02272.x
   Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921
   Korsheninnikova E, 2006, DIABETOLOGIA, V49, P3049, DOI 10.1007/s00125-006-0439-5
   Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Leontieva OV, 2014, AGING CELL, V13, P616, DOI 10.1111/acel.12211
   Lin AL, 2017, J CEREBR BLOOD F MET, V37, P217, DOI 10.1177/0271678X15621575
   Liu DX, 2018, MOL METAB, V9, P192, DOI 10.1016/j.molmet.2017.12.017
   Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532
   Liu YH, 2014, AGING-US, V6, P742, DOI 10.18632/aging.100688
   Makki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092684
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Morrisett JD, 2002, J LIPID RES, V43, P1170, DOI 10.1194/jlr.M100392-JLR200
   Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674
   Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846
   Paschoal VA, 2017, IMMUNOBIOLOGY, V222, P261, DOI 10.1016/j.imbio.2016.09.014
   Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   Quinn WJ, 2017, J CLIN INVEST, V127, P4207, DOI 10.1172/JCI96036
   Reifsnyder PC, 2018, ANN NY ACAD SCI, V1418, P106, DOI 10.1111/nyas.13557
   Reifsnyder PC, 2016, AGING-US, V8, P3120, DOI 10.18632/aging.101117
   Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026
   Shan TZ, 2016, DIABETOLOGIA, V59, P1995, DOI 10.1007/s00125-016-4006-4
   Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979
   Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685
   Teutonico A, 2005, J AM SOC NEPHROL, V16, P3128, DOI 10.1681/ASN.2005050487
   Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546
   Tran CM, 2016, DIABETES, V65, P927, DOI 10.2337/db15-0502
   Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674
   Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xiong Y, 2018, J LIPID RES, V59, P974, DOI 10.1194/jlr.M081463
   Yang SB, 2012, J MOL MED, V90, P575, DOI 10.1007/s00109-011-0834-3
NR 57
TC 20
Z9 20
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0958-0670
EI 1469-445X
J9 EXP PHYSIOL
JI Exp. Physiol.
PD NOV 1
PY 2018
VL 103
IS 11
BP 1469
EP 1480
DI 10.1113/EP087207
PG 12
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA HA1OX
UT WOS:000449988700004
PM 30117227
OA Bronze, Green Accepted
DA 2024-02-19
ER

PT J
AU Laurent, C
   Chabi, B
   Fouret, G
   Py, G
   Sairafi, B
   Elong, C
   Gaillet, S
   Cristol, JP
   Coudray, C
   Feillet-Coudray, C
AF Laurent, Caroline
   Chabi, Beatrice
   Fouret, Gilles
   Py, Guillaume
   Sairafi, Badie
   Elong, Cecile
   Gaillet, Sylvie
   Cristol, Jean Paul
   Coudray, Charles
   Feillet-Coudray, Christine
TI Polyphenols decreased liver NADPH oxidase activity, increased muscle
   mitochondrial biogenesis and decreased gastrocnemius age-dependent
   autophagy in aged rats
SO FREE RADICAL RESEARCH
LA English
DT Article
DE aging; antioxidant status; mitochondria; xanthine oxidase; atrophy
ID OXIDATIVE STRESS; XANTHINE-OXIDASE; SKELETAL-MUSCLE; RESPIRATORY-CHAIN;
   ENDOTHELIAL DYSFUNCTION; CALORIC RESTRICTION; ANTIOXIDANT ENZYMES;
   LIPID-PEROXIDATION; METABOLIC DISEASE; FREE-RADICALS
AB This study explored major systems of reactive oxygen species (ROS) production and their consequences on oxidative stress, mitochondriogenesis and muscle metabolism in aged rats, and evaluated the efficiency of 30-day oral supplementation with a moderate dose of a red grape polyphenol extract (RGPE) on these parameters. In the liver of aged rats, NADPH oxidase activity was increased and mitochondrial respiratory chain complex activities were altered, while xanthine oxidase activity remained unchanged. In muscles, only mitochondrial activity was modified with aging. The oral intake of RGPE decreased liver NADPH oxidase activity in the aged rats without affecting global oxidative stress, suggesting that NADPH oxidase was probably not the dominant detrimental source of production of O-2(center dot-) in the liver. Interestingly, RGPE supplementation increased mitochondrial biogenesis and improved antioxidant status in the gastrocnemius of aged rats, while it had no significant effect in soleus. RGPE supplementation also decreased age-dependent autophagy in gastrocnemius of aged rats. These results extended existing findings on the beneficial effects of RGPE on mitochondriogenesis and muscle metabolism in aged rats.
C1 [Chabi, Beatrice; Fouret, Gilles; Py, Guillaume; Sairafi, Badie; Coudray, Charles; Feillet-Coudray, Christine] Univ Montpellier I, INRA UMR 866, F-34060 Montpellier, France.
   [Laurent, Caroline; Elong, Cecile; Gaillet, Sylvie; Cristol, Jean Paul] UMR 204 NUTRIPASS IRD Montpellier 1 Montpellier 2, F-34000 Montpellier, France.
C3 Universite de Montpellier; INRAE; Institut de Recherche pour le
   Developpement (IRD)
RP Feillet-Coudray, C (corresponding author), Univ Montpellier I, INRA UMR 866, F-34060 Montpellier, France.
EM cfeillet@supagro.inra.fr
RI Chabi, Beatrice/AAI-6545-2020; COUDRAY, Charles/AGG-4757-2022
OI Chabi, Beatrice/0000-0002-5604-5668; Py, Guillaume/0000-0002-3124-904X;
   Coudray, Charles/0000-0003-2680-7796
FU University of Montpellier II
FX The authors declare no conflicts of interest. This research was
   supported by a grant from the University of Montpellier II.
CR Agarwal B, 2011, ANN NY ACAD SCI, V1215, P138, DOI 10.1111/j.1749-6632.2010.05850.x
   Aoi Wataru, 2011, Curr Aging Sci, V4, P101
   Aranda R, 2007, FREE RADICAL RES, V41, P1195, DOI 10.1080/10715760701481461
   Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056
   Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Boyd O, 2011, FREE RADICAL BIO MED, V50, P1669, DOI 10.1016/j.freeradbiomed.2011.03.011
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bravard A, 2011, AM J PHYSIOL-ENDOC M, V300, pE581, DOI 10.1152/ajpendo.00455.2010
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003
   Clavel S, 2006, MECH AGEING DEV, V127, P794, DOI 10.1016/j.mad.2006.07.005
   COUDRAY C, 1992, BASIC RES CARDIOL, V87, P478
   COUDRAY C, 1994, AGENTS ACTIONS, V41, P144, DOI 10.1007/BF02001908
   Dal-Ros S, 2011, BIOCHEM BIOPH RES CO, V404, P743, DOI 10.1016/j.bbrc.2010.12.060
   Donato AJ, 2008, J APPL PHYSIOL, V105, P1359, DOI 10.1152/japplphysiol.90629.2008
   EDGERTON VR, 1975, HISTOCHEM J, V7, P259, DOI 10.1007/BF01003594
   Edström E, 2006, J GERONTOL A-BIOL, V61, P663, DOI 10.1093/gerona/61.7.663
   Faure P., 1995, P237
   Feillet-Coudray C, 2009, FREE RADICAL BIO MED, V46, P624, DOI 10.1016/j.freeradbiomed.2008.11.020
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   Gil Del Valle L, BIOMED PHARMACOTHER
   Gomes P, 2009, OXID MED CELL LONGEV, V2, P138, DOI 10.4161/oxim.2.3.8819
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   HARMAN D, 1968, J GERONTOL, V23, P476, DOI 10.1093/geronj/23.4.476
   Hemdan DII, 2009, J MED INVESTIG, V56, P26, DOI 10.2152/jmi.56.26
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   Houston M, 1999, J BIOL CHEM, V274, P4985, DOI 10.1074/jbc.274.8.4985
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Jackson JR, 2010, AM J PHYSIOL-REG I, V299, pR1572, DOI 10.1152/ajpregu.00489.2010
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Krause KH, 2007, EXP GERONTOL, V42, P256, DOI 10.1016/j.exger.2006.10.011
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027
   Li LX, 2010, ANN NY ACAD SCI, V1203, P151, DOI 10.1111/j.1749-6632.2010.05555.x
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Mahesh R, 2009, CELL BIOCHEM FUNCT, V27, P358, DOI 10.1002/cbf.1581
   MARKLUND S, 1976, J BIOL CHEM, V251, P7504
   Mosoni L, 2010, NUTRITION, V26, P1157, DOI 10.1016/j.nut.2009.09.016
   Pallauf K, AGEING RES REV
   Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034
   Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60
   Rossi Paola, 2008, Curr Aging Sci, V1, P182
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Ryan MJ, 2011, FREE RADICAL BIO MED, V51, P38, DOI 10.1016/j.freeradbiomed.2011.04.002
   Salminen A, 2009, TRENDS MOL MED, V15, P217, DOI 10.1016/j.molmed.2009.03.004
   Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
   Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009
   Simao S, 2011, EXP GERONTOL
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Srere P.A., 1969, METHOD ENZYMOL, V13, P3, DOI DOI 10.1016/0076-6879(69)13005-0
   Srividhya R, 2009, INT J DEV NEUROSCI, V27, P223, DOI 10.1016/j.ijdevneu.2009.01.003
   SUNDERMAN FW, 1985, ANN CLIN LAB SCI, V15, P229
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Unno K, 2011, BIOL PHARM BULL, V34, P311, DOI 10.1248/bpb.34.311
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Viña J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006
   Wang MY, 2010, J MOL CELL CARDIOL, V48, P765, DOI 10.1016/j.yjmcc.2010.01.006
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wharton DC, 1967, METHOD ENZYMOL, V10, P245
   Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524
   Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002
   Yokozawa T, 2007, J AGR FOOD CHEM, V55, P7744, DOI 10.1021/jf072105s
   Zangarelli A, 2006, FASEB J, V20, P2439, DOI 10.1096/fj.05-4544com
NR 65
TC 25
Z9 25
U1 0
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PD SEP
PY 2012
VL 46
IS 9
BP 1140
EP 1149
DI 10.3109/10715762.2012.694428
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 982TI
UT WOS:000307067900011
PM 22607117
DA 2024-02-19
ER

PT J
AU Stetzer, AJ
   Tucker, E
   McKeith, FK
   Brewer, MS
AF Stetzer, A. J.
   Tucker, E.
   McKeith, F. K.
   Brewer, M. S.
TI Quality changes in beef <i>complexus, serratus,</i> <i>ventralis</i>,
   <i>vastus lateralis</i>, <i>vastus medialis</i>, and <i>longissimus
   dorsi</i> muscles enhanced prior to aging
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE aging; beef; enhancement; muscles; quality
ID POLYPHOSPHATE INJECTION; SODIUM-CHLORIDE; BROILER CHICKEN; PORK;
   TENDERNESS; ACCEPTABILITY; FLAVOR; LOINS; PH
AB Beef complexus (chuck), serratus ventralis (chuck), vastus lateralis (round), vatsus medialis (round), and longissimus dorsi (loin) muscles were enhanced (0.3% salt, 0.4% phosphate), vacuum packaged, and aged for 7 or 14 d. Enhancement increased positive sensory attributes (tenderness, juiciness, beef flavor, saltiness) and decreased negative attributes (off-flavors) of all muscles but had greater effects on some than on others. It increased the oily mouthfeel (10%) and saltiness (40%) and decreased the L* value and chroma of the complexus (chuck). It increased tenderness, juiciness, and beef flavor and decreased off-flavors, visual red and brown colors, shear value, and cook loss of the serratus ventrali (chuck), vastus lateralis (round), vastus medialis (round), and longissiumus dorsi (loin). Aging slightly decreased rancid and liver off-flavor scores, visual brown color, and shear value and increased the hue angle and L* and b* values.
C1 [Stetzer, A. J.; Tucker, E.; Brewer, M. S.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.
   [McKeith, F. K.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign
RP Stetzer, AJ (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, 208 ABL,1302 W Pennsylvania, Urbana, IL 61801 USA.
EM msbrewer@uiuc.edu
CR [Anonymous], APPL SENSORY ANAL FO
   Baublits RT, 2006, J FOOD SCI, V71, pS91, DOI 10.1111/j.1365-2621.2006.tb08927.x
   Baublits RT, 2005, MEAT SCI, V71, P264, DOI 10.1016/j.meatsci.2005.03.015
   Baublits RT, 2005, MEAT SCI, V70, P205, DOI 10.1016/j.meatsci.2004.12.011
   Bauer F., 1983, Ernaehrung, V7, P688
   Brewer MS, 2002, J MUSCLE FOODS, V13, P53, DOI 10.1111/j.1745-4573.2002.tb00320.x
   BREWER MS, 2006, EFFECT AGING CONSUME
   CIE, 1978, CIE PUBL S2, V15
   Eilers JD, 1996, J ANIM SCI, V74, P790
   George MH, 1999, J ANIM SCI, V77, P1735
   Gorraiz C, 2002, J FOOD SCI, V67, P916, DOI 10.1111/j.1365-2621.2002.tb09428.x
   GREY TC, 1978, J FOOD TECHNOL, V13, P529, DOI 10.1089/105072503322238782
   GRIFFITHS NM, 1978, J FOOD TECHNOL, V13, P541
   Kato H, 1987, UMAMI ONE BASIC TAST
   KERTH CR, 1995, J ANIM SCI, V73, P750
   MOSKOWITZ HR, 1988, APPL SENSORY ANAL FO, V2
   NOVAKOFSKI J, 1989, J FOOD SCI, V54, P15, DOI 10.1111/j.1365-2621.1989.tb08556.x
   Prestat C, 2002, MEAT SCI, V60, P395, DOI 10.1016/S0309-1740(01)00150-4
   Purchas RW, 1999, MEAT SCI, V51, P135, DOI 10.1016/S0309-1740(98)00111-9
   Robbins K, 2003, MEAT SCI, V65, P721, DOI 10.1016/S0309-1740(02)00274-7
   Robbins K, 2003, MEAT SCI, V64, P317, DOI 10.1016/S0309-1740(02)00203-6
   *SAS I INC, 2002, STAT AN SOFTW VERS 8
   SHACKELFORD SD, 1995, J ANIM SCI, V73, P3333, DOI 10.2527/1995.73113333x
   Shahidi F, 1994, FLAVOR MEAT MEAT PRO, P4, DOI 10.1007/978-1-4615-2177-8
   Sheard PR, 1999, MEAT SCI, V51, P371, DOI 10.1016/S0309-1740(98)00136-3
   Spanier AM, 1997, FOOD CHEM, V59, P531, DOI 10.1016/S0308-8146(97)00003-4
   Vote DJ, 2000, J ANIM SCI, V78, P952
   Wicklund SE, 2005, J FOOD SCI, V70, pS242, DOI 10.1111/j.1365-2621.2005.tb07164.x
   Zamora F, 1996, MEAT SCI, V43, P321, DOI 10.1016/S0309-1740(96)00020-4
NR 29
TC 7
Z9 10
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD JAN-FEB
PY 2008
VL 73
IS 1
BP S6
EP S10
DI 10.1111/j.1750-3841.2007.00582.x
PG 5
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 255OF
UT WOS:000252666600021
PM 18211371
DA 2024-02-19
ER

PT J
AU Samokhvalov, V
   Ignatov, V
   Kondrashova, M
AF Samokhvalov, V
   Ignatov, V
   Kondrashova, M
TI Inhibition of Krebs cycle and activation of glyoxylate cycle in the
   course of chronological aging of <i>Saccharomyces cerevisiae</i>.:
   Compensatory role of succinate oxidation
SO BIOCHIMIE
LA English
DT Article
DE succinate dehydrogenase; mitochondria; aging; glyoxylate cycle; Krebs
   cycle
ID CELL-DEATH; LIFE-SPAN; YEAST; MITOCHONDRIA; ENZYMES; STRESS; LIVER;
   ACID; METABOLISM; LONGEVITY
AB We investigated oxidative processes in mitochondria of Saccharomyces cerevisiae grown on ethanol in the course of chronological aging. We elaborated a model of chronological aging that avoids the influence of exhaustion of medium, as well as the accumulation of toxic metabolites during aging. A decrease in total respiration of cells and, even more, of the contribution of respiration coupled with ATP-synthesis was observed during aging. Aging is also related with the decrease of the contribution of malonate-insensitive respiration. Activities of citrate-synthase (CS), alpha-ketoglutarate dehydrogenase (KGDH) and malate dehydrogenase (MDH) were threefold decreased. The activity of NADP-dependent isocitrate dehydrogenase (NADP-ICDH) decreased more significantly. while the activity of NAD-dependent isocitrate dehydrogenase (NAD-ICDH) fell even greater, being completely inactivated on the third week of aging. In contrast, succinate dehydrogenase (SDH), enzymes of glyoxylate cycle (GCL) (isocitrate lyase (ICL) and malate synthase (MLS)), and enzymes of ethanol oxidation (alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ACDH)), were activated by 50% or more. The behavior of oxidative enzymes and metabolic pathways are apparently inherent to a more viable, long-lived cells in population, selected in the course of chronological aging. This selection allows cells to reveal the mechanism of their higher viability as Caused by shunting of complete Krebs cycle by glyoxylate cycle, with a concomitant increased rate of the most efficient energy source, namely succinate formation and oxidation. Thiobarbituric-reactive species (TAR species) increased during aging. We supposed that to be the immediate cause of damage of a part of yeast population. These data show that a greater succinate contribution to respiration in more active cells is a general property of yeast and animal tissues. (C) 2003 Elsevier SAS. All rights reserved.
C1 Saratov NG Chernyshevskii State Univ, Dept Biochem, Saratov 410026, Russia.
   Russian Acad Sci, Inst Theoret & Expt Biophys, Lab Metab Biophys, Pushchino 142290, Moscow, Russia.
   Russian Acad Sci, Inst Biochem & Physiol Plants & Microorgan, Saratov 410015, Russia.
C3 Saratov State University; Russian Academy of Sciences; Pushchino
   Scientific Center for Biological Research (PSCBI) of the Russian Academy
   of Sciences; Institute of Theoretical & Experimental Biophysics; Russian
   Academy of Sciences; Saratov Scientific Center of the Russian Academy of
   Sciences; Institute of Biochemistry & Physiology of Plants &
   Microorganisms, Russian Academy of Sciences
RP Samokhvalov, V (corresponding author), Saratov NG Chernyshevskii State Univ, Dept Biochem, Astarkhanskaya St 83, Saratov 410026, Russia.
EM samokhvalov@mail.ru
CR AKHMEROV RN, 1986, FEBS LETT, V198, P251, DOI 10.1016/0014-5793(86)80415-X
   Alfenore S, 2002, APPL MICROBIOL BIOT, V60, P67, DOI 10.1007/s00253-002-1092-7
   ANISIMOV VN, 2000, USP SOVREM BIOL, V120, P146
   BARTELS PD, 1979, BIOCHIM BIOPHYS ACTA, V582, P246, DOI 10.1016/0304-4165(79)90388-X
   COLEMAN PS, 1991, CHEM CARCINOGENESIS, V2, P265
   DAVIS WL, 1990, ANAT REC, V227, P271, DOI 10.1002/ar.1092270302
   Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0
   DUNTZE W, 1969, EUR J BIOCHEM, V10, P83
   EVTODIENKO YV, 1973, BIOL BIOCH OSCILLATO, P390
   FEDOTCHEVA NJ, 1985, COMP BIOCHEM PHYS B, V82, P191, DOI 10.1016/0305-0491(85)90151-8
   Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X
   GOODMAN DBP, 1980, P NATL ACAD SCI-BIOL, V77, P1521, DOI 10.1073/pnas.77.3.1521
   Guarente L, 2000, GENE DEV, V14, P1021
   Hamel RD, 2001, J INORG BIOCHEM, V87, P1, DOI 10.1016/S0162-0134(01)00307-5
   Harman D, 1998, J Int Fed Clin Chem, V10, P24
   HIRAI M, 1976, AGR BIOL CHEM TOKYO, V40, P1879
   Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h
   Il'chenko AP, 2001, MICROBIOLOGY+, V70, P151, DOI 10.1023/A:1010421328285
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Jazwinski SM, 1999, TRENDS MICROBIOL, V7, P247, DOI 10.1016/S0966-842X(99)01509-7
   Jazwinski SM, 2000, TRENDS GENET, V16, P506, DOI 10.1016/S0168-9525(00)02119-3
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   JONES CT, 1980, BIOCHEM BIOPH RES CO, V95, P849, DOI 10.1016/0006-291X(80)90865-7
   KONDRASH.MN, 1971, DOKL AKAD NAUK SSSR+, V196, P1225
   KONDRASHOVA MN, 1991, BIOCHEMISTRY-MOSCOW+, V56, P243
   KONDRASHOVA MN, 1982, BIOCHEM BIOPH RES CO, V109, P376, DOI 10.1016/0006-291X(82)91731-4
   KONDRASHOVA MN, 1988, RAPID CYCLE SUBSTRAT, P297
   KONDRASHOVA MN, 1973, BIOL BIOCH OSCILLATO, P373
   KONDRASHOVA MN, 1984, J GEN BIOL, V46, P516
   Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x
   LIN S, 1999, J BIOL CHEM, V276, P36000
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   Longo VD, 1999, NEUROBIOL AGING, V20, P479, DOI 10.1016/S0197-4580(99)00089-5
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MacLean M, 2001, YEAST, V18, P499, DOI 10.1002/yea.701
   MAEVSKY E, 1982, 2ND EUR BIOEN C LYON, P537
   Popov VN, 1996, FEBS LETT, V390, P258, DOI 10.1016/0014-5793(96)00668-0
   Priault M, 2002, EUR J BIOCHEM, V269, P5440, DOI 10.1046/j.1432-1033.2002.03234.x
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   RUBIN H, 1976, J CELL BIOL, V70, P374, DOI 10.1083/jcb.70.2.374
   SAMOKHVALOV VA, 2003, 1 FEMS C 29 JUN 3 JU, P71
   Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6
   STEELS EL, 1994, MICROBIOL-SGM, V140, P569, DOI 10.1099/00221287-140-3-569
   van Roermund CWT, 1998, EMBO J, V17, P677, DOI 10.1093/emboj/17.3.677
   VENTURIN C, 1995, YEAST, V11, P327, DOI 10.1002/yea.320110405
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
NR 46
TC 41
Z9 50
U1 0
U2 29
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD JAN
PY 2004
VL 86
IS 1
BP 39
EP 46
DI 10.1016/j.biochi.2003.10.019
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 800PW
UT WOS:000220041200006
PM 14987799
DA 2024-02-19
ER

PT J
AU Celestino, M
   Balmaceda Valdez, V
   Brun, P
   Castagliuolo, I
   Mucignat-Caretta, C
AF Celestino, Michele
   Balmaceda Valdez, Valeria
   Brun, Paola
   Castagliuolo, Ignazio
   Mucignat-Caretta, Carla
TI Differential effects of sodium chloride and monosodium glutamate on
   kidney of adult and aging mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SALT INTAKE; OXIDATIVE STRESS; BLOOD-PRESSURE; AMINO-ACIDS; AQUAPORIN-2;
   CHANNELS; LIVER; RATS; INFLAMMATION; VASOPRESSIN
AB Monosodium Glutamate (MSG) is used as flavour enhancer, with potential beneficial effects due to its nutritional value. Given the decline in kidney functions during aging, we investigated the impact of MSG voluntary intake on the kidney of male mice, aged 6 or 18 months. For 2 months, they freely consumed water (control group), sodium chloride (0.3% NaCl) or MSG (1% MSG) in addition to standard diet. Young animals consuming sodium chloride presented signs of proteinuria, hyperfiltration, enhanced expression and excretion of Aquaporin 2 and initial degenerative reactions suggestive of fibrosis, while MSG-consuming mice were similar to controls. In old mice, aging-related effects including proteinuria and increased renal corpuscle volume were observed in all groups. At an advanced age, MSG caused no adverse effects on the kidney compared to controls, despite the presence of a sodium moiety, similar to sodium chloride. These data show that prolonged MSG intake in mice has less impact on kidney compared to sodium chloride, that already in young animals induced some effects on kidney, possibly related to hypertension.
C1 [Celestino, Michele; Balmaceda Valdez, Valeria; Brun, Paola; Castagliuolo, Ignazio; Mucignat-Caretta, Carla] Univ Padua, Dept Mol Med, I-35131 Padua, Italy.
   [Mucignat-Caretta, Carla] Biostruct & Biosyst Natl Inst, I-00136 Rome, Italy.
C3 University of Padua
RP Mucignat-Caretta, C (corresponding author), Univ Padua, Dept Mol Med, I-35131 Padua, Italy.; Mucignat-Caretta, C (corresponding author), Biostruct & Biosyst Natl Inst, I-00136 Rome, Italy.
EM carla.mucignat@unipd.it
RI Brun, Paola/A-3380-2016; Mucignat, Carla/N-6299-2017
OI Brun, Paola/0000-0002-3279-9000; Mucignat, Carla/0000-0001-5307-0414
FU Ajinomoto Innovation Alliance Program (AIAP)
FX This work was supported by Ajinomoto Innovation Alliance Program (AIAP),
   duration of the fund: March 2016-July 2018. The funders had no influence
   in the experimental design, selection of methods, performing
   experiments, analysis of data and writing of the text.
CR Bachmanov AA, 2000, J NUTR, V130, p935S, DOI 10.1093/jn/130.4.935S
   Bahadoran Z, 2019, METHODS MOL BIOL, V1916, P49, DOI 10.1007/978-1-4939-8994-2_3
   Bellisle F, 1998, ANN NY ACAD SCI, V855, P438, DOI 10.1111/j.1749-6632.1998.tb10603.x
   BELLISLE F, 1991, PHYSIOL BEHAV, V49, P869, DOI 10.1016/0031-9384(91)90196-U
   Best RL, 2011, APPETITE, V56, P179, DOI 10.1016/j.appet.2010.10.011
   Boero R, 2002, J NEPHROL, V15, P225
   Brown KL, 2018, CURR OPIN NEPHROL HY, V27, P171, DOI 10.1097/MNH.0000000000000401
   Combet S, 2008, AM J PHYSIOL-RENAL, V294, pF1408, DOI 10.1152/ajprenal.00437.2007
   Contini MD, 2017, EXP TOXICOL PATHOL, V69, P547, DOI 10.1016/j.etp.2017.03.003
   Delpire E, 2018, COMPR PHYSIOL, V8, P871, DOI 10.1002/cphy.c170018
   Dixit SG, 2014, RENAL FAILURE, V36, P266, DOI 10.3109/0886022X.2013.846865
   Du YH, 2015, CURR VASC PHARMACOL, V13, P441, DOI 10.2174/1570161112666141014145040
   Eddy AA, 2014, KIDNEY INT SUPPL, V4, P2, DOI 10.1038/kisup.2014.2
   Elliot S, 1996, J AM SOC NEPHROL, V7, P403
   Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4
   Geha RS, 2000, J NUTR, V130, p1058S, DOI 10.1093/jn/130.4.1058S
   Gill SS, 2000, TOXICOL PATHOL, V28, P277, DOI 10.1177/019262330002800207
   Graffe CC, 2012, AM J PHYSIOL-RENAL, V302, pF264, DOI 10.1152/ajprenal.00442.2010
   He K, 2008, OBESITY, V16, P1875, DOI 10.1038/oby.2008.274
   Henry-Unaeze Helen Nonye, 2017, Pathophysiology, V24, P243, DOI 10.1016/j.pathophys.2017.08.001
   Hew-Butler T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071539
   Hou JH, 2016, CURR OPIN NEPHROL HY, V25, P424, DOI 10.1097/MNH.0000000000000253
   Houghton BL, 2011, J HYPERTENS, V29, P915, DOI 10.1097/HJH.0b013e328344b86b
   Ikeda M, 2015, VITAM HORM, V98, P307, DOI 10.1016/bs.vh.2014.12.008
   Ji QS, 2019, J CELL PHYSIOL, V234, P7856, DOI 10.1002/jcp.27865
   Joffre C, 2016, PROSTAG LEUKOTR ESS, V114, P1, DOI 10.1016/j.plefa.2016.09.003
   Jung HJ, 2016, AM J PHYSIOL-RENAL, V311, pF1318, DOI 10.1152/ajprenal.00485.2016
   Kakoki M, 2006, AM J PHYSIOL-RENAL, V291, pF297, DOI 10.1152/ajprenal.00417.2005
   김준모, 2016, Childhood Kidney diseases, V20, P11
   Kitada K, 2017, J CLIN INVEST, V127, P1944, DOI 10.1172/JCI88532
   Kobayashi A, 2015, NEPHROLOGY, V20, P31, DOI 10.1111/nep.12463
   Kurihara K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/189402
   Kuusniemi AM, 2005, KIDNEY INT, V68, P121, DOI 10.1111/j.1523-1755.2005.00386.x
   Kwon TH, 2013, KIDNEY RES CLIN PRAC, V32, P96, DOI 10.1016/j.krcp.2013.07.005
   Lauridsen TG, 2010, NEPHROL DIAL TRANSPL, V25, P2502, DOI 10.1093/ndt/gfq111
   LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218
   Liu M, 2014, EUR REV MED PHARMACO, V18, P2918
   Liu XY, 2016, MOL MED REP, V14, P3669, DOI 10.3892/mmr.2016.5673
   López-Miranda V, 2015, NEUROGASTROENT MOTIL, V27, P1559, DOI 10.1111/nmo.12653
   Berger RCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141288
   Mahieu S, 2016, LIFE SCI, V149, P114, DOI 10.1016/j.lfs.2016.02.023
   Matchkov VV, 2015, CURR OPIN PHARMACOL, V21, P127, DOI 10.1016/j.coph.2015.02.003
   McCallum L, 2015, PFLUG ARCH EUR J PHY, V467, P595, DOI 10.1007/s00424-015-1690-8
   Mortensen A, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4910
   Nabokov A, 1997, AM J KIDNEY DIS, V30, P87, DOI 10.1016/S0272-6386(97)90569-2
   Nakagawa T, 2000, EXP ANIM TOKYO, V49, P239, DOI 10.1538/expanim.49.239
   Novakovic ZS, 2012, MED SCI MONITOR, V18, pCR235, DOI 10.12659/MSM.882623
   Orlov SN, 2015, GENES DIS, V2, P186, DOI 10.1016/j.gendis.2015.02.007
   Ortiz GG, 2006, BIOMED PHARMACOTHER, V60, P86, DOI 10.1016/j.biopha.2005.07.012
   Paul MVS, 2012, TOXICOL MECH METHOD, V22, P625, DOI 10.3109/15376516.2012.714008
   Rodan AR, 2019, CURR OPIN NEPHROL HY, V28, P360, DOI 10.1097/MNH.0000000000000502
   Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z
   Saikrishna K, 2018, J ENVIRON PATHOL TOX, V37, P63, DOI 10.1615/JEnvironPatholToxicolOncol.2018017186
   Sands JM, 2012, J GERONTOL A-BIOL, V67, P1352, DOI 10.1093/gerona/gls128
   Sasaki T, 2018, KIDNEY INT REP, V3, P314, DOI 10.1016/j.ekir.2017.10.007
   Sasano T, 2014, CURR PHARM DESIGN, V20, P2750, DOI 10.2174/13816128113199990577
   Schiffman SS, 2000, J NUTR, V130, p927S, DOI 10.1093/jn/130.4.927S
   Seeger DR, 2016, LIPIDS, V51, P549, DOI 10.1007/s11745-015-4117-6
   Sharma A., 2014, PLOS ONE, V9, P2014, DOI [10.1371/journal.pone.0116233.eCollection, DOI 10.1371/JOURNAL.PONE.0116233.ECOLLECTION]
   Sharma A., 2013, PLOS ONE, V8, P2013, DOI [10.1371/journal.pone.0075546.eCollection, DOI 10.1371/JOURNAL.PONE.0075546.ECOLLECTION]
   Stamler J, 2018, HYPERTENSION, V71, P631, DOI 10.1161/HYPERTENSIONAHA.117.09928
   Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226
   Tamma G, 2015, ENDOCRINOLOGY, V156, P777, DOI 10.1210/en.2014-1812
   Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P446, DOI 10.1016/S0753-3322(02)00285-8
   Toyama K, 2008, BIOL PHARM BULL, V31, P1852, DOI 10.1248/bpb.31.1852
   Wei SY, 2017, SCI REP-UK, V7, DOI 10.1038/srep45952
   Wiggins JE, 2012, J GERONTOL A-BIOL, V67, P1358, DOI 10.1093/gerona/gls157
   Yilmaz R, 2012, EUR J CLIN NUTR, V66, P1214, DOI 10.1038/ejcn.2012.110
NR 68
TC 4
Z9 5
U1 2
U2 8
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 12
PY 2021
VL 11
IS 1
AR 481
DI 10.1038/s41598-020-80048-z
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA QM6WS
UT WOS:000621918100005
PM 33436880
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Mahemuti, L
   Chen, QX
   Coughlan, MC
   Qiao, CY
   Chepelev, NL
   Florian, M
   Dong, DL
   Woodworth, RG
   Yan, J
   Cao, XL
   Scoggan, KA
   Jin, XL
   Willmore, WG
AF Mahemuti, Laziyan
   Chen, Qixuan
   Coughlan, Melanie C.
   Qiao, Cunye
   Chepelev, Nikolai L.
   Florian, Maria
   Dong, Dillon
   Woodworth, Robert G.
   Yan, Jin
   Cao, Xu-liang
   Scoggan, Kylie A.
   Jin, Xiaolei
   Willmore, William G.
TI Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest,
   senescence, autophagy, stress response, and estrogen release in human
   fetal lung fibroblasts
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE Bisphenol A; Human fetal lung fibroblasts; ATM signaling; DNA
   double-strand breaks; g-H2AX; p53; Nrf2; ROS; Estradiol release; CYP1B1;
   HSD17B14; Cell cycle arrest; G1/S transition; Senescence; Autophagy;
   Steroid synthesis and metabolism
ID PRENATAL EXPOSURE; DNA-DAMAGE; UDP-GLUCURONOSYLTRANSFERASE;
   GENE-EXPRESSION; HUMAN FETUS; LIVER; GLUCURONIDATION; TISSUES; URINARY;
   METABOLISM
AB Experimental and/or epidemiological studies suggest that prenatal exposure to bisphenol A (BPA) may delay fetal lung development and maturation and increase the susceptibility to childhood respiratory disease. However, the underlying mechanisms remain to be elucidated. In our previous study with cultured human fetal lung fibroblasts (HFLF), we demonstrated that 24-h exposure to 1 and 100 mu M BPA increased GPR30 protein in the nuclear fraction. Exposure to 100 mu M BPA had no effects on cell viability, but increased cytoplasmic expression of ER beta and release of GDF-15, as well as decreased release of IL-6, ET-1, and IP-10 through suppression of NF kappa B phosphorylation. By performing global gene expression and pathway analysis in this study, we identified molecular pathways, gene networks, and key molecules that were affected by 100, but not 0.01 and 1 mu M BPA in HFLF. Using multiple genomic and proteomic tools, we confirmed these changes at both gene and protein levels. Our data suggest that 100 mu M BPA increased CYP1B1 and HSD17B14 gene and protein expression and release of endogenous estradiol, which was associated with increased ROS production and DNA double-strand breaks, upregulation of genes and/or proteins in steroid synthesis and metabolism, and activation of Nrf2-regulated stress response pathways. In addition, BPA activated ATM-p53 signaling pathway, resulting in increased cell cycle arrest at G1 phase, senescence and autophagy, and decreased cell proliferation in HFLF. The results suggest that prenatal exposure to BPA at certain concentrations may affect fetal lung development and maturation, and thereby affecting susceptibility to childhood respiratory diseases.
C1 [Mahemuti, Laziyan; Coughlan, Melanie C.; Florian, Maria; Dong, Dillon; Woodworth, Robert G.; Yan, Jin; Jin, Xiaolei] Hlth Canada, HPFB, Food Directorate, Regulatory Toxicol Res Div,Bur Chem Safety, PL2202D,251 Sir Frederick Banting Dr Way, Ottawa, ON K1A 0K9, Canada.
   [Chen, Qixuan; Scoggan, Kylie A.] Hlth Canada, HPFB, Food Directorate, Bur Nutr Sci,Nutr Res Div, Ottawa, ON, Canada.
   [Qiao, Cunye] Hlth Canada, HPFB, Food Directorate, Biostat & Modeling Div,Bur Food Surveillance & Sc, Ottawa, ON, Canada.
   [Mahemuti, Laziyan; Chepelev, Nikolai L.; Florian, Maria; Willmore, William G.] Carleton Univ, Inst Biochem, Dept Biol, Ottawa, ON, Canada.
   [Mahemuti, Laziyan; Chepelev, Nikolai L.; Florian, Maria; Willmore, William G.] Carleton Univ, Inst Biochem, Dept Chem, Ottawa, ON, Canada.
   [Cao, Xu-liang] Hlth Canada, HPFB, Food Directorate, Food Res Div,Bur Chem Safety, Ottawa, ON, Canada.
   [Chepelev, Nikolai L.] Hlth Canada, HECSB, Environm & Radiat Hlth Sci Directorate, Mechanist Studies Div,Environm Hlth Sci & Res Bur, Ottawa, ON, Canada.
   [Scoggan, Kylie A.] Hlth Canada, Sect Strategies Div, Risk Management Bur, Safe Environm Directorate,HECSB, Ottawa, ON, Canada.
C3 Health Canada; Health Canada; Health Canada; Carleton University;
   Carleton University; Health Canada; Health Canada; Health Canada
RP Jin, XL (corresponding author), Hlth Canada, HPFB, Food Directorate, Regulatory Toxicol Res Div,Bur Chem Safety, PL2202D,251 Sir Frederick Banting Dr Way, Ottawa, ON K1A 0K9, Canada.
EM Dawn.Jin@canada.ca
RI Zhang, Yihao/JGM-3514-2023; wang, yu/IUQ-6654-2023; CAO,
   XU-LIANG/AAU-9833-2020
OI CAO, XU-LIANG/0000-0002-8094-062X
FU Chemical Management Plan Research Fund, Government of Canada; Natural
   Sciences and Engineering Research Council of Canada (NSERC)
   [06414-2012]; NSERC-CREATE-REACT [449153-2014]; Health Canada internal
   research fund; CGS D Scholarship
FX This research was funded by the Chemical Management Plan Research Fund,
   Government of Canada, Granted to the research team; Discovery Grant
   (06414-2012) from the Natural Sciences and Engineering Research Council
   of Canada (NSERC) Granted to WGW and NLC; NSERC-CREATE-REACT
   (449153-2014) Granted to WGW and LM, Health Canada internal research
   fund to XJ; and CGS D Scholarship to NLC. The authors thank Ms. Bai Li
   from University of Ottawa for helping with cell plating and splitting.
   The authors thank Dr. Ivan Curran in RTRD, Health Canada, for sharing
   IPA license.
CR Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039
   ADAMSON IYR, 1990, IN VITRO CELL DEV B, V26, P784
   Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071
   Arase S, 2011, BIOL REPROD, V84, P734, DOI 10.1095/biolreprod.110.087502
   ATKINSON A, 1995, ENVIRON MOL MUTAGEN, V26, P60, DOI 10.1002/em.2850260109
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bieche I, 2007, PHARMACOGENET GENOM, V17, P731, DOI 10.1097/FPC.0b013e32810f2e58
   Bloom MS, 2016, FERTIL STERIL, V106, P857, DOI 10.1016/j.fertnstert.2016.08.021
   Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534
   Cao XL, 2015, FOOD ADDIT CONTAM A, V32, P2154, DOI 10.1080/19440049.2015.1088663
   Cao XL, 2012, CHEMOSPHERE, V89, P505, DOI 10.1016/j.chemosphere.2012.05.003
   Cao XL, 2010, CHEMOSPHERE, V81, P817, DOI 10.1016/j.chemosphere.2010.07.048
   Chen QX, 2009, BRIT J NUTR, V102, P93, DOI 10.1017/S0007114508137904
   Chen R, 2016, TOXICOL APPL PHARM, V295, P1, DOI 10.1016/j.taap.2016.01.017
   Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018
   Edlow AG, 2012, REPROD TOXICOL, V34, P1, DOI 10.1016/j.reprotox.2012.03.009
   Ekström L, 2013, DRUG METAB DISPOS, V41, P291, DOI 10.1124/dmd.112.049197
   Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200
   Gao CJ, 2016, B ENVIRON CONTAM TOX, V96, P162, DOI 10.1007/s00128-015-1703-5
   Hanioka N, 2008, CHEMOSPHERE, V74, P33, DOI 10.1016/j.chemosphere.2008.09.053
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hijazi A, 2015, FASEB J, V29, P4968, DOI 10.1096/fj.15-270942
   Hines CJ, 2017, ANN WORK EXPOS HEAL, V61, P164, DOI 10.1093/annweh/wxw021
   Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687
   Jaeg JP, 2004, J AGR FOOD CHEM, V52, P4935, DOI 10.1021/jf049762u
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kang JH, 2006, TOXICOLOGY, V226, P79, DOI 10.1016/j.tox.2006.06.009
   KNAAK JB, 1966, TOXICOL APPL PHARM, V8, P175, DOI 10.1016/S0041-008X(66)80001-7
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   LUCIER GW, 1977, DRUG METAB DISPOS, V5, P279
   Mahemuti L, 2016, J ENVIRON SCI, V48, P11, DOI 10.1016/j.jes.2016.02.013
   Mathiassen SG, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00051
   Nahar MS, 2015, CHEMOSPHERE, V124, P54, DOI 10.1016/j.chemosphere.2014.10.071
   Nishikawa M, 2010, ENVIRON HEALTH PERSP, V118, P1196, DOI 10.1289/ehp.0901575
   Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029
   Paine MG, 2005, FEBS LETT, V579, P5029, DOI 10.1016/j.febslet.2005.08.010
   POST M, 1986, J BIOL CHEM, V261, P2179
   Roy D, 1997, J TOXICOL ENV HEALTH, V50, P1, DOI 10.1080/009841097160573
   Russo G, 2017, SCI TOTAL ENVIRON, V599, P68, DOI 10.1016/j.scitotenv.2017.04.192
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Seaborn T, 2010, TRENDS ENDOCRIN MET, V21, P729, DOI 10.1016/j.tem.2010.09.001
   Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175
   Takahashi O, 2000, ENVIRON HEALTH PERSP, V108, P931, DOI 10.2307/3435050
   Tonnessen-Murray CA, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026112
   Torday JS, 1998, AM J MED SCI, V316, P205, DOI 10.1097/00000441-199809000-00010
   Vandenberg LN, 2012, CIENC SAUDE COLETIVA, V17, P407, DOI 10.1590/S1413-81232012000200015
   Williams C., 2014, ENDOCR DISRUPTORS AU, V2
   Wu HK.K., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14
   Yager J D, 2000, J Natl Cancer Inst Monogr, P67
   Ye XY, 2011, ANAL BIOANAL CHEM, V399, P1071, DOI 10.1007/s00216-010-4344-x
   Yokota H, 1999, BIOCHEM J, V340, P405, DOI 10.1042/0264-6021:3400405
   Zhang D, 2015, CANCER BIOL THER, V16, P1005, DOI 10.1080/15384047.2015.1046022
   Zhang Y, 2007, METABOLISM, V56, P887, DOI 10.1016/j.metabol.2007.03.001
NR 56
TC 41
Z9 45
U1 1
U2 43
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD APR
PY 2018
VL 92
IS 4
BP 1453
EP 1469
DI 10.1007/s00204-017-2150-3
PG 17
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA GB5KT
UT WOS:000429103700008
PM 29275510
DA 2024-02-19
ER

PT J
AU Burke, LK
   Doslikova, B
   D'Agostino, G
   Garfield, AS
   Farooq, G
   Burdakov, D
   Low, MJ
   Rubinstein, M
   Evans, ML
   Billups, B
   Heisler, LK
AF Burke, Luke K.
   Doslikova, Barbora
   D'Agostino, Giuseppe
   Garfield, Alastair S.
   Farooq, Gala
   Burdakov, Denis
   Low, Malcolm J.
   Rubinstein, Marcelo
   Evans, Mark L.
   Billups, Brian
   Heisler, Lora K.
TI 5-HT Obesity Medication Efficacy via POMC Activation is Maintained
   During Aging
SO ENDOCRINOLOGY
LA English
DT Article
ID BODY-WEIGHT; NEURONS; SEROTONIN; FENFLURAMINE; PATHWAYS; NUCLEUS; LIVER;
   MICE; AGE
AB The phenomenon commonly described as the middle-age spread is the result of elevated adiposity accumulation throughout adulthood until late middle-age. It is a clinical imperative to gain a greater understanding of the underpinnings of age-dependent obesity and, in turn, how these mechanisms may impact the efficacy of obesity treatments. In particular, both obesity and aging are associated with rewiring of a principal brain pathway modulating energy homeostasis, promoting reduced activity of satiety pro-opiomelanocortin (POMC) neurons within the arcuate nucleus of the hypothalamus (ARC). Using a selective ARC-deficient POMC mouse line, here we report that former obesity medications augmenting endogenous 5-hydroxytryptamine (5-HT) activity D-fenfluramine and sibutramine require ARC POMC neurons to elicit therapeutic appetite-suppressive effects. We next investigated whether age-related diminished ARC POMC activity therefore impacts the potency of 5-HT obesity pharmacotherapies, lorcaserin, D-fenfluramine, and sibutramine and report that all compounds reduced food intake to a comparable extent in both chow-fed young lean (3-5 months old) and middle-aged obese (12-14 months old) male and female mice. We provide a mechanism through which 5-HT anorectic potency is maintained with age, via preserved 5-HT-POMC appetitive anatomical machinery. Specifically, the abundance and signaling of the primary 5-HT receptor influencing appetite via POMC activation, the 5-HT2CR, is not perturbed with age. These data reveal that although 5-HT obesity medications require ARC POMC neurons to achieve appetitive effects, the anorectic efficacy is maintained with aging, findings of clinical significance to the global aging obese population.
C1 [Burke, Luke K.; Doslikova, Barbora; D'Agostino, Giuseppe; Garfield, Alastair S.; Farooq, Gala; Burdakov, Denis; Billups, Brian; Heisler, Lora K.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 0QQ, England.
   [Evans, Mark L.] Univ Cambridge, Wellcome Trust, MRC, Inst Metab Sci, Cambridge CB2 0QQ, England.
   [D'Agostino, Giuseppe; Heisler, Lora K.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB21 9SB, Scotland.
   [Low, Malcolm J.; Rubinstein, Marcelo] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA.
   [Rubinstein, Marcelo] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, RA-1428 Buenos Aires, DF, Argentina.
C3 University of Cambridge; University of Cambridge; Wellcome Trust Sanger
   Institute; University of Aberdeen; University of Michigan System;
   University of Michigan; Consejo Nacional de Investigaciones Cientificas
   y Tecnicas (CONICET)
RP Heisler, LK (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB25 2ZD, Scotland.
EM lora.heisler@abdn.ac.uk
RI D'Agostino, Giuseppe/F-3399-2012; Burke, Luke/GRJ-4878-2022
OI D'Agostino, Giuseppe/0000-0002-3502-4251; Heisler,
   Lora/0000-0002-7731-1419; Billups, Brian/0000-0001-5378-2809; Burdakov,
   Denis/0000-0002-9134-9165; Garfield, Alastair/0000-0002-9628-6140; Low,
   Malcolm/0000-0002-9900-3708; Evans, Mark/0000-0001-8122-8987
FU Diabetes UK [RD05/003059]; Wellcome Trust [WT081713, WT098012]; National
   Institutes of Health [DK066604, DK068400]; Medical Research Council
   Centre for Study of Obesity and Related Disorders; MRC [G0600717,
   MC_UU_12012/5, MC_UP_1202/2] Funding Source: UKRI; Medical Research
   Council [G0600717, MC_UU_12012/5/B, G0600717B, MC_UU_12012/5,
   MC_UP_1202/2] Funding Source: researchfish
FX Work was supported by Diabetes UK (RD05/003059 to M.L.E.), the Wellcome
   Trust (WT081713 and WT098012 to L.K.B. and L.K.H.), the National
   Institutes of Health (DK066604 to M.J.L. and DK068400 to M.J.L. and
   M.R.), and the Medical Research Council Centre for Study of Obesity and
   Related Disorders (to M.L.E., L.K.H., L.K.B., and B.D.).
CR Alon T, 2009, ENDOCRINOLOGY, V150, P5626, DOI 10.1210/en.2009-0881
   Berglund ED, 2013, J CLIN INVEST
   Bumaschny VF, 2012, J CLIN INVEST, V122, P4203, DOI 10.1172/JCI62543
   Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085
   Doslikova B, 2013, J NEUROSCI, V33, P9800, DOI 10.1523/JNEUROSCI.4326-12.2013
   Garfield AS, 2012, ENDOCRINOLOGY, V153, P4600, DOI 10.1210/en.2012-1282
   Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002
   Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327
   Lam DD, 2008, ENDOCRINOLOGY, V149, P1323, DOI 10.1210/en.2007-1321
   Lam DD, 2010, PHARMACOL BIOCHEM BE, V97, P84, DOI 10.1016/j.pbb.2010.09.003
   Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005
   Newton AJ, 2013, ENDOCRINOLOGY, V154, P172, DOI 10.1210/en.2012-1643
   Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743
   Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123
   Stanley S, 2010, P NATL ACAD SCI USA, V107, P7024, DOI 10.1073/pnas.1002790107
   Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3
   Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664
   Xu Y, 2010, J NEUROSCI, V30, P14630, DOI 10.1523/JNEUROSCI.5412-09.2010
   Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033
   Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043
   Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008
NR 21
TC 29
Z9 32
U1 0
U2 12
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD OCT
PY 2014
VL 155
IS 10
BP 3732
EP 3738
DI 10.1210/en.2014-1223
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA AP8QX
UT WOS:000342345000003
PM 25051442
OA Green Published, Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU Bailey, KJ
   Maslov, AY
   Pruitt, SC
AF Bailey, KJ
   Maslov, AY
   Pruitt, SC
TI Accumulation of mutations and somatic selection in aging neural
   stem/progenitor cells
SO AGING CELL
LA English
DT Article
DE aging; central nervous system; DNA damage; genetics; molecular biology
   of aging; mutagenesis; neural stem cells; neurogenesis
ID LACI TRANSGENIC MICE; AGE; MOUSE; FREQUENCY; BRAIN; PROLIFERATION;
   NEUROGENESIS; CHROMOSOME; LIVER; ZONE
AB Genomic instability within somatic stem cells may lead to the accumulation of mutations and contribute to cancer or other age-related phenotypes. However, determining the frequency of mutations that differ among individual stem cells is difficult from whole tissue samples because each event is diluted in the total population of both stem cells and differentiated tissue. Here the ability to expand neural stem/progenitor cells clonally permitted measurement of genomic alterations derived from a single initial cell. C57Bl/6 x DBA/2 hybrid mice were used and PCR analysis with strain-specific primers was performed to detect loss of heterozygosity on nine different chromosomes for each neurosphere. The frequency with which changes occurred in neurospheres derived from 2-month- and 2-year-old mice was compared. In 15 neurospheres derived from young animals both parental chromosomes were present for all nine chromosome pairs. In contrast, 16/17 neurospheres from old animals demonstrated loss of heterozygosity (LOH) on one or more chromosomes and seven exhibited a complete deletion of at least one chromosomal region. For chromosomes 9 and 19 there is a significant bias in the allele that is lost where in each case the C57Bl/6 allele is retained in 6/6 neurospheres exhibiting LOH. These data suggest that aging leads to a substantial mutational load within the neural stem cell compartment which can be expected to affect the normal function of these cells. Furthermore, the retention of specific alleles for chromosomes 9 and 19 suggests that a subset of mutational events lead to an allele-specific survival advantage within the neural stem cell compartment.
C1 Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.
C3 Roswell Park Comprehensive Cancer Center
RP Pruitt, SC (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.
EM steven.pruitt@roswellpark.org
RI Maslov, Alexander/AAH-3788-2019
FU NIA NIH HHS [AG019863, AG020946] Funding Source: Medline
CR BOERRIGTER METI, 1995, NATURE, V377, P657, DOI 10.1038/377657a0
   BOVERI T, 1914, QUESTION ORIGIN MALI
   CURTIS H, 1963, RADIAT RES, V19, P337, DOI 10.2307/3571455
   Deubel W, 1996, MUTAT RES-FUND MOL M, V351, P67, DOI 10.1016/0027-5107(95)00214-6
   Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9
   Doetsch F, 1997, J NEUROSCI, V17, P5046
   FAILLA G, 1958, ANN NY ACAD SCI, V71, P1124, DOI 10.1111/j.1749-6632.1958.tb46828.x
   GOSSEN JA, 1991, MUTAT RES, V250, P423, DOI 10.1016/0027-5107(91)90198-W
   INAMIZU T, 1986, P NATL ACAD SCI USA, V83, P2488, DOI 10.1073/pnas.83.8.2488
   KING CM, 1994, MUTAT RES-DNAGING G, V316, P79, DOI 10.1016/0921-8734(94)90010-8
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Martin GM, 1996, HUM MOL GENET, V5, P215, DOI 10.1093/hmg/5.2.215
   MARTUS HJ, 1995, MUTAT RES-DNAGING G, V338, P203, DOI 10.1016/0921-8734(95)00025-2
   Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004
   Mohaghegh P, 2001, HUM MOL GENET, V10, P741, DOI 10.1093/hmg/10.7.741
   Nakayama H, 2002, ONCOGENE, V21, P9008, DOI 10.1038/sj.onc.1205959
   ONO T, 1995, MUTAT RES-DNAGING G, V338, P183, DOI 10.1016/0921-8734(95)00023-Y
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   SCNEIDER BL, 2004, CARCINOGENESIS
   Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230
   Stuart GR, 2000, GENETICS, V154, P1291
   Stuart GR, 2000, GENETICS, V155, P1359
   Tropepe V, 1997, J NEUROSCI, V17, P7850
   Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X
   Vijg J, 1997, MECH AGEING DEV, V99, P257
   Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100
NR 26
TC 53
Z9 58
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9726
J9 AGING CELL
JI Aging Cell
PD DEC
PY 2004
VL 3
IS 6
BP 391
EP 397
DI 10.1111/j.1474-9728.2004.00128.x
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 878DL
UT WOS:000225626600008
PM 15569356
OA hybrid
DA 2024-02-19
ER

PT J
AU Campanero-Rhodes, MA
   Solís, D
   Carrera, E
   de la Cruz, MJ
   Díaz-Mauriño, T
AF Campanero-Rhodes, MA
   Solís, D
   Carrera, E
   de la Cruz, MJ
   Díaz-Mauriño, T
TI Rat liver contains age-regulated cytosolic
   3-deoxy-<i>D</i>-<i>glycero</i>-<i>D</i>-<i>galacto</i>-non-2-ulopyranos
   onic acid (Kdn)
SO GLYCOBIOLOGY
LA English
DT Article
DE age; fluorometric HPLC; Kdn; rat liver; sialic acids
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; DEAMINATED NEURAMINIC ACID;
   CELL-ADHESION MOLECULE; SIALIC-ACID; POLY(ALPHA-2,8-DEAMINONEURAMINIC
   ACID); DEVELOPMENTAL EXPRESSION; MAMMALIAN-TISSUES; IDENTIFICATION;
   HYDROXYLATION; GLYCOPROTEINS
AB Kdn (3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid), a unique deaminated member of the sialic acid family, has emerged as a new building block of glycoconjugates from a wide variety of organisms, ranging from bacteria to mammals. In particular, the presence of Kdn has been demonstrated in different rat organs and tissues, but not in liver. Here we report on the detection and quantitation of Kdn in rat li, er and on its variations with postnatal development and aging, We have previously established the optimal conditions for derivatization of Kdn with 1,2-diamino-4,5-methylene-dioxybenzene (DMB), and detection by reverse-phase HPLC. Analysis of whole liver homogenates and different subcellular fractions reveals that Kdn is fundamentally present in the cytosolic fraction as nucleotide precursor. The expression of Kdn, NeuSGc, and Neu5Ac changes unevenly with age. While the content of Neu5Ac, the major species, and NeuSGc decreases to a different extent from newborn to old animals, Kdn content decreases from newborn to trace amounts in adult rats and increases again with aging. Thus, expression of Kdn, NeuSGc, and Neu5Ac appears to be independently regulated.
C1 Inst Quim Fis Rocasolano, CSIC, Madrid 28006, Spain.
   Univ Complutense, Fac Med, Dept Bioquim, Madrid 28040, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Quimica Fisica Rocasolano (IQFR); Complutense University of Madrid
RP Díaz-Mauriño, T (corresponding author), Inst Quim Fis Rocasolano, CSIC, Serrano 119, Madrid 28006, Spain.
RI Campanero-Rhodes, María Asunción/M-3158-2014; Solís, Dolores/E-5992-2015
OI Campanero-Rhodes, María Asunción/0000-0002-3373-0064; Solís,
   Dolores/0000-0002-8148-1875
CR Angata T, 1998, GLYCOBIOLOGY, V8, P277, DOI 10.1093/glycob/8.3.277
   ANGATA T, 1994, GLYCOCONJUGATE J, V11, P493, DOI 10.1007/BF00731286
   BOUHOURS JF, 1989, J BIOL CHEM, V264, P16992
   COATES SW, 1980, J BIOL CHEM, V255, P9225
   FENDERSON BA, 1990, BIOESSAYS, V12, P173, DOI 10.1002/bies.950120406
   Fox GB, 1995, INT J DEV NEUROSCI, V13, P663, DOI 10.1016/0736-5748(95)00067-4
   HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2
   HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0
   Inoue S, 1996, J BIOL CHEM, V271, P24341, DOI 10.1074/jbc.271.40.24341
   Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0
   Keusch J, 1996, CLIN CHIM ACTA, V252, P147, DOI 10.1016/0009-8981(96)06326-7
   KING TP, 1995, GLYCOBIOLOGY, V5, P525, DOI 10.1093/glycob/5.5.525
   KNIREL YA, 1989, CARBOHYD RES, V188, P145, DOI 10.1016/0008-6215(89)84067-4
   MUCHMORE EA, 1989, J BIOL CHEM, V264, P20216
   NADANO D, 1986, J BIOL CHEM, V261, P1550
   NAKAMURA M, 1987, CHEM PHARM BULL, V35, P687
   NARAYANAN S, 1994, ANN CLIN LAB SCI, V24, P376
   Phillips GR, 1997, DEV BRAIN RES, V102, P143, DOI 10.1016/S0165-3806(97)00069-2
   Qu BX, 1996, P NATL ACAD SCI USA, V93, P8995, DOI 10.1073/pnas.93.17.8995
   Reutter W., 1997, GLYCOSCIENCES, P245
   ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064
   Schauer R., 1995, Biology of Sialic Acids, P7, DOI [DOI 10.1007/978-1-4757-9504-2_2, 10.1007/978-1-4757-9504-2, DOI 10.1007/978-1-4757-9504-2]
   SCHNAAR RL, 1994, METHOD ENZYMOL, V230, P348
   SEPPALA R, 1991, J BIOL CHEM, V266, P7456
   STRECKER G, 1992, EUR J BIOCHEM, V207, P995, DOI 10.1111/j.1432-1033.1992.tb17135.x
   Svennerholm L, 1997, ACTA NEUROPATHOL, V94, P345, DOI 10.1007/s004010050717
   TAATJES DJ, 1990, EUR J CELL BIOL, V53, P255
   TERADA T, 1993, J BIOL CHEM, V268, P2640
   Ziak M, 1996, P NATL ACAD SCI USA, V93, P2759, DOI 10.1073/pnas.93.7.2759
NR 29
TC 14
Z9 14
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0959-6658
J9 GLYCOBIOLOGY
JI Glycobiology
PD JUN
PY 1999
VL 9
IS 6
BP 527
EP 532
DI 10.1093/glycob/9.6.527
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 197WW
UT WOS:000080390200001
PM 10336984
OA Bronze
DA 2024-02-19
ER

PT J
AU Peng, ZS
   Duggan, MR
   Dark, HE
   Daya, GN
   An, Y
   Davatzikos, C
   Erus, G
   Lewis, A
   Moghekar, AR
   Walker, KA
AF Peng, Zhongsheng
   Duggan, Michael R.
   Dark, Heather E.
   Daya, Gulzar N.
   An, Yang
   Davatzikos, Christos
   Erus, Guray
   Lewis, Alexandria
   Moghekar, Abhay R.
   Walker, Keenan A.
TI Association of liver disease with brain volume loss, cognitive decline,
   and plasma neurodegenerative disease biomarkers
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE Alzheimer?s disease; Liver disease; Longitudinal study; MRI; Cognitive
   assessment; AD plasma biomarkers
ID MIDDLE-AGED ADULTS; AMYLOID-BETA; PERFORMANCE; ALZHEIMERS; RISK; SEX
AB Although liver dysfunction has been implicated in Alzheimer's disease (AD), it remains unknown how liver disease may influence the trajectory of brain and cognitive changes in older adults. We related selfreported liver disease to longitudinal measures of brain structure and cognition, as well as baseline measures of plasma AD/neurodegeneration biomarkers in the Baltimore Longitudinal Study of Aging. Liver disease was identified using ICD-9 classification codes. Brain volume and cognition were assessed serially using 3T-MRI and a cognitive battery. 1008, 2157, and 780 participants were included in the MRI, cognitive, and plasma biomarker analysis, respectively. After adjustment for confounders, liver disease was associated with accelerated decline in total brain and white matter volume, but not total gray matter or AD signature region volume. Although liver disease showed no relationship with domain-specific cognitive decline or plasma biomarkers, participants with a history of hepatitis demonstrated accelerated decline in verbal fluency and elevated neurofilament light. Results suggest all-cause liver disease may accelerate brain volume loss but does not appear to promote AD-specific neurocognitive changes.Published by Elsevier Inc.
C1 [Peng, Zhongsheng; Duggan, Michael R.; Dark, Heather E.; Daya, Gulzar N.; An, Yang; Walker, Keenan A.] Natl Inst Aging, Lab Behav Neurosci, Baltimore, MD USA.
   [Davatzikos, Christos; Erus, Guray] Univ Penn, Dept Radiol, Sect Biomed Image Anal, Philadelphia, PA USA.
   [Lewis, Alexandria; Moghekar, Abhay R.] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD USA.
   [Walker, Keenan A.] Natl Inst Aging, Lab Behav Neurosci, 251 Bayview BLVD, Baltimore, MD 21224 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); University of Pennsylvania; Johns Hopkins University;
   National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA)
RP Walker, KA (corresponding author), Natl Inst Aging, Lab Behav Neurosci, 251 Bayview BLVD, Baltimore, MD 21224 USA.
EM keenan.walker@nih.gov
RI Erus, Guray/L-6712-2018
OI Erus, Guray/0000-0001-6633-4861; Walker, Keenan/0000-0002-5989-9853;
   Duggan, Michael/0000-0002-1029-4423; Dark, Heather/0000-0001-7194-3637
FU Intramural Research Program of the NIH, National Institute on Aging;
   National Institute on Aging (NIA/NIH) Intramural Research Program
   [RF1-AG054409]
FX The authors thank the BLSA participants and staff for their
   participation and continued dedication. This research was supported in
   part by the Intramural Research Program of the NIH, National Institute
   on Aging. The authors of this manuscript participated in all aspects of
   the project.This study was supported by the National Institute on Aging
   (NIA/NIH) Intramural Research Program and in part by grant RF1-AG054409
   to C. Davatzikos.
CR Adekanle O, 2012, ANN AFR MED, V11, P222, DOI 10.4103/1596-3519.102853
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Association A. P., 2013, DIAGN STAT MAN MENT
   Bassendine MF, 2020, J ALZHEIMERS DIS, V75, P1, DOI 10.3233/JAD-190848
   Basu E, 2022, J NEUROL SCI, V434, DOI 10.1016/j.jns.2021.120117
   BLACKBURN HL, 1957, J CONSULT PSYCHOL, V21, P139, DOI 10.1037/h0047235
   BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019
   Butler L, 2021, CURR CLIN MICROBIOL, V8, P199, DOI 10.1007/s40588-021-00168-6
   Celikbilek A, 2018, EUR J GASTROEN HEPAT, V30, P944, DOI 10.1097/MEG.0000000000001131
   Chen HJ, 2012, J NEUROL SCI, V321, P65, DOI 10.1016/j.jns.2012.07.056
   Chen TB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175475
   Cheng Y, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00195-1
   Chiu WC, 2014, EUR J NEUROL, V21, P1068, DOI 10.1111/ene.12317
   Delis D., 1994, CVLT, California verbal learning test: Adult version: Manual
   Doshi J, 2019, Arxiv, DOI arXiv:1907.02110
   Doshi J, 2016, NEUROIMAGE, V127, P186, DOI 10.1016/j.neuroimage.2015.11.073
   Erus G, 2018, NEUROIMAGE, V166, P71, DOI 10.1016/j.neuroimage.2017.10.026
   Estrada LD, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00174
   Ferrucci L, 2008, J GERONTOL A-BIOL, V63, P1416, DOI 10.1093/gerona/63.12.1416
   Gerber Y, 2021, BMC GASTROENTEROL, V21, DOI 10.1186/s12876-021-01681-0
   Graff-Radford J, 2017, STROKE, V48, P2964, DOI 10.1161/STROKEAHA.117.018336
   Gresham G, 2018, CANCER-AM CANCER SOC, V124, P1279, DOI 10.1002/cncr.31238
   Hjerrild S, 2016, METAB BRAIN DIS, V31, P311, DOI 10.1007/s11011-015-9752-3
   Iwasa M, 2012, METAB BRAIN DIS, V27, P551, DOI 10.1007/s11011-012-9314-x
   June D, 2020, NEUROIMAGE, V221, DOI 10.1016/j.neuroimage.2020.117182
   Karaivazoglou K, 2007, LIVER INT, V27, P798, DOI 10.1111/j.1478-3231.2007.01486.x
   Kim DG, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0467-5
   Kim YD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139227
   Labenz C, 2021, DIGEST DIS SCI, V66, P3179, DOI 10.1007/s10620-020-06644-1
   Lampignano L, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.748888
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Lowry D, 2010, J VIRAL HEPATITIS, V17, P352, DOI 10.1111/j.1365-2893.2009.01188.x
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Monaco S, 2015, WORLD J GASTROENTERO, V21, P11974, DOI 10.3748/wjg.v21.i42.11974
   Nho K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7978
   Parikh NS, 2020, EUR J NEUROL, V27, P1895, DOI 10.1111/ene.14384
   Patterson C., 2018, WORLD ALZHEIMER REPO, P32, DOI APO-260056
   Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x
   Petta S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003446
   Prell T, 2019, J NEUROVIROL, V25, P229, DOI 10.1007/s13365-018-0709-2
   Reitan RM, 1992, TRAIL MAKING TEST MA
   Resnick SM, 2003, J NEUROSCI, V23, P3295
   Rich NE, 2018, CLIN GASTROENTEROL H, V16, P198, DOI 10.1016/j.cgh.2017.09.041
   ROULEAU I, 1992, BRAIN COGNITION, V18, P70, DOI 10.1016/0278-2626(92)90112-Y
   Schrack JA, 2014, J AM GERIATR SOC, V62, P667, DOI 10.1111/jgs.12740
   Shafer AT, 2021, NEUROBIOL AGING, V104, P10, DOI 10.1016/j.neurobiolaging.2021.03.013
   Shock NW., 1984, NORMAL HUMAN AGING B
   STONE JL, 1966, J GERONTOL, V21, P575, DOI 10.1093/geronj/21.4.575
   Sutcliffe JG, 2011, J NEUROSCI RES, V89, P808, DOI 10.1002/jnr.22603
   Varadaraj V, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.17416
   Weinstein G, 2018, JAMA NEUROL, V75, P97, DOI 10.1001/jamaneurol.2017.3229
   Weinsteina G, 2022, J ALZHEIMERS DIS, V86, P1371, DOI 10.3233/JAD-215409
   WILSON JR, 1975, INT J AGING HUM DEV, V6, P261, DOI 10.2190/BBJP-XKUG-C6EW-KYB7
   Wu DM, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.634948
NR 54
TC 7
Z9 8
U1 2
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0197-4580
EI 1558-1497
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD DEC
PY 2022
VL 120
BP 34
EP 42
DI 10.1016/j.neurobiolaging.2022.08.004
PG 9
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA 4Q3XR
UT WOS:000856017600002
PM 36115133
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Dinarello, CA
AF Dinarello, CA
TI Interleukin 1 and interleukin 18 as mediators of inflammation and the
   aging process
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article; Proceedings Paper
CT Conference on Living Well 100 - Nutrition, Genetics, Inflammation
CY NOV 15-16, 2004
CL Boston, MA
SP Tufts Univ, Sch Med, Gerald J & Dorothy R Friedman Sch Nutr Sci & Policy, Jean Mayer USDA Human Nutr Res Ctr Aging, Interleukin Genet Inc, Nutrilite Hlth Inst
DE cytokines; inflammation; atherosclerosis; aging
ID IL-18 BINDING-PROTEIN; COLD AUTOINFLAMMATORY SYNDROME; COLLAGEN-INDUCED
   ARTHRITIS; NECROSIS-FACTOR-ALPHA; ACUTE-PHASE RESPONSE; REGULATORY
   FACTOR-I; IFN-GAMMA; FUNCTIONAL EPITOPES; INDUCED COLITIS; LIVER-INJURY
AB In this review, 2 cytokines are discussed with respect to the inflammatory processes that are fundamental to aging and mortality. Both interleukin (IL)-1 and IL-18 are members of the same structural family (IL-1 family, or IL-F); there are presently 9 members of this family, but with the exception of IL-1 alpha, IL-1 beta, and IL-18, the others are antagonists or remain without known function. IL-1 alpha is an intracellular cytokine with properties of both a cytokine and a transcription factor. IL-1 beta and IL-18 are closely related; both possess a similar three-dimensional structure, and their respective precursor forms are inactive until cleaved by the intracellular cysteine protease caspase-1. Patients with mutations in the NALP3 gene, which controls the activity of caspase-1, readily secrete more IL-1 beta and IL-18 and suffer from systemic inflammatory diseases. Patients with defects in this gene have high circulating concentrations of IL-6, serum amyloid A, and C-reactive protein, each of which decrease rapidly upon blockade of the IL-1 receptor, which suggests that IL-1 beta contributes to the elevation of these markers of the inflammatory mechanisms of aging. Animal studies support the concept that IL-1 beta and IL-18 participate in the pathogenesis of atherosclerosis. For example, overexpression of the IL-18 binding protein, a naturally occurring, specific inhibitor of IL-18, prevents the spontaneous development of atherosclerosis in apolipoprotein E-deficient mice. From human and animal studies, one may conclude that IL-1 beta and IL-18 participate in fundamental inflammatory processes that increase during the aging process.
C1 Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA.
C3 University of Colorado System; University of Colorado Denver; University
   of Colorado Anschutz Medical Campus
RP Dinarello, CA (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, 4200 E 9th Ave,B168, Denver, CO 80262 USA.
EM cdinare333@aol.com
RI Dinarello, Charles/C-8524-2013
FU NCI NIH HHS [CA 046934] Funding Source: Medline; NHLBI NIH HHS
   [HL-68743] Funding Source: Medline; NIAID NIH HHS [AI-15614] Funding
   Source: Medline
CR Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9
   Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688
   AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907
   Azam T, 2003, J IMMUNOL, V171, P6574, DOI 10.4049/jimmunol.171.12.6574
   Bossù P, 2003, P NATL ACAD SCI USA, V100, P14181, DOI 10.1073/pnas.2336094100
   Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2
   Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099
   CANNON JG, 1988, LYMPHOKINE RES, V7, P457
   CANNON JG, 1993, J APPL PHYSIOL, V75, P1897, DOI 10.1152/jappl.1993.75.4.1897
   Cardoso SMP, 2004, BRIT J HAEMATOL, V126, P704, DOI 10.1111/j.1365-2141.2004.05128.x
   Carrascal MT, 2003, CANCER RES, V63, P491
   Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X
   Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261
   CROWN J, 1993, LEUKEMIA LYMPHOMA, V9, P433, DOI 10.3109/10428199309145750
   Dierselhuis MP, 2005, RHEUMATOLOGY, V44, P406, DOI 10.1093/rheumatology/keh479
   DINARELLO CA, 1986, J CLIN INVEST, V77, P1734, DOI 10.1172/JCI112495
   Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095
   DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3
   ENDRES S, 1989, EUR J IMMUNOL, V19, P2327, DOI 10.1002/eji.1830191222
   Faggioni R, 2000, P NATL ACAD SCI USA, V97, P2367, DOI 10.1073/pnas.040561297
   Faggioni R, 2001, J IMMUNOL, V167, P5913, DOI 10.4049/jimmunol.167.10.5913
   Fantuzzi G, 1999, J CLIN INVEST, V104, P761, DOI 10.1172/JCI7501
   Fantuzzi G, 2003, J LEUKOCYTE BIOL, V74, P889, DOI 10.1189/jlb.0503230
   Fantuzzi G, 2001, EUR J IMMUNOL, V31, P369, DOI 10.1002/1521-4141(200102)31:2<369::AID-IMMU369>3.0.CO;2-Y
   FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008
   Fitzgerald AA, 2005, ARTHRITIS RHEUM-US, V52, P1794, DOI 10.1002/art.21061
   Frenkel J, 2004, ARTHRITIS RHEUM-US, V50, P3738, DOI 10.1002/art.20497
   FRITEAU L, 1988, BIOCHEM BIOPH RES CO, V157, P1197, DOI 10.1016/S0006-291X(88)81001-5
   Furlan R, 1999, J IMMUNOL, V163, P2403
   Gatti S, 2002, AM J PHYSIOL-REG I, V282, pR702, DOI 10.1152/ajpregu.00393.2001
   Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022
   Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033
   HELLERSTEIN MK, 1989, J CLIN INVEST, V84, P228, DOI 10.1172/JCI114145
   Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1
   Hoffman HM, 2003, HUM GENET, V112, P209, DOI 10.1007/s00439-002-0860-x
   Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756
   Hofstra CL, 1998, J IMMUNOL, V161, P5054
   Hoshino T, 2000, EUR J IMMUNOL, V30, P1998, DOI 10.1002/1521-4141(200007)30:7<1998::AID-IMMU1998>3.0.CO;2-U
   Hurgin V, 2002, P NATL ACAD SCI USA, V99, P16957, DOI 10.1073/pnas.262663399
   Im SH, 2001, FASEB J, V15, P2140, DOI 10.1096/fj.01-0072com
   Joosten LAB, 2000, J IMMUNOL, V165, P6553, DOI 10.4049/jimmunol.165.11.6553
   Josephs MD, 2000, AM J PHYSIOL-REG I, V278, pR824, DOI 10.1152/ajpregu.2000.278.4.R824
   Kaser A, 2004, BLOOD, V103, P648, DOI 10.1182/blood-2002-07-2322
   Kato Z, 2003, NAT STRUCT BIOL, V10, P966, DOI 10.1038/nsb993
   Kawase Y, 2003, J INVEST DERMATOL, V121, P502, DOI 10.1046/j.1523-1747.2003.12407.x
   Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190
   Kim SH, 2002, J BIOL CHEM, V277, P10998, DOI 10.1074/jbc.M108311200
   Kim SH, 2000, PROG BIOM O, V1, P166, DOI 10.1117/12.379574
   Konishi H, 2002, P NATL ACAD SCI USA, V99, P11340, DOI 10.1073/pnas.152337799
   Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308
   Kumar S, 2002, CYTOKINE, V18, P61, DOI 10.1006/cyto.2002.0873
   Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101
   Li SX, 2003, BRAIN RES, V992, P76, DOI 10.1016/j.brainres.2003.08.033
   LOMEDICO PT, 1984, NATURE, V312, P458, DOI 10.1038/312458a0
   LOTZE MT, 1997, J LEUK BIOL, V25
   Lovell DJ, 2005, ARTHRITIS RHEUM-US, V52, P1283, DOI 10.1002/art.20953
   Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100
   Maecker HT, 2001, J IMMUNOL, V166, P959, DOI 10.4049/jimmunol.166.2.959
   Mallat Z, 2004, FASEB J, V18, P1752, DOI 10.1096/fj.04-2426fje
   Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735
   Melnikov VY, 2001, J CLIN INVEST, V107, P1145, DOI 10.1172/JCI12089
   MEYDANI SN, 1993, J CLIN INVEST, V92, P105, DOI 10.1172/JCI116537
   MEYDANI SN, 1991, J NUTR, V121, P547, DOI 10.1093/jn/121.4.547
   Min CK, 2004, BLOOD, V104, P3393, DOI 10.1182/blood-2004-02-0763
   MROSOVSKY N, 1989, AM J PHYSIOL, V257, pR1315, DOI 10.1152/ajpregu.1989.257.6.R1315
   NAKAMURA K, 1989, INFECT IMMUN, V57, P590, DOI 10.1128/IAI.57.2.590-595.1989
   Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423
   Netea MG, 2000, J IMMUNOL, V164, P2644, DOI 10.4049/jimmunol.164.5.2644
   Neumann D, 2001, J INTERF CYTOK RES, V21, P635, DOI 10.1089/10799900152547902
   Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8
   Novick D, 2001, CYTOKINE, V14, P334, DOI 10.1006/cyto.2001.0914
   NOVICK D, 1990, J CHROMATOGR, V510, P331, DOI 10.1016/S0021-9673(01)93767-7
   OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0
   Osaki T, 1998, J IMMUNOL, V160, P1742
   Pan GH, 2001, CYTOKINE, V13, P1, DOI 10.1006/cyto.2000.0799
   Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473
   Paulukat J, 2001, J IMMUNOL, V167, P7038, DOI 10.4049/jimmunol.167.12.7038
   Plater-Zyberk C, 2001, J CLIN INVEST, V108, P1825, DOI 10.1172/JCI12097
   Pomerantz BJ, 2001, P NATL ACAD SCI USA, V98, P2871, DOI 10.1073/pnas.041611398
   Raeburn CD, 2002, AM J PHYSIOL-HEART C, V283, pH650, DOI 10.1152/ajpheart.00043.2002
   Reddy P, 2003, J LAB CLIN MED, V141, P365, DOI 10.1016/S0022-2143(03)00028-3
   Reznikov LL, 2000, P NATL ACAD SCI USA, V97, P2174, DOI 10.1073/pnas.040582597
   Reznikov LL, 2002, J INTERF CYTOK RES, V22, P593, DOI 10.1089/10799900252982070
   Roubenoff R, 2003, AM J MED, V115, P429, DOI 10.1016/j.amjmed.2003.05.001
   ROUBENOFF R, 1994, J CLIN INVEST, V93, P2379, DOI 10.1172/JCI117244
   Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100
   Siegmund B, 2004, EUR J IMMUNOL, V34, P2356, DOI 10.1002/eji.200425124
   Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998
   Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264
   Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812
   Smeets RL, 2003, GENE THER, V10, P1004, DOI 10.1038/sj.gt.3301986
   SMITH JW, 1993, NEW ENGL J MED, V328, P756, DOI 10.1056/NEJM199303183281103
   Sugawara S, 2001, J IMMUNOL, V167, P6568, DOI 10.4049/jimmunol.167.11.6568
   Swiergiel AH, 1997, BRAIN RES, V776, P96, DOI 10.1016/S0006-8993(97)01009-3
   Takeuchi D, 2004, HEPATOLOGY, V39, P699, DOI 10.1002/hep.20117
   Ten Hove T, 2001, GASTROENTEROLOGY, V121, P1372, DOI 10.1053/gast.2001.29579
   Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9
   Tsutsui H, 1997, J IMMUNOL, V159, P3961
   Vidal-Vanaclocha F, 2000, P NATL ACAD SCI USA, V97, P734, DOI 10.1073/pnas.97.2.734
   Wei XQ, 2001, J IMMUNOL, V166, P517, DOI 10.4049/jimmunol.166.1.517
   Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292
   Wildbaum G, 1998, J IMMUNOL, V161, P6368
   Wirtz S, 2002, J IMMUNOL, V168, P411, DOI 10.4049/jimmunol.168.1.411
   Xiang Y, 2001, J VIROL, V75, P9947, DOI 10.1128/JVI.75.20.9947-9954.2001
   Xiang Y, 2001, J BIOL CHEM, V276, P17380, DOI 10.1074/jbc.M009581200
   Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962
   Yoshimoto T, 1998, J IMMUNOL, V161, P3400
   ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X
NR 108
TC 286
Z9 351
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD FEB
PY 2006
VL 83
IS 2
BP 447S
EP 455S
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics
GA 013CN
UT WOS:000235387300042
PM 16470011
DA 2024-02-19
ER

PT J
AU Wilson, CH
   Nikolic, A
   Kentish, SJ
   Shalini, S
   Hatzinikolas, G
   Page, AJ
   Dorstyn, L
   Kumar, S
AF Wilson, C. H.
   Nikolic, A.
   Kentish, S. J.
   Shalini, S.
   Hatzinikolas, G.
   Page, A. J.
   Dorstyn, L.
   Kumar, S.
TI Sex-specific alterations in glucose homeostasis and metabolic parameters
   during ageing of caspase-2-deficient mice
SO CELL DEATH DISCOVERY
LA English
DT Article
AB Gender-specific differences are commonly found in metabolic pathways and in response to nutritional manipulation. Previously, we identified a role for caspase-2 in age-related glucose homeostasis and lipid metabolism using male caspase-2-deficient (Casp2(-/-)) mice. Here we show that the resistance to age-induced glucose tolerance does not occur in female Casp2(-/-) mice and it appears to be independent of insulin sensitivity in males. Using fasting (18 h) as a means to further investigate the role of caspase-2 in energy and lipid metabolism, we identified sex-specific differences in the fasting response and lipid mobilization. In aged (18-22 months) male Casp2(-/-) mice, a significant decrease in fasting liver mass, but not total body weight, was observed while in females, total body weight, but not liver mass, was reduced when compared with wild-type (WT) animals. Fasting-induced lipolysis of adipose tissue was enhanced in male Casp2(-/-) mice as indicated by a significant reduction in white adipocyte cell size, and increased serum-free fatty acids. In females, white adipocyte cell size was significantly smaller in both fed and fasted Casp2(-/-) mice. No difference in fasting-induced hepatosteatosis was observed in the absence of caspase-2. Further analysis of white adipose tissue (WAT) indicated that female Casp2(-/-) mice may have enhanced fatty acid recycling and metabolism with expression of genes involved in glyceroneogenesis and fatty acid oxidation increased. Loss of Casp2 also increased fasting-induced autophagy in both male and female liver and in female skeletal muscle. Our observations suggest that caspase-2 can regulate glucose homeostasis and lipid metabolism in a tissue and sex-specific manner.
C1 [Wilson, C. H.; Nikolic, A.; Shalini, S.; Dorstyn, L.; Kumar, S.] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia.
   [Kentish, S. J.; Hatzinikolas, G.; Page, A. J.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia.
   [Kentish, S. J.; Page, A. J.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.
C3 University of South Australia; Centre for Cancer Biology; University of
   Adelaide; South Australian Health & Medical Research Institute (SAHMRI)
RP Wilson, CH; Kumar, S (corresponding author), Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia.
EM claire.wilson@unisa.edu.au; sharad.kumar@unisa.edu.au
RI Dorstyn, Loretta/F-3673-2013; Kumar, Sathish/B-7966-2013; Kumar,
   Sharad/AAX-7787-2020
OI Dorstyn, Loretta/0000-0001-9886-0989; Kumar,
   Sathish/0000-0002-2792-7047; Kumar, Sharad/0000-0001-7126-9814; Page,
   Amanda/0000-0002-7086-5865; Nikolic, Andrej/0000-0002-6939-3119
FU National Health and Medical Research Council (NHMRC) of Australia
   [1021456]; Cancer Council Collaborative Research Fellowship; NHMRC Early
   Career Research Fellowship [1073771, 1091586]; NHMRC Senior Principal
   Research Fellowship [1002863]; National Health and Medical Research
   Council of Australia [1091586, 1073771] Funding Source: NHMRC
FX We thank the staff at the SA Pathology animal resource facility for help
   in maintaining the mouse strains. Professor Jim Manavis and Dr. John
   Finnie are acknowledged for their assistance with histopathology
   analyses. This work was supported by the National Health and Medical
   Research Council (NHMRC) of Australia project grant 1021456 to SK, a
   Cancer Council Collaborative Research Fellowship to LD, a NHMRC Early
   Career Research Fellowship to CHW (1073771) and SJK (1091586) and a
   NHMRC Senior Principal Research Fellowship to SK (1002863).
CR Anand P, 2005, J BIOL CHEM, V280, P16427, DOI 10.1074/jbc.M410576200
   Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891
   Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016
   Coe LM, 2011, J CELL BIOCHEM, V112, P2403, DOI 10.1002/jcb.23163
   Dorstyn L, 2012, CELL DEATH DIFFER, V19, P1288, DOI 10.1038/cdd.2012.36
   Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371
   Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400
   Gürtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010
   Hardie DG, 2012, COLD SPRING HARB PER, V4
   Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106
   Jobgen W, 2009, AMINO ACIDS, V37, P187, DOI 10.1007/s00726-009-0246-7
   Johnson ES, 2013, J BIOL CHEM, V288, P14463, DOI 10.1074/jbc.M112.437210
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613
   Li JJ, 2015, ENDOCRINOLOGY, V156, P1283, DOI 10.1210/en.2014-1909
   Logette E, 2005, MOL CELL BIOL, V25, P9621, DOI 10.1128/MCB.25.21.9621-9631.2005
   Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009
   Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054
   O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033
   Puccini J, 2013, CELL DEATH DIFFER, V20, P1133, DOI 10.1038/cdd.2013.87
   Puccini J, 2013, P NATL ACAD SCI USA, V110, P19920, DOI 10.1073/pnas.1311947110
   Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200
   Rivero-Gutiérrez B, 2014, ANAL BIOCHEM, V467, P1, DOI 10.1016/j.ab.2014.08.027
   Rodriguez A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00171
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344
   Shalini S, 2015, ONCOGENE, V34, P4995, DOI 10.1038/onc.2014.413
   Shalini S, 2012, CELL DEATH DIFFER, V19, P1370, DOI 10.1038/cdd.2012.13
   Tiwari M, 2014, AUTOPHAGY, V10, P1054, DOI 10.4161/auto.28528
   Tiwari M, 2011, J BIOL CHEM, V286, P8493, DOI 10.1074/jbc.M110.163824
   Wan ZX, 2010, AM J PHYSIOL-CELL PH, V299, pC1162, DOI 10.1152/ajpcell.00188.2010
   White UA, 2014, BBA-MOL BASIS DIS, V1842, P377, DOI 10.1016/j.bbadis.2013.05.006
   Wilson CH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.567
   Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018
   Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030
NR 35
TC 14
Z9 17
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2058-7716
J9 CELL DEATH DISCOV
JI Cell Death Discov.
PY 2016
VL 2
AR 16009
DI 10.1038/cddiscovery.2016.9
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA VI2GA
UT WOS:000463076300092
PM 27551503
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ahluwalia, A
   Jones, MK
   Szabo, S
   Tarnawski, AS
AF Ahluwalia, A.
   Jones, M. K.
   Szabo, S.
   Tarnawski, A. S.
TI AGING IMPAIRS TRANSCRIPTIONAL REGULATION OF VASCULAR ENDOTHELIAL GROWTH
   FACTOR IN HUMAN MICRO VASCULAR ENDOTHELIAL CELLS: IMPLICATIONS FOR
   ANGIOGENESIS AND CELL SURVIVAL
SO JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article
DE aging; angiogenesis; vascular endothelial growth factor; endothelial
   cells; apoptosis; P-CREB; P-STAT3; importin-alpha
ID NUCLEAR-PROTEIN IMPORT; VEGF EXPRESSION; STAT3; HYPOXIA; ALPHA;
   MECHANISMS; PATHWAY; BINDING; GENE; GASTROPATHY
AB In some tissues, aging impairs angiogenesis and reduces expression of vascular endothelial growth factor A (VEGF), a fundamental regulator of angiogenesis. We previously examined angiogenesis in aging and young gastric mucosa in vivo and in vitro and showed that an imbalance between expressions of VEGF (pro-angiogenic factor) and endostatin (anti-angiogenic protein) results in an aging-related impairment of angiogenesis in rats. However, the human relevance of these findings, and whether these mechanisms apply to endothelial cells derived from other tissues, is not clear. Since P-STAT3 and P-CREB are transcription factors that, in association with HIF-1 alpha, can activate VEGF gene expression in some cells (e.g., liver cancer cells, vascular smooth muscle cells), we examined the expression of these two proteins in human dermal microvascular endothelial cells (HMVECs) derived from aging and neonatal individuals. We examined and quantified in vitro angiogenesis, expression of VEGF, P-STAT3, P-CREB and importin-a in HMVECs isolated from neonates (neonatal) and a 66 year old subject (aging). We also examined the effects of treatment with exogenous VEGF and endostatin on in vitro angiogenesis in these cells. Endothelial cells isolated from aging individuals had impaired angiogenesis (vs. neonatal endothelial cells) and reduced expression of VEGF mRNA and protein. Aged HMVECs also had reduced importin-alpha expression, and reduced expression and nuclear translocation of P-STAT3 and P-CREB. Reduced VEGF gene expression in aged HMVECs strongly correlated with the decreased levels of P-STAT3, P-CREB and importin-alpha in these cells. Our study clearly demonstrates that endothelial cells from aging individuals have impaired angiogenesis and reduced expression of VEGF likely due to impaired nuclear transport of P-STAT3 and P-CREB transcription factors in these cells.
C1 [Ahluwalia, A.; Jones, M. K.; Szabo, S.; Tarnawski, A. S.] Vet Affairs Long Beach Healthcare Syst, Long Beach, CA USA.
   [Szabo, S.; Tarnawski, A. S.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA.
   [Szabo, S.; Tarnawski, A. S.] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   VA Long Beach Healthcare System; University of California System;
   University of California Irvine; University of California System;
   University of California Irvine
RP Tarnawski, AS (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.
EM atarnawski@yahoo.com
FU VA Merit Review Award; Southern California Institute for Research and
   Education grant
FX Source of Funding: this research was supported by a VA Merit Review
   Award to AST and a Southern California Institute for Research and
   Education grant to AA.
CR Ahluwalia A, 2011, J PHYSIOL PHARMACOL, V62, P583
   Ahluwalia A, 2010, J PHYSIOL PHARMACOL, V61, P133
   Ahluwalia A, 2014, AM J PHYSIOL-GASTR L, V306, pG338, DOI 10.1152/ajpgi.00382.2013
   Ahluwalia A, 2013, AM J PHYSIOL-GASTR L, V305, pG325, DOI 10.1152/ajpgi.00127.2013
   AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6
   Albasanz-Puig A, 2012, BIOCHEM BIOPH RES CO, V428, P179, DOI 10.1016/j.bbrc.2012.10.037
   ALEMANY J, 1988, EXP GERONTOL, V23, P25, DOI 10.1016/0531-5565(88)90017-4
   Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395
   Besse S, 2010, J PHYSIOL PHARMACOL, V61, P651
   Bialas M, 2011, J PHYSIOL PHARMACOL, V62, P219
   Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188
   Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   Ferrara N, 2005, EXP SUPPL, V94, P209
   Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170
   Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3
   GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0
   Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513
   GRONBECH JE, 1995, AM J PHYSIOL-GASTR L, V269, pG737, DOI 10.1152/ajpgi.1995.269.5.G737
   Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970
   Hoenig MR, 2008, CURR MOL MED, V8, P754, DOI 10.2174/156652408786733685
   Jeon SH, 2007, MOL CELLS, V23, P23
   Jones MK, 1999, NAT MED, V5, P1418
   Kan J, 2014, ANTIOXID REDOX SIGNA
   Khomenko T, 2014, DIGEST DIS SCI, V59, P297, DOI 10.1007/s10620-013-2807-6
   Köhler M, 1999, MOL CELL BIOL, V19, P7782
   Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   Li AH, 2007, BIOCHEM BIOPH RES CO, V353, P238, DOI 10.1016/j.bbrc.2006.11.144
   Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102
   MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0
   Sandor Z, 2006, BIOCHEM BIOPH RES CO, V350, P147, DOI 10.1016/j.bbrc.2006.09.021
   Tarnawski A, 2007, GASTROENTEROLOGY, V133, P1938, DOI 10.1053/j.gastro.2007.08.037
   Ushijima R, 2005, BIOCHEM BIOPH RES CO, V330, P880, DOI 10.1016/j.bbrc.2005.03.063
   Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316
   Yokogami K, 2013, BRAIN TUMOR PATHOL, V30, P135, DOI 10.1007/s10014-012-0122-0
NR 38
TC 33
Z9 35
U1 0
U2 3
PU POLISH PHYSIOLOGICAL SOC
PI GRZEGORZECKA
PA JAGIELLONIAN UNIV SCHOOL MED, INST PHYSIOLOGY, 31-531 KRAKOW, 16
   GRZEGORZECKA, POLAND
SN 0867-5910
J9 J PHYSIOL PHARMACOL
JI J. Physiol. Pharmacol.
PD APR
PY 2014
VL 65
IS 2
BP 209
EP 215
PG 7
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA AH3GA
UT WOS:000336010500005
PM 24781730
DA 2024-02-19
ER

PT J
AU TAN, BH
   BENCSATH, FA
   GAUBATZ, JW
AF TAN, BH
   BENCSATH, FA
   GAUBATZ, JW
TI STEADY-STATE LEVELS OF 7-METHYLGUANINE INCREASE IN NUCLEAR-DNA OF
   POSTMITOTIC MOUSE-TISSUES DURING AGING
SO MUTATION RESEARCH
LA English
DT Article
DE DNA DAMAGE; AGING; 7-METHYLGUANINE; INDIGENOUS DNA ADDUCTS;
   CARCINOGENESIS; DNA ALKYLATION
ID NON-ENZYMATIC METHYLATION; DEOXYRIBONUCLEIC-ACID; ELECTROCHEMICAL
   DETECTION; LIQUID-CHROMATOGRAPHY; S-ADENOSYLMETHIONINE; CHEMICAL
   CARCINOGENS; APURINIC SITES; LIVER DNA; AGE; MICE
AB The major DNA product formed by methylating agents in vitro and in vivo is 7-methylguanine (m7Gua).  In untreated rodent genomes, this damage is thought to arise as a consequence of endogenous processes.  Using 2 independent HPLC systems and 2 methods of detection, we observed that low levels of m7Gua are present in nuclear DNA of normal 23-month-old postmitotic mouse tissues.  We then asked whether the steady-state levels of indigenous m7Gua change as a function of age in these tissues.  C57BL/6NNia male mice 11 months, 23 months, and 28 months of age were analyzed.  The results showed that in nuclear DNA of brain, liver, and kidney tissues, the steady-state levels of m7Gua increased approximately 2-fold between the young and old age groups.  The persistence of N-methyl-N-nitrosourea (MNU)-induced m7Gua in these tissues in treated animals was also studied.  Following a 25 mg MNU/kg body weight dose, administered by the intraperitoneal route, m7Gua appeared to be at least partially persistent for a period of up to 20 days.  The degree of persistence of m7Gua, however, appeared to be independent of tissue or age.  Since m7Gua has intrinsic mutagenic potential and the content of m7Gua is generally a good indicator of overall alkylation damage to DNA, an age-related increase in the steady-state amounts of m7Gua may be relevant to basic mechanisms of aging and carcinogenesis.
C1 UNIV SO ALABAMA,COLL MED,DEPT BIOCHEM,MOBILE,AL 36688.
C3 University of South Alabama
FU NIA NIH HHS [AG07860] Funding Source: Medline
CR AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   Aucher M., 1982, NUTRITIONAL TOXICOLO, P328
   BALSIGER RW, 1960, J ORG CHEM, V25, P1273
   BARROWS LR, 1981, TOXICOL APPL PHARM, V60, P334, DOI 10.1016/0041-008X(91)90236-8
   BARROWS LR, 1982, CARCINOGENESIS, V3, P349, DOI 10.1093/carcin/3.3.349
   BOITEUX S, 1983, BIOCHEM BIOPH RES CO, V110, P552, DOI 10.1016/0006-291X(83)91185-3
   CROW FW, 1984, ANAL BIOCHEM, V139, P243, DOI 10.1016/0003-2697(84)90412-3
   CURTIS HJ, 1963, SCIENCE, V141, P686, DOI 10.1126/science.141.3582.686
   CURTIS HJ, 1971, ADV GENET, V16, P305, DOI 10.1016/S0065-2660(08)60361-2
   ELORANTA TO, 1977, BIOCHEM J, V166, P521, DOI 10.1042/bj1660521
   FREI JV, 1978, BIOCHEM J, V174, P1031, DOI 10.1042/bj1741031
   GAUBATZ JW, 1989, ARCH GERONTOL GERIAT, V8, P47, DOI 10.1016/0167-4943(89)90069-1
   GAUBATZ JW, 1986, J MOL CELL CARDIOL, V18, P1317, DOI 10.1016/S0022-2828(86)80435-7
   GENSLER HL, 1981, Q REV BIOL, V56, P279, DOI 10.1086/412317
   HERRON DC, 1979, ANAL BIOCHEM, V100, P58, DOI 10.1016/0003-2697(79)90109-X
   KUNSTYR I, 1975, J GERONTOL, V30, P157, DOI 10.1093/geronj/30.2.157
   LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018
   LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019
   LOEB LA, 1985, CELL, V40, P483, DOI 10.1016/0092-8674(85)90191-6
   MARGISON GP, 1981, P NATL ACAD SCI-BIOL, V78, P861, DOI 10.1073/pnas.78.2.861
   MASSIE HR, 1972, ARCH BIOCHEM BIOPHYS, V153, P736, DOI 10.1016/0003-9861(72)90392-X
   MULLAART E, 1988, MECH AGEING DEV, V45, P41, DOI 10.1016/0047-6374(88)90017-6
   ONO T, 1976, EXP GERONTOL, V11, P127, DOI 10.1016/0531-5565(76)90022-X
   PARK JW, 1988, P NATL ACAD SCI USA, V85, P7467, DOI 10.1073/pnas.85.20.7467
   PARK JW, 1988, P NATL ACAD SCI USA, V85, P9508
   PARK JW, 1989, CARCINOGENESIS, V10, P827, DOI 10.1093/carcin/10.5.827
   PEDERSON DS, 1986, ANNU REV CELL BIOL, V2, P117, DOI 10.1146/annurev.cb.02.110186.001001
   PEGG AE, 1983, REV BIOCHEM TOXICOL, V5, P83
   PETERSON CRD, 1984, ARCH GERONTOL GERIAT, V3, P115, DOI 10.1016/0167-4943(84)90004-9
   PRICE GB, 1971, SCIENCE, V171, P917, DOI 10.1126/science.171.3974.917
   RANDERATH K, 1986, CARCINOGENESIS, V7, P1615, DOI 10.1093/carcin/7.9.1615
   RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x
   SAFHILL R, 1985, BIOCHIM BIOPHYS ACTA, V823, P111
   Saul R.L., 1987, MODERN BIOL THEORIES, P113
   SAUL RL, 1986, MECHANISMS DNA DAMAG, P529
   SINGER B, 1982, ANNU REV BIOCHEM, V52, P655
   SPROTT RL, 1986, FASEB J, V45, P42
   STRAMENTINOLI G, 1977, J GERONTOL, V4, P392
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P35
   Tice R.R., 1985, HDB BIOL AGING, P173
   WHEELER KT, 1974, P NATL ACAD SCI USA, V71, P1862, DOI 10.1073/pnas.71.5.1862
   ZAHN RK, 1987, MECH AGEING DEV, V41, P73, DOI 10.1016/0047-6374(87)90055-8
   ZIMMERMAN JA, 1982, GERONTOLOGY, V28, P114, DOI 10.1159/000212520
   ZIMMERMAN JA, 1989, J GERONTOL, V44, P19, DOI 10.1093/geronj/44.6.19
NR 44
TC 33
Z9 35
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
PD SEP-NOV
PY 1990
VL 237
IS 5-6
BP 229
EP 238
DI 10.1016/0921-8734(90)90004-B
PG 10
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Genetics & Heredity; Toxicology
GA FF366
UT WOS:A1990FF36600004
PM 2079962
DA 2024-02-19
ER

PT J
AU Alam, MS
   Gangiredla, J
   Hasan, NA
   Barnaba, T
   Tartera, C
AF Alam, Mohammad S.
   Gangiredla, Jayanthi
   Hasan, Nur A.
   Barnaba, Tammy
   Tartera, Carmen
TI Aging-Induced Dysbiosis of Gut Microbiota as a Risk Factor for Increased
   <i>Listeria monocytogenes</i> Infection
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Listeria monocytogenes; listeriosis; aging; dysbiosis; inflammation; gut
   microbiota; metagenomics
ID RESISTANCE; CELLS
AB Invasive foodborne Listeria monocytogenes infection causes gastroenteritis, septicemia, meningitis, and chorioamnionitis, and is associated with high case-fatality rates in the elderly. It is unclear how aging alters gut microbiota, increases risk of listeriosis, and causes dysbiosis post-infection. We used a geriatric murine model of listeriosis as human surrogate of listeriosis for aging individuals to study the effect of aging and L. monocytogenes infection. Aging and listeriosis-induced perturbation of gut microbiota and disease severity were compared between young-adult and old mice. Young-adult and old mice were dosed intragastrically with L. monocytogenes. Fecal pellets were collected pre- and post-infection for microbiome analysis. Infected old mice had higher Listeria colonization in liver, spleen, and feces. Metagenomics analyses of fecal DNA-sequences showed increase in alpha-diversity as mice aged, and infection reduced its diversity. The relative abundance of major bacterial phylum like, Bacteroidetes and Firmicutes remained stable over aging or infection, while the Verrucomicrobia phylum was significantly reduced only in infected old mice. Old mice showed a marked reduction in Clostridaiceae and Lactobacillaceae bacteria even before infection when compared to uninfected young-adult mice. L. monocytogenes infection increased the abundance of Porphyromonadaceae and Prevotellaceae in young-adult mice, while members of the Ruminococcaceae and Lachnospiraceae family were significantly increased in old mice. The abundance of the genera Blautia and Alistipes were significantly reduced post-infection in young-adult and in old mice as compared to their uninfected counterparts. Butyrate producing, immune-modulating bacterial species, like Pseudoflavonifractor and Faecalibacterium were significantly increased only in old infected mice, correlating with increased intestinal inflammatory mRNA up-regulation from old mice tissue. Histologic analyses of gastric tissues showed extensive lesions in the Listeria-infected old mice, more so in the non-glandular region and fundus than in the pylorus. Commensal species like Lactobacillus, Clostridiales, and Akkermansia were only abundant in infected young-adult mice but their abundance diminished in the infected old mice. Listeriosis in old mice enhances the abundance of butyrate-producing inflammatory members of the Ruminococcaceae/Lachnospiraceae bacteria while reducing/eliminating beneficial commensals in the gut. Results of this study indicate that, aging may affect the composition of gut microbiota and increase the risk of invasive L. monocytogenes infection.
C1 [Alam, Mohammad S.; Gangiredla, Jayanthi; Barnaba, Tammy; Tartera, Carmen] US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA.
   [Hasan, Nur A.] CosmosID, Rockville, MD USA.
   Univ Maryland, Ctr Bioinformat & Computat Biol CBCB, College Pk, MD 20742 USA.
C3 US Food & Drug Administration (FDA); University System of Maryland;
   University of Maryland College Park
RP Tartera, C (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA.
EM Carmen.Tartera@fda.hhs.gov
RI hasan, nur a/AAX-3881-2021
OI hasan, nur a/0000-0003-0175-8879
FU intramural research program for the Center for Food Safety and Applied
   Nutrition, U.S. Food and Drug Administration
FX This research was supported by the intramural research program for the
   Center for Food Safety and Applied Nutrition, U.S. Food and Drug
   Administration.
CR Alam MS, 2009, MUCOSAL IMMUNOL, V2, P232, DOI 10.1038/mi.2009.4
   Alam MS, 2020, INT J MED MICROBIOL, V310, DOI 10.1016/j.ijmm.2020.151397
   Alam MS, 2016, MICROB PATHOGENESIS, V99, P236, DOI 10.1016/j.micpath.2016.08.035
   Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058
   Becattini S, 2017, J EXP MED, V214, P1973, DOI 10.1084/jem.20170495
   Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667
   Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640
   Brumfield KD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231210
   Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535
   Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191
   CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532
   Chewning JH, 2014, J IMMUNOL, V193, P4769, DOI 10.4049/jimmunol.1401835
   Connelly S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00101
   Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104
   Daniel SG, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00065-17
   Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032
   Forbes JD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01081
   Fransen F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01385
   Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448
   Kameyama K, 2014, MICROBES ENVIRON, V29, P427, DOI 10.1264/jsme2.ME14054
   Kared H, 2014, CURR OPIN IMMUNOL, V29, P79, DOI 10.1016/j.coi.2014.05.003
   Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008
   Kundu P, 2017, CELL, V171, P1481, DOI 10.1016/j.cell.2017.11.024
   Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9
   Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760
   Leonard SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167870
   Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
   Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Petersen C, 2014, CELL MICROBIOL, V16, P1024, DOI 10.1111/cmi.12308
   Plöger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x
   Pohl AM, 2019, FOODBORNE PATHOG DIS, V16, P290, DOI 10.1089/fpd.2018.2548
   Pohl AM, 2017, FOODBORNE PATHOG DIS, V14, P524, DOI 10.1089/fpd.2017.2297
   Ponnusamy D, 2016, P NATL ACAD SCI USA, V113, P722, DOI 10.1073/pnas.1523817113
   Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12
   Rehman Tayyab, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P361
   Rescigno M, 2014, CELL MICROBIOL, V16, P1004, DOI 10.1111/cmi.12301
   Rolhion N, 2019, CELL HOST MICROBE, V26, P691, DOI 10.1016/j.chom.2019.10.016
   Rossi O, 2016, SCI REP-UK, V6, DOI 10.1038/srep18507
   Roy MA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102211
   Silk BJ, 2013, MMWR-MORBID MORTAL W, V62, P448, DOI 10.1016/j.annemergmed.2013.08.006
   Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007
   Smithey MJ, 2011, EUR J IMMUNOL, V41, P1352, DOI 10.1002/eji.201041141
   Spychala MS, 2018, ANN NEUROL, V84, P23, DOI 10.1002/ana.25250
   Vinolo MAR, 2009, CLIN SCI, V117, P331, DOI 10.1042/CS20080642
   Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049
   Yan H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179586
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
   Zhu WM, 2000, J APPL MICROBIOL, V88, P877, DOI 10.1046/j.1365-2672.2000.01027.x
NR 52
TC 14
Z9 16
U1 2
U2 17
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD APR 28
PY 2021
VL 12
AR 672353
DI 10.3389/fimmu.2021.672353
PG 13
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA SA6SY
UT WOS:000649433000001
PM 33995413
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Hwang, MH
   Yoo, JK
   Luttrell, M
   Kim, HK
   Meade, TH
   English, M
   Nichols, WW
   Christou, DD
AF Hwang, Moon-Hyon
   Yoo, Jeung-Ki
   Luttrell, Meredith
   Kim, Han-Kyul
   Meade, Thomas H.
   English, Mark
   Nichols, Wilmer W.
   Christou, Demetra D.
TI Role of mineralocorticoid receptors in arterial stiffness in human aging
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Oxidative stress; Arterial stiffness; Compliance; Augmentation
   index; Pulse wave velocity
ID PULSE-WAVE VELOCITY; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; SYSTOLIC
   HYPERTENSION; CARDIOVASCULAR EVENTS; OLDER-ADULTS; ATHEROSCLEROSIS;
   DYSFUNCTION; MORTALITY; EXERCISE
AB Arterial stiffness, an independent predictor of cardiovascular disease, is increased in aging, but the underlying mechanisms are not completely understood. Mineralocorticoid receptors (MR) may contribute to oxidative stress and arterial stiffness in healthy older adults. To test the hypothesis that short-term MR blockade may reduce oxidative stress and improve arterial stiffness, we conducted a randomized, double blind, crossover study using the selective MR blocker Eplerenone or placebo in 23 older adults (age, 64 +/- 1 years; mean +/- SE) free from overt cardiovascular and other clinical disease (e.g, diabetes, renal and liver disease). In response to MR blockade, brachial and carotid blood pressure decreased (P <= 0.01). However, MR blockade had no effect on oxidative stress (oxidized LDL, 61.2 +/- 6.8 vs. 62.4 +/- 7.4 U/L, P = 0.9; placebo vs. Eplerenone) and arterial stiffness (aortic pulse wave velocity (PWV), 9.17 +/- 1.19 vs. 8.92 +/- 1.19 m/s, P = 0.5; leg PWV, 13.45 +/- 0.45 vs. 12.81 +/- 0.47 m/s, P = 0.3; arm PWV, 11.43 +/- 0.62 vs. 11.73 +/- 0.68 m/s, P = 0.7; carotid artery compliance, 0.150 +/- 0.013 vs. 0.149 +/- 0.014 mm(2)/mm Hg, P = 0.8; distensibility, 23.1 +/- 1.8 vs. 23.3 +/- 1.7 10(-3)/kPa, P = 0.8; beta stiffness index, 3.5 +/- 0.3 vs. 3.6 +/- 0.3, P = 0.6; and augmentation index, 16.0 +/- 2.2 vs. 15.6 +/- 2.8%, P = 0.8). These results provide the first evidence that MR do not appear to contribute to oxidative stress in human aging and that short-term MR blockade does not result in reduced oxidative stress and improved arterial stiffness. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Hwang, Moon-Hyon; Yoo, Jeung-Ki; Kim, Han-Kyul; Christou, Demetra D.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.
   [Luttrell, Meredith] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA.
   [Meade, Thomas H.] Texas A&M Univ, Dept Cardiol, Scott & White Healthcare, College Stn, TX USA.
   [English, Mark] Texas A&M Univ, Scott & White Healthcare, Dept Family & Community Med, Hlth Sci Ctr, Bryan, TX USA.
   [Nichols, Wilmer W.] Univ Florida, Dept Med, Div Cardiovasc Med, Gainesville, FL 32611 USA.
C3 State University System of Florida; University of Florida; Texas A&M
   University System; Texas A&M University College Station; Texas A&M
   University System; Texas A&M University College Station; Texas A&M
   University System; Texas A&M University College Station; Texas A&M
   Health Science Center; State University System of Florida; University of
   Florida
RP Christou, DD (corresponding author), Univ Florida, 100 FLG, Gainesville, FL 32611 USA.
EM ddchristou@ufl.edu
RI ; Stefanadis, Christodoulos/ABH-2232-2020
OI Yoo, Jeung-Ki/0000-0003-1350-2491; Stefanadis,
   Christodoulos/0000-0001-5974-6454; Hwang, Moon-Hyon/0000-0001-6095-4349;
   Kim, Han Kyul/0000-0003-1048-9543
FU NIH [AG 032067]; AHA [0865117F]
FX This work was supported by NIH AG 032067 and AHA 0865117F grants to DDC.
   The authors would like to thank Ms. Sharon Greer, R.N., Mr. Creighton
   Wilson R. N. and the Division of Cardiology and Radiology at the Scott
   and White Clinic at College Station, Texas, for their contributions. The
   authors would also like to thank Ms. Molly Cernosek for the technical
   assistance and the study participants for their time and efforts.
CR Adler A, 2003, AM J PHYSIOL-HEART C, V285, pH1015, DOI 10.1152/ajpheart.01047.2002
   ARMENTANO R, 1995, HYPERTENSION, V26, P48, DOI 10.1161/01.HYP.26.1.48
   Cat AND, 2010, FASEB J, V24, P2454, DOI 10.1096/fj.09-147926
   Christou DD, 2005, CIRCULATION, V111, P1904, DOI 10.1161/01.CIR.0000161818.28974.1A
   DEGASPARO M, 1987, J PHARMACOL EXP THER, V240, P650
   Gates PE, 2004, HYPERTENSION, V44, P35, DOI 10.1161/01.HYP.0000132767.74476.64
   HIRAI T, 1989, CIRCULATION, V80, P78, DOI 10.1161/01.CIR.80.1.78
   JEUNEMAITRE X, 1988, AM J CARDIOL, V62, P1072, DOI 10.1016/0002-9149(88)90551-6
   Keidar S, 2004, CIRCULATION, V109, P2213, DOI 10.1161/01.CIR.0000127949.05756.9D
   Kinlay S, 2001, HYPERTENSION, V38, P1049, DOI 10.1161/hy1101.095329
   Mackenzie IS, 2009, HYPERTENSION, V54, P409, DOI 10.1161/HYPERTENSIONAHA.109.133801
   McCurley A, 2012, NAT MED, V18, P1429, DOI 10.1038/nm.2891
   McCurley A, 2012, MOL CELL ENDOCRINOL, V350, P256, DOI 10.1016/j.mce.2011.06.014
   Meaume S, 2001, ARTERIOSCL THROM VAS, V21, P2046, DOI 10.1161/hq1201.100226
   Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008
   Moreau KL, 2005, HYPERTENSION, V45, P1107, DOI 10.1161/01.HYP.0000165678.63373.8c
   Mullan BA, 2002, HYPERTENSION, V40, P804, DOI 10.1161/01.HYP.0000039961.13718.00
   Nashar K, 2004, AM J HYPERTENS, V17, P477, DOI 10.1016/j.amjhyper.2004.02.015
   O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6
   Rajagopalan S, 2002, CIRCULATION, V105, P2212, DOI 10.1161/01.CIR.0000015854.60710.10
   Reneman RS, 2005, EUR HEART J, V26, P960, DOI 10.1093/eurheartj/ehi177
   Rossignol P, 2011, J AM COLL CARDIOL, V58, P1958, DOI 10.1016/j.jacc.2011.04.049
   Sartório CL, 2007, HYPERTENSION, V50, P919, DOI 10.1161/HYPERTENSIONAHA.107.093450
   Sindler AL, 2011, AGING CELL, V10, P429, DOI 10.1111/j.1474-9726.2011.00679.x
   Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628
   Tanaka H, 2000, CIRCULATION, V102, P1270, DOI 10.1161/01.CIR.102.11.1270
   Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061
NR 27
TC 11
Z9 12
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG
PY 2013
VL 48
IS 8
BP 701
EP 704
DI 10.1016/j.exger.2013.05.058
PG 4
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 181WI
UT WOS:000321700300001
PM 23707930
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Srividhya, R
   Zarkovic, K
   Stroser, M
   Waeg, G
   Zarkovic, N
   Kalaiselvi, P
AF Srividhya, Ravichandran
   Zarkovic, Kamelija
   Stroser, Marina
   Waeg, Georg
   Zarkovic, Neven
   Kalaiselvi, Periandavan
TI Mitochondrial alterations in aging rat brain: effective role of
   (-)-epigallo catechin gallate
SO INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
LA English
DT Article
DE Epigallo catechin gallate; Brain; Aging; Mitochondria; Oxidative stress
ID OXIDATIVE STRESS; TEA CATECHINS; LIVER-MITOCHONDRIA; LIPID-PEROXIDATION;
   ELECTRON-TRANSFER; FREE-RADICALS; DAMAGE; DYSFUNCTION; GLUTATHIONE;
   CELLS
AB Aging is a multi-factorial process which involves deprivation in body's metabolism. Brain mitochondria are prone to oxidative damage owing to their high metabolic rate. The decline in antioxidant system during aging augments the neuronal damage to mitochondrial components like antioxidant system, Kreb's cycle enzymes and electron transport chain complexes. Since brain is an organ rich in fatty acids, lipid peroxidation products like hydroxynonenal are predominant. Those lipid peroxidation products conjugate with amino acids to form adducts which alter their structural and functional properties. Epigallo catechin gallate is a potent antioxidant which is rich in green tea extract. This study elucidated the antioxidant potential of epigallo catechin gallate to counteract the mitochondrial oxidative damage in brain. The study comprised of young (3-4 months old; 150 + 20g) and aged (above 24 months; 420 +/- 20 g) male albino rats of Wistar strain in Groups I and II Groups III and IV comprised of young and aged rats supplemented with epigallo catechin gallate (2 mg/kg body weight) for 30 days. Antioxidants, Kreb's cycle enzymes and electron transport chain complexes were assayed in the mitochondrial fraction. Hydroxynonenal expression was carried out using immunohistochemical analysis. Epigallo catechin gallate supplementation decreased the expression of hydroxyrronenal in aged brain, up-regulated the antioxidant system and augmented the activities of Kreb's cycle enzymes and electron transport chain complexes in aged brain mitochondria thus proving its antioxidant potential at the level of mitochondria. (C) 2009 ISDN. Published by Elsevier Ltd. All rights reserved.
C1 [Srividhya, Ravichandran; Kalaiselvi, Periandavan] Univ Madras, Dept Biochem Med, Dr ALM Postgrad Inst Basic Med Sci, Madras 600113, Tamil Nadu, India.
   [Zarkovic, Kamelija; Stroser, Marina] Univ Zagreb, Clin Hosp Ctr, Fac Med, Div Neuropathol, HR-10000 Zagreb, Croatia.
   [Waeg, Georg] Graz Univ, Inst Mol Sci, A-8010 Graz, Austria.
   [Zarkovic, Neven] Rudjer Boskovic Inst, Lab Oxidat Stress, HR-10000 Zagreb, Croatia.
C3 University of Madras; University of Zagreb; University of Graz; Rudjer
   Boskovic Institute
RP Kalaiselvi, P (corresponding author), Univ Madras, Dept Biochem Med, Dr ALM Postgrad Inst Basic Med Sci, Taramani Campus, Madras 600113, Tamil Nadu, India.
EM pkalaiselvi@yahoo.com
RI Zarkovic, Neven/AAG-5836-2019
OI Zarkovic, Neven/0000-0001-5032-0369; Periandavan,
   Kalaiselvi/0000-0001-5270-2651
FU Indian Council of Medical Research, New Delhi; Government of India;
   Croatian Ministry of Science, Education and Sports; COST Action B35
FX The financial assistance from the Indian Council of Medical Research,
   New Delhi, Government of India in the form of Senior Research Fellowship
   is greatly acknowledged. The study was supported by Croatian Ministry of
   Science, Education and Sports and by COST Action B35.
CR ADIBHATLA RM, 2008, SUBCELL BIOCH, V48
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X
   Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200
   Bolanos JP, 1996, FREE RADICAL BIO MED, V21, P995, DOI 10.1016/S0891-5849(96)00240-7
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chen LJ, 2003, CHEM RES TOXICOL, V16, P1155, DOI 10.1021/tx0340605
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   ESTERBAUER H, 1991, AM J CLIN NUTR, V53, pS314, DOI 10.1093/ajcn/53.1.314S
   Feng Y, 2008, BBA-GEN SUBJECTS, V1780, P659, DOI 10.1016/j.bbagen.2008.01.002
   Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2
   Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x
   Fu YM, 2008, MOL PHARMACOL, V73, P1465, DOI 10.1124/mol.107.040634
   GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hatefi Y, 1978, Methods Enzymol, V53, P21
   Hatefi Y, 1967, METHOD ENZYMOL, P235
   HOGBERG J, 1974, BIOCHEM BIOPH RES CO, V56, P836, DOI 10.1016/0006-291X(74)90681-0
   Humphries KM, 2006, FREE RADICAL RES, V40, P1239, DOI 10.1080/10715760600913184
   Itakura A, 2002, EARLY HUM DEV, V67, P19, DOI 10.1016/S0378-3782(01)00247-X
   Joitihan HA, 2008, MOL MED, V14, P98, DOI 10.2119/2007-00114.Jouihan
   KAMBOJ SS, 2008, CELL MOL NEUROBIOL, V14
   KANAREK L, 1964, J BIOL CHEM, V239, P4202
   Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1
   King J., 1965, Practical Clinical Enzymology, P191
   Kumar P, 2008, BIOGERONTOLOGY, V9, P235, DOI 10.1007/s10522-008-9133-y
   Lee JY, 2006, TOXICOL LETT, V166, P212, DOI 10.1016/j.toxlet.2006.07.305
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   MEHLER AH, 1948, J BIOL CHEM, V174, P961
   Meng QY, 2008, REJUV RES, V11, P649, DOI 10.1089/rej.2007.0645
   Mertsch K, 2001, NEUROSCI LETT, V314, P135, DOI 10.1016/S0304-3940(01)02299-6
   Modi HR, 2008, J MEMBRANE BIOL, V221, P51, DOI 10.1007/s00232-007-9086-0
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Muyderman H, 2004, J NEUROSCI, V24, P8019, DOI 10.1523/JNEUROSCI.1103-04.2004
   Nanjo F, 1996, FREE RADICAL BIO MED, V21, P895, DOI 10.1016/0891-5849(96)00237-7
   Navarro A, 2005, AM J PHYSIOL-REG I, V289, pR1392, DOI 10.1152/ajpregu.00834.2004
   Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001
   Omaye S. T., 1979, METHOD ENZYMOL, P3, DOI [DOI 10.1016/0076-6879(79)62181-X, 10.1016/0076-6879(79)62181-X, 10.1016/0076-6879(79)62181-x]
   Palaniappan AR, 2007, NEUROCHEM RES, V32, P1552, DOI 10.1007/s11064-007-9355-4
   QUAIFE ML, 1949, J BIOL CHEM, V180, P1229
   RACKER E, 1950, BIOCHIM BIOPHYS ACTA, V4, P211, DOI 10.1016/0006-3002(50)90026-6
   RADI R, 1991, J BIOL CHEM, V266, P22028
   Raza H, 2007, FOOD CHEM TOXICOL, V45, P1814, DOI 10.1016/j.fct.2007.03.017
   Raza H, 2006, TOXICOL APPL PHARM, V216, P309, DOI 10.1016/j.taap.2006.06.001
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   Saffari Y, 2004, LIFE SCI, V74, P1513, DOI 10.1016/j.lfs.2003.08.019
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   Sastre J, 2002, CELL MOL BIOL, V48, P685
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Schlag G, 1997, SHOCK, SEPSIS AND ORGAN FAILURE, P3
   SCHROEDER EK, 2008, ANTIOXID REDOX SIGNA, V28
   SHIMOMURA Y, 1984, J BIOL CHEM, V259, P4059
   Srere P.A., 1969, Methods of Enzymology, V13, P3, DOI DOI 10.1016/0076-6879(69)13005-0
   Srividhya R, 2008, INT J DEV NEUROSCI, V26, P217, DOI 10.1016/j.ijdevneu.2007.12.003
   Sutherland BA, 2004, FASEB J, V18, P258, DOI 10.1096/fj.04-2806fje
   Tretter L, 2000, J NEUROSCI, V20, P8972
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   UCHIDA K, 1994, BIOCHEMISTRY-US, V33, P12487, DOI 10.1021/bi00207a016
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Vrbacky M, 2007, BBA-BIOENERGETICS, V1767, P989, DOI 10.1016/j.bbabio.2007.05.002
   Waeg G, 1996, FREE RADICAL RES, V25, P149, DOI 10.3109/10715769609149920
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WHARTON DC, 1964, J BIOL CHEM, V239, P2036
   Yamashita T, 2000, J NEUROL SCI, V175, P107, DOI 10.1016/S0022-510X(00)00296-3
   Yao K, 2008, MOL VIS, V14, P217
   Yin ST, 2008, TOXICOLOGY, V249, P45, DOI 10.1016/j.tox.2008.04.006
   Zarkovic K, 1997, SHOCK, SEPSIS AND ORGAN FAILURE, P146
   Zarkovic Kamelija, 2003, Molecular Aspects of Medicine, V24, P293, DOI 10.1016/S0098-2997(03)00024-4
   Zarkovic N, 1999, LIFE SCI, V65, P1901, DOI 10.1016/S0024-3205(99)00444-0
   ZARKOVIC N, 2003, MOL ASPECTS MED, V24, P293
NR 76
TC 47
Z9 50
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-5748
EI 1873-474X
J9 INT J DEV NEUROSCI
JI Int. J. Dev. Neurosci.
PD MAY
PY 2009
VL 27
IS 3
BP 223
EP 231
DI 10.1016/j.ijdevneu.2009.01.003
PG 9
WC Developmental Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology; Neurosciences & Neurology
GA 425VK
UT WOS:000264665500003
PM 19429387
DA 2024-02-19
ER

PT J
AU Pabis, K
   Chiari, Y
   Sala, C
   Straka, E
   Giacconi, R
   Provinciali, M
   Li, XN
   Brown-Borg, H
   Nowikovsky, K
   Valencak, TG
   Gundacker, C
   Garagnani, P
   Malavolta, M
AF Pabis, Kamil
   Chiari, Ylenia
   Sala, Claudia
   Straka, Elisabeth
   Giacconi, Robertina
   Provinciali, Mauro
   Li, Xinna
   Brown-Borg, Holly
   Nowikovsky, Karin
   Valencak, Teresa G.
   Gundacker, Claudia
   Garagnani, Paolo
   Malavolta, Marco
TI Elevated metallothionein expression in long-lived species mediates the
   influence of cadmium accumulation on aging
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Aging; Comparative biogerontology; Cadmium; Mammals; Metallothionein;
   Longevity
ID AND-2 GENES SHORTENS; LIFE-SPAN; OXIDATIVE STRESS; LONGEVITY; MICE;
   DEFICIENCY; METABOLISM; ABSORPTION; SURVIVAL; ZINC
AB Cadmium (Cd) accumulates with aging and is elevated in long-lived species. Metallothioneins (MTs), small cysteine-rich proteins involved in metal homeostasis and Cd detoxification, are known to be related to longevity. However, the relationship between Cd accumulation, the role of MTs, and aging is currently unclear. Specifically, we do not know if long-lived species evolved an efficient metal stress response by upregulating their MT levels to reduce the toxic effects of environmental pollutants, such as Cd, that accumulate over their longer life span. It is also unknown if the number of MT genes, their expression, or both protect the organisms from potentially damaging effects during aging. To address these questions, we reanalyzed several cross-species studies and obtained data on MT expression and Cd accumulation in long-lived mouse models. We confirmed a relationship between species maximum life span in captive mammals and their Cd content in liver and kidney. We found that although the number of MT genes does not affect longevity, gene expression and protein amount of specific MT paralogs are strongly related to life span in mammals. MT expression rather than gene number may influence the high Cd levels and longevity of some species. In support of this, we found that overexpression of MT-1 accelerated Cd accumulation in mice and that tissue Cd was higher in long-lived mouse strains with high MT expression. We conclude that long-lived species have evolved a more efficient stress response by upregulating the expression of MT genes in presence of Cd, which contributes to elevated tissue Cd levels.
C1 [Pabis, Kamil; Straka, Elisabeth; Gundacker, Claudia] Med Univ Vienna, Ctr Pathobiochem & Genet, Inst Med Genet, Wahringer Str 10, A-1090 Vienna, Austria.
   [Chiari, Ylenia] George Mason Univ, Dept Biol, Fairfax, VA 22030 USA.
   [Sala, Claudia] Univ Bologna, Dept Phys & Astron, I-40126 Bologna, Italy.
   [Giacconi, Robertina; Provinciali, Mauro; Malavolta, Marco] IRCCS INRCA, Adv Technol Ctr Aging Res, I-60121 Ancona, Italy.
   [Li, Xinna] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA.
   [Brown-Borg, Holly] Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA.
   [Nowikovsky, Karin] Med Univ Vienna, Dept Internal Med 1, Vienna, Austria.
   [Nowikovsky, Karin] Med Univ Vienna, Comprehens Canc Ctr, Vienna, Austria.
   [Valencak, Teresa G.] Zhejiang Univ, Coll Anim Sci, Dept Anim Sci & Technol, Hangzhou 310058, Peoples R China.
   [Garagnani, Paolo] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy.
   [Garagnani, Paolo] Univ Bologna, Interdept Ctr L Galvani CIG, Bologna, Italy.
   [Garagnani, Paolo] Karolinska Inst, Dept Lab Med, Div Clin Chem, Stockholm, Sweden.
C3 Medical University of Vienna; George Mason University; University of
   Bologna; IRCCS INRCA; University of Michigan System; University of
   Michigan; University of North Dakota Grand Forks; Medical University of
   Vienna; Medical University of Vienna; Zhejiang University; University of
   Bologna; University of Bologna; Karolinska Institutet
RP Malavolta, M (corresponding author), IRCCS INRCA, Adv Technol Ctr Aging Res, I-60121 Ancona, Italy.
EM kamil.pabis@gmail.com; ychiari@gmu.edu; claudia.sala3@unibo.it;
   elisabeth_straka@gmx.at; m.provinciali@inrca.it; xinna@umich.edu;
   holly.brown.borg@und.edu; karin.nowikovsky@meduniwien.ac.at;
   teresa.valencak@vetmeduni.ac.at; claudia.gundacker@meduniwien.ac.at;
   paolo.garagnani2@unibo.it; m.malavolta@inrca.it
RI Chiari, Ylenia/AAW-3108-2020; Valencak, Teresa G./ABG-7985-2020; Sala,
   Claudia/AAC-2293-2022; Brown-Borg, Holly/IQV-8650-2023; yang,
   qing/JBR-8440-2023; Malavolta, Marco/J-8215-2012; Provinciali,
   Mauro/K-5683-2016
OI Chiari, Ylenia/0000-0003-2338-8602; Valencak, Teresa
   G./0000-0002-7222-2265; Sala, Claudia/0000-0002-4889-1047; Li,
   Xinna/0000-0002-7461-5628; Malavolta, Marco/0000-0002-8442-1763;
   Gundacker, Claudia/0000-0003-4093-3780; Provinciali,
   Mauro/0000-0002-0568-3002; Garagnani, Paolo/0000-0002-4161-3626;
   Nowikovsky, Karin/0000-0001-8435-8410
FU Italian Ministry of Health; Austrian Science Fund FWF [P22323-B17, V
   197-B17]; Austrian Science Fund (FWF) [P22323] Funding Source: Austrian
   Science Fund (FWF)
FX This study was supported by Ricerca Corrente funding from Italian
   Ministry of Health to MP, MM, and RG as well as from Austrian Science
   Fund FWF (Grant: P22323-B17 and V 197-B17) to TV.
CR Akesson A, 2014, NONRENAL EFFECTS RIS
   Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9
   [Anonymous], 2018, GRUBIC KEZELE T IRON, P1
   Arredondo M, 2018, HEALTHY AGEING LONG, V8, P35, DOI 10.1007/978-3-030-03742-0_2
   BARRETT T, 2013, NUCLEIC ACIDS RES
   Bartke A, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0014-y
   Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150
   Beattie JH, 2018, KORICHNEVA I ZINC, P99
   BININDAEMONDS O, 2007, NATURE
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Buchwalter DB, 2008, P NATL ACAD SCI USA, V105, P8321, DOI 10.1073/pnas.0801686105
   CARRUTHERS M, 2018, BMC GENOMICS
   CHIARI Y, 2015, ECOL APPL
   Chiaverini N, 2010, FREE RADICAL RES, V44, P605, DOI 10.3109/10715761003692511
   Cipriano C, 2006, BIOGERONTOLOGY, V7, P357, DOI 10.1007/s10522-006-9050-x
   COUSINS RJ, 1985, PHYSIOL REV, V65, P238, DOI 10.1152/physrev.1985.65.2.238
   de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149
   DEMIROVIC D, 2013, EXP GERONTOL
   Dobin A, 2013, BIOINFORMATICS
   DOSTAL L, 2015, J GERONTOL A-BIOL
   DURINCK S, 2009, NAT PROTOC
   Dziegiel P, 2016, J NEUROL NEUROSUR PS
   Eisler R, 2010, Compendium of Trace Metals and Marine Biota: 2 Vertebrates, V1st
   FOK W, 2014, PLOS ONE
   FRANK A, 1986, SCI TOTAL ENVIRON
   FUSHAN A, 2015, AGING CELL
   GIACCONI R, 2018, J GERONTOL A, V73
   GU J, 2017, DIABETES
   Gundacker C, 2007, J EXPO SCI ENV EPID, V17, P39, DOI 10.1038/sj.jes.7500518
   HALL JA, 2017, PLOS ONE
   HARPER J, 2011, J EXP BIOL
   HARPER J, 2007, AGING CELL
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   HENRY RB, 1994, TOXICOL LETT, V74, P23, DOI 10.1016/0378-4274(94)90071-X
   Hidalgo Juan, 2009, V5, P279, DOI 10.1039/9781847558992-00279
   Hunt SE, 2018, DATABASE-OXFORD, DOI [10.1093/database/bay119, 10.1186/1471-2164-11-293]
   HYLTON A, 2018, ECOL APPL
   ISZARD MB, 1995, TOXICOL APPL PHARM, V133, P305, DOI 10.1006/taap.1995.1155
   Järup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020
   JEFFERY E, 1989, COMP BIOCHEM PHYS C
   JETZ W, 2012, NATURE
   Kadota Y, 2015, EXP GERONTOL, V66, P21, DOI 10.1016/j.exger.2015.04.007
   KLANG IM, 2014, AGING-US
   KOIZUMI N, 1989, ENVIRON RES
   KOIZUMI N, 2008, BIOL TRACE ELEM RES
   Kolde R., 2015, R Package Version, V1, P790
   Krizkova S, 2016, J PHARMACEUT BIOMED, V117, P464, DOI 10.1016/j.jpba.2015.09.031
   Larsson SC, 2016, INT J EPIDEMIOL, V45, P782, DOI 10.1093/ije/dyv086
   LI X, 2013, AM J PHYSIOL-ENDOC M
   Liu J, 1996, FUND APPL TOXICOL, V29, P294, DOI 10.1006/faat.1996.0034
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ma SM, 2015, CELL REP, V13, P1319, DOI 10.1016/j.celrep.2015.10.014
   Malavolta M, 2016, EXP GERONTOL, V73, P28, DOI 10.1016/j.exger.2015.11.014
   Malavolta M, 2012, REJUV RES, V15, P140, DOI 10.1089/rej.2011.1261
   Maret W, 2007, MOL MED, V13, P371, DOI 10.2119/2007-00036.Maret
   Maret W, 2019, FREE RADICAL BIO MED, V134, P311, DOI 10.1016/j.freeradbiomed.2019.01.006
   MCKINNEY G, 2017, MOL ECOL RESOUR
   Miura N, 2007, YAKUGAKU ZASSHI, V127, P665, DOI 10.1248/yakushi.127.665
   NINOMIYA R, 2004, BIOL TRACE ELEM RES
   NINOMIYA R, 2002, BIOL TRACE ELEM RES
   Orme D., 2014, CAPER COMP ANAL PHYL
   OVERJORDET I, 2015, CHEMOSPHERE
   PABIS K, 2018, CHEMOSPHERE
   PALUMAA P, 2005, BBA-PROTEINS PROTEOM
   PASTORELLI A, 2016, INT J OSTEOARCHAEOL
   Peng X, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku818
   Pugh TD, 1999, CANCER RES, V59, P1642
   Sabolic I, 2010, BIOMETALS, V23, P897, DOI 10.1007/s10534-010-9351-z
   Sahm A, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007272
   SATO M, 1993, FREE RADICAL BIO MED
   SCHEUHAMMER A, 1986, TOXICOL APPL PHARM
   SCHMIDT K, 2016, BIOMETALS
   SEREN N, 2014, J MOL EVOL
   Speakman JR, 2005, AGING CELL, V4, P167, DOI 10.1111/j.1474-9726.2005.00162.x
   STIEDL P, 2015, HEPATOLOGY
   SWINDELL W, 2012, PLOS ONE
   Swindell WR, 2011, AGEING RES REV, V10, P132, DOI 10.1016/j.arr.2010.09.007
   Swindell WR, 2010, EXP GERONTOL, V45, P366, DOI 10.1016/j.exger.2010.02.009
   Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155
   Teranishi A, 1999, METALLOTHIONEIN IV, P485
   VALENCAK T, 2013, AGE
   Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014
   Wills NK, 2008, EXP EYE RES, V86, P41, DOI 10.1016/j.exer.2007.09.005
   YANG X, 2020, CHEMOSPHERE
   Yang XP, 2006, FASEB J, V20, P1024, DOI 10.1096/fj.05-5288fje
   YU C, 2011, PLOS ONE
   Zhang Dan, 2012, J Circadian Rhythms, V10, P5, DOI 10.1186/1740-3391-10-5
   ZOTA A, 2015, AM J EPIDEMIOL
NR 88
TC 6
Z9 6
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2021 AUG
PY 2021
VL 43
IS 4
SI SI
BP 1975
EP 1993
DI 10.1007/s11357-021-00393-3
EA JUN 2021
PG 19
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA WU2HV
UT WOS:000660454500001
PM 34117600
OA Green Published
DA 2024-02-19
ER

PT J
AU Nakamura, S
   Okabayashi, S
   Ageyama, N
   Koie, H
   Sankai, T
   Ono, F
   Fujimoto, K
   Terao, K
AF Nakamura, S.
   Okabayashi, S.
   Ageyama, N.
   Koie, H.
   Sankai, T.
   Ono, F.
   Fujimoto, K.
   Terao, K.
TI Transthyretin amyloidosis and two other aging-related amyloidoses in an
   aged vervet monkey
SO VETERINARY PATHOLOGY
LA English
DT Article
DE amyloidosis; amyloid beta protein; IAPP; transthyretin
ID SENILE SYSTEMIC AMYLOIDOSIS; ALZHEIMERS-DISEASE; DEPOSITS; MODEL;
   PATHOGENESIS; POLYPEPTIDE; PRECURSOR; PRIMATE
AB An aged male vervet monkey showed severe cardiac arrhythmia for more than 3 years. A multifocal amyloid consisting of transthyretin was deposited in all areas of the heart wall, especially in the extracellular stroma among muscle fibers and external tunica of arterioles. Moreover, the amyloid was deposited in the stroma and arterioles of other systemic organs except the liver and spleen. These characteristics are consistent with senile systemic amyloidosis in humans. A second amyloid consisting of amyloid P protein was in senile plaques and cerebral amyloid angiopathy in the cerebral cortex. A third amyloid consisting of islet amyloid polypeptide was deposited in islets of the pancreas. Apolipoprotein E and amyloid P component colocalized with the 3 amyloids. Thus, 3 different aging-related amyloids were found in an aged vervet monkey. In particular, to our knowledge, this is the first report on spontaneous transthyretin amyloidosis in animals.
C1 [Nakamura, S.; Okabayashi, S.; Ono, F.; Fujimoto, K.] Corp Prod & Res Lab Primates, Tsukuba, Ibaraki, Japan.
   [Ageyama, N.; Sankai, T.; Terao, K.] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan.
   [Koie, H.] Nihon Univ, Coll Biosci, Dept Vet Med, Fujisawa, Kanagawa, Japan.
C3 National Institute of Health Sciences - Japan; Nihon University
RP Nakamura, S (corresponding author), Shiga Univ Med Sci, Res Ctr Anim Med Sci, Seta Tsukinowa Cho, Shiga 5202192, Japan.
EM snakamur@belle.shiga-med.ac.jp
RI Ageyama, Naohide/ABG-5014-2020
OI Ageyama, Naohide/0000-0002-5722-2638
CR Hass S, 1998, J BIOL CHEM, V273, P13892
   HIGUCHI K, 1991, VIRCHOWS ARCH B, V60, P231, DOI 10.1007/BF02899551
   Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405
   Lemere CA, 2004, AM J PATHOL, V165, P283, DOI 10.1016/S0002-9440(10)63296-8
   Ma Z, 1998, AMYLOID, V5, P255, DOI 10.3109/13506129809007298
   Mazor Y, 2002, J MOL BIOL, V322, P1013, DOI 10.1016/S0022-2836(02)00887-2
   Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2
   Nakamura S, 1996, J MED PRIMATOL, V25, P294, DOI 10.1111/j.1600-0684.1996.tb00213.x
   NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F
   OBrien TD, 1996, VET PATHOL, V33, P479, DOI 10.1177/030098589603300501
   PODLISNY MB, 1991, AM J PATHOL, V138, P1423
   Sawabe M, 2003, VIRCHOWS ARCH, V442, P252, DOI 10.1007/s00428-003-0759-5
   Sipe JD, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P1, DOI 10.1002/9783527619344
   Teng MH, 2001, LAB INVEST, V81, P385, DOI 10.1038/labinvest.3780246
   Westermark P, 2003, AMYLOID, V10, P48
NR 15
TC 16
Z9 20
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0300-9858
EI 1544-2217
J9 VET PATHOL
JI Vet. Pathol.
PD JAN
PY 2008
VL 45
IS 1
BP 67
EP 72
DI 10.1354/vp.45-1-67
PG 6
WC Pathology; Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Veterinary Sciences
GA 254HU
UT WOS:000252578500015
PM 18192580
DA 2024-02-19
ER

PT J
AU Xu, Q
   Cai, J
   Cong, YB
   Xiao, SJ
   Liu, Y
   Qin, W
   Chen, SY
   Shi, H
AF Xu, Qian
   Cai, Jing
   Cong, Yi-Bo
   Xiao, Shao-Jian
   Liu, Yun
   Qin, Wei
   Chen, Shi-Ya
   Shi, Hong
TI A Comparative Transcriptome and Proteome Analysis in Rat Models Reveals
   Effects of Aging and Diabetes on Expression of Neuronal Genes
SO INTERNATIONAL JOURNAL OF GERONTOLOGY
LA English
DT Article
DE diabetes; aging; neuronal genes; transcriptome; proteome
ID E-CADHERIN; BETA-CATENIN; FERRITIN LEVELS; ALPHA-CATENIN; SYNAPTOPHYSIN;
   NEUROPATHY; MOLECULES; DISEASE; OBESITY; GROWTH
AB Background: To understand neuronal molecular changes in senile diabetes we established a rat senile diabetes model and analyzed transcriptome and proteome changes.
   Methods: Wistar rats were fed a high sugar, high fat diet for 16 months to induce diabetes. Non-diabetic aged rats and young rats were used as controls. Transcript and protein levels in the liver were then analyzed by microarray and antibody arrays, respectively.
   Results: Neuronal genes that were differentially expressed between senile diabetic rats, non-diabetic aged rats, and young rats were distributed across 12 pathways and 23 Gene Ontology (GO) clusters. Among them, 2267 genes were aging-related, 1230 genes were diabetes-associated, and 9 proteins might be associated with neurological disorders.
   Conclusion: In this study, we investigated transcriptome and proteome changes in animal models, analyzed the impact of aging and diabetes on neuronal molecules, and confirmed the correlations. Our study provides support for further studies on mechanisms of neuronal diseases. Copyright (C) 2016, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier Taiwan LLC.
C1 [Xu, Qian; Cai, Jing; Cong, Yi-Bo; Liu, Yun; Qin, Wei; Chen, Shi-Ya; Shi, Hong] Fujian Univ Tradit Chinese Med, Inst Integrated Chinese & Western Med, 1 Qiuyang Rd, Fuzhou 350122, Fujian, Peoples R China.
   [Xiao, Shao-Jian] Third Peoples Hosp Fujian Prov, Fuzhou 350122, Fujian, Peoples R China.
C3 Fujian University of Traditional Chinese Medicine
RP Shi, H (corresponding author), Fujian Univ Tradit Chinese Med, Inst Integrated Chinese & Western Med, 1 Qiuyang Rd, Fuzhou 350122, Fujian, Peoples R China.
EM shihong3327@sina.com
FU Fujian Natural Science Foundation [2015J01686]; Scientific Research Fund
   of the National Health and Family Planning Commission of the People's
   Republic of China [WKJ-FJ-38]; Key Foundation of Society Development in
   Fujian Province [2013Y0059]
FX The work was supported by Fujian Natural Science Foundation
   (2015J01686), the Scientific Research Fund of the National Health and
   Family Planning Commission of the People's Republic of China
   (WKJ-FJ-38), and the Key Foundation of Society Development in Fujian
   Province (2013Y0059).
CR Booya F, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-24
   CALAKOS N, 1994, J BIOL CHEM, V269, P24534
   Cardoso S, 2013, CURR MOL MED, V13, P586
   Chirasani SR, 2009, J MOL MED, V87, P153, DOI 10.1007/s00109-008-0414-3
   Connor JR, 2004, NEUROLOGY, V62, P1563, DOI 10.1212/01.WNL.0000123251.60485.AC
   Derrell C., 1996, GUIDE CARE USE LAB A
   Foltynie T, 2002, NEUROEPIDEMIOLOGY, V21, P1, DOI 10.1159/000048607
   Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.1978
   Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5
   GUARINO M, 1993, PATHOL RES PRACT, V189, P913
   Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7
   Hoybergs YMJJ, 2007, NEUROSCI LETT, V417, P149, DOI 10.1016/j.neulet.2007.02.087
   JENSEN TS, 1991, ACTA NEUROL SCAND, V84, P326, DOI 10.1111/j.1600-0404.1991.tb04963.x
   Ramos-Rodriguez JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089229
   Kitano Y, 2004, ANN NEUROL, V56, P462, DOI 10.1002/ana.20232
   Kurtz KA, 2006, OTOLARYNG HEAD NECK, V134, P142, DOI 10.1016/j.otohns.2005.08.026
   Lecube A, 2008, INT J OBESITY, V32, P1665, DOI 10.1038/ijo.2008.154
   LEIN PJ, 1991, J CELL BIOL, V113, P417, DOI 10.1083/jcb.113.2.417
   Mandel S, 2007, PROG NEUROBIOL, V82, P348, DOI 10.1016/j.pneurobio.2007.06.001
   Mohan A, 2007, EXP EYE RES, V84, P781, DOI 10.1016/j.exer.2006.06.014
   Morris JK, 2014, NEUROBIOL AGING, V35, P585, DOI 10.1016/j.neurobiolaging.2013.09.033
   Palacios N, 2011, MOVEMENT DISORD, V26, P2253, DOI 10.1002/mds.23855
   Qian ZR, 2002, MODERN PATHOL, V15, P1357, DOI 10.1097/01.MP.0000039572.75188.1A
   REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531
   Rizzuto D, 2014, GERONTOLOGY, V60, P327, DOI 10.1159/000356771
   Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999
   Torres VA, 2007, MOL CELL BIOL, V27, P7703, DOI 10.1128/MCB.01991-06
   WICHA MS, 1979, EXP CELL RES, V124, P181, DOI 10.1016/0014-4827(79)90268-4
   Xu Q, 2011, DIABETES CARE, V34, P910, DOI 10.2337/dc10-1922
   Zhao XJ, 2003, WORLD J GASTROENTERO, V9, P225, DOI 10.3748/wjg.v9.i2.225
NR 30
TC 0
Z9 0
U1 0
U2 10
PU TAIWAN SOC GERIATRIC EMERGENCY & CRITICAL CARE MEDICINE-TSGECM
PI TAIPEI
PA 12F-14, NO 42, SEC 1, MINSHENG E RD, ZHONGSHAN DIST, TAIPEI, 104, TAIWAN
SN 1873-9598
EI 1873-958X
J9 INT J GERONTOL
JI Int. J. Gerontol.
PD DEC
PY 2016
VL 10
IS 4
BP 212
EP 217
DI 10.1016/j.ijge.2016.05.001
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA EK9VF
UT WOS:000394271300007
OA gold
DA 2024-02-19
ER

PT J
AU da Silva, ACA
   Salomon, TB
   Behling, CS
   Putti, J
   Hackenhaar, FS
   Alabarse, PVG
   Schüller, AK
   Benfato, MS
AF da Silva, Ana Carolina A.
   Salomon, Tiago B.
   Behling, Camile Saul
   Putti, Jordana
   Hackenhaar, Fernanda S.
   Alabarse, Paulo V. G.
   Schueller, Artur K.
   Benfato, Mara S.
TI Oxidative stress in the kidney of reproductive female rats during aging
SO BIOGERONTOLOGY
LA English
DT Article
DE Reproduction; Aging; Antioxidant enzymes; Oxidative stress; Kidneys
ID ASCORBIC-ACID; GENE-EXPRESSION; PROTEIN DAMAGE; NITRIC-OXIDE; LONGEVITY;
   LIVER; AGE; QUANTITATION; DISEASE; TISSUES
AB Reproduction is a costly life process, and the reproductive investment by females appears to be greater than males in many species. We have analyzed the effects of reproductive investment during aging with respect to oxidative stress parameters in female Wistar rats. We measured the activity glutathione peroxidase, glutathione S-transferase, superoxide dismutase, consumption of hydrogen peroxide, protein carbonylation, lipid peroxidation, nitrite and nitrate levels, and Vitamin C (Vit. C) and E levels. We traced oxidative profiles at ages 3, 6, 12, and 24 months. Animals were grouped according to reproductive experience: experienced or naive with respect to reproductive activity. We measured aconitase activity and sex hormone levels. The naive animals exhibited an increase with respect to experienced in most parameters studied at 6 and 24 months, whereas experienced animals exhibited a similar increase at 3 and 12 months. At 6 months of age, during the period that would represent peak reproductive activity, naive animals showed higher levels of MDA, Vit. C, consumption of hydrogen peroxide and GPx, aconitase, and SOD activities. In naive elderly rats, we observed an increase in oxidative damage markers and an increase in enzymatic and non-enzymatic antioxidants, with the exception of consumption of hydrogen peroxide and Vit. C. In the long term, the reproductive investment was not sufficient to interfere with antioxidant capacity, and did not contribute to oxidative damage in kidneys of female Wistar rats.
C1 [da Silva, Ana Carolina A.; Salomon, Tiago B.; Behling, Camile Saul; Hackenhaar, Fernanda S.; Benfato, Mara S.] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, BR-91501970 Porto Alegre, RS, Brazil.
   [da Silva, Ana Carolina A.; Salomon, Tiago B.; Behling, Camile Saul; Putti, Jordana; Hackenhaar, Fernanda S.; Alabarse, Paulo V. G.; Schueller, Artur K.; Benfato, Mara S.] Univ Fed Rio Grande do Sul, Dept Biofis, Lab Estresse Oxidat, IB, BR-91501970 Porto Alegre, RS, Brazil.
C3 Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio
   Grande do Sul
RP Benfato, MS (corresponding author), Univ Fed Rio Grande do Sul, Dept Biofis, Lab Estresse Oxidat, IB, Av Bento Goncalves 9500 Predio 43431, BR-91501970 Porto Alegre, RS, Brazil.
EM mara.benfato@ufrgs.br
RI Alabarse, Paulo VG/C-3122-2013; Hackenhaar, Fernanda
   Schäfer/R-7660-2016; Salomon, Tiago/L-9319-2015; da Silva,
   Ana/GXH-4851-2022; Salomon, Tiago/T-8230-2019; Benfato, Mara
   S/G-4873-2012; Silva, Ana/JGM-6679-2023
OI Alabarse, Paulo VG/0000-0002-9721-9302; Salomon,
   Tiago/0000-0002-6095-8291; Salomon, Tiago/0000-0002-6095-8291; Benfato,
   Mara S/0000-0001-5997-1926; Hackenhaar, Fernanda/0000-0002-9395-2216
FU CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
FX We thank Zelma Almeida for technical assistance. We thank the
   laboratories of professors Itabajara Vaz and Arthur Fett Neto for the
   loan of equipment. This research was supported by grants from
   CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (Brazilian agencies for research support).
CR Aebi H, 1984, Methods Enzymol, V105, P121
   Aydin S, 2012, BIOGERONTOLOGY, V13, P251, DOI 10.1007/s10522-011-9370-3
   Barbas C, 1997, J CHROMATOGR A, V778, P415, DOI 10.1016/S0021-9673(97)00416-0
   Baylis C, 2009, NAT REV NEPHROL, V5, P384, DOI 10.1038/nrneph.2009.90
   Bergeron P, 2011, FUNCT ECOL, V25, P1063, DOI 10.1111/j.1365-2435.2011.01868.x
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   Borrás C, 2010, BBA-MOL BASIS DIS, V1802, P205, DOI 10.1016/j.bbadis.2009.09.007
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   De Loof A, 2011, J INSECT PHYSIOL, V57, P1, DOI 10.1016/j.jinsphys.2010.08.018
   Del Vecchio L, 2011, SEMIN DIALYSIS, V24, P56, DOI 10.1111/j.1525-139X.2010.00819.x
   Ehrenbrink G, 2006, EXP GERONTOL, V41, P368, DOI 10.1016/j.exger.2006.02.007
   Garratt M, 2012, FUNCT ECOL, V26, P423, DOI 10.1111/j.1365-2435.2011.01952.x
   Garratt M, 2011, P ROY SOC B-BIOL SCI, V278, P1098, DOI 10.1098/rspb.2010.1818
   Gems D, 2005, MECH AGEING DEV, V126, P381, DOI 10.1016/j.mad.2004.09.001
   Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712
   Grisham MB, 1996, METHOD ENZYMOL, V268, P237
   GUPTA SD, 1973, INT J BIOCHEM, V4, P309
   Hackenhaar FS, 2009, CELL BIOCHEM FUNCT, V27, P378, DOI 10.1002/cbf.1585
   Halliwell B, 2007, FREE RADICALS BIOL M
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Imaizumi N, 2006, LIFE SCI, V78, P2998, DOI 10.1016/j.lfs.2005.11.026
   Karatepe M, 2004, LC GC N AM, V22, P362
   KIMURA H, 1992, J NUTR, V122, P1904, DOI 10.1093/jn/122.9.1904
   Krinke G. J., 2000, HDB EXPT ANIMALS LAB
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Li GL, 2012, REJUV RES, V15, P257, DOI 10.1089/rej.2011.1259
   Matt DW, 1998, BIOL REPROD, V59, P1477, DOI 10.1095/biolreprod59.6.1477
   Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Mladenov M, 2008, J THERM BIOL, V33, P431, DOI 10.1016/j.jtherbio.2008.07.001
   Modlinger PS, 2004, SEMIN NEPHROL, V24, P354, DOI 10.1016/j.semnephrol.2004.04.007
   Musci G, 2006, MECH AGEING DEV, V127, P544, DOI 10.1016/j.mad.2006.01.012
   Oldakowski L, 2012, J EXP BIOL, V215, P1799, DOI 10.1242/jeb.068452
   Percy CJ, 2008, NEPHROLOGY, V13, P147, DOI 10.1111/j.1440-1797.2008.00924.x
   PINTO RE, 1969, BIOCHEM J, V112, P109, DOI 10.1042/bj1120109
   Ramara A, 2007, BRAIN RES, V1176, P71, DOI 10.1016/j.brainres.2007.08.036
   Rizzo A, 2012, REPROD DOMEST ANIM, V47, P344, DOI 10.1111/j.1439-0531.2011.01891.x
   Teixeira HD, 1998, P NATL ACAD SCI USA, V95, P7872, DOI 10.1073/pnas.95.14.7872
   Tower John, 2009, Journal of Biology (London), V8, P38, DOI 10.1186/jbiol141
   Tsuchida S., 2000, EXPT PROTOCOLS REACT, P83
   Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109
   Viña J, 2006, FREE RADICAL RES, V40, P1359, DOI 10.1080/10715760600952851
   Vina J, 2006, FREE RADICAL RES, V40, P111, DOI 10.1080/10715760500405778
   Viña J, 2005, FEBS LETT, V579, P2541, DOI 10.1016/j.febslet.2005.03.090
   Westwood FR, 2008, TOXICOL PATHOL, V36, P375, DOI 10.1177/0192623308315665
NR 46
TC 7
Z9 7
U1 0
U2 20
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD AUG
PY 2013
VL 14
IS 4
BP 411
EP 422
DI 10.1007/s10522-013-9440-9
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 197SX
UT WOS:000322872300006
PM 23820883
DA 2024-02-19
ER

PT J
AU De Cabo, R
   Cabello, R
   Rios, M
   López-Lluch, G
   Ingram, DK
   Lane, MA
   Navas, P
AF De Cabo, R
   Cabello, R
   Rios, M
   López-Lluch, G
   Ingram, DK
   Lane, MA
   Navas, P
TI Calorie restriction attenuates age-related alterations in the plasma
   membrane antioxidant system in rat liver
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE caloric restriction; coenzyme Q; plasma membrane
ID OXIDATIVE DNA-DAMAGE; COENZYME-Q; LIFE-SPAN; VITAMIN-E;
   SACCHAROMYCES-CEREVISIAE; ASCORBATE STABILIZATION; ELECTRON-TRANSPORT;
   FOOD RESTRICTION; SKELETAL-MUSCLE; CELLS
AB Aging is associated with increased production of reactive oxygen species and oxidation-induced damage to intracellular structures and membranes. Caloric restriction (CR) is the only non-genetic method proven to extend lifespan in mammals. Although the mechanisms of CR remain to be clearly elucidated, reductions in oxidative stress have been shown to increase lifespan in several model systems. Oxidative stress can be attenuated by CR. Mitochondria and plasma membrane (PM) are normal sources of free radicals. The PM has a trans-membrane redox system that provides electrons to recycle lipophilic antioxidants, such as alpha-tocopherol and coenzyme Q (CoQ). The idea developed in this study is that the PM is intimately involved in cellular physiology controlling the relationship of the cell to its environment. PM is the key for protecting cellular integrity during aging. Specifically, we have investigated age-related alterations and the effects of CR in the trans-PM redox (antioxidant) system in rat liver. We found that age-related declines in the ratio of CoQ(10)/CoQ(9) and alpha-tocopherol in liver PM were attenuated by CR compared to those fed ad libitum (AL). CoQ-dependent NAD(P)H dehydrogenases were increased in CR old rat liver PMs. As a consequence, the liver PM of CR old rats was more resistant to oxidative stress-induced lipid peroxidation than AL rats. Thus, our results suggest that CR induces a higher capacity to oxidize NAD(P)H in the PM of old rat livers and as a result, a higher resistance to oxidative stress-induced damage. (C) 2004 Elsevier Inc. All rights reserved.
C1 NIA, Lab Expt Gerontol, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA.
   Univ Pablo Olavide, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); Consejo Superior de Investigaciones Cientificas (CSIC);
   Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental
   Biology (CABD)
RP De Cabo, R (corresponding author), NIA, Lab Expt Gerontol, Gerontol Res Ctr, NIH, Box 10,5600 Nathan Shock Dr, Baltimore, MD 21224 USA.
EM decabora@grc.nia.nih.gov
RI NAVAS, PLACIDO/R-5943-2019; Lopez-Lluch, Guillermo/N-4742-2014; de Cabo,
   Rafael Carlos/E-7996-2010; de Cabo, Rafael/J-5230-2016
OI NAVAS, PLACIDO/0000-0002-4115-7966; Lopez-Lluch,
   Guillermo/0000-0001-9830-8502; de Cabo, Rafael
   Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442
CR Barja G, 2002, AGEING RES REV, V1, P397, DOI 10.1016/S1568-1637(02)00008-9
   BEYER RE, 1994, J BIOENERG BIOMEMBR, V26, P349, DOI 10.1007/BF00762775
   Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CASTILLOOLIVARE.A, 2000, CRIT REV BIOCHEM MOL, P197
   de Cabo R, 2003, EXP GERONTOL, V38, P631, DOI 10.1016/S0531-5565(03)00055-X
   de Grey ADNJ, 2001, MITOCHONDRION, V1, P129, DOI 10.1016/S1567-7249(01)00008-3
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   GomezDiaz C, 1997, BIOCHEM BIOPH RES CO, V234, P79, DOI 10.1006/bbrc.1997.6582
   GomezDiaz C, 1997, J BIOENERG BIOMEMBR, V29, P251, DOI 10.1023/A:1022410127104
   Gredilla R, 2002, MICROSC RES TECHNIQ, V59, P273, DOI 10.1002/jemt.10204
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Guo ZM, 2001, MECH AGEING DEV, V122, P1771, DOI 10.1016/S0047-6374(01)00298-6
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Kagan VE, 1998, FEBS LETT, V428, P43, DOI 10.1016/S0014-5793(98)00482-7
   Lal SB, 2001, J GERONTOL A-BIOL, V56, pB116, DOI 10.1093/gerona/56.3.B116
   LARM JA, 1994, J BIOL CHEM, V269, P30097
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   Lass A, 1997, J BIOL CHEM, V272, P19199, DOI 10.1074/jbc.272.31.19199
   LEON TI, 2001, LIPIDS, V36, P589
   Li Y, 1998, EXP CELL RES, V239, P254, DOI 10.1006/excr.1997.3870
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   Macho A, 1999, CELL DEATH DIFFER, V6, P155, DOI 10.1038/sj.cdd.4400465
   Mataix J, 1997, MOL ASPECTS MED, V18, pS129
   May JM, 1999, BBA-BIOMEMBRANES, V1421, P19, DOI 10.1016/S0005-2736(99)00107-8
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Merker MP, 2002, AM J PHYSIOL-LUNG C, V282, pL36, DOI 10.1152/ajplung.00283.2001
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Navarro F, 1998, FASEB J, V12, P1665, DOI 10.1096/fasebj.12.15.1665
   NAVAS P, 1989, CANCER RES, V49, P2147
   NAVAS P, 1986, BIOCHEM BIOPH RES CO, V135, P110, DOI 10.1016/0006-291X(86)90949-6
   Navas P, 2002, FREE RADICAL RES, V36, P369, DOI 10.1080/10715760290021207
   Santos-Ocaña C, 1998, J BIOL CHEM, V273, P8099, DOI 10.1074/jbc.273.14.8099
   Schelonka LP, 2000, INVEST OPHTH VIS SCI, V41, P1617
   Slater AFG, 1995, TOXICOL LETT, V82-3, P149, DOI 10.1016/0378-4274(95)03474-9
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   VILLALBA JM, 1995, P NATL ACAD SCI USA, V92, P4887, DOI 10.1073/pnas.92.11.4887
   VILLALBA JM, MITOCHONDRIAL UBIQUI, P89
   Villalba JM, 2000, ANTIOXID REDOX SIGN, V2, P213, DOI 10.1089/ars.2000.2.2-213
   YU BP, 1994, FREE RADICALS AGING
   Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com
NR 41
TC 115
Z9 120
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAR
PY 2004
VL 39
IS 3
BP 297
EP 304
DI 10.1016/j.exger.2003.12.003
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 804DJ
UT WOS:000220279100003
PM 15036389
DA 2024-02-19
ER

PT J
AU Troyer, DA
   Venkatraman, JT
   Fernandes, G
AF Troyer, DA
   Venkatraman, JT
   Fernandes, G
TI Effects of calorie restriction and ω-3 dietary fat on aging in short-
   and long-lived rodents
SO AGE
LA English
DT Article
ID GROWTH-FACTOR-BETA; CONJUGATED LINOLEIC-ACID; AUTOIMMUNE MURINE LUPUS;
   FOOD RESTRICTION; FISCHER-344 RATS; ANTIOXIDANT ENZYMES;
   GENE-EXPRESSION; MESSENGER-RNA; B/W MICE; NUTRITIONAL INFLUENCES
AB Aging is accompanied by a steady increase in the incidence of spontaneous tumors and a decline in immune function. Calorie restriction (CR)or supplementation with omega-3 fats prolongs life span, suppresses tumorigenesis, and ameliorates immune function in a variety of experimental models. We suggest that decreased oxidant stress and upregulation of apoptosis mediate the effects of calorie restriction on immunity and longevity. CR prolongs life span in several animal models and our studies have examined the effects of CR on the immune system and on tumorigenesis. CR maintains naive T cells, prevents the rise in "double-negative" T cells, maintains lymphocyte responsiveness to mitogens, and preserves Dexamethasone induced apoptosis in spleen cells of MRL/lpr mice. CR also modulates the expression of inflammatory mediators and cytokines. CR decreases the Sjogren's syndrome-like chronic inflammation of salivary glands of B/W animals while increasing expression of the immunosuppressive cytokine TGF beta 1 and decreasing expression of the pro-inflammatory cytokines IL-6 and TNF alpha. The autoimmune disease in the B/W mouse also affects the kidneys, and we fi nd that renal expression of platelet derived growth factor-A, (PDGF-A) and thrombin receptor are decreased in CR animals. Similarly, CR decreases the expression and localization of plasminogen activator inhibitor type 1 in glomeruli of B/W animals. CR also modulates expression and function of androgen receptors and the binding of insulin to liver nuclei. Finally, CR suppresses the development of breast tumors in the Ras oncomouse. These effects of calorie restriction are paralleled in shout-lived B/W animals fed diets supplemented with omega-3 fatty acids. Omega-a fatty acids induce the expression of hepatic antioxidant enzymes, and enhance apoptosis in lymphocytes of B/W animals.
C1 Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA.
   Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA.
   SUNY Buffalo, Dept Phys Therapy Exercise & Nutr Sci, Buffalo, NY 14214 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; State University of New York (SUNY)
   System; State University of New York (SUNY) Buffalo
RP Fernandes, G (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, 770 Floyd Curl Dr, San Antonio, TX 78284 USA.
CR BOGDEN JD, 1995, NUTR REV, V53, pS59
   BYUN DS, 1995, AGING-CLIN EXP RES, V7, P40, DOI 10.1007/BF03324291
   CALLAHAN JE, 1990, J IMMUNOL, V144, P2473
   CHANDRASEKAR B, 1995, CLIN IMMUNOL IMMUNOP, V76, P291, DOI 10.1006/clin.1995.1128
   CHANDRASEKAR B, 1994, BIOCHEM BIOPH RES CO, V200, P893, DOI 10.1006/bbrc.1994.1534
   Chandrasekar B, 1996, NUTR RES, V16, P489, DOI 10.1016/0271-5317(96)00030-9
   CHANDRASEKAR B, 1995, J AUTOIMMUN, V8, P381, DOI 10.1006/jaut.1995.0030
   CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518
   CHUNG OK, 1983, J AM OIL CHEM SOC, V60, P1848, DOI 10.1007/BF02901536
   Connor W E, 1990, Adv Intern Med, V35, P139
   DUDL RJ, 1977, METABOLISM, V26, P33, DOI 10.1016/0026-0495(77)90125-1
   Durgam VR, 1997, CANCER LETT, V116, P121, DOI 10.1016/S0304-3835(97)00192-4
   EMLEN W, 1994, J IMMUNOL, V152, P3685
   Fernandes G, 1998, NUTR REV, V56, pS161
   FERNANDES G, 1994, J IMMUNOL, V152, P5979
   FERNANDES G, 1994, CLIN IMMUNOL IMMUNOP, V72, P193, DOI 10.1006/clin.1994.1129
   FERNANDES G, 1995, FASEB J, V9, pA787
   FERNANDES G, 1976, NATURE, V263, P504, DOI 10.1038/263504b0
   FERNANDES G, 1995, P NATL ACAD SCI USA, V92, P6494, DOI 10.1073/pnas.92.14.6494
   FERNANDES G, 1978, P NATL ACAD SCI USA, V75, P1500, DOI 10.1073/pnas.75.3.1500
   Fernandes G, 1996, LIPIDS, V31, pS91, DOI 10.1007/BF02637058
   FERNANDES G, 1975, CLIN IMMUNOL IMMUNOP, V4, P304, DOI 10.1016/0090-1229(75)90066-5
   Fernandes G., 1993, V8, P91
   FERNANDES G, 1993, NUTR RES, V13, pS19, DOI 10.1016/S0271-5317(05)80282-9
   Fernandes G, 1997, J CLIN IMMUNOL, V17, P85, DOI 10.1023/A:1027344730553
   FERNANDES G, 1990, Aging Immunology and Infectious Disease, V2, P117
   FERNANDES G, 1996, INT SOC STUD FATT AC, V3, P10
   FEUERS RJ, 1993, MUTAT RES, V295, P191, DOI 10.1016/0921-8734(93)90020-4
   FRANCESCHI C, 1995, IMMUNOL TODAY, V16, P12, DOI 10.1016/0167-5699(95)80064-6
   GALLI C, 1991, WORLD REV NUTR DIET, V66, P446
   GRUBER J, 1994, EUR J IMMUNOL, V24, P1115, DOI 10.1002/eji.1830240516
   HART RW, 1992, EXERCISE CALORIES FA
   HURSTING SD, 1994, P NATL ACAD SCI USA, V91, P7036, DOI 10.1073/pnas.91.15.7036
   INOMATA T, 1989, BIOL NEONATE, V55, P238
   Ip C, 1997, AM J CLIN NUTR, V66, P1523
   JANEWAY CA, 1990, CELL, V63, P659, DOI 10.1016/0092-8674(90)90130-7
   KAHN CR, 1988, J CLIN INVEST, V82, P1151, DOI 10.1172/JCI113711
   KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037
   KEHRL JH, 1991, J IMMUNOL, V146, P4016
   KELLEY DS, 1976, AM J CLIN NUTR, V63, pS994
   LEAF A, 1988, NEW ENGL J MED, V318, P549, DOI 10.1056/NEJM198803033180905
   LUAN XH, 1995, IMMUNOL LETT, V47, P181, DOI 10.1016/0165-2478(95)00091-5
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MURASKO D M, 1990, Aging Immunology and Infectious Disease, V2, P171
   NATH KA, 1994, KIDNEY INT, V45, pS111
   NELSON JF, 1994, MODULATION DIET REST
   OGAWA N, 1995, J AUTOIMMUN, V8, P1, DOI 10.1006/jaut.1995.0001
   PRICKETT JD, 1981, J CLIN INVEST, V68, P556, DOI 10.1172/JCI110288
   ROBINSON D, 1993, SIGHT SOUND, V3, P34
   SABATINO F, 1991, J GERONTOL, V46, pB171, DOI 10.1093/geronj/46.5.B171
   SARDESAI VM, 1992, J NUTR BIOCHEM, V3, P562, DOI 10.1016/0955-2863(92)90050-S
   SARDESAI VM, 1992, J NUTR BIOCHEM, V3, P154, DOI 10.1016/0955-2863(92)90110-5
   SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438
   Sprott RL, 1997, EXP GERONTOL, V32, P205, DOI 10.1016/S0531-5565(96)00065-4
   Talal N, 1974, Curr Top Microbiol Immunol, V64, P79
   Trichopoulou A, 1997, NUTR REV, V55, P383, DOI 10.1111/j.1753-4887.1997.tb01578.x
   Troyer D, 1996, NUTR RES, V16, P1959, DOI 10.1016/S0271-5317(96)00219-9
   Troyer DA, 1997, CLIN EXP IMMUNOL, V108, P58, DOI 10.1046/j.1365-2249.1997.d01-970.x
   TROYER DA, 1995, AM J PATHOL, V146, P111
   TURTURRO A, 1992, EXP GERONTOL, V27, P583, DOI 10.1016/0531-5565(92)90013-P
   VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835
   VENKATRAMAN J, 1992, MECH AGEING DEV, V63, P27, DOI 10.1016/0047-6374(92)90014-5
   Venkatraman Jaya T., 1994, Aging Immunology and Infectious Disease, V5, P13
   VENKATRAMAN JT, 1991, AGE, V14, P45, DOI 10.1007/BF02434837
   VENKATRAMAN JT, 1994, LIPIDS, V29, P561, DOI 10.1007/BF02536628
   VENKATRAMAN JT, 1991, NUTRITION IMMUNOLOGY, P309
   WARNER HR, 1995, J GERONTOL A-BIOL, V50, pB107, DOI 10.1093/gerona/50A.3.B107
   WEINDRUCH R, 1988, RETARDATION AGING DI, P436
   YU BP, 1990, P SOC EXP BIOL MED, V193, P13, DOI 10.3181/00379727-193-42982
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   ZHU BQ, 1990, AM HEART J, V119, P168, DOI 10.1016/S0002-8703(05)80097-3
   Zock PL, 1997, CAN J PHYSIOL PHARM, V75, P211, DOI 10.1139/cjpp-75-3-211
NR 74
TC 3
Z9 4
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD OCT
PY 1998
VL 21
IS 4
BP 175
EP 182
DI 10.1007/s11357-998-0026-4
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 179PW
UT WOS:000079338700003
PM 23604378
OA Green Published
DA 2024-02-19
ER

PT J
AU Lian, SS
   Wang, J
   Zhang, LL
   Xing, Q
   Hu, NN
   Liu, SN
   Dai, XT
   Zhang, FM
   Hu, XL
   Bao, ZM
   Wang, S
AF Lian, Shanshan
   Wang, Jing
   Zhang, Lingling
   Xing, Qiang
   Hu, Naina
   Liu, Sinuo
   Dai, Xiaoting
   Zhang, Fengmei
   Hu, Xiaoli
   Bao, Zhenmin
   Wang, Shi
TI Integration of Biochemical, Cellular, and Genetic Indicators for
   Understanding the Aging Process in a Bivalve Mollusk <i>Chlamys
   farreri</i>
SO MARINE BIOTECHNOLOGY
LA English
DT Article
DE Scallop; Physiological vitality; Aging; Adaptation; Evolution
ID OXIDATIVE STRESS; ANTIOXIDANT ENZYMES; ARCTICA-ISLANDICA; EXTREME
   LONGEVITY; LIVER; METABOLISM; GROWTH; AGE; MALONDIALDEHYDE; GENERATION
AB The major causal factors for the irreversible decline in physical vitality during organismal aging are postulated to be a chronic state of cellular redox imbalance, metabolic toxicity, and impaired energy homeostasis. We assessed whether the relevant enzyme activity, oxidative stress, and intracellular ATP might be causally involved in the aging of short-lived Chlamys farreri (life span 4 similar to 5 years). A total of eight related biochemical and cellular indicators were chosen for the subsequent analysis. All the indicators were measured in seven different tissues from scallops aged one to four years, and our data support that the aging of C. farreri is associated with attenuated tissue enzyme activity as well as a decreased metabolic rate. Through principal component analysis, we developed an integrated vigor index for each tissue for comprehensive age-related fitness evaluation. Remarkably, all tissue-integrated vigor indexes significantly declined with age, and the kidney was observed to be the most representative tissue. Further transcriptional profiling of the enzymatic genes provided additional detail on the molecular responses that may underlie the corresponding biochemical results. Moreover, these critical molecular responses may be attributed to the conserved hierarchical regulators, e.g., FOXO, AMPKs, mTOR, and IGF1R, which were identified as potentially novel markers for chronic fitness decline with age in bivalves. The present study provides a systematic approach that could potentially benefit the global assessment of the aging process in C. farreri and provide detailed evaluation of the biochemical, cellular, and genetic indicators that might be involved. This information may assist in a better understanding of bivalve adaptability and life span.
C1 [Lian, Shanshan; Wang, Jing; Zhang, Lingling; Xing, Qiang; Hu, Naina; Liu, Sinuo; Dai, Xiaoting; Zhang, Fengmei; Hu, Xiaoli; Bao, Zhenmin; Wang, Shi] Ocean Univ China, MOE Key Lab Marine Genet & Breeding, Qingdao 266003, Shandong, Peoples R China.
   [Lian, Shanshan; Zhang, Lingling; Wang, Shi] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Shandong, Peoples R China.
   [Xing, Qiang; Hu, Xiaoli; Bao, Zhenmin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao 266237, Shandong, Peoples R China.
C3 Ocean University of China; Laoshan Laboratory; Laoshan Laboratory
RP Wang, S (corresponding author), Ocean Univ China, MOE Key Lab Marine Genet & Breeding, Qingdao 266003, Shandong, Peoples R China.; Wang, S (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Shandong, Peoples R China.
EM swang@ouc.edu.cn
RI Liu, Sinuo/JLM-6911-2023; Lian, Shanshan/GXV-4833-2022; zhang,
   lingling/HDM-2189-2022
OI lian, shanshan/0000-0002-0088-8826
FU National Natural Science Foundation of China [U1706203]; Fundamental
   Research Funds for the Central Universities [201841001]; key Research
   and Development Program of Shandong Province [2016ZDJQ0208,
   2018-MFS-T06]; Taishan Scholar Project Fund of Shandong Province of
   China
FX We acknowledge the grant support from the National Natural Science
   Foundation of China (U1706203), the Fundamental Research Funds for the
   Central Universities (201841001), the key Research and Development
   Program of Shandong Province (2016ZDJQ0208), Youth Talent Program
   Supported by Laboratory for Marine Fisheries Science and Food Production
   Processes (2018-MFS-T06) and Taishan Scholar Project Fund of Shandong
   Province of China.
CR Abele D, 2008, FREE RADICAL RES, V42, P474, DOI 10.1080/10715760802108849
   Abele D, 2013, GERONTOLOGY, V59, P261, DOI 10.1159/000345331
   Abele D, 2009, EXP GERONTOL, V44, P307, DOI 10.1016/j.exger.2009.02.012
   Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71
   Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036
   Arivazhagan P, 2000, J NUTR BIOCHEM, V11, P122, DOI 10.1016/S0955-2863(99)00079-0
   Austad SN, 2009, J GERONTOL A-BIOL, V64, P192, DOI 10.1093/gerona/gln059
   Barja G, 2013, ANTIOXID REDOX SIGN, V19, P1420, DOI 10.1089/ars.2012.5148
   Basova L, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3110-4
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Budanov AV, 2011, ANTIOXID REDOX SIGN, V15, P1679, DOI 10.1089/ars.2010.3530
   Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29
   Buttemer WA, 2010, FUNCT ECOL, V24, P971, DOI 10.1111/j.1365-2435.2010.01740.x
   CARROLL NV, 1956, J BIOL CHEM, V220, P583
   Chi C, 2016, MOLECULES, V21, DOI 10.3390/molecules21091108
   Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83
   Clark JF, 1997, J ATHL TRAINING, V32, P45
   Clark MS, 2013, ECOL EVOL, V3, P3283, DOI 10.1002/ece3.719
   de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149
   DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M
   Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x
   Guderley H, 2010, CAN J ZOOL, V88, P753, DOI 10.1139/Z10-039
   Guerra C, 2012, COMP BIOCHEM PHYS A, V162, P421, DOI 10.1016/j.cbpa.2012.04.018
   Guo XM, 1999, J SHELLFISH RES, V18, P19
   Haag WR, 2011, BIOL REV, V86, P225, DOI 10.1111/j.1469-185X.2010.00146.x
   Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4
   Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19
   Hu XL, 2006, AQUAC RES, V37, P1187, DOI 10.1111/j.1365-2109.2006.01546.x
   Hung CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008771
   JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2
   Johnson ACM, 2014, NEPHRON CLIN PRACT, V127, P129, DOI 10.1159/000363547
   Jolliffe I., 2002, PRINCIPAL COMPONENT, DOI DOI 10.1007/B98835
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0
   Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019
   KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4
   Kumar V, 2018, Basic concepts in clinical biochemistry: a practical guide
   Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206
   Li YL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01927-0
   Liao H, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01967
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   McCormick MA, 2011, PHILOS T R SOC B, V366, P17, DOI 10.1098/rstb.2010.0198
   Philipp E, 2006, MAR ECOL PROG SER, V307, P187, DOI 10.3354/meps307187
   Philipp E, 2005, MECH AGEING DEV, V126, P598, DOI 10.1016/j.mad.2004.12.003
   Philipp EER, 2008, J EXP BIOL, V211, P2492, DOI 10.1242/jeb.015966
   Philipp EER, 2010, GERONTOLOGY, V56, P55, DOI 10.1159/000221004
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   Ridgway ID, 2011, J GERONTOL A-BIOL, V66, P183, DOI 10.1093/gerona/glq172
   Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   Strahl J, 2007, AQUAT BIOL, V1, P77, DOI 10.3354/ab00008
   Strahl J, 2011, COMP BIOCHEM PHYS A, V158, P513, DOI 10.1016/j.cbpa.2010.12.015
   Strahl J, 2010, MAR BIOL, V157, P1283, DOI 10.1007/s00227-010-1408-6
   Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Ungvari Z, 2013, J GERONTOL A-BIOL, V68, P521, DOI 10.1093/gerona/gls193
   Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P741, DOI 10.1093/gerona/glr044
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Viña J, 2007, IUBMB LIFE, V59, P249, DOI 10.1080/15216540601178067
   Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0
   Weeks L. E, 1977, U.S. Patent, Patent No. [4,006,061, 4006061]
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x
   Yang RL, 2008, J CLIN BIOCHEM NUTR, V43, P154, DOI 10.3164/jcbn.2008044
   You H, 2005, CELL CYCLE, V4, P37, DOI 10.4161/cc.4.1.1401
   Zahn JM, 2007, CURR OPIN BIOTECH, V18, P355, DOI 10.1016/j.copbio.2007.07.004
   Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047
   Zulueta JJ, 1997, AM J PHYSIOL-LUNG C, V272, pL897, DOI 10.1152/ajplung.1997.272.5.L897
NR 73
TC 7
Z9 7
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1436-2228
EI 1436-2236
J9 MAR BIOTECHNOL
JI Mar. Biotechnol.
PD OCT
PY 2019
VL 21
IS 5
BP 718
EP 730
DI 10.1007/s10126-019-09917-7
PG 13
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA IZ5MK
UT WOS:000487127600013
PM 31392593
DA 2024-02-19
ER

PT J
AU Grizzi, F
   Franceschini, B
   Barbieri, B
   Gagliano, N
   Arosio, B
   Chiriva-Internati, M
   Annoni, G
   Dioguardi, N
AF Grizzi, F
   Franceschini, B
   Barbieri, B
   Gagliano, N
   Arosio, B
   Chiriva-Internati, M
   Annoni, G
   Dioguardi, N
TI Mast cell density - A quantitative index of acute liver inflammation
SO ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
LA English
DT Article
DE liver diseases; mast cells; inflammation; image analysis,
   computer-assisted; mast cell density
ID CIRRHOSIS; FIBROSIS; DISEASES; RATS
AB OBJECTIVE: To evaluate mast cell (MC) density, in liver tissues taken from young and aging rats treated with carbon tetrachloride (CCl4) or untreated, as a quantitative marker of acute liver inflammation and to investigate whether the density of MCs varied with the rats' age.
   STUDY DESIGN: Rats aged 2, 6, 12 and 19 months treated intraperitoneally with CCl4 were killed 2 and 24 hours after intoxication. Hepatocellular damage was established by measuring alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity. Four histologic sections of 12 specimens from each age group were stained with toluidine blue to identify the MCs, which were counted using a computer-assisted image analysis system.
   RESULTS: Histology showed hepatocellular necrosis with inflammatory infiltration both 2 and 24 hours after intoxication. Serum AST levels were high in the 6- and 12-month-old rats, whereas ALT levels were high in the those aged 2 and 19 months. Two and 24 hours after intoxication, MC density increased considerably in young rats but less so in rats aged 19 months.
   CONCLUSION: MC density can be a useful marker of acute liver inflammation. The greater density in young rats suggests that older rats have a reduced immune response or recruit fewer MCs.
C1 Ist Clin Humanitas, Sci Direct, I-20089 Rozzano, MI, Italy.
   Ist Sci Misure Quantit Med, Fdn Michele Rodriguez, Milan, Italy.
   Univ Milan, Dept Human Anat, Milan, Italy.
   Univ Milan, Dept Internal Med, Milan, Italy.
   Univ Milan, Dept Geriatr, Milan, Italy.
   Univ Milan Bicocca, Dept Clin Med Prevent & Med Biotechnol, Milan, Italy.
   Osped Maggiore Ist Ricovero & Cura Carattere Sci, Milan, Italy.
   Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.
C3 IRCCS Humanitas Research Hospital; University of Milan; University of
   Milan; University of Milan; University of Milano-Bicocca; Albany Medical
   College
RP Grizzi, F (corresponding author), Ist Clin Humanitas, Sci Direct, Via Manzoni 56, I-20089 Rozzano, MI, Italy.
RI Gagliano, Nicoletta/L-1485-2016; franceschini, barbara/AAB-8713-2020;
   Grizzi, Fabio/K-3448-2018
OI Gagliano, Nicoletta/0000-0002-3393-3144; franceschini,
   barbara/0000-0001-6348-248X; Grizzi, Fabio/0000-0003-0925-742X; Arosio,
   Beatrice/0000-0002-0615-3580
CR Ahmed AFKU, 2000, J PEDIATR SURG, V35, P1762, DOI 10.1053/jpsu.2000.19245
   Akiyoshi H, 1998, J HEPATOL, V29, P112, DOI 10.1016/S0168-8278(98)80185-2
   ATKINS FM, 1987, ARCH DERMATOL, V123, P191, DOI 10.1001/archderm.123.2.191
   Benyon RC, 1999, CLIN EXP ALLERGY, V29, P155
   DIGIROLAMO, 2000, DEV IMMUNOL, V7, P131
   Ehrlich P., 1877, Arch mikr anat u entwcklngsmech, V13, P263, DOI DOI 10.1007/BF02933937
   FARRELL DJ, 1995, HEPATOLOGY, V22, P1175, DOI 10.1016/0270-9139(95)90627-4
   FODINGER M, 1994, BLOOD, V84, P2954
   Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007
   Matsunaga Y, 2000, LIVER, V20, P152, DOI 10.1034/j.1600-0676.2000.020002152.x
   Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033
   Onori P, 2000, J HEPATOL, V33, P555, DOI 10.1034/j.1600-0641.2000.033004555.x
   Rioux KP, 1996, HEPATOLOGY, V23, P888, DOI 10.1053/jhep.1996.v23.pm0008666346
   STROBEL S, 1981, J CLIN PATHOL, V34, P851, DOI 10.1136/jcp.34.8.851
   Tomita M, 2000, ANN THORAC SURG, V69, P1686, DOI 10.1016/S0003-4975(00)01160-7
   WALLS AF, 1990, J PATHOL, V162, P119, DOI 10.1002/path.1711620204
   Zimmermann A, 1999, J HEPATOL, V30, P646, DOI 10.1016/S0168-8278(99)80195-0
NR 17
TC 12
Z9 12
U1 0
U2 0
PU SCI PRINTERS & PUBL INC
PI ST LOUIS
PA PO DRAWER 12425 8342 OLIVE BLVD, ST LOUIS, MO 63132 USA
SN 0884-6812
J9 ANAL QUANT CYTOL
JI Anal. Quant. Cytol. Histol.
PD APR
PY 2002
VL 24
IS 2
BP 63
EP 69
PG 7
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 547LR
UT WOS:000175334300001
PM 12026051
DA 2024-02-19
ER

PT J
AU Jazbutyte, V
   Hu, K
   Kruchten, P
   Bey, E
   Maier, SKG
   Fritzemeier, KH
   Prelle, K
   Hegele-Hartung, C
   Hartmann, RW
   Neyses, L
   Ertl, G
   Pelzer, T
AF Jazbutyte, Virginija
   Hu, Kai
   Kruchten, Patricia
   Bey, Emmanuel
   Maier, Sebastian K. G.
   Fritzemeier, Karl-Heinrich
   Prelle, Kaija
   Hegele-Hartung, Christa
   Hartmann, Rolf W.
   Neyses, Ludwig
   Ertl, Georg
   Pelzer, Theo
TI Aging reduces the efficacy of estrogen substitution to attenuate cardiac
   hypertrophy in female spontaneously hypertensive rats
SO HYPERTENSION
LA English
DT Article
DE estrogen receptors; cardiac hypertrophy; aging; hypertension
ID HORMONE REPLACEMENT THERAPY; 17-BETA-HYDROXYSTEROID DEHYDROGENASE;
   POSTMENOPAUSAL HYPERTENSION; CARDIOVASCULAR-DISEASE; WOMEN; HEART;
   STIMULATION; OVARIECTOMY; BENEFITS; HEALTH
AB Clinical trials failed to show a beneficial effect of postmenopausal hormone replacement therapy, whereas experimental studies in young animals reported a protective function of estrogen replacement in cardiovascular disease. Because these diverging results could in part be explained by aging effects, we compared the efficacy of estrogen substitution to modulate cardiac hypertrophy and cardiac gene expression among young (age 3 months) and senescent (age 24 months) spontaneously hypertensive rats (SHRs), which were sham operated or ovariectomized and injected with placebo or identical doses of 17 ss-estradiol (E2; 2 mu g/kg body weight per day) for 6 weeks (n = 10/group). Blood pressure was comparable among sham-operated senescent and young SHRs and not altered by ovariectomy or E2 treatment among young or among senescent rats. Estrogen substitution inhibited uterus atrophy and gain of body weight in young and senescent ovariectomized SHRs, but cardiac hypertrophy was attenuated only in young rats. Cardiac estrogen receptor-a expression was lower in intact and in ovariectomized senescent compared with young SHRs and increased with estradiol substitution in aged rats. Plasma estradiol and estrone levels were lower not only in sham-operated but surprisingly also in E2-substituted senescent SHRs and associated with a reduction of hepatic 17 ss-hydroxysteroid dehydrogenase type I enzyme activity, which converts weak (ie, estrone) into potent estrogens, such as E2. Aging attenuates the antihypertrophic effect of estradiol in female SHRs and is associated with profound alterations in cardiac estrogen receptor-alpha expression and estradiol metabolism. These observations contribute to explain the lower efficiency of estrogen substitution in senescent SHRs.
C1 Univ Wurzburg, Dept Med, D-97080 Wurzburg, Germany.
   Univ Saarland, Saarland, Germany.
   Schering AG, Berlin, Germany.
   Univ Manchester, Div Cardiol, Manchester, Lancs, England.
C3 University of Wurzburg; Saarland University; Schering AG; University of
   Manchester
RP Pelzer, T (corresponding author), Univ Wurzburg, Dept Med, Josef Schneider Str 2, D-97080 Wurzburg, Germany.
EM pelzer_t@klinik.uni-wuerzburg.de
RI Neyses, Ludwig/AGY-7446-2022
CR Adamski J, 2001, MOL CELL ENDOCRINOL, V171, P1, DOI 10.1016/S0303-7207(00)00383-X
   August P, 1999, J CLIN ENDOCR METAB, V84, P1862, DOI 10.1210/jc.84.6.1862
   Babiker FA, 2004, CIRCULATION, V109, P269, DOI 10.1161/01.CIR.0000105682.85732.BD
   Burger HG, 2002, FERTIL STERIL, V77, pS3
   Burger HG, 2002, RECENT PROG HORM RES, V57, P257, DOI 10.1210/rp.57.1.257
   BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305
   Förster C, 2004, P NATL ACAD SCI USA, V101, P14234, DOI 10.1073/pnas.0405571101
   Fortepiani LA, 2003, HYPERTENSION, V41, P640, DOI 10.1161/01.HYP.0000046924.94886.EF
   GREEN S, 1986, J STEROID BIOCHEM, V24, P77, DOI 10.1016/0022-4731(86)90035-X
   HILLARD TC, 1991, J CLIN PHARM THER, V16, P231, DOI 10.1111/j.1365-2710.1991.tb00310.x
   Hinojosa-Laborde C, 2004, HYPERTENSION, V44, P405, DOI 10.1161/01.HYP.0000142893.08655.96
   Hinojosa-Laborde C, 2000, HYPERTENSION, V35, P484, DOI 10.1161/01.HYP.35.1.484
   Ihionkhan CE, 2002, CIRC RES, V91, P814, DOI 10.1161/01.RES.0000038304.62046.4C
   LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203
   LIN SX, 1992, J BIOL CHEM, V267, P16182
   Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306
   Nordmeyer J, 2004, CIRCULATION, V110, P3270, DOI 10.1161/01.CIR.0000147610.41984.E8
   Peltoketo H, 1999, J MOL ENDOCRINOL, V23, P1, DOI 10.1677/jme.0.0230001
   Pelzer T, 2005, CARDIOVASC RES, V67, P604, DOI 10.1016/j.cardiores.2005.04.035
   Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281
   Qiu W, 2002, FASEB J, V16, P1829, DOI 10.1096/fj.02-0026fje
   Reckelhoff JF, 2004, HYPERTENSION, V43, P918, DOI 10.1161/01.HYP.0000124670.03674.15
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321
   Sam K M, 1998, Drug Des Discov, V15, P157
   SAM KM, 1995, J MED CHEM, V38, P4518, DOI 10.1021/jm00022a018
   Sharkey LC, 1999, J MOL CELL CARDIOL, V31, P1527, DOI 10.1006/jmcc.1999.0985
   van Eickels M, 2005, EUR J HEART FAIL, V7, P1079, DOI 10.1016/j.ejheart.2005.03.004
   Vihko P, 2004, MOL CELL ENDOCRINOL, V215, P83, DOI 10.1016/j.mce.2003.11.021
   Wallen WJ, 2000, HYPERTENSION, V36, P774, DOI 10.1161/01.HYP.36.5.774
   Widder J, 2003, HYPERTENSION, V42, P991, DOI 10.1161/01.HYP.0000098661.37637.89
   Williams JK, 2004, ILAR J, V45, P139, DOI 10.1093/ilar.45.2.139
   Xu Y, 2003, CARDIOVASC RES, V57, P388, DOI 10.1016/S0008-6363(02)00705-8
   ZHU DW, 1993, J MOL BIOL, V234, P242, DOI 10.1006/jmbi.1993.1578
NR 33
TC 29
Z9 37
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0194-911X
J9 HYPERTENSION
JI Hypertension
PD OCT
PY 2006
VL 48
IS 4
BP 579
EP 586
DI 10.1161/01.HYP.0000240053.48517.c7
PG 8
WC Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 127FR
UT WOS:000243571200016
PM 16940216
OA Bronze
DA 2024-02-19
ER

PT J
AU Lai, L
   Luo, YL
   Cui, JB
   Yang, XL
   Hu, ZH
   Li, JP
AF Lai, Li
   Luo, Yanli
   Cui, Jinbo
   Yang, Xiaoling
   Hu, Zhonghua
   Li, Jiping
TI Longitudinal Study on Quality of Life in Liver Transplant Recipients in
   Southwest China
SO ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY
LA English
DT Article
DE end stage liver disease; health-related quality of life; liver
   transplant; liver transplantation; organ transplant; organ
   transplantation; patient-reported outcome; quality of life; transplant
   recipients; treatment outcome
AB OBJECTIVE: To explore the long-term postoperative health-related quality of life (HRQoL) of liver transplant recipients in Southwest China. Survivors' physical rehabilitation and psychological changes at 3 stages were used to investigate parameters of their life and assess long-term outcomes of liver transplant among the subjects, especially those living more than 10 years postoperatively.
   STUDY DESIGN: Data were collected using Medical Outcomes Study Short Form 36 (MOS SF-36) for self-reported HRQoL variables at 3 stages over 8 years. Changes in all dimensions of HRQoL were analyzed every 4 years. Disease-related information of the subjects was obtained from the Transplantation Center database.
   RESULTS: Compared with a reference general population, the liver transplant recipients showed significantly worse HRQoL scores for all SF-36 domains (p <0.05). However, scores improved postoperatively in subsequent years. Patients living for more than 10 years postoperatively showed significant improvements in health status. Despite aging and reductions in somatic function and physical activity, the long-term survivors showed their mental health scores improved, indicating improved psychological conditions in patients.
   CONCLUSION: Liver transplant recipients demonstrated gradual HRQoL development. Patients living for more than 10 years postoperatively showed high mental health scores, suggesting improvement in their psychological condition.
C1 [Lai, Li; Cui, Jinbo; Li, Jiping] Sichuan Univ, West China Sch Nursing, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China.
   [Lai, Li] Chengdu Med Coll, Sch Nursing, Chengdu, Peoples R China.
   [Luo, Yanli; Cui, Jinbo; Yang, Xiaoling] Sichuan Univ, West China Hosp, Liver Transplant Ctr, Chengdu, Peoples R China.
   [Hu, Zhonghua] Chengdu Univ Tradit Chinese Med, Sch Nursing, Chengdu, Peoples R China.
   [Li, Jiping] Sichuan Univ, West China Hosp, Nursing Dept, Chengdu, Peoples R China.
C3 Sichuan University; Chengdu Medical College; Sichuan University; Chengdu
   University of Traditional Chinese Medicine; Sichuan University
RP Li, JP (corresponding author), Sichuan Univ, West China Sch Nursing, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China.
EM jp-li@163.com
RI yang, xiao/HJI-7815-2023; Hu, Zhonghua/F-9493-2014
CR Bucuvalas JC, 2005, CURR OPIN ORGAN TRAN, V10, P77, DOI 10.1097/01.mot.0000163043.71825.cf
   Bucuvalas JC, 2006, J PEDIATR GASTR NUTR, V43, pS41, DOI 10.1097/01.mpg.0000226389.64236.dc
   De Bona M, 2000, J HEPATOL, V33, P609, DOI 10.1034/j.1600-0641.2000.033004609.x
   Jacobsen PB, 2002, J CONSULT CLIN PSYCH, V70, P235, DOI 10.1037//0022-006X.70.1.235
   Jia J, 2016, CHINESE J TRANSPLANT, V10, P141
   Lai L, 2010, CHINESE J NURSING, V45, P401
   Li X., 2001, J W CHINA MED U, V32, P43
   Liu YB, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/973069
   Starzl TE, 2012, NAT MED, V18, P1489, DOI 10.1038/nm.2927
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Whiting JF, 1999, J SURG OUTCOMES, V2, P21
   Zeng K, 2017, ORGAN TRANSPLANTATIO, V8, P106
NR 12
TC 0
Z9 0
U1 1
U2 11
PU SCI PRINTERS & PUBL INC
PI ST LOUIS
PA PO DRAWER 12425 8342 OLIVE BLVD, ST LOUIS, MO 63132 USA
SN 0884-6812
J9 ANAL QUANT CYTOPATHO
JI Anal. Quant. Cytopathol. Histopathol.
PD APR
PY 2020
VL 42
IS 2
BP 42
EP 48
PG 7
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA MK0XD
UT WOS:000548509900002
DA 2024-02-19
ER

PT J
AU Wu, JL
   Wu, QP
   Yang, XF
   Wei, MK
   Zhang, JM
   Huang, Q
   Zhou, XY
AF Wu, J. -L.
   Wu, Q. -P.
   Yang, X. -F.
   Wei, M. -K.
   Zhang, J. -M.
   Huang, Q.
   Zhou, X. -Y.
TI L-malate reverses oxidative stress and antioxidative defenses in liver
   and heart of aged rats
SO PHYSIOLOGICAL RESEARCH
LA English
DT Article
DE antioxidative defense system; glutathione peroxidase; L-malate;
   mitochondria; reactive oxygen species
ID TRANSPORT CHAIN COMPLEXES; LIPID-PEROXIDATION; LIPOIC ACID;
   SUPEROXIDE-DISMUTASE; SKELETAL-MUSCLE; L-CARNITINE; OLD RATS;
   GLUTATHIONE; METABOLISM; EXERCISE
AB The intracellular levels of antioxidant and free radical scavenging enzymes are gradually altered during the aging process. An age-dependent increase of oxidative stress occurring throughout the lifetime is hypothesized to be the major cause of aging. The current study examined the effects of L-malate on oxidative stress and antioxidative defenses in the liver and heart of aged rats. Sprague-Dawley male rats were randomly divided into four groups, each group consisting of 6 animals. Group Ia and Group IIa were young and aged control rats. Group Ib and Group IIb were young and aged rats treated with L-malate (210 mg/kg body weight per day). L-malate was orally administrated via intragastric canula for 30 days, then the rats were sacrificed and the liver and heart were removed to determine the oxidant production, lipid peroxidation and antioxidative defenses of young and aged rats. Dietary L-malate reduced the accumulation of reactive oxygen species (ROS) and significantly decreased the level of lipid peroxidation in the liver and heart of the aged rats. Accordingly, L-malate was found to enhance the antioxidative defense system with an increased activity of antioxidant enzymes, such as superoxide dismutase (SOD) and glutathione peroxidase (GPx) and increased glutathione (GSH) levels in the liver of aged rats, a phenomenon not observed in the heart of aged rats. Our data indicate that oxidative stress was reversed and the antioxidative defense system was strengthened by dietary supplementation with L-malate.
C1 [Wu, J. -L.; Wu, Q. -P.; Wei, M. -K.; Zhang, J. -M.; Zhou, X. -Y.] Guangdong Inst Microbiol, Guangzhou 510070, Guangdong, Peoples R China.
   [Wu, J. -L.] Chinese Acad Sci, S China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.
   [Yang, X. -F.; Huang, Q.] Ctr Dis Control & Prevent Guangdong Prov, Dept Toxicol, Guangzhou, Guangdong, Peoples R China.
   [Wu, J. -L.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China.
C3 Guangdong Academy of Sciences; Institute of Microbiology, Guangdong
   Academy of Sciences; Chinese Academy of Sciences; South China Sea
   Institute of Oceanology, CAS; Chinese Academy of Sciences; University of
   Chinese Academy of Sciences, CAS
RP Wu, QP (corresponding author), Guangdong Inst Microbiol, Guangzhou 510070, Guangdong, Peoples R China.
EM wuqp@gdas.ac.cn
CR Acharya UR, 2004, ENVIRON TOXICOL PHAR, V17, P117, DOI 10.1016/j.etap.2004.02.005
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   Bendahan D, 2002, BRIT J SPORT MED, V36, P282, DOI 10.1136/bjsm.36.4.282
   BOBYLEVAGUARRIERO V, 1986, ARCH BIOCHEM BIOPHYS, V245, P477, DOI 10.1016/0003-9861(86)90240-7
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163
   CLARK MG, 1978, J MOL CELL CARDIOL, V10, P1101, DOI 10.1016/0022-2828(78)90355-3
   Diaz G, 2003, HISTOCHEM CELL BIOL, V120, P319, DOI 10.1007/s00418-003-0566-8
   DURAK I, 1993, CLIN CHIM ACTA, V214, P103, DOI 10.1016/0009-8981(93)90307-P
   Fiebig R, 1996, AGE, V19, P83, DOI 10.1007/BF02434087
   Hagen TM, 1999, FASEB J, V13, P411, DOI 10.1096/fasebj.13.2.411
   Hagen TM, 2002, P NATL ACAD SCI USA, V99, P7184
   HARMAN D, 1993, DRUG AGING, V3, P60, DOI 10.2165/00002512-199303010-00006
   Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1
   Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   Husain K, 2001, ALCOHOL, V25, P89, DOI 10.1016/S0741-8329(01)00176-8
   Ji LL, 1998, ANN NY ACAD SCI, V854, P102, DOI 10.1111/j.1749-6632.1998.tb09896.x
   Kabuto H, 2003, ENVIRON RES, V93, P31, DOI 10.1016/S0013-9351(03)00062-8
   Kalaiselvi T, 1998, J NUTR BIOCHEM, V9, P575, DOI 10.1016/S0955-2863(98)00052-7
   KOHL C, 1995, CHEM-BIOL INTERACT, V97, P175, DOI 10.1016/0009-2797(95)03614-R
   Kumaran S, 2004, CHEM-BIOL INTERACT, V148, P11, DOI 10.1016/j.cbi.2003.10.010
   LOEPER J, 1983, IRCS MED SCI-BIOCHEM, V11, P1034
   MACHADO A, 1991, ARCH GERONTOL GERIAT, V12, P187, DOI 10.1016/0167-4943(91)90027-N
   MASORO EJ, 1958, J BIOL CHEM, V231, P347
   Moldeus P, 1978, Methods Enzymol, V52, P60
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   Mosoni L, 2004, EXP GERONTOL, V39, P203, DOI 10.1016/j.exger.2003.10.014
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   ROMANOVICH EA, 1975, VOP MED KHIM, V21, P131
   Sandhu SK, 2003, BIOGERONTOLOGY, V4, P19, DOI 10.1023/A:1022473219044
   Savitha S, 2005, CLIN CHIM ACTA, V355, P173, DOI 10.1016/j.cccn.2004.12.005
   SAZUKA Y, 1989, JPN J CANCER RES, V80, P89, DOI 10.1111/j.1349-7006.1989.tb02250.x
   Schönau W, 2000, JAHRB INT GERMAN, V32, P10
   Schuessel K, 2006, FREE RADICAL BIO MED, V40, P850, DOI 10.1016/j.freeradbiomed.2005.10.041
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   Sethumadhavan S, 2006, BIOGERONTOLOGY, V7, P101, DOI 10.1007/s10522-006-6497-8
   Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x
   SUN Y, 1988, CLIN CHEM, V34, P497
   Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X
   Veerappan RM, 2004, CLIN CHIM ACTA, V340, P207, DOI 10.1016/j.cccn.2003.11.004
   VORBECK ML, 1982, ARCH BIOCHEM BIOPHYS, V214, P67, DOI 10.1016/0003-9861(82)90009-1
   Walrand S, 2003, CLIN CHIM ACTA, V331, P103, DOI 10.1016/S0009-8981(03)00086-X
   WITTER RF, 1953, J BIOL CHEM, V200, P703
   Wu JL, 2007, PHYSIOL RES, V56, P213, DOI 10.33549/physiolres.930937
   YU PB, 1994, PHYSIOL REV, V74, P134
NR 48
TC 41
Z9 43
U1 1
U2 12
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PY 2008
VL 57
IS 2
BP 261
EP 268
DI 10.33549/physiolres.931161
PG 8
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 320YI
UT WOS:000257270700013
PM 17298203
OA gold
DA 2024-02-19
ER

PT J
AU Fox, JG
   Shen, Z
   Muthupalani, S
   Rogers, AR
   Kirchain, SM
   Dewhirst, FE
AF Fox, J. G.
   Shen, Z.
   Muthupalani, S.
   Rogers, A. R.
   Kirchain, S. M.
   Dewhirst, F. E.
TI Chronic Hepatitis, Hepatic Dysplasia, Fibrosis, and Biliary Hyperplasia
   in Hamsters Naturally Infected with a Novel Helicobacter Classified in
   the <i>H</i>. <i>bilis</i> Cluster
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID OPISTHORCHIS-VIVERRINI; SYRIAN-HAMSTERS; SPONTANEOUS TUMORS; COMMON
   DISEASES; SP-NOV; N-NITROSODIMETHYLAMINE; BACTERIAL-INFECTION;
   BOWEL-DISEASE; 2 COLONIES; 16S
AB We recently described helicobacter-associated progressive, proliferative, and dysplastic typhlocolitis in aging (18- to 24-month-old) Syrian hamsters. Other pathogens associated with typhlocolitis in hamsters, Clostridium difficile, Lawsonia intracellularis, and Giardia spp., were not indentified. The presence of Helicobacter genus-specific DNA was noted by PCR in cecal and paraffin-embedded liver samples from aged hamsters by the use of Helicobacter-specific PCR primers. By 16S rRNA analysis, the Helicobacter sp. isolated from the liver tissue was identical to the cecal isolates from hamsters. The six hamster 16S rRNA sequences form a genotypic cluster most closely related to Helicobacter sp. Flexispira taxon 8, part of the Helicobacter bilis/H. cinaedi group. Livers from aged helicobacter-infected hamsters showed various stages of predominantly portocentric and, to a lesser extent, perivenular fibrosis. Within nodules, there was cellular atypia consistent with nodular dysplasia. The livers also exhibited a range of chronic active portal/interface and lobular inflammation, with significant portal hepatitis being present. The inflammation was composed of a mixture of lymphocytes, neutrophils, and macrophages, indicative of its chronic-active nature in these aged hamsters infected with Helicobacter spp. The isolation of novel Helicobacter spp., their identification by PCR from the diseased livers of aged hamsters, and their taxonomic classification as belonging to the Helicobacter bilis cluster strengthen the argument that H. bilis and closely related Helicobacter spp. play an etiological role in hepatobiliary disease in both animals and humans.
C1 [Fox, J. G.; Shen, Z.; Muthupalani, S.; Rogers, A. R.; Kirchain, S. M.] MIT, Div Comparat Med, Cambridge, MA 02139 USA.
   [Dewhirst, F. E.] Forsyth Inst, Dept Mol Genet, Boston, MA 02115 USA.
C3 Massachusetts Institute of Technology (MIT); Harvard University; Forsyth
   Institute
RP Fox, JG (corresponding author), MIT, Div Comparat Med, 77 Massachusetts Ave,Bldg 16-825, Cambridge, MA 02139 USA.
EM jgfox@mit.edu
RI Muthupalani, Sureshkumar/C-7244-2015
OI Dewhirst, Floyd E./0000-0003-4427-7928
FU NIH [R01CA67529, P30ES102109, RR07036, DE016937]
FX This work was supported by NIH grants R01CA67529 (to J. G. F.),
   P30ES102109 (to J. G. F.), RR07036 (to J. G. F.), and DE016937 (to F. E.
   D.).
CR Boutin SR, 2005, INFECT IMMUN, V73, P8449, DOI 10.1128/IAI.73.12.8449-8452.2005
   Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997
   CHESTERMAN FC, 1965, BRIT J CANCER, V19, P802, DOI 10.1038/bjc.1965.92
   Cooper DM, 1997, INT J SYST BACTERIOL, V47, P635, DOI 10.1099/00207713-47-3-635
   Dewhirst FE, 2000, INT J SYST EVOL MICR, V50, P1781, DOI 10.1099/00207713-50-5-1781
   Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287
   Dewhirst FE, 2005, J BACTERIOL, V187, P6106, DOI 10.1128/JB.187.17.6106-6118.2005
   Diwan BA, 1997, TOXICOL PATHOL, V25, P597, DOI 10.1177/019262339702500610
   FLAVELL DJ, 1982, BRIT J CANCER, V46, P985, DOI 10.1038/bjc.1982.313
   FLAVELL DJ, 1983, CARCINOGENESIS, V4, P927, DOI 10.1093/carcin/4.7.927
   FOSTER JR, 1984, J COMP PATHOL, V94, P175, DOI 10.1016/0021-9975(84)90038-0
   Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X
   Fox JG, 2002, GUT, V50, P273, DOI 10.1136/gut.50.2.273
   Fox JG, 2004, COMPARATIVE MED, V54, P571
   FOX JG, 1995, J CLIN MICROBIOL, V33, P445, DOI 10.1128/JCM.33.2.445-454.1995
   FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994
   Franklin CL, 1996, J CLIN MICROBIOL, V34, P2952, DOI 10.1128/JCM.34.12.2952-2958.1996
   Franklin CL, 1998, LAB ANIM SCI, V48, P334
   Garcia A, 2008, INFECT IMMUN, V76, P1866, DOI 10.1128/IAI.01044-07
   Hailey JR, 1998, TOXICOL PATHOL, V26, P602, DOI 10.1177/019262339802600503
   Haines DC, 1998, VET PATHOL, V35, P202, DOI 10.1177/030098589803500305
   Hänninen ML, 2005, INT J SYST EVOL MICR, V55, P891, DOI 10.1099/ijs.0.63245-0
   International Agency for Research on Cancer (IARC), 1994, IARC MON EV CARC RIS
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   JACOBY RO, 1981, ADV EXP MED BIOL, V34, P267
   Jukes T. H., 1969, MAMMALIAN PROTEIN ME, V3, P21, DOI [DOI 10.1016/B978-1-4832-3211-9.50009-7, DOI 10.1093/BIOINFORMATICS/BTM404]
   Maggio-Price L, 2002, AM J PATHOL, V160, P739, DOI 10.1016/S0002-9440(10)64894-8
   Matsukura N, 2002, JPN J CANCER RES, V93, P842, DOI 10.1111/j.1349-7006.2002.tb01327.x
   Maurer KJ, 2005, GASTROENTEROLOGY, V128, P1023, DOI 10.1053/j.gastro.2005.01.008
   Mitacek EJ, 1999, FOOD CHEM TOXICOL, V37, P297, DOI 10.1016/S0278-6915(99)00017-4
   Nambiar PR, 2006, VET PATHOL, V43, P2, DOI 10.1354/vp.43-1-2
   OHSHIMA H, 1994, CARCINOGENESIS, V15, P271, DOI 10.1093/carcin/15.2.271
   PASTER BJ, 1988, INT J SYST BACTERIOL, V38, P56, DOI 10.1099/00207713-38-1-56
   Pinlaor S, 2004, CARCINOGENESIS, V25, P1535, DOI 10.1093/carcin/bgh157
   Pisani P, 2008, CLIN VACCINE IMMUNOL, V15, P1363, DOI 10.1128/CVI.00132-08
   POUR P, 1976, J NATL CANCER I, V56, P937, DOI 10.1093/jnci/56.5.937
   POUR P, 1976, J NATL CANCER I, V56, P931, DOI 10.1093/jnci/56.5.931
   POUR P, 1979, J NATL CANCER I, V63, P797, DOI 10.1093/jnci/63.3.797
   Rogers AB, 2004, TOXICOL PATHOL, V32, P668, DOI 10.1080/01926230490524247
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Shen ZL, 2000, HELICOBACTER, V5, P121, DOI 10.1046/j.1523-5378.2000.00019.x
   Shomer NH, 2001, EXP BIOL MED, V226, P420, DOI 10.1177/153537020122600505
   SRIANUJATA S, 1987, RELEVANCE N NITROSO, P544
   SRIVATANAKUL P, 1991, INT J CANCER, V48, P821, DOI 10.1002/ijc.2910480606
   Tee W, 1998, J CLIN MICROBIOL, V36, P1679, DOI 10.1128/JCM.36.6.1679-1682.1998
   THAMAVIT W, 1978, CANCER RES, V38, P4634
   THAMAVIT W, 1988, JPN J CANCER RES, V79, P909, DOI 10.1111/j.1349-7006.1988.tb00054.x
   THAMAVIT W, 1987, VIRCHOWS ARCH B, V54, P52, DOI 10.1007/BF02899196
   Weir S, 1999, J CLIN MICROBIOL, V37, P2439, DOI 10.1128/JCM.37.8.2439-2445.1999
   Whary MT, 2004, COMPARATIVE MED, V54, P128
   Zhang L, 2006, J CLIN MICROBIOL, V44, P2276, DOI 10.1128/JCM.02017-05
   Zhao XY, 2008, PATHOL INT, V58, P580, DOI 10.1111/j.1440-1827.2008.02274.x
NR 52
TC 30
Z9 30
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 2009
VL 47
IS 11
BP 3673
EP 3681
DI 10.1128/JCM.00879-09
PG 9
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 514CZ
UT WOS:000271373000043
PM 19759229
OA Green Published
DA 2024-02-19
ER

PT J
AU Morr, AS
   Herthum, H
   Schrank, F
   Görner, S
   Anders, MS
   Lerchbaumer, M
   Müller, HP
   Fischer, T
   Jenderka, KV
   Hansen, HHG
   Janmey, PA
   Braun, J
   Sack, I
   Tzschätzsch, H
AF Morr, Anna S.
   Herthum, Helge
   Schrank, Felix
   Goerner, Steffen
   Anders, Matthias S.
   Lerchbaumer, Markus
   Mueller, Hans-Peter
   Fischer, Thomas
   Jenderka, Klaus-Vitold
   Hansen, Hendrik H. G.
   Janmey, Paul A.
   Braun, Juergen
   Sack, Ingolf
   Tzschatzsch, Heiko
TI Liquid-Liver Phantom Mimicking the Viscoelastic Dispersion of Human
   Liver for Ultrasound- and MRI-Based Elastography
SO INVESTIGATIVE RADIOLOGY
LA English
DT Article
DE elastography; phantom; viscoelasticity; shear wave dispersion; shear
   modulus; shear viscosity; ultrasound elastography; magnetic resonance
   elastography; liver
ID MAGNETIC-RESONANCE ELASTOGRAPHY; TISSUE; STIFFNESS
AB Objectives Tissue stiffness can guide medical diagnoses and is exploited as an imaging contrast in elastography. However, different elastography devices show different liver stiffness values in the same subject, hindering comparison of values and establishment of system-independent thresholds for disease detection. There is a need for standardized phantoms that specifically address the viscosity-related dispersion of stiffness over frequency. To improve standardization of clinical elastography across devices and platforms including ultrasound and magnetic resonance imaging (MRI), a comprehensively characterized phantom is introduced that mimics the dispersion of stiffness of the human liver and can be generated reproducibly. Materials and Methods The phantom was made of linear polymerized polyacrylamide (PAAm) calibrated to the viscoelastic properties of healthy human liver in vivo as reported in the literature. Stiffness dispersion was analyzed using the 2-parameter springpot model fitted to the dispersion of shear wave speed of PAAm, which was measured by shear rheometry, ultrasound-based time-harmonic elastography, clinical magnetic resonance elastography (MRE), and tabletop MRE in the frequency range of 5 to 3000 Hz. Imaging parameters for ultrasound and MRI, reproducibility, aging behavior, and temperature dependency were assessed. In addition, the frequency bandwidth of shear wave speed of clinical elastography methods (Aplio i900, Canon; Acuson Sequoia, Siemens; FibroScan, EchoSense) was characterized. Results Within the entire frequency range analyzed in this study, the PAAm phantom reproduced well the stiffness dispersion of human liver in vivo despite its fluid properties under static loading (springpot stiffness parameter, 2.14 [95% confidence interval, 2.08-2.19] kPa; springpot powerlaw exponent, 0.367 [95% confidence interval, 0.362-0.373]). Imaging parameters were close to those of liver in vivo with only slight variability in stiffness values of 0.5% (0.4%, 0.6%), 4.1% (3.9%, 4.5%), and -0.63% (-0.67%, -0.58%), respectively, between batches, over a 6-month period, and per degrees C increase in temperature. Conclusions The liquid-liver phantom has useful properties for standardization and development of liver elastography. First, it can be used across clinical and experimental elastography devices in ultrasound and MRI. Second, being a liquid, it can easily be adapted in size and shape to specific technical requirements, and by adding inclusions and scatterers. Finally, because the phantom is based on noncrosslinked linear PAAm constituents, it is easy to produce, indicating potential widespread use among researchers and vendors to standardize liver stiffness measurements.
C1 [Morr, Anna S.; Herthum, Helge; Schrank, Felix; Goerner, Steffen; Anders, Matthias S.; Lerchbaumer, Markus; Mueller, Hans-Peter; Fischer, Thomas; Sack, Ingolf; Tzschatzsch, Heiko] Charite Univ Med Berlin, Dept Radiol, Charitepl 1, D-10117 Berlin, Germany.
   [Herthum, Helge; Braun, Juergen] Charite Univ Med Berlin, Inst Med Informat, Berlin, Germany.
   [Herthum, Helge; Braun, Juergen] Free Univ Berlin, Berlin, Germany.
   [Herthum, Helge; Braun, Juergen] Free Univ Berlin, Berlin, Germany.
   [Herthum, Helge; Braun, Juergen] Humboldt Univ, Berlin, Germany.
   [Jenderka, Klaus-Vitold] Univ Appl Sci Merseburg, Dept Engn & Nat Sci, Merseburg, Germany.
   [Hansen, Hendrik H. G.] Radboud Univ Nijmegen, Dept Med Imaging, Med Ultrasound Imaging Ctr, Med Ctr, Nijmegen, Netherlands.
   [Janmey, Paul A.] Univ Penn, Ctr Engn Mech, Inst Med & Engn, Philadelphia, PA 19104 USA.
   [Janmey, Paul A.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.
C3 Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin; Free
   University of Berlin; Free University of Berlin; Humboldt University of
   Berlin; Radboud University Nijmegen; University of Pennsylvania;
   University of Pennsylvania
RP Sack, I (corresponding author), Charite Univ Med Berlin, Dept Radiol, Charitepl 1, D-10117 Berlin, Germany.
EM anna-sophie.morr@charite.de; helge.herthum@charite.de;
   felix.schrank@charite.de; steffen.goerner@charite.de;
   matthias-stephan.anders@charite.de; markus.lerchbaumer@charite.de;
   hans_peter.mueller@charite.de; thom.fischer@charite.de;
   klaus.jenderka@hs-merseburg.de; Rik.Hansen@radboudumc.nl;
   janmey@pennmedicine.upenn.edu; juergen.braun@charite.de;
   ingolf.sack@charite.de; heiko.tzschaetzsch@charite.de
RI Hansen, Hendrik/C-1087-2012; Herthum, Helge/JGL-8198-2023; Braun,
   Jochen/F-1370-2013; Mueller, Hans/JYQ-4388-2024
OI Hansen, Hendrik/0000-0001-5860-8981; Braun, Jochen/0000-0002-8886-078X;
   Braun, Jurgen/0000-0001-5183-7546; Herthum, Helge/0000-0001-6494-0833;
   Tzschatzsch, Heiko/0000-0001-9458-2221; Muller, Hans
   Peter/0000-0002-8016-0631
FU Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [SFB
   1340, BIOQIC GRK2260]
FX Funding from the Deutsche Forschungsgemeinschaft (DFG, German Research
   Foundation, SFB 1340 and BIOQIC GRK2260) is gratefully acknowledged.
CR Asbach P, 2020, INVEST RADIOL, V55, P524, DOI 10.1097/RLI.0000000000000685
   Bertalan G, 2019, MAGN RESON MED, V81, P2676, DOI 10.1002/mrm.27586
   Braun J, 2018, MAGN RESON MED, V79, P470, DOI 10.1002/mrm.26659
   Brown TE, 2018, BIOMATERIALS, V178, P496, DOI 10.1016/j.biomaterials.2018.03.060
   Burkhardt C, 2020, INVEST RADIOL, V55, P270, DOI 10.1097/RLI.0000000000000638
   Cafarelli A, 2017, ACTA BIOMATER, V49, P368, DOI 10.1016/j.actbio.2016.11.049
   Charrier EE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02906-9
   Chatelin S, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.577358
   Chaudhuri O, 2020, NATURE, V584, P535, DOI 10.1038/s41586-020-2612-2
   Chen SG, 2013, RADIOLOGY, V266, P964, DOI 10.1148/radiol.12120837
   Choi YR, 2013, INVEST RADIOL, V48, P607, DOI 10.1097/RLI.0b013e318289ff8f
   Dietrich CF, 2017, ULTRASCHALL MED, V38, pE16, DOI 10.1055/s-0043-103952
   Dirrichs T, 2019, INVEST RADIOL, V54, P719, DOI 10.1097/RLI.0000000000000602
   Dittmann F, 2016, MAGN RESON MED, V76, P1116, DOI 10.1002/mrm.26006
   Garczynska K, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.696304
   Garra B., 2019, QIBA PROFILE ULTRASO
   Gilligan LA, 2020, INVEST RADIOL, V55, P191, DOI 10.1097/RLI.0000000000000627
   Guo J, 2015, INVEST RADIOL, V50, P347, DOI 10.1097/RLI.0000000000000136
   Hall TJ, 2013, IEEE INT ULTRA SYM, P397, DOI 10.1109/ULTSYM.2013.0103
   Herthum H, 2021, ACTA BIOMATER, V121, P393, DOI 10.1016/j.actbio.2020.12.027
   Jordan JEL, 2022, MAGN RESON MED, V87, P1435, DOI 10.1002/mrm.29066
   Kapetas P, 2019, INVEST RADIOL, V54, P257, DOI 10.1097/RLI.0000000000000543
   Klatt D, 2006, INVEST RADIOL, V41, P841, DOI 10.1097/01.rli.0000244341.16372.08
   Klatt D, 2010, BIORHEOLOGY, V47, P133, DOI 10.3233/BIR-2010-0565
   Kreft B, 2022, INVEST RADIOL, V57, P77, DOI 10.1097/RLI.0000000000000817
   Lefebvre PM, 2016, IEEE ENG MED BIO, P1216, DOI 10.1109/EMBC.2016.7590924
   Li CH, 2011, OPT EXPRESS, V19, P10153, DOI 10.1364/OE.19.010153
   Madsen EL, 2005, PHYS MED BIOL, V50, P5597, DOI 10.1088/0031-9155/50/23/013
   Garcia SMR, 2020, INVEST RADIOL, V55, P769, DOI 10.1097/RLI.0000000000000704
   McIlvain G, 2019, J MECH BEHAV BIOMED, V97, P65, DOI 10.1016/j.jmbbm.2019.05.001
   Muller M, 2009, ULTRASOUND MED BIOL, V35, P219, DOI 10.1016/j.ultrasmedbio.2008.08.018
   Murphy MC, 2020, INVEST RADIOL, V55, P200, DOI 10.1097/RLI.0000000000000630
   Nguyen MM, 2014, ULTRASOUND MED BIOL, V40, P168, DOI 10.1016/j.ultrasmedbio.2013.08.020
   Nightingale KR, 2015, IEEE T ULTRASON FERR, V62, P165, DOI 10.1109/TUFFC.2014.006653
   Okamoto RJ, 2011, PHYS MED BIOL, V56, P6379, DOI 10.1088/0031-9155/56/19/014
   Palmeri ML, 2021, J ULTRAS MED, V40, P569, DOI 10.1002/jum.15609
   Reiter R, 2020, EUR RADIOL, V30, P1719, DOI 10.1007/s00330-019-06471-7
   Sack I, 2013, SOFT MATTER, V9, P5672, DOI 10.1039/c3sm50552a
   Schaafs LA, 2019, INVEST RADIOL, V54, P675, DOI 10.1097/RLI.0000000000000590
   Schrank F., 2017, 1 INT MRE WORKSHOP 1
   Solamen LM, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aacb08
   Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605
   Tzschätzsch H, 2016, MED IMAGE ANAL, V30, P1, DOI 10.1016/j.media.2016.01.001
   Tzschätzsch H, 2016, ULTRASOUND MED BIOL, V42, P2562, DOI 10.1016/j.ultrasmedbio.2016.07.004
   Usumura M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250667
   Zampini MA, 2021, J MECH BEHAV BIOMED, V120, DOI 10.1016/j.jmbbm.2021.104587
NR 46
TC 11
Z9 10
U1 4
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0020-9996
EI 1536-0210
J9 INVEST RADIOL
JI Invest. Radiol.
PD AUG
PY 2022
VL 57
IS 8
BP 502
EP 509
DI 10.1097/RLI.0000000000000862
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA 2R6BA
UT WOS:000821194200002
PM 35195086
DA 2024-02-19
ER

PT J
AU Hong, Y
   Dong, H
   Zhou, J
   Luo, Y
   Yuan, MM
   Zhan, JF
   Liu, YL
   Xia, JY
   Zhang, L
AF Hong, Yang
   Dong, Han
   Zhou, Jing
   Luo, Ya
   Yuan, Ming-Ming
   Zhan, Jia-Fei
   Liu, Yang-Lu M.
   Xia, Jie-Ying M.
   Zhang, Lei M.
TI Aged gut microbiota contribute to different changes in antioxidant
   defense in the heart and liver after transfer to germ-free mice
SO PLOS ONE
LA English
DT Article
ID OXIDATIVE STRESS; CAPACITY; ENZYMES; RAT
AB Age-associated impairment in antioxidant defense is an important cause of oxidative stress, and elderly individuals are usually associated with gut microbiota (GM) changes. Studies have suggested a potential relationship between the GM and changes in antioxidant defense in aging animals. Direct evidence regarding the impact of aging-associated shifts in GM on the antioxidant defense is lacking. The heart is a kind of postmitotic tissue, which is more prone to oxidative stress than the liver (mitotic tissue). To test and compare the influence of an aged GM on antioxidant defense changes in the heart and liver of the host, in this study, GM from young adolescent (5 weeks) or aged (20 months) mice was transferred to young adolescent (5 weeks) germ-free (GF) mice (N = 5 per group) by fecal microbiota transplantation (FMT). Four weeks after the first FMT was performed, fecal samples were collected for 16S rRNA sequencing. Blood, heart and liver samples were harvested for oxidative stress marker and antioxidant defense analysis. The results showed that mice that received young or aged microbiota showed clear differences in GM composition and diversity. Mice that received aged microbiota had a lower ratio of Bacteroidetes/Firmicutes in GM at the phylum level and an increased relative abundance of four GM genera: Akkermansia, Dubosiella, Alistipes and Rikenellaceae_RC9_gut_group. In addition, GM & alpha;-diversity scores based on the Shannon index and Simpson index were significantly higher in aged GM-treated mice. Oxidative stress marker and antioxidant defense tests showed that FMT from aged donors did not have a significant influence on malondialdehyde content in serum, heart and liver. However, the capacity of anti-hydroxyl radicals in the heart and liver, as well as the capacity of anti-superoxide anions in the liver, were significantly increased in mice with aged microbiota. FMT from aged donors increased the activities of Cu/Zn superoxide SOD (Cu/Zn-SOD), catalase (CAT) and glutathione-S-transferase in the heart, as well as the activity of Cu/Zn-SOD in the liver. Positive correlations were found between Cu/Zn-SOD activity and radical scavenging capacities. On the other hand, glutathione reductase activity and glutathione content in the liver were decreased in mice that received aged GM. These findings suggest that aged GM transplantation from hosts is sufficient to influence the antioxidant defense system of young adolescent recipients in an organ-dependent manner, which highlights the importance of the GM in the aging process of the host.
C1 [Hong, Yang; Dong, Han; Zhou, Jing; Luo, Ya; Yuan, Ming-Ming; Zhan, Jia-Fei; Liu, Yang-Lu M.; Xia, Jie-Ying M.; Zhang, Lei M.] Sichuan Acad Tradit Chinese Med Sci, Anim Expt Ctr, Chengdu, Peoples R China.
RP Zhang, L (corresponding author), Sichuan Acad Tradit Chinese Med Sci, Anim Expt Ctr, Chengdu, Peoples R China.
EM leizhangTCM@163.com
FU Sichuan Provincial Science and Technology Plan Project [2022YFS0432];
   Basic Research Project of Sichuan Province [2022JDKY0013]; Scientific
   and Technical Research Project of Sichuan Provincial Administration of
   TCM [2023MS485]
FX This research was financially supported by the Sichuan Provincial
   Science and Technology Plan Project (2022YFS0432), Basic Research
   Project of Sichuan Province (2022JDKY0013), Scientific and Technical
   Research Project of Sichuan Provincial Administration of TCM
   (2023MS485). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Bezek K, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092695
   Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]
   Brunt VE, 2019, J PHYSIOL-LONDON, V597, P2361, DOI 10.1113/JP277336
   Burz SD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45173-4
   Carbone MC, 2003, MOL HUM REPROD, V9, P639, DOI 10.1093/molehr/gag090
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P187, DOI 10.1016/0047-6374(92)90035-C
   CEBALLOSPICOT I, 1992, MUTAT RES, V275, P281, DOI 10.1016/0921-8734(92)90032-K
   Chen DC, 2015, FISH SHELLFISH IMMUN, V44, P12, DOI 10.1016/j.fsi.2015.01.014
   Chen HY, 2022, EXP GERONTOL, V163, DOI 10.1016/j.exger.2022.111769
   Cheng Ju-E, 2022, PLoS One, V17, pe0262517, DOI 10.1371/journal.pone.0262517
   de La Cuesta-Zuluag J, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00261-19
   DeJong EN, 2020, CELL HOST MICROBE, V28, P180, DOI 10.1016/j.chom.2020.07.013
   Fransen F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01385
   Frolinger T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39994-6
   Fu Q, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.965653
   Guo X, 2022, PHYTOMEDICINE, V104, DOI 10.1016/j.phymed.2022.154270
   Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387
   Ikeda Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/210934
   Jia QJ, 2019, J CELL MOL MED, V23, P2314, DOI 10.1111/jcmm.14164
   Jiang WD, 2013, AQUACULT NUTR, V19, P45, DOI 10.1111/j.1365-2095.2011.00934.x
   Kabanov DS, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6043245
   KARLSSON A, 1995, INFECT IMMUN, V63, P4606, DOI 10.1128/IAI.63.12.4606-4612.1995
   Khannous-Lleiffe O, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9030641
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Lange Maximo E, 2019, Curr Protoc Mouse Biol, V9, pe59, DOI 10.1002/cpmo.59
   Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9
   Lee J, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1814107
   Leite G, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109765
   Li XA, 2021, PHARMACOL RES, V168, DOI 10.1016/j.phrs.2021.105587
   Li YL, 2020, AGING-US, V12, P7801, DOI 10.18632/aging.103093
   Li YJ, 2010, ACTA PHARMACOL SIN, V31, P560, DOI 10.1038/aps.2010.31
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Liu TH, 2023, FRONT ENDOCRINOL, V14, DOI 10.3389/fendo.2023.1133167
   Liu XL, 2021, FOOD FUNCT, V12, P12142, DOI [10.1039/d1fo01349a, 10.1039/D1FO01349A]
   Lora J, 2004, EUR J BIOCHEM, V271, P4298, DOI 10.1111/j.1432-1033.2004.04370.x
   Lushchak VI, 2001, AM J PHYSIOL-REG I, V280, pR100, DOI 10.1152/ajpregu.2001.280.1.R100
   Maynard C, 2018, SUBCELL BIOCHEM, V90, P351, DOI 10.1007/978-981-13-2835-0_12
   Meng C, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0265430
   Nielsen CC, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105881
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   SAWADA M, 1992, J CELL BIOCHEM, V48, P296, DOI 10.1002/jcb.240480310
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   Studer N, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00191
   Vardi N, 2008, FOOD CHEM TOXICOL, V46, P3015, DOI 10.1016/j.fct.2008.05.039
   Xu H, 2021, FOOD SCI NUTR, V9, P367, DOI 10.1002/fsn3.2002
   Yoon K, 2021, J NEUROGASTROENTEROL, V27, P314, DOI 10.5056/jnm20208
   Zhang J, 2017, J DAIRY SCI, V100, P6025, DOI 10.3168/jds.2016-12480
NR 47
TC 1
Z9 1
U1 4
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 11
PY 2023
VL 18
IS 8
AR e0289892
DI 10.1371/journal.pone.0289892
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA P6IZ3
UT WOS:001051705700018
PM 37566569
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Lima, IOL
   Peres, WAF
   Cruz, S
   Ramalho, A
AF Lima, I. O. L.
   Peres, W. A. F.
   Cruz, S.
   Ramalho, A.
TI Association of Ischemic Cardiovascular Disease with Inadequacy of Liver
   Store of Retinol in Elderly Individuals
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID CAUSE-SPECIFIC MORTALITY; VITAMIN-A-DEFICIENCY; ALL-CAUSE; PNPLA3;
   PLASMA; SEVERITY; OBESITY; RISK; GENE
AB Objective. Vitamin A antioxidant role has an important relationship with the metabolic processes of aging and cardiovascular disease (CVD). This study aimed at assessing the liver store of retinol in elderly individuals who died from cardiovascular disease and its relationship with liver weight and body weight. Methods and Results. This is a cross-sectional study conducted in necropsied individuals, aged 60 years or over, until 48 hours postmortem. The study assessed 65 elderly individuals who died from ischemic heart diseases (G1), cerebrovascular diseases (G2), other forms of heart disease (G3), or infectious heart diseases (G4). Twenty percent had inadequate liver store of retinol. G1 showed lower median of liver store of retinol when compared to G3 (p < 0.001), and G3 showed the highest median when compared to G2 (p = 0.007). A significant association was observed between inadequate liver store of retinol and death by ischemic CVD (G1) (p = 0.001) with an odds ratio of 10.38. It was observed that individuals with higher body weight and liver weight showed lower liver store of retinol with significant differences (p = 0.027 and p = 0.026). Conclusion. Ischemic CVD and increased body weight and liver weight are related to a greater impairment of the liver store of retinol.
C1 [Lima, I. O. L.] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
   [Peres, W. A. F.; Cruz, S.; Ramalho, A.] NPqM UFRJ, Rio De Janeiro, RJ, Brazil.
C3 Universidade Federal do Rio de Janeiro
RP Cruz, S (corresponding author), NPqM UFRJ, Rio De Janeiro, RJ, Brazil.
EM sabrina.cruz.ufrj@gmail.com
OI Pereira da Cruz, Sabrina/0000-0003-1945-1672; ,
   Wilza/0000-0003-0269-5363
CR ABESO Associacao Brasileira para o Estudo de Obesidade e Sindrome Metabolica, 2015, MAP OB
   Aikawa M, 2004, CARDIOVASC PATHOL, V13, P125, DOI 10.1016/S1054-8807(04)00004-3
   Amann PM, 2011, CURR MED CHEM, V18, P1405
   [Anonymous], 2015, PESQ NAC SAUD 2013 P
   Araujo Marina Campos, 2013, Rev Saude Publica, V47 Suppl 1, p177S, DOI 10.1590/S0034-89102013000700004
   Bento C., 2013, THESIS
   BRASIL. Ministerio da Saude, 2010, DATASUS INF SAUD MIN
   Chaimowicz F., 2013, SAUDE DO IDOSO
   Chaves GV, 2014, OBES SURG, V24, P219, DOI 10.1007/s11695-013-1087-8
   Chen W, 2014, J CLIN MED, V3, P453, DOI 10.3390/jcm3020453
   de la Grandmaison GL, 2001, FORENSIC SCI INT, V119, P149, DOI 10.1016/S0379-0738(00)00401-1
   Desai CK, 2014, CLIN CARDIOL, V37, P576, DOI 10.1002/clc.22299
   Di Costanzo A, 2017, ATHEROSCLEROSIS, V257, P232, DOI 10.1016/j.atherosclerosis.2016.12.018
   FLORES H, 1988, INT J VITAM NUTR RES, V58, P276
   García OP, 2012, P NUTR SOC, V71, P290, DOI 10.1017/S0029665112000079
   Gey KF, 2010, ATHEROSCLEROSIS, V208, P270, DOI 10.1016/j.atherosclerosis.2009.07.018
   HESS D, 1991, INT J VITAM NUTR RES, V61, P232
   HOPPNER K, 1968, CAN MED ASSOC J, V99, P983
   Jeyakumar SM, 2015, INDIAN J MED RES, V141, P275, DOI 10.4103/0971-5916.156554
   Koh WP, 2011, NUTR METAB CARDIOVAS, V21, P685, DOI 10.1016/j.numecd.2009.12.005
   Kovarova M, 2015, J CLIN ENDOCR METAB, V100, pE1568, DOI 10.1210/jc.2015-2978
   Min KB, 2014, NUTR METAB CARDIOVAS, V24, P1197, DOI 10.1016/j.numecd.2014.06.004
   MITCHELL GV, 1973, AM J CLIN NUTR, V26, P992
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   OLSON JA, 1979, AM J CLIN NUTR, V32, P2500, DOI 10.1093/ajcn/32.12.2500
   Peres WAF, 2011, BRIT J NUTR, V106, P1724, DOI 10.1017/S0007114511002145
   Ramalho A, 2008, INT J FOOD SCI NUTR, V59, P202, DOI 10.1080/09637480701497311
   Reho JJ, 2017, CLIN SCI, V131, P1689, DOI 10.1042/CS20170219
   Riccioni G, 2008, ANN NUTR METAB, V53, P86, DOI 10.1159/000164691
   Riccioni G, 2009, EUR J CARDIOV PREV R, V16, P351, DOI 10.1097/HJR.0b013e328325d807
   Ross AC, 2012, AM J CLIN NUTR, V96, p1166S, DOI 10.3945/ajcn.112.034637
   Salameh H, 2016, J CLIN TRANSL HEPATO, V4, P175, DOI 10.14218/JCTH.2016.00009
   SBDCV. Sociedade Brasileira de Doencas Cerebrovasculares, 2016, DOENC CER
   SUNDBOOM J, 1984, EXP GERONTOL, V19, P257, DOI 10.1016/0531-5565(84)90021-4
   Tanumihardjo SA, 2011, AM J CLIN NUTR, V94, p658S, DOI 10.3945/ajcn.110.005777
   Tesoriere L, 1997, ARCH BIOCHEM BIOPHYS, V343, P13, DOI 10.1006/abbi.1997.0128
   Trépo E, 2016, J HEPATOL, V65, P399, DOI 10.1016/j.jhep.2016.03.011
   Vadgama DK, 2014, J INDIAN ACAD FORENS, V36, P238
   Walker GE, 2014, HORM MOL BIOL CLIN I, V19, P57, DOI 10.1515/hmbci-2014-0023
   World Health Organization, 1996, IND ASS VIT A DEF TH
   World Health Organization, 2015, International Statistical Classification of Diseases and Related Health Problems
   Wu JZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/615312
NR 42
TC 5
Z9 5
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2018
VL 2018
AR 9785231
DI 10.1155/2018/9785231
PG 6
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GD1RC
UT WOS:000430278000001
PM 29805732
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Liu, C
   Tseng, YP
   Chan, LP
   Liang, CH
AF Liu, Cheng
   Tseng, Ya-Ping
   Chan, Leong-Perng
   Liang, Chia-Hua
TI The potential of <i>Streptococcus thermophiles</i> (TCI633) in the
   anti-aging
SO JOURNAL OF COSMETIC DERMATOLOGY
LA English
DT Article; Early Access
DE anti-aging; skin; Streptococcus thermophiles
ID HYALURONIC-ACID PRODUCTION; DOUBLE-BLIND; SKIN HYDRATION; PROBIOTICS;
   HEALTH; SUPPLEMENTATION; MICROBIOTA; GUT
AB Background Streptococcus thermophilus (TCI633) is a probiotic that has been newly isolated from human breast milk, and it can produce hyaluronic acid (HA) when colonizing the gastrointestinal (GI) tract of rodents and humans. A recent study has the established that TCI633 can alleviate synovial tissue inflammation and has potential to mitigate the progression of osteoarthritis. Objective TCI633 has not been available for use in skincare and this preliminary clinical study will assess its improvement of the skin. Methods In this study, DNA protection, Hyaluronidase assay, cell viability, and collagen synthesis on human fibroblasts of TCI633 were assessed. Subjects were enrolled in this clinical study and randomly assigned to the TCI633 or placebo group. Each subject was informed to intake two tablets daily for 8 weeks. Each subject was required to undergo skin condition inspection at weeks 0, 4, and 8 and hematology tests to monitor HA, superoxide dismutase (SOD) and catalase levels, and kidney and liver function at weeks 0 and 8. Results The effects of TCI633 supplementation, including the promotion of skin cell proliferation, the increase of their collagen content, their protection against DNA damage, and the inhibition of hyaluronidase activities, are investigated. Subjects were recruited for an 8-week long clinical trial to confirm the efficacy of TCI633 in improving the serum biochemical HA, SOD and catalase levels, and anti-skin age markers. Conclusions This work provides an alternative approach to improving health, indicating the potential of TCI633 supplementation to delay the aging of skin and improve its condition.
C1 [Liu, Cheng] Dept Hlth & Beauty, Kaohsiung, Taiwan.
   [Liu, Cheng] Dept Optometry, Kaohsiung, Taiwan.
   [Liu, Cheng] Shu Zen Jr Coll Med & Management, Dept Dent Technol, Kaohsiung, Taiwan.
   [Tseng, Ya-Ping] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan, Taiwan.
   [Chan, Leong-Perng] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan.
   [Chan, Leong-Perng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg,Fac Med, Kaohsiung, Taiwan.
   [Liang, Chia-Hua] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, 60,Sec 1,Erren Rd, Tainan 71710, Taiwan.
   [Liang, Chia-Hua] Chia Nan Univ Pharm & Sci, Inst Cosmet Sci, 60,Sec 1,Erren Rd, Tainan 71710, Taiwan.
C3 National Cheng Kung University; Kaohsiung Medical University; Kaohsiung
   Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung
   Medical University Hospital; Chia Nan University of Pharmacy & Science;
   Chia Nan University of Pharmacy & Science
RP Chan, LP (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg,Fac Med, Kaohsiung, Taiwan.; Liang, CH (corresponding author), Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, 60,Sec 1,Erren Rd, Tainan 71710, Taiwan.; Liang, CH (corresponding author), Chia Nan Univ Pharm & Sci, Inst Cosmet Sci, 60,Sec 1,Erren Rd, Tainan 71710, Taiwan.
EM oleon24@yahoo.com.tw; tinna_ling@mail.cnu.edu.tw
FU Kaohsiung Municipal Ta-Tung Hospital, Taiwan, Republic of China
   [KMTTH-108-053]; Ministry of Health and Welfare
   [MOHW109-TDU-B-212-134016]; (Health and welfare surcharge of tobacco
   products) of Taiwan
FX The authors would like to thank the Kaohsiung Municipal Ta-Tung
   Hospital, Taiwan, Republic of China (KMTTH-108-053) and Ministry of
   Health and Welfare (MOHW109-TDU-B-212-134016, Health and welfare
   surcharge of tobacco products) of Taiwan
CR Ballini A, 2019, EUR REV MED PHARMACO, V23, P8645, DOI 10.26355/eurrev_201910_19182
   Ballini A, 2019, ENDOCR METAB IMMUNE, V19, P373, DOI 10.2174/1871530319666181221150352
   Cabré E, 2007, J CROHNS COLITIS, V1, P47, DOI 10.1016/j.crohns.2007.06.003
   Chou TH, 2010, J NAT PROD, V73, P1767, DOI 10.1021/np100281g
   Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153
   Di Marzio L, 1999, J INVEST DERMATOL, V113, P98, DOI 10.1046/j.1523-1747.1999.00633.x
   Dietert RR, 2015, HEALTHCARE-BASEL, V3, P100, DOI 10.3390/healthcare3010100
   Dong KK, 2008, EXP DERMATOL, V17, P1037, DOI 10.1111/j.1600-0625.2008.00747.x
   Friedman O, 2021, AESTHET PLAST SURG, V45, P2180, DOI 10.1007/s00266-021-02255-x
   GANCEVICIENE R, 2012, DERM-ENDOCRINOL, V4
   Göllner I, 2017, J EVID-BASED INTEGR, V22, P816, DOI 10.1177/2156587217743640
   Górska A, 2019, CURR MICROBIOL, V76, P939, DOI 10.1007/s00284-019-01679-8
   Guéniche A, 2009, DERM-ENDOCRINOL, V1, P275, DOI 10.4161/derm.1.5.9849
   Hemarajata P, 2013, THER ADV GASTROENTER, V6, P39, DOI 10.1177/1756283X12459294
   Inchingolo AD, 2021, J BIOL REG HOMEOS AG, V35, P303, DOI 10.23812/21-2supp1-30
   Izawa N, 2011, J BIOSCI BIOENG, V111, P665, DOI 10.1016/j.jbiosc.2011.02.005
   Izawa N, 2010, J BIOSCI BIOENG, V109, P356, DOI 10.1016/j.jbiosc.2009.10.011
   Izawa N, 2009, J BIOSCI BIOENG, V107, P119, DOI 10.1016/j.jbiosc.2008.11.007
   Kechagia Maria, 2013, ISRN Nutr, V2013, P481651, DOI 10.5402/2013/481651
   Kim HM, 2014, J MICROBIOL BIOTECHN, V24, P1583, DOI 10.4014/jmb.1406.06038
   Kleniewska P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1340903
   Knackstedt R, 2020, EXP DERMATOL, V29, P15, DOI 10.1111/exd.14032
   Kober Mary-Margaret, 2015, Int J Womens Dermatol, V1, P85, DOI 10.1016/j.ijwd.2015.02.001
   Kong LH, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.579804
   Kozakiewicz M, 2019, CLIN INTERV AGING, V14, P763, DOI 10.2147/CIA.S201250
   Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104
   Li SQ, 2017, COMPR REV FOOD SCI F, V16, P282, DOI 10.1111/1541-4337.12252
   Lin YY, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9653
   Lolou V, 2019, FERMENTATION-BASEL, V5, DOI 10.3390/fermentation5020041
   Lyu JL, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03757
   Masnec IS, 2008, COLLEGIUM ANTROPOL, V32, P177
   Minami J, 2018, BIOSCI MICROB FOOD H, V37, P67, DOI 10.12938/bmfh.18-001
   Mitura S, 2020, J MATER SCI-MATER M, V31, DOI 10.1007/s10856-020-06390-w
   Morifuji M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010146
   Mu S, 2021, CHEM BIOL DRUG DES, V97, P628, DOI 10.1111/cbdd.13798
   Oe M, 2017, CLIN COSMET INV DERM, V10, DOI 10.2147/CCID.S141845
   Peguet-Navarro J, 2008, EUR J DERMATOL, V18, P504, DOI 10.1684/ejd.2008.0496
   Rittié L, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a015370
   Roudsari MR, 2015, CRIT REV FOOD SCI, V55, P1219, DOI 10.1080/10408398.2012.680078
   Saito Y, 2017, BIOSCI MICROB FOOD H, V36, P111, DOI 10.12938/bmfh.16-031
   Seok J, 2016, J COSMET DERMATOL-US, V15, P578, DOI 10.1111/jocd.12244
   Surber G, 2019, FOODS, V8, DOI 10.3390/foods8050146
   Tsuji R, 2018, EXP GERONTOL, V111, P10, DOI 10.1016/j.exger.2018.06.028
   Yu Y, 2020, BRIT J DERMATOL, V182, P39, DOI 10.1111/bjd.18088
NR 44
TC 7
Z9 8
U1 4
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1473-2130
EI 1473-2165
J9 J COSMET DERMATOL-US
JI J. Cosmet. Dermatol.
PD 2022 JUN
PY 2022
VL 21
IS 6
BP 2635
EP 2647
DI 10.1111/jocd.14445
EA SEP 2021
PG 13
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA 2I1AR
UT WOS:000701060500001
PM 34587358
OA hybrid
DA 2024-02-19
ER

PT J
AU DORNER, H
   FISCHER, B
   SEEFRIED, G
   PLATT, D
   POPAWAGNER, A
AF DORNER, H
   FISCHER, B
   SEEFRIED, G
   PLATT, D
   POPAWAGNER, A
TI FIBRONECTIN MESSENGER-RNA (FN-V95(+)) IS INCREASED IN THE LIVER OF OLD
   SPRAGUE-DAWLEY RATS - EFFECT OF FOOD RESTRICTION
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID SECRETE CELLULAR FIBRONECTIN; PRE-MESSENGER-RNA; FAT-STORING CELLS;
   DIETARY RESTRICTION; PLASMA FIBRONECTIN; ENDOTHELIAL-CELLS;
   STEREOLOGICAL ANALYSIS; SKIN FIBROBLASTS; HEPARIN-BINDING; EXPRESSION
AB Because fibronectin (FN) mRNA has been shown to be increased in the brain of old rats and during in vivo and in vitro aging of both endothelial cells and fibroblasts, it was of interest to determine,what effect age and caloric restriction have on the ability of liver cells to express FN mRNA. The prevalence of fibronectin mRNA containing the alternatively spliced variant V95 (FN-V95) was examined by RNA gel blot hybridization in the liver of IO-mo, 18-mo, 30-mo ad lib-fed (AL) and 30-mo food-restricted (FR) rats. The transcripts coding for FN-V95 mRNA were well expressed in the liver of IO-mo and 18-mo-old rats. The hybridization signal then increased (1.3-fold, p < .05) in the liver of 30-mo AL rats vs 10-mo-old rats. However, the prevalence of FN-V95 mRNA was dramatically decreased (similar to 4.5-fold, p < .01) in the liver of 30-mo food-restricted rats as compared to 30-mo-old AL rats. The distribution of FN-V95 mRNA was also investigated by non-radioactive in situ hybridization (ISH) on liver frozen sections, The hybridization signal for FN-V95 mRNA was evenly distributed among liver cells of IO-mo and 18-mo-old rats, while weak hybridization signals were sparsely scattered on liver sections derived from 30-mo-old FR rats. In contrast, strong hybridization signals showing a localized distribution were detected on liver sections obtained from 30-mo-old AL rats. Histologic examination of cryostat sections also revealed a massive accumulation of lipid droplets in the liver of 30-mo-old AL rats. Since fibronectin mRNA is mainly contributed by fat-storing cells, sinusoidal endothelial cells and, to a lesser extent, hepatocytes, we conclude that the increased expression of FN-V95 mRNA in the liver of 30-mo-old AL rats is the result of the increase in the number of fat-storing cells in the liver of aged rots. We hypothesize that a reduction in the rate of fibronectin synthesis and incorporation into the extracellular matrix of the liver would render the aged rat liver more susceptible to mechanical damage. These observations are in line with the available data on the aging rat liver.
C1 UNIV ERLANGEN NURNBERG,INST GERONTOL,D-90419 NURNBERG,GERMANY.
   UNIV ERLANGEN NURNBERG,DEPT INTERNAL MED,D-90419 NURNBERG,GERMANY.
C3 University of Erlangen Nuremberg; University of Erlangen Nuremberg
RI Popa-Wagner, Aurel/I-2581-2019; Popa-Wagner, Aurel/E-2541-2013
OI Popa-Wagner, Aurel/0000-0003-4574-8605
CR Ausubel FM., 1992, Short protocols in molecular biology
   BOWERSOX JC, 1985, J SURG RES, V39, P445, DOI 10.1016/0022-4804(85)90099-X
   BURKE EM, 1991, BIOCHEM BIOPH RES CO, V178, P620, DOI 10.1016/0006-291X(91)90153-X
   CAMPBELL BA, 1987, J GERONTOL, V42, P154, DOI 10.1093/geronj/42.2.154
   CHADWICK SJD, 1986, BRIT J NUTR, V55, P7, DOI 10.1079/BJN19860004
   CHANDRASEKHAR S, 1980, J CELL PHYSIOL, V103, P47, DOI 10.1002/jcp.1041030108
   CHANDRASEKHAR S, 1983, P NATL ACAD SCI-BIOL, V80, P4747, DOI 10.1073/pnas.80.15.4747
   CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851
   CHESLYNCURTIS S, 1990, BRIT J SURG, V77, P199, DOI 10.1002/bjs.1800770224
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DEPRIESTER W, 1984, MECH AGEING DEV, V26, P205, DOI 10.1016/0047-6374(84)90094-0
   GOODRICK CL, 1983, J GERONTOL, V38, P36, DOI 10.1093/geronj/38.1.36
   GUAN JL, 1990, J CELL BIOL, V110, P833, DOI 10.1083/jcb.110.3.833
   GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q
   HAUGEN PK, 1992, J NEUROSCI, V12, P2034
   HAUGEN PK, 1992, J NEUROSCI, V12, P2597
   HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909
   HOWARD L, 1984, JPEN-PARENTER ENTER, V8, P237, DOI 10.1177/0148607184008003237
   HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886
   INGRAM DK, 1990, J GERONTOL, V45, pB148, DOI 10.1093/geronj/45.5.B148
   IWASAKI K, 1988, ACTA PATHOL JAPON, V38, P1119
   KEMNITZ JW, 1993, J GERONTOL, V48, pB17, DOI 10.1093/geronj/48.1.B17
   KUMAZAKI T, 1993, EXP CELL RES, V205, P396, DOI 10.1006/excr.1993.1103
   KUMAZAKI T, 1991, EXP CELL RES, V195, P13, DOI 10.1016/0014-4827(91)90494-F
   LEVIN P, 1981, SCIENCE, V214, P561, DOI 10.1126/science.7291993
   MAGNUSON VL, 1991, J BIOL CHEM, V266, P14654
   MARTIN M, 1990, EXP CELL RES, V191, P8, DOI 10.1016/0014-4827(90)90028-9
   MASORO EJ, 1992, NEWS PHYSIOL SCI, V7, P157
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   MURO AF, 1992, J BIOL CHEM, V267, P12767
   MYERS BA, 1984, TOXICOL LETT, V23, P43, DOI 10.1016/0378-4274(84)90008-0
   NAKAMURA KD, 1989, MECH AGEING DEV, V48, P199, DOI 10.1016/0047-6374(89)90051-1
   ODENTHAL M, 1992, EXP CELL RES, V203, P289, DOI 10.1016/0014-4827(92)90001-O
   OYAMA F, 1989, BIOCHEMISTRY-US, V28, P1428, DOI 10.1021/bi00429a072
   OYAMA F, 1993, CANCER RES, V53, P2005
   PAGANI F, 1993, BIOCHIM BIOPHYS ACTA, V1173, P172, DOI 10.1016/0167-4781(93)90178-G
   PIERI C, 1975, EXP GERONTOL, V10, P291, DOI 10.1016/0531-5565(75)90006-6
   RAMADORI G, 1992, GASTROENTEROLOGY, V103, P1313, DOI 10.1016/0016-5085(92)91522-6
   RAMADORI G, 1992, BIOCHEM BIOPH RES CO, V183, P739, DOI 10.1016/0006-291X(92)90545-V
   RAMADORI G, 1987, J HEPATOL, V4, P190, DOI 10.1016/S0168-8278(87)80079-X
   RICHARDSON A, 1987, J BIOL CHEM, V262, P12821
   RIEDER H, 1987, HEPATOLOGY, V7, P856, DOI 10.1002/hep.1840070511
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   SCHWARZBAUER JE, 1991, BIOESSAYS, V13, P527, DOI 10.1002/bies.950131006
   SCHWARZBAUER JE, 1987, EMBO J, V6, P2573, DOI 10.1002/j.1460-2075.1987.tb02547.x
   SOPER NJ, 1984, J SURG RES, V37, P431, DOI 10.1016/0022-4804(84)90209-9
   SPINDLER SR, 1990, J NUTR, V120, P1412, DOI 10.1093/jn/120.11.1412
   WAGNER AP, 1991, NEUROREPORT, V2, P691, DOI 10.1097/00001756-199111000-00015
   WAYNER EA, 1992, J CELL BIOL, V116, P489, DOI 10.1083/jcb.116.2.489
   WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 51
TC 2
Z9 2
U1 0
U2 1
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JUL
PY 1995
VL 50
IS 4
BP B218
EP B223
DI 10.1093/gerona/50A.4.B218
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA RY604
UT WOS:A1995RY60400006
PM 7614234
DA 2024-02-19
ER

PT J
AU Intano, GW
   Cho, EJ
   McMahan, CA
   Walter, CA
AF Intano, GW
   Cho, EJ
   McMahan, CA
   Walter, CA
TI Age-related base excision repair activity in mouse brain and liver
   nuclear extracts
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID DNA-POLYMERASE-BETA; OLD MICE; GENE; EXPRESSION; CELLS; MUTATION;
   PROTEIN; DAMAGE; SITES; RECONSTITUTION
AB To assess DNA repair activity relative to age, in vitro base excision repair assays were performed using brain and liver nuclear extracts prepared from mice of various ages. An 85% decline in repair activity was observed in brain nuclear extracts and a 50% decrease in liver nuclear extracts prepared from old mice compared with 6-day-old mice. Brain nuclear extracts prepared from old mice showed a decreased abundance of DNA polymerase-beta, but the addition of purified protein did not restore base excision repair activity. Abundances of other tested base excision repair proteins did not change relative to age. The conclusion is that, during aging, a decline in DNA repair could contribute to increased levels of DNA damage and mutagenesis.
C1 Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA.
   Audie L Murphy Hosp, S Texas Vet Hlth Care Syst, San Antonio, TX USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans
   Hospital
RP Walter, CA (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, Mail Code 7762,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.
FU NIA NIH HHS [AG00205, AG19360, AG14674, AG13560] Funding Source:
   Medline; NIEHS NIH HHS [ESO9136] Funding Source: Medline
CR Alexander P, 1967, Symp Soc Exp Biol, V21, P29
   Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686
   BARNETT YA, 1995, MUTAT RES-DNAGING G, V338, P115, DOI 10.1016/0921-8734(95)00017-Z
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cabelof DC, 2002, MUTAT RES-FUND MOL M, V500, P135, DOI 10.1016/S0027-5107(02)00003-9
   Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870
   DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725
   DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1
   Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431
   Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X
   FAILLA G, 1958, ANN NY ACAD SCI, V71, P1124, DOI 10.1111/j.1749-6632.1958.tb46828.x
   FENECH M, 1985, MUTAT RES, V148, P99, DOI 10.1016/0027-5107(85)90212-X
   FU CS, 1991, J GERONTOL, V46, pB78, DOI 10.1093/geronj/46.2.B78
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169
   Hughes KA, 2002, P NATL ACAD SCI USA, V99, P14286, DOI 10.1073/pnas.222326199
   Intano GW, 2002, MOL CELL BIOL, V22, P2410, DOI 10.1128/MCB.22.7.2410-2418.2002
   Intano GW, 2001, NUCLEIC ACIDS RES, V29, P1366, DOI 10.1093/nar/29.6.1366
   Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842
   KING CM, 1994, MUTAT RES-DNAGING G, V316, P79, DOI 10.1016/0921-8734(94)90010-8
   Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7
   Matsumoto Y, 1999, J BIOL CHEM, V274, P33703, DOI 10.1074/jbc.274.47.33703
   MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187
   Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8
   MORLEY AA, 1982, MECH AGEING DEV, V19, P21, DOI 10.1016/0047-6374(82)90046-X
   MULLAART E, 1988, MECH AGEING DEV, V45, P41, DOI 10.1016/0047-6374(88)90017-6
   MULLAART E, 1990, MUTAT RES, V237, P189, DOI 10.1016/0921-8734(90)90001-8
   Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987
   ONO T, 1995, MUTAT RES-DNAGING G, V338, P183, DOI 10.1016/0921-8734(95)00023-Y
   PARK JW, 1988, P NATL ACAD SCI USA, V85, P7467, DOI 10.1073/pnas.85.20.7467
   Ploskonosova II, 1999, MUTAT RES-DNA REPAIR, V434, P109, DOI 10.1016/S0921-8777(99)00019-1
   PRICE GB, 1971, SCIENCE, V171, P917, DOI 10.1126/science.171.3974.917
   Rao KS, 2000, MOL BRAIN RES, V85, P251, DOI 10.1016/S0169-328X(00)00266-7
   RAO KS, 1994, BIOCHEM MOL BIOL INT, V32, P287
   SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Stuart GR, 2000, GENETICS, V154, P1291
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   TATES AD, 1991, MUTAT RES, V253, P199, DOI 10.1016/0165-1161(91)90133-S
   WALTER CA, 1994, SOMAT CELL MOLEC GEN, V20, P451, DOI 10.1007/BF02255837
   WIDEN SG, 1991, BIOCHEMISTRY-US, V30, P6296, DOI 10.1021/bi00239a031
   ZHOU ZQ, 1995, MUTAT RES LETT, V348, P111, DOI 10.1016/0165-7992(95)00053-4
NR 44
TC 72
Z9 80
U1 1
U2 4
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAR
PY 2003
VL 58
IS 3
BP 205
EP 211
PG 7
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 653QA
UT WOS:000181447200002
PM 12634285
DA 2024-02-19
ER

PT J
AU Bokov, AF
   Garg, N
   Ikeno, Y
   Thakur, S
   Musi, N
   DeFronzo, RA
   Zhang, N
   Erickson, RC
   Gelfond, J
   Hubbard, GB
   Adamo, ML
   Richardson, A
AF Bokov, Alex F.
   Garg, Neha
   Ikeno, Yuji
   Thakur, Sachin
   Musi, Nicolas
   DeFronzo, Ralph A.
   Zhang, Ning
   Erickson, Rebecca C.
   Gelfond, Jon
   Hubbard, Gene B.
   Adamo, Martin L.
   Richardson, Arlan
TI Does Reduced IGF-1R Signaling in <i>Igf1r</i><SUP>+/-</SUP> Mice Alter
   Aging?
SO PLOS ONE
LA English
DT Article
ID GROWTH-FACTOR-I; FATAL NEOPLASTIC DISEASES; LIFE-SPAN EXTENSION;
   INSULIN-RECEPTOR; CAENORHABDITIS-ELEGANS; DELAYED OCCURRENCE; DWARF
   MICE; GENE; LONGEVITY; HORMONE
AB Mutations in insulin/IGF-1 signaling pathway have been shown to lead to increased longevity in various invertebrate models. Therefore, the effect of the haplo-insufficiency of the IGF-1 receptor (Igf1r(+/-)) on longevity/aging was evaluated in C57Bl/6 mice using rigorous criteria where lifespan and end-of-life pathology were measured under optimal husbandry conditions using large sample sizes. Igf1r(+/-) mice exhibited reductions in IGF-1 receptor levels and the activation of Akt by IGF-1, with no compensatory increases in serum IGF-1 or tissue IGF-1 mRNA levels, indicating that the Igf1r(+/-) mice show reduced IGF-1 signaling. Aged male, but not female Igf1r(+/-) mice were glucose intolerant, and both genders developed insulin resistance as they aged. Female, but not male Igf1r(+/-) mice survived longer than wild type mice after lethal paraquat and diquat exposure, and female Igf1r(+/-) mice also exhibited less diquat-induced liver damage. However, no significant difference between the lifespans of the male Igf1r(+/-) and wild type mice was observed; and the mean lifespan of the Igf1r(+/-) females was increased only slightly (less than 5%) compared to wild type mice. A comprehensive pathological analysis showed no significant difference in end-of-life pathological lesions between the Igf1r(+/-) and wild type mice. These data show that the Igf1r(+/-) mouse is not a model of increased longevity and delayed aging as predicted by invertebrate models with mutations in the insulin/IGF-1 signaling pathway.
C1 [Bokov, Alex F.; Ikeno, Yuji; Musi, Nicolas; Gelfond, Jon; Hubbard, Gene B.; Adamo, Martin L.; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   [Bokov, Alex F.; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   [Garg, Neha; Thakur, Sachin; Adamo, Martin L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.
   [Gelfond, Jon] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA.
   [Ikeno, Yuji; Hubbard, Gene B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA.
   [Musi, Nicolas; DeFronzo, Ralph A.; Zhang, Ning] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.
   [Ikeno, Yuji; Musi, Nicolas; Richardson, Arlan] S Texas Vet Hlth Care Syst, GRECC, San Antonio, TX USA.
   [Erickson, Rebecca C.] Univ Texas Austin, Coll Nat Sci, Austin, TX 78712 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; University of
   Texas System; University of Texas Health Science Center at San Antonio;
   University of Texas System; University of Texas Health Science Center at
   San Antonio; Geriatric Research Education & Clinical Center; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital; University of Texas System;
   University of Texas Austin
RP Bokov, AF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
EM Richardson@uthscsa.edu
RI Bokov, Alex/O-9952-2014
OI Bokov, Alex/0000-0002-0511-9815
FU National Institutes of Health (NIH) [AGO-21890]; Beeson Career
   Development Award [AG-030979, DK-80157, DK-089229, DK-24092 RAD,
   R01AG026012, AG-19316, AG-13319, AG-23843, AG-26557]; Nathan Shock
   [1P30-AG-13319]; Department of Veteran's Affairs; University of Texas
   System
FX This work was supported by National Institutes of Health (NIH)
   (http://grants.nih.gov/grants/oer.htm) AGO-21890 to AFB; AG-030979
   (Beeson Career Development Award), DK-80157 and DK-089229 to NM;
   DK-24092 RAD; R01AG026012 to MLA; AG-19316, AG-13319, AG-23843, and
   AG-26557 to AR; Nathan Shock: 1P30-AG-13319 to AR; Department of
   Veteran's Affairs: Research Enhancement Award Program, Merit Grant to
   AR; and University of Texas System's Graduate Programs Initiative:
   Translational Science Training (TST) Across Disciplines to NG. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR [Anonymous], SURV2SAMPLE 2 SAMPLE
   Bartke A, 2009, EXP GERONTOL, V44, P372, DOI 10.1016/j.exger.2009.04.001
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Delahunty KM, 2006, ENDOCRINOLOGY, V147, P3915, DOI 10.1210/en.2006-0277
   Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081
   Dorai-Raj S, 2009, BINOM BINOMIAL CONFI
   Duan CM, 1996, J BIOL CHEM, V271, P4280
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Fox J, 2010, R Package Version 2.0-2
   FRIEDMAN DB, 1988, GENETICS, V118, P75
   Goran B, 2010, EHA EVENT HIST ANAL
   HOLM S, 1979, SCAND J STAT, V6, P65
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Ikeno Y, 2005, J GERONTOL A-BIOL, V60, P1510, DOI 10.1093/gerona/60.12.1510
   Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291
   Ikeno Y, 2009, J GERONTOL A-BIOL, V64, P522, DOI 10.1093/gerona/glp017
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9
   Koenker R, 2008, J STAT SOFTW, V27, P1
   Ladiges W, 2009, AGING CELL, V8, P346, DOI 10.1111/j.1474-9726.2009.00491.x
   LEITER EH, 1988, FASEB J, V2, P2807, DOI 10.1096/fasebj.2.12.3044905
   Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019
   LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4
   McCarter R, 2007, J GERONTOL A-BIOL, V62, P1059, DOI 10.1093/gerona/62.10.1059
   Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0
   Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998
   Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Riddle D. L., 1988, Cold Spring Harb. Monogr. Arch, V17, P393
   Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415
   Selman C, 2008, SCIENCE, V320, DOI 10.1126/science.1152366
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195
   Sonntag WE, 1999, J GERONTOL A-BIOL, V54, pB521, DOI 10.1093/gerona/54.12.B521
   STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404
   Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   Valverde AM, 2001, MOL CELL BIOL, V21, P2269, DOI 10.1128/MCB.21.7.2269-2280.2001
   Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07
   WEINDRUCH R, 1991, J GERONTOL, V46, pB87, DOI 10.1093/geronj/46.3.B87
   Ye P, 1998, ENDOCRINOLOGY, V139, P65, DOI 10.1210/en.139.1.65
   Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x
   Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132
NR 51
TC 122
Z9 134
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 23
PY 2011
VL 6
IS 11
AR e26891
DI 10.1371/journal.pone.0026891
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 863KL
UT WOS:000298162000007
PM 22132081
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Chigorno, V
   Negroni, E
   Nicolini, M
   Sonnino, S
AF Chigorno, V
   Negroni, E
   Nicolini, M
   Sonnino, S
TI Activity of 3-ketosphinganine synthase during differentiation and aging
   of neuronal cells in culture
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE gangliosides; biosynthesis; sphinganine; sphingosine
ID CEREBELLAR GRANULE CELLS; LONG-CHAIN BASE; SERINE PALMITOYLTRANSFERASE;
   SPHINGOLIPID BIOSYNTHESIS; FATTY-ACID; RAT-LIVER; GANGLIOSIDES;
   SPHINGOSINE; METABOLISM; SPHINGANINE
AB Changes in the enzyme 3-ketosphinganine synthase activity in rat cerebellar granule cells in culture were studied during differentiation and aging. The enzyme activity with palmitoyl-CoA and stearoyl-CoA, precursors of, respectively, C18-sphinganine and C20-sphinganine, was studied on the total cell homogenate using radioactive serine. The enzyme assay was performed by thin-layer chromatography (TLC) separation of the enzyme reaction mixture, and the resultant radioactive 3-ketosphinganine was identified by chromatographic comparison with a chemically synthesized 3-ketosphinganine, and quantified by determination of the TLC radioactivity distribution on the basis of the radioactivity content of cell lipid extract that was determined by scintillation counting. Using palmitoyl-CoA, the enzyme activity progressively increased from 40 to 54 pmol of 3-ketosphinganine/mg cell DNA per min in the first 8 days and then progressively decreased, and was 39 pmol of C18-(3-ketosphinganine)/mg cell DNA per mill at day 22 in culture. For stearoyl-Coh the enzyme activity was very low at day one and then increased to a constant value of about 15 pmol of C20-(3-ketosphinganine) /mg cell DNA per min. These results are in good agreement with the finding that the ganglioside species that contain C18-sphingosine increase during cell differentiation and remain constant during cell aging, while the ganglioside species that contain C20-sphingosine continuously increase during both cell differentiation and aging.
C1 UNIV MILAN, SCH MED, DEPT MED CHEM & BIOCHEM, STUDY CTR FUNCT BIOCHEM BRAIN LIPIDS, I-20133 MILAN, ITALY.
C3 University of Milan
RI Sonnino, Sandro/R-4154-2017
OI Sonnino, Sandro/0000-0001-8180-5908
CR BARENHOLZ Y, 1980, BIOCHIM BIOPHYS ACTA, V604, P129, DOI 10.1016/0005-2736(80)90572-6
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   CARTER HE, 1961, J LIPID RES, V2, P228
   CHIGORNO V, 1994, EUR J BIOCHEM, V221, P1095, DOI 10.1111/j.1432-1033.1994.tb18829.x
   Chigorno V, 1996, J BIOL CHEM, V271, P21738, DOI 10.1074/jbc.271.36.21738
   GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919
   HOLLERAN WM, 1990, J LIPID RES, V31, P1655
   KARLSSON KA, 1970, CHEM PHYS LIPIDS, V5, P6, DOI 10.1016/0009-3084(70)90008-3
   MANDON EC, 1991, EUR J BIOCHEM, V198, P667, DOI 10.1111/j.1432-1033.1991.tb16065.x
   MANSSON JE, 1978, J NEUROCHEM, V30, P273, DOI 10.1111/j.1471-4159.1978.tb07064.x
   MERRILL AH, 1983, BIOCHIM BIOPHYS ACTA, V754, P284, DOI 10.1016/0005-2760(83)90144-3
   MERRILL AH, 1985, J LIPID RES, V26, P617
   MERRILL AH, 1993, J BIOL CHEM, V268, P27299
   PALESTINI P, 1991, J NEUROCHEM, V56, P2048, DOI 10.1111/j.1471-4159.1991.tb03465.x
   PALESTINI P, 1990, J NEUROCHEM, V54, P230, DOI 10.1111/j.1471-4159.1990.tb13305.x
   RIBONI L, 1990, NEUROCHEM RES, V15, P1175, DOI 10.1007/BF01208577
   RIBONI L, 1993, FEBS LETT, V322, P257, DOI 10.1016/0014-5793(93)81582-K
   ROSENBERG A, 1966, J LIPID RES, V7, P122
   ROTHER J, 1992, BIOCHEM BIOPH RES CO, V189, P14, DOI 10.1016/0006-291X(92)91518-U
   SCHWARZ HP, 1967, J NEUROCHEM, V14, P91, DOI 10.1111/j.1471-4159.1967.tb09497.x
   SONDERFELD S, 1985, EUR J BIOCHEM, V149, P247, DOI 10.1111/j.1432-1033.1985.tb08919.x
   SONNINO S, 1990, J NEUROCHEM, V54, P1653, DOI 10.1111/j.1471-4159.1990.tb01218.x
   STAHL E, 1962, DUNNSCHICHT CHROMATO, P489
   TRINCHERA M, 1990, BIOCHEM J, V270, P815, DOI 10.1042/bj2700815
   VACCARINO F, 1987, P NATL ACAD SCI USA, V84, P8707, DOI 10.1073/pnas.84.23.8707
   Valsecchi M, 1996, NEUROCHEM INT, V28, P183, DOI 10.1016/0197-0186(95)00069-0
   Valsecchi M, 1996, J NEUROCHEM, V67, P1866
   VALSECCHI M, 1992, CHEM PHYS LIPIDS, V60, P247, DOI 10.1016/0009-3084(92)90076-2
   VALSECCHI M, 1993, J NEUROCHEM, V60, P193, DOI 10.1111/j.1471-4159.1993.tb05837.x
   VANECHTEN G, 1993, J BIOL CHEM, V268, P5341
   VANECHTEN G, 1989, J NEUROCHEM, V52, P207
   VANECHTEN G, 1990, J BIOL CHEM, V265, P9333
   WIEGANDT H, 1985, NEW COMPREHENSIVE BI, V10, P199
   WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9
NR 35
TC 15
Z9 15
U1 0
U2 1
PU LIPID RESEARCH INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0022-2275
J9 J LIPID RES
JI J. Lipid Res.
PD JUN
PY 1997
VL 38
IS 6
BP 1163
EP 1169
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)
SC Biochemistry & Molecular Biology
GA XF807
UT WOS:A1997XF80700010
PM 9215544
DA 2024-02-19
ER

PT J
AU AGARWAL, S
   SOHAL, RS
AF AGARWAL, S
   SOHAL, RS
TI AGING AND PROTEOLYSIS OF OXIDIZED PROTEINS
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
ID AGE-RELATED-CHANGES; MUSCA-DOMESTICA; GLUTAMINE-SYNTHETASE; CATALYZED
   OXIDATION; OXYGEN RADICALS; REDOX STATUS; DEGRADATION; CONSEQUENCES;
   PENTANE; STRESS
AB The main objective of this study was to investigate the possible cause(s) of the age-related augmentation of oxidatively damaged proteins in animal tissues. The hypothesis that activity of alkaline proteases, involved in the proteolysis of oxidized proteins, declines during aging was tested in the adult male housefly and further explored in the rat. Alkaline protease activity was measured fluorometrically by the release of trichloroacetic acid-soluble fluorescamine-reactive material from X ray-oxidized bovine serum albumin (BSA). Alkaline protease activity in the housefly was linearly related to the number of protein carbonyl groups. Possible involvement of serine or serine and thiol proteases was deduced from a 70% proteolytic inhibition by aprotinin and a 50% inhibition by leupeptin. Protease activity of houseflies for oxidized or native BSA did not alter with age. In contrast, a varied age-related pattern of protease activity was observed in the tissues of the rat. A comparison of 3-, 13-, and 23-month-old Sprague-Dawley rats indicated no age-related decline in alkaline protease activity in the brain, a 50% decline in the liver, and a 20% decline in the heart during 13 to 22 months. Results of this study suggest that in some species or tissues an age-related increase in the oxidized protein content is primarily due to a corresponding increase in the rate of protein oxidation, while in some other tissues a decline in proteolysis may be a contributory factor. (C) 1994 Academic Press. Inc.
C1 SO METHODIST UNIV,DEPT BIOL SCI,DALLAS,TX 75275.
C3 Southern Methodist University
FU NIA NIH HHS [R01AG7657] Funding Source: Medline
CR BOHLEN P, 1973, ARCH BIOCHEM BIOPHYS, V155, P213, DOI 10.1016/S0003-9861(73)80023-2
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9914
   DAVIES KJA, 1987, J BIOL CHEM, V262, P8227
   Davis RA, 1940, J EXP BIOL, V17, P402
   FARMER KJ, 1989, FREE RADICAL BIO MED, V7, P23, DOI 10.1016/0891-5849(89)90096-8
   GOLDBERG AL, 1982, SCIENCE, V215, P1107, DOI 10.1126/science.7038874
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120
   NOY N, 1985, MECH AGEING DEV, V29, P63, DOI 10.1016/0047-6374(85)90047-8
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   PACIFICI RE, 1991, GERONTOLOGY, V37, P166
   RAGLAND SS, 1984, THESIS SO METHODIST
   RIVETT AJ, 1985, J BIOL CHEM, V260, P300
   RIVETT AJ, 1985, ARCH BIOCHEM BIOPHYS, V243, P624, DOI 10.1016/0003-9861(85)90540-5
   SAGAI M, 1980, LIFE SCI, V27, P731, DOI 10.1016/0024-3205(80)90326-4
   SOHAL RS, 1985, MECH AGEING DEV, V29, P317, DOI 10.1016/0047-6374(85)90071-5
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1987, ARCH GERONTOL GERIAT, V6, P95, DOI 10.1016/0167-4943(87)90001-X
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   SOHAL RS, 1990, FREE RADICAL BIO MED, V10, P495
   STADTMAN ER, 1991, J BIOL CHEM, V266, P2005
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
NR 26
TC 95
Z9 97
U1 0
U2 8
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 1994
VL 309
IS 1
BP 24
EP 28
DI 10.1006/abbi.1994.1078
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA MY517
UT WOS:A1994MY51700004
PM 7509589
DA 2024-02-19
ER

PT J
AU McNeill, DR
   Lin, PC
   Miller, MG
   Pistell, PJ
   de Souza-Pinto, NC
   Fishbein, KW
   Spencer, RG
   Liu, Y
   Pettan-Brewer, C
   Ladiges, WC
   Wilson, DM
AF McNeill, Daniel R.
   Lin, Ping-Chang
   Miller, Marshall G.
   Pistell, Paul J.
   de Souza-Pinto, Nadja C.
   Fishbein, Kenneth W.
   Spencer, Richard G.
   Liu, Yie
   Pettan-Brewer, Christina
   Ladiges, Warren C.
   Wilson, David M., III
TI XRCC1 haploinsufficiency in mice has little effect on aging, but
   adversely modifies exposure-dependent susceptibility
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID BASE EXCISION-REPAIR; STRAND BREAK REPAIR; DNA-LIGASE-III; DAMAGE;
   DISEASE; PROTEIN; CANCER; MOUSE; GENE; POLYMORPHISMS
AB Oxidative DNA damage plays a role in disease development and the aging process. A prominent participant in orchestrating the repair of oxidative DNA damage, particularly single-strand breaks, is the scaffold protein XRCC1. A series of chronological and biological aging parameters in XRCC1 heterozygous (HZ) mice were examined. HZ and wild-type (WT) C57BL/6 mice exhibit a similar median lifespan of similar to 26 months and a nearly identical maximal life expectancy of similar to 37 months. However, a number of HZ animals (7 of 92) showed a propensity for abdominal organ rupture, which may stem from developmental abnormalities given the prominent role of XRCC1 in endoderm and mesoderm formation. For other end-points evaluated-weight, fat composition, blood chemistries, condition of major organs, tissues and relevant cell types, behavior, brain volume and function, and chromosome and telomere integrity-HZ mice exhibited by-and-large a normal phenotype. Treatment of animals with the alkylating agent azoxymethane resulted in both liver toxicity and an increased incidence of precancerous lesions in the colon of HZ mice. Our study indicates that XRCC1 haploinsufficiency in mammals has little effect on chronological longevity and many key biological markers of aging in the absence of environmental challenges, but may adversely affect normal animal development or increase disease susceptibility to a relevant genotoxic exposure.
C1 [McNeill, Daniel R.; Liu, Yie; Wilson, David M., III] NIA, Lab Mol Gerontol, NIH, IRP,Biomed Res Ctr, Baltimore, MD 21224 USA.
   [Lin, Ping-Chang; Fishbein, Kenneth W.; Spencer, Richard G.] NIA, Clin Invest Lab, NIH, IRP,Biomed Res Ctr, Baltimore, MD 21224 USA.
   [Miller, Marshall G.] Tufts Univ, Human Nutr Res Ctr Aging, Boston, MA 02111 USA.
   [Pistell, Paul J.] Towson Univ, Dept Psychol, Towson, MD 21252 USA.
   [de Souza-Pinto, Nadja C.] Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508000 Sao Paulo, Brazil.
   [Pettan-Brewer, Christina; Ladiges, Warren C.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA); Tufts University; United States Department of
   Agriculture (USDA); University System of Maryland; Towson University;
   Universidade de Sao Paulo; University of Washington; University of
   Washington Seattle
RP Wilson, DM (corresponding author), NIA, Lab Mol Gerontol, NIH, IRP,Biomed Res Ctr, Baltimore, MD 21224 USA.
EM wladiges@u.washington.edu; wilsonda@mail.nih.gov
RI Wilson, David M/AAK-5409-2021; Liu, Yie/AAO-2092-2020; Fishbein,
   Kenneth/AAN-2595-2021; Souza-Pinto, Nadja/T-3050-2019; Souza-Pinto,
   Nadja C./C-3462-2013
OI Wilson, David M/0000-0002-8945-0395; Fishbein,
   Kenneth/0000-0002-6353-4603; Souza-Pinto, Nadja/0000-0003-4206-964X;
   Souza-Pinto, Nadja C./0000-0003-4206-964X; Lin,
   Ping-Chang/0000-0003-0918-4072; Miller, Marshall/0000-0001-7461-6631
FU National Institute on Aging; National Institute of Environmental Health
   Sciences [R21ES016572]
FX Funding for open access charge: Intramural Research Program of the
   National Institute on Aging and National Institute of Environmental
   Health Sciences grant R21ES016572 (to W.L.).
CR Berquist BR, 2010, NUCLEIC ACIDS RES, V38, P5023, DOI 10.1093/nar/gkq193
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6
   Chen JZ, 2009, CANCER BIOL THER, V8, P1313, DOI 10.4161/cbt.8.14.8983
   Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184
   Dutra AVC, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-78
   Enns LC, 2009, J GERONTOL A-BIOL, V64, P1221, DOI 10.1093/gerona/glp133
   Fujimura M, 1999, STROKE, V30, P2456, DOI 10.1161/01.STR.30.11.2456
   Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
   Jiang Jun, 2009, V471, P305, DOI 10.1007/978-1-59745-416-2_16
   Kulkarni A, 2008, NUCLEIC ACIDS RES, V36, P5111, DOI 10.1093/nar/gkn480
   Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009
   Ladiges WC, 2006, ONCOGENE, V25, P1612, DOI 10.1038/sj.onc.1209370
   Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880
   Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375
   Li N, 2007, DNA REPAIR, V6, P1297, DOI 10.1016/j.dnarep.2007.02.027
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   Mahabir S, 2007, J EPIDEMIOL COMMUN H, V61, P737, DOI 10.1136/jech.2006.048934
   McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559
   Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189
   Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526
   Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987
   Tebbs RS, 2003, DNA REPAIR, V2, P1405, DOI 10.1016/j.dnarep.2003.08.007
   Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232
   Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0
   Tkác I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G
   Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   Wilson DM, 2008, MECH AGEING DEV, V129, P349, DOI 10.1016/j.mad.2008.02.013
   Wilson DM, 2007, ENVIRON MOL MUTAGEN, V48, P772, DOI 10.1002/em.20346
   Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017
   Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017
   Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754
   WILSON DM, 2010, MUTAT RES
   Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423
NR 35
TC 21
Z9 24
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD OCT
PY 2011
VL 39
IS 18
BP 7992
EP 8004
DI 10.1093/nar/gkr280
PG 13
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 830WC
UT WOS:000295687700017
PM 21737425
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Martín-González, C
   González-Reimers, E
   Quintero-Platt, G
   Martínez-Riera, A
   Santolaria-Fernández, F
AF Martin-Gonzalez, C.
   Gonzalez-Reimers, E.
   Quintero-Platt, G.
   Martinez-Riera, A.
   Santolaria-Fernandez, F.
TI Soluble α-Klotho in Liver Cirrhosis and Alcoholism
SO ALCOHOL AND ALCOHOLISM
LA English
DT Article
ID OXIDATIVE STRESS; OVARIAN-CANCER; EXPRESSION; CELLS; GENE; HORMONE;
   FGF23; INFLAMMATION; POLYMORPHISM; CLEAVAGE
AB Aims and background: Alpha Klotho is a transmembrane protein that serves as co-receptor for FGF23. Ectodomain of membrane bound a Klotho may be shed by membrane bound proteases (activated, among other factors, by tumor necrosis factor (TNF)-alpha) generating the soluble form of the protein (sKl) that functions as a hormone by itself. It modulates calcium influx into cells, blunts IGF-1/Insulin signaling, promotes synthesis of antioxidants, generally slows down tumor progression, delays cell senescence, is neuroprotective and promotes oligodendrocyte maturation and myelin synthesis, and muscle rejuvenation. It may be involved in inflammation and exerts antifi-brogenic effects. Some of these pathways may become altered in alcoholism or liver cirrhosis, but data are scattered and scarce and an update is required.
   Method: Literature survey.
   Results and Conclusions: Alcohol consumption in non-alcoholics is inversely related to sKl, but alcoholic cirrhotics showed higher-than-normal sKl values in association with liver function derangement. In hepatoma cells, the intensity of Klotho staining was related to faster tumor progression and a shortened life span. Among severe alcoholic cirrhotics sKl is directly related to serum TNF-alpha levels, and, inversely, to brain atrophy. Given the antioxidant, anti-inflammatory, and antifibrogenic effects of Klotho, perhaps the increase in cirrhosis (and in other inflammatory conditions, such as sepsis or cancer) reflects an attempt to regulate increased inflammation, but clinical and experimental research is urgently needed in this field.
C1 [Martin-Gonzalez, C.; Gonzalez-Reimers, E.; Quintero-Platt, G.; Martinez-Riera, A.; Santolaria-Fernandez, F.] Univ La Laguna, Hosp Univ Canarias, Serv Med Interna, Tenerife, Canary Islands, Spain.
C3 Universidad de la Laguna
RP González-Reimers, E (corresponding author), Univ La Laguna, Hosp Univ Canarias, Serv Med Interna, Tenerife, Canary Islands, Spain.
EM egonrey@ull.es
RI Martín-González, Candelaria/G-3629-2016
OI Martinez Riera, Antonio Maria/0000-0003-2901-3502
CR Abdelmalik PA, 2018, J CRIT CARE, V44, P323, DOI 10.1016/j.jcrc.2017.11.023
   Abraham CR, 2016, VITAM HORM, V101, P215, DOI 10.1016/bs.vh.2016.02.004
   Almeida OP, 2017, MATURITAS, V101, P1, DOI [10.1016/j.maturitas., 10.1016/j.maturitas.2017.04.005]
   Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015
   Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409
   Bian A, 2015, CLIN INTERV AGING, V10, P1233, DOI 10.2147/CIA.S84978
   Cararo-Lopes MM, 2017, AGEING RES REV, V36, P137, DOI 10.1016/j.arr.2017.03.003
   Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780
   Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104
   Chen CD, 2014, BIOCHEMISTRY-US, V53, P5579, DOI 10.1021/bi500409n
   Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058413
   Crasto CL, 2012, REJUV RES, V15, P295, DOI 10.1089/rej.2011.1268
   Dalton G, 2017, P NATL ACAD SCI USA, V114, P752, DOI 10.1073/pnas.1620301114
   Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037
   Dounousi E, 2016, EUR J CLIN INVEST, V46, P234, DOI 10.1111/eci.12588
   Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076
   Erben RG, 2017, BONE, V100, P62, DOI 10.1016/j.bone.2016.09.010
   Gao LL, 2015, GENET MOL RES, V14, P15444, DOI 10.4238/2015.November.30.22
   González-Reimers E, 2018, ALCOHOL ALCOHOLISM, V53, P503, DOI 10.1093/alcalc/agy037
   Hayashi Y, 2016, VITAM HORM, V101, P1, DOI 10.1016/bs.vh.2016.02.011
   Hsieh CC, 2010, AGING-US, V2, P582, DOI 10.18632/aging.100194
   Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094
   Inci A, 2016, EUR REV MED PHARMACO, V20, P3230
   Jou-Valencia D, 2018, CRIT CARE MED, V46, pE1196, DOI 10.1097/CCM.0000000000003427
   Jurado-Fasoli L, 2019, DRUG ALCOHOL DEPEN, V194, P107, DOI 10.1016/j.drugalcdep.2018.09.024
   Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036
   Krick S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14811-0
   Kuro-o M, 2019, NAT REV NEPHROL, V15, P27, DOI 10.1038/s41581-018-0078-3
   Kuro-o M, 2012, ADV EXP MED BIOL, V728, P25, DOI 10.1007/978-1-4614-0887-1_2
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107
   Lim K, 2015, J CLIN ENDOCR METAB, V100, pE1308, DOI 10.1210/jc.2015-1800
   Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578
   Lu L, 2008, CANCER INVEST, V26, P185, DOI 10.1080/07357900701638343
   Lu P, 2008, NEPHROL DIAL TRANSPL, V23, P3397, DOI 10.1093/ndt/gfn291
   Maekawa Y, 2009, ENDOCRINE, V35, P341, DOI 10.1007/s12020-009-9181-3
   Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje
   Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576
   Prystupa A, 2016, EXP THER MED, V12, P3464, DOI 10.3892/etm.2016.3754
   Rakugi H, 2007, ENDOCRINE, V31, P82, DOI 10.1007/s12020-007-0016-9
   Sahu A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07253-3
   Semba RD, 2014, NEUROSCI LETT, V558, P37, DOI 10.1016/j.neulet.2013.10.058
   Shardell M, 2016, J GERONTOL A-BIOL, V71, P677, DOI 10.1093/gerona/glv140
   Wang HJ, 2010, WORLD J GASTROENTERO, V16, P1304, DOI 10.3748/wjg.v16.i11.1304
   Wang YH, 2012, AGING CELL, V11, P410, DOI 10.1111/j.1474-9726.2012.00796.x
   Xia WW, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/2193210
   Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240
   Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200
   Yan YL, 2017, MOL MED REP, V15, P1777, DOI 10.3892/mmr.2017.6172
   Zhu LB, 2014, ONCOL LETT, V7, P897, DOI 10.3892/ol.2014.1810
NR 50
TC 13
Z9 14
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0735-0414
EI 1464-3502
J9 ALCOHOL ALCOHOLISM
JI Alcohol Alcohol.
PD MAY
PY 2019
VL 54
IS 3
BP 204
EP 208
DI 10.1093/alcalc/agz019
PG 5
WC Substance Abuse
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Substance Abuse
GA JE2DY
UT WOS:000490506300003
PM 30860544
DA 2024-02-19
ER

PT J
AU Kadish, I
   Thibault, O
   Blalock, EM
   Chen, KC
   Gant, JC
   Porter, NM
   Landfield, PW
AF Kadish, Inga
   Thibault, Olivier
   Blalock, Eric M.
   Chen, Kuey-C.
   Gant, John C.
   Porter, Nada M.
   Landfield, Philip W.
TI Hippocampal and Cognitive Aging across the Lifespan: A Bioenergetic
   Shift Precedes and Increased Cholesterol Trafficking Parallels Memory
   Impairment
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE spatial learning; brain aging; Alzheimer's; cholesterol; inflammation;
   myelination
ID LIVER-X-RECEPTOR; APOLIPOPROTEIN-E EXPRESSION; ALZHEIMERS-DISEASE;
   NEURODEGENERATIVE DISEASE; THERAPEUTIC IMPLICATIONS; SYNAPTIC
   PLASTICITY; GENE MICROARRAYS; HUMAN BRAIN; INFLAMMATION; ASTROCYTES
AB Multiple hippocampal processes and cognitive functions change with aging or Alzheimer's disease, but the potential triggers of these aging cascades are not well understood. Here, we quantified hippocampal expression profiles and behavior across the adult lifespan to identify early aging changes and changes that coincide with subsequent onset of cognitive impairment. Well powered microarray analyses (N = 49 arrays), immunohistochemistry, and Morris spatial maze learning were used to study male F344 rats at five age points. Genes that changed with aging ( by ANOVA) were assigned to one of four onset age ranges based on template pattern matching; functional pathways represented by these genes were identified statistically ( Gene Ontology). In the earliest onset age range (3-6 months old), upregulation began for genes in lipid/protein catabolic and lysosomal pathways, indicating a shift in metabolic substrates, whereas downregulation began for lipid synthesis, GTP/ATP-dependent signaling, and neural development genes. By 6-9 months of age, upregulation of immune/inflammatory cytokines was pronounced. Cognitive impairment first appeared in the midlife range (9-12 months) and coincided and correlated primarily with midlife upregulation of genes associated with cholesterol trafficking ( apolipoprotein E), myelinogenic, and proteolytic/major histocompatibility complex antigen-presenting pathways. Immunolabeling revealed that cholesterol trafficking proteins were substantially increased in astrocytes and that myelination increased with aging. Together, our data suggest a novel sequential model in which an early-adult metabolic shift, favoring lipid/ketone body oxidation, triggers inflammatory degradation of myelin and resultant excess cholesterol that, by midlife, activates cholesterol transport from astrocytes to remyelinating oligodendrocytes. These processes may damage structure and compete with neuronal pathways for bioenergetic resources, thereby impairing cognitive function.
C1 [Thibault, Olivier; Blalock, Eric M.; Chen, Kuey-C.; Gant, John C.; Porter, Nada M.; Landfield, Philip W.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.
   [Kadish, Inga] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA.
C3 University of Kentucky; University of Alabama System; University of
   Alabama Birmingham
RP Landfield, PW (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, 800 Rose St,MS 310, Lexington, KY 40536 USA.
EM pwland@uky.edu
RI Thibault, Olivier/AAY-7614-2020
OI Thibault, Olivier/0000-0002-3548-3466
FU National Institute on Aging [PO1 AG10836, R37 AG04542]
FX This work was supported in part by National Institute on Aging Grants
   PO1 AG10836 and R37 AG04542. We thank Michael Bridges for important
   assistance in the behavioral studies.
CR Abildayeva K, 2006, J BIOL CHEM, V281, P12799, DOI 10.1074/jbc.M601019200
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bartzokis G, 2007, ALZHEIMERS DEMENT, V3, P122, DOI 10.1016/j.jalz.2007.01.019
   Bi X, 2000, NEUROSCIENCE, V97, P395, DOI 10.1016/S0306-4522(00)00021-X
   Björkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x
   Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006
   Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100
   Blalock EM, 2003, J NEUROSCI, V23, P3807
   Brinton RD, 2008, ADV DRUG DELIVER REV, V60, P1504, DOI 10.1016/j.addr.2008.06.003
   Burger C, 2007, NEUROBIOL LEARN MEM, V87, P21, DOI 10.1016/j.nlm.2006.05.003
   Butterfield DA, 2006, NEUROBIOL DIS, V22, P223, DOI 10.1016/j.nbd.2005.11.002
   Cao GQ, 2007, CURR ALZHEIMER RES, V4, P179, DOI 10.2174/156720507780362173
   Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7
   Craft S, 2006, ALZ DIS ASSOC DIS, V20, P298, DOI 10.1097/01.wad.0000213866.86934.7e
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Dickey CA, 2003, J NEUROSCI, V23, P5219
   Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003
   Disterhoft JF, 2006, TRENDS NEUROSCI, V29, P587, DOI 10.1016/j.tins.2006.08.005
   Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254
   Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013
   Gallagher M, 2003, EXP GERONTOL, V38, P71, DOI 10.1016/S0531-5565(02)00159-6
   Gallardo G, 2008, NAT NEUROSCI, V11, P301, DOI 10.1038/nn2058
   Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006
   Gemma C, 2007, REV NEUROSCIENCE, V18, P137
   Gibson GE, 2008, ANN NY ACAD SCI, V1147, P221, DOI 10.1196/annals.1427.038
   Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4
   HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710
   Holness MJ, 2003, BIOCHEM SOC T, V31, P1143
   Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797
   Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006
   Kadish I, 2002, J NEUROSCI, V22, P4095, DOI 10.1523/JNEUROSCI.22-10-04095.2002
   Koldamova R, 2007, CURR ALZHEIMER RES, V4, P171, DOI 10.2174/156720507780362227
   LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791
   Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Liang Y, 2004, J NEUROCHEM, V88, P623, DOI 10.1111/j.1471-4159.2004.02183.x
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Lynch G, 2006, AGEING RES REV, V5, P255, DOI 10.1016/j.arr.2006.03.008
   Markowska AL, 2002, NEUROBIOL LEARN MEM, V78, P294, DOI 10.1006/nlme.2002.4064
   McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007
   Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001
   Mirnics K, 2004, NAT NEUROSCI, V7, P434, DOI 10.1038/nn1230
   MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4
   Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038
   Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7
   Mrak RE, 2005, J ALZHEIMERS DIS, V8, P369
   Mufson EJ, 2006, PROG BRAIN RES, V158, P197, DOI 10.1016/S0079-6123(06)58010-0
   Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277
   Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005
   Petanceska SS, 2003, J MOL NEUROSCI, V20, P395, DOI 10.1385/JMN:20:3:395
   Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2
   Peters A, 2000, J COMP NEUROL, V419, P364, DOI 10.1002/(SICI)1096-9861(20000410)419:3<364::AID-CNE8>3.0.CO;2-R
   Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345
   Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C
   Rebeck GW, 2002, J ALZHEIMERS DIS, V4, P145, DOI 10.3233/JAD-2002-4304
   Roses AD, 2006, J ALZHEIMERS DIS, V9, P361
   Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007
   Sparks D. Larry, 2005, Current Alzheimer Research, V2, P527, DOI 10.2174/156720505774932296
   Wolozin B, 2004, CURR OPIN LIPIDOL, V15, P667, DOI 10.1097/00041433-200412000-00007
   Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8
   Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237
NR 61
TC 131
Z9 147
U1 0
U2 8
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD FEB 11
PY 2009
VL 29
IS 6
BP 1805
EP 1816
DI 10.1523/JNEUROSCI.4599-08.2009
PG 12
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 406NC
UT WOS:000263301200022
PM 19211887
OA hybrid, Green Accepted, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Philipp, C
AF Philipp, Claire
TI The Aging Patient with Hemophilia: Complications, Comorbidities, and
   Management Issues
SO HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM
LA English
DT Article
AB Improvements in hemophilia care and antiviral treatments have resulted in increases in median life expectancy for persons with congenital hemophilia A and B. Currently, 2% of hemophilia A and B patients surveyed in US comprehensive hemophilia treatment centers are 65 years of age or older and 15% are 45 years or older. Many of the complications of hemophilia, including intracranial hemorrhage, joint disease, and inhibitor development, increase with increasing age. Hepatocellular carcinoma and end-stage liver disease are increasing in the older hemophilia population due to infection with hepatitis C (HCV) and HCV/HIV coinfection. Older hemophilia patients also now face the same medical conditions associated with aging in the general population, including cardiovascular disease and cancer. Complex hemostatic management, sometimes in conjunction with antithrombotic management, with extensive cross-specialty clinical and laboratory coordination may be required for the care of the older hemophilia patient. Because elderly hemophilia patients currently represent a small portion of the overall hemophilia population, there is little in the way of clinical data to guide recommendations. Registry databases and cooperative group studies are needed for the development of evidence-based guidelines for the older hemophilia population, which is anticipated to expand in the future.
C1 [Philipp, Claire] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Rutgers
   University Biomedical & Health Sciences
RP Philipp, C (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Hematol, MEB 378, New Brunswick, NJ 08903 USA.
EM philipp@umdnj.edu
FU Baxter; Pfizer; Octapharma; Bayer; CSL Behring
FX The author has received research funding from Baxter, Pfizer,
   Octapharma, Bayer, and CSL Behring. The author has received an
   honorarium and been a member of an advisory board for CSL Behring.
CR Arnold DM, 2006, BLOOD, V108, P460, DOI 10.1182/blood-2005-11-4407
   *CDCP, 1982, MMWR-MORBID MORTAL W, V31, P365
   Chorba TL, 2001, AM J HEMATOL, V66, P229, DOI 10.1002/ajh.1050
   Darby SC, 2007, BLOOD, V110, P815, DOI 10.1182/blood-2006-10-050435
   Darby SC, 2004, J THROMB HAEMOST, V2, P1047, DOI 10.1046/j.1538-7836.2004.00710.x
   Dolan G, 2010, HAEMOPHILIA, V16, P11, DOI 10.1111/j.1365-2516.2010.02287.x
   Eckhardt CL, 2009, J THROMB HAEMOST, V7, P930, DOI 10.1111/j.1538-7836.2009.03357.x
   Eyster ME, 2008, HAEMOPHILIA, V14, P697, DOI 10.1111/j.1365-2516.2008.01702.x
   Eyster ME, 2007, HAEMOPHILIA, V13, P279, DOI 10.1111/j.1365-2516.2007.01453.x
   Foley CJ, 2010, J THROMB HAEMOST, V8, P208, DOI 10.1111/j.1538-7836.2009.03669.x
   Franchini M, 2008, HAEMOPHILIA, V14, P903, DOI 10.1111/j.1365-2516.2008.01839.x
   Franchini M, 2009, CANCER TREAT REV, V35, P374, DOI 10.1016/j.ctrv.2009.01.001
   Hermans C, 2009, HAEMOPHILIA, V15, P639, DOI 10.1111/j.1365-2516.2008.01950.x
   Hill FGH, 2004, AIDS, V18, P525, DOI [10.1097/01.aids.0000104368.21567.3c, 10.1097/00002030-200402200-00020]
   Hsue PY, 2010, CIRC-HEART FAIL, V3, P132, DOI 10.1161/CIRCHEARTFAILURE.109.854943
   Konkle BA, 2009, HAEMOPHILIA, V15, P1197, DOI 10.1111/j.1365-2516.2009.02066.x
   Kulkarni R, 2005, AM J HEMATOL, V79, P36, DOI 10.1002/ajh.20339
   Lichterfeld M, 2005, J INFECTION, V50, P221, DOI 10.1016/j.jinf.2004.04.003
   Ljung RCR, 2008, BRIT J HAEMATOL, V140, P378, DOI 10.1111/j.1365-2141.2007.06949.x
   Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659
   Mannucci PM, 2008, HAEMOPHILIA, V14, P10, DOI 10.1111/j.1365-2516.2008.01708.x
   Mannucci PM, 2009, BLOOD, V114, P5256, DOI 10.1182/blood-2009-07-215665
   Mauser-Bunschoten EP, 2009, HAEMOPHILIA, V15, P853, DOI 10.1111/j.1365-2516.2009.01987.x
   Noda I, 2010, J GASTROENTEROL, V45, P105, DOI 10.1007/s00535-009-0131-x
   Nuss R, 2001, AM J HEMATOL, V68, P37, DOI 10.1002/ajh.1146
   Oldenburg J, 2009, HAEMOPHILIA, V15, P2, DOI 10.1111/j.1365-2516.2008.01946.x
   Plug I, 2006, J THROMB HAEMOST, V4, P510, DOI 10.1111/j.1538-7836.2006.01808.x
   Posthouwer D, 2007, J THROMB HAEMOST, V5, P1624, DOI 10.1111/j.1538-7836.2007.02619.x
   Posthouwer D, 2007, J THROMB HAEMOST, V5, P25, DOI 10.1111/j.1538-7836.2006.02272.x
   Posthouwer D, 2007, BLOOD, V109, P3667, DOI 10.1182/blood-2006-08-038349
   Ragni MV, 2010, HAEMOPHILIA, V16, P40, DOI 10.1111/j.1365-2516.2010.02292.x
   Ragni MV, 2009, HAEMOPHILIA, V15, P552, DOI 10.1111/j.1365-2516.2008.01935.x
   Reitter S, 2009, HAEMOPHILIA, V15, P888, DOI 10.1111/j.1365-2516.2009.02029.x
   Richards M, 2007, HAEMOPHILIA, V13, P473, DOI 10.1111/j.1365-2516.2007.01478.x
   Sax PE, 2010, CIRCULATION, V121, P620, DOI 10.1161/CIR.0b013e3181d2c863
   Schutgens REG, 2009, HAEMOPHILIA, V15, P952, DOI 10.1111/j.1365-2516.2009.02020.x
   Shin JL, 2005, AM J HEMATOL, V78, P85, DOI 10.1002/ajh.20263
   Siboni SM, 2009, J THROMB HAEMOST, V7, P780, DOI 10.1111/j.1538-7836.2009.03318.x
   Soucie JM, 2000, BLOOD, V96, P437
   Soucie JM, 2001, HAEMOPHILIA, V7, P198, DOI 10.1046/j.1365-2516.2001.00484.x
   Soucie JM, 2001, TRANSFUSION, V41, P338, DOI 10.1046/j.1537-2995.2001.41030338.x
   Street A, 2006, HAEMOPHILIA, V12, P8, DOI 10.1111/j.1365-2516.2006.01254.x
   Tagliaferri A, 2010, HAEMOPHILIA, V16, P437, DOI 10.1111/j.1365-2516.2009.02188.x
   Tang M, 2009, HAEMOPHILIA, V15, P101, DOI 10.1111/j.1365-2516.2008.01895.x
   Tradati F, 1998, BLOOD, V91, P1173
   Tuinenburg A, 2009, J THROMB HAEMOST, V7, P247, DOI 10.1111/j.1538-7836.2008.03201.x
   Valentino LA, 2009, HAEMOPHILIA, V15, P5, DOI 10.1111/j.1365-2516.2009.02159.x
   Van Veen JJ, 2008, HAEMOPHILIA, V14, P434, DOI 10.1111/j.1365-2516.2008.01653.x
NR 48
TC 53
Z9 59
U1 0
U2 4
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 1520-4391
EI 1520-4383
J9 HEMATOL-AM SOC HEMAT
JI Hematol.-Am. Soc. Hematol. Educ. Program
PD DEC
PY 2010
BP 191
EP 196
DI 10.1182/asheducation-2010.1.191
PG 6
WC Education, Scientific Disciplines; Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Education & Educational Research; Hematology
GA V29PF
UT WOS:000208759600031
PM 21239793
OA Bronze
DA 2024-02-19
ER

PT J
AU VieiraCoelho, MA
   SoaresdaSilva, P
AF VieiraCoelho, MA
   SoaresdaSilva, P
TI Ontogenic aspects of liver and kidney catechol-O-methyltransferase
   sensitivity to tolcapone
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE catechol-O-methyltransferase; kidney; liver; tolcapone; ontogeny
AB 1 The present work describes the catechol-O-methyltransferase (COMT) activities in the liver and kidney of developing and adult rats (aged 3, 6, 9, 18, 30 and 60 days; n = 5 per group) and evaluates the enzyme sensitivity to inhibition by tolcapone, a reversible COMT inhibitor.
   2 COMT activity, evaluated by the ability to methylate adrenaline to metanephrine, was determined in liver and kidney homogenates prepared in 0.5 mM phosphate buffer (pH = 7.8) containing pargyline (0.1 mM), MgCl2 (0.1 mM), EGTA (1 mM) and S-adenosyl-L-methionine (0.1 mM). V-max (in nmol mg(-1) protein h(-1)) of liver COMT was found to decrease gradually with age, from 5.3 +/- 0.5 at the age of 3 days up to 2.9 +/- 0.2 at the age of 60 days; for the same age range, K-m values (in mu M; geometric means with 95% confidence limits) increased from 3.3 (1.0, 7.5) up to 13.1 (2.1, 24.1). At the age of 3 days, V-max values for kidney COMT (2.6 +/- 0.1) were lower than those for the liver COMT. However, V-max values for kidney COMT were found to increase up to 6.2 +/- 0.6 at the age of 18 days and then declined by 44% at the age of 30 and 60 days. In kidney, aging was also accompanied by an increase in K-m values for COMT (from 2.7 [1.1, 4.3] up to 24.0 [11.7, 36.3]).
   3 The sensitivity of liver and renal COMT activity to tolcapone was markedly dependent on the age, 3-days old rats being more sensitive to tolcapone than older animals. The IC50 values (in nM) for inhibition of liver COMT by tolcapone increased gradually with age, from 41 (26, 65) at the age of 3 days up to 720 (640, 800) at the age of 60 days. As was found in the liver, IC50 values (in nM) for inhibition of kidney COMT by tolcapone also increased with age, from 8 (6, 10) at the age of 3 days up to 177 (131, 240) at the age of 60 days. In all experimental groups, the IC50 values for inhibition of liver COMT by tolcapone was higher than those for kidney COMT.
   4 In conclusion, these results suggest that aging is accompanied by a decrease in liver and kidney COMT affinity for the substrate (evidenced by the increase in K-m values) and a decrease in sensivity towards inhibition by tolcapone (evidenced by the increase in IC50 values). Furthermore, kidney COMT is shown to be more sensitive to inhibition by tolcapone than liver COMT, irrespective of the age of the animal.
C1 FAC MED, INST PHARMACOL & THERAPEUT, P-4200 OPORTO, PORTUGAL.
C3 Universidade do Porto
RI Soares-da-Silva, Patricio/A-6704-2015
OI Soares-da-Silva, Patricio/0000-0002-2446-5078; Vieira-Coelho, Maria
   Augusta/0000-0001-8968-1348
CR APPRILE J, 1975, BIOCHEM BIOPH RES CO, V64, P1293
   AXELROD J, 1959, J NEUROCHEM, V5, P68, DOI 10.1111/j.1471-4159.1959.tb13334.x
   AXELROD J, 1958, J BIOL CHEM, V233, P702
   AXELROD J, 1966, PHARMACOL REV, V18, P995
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   FERNANDES MH, 1993, ADV BIOSCI, V88, P21
   GULDBERG HC, 1975, PHARMACOL REV, V27, P135
   KOPIN I, 1986, PHARMACOL REV, V37, P334
   MANNISTO PT, 1989, TRENDS PHARMACOL SCI, V10, P54, DOI 10.1016/0165-6147(89)90075-8
   MEISTER B, 1993, KIDNEY INT, V44, P726, DOI 10.1038/ki.1993.306
   MOTULSKY HG, 1994, GRAPHPAD PRIMS VERSI
   ROBERTS JW, 1993, NEUROLOGY S2, V43
   ROTH JA, 1992, REV PHYSL BIOCH PHAR, V88, P1
   SAORESDASILVA P, 1993, J AM SOC NEPHROL, V4, P896
   SOARESDASILVA P, 1994, BRIT J PHARMACOL, V112, P611, DOI 10.1111/j.1476-5381.1994.tb13118.x
   SOARESDASILVA P, 1994, NEWS PHYSIOL SCI, V9, P128
   TONG JH, 1977, CAN J BIOCHEM CELL B, V55, P1108, DOI 10.1139/o77-164
   TRENDELENBURG U, 1988, HDB EXP PHARM, V90, P279
   VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0
   Vieira-Coelho M. A., 1994, British Journal of Pharmacology, V112, p410P
   VIEIRACOELHO MA, 1994, J NEURAL TRANSM-SUPP, P365
   ZURCHER G, 1990, ADV NEUROL, V53, P497
   ZURCHER G, 1990, J NEUR TR S, P375
NR 23
TC 50
Z9 51
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0007-1188
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD FEB
PY 1996
VL 117
IS 3
BP 516
EP 520
DI 10.1111/j.1476-5381.1996.tb15220.x
PG 5
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA TY676
UT WOS:A1996TY67600017
PM 8821542
OA Green Published
DA 2024-02-19
ER

PT J
AU Tarantini, S
   Valcarcel-Ares, NM
   Yabluchanskiy, A
   Springo, Z
   Fulop, GA
   Ashpole, N
   Gautam, T
   Giles, CB
   Wren, JD
   Sonntag, WE
   Csiszar, A
   Ungvari, Z
AF Tarantini, Stefano
   Valcarcel-Ares, Noa M.
   Yabluchanskiy, Andriy
   Springo, Zsolt
   Fulop, Gabor A.
   Ashpole, Nicole
   Gautam, Tripti
   Giles, Cory B.
   Wren, Jonathan D.
   Sonntag, William E.
   Csiszar, Anna
   Ungvari, Zoltan
TI Insulin-like growth factor 1 deficiency exacerbates hypertension-induced
   cerebral microhemorrhages in mice, mimicking the aging phenotype
SO AGING CELL
LA English
DT Article
DE arteriole; dementia; gait dysfunction; microbleed; oxidative stress
ID VASCULAR OXIDATIVE STRESS; IGF-1 DEFICIENCY; ANTIOXIDANT RESPONSE;
   MICROBLEEDS; DYSFUNCTION; ACTIVATION; DEMENTIA; ARTERIES; RISK
AB Clinical and experimental studies show that aging exacerbates hypertension-induced cerebral microhemorrhages (CMHs), which progressively impair neuronal function. There is growing evidence that aging promotes insulin-like growth factor 1 (IGF-1) deficiency, which compromises multiple aspects of cerebromicrovascular and brain health. To determine the role of IGF-1 deficiency in the pathogenesis of CMHs, we induced hypertension in mice with liver-specific knockdown of IGF-1 (Igf1(f/f) + TBG-Cre-AAV8) and control mice by angiotensin II plus L-NAME treatment. In IGF-1-deficient mice, the same level of hypertension led to significantly earlier onset and increased incidence and neurological consequences of CMHs, as compared to control mice, as shown by neurological examination, gait analysis, and histological assessment of CMHs in serial brain sections. Previous studies showed that in aging, increased oxidative stress-mediated matrix metalloprotease (MMP) activation importantly contributes to the pathogenesis of CMHs. Thus, it is significant that hypertension-induced cerebrovascular oxidative stress and MMP activation were increased in IGF-1-deficient mice. We found that IGF-1 deficiency impaired hypertension-induced adaptive media hypertrophy and extracellular matrix remodeling, which together with the increased MMP activation likely also contributes to increased fragility of intracerebral arterioles. Collectively, IGF-1 deficiency promotes the pathogenesis of CMHs, mimicking the aging phenotype, which likely contribute to its deleterious effect on cognitive function. Therapeutic strategies that upregulate IGF-1 signaling in the cerebral vessels and/or
C1 [Tarantini, Stefano; Valcarcel-Ares, Noa M.; Yabluchanskiy, Andriy; Springo, Zsolt; Fulop, Gabor A.; Ashpole, Nicole; Gautam, Tripti; Giles, Cory B.; Wren, Jonathan D.; Sonntag, William E.; Csiszar, Anna; Ungvari, Zoltan] Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Reynolds Oklahoma Ctr Aging,Translat Gerosci Lab, Oklahoma City, OK USA.
   [Tarantini, Stefano; Csiszar, Anna; Ungvari, Zoltan] Univ Oklahoma, Dept Physiol, Hlth Sci Ctr, Oklahoma City, OK USA.
   [Giles, Cory B.; Wren, Jonathan D.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.
   [Giles, Cory B.; Wren, Jonathan D.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.
   [Csiszar, Anna; Ungvari, Zoltan] Univ Szeged, Dept Med Phys & Informat, Szeged, Hungary.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Oklahoma System; University of Oklahoma Health
   Sciences Center; Oklahoma Medical Research Foundation; University of
   Oklahoma System; University of Oklahoma Health Sciences Center; Szeged
   University
RP Ungvari, Z (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, 975 NE 10th St, Oklahoma City, OK 73104 USA.
EM zoltan-ungvari@ouhsc.edu
RI Springo, Zsolt/A-3398-2013; Wren, Jonathan D/E-5611-2011; Tarantini,
   Stefano/JMQ-7733-2023; Wrong, Wrong/ADU-0095-2022; Ungvari,
   Zoltan/GZK-8127-2022
OI Springo, Zsolt/0000-0003-2277-9740; Wren, Jonathan
   D/0000-0003-2776-3545; Tarantini, Stefano/0000-0001-5627-1430; sonntag,
   William/0000-0003-1850-2407; Yabluchanskiy, Andriy/0000-0002-9648-7161
FU American Heart Association; National Center for Complementary and
   Alternative Medicine [R01-AT006526]; National Institute on Aging
   [R01-AG047879, R01-AG038747, 3P30AG050911-02S1]; National Institute of
   Neurological Disorders and Stroke (NINDS) [R01-NS056218]; National
   Heart, Lung and Blood Institute [1R01HL132553-01]; Arkansas Claude
   Pepper Older Americans Independence Center at University of Arkansas
   Medical Center [P30 AG028718]; Oklahoma Center for the Advancement of
   Science and Technology; Oklahoma IDeA Network for Biomedical Research
   Excellence; NIA [T32 AG052363-01]; Reynolds Foundation
FX This work was supported by grants from the American Heart Association
   (to ST, MNVA, AC and ZU), the National Center for Complementary and
   Alternative Medicine (R01-AT006526 to ZU), the National Institute on
   Aging (R01-AG047879; R01-AG038747; 3P30AG050911-02S1), the National
   Institute of Neurological Disorders and Stroke (NINDS; R01-NS056218 to
   AC), the National Heart, Lung and Blood Institute (1R01HL132553-01), the
   Arkansas Claude Pepper Older Americans Independence Center at University
   of Arkansas Medical Center (to ZU; P30 AG028718), the Oklahoma Center
   for the Advancement of Science and Technology (to AC, ZU), the Oklahoma
   IDeA Network for Biomedical Research Excellence (to AC), the
   NIA-supported Geroscience Training Program in Oklahoma (T32
   AG052363-01), and the Reynolds Foundation (to ZU and AC).
CR Akoudad S, 2016, JAMA NEUROL, V73, P934, DOI 10.1001/jamaneurol.2016.1017
   Bailey-Downs LC, 2012, J GERONTOL A-BIOL, V67, P313, DOI 10.1093/gerona/glr164
   BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968
   Choi P, 2012, STROKE, V43, P1505, DOI 10.1161/STROKEAHA.111.647271
   Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH1882, DOI 10.1152/ajpheart.412.2008
   de Laat KF, 2011, STROKE, V42, P494, DOI 10.1161/STROKEAHA.110.596122
   Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86
   Lee SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025930
   Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x
   Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928
   Poels MMF, 2011, STROKE, V42, P656, DOI 10.1161/STROKEAHA.110.607184
   Romero JR, 2014, STROKE, V45, P1492, DOI 10.1161/STROKEAHA.114.004130
   Seo SW, 2007, STROKE, V38, P1949, DOI 10.1161/STROKEAHA.106.477315
   Sonntag WE, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00027
   Springo Z, 2015, J GERONTOL A-BIOL, V70, P1355, DOI 10.1093/gerona/glu244
   Tarantini S, 2016, AGE, V38, P239, DOI 10.1007/s11357-016-9943-9
   Tarantini S, 2016, AGE, V38, P273, DOI 10.1007/s11357-016-9931-0
   Tarumi T, 2014, J CEREBR BLOOD F MET, V34, P971, DOI 10.1038/jcbfm.2014.44
   Toth P, 2015, AGING CELL, V14, P1034, DOI 10.1111/acel.12372
   Toth P, 2015, AGING CELL, V14, P400, DOI 10.1111/acel.12315
   Toth P, 2014, J CEREBR BLOOD F MET, V34, P1887, DOI 10.1038/jcbfm.2014.156
   Toth P, 2013, J CEREBR BLOOD F MET, V33, P1732, DOI 10.1038/jcbfm.2013.143
   Ungvari Z, 2003, CIRCULATION, V108, P1253, DOI 10.1161/01.CIR.0000079165.84309.4D
   Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P866, DOI 10.1093/gerona/glr092
   Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, pH363, DOI 10.1152/ajpheart.01134.2010
   Wakisaka Y, 2010, STROKE, V41, P790, DOI 10.1161/STROKEAHA.109.569616
   Wakisaka Y, 2010, J CEREBR BLOOD F MET, V30, P56, DOI 10.1038/jcbfm.2009.183
   Wren JD, 2004, BIOINFORMATICS, V20, P191, DOI 10.1093/bioinformatics/btg390
NR 28
TC 69
Z9 78
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9726
J9 AGING CELL
JI Aging Cell
PD JUN
PY 2017
VL 16
IS 3
BP 469
EP 479
DI 10.1111/acel.12583
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EW3TY
UT WOS:000402426900006
PM 28295976
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Wang, S
   Zhang, J
   Zhu, L
   Song, LL
   Meng, ZW
   Jia, Q
   Li, X
   Liu, N
   Hu, TP
   Zhou, PP
   Zhang, Q
   Liu, L
   Song, K
   Jia, QY
AF Wang, Sen
   Zhang, Jie
   Zhu, Li
   Song, Linlin
   Meng, Zhaowei
   Jia, Qiang
   Li, Xue
   Liu, Na
   Hu, Tianpeng
   Zhou, Pingping
   Zhang, Qing
   Liu, Li
   Song, Kun
   Jia, Qiyu
TI Association between liver function and metabolic syndrome in Chinese men
   and women
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; TOTAL BILIRUBIN; ALANINE
   AMINOTRANSFERASE; RISK-FACTORS; ECTOPIC FAT; PREVALENCE; ADULTS;
   ENZYMES; GENDER
AB Metabolic syndrome (MS) could be associated with liver function. Our study aimed to investigate the association between liver function and MS in a large cohort of Chinese men and women. We enrolled 32,768 ostensibly healthy participants. The associations between liver function and MS of both genders were analyzed separately after dividing total bilirubin (TBIL), gamma glutamyltransferase (GGT), alanine aminotransferase (ALT) into quartiles. Young males had significantly higher MS prevalence than females, yet after menopause, females had higher MS prevalence. We used TBIL, GGT and ALT quartiles as categorical variables in binary logistic regression models. Significantly decreased MS risks were demonstrated in TBIL quartiles 2 to 4 for males, and quartiles 3 to 4 for females. As to GGT and ALT, significantly increased MS risks were shown in high quartiles for both genders. Aging also resulted in significantly higher MS risks in both genders except for young females. This study displayed close associations between liver function and MS, which were influenced by gender and age. A high TBIL level had protective effect against MS, while high GGT and ALT levels were risk factors for MS. It is meaningful that liver function is used as clinical risk predictors for MS.
C1 [Wang, Sen; Meng, Zhaowei; Jia, Qiang; Li, Xue; Liu, Na; Hu, Tianpeng; Zhou, Pingping] Tianjin Med Univ Gen Hosp, Dept Nucl Med, Tianjin, Peoples R China.
   [Zhang, Jie] Tianjin Med Univ Gen Hosp, Dept Surg, Sect Ultrasound & Intervent Therapy, Tianjin, Peoples R China.
   [Zhu, Li; Song, Linlin] Tianjin Med Univ Gen Hosp, Dept Ultrasound, Tianjin, Peoples R China.
   [Zhang, Qing; Liu, Li; Song, Kun; Jia, Qiyu] Tianjin Med Univ Gen Hosp, Dept Hlth Management, Tianjin, Peoples R China.
C3 Tianjin Medical University; Tianjin Medical University; Tianjin Medical
   University; Tianjin Medical University
RP Meng, ZW (corresponding author), Tianjin Med Univ Gen Hosp, Dept Nucl Med, Tianjin, Peoples R China.
EM jamesmencius@163.com
RI Yang, Jie/JDM-6213-2023; Hu, Peng Tian/GQA-9639-2022; Meng,
   Zhaowei/AAE-4732-2022
OI Yang, Jie/0000-0002-3941-0053; 
FU National Key Clinical Specialty Project (awarded to the Departments of
   Nuclear Medicine and Radiology); Tianjin Medical University General
   Hospital New Century Excellent Talent Program; Young and Middle-aged
   Innovative Talent Training Program from Tianjin Education Committee;
   Tianjin Education Committee; China National Natural Science Foundation
   [81571709]; Key Project of Tianjin Science and Technology Committee
   Foundation [16JCZDJC34300]; Tianjin Science and Technology Committee
   Foundation [11ZCGYSY05700, 12ZCZDSY20400, 13ZCZDSY20200]; Tianjin Human
   Resources and Social Security Bureau
FX This study was supported by the National Key Clinical Specialty Project
   (awarded to the Departments of Nuclear Medicine and Radiology). This
   study was supported by Tianjin Medical University General Hospital New
   Century Excellent Talent Program; Young and Middle-aged Innovative
   Talent Training Program from Tianjin Education Committee; and Talent
   Fostering Program (the 131 Project) from Tianjin Education Committee,
   Tianjin Human Resources and Social Security Bureau (awarded to Zhaowei
   Meng). This study was supported by China National Natural Science
   Foundation grant 81571709, Key Project of Tianjin Science and Technology
   Committee Foundation grant 16JCZDJC34300 (awarded to Zhaowei Meng). This
   study was also supported by Tianjin Science and Technology Committee
   Foundation grants 11ZCGYSY05700, 12ZCZDSY20400, 13ZCZDSY20200 and
   (awarded to Qing Zhang, Qiyu Jia and Kun Song). We also want to thank
   Kai Jin (Department of Statistics, University of California, Davis, USA)
   and Breanna Snow Chan (writing specialist, University of California,
   Davis, USA) for their valuable suggestions and advices on the language
   of this paper during revision.
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264
   Byrne CD, 2012, DIABETIC MED, V29, P1098, DOI 10.1111/j.1464-5491.2012.03732.x
   Byrne CD, 2014, ARTERIOSCL THROM VAS, V34, P1155, DOI 10.1161/ATVBAHA.114.303034
   Byrne CD, 2009, CLIN SCI, V116, P539, DOI 10.1042/CS20080253
   Campbell B, 2016, DIABETES METAB SYND, V10, P230, DOI 10.1016/j.dsx.2016.06.014
   Choi SH, 2013, NUTR METAB CARDIOVAS, V23, P31, DOI 10.1016/j.numecd.2011.03.001
   Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D
   Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1
   Hopps E, 2010, NUTR METAB CARDIOVAS, V20, P72, DOI 10.1016/j.numecd.2009.06.002
   Hsieh MH, 2009, INT J OBESITY, V33, P1309, DOI 10.1038/ijo.2009.172
   Hwang HJ, 2011, CLIN CHEM LAB MED, V49, P1823, DOI 10.1515/CCLM.2011.662
   Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26
   Jenko-Praznikar Z, 2013, METABOLISM, V62, P976, DOI 10.1016/j.metabol.2013.01.011
   Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021
   Lee Han Chu, 2011, Korean J Hepatol, V17, P9, DOI 10.3350/kjhep.2011.17.1.9
   Li G, 2010, ASIA PAC J CLIN NUTR, V19, P98
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P997, DOI 10.1016/j.dld.2015.08.004
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020
   Lu JL, 2017, J CLIN ENDOCR METAB, V102, P507, DOI 10.1210/jc.2016-2477
   Meng ZW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002193
   Moebus S, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-34
   Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623
   Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757
   Nano J, 2016, DIABETES METAB, V42, P389, DOI 10.1016/j.diabet.2016.06.002
   Oda E, 2009, INTERNAL MED, V48, P1343, DOI 10.2169/internalmedicine.48.2094
   Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690
   Perera S, 2008, DIABETES METAB SYND, V2, P171, DOI 10.1016/j.dsx.2008.04.012
   Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5
   Regitz-Zagrosek V, 2007, GENDER MED, V4, pS162, DOI 10.1016/S1550-8579(07)80056-8
   Song QB, 2015, DIABETES VASC DIS RE, V12, P189, DOI 10.1177/1479164114562410
   Tomaro ML, 2002, INT J BIOCHEM CELL B, V34, P216, DOI 10.1016/S1357-2725(01)00130-3
   Tsai PY, 2007, J ADOLESCENT HEALTH, V41, P132, DOI 10.1016/j.jadohealth.2007.03.002
   Villegas R, 2011, METAB SYNDR RELAT D, V9, P305, DOI 10.1089/met.2011.0016
   Vítek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055
   Wang GR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-599
   Wei C, 2011, ARCH DIS CHILD, V96, P1003, DOI 10.1136/adc.2010.190975
   Wu YH, 2011, J DIABETES, V3, P217, DOI 10.1111/j.1753-0407.2011.00138.x
   Xia MF, 2011, CLIN EXP PHARMACOL P, V38, P373, DOI 10.1111/j.1440-1681.2011.05519.x
   Xu SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078270
   Yki-Järvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4
   Zhang L, 2015, ONCOTARGET, V6, P26782, DOI 10.18632/oncotarget.5792
   Zhang Q, 2011, CLIN RHEUMATOL, V30, P777, DOI 10.1007/s10067-010-1660-7
   Zhang XB, 2014, INT J ENV RES PUB HE, V11, P12767, DOI 10.3390/ijerph111212767
   Zhang YF, 2010, ENDOCRINE, V38, P181, DOI 10.1007/s12020-010-9369-6
NR 45
TC 37
Z9 38
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 20
PY 2017
VL 7
AR 44844
DI 10.1038/srep44844
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EP1XZ
UT WOS:000397178900001
PM 28317840
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Snider, TA
   Richardson, A
   Stoner, JA
   Deepa, SS
AF Snider, Timothy A.
   Richardson, Arlan
   Stoner, Julie A.
   Deepa, Sathyaseelan S.
TI The Geropathology Grading Platform demonstrates that mice null for
   Cu/Zn-superoxide dismutase show accelerated biological aging
SO GEROSCIENCE
LA English
DT Article
DE Pathology; Cu/Zn-superoxide dismutase; Aging; Geropathology Grading
   Platform; Healthspan
ID OXIDATIVE STRESS; SOD1(-/-) MICE; MUSCLE ATROPHY; PATHOLOGY; PHENOTYPE;
   RAPAMYCIN; DISEASE; LEADS; LIFE
AB The Geropathology Grading Platform (GGP) that is being developed by the Geropathology Research Network provides a grading system that allows investigators to assess biological aging in mice by measuring the pathological status of a wide range of tissues in a standardized scoring system. The GGP is a grading system that generates a numerical score for the total lesions in each tissue, which when averaged over the mice in the cohort provides a composite lesion score (CLS) for each tissue and mouse. In this study, we tested ability of the GGP to predict accelerated aging in mice null for Cu/Zn-superoxide dismutase (Sod1KO mice), which have been shown to have reduced lifespan and healthspan. Using the GGP, we evaluated the pathological status of 11 tissues from male and female wild-type WT) and Sod1KO mice at 9 to 10 months of age. The whole animal CLS was 2- to 3.5-fold higher for both male and female Sod1KO mice compared to WT mice. The tissues most affected in the Sod1KO mice were the liver, lung, and kidney. These data demonstrate that the GGP is able to predict the accelerated aging phenotype observed in the Sod1KO mice and correlates with the changes in healthspan that have been reported for Sod1KO mice. Thus, the GGP is a new paradigm for evaluating the effect of an intervention on the pathological status of an animal as well as the healthspan of the mice.
C1 [Snider, Timothy A.] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA.
   [Richardson, Arlan; Deepa, Sathyaseelan S.] Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK USA.
   [Richardson, Arlan] Oklahoma City VA Med Ctr, Oklahoma City, OK USA.
   [Stoner, Julie A.] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA.
C3 Oklahoma State University System; Oklahoma State University -
   Stillwater; University of Oklahoma System; University of Oklahoma Health
   Sciences Center; University of Oklahoma System; University of Oklahoma
   Health Sciences Center; University of Oklahoma System; University of
   Oklahoma Health Sciences Center
RP Snider, TA (corresponding author), Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA.
EM tim.snider@okstate.edu
OI Snider, Timothy/0000-0002-2659-835X
FU Geropathology Research Network [1R24AG047115]; National Institute on
   Aging [P01AG020591, R01AG045693, R01 AG057424]; Department of Veterans
   Affairs
FX This study was made possible by a grant to Dr. Warren Ladiges
   (1R24AG047115), which supported the development of the GGP by the
   Geropathology Research Network. The research described above was
   supported by grants to Dr. Arlan Richardson from the National Institute
   on Aging (P01AG020591, R01AG045693, and R01 AG057424) and a Senior
   Research Scientist Career Award from the Department of Veterans Affairs.
CR BRONSON RT, 1993, AGING-CLIN EXP RES, V5, P253, DOI 10.1007/BF03324169
   Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
   Daniel W. W, 2014, BIOSTATISTICS FDN AN
   Deepa SS, 2017, GEROSCIENCE, V39, P187, DOI 10.1007/s11357-017-9975-9
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Fischer KE, 2016, AGING-US, V8, P2370, DOI 10.18632/aging.101059
   Iuchi Y, 2010, MOL CELL BIOCHEM, V341, P181, DOI 10.1007/s11010-010-0449-y
   Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009
   Ladiges W, 2017, J GERONTOL A-BIOL, V72, P760, DOI 10.1093/gerona/glx019
   Ladiges W, 2017, PATHOBIOL AGING AGE, V7, DOI [10.1080/20010001.2017.304005, 10.1080/20010001.2017.1304005]
   Ladiges W, 2016, J GERONTOL A-BIOL, V71, P431, DOI 10.1093/gerona/glv079
   Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036
   Olofsson EM, 2007, FREE RADICAL BIO MED, V42, P1098, DOI 10.1016/j.freeradbiomed.2007.01.012
   Richardson A, 2015, EXP GERONTOL, V68, P51, DOI 10.1016/j.exger.2014.12.002
   Richardson A, 2013, J CLIN INVEST, V123, P3204, DOI 10.1172/JCI70800
   Zhang YQ, 2017, REDOX BIOL, V11, P30, DOI 10.1016/j.redox.2016.10.014
   Zhang YQ, 2013, FREE RADICAL BIO MED, V60, P300, DOI 10.1016/j.freeradbiomed.2013.02.026
NR 19
TC 10
Z9 13
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD APR
PY 2018
VL 40
IS 2
BP 97
EP 103
DI 10.1007/s11357-018-0008-0
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA GG9RZ
UT WOS:000433040100002
PM 29478190
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Xin, G
   Shong, L
   Hui, L
AF Xin, Ge
   Shong, Liu
   Hui, Liu
TI Effect of genetic and non-genetic factors, including aging, on waist
   circumference and BMI, and inter-indicator differences in risk
   assessment
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Abdominal obesity; Genetic; Geriatric disease
ID BODY-MASS INDEX; LIFE EXPECTANCY; ARTERY-DISEASE; LIVER-CANCER; HIP
   RATIO; OBESITY; ASSOCIATION; POPULATION; CHINESE; WOMEN
AB Objective: To assess the effect of genetic and non-genetic factors on indicators derived from waist circumference (WC) and body mass index (BMI) as well as inter-indicator differences in risk assessment age-related diseases including diabetes mellitus, coronary heart disease and liver cancer.
   Methods: Height, weight and WC were measured in 100 families (students and their two parents), 41 subjects with regular physical exercise routines, and 170 patients with diabetes mellitus, coronary heart disease or liver cancer. The BMI, waist-height ratio (WHtR) and waist circumference density index (WCDI) were calculated for each subject.
   Results: BMI was less affected by genetic factors, while WHtR and WCDI were greatly affected by genetic factors as revealed using multiple regression analysis. BMI, WHtR and WCDI were all sensitive to physical exercise according to ROC analysis; among these factors, the most sensitive indicator was WHtR. However, ROC analysis demonstrated that WCDI was more effective than BMI and WHtR for assessing the risk of three diseases.
   Conclusions: WCDI more accurately reflects the roles of both genetic and non-genetic factors, including aging, which can better predict disease. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Xin, Ge; Shong, Liu; Hui, Liu] Dalian Med Univ, Coll Med Lab, Dalian 116044, Peoples R China.
C3 Dalian Medical University
RP Hui, L (corresponding author), Dalian Med Univ, Coll Med Lab, Dalian 116044, Peoples R China.
EM liuhui60@sina.com
CR Carmienke S, 2013, EUR J CLIN NUTR, V67, P573, DOI 10.1038/ejcn.2013.61
   Chen Y, 2012, EUR J CANCER, V48, P2137, DOI 10.1016/j.ejca.2012.02.063
   Choi JH, 2013, CURR OPIN ENDOCRINOL, V20, P62, DOI 10.1097/MED.0b013e32835b7ec7
   Chrysant SG, 2013, J AM SOC HYPERTENS, V7, P85, DOI 10.1016/j.jash.2012.11.008
   Cronin O, 2013, ATHEROSCLEROSIS, V228, P316, DOI 10.1016/j.atherosclerosis.2013.03.002
   Edwards DRV, 2013, HUM GENET, V132, P323, DOI 10.1007/s00439-012-1246-3
   Finkelstein EA, 2010, OBESITY, V18, P333, DOI 10.1038/oby.2009.253
   Gonzalez-Bulnes A, 2012, CURR DIABETES REV, V8, P144, DOI 10.2174/157339912799424537
   Gupta V, 2012, GENET TEST MOL BIOMA, V16, P948, DOI 10.1089/gtmb.2012.0051
   Kalra S, 2013, J PAK MED ASSOC, V63, P532
   Manco M, 2012, PEDIATRICS, V130, P123, DOI 10.1542/peds.2011-2717
   Mi SQ, 2013, BIOMED ENVIRON SCI, V26, P485, DOI 10.3967/0895-3988.2013.06.009
   Mutschler J, 2013, ANN NUTR METAB, V62, P271, DOI 10.1159/000346799
   Oboh Henrietta A, 2011, Nig Q J Hosp Med, V21, P16
   Page JH, 2009, EPIDEMIOLOGY, V20, P361, DOI 10.1097/EDE.0b013e31819f38f1
   Phan-Hug F, 2012, BEST PRACT RES CL EN, V26, P133, DOI 10.1016/j.beem.2011.11.010
   Preston SH, 2011, AM J PUBLIC HEALTH, V101, P2137, DOI 10.2105/AJPH.2011.300219
   Prudente S, 2012, NUTR METAB CARDIOVAS, V22, P929, DOI 10.1016/j.numecd.2012.04.010
   Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610
   Qin L, 2010, DIABETES CARE, V33, P2342, DOI 10.2337/dc10-0369
   Radzeviciene L, 2013, PUBLIC HEALTH, V127, P241, DOI 10.1016/j.puhe.2012.12.001
   Shen C, 2012, FRONT BIOSCI-LANDMRK, V17, P2356, DOI 10.2741/4057
   Siavash M, 2008, ANN NUTR METAB, V53, P162, DOI 10.1159/000172977
   Singh PN, 2011, J AM GERIATR SOC, V59, P1003, DOI 10.1111/j.1532-5415.2011.03419.x
   Surakka I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002333
   Tanaka K, 2012, JPN J CLIN ONCOL, V42, P212, DOI 10.1093/jjco/hyr198
   Xin G, 2014, DIABETES RES CLIN PR, V106, P95, DOI 10.1016/j.diabres.2014.07.024
   Yang F, 2014, BIOMED ENVIRON SCI, V27, P360, DOI 10.3967/bes2014.061
   Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6
   Zhao XY, 2013, EXP GERONTOL, V48, P422, DOI 10.1016/j.exger.2013.02.007
NR 30
TC 6
Z9 6
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 2014
VL 60
BP 83
EP 86
DI 10.1016/j.exger.2014.10.005
PG 4
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AW1RW
UT WOS:000346068300011
PM 25305560
DA 2024-02-19
ER

PT J
AU Hiraoka, A
   Hidaka, S
   Shimizu, Y
   Utsunomiya, H
   Imai, Y
   Tatsukawa, H
   Tazuya, N
   Yamago, H
   Yorimitsu, N
   Tanihira, T
   Hasebe, A
   Miyamoto, Y
   Ninomiya, T
   Kawasaki, H
   Hirooka, M
   Abe, M
   Hiasa, Y
   Matsuura, B
   Onji, M
   Michitaka, K
AF Hiraoka, Atsushi
   Hidaka, Satoshi
   Shimizu, Yuko
   Utsunomiya, Hiroki
   Imai, Yusuke
   Tatsukawa, Haruka
   Tazuya, Nayu
   Yamago, Hiroka
   Yorimitsu, Nobukazu
   Tanihira, Tetsuya
   Hasebe, Aki
   Miyamoto, Yasunao
   Ninomiya, Tomoyuki
   Kawasaki, Hideki
   Hirooka, Masashi
   Abe, Masanori
   Hiasa, Yoichi
   Matsuura, Bunzo
   Onji, Morikazu
   Michitaka, Kojiro
TI Recent Trends of Japanese Hepatocellular Carcinoma due to HCV in Aging
   Society
SO HEPATO-GASTROENTEROLOGY
LA English
DT Article
DE Hepatocellular carcinoma; Aging society; Elderly; HCV
ID CONTRAST-ENHANCED ULTRASONOGRAPHY; RADIOFREQUENCY ABLATION THERAPY;
   CHRONIC HEPATITIS-C; SORAFENIB; RESECTION; IMPACT; TRIAL; RISK
AB Background/Aims: The mean age of hepatocellular carcinoma (HCC) patients has increased (>= 65 years old). We want to identify the recent trend of the clinical features of HCC patients due to hepatitis C virus (HCV) (HCV-HCC). Methodology: From 2000 to 2009, 855 naive HCC patients were admitted. HCV-HCC patients were divided into two groups, first period group (2000-04, n = 270) and second period group (2005-09, n = 343) and the clinical features of HCV-HCC were investigated. Results: There was no difference in gender, TNM stage and percentages of HCV-HCC between the periods. On the other hand, the ratio of HCV-HCC patients with worse liver function (Child-Pugh B or C), elderly (>= 75 years old) and the population of patients treated with low invasive radiofrequency ablation were increased (30.0% to 42.0%, 17.8% to 33.5% and 26.7% to 42.9%, respectively; p<0.01). The 1y-, 3y- and 5y-survival rate of HCV-HCC did not show differences (82.1%, 60.5% and 44.7% vs. 81.8%, 56.9% and 37.7%, respectively; p = 0.219). Conclusions: The ratio of aged HCV-HCC as well as HCV-HCC patients with worse liver function was increased. The less invasive treatment for HCC in these patients and the quick anti-viral treatment for HCV patients should be considered to avoid occurrence of HCC in Japan.
C1 [Hiraoka, Atsushi; Hidaka, Satoshi; Shimizu, Yuko; Utsunomiya, Hiroki; Imai, Yusuke; Tatsukawa, Haruka; Tazuya, Nayu; Yamago, Hiroka; Yorimitsu, Nobukazu; Tanihira, Tetsuya; Hasebe, Aki; Miyamoto, Yasunao; Ninomiya, Tomoyuki; Michitaka, Kojiro] Ehime Prefectural Cent Hosp, Gastroenterol Ctr, Matsuyama, Ehime 7900024, Japan.
   [Kawasaki, Hideki] Ehime Prefectural Cent Hosp, Dept Surg, Matsuyama, Ehime 7900024, Japan.
   [Hirooka, Masashi; Abe, Masanori; Hiasa, Yoichi; Matsuura, Bunzo; Onji, Morikazu] Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Matsuyama, Ehime 790, Japan.
C3 Ehime University
RP Hiraoka, A (corresponding author), Ehime Prefectural Cent Hosp, Gastroenterol Ctr, Kasuga Cho 83, Matsuyama, Ehime 7900024, Japan.
EM hirage@m.ehime-u.ac.jp
RI Hirooka, Masashi/JUF-2562-2023; Hiraoka, Atsushi/AFR-0440-2022; Hiasa,
   Yoichi/ABD-2759-2021
OI Hiraoka, Atsushi/0000-0003-1989-0480; Hiasa, Yoichi/0000-0003-4117-339X
CR Arase Y, 2007, J MED VIROL, V79, P1095, DOI 10.1002/jmv.20866
   Fujiki M, 2009, AM J TRANSPLANT, V9, P2362, DOI 10.1111/j.1600-6143.2009.02783.x
   Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db
   Hiraoka A, 2011, J GASTROEN HEPATOL, V26, P616, DOI 10.1111/j.1440-1746.2011.06678.x
   Hiraoka A, 2010, ONCOL LETT, V1, P57, DOI 10.3892/ol_00000010
   Hiraoka A, 2010, J GASTROEN HEPATOL, V25, P403, DOI 10.1111/j.1440-1746.2009.06037.x
   Hiraoka A, 2008, HEPATO-GASTROENTEROL, V55, P2171
   Liver cancer study group of Japan, 2009, GEN RUL CLIN PATH ST, P24
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Makuuchi M, 2006, WORLD J GASTROENTERO, V12, P828, DOI 10.3748/wjg.v12.i5.828
   Nishiguchi S, 2001, LANCET, V357, P196, DOI 10.1016/S0140-6736(00)03595-9
   Nishiguchi T, 1995, LANCET, V346, P1051
   PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817
   Rimassa L, 2009, EXPERT REV ANTICANC, V9, P739, DOI [10.1586/era.09.41, 10.1586/ERA.09.41]
   Saito Kazuhiro, 2005, Magn Reson Med Sci, V4, P1, DOI 10.2463/mrms.4.1
   Shiina S, 2005, GASTROENTEROLOGY, V129, P122, DOI 10.1053/j.gastro.2005.04.009
   TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501
   Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003
NR 18
TC 10
Z9 10
U1 0
U2 1
PU H G E UPDATE MEDICAL PUBLISHING S A
PI ATHENS
PA PO BOX 17257, ATHENS GR-10024, GREECE
SN 0172-6390
J9 HEPATO-GASTROENTEROL
JI Hepato-Gastroenterol.
PD SEP
PY 2012
VL 59
IS 118
BP 1893
EP 1895
DI 10.5754/hge11732
PG 3
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery
GA 018UN
UT WOS:000309692100047
PM 22193439
DA 2024-02-19
ER

PT J
AU Harper, JM
   Salmon, AB
   Chang, YY
   Bonkowski, M
   Bartke, A
   Miller, RA
AF Harper, James M.
   Salmon, Adam B.
   Chang, Yayi
   Bonkowski, Michael
   Bartke, Andrzej
   Miller, Richard A.
TI Stress resistance and aging: Influence of genes and nutrition
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE stress resistance; caloric restriction; methionine restriction; snell
   dwarf; growth hormone receptor knockout
ID TERM CALORIC RESTRICTION; RECEPTOR/BINDING PROTEIN GENE; OXYGEN SPECIES
   PRODUCTION; LENS EPITHELIAL-CELLS; EXTENDED LIFE-SPAN; GROWTH-HORMONE;
   FISCHER-344 RATS; IN-VITRO; ACETAMINOPHEN NEPHROTOXICITY; OXIDATIVE
   STRESS
AB Previous studies have shown that dermal fibroblast cell lines derived from young adult mice of the long-lived Snell dwarf (dw/dw), Ames dwarf (df/df) and growth hormone receptor knockout (GHR-KO) mouse stocks are resistant, in vitro, to the cytotoxic effects of hydrogen peroxide, cadmium, ultraviolet light, paraquat, and heat. Here we show that, in contrast, fibroblasts from mice on low-calorie (CR) or low methionine (Meth-R) diets are not stress resistant in culture, despite the longevity induced by both dietary regimes. A second approach, involving induction of liver cell death in live animals using acetaminophen (APAP), documented hepatotoxin resistance in the CR and Meth-R mice, but dw/dw and GHR-KO mutant mice were not resistant to this agent, and were in fact more susceptible than littermate controls to the toxic effects of APAP. These data thus suggest that while resistance to stress is a common characteristic of experimental life span extension in mice, the cell types showing resistance may differ among the various models of delayed or decelerated aging. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA.
   Univ Michigan, Sch Med, Geriatr Ctr, Ann Arbor, MI USA.
   Univ Michigan, Sch Med, Cellular & Mol Biol Grad Program, Ann Arbor, MI USA.
   So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL USA.
   So Illinois Univ, Sch Med, Dept Physiol, Springfield, IL USA.
   So Illinois Univ, Sch Med, Dept Geriatr Res, Springfield, IL USA.
   Ann Arbor DVA Med Ctr, Ann Arbor, MI USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan; Southern Illinois University System; Southern
   Illinois University; Southern Illinois University System; Southern
   Illinois University; Southern Illinois University System; Southern
   Illinois University
RP Harper, JM (corresponding author), 109 Zina Pitcher Pl,Room 3005,Box 2200, Ann Arbor, MI 48109 USA.
EM jmharper@umich.edu
RI Bartke, Andzej/D-6640-2017
OI Bartke, Andzej/0000-0002-2569-557X; Harper, James/0000-0003-0765-8828;
   Bonkowski, Michael/0000-0003-3416-4612
FU NIA NIH HHS [R01 AG011687, P60 AG008808, AG08808, AG16699, AG11687, P01
   AG016699-01, P01 AG016699] Funding Source: Medline
CR Ahluwalia A, 2004, MOL ENDOCRINOL, V18, P747, DOI 10.1210/me.2003-0138
   Aidoo A, 1999, MUTAT RES-FUND MOL M, V430, P155, DOI 10.1016/S0027-5107(99)00197-9
   Apte UM, 2003, TOXICOL SCI, V72, P272, DOI 10.1093/toxsci/kfg021
   Arking R, 2001, ANN NY ACAD SCI, V928, P157
   Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7
   Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646
   Bartke A, 2001, EXP GERONTOL, V36, P21, DOI 10.1016/S0531-5565(00)00205-9
   BEIERSCHMITT WP, 1986, LIFE SCI, V39, P2335, DOI 10.1016/0024-3205(86)90664-8
   BEIERSCHMITT WP, 1989, TOXICOL APPL PHARM, V98, P517, DOI 10.1016/0041-008X(89)90180-4
   Brown-Borg HM, 2000, EXP GERONTOL, V35, P199, DOI 10.1016/S0531-5565(00)00079-6
   Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V
   BURK RF, 1980, J CLIN INVEST, V65, P1024, DOI 10.1172/JCI109754
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Cheng Q, 2003, TOXICOL SCI, V73, P60, DOI 10.1093/toxsci/kfg049
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   de Cabo R, 2003, EXP GERONTOL, V38, P631, DOI 10.1016/S0531-5565(03)00055-X
   De Castro E, 2004, FREE RADICAL BIO MED, V37, P139, DOI 10.1016/j.freeradbiomed.2004.04.021
   Dubey A, 1996, ARCH BIOCHEM BIOPHYS, V333, P189, DOI 10.1006/abbi.1996.0380
   Forster MJ, 2000, J GERONTOL A-BIOL, V55, pB522, DOI 10.1093/gerona/55.11.B522
   GALINSKY RE, 1990, J PHARMACOL EXP THER, V255, P577
   Hauck SJ, 2002, HORM METAB RES, V34, P481, DOI 10.1055/s-2002-34787
   HOIVIK DJ, 1995, TOXICOL APPL PHARM, V130, P257, DOI 10.1006/taap.1995.1031
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Jarukamjorn K, 2006, TOXICOLOGY, V219, P97, DOI 10.1016/j.tox.2005.11.014
   Jenniskens FA, 2002, PEDIATR RES, V52, P437, DOI [10.1203/01.PDR.0000025346.04153.80, 10.1203/00006450-200209000-00022]
   Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   Lambert AJ, 2005, J GERONTOL A-BIOL, V60, P175, DOI 10.1093/gerona/60.2.175
   Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003
   LANGLEY SC, 1992, BIOCHEM PHARMACOL, V44, P1489, DOI 10.1016/0006-2952(92)90462-R
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   Laskin DL, 2001, TOXICOLOGY, V160, P111, DOI 10.1016/S0300-483X(00)00437-6
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Li Y, 1998, EXP CELL RES, V239, P254, DOI 10.1006/excr.1997.3870
   Li Y, 1997, INVEST OPHTH VIS SCI, V38, P100
   Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019
   Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943
   LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540
   MANJGALADZE M, 1993, MUTAT RES, V295, P201, DOI 10.1016/0921-8734(93)90021-T
   Masternak MM, 2005, J GERONTOL A-BIOL, V60, P1394, DOI 10.1093/gerona/60.11.1394
   Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015
   Mathijssen RHJ, 2006, EUR J CANCER, V42, P141, DOI 10.1016/j.ejca.2005.08.035
   Mattow J, 2006, ELECTROPHORESIS, V27, P1683, DOI 10.1002/elps.200500703
   Mehendale HM, 2005, TOXICOL PATHOL, V33, P41, DOI 10.1080/01926230590881808
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142
   Mugford CA, 1997, TOXICOL LETT, V93, P15, DOI 10.1016/S0378-4274(97)00063-5
   Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje
   NAKAJIMA T, 1994, AM J PHYSIOL, V266, pF425, DOI 10.1152/ajprenal.1994.266.3.F425
   Neff SB, 2003, EXP MOL PATHOL, V75, P187, DOI 10.1016/S0014-4800(03)00096-0
   Nguyen KA, 1999, J TOXICOL ENV HEAL A, V58, P171, DOI 10.1080/009841099157377
   ORENTREICH N, 1993, J NUTR, V123, P269
   Oz HS, 2004, J BIOCHEM MOL TOXIC, V18, P361, DOI 10.1002/jbt.20042
   PENDERGRASS WR, 1995, EXP CELL RES, V217, P309, DOI 10.1006/excr.1995.1091
   PIGNOLO RJ, 1992, EXP CELL RES, V201, P16, DOI 10.1016/0014-4827(92)90343-7
   RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743
   Ruepp SU, 2002, TOXICOL SCI, V65, P135, DOI 10.1093/toxsci/65.1.135
   Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004
   Seng JE, 1996, ARCH BIOCHEM BIOPHYS, V335, P42, DOI 10.1006/abbi.1996.0480
   Shaikh ZA, 1999, TOXICOLOGY, V133, P93, DOI 10.1016/S0300-483X(99)00012-8
   Shankar K, 2003, FASEB J, V17, P1748, DOI 10.1096/fj.02-1186fje
   Sorensen JG, 2001, J INSECT PHYSIOL, V47, P1301, DOI 10.1016/S0022-1910(01)00119-6
   Stauber AJ, 2005, MOL PHARMACOL, V67, P681, DOI 10.1124/mol.104.007278
   Tarloff JB, 1996, FUND APPL TOXICOL, V30, P13, DOI 10.1006/faat.1996.0038
   TARLOFF JB, 1991, P SOC EXP BIOL MED, V197, P297
   TARLOFF JB, 1989, TOXICOLOGY, V56, P167, DOI 10.1016/0300-483X(89)90131-5
   Tolson JK, 2006, TOXICOL APPL PHARM, V210, P157, DOI 10.1016/j.taap.2005.10.001
   Tsuchiya T, 2005, MECH AGEING DEV, V126, P568, DOI 10.1016/j.mad.2004.11.007
   Usuki F, 2004, ACTA NEUROPATHOL, V108, P1, DOI 10.1007/s00401-004-0844-0
   Weindruch R., 1988, RETARDATION AGING DI
   Yu BP, 2001, ANN NY ACAD SCI, V928, P39
   Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215
NR 73
TC 63
Z9 75
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD AUG
PY 2006
VL 127
IS 8
BP 687
EP 694
DI 10.1016/j.mad.2006.04.002
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 064XW
UT WOS:000239125000006
PM 16713617
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Vomel, T
AF Vomel, T
TI The elimination of aged glycoproteins by the isolated perfused rat liver
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article; Proceedings Paper
CT Symposium on Aging from the Molecules to the Organisms
CY MAY 17-18, 1996
CL FRIEDRICH-ALEXANDER UNIV, ERLANGEN, GERMANY
HO FRIEDRICH-ALEXANDER UNIV
DE liver perfusion; glycoprotein; phagocytosis
ID SENESCENT
AB The isolated livers of Sprague-Dawley rats aged ten months were perfused with nine different glycoproteins (coeruloplasmine, haptoglobin, transferrin, alpha(2)-mocroglobulin, apolipoprotein A, plasminogen, acid alpha(1)-glycoprotein, alpha(1)-antitrypsin, beta(2)-glycoprotein), which were suspended in a basic medium free of hemoglobin and other proteins. Besides a control group two other groups were formed to give a model for aging: one group of glycoproteins was desialysed, another was desilysed and incubated with immunoglobulins before the perfusion. In spite of the application of two procedures which are supposed to produce a model of old glycoproteins, neither treatment resulted in the recognition, binding and elimination of the glycoproteins from the perfusion medium. (C) 1997 Elsevier Science Ireland Ltd.
RP Vomel, T (corresponding author), HUTTENHOSP DORTMUND HORDE,DEPT INTERNAL MED GERIATR,MARKSBACH 28,D-44269 DORTMUND,GERMANY.
CR BALDUINI C, 1981, ACTA BIOL MED GER, V40, P401
   BALDUINI CL, 1978, H-S Z PHYSIOL CHEM, V359, P1573, DOI 10.1515/bchm2.1978.359.2.1573
   BALDUINI CL, 1977, ACTA HAEMATOL-BASEL, V57, P178, DOI 10.1159/000207879
   BAXTER A, 1975, BIOCH SOC T 553 M, P132
   BLADIER D, 1980, CARBOHYD RES, V83, P371, DOI 10.1016/S0008-6215(00)84549-8
   FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P253
   FRIMMER M, 1967, N-S ARCH PHARMAKOL, V258, P197, DOI 10.1007/BF00535792
   GATTEGNO L, 1975, HOPPESEYLERS Z PHYSL, V356, P3391
   GATTEGNO L, 1975, CARBOHYD RES, V34, P361
   GREGORIA.G, 1970, J BIOL CHEM, V245, P5833
   HALHUBR K, 1972, FOLIA HAEMATOL LEIPZ, V97, P196
   KAY MMB, 1978, J SUPRAMOL STR CELL, V9, P555, DOI 10.1002/jss.400090409
   LUTZ HU, 1981, MECH AGEING DEV, V15, P65, DOI 10.1016/0047-6374(81)90008-7
   LUTZ HU, 1979, J BIOL CHEM, V354, P11177
   MORELL AG, 1971, J BIOL CHEM, V246, P1461
   MORELL GA, 1969, J BIOL CHEM, V243, P155
   PESSINA GP, 1979, VOX SANG, V37, P338, DOI 10.1111/j.1423-0410.1979.tb02313.x
   PRICER WE, 1971, J BIOL CHEM, V246, P4852
   ROGERS JC, 1971, BIOCHEM BIOPH RES CO, V45, P622, DOI 10.1016/0006-291X(71)90462-1
   STAIB W, 1968, STOFFWECHSEL ISOLIER
   VIOMEL T, 1981, FORTSCHR MED, V9937, P1511
   VOMEL T, 1981, MECH AGEING DEV, V17, P261, DOI 10.1016/0047-6374(81)90063-4
   Vomel T, 1983, Aktuelle Gerontol, V13, P122
   WICKMANN J, 1970, J BIOL CHEM, V245, P759
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JUL-AUG
PY 1997
VL 25
IS 1
BP 141
EP 146
DI 10.1016/S0167-4943(96)00779-0
PG 6
WC Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA WY425
UT WOS:A1997WY42500014
PM 15374109
DA 2024-02-19
ER

PT J
AU Yu, Z
   Sunchu, B
   Fok, WC
   Alshaikh, N
   Pérez, VI
AF Yu, Zhen
   Sunchu, Bharath
   Fok, Wilson C.
   Alshaikh, Nahla
   Perez, Viviana I.
TI Gene expression in the liver of female, but not male mice treated with
   rapamycin resembles changes observed under dietary restriction
SO SPRINGERPLUS
LA English
DT Article
DE Rapamycin; Dietary restriction; Gene expression; Female mice; Longevity
   pathways
ID LIFE-SPAN; HEPATIC GLUCONEOGENESIS; CIRCADIAN-RHYTHMS; CHRONIC DISEASE;
   EXTENDS LIFE; CLOCK; METABOLISM; CHAPERONE; HEALTH
AB It is well known that in mice the extension in lifespan by rapamycin is sexually dimorphic, in that it has a larger effect in females than males. In a previous study we showed that in male C57BL6 mice, rapamycin had less profound effects in both gene expression and liver metabolites when compared to dietary restriction (DR), but no data was available in females. Because recent studies showed that rapamycin increases longevity in a dose dependent manner and at every dose tested the effect remains larger in females than in males, we hypothesized that rapamycin should have a stronger effect on gene expression in females, and this effect could be dose dependent. To test this hypothesis, we measured the changes in liver gene expression induced by rapamycin (14 ppm) with a focus on several genes involved in pathways known to play a role in aging and that are altered by DR. To investigate whether any effects are dose dependent, we also analyzed females treated with two additional doses of rapamycin (22 and 42 ppm). We observed striking differences between male and female in gene expression at 14 ppm, where females have a larger response to rapamycin than males, and the effects of rapamycin in females resemble what we observed under DR. However, these effects were generally not dose dependent. These data support the notion that female mice respond better to rapamycin, and at least with the set of genes studied here, the effect of rapamycin in females resemble the effect of DR.
C1 [Yu, Zhen; Perez, Viviana I.] Oregon State Univ, Linus Pauling Sci Ctr 307, Linus Pauling Inst, Corvallis, OR 97331 USA.
   [Sunchu, Bharath; Alshaikh, Nahla; Perez, Viviana I.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.
   [Fok, Wilson C.] Washington Univ, Dept Med, Div Hematol, St Louis, MO 63110 USA.
C3 Oregon State University; Oregon State University; Washington University
   (WUSTL)
RP Pérez, VI (corresponding author), Oregon State Univ, Linus Pauling Sci Ctr 307, Linus Pauling Inst, Corvallis, OR 97331 USA.
EM viviana.perez@oregonstate.edu
RI Sunchu, Bharath/AAX-1846-2021
OI Sunchu, Bharath/0000-0001-9961-9927
FU NIA NIH HHS [P30 AG013319, RC2 AG036613, T32 AG021890] Funding Source:
   Medline
CR Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107
   Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759
   Burch JB, 2014, J GERONTOL A-BIOL, V69, pS1, DOI 10.1093/gerona/glu041
   Challet E, 1998, AM J PHYSIOL-REG I, V274, pR1751, DOI 10.1152/ajpregu.1998.274.6.R1751
   Fok WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092346
   Fok WC, 2014, AGING CELL, V13, P311, DOI 10.1111/acel.12175
   Fok WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083988
   Fok WC, 2013, J GERONTOL A-BIOL, V68, P108, DOI 10.1093/gerona/gls127
   Froy O, 2007, PROG NEUROBIOL, V82, P142, DOI 10.1016/j.pneurobio.2007.03.002
   Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012
   Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377
   Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718
   Sangith N, 2014, FEBS OPEN BIO, V4, P571, DOI 10.1016/j.fob.2014.05.005
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567
   Tevy MF, 2013, TRENDS ENDOCRIN MET, V24, P229, DOI 10.1016/j.tem.2012.12.002
   Thomas M, 2010, SYNAPSE, V64, P579, DOI 10.1002/syn.20763
   Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546
   Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214
   Zhang YQ, 2014, J GERONTOL A-BIOL, V69, P119, DOI 10.1093/gerona/glt056
NR 33
TC 3
Z9 4
U1 1
U2 3
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 2193-1801
J9 SPRINGERPLUS
JI SpringerPlus
PD APR 11
PY 2015
VL 4
AR 174
DI 10.1186/s40064-015-0909-7
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CO5LI
UT WOS:000359200200001
PM 26034704
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Shan, YS
   Hsieh, YH
   Lin, PW
AF Shan, Yan-Shen
   Hsieh, Yu-Hsiang
   Lin, Pin-Wen
TI Telomerase activity in tumor and remnant liver as predictor of
   recurrence and survival in hepatocellular carcinoma after resection
SO WORLD JOURNAL OF SURGERY
LA English
DT Article
ID TRANSCRIPTASE MESSENGER-RNA; POSTOPERATIVE RECURRENCE; INTRAHEPATIC
   RECURRENCE; PERIPHERAL-BLOOD; HEPATOCARCINOGENESIS; CIRRHOSIS; CANCER;
   LYMPHOCYTES; SENESCENCE; HEPATITIS
AB Background and Aim: Results after curative liver resection in hepatocellular carcinoma are unsatisfactory with regard to high postoperative intrahepatic recurrence and liver failure. This study evaluates telomerase activity in liver with and without tumor as a predictor of recurrence and survival.
   Materials and Methods: Liver tissue with and without tumor from 53 hepatocellular carcinoma patients receiving curative resection during the period of 1998-2000 was used for detecting telomerase activity by PCR-ELISA. Clinicopathological data were compared to identify predictors of recurrence and survival.
   Results: Telomerase activity was detected in 98% of liver tissue with tumor and 70% liver tissue without. Telomerase activity in cancerous liver correlated significantly with HCV infection (P = 0.012) and cirrhotic change in liver parenchyma (P = 0.006). Telomerase activity in non-cancerous liver correlated with high serum AFP level (P = 0.002). The telomerase activity of liver tissue with and without tumor is significant higher in patients with recurrence than in those without recurrence, 413.7 +/- 100.5 versus 110.8 +/- 32.7, P = 0.006, and 34.7 +/- 14.2 versus 4.2 +/- 1.4, P = 0.039. Recurrence could be predicted by abnormally high tumor telomerase activity (P = 0.026) or by advanced TNM stage (P = 0.001). TNM stage or high serum ALT level could predict multinodular intrahepatic recurrence (P = 0.028 and P = 0.030). High serum AFP combined with high telomerase activity in liver without tumor had a significant ability to predict poor survival (OR: 11.19, CI: 1.95-64.12, P = 0.007).
   Conclusion: Tumor telomerase is an independent predictor of recurrence. Simultaneous high remnant liver telomerase and high serum AFP is a strong negative predictor of survival.
C1 Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Surg, Coll Med, Tainan 70428, Taiwan.
   Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21205 USA.
C3 National Cheng Kung University; National Cheng Kung University Hospital;
   Johns Hopkins University
RP Lin, PW (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Surg, Coll Med, 138 Sheng Li Rd, Tainan 70428, Taiwan.
EM pinwen@mail.ncku.edu.tw
CR BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004
   Blasco Maria A., 1999, Genes and Development, V13, P2353, DOI 10.1101/gad.13.18.2353
   CHEN MF, 1994, ARCH SURG-CHICAGO, V129, P738
   Coleman WB, 2003, CURR MOL MED, V3, P573, DOI 10.2174/1566524033479546
   DUSHEIKO GM, 1992, LANCET, V340, P285, DOI 10.1016/0140-6736(92)92367-O
   HERMANEK P, 1992, UICC TNM CLASSIFICAT
   HIYAMA E, 1995, CANCER RES, V55, P3258
   Homma S, 2005, IMMUNOLOGY, V115, P451, DOI 10.1111/j.1365-2567.2005.02179.x
   Huang GT, 1998, EUR J CANCER, V34, P1946, DOI 10.1016/S0959-8049(98)00237-8
   Huo TI, 2004, ONCOL REP, V11, P543
   Kishimoto K, 1998, J SURG ONCOL, V69, P119
   Kobayashi T, 2001, AM J SURG, V181, P284, DOI 10.1016/S0002-9610(01)00566-9
   Koike K, 2002, ONCOLOGY-BASEL, V62, P29, DOI 10.1159/000048273
   Miura N, 2005, CLIN CANCER RES, V11, P3205, DOI 10.1158/1078-0432.CCR-04-1487
   Ogami M, 1999, LAB INVEST, V79, P15
   Ohta K, 1997, J GASTROENTEROL, V32, P791, DOI 10.1007/BF02936956
   Park YM, 1998, EXP MOL MED, V30, P35, DOI 10.1038/emm.1998.5
   Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009
   Puebla-Mora Ana Graciela, 2006, Ann Diagn Pathol, V10, P205, DOI 10.1016/j.anndiagpath.2005.09.021
   Reddel RR, 2000, CARCINOGENESIS, V21, P477, DOI 10.1093/carcin/21.3.477
   Sato Y, 2005, HEPATO-GASTROENTEROL, V52, P1325
   Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2
   Suda T, 1998, HEPATOLOGY, V27, P402, DOI 10.1002/hep.510270213
   TAHARA H, 1995, CANCER RES, V55, P2734
   Tarao K, 2002, CANCER-AM CANCER SOC, V94, P1787, DOI 10.1002/cncr.10391
   Tatsuma T, 2000, J GASTROEN HEPATOL, V15, P1064, DOI 10.1046/j.1440-1746.2000.02293.x
   Ulmer SC, 2000, POSTGRAD MED, V107, P117, DOI 10.3810/pgm.2000.5.1.1062
   Unitt E, 2005, HEPATOLOGY, V41, P722, DOI 10.1002/hep.20644
   Urquidi V, 2000, ANNU REV MED, V51, P65, DOI 10.1146/annurev.med.51.1.65
   Yu Andy S, 2003, Rev Gastroenterol Disord, V3, P8
   Zhang WB, 1998, CANCER RES, V58, P619
NR 31
TC 10
Z9 14
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0364-2313
J9 WORLD J SURG
JI World J.Surg.
PD MAY
PY 2007
VL 31
IS 5
BP 1121
EP 1128
DI 10.1007/s00268-006-0783-0
PG 8
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA 164LF
UT WOS:000246234500032
PM 17429564
DA 2024-02-19
ER

PT J
AU Lei, LH
   Chen, YH
   Ou, LJ
   Xu, YL
   Yu, XY
AF Lei, Linghua
   Chen, Yanhua
   Ou, Lijun
   Xu, Yinglong
   Yu, Xiaoying
TI Aqueous root extract of <i>Asparagus cochinchinensis</i> (Lour.) Merr.
   Has antioxidant activity in D-galactose-induced aging mice
SO BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
DE Asparagus cochinchinensis (Lour.) Merr; Antioxidant; Aging; Enzyme
   activity; Root
ID NITRIC-OXIDE SYNTHASE; RAT-BRAIN; IN-VITRO; RADICALS
AB Background: Extracts of plants have been considered as sources of natural antioxidant agents. In this study, we aimed to explore the antioxidant capacity of the aqueous root extract of Asparagus cochinchinensis (Lour.) Merr.
   Methods: Using vitamin C (Vc) as a positive control, we analyzed the aqueous root extract of A. cochinchinensis free radical scavenging ability in vitro. We also established a mouse aging model using D-galactose and then treated it with aqueous root extract or Vc. The blood cell count and superoxide dismutase (SOD), catalase (CAT), and nitric oxide synthase (NOS) activities as well as malondialdehyde (MDA) and nitric oxide (NO) contents were measured; pathological examination of tissues was performed; and SOD, glutathione peroxidase (GPX), and NOS expression levels in the serum, liver, and brain tissues were investigated.
   Results: In vitro, compared with the antioxidant Vc, the aqueous root extract showed similar 1,1-Diphenyl-2picrylhydrazyl radical and 3-ethylbenzothiazoline-6-sulfonic scavenging activities and even significantly increased superoxide anion (p < 0.05) and hydroxyl radical (OH) (p < 0.01) scavenging activities. The aqueous extract significantly increased the white blood cell count as well as enhanced SOD, CAT, and NOS activities (p < 0.01) in aging mice. In addition, the aqueous extract increased the NO content (p < 0.05) and reduced the MDA content (p < 0.05).
   Conclusions: The aqueous root extract of A. cochinchinensis showed as strong antioxidant ability as Vc and might prevent aging by reducing radicals.
C1 [Lei, Linghua] Lishui Univ, Coll Ecol, Lishui 323000, Zhejiang, Peoples R China.
   [Lei, Linghua; Chen, Yanhua; Xu, Yinglong; Yu, Xiaoying] Hunan Agr Univ, Coll Hort & Landscape, Changsha 410128, Hunan, Peoples R China.
   [Ou, Lijun] Agr Sci Acad Hunan Prov, Vegetable Res Inst, Changsha 410125, Hunan, Peoples R China.
   [Chen, Yanhua] Hunan Inst Sci & Technol, Yueyang 414006, Hunan, Peoples R China.
C3 Lishui University; Hunan Agricultural University; Hunan Institute of
   Science & Technology
RP Xu, YL; Yu, XY (corresponding author), Hunan Agr Univ, Coll Hort & Landscape, Changsha 410128, Hunan, Peoples R China.
EM xuyinglongxyl@163.com; xiaoyingyuyuu@yeah.net
RI Jiang, Tao/IWM-7503-2023; chen, yanhua/JNE-3039-2023
FU Science and Technology Project of Hunan Province [2012FJ4292,
   2011NK3046]; Priority Development Discipline of Hunan Province
   [2011042]; Ecology of First-class Subject of Zhejiang province, Public
   Welfare Technology Application Research Project of Lishui
FX This study was supported by Science and Technology Project of Hunan
   Province (No. 2012FJ4292; No. 2011NK3046), Priority Development
   Discipline of Hunan Province (No. 2011042), and Ecology of First-class
   Subject of Zhejiang province, Public Welfare Technology Application
   Research Project of Lishui (2017).
CR Alvarez-Suarez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025878
   AMBROSIO G, 1991, J CLIN INVEST, V87, P2056, DOI 10.1172/JCI115236
   [Anonymous], TUBER J MED PLANTS R
   CADET JL, 1994, BRAIN RES, V655, P259, DOI 10.1016/0006-8993(94)91624-1
   Committee C. P, 2010, CHINESE PHARMACOPOEI
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   Dahiya K, 2012, ANN CLIN LAB SCI, V42, P94
   Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003
   Duan Shilian, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1402
   FANG F, 2012, SCIENCES, V5
   Fisch KM, 2003, J NAT PROD, V66, P968, DOI 10.1021/np030082f
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Jalsrai A, 2016, NEUROSCIENCE, V322, P452, DOI 10.1016/j.neuroscience.2016.02.065
   Jesko H, 2003, NEUROCHEM INT, V42, P315, DOI 10.1016/S0197-0186(02)00098-0
   Khan MA, 2010, CHINESE J CANCER RES, V22, P87, DOI 10.1007/s11670-010-0087-7
   Kibbe M, 1999, CARDIOVASC RES, V43, P650, DOI 10.1016/S0008-6363(99)00130-3
   Law A, 2002, NEUROSCIENCE, V112, P267, DOI 10.1016/S0306-4522(02)00082-9
   Lee DY, 2009, J ETHNOPHARMACOL, V121, P28, DOI 10.1016/j.jep.2008.07.006
   Lei LH, 2016, J CHIN MED ASSOC, V79, P205, DOI 10.1016/j.jcma.2015.06.023
   Luo J, 2000, J GUIYANG MED COLL, V25, P15
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   MOLLACE V, 1995, BIOCHEM BIOPH RES CO, V215, P822, DOI 10.1006/bbrc.1995.2537
   Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1007/BF02253360
   Sáenz AT, 2009, J FOOD COMPOS ANAL, V22, P694, DOI 10.1016/j.jfca.2009.01.021
   Salehpour F, 2017, NEUROBIOL AGING, V58, P140, DOI 10.1016/j.neurobiolaging.2017.06.025
   Suh HJ, 2005, FOOD ADDIT CONTAM A, V22, P1176, DOI 10.1080/02652030500195288
   Sun J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032021
   Zhang P, 2000, CHINESE J GERONTOLOG, V1, P1
   Zheng Haiyin, 2011, Zhongguo Zhong Yao Za Zhi, V36, P2383
NR 30
TC 30
Z9 31
U1 3
U2 25
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6882
J9 BMC COMPLEM ALTERN M
JI BMC Complement. Altern. Med.
PD SEP 25
PY 2017
VL 17
AR 469
DI 10.1186/s12906-017-1975-x
PG 7
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA FI2JD
UT WOS:000411764000002
PM 28946917
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Snyder, JM
   Casey, KM
   Galecki, A
   Harrison, DE
   Jayarathne, H
   Kumar, N
   Macchiarini, F
   Rosenthal, N
   Sadagurski, M
   Salmon, AB
   Strong, R
   Miller, RA
   Ladiges, W
AF Snyder, Jessica M.
   Casey, Kerriann M.
   Galecki, Andrzej
   Harrison, David E.
   Jayarathne, Hashan
   Kumar, Navasuja
   Macchiarini, Francesca
   Rosenthal, Nadia
   Sadagurski, Marianna
   Salmon, Adam B.
   Strong, Randy
   Miller, Richard A.
   Ladiges, Warren
TI Canagliflozin retards age-related lesions in heart, kidney, liver, and
   adrenal gland in genetically heterogenous male mice
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Age-related pathology; Canagliflozin; Lifespan; ITP; Sexual dimorphism
ID RAPAMYCIN; 17-ALPHA-ESTRADIOL; OVEREXPRESSION; PATHOLOGY; CATALASE;
   ACARBOSE; DISEASE
AB Canagliflozin (Cana), a clinically important anti-diabetes drug, leads to a 14% increase in median lifespan and a 9% increase in the 90th percentile age when given to genetically heterogeneous male mice from 7 months of age, but does not increase lifespan in female mice. A histopathological study was conducted on 22-month-old mice to see if Cana retarded diverse forms of age-dependent pathology. This agent was found to diminish incidence or severity, in male mice only, of cardiomyopathy, glomerulo-nephropathy, arteriosclerosis, hepatic microvesicular cytoplasmic vacuolation (lipidosis), and adrenal cortical neoplasms. Protection against atrophy of the exocrine pancreas was seen in both males and females. Thus, the extension of lifespan in Cana-treated male mice, which is likely to reflect host- or tumor-mediated delay in lethal neoplasms, is accompanied by parallel retardation of lesions, in multiple tissues, that seldom if ever lead to death in these mice. Canagliflozin thus can be considered a drug that acts to slow the aging process and should be evaluated for potential protective effects against many other late-life conditions.
C1 [Snyder, Jessica M.; Ladiges, Warren] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA.
   [Snyder, Jessica M.] Univ Washington, Hlth Sci Ctr, I-446 Box 357350, Seattle, WA 98195 USA.
   [Casey, Kerriann M.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA.
   [Galecki, Andrzej] Univ Michigan, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA.
   [Harrison, David E.; Rosenthal, Nadia] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.
   [Jayarathne, Hashan; Sadagurski, Marianna] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.
   [Kumar, Navasuja] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA.
   [Macchiarini, Francesca] NIA, Div Aging Biol, Bethesda, MD 20892 USA.
   [Rosenthal, Nadia] Imperial Coll, Natl Heart & Lung Inst, London, England.
   [Salmon, Adam B.; Strong, Randy] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr & Res Serv, San Antonio, TX USA.
   [Salmon, Adam B.; Strong, Randy] Univ Texas San Antonio, Hlth Sci Ctr, Barshop Inst Longev & Aging Studies, San Antonio, TX USA.
   [Salmon, Adam B.] Univ Texas San Antonio, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX USA.
   [Strong, Randy] Univ Texas San Antonio, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX USA.
   [Miller, Richard A.] Univ Michigan, Pathol & Geriatr Ctr, Ann Arbor, MI 48109 USA.
C3 University of Washington; University of Washington Seattle; University
   of Washington; University of Washington Seattle; Stanford University;
   University of Michigan System; University of Michigan; Jackson
   Laboratory; Wayne State University; University of Michigan System;
   University of Michigan; National Institutes of Health (NIH) - USA; NIH
   National Institute on Aging (NIA); Imperial College London; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education
   & Clinical Center; University of Texas System; University of Texas
   Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; University of
   Texas System; University of Texas Health Science Center at San Antonio;
   University of Michigan System; University of Michigan
RP Snyder, JM (corresponding author), Univ Washington, Hlth Sci Ctr, I-446 Box 357350, Seattle, WA 98195 USA.
EM snyderjm@uw.edu
RI Rosenthal, Nadia/JQI-7049-2023; Rosenthal, Nadia A/H-4012-2013
OI Casey, Kerriann/0000-0003-4228-928X
FU NIA [U01-AG022303, U01-AG022308, P30-AG024824, AG022307, AG013319];
   Senior Research Career Scientist Award from the Department of Veterans
   Affairs Office of Research and Development
FX This work was funded by NIA grants, U01-AG022303, U01-AG022308,
   P30-AG024824, AG022307, and AG013319. RS is supported by a Senior
   Research Career Scientist Award from the Department of Veterans Affairs
   Office of Research and Development.
CR Abdelrahman AM, 2019, N-S ARCH PHARMACOL, V392, P45, DOI 10.1007/s00210-018-1564-7
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   De Jonghe S, 2014, CHEM-BIOL INTERACT, V224, P1, DOI 10.1016/j.cbi.2014.09.018
   Ferder LF, 2003, EXP GERONTOL, V38, P237, DOI 10.1016/S0531-5565(02)00264-4
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Harrison DE, 2019, AGING CELL, V18, DOI 10.1111/acel.12898
   Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170
   Herrera JJ, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137474
   Itani T, 2018, OBES SCI PRACT, V4, P477, DOI 10.1002/osp4.294
   Jayarathne HSM, 2022, AGING CELL, V21, DOI 10.1111/acel.13653
   Jin XD, 2009, SCAND J UROL NEPHROL, V43, P73, DOI 10.1080/00365590802580208
   Jojima T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205237
   Korfhage J, 2022, J GERONTOL A-BIOL, V77, P215, DOI 10.1093/gerona/glab254
   La Perle KMD, 2019, VET PATHOL, V56, P19, DOI 10.1177/0300985818806047
   Lamming DW, 2013, AGING CELL, V12, P712, DOI 10.1111/acel.12097
   Lim JH, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/171383
   Lin FY, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106969
   Miller RA, 2002, J IMMUNOL, V169, P1619, DOI 10.4049/jimmunol.169.3.1619
   Miller RA, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140019
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Roncal-Jimenez CA, 2016, AM J PHYSIOL-RENAL, V311, pF722, DOI 10.1152/ajprenal.00306.2016
   Sadagurski M, 2017, AGING CELL, V16, P652, DOI 10.1111/acel.12590
   Shen ZQ, 2021, AGING CELL, V20, DOI 10.1111/acel.13345
   Shiba K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19658-7
   Snyder JM, 2016, VET PATHOL, V53, P233, DOI 10.1177/0300985815610391
   Snyder JM, 2019, GEROSCIENCE, V41, P455, DOI 10.1007/s11357-019-00088-w
   Stahl EC, 2020, AM J PATHOL, V190, P372, DOI 10.1016/j.ajpath.2019.10.016
   Sun PB, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102521
   Treuting PM, 2016, VET PATHOL, V53, P244, DOI 10.1177/0300985815620629
   Treuting PM, 2008, J GERONTOL A-BIOL, V63, P813, DOI 10.1093/gerona/63.8.813
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Wink L, 2022, IMMUN AGEING, V19, DOI 10.1186/s12979-022-00264-1
   Woods TC, 2019, AM J NEPHROL, V49, P331, DOI 10.1159/000499597
   Xu CK, 2018, BIOCHEM PHARMACOL, V152, P45, DOI 10.1016/j.bcp.2018.03.013
   Xu DY, 2020, INT J ONCOL, V57, P1223, DOI 10.3892/ijo.2020.5120
   Yoshino K, 2021, BIOCHEM BIOPH RES CO, V557, P62, DOI 10.1016/j.bbrc.2021.04.012
   YUMURA W, 1989, EXP GERONTOL, V24, P237, DOI 10.1016/0531-5565(89)90015-6
NR 37
TC 10
Z9 10
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2023 FEB
PY 2023
VL 45
IS 1
SI SI
BP 385
EP 397
DI 10.1007/s11357-022-00641-0
EA AUG 2022
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 8R9OV
UT WOS:000841061300001
PM 35974129
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Maiti, S
   Chen, GP
AF Maiti, Smarajit
   Chen, Guangping
TI Ethanol up-regulates phenol sulfotransferase (SULT1A1) and
   hydroxysteroid sulfotransferase (SULT2A1) in rat liver and intestine
SO ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Ethanol regulation; Hep G2 cells; protein expression; rat liver and
   intestine; sulfotransferases
ID HUMAN CYTOSOLIC SULFOTRANSFERASES; INDUCIBLE STEROID SULFOTRANSFERASE;
   X-RECEPTOR PXR; RETINOIC ACID; ALCOHOL-CONSUMPTION; NUCLEAR RECEPTOR;
   IN-VITRO; DEHYDROEPIANDROSTERONE SULFOTRANSFERASE; METABOLIC SYNDROME;
   BRASSICA-NAPUS
AB Ethanol-consumption impairs physiological-efficiency/endurance, expedites senescence. Impaired-regulations of steroids/biomolecules link these processes. Steroids are catabolized by cytosolic-sulfotransferases (SULTs). Ethanol-induction of eukaryotic-SULTs-expression is scanty. Plant (Brassica-napus) steroid-sulfotransferase; BNST3/BNST4 (gene/BNST) is highly ethanol-inducible (protein/mRNA). Resembling mammalian-SULTs catalytic-mechanism BNSTs show broad substrate-specificities (mammalian-steroids; estradiol/dehydroepiandrosterone/pregnanolone). Recently, ethanol-regulation of SULTs-expression is verified in rat liver/intestine/cultured human-hepatocarcinoma (Hep-G2) cells at enzyme-activity/protein-expression (Western-blot) level. Here, two week's ethanol ingestion by male rat significantly increased SULT2A1 in their liver/intestine (p<0.05-p<0.001) and phenol-sulfotransferase (SULT1A1) in intestine (p<0.001) at enzyme-activity/protein levels. In human cells, ethanol significantly (2-fold) increased hSULT1A1/hSULT1E (2-3 fold) protein expressions paralleling their enzymatic-activities (p<0.05-p<0.01). The earlier finding of alcohol-association to the physiological impairment may be corroborated by our present findings. Inductions of SULT-expressions by ethanol have significant physiological/pharmacological consequences.
C1 [Maiti, Smarajit; Chen, Guangping] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Physiol Sci, Stillwater, OK 74078 USA.
   [Maiti, Smarajit] Agricure Biotech Res Soc, Midnapore, W Bengal, India.
C3 Oklahoma State University System; Oklahoma State University - Stillwater
RP Maiti, S (corresponding author), Vidyasagar Univ, Oriental Inst Sci & Technol, Post Grad Dept Biochem & Biotechnol, Cell & Mol Therapeut Lab, Midnapore 721102, WB, India.
EM maitism@rediffmail.com
CR Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496
   Alkerwi A, 2009, ATHEROSCLEROSIS, V204, P624, DOI 10.1016/j.atherosclerosis.2008.10.036
   BADR FM, 1974, STEROIDS, V23, P921, DOI 10.1016/0039-128X(74)90064-6
   Buja A, 2010, EUR J CLIN NUTR, V64, P297, DOI 10.1038/ejcn.2009.136
   CHATTERJEE B, 1994, CHEM-BIOL INTERACT, V92, P273, DOI 10.1016/0009-2797(94)90069-8
   Chen GP, 2003, TOXICOL APPL PHARM, V187, P186, DOI 10.1016/S0041-008X(02)00073-X
   Chen XS, 2011, LAB INVEST, V91, P1136, DOI 10.1038/labinvest.2011.68
   Chen XR, 2006, J BIOCHEM MOL TOXIC, V20, P309, DOI 10.1002/jbt.20149
   Chen Y, 2008, BASIC CLIN PHARMACOL, V103, P553, DOI 10.1111/j.1742-7843.2008.00316.x
   Chen Y, 2010, J BIOCHEM MOL TOXIC, V24, P102, DOI 10.1002/jbt.20318
   Dammanahalli JK, 2012, DRUG METAB DISPOS, V40, P298, DOI 10.1124/dmd.111.042044
   Davies BT, 1999, ALCOHOL CLIN EXP RES, V23, P969, DOI 10.1097/00000374-199906000-00003
   Dharia S, 2004, SEMIN REPROD MED, V22, P361, DOI 10.1055/s-2004-861552
   Echchgadda I, 2004, MECH AGEING DEV, V125, P733, DOI 10.1016/j.mad.2004.08.008
   Echchgadda I, 2004, MOL PHARMACOL, V65, P720, DOI 10.1124/mol.65.3.720
   El-Sayed M, 2005, SPORTS MED, V35, P257, DOI 10.2165/00007256-200535030-00005
   Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609
   FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205
   Fu ZD, 2014, TOXICOL APPL PHARM, V274, P137, DOI 10.1016/j.taap.2013.11.003
   Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061
   GORDON GG, 1976, NEW ENGL J MED, V295, P793, DOI 10.1056/NEJM197610072951501
   Heinz AJ, 2011, NAT REV NEUROSCI, V12, P400, DOI 10.1038/nrn3042
   Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520
   Knockaert L, 2011, TOXICOL IN VITRO, V25, P475, DOI 10.1016/j.tiv.2010.11.019
   Kurogi K, 2012, BIOL PHARM BULL, V35, P2180, DOI 10.1248/bpb.b12-00547
   Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419
   Lindsay J, 2008, CURR DRUG METAB, V9, P99
   Lingen MW, 1998, CANCER RES, V58, P5551
   Liu C, 2001, GASTROENTEROLOGY, V120, P179, DOI 10.1053/gast.2001.20877
   Maiti S, 2005, J BIOCHEM MOL TOXIC, V19, P109, DOI 10.1002/jbt.20064
   Maiti S, 2004, BIOCHEM BIOPH RES CO, V323, P235, DOI 10.1016/j.bbrc.2004.08.074
   Maiti S, 2003, DRUG METAB DISPOS, V31, P637, DOI 10.1124/dmd.31.5.637
   Maiti S, 2005, BASIC CLIN PHARMACOL, V96, P44, DOI 10.1111/j.1742-7843.2005.pto960107.x
   Maiti S, 2003, ARCH BIOCHEM BIOPHYS, V418, P161, DOI 10.1016/j.abb.2003.08.019
   Maiti S, 2010, SAARC J TUBERCULOSIS, VVII, P1
   Maiti S, 2007, BIOCHEM PHARMACOL, V73, P1474, DOI 10.1016/j.bcp.2006.12.026
   Marsolais F, 2004, PLANT SCI, V166, P1359, DOI 10.1016/j.plantsci.2004.01.019
   Marsolais F, 2000, THESIS CONCORDIA U
   Noordam C, 2009, NEW ENGL J MED, V360, P2310, DOI 10.1056/NEJMoa0810489
   Onland-Moret NC, 2005, J CLIN ENDOCR METAB, V90, P1414, DOI 10.1210/jc.2004-0614
   Ramaprasad P, 1998, ALCOHOL CLIN EXP RES, V22, P1120
   Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045
   Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399
   Rouleau M, 1999, J BIOL CHEM, V274, P20925, DOI 10.1074/jbc.274.30.20925
   Runge-Morris M, 1999, MOL PHARMACOL, V56, P1198, DOI 10.1124/mol.56.6.1198
   Runge-Morris M, 2013, DRUG METAB REV, V45, P15, DOI 10.3109/03602532.2012.748794
   Schneider H, 2004, BIOCHEM J, V383, P543, DOI 10.1042/BJ20040925
   Schröder E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029559
   Seitz HK, 1997, ALCOHOL ALCOHOLISM, V32, P543
   Sharda DR, 2012, J PHARMACOL TOX MET, V66, P257, DOI 10.1016/j.vascn.2012.08.166
   Sonoda J, 2002, P NATL ACAD SCI USA, V99, P13801, DOI 10.1073/pnas.212494599
   Traish AM, 2011, J SEX MED, V8, P2960, DOI 10.1111/j.1743-6109.2011.02523.x
   van den Boom J, 2012, J BIOL CHEM, V287, P17645, DOI 10.1074/jbc.M111.325498
   Vidyashankar S, 2012, TOXICOLOGY, V302, P34, DOI 10.1016/j.tox.2012.07.009
   Wang T, 2014, J BIOL CHEM, V289, P26474, DOI 10.1074/jbc.M114.573501
   Woods NF, 2007, J WOMENS HEALTH, V16, P667, DOI 10.1089/jwh.2006.0138
   Zhou TY, 2013, NEUROTOXICOLOGY, V34, P212, DOI 10.1016/j.neuro.2012.09.010
   Zhou TY, 2012, J APPL TOXICOL, V32, P804, DOI 10.1002/jat.1698
NR 58
TC 13
Z9 14
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1381-3455
EI 1744-4160
J9 ARCH PHYSIOL BIOCHEM
JI Arch. Physiol. Biochem.
PD MAY
PY 2015
VL 121
IS 2
BP 68
EP 74
DI 10.3109/13813455.2014.992440
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
GA CP3OZ
UT WOS:000359791200005
PM 25720860
DA 2024-02-19
ER

PT J
AU Higami, Y
   Shimokawa, I
   Tomita, M
   Okimoto, T
   Koji, T
   Kobayashi, N
   Ikeda, T
AF Higami, Y
   Shimokawa, I
   Tomita, M
   Okimoto, T
   Koji, T
   Kobayashi, N
   Ikeda, T
TI Aging accelerates but life-long dietary restriction suppresses
   apoptosis-related Fas expression on hepatocytes
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID CULTURED RAT HEPATOCYTES; QUANTITATIVE RT-PCR; GENE-EXPRESSION;
   CELL-DEATH; F344 RATS; LIVER; CYCLOHEXIMIDE; ANTIGEN; DAMAGE; BETA
AB Aging enhances apoptosis of hepatocytes under normal physiological conditions and increases the susceptibility of hepatocytes to apoptosis whereas life-long dietary restriction suppresses the age-enhanced susceptibility to apoptosis. We examined the subcellular mechanisms of the age-associated changes and effect of dietary restriction using quantitative reverse transcription polymerase chain reaction and immunohistochemistry for Fas in the Livers of 6- and 24-month-old male Fischer 344 rats fed ad libitum or 70% diet restricted. We also analyzed the level of ordinary and variant forms of Fas mRNA. The ordinary form of Fas mRNA, but not the variant form of Fas mRNA, significantly increased with age, Dietary restriction significantly suppressed the ordinary form of Fas mRNA in advanced age. Aging enhanced Fas immunoreactivity in the hyperplastic bile epithelium and hepatocytes whereas dietary restriction suppressed it. Our findings indicate that Fas protein, particularly the ordinary form of Fas, is involved in age-associated apoptosis of hepatocytes. Fas overexpression in advanced age may explain the age-enhanced susceptibility to apoptosis, Our results also suggest that dietary restriction suppresses Fas overexpression, resulting in a reduction of the age-enhanced susceptibility to apoptosis.
C1 NAGASAKI UNIV,SCH MED,DEPT ANAT,NAGASAKI 852,JAPAN.
   NAGASAKI UNIV,FAC PHARMACEUT SCI,NAGASAKI 852,JAPAN.
C3 Nagasaki University; Nagasaki University
RP Higami, Y (corresponding author), NAGASAKI UNIV,SCH MED,DEPT PATHOL,1-12-4 SAKAMOTO,NAGASAKI 852,JAPAN.
RI Koji, Takehiko/JJF-3367-2023
OI Shimokawa, Isao/0000-0001-8901-1029; Higami,
   Yoshikazu/0000-0003-1381-0777
CR ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294
   AFFORD SC, 1995, J PATHOL, V176, P373, DOI 10.1002/path.1711760408
   CAVALLI G, 1968, DIGESTION, V1, P353, DOI 10.1159/000196877
   ELHUSSEINI AE, 1994, MOL CELL ENDOCRINOL, V104, P191, DOI 10.1016/0303-7207(94)90122-8
   GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223
   GRISHAM JW, 1994, AM J PATHOL, V144, P849
   Hakuno N, 1996, ENDOCRINOLOGY, V137, P1938, DOI 10.1210/en.137.5.1938
   HIGAMI Y, 1994, MUTAT RES-DNAGING G, V316, P59, DOI 10.1016/0921-8734(94)90008-6
   Higami Y, 1997, CELL TISSUE RES, V288, P69, DOI 10.1007/s004410050793
   Higami Y, 1996, MUTAT RES-FUND MOL M, V357, P225, DOI 10.1016/0027-5107(96)00127-3
   KIMURA K, 1994, BIOCHEM BIOPH RES CO, V198, P666, DOI 10.1006/bbrc.1994.1097
   KRISTAL BS, 1994, MODULATION AGING PRO, P1
   LEDDACOLUMBANO GM, 1992, AM J PATHOL, V140, P545
   MCCONKEY DJ, 1988, TOXICOL LETT, V42, P123, DOI 10.1016/0378-4274(88)90069-0
   MUSKHELISHVILI L, 1995, AM J PATHOL, V147, P20
   NOONAN KE, 1990, P NATL ACAD SCI USA, V87, P7160, DOI 10.1073/pnas.87.18.7160
   NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759
   OBERHAMMER F, 1991, CANCER RES, V51, P2478
   OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0
   SHIMOKAWA I, 1994, EFFECT DIETARY RESTR, P247
   SHINAGAWA T, 1991, J PATHOL, V165, P247, DOI 10.1002/path.1711650309
   WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274
   YOKOI H, 1993, BIOCHEM BIOPH RES CO, V195, P769, DOI 10.1006/bbrc.1993.2112
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 24
TC 50
Z9 53
U1 0
U2 0
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BALTIMORE
PA 428 EAST PRESTON ST, BALTIMORE, MD 21202-3993
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD SEP
PY 1997
VL 151
IS 3
BP 659
EP 663
PG 5
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA XU378
UT WOS:A1997XU37800004
PM 9284813
DA 2024-02-19
ER

PT J
AU Feng, QX
   Li, YN
   Lu, XC
   Yu, Y
   Yuan, GX
   Sun, JB
   Tian, CX
   Hu, L
   Xu, GY
   An, LP
   Du, PG
AF Feng, Qingxia
   Li, Yingna
   Lu, Xuechun
   Yu, Ying
   Yuan, Guangxin
   Sun, Jingbo
   Tian, Chenxi
   Hu, Lian
   Xu, Guangyu
   An, Liping
   Du, Peige
TI <i>Agaricus blazei</i> polypeptide exerts a protective effect on
   D-galactose-induced aging mice via the Keap1/Nrf2/ARE and P53/Trim32
   signaling pathways
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article; Early Access
DE ABp (Agaricus Blazei polypeptide); aging; Keap1; Nrf2; ARE; oxidative
   stress; RNA&#8208; seq
ID IN-VITRO; ANTIOXIDATION; PROMOTES; IMPAIRMENT; ACTIVATION; LIVER
AB This experiment mainly optimized the extraction technology of Agaricus blazei polypeptide (ABp) and evaluated its protective effect on aging mice. In this study, a novel single component, the M is 3 kD, was isolated and purified from Agaricus blazei. An aging mouse model was established using D-galactose. After the administration of ABp, the contents of total antioxidant capacity (T-AOC), malondialdehyde (MDA), catalase (CAT), and reactive oxygen species were significantly changed. Through immunofluorescence staining, it was observed that ABp can reduce changes in brain tissue. The differential expression of genes was analyzed by RNA-seq. A total of 295 differentially expressed genes were screened out in the ABp group.RT-qPCR verified important genes and showed that the mRNA expression levels of Hsph1, Trim32, HK1, Hnrnpa1, and Grik5 were significantly increased, and those of ApoE, Atp1a3, Stxbp1, and Mapk8ip1 was significantly decreased. Western blotting showed that the protein expression levels of Keap1 and p53 were significantly lower, while the protein expression levels of Nrf2, HO-1, Hsph1, and Trim32 were significantly higher in the ABP group. ABp played an anti-aging role in an aging mouse model. The specific mechanism of action may be related to the regulation of the expression of the Keap1/Nrf2/P53 signaling pathway and related factors.
   Practical applications The research may contribute to the development of ABp as functional foods or dietary supplements for anti-aging in the future.
C1 [Feng, Qingxia; Li, Yingna; Yuan, Guangxin; Sun, Jingbo; Tian, Chenxi; Hu, Lian; Xu, Guangyu; An, Liping; Du, Peige] Beihua Univ, Coll Pharm, 3999 Binjiang East Rd, Jilin 132013, Jilin, Peoples R China.
   [Lu, Xuechun] Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China.
   [Yu, Ying] Jilin Univ, Hosp 2, Dept Cardiovasc Surg, Changchun, Peoples R China.
C3 Beihua University; Chinese People's Liberation Army General Hospital;
   Jilin University
RP An, LP; Du, PG (corresponding author), Beihua Univ, Coll Pharm, 3999 Binjiang East Rd, Jilin 132013, Jilin, Peoples R China.
EM lpan@beihua.edu.cn; dupeige@beihua.edu.cn
OI Yuan, Guangxin/0000-0003-1333-8767
FU Jilin Province Development and Reform Commission Project [2018C046-3];
   Jilin Provincial Health and Family Planning Commission Project
   [2017J083]
FX Jilin Province Development and Reform Commission Project, Grant/Award
   Number: 2018C046-3; Jilin Provincial Health and Family Planning
   Commission Project, Grant/Award Number: 2017J083
CR Borlepawar A, 2017, J BIOL CHEM, V292, P10180, DOI 10.1074/jbc.M116.752543
   Carvill GL, 2014, NEUROLOGY, V82, P1245, DOI 10.1212/WNL.0000000000000291
   Chang JB, 2011, IN VIVO, V25, P971
   de Souza ACD, 2017, CURR PHARM DESIGN, V23, P2807, DOI 10.2174/1381612823666170119093719
   Ding JF, 2011, FOOD HYDROCOLLOID, V25, P1350, DOI 10.1016/j.foodhyd.2010.12.013
   Feng QX, 2020, J FUNCT FOODS, V72, DOI 10.1016/j.jff.2020.104037
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Gobi VV, 2018, NUTR NEUROSCI, V21, P657, DOI 10.1080/1028415X.2017.1337290
   Haghiralsadat F, 2018, INT J NANOMED, V13, P3853, DOI 10.2147/IJN.S150017
   Howard JM, 2018, GENOME RES, V28, P689, DOI 10.1101/gr.229062.117
   Ikeda K, 2017, BRAIN RES, V1666, P27, DOI 10.1016/j.brainres.2017.04.014
   Jeong Y, 2017, CANCER DISCOV, V7, P86, DOI 10.1158/2159-8290.CD-16-0127
   Jiang LY, 2018, ONCOL LETT, V15, P3429, DOI 10.3892/ol.2018.7794
   Khayyer A., 2017, J JAPAN SOC CIVIL B2, V73, pI_1039
   Korytina GF, 2017, MOL BIOL+, V51, P533, DOI 10.1134/S0026893317040124
   Kou XJ, 2016, ONCOTARGET, V7, P74484, DOI 10.18632/oncotarget.12811
   Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115
   Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008
   Lallemand T, 2018, ARTERIOSCL THROM VAS, V38, P1479, DOI 10.1161/ATVBAHA.118.311208
   Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005
   Li QS, 2018, BRAIN RES BULL, V137, P311, DOI 10.1016/j.brainresbull.2018.01.007
   Liu XJ, 2016, J FUNCT FOODS, V25, P50, DOI 10.1016/j.jff.2016.05.009
   Lu YY, 2017, ONCOL LETT, V13, P1131, DOI 10.3892/ol.2016.5544
   Maltese G, 2017, J CELL MOL MED, V21, P621, DOI 10.1111/jcmm.12996
   Uranga RM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2850341
   Nita M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3164734
   Planche V, 2017, BRAIN BEHAV IMMUN, V60, P240, DOI 10.1016/j.bbi.2016.11.010
   Ren Chao, 2018, Agricultural Biotechnology, V7, P102
   Schirinzi T, 2018, CEREBELLUM, V17, P489, DOI 10.1007/s12311-018-0920-y
   Sullivan LS, 2014, INVEST OPHTH VIS SCI, V55, P7147, DOI 10.1167/iovs.14-15419
   Tian B, 2004, LUMINESCENCE, V19, P78, DOI 10.1002/bio.761
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Xu JJ, 2017, FOOD BIOSCI, V18, P9, DOI 10.1016/j.fbio.2017.03.002
   Zhao TT, 2018, J CANCER, V9, P1349, DOI 10.7150/jca.22390
NR 34
TC 6
Z9 6
U1 3
U2 33
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD 2021 JAN
PY 2021
VL 45
IS 1
AR e13555
DI 10.1111/jfbc.13555
EA NOV 2020
PG 12
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA PV2NW
UT WOS:000590296900001
PM 33200472
OA gold
DA 2024-02-19
ER

PT J
AU Sanmartin, R
   Tor, J
   Sanvisens, A
   López, JJ
   Jou, A
   Muga, R
   Ojanguren, I
   Barluenga, E
   Videla, S
   Planas, R
   Clotet, B
   Tural, C
AF Sanmartin, R.
   Tor, J.
   Sanvisens, A.
   Lopez, J. J.
   Jou, A.
   Muga, R.
   Ojanguren, I.
   Barluenga, E.
   Videla, S.
   Planas, R.
   Clotet, B.
   Tural, C.
TI Progression of liver fibrosis in HIV/hepatitis C virus-coinfected
   individuals on antiretroviral therapy with early stages of liver
   fibrosis at baseline
SO HIV MEDICINE
LA English
DT Article
DE HIV; HCV coinfection; liver biopsy; liver fibrosis; transient
   elastometry
ID CHRONIC HEPATITIS-C; HUMAN-IMMUNODEFICIENCY-VIRUS; GENOTYPE 1 INFECTION;
   NATURAL-HISTORY; HIV; HIV/HCV; DISEASE; COMPLICATIONS; BOCEPREVIR;
   TELAPREVIR
AB ObjectivesThe aim of the study was to assess the progression of liver fibrosis in HIV/hepatitis C virus (HCV)-coinfected patients with no or mild-to-moderate fibrosis (stages F0-F2).
   MethodsLiver fibrosis was reassessed by transient elastometry (TE) between January 2009 and November 2011 in HIV/HCV-coinfected patients with stage F0-F2 fibrosis in a liver biopsy performed between January 1997 and December 2007. Patients with liver stiffness at the end of follow-up <7.1kPa were defined as nonprogressors, and those with values 9.5kPa or who died from liver disease were defined as progressors. Cirrhosis was defined as a cut-off of 14.6kPa. The follow-up period was the time between liver biopsy and TE. Cox regression models adjusted for age, gender and liver fibrosis stage at baseline were applied.
   ResultsThe median follow-up time was 7.8 years [interquartile range (IQR) 5.5-10 years]. The study population comprised 162 patients [115 (71%) nonprogressors and 47 (29%) progressors; 19 patients (11.7%) had cirrhosis]. The median time from the diagnosis of HCV infection to the end of follow-up was 20 years (IQR 16.3-23.1 years). Three progressors died from liver disease (1.8%). The variables associated with a lower risk of progression were age 38 years (hazard ratio (HR) 0.32; 95% confidence interval (CI) 0.16-0.62; P=0.001], having received interferon (HR 2.18; 95% CI 1.14-4.15; P=0.017), being hepatitis B virus surface antigen (HBsAg) negative (HR 0.20; 95% CI 0.04-0.92; P=0.039), and baseline F0-F1 (HR 0.43; 95% CI 0.28-0.86; P=0.017).
   ConclusionsA high proportion of patients with stage F0-F2 fibrosis progress to advanced liver fibrosis. Advanced liver fibrosis must be included in the list of diseases associated with aging. Our results support the recommendation to offer HCV antiviral therapy to HIV/HCV-coinfected patients at early stages of liver fibrosis.
C1 [Sanmartin, R.; Tor, J.; Sanvisens, A.; Lopez, J. J.; Muga, R.; Clotet, B.; Tural, C.] Univ Autonoma Barcelona, Internal Med Serv, Univ Hosp Germans Trias & Pujol, HIV Clin Unit, E-08193 Barcelona, Spain.
   [Jou, A.; Videla, S.; Clotet, B.; Tural, C.] Univ Autonoma Barcelona, LLuita SIDA Fdn, Univ Hosp Germans Trias & Pujol, E-08193 Barcelona, Spain.
   [Ojanguren, I.] Univ Autonoma Barcelona, Pathol Serv, Univ Hosp Germans Trias & Pujol, E-08193 Barcelona, Spain.
   [Barluenga, E.] Univ Autonoma Barcelona, Radiol Serv, Univ Hosp Germans Trias & Pujol, E-08193 Barcelona, Spain.
   [Planas, R.] Univ Autonoma Barcelona, Dept Gastroenterol, Univ Hosp Germans Trias & Pujol, CIBERehd, E-08193 Barcelona, Spain.
   [Clotet, B.] Univ Autonoma Barcelona, Irsicaixa Fdn, Univ Hosp Germans Trias & Pujol, E-08193 Barcelona, Spain.
C3 Autonomous University of Barcelona; Autonomous University of Barcelona;
   Autonomous University of Barcelona; Autonomous University of Barcelona;
   CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous
   University of Barcelona; Institut de Recerca de la Sida - IrsiCaixa;
   Autonomous University of Barcelona
RP Tural, C (corresponding author), Univ Hosp Germans Trias & Pujol, HIV Clin Unit, C Carretera Canyet S-N, Badalona 08916, Spain.
EM ctural.germanstrias@gencat.cat
RI Lopez, Jose Ignacio/L-3884-2019; Muga, Roberto/AAY-8655-2021
OI Lopez, Jose Ignacio/0000-0003-0842-5348; Muga,
   Roberto/0000-0001-6301-431X; Sanvisens, Arantza/0000-0001-6269-5491
FU RETICS de SIDA [RD 12/0017, RD 12/0028]; FIS [PI051550];  [EC11-042]
FX This study was partially funded by RETICS de SIDA (RD 12/0017 and RD
   12/0028), an FIS grant (PI051550) and EC11-042.
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   [Anonymous], EUR AIDS CLIN SOC EA
   Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482
   Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409
   Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020
   Blanco F, 2011, J VIRAL HEPATITIS, V18, P11, DOI 10.1111/j.1365-2893.2009.01261.x
   Bräu N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006
   Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771
   Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073
   Fontaine H, 2001, HUM PATHOL, V32, P904, DOI 10.1053/hupa.2001.28228
   Fuster D, 2004, AIDS RES HUM RETROV, V20, P1293, DOI 10.1089/aid.2004.20.1293
   Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641
   Kanwal F, 2011, GASTROENTEROLOGY, V140, P1182, DOI 10.1053/j.gastro.2010.12.032
   Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844
   Macías J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136
   Mallolas J, 2012, 47 ANN M EUR ASS STU
   Martínez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013
   Merchante N, 2006, AIDS, V20, P49, DOI 10.1097/01.aids.0000198087.47454.e1
   Pineda JA, 2005, HEPATOLOGY, V41, P779, DOI 10.1002/hep.20626
   Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757
   Pineda JA, 2009, CLIN INFECT DIS, V49, P1274, DOI 10.1086/605676
   Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494
   Saadeh S, 2001, HEPATOLOGY, V33, P196, DOI 10.1053/jhep.2001.20534
   Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001
   Sanmartin R, 2012, AIDS RES HUM RETROV, V28, P1235, DOI 10.1089/aid.2011.0322
   SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O
   Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806
   Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463
   Sherman KE, 2010, JAIDS-J ACQ IMM DEF, V55, P597, DOI 10.1097/QAI.0b013e3181f6d916
   Soriano V, 2007, AIDS, V21, P1073, DOI 10.1097/QAD.0b013e3281084e4d
   Sulkowski MS, 2007, AIDS, V21, P2209, DOI 10.1097/QAD.0b013e3282f10de9
   Sulkowski MS, 2012, 63 ANN M AM ASS STUD
   Tural C, 2003, J VIRAL HEPATITIS, V10, P118, DOI 10.1046/j.1365-2893.2003.00413.x
   Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086
NR 36
TC 16
Z9 16
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-2662
EI 1468-1293
J9 HIV MED
JI HIV Med.
PD APR
PY 2014
VL 15
IS 4
BP 203
EP 212
DI 10.1111/hiv.12105
PG 10
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA AB8XW
UT WOS:000332074300003
PM 24245909
OA Bronze
DA 2024-02-19
ER

PT J
AU Sandoval-Sierra, JV
   Helbing, AHB
   Williams, EG
   Ashbrook, DG
   Roy, S
   Williams, RW
   Mozhui, K
AF Sandoval-Sierra, Jose Vladimir
   Helbing, Alexandra H. B.
   Williams, Evan G.
   Ashbrook, David G.
   Roy, Suheeta
   Williams, Robert W.
   Mozhui, Khyobeni
TI Body weight and high-fat diet are associated with epigenetic aging in
   female members of the BXD murine family
SO AGING CELL
LA English
DT Article; Early Access
DE age acceleration; DNA methylation clock; life span; longevity
ID DNA METHYLATION AGE; LIFE-SPAN; BIOLOGICAL AGE; MICE; LOCI; LONGEVITY;
   VARIANTS; C57BL/6J; GENE; TIME
AB DNA methylation (DNAm) is shaped by genetic and environmental factors and modulated by aging. Here, we examine interrelations between epigenetic aging, body weight (BW), and life span in 12 isogenic strains from the BXD family of mice that exhibit over twofold variation in longevity. Genome-wide DNAm was assayed in 70 liver specimens from predominantly female cases, 6-25 months old, that were maintained on normal chow or high-fat diet (HFD). We defined subsets of CpG regions associated with age, BW at young adulthood, and strain-by-diet-dependent life span. These age-associated differentially methylated CpG regions (age-DMRs) featured distinct genomic characteristics, with DNAm gains over time occurring in sites such as promoters and exons that have high CpG density and low average methylation. CpG regions associated with BW were enriched in introns, tended to have lower methylation in mice with higher BW, and were inversely correlated with gene expression (i.e., higher mRNA levels in mice with higher BW). CpG regions associated with life span were linked to genes involved in life span modulation, including the telomerase reverse transcriptase gene,Tert, which had both lower methylation and higher expression in long-lived strains. An epigenetic clock defined from age-DMRs revealed accelerated aging in mice belonging to strains with shorter life spans. Both higher BW and the HFD were associated with accelerated epigenetic aging. Our results highlight the age-accelerating effect of heavier BW. Furthermore, we demonstrate that the measure of epigenetic aging derived from age-DMRs can predict genotype and diet-induced differences in life span among female BXD members.
C1 [Sandoval-Sierra, Jose Vladimir; Helbing, Alexandra H. B.; Mozhui, Khyobeni] Univ Tennessee, Coll Med, Dept Prevent Med, Hlth Sci Ctr, Memphis, TN 38103 USA.
   [Ashbrook, David G.; Roy, Suheeta; Williams, Robert W.; Mozhui, Khyobeni] Univ Tennessee, Coll Med, Dept Genet Genom & Informat, Hlth Sci Ctr, Memphis, TN USA.
   [Williams, Evan G.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.
C3 University of Tennessee System; University of Tennessee Health Science
   Center; University of Tennessee System; University of Tennessee Health
   Science Center; University of Luxembourg
RP Mozhui, K (corresponding author), Univ Tennessee, Coll Med, Dept Prevent Med, Hlth Sci Ctr, Memphis, TN 38103 USA.
EM kmozhui@uthsc.edu
RI Williams, Evan G/M-7539-2017; Ashbrook, David George/H-5702-2019;
   Sandoval Sierra, Jose Vladimir/GYD-5018-2022
OI Williams, Evan G/0000-0002-9746-376X; Ashbrook, David
   George/0000-0002-7397-8910; Sandoval Sierra, Jose
   Vladimir/0000-0003-2007-6582
FU National Institute on Aging [R01AG043930, R21AG055841]
FX National Institute on Aging, Grant/Award Number: R01AG043930 and
   R21AG055841
CR Aberg KA, 2018, METHODS MOL BIOL, V1708, P171, DOI 10.1007/978-1-4939-7481-8_10
   Ashbrook D.G., 2019, 672097 BIORXIV
   Bartke A, 2012, GERONTOLOGY, V58, P337, DOI 10.1159/000335166
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Berger H, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00031
   Breitling LP, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0186-5
   Budovsky A, 2011, BIOGERONTOLOGY, V12, P167, DOI 10.1007/s10522-010-9305-4
   Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120
   Carter CJ, 2007, NEUROCHEM INT, V50, P12, DOI 10.1016/j.neuint.2006.07.007
   Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020
   Ciccarone F, 2018, MECH AGEING DEV, V174, P3, DOI 10.1016/j.mad.2017.12.002
   Cole JJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1185-3
   De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707
   de Haan G, 1998, NAT GENET, V19, P114, DOI 10.1038/465
   GELMAN R, 1988, GENETICS, V118, P693
   Gujar H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193496
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Hsu HC, 2005, MECH AGEING DEV, V126, P87, DOI 10.1016/j.mad.2004.09.016
   Lang DH, 2010, AGING CLIN EXP RES, V22, P8, DOI 10.1007/BF03324809
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Lowe R, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1397-1
   Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684
   Lu AT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02697-5
   Marioni RE, 2018, INT J EPIDEMIOL, V47, P356, DOI 10.1093/ije/dyx233
   Marioni RE, 2015, INT J EPIDEMIOL, V44, P1388, DOI 10.1093/ije/dyu277
   Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6
   McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630
   Metrustry SJ, 2014, TWIN RES HUM GENET, V17, P254, DOI 10.1017/thg.2014.34
   Mozhui K, 2017, MECH AGEING DEV, V162, P27, DOI 10.1016/j.mad.2017.02.006
   Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016
   Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109
   Roy S., 2019, 776559 BIORXIV, V776559
   Sloane LB, 2011, J GERONTOL A-BIOL, V66, P170, DOI 10.1093/gerona/glq169
   Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5
   Sziráki A, 2018, AGING CELL, V17, DOI 10.1111/acel.12738
   Teumer A, 2016, AGING CELL, V15, P811, DOI 10.1111/acel.12490
   Thompson MJ, 2018, AGING-US, V10, P2832, DOI 10.18632/aging.101590
   Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274
   Turner SD., 2018, The Journal of Open Source Software, V3, P731, DOI [10.1101/005165, 10.21105/joss.00731, DOI 10.1101/005165, DOI 10.21105/JOSS.00731]
   Wang TN, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1186-2
   Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121
   Yuan R, 2011, ILAR J, V52, P4, DOI 10.1093/ilar.52.1.4
   Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x
   Zhou Y, 2017, INT J OBESITY, V41, P1427, DOI 10.1038/ijo.2017.127
NR 45
TC 19
Z9 20
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2020 SEP
PY 2020
VL 19
IS 9
AR e13207
DI 10.1111/acel.13207
EA AUG 2020
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA NW7UG
UT WOS:000559384700001
PM 32790008
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Nguyen, QV
   Vu, TT
   Tran, MT
   Thi, PTH
   Thu, H
   Le Thi, TH
   Van Chuyen, H
   Dinh, MH
AF Quang-Vinh Nguyen
   Thi-Tuoi Vu
   Minh-Trang Tran
   Phuong Tham Ho Thi
   Huynh Thu
   Thuy Hang Le Thi
   Hoang Van Chuyen
   Minh-Hiep Dinh
TI Antioxidant Activity and Hepatoprotective Effect of Exopolysaccharides
   From Cultivated <i>Ophiocordyceps Sinensis</i> Against
   CCl<sub>4</sub>-Induced Liver Damages
SO NATURAL PRODUCT COMMUNICATIONS
LA English
DT Article
DE Ophiocordyceps sinensis; exopolysaccharide; hepatoprotective effect;
   CCl4; antioxidant activity; lipid peroxidation
ID OXIDATIVE STRESS; MYCELIAL POLYSACCHARIDES; ANTITUMOR-ACTIVITY;
   CORDYCEPS; INJURY
AB Cordyceps is a well-known and valuable fungal Chinese medicine and health food. The polysaccharides from C. sinensis have been reported as the main bioactive components, which possess antioxidant, anti-aging, and liver protective activities. This study aimed to investigate the in vitro antioxidative and protective effects of exopolysaccharides (EPS) from cultivated Ophiocordyceps sinensis (O. sinensis) on rats with liver damage induced by CCl4. The results indicated that cultivated O. sinensis EPS possess moderate ABTS and hydroxyl radical scavenging abilities with IC50 values of 2.00 and 3.78 mg/mL, respectively. EPS and the positive control (silymarin) could also protect rat liver from the oxidative effect induced by CCl4 via increasing GSH levels, reducing MAD levels and decreasing serum AST and ALT activities. Moreover, the changes in histopathological liver tissue showed that EPS significantly reduced the damage induced by CCl4 in the liver. The findings suggest that EPS possesses a significant hepatoprotective effect against hepatotoxicity induced by CCl4 in rats.
C1 [Quang-Vinh Nguyen] Tay Nguyen Univ, Inst Biotechnol & Environm, 567 Le Duan, Buon Ma Thuot City 630000, Daklak Province, Vietnam.
   [Thi-Tuoi Vu; Minh-Trang Tran; Phuong Tham Ho Thi] Vietnam Natl Univ HCMC, Univ Sci, Ho Chi Minh City, Vietnam.
   [Huynh Thu] Ho Chi Minh Univ Technol HCMUT, Fac Chem Engn, Dept Biotecnol, Ho Chi Minh City, Vietnam.
   [Thuy Hang Le Thi] Vietnam Acad Sci & Technol, Grad Univ Sci & Technol, Hanoi, Vietnam.
   [Hoang Van Chuyen] Thu Dau Mot Univ, Fac Food Sci & Technol, Thu Dau Mot, Binh Duong Prov, Vietnam.
   [Minh-Hiep Dinh] Ho Chi Minh City Dept Agr & Rural Dev, 176 Hai Ba Trung St,Dist 1, Hcmc 22640100, Vietnam.
C3 Tay Nguyen University; Vietnam National University Hochiminh City; Ho
   Chi Minh City University of Technology (HCMCUT); Vietnam National
   University Hochiminh City; Vietnam Academy of Science & Technology
   (VAST); Thu Dau Mot University
RP Nguyen, QV (corresponding author), Tay Nguyen Univ, Inst Biotechnol & Environm, 567 Le Duan, Buon Ma Thuot City 630000, Daklak Province, Vietnam.; Dinh, MH (corresponding author), Ho Chi Minh City Dept Agr & Rural Dev, 176 Hai Ba Trung St,Dist 1, Hcmc 22640100, Vietnam.
EM vinh12b@gmail.com; hiepdm75@yahoo.com.vn
RI ling, yuan/HGC-1455-2022
OI Nguyen Quang, Vinh/0000-0003-2584-1466; Thu, Huynh/0000-0001-6042-3353
FU Department of Science and Technology; Center of Science and Technology
   Development in Ho Chi Minh City
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was financially supported by The Department of Science and Technology
   and Center of Science and Technology Development in Ho Chi Minh City.
CR Akashi K, 2001, FEBS LETT, V508, P438, DOI 10.1016/S0014-5793(01)03123-4
   Campo GM, 2001, FREE RADICAL RES, V34, P379, DOI 10.1080/10715760100300321
   Dey A, 2013, FOOD FUNCT, V4, P1148, DOI 10.1039/c3fo30317a
   Gan D, 2012, FOOD CHEM TOXICOL, V50, P2681, DOI 10.1016/j.fct.2012.05.003
   Ho-Thi P-T, 2016, J SCI TECH, V54, P148, DOI [10.13005/bpj/449, DOI 10.13005/BPJ/449]
   Jafari M, 2014, EXCLI J, V13, P161
   Jain A, 2008, J ETHNOPHARMACOL, V115, P61, DOI 10.1016/j.jep.2007.09.009
   Ji DB, 2009, PHYTOTHER RES, V23, P116, DOI 10.1002/ptr.2576
   Jing LY, 2017, J FUNCT FOODS, V36, P203, DOI 10.1016/j.jff.2017.06.057
   Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047
   Leung PH, 2006, J APPL MICROBIOL, V101, P275, DOI 10.1111/j.1365-2672.2006.02930.x
   Li SP., 2004, OXIDAT STRESS DIS, P657
   Li Yang-mei, 2017, Mycology-An International Journal On Fungal Biology, V8, P276, DOI 10.1080/21501203.2017.1383318
   Lu ZQ, 2013, CARBOHYD POLYM, V96, P131, DOI 10.1016/j.carbpol.2013.03.063
   Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005
   Nada SA, 2010, FOOD CHEM TOXICOL, V48, P3184, DOI 10.1016/j.fct.2010.08.019
   Nan JX, 2001, ARCH PHARM RES, V24, P327, DOI 10.1007/BF02975101
   Nie S., 2013, Bioact Carbohydr, V1, P38, DOI DOI 10.1016/J.BCDF.2012.12.002
   Sharma SK, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0967-y
   Shirwaikar A, 2006, BIOL PHARM BULL, V29, P1906, DOI 10.1248/bpb.29.1906
   Song XL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28785-0
   Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01
   Tsai CF, 2009, FOOD CHEM TOXICOL, V47, P2031, DOI 10.1016/j.fct.2009.05.021
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033
   Yang JY, 2010, J AGR FOOD CHEM, V58, P6525, DOI 10.1021/jf903070a
   Yang ML, 2011, J NAT PROD, V74, P1996, DOI 10.1021/np100902f
   Yang XB, 2013, FOOD CHEM, V138, P1256, DOI 10.1016/j.foodchem.2012.10.030
   Zangar RC, 2000, CHEM-BIOL INTERACT, V125, P233, DOI 10.1016/S0009-2797(00)00149-6
   Zhang SS, 2014, FOOD CHEM TOXICOL, V68, P239, DOI 10.1016/j.fct.2014.03.020
   Zhang YongJie, 2012, Mycology - An International Journal on Fungal Biology, V3, P2
   Zhong WQ, 2013, INT J BIOL MACROMOL, V60, P355, DOI 10.1016/j.ijbiomac.2013.06.018
NR 32
TC 4
Z9 4
U1 4
U2 23
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1934-578X
EI 1555-9475
J9 NAT PROD COMMUN
JI Nat. Prod. Commun.
PD FEB
PY 2021
VL 16
IS 2
AR 1934578X21997670
DI 10.1177/1934578X21997670
PG 9
WC Chemistry, Medicinal; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology
GA QQ7JX
UT WOS:000624698700001
OA gold
DA 2024-02-19
ER

PT J
AU Sha, AL
   Liu, Y
   Qiu, XY
   Xiong, BB
AF Sha, Ailong
   Liu, Yi
   Qiu, Xinyu
   Xiong, Binbing
TI Polysaccharide from Paris polyphylla improves learning and memory
   ability in D-galactose-induced aging model mice based on antioxidation,
   p19/p53/p21, and Wnt/β-catenin signaling pathways
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Paris polyphylla polysaccharide; Learning and memory; Antioxidation;
   p19/p53/p21 signaling pathway; Wnt/beta-catenin signaling pathway
ID OXIDATIVE STRESS; CEREBRAL-ISCHEMIA; DOWN-REGULATION; STEM-CELLS; CYCLIN
   D1; WNT; HIPPOCAMPUS; P53; DYSFUNCTION; IMPAIRMENT
AB The current study aimed to investigate the effects and mechanisms of Paris polyphylla polysaccharide component 1 (PPPm-1) to improve learning and memory in D-galactose-induced aging model mice. We determined the effects of PPPm-1 on the brain, organ index, and behavior in the aging model mice induced by D-galactose to study learning and memory improvement. UV-Vis spectrophotometry helped determine the PPPm-1 effect on antioxidant parameters associated with learning and memory in the brain and related organs of aging mice. Moreover, in the hippocampi of aging model mice, PPPm-1 effect on the mRNA and protein expressions of p19, p53, p21, P16, Rb, Wnt/1, beta-catenin, CyclinD1, TCF-4, and GSK-3 beta were detected using the quantitative real-time PCR and enzyme-linked immunosorbent assay (ELISA), respectively. The results indicated that PPPm-1 could increase the brain and organ indexes, the avoidance latency, the total distance and average speed in the water maze, and the SOD and GSH-P-X activities in the brain, liver tissues, and plasma. Moreover, the mRNA and protein expressions of Wnt/1, beta-catenin, CyclinD1, and TCF-4 were also elevated in the hippocampi of aging model mice. However, the error times in step-through tests, the MDA content in the brain and liver tissues, the AChE activity in the brain tissue, the protein expressions of P16, Rb in the hippocampi, and the mRNA and protein expressions of p19, p53, p21, and GSK-3 beta in the hippocampi of aging model mice were significantly decreased. Thus, PPPm-1 significantly enhanced the learning and memory impairment induced by D-galactose in mice. The action mechanisms were associated with anti-oxidative stress, cholinergic nervous system function regulation, LTP enhancement in long-term memory, down-regulated expression of p19/p53/p21 signaling pathway factors, and Wnt/beta-catenin signaling pathway activation.
C1 [Sha, Ailong] Chongqing Three Gorges Univ, Sch Teacher Educ, Chongqing 404120, Peoples R China.
   [Sha, Ailong; Liu, Yi; Qiu, Xinyu; Xiong, Binbing] Chongqing Three Gorges Univ, Sch Biol & Food Engn, Chongqing 404120, Peoples R China.
C3 Chongqing Three Gorges University; Chongqing Three Gorges University
RP Sha, AL (corresponding author), Chongqing Three Gorges Univ, Sch Teacher Educ, Chongqing 404120, Peoples R China.
EM lyshaailong@163.com
FU Science and Technology Research Project of Chongqing Education
   Commission [KJQN201901235, KJQN20201226, KJQN202101247]; Talent
   Introduction and Scientific Research Startup Fund Project of Chongqing
   Three Gorges University [20190002]
FX The Science and Technology Research Project of Chongqing Education
   Commission (KJQN201901235, KJQN20201226, KJQN202101247) , the Talent
   Introduction and Scientific Research Startup Fund Project of Chongqing
   Three Gorges University (20190002) .
CR Anand P, 2013, ARCH PHARM RES, V36, P375, DOI 10.1007/s12272-013-0036-3
   Bai LD, 2023, INT J BIOL MACROMOL, V227, P158, DOI 10.1016/j.ijbiomac.2022.12.071
   Bizen N, 2014, STEM CELLS, V32, P1602, DOI 10.1002/stem.1613
   BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492
   Calabrese V, 2018, FREE RADICAL BIO MED, V115, P80, DOI 10.1016/j.freeradbiomed.2017.10.379
   Chen HL, 2016, BIOTECHNOL LETT, V38, P2071, DOI 10.1007/s10529-016-2210-4
   Chen WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088076
   Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009
   Cho YH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19173-2
   [丁立帅 Ding Lishuai], 2018, [天然产物研究与开发, Natural Product Research and Development], V30, P832
   Ding VW, 2007, J MOL MED-JMM, V85, P1281, DOI 10.1007/s00109-007-0228-8
   Du Q, 2020, EXP BIOL MED, V245, P1, DOI 10.1177/1535370219894558
   Esteras N, 2013, NEUROBIOL AGING, V34, P1090, DOI 10.1016/j.neurobiolaging.2012.10.014
   Gao J, 2018, NEUROSCIENCE, V388, P357, DOI 10.1016/j.neuroscience.2018.07.052
   Han C, 2020, J. Tradit. Chin. Med., V35, P5112
   He JT, 2019, CELL MOL NEUROBIOL, V39, P671, DOI 10.1007/s10571-019-00670-y
   Heng Y.X., 2017, J. Chongqing Univ. Ind. Commerce Nat. Sci. Ed., V34, P111
   Heyck M, 2019, BRAIN CIRC, V5, P124, DOI 10.4103/bc.bc_34_19
   Hu YQ, 2019, J MOL NEUROSCI, V67, P142, DOI 10.1007/s12031-018-1219-7
   Huang JL, 2019, AGING-US, V11, P8542, DOI 10.18632/aging.102337
   Huang RZ, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3371
   Jirawatnotai S, 2016, DNA REPAIR, V42, P56, DOI 10.1016/j.dnarep.2016.04.011
   Joseph M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0230-8
   Jung TW, 2007, J NEUROL SCI, V253, P53, DOI 10.1016/j.jns.2006.11.020
   Kumral E, 2021, J NEUROPSYCH CLIN N, V33, P49, DOI 10.1176/appi.neuropsych.19120356
   Lee YH, 2014, FEBS LETT, V588, P3251, DOI 10.1016/j.febslet.2014.07.009
   Li J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060849
   [李娟 Li Juan], 2014, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V19, P512
   Li L., 2017, Guangming Tradit. Chin. Med., V32, P1214
   Liang J, 2019, INT J BIOL MACROMOL, V126, P414, DOI 10.1016/j.ijbiomac.2018.12.230
   Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108
   Liu C, 2018, J MED FOOD, V21, P678, DOI 10.1089/jmf.2017.4090
   Liu G.C., 2015, Food Ind. Sci. Technol., V36, P366
   Liu HM, 2010, PLANT GROWTH REGUL, V60, P69, DOI 10.1007/s10725-009-9420-x
   Liu J.Y., 2018, J CLIN MED PRACT, V17, P224
   Maguschak KA, 2012, NEUROPHARMACOLOGY, V62, P78, DOI 10.1016/j.neuropharm.2011.08.032
   Mardones MD, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0209-3
   Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014
   Marzo A, 2016, CURR BIOL, V26, P2551, DOI 10.1016/j.cub.2016.07.024
   Mateos-Aparicio P, 2020, ADV EXP MED BIOL, V1131, P965, DOI 10.1007/978-3-030-12457-1_38
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   Nair JD, 2021, NEUROPHARMACOLOGY, V196, DOI 10.1016/j.neuropharm.2021.108540
   Naqvi F, 2019, PAK J PHARM SCI, V32, P1893
   Ou HL, 2018, BLOOD, V131, P488, DOI 10.1182/blood-2017-07-746396
   Pang DJ, 2020, BIOL OPEN, V9, DOI 10.1242/bio.046854
   Peng X., 2014, PLoS ONE, V9
   Pereira IT, 2015, BEHAV NEUROSCI, V129, P533, DOI 10.1037/bne0000078
   Qin XD, 2020, BIOCHEM BIOPH RES CO, V531, P431, DOI 10.1016/j.bbrc.2020.07.122
   Qiu CW, 2018, EXP NEUROL, V309, P44, DOI 10.1016/j.expneurol.2018.07.011
   Qu ZY, 2017, CELL BIOCHEM FUNCT, V35, P472, DOI 10.1002/cbf.3306
   Rababa'h AM, 2019, CURR ALZHEIMER RES, V16, P1300, DOI 10.2174/1567205017666200102153239
   Rolando C, 2014, CURR TOP DEV BIOL, V107, P183, DOI 10.1016/B978-0-12-416022-4.00007-X
   Sha Ai-Long, 2016, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V32, P121, DOI 10.13459/j.cnki.cjap.2016.02.007
   Sha AL, 2022, LAT AM J PHARM, V41, P2419
   [沙爱龙 Sha Ailong], 2013, [动物医学进展, Progress in Veterinary Medicine], V34, P66
   Shen S, 2018, INT J BIOL MACROMOL, V107, P1613, DOI 10.1016/j.ijbiomac.2017.10.026
   Shen SA, 2014, CARBOHYD POLYM, V104, P80, DOI 10.1016/j.carbpol.2014.01.006
   Song N., 2019, J. Southeast Univ. (Med. Sci. Ed.), V38, P979
   Tell S, 2006, BIOCHEM BIOPH RES CO, V349, P261, DOI 10.1016/j.bbrc.2006.08.044
   Teng JF, 2020, CANCERS, V12, DOI 10.3390/cancers12010193
   Tian HL, 2019, JOVE-J VIS EXP, DOI 10.3791/60055
   Titley HK, 2017, NEURON, V95, P19, DOI 10.1016/j.neuron.2017.05.021
   Wang FJ, 2021, J PHARMACOL SCI, V146, P105, DOI 10.1016/j.jphs.2021.02.004
   Wang Lan, 2021, Journal of Third Military Medical University, V43, P1839
   Wang T.H., 2018, Physiology, VNinth, P47
   Wang T.H., 2018, Physiology, V9th, P69
   Wang Y, 2016, CURR MOL MED, V16, P738, DOI 10.2174/1566524016666160829153453
   [王宇飞 Wang Yufei], 2022, [中草药, Chinese Traditional and Herbal Drugs], V53, P7633
   Weiner AT, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000647
   Wen Jing, 2016, Chinese Pharmacological Bulletin, V32, P310, DOI 10.3969/j.issn.1001-1978.2016.03.003
   Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444
   Wu Mingcai, 2020, Nan Fang Yi Ke Da Xue Xue Bao, V40, P1230, DOI 10.12122/j.issn.1673-4254.2020.09.02
   [吴杨阳 Wu Yangyang], 2021, [中国野生植物资源, Chinese Wild Plant Resources], V40, P15
   Xiang J, 2021, J CELL MOL MED, V25, P10698, DOI 10.1111/jcmm.17006
   Xing P., 2021, Food Sci. Technol., V46, P222
   Yang K, 2016, LAB INVEST, V96, P116, DOI 10.1038/labinvest.2015.144
   Yin S.L., 2020, Chin. J. Integr. Med. Cardio-/Cerebrovascuiar Dis., V18, P1227
   Zhai C.M., 2021, J. Tradit. Chin. Med., V49, P26
   Zhang C, 2019, MOLECULES, V24, DOI 10.3390/molecules24050875
   Zhang Min, 2018, Journal of Beihua University, V19, P39
   Zhang WX, 2016, INDIAN J ANIM RES, V50, P769, DOI 10.18805/ijar.9630
   Zhang X, 2011, EUR J PHARM SCI, V42, P540, DOI 10.1016/j.ejps.2011.02.009
   Zhang YW, 2017, DEV BIOL, V423, P34, DOI 10.1016/j.ydbio.2017.01.014
   Zhang ZY, 2022, CARBOHYD POLYM, V296, DOI 10.1016/j.carbpol.2022.119961
   Zhao Fan-fan, 2017, Yaoxue Xuebao, V52, P347, DOI 10.16438/j.0513-4870.2016-0696
   Zhao YC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-00071-6
   Zhao Y, 2018, EXP THER MED, V16, P3082, DOI 10.3892/etm.2018.6512
   Zhu KR, 2021, EUR REV MED PHARMACO, V25, P1763, DOI [10.26355/eurrev_202102_25049, 10.26355/eurrev_202102_25054]
   李祖成, 2016, [中国老年学杂志, Chinese Journal of Gerontology], V36, P2583
   马静遥, 2013, [中国中医药信息杂志, Chinese Journal of Information on Traditional Chinese Medicine], V20, P104
NR 90
TC 1
Z9 1
U1 6
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD NOV 1
PY 2023
VL 251
AR 126311
DI 10.1016/j.ijbiomac.2023.126311
EA AUG 2023
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA R4JU0
UT WOS:001064032900001
PM 37579895
DA 2024-02-19
ER

PT J
AU Fujiwara, N
   Tateishi, R
   Kondo, M
   Minami, T
   Mikami, S
   Sato, M
   Uchino, K
   Enooku, K
   Masuzaki, R
   Nakagawa, H
   Kondo, Y
   Asaoka, Y
   Shiina, S
   Yoshida, H
   Koike, K
AF Fujiwara, Naoto
   Tateishi, Ryosuke
   Kondo, Mayuko
   Minami, Tatsuya
   Mikami, Shintaro
   Sato, Masaya
   Uchino, Koji
   Enooku, Kenichiro
   Masuzaki, Ryota
   Nakagawa, Hayato
   Kondo, Yuji
   Asaoka, Yoshinari
   Shiina, Shuichiro
   Yoshida, Haruhiko
   Koike, Kazuhiko
TI Cause-specific mortality associated with aging in patients with
   hepatocellular carcinoma undergoing percutaneous radiofrequency ablation
SO EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
LA English
DT Article
DE age factors; hepatocellular carcinoma; percutaneous radiofrequency
   ablation
ID LIVER-CANCER; ETHANOL INJECTION; ELDERLY-PATIENTS; HEPATITIS-B;
   RESECTION; CIRRHOSIS; TRANSPLANTATION; EPIDEMIOLOGY; MULTICENTER;
   EXPERIENCE
AB Objective The number of elderly patients diagnosed with hepatocellular carcinoma (HCC) is expected to increase. The aim of this study is to evaluate the efficacy of radiofrequency ablation (RFA) in elderly patients with HCC and to investigate cause-specific excess deaths associated with increasing number of elderly patients.
   Materials and methods We enrolled 1401 naive patients with HCC who were treated initially by RFA from 1999 to 2011. Patients below 75 years of age were categorized as 'younger' and those at least 75 as 'elderly'. Differences in the demographic and laboratory data of these patients were assessed, along with Kaplan-Meier analysis of survival using the log-rank test. In addition, we assessed the causes of death, defined as liver related and liver unrelated, by competing risk analysis and risk factors for respective causes of death by a proportional subdistribution model.
   Results Overall, 353 patients were categorized as elderly. Elderly patients were more likely to be women, infected with hepatitis C virus, and score better in the Child-Pugh classification. The mortality at 5 years was lower in the elderly than in the younger patients (47.3 vs. 37.1%; P<0.001). Competing risk analysis showed a significant difference in liver-unrelated death (P<0.001) between the two groups, whereas there were no significant differences in liver-related death (P=0.64). By the proportional subdistribution model, age was a significant risk factor only for liver-unrelated death.
   Conclusion RFA provided satisfactory 5-year survival rates in elderly patients with HCC. The elderly tended to die from liver-unrelated causes. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
C1 [Fujiwara, Naoto; Tateishi, Ryosuke; Kondo, Mayuko; Minami, Tatsuya; Mikami, Shintaro; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Masuzaki, Ryota; Nakagawa, Hayato; Kondo, Yuji; Asaoka, Yoshinari; Shiina, Shuichiro; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan.
C3 University of Tokyo
RP Tateishi, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.
EM tateishi-tky@umin.ac.jp
RI Fujiwara, Naoto/Y-5938-2019; Nakagawa, Hayato/I-2837-2012; Asaoka,
   Yoshinari/ABC-5412-2021; Tateishi, Ryosuke/G-7758-2014
OI Fujiwara, Naoto/0000-0002-4109-3421; Nakagawa,
   Hayato/0000-0002-6973-5094; Asaoka, Yoshinari/0000-0002-2805-8226;
   Tateishi, Ryosuke/0000-0003-3021-2517
FU The Ministry of Health, Labour and Welfare of Japan (Research on
   Hepatitis)
FX This work was supported by Health Sciences Research Grants of The
   Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis).
CR ARAKI T, 1980, AM J ROENTGENOL, V135, P1037, DOI 10.2214/ajr.135.5.1037
   Beyersmann J., 2011, Competing Risks and Multistate Models With R
   Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011
   Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Cammà C, 2001, J HEPATOL, V34, P593, DOI 10.1016/S0168-8278(01)00005-8
   Doyle MBM, 2012, J AM COLL SURGEONS, V215, P19, DOI 10.1016/j.jamcollsurg.2012.02.022
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170
   Giuliante F, 2012, J AM COLL SURGEONS, V215, P244, DOI 10.1016/j.jamcollsurg.2012.04.013
   Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205
   Hiraoka A, 2010, J GASTROEN HEPATOL, V25, P403, DOI 10.1111/j.1440-1746.2009.06037.x
   Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180
   Kao WY, 2012, J CLIN GASTROENTEROL, V46, P62, DOI 10.1097/MCG.0b013e31822b36cc
   Kondo Y, 2008, BRIT J SURG, V95, P996, DOI 10.1002/bjs.6058
   Kondo Y, 2006, BRIT J SURG, V93, P1277, DOI 10.1002/bjs.5374
   Lin SM, 2004, GASTROENTEROLOGY, V127, P1714, DOI 10.1053/j.gastro.2004.09.003
   Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933
   Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x
   Marchesini G, 1999, AM J GASTROENTEROL, V94, P655, DOI 10.1111/j.1572-0241.1999.00931.x
   McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004
   Mirici-Cappa F, 2010, GUT, V59, P387, DOI 10.1136/gut.2009.194217
   Peng ZW, 2012, RADIOLOGY, V262, P1022, DOI 10.1148/radiol.11110817
   Sacks David, 2003, J Vasc Interv Radiol, V14, pS199
   Sato M, 2012, J GASTROENTEROL, V47, P1125, DOI 10.1007/s00535-012-0569-0
   Schwartz JJ, 2012, LIVER TRANSPLANT, V18, P423, DOI 10.1002/lt.23385
   Shiina S, 2005, GASTROENTEROLOGY, V129, P122, DOI 10.1053/j.gastro.2005.04.009
   Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425
   SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1002/hep.1840220403
   Teratani T, 2006, HEPATOLOGY, V43, P1101, DOI 10.1002/hep.21164
   Varadhan R, 2010, MED CARE, V48, pS96, DOI 10.1097/MLR.0b013e3181d99107
   Vital Health and Social Statistics Division Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, 2009, VITAL STAT JAPAN LAT
   Wang JH, 2012, J HEPATOL, V56, P412, DOI 10.1016/j.jhep.2011.05.020
NR 34
TC 9
Z9 10
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0954-691X
EI 1473-5687
J9 EUR J GASTROEN HEPAT
JI Eur. J. Gastroenterol. Hepatol.
PD SEP
PY 2014
VL 26
IS 9
BP 1039
EP 1046
DI 10.1097/MEG.0000000000000161
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AM6CN
UT WOS:000339949100008
PM 25051219
DA 2024-02-19
ER

PT J
AU Mikhailova, ON
   Gulyaeva, LF
   Filipenko, ML
AF Mikhailova, ON
   Gulyaeva, LF
   Filipenko, ML
TI Gene expression of drug metabolizing enzymes in adult and aged mouse
   liver: A modulation by immobilization stress
SO TOXICOLOGY
LA English
DT Article
DE ageing; immobilization stress; drug metabolizing enzymes; cytochrome
   P450 1A; catechol-O-methyttransferase; mouse liver
ID RAT-LIVER; MESSENGER-RNA; TRANSCRIPTIONAL ACTIVATION; CYTOCHROME-P450
   GENES; HYDROCARBON RECEPTOR; AH RECEPTOR; MICE; INDUCTION; TISSUES;
   CYP1A2
AB The role of stress in the regulation of enzymatic systems involved in the biotransformation of xenobiotics, as well as endogenous substrates in the liver was investigated using single immobilization stress as a model. Adult (3 months of age) and aged (26 months) C3H/a male mice were used. Cytochrome P450 1A1 and 1A2 (CYP1A1 and CYP1A2), glutathione S-transferase M1 (GSTM1), aryl hydrocarbon receptor (AHR), aryl hydrocarbon receptor nuclear translocator (ARNT) and catechol-O-methyltransferase (COMT) mRNA levels in the mouse liver were measured by a semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) method. Excluding CYP1A1, experiments revealed significant differences in the expression of these genes between adult- and aged-control animals. The influence of stress on the expression of genes studied was shown to be higher in adult mice than in aged ones. Our results clearly demonstrate the lack of response or even the attenuation of gene expression in aged animals that may play an important role in age-related pathologies and diseases. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Inst Chem Biol & Fundamental Med, Novosibirsk 630117, Russia.
C3 Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of
   the RAS
RP Mikhailova, ON (corresponding author), Inst Chem Biol & Fundamental Med, Novosibirsk 630117, Russia.
EM pharmacogenomics@ngs.ru
RI Gulyaeva, Lyudmila/A-8890-2016
OI Gulyaeva, Lyudmila/0000-0002-7693-3777
CR ADAMS NH, 1993, CHEM-BIOL INTERACT, V86, P255, DOI 10.1016/0009-2797(93)90101-4
   Alexandrie AK, 2000, CARCINOGENESIS, V21, P669, DOI 10.1093/carcin/21.4.669
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   BURKE MD, 1994, BIOCHEM PHARMACOL, V48, P923, DOI 10.1016/0006-2952(94)90363-8
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   CHALOUPKA K, 1994, CARCINOGENESIS, V15, P2835, DOI 10.1093/carcin/15.12.2835
   CHATTOPADHYAY N, 1993, BIOTECHNIQUES, V15, P24
   Chen SY, 2002, INT J CANCER, V99, P14, DOI 10.1002/ijc.10291
   Corcos L, 1998, FEBS LETT, V425, P293, DOI 10.1016/S0014-5793(98)00246-4
   DALY AK, 1994, ENVIRON HEALTH PERSP, V102, P55, DOI 10.1289/ehp.94102s955
   Dogra SC, 1998, CLIN EXP PHARMACOL P, V25, P1, DOI 10.1111/j.1440-1681.1998.tb02135.x
   Eke BC, 1997, ARCH TOXICOL, V71, P696, DOI 10.1007/s002040050447
   FROLKIS VV, 1993, MECH AGEING DEV, V69, P93, DOI 10.1016/0047-6374(93)90074-2
   GASIEWICZ TA, 1984, BIOCHEM BIOPH RES CO, V118, P183, DOI 10.1016/0006-291X(84)91084-2
   GONZALEZ FJ, 1993, PHARMACOGENETICS, V3, P51, DOI 10.1097/00008571-199302000-00006
   Hamm JT, 1998, BIOCHEM PHARMACOL, V56, P1657, DOI 10.1016/S0006-2952(98)00241-X
   IOANNIDES C, 1993, DRUG METAB REV, V25, P485, DOI 10.3109/03602539308993983
   KADLUBAR FF, 1994, DRUG METAB REV, V26, P37, DOI 10.3109/03602539409029783
   KIMURA S, 1986, MOL CELL BIOL, V6, P1471, DOI 10.1128/MCB.6.5.1471
   Konstandi M, 1998, EUR J DRUG METAB PH, V23, P483, DOI 10.1007/BF03189999
   Konstandi M, 2000, PHARMACOL RES, V42, P205, DOI 10.1006/phrs.2000.0675
   Kvetnansky R, 1995, ANN NY ACAD SCI, V771, P131, DOI 10.1111/j.1749-6632.1995.tb44676.x
   KVETNANSKY R, 1970, ENDOCRINOLOGY, V87, P738, DOI 10.1210/endo-87-4-738
   Matamoros RA, 1996, FUND APPL TOXICOL, V30, P255, DOI 10.1006/faat.1996.0063
   Mitrunen K, 2002, PHARMACOGENETICS, V12, P67, DOI 10.1097/00008571-200201000-00009
   Moreno F, 1980, Adv Exp Med Biol, V132, P109
   MOTE PL, 1990, MECH AGEING DEV, V53, P101, DOI 10.1016/0047-6374(90)90038-H
   Mugford CA, 1998, DRUG METAB REV, V30, P441, DOI 10.3109/03602539808996322
   Nebert D W, 1994, Prog Liver Dis, V12, P63
   Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X
   Pacák K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502
   PEGRAM RA, 1995, TOXICOL LETT, V76, P119, DOI 10.1016/0378-4274(94)03212-P
   POLLACK GM, 1991, DRUG METAB DISPOS, V19, P130
   Selye H, 1936, BRIT J EXP PATHOL, V17, P234
   Shou MG, 1997, CARCINOGENESIS, V18, P207, DOI 10.1093/carcin/18.1.207
   SRIVASTAVA PK, 1993, BIOCHEM J, V294, P159, DOI 10.1042/bj2940159
   Suchar LA, 1996, ENDOCRINOLOGY, V137, P663, DOI 10.1210/en.137.2.663
   TSYRLOV IB, 1993, ARCH BIOCHEM BIOPHYS, V307, P259, DOI 10.1006/abbi.1993.1588
   TUKEY RH, 1984, BIOCHEMISTRY-US, V23, P6003, DOI 10.1021/bi00320a016
   VieiraCoelho MA, 1996, BRIT J PHARMACOL, V117, P516, DOI 10.1111/j.1476-5381.1996.tb15220.x
   WAXMAN DJ, 1991, ARCH BIOCHEM BIOPHYS, V290, P160, DOI 10.1016/0003-9861(91)90602-F
   Whalen R, 1998, SEMIN LIVER DIS, V18, P345, DOI 10.1055/s-2007-1007169
   WONG H, 1994, ANAL BIOCHEM, V223, P251, DOI 10.1006/abio.1994.1581
   Yager J D, 2000, J Natl Cancer Inst Monogr, P67
   Zacharova LY, 2003, TOXICOL SCI, V73, P108, DOI 10.1093/toxsci/kfg053
   Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586
NR 46
TC 18
Z9 21
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD JUN 1
PY 2005
VL 210
IS 2-3
BP 189
EP 196
DI 10.1016/j.tox.2005.01.018
PG 8
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 922XM
UT WOS:000228873200009
PM 15840432
DA 2024-02-19
ER

PT J
AU Law, IKM
   Xu, AM
   Lam, KSL
   Berger, T
   Mak, TW
   Vanhoutte, PM
   Liu, JTC
   Sweeney, G
   Zhou, MY
   Yang, B
   Wang, Y
AF Law, Ivy K. M.
   Xu, Aimin
   Lam, Karen S. L.
   Berger, Thorsten
   Mak, Tak W.
   Vanhoutte, Paul M.
   Liu, Jacky T. C.
   Sweeney, Gary
   Zhou, Mingyan
   Yang, Bo
   Wang, Yu
TI Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With
   Aging and Obesity
SO DIABETES
LA English
DT Article
ID NECROSIS-FACTOR-ALPHA; GELATINASE-ASSOCIATED LIPOCALIN; ADIPOSE-TISSUE;
   NEUTROPHIL GELATINASE; TNF-ALPHA; MICE; INFLAMMATION; ADIPOCYTES;
   EXPRESSION; IDENTIFICATION
AB OBJECTIVE-The proinflammatory cytokines/adipokines produced from adipose tissue act in an autocrine and/or endocrine manner to perpetuate local inflammation and to induce peripheral insulin resistance. The present study investigates whether lipocalin-2 deficiency or replenishment with this adipokine has any impact on systemic insulin sensitivity and the underlying mechanisms.
   METHODS AND RESULTS-Under conditions of aging or dietary-/genetic-induced obesity, lipocalin-2 knockout (Lcn2-KO) mice show significantly decreased fasting glucose and insulin levels and improved insulin sensitivity compared with their wild-type littermates. Despite enlarged fat mass, inflammation and the accumulation of lipid peroxidation products are significantly attenuated in the adipose tissues of Lcn2-KO mice. Adipose fatty acid composition of these mice varies significantly from that in wild-type animals. The amounts of arachidonic acid (C20:4 n6) are elevated by aging and obesity and are paradoxically further increased in adipose tissue, but not skeletal muscle and liver of Lcn2-KO mice. On the other hand, the expression and activity of 12-lipoxygenase, an enzyme responsible for metabolizing arachidonic acid, and the production of tumor necrosis factor-alpha (TNF-alpha), a critical insulin resistance-inducing factor, are largely inhibited by lipocalin-2 deficiency. Lipocalin-2 stimulates the expression and activity of 12-lipoxygenase and TNF-alpha production in fat. tissues. Cinnamy1-3,4-dihydroxy-alpha-cyanocinnamate (CDC), an arachidonate lipoxygenase inhibitor, prevents TNF-alpha expression induced by lipocalin-2. Moreover, treatment with TNF-alpha neutralization antibody or CDC significantly attenuated the differences of insulin sensitivity between wild-type and Lcn2-KO mice.
   CONCLUSIONS-Lipocalin-2 deficiency protects mice from developing aging- and obesity-induced insulin resistance largely by modulating 12-lipoxygenase and TNF-alpha levels in adipose tissue. Diabetes 59:872-882, 2010
C1 [Law, Ivy K. M.; Xu, Aimin; Vanhoutte, Paul M.; Liu, Jacky T. C.; Zhou, Mingyan; Yang, Bo; Wang, Yu] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.
   [Xu, Aimin; Lam, Karen S. L.; Zhou, Mingyan; Wang, Yu] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.
   [Xu, Aimin; Lam, Karen S. L.; Zhou, Mingyan; Wang, Yu] Univ Hong Kong, Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China.
   [Berger, Thorsten; Mak, Tak W.] Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M4X 1K9, Canada.
   [Sweeney, Gary] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.
C3 University of Hong Kong; University of Hong Kong; University of Hong
   Kong; University of Toronto; University Health Network Toronto; Princess
   Margaret Cancer Centre; York University - Canada
RP Wang, Y (corresponding author), Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.
EM yuwanghk@hku.hk
RI Wang, Yu/B-4534-2009; Xu, Aimin/D-3291-2013; Law, Ka Man
   (Ivy)/AAF-7097-2020; Berger, Thorsten/J-7632-2012
OI Xu, Aimin/0000-0002-0668-033X; Law, Ka Man (Ivy)/0000-0002-7430-1215;
   wang, yu/0000-0001-8697-2940
FU Hong Kong Research Grant Council [HKU 778007, HKU 7645/06M];
   Collaborative Research Fund [HKU 2/07C]; University Grants Committee,
   HKSAR [AoE/P-10-01]
FX This work was supported by grants from Hong Kong Research Grant Council
   HKU 778007 (Y.W.) and HKU 7645/06M (A.X.), the Collaborative Research
   Fund (HKU 2/07C), and the Area of Excellent Scheme (AoE/P-10-01)
   established under the University Grants Committee, HKSAR.
CR Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103
   Borst SE, 2004, AM J PHYSIOL-ENDOC M, V287, pE934, DOI 10.1152/ajpendo.00054.2004
   Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8
   Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192
   Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200
   Collins JF, 2008, AM J PHYSIOL-GASTR L, V294, pG948, DOI 10.1152/ajpgi.00274.2007
   Consitt LA, 2009, IUBMB LIFE, V61, P47, DOI 10.1002/iub.142
   Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559
   DAVIS TR, 1991, BIOCHIM BIOPHYS ACTA, V1095, P145, DOI 10.1016/0167-4889(91)90077-B
   Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023
   Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5
   HAAN GJ, 1979, J CHROMATOGR, V162, P261, DOI 10.1016/S0378-4347(00)81513-3
   Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502
   Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   HRABARENEVEY S, 1989, ONCOGENE, V4, P601
   Jessen BA, 2002, GENE, V299, P95, DOI 10.1016/S0378-1119(02)01017-X
   KJELDSEN L, 1993, J BIOL CHEM, V268, P10425
   Kratchmarova I, 2002, MOL CELL PROTEOMICS, V1, P213, DOI 10.1074/mcp.M200006-MCP200
   Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200
   Lögdberg L, 2000, BBA-PROTEIN STRUCT M, V1482, P284, DOI 10.1016/S0167-4838(00)00164-3
   Lorenzo M, 2008, J Anim Sci, V86, pE94
   MEHEUS LA, 1993, J IMMUNOL, V151, P1535
   Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X
   Morin CL, 1997, J GERONTOL A-BIOL, V52, pB190, DOI 10.1093/gerona/52A.4.B190
   National Research Council, 1996, GUID CAR US LAB AN
   Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008
   Paolisso G, 1999, EUR J CLIN INVEST, V29, P758
   Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176
   Runge CF, 2007, DIABETES, V56, P2668, DOI 10.2337/db07-0633
   Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200
   STENGER J, 1995, PHYSIOL BEHAV, V57, P319, DOI 10.1016/0031-9384(94)00216-R
   Stoesz SP, 1995, ONCOGENE, V11, P2233
   Tataranni PA, 2005, DIABETES, V54, P917, DOI 10.2337/diabetes.54.4.917
   Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937
   Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335
   van Dam RM, 2007, CLIN CHEM, V53, P5, DOI 10.1373/clinchem.2006.080432
   Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526
   Wang Y, 2001, DIABETES, V50, P1821, DOI 10.2337/diabetes.50.8.1821
   Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614
   Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Xu AM, 2004, ENDOCRINOLOGY, V145, P487, DOI 10.1210/en.2003-1140
   Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797
   Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007
   Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106
   Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420
NR 50
TC 225
Z9 253
U1 0
U2 24
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
J9 DIABETES
JI Diabetes
PD APR
PY 2010
VL 59
IS 4
BP 872
EP 882
DI 10.2337/db09-1541
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 582MH
UT WOS:000276601200013
PM 20068130
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU MAJEED, SK
AF MAJEED, SK
TI SURVEY ON SPONTANEOUS SYSTEMIC AMYLOIDOSIS IN AGING MICE
SO ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH
LA English
DT Article
DE AMYLOIDOSIS, SPONTANEOUS SYSTEMIC; SPONTANEOUS SYSTEMIC AMYLOIDOSIS,
   SURVEY OF LONG TERM STUDIES
ID FAMILIAL AMYLOIDOSIS; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; SENILE
   PLAQUES; FINNISH TYPE; GELSOLIN; AMYLOIDOGENESIS; DEPOSITS; LESION;
   BRAIN
AB The incidence of systemic amyloidosis in CD-1 mice (Charles River, caesarian derived) obtained from long term studies over more than a 15-year period is reported. The survey included samples of visceral organs, peripheral and central nervous tissues, bone and bone marrow. The total incidence in all mice of this survey did not show any clear evidence of a difference between males and females. Amyloidosis deposits were mainly seen in the stomach (glandular), heart, small intestines, kidney, liver, spleen, thyroid, parathyroid, adrenals, salivary glands and ovaries, but not in the brain, spinal cord, bone or bone marrow. The survey showed that amyloidosis in CD-1 mice was spontaneous, systemic and it is age-related. Amyloid deposition was extracellular and it stained positively with Congo Red and also stained positively with Oil Red O and Alcian blue. In general, amyloidosis in CD-1 mice, was higher in comparison with B6C3F (cross between C57BL/C6 NCRLB and C3H/HEN NCRLB, (bred by Charles River), CFLP strain (hystercetomy derived strain of Swiss origin) and MAGF: TIF (SPF). This survey also showed that spontaneous systemic amyloidosis in CD-1 mice, was one of the major factors contributory to death in aging CD-1 mice.
C1 HUNTINGDON RES CTR LTD,HUNTINGDON,ENGLAND.
CR ANDERVONT HB, 1970, JNCI-J NATL CANCER I, V44, P719
   AXELRAD MA, 1982, LAB INVEST, V47, P139
   COHEN AS, 1983, LAB INVEST, V48, P1
   COHEN AS, 1987, J PATHOL, V151, P1, DOI 10.1002/path.1711510102
   DIBARTOLA SP, 1986, J COMP PATHOL, V96, P387, DOI 10.1016/0021-9975(86)90034-4
   DUNN TB, 1967, PATHOLOGY LABORATORY, P181
   FRITH CH, 1991, TOXICOL PATHOL, V19, P123, DOI 10.1177/019262339101900206
   GAJDUSEK DC, 1968, SCIENCE, V162, P694
   GILMOUR JS, 1985, NEUROPATHOL APPL NEU, V11, P173
   Glenner G G, 1976, Int Rev Exp Pathol, V15, P1
   GOREVIC PD, 1991, NEW ENGL J MED, V325, P1780, DOI 10.1056/NEJM199112193252505
   HALTIA M, 1990, AM J PATHOL, V136, P1223
   HIGUCHI K, 1983, LAB INVEST, V48, P231
   ICHIHARA T, 1991, J PATHOL, V165, P229
   JAKOB W, 1971, VET PATHOL, V8, P292, DOI 10.1177/030098587100800402
   KAHN H, 1991, ARCH PATHOL LAB MED, V115, P948
   KAWABATA S, 1991, NATURE, V354, P476, DOI 10.1038/354476a0
   KO LW, 1991, AM J PATHOL, V139, P523
   LECOZ P, 1991, NEUROPATH APPL NEURO, V17, P149
   LING YS, 1991, VET PATHOL, V28, P519, DOI 10.1177/030098589102800609
   LOOI LM, 1991, HISTOPATHOLOGY, V8, P133
   MAJEED SK, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1372
   MIYAZONO M, 1991, AM J PATHOL, V139, P589
   NAIKI H, 1988, AM J PATHOL, V130, P579
   PAGE DL, 1972, AM J PATHOL, V67, P559
   PAPPOLLA MA, 1991, AM J PATHOL, V139, P599
   PODLISNY MB, 1991, AM J PATHOL, V138, P1423
   PUCCI A, 1991, J PATHOL, V165, P235, DOI 10.1002/path.1711650307
   RINDI G, 1991, AM J PATHOL, V138, P1321
   ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G
   Scheinberg M A, 1980, Prog Allergy, V27, P250
   SCHULTZ RT, 1985, AM J PATHOL, V119, P138
   SHIGEHIRO Y, 1991, AM J PATHOL, V138, P403
   SHIRAHAMA T, 1982, AM J PATHOL, V107, P41
   WISNIEWSKI T, 1991, AM J PATHOL, V138, P1077
   WRIGHT JR, 1974, LAB INVEST, V30, P767
   YANKNER BA, 1991, NEW ENGL J MED, V325, P1849
   Zschiesche W, 1972, Acta Pathol Microbiol Scand Suppl, V233, P135
NR 38
TC 12
Z9 12
U1 0
U2 0
PU ECV-EDITIO CANTOR VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI AULENDORF
PA BANDELSTOCKWEG 20, POSTFACH 1255, D-88322 AULENDORF, GERMANY
SN 0004-4172
J9 ARZNEIMITTEL-FORSCH
JI Arzneimittelforschung
PD FEB
PY 1993
VL 43-1
IS 2
BP 170
EP 178
PG 9
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Chemistry
GA KP352
UT WOS:A1993KP35200018
PM 8457241
DA 2024-02-19
ER

PT J
AU Okamoto, S
   Zhao, Y
   Lindqvist, P
   Backman, C
   Ericzon, BG
   Wijayatunga, P
   Henein, MY
   Suhr, OB
AF Okamoto, Sadahisa
   Zhao, Ying
   Lindqvist, Per
   Backman, Christer
   Ericzon, Bo-Goran
   Wijayatunga, Priyantha
   Henein, Michael Y.
   Suhr, Ole B.
TI Development of cardiomyopathy after liver transplantation in Swedish
   hereditary transthyretin amyloidosis (ATTR) patients
SO AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
LA English
DT Article
DE Amyloidosis-hereditary-neuropathic; cardiomyopathy-hypertrophic;
   senescence; transplantation-liver; transthyretin
ID WILD-TYPE TRANSTHYRETIN; POLYNEUROPATHY TYPE-I; PORTUGUESE-TYPE;
   HYPERTROPHIC CARDIOMYOPATHY; FAMILIAL AMYLOIDOSIS; SYSTEMIC AMYLOIDOSIS;
   PROGNOSTIC-FACTORS; IMPACT; PROGRESSION; SURVIVAL
AB Background: Recent studies of liver transplanted (LTx) familial amyloidotic polyneuropathy (FAP) patients have shown a progression of cardiomyopathy in some patients after LTx, but knowledge of the underlying factors remains limited. Methods: Seventy-five patients, who had undergone LTx from 1996 to 2008, were included. They had all been examined by echocardiography 1-16 months before LTx. Fifty-four had been re-examined 7-34 months, and forty-two 36-137 months after LTx. Results: A significant increase in interventricular septum (IVS) thickness occurred after LTx (p < 0.01), particularly in males (p = 0.002) and late onset patients (p = 0.003). The development of post-LTx cardiomyopathy was related to patient's age at onset of the disease, male gender and pre-LTx IVS thickness. On multivariate regression analysis, however, age at onset was the only significant predictor for the development of cardiomyopathy (odds ratio = 1.14, 95% confident interval 1.01-1.30, p = 0.04). Conclusion: An increase of IVS thickness can be observed in FAP patients after LTx. Age at onset of the disease is the main predictor for increased IVS thickness and for the development of cardiomyopathy after liver transplantation.
C1 [Zhao, Ying; Lindqvist, Per; Backman, Christer; Henein, Michael Y.] Umea Univ, Ctr Heart, Umea, Sweden.
   [Okamoto, Sadahisa] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan.
   [Zhao, Ying] Capital Med Univ, Beijing Anzhen Hosp, Ultrasound Dept, Beijing, Peoples R China.
   [Ericzon, Bo-Goran] Karolinska Inst, Karolinska Univ Hosp, Surg Sci Ctr, Huddinge, Sweden.
   [Wijayatunga, Priyantha] Umea Univ, Dept Stat, S-90187 Umea, Sweden.
C3 Umea University; Kumamoto University; Capital Medical University;
   Karolinska Institutet; Karolinska University Hospital; Umea University
RP Suhr, OB (corresponding author), Umea Univ Hosp, Dept Med, SE-90185 Umea, Sweden.
EM ole.suhr@medicin.umu.se
RI Wijayatunga, Priyantha/AAG-5817-2019; LIndqvist, Per/AAK-1377-2021;
   zhao, ying/ISA-2502-2023; Lindqvist, Per/AFM-9851-2022; Wijayatunga,
   Priyantha/P-8098-2017; Ericzon, Bo-Goran/AAH-5328-2020
OI Wijayatunga, Priyantha/0000-0003-1654-9148; Wijayatunga,
   Priyantha/0000-0003-1654-9148; Suhr, Ole/0000-0002-1175-2369
FU patient organization FAMY Vasterbotten, FAMY/AMYL Norrbotten; Swedish
   Heart and Lung Foundation; Vasterbotten's County Council; Umea
   University; University Hospital
FX This work was supported by grants from the patient organization FAMY
   Vasterbotten, FAMY/AMYL Norrbotten, the Swedish Heart and Lung
   Foundation, a Spearhead grant from Vasterbotten's County Council and a
   grant from the regional agreement on clinical research (ALF) from Umea
   University and University Hospital.
CR Adams D, 2000, BRAIN, V123, P1495, DOI 10.1093/brain/123.7.1495
   Ando Y, 1996, TRANSPLANTATION, V62, P1037, DOI 10.1097/00007890-199610150-00028
   Delahaye N, 2006, MEDICINE, V85, P229, DOI 10.1097/01.md.0000232559.22098.c3
   Dubrey SW, 1997, TRANSPLANTATION, V64, P74, DOI 10.1097/00007890-199707150-00014
   Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7
   Gonçalves I, 2008, MOL CELL BIOCHEM, V317, P137, DOI 10.1007/s11010-008-9841-2
   HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M
   Hörnsten R, 2004, TRANSPLANTATION, V78, P112, DOI 10.1097/01.TP.0000133517.20972.27
   Hörnsten R, 2010, AMYLOID, V17, P63, DOI 10.3109/13506129.2010.483114
   Ihse E, 2008, J PATHOL, V216, P253, DOI 10.1002/path.2411
   Ihse E, 2011, J MOL MED, V89, P171, DOI 10.1007/s00109-010-0695-1
   Jacobson DR, 1996, HUM GENET, V98, P236, DOI 10.1007/s004390050199
   Koike H, 2009, J NEUROL SCI, V287, P178, DOI 10.1016/j.jns.2009.07.028
   Liepnieks JJ, 2007, AMYLOID, V14, P277, DOI 10.1080/13506120701614032
   Misu K, 1999, BRAIN, V122, P1951, DOI 10.1093/brain/122.10.1951
   Mörner S, 2005, J INTERN MED, V258, P225, DOI 10.1111/j.1365-2796.2005.01522.x
   Nowak G, 2005, TRANSPLANT INT, V18, P111, DOI 10.1111/j.1432-2277.2004.00015.x
   Okamoto S, 2009, LIVER TRANSPLANT, V15, P1229, DOI 10.1002/lt.21817
   Okamoto S, 2008, INTERNAL MED, V47, P2133, DOI 10.2169/internalmedicine.47.1399
   OLOFSSON BO, 1980, ACTA MED SCAND, V208, P77
   Olofsson BO, 2002, TRANSPLANTATION, V73, P745, DOI 10.1097/00007890-200203150-00015
   Parrilla P, 1997, TRANSPLANTATION, V64, P646, DOI 10.1097/00007890-199708270-00017
   RANLOV I, 1992, AM J MED, V93, P3, DOI 10.1016/0002-9343(92)90672-X
   Rapezzi C, 2008, AMYLOID, V15, P40, DOI 10.1080/13506120701815373
   Sandgren O, 2008, ACTA OPHTHALMOL, V86, P520, DOI 10.1111/j.1600-0420.2007.01098.x
   Stangou AJ, 1998, TRANSPLANTATION, V66, P229, DOI 10.1097/00007890-199807270-00016
   SUHR O, 1994, J INTERN MED, V235, P479, DOI 10.1111/j.1365-2796.1994.tb01106.x
   Suhr OB, 2002, LIVER TRANSPLANT, V8, P787, DOI 10.1053/jlts.2002.34386
   Suhr OB, 2009, AMYLOID, V16, P208, DOI 10.3109/13506120903421587
   Westermark P, 2003, AMYLOID, V10, P48
   Yamamoto S, 2007, AM J TRANSPLANT, V7, P2597, DOI 10.1111/j.1600-6143.2007.01969.x
   Yazaki M, 2007, AM J TRANSPLANT, V7, P235, DOI 10.1111/j.1600-6143.2006.01585.x
   Yazaki M, 2000, BIOCHEM BIOPH RES CO, V274, P702, DOI 10.1006/bbrc.2000.3203
NR 33
TC 51
Z9 54
U1 0
U2 9
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1350-6129
J9 AMYLOID
JI Amyloid-J. Protein Fold. Disord.
PD DEC
PY 2011
VL 18
IS 4
BP 200
EP 205
DI 10.3109/13506129.2011.615872
PG 6
WC Biochemistry & Molecular Biology; Medicine, General & Internal;
   Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; General & Internal Medicine; Research
   & Experimental Medicine
GA 847PP
UT WOS:000296985200005
PM 22080763
DA 2024-02-19
ER

PT J
AU Nair, J
   Sinitsina, O
   Vasunina, EA
   Nevinsky, GA
   Laval, J
   Bartsch, H
AF Nair, J
   Sinitsina, O
   Vasunina, EA
   Nevinsky, GA
   Laval, J
   Bartsch, H
TI Age-dependent increase of etheno-DNA-adducts in liver and brain of ROS
   overproducing OXYS rats
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE etheno-DNA-adducts; lipid peroxidation; OXYS rats; aging; degenerative
   diseases
ID CINNAMON LEC RATS; LIPID-PEROXIDATION; VINYL-CHLORIDE;
   IMMUNOHISTOCHEMICAL DETECTION; 1,N-6-ETHENODEOXYADENOSINE;
   1,N(6)-ETHENODEOXYADENOSINE; 3,N-4-ETHENOCYTOSINE; ANTIOXIDANTS;
   CARCINOGENS; PRODUCTS
AB Reactive oxygen species (ROS) and lipid peroxidation (LPO) play a role in aging and degenerative diseases. To correlate oxidative stress and LPO-derived DNA damage, we determined etheno-DNA-adducts in liver and brain from ROS overproducing OXYS rats in comparison with age-matched Wistar rats. Liver DNA samples from 3- and 15-month-old OXYS and Wistar rats were analyzed for 1,N-6-ethenodeoxyadenosine (epsilon dA) and 3,N-4-ethenodeoxycytidine (epsilon dC) by immunoaffinity/(32)p-postlabelling. While epsilon dA and epsilon dC levels were not different in young rats, adduct levels were significantly higher in old OXYS rats when compared to old Wistar or young OXYS rats. Frozen rat brain sections were analyzed for epsilon dA by immunostaining of nuclei. Brains from old OXYS rats accumulated epsilon dA more frequently than age-matched Wistar rats. Our results demonstrate increased LPO-induced DNA damage in organs of OXYS rats which correlates with their known shorter life-span and elevated frequency of chronic degenerative diseases. (c) 2005 Elsevier Inc. All rights reserved.
C1 German Canc Res Ctr, DKFZ, Div Toxicol & Canc Risk Factors, D-69120 Heidelberg, Germany.
   RAS, SD, Inst Cytol & Genet, Novosibirsk 630090, Russia.
   RAS, SD, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia.
   Inst Gustave Roussy, CNRS, UMR 8126, Grp Reparat ADN, F-94805 Villejuif, France.
C3 Helmholtz Association; German Cancer Research Center (DKFZ); Russian
   Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS;
   Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of
   the RAS; Russian Academy of Sciences; Centre National de la Recherche
   Scientifique (CNRS); CNRS - National Institute for Biology (INSB);
   UNICANCER; Gustave Roussy; Universite Paris Saclay
RP Bartsch, H (corresponding author), German Canc Res Ctr, DKFZ, Div Toxicol & Canc Risk Factors, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.
EM h.bartsch@dkfz.de
RI Nevinsky, Georgy/E-6053-2012
CR AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   BARBIN A, 1981, NUCLEIC ACIDS RES, V9, P375, DOI 10.1093/nar/9.2.375
   Bartsch H, 2004, CANCER DETECT PREV, V28, P385, DOI 10.1016/j.cdp.2004.07.004
   Bartsch H, 1999, IARC SCI PUBL, P1
   BARTSCH H, 2005, IN PRESS MUTAT RES
   BASU AK, 1993, BIOCHEMISTRY-US, V32, P12793, DOI 10.1021/bi00210a031
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   CHENG KC, 1991, P NATL ACAD SCI USA, V88, P9974, DOI 10.1073/pnas.88.22.9974
   Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105
   Frank A, 2004, CARCINOGENESIS, V25, P1027, DOI 10.1093/carcin/bgh089
   Gros L, 2003, MUTAT RES-FUND MOL M, V531, P219, DOI 10.1016/j.mrfmmm.2003.07.008
   Gros L, 2004, J BIOL CHEM, V279, P17723, DOI 10.1074/jbc.M314010200
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   Hang B, 1996, CARCINOGENESIS, V17, P155, DOI 10.1093/carcin/17.1.155
   Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046
   Ishchenko A, 2003, MED SCI MONITOR, V9, pBR16
   Kolosova NG, 2003, B EXP BIOL MED+, V135, P593, DOI 10.1023/A:1025445822566
   Levine RL, 2000, CANCER RES, V60, P4098
   MILLER JA, 1983, BRIT J CANCER, V48, P1, DOI 10.1038/bjc.1983.151
   MORIYA M, 1994, P NATL ACAD SCI USA, V91, P11899, DOI 10.1073/pnas.91.25.11899
   Nair J, 2005, CARCINOGENESIS, V26, P1307, DOI 10.1093/carcin/bgi073
   Nair J, 1998, CANCER EPIDEM BIOMAR, V7, P435
   Nair J, 1996, CANCER RES, V56, P1267
   NAIR J, 1995, CARCINOGENESIS, V16, P613, DOI 10.1093/carcin/16.3.613
   Nair Urmila, 2003, Mutagenesis, V18, P477, DOI 10.1093/mutage/geg009
   PALEJWALA VA, 1993, BIOCHEMISTRY-US, V32, P4105, DOI 10.1021/bi00066a036
   Pandya GA, 1996, BIOCHEMISTRY-US, V35, P11487, DOI 10.1021/bi960170h
   SALGANIC RI, 1994, FREE RADICAL BIO MED, V16, P13, DOI 10.1016/0891-5849(94)90231-3
   Salganik R, 2001, J ANTI-AGING MED, V4, P49, DOI 10.1089/109454501750225686
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V199, P726, DOI 10.1006/bbrc.1994.1289
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V205, P180, DOI 10.1006/bbrc.1994.2647
   Shabalina I G, 2001, Eksp Klin Farmakol, V64, P34
   SINGER B, 1999, IARC SCI PUBL, V150, P1
   SOLOVEVA NA, 1975, GENETIKA+, V11, P63
   Yang Y, 2000, CARCINOGENESIS, V21, P777, DOI 10.1093/carcin/21.4.777
NR 35
TC 15
Z9 15
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 21
PY 2005
VL 336
IS 2
BP 478
EP 482
DI 10.1016/j.bbrc.2005.08.114
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 968OZ
UT WOS:000232173200016
PM 16137653
DA 2024-02-19
ER

PT J
AU LOPEZTORRES, M
   PEREZCAMPO, R
   ROJAS, C
   CADENAS, S
   BARJA, G
AF LOPEZTORRES, M
   PEREZCAMPO, R
   ROJAS, C
   CADENAS, S
   BARJA, G
TI MAXIMUM LIFE-SPAN IN VERTEBRATES - RELATIONSHIP WITH LIVER ANTIOXIDANT
   ENZYMES, GLUTATHIONE SYSTEM, ASCORBATE, URATE, SENSITIVITY TO
   PEROXIDATION, TRUE MALONDIALDEHYDE, IN-VIVO H2O2, AND BASAL AND MAXIMUM
   AEROBIC CAPACITY
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; LONGEVITY; FREE RADICALS; SUPEROXIDE DISMUTASE; CATALASE;
   GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; CYTOCHROME OXIDASE;
   OXYGEN CONSUMPTION; HYDROGEN PEROXIDE
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; SUPEROXIDE-DISMUTASE;
   HYDROGEN-PEROXIDE; DROSOPHILA-MELANOGASTER; INORGANIC PEROXIDES;
   MUSCA-DOMESTICA; METABOLIC-RATE; BRAIN INVIVO; CATALASE; DEFENSES
AB In order to help clarify whether free radicals are implicated or not in the evolution of maximum life span (MLSP) of animals, a comprehensive study was performed in the liver of various vertebrate species. Strongly significant negative correlations against MLSP were found for hepatic catalase, Se-dependent and -independent glutathione peroxidases, and GSH, whereas superoxide dismutase, glutathione reductase, ascorbate, uric acid, GSSG/GSH, in vitro peroxidation (TBA-RS), and in vivo steady-state H2O2 concentration in the liver did not correlate with MLSP. Superoxide dismutase, catalase, glutathione peroxidase, and GSH results were in agreement with those independently reported by other authors, whereas the rest of our data are reported for the first time. Potential limitations arising from the use of animals of different vertebrate Classes were counterbalanced by the possibility to study animals with very different MLSPs and life energy potentials. Furthermore, the results agreed with previous data obtained using only mammals. Since liver GSSG/GSH, peroxidation, and specially H2O2 concentration were similar in species with widely different MLSPs, it is suggested that the decrease in enzymatic H2O2 detoxifying capacity of longevous species represents an evolutionary co-adaptation with a smaller in vivo rate of free radical generation. We propose the possibility that maximum longevity was increased during vertebrate evolution by lowering the rate of free radical recycling in the tissues.
C1 UNIV COMPLUTENSE MADRID, FAC BIOL, DEPT ANIM BIOL ANIM PHYSIOL 2, E-28040 MADRID, SPAIN.
C3 Complutense University of Madrid
RI Cadenas, Susana/D-1523-2016; Barja, Gustavo/AAA-5903-2019; Gustavo,
   Barja/B-5591-2012
OI Barja, Gustavo/0000-0001-5736-4735; Cadenas, Susana/0000-0003-0726-0369
CR ALLEN RG, 1983, BIOCHEM J, V216, P503, DOI 10.1042/bj2160503
   ALTMAN PL, 1974, BIOL DATA BOOK, V3, P1804
   ALTMAN PL, 1972, BIOL DATA BOOK, V1, P1804
   ALTMAN PL, 1971, BIOL HDB RESPIRATION, V1, P492
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   BARJA G, 1993, IN PRESS FREE RAD RE
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   BODDINGTON MJ, 1978, J THEOR BIOL, V75, P443, DOI 10.1016/0022-5193(78)90355-7
   BULL AW, 1985, ANAL BIOCHEM, V149, P284, DOI 10.1016/0003-2697(85)90506-8
   CHANCE B, 1992, FREE RADICALS AGING, P58
   Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9
   CRESCIMANNO M, 1989, FREE RADICAL RES COM, V7, P67, DOI 10.3109/10715768909087925
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S
   CUTLER RG, 1984, ARCH GERONTOL GERIAT, V3, P321, DOI 10.1016/0167-4943(84)90033-5
   Cutler RG, 1986, PHYSL OXYGEN RADICAL, P251
   DABROWSKI K, 1990, COMP BIOCHEM PHYS A, V95, P481, DOI 10.1016/0300-9629(90)90727-A
   DEQUIROGA GB, 1991, ANAL BIOCHEM, V199, P81
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   DUELLMAN WE, 1986, BIOL AMPHIBIANS, P264
   FLOWER SS, 1936, P ZOOL SOC LOND, P392
   FLOWER SS, 1925, P ZOOL SOC LOND, P1378
   FLOWER SS, 1936, P ZOOL SOC LOND, P382
   FLOWER SS, 1925, P ZOOL SOC LOND, P274
   FLOWER SS, 1925, P ZOOL SOC LOND, P1404
   GEERTS A, 1982, FEBS LETT, V140, P245, DOI 10.1016/0014-5793(82)80904-6
   GEY KF, 1990, BIOCHEM SOC T, V18, P1041, DOI 10.1042/bst0181041
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   LAWRENCE RA, 1978, J NUTR, V108, P211, DOI 10.1093/jn/108.2.211
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   LIDSTEDT SL, 1978, CONDOR, V78, P91
   LOPEZTORRES M, 1990, PHARMACOL TOXICOL, V66, P27, DOI 10.1111/j.1600-0773.1990.tb00696.x
   LOPEZTORRES M, 1993, IN PRESS FREE RAD BI
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARCHENA OD, 1974, J NEUROCHEM, V22, P773, DOI 10.1111/j.1471-4159.1974.tb04293.x
   MARGOLIASH E, 1960, BIOCHEM J, V74, P339, DOI 10.1042/bj0740339
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I
   NICHOLLS P, 1962, BIOCHIM BIOPHYS ACTA, V59, P414, DOI 10.1016/0006-3002(62)90191-9
   ORR WC, 1992, MECH AGEING DEV, V63, P287, DOI 10.1016/0047-6374(92)90006-Y
   ORR WC, 1992, ARCH BIOCHEM BIOPHYS, V297, P35, DOI 10.1016/0003-9861(92)90637-C
   PAGLIA DE, 1967, J LAB CLIN MED, V276, P368
   PALLER MS, 1991, FREE RADICAL BIO MED, V10, P29, DOI 10.1016/0891-5849(91)90018-X
   PAOLETTI F, 1986, ANAL BIOCHEM, V154, P536, DOI 10.1016/0003-2697(86)90026-6
   PATON D, 1991, J HERPETOL, V25, P389, DOI 10.2307/1564759
   Pearl R., 1928, RATE LIVING
   PEREZCAMPO R, 1993, MECH AGEING DEV, V67, P115, DOI 10.1016/0047-6374(93)90116-9
   ROGERS JB, 1950, ANAT REC, V106, P286
   Rubner M., 1908, PROBLEM LEBENSDAUER
   RUBNER M, 1909, KRAFT STOFF HAUSHALT
   SINET PM, 1980, J NEUROCHEM, V34, P1421, DOI 10.1111/j.1471-4159.1980.tb11222.x
   SMITH L, 1955, Methods Biochem Anal, V2, P427, DOI 10.1002/9780470110188.ch13
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1990, MECH AGEING DEV, V53, P217, DOI 10.1016/0047-6374(90)90040-M
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   SOHAL RS, 1984, MECH AGEING DEV, V24, P175, DOI 10.1016/0047-6374(84)90069-1
   STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5
   TELPHY TR, 1961, J PHARMACOL EXP THER, V134, P77
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   TOLMASOFF JM, 1980, P NATL ACAD SCI-BIOL, V77, P2777, DOI 10.1073/pnas.77.5.2777
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   YUSA T, 1987, J APPL PHYSIOL, V63, P353, DOI 10.1152/jappl.1987.63.1.353
NR 63
TC 83
Z9 90
U1 0
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD AUG 15
PY 1993
VL 70
IS 3
BP 177
EP 199
DI 10.1016/0047-6374(93)90047-U
PG 23
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA LV100
UT WOS:A1993LV10000002
PM 8246633
DA 2024-02-19
ER

PT J
AU Chen, PC
   Zhang, Y
   Xu, M
   Chen, HJ
   Zou, HX
   Zhang, X
   Tong, HB
   You, CP
   Wu, MJ
AF Chen, Peichao
   Zhang, Ya
   Xu, Man
   Chen, Hongjun
   Zou, Huixi
   Zhang, Xu
   Tong, Haibin
   You, Cuiping
   Wu, Mingjiang
TI Proteomic landscape of liver tissue in old male mice that are long-term
   treated with polysaccharides from<i>Sargassum fusiforme</i>
SO FOOD & FUNCTION
LA English
DT Article
ID ANTIOXIDANT SUPPLEMENTATION; ALDEHYDE DEHYDROGENASE;
   SARGASSUM-FUSIFORME; DAMAGE; STRESS; MITOCHONDRIA; PROTEINS; DEFENSE;
   ALDH7A1; ENZYMES
AB Sargassum fusiformeis a type of brown algae and well known as a longevity promoting vegetable in Northeastern Asia. The polysaccharides derived fromSargassum fusiforme(SFPs) have been suggested as an antioxidant component for anti-aging function. However, global molecular changesin vivoby SFPs have not been fully elucidated. Here, we present a proteomics study using liver tissues of aged male mice that were fed with SFPs. Of forty-nine protein spots, thirty-eight were up-regulated and eleven were down-regulated, showing significant changes in abundance by two-dimensional gel electrophoresis. These differentially expressed proteins were mainly involved in oxidation-reduction, amino acid metabolism, and energy metabolism. Forty-six proteins were integrated into a unified network, with catalase (Cat) at the center. Intriguingly, most of the proteins were speculated as mitochondrial-located proteins. Our findings suggested that SFPs modulated antioxidant enzymes to scavenge redundant free radicals, thus preventing oxidative damage. In conclusion, our study provides a proteomic view on how SFPs have beneficial effects on the aspects of antioxidant and energy metabolism during the aging process. This study facilitates the understanding of anti-aging molecular mechanisms in polysaccharides derived fromSargassum fusiforme.
C1 [Chen, Peichao; Zhang, Ya; Xu, Man; Chen, Hongjun; Zou, Huixi; Zhang, Xu; Tong, Haibin; Wu, Mingjiang] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou 325035, Peoples R China.
   [Zhang, Ya] Univ Northern British Columbia, Dept Nat Resources & Environm Studies, Prince George, BC, Canada.
   [You, Cuiping] Shandong Univ, Linyi Peoples Hosp, Dept Cent Lab, Linyi 276000, Shandong, Peoples R China.
C3 Wenzhou University; University of Northern British Columbia; Shandong
   University
RP You, CP (corresponding author), Shandong Univ, Linyi Peoples Hosp, Dept Cent Lab, Linyi 276000, Shandong, Peoples R China.
EM happyuv@126.com; wumingjiangwz@163.com
RI Zou, Hui-Xi/GPS-6496-2022; Liu, Kai/IST-6808-2023; LI,
   SHA/JNR-9956-2023; chen, hongjun/IZD-4640-2023
OI Zou, Hui-Xi/0000-0002-8141-8059; Chen, Peichao/0000-0001-9587-7080;
   Tong, Haibin/0000-0002-7645-3458
FU National Natural Science Foundation of China [41876197, 81872952];
   Public Welfare Technology Application Research Plan Project of Zhejiang
   Science and Technology Department [2017C32103, LGN18C020004]; Wenzhou
   Municipal Science and Technology Bureau [N20190014]; China Postdoctoral
   Science Foundation [2016M5-92198]; Talent training foundation of Natural
   Science Foundation of Shandong Province [ZR2015PH014]
FX This work was supported by the National Natural Science Foundation of
   China (41876197 and 81872952), the Public Welfare Technology Application
   Research Plan Project of Zhejiang Science and Technology Department
   (2017C32103, LGN18C020004), the Wenzhou Municipal Science and Technology
   Bureau (N20190014), the China Postdoctoral Science Foundation
   (2016M5-92198) and the Talent training foundation of Natural Science
   Foundation of Shandong Province (ZR2015PH014). We thank Dr Tao Xu for
   her constructive comments to this study.
CR Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008
   Amarya S., 2018, GERONTOLOGY, DOI DOI 10.5772/INTECHOPEN.76249
   Amelina H, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-16
   [Anonymous], 2019, ENV TOXICOL
   ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barrera G, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080102
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brocker C, 2011, CHEM-BIOL INTERACT, V191, P269, DOI 10.1016/j.cbi.2011.02.016
   Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925
   Chang JS, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0327-y
   Chen BJ, 2016, INT J BIOL MACROMOL, V92, P715, DOI 10.1016/j.ijbiomac.2016.07.082
   Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554
   Chen Che-Hong, 2016, Acta Neurol Taiwan, V25(4), P111
   Chen LJ, 2018, MAR DRUGS, V16, DOI 10.3390/md16080264
   Chen P, 2017, CURR MOL MED, V17, P350, DOI 10.2174/1566524018666171205115516
   Chen PC, 2016, FOOD FUNCT, V7, P4576, DOI [10.1039/C6FO00628K, 10.1039/c6fo00628k]
   Cojoc M, 2015, CANCER RES, V75, P1482, DOI 10.1158/0008-5472.CAN-14-1924
   Duthie SJ, 1996, CANCER RES, V56, P1291
   Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607
   ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F
   Gallagher RC, 2009, ANN NEUROL, V65, P550, DOI 10.1002/ana.21568
   Gasparetto M, 2017, CHEM-BIOL INTERACT, V276, P46, DOI 10.1016/j.cbi.2017.06.020
   Guo JM, 2013, CELL RES, V23, P915, DOI 10.1038/cr.2013.69
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Hjelm BE, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz164
   JARABAK J, 1993, ARCH BIOCHEM BIOPHYS, V303, P394, DOI 10.1006/abbi.1993.1300
   Jaruga P, 1996, NUCLEIC ACIDS RES, V24, P1389, DOI 10.1093/nar/24.8.1389
   Jiang XQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16087
   Kajita R, 2013, CHEM RES TOXICOL, V26, P1926, DOI 10.1021/tx400354d
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kimmel C, 2011, WMSCI 2011: 15TH WORLD MULTI-CONFERENCE ON SYSTEMICS, CYBERNETICS AND INFORMATICS, VOL II, P177
   Kriaucionis S, 2006, MOL CELL BIOL, V26, P5033, DOI 10.1128/MCB.01665-05
   Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246
   Lakatta E. G., 2003, ARTERIAL CARDIAC A 2
   Lassen N, 2007, J BIOL CHEM, V282, P25668, DOI 10.1074/jbc.M702076200
   Li DY, 2004, BIOCHEM BIOPH RES CO, V318, P253, DOI 10.1016/j.bbrc.2004.04.022
   Liu L, 2012, J ETHNOPHARMACOL, V142, P591, DOI 10.1016/j.jep.2012.05.046
   Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 
   Matsumoto A, 2016, ENVIRON HEALTH PREV, V21, P395, DOI 10.1007/s12199-016-0579-2
   Meydani M, 1998, ANN NY ACAD SCI, V854, P352, DOI 10.1111/j.1749-6632.1998.tb09915.x
   Morris SM, 2004, J NUTR, V134, p2743S, DOI 10.1093/jn/134.10.2743S
   Nebert Daniel W., 2004, Human Genomics, V1, P460
   Ohta S, 2004, ANN NY ACAD SCI, V1011, P36, DOI 10.1196/annals.1293.004
   Oldham KM, 1998, J AM DIET ASSOC, V98, P1001, DOI 10.1016/S0002-8223(98)00230-2
   Ouaissi A, 2002, IMMUNOL LETT, V81, P159, DOI 10.1016/S0165-2478(02)00035-4
   Oyama Tsunehiro, 2010, Front Biosci (Elite Ed), V2, P1344
   Panel M, 2018, AGING CELL, V17, DOI 10.1111/acel.12793
   Pena IA, 2017, GENETICS, V207, P1501, DOI 10.1534/genetics.117.300137
   Peternelj TT, 2011, SPORTS MED, V41, P1043, DOI 10.2165/11594400-000000000-00000
   PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T
   Rajapakse NW, 2008, HYPERTENSION, V52, P1084, DOI 10.1161/HYPERTENSIONAHA.108.114298
   Shibanuma M, 2011, FREE RADICAL RES, V45, P672, DOI 10.3109/10715762.2011.564169
   Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445
   Spinelli JB, 2017, SCIENCE, V358, P941, DOI 10.1126/science.aam9305
   Srivastava S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120398
   Stechmiller Joyce K, 2005, Nutr Clin Pract, V20, P52, DOI 10.1177/011542650502000152
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Townsend Danyelle, 2003, Am J Pharmacogenomics, V3, P157, DOI 10.2165/00129785-200303030-00002
   Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940
   TSAI CH, 1974, J BIOL CHEM, V249, P5790
   Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001
   Wang ED, 1997, MUTAT RES-FUND MOL M, V377, P157, DOI 10.1016/S0027-5107(97)00091-2
   WERMUTH B, 1986, BIOCHEM PHARMACOL, V35, P1277, DOI 10.1016/0006-2952(86)90271-6
   Wu MJ, 2013, INT J BIOL MACROMOL, V56, P28, DOI 10.1016/j.ijbiomac.2013.01.017
   Xu XF, 2016, FOOD FUNCT, V7, P250, DOI 10.1039/c5fo00904a
   Yagi M., 2018, GLYCATIVE STRESS RES, V5, P147
   Yancik R., 2005, POPULATION AGING CAN
   Yang CS, 2012, CANCER PREV RES, V5, P701, DOI 10.1158/1940-6207.CAPR-12-0045
   Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3
   Zhang Hua-fang, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1860
NR 71
TC 5
Z9 5
U1 2
U2 37
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD APR 1
PY 2020
VL 11
IS 4
BP 3632
EP 3644
DI 10.1039/d0fo00187b
PG 13
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA MV7HC
UT WOS:000556523100069
PM 32292988
DA 2024-02-19
ER

PT J
AU SAWADA, M
   SESTER, U
   CARLSON, JC
AF SAWADA, M
   SESTER, U
   CARLSON, JC
TI CHANGES IN SUPEROXIDE RADICAL FORMATION, LIPID-PEROXIDATION, MEMBRANE
   FLUIDITY AND CATHEPSIN-B ACTIVITY IN AGING AND SPAWNING MALE CHINOOK
   SALMON (ONCORHYNCHUS-TSCHAWYTSCHA)
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE SUPEROXIDE RADICALS; LIPID PEROXIDATION; FLUIDITY; PROTEOLYSIS; SPAWNING
   SALMON
ID RAT CORPORA-LUTEA; PLASMA-MEMBRANE; PHOSPHOLIPASE-A2 ACTIVITY;
   DROSOPHILA-MELANOGASTER; HUMAN-NEUTROPHILS; CORPUS-LUTEUM; CHUM SALMON;
   DISMUTASE; INVOLVEMENT; LUTEOLYSIS
AB Superoxide radical (SOR) formation in the brain and the liver of male Chinook salmon (Oncorhynchus tschawytscha) increased in mitochondrial and plasma membrane samples as they aged. In 2-year-old salmon, spawning also lead to a significant elevation in SOR formation in mitochondrial and plasma membrane samples. The rise in this free radical was associated with an increase in lipid peroxidation, a decrease in plasma membrane fluidity, and an elevation in cathepsin B activity in the brain and liver. In 2-year-old spawning salmon, the changes in these parameters was greater than in 2-year-old non-spawning salmon. These observations suggest that free radical levels increase with aging and during spawning and indicate that these changes may be involved in cellular degeneration. In addition, these results support the suggestion that cellular degeneration accelerates during the spawning process.
C1 UNIV WATERLOO, DEPT BIOL, WATERLOO N2L 3G1, ONTARIO, CANADA.
C3 University of Waterloo
CR BAILEY PJ, 1984, MECH AGEING DEV, V24, P233, DOI 10.1016/0047-6374(84)90074-5
   BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
   Beauchamp C., 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8
   CLARK RA, 1987, J BIOL CHEM, V262, P4065
   HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001
   HALLIWELL B, 1989, FREE RADICAL BIO MED, P416
   HARMAN D, 1991, P NATL ACAD SCI USA, V88, P5360, DOI 10.1073/pnas.88.12.5360
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   JONES JW, 1959, SALMON, P43
   KIM I, 1983, BIOL REPROD, V29, P48, DOI 10.1095/biolreprod29.1.48
   KIRSCHKE H, 1987, LYSOSOMES THEIR ROLE, P193
   KONAGAYA S, 1982, B JPN SOC SCI FISH, V48, P1503
   LEIBOVITZ BE, 1980, J GERONTOL, V35, P45, DOI 10.1093/geronj/35.1.45
   LESHEM YY, 1984, PLANT PHYSIOL, V75, P329, DOI 10.1104/pp.75.2.329
   MASSIE HR, 1980, MECH AGEING DEV, V12, P279, DOI 10.1016/0047-6374(80)90051-2
   MEITES J, 1987, EXP GERONTOL, V22, P1, DOI 10.1016/0531-5565(87)90010-6
   MILISAUSKAS V, 1973, EXP CELL RES, V81, P279, DOI 10.1016/0014-4827(73)90516-8
   MILLER RW, 1975, BIOCHIM BIOPHYS ACTA, V387, P176, DOI 10.1016/0005-2728(75)90062-6
   MIQUEL J, 1979, EXP GERONTOL, V14, P279, DOI 10.1016/0531-5565(79)90039-1
   NUNEZ MT, 1982, BIOCHEMISTRY-US, V21, P4139, DOI 10.1021/bi00260a034
   RILEY JCM, 1988, CAN J PHYSIOL PHARM, V66, P76, DOI 10.1139/y88-014
   RILEY JCM, 1987, ENDOCRINOLOGY, V121, P776, DOI 10.1210/endo-121-2-776
   ROBERTSON O, 1961, P NATL ACAD SCI USA, V47, P609, DOI 10.1073/pnas.47.4.609
   ROBERTSON OH, 1962, GEN COMP ENDOCR, V2, P458, DOI 10.1016/0016-6480(62)90044-8
   SAWADA M, 1989, CAN J PHYSIOL PHARM, V67, P465, DOI 10.1139/y89-074
   SAWADA M, 1985, EXP GERONTOL, V20, P179, DOI 10.1016/0531-5565(85)90035-X
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SAWADA M, 1992, J CELL BIOCHEM, V48, P296, DOI 10.1002/jcb.240480310
   SAWADA M, 1991, ENDOCRINOLOGY, V128, P2992, DOI 10.1210/endo-128-6-2992
   SAWADA M, 1990, J CELL BIOCHEM, V44, P153, DOI 10.1002/jcb.240440304
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   SESTINI EA, 1991, EXP GERONTOL, V26, P385, DOI 10.1016/0531-5565(91)90050-V
   Shock N. W., 1977, Handbook of the biology of aging, P639
   SIMCHOWITZ L, 1990, J BIOL CHEM, V265, P13449
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   SORENSEN K, 1986, EXPERIENTIA, V42, P161, DOI 10.1007/BF01952446
   TANAKA T, 1992, J BIOL CHEM, V267, P1239
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   YAMASHITA M, 1990, COMP BIOCHEM PHYS B, V95, P149, DOI 10.1016/0305-0491(90)90262-R
   YULI I, 1981, BIOCHEMISTRY-US, V20, P4250, DOI 10.1021/bi00518a003
NR 41
TC 18
Z9 18
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN
PY 1993
VL 69
IS 1-2
BP 137
EP 147
DI 10.1016/0047-6374(93)90078-6
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA LK784
UT WOS:A1993LK78400011
PM 8397327
DA 2024-02-19
ER

PT J
AU Wang, ZR
   Liang, YR
   Zhang, L
   Zhang, NN
   Liu, QF
   Wang, Z
AF Wang, Zhuoran
   Liang, Yaru
   Zhang, Lu
   Zhang, Nannan
   Liu, Qingfei
   Wang, Zhao
TI Phosphodiesterase 4 inhibitor activates AMPK-SIRT6 pathway to prevent
   aging-related adipose deposition induced by metabolic disorder
SO AGING-US
LA English
DT Article
DE rolipram; aging; adipose deposition; AMPK; SIRT6
ID SPINAL-CORD-INJURY; CALORIE RESTRICTION; CARDIOVASCULAR-DISEASE;
   ISCHEMIC-STROKE; PDE4 INHIBITOR; PROTEIN-KINASE; CYCLIC-AMP; LIFE-SPAN;
   ROLIPRAM; CAMP
AB Rolipram is a selective phosphodiesterase 4 (PDE4) inhibitor that exerts a variety of effects, including anti-inflammatory, immunosuppressive, and anti-tumor effects. The aim of this study was to investigate the effect of rolipram on metabolic disorder and its underlying mechanisms. Metabolic disorder was induced in 8-week-old wild type BABL/c mice by administration of D-galactose for 4 weeks. Simultaneously the mice were administered vehicle or rolipram. Alternatively, beginning at 3 or 21 months, the mice were administered db-cAMP for 3 months, with or without a high-fat-diet (HFD) to induce metabolic disorder. In both models, better metabolic function was observed in rolipram-treated mice. Rolipram reduced adipose deposition and inflammation and reserved metabolic disorder. Treatment with rolipram increased the AMPK phosphorylation and SIRT6 levels in the liver and kidney while reducing NF-kappa B acetylation. In vitro, these effects were blocked by suppression of SIRT6 expression using specific siRNA. Increased cAMP levels reduced excessive adipose deposition, and improved adipose distribution in presenile mice. These findings provide a promising strategy for the treatment of aging-related metabolic dysfunctions and suggest that selective PDE4 inhibitors may be useful agents for the treatment of aging-related metabolic diseases.
C1 [Wang, Zhuoran; Liang, Yaru; Zhang, Lu; Zhang, Nannan; Liu, Qingfei; Wang, Zhao] Tsinghua Univ, Sch Pharmaceut Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.
C3 Tsinghua University
RP Wang, Z (corresponding author), Tsinghua Univ, Sch Pharmaceut Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.
EM zwang@tsinghua.edu.cn
FU National Key R&D Program of China [2018YFD0400204]; Key International
   S&T Cooperation Program of China [2016YFE113700]; European Union's
   Horizon 2020 Research and Innovation Program [633589]; National Natural
   Science Foundation of China [81471396]
FX This work was financially supported by grants from the National Key R&D
   Program of China (2018YFD0400204), the Key International S&T Cooperation
   Program of China (2016YFE113700), the European Union's Horizon 2020
   Research and Innovation Program (633589), and the National Natural
   Science Foundation of China (81471396).
CR Akar F, 2015, DRUG RES, V65, P86, DOI 10.1055/s-0034-1372646
   Bate Clive, 2015, Biology-Basel, V4, P591, DOI 10.3390/biology4030591
   Boomkamp SD, 2014, BRIT J PHARMACOL, V171, P2385, DOI 10.1111/bph.12588
   Buler M, 2014, FASEB J, V28, P3225, DOI 10.1096/fj.13-245241
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Cedervall P, 2015, P NATL ACAD SCI USA, V112, pE1414, DOI 10.1073/pnas.1419906112
   Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003
   Costa LM, 2013, BEHAV BRAIN RES, V243, P66, DOI 10.1016/j.bbr.2012.12.056
   Doseyici S, 2014, BIOTECH HISTOCHEM, V89, P388, DOI 10.3109/10520295.2014.883463
   du Sert NP, 2012, BRIT J PHARMACOL, V165, P1848, DOI 10.1111/j.1476-5381.2011.01669.x
   Eschenhagen T, 2013, BRIT J PHARMACOL, V169, P524, DOI 10.1111/bph.12168
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Fujita M, 2017, MOL PSYCHIATR, V22, P754, DOI 10.1038/mp.2016.171
   Ghosh M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/308461
   Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831
   Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029
   Guo HBA, 2017, NEUROPHARMACOLOGY, V116, P260, DOI 10.1016/j.neuropharm.2017.01.004
   Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009
   Holloszy J O, 2000, Mayo Clin Proc, V75 Suppl, pS3
   Holthoff JH, 2013, J PHARMACOL EXP THER, V347, P357, DOI 10.1124/jpet.113.208520
   Hu SY, 2016, EXP THER MED, V11, P1005, DOI 10.3892/etm.2015.2958
   Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052
   Korhonen R, 2013, BRIT J PHARMACOL, V169, P1525, DOI 10.1111/bph.12189
   Kraft P, 2013, EXP NEUROL, V247, P80, DOI 10.1016/j.expneurol.2013.03.026
   Mammadov E, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.07.028
   Massimi M, 2017, J CELL BIOCHEM, V118, P1401, DOI 10.1002/jcb.25798
   Minguet S, 2005, EUR J IMMUNOL, V35, P31, DOI 10.1002/eji.200425524
   Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440
   Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]
   Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011
   Oishi Y, 2017, CELL METAB, V25, P412, DOI 10.1016/j.cmet.2016.11.009
   Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017
   Shlisky J, 2017, ADV NUTR, V8, P17, DOI 10.3945/an.116.013474
   Sung MMY, 2012, HEART FAIL REV, V17, P707, DOI 10.1007/s10741-011-9293-8
   Wang ZR, 2015, SCI REP-UK, V5, DOI 10.1038/srep12012
   Zachary I, 2011, HEART, V97, P181, DOI 10.1136/hrt.2009.180414
   Zhu J, 2001, CNS DRUG REV, V7, P387
NR 39
TC 15
Z9 15
U1 1
U2 18
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD SEP
PY 2018
VL 10
IS 9
BP 2394
EP 2406
DI 10.18632/aging.101559
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GV4UF
UT WOS:000446095600022
PM 30227388
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Perrot, N
   Pelletier, W
   Bourgault, J
   Couture, C
   Li, ZL
   Mitchell, PL
   Ghodsian, N
   Bossé, Y
   Thériault, S
   Mathieu, P
   Arsenault, BJ
AF Perrot, Nicolas
   Pelletier, William
   Bourgault, Jerome
   Couture, Christian
   Li, Zhonglin
   Mitchell, Patricia L.
   Ghodsian, Nooshin
   Bosse, Yohan
   Theriault, Sebastien
   Mathieu, Patrick
   Arsenault, Benoit J.
TI A trans-omic Mendelian randomization study of parental lifespan uncovers
   novel aging biology and therapeutic candidates for chronic diseases
SO AGING CELL
LA English
DT Article; Early Access
DE Mendelian Randomization; Metabolomics; Parental Lifespan; Proteomics;
   Transcriptomics
ID GENE-EXPRESSION; HUMAN PLASMA; CHOLESTEROL; PCSK9; ASSOCIATION; SORT1;
   RISK
AB The study of parental lifespan has emerged as an innovative tool to advance aging biology and our understanding of the genetic architecture of human longevity and aging-associated diseases. Here, we leveraged summary statistics of a genome-wide association study including over one million parental lifespans to identify genetically regulated genes from the Genotype-Tissue Expression project. Through a combination of multi-tissue transcriptome-wide association analyses and genetic colocalization, we identified novel genes that may be associated with parental lifespan. Mendelian randomization (MR) analyses also identified circulating proteins and metabolites causally associated with parental lifespan and chronic diseases offering new drug repositioning opportunities such as those targeting apolipoprotein-B-containing lipoproteins. Liver expression of HP, the gene encoding haptoglobin, and plasma haptoglobin levels were causally linked with parental lifespan. Phenome-wide MR analyses were used to map genetically regulated genes, proteins and metabolites with other human traits as well as the disease-related phenome in the FinnGen cohorts (n = 135,638). Altogether, this study identified new candidate genes, circulating proteins and metabolites that may influence human aging as well as potential therapeutic targets for chronic diseases that warrant further investigation.
C1 [Perrot, Nicolas; Pelletier, William; Bourgault, Jerome; Couture, Christian; Li, Zhonglin; Mitchell, Patricia L.; Ghodsian, Nooshin; Bosse, Yohan; Theriault, Sebastien; Mathieu, Patrick; Arsenault, Benoit J.] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.
   [Perrot, Nicolas; Pelletier, William; Arsenault, Benoit J.] Univ Laval, Fac Med, Dept Med, Quebec City, PQ, Canada.
   [Bosse, Yohan] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ, Canada.
   [Theriault, Sebastien] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada.
   [Mathieu, Patrick] Univ Laval, Fac Med, Dept Surg, Quebec City, PQ, Canada.
C3 Laval University; Laval University; Laval University; Laval University;
   Laval University
RP Arsenault, BJ (corresponding author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Y-3106,Pavillon Marguerite DYouville, Quebec City, PQ G1V 4G5, Canada.
EM benoit.arsenault@criucpq.ulaval.ca
OI LI, Zhonglin/0000-0003-3659-2389; Mitchell,
   Patricia/0000-0002-0773-1047; Theriault, Sebastien/0000-0003-1893-8307
CR [Anonymous], 2013, NAT GENET
   Arsenault BJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.0129
   Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1
   Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200
   Boettger LM, 2016, NAT GENET, V48, P359, DOI 10.1038/ng.3510
   Bowden J, 2017, STAT MED, V36, P1783, DOI 10.1002/sim.7221
   Burgess S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14156-4
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Carvalho-Silva D, 2019, NUCLEIC ACIDS RES, V47, pD1056, DOI 10.1093/nar/gky1133
   Chignon A, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0937-x
   Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5
   Cotto Kelsy C, 2018, Nucleic Acids Res, V46, pD1068, DOI 10.1093/nar/gkx1143
   Deelen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11558-2
   Defesche JC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.93
   Delaneau O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15452
   Foley CN, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20885-8
   Franz M, 2018, NUCLEIC ACIDS RES, V46, pW60, DOI 10.1093/nar/gky311
   Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367
   Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383
   He B, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00830-3
   Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408
   Kettunen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11122
   Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006
   Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370
   Kryuchkova-Mostacci N, 2017, BRIEF BIOINFORM, V18, P205, DOI 10.1093/bib/bbw008
   Liu BX, 2019, NAT GENET, V51, P768, DOI 10.1038/s41588-019-0404-0
   Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653
   Melzer D, 2020, NAT REV GENET, V21, P88, DOI 10.1038/s41576-019-0183-6
   Miura Y, 2011, EXP GERONTOL, V46, P81, DOI 10.1016/j.exger.2010.10.002
   Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266
   Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314
   Pedersen TR, 2016, CIRC RES, V118, P721, DOI 10.1161/CIRCRESAHA.115.306297
   Pilling LC, 2017, AGING-US, V9, P2504, DOI 10.18632/aging.101334
   Pividori M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba2083
   Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102
   Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3
   Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25
   Rosa M, 2019, NPJ GENOM MED, V4, DOI 10.1038/s41525-019-0097-4
   Spagnuolo MS, 2014, ACS CHEM NEUROSCI, V5, P837, DOI 10.1021/cn500099f
   Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457
   Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2
   Tavori H, 2016, CIRC RES, V119, P29, DOI 10.1161/CIRCRESAHA.116.308811
   Timmers PRHJ, 2019, ELIFE, V8, DOI 10.7554/eLife.39856
   Tsimikas S, 2018, J AM COLL CARDIOL, V71, P177, DOI 10.1016/j.jacc.2017.11.014
   Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7
   Vosa U., 2018, bioRxiv, P447367, DOI 10.1101/447367
   Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037
   Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951
   Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042
   Yang C., 2020, 20140277 MEDRXIV, V2020, DOI [10.1101/2020.06.25.20140277, DOI 10.1101/2020.06.25.20140277]
   Yang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15145
   Yashin AI, 2010, AGING-US, V2, P612, DOI 10.18632/aging.100191
   Zheng J, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy090
NR 54
TC 5
Z9 5
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2021 NOV
PY 2021
VL 20
IS 11
AR e13497
DI 10.1111/acel.13497
EA OCT 2021
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA WW5IH
UT WOS:000711453800001
PM 34704651
OA Green Published
DA 2024-02-19
ER

PT J
AU White, AM
   Orosz, A
   Powell, PA
   Koob, GF
AF White, Aaron M.
   Orosz, Andras
   Powell, Patricia A.
   Koob, George F.
TI Alcohol and aging- An area of increasing concern
SO ALCOHOL
LA English
DT Article; Early Access
DE falls; injury; medication interaction; overdose; screening
ID AGED GREATER-THAN-OR-EQUAL-TO-65 YEARS; EMERGENCY-DEPARTMENT VISITS;
   OLDER-ADULTS; UNITED-STATES; BRIEF INTERVENTION; ETHANOL-METABOLISM;
   ATRIAL-FIBRILLATION; HEART-FAILURE; USE DISORDERS; RISK-FACTORS
AB Alcohol use is increasing among adults 65 and older and the size of this population is expanding rapidly. Aging is associated with systemic inflammation, sleep disturbances, cancers, cognitive decline, and increased risk of injury and death from falls and other accidents. Alcohol misuse exacerbates and ac-celerates these age-related changes. Older drinkers are more sensitive to acute alcohol-induced im-pairments in memory, coordination, reaction time, and driving performance. Oxidative stress and DNA damage resulting from chronic heavy alcohol consumption contribute to an increased risk of cancer, liver disease, and cardiovascular disease. Medication use increases with age and many medications prescribed to older adults can interact negatively with alcohol. The rapid expansion of the population aged 65 and older, combined with higher levels of alcohol use and AUD in the Baby Boomer cohort than the preceding generation, could significantly increase the burden of alcohol on the healthcare system resulting from AUD and alcohol-related injuries and diseases. Screening and brief intervention for hazardous alcohol use among older patients along with education regarding potential interactions between alcohol and medications could substantially reduce the risk of harms from alcohol but currently is underutilized. Published by Elsevier Inc.
C1 [White, Aaron M.; Orosz, Andras; Powell, Patricia A.; Koob, George F.] Natl Inst Alcohol Abuse & Alcoholism, Bethesda, MD USA.
   [White, Aaron M.] Natl Inst Alcohol Abuse & Alcoholism, Off Director, NIH, 6700B Rockledge Dr, Bethesda, MD 20852 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH)
   - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)
RP White, AM (corresponding author), Natl Inst Alcohol Abuse & Alcoholism, Off Director, NIH, 6700B Rockledge Dr, Bethesda, MD 20852 USA.
EM aaron.white@nih.gov
OI White, Aaron/0000-0002-1610-6040
CR Acuff SF, 2022, PSYCHOL ADDICT BEHAV, V36, P1, DOI 10.1037/adb0000796
   Administration on Community Living, 2021, 2020 PROF OLD AM
   Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514
   American Psychological Association, 2021, ON YEAR UNH WEIGHT G
   Barefoot JC, 2002, AM J CLIN NUTR, V76, P466, DOI 10.1093/ajcn/76.2.466
   Biddinger KJ, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2022.3849
   Bouchette D., 2021, STATPEARLS
   Boudreaux ED, 2015, DRUG ALCOHOL DEPEN, V155, P236, DOI 10.1016/j.drugalcdep.2015.07.014
   Breslow RA, 2017, ALCOHOL CLIN EXP RES, V41, P976, DOI 10.1111/acer.13365
   Britton A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62227-0
   Bryazka D, 2022, LANCET, V400, P185, DOI 10.1016/S0140-6736(22)00847-9
   Burns E, 2018, MMWR-MORBID MORTAL W, V67, P509, DOI 10.15585/mmwr.mm6718a1
   Canham SL, 2015, INT J GERIATR PSYCH, V30, P284, DOI 10.1002/gps.4139
   Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238
   Castle IJP, 2016, ALCOHOL CLIN EXP RES, V40, DOI 10.1111/acer.13167
   Cauley JA, 2019, J BONE MINER RES, V34, P464, DOI 10.1002/jbmr.3619
   Census Bureau, 2019, 2020 CENS WILL HELP
   Centers for Disease Control and Prevention, 2022, MULT CAUS DEATH 2018
   Centers for Disease Control and Prevention, 2022, Alcohol-Related Disease Impact (ARDI) Application
   Chen C. M., 2018, TRENDS ALCOHOL RELAT
   Chen CM, 2017, SUBST USE MISUSE, V52, P1120, DOI 10.1080/10826084.2017.1293101
   Cochen V, 2009, J NUTR HEALTH AGING, V13, P322, DOI 10.1007/s12603-009-0030-0
   Csengeri D, 2021, EUR HEART J, V42, P1170, DOI 10.1093/eurheartj/ehaa953
   Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P1899, DOI 10.1001/jama.2018.16789
   Davis JS, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2016-000550
   Dixit S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185228
   Djoussé L, 2008, CURR ATHEROSCLER REP, V10, P117, DOI 10.1007/s11883-008-0017-z
   Domènech-Abella J, 2019, J AFFECT DISORDERS, V246, P82, DOI 10.1016/j.jad.2018.12.043
   Dorans KS, 2015, CIRC-HEART FAIL, V8, P422, DOI 10.1161/CIRCHEARTFAILURE.114.001787
   Eastman MR, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084222
   Fagbemi M, 2021, CLEV CLIN J MED, V88, P434, DOI 10.3949/ccjm.88a.20123
   Fernández-Solò J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020572
   Fleming MF, 1999, J FAM PRACTICE, V48, P378
   Food and Drug Administration, 2008, AMBIEN PRESCR INF SA
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Garcia CC, 2020, J STUD ALCOHOL DRUGS, V81, P372, DOI 10.15288/jsad.2020.81.372
   Golaszewski NM, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2021.46461
   Grucza RA, 2018, ALCOHOL CLIN EXP RES, V42, P1939, DOI 10.1111/acer.13859
   HAHN HKJ, 1983, ALCOHOL CLIN EXP RES, V7, P299, DOI 10.1111/j.1530-0277.1983.tb05464.x
   Han BH, 2018, J SUBST ABUSE TREAT, V86, P70, DOI 10.1016/j.jsat.2018.01.002
   Han BH, 2017, DRUG ALCOHOL DEPEN, V170, P198, DOI 10.1016/j.drugalcdep.2016.11.003
   Heron Melonie, 2016, Natl Vital Stat Rep, V65, P1
   HINGSON R, 1987, J STUD ALCOHOL, V48, P212, DOI 10.15288/jsa.1987.48.212
   Hirschtritt ME, 2019, AM J MANAG CARE, V25, pE358
   JONES AW, 1985, ALCOHOL ALCOHOLISM, V20, P45
   Kalla A, 2017, CLIN CARDIOL, V40, P444, DOI 10.1002/clc.22681
   Kaufman DW, 1999, AM J GASTROENTEROL, V94, P3189, DOI 10.1111/j.1572-0241.1999.01517.x
   Kelly S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191189
   Kelly S, 2018, AGE AGEING, V47, P175, DOI 10.1093/ageing/afx132
   Kerr WC, 2009, ADDICTION, V104, P27, DOI 10.1111/j.1360-0443.2008.02391.x
   Kolla BP, 2013, J HOSP MED, V8, P1, DOI 10.1002/jhm.1985
   Koob GF, 2020, NEUROPSYCHOPHARMACOL, V45, P141, DOI 10.1038/s41386-019-0446-0
   Kuerbis A, 2014, CLIN GERIATR MED, V30, P629, DOI 10.1016/j.cger.2014.04.008
   Kunzmann AT, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002585
   Larsson SC, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0721-4
   Leon BE, 2022, FRONT BEHAV NEUROSCI, V15, DOI 10.3389/fnbeh.2021.778456
   Lewis B, 2019, J STUD ALCOHOL DRUGS, V80, P86, DOI 10.15288/jsad.2019.80.86
   LILJEQUIST R, 1975, PSYCHOPHARMACOLOGIA, V44, P205, DOI 10.1007/BF00421011
   Marcus GM, 2021, ANN INTERN MED, V174, P1503, DOI 10.7326/M21-0228
   Matsumoto C, 2014, J CARDIOPULM REHABIL, V34, P159, DOI 10.1097/HCR.0000000000000042
   Matthews DB, 2021, INT REV NEUROBIOL, V161, P251, DOI 10.1016/bs.irn.2021.06.010
   Matthews D. B., 2022, ALCOHOL CLIN EXP RES
   McKnight-Eily LR, 2020, MMWR-MORBID MORTAL W, V69, P265, DOI 10.15585/mmwr.mm6910a3
   Meier P, 2008, CURR OPIN CLIN NUTR, V11, P21, DOI 10.1097/MCO.0b013e3282f30564
   Mejo S L, 1992, Nurse Pract, V17, P49, DOI 10.1097/00006205-199210000-00013
   Miner B, 2017, SLEEP MED CLIN, V12, P31, DOI 10.1016/j.jsmc.2016.10.008
   Moreland B, 2020, MMWR-MORBID MORTAL W, V69, P875, DOI [10.15585/mmwr.mm6927a5, 10.15585/mmwr.mm6927a5externalicon]
   MORRIS HH, 1987, JAMA-J AM MED ASSOC, V258, P945, DOI 10.1001/jama.258.7.945
   Murphy SL, 2021, NCHS DATA BRIEF, V427, P1
   National Cancer Institute, 2022, REC TRENDS SEER AG A
   National Survey on Drug Use and Health, 2020, US DEP HLTH HUM SERV
   Noguchi C, 2017, CELL CYCLE, V16, P45, DOI 10.1080/15384101.2016.1237326
   Noh JW, 2017, YONSEI MED J, V58, P1222, DOI 10.3349/ymj.2017.58.6.1222
   O'Connell H, 2003, BMJ-BRIT MED J, V327, P664, DOI 10.1136/bmj.327.7416.664
   O'Keefe EL, 2018, PROG CARDIOVASC DIS, V61, P68, DOI 10.1016/j.pcad.2018.02.001
   POZZATO G, 1995, J GERONTOL A-BIOL, V50, pB135, DOI 10.1093/gerona/50A.3.B135
   Price JL, 2018, PSYCHOPHARMACOLOGY, V235, P887, DOI 10.1007/s00213-017-4806-3
   Qian XX, 2021, J NUTR HEALTH AGING, V25, P425, DOI 10.1007/s12603-020-1539-5
   Rodgers JL, 2019, J CARDIOVASC DEV DIS, V6, DOI 10.3390/jcdd6020019
   Rodriguez FD, 2021, CANCERS, V13, DOI 10.3390/cancers13143548
   Roerecke M, 2017, LANCET PUBLIC HEALTH, V2, pE108, DOI 10.1016/S2468-2667(17)30003-8
   Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010
   Rumgay H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13093173
   Sabia S, 2014, NEUROLOGY, V82, P332, DOI 10.1212/WNL.0000000000000063
   Santini ZI, 2020, LANCET PUBLIC HEALTH, V5, pE62, DOI 10.1016/S2468-2667(19)30230-0
   Schonfeld L, 2015, AM J PUBLIC HEALTH, V105, P205, DOI 10.2105/AJPH.2013.301859
   Schonfeld L, 2010, AM J PUBLIC HEALTH, V100, P108, DOI 10.2105/AJPH.2008.149534
   SCOTT RB, 1988, J AM GERIATR SOC, V36, P255, DOI 10.1111/j.1532-5415.1988.tb01810.x
   Seitz HK, 2007, CLIN GERIATR MED, V23, P905, DOI 10.1016/j.cger.2007.06.010
   SEITZ HK, 1989, GASTROENTEROLOGY, V97, P446, DOI 10.1016/0016-5085(89)90082-6
   Shakya I, 2020, J SAFETY RES, V74, P125, DOI 10.1016/j.jsr.2020.06.001
   Sklar AL, 2012, ALCOHOL CLIN EXP RES, V36, P2150, DOI 10.1111/j.1530-0277.2012.01833.x
   Slade T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011827
   Slater M. E., 2022, Surveillance Report #119
   Strate LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165278
   Substance Abuse and Mental Health Services Administration, 2020, TREATING SUBSTANCE U, V26
   Sullivan EV, 2018, JAMA PSYCHIAT, V75, P474, DOI 10.1001/jamapsychiatry.2018.0021
   Santana NMT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190239
   Theocharis GJ, 2008, WORLD J GASTROENTERO, V14, P4047, DOI 10.3748/wjg.14.4047
   van der Schrier R, 2017, ANESTHESIOLOGY, V126, P534, DOI 10.1097/ALN.0000000000001505
   VESTAL RE, 1977, CLIN PHARMACOL THER, V21, P343
   VOGELSPROTT M, 1984, J STUD ALCOHOL, V45, P517, DOI 10.15288/jsa.1984.45.517
   Voskoboinik A, 2020, NEW ENGL J MED, V382, P20, DOI 10.1056/NEJMoa1817591
   Wannamethee SG, 2002, J EPIDEMIOL COMMUN H, V56, P542, DOI 10.1136/jech.56.7.542
   Westerlind B, 2019, AGING CLIN EXP RES, V31, P1087, DOI 10.1007/s40520-018-1056-0
   White AM, 2022, JAMA-J AM MED ASSOC, V327, P1704, DOI 10.1001/jama.2022.4308
   White AM, 2020, ALCOHOL CLIN EXP RES, V44, P178, DOI 10.1111/acer.14239
   White AM, 2018, ALCOHOL CLIN EXP RES, V42, P352, DOI 10.1111/acer.13559
   White AM, 2003, ALCOHOL RES HEALTH, V27, P186
   White MC, 2014, AM J PREV MED, V46, pS7, DOI 10.1016/j.amepre.2013.10.029
   Wu ZH, 2017, PERCEPT MOTOR SKILL, V124, P912, DOI 10.1177/0031512517721069
   Zosel A, 2011, AM J THER, V18, P305, DOI 10.1097/MJT.0b013e3181d169ed
NR 112
TC 10
Z9 10
U1 5
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0741-8329
EI 1873-6823
J9 ALCOHOL
JI Alcohol
PD 2023 MAR
PY 2023
VL 107
BP 19
EP 27
DI 10.1016/j.alcohol.2022.07.005
EA MAR 2023
PG 9
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA A4YM5
UT WOS:000955196800001
PM 35940508
DA 2024-02-19
ER

PT J
AU Fontenla, A
   Prchal, A
   Cena, AA
   Albarracín, AL
   Pintos, S
   Benvenuto, S
   Sosa, ML
   de Petrino, SF
AF Fontenla, A.
   Prchal, A.
   Cena, A. A.
   Albarracin, A. L.
   Pintos, S.
   Benvenuto, S.
   Sosa, M. L.
   Fontenla de Petrino, S.
TI Effects of soy milk as a dietary complement during the natural aging
   process
SO NUTRICION HOSPITALARIA
LA English
DT Article
DE Soymilk; Oxidative stress; Lipid profile; Neuronal bodies
ID OXIDATIVE STRESS; BRAIN; PROTEIN; SUPPLEMENTATION; PHYTOESTROGENS;
   ISOFLAVONE; DENSITY; DISEASE; LIPIDS; RISK
AB Introduction: Oxidative stress is one mechanism that could contribute to the acceleration of aging and age-related diseases. On the other hand, because of their antioxidative qualities soybean derived foods could have beneficial effects on the aging process.
   Objectives: The aim of our work was to study the effects of a diet supplemented with soy milk on certain biological features of aging in rats
   Methods: Male Wistar rats of 3 to 18 months of age, were assigned to one of two diets: 1) Experimental Group, commercial rat formula and soy milk; 2) Control Group, commercial rat formula and water. Every three months both lipid profile and lipid peroxidation were determined and neuronal cells of hippocampus were counted in control and experimental rats.
   Results: The soy milk diet significantly improved the plasmatic lipid profile, decreasing serum cholesterol (total as well as LDL) and serum triglycerides, HDL-cholesterol was significatively higher in experimental animals. The LDL/HDL ratio was thus significantly lowered. The soy diet also produced decreased values of lipid peroxidation in brain, liver and kidney. These effects were significant after 6 to 9 months. The experimental animals lost fewer hippocampal neurons than the controls. Finally at 18 months of age, a greater number of surviving animals in experimental group with respect to the control one was observed.
   Conclusions: 1) soy intake could have beneficial effects as a complement of normal diet, but not as a replacement for animal proteins and 2) these effects are the result of a very long period (almost lifelong) of consumption of this diet.
C1 [Fontenla, A.; Cena, A. A.; Pintos, S.; Benvenuto, S.; Sosa, M. L.; Fontenla de Petrino, S.] Univ Nacl Tucuman, Fac Med, Dept Biomed, Catedra Biol, RA-4000 San Miguel De Tucuman, Tucuman, Argentina.
C3 Universidad Nacional de Tucuman
RP de Petrino, SF (corresponding author), Jose Colombres 255, RA-4000 San Miguel De Tucuman, Tucuman, Argentina.
EM fontenla@arnet.com.ar
OI Prchal, Abigail/0000-0001-5702-7261
FU Consejo de Investigaciones de la Universidad Nacional de Tucuman (CIUNT)
   [26/1307-2005-2008]; Argentina National University of Tucuman, Argentina
FX This work was financially supported by a grant from Consejo de
   Investigaciones de la Universidad Nacional de Tucuman (CIUNT)
   26/1307-2005-2008, Argentina National University of Tucuman, Argentina.;
   The authors thank UNILEVER BESTFOODS (Argentina) for supplying the AdeS
   soy milk used in this work.; We also gratefully thank Patricia
   Black-Decima, PhD for helpful discussions during the preparation of the
   manuscript.
CR Adams MR, 2004, J NUTR, V134, P511, DOI 10.1093/jn/134.3.511
   ADLERCREUTZ CHT, 1995, J NUTR, V125, pS757, DOI 10.1093/jn/125.3_Suppl.757S
   *AHS, SYST 2007
   Anderson JW, 1998, AM J CLIN NUTR, V68, p1347S, DOI 10.1093/ajcn/68.6.1347S
   Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005
   Cao DH, 2004, PHARMACOL BIOCHEM BE, V79, P651, DOI 10.1016/j.pbb.2004.09.016
   de Petrino SF, 2007, NUTR HOSP, V22, P244
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Farriol M, 2006, NUTR HOSP, V21, P448
   Fukagawa NK, 1999, P SOC EXP BIOL MED, V222, P293, DOI 10.1046/j.1525-1373.1999.d01-146.x
   Green P, 2001, BBA-MOL CELL BIOL L, V1532, P203, DOI 10.1016/S1388-1981(01)00132-9
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Hermansen K, 2003, ADV THER, V20, P50, DOI 10.1007/BF02850119
   Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2
   Jenkins DJA, 2002, AM J CLIN NUTR, V76, P365, DOI 10.1093/ajcn/76.2.365
   Kagan VE., 1988, LIPID PEROXIDATION B
   Kreijkamp-Kaspers S, 2004, JAMA-J AM MED ASSOC, V292, P65, DOI 10.1001/jama.292.1.65
   Lamberts S.W.J, 2005, ENDOCRINOLOGY BASIC, P419
   Liao FH, 2007, NUTRITION, V23, P551, DOI 10.1016/j.nut.2007.05.003
   Lin CY, 2005, WORLD J GASTROENTERO, V11, P7355, DOI 10.3748/wjg.v11.i46.7355
   Liu JK, 1999, NEUROCHEM RES, V24, P1479, DOI 10.1023/A:1022597010078
   Mattson MP, 2002, PHYSIOL REV, V82, P637, DOI 10.1152/physrev.00004.2002
   Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s
   Meydani M, 2001, ANN NY ACAD SCI, V928, P226
   Morillas J, 2006, NUTR HOSP, V21, P650
   OAKENFULL D, 1990, EUR J CLIN NUTR, V44, P79
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Scheiber MD, 2001, MENOPAUSE, V8, P384, DOI 10.1097/00042192-200109000-00015
   SHEILA M, 2007, J NUTR, V137, P855
   Sierens J, 2001, MUTAT RES-DNA REPAIR, V485, P169, DOI 10.1016/S0921-8777(00)00069-0
   Soulsby ME, 2004, ANN CLIN LAB SCI, V34, P103
   Teixeira SR, 2004, J NUTR, V134, P1874, DOI 10.1093/jn/134.8.1874
   TILSON WB, 1974, J AM OIL CHEM SOC, V51, pA51, DOI 10.1007/BF02542087
   Velasquez MT, 2001, AM J KIDNEY DIS, V37, P1056, DOI 10.1016/S0272-6386(05)80025-3
   Wiseman H, 2000, AM J CLIN NUTR, V72, P395
   Yousef MI, 2004, FOOD CHEM TOXICOL, V42, P1497, DOI 10.1016/j.fct.2004.04.012
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 37
TC 3
Z9 3
U1 0
U2 3
PU ARAN EDICIONES, S L
PI MADRID
PA C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN
SN 0212-1611
EI 1699-5198
J9 NUTR HOSP
JI Nutr. Hosp.
PD NOV-DEC
PY 2008
VL 23
IS 6
BP 607
EP 613
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 374FG
UT WOS:000261028000013
PM 19132270
DA 2024-02-19
ER

PT J
AU André, A
   Juanéda, P
   Sébédio, JL
   Chardigny, JM
AF André, A
   Juanéda, P
   Sébédio, JL
   Chardigny, JM
TI Effects of aging and dietary n-3 fatty acids on rat brain
   phospholipids:: Focus on plasmalogens
SO LIPIDS
LA English
DT Article
ID ALPHA-LINOLENIC ACID; AGE-RELATED-CHANGES; FRONTAL-CORTEX; DEFICIENCY;
   TURNOVER; LIPIDS; LIVER; PLASMENYLETHANOLAMINE; NEUROTRANSMISSION;
   BIOSYNTHESIS
AB The aging brain undergoes modifications in the lipid composition of cell membranes and especially in plasmalogens. These phospholipids represent between one-half and two-thirds of the ethanolamine phospholipids in the brain. They are known to facilitate membrane fusion and act as enclogenous antioxiclants. During normal aging and in some pathological conditions, plasmalogen and DHA levels fall. In this context, we aimed to evaluate the influence of n-3 FA intake on plasmalogens in the brain during aging. Littermates from two generations of n-3-deficient rats were fed an n-3-deficient diet or an equilibrated diet containing either alpha-linolenic acid alone (alpha-LNA) or with two doses of DHA (0.3 or 0.6% w/w). After weaning, 9 mon of diet, or 21 mon of diet, plasmalogen levels were assessed, and the sn-2 substitutions of plasmenylethanolamines were analyzed in the cortex, striatum, and hippocampus. Our results showed that plasmalogen contents were not influenced by the diet. Plasmalogen levels were significantly decreased in aged rats compared with adults, whereas DHA levels increased in the hippocampus and remained stable in the cortex and striatum. DHA levels were significantly and similarly increased in total phospholipids and especially in plasmenylethanolannines after 9 mon of diet containing alpha-LNA alone or combined with DHA. This study showed that each structure sustained specific age-induced modifications. Dietary n-3 FA may not oppose the physiological decrease in brain plasmalogen levels during aging. Moreover, alpha-LNA appears to be equally as potent as preformed DHA at replacing DHA in the brain of our rat model.
C1 ENESAD, UMR, INRA, F-21065 Dijon, France.
   Unite Metab Prot Energet, F-63001 Clermont Ferrand, France.
C3 INRAE
RP Chardigny, JM (corresponding author), ENESAD, UMR, INRA, 17 Rue Sully,BP 86510, F-21065 Dijon, France.
EM chardign@dijon.inra.fr
OI Chardigny, Jean-Michel/0000-0001-5446-6517
CR BOURRE JM, 1984, J NEUROCHEM, V43, P342, DOI 10.1111/j.1471-4159.1984.tb00906.x
   Delion S, 1996, J NEUROCHEM, V66, P1582
   Delion S, 1997, J LIPID RES, V38, P680
   EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I
   Farooqui AA, 2001, J MOL NEUROSCI, V16, P263, DOI 10.1385/JMN:16:2-3:263
   Favrelière S, 2000, NEUROBIOL AGING, V21, P653, DOI 10.1016/S0197-4580(00)00170-6
   Favrelière S, 1998, LIPIDS, V33, P401, DOI 10.1007/s11745-998-0221-y
   Favrelière S, 2003, NEUROBIOL AGING, V24, P233, DOI 10.1016/S0197-4580(02)00064-7
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Frances H, 1996, EUR J PHARMACOL, V298, P217, DOI 10.1016/0014-2999(95)00825-X
   GAZZAH N, 1994, NEUROSCI LETT, V177, P103, DOI 10.1016/0304-3940(94)90055-8
   GLASER PE, 1994, BIOCHEMISTRY-US, V33, P5805, DOI 10.1021/bi00185a019
   Guttmann CRG, 1998, NEUROLOGY, V50, P972, DOI 10.1212/WNL.50.4.972
   Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HAZEN SL, 1991, J BIOL CHEM, V266, P5629
   HIRASHIMA Y, 1992, J NEUROCHEM, V59, P708, DOI 10.1111/j.1471-4159.1992.tb09426.x
   Horrocks LA., 1972, ETHER LIPIDS CHEM BI, P177, DOI DOI 10.1016/B978-0-12-654150-2.50016-6
   JUANEDA P, 1990, LIPIDS, V25, P756, DOI 10.1007/BF02544047
   JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360
   MANGOLD HK, 1987, LIPIDS, V22, P789, DOI 10.1007/BF02535533
   MARTINEZ M, 1992, BRAIN RES, V583, P171, DOI 10.1016/S0006-8993(10)80021-6
   Martinez M, 2001, J MOL NEUROSCI, V16, P309, DOI 10.1385/JMN:16:2-3:309
   McHowat J, 1998, AM J PHYSIOL-CELL PH, V274, pC1727, DOI 10.1152/ajpcell.1998.274.6.C1727
   Menard CR, 1998, J NEUROCHEM, V71, P2151
   Mitchell DC, 1998, BIOCHEM SOC T, V26, P365, DOI 10.1042/bst0260365
   Moore SA, 2001, J MOL NEUROSCI, V16, P195, DOI 10.1385/JMN:16:2-3:195
   Moriguchi T, 2001, J LIPID RES, V42, P419
   MORRISON WR, 1964, J LIPID RES, V5, P600
   Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0
   NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0
   Rapoport SI, 2001, J LIPID RES, V42, P678
   Rapoport SI, 1996, LIPIDS, V31, pS97, DOI 10.1007/BF02637059
   Rosenberger TA, 2002, J LIPID RES, V43, P59
   Sinclair AJ, 2002, LIPIDS, V37, P1113, DOI 10.1007/s11745-002-1008-x
   SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067
   Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159
   Su HM, 1999, LIPIDS, V34, pS347, DOI 10.1007/BF02562339
   SVENNERHOLM L, 1991, J NEUROCHEM, V56, P2051, DOI 10.1111/j.1471-4159.1991.tb03466.x
   Weisser M, 1997, CHEM PHYS LIPIDS, V90, P135, DOI 10.1016/S0009-3084(97)00089-3
   Weisser M, 1996, CHEM PHYS LIPIDS, V82, P173, DOI 10.1016/0009-3084(96)02588-1
   Zoeller RA, 1999, BIOCHEM J, V338, P769, DOI 10.1042/0264-6021:3380769
NR 42
TC 23
Z9 27
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0024-4201
EI 1558-9307
J9 LIPIDS
JI Lipids
PD AUG
PY 2005
VL 40
IS 8
BP 799
EP 806
DI 10.1007/s11745-005-1441-x
PG 8
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 968RR
UT WOS:000232180400004
PM 16296398
DA 2024-02-19
ER

PT J
AU Fomin, G
   Tabynov, K
   Islamov, R
   Turebekov, N
   Yessimseit, D
   Yerubaev, T
AF Fomin, Gleb
   Tabynov, Kairat
   Islamov, Rinat
   Turebekov, Nurkeldi
   Yessimseit, Duman
   Yerubaev, Toktasyn
TI Cytokine response and damages in the lungs of aging Syrian hamsters on a
   high-fat diet infected with the SARS-CoV-2 virus
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE SARS-CoV-2; COVID-19; Syrian hamster; cytokine response; high-fat diet
ID COVID-19; OBESITY
AB Hypertriglyceridemia, obesity, and aging are among the key risk factors for severe COVID-19 with acute respiratory distress syndrome (ARDS). One of the main prognostic biomarkers of ARDS is the level of cytokines IL-6 and TNF-& alpha; in the blood. In our study, we modeled hyperglyceridemia and hypercholesterolemia on 18-month-old Syrian hamsters (Mesocricetus auratus). By 18 months, the animals showed such markers of aging as weight stabilization with a tendency to reduce it, polycystic liver disease, decreased motor activity, and foci of alopecia. The high-fat diet caused an increase in triglycerides and cholesterol, as well as fatty changes in the liver. On the third day after infection with the SARS-CoV-2 virus, animals showed a decrease in weight in the groups with a high-fat diet. In the lungs of males on both diets, there was an increase in the concentration of IFN-& alpha;, as well as IL-6 in both males and females, regardless of the type of diet. At the same time, the levels of TNF-& alpha; and IFN-& gamma; did not change in infected animals. Morphological studies of the lungs of hamsters with SARS-CoV-2 showed the presence of a pathological process characteristic of ARDS. These included bronchointerstitial pneumonia and diffuse alveolar damages. These observations suggest that in aging hamsters, the immune response to pro-inflammatory cytokines may be delayed to a later period. Hypertriglyceridemia, age, and gender affect the severity of COVID-19. These results will help to understand the pathogenesis of COVID-19 associated with age, gender, and disorders of fat metabolism in humans.
C1 [Fomin, Gleb; Tabynov, Kairat; Islamov, Rinat; Turebekov, Nurkeldi; Yessimseit, Duman; Yerubaev, Toktasyn] Aikimbayevs Natl Sci Ctr Especially Dangerous Infe, Cent Reference Lab, Alma Ata, Kazakhstan.
   [Fomin, Gleb] Al Farabi Kazakh Natl Univ, Fac Biol & Biotechnol, Dept Biodivers & Bioresources, Alma Ata, Kazakhstan.
   [Tabynov, Kairat] Kazakh Natl Agrarian Res Univ, Int Ctr Vaccinol, Alma Ata, Kazakhstan.
C3 Al-Farabi Kazakh National University
RP Fomin, G (corresponding author), Aikimbayevs Natl Sci Ctr Especially Dangerous Infe, Cent Reference Lab, Alma Ata, Kazakhstan.; Fomin, G (corresponding author), Al Farabi Kazakh Natl Univ, Fac Biol & Biotechnol, Dept Biodivers & Bioresources, Alma Ata, Kazakhstan.
EM gleb.fomeen@gmail.com
RI Islamov, Rinat A/T-3925-2018; Tabynov, Kairat/JLL-3304-2023
FU Science Committee of the Ministry of Science and Higher Education of the
   Republic of Kazakhstan [AP09259865]
FX This study was funded by the Science Committee of the Ministry of
   Science and Higher Education of the Republic of Kazakhstan (IRN grant
   AP09259865).
CR Akha AAS, 2018, J IMMUNOL METHODS, V463, P21, DOI 10.1016/j.jim.2018.08.005
   Cantwell AM, 2021, J VIROL, V95, DOI 10.1128/JVI.01010-21
   Dalboge LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135634
   Lorenzo A, 2006, NUTR METAB CARDIOVAS, V16, P513, DOI 10.1016/j.numecd.2005.10.010
   DEAMOND SF, 1990, EXP GERONTOL, V25, P433, DOI 10.1016/0531-5565(90)90032-W
   Dhakal S, 2021, MBIO, V12, DOI 10.1128/mBio.00974-21
   Dong MZ, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110678
   Drucker DJ, 2021, CELL METAB, V33, P479, DOI 10.1016/j.cmet.2021.01.016
   Fomin G., 2022, 22 SGEM INT MULT SCI, P81, DOI [10.5593/sgem2022/6.1/s25.10, DOI 10.5593/SGEM2022/6.1/S25.10]
   Frere JJ, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abq3059
   Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   Heianza Y, 2014, J CLIN ENDOCR METAB, V99, P2952, DOI 10.1210/jc.2013-4427
   Hu BY, 2021, J MED VIROL, V93, P250, DOI 10.1002/jmv.26232
   Huang WJ, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-03159-9
   Ipsen DH, 2016, OBESITY, V24, P556, DOI 10.1002/oby.21443
   Karki Rajendra, 2021, Cell, V184, P149, DOI [10.1101/2020.10.29.361048, 10.1016/j.cell.2020.11.025]
   Kaur S, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2020.115327
   Kothari P, 2014, J IMMUNOL, V192, P349, DOI 10.4049/jimmunol.1301906
   Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554
   Matzkin ME, 2019, EXP GERONTOL, V124, DOI 10.1016/j.exger.2019.110649
   McInnes EF, 2015, TOXICOL PATHOL, V43, P272, DOI 10.1177/0192623314532569
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Miedel EL., 2015, LAB ANIMAL MED, P209
   O'Neill DG, 2022, J SMALL ANIM PRACT, V63, P747, DOI 10.1111/jsap.13527
   Oishi K, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.111002
   Osterrieder N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070779
   Port JR, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13122506
   Rizvi ZA, 2022, ELIFE, V11, DOI [10.7554/eLife.73522, 10.7554/eLife.73522.sa0, 10.7554/eLife.73522.sa1, 10.7554/eLife.73522.sa2]
   Spadaro S, 2019, J INFLAMM-LOND, V16, DOI 10.1186/s12950-018-0202-y
   Sun XJ, 2020, CYTOKINE GROWTH F R, V53, P38, DOI 10.1016/j.cytogfr.2020.04.002
   Tabynov K, 2022, FRONT VET SCI, V9, DOI 10.3389/fvets.2022.815978
   Tabynov K, 2022, NPJ VACCINES, V7, DOI 10.1038/s41541-022-00450-8
   Tsai PH, 2021, J CHIN MED ASSOC, V84, P3, DOI 10.1097/JCMA.0000000000000463
   Yoshikawa M, 2021, BMC MED GENOMICS, V14, DOI 10.1186/s12920-021-01127-2
   Yuan LZ, 2022, CELL MOL IMMUNOL, V19, P1392, DOI 10.1038/s41423-022-00923-9
   Yuan LZ, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00552-0
   Zinellu A, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.705916
NR 38
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUL 14
PY 2023
VL 14
AR 1223086
DI 10.3389/fimmu.2023.1223086
PG 11
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA N5XF9
UT WOS:001037732000001
PM 37520568
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Richardson, BC
AF Richardson, BC
TI Role of DNA methylation in the regulation of cell function:
   Autoimmunity, aging and cancer
SO JOURNAL OF NUTRITION
LA English
DT Article; Proceedings Paper
CT Trans-HHS Workshop on Diet, DNA Methylation Processes and Health
CY AUG 06-08, 2001
CL BETHESDA, MD
SP Natl Ctr Toxicol Res, Food & Durg Adm, Ctr Canc Res, Div Canc Prevent, NHLBI, NICHHD, NIDDK, NIEHS, Div Nutr Res Coordinat, Off Dietary Supplements, Amer Soc Nutrit Sci, Int Life Sci Inst N Amer
DE aging; lupus; carcinogenesis
ID DRUG-INDUCED LUPUS; FUNCTION-ASSOCIATED ANTIGEN-1; T-CELLS; SIGNALING
   PATHWAY; GENE-EXPRESSION; DEFICIENT DIET; SYNGENEIC MICE; RAT-LIVER;
   IN-VITRO; METHYLTRANSFERASE
AB DNA methylation plays an essential role in maintaining cellular function, and changes in methylation patterns may contribute to the development of autoimmunity, aging and cancer. Evidence for a role in autoimmunity comes from studies demonstrating that inhibiting T lymphocyte DNA methylation causes autoreactivity in vitro and a lupus-like disease in vivo. The autoimmunity is due in part to the heterodimeric beta(2) integrin lymphocyte function-associated antigen-1 (LFA-1) (CD11a/CD18) overexpression, and T lymphocytes from lupus patients hypomethylate the same CD11a promoter sequences, overexpress LFA-1 and demonstrate the same autoreactivity. Procainamide and hydralazine, two drugs that cause a lupus-like disease, also inhibit T cell DNA methylation, increase LFA-1 expression and induce autoreactivity in vitro and autoimmunity in vivo, supporting the association of DNA hypomethylation and autoimmunity. Methylation patterns also change with age in T lymphocytes as well as other tissues, typically with an overall decrease in methylcytosine content, but with increases in some cytosine guanine dinucleotide (CpG) islands. Age-dependent hypomethylation contributes to LFA-1 overexpression with aging, which may play a role in the development of autoimmunity in the elderly and age-dependent methylation of CpG islands in the promoters of tumor suppressor genes is an early event in the development of some cancers. DNA hypomethylation also may contribute to carcinogenesis by promoting overexpression of proto-oncogenes, chromosomal translocations and loss of imprinting. The mechanisms causing altered DNA methylation in autoimmunity, aging and carcinogenesis are incompletely characterized but include exposure to environmental agents and drugs, diet, altered signaling in pathways regulating DNA methyltransferase expression and changes in endogenous regulatory mechanisms. Other mechanisms are likely to be identified as well.
C1 Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA.
   Vet Affairs Hosp, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan
RP Richardson, BC (corresponding author), Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA.
EM brichard@umich.edu
FU NIAID NIH HHS [AI42753] Funding Source: Medline; NIAMS NIH HHS [AR42525]
   Funding Source: Medline; NIA NIH HHS [AG014783] Funding Source: Medline
CR Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X
   Baylin SB, 1998, ADV CANCER RES, V72, P141
   BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2
   CHRISTMAN JK, 1993, CARCINOGENESIS, V14, P551, DOI 10.1093/carcin/14.4.551
   COMACCHIA E, 1988, J IMMUNOL, V140, P2197
   Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285
   Deng C, 1998, BIOL CHEM, V379, P1113, DOI 10.1515/bchm.1998.379.8-9.1113
   Deng C, 2001, ARTHRITIS RHEUM, V44, P397, DOI 10.1002/1529-0131(200102)44:2<397::AID-ANR59>3.0.CO;2-N
   DIZIK M, 1991, CARCINOGENESIS, V12, P1307, DOI 10.1093/carcin/12.7.1307
   GOLBUS J, 1990, EUR J IMMUNOL, V20, P1869, DOI 10.1002/eji.1830200836
   ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536
   Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757
   JOHNSTON JM, 1979, J IMMUNOL, V123, P97
   Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947
   JUNG R, 2001, J GERONTOL A-BIOL, V56, pB268
   Kaplan MJ, 2000, IMMUNOL INVEST, V29, P411
   Kim YI, 1997, AM J CLIN NUTR, V65, P46, DOI 10.1093/ajcn/65.1.46
   LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1
   LAPING NJ, 1994, J NEUROSCI RES, V39, P710, DOI 10.1002/jnr.490390612
   MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327
   Miller Richard A., 1995, P555
   Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764
   Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890
   ONO T, 1993, AGE AGEING, V22, pS34, DOI 10.1093/ageing/22.suppl_1.S34
   ONO T, 1989, MECH AGEING DEV, V50, P27, DOI 10.1016/0047-6374(89)90056-0
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   PALLIS M, 1993, SCAND J IMMUNOL, V38, P559, DOI 10.1111/j.1365-3083.1993.tb03241.x
   POGRIBNY IP, 1995, CANCER RES, V55, P1894
   QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576
   RATH PC, 1989, FEBS LETT, V244, P193, DOI 10.1016/0014-5793(89)81191-3
   RICHARDSON B, 1990, ARTHRITIS RHEUM, V33, P1665, DOI 10.1002/art.1780331109
   RICHARDSON B, 1994, ARTHRITIS RHEUM, V37, P1363, DOI 10.1002/art.1780370915
   RICHARDSON B, 1986, HUM IMMUNOL, V17, P456, DOI 10.1016/0198-8859(86)90304-6
   RICHARDSON BC, 1992, ARTHRITIS RHEUM, V35, P647, DOI 10.1002/art.1780350608
   ROMANOV GA, 1980, MOL BIOL, V2, P357
   SCHEINBART LS, 1991, J RHEUMATOL, V18, P530
   SLAGBOOM PE, 1990, MECH AGEING DEV, V53, P243, DOI 10.1016/0047-6374(90)90042-E
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681
   VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967
   VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0
   VARELAMOREIRAS G, 1994, INT J VITAM NUTR RES, V64, P294
   WADA Y, 1993, INT ARCH OCC ENV HEA, V65, pS235, DOI 10.1007/BF00381349
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
   Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8
   Yang J, 1997, J IMMUNOL, V159, P1303
   Yung R, 1997, ARTHRITIS RHEUM, V40, P1436, DOI 10.1002/art.1780400811
   Yung R, 1996, J CLIN INVEST, V97, P2866, DOI 10.1172/JCI118743
   YUNG RL, 1995, J IMMUNOL, V154, P3025
   Zhu B, 2000, NUCLEIC ACIDS RES, V28, P4157, DOI 10.1093/nar/28.21.4157
   Zhu XX, 1999, P NATL ACAD SCI USA, V96, P8058, DOI 10.1073/pnas.96.14.8058
NR 51
TC 153
Z9 181
U1 1
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD AUG
PY 2002
VL 132
IS 8
SU S
BP 2401S
EP 2405S
DI 10.1093/jn/132.8.2401S
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics
GA 583GH
UT WOS:000177398500015
PM 12163700
OA hybrid
DA 2024-02-19
ER

PT J
AU Kol, AG
   Günes, HY
AF Kol, Afife Guler
   Gunes, Haci Yusuf
TI THE EFFECTS OF LOW FLOW AND NORMAL FLOW DESFLURANE ANESTHESIA ON LIVER
   AND RENAL FUNCTIONS AND SERUM CYSTATIN C LEVELS IN GERIATRIC PATIENTS: A
   PROSPECTIVE RANDOMIZED CONTROLLED STUDY
SO TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI
LA English
DT Article
DE Anesthesia; Cystatin C; Desflurane; Aged; Kidney; Liver
ID SEVOFLURANE; INHALATION; MARKER
AB Introduction: Aging is a physiological process and the elderly population is increasing. In parallel to the increasing of the elderly population, the number of geriatric patients who required an invasive procedure or surgical intervention under anesthesia are also increasing. The geriatric patients who are frailty and have a loss of functional reserve in all organ systems are more sensitive to anesthetic agents. The purpose of this research was to investigate whether low flow desflurane anesthesia also affects hepatic and kidney functions, in elderly patients. Methods: After approval from the local ethics committee, the patients were divided into two groups; as the low flow desflurane anesthesia group and the normal flow desflurane anesthesia group using the closed-envelope method. Calibration and leakage tests of the anesthesia device (Primus, Drager) were performed before anesthesia. Heamodynamics parametres, peripheral oxygen saturation, and bispectral index monitoring were performed to all patients in operating room. The blood samples were collected before anesthesia induction, after surgery, and at the postoperative 24th hour. The serum alanine aminotransferase and aspartate aminotransferase levels were measured to assess the liver damage. The serum creatinine, blood urea nitrogen, and cystatin C levels were measured to assess the kidney function. Results: The serum alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, creatinine and cystatin C levels and hemodynamic parameters, peripheral oxygen saturation and bispectral index values were similar in both groups. Conclusions: It was concluded that low-flow desflurane anesthesia does not adversely affect liver and kidney functions in geriatric patients and is as safe as normal-flow desflurane anesthesia.
C1 [Kol, Afife Guler; Gunes, Haci Yusuf] Van Yuzuncu Yil Univ, Fac Med, Dept Anesthesiol & Reanimat, Van, Turkiye.
C3 Yuzuncu Yil University
RP Günes, HY (corresponding author), Van Yuzuncu Yil Univ, Fac Med, Dept Anesthesiol & Reanimat, Van, Turkiye.
EM hyusufgunes@hotmail.com
OI GUNES, HACI YUSUF/0000-0003-3594-0345
CR BAUM J, 1994, ANAESTHESIST, V43, P194, DOI 10.1007/s001010050049
   Baum J A, 1999, J Anesth, V13, P166, DOI 10.1007/s005400050050
   BAUM JA, 1995, ANAESTHESIA, V50, P37, DOI 10.1111/j.1365-2044.1995.tb06189.x
   Bosna G, 2015, HAYDARPASA NUMUNE ME, V55, P37
   Brattwall M, 2012, CAN J ANESTH, V59, P785, DOI 10.1007/s12630-012-9736-2
   Ceylan A, 2004, GULHANE MED J, V46, P291
   Duymaz G, 2017, TURK J ANAESTHESIOL, V45, P93, DOI 10.5152/TJAR.2017.72325
   Ebert TJ, 2000, ANESTHESIOLOGY, V93, P1401, DOI 10.1097/00000542-200012000-00010
   Eger EI, 1997, ANESTH ANALG, V84, P160, DOI 10.1097/00000539-199701000-00029
   Eger EI, 2005, ANESTH ANALG, P131
   Elmacioglu MA, 2005, CURR THER RES CLIN E, V66, P4, DOI 10.1016/j.curtheres.2005.03.001
   GRUBB A, 1992, CLIN NEPHROL, V38, pS20
   KELLER KA, 1995, ANESTHESIOLOGY, V83, P1220, DOI 10.1097/00000542-199512000-00013
   KOBAYASHI Y, 1992, ANESTH ANALG, V74, P753
   Laterza OF, 2002, CLIN CHEM, V48, P699
   Le Bricon T, 2005, CLIN CHEM LAB MED, V43, P953, DOI 10.1515/CCLM.2005.163
   Lebanidze N G, 2006, Georgian Med News, P27
   Lebanidze N G, 2006, Georgian Med News, P63
   Lofrumento RJ, 2006, GERIATRIC ANESTHTESI, P3
   Park SY, 2012, KOREAN J ANESTHESIOL, V63, P498, DOI 10.4097/kjae.2012.63.6.498
   Randers E, 1999, CLIN CHEM LAB MED, V37, P389, DOI 10.1515/CCLM.1999.064
   SMILEY RM, 1991, CAN J ANAESTH, V38, P965, DOI 10.1007/BF03008612
   Soliman R, 2020, INDIAN J ANAESTH, V64, P383, DOI 10.4103/ija.IJA_168_20
   Togal T, 2004, TURK J ANAESTHESIOL, V32, P91
   Turkmen A., 2007, TURKISH J GERIATR, V10, P49
   Villa P, 2005, CRIT CARE, V9, pR139, DOI 10.1186/cc3044
   Xie GM, 1997, CHINESE MED J-PEKING, V110, P707
   Yildirim A, 2006, FIRAT MED J, V11, P170
   Yildiz TS, 2005, TURK ANESTEZIYOLOJI, V33, P29
   YOUNG CJ, 1995, J CLIN ANESTH, V7, P564, DOI 10.1016/0952-8180(95)00129-8
NR 30
TC 0
Z9 0
U1 1
U2 1
PU GUNES KITABEVI LTD STI
PI ANKARA
PA M RAUF INAN SOK NO 3, ANKARA, SIHHIYE 06410, TURKEY
SN 1304-2947
EI 1307-9948
J9 TURK J GERIATR
JI Turk. J. Geriatr.
PY 2023
VL 26
IS 1
BP 68
EP 78
DI 10.29400/tjgeri.2023.332
PG 11
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA C4XA0
UT WOS:000961949400008
OA gold
DA 2024-02-19
ER

PT J
AU Shi, M
   Takeshita, H
   Komatsu, M
   Xu, BH
   Aoyama, K
   Takeuchi, T
AF Shi, M
   Takeshita, H
   Komatsu, M
   Xu, BH
   Aoyama, K
   Takeuchi, T
TI Generation of 8-hydroxydeoxyguanosine from DNA using rat liver
   homogenates
SO CANCER SCIENCE
LA English
DT Article
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; OXIDATIVE DAMAGE; HUMAN URINE;
   IN-VIVO; MUTAGENIC SUBSTRATE; MASS-SPECTROMETRY; OXYGEN RADICALS;
   HUMAN-CELLS; REPAIR; 8-HYDROXY-2'-DEOXYGUANOSINE
AB In relation to carcinogenesis, aging and other pathologic conditions, urinary 8-hydroxydeoxyguanosine (80HdG) is widely used as a marker for evaluating the effect of oxidative stress on DNA. Because no reports have described how 80HdG is generated from DNA in vivo or by biological materials, and how it is excreted into urine, the authors investigated the generation of 80HdG from DNA, using rat liver homogenate. Oxidatively damaged DNA samples containing different levels of 80HdG were prepared using ultraviolet irradiation with three different concentrations of riboflavin. Following incubation of damaged DNA samples with rat liver homogenates, the generation of 80HdG from the DNA was determined using high-performance liquid chromatography with electrochemical detection after ultrafiltration of the incubation mixtures. The generation of 80HdG was also tested with an anti-80HdG antibody. The quantity of 80HdG generated from the DNA by rat liver homogenates was dependent on the 80HdG levels in the DNA: almost all 80HdG in the DNA was released as 80HdG by rat liver homogenates. Generation of 80HdG correlated with the degradation of DNA. Interestingly, the generated 80HdG was stable in the presence of rat liver homogenates, whereas deoxyguanosine (dG) rapidly disappeared in the same conditions. Less than 1/10000 of dG was converted to 80HdG when dG was incubated with rat liver homogenate. Incubation of 8-hydroxyguanine with rat liver homogenates did not generate 80HdG. These findings suggest that most of the 80HdG in DNA is released as 80HdG during DNA degradation and that, because of its stability, 80HdG is excreted into urine, thus providing a convenient measure of oxidative damage to DNA.
C1 Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Environm Med, Kagoshima 8908544, Japan.
C3 Kagoshima University
RP Takeuchi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Environm Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.
EM takeuchi@m.kufm.kagoshima-u.ac.jp
OI Xu, Baohui/0000-0002-2857-7464
CR ALPERS DH, 1990, CLIN CHIM ACTA, V186, P211, DOI 10.1016/0009-8981(90)90039-U
   AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   Barry ME, 1999, HUM GENE THER, V10, P2461, DOI 10.1089/10430349950016816
   Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633
   BERGTOLD DS, 1988, OXYGEN RADICALS BIOL, P483
   BESSHO T, 1993, J BIOL CHEM, V268, P19416
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   Collins AR, 1998, FASEB J, V12, P1397, DOI 10.1096/fasebj.12.13.1397
   Cooke MS, 2000, FREE RADICAL RES, V32, P381, DOI 10.1080/10715760000300391
   CORDIS GA, 1975, BIOCHEMISTRY-US, V14, P2596, DOI 10.1021/bi00683a006
   David SS, 1998, CHEM REV, V98, P1221, DOI 10.1021/cr980321h
   Davies AM, 2003, NUCLEIC ACIDS RES, V31, P1364, DOI 10.1093/nar/gkg205
   DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915
   Dianov G, 1998, J BIOL CHEM, V273, P33811, DOI 10.1074/jbc.273.50.33811
   Floyd R A, 1986, Free Radic Res Commun, V1, P163, DOI 10.3109/10715768609083148
   FLOYD RA, 1990, CARCINOGENESIS, V11, P1447, DOI 10.1093/carcin/11.9.1447
   Foksinski M, 2000, FREE RADICAL BIO MED, V29, P597, DOI 10.1016/S0891-5849(00)00358-0
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Gackowski D, 2001, FREE RADICAL RES, V35, P825, DOI 10.1080/10715760100301321
   Gackowski D, 2003, CANCER RES, V63, P4899
   Greenberg MM, 2004, BIOCHEM SOC T, V32, P46, DOI 10.1042/BST0320046
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6
   HAYAKAWA H, 1995, BIOCHEMISTRY-US, V34, P89, DOI 10.1021/bi00001a011
   Hazra IK, 1998, NUCLEIC ACIDS RES, V26, P5116, DOI 10.1093/nar/26.22.5116
   Hengartner MO, 2001, NATURE, V412, P27, DOI 10.1038/35083663
   HIBINO Y, 1991, BIOCHIM BIOPHYS ACTA, V1088, P305, DOI 10.1016/0167-4781(91)90068-W
   Higuchi Y, 2003, BIOCHEM PHARMACOL, V66, P1527, DOI 10.1016/S0006-2952(03)00508-2
   Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5
   KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137
   KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849
   Lin HS, 2004, BIOCHEM J, V380, P541, DOI 10.1042/BJ20040004
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241
   Loft S, 1998, ACTA BIOCHIM POL, V45, P133, DOI 10.18388/abp.1998_4328
   Lunec J, 2002, FREE RADICAL BIO MED, V33, P875, DOI 10.1016/S0891-5849(02)00882-1
   MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0
   Pan CQ, 1998, J BIOL CHEM, V273, P11701, DOI 10.1074/jbc.273.19.11701
   SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0
   SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697
   Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304
   TAGESSON C, 1995, EUR J CANCER, V31A, P934, DOI 10.1016/0959-8049(94)00490-0
   TAKEUCHI T, 1994, CANCER RES, V54, P5837
   TAKEUCHI T, 1994, CARCINOGENESIS, V15, P1519, DOI 10.1093/carcin/15.8.1519
   TCHOU J, 1994, J BIOL CHEM, V269, P15318
   TOH Y, 1989, EUR J BIOCHEM, V182, P231, DOI 10.1111/j.1432-1033.1989.tb14822.x
   Weimann A, 2004, FREE RADICAL BIO MED, V36, P1378, DOI 10.1016/j.freeradbiomed.2004.02.070
   Weimann A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e7
   Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010
   Yoshida R, 2002, CANCER EPIDEM BIOMAR, V11, P1076
   Yusifov TN, 2000, BIOCHEM J, V347, P815, DOI 10.1042/0264-6021:3470815
   Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5
NR 52
TC 15
Z9 15
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1349-7006
J9 CANCER SCI
JI Cancer Sci.
PD JAN
PY 2005
VL 96
IS 1
BP 13
EP 18
DI 10.1111/j.1349-7006.2005.00004.x
PG 6
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 895JK
UT WOS:000226857000003
PM 15649249
OA hybrid
DA 2024-02-19
ER

PT J
AU Karagiannides, I
   Tchkonia, T
   Dobson, DE
   Steppan, CM
   Cummins, P
   Chan, G
   Salvatori, K
   Hadzopoulou-Cladaras, M
   Kirkland, JL
AF Karagiannides, I
   Tchkonia, T
   Dobson, DE
   Steppan, CM
   Cummins, P
   Chan, G
   Salvatori, K
   Hadzopoulou-Cladaras, M
   Kirkland, JL
TI Altered expression of C/EBP family members results in decreased
   adipogenesis with aging
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE preadipocytes; differentiation; C/EBP alpha; C/EBP beta; c/EBP delta
ID BINDING-PROTEIN-ALPHA; FED AD-LIBITUM; ADIPOSE-TISSUE; GENE-EXPRESSION;
   PPAR-GAMMA; ANATOMIC SITE; PEROXISOME PROLIFERATOR; MESSENGER-RNA;
   DIFFERENTIATION; RAT
AB Fat mass, adipocyte size and metabolic responsiveness, and preadipocyte differentiation decrease between middle and old age. We show that expression of CCAAT/enhancer binding protein (C/EBP)-alpha, a key regulator of adipogenesis and fat cell function, declined substantially with aging in differentiating preadipocytes cultured under identical conditions from rats of various ages. Overexpression of C/EBP alpha in preadipocytes cultured from old rats restored capacity to differentiate into fat cells, indicating that downstream differentiation-dependent genes maintain responsiveness to regulators of adipogenesis. C/EBP alpha -expression also decreased with age in fat tissue from three different depots and in isolated fat cells. The overall level of C/EBP beta, which modulates C/EBP alpha -expression, did not change with age, but the truncated, dominant-negative C/EBP beta -liver inhibitory protein (LIP) isoform increased in cultured preadipocytes and isolated fat cells. Overexpression of C/EBP beta -LIP in preadipocytes from young rats impaired adipogenesis. C/EBP delta, which acts with full-length C/EBP beta to enhance adipogenesis, decreased with age. Thus processes intrinsic to adipose cells involving changes in C/EBP family members contribute to impaired adipogenesis and altered fat tissue function with aging. These effects are potentially reversible.
C1 Boston Univ, Dept Med, Boston, MA 02118 USA.
   Boston Univ, Dept Pathol, Boston, MA 02118 USA.
   Boston Univ, Dept Biochem, Boston, MA 02118 USA.
C3 Boston University; Boston University; Boston University
RP Kirkland, JL (corresponding author), Boston Univ, Dept Med, 88 E Newton St,F435, Boston, MA 02118 USA.
RI Kirkland, James/F-9159-2016
OI Tchkonia, Tamar/0000-0003-4623-7145
FU NHLBI NIH HHS [HL-56104] Funding Source: Medline; NIA NIH HHS [AG-13925]
   Funding Source: Medline; NIDDK NIH HHS [DK-46200, DK-44269] Funding
   Source: Medline
CR [Anonymous], 1986, STAT ANAL
   Baer M, 1998, BLOOD, V92, P4353, DOI 10.1182/blood.V92.11.4353.423k21_4353_4365
   Baer M, 2000, J BIOL CHEM, V275, P26582, DOI 10.1074/jbc.M004268200
   Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9
   BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827
   BERTRAND HA, 1978, SCIENCE, V201, P1234, DOI 10.1126/science.151328
   CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538
   Caserta F, 2001, AM J PHYSIOL-ENDOC M, V280, pE238, DOI 10.1152/ajpendo.2001.280.2.E238
   CHAWLA A, 1994, P NATL ACAD SCI USA, V91, P1786, DOI 10.1073/pnas.91.5.1786
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323
   CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593
   DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3
   DIMRI GP, 1994, EXP CELL RES, V212, P132, DOI 10.1006/excr.1994.1127
   DJIAN P, 1983, J CLIN INVEST, V72, P1200, DOI 10.1172/JCI111075
   El-Jack AK, 1999, J BIOL CHEM, V274, P7946, DOI 10.1074/jbc.274.12.7946
   GREGERMAN RI, 1994, J GERONTOL, V49, pB135, DOI 10.1093/geronj/49.4.B135
   HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345
   HAZZARD DG, 1988, EXP AGING RES, V14, P59, DOI 10.1080/03610738808259727
   Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283
   HOLLENBERG CH, 1968, J CLIN INVEST, V47, P2485, DOI 10.1172/JCI105930
   HOLT PR, 1985, GASTROENTEROLOGY, V89, P1026, DOI 10.1016/0016-5085(85)90204-5
   HORNSBY PJ, 1989, EXP GERONTOL, V24, P539, DOI 10.1016/0531-5565(89)90059-4
   Hotta K, 1999, J GERONTOL A-BIOL, V54, pB183, DOI 10.1093/gerona/54.5.B183
   Hsieh CC, 1998, MOL BIOL CELL, V9, P1479, DOI 10.1091/mbc.9.6.1479
   IBRAHIM M, 1994, MOL CELL BIOCHEM, V131, P49, DOI 10.1007/BF01075724
   JARVINEN HY, 1986, ACTA ENDOCRINOL-COP, V113, P88
   JENSEN PKA, 1992, VIRCHOWS ARCH B, V62, P189, DOI 10.1007/BF02899682
   Keppel G, 1973, Design and Analysis: A Researcher's Handbook
   KIRKLAND JL, 1990, AM J PHYSIOL, V258, pC206, DOI 10.1152/ajpcell.1990.258.2.C206
   KIRKLAND JL, 1984, J AM GERIATR SOC, V32, P219, DOI 10.1111/j.1532-5415.1984.tb02006.x
   Kirkland JL, 1997, J AM GERIATR SOC, V45, P959, DOI 10.1111/j.1532-5415.1997.tb02967.x
   KIRKLAND JL, 1993, BIOCHEM CELL BIOL, V71, P556, DOI 10.1139/o93-079
   Kirkland JL, 1996, INT J OBESITY, V20, pS102
   Kirkland JL, 1999, J GERONTOL A-BIOL, V54, pB189, DOI 10.1093/gerona/54.5.B189
   KIRKLAND JL, 1994, J GERONTOL, V49, pB31, DOI 10.1093/geronj/49.1.B31
   Kleinbaum D.G., 1998, APPL REGRESSION ANAL
   KLIPSTEINGROBUSCH K, 1995, BRIT J NUTR, V73, P323, DOI 10.1079/BJN19950033
   KLYDE BJ, 1979, J LIPID RES, V20, P691
   LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606
   LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533
   Lipman RD, 1996, J GERONTOL A-BIOL, V51, pB54, DOI 10.1093/gerona/51A.1.B54
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   MAJUMDAR S, 1991, J BIOL CHEM, V266, P9285
   MILLER WH, 1984, J LIPID RES, V25, P336
   Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168
   Norsgaard H, 1996, EXP GERONTOL, V31, P563, DOI 10.1016/0531-5565(96)00011-3
   Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7
   SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x
   SHIMAZU M, 1993, PHOTON SPECTRA, V27, P32
   Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182
   SILVER AJ, 1993, J AM GERIATR SOC, V41, P211, DOI 10.1111/j.1532-5415.1993.tb06693.x
   Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8
   Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517
   WANG H, 1989, J CLIN INVEST, V83, P1741, DOI 10.1172/JCI114075
   WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557
   WATTERS JM, 1994, SURG CLIN N AM, V74, P187
   WU Z, 1996, MOL CELL BIOL, V16, P5964
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   Zapata JM, 1998, J BIOL CHEM, V273, P6916, DOI 10.1074/jbc.273.12.6916
NR 62
TC 132
Z9 150
U1 0
U2 8
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD JUN
PY 2001
VL 280
IS 6
BP R1772
EP R1780
DI 10.1152/ajpregu.2001.280.6.R1772
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 432DK
UT WOS:000168676800023
PM 11353682
DA 2024-02-19
ER

PT J
AU Ma, Z
   Peng, L
   Chu, WH
   Wang, P
   Fu, YQ
AF Ma, Zhe
   Peng, Lin
   Chu, Wenhui
   Wang, Pan
   Fu, Yongqian
TI Osthole Alleviates D-Galactose-Induced Liver Injury <i>In Vivo</i> via
   the TLR4/MAPK/NF-κB Pathways
SO MOLECULES
LA English
DT Article
DE osthole; aging; liver injury; inflammation; oxidative stress
ID NF-KAPPA-B; HEME OXYGENASE-1; INHIBITION; APOPTOSIS; DAMAGE
AB Osthole, a coumarin derivative, is found in several medicinal herbs. However, the protective effects of osthole against D-galactose (D-Gal)-induced liver injury still remain unclear. In this study, osthole treatment effectively reversed D-Gal-induced liver injury, according to the results of liver HE staining, and improved ALT and AST activities. Feeding with D-Gal significantly increased MDA content, and reduced the level or activity of SOD, CAT and GSH-Px, which were all alleviated by osthole intervention. Meanwhile, osthole treatment significantly inhibited the D-Gal-induced secretion of pro-inflammatory cytokines, such as TNF-alpha, IL-1 beta and IL-6, in both serum and liver tissue. Investigations revealed that osthole ameliorated the D-Gal-induced activation of TLR4, MYD88 and its downstream signaling pathways of MAPK (p38 and JNK) and NF-kappa B (nucleus p65). Therefore, osthole mediates a protective effect against D-Gal-induced liver injury via the TLR4/MAPK/NF-kappa B pathways, and this coumarin derivative could be developed as a candidate bioactive component for functional food.
C1 [Ma, Zhe; Peng, Lin; Chu, Wenhui; Fu, Yongqian] Taizhou Univ, Sch Life Sci, Taizhou 318000, Peoples R China.
   [Ma, Zhe; Peng, Lin; Chu, Wenhui; Fu, Yongqian] Taizhou Univ, Taizhou Key Lab Biomass Funct Mat Dev & Applicat, Taizhou 318000, Peoples R China.
   [Wang, Pan] Tradit Chinese Med Ind Dev & Promot Ctr Panan Cty, Panan 322300, Peoples R China.
C3 Taizhou University; Taizhou University
RP Wang, P (corresponding author), Tradit Chinese Med Ind Dev & Promot Ctr Panan Cty, Panan 322300, Peoples R China.
EM tcmidpc.wp@outlook.com
OI Chu, Wenhui/0009-0005-7694-8249
FU Natural Science Foundation of Zhejiang Province; Taizhou Science and
   Technology Plan Project; Qingyuan Science and Technology plan project; 
   [Q21C200006];  [2001xg06];  [21ywa67];  [kjtpy-16]
FX This research was funded by Natural Science Foundation of Zhejiang
   Province (Q21C200006), Taizhou Science and Technology Plan Project
   (2001xg06, 21ywa67), and Qingyuan Science and Technology plan project
   (kjtpy-16).
CR Annunziata F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134618
   Aydin S, 2012, BIOGERONTOLOGY, V13, P251, DOI 10.1007/s10522-011-9370-3
   Bao YX, 2018, MOL MED REP, V17, P4561, DOI 10.3892/mmr.2018.8447
   Bindu S, 2013, FREE RADICAL BIO MED, V65, P456, DOI 10.1016/j.freeradbiomed.2013.07.027
   Cha H, 2018, FOOD CHEM TOXICOL, V121, P131, DOI 10.1016/j.fct.2018.08.060
   Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021
   Dugum M, 2015, J CLIN TRANSL HEPATO, V3, P109, DOI 10.14218/JCTH.2015.00008
   Fan HY, 2019, PHYTOMEDICINE, V58, DOI 10.1016/j.phymed.2019.152864
   Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]
   Fouad D, 2019, TOXICOL RES-UK, V8, P663, DOI 10.1039/c9tx00068b
   He Y, 2017, HEPATOLOGY, V66, P220, DOI 10.1002/hep.29153
   Jiang P, 2020, CARBOHYD POLYM, V234, DOI 10.1016/j.carbpol.2020.115936
   Jiang XX, 2020, PROCESS BIOCHEM, V92, P303, DOI 10.1016/j.procbio.2020.01.023
   Kong L, 2019, IMMUNOPHARM IMMUNOT, V41, P349, DOI 10.1080/08923973.2019.1608560
   Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651
   Li YY, 2015, INT IMMUNOPHARMACOL, V25, P332, DOI 10.1016/j.intimp.2015.02.002
   Liu C, 2019, J AGR FOOD CHEM, V67, P10059, DOI 10.1021/acs.jafc.9b03847
   Luo LN, 2016, EXP THER MED, V12, P2009, DOI 10.3892/etm.2016.3603
   Mark R, 2019, J FUNCT FOODS, V57, P233, DOI 10.1016/j.jff.2019.04.008
   Negash AA, 2015, IMMUNOL REV, V265, P143, DOI 10.1111/imr.12279
   Qiao JY, 2019, MOLECULES, V24, DOI 10.3390/molecules24162887
   Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005
   Sairam KV, 2016, CURR DRUG DELIV, V13, P186, DOI 10.2174/1567201812666150702102800
   Stefanachi A, 2018, MOLECULES, V23, DOI 10.3390/molecules23020250
   Sun MN, 2021, MED CHEM RES, V30, P1767, DOI 10.1007/s00044-021-02775-w
   Sun Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031006
   Tashiro S, 2022, TOXICOL APPL PHARM, V434, DOI 10.1016/j.taap.2021.115817
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Xu RG, 2018, CELL MOL BIOL LETT, V23, DOI 10.1186/s11658-018-0086-0
   Yamada N, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2334-2
   Yang X., 2015, PRACT PHARM CLIN REM, V18, P893, DOI DOI 10.14053/J.CNKI.PPCR.201508004
   Zhao MX, 2019, CELL STRESS CHAPERON, V24, P609, DOI 10.1007/s12192-019-00993-1
NR 32
TC 3
Z9 3
U1 8
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JAN
PY 2023
VL 28
IS 1
AR 443
DI 10.3390/molecules28010443
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 7P7RF
UT WOS:000908897300001
PM 36615637
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Yanagita, T
   Miyazawa, T
AF Yanagita, Teruyoshi
   Miyazawa, Teruo
TI Lipid Nutrition and Healthy Aging
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE metabolic syndrome; lipids; C/EBP beta; carotenoid; food factor
ID UNSATURATED FATTY-ACIDS; MICE
AB Bioactive food factors are considered to be critical for health promotion and play an important role in the prevention of lifestyle-related diseases. Metabolic syndrome, a typical common disease, is a cluster of metabolic disorders, such as abdominal obesity, the combination of hypertriglyceridemia and lower level of HDL, hypertension and diabetes mellitus, that contribute to increased cardiovascular morbidity and mortality. In addition, the incidence of metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) is closely linked with the increase in inflammation and the disorders of lipid metabolism. The pathogenesis of metabolic syndrome and related diseases is complicated. However, food factors have been recognized as contributing factors in the development and prevention of these diseases. Provocative evidence profoundly supports the preventive role of dietary bioactive lipids, polyphenols and other food ingredients. Recent studies suggest the central role of nuclear transcription factors in the pathogenesis of obesity and NAFLD. The goal of the present symposium is to enhance our understanding of cellular and molecular effects of bioactive food factors against obesity related pathogenesis.
C1 [Yanagita, Teruyoshi] Nishikyushu Univ, Kanzaki, Saga, Japan.
   Tohoku Univ, Grad Sch, Sendai, Miyagi 980, Japan.
C3 Tohoku University
RP Yanagita, T (corresponding author), Nishikyushu Univ, Kanzaki, Saga, Japan.
EM yanagitt@gmail.com
CR Chandrika UG, 2006, J SCI FOOD AGR, V86, P54, DOI 10.1002/jsfa.2307
   Huang Y.-S., 2006, DIETARY FATS RISK CH
   Nagao K, 2014, J OLEO SCI, V63, P979, DOI 10.5650/jos.ess14118
   Rahman SM, 2013, BIOCHEM BIOPH RES CO, V430, P336, DOI 10.1016/j.bbrc.2012.11.027
   Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613
   Yoshinaga K, 2015, J NUTR BIOCHEM, V26, P57, DOI 10.1016/j.jnutbio.2014.09.004
NR 6
TC 1
Z9 1
U1 0
U2 5
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
EI 1881-7742
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PD MAY
PY 2015
VL 61
SU S
BP S157
EP S158
DI 10.3177/jnsv.61.S157
PG 2
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CI8KH
UT WOS:000355020700062
PM 26598837
OA gold
DA 2024-02-19
ER

PT J
AU Lee, JH
   Lee, HS
   Lee, BK
   Kwon, YJ
   Lee, JW
AF Lee, Jun-Hyuk
   Lee, Hye-Sun
   Lee, Byoung-Kwon
   Kwon, Yu-Jin
   Lee, Ji-Won
TI Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease
SO BIOLOGY-BASEL
LA English
DT Article
DE sarcopenia; non-alcoholic fatty liver disease; obesity; skeletal muscle
   mass; inflammation
ID AMERICAN ASSOCIATION; INSULIN-RESISTANCE; ECTOPIC FAT; SARCOPENIA;
   MANAGEMENT; OBESITY; DIAGNOSIS; HEPATITIS
AB Simple Summary
   Sarcopenia and non-alcoholic fatty liver disease share common pathological and physiological mechanisms that can co-occur with aging. Low skeletal muscle mass index and non-alcoholic fatty liver disease were related, regardless of abdominal obesity. Maintenance of muscle mass should be emphasized for prevention of non-alcoholic fatty liver disease. Management of fatty liver also could be an important strategy to preserve muscle mass.
   Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whether NAFLD is a risk factor for the development of sarcopenia is not clear. We investigated relationships between NAFLD and low skeletal muscle mass index (LSMI) using three different datasets. Participants were classified into LSMI and normal groups. LSMI was defined as a body mass index (BMI)-adjusted appendicular skeletal muscle mass <0.789 in men and <0.512 in women or as the sex-specific lowest quintile of BMI-adjusted total skeletal muscle mass. NAFLD was determined according to NAFLD liver fat score or abdominal ultrasonography. The NAFLD groups showed a higher hazard ratios (HRs) with 95% confidence intervals (CIs) for LSMI than the normal groups (HRs = 1.21, 95% CIs = 1.05-1.40). The LSMI groups also showed a higher HRs with 95% CIs for NAFLD than normal groups (HRs = 1.56, 95% CIs = 1.38-1.78). Participants with NAFLD had consistently less skeletal muscle mass over 12 years of follow-up. In conclusion, LSMI and NAFLD showed a relationship. Maintaining muscle mass should be emphasized in the management of NAFLD.
C1 [Lee, Jun-Hyuk] Yonsei Univ, Coll Med, Grad Sch, Dept Med, Seoul 03722, South Korea.
   [Lee, Jun-Hyuk; Kwon, Yu-Jin] Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Family Med, Yongin 16995, South Korea.
   [Lee, Hye-Sun] Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Unit, Seoul 06273, South Korea.
   [Lee, Byoung-Kwon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, Seoul 06273, South Korea.
   [Lee, Ji-Won] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Family Med, Seoul 06273, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University;
   Yonsei University Health System; Yonsei University; Yonsei University
   Health System; Yonsei University; Yonsei University Health System;
   Yonsei University; Yonsei University Health System
RP Kwon, YJ (corresponding author), Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Family Med, Yongin 16995, South Korea.; Lee, JW (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Family Med, Seoul 06273, South Korea.
EM muzzyljh@yuhs.ac; HSLEE1@yuhs.ac; CARDIOBK@yuhs.ac; digda3@yuhs.ac;
   indi5645@yuhs.ac
RI Kwon, Yu-Jin/ACB-8082-2022; Lee, Hye Sun/J-2154-2015
OI Lee, Hye Sun/0000-0001-6328-6948; Lee, Jun-Hyuk/0000-0002-1007-1633;
   Lee, Byoung Kwon/0000-0001-9259-2776; KWON, YUJIN/0000-0002-9021-3856;
   LEE, JI WON/0000-0002-2666-4249
FU Yonsei University College of Medicine [6-2020-0143]; Ministry of Science
   and ICT, and the Technology Innovation Program - Ministry of Trade,
   Industry & Energy (MOTIE, Korea) [20002781]
FX This work was supported by a 2020 faculty research grant from Yonsei
   University College of Medicine (6-2020-0143) and the Ministry of Science
   and ICT, and the Technology Innovation Program (20002781, A Platform for
   Prediction and Management of Health Risk Based on Personal Big Data and
   Lifelogging) funded by the Ministry of Trade, Industry & Energy (MOTIE,
   Korea).
CR Brown JC, 2016, J CACHEXIA SARCOPENI, V7, P290, DOI 10.1002/jcsm.12073
   Byrne CD, 2014, ARTERIOSCL THROM VAS, V34, P1155, DOI 10.1161/ATVBAHA.114.303034
   Byun KS, 2005, J KOREAN MED ASSOC, V48, P423, DOI 10.5124/jkma.2005.48.5.423
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   Cho YJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66249-6
   Gonzalez MC, 2018, CURR OPIN CLIN NUTR, V21, P366, DOI 10.1097/MCO.0000000000000496
   De Bandt JP, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091195
   Elsen M, 2014, J ENDOCRINOL, V222, pR25, DOI 10.1530/JOE-14-0189
   Haga Y, 2015, WORLD J GASTROENTERO, V21, P12989, DOI 10.3748/wjg.v21.i46.12989
   Jung TW, 2018, MOL CELL ENDOCRINOL, V470, P26, DOI 10.1016/j.mce.2017.10.014
   KASL, 2013, CLIN MOL HEPATOL, V19, P325, DOI 10.3350/cmh.2013.19.4.325
   Kim Y, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv316
   Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005
   Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728
   Lee MJ, 2019, GUT LIVER, V13, P67, DOI 10.5009/gnl18070
   Lee SB, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0692-1
   Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013
   Lee YH, 2015, J HEPATOL, V63, P486, DOI 10.1016/j.jhep.2015.02.051
   Li Andrew A, 2020, Clin Liver Dis (Hoboken), V16, P73, DOI 10.1002/cld.900
   Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004
   Meng NH, 2015, J AGING PHYS ACTIV, V23, P597, DOI 10.1123/japa.2014-0036
   Ministry of Health and Welfare, 2015, DIETARY REFERENCE IN
   Palikaras K, 2017, J LIPID RES, V58, P72, DOI 10.1194/jlr.M069385
   Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x
   Peng TC, 2019, CLIN NUTR, V38, P422, DOI 10.1016/j.clnu.2017.11.021
   Sobestiansky S, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1338-1
   Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010
   Tang H, 2016, EBIOMEDICINE, V6, P139, DOI 10.1016/j.ebiom.2016.02.041
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Wijampreecha K, 2019, MATURITAS, V124, P48, DOI 10.1016/j.maturitas.2019.03.016
   Wijarnpreecha K, 2019, EUR J GASTROEN HEPAT, V31, P1121, DOI 10.1097/MEG.0000000000001397
   Zhai Y, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/5016091
NR 34
TC 11
Z9 11
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD FEB
PY 2021
VL 10
IS 2
AR 122
DI 10.3390/biology10020122
PG 14
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA QN0FE
UT WOS:000622146200001
PM 33562473
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tamura, I
   Tamura, H
   Kawamoto-Jozaki, M
   Doi-Tanaka, Y
   Takagi, H
   Shirafuta, Y
   Mihara, Y
   Maekawa, R
   Taketani, T
   Sato, S
   Sugino, N
AF Tamura, Isao
   Tamura, Hiroshi
   Kawamoto-Jozaki, Mai
   Doi-Tanaka, Yumiko
   Takagi, Haruka
   Shirafuta, Yuichiro
   Mihara, Yumiko
   Maekawa, Ryo
   Taketani, Toshiaki
   Sato, Shun
   Sugino, Norihiro
TI Long-term melatonin treatment attenuates body weight gain with aging in
   female mice
SO JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
DE melatonin; female mice; obesity; body weight
ID ALL-CAUSE MORTALITY; CHILDHOOD OBESITY; MASS INDEX; POSTMENOPAUSAL
   WOMEN; ADIPOSE-TISSUE; METABOLISM; LEPTIN; METAANALYSIS; ASSOCIATION;
   ADIPONECTIN
AB Women usually experience body weight gain with aging, which can put them at risk for many chronic diseases. Previous studies indicated that melatonin treatment attenuates body weight gain and abdominal fat deposition in several male animals. However, it is unclear whether melatonin affects female animals in the sa me way. This study investigated whether long-term melatonin treatment can attenuate body weight gain with aging and, if it does, what the mechanism is. Ten-week-old female ICR mice were given melatonin-containing water ( 100 mu g/mL) or only water until 43 weeks. Melatonin treatment significantly attenuated body weight gain at 23 weeks (control; 57.2 +/- 2.0 g vs melatonin; 44.4 +/- 3.1 g), 33 weeks (control; 65.4 +/- 2.6 g vs me latonin; 52.2 +/- 4.2 g) and 43 weeks (control; 66.1 +/- 3.2 g vs melatonin; 54.4 +/- 2.5 g) wit hout decreasing the amount of food intake. Micro- CT analyses showed that melatonin signific antly decreased the deposition of visceral and s.c. fat. These results suggested th at melatonin attenuates body weight gain by inhibiting abdominal fat deposition. Metabolome analysis of the liver revealed that melatonin treatment induced a drastic change in the metabolome with the downregulation of 149 metabolites, including the metabolites of glucose and amino acids. Citrate, which serves as a source of de novo lipogenesis, was one of the downregulated metabolites. These results show that long-term me latonin treatment induces drastic changes in metabolism and attenuates body weight gain and fat deposition with aging in female mice.
C1 [Tamura, Isao; Tamura, Hiroshi; Kawamoto-Jozaki, Mai; Doi-Tanaka, Yumiko; Takagi, Haruka; Shirafuta, Yuichiro; Mihara, Yumiko; Maekawa, Ryo; Taketani, Toshiaki; Sato, Shun; Sugino, Norihiro] Yamaguchi Univ, Dept Obstet & Gynecol, Grad Sch Med, Ube, Yamaguchi, Japan.
C3 Yamaguchi University
RP Tamura, H (corresponding author), Yamaguchi Univ, Dept Obstet & Gynecol, Grad Sch Med, Ube, Yamaguchi, Japan.
EM hitamura@yamaguchi-u.ac.jp
RI Maekawa, Ryo/AAR-4233-2020
OI Maekawa, Ryo/0000-0003-0923-376X
FU JSPS KAKENHI [17K11239, 18K09230, 18K09262, 19K09803, 20K09645,
   20H03825, 20K18191]; Grants-in-Aid for Scientific Research [20H03825,
   20K18191, 20K09645, 19K09803, 18K09262, 17K11239, 18K09230] Funding
   Source: KAKEN
FX This work was supported in part by JSPS KAKENHI (Grant Number 17K11239,
   18K09230, 18K09262, 19K09803, 20K09645, 20H03825 and 20K18191).
CR Agil A, 2011, J PINEAL RES, V50, P207, DOI 10.1111/j.1600-079X.2010.00830.x
   Akram M, 2014, CELL BIOCHEM BIOPHYS, V68, P475, DOI 10.1007/s12013-013-9750-1
   Alves-Bezerra M, 2018, COMPR PHYSIOL, V8, P1, DOI 10.1002/cphy.c170012
   Amstrup AK, 2016, CLIN ENDOCRINOL, V84, P342, DOI 10.1111/cen.12942
   Andersen LPH, 2016, CLIN DRUG INVEST, V36, P169, DOI 10.1007/s40261-015-0368-5
   Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156
   Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258
   Chatzakis C, 2019, DIABETES RES CLIN PR, V158, DOI 10.1016/j.diabres.2019.107924
   Chojnacki C, 2015, J PHYSIOL PHARMACOL, V66, P665
   Cipolla-Neto J, 2014, J PINEAL RES, V56, P371, DOI 10.1111/jpi.12137
   Cote AT, 2013, J AM COLL CARDIOL, V62, P1309, DOI 10.1016/j.jacc.2013.07.042
   Cunningham SA, 2014, NEW ENGL J MED, V370, P1660, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]
   Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1
   Favero G, 2015, NUTR RES, V35, P891, DOI 10.1016/j.nutres.2015.07.001
   Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905
   Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017
   Gaudet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/640291
   Genario R, 2021, PHARMACOL RES, V163, DOI 10.1016/j.phrs.2020.105254
   Gortmaker SL, 2014, NEW ENGL J MED, V370, P475, DOI 10.1056/NEJMe1315169
   Greaves C, 2017, HEALTH PSYCHOL REV, V11, P145, DOI 10.1080/17437199.2017.1299583
   Guthrie J R, 1999, Climacteric, V2, P205, DOI 10.3109/13697139909038063
   Halpern B, 2019, DIABETES, V68, P947, DOI 10.2337/db18-0956
   Hong F, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020489
   Hürter H, 2019, BEST PRACT RES CL EN, V33, P127, DOI 10.1016/j.beem.2019.05.001
   Inelmen E M, 2003, Obes Rev, V4, P147, DOI 10.1046/j.1467-789X.2003.00107.x
   Isobe Y, 2002, PHARMACOL BIOCHEM BE, V73, P805, DOI 10.1016/S0091-3057(02)00944-9
   Jiménez-Aranda A, 2013, J PINEAL RES, V55, P416, DOI 10.1111/jpi.12089
   Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055
   Kina-Tanada M, 2017, DIABETOLOGIA, V60, P1138, DOI 10.1007/s00125-017-4259-6
   Lainez NM, 2019, ENDOCRINOLOGY, V160, P2719, DOI 10.1210/en.2019-00487
   Li MF, 2011, WORLD J DIABETES, V2, P19, DOI 10.4239/wjd.v2.i2.19
   Liu G, 2017, AMINO ACIDS, V49, P2065, DOI 10.1007/s00726-017-2489-z
   Martínez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3
   Matsui T, 2017, P NATL ACAD SCI USA, V114, P6358, DOI 10.1073/pnas.1702739114
   Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055
   de Farias TDM, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00750
   Modabbernia A, 2014, J PSYCHIATR RES, V53, P133, DOI 10.1016/j.jpsychires.2014.02.013
   Nava M, 2003, AM J PHYSIOL-RENAL, V284, pF447, DOI 10.1152/ajprenal.00264.2002
   Nduhirabandi F, 2011, J PINEAL RES, V50, P171, DOI 10.1111/j.1600-079X.2010.00826.x
   Park YMM, 2019, JAMA INTERN MED, V179, P1061, DOI 10.1001/jamainternmed.2019.0571
   Perissinotto E, 2002, BRIT J NUTR, V87, P177, DOI 10.1079/BJN2001487
   Porter C, 2017, ADIPOCYTE, V6, P167, DOI 10.1080/21623945.2017.1319535
   Prunet-Marcassus B, 2003, ENDOCRINOLOGY, V144, P5347, DOI 10.1210/en.2003-0693
   Raskind MA, 2007, NEUROPSYCHOPHARMACOL, V32, P284, DOI 10.1038/sj.npp.1301093
   Rasmussen DD, 2001, J PINEAL RES, V31, P89, DOI 10.1034/j.1600-079X.2001.310113.x
   Ríos-Lugo MJ, 2010, J PINEAL RES, V49, P342, DOI 10.1111/j.1600-079X.2010.00798.x
   Rondanelli M, 2019, GERIATRICS-BASEL, V4, DOI 10.3390/geriatrics4010004
   Santana-Santos L, 2008, GENET MOL RES, V7, P839, DOI 10.4238/vol7-3X-Meeting002
   Szewczyk-Golec K, 2015, J PINEAL RES, V59, P277, DOI 10.1111/jpi.12257
   Tamura H, 2008, J PINEAL RES, V45, P101, DOI 10.1111/j.1600-079X.2008.00561.x
   Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X
   Tamura H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031135
   Tamura H, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12381
   Tamura H, 2014, J OBSTET GYNAECOL RE, V40, P1, DOI 10.1111/jog.12177
   Tamura H, 2013, ENDOCR J, V60, P1
   Tamura H, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-5
   Tamura H, 2009, FERTIL STERIL, V92, P328, DOI 10.1016/j.fertnstert.2008.05.016
   Tan DX, 2011, OBES REV, V12, P167, DOI 10.1111/j.1467-789X.2010.00756.x
   Walecka-Kapica E, 2014, MENOPAUSE REV, V13, P334, DOI 10.5114/pm.2014.47986
   Wane S, 2010, J WOMENS HEALTH, V19, P1327, DOI 10.1089/jwh.2009.1738
   Wang YF, 2012, INT REV PSYCHIATR, V24, P176, DOI 10.3109/09540261.2012.688195
   Wolden-Hanson T, 2000, ENDOCRINOLOGY, V141, P487, DOI 10.1210/en.141.2.487
NR 62
TC 4
Z9 5
U1 1
U2 8
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 0022-0795
EI 1479-6805
J9 J ENDOCRINOL
JI J. Endocrinol.
PD OCT
PY 2021
VL 251
IS 1
BP 15
EP 25
DI 10.1530/JOE-20-0462
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA UN1DC
UT WOS:000693760900002
PM 34156346
OA Bronze
DA 2024-02-19
ER

PT J
AU Woudstra, TD
   Dirozdowski, LA
   Wild, GE
   Clandinin, MT
   Agellon, LB
   Thomson, ABR
AF Woudstra, TD
   Dirozdowski, LA
   Wild, GE
   Clandinin, MT
   Agellon, LB
   Thomson, ABR
TI An isocaloric PUFA diet enhances lipid uptake and weight gain in aging
   rats
SO LIPIDS
LA English
DT Article
ID ACID-BINDING PROTEIN; PROLIFERATOR-ACTIVATED RECEPTORS; FATTY-ACID;
   INTESTINAL MORPHOLOGY; TRANSPORT PROTEIN; GAMMA ACTIVATORS; PPAR-ALPHA;
   ABSORPTION; EXPRESSION; JEJUNUM
AB Aging is associated with a change in the morphology and absorptive capacity of the small intestine. In young rats, feeding a semisynthetic diet containing saturated FA (SFA) increases nutrient uptake, as compared with an isocaloric diet containing polyunsaturated FA (PUFA). We tested the hypotheses that (i) aging is associated with a decline in lipid absorption in the Fischer 344 rat; (ii) this decline can be corrected by manipulating the fat composition of the diet; and (iii) the age- and diet-associated variations in lipid uptake are associated with changes in the ileal lipid-binding protein (ILBP) or the intestinal or liver FA-binding proteins (I- or L-FABP, respectively) in the cytosol of the enterocyte. In rats fed SFA or PUFA, aging was associated with a decline in the in vitro uptake of stearic acid (18:0) when expressed on the basis of intestinal or mucosal weight. In contrast, age had no effect on lipid uptake when expressed on the basis of serosal surface area, whereas lipid uptake increased with age when expressed on the basis of mucosal surface area. The age-associated variations in lipid uptake were not associated with changes in protein abundance and/or expression of ILBP, I-FABP, or L-FABP. In 24-mon-old rats, when uptake of lipids was expressed on the basis of mucosal surface area, feeding PUFA enhanced lipid uptake and body weight gain as compared with rats fed SFA. Future studies must determine whether the enhanced lipid uptake and body weight gain observed in older animals fed PUFA have any therapeutic benefit.
C1 Univ Alberta, Dept Med, Div Gastroenterol, Nutr & Metab Grp, Edmonton, AB T6G 2C8, Canada.
   McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2T5, Canada.
C3 University of Alberta; McGill University
RP Thomson, ABR (corresponding author), Univ Alberta, Dept Med, Div Gastroenterol, Nutr & Metab Grp, 205 Coll Plaza, Edmonton, AB T6G 2C8, Canada.
EM alan.thomson@ualberta.ca
CR ABUMRAD NA, 1984, J BIOL CHEM, V259, P8945
   Agellon LB, 2002, MOL CELL BIOCHEM, V239, P79, DOI 10.1023/A:1020520521025
   BASS NM, 1985, J BIOL CHEM, V260, P1432
   CHEN TS, 1990, J GERONTOL, V45, P129
   Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   *DIV AG SEN HLTH C, 2002, CAN AG POP
   ECKNAUER R, 1982, J GERONTOL, V37, P151, DOI 10.1093/geronj/37.2.151
   FERRARIS RP, 1993, J NUTR, V123, P502, DOI 10.1093/jn/123.3.502
   FERRARIS RP, 1989, ANNU REV PHYSIOL, V51, P125, DOI 10.1146/annurev.ph.51.030189.001013
   FERRARIS RP, 1997, FRONT BIOSCI, V2, P108
   Hallden G, 1997, J BIOL CHEM, V272, P12591, DOI 10.1074/jbc.272.19.12591
   HALTER JB, 1999, PRINCIPLES GERIATRIC, P991
   HIGGINS CF, 1994, CELL, V79, P393, DOI 10.1016/0092-8674(94)90248-8
   HOLT PR, 1993, AM J PHYSIOL, V264, pG1, DOI 10.1152/ajpgi.1993.264.1.G1
   Hsu KT, 1996, J BIOL CHEM, V271, P13317, DOI 10.1074/jbc.271.23.13317
   Ikuma M, 1996, BBA-BIOMEMBRANES, V1280, P19, DOI 10.1016/0005-2736(95)00261-8
   KEELAN M, 1985, CAN J PHYSIOL PHARM, V63, P1312, DOI 10.1139/y85-217
   KEELAN M, 1986, RADIAT RES, V105, P84, DOI 10.2307/3576728
   KEELAN M, 2001, HDB NUTR AGED, P275
   Kramer W, 1998, BIOCHEM J, V333, P335, DOI 10.1042/bj3330335
   Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779
   LIN MC, 1991, BIOCHIM BIOPHYS ACTA, V1078, P329, DOI 10.1016/0167-4838(91)90152-P
   LUKIE BE, 1974, GASTROENTEROLOGY, V67, P652
   Mansbach CM, 2000, J LIPID RES, V41, P605
   Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210
   Morley JE, 1999, CLIN GERIATR MED, V15, P211
   Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710
   Motojima K, 2000, INT J BIOCHEM CELL B, V32, P1085, DOI 10.1016/S1357-2725(00)00046-7
   Peachey SE, 1999, GROWTH DEVELOP AGING, V63, P61
   Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x
   Scopacasa F, 2004, EUR J CLIN NUTR, V58, P264, DOI 10.1038/sj.ejcn.1601777
   SHIAU YF, 1990, J PHYSIOL-LONDON, V421, P463, DOI 10.1113/jphysiol.1990.sp017955
   Sprott Richard L., 1997, ILAR J, V38, P104
   Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9
   Teboul L, 2001, BIOCHEM J, V360, P305, DOI 10.1042/0264-6021:3600305
   THOMSON ABR, 1986, J CLIN INVEST, V77, P279, DOI 10.1172/JCI112288
   THOMSON ABR, 1980, AM J PHYSIOL, V239, pG363, DOI 10.1152/ajpgi.1980.239.5.G363
   THOMSON ABR, 1987, BIOCHIM BIOPHYS ACTA, V905, P426, DOI 10.1016/0005-2736(87)90472-X
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   Umezawa M, 2000, J NUTR, V130, P221, DOI 10.1093/jn/130.2.221
   Vassileva G, 2000, FASEB J, V14, P2040, DOI 10.1096/fj.99-0959com
   WAHNON R, 1989, MECH AGEING DEV, V50, P249, DOI 10.1016/0047-6374(89)90103-6
   WESTERGAARD H, 1976, J CLIN INVEST, V58, P97, DOI 10.1172/JCI108465
   WOUDSTRA T, 2002, THESIS U ALBERTA EDM
NR 45
TC 10
Z9 10
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0024-4201
EI 1558-9307
J9 LIPIDS
JI Lipids
PD APR
PY 2004
VL 39
IS 4
BP 343
EP 354
DI 10.1007/s11745-004-1238-y
PG 12
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 842OB
UT WOS:000223012600006
PM 15357022
DA 2024-02-19
ER

EF